white f 41 $nan$hematology blood hematocrit  30.3  %; hematology blood hemoglobin  10.4  g dl; hematology blood platelet count  187  k ul; chemistry blood anion gap  10  meq l; chemistry blood bicarbonate  24  meq l; chemistry blood chloride  112  meq l; chemistry blood creatinine  0.7  mg dl; chemistry blood potassium  4.0  meq l; chemistry blood sodium  142  meq l; chemistry blood urea nitrogen  7  mg dl; chemistry blood glucose  75  mg dl$clonazepam  1  mg ; heparin  5000  unit ; citalopram hydrobromide  20  mg ; nicotine patch  14  mg ; vial  1  vial ; pantoprazole sodium  40  mg ; heparin flush (10 units ml)  2  ml ; acetaminophen  650  mg ; polyethylene glycol  17  g ; metoclopramide  10  mg ; bisacodyl  10  mg ; diazepam  5  mg ; prochlorperazine  5-10  mg ; 
ventral, unspecified, hernia without mention of obstruction or gangrene bariatric surgery status acute pancreatitis 
white f 41 $nan$hematology blood hematocrit  29.4  %; hematology blood hemoglobin  10.2  g dl; hematology blood platelet count  181  k ul; chemistry blood anion gap  9  meq l; chemistry blood bicarbonate  25  meq l; chemistry blood chloride  111  meq l; chemistry blood creatinine  0.7  mg dl; chemistry blood potassium  4.0  meq l; chemistry blood sodium  141  meq l; chemistry blood urea nitrogen  8  mg dl; chemistry blood calcium, total  7.9  mg dl; chemistry blood glucose  77  mg dl; chemistry blood albumin  3.1  g dl$heparin  5000  unit ; citalopram hydrobromide  20  mg ; nicotine patch  14  mg ; vial  1  vial ; pantoprazole sodium  40  mg ; heparin flush (10 units ml)  2  ml ; metoclopramide  10  mg ; bisacodyl  10  mg ; diazepam  5  mg ; prochlorperazine  5-10  mg ; lorazepam  1  mg ; 
ventral, unspecified, hernia without mention of obstruction or gangrene bariatric surgery status acute pancreatitis 
white f 41 $nan$hematology blood hematocrit  32.5  %; hematology blood hemoglobin  11.1  g dl; hematology blood platelet count  192  k ul; chemistry blood anion gap  12  meq l; chemistry blood bicarbonate  25  meq l; chemistry blood chloride  110  meq l; chemistry blood creatinine  0.7  mg dl; chemistry blood potassium  4.1  meq l; chemistry blood sodium  143  meq l; chemistry blood urea nitrogen  14  mg dl; chemistry blood calcium, total  8.1  mg dl; chemistry blood glucose  105  mg dl$heparin  5000  unit ; citalopram hydrobromide  20  mg ; nicotine patch  14  mg ; heparin flush (10 units ml)  2  ml ; metoclopramide  10  mg ; bisacodyl  10  mg ; diazepam  5  mg ; lorazepam  1  mg ; hydromorphone (dilaudid)  3  mg ; prochlorperazine  25  mg ; 
ventral, unspecified, hernia without mention of obstruction or gangrene bariatric surgery status acute pancreatitis 
white f 41 $nan$chemistry blood anion gap  8  meq l; chemistry blood bicarbonate  26  meq l; chemistry blood chloride  111  meq l; chemistry blood creatinine  0.6  mg dl; chemistry blood potassium  4.0  meq l; chemistry blood sodium  141  meq l; chemistry blood urea nitrogen  14  mg dl; chemistry blood calcium, total  8.1  mg dl; chemistry blood glucose  94  mg dl$heparin  5000  unit ; citalopram hydrobromide  20  mg ; nicotine patch  14  mg ; heparin flush (10 units ml)  2  ml ; metoclopramide  10  mg ; bisacodyl  10  mg ; diazepam  5  mg ; lorazepam  1  mg ; hydromorphone (dilaudid)  3  mg ; prochlorperazine  25  mg ; hydromorphone (dilaudid)  1  mg ; 5% dextrose  100  ml ; ciprofloxacin iv  200  mg ; 
ventral, unspecified, hernia without mention of obstruction or gangrene bariatric surgery status acute pancreatitis 
white f 41 $nan$hematology blood hematocrit  30.8  %; hematology blood hematocrit  28  %; hematology blood hemoglobin  9.2  g dl; hematology blood hemoglobin  10.8  g dl; hematology blood platelet count  175  k ul; hematology blood platelet count  193  k ul; chemistry blood anion gap  11  meq l; chemistry blood bicarbonate  25  meq l; chemistry blood chloride  109  meq l; chemistry blood creatinine  0.7  mg dl; chemistry blood potassium  3.8  meq l; chemistry blood sodium  141  meq l; chemistry blood urea nitrogen  15  mg dl; chemistry blood calcium, total  8.3  mg dl; chemistry blood glucose  81  mg dl$heparin  5000  unit ; citalopram hydrobromide  20  mg ; nicotine patch  14  mg ; heparin flush (10 units ml)  2  ml ; metoclopramide  10  mg ; bisacodyl  10  mg ; lorazepam  1  mg ; prochlorperazine  25  mg ; hydromorphone (dilaudid)  1  mg ; 5% dextrose  100  ml ; ciprofloxacin iv  200  mg ; enoxaparin sodium  40  mg ; 
ventral, unspecified, hernia without mention of obstruction or gangrene bariatric surgery status acute pancreatitis 
white f 41 $nan$hematology blood hematocrit  29.7  %; hematology blood hemoglobin  10.3  g dl; hematology blood platelet count  168  k ul; chemistry blood anion gap  9  meq l; chemistry blood bicarbonate  27  meq l; chemistry blood chloride  109  meq l; chemistry blood creatinine  0.7  mg dl; chemistry blood potassium  4.1  meq l; chemistry blood sodium  141  meq l; chemistry blood urea nitrogen  19  mg dl; chemistry blood calcium, total  8.3  mg dl; chemistry blood glucose  88  mg dl$citalopram hydrobromide  20  mg ; nicotine patch  14  mg ; heparin flush (10 units ml)  2  ml ; metoclopramide  10  mg ; bisacodyl  10  mg ; lorazepam  1  mg ; prochlorperazine  25  mg ; 5% dextrose  100  ml ; ciprofloxacin iv  200  mg ; enoxaparin sodium  40  mg ; ciprofloxacin hcl  500  mg ; hydromorphone (dilaudid)  8  mg ; 
ventral, unspecified, hernia without mention of obstruction or gangrene bariatric surgery status acute pancreatitis 
white m 72 $nan$nan$finasteride  5  mg ; multivitamins  1  tab ; 
unspecified essential hypertension surgical operation with anastomosis, bypass, or graft, with natural or artificial tissues used as implant causing abnormal patient reaction, or later complication, without mention of misadventure at time of operation fever, unspecified digestive system complications, not elsewhere classified esophageal reflux hypertrophy (benign) of prostate without urinary obstruction and other lower urinary tract symptom (luts) obstruction of bile duct chronic airway obstruction, not elsewhere classified personal history of malignant neoplasm of other gastrointestinal tract esophageal reflux surgical operation with anastomosis, bypass, or graft, with natural or artificial tissues used as implant causing abnormal patient reaction, or later complication, without mention of misadventure at time of operation mechanical complication due to other implant and internal device, not elsewhere classified passenger of special construction vehicle injured in traffic accident cachexia digestive system complications, not elsewhere classified body mass index between 19-24, adult chronic airway obstruction, not elsewhere classified hypertrophy (benign) of prostate without urinary obstruction and other lower urinary tract symptom (luts) personal history of malignant neoplasm of other gastrointestinal tract hypertrophy (benign) of prostate without urinary obstruction and other lower urinary tract symptom (luts) esophageal reflux surgical operation with anastomosis, bypass, or graft, with natural or artificial tissues used as implant causing abnormal patient reaction, or later complication, without mention of misadventure at time of operation digestive system complications, not elsewhere classified driver of special construction vehicle injured in traffic accident unspecified essential hypertension mechanical complication due to other implant and internal device, not elsewhere classified unspecified protein-calorie malnutrition chronic airway obstruction, not elsewhere classified body mass index less than 19, adult personal history of malignant neoplasm of other gastrointestinal tract esophageal reflux malignant neoplasm of extrahepatic bile ducts digestive system complications, not elsewhere classified chronic airway obstruction, not elsewhere classified mechanical complication due to other implant and internal device, not elsewhere classified hypertrophy (benign) of prostate without urinary obstruction and other lower urinary tract symptom (luts) unspecified essential hypertension personal history of malignant neoplasm of other gastrointestinal tract other specified surgical operations and procedures causing abnormal patient reaction, or later complication, without mention of misadventure at time of operation mechanical complication due to other implant and internal device, not elsewhere classified peritoneal abscess bacteremia digestive system complications, not elsewhere classified hypertrophy (benign) of prostate without urinary obstruction and other lower urinary tract symptom (luts) heparin-induced thrombocytopenia (hit) surgical operation with anastomosis, bypass, or graft, with natural or artificial tissues used as implant causing abnormal patient reaction, or later complication, without mention of misadventure at time of operation chronic airway obstruction, not elsewhere classified unspecified essential hypertension
white m 72 $nan$hematology blood hematocrit  30.0  %; hematology blood hemoglobin  9.9  g dl; hematology blood platelet count  189  k ul; chemistry blood anion gap  13  meq l; chemistry blood bicarbonate  22  meq l; chemistry blood chloride  106  meq l; chemistry blood creatinine  0.7  mg dl; chemistry blood potassium  3.6  meq l; chemistry blood sodium  137  meq l; chemistry blood urea nitrogen  7  mg dl; chemistry blood calcium, total  8.6  mg dl; chemistry blood bilirubin, total  3.5  mg dl; chemistry blood glucose  112  mg dl$finasteride  5  mg ; multivitamins  1  tab ; sodium chloride 0.9%  flush  3  ml ; pantoprazole  40  mg ; ursodiol  300  mg ; d5 1 2ns  1000  ml ; 0.9% sodium chloride (mini bag plus)  100  ml ; ampicillin-sulbactam  3  g ; megestrol acetate  40  mg ; megestrol acetate  400  mg ; 
unspecified essential hypertension surgical operation with anastomosis, bypass, or graft, with natural or artificial tissues used as implant causing abnormal patient reaction, or later complication, without mention of misadventure at time of operation fever, unspecified digestive system complications, not elsewhere classified esophageal reflux hypertrophy (benign) of prostate without urinary obstruction and other lower urinary tract symptom (luts) obstruction of bile duct chronic airway obstruction, not elsewhere classified personal history of malignant neoplasm of other gastrointestinal tract esophageal reflux surgical operation with anastomosis, bypass, or graft, with natural or artificial tissues used as implant causing abnormal patient reaction, or later complication, without mention of misadventure at time of operation mechanical complication due to other implant and internal device, not elsewhere classified passenger of special construction vehicle injured in traffic accident cachexia digestive system complications, not elsewhere classified body mass index between 19-24, adult chronic airway obstruction, not elsewhere classified hypertrophy (benign) of prostate without urinary obstruction and other lower urinary tract symptom (luts) personal history of malignant neoplasm of other gastrointestinal tract hypertrophy (benign) of prostate without urinary obstruction and other lower urinary tract symptom (luts) esophageal reflux surgical operation with anastomosis, bypass, or graft, with natural or artificial tissues used as implant causing abnormal patient reaction, or later complication, without mention of misadventure at time of operation digestive system complications, not elsewhere classified driver of special construction vehicle injured in traffic accident unspecified essential hypertension mechanical complication due to other implant and internal device, not elsewhere classified unspecified protein-calorie malnutrition chronic airway obstruction, not elsewhere classified body mass index less than 19, adult personal history of malignant neoplasm of other gastrointestinal tract esophageal reflux malignant neoplasm of extrahepatic bile ducts digestive system complications, not elsewhere classified chronic airway obstruction, not elsewhere classified mechanical complication due to other implant and internal device, not elsewhere classified hypertrophy (benign) of prostate without urinary obstruction and other lower urinary tract symptom (luts) unspecified essential hypertension personal history of malignant neoplasm of other gastrointestinal tract other specified surgical operations and procedures causing abnormal patient reaction, or later complication, without mention of misadventure at time of operation mechanical complication due to other implant and internal device, not elsewhere classified peritoneal abscess bacteremia digestive system complications, not elsewhere classified hypertrophy (benign) of prostate without urinary obstruction and other lower urinary tract symptom (luts) heparin-induced thrombocytopenia (hit) surgical operation with anastomosis, bypass, or graft, with natural or artificial tissues used as implant causing abnormal patient reaction, or later complication, without mention of misadventure at time of operation chronic airway obstruction, not elsewhere classified unspecified essential hypertension
white m 72 $nan$hematology blood hematocrit  29.7  %; hematology blood hemoglobin  10.0  g dl; hematology blood platelet count  164  k ul; chemistry blood anion gap  11  meq l; chemistry blood bicarbonate  23  meq l; chemistry blood chloride  106  meq l; chemistry blood creatinine  0.7  mg dl; chemistry blood potassium  3.8  meq l; chemistry blood sodium  136  meq l; chemistry blood urea nitrogen  8  mg dl; chemistry blood bilirubin, total  3.0  mg dl; chemistry blood glucose  116  mg dl; chemistry blood albumin  3.0  g dl$finasteride  5  mg ; multivitamins  1  tab ; sodium chloride 0.9%  flush  3  ml ; pantoprazole  40  mg ; ursodiol  300  mg ; 0.9% sodium chloride (mini bag plus)  100  ml ; ampicillin-sulbactam  3  g ; megestrol acetate  400  mg ; 
unspecified essential hypertension surgical operation with anastomosis, bypass, or graft, with natural or artificial tissues used as implant causing abnormal patient reaction, or later complication, without mention of misadventure at time of operation fever, unspecified digestive system complications, not elsewhere classified esophageal reflux hypertrophy (benign) of prostate without urinary obstruction and other lower urinary tract symptom (luts) obstruction of bile duct chronic airway obstruction, not elsewhere classified personal history of malignant neoplasm of other gastrointestinal tract esophageal reflux surgical operation with anastomosis, bypass, or graft, with natural or artificial tissues used as implant causing abnormal patient reaction, or later complication, without mention of misadventure at time of operation mechanical complication due to other implant and internal device, not elsewhere classified passenger of special construction vehicle injured in traffic accident cachexia digestive system complications, not elsewhere classified body mass index between 19-24, adult chronic airway obstruction, not elsewhere classified hypertrophy (benign) of prostate without urinary obstruction and other lower urinary tract symptom (luts) personal history of malignant neoplasm of other gastrointestinal tract hypertrophy (benign) of prostate without urinary obstruction and other lower urinary tract symptom (luts) esophageal reflux surgical operation with anastomosis, bypass, or graft, with natural or artificial tissues used as implant causing abnormal patient reaction, or later complication, without mention of misadventure at time of operation digestive system complications, not elsewhere classified driver of special construction vehicle injured in traffic accident unspecified essential hypertension mechanical complication due to other implant and internal device, not elsewhere classified unspecified protein-calorie malnutrition chronic airway obstruction, not elsewhere classified body mass index less than 19, adult personal history of malignant neoplasm of other gastrointestinal tract esophageal reflux malignant neoplasm of extrahepatic bile ducts digestive system complications, not elsewhere classified chronic airway obstruction, not elsewhere classified mechanical complication due to other implant and internal device, not elsewhere classified hypertrophy (benign) of prostate without urinary obstruction and other lower urinary tract symptom (luts) unspecified essential hypertension personal history of malignant neoplasm of other gastrointestinal tract other specified surgical operations and procedures causing abnormal patient reaction, or later complication, without mention of misadventure at time of operation mechanical complication due to other implant and internal device, not elsewhere classified peritoneal abscess bacteremia digestive system complications, not elsewhere classified hypertrophy (benign) of prostate without urinary obstruction and other lower urinary tract symptom (luts) heparin-induced thrombocytopenia (hit) surgical operation with anastomosis, bypass, or graft, with natural or artificial tissues used as implant causing abnormal patient reaction, or later complication, without mention of misadventure at time of operation chronic airway obstruction, not elsewhere classified unspecified essential hypertension
white m 72 $nan$nan$finasteride  5  mg ; multivitamins  1  tab ; sodium chloride 0.9%  flush  3  ml ; pantoprazole  40  mg ; ursodiol  300  mg ; 0.9% sodium chloride (mini bag plus)  100  ml ; ampicillin-sulbactam  3  g ; 
unspecified essential hypertension surgical operation with anastomosis, bypass, or graft, with natural or artificial tissues used as implant causing abnormal patient reaction, or later complication, without mention of misadventure at time of operation fever, unspecified digestive system complications, not elsewhere classified esophageal reflux hypertrophy (benign) of prostate without urinary obstruction and other lower urinary tract symptom (luts) obstruction of bile duct chronic airway obstruction, not elsewhere classified personal history of malignant neoplasm of other gastrointestinal tract esophageal reflux surgical operation with anastomosis, bypass, or graft, with natural or artificial tissues used as implant causing abnormal patient reaction, or later complication, without mention of misadventure at time of operation mechanical complication due to other implant and internal device, not elsewhere classified passenger of special construction vehicle injured in traffic accident cachexia digestive system complications, not elsewhere classified body mass index between 19-24, adult chronic airway obstruction, not elsewhere classified hypertrophy (benign) of prostate without urinary obstruction and other lower urinary tract symptom (luts) personal history of malignant neoplasm of other gastrointestinal tract hypertrophy (benign) of prostate without urinary obstruction and other lower urinary tract symptom (luts) esophageal reflux surgical operation with anastomosis, bypass, or graft, with natural or artificial tissues used as implant causing abnormal patient reaction, or later complication, without mention of misadventure at time of operation digestive system complications, not elsewhere classified driver of special construction vehicle injured in traffic accident unspecified essential hypertension mechanical complication due to other implant and internal device, not elsewhere classified unspecified protein-calorie malnutrition chronic airway obstruction, not elsewhere classified body mass index less than 19, adult personal history of malignant neoplasm of other gastrointestinal tract esophageal reflux malignant neoplasm of extrahepatic bile ducts digestive system complications, not elsewhere classified chronic airway obstruction, not elsewhere classified mechanical complication due to other implant and internal device, not elsewhere classified hypertrophy (benign) of prostate without urinary obstruction and other lower urinary tract symptom (luts) unspecified essential hypertension personal history of malignant neoplasm of other gastrointestinal tract other specified surgical operations and procedures causing abnormal patient reaction, or later complication, without mention of misadventure at time of operation mechanical complication due to other implant and internal device, not elsewhere classified peritoneal abscess bacteremia digestive system complications, not elsewhere classified hypertrophy (benign) of prostate without urinary obstruction and other lower urinary tract symptom (luts) heparin-induced thrombocytopenia (hit) surgical operation with anastomosis, bypass, or graft, with natural or artificial tissues used as implant causing abnormal patient reaction, or later complication, without mention of misadventure at time of operation chronic airway obstruction, not elsewhere classified unspecified essential hypertension
white f 72 $nan$hematology blood hematocrit  40.3  %; hematology blood hemoglobin  13.3  g dl; hematology blood platelet count  152  k ul; chemistry blood anion gap  14  meq l; chemistry blood bicarbonate  24  meq l; chemistry blood chloride  102  meq l; chemistry blood creatinine  0.6  mg dl; chemistry blood potassium  4.2  meq l; chemistry blood sodium  136  meq l; chemistry blood urea nitrogen  9  mg dl; hematology blood inr(pt)  1.0  ; chemistry blood calcium, total  8.9  mg dl; chemistry blood bilirubin, total  0.7  mg dl; chemistry blood glucose  202  mg dl; chemistry blood lactate dehydrogenase (ld)  174  iu l; chemistry blood albumin  3.4  g dl; blood gas blood potassium, whole blood  4.0  meq l$sodium chloride 0.9%  flush  3  ml ; heparin  5000  unit ; sodium chloride 0.9%  1000  ml ; acetaminophen  650  mg ; aspirin  81  mg ; lorazepam  0.5  mg ; metoprolol tartrate  25  mg ; simvastatin  40  mg ; vitamin d  4000  unit ; dextrose 50%  12.5  gm ; glucagon  1  mg ; glucose gel  15  g ; ondansetron  4-8  mg ; insulin  0  unit ; levothyroxine sodium  112  mcg ; omeprazole  20  mg ; paroxetine  20  mg ; 
diabetes mellitus without mention of complication, type ii or unspecified type, not stated as uncontrolled malignant neoplasm of thyroid gland other and unspecified hyperlipidemia dysthymic disorder unspecified essential hypertension malignant neoplasm of thyroid gland diabetes mellitus without mention of complication, type ii or unspecified type, not stated as uncontrolled 
white f 72 $nan$hematology blood hematocrit  37.8  %; hematology blood hemoglobin  12.5  g dl; hematology blood platelet count  143  k ul; chemistry blood anion gap  11  meq l; chemistry blood bicarbonate  27  meq l; chemistry blood chloride  100  meq l; chemistry blood creatinine  0.6  mg dl; chemistry blood potassium  3.9  meq l; chemistry blood sodium  134  meq l; chemistry blood urea nitrogen  7  mg dl; hematology blood inr(pt)  1.0  ; chemistry blood calcium, total  9.1  mg dl; chemistry blood bilirubin, total  0.5  mg dl; chemistry blood glucose  245  mg dl; chemistry blood lactate dehydrogenase (ld)  157  iu l; chemistry blood albumin  3.3  g dl$sodium chloride 0.9%  flush  3  ml ; heparin  5000  unit ; acetaminophen  650  mg ; aspirin  81  mg ; lorazepam  0.5  mg ; metoprolol tartrate  25  mg ; simvastatin  40  mg ; vitamin d  4000  unit ; dextrose 50%  12.5  gm ; glucagon  1  mg ; glucose gel  15  g ; ondansetron  4-8  mg ; insulin  0  unit ; levothyroxine sodium  112  mcg ; omeprazole  20  mg ; paroxetine  20  mg ; lisinopril  10  mg ; 
diabetes mellitus without mention of complication, type ii or unspecified type, not stated as uncontrolled malignant neoplasm of thyroid gland other and unspecified hyperlipidemia dysthymic disorder unspecified essential hypertension malignant neoplasm of thyroid gland diabetes mellitus without mention of complication, type ii or unspecified type, not stated as uncontrolled 
white f 72 $nan$nan$sodium chloride 0.9%  flush  3  ml ; heparin  5000  unit ; acetaminophen  650  mg ; aspirin  81  mg ; lorazepam  0.5  mg ; metoprolol tartrate  25  mg ; simvastatin  40  mg ; vitamin d  4000  unit ; dextrose 50%  12.5  gm ; glucagon  1  mg ; glucose gel  15  g ; ondansetron  4-8  mg ; insulin  0  unit ; levothyroxine sodium  112  mcg ; omeprazole  20  mg ; paroxetine  20  mg ; 
diabetes mellitus without mention of complication, type ii or unspecified type, not stated as uncontrolled malignant neoplasm of thyroid gland other and unspecified hyperlipidemia dysthymic disorder unspecified essential hypertension malignant neoplasm of thyroid gland diabetes mellitus without mention of complication, type ii or unspecified type, not stated as uncontrolled 
white m 64 $nan$nan$insulin  84  unit ; insulin  10  unit ; omeprazole  20  mg ; aspirin  325  mg ; vitamin d  1000  unit ; multivitamins  1  tab ; atenolol  100  mg ; rosuvastatin calcium  20  mg ; isosorbide mononitrate (extended release)  240  mg ; namenda  5  mg ; amlodipine  10  mg ; prazosin  3  mg ; furosemide  10  mg ; insulin  15  unit ; insulin  30  unit ; 
hypertensive chronic kidney disease, unspecified, with chronic kidney disease stage i through stage iv, or unspecified esophageal reflux dementia in conditions classified elsewhere without behavioral disturbance chronic kidney disease, unspecified dizziness and giddiness delirium due to conditions classified elsewhere other and unspecified hyperlipidemia diabetes mellitus without mention of complication, type ii or unspecified type, not stated as uncontrolled personal history of malignant neoplasm of prostate dementia with lewy bodies obstructive sleep apnea (adult)(pediatric) asthma, unspecified type, unspecified other and unspecified angina pectoris long-term (current) use of insulin diabetes with neurological manifestations, type ii or unspecified type, not stated as uncontrolled other specified cardiac dysrhythmias polyneuropathy in diabetes personal history of malignant neoplasm of prostate coronary atherosclerosis of native coronary artery other persistent mental disorders due to conditions classified elsewhere major depressive affective disorder, single episode, unspecified unspecified essential hypertension posttraumatic stress disorder acute kidney failure, unspecified other and unspecified hyperlipidemia esophageal reflux obstructive sleep apnea (adult)(pediatric) chronic airway obstruction, not elsewhere classified
white m 64 $nan$chemistry blood anion gap  11  meq l; chemistry blood bicarbonate  33  meq l; chemistry blood chloride  102  meq l; chemistry blood creatinine  1.1  mg dl; chemistry blood potassium  4.5  meq l; chemistry blood sodium  141  meq l; chemistry blood urea nitrogen  20  mg dl; chemistry blood calcium, total  9.4  mg dl; chemistry blood glucose  144  mg dl$insulin  84  unit ; insulin  10  unit ; omeprazole  20  mg ; aspirin  325  mg ; vitamin d  1000  unit ; multivitamins  1  tab ; atenolol  100  mg ; rosuvastatin calcium  20  mg ; isosorbide mononitrate (extended release)  240  mg ; namenda  5  mg ; amlodipine  10  mg ; prazosin  3  mg ; furosemide  10  mg ; insulin  15  unit ; insulin  30  unit ; clonazepam  1  mg ; fish oil (omega 3)  1000  mg ; venlafaxine  75  mg ; influenza virus vaccine  0.5  ml ; sodium chloride 0.9%  flush  3  ml ; gabapentin  600  mg ; acetaminophen  650  mg ; dextrose 50%  12.5  gm ; glucagon  1  mg ; guaifenesin-codeine phosphate  5-10  ml ; insulin  0  unit ; hydralazine  25  mg ; mirapex  0.125  mg ; quetiapine fumarate  25  mg ; trazodone  25  mg ; albuterol 0.083% neb soln  1  neb ; 
hypertensive chronic kidney disease, unspecified, with chronic kidney disease stage i through stage iv, or unspecified esophageal reflux dementia in conditions classified elsewhere without behavioral disturbance chronic kidney disease, unspecified dizziness and giddiness delirium due to conditions classified elsewhere other and unspecified hyperlipidemia diabetes mellitus without mention of complication, type ii or unspecified type, not stated as uncontrolled personal history of malignant neoplasm of prostate dementia with lewy bodies obstructive sleep apnea (adult)(pediatric) asthma, unspecified type, unspecified other and unspecified angina pectoris long-term (current) use of insulin diabetes with neurological manifestations, type ii or unspecified type, not stated as uncontrolled other specified cardiac dysrhythmias polyneuropathy in diabetes personal history of malignant neoplasm of prostate coronary atherosclerosis of native coronary artery other persistent mental disorders due to conditions classified elsewhere major depressive affective disorder, single episode, unspecified unspecified essential hypertension posttraumatic stress disorder acute kidney failure, unspecified other and unspecified hyperlipidemia esophageal reflux obstructive sleep apnea (adult)(pediatric) chronic airway obstruction, not elsewhere classified
white m 64 $nan$nan$insulin  84  unit ; insulin  10  unit ; omeprazole  20  mg ; aspirin  325  mg ; vitamin d  1000  unit ; multivitamins  1  tab ; atenolol  100  mg ; rosuvastatin calcium  20  mg ; isosorbide mononitrate (extended release)  240  mg ; namenda  5  mg ; amlodipine  10  mg ; prazosin  3  mg ; furosemide  10  mg ; insulin  15  unit ; insulin  30  unit ; clonazepam  1  mg ; fish oil (omega 3)  1000  mg ; venlafaxine  75  mg ; influenza virus vaccine  0.5  ml ; sodium chloride 0.9%  flush  3  ml ; acetaminophen  650  mg ; dextrose 50%  12.5  gm ; glucagon  1  mg ; guaifenesin-codeine phosphate  5-10  ml ; insulin  0  unit ; hydralazine  25  mg ; mirapex  0.125  mg ; quetiapine fumarate  25  mg ; albuterol 0.083% neb soln  1  neb ; gabapentin  900  mg ; trazodone  250  mg ; 
hypertensive chronic kidney disease, unspecified, with chronic kidney disease stage i through stage iv, or unspecified esophageal reflux dementia in conditions classified elsewhere without behavioral disturbance chronic kidney disease, unspecified dizziness and giddiness delirium due to conditions classified elsewhere other and unspecified hyperlipidemia diabetes mellitus without mention of complication, type ii or unspecified type, not stated as uncontrolled personal history of malignant neoplasm of prostate dementia with lewy bodies obstructive sleep apnea (adult)(pediatric) asthma, unspecified type, unspecified other and unspecified angina pectoris long-term (current) use of insulin diabetes with neurological manifestations, type ii or unspecified type, not stated as uncontrolled other specified cardiac dysrhythmias polyneuropathy in diabetes personal history of malignant neoplasm of prostate coronary atherosclerosis of native coronary artery other persistent mental disorders due to conditions classified elsewhere major depressive affective disorder, single episode, unspecified unspecified essential hypertension posttraumatic stress disorder acute kidney failure, unspecified other and unspecified hyperlipidemia esophageal reflux obstructive sleep apnea (adult)(pediatric) chronic airway obstruction, not elsewhere classified
white m 81 $nan$chemistry blood creatinine  2.1  mg dl; chemistry blood urea nitrogen  35  mg dl$sodium chloride 0.9%  flush  3-10  ml ; aluminum-magnesium hydrox.-simethicone  30  ml ; ramelteon  8  mg ; acetaminophen  650  mg ; polyethylene glycol  17  g ; senna  8.6  mg ; docusate sodium  100  mg ; albuterol 0.083% neb soln  1  neb ; famotidine  20  mg ; atorvastatin  80  mg ; aspirin  81  mg ; clopidogrel  75  mg ; metoprolol succinate xl  25  mg ; lisinopril  5  mg ; 
chest pain, unspecified old myocardial infarction hypertensive chronic kidney disease with stage 1 through stage 4 chronic kidney disease, or unspecified chronic kidney disease chronic kidney disease, unspecified personal history of nicotine dependence long term (current) use of antithrombotics/antiplatelets conduction disorder, unspecified atherosclerotic heart disease of native coronary artery without angina pectoris presence of coronary angioplasty implant and graft personal history of other malignant neoplasm of kidney anemia, unspecified obstructive sleep apnea (adult) (pediatric) chronic obstructive pulmonary disease, unspecified prediabetes somatization disorder shortness of breath hyperlipidemia, unspecified atrioventricular block, second degree acute kidney failure, unspecified other nonspecific abnormal finding of lung field nausea with vomiting, unspecified chronic kidney disease, unspecified personal history of nicotine dependence other seborrheic keratosis acute kidney failure, unspecified other chronic pain palpitations atrioventricular block, second degree somatoform disorder, unspecified constipation, unspecified anxiety disorder, unspecified non-st elevation (nstemi) myocardial infarction personal history of other malignant neoplasm of kidney hypertensive chronic kidney disease with stage 1 through stage 4 chronic kidney disease, or unspecified chronic kidney disease unspecified symptoms and signs involving cognitive functions and awareness hyperlipidemia, unspecified anemia, unspecified prediabetes insomnia, unspecified other long term (current) drug therapy unspecified hearing loss, unspecified ear ventricular premature depolarization personal history of traumatic brain injury gastritis, unspecified, without bleeding adult failure to thrive acquired absence of kidney chronic obstructive pulmonary disease, unspecified adjustment disorder with depressed mood
white m 60 $nan$hematology blood hematocrit  30.5  %; hematology blood hemoglobin  10.7  g dl; hematology blood platelet count  213  k ul; chemistry blood anion gap  18  meq l; chemistry blood bicarbonate  18  meq l; chemistry blood chloride  110  meq l; chemistry blood creatinine  5.0  mg dl; chemistry blood potassium  5.0  meq l; chemistry blood sodium  141  meq l; chemistry blood urea nitrogen  73  mg dl; hematology blood inr(pt)  13.5  ; chemistry urine chloride, urine  64  meq l; chemistry urine creatinine, urine  45  mg dl; chemistry urine potassium, urine  27  meq l; chemistry urine sodium, urine  65  meq l; chemistry urine urea nitrogen, urine  380  mg dl; chemistry blood calcium, total  8.6  mg dl; chemistry blood bilirubin, total  0.3  mg dl; chemistry blood glucose  125  mg dl; chemistry blood lactate dehydrogenase (ld)  305  iu l; chemistry blood albumin  3.4  g dl$sodium chloride 0.9%  flush  3  ml ; 0.9% sodium chloride  1000  ml ; insulin  20  unit ; aspirin  325  mg ; phytonadione  10  mg ; valsartan  40  mg ; dextrose 50%  12.5  gm ; glucagon  1  mg ; senna  1  tab ; insulin  0  unit ; docusate sodium  100  mg ; 
chronic kidney disease, unspecified aortocoronary bypass status other and unspecified hyperlipidemia diabetes mellitus without mention of complication, type ii or unspecified type, not stated as uncontrolled hypertensive chronic kidney disease, unspecified, with chronic kidney disease stage i through stage iv, or unspecified long-term (current) use of insulin cerebral artery occlusion, unspecified with cerebral infarction coronary atherosclerosis of unspecified type of vessel, native or graft sinoatrial node dysfunction atrial fibrillation long-term (current) use of anticoagulants 
white m 60 $nan$hematology blood hematocrit  30.7  %; hematology blood hemoglobin  10.6  g dl; hematology blood platelet count  252  k ul; chemistry blood anion gap  19  meq l; chemistry blood bicarbonate  18  meq l; chemistry blood chloride  110  meq l; chemistry blood creatinine  4.7  mg dl; chemistry blood potassium  4.8  meq l; chemistry blood sodium  142  meq l; chemistry blood urea nitrogen  72  mg dl; hematology blood inr(pt)  1.6  ; chemistry blood calcium, total  8.1  mg dl; chemistry blood glucose  84  mg dl$sodium chloride 0.9%  flush  3  ml ; 0.9% sodium chloride  1000  ml ; insulin  20  unit ; aspirin  325  mg ; phytonadione  10  mg ; dextrose 50%  12.5  gm ; glucagon  1  mg ; senna  1  tab ; insulin  0  unit ; docusate sodium  100  mg ; heparin  8600  unit ; heparin  2100-4300  unit ; 5% dextrose  250  ml ; heparin sodium  25,000  unit ; 
chronic kidney disease, unspecified aortocoronary bypass status other and unspecified hyperlipidemia diabetes mellitus without mention of complication, type ii or unspecified type, not stated as uncontrolled hypertensive chronic kidney disease, unspecified, with chronic kidney disease stage i through stage iv, or unspecified long-term (current) use of insulin cerebral artery occlusion, unspecified with cerebral infarction coronary atherosclerosis of unspecified type of vessel, native or graft sinoatrial node dysfunction atrial fibrillation long-term (current) use of anticoagulants 
white m 60 $nan$hematology blood hematocrit  30.8  %; hematology blood hemoglobin  10.9  g dl; hematology blood platelet count  244  k ul; chemistry blood anion gap  20  meq l; chemistry blood bicarbonate  18  meq l; chemistry blood chloride  110  meq l; chemistry blood creatinine  4.3  mg dl; chemistry blood potassium  4.7  meq l; chemistry blood sodium  143  meq l; chemistry blood urea nitrogen  67  mg dl; hematology blood inr(pt)  1.3  ; chemistry blood calcium, total  9.0  mg dl; chemistry blood glucose  208  mg dl$sodium chloride 0.9%  flush  3  ml ; insulin  20  unit ; aspirin  325  mg ; dextrose 50%  12.5  gm ; glucagon  1  mg ; senna  1  tab ; insulin  0  unit ; docusate sodium  100  mg ; heparin  8600  unit ; heparin  2100-4300  unit ; 5% dextrose  250  ml ; heparin sodium  25,000  unit ; hydralazine  10  mg ; amlodipine  5  mg ; warfarin  1  mg ; warfarin  2  mg ; 
chronic kidney disease, unspecified aortocoronary bypass status other and unspecified hyperlipidemia diabetes mellitus without mention of complication, type ii or unspecified type, not stated as uncontrolled hypertensive chronic kidney disease, unspecified, with chronic kidney disease stage i through stage iv, or unspecified long-term (current) use of insulin cerebral artery occlusion, unspecified with cerebral infarction coronary atherosclerosis of unspecified type of vessel, native or graft sinoatrial node dysfunction atrial fibrillation long-term (current) use of anticoagulants 
white m 60 $nan$hematology blood hematocrit  32.4  %; hematology blood hemoglobin  11.9  g dl; hematology blood platelet count  253  k ul; chemistry blood anion gap  15  meq l; chemistry blood bicarbonate  21  meq l; chemistry blood chloride  110  meq l; chemistry blood creatinine  4.2  mg dl; chemistry blood potassium  4.5  meq l; chemistry blood sodium  141  meq l; chemistry blood urea nitrogen  59  mg dl; hematology blood inr(pt)  1.2  ; chemistry blood calcium, total  8.9  mg dl; chemistry blood glucose  189  mg dl$sodium chloride 0.9%  flush  3  ml ; insulin  20  unit ; aspirin  325  mg ; dextrose 50%  12.5  gm ; glucagon  1  mg ; senna  1  tab ; insulin  0  unit ; docusate sodium  100  mg ; amlodipine  5  mg ; warfarin  1  mg ; warfarin  2  mg ; amlodipine  10  mg ; iso-osmotic dextrose  200  ml ; vancomycin  1000  mg ; bag  50  ml ; magnesium sulfate  2  gm ; warfarin  5  mg ; hydralazine  25  mg ; trazodone  50  mg ; 
chronic kidney disease, unspecified aortocoronary bypass status other and unspecified hyperlipidemia diabetes mellitus without mention of complication, type ii or unspecified type, not stated as uncontrolled hypertensive chronic kidney disease, unspecified, with chronic kidney disease stage i through stage iv, or unspecified long-term (current) use of insulin cerebral artery occlusion, unspecified with cerebral infarction coronary atherosclerosis of unspecified type of vessel, native or graft sinoatrial node dysfunction atrial fibrillation long-term (current) use of anticoagulants 
white m 60 $nan$hematology blood hematocrit  28.4  %; hematology blood hemoglobin  9.9  g dl; hematology blood platelet count  250  k ul; chemistry blood anion gap  14  meq l; chemistry blood bicarbonate  21  meq l; chemistry blood chloride  111  meq l; chemistry blood creatinine  4.3  mg dl; chemistry blood potassium  4.6  meq l; chemistry blood sodium  141  meq l; chemistry blood urea nitrogen  59  mg dl; hematology blood inr(pt)  1.2  ; chemistry blood calcium, total  8.4  mg dl; chemistry blood glucose  109  mg dl$sodium chloride 0.9%  flush  3  ml ; insulin  20  unit ; aspirin  325  mg ; dextrose 50%  12.5  gm ; glucagon  1  mg ; senna  1  tab ; insulin  0  unit ; docusate sodium  100  mg ; amlodipine  10  mg ; iso-osmotic dextrose  200  ml ; vancomycin  1000  mg ; bag  50  ml ; magnesium sulfate  2  gm ; warfarin  5  mg ; trazodone  50  mg ; oxycodone-acetaminophen  1-2  tab ; trazodone  25  mg ; 
chronic kidney disease, unspecified aortocoronary bypass status other and unspecified hyperlipidemia diabetes mellitus without mention of complication, type ii or unspecified type, not stated as uncontrolled hypertensive chronic kidney disease, unspecified, with chronic kidney disease stage i through stage iv, or unspecified long-term (current) use of insulin cerebral artery occlusion, unspecified with cerebral infarction coronary atherosclerosis of unspecified type of vessel, native or graft sinoatrial node dysfunction atrial fibrillation long-term (current) use of anticoagulants 
white m 60 $nan$hematology blood hematocrit  28.3  %; hematology blood hemoglobin  10.0  g dl; hematology blood platelet count  241  k ul; chemistry blood anion gap  14  meq l; chemistry blood bicarbonate  19  meq l; chemistry blood chloride  113  meq l; chemistry blood creatinine  4.2  mg dl; chemistry blood potassium  4.7  meq l; chemistry blood sodium  141  meq l; chemistry blood urea nitrogen  57  mg dl; hematology blood inr(pt)  1.3  ; chemistry blood calcium, total  8.3  mg dl; chemistry blood glucose  126  mg dl$sodium chloride 0.9%  flush  3  ml ; insulin  20  unit ; aspirin  325  mg ; dextrose 50%  12.5  gm ; glucagon  1  mg ; senna  1  tab ; insulin  0  unit ; docusate sodium  100  mg ; amlodipine  10  mg ; warfarin  5  mg ; oxycodone-acetaminophen  1-2  tab ; trazodone  25  mg ; hydralazine  50  mg ; 
chronic kidney disease, unspecified aortocoronary bypass status other and unspecified hyperlipidemia diabetes mellitus without mention of complication, type ii or unspecified type, not stated as uncontrolled hypertensive chronic kidney disease, unspecified, with chronic kidney disease stage i through stage iv, or unspecified long-term (current) use of insulin cerebral artery occlusion, unspecified with cerebral infarction coronary atherosclerosis of unspecified type of vessel, native or graft sinoatrial node dysfunction atrial fibrillation long-term (current) use of anticoagulants 
black african american m 64 $temp  98.4  heartrate  83.0  resprate  16.0  o2sat  100.0  sbp  134.0  dbp  78.0  rhythm    pain  9  ; temp  100.7  heartrate  86.0  resprate  16.0  o2sat  100.0  sbp  125.0  dbp  66.0  rhythm    pain  9  ; temp  99.6  heartrate    resprate    o2sat    sbp    dbp    rhythm    pain    ; temp  99.4  heartrate    resprate    o2sat    sbp    dbp    rhythm    pain    ; temp  99.3  heartrate  72.0  resprate  18.0  o2sat  99.0  sbp  119.0  dbp  65.0  rhythm    pain  0  $hematology blood hematocrit  39.6  %; hematology blood hemoglobin  12.6  g dl; hematology blood platelet count  182  k ul; chemistry blood anion gap  14  meq l; chemistry blood bicarbonate  28  meq l; chemistry blood chloride  98  meq l; chemistry blood creatinine  1.1  mg dl; chemistry blood potassium  3.7  meq l; chemistry blood sodium  136  meq l; chemistry blood urea nitrogen  13  mg dl; chemistry blood glucose  97  mg dl; blood gas blood lactate  1.6  mmol l$nan
 
white f 75 $temp  98.7  heartrate  101.0  resprate  24.0  o2sat  99.0  sbp  145.0  dbp  72.0  rhythm    pain  0  ; temp  98.6  heartrate  88.0  resprate  21.0  o2sat  99.0  sbp  142.0  dbp  68.0  rhythm    pain  0  ; temp  98.4  heartrate  82.0  resprate  21.0  o2sat  98.0  sbp  137.0  dbp  71.0  rhythm    pain  0  ; temp  98.6  heartrate  77.0  resprate  18.0  o2sat  99.0  sbp  132.0  dbp  69.0  rhythm    pain  0  ; temp  98.7  heartrate  79.0  resprate  20.0  o2sat  98.0  sbp  138.0  dbp  74.0  rhythm    pain  0  $hematology blood hematocrit  37.7  %; hematology blood hemoglobin  10.9  g dl; hematology blood platelet count  278  k ul; chemistry blood anion gap  13  meq l; chemistry blood bicarbonate  38  meq l; chemistry blood chloride  94  meq l; chemistry blood creatinine  0.5  mg dl; chemistry blood potassium  3.8  meq l; chemistry blood sodium  141  meq l; chemistry blood urea nitrogen  10  mg dl; hematology urine wbc  3  # hpf; chemistry blood glucose  138  mg dl$nan
atherosclerotic heart disease of native coronary artery with other forms of angina pectoris nicotine dependence, cigarettes, uncomplicated gastro-esophageal reflux disease without esophagitis major depressive disorder, single episode, unspecified chronic obstructive pulmonary disease with (acute) exacerbation age-related osteoporosis without current pathological fracture dependence on supplemental oxygen do not resuscitate hyperlipidemia, unspecified insomnia, unspecified hyperlipidemia, unspecified gastro-esophageal reflux disease without esophagitis unspecified place in unspecified non-institutional (private) residence as the place of occurrence of the external cause nicotine dependence, cigarettes, uncomplicated age-related osteoporosis without current pathological fracture atherosclerotic heart disease of native coronary artery with other forms of angina pectoris dependence on supplemental oxygen encounter for immunization unspecified intracapsular fracture of left femur, initial encounter for closed fracture unspecified place in hospital as the place of occurrence of the external cause unspecified fall, initial encounter iron deficiency anemia secondary to blood loss (chronic) urinary catheterization as the cause of abnormal reaction of the patient, or of later complication, without mention of misadventure at the time of the procedure respiratory failure, unspecified with hypercapnia chronic obstructive pulmonary disease with (acute) exacerbation other specified fracture of left pubis, initial encounter for closed fracture myoclonus anxiety disorder, unspecified other urogenital candidiasis physical restraint status anuria and oliguria infection and inflammatory reaction due to other urinary catheter, initial encounter major depressive disorder, single episode, unspecified tobacco use disorder coronary atherosclerosis of native coronary artery need for prophylactic vaccination and inoculation against influenza obstructive chronic bronchitis with (acute) exacerbation esophageal reflux physical restraints status depressive disorder, not elsewhere classified hyperpotassemia osteoporosis, unspecified osteoporosis, unspecified depressive disorder, not elsewhere classified long-term (current) use of steroids other and unspecified hyperlipidemia obstructive chronic bronchitis with (acute) exacerbation esophageal reflux
white f 75 $nan$hematology blood hematocrit  35.6  %; hematology blood hemoglobin  10.3  g dl; hematology blood platelet count  266  k ul; chemistry blood anion gap  12  meq l; chemistry blood bicarbonate  38  meq l; chemistry blood chloride  96  meq l; chemistry blood creatinine  0.5  mg dl; chemistry blood potassium  4.1  meq l; chemistry blood sodium  142  meq l; chemistry blood urea nitrogen  12  mg dl; chemistry blood calcium, total  9.3  mg dl; chemistry blood glucose  205  mg dl$sodium chloride 0.9%  flush  3  ml ; heparin  5000  unit ; ipratropium-albuterol neb  1  neb ; azithromycin  250  mg ; acetaminophen  1000  mg ; aspirin  81  mg ; fluticasone-salmeterol diskus (500 50)   1  inh ; levalbuterol neb  0.63  mg ; lorazepam  0.25  mg ; lorazepam  1  mg ; nystatin oral suspension  5  ml ; pantoprazole  40  mg ; vitamin d  2000  unit ; prednisone  40  mg ; nicotine patch  7  mg ; lorazepam  0.5  mg ; 
atherosclerotic heart disease of native coronary artery with other forms of angina pectoris nicotine dependence, cigarettes, uncomplicated gastro-esophageal reflux disease without esophagitis major depressive disorder, single episode, unspecified chronic obstructive pulmonary disease with (acute) exacerbation age-related osteoporosis without current pathological fracture dependence on supplemental oxygen do not resuscitate hyperlipidemia, unspecified insomnia, unspecified hyperlipidemia, unspecified gastro-esophageal reflux disease without esophagitis unspecified place in unspecified non-institutional (private) residence as the place of occurrence of the external cause nicotine dependence, cigarettes, uncomplicated age-related osteoporosis without current pathological fracture atherosclerotic heart disease of native coronary artery with other forms of angina pectoris dependence on supplemental oxygen encounter for immunization unspecified intracapsular fracture of left femur, initial encounter for closed fracture unspecified place in hospital as the place of occurrence of the external cause unspecified fall, initial encounter iron deficiency anemia secondary to blood loss (chronic) urinary catheterization as the cause of abnormal reaction of the patient, or of later complication, without mention of misadventure at the time of the procedure respiratory failure, unspecified with hypercapnia chronic obstructive pulmonary disease with (acute) exacerbation other specified fracture of left pubis, initial encounter for closed fracture myoclonus anxiety disorder, unspecified other urogenital candidiasis physical restraint status anuria and oliguria infection and inflammatory reaction due to other urinary catheter, initial encounter major depressive disorder, single episode, unspecified tobacco use disorder coronary atherosclerosis of native coronary artery need for prophylactic vaccination and inoculation against influenza obstructive chronic bronchitis with (acute) exacerbation esophageal reflux physical restraints status depressive disorder, not elsewhere classified hyperpotassemia osteoporosis, unspecified osteoporosis, unspecified depressive disorder, not elsewhere classified long-term (current) use of steroids other and unspecified hyperlipidemia obstructive chronic bronchitis with (acute) exacerbation esophageal reflux
white f 75 $nan$hematology blood hematocrit  34.2  %; hematology blood hemoglobin  10.3  g dl; hematology blood platelet count  270  k ul; chemistry blood anion gap  9  meq l; chemistry blood bicarbonate  40  meq l; chemistry blood chloride  98  meq l; chemistry blood creatinine  0.5  mg dl; chemistry blood potassium  4.0  meq l; chemistry blood sodium  143  meq l; chemistry blood urea nitrogen  13  mg dl; chemistry blood glucose  92  mg dl$sodium chloride 0.9%  flush  3  ml ; heparin  5000  unit ; ipratropium-albuterol neb  1  neb ; azithromycin  250  mg ; acetaminophen  1000  mg ; aspirin  81  mg ; fluticasone-salmeterol diskus (500 50)   1  inh ; levalbuterol neb  0.63  mg ; lorazepam  1  mg ; nystatin oral suspension  5  ml ; pantoprazole  40  mg ; vitamin d  2000  unit ; prednisone  40  mg ; nicotine patch  7  mg ; lorazepam  0.5  mg ; calcium carbonate  500  mg ; bisacodyl  10  mg ; 
atherosclerotic heart disease of native coronary artery with other forms of angina pectoris nicotine dependence, cigarettes, uncomplicated gastro-esophageal reflux disease without esophagitis major depressive disorder, single episode, unspecified chronic obstructive pulmonary disease with (acute) exacerbation age-related osteoporosis without current pathological fracture dependence on supplemental oxygen do not resuscitate hyperlipidemia, unspecified insomnia, unspecified hyperlipidemia, unspecified gastro-esophageal reflux disease without esophagitis unspecified place in unspecified non-institutional (private) residence as the place of occurrence of the external cause nicotine dependence, cigarettes, uncomplicated age-related osteoporosis without current pathological fracture atherosclerotic heart disease of native coronary artery with other forms of angina pectoris dependence on supplemental oxygen encounter for immunization unspecified intracapsular fracture of left femur, initial encounter for closed fracture unspecified place in hospital as the place of occurrence of the external cause unspecified fall, initial encounter iron deficiency anemia secondary to blood loss (chronic) urinary catheterization as the cause of abnormal reaction of the patient, or of later complication, without mention of misadventure at the time of the procedure respiratory failure, unspecified with hypercapnia chronic obstructive pulmonary disease with (acute) exacerbation other specified fracture of left pubis, initial encounter for closed fracture myoclonus anxiety disorder, unspecified other urogenital candidiasis physical restraint status anuria and oliguria infection and inflammatory reaction due to other urinary catheter, initial encounter major depressive disorder, single episode, unspecified tobacco use disorder coronary atherosclerosis of native coronary artery need for prophylactic vaccination and inoculation against influenza obstructive chronic bronchitis with (acute) exacerbation esophageal reflux physical restraints status depressive disorder, not elsewhere classified hyperpotassemia osteoporosis, unspecified osteoporosis, unspecified depressive disorder, not elsewhere classified long-term (current) use of steroids other and unspecified hyperlipidemia obstructive chronic bronchitis with (acute) exacerbation esophageal reflux
white f 75 $nan$hematology blood hematocrit  31.7  %; hematology blood hemoglobin  9.4  g dl; hematology blood platelet count  247  k ul; chemistry blood anion gap  11  meq l; chemistry blood bicarbonate  36  meq l; chemistry blood chloride  99  meq l; chemistry blood creatinine  0.4  mg dl; chemistry blood potassium  3.7  meq l; chemistry blood sodium  142  meq l; chemistry blood urea nitrogen  17  mg dl; chemistry blood calcium, total  8.7  mg dl; chemistry blood glucose  83  mg dl$sodium chloride 0.9%  flush  3  ml ; heparin  5000  unit ; ipratropium-albuterol neb  1  neb ; azithromycin  250  mg ; acetaminophen  1000  mg ; aspirin  81  mg ; fluticasone-salmeterol diskus (500 50)   1  inh ; levalbuterol neb  0.63  mg ; lorazepam  1  mg ; nystatin oral suspension  5  ml ; pantoprazole  40  mg ; vitamin d  2000  unit ; prednisone  40  mg ; nicotine patch  7  mg ; lorazepam  0.5  mg ; calcium carbonate  500  mg ; bisacodyl  10  mg ; 
atherosclerotic heart disease of native coronary artery with other forms of angina pectoris nicotine dependence, cigarettes, uncomplicated gastro-esophageal reflux disease without esophagitis major depressive disorder, single episode, unspecified chronic obstructive pulmonary disease with (acute) exacerbation age-related osteoporosis without current pathological fracture dependence on supplemental oxygen do not resuscitate hyperlipidemia, unspecified insomnia, unspecified hyperlipidemia, unspecified gastro-esophageal reflux disease without esophagitis unspecified place in unspecified non-institutional (private) residence as the place of occurrence of the external cause nicotine dependence, cigarettes, uncomplicated age-related osteoporosis without current pathological fracture atherosclerotic heart disease of native coronary artery with other forms of angina pectoris dependence on supplemental oxygen encounter for immunization unspecified intracapsular fracture of left femur, initial encounter for closed fracture unspecified place in hospital as the place of occurrence of the external cause unspecified fall, initial encounter iron deficiency anemia secondary to blood loss (chronic) urinary catheterization as the cause of abnormal reaction of the patient, or of later complication, without mention of misadventure at the time of the procedure respiratory failure, unspecified with hypercapnia chronic obstructive pulmonary disease with (acute) exacerbation other specified fracture of left pubis, initial encounter for closed fracture myoclonus anxiety disorder, unspecified other urogenital candidiasis physical restraint status anuria and oliguria infection and inflammatory reaction due to other urinary catheter, initial encounter major depressive disorder, single episode, unspecified tobacco use disorder coronary atherosclerosis of native coronary artery need for prophylactic vaccination and inoculation against influenza obstructive chronic bronchitis with (acute) exacerbation esophageal reflux physical restraints status depressive disorder, not elsewhere classified hyperpotassemia osteoporosis, unspecified osteoporosis, unspecified depressive disorder, not elsewhere classified long-term (current) use of steroids other and unspecified hyperlipidemia obstructive chronic bronchitis with (acute) exacerbation esophageal reflux
white f 75 $nan$hematology blood hematocrit  34.5  %; hematology blood hemoglobin  10.2  g dl; hematology blood platelet count  290  k ul; chemistry blood anion gap  11  meq l; chemistry blood bicarbonate  36  meq l; chemistry blood chloride  98  meq l; chemistry blood creatinine  0.5  mg dl; chemistry blood potassium  3.8  meq l; chemistry blood sodium  141  meq l; chemistry blood urea nitrogen  21  mg dl; chemistry blood calcium, total  9.6  mg dl; chemistry blood glucose  83  mg dl$sodium chloride 0.9%  flush  3  ml ; heparin  5000  unit ; ipratropium-albuterol neb  1  neb ; azithromycin  250  mg ; acetaminophen  1000  mg ; aspirin  81  mg ; fluticasone-salmeterol diskus (500 50)   1  inh ; levalbuterol neb  0.63  mg ; lorazepam  1  mg ; nystatin oral suspension  5  ml ; pantoprazole  40  mg ; vitamin d  2000  unit ; prednisone  40  mg ; nicotine patch  7  mg ; lorazepam  0.5  mg ; calcium carbonate  500  mg ; bisacodyl  10  mg ; 
atherosclerotic heart disease of native coronary artery with other forms of angina pectoris nicotine dependence, cigarettes, uncomplicated gastro-esophageal reflux disease without esophagitis major depressive disorder, single episode, unspecified chronic obstructive pulmonary disease with (acute) exacerbation age-related osteoporosis without current pathological fracture dependence on supplemental oxygen do not resuscitate hyperlipidemia, unspecified insomnia, unspecified hyperlipidemia, unspecified gastro-esophageal reflux disease without esophagitis unspecified place in unspecified non-institutional (private) residence as the place of occurrence of the external cause nicotine dependence, cigarettes, uncomplicated age-related osteoporosis without current pathological fracture atherosclerotic heart disease of native coronary artery with other forms of angina pectoris dependence on supplemental oxygen encounter for immunization unspecified intracapsular fracture of left femur, initial encounter for closed fracture unspecified place in hospital as the place of occurrence of the external cause unspecified fall, initial encounter iron deficiency anemia secondary to blood loss (chronic) urinary catheterization as the cause of abnormal reaction of the patient, or of later complication, without mention of misadventure at the time of the procedure respiratory failure, unspecified with hypercapnia chronic obstructive pulmonary disease with (acute) exacerbation other specified fracture of left pubis, initial encounter for closed fracture myoclonus anxiety disorder, unspecified other urogenital candidiasis physical restraint status anuria and oliguria infection and inflammatory reaction due to other urinary catheter, initial encounter major depressive disorder, single episode, unspecified tobacco use disorder coronary atherosclerosis of native coronary artery need for prophylactic vaccination and inoculation against influenza obstructive chronic bronchitis with (acute) exacerbation esophageal reflux physical restraints status depressive disorder, not elsewhere classified hyperpotassemia osteoporosis, unspecified osteoporosis, unspecified depressive disorder, not elsewhere classified long-term (current) use of steroids other and unspecified hyperlipidemia obstructive chronic bronchitis with (acute) exacerbation esophageal reflux
white m 32 $nan$nan$influenza vaccine quadrivalent  0.5  ml ; alprazolam  1  mg ; clonazepam  2  mg ; sertraline  200  mg ; nicotine polacrilex  2  mg ; 
tobacco use disorder depressive disorder, not elsewhere classified
white m 32 $nan$nan$influenza vaccine quadrivalent  0.5  ml ; clonazepam  2  mg ; sertraline  200  mg ; nicotine patch  21  mg ; olanzapine  5  mg ; olanzapine (disintegrating tablet)  5  mg ; 
tobacco use disorder depressive disorder, not elsewhere classified
white f 84 $nan$nan$aspirin  81  mg ; atenolol  25  mg ; 
 
white f 84 $nan$hematology blood hematocrit  37.5  %; hematology blood hemoglobin  12.3  g dl; hematology blood platelet count  348  k ul; chemistry blood anion gap  16  meq l; chemistry blood bicarbonate  23  meq l; chemistry blood chloride  103  meq l; chemistry blood creatinine  1.0  mg dl; chemistry blood potassium  4.2  meq l; chemistry blood sodium  138  meq l; chemistry blood urea nitrogen  16  mg dl; chemistry blood glucose  181  mg dl$aspirin  81  mg ; atenolol  25  mg ; 1 2 ns  1000  ml ; pneumococcal vac polyvalent  0.5  ml ; sodium chloride 0.9%  flush  3  ml ; syringe  1  ml ; heparin sodium  5000  unit ; docusate sodium  100  mg ; 0.9% sodium chloride  1000  ml ; olanzapine  10  mg ; olanzapine  5  mg ; donepezil  10  mg ; olanzapine (disintegrating tablet)  5  mg ; pantoprazole  40  mg ; senna  1  tab ; iso-osmotic dextrose  50  ml ; ceftriaxone  1  gm ; acetaminophen  325-650  mg ; hydromorphone (dilaudid)  0.5  mg ; 
 
white f 84 $nan$hematology blood hematocrit  39.1  %; hematology blood hemoglobin  12.7  g dl; hematology blood platelet count  331  k ul; chemistry blood anion gap  13  meq l; chemistry blood bicarbonate  23  meq l; chemistry blood chloride  107  meq l; chemistry blood creatinine  0.9  mg dl; chemistry blood potassium  4.1  meq l; chemistry blood sodium  139  meq l; chemistry blood urea nitrogen  15  mg dl; hematology urine wbc  >50  # hpf; chemistry blood glucose  112  mg dl; hematology urine glucose  neg  mg dl; hematology urine bilirubin  neg  mg dl$aspirin  81  mg ; sodium chloride 0.9%  flush  3  ml ; syringe  1  ml ; heparin sodium  5000  unit ; docusate sodium  100  mg ; olanzapine  5  mg ; donepezil  10  mg ; olanzapine (disintegrating tablet)  5  mg ; pantoprazole  40  mg ; senna  1  tab ; iso-osmotic dextrose  50  ml ; ceftriaxone  1  gm ; acetaminophen  325-650  mg ; guaifenesin-dextromethorphan  5-10  ml ; azithromycin  500  mg ; 
 
white f 84 $nan$hematology blood hematocrit  33.8  %; hematology blood hemoglobin  11.2  g dl; hematology blood platelet count  301  k ul$aspirin  81  mg ; sodium chloride 0.9%  flush  3  ml ; syringe  1  ml ; heparin sodium  5000  unit ; docusate sodium  100  mg ; olanzapine  5  mg ; donepezil  10  mg ; olanzapine (disintegrating tablet)  5  mg ; pantoprazole  40  mg ; senna  1  tab ; iso-osmotic dextrose  50  ml ; ceftriaxone  1  gm ; acetaminophen  325-650  mg ; guaifenesin-dextromethorphan  5-10  ml ; azithromycin  500  mg ; ns  100  ml ; metronidazole (flagyl)  500  mg ; 
 
white f 84 $nan$hematology blood hematocrit  37.2  %; hematology blood hematocrit  41.8  %; hematology blood hemoglobin  12.4  g dl; hematology blood hemoglobin  13.6  g dl; hematology blood platelet count  358  k ul; hematology blood platelet count  387  k ul$aspirin  81  mg ; sodium chloride 0.9%  flush  3  ml ; syringe  1  ml ; heparin sodium  5000  unit ; olanzapine  5  mg ; donepezil  10  mg ; olanzapine (disintegrating tablet)  5  mg ; pantoprazole  40  mg ; senna  1  tab ; iso-osmotic dextrose  50  ml ; ceftriaxone  1  gm ; acetaminophen  325-650  mg ; guaifenesin-dextromethorphan  5-10  ml ; azithromycin  500  mg ; docusate sodium (liquid)  100  mg ; ciprofloxacin hcl  500  mg ; 
 
white f 84 $nan$nan$aspirin  81  mg ; sodium chloride 0.9%  flush  3  ml ; syringe  1  ml ; heparin sodium  5000  unit ; olanzapine  5  mg ; donepezil  10  mg ; olanzapine (disintegrating tablet)  5  mg ; pantoprazole  40  mg ; senna  1  tab ; acetaminophen  325-650  mg ; guaifenesin-dextromethorphan  5-10  ml ; azithromycin  500  mg ; docusate sodium (liquid)  100  mg ; ciprofloxacin hcl  500  mg ; 
 
white f 84 $nan$nan$aspirin  81  mg ; sodium chloride 0.9%  flush  3  ml ; syringe  1  ml ; heparin sodium  5000  unit ; olanzapine  5  mg ; donepezil  10  mg ; olanzapine (disintegrating tablet)  5  mg ; pantoprazole  40  mg ; senna  1  tab ; acetaminophen  325-650  mg ; guaifenesin-dextromethorphan  5-10  ml ; azithromycin  500  mg ; docusate sodium (liquid)  100  mg ; ciprofloxacin hcl  500  mg ; 
 
white f 84 $nan$nan$aspirin  81  mg ; sodium chloride 0.9%  flush  3  ml ; syringe  1  ml ; heparin sodium  5000  unit ; olanzapine  5  mg ; donepezil  10  mg ; olanzapine (disintegrating tablet)  5  mg ; pantoprazole  40  mg ; senna  1  tab ; acetaminophen  325-650  mg ; guaifenesin-dextromethorphan  5-10  ml ; azithromycin  500  mg ; docusate sodium (liquid)  100  mg ; ciprofloxacin hcl  500  mg ; 
 
hispanic latino f 73 $nan$hematology blood hematocrit  37.2  %; hematology blood hemoglobin  11.5  g dl; hematology blood platelet count  242  k ul; chemistry blood anion gap  19  meq l; chemistry blood bicarbonate  21  meq l; chemistry blood chloride  102  meq l; chemistry blood creatinine  0.7  mg dl; chemistry blood potassium  4.4  meq l; chemistry blood sodium  138  meq l; chemistry blood urea nitrogen  16  mg dl; hematology blood inr(pt)  1.3  $heparin  1500-3000  unit ; 5% dextrose  250  ml ; heparin sodium  25,000  unit ; sodium chloride 0.9%  flush  3  ml ; acetaminophen  650  mg ; simethicone  40-80  mg ; trazodone  25  mg ; warfarin  5  mg ; dextrose 50%  12.5  gm ; glucagon  1  mg ; glucose gel  15  g ; pravastatin  80  mg ; albuterol inhaler  2  puff ; polyethylene glycol  17  g ; fluticasone-salmeterol diskus (250 50)   1  inh ; insulin  0  unit ; insulin  16  unit ; metoprolol tartrate  12.5  mg ; digoxin  0.125  mg ; furosemide  20  mg ; lisinopril  2.5  mg ; metoprolol succinate xl  50  mg ; vitamin d  800  unit ; docusate sodium  100  mg ; metoprolol succinate xl  25  mg ; 
 
hispanic latino f 73 $nan$chemistry blood anion gap  14  meq l; chemistry blood bicarbonate  26  meq l; chemistry blood chloride  104  meq l; chemistry blood creatinine  0.7  mg dl; chemistry blood potassium  4.4  meq l; chemistry blood sodium  140  meq l; chemistry blood urea nitrogen  19  mg dl; hematology blood inr(pt)  1.4  ; chemistry blood glucose  203  mg dl$heparin  1500-3000  unit ; 5% dextrose  250  ml ; heparin sodium  25,000  unit ; sodium chloride 0.9%  flush  3  ml ; acetaminophen  650  mg ; simethicone  40-80  mg ; trazodone  25  mg ; warfarin  5  mg ; dextrose 50%  12.5  gm ; glucagon  1  mg ; glucose gel  15  g ; pravastatin  80  mg ; albuterol inhaler  2  puff ; polyethylene glycol  17  g ; fluticasone-salmeterol diskus (250 50)   1  inh ; insulin  0  unit ; insulin  16  unit ; digoxin  0.125  mg ; furosemide  20  mg ; lisinopril  2.5  mg ; vitamin d  800  unit ; docusate sodium  100  mg ; metoprolol succinate xl  25  mg ; senna  8.6  mg ; metoprolol succinate xl  100  mg ; warfarin  4  mg ; 
 
hispanic latino f 73 $nan$hematology blood hematocrit  34.9  %; hematology blood hemoglobin  11.0  g dl; hematology blood platelet count  252  k ul; chemistry blood anion gap  20  meq l; chemistry blood bicarbonate  24  meq l; chemistry blood chloride  97  meq l; chemistry blood creatinine  0.8  mg dl; chemistry blood potassium  4.0  meq l; chemistry blood sodium  137  meq l; chemistry blood urea nitrogen  23  mg dl; hematology blood inr(pt)  1.8  ; chemistry blood calcium, total  8.9  mg dl; chemistry blood glucose  267  mg dl$heparin  1500-3000  unit ; 5% dextrose  250  ml ; heparin sodium  25,000  unit ; sodium chloride 0.9%  flush  3  ml ; acetaminophen  650  mg ; simethicone  40-80  mg ; trazodone  25  mg ; dextrose 50%  12.5  gm ; glucagon  1  mg ; glucose gel  15  g ; pravastatin  80  mg ; albuterol inhaler  2  puff ; polyethylene glycol  17  g ; fluticasone-salmeterol diskus (250 50)   1  inh ; insulin  0  unit ; insulin  16  unit ; lisinopril  2.5  mg ; vitamin d  800  unit ; docusate sodium  100  mg ; senna  8.6  mg ; warfarin  4  mg ; metoprolol succinate xl  150  mg ; 
 
hispanic latino f 73 $nan$nan$sodium chloride 0.9%  flush  3  ml ; acetaminophen  650  mg ; simethicone  40-80  mg ; trazodone  25  mg ; dextrose 50%  12.5  gm ; glucagon  1  mg ; glucose gel  15  g ; pravastatin  80  mg ; albuterol inhaler  2  puff ; polyethylene glycol  17  g ; fluticasone-salmeterol diskus (250 50)   1  inh ; insulin  0  unit ; insulin  16  unit ; vitamin d  800  unit ; docusate sodium  100  mg ; senna  8.6  mg ; metoprolol succinate xl  150  mg ; 
 
white f 91 $temp  97.9  heartrate  89.0  resprate  18.0  o2sat  93.0  sbp  109.0  dbp  59.0  rhythm    pain  4  ; temp    heartrate  95.0  resprate  20.0  o2sat  91.0  sbp  96.0  dbp  55.0  rhythm    pain  4  ; temp  97.9  heartrate  89.0  resprate  24.0  o2sat  91.0  sbp  93.0  dbp  49.0  rhythm    pain    ; temp    heartrate  90.0  resprate  22.0  o2sat  92.0  sbp  106.0  dbp  59.0  rhythm    pain  5  ; temp    heartrate  89.0  resprate  24.0  o2sat  91.0  sbp  118.0  dbp  59.0  rhythm    pain  5  ; temp    heartrate  94.0  resprate  26.0  o2sat  91.0  sbp  118.0  dbp  51.0  rhythm    pain  5  ; temp  98.0  heartrate  91.0  resprate  20.0  o2sat  92.0  sbp  103.0  dbp  53.0  rhythm    pain    ; temp    heartrate  91.0  resprate  18.0  o2sat  89.0  sbp  117.0  dbp  60.0  rhythm    pain    ; temp  98.0  heartrate  94.0  resprate  18.0  o2sat  90.0  sbp  101.0  dbp  56.0  rhythm    pain  sleeping  $hematology blood hematocrit  30.6  %; hematology blood hematocrit  29.3  %; hematology blood hemoglobin  10.5  g dl; hematology blood hemoglobin  9.9  g dl; hematology blood platelet count  190  k ul; hematology blood platelet count  173  k ul; chemistry blood anion gap  13  meq l; chemistry blood bicarbonate  24  meq l; chemistry blood chloride  108  meq l; chemistry blood creatinine  2.3  mg dl; chemistry blood potassium  5.5  meq l; chemistry blood sodium  139  meq l; chemistry blood urea nitrogen  46  mg dl; hematology blood inr(pt)  3.3  ; chemistry urine chloride, urine  74  meq l; chemistry urine creatinine, urine  144  mg dl; chemistry urine potassium, urine  81  meq l; chemistry urine sodium, urine  60  meq l; chemistry urine urea nitrogen, urine  797  mg dl; hematology urine wbc  38  # hpf; chemistry blood glucose  153  mg dl$influenza vaccine quadrivalent  0.5  ml ; pneumococcal 23-valent polysaccharide vaccine  0.5  ml ; sodium chloride 0.9%  flush  3  ml ; lactated ringers  1000  ml ; acetaminophen  650  mg ; docusate sodium  100  mg ; vitamin d  800  unit ; calcium carbonate  500  mg ; multivitamins  1  tab ; oxycodone (immediate release)   2.5  mg ; pantoprazole  40  mg ; aspirin  81  mg ; ipratropium-albuterol neb  1  neb ; albuterol 0.083% neb soln  1  neb ; citalopram  20  mg ; carvedilol  3.125  mg ; amlodipine  5  mg ; ropinirole  0.25  mg ; oxycodone (immediate release)   5  mg ; phytonadione  5  mg ; hydromorphone (dilaudid)  0.125-0.25  mg ; 
 
white f 91 $nan$hematology blood hematocrit  22.8  %; hematology blood hematocrit  22.8  %; hematology blood hemoglobin  7.9  g dl; hematology blood hemoglobin  8.0  g dl; hematology blood platelet count  145  k ul; chemistry blood anion gap  16  meq l; chemistry blood anion gap  12  meq l; chemistry blood bicarbonate  21  meq l; chemistry blood bicarbonate  23  meq l; chemistry blood chloride  107  meq l; chemistry blood chloride  104  meq l; chemistry blood creatinine  1.9  mg dl; chemistry blood creatinine  1.7  mg dl; chemistry blood potassium  4.7  meq l; chemistry blood potassium  4.8  meq l; chemistry blood sodium  139  meq l; chemistry blood sodium  134  meq l; chemistry blood urea nitrogen  45  mg dl; chemistry blood urea nitrogen  43  mg dl; hematology blood inr(pt)  3.7  ; chemistry blood calcium, total  8.7  mg dl; chemistry blood calcium, total  8.4  mg dl; chemistry blood bilirubin, indirect  0.2  mg dl; chemistry blood bilirubin, total  0.4  mg dl; chemistry blood glucose  141  mg dl; chemistry blood glucose  113  mg dl; chemistry blood lactate dehydrogenase (ld)  245  iu l; blood gas blood lactate  1.7  mmol l; chemistry blood bilirubin, direct  0.2  mg dl$influenza vaccine quadrivalent  0.5  ml ; pneumococcal 23-valent polysaccharide vaccine  0.5  ml ; sodium chloride 0.9%  flush  3  ml ; lactated ringers  1000  ml ; acetaminophen  650  mg ; docusate sodium  100  mg ; vitamin d  800  unit ; calcium carbonate  500  mg ; multivitamins  1  tab ; pantoprazole  40  mg ; aspirin  81  mg ; ipratropium-albuterol neb  1  neb ; albuterol 0.083% neb soln  1  neb ; citalopram  20  mg ; carvedilol  3.125  mg ; amlodipine  5  mg ; ropinirole  0.25  mg ; phytonadione  5  mg ; hydromorphone (dilaudid)  0.125-0.25  mg ; naloxone  0.04  mg ; 0.9% sodium chloride (mini bag plus)  100  ml ; ceftriaxone  1  gm ; acetaminophen iv  1000  mg ; trazodone  25  mg ; sodium chloride 0.9%  1000  ml ; bag  1  bag ; magnesium sulfate  2  gm ; bag  2  bag ; magnesium sulfate  4  gm ; 0.9% sodium chloride  1  bag ; calcium gluconate  2  g ; 0.9% sodium chloride  2  bag ; calcium gluconate  4  g ; tramadol (ultram)  12.5  mg ; sw  200  ml ; potassium chloride  20  meq ; sw  400  ml ; potassium chloride  40  meq ; sw  600  ml ; potassium chloride  60  meq ; 
 
white f 91 $nan$nan$sodium chloride 0.9%  flush  3  ml ; trazodone  25  mg ; oxycodone (concentrated oral soln)  2.5-5  mg ; hydromorphone (dilaudid)  0.25-0.5  mg ; hyoscyamine  0.125  mg ; haloperidol  0.5-2  mg ; ondansetron  4-8  mg ; midazolam  1-3  mg ; 5% dextrose  100  ml ; morphine sulfate  100  mg ; lorazepam  0.5  mg ; lidocaine 5% patch  1  ptch ; scopolamine patch  1  ptch ; 
 
white f 91 $nan$nan$sodium chloride 0.9%  flush  3  ml ; ondansetron  4-8  mg ; 5% dextrose  100  ml ; morphine sulfate  100  mg ; lorazepam  0.5  mg ; lidocaine 5% patch  1  ptch ; 
 
black african american m 76 $temp  97.4  heartrate  80.0  resprate  18.0  o2sat  100.0  sbp  150.0  dbp  70.0  rhythm    pain  ua  ; temp  98.4  heartrate  73.0  resprate  18.0  o2sat  100.0  sbp  134.0  dbp  50.0  rhythm    pain  0  ; temp    heartrate  62.0  resprate  19.0  o2sat  100.0  sbp  124.0  dbp  46.0  rhythm    pain  0  ; temp    heartrate  69.0  resprate  15.0  o2sat  91.0  sbp  127.0  dbp  48.0  rhythm  paced rhythm  pain  0  ; temp    heartrate  64.0  resprate  18.0  o2sat  95.0  sbp  120.0  dbp  45.0  rhythm    pain  0  ; temp    heartrate  75.0  resprate  20.0  o2sat  99.0  sbp  125.0  dbp  46.0  rhythm    pain  0  ; temp    heartrate  66.0  resprate  17.0  o2sat  95.0  sbp  123.0  dbp  46.0  rhythm    pain    ; temp  98.7  heartrate  89.0  resprate  33.0  o2sat  93.0  sbp  145.0  dbp  53.0  rhythm    pain  0  ; temp  98.4  heartrate  55.0  resprate  21.0  o2sat  100.0  sbp  134.0  dbp  98.0  rhythm    pain    $nan$gabapentin  300  mg ; 
acute kidney failure, unspecified presence of prosthetic heart valve unspecified atherosclerosis of native arteries of extremities, unspecified extremity adverse effect of other systemic antibiotics, sequela long term (current) use of anticoagulants encephalopathy, unspecified other injury of urethra, initial encounter unspecified place or not applicable pneumonia due to other gram-negative bacteria tracheostomy status hyperlipidemia, unspecified presence of cardiac pacemaker abdominal distension (gaseous) retention of urine, unspecified personal history of other malignant neoplasm of bronchus and lung cellulitis of right lower limb acute posthemorrhagic anemia anxiety disorder, unspecified diarrhea, unspecified pulmonary hypertension, unspecified other specified disorders of urethra personal history of sudden cardiac arrest personal history of nicotine dependence urinary catheterization as the cause of abnormal reaction of the patient, or of later complication, without mention of misadventure at the time of the procedure hypokalemia hyperosmolality and hypernatremia physical restraint status gastrostomy status other vasculitis limited to the skin acute and chronic respiratory failure with hypercapnia delirium due to known physiological condition adverse effect of penicillins, sequela chronic obstructive pulmonary disease, unspecified unspecified place in hospital as the place of occurrence of the external cause other vasculitis limited to the skin chronic obstructive pulmonary disease, unspecified chronic pulmonary edema acute and chronic respiratory failure, unspecified whether with hypoxia or hypercapnia pulmonary hypertension, unspecified presence of cardiac pacemaker thrombocytopenia, unspecified pneumonia, unspecified organism essential (primary) hypertension rash and other nonspecific skin eruption tracheostomy status chronic respiratory failure, unspecified whether with hypoxia or hypercapnia personal history of other malignant neoplasm of bronchus and lung long term (current) use of anticoagulants
black african american m 76 $temp    heartrate  67.0  resprate  22.0  o2sat  100.0  sbp    dbp    rhythm    pain  0  $hematology blood hematocrit  25.8  %; hematology blood hematocrit  26.9  %; hematology blood hemoglobin  7.8  g dl; hematology blood hemoglobin  8.0  g dl; hematology blood platelet count  152  k ul; hematology blood platelet count  156  k ul; chemistry blood anion gap  9  meq l; chemistry blood bicarbonate  41  meq l; chemistry blood chloride  95  meq l; chemistry blood creatinine  0.8  mg dl; chemistry blood potassium  3.6  meq l; chemistry blood sodium  146  meq l; chemistry blood urea nitrogen  27  mg dl; hematology blood inr(pt)  1.5  ; chemistry blood calcium, total  8.8  mg dl; chemistry blood glucose  102  mg dl; chemistry blood lactate dehydrogenase (ld)  319  iu l$0.9% sodium chloride  100  ml ; gabapentin  300  mg ; bisacodyl  10  mg ; senna  8.6  mg ; calcium gluconate  2  g ; 0.9% sodium chloride  250  ml ; calcium gluconate  4  g ; sterile water  50  ml ; potassium chloride  20  meq ; sterile water  100  ml ; potassium chloride  40  meq ; sterile water  150  ml ; potassium chloride  60  meq ; bag  1  bag ; magnesium sulfate  4  gm ; acetylcysteine 20%  3-5  ml ; albuterol inhaler  2  puff ; amlodipine  5  mg ; aspirin  81  mg ; vial  1  vial ; ceftazidime  2  g ; chlorhexidine gluconate 0.12% oral rinse  15  ml ; clobetasol propionate 0.05% cream  1  appl ; creon 12  2  cap ; gabapentin  600  mg ; hydromorphone (dilaudid)  0.25  mg ; ipratropium bromide neb  1  neb ; ipratropium-albuterol neb  1  neb ; lactulose  15  ml ; acetaminophen (liquid)  975  mg ; hydromorphone (dilaudid)  0.5  mg ; lidocaine 5% patch  1  ptch ; mirtazapine  7.5  mg ; polyethylene glycol  17  g ; pravastatin  40  mg ; sarna lotion  1  appl ; senna  17.2  mg ; simethicone  80  mg ; sodium bicarbonate  650  mg ; tamsulosin  0.4  mg ; trazodone  100  mg ; vitamin d  1000  unit ; heparin  2100-4100  unit ; 5% dextrose  250  ml ; heparin sodium  25,000  unit ; lansoprazole oral disintegrating tab  30  mg ; prednisone  30  mg ; linezolid  600  mg ; heparin  2100  unit ; losartan potassium  25  mg ; metoprolol tartrate  25  mg ; furosemide  20  mg ; prednisone  20  mg ; 
acute kidney failure, unspecified presence of prosthetic heart valve unspecified atherosclerosis of native arteries of extremities, unspecified extremity adverse effect of other systemic antibiotics, sequela long term (current) use of anticoagulants encephalopathy, unspecified other injury of urethra, initial encounter unspecified place or not applicable pneumonia due to other gram-negative bacteria tracheostomy status hyperlipidemia, unspecified presence of cardiac pacemaker abdominal distension (gaseous) retention of urine, unspecified personal history of other malignant neoplasm of bronchus and lung cellulitis of right lower limb acute posthemorrhagic anemia anxiety disorder, unspecified diarrhea, unspecified pulmonary hypertension, unspecified other specified disorders of urethra personal history of sudden cardiac arrest personal history of nicotine dependence urinary catheterization as the cause of abnormal reaction of the patient, or of later complication, without mention of misadventure at the time of the procedure hypokalemia hyperosmolality and hypernatremia physical restraint status gastrostomy status other vasculitis limited to the skin acute and chronic respiratory failure with hypercapnia delirium due to known physiological condition adverse effect of penicillins, sequela chronic obstructive pulmonary disease, unspecified unspecified place in hospital as the place of occurrence of the external cause other vasculitis limited to the skin chronic obstructive pulmonary disease, unspecified chronic pulmonary edema acute and chronic respiratory failure, unspecified whether with hypoxia or hypercapnia pulmonary hypertension, unspecified presence of cardiac pacemaker thrombocytopenia, unspecified pneumonia, unspecified organism essential (primary) hypertension rash and other nonspecific skin eruption tracheostomy status chronic respiratory failure, unspecified whether with hypoxia or hypercapnia personal history of other malignant neoplasm of bronchus and lung long term (current) use of anticoagulants
black african american m 76 $nan$hematology blood hematocrit  27.0  %; hematology blood hematocrit  26.2  %; hematology blood hemoglobin  8.3  g dl; hematology blood hemoglobin  7.8  g dl; hematology blood platelet count  163  k ul; hematology blood platelet count  160  k ul; chemistry blood anion gap  11  meq l; chemistry blood anion gap  8  meq l; chemistry blood bicarbonate  38  meq l; chemistry blood bicarbonate  39  meq l; chemistry blood chloride  94  meq l; chemistry blood chloride  97  meq l; chemistry blood creatinine  0.9  mg dl; chemistry blood creatinine  0.9  mg dl; chemistry blood potassium  3.3  meq l; chemistry blood potassium  3.9  meq l; chemistry blood sodium  144  meq l; chemistry blood sodium  143  meq l; chemistry blood urea nitrogen  32  mg dl; chemistry blood urea nitrogen  33  mg dl; hematology blood inr(pt)  1.4  ; chemistry blood calcium, total  8.7  mg dl; chemistry blood calcium, total  8.8  mg dl; chemistry blood bilirubin, total  0.6  mg dl; chemistry blood glucose  131  mg dl; chemistry blood glucose  111  mg dl; blood gas blood free calcium  1.18  mmol l$0.9% sodium chloride  100  ml ; gabapentin  300  mg ; acetaminophen (liquid)  975  mg ; hydromorphone (dilaudid)  0.5  mg ; lidocaine 5% patch  1  ptch ; polyethylene glycol  17  g ; pravastatin  40  mg ; sarna lotion  1  appl ; senna  17.2  mg ; simethicone  80  mg ; sodium bicarbonate  650  mg ; tamsulosin  0.4  mg ; trazodone  100  mg ; vitamin d  1000  unit ; lansoprazole oral disintegrating tab  30  mg ; prednisone  30  mg ; linezolid  600  mg ; heparin  2100  unit ; losartan potassium  25  mg ; metoprolol tartrate  25  mg ; furosemide  20  mg ; prednisone  20  mg ; furosemide  40  mg ; furosemide  80  mg ; 
acute kidney failure, unspecified presence of prosthetic heart valve unspecified atherosclerosis of native arteries of extremities, unspecified extremity adverse effect of other systemic antibiotics, sequela long term (current) use of anticoagulants encephalopathy, unspecified other injury of urethra, initial encounter unspecified place or not applicable pneumonia due to other gram-negative bacteria tracheostomy status hyperlipidemia, unspecified presence of cardiac pacemaker abdominal distension (gaseous) retention of urine, unspecified personal history of other malignant neoplasm of bronchus and lung cellulitis of right lower limb acute posthemorrhagic anemia anxiety disorder, unspecified diarrhea, unspecified pulmonary hypertension, unspecified other specified disorders of urethra personal history of sudden cardiac arrest personal history of nicotine dependence urinary catheterization as the cause of abnormal reaction of the patient, or of later complication, without mention of misadventure at the time of the procedure hypokalemia hyperosmolality and hypernatremia physical restraint status gastrostomy status other vasculitis limited to the skin acute and chronic respiratory failure with hypercapnia delirium due to known physiological condition adverse effect of penicillins, sequela chronic obstructive pulmonary disease, unspecified unspecified place in hospital as the place of occurrence of the external cause other vasculitis limited to the skin chronic obstructive pulmonary disease, unspecified chronic pulmonary edema acute and chronic respiratory failure, unspecified whether with hypoxia or hypercapnia pulmonary hypertension, unspecified presence of cardiac pacemaker thrombocytopenia, unspecified pneumonia, unspecified organism essential (primary) hypertension rash and other nonspecific skin eruption tracheostomy status chronic respiratory failure, unspecified whether with hypoxia or hypercapnia personal history of other malignant neoplasm of bronchus and lung long term (current) use of anticoagulants
black african american m 76 $nan$hematology blood hematocrit  27.1  %; hematology blood hematocrit  26.0  %; hematology blood hematocrit  26.0  %; hematology blood hemoglobin  8.0  g dl; hematology blood hemoglobin  7.7  g dl; hematology blood hemoglobin  7.8  g dl; hematology blood platelet count  163  k ul; hematology blood platelet count  158  k ul; hematology blood platelet count  148  k ul; chemistry blood anion gap  10  meq l; chemistry blood anion gap  11  meq l; chemistry blood anion gap  7  meq l; chemistry blood bicarbonate  39  meq l; chemistry blood bicarbonate  38  meq l; chemistry blood bicarbonate  37  meq l; chemistry blood chloride  93  meq l; chemistry blood chloride  96  meq l; chemistry blood chloride  96  meq l; chemistry blood creatinine  0.9  mg dl; chemistry blood creatinine  0.8  mg dl; chemistry blood creatinine  0.8  mg dl; chemistry blood potassium  3.9  meq l; chemistry blood potassium  3.4  meq l; chemistry blood potassium  4.7  meq l; chemistry blood sodium  142  meq l; chemistry blood sodium  145  meq l; chemistry blood sodium  140  meq l; chemistry blood urea nitrogen  33  mg dl; chemistry blood urea nitrogen  31  mg dl; chemistry blood urea nitrogen  32  mg dl; hematology blood inr(pt)  1.3  ; chemistry blood calcium, total  8.5  mg dl; chemistry blood calcium, total  8.3  mg dl; chemistry blood calcium, total  8.6  mg dl; chemistry blood glucose  201  mg dl; chemistry blood glucose  124  mg dl; chemistry blood glucose  168  mg dl$0.9% sodium chloride  100  ml ; gabapentin  300  mg ; acetaminophen (liquid)  975  mg ; hydromorphone (dilaudid)  0.5  mg ; lidocaine 5% patch  1  ptch ; polyethylene glycol  17  g ; pravastatin  40  mg ; sarna lotion  1  appl ; senna  17.2  mg ; simethicone  80  mg ; sodium bicarbonate  650  mg ; tamsulosin  0.4  mg ; trazodone  100  mg ; vitamin d  1000  unit ; lansoprazole oral disintegrating tab  30  mg ; heparin  2100  unit ; losartan potassium  25  mg ; metoprolol tartrate  25  mg ; prednisone  20  mg ; furosemide  40  mg ; furosemide  80  mg ; warfarin  10  mg ; furosemide  100  mg ; 
acute kidney failure, unspecified presence of prosthetic heart valve unspecified atherosclerosis of native arteries of extremities, unspecified extremity adverse effect of other systemic antibiotics, sequela long term (current) use of anticoagulants encephalopathy, unspecified other injury of urethra, initial encounter unspecified place or not applicable pneumonia due to other gram-negative bacteria tracheostomy status hyperlipidemia, unspecified presence of cardiac pacemaker abdominal distension (gaseous) retention of urine, unspecified personal history of other malignant neoplasm of bronchus and lung cellulitis of right lower limb acute posthemorrhagic anemia anxiety disorder, unspecified diarrhea, unspecified pulmonary hypertension, unspecified other specified disorders of urethra personal history of sudden cardiac arrest personal history of nicotine dependence urinary catheterization as the cause of abnormal reaction of the patient, or of later complication, without mention of misadventure at the time of the procedure hypokalemia hyperosmolality and hypernatremia physical restraint status gastrostomy status other vasculitis limited to the skin acute and chronic respiratory failure with hypercapnia delirium due to known physiological condition adverse effect of penicillins, sequela chronic obstructive pulmonary disease, unspecified unspecified place in hospital as the place of occurrence of the external cause other vasculitis limited to the skin chronic obstructive pulmonary disease, unspecified chronic pulmonary edema acute and chronic respiratory failure, unspecified whether with hypoxia or hypercapnia pulmonary hypertension, unspecified presence of cardiac pacemaker thrombocytopenia, unspecified pneumonia, unspecified organism essential (primary) hypertension rash and other nonspecific skin eruption tracheostomy status chronic respiratory failure, unspecified whether with hypoxia or hypercapnia personal history of other malignant neoplasm of bronchus and lung long term (current) use of anticoagulants
black african american m 76 $nan$hematology blood hematocrit  27.3  %; hematology blood hemoglobin  8.0  g dl; hematology blood platelet count  150  k ul; chemistry blood anion gap  7  meq l; chemistry blood bicarbonate  38  meq l; chemistry blood chloride  95  meq l; chemistry blood creatinine  0.7  mg dl; chemistry blood potassium  4.2  meq l; chemistry blood sodium  140  meq l; chemistry blood urea nitrogen  31  mg dl; hematology blood inr(pt)  1.2  ; chemistry blood calcium, total  8.5  mg dl; chemistry blood glucose  111  mg dl$0.9% sodium chloride  100  ml ; gabapentin  300  mg ; acetaminophen (liquid)  975  mg ; hydromorphone (dilaudid)  0.5  mg ; lidocaine 5% patch  1  ptch ; polyethylene glycol  17  g ; pravastatin  40  mg ; sarna lotion  1  appl ; senna  17.2  mg ; simethicone  80  mg ; sodium bicarbonate  650  mg ; tamsulosin  0.4  mg ; trazodone  100  mg ; vitamin d  1000  unit ; lansoprazole oral disintegrating tab  30  mg ; heparin  2100  unit ; losartan potassium  25  mg ; metoprolol tartrate  25  mg ; prednisone  20  mg ; warfarin  10  mg ; furosemide  100  mg ; 5% dextrose  50  ml ; phytonadione  5  mg ; furosemide  160  mg ; prednisone  10  mg ; furosemide  200  mg ; 
acute kidney failure, unspecified presence of prosthetic heart valve unspecified atherosclerosis of native arteries of extremities, unspecified extremity adverse effect of other systemic antibiotics, sequela long term (current) use of anticoagulants encephalopathy, unspecified other injury of urethra, initial encounter unspecified place or not applicable pneumonia due to other gram-negative bacteria tracheostomy status hyperlipidemia, unspecified presence of cardiac pacemaker abdominal distension (gaseous) retention of urine, unspecified personal history of other malignant neoplasm of bronchus and lung cellulitis of right lower limb acute posthemorrhagic anemia anxiety disorder, unspecified diarrhea, unspecified pulmonary hypertension, unspecified other specified disorders of urethra personal history of sudden cardiac arrest personal history of nicotine dependence urinary catheterization as the cause of abnormal reaction of the patient, or of later complication, without mention of misadventure at the time of the procedure hypokalemia hyperosmolality and hypernatremia physical restraint status gastrostomy status other vasculitis limited to the skin acute and chronic respiratory failure with hypercapnia delirium due to known physiological condition adverse effect of penicillins, sequela chronic obstructive pulmonary disease, unspecified unspecified place in hospital as the place of occurrence of the external cause other vasculitis limited to the skin chronic obstructive pulmonary disease, unspecified chronic pulmonary edema acute and chronic respiratory failure, unspecified whether with hypoxia or hypercapnia pulmonary hypertension, unspecified presence of cardiac pacemaker thrombocytopenia, unspecified pneumonia, unspecified organism essential (primary) hypertension rash and other nonspecific skin eruption tracheostomy status chronic respiratory failure, unspecified whether with hypoxia or hypercapnia personal history of other malignant neoplasm of bronchus and lung long term (current) use of anticoagulants
black african american m 76 $nan$hematology blood hematocrit  27.5  %; hematology blood hemoglobin  8.0  g dl; hematology blood platelet count  148  k ul; chemistry blood anion gap  15  meq l; chemistry blood anion gap  8  meq l; chemistry blood anion gap  12  meq l; chemistry blood bicarbonate  36  meq l; chemistry blood bicarbonate  40  meq l; chemistry blood bicarbonate  39  meq l; chemistry blood chloride  91  meq l; chemistry blood chloride  93  meq l; chemistry blood chloride  90  meq l; chemistry blood creatinine  0.8  mg dl; chemistry blood creatinine  0.7  mg dl; chemistry blood creatinine  0.7  mg dl; chemistry blood potassium  4.7  meq l; chemistry blood potassium  4.2  meq l; chemistry blood potassium  4.3  meq l; chemistry blood sodium  142  meq l; chemistry blood sodium  141  meq l; chemistry blood sodium  141  meq l; chemistry blood urea nitrogen  32  mg dl; chemistry blood urea nitrogen  32  mg dl; chemistry blood urea nitrogen  31  mg dl; hematology blood inr(pt)  1.2  ; chemistry blood calcium, total  9.0  mg dl; chemistry blood calcium, total  8.9  mg dl; chemistry blood calcium, total  8.7  mg dl; chemistry blood glucose  165  mg dl; chemistry blood glucose  183  mg dl; chemistry blood glucose  141  mg dl$0.9% sodium chloride  100  ml ; gabapentin  300  mg ; acetaminophen (liquid)  975  mg ; hydromorphone (dilaudid)  0.5  mg ; lidocaine 5% patch  1  ptch ; polyethylene glycol  17  g ; pravastatin  40  mg ; sarna lotion  1  appl ; senna  17.2  mg ; simethicone  80  mg ; sodium bicarbonate  650  mg ; tamsulosin  0.4  mg ; trazodone  100  mg ; vitamin d  1000  unit ; lansoprazole oral disintegrating tab  30  mg ; heparin  2100  unit ; losartan potassium  25  mg ; metoprolol tartrate  25  mg ; 5% dextrose  50  ml ; phytonadione  5  mg ; furosemide  160  mg ; prednisone  10  mg ; furosemide  200  mg ; furosemide  120  mg ; 
acute kidney failure, unspecified presence of prosthetic heart valve unspecified atherosclerosis of native arteries of extremities, unspecified extremity adverse effect of other systemic antibiotics, sequela long term (current) use of anticoagulants encephalopathy, unspecified other injury of urethra, initial encounter unspecified place or not applicable pneumonia due to other gram-negative bacteria tracheostomy status hyperlipidemia, unspecified presence of cardiac pacemaker abdominal distension (gaseous) retention of urine, unspecified personal history of other malignant neoplasm of bronchus and lung cellulitis of right lower limb acute posthemorrhagic anemia anxiety disorder, unspecified diarrhea, unspecified pulmonary hypertension, unspecified other specified disorders of urethra personal history of sudden cardiac arrest personal history of nicotine dependence urinary catheterization as the cause of abnormal reaction of the patient, or of later complication, without mention of misadventure at the time of the procedure hypokalemia hyperosmolality and hypernatremia physical restraint status gastrostomy status other vasculitis limited to the skin acute and chronic respiratory failure with hypercapnia delirium due to known physiological condition adverse effect of penicillins, sequela chronic obstructive pulmonary disease, unspecified unspecified place in hospital as the place of occurrence of the external cause other vasculitis limited to the skin chronic obstructive pulmonary disease, unspecified chronic pulmonary edema acute and chronic respiratory failure, unspecified whether with hypoxia or hypercapnia pulmonary hypertension, unspecified presence of cardiac pacemaker thrombocytopenia, unspecified pneumonia, unspecified organism essential (primary) hypertension rash and other nonspecific skin eruption tracheostomy status chronic respiratory failure, unspecified whether with hypoxia or hypercapnia personal history of other malignant neoplasm of bronchus and lung long term (current) use of anticoagulants
black african american m 76 $nan$hematology blood hematocrit  26.2  %; hematology blood hemoglobin  7.6  g dl; hematology blood platelet count  154  k ul; chemistry blood anion gap  13  meq l; chemistry blood bicarbonate  38  meq l; chemistry blood chloride  89  meq l; chemistry blood creatinine  0.7  mg dl; chemistry blood potassium  4.1  meq l; chemistry blood sodium  140  meq l; chemistry blood urea nitrogen  32  mg dl; hematology blood inr(pt)  1.2  ; chemistry blood calcium, total  8.8  mg dl; chemistry blood glucose  105  mg dl$0.9% sodium chloride  100  ml ; gabapentin  300  mg ; acetaminophen (liquid)  975  mg ; hydromorphone (dilaudid)  0.5  mg ; lidocaine 5% patch  1  ptch ; polyethylene glycol  17  g ; pravastatin  40  mg ; sarna lotion  1  appl ; senna  17.2  mg ; simethicone  80  mg ; sodium bicarbonate  650  mg ; tamsulosin  0.4  mg ; trazodone  100  mg ; vitamin d  1000  unit ; lansoprazole oral disintegrating tab  30  mg ; heparin  2100  unit ; losartan potassium  25  mg ; metoprolol tartrate  25  mg ; prednisone  10  mg ; furosemide  120  mg ; warfarin  2.5  mg ; warfarin  5  mg ; metolazone  2.5  mg ; syringe  5  ml ; tranexamic acid  500  mg ; 
acute kidney failure, unspecified presence of prosthetic heart valve unspecified atherosclerosis of native arteries of extremities, unspecified extremity adverse effect of other systemic antibiotics, sequela long term (current) use of anticoagulants encephalopathy, unspecified other injury of urethra, initial encounter unspecified place or not applicable pneumonia due to other gram-negative bacteria tracheostomy status hyperlipidemia, unspecified presence of cardiac pacemaker abdominal distension (gaseous) retention of urine, unspecified personal history of other malignant neoplasm of bronchus and lung cellulitis of right lower limb acute posthemorrhagic anemia anxiety disorder, unspecified diarrhea, unspecified pulmonary hypertension, unspecified other specified disorders of urethra personal history of sudden cardiac arrest personal history of nicotine dependence urinary catheterization as the cause of abnormal reaction of the patient, or of later complication, without mention of misadventure at the time of the procedure hypokalemia hyperosmolality and hypernatremia physical restraint status gastrostomy status other vasculitis limited to the skin acute and chronic respiratory failure with hypercapnia delirium due to known physiological condition adverse effect of penicillins, sequela chronic obstructive pulmonary disease, unspecified unspecified place in hospital as the place of occurrence of the external cause other vasculitis limited to the skin chronic obstructive pulmonary disease, unspecified chronic pulmonary edema acute and chronic respiratory failure, unspecified whether with hypoxia or hypercapnia pulmonary hypertension, unspecified presence of cardiac pacemaker thrombocytopenia, unspecified pneumonia, unspecified organism essential (primary) hypertension rash and other nonspecific skin eruption tracheostomy status chronic respiratory failure, unspecified whether with hypoxia or hypercapnia personal history of other malignant neoplasm of bronchus and lung long term (current) use of anticoagulants
black african american m 76 $nan$hematology blood hematocrit  29.1  %; hematology blood hemoglobin  8.3  g dl; hematology blood platelet count  171  k ul; chemistry blood anion gap  9  meq l; chemistry blood bicarbonate  40  meq l; chemistry blood chloride  89  meq l; chemistry blood creatinine  0.7  mg dl; chemistry blood potassium  4.0  meq l; chemistry blood sodium  141  meq l; chemistry blood urea nitrogen  31  mg dl; hematology blood inr(pt)  1.2  ; chemistry blood calcium, total  9.2  mg dl; chemistry blood glucose  138  mg dl$0.9% sodium chloride  100  ml ; gabapentin  300  mg ; acetaminophen (liquid)  975  mg ; hydromorphone (dilaudid)  0.5  mg ; lidocaine 5% patch  1  ptch ; polyethylene glycol  17  g ; pravastatin  40  mg ; sarna lotion  1  appl ; senna  17.2  mg ; simethicone  80  mg ; sodium bicarbonate  650  mg ; tamsulosin  0.4  mg ; trazodone  100  mg ; vitamin d  1000  unit ; lansoprazole oral disintegrating tab  30  mg ; heparin  2100  unit ; losartan potassium  25  mg ; metoprolol tartrate  25  mg ; prednisone  10  mg ; metolazone  2.5  mg ; syringe  5  ml ; tranexamic acid  500  mg ; warfarin  1  dose ; lorazepam  0.125-0.25  mg ; 
acute kidney failure, unspecified presence of prosthetic heart valve unspecified atherosclerosis of native arteries of extremities, unspecified extremity adverse effect of other systemic antibiotics, sequela long term (current) use of anticoagulants encephalopathy, unspecified other injury of urethra, initial encounter unspecified place or not applicable pneumonia due to other gram-negative bacteria tracheostomy status hyperlipidemia, unspecified presence of cardiac pacemaker abdominal distension (gaseous) retention of urine, unspecified personal history of other malignant neoplasm of bronchus and lung cellulitis of right lower limb acute posthemorrhagic anemia anxiety disorder, unspecified diarrhea, unspecified pulmonary hypertension, unspecified other specified disorders of urethra personal history of sudden cardiac arrest personal history of nicotine dependence urinary catheterization as the cause of abnormal reaction of the patient, or of later complication, without mention of misadventure at the time of the procedure hypokalemia hyperosmolality and hypernatremia physical restraint status gastrostomy status other vasculitis limited to the skin acute and chronic respiratory failure with hypercapnia delirium due to known physiological condition adverse effect of penicillins, sequela chronic obstructive pulmonary disease, unspecified unspecified place in hospital as the place of occurrence of the external cause other vasculitis limited to the skin chronic obstructive pulmonary disease, unspecified chronic pulmonary edema acute and chronic respiratory failure, unspecified whether with hypoxia or hypercapnia pulmonary hypertension, unspecified presence of cardiac pacemaker thrombocytopenia, unspecified pneumonia, unspecified organism essential (primary) hypertension rash and other nonspecific skin eruption tracheostomy status chronic respiratory failure, unspecified whether with hypoxia or hypercapnia personal history of other malignant neoplasm of bronchus and lung long term (current) use of anticoagulants
black african american m 76 $nan$hematology blood hematocrit  24.8  %; hematology blood hematocrit  15.2  %; hematology blood hematocrit  26.1  %; hematology blood hemoglobin  7.1  g dl; hematology blood hemoglobin  7.7  g dl; hematology blood hemoglobin  4.5  g dl; hematology blood platelet count  154  k ul; hematology blood platelet count  135  k ul; hematology blood platelet count  165  k ul; chemistry blood anion gap  11  meq l; chemistry blood anion gap  8  meq l; chemistry blood bicarbonate  43  meq l; chemistry blood bicarbonate  42  meq l; chemistry blood chloride  88  meq l; chemistry blood chloride  92  meq l; chemistry blood creatinine  0.7  mg dl; chemistry blood creatinine  0.7  mg dl; chemistry blood potassium  4.3  meq l; chemistry blood potassium  4.0  meq l; chemistry blood sodium  141  meq l; chemistry blood sodium  143  meq l; chemistry blood urea nitrogen  32  mg dl; chemistry blood urea nitrogen  32  mg dl; hematology blood inr(pt)  1.3  ; chemistry blood calcium, total  8.9  mg dl; chemistry blood calcium, total  8.7  mg dl; chemistry blood glucose  127  mg dl; chemistry blood glucose  156  mg dl; blood gas blood hematocrit, calculated  24  %; blood gas blood hemoglobin  8.1  g dl$0.9% sodium chloride  100  ml ; gabapentin  300  mg ; acetaminophen (liquid)  975  mg ; polyethylene glycol  17  g ; pravastatin  40  mg ; senna  17.2  mg ; tamsulosin  0.4  mg ; trazodone  100  mg ; vitamin d  1000  unit ; lansoprazole oral disintegrating tab  30  mg ; heparin  2100  unit ; losartan potassium  25  mg ; metoprolol tartrate  25  mg ; syringe  5  ml ; tranexamic acid  500  mg ; warfarin  1  dose ; lorazepam  0.125-0.25  mg ; 
acute kidney failure, unspecified presence of prosthetic heart valve unspecified atherosclerosis of native arteries of extremities, unspecified extremity adverse effect of other systemic antibiotics, sequela long term (current) use of anticoagulants encephalopathy, unspecified other injury of urethra, initial encounter unspecified place or not applicable pneumonia due to other gram-negative bacteria tracheostomy status hyperlipidemia, unspecified presence of cardiac pacemaker abdominal distension (gaseous) retention of urine, unspecified personal history of other malignant neoplasm of bronchus and lung cellulitis of right lower limb acute posthemorrhagic anemia anxiety disorder, unspecified diarrhea, unspecified pulmonary hypertension, unspecified other specified disorders of urethra personal history of sudden cardiac arrest personal history of nicotine dependence urinary catheterization as the cause of abnormal reaction of the patient, or of later complication, without mention of misadventure at the time of the procedure hypokalemia hyperosmolality and hypernatremia physical restraint status gastrostomy status other vasculitis limited to the skin acute and chronic respiratory failure with hypercapnia delirium due to known physiological condition adverse effect of penicillins, sequela chronic obstructive pulmonary disease, unspecified unspecified place in hospital as the place of occurrence of the external cause other vasculitis limited to the skin chronic obstructive pulmonary disease, unspecified chronic pulmonary edema acute and chronic respiratory failure, unspecified whether with hypoxia or hypercapnia pulmonary hypertension, unspecified presence of cardiac pacemaker thrombocytopenia, unspecified pneumonia, unspecified organism essential (primary) hypertension rash and other nonspecific skin eruption tracheostomy status chronic respiratory failure, unspecified whether with hypoxia or hypercapnia personal history of other malignant neoplasm of bronchus and lung long term (current) use of anticoagulants
black african american m 76 $nan$hematology blood hematocrit  26.4  %; hematology blood hemoglobin  7.6  g dl; hematology blood platelet count  158  k ul; chemistry blood anion gap  13  meq l; chemistry blood anion gap  5  meq l; chemistry blood bicarbonate  49  meq l; chemistry blood bicarbonate  42  meq l; chemistry blood chloride  89  meq l; chemistry blood chloride  87  meq l; chemistry blood creatinine  0.8  mg dl; chemistry blood creatinine  0.7  mg dl; chemistry blood potassium  4.8  meq l; chemistry blood potassium  3.8  meq l; chemistry blood sodium  144  meq l; chemistry blood sodium  141  meq l; chemistry blood urea nitrogen  28  mg dl; chemistry blood urea nitrogen  29  mg dl; hematology blood inr(pt)  1.4  ; chemistry blood calcium, total  9.5  mg dl; chemistry blood calcium, total  8.7  mg dl; chemistry blood glucose  110  mg dl; chemistry blood glucose  129  mg dl$0.9% sodium chloride  100  ml ; gabapentin  300  mg ; acetaminophen (liquid)  975  mg ; polyethylene glycol  17  g ; pravastatin  40  mg ; senna  17.2  mg ; tamsulosin  0.4  mg ; trazodone  100  mg ; vitamin d  1000  unit ; lansoprazole oral disintegrating tab  30  mg ; losartan potassium  25  mg ; metoprolol tartrate  25  mg ; syringe  5  ml ; tranexamic acid  500  mg ; warfarin  1  dose ; lorazepam  0.125-0.25  mg ; furosemide  250  mg ; lactated ringers  1000  ml ; 
acute kidney failure, unspecified presence of prosthetic heart valve unspecified atherosclerosis of native arteries of extremities, unspecified extremity adverse effect of other systemic antibiotics, sequela long term (current) use of anticoagulants encephalopathy, unspecified other injury of urethra, initial encounter unspecified place or not applicable pneumonia due to other gram-negative bacteria tracheostomy status hyperlipidemia, unspecified presence of cardiac pacemaker abdominal distension (gaseous) retention of urine, unspecified personal history of other malignant neoplasm of bronchus and lung cellulitis of right lower limb acute posthemorrhagic anemia anxiety disorder, unspecified diarrhea, unspecified pulmonary hypertension, unspecified other specified disorders of urethra personal history of sudden cardiac arrest personal history of nicotine dependence urinary catheterization as the cause of abnormal reaction of the patient, or of later complication, without mention of misadventure at the time of the procedure hypokalemia hyperosmolality and hypernatremia physical restraint status gastrostomy status other vasculitis limited to the skin acute and chronic respiratory failure with hypercapnia delirium due to known physiological condition adverse effect of penicillins, sequela chronic obstructive pulmonary disease, unspecified unspecified place in hospital as the place of occurrence of the external cause other vasculitis limited to the skin chronic obstructive pulmonary disease, unspecified chronic pulmonary edema acute and chronic respiratory failure, unspecified whether with hypoxia or hypercapnia pulmonary hypertension, unspecified presence of cardiac pacemaker thrombocytopenia, unspecified pneumonia, unspecified organism essential (primary) hypertension rash and other nonspecific skin eruption tracheostomy status chronic respiratory failure, unspecified whether with hypoxia or hypercapnia personal history of other malignant neoplasm of bronchus and lung long term (current) use of anticoagulants
black african american m 76 $nan$hematology blood hematocrit  26.0  %; hematology blood hematocrit  26.0  %; hematology blood hemoglobin  7.5  g dl; hematology blood hemoglobin  7.4  g dl; hematology blood platelet count  150  k ul; hematology blood platelet count  160  k ul; chemistry blood anion gap  8  meq l; chemistry blood bicarbonate  43  meq l; chemistry blood chloride  91  meq l; chemistry blood creatinine  0.7  mg dl; chemistry blood potassium  4.1  meq l; chemistry blood sodium  142  meq l; chemistry blood urea nitrogen  29  mg dl; hematology blood inr(pt)  1.3  ; hematology blood inr(pt)  1.3  ; chemistry blood calcium, total  8.9  mg dl; chemistry blood glucose  126  mg dl$0.9% sodium chloride  100  ml ; gabapentin  300  mg ; acetaminophen (liquid)  975  mg ; polyethylene glycol  17  g ; pravastatin  40  mg ; senna  17.2  mg ; tamsulosin  0.4  mg ; trazodone  100  mg ; vitamin d  1000  unit ; lansoprazole oral disintegrating tab  30  mg ; losartan potassium  25  mg ; metoprolol tartrate  25  mg ; syringe  5  ml ; tranexamic acid  500  mg ; warfarin  1  dose ; lorazepam  0.125-0.25  mg ; lactated ringers  1000  ml ; lidocaine 1%  5  ml ; albuterol 0.083% neb soln  1  neb ; heparin  1900-3900  unit ; sodium chloride 0.9%  flush  10-20  ml ; 
acute kidney failure, unspecified presence of prosthetic heart valve unspecified atherosclerosis of native arteries of extremities, unspecified extremity adverse effect of other systemic antibiotics, sequela long term (current) use of anticoagulants encephalopathy, unspecified other injury of urethra, initial encounter unspecified place or not applicable pneumonia due to other gram-negative bacteria tracheostomy status hyperlipidemia, unspecified presence of cardiac pacemaker abdominal distension (gaseous) retention of urine, unspecified personal history of other malignant neoplasm of bronchus and lung cellulitis of right lower limb acute posthemorrhagic anemia anxiety disorder, unspecified diarrhea, unspecified pulmonary hypertension, unspecified other specified disorders of urethra personal history of sudden cardiac arrest personal history of nicotine dependence urinary catheterization as the cause of abnormal reaction of the patient, or of later complication, without mention of misadventure at the time of the procedure hypokalemia hyperosmolality and hypernatremia physical restraint status gastrostomy status other vasculitis limited to the skin acute and chronic respiratory failure with hypercapnia delirium due to known physiological condition adverse effect of penicillins, sequela chronic obstructive pulmonary disease, unspecified unspecified place in hospital as the place of occurrence of the external cause other vasculitis limited to the skin chronic obstructive pulmonary disease, unspecified chronic pulmonary edema acute and chronic respiratory failure, unspecified whether with hypoxia or hypercapnia pulmonary hypertension, unspecified presence of cardiac pacemaker thrombocytopenia, unspecified pneumonia, unspecified organism essential (primary) hypertension rash and other nonspecific skin eruption tracheostomy status chronic respiratory failure, unspecified whether with hypoxia or hypercapnia personal history of other malignant neoplasm of bronchus and lung long term (current) use of anticoagulants
black african american m 76 $nan$hematology blood hematocrit  24.3  %; hematology blood hemoglobin  7.1  g dl; hematology blood platelet count  149  k ul; chemistry blood anion gap  12  meq l; chemistry blood anion gap  11  meq l; chemistry blood anion gap  13  meq l; chemistry blood bicarbonate  42  meq l; chemistry blood bicarbonate  42  meq l; chemistry blood bicarbonate  42  meq l; chemistry blood chloride  88  meq l; chemistry blood chloride  90  meq l; chemistry blood chloride  89  meq l; chemistry blood creatinine  0.8  mg dl; chemistry blood creatinine  0.8  mg dl; chemistry blood creatinine  1.1  mg dl; chemistry blood potassium  4.4  meq l; chemistry blood potassium  4.3  meq l; chemistry blood potassium  4.2  meq l; chemistry blood sodium  142  meq l; chemistry blood sodium  143  meq l; chemistry blood sodium  144  meq l; chemistry blood urea nitrogen  34  mg dl; chemistry blood urea nitrogen  35  mg dl; chemistry blood urea nitrogen  42  mg dl; hematology blood inr(pt)  1.3  ; hematology blood inr(pt)  1.2  ; hematology blood inr(pt)  1.3  ; chemistry blood calcium, total  9.3  mg dl; chemistry blood calcium, total  8.9  mg dl; chemistry blood calcium, total  8.9  mg dl; chemistry blood glucose  139  mg dl; chemistry blood glucose  142  mg dl; chemistry blood glucose  129  mg dl; blood gas blood lactate  1.4  mmol l; blood gas blood lactate  0.9  mmol l; blood gas blood lactate  0.7  mmol l$0.9% sodium chloride  100  ml ; gabapentin  300  mg ; acetaminophen (liquid)  975  mg ; polyethylene glycol  17  g ; pravastatin  40  mg ; senna  17.2  mg ; tamsulosin  0.4  mg ; trazodone  100  mg ; vitamin d  1000  unit ; lansoprazole oral disintegrating tab  30  mg ; losartan potassium  25  mg ; metoprolol tartrate  25  mg ; syringe  5  ml ; tranexamic acid  500  mg ; warfarin  1  dose ; lorazepam  0.125-0.25  mg ; lactated ringers  1000  ml ; heparin  1900-3900  unit ; sodium chloride 0.9%  flush  10-20  ml ; lorazepam  0.25  mg ; acetaminophen (liquid)  1000  mg ; cefepime  2  g ; bumetanide  1  mg ; simethicone  40-80  mg ; 
acute kidney failure, unspecified presence of prosthetic heart valve unspecified atherosclerosis of native arteries of extremities, unspecified extremity adverse effect of other systemic antibiotics, sequela long term (current) use of anticoagulants encephalopathy, unspecified other injury of urethra, initial encounter unspecified place or not applicable pneumonia due to other gram-negative bacteria tracheostomy status hyperlipidemia, unspecified presence of cardiac pacemaker abdominal distension (gaseous) retention of urine, unspecified personal history of other malignant neoplasm of bronchus and lung cellulitis of right lower limb acute posthemorrhagic anemia anxiety disorder, unspecified diarrhea, unspecified pulmonary hypertension, unspecified other specified disorders of urethra personal history of sudden cardiac arrest personal history of nicotine dependence urinary catheterization as the cause of abnormal reaction of the patient, or of later complication, without mention of misadventure at the time of the procedure hypokalemia hyperosmolality and hypernatremia physical restraint status gastrostomy status other vasculitis limited to the skin acute and chronic respiratory failure with hypercapnia delirium due to known physiological condition adverse effect of penicillins, sequela chronic obstructive pulmonary disease, unspecified unspecified place in hospital as the place of occurrence of the external cause other vasculitis limited to the skin chronic obstructive pulmonary disease, unspecified chronic pulmonary edema acute and chronic respiratory failure, unspecified whether with hypoxia or hypercapnia pulmonary hypertension, unspecified presence of cardiac pacemaker thrombocytopenia, unspecified pneumonia, unspecified organism essential (primary) hypertension rash and other nonspecific skin eruption tracheostomy status chronic respiratory failure, unspecified whether with hypoxia or hypercapnia personal history of other malignant neoplasm of bronchus and lung long term (current) use of anticoagulants
black african american m 76 $nan$hematology blood hematocrit  23.6  %; hematology blood hematocrit  29.6  %; hematology blood hemoglobin  6.8  g dl; hematology blood hemoglobin  8.5  g dl; hematology blood platelet count  140  k ul; hematology blood platelet count  165  k ul; chemistry blood anion gap  9  meq l; chemistry blood bicarbonate  40  meq l; chemistry blood chloride  91  meq l; chemistry blood chloride  93  meq l; chemistry blood creatinine  0.9  mg dl; chemistry blood creatinine  0.8  mg dl; chemistry blood potassium  3.7  meq l; chemistry blood potassium  4.4  meq l; chemistry blood sodium  144  meq l; chemistry blood sodium  142  meq l; chemistry blood urea nitrogen  40  mg dl; chemistry blood urea nitrogen  37  mg dl; hematology blood inr(pt)  1.5  ; hematology urine wbc  10  # hpf; chemistry blood calcium, total  8.7  mg dl; chemistry blood calcium, total  9.0  mg dl; chemistry blood glucose  147  mg dl; chemistry blood glucose  150  mg dl; blood gas blood lactate  0.6  mmol l$0.9% sodium chloride  100  ml ; acetaminophen (liquid)  975  mg ; polyethylene glycol  17  g ; pravastatin  40  mg ; senna  17.2  mg ; tamsulosin  0.4  mg ; trazodone  100  mg ; vitamin d  1000  unit ; lansoprazole oral disintegrating tab  30  mg ; losartan potassium  25  mg ; metoprolol tartrate  25  mg ; warfarin  1  dose ; lorazepam  0.125-0.25  mg ; sodium chloride 0.9%  flush  10-20  ml ; acetaminophen (liquid)  1000  mg ; cefepime  2  g ; simethicone  40-80  mg ; 
acute kidney failure, unspecified presence of prosthetic heart valve unspecified atherosclerosis of native arteries of extremities, unspecified extremity adverse effect of other systemic antibiotics, sequela long term (current) use of anticoagulants encephalopathy, unspecified other injury of urethra, initial encounter unspecified place or not applicable pneumonia due to other gram-negative bacteria tracheostomy status hyperlipidemia, unspecified presence of cardiac pacemaker abdominal distension (gaseous) retention of urine, unspecified personal history of other malignant neoplasm of bronchus and lung cellulitis of right lower limb acute posthemorrhagic anemia anxiety disorder, unspecified diarrhea, unspecified pulmonary hypertension, unspecified other specified disorders of urethra personal history of sudden cardiac arrest personal history of nicotine dependence urinary catheterization as the cause of abnormal reaction of the patient, or of later complication, without mention of misadventure at the time of the procedure hypokalemia hyperosmolality and hypernatremia physical restraint status gastrostomy status other vasculitis limited to the skin acute and chronic respiratory failure with hypercapnia delirium due to known physiological condition adverse effect of penicillins, sequela chronic obstructive pulmonary disease, unspecified unspecified place in hospital as the place of occurrence of the external cause other vasculitis limited to the skin chronic obstructive pulmonary disease, unspecified chronic pulmonary edema acute and chronic respiratory failure, unspecified whether with hypoxia or hypercapnia pulmonary hypertension, unspecified presence of cardiac pacemaker thrombocytopenia, unspecified pneumonia, unspecified organism essential (primary) hypertension rash and other nonspecific skin eruption tracheostomy status chronic respiratory failure, unspecified whether with hypoxia or hypercapnia personal history of other malignant neoplasm of bronchus and lung long term (current) use of anticoagulants
black african american m 76 $nan$nan$0.9% sodium chloride  100  ml ; acetaminophen (liquid)  975  mg ; polyethylene glycol  17  g ; pravastatin  40  mg ; senna  17.2  mg ; tamsulosin  0.4  mg ; trazodone  100  mg ; vitamin d  1000  unit ; lansoprazole oral disintegrating tab  30  mg ; losartan potassium  25  mg ; metoprolol tartrate  25  mg ; warfarin  1  dose ; lorazepam  0.125-0.25  mg ; sodium chloride 0.9%  flush  10-20  ml ; acetaminophen (liquid)  1000  mg ; simethicone  40-80  mg ; 
acute kidney failure, unspecified presence of prosthetic heart valve unspecified atherosclerosis of native arteries of extremities, unspecified extremity adverse effect of other systemic antibiotics, sequela long term (current) use of anticoagulants encephalopathy, unspecified other injury of urethra, initial encounter unspecified place or not applicable pneumonia due to other gram-negative bacteria tracheostomy status hyperlipidemia, unspecified presence of cardiac pacemaker abdominal distension (gaseous) retention of urine, unspecified personal history of other malignant neoplasm of bronchus and lung cellulitis of right lower limb acute posthemorrhagic anemia anxiety disorder, unspecified diarrhea, unspecified pulmonary hypertension, unspecified other specified disorders of urethra personal history of sudden cardiac arrest personal history of nicotine dependence urinary catheterization as the cause of abnormal reaction of the patient, or of later complication, without mention of misadventure at the time of the procedure hypokalemia hyperosmolality and hypernatremia physical restraint status gastrostomy status other vasculitis limited to the skin acute and chronic respiratory failure with hypercapnia delirium due to known physiological condition adverse effect of penicillins, sequela chronic obstructive pulmonary disease, unspecified unspecified place in hospital as the place of occurrence of the external cause other vasculitis limited to the skin chronic obstructive pulmonary disease, unspecified chronic pulmonary edema acute and chronic respiratory failure, unspecified whether with hypoxia or hypercapnia pulmonary hypertension, unspecified presence of cardiac pacemaker thrombocytopenia, unspecified pneumonia, unspecified organism essential (primary) hypertension rash and other nonspecific skin eruption tracheostomy status chronic respiratory failure, unspecified whether with hypoxia or hypercapnia personal history of other malignant neoplasm of bronchus and lung long term (current) use of anticoagulants
white f 83 $nan$nan$aspirin ec  325  mg ; clopidogrel  75  mg ; lisinopril  20  mg ; isosorbide mononitrate (extended release)  30  mg ; ranitidine  150  mg ; hydrochlorothiazide  12.5  mg ; atenolol  100  mg ; simvastatin  40  mg ; vitamin d  1000  unit ; 
swelling of limb irritable bowel syndrome peripheral vascular disease, unspecified coronary atherosclerosis of native coronary artery thrombocytopenia, unspecified other and unspecified hyperlipidemia mitral valve insufficiency and aortic valve insufficiency esophageal reflux chronic diastolic heart failure gout, unspecified abdominal aneurysm without mention of rupture accidental puncture or laceration during a procedure, not elsewhere classified acute kidney failure, unspecified chronic vascular insufficiency of intestine dehydration subendocardial infarction, initial episode of care congestive heart failure, unspecified person boarding or alighting a pedal cycle injured in collision with pedestrian or animal personal history of malignant neoplasm of breast 
white f 83 $nan$hematology blood hematocrit  26.6  %; hematology blood hematocrit  24.7  %; hematology blood hematocrit  22.4  %; hematology blood hemoglobin  8.3  g dl; hematology blood hemoglobin  7.9  g dl; hematology blood platelet count  155  k ul; hematology blood platelet count  161  k ul; hematology blood platelet count  136  k ul; chemistry blood anion gap  16  meq l; chemistry blood anion gap  16  meq l; chemistry blood bicarbonate  25  meq l; chemistry blood bicarbonate  24  meq l; chemistry blood chloride  98  meq l; chemistry blood chloride  99  meq l; chemistry blood chloride  99  meq l; chemistry blood creatinine  1.4  mg dl; chemistry blood creatinine  1.6  mg dl; chemistry blood potassium  4.4  meq l; chemistry blood potassium  4.6  meq l; chemistry blood potassium  4.7  meq l; chemistry blood sodium  135  meq l; chemistry blood sodium  135  meq l; chemistry blood sodium  134  meq l; chemistry blood urea nitrogen  43  mg dl; chemistry blood urea nitrogen  50  mg dl; chemistry blood calcium, total  9.0  mg dl; chemistry blood calcium, total  8.7  mg dl; chemistry blood glucose  103  mg dl; chemistry blood glucose  114  mg dl$aspirin ec  325  mg ; clopidogrel  75  mg ; lisinopril  20  mg ; isosorbide mononitrate (extended release)  30  mg ; ranitidine  150  mg ; hydrochlorothiazide  12.5  mg ; atenolol  100  mg ; simvastatin  40  mg ; vitamin d  1000  unit ; heparin  3000  unit ; heparin  500  unit ; 5% dextrose  250  ml ; heparin sodium  25,000  unit ; 1 2 ns  1000  ml ; atropine sulfate  0.5  mg ; sodium chloride 0.9%  flush  3  ml ; acetaminophen  500  mg ; furosemide  40  mg ; ipratropium bromide neb  1  neb ; furosemide  20  mg ; senna  1  tab ; heparin  5000  unit ; docusate sodium  100  mg ; ondansetron  4  mg ; trazodone  25  mg ; 0.9% sodium chloride  1000  ml ; polyethylene glycol  17  g ; 
swelling of limb irritable bowel syndrome peripheral vascular disease, unspecified coronary atherosclerosis of native coronary artery thrombocytopenia, unspecified other and unspecified hyperlipidemia mitral valve insufficiency and aortic valve insufficiency esophageal reflux chronic diastolic heart failure gout, unspecified abdominal aneurysm without mention of rupture accidental puncture or laceration during a procedure, not elsewhere classified acute kidney failure, unspecified chronic vascular insufficiency of intestine dehydration subendocardial infarction, initial episode of care congestive heart failure, unspecified person boarding or alighting a pedal cycle injured in collision with pedestrian or animal personal history of malignant neoplasm of breast 
white f 83 $nan$hematology blood hematocrit  24.0  %; hematology blood hemoglobin  8.6  g dl; hematology blood platelet count  116  k ul; chemistry blood anion gap  15  meq l; chemistry blood bicarbonate  25  meq l; chemistry blood chloride  101  meq l; chemistry blood creatinine  1.8  mg dl; chemistry blood potassium  4.3  meq l; chemistry blood sodium  137  meq l; chemistry blood urea nitrogen  59  mg dl; chemistry blood calcium, total  8.3  mg dl; chemistry blood glucose  113  mg dl$aspirin ec  325  mg ; clopidogrel  75  mg ; lisinopril  20  mg ; ranitidine  150  mg ; simvastatin  40  mg ; vitamin d  1000  unit ; atropine sulfate  0.5  mg ; sodium chloride 0.9%  flush  3  ml ; acetaminophen  500  mg ; ipratropium bromide neb  1  neb ; furosemide  20  mg ; senna  1  tab ; heparin  5000  unit ; docusate sodium  100  mg ; ondansetron  4  mg ; trazodone  25  mg ; 0.9% sodium chloride  1000  ml ; polyethylene glycol  17  g ; metoprolol tartrate  12.5  mg ; 
swelling of limb irritable bowel syndrome peripheral vascular disease, unspecified coronary atherosclerosis of native coronary artery thrombocytopenia, unspecified other and unspecified hyperlipidemia mitral valve insufficiency and aortic valve insufficiency esophageal reflux chronic diastolic heart failure gout, unspecified abdominal aneurysm without mention of rupture accidental puncture or laceration during a procedure, not elsewhere classified acute kidney failure, unspecified chronic vascular insufficiency of intestine dehydration subendocardial infarction, initial episode of care congestive heart failure, unspecified person boarding or alighting a pedal cycle injured in collision with pedestrian or animal personal history of malignant neoplasm of breast 
white f 83 $nan$hematology blood hematocrit  27.3  %; hematology blood hematocrit  27.4  %; hematology blood hemoglobin  10.0  g dl; hematology blood platelet count  127  k ul; chemistry blood anion gap  15  meq l; chemistry blood bicarbonate  25  meq l; chemistry blood chloride  99  meq l; chemistry blood creatinine  1.8  mg dl; chemistry blood potassium  3.7  meq l; chemistry blood sodium  135  meq l; chemistry blood urea nitrogen  69  mg dl; chemistry blood calcium, total  8.7  mg dl; chemistry blood glucose  97  mg dl$aspirin ec  325  mg ; clopidogrel  75  mg ; lisinopril  20  mg ; ranitidine  150  mg ; simvastatin  40  mg ; vitamin d  1000  unit ; atropine sulfate  0.5  mg ; sodium chloride 0.9%  flush  3  ml ; acetaminophen  500  mg ; senna  1  tab ; heparin  5000  unit ; docusate sodium  100  mg ; ondansetron  4  mg ; trazodone  25  mg ; polyethylene glycol  17  g ; potassium chloride  20  meq ; 
swelling of limb irritable bowel syndrome peripheral vascular disease, unspecified coronary atherosclerosis of native coronary artery thrombocytopenia, unspecified other and unspecified hyperlipidemia mitral valve insufficiency and aortic valve insufficiency esophageal reflux chronic diastolic heart failure gout, unspecified abdominal aneurysm without mention of rupture accidental puncture or laceration during a procedure, not elsewhere classified acute kidney failure, unspecified chronic vascular insufficiency of intestine dehydration subendocardial infarction, initial episode of care congestive heart failure, unspecified person boarding or alighting a pedal cycle injured in collision with pedestrian or animal personal history of malignant neoplasm of breast 
white f 83 $nan$hematology blood hematocrit  30.2  %; hematology blood hemoglobin  9.9  g dl; hematology blood platelet count  176  k ul; chemistry blood anion gap  14  meq l; chemistry blood bicarbonate  25  meq l; chemistry blood chloride  101  meq l; chemistry blood creatinine  1.5  mg dl; chemistry blood potassium  4.0  meq l; chemistry blood sodium  136  meq l; chemistry blood urea nitrogen  62  mg dl; chemistry blood calcium, total  8.7  mg dl; chemistry blood glucose  90  mg dl$aspirin ec  325  mg ; clopidogrel  75  mg ; lisinopril  20  mg ; ranitidine  150  mg ; simvastatin  40  mg ; vitamin d  1000  unit ; atropine sulfate  0.5  mg ; sodium chloride 0.9%  flush  3  ml ; acetaminophen  500  mg ; senna  1  tab ; heparin  5000  unit ; docusate sodium  100  mg ; ondansetron  4  mg ; trazodone  25  mg ; polyethylene glycol  17  g ; potassium chloride  20  meq ; 
swelling of limb irritable bowel syndrome peripheral vascular disease, unspecified coronary atherosclerosis of native coronary artery thrombocytopenia, unspecified other and unspecified hyperlipidemia mitral valve insufficiency and aortic valve insufficiency esophageal reflux chronic diastolic heart failure gout, unspecified abdominal aneurysm without mention of rupture accidental puncture or laceration during a procedure, not elsewhere classified acute kidney failure, unspecified chronic vascular insufficiency of intestine dehydration subendocardial infarction, initial episode of care congestive heart failure, unspecified person boarding or alighting a pedal cycle injured in collision with pedestrian or animal personal history of malignant neoplasm of breast 
white f 83 $nan$nan$aspirin ec  325  mg ; clopidogrel  75  mg ; lisinopril  20  mg ; ranitidine  150  mg ; simvastatin  40  mg ; vitamin d  1000  unit ; atropine sulfate  0.5  mg ; sodium chloride 0.9%  flush  3  ml ; acetaminophen  500  mg ; senna  1  tab ; heparin  5000  unit ; docusate sodium  100  mg ; ondansetron  4  mg ; trazodone  25  mg ; polyethylene glycol  17  g ; 
swelling of limb irritable bowel syndrome peripheral vascular disease, unspecified coronary atherosclerosis of native coronary artery thrombocytopenia, unspecified other and unspecified hyperlipidemia mitral valve insufficiency and aortic valve insufficiency esophageal reflux chronic diastolic heart failure gout, unspecified abdominal aneurysm without mention of rupture accidental puncture or laceration during a procedure, not elsewhere classified acute kidney failure, unspecified chronic vascular insufficiency of intestine dehydration subendocardial infarction, initial episode of care congestive heart failure, unspecified person boarding or alighting a pedal cycle injured in collision with pedestrian or animal personal history of malignant neoplasm of breast 
hispanic latino m 53 $nan$hematology blood hematocrit  41.4  %; hematology blood hemoglobin  14.5  g dl; hematology blood platelet count  259  k ul; chemistry blood anion gap  15  meq l; chemistry blood bicarbonate  24  meq l; chemistry blood chloride  98  meq l; chemistry blood creatinine  0.8  mg dl; chemistry blood potassium  4.1  meq l; chemistry blood sodium  133  meq l; chemistry blood urea nitrogen  14  mg dl; chemistry blood calcium, total  8.7  mg dl; chemistry blood glucose  156  mg dl$senna  1  tab ; bisacodyl  10  mg ; influenza virus vaccine  0.5  ml ; sodium chloride 0.9%  flush  3  ml ; 0.45% sodium chloride  1000  ml ; acetaminophen  325-650  mg ; oxycodone-acetaminophen  1-2  tab ; morphine sulfate  1-2  mg ; ondansetron  4  mg ; hydralazine  25  mg ; acetaminophen iv  1000  mg ; isotonic sodium chloride  50  ml ; gentamicin  80  mg ; cyclobenzaprine  10  mg ; docusate sodium  100  mg ; heparin  5000  unit ; gabapentin  600  mg ; iso-osmotic dextrose  200  ml ; vancomycin  1000  mg ; simethicone  40-80  mg ; 
 
hispanic latino m 53 $nan$nan$senna  1  tab ; bisacodyl  10  mg ; influenza virus vaccine  0.5  ml ; sodium chloride 0.9%  flush  3  ml ; 0.45% sodium chloride  1000  ml ; acetaminophen  325-650  mg ; oxycodone-acetaminophen  1-2  tab ; morphine sulfate  1-2  mg ; ondansetron  4  mg ; hydralazine  25  mg ; isotonic sodium chloride  50  ml ; gentamicin  80  mg ; cyclobenzaprine  10  mg ; docusate sodium  100  mg ; heparin  5000  unit ; gabapentin  600  mg ; iso-osmotic dextrose  200  ml ; vancomycin  1000  mg ; simethicone  40-80  mg ; fexofenadine  60  mg ; morphine sulfate  2-6  mg ; morphine sulfate  2  mg ; atenolol  25  mg ; fluticasone propionate nasal  2  spry ; oxycodone sr (oxycontin)  20  mg ; oxycodone (immediate release)   5-10  mg ; 
 
hispanic latino m 53 $nan$nan$senna  1  tab ; bisacodyl  10  mg ; influenza virus vaccine  0.5  ml ; sodium chloride 0.9%  flush  3  ml ; 0.45% sodium chloride  1000  ml ; acetaminophen  325-650  mg ; ondansetron  4  mg ; hydralazine  25  mg ; cyclobenzaprine  10  mg ; docusate sodium  100  mg ; heparin  5000  unit ; gabapentin  600  mg ; simethicone  40-80  mg ; fexofenadine  60  mg ; atenolol  25  mg ; fluticasone propionate nasal  2  spry ; oxycodone sr (oxycontin)  20  mg ; oxycodone (immediate release)   5-10  mg ; magnesium citrate  150  ml ; milk of magnesia  30  ml ; fleet enema  1  enema ; 
 
hispanic latino m 53 $nan$nan$senna  1  tab ; bisacodyl  10  mg ; influenza virus vaccine  0.5  ml ; sodium chloride 0.9%  flush  3  ml ; 0.45% sodium chloride  1000  ml ; acetaminophen  325-650  mg ; ondansetron  4  mg ; hydralazine  25  mg ; cyclobenzaprine  10  mg ; docusate sodium  100  mg ; heparin  5000  unit ; gabapentin  600  mg ; simethicone  40-80  mg ; fexofenadine  60  mg ; atenolol  25  mg ; fluticasone propionate nasal  2  spry ; oxycodone sr (oxycontin)  20  mg ; oxycodone (immediate release)   5-10  mg ; magnesium citrate  150  ml ; milk of magnesia  30  ml ; fleet enema  1  enema ; 
 
white m 92 $nan$hematology blood hematocrit  29.5  %; hematology blood hemoglobin  9.8  g dl; hematology blood platelet count  243  k ul; chemistry blood anion gap  11  meq l; chemistry blood bicarbonate  20  meq l; chemistry blood chloride  114  meq l; chemistry blood creatinine  1.6  mg dl; chemistry blood potassium  4.9  meq l; chemistry blood sodium  140  meq l; chemistry blood urea nitrogen  39  mg dl; chemistry blood calcium, total  8.7  mg dl; chemistry blood glucose  102  mg dl$clopidogrel  75  mg ; finasteride  5  mg ; lisinopril  5  mg ; omeprazole  40  mg ; aspirin  325  mg ; sodium chloride 0.9%  flush  3  ml ; metronidazole topical 1 % gel  1  appl ; pravastatin  10  mg ; 
other and unspecified hyperlipidemia streptococcus infection in conditions classified elsewhere and of unspecified site, streptococcus, group d [enterococcus] chronic kidney disease, unspecified syncope and collapse osteoporosis, unspecified percutaneous transluminal coronary angioplasty status hypertrophy (benign) of prostate without urinary obstruction and other lower urinary tract symptom (luts) coronary atherosclerosis of native coronary artery dehydration acute upper respiratory infections of unspecified site hypertensive chronic kidney disease, unspecified, with chronic kidney disease stage i through stage iv, or unspecified urinary tract infection, site not specified
white m 92 $nan$nan$clopidogrel  75  mg ; finasteride  5  mg ; lisinopril  5  mg ; omeprazole  40  mg ; aspirin  325  mg ; sodium chloride 0.9%  flush  3  ml ; metronidazole topical 1 % gel  1  appl ; pravastatin  10  mg ; 
other and unspecified hyperlipidemia streptococcus infection in conditions classified elsewhere and of unspecified site, streptococcus, group d [enterococcus] chronic kidney disease, unspecified syncope and collapse osteoporosis, unspecified percutaneous transluminal coronary angioplasty status hypertrophy (benign) of prostate without urinary obstruction and other lower urinary tract symptom (luts) coronary atherosclerosis of native coronary artery dehydration acute upper respiratory infections of unspecified site hypertensive chronic kidney disease, unspecified, with chronic kidney disease stage i through stage iv, or unspecified urinary tract infection, site not specified
white m 64 $nan$hematology blood hematocrit  26.2  %; hematology blood hematocrit  23.9  %; hematology blood hemoglobin  8.5  g dl; hematology blood hemoglobin  8.0  g dl; hematology blood platelet count  128  k ul; hematology blood platelet count  104  k ul; chemistry blood anion gap  20  meq l; chemistry blood anion gap  13  meq l; chemistry blood bicarbonate  22  meq l; chemistry blood bicarbonate  25  meq l; chemistry blood chloride  103  meq l; chemistry blood chloride  107  meq l; chemistry blood creatinine  6.8  mg dl; chemistry blood creatinine  3.2  mg dl; chemistry blood potassium  4.8  meq l; chemistry blood potassium  4.4  meq l; chemistry blood sodium  140  meq l; chemistry blood sodium  141  meq l; chemistry blood urea nitrogen  159  mg dl; chemistry blood urea nitrogen  84  mg dl; chemistry blood calcium, total  7.7  mg dl; chemistry blood calcium, total  7.0  mg dl; chemistry blood glucose  164  mg dl; chemistry blood glucose  168  mg dl$valganciclovir  450  mg ; famotidine  20  mg ; influenza virus vaccine  0.5  ml ; heparin flush (10 units ml)  1  ml ; d5 1 2ns  1000  ml ; 0.45% sodium chloride  1000  ml ; nystatin oral suspension  5  ml ; morphine sulfate  1  mg ; acetaminophen  650  mg ; diphenhydramine  25-50  mg ; ondansetron  4  mg ; 0.9% sodium chloride  100  ml ; cefazolin  2  g ; allopurinol  100  mg ; tacrolimus  2  mg ; docusate sodium  100  mg ; heparin  5000  unit ; mycophenolate mofetil  1000  mg ; insulin  0  unit ; dextrose 50%  12.5  gm ; glucagon  1  mg ; tacrolimus  4  mg ; 
acute kidney failure, unspecified chronic kidney disease, unspecified unspecified otitis media other and unspecified hyperlipidemia personal history of noncompliance with medical treatment, presenting hazards to health pancreas replaced by transplant hip joint replacement car passenger injured in collision with van in traffic accident background retinopathy, unspecified hyperpotassemia hypertensive chronic kidney disease, unspecified, with chronic kidney disease stage i through stage iv, or unspecified anemia in chronic kidney disease gout, unspecified complications of transplanted kidney atrial fibrillation nephritis and nephropathy, not specified as acute or chronic, with other specified pathological lesion in kidney precipitous drop in hematocrit atrial fibrillation chronic kidney disease, stage iv (severe) disorder of bone and cartilage, unspecified pancreas replaced by transplant unspecified otitis media hypertensive chronic kidney disease, unspecified, with chronic kidney disease stage i through stage iv, or unspecified background retinopathy, unspecified surgical operation with transplant of whole organ causing abnormal patient reaction, or later complication, without mention of misadventure at time of operation other and unspecified hyperlipidemia hypertrophy (benign) of prostate with urinary obstruction and other lower urinary tract symptoms (luts) gout, unspecified osteoarthrosis, unspecified whether generalized or localized, pelvic region and thigh other specified retention of urine complications of transplanted kidney unspecified otitis media chronic glomerulonephritis with other specified pathological lesion in kidney cellulitis and abscess of leg, except foot gout, unspecified other and unspecified hyperlipidemia transplanted organ removal status other complications due to other internal prosthetic device, implant, and graft long-term (current) use of steroids atrial fibrillation background diabetic retinopathy surgical operation with transplant of whole organ causing abnormal patient reaction, or later complication, without mention of misadventure at time of operation diabetes with ophthalmic manifestations, type ii or unspecified type, not stated as uncontrolled pancreas replaced by transplant hypertensive chronic kidney disease, unspecified, with chronic kidney disease stage i through stage iv, or unspecified chronic kidney disease, stage iv (severe) gout, unspecified car driver injured in collision with two- or three-wheeled motor vehicle in nontraffic accident
white m 64 $nan$hematology blood hematocrit  20.8  %; hematology blood hematocrit  25.5  %; hematology blood hematocrit  23.9  %; hematology blood hemoglobin  8.5  g dl; hematology blood platelet count  101  k ul; chemistry blood anion gap  11  meq l; chemistry blood anion gap  11  meq l; chemistry blood bicarbonate  25  meq l; chemistry blood bicarbonate  23  meq l; chemistry blood chloride  112  meq l; chemistry blood chloride  113  meq l; chemistry blood creatinine  2.1  mg dl; chemistry blood creatinine  1.8  mg dl; chemistry blood potassium  4.8  meq l; chemistry blood potassium  5.0  meq l; chemistry blood sodium  143  meq l; chemistry blood sodium  142  meq l; chemistry blood urea nitrogen  55  mg dl; chemistry blood urea nitrogen  47  mg dl; chemistry blood calcium, total  6.8  mg dl; chemistry blood glucose  132  mg dl; chemistry blood glucose  141  mg dl$valganciclovir  450  mg ; famotidine  20  mg ; heparin flush (10 units ml)  1  ml ; d5 1 2ns  1000  ml ; nystatin oral suspension  5  ml ; morphine sulfate  1  mg ; acetaminophen  650  mg ; diphenhydramine  25-50  mg ; ondansetron  4  mg ; 0.9% sodium chloride  100  ml ; cefazolin  2  g ; allopurinol  100  mg ; tacrolimus  2  mg ; docusate sodium  100  mg ; heparin  5000  unit ; mycophenolate mofetil  1000  mg ; tacrolimus  4  mg ; methylprednisolone sodium succ  100  mg ; cephalexin  500  mg ; 0.9% sodium chloride  250  ml ; anti-thymocyte globulin (rabbit)  100  mg ; ciprofloxacin 0.3% ophth soln  5  drop ; anti-thymocyte globulin (rabbit)  0  md to order daily dose ; prednisone  5  mg ; polyethylene glycol  17  g ; folic acid  1  mg ; transplant self medication program  1  bag ; hydromorphone (dilaudid)  0.5-1  mg ; tacrolimus  3  mg ; doxazosin  2  mg ; sodium chloride 0.9%  flush  3  ml ; 0.9% sodium chloride  2  bag ; calcium gluconate  4  g ; 
acute kidney failure, unspecified chronic kidney disease, unspecified unspecified otitis media other and unspecified hyperlipidemia personal history of noncompliance with medical treatment, presenting hazards to health pancreas replaced by transplant hip joint replacement car passenger injured in collision with van in traffic accident background retinopathy, unspecified hyperpotassemia hypertensive chronic kidney disease, unspecified, with chronic kidney disease stage i through stage iv, or unspecified anemia in chronic kidney disease gout, unspecified complications of transplanted kidney atrial fibrillation nephritis and nephropathy, not specified as acute or chronic, with other specified pathological lesion in kidney precipitous drop in hematocrit atrial fibrillation chronic kidney disease, stage iv (severe) disorder of bone and cartilage, unspecified pancreas replaced by transplant unspecified otitis media hypertensive chronic kidney disease, unspecified, with chronic kidney disease stage i through stage iv, or unspecified background retinopathy, unspecified surgical operation with transplant of whole organ causing abnormal patient reaction, or later complication, without mention of misadventure at time of operation other and unspecified hyperlipidemia hypertrophy (benign) of prostate with urinary obstruction and other lower urinary tract symptoms (luts) gout, unspecified osteoarthrosis, unspecified whether generalized or localized, pelvic region and thigh other specified retention of urine complications of transplanted kidney unspecified otitis media chronic glomerulonephritis with other specified pathological lesion in kidney cellulitis and abscess of leg, except foot gout, unspecified other and unspecified hyperlipidemia transplanted organ removal status other complications due to other internal prosthetic device, implant, and graft long-term (current) use of steroids atrial fibrillation background diabetic retinopathy surgical operation with transplant of whole organ causing abnormal patient reaction, or later complication, without mention of misadventure at time of operation diabetes with ophthalmic manifestations, type ii or unspecified type, not stated as uncontrolled pancreas replaced by transplant hypertensive chronic kidney disease, unspecified, with chronic kidney disease stage i through stage iv, or unspecified chronic kidney disease, stage iv (severe) gout, unspecified car driver injured in collision with two- or three-wheeled motor vehicle in nontraffic accident
white m 64 $nan$hematology blood hematocrit  25.8  %; hematology blood hematocrit  26.1  %; hematology blood hematocrit  30.2  %; hematology blood hematocrit  29.9  %; hematology blood hemoglobin  10.2  g dl; hematology blood platelet count  67  k ul; chemistry blood anion gap  8  meq l; chemistry blood bicarbonate  25  meq l; chemistry blood chloride  110  meq l; chemistry blood creatinine  1.3  mg dl; chemistry blood potassium  5.1  meq l; chemistry blood sodium  138  meq l; chemistry blood urea nitrogen  33  mg dl; hematology blood inr(pt)  1.0  ; chemistry blood calcium, total  7.8  mg dl; chemistry blood glucose  114  mg dl$heparin flush (10 units ml)  1  ml ; acetaminophen  650  mg ; diphenhydramine  25-50  mg ; ondansetron  4  mg ; allopurinol  100  mg ; docusate sodium  100  mg ; heparin  5000  unit ; cephalexin  500  mg ; anti-thymocyte globulin (rabbit)  0  md to order daily dose ; prednisone  5  mg ; polyethylene glycol  17  g ; folic acid  1  mg ; transplant self medication program  1  bag ; hydromorphone (dilaudid)  0.5-1  mg ; doxazosin  2  mg ; sodium chloride 0.9%  flush  3  ml ; 0.9% sodium chloride  2  bag ; calcium gluconate  4  g ; methylprednisolone sodium succ  50  mg ; hydromorphone (dilaudid)  2-4  mg ; 
acute kidney failure, unspecified chronic kidney disease, unspecified unspecified otitis media other and unspecified hyperlipidemia personal history of noncompliance with medical treatment, presenting hazards to health pancreas replaced by transplant hip joint replacement car passenger injured in collision with van in traffic accident background retinopathy, unspecified hyperpotassemia hypertensive chronic kidney disease, unspecified, with chronic kidney disease stage i through stage iv, or unspecified anemia in chronic kidney disease gout, unspecified complications of transplanted kidney atrial fibrillation nephritis and nephropathy, not specified as acute or chronic, with other specified pathological lesion in kidney precipitous drop in hematocrit atrial fibrillation chronic kidney disease, stage iv (severe) disorder of bone and cartilage, unspecified pancreas replaced by transplant unspecified otitis media hypertensive chronic kidney disease, unspecified, with chronic kidney disease stage i through stage iv, or unspecified background retinopathy, unspecified surgical operation with transplant of whole organ causing abnormal patient reaction, or later complication, without mention of misadventure at time of operation other and unspecified hyperlipidemia hypertrophy (benign) of prostate with urinary obstruction and other lower urinary tract symptoms (luts) gout, unspecified osteoarthrosis, unspecified whether generalized or localized, pelvic region and thigh other specified retention of urine complications of transplanted kidney unspecified otitis media chronic glomerulonephritis with other specified pathological lesion in kidney cellulitis and abscess of leg, except foot gout, unspecified other and unspecified hyperlipidemia transplanted organ removal status other complications due to other internal prosthetic device, implant, and graft long-term (current) use of steroids atrial fibrillation background diabetic retinopathy surgical operation with transplant of whole organ causing abnormal patient reaction, or later complication, without mention of misadventure at time of operation diabetes with ophthalmic manifestations, type ii or unspecified type, not stated as uncontrolled pancreas replaced by transplant hypertensive chronic kidney disease, unspecified, with chronic kidney disease stage i through stage iv, or unspecified chronic kidney disease, stage iv (severe) gout, unspecified car driver injured in collision with two- or three-wheeled motor vehicle in nontraffic accident
white m 64 $nan$hematology blood hematocrit  30.4  %; hematology blood hematocrit  29.2  %; hematology blood hemoglobin  10.0  g dl; hematology blood platelet count  83  k ul; chemistry blood anion gap  13  meq l; chemistry blood bicarbonate  22  meq l; chemistry blood chloride  111  meq l; chemistry blood creatinine  1.1  mg dl; chemistry blood potassium  5.1  meq l; chemistry blood sodium  141  meq l; chemistry blood urea nitrogen  32  mg dl; chemistry blood calcium, total  8.5  mg dl; chemistry blood glucose  87  mg dl$heparin flush (10 units ml)  1  ml ; acetaminophen  650  mg ; diphenhydramine  25-50  mg ; ondansetron  4  mg ; docusate sodium  100  mg ; heparin  5000  unit ; cephalexin  500  mg ; anti-thymocyte globulin (rabbit)  0  md to order daily dose ; polyethylene glycol  17  g ; folic acid  1  mg ; transplant self medication program  1  bag ; doxazosin  2  mg ; sodium chloride 0.9%  flush  3  ml ; methylprednisolone sodium succ  50  mg ; hydromorphone (dilaudid)  2-4  mg ; amlodipine  5  mg ; tacrolimus  5  mg ; lidocaine jelly 2% (urojet)  1  appl ; 
acute kidney failure, unspecified chronic kidney disease, unspecified unspecified otitis media other and unspecified hyperlipidemia personal history of noncompliance with medical treatment, presenting hazards to health pancreas replaced by transplant hip joint replacement car passenger injured in collision with van in traffic accident background retinopathy, unspecified hyperpotassemia hypertensive chronic kidney disease, unspecified, with chronic kidney disease stage i through stage iv, or unspecified anemia in chronic kidney disease gout, unspecified complications of transplanted kidney atrial fibrillation nephritis and nephropathy, not specified as acute or chronic, with other specified pathological lesion in kidney precipitous drop in hematocrit atrial fibrillation chronic kidney disease, stage iv (severe) disorder of bone and cartilage, unspecified pancreas replaced by transplant unspecified otitis media hypertensive chronic kidney disease, unspecified, with chronic kidney disease stage i through stage iv, or unspecified background retinopathy, unspecified surgical operation with transplant of whole organ causing abnormal patient reaction, or later complication, without mention of misadventure at time of operation other and unspecified hyperlipidemia hypertrophy (benign) of prostate with urinary obstruction and other lower urinary tract symptoms (luts) gout, unspecified osteoarthrosis, unspecified whether generalized or localized, pelvic region and thigh other specified retention of urine complications of transplanted kidney unspecified otitis media chronic glomerulonephritis with other specified pathological lesion in kidney cellulitis and abscess of leg, except foot gout, unspecified other and unspecified hyperlipidemia transplanted organ removal status other complications due to other internal prosthetic device, implant, and graft long-term (current) use of steroids atrial fibrillation background diabetic retinopathy surgical operation with transplant of whole organ causing abnormal patient reaction, or later complication, without mention of misadventure at time of operation diabetes with ophthalmic manifestations, type ii or unspecified type, not stated as uncontrolled pancreas replaced by transplant hypertensive chronic kidney disease, unspecified, with chronic kidney disease stage i through stage iv, or unspecified chronic kidney disease, stage iv (severe) gout, unspecified car driver injured in collision with two- or three-wheeled motor vehicle in nontraffic accident
white m 64 $nan$nan$heparin flush (10 units ml)  1  ml ; acetaminophen  650  mg ; diphenhydramine  25-50  mg ; ondansetron  4  mg ; docusate sodium  100  mg ; heparin  5000  unit ; cephalexin  500  mg ; anti-thymocyte globulin (rabbit)  0  md to order daily dose ; polyethylene glycol  17  g ; folic acid  1  mg ; transplant self medication program  1  bag ; doxazosin  2  mg ; sodium chloride 0.9%  flush  3  ml ; hydromorphone (dilaudid)  2-4  mg ; amlodipine  5  mg ; tacrolimus  5  mg ; lidocaine jelly 2% (urojet)  1  appl ; prednisone  20  mg ; syringe (sterile water)  6  ml ; pentamidine-inhalation  300  mg ; tacrolimus  6  mg ; 
acute kidney failure, unspecified chronic kidney disease, unspecified unspecified otitis media other and unspecified hyperlipidemia personal history of noncompliance with medical treatment, presenting hazards to health pancreas replaced by transplant hip joint replacement car passenger injured in collision with van in traffic accident background retinopathy, unspecified hyperpotassemia hypertensive chronic kidney disease, unspecified, with chronic kidney disease stage i through stage iv, or unspecified anemia in chronic kidney disease gout, unspecified complications of transplanted kidney atrial fibrillation nephritis and nephropathy, not specified as acute or chronic, with other specified pathological lesion in kidney precipitous drop in hematocrit atrial fibrillation chronic kidney disease, stage iv (severe) disorder of bone and cartilage, unspecified pancreas replaced by transplant unspecified otitis media hypertensive chronic kidney disease, unspecified, with chronic kidney disease stage i through stage iv, or unspecified background retinopathy, unspecified surgical operation with transplant of whole organ causing abnormal patient reaction, or later complication, without mention of misadventure at time of operation other and unspecified hyperlipidemia hypertrophy (benign) of prostate with urinary obstruction and other lower urinary tract symptoms (luts) gout, unspecified osteoarthrosis, unspecified whether generalized or localized, pelvic region and thigh other specified retention of urine complications of transplanted kidney unspecified otitis media chronic glomerulonephritis with other specified pathological lesion in kidney cellulitis and abscess of leg, except foot gout, unspecified other and unspecified hyperlipidemia transplanted organ removal status other complications due to other internal prosthetic device, implant, and graft long-term (current) use of steroids atrial fibrillation background diabetic retinopathy surgical operation with transplant of whole organ causing abnormal patient reaction, or later complication, without mention of misadventure at time of operation diabetes with ophthalmic manifestations, type ii or unspecified type, not stated as uncontrolled pancreas replaced by transplant hypertensive chronic kidney disease, unspecified, with chronic kidney disease stage i through stage iv, or unspecified chronic kidney disease, stage iv (severe) gout, unspecified car driver injured in collision with two- or three-wheeled motor vehicle in nontraffic accident
white f 40 $temp  98.6  heartrate  59.0  resprate  18.0  o2sat  100.0  sbp  119.0  dbp  70.0  rhythm    pain  8  $hematology blood hematocrit  34.5  %; hematology blood hemoglobin  11.3  g dl; hematology blood platelet count  199  k ul; chemistry blood anion gap  13  meq l; chemistry blood bicarbonate  27  meq l; chemistry blood chloride  106  meq l; chemistry blood creatinine  0.7  mg dl; chemistry blood potassium  4.0  meq l; chemistry blood sodium  142  meq l; chemistry blood urea nitrogen  6  mg dl; chemistry blood calcium, total  8.7  mg dl; chemistry blood bilirubin, total  0.2  mg dl; chemistry blood glucose  94  mg dl; chemistry blood lactate dehydrogenase (ld)  149  iu l$influenza vaccine quadrivalent  0.5  ml ; sodium chloride 0.9%  flush  3  ml ; sodium chloride 0.9%  1000  ml ; hydromorphone (dilaudid)  0.5-1  mg ; nicotine patch  21  mg ; clonazepam  1.5  mg ; clonazepam  0.5  mg ; fluticasone propionate nasal  2  spry ; hydroxyzine  25-50  mg ; lamotrigine  200  mg ; levothyroxine sodium  75  mcg ; lidocaine 5% ointment  1  appl ; oxycodone (immediate release)   15-30  mg ; sertraline  200  mg ; ranitidine  150  mg ; heparin  5000  unit ; vancomycin oral liquid  125  mg ; hydromorphone (dilaudid)  1  mg ; hydromorphone (dilaudid)  1.5  mg ; 
unspecified acquired hypothyroidism opiate antagonists causing adverse effects in therapeutic use ulcerative colitis, unspecified other constipation opioid type dependence, continuous myalgia and myositis, unspecified paralytic ileus unspecified car occupant injured in collision with railway train or railway vehicle in nontraffic accident anxiety state, unspecified endometriosis, site unspecified other chronic pain posttraumatic stress disorder acquired absence of intestine (large) (small) adjustment disorder with mixed anxiety and depressed mood tobacco use disorder depressive disorder, not elsewhere classified intestinal bypass or anastomosis status anxiety state, unspecified unspecified acquired hypothyroidism ulcerative colitis, unspecified endometriosis, site unspecified disturbance of skin sensation chronic salpingitis and oophoritis depressive disorder, not elsewhere classified personal history of tobacco use acquired absence of intestine (large) (small) other chronic pain diarrhea other specified disorders of rectum and anus endometriosis, site unspecified nausea with vomiting unspecified acquired hypothyroidism diarrhea ulcerative colitis, unspecified abdominal pain, unspecified site depressive disorder, not elsewhere classified other chronic pain other functional disorders of intestine paralytic ileus anxiety state, unspecified personal history of tobacco use personal history of other diseases of digestive system abdominal pain, unspecified site acquired absence of intestine (large) (small) anxiety state, unspecified diarrhea other chronic pain unspecified acquired hypothyroidism
white f 40 $nan$hematology blood hematocrit  35.4  %; hematology blood hemoglobin  11.4  g dl; hematology blood platelet count  184  k ul; chemistry blood anion gap  8  meq l; chemistry blood bicarbonate  27  meq l; chemistry blood chloride  104  meq l; chemistry blood creatinine  0.6  mg dl; chemistry blood potassium  3.9  meq l; chemistry blood sodium  135  meq l; chemistry blood urea nitrogen  8  mg dl; chemistry blood glucose  94  mg dl$influenza vaccine quadrivalent  0.5  ml ; sodium chloride 0.9%  flush  3  ml ; nicotine patch  21  mg ; clonazepam  1.5  mg ; clonazepam  0.5  mg ; fluticasone propionate nasal  2  spry ; hydroxyzine  25-50  mg ; lamotrigine  200  mg ; levothyroxine sodium  75  mcg ; lidocaine 5% ointment  1  appl ; oxycodone (immediate release)   15-30  mg ; sertraline  200  mg ; ranitidine  150  mg ; heparin  5000  unit ; vancomycin oral liquid  125  mg ; hydromorphone (dilaudid)  1  mg ; hydromorphone (dilaudid)  1.5  mg ; hydromorphone (dilaudid)  2  mg ; simethicone  120  mg ; 
unspecified acquired hypothyroidism opiate antagonists causing adverse effects in therapeutic use ulcerative colitis, unspecified other constipation opioid type dependence, continuous myalgia and myositis, unspecified paralytic ileus unspecified car occupant injured in collision with railway train or railway vehicle in nontraffic accident anxiety state, unspecified endometriosis, site unspecified other chronic pain posttraumatic stress disorder acquired absence of intestine (large) (small) adjustment disorder with mixed anxiety and depressed mood tobacco use disorder depressive disorder, not elsewhere classified intestinal bypass or anastomosis status anxiety state, unspecified unspecified acquired hypothyroidism ulcerative colitis, unspecified endometriosis, site unspecified disturbance of skin sensation chronic salpingitis and oophoritis depressive disorder, not elsewhere classified personal history of tobacco use acquired absence of intestine (large) (small) other chronic pain diarrhea other specified disorders of rectum and anus endometriosis, site unspecified nausea with vomiting unspecified acquired hypothyroidism diarrhea ulcerative colitis, unspecified abdominal pain, unspecified site depressive disorder, not elsewhere classified other chronic pain other functional disorders of intestine paralytic ileus anxiety state, unspecified personal history of tobacco use personal history of other diseases of digestive system abdominal pain, unspecified site acquired absence of intestine (large) (small) anxiety state, unspecified diarrhea other chronic pain unspecified acquired hypothyroidism
white f 40 $nan$hematology blood hematocrit  33.5  %; hematology blood hemoglobin  11.2  g dl; hematology blood platelet count  194  k ul; chemistry blood anion gap  9  meq l; chemistry blood bicarbonate  28  meq l; chemistry blood chloride  105  meq l; chemistry blood creatinine  0.6  mg dl; chemistry blood potassium  4.1  meq l; chemistry blood sodium  138  meq l; chemistry blood urea nitrogen  10  mg dl; chemistry blood glucose  92  mg dl$sodium chloride 0.9%  flush  3  ml ; clonazepam  1.5  mg ; clonazepam  0.5  mg ; fluticasone propionate nasal  2  spry ; hydroxyzine  25-50  mg ; lamotrigine  200  mg ; levothyroxine sodium  75  mcg ; lidocaine 5% ointment  1  appl ; oxycodone (immediate release)   15-30  mg ; sertraline  200  mg ; ranitidine  150  mg ; heparin  5000  unit ; vancomycin oral liquid  125  mg ; hydromorphone (dilaudid)  2  mg ; simethicone  120  mg ; 
unspecified acquired hypothyroidism opiate antagonists causing adverse effects in therapeutic use ulcerative colitis, unspecified other constipation opioid type dependence, continuous myalgia and myositis, unspecified paralytic ileus unspecified car occupant injured in collision with railway train or railway vehicle in nontraffic accident anxiety state, unspecified endometriosis, site unspecified other chronic pain posttraumatic stress disorder acquired absence of intestine (large) (small) adjustment disorder with mixed anxiety and depressed mood tobacco use disorder depressive disorder, not elsewhere classified intestinal bypass or anastomosis status anxiety state, unspecified unspecified acquired hypothyroidism ulcerative colitis, unspecified endometriosis, site unspecified disturbance of skin sensation chronic salpingitis and oophoritis depressive disorder, not elsewhere classified personal history of tobacco use acquired absence of intestine (large) (small) other chronic pain diarrhea other specified disorders of rectum and anus endometriosis, site unspecified nausea with vomiting unspecified acquired hypothyroidism diarrhea ulcerative colitis, unspecified abdominal pain, unspecified site depressive disorder, not elsewhere classified other chronic pain other functional disorders of intestine paralytic ileus anxiety state, unspecified personal history of tobacco use personal history of other diseases of digestive system abdominal pain, unspecified site acquired absence of intestine (large) (small) anxiety state, unspecified diarrhea other chronic pain unspecified acquired hypothyroidism
white f 40 $nan$hematology blood hematocrit  36.6  %; hematology blood hemoglobin  12.1  g dl; hematology blood platelet count  213  k ul; chemistry blood anion gap  12  meq l; chemistry blood bicarbonate  29  meq l; chemistry blood chloride  104  meq l; chemistry blood creatinine  0.7  mg dl; chemistry blood potassium  4.0  meq l; chemistry blood sodium  141  meq l; chemistry blood urea nitrogen  9  mg dl; chemistry blood calcium, total  9.3  mg dl; chemistry blood glucose  94  mg dl$sodium chloride 0.9%  flush  3  ml ; clonazepam  1.5  mg ; clonazepam  0.5  mg ; fluticasone propionate nasal  2  spry ; hydroxyzine  25-50  mg ; lamotrigine  200  mg ; levothyroxine sodium  75  mcg ; lidocaine 5% ointment  1  appl ; oxycodone (immediate release)   15-30  mg ; sertraline  200  mg ; ranitidine  150  mg ; heparin  5000  unit ; vancomycin oral liquid  125  mg ; hydromorphone (dilaudid)  2  mg ; simethicone  120  mg ; zolpidem tartrate  5  mg ; lorazepam  0.5-1  mg ; hydromorphone (dilaudid)  20  mg ; pantoprazole  40  mg ; 
unspecified acquired hypothyroidism opiate antagonists causing adverse effects in therapeutic use ulcerative colitis, unspecified other constipation opioid type dependence, continuous myalgia and myositis, unspecified paralytic ileus unspecified car occupant injured in collision with railway train or railway vehicle in nontraffic accident anxiety state, unspecified endometriosis, site unspecified other chronic pain posttraumatic stress disorder acquired absence of intestine (large) (small) adjustment disorder with mixed anxiety and depressed mood tobacco use disorder depressive disorder, not elsewhere classified intestinal bypass or anastomosis status anxiety state, unspecified unspecified acquired hypothyroidism ulcerative colitis, unspecified endometriosis, site unspecified disturbance of skin sensation chronic salpingitis and oophoritis depressive disorder, not elsewhere classified personal history of tobacco use acquired absence of intestine (large) (small) other chronic pain diarrhea other specified disorders of rectum and anus endometriosis, site unspecified nausea with vomiting unspecified acquired hypothyroidism diarrhea ulcerative colitis, unspecified abdominal pain, unspecified site depressive disorder, not elsewhere classified other chronic pain other functional disorders of intestine paralytic ileus anxiety state, unspecified personal history of tobacco use personal history of other diseases of digestive system abdominal pain, unspecified site acquired absence of intestine (large) (small) anxiety state, unspecified diarrhea other chronic pain unspecified acquired hypothyroidism
white f 40 $nan$hematology blood hematocrit  36.2  %; hematology blood hemoglobin  11.8  g dl; hematology blood platelet count  213  k ul; chemistry blood anion gap  8  meq l; chemistry blood bicarbonate  32  meq l; chemistry blood chloride  103  meq l; chemistry blood creatinine  0.6  mg dl; chemistry blood potassium  4.1  meq l; chemistry blood sodium  139  meq l; chemistry blood urea nitrogen  10  mg dl; chemistry blood calcium, total  9.4  mg dl; chemistry blood glucose  87  mg dl$sodium chloride 0.9%  flush  3  ml ; clonazepam  1.5  mg ; clonazepam  0.5  mg ; fluticasone propionate nasal  2  spry ; hydroxyzine  25-50  mg ; lamotrigine  200  mg ; levothyroxine sodium  75  mcg ; lidocaine 5% ointment  1  appl ; oxycodone (immediate release)   15-30  mg ; sertraline  200  mg ; ranitidine  150  mg ; heparin  5000  unit ; vancomycin oral liquid  125  mg ; simethicone  120  mg ; hydromorphone (dilaudid)  20  mg ; pantoprazole  40  mg ; aluminum-magnesium hydrox.-simethicone  15-30  ml ; 
unspecified acquired hypothyroidism opiate antagonists causing adverse effects in therapeutic use ulcerative colitis, unspecified other constipation opioid type dependence, continuous myalgia and myositis, unspecified paralytic ileus unspecified car occupant injured in collision with railway train or railway vehicle in nontraffic accident anxiety state, unspecified endometriosis, site unspecified other chronic pain posttraumatic stress disorder acquired absence of intestine (large) (small) adjustment disorder with mixed anxiety and depressed mood tobacco use disorder depressive disorder, not elsewhere classified intestinal bypass or anastomosis status anxiety state, unspecified unspecified acquired hypothyroidism ulcerative colitis, unspecified endometriosis, site unspecified disturbance of skin sensation chronic salpingitis and oophoritis depressive disorder, not elsewhere classified personal history of tobacco use acquired absence of intestine (large) (small) other chronic pain diarrhea other specified disorders of rectum and anus endometriosis, site unspecified nausea with vomiting unspecified acquired hypothyroidism diarrhea ulcerative colitis, unspecified abdominal pain, unspecified site depressive disorder, not elsewhere classified other chronic pain other functional disorders of intestine paralytic ileus anxiety state, unspecified personal history of tobacco use personal history of other diseases of digestive system abdominal pain, unspecified site acquired absence of intestine (large) (small) anxiety state, unspecified diarrhea other chronic pain unspecified acquired hypothyroidism
white f 40 $nan$hematology blood hematocrit  34.3  %; hematology blood hemoglobin  11.3  g dl; hematology blood platelet count  201  k ul; chemistry blood anion gap  9  meq l; chemistry blood bicarbonate  30  meq l; chemistry blood chloride  106  meq l; chemistry blood creatinine  0.7  mg dl; chemistry blood potassium  4.1  meq l; chemistry blood sodium  141  meq l; chemistry blood urea nitrogen  11  mg dl; chemistry blood calcium, total  8.8  mg dl; chemistry blood bilirubin, total  0.1  mg dl; chemistry blood glucose  83  mg dl$sodium chloride 0.9%  flush  3  ml ; clonazepam  1.5  mg ; clonazepam  0.5  mg ; fluticasone propionate nasal  2  spry ; hydroxyzine  25-50  mg ; lamotrigine  200  mg ; levothyroxine sodium  75  mcg ; lidocaine 5% ointment  1  appl ; oxycodone (immediate release)   15-30  mg ; sertraline  200  mg ; ranitidine  150  mg ; heparin  5000  unit ; vancomycin oral liquid  125  mg ; simethicone  120  mg ; hydromorphone (dilaudid)  20  mg ; pantoprazole  40  mg ; aluminum-magnesium hydrox.-simethicone  15-30  ml ; 0.9% sodium chloride  100  ml ; hydromorphone  20  mg ; acetaminophen  650  mg ; sarna lotion  1  appl ; trazodone  25  mg ; metronidazole (flagyl)  500  mg ; 
unspecified acquired hypothyroidism opiate antagonists causing adverse effects in therapeutic use ulcerative colitis, unspecified other constipation opioid type dependence, continuous myalgia and myositis, unspecified paralytic ileus unspecified car occupant injured in collision with railway train or railway vehicle in nontraffic accident anxiety state, unspecified endometriosis, site unspecified other chronic pain posttraumatic stress disorder acquired absence of intestine (large) (small) adjustment disorder with mixed anxiety and depressed mood tobacco use disorder depressive disorder, not elsewhere classified intestinal bypass or anastomosis status anxiety state, unspecified unspecified acquired hypothyroidism ulcerative colitis, unspecified endometriosis, site unspecified disturbance of skin sensation chronic salpingitis and oophoritis depressive disorder, not elsewhere classified personal history of tobacco use acquired absence of intestine (large) (small) other chronic pain diarrhea other specified disorders of rectum and anus endometriosis, site unspecified nausea with vomiting unspecified acquired hypothyroidism diarrhea ulcerative colitis, unspecified abdominal pain, unspecified site depressive disorder, not elsewhere classified other chronic pain other functional disorders of intestine paralytic ileus anxiety state, unspecified personal history of tobacco use personal history of other diseases of digestive system abdominal pain, unspecified site acquired absence of intestine (large) (small) anxiety state, unspecified diarrhea other chronic pain unspecified acquired hypothyroidism
white f 40 $nan$hematology blood hematocrit  34.1  %; hematology blood hemoglobin  11.2  g dl; hematology blood platelet count  214  k ul; chemistry blood anion gap  10  meq l; chemistry blood bicarbonate  28  meq l; chemistry blood chloride  105  meq l; chemistry blood creatinine  0.6  mg dl; chemistry blood potassium  4.1  meq l; chemistry blood sodium  139  meq l; chemistry blood urea nitrogen  15  mg dl; chemistry blood calcium, total  9.0  mg dl; chemistry blood glucose  86  mg dl$sodium chloride 0.9%  flush  3  ml ; clonazepam  1.5  mg ; clonazepam  0.5  mg ; fluticasone propionate nasal  2  spry ; hydroxyzine  25-50  mg ; lamotrigine  200  mg ; levothyroxine sodium  75  mcg ; lidocaine 5% ointment  1  appl ; oxycodone (immediate release)   15-30  mg ; sertraline  200  mg ; ranitidine  150  mg ; heparin  5000  unit ; vancomycin oral liquid  125  mg ; simethicone  120  mg ; pantoprazole  40  mg ; aluminum-magnesium hydrox.-simethicone  15-30  ml ; 0.9% sodium chloride  100  ml ; hydromorphone  20  mg ; acetaminophen  650  mg ; sarna lotion  1  appl ; trazodone  25  mg ; metronidazole (flagyl)  500  mg ; 
unspecified acquired hypothyroidism opiate antagonists causing adverse effects in therapeutic use ulcerative colitis, unspecified other constipation opioid type dependence, continuous myalgia and myositis, unspecified paralytic ileus unspecified car occupant injured in collision with railway train or railway vehicle in nontraffic accident anxiety state, unspecified endometriosis, site unspecified other chronic pain posttraumatic stress disorder acquired absence of intestine (large) (small) adjustment disorder with mixed anxiety and depressed mood tobacco use disorder depressive disorder, not elsewhere classified intestinal bypass or anastomosis status anxiety state, unspecified unspecified acquired hypothyroidism ulcerative colitis, unspecified endometriosis, site unspecified disturbance of skin sensation chronic salpingitis and oophoritis depressive disorder, not elsewhere classified personal history of tobacco use acquired absence of intestine (large) (small) other chronic pain diarrhea other specified disorders of rectum and anus endometriosis, site unspecified nausea with vomiting unspecified acquired hypothyroidism diarrhea ulcerative colitis, unspecified abdominal pain, unspecified site depressive disorder, not elsewhere classified other chronic pain other functional disorders of intestine paralytic ileus anxiety state, unspecified personal history of tobacco use personal history of other diseases of digestive system abdominal pain, unspecified site acquired absence of intestine (large) (small) anxiety state, unspecified diarrhea other chronic pain unspecified acquired hypothyroidism
white f 40 $nan$hematology blood hematocrit  33.1  %; hematology blood hemoglobin  11.0  g dl; hematology blood platelet count  192  k ul; chemistry blood anion gap  10  meq l; chemistry blood bicarbonate  28  meq l; chemistry blood chloride  106  meq l; chemistry blood creatinine  0.6  mg dl; chemistry blood potassium  4.2  meq l; chemistry blood sodium  140  meq l; chemistry blood urea nitrogen  14  mg dl; chemistry blood calcium, total  8.9  mg dl; chemistry blood glucose  102  mg dl$sodium chloride 0.9%  flush  3  ml ; clonazepam  1.5  mg ; clonazepam  0.5  mg ; fluticasone propionate nasal  2  spry ; hydroxyzine  25-50  mg ; lamotrigine  200  mg ; levothyroxine sodium  75  mcg ; lidocaine 5% ointment  1  appl ; oxycodone (immediate release)   15-30  mg ; sertraline  200  mg ; ranitidine  150  mg ; heparin  5000  unit ; vancomycin oral liquid  125  mg ; simethicone  120  mg ; pantoprazole  40  mg ; aluminum-magnesium hydrox.-simethicone  15-30  ml ; acetaminophen  650  mg ; sarna lotion  1  appl ; trazodone  25  mg ; metronidazole (flagyl)  500  mg ; olanzapine (disintegrating tablet)  2.5  mg ; lorazepam  0.5  mg ; 
unspecified acquired hypothyroidism opiate antagonists causing adverse effects in therapeutic use ulcerative colitis, unspecified other constipation opioid type dependence, continuous myalgia and myositis, unspecified paralytic ileus unspecified car occupant injured in collision with railway train or railway vehicle in nontraffic accident anxiety state, unspecified endometriosis, site unspecified other chronic pain posttraumatic stress disorder acquired absence of intestine (large) (small) adjustment disorder with mixed anxiety and depressed mood tobacco use disorder depressive disorder, not elsewhere classified intestinal bypass or anastomosis status anxiety state, unspecified unspecified acquired hypothyroidism ulcerative colitis, unspecified endometriosis, site unspecified disturbance of skin sensation chronic salpingitis and oophoritis depressive disorder, not elsewhere classified personal history of tobacco use acquired absence of intestine (large) (small) other chronic pain diarrhea other specified disorders of rectum and anus endometriosis, site unspecified nausea with vomiting unspecified acquired hypothyroidism diarrhea ulcerative colitis, unspecified abdominal pain, unspecified site depressive disorder, not elsewhere classified other chronic pain other functional disorders of intestine paralytic ileus anxiety state, unspecified personal history of tobacco use personal history of other diseases of digestive system abdominal pain, unspecified site acquired absence of intestine (large) (small) anxiety state, unspecified diarrhea other chronic pain unspecified acquired hypothyroidism
white f 40 $nan$hematology blood hematocrit  33.4  %; hematology blood hemoglobin  10.9  g dl; hematology blood platelet count  204  k ul; chemistry blood anion gap  8  meq l; chemistry blood bicarbonate  30  meq l; chemistry blood chloride  104  meq l; chemistry blood creatinine  0.7  mg dl; chemistry blood potassium  4.4  meq l; chemistry blood sodium  138  meq l; chemistry blood urea nitrogen  12  mg dl; chemistry blood calcium, total  9.1  mg dl; chemistry blood glucose  108  mg dl$sodium chloride 0.9%  flush  3  ml ; clonazepam  1.5  mg ; clonazepam  0.5  mg ; fluticasone propionate nasal  2  spry ; hydroxyzine  25-50  mg ; lamotrigine  200  mg ; levothyroxine sodium  75  mcg ; lidocaine 5% ointment  1  appl ; oxycodone (immediate release)   15-30  mg ; sertraline  200  mg ; ranitidine  150  mg ; heparin  5000  unit ; vancomycin oral liquid  125  mg ; simethicone  120  mg ; pantoprazole  40  mg ; aluminum-magnesium hydrox.-simethicone  15-30  ml ; acetaminophen  650  mg ; sarna lotion  1  appl ; trazodone  25  mg ; metronidazole (flagyl)  500  mg ; olanzapine (disintegrating tablet)  2.5  mg ; lorazepam  0.5  mg ; 
unspecified acquired hypothyroidism opiate antagonists causing adverse effects in therapeutic use ulcerative colitis, unspecified other constipation opioid type dependence, continuous myalgia and myositis, unspecified paralytic ileus unspecified car occupant injured in collision with railway train or railway vehicle in nontraffic accident anxiety state, unspecified endometriosis, site unspecified other chronic pain posttraumatic stress disorder acquired absence of intestine (large) (small) adjustment disorder with mixed anxiety and depressed mood tobacco use disorder depressive disorder, not elsewhere classified intestinal bypass or anastomosis status anxiety state, unspecified unspecified acquired hypothyroidism ulcerative colitis, unspecified endometriosis, site unspecified disturbance of skin sensation chronic salpingitis and oophoritis depressive disorder, not elsewhere classified personal history of tobacco use acquired absence of intestine (large) (small) other chronic pain diarrhea other specified disorders of rectum and anus endometriosis, site unspecified nausea with vomiting unspecified acquired hypothyroidism diarrhea ulcerative colitis, unspecified abdominal pain, unspecified site depressive disorder, not elsewhere classified other chronic pain other functional disorders of intestine paralytic ileus anxiety state, unspecified personal history of tobacco use personal history of other diseases of digestive system abdominal pain, unspecified site acquired absence of intestine (large) (small) anxiety state, unspecified diarrhea other chronic pain unspecified acquired hypothyroidism
white f 40 $nan$hematology blood hematocrit  33.9  %; hematology blood hemoglobin  11.1  g dl; hematology blood platelet count  205  k ul; chemistry blood anion gap  11  meq l; chemistry blood bicarbonate  29  meq l; chemistry blood chloride  104  meq l; chemistry blood creatinine  0.7  mg dl; chemistry blood potassium  4.1  meq l; chemistry blood sodium  140  meq l; chemistry blood urea nitrogen  10  mg dl; chemistry blood calcium, total  9.1  mg dl; chemistry blood glucose  87  mg dl$sodium chloride 0.9%  flush  3  ml ; clonazepam  1.5  mg ; clonazepam  0.5  mg ; fluticasone propionate nasal  2  spry ; hydroxyzine  25-50  mg ; lamotrigine  200  mg ; levothyroxine sodium  75  mcg ; lidocaine 5% ointment  1  appl ; oxycodone (immediate release)   15-30  mg ; sertraline  200  mg ; ranitidine  150  mg ; heparin  5000  unit ; vancomycin oral liquid  125  mg ; simethicone  120  mg ; pantoprazole  40  mg ; aluminum-magnesium hydrox.-simethicone  15-30  ml ; acetaminophen  650  mg ; sarna lotion  1  appl ; trazodone  25  mg ; metronidazole (flagyl)  500  mg ; trazodone  50  mg ; hydromorphone (dilaudid)  8  mg ; loperamide  2  mg ; 
unspecified acquired hypothyroidism opiate antagonists causing adverse effects in therapeutic use ulcerative colitis, unspecified other constipation opioid type dependence, continuous myalgia and myositis, unspecified paralytic ileus unspecified car occupant injured in collision with railway train or railway vehicle in nontraffic accident anxiety state, unspecified endometriosis, site unspecified other chronic pain posttraumatic stress disorder acquired absence of intestine (large) (small) adjustment disorder with mixed anxiety and depressed mood tobacco use disorder depressive disorder, not elsewhere classified intestinal bypass or anastomosis status anxiety state, unspecified unspecified acquired hypothyroidism ulcerative colitis, unspecified endometriosis, site unspecified disturbance of skin sensation chronic salpingitis and oophoritis depressive disorder, not elsewhere classified personal history of tobacco use acquired absence of intestine (large) (small) other chronic pain diarrhea other specified disorders of rectum and anus endometriosis, site unspecified nausea with vomiting unspecified acquired hypothyroidism diarrhea ulcerative colitis, unspecified abdominal pain, unspecified site depressive disorder, not elsewhere classified other chronic pain other functional disorders of intestine paralytic ileus anxiety state, unspecified personal history of tobacco use personal history of other diseases of digestive system abdominal pain, unspecified site acquired absence of intestine (large) (small) anxiety state, unspecified diarrhea other chronic pain unspecified acquired hypothyroidism
white f 40 $nan$nan$sodium chloride 0.9%  flush  3  ml ; clonazepam  1.5  mg ; clonazepam  0.5  mg ; fluticasone propionate nasal  2  spry ; hydroxyzine  25-50  mg ; lamotrigine  200  mg ; levothyroxine sodium  75  mcg ; lidocaine 5% ointment  1  appl ; oxycodone (immediate release)   15-30  mg ; sertraline  200  mg ; heparin  5000  unit ; vancomycin oral liquid  125  mg ; simethicone  120  mg ; pantoprazole  40  mg ; aluminum-magnesium hydrox.-simethicone  15-30  ml ; acetaminophen  650  mg ; sarna lotion  1  appl ; metronidazole (flagyl)  500  mg ; trazodone  50  mg ; hydromorphone (dilaudid)  8  mg ; loperamide  2  mg ; ondansetron  4  mg ; 
unspecified acquired hypothyroidism opiate antagonists causing adverse effects in therapeutic use ulcerative colitis, unspecified other constipation opioid type dependence, continuous myalgia and myositis, unspecified paralytic ileus unspecified car occupant injured in collision with railway train or railway vehicle in nontraffic accident anxiety state, unspecified endometriosis, site unspecified other chronic pain posttraumatic stress disorder acquired absence of intestine (large) (small) adjustment disorder with mixed anxiety and depressed mood tobacco use disorder depressive disorder, not elsewhere classified intestinal bypass or anastomosis status anxiety state, unspecified unspecified acquired hypothyroidism ulcerative colitis, unspecified endometriosis, site unspecified disturbance of skin sensation chronic salpingitis and oophoritis depressive disorder, not elsewhere classified personal history of tobacco use acquired absence of intestine (large) (small) other chronic pain diarrhea other specified disorders of rectum and anus endometriosis, site unspecified nausea with vomiting unspecified acquired hypothyroidism diarrhea ulcerative colitis, unspecified abdominal pain, unspecified site depressive disorder, not elsewhere classified other chronic pain other functional disorders of intestine paralytic ileus anxiety state, unspecified personal history of tobacco use personal history of other diseases of digestive system abdominal pain, unspecified site acquired absence of intestine (large) (small) anxiety state, unspecified diarrhea other chronic pain unspecified acquired hypothyroidism
white m 61 $nan$hematology blood hematocrit  35.7  %; hematology blood hemoglobin  10.9  g dl; hematology blood platelet count  147  k ul; chemistry blood anion gap  14  meq l; chemistry blood bicarbonate  28  meq l; chemistry blood chloride  102  meq l; chemistry blood chloride  101  meq l; chemistry blood creatinine  1.2  mg dl; chemistry blood potassium  4.5  meq l; chemistry blood potassium  4.6  meq l; chemistry blood sodium  139  meq l; chemistry blood sodium  137  meq l; chemistry blood urea nitrogen  17  mg dl; hematology blood inr(pt)  3.1  ; chemistry blood calcium, total  8.5  mg dl; chemistry blood calcium, total  8.7  mg dl; chemistry blood glucose  210  mg dl; chemistry blood % hemoglobin a1c  9.0  %$sodium chloride 0.9%  flush  3  ml ; flecainide acetate  50  mg ; dextrose 50%  12.5  gm ; glucagon  1  mg ; insulin  0  unit ; metoprolol tartrate  25  mg ; lisinopril  20  mg ; furosemide  40  mg ; duloxetine  30  mg ; aspirin  81  mg ; furosemide  80  mg ; warfarin  12  mg ; dronedarone  400  mg ; insulin  100  unit ; 
other specified cardiac dysrhythmias heart valve replaced by other means anxiety state, unspecified abnormal coagulation profile unspecified hereditary and idiopathic peripheral neuropathy unspecified essential hypertension diabetes mellitus without mention of complication, type ii or unspecified type, not stated as uncontrolled unspecified car occupant injured in collision with car, pick-up truck or van in nontraffic accident heart valve replaced by other means thrombocytopenia, unspecified unspecified car occupant injured in collision with car, pick-up truck or van in nontraffic accident long-term (current) use of anticoagulants diabetes mellitus without mention of complication, type ii or unspecified type, not stated as uncontrolled acute on chronic diastolic heart failure congestive heart failure, unspecified unspecified viral infection pure hypercholesterolemia 
white m 61 $nan$hematology blood hematocrit  33.2  %; hematology blood hemoglobin  10.3  g dl; hematology blood platelet count  136  k ul; chemistry blood anion gap  14  meq l; chemistry blood anion gap  13  meq l; chemistry blood bicarbonate  28  meq l; chemistry blood bicarbonate  30  meq l; chemistry blood chloride  102  meq l; chemistry blood chloride  101  meq l; chemistry blood creatinine  0.9  mg dl; chemistry blood creatinine  1.1  mg dl; chemistry blood potassium  4.0  meq l; chemistry blood potassium  3.8  meq l; chemistry blood sodium  140  meq l; chemistry blood sodium  140  meq l; chemistry blood urea nitrogen  22  mg dl; chemistry blood urea nitrogen  29  mg dl; hematology blood inr(pt)  4.6  ; hematology blood inr(pt)  4.9  ; chemistry blood calcium, total  8.2  mg dl; chemistry blood glucose  91  mg dl$sodium chloride 0.9%  flush  3  ml ; dextrose 50%  12.5  gm ; glucagon  1  mg ; insulin  0  unit ; metoprolol tartrate  25  mg ; lisinopril  20  mg ; duloxetine  30  mg ; aspirin  81  mg ; warfarin  12  mg ; dronedarone  400  mg ; insulin  100  unit ; insulin  4  unit ; warfarin  6  mg ; potassium chloride  20  meq ; sw  50  ml ; magnesium sulfate  2  gm ; metoprolol tartrate  37.5  mg ; 
other specified cardiac dysrhythmias heart valve replaced by other means anxiety state, unspecified abnormal coagulation profile unspecified hereditary and idiopathic peripheral neuropathy unspecified essential hypertension diabetes mellitus without mention of complication, type ii or unspecified type, not stated as uncontrolled unspecified car occupant injured in collision with car, pick-up truck or van in nontraffic accident heart valve replaced by other means thrombocytopenia, unspecified unspecified car occupant injured in collision with car, pick-up truck or van in nontraffic accident long-term (current) use of anticoagulants diabetes mellitus without mention of complication, type ii or unspecified type, not stated as uncontrolled acute on chronic diastolic heart failure congestive heart failure, unspecified unspecified viral infection pure hypercholesterolemia 
white m 61 $nan$hematology blood hematocrit  31.4  %; hematology blood hemoglobin  10.1  g dl; hematology blood platelet count  123  k ul; chemistry blood anion gap  10  meq l; chemistry blood bicarbonate  34  meq l; chemistry blood chloride  102  meq l; chemistry blood creatinine  1.1  mg dl; chemistry blood potassium  3.5  meq l; chemistry blood potassium  4.0  meq l; chemistry blood sodium  142  meq l; chemistry blood urea nitrogen  29  mg dl; hematology blood inr(pt)  3.6  ; chemistry blood calcium, total  8.7  mg dl; chemistry blood glucose  125  mg dl$sodium chloride 0.9%  flush  3  ml ; dextrose 50%  12.5  gm ; glucagon  1  mg ; duloxetine  30  mg ; aspirin  81  mg ; dronedarone  400  mg ; insulin  4  unit ; warfarin  6  mg ; potassium chloride  20  meq ; sw  50  ml ; magnesium sulfate  2  gm ; metoprolol tartrate  37.5  mg ; lisinopril  40  mg ; potassium chloride  40  meq ; warfarin  10  mg ; 
other specified cardiac dysrhythmias heart valve replaced by other means anxiety state, unspecified abnormal coagulation profile unspecified hereditary and idiopathic peripheral neuropathy unspecified essential hypertension diabetes mellitus without mention of complication, type ii or unspecified type, not stated as uncontrolled unspecified car occupant injured in collision with car, pick-up truck or van in nontraffic accident heart valve replaced by other means thrombocytopenia, unspecified unspecified car occupant injured in collision with car, pick-up truck or van in nontraffic accident long-term (current) use of anticoagulants diabetes mellitus without mention of complication, type ii or unspecified type, not stated as uncontrolled acute on chronic diastolic heart failure congestive heart failure, unspecified unspecified viral infection pure hypercholesterolemia 
white m 61 $nan$hematology blood hematocrit  33.4  %; hematology blood hemoglobin  10.2  g dl; hematology blood platelet count  132  k ul; chemistry blood anion gap  10  meq l; chemistry blood anion gap  14  meq l; chemistry blood bicarbonate  33  meq l; chemistry blood bicarbonate  30  meq l; chemistry blood chloride  101  meq l; chemistry blood chloride  97  meq l; chemistry blood creatinine  1.2  mg dl; chemistry blood creatinine  1.4  mg dl; chemistry blood potassium  3.6  meq l; chemistry blood potassium  4.5  meq l; chemistry blood sodium  140  meq l; chemistry blood sodium  136  meq l; chemistry blood urea nitrogen  32  mg dl; chemistry blood urea nitrogen  36  mg dl; hematology blood inr(pt)  3.1  ; chemistry blood calcium, total  8.4  mg dl; chemistry blood calcium, total  8.6  mg dl; chemistry blood glucose  217  mg dl; chemistry blood glucose  121  mg dl$sodium chloride 0.9%  flush  3  ml ; dextrose 50%  12.5  gm ; glucagon  1  mg ; duloxetine  30  mg ; aspirin  81  mg ; dronedarone  400  mg ; insulin  4  unit ; metoprolol tartrate  37.5  mg ; lisinopril  40  mg ; potassium chloride  40  meq ; warfarin  10  mg ; warfarin  2  mg ; 
other specified cardiac dysrhythmias heart valve replaced by other means anxiety state, unspecified abnormal coagulation profile unspecified hereditary and idiopathic peripheral neuropathy unspecified essential hypertension diabetes mellitus without mention of complication, type ii or unspecified type, not stated as uncontrolled unspecified car occupant injured in collision with car, pick-up truck or van in nontraffic accident heart valve replaced by other means thrombocytopenia, unspecified unspecified car occupant injured in collision with car, pick-up truck or van in nontraffic accident long-term (current) use of anticoagulants diabetes mellitus without mention of complication, type ii or unspecified type, not stated as uncontrolled acute on chronic diastolic heart failure congestive heart failure, unspecified unspecified viral infection pure hypercholesterolemia 
white m 61 $nan$hematology blood hematocrit  32.6  %; hematology blood hemoglobin  10.3  g dl; hematology blood platelet count  182  k ul; chemistry blood anion gap  11  meq l; chemistry blood anion gap  12  meq l; chemistry blood bicarbonate  33  meq l; chemistry blood bicarbonate  31  meq l; chemistry blood chloride  101  meq l; chemistry blood chloride  99  meq l; chemistry blood creatinine  1.2  mg dl; chemistry blood creatinine  1.4  mg dl; chemistry blood potassium  4.2  meq l; chemistry blood potassium  4.6  meq l; chemistry blood sodium  141  meq l; chemistry blood sodium  137  meq l; chemistry blood urea nitrogen  31  mg dl; chemistry blood urea nitrogen  35  mg dl; hematology blood inr(pt)  3.5  ; chemistry blood calcium, total  8.6  mg dl; chemistry blood calcium, total  8.6  mg dl; chemistry blood glucose  203  mg dl; chemistry blood glucose  95  mg dl$sodium chloride 0.9%  flush  3  ml ; dextrose 50%  12.5  gm ; glucagon  1  mg ; duloxetine  30  mg ; aspirin  81  mg ; dronedarone  400  mg ; insulin  4  unit ; metoprolol tartrate  37.5  mg ; lisinopril  40  mg ; warfarin  2  mg ; 
other specified cardiac dysrhythmias heart valve replaced by other means anxiety state, unspecified abnormal coagulation profile unspecified hereditary and idiopathic peripheral neuropathy unspecified essential hypertension diabetes mellitus without mention of complication, type ii or unspecified type, not stated as uncontrolled unspecified car occupant injured in collision with car, pick-up truck or van in nontraffic accident heart valve replaced by other means thrombocytopenia, unspecified unspecified car occupant injured in collision with car, pick-up truck or van in nontraffic accident long-term (current) use of anticoagulants diabetes mellitus without mention of complication, type ii or unspecified type, not stated as uncontrolled acute on chronic diastolic heart failure congestive heart failure, unspecified unspecified viral infection pure hypercholesterolemia 
white m 61 $nan$hematology blood hematocrit  30.0  %; hematology blood hemoglobin  9.4  g dl; hematology blood platelet count  147  k ul; chemistry blood anion gap  11  meq l; chemistry blood bicarbonate  30  meq l; chemistry blood chloride  105  meq l; chemistry blood creatinine  1.2  mg dl; chemistry blood potassium  4.1  meq l; chemistry blood sodium  142  meq l; chemistry blood urea nitrogen  29  mg dl; hematology blood inr(pt)  3.6  ; hematology blood inr(pt)  3.9  ; chemistry blood calcium, total  8.9  mg dl; chemistry blood bilirubin, indirect  0.1  mg dl; chemistry blood bilirubin, total  0.3  mg dl; chemistry blood glucose  95  mg dl; chemistry blood lactate dehydrogenase (ld)  208  iu l; chemistry blood bilirubin, direct  0.2  mg dl$sodium chloride 0.9%  flush  3  ml ; dextrose 50%  12.5  gm ; glucagon  1  mg ; duloxetine  30  mg ; aspirin  81  mg ; dronedarone  400  mg ; insulin  4  unit ; metoprolol tartrate  37.5  mg ; lisinopril  40  mg ; warfarin  2  mg ; warfarin  1  mg ; 
other specified cardiac dysrhythmias heart valve replaced by other means anxiety state, unspecified abnormal coagulation profile unspecified hereditary and idiopathic peripheral neuropathy unspecified essential hypertension diabetes mellitus without mention of complication, type ii or unspecified type, not stated as uncontrolled unspecified car occupant injured in collision with car, pick-up truck or van in nontraffic accident heart valve replaced by other means thrombocytopenia, unspecified unspecified car occupant injured in collision with car, pick-up truck or van in nontraffic accident long-term (current) use of anticoagulants diabetes mellitus without mention of complication, type ii or unspecified type, not stated as uncontrolled acute on chronic diastolic heart failure congestive heart failure, unspecified unspecified viral infection pure hypercholesterolemia 
white m 79 $nan$nan$amiodarone  200  mg ; aspirin  81  mg ; furosemide  40  mg ; omeprazole  20  mg ; simvastatin  20  mg ; 
scoliosis [and kyphoscoliosis], idiopathic mechanical complication of gastrostomy paralysis agitans pneumonitis due to inhalation of food or vomitus atrial fibrillation chronic airway obstruction, not elsewhere classified scoliosis [and kyphoscoliosis], idiopathic other gastrostomy complications chronic airway obstruction, not elsewhere classified esophageal reflux other and unspecified hyperlipidemia pneumonia, organism unspecified urinary tract infection, site not specified infection of gastrostomy cellulitis and abscess of trunk pulmonary collapse surgical operation with formation of external stoma causing abnormal patient reaction, or later complication, without mention of misadventure at time of operation pseudomonas infection in conditions classified elsewhere and of unspecified site atrial fibrillation other dependence on machines, supplemental oxygen paralysis agitans person on outside of car injured in collision with other nonmotor vehicle in nontraffic accident other and unspecified hyperlipidemia anxiety state, unspecified hyperpotassemia acute respiratory failure dehydration car passenger injured in collision with heavy transport vehicle or bus in nontraffic accident pseudomonas infection in conditions classified elsewhere and of unspecified site gastrostomy status urinary tract infection, site not specified dysphagia, unspecified esophageal reflux atrial fibrillation personal history of venous thrombosis and embolism scoliosis [and kyphoscoliosis], idiopathic chronic airway obstruction, not elsewhere classified paralysis agitans pneumonia due to pseudomonas unspecified deficiency anemia pneumonitis due to inhalation of food or vomitus esophageal reflux gastrostomy status atrial fibrillation paralysis agitans obstructive chronic bronchitis with (acute) exacerbation anxiety state, unspecified car passenger injured in collision with heavy transport vehicle or bus in nontraffic accident
white m 79 $nan$hematology blood hematocrit  40.7  %; hematology blood hemoglobin  14.1  g dl; hematology blood platelet count  134  k ul; chemistry blood anion gap  14  meq l; chemistry blood bicarbonate  33  meq l; chemistry blood chloride  95  meq l; chemistry blood creatinine  0.6  mg dl; chemistry blood potassium  4.1  meq l; chemistry blood sodium  138  meq l; chemistry blood urea nitrogen  22  mg dl; chemistry blood calcium, total  9.3  mg dl; chemistry blood glucose  88  mg dl; blood gas blood lactate  1.3  mmol l$amiodarone  200  mg ; aspirin  81  mg ; furosemide  40  mg ; omeprazole  20  mg ; simvastatin  20  mg ; sodium chloride 0.9%  flush  3  ml ; albuterol 0.083% neb soln  1  neb ; ipratropium bromide neb  1  neb ; guaifenesin  5  ml ; carbidopa-levodopa (25-100)  1  tab ; heparin  5000  unit ; iso-osmotic dextrose  200  ml ; vancomycin  1000  mg ; lorazepam  1  mg ; acetaminophen (liquid)  650  mg ; bisacodyl  10  mg ; trazodone  25  mg ; d5 1 2ns  1000  ml ; 
scoliosis [and kyphoscoliosis], idiopathic mechanical complication of gastrostomy paralysis agitans pneumonitis due to inhalation of food or vomitus atrial fibrillation chronic airway obstruction, not elsewhere classified scoliosis [and kyphoscoliosis], idiopathic other gastrostomy complications chronic airway obstruction, not elsewhere classified esophageal reflux other and unspecified hyperlipidemia pneumonia, organism unspecified urinary tract infection, site not specified infection of gastrostomy cellulitis and abscess of trunk pulmonary collapse surgical operation with formation of external stoma causing abnormal patient reaction, or later complication, without mention of misadventure at time of operation pseudomonas infection in conditions classified elsewhere and of unspecified site atrial fibrillation other dependence on machines, supplemental oxygen paralysis agitans person on outside of car injured in collision with other nonmotor vehicle in nontraffic accident other and unspecified hyperlipidemia anxiety state, unspecified hyperpotassemia acute respiratory failure dehydration car passenger injured in collision with heavy transport vehicle or bus in nontraffic accident pseudomonas infection in conditions classified elsewhere and of unspecified site gastrostomy status urinary tract infection, site not specified dysphagia, unspecified esophageal reflux atrial fibrillation personal history of venous thrombosis and embolism scoliosis [and kyphoscoliosis], idiopathic chronic airway obstruction, not elsewhere classified paralysis agitans pneumonia due to pseudomonas unspecified deficiency anemia pneumonitis due to inhalation of food or vomitus esophageal reflux gastrostomy status atrial fibrillation paralysis agitans obstructive chronic bronchitis with (acute) exacerbation anxiety state, unspecified car passenger injured in collision with heavy transport vehicle or bus in nontraffic accident
white m 79 $nan$nan$amiodarone  200  mg ; aspirin  81  mg ; furosemide  40  mg ; omeprazole  20  mg ; simvastatin  20  mg ; sodium chloride 0.9%  flush  3  ml ; albuterol 0.083% neb soln  1  neb ; ipratropium bromide neb  1  neb ; guaifenesin  5  ml ; carbidopa-levodopa (25-100)  1  tab ; heparin  5000  unit ; lorazepam  1  mg ; acetaminophen (liquid)  650  mg ; bisacodyl  10  mg ; trazodone  25  mg ; d5 1 2ns  1000  ml ; 
scoliosis [and kyphoscoliosis], idiopathic mechanical complication of gastrostomy paralysis agitans pneumonitis due to inhalation of food or vomitus atrial fibrillation chronic airway obstruction, not elsewhere classified scoliosis [and kyphoscoliosis], idiopathic other gastrostomy complications chronic airway obstruction, not elsewhere classified esophageal reflux other and unspecified hyperlipidemia pneumonia, organism unspecified urinary tract infection, site not specified infection of gastrostomy cellulitis and abscess of trunk pulmonary collapse surgical operation with formation of external stoma causing abnormal patient reaction, or later complication, without mention of misadventure at time of operation pseudomonas infection in conditions classified elsewhere and of unspecified site atrial fibrillation other dependence on machines, supplemental oxygen paralysis agitans person on outside of car injured in collision with other nonmotor vehicle in nontraffic accident other and unspecified hyperlipidemia anxiety state, unspecified hyperpotassemia acute respiratory failure dehydration car passenger injured in collision with heavy transport vehicle or bus in nontraffic accident pseudomonas infection in conditions classified elsewhere and of unspecified site gastrostomy status urinary tract infection, site not specified dysphagia, unspecified esophageal reflux atrial fibrillation personal history of venous thrombosis and embolism scoliosis [and kyphoscoliosis], idiopathic chronic airway obstruction, not elsewhere classified paralysis agitans pneumonia due to pseudomonas unspecified deficiency anemia pneumonitis due to inhalation of food or vomitus esophageal reflux gastrostomy status atrial fibrillation paralysis agitans obstructive chronic bronchitis with (acute) exacerbation anxiety state, unspecified car passenger injured in collision with heavy transport vehicle or bus in nontraffic accident
black african american f 64 $temp    heartrate  62.0  resprate  14.0  o2sat  99.0  sbp  105.0  dbp  40.0  rhythm    pain  uta  ; temp    heartrate  62.0  resprate  11.0  o2sat  99.0  sbp  91.0  dbp  38.0  rhythm    pain    ; temp    heartrate  58.0  resprate  14.0  o2sat  99.0  sbp  83.0  dbp  35.0  rhythm    pain  uta  ; temp    heartrate  58.0  resprate  16.0  o2sat  99.0  sbp  95.0  dbp  39.0  rhythm    pain  uta  ; temp    heartrate  61.0  resprate  18.0  o2sat  98.0  sbp  88.0  dbp  38.0  rhythm    pain  uta   ; temp  94.8  heartrate  59.0  resprate  12.0  o2sat  100.0  sbp  111.0  dbp  49.0  rhythm    pain  0  $hematology blood hematocrit  34.2  %; hematology blood hemoglobin  11.3  g dl; hematology blood platelet count  181  k ul; chemistry blood anion gap  22  meq l; chemistry blood anion gap  18  meq l; chemistry blood anion gap  13  meq l; chemistry blood bicarbonate  19  meq l; chemistry blood bicarbonate  20  meq l; chemistry blood bicarbonate  26  meq l; chemistry blood chloride  85  meq l; chemistry blood chloride  92  meq l; chemistry blood chloride  92  meq l; chemistry blood creatinine  5.7  mg dl; chemistry blood creatinine  5.6  mg dl; chemistry blood creatinine  2.7  mg dl; chemistry blood potassium  4.2  meq l; chemistry blood potassium  3.0  meq l; chemistry blood potassium  3.3  meq l; chemistry blood sodium  127  meq l; chemistry blood sodium  128  meq l; chemistry blood sodium  122  meq l; chemistry blood urea nitrogen  59  mg dl; chemistry blood urea nitrogen  59  mg dl; chemistry blood urea nitrogen  19  mg dl; hematology blood inr(pt)  1.0  ; chemistry blood calcium, total  8.2  mg dl; chemistry blood calcium, total  8.0  mg dl; chemistry blood calcium, total  7.7  mg dl; chemistry blood bilirubin, total  0.4  mg dl; chemistry blood glucose  677  mg dl; chemistry blood glucose  409  mg dl; chemistry blood glucose  202  mg dl; chemistry blood lactate dehydrogenase (ld)  281  iu l; chemistry blood albumin  2.8  g dl; blood gas blood lactate  1.2  mmol l; blood gas blood lactate  1.3  mmol l$bag  1  bag ; bag  2  bag ; pneumococcal 23-valent polysaccharide vaccine  0.5  ml ; sodium chloride 0.9%  flush  10  ml ; heparin  5000  unit ; 0.9% sodium chloride  100  ml ; insulin human regular  100  unit ; dextrose 50%  12.5  gm ; glucagon  1  mg ; glucose gel  15  g ; insulin  6  unit ; albuterol 0.083% neb soln  1  neb ; ferrous sulfate  325  mg ; levothyroxine sodium  25  mcg ; montelukast  10  mg ; vitamin d  2000  unit ; nephrocaps  1  cap ; aspirin  81  mg ; atorvastatin  10  mg ; calcium acetate  667  mg ; 0.9% sodium chloride  250  ml ; norepinephrine  8  mg ; sodium chloride 0.9%  1000  ml ; insulin  10  unit ; 0.9% sodium chloride  1  bag ; calcium gluconate  2  g ; 0.9% sodium chloride  2  bag ; calcium gluconate  4  g ; magnesium sulfate  2  gm ; magnesium sulfate  4  gm ; aspirin  243  mg ; potassium chloride  20  meq ; 0.9% sodium chloride (mini bag plus)  100  ml ; ceftazidime  2  g ; lidocaine 1%  1  ml ; iso-osmotic dextrose  200  ml ; vancomycin  1000  mg ; iso-osmotic dextrose  100  ml ; vancomycin  500  mg ; bisacodyl  10  mg ; senna  8.6  mg ; sodium chloride 0.9%  flush  3  ml ; vancomycin  0  md to order daily dose ; omeprazole  20  mg ; acetaminophen  650  mg ; atorvastatin  40  mg ; docusate sodium (liquid)  100  mg ; 
hypertensive chronic kidney disease with stage 5 chronic kidney disease or end stage renal disease cough other sequelae of cerebral infarction type 1 diabetes mellitus with mild nonproliferative diabetic retinopathy without macular edema end stage renal disease posterior reversible encephalopathy syndrome hypo-osmolality and hyponatremia type 1 diabetes mellitus with diabetic neuropathy, unspecified abnormal electrocardiogram [ecg] [ekg] gastroparesis acute kidney failure, unspecified renal osteodystrophy unspecified asthma, uncomplicated foot drop, right foot unspecified abdominal pain thyrotoxicosis with diffuse goiter without thyrotoxic crisis or storm dependence on renal dialysis unspecified viral hepatitis c without hepatic coma anemia in chronic kidney disease foot drop, left foot toxic encephalopathy type 1 diabetes mellitus with diabetic autonomic (poly)neuropathy type 1 diabetes mellitus with diabetic chronic kidney disease chronic diastolic (congestive) heart failure gout, unspecified diarrhea, unspecified type 1 diabetes mellitus with ketoacidosis without coma diabetes with renal manifestations, type i [juvenile type], uncontrolled hypertensive chronic kidney disease, unspecified, with chronic kidney disease stage i through stage iv, or unspecified diabetes with other specified manifestations, type i [juvenile type], uncontrolled urinary tract infection, site not specified rheumatoid arthritis esophageal reflux morbid obesity other and unspecified hyperlipidemia diabetes with ophthalmic manifestations, type i [juvenile type], uncontrolled chronic obstructive asthma, unspecified gastroparesis toxic diffuse goiter without mention of thyrotoxic crisis or storm unspecified vitamin d deficiency acute kidney failure, unspecified renal dialysis status congestive heart failure, unspecified chronic kidney disease, stage iv (severe) diabetes with neurological manifestations, type i [juvenile type], uncontrolled personal history of transient ischemic attack (tia), and cerebral infarction without residual deficits wheelchair dependence long-term (current) use of insulin
black african american f 64 $nan$hematology blood hematocrit  33.5  %; hematology blood hemoglobin  11.1  g dl; hematology blood platelet count  144  k ul; chemistry blood anion gap  12  meq l; chemistry blood anion gap  22  meq l; chemistry blood bicarbonate  27  meq l; chemistry blood bicarbonate  22  meq l; chemistry blood chloride  92  meq l; chemistry blood chloride  87  meq l; chemistry blood creatinine  3.3  mg dl; chemistry blood creatinine  3.6  mg dl; chemistry blood potassium  3.1  meq l; chemistry blood potassium  4.7  meq l; chemistry blood sodium  128  meq l; chemistry blood sodium  126  meq l; chemistry blood urea nitrogen  22  mg dl; chemistry blood urea nitrogen  24  mg dl; hematology blood inr(pt)  1.0  ; chemistry blood calcium, total  7.6  mg dl; chemistry blood calcium, total  7.4  mg dl; chemistry blood glucose  199  mg dl; chemistry blood glucose  329  mg dl; chemistry blood lactate dehydrogenase (ld)  581  iu l$bag  1  bag ; bag  2  bag ; pneumococcal 23-valent polysaccharide vaccine  0.5  ml ; dextrose 50%  12.5  gm ; albuterol 0.083% neb soln  1  neb ; vitamin d  2000  unit ; potassium chloride  20  meq ; bisacodyl  10  mg ; senna  8.6  mg ; sodium chloride 0.9%  flush  3  ml ; vancomycin  0  md to order daily dose ; omeprazole  20  mg ; acetaminophen  650  mg ; docusate sodium (liquid)  100  mg ; sterile water  50  ml ; insulin  4  unit ; insulin  0  unit ; insulin  20  unit ; oxycodone (immediate release)   5  mg ; 
hypertensive chronic kidney disease with stage 5 chronic kidney disease or end stage renal disease cough other sequelae of cerebral infarction type 1 diabetes mellitus with mild nonproliferative diabetic retinopathy without macular edema end stage renal disease posterior reversible encephalopathy syndrome hypo-osmolality and hyponatremia type 1 diabetes mellitus with diabetic neuropathy, unspecified abnormal electrocardiogram [ecg] [ekg] gastroparesis acute kidney failure, unspecified renal osteodystrophy unspecified asthma, uncomplicated foot drop, right foot unspecified abdominal pain thyrotoxicosis with diffuse goiter without thyrotoxic crisis or storm dependence on renal dialysis unspecified viral hepatitis c without hepatic coma anemia in chronic kidney disease foot drop, left foot toxic encephalopathy type 1 diabetes mellitus with diabetic autonomic (poly)neuropathy type 1 diabetes mellitus with diabetic chronic kidney disease chronic diastolic (congestive) heart failure gout, unspecified diarrhea, unspecified type 1 diabetes mellitus with ketoacidosis without coma diabetes with renal manifestations, type i [juvenile type], uncontrolled hypertensive chronic kidney disease, unspecified, with chronic kidney disease stage i through stage iv, or unspecified diabetes with other specified manifestations, type i [juvenile type], uncontrolled urinary tract infection, site not specified rheumatoid arthritis esophageal reflux morbid obesity other and unspecified hyperlipidemia diabetes with ophthalmic manifestations, type i [juvenile type], uncontrolled chronic obstructive asthma, unspecified gastroparesis toxic diffuse goiter without mention of thyrotoxic crisis or storm unspecified vitamin d deficiency acute kidney failure, unspecified renal dialysis status congestive heart failure, unspecified chronic kidney disease, stage iv (severe) diabetes with neurological manifestations, type i [juvenile type], uncontrolled personal history of transient ischemic attack (tia), and cerebral infarction without residual deficits wheelchair dependence long-term (current) use of insulin
black african american f 64 $nan$hematology blood hematocrit  36.0  %; hematology blood hemoglobin  11.8  g dl; hematology blood platelet count  129  k ul; chemistry blood anion gap  15  meq l; chemistry blood bicarbonate  26  meq l; chemistry blood chloride  88  meq l; chemistry blood creatinine  4.3  mg dl; chemistry blood potassium  3.3  meq l; chemistry blood sodium  126  meq l; chemistry blood urea nitrogen  32  mg dl; hematology blood inr(pt)  0.9  ; chemistry blood calcium, total  8.5  mg dl; chemistry blood bilirubin, total  0.4  mg dl; chemistry blood glucose  339  mg dl; chemistry blood lactate dehydrogenase (ld)  520  iu l$pneumococcal 23-valent polysaccharide vaccine  0.5  ml ; bisacodyl  10  mg ; senna  8.6  mg ; sodium chloride 0.9%  flush  3  ml ; omeprazole  20  mg ; acetaminophen  650  mg ; docusate sodium (liquid)  100  mg ; oxycodone-acetaminophen (5mg-325mg)  1  tab ; heparin (hemodialysis)  1000  unit ; labetalol  200  mg ; insulin  8  unit ; insulin  15  unit ; 
hypertensive chronic kidney disease with stage 5 chronic kidney disease or end stage renal disease cough other sequelae of cerebral infarction type 1 diabetes mellitus with mild nonproliferative diabetic retinopathy without macular edema end stage renal disease posterior reversible encephalopathy syndrome hypo-osmolality and hyponatremia type 1 diabetes mellitus with diabetic neuropathy, unspecified abnormal electrocardiogram [ecg] [ekg] gastroparesis acute kidney failure, unspecified renal osteodystrophy unspecified asthma, uncomplicated foot drop, right foot unspecified abdominal pain thyrotoxicosis with diffuse goiter without thyrotoxic crisis or storm dependence on renal dialysis unspecified viral hepatitis c without hepatic coma anemia in chronic kidney disease foot drop, left foot toxic encephalopathy type 1 diabetes mellitus with diabetic autonomic (poly)neuropathy type 1 diabetes mellitus with diabetic chronic kidney disease chronic diastolic (congestive) heart failure gout, unspecified diarrhea, unspecified type 1 diabetes mellitus with ketoacidosis without coma diabetes with renal manifestations, type i [juvenile type], uncontrolled hypertensive chronic kidney disease, unspecified, with chronic kidney disease stage i through stage iv, or unspecified diabetes with other specified manifestations, type i [juvenile type], uncontrolled urinary tract infection, site not specified rheumatoid arthritis esophageal reflux morbid obesity other and unspecified hyperlipidemia diabetes with ophthalmic manifestations, type i [juvenile type], uncontrolled chronic obstructive asthma, unspecified gastroparesis toxic diffuse goiter without mention of thyrotoxic crisis or storm unspecified vitamin d deficiency acute kidney failure, unspecified renal dialysis status congestive heart failure, unspecified chronic kidney disease, stage iv (severe) diabetes with neurological manifestations, type i [juvenile type], uncontrolled personal history of transient ischemic attack (tia), and cerebral infarction without residual deficits wheelchair dependence long-term (current) use of insulin
black african american f 64 $nan$hematology blood hematocrit  37.0  %; hematology blood hemoglobin  11.7  g dl; hematology blood platelet count  114  k ul; chemistry blood anion gap  14  meq l; chemistry blood bicarbonate  28  meq l; chemistry blood chloride  93  meq l; chemistry blood creatinine  3.4  mg dl; chemistry blood potassium  4.0  meq l; chemistry blood sodium  131  meq l; chemistry blood urea nitrogen  24  mg dl; hematology blood inr(pt)  0.9  ; chemistry blood calcium, total  8.7  mg dl; chemistry blood bilirubin, total  0.4  mg dl; chemistry blood glucose  299  mg dl; chemistry blood lactate dehydrogenase (ld)  589  iu l; hematology blood bands  1  %$pneumococcal 23-valent polysaccharide vaccine  0.5  ml ; bisacodyl  10  mg ; senna  8.6  mg ; sodium chloride 0.9%  flush  3  ml ; omeprazole  20  mg ; acetaminophen  650  mg ; docusate sodium (liquid)  100  mg ; oxycodone-acetaminophen (5mg-325mg)  1  tab ; heparin (hemodialysis)  1000  unit ; labetalol  200  mg ; insulin  8  unit ; insulin  15  unit ; levofloxacin  500  mg ; amlodipine  10  mg ; metoclopramide  5  mg ; metronidazole  500  mg ; neutra-phos  1  pkt ; 
hypertensive chronic kidney disease with stage 5 chronic kidney disease or end stage renal disease cough other sequelae of cerebral infarction type 1 diabetes mellitus with mild nonproliferative diabetic retinopathy without macular edema end stage renal disease posterior reversible encephalopathy syndrome hypo-osmolality and hyponatremia type 1 diabetes mellitus with diabetic neuropathy, unspecified abnormal electrocardiogram [ecg] [ekg] gastroparesis acute kidney failure, unspecified renal osteodystrophy unspecified asthma, uncomplicated foot drop, right foot unspecified abdominal pain thyrotoxicosis with diffuse goiter without thyrotoxic crisis or storm dependence on renal dialysis unspecified viral hepatitis c without hepatic coma anemia in chronic kidney disease foot drop, left foot toxic encephalopathy type 1 diabetes mellitus with diabetic autonomic (poly)neuropathy type 1 diabetes mellitus with diabetic chronic kidney disease chronic diastolic (congestive) heart failure gout, unspecified diarrhea, unspecified type 1 diabetes mellitus with ketoacidosis without coma diabetes with renal manifestations, type i [juvenile type], uncontrolled hypertensive chronic kidney disease, unspecified, with chronic kidney disease stage i through stage iv, or unspecified diabetes with other specified manifestations, type i [juvenile type], uncontrolled urinary tract infection, site not specified rheumatoid arthritis esophageal reflux morbid obesity other and unspecified hyperlipidemia diabetes with ophthalmic manifestations, type i [juvenile type], uncontrolled chronic obstructive asthma, unspecified gastroparesis toxic diffuse goiter without mention of thyrotoxic crisis or storm unspecified vitamin d deficiency acute kidney failure, unspecified renal dialysis status congestive heart failure, unspecified chronic kidney disease, stage iv (severe) diabetes with neurological manifestations, type i [juvenile type], uncontrolled personal history of transient ischemic attack (tia), and cerebral infarction without residual deficits wheelchair dependence long-term (current) use of insulin
black african american f 64 $nan$hematology blood hematocrit  32.3  %; hematology blood hemoglobin  10.4  g dl; hematology blood platelet count  140  k ul; chemistry blood anion gap  14  meq l; chemistry blood bicarbonate  27  meq l; chemistry blood chloride  93  meq l; chemistry blood creatinine  4.0  mg dl; chemistry blood potassium  4.0  meq l; chemistry blood sodium  130  meq l; chemistry blood urea nitrogen  35  mg dl; hematology blood inr(pt)  0.9  ; hematology urine wbc  24  # hpf; chemistry blood calcium, total  8.1  mg dl; chemistry blood bilirubin, total  0.2  mg dl; chemistry blood glucose  178  mg dl; chemistry blood lactate dehydrogenase (ld)  433  iu l; hematology urine glucose  300  mg dl$pneumococcal 23-valent polysaccharide vaccine  0.5  ml ; bisacodyl  10  mg ; senna  8.6  mg ; sodium chloride 0.9%  flush  3  ml ; omeprazole  20  mg ; acetaminophen  650  mg ; docusate sodium (liquid)  100  mg ; labetalol  200  mg ; amlodipine  10  mg ; metoclopramide  5  mg ; metronidazole  500  mg ; neutra-phos  1  pkt ; phosphorus  500  mg ; 
hypertensive chronic kidney disease with stage 5 chronic kidney disease or end stage renal disease cough other sequelae of cerebral infarction type 1 diabetes mellitus with mild nonproliferative diabetic retinopathy without macular edema end stage renal disease posterior reversible encephalopathy syndrome hypo-osmolality and hyponatremia type 1 diabetes mellitus with diabetic neuropathy, unspecified abnormal electrocardiogram [ecg] [ekg] gastroparesis acute kidney failure, unspecified renal osteodystrophy unspecified asthma, uncomplicated foot drop, right foot unspecified abdominal pain thyrotoxicosis with diffuse goiter without thyrotoxic crisis or storm dependence on renal dialysis unspecified viral hepatitis c without hepatic coma anemia in chronic kidney disease foot drop, left foot toxic encephalopathy type 1 diabetes mellitus with diabetic autonomic (poly)neuropathy type 1 diabetes mellitus with diabetic chronic kidney disease chronic diastolic (congestive) heart failure gout, unspecified diarrhea, unspecified type 1 diabetes mellitus with ketoacidosis without coma diabetes with renal manifestations, type i [juvenile type], uncontrolled hypertensive chronic kidney disease, unspecified, with chronic kidney disease stage i through stage iv, or unspecified diabetes with other specified manifestations, type i [juvenile type], uncontrolled urinary tract infection, site not specified rheumatoid arthritis esophageal reflux morbid obesity other and unspecified hyperlipidemia diabetes with ophthalmic manifestations, type i [juvenile type], uncontrolled chronic obstructive asthma, unspecified gastroparesis toxic diffuse goiter without mention of thyrotoxic crisis or storm unspecified vitamin d deficiency acute kidney failure, unspecified renal dialysis status congestive heart failure, unspecified chronic kidney disease, stage iv (severe) diabetes with neurological manifestations, type i [juvenile type], uncontrolled personal history of transient ischemic attack (tia), and cerebral infarction without residual deficits wheelchair dependence long-term (current) use of insulin
black african american f 64 $nan$hematology blood hematocrit  36.2  %; hematology blood hemoglobin  11.3  g dl; hematology blood platelet count  164  k ul; chemistry blood anion gap  13  meq l; chemistry blood bicarbonate  29  meq l; chemistry blood chloride  92  meq l; chemistry blood creatinine  3.2  mg dl; chemistry blood potassium  4.4  meq l; chemistry blood sodium  130  meq l; chemistry blood urea nitrogen  29  mg dl; hematology blood inr(pt)  0.9  ; chemistry blood calcium, total  8.1  mg dl; chemistry blood bilirubin, total  0.3  mg dl; chemistry blood glucose  328  mg dl; chemistry blood lactate dehydrogenase (ld)  465  iu l$pneumococcal 23-valent polysaccharide vaccine  0.5  ml ; bisacodyl  10  mg ; senna  8.6  mg ; sodium chloride 0.9%  flush  3  ml ; omeprazole  20  mg ; acetaminophen  650  mg ; docusate sodium (liquid)  100  mg ; labetalol  200  mg ; amlodipine  10  mg ; metoclopramide  5  mg ; metronidazole  500  mg ; phosphorus  500  mg ; 
hypertensive chronic kidney disease with stage 5 chronic kidney disease or end stage renal disease cough other sequelae of cerebral infarction type 1 diabetes mellitus with mild nonproliferative diabetic retinopathy without macular edema end stage renal disease posterior reversible encephalopathy syndrome hypo-osmolality and hyponatremia type 1 diabetes mellitus with diabetic neuropathy, unspecified abnormal electrocardiogram [ecg] [ekg] gastroparesis acute kidney failure, unspecified renal osteodystrophy unspecified asthma, uncomplicated foot drop, right foot unspecified abdominal pain thyrotoxicosis with diffuse goiter without thyrotoxic crisis or storm dependence on renal dialysis unspecified viral hepatitis c without hepatic coma anemia in chronic kidney disease foot drop, left foot toxic encephalopathy type 1 diabetes mellitus with diabetic autonomic (poly)neuropathy type 1 diabetes mellitus with diabetic chronic kidney disease chronic diastolic (congestive) heart failure gout, unspecified diarrhea, unspecified type 1 diabetes mellitus with ketoacidosis without coma diabetes with renal manifestations, type i [juvenile type], uncontrolled hypertensive chronic kidney disease, unspecified, with chronic kidney disease stage i through stage iv, or unspecified diabetes with other specified manifestations, type i [juvenile type], uncontrolled urinary tract infection, site not specified rheumatoid arthritis esophageal reflux morbid obesity other and unspecified hyperlipidemia diabetes with ophthalmic manifestations, type i [juvenile type], uncontrolled chronic obstructive asthma, unspecified gastroparesis toxic diffuse goiter without mention of thyrotoxic crisis or storm unspecified vitamin d deficiency acute kidney failure, unspecified renal dialysis status congestive heart failure, unspecified chronic kidney disease, stage iv (severe) diabetes with neurological manifestations, type i [juvenile type], uncontrolled personal history of transient ischemic attack (tia), and cerebral infarction without residual deficits wheelchair dependence long-term (current) use of insulin
black african american f 64 $nan$hematology blood hematocrit  35.7  %; hematology blood hemoglobin  11.2  g dl; hematology blood platelet count  190  k ul; chemistry blood anion gap  14  meq l; chemistry blood bicarbonate  31  meq l; chemistry blood chloride  90  meq l; chemistry blood creatinine  3.9  mg dl; chemistry blood potassium  4.0  meq l; chemistry blood sodium  131  meq l; chemistry blood urea nitrogen  40  mg dl; chemistry blood calcium, total  8.2  mg dl; chemistry blood bilirubin, total  0.3  mg dl; chemistry blood glucose  149  mg dl; chemistry blood lactate dehydrogenase (ld)  345  iu l$pneumococcal 23-valent polysaccharide vaccine  0.5  ml ; bisacodyl  10  mg ; senna  8.6  mg ; sodium chloride 0.9%  flush  3  ml ; omeprazole  20  mg ; acetaminophen  650  mg ; docusate sodium (liquid)  100  mg ; labetalol  200  mg ; amlodipine  10  mg ; metoclopramide  5  mg ; metronidazole  500  mg ; 
hypertensive chronic kidney disease with stage 5 chronic kidney disease or end stage renal disease cough other sequelae of cerebral infarction type 1 diabetes mellitus with mild nonproliferative diabetic retinopathy without macular edema end stage renal disease posterior reversible encephalopathy syndrome hypo-osmolality and hyponatremia type 1 diabetes mellitus with diabetic neuropathy, unspecified abnormal electrocardiogram [ecg] [ekg] gastroparesis acute kidney failure, unspecified renal osteodystrophy unspecified asthma, uncomplicated foot drop, right foot unspecified abdominal pain thyrotoxicosis with diffuse goiter without thyrotoxic crisis or storm dependence on renal dialysis unspecified viral hepatitis c without hepatic coma anemia in chronic kidney disease foot drop, left foot toxic encephalopathy type 1 diabetes mellitus with diabetic autonomic (poly)neuropathy type 1 diabetes mellitus with diabetic chronic kidney disease chronic diastolic (congestive) heart failure gout, unspecified diarrhea, unspecified type 1 diabetes mellitus with ketoacidosis without coma diabetes with renal manifestations, type i [juvenile type], uncontrolled hypertensive chronic kidney disease, unspecified, with chronic kidney disease stage i through stage iv, or unspecified diabetes with other specified manifestations, type i [juvenile type], uncontrolled urinary tract infection, site not specified rheumatoid arthritis esophageal reflux morbid obesity other and unspecified hyperlipidemia diabetes with ophthalmic manifestations, type i [juvenile type], uncontrolled chronic obstructive asthma, unspecified gastroparesis toxic diffuse goiter without mention of thyrotoxic crisis or storm unspecified vitamin d deficiency acute kidney failure, unspecified renal dialysis status congestive heart failure, unspecified chronic kidney disease, stage iv (severe) diabetes with neurological manifestations, type i [juvenile type], uncontrolled personal history of transient ischemic attack (tia), and cerebral infarction without residual deficits wheelchair dependence long-term (current) use of insulin
black african american f 64 $nan$hematology blood hematocrit  33.7  %; hematology blood hemoglobin  10.9  g dl; hematology blood platelet count  224  k ul; chemistry blood anion gap  12  meq l; chemistry blood bicarbonate  31  meq l; chemistry blood chloride  94  meq l; chemistry blood creatinine  4.6  mg dl; chemistry blood potassium  3.9  meq l; chemistry blood sodium  133  meq l; chemistry blood urea nitrogen  50  mg dl; chemistry blood calcium, total  8.4  mg dl; chemistry blood bilirubin, total  0.3  mg dl; chemistry blood glucose  78  mg dl; chemistry blood lactate dehydrogenase (ld)  316  iu l$pneumococcal 23-valent polysaccharide vaccine  0.5  ml ; bisacodyl  10  mg ; senna  8.6  mg ; sodium chloride 0.9%  flush  3  ml ; omeprazole  20  mg ; acetaminophen  650  mg ; docusate sodium (liquid)  100  mg ; labetalol  200  mg ; amlodipine  10  mg ; metoclopramide  5  mg ; metronidazole  500  mg ; insulin  18  unit ; lisinopril  30  mg ; 
hypertensive chronic kidney disease with stage 5 chronic kidney disease or end stage renal disease cough other sequelae of cerebral infarction type 1 diabetes mellitus with mild nonproliferative diabetic retinopathy without macular edema end stage renal disease posterior reversible encephalopathy syndrome hypo-osmolality and hyponatremia type 1 diabetes mellitus with diabetic neuropathy, unspecified abnormal electrocardiogram [ecg] [ekg] gastroparesis acute kidney failure, unspecified renal osteodystrophy unspecified asthma, uncomplicated foot drop, right foot unspecified abdominal pain thyrotoxicosis with diffuse goiter without thyrotoxic crisis or storm dependence on renal dialysis unspecified viral hepatitis c without hepatic coma anemia in chronic kidney disease foot drop, left foot toxic encephalopathy type 1 diabetes mellitus with diabetic autonomic (poly)neuropathy type 1 diabetes mellitus with diabetic chronic kidney disease chronic diastolic (congestive) heart failure gout, unspecified diarrhea, unspecified type 1 diabetes mellitus with ketoacidosis without coma diabetes with renal manifestations, type i [juvenile type], uncontrolled hypertensive chronic kidney disease, unspecified, with chronic kidney disease stage i through stage iv, or unspecified diabetes with other specified manifestations, type i [juvenile type], uncontrolled urinary tract infection, site not specified rheumatoid arthritis esophageal reflux morbid obesity other and unspecified hyperlipidemia diabetes with ophthalmic manifestations, type i [juvenile type], uncontrolled chronic obstructive asthma, unspecified gastroparesis toxic diffuse goiter without mention of thyrotoxic crisis or storm unspecified vitamin d deficiency acute kidney failure, unspecified renal dialysis status congestive heart failure, unspecified chronic kidney disease, stage iv (severe) diabetes with neurological manifestations, type i [juvenile type], uncontrolled personal history of transient ischemic attack (tia), and cerebral infarction without residual deficits wheelchair dependence long-term (current) use of insulin
black african american f 64 $nan$nan$pneumococcal 23-valent polysaccharide vaccine  0.5  ml ; bisacodyl  10  mg ; senna  8.6  mg ; sodium chloride 0.9%  flush  3  ml ; omeprazole  20  mg ; acetaminophen  650  mg ; docusate sodium (liquid)  100  mg ; labetalol  200  mg ; amlodipine  10  mg ; metoclopramide  5  mg ; metronidazole  500  mg ; insulin  18  unit ; lisinopril  30  mg ; gabapentin  400  mg ; 
hypertensive chronic kidney disease with stage 5 chronic kidney disease or end stage renal disease cough other sequelae of cerebral infarction type 1 diabetes mellitus with mild nonproliferative diabetic retinopathy without macular edema end stage renal disease posterior reversible encephalopathy syndrome hypo-osmolality and hyponatremia type 1 diabetes mellitus with diabetic neuropathy, unspecified abnormal electrocardiogram [ecg] [ekg] gastroparesis acute kidney failure, unspecified renal osteodystrophy unspecified asthma, uncomplicated foot drop, right foot unspecified abdominal pain thyrotoxicosis with diffuse goiter without thyrotoxic crisis or storm dependence on renal dialysis unspecified viral hepatitis c without hepatic coma anemia in chronic kidney disease foot drop, left foot toxic encephalopathy type 1 diabetes mellitus with diabetic autonomic (poly)neuropathy type 1 diabetes mellitus with diabetic chronic kidney disease chronic diastolic (congestive) heart failure gout, unspecified diarrhea, unspecified type 1 diabetes mellitus with ketoacidosis without coma diabetes with renal manifestations, type i [juvenile type], uncontrolled hypertensive chronic kidney disease, unspecified, with chronic kidney disease stage i through stage iv, or unspecified diabetes with other specified manifestations, type i [juvenile type], uncontrolled urinary tract infection, site not specified rheumatoid arthritis esophageal reflux morbid obesity other and unspecified hyperlipidemia diabetes with ophthalmic manifestations, type i [juvenile type], uncontrolled chronic obstructive asthma, unspecified gastroparesis toxic diffuse goiter without mention of thyrotoxic crisis or storm unspecified vitamin d deficiency acute kidney failure, unspecified renal dialysis status congestive heart failure, unspecified chronic kidney disease, stage iv (severe) diabetes with neurological manifestations, type i [juvenile type], uncontrolled personal history of transient ischemic attack (tia), and cerebral infarction without residual deficits wheelchair dependence long-term (current) use of insulin
white f 72 $temp    heartrate  71.0  resprate  18.0  o2sat    sbp  126.0  dbp  58.0  rhythm    pain    ; temp    heartrate  74.0  resprate  18.0  o2sat    sbp    dbp    rhythm    pain    ; temp  98.1  heartrate  75.0  resprate  18.0  o2sat  98.0  sbp  161.0  dbp  66.0  rhythm    pain  0  ; temp    heartrate  77.0  resprate  17.0  o2sat  99.0  sbp  148.0  dbp  56.0  rhythm    pain  6  ; temp    heartrate  74.0  resprate  18.0  o2sat  99.0  sbp  119.0  dbp  61.0  rhythm    pain    ; temp    heartrate  73.0  resprate  18.0  o2sat  99.0  sbp  106.0  dbp  71.0  rhythm    pain  3  $nan$aspirin  325  mg ; atorvastatin  80  mg ; lisinopril  10  mg ; omeprazole  20  mg ; vitamin d  800  unit ; 
congestive heart failure, unspecified coronary atherosclerosis of native coronary artery pure hypercholesterolemia other chest pain chronic systolic heart failure spinal stenosis, unspecified region pain in limb unspecified essential hypertension osteoporosis, unspecified esophageal reflux percutaneous transluminal coronary angioplasty status other primary cardiomyopathies
white f 72 $temp  98.1  heartrate  74.0  resprate  18.0  o2sat  98.0  sbp  113.0  dbp  49.0  rhythm    pain  2  $hematology blood hematocrit  40.4  %; hematology blood hemoglobin  13.5  g dl; hematology blood platelet count  171  k ul; chemistry blood anion gap  13  meq l; chemistry blood bicarbonate  28  meq l; chemistry blood chloride  107  meq l; chemistry blood creatinine  0.4  mg dl; chemistry blood potassium  3.7  meq l; chemistry blood sodium  144  meq l; chemistry blood urea nitrogen  10  mg dl; chemistry blood calcium, total  9.0  mg dl; chemistry blood glucose  91  mg dl$aspirin  325  mg ; atorvastatin  80  mg ; lisinopril  10  mg ; omeprazole  20  mg ; vitamin d  800  unit ; heparin  5000  unit ; carvedilol  12.5  mg ; calcium carbonate  1000  mg ; influenza virus vaccine  0.5  ml ; pneumococcal vac polyvalent  0.5  ml ; sodium chloride 0.9%  flush  3  ml ; oxycodone (immediate release)   5-10  mg ; acetaminophen  1000  mg ; senna  1  tab ; docusate sodium  100  mg ; nitroglycerin sl  0.3  mg ; atorvastatin  20  mg ; 
congestive heart failure, unspecified coronary atherosclerosis of native coronary artery pure hypercholesterolemia other chest pain chronic systolic heart failure spinal stenosis, unspecified region pain in limb unspecified essential hypertension osteoporosis, unspecified esophageal reflux percutaneous transluminal coronary angioplasty status other primary cardiomyopathies
white f 72 $nan$hematology blood hematocrit  40.0  %; hematology blood hemoglobin  13.6  g dl; hematology blood platelet count  175  k ul; chemistry blood anion gap  14  meq l; chemistry blood bicarbonate  30  meq l; chemistry blood chloride  101  meq l; chemistry blood creatinine  0.5  mg dl; chemistry blood potassium  3.8  meq l; chemistry blood sodium  141  meq l; chemistry blood urea nitrogen  17  mg dl; chemistry blood glucose  93  mg dl$aspirin  325  mg ; lisinopril  10  mg ; omeprazole  20  mg ; vitamin d  800  unit ; heparin  5000  unit ; carvedilol  12.5  mg ; calcium carbonate  1000  mg ; influenza virus vaccine  0.5  ml ; pneumococcal vac polyvalent  0.5  ml ; sodium chloride 0.9%  flush  3  ml ; oxycodone (immediate release)   5-10  mg ; acetaminophen  1000  mg ; senna  1  tab ; docusate sodium  100  mg ; nitroglycerin sl  0.3  mg ; atorvastatin  20  mg ; isosorbide mononitrate  20  mg ; furosemide  40  mg ; ondansetron  4  mg ; oxycodone (immediate release)   10  mg ; 
congestive heart failure, unspecified coronary atherosclerosis of native coronary artery pure hypercholesterolemia other chest pain chronic systolic heart failure spinal stenosis, unspecified region pain in limb unspecified essential hypertension osteoporosis, unspecified esophageal reflux percutaneous transluminal coronary angioplasty status other primary cardiomyopathies
white f 72 $nan$nan$aspirin  325  mg ; lisinopril  10  mg ; omeprazole  20  mg ; vitamin d  800  unit ; heparin  5000  unit ; carvedilol  12.5  mg ; calcium carbonate  1000  mg ; influenza virus vaccine  0.5  ml ; pneumococcal vac polyvalent  0.5  ml ; sodium chloride 0.9%  flush  3  ml ; oxycodone (immediate release)   5-10  mg ; acetaminophen  1000  mg ; senna  1  tab ; docusate sodium  100  mg ; nitroglycerin sl  0.3  mg ; atorvastatin  20  mg ; isosorbide mononitrate  20  mg ; furosemide  40  mg ; ondansetron  4  mg ; oxycodone (immediate release)   10  mg ; hydromorphone (dilaudid)  1  mg ; 
congestive heart failure, unspecified coronary atherosclerosis of native coronary artery pure hypercholesterolemia other chest pain chronic systolic heart failure spinal stenosis, unspecified region pain in limb unspecified essential hypertension osteoporosis, unspecified esophageal reflux percutaneous transluminal coronary angioplasty status other primary cardiomyopathies
white f 72 $nan$nan$aspirin  325  mg ; lisinopril  10  mg ; omeprazole  20  mg ; vitamin d  800  unit ; heparin  5000  unit ; carvedilol  12.5  mg ; calcium carbonate  1000  mg ; influenza virus vaccine  0.5  ml ; pneumococcal vac polyvalent  0.5  ml ; sodium chloride 0.9%  flush  3  ml ; oxycodone (immediate release)   5-10  mg ; acetaminophen  1000  mg ; senna  1  tab ; docusate sodium  100  mg ; nitroglycerin sl  0.3  mg ; atorvastatin  20  mg ; isosorbide mononitrate  20  mg ; furosemide  40  mg ; ondansetron  4  mg ; hydromorphone (dilaudid)  1  mg ; 
congestive heart failure, unspecified coronary atherosclerosis of native coronary artery pure hypercholesterolemia other chest pain chronic systolic heart failure spinal stenosis, unspecified region pain in limb unspecified essential hypertension osteoporosis, unspecified esophageal reflux percutaneous transluminal coronary angioplasty status other primary cardiomyopathies
white m 56 $nan$nan$vitamin d  1000  unit ; thiamine  100  mg ; multivitamins  1  tab ; folic acid  1  mg ; fluoxetine  20  mg ; testosterone 4 mg patch  1  ptch ; calcitriol  0.25  mcg ; calcitonin salmon  200  unit ; 
other ascites anemia of other chronic disease hepatic encephalopathy other sequelae of chronic liver disease alcoholic cirrhosis of liver unspecified pleural effusion adult failure to thrive pneumonitis due to inhalation of food or vomitus other pulmonary insufficiency, not elsewhere classified unspecified essential hypertension encephalopathy, unspecified osteoporosis, unspecified pathologic fracture of vertebrae alcoholic cirrhosis of liver pulmonary collapse unspecified protein-calorie malnutrition other and unspecified alcohol dependence, in remission unspecified pleural effusion pneumonitis due to inhalation of food or vomitus hyposmolality and/or hyponatremia other hemochromatosis other ascites anemia, unspecified portal hypertension other sequelae of chronic liver disease osteoporosis, unspecified hepatic encephalopathy portal hypertension anemia, unspecified unspecified protein-calorie malnutrition encephalopathy, unspecified pneumonitis due to inhalation of food or vomitus other hemochromatosis other ascites other and unspecified alcohol dependence, in remission unspecified pleural effusion pathologic fracture of vertebrae esophageal varices in diseases classified elsewhere, without mention of bleeding pulmonary collapse unspecified essential hypertension alcoholic cirrhosis of liver hyposmolality and/or hyponatremia alcoholic cirrhosis of liver leukocytosis, unspecified hepatic encephalopathy backache, unspecified pathologic fracture of vertebrae other hemochromatosis
white m 56 $nan$hematology blood hematocrit  22.5  %; hematology blood hematocrit  25.4  %; hematology blood hematocrit  25.4  %; hematology blood hematocrit  22.9  %; hematology blood hemoglobin  7.4  g dl; hematology blood hemoglobin  8.3  g dl; hematology blood platelet count  150  k ul; hematology blood platelet count  141  k ul; chemistry blood anion gap  12  meq l; chemistry blood anion gap  15  meq l; chemistry blood bicarbonate  32  meq l; chemistry blood bicarbonate  29  meq l; chemistry blood chloride  86  meq l; chemistry blood chloride  88  meq l; chemistry blood creatinine  2.7  mg dl; chemistry blood creatinine  2.5  mg dl; chemistry blood potassium  5.3  meq l; chemistry blood potassium  5.0  meq l; chemistry blood sodium  125  meq l; chemistry blood sodium  127  meq l; chemistry blood urea nitrogen  86  mg dl; chemistry blood urea nitrogen  88  mg dl; hematology blood inr(pt)  1.9  ; hematology blood inr(pt)  1.8  ; chemistry urine chloride, urine  12  meq l; chemistry urine creatinine, urine  74  mg dl; chemistry urine potassium, urine  70  meq l; chemistry urine sodium, urine  11  meq l; chemistry urine urea nitrogen, urine  609  mg dl; chemistry blood calcium, total  8.1  mg dl; chemistry blood calcium, total  8.6  mg dl; chemistry blood bilirubin, total  5.0  mg dl; chemistry blood bilirubin, total  6.1  mg dl; chemistry blood glucose  117  mg dl; chemistry blood glucose  120  mg dl$ceftriaxone  2  gm ; vitamin d  1000  unit ; thiamine  100  mg ; multivitamins  1  tab ; folic acid  1  mg ; fluoxetine  20  mg ; testosterone 4 mg patch  1  ptch ; calcitriol  0.25  mcg ; calcitonin salmon  200  unit ; sodium chloride 0.9%  flush  3  ml ; heparin  5000  unit ; acetaminophen  325  mg ; albuterol 0.083% neb soln  1  neb ; rifaximin  550  mg ; ondansetron  8  mg ; lactulose  30  ml ; ipratropium bromide neb  1  neb ; calcium carbonate  500  mg ; iso-osmotic dextrose  50  ml ; albumin 25% (12.5g   50ml)  137.5  g ; iso-osmotic dextrose  200  ml ; vancomycin  1000  mg ; albumin 25% (12.5g   50ml)  50  g ; 
other ascites anemia of other chronic disease hepatic encephalopathy other sequelae of chronic liver disease alcoholic cirrhosis of liver unspecified pleural effusion adult failure to thrive pneumonitis due to inhalation of food or vomitus other pulmonary insufficiency, not elsewhere classified unspecified essential hypertension encephalopathy, unspecified osteoporosis, unspecified pathologic fracture of vertebrae alcoholic cirrhosis of liver pulmonary collapse unspecified protein-calorie malnutrition other and unspecified alcohol dependence, in remission unspecified pleural effusion pneumonitis due to inhalation of food or vomitus hyposmolality and/or hyponatremia other hemochromatosis other ascites anemia, unspecified portal hypertension other sequelae of chronic liver disease osteoporosis, unspecified hepatic encephalopathy portal hypertension anemia, unspecified unspecified protein-calorie malnutrition encephalopathy, unspecified pneumonitis due to inhalation of food or vomitus other hemochromatosis other ascites other and unspecified alcohol dependence, in remission unspecified pleural effusion pathologic fracture of vertebrae esophageal varices in diseases classified elsewhere, without mention of bleeding pulmonary collapse unspecified essential hypertension alcoholic cirrhosis of liver hyposmolality and/or hyponatremia alcoholic cirrhosis of liver leukocytosis, unspecified hepatic encephalopathy backache, unspecified pathologic fracture of vertebrae other hemochromatosis
white m 56 $nan$hematology blood hematocrit  25.5  %; hematology blood hematocrit  25.2  %; hematology blood hemoglobin  8.9  g dl; hematology blood platelet count  135  k ul; chemistry blood anion gap  18  meq l; chemistry blood bicarbonate  28  meq l; chemistry blood chloride  88  meq l; chemistry blood creatinine  2.4  mg dl; chemistry blood potassium  4.1  meq l; chemistry blood sodium  130  meq l; chemistry blood urea nitrogen  96  mg dl; hematology blood inr(pt)  2.0  ; chemistry blood calcium, total  8.6  mg dl; chemistry blood bilirubin, total  7.5  mg dl; chemistry blood glucose  144  mg dl; chemistry blood albumin  3.3  g dl$ceftriaxone  2  gm ; vitamin d  1000  unit ; thiamine  100  mg ; multivitamins  1  tab ; folic acid  1  mg ; fluoxetine  20  mg ; testosterone 4 mg patch  1  ptch ; calcitriol  0.25  mcg ; calcitonin salmon  200  unit ; sodium chloride 0.9%  flush  3  ml ; heparin  5000  unit ; acetaminophen  325  mg ; albuterol 0.083% neb soln  1  neb ; rifaximin  550  mg ; ondansetron  8  mg ; lactulose  30  ml ; ipratropium bromide neb  1  neb ; calcium carbonate  500  mg ; iso-osmotic dextrose  50  ml ; iso-osmotic dextrose  200  ml ; vancomycin  1000  mg ; albumin 25% (12.5g   50ml)  50  g ; 5% dextrose  150  ml ; vancomycin  500  mg ; amp  1  amp ; octreotide acetate  100  mcg ; midodrine  10  mg ; 
other ascites anemia of other chronic disease hepatic encephalopathy other sequelae of chronic liver disease alcoholic cirrhosis of liver unspecified pleural effusion adult failure to thrive pneumonitis due to inhalation of food or vomitus other pulmonary insufficiency, not elsewhere classified unspecified essential hypertension encephalopathy, unspecified osteoporosis, unspecified pathologic fracture of vertebrae alcoholic cirrhosis of liver pulmonary collapse unspecified protein-calorie malnutrition other and unspecified alcohol dependence, in remission unspecified pleural effusion pneumonitis due to inhalation of food or vomitus hyposmolality and/or hyponatremia other hemochromatosis other ascites anemia, unspecified portal hypertension other sequelae of chronic liver disease osteoporosis, unspecified hepatic encephalopathy portal hypertension anemia, unspecified unspecified protein-calorie malnutrition encephalopathy, unspecified pneumonitis due to inhalation of food or vomitus other hemochromatosis other ascites other and unspecified alcohol dependence, in remission unspecified pleural effusion pathologic fracture of vertebrae esophageal varices in diseases classified elsewhere, without mention of bleeding pulmonary collapse unspecified essential hypertension alcoholic cirrhosis of liver hyposmolality and/or hyponatremia alcoholic cirrhosis of liver leukocytosis, unspecified hepatic encephalopathy backache, unspecified pathologic fracture of vertebrae other hemochromatosis
white m 56 $nan$hematology blood hematocrit  27.1  %; hematology blood hematocrit  27.6  %; hematology blood hemoglobin  9.0  g dl; hematology blood platelet count  132  k ul; chemistry blood anion gap  18  meq l; chemistry blood bicarbonate  28  meq l; chemistry blood chloride  89  meq l; chemistry blood creatinine  2.5  mg dl; chemistry blood potassium  3.7  meq l; chemistry blood sodium  131  meq l; chemistry blood urea nitrogen  97  mg dl; hematology blood inr(pt)  1.8  ; chemistry blood calcium, total  8.7  mg dl; chemistry blood bilirubin, total  4.0  mg dl; chemistry blood glucose  149  mg dl$ceftriaxone  2  gm ; vitamin d  1000  unit ; thiamine  100  mg ; multivitamins  1  tab ; folic acid  1  mg ; fluoxetine  20  mg ; testosterone 4 mg patch  1  ptch ; calcitriol  0.25  mcg ; calcitonin salmon  200  unit ; sodium chloride 0.9%  flush  3  ml ; heparin  5000  unit ; acetaminophen  325  mg ; albuterol 0.083% neb soln  1  neb ; rifaximin  550  mg ; ondansetron  8  mg ; lactulose  30  ml ; ipratropium bromide neb  1  neb ; calcium carbonate  500  mg ; iso-osmotic dextrose  50  ml ; 5% dextrose  150  ml ; vancomycin  500  mg ; potassium chloride  20  meq ; 
other ascites anemia of other chronic disease hepatic encephalopathy other sequelae of chronic liver disease alcoholic cirrhosis of liver unspecified pleural effusion adult failure to thrive pneumonitis due to inhalation of food or vomitus other pulmonary insufficiency, not elsewhere classified unspecified essential hypertension encephalopathy, unspecified osteoporosis, unspecified pathologic fracture of vertebrae alcoholic cirrhosis of liver pulmonary collapse unspecified protein-calorie malnutrition other and unspecified alcohol dependence, in remission unspecified pleural effusion pneumonitis due to inhalation of food or vomitus hyposmolality and/or hyponatremia other hemochromatosis other ascites anemia, unspecified portal hypertension other sequelae of chronic liver disease osteoporosis, unspecified hepatic encephalopathy portal hypertension anemia, unspecified unspecified protein-calorie malnutrition encephalopathy, unspecified pneumonitis due to inhalation of food or vomitus other hemochromatosis other ascites other and unspecified alcohol dependence, in remission unspecified pleural effusion pathologic fracture of vertebrae esophageal varices in diseases classified elsewhere, without mention of bleeding pulmonary collapse unspecified essential hypertension alcoholic cirrhosis of liver hyposmolality and/or hyponatremia alcoholic cirrhosis of liver leukocytosis, unspecified hepatic encephalopathy backache, unspecified pathologic fracture of vertebrae other hemochromatosis
white m 56 $nan$hematology blood hematocrit  30.4  %; hematology blood hemoglobin  9.8  g dl; hematology blood platelet count  159  k ul; chemistry blood anion gap  19  meq l; chemistry blood bicarbonate  27  meq l; chemistry blood chloride  89  meq l; chemistry blood creatinine  2.1  mg dl; chemistry blood potassium  3.8  meq l; chemistry blood sodium  131  meq l; chemistry blood urea nitrogen  95  mg dl; hematology blood inr(pt)  2.1  ; chemistry blood calcium, total  8.3  mg dl; chemistry blood bilirubin, total  3.5  mg dl; chemistry blood glucose  119  mg dl$ceftriaxone  2  gm ; vitamin d  1000  unit ; thiamine  100  mg ; multivitamins  1  tab ; folic acid  1  mg ; fluoxetine  20  mg ; testosterone 4 mg patch  1  ptch ; calcitriol  0.25  mcg ; calcitonin salmon  200  unit ; sodium chloride 0.9%  flush  3  ml ; acetaminophen  325  mg ; albuterol 0.083% neb soln  1  neb ; rifaximin  550  mg ; ondansetron  8  mg ; ipratropium bromide neb  1  neb ; calcium carbonate  500  mg ; iso-osmotic dextrose  50  ml ; 5% dextrose  150  ml ; vancomycin  500  mg ; potassium chloride  20  meq ; pancrelipase 5000  1  cap ; sodium bicarbonate  650  mg ; lidocaine jelly 2%  1  appl ; 
other ascites anemia of other chronic disease hepatic encephalopathy other sequelae of chronic liver disease alcoholic cirrhosis of liver unspecified pleural effusion adult failure to thrive pneumonitis due to inhalation of food or vomitus other pulmonary insufficiency, not elsewhere classified unspecified essential hypertension encephalopathy, unspecified osteoporosis, unspecified pathologic fracture of vertebrae alcoholic cirrhosis of liver pulmonary collapse unspecified protein-calorie malnutrition other and unspecified alcohol dependence, in remission unspecified pleural effusion pneumonitis due to inhalation of food or vomitus hyposmolality and/or hyponatremia other hemochromatosis other ascites anemia, unspecified portal hypertension other sequelae of chronic liver disease osteoporosis, unspecified hepatic encephalopathy portal hypertension anemia, unspecified unspecified protein-calorie malnutrition encephalopathy, unspecified pneumonitis due to inhalation of food or vomitus other hemochromatosis other ascites other and unspecified alcohol dependence, in remission unspecified pleural effusion pathologic fracture of vertebrae esophageal varices in diseases classified elsewhere, without mention of bleeding pulmonary collapse unspecified essential hypertension alcoholic cirrhosis of liver hyposmolality and/or hyponatremia alcoholic cirrhosis of liver leukocytosis, unspecified hepatic encephalopathy backache, unspecified pathologic fracture of vertebrae other hemochromatosis
white m 56 $nan$hematology blood hematocrit  31.6  %; hematology blood hemoglobin  10.4  g dl; hematology blood platelet count  193  k ul; chemistry blood anion gap  16  meq l; chemistry blood bicarbonate  30  meq l; chemistry blood chloride  88  meq l; chemistry blood creatinine  2.2  mg dl; chemistry blood potassium  3.6  meq l; chemistry blood sodium  130  meq l; chemistry blood urea nitrogen  92  mg dl; hematology blood inr(pt)  2.2  ; chemistry blood calcium, total  9.0  mg dl; chemistry blood bilirubin, total  4.6  mg dl; chemistry blood glucose  92  mg dl$ceftriaxone  2  gm ; vitamin d  1000  unit ; thiamine  100  mg ; multivitamins  1  tab ; folic acid  1  mg ; fluoxetine  20  mg ; testosterone 4 mg patch  1  ptch ; calcitriol  0.25  mcg ; calcitonin salmon  200  unit ; sodium chloride 0.9%  flush  3  ml ; acetaminophen  325  mg ; albuterol 0.083% neb soln  1  neb ; rifaximin  550  mg ; ondansetron  8  mg ; ipratropium bromide neb  1  neb ; calcium carbonate  500  mg ; iso-osmotic dextrose  50  ml ; 5% dextrose  150  ml ; vancomycin  500  mg ; pancrelipase 5000  1  cap ; sodium bicarbonate  650  mg ; lidocaine jelly 2%  1  appl ; 
other ascites anemia of other chronic disease hepatic encephalopathy other sequelae of chronic liver disease alcoholic cirrhosis of liver unspecified pleural effusion adult failure to thrive pneumonitis due to inhalation of food or vomitus other pulmonary insufficiency, not elsewhere classified unspecified essential hypertension encephalopathy, unspecified osteoporosis, unspecified pathologic fracture of vertebrae alcoholic cirrhosis of liver pulmonary collapse unspecified protein-calorie malnutrition other and unspecified alcohol dependence, in remission unspecified pleural effusion pneumonitis due to inhalation of food or vomitus hyposmolality and/or hyponatremia other hemochromatosis other ascites anemia, unspecified portal hypertension other sequelae of chronic liver disease osteoporosis, unspecified hepatic encephalopathy portal hypertension anemia, unspecified unspecified protein-calorie malnutrition encephalopathy, unspecified pneumonitis due to inhalation of food or vomitus other hemochromatosis other ascites other and unspecified alcohol dependence, in remission unspecified pleural effusion pathologic fracture of vertebrae esophageal varices in diseases classified elsewhere, without mention of bleeding pulmonary collapse unspecified essential hypertension alcoholic cirrhosis of liver hyposmolality and/or hyponatremia alcoholic cirrhosis of liver leukocytosis, unspecified hepatic encephalopathy backache, unspecified pathologic fracture of vertebrae other hemochromatosis
white m 56 $nan$hematology blood hematocrit  28.8  %; hematology blood hemoglobin  9.5  g dl; hematology blood platelet count  178  k ul; chemistry blood anion gap  16  meq l; chemistry blood bicarbonate  29  meq l; chemistry blood chloride  91  meq l; chemistry blood creatinine  2.1  mg dl; chemistry blood potassium  3.9  meq l; chemistry blood sodium  132  meq l; chemistry blood urea nitrogen  96  mg dl; hematology blood inr(pt)  2.2  ; chemistry blood calcium, total  9.2  mg dl; chemistry blood bilirubin, total  4.5  mg dl; chemistry blood glucose  100  mg dl$ceftriaxone  2  gm ; vitamin d  1000  unit ; thiamine  100  mg ; multivitamins  1  tab ; folic acid  1  mg ; fluoxetine  20  mg ; testosterone 4 mg patch  1  ptch ; calcitriol  0.25  mcg ; calcitonin salmon  200  unit ; sodium chloride 0.9%  flush  3  ml ; acetaminophen  325  mg ; albuterol 0.083% neb soln  1  neb ; rifaximin  550  mg ; ondansetron  8  mg ; ipratropium bromide neb  1  neb ; calcium carbonate  500  mg ; iso-osmotic dextrose  50  ml ; midodrine  12.5  mg ; 0.9% sodium chloride  50  ml ; daptomycin  550  mg ; syringe  0.3  ml ; octreotide acetate  150  mcg ; 
other ascites anemia of other chronic disease hepatic encephalopathy other sequelae of chronic liver disease alcoholic cirrhosis of liver unspecified pleural effusion adult failure to thrive pneumonitis due to inhalation of food or vomitus other pulmonary insufficiency, not elsewhere classified unspecified essential hypertension encephalopathy, unspecified osteoporosis, unspecified pathologic fracture of vertebrae alcoholic cirrhosis of liver pulmonary collapse unspecified protein-calorie malnutrition other and unspecified alcohol dependence, in remission unspecified pleural effusion pneumonitis due to inhalation of food or vomitus hyposmolality and/or hyponatremia other hemochromatosis other ascites anemia, unspecified portal hypertension other sequelae of chronic liver disease osteoporosis, unspecified hepatic encephalopathy portal hypertension anemia, unspecified unspecified protein-calorie malnutrition encephalopathy, unspecified pneumonitis due to inhalation of food or vomitus other hemochromatosis other ascites other and unspecified alcohol dependence, in remission unspecified pleural effusion pathologic fracture of vertebrae esophageal varices in diseases classified elsewhere, without mention of bleeding pulmonary collapse unspecified essential hypertension alcoholic cirrhosis of liver hyposmolality and/or hyponatremia alcoholic cirrhosis of liver leukocytosis, unspecified hepatic encephalopathy backache, unspecified pathologic fracture of vertebrae other hemochromatosis
white m 56 $nan$hematology blood hematocrit  29.4  %; hematology blood hemoglobin  9.5  g dl; hematology blood platelet count  193  k ul; chemistry blood anion gap  20  meq l; chemistry blood bicarbonate  26  meq l; chemistry blood chloride  94  meq l; chemistry blood creatinine  1.9  mg dl; chemistry blood potassium  3.6  meq l; chemistry blood sodium  136  meq l; chemistry blood urea nitrogen  92  mg dl; hematology blood inr(pt)  2.0  ; chemistry blood calcium, total  9.5  mg dl; chemistry blood bilirubin, total  4.3  mg dl; chemistry blood glucose  122  mg dl; chemistry blood lactate dehydrogenase (ld)  172  iu l$vitamin d  1000  unit ; thiamine  100  mg ; multivitamins  1  tab ; folic acid  1  mg ; fluoxetine  20  mg ; testosterone 4 mg patch  1  ptch ; calcitriol  0.25  mcg ; calcitonin salmon  200  unit ; sodium chloride 0.9%  flush  3  ml ; acetaminophen  325  mg ; albuterol 0.083% neb soln  1  neb ; rifaximin  550  mg ; ondansetron  8  mg ; ipratropium bromide neb  1  neb ; calcium carbonate  500  mg ; midodrine  12.5  mg ; 0.9% sodium chloride  50  ml ; daptomycin  550  mg ; syringe  0.3  ml ; octreotide acetate  150  mcg ; 
other ascites anemia of other chronic disease hepatic encephalopathy other sequelae of chronic liver disease alcoholic cirrhosis of liver unspecified pleural effusion adult failure to thrive pneumonitis due to inhalation of food or vomitus other pulmonary insufficiency, not elsewhere classified unspecified essential hypertension encephalopathy, unspecified osteoporosis, unspecified pathologic fracture of vertebrae alcoholic cirrhosis of liver pulmonary collapse unspecified protein-calorie malnutrition other and unspecified alcohol dependence, in remission unspecified pleural effusion pneumonitis due to inhalation of food or vomitus hyposmolality and/or hyponatremia other hemochromatosis other ascites anemia, unspecified portal hypertension other sequelae of chronic liver disease osteoporosis, unspecified hepatic encephalopathy portal hypertension anemia, unspecified unspecified protein-calorie malnutrition encephalopathy, unspecified pneumonitis due to inhalation of food or vomitus other hemochromatosis other ascites other and unspecified alcohol dependence, in remission unspecified pleural effusion pathologic fracture of vertebrae esophageal varices in diseases classified elsewhere, without mention of bleeding pulmonary collapse unspecified essential hypertension alcoholic cirrhosis of liver hyposmolality and/or hyponatremia alcoholic cirrhosis of liver leukocytosis, unspecified hepatic encephalopathy backache, unspecified pathologic fracture of vertebrae other hemochromatosis
white m 56 $nan$hematology blood hematocrit  28.2  %; hematology blood hemoglobin  9.5  g dl; hematology blood platelet count  201  k ul; chemistry blood anion gap  14  meq l; chemistry blood bicarbonate  31  meq l; chemistry blood chloride  98  meq l; chemistry blood creatinine  1.9  mg dl; chemistry blood potassium  3.2  meq l; chemistry blood sodium  140  meq l; chemistry blood urea nitrogen  91  mg dl; hematology blood inr(pt)  2.1  ; chemistry blood calcium, total  9.7  mg dl; chemistry blood bilirubin, total  4.4  mg dl; chemistry blood glucose  209  mg dl$vitamin d  1000  unit ; thiamine  100  mg ; multivitamins  1  tab ; folic acid  1  mg ; fluoxetine  20  mg ; testosterone 4 mg patch  1  ptch ; calcitriol  0.25  mcg ; calcitonin salmon  200  unit ; sodium chloride 0.9%  flush  3  ml ; acetaminophen  325  mg ; albuterol 0.083% neb soln  1  neb ; rifaximin  550  mg ; ondansetron  8  mg ; ipratropium bromide neb  1  neb ; calcium carbonate  500  mg ; midodrine  12.5  mg ; 0.9% sodium chloride  50  ml ; daptomycin  550  mg ; potassium chloride  40  meq ; 
other ascites anemia of other chronic disease hepatic encephalopathy other sequelae of chronic liver disease alcoholic cirrhosis of liver unspecified pleural effusion adult failure to thrive pneumonitis due to inhalation of food or vomitus other pulmonary insufficiency, not elsewhere classified unspecified essential hypertension encephalopathy, unspecified osteoporosis, unspecified pathologic fracture of vertebrae alcoholic cirrhosis of liver pulmonary collapse unspecified protein-calorie malnutrition other and unspecified alcohol dependence, in remission unspecified pleural effusion pneumonitis due to inhalation of food or vomitus hyposmolality and/or hyponatremia other hemochromatosis other ascites anemia, unspecified portal hypertension other sequelae of chronic liver disease osteoporosis, unspecified hepatic encephalopathy portal hypertension anemia, unspecified unspecified protein-calorie malnutrition encephalopathy, unspecified pneumonitis due to inhalation of food or vomitus other hemochromatosis other ascites other and unspecified alcohol dependence, in remission unspecified pleural effusion pathologic fracture of vertebrae esophageal varices in diseases classified elsewhere, without mention of bleeding pulmonary collapse unspecified essential hypertension alcoholic cirrhosis of liver hyposmolality and/or hyponatremia alcoholic cirrhosis of liver leukocytosis, unspecified hepatic encephalopathy backache, unspecified pathologic fracture of vertebrae other hemochromatosis
white m 56 $nan$hematology blood hematocrit  28.9  %; hematology blood hemoglobin  9.7  g dl; hematology blood platelet count  173  k ul; chemistry blood anion gap  15  meq l; chemistry blood anion gap  15  meq l; chemistry blood bicarbonate  30  meq l; chemistry blood bicarbonate  27  meq l; chemistry blood chloride  96  meq l; chemistry blood chloride  98  meq l; chemistry blood creatinine  1.8  mg dl; chemistry blood creatinine  1.9  mg dl; chemistry blood potassium  3.4  meq l; chemistry blood potassium  2.9  meq l; chemistry blood sodium  138  meq l; chemistry blood sodium  137  meq l; chemistry blood urea nitrogen  90  mg dl; chemistry blood urea nitrogen  87  mg dl; hematology blood inr(pt)  2.0  ; hematology urine wbc  4  # hpf; chemistry blood calcium, total  9.6  mg dl; chemistry blood calcium, total  10.1  mg dl; chemistry blood bilirubin, total  3.4  mg dl; chemistry blood glucose  218  mg dl; chemistry blood glucose  140  mg dl$vitamin d  1000  unit ; thiamine  100  mg ; multivitamins  1  tab ; folic acid  1  mg ; fluoxetine  20  mg ; testosterone 4 mg patch  1  ptch ; calcitriol  0.25  mcg ; calcitonin salmon  200  unit ; sodium chloride 0.9%  flush  3  ml ; acetaminophen  325  mg ; albuterol 0.083% neb soln  1  neb ; rifaximin  550  mg ; ondansetron  8  mg ; ipratropium bromide neb  1  neb ; calcium carbonate  500  mg ; midodrine  12.5  mg ; 0.9% sodium chloride  50  ml ; daptomycin  550  mg ; potassium chloride  40  meq ; potassium chloride  60  meq ; neutra-phos  1  pkt ; 
other ascites anemia of other chronic disease hepatic encephalopathy other sequelae of chronic liver disease alcoholic cirrhosis of liver unspecified pleural effusion adult failure to thrive pneumonitis due to inhalation of food or vomitus other pulmonary insufficiency, not elsewhere classified unspecified essential hypertension encephalopathy, unspecified osteoporosis, unspecified pathologic fracture of vertebrae alcoholic cirrhosis of liver pulmonary collapse unspecified protein-calorie malnutrition other and unspecified alcohol dependence, in remission unspecified pleural effusion pneumonitis due to inhalation of food or vomitus hyposmolality and/or hyponatremia other hemochromatosis other ascites anemia, unspecified portal hypertension other sequelae of chronic liver disease osteoporosis, unspecified hepatic encephalopathy portal hypertension anemia, unspecified unspecified protein-calorie malnutrition encephalopathy, unspecified pneumonitis due to inhalation of food or vomitus other hemochromatosis other ascites other and unspecified alcohol dependence, in remission unspecified pleural effusion pathologic fracture of vertebrae esophageal varices in diseases classified elsewhere, without mention of bleeding pulmonary collapse unspecified essential hypertension alcoholic cirrhosis of liver hyposmolality and/or hyponatremia alcoholic cirrhosis of liver leukocytosis, unspecified hepatic encephalopathy backache, unspecified pathologic fracture of vertebrae other hemochromatosis
white m 56 $nan$hematology blood hematocrit  27.2  %; hematology blood hemoglobin  9.1  g dl; hematology blood platelet count  151  k ul; chemistry blood anion gap  15  meq l; chemistry blood anion gap  18  meq l; chemistry blood bicarbonate  28  meq l; chemistry blood bicarbonate  28  meq l; chemistry blood chloride  95  meq l; chemistry blood chloride  94  meq l; chemistry blood creatinine  2.0  mg dl; chemistry blood creatinine  2.0  mg dl; chemistry blood potassium  3.8  meq l; chemistry blood potassium  3.7  meq l; chemistry blood sodium  134  meq l; chemistry blood sodium  136  meq l; chemistry blood urea nitrogen  89  mg dl; chemistry blood urea nitrogen  88  mg dl; hematology blood inr(pt)  1.9  ; chemistry blood calcium, total  9.9  mg dl; chemistry blood calcium, total  10.1  mg dl; chemistry blood bilirubin, total  3.5  mg dl; chemistry blood glucose  132  mg dl; chemistry blood glucose  161  mg dl$vitamin d  1000  unit ; thiamine  100  mg ; multivitamins  1  tab ; folic acid  1  mg ; fluoxetine  20  mg ; testosterone 4 mg patch  1  ptch ; calcitriol  0.25  mcg ; calcitonin salmon  200  unit ; sodium chloride 0.9%  flush  3  ml ; acetaminophen  325  mg ; albuterol 0.083% neb soln  1  neb ; rifaximin  550  mg ; ondansetron  8  mg ; ipratropium bromide neb  1  neb ; calcium carbonate  500  mg ; midodrine  12.5  mg ; 0.9% sodium chloride  50  ml ; daptomycin  550  mg ; potassium chloride  60  meq ; neutra-phos  1  pkt ; neutra-phos  2  pkt ; potassium chloride (powder)  40  meq ; octreotide acetate  200  mcg ; syringe  0.4  ml ; 
other ascites anemia of other chronic disease hepatic encephalopathy other sequelae of chronic liver disease alcoholic cirrhosis of liver unspecified pleural effusion adult failure to thrive pneumonitis due to inhalation of food or vomitus other pulmonary insufficiency, not elsewhere classified unspecified essential hypertension encephalopathy, unspecified osteoporosis, unspecified pathologic fracture of vertebrae alcoholic cirrhosis of liver pulmonary collapse unspecified protein-calorie malnutrition other and unspecified alcohol dependence, in remission unspecified pleural effusion pneumonitis due to inhalation of food or vomitus hyposmolality and/or hyponatremia other hemochromatosis other ascites anemia, unspecified portal hypertension other sequelae of chronic liver disease osteoporosis, unspecified hepatic encephalopathy portal hypertension anemia, unspecified unspecified protein-calorie malnutrition encephalopathy, unspecified pneumonitis due to inhalation of food or vomitus other hemochromatosis other ascites other and unspecified alcohol dependence, in remission unspecified pleural effusion pathologic fracture of vertebrae esophageal varices in diseases classified elsewhere, without mention of bleeding pulmonary collapse unspecified essential hypertension alcoholic cirrhosis of liver hyposmolality and/or hyponatremia alcoholic cirrhosis of liver leukocytosis, unspecified hepatic encephalopathy backache, unspecified pathologic fracture of vertebrae other hemochromatosis
white m 56 $nan$hematology blood hematocrit  28.2  %; hematology blood hemoglobin  8.9  g dl; hematology blood platelet count  149  k ul; chemistry blood anion gap  17  meq l; chemistry blood bicarbonate  28  meq l; chemistry blood chloride  95  meq l; chemistry blood creatinine  2.1  mg dl; chemistry blood potassium  3.5  meq l; chemistry blood sodium  136  meq l; chemistry blood urea nitrogen  94  mg dl; hematology blood inr(pt)  1.8  ; chemistry blood calcium, total  9.9  mg dl; chemistry blood bilirubin, total  3.3  mg dl; chemistry blood glucose  161  mg dl$vitamin d  1000  unit ; thiamine  100  mg ; multivitamins  1  tab ; folic acid  1  mg ; fluoxetine  20  mg ; testosterone 4 mg patch  1  ptch ; calcitriol  0.25  mcg ; calcitonin salmon  200  unit ; sodium chloride 0.9%  flush  3  ml ; acetaminophen  325  mg ; albuterol 0.083% neb soln  1  neb ; rifaximin  550  mg ; ondansetron  8  mg ; ipratropium bromide neb  1  neb ; calcium carbonate  500  mg ; midodrine  12.5  mg ; 0.9% sodium chloride  50  ml ; daptomycin  550  mg ; potassium chloride (powder)  40  meq ; syringe  0.4  ml ; megestrol acetate  400  mg ; dextrose 50%  12.5  gm ; glucagon  1  mg ; glucose gel  15  g ; insulin  0  unit ; 
other ascites anemia of other chronic disease hepatic encephalopathy other sequelae of chronic liver disease alcoholic cirrhosis of liver unspecified pleural effusion adult failure to thrive pneumonitis due to inhalation of food or vomitus other pulmonary insufficiency, not elsewhere classified unspecified essential hypertension encephalopathy, unspecified osteoporosis, unspecified pathologic fracture of vertebrae alcoholic cirrhosis of liver pulmonary collapse unspecified protein-calorie malnutrition other and unspecified alcohol dependence, in remission unspecified pleural effusion pneumonitis due to inhalation of food or vomitus hyposmolality and/or hyponatremia other hemochromatosis other ascites anemia, unspecified portal hypertension other sequelae of chronic liver disease osteoporosis, unspecified hepatic encephalopathy portal hypertension anemia, unspecified unspecified protein-calorie malnutrition encephalopathy, unspecified pneumonitis due to inhalation of food or vomitus other hemochromatosis other ascites other and unspecified alcohol dependence, in remission unspecified pleural effusion pathologic fracture of vertebrae esophageal varices in diseases classified elsewhere, without mention of bleeding pulmonary collapse unspecified essential hypertension alcoholic cirrhosis of liver hyposmolality and/or hyponatremia alcoholic cirrhosis of liver leukocytosis, unspecified hepatic encephalopathy backache, unspecified pathologic fracture of vertebrae other hemochromatosis
white m 56 $nan$hematology blood hematocrit  27.8  %; hematology blood hemoglobin  9.1  g dl; hematology blood platelet count  144  k ul; chemistry blood anion gap  20  meq l; chemistry blood bicarbonate  26  meq l; chemistry blood chloride  92  meq l; chemistry blood creatinine  2.5  mg dl; chemistry blood potassium  3.7  meq l; chemistry blood sodium  134  meq l; chemistry blood urea nitrogen  103  mg dl; hematology blood inr(pt)  1.7  ; chemistry blood calcium, total  9.7  mg dl; chemistry blood bilirubin, total  3.2  mg dl; chemistry blood glucose  142  mg dl$vitamin d  1000  unit ; thiamine  100  mg ; folic acid  1  mg ; fluoxetine  20  mg ; testosterone 4 mg patch  1  ptch ; calcitriol  0.25  mcg ; calcitonin salmon  200  unit ; sodium chloride 0.9%  flush  3  ml ; acetaminophen  325  mg ; albuterol 0.083% neb soln  1  neb ; rifaximin  550  mg ; ondansetron  8  mg ; ipratropium bromide neb  1  neb ; calcium carbonate  500  mg ; midodrine  12.5  mg ; 0.9% sodium chloride  50  ml ; daptomycin  550  mg ; syringe  0.4  ml ; megestrol acetate  400  mg ; dextrose 50%  12.5  gm ; glucagon  1  mg ; glucose gel  15  g ; insulin  0  unit ; fluoxetine  30  mg ; 
other ascites anemia of other chronic disease hepatic encephalopathy other sequelae of chronic liver disease alcoholic cirrhosis of liver unspecified pleural effusion adult failure to thrive pneumonitis due to inhalation of food or vomitus other pulmonary insufficiency, not elsewhere classified unspecified essential hypertension encephalopathy, unspecified osteoporosis, unspecified pathologic fracture of vertebrae alcoholic cirrhosis of liver pulmonary collapse unspecified protein-calorie malnutrition other and unspecified alcohol dependence, in remission unspecified pleural effusion pneumonitis due to inhalation of food or vomitus hyposmolality and/or hyponatremia other hemochromatosis other ascites anemia, unspecified portal hypertension other sequelae of chronic liver disease osteoporosis, unspecified hepatic encephalopathy portal hypertension anemia, unspecified unspecified protein-calorie malnutrition encephalopathy, unspecified pneumonitis due to inhalation of food or vomitus other hemochromatosis other ascites other and unspecified alcohol dependence, in remission unspecified pleural effusion pathologic fracture of vertebrae esophageal varices in diseases classified elsewhere, without mention of bleeding pulmonary collapse unspecified essential hypertension alcoholic cirrhosis of liver hyposmolality and/or hyponatremia alcoholic cirrhosis of liver leukocytosis, unspecified hepatic encephalopathy backache, unspecified pathologic fracture of vertebrae other hemochromatosis
white m 56 $nan$hematology blood hematocrit  27.5  %; hematology blood hemoglobin  9.0  g dl; hematology blood platelet count  139  k ul; chemistry blood anion gap  19  meq l; chemistry blood bicarbonate  26  meq l; chemistry blood chloride  92  meq l; chemistry blood creatinine  2.7  mg dl; chemistry blood potassium  3.4  meq l; chemistry blood sodium  134  meq l; chemistry blood urea nitrogen  111  mg dl; hematology blood inr(pt)  1.6  ; chemistry blood calcium, total  9.7  mg dl; chemistry blood bilirubin, total  2.5  mg dl; chemistry blood glucose  185  mg dl$vitamin d  1000  unit ; thiamine  100  mg ; folic acid  1  mg ; testosterone 4 mg patch  1  ptch ; calcitriol  0.25  mcg ; calcitonin salmon  200  unit ; sodium chloride 0.9%  flush  3  ml ; acetaminophen  325  mg ; albuterol 0.083% neb soln  1  neb ; rifaximin  550  mg ; ondansetron  8  mg ; ipratropium bromide neb  1  neb ; calcium carbonate  500  mg ; 0.9% sodium chloride  50  ml ; daptomycin  550  mg ; syringe  0.4  ml ; megestrol acetate  400  mg ; dextrose 50%  12.5  gm ; glucagon  1  mg ; glucose gel  15  g ; insulin  0  unit ; fluoxetine  30  mg ; midodrine  15  mg ; 
other ascites anemia of other chronic disease hepatic encephalopathy other sequelae of chronic liver disease alcoholic cirrhosis of liver unspecified pleural effusion adult failure to thrive pneumonitis due to inhalation of food or vomitus other pulmonary insufficiency, not elsewhere classified unspecified essential hypertension encephalopathy, unspecified osteoporosis, unspecified pathologic fracture of vertebrae alcoholic cirrhosis of liver pulmonary collapse unspecified protein-calorie malnutrition other and unspecified alcohol dependence, in remission unspecified pleural effusion pneumonitis due to inhalation of food or vomitus hyposmolality and/or hyponatremia other hemochromatosis other ascites anemia, unspecified portal hypertension other sequelae of chronic liver disease osteoporosis, unspecified hepatic encephalopathy portal hypertension anemia, unspecified unspecified protein-calorie malnutrition encephalopathy, unspecified pneumonitis due to inhalation of food or vomitus other hemochromatosis other ascites other and unspecified alcohol dependence, in remission unspecified pleural effusion pathologic fracture of vertebrae esophageal varices in diseases classified elsewhere, without mention of bleeding pulmonary collapse unspecified essential hypertension alcoholic cirrhosis of liver hyposmolality and/or hyponatremia alcoholic cirrhosis of liver leukocytosis, unspecified hepatic encephalopathy backache, unspecified pathologic fracture of vertebrae other hemochromatosis
white m 56 $nan$hematology blood hematocrit  25.7  %; hematology blood hemoglobin  8.5  g dl; hematology blood platelet count  136  k ul; chemistry blood anion gap  20  meq l; chemistry blood anion gap  21  meq l; chemistry blood bicarbonate  25  meq l; chemistry blood bicarbonate  24  meq l; chemistry blood chloride  92  meq l; chemistry blood chloride  93  meq l; chemistry blood creatinine  3.4  mg dl; chemistry blood creatinine  3.3  mg dl; chemistry blood potassium  3.9  meq l; chemistry blood potassium  4.0  meq l; chemistry blood sodium  133  meq l; chemistry blood sodium  134  meq l; chemistry blood urea nitrogen  126  mg dl; chemistry blood urea nitrogen  125  mg dl; hematology blood inr(pt)  1.7  ; chemistry blood calcium, total  9.7  mg dl; chemistry blood calcium, total  9.7  mg dl; chemistry blood bilirubin, total  2.3  mg dl; chemistry blood glucose  192  mg dl; chemistry blood glucose  176  mg dl$vitamin d  1000  unit ; thiamine  100  mg ; folic acid  1  mg ; testosterone 4 mg patch  1  ptch ; calcitriol  0.25  mcg ; calcitonin salmon  200  unit ; sodium chloride 0.9%  flush  3  ml ; acetaminophen  325  mg ; albuterol 0.083% neb soln  1  neb ; rifaximin  550  mg ; ondansetron  8  mg ; ipratropium bromide neb  1  neb ; calcium carbonate  500  mg ; syringe  0.4  ml ; megestrol acetate  400  mg ; dextrose 50%  12.5  gm ; glucagon  1  mg ; glucose gel  15  g ; insulin  0  unit ; fluoxetine  30  mg ; midodrine  15  mg ; potassium chloride  30  meq ; 
other ascites anemia of other chronic disease hepatic encephalopathy other sequelae of chronic liver disease alcoholic cirrhosis of liver unspecified pleural effusion adult failure to thrive pneumonitis due to inhalation of food or vomitus other pulmonary insufficiency, not elsewhere classified unspecified essential hypertension encephalopathy, unspecified osteoporosis, unspecified pathologic fracture of vertebrae alcoholic cirrhosis of liver pulmonary collapse unspecified protein-calorie malnutrition other and unspecified alcohol dependence, in remission unspecified pleural effusion pneumonitis due to inhalation of food or vomitus hyposmolality and/or hyponatremia other hemochromatosis other ascites anemia, unspecified portal hypertension other sequelae of chronic liver disease osteoporosis, unspecified hepatic encephalopathy portal hypertension anemia, unspecified unspecified protein-calorie malnutrition encephalopathy, unspecified pneumonitis due to inhalation of food or vomitus other hemochromatosis other ascites other and unspecified alcohol dependence, in remission unspecified pleural effusion pathologic fracture of vertebrae esophageal varices in diseases classified elsewhere, without mention of bleeding pulmonary collapse unspecified essential hypertension alcoholic cirrhosis of liver hyposmolality and/or hyponatremia alcoholic cirrhosis of liver leukocytosis, unspecified hepatic encephalopathy backache, unspecified pathologic fracture of vertebrae other hemochromatosis
white m 56 $nan$hematology blood hematocrit  27.5  %; hematology blood hemoglobin  8.9  g dl; hematology blood platelet count  136  k ul; chemistry blood anion gap  22  meq l; chemistry blood bicarbonate  24  meq l; chemistry blood chloride  94  meq l; chemistry blood creatinine  3.6  mg dl; chemistry blood potassium  4.5  meq l; chemistry blood sodium  135  meq l; chemistry blood urea nitrogen  137  mg dl; hematology blood inr(pt)  1.6  ; chemistry blood calcium, total  9.7  mg dl; chemistry blood bilirubin, total  2.4  mg dl; chemistry blood glucose  238  mg dl$vitamin d  1000  unit ; thiamine  100  mg ; folic acid  1  mg ; testosterone 4 mg patch  1  ptch ; calcitriol  0.25  mcg ; calcitonin salmon  200  unit ; sodium chloride 0.9%  flush  3  ml ; acetaminophen  325  mg ; albuterol 0.083% neb soln  1  neb ; rifaximin  550  mg ; ondansetron  8  mg ; ipratropium bromide neb  1  neb ; calcium carbonate  500  mg ; syringe  0.4  ml ; megestrol acetate  400  mg ; dextrose 50%  12.5  gm ; glucagon  1  mg ; glucose gel  15  g ; insulin  0  unit ; fluoxetine  30  mg ; midodrine  15  mg ; potassium chloride  30  meq ; 
other ascites anemia of other chronic disease hepatic encephalopathy other sequelae of chronic liver disease alcoholic cirrhosis of liver unspecified pleural effusion adult failure to thrive pneumonitis due to inhalation of food or vomitus other pulmonary insufficiency, not elsewhere classified unspecified essential hypertension encephalopathy, unspecified osteoporosis, unspecified pathologic fracture of vertebrae alcoholic cirrhosis of liver pulmonary collapse unspecified protein-calorie malnutrition other and unspecified alcohol dependence, in remission unspecified pleural effusion pneumonitis due to inhalation of food or vomitus hyposmolality and/or hyponatremia other hemochromatosis other ascites anemia, unspecified portal hypertension other sequelae of chronic liver disease osteoporosis, unspecified hepatic encephalopathy portal hypertension anemia, unspecified unspecified protein-calorie malnutrition encephalopathy, unspecified pneumonitis due to inhalation of food or vomitus other hemochromatosis other ascites other and unspecified alcohol dependence, in remission unspecified pleural effusion pathologic fracture of vertebrae esophageal varices in diseases classified elsewhere, without mention of bleeding pulmonary collapse unspecified essential hypertension alcoholic cirrhosis of liver hyposmolality and/or hyponatremia alcoholic cirrhosis of liver leukocytosis, unspecified hepatic encephalopathy backache, unspecified pathologic fracture of vertebrae other hemochromatosis
white m 56 $nan$hematology blood hematocrit  27.9  %; hematology blood hemoglobin  9.0  g dl; hematology blood platelet count  126  k ul; chemistry blood anion gap  20  meq l; chemistry blood bicarbonate  25  meq l; chemistry blood chloride  94  meq l; chemistry blood creatinine  3.8  mg dl; chemistry blood potassium  4.1  meq l; chemistry blood sodium  135  meq l; chemistry blood urea nitrogen  148  mg dl; hematology blood inr(pt)  1.6  ; chemistry blood calcium, total  9.7  mg dl; chemistry blood bilirubin, total  2.4  mg dl; chemistry blood glucose  205  mg dl; chemistry blood albumin  3.7  g dl$vitamin d  1000  unit ; thiamine  100  mg ; folic acid  1  mg ; testosterone 4 mg patch  1  ptch ; calcitriol  0.25  mcg ; calcitonin salmon  200  unit ; sodium chloride 0.9%  flush  3  ml ; acetaminophen  325  mg ; albuterol 0.083% neb soln  1  neb ; rifaximin  550  mg ; ondansetron  8  mg ; ipratropium bromide neb  1  neb ; calcium carbonate  500  mg ; megestrol acetate  400  mg ; fluoxetine  30  mg ; 
other ascites anemia of other chronic disease hepatic encephalopathy other sequelae of chronic liver disease alcoholic cirrhosis of liver unspecified pleural effusion adult failure to thrive pneumonitis due to inhalation of food or vomitus other pulmonary insufficiency, not elsewhere classified unspecified essential hypertension encephalopathy, unspecified osteoporosis, unspecified pathologic fracture of vertebrae alcoholic cirrhosis of liver pulmonary collapse unspecified protein-calorie malnutrition other and unspecified alcohol dependence, in remission unspecified pleural effusion pneumonitis due to inhalation of food or vomitus hyposmolality and/or hyponatremia other hemochromatosis other ascites anemia, unspecified portal hypertension other sequelae of chronic liver disease osteoporosis, unspecified hepatic encephalopathy portal hypertension anemia, unspecified unspecified protein-calorie malnutrition encephalopathy, unspecified pneumonitis due to inhalation of food or vomitus other hemochromatosis other ascites other and unspecified alcohol dependence, in remission unspecified pleural effusion pathologic fracture of vertebrae esophageal varices in diseases classified elsewhere, without mention of bleeding pulmonary collapse unspecified essential hypertension alcoholic cirrhosis of liver hyposmolality and/or hyponatremia alcoholic cirrhosis of liver leukocytosis, unspecified hepatic encephalopathy backache, unspecified pathologic fracture of vertebrae other hemochromatosis
white m 56 $nan$nan$vitamin d  1000  unit ; thiamine  100  mg ; folic acid  1  mg ; testosterone 4 mg patch  1  ptch ; calcitriol  0.25  mcg ; calcitonin salmon  200  unit ; sodium chloride 0.9%  flush  3  ml ; acetaminophen  325  mg ; albuterol 0.083% neb soln  1  neb ; rifaximin  550  mg ; ondansetron  8  mg ; ipratropium bromide neb  1  neb ; calcium carbonate  500  mg ; megestrol acetate  400  mg ; fluoxetine  30  mg ; 
other ascites anemia of other chronic disease hepatic encephalopathy other sequelae of chronic liver disease alcoholic cirrhosis of liver unspecified pleural effusion adult failure to thrive pneumonitis due to inhalation of food or vomitus other pulmonary insufficiency, not elsewhere classified unspecified essential hypertension encephalopathy, unspecified osteoporosis, unspecified pathologic fracture of vertebrae alcoholic cirrhosis of liver pulmonary collapse unspecified protein-calorie malnutrition other and unspecified alcohol dependence, in remission unspecified pleural effusion pneumonitis due to inhalation of food or vomitus hyposmolality and/or hyponatremia other hemochromatosis other ascites anemia, unspecified portal hypertension other sequelae of chronic liver disease osteoporosis, unspecified hepatic encephalopathy portal hypertension anemia, unspecified unspecified protein-calorie malnutrition encephalopathy, unspecified pneumonitis due to inhalation of food or vomitus other hemochromatosis other ascites other and unspecified alcohol dependence, in remission unspecified pleural effusion pathologic fracture of vertebrae esophageal varices in diseases classified elsewhere, without mention of bleeding pulmonary collapse unspecified essential hypertension alcoholic cirrhosis of liver hyposmolality and/or hyponatremia alcoholic cirrhosis of liver leukocytosis, unspecified hepatic encephalopathy backache, unspecified pathologic fracture of vertebrae other hemochromatosis
black african american m 44 $nan$hematology blood hematocrit  38.0  %; hematology blood hemoglobin  13.3  g dl; hematology blood platelet count  175  k ul; chemistry blood anion gap  12  meq l; chemistry blood bicarbonate  29  meq l; chemistry blood chloride  107  meq l; chemistry blood creatinine  1.0  mg dl; chemistry blood potassium  4.0  meq l; chemistry blood sodium  144  meq l; chemistry blood urea nitrogen  8  mg dl; hematology blood inr(pt)  1.3  ; chemistry blood calcium, total  9.2  mg dl; chemistry blood bilirubin, total  0.5  mg dl; chemistry blood glucose  83  mg dl$sodium chloride 0.9%  flush  3  ml ; 0.9% sodium chloride  1000  ml ; 0.9% sodium chloride  100  ml ; levetiracetam  1000  mg ; acetaminophen  650  mg ; lorazepam  0.5  mg ; iso-osmotic sodium chloride  50  ml ; famotidine  20  mg ; insulin  0  unit ; 
other and unspecified anticonvulsants causing adverse effects in therapeutic use dizziness and giddiness subarachnoid hemorrhage epilepsy, unspecified, without mention of intractable epilepsy unspecified hearing loss intracerebral hemorrhage other convulsions anomalies of cerebrovascular system
white m 47 $temp  99.0  heartrate  95.0  resprate  16.0  o2sat  99.0  sbp  177.0  dbp  121.0  rhythm    pain    $hematology blood hematocrit  46.1  %; hematology blood hemoglobin  16.0  g dl; hematology blood platelet count  324  k ul; chemistry blood anion gap  17  meq l; chemistry blood bicarbonate  23  meq l; chemistry blood chloride  101  meq l; chemistry blood creatinine  1.1  mg dl; chemistry blood creatinine  1.2  mg dl; chemistry blood potassium  4.8  meq l; chemistry blood sodium  141  meq l; chemistry blood sodium  139  meq l; chemistry blood urea nitrogen  13  mg dl; chemistry urine chloride, urine  22  meq l; chemistry urine chloride, urine  34  meq l; chemistry urine chloride, urine  42  meq l; chemistry urine creatinine, urine  44  mg dl; chemistry urine potassium, urine  28  meq l; chemistry urine potassium, urine  49  meq l; chemistry urine sodium, urine  23  meq l; chemistry urine sodium, urine  22  meq l; chemistry urine sodium, urine  45  meq l; chemistry blood calcium, total  9.8  mg dl; chemistry blood bilirubin, total  0.8  mg dl; chemistry blood glucose  109  mg dl$influenza vaccine quadrivalent  0.5  ml ; sodium chloride 0.9%  flush  3-10  ml ; acetaminophen  650  mg ; ramelteon  8  mg ; senna  8.6  mg ; ibuprofen  600  mg ; amlodipine  5  mg ; omeprazole  20  mg ; 
 
other m 74 $temp  98.0  heartrate  64.0  resprate  18.0  o2sat  100.0  sbp  107.0  dbp  78.0  rhythm  sinus rhythm  pain  0  ; temp    heartrate  72.0  resprate  18.0  o2sat  100.0  sbp  112.0  dbp  48.0  rhythm  sinus rhythm  pain  0  $hematology blood hematocrit  31.4  %; hematology blood hemoglobin  9.8  g dl; hematology blood platelet count  133  k ul; chemistry blood anion gap  13  meq l; chemistry blood anion gap  10  meq l; chemistry blood bicarbonate  22  meq l; chemistry blood bicarbonate  23  meq l; chemistry blood chloride  111  meq l; chemistry blood chloride  111  meq l; chemistry blood creatinine  1.8  mg dl; chemistry blood creatinine  1.4  mg dl; chemistry blood potassium  4.8  meq l; chemistry blood potassium  5.0  meq l; chemistry blood sodium  141  meq l; chemistry blood sodium  139  meq l; chemistry blood urea nitrogen  32  mg dl; chemistry blood calcium, total  8.9  mg dl; chemistry blood glucose  127  mg dl; chemistry blood glucose  90  mg dl$pneumococcal 23-valent polysaccharide vaccine  0.5  ml ; sodium chloride 0.9%  flush  3  ml ; heparin  5000  unit ; senna  8.6  mg ; docusate sodium  100  mg ; furosemide  10  mg ; sodium chloride 0.9%  1000  ml ; simvastatin  10  mg ; lidocaine jelly 2% (urojet)  1  appl ; 
 
other m 74 $nan$nan$sodium chloride 0.9%  flush  3  ml ; heparin  5000  unit ; senna  8.6  mg ; docusate sodium  100  mg ; simvastatin  10  mg ; lidocaine jelly 2% (urojet)  1  appl ; 
 
white f 47 $nan$nan$pravastatin  20  mg ; aspirin  81  mg ; ezetimibe  10  mg ; omeprazole  20  mg ; prednisone  5  mg ; 
neurogenic bladder nos acute kidney failure, unspecified acidosis urinary incontinence, unspecified kidney replaced by transplant background diabetic retinopathy car driver injured in collision with two- or three-wheeled motor vehicle in nontraffic accident diabetes with neurological manifestations, type i [juvenile type], not stated as uncontrolled urinary tract infection, site not specified chronic hepatitis c without mention of hepatic coma diabetes with renal manifestations, type i [juvenile type], not stated as uncontrolled ulcer of heel and midfoot long-term (current) use of insulin venous (peripheral) insufficiency, unspecified friedlnder's bacillus infection in conditions classified elsewhere and of unspecified site diabetes with ophthalmic manifestations, type i [juvenile type], not stated as uncontrolled nephritis and nephropathy, not specified as acute or chronic, in diseases classified elsewhere unspecified essential hypertension long-term (current) use of insulin neurogenic bladder nos urinary tract infection, site not specified unspecified viral hepatitis c without hepatic coma chronic kidney disease, unspecified acute kidney failure, unspecified old myocardial infarction nephritis and nephropathy, not specified as acute or chronic, in diseases classified elsewhere diabetes with neurological manifestations, type i [juvenile type], not stated as uncontrolled car driver injured in collision with two- or three-wheeled motor vehicle in nontraffic accident polyneuropathy in diabetes kidney replaced by transplant peripheral vascular disease, unspecified diabetes with renal manifestations, type i [juvenile type], not stated as uncontrolled diarrhea atherosclerosis of native arteries of the extremities with gangrene long-term (current) use of insulin diabetes with renal manifestations, type i [juvenile type], not stated as uncontrolled polyneuropathy in diabetes dissection of other artery accidental puncture or laceration during a procedure, not elsewhere classified accidental cut, puncture, perforation or hemorrhage during other specified medical care hyperpotassemia old myocardial infarction unspecified essential hypertension nephritis and nephropathy, not specified as acute or chronic, in diseases classified elsewhere ulcer of heel and midfoot chronic hepatitis c without mention of hepatic coma diabetes with neurological manifestations, type i [juvenile type], not stated as uncontrolled neurogenic bladder nos
white f 47 $nan$hematology blood hematocrit  29.3  %; hematology blood hemoglobin  9.4  g dl; hematology blood platelet count  221  k ul; chemistry blood anion gap  12  meq l; chemistry blood bicarbonate  24  meq l; chemistry blood chloride  107  meq l; chemistry blood creatinine  0.9  mg dl; chemistry blood potassium  4.8  meq l; chemistry blood sodium  138  meq l; chemistry blood urea nitrogen  30  mg dl; hematology blood inr(pt)  1.0  ; chemistry blood calcium, total  10.1  mg dl; chemistry blood glucose  115  mg dl$pravastatin  20  mg ; aspirin  81  mg ; ezetimibe  10  mg ; omeprazole  20  mg ; prednisone  5  mg ; lorazepam  1  mg ; bisacodyl  10  mg ; senna  1  tab ; insulin  0  unit ; docusate sodium (liquid)  100  mg ; fentanyl citrate  25  mcg ; lorazepam  2  mg ; mycophenolate mofetil  250  mg ; metoclopramide  5  mg ; tacrolimus  4  mg ; hydromorphone (dilaudid)  2  mg ; heparin  5000  unit ; insulin  26  unit ; pregabalin  50  mg ; pregabalin  150  mg ; sw  100  ml ; magnesium sulfate  4  gm ; pregabalin  25  mg ; pregabalin  75  mg ; oxycodone-acetaminophen  1  tab ; 
neurogenic bladder nos acute kidney failure, unspecified acidosis urinary incontinence, unspecified kidney replaced by transplant background diabetic retinopathy car driver injured in collision with two- or three-wheeled motor vehicle in nontraffic accident diabetes with neurological manifestations, type i [juvenile type], not stated as uncontrolled urinary tract infection, site not specified chronic hepatitis c without mention of hepatic coma diabetes with renal manifestations, type i [juvenile type], not stated as uncontrolled ulcer of heel and midfoot long-term (current) use of insulin venous (peripheral) insufficiency, unspecified friedlnder's bacillus infection in conditions classified elsewhere and of unspecified site diabetes with ophthalmic manifestations, type i [juvenile type], not stated as uncontrolled nephritis and nephropathy, not specified as acute or chronic, in diseases classified elsewhere unspecified essential hypertension long-term (current) use of insulin neurogenic bladder nos urinary tract infection, site not specified unspecified viral hepatitis c without hepatic coma chronic kidney disease, unspecified acute kidney failure, unspecified old myocardial infarction nephritis and nephropathy, not specified as acute or chronic, in diseases classified elsewhere diabetes with neurological manifestations, type i [juvenile type], not stated as uncontrolled car driver injured in collision with two- or three-wheeled motor vehicle in nontraffic accident polyneuropathy in diabetes kidney replaced by transplant peripheral vascular disease, unspecified diabetes with renal manifestations, type i [juvenile type], not stated as uncontrolled diarrhea atherosclerosis of native arteries of the extremities with gangrene long-term (current) use of insulin diabetes with renal manifestations, type i [juvenile type], not stated as uncontrolled polyneuropathy in diabetes dissection of other artery accidental puncture or laceration during a procedure, not elsewhere classified accidental cut, puncture, perforation or hemorrhage during other specified medical care hyperpotassemia old myocardial infarction unspecified essential hypertension nephritis and nephropathy, not specified as acute or chronic, in diseases classified elsewhere ulcer of heel and midfoot chronic hepatitis c without mention of hepatic coma diabetes with neurological manifestations, type i [juvenile type], not stated as uncontrolled neurogenic bladder nos
white f 47 $nan$hematology blood hematocrit  25.0  %; hematology blood hemoglobin  7.9  g dl; hematology blood platelet count  155  k ul; chemistry blood anion gap  8  meq l; chemistry blood bicarbonate  21  meq l; chemistry blood chloride  115  meq l; chemistry blood creatinine  0.8  mg dl; chemistry blood potassium  4.4  meq l; chemistry blood sodium  140  meq l; chemistry blood urea nitrogen  23  mg dl; chemistry blood glucose  153  mg dl$pravastatin  20  mg ; aspirin  81  mg ; ezetimibe  10  mg ; omeprazole  20  mg ; prednisone  5  mg ; bisacodyl  10  mg ; senna  1  tab ; insulin  0  unit ; docusate sodium (liquid)  100  mg ; fentanyl citrate  25  mcg ; lorazepam  2  mg ; mycophenolate mofetil  250  mg ; metoclopramide  5  mg ; tacrolimus  4  mg ; hydromorphone (dilaudid)  2  mg ; heparin  5000  unit ; insulin  26  unit ; sw  100  ml ; magnesium sulfate  4  gm ; oxycodone-acetaminophen  1  tab ; acetaminophen  325-650  mg ; 0.9% sodium chloride  500  ml ; 0.9% sodium chloride  1000  ml ; 
neurogenic bladder nos acute kidney failure, unspecified acidosis urinary incontinence, unspecified kidney replaced by transplant background diabetic retinopathy car driver injured in collision with two- or three-wheeled motor vehicle in nontraffic accident diabetes with neurological manifestations, type i [juvenile type], not stated as uncontrolled urinary tract infection, site not specified chronic hepatitis c without mention of hepatic coma diabetes with renal manifestations, type i [juvenile type], not stated as uncontrolled ulcer of heel and midfoot long-term (current) use of insulin venous (peripheral) insufficiency, unspecified friedlnder's bacillus infection in conditions classified elsewhere and of unspecified site diabetes with ophthalmic manifestations, type i [juvenile type], not stated as uncontrolled nephritis and nephropathy, not specified as acute or chronic, in diseases classified elsewhere unspecified essential hypertension long-term (current) use of insulin neurogenic bladder nos urinary tract infection, site not specified unspecified viral hepatitis c without hepatic coma chronic kidney disease, unspecified acute kidney failure, unspecified old myocardial infarction nephritis and nephropathy, not specified as acute or chronic, in diseases classified elsewhere diabetes with neurological manifestations, type i [juvenile type], not stated as uncontrolled car driver injured in collision with two- or three-wheeled motor vehicle in nontraffic accident polyneuropathy in diabetes kidney replaced by transplant peripheral vascular disease, unspecified diabetes with renal manifestations, type i [juvenile type], not stated as uncontrolled diarrhea atherosclerosis of native arteries of the extremities with gangrene long-term (current) use of insulin diabetes with renal manifestations, type i [juvenile type], not stated as uncontrolled polyneuropathy in diabetes dissection of other artery accidental puncture or laceration during a procedure, not elsewhere classified accidental cut, puncture, perforation or hemorrhage during other specified medical care hyperpotassemia old myocardial infarction unspecified essential hypertension nephritis and nephropathy, not specified as acute or chronic, in diseases classified elsewhere ulcer of heel and midfoot chronic hepatitis c without mention of hepatic coma diabetes with neurological manifestations, type i [juvenile type], not stated as uncontrolled neurogenic bladder nos
white f 47 $nan$nan$pravastatin  20  mg ; aspirin  81  mg ; ezetimibe  10  mg ; omeprazole  20  mg ; prednisone  5  mg ; bisacodyl  10  mg ; senna  1  tab ; docusate sodium (liquid)  100  mg ; mycophenolate mofetil  250  mg ; metoclopramide  5  mg ; tacrolimus  4  mg ; heparin  5000  unit ; oxycodone-acetaminophen  1  tab ; acetaminophen  325-650  mg ; cephalexin  500  mg ; sodium chloride 0.9%  flush  3  ml ; hydromorphone (dilaudid)  2-4  mg ; 
neurogenic bladder nos acute kidney failure, unspecified acidosis urinary incontinence, unspecified kidney replaced by transplant background diabetic retinopathy car driver injured in collision with two- or three-wheeled motor vehicle in nontraffic accident diabetes with neurological manifestations, type i [juvenile type], not stated as uncontrolled urinary tract infection, site not specified chronic hepatitis c without mention of hepatic coma diabetes with renal manifestations, type i [juvenile type], not stated as uncontrolled ulcer of heel and midfoot long-term (current) use of insulin venous (peripheral) insufficiency, unspecified friedlnder's bacillus infection in conditions classified elsewhere and of unspecified site diabetes with ophthalmic manifestations, type i [juvenile type], not stated as uncontrolled nephritis and nephropathy, not specified as acute or chronic, in diseases classified elsewhere unspecified essential hypertension long-term (current) use of insulin neurogenic bladder nos urinary tract infection, site not specified unspecified viral hepatitis c without hepatic coma chronic kidney disease, unspecified acute kidney failure, unspecified old myocardial infarction nephritis and nephropathy, not specified as acute or chronic, in diseases classified elsewhere diabetes with neurological manifestations, type i [juvenile type], not stated as uncontrolled car driver injured in collision with two- or three-wheeled motor vehicle in nontraffic accident polyneuropathy in diabetes kidney replaced by transplant peripheral vascular disease, unspecified diabetes with renal manifestations, type i [juvenile type], not stated as uncontrolled diarrhea atherosclerosis of native arteries of the extremities with gangrene long-term (current) use of insulin diabetes with renal manifestations, type i [juvenile type], not stated as uncontrolled polyneuropathy in diabetes dissection of other artery accidental puncture or laceration during a procedure, not elsewhere classified accidental cut, puncture, perforation or hemorrhage during other specified medical care hyperpotassemia old myocardial infarction unspecified essential hypertension nephritis and nephropathy, not specified as acute or chronic, in diseases classified elsewhere ulcer of heel and midfoot chronic hepatitis c without mention of hepatic coma diabetes with neurological manifestations, type i [juvenile type], not stated as uncontrolled neurogenic bladder nos
white f 47 $nan$hematology blood hematocrit  23.4  %; hematology blood hemoglobin  7.7  g dl; hematology blood platelet count  172  k ul; chemistry blood anion gap  11  meq l; chemistry blood bicarbonate  20  meq l; chemistry blood chloride  110  meq l; chemistry blood creatinine  0.9  mg dl; chemistry blood potassium  5.2  meq l; chemistry blood sodium  136  meq l; chemistry blood urea nitrogen  19  mg dl; chemistry blood calcium, total  9.2  mg dl; chemistry blood glucose  275  mg dl$pravastatin  20  mg ; aspirin  81  mg ; ezetimibe  10  mg ; omeprazole  20  mg ; prednisone  5  mg ; bisacodyl  10  mg ; senna  1  tab ; docusate sodium (liquid)  100  mg ; mycophenolate mofetil  250  mg ; metoclopramide  5  mg ; tacrolimus  4  mg ; heparin  5000  unit ; acetaminophen  325-650  mg ; sodium chloride 0.9%  flush  3  ml ; hydromorphone (dilaudid)  2-4  mg ; prochlorperazine  10  mg ; 
neurogenic bladder nos acute kidney failure, unspecified acidosis urinary incontinence, unspecified kidney replaced by transplant background diabetic retinopathy car driver injured in collision with two- or three-wheeled motor vehicle in nontraffic accident diabetes with neurological manifestations, type i [juvenile type], not stated as uncontrolled urinary tract infection, site not specified chronic hepatitis c without mention of hepatic coma diabetes with renal manifestations, type i [juvenile type], not stated as uncontrolled ulcer of heel and midfoot long-term (current) use of insulin venous (peripheral) insufficiency, unspecified friedlnder's bacillus infection in conditions classified elsewhere and of unspecified site diabetes with ophthalmic manifestations, type i [juvenile type], not stated as uncontrolled nephritis and nephropathy, not specified as acute or chronic, in diseases classified elsewhere unspecified essential hypertension long-term (current) use of insulin neurogenic bladder nos urinary tract infection, site not specified unspecified viral hepatitis c without hepatic coma chronic kidney disease, unspecified acute kidney failure, unspecified old myocardial infarction nephritis and nephropathy, not specified as acute or chronic, in diseases classified elsewhere diabetes with neurological manifestations, type i [juvenile type], not stated as uncontrolled car driver injured in collision with two- or three-wheeled motor vehicle in nontraffic accident polyneuropathy in diabetes kidney replaced by transplant peripheral vascular disease, unspecified diabetes with renal manifestations, type i [juvenile type], not stated as uncontrolled diarrhea atherosclerosis of native arteries of the extremities with gangrene long-term (current) use of insulin diabetes with renal manifestations, type i [juvenile type], not stated as uncontrolled polyneuropathy in diabetes dissection of other artery accidental puncture or laceration during a procedure, not elsewhere classified accidental cut, puncture, perforation or hemorrhage during other specified medical care hyperpotassemia old myocardial infarction unspecified essential hypertension nephritis and nephropathy, not specified as acute or chronic, in diseases classified elsewhere ulcer of heel and midfoot chronic hepatitis c without mention of hepatic coma diabetes with neurological manifestations, type i [juvenile type], not stated as uncontrolled neurogenic bladder nos
white f 47 $nan$nan$pravastatin  20  mg ; aspirin  81  mg ; ezetimibe  10  mg ; omeprazole  20  mg ; prednisone  5  mg ; bisacodyl  10  mg ; senna  1  tab ; docusate sodium (liquid)  100  mg ; mycophenolate mofetil  250  mg ; metoclopramide  5  mg ; tacrolimus  4  mg ; heparin  5000  unit ; acetaminophen  325-650  mg ; sodium chloride 0.9%  flush  3  ml ; hydromorphone (dilaudid)  2-4  mg ; prochlorperazine  10  mg ; magnesium oxide  400  mg ; 
neurogenic bladder nos acute kidney failure, unspecified acidosis urinary incontinence, unspecified kidney replaced by transplant background diabetic retinopathy car driver injured in collision with two- or three-wheeled motor vehicle in nontraffic accident diabetes with neurological manifestations, type i [juvenile type], not stated as uncontrolled urinary tract infection, site not specified chronic hepatitis c without mention of hepatic coma diabetes with renal manifestations, type i [juvenile type], not stated as uncontrolled ulcer of heel and midfoot long-term (current) use of insulin venous (peripheral) insufficiency, unspecified friedlnder's bacillus infection in conditions classified elsewhere and of unspecified site diabetes with ophthalmic manifestations, type i [juvenile type], not stated as uncontrolled nephritis and nephropathy, not specified as acute or chronic, in diseases classified elsewhere unspecified essential hypertension long-term (current) use of insulin neurogenic bladder nos urinary tract infection, site not specified unspecified viral hepatitis c without hepatic coma chronic kidney disease, unspecified acute kidney failure, unspecified old myocardial infarction nephritis and nephropathy, not specified as acute or chronic, in diseases classified elsewhere diabetes with neurological manifestations, type i [juvenile type], not stated as uncontrolled car driver injured in collision with two- or three-wheeled motor vehicle in nontraffic accident polyneuropathy in diabetes kidney replaced by transplant peripheral vascular disease, unspecified diabetes with renal manifestations, type i [juvenile type], not stated as uncontrolled diarrhea atherosclerosis of native arteries of the extremities with gangrene long-term (current) use of insulin diabetes with renal manifestations, type i [juvenile type], not stated as uncontrolled polyneuropathy in diabetes dissection of other artery accidental puncture or laceration during a procedure, not elsewhere classified accidental cut, puncture, perforation or hemorrhage during other specified medical care hyperpotassemia old myocardial infarction unspecified essential hypertension nephritis and nephropathy, not specified as acute or chronic, in diseases classified elsewhere ulcer of heel and midfoot chronic hepatitis c without mention of hepatic coma diabetes with neurological manifestations, type i [juvenile type], not stated as uncontrolled neurogenic bladder nos
unknown m 67 $nan$hematology blood hematocrit  30.3  %; hematology blood hemoglobin  10.3  g dl; hematology blood platelet count  209  k ul; chemistry blood anion gap  16  meq l; chemistry blood bicarbonate  22  meq l; chemistry blood chloride  103  meq l; chemistry blood creatinine  1.2  mg dl; chemistry blood potassium  4.9  meq l; chemistry blood sodium  141  meq l; chemistry blood urea nitrogen  14  mg dl; chemistry blood calcium, total  8.7  mg dl; chemistry blood glucose  119  mg dl$influenza vaccine quadrivalent  0.5  ml ; lidocaine jelly 2% (glydo)  1  appl ; hydralazine  5  mg ; lactated ringers  1000  ml ; acetaminophen  1000  mg ; ziprasidone hydrochloride  20  mg ; clonazepam  1  mg ; buspirone  20  mg ; atenolol  25  mg ; carbidopa-levodopa (25-100)  1  tab ; 
 
unknown m 67 $nan$nan$influenza vaccine quadrivalent  0.5  ml ; lidocaine jelly 2% (glydo)  1  appl ; hydralazine  5  mg ; acetaminophen  1000  mg ; ziprasidone hydrochloride  20  mg ; buspirone  20  mg ; atenolol  25  mg ; carbidopa-levodopa (25-100)  1  tab ; amitriptyline  100  mg ; nuplazid  34  mg ; 
 
unknown m 67 $nan$nan$acetaminophen  1000  mg ; ziprasidone hydrochloride  20  mg ; buspirone  20  mg ; atenolol  25  mg ; carbidopa-levodopa (25-100)  1  tab ; amitriptyline  100  mg ; nuplazid  34  mg ; tetanus-diphtox-acellular pertuss (adacel)  0.5  ml ; 
 
unknown m 67 $nan$nan$acetaminophen  1000  mg ; ziprasidone hydrochloride  20  mg ; buspirone  20  mg ; atenolol  25  mg ; carbidopa-levodopa (25-100)  1  tab ; amitriptyline  100  mg ; nuplazid  34  mg ; tetanus-diphtox-acellular pertuss (adacel)  0.5  ml ; 
 
unknown m 67 $nan$nan$acetaminophen  1000  mg ; ziprasidone hydrochloride  20  mg ; buspirone  20  mg ; atenolol  25  mg ; carbidopa-levodopa (25-100)  1  tab ; amitriptyline  100  mg ; nuplazid  34  mg ; 
 
unknown m 67 $nan$nan$acetaminophen  1000  mg ; ziprasidone hydrochloride  20  mg ; buspirone  20  mg ; atenolol  25  mg ; carbidopa-levodopa (25-100)  1  tab ; amitriptyline  100  mg ; nuplazid  34  mg ; 
 
white f 77 $temp    heartrate  78.0  resprate  16.0  o2sat    sbp  110.0  dbp  52.0  rhythm    pain  0  $nan$aspirin  81  mg ; simvastatin  10  mg ; 
antineoplastic and immunosuppressive drugs causing adverse effects in therapeutic use malignant neoplasm of bronchus and lung, unspecified hypertensive chronic kidney disease, unspecified, with chronic kidney disease stage i through stage iv, or unspecified malignant neoplasm of liver, secondary accidents occurring in unspecified place chronic kidney disease, unspecified orthostatic hypotension other and unspecified hyperlipidemia mitral valve disorders long-term (current) use of other medications syncope and collapse antineoplastic chemotherapy induced anemia other specified cardiac dysrhythmias other and unspecified hyperlipidemia personal history of tobacco use unspecified essential hypertension malignant neoplasm of upper lobe, bronchus or lung gout, unspecified iatrogenic pneumothorax personal history of tobacco use person boarding or alighting a pedal cycle injured in collision with fixed or stationary object car passenger injured in collision with van in traffic accident mitral valve disorders other and unspecified hyperlipidemia unspecified essential hypertension osteoarthrosis, unspecified whether generalized or localized, site unspecified family history of ischemic heart disease other specified surgical operations and procedures causing abnormal patient reaction, or later complication, without mention of misadventure at time of operation hip joint replacement other diseases of lung, not elsewhere classified
white f 77 $temp  98.3  heartrate  81.0  resprate  16.0  o2sat  97.0  sbp  114.0  dbp  67.0  rhythm    pain    $hematology blood hematocrit  36.2  %; hematology blood hemoglobin  12.0  g dl; hematology blood platelet count  323  k ul; chemistry blood anion gap  16  meq l; chemistry blood bicarbonate  22  meq l; chemistry blood chloride  98  meq l; chemistry blood creatinine  2.2  mg dl; chemistry blood potassium  3.4  meq l; chemistry blood sodium  133  meq l; chemistry blood urea nitrogen  42  mg dl; chemistry urine chloride, urine  14  meq l; chemistry urine creatinine, urine  154  mg dl; chemistry urine potassium, urine  28  meq l; hematology urine wbc  65  # hpf; chemistry blood calcium, total  8.8  mg dl; chemistry blood glucose  97  mg dl$aspirin  81  mg ; simvastatin  10  mg ; sodium chloride 0.9%  flush  3  ml ; ondansetron  4  mg ; maalox diphenhydramine lidocaine  15  ml ; 0.9% sodium chloride  1000  ml ; heparin  5000  unit ; acetaminophen  500-1000  mg ; calcium carbonate  500  mg ; oxycodone (immediate release)   5  mg ; prochlorperazine  10  mg ; nystatin oral suspension  5  ml ; oxycodone (immediate release)   5-10  mg ; 
antineoplastic and immunosuppressive drugs causing adverse effects in therapeutic use malignant neoplasm of bronchus and lung, unspecified hypertensive chronic kidney disease, unspecified, with chronic kidney disease stage i through stage iv, or unspecified malignant neoplasm of liver, secondary accidents occurring in unspecified place chronic kidney disease, unspecified orthostatic hypotension other and unspecified hyperlipidemia mitral valve disorders long-term (current) use of other medications syncope and collapse antineoplastic chemotherapy induced anemia other specified cardiac dysrhythmias other and unspecified hyperlipidemia personal history of tobacco use unspecified essential hypertension malignant neoplasm of upper lobe, bronchus or lung gout, unspecified iatrogenic pneumothorax personal history of tobacco use person boarding or alighting a pedal cycle injured in collision with fixed or stationary object car passenger injured in collision with van in traffic accident mitral valve disorders other and unspecified hyperlipidemia unspecified essential hypertension osteoarthrosis, unspecified whether generalized or localized, site unspecified family history of ischemic heart disease other specified surgical operations and procedures causing abnormal patient reaction, or later complication, without mention of misadventure at time of operation hip joint replacement other diseases of lung, not elsewhere classified
white f 77 $nan$hematology blood hematocrit  29.0  %; hematology blood hemoglobin  9.7  g dl; hematology blood platelet count  243  k ul; chemistry blood anion gap  12  meq l; chemistry blood bicarbonate  19  meq l; chemistry blood chloride  103  meq l; chemistry blood chloride  104  meq l; chemistry blood creatinine  1.8  mg dl; chemistry blood creatinine  1.6  mg dl; chemistry blood potassium  3.3  meq l; chemistry blood potassium  2.9  meq l; chemistry blood sodium  131  meq l; chemistry blood sodium  134  meq l; chemistry blood urea nitrogen  31  mg dl; chemistry blood urea nitrogen  25  mg dl; chemistry blood glucose  92  mg dl$aspirin  81  mg ; simvastatin  10  mg ; sodium chloride 0.9%  flush  3  ml ; ondansetron  4  mg ; maalox diphenhydramine lidocaine  15  ml ; 0.9% sodium chloride  1000  ml ; heparin  5000  unit ; calcium carbonate  500  mg ; prochlorperazine  10  mg ; nystatin oral suspension  5  ml ; oxycodone (immediate release)   5-10  mg ; loperamide  2  mg ; acetaminophen (liquid)  325-650  mg ; iso-osmotic dextrose  50  ml ; ceftriaxone  1  gm ; guaifenesin  5-10  ml ; potassium chloride  40  meq ; potassium chloride  60  meq ; potassium chloride  80  meq ; sw  200  ml ; potassium chloride  20  meq ; sw  400  ml ; sw  600  ml ; hydromorphone (dilaudid)  0.25  mg ; 0.9% sodium chloride  600  ml ; lidocaine viscous 2%  20  ml ; 
antineoplastic and immunosuppressive drugs causing adverse effects in therapeutic use malignant neoplasm of bronchus and lung, unspecified hypertensive chronic kidney disease, unspecified, with chronic kidney disease stage i through stage iv, or unspecified malignant neoplasm of liver, secondary accidents occurring in unspecified place chronic kidney disease, unspecified orthostatic hypotension other and unspecified hyperlipidemia mitral valve disorders long-term (current) use of other medications syncope and collapse antineoplastic chemotherapy induced anemia other specified cardiac dysrhythmias other and unspecified hyperlipidemia personal history of tobacco use unspecified essential hypertension malignant neoplasm of upper lobe, bronchus or lung gout, unspecified iatrogenic pneumothorax personal history of tobacco use person boarding or alighting a pedal cycle injured in collision with fixed or stationary object car passenger injured in collision with van in traffic accident mitral valve disorders other and unspecified hyperlipidemia unspecified essential hypertension osteoarthrosis, unspecified whether generalized or localized, site unspecified family history of ischemic heart disease other specified surgical operations and procedures causing abnormal patient reaction, or later complication, without mention of misadventure at time of operation hip joint replacement other diseases of lung, not elsewhere classified
white f 77 $nan$hematology blood hematocrit  29.7  %; hematology blood hemoglobin  9.8  g dl; hematology blood platelet count  249  k ul; chemistry blood anion gap  12  meq l; chemistry blood bicarbonate  19  meq l; chemistry blood chloride  108  meq l; chemistry blood creatinine  1.3  mg dl; chemistry blood potassium  3.4  meq l; chemistry blood sodium  136  meq l; chemistry blood urea nitrogen  21  mg dl; chemistry blood calcium, total  7.7  mg dl; chemistry blood glucose  72  mg dl$aspirin  81  mg ; simvastatin  10  mg ; sodium chloride 0.9%  flush  3  ml ; ondansetron  4  mg ; maalox diphenhydramine lidocaine  15  ml ; heparin  5000  unit ; calcium carbonate  500  mg ; prochlorperazine  10  mg ; nystatin oral suspension  5  ml ; oxycodone (immediate release)   5-10  mg ; loperamide  2  mg ; acetaminophen (liquid)  325-650  mg ; iso-osmotic dextrose  50  ml ; ceftriaxone  1  gm ; guaifenesin  5-10  ml ; sw  200  ml ; potassium chloride  20  meq ; sw  400  ml ; hydromorphone (dilaudid)  0.25  mg ; lidocaine viscous 2%  20  ml ; caphosol  30  ml ; acetaminophen iv  1000  mg ; bag  50  ml ; magnesium sulfate  2  gm ; bag  100  ml ; magnesium sulfate  4  gm ; hydromorphone (dilaudid)  0.25-0.75  mg ; neutra-phos  1  pkt ; hydromorphone (dilaudid)  0.5-1.0  mg ; 0.9% sodium chloride  500  ml ; potassium phosphate  15  mmol ; sarna lotion  1  appl ; diphenhydramine  12.5  mg ; diphenhydramine  25  mg ; iso-osmotic sodium chloride  100  ml ; fluconazole  200  mg ; 
antineoplastic and immunosuppressive drugs causing adverse effects in therapeutic use malignant neoplasm of bronchus and lung, unspecified hypertensive chronic kidney disease, unspecified, with chronic kidney disease stage i through stage iv, or unspecified malignant neoplasm of liver, secondary accidents occurring in unspecified place chronic kidney disease, unspecified orthostatic hypotension other and unspecified hyperlipidemia mitral valve disorders long-term (current) use of other medications syncope and collapse antineoplastic chemotherapy induced anemia other specified cardiac dysrhythmias other and unspecified hyperlipidemia personal history of tobacco use unspecified essential hypertension malignant neoplasm of upper lobe, bronchus or lung gout, unspecified iatrogenic pneumothorax personal history of tobacco use person boarding or alighting a pedal cycle injured in collision with fixed or stationary object car passenger injured in collision with van in traffic accident mitral valve disorders other and unspecified hyperlipidemia unspecified essential hypertension osteoarthrosis, unspecified whether generalized or localized, site unspecified family history of ischemic heart disease other specified surgical operations and procedures causing abnormal patient reaction, or later complication, without mention of misadventure at time of operation hip joint replacement other diseases of lung, not elsewhere classified
white f 77 $nan$hematology blood hematocrit  28.1  %; hematology blood hemoglobin  9.4  g dl; hematology blood platelet count  255  k ul; chemistry blood anion gap  13  meq l; chemistry blood bicarbonate  20  meq l; chemistry blood chloride  104  meq l; chemistry blood creatinine  1.3  mg dl; chemistry blood potassium  3.2  meq l; chemistry blood sodium  134  meq l; chemistry blood urea nitrogen  15  mg dl; chemistry blood calcium, total  7.4  mg dl; chemistry blood glucose  90  mg dl$aspirin  81  mg ; simvastatin  10  mg ; sodium chloride 0.9%  flush  3  ml ; ondansetron  4  mg ; maalox diphenhydramine lidocaine  15  ml ; heparin  5000  unit ; calcium carbonate  500  mg ; prochlorperazine  10  mg ; oxycodone (immediate release)   5-10  mg ; loperamide  2  mg ; acetaminophen (liquid)  325-650  mg ; iso-osmotic dextrose  50  ml ; ceftriaxone  1  gm ; guaifenesin  5-10  ml ; iso-osmotic dextrose  200  ml ; sw  200  ml ; potassium chloride  20  meq ; sw  400  ml ; caphosol  30  ml ; acetaminophen iv  1000  mg ; bag  50  ml ; magnesium sulfate  2  gm ; bag  100  ml ; magnesium sulfate  4  gm ; 0.9% sodium chloride  500  ml ; potassium phosphate  15  mmol ; sarna lotion  1  appl ; diphenhydramine  25  mg ; iso-osmotic sodium chloride  100  ml ; fluconazole  200  mg ; albuterol 0.083% neb soln  1  neb ; ipratropium bromide neb  1  neb ; piperacillin-tazobactam  2.25  g ; acetaminophen iv  500  mg ; vancomycin  1000  mg ; hydromorphone (dilaudid)  20  mg ; diphenhydramine  50  mg ; hydromorphone (dilaudid)  1.25  mg ; hydromorphone (dilaudid)  0.75-1.25  mg ; 0.9% sodium chloride  50  ml ; cefepime  500  mg ; 
antineoplastic and immunosuppressive drugs causing adverse effects in therapeutic use malignant neoplasm of bronchus and lung, unspecified hypertensive chronic kidney disease, unspecified, with chronic kidney disease stage i through stage iv, or unspecified malignant neoplasm of liver, secondary accidents occurring in unspecified place chronic kidney disease, unspecified orthostatic hypotension other and unspecified hyperlipidemia mitral valve disorders long-term (current) use of other medications syncope and collapse antineoplastic chemotherapy induced anemia other specified cardiac dysrhythmias other and unspecified hyperlipidemia personal history of tobacco use unspecified essential hypertension malignant neoplasm of upper lobe, bronchus or lung gout, unspecified iatrogenic pneumothorax personal history of tobacco use person boarding or alighting a pedal cycle injured in collision with fixed or stationary object car passenger injured in collision with van in traffic accident mitral valve disorders other and unspecified hyperlipidemia unspecified essential hypertension osteoarthrosis, unspecified whether generalized or localized, site unspecified family history of ischemic heart disease other specified surgical operations and procedures causing abnormal patient reaction, or later complication, without mention of misadventure at time of operation hip joint replacement other diseases of lung, not elsewhere classified
white f 77 $nan$hematology blood hematocrit  26.6  %; hematology blood hemoglobin  8.9  g dl; hematology blood platelet count  259  k ul; chemistry blood anion gap  11  meq l; chemistry blood bicarbonate  22  meq l; chemistry blood chloride  105  meq l; chemistry blood creatinine  1.1  mg dl; chemistry blood potassium  3.4  meq l; chemistry blood sodium  135  meq l; chemistry blood urea nitrogen  11  mg dl; chemistry blood calcium, total  7.5  mg dl; chemistry blood bilirubin, indirect  0.0  mg dl; chemistry blood bilirubin, total  0.1  mg dl; chemistry blood glucose  98  mg dl; chemistry blood lactate dehydrogenase (ld)  202  iu l; chemistry blood albumin  2.5  g dl; chemistry blood bilirubin, direct  0.1  mg dl; chemistry blood % hemoglobin a1c  6.6  %$aspirin  81  mg ; simvastatin  10  mg ; sodium chloride 0.9%  flush  3  ml ; ondansetron  4  mg ; maalox diphenhydramine lidocaine  15  ml ; heparin  5000  unit ; calcium carbonate  500  mg ; prochlorperazine  10  mg ; oxycodone (immediate release)   5-10  mg ; loperamide  2  mg ; acetaminophen (liquid)  325-650  mg ; guaifenesin  5-10  ml ; iso-osmotic dextrose  200  ml ; sw  200  ml ; potassium chloride  20  meq ; sw  400  ml ; caphosol  30  ml ; bag  50  ml ; magnesium sulfate  2  gm ; bag  100  ml ; magnesium sulfate  4  gm ; sarna lotion  1  appl ; piperacillin-tazobactam  2.25  g ; acetaminophen iv  500  mg ; vancomycin  1000  mg ; hydromorphone (dilaudid)  1.25  mg ; hydromorphone (dilaudid)  0.75-1.25  mg ; 0.9% sodium chloride  50  ml ; cefepime  500  mg ; iso-osmotic sodium chloride  50  ml ; fluconazole  100  mg ; d5ns  1000  ml ; 
antineoplastic and immunosuppressive drugs causing adverse effects in therapeutic use malignant neoplasm of bronchus and lung, unspecified hypertensive chronic kidney disease, unspecified, with chronic kidney disease stage i through stage iv, or unspecified malignant neoplasm of liver, secondary accidents occurring in unspecified place chronic kidney disease, unspecified orthostatic hypotension other and unspecified hyperlipidemia mitral valve disorders long-term (current) use of other medications syncope and collapse antineoplastic chemotherapy induced anemia other specified cardiac dysrhythmias other and unspecified hyperlipidemia personal history of tobacco use unspecified essential hypertension malignant neoplasm of upper lobe, bronchus or lung gout, unspecified iatrogenic pneumothorax personal history of tobacco use person boarding or alighting a pedal cycle injured in collision with fixed or stationary object car passenger injured in collision with van in traffic accident mitral valve disorders other and unspecified hyperlipidemia unspecified essential hypertension osteoarthrosis, unspecified whether generalized or localized, site unspecified family history of ischemic heart disease other specified surgical operations and procedures causing abnormal patient reaction, or later complication, without mention of misadventure at time of operation hip joint replacement other diseases of lung, not elsewhere classified
white f 77 $nan$hematology blood hematocrit  26.1  %; hematology blood hemoglobin  8.8  g dl; hematology blood platelet count  244  k ul; chemistry blood anion gap  11  meq l; chemistry blood bicarbonate  25  meq l; chemistry blood chloride  104  meq l; chemistry blood creatinine  1.0  mg dl; chemistry blood potassium  4.3  meq l; chemistry blood sodium  136  meq l; chemistry blood urea nitrogen  7  mg dl; chemistry blood calcium, total  7.5  mg dl; chemistry blood bilirubin, total  0.2  mg dl; chemistry blood glucose  131  mg dl; chemistry blood lactate dehydrogenase (ld)  216  iu l$aspirin  81  mg ; simvastatin  10  mg ; sodium chloride 0.9%  flush  3  ml ; ondansetron  4  mg ; maalox diphenhydramine lidocaine  15  ml ; heparin  5000  unit ; calcium carbonate  500  mg ; prochlorperazine  10  mg ; oxycodone (immediate release)   5-10  mg ; loperamide  2  mg ; acetaminophen (liquid)  325-650  mg ; guaifenesin  5-10  ml ; iso-osmotic dextrose  200  ml ; sw  200  ml ; potassium chloride  20  meq ; caphosol  30  ml ; bag  50  ml ; magnesium sulfate  2  gm ; bag  100  ml ; magnesium sulfate  4  gm ; sarna lotion  1  appl ; vancomycin  1000  mg ; hydromorphone (dilaudid)  0.75-1.25  mg ; iso-osmotic sodium chloride  50  ml ; fluconazole  100  mg ; d5ns  1000  ml ; fluticasone propionate 110mcg  2  puff ; neutra-phos  2  pkt ; 
antineoplastic and immunosuppressive drugs causing adverse effects in therapeutic use malignant neoplasm of bronchus and lung, unspecified hypertensive chronic kidney disease, unspecified, with chronic kidney disease stage i through stage iv, or unspecified malignant neoplasm of liver, secondary accidents occurring in unspecified place chronic kidney disease, unspecified orthostatic hypotension other and unspecified hyperlipidemia mitral valve disorders long-term (current) use of other medications syncope and collapse antineoplastic chemotherapy induced anemia other specified cardiac dysrhythmias other and unspecified hyperlipidemia personal history of tobacco use unspecified essential hypertension malignant neoplasm of upper lobe, bronchus or lung gout, unspecified iatrogenic pneumothorax personal history of tobacco use person boarding or alighting a pedal cycle injured in collision with fixed or stationary object car passenger injured in collision with van in traffic accident mitral valve disorders other and unspecified hyperlipidemia unspecified essential hypertension osteoarthrosis, unspecified whether generalized or localized, site unspecified family history of ischemic heart disease other specified surgical operations and procedures causing abnormal patient reaction, or later complication, without mention of misadventure at time of operation hip joint replacement other diseases of lung, not elsewhere classified
white f 77 $nan$hematology blood hematocrit  23.4  %; hematology blood hematocrit  23.8  %; hematology blood hemoglobin  7.8  g dl; hematology blood platelet count  246  k ul; chemistry blood anion gap  10  meq l; chemistry blood bicarbonate  29  meq l; chemistry blood chloride  99  meq l; chemistry blood creatinine  0.9  mg dl; chemistry blood potassium  3.3  meq l; chemistry blood sodium  135  meq l; chemistry blood urea nitrogen  5  mg dl; chemistry blood calcium, total  7.6  mg dl; chemistry blood glucose  143  mg dl$aspirin  81  mg ; simvastatin  10  mg ; sodium chloride 0.9%  flush  3  ml ; ondansetron  4  mg ; maalox diphenhydramine lidocaine  15  ml ; heparin  5000  unit ; calcium carbonate  500  mg ; prochlorperazine  10  mg ; oxycodone (immediate release)   5-10  mg ; loperamide  2  mg ; acetaminophen (liquid)  325-650  mg ; guaifenesin  5-10  ml ; sw  200  ml ; potassium chloride  20  meq ; caphosol  30  ml ; bag  50  ml ; magnesium sulfate  2  gm ; bag  100  ml ; magnesium sulfate  4  gm ; sarna lotion  1  appl ; hydromorphone (dilaudid)  0.75-1.25  mg ; iso-osmotic sodium chloride  50  ml ; fluconazole  100  mg ; d5ns  1000  ml ; fluticasone propionate 110mcg  2  puff ; neutra-phos  2  pkt ; hydromorphone (dilaudid)  1  mg ; 
antineoplastic and immunosuppressive drugs causing adverse effects in therapeutic use malignant neoplasm of bronchus and lung, unspecified hypertensive chronic kidney disease, unspecified, with chronic kidney disease stage i through stage iv, or unspecified malignant neoplasm of liver, secondary accidents occurring in unspecified place chronic kidney disease, unspecified orthostatic hypotension other and unspecified hyperlipidemia mitral valve disorders long-term (current) use of other medications syncope and collapse antineoplastic chemotherapy induced anemia other specified cardiac dysrhythmias other and unspecified hyperlipidemia personal history of tobacco use unspecified essential hypertension malignant neoplasm of upper lobe, bronchus or lung gout, unspecified iatrogenic pneumothorax personal history of tobacco use person boarding or alighting a pedal cycle injured in collision with fixed or stationary object car passenger injured in collision with van in traffic accident mitral valve disorders other and unspecified hyperlipidemia unspecified essential hypertension osteoarthrosis, unspecified whether generalized or localized, site unspecified family history of ischemic heart disease other specified surgical operations and procedures causing abnormal patient reaction, or later complication, without mention of misadventure at time of operation hip joint replacement other diseases of lung, not elsewhere classified
white f 77 $nan$hematology blood hematocrit  29.2  %; hematology blood hematocrit  27.6  %; hematology blood hematocrit  29.4  %; hematology blood hematocrit  28.8  %; hematology blood hemoglobin  10.3  g dl; hematology blood platelet count  245  k ul; chemistry blood anion gap  9  meq l; chemistry blood bicarbonate  30  meq l; chemistry blood chloride  98  meq l; chemistry blood creatinine  0.9  mg dl; chemistry blood potassium  3.4  meq l; chemistry blood sodium  134  meq l; chemistry blood urea nitrogen  5  mg dl; hematology blood inr(pt)  1.1  ; hematology blood inr(pt)  1.1  ; chemistry blood calcium, total  7.9  mg dl; chemistry blood glucose  119  mg dl; chemistry blood albumin  2.6  g dl$aspirin  81  mg ; simvastatin  10  mg ; sodium chloride 0.9%  flush  3  ml ; ondansetron  4  mg ; maalox diphenhydramine lidocaine  15  ml ; heparin  5000  unit ; calcium carbonate  500  mg ; prochlorperazine  10  mg ; oxycodone (immediate release)   5-10  mg ; loperamide  2  mg ; acetaminophen (liquid)  325-650  mg ; guaifenesin  5-10  ml ; sw  200  ml ; potassium chloride  20  meq ; caphosol  30  ml ; bag  50  ml ; magnesium sulfate  2  gm ; bag  100  ml ; magnesium sulfate  4  gm ; sarna lotion  1  appl ; hydromorphone (dilaudid)  0.75-1.25  mg ; iso-osmotic sodium chloride  50  ml ; fluconazole  100  mg ; d5ns  1000  ml ; fluticasone propionate 110mcg  2  puff ; hydromorphone (dilaudid)  1  mg ; furosemide  10  mg ; lorazepam  0.25  mg ; 
antineoplastic and immunosuppressive drugs causing adverse effects in therapeutic use malignant neoplasm of bronchus and lung, unspecified hypertensive chronic kidney disease, unspecified, with chronic kidney disease stage i through stage iv, or unspecified malignant neoplasm of liver, secondary accidents occurring in unspecified place chronic kidney disease, unspecified orthostatic hypotension other and unspecified hyperlipidemia mitral valve disorders long-term (current) use of other medications syncope and collapse antineoplastic chemotherapy induced anemia other specified cardiac dysrhythmias other and unspecified hyperlipidemia personal history of tobacco use unspecified essential hypertension malignant neoplasm of upper lobe, bronchus or lung gout, unspecified iatrogenic pneumothorax personal history of tobacco use person boarding or alighting a pedal cycle injured in collision with fixed or stationary object car passenger injured in collision with van in traffic accident mitral valve disorders other and unspecified hyperlipidemia unspecified essential hypertension osteoarthrosis, unspecified whether generalized or localized, site unspecified family history of ischemic heart disease other specified surgical operations and procedures causing abnormal patient reaction, or later complication, without mention of misadventure at time of operation hip joint replacement other diseases of lung, not elsewhere classified
white f 77 $nan$hematology blood hematocrit  29.5  %; hematology blood hematocrit  29.1  %; hematology blood hemoglobin  9.9  g dl; hematology blood platelet count  250  k ul; chemistry blood anion gap  7  meq l; chemistry blood bicarbonate  33  meq l; chemistry blood chloride  100  meq l; chemistry blood creatinine  0.9  mg dl; chemistry blood potassium  3.8  meq l; chemistry blood sodium  136  meq l; chemistry blood urea nitrogen  6  mg dl; chemistry blood calcium, total  7.8  mg dl; chemistry blood glucose  133  mg dl$simvastatin  10  mg ; sodium chloride 0.9%  flush  3  ml ; ondansetron  4  mg ; maalox diphenhydramine lidocaine  15  ml ; calcium carbonate  500  mg ; prochlorperazine  10  mg ; oxycodone (immediate release)   5-10  mg ; loperamide  2  mg ; acetaminophen (liquid)  325-650  mg ; guaifenesin  5-10  ml ; sw  200  ml ; potassium chloride  20  meq ; caphosol  30  ml ; bag  50  ml ; magnesium sulfate  2  gm ; bag  100  ml ; magnesium sulfate  4  gm ; sarna lotion  1  appl ; hydromorphone (dilaudid)  0.75-1.25  mg ; iso-osmotic sodium chloride  50  ml ; fluconazole  100  mg ; d5ns  1000  ml ; fluticasone propionate 110mcg  2  puff ; furosemide  10  mg ; benzonatate  100  mg ; atenolol  25  mg ; 
antineoplastic and immunosuppressive drugs causing adverse effects in therapeutic use malignant neoplasm of bronchus and lung, unspecified hypertensive chronic kidney disease, unspecified, with chronic kidney disease stage i through stage iv, or unspecified malignant neoplasm of liver, secondary accidents occurring in unspecified place chronic kidney disease, unspecified orthostatic hypotension other and unspecified hyperlipidemia mitral valve disorders long-term (current) use of other medications syncope and collapse antineoplastic chemotherapy induced anemia other specified cardiac dysrhythmias other and unspecified hyperlipidemia personal history of tobacco use unspecified essential hypertension malignant neoplasm of upper lobe, bronchus or lung gout, unspecified iatrogenic pneumothorax personal history of tobacco use person boarding or alighting a pedal cycle injured in collision with fixed or stationary object car passenger injured in collision with van in traffic accident mitral valve disorders other and unspecified hyperlipidemia unspecified essential hypertension osteoarthrosis, unspecified whether generalized or localized, site unspecified family history of ischemic heart disease other specified surgical operations and procedures causing abnormal patient reaction, or later complication, without mention of misadventure at time of operation hip joint replacement other diseases of lung, not elsewhere classified
white f 77 $nan$nan$simvastatin  10  mg ; sodium chloride 0.9%  flush  3  ml ; ondansetron  4  mg ; maalox diphenhydramine lidocaine  15  ml ; calcium carbonate  500  mg ; prochlorperazine  10  mg ; oxycodone (immediate release)   5-10  mg ; loperamide  2  mg ; acetaminophen (liquid)  325-650  mg ; guaifenesin  5-10  ml ; sw  200  ml ; potassium chloride  20  meq ; caphosol  30  ml ; bag  50  ml ; magnesium sulfate  2  gm ; bag  100  ml ; magnesium sulfate  4  gm ; sarna lotion  1  appl ; hydromorphone (dilaudid)  0.75-1.25  mg ; d5ns  1000  ml ; fluticasone propionate 110mcg  2  puff ; benzonatate  100  mg ; atenolol  25  mg ; 
antineoplastic and immunosuppressive drugs causing adverse effects in therapeutic use malignant neoplasm of bronchus and lung, unspecified hypertensive chronic kidney disease, unspecified, with chronic kidney disease stage i through stage iv, or unspecified malignant neoplasm of liver, secondary accidents occurring in unspecified place chronic kidney disease, unspecified orthostatic hypotension other and unspecified hyperlipidemia mitral valve disorders long-term (current) use of other medications syncope and collapse antineoplastic chemotherapy induced anemia other specified cardiac dysrhythmias other and unspecified hyperlipidemia personal history of tobacco use unspecified essential hypertension malignant neoplasm of upper lobe, bronchus or lung gout, unspecified iatrogenic pneumothorax personal history of tobacco use person boarding or alighting a pedal cycle injured in collision with fixed or stationary object car passenger injured in collision with van in traffic accident mitral valve disorders other and unspecified hyperlipidemia unspecified essential hypertension osteoarthrosis, unspecified whether generalized or localized, site unspecified family history of ischemic heart disease other specified surgical operations and procedures causing abnormal patient reaction, or later complication, without mention of misadventure at time of operation hip joint replacement other diseases of lung, not elsewhere classified
white f 77 $nan$nan$simvastatin  10  mg ; sodium chloride 0.9%  flush  3  ml ; ondansetron  4  mg ; maalox diphenhydramine lidocaine  15  ml ; calcium carbonate  500  mg ; prochlorperazine  10  mg ; oxycodone (immediate release)   5-10  mg ; loperamide  2  mg ; acetaminophen (liquid)  325-650  mg ; guaifenesin  5-10  ml ; sw  200  ml ; potassium chloride  20  meq ; caphosol  30  ml ; bag  50  ml ; magnesium sulfate  2  gm ; bag  100  ml ; magnesium sulfate  4  gm ; sarna lotion  1  appl ; fluticasone propionate 110mcg  2  puff ; benzonatate  100  mg ; atenolol  25  mg ; 
antineoplastic and immunosuppressive drugs causing adverse effects in therapeutic use malignant neoplasm of bronchus and lung, unspecified hypertensive chronic kidney disease, unspecified, with chronic kidney disease stage i through stage iv, or unspecified malignant neoplasm of liver, secondary accidents occurring in unspecified place chronic kidney disease, unspecified orthostatic hypotension other and unspecified hyperlipidemia mitral valve disorders long-term (current) use of other medications syncope and collapse antineoplastic chemotherapy induced anemia other specified cardiac dysrhythmias other and unspecified hyperlipidemia personal history of tobacco use unspecified essential hypertension malignant neoplasm of upper lobe, bronchus or lung gout, unspecified iatrogenic pneumothorax personal history of tobacco use person boarding or alighting a pedal cycle injured in collision with fixed or stationary object car passenger injured in collision with van in traffic accident mitral valve disorders other and unspecified hyperlipidemia unspecified essential hypertension osteoarthrosis, unspecified whether generalized or localized, site unspecified family history of ischemic heart disease other specified surgical operations and procedures causing abnormal patient reaction, or later complication, without mention of misadventure at time of operation hip joint replacement other diseases of lung, not elsewhere classified
white f 77 $nan$nan$simvastatin  10  mg ; sodium chloride 0.9%  flush  3  ml ; ondansetron  4  mg ; maalox diphenhydramine lidocaine  15  ml ; calcium carbonate  500  mg ; prochlorperazine  10  mg ; oxycodone (immediate release)   5-10  mg ; loperamide  2  mg ; acetaminophen (liquid)  325-650  mg ; guaifenesin  5-10  ml ; sw  200  ml ; potassium chloride  20  meq ; caphosol  30  ml ; bag  50  ml ; magnesium sulfate  2  gm ; bag  100  ml ; magnesium sulfate  4  gm ; sarna lotion  1  appl ; fluticasone propionate 110mcg  2  puff ; benzonatate  100  mg ; atenolol  25  mg ; 
antineoplastic and immunosuppressive drugs causing adverse effects in therapeutic use malignant neoplasm of bronchus and lung, unspecified hypertensive chronic kidney disease, unspecified, with chronic kidney disease stage i through stage iv, or unspecified malignant neoplasm of liver, secondary accidents occurring in unspecified place chronic kidney disease, unspecified orthostatic hypotension other and unspecified hyperlipidemia mitral valve disorders long-term (current) use of other medications syncope and collapse antineoplastic chemotherapy induced anemia other specified cardiac dysrhythmias other and unspecified hyperlipidemia personal history of tobacco use unspecified essential hypertension malignant neoplasm of upper lobe, bronchus or lung gout, unspecified iatrogenic pneumothorax personal history of tobacco use person boarding or alighting a pedal cycle injured in collision with fixed or stationary object car passenger injured in collision with van in traffic accident mitral valve disorders other and unspecified hyperlipidemia unspecified essential hypertension osteoarthrosis, unspecified whether generalized or localized, site unspecified family history of ischemic heart disease other specified surgical operations and procedures causing abnormal patient reaction, or later complication, without mention of misadventure at time of operation hip joint replacement other diseases of lung, not elsewhere classified
white f 32 $nan$nan$sodium chloride 0.9%  flush  3  ml ; sodium chloride 0.9%  1000  ml ; oxycodone (immediate release)   5-10  mg ; acetaminophen  325-650  mg ; ondansetron  4  mg ; hydromorphone (dilaudid)  0.5-1  mg ; 5% dextrose  50  ml ; clindamycin  600  mg ; 
 
white f 32 $nan$nan$sodium chloride 0.9%  flush  3  ml ; sodium chloride 0.9%  1000  ml ; oxycodone (immediate release)   5-10  mg ; acetaminophen  325-650  mg ; ondansetron  4  mg ; hydromorphone (dilaudid)  0.5-1  mg ; 5% dextrose  50  ml ; clindamycin  600  mg ; senna  8.6  mg ; polyethylene glycol  17  g ; bisacodyl  10  mg ; cyanocobalamin  500  mcg ; levothyroxine sodium  100  mcg ; mercaptopurine  25  mg ; 
 
white m 71 $temp    heartrate    resprate    o2sat    sbp    dbp    rhythm    pain  0  ; temp  98.7  heartrate  81.0  resprate  18.0  o2sat  96.0  sbp  142.0  dbp  82.0  rhythm    pain    ; temp  98.4  heartrate  70.0  resprate  18.0  o2sat  100.0  sbp  130.0  dbp  66.0  rhythm    pain    ; temp    heartrate  80.0  resprate  18.0  o2sat  100.0  sbp  139.0  dbp  73.0  rhythm    pain    ; temp  98.3  heartrate  80.0  resprate  18.0  o2sat  99.0  sbp  108.0  dbp  60.0  rhythm    pain    ; temp  98.0  heartrate  64.0  resprate  18.0  o2sat  98.0  sbp  132.0  dbp  82.0  rhythm    pain    ; temp    heartrate  69.0  resprate  18.0  o2sat  98.0  sbp  124.0  dbp  65.0  rhythm    pain    ; temp    heartrate  75.0  resprate  18.0  o2sat  99.0  sbp  125.0  dbp  67.0  rhythm    pain    $hematology blood hematocrit  41.1  %; hematology blood hemoglobin  14.2  g dl; hematology blood platelet count  200  k ul; chemistry blood anion gap  14  meq l; chemistry blood bicarbonate  26  meq l; chemistry blood chloride  106  meq l; chemistry blood creatinine  1.2  mg dl; chemistry blood potassium  3.8  meq l; chemistry blood sodium  142  meq l; chemistry blood urea nitrogen  28  mg dl; hematology urine wbc  1  # hpf; chemistry blood calcium, total  8.9  mg dl; chemistry blood glucose  99  mg dl$nan
paralysis agitans other specified metabolic disorders home accidents rhabdomyolysis other sleep disturbances retention of urine, unspecified restless legs syndrome (rls) unspecified fall hypertrophy (benign) of prostate with urinary obstruction and other lower urinary tract symptoms (luts) urinary incontinence, unspecified impotence of organic origin psychophysical visual disturbances unspecified sleep apnea closed fracture of two ribs restless legs syndrome (rls) rhabdomyolysis paralysis agitans other specified cardiac dysrhythmias
black african american f 83 $nan$nan$acetaminophen  1000  mg ; lisinopril  10  mg ; atenolol  50  mg ; pioglitazone  15  mg ; aspirin  81  mg ; 
unspecified essential hypertension ulcer of calf coronary atherosclerosis of native coronary artery other and unspecified hyperlipidemia atherosclerosis of native arteries of the extremities with ulceration depressive disorder, not elsewhere classified diabetes mellitus without mention of complication, type ii or unspecified type, not stated as uncontrolled chronic airway obstruction, not elsewhere classified urinary incontinence, unspecified 
black african american f 83 $nan$hematology blood hematocrit  34.3  %; hematology blood hemoglobin  10.9  g dl; hematology blood platelet count  527  k ul; chemistry blood anion gap  14  meq l; chemistry blood bicarbonate  30  meq l; chemistry blood chloride  98  meq l; chemistry blood creatinine  1.1  mg dl; chemistry blood potassium  4.8  meq l; chemistry blood sodium  137  meq l; chemistry blood urea nitrogen  15  mg dl; hematology blood inr(pt)  1.1  ; chemistry blood calcium, total  9.2  mg dl; chemistry blood glucose  116  mg dl; blood gas blood free calcium  1.10  mmol l; blood gas blood lactate  1.6  mmol l; blood gas blood chloride, whole blood  104  meq l; blood gas blood glucose  115  mg dl; blood gas blood hematocrit, calculated  29  %; blood gas blood hemoglobin  9.5  g dl; blood gas blood potassium, whole blood  4.0  meq l; blood gas blood sodium, whole blood  136  meq l$acetaminophen  1000  mg ; lisinopril  10  mg ; atenolol  50  mg ; pioglitazone  15  mg ; aspirin  81  mg ; metformin (glucophage)  500  mg ; pneumococcal vac polyvalent  0.5  ml ; sodium chloride 0.9%  flush  3  ml ; 0.9% sodium chloride  1000  ml ; ipratropium bromide mdi  1-2  puff ; ns  100  ml ; metronidazole (flagyl)  500  mg ; insulin  0  unit ; 5% dextrose  100  ml ; ciprofloxacin iv  200  mg ; docusate sodium  100  mg ; iso-osmotic dextrose  200  ml ; vancomycin  1000  mg ; atorvastatin  10  mg ; donepezil  10  mg ; mirtazapine  30  mg ; 
unspecified essential hypertension ulcer of calf coronary atherosclerosis of native coronary artery other and unspecified hyperlipidemia atherosclerosis of native arteries of the extremities with ulceration depressive disorder, not elsewhere classified diabetes mellitus without mention of complication, type ii or unspecified type, not stated as uncontrolled chronic airway obstruction, not elsewhere classified urinary incontinence, unspecified 
black african american f 83 $nan$hematology blood hematocrit  24.7  %; hematology blood hematocrit  34.2  %; hematology blood hematocrit  30.7  %; hematology blood hemoglobin  7.8  g dl; hematology blood hemoglobin  10.4  g dl; hematology blood platelet count  493  k ul; hematology blood platelet count  349  k ul; chemistry blood anion gap  11  meq l; chemistry blood anion gap  13  meq l; chemistry blood bicarbonate  25  meq l; chemistry blood bicarbonate  21  meq l; chemistry blood chloride  105  meq l; chemistry blood chloride  105  meq l; chemistry blood creatinine  0.9  mg dl; chemistry blood creatinine  0.9  mg dl; chemistry blood potassium  4.4  meq l; chemistry blood potassium  4.6  meq l; chemistry blood sodium  137  meq l; chemistry blood sodium  134  meq l; chemistry blood urea nitrogen  12  mg dl; chemistry blood urea nitrogen  13  mg dl; hematology blood inr(pt)  1.3  ; chemistry blood calcium, total  8.2  mg dl; chemistry blood calcium, total  7.9  mg dl; chemistry blood glucose  200  mg dl; chemistry blood glucose  164  mg dl; blood gas blood free calcium  1.18  mmol l; blood gas blood lactate  2.3  mmol l; blood gas blood chloride, whole blood  105  meq l; blood gas blood glucose  154  mg dl; blood gas blood hematocrit, calculated  27  %; blood gas blood hemoglobin  9.1  g dl; blood gas blood potassium, whole blood  4.3  meq l; blood gas blood sodium, whole blood  136  meq l$acetaminophen  1000  mg ; lisinopril  10  mg ; atenolol  50  mg ; pioglitazone  15  mg ; aspirin  81  mg ; pneumococcal vac polyvalent  0.5  ml ; sodium chloride 0.9%  flush  3  ml ; 0.9% sodium chloride  1000  ml ; ipratropium bromide mdi  1-2  puff ; ns  100  ml ; metronidazole (flagyl)  500  mg ; insulin  0  unit ; docusate sodium  100  mg ; iso-osmotic dextrose  200  ml ; vancomycin  1000  mg ; atorvastatin  10  mg ; donepezil  10  mg ; mirtazapine  30  mg ; morphine sulfate  1-5  mg ; ondansetron  4  mg ; oxycodone (immediate release)   5-10  mg ; metoprolol tartrate  5  mg ; meperidine  12.5  mg ; promethazine hcl  6.25-12.5  mg ; prochlorperazine  2.5-5  mg ; haloperidol  0.25-0.5  mg ; hydromorphone (dilaudid)  0.2-0.6  mg ; 0.9% sodium chloride  250  ml ; phenylephrine  60  mg ; lr  500  ml ; labetalol  10-20  mg ; 0.9% sodium chloride  500  ml ; sw  50  ml ; magnesium sulfate  2  gm ; aspirin  325  mg ; heparin  5000  unit ; chlorhexidine gluconate 0.12% oral rinse  15  ml ; albuterol 0.083% neb soln  1  neb ; d5 1 2ns  1000  ml ; 
unspecified essential hypertension ulcer of calf coronary atherosclerosis of native coronary artery other and unspecified hyperlipidemia atherosclerosis of native arteries of the extremities with ulceration depressive disorder, not elsewhere classified diabetes mellitus without mention of complication, type ii or unspecified type, not stated as uncontrolled chronic airway obstruction, not elsewhere classified urinary incontinence, unspecified 
black african american f 83 $nan$hematology blood hematocrit  30.5  %; hematology blood hematocrit  29.1  %; hematology blood hemoglobin  10.1  g dl; hematology blood platelet count  362  k ul; hematology blood platelet count  358  k ul; chemistry blood anion gap  10  meq l; chemistry blood bicarbonate  25  meq l; chemistry blood chloride  106  meq l; chemistry blood creatinine  0.8  mg dl; chemistry blood creatinine  0.6  mg dl; chemistry blood potassium  4.2  meq l; chemistry blood potassium  4.6  meq l; chemistry blood sodium  137  meq l; chemistry blood sodium  139  meq l; chemistry blood urea nitrogen  10  mg dl; chemistry blood urea nitrogen  9  mg dl; chemistry blood calcium, total  7.9  mg dl; chemistry blood glucose  113  mg dl$acetaminophen  1000  mg ; lisinopril  10  mg ; atenolol  50  mg ; pioglitazone  15  mg ; pneumococcal vac polyvalent  0.5  ml ; sodium chloride 0.9%  flush  3  ml ; ipratropium bromide mdi  1-2  puff ; ns  100  ml ; metronidazole (flagyl)  500  mg ; insulin  0  unit ; docusate sodium  100  mg ; iso-osmotic dextrose  200  ml ; vancomycin  1000  mg ; atorvastatin  10  mg ; donepezil  10  mg ; mirtazapine  30  mg ; morphine sulfate  1-5  mg ; ondansetron  4  mg ; oxycodone (immediate release)   5-10  mg ; aspirin  325  mg ; heparin  5000  unit ; albuterol 0.083% neb soln  1  neb ; d5 1 2ns  1000  ml ; bisacodyl  10  mg ; 
unspecified essential hypertension ulcer of calf coronary atherosclerosis of native coronary artery other and unspecified hyperlipidemia atherosclerosis of native arteries of the extremities with ulceration depressive disorder, not elsewhere classified diabetes mellitus without mention of complication, type ii or unspecified type, not stated as uncontrolled chronic airway obstruction, not elsewhere classified urinary incontinence, unspecified 
black african american f 83 $nan$nan$acetaminophen  1000  mg ; lisinopril  10  mg ; atenolol  50  mg ; pioglitazone  15  mg ; pneumococcal vac polyvalent  0.5  ml ; ipratropium bromide mdi  1-2  puff ; insulin  0  unit ; docusate sodium  100  mg ; atorvastatin  10  mg ; donepezil  10  mg ; mirtazapine  30  mg ; morphine sulfate  1-5  mg ; ondansetron  4  mg ; oxycodone (immediate release)   5-10  mg ; aspirin  325  mg ; heparin  5000  unit ; albuterol 0.083% neb soln  1  neb ; d5 1 2ns  1000  ml ; bisacodyl  10  mg ; senna  1  tab ; sulfameth trimethoprim ds  1  tab ; 
unspecified essential hypertension ulcer of calf coronary atherosclerosis of native coronary artery other and unspecified hyperlipidemia atherosclerosis of native arteries of the extremities with ulceration depressive disorder, not elsewhere classified diabetes mellitus without mention of complication, type ii or unspecified type, not stated as uncontrolled chronic airway obstruction, not elsewhere classified urinary incontinence, unspecified 
black african american f 83 $nan$hematology blood hematocrit  28.0  %; hematology blood platelet count  378  k ul; chemistry blood potassium  4.5  meq l$acetaminophen  1000  mg ; lisinopril  10  mg ; atenolol  50  mg ; pioglitazone  15  mg ; ipratropium bromide mdi  1-2  puff ; insulin  0  unit ; docusate sodium  100  mg ; atorvastatin  10  mg ; donepezil  10  mg ; mirtazapine  30  mg ; morphine sulfate  1-5  mg ; oxycodone (immediate release)   5-10  mg ; aspirin  325  mg ; heparin  5000  unit ; albuterol 0.083% neb soln  1  neb ; d5 1 2ns  1000  ml ; bisacodyl  10  mg ; senna  1  tab ; sulfameth trimethoprim ds  1  tab ; 
unspecified essential hypertension ulcer of calf coronary atherosclerosis of native coronary artery other and unspecified hyperlipidemia atherosclerosis of native arteries of the extremities with ulceration depressive disorder, not elsewhere classified diabetes mellitus without mention of complication, type ii or unspecified type, not stated as uncontrolled chronic airway obstruction, not elsewhere classified urinary incontinence, unspecified 
black african american f 83 $nan$nan$acetaminophen  1000  mg ; lisinopril  10  mg ; atenolol  50  mg ; pioglitazone  15  mg ; ipratropium bromide mdi  1-2  puff ; insulin  0  unit ; docusate sodium  100  mg ; atorvastatin  10  mg ; donepezil  10  mg ; mirtazapine  30  mg ; morphine sulfate  1-5  mg ; oxycodone (immediate release)   5-10  mg ; aspirin  325  mg ; heparin  5000  unit ; albuterol 0.083% neb soln  1  neb ; d5 1 2ns  1000  ml ; bisacodyl  10  mg ; senna  1  tab ; sulfameth trimethoprim ds  1  tab ; 
unspecified essential hypertension ulcer of calf coronary atherosclerosis of native coronary artery other and unspecified hyperlipidemia atherosclerosis of native arteries of the extremities with ulceration depressive disorder, not elsewhere classified diabetes mellitus without mention of complication, type ii or unspecified type, not stated as uncontrolled chronic airway obstruction, not elsewhere classified urinary incontinence, unspecified 
black african american f 83 $nan$nan$acetaminophen  1000  mg ; lisinopril  10  mg ; atenolol  50  mg ; pioglitazone  15  mg ; ipratropium bromide mdi  1-2  puff ; insulin  0  unit ; docusate sodium  100  mg ; atorvastatin  10  mg ; donepezil  10  mg ; mirtazapine  30  mg ; morphine sulfate  1-5  mg ; oxycodone (immediate release)   5-10  mg ; aspirin  325  mg ; heparin  5000  unit ; albuterol 0.083% neb soln  1  neb ; d5 1 2ns  1000  ml ; bisacodyl  10  mg ; senna  1  tab ; sulfameth trimethoprim ds  1  tab ; 
unspecified essential hypertension ulcer of calf coronary atherosclerosis of native coronary artery other and unspecified hyperlipidemia atherosclerosis of native arteries of the extremities with ulceration depressive disorder, not elsewhere classified diabetes mellitus without mention of complication, type ii or unspecified type, not stated as uncontrolled chronic airway obstruction, not elsewhere classified urinary incontinence, unspecified 
white f 88 $nan$nan$rosuvastatin calcium  40  mg ; 
cerebral artery occlusion, unspecified with cerebral infarction anemia, unspecified diabetes with neurological manifestations, type ii or unspecified type, not stated as uncontrolled polyneuropathy in diabetes unspecified essential hypertension other and unspecified hyperlipidemia
white f 88 $nan$hematology blood hematocrit  32.2  %; hematology blood hemoglobin  11.2  g dl; hematology blood platelet count  193  k ul; chemistry blood anion gap  16  meq l; chemistry blood bicarbonate  19  meq l; chemistry blood chloride  110  meq l; chemistry blood creatinine  1.3  mg dl; chemistry blood potassium  4.3  meq l; chemistry blood sodium  141  meq l; chemistry blood urea nitrogen  27  mg dl; hematology blood inr(pt)  1.0  ; chemistry blood calcium, total  9.5  mg dl; chemistry blood glucose  139  mg dl; chemistry blood % hemoglobin a1c  7.8  %$rosuvastatin calcium  40  mg ; pneumococcal vac polyvalent  0.5  ml ; sodium chloride 0.9%  flush  3  ml ; 0.9% sodium chloride  1000  ml ; labetalol  10  mg ; acetaminophen  650  mg ; iso-osmotic sodium chloride  50  ml ; famotidine  20  mg ; dextrose 50%  12.5  gm ; glucagon  1  mg ; insulin  0  unit ; 
cerebral artery occlusion, unspecified with cerebral infarction anemia, unspecified diabetes with neurological manifestations, type ii or unspecified type, not stated as uncontrolled polyneuropathy in diabetes unspecified essential hypertension other and unspecified hyperlipidemia
white f 88 $nan$hematology blood hematocrit  33.7  %; hematology blood hemoglobin  11.7  g dl; hematology blood platelet count  195  k ul; chemistry blood anion gap  18  meq l; chemistry blood bicarbonate  17  meq l; chemistry blood chloride  108  meq l; chemistry blood creatinine  1.2  mg dl; chemistry blood potassium  4.2  meq l; chemistry blood sodium  139  meq l; chemistry blood urea nitrogen  21  mg dl; chemistry blood calcium, total  9.1  mg dl; chemistry blood glucose  173  mg dl$rosuvastatin calcium  40  mg ; pneumococcal vac polyvalent  0.5  ml ; sodium chloride 0.9%  flush  3  ml ; labetalol  10  mg ; acetaminophen  650  mg ; dextrose 50%  12.5  gm ; glucagon  1  mg ; insulin  0  unit ; 0.9% sodium chloride  250  ml ; capsaicin 0.025%  1  appl ; artificial tears  1-2  drop ; hydralazine  10  mg ; aspirin  325  mg ; 
cerebral artery occlusion, unspecified with cerebral infarction anemia, unspecified diabetes with neurological manifestations, type ii or unspecified type, not stated as uncontrolled polyneuropathy in diabetes unspecified essential hypertension other and unspecified hyperlipidemia
white f 88 $nan$hematology blood hematocrit  32.6  %; hematology blood hemoglobin  11.1  g dl; hematology blood platelet count  184  k ul; chemistry blood anion gap  16  meq l; chemistry blood bicarbonate  18  meq l; chemistry blood chloride  106  meq l; chemistry blood creatinine  1.4  mg dl; chemistry blood potassium  4.7  meq l; chemistry blood sodium  135  meq l; chemistry blood urea nitrogen  20  mg dl; hematology blood inr(pt)  1.0  ; hematology urine wbc  48  # hpf; chemistry blood calcium, total  9.2  mg dl; chemistry blood glucose  151  mg dl$rosuvastatin calcium  40  mg ; pneumococcal vac polyvalent  0.5  ml ; sodium chloride 0.9%  flush  3  ml ; acetaminophen  650  mg ; dextrose 50%  12.5  gm ; glucagon  1  mg ; insulin  0  unit ; capsaicin 0.025%  1  appl ; artificial tears  1-2  drop ; hydralazine  10  mg ; aspirin  325  mg ; miconazole powder 2%  1  appl ; diphenhydramine  25  mg ; sarna lotion  1  appl ; 
cerebral artery occlusion, unspecified with cerebral infarction anemia, unspecified diabetes with neurological manifestations, type ii or unspecified type, not stated as uncontrolled polyneuropathy in diabetes unspecified essential hypertension other and unspecified hyperlipidemia
white f 88 $nan$nan$rosuvastatin calcium  40  mg ; pneumococcal vac polyvalent  0.5  ml ; sodium chloride 0.9%  flush  3  ml ; acetaminophen  650  mg ; dextrose 50%  12.5  gm ; glucagon  1  mg ; insulin  0  unit ; capsaicin 0.025%  1  appl ; artificial tears  1-2  drop ; hydralazine  10  mg ; aspirin  325  mg ; miconazole powder 2%  1  appl ; diphenhydramine  25  mg ; sarna lotion  1  appl ; sulfameth trimethoprim ds  1  tab ; 5% dextrose  250  ml ; heparin sodium  25,000  unit ; ciprofloxacin hcl  250  mg ; amlodipine  5  mg ; 
cerebral artery occlusion, unspecified with cerebral infarction anemia, unspecified diabetes with neurological manifestations, type ii or unspecified type, not stated as uncontrolled polyneuropathy in diabetes unspecified essential hypertension other and unspecified hyperlipidemia
white f 88 $nan$hematology blood inr(pt)  1.1  ; hematology blood inr(pt)  1.2  $rosuvastatin calcium  40  mg ; pneumococcal vac polyvalent  0.5  ml ; sodium chloride 0.9%  flush  3  ml ; acetaminophen  650  mg ; dextrose 50%  12.5  gm ; glucagon  1  mg ; insulin  0  unit ; capsaicin 0.025%  1  appl ; artificial tears  1-2  drop ; hydralazine  10  mg ; miconazole powder 2%  1  appl ; sarna lotion  1  appl ; 5% dextrose  250  ml ; heparin sodium  25,000  unit ; ciprofloxacin hcl  250  mg ; amlodipine  5  mg ; oxycodone-acetaminophen  1  tab ; hydroxyzine  25  mg ; warfarin  5  mg ; irbesartan  150  mg ; 
cerebral artery occlusion, unspecified with cerebral infarction anemia, unspecified diabetes with neurological manifestations, type ii or unspecified type, not stated as uncontrolled polyneuropathy in diabetes unspecified essential hypertension other and unspecified hyperlipidemia
white f 88 $nan$hematology blood inr(pt)  1.3  ; hematology blood inr(pt)  1.4  ; hematology blood inr(pt)  1.8  $rosuvastatin calcium  40  mg ; pneumococcal vac polyvalent  0.5  ml ; sodium chloride 0.9%  flush  3  ml ; acetaminophen  650  mg ; dextrose 50%  12.5  gm ; glucagon  1  mg ; insulin  0  unit ; capsaicin 0.025%  1  appl ; artificial tears  1-2  drop ; hydralazine  10  mg ; miconazole powder 2%  1  appl ; sarna lotion  1  appl ; ciprofloxacin hcl  250  mg ; amlodipine  5  mg ; oxycodone-acetaminophen  1  tab ; warfarin  5  mg ; irbesartan  150  mg ; amlodipine  10  mg ; 
cerebral artery occlusion, unspecified with cerebral infarction anemia, unspecified diabetes with neurological manifestations, type ii or unspecified type, not stated as uncontrolled polyneuropathy in diabetes unspecified essential hypertension other and unspecified hyperlipidemia
white f 88 $nan$hematology blood hematocrit  33.3  %; hematology blood hematocrit  33.3  %; hematology blood hemoglobin  11.5  g dl; hematology blood hemoglobin  11.4  g dl; hematology blood platelet count  204  k ul; hematology blood platelet count  193  k ul; chemistry blood anion gap  16  meq l; chemistry blood anion gap  16  meq l; chemistry blood bicarbonate  19  meq l; chemistry blood bicarbonate  19  meq l; chemistry blood chloride  109  meq l; chemistry blood chloride  108  meq l; chemistry blood creatinine  1.6  mg dl; chemistry blood creatinine  1.6  mg dl; chemistry blood potassium  4.1  meq l; chemistry blood potassium  4.2  meq l; chemistry blood sodium  140  meq l; chemistry blood sodium  139  meq l; chemistry blood urea nitrogen  21  mg dl; chemistry blood urea nitrogen  21  mg dl; hematology blood inr(pt)  2.1  ; hematology blood inr(pt)  3.6  ; chemistry blood calcium, total  8.6  mg dl; chemistry blood bilirubin, total  0.2  mg dl; chemistry blood glucose  200  mg dl; chemistry blood glucose  172  mg dl; chemistry blood lactate dehydrogenase (ld)  211  iu l; chemistry blood albumin  3.4  g dl$rosuvastatin calcium  40  mg ; sodium chloride 0.9%  flush  3  ml ; acetaminophen  650  mg ; dextrose 50%  12.5  gm ; glucagon  1  mg ; insulin  0  unit ; capsaicin 0.025%  1  appl ; artificial tears  1-2  drop ; hydralazine  10  mg ; miconazole powder 2%  1  appl ; sarna lotion  1  appl ; amlodipine  5  mg ; oxycodone-acetaminophen  1  tab ; warfarin  5  mg ; irbesartan  150  mg ; amlodipine  10  mg ; hydrocortisone cream 0.5%  1  appl ; 
cerebral artery occlusion, unspecified with cerebral infarction anemia, unspecified diabetes with neurological manifestations, type ii or unspecified type, not stated as uncontrolled polyneuropathy in diabetes unspecified essential hypertension other and unspecified hyperlipidemia
white f 88 $nan$nan$rosuvastatin calcium  40  mg ; sodium chloride 0.9%  flush  3  ml ; acetaminophen  650  mg ; dextrose 50%  12.5  gm ; glucagon  1  mg ; insulin  0  unit ; capsaicin 0.025%  1  appl ; artificial tears  1-2  drop ; hydralazine  10  mg ; miconazole powder 2%  1  appl ; sarna lotion  1  appl ; oxycodone-acetaminophen  1  tab ; irbesartan  150  mg ; amlodipine  10  mg ; hydrocortisone cream 0.5%  1  appl ; clobetasol propionate 0.05% ointment  1  appl ; 
cerebral artery occlusion, unspecified with cerebral infarction anemia, unspecified diabetes with neurological manifestations, type ii or unspecified type, not stated as uncontrolled polyneuropathy in diabetes unspecified essential hypertension other and unspecified hyperlipidemia
white m 30 $nan$hematology blood hematocrit  23.2  %; hematology blood hematocrit  23.1  %; hematology blood hematocrit  24.3  %; hematology blood hemoglobin  7.3  g dl; hematology blood hemoglobin  7.2  g dl; hematology blood hemoglobin  7.8  g dl; hematology blood platelet count  14  k ul; hematology blood platelet count  12  k ul; hematology blood platelet count  11  k ul; chemistry blood anion gap  14  meq l; chemistry blood anion gap  13  meq l; chemistry blood anion gap  14  meq l; chemistry blood bicarbonate  23  meq l; chemistry blood bicarbonate  22  meq l; chemistry blood bicarbonate  19  meq l; chemistry blood chloride  120  meq l; chemistry blood chloride  116  meq l; chemistry blood chloride  116  meq l; chemistry blood creatinine  2.1  mg dl; chemistry blood creatinine  2.1  mg dl; chemistry blood creatinine  2.1  mg dl; chemistry blood potassium  4.3  meq l; chemistry blood potassium  3.9  meq l; chemistry blood potassium  3.5  meq l; chemistry blood sodium  147  meq l; chemistry blood sodium  145  meq l; chemistry blood sodium  153  meq l; chemistry blood urea nitrogen  77  mg dl; chemistry blood urea nitrogen  82  mg dl; chemistry blood urea nitrogen  85  mg dl; hematology blood inr(pt)  1.9  ; hematology blood inr(pt)  1.9  ; chemistry urine chloride, urine  51  meq l; chemistry urine creatinine, urine  25  mg dl; chemistry urine potassium, urine  26  meq l; chemistry urine sodium, urine  70  meq l; chemistry blood calcium, total  6.5  mg dl; chemistry blood calcium, total  6.3  mg dl; chemistry blood calcium, total  6.6  mg dl; chemistry blood bilirubin, total  7.0  mg dl; chemistry blood bilirubin, total  6.6  mg dl; chemistry blood glucose  151  mg dl; chemistry blood glucose  111  mg dl; chemistry blood glucose  74  mg dl; chemistry blood lactate dehydrogenase (ld)  197  iu l; chemistry blood albumin  2.4  g dl; chemistry blood albumin  2.0  g dl; hematology blood bands  1  %; blood gas blood free calcium  0.92  mmol l; blood gas blood lactate  2.1  mmol l$5% dextrose  500  ml ; fentanyl patch  100  mcg h ; hydromorphone (dilaudid)  0.25  mg ; vial  2  vial ; pantoprazole  80  mg ; diphenhydramine  50  mg ; iso-osmotic dextrose  50  ml ; piperacillin-tazobactam  2.25  g ; vial  1  vial ; 5% dextrose  250  ml ; vancomycin  750  mg ; nystatin oral suspension  5  ml ; 0.9% sodium chloride  1000  ml ; d5 1 2ns  1000  ml ; 0.9% sodium chloride (mini bag plus)  100  ml ; ceftazidime  1  g ; sodium chloride 0.9%  flush  10  ml ; 
bloodstream infection due to central venous catheter gastrostomy status anemia, unspecified acute kidney failure, unspecified other pancytopenia hyperosmolality and/or hypernatremia car passenger injured in collision with heavy transport vehicle or bus in nontraffic accident cirrhosis of liver without mention of alcohol automatic implantable cardiac defibrillator in situ staphylococcus infection in conditions classified elsewhere and of unspecified site, other staphylococcus personal history of venous thrombosis and embolism complications of transplanted intestine bacteremia other specified procedures as the cause of abnormal reaction of patient, or of later complication, without mention of misadventure at time of procedure acquired absence of intestine (large) (small) unspecified protein-calorie malnutrition hypopotassemia gastrostomy status car passenger injured in collision with heavy transport vehicle or bus in nontraffic accident methicillin susceptible staphylococcus aureus in conditions classified elsewhere and of unspecified site other specified procedures as the cause of abnormal reaction of patient, or of later complication, without mention of misadventure at time of procedure acquired absence of intestine (large) (small) bloodstream infection due to central venous catheter other neutropenia bacteremia other pancytopenia complications of transplanted intestine other and unspecified postsurgical nonabsorption personal history of venous thrombosis and embolism acute venous embolism and thrombosis of superficial veins of upper extremity chest pain, unspecified unspecified car occupant injured in collision with railway train or railway vehicle in nontraffic accident driver of special construction vehicle injured in traffic accident body mass index less than 19, adult gastrostomy status chills (without fever) unspecified pruritic disorder hypoglycemia, unspecified personal history of methicillin resistant staphylococcus aureus car passenger injured in collision with heavy transport vehicle or bus in nontraffic accident leukocytopenia, unspecified other malaise and fatigue alkalosis hyperosmolality and/or hypernatremia cirrhosis of liver without mention of alcohol intestinal bypass or anastomosis status other chronic pain vomiting alone
white m 30 $nan$hematology blood hematocrit  22.9  %; hematology blood hemoglobin  7.2  g dl; hematology blood platelet count  10  k ul; chemistry blood anion gap  10  meq l; chemistry blood bicarbonate  18  meq l; chemistry blood chloride  113  meq l; chemistry blood creatinine  2.3  mg dl; chemistry blood potassium  4.1  meq l; chemistry blood sodium  137  meq l; chemistry blood urea nitrogen  90  mg dl; hematology blood inr(pt)  1.6  ; chemistry blood calcium, total  7.4  mg dl; chemistry blood bilirubin, total  9.5  mg dl; chemistry blood glucose  122  mg dl; blood gas blood lactate  1.3  mmol l; blood gas blood lactate  1.4  mmol l$fentanyl patch  100  mcg h ; vial  1  vial ; 5% dextrose  250  ml ; vancomycin  750  mg ; nystatin oral suspension  5  ml ; 0.9% sodium chloride (mini bag plus)  100  ml ; ceftazidime  1  g ; sodium chloride 0.9%  flush  10  ml ; lactated ringers  1000  ml ; albumin 25% (12.5g   50ml)  50  g ; lidocaine jelly 2% (urojet)  1  appl ; diphenhydramine  12.5  mg ; 
bloodstream infection due to central venous catheter gastrostomy status anemia, unspecified acute kidney failure, unspecified other pancytopenia hyperosmolality and/or hypernatremia car passenger injured in collision with heavy transport vehicle or bus in nontraffic accident cirrhosis of liver without mention of alcohol automatic implantable cardiac defibrillator in situ staphylococcus infection in conditions classified elsewhere and of unspecified site, other staphylococcus personal history of venous thrombosis and embolism complications of transplanted intestine bacteremia other specified procedures as the cause of abnormal reaction of patient, or of later complication, without mention of misadventure at time of procedure acquired absence of intestine (large) (small) unspecified protein-calorie malnutrition hypopotassemia gastrostomy status car passenger injured in collision with heavy transport vehicle or bus in nontraffic accident methicillin susceptible staphylococcus aureus in conditions classified elsewhere and of unspecified site other specified procedures as the cause of abnormal reaction of patient, or of later complication, without mention of misadventure at time of procedure acquired absence of intestine (large) (small) bloodstream infection due to central venous catheter other neutropenia bacteremia other pancytopenia complications of transplanted intestine other and unspecified postsurgical nonabsorption personal history of venous thrombosis and embolism acute venous embolism and thrombosis of superficial veins of upper extremity chest pain, unspecified unspecified car occupant injured in collision with railway train or railway vehicle in nontraffic accident driver of special construction vehicle injured in traffic accident body mass index less than 19, adult gastrostomy status chills (without fever) unspecified pruritic disorder hypoglycemia, unspecified personal history of methicillin resistant staphylococcus aureus car passenger injured in collision with heavy transport vehicle or bus in nontraffic accident leukocytopenia, unspecified other malaise and fatigue alkalosis hyperosmolality and/or hypernatremia cirrhosis of liver without mention of alcohol intestinal bypass or anastomosis status other chronic pain vomiting alone
white m 30 $nan$hematology blood hematocrit  21.3  %; hematology blood hematocrit  21.1  %; hematology blood hematocrit  20.2  %; hematology blood hemoglobin  6.7  g dl; hematology blood hemoglobin  6.9  g dl; hematology blood hemoglobin  6.5  g dl; hematology blood platelet count  10  k ul; hematology blood platelet count  9  k ul; hematology blood platelet count  8  k ul; hematology blood platelet count  9  k ul; chemistry blood anion gap  12  meq l; chemistry blood anion gap  15  meq l; chemistry blood anion gap  11  meq l; chemistry blood bicarbonate  16  meq l; chemistry blood bicarbonate  16  meq l; chemistry blood bicarbonate  14  meq l; chemistry blood chloride  111  meq l; chemistry blood chloride  111  meq l; chemistry blood chloride  112  meq l; chemistry blood creatinine  2.5  mg dl; chemistry blood creatinine  2.5  mg dl; chemistry blood creatinine  2.5  mg dl; chemistry blood potassium  5.5  meq l; chemistry blood potassium  5.7  meq l; chemistry blood potassium  5.6  meq l; chemistry blood sodium  133  meq l; chemistry blood sodium  134  meq l; chemistry blood sodium  133  meq l; chemistry blood urea nitrogen  97  mg dl; chemistry blood urea nitrogen  99  mg dl; chemistry blood urea nitrogen  95  mg dl; hematology blood inr(pt)  1.6  ; chemistry blood calcium, total  8.1  mg dl; chemistry blood calcium, total  7.9  mg dl; chemistry blood bilirubin, indirect  3.4  mg dl; chemistry blood bilirubin, total  13.1  mg dl; chemistry blood bilirubin, total  15.6  mg dl; chemistry blood glucose  141  mg dl; chemistry blood glucose  85  mg dl; chemistry blood glucose  77  mg dl; chemistry blood bilirubin, direct  9.7  mg dl$fentanyl patch  100  mcg h ; vial  1  vial ; nystatin oral suspension  5  ml ; 0.9% sodium chloride (mini bag plus)  100  ml ; ceftazidime  1  g ; sodium chloride 0.9%  flush  10  ml ; albumin 25% (12.5g   50ml)  50  g ; lidocaine jelly 2% (urojet)  1  appl ; diphenhydramine  12.5  mg ; ethanol 70% catheter dwell  2  ml ; 0.9% sodium chloride  250  ml ; sodium phosphate  30  mmol ; lactulose  30  ml ; rifaximin  550  mg ; furosemide  80  mg ; diphenhydramine  25  mg ; 
bloodstream infection due to central venous catheter gastrostomy status anemia, unspecified acute kidney failure, unspecified other pancytopenia hyperosmolality and/or hypernatremia car passenger injured in collision with heavy transport vehicle or bus in nontraffic accident cirrhosis of liver without mention of alcohol automatic implantable cardiac defibrillator in situ staphylococcus infection in conditions classified elsewhere and of unspecified site, other staphylococcus personal history of venous thrombosis and embolism complications of transplanted intestine bacteremia other specified procedures as the cause of abnormal reaction of patient, or of later complication, without mention of misadventure at time of procedure acquired absence of intestine (large) (small) unspecified protein-calorie malnutrition hypopotassemia gastrostomy status car passenger injured in collision with heavy transport vehicle or bus in nontraffic accident methicillin susceptible staphylococcus aureus in conditions classified elsewhere and of unspecified site other specified procedures as the cause of abnormal reaction of patient, or of later complication, without mention of misadventure at time of procedure acquired absence of intestine (large) (small) bloodstream infection due to central venous catheter other neutropenia bacteremia other pancytopenia complications of transplanted intestine other and unspecified postsurgical nonabsorption personal history of venous thrombosis and embolism acute venous embolism and thrombosis of superficial veins of upper extremity chest pain, unspecified unspecified car occupant injured in collision with railway train or railway vehicle in nontraffic accident driver of special construction vehicle injured in traffic accident body mass index less than 19, adult gastrostomy status chills (without fever) unspecified pruritic disorder hypoglycemia, unspecified personal history of methicillin resistant staphylococcus aureus car passenger injured in collision with heavy transport vehicle or bus in nontraffic accident leukocytopenia, unspecified other malaise and fatigue alkalosis hyperosmolality and/or hypernatremia cirrhosis of liver without mention of alcohol intestinal bypass or anastomosis status other chronic pain vomiting alone
white m 30 $nan$hematology blood hematocrit  21.2  %; hematology blood hematocrit  20.9  %; hematology blood hemoglobin  6.6  g dl; hematology blood hemoglobin  6.9  g dl; hematology blood platelet count  16  k ul; hematology blood platelet count  12  k ul; chemistry blood anion gap  11  meq l; chemistry blood anion gap  16  meq l; chemistry blood anion gap  11  meq l; chemistry blood bicarbonate  15  meq l; chemistry blood bicarbonate  17  meq l; chemistry blood bicarbonate  17  meq l; chemistry blood chloride  111  meq l; chemistry blood chloride  113  meq l; chemistry blood chloride  112  meq l; chemistry blood creatinine  2.5  mg dl; chemistry blood creatinine  2.1  mg dl; chemistry blood creatinine  2.4  mg dl; chemistry blood potassium  4.9  meq l; chemistry blood potassium  4.7  meq l; chemistry blood potassium  5.7  meq l; chemistry blood sodium  139  meq l; chemistry blood sodium  136  meq l; chemistry blood sodium  132  meq l; chemistry blood urea nitrogen  100  mg dl; chemistry blood urea nitrogen  104  mg dl; chemistry blood urea nitrogen  106  mg dl; hematology blood inr(pt)  1.7  ; chemistry blood calcium, total  8.9  mg dl; chemistry blood calcium, total  8.9  mg dl; chemistry blood calcium, total  8.9  mg dl; chemistry blood bilirubin, total  18.4  mg dl; chemistry blood glucose  660  mg dl; chemistry blood glucose  130  mg dl; chemistry blood glucose  147  mg dl; chemistry blood lactate dehydrogenase (ld)  104  iu l; chemistry blood albumin  2.7  g dl$fentanyl patch  100  mcg h ; vial  1  vial ; nystatin oral suspension  5  ml ; 0.9% sodium chloride (mini bag plus)  100  ml ; ceftazidime  1  g ; sodium chloride 0.9%  flush  10  ml ; ethanol 70% catheter dwell  2  ml ; 0.9% sodium chloride  250  ml ; sodium phosphate  30  mmol ; furosemide  80  mg ; diphenhydramine  25  mg ; fentanyl patch  50  mcg h ; scopolamine patch  1  ptch ; hydromorphone (dilaudid)  2  mg ; 0.9% sodium chloride  100  ml ; hydromorphone  20  mg ; heparin flush (10 units ml)  2  ml ; atropine sulfate 1%  1-2  drop ; 
bloodstream infection due to central venous catheter gastrostomy status anemia, unspecified acute kidney failure, unspecified other pancytopenia hyperosmolality and/or hypernatremia car passenger injured in collision with heavy transport vehicle or bus in nontraffic accident cirrhosis of liver without mention of alcohol automatic implantable cardiac defibrillator in situ staphylococcus infection in conditions classified elsewhere and of unspecified site, other staphylococcus personal history of venous thrombosis and embolism complications of transplanted intestine bacteremia other specified procedures as the cause of abnormal reaction of patient, or of later complication, without mention of misadventure at time of procedure acquired absence of intestine (large) (small) unspecified protein-calorie malnutrition hypopotassemia gastrostomy status car passenger injured in collision with heavy transport vehicle or bus in nontraffic accident methicillin susceptible staphylococcus aureus in conditions classified elsewhere and of unspecified site other specified procedures as the cause of abnormal reaction of patient, or of later complication, without mention of misadventure at time of procedure acquired absence of intestine (large) (small) bloodstream infection due to central venous catheter other neutropenia bacteremia other pancytopenia complications of transplanted intestine other and unspecified postsurgical nonabsorption personal history of venous thrombosis and embolism acute venous embolism and thrombosis of superficial veins of upper extremity chest pain, unspecified unspecified car occupant injured in collision with railway train or railway vehicle in nontraffic accident driver of special construction vehicle injured in traffic accident body mass index less than 19, adult gastrostomy status chills (without fever) unspecified pruritic disorder hypoglycemia, unspecified personal history of methicillin resistant staphylococcus aureus car passenger injured in collision with heavy transport vehicle or bus in nontraffic accident leukocytopenia, unspecified other malaise and fatigue alkalosis hyperosmolality and/or hypernatremia cirrhosis of liver without mention of alcohol intestinal bypass or anastomosis status other chronic pain vomiting alone
white m 30 $nan$nan$sodium chloride 0.9%  flush  10  ml ; ethanol 70% catheter dwell  2  ml ; scopolamine patch  1  ptch ; hydromorphone (dilaudid)  2  mg ; 0.9% sodium chloride  100  ml ; hydromorphone  20  mg ; heparin flush (10 units ml)  2  ml ; atropine sulfate 1%  1-2  drop ; sarna lotion  1  appl ; hydromorphone (dilaudid)  0.5  mg ; diphenhydramine  25-50  mg ; 
bloodstream infection due to central venous catheter gastrostomy status anemia, unspecified acute kidney failure, unspecified other pancytopenia hyperosmolality and/or hypernatremia car passenger injured in collision with heavy transport vehicle or bus in nontraffic accident cirrhosis of liver without mention of alcohol automatic implantable cardiac defibrillator in situ staphylococcus infection in conditions classified elsewhere and of unspecified site, other staphylococcus personal history of venous thrombosis and embolism complications of transplanted intestine bacteremia other specified procedures as the cause of abnormal reaction of patient, or of later complication, without mention of misadventure at time of procedure acquired absence of intestine (large) (small) unspecified protein-calorie malnutrition hypopotassemia gastrostomy status car passenger injured in collision with heavy transport vehicle or bus in nontraffic accident methicillin susceptible staphylococcus aureus in conditions classified elsewhere and of unspecified site other specified procedures as the cause of abnormal reaction of patient, or of later complication, without mention of misadventure at time of procedure acquired absence of intestine (large) (small) bloodstream infection due to central venous catheter other neutropenia bacteremia other pancytopenia complications of transplanted intestine other and unspecified postsurgical nonabsorption personal history of venous thrombosis and embolism acute venous embolism and thrombosis of superficial veins of upper extremity chest pain, unspecified unspecified car occupant injured in collision with railway train or railway vehicle in nontraffic accident driver of special construction vehicle injured in traffic accident body mass index less than 19, adult gastrostomy status chills (without fever) unspecified pruritic disorder hypoglycemia, unspecified personal history of methicillin resistant staphylococcus aureus car passenger injured in collision with heavy transport vehicle or bus in nontraffic accident leukocytopenia, unspecified other malaise and fatigue alkalosis hyperosmolality and/or hypernatremia cirrhosis of liver without mention of alcohol intestinal bypass or anastomosis status other chronic pain vomiting alone
white m 30 $nan$nan$sodium chloride 0.9%  flush  10  ml ; ethanol 70% catheter dwell  2  ml ; heparin flush (10 units ml)  2  ml ; atropine sulfate 1%  1-2  drop ; sarna lotion  1  appl ; hydromorphone (dilaudid)  0.5  mg ; lorazepam  0.5-1  mg ; rifampin  300  mg ; 
bloodstream infection due to central venous catheter gastrostomy status anemia, unspecified acute kidney failure, unspecified other pancytopenia hyperosmolality and/or hypernatremia car passenger injured in collision with heavy transport vehicle or bus in nontraffic accident cirrhosis of liver without mention of alcohol automatic implantable cardiac defibrillator in situ staphylococcus infection in conditions classified elsewhere and of unspecified site, other staphylococcus personal history of venous thrombosis and embolism complications of transplanted intestine bacteremia other specified procedures as the cause of abnormal reaction of patient, or of later complication, without mention of misadventure at time of procedure acquired absence of intestine (large) (small) unspecified protein-calorie malnutrition hypopotassemia gastrostomy status car passenger injured in collision with heavy transport vehicle or bus in nontraffic accident methicillin susceptible staphylococcus aureus in conditions classified elsewhere and of unspecified site other specified procedures as the cause of abnormal reaction of patient, or of later complication, without mention of misadventure at time of procedure acquired absence of intestine (large) (small) bloodstream infection due to central venous catheter other neutropenia bacteremia other pancytopenia complications of transplanted intestine other and unspecified postsurgical nonabsorption personal history of venous thrombosis and embolism acute venous embolism and thrombosis of superficial veins of upper extremity chest pain, unspecified unspecified car occupant injured in collision with railway train or railway vehicle in nontraffic accident driver of special construction vehicle injured in traffic accident body mass index less than 19, adult gastrostomy status chills (without fever) unspecified pruritic disorder hypoglycemia, unspecified personal history of methicillin resistant staphylococcus aureus car passenger injured in collision with heavy transport vehicle or bus in nontraffic accident leukocytopenia, unspecified other malaise and fatigue alkalosis hyperosmolality and/or hypernatremia cirrhosis of liver without mention of alcohol intestinal bypass or anastomosis status other chronic pain vomiting alone
white m 30 $nan$nan$sodium chloride 0.9%  flush  10  ml ; ethanol 70% catheter dwell  2  ml ; heparin flush (10 units ml)  2  ml ; atropine sulfate 1%  1-2  drop ; sarna lotion  1  appl ; lorazepam  0.5-1  mg ; 
bloodstream infection due to central venous catheter gastrostomy status anemia, unspecified acute kidney failure, unspecified other pancytopenia hyperosmolality and/or hypernatremia car passenger injured in collision with heavy transport vehicle or bus in nontraffic accident cirrhosis of liver without mention of alcohol automatic implantable cardiac defibrillator in situ staphylococcus infection in conditions classified elsewhere and of unspecified site, other staphylococcus personal history of venous thrombosis and embolism complications of transplanted intestine bacteremia other specified procedures as the cause of abnormal reaction of patient, or of later complication, without mention of misadventure at time of procedure acquired absence of intestine (large) (small) unspecified protein-calorie malnutrition hypopotassemia gastrostomy status car passenger injured in collision with heavy transport vehicle or bus in nontraffic accident methicillin susceptible staphylococcus aureus in conditions classified elsewhere and of unspecified site other specified procedures as the cause of abnormal reaction of patient, or of later complication, without mention of misadventure at time of procedure acquired absence of intestine (large) (small) bloodstream infection due to central venous catheter other neutropenia bacteremia other pancytopenia complications of transplanted intestine other and unspecified postsurgical nonabsorption personal history of venous thrombosis and embolism acute venous embolism and thrombosis of superficial veins of upper extremity chest pain, unspecified unspecified car occupant injured in collision with railway train or railway vehicle in nontraffic accident driver of special construction vehicle injured in traffic accident body mass index less than 19, adult gastrostomy status chills (without fever) unspecified pruritic disorder hypoglycemia, unspecified personal history of methicillin resistant staphylococcus aureus car passenger injured in collision with heavy transport vehicle or bus in nontraffic accident leukocytopenia, unspecified other malaise and fatigue alkalosis hyperosmolality and/or hypernatremia cirrhosis of liver without mention of alcohol intestinal bypass or anastomosis status other chronic pain vomiting alone
white m 30 $nan$nan$sodium chloride 0.9%  flush  10  ml ; ethanol 70% catheter dwell  2  ml ; heparin flush (10 units ml)  2  ml ; atropine sulfate 1%  1-2  drop ; sarna lotion  1  appl ; lorazepam  0.5-1  mg ; hydromorphone (dilaudid)  1  mg ; hydromorphone (dilaudid)  20  mg ; 
bloodstream infection due to central venous catheter gastrostomy status anemia, unspecified acute kidney failure, unspecified other pancytopenia hyperosmolality and/or hypernatremia car passenger injured in collision with heavy transport vehicle or bus in nontraffic accident cirrhosis of liver without mention of alcohol automatic implantable cardiac defibrillator in situ staphylococcus infection in conditions classified elsewhere and of unspecified site, other staphylococcus personal history of venous thrombosis and embolism complications of transplanted intestine bacteremia other specified procedures as the cause of abnormal reaction of patient, or of later complication, without mention of misadventure at time of procedure acquired absence of intestine (large) (small) unspecified protein-calorie malnutrition hypopotassemia gastrostomy status car passenger injured in collision with heavy transport vehicle or bus in nontraffic accident methicillin susceptible staphylococcus aureus in conditions classified elsewhere and of unspecified site other specified procedures as the cause of abnormal reaction of patient, or of later complication, without mention of misadventure at time of procedure acquired absence of intestine (large) (small) bloodstream infection due to central venous catheter other neutropenia bacteremia other pancytopenia complications of transplanted intestine other and unspecified postsurgical nonabsorption personal history of venous thrombosis and embolism acute venous embolism and thrombosis of superficial veins of upper extremity chest pain, unspecified unspecified car occupant injured in collision with railway train or railway vehicle in nontraffic accident driver of special construction vehicle injured in traffic accident body mass index less than 19, adult gastrostomy status chills (without fever) unspecified pruritic disorder hypoglycemia, unspecified personal history of methicillin resistant staphylococcus aureus car passenger injured in collision with heavy transport vehicle or bus in nontraffic accident leukocytopenia, unspecified other malaise and fatigue alkalosis hyperosmolality and/or hypernatremia cirrhosis of liver without mention of alcohol intestinal bypass or anastomosis status other chronic pain vomiting alone
white m 50 $nan$nan$omeprazole  20  mg ; phenelzine sulfate  60  mg ; lamotrigine  100  mg ; 
anemia, unspecified amphetamine or related acting sympathomimetic abuse, unspecified bariatric surgery status bipolar i disorder, most recent episode (or current) manic, unspecified
white m 50 $nan$nan$omeprazole  20  mg ; phenelzine sulfate  60  mg ; lamotrigine  100  mg ; milk of magnesia  30  ml ; acetaminophen  325  mg ; lamotrigine  25  mg ; quetiapine fumarate  75  mg ; lithium carbonate sr (lithobid)  300  mg ; phenelzine sulfate  15  mg ; 
anemia, unspecified amphetamine or related acting sympathomimetic abuse, unspecified bariatric surgery status bipolar i disorder, most recent episode (or current) manic, unspecified
white m 50 $nan$nan$omeprazole  20  mg ; phenelzine sulfate  60  mg ; lamotrigine  100  mg ; milk of magnesia  30  ml ; acetaminophen  325  mg ; quetiapine fumarate  75  mg ; lithium carbonate sr (lithobid)  300  mg ; 
anemia, unspecified amphetamine or related acting sympathomimetic abuse, unspecified bariatric surgery status bipolar i disorder, most recent episode (or current) manic, unspecified
white m 50 $nan$nan$omeprazole  20  mg ; phenelzine sulfate  60  mg ; lamotrigine  100  mg ; milk of magnesia  30  ml ; acetaminophen  325  mg ; quetiapine fumarate  75  mg ; lithium carbonate sr (lithobid)  300  mg ; 
anemia, unspecified amphetamine or related acting sympathomimetic abuse, unspecified bariatric surgery status bipolar i disorder, most recent episode (or current) manic, unspecified
white m 50 $temp  98.2  heartrate  57.0  resprate  18.0  o2sat  100.0  sbp  115.0  dbp  71.0  rhythm    pain  0  $hematology blood hematocrit  34.4  %; hematology blood hemoglobin  11.9  g dl; hematology blood platelet count  346  k ul; chemistry blood anion gap  14  meq l; chemistry blood bicarbonate  25  meq l; chemistry blood chloride  105  meq l; chemistry blood creatinine  1.0  mg dl; chemistry blood potassium  3.9  meq l; chemistry blood sodium  140  meq l; chemistry blood urea nitrogen  12  mg dl; chemistry blood calcium, total  9.2  mg dl; chemistry blood glucose  107  mg dl; chemistry blood % hemoglobin a1c  5.2  %$prazosin  1  mg ; prazosin  5  mg ; heparin  5000  unit ; sodium chloride 0.9%  flush  3  ml ; milk of magnesia  30  ml ; chlorpromazine  100  mg ; zolpidem tartrate  5  mg ; acetaminophen  650  mg ; docusate sodium  100  mg ; clonazepam  0.5  mg ; metoprolol tartrate  37.5  mg ; aspirin  325  mg ; atorvastatin  20  mg ; clopidogrel  75  mg ; multivitamins  1  tab ; polyethylene glycol  17  g ; thiamine  100  mg ; folic acid  1  mg ; hydrochlorothiazide  25  mg ; nicotine patch  14  mg ; lisinopril  40  mg ; 
 
white m 50 $nan$nan$prazosin  1  mg ; prazosin  5  mg ; heparin  5000  unit ; sodium chloride 0.9%  flush  3  ml ; milk of magnesia  30  ml ; acetaminophen  650  mg ; docusate sodium  100  mg ; clonazepam  0.5  mg ; metoprolol tartrate  37.5  mg ; aspirin  325  mg ; atorvastatin  20  mg ; clopidogrel  75  mg ; multivitamins  1  tab ; polyethylene glycol  17  g ; thiamine  100  mg ; folic acid  1  mg ; nicotine patch  14  mg ; prazosin  3  mg ; aluminum-magnesium hydrox.-simethicone  30  ml ; trazodone  50  mg ; 
 
white m 50 $nan$nan$prazosin  3  mg ; aluminum-magnesium hydrox.-simethicone  30  ml ; trazodone  50  mg ; benztropine mesylate  0.5  mg ; 
 
white m 69 $nan$hematology blood hematocrit  34.2  %; hematology blood hemoglobin  11.9  g dl; hematology blood platelet count  258  k ul; chemistry blood anion gap  9  meq l; chemistry blood bicarbonate  28  meq l; chemistry blood chloride  107  meq l; chemistry blood creatinine  0.8  mg dl; chemistry blood potassium  3.8  meq l; chemistry blood sodium  140  meq l; chemistry blood urea nitrogen  12  mg dl; chemistry blood calcium, total  8.1  mg dl; chemistry blood glucose  121  mg dl$metoprolol succinate xl  25  mg ; aspirin  81  mg ; rosuvastatin calcium  10  mg ; pneumococcal vac polyvalent  0.5  ml ; sodium chloride 0.9%  flush  3  ml ; d5 1 2ns  1000  ml ; morphine sulfate  2-4  mg ; oxycodone-acetaminophen  1-2  tab ; heparin  5000  unit ; d5w  250  ml ; nitroglycerin  100  mg ; 5% dextrose  250  ml ; phenylephrine  60  mg ; docusate sodium  100  mg ; 
 
white m 69 $nan$nan$metoprolol succinate xl  25  mg ; aspirin  81  mg ; rosuvastatin calcium  10  mg ; pneumococcal vac polyvalent  0.5  ml ; sodium chloride 0.9%  flush  3  ml ; d5 1 2ns  1000  ml ; morphine sulfate  2-4  mg ; oxycodone-acetaminophen  1-2  tab ; heparin  5000  unit ; d5w  250  ml ; nitroglycerin  100  mg ; 5% dextrose  250  ml ; phenylephrine  60  mg ; docusate sodium  100  mg ; potassium chloride  20  meq ; 
 
white f 54 $temp  99.5  heartrate  70.0  resprate  18.0  o2sat  98.0  sbp  152.0  dbp  61.0  rhythm    pain    $hematology blood hematocrit  35.4  %; hematology blood hemoglobin  11.2  g dl; hematology blood platelet count  177  k ul; chemistry blood anion gap  10  meq l; chemistry blood bicarbonate  26  meq l; chemistry blood chloride  105  meq l; chemistry blood creatinine  2.3  mg dl; chemistry blood potassium  3.9  meq l; chemistry blood sodium  137  meq l; chemistry blood urea nitrogen  44  mg dl; chemistry blood glucose  160  mg dl$0.45% sodium chloride  1000  ml ; heparin flush (10 units ml)  5  ml ; heparin flush (100 units ml)  5  ml ; acetaminophen  325-650  mg ; calcitriol  0.25  mcg ; zolpidem tartrate  5  mg ; heparin  5000  unit ; risperidone  3  mg ; fluticasone propionate 110mcg  2  puff ; sevelamer carbonate  800  mg ; miconazole powder 2%  1  appl ; aspirin  325  mg ; diltiazem extended-release  360  mg ; levothyroxine sodium  75  mcg ; metoprolol succinate xl  50  mg ; ferrous sulfate  325  mg ; aripiprazole  45  mg ; 
asthma, unspecified type, unspecified mild intellectual disabilities long-term (current) use of insulin hypertensive chronic kidney disease, unspecified, with chronic kidney disease stage i through stage iv, or unspecified other candidiasis of other specified sites other bone involvement in diseases classified elsewhere brachial plexus lesions chronic kidney disease, stage iv (severe) diabetes with other specified manifestations, type ii or unspecified type, not stated as uncontrolled acute kidney failure, unspecified ulcer of heel and midfoot secondary hyperparathyroidism (of renal origin) unspecified osteomyelitis, ankle and foot diabetes with renal manifestations, type ii or unspecified type, not stated as uncontrolled late effects of cerebrovascular disease, hemiplegia affecting unspecified side atrial fibrillation nonunion of fracture unspecified acquired hypothyroidism bipolar disorder, unspecified other psychotropic agents causing adverse effects in therapeutic use diarrhea anemia in chronic kidney disease disorder of bone and cartilage, unspecified other specified cardiac dysrhythmias suicidal ideation other specified diseases of blood and blood-forming organs bipolar i disorder, most recent episode (or current) depressed, severe, without mention of psychotic behavior hemiplegia, unspecified, affecting unspecified side disorder of bone and cartilage, unspecified obstructive sleep apnea (adult)(pediatric) other antihypertensive agents causing adverse effects in therapeutic use asthma, unspecified type, unspecified hypertensive chronic kidney disease, unspecified, with chronic kidney disease stage i through stage iv, or unspecified unspecified acquired hypothyroidism acute kidney failure, unspecified other and unspecified anticonvulsants causing adverse effects in therapeutic use other psychotropic agents causing adverse effects in therapeutic use brachial plexus lesions secondary hyperparathyroidism (of renal origin) polydipsia chronic kidney disease, stage iv (severe) diabetes mellitus without mention of complication, type ii or unspecified type, not stated as uncontrolled thrombocytopenia, unspecified other and unspecified agents primarily affecting the cardiovascular system causing adverse effects in therapeutic use diabetes insipidus other and unspecified hyperlipidemia other persistent mental disorders due to conditions classified elsewhere coronary vasodilators causing adverse effects in therapeutic use
white f 53 $nan$nan$omeprazole  20  mg ; hydrochlorothiazide  25  mg ; citalopram  20  mg ; levothyroxine sodium  75  mcg ; docusate sodium  100  mg ; 
esophageal reflux other tenosynovitis of hand and wrist other specified bacterial infections in conditions classified elsewhere and of unspecified site, other anaerobes unspecified acquired hypothyroidism depressive disorder, not elsewhere classified bacteroides fragilis cellulitis and abscess of foot, except toes cellulitis and abscess of finger, unspecified open wound of hand except finger(s) alone, complicated other specified bacterial infections in conditions classified elsewhere and of unspecified site, other gram-negative organisms myalgia and myositis, unspecified streptococcus infection in conditions classified elsewhere and of unspecified site, streptococcus, group d [enterococcus] cellulitis and abscess of hand, except fingers and thumb bite of other animal except arthropod
white f 53 $nan$hematology blood hematocrit  32.5  %; hematology blood hemoglobin  11.0  g dl; hematology blood platelet count  279  k ul$omeprazole  20  mg ; hydrochlorothiazide  25  mg ; citalopram  20  mg ; levothyroxine sodium  75  mcg ; docusate sodium  100  mg ; dicyclomine  20  mg ; amitriptyline  50  mg ; sodium chloride 0.9%  flush  3  ml ; potassium chl 40 meq   1000 ml ns  1000  ml ; acetaminophen  650  mg ; hydromorphone (dilaudid)  2-6  mg ; hydromorphone (dilaudid)  0.5  mg ; senna  1  tab ; alprazolam  0.5  mg ; potassium chl 20 meq   1000 ml ns  1000  ml ; potassium chl 20 meq   1000 ml d5 1 2 ns  1000  ml ; 0.9% sodium chloride (mini bag plus)  100  ml ; ampicillin-sulbactam  3  g ; meropenem  500  mg ; sulfameth trimethoprim ds  3  tab ; 
esophageal reflux other tenosynovitis of hand and wrist other specified bacterial infections in conditions classified elsewhere and of unspecified site, other anaerobes unspecified acquired hypothyroidism depressive disorder, not elsewhere classified bacteroides fragilis cellulitis and abscess of foot, except toes cellulitis and abscess of finger, unspecified open wound of hand except finger(s) alone, complicated other specified bacterial infections in conditions classified elsewhere and of unspecified site, other gram-negative organisms myalgia and myositis, unspecified streptococcus infection in conditions classified elsewhere and of unspecified site, streptococcus, group d [enterococcus] cellulitis and abscess of hand, except fingers and thumb bite of other animal except arthropod
white f 53 $nan$nan$omeprazole  20  mg ; hydrochlorothiazide  25  mg ; citalopram  20  mg ; levothyroxine sodium  75  mcg ; docusate sodium  100  mg ; dicyclomine  20  mg ; amitriptyline  50  mg ; sodium chloride 0.9%  flush  3  ml ; acetaminophen  650  mg ; hydromorphone (dilaudid)  2-6  mg ; hydromorphone (dilaudid)  0.5  mg ; senna  1  tab ; alprazolam  0.5  mg ; potassium chl 20 meq   1000 ml d5 1 2 ns  1000  ml ; 0.9% sodium chloride (mini bag plus)  100  ml ; ampicillin-sulbactam  3  g ; meropenem  500  mg ; sulfameth trimethoprim ds  3  tab ; ns  100  ml ; metronidazole (flagyl)  500  mg ; iso-osmotic sodium chloride  100  ml ; fluconazole  200  mg ; iso-osmotic dextrose  200  ml ; vancomycin  1000  mg ; iso-osmotic dextrose  50  ml ; ceftriaxone  1  gm ; hydromorphone (dilaudid)  0.5-2  mg ; cefepime  1  g ; 
esophageal reflux other tenosynovitis of hand and wrist other specified bacterial infections in conditions classified elsewhere and of unspecified site, other anaerobes unspecified acquired hypothyroidism depressive disorder, not elsewhere classified bacteroides fragilis cellulitis and abscess of foot, except toes cellulitis and abscess of finger, unspecified open wound of hand except finger(s) alone, complicated other specified bacterial infections in conditions classified elsewhere and of unspecified site, other gram-negative organisms myalgia and myositis, unspecified streptococcus infection in conditions classified elsewhere and of unspecified site, streptococcus, group d [enterococcus] cellulitis and abscess of hand, except fingers and thumb bite of other animal except arthropod
white f 53 $nan$hematology blood hematocrit  30.3  %; hematology blood hemoglobin  9.9  g dl; hematology blood platelet count  342  k ul$omeprazole  20  mg ; hydrochlorothiazide  25  mg ; citalopram  20  mg ; levothyroxine sodium  75  mcg ; docusate sodium  100  mg ; dicyclomine  20  mg ; amitriptyline  50  mg ; sodium chloride 0.9%  flush  3  ml ; acetaminophen  650  mg ; senna  1  tab ; alprazolam  0.5  mg ; potassium chl 20 meq   1000 ml d5 1 2 ns  1000  ml ; ns  100  ml ; metronidazole (flagyl)  500  mg ; iso-osmotic sodium chloride  100  ml ; fluconazole  200  mg ; iso-osmotic dextrose  200  ml ; vancomycin  1000  mg ; cefepime  1  g ; 
esophageal reflux other tenosynovitis of hand and wrist other specified bacterial infections in conditions classified elsewhere and of unspecified site, other anaerobes unspecified acquired hypothyroidism depressive disorder, not elsewhere classified bacteroides fragilis cellulitis and abscess of foot, except toes cellulitis and abscess of finger, unspecified open wound of hand except finger(s) alone, complicated other specified bacterial infections in conditions classified elsewhere and of unspecified site, other gram-negative organisms myalgia and myositis, unspecified streptococcus infection in conditions classified elsewhere and of unspecified site, streptococcus, group d [enterococcus] cellulitis and abscess of hand, except fingers and thumb bite of other animal except arthropod
white f 53 $nan$hematology blood hematocrit  28.8  %; hematology blood hemoglobin  9.6  g dl; hematology blood platelet count  376  k ul; chemistry blood anion gap  10  meq l; chemistry blood bicarbonate  32  meq l; chemistry blood chloride  103  meq l; chemistry blood creatinine  0.7  mg dl; chemistry blood potassium  3.8  meq l; chemistry blood sodium  141  meq l; chemistry blood urea nitrogen  6  mg dl; chemistry blood calcium, total  8.5  mg dl; chemistry blood glucose  96  mg dl$omeprazole  20  mg ; hydrochlorothiazide  25  mg ; citalopram  20  mg ; levothyroxine sodium  75  mcg ; docusate sodium  100  mg ; dicyclomine  20  mg ; amitriptyline  50  mg ; sodium chloride 0.9%  flush  3  ml ; senna  1  tab ; alprazolam  0.5  mg ; potassium chl 20 meq   1000 ml d5 1 2 ns  1000  ml ; ns  100  ml ; metronidazole (flagyl)  500  mg ; iso-osmotic dextrose  200  ml ; vancomycin  1000  mg ; citalopram  30  mg ; sodium chloride 0.9%  flush  10  ml ; 
esophageal reflux other tenosynovitis of hand and wrist other specified bacterial infections in conditions classified elsewhere and of unspecified site, other anaerobes unspecified acquired hypothyroidism depressive disorder, not elsewhere classified bacteroides fragilis cellulitis and abscess of foot, except toes cellulitis and abscess of finger, unspecified open wound of hand except finger(s) alone, complicated other specified bacterial infections in conditions classified elsewhere and of unspecified site, other gram-negative organisms myalgia and myositis, unspecified streptococcus infection in conditions classified elsewhere and of unspecified site, streptococcus, group d [enterococcus] cellulitis and abscess of hand, except fingers and thumb bite of other animal except arthropod
white f 53 $nan$hematology blood hematocrit  27.7  %; hematology blood hemoglobin  9.2  g dl; hematology blood platelet count  431  k ul$omeprazole  20  mg ; hydrochlorothiazide  25  mg ; citalopram  20  mg ; levothyroxine sodium  75  mcg ; docusate sodium  100  mg ; dicyclomine  20  mg ; amitriptyline  50  mg ; sodium chloride 0.9%  flush  3  ml ; senna  1  tab ; alprazolam  0.5  mg ; potassium chl 20 meq   1000 ml d5 1 2 ns  1000  ml ; citalopram  30  mg ; sodium chloride 0.9%  flush  10  ml ; 5% dextrose  100  ml ; tigecycline  100  mg ; nystatin oral suspension  5  ml ; tigecycline  50  mg ; ondansetron  4  mg ; 
esophageal reflux other tenosynovitis of hand and wrist other specified bacterial infections in conditions classified elsewhere and of unspecified site, other anaerobes unspecified acquired hypothyroidism depressive disorder, not elsewhere classified bacteroides fragilis cellulitis and abscess of foot, except toes cellulitis and abscess of finger, unspecified open wound of hand except finger(s) alone, complicated other specified bacterial infections in conditions classified elsewhere and of unspecified site, other gram-negative organisms myalgia and myositis, unspecified streptococcus infection in conditions classified elsewhere and of unspecified site, streptococcus, group d [enterococcus] cellulitis and abscess of hand, except fingers and thumb bite of other animal except arthropod
white f 53 $nan$nan$omeprazole  20  mg ; hydrochlorothiazide  25  mg ; levothyroxine sodium  75  mcg ; dicyclomine  20  mg ; amitriptyline  50  mg ; sodium chloride 0.9%  flush  3  ml ; senna  1  tab ; alprazolam  0.5  mg ; citalopram  30  mg ; sodium chloride 0.9%  flush  10  ml ; nystatin oral suspension  5  ml ; ondansetron  4  mg ; 
esophageal reflux other tenosynovitis of hand and wrist other specified bacterial infections in conditions classified elsewhere and of unspecified site, other anaerobes unspecified acquired hypothyroidism depressive disorder, not elsewhere classified bacteroides fragilis cellulitis and abscess of foot, except toes cellulitis and abscess of finger, unspecified open wound of hand except finger(s) alone, complicated other specified bacterial infections in conditions classified elsewhere and of unspecified site, other gram-negative organisms myalgia and myositis, unspecified streptococcus infection in conditions classified elsewhere and of unspecified site, streptococcus, group d [enterococcus] cellulitis and abscess of hand, except fingers and thumb bite of other animal except arthropod
black african american f 33 $nan$hematology blood hematocrit  40.1  %; hematology blood hemoglobin  13.6  g dl; hematology blood platelet count  231  k ul; chemistry blood anion gap  15  meq l; chemistry blood bicarbonate  24  meq l; chemistry blood chloride  105  meq l; chemistry blood creatinine  0.9  mg dl; chemistry blood potassium  3.8  meq l; chemistry blood sodium  140  meq l; chemistry blood urea nitrogen  17  mg dl; chemistry blood glucose  91  mg dl; hematology urine glucose  neg  mg dl; hematology urine bilirubin  neg  mg dl$nan
 
black african american f 33 $nan$hematology blood inr(pt)  1.1  $sodium chloride 0.9%  flush  3  ml ; morphine sulfate  2-4  mg ; potassium chl 20 meq   1000 ml d5ns  1000  ml ; oxycodone-acetaminophen  1-2  tab ; albuterol mdi  2  puff ; ondansetron  4  mg ; fluticasone-salmeterol  1  puff ; ketorolac  30  mg ; hydromorphone (dilaudid)  0.25  mg ; ketorolac  15  mg ; cyclobenzaprine  10  mg ; 
 
black african american f 33 $nan$hematology blood hematocrit  37.5  %; hematology blood hemoglobin  13.0  g dl; hematology blood platelet count  217  k ul; chemistry blood anion gap  9  meq l; chemistry blood bicarbonate  30  meq l; chemistry blood chloride  105  meq l; chemistry blood creatinine  0.9  mg dl; chemistry blood potassium  4.0  meq l; chemistry blood sodium  140  meq l; chemistry blood urea nitrogen  16  mg dl; chemistry blood calcium, total  9.2  mg dl; chemistry blood glucose  98  mg dl$sodium chloride 0.9%  flush  3  ml ; oxycodone-acetaminophen  1-2  tab ; albuterol mdi  2  puff ; ondansetron  4  mg ; fluticasone-salmeterol  1  puff ; hydromorphone (dilaudid)  0.25  mg ; ketorolac  15  mg ; cyclobenzaprine  10  mg ; tramadol (ultram)  50  mg ; methocarbamol  750  mg ; famotidine  20  mg ; 
 
black african american f 33 $nan$chemistry blood anion gap  10  meq l; chemistry blood bicarbonate  30  meq l; chemistry blood chloride  107  meq l; chemistry blood creatinine  1.0  mg dl; chemistry blood potassium  3.8  meq l; chemistry blood sodium  143  meq l; chemistry blood urea nitrogen  24  mg dl; chemistry blood calcium, total  9.0  mg dl; chemistry blood glucose  72  mg dl$sodium chloride 0.9%  flush  3  ml ; oxycodone-acetaminophen  1-2  tab ; albuterol mdi  2  puff ; ondansetron  4  mg ; fluticasone-salmeterol  1  puff ; ketorolac  15  mg ; tramadol (ultram)  50  mg ; methocarbamol  750  mg ; famotidine  20  mg ; heparin  5000  unit ; ibuprofen  800  mg ; docusate sodium  100  mg ; senna  1  tab ; tizanidine hcl  4  mg ; 
 
black african american f 33 $nan$nan$sodium chloride 0.9%  flush  3  ml ; oxycodone-acetaminophen  1-2  tab ; albuterol mdi  2  puff ; ondansetron  4  mg ; fluticasone-salmeterol  1  puff ; famotidine  20  mg ; heparin  5000  unit ; ibuprofen  800  mg ; docusate sodium  100  mg ; senna  1  tab ; tizanidine hcl  4  mg ; diazepam  2.5  mg ; gabapentin  300  mg ; prochlorperazine  5  mg ; 
 
black african american f 33 $nan$hematology blood hematocrit  36.6  %; hematology blood hemoglobin  12.6  g dl; hematology blood platelet count  179  k ul; chemistry blood anion gap  12  meq l; chemistry blood bicarbonate  28  meq l; chemistry blood chloride  104  meq l; chemistry blood creatinine  0.9  mg dl; chemistry blood potassium  4.2  meq l; chemistry blood sodium  140  meq l; chemistry blood urea nitrogen  13  mg dl; hematology blood inr(pt)  1.0  ; chemistry blood calcium, total  9.2  mg dl; chemistry blood bilirubin, total  0.2  mg dl; chemistry blood glucose  83  mg dl; chemistry blood lactate dehydrogenase (ld)  146  iu l; chemistry blood albumin  3.7  g dl$sodium chloride 0.9%  flush  3  ml ; oxycodone-acetaminophen  1-2  tab ; albuterol mdi  2  puff ; ondansetron  4  mg ; fluticasone-salmeterol  1  puff ; famotidine  20  mg ; heparin  5000  unit ; ibuprofen  800  mg ; docusate sodium  100  mg ; senna  1  tab ; diazepam  2.5  mg ; gabapentin  300  mg ; prochlorperazine  5  mg ; 
 
black african american f 33 $nan$nan$sodium chloride 0.9%  flush  3  ml ; oxycodone-acetaminophen  1-2  tab ; albuterol mdi  2  puff ; ondansetron  4  mg ; fluticasone-salmeterol  1  puff ; famotidine  20  mg ; heparin  5000  unit ; ibuprofen  800  mg ; docusate sodium  100  mg ; senna  1  tab ; gabapentin  300  mg ; bisacodyl  10  mg ; prochlorperazine  10  mg ; 
 
black african american f 33 $nan$hematology blood hematocrit  36.4  %; hematology blood hemoglobin  12.7  g dl; hematology blood platelet count  170  k ul; chemistry blood anion gap  13  meq l; chemistry blood bicarbonate  28  meq l; chemistry blood chloride  102  meq l; chemistry blood creatinine  1.0  mg dl; chemistry blood potassium  4.5  meq l; chemistry blood sodium  138  meq l; chemistry blood urea nitrogen  14  mg dl; chemistry blood calcium, total  9.2  mg dl; chemistry blood glucose  82  mg dl$sodium chloride 0.9%  flush  3  ml ; oxycodone-acetaminophen  1-2  tab ; albuterol mdi  2  puff ; ondansetron  4  mg ; fluticasone-salmeterol  1  puff ; famotidine  20  mg ; heparin  5000  unit ; ibuprofen  800  mg ; docusate sodium  100  mg ; senna  1  tab ; gabapentin  300  mg ; bisacodyl  10  mg ; prochlorperazine  10  mg ; 
 
white f 22 $nan$nan$bupro  150  mg ; adderall  10  mg ; 
 
white f 22 $nan$nan$bupro  150  mg ; adderall  10  mg ; sodium chloride 0.9%  flush  3  ml ; d5 1 2ns  1000  ml ; acetaminophen  325-650  mg ; iso-osmotic dextrose  50  ml ; cefazolin  1  g ; diphenhydramine  25  mg ; oxycodone-acetaminophen  1-2  tab ; 
 
white f 22 $nan$nan$bupro  150  mg ; adderall  10  mg ; sodium chloride 0.9%  flush  3  ml ; acetaminophen  325-650  mg ; iso-osmotic dextrose  50  ml ; cefazolin  1  g ; diphenhydramine  25  mg ; oxycodone-acetaminophen  1-2  tab ; senna  1  tab ; docusate sodium  100  mg ; 
 
white f 51 $temp  97.7  heartrate  105.0  resprate  18.0  o2sat  93.0  sbp  134.0  dbp  91.0  rhythm    pain  7  $hematology blood hematocrit  41.6  %; hematology blood hemoglobin  12.7  g dl; hematology blood platelet count  156  k ul; chemistry blood anion gap  14  meq l; chemistry blood bicarbonate  24  meq l; chemistry blood chloride  103  meq l; chemistry blood creatinine  0.8  mg dl; chemistry blood potassium  3.9  meq l; chemistry blood sodium  137  meq l; chemistry blood urea nitrogen  12  mg dl; hematology blood inr(pt)  1.1  ; chemistry blood calcium, total  7.8  mg dl; chemistry blood bilirubin, total  3.8  mg dl; chemistry blood glucose  129  mg dl; chemistry blood lactate dehydrogenase (ld)  405  iu l; hematology blood bands  13  %$sodium chloride 0.9%  flush  3  ml ; lactated ringers  1000  ml ; senna  8.6  mg ; hydromorphone (dilaudid)  0.5  mg ; ondansetron  4  mg ; ciprofloxacin hcl  500  mg ; 
 
white f 51 $nan$hematology blood hematocrit  39.7  %; hematology blood hemoglobin  12.3  g dl; hematology blood platelet count  157  k ul; chemistry blood anion gap  15  meq l; chemistry blood bicarbonate  25  meq l; chemistry blood chloride  100  meq l; chemistry blood creatinine  0.8  mg dl; chemistry blood potassium  3.9  meq l; chemistry blood sodium  136  meq l; chemistry blood urea nitrogen  10  mg dl; chemistry blood bilirubin, total  1.5  mg dl; chemistry blood glucose  116  mg dl$sodium chloride 0.9%  flush  3  ml ; senna  8.6  mg ; hydromorphone (dilaudid)  0.5  mg ; ondansetron  4  mg ; ciprofloxacin hcl  500  mg ; lorazepam  1  mg ; diphenhydramine  25  mg ; 
 
white f 51 $nan$hematology blood hematocrit  32.4  %; hematology blood hemoglobin  10.2  g dl; hematology blood platelet count  115  k ul; chemistry blood anion gap  16  meq l; chemistry blood bicarbonate  25  meq l; chemistry blood chloride  99  meq l; chemistry blood creatinine  0.6  mg dl; chemistry blood potassium  3.3  meq l; chemistry blood sodium  137  meq l; chemistry blood urea nitrogen  8  mg dl; hematology blood inr(pt)  1.2  ; chemistry blood bilirubin, total  0.9  mg dl; chemistry blood glucose  85  mg dl$sodium chloride 0.9%  flush  3  ml ; senna  8.6  mg ; hydromorphone (dilaudid)  0.5  mg ; ondansetron  4  mg ; ciprofloxacin hcl  500  mg ; lorazepam  1  mg ; diphenhydramine  25  mg ; heparin  5000  unit ; hydromorphone (dilaudid)  0.2-0.6  mg ; oxycodone (immediate release)  5-20  mg ; acetaminophen  500-1000  mg ; oxycodone--acetaminophen (5mg-325mg)  1-2  tab ; oxycodone (immediate release)  5-10  mg ; 
 
white f 51 $nan$nan$heparin  5000  unit ; 
 
black african american f 46 $nan$nan$olanzapine  10  mg ; citalopram hydrobromide  20  mg ; 
 
black african american f 46 $nan$hematology blood hematocrit  30.1  %; hematology blood hematocrit  30.4  %; hematology blood hemoglobin  9.8  g dl; hematology blood platelet count  449  k ul; chemistry blood anion gap  13  meq l; chemistry blood bicarbonate  23  meq l; chemistry blood chloride  110  meq l; chemistry blood creatinine  0.8  mg dl; chemistry blood potassium  3.8  meq l; chemistry blood sodium  142  meq l; chemistry blood urea nitrogen  5  mg dl; chemistry blood calcium, total  8.8  mg dl; chemistry blood glucose  117  mg dl$olanzapine  10  mg ; citalopram hydrobromide  20  mg ; sodium chloride 0.9%  flush  3  ml ; potassium chl 20 meq   1000 ml d5 1 2 ns  1000  ml ; ondansetron  4  mg ; morphine sulfate  2-4  mg ; heparin  5000  unit ; docusate sodium  100  mg ; carbatrol  800  mg ; levetiracetam  1500  mg ; metoclopramide  10  mg ; senna  2  tab ; carbatrol  600  mg ; zonisamide  300  mg ; acetaminophen  650  mg ; vial  1  vial ; pantoprazole sodium  40  mg ; 0.9% sodium chloride  500  ml ; potassium chloride  40  meq ; 0.9% sodium chloride  1000  ml ; 
 
black african american f 46 $nan$hematology blood hematocrit  30.0  %; hematology blood hemoglobin  9.8  g dl; hematology blood platelet count  409  k ul; chemistry blood anion gap  13  meq l; chemistry blood bicarbonate  23  meq l; chemistry blood chloride  110  meq l; chemistry blood creatinine  0.6  mg dl; chemistry blood potassium  3.1  meq l; chemistry blood sodium  143  meq l; chemistry blood urea nitrogen  4  mg dl; chemistry blood glucose  111  mg dl$olanzapine  10  mg ; citalopram hydrobromide  20  mg ; heparin  5000  unit ; docusate sodium  100  mg ; carbatrol  800  mg ; levetiracetam  1500  mg ; metoclopramide  10  mg ; senna  2  tab ; carbatrol  600  mg ; zonisamide  300  mg ; acetaminophen  650  mg ; vial  1  vial ; pantoprazole sodium  40  mg ; 0.9% sodium chloride  500  ml ; potassium chloride  40  meq ; 5% dextrose  500  ml ; pantoprazole  40  mg ; promethazine  25  mg ; 
 
black african american f 46 $nan$hematology blood hematocrit  30.6  %; hematology blood hemoglobin  9.9  g dl; hematology blood platelet count  424  k ul; chemistry blood anion gap  9  meq l; chemistry blood bicarbonate  27  meq l; chemistry blood chloride  109  meq l; chemistry blood creatinine  0.7  mg dl; chemistry blood potassium  3.9  meq l; chemistry blood sodium  141  meq l; chemistry blood urea nitrogen  4  mg dl; chemistry blood glucose  120  mg dl$olanzapine  10  mg ; citalopram hydrobromide  20  mg ; heparin  5000  unit ; docusate sodium  100  mg ; carbatrol  800  mg ; levetiracetam  1500  mg ; senna  2  tab ; carbatrol  600  mg ; zonisamide  300  mg ; acetaminophen  650  mg ; 5% dextrose  500  ml ; pantoprazole  40  mg ; promethazine  25  mg ; polyethylene glycol  17  g ; 
 
black african american f 46 $nan$nan$olanzapine  10  mg ; citalopram hydrobromide  20  mg ; heparin  5000  unit ; docusate sodium  100  mg ; carbatrol  800  mg ; levetiracetam  1500  mg ; senna  2  tab ; carbatrol  600  mg ; zonisamide  300  mg ; acetaminophen  650  mg ; pantoprazole  40  mg ; promethazine  25  mg ; polyethylene glycol  17  g ; 
 
unknown m 81 $nan$hematology blood hematocrit  33.8  %; hematology blood hemoglobin  11.0  g dl; hematology blood platelet count  178  k ul; chemistry blood anion gap  11  meq l; chemistry blood bicarbonate  25  meq l; chemistry blood chloride  106  meq l; chemistry blood creatinine  1.0  mg dl; chemistry blood potassium  3.9  meq l; chemistry blood sodium  138  meq l; chemistry blood urea nitrogen  12  mg dl; hematology blood inr(pt)  1.2  ; chemistry blood glucose  99  mg dl$nan
 
unknown m 81 $nan$hematology blood hematocrit  33.8  %; hematology blood hemoglobin  11.1  g dl; hematology blood platelet count  179  k ul; chemistry blood anion gap  13  meq l; chemistry blood bicarbonate  25  meq l; chemistry blood chloride  109  meq l; chemistry blood potassium  3.8  meq l; chemistry blood sodium  143  meq l; chemistry blood urea nitrogen  10  mg dl; hematology blood inr(pt)  1.1  ; chemistry blood glucose  92  mg dl; chemistry blood % hemoglobin a1c  5.3  %$pneumococcal vac polyvalent  0.5  ml ; sodium chloride 0.9%  flush  3  ml ; docusate sodium  100  mg ; hydralazine  10  mg ; metoprolol tartrate  5  mg ; acetaminophen  325-650  mg ; ondansetron  4  mg ; lisinopril  10  mg ; lisinopril  40  mg ; hydrochlorothiazide  25  mg ; omeprazole  20  mg ; 
 
unknown m 81 $nan$nan$pneumococcal vac polyvalent  0.5  ml ; sodium chloride 0.9%  flush  3  ml ; docusate sodium  100  mg ; hydralazine  10  mg ; acetaminophen  325-650  mg ; ondansetron  4  mg ; lisinopril  40  mg ; hydrochlorothiazide  25  mg ; omeprazole  20  mg ; heparin  5000  unit ; 
 
unknown m 81 $nan$nan$pneumococcal vac polyvalent  0.5  ml ; sodium chloride 0.9%  flush  3  ml ; docusate sodium  100  mg ; hydralazine  10  mg ; acetaminophen  325-650  mg ; ondansetron  4  mg ; lisinopril  40  mg ; hydrochlorothiazide  25  mg ; omeprazole  20  mg ; heparin  5000  unit ; 
 
unknown m 81 $nan$nan$sodium chloride 0.9%  flush  3  ml ; docusate sodium  100  mg ; hydralazine  10  mg ; acetaminophen  325-650  mg ; ondansetron  4  mg ; lisinopril  40  mg ; hydrochlorothiazide  25  mg ; omeprazole  20  mg ; heparin  5000  unit ; 
 
hispanic latino m 42 $temp    heartrate  106.0  resprate  16.0  o2sat  98.0  sbp  126.0  dbp  82.0  rhythm    pain    $hematology blood hematocrit  35.1  %; hematology blood hemoglobin  11.6  g dl; hematology blood platelet count  245  k ul; chemistry blood anion gap  15  meq l; chemistry blood bicarbonate  26  meq l; chemistry blood chloride  108  meq l; chemistry blood creatinine  0.7  mg dl; chemistry blood potassium  3.8  meq l; chemistry blood sodium  145  meq l; chemistry blood urea nitrogen  18  mg dl; hematology blood inr(pt)  1.0  ; chemistry blood bilirubin, indirect  1.8  mg dl; chemistry blood bilirubin, total  2.2  mg dl; chemistry blood glucose  100  mg dl; chemistry blood albumin  3.8  g dl; chemistry blood bilirubin, direct  0.4  mg dl$nan
chest pain, unspecified assault by unspecified means backache, unspecified alcoholic gastritis, with hemorrhage unspecified essential hypertension rash and other nonspecific skin eruption personal history of pulmonary embolism atrial flutter alcohol withdrawal old myocardial infarction nausea with vomiting acute alcoholic intoxication in alcoholism, continuous coronary atherosclerosis of native coronary artery congestive heart failure, unspecified atrial fibrillation other primary cardiomyopathies chronic systolic heart failure automatic implantable cardiac defibrillator in situ percutaneous transluminal coronary angioplasty status unspecified gastritis and gastroduodenitis, without mention of hemorrhage acute alcoholic intoxication in alcoholism, unspecified atrial flutter unspecified essential hypertension hypopotassemia driver of heavy transport vehicle injured in collision with pedestrian or animal in nontraffic accident coronary atherosclerosis of native coronary artery congestive heart failure, unspecified personal history of noncompliance with medical treatment, presenting hazards to health nonspecific elevation of levels of transaminase or lactic acid dehydrogenase [ldh] anemia, unspecified acute alcoholic hepatitis personal history of pulmonary embolism atrial fibrillation automatic implantable cardiac defibrillator in situ old myocardial infarction alcoholic fatty liver chronic systolic heart failure esophageal reflux lack of housing other and unspecified angina pectoris duodenitis, without mention of hemorrhage long-term (current) use of anticoagulants chronic systolic heart failure congestive heart failure, unspecified other chest pain personal history of pulmonary embolism automatic implantable cardiac defibrillator in situ alcohol withdrawal
hispanic latino m 42 $temp    heartrate  110.0  resprate  16.0  o2sat  96.0  sbp  145.0  dbp  90.0  rhythm    pain    $hematology blood hematocrit  34.3  %; hematology blood hemoglobin  11.0  g dl; hematology blood platelet count  242  k ul; chemistry blood anion gap  18  meq l; chemistry blood bicarbonate  24  meq l; chemistry blood chloride  103  meq l; chemistry blood creatinine  0.7  mg dl; chemistry blood potassium  3.9  meq l; chemistry blood sodium  141  meq l; chemistry blood urea nitrogen  14  mg dl; hematology blood inr(pt)  1.0  ; chemistry blood calcium, total  8.1  mg dl; chemistry blood bilirubin, total  2.5  mg dl; chemistry blood glucose  102  mg dl; chemistry blood lactate dehydrogenase (ld)  304  iu l$influenza virus vaccine  0.5  ml ; sodium chloride 0.9%  flush  3  ml ; enoxaparin sodium  80  mg ; acetaminophen  325-650  mg ; senna  1  tab ; ondansetron  4  mg ; d5 1 2ns  1000  ml ; lorazepam  1  mg ; oxycodone (immediate release)   5  mg ; furosemide  40  mg ; docusate sodium  100  mg ; metoprolol tartrate  25  mg ; omeprazole  20  mg ; aspirin  81  mg ; losartan potassium  25  mg ; simvastatin  10  mg ; multivitamins  1  tab ; thiamine  100  mg ; diazepam  5-10  mg ; prochlorperazine  5-10  mg ; omeprazole  40  mg ; 
chest pain, unspecified assault by unspecified means backache, unspecified alcoholic gastritis, with hemorrhage unspecified essential hypertension rash and other nonspecific skin eruption personal history of pulmonary embolism atrial flutter alcohol withdrawal old myocardial infarction nausea with vomiting acute alcoholic intoxication in alcoholism, continuous coronary atherosclerosis of native coronary artery congestive heart failure, unspecified atrial fibrillation other primary cardiomyopathies chronic systolic heart failure automatic implantable cardiac defibrillator in situ percutaneous transluminal coronary angioplasty status unspecified gastritis and gastroduodenitis, without mention of hemorrhage acute alcoholic intoxication in alcoholism, unspecified atrial flutter unspecified essential hypertension hypopotassemia driver of heavy transport vehicle injured in collision with pedestrian or animal in nontraffic accident coronary atherosclerosis of native coronary artery congestive heart failure, unspecified personal history of noncompliance with medical treatment, presenting hazards to health nonspecific elevation of levels of transaminase or lactic acid dehydrogenase [ldh] anemia, unspecified acute alcoholic hepatitis personal history of pulmonary embolism atrial fibrillation automatic implantable cardiac defibrillator in situ old myocardial infarction alcoholic fatty liver chronic systolic heart failure esophageal reflux lack of housing other and unspecified angina pectoris duodenitis, without mention of hemorrhage long-term (current) use of anticoagulants chronic systolic heart failure congestive heart failure, unspecified other chest pain personal history of pulmonary embolism automatic implantable cardiac defibrillator in situ alcohol withdrawal
hispanic latino m 42 $nan$hematology blood hematocrit  40.2  %; hematology blood hemoglobin  12.8  g dl; hematology blood platelet count  246  k ul; chemistry blood anion gap  16  meq l; chemistry blood bicarbonate  27  meq l; chemistry blood chloride  95  meq l; chemistry blood creatinine  0.9  mg dl; chemistry blood potassium  2.9  meq l; chemistry blood sodium  135  meq l; chemistry blood urea nitrogen  12  mg dl; chemistry blood calcium, total  8.1  mg dl; chemistry blood bilirubin, total  2.9  mg dl; chemistry blood glucose  109  mg dl; chemistry blood lactate dehydrogenase (ld)  265  iu l$influenza virus vaccine  0.5  ml ; sodium chloride 0.9%  flush  3  ml ; acetaminophen  325-650  mg ; senna  1  tab ; ondansetron  4  mg ; oxycodone (immediate release)   5  mg ; furosemide  40  mg ; docusate sodium  100  mg ; metoprolol tartrate  25  mg ; aspirin  81  mg ; losartan potassium  25  mg ; simvastatin  10  mg ; multivitamins  1  tab ; thiamine  100  mg ; diazepam  5-10  mg ; prochlorperazine  5-10  mg ; omeprazole  40  mg ; 0.9% sodium chloride  500  ml ; potassium chloride  40  meq ; bag  100  ml ; magnesium sulfate  4  gm ; magnesium oxide  800  mg ; dabigatran etexilate  150  mg ; 
chest pain, unspecified assault by unspecified means backache, unspecified alcoholic gastritis, with hemorrhage unspecified essential hypertension rash and other nonspecific skin eruption personal history of pulmonary embolism atrial flutter alcohol withdrawal old myocardial infarction nausea with vomiting acute alcoholic intoxication in alcoholism, continuous coronary atherosclerosis of native coronary artery congestive heart failure, unspecified atrial fibrillation other primary cardiomyopathies chronic systolic heart failure automatic implantable cardiac defibrillator in situ percutaneous transluminal coronary angioplasty status unspecified gastritis and gastroduodenitis, without mention of hemorrhage acute alcoholic intoxication in alcoholism, unspecified atrial flutter unspecified essential hypertension hypopotassemia driver of heavy transport vehicle injured in collision with pedestrian or animal in nontraffic accident coronary atherosclerosis of native coronary artery congestive heart failure, unspecified personal history of noncompliance with medical treatment, presenting hazards to health nonspecific elevation of levels of transaminase or lactic acid dehydrogenase [ldh] anemia, unspecified acute alcoholic hepatitis personal history of pulmonary embolism atrial fibrillation automatic implantable cardiac defibrillator in situ old myocardial infarction alcoholic fatty liver chronic systolic heart failure esophageal reflux lack of housing other and unspecified angina pectoris duodenitis, without mention of hemorrhage long-term (current) use of anticoagulants chronic systolic heart failure congestive heart failure, unspecified other chest pain personal history of pulmonary embolism automatic implantable cardiac defibrillator in situ alcohol withdrawal
white m 52 $temp  98.8  heartrate  115.0  resprate  18.0  o2sat  98.0  sbp  110.0  dbp  82.0  rhythm    pain  0  $nan$sodium chloride 0.9%  flush  3  ml ; potassium chl 20 meq   1000 ml d5 1 2 ns  1000  ml ; morphine sulfate  2-4  mg ; perphenazine  4  mg ; 0.9% sodium chloride  100  ml ; cefazolin  2  g ; metoprolol tartrate  100  mg ; levothyroxine sodium  175  mcg ; clozapine  100  mg ; lactated ringers  1000  ml ; hydromorphone  20  mg ; oxycodone (immediate release)   5-10  mg ; acetaminophen  650  mg ; aluminum-magnesium hydrox.-simethicone  15-30  ml ; bisacodyl  10  mg ; milk of magnesia  30  ml ; promethazine  12.5-25  mg ; ondansetron  4  mg ; docusate sodium  100  mg ; senna  1  tab ; enoxaparin sodium  40  mg ; clozapine  200  mg ; lorazepam  0.5-1  mg ; 
 
white m 52 $nan$hematology blood hematocrit  27.0  %; hematology blood hemoglobin  9.4  g dl; hematology blood platelet count  110  k ul; chemistry blood anion gap  9  meq l; chemistry blood bicarbonate  30  meq l; chemistry blood chloride  105  meq l; chemistry blood creatinine  1.4  mg dl; chemistry blood potassium  3.9  meq l; chemistry blood sodium  140  meq l; chemistry blood urea nitrogen  22  mg dl; hematology urine wbc  1  # hpf; chemistry blood calcium, total  8.4  mg dl; chemistry blood glucose  148  mg dl$sodium chloride 0.9%  flush  3  ml ; perphenazine  4  mg ; 0.9% sodium chloride  100  ml ; cefazolin  2  g ; metoprolol tartrate  100  mg ; levothyroxine sodium  175  mcg ; clozapine  100  mg ; hydromorphone  20  mg ; oxycodone (immediate release)   5-10  mg ; acetaminophen  650  mg ; aluminum-magnesium hydrox.-simethicone  15-30  ml ; bisacodyl  10  mg ; milk of magnesia  30  ml ; promethazine  12.5-25  mg ; ondansetron  4  mg ; docusate sodium  100  mg ; senna  1  tab ; enoxaparin sodium  40  mg ; clozapine  200  mg ; lorazepam  0.5-1  mg ; 
 
white m 52 $nan$hematology blood hematocrit  38.1  %; hematology blood hematocrit  28.6  %; hematology blood hematocrit  29.4  %; hematology blood hemoglobin  12.3  g dl; hematology blood hemoglobin  9.7  g dl; hematology blood platelet count  288  k ul; hematology blood platelet count  130  k ul; chemistry blood anion gap  15  meq l; chemistry blood anion gap  10  meq l; chemistry blood anion gap  9  meq l; chemistry blood bicarbonate  28  meq l; chemistry blood bicarbonate  30  meq l; chemistry blood bicarbonate  31  meq l; chemistry blood chloride  99  meq l; chemistry blood chloride  102  meq l; chemistry blood chloride  102  meq l; chemistry blood creatinine  0.8  mg dl; chemistry blood creatinine  1.5  mg dl; chemistry blood creatinine  1.6  mg dl; chemistry blood potassium  4.4  meq l; chemistry blood potassium  4.2  meq l; chemistry blood potassium  4.0  meq l; chemistry blood sodium  138  meq l; chemistry blood sodium  138  meq l; chemistry blood sodium  138  meq l; chemistry blood urea nitrogen  10  mg dl; chemistry blood urea nitrogen  21  mg dl; chemistry blood urea nitrogen  23  mg dl; chemistry blood calcium, total  8.7  mg dl; chemistry blood calcium, total  8.4  mg dl; chemistry blood calcium, total  8.6  mg dl; chemistry blood glucose  218  mg dl; chemistry blood glucose  179  mg dl; chemistry blood glucose  81  mg dl$sodium chloride 0.9%  flush  3  ml ; perphenazine  4  mg ; metoprolol tartrate  100  mg ; levothyroxine sodium  175  mcg ; clozapine  100  mg ; oxycodone (immediate release)   5-10  mg ; acetaminophen  650  mg ; aluminum-magnesium hydrox.-simethicone  15-30  ml ; bisacodyl  10  mg ; milk of magnesia  30  ml ; promethazine  12.5-25  mg ; ondansetron  4  mg ; docusate sodium  100  mg ; senna  1  tab ; enoxaparin sodium  40  mg ; clozapine  200  mg ; lorazepam  0.5-1  mg ; 0.9% sodium chloride  500  ml ; potassium chl 20 meq   1000 ml ns  1000  ml ; 
 
white m 52 $nan$hematology blood hematocrit  25.3  %; hematology blood hematocrit  25.0  %; hematology blood hemoglobin  8.6  g dl; hematology blood platelet count  135  k ul; chemistry blood anion gap  12  meq l; chemistry blood bicarbonate  26  meq l; chemistry blood chloride  107  meq l; chemistry blood creatinine  1.3  mg dl; chemistry blood creatinine  1.3  mg dl; chemistry blood potassium  4.0  meq l; chemistry blood sodium  141  meq l; chemistry blood urea nitrogen  21  mg dl; chemistry blood urea nitrogen  20  mg dl; chemistry blood calcium, total  8.0  mg dl; chemistry blood glucose  255  mg dl$sodium chloride 0.9%  flush  3  ml ; perphenazine  4  mg ; metoprolol tartrate  100  mg ; levothyroxine sodium  175  mcg ; clozapine  100  mg ; oxycodone (immediate release)   5-10  mg ; acetaminophen  650  mg ; aluminum-magnesium hydrox.-simethicone  15-30  ml ; bisacodyl  10  mg ; milk of magnesia  30  ml ; promethazine  12.5-25  mg ; ondansetron  4  mg ; docusate sodium  100  mg ; senna  1  tab ; enoxaparin sodium  40  mg ; clozapine  200  mg ; lorazepam  0.5-1  mg ; potassium chl 20 meq   1000 ml ns  1000  ml ; 
 
black african american f 42 $nan$nan$atenolol  100  mg ; furosemide  40  mg ; lisinopril  40  mg ; nifedipine cr  90  mg ; 
morbid obesity pain in joint, lower leg unspecified essential hypertension asthma, unspecified type, unspecified other lymphedema osteoarthrosis, localized, primary, lower leg leukocytosis, unspecified iron deficiency anemia, unspecified cellulitis and abscess of leg, except foot morbid obesity other lymphedema unspecified essential hypertension asthma, unspecified type, unspecified other lymphedema morbid obesity unspecified essential hypertension asthma, unspecified type, unspecified cellulitis and abscess of leg, except foot
black african american f 42 $nan$hematology blood hematocrit  32.4  %; hematology blood hemoglobin  11.3  g dl; hematology blood platelet count  234  k ul; chemistry blood anion gap  11  meq l; chemistry blood bicarbonate  27  meq l; chemistry blood chloride  101  meq l; chemistry blood creatinine  1.2  mg dl; chemistry blood potassium  3.9  meq l; chemistry blood sodium  135  meq l; chemistry blood urea nitrogen  16  mg dl; chemistry blood glucose  94  mg dl$atenolol  100  mg ; furosemide  40  mg ; lisinopril  40  mg ; nifedipine cr  90  mg ; 0.9% sodium chloride  1000  ml ; sodium chloride 0.9%  flush  3  ml ; albuterol mdi  1-2  puff ; acetaminophen  650  mg ; ibuprofen  800  mg ; levofloxacin  500  mg ; ipratropium bromide neb  1  neb ; acetaminophen w codeine  1-2  tab ; fluticasone propionate 110mcg  2  puff ; 
morbid obesity pain in joint, lower leg unspecified essential hypertension asthma, unspecified type, unspecified other lymphedema osteoarthrosis, localized, primary, lower leg leukocytosis, unspecified iron deficiency anemia, unspecified cellulitis and abscess of leg, except foot morbid obesity other lymphedema unspecified essential hypertension asthma, unspecified type, unspecified other lymphedema morbid obesity unspecified essential hypertension asthma, unspecified type, unspecified cellulitis and abscess of leg, except foot
black african american f 42 $nan$chemistry blood creatinine  1.2  mg dl; chemistry blood urea nitrogen  16  mg dl$atenolol  100  mg ; lisinopril  40  mg ; nifedipine cr  90  mg ; sodium chloride 0.9%  flush  3  ml ; albuterol mdi  1-2  puff ; acetaminophen  650  mg ; levofloxacin  500  mg ; ipratropium bromide neb  1  neb ; acetaminophen w codeine  1-2  tab ; fluticasone propionate 110mcg  2  puff ; 
morbid obesity pain in joint, lower leg unspecified essential hypertension asthma, unspecified type, unspecified other lymphedema osteoarthrosis, localized, primary, lower leg leukocytosis, unspecified iron deficiency anemia, unspecified cellulitis and abscess of leg, except foot morbid obesity other lymphedema unspecified essential hypertension asthma, unspecified type, unspecified other lymphedema morbid obesity unspecified essential hypertension asthma, unspecified type, unspecified cellulitis and abscess of leg, except foot
black african american m 47 $temp  98.6  heartrate  90.0  resprate  18.0  o2sat  99.0  sbp  160.0  dbp  84.0  rhythm    pain  8  $hematology blood hematocrit  36.1  %; hematology blood hemoglobin  11.9  g dl; hematology blood platelet count  100  k ul; chemistry blood anion gap  9  meq l; chemistry blood bicarbonate  29  meq l; chemistry blood chloride  102  meq l; chemistry blood creatinine  0.6  mg dl; chemistry blood potassium  4.2  meq l; chemistry blood sodium  140  meq l; chemistry blood urea nitrogen  11  mg dl; chemistry blood calcium, total  9.1  mg dl; chemistry blood glucose  100  mg dl$heparin  5000  unit ; sodium chloride 0.9%  flush  3-10  ml ; acetaminophen  650  mg ; amphetamine-dextroamphetamine  20  mg ; bupropion (sustained release)  150  mg ; gabapentin  800  mg ; hydrochlorothiazide  12.5  mg ; polyethylene glycol  17  g ; hydromorphone (dilaudid)  4  mg ; nicotine polacrilex  2  mg ; iso-osmotic dextrose  200  ml ; vancomycin  1000  mg ; bag  1  bag ; magnesium sulfate  2  gm ; methadone  10  mg ; lidocaine 1%  10  ml ; 
cellulitis of left upper limb essential (primary) hypertension methicillin resistant staphylococcus aureus infection as the cause of diseases classified elsewhere attention-deficit hyperactivity disorder, unspecified type unspecified viral hepatitis c without hepatic coma cutaneous abscess of left upper limb other chronic pain anemia, unspecified homelessness nicotine dependence, cigarettes, uncomplicated opioid use, unspecified, uncomplicated major depressive disorder, single episode, unspecified thrombocytopenia, unspecified essential (primary) hypertension infective myositis, other site personal history of other infectious and parasitic diseases other specified bacterial agents as the cause of diseases classified elsewhere major depressive disorder, single episode, unspecified attention-deficit hyperactivity disorder, unspecified type polyneuropathy, unspecified opioid dependence, in remission 
black african american m 47 $nan$hematology blood hematocrit  38.6  %; hematology blood hemoglobin  12.8  g dl; hematology blood platelet count  87  k ul; chemistry blood anion gap  17  meq l; chemistry blood bicarbonate  23  meq l; chemistry blood chloride  102  meq l; chemistry blood creatinine  0.7  mg dl; chemistry blood potassium  3.9  meq l; chemistry blood sodium  142  meq l; chemistry blood urea nitrogen  14  mg dl; chemistry blood calcium, total  9.2  mg dl; chemistry blood bilirubin, total  0.2  mg dl; chemistry blood glucose  103  mg dl$heparin  5000  unit ; sodium chloride 0.9%  flush  3-10  ml ; acetaminophen  650  mg ; amphetamine-dextroamphetamine  20  mg ; bupropion (sustained release)  150  mg ; gabapentin  800  mg ; hydrochlorothiazide  12.5  mg ; polyethylene glycol  17  g ; hydromorphone (dilaudid)  4  mg ; nicotine polacrilex  2  mg ; bag  1  bag ; magnesium sulfate  2  gm ; methadone  10  mg ; lidocaine 1%  10  ml ; methadone  40  mg ; magnesium oxide  400  mg ; acetaminophen  1000  mg ; 0.9% sodium chloride  500  ml ; vancomycin  1500  mg ; sulfameth trimethoprim ds  2  tab ; 
cellulitis of left upper limb essential (primary) hypertension methicillin resistant staphylococcus aureus infection as the cause of diseases classified elsewhere attention-deficit hyperactivity disorder, unspecified type unspecified viral hepatitis c without hepatic coma cutaneous abscess of left upper limb other chronic pain anemia, unspecified homelessness nicotine dependence, cigarettes, uncomplicated opioid use, unspecified, uncomplicated major depressive disorder, single episode, unspecified thrombocytopenia, unspecified essential (primary) hypertension infective myositis, other site personal history of other infectious and parasitic diseases other specified bacterial agents as the cause of diseases classified elsewhere major depressive disorder, single episode, unspecified attention-deficit hyperactivity disorder, unspecified type polyneuropathy, unspecified opioid dependence, in remission 
black african american m 47 $nan$hematology blood hematocrit  41.8  %; hematology blood hemoglobin  13.9  g dl; hematology blood platelet count  82  k ul; chemistry blood anion gap  13  meq l; chemistry blood bicarbonate  26  meq l; chemistry blood chloride  100  meq l; chemistry blood creatinine  0.7  mg dl; chemistry blood potassium  4.3  meq l; chemistry blood sodium  139  meq l; chemistry blood urea nitrogen  15  mg dl; chemistry blood calcium, total  9.4  mg dl; chemistry blood glucose  85  mg dl$heparin  5000  unit ; sodium chloride 0.9%  flush  3-10  ml ; amphetamine-dextroamphetamine  20  mg ; bupropion (sustained release)  150  mg ; gabapentin  800  mg ; hydrochlorothiazide  12.5  mg ; polyethylene glycol  17  g ; nicotine polacrilex  2  mg ; methadone  40  mg ; magnesium oxide  400  mg ; acetaminophen  1000  mg ; sulfameth trimethoprim ds  2  tab ; hydromorphone (dilaudid)  2  mg ; 
cellulitis of left upper limb essential (primary) hypertension methicillin resistant staphylococcus aureus infection as the cause of diseases classified elsewhere attention-deficit hyperactivity disorder, unspecified type unspecified viral hepatitis c without hepatic coma cutaneous abscess of left upper limb other chronic pain anemia, unspecified homelessness nicotine dependence, cigarettes, uncomplicated opioid use, unspecified, uncomplicated major depressive disorder, single episode, unspecified thrombocytopenia, unspecified essential (primary) hypertension infective myositis, other site personal history of other infectious and parasitic diseases other specified bacterial agents as the cause of diseases classified elsewhere major depressive disorder, single episode, unspecified attention-deficit hyperactivity disorder, unspecified type polyneuropathy, unspecified opioid dependence, in remission 
black african american m 47 $nan$hematology blood hematocrit  38.4  %; hematology blood hemoglobin  12.8  g dl; hematology blood platelet count  73  k ul$heparin  5000  unit ; sodium chloride 0.9%  flush  3-10  ml ; amphetamine-dextroamphetamine  20  mg ; bupropion (sustained release)  150  mg ; gabapentin  800  mg ; hydrochlorothiazide  12.5  mg ; polyethylene glycol  17  g ; nicotine polacrilex  2  mg ; methadone  40  mg ; acetaminophen  1000  mg ; sulfameth trimethoprim ds  2  tab ; hydromorphone (dilaudid)  2  mg ; 
cellulitis of left upper limb essential (primary) hypertension methicillin resistant staphylococcus aureus infection as the cause of diseases classified elsewhere attention-deficit hyperactivity disorder, unspecified type unspecified viral hepatitis c without hepatic coma cutaneous abscess of left upper limb other chronic pain anemia, unspecified homelessness nicotine dependence, cigarettes, uncomplicated opioid use, unspecified, uncomplicated major depressive disorder, single episode, unspecified thrombocytopenia, unspecified essential (primary) hypertension infective myositis, other site personal history of other infectious and parasitic diseases other specified bacterial agents as the cause of diseases classified elsewhere major depressive disorder, single episode, unspecified attention-deficit hyperactivity disorder, unspecified type polyneuropathy, unspecified opioid dependence, in remission 
black african american m 47 $nan$nan$heparin  5000  unit ; sodium chloride 0.9%  flush  3-10  ml ; amphetamine-dextroamphetamine  20  mg ; bupropion (sustained release)  150  mg ; gabapentin  800  mg ; hydrochlorothiazide  12.5  mg ; polyethylene glycol  17  g ; nicotine polacrilex  2  mg ; methadone  40  mg ; acetaminophen  1000  mg ; sulfameth trimethoprim ds  2  tab ; hydromorphone (dilaudid)  2  mg ; 
cellulitis of left upper limb essential (primary) hypertension methicillin resistant staphylococcus aureus infection as the cause of diseases classified elsewhere attention-deficit hyperactivity disorder, unspecified type unspecified viral hepatitis c without hepatic coma cutaneous abscess of left upper limb other chronic pain anemia, unspecified homelessness nicotine dependence, cigarettes, uncomplicated opioid use, unspecified, uncomplicated major depressive disorder, single episode, unspecified thrombocytopenia, unspecified essential (primary) hypertension infective myositis, other site personal history of other infectious and parasitic diseases other specified bacterial agents as the cause of diseases classified elsewhere major depressive disorder, single episode, unspecified attention-deficit hyperactivity disorder, unspecified type polyneuropathy, unspecified opioid dependence, in remission 
black african american m 47 $nan$nan$heparin  5000  unit ; sodium chloride 0.9%  flush  3-10  ml ; amphetamine-dextroamphetamine  20  mg ; bupropion (sustained release)  150  mg ; gabapentin  800  mg ; hydrochlorothiazide  12.5  mg ; polyethylene glycol  17  g ; nicotine polacrilex  2  mg ; methadone  40  mg ; acetaminophen  1000  mg ; sulfameth trimethoprim ds  2  tab ; hydromorphone (dilaudid)  2  mg ; 
cellulitis of left upper limb essential (primary) hypertension methicillin resistant staphylococcus aureus infection as the cause of diseases classified elsewhere attention-deficit hyperactivity disorder, unspecified type unspecified viral hepatitis c without hepatic coma cutaneous abscess of left upper limb other chronic pain anemia, unspecified homelessness nicotine dependence, cigarettes, uncomplicated opioid use, unspecified, uncomplicated major depressive disorder, single episode, unspecified thrombocytopenia, unspecified essential (primary) hypertension infective myositis, other site personal history of other infectious and parasitic diseases other specified bacterial agents as the cause of diseases classified elsewhere major depressive disorder, single episode, unspecified attention-deficit hyperactivity disorder, unspecified type polyneuropathy, unspecified opioid dependence, in remission 
white m 79 $temp  96.8  heartrate  72.0  resprate  14.0  o2sat  100.0  sbp  149.0  dbp  70.0  rhythm    pain  4  ; temp  98.1  heartrate  68.0  resprate  16.0  o2sat  100.0  sbp  132.0  dbp  69.0  rhythm    pain    $nan$pravastatin  40  mg ; metoprolol succinate xl  50  mg ; megestrol acetate  800  mg ; citalopram  40  mg ; enoxaparin sodium  80  mg ; 
esophageal reflux atrial fibrillation depressive disorder, not elsewhere classified cellulitis and abscess of upper arm and forearm osteoarthrosis, localized, not specified whether primary or secondary, forearm malignant neoplasm of duodenum benign essential hypertension other and unspecified hyperlipidemia congestive heart failure, unspecified chondrocalcinosis, due to pyrophosphate crystals, forearm paralytic ileus malignant neoplasm of pancreas, part unspecified atrial fibrillation personal history of tobacco use gout, unspecified other disorders of calcium metabolism secondary and unspecified malignant neoplasm of intra-abdominal lymph nodes persistent vomiting paroxysmal ventricular tachycardia coronary atherosclerosis of native coronary artery chronic diastolic heart failure macroglobulinemia acquired hypertrophic pyloric stenosis long-term (current) use of anticoagulants other and unspecified hyperlipidemia unspecified essential hypertension secondary malignant neoplasm of small intestine including duodenum chronic cholecystitis secondary malignant neoplasm of other specified sites other fluid overload unspecified essential hypertension chronic or unspecified gastric ulcer with hemorrhage, without mention of obstruction long-term (current) use of anticoagulants atrial fibrillation gout, unspecified precipitous drop in hematocrit other and unspecified hyperlipidemia 
white m 79 $nan$hematology blood hematocrit  29.2  %; hematology blood hemoglobin  9.7  g dl; hematology blood platelet count  188  k ul; chemistry blood anion gap  10  meq l; chemistry blood bicarbonate  26  meq l; chemistry blood chloride  100  meq l; chemistry blood creatinine  0.6  mg dl; chemistry blood potassium  4.4  meq l; chemistry blood sodium  132  meq l; chemistry blood urea nitrogen  15  mg dl; chemistry blood calcium, total  7.3  mg dl; chemistry blood albumin  2.8  g dl$iso-osmotic dextrose  200  ml ; pravastatin  40  mg ; metoprolol succinate xl  50  mg ; megestrol acetate  800  mg ; citalopram  40  mg ; enoxaparin sodium  80  mg ; verapamil sr  120  mg ; metoclopramide  10-20  mg ; lorazepam  0.5-1  mg ; sodium chloride 0.9%  flush  3  ml ; 0.9% sodium chloride  1000  ml ; oxycodone (immediate release)   5  mg ; acetaminophen  650  mg ; hydromorphone (dilaudid)  0.125  mg ; senna  1  tab ; 0.9% sodium chloride (mini bag plus)  100  ml ; ampicillin-sulbactam  3  g ; omeprazole  40  mg ; docusate sodium  100  mg ; vancomycin  1000  mg ; xeloda  1000  mg ; metoclopramide  5  mg ; 
esophageal reflux atrial fibrillation depressive disorder, not elsewhere classified cellulitis and abscess of upper arm and forearm osteoarthrosis, localized, not specified whether primary or secondary, forearm malignant neoplasm of duodenum benign essential hypertension other and unspecified hyperlipidemia congestive heart failure, unspecified chondrocalcinosis, due to pyrophosphate crystals, forearm paralytic ileus malignant neoplasm of pancreas, part unspecified atrial fibrillation personal history of tobacco use gout, unspecified other disorders of calcium metabolism secondary and unspecified malignant neoplasm of intra-abdominal lymph nodes persistent vomiting paroxysmal ventricular tachycardia coronary atherosclerosis of native coronary artery chronic diastolic heart failure macroglobulinemia acquired hypertrophic pyloric stenosis long-term (current) use of anticoagulants other and unspecified hyperlipidemia unspecified essential hypertension secondary malignant neoplasm of small intestine including duodenum chronic cholecystitis secondary malignant neoplasm of other specified sites other fluid overload unspecified essential hypertension chronic or unspecified gastric ulcer with hemorrhage, without mention of obstruction long-term (current) use of anticoagulants atrial fibrillation gout, unspecified precipitous drop in hematocrit other and unspecified hyperlipidemia 
white m 79 $nan$hematology blood hematocrit  28.4  %; hematology blood hemoglobin  9.6  g dl; hematology blood platelet count  182  k ul; chemistry blood anion gap  11  meq l; chemistry blood bicarbonate  26  meq l; chemistry blood chloride  100  meq l; chemistry blood creatinine  0.6  mg dl; chemistry blood potassium  4.5  meq l; chemistry blood sodium  132  meq l; chemistry blood urea nitrogen  16  mg dl; hematology blood inr(pt)  1.3  ; chemistry blood calcium, total  7.8  mg dl; chemistry blood glucose  114  mg dl$iso-osmotic dextrose  200  ml ; pravastatin  40  mg ; citalopram  40  mg ; enoxaparin sodium  80  mg ; sodium chloride 0.9%  flush  3  ml ; 0.9% sodium chloride  1000  ml ; oxycodone (immediate release)   5  mg ; acetaminophen  650  mg ; hydromorphone (dilaudid)  0.125  mg ; senna  1  tab ; 0.9% sodium chloride (mini bag plus)  100  ml ; ampicillin-sulbactam  3  g ; omeprazole  40  mg ; docusate sodium  100  mg ; vancomycin  1000  mg ; xeloda  1000  mg ; metoclopramide  5  mg ; polyethylene glycol  17  g ; 
esophageal reflux atrial fibrillation depressive disorder, not elsewhere classified cellulitis and abscess of upper arm and forearm osteoarthrosis, localized, not specified whether primary or secondary, forearm malignant neoplasm of duodenum benign essential hypertension other and unspecified hyperlipidemia congestive heart failure, unspecified chondrocalcinosis, due to pyrophosphate crystals, forearm paralytic ileus malignant neoplasm of pancreas, part unspecified atrial fibrillation personal history of tobacco use gout, unspecified other disorders of calcium metabolism secondary and unspecified malignant neoplasm of intra-abdominal lymph nodes persistent vomiting paroxysmal ventricular tachycardia coronary atherosclerosis of native coronary artery chronic diastolic heart failure macroglobulinemia acquired hypertrophic pyloric stenosis long-term (current) use of anticoagulants other and unspecified hyperlipidemia unspecified essential hypertension secondary malignant neoplasm of small intestine including duodenum chronic cholecystitis secondary malignant neoplasm of other specified sites other fluid overload unspecified essential hypertension chronic or unspecified gastric ulcer with hemorrhage, without mention of obstruction long-term (current) use of anticoagulants atrial fibrillation gout, unspecified precipitous drop in hematocrit other and unspecified hyperlipidemia 
white m 79 $nan$hematology blood hematocrit  29.0  %; hematology blood hemoglobin  9.6  g dl; hematology blood platelet count  193  k ul; chemistry blood anion gap  10  meq l; chemistry blood bicarbonate  26  meq l; chemistry blood chloride  98  meq l; chemistry blood creatinine  0.6  mg dl; chemistry blood potassium  4.0  meq l; chemistry blood sodium  130  meq l; chemistry blood urea nitrogen  12  mg dl; hematology blood inr(pt)  1.2  ; chemistry blood calcium, total  7.8  mg dl; chemistry blood glucose  105  mg dl$pravastatin  40  mg ; citalopram  40  mg ; enoxaparin sodium  80  mg ; sodium chloride 0.9%  flush  3  ml ; acetaminophen  650  mg ; hydromorphone (dilaudid)  0.125  mg ; senna  1  tab ; omeprazole  40  mg ; docusate sodium  100  mg ; xeloda  1000  mg ; metoclopramide  5  mg ; heparin flush (10 units ml)  2  ml ; 5% dextrose  250  ml ; vancomycin  1250  mg ; 
esophageal reflux atrial fibrillation depressive disorder, not elsewhere classified cellulitis and abscess of upper arm and forearm osteoarthrosis, localized, not specified whether primary or secondary, forearm malignant neoplasm of duodenum benign essential hypertension other and unspecified hyperlipidemia congestive heart failure, unspecified chondrocalcinosis, due to pyrophosphate crystals, forearm paralytic ileus malignant neoplasm of pancreas, part unspecified atrial fibrillation personal history of tobacco use gout, unspecified other disorders of calcium metabolism secondary and unspecified malignant neoplasm of intra-abdominal lymph nodes persistent vomiting paroxysmal ventricular tachycardia coronary atherosclerosis of native coronary artery chronic diastolic heart failure macroglobulinemia acquired hypertrophic pyloric stenosis long-term (current) use of anticoagulants other and unspecified hyperlipidemia unspecified essential hypertension secondary malignant neoplasm of small intestine including duodenum chronic cholecystitis secondary malignant neoplasm of other specified sites other fluid overload unspecified essential hypertension chronic or unspecified gastric ulcer with hemorrhage, without mention of obstruction long-term (current) use of anticoagulants atrial fibrillation gout, unspecified precipitous drop in hematocrit other and unspecified hyperlipidemia 
white m 79 $nan$nan$pravastatin  40  mg ; citalopram  40  mg ; enoxaparin sodium  80  mg ; sodium chloride 0.9%  flush  3  ml ; acetaminophen  650  mg ; hydromorphone (dilaudid)  0.125  mg ; senna  1  tab ; omeprazole  40  mg ; docusate sodium  100  mg ; xeloda  1000  mg ; metoclopramide  5  mg ; heparin flush (10 units ml)  2  ml ; 5% dextrose  250  ml ; vancomycin  1250  mg ; 
esophageal reflux atrial fibrillation depressive disorder, not elsewhere classified cellulitis and abscess of upper arm and forearm osteoarthrosis, localized, not specified whether primary or secondary, forearm malignant neoplasm of duodenum benign essential hypertension other and unspecified hyperlipidemia congestive heart failure, unspecified chondrocalcinosis, due to pyrophosphate crystals, forearm paralytic ileus malignant neoplasm of pancreas, part unspecified atrial fibrillation personal history of tobacco use gout, unspecified other disorders of calcium metabolism secondary and unspecified malignant neoplasm of intra-abdominal lymph nodes persistent vomiting paroxysmal ventricular tachycardia coronary atherosclerosis of native coronary artery chronic diastolic heart failure macroglobulinemia acquired hypertrophic pyloric stenosis long-term (current) use of anticoagulants other and unspecified hyperlipidemia unspecified essential hypertension secondary malignant neoplasm of small intestine including duodenum chronic cholecystitis secondary malignant neoplasm of other specified sites other fluid overload unspecified essential hypertension chronic or unspecified gastric ulcer with hemorrhage, without mention of obstruction long-term (current) use of anticoagulants atrial fibrillation gout, unspecified precipitous drop in hematocrit other and unspecified hyperlipidemia 
black african american f 37 $temp  98.1  heartrate  114.0  resprate  20.0  o2sat  94.0  sbp  157.0  dbp  92.0  rhythm    pain    ; temp    heartrate  105.0  resprate  20.0  o2sat  94.0  sbp  166.0  dbp  100.0  rhythm    pain  6  ; temp    heartrate  102.0  resprate  20.0  o2sat    sbp  153.0  dbp  100.0  rhythm    pain    $hematology blood hematocrit  35.1  %; hematology blood hemoglobin  11.6  g dl; hematology blood platelet count  237  k ul; chemistry blood anion gap  14  meq l; chemistry blood bicarbonate  19  meq l; chemistry blood chloride  108  meq l; chemistry blood creatinine  0.8  mg dl; chemistry blood potassium  4.1  meq l; chemistry blood sodium  137  meq l; chemistry blood urea nitrogen  8  mg dl; hematology blood inr(pt)  1.1  ; hematology blood inr(pt)  1.1  ; chemistry blood calcium, total  8.7  mg dl; chemistry blood bilirubin, total  0.6  mg dl; chemistry blood glucose  90  mg dl; chemistry blood albumin  4.0  g dl$metoprolol succinate xl  200  mg ; montelukast sodium  10  mg ; nifedipine cr  90  mg ; prednisone  10  mg ; leflunomide  20  mg ; prednisone  5  mg ; sodium chloride 0.9%  flush  3  ml ; d5 1 2ns  1000  ml ; albuterol inhaler  2  puff ; morphine sulfate ir  30  mg ; morphine sulfate  4  mg ; fentanyl patch  75  mcg h ; ondansetron  8  mg ; vial  1  vial ; pantoprazole  40  mg ; heparin  5000  unit ; baclofen  10  mg ; sildenafil  20  mg ; lorazepam  0.5  mg ; bag  1  bag ; magnesium sulfate (latex free)  2  gm ; 5% dextrose  500  ml ; potassium chloride  40  meq ; docusate sodium  100  mg ; duloxetine  30  mg ; amitriptyline  50  mg ; ondansetron  4  mg ; senna  1  tab ; 
esophageal reflux cellulitis and abscess of finger, unspecified leukocytopenia, unspecified other specified diffuse diseases of connective tissue methicillin susceptible staphylococcus aureus in conditions classified elsewhere and of unspecified site alcohol abuse, unspecified other and unspecified noninfectious gastroenteritis and colitis acidosis allergic rhinitis, cause unspecified asthma, unspecified type, unspecified unspecified essential hypertension anemia, unspecified chronic ulcer of other specified sites hypopotassemia mononeuritis of unspecified site hyperpotassemia raynaud's syndrome other and unspecified nonspecific immunological findings acute pancreatitis dehydration asthma, unspecified type, unspecified chronic osteomyelitis, site unspecified other and unspecified nonspecific immunological findings unspecified essential hypertension long-term (current) use of antibiotics disturbance of skin sensation unspecified derangement of joint, ankle and foot esophageal reflux other specified diffuse diseases of connective tissue pain in limb long-term (current) use of other medications lumbago mononeuritis of unspecified site exercise induced bronchospasm systemic lupus erythematosus lesion of sciatic nerve proteus (mirabilis) (morganii) infection in conditions classified elsewhere and of unspecified site urinary catheterization as the cause of abnormal reaction of patient, or of later complication, without mention of misadventure at time of procedure other finger(s) amputation status infection and inflammatory reaction due to indwelling urinary catheter chronic osteomyelitis, other specified sites rheumatoid arthritis unspecified essential hypertension esophageal reflux long-term (current) use of steroids tobacco use disorder other acute pain systemic sclerosis
black african american f 37 $nan$nan$metoprolol succinate xl  200  mg ; nifedipine cr  90  mg ; leflunomide  20  mg ; prednisone  5  mg ; sodium chloride 0.9%  flush  3  ml ; d5 1 2ns  1000  ml ; albuterol inhaler  2  puff ; morphine sulfate ir  30  mg ; fentanyl patch  75  mcg h ; ondansetron  8  mg ; heparin  5000  unit ; baclofen  10  mg ; sildenafil  20  mg ; lorazepam  0.5  mg ; bag  1  bag ; magnesium sulfate (latex free)  2  gm ; 5% dextrose  500  ml ; potassium chloride  40  meq ; docusate sodium  100  mg ; duloxetine  30  mg ; amitriptyline  50  mg ; ondansetron  4  mg ; senna  1  tab ; 
esophageal reflux cellulitis and abscess of finger, unspecified leukocytopenia, unspecified other specified diffuse diseases of connective tissue methicillin susceptible staphylococcus aureus in conditions classified elsewhere and of unspecified site alcohol abuse, unspecified other and unspecified noninfectious gastroenteritis and colitis acidosis allergic rhinitis, cause unspecified asthma, unspecified type, unspecified unspecified essential hypertension anemia, unspecified chronic ulcer of other specified sites hypopotassemia mononeuritis of unspecified site hyperpotassemia raynaud's syndrome other and unspecified nonspecific immunological findings acute pancreatitis dehydration asthma, unspecified type, unspecified chronic osteomyelitis, site unspecified other and unspecified nonspecific immunological findings unspecified essential hypertension long-term (current) use of antibiotics disturbance of skin sensation unspecified derangement of joint, ankle and foot esophageal reflux other specified diffuse diseases of connective tissue pain in limb long-term (current) use of other medications lumbago mononeuritis of unspecified site exercise induced bronchospasm systemic lupus erythematosus lesion of sciatic nerve proteus (mirabilis) (morganii) infection in conditions classified elsewhere and of unspecified site urinary catheterization as the cause of abnormal reaction of patient, or of later complication, without mention of misadventure at time of procedure other finger(s) amputation status infection and inflammatory reaction due to indwelling urinary catheter chronic osteomyelitis, other specified sites rheumatoid arthritis unspecified essential hypertension esophageal reflux long-term (current) use of steroids tobacco use disorder other acute pain systemic sclerosis
white f 28 $nan$hematology blood hematocrit  38.5  %; hematology blood hemoglobin  13.0  g dl; hematology blood platelet count  256  k ul; chemistry blood anion gap  12  meq l; chemistry blood bicarbonate  28  meq l; chemistry blood chloride  102  meq l; chemistry blood creatinine  1.0  mg dl; chemistry blood potassium  3.8  meq l; chemistry blood sodium  138  meq l; chemistry blood urea nitrogen  14  mg dl; chemistry blood glucose  148  mg dl; hematology urine glucose  100  mg dl; hematology urine bilirubin  neg  mg dl$nan
 
black african american f 30 $nan$hematology blood hematocrit  31.5  %; hematology blood hematocrit  24.9  %; hematology blood hemoglobin  9.9  g dl; hematology blood platelet count  251  k ul; hematology blood inr(pt)  1.1  $naloxone  40-80  mcg ; 0.9% sodium chloride  250  ml ; naloxone  0.4  mg ; metoclopramide  10  mg ; ondansetron  4  mg ; acetaminophen  1000  mg ; ketorolac  15-30  mg ; influenza vaccine quadrivalent  0.5  ml ; lactated ringers  1000  ml ; sodium chloride 0.9%  flush  3-10  ml ; simethicone  80  mg ; calcium carbonate  500  mg ; 0.9% sodium chloride  1000  ml ; oxytocin  20  unit ; docusate sodium  100  mg ; senna  8.6  mg ; bisacodyl  10  mg ; enoxaparin sodium  40  mg ; 
 
black african american f 30 $nan$nan$naloxone  40-80  mcg ; 0.9% sodium chloride  250  ml ; naloxone  0.4  mg ; metoclopramide  10  mg ; ondansetron  4  mg ; acetaminophen  1000  mg ; ketorolac  15-30  mg ; influenza vaccine quadrivalent  0.5  ml ; lactated ringers  1000  ml ; sodium chloride 0.9%  flush  3-10  ml ; simethicone  80  mg ; calcium carbonate  500  mg ; 0.9% sodium chloride  1000  ml ; oxytocin  20  unit ; docusate sodium  100  mg ; senna  8.6  mg ; bisacodyl  10  mg ; enoxaparin sodium  40  mg ; ibuprofen  600  mg ; oxycodone (immediate release)  5-10  mg ; medroxyprogesterone acetate  150  mg ; 
 
black african american f 30 $nan$nan$naloxone  40-80  mcg ; 0.9% sodium chloride  250  ml ; naloxone  0.4  mg ; metoclopramide  10  mg ; ondansetron  4  mg ; influenza vaccine quadrivalent  0.5  ml ; lactated ringers  1000  ml ; sodium chloride 0.9%  flush  3-10  ml ; simethicone  80  mg ; calcium carbonate  500  mg ; 0.9% sodium chloride  1000  ml ; oxytocin  20  unit ; docusate sodium  100  mg ; senna  8.6  mg ; bisacodyl  10  mg ; enoxaparin sodium  40  mg ; ibuprofen  600  mg ; oxycodone (immediate release)  5-10  mg ; medroxyprogesterone acetate  150  mg ; 
 
black african american f 30 $nan$nan$naloxone  40-80  mcg ; 0.9% sodium chloride  250  ml ; naloxone  0.4  mg ; metoclopramide  10  mg ; ondansetron  4  mg ; influenza vaccine quadrivalent  0.5  ml ; lactated ringers  1000  ml ; sodium chloride 0.9%  flush  3-10  ml ; simethicone  80  mg ; calcium carbonate  500  mg ; 0.9% sodium chloride  1000  ml ; oxytocin  20  unit ; docusate sodium  100  mg ; senna  8.6  mg ; bisacodyl  10  mg ; enoxaparin sodium  40  mg ; ibuprofen  600  mg ; oxycodone (immediate release)  5-10  mg ; medroxyprogesterone acetate  150  mg ; 
 
white m 68 $nan$nan$heparin  5000  unit ; 
 
white m 68 $nan$hematology blood hematocrit  41.7  %; hematology blood hemoglobin  13.2  g dl; hematology blood platelet count  225  k ul; chemistry blood anion gap  14  meq l; chemistry blood bicarbonate  27  meq l; chemistry blood chloride  102  meq l; chemistry blood creatinine  0.9  mg dl; chemistry blood potassium  3.8  meq l; chemistry blood sodium  139  meq l; chemistry blood urea nitrogen  10  mg dl; chemistry blood calcium, total  8.9  mg dl; chemistry blood bilirubin, total  0.8  mg dl; chemistry blood glucose  101  mg dl$heparin  5000  unit ; influenza vaccine quadrivalent  0.5  ml ; pneumococcal 23-valent polysaccharide vaccine  0.5  ml ; sodium chloride 0.9%  flush  3  ml ; lactated ringers  1000  ml ; oxycodone (immediate release)  5-10  mg ; acetaminophen  1000  mg ; ondansetron  4  mg ; lisinopril  5  mg ; 
 
white m 68 $nan$nan$heparin  5000  unit ; influenza vaccine quadrivalent  0.5  ml ; pneumococcal 23-valent polysaccharide vaccine  0.5  ml ; sodium chloride 0.9%  flush  3  ml ; oxycodone (immediate release)  5-10  mg ; acetaminophen  1000  mg ; ondansetron  4  mg ; lisinopril  5  mg ; tamsulosin  0.4  mg ; 
 
unable to obtain m 75 $nan$nan$gabapentin  300  mg ; losartan potassium  25  mg ; rosuvastatin calcium  10  mg ; tiotropium bromide  1  cap ; ferrous sulfate  325  mg ; carvedilol  6.25  mg ; docusate sodium  100  mg ; 
congestive heart failure, unspecified acute myocardial infarction of unspecified site, initial episode of care unspecified essential hypertension chronic total occlusion of coronary artery acute kidney failure, unspecified chronic airway obstruction, not elsewhere classified other and unspecified hyperlipidemia acute systolic heart failure personal history of tobacco use esophageal reflux hypertrophy (benign) of prostate without urinary obstruction and other lower urinary tract symptom (luts) coronary atherosclerosis of native coronary artery
unable to obtain m 75 $nan$hematology blood hematocrit  40.3  %; hematology blood hematocrit  38.2  %; hematology blood hemoglobin  13.1  g dl; hematology blood hemoglobin  12.2  g dl; hematology blood platelet count  184  k ul; hematology blood platelet count  185  k ul; chemistry blood anion gap  12  meq l; chemistry blood anion gap  11  meq l; chemistry blood bicarbonate  27  meq l; chemistry blood bicarbonate  26  meq l; chemistry blood chloride  107  meq l; chemistry blood chloride  104  meq l; chemistry blood creatinine  0.9  mg dl; chemistry blood creatinine  0.9  mg dl; chemistry blood potassium  4.1  meq l; chemistry blood potassium  3.6  meq l; chemistry blood sodium  142  meq l; chemistry blood sodium  137  meq l; chemistry blood urea nitrogen  14  mg dl; chemistry blood urea nitrogen  13  mg dl; hematology blood inr(pt)  1.0  ; chemistry blood calcium, total  9.0  mg dl; chemistry blood calcium, total  9.0  mg dl; chemistry blood bilirubin, total  1.0  mg dl; chemistry blood glucose  91  mg dl; chemistry blood glucose  85  mg dl$senna  1  tab ; gabapentin  300  mg ; losartan potassium  25  mg ; rosuvastatin calcium  10  mg ; tiotropium bromide  1  cap ; ferrous sulfate  325  mg ; carvedilol  6.25  mg ; docusate sodium  100  mg ; pneumococcal vac polyvalent  0.5  ml ; 0.9% sodium chloride  1000  ml ; gabapentin  600  mg ; tamsulosin  0.4  mg ; oxycodone (immediate release)   5  mg ; pantoprazole  40  mg ; ondansetron  4  mg ; morphine sulfate  2-4  mg ; gastroview (diatrizoate meglumine & sodium)  30  ml ; 
congestive heart failure, unspecified acute myocardial infarction of unspecified site, initial episode of care unspecified essential hypertension chronic total occlusion of coronary artery acute kidney failure, unspecified chronic airway obstruction, not elsewhere classified other and unspecified hyperlipidemia acute systolic heart failure personal history of tobacco use esophageal reflux hypertrophy (benign) of prostate without urinary obstruction and other lower urinary tract symptom (luts) coronary atherosclerosis of native coronary artery
unable to obtain m 75 $nan$hematology blood hematocrit  39.0  %; blood gas blood lactate  1.4  mmol l$senna  1  tab ; gabapentin  300  mg ; losartan potassium  25  mg ; rosuvastatin calcium  10  mg ; tiotropium bromide  1  cap ; ferrous sulfate  325  mg ; carvedilol  6.25  mg ; docusate sodium  100  mg ; pneumococcal vac polyvalent  0.5  ml ; gabapentin  600  mg ; tamsulosin  0.4  mg ; oxycodone (immediate release)   5  mg ; pantoprazole  40  mg ; ondansetron  4  mg ; morphine sulfate  2-4  mg ; gastroview (diatrizoate meglumine & sodium)  30  ml ; nitroglycerin sl  0.3  mg ; 
congestive heart failure, unspecified acute myocardial infarction of unspecified site, initial episode of care unspecified essential hypertension chronic total occlusion of coronary artery acute kidney failure, unspecified chronic airway obstruction, not elsewhere classified other and unspecified hyperlipidemia acute systolic heart failure personal history of tobacco use esophageal reflux hypertrophy (benign) of prostate without urinary obstruction and other lower urinary tract symptom (luts) coronary atherosclerosis of native coronary artery
white f 58 $nan$nan$sodium chloride 0.9%  flush  3  ml ; lactated ringers  1000  ml ; acetaminophen  1000  mg ; pantoprazole  40  mg ; loperamide  2  mg ; bupivacaine 0.1%  250  ml ; yellow cadd cassette  1  cadd ; hydromorphone  2500  mcg ; ondansetron  4  mg ; 5% dextrose  100  ml ; naloxone  2  mg ; heparin  5000  unit ; ranitidine  150  mg ; gabapentin  250  mg ; lidocaine jelly 2% (urojet)  1  appl ; amitriptyline  20  mg ; hydromorphone (dilaudid)  0.25  mg ; loperamide  4  mg ; hydromorphone (dilaudid)  0.5  mg ; oxycodone (immediate release)  5-10  mg ; 
encounter for immunization fibromyalgia calculus of bile duct without cholangitis or cholecystitis without obstruction acquired absence of other specified parts of digestive tract ileostomy status gastro-esophageal reflux disease without esophagitis unspecified atrial fibrillation personal history of nicotine dependence diarrhea, unspecified hyperlipidemia, unspecified unspecified atrial fibrillation pure hypercholesterolemia diaphragmatic hernia without obstruction or gangrene ileus, unspecified fibromyalgia other postprocedural complications and disorders of digestive system surgical operation with anastomosis, bypass or graft as the cause of abnormal reaction of the patient, or of later complication, without mention of misadventure at the time of the procedure essential (primary) hypertension unspecified intestinal obstruction personal history of nicotine dependence gastro-esophageal reflux disease without esophagitis diverticulosis of colon (without mention of hemorrhage) acquired absence of intestine (large) (small) unspecified intestinal obstruction nausea with vomiting acute kidney failure, unspecified esophageal reflux atrial fibrillation esophageal reflux other and unspecified hyperlipidemia other abnormal blood chemistry acquired absence of intestine (large) (small) atrial fibrillation personal history of tobacco use unspecified intestinal obstruction personal history of other infectious and parasitic diseases peritoneal adhesions (postoperative) (postinfection) diarrhea person on outside of pick-up truck or van injured in collision with railway train or railway vehicle in nontraffic accident vomiting alone raynaud's syndrome atrial fibrillation long-term (current) use of aspirin attention to ileostomy acquired absence of intestine (large) (small) esophageal reflux intestinal or peritoneal adhesions with obstruction (postoperative) (postinfection) other and unspecified hyperlipidemia
white f 58 $nan$nan$sodium chloride 0.9%  flush  3  ml ; acetaminophen  1000  mg ; pantoprazole  40  mg ; heparin  5000  unit ; ranitidine  150  mg ; gabapentin  250  mg ; lidocaine jelly 2% (urojet)  1  appl ; amitriptyline  20  mg ; hydromorphone (dilaudid)  0.25  mg ; loperamide  4  mg ; hydromorphone (dilaudid)  0.5  mg ; oxycodone (immediate release)  5-10  mg ; lorazepam  0.5-1  mg ; metoprolol succinate xl  50  mg ; hydromorphone (dilaudid)  2-4  mg ; 
encounter for immunization fibromyalgia calculus of bile duct without cholangitis or cholecystitis without obstruction acquired absence of other specified parts of digestive tract ileostomy status gastro-esophageal reflux disease without esophagitis unspecified atrial fibrillation personal history of nicotine dependence diarrhea, unspecified hyperlipidemia, unspecified unspecified atrial fibrillation pure hypercholesterolemia diaphragmatic hernia without obstruction or gangrene ileus, unspecified fibromyalgia other postprocedural complications and disorders of digestive system surgical operation with anastomosis, bypass or graft as the cause of abnormal reaction of the patient, or of later complication, without mention of misadventure at the time of the procedure essential (primary) hypertension unspecified intestinal obstruction personal history of nicotine dependence gastro-esophageal reflux disease without esophagitis diverticulosis of colon (without mention of hemorrhage) acquired absence of intestine (large) (small) unspecified intestinal obstruction nausea with vomiting acute kidney failure, unspecified esophageal reflux atrial fibrillation esophageal reflux other and unspecified hyperlipidemia other abnormal blood chemistry acquired absence of intestine (large) (small) atrial fibrillation personal history of tobacco use unspecified intestinal obstruction personal history of other infectious and parasitic diseases peritoneal adhesions (postoperative) (postinfection) diarrhea person on outside of pick-up truck or van injured in collision with railway train or railway vehicle in nontraffic accident vomiting alone raynaud's syndrome atrial fibrillation long-term (current) use of aspirin attention to ileostomy acquired absence of intestine (large) (small) esophageal reflux intestinal or peritoneal adhesions with obstruction (postoperative) (postinfection) other and unspecified hyperlipidemia
white f 58 $nan$nan$sodium chloride 0.9%  flush  3  ml ; acetaminophen  1000  mg ; pantoprazole  40  mg ; heparin  5000  unit ; ranitidine  150  mg ; gabapentin  250  mg ; amitriptyline  20  mg ; loperamide  4  mg ; metoprolol succinate xl  50  mg ; hydromorphone (dilaudid)  2-4  mg ; zolpidem tartrate  5  mg ; hydromorphone (dilaudid)  2-6  mg ; 
encounter for immunization fibromyalgia calculus of bile duct without cholangitis or cholecystitis without obstruction acquired absence of other specified parts of digestive tract ileostomy status gastro-esophageal reflux disease without esophagitis unspecified atrial fibrillation personal history of nicotine dependence diarrhea, unspecified hyperlipidemia, unspecified unspecified atrial fibrillation pure hypercholesterolemia diaphragmatic hernia without obstruction or gangrene ileus, unspecified fibromyalgia other postprocedural complications and disorders of digestive system surgical operation with anastomosis, bypass or graft as the cause of abnormal reaction of the patient, or of later complication, without mention of misadventure at the time of the procedure essential (primary) hypertension unspecified intestinal obstruction personal history of nicotine dependence gastro-esophageal reflux disease without esophagitis diverticulosis of colon (without mention of hemorrhage) acquired absence of intestine (large) (small) unspecified intestinal obstruction nausea with vomiting acute kidney failure, unspecified esophageal reflux atrial fibrillation esophageal reflux other and unspecified hyperlipidemia other abnormal blood chemistry acquired absence of intestine (large) (small) atrial fibrillation personal history of tobacco use unspecified intestinal obstruction personal history of other infectious and parasitic diseases peritoneal adhesions (postoperative) (postinfection) diarrhea person on outside of pick-up truck or van injured in collision with railway train or railway vehicle in nontraffic accident vomiting alone raynaud's syndrome atrial fibrillation long-term (current) use of aspirin attention to ileostomy acquired absence of intestine (large) (small) esophageal reflux intestinal or peritoneal adhesions with obstruction (postoperative) (postinfection) other and unspecified hyperlipidemia
white f 58 $nan$nan$sodium chloride 0.9%  flush  3  ml ; acetaminophen  1000  mg ; pantoprazole  40  mg ; heparin  5000  unit ; ranitidine  150  mg ; gabapentin  250  mg ; amitriptyline  20  mg ; loperamide  4  mg ; metoprolol succinate xl  50  mg ; zolpidem tartrate  5  mg ; hydromorphone (dilaudid)  2-6  mg ; 
encounter for immunization fibromyalgia calculus of bile duct without cholangitis or cholecystitis without obstruction acquired absence of other specified parts of digestive tract ileostomy status gastro-esophageal reflux disease without esophagitis unspecified atrial fibrillation personal history of nicotine dependence diarrhea, unspecified hyperlipidemia, unspecified unspecified atrial fibrillation pure hypercholesterolemia diaphragmatic hernia without obstruction or gangrene ileus, unspecified fibromyalgia other postprocedural complications and disorders of digestive system surgical operation with anastomosis, bypass or graft as the cause of abnormal reaction of the patient, or of later complication, without mention of misadventure at the time of the procedure essential (primary) hypertension unspecified intestinal obstruction personal history of nicotine dependence gastro-esophageal reflux disease without esophagitis diverticulosis of colon (without mention of hemorrhage) acquired absence of intestine (large) (small) unspecified intestinal obstruction nausea with vomiting acute kidney failure, unspecified esophageal reflux atrial fibrillation esophageal reflux other and unspecified hyperlipidemia other abnormal blood chemistry acquired absence of intestine (large) (small) atrial fibrillation personal history of tobacco use unspecified intestinal obstruction personal history of other infectious and parasitic diseases peritoneal adhesions (postoperative) (postinfection) diarrhea person on outside of pick-up truck or van injured in collision with railway train or railway vehicle in nontraffic accident vomiting alone raynaud's syndrome atrial fibrillation long-term (current) use of aspirin attention to ileostomy acquired absence of intestine (large) (small) esophageal reflux intestinal or peritoneal adhesions with obstruction (postoperative) (postinfection) other and unspecified hyperlipidemia
white f 77 $temp  97.4  heartrate  85.0  resprate  24.0  o2sat    sbp  116.0  dbp  70.0  rhythm  atrial fibrillation  pain  0  $hematology blood hematocrit  48.0  %; hematology blood hemoglobin  14.4  g dl; hematology blood platelet count  259  k ul; chemistry blood anion gap  16  meq l; chemistry blood anion gap  18  meq l; chemistry blood bicarbonate  22  meq l; chemistry blood bicarbonate  18  meq l; chemistry blood chloride  95  meq l; chemistry blood chloride  95  meq l; chemistry blood creatinine  0.9  mg dl; chemistry blood creatinine  0.9  mg dl; chemistry blood potassium  5.3  meq l; chemistry blood potassium  5.5  meq l; chemistry blood sodium  128  meq l; chemistry blood sodium  125  meq l; chemistry blood urea nitrogen  18  mg dl; chemistry blood urea nitrogen  23  mg dl; hematology blood inr(pt)  1.8  ; chemistry blood calcium, total  8.9  mg dl; chemistry blood glucose  119  mg dl$influenza virus vaccine  0.5  ml ; pneumococcal vac polyvalent  0.5  ml ; sodium chloride 0.9%  flush  3  ml ; senna  1  tab ; morphine sulfate  1  mg ; guaifenesin  5-10  ml ; dextrose 50%  12.5  gm ; glucagon  1  mg ; heparin  5000  unit ; docusate sodium  100  mg ; amiodarone  200  mg ; creon 12  2  cap ; trazodone  25  mg ; verapamil sr  360  mg ; pantoprazole  40  mg ; metoprolol tartrate  200  mg ; insulin  0  unit ; insulin  16  unit ; allopurinol  300  mg ; aspirin  81  mg ; ezetimibe  10  mg ; levothyroxine sodium  100  mcg ; psyllium  1  pkt ; rivaroxaban  20  mg ; furosemide  10  mg ; sodium polystyrene sulfonate  30  gm ; insulin  20  unit ; 
person boarding or alighting a pedal cycle injured in collision with railway train or railway vehicle secondary malignant neoplasm of bone and bone marrow other and unspecified hyperlipidemia person boarding or alighting a pedal cycle injured in collision with pedestrian or animal long-term (current) use of insulin acidosis diabetes mellitus without mention of complication, type ii or unspecified type, not stated as uncontrolled acquired absence of breast and nipple unspecified acquired hypothyroidism atrial fibrillation unspecified essential hypertension unspecified pleural effusion personal history of malignant neoplasm of breast cardiac rhythm regulators causing adverse effects in therapeutic use hyposmolality and/or hyponatremia enlargement of lymph nodes personal history of irradiation, presenting hazards to health paroxysmal ventricular tachycardia
white f 77 $nan$hematology blood hematocrit  41.9  %; hematology blood hemoglobin  13.2  g dl; hematology blood platelet count  226  k ul; chemistry blood anion gap  13  meq l; chemistry blood bicarbonate  27  meq l; chemistry blood chloride  96  meq l; chemistry blood chloride  96  meq l; chemistry blood creatinine  0.9  mg dl; chemistry blood potassium  3.9  meq l; chemistry blood potassium  4.0  meq l; chemistry blood sodium  132  meq l; chemistry blood sodium  131  meq l; chemistry blood urea nitrogen  20  mg dl; hematology blood inr(pt)  1.7  ; chemistry blood calcium, total  8.4  mg dl; chemistry blood glucose  53  mg dl$influenza virus vaccine  0.5  ml ; pneumococcal vac polyvalent  0.5  ml ; sodium chloride 0.9%  flush  3  ml ; senna  1  tab ; morphine sulfate  1  mg ; guaifenesin  5-10  ml ; dextrose 50%  12.5  gm ; glucagon  1  mg ; docusate sodium  100  mg ; amiodarone  200  mg ; creon 12  2  cap ; trazodone  25  mg ; pantoprazole  40  mg ; insulin  0  unit ; insulin  16  unit ; allopurinol  300  mg ; aspirin  81  mg ; ezetimibe  10  mg ; levothyroxine sodium  100  mcg ; psyllium  1  pkt ; rivaroxaban  20  mg ; furosemide  10  mg ; sodium polystyrene sulfonate  30  gm ; insulin  20  unit ; metoprolol succinate xl  25  mg ; bag  50  ml ; magnesium sulfate  2  gm ; metoprolol succinate xl  50  mg ; insulin  15  unit ; 
person boarding or alighting a pedal cycle injured in collision with railway train or railway vehicle secondary malignant neoplasm of bone and bone marrow other and unspecified hyperlipidemia person boarding or alighting a pedal cycle injured in collision with pedestrian or animal long-term (current) use of insulin acidosis diabetes mellitus without mention of complication, type ii or unspecified type, not stated as uncontrolled acquired absence of breast and nipple unspecified acquired hypothyroidism atrial fibrillation unspecified essential hypertension unspecified pleural effusion personal history of malignant neoplasm of breast cardiac rhythm regulators causing adverse effects in therapeutic use hyposmolality and/or hyponatremia enlargement of lymph nodes personal history of irradiation, presenting hazards to health paroxysmal ventricular tachycardia
white f 77 $nan$hematology blood hematocrit  45.4  %; hematology blood hemoglobin  14.4  g dl; hematology blood platelet count  255  k ul; chemistry blood anion gap  15  meq l; chemistry blood bicarbonate  28  meq l; chemistry blood chloride  98  meq l; chemistry blood creatinine  0.9  mg dl; chemistry blood potassium  4.1  meq l; chemistry blood sodium  137  meq l; chemistry blood urea nitrogen  14  mg dl; chemistry blood calcium, total  8.4  mg dl; chemistry blood glucose  74  mg dl$influenza virus vaccine  0.5  ml ; pneumococcal vac polyvalent  0.5  ml ; sodium chloride 0.9%  flush  3  ml ; senna  1  tab ; guaifenesin  5-10  ml ; dextrose 50%  12.5  gm ; glucagon  1  mg ; docusate sodium  100  mg ; amiodarone  200  mg ; creon 12  2  cap ; trazodone  25  mg ; pantoprazole  40  mg ; allopurinol  300  mg ; aspirin  81  mg ; ezetimibe  10  mg ; levothyroxine sodium  100  mcg ; psyllium  1  pkt ; rivaroxaban  20  mg ; bag  50  ml ; magnesium sulfate  2  gm ; metoprolol succinate xl  50  mg ; insulin  15  unit ; cepacol (menthol)  1  loz ; insulin  10  unit ; metoprolol succinate xl  75  mg ; 
person boarding or alighting a pedal cycle injured in collision with railway train or railway vehicle secondary malignant neoplasm of bone and bone marrow other and unspecified hyperlipidemia person boarding or alighting a pedal cycle injured in collision with pedestrian or animal long-term (current) use of insulin acidosis diabetes mellitus without mention of complication, type ii or unspecified type, not stated as uncontrolled acquired absence of breast and nipple unspecified acquired hypothyroidism atrial fibrillation unspecified essential hypertension unspecified pleural effusion personal history of malignant neoplasm of breast cardiac rhythm regulators causing adverse effects in therapeutic use hyposmolality and/or hyponatremia enlargement of lymph nodes personal history of irradiation, presenting hazards to health paroxysmal ventricular tachycardia
black african american f 42 $nan$hematology blood hematocrit  36.4  %; hematology blood hematocrit  31.5  %; hematology blood hemoglobin  11.5  g dl; hematology blood hemoglobin  10.1  g dl; hematology blood platelet count  328  k ul; hematology blood platelet count  288  k ul; chemistry blood anion gap  21  meq l; chemistry blood anion gap  13  meq l; chemistry blood anion gap  16  meq l; chemistry blood bicarbonate  15  meq l; chemistry blood bicarbonate  13  meq l; chemistry blood bicarbonate  14  meq l; chemistry blood chloride  110  meq l; chemistry blood chloride  114  meq l; chemistry blood chloride  114  meq l; chemistry blood creatinine  0.8  mg dl; chemistry blood creatinine  0.6  mg dl; chemistry blood potassium  3.5  meq l; chemistry blood potassium  3.3  meq l; chemistry blood potassium  3.8  meq l; chemistry blood sodium  140  meq l; chemistry blood sodium  139  meq l; chemistry blood sodium  140  meq l; chemistry blood urea nitrogen  13  mg dl; chemistry blood urea nitrogen  11  mg dl; chemistry blood calcium, total  8.6  mg dl; chemistry blood calcium, total  7.9  mg dl; chemistry blood calcium, total  8.1  mg dl; chemistry blood glucose  106  mg dl; chemistry blood glucose  125  mg dl; chemistry blood glucose  205  mg dl; chemistry blood % hemoglobin a1c  12.6  %$0.9% sodium chloride  100  ml ; insulin human regular  100  unit ; dextrose 50%  12.5  gm ; glucagon  1  mg ; sodium chloride 0.9%  flush  3  ml ; trazodone  25  mg ; senna  1  tab ; ondansetron  4  mg ; heparin  5000  unit ; docusate sodium  100  mg ; 0.9% sodium chloride  1000  ml ; 0.9% sodium chloride  500  ml ; potassium phosphate  30  mmol ; potassium chloride  20  meq ; bag  100  ml ; magnesium sulfate  4  gm ; insulin  0  unit ; acetaminophen  500-1000  mg ; paroxetine  20  mg ; lidocaine 1%  1  ml ; 
dehydration unspecified essential hypertension diabetes with ophthalmic manifestations, type ii or unspecified type, not stated as uncontrolled acidosis depressive disorder, not elsewhere classified alcohol abuse, unspecified nonproliferative diabetic retinopathy nos leukocytopenia, unspecified diabetes with other specified manifestations, type ii or unspecified type, uncontrolled anemia, unspecified diabetes with ophthalmic manifestations, type ii or unspecified type, uncontrolled cellulitis and abscess of trunk diabetes with ophthalmic manifestations, type ii or unspecified type, not stated as uncontrolled depressive disorder, not elsewhere classified severe nonproliferative diabetic retinopathy nonspecific abnormal results of function study of kidney hypopotassemia unspecified essential hypertension alcohol abuse, unspecified major depressive affective disorder, recurrent episode, moderate vomiting alone disorders of phosphorus metabolism tobacco use disorder methicillin susceptible staphylococcus aureus in conditions classified elsewhere and of unspecified site diabetes with ketoacidosis, type ii or unspecified type, uncontrolled unspecified essential hypertension diabetes with ophthalmic manifestations, type ii or unspecified type, uncontrolled cellulitis and abscess of trunk hypotension, unspecified streptococcus infection in conditions classified elsewhere and of unspecified site, streptococcus, group b diabetes with other specified manifestations, type ii or unspecified type, uncontrolled personal history of noncompliance with medical treatment, presenting hazards to health acute kidney failure with lesion of tubular necrosis streptococcus infection in conditions classified elsewhere and of unspecified site, other streptococcus severe nonproliferative diabetic retinopathy anemia, unspecified abscess of anal and rectal regions long-term (current) use of insulin depressive disorder, not elsewhere classified diabetes with ophthalmic manifestations, type ii or unspecified type, uncontrolled dehydration personal history of noncompliance with medical treatment, presenting hazards to health urinary tract infection, site not specified unspecified essential hypertension cellulitis and abscess of leg, except foot nonproliferative diabetic retinopathy nos tobacco use disorder diabetes with ketoacidosis, type ii or unspecified type, uncontrolled
black african american f 42 $nan$hematology blood hematocrit  32.6  %; hematology blood hemoglobin  10.7  g dl; hematology blood platelet count  254  k ul; chemistry blood anion gap  15  meq l; chemistry blood anion gap  8  meq l; chemistry blood bicarbonate  16  meq l; chemistry blood bicarbonate  18  meq l; chemistry blood chloride  107  meq l; chemistry blood chloride  114  meq l; chemistry blood creatinine  0.7  mg dl; chemistry blood creatinine  0.5  mg dl; chemistry blood potassium  3.9  meq l; chemistry blood potassium  3.6  meq l; chemistry blood sodium  134  meq l; chemistry blood sodium  136  meq l; chemistry blood urea nitrogen  10  mg dl; chemistry blood urea nitrogen  9  mg dl; chemistry blood calcium, total  8.6  mg dl; chemistry blood calcium, total  8.3  mg dl; chemistry blood glucose  151  mg dl; chemistry blood glucose  302  mg dl$dextrose 50%  12.5  gm ; glucagon  1  mg ; sodium chloride 0.9%  flush  3  ml ; trazodone  25  mg ; senna  1  tab ; ondansetron  4  mg ; docusate sodium  100  mg ; acetaminophen  500-1000  mg ; paroxetine  20  mg ; neutra-phos  2  pkt ; insulin  12  unit ; potassium chloride  40  meq ; 
dehydration unspecified essential hypertension diabetes with ophthalmic manifestations, type ii or unspecified type, not stated as uncontrolled acidosis depressive disorder, not elsewhere classified alcohol abuse, unspecified nonproliferative diabetic retinopathy nos leukocytopenia, unspecified diabetes with other specified manifestations, type ii or unspecified type, uncontrolled anemia, unspecified diabetes with ophthalmic manifestations, type ii or unspecified type, uncontrolled cellulitis and abscess of trunk diabetes with ophthalmic manifestations, type ii or unspecified type, not stated as uncontrolled depressive disorder, not elsewhere classified severe nonproliferative diabetic retinopathy nonspecific abnormal results of function study of kidney hypopotassemia unspecified essential hypertension alcohol abuse, unspecified major depressive affective disorder, recurrent episode, moderate vomiting alone disorders of phosphorus metabolism tobacco use disorder methicillin susceptible staphylococcus aureus in conditions classified elsewhere and of unspecified site diabetes with ketoacidosis, type ii or unspecified type, uncontrolled unspecified essential hypertension diabetes with ophthalmic manifestations, type ii or unspecified type, uncontrolled cellulitis and abscess of trunk hypotension, unspecified streptococcus infection in conditions classified elsewhere and of unspecified site, streptococcus, group b diabetes with other specified manifestations, type ii or unspecified type, uncontrolled personal history of noncompliance with medical treatment, presenting hazards to health acute kidney failure with lesion of tubular necrosis streptococcus infection in conditions classified elsewhere and of unspecified site, other streptococcus severe nonproliferative diabetic retinopathy anemia, unspecified abscess of anal and rectal regions long-term (current) use of insulin depressive disorder, not elsewhere classified diabetes with ophthalmic manifestations, type ii or unspecified type, uncontrolled dehydration personal history of noncompliance with medical treatment, presenting hazards to health urinary tract infection, site not specified unspecified essential hypertension cellulitis and abscess of leg, except foot nonproliferative diabetic retinopathy nos tobacco use disorder diabetes with ketoacidosis, type ii or unspecified type, uncontrolled
black african american f 42 $nan$nan$dextrose 50%  12.5  gm ; glucagon  1  mg ; sodium chloride 0.9%  flush  3  ml ; trazodone  25  mg ; senna  1  tab ; ondansetron  4  mg ; docusate sodium  100  mg ; acetaminophen  500-1000  mg ; paroxetine  20  mg ; neutra-phos  2  pkt ; insulin  12  unit ; potassium chloride  40  meq ; 
dehydration unspecified essential hypertension diabetes with ophthalmic manifestations, type ii or unspecified type, not stated as uncontrolled acidosis depressive disorder, not elsewhere classified alcohol abuse, unspecified nonproliferative diabetic retinopathy nos leukocytopenia, unspecified diabetes with other specified manifestations, type ii or unspecified type, uncontrolled anemia, unspecified diabetes with ophthalmic manifestations, type ii or unspecified type, uncontrolled cellulitis and abscess of trunk diabetes with ophthalmic manifestations, type ii or unspecified type, not stated as uncontrolled depressive disorder, not elsewhere classified severe nonproliferative diabetic retinopathy nonspecific abnormal results of function study of kidney hypopotassemia unspecified essential hypertension alcohol abuse, unspecified major depressive affective disorder, recurrent episode, moderate vomiting alone disorders of phosphorus metabolism tobacco use disorder methicillin susceptible staphylococcus aureus in conditions classified elsewhere and of unspecified site diabetes with ketoacidosis, type ii or unspecified type, uncontrolled unspecified essential hypertension diabetes with ophthalmic manifestations, type ii or unspecified type, uncontrolled cellulitis and abscess of trunk hypotension, unspecified streptococcus infection in conditions classified elsewhere and of unspecified site, streptococcus, group b diabetes with other specified manifestations, type ii or unspecified type, uncontrolled personal history of noncompliance with medical treatment, presenting hazards to health acute kidney failure with lesion of tubular necrosis streptococcus infection in conditions classified elsewhere and of unspecified site, other streptococcus severe nonproliferative diabetic retinopathy anemia, unspecified abscess of anal and rectal regions long-term (current) use of insulin depressive disorder, not elsewhere classified diabetes with ophthalmic manifestations, type ii or unspecified type, uncontrolled dehydration personal history of noncompliance with medical treatment, presenting hazards to health urinary tract infection, site not specified unspecified essential hypertension cellulitis and abscess of leg, except foot nonproliferative diabetic retinopathy nos tobacco use disorder diabetes with ketoacidosis, type ii or unspecified type, uncontrolled
white f 91 $temp    heartrate  102.0  resprate  18.0  o2sat  99.0  sbp  127.0  dbp  65.0  rhythm    pain    ; temp    heartrate  104.0  resprate  19.0  o2sat    sbp    dbp    rhythm    pain  0  ; temp    heartrate  103.0  resprate  18.0  o2sat    sbp  103.0  dbp  66.0  rhythm    pain  0  ; temp  99.9  heartrate  79.0  resprate  20.0  o2sat  98.0  sbp  119.0  dbp  74.0  rhythm  atrial fibrillation  pain  0  ; temp    heartrate  64.0  resprate  18.0  o2sat  100.0  sbp  136.0  dbp  92.0  rhythm    pain  0  $hematology blood hematocrit  43.3  %; hematology blood hemoglobin  14.3  g dl; hematology blood platelet count  317  k ul; chemistry blood anion gap  19  meq l; chemistry blood bicarbonate  22  meq l; chemistry blood chloride  101  meq l; chemistry blood creatinine  1.2  mg dl; chemistry blood potassium  4.3  meq l; chemistry blood sodium  138  meq l; chemistry blood urea nitrogen  47  mg dl; hematology blood inr(pt)  1.0  ; chemistry blood bilirubin, total  0.5  mg dl; chemistry blood glucose  200  mg dl; chemistry blood albumin  3.8  g dl; blood gas blood lactate  3.5  mmol l; blood gas blood lactate  1.0  mmol l$nan
 
white f 91 $temp  99.8  heartrate  75.0  resprate  16.0  o2sat  99.0  sbp  136.0  dbp  93.0  rhythm    pain  0  $nan$influenza virus vaccine  0.5  ml ; sodium chloride 0.9%  flush  3  ml ; docusate sodium  100  mg ; vitamin d  2000  unit ; iso-osmotic dextrose  50  ml ; piperacillin-tazobactam  2.25  g ; senna  2  tab ; 
 
white f 91 $nan$hematology blood hematocrit  39.7  %; hematology blood hemoglobin  13.0  g dl; hematology blood platelet count  233  k ul; chemistry blood anion gap  16  meq l; chemistry blood bicarbonate  20  meq l; chemistry blood chloride  105  meq l; chemistry blood creatinine  1.0  mg dl; chemistry blood potassium  4.1  meq l; chemistry blood sodium  137  meq l; chemistry blood urea nitrogen  25  mg dl; chemistry blood calcium, total  9.6  mg dl; chemistry blood glucose  164  mg dl; chemistry blood albumin  3.3  g dl$influenza virus vaccine  0.5  ml ; sodium chloride 0.9%  flush  3  ml ; docusate sodium  100  mg ; vitamin d  2000  unit ; iso-osmotic dextrose  50  ml ; piperacillin-tazobactam  2.25  g ; senna  2  tab ; d5ns  1000  ml ; 
 
white f 91 $nan$nan$influenza virus vaccine  0.5  ml ; sodium chloride 0.9%  flush  3  ml ; docusate sodium  100  mg ; vitamin d  2000  unit ; iso-osmotic dextrose  50  ml ; piperacillin-tazobactam  2.25  g ; senna  2  tab ; d5ns  1000  ml ; 
 
white f 91 $nan$hematology blood hematocrit  37.3  %; hematology blood hemoglobin  12.3  g dl; hematology blood platelet count  238  k ul; chemistry blood anion gap  11  meq l; chemistry blood bicarbonate  27  meq l; chemistry blood chloride  108  meq l; chemistry blood creatinine  0.8  mg dl; chemistry blood potassium  4.0  meq l; chemistry blood sodium  142  meq l; chemistry blood urea nitrogen  20  mg dl; chemistry blood calcium, total  9.4  mg dl; chemistry blood glucose  100  mg dl$influenza virus vaccine  0.5  ml ; sodium chloride 0.9%  flush  3  ml ; docusate sodium  100  mg ; vitamin d  2000  unit ; senna  2  tab ; 
 
asian f 91 $temp  98.0  heartrate  104.0  resprate  14.0  o2sat  98.0  sbp  129.0  dbp  87.0  rhythm    pain  0  $hematology blood hematocrit  35.5  %; hematology blood hemoglobin  11.7  g dl; hematology blood platelet count  123  k ul; chemistry blood anion gap  15  meq l; chemistry blood anion gap  12  meq l; chemistry blood bicarbonate  33  meq l; chemistry blood bicarbonate  31  meq l; chemistry blood chloride  98  meq l; chemistry blood chloride  97  meq l; chemistry blood creatinine  1.2  mg dl; chemistry blood creatinine  1.2  mg dl; chemistry blood potassium  3.0  meq l; chemistry blood potassium  4.2  meq l; chemistry blood sodium  143  meq l; chemistry blood sodium  143  meq l; chemistry blood urea nitrogen  20  mg dl; chemistry blood urea nitrogen  22  mg dl; hematology blood inr(pt)  1.2  ; chemistry blood calcium, total  8.5  mg dl; chemistry blood calcium, total  8.9  mg dl; chemistry blood glucose  109  mg dl; chemistry blood glucose  96  mg dl$influenza vaccine quadrivalent  0.5  ml ; sodium chloride 0.9%  flush  3-10  ml ; heparin  5000  unit ; atorvastatin  20  mg ; heparin  1000-2100  unit ; 5% dextrose  250  ml ; heparin sodium  25,000  unit ; furosemide  20  mg ; polyethylene glycol  17  g ; metoprolol tartrate  12.5  mg ; potassium chloride  40  meq ; potassium chloride  20  meq ; bag  2  bag ; magnesium sulfate  4  gm ; metoprolol tartrate  25  mg ; 
 
asian f 91 $nan$hematology blood hematocrit  33.8  %; hematology blood hemoglobin  11.0  g dl; hematology blood platelet count  115  k ul; chemistry blood anion gap  13  meq l; chemistry blood bicarbonate  31  meq l; chemistry blood chloride  100  meq l; chemistry blood creatinine  1.5  mg dl; chemistry blood potassium  4.3  meq l; chemistry blood sodium  144  meq l; chemistry blood urea nitrogen  28  mg dl; chemistry blood calcium, total  8.2  mg dl; chemistry blood glucose  80  mg dl$influenza vaccine quadrivalent  0.5  ml ; sodium chloride 0.9%  flush  3-10  ml ; atorvastatin  20  mg ; polyethylene glycol  17  g ; apixaban  2.5  mg ; vial  1  vial ; ceftriaxone  1  gm ; 
 
asian f 91 $nan$hematology blood hematocrit  36.2  %; hematology blood hemoglobin  11.7  g dl; hematology blood platelet count  120  k ul; chemistry blood anion gap  14  meq l; chemistry blood anion gap  13  meq l; chemistry blood bicarbonate  31  meq l; chemistry blood bicarbonate  31  meq l; chemistry blood chloride  97  meq l; chemistry blood chloride  97  meq l; chemistry blood creatinine  1.4  mg dl; chemistry blood creatinine  1.5  mg dl; chemistry blood potassium  4.1  meq l; chemistry blood potassium  5.1  meq l; chemistry blood sodium  142  meq l; chemistry blood sodium  141  meq l; chemistry blood urea nitrogen  35  mg dl; chemistry blood urea nitrogen  38  mg dl; chemistry blood calcium, total  8.0  mg dl; chemistry blood calcium, total  8.4  mg dl; chemistry blood glucose  175  mg dl; chemistry blood glucose  68  mg dl$sodium chloride 0.9%  flush  3-10  ml ; atorvastatin  20  mg ; polyethylene glycol  17  g ; apixaban  2.5  mg ; vial  1  vial ; ceftriaxone  1  gm ; furosemide  40  mg ; metoprolol succinate xl  100  mg ; 
 
asian f 91 $nan$nan$sodium chloride 0.9%  flush  3-10  ml ; atorvastatin  20  mg ; polyethylene glycol  17  g ; apixaban  2.5  mg ; furosemide  40  mg ; metoprolol succinate xl  100  mg ; metoprolol succinate xl  50  mg ; ciprofloxacin hcl  250  mg ; 
 
white f 86 $temp  98.0  heartrate  84.0  resprate  16.0  o2sat  96.0  sbp  144.0  dbp  47.0  rhythm    pain  5  ; temp  98.5  heartrate  91.0  resprate  16.0  o2sat  95.0  sbp  158.0  dbp  67.0  rhythm    pain  4  $hematology blood hematocrit  34.3  %; hematology blood hemoglobin  11.1  g dl; hematology blood platelet count  232  k ul; chemistry blood anion gap  13  meq l; chemistry blood bicarbonate  22  meq l; chemistry blood chloride  106  meq l; chemistry blood creatinine  0.7  mg dl; chemistry blood potassium  5.2  meq l; chemistry blood sodium  141  meq l; chemistry blood urea nitrogen  14  mg dl; hematology blood inr(pt)  1.0  ; chemistry blood glucose  113  mg dl; blood gas blood lactate  1.3  mmol l; blood gas blood potassium, whole blood  4.3  meq l$nan
 
white f 86 $temp    heartrate  86.0  resprate  16.0  o2sat  97.0  sbp  135.0  dbp  60.0  rhythm    pain  4  $hematology blood hematocrit  33.1  %; hematology blood hemoglobin  10.6  g dl; hematology blood platelet count  226  k ul; chemistry blood anion gap  11  meq l; chemistry blood bicarbonate  26  meq l; chemistry blood chloride  104  meq l; chemistry blood creatinine  0.7  mg dl; chemistry blood potassium  4.2  meq l; chemistry blood sodium  141  meq l; chemistry blood urea nitrogen  11  mg dl; chemistry blood calcium, total  8.3  mg dl; chemistry blood glucose  145  mg dl$lactated ringers  1000  ml ; oxycodone (immediate release)  5  mg ; acetaminophen  1000  mg ; diazepam  2  mg ; tramadol  25  mg ; senna  8.6  mg ; heparin  5000  unit ; folic acid  1  mg ; levothyroxine sodium  75  mcg ; atorvastatin  40  mg ; enoxaparin sodium  40  mg ; 
 
white f 86 $nan$hematology blood hematocrit  26.8  %; hematology blood hemoglobin  8.9  g dl; hematology blood platelet count  191  k ul; chemistry blood anion gap  10  meq l; chemistry blood bicarbonate  24  meq l; chemistry blood chloride  105  meq l; chemistry blood creatinine  0.6  mg dl; chemistry blood potassium  4.4  meq l; chemistry blood sodium  139  meq l; chemistry blood urea nitrogen  12  mg dl; chemistry blood glucose  141  mg dl$lactated ringers  1000  ml ; acetaminophen  1000  mg ; diazepam  2  mg ; tramadol  25  mg ; senna  8.6  mg ; folic acid  1  mg ; levothyroxine sodium  75  mcg ; atorvastatin  40  mg ; enoxaparin sodium  40  mg ; morphine sulfate  1-2  mg ; oxycodone (immediate release)  2.5-5  mg ; metoprolol tartrate  5  mg ; 
 
white f 86 $nan$hematology blood hematocrit  26.7  %; hematology blood hemoglobin  8.1  g dl; hematology blood platelet count  184  k ul; chemistry blood anion gap  11  meq l; chemistry blood bicarbonate  23  meq l; chemistry blood chloride  107  meq l; chemistry blood creatinine  0.7  mg dl; chemistry blood potassium  4.4  meq l; chemistry blood sodium  141  meq l; chemistry blood urea nitrogen  15  mg dl; chemistry blood calcium, total  7.9  mg dl; chemistry blood glucose  89  mg dl$acetaminophen  1000  mg ; diazepam  2  mg ; tramadol  25  mg ; senna  8.6  mg ; folic acid  1  mg ; levothyroxine sodium  75  mcg ; atorvastatin  40  mg ; enoxaparin sodium  40  mg ; morphine sulfate  1-2  mg ; oxycodone (immediate release)  2.5-5  mg ; diltiazem  5  mg ; metoprolol tartrate  12.5  mg ; 
 
white f 86 $nan$hematology blood hematocrit  22.0  %; hematology blood hemoglobin  7.0  g dl; hematology blood platelet count  182  k ul; chemistry blood anion gap  10  meq l; chemistry blood bicarbonate  24  meq l; chemistry blood chloride  105  meq l; chemistry blood creatinine  0.6  mg dl; chemistry blood potassium  4.2  meq l; chemistry blood sodium  139  meq l; chemistry blood urea nitrogen  14  mg dl; chemistry blood glucose  138  mg dl$acetaminophen  1000  mg ; diazepam  2  mg ; tramadol  25  mg ; senna  8.6  mg ; folic acid  1  mg ; levothyroxine sodium  75  mcg ; atorvastatin  40  mg ; enoxaparin sodium  40  mg ; morphine sulfate  1-2  mg ; oxycodone (immediate release)  2.5-5  mg ; metoprolol tartrate  25  mg ; 
 
white f 86 $nan$hematology blood hematocrit  25.0  %; hematology blood hemoglobin  8.1  g dl; hematology blood platelet count  206  k ul; chemistry blood anion gap  10  meq l; chemistry blood bicarbonate  23  meq l; chemistry blood chloride  106  meq l; chemistry blood creatinine  0.6  mg dl; chemistry blood potassium  4.3  meq l; chemistry blood sodium  139  meq l; chemistry blood urea nitrogen  14  mg dl; chemistry blood glucose  88  mg dl$acetaminophen  1000  mg ; diazepam  2  mg ; tramadol  25  mg ; senna  8.6  mg ; folic acid  1  mg ; levothyroxine sodium  75  mcg ; atorvastatin  40  mg ; enoxaparin sodium  40  mg ; morphine sulfate  1-2  mg ; oxycodone (immediate release)  2.5-5  mg ; metoprolol tartrate  25  mg ; ciprofloxacin hcl  250  mg ; apixaban  2.5  mg ; trazodone  25  mg ; 
 
white f 86 $nan$hematology blood hematocrit  26.4  %; hematology blood hemoglobin  8.6  g dl; hematology blood platelet count  233  k ul; chemistry blood anion gap  13  meq l; chemistry blood bicarbonate  24  meq l; chemistry blood chloride  106  meq l; chemistry blood creatinine  0.6  mg dl; chemistry blood potassium  4.3  meq l; chemistry blood sodium  143  meq l; chemistry blood urea nitrogen  12  mg dl; hematology blood inr(pt)  1.1  ; chemistry blood glucose  80  mg dl$acetaminophen  1000  mg ; diazepam  2  mg ; tramadol  25  mg ; senna  8.6  mg ; folic acid  1  mg ; levothyroxine sodium  75  mcg ; atorvastatin  40  mg ; morphine sulfate  1-2  mg ; oxycodone (immediate release)  2.5-5  mg ; metoprolol tartrate  25  mg ; ciprofloxacin hcl  250  mg ; apixaban  2.5  mg ; trazodone  25  mg ; metoprolol succinate xl  50  mg ; metoprolol succinate xl  75  mg ; 
 
white f 86 $nan$nan$acetaminophen  1000  mg ; diazepam  2  mg ; tramadol  25  mg ; senna  8.6  mg ; folic acid  1  mg ; levothyroxine sodium  75  mcg ; atorvastatin  40  mg ; morphine sulfate  1-2  mg ; oxycodone (immediate release)  2.5-5  mg ; ciprofloxacin hcl  250  mg ; apixaban  2.5  mg ; trazodone  25  mg ; metoprolol succinate xl  75  mg ; 
 
black african american f 66 $nan$nan$iso-osmotic dextrose  50  ml ; cefazolin  1  g ; oxycodone (immediate release)  5  mg ; gabapentin  100  mg ; influenza vaccine quadrivalent  0.5  ml ; pneumococcal 23-valent polysaccharide vaccine  0.5  ml ; sodium chloride 0.9%  flush  3  ml ; sodium chloride 0.9%  1000  ml ; hydromorphone (dilaudid)  0.5-1  mg ; diazepam  5  mg ; acetaminophen  1000  mg ; senna  8.6  mg ; docusate sodium  100  mg ; levothyroxine sodium  125  mcg ; omeprazole  20  mg ; fluticasone propionate 110mcg  2  puff ; albuterol inhaler  2  puff ; labetalol  100  mg ; 
surgical operation with implant of artificial internal device causing abnormal patient reaction, or later complication,without mention of misadventure at time of operation acquired spondylolisthesis other and unspecified hyperlipidemia unspecified gastritis and gastroduodenitis, without mention of hemorrhage other digestive system complications spinal stenosis, lumbar region, without neurogenic claudication esophageal reflux unspecified acquired hypothyroidism paralytic ileus duodenal ulcer, unspecified as acute or chronic, without hemorrhage or perforation, without mention of obstruction asthma, unspecified type, unspecified 
black african american f 66 $nan$nan$oxycodone (immediate release)  5  mg ; gabapentin  100  mg ; influenza vaccine quadrivalent  0.5  ml ; pneumococcal 23-valent polysaccharide vaccine  0.5  ml ; sodium chloride 0.9%  flush  3  ml ; sodium chloride 0.9%  1000  ml ; hydromorphone (dilaudid)  0.5-1  mg ; diazepam  5  mg ; acetaminophen  1000  mg ; senna  8.6  mg ; docusate sodium  100  mg ; levothyroxine sodium  125  mcg ; omeprazole  20  mg ; fluticasone propionate 110mcg  2  puff ; albuterol inhaler  2  puff ; labetalol  100  mg ; ezetimibe  10  mg ; hydrochlorothiazide  25  mg ; oxycodone (immediate release)  2.5  mg ; oxybutynin  5  mg ; colestipol  2  g ; irbesartan  150  mg ; 
surgical operation with implant of artificial internal device causing abnormal patient reaction, or later complication,without mention of misadventure at time of operation acquired spondylolisthesis other and unspecified hyperlipidemia unspecified gastritis and gastroduodenitis, without mention of hemorrhage other digestive system complications spinal stenosis, lumbar region, without neurogenic claudication esophageal reflux unspecified acquired hypothyroidism paralytic ileus duodenal ulcer, unspecified as acute or chronic, without hemorrhage or perforation, without mention of obstruction asthma, unspecified type, unspecified 
black african american f 66 $nan$nan$oxycodone (immediate release)  5  mg ; gabapentin  100  mg ; influenza vaccine quadrivalent  0.5  ml ; pneumococcal 23-valent polysaccharide vaccine  0.5  ml ; sodium chloride 0.9%  flush  3  ml ; sodium chloride 0.9%  1000  ml ; diazepam  5  mg ; acetaminophen  1000  mg ; senna  8.6  mg ; docusate sodium  100  mg ; levothyroxine sodium  125  mcg ; omeprazole  20  mg ; fluticasone propionate 110mcg  2  puff ; albuterol inhaler  2  puff ; labetalol  100  mg ; ezetimibe  10  mg ; hydrochlorothiazide  25  mg ; oxybutynin  5  mg ; colestipol  2  g ; irbesartan  150  mg ; 
surgical operation with implant of artificial internal device causing abnormal patient reaction, or later complication,without mention of misadventure at time of operation acquired spondylolisthesis other and unspecified hyperlipidemia unspecified gastritis and gastroduodenitis, without mention of hemorrhage other digestive system complications spinal stenosis, lumbar region, without neurogenic claudication esophageal reflux unspecified acquired hypothyroidism paralytic ileus duodenal ulcer, unspecified as acute or chronic, without hemorrhage or perforation, without mention of obstruction asthma, unspecified type, unspecified 
black african american f 66 $nan$nan$oxycodone (immediate release)  5  mg ; gabapentin  100  mg ; influenza vaccine quadrivalent  0.5  ml ; pneumococcal 23-valent polysaccharide vaccine  0.5  ml ; sodium chloride 0.9%  flush  3  ml ; sodium chloride 0.9%  1000  ml ; diazepam  5  mg ; acetaminophen  1000  mg ; senna  8.6  mg ; docusate sodium  100  mg ; levothyroxine sodium  125  mcg ; omeprazole  20  mg ; fluticasone propionate 110mcg  2  puff ; albuterol inhaler  2  puff ; labetalol  100  mg ; ezetimibe  10  mg ; hydrochlorothiazide  25  mg ; oxybutynin  5  mg ; colestipol  2  g ; irbesartan  150  mg ; 
surgical operation with implant of artificial internal device causing abnormal patient reaction, or later complication,without mention of misadventure at time of operation acquired spondylolisthesis other and unspecified hyperlipidemia unspecified gastritis and gastroduodenitis, without mention of hemorrhage other digestive system complications spinal stenosis, lumbar region, without neurogenic claudication esophageal reflux unspecified acquired hypothyroidism paralytic ileus duodenal ulcer, unspecified as acute or chronic, without hemorrhage or perforation, without mention of obstruction asthma, unspecified type, unspecified 
black african american f 66 $nan$nan$oxycodone (immediate release)  5  mg ; gabapentin  100  mg ; influenza vaccine quadrivalent  0.5  ml ; pneumococcal 23-valent polysaccharide vaccine  0.5  ml ; sodium chloride 0.9%  flush  3  ml ; sodium chloride 0.9%  1000  ml ; diazepam  5  mg ; acetaminophen  1000  mg ; senna  8.6  mg ; docusate sodium  100  mg ; levothyroxine sodium  125  mcg ; omeprazole  20  mg ; fluticasone propionate 110mcg  2  puff ; albuterol inhaler  2  puff ; ezetimibe  10  mg ; hydrochlorothiazide  25  mg ; oxybutynin  5  mg ; colestipol  2  g ; 
surgical operation with implant of artificial internal device causing abnormal patient reaction, or later complication,without mention of misadventure at time of operation acquired spondylolisthesis other and unspecified hyperlipidemia unspecified gastritis and gastroduodenitis, without mention of hemorrhage other digestive system complications spinal stenosis, lumbar region, without neurogenic claudication esophageal reflux unspecified acquired hypothyroidism paralytic ileus duodenal ulcer, unspecified as acute or chronic, without hemorrhage or perforation, without mention of obstruction asthma, unspecified type, unspecified 
white m 40 $nan$nan$aspirin ec  325  mg ; clopidogrel bisulfate  75  mg ; pravastatin  80  mg ; lisinopril  2.5  mg ; 
 
white m 40 $nan$hematology blood hematocrit  39.6  %; hematology blood hemoglobin  13.9  g dl; hematology blood platelet count  263  k ul; chemistry blood anion gap  17  meq l; chemistry blood bicarbonate  26  meq l; chemistry blood chloride  103  meq l; chemistry blood creatinine  1.1  mg dl; chemistry blood potassium  4.5  meq l; chemistry blood sodium  141  meq l; chemistry blood urea nitrogen  15  mg dl; hematology blood inr(pt)  1.1  ; chemistry blood bilirubin, total  0.8  mg dl; chemistry blood glucose  110  mg dl; chemistry blood lactate dehydrogenase (ld)  249  iu l; chemistry blood albumin  4.8  g dl; chemistry blood % hemoglobin a1c  6.0  %$aspirin ec  325  mg ; clopidogrel bisulfate  75  mg ; pravastatin  80  mg ; lisinopril  2.5  mg ; 1 2 ns  1000  ml ; sw  100  ml ; eptifibatide  75  mg ; sodium chloride 0.9%  flush  3  ml ; metoprolol  12.5  mg ; acetaminophen  325-650  mg ; lamotrigine  75  mg ; 
 
white m 40 $nan$hematology blood hematocrit  41.0  %; hematology blood hemoglobin  13.8  g dl; hematology blood platelet count  274  k ul; chemistry blood anion gap  23  meq l; chemistry blood bicarbonate  18  meq l; chemistry blood chloride  108  meq l; chemistry blood creatinine  1.3  mg dl; chemistry blood potassium  4.7  meq l; chemistry blood sodium  144  meq l; chemistry blood urea nitrogen  18  mg dl; hematology blood inr(pt)  1.2  ; chemistry blood bilirubin, total  0.6  mg dl; chemistry blood glucose  122  mg dl; chemistry blood lactate dehydrogenase (ld)  279  iu l; chemistry blood albumin  4.7  g dl$aspirin ec  325  mg ; clopidogrel bisulfate  75  mg ; pravastatin  80  mg ; lisinopril  2.5  mg ; sodium chloride 0.9%  flush  3  ml ; acetaminophen  325-650  mg ; lamotrigine  75  mg ; warfarin  5  mg ; heparin  1600-3300  unit ; d5w  250  ml ; heparin sodium  25,000  unit ; metoprolol  25  mg ; fluticasone propionate nasal  1  spry ; enoxaparin sodium  120  mg ; 
 
white m 40 $nan$hematology blood hematocrit  41.1  %; hematology blood hemoglobin  13.8  g dl; hematology blood platelet count  274  k ul; chemistry blood anion gap  13  meq l; chemistry blood bicarbonate  26  meq l; chemistry blood chloride  105  meq l; chemistry blood creatinine  1.2  mg dl; chemistry blood potassium  4.3  meq l; chemistry blood sodium  140  meq l; chemistry blood urea nitrogen  20  mg dl; hematology blood inr(pt)  1.1  ; chemistry blood glucose  102  mg dl$aspirin ec  325  mg ; clopidogrel bisulfate  75  mg ; pravastatin  80  mg ; lisinopril  2.5  mg ; sodium chloride 0.9%  flush  3  ml ; acetaminophen  325-650  mg ; lamotrigine  75  mg ; warfarin  5  mg ; metoprolol  25  mg ; fluticasone propionate nasal  1  spry ; enoxaparin sodium  120  mg ; 
 
white m 40 $nan$nan$aspirin ec  325  mg ; clopidogrel bisulfate  75  mg ; pravastatin  80  mg ; lisinopril  2.5  mg ; sodium chloride 0.9%  flush  3  ml ; acetaminophen  325-650  mg ; lamotrigine  75  mg ; warfarin  5  mg ; metoprolol  25  mg ; fluticasone propionate nasal  1  spry ; enoxaparin sodium  120  mg ; 
 
white m 77 $temp  97.8  heartrate  70.0  resprate  16.0  o2sat  96.0  sbp  154.0  dbp  52.0  rhythm    pain  3  ; temp    heartrate  67.0  resprate  15.0  o2sat  99.0  sbp  169.0  dbp  84.0  rhythm    pain  0  ; temp    heartrate  63.0  resprate  17.0  o2sat  100.0  sbp  151.0  dbp  70.0  rhythm    pain  0  ; temp    heartrate  68.0  resprate  20.0  o2sat  97.0  sbp  143.0  dbp  88.0  rhythm    pain  0  ; temp    heartrate  73.0  resprate  17.0  o2sat  99.0  sbp  134.0  dbp  61.0  rhythm    pain  0  ; temp    heartrate  76.0  resprate  20.0  o2sat  99.0  sbp  129.0  dbp  68.0  rhythm    pain  0  ; temp    heartrate  81.0  resprate  16.0  o2sat  97.0  sbp  137.0  dbp  72.0  rhythm    pain  0  ; temp    heartrate  79.0  resprate  20.0  o2sat  97.0  sbp  121.0  dbp  56.0  rhythm    pain    ; temp  97.5  heartrate  85.0  resprate  22.0  o2sat  97.0  sbp  123.0  dbp  61.0  rhythm    pain  8  ; temp    heartrate  75.0  resprate  18.0  o2sat  96.0  sbp  123.0  dbp  47.0  rhythm    pain  asleep  ; temp  98.0  heartrate  76.0  resprate  13.0  o2sat  98.0  sbp  97.0  dbp  56.0  rhythm    pain  unable  ; temp    heartrate  81.0  resprate  19.0  o2sat  97.0  sbp  108.0  dbp  55.0  rhythm    pain  unable  ; temp    heartrate  86.0  resprate  24.0  o2sat  95.0  sbp  129.0  dbp  65.0  rhythm    pain    ; temp    heartrate  76.0  resprate  27.0  o2sat  91.0  sbp  110.0  dbp  67.0  rhythm    pain    $hematology blood hematocrit  41.7  %; hematology blood hemoglobin  14.2  g dl; hematology blood platelet count  155  k ul; hematology blood platelet count  219  k ul; chemistry blood anion gap  22  meq l; chemistry blood bicarbonate  19  meq l; chemistry blood chloride  104  meq l; chemistry blood creatinine  1.0  mg dl; chemistry blood potassium  4.1  meq l; chemistry blood sodium  141  meq l; chemistry blood urea nitrogen  25  mg dl; hematology blood inr(pt)  1.0  ; hematology urine wbc  1  # hpf; chemistry blood calcium, total  9.0  mg dl; chemistry blood glucose  122  mg dl$nan
 
white m 77 $temp  97.6  heartrate  72.0  resprate  26.0  o2sat  92.0  sbp  98.0  dbp  55.0  rhythm    pain  6  ; temp    heartrate  69.0  resprate  26.0  o2sat  91.0  sbp  124.0  dbp  52.0  rhythm    pain  4  ; temp  97.6  heartrate  75.0  resprate  22.0  o2sat  98.0  sbp  109.0  dbp  50.0  rhythm    pain  0  $hematology blood hematocrit  40.0  %; hematology blood hemoglobin  13.5  g dl; hematology blood platelet count  200  k ul; chemistry blood anion gap  23  meq l; chemistry blood anion gap  17  meq l; chemistry blood bicarbonate  18  meq l; chemistry blood bicarbonate  22  meq l; chemistry blood chloride  102  meq l; chemistry blood chloride  105  meq l; chemistry blood creatinine  0.9  mg dl; chemistry blood creatinine  0.8  mg dl; chemistry blood potassium  4.3  meq l; chemistry blood potassium  3.8  meq l; chemistry blood sodium  139  meq l; chemistry blood sodium  140  meq l; chemistry blood urea nitrogen  25  mg dl; chemistry blood urea nitrogen  21  mg dl; hematology blood inr(pt)  1.1  ; chemistry blood calcium, total  8.7  mg dl; chemistry blood bilirubin, total  2.7  mg dl; chemistry blood bilirubin, total  2.4  mg dl; chemistry blood glucose  202  mg dl; chemistry blood glucose  171  mg dl; blood gas blood lactate  1.5  mmol l; chemistry blood % hemoglobin a1c  6.6  %$influenza vaccine quadrivalent  0.5  ml ; pneumococcal 23-valent polysaccharide vaccine  0.5  ml ; sodium chloride 0.9%  flush  3  ml ; docusate sodium  100  mg ; senna  8.6  mg ; bisacodyl  10  mg ; acetaminophen  650  mg ; hydralazine  10  mg ; dextrose 50%  12.5  gm ; glucagon  1  mg ; glucose gel  15  g ; insulin  0  unit ; 0.83% sodium chloride  200  ml ; nicardipine iv  40  mg ; sodium chloride 0.9%  1000  ml ; lisinopril  10  mg ; loratadine  10  mg ; hydralazine  10-20  mg ; labetalol  10  mg ; metoprolol tartrate  12.5  mg ; latanoprost 0.005% ophth. soln.  1  drop ; 
 
white m 77 $nan$hematology blood hematocrit  41.8  %; hematology blood hemoglobin  14.2  g dl; hematology blood platelet count  205  k ul; chemistry blood anion gap  21  meq l; chemistry blood anion gap  19  meq l; chemistry blood bicarbonate  19  meq l; chemistry blood bicarbonate  21  meq l; chemistry blood chloride  103  meq l; chemistry blood chloride  103  meq l; chemistry blood creatinine  0.8  mg dl; chemistry blood creatinine  0.8  mg dl; chemistry blood potassium  3.9  meq l; chemistry blood potassium  5.1  meq l; chemistry blood sodium  138  meq l; chemistry blood sodium  139  meq l; chemistry blood urea nitrogen  18  mg dl; chemistry blood urea nitrogen  23  mg dl; hematology blood inr(pt)  1.1  ; chemistry blood calcium, total  8.7  mg dl; chemistry blood calcium, total  9.0  mg dl; chemistry blood glucose  181  mg dl; chemistry blood glucose  238  mg dl$influenza vaccine quadrivalent  0.5  ml ; pneumococcal 23-valent polysaccharide vaccine  0.5  ml ; sodium chloride 0.9%  flush  3  ml ; docusate sodium  100  mg ; senna  8.6  mg ; bisacodyl  10  mg ; dextrose 50%  12.5  gm ; glucagon  1  mg ; glucose gel  15  g ; 0.83% sodium chloride  200  ml ; nicardipine iv  40  mg ; sodium chloride 0.9%  1000  ml ; lisinopril  10  mg ; loratadine  10  mg ; hydralazine  10-20  mg ; labetalol  10  mg ; metoprolol tartrate  12.5  mg ; latanoprost 0.005% ophth. soln.  1  drop ; lisinopril  20  mg ; metoprolol tartrate  25  mg ; insulin  10  unit ; insulin  15  unit ; 
 
white m 77 $nan$hematology blood hematocrit  42.4  %; hematology blood hemoglobin  14.2  g dl; hematology blood platelet count  207  k ul; chemistry blood anion gap  19  meq l; chemistry blood bicarbonate  20  meq l; chemistry blood chloride  104  meq l; chemistry blood creatinine  0.7  mg dl; chemistry blood potassium  3.5  meq l; chemistry blood sodium  139  meq l; chemistry blood urea nitrogen  23  mg dl; hematology blood inr(pt)  1.1  ; chemistry blood calcium, total  8.7  mg dl; chemistry blood glucose  177  mg dl$influenza vaccine quadrivalent  0.5  ml ; pneumococcal 23-valent polysaccharide vaccine  0.5  ml ; sodium chloride 0.9%  flush  3  ml ; docusate sodium  100  mg ; senna  8.6  mg ; bisacodyl  10  mg ; dextrose 50%  12.5  gm ; glucagon  1  mg ; glucose gel  15  g ; sodium chloride 0.9%  1000  ml ; loratadine  10  mg ; hydralazine  10-20  mg ; latanoprost 0.005% ophth. soln.  1  drop ; lisinopril  20  mg ; metoprolol tartrate  25  mg ; cyclobenzaprine  5  mg ; oxycodone--acetaminophen (5mg-325mg)  1  tab ; insulin  17  unit ; 
 
white m 77 $nan$nan$influenza vaccine quadrivalent  0.5  ml ; pneumococcal 23-valent polysaccharide vaccine  0.5  ml ; sodium chloride 0.9%  flush  3  ml ; docusate sodium  100  mg ; senna  8.6  mg ; bisacodyl  10  mg ; dextrose 50%  12.5  gm ; glucagon  1  mg ; glucose gel  15  g ; loratadine  10  mg ; hydralazine  10-20  mg ; latanoprost 0.005% ophth. soln.  1  drop ; metoprolol tartrate  25  mg ; cyclobenzaprine  5  mg ; oxycodone--acetaminophen (5mg-325mg)  1  tab ; insulin  17  unit ; lisinopril  40  mg ; carvedilol  6.25  mg ; insulin  19  unit ; calcium carbonate  500  mg ; 
 
white m 77 $nan$hematology blood hematocrit  44.5  %; hematology blood hemoglobin  14.7  g dl; hematology blood platelet count  220  k ul; chemistry blood anion gap  18  meq l; chemistry blood bicarbonate  24  meq l; chemistry blood chloride  103  meq l; chemistry blood creatinine  0.7  mg dl; chemistry blood potassium  3.6  meq l; chemistry blood sodium  141  meq l; chemistry blood urea nitrogen  31  mg dl; chemistry blood calcium, total  8.9  mg dl; chemistry blood glucose  190  mg dl$influenza vaccine quadrivalent  0.5  ml ; pneumococcal 23-valent polysaccharide vaccine  0.5  ml ; sodium chloride 0.9%  flush  3  ml ; docusate sodium  100  mg ; senna  8.6  mg ; bisacodyl  10  mg ; dextrose 50%  12.5  gm ; glucagon  1  mg ; glucose gel  15  g ; loratadine  10  mg ; hydralazine  10-20  mg ; latanoprost 0.005% ophth. soln.  1  drop ; cyclobenzaprine  5  mg ; oxycodone--acetaminophen (5mg-325mg)  1  tab ; lisinopril  40  mg ; carvedilol  6.25  mg ; insulin  19  unit ; calcium carbonate  500  mg ; amlodipine  5  mg ; insulin  21  unit ; diphenhydramine  12.5  mg ; prochlorperazine  10  mg ; 
 
white m 77 $nan$hematology blood hematocrit  42.1  %; hematology blood hemoglobin  14.2  g dl; hematology blood platelet count  202  k ul; chemistry blood anion gap  16  meq l; chemistry blood bicarbonate  26  meq l; chemistry blood chloride  104  meq l; chemistry blood creatinine  0.7  mg dl; chemistry blood potassium  3.5  meq l; chemistry blood sodium  142  meq l; chemistry blood urea nitrogen  35  mg dl; chemistry blood calcium, total  8.6  mg dl; chemistry blood glucose  85  mg dl$influenza vaccine quadrivalent  0.5  ml ; pneumococcal 23-valent polysaccharide vaccine  0.5  ml ; sodium chloride 0.9%  flush  3  ml ; docusate sodium  100  mg ; senna  8.6  mg ; bisacodyl  10  mg ; dextrose 50%  12.5  gm ; glucagon  1  mg ; glucose gel  15  g ; loratadine  10  mg ; hydralazine  10-20  mg ; latanoprost 0.005% ophth. soln.  1  drop ; cyclobenzaprine  5  mg ; oxycodone--acetaminophen (5mg-325mg)  1  tab ; lisinopril  40  mg ; calcium carbonate  500  mg ; insulin  21  unit ; diphenhydramine  12.5  mg ; prochlorperazine  10  mg ; amlodipine  10  mg ; 
 
white f 61 $temp  99.0  heartrate  110.0  resprate  16.0  o2sat  96.0  sbp  119.0  dbp  76.0  rhythm    pain    $hematology blood hematocrit  28.0  %; hematology blood hemoglobin  9.4  g dl; hematology blood platelet count  269  k ul; chemistry blood anion gap  18  meq l; chemistry blood bicarbonate  22  meq l; chemistry blood chloride  99  meq l; chemistry blood creatinine  0.9  mg dl; chemistry blood potassium  3.0  meq l; chemistry blood sodium  136  meq l; chemistry blood urea nitrogen  13  mg dl; chemistry blood calcium, total  7.1  mg dl; chemistry blood glucose  103  mg dl$sodium chloride 0.9%  flush  3  ml ; sodium chloride 0.9%  1000  ml ; heparin  5000  unit ; acetaminophen  1000  mg ; docusate sodium  200  mg ; folic acid  1  mg ; ondansetron  4-8  mg ; oxycodone (immediate release)  5  mg ; polyethylene glycol  17  g ; prochlorperazine  10  mg ; atorvastatin  40  mg ; clonazepam  0.5  mg ; ramelteon  8  mg ; trazodone  50  mg ; ranitidine  150  mg ; escitalopram oxalate  5  mg ; clotrimazole  1  troc ; potassium chloride replacement (critical care and oncology)   40  meq ; potassium chloride replacement (critical care and oncology)   60  meq ; potassium chloride replacement (critical care and oncology)   80  meq ; bag  1  bag ; magnesium sulfate  2  gm ; bag  2  bag ; magnesium sulfate  4  gm ; 
neoplasm related pain (acute) (chronic) toxic encephalopathy dehydration adverse effect of benzodiazepines, initial encounter emphysema, unspecified hypotension, unspecified visual hallucinations nausea with vomiting, unspecified malignant neoplasm of lower lobe, right bronchus or lung adverse effect of other opioids, initial encounter unspecified place in unspecified non-institutional (private) residence as the place of occurrence of the external cause secondary malignant neoplasm of pleura pure hypercholesterolemia, unspecified insomnia, unspecified personal history of other malignant neoplasm of skin anxiety disorder, unspecified secondary malignant neoplasm of bone do not resuscitate other fatigue contact with and (suspected) exposure to asbestos personal history of nicotine dependence 
white f 61 $nan$nan$sodium chloride 0.9%  flush  3  ml ; heparin  5000  unit ; acetaminophen  1000  mg ; docusate sodium  200  mg ; folic acid  1  mg ; ondansetron  4-8  mg ; oxycodone (immediate release)  5  mg ; polyethylene glycol  17  g ; prochlorperazine  10  mg ; atorvastatin  40  mg ; clonazepam  0.5  mg ; ramelteon  8  mg ; trazodone  50  mg ; ranitidine  150  mg ; escitalopram oxalate  5  mg ; clotrimazole  1  troc ; potassium chloride replacement (critical care and oncology)   40  meq ; potassium chloride replacement (critical care and oncology)   60  meq ; potassium chloride replacement (critical care and oncology)   80  meq ; bag  1  bag ; magnesium sulfate  2  gm ; bag  2  bag ; magnesium sulfate  4  gm ; 
neoplasm related pain (acute) (chronic) toxic encephalopathy dehydration adverse effect of benzodiazepines, initial encounter emphysema, unspecified hypotension, unspecified visual hallucinations nausea with vomiting, unspecified malignant neoplasm of lower lobe, right bronchus or lung adverse effect of other opioids, initial encounter unspecified place in unspecified non-institutional (private) residence as the place of occurrence of the external cause secondary malignant neoplasm of pleura pure hypercholesterolemia, unspecified insomnia, unspecified personal history of other malignant neoplasm of skin anxiety disorder, unspecified secondary malignant neoplasm of bone do not resuscitate other fatigue contact with and (suspected) exposure to asbestos personal history of nicotine dependence 
other f 79 $temp  97.9  heartrate  36.0  resprate  20.0  o2sat  96.0  sbp  156.0  dbp  43.0  rhythm  sinus bradycardia  pain  4  ; temp  98.3  heartrate  38.0  resprate  20.0  o2sat  98.0  sbp  156.0  dbp  80.0  rhythm    pain  4  $hematology blood hematocrit  37.1  %; hematology blood hemoglobin  12.0  g dl; hematology blood platelet count  248  k ul; chemistry blood anion gap  15  meq l; chemistry blood bicarbonate  24  meq l; chemistry blood chloride  111  meq l; chemistry blood creatinine  2.2  mg dl; chemistry blood potassium  4.1  meq l; chemistry blood sodium  146  meq l; chemistry blood urea nitrogen  61  mg dl; hematology blood inr(pt)  1.0  ; chemistry urine chloride, urine  82  meq l; chemistry urine creatinine, urine  74  mg dl; chemistry urine potassium, urine  57  meq l; chemistry urine sodium, urine  76  meq l; chemistry urine urea nitrogen, urine  667  mg dl; hematology urine wbc  3  # hpf; hematology urine wbc  1  # hpf; chemistry blood calcium, total  8.4  mg dl; chemistry blood glucose  210  mg dl$influenza virus vaccine  0.5  ml ; pneumococcal 23-valent polysaccharide vaccine  0.5  ml ; sodium chloride 0.9%  flush  3  ml ; 0.9% sodium chloride  1000  ml ; albuterol inhaler  1  puff ; aspirin  81  mg ; dextrose 50%  12.5  gm ; glucagon  1  mg ; glucose gel  15  g ; insulin  0  unit ; heparin  5000  unit ; simvastatin  20  mg ; hydralazine  25  mg ; 
constipation, unspecified diabetes mellitus without mention of complication, type ii or unspecified type, not stated as uncontrolled subarachnoid hemorrhage unspecified essential hypertension other and unspecified hyperlipidemia 
other f 79 $nan$chemistry blood anion gap  20  meq l; chemistry blood bicarbonate  20  meq l; chemistry blood chloride  110  meq l; chemistry blood creatinine  2.1  mg dl; chemistry blood potassium  3.8  meq l; chemistry blood sodium  146  meq l; chemistry blood urea nitrogen  54  mg dl$sodium chloride 0.9%  flush  3  ml ; albuterol inhaler  1  puff ; aspirin  81  mg ; dextrose 50%  12.5  gm ; glucagon  1  mg ; glucose gel  15  g ; insulin  0  unit ; heparin  5000  unit ; simvastatin  20  mg ; hydralazine  25  mg ; hydralazine  50  mg ; acetaminophen  650  mg ; 
constipation, unspecified diabetes mellitus without mention of complication, type ii or unspecified type, not stated as uncontrolled subarachnoid hemorrhage unspecified essential hypertension other and unspecified hyperlipidemia 
other f 79 $nan$chemistry blood anion gap  13  meq l; chemistry blood bicarbonate  24  meq l; chemistry blood chloride  106  meq l; chemistry blood creatinine  2.0  mg dl; chemistry blood potassium  4.4  meq l; chemistry blood sodium  139  meq l; chemistry blood urea nitrogen  49  mg dl$sodium chloride 0.9%  flush  3  ml ; albuterol inhaler  1  puff ; aspirin  81  mg ; dextrose 50%  12.5  gm ; glucagon  1  mg ; glucose gel  15  g ; insulin  0  unit ; heparin  5000  unit ; simvastatin  20  mg ; acetaminophen  650  mg ; acetaminophen  1000  mg ; tramadol (ultram)  12.5  mg ; iso-osmotic dextrose  200  ml ; vancomycin  1000  mg ; insulin  12  unit ; cephalexin  500  mg ; docusate sodium  100  mg ; senna  8.6  mg ; sodium chloride 0.9%  1  ml ; 
constipation, unspecified diabetes mellitus without mention of complication, type ii or unspecified type, not stated as uncontrolled subarachnoid hemorrhage unspecified essential hypertension other and unspecified hyperlipidemia 
other f 79 $nan$chemistry blood anion gap  15  meq l; chemistry blood bicarbonate  23  meq l; chemistry blood chloride  105  meq l; chemistry blood creatinine  2.3  mg dl; chemistry blood potassium  4.5  meq l; chemistry blood sodium  138  meq l; chemistry blood urea nitrogen  53  mg dl$sodium chloride 0.9%  flush  3  ml ; albuterol inhaler  1  puff ; aspirin  81  mg ; dextrose 50%  12.5  gm ; glucagon  1  mg ; glucose gel  15  g ; heparin  5000  unit ; simvastatin  20  mg ; acetaminophen  1000  mg ; tramadol (ultram)  12.5  mg ; insulin  12  unit ; docusate sodium  100  mg ; senna  8.6  mg ; sodium chloride 0.9%  1  ml ; bisacodyl  10  mg ; 
constipation, unspecified diabetes mellitus without mention of complication, type ii or unspecified type, not stated as uncontrolled subarachnoid hemorrhage unspecified essential hypertension other and unspecified hyperlipidemia 
white m 87 $nan$nan$quinapril  40  mg ; hydrochlorothiazide  12.5  mg ; finasteride  5  mg ; aspirin  81  mg ; atorvastatin  40  mg ; 
pure hypercholesterolemia hypertrophy (benign) of prostate without urinary obstruction and other lower urinary tract symptom (luts) open wound of forehead, without mention of complication old myocardial infarction coronary atherosclerosis of native coronary artery chest pain, unspecified black eye, not otherwise specified fall from other slipping, tripping, or stumbling
white m 87 $nan$hematology blood hematocrit  44.1  %; hematology blood hemoglobin  15.0  g dl; hematology blood platelet count  157  k ul; chemistry blood anion gap  14  meq l; chemistry blood bicarbonate  28  meq l; chemistry blood chloride  103  meq l; chemistry blood creatinine  1.0  mg dl; chemistry blood potassium  4.1  meq l; chemistry blood sodium  141  meq l; chemistry blood urea nitrogen  24  mg dl; hematology blood inr(pt)  1.2  ; chemistry blood calcium, total  9.2  mg dl; chemistry blood glucose  92  mg dl$quinapril  40  mg ; hydrochlorothiazide  12.5  mg ; finasteride  5  mg ; aspirin  81  mg ; atorvastatin  40  mg ; pneumococcal vac polyvalent  0.5  ml ; sodium chloride 0.9%  flush  3  ml ; docusate sodium  100  mg ; heparin  5000  unit ; metoprolol tartrate  25  mg ; potassium chloride  20  meq ; tamsulosin  0.4  mg ; aspirin  325  mg ; 
pure hypercholesterolemia hypertrophy (benign) of prostate without urinary obstruction and other lower urinary tract symptom (luts) open wound of forehead, without mention of complication old myocardial infarction coronary atherosclerosis of native coronary artery chest pain, unspecified black eye, not otherwise specified fall from other slipping, tripping, or stumbling
white m 87 $nan$nan$quinapril  40  mg ; hydrochlorothiazide  12.5  mg ; finasteride  5  mg ; atorvastatin  40  mg ; pneumococcal vac polyvalent  0.5  ml ; sodium chloride 0.9%  flush  3  ml ; docusate sodium  100  mg ; heparin  5000  unit ; metoprolol tartrate  25  mg ; potassium chloride  20  meq ; tamsulosin  0.4  mg ; aspirin  325  mg ; 
pure hypercholesterolemia hypertrophy (benign) of prostate without urinary obstruction and other lower urinary tract symptom (luts) open wound of forehead, without mention of complication old myocardial infarction coronary atherosclerosis of native coronary artery chest pain, unspecified black eye, not otherwise specified fall from other slipping, tripping, or stumbling
black african american f 61 $temp    heartrate  103.0  resprate  20.0  o2sat  92.0  sbp  114.0  dbp  50.0  rhythm    pain  0  ; temp  98.8  heartrate  101.0  resprate  20.0  o2sat  95.0  sbp  114.0  dbp  50.0  rhythm    pain  0  $hematology blood hematocrit  32.1  %; hematology blood hemoglobin  10.3  g dl; hematology blood platelet count  151  k ul; chemistry blood anion gap  13  meq l; chemistry blood bicarbonate  28  meq l; chemistry blood chloride  101  meq l; chemistry blood creatinine  1.7  mg dl; chemistry blood potassium  3.5  meq l; chemistry blood sodium  138  meq l; chemistry blood urea nitrogen  21  mg dl; chemistry blood calcium, total  9.1  mg dl; chemistry blood glucose  130  mg dl$influenza virus vaccine  0.5  ml ; sodium chloride 0.9%  flush  3  ml ; acetaminophen  1000  mg ; metronidazole (flagyl)  500  mg ; docusate sodium  100  mg ; senna  1  tab ; albuterol 0.083% neb soln  1  neb ; ipratropium bromide neb  1  neb ; diazepam  10  mg ; multivitamin iv  10  ml ; thiamine  100  mg ; 0.9% sodium chloride  1000  ml ; folic acid  1  mg ; heparin  5000  unit ; quetiapine fumarate  100  mg ; oxycodone (immediate release)   5  mg ; levofloxacin  750  mg ; amlodipine  10  mg ; multivitamins  1  tab ; nicotine patch  21  mg ; amlodipine  5  mg ; furosemide  20  mg ; omeprazole  20  mg ; lidocaine 5% patch  1  ptch ; citalopram  40  mg ; citalopram  20  mg ; gabapentin  600  mg ; quetiapine fumarate  25  mg ; 5% dextrose  250  ml ; thiamine  500  mg ; bisacodyl  10  mg ; 
edema hypopotassemia nonspecific reaction to tuberculin skin test without active tuberculosis cocaine dependence, unspecified osteoporosis, unspecified asthma, unspecified type, unspecified suicidal ideation acute kidney failure, unspecified chronic kidney disease, stage ii (mild) personal history of venous thrombosis and embolism tobacco use disorder hypertensive chronic kidney disease, benign, with chronic kidney disease stage i through stage iv, or unspecified hypoxemia metabolic encephalopathy other and unspecified hyperlipidemia unspecified viral hepatitis c without hepatic coma unspecified persistent mental disorders due to conditions classified elsewhere pain in limb personal history of malignant neoplasm of breast person boarding or alighting a pedal cycle injured in collision with pedestrian or animal depressive disorder, not elsewhere classified other and unspecified alcohol dependence, continuous dehydration prinzmetal angina other and unspecified hyperlipidemia other and unspecified alcohol dependence, continuous cocaine dependence, unspecified old myocardial infarction poisoning by cocaine osteoporosis, unspecified hypertensive chronic kidney disease, unspecified, with chronic kidney disease stage i through stage iv, or unspecified accidental poisoning by central nervous system stimulants chronic obstructive asthma, unspecified chronic kidney disease, unspecified pain in limb tobacco use disorder personal history of transient ischemic attack (tia), and cerebral infarction without residual deficits person boarding or alighting a pedal cycle injured in collision with pedestrian or animal depressive disorder, not elsewhere classified suicidal ideation rheumatoid arthritis acquired absence of breast and nipple personal history of venous thrombosis and embolism diarrhea personal history of malignant neoplasm of breast acidosis unspecified viral hepatitis c without hepatic coma obstructive chronic bronchitis with acute bronchitis
black african american f 61 $nan$hematology blood hematocrit  33.6  %; hematology blood hemoglobin  10.6  g dl; hematology blood platelet count  161  k ul; chemistry blood anion gap  9  meq l; chemistry blood bicarbonate  33  meq l; chemistry blood chloride  104  meq l; chemistry blood creatinine  1.5  mg dl; chemistry blood potassium  4.7  meq l; chemistry blood sodium  141  meq l; chemistry blood urea nitrogen  21  mg dl; chemistry blood calcium, total  9.3  mg dl; chemistry blood glucose  86  mg dl; chemistry blood albumin  3.8  g dl$influenza virus vaccine  0.5  ml ; sodium chloride 0.9%  flush  3  ml ; metronidazole (flagyl)  500  mg ; docusate sodium  100  mg ; senna  1  tab ; albuterol 0.083% neb soln  1  neb ; ipratropium bromide neb  1  neb ; diazepam  10  mg ; heparin  5000  unit ; levofloxacin  750  mg ; multivitamins  1  tab ; nicotine patch  21  mg ; amlodipine  5  mg ; furosemide  20  mg ; omeprazole  20  mg ; lidocaine 5% patch  1  ptch ; citalopram  20  mg ; gabapentin  600  mg ; quetiapine fumarate  25  mg ; 5% dextrose  250  ml ; thiamine  500  mg ; bisacodyl  10  mg ; mirtazapine  7.5  mg ; quetiapine fumarate  50  mg ; bag  100  ml ; magnesium sulfate  4  gm ; neutra-phos  2  pkt ; potassium chloride  40  meq ; bag  50  ml ; docusate sodium  200  mg ; 0.9% sodium chloride  250  ml ; sodium phosphate  15  mmol ; 
edema hypopotassemia nonspecific reaction to tuberculin skin test without active tuberculosis cocaine dependence, unspecified osteoporosis, unspecified asthma, unspecified type, unspecified suicidal ideation acute kidney failure, unspecified chronic kidney disease, stage ii (mild) personal history of venous thrombosis and embolism tobacco use disorder hypertensive chronic kidney disease, benign, with chronic kidney disease stage i through stage iv, or unspecified hypoxemia metabolic encephalopathy other and unspecified hyperlipidemia unspecified viral hepatitis c without hepatic coma unspecified persistent mental disorders due to conditions classified elsewhere pain in limb personal history of malignant neoplasm of breast person boarding or alighting a pedal cycle injured in collision with pedestrian or animal depressive disorder, not elsewhere classified other and unspecified alcohol dependence, continuous dehydration prinzmetal angina other and unspecified hyperlipidemia other and unspecified alcohol dependence, continuous cocaine dependence, unspecified old myocardial infarction poisoning by cocaine osteoporosis, unspecified hypertensive chronic kidney disease, unspecified, with chronic kidney disease stage i through stage iv, or unspecified accidental poisoning by central nervous system stimulants chronic obstructive asthma, unspecified chronic kidney disease, unspecified pain in limb tobacco use disorder personal history of transient ischemic attack (tia), and cerebral infarction without residual deficits person boarding or alighting a pedal cycle injured in collision with pedestrian or animal depressive disorder, not elsewhere classified suicidal ideation rheumatoid arthritis acquired absence of breast and nipple personal history of venous thrombosis and embolism diarrhea personal history of malignant neoplasm of breast acidosis unspecified viral hepatitis c without hepatic coma obstructive chronic bronchitis with acute bronchitis
black african american f 61 $nan$chemistry blood anion gap  14  meq l; chemistry blood bicarbonate  29  meq l; chemistry blood chloride  103  meq l; chemistry blood creatinine  1.5  mg dl; chemistry blood potassium  4.3  meq l; chemistry blood sodium  142  meq l; chemistry blood urea nitrogen  20  mg dl; chemistry blood calcium, total  8.9  mg dl; chemistry blood glucose  104  mg dl$influenza virus vaccine  0.5  ml ; sodium chloride 0.9%  flush  3  ml ; albuterol 0.083% neb soln  1  neb ; ipratropium bromide neb  1  neb ; diazepam  10  mg ; heparin  5000  unit ; levofloxacin  750  mg ; multivitamins  1  tab ; nicotine patch  21  mg ; amlodipine  5  mg ; furosemide  20  mg ; omeprazole  20  mg ; lidocaine 5% patch  1  ptch ; citalopram  20  mg ; gabapentin  600  mg ; 5% dextrose  250  ml ; thiamine  500  mg ; quetiapine fumarate  50  mg ; bag  50  ml ; docusate sodium  200  mg ; 0.9% sodium chloride  250  ml ; sodium phosphate  15  mmol ; mirtazapine  15  mg ; polyethylene glycol  17  g ; 
edema hypopotassemia nonspecific reaction to tuberculin skin test without active tuberculosis cocaine dependence, unspecified osteoporosis, unspecified asthma, unspecified type, unspecified suicidal ideation acute kidney failure, unspecified chronic kidney disease, stage ii (mild) personal history of venous thrombosis and embolism tobacco use disorder hypertensive chronic kidney disease, benign, with chronic kidney disease stage i through stage iv, or unspecified hypoxemia metabolic encephalopathy other and unspecified hyperlipidemia unspecified viral hepatitis c without hepatic coma unspecified persistent mental disorders due to conditions classified elsewhere pain in limb personal history of malignant neoplasm of breast person boarding or alighting a pedal cycle injured in collision with pedestrian or animal depressive disorder, not elsewhere classified other and unspecified alcohol dependence, continuous dehydration prinzmetal angina other and unspecified hyperlipidemia other and unspecified alcohol dependence, continuous cocaine dependence, unspecified old myocardial infarction poisoning by cocaine osteoporosis, unspecified hypertensive chronic kidney disease, unspecified, with chronic kidney disease stage i through stage iv, or unspecified accidental poisoning by central nervous system stimulants chronic obstructive asthma, unspecified chronic kidney disease, unspecified pain in limb tobacco use disorder personal history of transient ischemic attack (tia), and cerebral infarction without residual deficits person boarding or alighting a pedal cycle injured in collision with pedestrian or animal depressive disorder, not elsewhere classified suicidal ideation rheumatoid arthritis acquired absence of breast and nipple personal history of venous thrombosis and embolism diarrhea personal history of malignant neoplasm of breast acidosis unspecified viral hepatitis c without hepatic coma obstructive chronic bronchitis with acute bronchitis
black african american f 61 $nan$nan$influenza virus vaccine  0.5  ml ; sodium chloride 0.9%  flush  3  ml ; albuterol 0.083% neb soln  1  neb ; ipratropium bromide neb  1  neb ; diazepam  10  mg ; heparin  5000  unit ; levofloxacin  750  mg ; multivitamins  1  tab ; nicotine patch  21  mg ; amlodipine  5  mg ; furosemide  20  mg ; omeprazole  20  mg ; lidocaine 5% patch  1  ptch ; citalopram  20  mg ; gabapentin  600  mg ; 5% dextrose  250  ml ; thiamine  500  mg ; quetiapine fumarate  50  mg ; docusate sodium  200  mg ; mirtazapine  15  mg ; polyethylene glycol  17  g ; magnesium sulfate  2  gm ; acetaminophen  325  mg ; 
edema hypopotassemia nonspecific reaction to tuberculin skin test without active tuberculosis cocaine dependence, unspecified osteoporosis, unspecified asthma, unspecified type, unspecified suicidal ideation acute kidney failure, unspecified chronic kidney disease, stage ii (mild) personal history of venous thrombosis and embolism tobacco use disorder hypertensive chronic kidney disease, benign, with chronic kidney disease stage i through stage iv, or unspecified hypoxemia metabolic encephalopathy other and unspecified hyperlipidemia unspecified viral hepatitis c without hepatic coma unspecified persistent mental disorders due to conditions classified elsewhere pain in limb personal history of malignant neoplasm of breast person boarding or alighting a pedal cycle injured in collision with pedestrian or animal depressive disorder, not elsewhere classified other and unspecified alcohol dependence, continuous dehydration prinzmetal angina other and unspecified hyperlipidemia other and unspecified alcohol dependence, continuous cocaine dependence, unspecified old myocardial infarction poisoning by cocaine osteoporosis, unspecified hypertensive chronic kidney disease, unspecified, with chronic kidney disease stage i through stage iv, or unspecified accidental poisoning by central nervous system stimulants chronic obstructive asthma, unspecified chronic kidney disease, unspecified pain in limb tobacco use disorder personal history of transient ischemic attack (tia), and cerebral infarction without residual deficits person boarding or alighting a pedal cycle injured in collision with pedestrian or animal depressive disorder, not elsewhere classified suicidal ideation rheumatoid arthritis acquired absence of breast and nipple personal history of venous thrombosis and embolism diarrhea personal history of malignant neoplasm of breast acidosis unspecified viral hepatitis c without hepatic coma obstructive chronic bronchitis with acute bronchitis
black african american f 61 $nan$nan$influenza virus vaccine  0.5  ml ; sodium chloride 0.9%  flush  3  ml ; albuterol 0.083% neb soln  1  neb ; ipratropium bromide neb  1  neb ; diazepam  10  mg ; heparin  5000  unit ; levofloxacin  750  mg ; multivitamins  1  tab ; nicotine patch  21  mg ; amlodipine  5  mg ; furosemide  20  mg ; omeprazole  20  mg ; lidocaine 5% patch  1  ptch ; citalopram  20  mg ; gabapentin  600  mg ; quetiapine fumarate  50  mg ; docusate sodium  200  mg ; mirtazapine  15  mg ; polyethylene glycol  17  g ; magnesium sulfate  2  gm ; acetaminophen  325  mg ; 
edema hypopotassemia nonspecific reaction to tuberculin skin test without active tuberculosis cocaine dependence, unspecified osteoporosis, unspecified asthma, unspecified type, unspecified suicidal ideation acute kidney failure, unspecified chronic kidney disease, stage ii (mild) personal history of venous thrombosis and embolism tobacco use disorder hypertensive chronic kidney disease, benign, with chronic kidney disease stage i through stage iv, or unspecified hypoxemia metabolic encephalopathy other and unspecified hyperlipidemia unspecified viral hepatitis c without hepatic coma unspecified persistent mental disorders due to conditions classified elsewhere pain in limb personal history of malignant neoplasm of breast person boarding or alighting a pedal cycle injured in collision with pedestrian or animal depressive disorder, not elsewhere classified other and unspecified alcohol dependence, continuous dehydration prinzmetal angina other and unspecified hyperlipidemia other and unspecified alcohol dependence, continuous cocaine dependence, unspecified old myocardial infarction poisoning by cocaine osteoporosis, unspecified hypertensive chronic kidney disease, unspecified, with chronic kidney disease stage i through stage iv, or unspecified accidental poisoning by central nervous system stimulants chronic obstructive asthma, unspecified chronic kidney disease, unspecified pain in limb tobacco use disorder personal history of transient ischemic attack (tia), and cerebral infarction without residual deficits person boarding or alighting a pedal cycle injured in collision with pedestrian or animal depressive disorder, not elsewhere classified suicidal ideation rheumatoid arthritis acquired absence of breast and nipple personal history of venous thrombosis and embolism diarrhea personal history of malignant neoplasm of breast acidosis unspecified viral hepatitis c without hepatic coma obstructive chronic bronchitis with acute bronchitis
black african american f 61 $nan$nan$influenza virus vaccine  0.5  ml ; sodium chloride 0.9%  flush  3  ml ; albuterol 0.083% neb soln  1  neb ; ipratropium bromide neb  1  neb ; heparin  5000  unit ; levofloxacin  750  mg ; multivitamins  1  tab ; nicotine patch  21  mg ; amlodipine  5  mg ; furosemide  20  mg ; omeprazole  20  mg ; lidocaine 5% patch  1  ptch ; citalopram  20  mg ; gabapentin  600  mg ; docusate sodium  200  mg ; mirtazapine  15  mg ; polyethylene glycol  17  g ; acetaminophen  325  mg ; 
edema hypopotassemia nonspecific reaction to tuberculin skin test without active tuberculosis cocaine dependence, unspecified osteoporosis, unspecified asthma, unspecified type, unspecified suicidal ideation acute kidney failure, unspecified chronic kidney disease, stage ii (mild) personal history of venous thrombosis and embolism tobacco use disorder hypertensive chronic kidney disease, benign, with chronic kidney disease stage i through stage iv, or unspecified hypoxemia metabolic encephalopathy other and unspecified hyperlipidemia unspecified viral hepatitis c without hepatic coma unspecified persistent mental disorders due to conditions classified elsewhere pain in limb personal history of malignant neoplasm of breast person boarding or alighting a pedal cycle injured in collision with pedestrian or animal depressive disorder, not elsewhere classified other and unspecified alcohol dependence, continuous dehydration prinzmetal angina other and unspecified hyperlipidemia other and unspecified alcohol dependence, continuous cocaine dependence, unspecified old myocardial infarction poisoning by cocaine osteoporosis, unspecified hypertensive chronic kidney disease, unspecified, with chronic kidney disease stage i through stage iv, or unspecified accidental poisoning by central nervous system stimulants chronic obstructive asthma, unspecified chronic kidney disease, unspecified pain in limb tobacco use disorder personal history of transient ischemic attack (tia), and cerebral infarction without residual deficits person boarding or alighting a pedal cycle injured in collision with pedestrian or animal depressive disorder, not elsewhere classified suicidal ideation rheumatoid arthritis acquired absence of breast and nipple personal history of venous thrombosis and embolism diarrhea personal history of malignant neoplasm of breast acidosis unspecified viral hepatitis c without hepatic coma obstructive chronic bronchitis with acute bronchitis
white m 47 $nan$nan$insulin  52  unit ; insulin  15  unit ; 
 
white m 47 $nan$hematology blood hematocrit  35.6  %; hematology blood hematocrit  34.0  %; hematology blood hemoglobin  12.2  g dl; hematology blood hemoglobin  11.5  g dl; hematology blood platelet count  207  k ul; hematology blood platelet count  197  k ul; chemistry blood anion gap  14  meq l; chemistry blood anion gap  12  meq l; chemistry blood bicarbonate  25  meq l; chemistry blood bicarbonate  26  meq l; chemistry blood chloride  103  meq l; chemistry blood chloride  101  meq l; chemistry blood creatinine  1.0  mg dl; chemistry blood creatinine  1.0  mg dl; chemistry blood potassium  5.0  meq l; chemistry blood potassium  4.4  meq l; chemistry blood sodium  137  meq l; chemistry blood sodium  135  meq l; chemistry blood urea nitrogen  22  mg dl; chemistry blood urea nitrogen  20  mg dl; chemistry blood calcium, total  9.1  mg dl; chemistry blood calcium, total  8.9  mg dl; chemistry blood glucose  209  mg dl; chemistry blood glucose  212  mg dl$insulin  52  unit ; insulin  15  unit ; hydrochlorothiazide  25  mg ; levothyroxine sodium  300  mcg ; lisinopril  80  mg ; rosuvastatin calcium  20  mg ; aspirin  81  mg ; omeprazole  40  mg ; insulin  48  unit ; sodium chloride 0.9%  flush  3  ml ; iso-osmotic dextrose  50  ml ; cefazolin  1  g ; bisacodyl  10  mg ; docusate sodium  100  mg ; senna  1  tab ; oxycodone-acetaminophen  1-2  tab ; ondansetron  4  mg ; acetaminophen  325-650  mg ; oxycodone sr (oxycontin)  10  mg ; pantoprazole  40  mg ; zolpidem tartrate  5  mg ; heparin  5000  unit ; gemfibrozil  600  mg ; carvedilol  25  mg ; insulin  100  unit ; 
 
white m 47 $nan$nan$insulin  52  unit ; insulin  15  unit ; hydrochlorothiazide  25  mg ; levothyroxine sodium  300  mcg ; lisinopril  80  mg ; rosuvastatin calcium  20  mg ; aspirin  81  mg ; omeprazole  40  mg ; insulin  48  unit ; sodium chloride 0.9%  flush  3  ml ; iso-osmotic dextrose  50  ml ; cefazolin  1  g ; bisacodyl  10  mg ; docusate sodium  100  mg ; senna  1  tab ; oxycodone-acetaminophen  1-2  tab ; ondansetron  4  mg ; acetaminophen  325-650  mg ; oxycodone sr (oxycontin)  10  mg ; zolpidem tartrate  5  mg ; heparin  5000  unit ; gemfibrozil  600  mg ; carvedilol  25  mg ; insulin  100  unit ; 
 
white m 47 $nan$nan$insulin  52  unit ; insulin  15  unit ; hydrochlorothiazide  25  mg ; levothyroxine sodium  300  mcg ; lisinopril  80  mg ; rosuvastatin calcium  20  mg ; aspirin  81  mg ; omeprazole  40  mg ; insulin  48  unit ; sodium chloride 0.9%  flush  3  ml ; iso-osmotic dextrose  50  ml ; cefazolin  1  g ; bisacodyl  10  mg ; docusate sodium  100  mg ; senna  1  tab ; oxycodone-acetaminophen  1-2  tab ; ondansetron  4  mg ; acetaminophen  325-650  mg ; oxycodone sr (oxycontin)  10  mg ; zolpidem tartrate  5  mg ; heparin  5000  unit ; gemfibrozil  600  mg ; carvedilol  25  mg ; insulin  100  unit ; 
 
white f 84 $nan$hematology blood hematocrit  35.9  %; hematology blood platelet count  183  k ul; hematology blood platelet count  194  k ul; chemistry blood chloride  100  meq l; chemistry blood chloride  108  meq l; chemistry blood creatinine  1.1  mg dl; chemistry blood potassium  3.9  meq l; chemistry blood potassium  4.1  meq l; chemistry blood sodium  137  meq l; chemistry blood sodium  144  meq l; chemistry blood urea nitrogen  19  mg dl$0.45% sodium chloride  1000  ml ; sodium chloride 0.9%  flush  3  ml ; acetaminophen  650  mg ; trazodone  25  mg ; senna  17.2  mg ; docusate sodium  100  mg ; tramadol (ultram)  25  mg ; heparin  5000  unit ; acetaminophen  500-1000  mg ; potassium chloride  20  meq ; potassium chloride  40  meq ; potassium chloride  60  meq ; aluminum-magnesium hydrox.-simethicone  30  ml ; simethicone  40-80  mg ; nicotine patch  7  mg ; clopidogrel  75  mg ; atorvastatin  80  mg ; aspirin ec  81  mg ; metoprolol tartrate  25  mg ; 
personal history of traumatic fracture atherosclerosis of native arteries of the extremities, unspecified passenger of special construction vehicle injured in traffic accident body mass index between 19-24, adult unspecified renovascular hypertension aortic valve disorders coronary atherosclerosis of native coronary artery atherosclerosis of renal artery hypoxemia congestive heart failure, unspecified other chronic pulmonary heart diseases other and unspecified hyperlipidemia cough acute on chronic diastolic heart failure tobacco use disorder loss of weight
white f 84 $nan$nan$acetaminophen  500-1000  mg ; potassium chloride  20  meq ; potassium chloride  40  meq ; potassium chloride  60  meq ; aluminum-magnesium hydrox.-simethicone  30  ml ; simethicone  40-80  mg ; nicotine patch  7  mg ; carbamide peroxide 6.5%  5-10  drop ; 
personal history of traumatic fracture atherosclerosis of native arteries of the extremities, unspecified passenger of special construction vehicle injured in traffic accident body mass index between 19-24, adult unspecified renovascular hypertension aortic valve disorders coronary atherosclerosis of native coronary artery atherosclerosis of renal artery hypoxemia congestive heart failure, unspecified other chronic pulmonary heart diseases other and unspecified hyperlipidemia cough acute on chronic diastolic heart failure tobacco use disorder loss of weight
white m 27 $temp  98.1  heartrate  76.0  resprate  18.0  o2sat  99.0  sbp  138.0  dbp  76.0  rhythm    pain  0  ; temp  98.1  heartrate  77.0  resprate  18.0  o2sat  100.0  sbp  12.0  dbp  981.0  rhythm    pain  0  $hematology blood hematocrit  42.9  %; hematology blood hemoglobin  15.8  g dl; hematology blood platelet count  315  k ul; chemistry blood anion gap  16  meq l; chemistry blood bicarbonate  28  meq l; chemistry blood chloride  102  meq l; chemistry blood creatinine  0.9  mg dl; chemistry blood potassium  3.8  meq l; chemistry blood sodium  142  meq l; chemistry blood urea nitrogen  15  mg dl; hematology blood inr(pt)  1.1  ; chemistry blood glucose  109  mg dl$nan
 
white m 27 $temp  98.0  heartrate  81.0  resprate  18.0  o2sat  100.0  sbp  132.0  dbp  82.0  rhythm    pain  0  $hematology blood hematocrit  39.1  %; hematology blood hemoglobin  13.9  g dl; hematology blood platelet count  255  k ul; chemistry blood anion gap  15  meq l; chemistry blood bicarbonate  28  meq l; chemistry blood chloride  104  meq l; chemistry blood creatinine  0.9  mg dl; chemistry blood potassium  3.7  meq l; chemistry blood sodium  143  meq l; chemistry blood urea nitrogen  12  mg dl; chemistry blood calcium, total  9.2  mg dl; chemistry blood glucose  90  mg dl; chemistry blood % hemoglobin a1c  5.3  %$influenza virus vaccine  0.5  ml ; sodium chloride 0.9%  flush  3  ml ; aspirin  81  mg ; heparin  5000  unit ; senna  8.6  mg ; docusate sodium  100  mg ; acetaminophen  1000  mg ; 
 
white m 27 $nan$nan$influenza virus vaccine  0.5  ml ; sodium chloride 0.9%  flush  3  ml ; aspirin  81  mg ; heparin  5000  unit ; senna  8.6  mg ; docusate sodium  100  mg ; acetaminophen  1000  mg ; sodium chloride 0.9%  1000  ml ; diphenhydramine  50  mg ; prednisone  50  mg ; 
 
white m 27 $nan$nan$influenza virus vaccine  0.5  ml ; sodium chloride 0.9%  flush  3  ml ; aspirin  81  mg ; heparin  5000  unit ; senna  8.6  mg ; docusate sodium  100  mg ; acetaminophen  1000  mg ; diphenhydramine  50  mg ; prednisone  50  mg ; 
 
hispanic latino f 69 $nan$nan$nadolol  40  mg ; spironolactone  200  mg ; ranitidine  150  mg ; 
awaiting organ transplant status thrombocytopenia, unspecified chronic hepatitis c without mention of hepatic coma unspecified vitamin d deficiency calculus of kidney portal vein thrombosis hydronephrosis chronic peptic ulcer of unspecified site without mention of hemorrhage or perforation, without mention of obstruction unspecified pruritic disorder insomnia, unspecified personal history of pulmonary embolism abdominal pain, other specified site malignant neoplasm of liver, primary cirrhosis of liver without mention of alcohol anemia, unspecified personal history of tobacco use unspecified pleural effusion chills (without fever) long-term (current) use of anticoagulants other ascites other malaise and fatigue malignant neoplasm of liver, not specified as primary or secondary cirrhosis of liver without mention of alcohol other nonspecific findings on examination of urine abnormal involuntary movements lumbago headache insomnia, unspecified history of fall thrombocytopenia, unspecified chronic hepatitis c without mention of hepatic coma esophageal reflux other specified forms of effusion, except tuberculous unspecified vitamin d deficiency depressive disorder, not elsewhere classified esophageal varices in diseases classified elsewhere, without mention of bleeding personal history of peptic ulcer disease personal history of tuberculosis awaiting organ transplant status personal history of malignant neoplasm of liver personal history of pulmonary embolism unspecified pruritic disorder portal vein thrombosis disorders of bursae and tendons in shoulder region, unspecified personal history of tobacco use anemia of other chronic disease cirrhosis of liver without mention of alcohol awaiting organ transplant status
hispanic latino f 69 $nan$hematology blood hematocrit  34.1  %; hematology blood hematocrit  29.3  %; hematology blood hematocrit  28.3  %; hematology blood hemoglobin  10.3  g dl; hematology blood hemoglobin  9.2  g dl; hematology blood hemoglobin  8.9  g dl; hematology blood platelet count  122  k ul; hematology blood platelet count  120  k ul; hematology blood platelet count  107  k ul; chemistry blood anion gap  14  meq l; chemistry blood bicarbonate  26  meq l; chemistry blood chloride  101  meq l; chemistry blood creatinine  0.9  mg dl; chemistry blood potassium  4.6  meq l; chemistry blood sodium  136  meq l; chemistry blood urea nitrogen  13  mg dl; hematology blood inr(pt)  1.5  ; hematology blood inr(pt)  1.5  ; hematology blood inr(pt)  1.7  ; chemistry blood calcium, total  8.9  mg dl; chemistry blood bilirubin, total  0.9  mg dl; chemistry blood glucose  83  mg dl; chemistry blood albumin  3.8  g dl; blood gas blood free calcium  1.11  mmol l; blood gas blood free calcium  0.97  mmol l; blood gas blood lactate  1.4  mmol l; blood gas blood lactate  2.4  mmol l; blood gas blood chloride, whole blood  101  meq l; blood gas blood chloride, whole blood  102  meq l; blood gas blood glucose  79  mg dl; blood gas blood glucose  95  mg dl; blood gas blood hematocrit, calculated  29  %; blood gas blood hematocrit, calculated  28  %; blood gas blood hemoglobin  9.7  g dl; blood gas blood hemoglobin  9.3  g dl; blood gas blood potassium, whole blood  3.9  meq l; blood gas blood potassium, whole blood  4.1  meq l; blood gas blood sodium, whole blood  135  meq l; blood gas blood sodium, whole blood  136  meq l$nadolol  40  mg ; spironolactone  200  mg ; ranitidine  150  mg ; furosemide  80  mg ; omeprazole  40  mg ; heparin  5000  unit ; 5% dextrose  250  ml ; heparin sodium  25,000  unit ; 0.9% sodium chloride (mini bag plus)  100  ml ; ampicillin-sulbactam  3  g ; mycophenolate mofetil  1000  mg ; fluconazole  400  mg ; sodium chloride 0.9%  flush  3  ml ; d5 1 2ns  1000  ml ; mirtazapine  15  mg ; 0.9% sodium chloride  50  ml ; methylprednisolone sodium succ  500  mg ; 
awaiting organ transplant status thrombocytopenia, unspecified chronic hepatitis c without mention of hepatic coma unspecified vitamin d deficiency calculus of kidney portal vein thrombosis hydronephrosis chronic peptic ulcer of unspecified site without mention of hemorrhage or perforation, without mention of obstruction unspecified pruritic disorder insomnia, unspecified personal history of pulmonary embolism abdominal pain, other specified site malignant neoplasm of liver, primary cirrhosis of liver without mention of alcohol anemia, unspecified personal history of tobacco use unspecified pleural effusion chills (without fever) long-term (current) use of anticoagulants other ascites other malaise and fatigue malignant neoplasm of liver, not specified as primary or secondary cirrhosis of liver without mention of alcohol other nonspecific findings on examination of urine abnormal involuntary movements lumbago headache insomnia, unspecified history of fall thrombocytopenia, unspecified chronic hepatitis c without mention of hepatic coma esophageal reflux other specified forms of effusion, except tuberculous unspecified vitamin d deficiency depressive disorder, not elsewhere classified esophageal varices in diseases classified elsewhere, without mention of bleeding personal history of peptic ulcer disease personal history of tuberculosis awaiting organ transplant status personal history of malignant neoplasm of liver personal history of pulmonary embolism unspecified pruritic disorder portal vein thrombosis disorders of bursae and tendons in shoulder region, unspecified personal history of tobacco use anemia of other chronic disease cirrhosis of liver without mention of alcohol awaiting organ transplant status
hispanic latino f 69 $nan$hematology blood hematocrit  31.8  %; hematology blood hematocrit  31.6  %; hematology blood hematocrit  27.8  %; hematology blood hematocrit  30.3  %; hematology blood hematocrit  32.3  %; hematology blood hemoglobin  10.1  g dl; hematology blood hemoglobin  10.3  g dl; hematology blood hemoglobin  9.3  g dl; hematology blood hemoglobin  10.5  g dl; hematology blood hemoglobin  10.8  g dl; hematology blood platelet count  114  k ul; hematology blood platelet count  132  k ul; hematology blood platelet count  71  k ul; hematology blood platelet count  62  k ul; hematology blood platelet count  68  k ul; hematology blood platelet count  108  k ul; hematology blood platelet count  88  k ul; chemistry blood anion gap  18  meq l; chemistry blood anion gap  15  meq l; chemistry blood anion gap  15  meq l; chemistry blood bicarbonate  24  meq l; chemistry blood bicarbonate  25  meq l; chemistry blood bicarbonate  25  meq l; chemistry blood chloride  102  meq l; chemistry blood chloride  101  meq l; chemistry blood chloride  102  meq l; chemistry blood creatinine  0.6  mg dl; chemistry blood creatinine  0.7  mg dl; chemistry blood creatinine  0.9  mg dl; chemistry blood potassium  4.1  meq l; chemistry blood potassium  3.7  meq l; chemistry blood potassium  3.8  meq l; chemistry blood sodium  140  meq l; chemistry blood sodium  137  meq l; chemistry blood sodium  138  meq l; chemistry blood urea nitrogen  13  mg dl; chemistry blood urea nitrogen  16  mg dl; chemistry blood urea nitrogen  21  mg dl; hematology blood inr(pt)  1.7  ; hematology blood inr(pt)  1.6  ; hematology blood inr(pt)  1.3  ; hematology blood inr(pt)  1.7  ; hematology blood inr(pt)  1.6  ; hematology blood inr(pt)  1.4  ; hematology blood inr(pt)  1.2  ; chemistry blood calcium, total  8.8  mg dl; chemistry blood calcium, total  8.4  mg dl; chemistry blood calcium, total  7.3  mg dl; chemistry blood bilirubin, indirect  2.7  mg dl; chemistry blood bilirubin, indirect  2.5  mg dl; chemistry blood bilirubin, indirect  1.0  mg dl; chemistry blood bilirubin, total  4.1  mg dl; chemistry blood bilirubin, total  3.9  mg dl; chemistry blood bilirubin, total  2.6  mg dl; chemistry blood glucose  203  mg dl; chemistry blood glucose  244  mg dl; chemistry blood glucose  192  mg dl; chemistry blood albumin  3.2  g dl; chemistry blood albumin  3.2  g dl; chemistry blood albumin  3.1  g dl; blood gas blood free calcium  1.14  mmol l; blood gas blood free calcium  1.20  mmol l; blood gas blood free calcium  1.13  mmol l; blood gas blood free calcium  0.86  mmol l; blood gas blood free calcium  0.86  mmol l; blood gas blood lactate  3.8  mmol l; blood gas blood lactate  3.8  mmol l; blood gas blood lactate  2.3  mmol l; blood gas blood lactate  2.2  mmol l; blood gas blood lactate  2.2  mmol l; blood gas blood lactate  2.1  mmol l; blood gas blood lactate  4.7  mmol l; blood gas blood lactate  4.1  mmol l; chemistry blood bilirubin, direct  1.4  mg dl; chemistry blood bilirubin, direct  1.4  mg dl; chemistry blood bilirubin, direct  1.6  mg dl; blood gas blood chloride, whole blood  102  meq l; blood gas blood chloride, whole blood  102  meq l; blood gas blood chloride, whole blood  103  meq l; blood gas blood chloride, whole blood  103  meq l; blood gas blood glucose  148  mg dl; blood gas blood glucose  150  mg dl; blood gas blood glucose  150  mg dl; blood gas blood glucose  215  mg dl; blood gas blood hematocrit, calculated  31  %; blood gas blood hematocrit, calculated  32  %; blood gas blood hematocrit, calculated  28  %; blood gas blood hematocrit, calculated  32  %; blood gas blood hematocrit, calculated  22  %; blood gas blood hematocrit, calculated  27  %; blood gas blood hemoglobin  10.4  g dl; blood gas blood hemoglobin  10.5  g dl; blood gas blood hemoglobin  9.3  g dl; blood gas blood hemoglobin  10.6  g dl; blood gas blood hemoglobin  7.4  g dl; blood gas blood hemoglobin  8.9  g dl; blood gas blood potassium, whole blood  5.0  meq l; blood gas blood potassium, whole blood  4.7  meq l; blood gas blood potassium, whole blood  4.5  meq l; blood gas blood potassium, whole blood  4.9  meq l; blood gas blood sodium, whole blood  135  meq l; blood gas blood sodium, whole blood  136  meq l; blood gas blood sodium, whole blood  137  meq l; blood gas blood sodium, whole blood  136  meq l$nadolol  40  mg ; spironolactone  200  mg ; ranitidine  150  mg ; furosemide  80  mg ; omeprazole  40  mg ; heparin  5000  unit ; 0.9% sodium chloride (mini bag plus)  100  ml ; ampicillin-sulbactam  3  g ; mycophenolate mofetil  1000  mg ; fluconazole  400  mg ; sodium chloride 0.9%  flush  3  ml ; d5 1 2ns  1000  ml ; mirtazapine  15  mg ; 0.9% sodium chloride  50  ml ; methylprednisolone sodium succ  500  mg ; insulin  0  unit ; sodium chloride 0.9%  flush  10  ml ; morphine sulfate  1-4  mg ; prochlorperazine  5-10  mg ; ondansetron  4  mg ; dextrose 50%  12.5  gm ; glucagon  1  mg ; glucose gel  15  g ; propofol  1000  mg ; propofol  200  mg ; bag  50  ml ; magnesium sulfate  2  gm ; bag  100  ml ; magnesium sulfate  4  gm ; docusate sodium  100  mg ; mycophenolate mofetil suspension  1000  mg ; valganciclovir  450  mg ; sulfameth trimethoprim ss  1  tab ; vial  1  vial ; pantoprazole  40  mg ; sulfameth trimethoprim suspension  10  ml ; 0.9% sodium chloride  100  ml ; methylprednisolone sodium succ  200  mg ; 0.9% sodium chloride  250  ml ; sodium phosphate  30  mmol ; tacrolimus  2  mg ; 
awaiting organ transplant status thrombocytopenia, unspecified chronic hepatitis c without mention of hepatic coma unspecified vitamin d deficiency calculus of kidney portal vein thrombosis hydronephrosis chronic peptic ulcer of unspecified site without mention of hemorrhage or perforation, without mention of obstruction unspecified pruritic disorder insomnia, unspecified personal history of pulmonary embolism abdominal pain, other specified site malignant neoplasm of liver, primary cirrhosis of liver without mention of alcohol anemia, unspecified personal history of tobacco use unspecified pleural effusion chills (without fever) long-term (current) use of anticoagulants other ascites other malaise and fatigue malignant neoplasm of liver, not specified as primary or secondary cirrhosis of liver without mention of alcohol other nonspecific findings on examination of urine abnormal involuntary movements lumbago headache insomnia, unspecified history of fall thrombocytopenia, unspecified chronic hepatitis c without mention of hepatic coma esophageal reflux other specified forms of effusion, except tuberculous unspecified vitamin d deficiency depressive disorder, not elsewhere classified esophageal varices in diseases classified elsewhere, without mention of bleeding personal history of peptic ulcer disease personal history of tuberculosis awaiting organ transplant status personal history of malignant neoplasm of liver personal history of pulmonary embolism unspecified pruritic disorder portal vein thrombosis disorders of bursae and tendons in shoulder region, unspecified personal history of tobacco use anemia of other chronic disease cirrhosis of liver without mention of alcohol awaiting organ transplant status
hispanic latino f 69 $nan$hematology blood hematocrit  31.5  %; hematology blood hematocrit  31.1  %; hematology blood hematocrit  28.9  %; hematology blood hemoglobin  10.8  g dl; hematology blood hemoglobin  10.2  g dl; hematology blood hemoglobin  9.4  g dl; hematology blood platelet count  74  k ul; hematology blood platelet count  74  k ul; hematology blood platelet count  79  k ul; chemistry blood anion gap  15  meq l; chemistry blood anion gap  10  meq l; chemistry blood anion gap  14  meq l; chemistry blood bicarbonate  24  meq l; chemistry blood bicarbonate  29  meq l; chemistry blood bicarbonate  26  meq l; chemistry blood chloride  103  meq l; chemistry blood chloride  100  meq l; chemistry blood chloride  100  meq l; chemistry blood creatinine  1.1  mg dl; chemistry blood creatinine  1.3  mg dl; chemistry blood creatinine  1.5  mg dl; chemistry blood potassium  3.9  meq l; chemistry blood potassium  4.1  meq l; chemistry blood potassium  4.1  meq l; chemistry blood sodium  138  meq l; chemistry blood sodium  135  meq l; chemistry blood sodium  136  meq l; chemistry blood urea nitrogen  28  mg dl; chemistry blood urea nitrogen  36  mg dl; chemistry blood urea nitrogen  44  mg dl; hematology blood inr(pt)  1.1  ; hematology blood inr(pt)  1.1  ; hematology blood inr(pt)  1.1  ; chemistry blood calcium, total  8.0  mg dl; chemistry blood calcium, total  7.8  mg dl; chemistry blood calcium, total  7.9  mg dl; chemistry blood bilirubin, indirect  0.8  mg dl; chemistry blood bilirubin, total  2.2  mg dl; chemistry blood bilirubin, total  1.2  mg dl; chemistry blood bilirubin, total  0.8  mg dl; chemistry blood glucose  121  mg dl; chemistry blood glucose  175  mg dl; chemistry blood glucose  189  mg dl; chemistry blood albumin  3.1  g dl; chemistry blood bilirubin, direct  1.4  mg dl$insulin  0  unit ; sodium chloride 0.9%  flush  10  ml ; morphine sulfate  1-4  mg ; prochlorperazine  5-10  mg ; ondansetron  4  mg ; dextrose 50%  12.5  gm ; glucagon  1  mg ; glucose gel  15  g ; bag  50  ml ; magnesium sulfate  2  gm ; bag  100  ml ; magnesium sulfate  4  gm ; mycophenolate mofetil suspension  1000  mg ; valganciclovir  450  mg ; sulfameth trimethoprim ss  1  tab ; sulfameth trimethoprim suspension  10  ml ; 0.9% sodium chloride  100  ml ; methylprednisolone sodium succ  200  mg ; 0.9% sodium chloride  250  ml ; sodium phosphate  30  mmol ; tacrolimus  2  mg ; hydromorphone (dilaudid)  0.5-1  mg ; methylprednisolone sodium succ  150  mg ; tacrolimus  4  mg ; heparin flush (10 units ml)  1  ml ; 
awaiting organ transplant status thrombocytopenia, unspecified chronic hepatitis c without mention of hepatic coma unspecified vitamin d deficiency calculus of kidney portal vein thrombosis hydronephrosis chronic peptic ulcer of unspecified site without mention of hemorrhage or perforation, without mention of obstruction unspecified pruritic disorder insomnia, unspecified personal history of pulmonary embolism abdominal pain, other specified site malignant neoplasm of liver, primary cirrhosis of liver without mention of alcohol anemia, unspecified personal history of tobacco use unspecified pleural effusion chills (without fever) long-term (current) use of anticoagulants other ascites other malaise and fatigue malignant neoplasm of liver, not specified as primary or secondary cirrhosis of liver without mention of alcohol other nonspecific findings on examination of urine abnormal involuntary movements lumbago headache insomnia, unspecified history of fall thrombocytopenia, unspecified chronic hepatitis c without mention of hepatic coma esophageal reflux other specified forms of effusion, except tuberculous unspecified vitamin d deficiency depressive disorder, not elsewhere classified esophageal varices in diseases classified elsewhere, without mention of bleeding personal history of peptic ulcer disease personal history of tuberculosis awaiting organ transplant status personal history of malignant neoplasm of liver personal history of pulmonary embolism unspecified pruritic disorder portal vein thrombosis disorders of bursae and tendons in shoulder region, unspecified personal history of tobacco use anemia of other chronic disease cirrhosis of liver without mention of alcohol awaiting organ transplant status
hispanic latino f 69 $nan$hematology blood hematocrit  26.8  %; hematology blood hemoglobin  8.8  g dl; hematology blood platelet count  87  k ul; chemistry blood anion gap  16  meq l; chemistry blood bicarbonate  26  meq l; chemistry blood chloride  98  meq l; chemistry blood creatinine  1.8  mg dl; chemistry blood potassium  4.1  meq l; chemistry blood sodium  136  meq l; chemistry blood urea nitrogen  55  mg dl; hematology blood inr(pt)  1.0  ; chemistry blood calcium, total  7.7  mg dl; chemistry blood bilirubin, total  0.7  mg dl; chemistry blood glucose  99  mg dl$ondansetron  4  mg ; dextrose 50%  12.5  gm ; glucagon  1  mg ; glucose gel  15  g ; sulfameth trimethoprim ss  1  tab ; hydromorphone (dilaudid)  0.5-1  mg ; methylprednisolone sodium succ  150  mg ; tacrolimus  4  mg ; heparin flush (10 units ml)  1  ml ; hydromorphone (dilaudid)  0.5  mg ; methylprednisolone sodium succ  100  mg ; acetaminophen  650  mg ; transplant self medication program  1  bag ; 
awaiting organ transplant status thrombocytopenia, unspecified chronic hepatitis c without mention of hepatic coma unspecified vitamin d deficiency calculus of kidney portal vein thrombosis hydronephrosis chronic peptic ulcer of unspecified site without mention of hemorrhage or perforation, without mention of obstruction unspecified pruritic disorder insomnia, unspecified personal history of pulmonary embolism abdominal pain, other specified site malignant neoplasm of liver, primary cirrhosis of liver without mention of alcohol anemia, unspecified personal history of tobacco use unspecified pleural effusion chills (without fever) long-term (current) use of anticoagulants other ascites other malaise and fatigue malignant neoplasm of liver, not specified as primary or secondary cirrhosis of liver without mention of alcohol other nonspecific findings on examination of urine abnormal involuntary movements lumbago headache insomnia, unspecified history of fall thrombocytopenia, unspecified chronic hepatitis c without mention of hepatic coma esophageal reflux other specified forms of effusion, except tuberculous unspecified vitamin d deficiency depressive disorder, not elsewhere classified esophageal varices in diseases classified elsewhere, without mention of bleeding personal history of peptic ulcer disease personal history of tuberculosis awaiting organ transplant status personal history of malignant neoplasm of liver personal history of pulmonary embolism unspecified pruritic disorder portal vein thrombosis disorders of bursae and tendons in shoulder region, unspecified personal history of tobacco use anemia of other chronic disease cirrhosis of liver without mention of alcohol awaiting organ transplant status
hispanic latino f 69 $nan$hematology blood hematocrit  25.6  %; hematology blood hematocrit  23.3  %; hematology blood hemoglobin  8.7  g dl; hematology blood hemoglobin  7.9  g dl; hematology blood platelet count  94  k ul; hematology blood platelet count  84  k ul; chemistry blood anion gap  11  meq l; chemistry blood bicarbonate  27  meq l; chemistry blood chloride  99  meq l; chemistry blood creatinine  2.1  mg dl; chemistry blood potassium  4.3  meq l; chemistry blood sodium  133  meq l; chemistry blood urea nitrogen  64  mg dl; hematology blood inr(pt)  1.0  ; chemistry urine creatinine, urine  105  mg dl; chemistry urine potassium, urine  20  meq l; chemistry urine sodium, urine  42  meq l; hematology urine wbc  4  # hpf; chemistry blood calcium, total  7.8  mg dl; chemistry blood bilirubin, total  0.5  mg dl; chemistry blood glucose  102  mg dl$ondansetron  4  mg ; dextrose 50%  12.5  gm ; glucagon  1  mg ; glucose gel  15  g ; hydromorphone (dilaudid)  0.5-1  mg ; heparin flush (10 units ml)  1  ml ; hydromorphone (dilaudid)  0.5  mg ; methylprednisolone sodium succ  100  mg ; acetaminophen  650  mg ; transplant self medication program  1  bag ; methylprednisolone sodium succ  70  mg ; 0.9% sodium chloride  1000  ml ; vitamin d  50,000  unit ; oxycodone (immediate release)   5  mg ; 
awaiting organ transplant status thrombocytopenia, unspecified chronic hepatitis c without mention of hepatic coma unspecified vitamin d deficiency calculus of kidney portal vein thrombosis hydronephrosis chronic peptic ulcer of unspecified site without mention of hemorrhage or perforation, without mention of obstruction unspecified pruritic disorder insomnia, unspecified personal history of pulmonary embolism abdominal pain, other specified site malignant neoplasm of liver, primary cirrhosis of liver without mention of alcohol anemia, unspecified personal history of tobacco use unspecified pleural effusion chills (without fever) long-term (current) use of anticoagulants other ascites other malaise and fatigue malignant neoplasm of liver, not specified as primary or secondary cirrhosis of liver without mention of alcohol other nonspecific findings on examination of urine abnormal involuntary movements lumbago headache insomnia, unspecified history of fall thrombocytopenia, unspecified chronic hepatitis c without mention of hepatic coma esophageal reflux other specified forms of effusion, except tuberculous unspecified vitamin d deficiency depressive disorder, not elsewhere classified esophageal varices in diseases classified elsewhere, without mention of bleeding personal history of peptic ulcer disease personal history of tuberculosis awaiting organ transplant status personal history of malignant neoplasm of liver personal history of pulmonary embolism unspecified pruritic disorder portal vein thrombosis disorders of bursae and tendons in shoulder region, unspecified personal history of tobacco use anemia of other chronic disease cirrhosis of liver without mention of alcohol awaiting organ transplant status
hispanic latino f 69 $nan$hematology blood hematocrit  30.4  %; hematology blood hematocrit  30.4  %; hematology blood hemoglobin  10.2  g dl; hematology blood hemoglobin  10.0  g dl; hematology blood platelet count  71  k ul; hematology blood platelet count  82  k ul; chemistry blood anion gap  9  meq l; chemistry blood bicarbonate  26  meq l; chemistry blood chloride  105  meq l; chemistry blood creatinine  1.5  mg dl; chemistry blood potassium  4.3  meq l; chemistry blood sodium  136  meq l; chemistry blood urea nitrogen  57  mg dl; hematology blood inr(pt)  1.0  ; chemistry blood calcium, total  7.9  mg dl; chemistry blood bilirubin, total  0.5  mg dl; chemistry blood glucose  99  mg dl$ondansetron  4  mg ; dextrose 50%  12.5  gm ; glucagon  1  mg ; glucose gel  15  g ; heparin flush (10 units ml)  1  ml ; transplant self medication program  1  bag ; methylprednisolone sodium succ  70  mg ; vitamin d  50,000  unit ; oxycodone (immediate release)   5  mg ; prednisone  35  mg ; bisacodyl  10  mg ; 
awaiting organ transplant status thrombocytopenia, unspecified chronic hepatitis c without mention of hepatic coma unspecified vitamin d deficiency calculus of kidney portal vein thrombosis hydronephrosis chronic peptic ulcer of unspecified site without mention of hemorrhage or perforation, without mention of obstruction unspecified pruritic disorder insomnia, unspecified personal history of pulmonary embolism abdominal pain, other specified site malignant neoplasm of liver, primary cirrhosis of liver without mention of alcohol anemia, unspecified personal history of tobacco use unspecified pleural effusion chills (without fever) long-term (current) use of anticoagulants other ascites other malaise and fatigue malignant neoplasm of liver, not specified as primary or secondary cirrhosis of liver without mention of alcohol other nonspecific findings on examination of urine abnormal involuntary movements lumbago headache insomnia, unspecified history of fall thrombocytopenia, unspecified chronic hepatitis c without mention of hepatic coma esophageal reflux other specified forms of effusion, except tuberculous unspecified vitamin d deficiency depressive disorder, not elsewhere classified esophageal varices in diseases classified elsewhere, without mention of bleeding personal history of peptic ulcer disease personal history of tuberculosis awaiting organ transplant status personal history of malignant neoplasm of liver personal history of pulmonary embolism unspecified pruritic disorder portal vein thrombosis disorders of bursae and tendons in shoulder region, unspecified personal history of tobacco use anemia of other chronic disease cirrhosis of liver without mention of alcohol awaiting organ transplant status
hispanic latino f 69 $nan$hematology blood hematocrit  31.0  %; hematology blood hemoglobin  10.5  g dl; hematology blood platelet count  91  k ul; chemistry blood anion gap  8  meq l; chemistry blood bicarbonate  26  meq l; chemistry blood chloride  108  meq l; chemistry blood creatinine  1.4  mg dl; chemistry blood potassium  4.4  meq l; chemistry blood sodium  138  meq l; chemistry blood urea nitrogen  45  mg dl; hematology blood inr(pt)  1.1  ; chemistry blood calcium, total  8.2  mg dl; chemistry blood bilirubin, total  0.5  mg dl; chemistry blood glucose  85  mg dl$ondansetron  4  mg ; dextrose 50%  12.5  gm ; glucagon  1  mg ; glucose gel  15  g ; heparin flush (10 units ml)  1  ml ; transplant self medication program  1  bag ; vitamin d  50,000  unit ; oxycodone (immediate release)   5  mg ; prednisone  35  mg ; bisacodyl  10  mg ; tacrolimus  3  mg ; 
awaiting organ transplant status thrombocytopenia, unspecified chronic hepatitis c without mention of hepatic coma unspecified vitamin d deficiency calculus of kidney portal vein thrombosis hydronephrosis chronic peptic ulcer of unspecified site without mention of hemorrhage or perforation, without mention of obstruction unspecified pruritic disorder insomnia, unspecified personal history of pulmonary embolism abdominal pain, other specified site malignant neoplasm of liver, primary cirrhosis of liver without mention of alcohol anemia, unspecified personal history of tobacco use unspecified pleural effusion chills (without fever) long-term (current) use of anticoagulants other ascites other malaise and fatigue malignant neoplasm of liver, not specified as primary or secondary cirrhosis of liver without mention of alcohol other nonspecific findings on examination of urine abnormal involuntary movements lumbago headache insomnia, unspecified history of fall thrombocytopenia, unspecified chronic hepatitis c without mention of hepatic coma esophageal reflux other specified forms of effusion, except tuberculous unspecified vitamin d deficiency depressive disorder, not elsewhere classified esophageal varices in diseases classified elsewhere, without mention of bleeding personal history of peptic ulcer disease personal history of tuberculosis awaiting organ transplant status personal history of malignant neoplasm of liver personal history of pulmonary embolism unspecified pruritic disorder portal vein thrombosis disorders of bursae and tendons in shoulder region, unspecified personal history of tobacco use anemia of other chronic disease cirrhosis of liver without mention of alcohol awaiting organ transplant status
hispanic latino f 69 $nan$hematology blood hematocrit  30.3  %; hematology blood hemoglobin  9.8  g dl; hematology blood platelet count  109  k ul; chemistry blood anion gap  10  meq l; chemistry blood bicarbonate  26  meq l; chemistry blood chloride  108  meq l; chemistry blood creatinine  1.2  mg dl; chemistry blood potassium  4.7  meq l; chemistry blood sodium  139  meq l; chemistry blood urea nitrogen  35  mg dl; hematology blood inr(pt)  1.1  ; chemistry blood calcium, total  8.0  mg dl; chemistry blood bilirubin, total  0.4  mg dl; chemistry blood glucose  86  mg dl$ondansetron  4  mg ; dextrose 50%  12.5  gm ; glucagon  1  mg ; glucose gel  15  g ; heparin flush (10 units ml)  1  ml ; transplant self medication program  1  bag ; vitamin d  50,000  unit ; oxycodone (immediate release)   5  mg ; tacrolimus  3  mg ; aspirin  325  mg ; 
awaiting organ transplant status thrombocytopenia, unspecified chronic hepatitis c without mention of hepatic coma unspecified vitamin d deficiency calculus of kidney portal vein thrombosis hydronephrosis chronic peptic ulcer of unspecified site without mention of hemorrhage or perforation, without mention of obstruction unspecified pruritic disorder insomnia, unspecified personal history of pulmonary embolism abdominal pain, other specified site malignant neoplasm of liver, primary cirrhosis of liver without mention of alcohol anemia, unspecified personal history of tobacco use unspecified pleural effusion chills (without fever) long-term (current) use of anticoagulants other ascites other malaise and fatigue malignant neoplasm of liver, not specified as primary or secondary cirrhosis of liver without mention of alcohol other nonspecific findings on examination of urine abnormal involuntary movements lumbago headache insomnia, unspecified history of fall thrombocytopenia, unspecified chronic hepatitis c without mention of hepatic coma esophageal reflux other specified forms of effusion, except tuberculous unspecified vitamin d deficiency depressive disorder, not elsewhere classified esophageal varices in diseases classified elsewhere, without mention of bleeding personal history of peptic ulcer disease personal history of tuberculosis awaiting organ transplant status personal history of malignant neoplasm of liver personal history of pulmonary embolism unspecified pruritic disorder portal vein thrombosis disorders of bursae and tendons in shoulder region, unspecified personal history of tobacco use anemia of other chronic disease cirrhosis of liver without mention of alcohol awaiting organ transplant status
hispanic latino f 69 $nan$hematology blood hematocrit  31.1  %; hematology blood hemoglobin  9.9  g dl; hematology blood platelet count  125  k ul; chemistry blood anion gap  11  meq l; chemistry blood bicarbonate  24  meq l; chemistry blood chloride  108  meq l; chemistry blood creatinine  1.0  mg dl; chemistry blood potassium  4.7  meq l; chemistry blood sodium  138  meq l; chemistry blood urea nitrogen  27  mg dl; chemistry blood calcium, total  8.0  mg dl; chemistry blood bilirubin, total  0.5  mg dl; chemistry blood glucose  64  mg dl$ondansetron  4  mg ; dextrose 50%  12.5  gm ; glucagon  1  mg ; glucose gel  15  g ; heparin flush (10 units ml)  1  ml ; transplant self medication program  1  bag ; vitamin d  50,000  unit ; oxycodone (immediate release)   5  mg ; aspirin  325  mg ; 
awaiting organ transplant status thrombocytopenia, unspecified chronic hepatitis c without mention of hepatic coma unspecified vitamin d deficiency calculus of kidney portal vein thrombosis hydronephrosis chronic peptic ulcer of unspecified site without mention of hemorrhage or perforation, without mention of obstruction unspecified pruritic disorder insomnia, unspecified personal history of pulmonary embolism abdominal pain, other specified site malignant neoplasm of liver, primary cirrhosis of liver without mention of alcohol anemia, unspecified personal history of tobacco use unspecified pleural effusion chills (without fever) long-term (current) use of anticoagulants other ascites other malaise and fatigue malignant neoplasm of liver, not specified as primary or secondary cirrhosis of liver without mention of alcohol other nonspecific findings on examination of urine abnormal involuntary movements lumbago headache insomnia, unspecified history of fall thrombocytopenia, unspecified chronic hepatitis c without mention of hepatic coma esophageal reflux other specified forms of effusion, except tuberculous unspecified vitamin d deficiency depressive disorder, not elsewhere classified esophageal varices in diseases classified elsewhere, without mention of bleeding personal history of peptic ulcer disease personal history of tuberculosis awaiting organ transplant status personal history of malignant neoplasm of liver personal history of pulmonary embolism unspecified pruritic disorder portal vein thrombosis disorders of bursae and tendons in shoulder region, unspecified personal history of tobacco use anemia of other chronic disease cirrhosis of liver without mention of alcohol awaiting organ transplant status
white f 42 $nan$nan$insulin  6  unit ; atenolol  50  mg ; omeprazole  40  mg ; polyethylene glycol  17  g ; insulin  0  unit ; 
anemia, unspecified myalgia and myositis, unspecified gastroparesis diabetes with neurological manifestations, type i [juvenile type], not stated as uncontrolled anxiety state, unspecified unspecified essential hypertension family history of diabetes mellitus unspecified breast disorder gastroparesis diabetes with other specified manifestations, type i [juvenile type], uncontrolled anxiety state, unspecified iron deficiency anemia, unspecified candidiasis of vulva and vagina unspecified essential hypertension diabetes with neurological manifestations, type i [juvenile type], uncontrolled pedal cycle driver injured in noncollision transport accident in nontraffic accident background diabetic retinopathy diabetes with ophthalmic manifestations, type i [juvenile type], uncontrolled diabetes with neurological manifestations, type i [juvenile type], uncontrolled gastroparesis panic disorder without agoraphobia diabetes with ketoacidosis, type i [juvenile type], uncontrolled benign essential hypertension background diabetic retinopathy long-term (current) use of insulin diabetes with ophthalmic manifestations, type i [juvenile type], uncontrolled gastroparesis diabetes with neurological manifestations, type i [juvenile type], uncontrolled panic disorder without agoraphobia myalgia and myositis, unspecified anxiety state, unspecified unspecified essential hypertension urinary tract infection, site not specified long-term (current) use of insulin
white f 42 $nan$hematology blood hematocrit  32.6  %; hematology blood hemoglobin  10.3  g dl; hematology blood platelet count  335  k ul; chemistry blood anion gap  16  meq l; chemistry blood bicarbonate  18  meq l; chemistry blood chloride  106  meq l; chemistry blood creatinine  0.9  mg dl; chemistry blood potassium  4.0  meq l; chemistry blood sodium  136  meq l; chemistry blood urea nitrogen  11  mg dl; chemistry blood calcium, total  7.4  mg dl; chemistry blood glucose  156  mg dl$insulin  6  unit ; atenolol  50  mg ; omeprazole  40  mg ; polyethylene glycol  17  g ; insulin  0  unit ; sodium chloride 0.9%  flush  3  ml ; ondansetron  4  mg ; hydromorphone (dilaudid)  2  mg ; ns  1000  ml ; heparin flush (10 units ml)  2  ml ; lorazepam  2  mg ; lorazepam  1  mg ; buspirone  15  mg ; clonidine  0.1  mg ; heparin  5000  unit ; docusate sodium  200  mg ; lorazepam  0.5  mg ; hydromorphone (dilaudid)  1  mg ; duloxetine  20  mg ; hydromorphone (dilaudid)  12.5  mg ; 
anemia, unspecified myalgia and myositis, unspecified gastroparesis diabetes with neurological manifestations, type i [juvenile type], not stated as uncontrolled anxiety state, unspecified unspecified essential hypertension family history of diabetes mellitus unspecified breast disorder gastroparesis diabetes with other specified manifestations, type i [juvenile type], uncontrolled anxiety state, unspecified iron deficiency anemia, unspecified candidiasis of vulva and vagina unspecified essential hypertension diabetes with neurological manifestations, type i [juvenile type], uncontrolled pedal cycle driver injured in noncollision transport accident in nontraffic accident background diabetic retinopathy diabetes with ophthalmic manifestations, type i [juvenile type], uncontrolled diabetes with neurological manifestations, type i [juvenile type], uncontrolled gastroparesis panic disorder without agoraphobia diabetes with ketoacidosis, type i [juvenile type], uncontrolled benign essential hypertension background diabetic retinopathy long-term (current) use of insulin diabetes with ophthalmic manifestations, type i [juvenile type], uncontrolled gastroparesis diabetes with neurological manifestations, type i [juvenile type], uncontrolled panic disorder without agoraphobia myalgia and myositis, unspecified anxiety state, unspecified unspecified essential hypertension urinary tract infection, site not specified long-term (current) use of insulin
white f 42 $nan$nan$insulin  6  unit ; atenolol  50  mg ; omeprazole  40  mg ; polyethylene glycol  17  g ; insulin  0  unit ; sodium chloride 0.9%  flush  3  ml ; heparin flush (10 units ml)  2  ml ; lorazepam  2  mg ; lorazepam  1  mg ; buspirone  15  mg ; clonidine  0.1  mg ; heparin  5000  unit ; docusate sodium  200  mg ; lorazepam  0.5  mg ; hydromorphone (dilaudid)  1  mg ; duloxetine  20  mg ; hydromorphone (dilaudid)  12.5  mg ; ondansetron  8  mg ; sarna lotion  1  appl ; diphenhydramine  25  mg ; d5 1 2ns  1000  ml ; ns  150  ml ; erythromycin  125  mg ; hydromorphone (dilaudid)  0.5  mg ; insulin  9  unit ; insulin  3  unit ; 
anemia, unspecified myalgia and myositis, unspecified gastroparesis diabetes with neurological manifestations, type i [juvenile type], not stated as uncontrolled anxiety state, unspecified unspecified essential hypertension family history of diabetes mellitus unspecified breast disorder gastroparesis diabetes with other specified manifestations, type i [juvenile type], uncontrolled anxiety state, unspecified iron deficiency anemia, unspecified candidiasis of vulva and vagina unspecified essential hypertension diabetes with neurological manifestations, type i [juvenile type], uncontrolled pedal cycle driver injured in noncollision transport accident in nontraffic accident background diabetic retinopathy diabetes with ophthalmic manifestations, type i [juvenile type], uncontrolled diabetes with neurological manifestations, type i [juvenile type], uncontrolled gastroparesis panic disorder without agoraphobia diabetes with ketoacidosis, type i [juvenile type], uncontrolled benign essential hypertension background diabetic retinopathy long-term (current) use of insulin diabetes with ophthalmic manifestations, type i [juvenile type], uncontrolled gastroparesis diabetes with neurological manifestations, type i [juvenile type], uncontrolled panic disorder without agoraphobia myalgia and myositis, unspecified anxiety state, unspecified unspecified essential hypertension urinary tract infection, site not specified long-term (current) use of insulin
white f 42 $nan$hematology blood hematocrit  33.2  %; hematology blood hematocrit  34.2  %; hematology blood hemoglobin  10.7  g dl; hematology blood hemoglobin  11.0  g dl; hematology blood platelet count  352  k ul; hematology blood platelet count  341  k ul; chemistry blood anion gap  15  meq l; chemistry blood anion gap  14  meq l; chemistry blood bicarbonate  17  meq l; chemistry blood bicarbonate  19  meq l; chemistry blood chloride  103  meq l; chemistry blood chloride  104  meq l; chemistry blood creatinine  1.1  mg dl; chemistry blood creatinine  0.8  mg dl; chemistry blood potassium  4.4  meq l; chemistry blood potassium  3.7  meq l; chemistry blood sodium  131  meq l; chemistry blood sodium  133  meq l; chemistry blood urea nitrogen  7  mg dl; chemistry blood urea nitrogen  5  mg dl; chemistry blood glucose  286  mg dl; chemistry blood glucose  267  mg dl$atenolol  50  mg ; omeprazole  40  mg ; polyethylene glycol  17  g ; sodium chloride 0.9%  flush  3  ml ; heparin flush (10 units ml)  2  ml ; lorazepam  2  mg ; lorazepam  1  mg ; clonidine  0.1  mg ; heparin  5000  unit ; docusate sodium  200  mg ; duloxetine  20  mg ; ondansetron  8  mg ; sarna lotion  1  appl ; diphenhydramine  25  mg ; ns  150  ml ; erythromycin  125  mg ; hydromorphone (dilaudid)  0.5  mg ; insulin  9  unit ; insulin  3  unit ; heparin flush (10 units ml)  5  ml ; heparin flush (100 units ml)  5  ml ; insulin  8  unit ; metronidazole gel 0.75%-vaginal  1  appl ; insulin  12  unit ; insulin  13  unit ; ondansetron odt  8  mg ; hydromorphone (dilaudid)  4  mg ; 
anemia, unspecified myalgia and myositis, unspecified gastroparesis diabetes with neurological manifestations, type i [juvenile type], not stated as uncontrolled anxiety state, unspecified unspecified essential hypertension family history of diabetes mellitus unspecified breast disorder gastroparesis diabetes with other specified manifestations, type i [juvenile type], uncontrolled anxiety state, unspecified iron deficiency anemia, unspecified candidiasis of vulva and vagina unspecified essential hypertension diabetes with neurological manifestations, type i [juvenile type], uncontrolled pedal cycle driver injured in noncollision transport accident in nontraffic accident background diabetic retinopathy diabetes with ophthalmic manifestations, type i [juvenile type], uncontrolled diabetes with neurological manifestations, type i [juvenile type], uncontrolled gastroparesis panic disorder without agoraphobia diabetes with ketoacidosis, type i [juvenile type], uncontrolled benign essential hypertension background diabetic retinopathy long-term (current) use of insulin diabetes with ophthalmic manifestations, type i [juvenile type], uncontrolled gastroparesis diabetes with neurological manifestations, type i [juvenile type], uncontrolled panic disorder without agoraphobia myalgia and myositis, unspecified anxiety state, unspecified unspecified essential hypertension urinary tract infection, site not specified long-term (current) use of insulin
white f 42 $nan$hematology blood hematocrit  37.0  %; hematology blood hemoglobin  12.5  g dl; hematology blood platelet count  364  k ul; chemistry blood anion gap  16  meq l; chemistry blood bicarbonate  23  meq l; chemistry blood chloride  101  meq l; chemistry blood creatinine  0.8  mg dl; chemistry blood potassium  3.3  meq l; chemistry blood sodium  137  meq l; chemistry blood urea nitrogen  3  mg dl; chemistry blood glucose  64  mg dl$atenolol  50  mg ; omeprazole  40  mg ; polyethylene glycol  17  g ; sodium chloride 0.9%  flush  3  ml ; heparin flush (10 units ml)  2  ml ; lorazepam  2  mg ; clonidine  0.1  mg ; heparin  5000  unit ; docusate sodium  200  mg ; duloxetine  20  mg ; sarna lotion  1  appl ; ns  150  ml ; erythromycin  125  mg ; heparin flush (10 units ml)  5  ml ; heparin flush (100 units ml)  5  ml ; metronidazole gel 0.75%-vaginal  1  appl ; insulin  13  unit ; ondansetron odt  8  mg ; hydromorphone (dilaudid)  4  mg ; ibuprofen  600  mg ; sw  100  ml ; potassium chloride  10  meq ; 
anemia, unspecified myalgia and myositis, unspecified gastroparesis diabetes with neurological manifestations, type i [juvenile type], not stated as uncontrolled anxiety state, unspecified unspecified essential hypertension family history of diabetes mellitus unspecified breast disorder gastroparesis diabetes with other specified manifestations, type i [juvenile type], uncontrolled anxiety state, unspecified iron deficiency anemia, unspecified candidiasis of vulva and vagina unspecified essential hypertension diabetes with neurological manifestations, type i [juvenile type], uncontrolled pedal cycle driver injured in noncollision transport accident in nontraffic accident background diabetic retinopathy diabetes with ophthalmic manifestations, type i [juvenile type], uncontrolled diabetes with neurological manifestations, type i [juvenile type], uncontrolled gastroparesis panic disorder without agoraphobia diabetes with ketoacidosis, type i [juvenile type], uncontrolled benign essential hypertension background diabetic retinopathy long-term (current) use of insulin diabetes with ophthalmic manifestations, type i [juvenile type], uncontrolled gastroparesis diabetes with neurological manifestations, type i [juvenile type], uncontrolled panic disorder without agoraphobia myalgia and myositis, unspecified anxiety state, unspecified unspecified essential hypertension urinary tract infection, site not specified long-term (current) use of insulin
white f 42 $nan$nan$atenolol  50  mg ; omeprazole  40  mg ; polyethylene glycol  17  g ; sodium chloride 0.9%  flush  3  ml ; heparin flush (10 units ml)  2  ml ; lorazepam  2  mg ; clonidine  0.1  mg ; heparin  5000  unit ; docusate sodium  200  mg ; duloxetine  20  mg ; sarna lotion  1  appl ; ns  150  ml ; erythromycin  125  mg ; heparin flush (10 units ml)  5  ml ; heparin flush (100 units ml)  5  ml ; metronidazole gel 0.75%-vaginal  1  appl ; insulin  13  unit ; ondansetron odt  8  mg ; ibuprofen  600  mg ; sw  100  ml ; potassium chloride  10  meq ; 
anemia, unspecified myalgia and myositis, unspecified gastroparesis diabetes with neurological manifestations, type i [juvenile type], not stated as uncontrolled anxiety state, unspecified unspecified essential hypertension family history of diabetes mellitus unspecified breast disorder gastroparesis diabetes with other specified manifestations, type i [juvenile type], uncontrolled anxiety state, unspecified iron deficiency anemia, unspecified candidiasis of vulva and vagina unspecified essential hypertension diabetes with neurological manifestations, type i [juvenile type], uncontrolled pedal cycle driver injured in noncollision transport accident in nontraffic accident background diabetic retinopathy diabetes with ophthalmic manifestations, type i [juvenile type], uncontrolled diabetes with neurological manifestations, type i [juvenile type], uncontrolled gastroparesis panic disorder without agoraphobia diabetes with ketoacidosis, type i [juvenile type], uncontrolled benign essential hypertension background diabetic retinopathy long-term (current) use of insulin diabetes with ophthalmic manifestations, type i [juvenile type], uncontrolled gastroparesis diabetes with neurological manifestations, type i [juvenile type], uncontrolled panic disorder without agoraphobia myalgia and myositis, unspecified anxiety state, unspecified unspecified essential hypertension urinary tract infection, site not specified long-term (current) use of insulin
hispanic latino m 52 $nan$nan$indomethacin  50  mg ; colchicine  0.6  mg ; 
 
hispanic latino m 52 $nan$hematology blood hematocrit  38.2  %; hematology blood hemoglobin  12.9  g dl; hematology blood platelet count  283  k ul; chemistry blood anion gap  12  meq l; chemistry blood bicarbonate  30  meq l; chemistry blood chloride  104  meq l; chemistry blood creatinine  1.1  mg dl; chemistry blood potassium  4.0  meq l; chemistry blood sodium  142  meq l; chemistry blood urea nitrogen  21  mg dl; chemistry blood calcium, total  8.9  mg dl; chemistry blood glucose  101  mg dl$indomethacin  50  mg ; colchicine  0.6  mg ; oxycodone-acetaminophen  1-2  tab ; sodium chloride 0.9%  flush  3  ml ; acetaminophen  325-650  mg ; oxycodone-acetaminophen  1  tab ; heparin  5000  unit ; 
 
hispanic latino m 52 $nan$hematology blood hematocrit  38.4  %; hematology blood hemoglobin  13.0  g dl; hematology blood platelet count  298  k ul; chemistry blood anion gap  12  meq l; chemistry blood bicarbonate  30  meq l; chemistry blood chloride  103  meq l; chemistry blood creatinine  1.1  mg dl; chemistry blood potassium  4.4  meq l; chemistry blood sodium  141  meq l; chemistry blood urea nitrogen  22  mg dl; chemistry blood glucose  95  mg dl$colchicine  0.6  mg ; oxycodone-acetaminophen  1-2  tab ; sodium chloride 0.9%  flush  3  ml ; acetaminophen  325-650  mg ; oxycodone-acetaminophen  1  tab ; heparin  5000  unit ; diclofenac sodium dr  50  mg ; hydralazine  10  mg ; captopril  12.5  mg ; 
 
hispanic latino m 52 $nan$hematology blood hematocrit  38.8  %; hematology blood hemoglobin  12.8  g dl; hematology blood platelet count  339  k ul; chemistry blood anion gap  13  meq l; chemistry blood bicarbonate  30  meq l; chemistry blood chloride  106  meq l; chemistry blood creatinine  1.2  mg dl; chemistry blood potassium  4.5  meq l; chemistry blood sodium  144  meq l; chemistry blood urea nitrogen  23  mg dl; chemistry blood calcium, total  9.5  mg dl; chemistry blood glucose  98  mg dl$sodium chloride 0.9%  flush  3  ml ; acetaminophen  325-650  mg ; oxycodone-acetaminophen  1  tab ; heparin  5000  unit ; diclofenac sodium dr  50  mg ; hydralazine  10  mg ; captopril  12.5  mg ; captopril  25  mg ; lisinopril  20  mg ; prednisone  40  mg ; 
 
hispanic latino m 52 $nan$hematology blood hematocrit  41.6  %; hematology blood hemoglobin  13.8  g dl; hematology blood platelet count  366  k ul; chemistry blood anion gap  16  meq l; chemistry blood bicarbonate  28  meq l; chemistry blood chloride  102  meq l; chemistry blood creatinine  1.2  mg dl; chemistry blood potassium  4.6  meq l; chemistry blood sodium  141  meq l; chemistry blood urea nitrogen  28  mg dl; chemistry blood calcium, total  9.3  mg dl; chemistry blood glucose  117  mg dl$sodium chloride 0.9%  flush  3  ml ; acetaminophen  325-650  mg ; heparin  5000  unit ; lisinopril  20  mg ; prednisone  40  mg ; methylprednisolone sodium succ  20  mg ; 
 
hispanic latino m 52 $nan$nan$sodium chloride 0.9%  flush  3  ml ; acetaminophen  325-650  mg ; heparin  5000  unit ; lisinopril  20  mg ; prednisone  40  mg ; 
 
white m 23 $temp  98.9  heartrate  80.0  resprate  18.0  o2sat  96.0  sbp  103.0  dbp  65.0  rhythm    pain  5  $hematology blood hematocrit  43.5  %; hematology blood hemoglobin  15.0  g dl; hematology blood platelet count  208  k ul; chemistry blood anion gap  18  meq l; chemistry blood bicarbonate  26  meq l; chemistry blood chloride  101  meq l; chemistry blood creatinine  1.2  mg dl; chemistry blood potassium  3.8  meq l; chemistry blood sodium  141  meq l; chemistry blood urea nitrogen  10  mg dl; hematology blood inr(pt)  1.0  ; chemistry blood calcium, total  9.2  mg dl; chemistry blood glucose  91  mg dl$influenza vaccine quadrivalent  0.5  ml ; sodium chloride 0.9%  flush  3  ml ; acetaminophen  1000  mg ; oxycodone liquid  5  mg ; heparin  5000  unit ; lactated ringers  1000  ml ; d5 1 2ns  1000  ml ; 0.9% sodium chloride  250  ml ; potassium chloride  20  meq ; 
 
white m 23 $nan$hematology blood hematocrit  39.1  %; hematology blood hemoglobin  13.4  g dl; hematology blood platelet count  170  k ul; chemistry blood anion gap  14  meq l; chemistry blood bicarbonate  28  meq l; chemistry blood chloride  101  meq l; chemistry blood creatinine  1.2  mg dl; chemistry blood potassium  4.0  meq l; chemistry blood sodium  139  meq l; chemistry blood urea nitrogen  10  mg dl; chemistry blood calcium, total  8.8  mg dl; chemistry blood glucose  86  mg dl$influenza vaccine quadrivalent  0.5  ml ; sodium chloride 0.9%  flush  3  ml ; acetaminophen  1000  mg ; oxycodone liquid  5  mg ; heparin  5000  unit ; d5 1 2ns  1000  ml ; 0.9% sodium chloride  250  ml ; potassium chloride  20  meq ; acetaminophen iv  1000  mg ; 
 
white m 23 $nan$nan$influenza vaccine quadrivalent  0.5  ml ; sodium chloride 0.9%  flush  3  ml ; oxycodone liquid  5  mg ; heparin  5000  unit ; acetaminophen iv  1000  mg ; oxycodone liquid  10  mg ; senna  8.6  mg ; polyethylene glycol  17  g ; 
 
white m 23 $nan$nan$influenza vaccine quadrivalent  0.5  ml ; sodium chloride 0.9%  flush  3  ml ; heparin  5000  unit ; oxycodone liquid  10  mg ; senna  8.6  mg ; polyethylene glycol  17  g ; 
 
white m 61 $temp  97.7  heartrate  53.0  resprate  14.0  o2sat  96.0  sbp  104.0  dbp  62.0  rhythm    pain  5  $nan$tiotropium bromide  1  cap ; 0.45% sodium chloride  1000  ml ; heparin  5000  unit ; sodium chloride 0.9%  flush  3-10  ml ; albuterol  1-2  puff ; senna  8.6  mg ; docusate sodium  100  mg ; bisacodyl  10  mg ; ondansetron  4  mg ; acetaminophen  1000  mg ; morphine sr (ms contin)  30  mg ; quetiapine fumarate  200  mg ; tizanidine  8  mg ; venlafaxine xr  75  mg ; hydromorphone (dilaudid)  2-4  mg ; lorazepam  0.5  mg ; morphine sr (ms contin)  15  mg ; 
 
white m 61 $nan$hematology blood hematocrit  37.1  %; hematology blood hemoglobin  12.2  g dl; hematology blood platelet count  60  k ul; chemistry blood anion gap  11  meq l; chemistry blood bicarbonate  27  meq l; chemistry blood chloride  106  meq l; chemistry blood creatinine  0.7  mg dl; chemistry blood potassium  3.6  meq l; chemistry blood sodium  144  meq l; chemistry blood urea nitrogen  7  mg dl; hematology blood inr(pt)  1.3  ; chemistry blood calcium, total  8.4  mg dl; chemistry blood bilirubin, total  0.7  mg dl; chemistry blood glucose  79  mg dl$tiotropium bromide  1  cap ; heparin  5000  unit ; sodium chloride 0.9%  flush  3-10  ml ; albuterol  1-2  puff ; senna  8.6  mg ; docusate sodium  100  mg ; bisacodyl  10  mg ; ondansetron  4  mg ; acetaminophen  1000  mg ; morphine sr (ms contin)  30  mg ; quetiapine fumarate  200  mg ; tizanidine  8  mg ; venlafaxine xr  75  mg ; hydromorphone (dilaudid)  2-4  mg ; lorazepam  0.5  mg ; morphine sr (ms contin)  15  mg ; 
 
white m 61 $nan$nan$tiotropium bromide  1  cap ; heparin  5000  unit ; sodium chloride 0.9%  flush  3-10  ml ; albuterol  1-2  puff ; senna  8.6  mg ; docusate sodium  100  mg ; bisacodyl  10  mg ; ondansetron  4  mg ; acetaminophen  1000  mg ; morphine sr (ms contin)  30  mg ; quetiapine fumarate  200  mg ; tizanidine  8  mg ; venlafaxine xr  75  mg ; hydromorphone (dilaudid)  2-4  mg ; morphine sr (ms contin)  15  mg ; nicotine patch  14  mg ; lactated ringers  1000  ml ; lidocaine 5% patch  1  ptch ; sodium chloride 0.9%  1000  ml ; 
 
white m 61 $nan$hematology blood hematocrit  33.4  %; hematology blood hemoglobin  11.0  g dl; hematology blood platelet count  61  k ul; chemistry blood anion gap  8  meq l; chemistry blood bicarbonate  27  meq l; chemistry blood chloride  107  meq l; chemistry blood creatinine  0.7  mg dl; chemistry blood potassium  4.6  meq l; chemistry blood sodium  142  meq l; chemistry blood urea nitrogen  7  mg dl; hematology blood inr(pt)  1.4  ; chemistry blood bilirubin, total  0.5  mg dl; chemistry blood glucose  84  mg dl$tiotropium bromide  1  cap ; heparin  5000  unit ; sodium chloride 0.9%  flush  3-10  ml ; albuterol  1-2  puff ; senna  8.6  mg ; docusate sodium  100  mg ; bisacodyl  10  mg ; ondansetron  4  mg ; acetaminophen  1000  mg ; morphine sr (ms contin)  30  mg ; quetiapine fumarate  200  mg ; tizanidine  8  mg ; venlafaxine xr  75  mg ; hydromorphone (dilaudid)  2-4  mg ; morphine sr (ms contin)  15  mg ; nicotine patch  14  mg ; lactated ringers  1000  ml ; lidocaine 5% patch  1  ptch ; sodium chloride 0.9%  1000  ml ; phytonadione  5  mg ; 
 
white m 61 $nan$nan$tiotropium bromide  1  cap ; heparin  5000  unit ; sodium chloride 0.9%  flush  3-10  ml ; albuterol  1-2  puff ; senna  8.6  mg ; docusate sodium  100  mg ; bisacodyl  10  mg ; ondansetron  4  mg ; acetaminophen  1000  mg ; morphine sr (ms contin)  30  mg ; quetiapine fumarate  200  mg ; tizanidine  8  mg ; venlafaxine xr  75  mg ; hydromorphone (dilaudid)  2-4  mg ; morphine sr (ms contin)  15  mg ; nicotine patch  14  mg ; lidocaine 5% patch  1  ptch ; phytonadione  5  mg ; potassium chl 20 meq   1000 ml d5lr  1000  ml ; 
 
white m 61 $nan$nan$tiotropium bromide  1  cap ; heparin  5000  unit ; sodium chloride 0.9%  flush  3-10  ml ; albuterol  1-2  puff ; senna  8.6  mg ; docusate sodium  100  mg ; bisacodyl  10  mg ; ondansetron  4  mg ; acetaminophen  1000  mg ; morphine sr (ms contin)  30  mg ; quetiapine fumarate  200  mg ; tizanidine  8  mg ; venlafaxine xr  75  mg ; morphine sr (ms contin)  15  mg ; nicotine patch  14  mg ; lidocaine 5% patch  1  ptch ; phytonadione  5  mg ; potassium chl 20 meq   1000 ml d5lr  1000  ml ; 
 
white m 65 $nan$hematology blood hematocrit  25.5  %; hematology blood hematocrit  22.4  %; hematology blood hemoglobin  8.3  g dl; hematology blood hemoglobin  7.1  g dl; hematology blood platelet count  27  k ul; hematology blood platelet count  33  k ul; chemistry blood anion gap  9  meq l; chemistry blood anion gap  8  meq l; chemistry blood bicarbonate  28  meq l; chemistry blood bicarbonate  26  meq l; chemistry blood chloride  103  meq l; chemistry blood chloride  106  meq l; chemistry blood creatinine  1.0  mg dl; chemistry blood creatinine  0.8  mg dl; chemistry blood potassium  4.0  meq l; chemistry blood potassium  4.0  meq l; chemistry blood sodium  140  meq l; chemistry blood sodium  140  meq l; chemistry blood urea nitrogen  9  mg dl; chemistry blood urea nitrogen  9  mg dl; hematology blood inr(pt)  2.1  ; hematology blood inr(pt)  2.3  ; hematology urine wbc  5  # hpf; chemistry blood calcium, total  8.7  mg dl; chemistry blood calcium, total  8.6  mg dl; chemistry blood bilirubin, total  1.8  mg dl; chemistry blood bilirubin, total  1.6  mg dl; chemistry blood glucose  97  mg dl; chemistry blood glucose  115  mg dl; chemistry blood albumin  2.6  g dl$influenza vaccine quadrivalent  0.5  ml ; sodium chloride 0.9%  flush  3-10  ml ; heparin  5000  unit ; acetaminophen  500  mg ; aspirin  81  mg ; clonazepam  0.5  mg ; furosemide  20  mg ; lactulose  30  ml ; magnesium oxide  400  mg ; multivitamins  1  tab ; nicotine patch  14  mg day ; ondansetron  4  mg ; rifaximin  550  mg ; simethicone  80  mg ; thiamine  100  mg ; ursodiol  300  mg ; ramelteon  8  mg ; baclofen  5  mg ; morphine sr (ms contin)  30  mg ; morphine sulfate (oral solution) 2 mg ml  5-10  mg ; spironolactone  50  mg ; omeprazole  20  mg ; methadone  15  mg ; 
do not resuscitate unspecified viral hepatitis c without hepatic coma pneumonia, unspecified organism unspecified protein-calorie malnutrition unspecified cirrhosis of liver disease of gallbladder, unspecified presence of cardiac pacemaker body mass index (bmi) 24.0-24.9, adult thrombocytopenia, unspecified anemia, unspecified acute kidney failure, unspecified encounter for palliative care peritonitis, unspecified hepatic failure, unspecified without coma other chronic pain personal history of nicotine dependence portal hypertension insomnia, unspecified acquired absence of left finger(s) personal history of transient ischemic attack (tia), and cerebral infarction without residual deficits anxiety disorder, unspecified acquired coagulation factor deficiency other ascites portal hypertension acquired coagulation factor deficiency do not resuscitate unspecified viral hepatitis c without hepatic coma personal history of nicotine dependence encounter for palliative care constipation, unspecified acquired absence of left finger(s) other chronic pain other diseases of stomach and duodenum other cirrhosis of liver opioid dependence, uncomplicated hepatic failure, unspecified without coma unspecified protein-calorie malnutrition age-related osteoporosis without current pathological fracture presence of cardiac pacemaker other pancytopenia personal history of transient ischemic attack (tia), and cerebral infarction without residual deficits enterocolitis due to clostridium difficile, not specified as recurrent anxiety disorder, unspecified body mass index (bmi) 25.0-25.9, adult disseminated intravascular coagulation [defibrination syndrome] presence of cardiac pacemaker other pancytopenia personal history of other infectious and parasitic diseases
white m 65 $nan$nan$influenza vaccine quadrivalent  0.5  ml ; sodium chloride 0.9%  flush  3-10  ml ; aspirin  81  mg ; clonazepam  0.5  mg ; furosemide  20  mg ; magnesium oxide  400  mg ; multivitamins  1  tab ; nicotine patch  14  mg day ; ondansetron  4  mg ; rifaximin  550  mg ; simethicone  80  mg ; thiamine  100  mg ; ursodiol  300  mg ; ramelteon  8  mg ; baclofen  5  mg ; morphine sr (ms contin)  30  mg ; morphine sulfate (oral solution) 2 mg ml  5-10  mg ; spironolactone  50  mg ; omeprazole  20  mg ; methadone  15  mg ; ondansetron odt  4  mg ; hydrocerin  1  appl ; 
do not resuscitate unspecified viral hepatitis c without hepatic coma pneumonia, unspecified organism unspecified protein-calorie malnutrition unspecified cirrhosis of liver disease of gallbladder, unspecified presence of cardiac pacemaker body mass index (bmi) 24.0-24.9, adult thrombocytopenia, unspecified anemia, unspecified acute kidney failure, unspecified encounter for palliative care peritonitis, unspecified hepatic failure, unspecified without coma other chronic pain personal history of nicotine dependence portal hypertension insomnia, unspecified acquired absence of left finger(s) personal history of transient ischemic attack (tia), and cerebral infarction without residual deficits anxiety disorder, unspecified acquired coagulation factor deficiency other ascites portal hypertension acquired coagulation factor deficiency do not resuscitate unspecified viral hepatitis c without hepatic coma personal history of nicotine dependence encounter for palliative care constipation, unspecified acquired absence of left finger(s) other chronic pain other diseases of stomach and duodenum other cirrhosis of liver opioid dependence, uncomplicated hepatic failure, unspecified without coma unspecified protein-calorie malnutrition age-related osteoporosis without current pathological fracture presence of cardiac pacemaker other pancytopenia personal history of transient ischemic attack (tia), and cerebral infarction without residual deficits enterocolitis due to clostridium difficile, not specified as recurrent anxiety disorder, unspecified body mass index (bmi) 25.0-25.9, adult disseminated intravascular coagulation [defibrination syndrome] presence of cardiac pacemaker other pancytopenia personal history of other infectious and parasitic diseases
white m 65 $nan$nan$influenza vaccine quadrivalent  0.5  ml ; sodium chloride 0.9%  flush  3-10  ml ; aspirin  81  mg ; clonazepam  0.5  mg ; furosemide  20  mg ; magnesium oxide  400  mg ; multivitamins  1  tab ; nicotine patch  14  mg day ; rifaximin  550  mg ; simethicone  80  mg ; thiamine  100  mg ; ursodiol  300  mg ; ramelteon  8  mg ; baclofen  5  mg ; morphine sr (ms contin)  30  mg ; morphine sulfate (oral solution) 2 mg ml  5-10  mg ; spironolactone  50  mg ; omeprazole  20  mg ; methadone  15  mg ; ondansetron odt  4  mg ; hydrocerin  1  appl ; 
do not resuscitate unspecified viral hepatitis c without hepatic coma pneumonia, unspecified organism unspecified protein-calorie malnutrition unspecified cirrhosis of liver disease of gallbladder, unspecified presence of cardiac pacemaker body mass index (bmi) 24.0-24.9, adult thrombocytopenia, unspecified anemia, unspecified acute kidney failure, unspecified encounter for palliative care peritonitis, unspecified hepatic failure, unspecified without coma other chronic pain personal history of nicotine dependence portal hypertension insomnia, unspecified acquired absence of left finger(s) personal history of transient ischemic attack (tia), and cerebral infarction without residual deficits anxiety disorder, unspecified acquired coagulation factor deficiency other ascites portal hypertension acquired coagulation factor deficiency do not resuscitate unspecified viral hepatitis c without hepatic coma personal history of nicotine dependence encounter for palliative care constipation, unspecified acquired absence of left finger(s) other chronic pain other diseases of stomach and duodenum other cirrhosis of liver opioid dependence, uncomplicated hepatic failure, unspecified without coma unspecified protein-calorie malnutrition age-related osteoporosis without current pathological fracture presence of cardiac pacemaker other pancytopenia personal history of transient ischemic attack (tia), and cerebral infarction without residual deficits enterocolitis due to clostridium difficile, not specified as recurrent anxiety disorder, unspecified body mass index (bmi) 25.0-25.9, adult disseminated intravascular coagulation [defibrination syndrome] presence of cardiac pacemaker other pancytopenia personal history of other infectious and parasitic diseases
white m 65 $nan$nan$influenza vaccine quadrivalent  0.5  ml ; sodium chloride 0.9%  flush  3-10  ml ; aspirin  81  mg ; clonazepam  0.5  mg ; furosemide  20  mg ; magnesium oxide  400  mg ; multivitamins  1  tab ; nicotine patch  14  mg day ; rifaximin  550  mg ; simethicone  80  mg ; thiamine  100  mg ; ursodiol  300  mg ; ramelteon  8  mg ; baclofen  5  mg ; morphine sr (ms contin)  30  mg ; morphine sulfate (oral solution) 2 mg ml  5-10  mg ; spironolactone  50  mg ; omeprazole  20  mg ; methadone  15  mg ; ondansetron odt  4  mg ; hydrocerin  1  appl ; 
do not resuscitate unspecified viral hepatitis c without hepatic coma pneumonia, unspecified organism unspecified protein-calorie malnutrition unspecified cirrhosis of liver disease of gallbladder, unspecified presence of cardiac pacemaker body mass index (bmi) 24.0-24.9, adult thrombocytopenia, unspecified anemia, unspecified acute kidney failure, unspecified encounter for palliative care peritonitis, unspecified hepatic failure, unspecified without coma other chronic pain personal history of nicotine dependence portal hypertension insomnia, unspecified acquired absence of left finger(s) personal history of transient ischemic attack (tia), and cerebral infarction without residual deficits anxiety disorder, unspecified acquired coagulation factor deficiency other ascites portal hypertension acquired coagulation factor deficiency do not resuscitate unspecified viral hepatitis c without hepatic coma personal history of nicotine dependence encounter for palliative care constipation, unspecified acquired absence of left finger(s) other chronic pain other diseases of stomach and duodenum other cirrhosis of liver opioid dependence, uncomplicated hepatic failure, unspecified without coma unspecified protein-calorie malnutrition age-related osteoporosis without current pathological fracture presence of cardiac pacemaker other pancytopenia personal history of transient ischemic attack (tia), and cerebral infarction without residual deficits enterocolitis due to clostridium difficile, not specified as recurrent anxiety disorder, unspecified body mass index (bmi) 25.0-25.9, adult disseminated intravascular coagulation [defibrination syndrome] presence of cardiac pacemaker other pancytopenia personal history of other infectious and parasitic diseases
white m 65 $nan$nan$influenza vaccine quadrivalent  0.5  ml ; sodium chloride 0.9%  flush  3-10  ml ; aspirin  81  mg ; clonazepam  0.5  mg ; furosemide  20  mg ; magnesium oxide  400  mg ; multivitamins  1  tab ; nicotine patch  14  mg day ; rifaximin  550  mg ; simethicone  80  mg ; thiamine  100  mg ; ursodiol  300  mg ; ramelteon  8  mg ; baclofen  5  mg ; morphine sr (ms contin)  30  mg ; morphine sulfate (oral solution) 2 mg ml  5-10  mg ; spironolactone  50  mg ; omeprazole  20  mg ; methadone  15  mg ; ondansetron odt  4  mg ; hydrocerin  1  appl ; 
do not resuscitate unspecified viral hepatitis c without hepatic coma pneumonia, unspecified organism unspecified protein-calorie malnutrition unspecified cirrhosis of liver disease of gallbladder, unspecified presence of cardiac pacemaker body mass index (bmi) 24.0-24.9, adult thrombocytopenia, unspecified anemia, unspecified acute kidney failure, unspecified encounter for palliative care peritonitis, unspecified hepatic failure, unspecified without coma other chronic pain personal history of nicotine dependence portal hypertension insomnia, unspecified acquired absence of left finger(s) personal history of transient ischemic attack (tia), and cerebral infarction without residual deficits anxiety disorder, unspecified acquired coagulation factor deficiency other ascites portal hypertension acquired coagulation factor deficiency do not resuscitate unspecified viral hepatitis c without hepatic coma personal history of nicotine dependence encounter for palliative care constipation, unspecified acquired absence of left finger(s) other chronic pain other diseases of stomach and duodenum other cirrhosis of liver opioid dependence, uncomplicated hepatic failure, unspecified without coma unspecified protein-calorie malnutrition age-related osteoporosis without current pathological fracture presence of cardiac pacemaker other pancytopenia personal history of transient ischemic attack (tia), and cerebral infarction without residual deficits enterocolitis due to clostridium difficile, not specified as recurrent anxiety disorder, unspecified body mass index (bmi) 25.0-25.9, adult disseminated intravascular coagulation [defibrination syndrome] presence of cardiac pacemaker other pancytopenia personal history of other infectious and parasitic diseases
black african american m 42 $temp  98.3  heartrate  79.0  resprate  19.0  o2sat  100.0  sbp  160.0  dbp  56.0  rhythm    pain  0  ; temp  97.6  heartrate  90.0  resprate  18.0  o2sat  96.0  sbp  152.0  dbp  93.0  rhythm    pain    ; temp  98.1  heartrate  91.0  resprate  18.0  o2sat  100.0  sbp  148.0  dbp  85.0  rhythm    pain    ; temp  97.5  heartrate  89.0  resprate    o2sat  99.0  sbp  153.0  dbp  98.0  rhythm    pain    ; temp  97.7  heartrate  87.0  resprate  18.0  o2sat  99.0  sbp  161.0  dbp  92.0  rhythm    pain    ; temp  97.9  heartrate  92.0  resprate  19.0  o2sat  100.0  sbp  147.0  dbp  68.0  rhythm    pain  0  ; temp  97.8  heartrate  88.0  resprate  18.0  o2sat  99.0  sbp  152.0  dbp  89.0  rhythm    pain  0  $hematology blood hematocrit  27.3  %; hematology blood hemoglobin  8.5  g dl; hematology blood platelet count  159  k ul; chemistry blood anion gap  21  meq l; chemistry blood bicarbonate  21  meq l; chemistry blood chloride  102  meq l; chemistry blood creatinine  10.0  mg dl; chemistry blood potassium  4.4  meq l; chemistry blood sodium  140  meq l; chemistry blood urea nitrogen  83  mg dl; chemistry blood calcium, total  8.1  mg dl; chemistry blood bilirubin, total  0.5  mg dl; chemistry blood glucose  77  mg dl$nan
personal history of other venous thrombosis and embolism dermatitis, unspecified pneumonia, unspecified organism chronic diastolic (congestive) heart failure major depressive disorder, single episode, unspecified dissection of thoracoabdominal aorta allergic rhinitis, unspecified tobacco use other specified places as the place of occurrence of the external cause hypertensive chronic kidney disease with stage 5 chronic kidney disease or end stage renal disease von gierke disease strain of muscle, fascia and tendon at neck level, initial encounter nontoxic multinodular goiter lichen simplex chronicus dependence on renal dialysis nutritional anemia, unspecified lymphedema, not elsewhere classified end stage renal disease hypertensive chronic kidney disease with stage 5 chronic kidney disease or end stage renal disease strain of muscle, fascia and tendon of lower back, initial encounter dependence on renal dialysis end stage renal disease major depressive disorder, single episode, unspecified dissection of unspecified site of aorta unemployment, unspecified stenosis of other vascular prosthetic devices, implants and grafts, initial encounter lymphedema, not elsewhere classified other specified places as the place of occurrence of the external cause homelessness tobacco use allergic rhinitis, unspecified anemia due to glucose-6-phosphate dehydrogenase [g6pd] deficiency dermatitis, unspecified nutritional anemia, unspecified allergic rhinitis, unspecified thrombosis due to vascular prosthetic devices, implants and grafts, initial encounter dependence on renal dialysis major depressive disorder, single episode, unspecified dissection of abdominal aorta anemia due to glucose-6-phosphate dehydrogenase [g6pd] deficiency unemployment, unspecified tobacco use surgical operation with anastomosis, bypass or graft as the cause of abnormal reaction of the patient, or of later complication, without mention of misadventure at the time of the procedure dermatitis, unspecified other specified complication of vascular prosthetic devices, implants and grafts, initial encounter tinea pedis unspecified place in unspecified non-institutional (private) residence as the place of occurrence of the external cause lymphedema, not elsewhere classified
black african american m 42 $nan$hematology blood hematocrit  29.0  %; hematology blood hematocrit  27.1  %; hematology blood hemoglobin  8.9  g dl; hematology blood hemoglobin  8.5  g dl; hematology blood platelet count  153  k ul; hematology blood platelet count  143  k ul; chemistry blood anion gap  20  meq l; chemistry blood anion gap  16  meq l; chemistry blood bicarbonate  23  meq l; chemistry blood bicarbonate  26  meq l; chemistry blood chloride  98  meq l; chemistry blood chloride  99  meq l; chemistry blood creatinine  8.9  mg dl; chemistry blood creatinine  9.1  mg dl; chemistry blood potassium  4.0  meq l; chemistry blood potassium  4.3  meq l; chemistry blood sodium  137  meq l; chemistry blood sodium  137  meq l; chemistry blood urea nitrogen  64  mg dl; chemistry blood urea nitrogen  65  mg dl; chemistry blood calcium, total  8.4  mg dl; chemistry blood calcium, total  8.1  mg dl; chemistry blood glucose  110  mg dl; chemistry blood glucose  85  mg dl$sodium chloride 0.9%  flush  3  ml ; diphenhydramine  25  mg ; hydroxyzine  25  mg ; sarna lotion  1  appl ; labetalol  200  mg ; sevelamer carbonate  2400  mg ; tizanidine  4  mg ; heparin  5000  unit ; torsemide  60  mg ; econazole  1  % ; hydrocortisone cream 2.5%  1  appl ; epoetin alfa  10,000  unit ; epoetin alfa  1000  unit ; doxercalciferol  4  mcg ; sodium chloride 0.9%  1000  ml ; lidocaine 1%  1  ml ; heparin (hemodialysis)  4000  unit ; heparin (hemodialysis)  1000  unit ; cinacalcet  60  mg ; 
personal history of other venous thrombosis and embolism dermatitis, unspecified pneumonia, unspecified organism chronic diastolic (congestive) heart failure major depressive disorder, single episode, unspecified dissection of thoracoabdominal aorta allergic rhinitis, unspecified tobacco use other specified places as the place of occurrence of the external cause hypertensive chronic kidney disease with stage 5 chronic kidney disease or end stage renal disease von gierke disease strain of muscle, fascia and tendon at neck level, initial encounter nontoxic multinodular goiter lichen simplex chronicus dependence on renal dialysis nutritional anemia, unspecified lymphedema, not elsewhere classified end stage renal disease hypertensive chronic kidney disease with stage 5 chronic kidney disease or end stage renal disease strain of muscle, fascia and tendon of lower back, initial encounter dependence on renal dialysis end stage renal disease major depressive disorder, single episode, unspecified dissection of unspecified site of aorta unemployment, unspecified stenosis of other vascular prosthetic devices, implants and grafts, initial encounter lymphedema, not elsewhere classified other specified places as the place of occurrence of the external cause homelessness tobacco use allergic rhinitis, unspecified anemia due to glucose-6-phosphate dehydrogenase [g6pd] deficiency dermatitis, unspecified nutritional anemia, unspecified allergic rhinitis, unspecified thrombosis due to vascular prosthetic devices, implants and grafts, initial encounter dependence on renal dialysis major depressive disorder, single episode, unspecified dissection of abdominal aorta anemia due to glucose-6-phosphate dehydrogenase [g6pd] deficiency unemployment, unspecified tobacco use surgical operation with anastomosis, bypass or graft as the cause of abnormal reaction of the patient, or of later complication, without mention of misadventure at the time of the procedure dermatitis, unspecified other specified complication of vascular prosthetic devices, implants and grafts, initial encounter tinea pedis unspecified place in unspecified non-institutional (private) residence as the place of occurrence of the external cause lymphedema, not elsewhere classified
black african american m 42 $nan$hematology blood hematocrit  30.7  %; hematology blood hemoglobin  9.5  g dl; hematology blood platelet count  149  k ul; chemistry blood anion gap  16  meq l; chemistry blood bicarbonate  29  meq l; chemistry blood chloride  99  meq l; chemistry blood creatinine  7.2  mg dl; chemistry blood potassium  4.0  meq l; chemistry blood sodium  140  meq l; chemistry blood urea nitrogen  37  mg dl; chemistry blood calcium, total  8.3  mg dl; chemistry blood glucose  89  mg dl$sodium chloride 0.9%  flush  3  ml ; hydroxyzine  25  mg ; sarna lotion  1  appl ; sevelamer carbonate  2400  mg ; heparin  5000  unit ; econazole  1  % ; hydrocortisone cream 2.5%  1  appl ; epoetin alfa  10,000  unit ; epoetin alfa  1000  unit ; doxercalciferol  4  mcg ; sodium chloride 0.9%  1000  ml ; lidocaine 1%  1  ml ; heparin (hemodialysis)  4000  unit ; heparin (hemodialysis)  1000  unit ; cinacalcet  60  mg ; gabapentin  100  mg ; 
personal history of other venous thrombosis and embolism dermatitis, unspecified pneumonia, unspecified organism chronic diastolic (congestive) heart failure major depressive disorder, single episode, unspecified dissection of thoracoabdominal aorta allergic rhinitis, unspecified tobacco use other specified places as the place of occurrence of the external cause hypertensive chronic kidney disease with stage 5 chronic kidney disease or end stage renal disease von gierke disease strain of muscle, fascia and tendon at neck level, initial encounter nontoxic multinodular goiter lichen simplex chronicus dependence on renal dialysis nutritional anemia, unspecified lymphedema, not elsewhere classified end stage renal disease hypertensive chronic kidney disease with stage 5 chronic kidney disease or end stage renal disease strain of muscle, fascia and tendon of lower back, initial encounter dependence on renal dialysis end stage renal disease major depressive disorder, single episode, unspecified dissection of unspecified site of aorta unemployment, unspecified stenosis of other vascular prosthetic devices, implants and grafts, initial encounter lymphedema, not elsewhere classified other specified places as the place of occurrence of the external cause homelessness tobacco use allergic rhinitis, unspecified anemia due to glucose-6-phosphate dehydrogenase [g6pd] deficiency dermatitis, unspecified nutritional anemia, unspecified allergic rhinitis, unspecified thrombosis due to vascular prosthetic devices, implants and grafts, initial encounter dependence on renal dialysis major depressive disorder, single episode, unspecified dissection of abdominal aorta anemia due to glucose-6-phosphate dehydrogenase [g6pd] deficiency unemployment, unspecified tobacco use surgical operation with anastomosis, bypass or graft as the cause of abnormal reaction of the patient, or of later complication, without mention of misadventure at the time of the procedure dermatitis, unspecified other specified complication of vascular prosthetic devices, implants and grafts, initial encounter tinea pedis unspecified place in unspecified non-institutional (private) residence as the place of occurrence of the external cause lymphedema, not elsewhere classified
black african american m 42 $nan$nan$sodium chloride 0.9%  flush  3  ml ; hydroxyzine  25  mg ; sarna lotion  1  appl ; sevelamer carbonate  2400  mg ; heparin  5000  unit ; econazole  1  % ; hydrocortisone cream 2.5%  1  appl ; lidocaine 1%  1  ml ; heparin (hemodialysis)  1000  unit ; cinacalcet  60  mg ; 
personal history of other venous thrombosis and embolism dermatitis, unspecified pneumonia, unspecified organism chronic diastolic (congestive) heart failure major depressive disorder, single episode, unspecified dissection of thoracoabdominal aorta allergic rhinitis, unspecified tobacco use other specified places as the place of occurrence of the external cause hypertensive chronic kidney disease with stage 5 chronic kidney disease or end stage renal disease von gierke disease strain of muscle, fascia and tendon at neck level, initial encounter nontoxic multinodular goiter lichen simplex chronicus dependence on renal dialysis nutritional anemia, unspecified lymphedema, not elsewhere classified end stage renal disease hypertensive chronic kidney disease with stage 5 chronic kidney disease or end stage renal disease strain of muscle, fascia and tendon of lower back, initial encounter dependence on renal dialysis end stage renal disease major depressive disorder, single episode, unspecified dissection of unspecified site of aorta unemployment, unspecified stenosis of other vascular prosthetic devices, implants and grafts, initial encounter lymphedema, not elsewhere classified other specified places as the place of occurrence of the external cause homelessness tobacco use allergic rhinitis, unspecified anemia due to glucose-6-phosphate dehydrogenase [g6pd] deficiency dermatitis, unspecified nutritional anemia, unspecified allergic rhinitis, unspecified thrombosis due to vascular prosthetic devices, implants and grafts, initial encounter dependence on renal dialysis major depressive disorder, single episode, unspecified dissection of abdominal aorta anemia due to glucose-6-phosphate dehydrogenase [g6pd] deficiency unemployment, unspecified tobacco use surgical operation with anastomosis, bypass or graft as the cause of abnormal reaction of the patient, or of later complication, without mention of misadventure at the time of the procedure dermatitis, unspecified other specified complication of vascular prosthetic devices, implants and grafts, initial encounter tinea pedis unspecified place in unspecified non-institutional (private) residence as the place of occurrence of the external cause lymphedema, not elsewhere classified
white m 67 $temp  98.1  heartrate  85.0  resprate  16.0  o2sat  93.0  sbp  128.0  dbp  68.0  rhythm    pain  2  $hematology blood hematocrit  47.2  %; hematology blood hemoglobin  16.4  g dl; hematology blood platelet count  158  k ul; chemistry blood anion gap  13  meq l; chemistry blood bicarbonate  27  meq l; chemistry blood chloride  107  meq l; chemistry blood creatinine  0.8  mg dl; chemistry blood potassium  4.2  meq l; chemistry blood sodium  143  meq l; chemistry blood urea nitrogen  18  mg dl; hematology blood inr(pt)  1.2  ; chemistry blood calcium, total  8.5  mg dl; chemistry blood bilirubin, total  2.3  mg dl; chemistry blood glucose  188  mg dl; chemistry blood lactate dehydrogenase (ld)  250  iu l; chemistry blood albumin  4.1  g dl$sodium chloride 0.9%  flush  3  ml ; ondansetron  4  mg ; hydromorphone (dilaudid)  0.5-1.0  mg ; pneumococcal 23-valent polysaccharide vaccine  0.5  ml ; 0.9% sodium chloride  1000  ml ; dextrose 50%  12.5  gm ; glucagon  1  mg ; glucose gel  15  g ; omeprazole  20  mg ; insulin  0  unit ; docusate sodium  100  mg ; senna  1  tab ; 
 
white m 67 $nan$hematology blood hematocrit  44.9  %; hematology blood hemoglobin  15.5  g dl; hematology blood platelet count  147  k ul; chemistry blood anion gap  15  meq l; chemistry blood bicarbonate  24  meq l; chemistry blood chloride  106  meq l; chemistry blood creatinine  0.6  mg dl; chemistry blood potassium  4.2  meq l; chemistry blood sodium  141  meq l; chemistry blood urea nitrogen  21  mg dl; hematology blood inr(pt)  1.3  ; chemistry blood calcium, total  8.6  mg dl; chemistry blood bilirubin, indirect  1.9  mg dl; chemistry blood bilirubin, total  3.2  mg dl; chemistry blood glucose  175  mg dl; chemistry blood bilirubin, direct  1.3  mg dl$sodium chloride 0.9%  flush  3  ml ; ondansetron  4  mg ; hydromorphone (dilaudid)  0.5-1.0  mg ; pneumococcal 23-valent polysaccharide vaccine  0.5  ml ; dextrose 50%  12.5  gm ; glucagon  1  mg ; glucose gel  15  g ; omeprazole  20  mg ; docusate sodium  100  mg ; senna  1  tab ; aspirin  81  mg ; hydromorphone (dilaudid)  2-4  mg ; 
 
white m 67 $nan$hematology blood hematocrit  39.9  %; hematology blood hemoglobin  13.9  g dl; hematology blood platelet count  160  k ul; chemistry blood anion gap  14  meq l; chemistry blood bicarbonate  26  meq l; chemistry blood chloride  100  meq l; chemistry blood creatinine  0.7  mg dl; chemistry blood potassium  3.8  meq l; chemistry blood sodium  136  meq l; chemistry blood urea nitrogen  15  mg dl; hematology blood inr(pt)  1.4  ; chemistry blood calcium, total  8.2  mg dl; chemistry blood bilirubin, indirect  1.2  mg dl; chemistry blood bilirubin, total  2.6  mg dl; chemistry blood glucose  154  mg dl; chemistry blood lactate dehydrogenase (ld)  396  iu l; chemistry blood albumin  3.5  g dl; chemistry blood bilirubin, direct  1.4  mg dl$sodium chloride 0.9%  flush  3  ml ; ondansetron  4  mg ; pneumococcal 23-valent polysaccharide vaccine  0.5  ml ; dextrose 50%  12.5  gm ; glucagon  1  mg ; glucose gel  15  g ; omeprazole  20  mg ; docusate sodium  100  mg ; senna  1  tab ; aspirin  81  mg ; hydromorphone (dilaudid)  1  mg ; neutra-phos  1  pkt ; 0.9% sodium chloride  1  bag ; calcium gluconate  2  g ; lorazepam  0.5  mg ; 
 
white m 67 $nan$hematology blood hematocrit  37.7  %; hematology blood hematocrit  33.8  %; hematology blood hemoglobin  13.5  g dl; hematology blood platelet count  171  k ul; chemistry blood anion gap  14  meq l; chemistry blood bicarbonate  27  meq l; chemistry blood chloride  103  meq l; chemistry blood creatinine  0.7  mg dl; chemistry blood potassium  3.9  meq l; chemistry blood sodium  140  meq l; chemistry blood urea nitrogen  15  mg dl; hematology blood inr(pt)  1.3  ; chemistry blood calcium, total  8.5  mg dl; chemistry blood bilirubin, indirect  0.7  mg dl; chemistry blood bilirubin, total  1.9  mg dl; chemistry blood glucose  149  mg dl; chemistry blood lactate dehydrogenase (ld)  371  iu l; chemistry blood bilirubin, direct  1.2  mg dl$sodium chloride 0.9%  flush  3  ml ; ondansetron  4  mg ; pneumococcal 23-valent polysaccharide vaccine  0.5  ml ; dextrose 50%  12.5  gm ; glucagon  1  mg ; glucose gel  15  g ; omeprazole  20  mg ; docusate sodium  100  mg ; senna  1  tab ; aspirin  81  mg ; hydromorphone (dilaudid)  1  mg ; neutra-phos  1  pkt ; 0.9% sodium chloride  1  bag ; calcium gluconate  2  g ; lorazepam  0.5  mg ; heparin  5000  unit ; 
 
white m 67 $nan$hematology blood hematocrit  35.5  %$sodium chloride 0.9%  flush  3  ml ; ondansetron  4  mg ; pneumococcal 23-valent polysaccharide vaccine  0.5  ml ; dextrose 50%  12.5  gm ; glucagon  1  mg ; glucose gel  15  g ; omeprazole  20  mg ; docusate sodium  100  mg ; senna  1  tab ; aspirin  81  mg ; heparin  5000  unit ; lactated ringers  1000  ml ; oxycodone-acetaminophen (5mg-325mg)  1-2  tab ; 
 
white m 67 $nan$nan$sodium chloride 0.9%  flush  3  ml ; ondansetron  4  mg ; pneumococcal 23-valent polysaccharide vaccine  0.5  ml ; dextrose 50%  12.5  gm ; glucagon  1  mg ; glucose gel  15  g ; omeprazole  20  mg ; docusate sodium  100  mg ; senna  1  tab ; aspirin  81  mg ; heparin  5000  unit ; oxycodone-acetaminophen (5mg-325mg)  1-2  tab ; albuterol 0.083% neb soln  1  neb ; 
 
white m 67 $nan$nan$sodium chloride 0.9%  flush  3  ml ; ondansetron  4  mg ; pneumococcal 23-valent polysaccharide vaccine  0.5  ml ; dextrose 50%  12.5  gm ; glucagon  1  mg ; glucose gel  15  g ; omeprazole  20  mg ; docusate sodium  100  mg ; senna  1  tab ; aspirin  81  mg ; heparin  5000  unit ; oxycodone-acetaminophen (5mg-325mg)  1-2  tab ; albuterol 0.083% neb soln  1  neb ; bisacodyl  10  mg ; magnesium citrate  150  ml ; 
 
white m 70 $nan$hematology blood hematocrit  24.8  %; hematology blood hematocrit  23.5  %; hematology blood hemoglobin  8.0  g dl; hematology blood hemoglobin  7.5  g dl; hematology blood platelet count  203  k ul; hematology blood platelet count  203  k ul; chemistry blood anion gap  19  meq l; chemistry blood anion gap  17  meq l; chemistry blood bicarbonate  19  meq l; chemistry blood bicarbonate  23  meq l; chemistry blood chloride  96  meq l; chemistry blood chloride  94  meq l; chemistry blood creatinine  1.6  mg dl; chemistry blood creatinine  1.5  mg dl; chemistry blood potassium  3.9  meq l; chemistry blood potassium  3.3  meq l; chemistry blood sodium  130  meq l; chemistry blood sodium  131  meq l; chemistry blood urea nitrogen  81  mg dl; chemistry blood urea nitrogen  68  mg dl; hematology blood inr(pt)  1.3  ; hematology blood inr(pt)  1.3  ; chemistry blood calcium, total  8.2  mg dl; chemistry blood calcium, total  7.8  mg dl; chemistry blood bilirubin, total  0.2  mg dl; chemistry blood bilirubin, total  0.3  mg dl; chemistry blood glucose  157  mg dl; chemistry blood glucose  220  mg dl; chemistry blood lactate dehydrogenase (ld)  267  iu l; chemistry blood albumin  4.0  g dl$influenza vaccine quadrivalent  0.5  ml ; pneumococcal 23-valent polysaccharide vaccine  0.5  ml ; sodium chloride 0.9%  flush  3  ml ; atorvastatin  80  mg ; clopidogrel  75  mg ; cyanocobalamin  1000  mcg ; 5% dextrose  250  ml ; dobutamine  250  mg ; docusate sodium  100  mg ; ferrous gluconate  324  mg ; hydralazine  25  mg ; isosorbide dinitrate  20  mg ; levothyroxine sodium  50  mcg ; lisinopril  2.5  mg ; pantoprazole  40  mg ; senna  8.6  mg ; trazodone  75  mg ; apixaban  5  mg ; lactulose  30  ml ; furosemide  160  mg ; 5% dextrose  50  ml ; furosemide  250  mg ; ondansetron  4  mg ; dextrose 50%  12.5  gm ; glucagon  1  mg ; glucose gel  15  g ; insulin  0  unit ; insulin  40  unit ; furosemide  100  mg ; sodium chloride 0.9%  flush  10-20  ml ; potassium chloride  60  meq ; oseltamivir  30  mg ; 
other and unspecified infection due to central venous catheter other specified procedures as the cause of abnormal reaction of patient, or of later complication, without mention of misadventure at time of procedure other specified hypotension acute posthemorrhagic anemia coronary atherosclerosis of native coronary artery atrial fibrillation congestive heart failure, unspecified obesity, unspecified personal history of sudden cardiac arrest unspecified acquired hypothyroidism obstructive sleep apnea (adult)(pediatric) old myocardial infarction acute kidney failure, unspecified acute on chronic systolic heart failure hyposmolality and/or hyponatremia body mass index 34.0-34.9, adult staphylococcus infection in conditions classified elsewhere and of unspecified site, other staphylococcus other specified forms of chronic ischemic heart disease long-term (current) use of aspirin leukocytosis, unspecified chronic kidney disease, unspecified percutaneous transluminal coronary angioplasty status encounter for palliative care fitting and adjustment of automatic implantable cardiac defibrillator person on outside of heavy transport vehicle injured in collision with other nonmotor vehicle in traffic accident hypertensive heart and chronic kidney disease, unspecified, with heart failure and with chronic kidney disease stage i through stage iv, or unspecified long-term (current) use of antiplatelet/antithrombotic accidents occurring in residential institution long-term (current) use of insulin diabetes mellitus without mention of complication, type ii or unspecified type, not stated as uncontrolled atrial fibrillation paroxysmal ventricular tachycardia leukocytosis, unspecified congestive heart failure, unspecified body mass index 33.0-33.9, adult hypopotassemia obesity, unspecified sarcoidosis long-term (current) use of aspirin subendocardial infarction, initial episode of care coronary atherosclerosis of native coronary artery cardiogenic shock cardiomyopathy in other diseases classified elsewhere percutaneous transluminal coronary angioplasty status surgical operation with implant of artificial internal device causing abnormal patient reaction, or later complication,without mention of misadventure at time of operation atrioventricular block, complete long-term (current) use of insulin acute kidney failure, unspecified
white m 70 $nan$hematology blood hematocrit  25.2  %; hematology blood hemoglobin  7.9  g dl; hematology blood platelet count  206  k ul; chemistry blood anion gap  18  meq l; chemistry blood anion gap  17  meq l; chemistry blood anion gap  16  meq l; chemistry blood bicarbonate  23  meq l; chemistry blood bicarbonate  26  meq l; chemistry blood bicarbonate  28  meq l; chemistry blood chloride  92  meq l; chemistry blood chloride  94  meq l; chemistry blood chloride  94  meq l; chemistry blood creatinine  1.5  mg dl; chemistry blood creatinine  1.6  mg dl; chemistry blood creatinine  1.4  mg dl; chemistry blood potassium  4.2  meq l; chemistry blood potassium  4.2  meq l; chemistry blood potassium  3.8  meq l; chemistry blood sodium  129  meq l; chemistry blood sodium  133  meq l; chemistry blood sodium  134  meq l; chemistry blood urea nitrogen  62  mg dl; chemistry blood urea nitrogen  63  mg dl; chemistry blood urea nitrogen  58  mg dl; hematology blood inr(pt)  1.3  ; chemistry blood calcium, total  8.0  mg dl; chemistry blood calcium, total  8.7  mg dl; chemistry blood calcium, total  8.7  mg dl; chemistry blood glucose  78  mg dl; chemistry blood glucose  124  mg dl; chemistry blood glucose  327  mg dl$influenza vaccine quadrivalent  0.5  ml ; pneumococcal 23-valent polysaccharide vaccine  0.5  ml ; atorvastatin  80  mg ; clopidogrel  75  mg ; cyanocobalamin  1000  mcg ; 5% dextrose  250  ml ; dobutamine  250  mg ; docusate sodium  100  mg ; ferrous gluconate  324  mg ; levothyroxine sodium  50  mcg ; lisinopril  2.5  mg ; senna  8.6  mg ; trazodone  75  mg ; apixaban  5  mg ; lactulose  30  ml ; 5% dextrose  50  ml ; furosemide  250  mg ; ondansetron  4  mg ; dextrose 50%  12.5  gm ; glucagon  1  mg ; glucose gel  15  g ; insulin  0  unit ; insulin  40  unit ; furosemide  100  mg ; sodium chloride 0.9%  flush  10-20  ml ; potassium chloride  60  meq ; oseltamivir  30  mg ; benzonatate  100  mg ; furosemide  60  mg ; furosemide  80  mg ; 
other and unspecified infection due to central venous catheter other specified procedures as the cause of abnormal reaction of patient, or of later complication, without mention of misadventure at time of procedure other specified hypotension acute posthemorrhagic anemia coronary atherosclerosis of native coronary artery atrial fibrillation congestive heart failure, unspecified obesity, unspecified personal history of sudden cardiac arrest unspecified acquired hypothyroidism obstructive sleep apnea (adult)(pediatric) old myocardial infarction acute kidney failure, unspecified acute on chronic systolic heart failure hyposmolality and/or hyponatremia body mass index 34.0-34.9, adult staphylococcus infection in conditions classified elsewhere and of unspecified site, other staphylococcus other specified forms of chronic ischemic heart disease long-term (current) use of aspirin leukocytosis, unspecified chronic kidney disease, unspecified percutaneous transluminal coronary angioplasty status encounter for palliative care fitting and adjustment of automatic implantable cardiac defibrillator person on outside of heavy transport vehicle injured in collision with other nonmotor vehicle in traffic accident hypertensive heart and chronic kidney disease, unspecified, with heart failure and with chronic kidney disease stage i through stage iv, or unspecified long-term (current) use of antiplatelet/antithrombotic accidents occurring in residential institution long-term (current) use of insulin diabetes mellitus without mention of complication, type ii or unspecified type, not stated as uncontrolled atrial fibrillation paroxysmal ventricular tachycardia leukocytosis, unspecified congestive heart failure, unspecified body mass index 33.0-33.9, adult hypopotassemia obesity, unspecified sarcoidosis long-term (current) use of aspirin subendocardial infarction, initial episode of care coronary atherosclerosis of native coronary artery cardiogenic shock cardiomyopathy in other diseases classified elsewhere percutaneous transluminal coronary angioplasty status surgical operation with implant of artificial internal device causing abnormal patient reaction, or later complication,without mention of misadventure at time of operation atrioventricular block, complete long-term (current) use of insulin acute kidney failure, unspecified
white m 70 $nan$hematology blood hematocrit  25.1  %; hematology blood hemoglobin  7.9  g dl; hematology blood platelet count  223  k ul; chemistry blood anion gap  16  meq l; chemistry blood anion gap  13  meq l; chemistry blood anion gap  18  meq l; chemistry blood bicarbonate  27  meq l; chemistry blood bicarbonate  31  meq l; chemistry blood bicarbonate  27  meq l; chemistry blood chloride  89  meq l; chemistry blood chloride  91  meq l; chemistry blood chloride  87  meq l; chemistry blood creatinine  1.4  mg dl; chemistry blood creatinine  1.4  mg dl; chemistry blood creatinine  1.5  mg dl; chemistry blood potassium  4.4  meq l; chemistry blood potassium  3.9  meq l; chemistry blood potassium  4.6  meq l; chemistry blood sodium  128  meq l; chemistry blood sodium  131  meq l; chemistry blood sodium  127  meq l; chemistry blood urea nitrogen  53  mg dl; chemistry blood urea nitrogen  51  mg dl; chemistry blood urea nitrogen  51  mg dl; hematology blood inr(pt)  1.3  ; chemistry blood calcium, total  8.7  mg dl; chemistry blood calcium, total  8.8  mg dl; chemistry blood calcium, total  8.7  mg dl; chemistry blood glucose  290  mg dl; chemistry blood glucose  113  mg dl; chemistry blood glucose  316  mg dl$atorvastatin  80  mg ; clopidogrel  75  mg ; cyanocobalamin  1000  mcg ; 5% dextrose  250  ml ; dobutamine  250  mg ; docusate sodium  100  mg ; ferrous gluconate  324  mg ; levothyroxine sodium  50  mcg ; lisinopril  2.5  mg ; senna  8.6  mg ; trazodone  75  mg ; apixaban  5  mg ; lactulose  30  ml ; ondansetron  4  mg ; dextrose 50%  12.5  gm ; glucagon  1  mg ; glucose gel  15  g ; insulin  0  unit ; insulin  40  unit ; sodium chloride 0.9%  flush  10-20  ml ; oseltamivir  30  mg ; benzonatate  100  mg ; furosemide  80  mg ; spironolactone  25  mg ; potassium chloride  20  meq ; 
other and unspecified infection due to central venous catheter other specified procedures as the cause of abnormal reaction of patient, or of later complication, without mention of misadventure at time of procedure other specified hypotension acute posthemorrhagic anemia coronary atherosclerosis of native coronary artery atrial fibrillation congestive heart failure, unspecified obesity, unspecified personal history of sudden cardiac arrest unspecified acquired hypothyroidism obstructive sleep apnea (adult)(pediatric) old myocardial infarction acute kidney failure, unspecified acute on chronic systolic heart failure hyposmolality and/or hyponatremia body mass index 34.0-34.9, adult staphylococcus infection in conditions classified elsewhere and of unspecified site, other staphylococcus other specified forms of chronic ischemic heart disease long-term (current) use of aspirin leukocytosis, unspecified chronic kidney disease, unspecified percutaneous transluminal coronary angioplasty status encounter for palliative care fitting and adjustment of automatic implantable cardiac defibrillator person on outside of heavy transport vehicle injured in collision with other nonmotor vehicle in traffic accident hypertensive heart and chronic kidney disease, unspecified, with heart failure and with chronic kidney disease stage i through stage iv, or unspecified long-term (current) use of antiplatelet/antithrombotic accidents occurring in residential institution long-term (current) use of insulin diabetes mellitus without mention of complication, type ii or unspecified type, not stated as uncontrolled atrial fibrillation paroxysmal ventricular tachycardia leukocytosis, unspecified congestive heart failure, unspecified body mass index 33.0-33.9, adult hypopotassemia obesity, unspecified sarcoidosis long-term (current) use of aspirin subendocardial infarction, initial episode of care coronary atherosclerosis of native coronary artery cardiogenic shock cardiomyopathy in other diseases classified elsewhere percutaneous transluminal coronary angioplasty status surgical operation with implant of artificial internal device causing abnormal patient reaction, or later complication,without mention of misadventure at time of operation atrioventricular block, complete long-term (current) use of insulin acute kidney failure, unspecified
white m 70 $nan$hematology blood hematocrit  26.4  %; hematology blood hemoglobin  8.4  g dl; hematology blood platelet count  261  k ul; chemistry blood anion gap  19  meq l; chemistry blood anion gap  17  meq l; chemistry blood bicarbonate  28  meq l; chemistry blood bicarbonate  29  meq l; chemistry blood chloride  89  meq l; chemistry blood chloride  89  meq l; chemistry blood creatinine  1.6  mg dl; chemistry blood creatinine  1.4  mg dl; chemistry blood potassium  4.8  meq l; chemistry blood potassium  4.2  meq l; chemistry blood sodium  131  meq l; chemistry blood sodium  131  meq l; chemistry blood urea nitrogen  57  mg dl; chemistry blood urea nitrogen  54  mg dl; hematology blood inr(pt)  1.3  ; chemistry blood calcium, total  9.1  mg dl; chemistry blood calcium, total  8.8  mg dl; chemistry blood glucose  202  mg dl; chemistry blood glucose  133  mg dl$atorvastatin  80  mg ; clopidogrel  75  mg ; cyanocobalamin  1000  mcg ; 5% dextrose  250  ml ; dobutamine  250  mg ; docusate sodium  100  mg ; ferrous gluconate  324  mg ; levothyroxine sodium  50  mcg ; lisinopril  2.5  mg ; senna  8.6  mg ; trazodone  75  mg ; apixaban  5  mg ; lactulose  30  ml ; ondansetron  4  mg ; dextrose 50%  12.5  gm ; glucagon  1  mg ; glucose gel  15  g ; insulin  0  unit ; insulin  40  unit ; sodium chloride 0.9%  flush  10-20  ml ; oseltamivir  30  mg ; benzonatate  100  mg ; spironolactone  25  mg ; potassium chloride  20  meq ; acetaminophen  650  mg ; 
other and unspecified infection due to central venous catheter other specified procedures as the cause of abnormal reaction of patient, or of later complication, without mention of misadventure at time of procedure other specified hypotension acute posthemorrhagic anemia coronary atherosclerosis of native coronary artery atrial fibrillation congestive heart failure, unspecified obesity, unspecified personal history of sudden cardiac arrest unspecified acquired hypothyroidism obstructive sleep apnea (adult)(pediatric) old myocardial infarction acute kidney failure, unspecified acute on chronic systolic heart failure hyposmolality and/or hyponatremia body mass index 34.0-34.9, adult staphylococcus infection in conditions classified elsewhere and of unspecified site, other staphylococcus other specified forms of chronic ischemic heart disease long-term (current) use of aspirin leukocytosis, unspecified chronic kidney disease, unspecified percutaneous transluminal coronary angioplasty status encounter for palliative care fitting and adjustment of automatic implantable cardiac defibrillator person on outside of heavy transport vehicle injured in collision with other nonmotor vehicle in traffic accident hypertensive heart and chronic kidney disease, unspecified, with heart failure and with chronic kidney disease stage i through stage iv, or unspecified long-term (current) use of antiplatelet/antithrombotic accidents occurring in residential institution long-term (current) use of insulin diabetes mellitus without mention of complication, type ii or unspecified type, not stated as uncontrolled atrial fibrillation paroxysmal ventricular tachycardia leukocytosis, unspecified congestive heart failure, unspecified body mass index 33.0-33.9, adult hypopotassemia obesity, unspecified sarcoidosis long-term (current) use of aspirin subendocardial infarction, initial episode of care coronary atherosclerosis of native coronary artery cardiogenic shock cardiomyopathy in other diseases classified elsewhere percutaneous transluminal coronary angioplasty status surgical operation with implant of artificial internal device causing abnormal patient reaction, or later complication,without mention of misadventure at time of operation atrioventricular block, complete long-term (current) use of insulin acute kidney failure, unspecified
white m 70 $nan$hematology blood hematocrit  26.3  %; hematology blood hemoglobin  8.4  g dl; hematology blood platelet count  283  k ul; chemistry blood anion gap  18  meq l; chemistry blood anion gap  16  meq l; chemistry blood anion gap  16  meq l; chemistry blood bicarbonate  28  meq l; chemistry blood bicarbonate  28  meq l; chemistry blood bicarbonate  30  meq l; chemistry blood chloride  87  meq l; chemistry blood chloride  87  meq l; chemistry blood chloride  86  meq l; chemistry blood creatinine  1.6  mg dl; chemistry blood creatinine  1.6  mg dl; chemistry blood creatinine  1.5  mg dl; chemistry blood potassium  4.6  meq l; chemistry blood potassium  4.8  meq l; chemistry blood potassium  4.6  meq l; chemistry blood sodium  128  meq l; chemistry blood sodium  126  meq l; chemistry blood sodium  127  meq l; chemistry blood urea nitrogen  55  mg dl; chemistry blood urea nitrogen  62  mg dl; chemistry blood urea nitrogen  60  mg dl; hematology blood inr(pt)  1.3  ; chemistry blood calcium, total  9.2  mg dl; chemistry blood calcium, total  9.0  mg dl; chemistry blood calcium, total  9.1  mg dl; chemistry blood glucose  183  mg dl; chemistry blood glucose  210  mg dl; chemistry blood glucose  140  mg dl$atorvastatin  80  mg ; clopidogrel  75  mg ; cyanocobalamin  1000  mcg ; 5% dextrose  250  ml ; dobutamine  250  mg ; docusate sodium  100  mg ; ferrous gluconate  324  mg ; levothyroxine sodium  50  mcg ; lisinopril  2.5  mg ; senna  8.6  mg ; trazodone  75  mg ; apixaban  5  mg ; lactulose  30  ml ; ondansetron  4  mg ; dextrose 50%  12.5  gm ; glucagon  1  mg ; glucose gel  15  g ; insulin  0  unit ; insulin  40  unit ; sodium chloride 0.9%  flush  10-20  ml ; oseltamivir  30  mg ; benzonatate  100  mg ; spironolactone  25  mg ; acetaminophen  650  mg ; polyethylene glycol  17  g ; bisacodyl  10  mg ; lorazepam  0.5-1  mg ; 5% dextrose  100  ml ; dobutamine  500  mg ; 
other and unspecified infection due to central venous catheter other specified procedures as the cause of abnormal reaction of patient, or of later complication, without mention of misadventure at time of procedure other specified hypotension acute posthemorrhagic anemia coronary atherosclerosis of native coronary artery atrial fibrillation congestive heart failure, unspecified obesity, unspecified personal history of sudden cardiac arrest unspecified acquired hypothyroidism obstructive sleep apnea (adult)(pediatric) old myocardial infarction acute kidney failure, unspecified acute on chronic systolic heart failure hyposmolality and/or hyponatremia body mass index 34.0-34.9, adult staphylococcus infection in conditions classified elsewhere and of unspecified site, other staphylococcus other specified forms of chronic ischemic heart disease long-term (current) use of aspirin leukocytosis, unspecified chronic kidney disease, unspecified percutaneous transluminal coronary angioplasty status encounter for palliative care fitting and adjustment of automatic implantable cardiac defibrillator person on outside of heavy transport vehicle injured in collision with other nonmotor vehicle in traffic accident hypertensive heart and chronic kidney disease, unspecified, with heart failure and with chronic kidney disease stage i through stage iv, or unspecified long-term (current) use of antiplatelet/antithrombotic accidents occurring in residential institution long-term (current) use of insulin diabetes mellitus without mention of complication, type ii or unspecified type, not stated as uncontrolled atrial fibrillation paroxysmal ventricular tachycardia leukocytosis, unspecified congestive heart failure, unspecified body mass index 33.0-33.9, adult hypopotassemia obesity, unspecified sarcoidosis long-term (current) use of aspirin subendocardial infarction, initial episode of care coronary atherosclerosis of native coronary artery cardiogenic shock cardiomyopathy in other diseases classified elsewhere percutaneous transluminal coronary angioplasty status surgical operation with implant of artificial internal device causing abnormal patient reaction, or later complication,without mention of misadventure at time of operation atrioventricular block, complete long-term (current) use of insulin acute kidney failure, unspecified
white m 70 $nan$hematology blood hematocrit  26.4  %; hematology blood hemoglobin  8.5  g dl; hematology blood platelet count  289  k ul; chemistry blood anion gap  19  meq l; chemistry blood anion gap  16  meq l; chemistry blood anion gap  15  meq l; chemistry blood bicarbonate  28  meq l; chemistry blood bicarbonate  29  meq l; chemistry blood bicarbonate  31  meq l; chemistry blood chloride  81  meq l; chemistry blood chloride  86  meq l; chemistry blood chloride  87  meq l; chemistry blood creatinine  1.7  mg dl; chemistry blood creatinine  1.6  mg dl; chemistry blood creatinine  1.5  mg dl; chemistry blood potassium  4.5  meq l; chemistry blood potassium  4.5  meq l; chemistry blood potassium  4.7  meq l; chemistry blood sodium  126  meq l; chemistry blood sodium  128  meq l; chemistry blood sodium  123  meq l; chemistry blood urea nitrogen  59  mg dl; chemistry blood urea nitrogen  67  mg dl; chemistry blood urea nitrogen  66  mg dl; hematology blood inr(pt)  1.3  ; chemistry blood calcium, total  8.9  mg dl; chemistry blood calcium, total  9.1  mg dl; chemistry blood calcium, total  9.2  mg dl; chemistry blood glucose  132  mg dl; chemistry blood glucose  175  mg dl; chemistry blood glucose  320  mg dl$atorvastatin  80  mg ; clopidogrel  75  mg ; cyanocobalamin  1000  mcg ; docusate sodium  100  mg ; ferrous gluconate  324  mg ; levothyroxine sodium  50  mcg ; lisinopril  2.5  mg ; senna  8.6  mg ; trazodone  75  mg ; apixaban  5  mg ; lactulose  30  ml ; ondansetron  4  mg ; dextrose 50%  12.5  gm ; glucagon  1  mg ; glucose gel  15  g ; insulin  0  unit ; insulin  40  unit ; sodium chloride 0.9%  flush  10-20  ml ; oseltamivir  30  mg ; spironolactone  25  mg ; acetaminophen  650  mg ; polyethylene glycol  17  g ; bisacodyl  10  mg ; lorazepam  0.5-1  mg ; 5% dextrose  100  ml ; dobutamine  500  mg ; 
other and unspecified infection due to central venous catheter other specified procedures as the cause of abnormal reaction of patient, or of later complication, without mention of misadventure at time of procedure other specified hypotension acute posthemorrhagic anemia coronary atherosclerosis of native coronary artery atrial fibrillation congestive heart failure, unspecified obesity, unspecified personal history of sudden cardiac arrest unspecified acquired hypothyroidism obstructive sleep apnea (adult)(pediatric) old myocardial infarction acute kidney failure, unspecified acute on chronic systolic heart failure hyposmolality and/or hyponatremia body mass index 34.0-34.9, adult staphylococcus infection in conditions classified elsewhere and of unspecified site, other staphylococcus other specified forms of chronic ischemic heart disease long-term (current) use of aspirin leukocytosis, unspecified chronic kidney disease, unspecified percutaneous transluminal coronary angioplasty status encounter for palliative care fitting and adjustment of automatic implantable cardiac defibrillator person on outside of heavy transport vehicle injured in collision with other nonmotor vehicle in traffic accident hypertensive heart and chronic kidney disease, unspecified, with heart failure and with chronic kidney disease stage i through stage iv, or unspecified long-term (current) use of antiplatelet/antithrombotic accidents occurring in residential institution long-term (current) use of insulin diabetes mellitus without mention of complication, type ii or unspecified type, not stated as uncontrolled atrial fibrillation paroxysmal ventricular tachycardia leukocytosis, unspecified congestive heart failure, unspecified body mass index 33.0-33.9, adult hypopotassemia obesity, unspecified sarcoidosis long-term (current) use of aspirin subendocardial infarction, initial episode of care coronary atherosclerosis of native coronary artery cardiogenic shock cardiomyopathy in other diseases classified elsewhere percutaneous transluminal coronary angioplasty status surgical operation with implant of artificial internal device causing abnormal patient reaction, or later complication,without mention of misadventure at time of operation atrioventricular block, complete long-term (current) use of insulin acute kidney failure, unspecified
white m 70 $nan$hematology blood hematocrit  27.3  %; hematology blood hematocrit  27.2  %; hematology blood hemoglobin  8.6  g dl; hematology blood hemoglobin  8.6  g dl; hematology blood platelet count  312  k ul; hematology blood platelet count  308  k ul; chemistry blood anion gap  14  meq l; chemistry blood anion gap  16  meq l; chemistry blood anion gap  17  meq l; chemistry blood bicarbonate  32  meq l; chemistry blood bicarbonate  30  meq l; chemistry blood bicarbonate  30  meq l; chemistry blood chloride  87  meq l; chemistry blood chloride  90  meq l; chemistry blood chloride  89  meq l; chemistry blood creatinine  1.6  mg dl; chemistry blood creatinine  1.6  mg dl; chemistry blood creatinine  1.5  mg dl; chemistry blood potassium  4.8  meq l; chemistry blood potassium  4.6  meq l; chemistry blood potassium  4.6  meq l; chemistry blood sodium  128  meq l; chemistry blood sodium  131  meq l; chemistry blood sodium  131  meq l; chemistry blood urea nitrogen  68  mg dl; chemistry blood urea nitrogen  73  mg dl; chemistry blood urea nitrogen  72  mg dl; hematology blood inr(pt)  1.3  ; chemistry blood calcium, total  9.3  mg dl; chemistry blood calcium, total  9.3  mg dl; chemistry blood calcium, total  9.5  mg dl; chemistry blood bilirubin, total  0.3  mg dl; chemistry blood glucose  157  mg dl; chemistry blood glucose  124  mg dl; chemistry blood glucose  172  mg dl$atorvastatin  80  mg ; clopidogrel  75  mg ; cyanocobalamin  1000  mcg ; docusate sodium  100  mg ; ferrous gluconate  324  mg ; levothyroxine sodium  50  mcg ; lisinopril  2.5  mg ; senna  8.6  mg ; trazodone  75  mg ; apixaban  5  mg ; lactulose  30  ml ; ondansetron  4  mg ; dextrose 50%  12.5  gm ; glucagon  1  mg ; glucose gel  15  g ; insulin  0  unit ; insulin  40  unit ; sodium chloride 0.9%  flush  10-20  ml ; spironolactone  25  mg ; acetaminophen  650  mg ; polyethylene glycol  17  g ; 
other and unspecified infection due to central venous catheter other specified procedures as the cause of abnormal reaction of patient, or of later complication, without mention of misadventure at time of procedure other specified hypotension acute posthemorrhagic anemia coronary atherosclerosis of native coronary artery atrial fibrillation congestive heart failure, unspecified obesity, unspecified personal history of sudden cardiac arrest unspecified acquired hypothyroidism obstructive sleep apnea (adult)(pediatric) old myocardial infarction acute kidney failure, unspecified acute on chronic systolic heart failure hyposmolality and/or hyponatremia body mass index 34.0-34.9, adult staphylococcus infection in conditions classified elsewhere and of unspecified site, other staphylococcus other specified forms of chronic ischemic heart disease long-term (current) use of aspirin leukocytosis, unspecified chronic kidney disease, unspecified percutaneous transluminal coronary angioplasty status encounter for palliative care fitting and adjustment of automatic implantable cardiac defibrillator person on outside of heavy transport vehicle injured in collision with other nonmotor vehicle in traffic accident hypertensive heart and chronic kidney disease, unspecified, with heart failure and with chronic kidney disease stage i through stage iv, or unspecified long-term (current) use of antiplatelet/antithrombotic accidents occurring in residential institution long-term (current) use of insulin diabetes mellitus without mention of complication, type ii or unspecified type, not stated as uncontrolled atrial fibrillation paroxysmal ventricular tachycardia leukocytosis, unspecified congestive heart failure, unspecified body mass index 33.0-33.9, adult hypopotassemia obesity, unspecified sarcoidosis long-term (current) use of aspirin subendocardial infarction, initial episode of care coronary atherosclerosis of native coronary artery cardiogenic shock cardiomyopathy in other diseases classified elsewhere percutaneous transluminal coronary angioplasty status surgical operation with implant of artificial internal device causing abnormal patient reaction, or later complication,without mention of misadventure at time of operation atrioventricular block, complete long-term (current) use of insulin acute kidney failure, unspecified
white m 70 $nan$hematology blood hematocrit  27.6  %; hematology blood hemoglobin  8.7  g dl; hematology blood platelet count  309  k ul; chemistry blood anion gap  18  meq l; chemistry blood anion gap  16  meq l; chemistry blood anion gap  19  meq l; chemistry blood bicarbonate  28  meq l; chemistry blood bicarbonate  28  meq l; chemistry blood bicarbonate  26  meq l; chemistry blood chloride  90  meq l; chemistry blood chloride  90  meq l; chemistry blood chloride  91  meq l; chemistry blood creatinine  1.7  mg dl; chemistry blood creatinine  1.7  mg dl; chemistry blood creatinine  1.6  mg dl; chemistry blood potassium  4.8  meq l; chemistry blood potassium  4.6  meq l; chemistry blood potassium  4.5  meq l; chemistry blood sodium  131  meq l; chemistry blood sodium  129  meq l; chemistry blood sodium  131  meq l; chemistry blood urea nitrogen  75  mg dl; chemistry blood urea nitrogen  79  mg dl; chemistry blood urea nitrogen  79  mg dl; hematology blood inr(pt)  1.3  ; chemistry blood calcium, total  9.5  mg dl; chemistry blood calcium, total  9.4  mg dl; chemistry blood calcium, total  9.5  mg dl; chemistry blood bilirubin, total  0.4  mg dl; chemistry blood glucose  168  mg dl; chemistry blood glucose  136  mg dl; chemistry blood glucose  185  mg dl$atorvastatin  80  mg ; clopidogrel  75  mg ; cyanocobalamin  1000  mcg ; docusate sodium  100  mg ; ferrous gluconate  324  mg ; levothyroxine sodium  50  mcg ; lisinopril  2.5  mg ; senna  8.6  mg ; trazodone  75  mg ; apixaban  5  mg ; lactulose  30  ml ; ondansetron  4  mg ; dextrose 50%  12.5  gm ; glucagon  1  mg ; glucose gel  15  g ; insulin  0  unit ; insulin  40  unit ; sodium chloride 0.9%  flush  10-20  ml ; spironolactone  25  mg ; acetaminophen  650  mg ; polyethylene glycol  17  g ; 
other and unspecified infection due to central venous catheter other specified procedures as the cause of abnormal reaction of patient, or of later complication, without mention of misadventure at time of procedure other specified hypotension acute posthemorrhagic anemia coronary atherosclerosis of native coronary artery atrial fibrillation congestive heart failure, unspecified obesity, unspecified personal history of sudden cardiac arrest unspecified acquired hypothyroidism obstructive sleep apnea (adult)(pediatric) old myocardial infarction acute kidney failure, unspecified acute on chronic systolic heart failure hyposmolality and/or hyponatremia body mass index 34.0-34.9, adult staphylococcus infection in conditions classified elsewhere and of unspecified site, other staphylococcus other specified forms of chronic ischemic heart disease long-term (current) use of aspirin leukocytosis, unspecified chronic kidney disease, unspecified percutaneous transluminal coronary angioplasty status encounter for palliative care fitting and adjustment of automatic implantable cardiac defibrillator person on outside of heavy transport vehicle injured in collision with other nonmotor vehicle in traffic accident hypertensive heart and chronic kidney disease, unspecified, with heart failure and with chronic kidney disease stage i through stage iv, or unspecified long-term (current) use of antiplatelet/antithrombotic accidents occurring in residential institution long-term (current) use of insulin diabetes mellitus without mention of complication, type ii or unspecified type, not stated as uncontrolled atrial fibrillation paroxysmal ventricular tachycardia leukocytosis, unspecified congestive heart failure, unspecified body mass index 33.0-33.9, adult hypopotassemia obesity, unspecified sarcoidosis long-term (current) use of aspirin subendocardial infarction, initial episode of care coronary atherosclerosis of native coronary artery cardiogenic shock cardiomyopathy in other diseases classified elsewhere percutaneous transluminal coronary angioplasty status surgical operation with implant of artificial internal device causing abnormal patient reaction, or later complication,without mention of misadventure at time of operation atrioventricular block, complete long-term (current) use of insulin acute kidney failure, unspecified
white m 70 $nan$hematology blood hematocrit  27.5  %; hematology blood hemoglobin  8.6  g dl; hematology blood platelet count  308  k ul; chemistry blood anion gap  19  meq l; chemistry blood anion gap  15  meq l; chemistry blood bicarbonate  26  meq l; chemistry blood bicarbonate  29  meq l; chemistry blood chloride  89  meq l; chemistry blood chloride  93  meq l; chemistry blood creatinine  1.7  mg dl; chemistry blood creatinine  1.5  mg dl; chemistry blood potassium  4.6  meq l; chemistry blood potassium  4.5  meq l; chemistry blood sodium  129  meq l; chemistry blood sodium  132  meq l; chemistry blood urea nitrogen  77  mg dl; chemistry blood urea nitrogen  80  mg dl; hematology blood inr(pt)  1.3  ; chemistry blood calcium, total  9.4  mg dl; chemistry blood calcium, total  9.3  mg dl; chemistry blood glucose  166  mg dl; chemistry blood glucose  203  mg dl$atorvastatin  80  mg ; clopidogrel  75  mg ; cyanocobalamin  1000  mcg ; docusate sodium  100  mg ; ferrous gluconate  324  mg ; levothyroxine sodium  50  mcg ; lisinopril  2.5  mg ; senna  8.6  mg ; trazodone  75  mg ; apixaban  5  mg ; lactulose  30  ml ; ondansetron  4  mg ; dextrose 50%  12.5  gm ; glucagon  1  mg ; glucose gel  15  g ; insulin  0  unit ; insulin  40  unit ; sodium chloride 0.9%  flush  10-20  ml ; spironolactone  25  mg ; acetaminophen  650  mg ; polyethylene glycol  17  g ; furosemide  40  mg ; 
other and unspecified infection due to central venous catheter other specified procedures as the cause of abnormal reaction of patient, or of later complication, without mention of misadventure at time of procedure other specified hypotension acute posthemorrhagic anemia coronary atherosclerosis of native coronary artery atrial fibrillation congestive heart failure, unspecified obesity, unspecified personal history of sudden cardiac arrest unspecified acquired hypothyroidism obstructive sleep apnea (adult)(pediatric) old myocardial infarction acute kidney failure, unspecified acute on chronic systolic heart failure hyposmolality and/or hyponatremia body mass index 34.0-34.9, adult staphylococcus infection in conditions classified elsewhere and of unspecified site, other staphylococcus other specified forms of chronic ischemic heart disease long-term (current) use of aspirin leukocytosis, unspecified chronic kidney disease, unspecified percutaneous transluminal coronary angioplasty status encounter for palliative care fitting and adjustment of automatic implantable cardiac defibrillator person on outside of heavy transport vehicle injured in collision with other nonmotor vehicle in traffic accident hypertensive heart and chronic kidney disease, unspecified, with heart failure and with chronic kidney disease stage i through stage iv, or unspecified long-term (current) use of antiplatelet/antithrombotic accidents occurring in residential institution long-term (current) use of insulin diabetes mellitus without mention of complication, type ii or unspecified type, not stated as uncontrolled atrial fibrillation paroxysmal ventricular tachycardia leukocytosis, unspecified congestive heart failure, unspecified body mass index 33.0-33.9, adult hypopotassemia obesity, unspecified sarcoidosis long-term (current) use of aspirin subendocardial infarction, initial episode of care coronary atherosclerosis of native coronary artery cardiogenic shock cardiomyopathy in other diseases classified elsewhere percutaneous transluminal coronary angioplasty status surgical operation with implant of artificial internal device causing abnormal patient reaction, or later complication,without mention of misadventure at time of operation atrioventricular block, complete long-term (current) use of insulin acute kidney failure, unspecified
white m 70 $nan$hematology blood hematocrit  27.6  %; hematology blood hemoglobin  8.7  g dl; hematology blood platelet count  331  k ul; chemistry blood anion gap  19  meq l; chemistry blood anion gap  21  meq l; chemistry blood bicarbonate  26  meq l; chemistry blood bicarbonate  24  meq l; chemistry blood chloride  93  meq l; chemistry blood chloride  93  meq l; chemistry blood creatinine  1.7  mg dl; chemistry blood creatinine  1.5  mg dl; chemistry blood potassium  4.7  meq l; chemistry blood potassium  4.8  meq l; chemistry blood sodium  133  meq l; chemistry blood sodium  133  meq l; chemistry blood urea nitrogen  77  mg dl; chemistry blood urea nitrogen  79  mg dl; hematology blood inr(pt)  1.4  ; chemistry blood calcium, total  9.5  mg dl; chemistry blood calcium, total  9.3  mg dl; chemistry blood glucose  96  mg dl; chemistry blood glucose  186  mg dl$atorvastatin  80  mg ; clopidogrel  75  mg ; cyanocobalamin  1000  mcg ; docusate sodium  100  mg ; ferrous gluconate  324  mg ; levothyroxine sodium  50  mcg ; lisinopril  2.5  mg ; senna  8.6  mg ; trazodone  75  mg ; apixaban  5  mg ; lactulose  30  ml ; ondansetron  4  mg ; dextrose 50%  12.5  gm ; glucagon  1  mg ; glucose gel  15  g ; insulin  0  unit ; insulin  40  unit ; sodium chloride 0.9%  flush  10-20  ml ; spironolactone  25  mg ; acetaminophen  650  mg ; polyethylene glycol  17  g ; furosemide  40  mg ; torsemide  60  mg ; allopurinol  150  mg ; 
other and unspecified infection due to central venous catheter other specified procedures as the cause of abnormal reaction of patient, or of later complication, without mention of misadventure at time of procedure other specified hypotension acute posthemorrhagic anemia coronary atherosclerosis of native coronary artery atrial fibrillation congestive heart failure, unspecified obesity, unspecified personal history of sudden cardiac arrest unspecified acquired hypothyroidism obstructive sleep apnea (adult)(pediatric) old myocardial infarction acute kidney failure, unspecified acute on chronic systolic heart failure hyposmolality and/or hyponatremia body mass index 34.0-34.9, adult staphylococcus infection in conditions classified elsewhere and of unspecified site, other staphylococcus other specified forms of chronic ischemic heart disease long-term (current) use of aspirin leukocytosis, unspecified chronic kidney disease, unspecified percutaneous transluminal coronary angioplasty status encounter for palliative care fitting and adjustment of automatic implantable cardiac defibrillator person on outside of heavy transport vehicle injured in collision with other nonmotor vehicle in traffic accident hypertensive heart and chronic kidney disease, unspecified, with heart failure and with chronic kidney disease stage i through stage iv, or unspecified long-term (current) use of antiplatelet/antithrombotic accidents occurring in residential institution long-term (current) use of insulin diabetes mellitus without mention of complication, type ii or unspecified type, not stated as uncontrolled atrial fibrillation paroxysmal ventricular tachycardia leukocytosis, unspecified congestive heart failure, unspecified body mass index 33.0-33.9, adult hypopotassemia obesity, unspecified sarcoidosis long-term (current) use of aspirin subendocardial infarction, initial episode of care coronary atherosclerosis of native coronary artery cardiogenic shock cardiomyopathy in other diseases classified elsewhere percutaneous transluminal coronary angioplasty status surgical operation with implant of artificial internal device causing abnormal patient reaction, or later complication,without mention of misadventure at time of operation atrioventricular block, complete long-term (current) use of insulin acute kidney failure, unspecified
white m 70 $nan$hematology blood hematocrit  26.5  %; hematology blood hemoglobin  8.3  g dl; hematology blood platelet count  327  k ul; chemistry blood anion gap  18  meq l; chemistry blood anion gap  18  meq l; chemistry blood bicarbonate  26  meq l; chemistry blood bicarbonate  27  meq l; chemistry blood chloride  93  meq l; chemistry blood chloride  92  meq l; chemistry blood creatinine  1.5  mg dl; chemistry blood creatinine  1.5  mg dl; chemistry blood potassium  4.8  meq l; chemistry blood potassium  4.5  meq l; chemistry blood sodium  132  meq l; chemistry blood sodium  132  meq l; chemistry blood urea nitrogen  74  mg dl; hematology blood inr(pt)  1.2  ; chemistry blood calcium, total  9.2  mg dl; chemistry blood calcium, total  9.0  mg dl; chemistry blood glucose  191  mg dl; chemistry blood glucose  198  mg dl$atorvastatin  80  mg ; clopidogrel  75  mg ; cyanocobalamin  1000  mcg ; docusate sodium  100  mg ; ferrous gluconate  324  mg ; levothyroxine sodium  50  mcg ; lisinopril  2.5  mg ; senna  8.6  mg ; trazodone  75  mg ; apixaban  5  mg ; lactulose  30  ml ; ondansetron  4  mg ; dextrose 50%  12.5  gm ; glucagon  1  mg ; glucose gel  15  g ; insulin  0  unit ; insulin  40  unit ; sodium chloride 0.9%  flush  10-20  ml ; spironolactone  25  mg ; acetaminophen  650  mg ; polyethylene glycol  17  g ; torsemide  60  mg ; allopurinol  150  mg ; colchicine  0.6  mg ; 
other and unspecified infection due to central venous catheter other specified procedures as the cause of abnormal reaction of patient, or of later complication, without mention of misadventure at time of procedure other specified hypotension acute posthemorrhagic anemia coronary atherosclerosis of native coronary artery atrial fibrillation congestive heart failure, unspecified obesity, unspecified personal history of sudden cardiac arrest unspecified acquired hypothyroidism obstructive sleep apnea (adult)(pediatric) old myocardial infarction acute kidney failure, unspecified acute on chronic systolic heart failure hyposmolality and/or hyponatremia body mass index 34.0-34.9, adult staphylococcus infection in conditions classified elsewhere and of unspecified site, other staphylococcus other specified forms of chronic ischemic heart disease long-term (current) use of aspirin leukocytosis, unspecified chronic kidney disease, unspecified percutaneous transluminal coronary angioplasty status encounter for palliative care fitting and adjustment of automatic implantable cardiac defibrillator person on outside of heavy transport vehicle injured in collision with other nonmotor vehicle in traffic accident hypertensive heart and chronic kidney disease, unspecified, with heart failure and with chronic kidney disease stage i through stage iv, or unspecified long-term (current) use of antiplatelet/antithrombotic accidents occurring in residential institution long-term (current) use of insulin diabetes mellitus without mention of complication, type ii or unspecified type, not stated as uncontrolled atrial fibrillation paroxysmal ventricular tachycardia leukocytosis, unspecified congestive heart failure, unspecified body mass index 33.0-33.9, adult hypopotassemia obesity, unspecified sarcoidosis long-term (current) use of aspirin subendocardial infarction, initial episode of care coronary atherosclerosis of native coronary artery cardiogenic shock cardiomyopathy in other diseases classified elsewhere percutaneous transluminal coronary angioplasty status surgical operation with implant of artificial internal device causing abnormal patient reaction, or later complication,without mention of misadventure at time of operation atrioventricular block, complete long-term (current) use of insulin acute kidney failure, unspecified
white m 70 $nan$hematology blood hematocrit  27.4  %; hematology blood hemoglobin  8.5  g dl; hematology blood platelet count  342  k ul; chemistry blood anion gap  17  meq l; chemistry blood bicarbonate  27  meq l; chemistry blood chloride  92  meq l; chemistry blood creatinine  1.7  mg dl; chemistry blood potassium  4.7  meq l; chemistry blood sodium  131  meq l; chemistry blood urea nitrogen  83  mg dl; hematology blood inr(pt)  1.4  ; chemistry blood calcium, total  9.3  mg dl; chemistry blood glucose  154  mg dl; blood gas blood lactate  0.9  mmol l$atorvastatin  80  mg ; clopidogrel  75  mg ; cyanocobalamin  1000  mcg ; docusate sodium  100  mg ; ferrous gluconate  324  mg ; levothyroxine sodium  50  mcg ; lisinopril  2.5  mg ; senna  8.6  mg ; trazodone  75  mg ; apixaban  5  mg ; lactulose  30  ml ; ondansetron  4  mg ; dextrose 50%  12.5  gm ; glucagon  1  mg ; glucose gel  15  g ; insulin  0  unit ; insulin  40  unit ; sodium chloride 0.9%  flush  10-20  ml ; spironolactone  25  mg ; acetaminophen  650  mg ; polyethylene glycol  17  g ; torsemide  60  mg ; colchicine  0.6  mg ; syringe (0.9% sodium chloride)  2  ml ; alteplase (catheter clearance)  1  mg ; 
other and unspecified infection due to central venous catheter other specified procedures as the cause of abnormal reaction of patient, or of later complication, without mention of misadventure at time of procedure other specified hypotension acute posthemorrhagic anemia coronary atherosclerosis of native coronary artery atrial fibrillation congestive heart failure, unspecified obesity, unspecified personal history of sudden cardiac arrest unspecified acquired hypothyroidism obstructive sleep apnea (adult)(pediatric) old myocardial infarction acute kidney failure, unspecified acute on chronic systolic heart failure hyposmolality and/or hyponatremia body mass index 34.0-34.9, adult staphylococcus infection in conditions classified elsewhere and of unspecified site, other staphylococcus other specified forms of chronic ischemic heart disease long-term (current) use of aspirin leukocytosis, unspecified chronic kidney disease, unspecified percutaneous transluminal coronary angioplasty status encounter for palliative care fitting and adjustment of automatic implantable cardiac defibrillator person on outside of heavy transport vehicle injured in collision with other nonmotor vehicle in traffic accident hypertensive heart and chronic kidney disease, unspecified, with heart failure and with chronic kidney disease stage i through stage iv, or unspecified long-term (current) use of antiplatelet/antithrombotic accidents occurring in residential institution long-term (current) use of insulin diabetes mellitus without mention of complication, type ii or unspecified type, not stated as uncontrolled atrial fibrillation paroxysmal ventricular tachycardia leukocytosis, unspecified congestive heart failure, unspecified body mass index 33.0-33.9, adult hypopotassemia obesity, unspecified sarcoidosis long-term (current) use of aspirin subendocardial infarction, initial episode of care coronary atherosclerosis of native coronary artery cardiogenic shock cardiomyopathy in other diseases classified elsewhere percutaneous transluminal coronary angioplasty status surgical operation with implant of artificial internal device causing abnormal patient reaction, or later complication,without mention of misadventure at time of operation atrioventricular block, complete long-term (current) use of insulin acute kidney failure, unspecified
white m 70 $nan$nan$atorvastatin  80  mg ; clopidogrel  75  mg ; cyanocobalamin  1000  mcg ; docusate sodium  100  mg ; ferrous gluconate  324  mg ; levothyroxine sodium  50  mcg ; lisinopril  2.5  mg ; senna  8.6  mg ; trazodone  75  mg ; apixaban  5  mg ; lactulose  30  ml ; ondansetron  4  mg ; dextrose 50%  12.5  gm ; glucagon  1  mg ; glucose gel  15  g ; insulin  0  unit ; insulin  40  unit ; sodium chloride 0.9%  flush  10-20  ml ; spironolactone  25  mg ; acetaminophen  650  mg ; polyethylene glycol  17  g ; torsemide  60  mg ; colchicine  0.6  mg ; syringe (0.9% sodium chloride)  2  ml ; alteplase (catheter clearance)  1  mg ; 
other and unspecified infection due to central venous catheter other specified procedures as the cause of abnormal reaction of patient, or of later complication, without mention of misadventure at time of procedure other specified hypotension acute posthemorrhagic anemia coronary atherosclerosis of native coronary artery atrial fibrillation congestive heart failure, unspecified obesity, unspecified personal history of sudden cardiac arrest unspecified acquired hypothyroidism obstructive sleep apnea (adult)(pediatric) old myocardial infarction acute kidney failure, unspecified acute on chronic systolic heart failure hyposmolality and/or hyponatremia body mass index 34.0-34.9, adult staphylococcus infection in conditions classified elsewhere and of unspecified site, other staphylococcus other specified forms of chronic ischemic heart disease long-term (current) use of aspirin leukocytosis, unspecified chronic kidney disease, unspecified percutaneous transluminal coronary angioplasty status encounter for palliative care fitting and adjustment of automatic implantable cardiac defibrillator person on outside of heavy transport vehicle injured in collision with other nonmotor vehicle in traffic accident hypertensive heart and chronic kidney disease, unspecified, with heart failure and with chronic kidney disease stage i through stage iv, or unspecified long-term (current) use of antiplatelet/antithrombotic accidents occurring in residential institution long-term (current) use of insulin diabetes mellitus without mention of complication, type ii or unspecified type, not stated as uncontrolled atrial fibrillation paroxysmal ventricular tachycardia leukocytosis, unspecified congestive heart failure, unspecified body mass index 33.0-33.9, adult hypopotassemia obesity, unspecified sarcoidosis long-term (current) use of aspirin subendocardial infarction, initial episode of care coronary atherosclerosis of native coronary artery cardiogenic shock cardiomyopathy in other diseases classified elsewhere percutaneous transluminal coronary angioplasty status surgical operation with implant of artificial internal device causing abnormal patient reaction, or later complication,without mention of misadventure at time of operation atrioventricular block, complete long-term (current) use of insulin acute kidney failure, unspecified
unknown m 58 $nan$nan$oxycodone (immediate release)   10  mg ; oxycodone (immediate release)   15  mg ; influenza virus vaccine  0.5  ml ; pneumococcal 23-valent polysaccharide vaccine  0.5  ml ; sodium chloride 0.9%  flush  3  ml ; aspirin ec  81  mg ; diltiazem extended-release  120  mg ; ipratropium bromide neb  1  neb ; albuterol 0.083% neb soln  1  neb ; 
obstructive sleep apnea (adult)(pediatric) unspecified essential hypertension adrenal cortical steroids causing adverse effects in therapeutic use leukocytosis, unspecified atrial flutter obesity, unspecified atrial fibrillation obstructive chronic bronchitis with (acute) exacerbation personal history of tobacco use unspecified acquired hypothyroidism
white m 67 $nan$nan$lansoprazole oral disintegrating tab  30  mg ; 
laparoscopic surgical procedure converted to open procedure personal history of malignant neoplasm of bronchus and lung calculus of gallbladder with acute cholecystitis, without mention of obstruction long-term (current) use of insulin cardiac pacemaker in situ anemia, unspecified personal history of antineoplastic chemotherapy diabetes mellitus without mention of complication, type ii or unspecified type, not stated as uncontrolled person injured while boarding or alighting from special construction vehicle calculus of gallbladder with other cholecystitis, without mention of obstruction body mass index 40 and over, adult other dependence on machines, supplemental oxygen obstructive sleep apnea (adult)(pediatric) acute on chronic systolic heart failure automatic implantable cardiac defibrillator in situ pulmonary collapse other iatrogenic hypotension congestive heart failure, unspecified acute and chronic respiratory failure person on outside of car injured in collision with other nonmotor vehicle in nontraffic accident old myocardial infarction obstructive chronic bronchitis with (acute) exacerbation coronary atherosclerosis of native coronary artery osteoarthrosis, unspecified whether generalized or localized, lower leg morbid obesity chronic airway obstruction, not elsewhere classified anemia, unspecified long-term (current) use of insulin malignant neoplasm of bronchus and lung, unspecified other dependence on machines, supplemental oxygen personal history of tobacco use constipation, unspecified calculus of gallbladder without mention of cholecystitis, without mention of obstruction abdominal pain, right upper quadrant coronary atherosclerosis of native coronary artery personal history of antineoplastic chemotherapy acute kidney failure, unspecified person on outside of car injured in collision with other nonmotor vehicle in nontraffic accident
white m 67 $nan$hematology blood hematocrit  35.4  %; hematology blood hematocrit  36.0  %; hematology blood hemoglobin  11.5  g dl; hematology blood hemoglobin  11.6  g dl; hematology blood platelet count  282  k ul; hematology blood platelet count  292  k ul; chemistry blood anion gap  16  meq l; chemistry blood anion gap  13  meq l; chemistry blood bicarbonate  26  meq l; chemistry blood bicarbonate  26  meq l; chemistry blood chloride  101  meq l; chemistry blood chloride  104  meq l; chemistry blood creatinine  1.4  mg dl; chemistry blood creatinine  1.4  mg dl; chemistry blood potassium  4.3  meq l; chemistry blood potassium  4.0  meq l; chemistry blood sodium  139  meq l; chemistry blood sodium  139  meq l; chemistry blood urea nitrogen  60  mg dl; chemistry blood urea nitrogen  56  mg dl; hematology blood inr(pt)  1.2  ; hematology blood inr(pt)  1.3  ; chemistry urine chloride, urine  79  meq l; chemistry urine creatinine, urine  29  mg dl; chemistry urine potassium, urine  39  meq l; chemistry urine sodium, urine  63  meq l; chemistry urine urea nitrogen, urine  333  mg dl; chemistry blood calcium, total  7.8  mg dl; chemistry blood calcium, total  8.1  mg dl; chemistry blood glucose  137  mg dl; chemistry blood glucose  149  mg dl; chemistry blood albumin  2.5  g dl; blood gas blood lactate  1.6  mmol l; blood gas blood lactate  1.5  mmol l; blood gas blood lactate  1.7  mmol l; blood gas blood lactate  1.5  mmol l$lansoprazole oral disintegrating tab  30  mg ; 0.9% sodium chloride  1000  ml ; pneumococcal vac polyvalent  0.5  ml ; sodium chloride 0.9%  flush  10  ml ; 0.9% sodium chloride (mini bag plus)  100  ml ; piperacillin-tazobactam  4.5  g ; dextrose 5%  150  ml ; levofloxacin  750  mg ; vial  1  vial ; pantoprazole  40  mg ; soln  50  ml ; fentanyl citrate  2.5  mg ; 0.9% sodium chloride  100  ml ; midazolam  100  mg ; 5% dextrose  250  ml ; norepinephrine  8  mg ; dextrose 50%  12.5  gm ; glucagon  1  mg ; insulin  0  unit ; albuterol-ipratropium  2-4  puff ; iso-osmotic dextrose  200  ml ; vancomycin  1000  mg ; chlorhexidine gluconate 0.12% oral rinse  15  ml ; iso-osmotic dextrose  100  ml ; miconazole powder 2%  1  appl ; atorvastatin  80  mg ; sw  50  ml ; magnesium sulfate  2  gm ; 
laparoscopic surgical procedure converted to open procedure personal history of malignant neoplasm of bronchus and lung calculus of gallbladder with acute cholecystitis, without mention of obstruction long-term (current) use of insulin cardiac pacemaker in situ anemia, unspecified personal history of antineoplastic chemotherapy diabetes mellitus without mention of complication, type ii or unspecified type, not stated as uncontrolled person injured while boarding or alighting from special construction vehicle calculus of gallbladder with other cholecystitis, without mention of obstruction body mass index 40 and over, adult other dependence on machines, supplemental oxygen obstructive sleep apnea (adult)(pediatric) acute on chronic systolic heart failure automatic implantable cardiac defibrillator in situ pulmonary collapse other iatrogenic hypotension congestive heart failure, unspecified acute and chronic respiratory failure person on outside of car injured in collision with other nonmotor vehicle in nontraffic accident old myocardial infarction obstructive chronic bronchitis with (acute) exacerbation coronary atherosclerosis of native coronary artery osteoarthrosis, unspecified whether generalized or localized, lower leg morbid obesity chronic airway obstruction, not elsewhere classified anemia, unspecified long-term (current) use of insulin malignant neoplasm of bronchus and lung, unspecified other dependence on machines, supplemental oxygen personal history of tobacco use constipation, unspecified calculus of gallbladder without mention of cholecystitis, without mention of obstruction abdominal pain, right upper quadrant coronary atherosclerosis of native coronary artery personal history of antineoplastic chemotherapy acute kidney failure, unspecified person on outside of car injured in collision with other nonmotor vehicle in nontraffic accident
white m 67 $nan$hematology blood hematocrit  35.1  %; hematology blood hematocrit  36.0  %; hematology blood hemoglobin  11.3  g dl; hematology blood platelet count  194  k ul; chemistry blood anion gap  15  meq l; chemistry blood anion gap  16  meq l; chemistry blood bicarbonate  25  meq l; chemistry blood bicarbonate  25  meq l; chemistry blood chloride  103  meq l; chemistry blood chloride  102  meq l; chemistry blood creatinine  1.5  mg dl; chemistry blood creatinine  1.7  mg dl; chemistry blood potassium  3.9  meq l; chemistry blood potassium  4.0  meq l; chemistry blood sodium  139  meq l; chemistry blood sodium  139  meq l; chemistry blood urea nitrogen  57  mg dl; chemistry blood urea nitrogen  60  mg dl; hematology blood inr(pt)  1.4  ; chemistry urine creatinine, urine  191  mg dl; chemistry urine potassium, urine  56  meq l; chemistry urine sodium, urine  11  meq l; chemistry urine urea nitrogen, urine  462  mg dl; chemistry blood calcium, total  8.2  mg dl; chemistry blood calcium, total  8.3  mg dl; chemistry blood glucose  149  mg dl; chemistry blood glucose  185  mg dl; blood gas blood free calcium  1.17  mmol l; blood gas blood free calcium  1.14  mmol l; blood gas blood lactate  1.6  mmol l; blood gas blood lactate  1.7  mmol l; blood gas blood lactate  2.1  mmol l; blood gas blood potassium, whole blood  3.8  meq l$lansoprazole oral disintegrating tab  30  mg ; pneumococcal vac polyvalent  0.5  ml ; sodium chloride 0.9%  flush  10  ml ; 0.9% sodium chloride (mini bag plus)  100  ml ; piperacillin-tazobactam  4.5  g ; dextrose 5%  150  ml ; levofloxacin  750  mg ; vial  1  vial ; pantoprazole  40  mg ; soln  50  ml ; fentanyl citrate  2.5  mg ; 0.9% sodium chloride  100  ml ; midazolam  100  mg ; 5% dextrose  250  ml ; norepinephrine  8  mg ; dextrose 50%  12.5  gm ; glucagon  1  mg ; insulin  0  unit ; albuterol-ipratropium  2-4  puff ; chlorhexidine gluconate 0.12% oral rinse  15  ml ; miconazole powder 2%  1  appl ; atorvastatin  80  mg ; sw  50  ml ; magnesium sulfate  2  gm ; 0.9% sodium chloride  500  ml ; 5% dextrose  100  ml ; vasopressin  40  unit ; 
laparoscopic surgical procedure converted to open procedure personal history of malignant neoplasm of bronchus and lung calculus of gallbladder with acute cholecystitis, without mention of obstruction long-term (current) use of insulin cardiac pacemaker in situ anemia, unspecified personal history of antineoplastic chemotherapy diabetes mellitus without mention of complication, type ii or unspecified type, not stated as uncontrolled person injured while boarding or alighting from special construction vehicle calculus of gallbladder with other cholecystitis, without mention of obstruction body mass index 40 and over, adult other dependence on machines, supplemental oxygen obstructive sleep apnea (adult)(pediatric) acute on chronic systolic heart failure automatic implantable cardiac defibrillator in situ pulmonary collapse other iatrogenic hypotension congestive heart failure, unspecified acute and chronic respiratory failure person on outside of car injured in collision with other nonmotor vehicle in nontraffic accident old myocardial infarction obstructive chronic bronchitis with (acute) exacerbation coronary atherosclerosis of native coronary artery osteoarthrosis, unspecified whether generalized or localized, lower leg morbid obesity chronic airway obstruction, not elsewhere classified anemia, unspecified long-term (current) use of insulin malignant neoplasm of bronchus and lung, unspecified other dependence on machines, supplemental oxygen personal history of tobacco use constipation, unspecified calculus of gallbladder without mention of cholecystitis, without mention of obstruction abdominal pain, right upper quadrant coronary atherosclerosis of native coronary artery personal history of antineoplastic chemotherapy acute kidney failure, unspecified person on outside of car injured in collision with other nonmotor vehicle in nontraffic accident
white m 67 $nan$hematology blood hematocrit  34.4  %; hematology blood hematocrit  34.1  %; hematology blood hemoglobin  11.0  g dl; hematology blood hemoglobin  10.6  g dl; hematology blood platelet count  206  k ul; hematology blood platelet count  186  k ul; chemistry blood anion gap  15  meq l; chemistry blood bicarbonate  24  meq l; chemistry blood chloride  102  meq l; chemistry blood creatinine  2.3  mg dl; chemistry blood potassium  4.0  meq l; chemistry blood sodium  137  meq l; chemistry blood urea nitrogen  59  mg dl; hematology blood inr(pt)  1.5  ; hematology blood inr(pt)  1.6  ; hematology urine wbc  0-2  # hpf; chemistry blood calcium, total  7.8  mg dl; chemistry blood glucose  193  mg dl; blood gas blood free calcium  1.09  mmol l; blood gas blood free calcium  1.14  mmol l; blood gas blood lactate  1.8  mmol l; blood gas blood lactate  1.6  mmol l; blood gas blood lactate  1.8  mmol l; blood gas blood lactate  1.8  mmol l; blood gas blood lactate  1.9  mmol l; hematology urine glucose  neg  mg dl; hematology urine bilirubin  neg  mg dl$lansoprazole oral disintegrating tab  30  mg ; pneumococcal vac polyvalent  0.5  ml ; sodium chloride 0.9%  flush  10  ml ; dextrose 5%  150  ml ; levofloxacin  750  mg ; vial  1  vial ; pantoprazole  40  mg ; soln  50  ml ; fentanyl citrate  2.5  mg ; 0.9% sodium chloride  100  ml ; midazolam  100  mg ; 5% dextrose  250  ml ; norepinephrine  8  mg ; dextrose 50%  12.5  gm ; glucagon  1  mg ; insulin  0  unit ; albuterol-ipratropium  2-4  puff ; chlorhexidine gluconate 0.12% oral rinse  15  ml ; miconazole powder 2%  1  appl ; atorvastatin  80  mg ; 0.9% sodium chloride  500  ml ; 5% dextrose  100  ml ; vasopressin  40  unit ; phenylephrine  60  mg ; lidocaine 0.5%  2  ml ; d5 1 2ns  1000  ml ; iso-osmotic dextrose  50  ml ; ceftriaxone  1  gm ; 0.9% sodium chloride  250  ml ; phenylephrine  240  mg ; hydrocortisone na succ.  50  mg ; 
laparoscopic surgical procedure converted to open procedure personal history of malignant neoplasm of bronchus and lung calculus of gallbladder with acute cholecystitis, without mention of obstruction long-term (current) use of insulin cardiac pacemaker in situ anemia, unspecified personal history of antineoplastic chemotherapy diabetes mellitus without mention of complication, type ii or unspecified type, not stated as uncontrolled person injured while boarding or alighting from special construction vehicle calculus of gallbladder with other cholecystitis, without mention of obstruction body mass index 40 and over, adult other dependence on machines, supplemental oxygen obstructive sleep apnea (adult)(pediatric) acute on chronic systolic heart failure automatic implantable cardiac defibrillator in situ pulmonary collapse other iatrogenic hypotension congestive heart failure, unspecified acute and chronic respiratory failure person on outside of car injured in collision with other nonmotor vehicle in nontraffic accident old myocardial infarction obstructive chronic bronchitis with (acute) exacerbation coronary atherosclerosis of native coronary artery osteoarthrosis, unspecified whether generalized or localized, lower leg morbid obesity chronic airway obstruction, not elsewhere classified anemia, unspecified long-term (current) use of insulin malignant neoplasm of bronchus and lung, unspecified other dependence on machines, supplemental oxygen personal history of tobacco use constipation, unspecified calculus of gallbladder without mention of cholecystitis, without mention of obstruction abdominal pain, right upper quadrant coronary atherosclerosis of native coronary artery personal history of antineoplastic chemotherapy acute kidney failure, unspecified person on outside of car injured in collision with other nonmotor vehicle in nontraffic accident
white m 67 $nan$nan$lansoprazole oral disintegrating tab  30  mg ; 5% dextrose  250  ml ; norepinephrine  8  mg ; dextrose 50%  12.5  gm ; glucagon  1  mg ; insulin  0  unit ; albuterol-ipratropium  2-4  puff ; chlorhexidine gluconate 0.12% oral rinse  15  ml ; miconazole powder 2%  1  appl ; atorvastatin  80  mg ; 5% dextrose  100  ml ; vasopressin  40  unit ; lidocaine 0.5%  2  ml ; iso-osmotic dextrose  50  ml ; ceftriaxone  1  gm ; 0.9% sodium chloride  250  ml ; phenylephrine  240  mg ; hydrocortisone na succ.  50  mg ; morphine sulfate  100  mg ; 
laparoscopic surgical procedure converted to open procedure personal history of malignant neoplasm of bronchus and lung calculus of gallbladder with acute cholecystitis, without mention of obstruction long-term (current) use of insulin cardiac pacemaker in situ anemia, unspecified personal history of antineoplastic chemotherapy diabetes mellitus without mention of complication, type ii or unspecified type, not stated as uncontrolled person injured while boarding or alighting from special construction vehicle calculus of gallbladder with other cholecystitis, without mention of obstruction body mass index 40 and over, adult other dependence on machines, supplemental oxygen obstructive sleep apnea (adult)(pediatric) acute on chronic systolic heart failure automatic implantable cardiac defibrillator in situ pulmonary collapse other iatrogenic hypotension congestive heart failure, unspecified acute and chronic respiratory failure person on outside of car injured in collision with other nonmotor vehicle in nontraffic accident old myocardial infarction obstructive chronic bronchitis with (acute) exacerbation coronary atherosclerosis of native coronary artery osteoarthrosis, unspecified whether generalized or localized, lower leg morbid obesity chronic airway obstruction, not elsewhere classified anemia, unspecified long-term (current) use of insulin malignant neoplasm of bronchus and lung, unspecified other dependence on machines, supplemental oxygen personal history of tobacco use constipation, unspecified calculus of gallbladder without mention of cholecystitis, without mention of obstruction abdominal pain, right upper quadrant coronary atherosclerosis of native coronary artery personal history of antineoplastic chemotherapy acute kidney failure, unspecified person on outside of car injured in collision with other nonmotor vehicle in nontraffic accident
black african american m 63 $nan$nan$nephrocaps  1  cap ; aspirin  325  mg ; atorvastatin  20  mg ; diltiazem extended-release  360  mg ; lisinopril  20  mg ; cinacalcet  30  mg ; 
other chest pain diabetes with neurological manifestations, type ii or unspecified type, not stated as uncontrolled congestive heart failure, unspecified cocaine abuse, unspecified hypertensive chronic kidney disease, unspecified, with chronic kidney disease stage v or end stage renal disease atrial fibrillation end stage renal disease renal dialysis status anemia in chronic kidney disease chronic systolic heart failure polyneuropathy in diabetes atrial fibrillation esophageal reflux renal dialysis status chronic systolic heart failure acute pancreatitis polyneuropathy in diabetes chronic pancreatitis gout, unspecified congestive heart failure, unspecified end stage renal disease diabetes with neurological manifestations, type ii or unspecified type, not stated as uncontrolled atrial flutter hypertensive chronic kidney disease, unspecified, with chronic kidney disease stage v or end stage renal disease anemia, unspecified chronic systolic heart failure tobacco use disorder atrial fibrillation diabetes with neurological manifestations, type ii or unspecified type, not stated as uncontrolled end stage renal disease hypertensive chronic kidney disease, unspecified, with chronic kidney disease stage v or end stage renal disease other, mixed, or unspecified drug abuse, unspecified congestive heart failure, unspecified other chest pain polyneuropathy in diabetes esophageal reflux renal dialysis status esophageal reflux end stage renal disease diabetes with neurological manifestations, type ii or unspecified type, not stated as uncontrolled other chest pain chronic systolic heart failure chronic pancreatitis atrial fibrillation congestive heart failure, unspecified hypertensive chronic kidney disease, unspecified, with chronic kidney disease stage v or end stage renal disease cocaine abuse, unspecified gout, unspecified
black african american m 63 $nan$hematology blood hematocrit  30.7  %; hematology blood hemoglobin  10.0  g dl; hematology blood platelet count  184  k ul; chemistry blood anion gap  15  meq l; chemistry blood bicarbonate  32  meq l; chemistry blood chloride  92  meq l; chemistry blood creatinine  7.2  mg dl; chemistry blood potassium  4.8  meq l; chemistry blood sodium  134  meq l; chemistry blood urea nitrogen  47  mg dl; chemistry blood calcium, total  9.2  mg dl; chemistry blood glucose  121  mg dl$nephrocaps  1  cap ; aspirin  325  mg ; atorvastatin  20  mg ; diltiazem extended-release  360  mg ; lisinopril  20  mg ; cinacalcet  30  mg ; heparin flush (10 units ml)  1  ml ; senna  1  tab ; acetaminophen  325-650  mg ; neutra-phos  1  pkt ; tramadol (ultram)  50  mg ; ondansetron  4  mg ; sarna lotion  1  appl ; sevelamer carbonate  1600  mg ; dextrose 50%  12.5  gm ; glucagon  1  mg ; pantoprazole  40  mg ; artificial tears  1-2  drop ; diphenhydramine  25  mg ; insulin  0  unit ; azithromycin  500  mg ; iso-osmotic dextrose  50  ml ; ceftriaxone  1  gm ; heparin  5000  unit ; docusate sodium  100  mg ; insulin  10  unit ; xopenex neb  0.63  mg ; nicotine patch  14  mg ; diphenhydramine  25-50  mg ; 
other chest pain diabetes with neurological manifestations, type ii or unspecified type, not stated as uncontrolled congestive heart failure, unspecified cocaine abuse, unspecified hypertensive chronic kidney disease, unspecified, with chronic kidney disease stage v or end stage renal disease atrial fibrillation end stage renal disease renal dialysis status anemia in chronic kidney disease chronic systolic heart failure polyneuropathy in diabetes atrial fibrillation esophageal reflux renal dialysis status chronic systolic heart failure acute pancreatitis polyneuropathy in diabetes chronic pancreatitis gout, unspecified congestive heart failure, unspecified end stage renal disease diabetes with neurological manifestations, type ii or unspecified type, not stated as uncontrolled atrial flutter hypertensive chronic kidney disease, unspecified, with chronic kidney disease stage v or end stage renal disease anemia, unspecified chronic systolic heart failure tobacco use disorder atrial fibrillation diabetes with neurological manifestations, type ii or unspecified type, not stated as uncontrolled end stage renal disease hypertensive chronic kidney disease, unspecified, with chronic kidney disease stage v or end stage renal disease other, mixed, or unspecified drug abuse, unspecified congestive heart failure, unspecified other chest pain polyneuropathy in diabetes esophageal reflux renal dialysis status esophageal reflux end stage renal disease diabetes with neurological manifestations, type ii or unspecified type, not stated as uncontrolled other chest pain chronic systolic heart failure chronic pancreatitis atrial fibrillation congestive heart failure, unspecified hypertensive chronic kidney disease, unspecified, with chronic kidney disease stage v or end stage renal disease cocaine abuse, unspecified gout, unspecified
black african american m 63 $nan$hematology blood hematocrit  32.7  %; hematology blood hemoglobin  10.5  g dl; hematology blood platelet count  229  k ul; chemistry blood anion gap  15  meq l; chemistry blood bicarbonate  31  meq l; chemistry blood chloride  96  meq l; chemistry blood creatinine  4.2  mg dl; chemistry blood potassium  4.0  meq l; chemistry blood sodium  138  meq l; chemistry blood urea nitrogen  20  mg dl; chemistry blood calcium, total  8.7  mg dl; chemistry blood glucose  232  mg dl$nephrocaps  1  cap ; aspirin  325  mg ; atorvastatin  20  mg ; diltiazem extended-release  360  mg ; lisinopril  20  mg ; cinacalcet  30  mg ; heparin flush (10 units ml)  1  ml ; senna  1  tab ; acetaminophen  325-650  mg ; tramadol (ultram)  50  mg ; ondansetron  4  mg ; sarna lotion  1  appl ; sevelamer carbonate  1600  mg ; dextrose 50%  12.5  gm ; glucagon  1  mg ; pantoprazole  40  mg ; artificial tears  1-2  drop ; diphenhydramine  25  mg ; insulin  0  unit ; azithromycin  500  mg ; iso-osmotic dextrose  50  ml ; ceftriaxone  1  gm ; heparin  5000  unit ; docusate sodium  100  mg ; insulin  10  unit ; xopenex neb  0.63  mg ; nicotine patch  14  mg ; diphenhydramine  50  mg ; azithromycin  250  mg ; simethicone  40-80  mg ; cefpodoxime proxetil  200  mg ; 
other chest pain diabetes with neurological manifestations, type ii or unspecified type, not stated as uncontrolled congestive heart failure, unspecified cocaine abuse, unspecified hypertensive chronic kidney disease, unspecified, with chronic kidney disease stage v or end stage renal disease atrial fibrillation end stage renal disease renal dialysis status anemia in chronic kidney disease chronic systolic heart failure polyneuropathy in diabetes atrial fibrillation esophageal reflux renal dialysis status chronic systolic heart failure acute pancreatitis polyneuropathy in diabetes chronic pancreatitis gout, unspecified congestive heart failure, unspecified end stage renal disease diabetes with neurological manifestations, type ii or unspecified type, not stated as uncontrolled atrial flutter hypertensive chronic kidney disease, unspecified, with chronic kidney disease stage v or end stage renal disease anemia, unspecified chronic systolic heart failure tobacco use disorder atrial fibrillation diabetes with neurological manifestations, type ii or unspecified type, not stated as uncontrolled end stage renal disease hypertensive chronic kidney disease, unspecified, with chronic kidney disease stage v or end stage renal disease other, mixed, or unspecified drug abuse, unspecified congestive heart failure, unspecified other chest pain polyneuropathy in diabetes esophageal reflux renal dialysis status esophageal reflux end stage renal disease diabetes with neurological manifestations, type ii or unspecified type, not stated as uncontrolled other chest pain chronic systolic heart failure chronic pancreatitis atrial fibrillation congestive heart failure, unspecified hypertensive chronic kidney disease, unspecified, with chronic kidney disease stage v or end stage renal disease cocaine abuse, unspecified gout, unspecified
black african american m 63 $nan$hematology blood hematocrit  32.8  %; hematology blood hemoglobin  10.6  g dl; hematology blood platelet count  260  k ul; chemistry blood anion gap  18  meq l; chemistry blood bicarbonate  28  meq l; chemistry blood chloride  93  meq l; chemistry blood creatinine  5.9  mg dl; chemistry blood potassium  4.5  meq l; chemistry blood sodium  134  meq l; chemistry blood urea nitrogen  43  mg dl; hematology urine wbc  9  # hpf; chemistry blood calcium, total  9.4  mg dl; chemistry blood glucose  257  mg dl; hematology urine glucose  1000  mg dl$nephrocaps  1  cap ; aspirin  325  mg ; atorvastatin  20  mg ; diltiazem extended-release  360  mg ; cinacalcet  30  mg ; heparin flush (10 units ml)  1  ml ; senna  1  tab ; acetaminophen  325-650  mg ; tramadol (ultram)  50  mg ; sarna lotion  1  appl ; sevelamer carbonate  1600  mg ; dextrose 50%  12.5  gm ; glucagon  1  mg ; pantoprazole  40  mg ; artificial tears  1-2  drop ; diphenhydramine  25  mg ; insulin  0  unit ; heparin  5000  unit ; docusate sodium  100  mg ; insulin  10  unit ; xopenex neb  0.63  mg ; nicotine patch  14  mg ; azithromycin  250  mg ; simethicone  40-80  mg ; cefpodoxime proxetil  200  mg ; acetaminophen  650  mg ; 
other chest pain diabetes with neurological manifestations, type ii or unspecified type, not stated as uncontrolled congestive heart failure, unspecified cocaine abuse, unspecified hypertensive chronic kidney disease, unspecified, with chronic kidney disease stage v or end stage renal disease atrial fibrillation end stage renal disease renal dialysis status anemia in chronic kidney disease chronic systolic heart failure polyneuropathy in diabetes atrial fibrillation esophageal reflux renal dialysis status chronic systolic heart failure acute pancreatitis polyneuropathy in diabetes chronic pancreatitis gout, unspecified congestive heart failure, unspecified end stage renal disease diabetes with neurological manifestations, type ii or unspecified type, not stated as uncontrolled atrial flutter hypertensive chronic kidney disease, unspecified, with chronic kidney disease stage v or end stage renal disease anemia, unspecified chronic systolic heart failure tobacco use disorder atrial fibrillation diabetes with neurological manifestations, type ii or unspecified type, not stated as uncontrolled end stage renal disease hypertensive chronic kidney disease, unspecified, with chronic kidney disease stage v or end stage renal disease other, mixed, or unspecified drug abuse, unspecified congestive heart failure, unspecified other chest pain polyneuropathy in diabetes esophageal reflux renal dialysis status esophageal reflux end stage renal disease diabetes with neurological manifestations, type ii or unspecified type, not stated as uncontrolled other chest pain chronic systolic heart failure chronic pancreatitis atrial fibrillation congestive heart failure, unspecified hypertensive chronic kidney disease, unspecified, with chronic kidney disease stage v or end stage renal disease cocaine abuse, unspecified gout, unspecified
black african american m 63 $nan$nan$nephrocaps  1  cap ; aspirin  325  mg ; atorvastatin  20  mg ; diltiazem extended-release  360  mg ; cinacalcet  30  mg ; heparin flush (10 units ml)  1  ml ; senna  1  tab ; acetaminophen  325-650  mg ; tramadol (ultram)  50  mg ; sarna lotion  1  appl ; sevelamer carbonate  1600  mg ; dextrose 50%  12.5  gm ; glucagon  1  mg ; pantoprazole  40  mg ; artificial tears  1-2  drop ; diphenhydramine  25  mg ; insulin  0  unit ; heparin  5000  unit ; docusate sodium  100  mg ; insulin  10  unit ; xopenex neb  0.63  mg ; nicotine patch  14  mg ; azithromycin  250  mg ; simethicone  40-80  mg ; cefpodoxime proxetil  200  mg ; acetaminophen  650  mg ; 
other chest pain diabetes with neurological manifestations, type ii or unspecified type, not stated as uncontrolled congestive heart failure, unspecified cocaine abuse, unspecified hypertensive chronic kidney disease, unspecified, with chronic kidney disease stage v or end stage renal disease atrial fibrillation end stage renal disease renal dialysis status anemia in chronic kidney disease chronic systolic heart failure polyneuropathy in diabetes atrial fibrillation esophageal reflux renal dialysis status chronic systolic heart failure acute pancreatitis polyneuropathy in diabetes chronic pancreatitis gout, unspecified congestive heart failure, unspecified end stage renal disease diabetes with neurological manifestations, type ii or unspecified type, not stated as uncontrolled atrial flutter hypertensive chronic kidney disease, unspecified, with chronic kidney disease stage v or end stage renal disease anemia, unspecified chronic systolic heart failure tobacco use disorder atrial fibrillation diabetes with neurological manifestations, type ii or unspecified type, not stated as uncontrolled end stage renal disease hypertensive chronic kidney disease, unspecified, with chronic kidney disease stage v or end stage renal disease other, mixed, or unspecified drug abuse, unspecified congestive heart failure, unspecified other chest pain polyneuropathy in diabetes esophageal reflux renal dialysis status esophageal reflux end stage renal disease diabetes with neurological manifestations, type ii or unspecified type, not stated as uncontrolled other chest pain chronic systolic heart failure chronic pancreatitis atrial fibrillation congestive heart failure, unspecified hypertensive chronic kidney disease, unspecified, with chronic kidney disease stage v or end stage renal disease cocaine abuse, unspecified gout, unspecified
white m 63 $temp    heartrate  67.0  resprate  20.0  o2sat  99.0  sbp  91.0  dbp  51.0  rhythm    pain  uta  ; temp    heartrate  68.0  resprate  14.0  o2sat  97.0  sbp  103.0  dbp  65.0  rhythm    pain    ; temp  98.0  heartrate  68.0  resprate  16.0  o2sat  98.0  sbp  118.0  dbp  60.0  rhythm    pain    $nan$aspirin  325  mg ; atorvastatin  40  mg ; cyanocobalamin  1000  mcg ; duloxetine  30  mg ; tiotropium bromide  1  cap ; 
coronary atherosclerosis of native coronary artery other and unspecified alcohol dependence, continuous chronic kidney disease, stage iii (moderate) old myocardial infarction aphasia tobacco use disorder other, mixed, or unspecified drug abuse, in remission cerebral artery occlusion, unspecified with cerebral infarction hypertensive chronic kidney disease, unspecified, with chronic kidney disease stage i through stage iv, or unspecified chronic hepatitis c without mention of hepatic coma chronic airway obstruction, not elsewhere classified other late effects of cerebrovascular disease old myocardial infarction depressive disorder, not elsewhere classified percutaneous transluminal coronary angioplasty status other, mixed, or unspecified drug abuse, in remission personal history of noncompliance with medical treatment, presenting hazards to health chronic hepatitis c without mention of hepatic coma tobacco use disorder anxiety state, unspecified cerebral artery occlusion, unspecified with cerebral infarction hypoxemia other and unspecified alcohol dependence, continuous coronary atherosclerosis of native coronary artery chronic airway obstruction, not elsewhere classified hypertensive chronic kidney disease, unspecified, with chronic kidney disease stage i through stage iv, or unspecified chronic kidney disease, stage iii (moderate) encephalopathy, unspecified alcohol withdrawal chronic airway obstruction, not elsewhere classified chronic kidney disease, stage iii (moderate) old myocardial infarction unspecified viral hepatitis c without hepatic coma percutaneous transluminal coronary angioplasty status alcohol-induced psychotic disorder with hallucinations acute kidney failure, unspecified hypertensive chronic kidney disease, benign, with chronic kidney disease stage i through stage iv, or unspecified other and unspecified angina pectoris hyperparathyroidism, unspecified other and unspecified alcohol dependence, continuous anxiety state, unspecified acidosis coronary atherosclerosis of native coronary artery other and unspecified alcohol dependence, continuous tobacco use disorder old myocardial infarction percutaneous transluminal coronary angioplasty status chronic airway obstruction, not elsewhere classified
white m 63 $temp  97.0  heartrate  88.0  resprate  19.0  o2sat  99.0  sbp  122.0  dbp  67.0  rhythm    pain  asleep  $hematology blood hematocrit  38.8  %; hematology blood hemoglobin  13.4  g dl; hematology blood platelet count  275  k ul; chemistry blood anion gap  12  meq l; chemistry blood bicarbonate  22  meq l; chemistry blood chloride  107  meq l; chemistry blood creatinine  1.5  mg dl; chemistry blood potassium  4.4  meq l; chemistry blood sodium  137  meq l; chemistry blood urea nitrogen  22  mg dl; chemistry blood calcium, total  9.4  mg dl; chemistry blood bilirubin, total  0.7  mg dl; chemistry blood glucose  82  mg dl; blood gas blood lactate  2.3  mmol l$0.9% sodium chloride  500  ml ; aspirin  325  mg ; atorvastatin  40  mg ; cyanocobalamin  1000  mcg ; duloxetine  30  mg ; tiotropium bromide  1  cap ; fluticasone-salmeterol diskus (100 50)  1  inh ; sodium chloride 0.9%  flush  3  ml ; heparin  5000  unit ; diazepam  5  mg ; pneumococcal 23-valent polysaccharide vaccine  0.5  ml ; acetaminophen  650  mg ; multivitamins  1  tab ; folic acid  1  mg ; thiamine  100  mg ; senna  1  tab ; docusate sodium  100  mg ; carvedilol  12.5  mg ; albuterol inhaler  2  puff ; amlodipine  5  mg ; carvedilol  25  mg ; valsartan  80  mg ; bag  50  ml ; magnesium sulfate  2  gm ; 
coronary atherosclerosis of native coronary artery other and unspecified alcohol dependence, continuous chronic kidney disease, stage iii (moderate) old myocardial infarction aphasia tobacco use disorder other, mixed, or unspecified drug abuse, in remission cerebral artery occlusion, unspecified with cerebral infarction hypertensive chronic kidney disease, unspecified, with chronic kidney disease stage i through stage iv, or unspecified chronic hepatitis c without mention of hepatic coma chronic airway obstruction, not elsewhere classified other late effects of cerebrovascular disease old myocardial infarction depressive disorder, not elsewhere classified percutaneous transluminal coronary angioplasty status other, mixed, or unspecified drug abuse, in remission personal history of noncompliance with medical treatment, presenting hazards to health chronic hepatitis c without mention of hepatic coma tobacco use disorder anxiety state, unspecified cerebral artery occlusion, unspecified with cerebral infarction hypoxemia other and unspecified alcohol dependence, continuous coronary atherosclerosis of native coronary artery chronic airway obstruction, not elsewhere classified hypertensive chronic kidney disease, unspecified, with chronic kidney disease stage i through stage iv, or unspecified chronic kidney disease, stage iii (moderate) encephalopathy, unspecified alcohol withdrawal chronic airway obstruction, not elsewhere classified chronic kidney disease, stage iii (moderate) old myocardial infarction unspecified viral hepatitis c without hepatic coma percutaneous transluminal coronary angioplasty status alcohol-induced psychotic disorder with hallucinations acute kidney failure, unspecified hypertensive chronic kidney disease, benign, with chronic kidney disease stage i through stage iv, or unspecified other and unspecified angina pectoris hyperparathyroidism, unspecified other and unspecified alcohol dependence, continuous anxiety state, unspecified acidosis coronary atherosclerosis of native coronary artery other and unspecified alcohol dependence, continuous tobacco use disorder old myocardial infarction percutaneous transluminal coronary angioplasty status chronic airway obstruction, not elsewhere classified
white m 63 $nan$chemistry blood creatinine  1.6  mg dl$0.9% sodium chloride  500  ml ; aspirin  325  mg ; atorvastatin  40  mg ; cyanocobalamin  1000  mcg ; duloxetine  30  mg ; tiotropium bromide  1  cap ; fluticasone-salmeterol diskus (100 50)  1  inh ; acetaminophen  650  mg ; multivitamins  1  tab ; folic acid  1  mg ; thiamine  100  mg ; senna  1  tab ; docusate sodium  100  mg ; albuterol inhaler  2  puff ; carvedilol  25  mg ; bag  50  ml ; magnesium sulfate  2  gm ; 
coronary atherosclerosis of native coronary artery other and unspecified alcohol dependence, continuous chronic kidney disease, stage iii (moderate) old myocardial infarction aphasia tobacco use disorder other, mixed, or unspecified drug abuse, in remission cerebral artery occlusion, unspecified with cerebral infarction hypertensive chronic kidney disease, unspecified, with chronic kidney disease stage i through stage iv, or unspecified chronic hepatitis c without mention of hepatic coma chronic airway obstruction, not elsewhere classified other late effects of cerebrovascular disease old myocardial infarction depressive disorder, not elsewhere classified percutaneous transluminal coronary angioplasty status other, mixed, or unspecified drug abuse, in remission personal history of noncompliance with medical treatment, presenting hazards to health chronic hepatitis c without mention of hepatic coma tobacco use disorder anxiety state, unspecified cerebral artery occlusion, unspecified with cerebral infarction hypoxemia other and unspecified alcohol dependence, continuous coronary atherosclerosis of native coronary artery chronic airway obstruction, not elsewhere classified hypertensive chronic kidney disease, unspecified, with chronic kidney disease stage i through stage iv, or unspecified chronic kidney disease, stage iii (moderate) encephalopathy, unspecified alcohol withdrawal chronic airway obstruction, not elsewhere classified chronic kidney disease, stage iii (moderate) old myocardial infarction unspecified viral hepatitis c without hepatic coma percutaneous transluminal coronary angioplasty status alcohol-induced psychotic disorder with hallucinations acute kidney failure, unspecified hypertensive chronic kidney disease, benign, with chronic kidney disease stage i through stage iv, or unspecified other and unspecified angina pectoris hyperparathyroidism, unspecified other and unspecified alcohol dependence, continuous anxiety state, unspecified acidosis coronary atherosclerosis of native coronary artery other and unspecified alcohol dependence, continuous tobacco use disorder old myocardial infarction percutaneous transluminal coronary angioplasty status chronic airway obstruction, not elsewhere classified
white m 63 $nan$nan$aspirin  325  mg ; atorvastatin  40  mg ; cyanocobalamin  1000  mcg ; duloxetine  30  mg ; tiotropium bromide  1  cap ; fluticasone-salmeterol diskus (100 50)  1  inh ; acetaminophen  650  mg ; multivitamins  1  tab ; folic acid  1  mg ; thiamine  100  mg ; senna  1  tab ; docusate sodium  100  mg ; albuterol inhaler  2  puff ; carvedilol  25  mg ; 
coronary atherosclerosis of native coronary artery other and unspecified alcohol dependence, continuous chronic kidney disease, stage iii (moderate) old myocardial infarction aphasia tobacco use disorder other, mixed, or unspecified drug abuse, in remission cerebral artery occlusion, unspecified with cerebral infarction hypertensive chronic kidney disease, unspecified, with chronic kidney disease stage i through stage iv, or unspecified chronic hepatitis c without mention of hepatic coma chronic airway obstruction, not elsewhere classified other late effects of cerebrovascular disease old myocardial infarction depressive disorder, not elsewhere classified percutaneous transluminal coronary angioplasty status other, mixed, or unspecified drug abuse, in remission personal history of noncompliance with medical treatment, presenting hazards to health chronic hepatitis c without mention of hepatic coma tobacco use disorder anxiety state, unspecified cerebral artery occlusion, unspecified with cerebral infarction hypoxemia other and unspecified alcohol dependence, continuous coronary atherosclerosis of native coronary artery chronic airway obstruction, not elsewhere classified hypertensive chronic kidney disease, unspecified, with chronic kidney disease stage i through stage iv, or unspecified chronic kidney disease, stage iii (moderate) encephalopathy, unspecified alcohol withdrawal chronic airway obstruction, not elsewhere classified chronic kidney disease, stage iii (moderate) old myocardial infarction unspecified viral hepatitis c without hepatic coma percutaneous transluminal coronary angioplasty status alcohol-induced psychotic disorder with hallucinations acute kidney failure, unspecified hypertensive chronic kidney disease, benign, with chronic kidney disease stage i through stage iv, or unspecified other and unspecified angina pectoris hyperparathyroidism, unspecified other and unspecified alcohol dependence, continuous anxiety state, unspecified acidosis coronary atherosclerosis of native coronary artery other and unspecified alcohol dependence, continuous tobacco use disorder old myocardial infarction percutaneous transluminal coronary angioplasty status chronic airway obstruction, not elsewhere classified
white f 66 $nan$nan$vitamin d  1000  unit ; levothyroxine sodium  75  mcg ; venlafaxine xr  75  mg ; tiotropium bromide  1  cap ; prednisone  30  mg ; 
other postoperative infection polyneuropathy in diabetes other specified surgical operations and procedures causing abnormal patient reaction, or later complication, without mention of misadventure at time of operation chronic airway obstruction, not elsewhere classified ulcer of other part of foot diabetes with neurological manifestations, type ii or unspecified type, not stated as uncontrolled hypoxemia pulmonary eosinophilia unspecified essential hypertension congestive heart failure, unspecified unspecified osteomyelitis, ankle and foot obstructive sleep apnea (adult)(pediatric) urinary tract infection, site not specified proteus (mirabilis) (morganii) infection in conditions classified elsewhere and of unspecified site unspecified acquired hypothyroidism disruption of external operation (surgical) wound diastolic heart failure, unspecified polyneuropathy in diabetes other complications due to other internal orthopedic device, implant, and graft diabetes with neurological manifestations, type ii or unspecified type, not stated as uncontrolled diastolic heart failure, unspecified chronic airway obstruction, not elsewhere classified ulcer of other part of foot unspecified essential hypertension congestive heart failure, unspecified 
white f 66 $nan$hematology blood hematocrit  44.4  %; hematology blood hemoglobin  14.7  g dl; hematology blood platelet count  270  k ul; chemistry blood anion gap  9  meq l; chemistry blood anion gap  11  meq l; chemistry blood bicarbonate  31  meq l; chemistry blood bicarbonate  34  meq l; chemistry blood chloride  97  meq l; chemistry blood chloride  96  meq l; chemistry blood creatinine  1.0  mg dl; chemistry blood creatinine  1.0  mg dl; chemistry blood potassium  4.4  meq l; chemistry blood potassium  4.2  meq l; chemistry blood sodium  133  meq l; chemistry blood sodium  137  meq l; chemistry blood urea nitrogen  14  mg dl; chemistry blood urea nitrogen  14  mg dl; hematology blood inr(pt)  1.1  ; hematology urine wbc  2  # hpf; chemistry blood calcium, total  9.2  mg dl; chemistry blood glucose  148  mg dl; chemistry blood glucose  94  mg dl; blood gas blood lactate  0.7  mmol l; blood gas blood lactate  0.8  mmol l$vitamin d  1000  unit ; levothyroxine sodium  75  mcg ; venlafaxine xr  75  mg ; tiotropium bromide  1  cap ; prednisone  30  mg ; bisacodyl  10  mg ; senna  1  tab ; pantoprazole  40  mg ; salmeterol xinafoate diskus (50 mcg)  1  inh ; albuterol mdi  2  puff ; furosemide  20  mg ; fentanyl citrate  100  mcg ; insulin  0  unit ; ns  100  ml ; midazolam  100  mg ; ns  250  ml ; fentanyl citrate  2.5  mg ; docusate sodium (liquid)  100  mg ; heparin  5000  unit ; atovaquone suspension  750  mg ; calcium carbonate  500  mg ; divalproex sod. sprinkles  500  mg ; gabapentin  400  mg ; ipratropium bromide mdi  2  puff ; baclofen  20  mg ; gabapentin  600  mg ; levofloxacin  750  mg ; ns  500  ml ; sw  50  ml ; magnesium sulfate  2  gm ; metronidazole (flagyl)  500  mg ; chlorhexidine gluconate 0.12% oral rinse  15  ml ; acetaminophen (liquid)  650  mg ; lansoprazole oral disintegrating tab  30  mg ; 
other postoperative infection polyneuropathy in diabetes other specified surgical operations and procedures causing abnormal patient reaction, or later complication, without mention of misadventure at time of operation chronic airway obstruction, not elsewhere classified ulcer of other part of foot diabetes with neurological manifestations, type ii or unspecified type, not stated as uncontrolled hypoxemia pulmonary eosinophilia unspecified essential hypertension congestive heart failure, unspecified unspecified osteomyelitis, ankle and foot obstructive sleep apnea (adult)(pediatric) urinary tract infection, site not specified proteus (mirabilis) (morganii) infection in conditions classified elsewhere and of unspecified site unspecified acquired hypothyroidism disruption of external operation (surgical) wound diastolic heart failure, unspecified polyneuropathy in diabetes other complications due to other internal orthopedic device, implant, and graft diabetes with neurological manifestations, type ii or unspecified type, not stated as uncontrolled diastolic heart failure, unspecified chronic airway obstruction, not elsewhere classified ulcer of other part of foot unspecified essential hypertension congestive heart failure, unspecified 
white f 66 $nan$hematology blood hematocrit  38.7  %; hematology blood hemoglobin  12.5  g dl; hematology blood platelet count  192  k ul; chemistry blood anion gap  7  meq l; chemistry blood bicarbonate  33  meq l; chemistry blood chloride  101  meq l; chemistry blood creatinine  0.9  mg dl; chemistry blood potassium  3.8  meq l; chemistry blood sodium  137  meq l; chemistry blood urea nitrogen  14  mg dl; hematology blood inr(pt)  1.3  ; chemistry blood calcium, total  8.4  mg dl; chemistry blood glucose  76  mg dl; blood gas blood lactate  1.0  mmol l$vitamin d  1000  unit ; levothyroxine sodium  75  mcg ; venlafaxine xr  75  mg ; prednisone  30  mg ; bisacodyl  10  mg ; senna  1  tab ; pantoprazole  40  mg ; albuterol mdi  2  puff ; furosemide  20  mg ; insulin  0  unit ; ns  250  ml ; fentanyl citrate  2.5  mg ; docusate sodium (liquid)  100  mg ; heparin  5000  unit ; atovaquone suspension  750  mg ; calcium carbonate  500  mg ; divalproex sod. sprinkles  500  mg ; gabapentin  400  mg ; ipratropium bromide mdi  2  puff ; baclofen  20  mg ; gabapentin  600  mg ; levofloxacin  750  mg ; ns  500  ml ; sw  50  ml ; magnesium sulfate  2  gm ; metronidazole (flagyl)  500  mg ; chlorhexidine gluconate 0.12% oral rinse  15  ml ; acetaminophen (liquid)  650  mg ; lansoprazole oral disintegrating tab  30  mg ; trazodone  50  mg ; olanzapine (disintegrating tablet)  5  mg ; 
other postoperative infection polyneuropathy in diabetes other specified surgical operations and procedures causing abnormal patient reaction, or later complication, without mention of misadventure at time of operation chronic airway obstruction, not elsewhere classified ulcer of other part of foot diabetes with neurological manifestations, type ii or unspecified type, not stated as uncontrolled hypoxemia pulmonary eosinophilia unspecified essential hypertension congestive heart failure, unspecified unspecified osteomyelitis, ankle and foot obstructive sleep apnea (adult)(pediatric) urinary tract infection, site not specified proteus (mirabilis) (morganii) infection in conditions classified elsewhere and of unspecified site unspecified acquired hypothyroidism disruption of external operation (surgical) wound diastolic heart failure, unspecified polyneuropathy in diabetes other complications due to other internal orthopedic device, implant, and graft diabetes with neurological manifestations, type ii or unspecified type, not stated as uncontrolled diastolic heart failure, unspecified chronic airway obstruction, not elsewhere classified ulcer of other part of foot unspecified essential hypertension congestive heart failure, unspecified 
white f 66 $nan$hematology blood hematocrit  41.7  %; hematology blood hemoglobin  13.8  g dl; hematology blood platelet count  218  k ul; chemistry blood anion gap  9  meq l; chemistry blood bicarbonate  34  meq l; chemistry blood chloride  100  meq l; chemistry blood creatinine  1.0  mg dl; chemistry blood potassium  3.8  meq l; chemistry blood sodium  139  meq l; chemistry blood urea nitrogen  14  mg dl; hematology blood inr(pt)  1.4  ; chemistry blood calcium, total  9.1  mg dl; chemistry blood glucose  75  mg dl$vitamin d  1000  unit ; levothyroxine sodium  75  mcg ; venlafaxine xr  75  mg ; prednisone  30  mg ; bisacodyl  10  mg ; senna  1  tab ; albuterol mdi  2  puff ; insulin  0  unit ; ns  250  ml ; fentanyl citrate  2.5  mg ; docusate sodium (liquid)  100  mg ; heparin  5000  unit ; atovaquone suspension  750  mg ; calcium carbonate  500  mg ; divalproex sod. sprinkles  500  mg ; gabapentin  400  mg ; ipratropium bromide mdi  2  puff ; baclofen  20  mg ; gabapentin  600  mg ; levofloxacin  750  mg ; metronidazole (flagyl)  500  mg ; chlorhexidine gluconate 0.12% oral rinse  15  ml ; acetaminophen (liquid)  650  mg ; lansoprazole oral disintegrating tab  30  mg ; trazodone  50  mg ; olanzapine (disintegrating tablet)  5  mg ; potassium chloride  40  meq ; venlafaxine xr  150  mg ; 
other postoperative infection polyneuropathy in diabetes other specified surgical operations and procedures causing abnormal patient reaction, or later complication, without mention of misadventure at time of operation chronic airway obstruction, not elsewhere classified ulcer of other part of foot diabetes with neurological manifestations, type ii or unspecified type, not stated as uncontrolled hypoxemia pulmonary eosinophilia unspecified essential hypertension congestive heart failure, unspecified unspecified osteomyelitis, ankle and foot obstructive sleep apnea (adult)(pediatric) urinary tract infection, site not specified proteus (mirabilis) (morganii) infection in conditions classified elsewhere and of unspecified site unspecified acquired hypothyroidism disruption of external operation (surgical) wound diastolic heart failure, unspecified polyneuropathy in diabetes other complications due to other internal orthopedic device, implant, and graft diabetes with neurological manifestations, type ii or unspecified type, not stated as uncontrolled diastolic heart failure, unspecified chronic airway obstruction, not elsewhere classified ulcer of other part of foot unspecified essential hypertension congestive heart failure, unspecified 
white f 66 $nan$nan$vitamin d  1000  unit ; levothyroxine sodium  75  mcg ; prednisone  30  mg ; bisacodyl  10  mg ; senna  1  tab ; albuterol mdi  2  puff ; ns  250  ml ; fentanyl citrate  2.5  mg ; docusate sodium (liquid)  100  mg ; heparin  5000  unit ; atovaquone suspension  750  mg ; calcium carbonate  500  mg ; divalproex sod. sprinkles  500  mg ; gabapentin  400  mg ; ipratropium bromide mdi  2  puff ; baclofen  20  mg ; gabapentin  600  mg ; levofloxacin  750  mg ; chlorhexidine gluconate 0.12% oral rinse  15  ml ; acetaminophen (liquid)  650  mg ; lansoprazole oral disintegrating tab  30  mg ; trazodone  50  mg ; potassium chloride  40  meq ; venlafaxine xr  150  mg ; 
other postoperative infection polyneuropathy in diabetes other specified surgical operations and procedures causing abnormal patient reaction, or later complication, without mention of misadventure at time of operation chronic airway obstruction, not elsewhere classified ulcer of other part of foot diabetes with neurological manifestations, type ii or unspecified type, not stated as uncontrolled hypoxemia pulmonary eosinophilia unspecified essential hypertension congestive heart failure, unspecified unspecified osteomyelitis, ankle and foot obstructive sleep apnea (adult)(pediatric) urinary tract infection, site not specified proteus (mirabilis) (morganii) infection in conditions classified elsewhere and of unspecified site unspecified acquired hypothyroidism disruption of external operation (surgical) wound diastolic heart failure, unspecified polyneuropathy in diabetes other complications due to other internal orthopedic device, implant, and graft diabetes with neurological manifestations, type ii or unspecified type, not stated as uncontrolled diastolic heart failure, unspecified chronic airway obstruction, not elsewhere classified ulcer of other part of foot unspecified essential hypertension congestive heart failure, unspecified 
white f 51 $nan$nan$multivitamins  1  tab ; 
acute alcoholic hepatitis disorders of phosphorus metabolism other severe protein-calorie malnutrition dysthymic disorder hypopotassemia acute pancreatitis acidosis dehydration disorders of magnesium metabolism anemia, unspecified unspecified essential hypertension other and unspecified alcohol dependence, continuous alkalosis diarrhea unspecified hemorrhoids with other complication cirrhosis of liver without mention of alcohol
white f 51 $nan$hematology blood hematocrit  30.5  %; hematology blood hemoglobin  10.9  g dl; hematology blood platelet count  100  k ul; chemistry blood anion gap  27  meq l; chemistry blood anion gap  25  meq l; chemistry blood anion gap  16  meq l; chemistry blood bicarbonate  15  meq l; chemistry blood bicarbonate  17  meq l; chemistry blood bicarbonate  24  meq l; chemistry blood chloride  92  meq l; chemistry blood chloride  100  meq l; chemistry blood chloride  100  meq l; chemistry blood creatinine  0.8  mg dl; chemistry blood creatinine  0.6  mg dl; chemistry blood creatinine  0.6  mg dl; chemistry blood potassium  3.4  meq l; chemistry blood potassium  3.7  meq l; chemistry blood potassium  2.8  meq l; chemistry blood sodium  136  meq l; chemistry blood sodium  131  meq l; chemistry blood sodium  139  meq l; chemistry blood urea nitrogen  27  mg dl; chemistry blood urea nitrogen  16  mg dl; chemistry blood urea nitrogen  11  mg dl; hematology blood inr(pt)  1.1  ; hematology urine wbc  2  # hpf; chemistry blood calcium, total  9.0  mg dl; chemistry blood calcium, total  8.5  mg dl; chemistry blood calcium, total  8.5  mg dl; chemistry blood bilirubin, total  1.1  mg dl; chemistry blood glucose  84  mg dl; chemistry blood glucose  82  mg dl; chemistry blood glucose  98  mg dl; chemistry blood albumin  4.0  g dl; blood gas blood lactate  1.2  mmol l; blood gas blood lactate  0.7  mmol l; blood gas blood chloride, whole blood  101  meq l; blood gas blood potassium, whole blood  3.5  meq l; blood gas blood sodium, whole blood  135  meq l$diazepam  5  mg ; multivitamins  1  tab ; metoprolol tartrate  100  mg ; docusate sodium  100  mg ; sodium chloride 0.9%  flush  3  ml ; trazodone  100  mg ; pantoprazole  40  mg ; senna  1  tab ; sodium chloride nasal  1-2  spry ; nortriptyline  75  mg ; oxycodone (immediate release)   5  mg ; potassium chloride  60  meq ; d5ns  1000  ml ; 0.9% sodium chloride  500  ml ; potassium phosphate  30  mmol ; 0.9% sodium chloride  1000  ml ; bag  50  ml ; magnesium sulfate  2  gm ; syringe  1  syr ; folic acid  1  mg ; thiamine  100  mg ; tucks hemorrhoidal oint 1%  1  appl ; bag  100  ml ; magnesium sulfate  4  gm ; neutra-phos  2  pkt ; acetaminophen  325-650  mg ; 
acute alcoholic hepatitis disorders of phosphorus metabolism other severe protein-calorie malnutrition dysthymic disorder hypopotassemia acute pancreatitis acidosis dehydration disorders of magnesium metabolism anemia, unspecified unspecified essential hypertension other and unspecified alcohol dependence, continuous alkalosis diarrhea unspecified hemorrhoids with other complication cirrhosis of liver without mention of alcohol
white f 51 $nan$hematology blood hematocrit  29.4  %; hematology blood hemoglobin  10.5  g dl; hematology blood platelet count  111  k ul; chemistry blood anion gap  15  meq l; chemistry blood bicarbonate  27  meq l; chemistry blood chloride  99  meq l; chemistry blood creatinine  0.6  mg dl; chemistry blood potassium  3.2  meq l; chemistry blood sodium  138  meq l; chemistry blood urea nitrogen  7  mg dl; chemistry blood calcium, total  8.5  mg dl; chemistry blood glucose  116  mg dl$multivitamins  1  tab ; metoprolol tartrate  100  mg ; docusate sodium  100  mg ; sodium chloride 0.9%  flush  3  ml ; trazodone  100  mg ; pantoprazole  40  mg ; senna  1  tab ; sodium chloride nasal  1-2  spry ; nortriptyline  75  mg ; oxycodone (immediate release)   5  mg ; potassium chloride  60  meq ; 0.9% sodium chloride  500  ml ; potassium phosphate  30  mmol ; bag  50  ml ; magnesium sulfate  2  gm ; syringe  1  syr ; folic acid  1  mg ; thiamine  100  mg ; tucks hemorrhoidal oint 1%  1  appl ; bag  100  ml ; magnesium sulfate  4  gm ; neutra-phos  2  pkt ; acetaminophen  325-650  mg ; triamcinolone acetonide  1  appl ; maalox diphenhydramine lidocaine  15-30  ml ; tramadol (ultram)  50  mg ; prednisone  60  mg ; neutra-phos  1  pkt ; 
acute alcoholic hepatitis disorders of phosphorus metabolism other severe protein-calorie malnutrition dysthymic disorder hypopotassemia acute pancreatitis acidosis dehydration disorders of magnesium metabolism anemia, unspecified unspecified essential hypertension other and unspecified alcohol dependence, continuous alkalosis diarrhea unspecified hemorrhoids with other complication cirrhosis of liver without mention of alcohol
white f 51 $nan$hematology blood hematocrit  32.7  %; hematology blood hemoglobin  11.4  g dl; hematology blood platelet count  162  k ul; chemistry blood anion gap  14  meq l; chemistry blood anion gap  14  meq l; chemistry blood bicarbonate  29  meq l; chemistry blood bicarbonate  29  meq l; chemistry blood chloride  97  meq l; chemistry blood chloride  97  meq l; chemistry blood creatinine  0.6  mg dl; chemistry blood creatinine  0.5  mg dl; chemistry blood potassium  4.0  meq l; chemistry blood potassium  3.8  meq l; chemistry blood sodium  136  meq l; chemistry blood sodium  136  meq l; chemistry blood urea nitrogen  8  mg dl; chemistry blood urea nitrogen  5  mg dl; chemistry blood calcium, total  9.2  mg dl; chemistry blood calcium, total  9.4  mg dl; chemistry blood glucose  119  mg dl; chemistry blood glucose  125  mg dl$multivitamins  1  tab ; metoprolol tartrate  100  mg ; docusate sodium  100  mg ; sodium chloride 0.9%  flush  3  ml ; trazodone  100  mg ; pantoprazole  40  mg ; senna  1  tab ; sodium chloride nasal  1-2  spry ; nortriptyline  75  mg ; thiamine  100  mg ; tucks hemorrhoidal oint 1%  1  appl ; acetaminophen  325-650  mg ; triamcinolone acetonide  1  appl ; maalox diphenhydramine lidocaine  15-30  ml ; tramadol (ultram)  50  mg ; neutra-phos  1  pkt ; colchicine  0.6  mg ; ondansetron  4  mg ; milk of magnesia  30  ml ; 
acute alcoholic hepatitis disorders of phosphorus metabolism other severe protein-calorie malnutrition dysthymic disorder hypopotassemia acute pancreatitis acidosis dehydration disorders of magnesium metabolism anemia, unspecified unspecified essential hypertension other and unspecified alcohol dependence, continuous alkalosis diarrhea unspecified hemorrhoids with other complication cirrhosis of liver without mention of alcohol
white f 51 $nan$hematology blood hematocrit  32.5  %; hematology blood hemoglobin  11.2  g dl; hematology blood platelet count  219  k ul; chemistry blood anion gap  15  meq l; chemistry blood bicarbonate  28  meq l; chemistry blood chloride  98  meq l; chemistry blood creatinine  0.5  mg dl; chemistry blood potassium  4.0  meq l; chemistry blood sodium  137  meq l; chemistry blood urea nitrogen  9  mg dl; chemistry blood calcium, total  9.7  mg dl; chemistry blood glucose  117  mg dl$multivitamins  1  tab ; metoprolol tartrate  100  mg ; docusate sodium  100  mg ; sodium chloride 0.9%  flush  3  ml ; trazodone  100  mg ; pantoprazole  40  mg ; senna  1  tab ; sodium chloride nasal  1-2  spry ; nortriptyline  75  mg ; thiamine  100  mg ; tucks hemorrhoidal oint 1%  1  appl ; acetaminophen  325-650  mg ; triamcinolone acetonide  1  appl ; maalox diphenhydramine lidocaine  15-30  ml ; tramadol (ultram)  50  mg ; ondansetron  4  mg ; milk of magnesia  30  ml ; sarna lotion  1  appl ; diphenhydramine  12.5  mg ; cephalexin  500  mg ; 
acute alcoholic hepatitis disorders of phosphorus metabolism other severe protein-calorie malnutrition dysthymic disorder hypopotassemia acute pancreatitis acidosis dehydration disorders of magnesium metabolism anemia, unspecified unspecified essential hypertension other and unspecified alcohol dependence, continuous alkalosis diarrhea unspecified hemorrhoids with other complication cirrhosis of liver without mention of alcohol
white f 51 $nan$nan$multivitamins  1  tab ; metoprolol tartrate  100  mg ; docusate sodium  100  mg ; sodium chloride 0.9%  flush  3  ml ; trazodone  100  mg ; pantoprazole  40  mg ; senna  1  tab ; sodium chloride nasal  1-2  spry ; nortriptyline  75  mg ; thiamine  100  mg ; tucks hemorrhoidal oint 1%  1  appl ; acetaminophen  325-650  mg ; triamcinolone acetonide  1  appl ; maalox diphenhydramine lidocaine  15-30  ml ; tramadol (ultram)  50  mg ; ondansetron  4  mg ; milk of magnesia  30  ml ; sarna lotion  1  appl ; cephalexin  500  mg ; 
acute alcoholic hepatitis disorders of phosphorus metabolism other severe protein-calorie malnutrition dysthymic disorder hypopotassemia acute pancreatitis acidosis dehydration disorders of magnesium metabolism anemia, unspecified unspecified essential hypertension other and unspecified alcohol dependence, continuous alkalosis diarrhea unspecified hemorrhoids with other complication cirrhosis of liver without mention of alcohol
black african american f 26 $nan$nan$influenza vaccine quadrivalent  0.5  ml ; sodium chloride 0.9%  flush  3-10  ml ; 0.9% sodium chloride  500  ml ; oxytocin  30  unit ; lactated ringers  1000  ml ; docusate sodium  100  mg ; ibuprofen  600  mg ; acetaminophen  500-1000  mg ; simethicone  80  mg ; dermoplast spray  1  spry ; varicella virus vaccine  0.5  ml ; 
 
black african american f 26 $nan$hematology blood hematocrit  37.3  %$influenza vaccine quadrivalent  0.5  ml ; sodium chloride 0.9%  flush  3-10  ml ; lactated ringers  1000  ml ; docusate sodium  100  mg ; ibuprofen  600  mg ; acetaminophen  500-1000  mg ; simethicone  80  mg ; dermoplast spray  1  spry ; varicella virus vaccine  0.5  ml ; 
 
black african american f 26 $nan$nan$influenza vaccine quadrivalent  0.5  ml ; sodium chloride 0.9%  flush  3-10  ml ; lactated ringers  1000  ml ; docusate sodium  100  mg ; ibuprofen  600  mg ; acetaminophen  500-1000  mg ; simethicone  80  mg ; dermoplast spray  1  spry ; varicella virus vaccine  0.5  ml ; 
 
white m 37 $temp  98.4  heartrate  105.0  resprate  23.0  o2sat  100.0  sbp  158.0  dbp  115.0  rhythm    pain  5  ; temp    heartrate  94.0  resprate  20.0  o2sat  99.0  sbp  168.0  dbp  95.0  rhythm    pain  6  ; temp    heartrate  95.0  resprate  20.0  o2sat  97.0  sbp  162.0  dbp  86.0  rhythm    pain  6  $hematology blood hematocrit  37.5  %; hematology blood hemoglobin  12.0  g dl; hematology blood platelet count  201  k ul; chemistry blood anion gap  13  meq l; chemistry blood bicarbonate  29  meq l; chemistry blood chloride  102  meq l; chemistry blood creatinine  0.7  mg dl; chemistry blood potassium  3.6  meq l; chemistry blood sodium  144  meq l; chemistry blood urea nitrogen  10  mg dl; hematology blood inr(pt)  1.2  ; chemistry blood glucose  82  mg dl$nan
acute on chronic diastolic (congestive) heart failure unspecified asthma with (acute) exacerbation major depressive disorder, single episode, unspecified nicotine dependence, cigarettes, uncomplicated pain in left leg anemia, unspecified hypertensive heart disease with heart failure hypoxemia body mass index (bmi) 50.0-59.9, adult morbid (severe) obesity due to excess calories localized swelling, mass and lump, left lower limb unspecified asthma, uncomplicated other secondary pulmonary hypertension body mass index (bmi) 50.0-59.9, adult acute on chronic diastolic (congestive) heart failure nicotine dependence, cigarettes, uncomplicated homelessness spinal stenosis, site unspecified morbid (severe) obesity with alveolar hypoventilation weakness chronic passive congestion of liver polyneuropathy, unspecified major depressive disorder, single episode, unspecified hypertensive heart disease with heart failure
white m 71 $nan$nan$ursodiol  300  mg ; 
personal history of nicotine dependence presence of prosthetic heart valve other secondary thrombocytopenia atherosclerotic heart disease of native coronary artery without angina pectoris pneumonia, unspecified organism nonfamilial hypogammaglobulinemia personal history of other venous thrombosis and embolism personal history of other infectious and parasitic diseases diarrhea, unspecified hypertensive heart and chronic kidney disease with heart failure and stage 1 through stage 4 chronic kidney disease, or unspecified chronic kidney disease personal history of malignant neoplasm of liver anemia, unspecified liver transplant status chronic kidney disease, stage 4 (severe) pruritus, unspecified pericardial effusion (noninflammatory) chronic diastolic (congestive) heart failure other surgical procedures as the cause of abnormal reaction of the patient, or of later complication, without mention of misadventure at the time of the procedure portal vein thrombosis nonspecific elevation of levels of transaminase and lactic acid dehydrogenase [ldh] personal history of other infectious and parasitic diseases chronic diastolic (congestive) heart failure presence of prosthetic heart valve abnormal levels of other serum enzymes liver transplant rejection nonrheumatic aortic (valve) stenosis obstruction of bile duct atherosclerotic heart disease of native coronary artery without angina pectoris other cholangitis hypertensive heart disease with heart failure decreased white blood cell count, unspecified hypovolemia anemia, unspecified chronic diastolic (congestive) heart failure atherosclerotic heart disease of native coronary artery without angina pectoris obstruction of bile duct low back pain personal history of malignant neoplasm of liver other malaise personal history of other infectious and parasitic diseases personal history of nicotine dependence other chronic pain elevated c-reactive protein (crp) collapsed vertebra, not elsewhere classified, lumbar region, initial encounter for fracture hypertensive heart and chronic kidney disease with heart failure and stage 1 through stage 4 chronic kidney disease, or unspecified chronic kidney disease hypo-osmolality and hyponatremia acute kidney failure, unspecified liver transplant status
white m 71 $nan$hematology blood hematocrit  25.7  %; hematology blood hematocrit  23.9  %; hematology blood hemoglobin  7.9  g dl; hematology blood hemoglobin  7.4  g dl; hematology blood platelet count  122  k ul; hematology blood platelet count  106  k ul; chemistry blood anion gap  11  meq l; chemistry blood anion gap  9  meq l; chemistry blood bicarbonate  20  meq l; chemistry blood bicarbonate  23  meq l; chemistry blood chloride  104  meq l; chemistry blood chloride  106  meq l; chemistry blood creatinine  2.0  mg dl; chemistry blood creatinine  2.1  mg dl; chemistry blood potassium  5.1  meq l; chemistry blood potassium  5.8  meq l; chemistry blood potassium  6.1  meq l; chemistry blood sodium  135  meq l; chemistry blood sodium  138  meq l; chemistry blood urea nitrogen  52  mg dl; chemistry blood urea nitrogen  52  mg dl; chemistry blood glucose  321  mg dl; chemistry blood glucose  85  mg dl$ursodiol  300  mg ; sodium chloride 0.9%  flush  3-10  ml ; senna  8.6  mg ; heparin  5000  unit ; acetaminophen  500  mg ; tramadol  25  mg ; mycophenolate sodium dr  720  mg ; sertraline  25  mg ; fexofenadine  180  mg ; vitamin d  1000  unit ; aspirin  81  mg ; atovaquone suspension  1500  mg ; prednisone  15  mg ; tacrolimus  0.5  mg ; tacrolimus  2  mg ; 
personal history of nicotine dependence presence of prosthetic heart valve other secondary thrombocytopenia atherosclerotic heart disease of native coronary artery without angina pectoris pneumonia, unspecified organism nonfamilial hypogammaglobulinemia personal history of other venous thrombosis and embolism personal history of other infectious and parasitic diseases diarrhea, unspecified hypertensive heart and chronic kidney disease with heart failure and stage 1 through stage 4 chronic kidney disease, or unspecified chronic kidney disease personal history of malignant neoplasm of liver anemia, unspecified liver transplant status chronic kidney disease, stage 4 (severe) pruritus, unspecified pericardial effusion (noninflammatory) chronic diastolic (congestive) heart failure other surgical procedures as the cause of abnormal reaction of the patient, or of later complication, without mention of misadventure at the time of the procedure portal vein thrombosis nonspecific elevation of levels of transaminase and lactic acid dehydrogenase [ldh] personal history of other infectious and parasitic diseases chronic diastolic (congestive) heart failure presence of prosthetic heart valve abnormal levels of other serum enzymes liver transplant rejection nonrheumatic aortic (valve) stenosis obstruction of bile duct atherosclerotic heart disease of native coronary artery without angina pectoris other cholangitis hypertensive heart disease with heart failure decreased white blood cell count, unspecified hypovolemia anemia, unspecified chronic diastolic (congestive) heart failure atherosclerotic heart disease of native coronary artery without angina pectoris obstruction of bile duct low back pain personal history of malignant neoplasm of liver other malaise personal history of other infectious and parasitic diseases personal history of nicotine dependence other chronic pain elevated c-reactive protein (crp) collapsed vertebra, not elsewhere classified, lumbar region, initial encounter for fracture hypertensive heart and chronic kidney disease with heart failure and stage 1 through stage 4 chronic kidney disease, or unspecified chronic kidney disease hypo-osmolality and hyponatremia acute kidney failure, unspecified liver transplant status
white m 71 $nan$hematology urine wbc  0  # hpf; hematology urine glucose  100  mg dl$ursodiol  300  mg ; sodium chloride 0.9%  flush  3-10  ml ; senna  8.6  mg ; heparin  5000  unit ; acetaminophen  500  mg ; tramadol  25  mg ; mycophenolate sodium dr  720  mg ; sertraline  25  mg ; fexofenadine  180  mg ; vitamin d  1000  unit ; aspirin  81  mg ; atovaquone suspension  1500  mg ; prednisone  15  mg ; tacrolimus  0.5  mg ; tacrolimus  2  mg ; pantoprazole  40  mg ; valganciclovir  450  mg ; 
personal history of nicotine dependence presence of prosthetic heart valve other secondary thrombocytopenia atherosclerotic heart disease of native coronary artery without angina pectoris pneumonia, unspecified organism nonfamilial hypogammaglobulinemia personal history of other venous thrombosis and embolism personal history of other infectious and parasitic diseases diarrhea, unspecified hypertensive heart and chronic kidney disease with heart failure and stage 1 through stage 4 chronic kidney disease, or unspecified chronic kidney disease personal history of malignant neoplasm of liver anemia, unspecified liver transplant status chronic kidney disease, stage 4 (severe) pruritus, unspecified pericardial effusion (noninflammatory) chronic diastolic (congestive) heart failure other surgical procedures as the cause of abnormal reaction of the patient, or of later complication, without mention of misadventure at the time of the procedure portal vein thrombosis nonspecific elevation of levels of transaminase and lactic acid dehydrogenase [ldh] personal history of other infectious and parasitic diseases chronic diastolic (congestive) heart failure presence of prosthetic heart valve abnormal levels of other serum enzymes liver transplant rejection nonrheumatic aortic (valve) stenosis obstruction of bile duct atherosclerotic heart disease of native coronary artery without angina pectoris other cholangitis hypertensive heart disease with heart failure decreased white blood cell count, unspecified hypovolemia anemia, unspecified chronic diastolic (congestive) heart failure atherosclerotic heart disease of native coronary artery without angina pectoris obstruction of bile duct low back pain personal history of malignant neoplasm of liver other malaise personal history of other infectious and parasitic diseases personal history of nicotine dependence other chronic pain elevated c-reactive protein (crp) collapsed vertebra, not elsewhere classified, lumbar region, initial encounter for fracture hypertensive heart and chronic kidney disease with heart failure and stage 1 through stage 4 chronic kidney disease, or unspecified chronic kidney disease hypo-osmolality and hyponatremia acute kidney failure, unspecified liver transplant status
white m 81 $nan$nan$atorvastatin  5  mg ; gemfibrozil  600  mg ; finasteride  5  mg ; femara  2.5  mg ; 
 
white m 81 $nan$hematology blood hematocrit  35.7  %; hematology blood hematocrit  39.0  %; hematology blood hemoglobin  12.0  g dl; hematology blood platelet count  97  k ul; chemistry blood anion gap  18  meq l; chemistry blood bicarbonate  28  meq l; chemistry blood chloride  86  meq l; chemistry blood creatinine  4.6  mg dl; chemistry blood potassium  4.3  meq l; chemistry blood sodium  128  meq l; chemistry blood urea nitrogen  172  mg dl; hematology blood inr(pt)  3.0  ; chemistry urine creatinine, urine  129  mg dl; chemistry urine sodium, urine  14  meq l; chemistry urine urea nitrogen, urine  411  mg dl; hematology urine wbc  0-2  # hpf; chemistry blood calcium, total  8.1  mg dl; chemistry blood glucose  151  mg dl; chemistry urine protein creatinine ratio  0.7  ratio; hematology urine glucose  neg  mg dl; hematology urine bilirubin  neg  mg dl$atorvastatin  5  mg ; gemfibrozil  600  mg ; finasteride  5  mg ; femara  2.5  mg ; d5w  100  ml ; furosemide  200  mg ; d5w  25  ml ; chlorothiazide sodium  250  mg ; tamsulosin  0.4  mg ; senna  1  tab ; sodium chloride 0.9%  flush  3  ml ; furosemide  100  mg ; chlorothiazide  250  mg ; phytonadione  10  mg ; lorazepam  0.5  mg ; calcium acetate  1334  mg ; 
 
white m 81 $nan$hematology blood hematocrit  36.5  %; hematology blood hematocrit  32.6  %; hematology blood hematocrit  32.3  %; hematology blood hemoglobin  12.0  g dl; hematology blood hemoglobin  10.5  g dl; hematology blood platelet count  84  k ul; hematology blood platelet count  69  k ul; hematology blood platelet count  69  k ul; chemistry blood anion gap  14  meq l; chemistry blood anion gap  17  meq l; chemistry blood bicarbonate  32  meq l; chemistry blood bicarbonate  32  meq l; chemistry blood chloride  86  meq l; chemistry blood chloride  87  meq l; chemistry blood creatinine  4.3  mg dl; chemistry blood creatinine  4.1  mg dl; chemistry blood potassium  3.8  meq l; chemistry blood potassium  3.6  meq l; chemistry blood sodium  128  meq l; chemistry blood sodium  132  meq l; chemistry blood urea nitrogen  162  mg dl; chemistry blood urea nitrogen  155  mg dl; hematology blood inr(pt)  2.1  ; hematology urine wbc  2  # hpf; chemistry blood calcium, total  8.1  mg dl; chemistry blood glucose  150  mg dl; chemistry blood glucose  126  mg dl$atorvastatin  5  mg ; gemfibrozil  600  mg ; finasteride  5  mg ; femara  2.5  mg ; tamsulosin  0.4  mg ; senna  1  tab ; sodium chloride 0.9%  flush  3  ml ; phytonadione  10  mg ; lorazepam  0.5  mg ; calcium acetate  1334  mg ; heparin  1300  unit ; d5w  250  ml ; heparin sodium  25,000  unit ; oxycodone-acetaminophen  1-2  tab ; sw  50  ml ; potassium chloride  20  meq ; lorazepam  0.25  mg ; allopurinol  100  mg ; ns  500  ml ; heparin (iabp)  1000  unit ; 
 
white m 81 $nan$hematology blood hematocrit  31.0  %; hematology blood hemoglobin  10.1  g dl; hematology blood platelet count  56  k ul; chemistry blood anion gap  15  meq l; chemistry blood bicarbonate  32  meq l; chemistry blood chloride  89  meq l; chemistry blood creatinine  3.9  mg dl; chemistry blood potassium  3.9  meq l; chemistry blood sodium  132  meq l; chemistry blood urea nitrogen  158  mg dl; hematology blood inr(pt)  1.5  ; chemistry blood glucose  115  mg dl$atorvastatin  5  mg ; finasteride  5  mg ; femara  2.5  mg ; tamsulosin  0.4  mg ; senna  1  tab ; sodium chloride 0.9%  flush  3  ml ; calcium acetate  1334  mg ; oxycodone-acetaminophen  1-2  tab ; sw  50  ml ; potassium chloride  20  meq ; lorazepam  0.25  mg ; allopurinol  100  mg ; ns  500  ml ; heparin (iabp)  1000  unit ; sw  100  ml ; potassium chloride  40  meq ; albuterol 0.083% neb soln  1  neb ; ns  50  ml ; desmopressin acetate  25  mcg ; ipratropium bromide neb  1  neb ; morphine sulfate  100  mg ; morphine sulfate  2-4  mg ; 
 
white m 81 $nan$nan$lorazepam  0.25  mg ; ipratropium bromide neb  1  neb ; morphine sulfate  100  mg ; morphine sulfate  2-4  mg ; 
 
black african american f 53 $nan$nan$fluoxetine  60  mg ; aspirin  81  mg ; tiotropium bromide  1  cap ; 
other convulsions other encephalopathy migraine, unspecified, without mention of intractable migraine without mention of status migrainosus unspecified acquired hypothyroidism obstructive chronic bronchitis with (acute) exacerbation opioid type dependence, unspecified depressive disorder, not elsewhere classified 
black african american f 53 $nan$hematology blood hematocrit  38.0  %; hematology blood hemoglobin  12.8  g dl; hematology blood platelet count  124  k ul; chemistry blood anion gap  16  meq l; chemistry blood bicarbonate  26  meq l; chemistry blood chloride  102  meq l; chemistry blood creatinine  1.1  mg dl; chemistry blood potassium  4.6  meq l; chemistry blood sodium  139  meq l; chemistry blood urea nitrogen  13  mg dl; chemistry blood calcium, total  9.1  mg dl; chemistry blood glucose  104  mg dl$fluoxetine  60  mg ; aspirin  81  mg ; tiotropium bromide  1  cap ; sodium chloride 0.9%  flush  3  ml ; acetaminophen  325-650  mg ; verapamil sr  120  mg ; alprazolam  2  mg ; fluticasone-salmeterol diskus (250 50)   1  inh ; methadone  10  mg ; methadone  40  mg ; methadone  20  mg ; bisacodyl  10  mg ; levothyroxine sodium  75  mcg ; ketorolac  15-30  mg ; gabapentin  100  mg ; naloxone  0.4  mg ; flumazenil  0.2  mg ; 
other convulsions other encephalopathy migraine, unspecified, without mention of intractable migraine without mention of status migrainosus unspecified acquired hypothyroidism obstructive chronic bronchitis with (acute) exacerbation opioid type dependence, unspecified depressive disorder, not elsewhere classified 
black african american f 53 $nan$hematology blood hematocrit  32.1  %; hematology blood hemoglobin  10.8  g dl; hematology blood platelet count  102  k ul; chemistry blood anion gap  12  meq l; chemistry blood bicarbonate  25  meq l; chemistry blood chloride  106  meq l; chemistry blood creatinine  0.9  mg dl; chemistry blood potassium  4.3  meq l; chemistry blood sodium  139  meq l; chemistry blood urea nitrogen  13  mg dl; hematology urine wbc  2  # hpf; chemistry blood calcium, total  7.9  mg dl; chemistry blood glucose  112  mg dl; blood gas blood lactate  2.4  mmol l; blood gas blood lactate  1.2  mmol l$fluoxetine  60  mg ; aspirin  81  mg ; tiotropium bromide  1  cap ; sodium chloride 0.9%  flush  3  ml ; acetaminophen  325-650  mg ; alprazolam  2  mg ; fluticasone-salmeterol diskus (250 50)   1  inh ; methadone  10  mg ; methadone  40  mg ; methadone  20  mg ; bisacodyl  10  mg ; ketorolac  15-30  mg ; gabapentin  100  mg ; naloxone  0.4  mg ; flumazenil  0.2  mg ; senna  1  tab ; docusate sodium  100  mg ; 0.9% sodium chloride  1000  ml ; iso-osmotic dextrose  200  ml ; vancomycin  1000  mg ; 0.9% sodium chloride (mini bag plus)  100  ml ; cefepime  2  g ; 5% dextrose  100  ml ; naloxone  2  mg ; bag  50  ml ; magnesium sulfate  2  gm ; lidocaine 5% patch  1  ptch ; acetaminophen  500-1000  mg ; heparin  5000  unit ; 
other convulsions other encephalopathy migraine, unspecified, without mention of intractable migraine without mention of status migrainosus unspecified acquired hypothyroidism obstructive chronic bronchitis with (acute) exacerbation opioid type dependence, unspecified depressive disorder, not elsewhere classified 
black african american f 53 $nan$hematology blood hematocrit  34.1  %; hematology blood hemoglobin  11.5  g dl; hematology blood platelet count  115  k ul; chemistry blood anion gap  11  meq l; chemistry blood bicarbonate  27  meq l; chemistry blood chloride  109  meq l; chemistry blood creatinine  0.8  mg dl; chemistry blood potassium  4.0  meq l; chemistry blood sodium  143  meq l; chemistry blood urea nitrogen  12  mg dl; hematology blood inr(pt)  1.0  ; chemistry blood calcium, total  8.4  mg dl; chemistry blood glucose  91  mg dl$fluoxetine  60  mg ; aspirin  81  mg ; tiotropium bromide  1  cap ; sodium chloride 0.9%  flush  3  ml ; fluticasone-salmeterol diskus (250 50)   1  inh ; bisacodyl  10  mg ; ketorolac  15-30  mg ; gabapentin  100  mg ; senna  1  tab ; docusate sodium  100  mg ; 0.9% sodium chloride  1000  ml ; iso-osmotic dextrose  200  ml ; vancomycin  1000  mg ; 0.9% sodium chloride (mini bag plus)  100  ml ; cefepime  2  g ; 5% dextrose  100  ml ; naloxone  2  mg ; bag  50  ml ; magnesium sulfate  2  gm ; lidocaine 5% patch  1  ptch ; acetaminophen  500-1000  mg ; heparin  5000  unit ; 
other convulsions other encephalopathy migraine, unspecified, without mention of intractable migraine without mention of status migrainosus unspecified acquired hypothyroidism obstructive chronic bronchitis with (acute) exacerbation opioid type dependence, unspecified depressive disorder, not elsewhere classified 
black african american f 53 $nan$hematology blood hematocrit  33.7  %; hematology blood hemoglobin  11.4  g dl; hematology blood platelet count  106  k ul; chemistry blood anion gap  13  meq l; chemistry blood bicarbonate  27  meq l; chemistry blood chloride  106  meq l; chemistry blood creatinine  0.9  mg dl; chemistry blood potassium  4.2  meq l; chemistry blood sodium  142  meq l; chemistry blood urea nitrogen  15  mg dl; chemistry blood glucose  93  mg dl$fluoxetine  60  mg ; aspirin  81  mg ; tiotropium bromide  1  cap ; sodium chloride 0.9%  flush  3  ml ; fluticasone-salmeterol diskus (250 50)   1  inh ; bisacodyl  10  mg ; ketorolac  15-30  mg ; gabapentin  100  mg ; senna  1  tab ; docusate sodium  100  mg ; 5% dextrose  100  ml ; naloxone  2  mg ; lidocaine 5% patch  1  ptch ; acetaminophen  500-1000  mg ; heparin  5000  unit ; alprazolam  1  mg ; 
other convulsions other encephalopathy migraine, unspecified, without mention of intractable migraine without mention of status migrainosus unspecified acquired hypothyroidism obstructive chronic bronchitis with (acute) exacerbation opioid type dependence, unspecified depressive disorder, not elsewhere classified 
black african american f 53 $nan$hematology blood hematocrit  36.1  %; hematology blood hemoglobin  12.3  g dl; hematology blood platelet count  123  k ul; chemistry blood anion gap  12  meq l; chemistry blood bicarbonate  28  meq l; chemistry blood chloride  106  meq l; chemistry blood creatinine  0.8  mg dl; chemistry blood potassium  4.2  meq l; chemistry blood sodium  142  meq l; chemistry blood urea nitrogen  11  mg dl; chemistry blood glucose  84  mg dl$fluoxetine  60  mg ; aspirin  81  mg ; tiotropium bromide  1  cap ; sodium chloride 0.9%  flush  3  ml ; fluticasone-salmeterol diskus (250 50)   1  inh ; bisacodyl  10  mg ; gabapentin  100  mg ; senna  1  tab ; docusate sodium  100  mg ; lidocaine 5% patch  1  ptch ; acetaminophen  500-1000  mg ; heparin  5000  unit ; alprazolam  1  mg ; alprazolam  0.5  mg ; heparin flush (10 units ml)  2  ml ; 
other convulsions other encephalopathy migraine, unspecified, without mention of intractable migraine without mention of status migrainosus unspecified acquired hypothyroidism obstructive chronic bronchitis with (acute) exacerbation opioid type dependence, unspecified depressive disorder, not elsewhere classified 
black african american f 53 $nan$hematology blood hematocrit  32.2  %; hematology blood hemoglobin  11.0  g dl; hematology blood platelet count  111  k ul$fluoxetine  60  mg ; aspirin  81  mg ; tiotropium bromide  1  cap ; sodium chloride 0.9%  flush  3  ml ; fluticasone-salmeterol diskus (250 50)   1  inh ; bisacodyl  10  mg ; gabapentin  100  mg ; senna  1  tab ; docusate sodium  100  mg ; lidocaine 5% patch  1  ptch ; acetaminophen  500-1000  mg ; heparin  5000  unit ; alprazolam  0.5  mg ; heparin flush (10 units ml)  2  ml ; methadone  30  mg ; 
other convulsions other encephalopathy migraine, unspecified, without mention of intractable migraine without mention of status migrainosus unspecified acquired hypothyroidism obstructive chronic bronchitis with (acute) exacerbation opioid type dependence, unspecified depressive disorder, not elsewhere classified 
black african american f 53 $nan$nan$fluoxetine  60  mg ; aspirin  81  mg ; tiotropium bromide  1  cap ; sodium chloride 0.9%  flush  3  ml ; fluticasone-salmeterol diskus (250 50)   1  inh ; bisacodyl  10  mg ; gabapentin  100  mg ; senna  1  tab ; docusate sodium  100  mg ; lidocaine 5% patch  1  ptch ; acetaminophen  500-1000  mg ; heparin  5000  unit ; alprazolam  0.5  mg ; heparin flush (10 units ml)  2  ml ; methadone  30  mg ; 
other convulsions other encephalopathy migraine, unspecified, without mention of intractable migraine without mention of status migrainosus unspecified acquired hypothyroidism obstructive chronic bronchitis with (acute) exacerbation opioid type dependence, unspecified depressive disorder, not elsewhere classified 
white m 57 $nan$hematology blood hematocrit  31.0  %; hematology blood hemoglobin  10.8  g dl; hematology blood platelet count  202  k ul; chemistry blood anion gap  12  meq l; chemistry blood bicarbonate  23  meq l; chemistry blood chloride  104  meq l; chemistry blood creatinine  1.1  mg dl; chemistry blood potassium  3.2  meq l; chemistry blood sodium  136  meq l; chemistry blood urea nitrogen  16  mg dl; hematology blood inr(pt)  1.0  ; chemistry blood calcium, total  8.2  mg dl; chemistry blood glucose  107  mg dl$sodium chloride 0.9%  1000  ml ; hydralazine  10-20  mg ; ondansetron  4  mg ; bisacodyl  10  mg ; morphine sulfate  1-5  mg ; oxycodone (immediate release)   5-10  mg ; acetaminophen  325-650  mg ; iso-osmotic sodium chloride  1  bag ; famotidine  20  mg ; bag  1  bag ; magnesium sulfate  2  gm ; potassium chloride  40  meq ; sw  200  ml ; potassium chloride  20  meq ; docusate sodium  100  mg ; aspirin  325  mg ; clopidogrel  75  mg ; amlodipine  10  mg ; atenolol  100  mg ; 
tobacco use disorder subarachnoid hemorrhage unspecified essential hypertension 
white m 57 $nan$nan$sodium chloride 0.9%  1000  ml ; hydralazine  10-20  mg ; ondansetron  4  mg ; bisacodyl  10  mg ; morphine sulfate  1-5  mg ; oxycodone (immediate release)   5-10  mg ; acetaminophen  325-650  mg ; iso-osmotic sodium chloride  1  bag ; famotidine  20  mg ; bag  1  bag ; magnesium sulfate  2  gm ; potassium chloride  40  meq ; sw  200  ml ; potassium chloride  20  meq ; docusate sodium  100  mg ; aspirin  325  mg ; clopidogrel  75  mg ; amlodipine  10  mg ; atenolol  100  mg ; magnesium oxide  400  mg ; senna  17.2  mg ; 
tobacco use disorder subarachnoid hemorrhage unspecified essential hypertension 
white f 57 $nan$nan$furosemide  20  mg ; simvastatin  80  mg ; warfarin  5  mg ; 
 
white f 57 $nan$hematology blood hematocrit  37.4  %; hematology blood hemoglobin  12.7  g dl; hematology blood platelet count  339  k ul; chemistry blood anion gap  12  meq l; chemistry blood bicarbonate  28  meq l; chemistry blood chloride  104  meq l; chemistry blood creatinine  0.6  mg dl; chemistry blood potassium  3.8  meq l; chemistry blood sodium  140  meq l; chemistry blood urea nitrogen  11  mg dl; hematology blood inr(pt)  1.0  ; chemistry blood calcium, total  9.7  mg dl; chemistry blood glucose  107  mg dl$furosemide  20  mg ; simvastatin  80  mg ; warfarin  5  mg ; influenza virus vaccine  0.5  ml ; sodium chloride 0.9%  flush  3  ml ; ranitidine  150  mg ; sertraline  50  mg ; docusate sodium  200  mg ; enoxaparin sodium  80  mg ; hydrocodone-acetaminophen  1-2  tab ; pantoprazole  40  mg ; zolpidem tartrate  5  mg ; potassium chloride  20  meq ; ibuprofen  600  mg ; 
 
white f 57 $nan$nan$furosemide  20  mg ; simvastatin  80  mg ; warfarin  5  mg ; influenza virus vaccine  0.5  ml ; sodium chloride 0.9%  flush  3  ml ; ranitidine  150  mg ; sertraline  50  mg ; docusate sodium  200  mg ; enoxaparin sodium  80  mg ; hydrocodone-acetaminophen  1-2  tab ; zolpidem tartrate  5  mg ; potassium chloride  20  meq ; ibuprofen  600  mg ; 
 
white m 60 $nan$hematology blood hematocrit  30.6  %; hematology blood hemoglobin  10.3  g dl; hematology blood platelet count  109  k ul; chemistry blood anion gap  11  meq l; chemistry blood bicarbonate  26  meq l; chemistry blood chloride  108  meq l; chemistry blood creatinine  1.0  mg dl; chemistry blood potassium  4.0  meq l; chemistry blood sodium  141  meq l; chemistry blood urea nitrogen  18  mg dl; chemistry blood calcium, total  8.3  mg dl; chemistry blood glucose  81  mg dl$sodium chloride 0.9%  flush  3  ml ; lr  1000  ml ; ondansetron  8  mg ; metoclopramide  10  mg ; vial  1  vial ; pantoprazole  40  mg ; hydromorphone (dilaudid)  0.25  mg ; hydromorphone (dilaudid)  0.5  mg ; magnesium sulfate  2  gm ; 
other specified gastritis, without mention of hemorrhage other postprocedural status personal history of peptic ulcer disease personal history of urinary calculi anxiety state, unspecified shoulder joint replacement edema personal history of peptic ulcer disease abdominal pain, epigastric nausea with vomiting atrial fibrillation personal history of urinary calculi car passenger injured in collision with sport utility vehicle in traffic accident other specified retention of urine dehydration constipation, unspecified bariatric surgery status anorexia personal history of peptic ulcer disease abdominal pain, epigastric dehydration other postprocedural status intestinal bypass or anastomosis status acute gastritis, without mention of hemorrhage unspecified car occupant injured in collision with railway train or railway vehicle in nontraffic accident nausea alone dehydration personal history of urinary calculi intestinal bypass or anastomosis status car passenger injured in collision with sport utility vehicle in traffic accident shoulder joint replacement chronic or unspecified duodenal ulcer with hemorrhage, without mention of obstruction anxiety state, unspecified other acute postoperative pain other specified diseases of pancreas unspecified car occupant injured in collision with railway train or railway vehicle in nontraffic accident constipation, unspecified unspecified gastritis and gastroduodenitis, without mention of hemorrhage duodenal ulcer, unspecified as acute or chronic, without hemorrhage or perforation, without mention of obstruction other specified agents primarily affecting the gastro-intestinal system causing adverse effects in therapeutic use leukocytopenia, unspecified other postprocedural status eosinophilia anomalies of pancreas unspecified analgesic and antipyretic causing adverse effects in therapeutic use chronic or unspecified duodenal ulcer with hemorrhage, without mention of obstruction long-term (current) use of anticoagulants atrial fibrillation
white m 60 $nan$nan$sodium chloride 0.9%  flush  3  ml ; lr  1000  ml ; ondansetron  8  mg ; metoclopramide  10  mg ; vial  1  vial ; pantoprazole  40  mg ; hydromorphone (dilaudid)  0.5  mg ; magnesium sulfate  2  gm ; ondansetron  4  mg ; sucralfate  1  gm ; 
other specified gastritis, without mention of hemorrhage other postprocedural status personal history of peptic ulcer disease personal history of urinary calculi anxiety state, unspecified shoulder joint replacement edema personal history of peptic ulcer disease abdominal pain, epigastric nausea with vomiting atrial fibrillation personal history of urinary calculi car passenger injured in collision with sport utility vehicle in traffic accident other specified retention of urine dehydration constipation, unspecified bariatric surgery status anorexia personal history of peptic ulcer disease abdominal pain, epigastric dehydration other postprocedural status intestinal bypass or anastomosis status acute gastritis, without mention of hemorrhage unspecified car occupant injured in collision with railway train or railway vehicle in nontraffic accident nausea alone dehydration personal history of urinary calculi intestinal bypass or anastomosis status car passenger injured in collision with sport utility vehicle in traffic accident shoulder joint replacement chronic or unspecified duodenal ulcer with hemorrhage, without mention of obstruction anxiety state, unspecified other acute postoperative pain other specified diseases of pancreas unspecified car occupant injured in collision with railway train or railway vehicle in nontraffic accident constipation, unspecified unspecified gastritis and gastroduodenitis, without mention of hemorrhage duodenal ulcer, unspecified as acute or chronic, without hemorrhage or perforation, without mention of obstruction other specified agents primarily affecting the gastro-intestinal system causing adverse effects in therapeutic use leukocytopenia, unspecified other postprocedural status eosinophilia anomalies of pancreas unspecified analgesic and antipyretic causing adverse effects in therapeutic use chronic or unspecified duodenal ulcer with hemorrhage, without mention of obstruction long-term (current) use of anticoagulants atrial fibrillation
white m 60 $nan$nan$sodium chloride 0.9%  flush  3  ml ; lr  1000  ml ; ondansetron  8  mg ; metoclopramide  10  mg ; vial  1  vial ; pantoprazole  40  mg ; sucralfate  1  gm ; 
other specified gastritis, without mention of hemorrhage other postprocedural status personal history of peptic ulcer disease personal history of urinary calculi anxiety state, unspecified shoulder joint replacement edema personal history of peptic ulcer disease abdominal pain, epigastric nausea with vomiting atrial fibrillation personal history of urinary calculi car passenger injured in collision with sport utility vehicle in traffic accident other specified retention of urine dehydration constipation, unspecified bariatric surgery status anorexia personal history of peptic ulcer disease abdominal pain, epigastric dehydration other postprocedural status intestinal bypass or anastomosis status acute gastritis, without mention of hemorrhage unspecified car occupant injured in collision with railway train or railway vehicle in nontraffic accident nausea alone dehydration personal history of urinary calculi intestinal bypass or anastomosis status car passenger injured in collision with sport utility vehicle in traffic accident shoulder joint replacement chronic or unspecified duodenal ulcer with hemorrhage, without mention of obstruction anxiety state, unspecified other acute postoperative pain other specified diseases of pancreas unspecified car occupant injured in collision with railway train or railway vehicle in nontraffic accident constipation, unspecified unspecified gastritis and gastroduodenitis, without mention of hemorrhage duodenal ulcer, unspecified as acute or chronic, without hemorrhage or perforation, without mention of obstruction other specified agents primarily affecting the gastro-intestinal system causing adverse effects in therapeutic use leukocytopenia, unspecified other postprocedural status eosinophilia anomalies of pancreas unspecified analgesic and antipyretic causing adverse effects in therapeutic use chronic or unspecified duodenal ulcer with hemorrhage, without mention of obstruction long-term (current) use of anticoagulants atrial fibrillation
white f 42 $temp  98.4  heartrate  79.0  resprate  18.0  o2sat  99.0  sbp  111.0  dbp  69.0  rhythm    pain  0  $hematology blood hematocrit  21.4  %; hematology blood hemoglobin  7.2  g dl; hematology blood platelet count  158  k ul; chemistry blood anion gap  9  meq l; chemistry blood bicarbonate  26  meq l; chemistry blood chloride  106  meq l; chemistry blood creatinine  0.6  mg dl; chemistry blood potassium  3.6  meq l; chemistry blood sodium  137  meq l; chemistry blood urea nitrogen  6  mg dl; chemistry blood calcium, total  8.3  mg dl; chemistry blood bilirubin, total  0.4  mg dl; chemistry blood glucose  100  mg dl; chemistry blood lactate dehydrogenase (ld)  120  iu l; chemistry blood albumin  3.9  g dl; hematology blood bands  3  %$sodium chloride 0.9%  flush  3  ml ; acetaminophen  325-650  mg ; docusate sodium  100  mg ; polyethylene glycol  17  g ; heparin flush (100 units ml)  5  ml ; sodium chloride 0.9%  1000  ml ; maalox diphenhydramine lidocaine  15  ml ; vial  1  vial ; filgrastim  480  mcg ; 300 mcg vial  1  vial ; filgrastim  300  mcg ; 0.9% sodium chloride (mini bag plus)  2  bag ; cefepime  2  g ; heparin  5000  unit ; heparin flush (10 units ml)  5  ml ; sodium chloride 0.9%  flush  10  ml ; iso-osmotic dextrose  200  ml ; vancomycin  1000  mg ; iso-osmotic dextrose  150  ml ; vancomycin  750  mg ; lorazepam  0.5  mg ; pantoprazole  40  mg ; 
personal history of malignant neoplasm of breast fever presenting with conditions classified elsewhere family history of malignant neoplasm of other organs or systems neutropenia, unspecified other secondary thrombocytopenia adverse effect of antineoplastic and immunosuppressive drugs, initial encounter anemia due to antineoplastic chemotherapy unspecified hemorrhoids constipation, unspecified unspecified place or not applicable
white f 42 $nan$hematology blood hematocrit  24.3  %; hematology blood hemoglobin  8.1  g dl; hematology blood platelet count  161  k ul; chemistry blood anion gap  11  meq l; chemistry blood bicarbonate  27  meq l; chemistry blood chloride  101  meq l; chemistry blood creatinine  0.6  mg dl; chemistry blood potassium  3.4  meq l; chemistry blood sodium  136  meq l; chemistry blood urea nitrogen  6  mg dl; hematology blood inr(pt)  1.1  ; chemistry blood calcium, total  9.0  mg dl; chemistry blood bilirubin, total  0.3  mg dl; chemistry blood glucose  78  mg dl; chemistry blood lactate dehydrogenase (ld)  150  iu l; chemistry blood albumin  4.1  g dl; hematology blood bands  5  %$acetaminophen  325-650  mg ; heparin flush (100 units ml)  5  ml ; maalox diphenhydramine lidocaine  15  ml ; 0.9% sodium chloride (mini bag plus)  2  bag ; cefepime  2  g ; heparin  5000  unit ; heparin flush (10 units ml)  5  ml ; sodium chloride 0.9%  flush  10  ml ; lorazepam  0.5  mg ; pantoprazole  40  mg ; acetaminophen iv  1000  mg ; penicillin g benzathine  1.2  million units ; 
personal history of malignant neoplasm of breast fever presenting with conditions classified elsewhere family history of malignant neoplasm of other organs or systems neutropenia, unspecified other secondary thrombocytopenia adverse effect of antineoplastic and immunosuppressive drugs, initial encounter anemia due to antineoplastic chemotherapy unspecified hemorrhoids constipation, unspecified unspecified place or not applicable
white f 42 $nan$hematology blood hematocrit  23.3  %; hematology blood hemoglobin  7.9  g dl; hematology blood platelet count  140  k ul; chemistry blood anion gap  14  meq l; chemistry blood bicarbonate  28  meq l; chemistry blood chloride  101  meq l; chemistry blood creatinine  0.6  mg dl; chemistry blood potassium  3.6  meq l; chemistry blood sodium  139  meq l; chemistry blood urea nitrogen  9  mg dl; chemistry blood calcium, total  9.3  mg dl; chemistry blood glucose  80  mg dl; hematology blood bands  1  %$acetaminophen  325-650  mg ; heparin flush (100 units ml)  5  ml ; maalox diphenhydramine lidocaine  15  ml ; heparin  5000  unit ; heparin flush (10 units ml)  5  ml ; sodium chloride 0.9%  flush  10  ml ; lorazepam  0.5  mg ; pantoprazole  40  mg ; acetaminophen iv  1000  mg ; penicillin g benzathine  1.2  million units ; 
personal history of malignant neoplasm of breast fever presenting with conditions classified elsewhere family history of malignant neoplasm of other organs or systems neutropenia, unspecified other secondary thrombocytopenia adverse effect of antineoplastic and immunosuppressive drugs, initial encounter anemia due to antineoplastic chemotherapy unspecified hemorrhoids constipation, unspecified unspecified place or not applicable
white m 30 $temp  97.6  heartrate  114.0  resprate  18.0  o2sat  98.0  sbp  153.0  dbp  101.0  rhythm    pain  0  ; temp    heartrate  113.0  resprate  17.0  o2sat  100.0  sbp  141.0  dbp  97.0  rhythm    pain  0  ; temp  98.7  heartrate  79.0  resprate  20.0  o2sat  98.0  sbp  126.0  dbp  87.0  rhythm    pain  8  ; temp  99.2  heartrate  93.0  resprate  20.0  o2sat  96.0  sbp  132.0  dbp  74.0  rhythm    pain    ; temp  98.8  heartrate  92.0  resprate  18.0  o2sat  97.0  sbp  128.0  dbp  79.0  rhythm    pain  6  ; temp  98.6  heartrate  88.0  resprate  16.0  o2sat  95.0  sbp  124.0  dbp  81.0  rhythm    pain  8  $hematology blood hematocrit  38.2  %; hematology blood hemoglobin  14.1  g dl; hematology blood platelet count  176  k ul; chemistry blood anion gap  21  meq l; chemistry blood bicarbonate  29  meq l; chemistry blood chloride  85  meq l; chemistry blood creatinine  0.8  mg dl; chemistry blood potassium  3.1  meq l; chemistry blood sodium  135  meq l; chemistry blood urea nitrogen  9  mg dl; hematology blood inr(pt)  1.2  ; hematology blood inr(pt)  1.3  ; chemistry blood bilirubin, indirect  2.3  mg dl; chemistry blood bilirubin, total  4.6  mg dl; chemistry blood glucose  137  mg dl; chemistry blood albumin  5.1  g dl; blood gas blood lactate  2.6  mmol l; chemistry blood bilirubin, direct  2.3  mg dl$polyethylene glycol  17  g ; 
attention-deficit hyperactivity disorder, unspecified type hypomagnesemia other specified abnormal findings of blood chemistry epilepsy, unspecified, not intractable, without status epilepticus proteinuria, unspecified acute kidney failure, unspecified other fall from one level to another in water transport injuring occupant of other watercraft -- crew anxiety disorder, unspecified body mass index (bmi) 32.0-32.9, adult hypokalemia chronic cholecystitis thrombocytopenia, unspecified viral intestinal infection, unspecified obesity, unspecified cannabis abuse, unspecified nonspecific elevation of levels of transaminase or lactic acid dehydrogenase [ldh] dysthymic disorder 
white m 30 $temp    heartrate  82.0  resprate  16.0  o2sat  99.0  sbp  122.0  dbp  85.0  rhythm    pain  5  $hematology blood hematocrit  32.9  %; hematology blood hematocrit  33.3  %; hematology blood hemoglobin  12.1  g dl; hematology blood hemoglobin  12.3  g dl; hematology blood platelet count  129  k ul; hematology blood platelet count  127  k ul; chemistry blood anion gap  20  meq l; chemistry blood anion gap  15  meq l; chemistry blood bicarbonate  30  meq l; chemistry blood bicarbonate  29  meq l; chemistry blood chloride  90  meq l; chemistry blood chloride  96  meq l; chemistry blood creatinine  0.7  mg dl; chemistry blood creatinine  0.8  mg dl; chemistry blood potassium  3.4  meq l; chemistry blood potassium  3.5  meq l; chemistry blood sodium  140  meq l; chemistry blood sodium  140  meq l; chemistry blood urea nitrogen  7  mg dl; chemistry blood urea nitrogen  6  mg dl; hematology blood inr(pt)  1.3  ; hematology blood inr(pt)  1.2  ; chemistry blood bilirubin, indirect  1.5  mg dl; chemistry blood bilirubin, total  3.9  mg dl; chemistry blood bilirubin, total  3.6  mg dl; chemistry blood glucose  100  mg dl; chemistry blood glucose  143  mg dl; chemistry blood lactate dehydrogenase (ld)  277  iu l; chemistry blood bilirubin, direct  2.1  mg dl$polyethylene glycol  17  g ; clonazepam  0.5  mg ; oxycodone (immediate release)  5  mg ; sodium chloride 0.9%  flush  3-10  ml ; heparin  5000  unit ; dextroamphetamine  10  mg ; levetiracetam  500  mg ; multivitamins  1  tab ; senna  8.6  mg ; potassium chloride  60  meq ; acetaminophen  650  mg ; ondansetron  4  mg ; 
attention-deficit hyperactivity disorder, unspecified type hypomagnesemia other specified abnormal findings of blood chemistry epilepsy, unspecified, not intractable, without status epilepticus proteinuria, unspecified acute kidney failure, unspecified other fall from one level to another in water transport injuring occupant of other watercraft -- crew anxiety disorder, unspecified body mass index (bmi) 32.0-32.9, adult hypokalemia chronic cholecystitis thrombocytopenia, unspecified viral intestinal infection, unspecified obesity, unspecified cannabis abuse, unspecified nonspecific elevation of levels of transaminase or lactic acid dehydrogenase [ldh] dysthymic disorder 
white m 30 $nan$hematology blood hematocrit  35.2  %; hematology blood hemoglobin  12.6  g dl; hematology blood platelet count  157  k ul; chemistry blood anion gap  17  meq l; chemistry blood bicarbonate  27  meq l; chemistry blood chloride  97  meq l; chemistry blood creatinine  0.8  mg dl; chemistry blood potassium  3.7  meq l; chemistry blood sodium  141  meq l; chemistry blood urea nitrogen  6  mg dl; hematology blood inr(pt)  1.2  ; chemistry blood bilirubin, indirect  1.3  mg dl; chemistry blood bilirubin, total  3.0  mg dl; chemistry blood glucose  90  mg dl; chemistry blood bilirubin, direct  1.7  mg dl$polyethylene glycol  17  g ; clonazepam  0.5  mg ; oxycodone (immediate release)  5  mg ; sodium chloride 0.9%  flush  3-10  ml ; heparin  5000  unit ; dextroamphetamine  10  mg ; levetiracetam  500  mg ; multivitamins  1  tab ; senna  8.6  mg ; potassium chloride  60  meq ; acetaminophen  650  mg ; ondansetron  4  mg ; 
attention-deficit hyperactivity disorder, unspecified type hypomagnesemia other specified abnormal findings of blood chemistry epilepsy, unspecified, not intractable, without status epilepticus proteinuria, unspecified acute kidney failure, unspecified other fall from one level to another in water transport injuring occupant of other watercraft -- crew anxiety disorder, unspecified body mass index (bmi) 32.0-32.9, adult hypokalemia chronic cholecystitis thrombocytopenia, unspecified viral intestinal infection, unspecified obesity, unspecified cannabis abuse, unspecified nonspecific elevation of levels of transaminase or lactic acid dehydrogenase [ldh] dysthymic disorder 
white m 30 $nan$nan$polyethylene glycol  17  g ; clonazepam  0.5  mg ; oxycodone (immediate release)  5  mg ; sodium chloride 0.9%  flush  3-10  ml ; heparin  5000  unit ; dextroamphetamine  10  mg ; levetiracetam  500  mg ; multivitamins  1  tab ; senna  8.6  mg ; acetaminophen  650  mg ; ondansetron  4  mg ; 
attention-deficit hyperactivity disorder, unspecified type hypomagnesemia other specified abnormal findings of blood chemistry epilepsy, unspecified, not intractable, without status epilepticus proteinuria, unspecified acute kidney failure, unspecified other fall from one level to another in water transport injuring occupant of other watercraft -- crew anxiety disorder, unspecified body mass index (bmi) 32.0-32.9, adult hypokalemia chronic cholecystitis thrombocytopenia, unspecified viral intestinal infection, unspecified obesity, unspecified cannabis abuse, unspecified nonspecific elevation of levels of transaminase or lactic acid dehydrogenase [ldh] dysthymic disorder 
white f 21 $nan$hematology blood hematocrit  37.2  %; hematology blood hemoglobin  12.6  g dl; hematology blood platelet count  237  k ul; chemistry blood anion gap  17  meq l; chemistry blood bicarbonate  24  meq l; chemistry blood chloride  105  meq l; chemistry blood creatinine  0.6  mg dl; chemistry blood potassium  3.7  meq l; chemistry blood sodium  142  meq l; chemistry blood urea nitrogen  3  mg dl; chemistry blood glucose  89  mg dl; hematology urine glucose  neg  mg dl; hematology urine glucose  neg  mg dl; hematology urine bilirubin  neg  mg dl; hematology urine bilirubin  neg  mg dl$nan
 
white f 21 $nan$chemistry blood bilirubin, total  0.6  mg dl; chemistry blood lactate dehydrogenase (ld)  116  iu l; chemistry blood albumin  3.9  g dl$influenza virus vaccine  0.5  ml ; heparin  5000  unit ; 0.9% sodium chloride  1000  ml ; ondansetron  4  mg ; lorazepam  0.5  mg ; vial  1  vial ; pantoprazole  40  mg ; dextrose 50%  12.5  gm ; glucagon  1  mg ; ondansetron odt  4  mg ; insulin  0  unit ; hydrocodone-acetaminophen  1-2  tab ; morphine sulfate  2  mg ; insulin  6  unit ; milk of magnesia  30  ml ; senna  1  tab ; docusate sodium  100  mg ; 
 
white f 21 $nan$nan$influenza virus vaccine  0.5  ml ; heparin  5000  unit ; ondansetron  4  mg ; lorazepam  0.5  mg ; vial  1  vial ; pantoprazole  40  mg ; dextrose 50%  12.5  gm ; glucagon  1  mg ; ondansetron odt  4  mg ; insulin  0  unit ; hydrocodone-acetaminophen  1-2  tab ; morphine sulfate  2  mg ; insulin  6  unit ; milk of magnesia  30  ml ; senna  1  tab ; docusate sodium  100  mg ; 
 
white f 51 $temp  98.3  heartrate  81.0  resprate  18.0  o2sat  95.0  sbp  133.0  dbp  71.0  rhythm    pain  6  $hematology blood hematocrit  28.0  %; hematology blood hemoglobin  8.3  g dl; hematology blood platelet count  398  k ul; chemistry blood anion gap  14  meq l; chemistry blood bicarbonate  25  meq l; chemistry blood chloride  102  meq l; chemistry blood creatinine  1.6  mg dl; chemistry blood potassium  4.1  meq l; chemistry blood sodium  137  meq l; chemistry blood urea nitrogen  37  mg dl; hematology blood inr(pt)  2.5  ; hematology blood inr(pt)  2.5  ; chemistry blood calcium, total  8.2  mg dl; chemistry blood glucose  96  mg dl$insulin  20  unit ; iso-osmotic dextrose  100  ml ; piperacillin-tazobactam  4.5  g ; acetaminophen  650  mg ; albuterol 0.083% neb soln  1  neb ; aspirin  81  mg ; atorvastatin  80  mg ; bethanechol  50  mg ; cyanocobalamin  500  mcg ; docusate sodium  200  mg ; furosemide  40  mg ; gabapentin  300  mg ; levothyroxine sodium  25  mcg ; metoprolol succinate xl  12.5  mg ; nephrocaps  1  cap ; pantoprazole  40  mg ; dextrose 50%  12.5  gm ; glucagon  1  mg ; glucose gel  15  g ; insulin  0  unit ; senna  8.6  mg ; sodium chloride 0.9%  flush  10  ml ; iso-osmotic dextrose  200  ml ; vancomycin  1000  mg ; tramadol (ultram)  50  mg ; warfarin  2  mg ; ciprofloxacin 0.3% ophth soln  3  drop ; 
nephritis and nephropathy, not specified as acute or chronic, in diseases classified elsewhere long-term (current) use of insulin congestive heart failure, unspecified gastroparesis long-term (current) use of anticoagulants pure hypercholesterolemia long-term (current) use of aspirin aortocoronary bypass status heart valve replaced by transplant coronary atherosclerosis of unspecified type of vessel, native or graft peripheral autonomic neuropathy in disorders classified elsewhere end stage renal disease diabetes with ophthalmic manifestations, type i [juvenile type], not stated as uncontrolled anemia in chronic kidney disease diabetes with renal manifestations, type i [juvenile type], not stated as uncontrolled person on outside of car injured in collision with two- or three-wheeled motor vehicle in nontraffic accident renal dialysis status hypertensive chronic kidney disease, unspecified, with chronic kidney disease stage v or end stage renal disease acute kidney failure with lesion of tubular necrosis background diabetic retinopathy diabetes with neurological manifestations, type i [juvenile type], not stated as uncontrolled profound impairment, one eye, impairment level not further specified esophageal reflux ulcer of heel and midfoot arthropathy associated with neurological disorders cardiac complications, not elsewhere classified heparin-induced thrombocytopenia (hit) hypertensive chronic kidney disease, unspecified, with chronic kidney disease stage i through stage iv, or unspecified mitral valve disorders peripheral autonomic neuropathy in disorders classified elsewhere background diabetic retinopathy acute on chronic diastolic heart failure cardiogenic shock other and unspecified hyperlipidemia long-term (current) use of insulin leukocytosis, unspecified gastroparesis congestive heart failure, unspecified other pulmonary insufficiency, not elsewhere classified, following trauma and surgery coronary atherosclerosis of native coronary artery rupture of chordae tendineae diabetes with neurological manifestations, type i [juvenile type], not stated as uncontrolled diabetes with ophthalmic manifestations, type i [juvenile type], not stated as uncontrolled acute kidney failure with lesion of tubular necrosis chronic kidney disease, unspecified nephritis and nephropathy, not specified as acute or chronic, in diseases classified elsewhere diabetes with renal manifestations, type i [juvenile type], not stated as uncontrolled other second degree atrioventricular block
white f 51 $nan$hematology blood hematocrit  26.4  %; hematology blood hemoglobin  7.9  g dl; hematology blood platelet count  404  k ul; chemistry blood anion gap  16  meq l; chemistry blood anion gap  19  meq l; chemistry blood bicarbonate  25  meq l; chemistry blood bicarbonate  21  meq l; chemistry blood chloride  99  meq l; chemistry blood chloride  95  meq l; chemistry blood creatinine  2.0  mg dl; chemistry blood creatinine  2.4  mg dl; chemistry blood potassium  4.4  meq l; chemistry blood potassium  4.2  meq l; chemistry blood sodium  136  meq l; chemistry blood sodium  131  meq l; chemistry blood urea nitrogen  42  mg dl; chemistry blood urea nitrogen  42  mg dl; hematology blood inr(pt)  2.7  ; chemistry urine chloride, urine  55  meq l; chemistry urine creatinine, urine  72  mg dl; chemistry urine potassium, urine  59  meq l; chemistry urine sodium, urine  63  meq l; chemistry urine urea nitrogen, urine  142  mg dl; chemistry blood calcium, total  8.3  mg dl; chemistry blood calcium, total  8.2  mg dl; chemistry blood glucose  244  mg dl; chemistry blood glucose  205  mg dl$iso-osmotic dextrose  100  ml ; piperacillin-tazobactam  4.5  g ; acetaminophen  650  mg ; albuterol 0.083% neb soln  1  neb ; aspirin  81  mg ; atorvastatin  80  mg ; bethanechol  50  mg ; cyanocobalamin  500  mcg ; docusate sodium  200  mg ; furosemide  40  mg ; gabapentin  300  mg ; levothyroxine sodium  25  mcg ; metoprolol succinate xl  12.5  mg ; nephrocaps  1  cap ; pantoprazole  40  mg ; dextrose 50%  12.5  gm ; glucagon  1  mg ; glucose gel  15  g ; senna  8.6  mg ; sodium chloride 0.9%  flush  10  ml ; iso-osmotic dextrose  200  ml ; vancomycin  1000  mg ; tramadol (ultram)  50  mg ; warfarin  2  mg ; ciprofloxacin 0.3% ophth soln  3  drop ; 0.9% sodium chloride  500  ml ; 0.9% sodium chloride  1000  ml ; ondansetron  4  mg ; 
nephritis and nephropathy, not specified as acute or chronic, in diseases classified elsewhere long-term (current) use of insulin congestive heart failure, unspecified gastroparesis long-term (current) use of anticoagulants pure hypercholesterolemia long-term (current) use of aspirin aortocoronary bypass status heart valve replaced by transplant coronary atherosclerosis of unspecified type of vessel, native or graft peripheral autonomic neuropathy in disorders classified elsewhere end stage renal disease diabetes with ophthalmic manifestations, type i [juvenile type], not stated as uncontrolled anemia in chronic kidney disease diabetes with renal manifestations, type i [juvenile type], not stated as uncontrolled person on outside of car injured in collision with two- or three-wheeled motor vehicle in nontraffic accident renal dialysis status hypertensive chronic kidney disease, unspecified, with chronic kidney disease stage v or end stage renal disease acute kidney failure with lesion of tubular necrosis background diabetic retinopathy diabetes with neurological manifestations, type i [juvenile type], not stated as uncontrolled profound impairment, one eye, impairment level not further specified esophageal reflux ulcer of heel and midfoot arthropathy associated with neurological disorders cardiac complications, not elsewhere classified heparin-induced thrombocytopenia (hit) hypertensive chronic kidney disease, unspecified, with chronic kidney disease stage i through stage iv, or unspecified mitral valve disorders peripheral autonomic neuropathy in disorders classified elsewhere background diabetic retinopathy acute on chronic diastolic heart failure cardiogenic shock other and unspecified hyperlipidemia long-term (current) use of insulin leukocytosis, unspecified gastroparesis congestive heart failure, unspecified other pulmonary insufficiency, not elsewhere classified, following trauma and surgery coronary atherosclerosis of native coronary artery rupture of chordae tendineae diabetes with neurological manifestations, type i [juvenile type], not stated as uncontrolled diabetes with ophthalmic manifestations, type i [juvenile type], not stated as uncontrolled acute kidney failure with lesion of tubular necrosis chronic kidney disease, unspecified nephritis and nephropathy, not specified as acute or chronic, in diseases classified elsewhere diabetes with renal manifestations, type i [juvenile type], not stated as uncontrolled other second degree atrioventricular block
white f 51 $nan$hematology blood hematocrit  30.0  %; hematology blood hemoglobin  8.9  g dl; hematology blood platelet count  471  k ul; chemistry blood anion gap  19  meq l; chemistry blood anion gap  23  meq l; chemistry blood anion gap  19  meq l; chemistry blood bicarbonate  22  meq l; chemistry blood bicarbonate  22  meq l; chemistry blood bicarbonate  21  meq l; chemistry blood chloride  94  meq l; chemistry blood chloride  97  meq l; chemistry blood chloride  99  meq l; chemistry blood creatinine  2.5  mg dl; chemistry blood creatinine  3.0  mg dl; chemistry blood creatinine  3.1  mg dl; chemistry blood potassium  3.9  meq l; chemistry blood potassium  5.1  meq l; chemistry blood potassium  4.3  meq l; chemistry blood sodium  131  meq l; chemistry blood sodium  137  meq l; chemistry blood sodium  135  meq l; chemistry blood urea nitrogen  42  mg dl; chemistry blood urea nitrogen  44  mg dl; chemistry blood urea nitrogen  44  mg dl; hematology blood inr(pt)  3.4  ; chemistry blood calcium, total  8.1  mg dl; chemistry blood calcium, total  8.3  mg dl; chemistry blood calcium, total  8.2  mg dl; chemistry blood glucose  187  mg dl; chemistry blood glucose  105  mg dl; chemistry blood glucose  99  mg dl; chemistry blood albumin  2.8  g dl; blood gas blood lactate  1.4  mmol l$acetaminophen  650  mg ; albuterol 0.083% neb soln  1  neb ; aspirin  81  mg ; atorvastatin  80  mg ; bethanechol  50  mg ; cyanocobalamin  500  mcg ; docusate sodium  200  mg ; gabapentin  300  mg ; levothyroxine sodium  25  mcg ; metoprolol succinate xl  12.5  mg ; nephrocaps  1  cap ; pantoprazole  40  mg ; dextrose 50%  12.5  gm ; glucagon  1  mg ; glucose gel  15  g ; senna  8.6  mg ; sodium chloride 0.9%  flush  10  ml ; tramadol (ultram)  50  mg ; warfarin  2  mg ; ciprofloxacin 0.3% ophth soln  3  drop ; 0.9% sodium chloride  500  ml ; ondansetron  4  mg ; iso-osmotic dextrose  50  ml ; piperacillin-tazobactam  2.25  g ; insulin  5  unit ; vancomycin oral liquid  125  mg ; 
nephritis and nephropathy, not specified as acute or chronic, in diseases classified elsewhere long-term (current) use of insulin congestive heart failure, unspecified gastroparesis long-term (current) use of anticoagulants pure hypercholesterolemia long-term (current) use of aspirin aortocoronary bypass status heart valve replaced by transplant coronary atherosclerosis of unspecified type of vessel, native or graft peripheral autonomic neuropathy in disorders classified elsewhere end stage renal disease diabetes with ophthalmic manifestations, type i [juvenile type], not stated as uncontrolled anemia in chronic kidney disease diabetes with renal manifestations, type i [juvenile type], not stated as uncontrolled person on outside of car injured in collision with two- or three-wheeled motor vehicle in nontraffic accident renal dialysis status hypertensive chronic kidney disease, unspecified, with chronic kidney disease stage v or end stage renal disease acute kidney failure with lesion of tubular necrosis background diabetic retinopathy diabetes with neurological manifestations, type i [juvenile type], not stated as uncontrolled profound impairment, one eye, impairment level not further specified esophageal reflux ulcer of heel and midfoot arthropathy associated with neurological disorders cardiac complications, not elsewhere classified heparin-induced thrombocytopenia (hit) hypertensive chronic kidney disease, unspecified, with chronic kidney disease stage i through stage iv, or unspecified mitral valve disorders peripheral autonomic neuropathy in disorders classified elsewhere background diabetic retinopathy acute on chronic diastolic heart failure cardiogenic shock other and unspecified hyperlipidemia long-term (current) use of insulin leukocytosis, unspecified gastroparesis congestive heart failure, unspecified other pulmonary insufficiency, not elsewhere classified, following trauma and surgery coronary atherosclerosis of native coronary artery rupture of chordae tendineae diabetes with neurological manifestations, type i [juvenile type], not stated as uncontrolled diabetes with ophthalmic manifestations, type i [juvenile type], not stated as uncontrolled acute kidney failure with lesion of tubular necrosis chronic kidney disease, unspecified nephritis and nephropathy, not specified as acute or chronic, in diseases classified elsewhere diabetes with renal manifestations, type i [juvenile type], not stated as uncontrolled other second degree atrioventricular block
white f 51 $nan$hematology blood hematocrit  28.8  %; hematology blood hemoglobin  8.6  g dl; hematology blood platelet count  453  k ul; chemistry blood anion gap  22  meq l; chemistry blood bicarbonate  21  meq l; chemistry blood chloride  100  meq l; chemistry blood creatinine  3.4  mg dl; chemistry blood potassium  3.8  meq l; chemistry blood sodium  139  meq l; chemistry blood urea nitrogen  46  mg dl; hematology blood inr(pt)  4.2  ; chemistry urine creatinine, urine  162  mg dl; chemistry blood calcium, total  8.4  mg dl; chemistry blood glucose  89  mg dl; chemistry urine protein creatinine ratio  0.8  mg mg$acetaminophen  650  mg ; albuterol 0.083% neb soln  1  neb ; aspirin  81  mg ; atorvastatin  80  mg ; bethanechol  50  mg ; cyanocobalamin  500  mcg ; docusate sodium  200  mg ; gabapentin  300  mg ; levothyroxine sodium  25  mcg ; metoprolol succinate xl  12.5  mg ; nephrocaps  1  cap ; pantoprazole  40  mg ; dextrose 50%  12.5  gm ; glucagon  1  mg ; glucose gel  15  g ; senna  8.6  mg ; sodium chloride 0.9%  flush  10  ml ; tramadol (ultram)  50  mg ; ciprofloxacin 0.3% ophth soln  3  drop ; ondansetron  4  mg ; insulin  5  unit ; vancomycin oral liquid  125  mg ; sevelamer carbonate  1600  mg ; 
nephritis and nephropathy, not specified as acute or chronic, in diseases classified elsewhere long-term (current) use of insulin congestive heart failure, unspecified gastroparesis long-term (current) use of anticoagulants pure hypercholesterolemia long-term (current) use of aspirin aortocoronary bypass status heart valve replaced by transplant coronary atherosclerosis of unspecified type of vessel, native or graft peripheral autonomic neuropathy in disorders classified elsewhere end stage renal disease diabetes with ophthalmic manifestations, type i [juvenile type], not stated as uncontrolled anemia in chronic kidney disease diabetes with renal manifestations, type i [juvenile type], not stated as uncontrolled person on outside of car injured in collision with two- or three-wheeled motor vehicle in nontraffic accident renal dialysis status hypertensive chronic kidney disease, unspecified, with chronic kidney disease stage v or end stage renal disease acute kidney failure with lesion of tubular necrosis background diabetic retinopathy diabetes with neurological manifestations, type i [juvenile type], not stated as uncontrolled profound impairment, one eye, impairment level not further specified esophageal reflux ulcer of heel and midfoot arthropathy associated with neurological disorders cardiac complications, not elsewhere classified heparin-induced thrombocytopenia (hit) hypertensive chronic kidney disease, unspecified, with chronic kidney disease stage i through stage iv, or unspecified mitral valve disorders peripheral autonomic neuropathy in disorders classified elsewhere background diabetic retinopathy acute on chronic diastolic heart failure cardiogenic shock other and unspecified hyperlipidemia long-term (current) use of insulin leukocytosis, unspecified gastroparesis congestive heart failure, unspecified other pulmonary insufficiency, not elsewhere classified, following trauma and surgery coronary atherosclerosis of native coronary artery rupture of chordae tendineae diabetes with neurological manifestations, type i [juvenile type], not stated as uncontrolled diabetes with ophthalmic manifestations, type i [juvenile type], not stated as uncontrolled acute kidney failure with lesion of tubular necrosis chronic kidney disease, unspecified nephritis and nephropathy, not specified as acute or chronic, in diseases classified elsewhere diabetes with renal manifestations, type i [juvenile type], not stated as uncontrolled other second degree atrioventricular block
white f 51 $nan$hematology blood hematocrit  25.2  %; hematology blood hemoglobin  7.8  g dl; hematology blood platelet count  413  k ul; chemistry blood anion gap  17  meq l; chemistry blood bicarbonate  23  meq l; chemistry blood chloride  100  meq l; chemistry blood creatinine  3.0  mg dl; chemistry blood potassium  3.3  meq l; chemistry blood sodium  137  meq l; chemistry blood urea nitrogen  43  mg dl; hematology blood inr(pt)  3.6  ; chemistry blood calcium, total  8.0  mg dl; chemistry blood glucose  20  mg dl$acetaminophen  650  mg ; albuterol 0.083% neb soln  1  neb ; aspirin  81  mg ; atorvastatin  80  mg ; bethanechol  50  mg ; cyanocobalamin  500  mcg ; docusate sodium  200  mg ; gabapentin  300  mg ; levothyroxine sodium  25  mcg ; metoprolol succinate xl  12.5  mg ; nephrocaps  1  cap ; pantoprazole  40  mg ; dextrose 50%  12.5  gm ; glucagon  1  mg ; glucose gel  15  g ; senna  8.6  mg ; sodium chloride 0.9%  flush  10  ml ; tramadol (ultram)  50  mg ; ciprofloxacin 0.3% ophth soln  3  drop ; ondansetron  4  mg ; insulin  5  unit ; vancomycin oral liquid  125  mg ; sevelamer carbonate  1600  mg ; insulin  15  unit ; 
nephritis and nephropathy, not specified as acute or chronic, in diseases classified elsewhere long-term (current) use of insulin congestive heart failure, unspecified gastroparesis long-term (current) use of anticoagulants pure hypercholesterolemia long-term (current) use of aspirin aortocoronary bypass status heart valve replaced by transplant coronary atherosclerosis of unspecified type of vessel, native or graft peripheral autonomic neuropathy in disorders classified elsewhere end stage renal disease diabetes with ophthalmic manifestations, type i [juvenile type], not stated as uncontrolled anemia in chronic kidney disease diabetes with renal manifestations, type i [juvenile type], not stated as uncontrolled person on outside of car injured in collision with two- or three-wheeled motor vehicle in nontraffic accident renal dialysis status hypertensive chronic kidney disease, unspecified, with chronic kidney disease stage v or end stage renal disease acute kidney failure with lesion of tubular necrosis background diabetic retinopathy diabetes with neurological manifestations, type i [juvenile type], not stated as uncontrolled profound impairment, one eye, impairment level not further specified esophageal reflux ulcer of heel and midfoot arthropathy associated with neurological disorders cardiac complications, not elsewhere classified heparin-induced thrombocytopenia (hit) hypertensive chronic kidney disease, unspecified, with chronic kidney disease stage i through stage iv, or unspecified mitral valve disorders peripheral autonomic neuropathy in disorders classified elsewhere background diabetic retinopathy acute on chronic diastolic heart failure cardiogenic shock other and unspecified hyperlipidemia long-term (current) use of insulin leukocytosis, unspecified gastroparesis congestive heart failure, unspecified other pulmonary insufficiency, not elsewhere classified, following trauma and surgery coronary atherosclerosis of native coronary artery rupture of chordae tendineae diabetes with neurological manifestations, type i [juvenile type], not stated as uncontrolled diabetes with ophthalmic manifestations, type i [juvenile type], not stated as uncontrolled acute kidney failure with lesion of tubular necrosis chronic kidney disease, unspecified nephritis and nephropathy, not specified as acute or chronic, in diseases classified elsewhere diabetes with renal manifestations, type i [juvenile type], not stated as uncontrolled other second degree atrioventricular block
white f 51 $nan$hematology blood hematocrit  24.7  %; hematology blood hemoglobin  7.5  g dl; hematology blood platelet count  507  k ul; chemistry blood anion gap  17  meq l; chemistry blood bicarbonate  22  meq l; chemistry blood chloride  98  meq l; chemistry blood creatinine  2.4  mg dl; chemistry blood potassium  3.9  meq l; chemistry blood sodium  133  meq l; chemistry blood urea nitrogen  38  mg dl; hematology blood inr(pt)  2.8  ; hematology urine wbc  55  # hpf; chemistry blood calcium, total  7.6  mg dl; chemistry blood glucose  176  mg dl$acetaminophen  650  mg ; albuterol 0.083% neb soln  1  neb ; aspirin  81  mg ; atorvastatin  80  mg ; bethanechol  50  mg ; cyanocobalamin  500  mcg ; docusate sodium  200  mg ; gabapentin  300  mg ; levothyroxine sodium  25  mcg ; metoprolol succinate xl  12.5  mg ; nephrocaps  1  cap ; pantoprazole  40  mg ; dextrose 50%  12.5  gm ; glucagon  1  mg ; glucose gel  15  g ; senna  8.6  mg ; sodium chloride 0.9%  flush  10  ml ; tramadol (ultram)  50  mg ; ciprofloxacin 0.3% ophth soln  3  drop ; ondansetron  4  mg ; vancomycin oral liquid  125  mg ; sevelamer carbonate  1600  mg ; insulin  15  unit ; fluconazole  200  mg ; 
nephritis and nephropathy, not specified as acute or chronic, in diseases classified elsewhere long-term (current) use of insulin congestive heart failure, unspecified gastroparesis long-term (current) use of anticoagulants pure hypercholesterolemia long-term (current) use of aspirin aortocoronary bypass status heart valve replaced by transplant coronary atherosclerosis of unspecified type of vessel, native or graft peripheral autonomic neuropathy in disorders classified elsewhere end stage renal disease diabetes with ophthalmic manifestations, type i [juvenile type], not stated as uncontrolled anemia in chronic kidney disease diabetes with renal manifestations, type i [juvenile type], not stated as uncontrolled person on outside of car injured in collision with two- or three-wheeled motor vehicle in nontraffic accident renal dialysis status hypertensive chronic kidney disease, unspecified, with chronic kidney disease stage v or end stage renal disease acute kidney failure with lesion of tubular necrosis background diabetic retinopathy diabetes with neurological manifestations, type i [juvenile type], not stated as uncontrolled profound impairment, one eye, impairment level not further specified esophageal reflux ulcer of heel and midfoot arthropathy associated with neurological disorders cardiac complications, not elsewhere classified heparin-induced thrombocytopenia (hit) hypertensive chronic kidney disease, unspecified, with chronic kidney disease stage i through stage iv, or unspecified mitral valve disorders peripheral autonomic neuropathy in disorders classified elsewhere background diabetic retinopathy acute on chronic diastolic heart failure cardiogenic shock other and unspecified hyperlipidemia long-term (current) use of insulin leukocytosis, unspecified gastroparesis congestive heart failure, unspecified other pulmonary insufficiency, not elsewhere classified, following trauma and surgery coronary atherosclerosis of native coronary artery rupture of chordae tendineae diabetes with neurological manifestations, type i [juvenile type], not stated as uncontrolled diabetes with ophthalmic manifestations, type i [juvenile type], not stated as uncontrolled acute kidney failure with lesion of tubular necrosis chronic kidney disease, unspecified nephritis and nephropathy, not specified as acute or chronic, in diseases classified elsewhere diabetes with renal manifestations, type i [juvenile type], not stated as uncontrolled other second degree atrioventricular block
white f 51 $nan$hematology blood hematocrit  24.0  %; hematology blood hemoglobin  7.6  g dl; hematology blood platelet count  570  k ul; chemistry blood anion gap  15  meq l; chemistry blood bicarbonate  24  meq l; chemistry blood chloride  95  meq l; chemistry blood creatinine  1.8  mg dl; chemistry blood potassium  4.0  meq l; chemistry blood sodium  130  meq l; chemistry blood urea nitrogen  36  mg dl; hematology blood inr(pt)  1.8  ; hematology urine wbc  79  # hpf; chemistry blood calcium, total  8.1  mg dl; chemistry blood glucose  182  mg dl$acetaminophen  650  mg ; albuterol 0.083% neb soln  1  neb ; aspirin  81  mg ; atorvastatin  80  mg ; bethanechol  50  mg ; cyanocobalamin  500  mcg ; docusate sodium  200  mg ; gabapentin  300  mg ; levothyroxine sodium  25  mcg ; metoprolol succinate xl  12.5  mg ; nephrocaps  1  cap ; pantoprazole  40  mg ; dextrose 50%  12.5  gm ; glucagon  1  mg ; glucose gel  15  g ; senna  8.6  mg ; sodium chloride 0.9%  flush  10  ml ; tramadol (ultram)  50  mg ; ciprofloxacin 0.3% ophth soln  3  drop ; ondansetron  4  mg ; vancomycin oral liquid  125  mg ; sevelamer carbonate  1600  mg ; insulin  15  unit ; fluconazole  200  mg ; insulin  18  unit ; 
nephritis and nephropathy, not specified as acute or chronic, in diseases classified elsewhere long-term (current) use of insulin congestive heart failure, unspecified gastroparesis long-term (current) use of anticoagulants pure hypercholesterolemia long-term (current) use of aspirin aortocoronary bypass status heart valve replaced by transplant coronary atherosclerosis of unspecified type of vessel, native or graft peripheral autonomic neuropathy in disorders classified elsewhere end stage renal disease diabetes with ophthalmic manifestations, type i [juvenile type], not stated as uncontrolled anemia in chronic kidney disease diabetes with renal manifestations, type i [juvenile type], not stated as uncontrolled person on outside of car injured in collision with two- or three-wheeled motor vehicle in nontraffic accident renal dialysis status hypertensive chronic kidney disease, unspecified, with chronic kidney disease stage v or end stage renal disease acute kidney failure with lesion of tubular necrosis background diabetic retinopathy diabetes with neurological manifestations, type i [juvenile type], not stated as uncontrolled profound impairment, one eye, impairment level not further specified esophageal reflux ulcer of heel and midfoot arthropathy associated with neurological disorders cardiac complications, not elsewhere classified heparin-induced thrombocytopenia (hit) hypertensive chronic kidney disease, unspecified, with chronic kidney disease stage i through stage iv, or unspecified mitral valve disorders peripheral autonomic neuropathy in disorders classified elsewhere background diabetic retinopathy acute on chronic diastolic heart failure cardiogenic shock other and unspecified hyperlipidemia long-term (current) use of insulin leukocytosis, unspecified gastroparesis congestive heart failure, unspecified other pulmonary insufficiency, not elsewhere classified, following trauma and surgery coronary atherosclerosis of native coronary artery rupture of chordae tendineae diabetes with neurological manifestations, type i [juvenile type], not stated as uncontrolled diabetes with ophthalmic manifestations, type i [juvenile type], not stated as uncontrolled acute kidney failure with lesion of tubular necrosis chronic kidney disease, unspecified nephritis and nephropathy, not specified as acute or chronic, in diseases classified elsewhere diabetes with renal manifestations, type i [juvenile type], not stated as uncontrolled other second degree atrioventricular block
white f 51 $nan$hematology blood hematocrit  25.7  %; hematology blood hemoglobin  7.8  g dl; hematology blood platelet count  681  k ul; chemistry blood anion gap  13  meq l; chemistry blood bicarbonate  25  meq l; chemistry blood chloride  98  meq l; chemistry blood creatinine  1.5  mg dl; chemistry blood potassium  4.2  meq l; chemistry blood sodium  132  meq l; chemistry blood urea nitrogen  33  mg dl; hematology blood inr(pt)  1.8  ; chemistry blood calcium, total  8.2  mg dl; chemistry blood glucose  213  mg dl$acetaminophen  650  mg ; albuterol 0.083% neb soln  1  neb ; aspirin  81  mg ; atorvastatin  80  mg ; bethanechol  50  mg ; cyanocobalamin  500  mcg ; docusate sodium  200  mg ; gabapentin  300  mg ; levothyroxine sodium  25  mcg ; metoprolol succinate xl  12.5  mg ; nephrocaps  1  cap ; pantoprazole  40  mg ; dextrose 50%  12.5  gm ; glucagon  1  mg ; glucose gel  15  g ; senna  8.6  mg ; sodium chloride 0.9%  flush  10  ml ; tramadol (ultram)  50  mg ; ciprofloxacin 0.3% ophth soln  3  drop ; ondansetron  4  mg ; vancomycin oral liquid  125  mg ; sevelamer carbonate  1600  mg ; insulin  18  unit ; warfarin  1  mg ; 
nephritis and nephropathy, not specified as acute or chronic, in diseases classified elsewhere long-term (current) use of insulin congestive heart failure, unspecified gastroparesis long-term (current) use of anticoagulants pure hypercholesterolemia long-term (current) use of aspirin aortocoronary bypass status heart valve replaced by transplant coronary atherosclerosis of unspecified type of vessel, native or graft peripheral autonomic neuropathy in disorders classified elsewhere end stage renal disease diabetes with ophthalmic manifestations, type i [juvenile type], not stated as uncontrolled anemia in chronic kidney disease diabetes with renal manifestations, type i [juvenile type], not stated as uncontrolled person on outside of car injured in collision with two- or three-wheeled motor vehicle in nontraffic accident renal dialysis status hypertensive chronic kidney disease, unspecified, with chronic kidney disease stage v or end stage renal disease acute kidney failure with lesion of tubular necrosis background diabetic retinopathy diabetes with neurological manifestations, type i [juvenile type], not stated as uncontrolled profound impairment, one eye, impairment level not further specified esophageal reflux ulcer of heel and midfoot arthropathy associated with neurological disorders cardiac complications, not elsewhere classified heparin-induced thrombocytopenia (hit) hypertensive chronic kidney disease, unspecified, with chronic kidney disease stage i through stage iv, or unspecified mitral valve disorders peripheral autonomic neuropathy in disorders classified elsewhere background diabetic retinopathy acute on chronic diastolic heart failure cardiogenic shock other and unspecified hyperlipidemia long-term (current) use of insulin leukocytosis, unspecified gastroparesis congestive heart failure, unspecified other pulmonary insufficiency, not elsewhere classified, following trauma and surgery coronary atherosclerosis of native coronary artery rupture of chordae tendineae diabetes with neurological manifestations, type i [juvenile type], not stated as uncontrolled diabetes with ophthalmic manifestations, type i [juvenile type], not stated as uncontrolled acute kidney failure with lesion of tubular necrosis chronic kidney disease, unspecified nephritis and nephropathy, not specified as acute or chronic, in diseases classified elsewhere diabetes with renal manifestations, type i [juvenile type], not stated as uncontrolled other second degree atrioventricular block
white f 51 $nan$hematology blood hematocrit  26.5  %; hematology blood hemoglobin  7.9  g dl; hematology blood platelet count  680  k ul; chemistry blood anion gap  12  meq l; chemistry blood bicarbonate  27  meq l; chemistry blood chloride  101  meq l; chemistry blood creatinine  1.4  mg dl; chemistry blood potassium  3.9  meq l; chemistry blood sodium  136  meq l; chemistry blood urea nitrogen  31  mg dl; hematology blood inr(pt)  2.1  ; chemistry blood calcium, total  8.5  mg dl; chemistry blood glucose  154  mg dl$acetaminophen  650  mg ; albuterol 0.083% neb soln  1  neb ; aspirin  81  mg ; atorvastatin  80  mg ; bethanechol  50  mg ; cyanocobalamin  500  mcg ; docusate sodium  200  mg ; gabapentin  300  mg ; levothyroxine sodium  25  mcg ; metoprolol succinate xl  12.5  mg ; nephrocaps  1  cap ; pantoprazole  40  mg ; dextrose 50%  12.5  gm ; glucagon  1  mg ; glucose gel  15  g ; senna  8.6  mg ; sodium chloride 0.9%  flush  10  ml ; tramadol (ultram)  50  mg ; ciprofloxacin 0.3% ophth soln  3  drop ; ondansetron  4  mg ; vancomycin oral liquid  125  mg ; sevelamer carbonate  1600  mg ; insulin  18  unit ; warfarin  1  mg ; 
nephritis and nephropathy, not specified as acute or chronic, in diseases classified elsewhere long-term (current) use of insulin congestive heart failure, unspecified gastroparesis long-term (current) use of anticoagulants pure hypercholesterolemia long-term (current) use of aspirin aortocoronary bypass status heart valve replaced by transplant coronary atherosclerosis of unspecified type of vessel, native or graft peripheral autonomic neuropathy in disorders classified elsewhere end stage renal disease diabetes with ophthalmic manifestations, type i [juvenile type], not stated as uncontrolled anemia in chronic kidney disease diabetes with renal manifestations, type i [juvenile type], not stated as uncontrolled person on outside of car injured in collision with two- or three-wheeled motor vehicle in nontraffic accident renal dialysis status hypertensive chronic kidney disease, unspecified, with chronic kidney disease stage v or end stage renal disease acute kidney failure with lesion of tubular necrosis background diabetic retinopathy diabetes with neurological manifestations, type i [juvenile type], not stated as uncontrolled profound impairment, one eye, impairment level not further specified esophageal reflux ulcer of heel and midfoot arthropathy associated with neurological disorders cardiac complications, not elsewhere classified heparin-induced thrombocytopenia (hit) hypertensive chronic kidney disease, unspecified, with chronic kidney disease stage i through stage iv, or unspecified mitral valve disorders peripheral autonomic neuropathy in disorders classified elsewhere background diabetic retinopathy acute on chronic diastolic heart failure cardiogenic shock other and unspecified hyperlipidemia long-term (current) use of insulin leukocytosis, unspecified gastroparesis congestive heart failure, unspecified other pulmonary insufficiency, not elsewhere classified, following trauma and surgery coronary atherosclerosis of native coronary artery rupture of chordae tendineae diabetes with neurological manifestations, type i [juvenile type], not stated as uncontrolled diabetes with ophthalmic manifestations, type i [juvenile type], not stated as uncontrolled acute kidney failure with lesion of tubular necrosis chronic kidney disease, unspecified nephritis and nephropathy, not specified as acute or chronic, in diseases classified elsewhere diabetes with renal manifestations, type i [juvenile type], not stated as uncontrolled other second degree atrioventricular block
white f 51 $nan$nan$acetaminophen  650  mg ; albuterol 0.083% neb soln  1  neb ; aspirin  81  mg ; atorvastatin  80  mg ; bethanechol  50  mg ; cyanocobalamin  500  mcg ; docusate sodium  200  mg ; gabapentin  300  mg ; levothyroxine sodium  25  mcg ; metoprolol succinate xl  12.5  mg ; nephrocaps  1  cap ; pantoprazole  40  mg ; dextrose 50%  12.5  gm ; glucagon  1  mg ; glucose gel  15  g ; senna  8.6  mg ; sodium chloride 0.9%  flush  10  ml ; tramadol (ultram)  50  mg ; ciprofloxacin 0.3% ophth soln  3  drop ; ondansetron  4  mg ; vancomycin oral liquid  125  mg ; sevelamer carbonate  1600  mg ; insulin  18  unit ; warfarin  1  mg ; 
nephritis and nephropathy, not specified as acute or chronic, in diseases classified elsewhere long-term (current) use of insulin congestive heart failure, unspecified gastroparesis long-term (current) use of anticoagulants pure hypercholesterolemia long-term (current) use of aspirin aortocoronary bypass status heart valve replaced by transplant coronary atherosclerosis of unspecified type of vessel, native or graft peripheral autonomic neuropathy in disorders classified elsewhere end stage renal disease diabetes with ophthalmic manifestations, type i [juvenile type], not stated as uncontrolled anemia in chronic kidney disease diabetes with renal manifestations, type i [juvenile type], not stated as uncontrolled person on outside of car injured in collision with two- or three-wheeled motor vehicle in nontraffic accident renal dialysis status hypertensive chronic kidney disease, unspecified, with chronic kidney disease stage v or end stage renal disease acute kidney failure with lesion of tubular necrosis background diabetic retinopathy diabetes with neurological manifestations, type i [juvenile type], not stated as uncontrolled profound impairment, one eye, impairment level not further specified esophageal reflux ulcer of heel and midfoot arthropathy associated with neurological disorders cardiac complications, not elsewhere classified heparin-induced thrombocytopenia (hit) hypertensive chronic kidney disease, unspecified, with chronic kidney disease stage i through stage iv, or unspecified mitral valve disorders peripheral autonomic neuropathy in disorders classified elsewhere background diabetic retinopathy acute on chronic diastolic heart failure cardiogenic shock other and unspecified hyperlipidemia long-term (current) use of insulin leukocytosis, unspecified gastroparesis congestive heart failure, unspecified other pulmonary insufficiency, not elsewhere classified, following trauma and surgery coronary atherosclerosis of native coronary artery rupture of chordae tendineae diabetes with neurological manifestations, type i [juvenile type], not stated as uncontrolled diabetes with ophthalmic manifestations, type i [juvenile type], not stated as uncontrolled acute kidney failure with lesion of tubular necrosis chronic kidney disease, unspecified nephritis and nephropathy, not specified as acute or chronic, in diseases classified elsewhere diabetes with renal manifestations, type i [juvenile type], not stated as uncontrolled other second degree atrioventricular block
white m 46 $temp  99.14  heartrate  70.0  resprate  16.0  o2sat  94.0  sbp  128.0  dbp  77.0  rhythm  sr  pain  0  ; temp  97.9  heartrate  70.0  resprate  12.0  o2sat  95.0  sbp  136.0  dbp  76.0  rhythm  sr  pain  0  $nan$insulin  16  unit ; nephrocaps  1  cap ; amlodipine  10  mg ; aspirin  81  mg ; clopidogrel  75  mg ; enalapril maleate  5  mg ; sevelamer carbonate  800  mg ; 
constipation, unspecified diabetes with unspecified complication, type i [juvenile type], uncontrolled renal dialysis status hypertensive chronic kidney disease, unspecified, with chronic kidney disease stage v or end stage renal disease other and unspecified hyperlipidemia percutaneous transluminal coronary angioplasty status end stage renal disease coronary atherosclerosis of native coronary artery hyperpotassemia long-term (current) use of insulin hypertensive chronic kidney disease, unspecified, with chronic kidney disease stage v or end stage renal disease hemorrhage complicating a procedure coronary atherosclerosis of native coronary artery long-term (current) use of insulin old myocardial infarction end stage renal disease diabetes with renal manifestations, type ii or unspecified type, not stated as uncontrolled other specified surgical operations and procedures causing abnormal patient reaction, or later complication, without mention of misadventure at time of operation acute kidney failure, unspecified diabetes with neurological manifestations, type i [juvenile type], uncontrolled percutaneous transluminal coronary angioplasty status polyneuropathy in diabetes diabetes with renal manifestations, type i [juvenile type], uncontrolled unspecified fall chronic kidney disease, stage iv (severe) coronary atherosclerosis of native coronary artery diabetes with ophthalmic manifestations, type i [juvenile type], uncontrolled bimalleolar fracture, closed personal history of transient ischemic attack (tia), and cerebral infarction without residual deficits long-term (current) use of insulin other specified metabolic disorders background diabetic retinopathy hypertensive chronic kidney disease, unspecified, with chronic kidney disease stage i through stage iv, or unspecified old myocardial infarction sprain of tibiofibular (ligament), distal of ankle 
white m 46 $temp  98.3  heartrate  76.0  resprate  15.0  o2sat  98.0  sbp  153.0  dbp  73.0  rhythm    pain    $hematology blood hematocrit  37.7  %; hematology blood hemoglobin  12.8  g dl; hematology blood platelet count  238  k ul; chemistry blood anion gap  19  meq l; chemistry blood bicarbonate  19  meq l; chemistry blood chloride  102  meq l; chemistry blood creatinine  5.1  mg dl; chemistry blood potassium  5.4  meq l; chemistry blood sodium  135  meq l; chemistry blood urea nitrogen  50  mg dl; chemistry blood calcium, total  8.7  mg dl; chemistry blood glucose  258  mg dl$vancomycin  1500  mg ; insulin  16  unit ; nephrocaps  1  cap ; amlodipine  10  mg ; aspirin  81  mg ; clopidogrel  75  mg ; enalapril maleate  5  mg ; sevelamer carbonate  800  mg ; heparin  5000  unit ; metoprolol tartrate  25  mg ; diltiazem extended-release  120  mg ; influenza virus vaccine  0.5  ml ; pneumococcal vac polyvalent  0.5  ml ; sodium chloride 0.9%  flush  3  ml ; dextrose 50%  12.5  gm ; glucagon  1  mg ; glucose gel  15  g ; insulin  0  unit ; syringe (intraperitoneal)  1  syr ; syringe (intraperitoneal)  15  ml ; ceftazidime  1500  mg ; insulin  14  unit ; insulin  18  unit ; senna  1  tab ; docusate sodium  100  mg ; lactulose  15  ml ; 
constipation, unspecified diabetes with unspecified complication, type i [juvenile type], uncontrolled renal dialysis status hypertensive chronic kidney disease, unspecified, with chronic kidney disease stage v or end stage renal disease other and unspecified hyperlipidemia percutaneous transluminal coronary angioplasty status end stage renal disease coronary atherosclerosis of native coronary artery hyperpotassemia long-term (current) use of insulin hypertensive chronic kidney disease, unspecified, with chronic kidney disease stage v or end stage renal disease hemorrhage complicating a procedure coronary atherosclerosis of native coronary artery long-term (current) use of insulin old myocardial infarction end stage renal disease diabetes with renal manifestations, type ii or unspecified type, not stated as uncontrolled other specified surgical operations and procedures causing abnormal patient reaction, or later complication, without mention of misadventure at time of operation acute kidney failure, unspecified diabetes with neurological manifestations, type i [juvenile type], uncontrolled percutaneous transluminal coronary angioplasty status polyneuropathy in diabetes diabetes with renal manifestations, type i [juvenile type], uncontrolled unspecified fall chronic kidney disease, stage iv (severe) coronary atherosclerosis of native coronary artery diabetes with ophthalmic manifestations, type i [juvenile type], uncontrolled bimalleolar fracture, closed personal history of transient ischemic attack (tia), and cerebral infarction without residual deficits long-term (current) use of insulin other specified metabolic disorders background diabetic retinopathy hypertensive chronic kidney disease, unspecified, with chronic kidney disease stage i through stage iv, or unspecified old myocardial infarction sprain of tibiofibular (ligament), distal of ankle 
white m 46 $nan$hematology blood hematocrit  40.4  %; hematology blood hemoglobin  13.4  g dl; hematology blood platelet count  305  k ul; chemistry blood anion gap  18  meq l; chemistry blood bicarbonate  20  meq l; chemistry blood chloride  104  meq l; chemistry blood creatinine  5.0  mg dl; chemistry blood potassium  5.2  meq l; chemistry blood sodium  137  meq l; chemistry blood urea nitrogen  51  mg dl; chemistry blood calcium, total  9.2  mg dl; chemistry blood glucose  131  mg dl$insulin  16  unit ; nephrocaps  1  cap ; amlodipine  10  mg ; aspirin  81  mg ; clopidogrel  75  mg ; sevelamer carbonate  800  mg ; heparin  5000  unit ; metoprolol tartrate  25  mg ; diltiazem extended-release  120  mg ; influenza virus vaccine  0.5  ml ; pneumococcal vac polyvalent  0.5  ml ; sodium chloride 0.9%  flush  3  ml ; dextrose 50%  12.5  gm ; glucagon  1  mg ; glucose gel  15  g ; insulin  0  unit ; syringe (intraperitoneal)  15  ml ; ceftazidime  1500  mg ; insulin  14  unit ; insulin  18  unit ; senna  1  tab ; docusate sodium  100  mg ; lactulose  15  ml ; oxycodone (immediate release)   5  mg ; insulin  8  unit ; 
constipation, unspecified diabetes with unspecified complication, type i [juvenile type], uncontrolled renal dialysis status hypertensive chronic kidney disease, unspecified, with chronic kidney disease stage v or end stage renal disease other and unspecified hyperlipidemia percutaneous transluminal coronary angioplasty status end stage renal disease coronary atherosclerosis of native coronary artery hyperpotassemia long-term (current) use of insulin hypertensive chronic kidney disease, unspecified, with chronic kidney disease stage v or end stage renal disease hemorrhage complicating a procedure coronary atherosclerosis of native coronary artery long-term (current) use of insulin old myocardial infarction end stage renal disease diabetes with renal manifestations, type ii or unspecified type, not stated as uncontrolled other specified surgical operations and procedures causing abnormal patient reaction, or later complication, without mention of misadventure at time of operation acute kidney failure, unspecified diabetes with neurological manifestations, type i [juvenile type], uncontrolled percutaneous transluminal coronary angioplasty status polyneuropathy in diabetes diabetes with renal manifestations, type i [juvenile type], uncontrolled unspecified fall chronic kidney disease, stage iv (severe) coronary atherosclerosis of native coronary artery diabetes with ophthalmic manifestations, type i [juvenile type], uncontrolled bimalleolar fracture, closed personal history of transient ischemic attack (tia), and cerebral infarction without residual deficits long-term (current) use of insulin other specified metabolic disorders background diabetic retinopathy hypertensive chronic kidney disease, unspecified, with chronic kidney disease stage i through stage iv, or unspecified old myocardial infarction sprain of tibiofibular (ligament), distal of ankle 
white m 46 $nan$hematology blood hematocrit  39.8  %; hematology blood hemoglobin  13.2  g dl; hematology blood platelet count  302  k ul; chemistry blood anion gap  13  meq l; chemistry blood bicarbonate  26  meq l; chemistry blood chloride  102  meq l; chemistry blood creatinine  4.7  mg dl; chemistry blood potassium  5.4  meq l; chemistry blood sodium  136  meq l; chemistry blood urea nitrogen  49  mg dl; chemistry blood calcium, total  8.9  mg dl; chemistry blood glucose  255  mg dl$nephrocaps  1  cap ; amlodipine  10  mg ; aspirin  81  mg ; clopidogrel  75  mg ; sevelamer carbonate  800  mg ; heparin  5000  unit ; metoprolol tartrate  25  mg ; diltiazem extended-release  120  mg ; influenza virus vaccine  0.5  ml ; pneumococcal vac polyvalent  0.5  ml ; sodium chloride 0.9%  flush  3  ml ; dextrose 50%  12.5  gm ; glucagon  1  mg ; glucose gel  15  g ; senna  1  tab ; docusate sodium  100  mg ; lactulose  15  ml ; oxycodone (immediate release)   5  mg ; insulin  10  unit ; insulin  3  unit ; bisacodyl  10  mg ; lactulose  30  ml ; nystatin  500,000  unit ; 
constipation, unspecified diabetes with unspecified complication, type i [juvenile type], uncontrolled renal dialysis status hypertensive chronic kidney disease, unspecified, with chronic kidney disease stage v or end stage renal disease other and unspecified hyperlipidemia percutaneous transluminal coronary angioplasty status end stage renal disease coronary atherosclerosis of native coronary artery hyperpotassemia long-term (current) use of insulin hypertensive chronic kidney disease, unspecified, with chronic kidney disease stage v or end stage renal disease hemorrhage complicating a procedure coronary atherosclerosis of native coronary artery long-term (current) use of insulin old myocardial infarction end stage renal disease diabetes with renal manifestations, type ii or unspecified type, not stated as uncontrolled other specified surgical operations and procedures causing abnormal patient reaction, or later complication, without mention of misadventure at time of operation acute kidney failure, unspecified diabetes with neurological manifestations, type i [juvenile type], uncontrolled percutaneous transluminal coronary angioplasty status polyneuropathy in diabetes diabetes with renal manifestations, type i [juvenile type], uncontrolled unspecified fall chronic kidney disease, stage iv (severe) coronary atherosclerosis of native coronary artery diabetes with ophthalmic manifestations, type i [juvenile type], uncontrolled bimalleolar fracture, closed personal history of transient ischemic attack (tia), and cerebral infarction without residual deficits long-term (current) use of insulin other specified metabolic disorders background diabetic retinopathy hypertensive chronic kidney disease, unspecified, with chronic kidney disease stage i through stage iv, or unspecified old myocardial infarction sprain of tibiofibular (ligament), distal of ankle 
white m 46 $nan$hematology blood hematocrit  39.4  %; hematology blood hemoglobin  13.2  g dl; hematology blood platelet count  329  k ul; chemistry blood anion gap  14  meq l; chemistry blood bicarbonate  27  meq l; chemistry blood chloride  101  meq l; chemistry blood creatinine  5.0  mg dl; chemistry blood potassium  4.8  meq l; chemistry blood sodium  137  meq l; chemistry blood urea nitrogen  50  mg dl; chemistry blood calcium, total  8.9  mg dl; chemistry blood glucose  176  mg dl$nephrocaps  1  cap ; amlodipine  10  mg ; aspirin  81  mg ; clopidogrel  75  mg ; sevelamer carbonate  800  mg ; heparin  5000  unit ; metoprolol tartrate  25  mg ; diltiazem extended-release  120  mg ; influenza virus vaccine  0.5  ml ; pneumococcal vac polyvalent  0.5  ml ; sodium chloride 0.9%  flush  3  ml ; dextrose 50%  12.5  gm ; glucagon  1  mg ; glucose gel  15  g ; senna  1  tab ; docusate sodium  100  mg ; insulin  10  unit ; insulin  3  unit ; bisacodyl  10  mg ; lactulose  30  ml ; nystatin  500,000  unit ; iso-osmotic dextrose  200  ml ; vancomycin  1000  mg ; syringe  20  ml ; alprazolam  0.25  mg ; syringe (intraperitoneal)  1  ml ; 
constipation, unspecified diabetes with unspecified complication, type i [juvenile type], uncontrolled renal dialysis status hypertensive chronic kidney disease, unspecified, with chronic kidney disease stage v or end stage renal disease other and unspecified hyperlipidemia percutaneous transluminal coronary angioplasty status end stage renal disease coronary atherosclerosis of native coronary artery hyperpotassemia long-term (current) use of insulin hypertensive chronic kidney disease, unspecified, with chronic kidney disease stage v or end stage renal disease hemorrhage complicating a procedure coronary atherosclerosis of native coronary artery long-term (current) use of insulin old myocardial infarction end stage renal disease diabetes with renal manifestations, type ii or unspecified type, not stated as uncontrolled other specified surgical operations and procedures causing abnormal patient reaction, or later complication, without mention of misadventure at time of operation acute kidney failure, unspecified diabetes with neurological manifestations, type i [juvenile type], uncontrolled percutaneous transluminal coronary angioplasty status polyneuropathy in diabetes diabetes with renal manifestations, type i [juvenile type], uncontrolled unspecified fall chronic kidney disease, stage iv (severe) coronary atherosclerosis of native coronary artery diabetes with ophthalmic manifestations, type i [juvenile type], uncontrolled bimalleolar fracture, closed personal history of transient ischemic attack (tia), and cerebral infarction without residual deficits long-term (current) use of insulin other specified metabolic disorders background diabetic retinopathy hypertensive chronic kidney disease, unspecified, with chronic kidney disease stage i through stage iv, or unspecified old myocardial infarction sprain of tibiofibular (ligament), distal of ankle 
white m 46 $nan$hematology blood hematocrit  39.6  %; hematology blood hematocrit  38.3  %; hematology blood hemoglobin  12.9  g dl; hematology blood hemoglobin  12.7  g dl; hematology blood platelet count  352  k ul; hematology blood platelet count  363  k ul; chemistry blood anion gap  17  meq l; chemistry blood bicarbonate  24  meq l; chemistry blood chloride  99  meq l; chemistry blood creatinine  4.9  mg dl; chemistry blood potassium  5.4  meq l; chemistry blood sodium  135  meq l; chemistry blood urea nitrogen  50  mg dl; chemistry blood calcium, total  9.1  mg dl; chemistry blood glucose  204  mg dl$nephrocaps  1  cap ; amlodipine  10  mg ; aspirin  81  mg ; clopidogrel  75  mg ; sevelamer carbonate  800  mg ; heparin  5000  unit ; metoprolol tartrate  25  mg ; diltiazem extended-release  120  mg ; sodium chloride 0.9%  flush  3  ml ; dextrose 50%  12.5  gm ; glucagon  1  mg ; glucose gel  15  g ; senna  1  tab ; docusate sodium  100  mg ; bisacodyl  10  mg ; lactulose  30  ml ; nystatin  500,000  unit ; bactrim  960  mg ; 
constipation, unspecified diabetes with unspecified complication, type i [juvenile type], uncontrolled renal dialysis status hypertensive chronic kidney disease, unspecified, with chronic kidney disease stage v or end stage renal disease other and unspecified hyperlipidemia percutaneous transluminal coronary angioplasty status end stage renal disease coronary atherosclerosis of native coronary artery hyperpotassemia long-term (current) use of insulin hypertensive chronic kidney disease, unspecified, with chronic kidney disease stage v or end stage renal disease hemorrhage complicating a procedure coronary atherosclerosis of native coronary artery long-term (current) use of insulin old myocardial infarction end stage renal disease diabetes with renal manifestations, type ii or unspecified type, not stated as uncontrolled other specified surgical operations and procedures causing abnormal patient reaction, or later complication, without mention of misadventure at time of operation acute kidney failure, unspecified diabetes with neurological manifestations, type i [juvenile type], uncontrolled percutaneous transluminal coronary angioplasty status polyneuropathy in diabetes diabetes with renal manifestations, type i [juvenile type], uncontrolled unspecified fall chronic kidney disease, stage iv (severe) coronary atherosclerosis of native coronary artery diabetes with ophthalmic manifestations, type i [juvenile type], uncontrolled bimalleolar fracture, closed personal history of transient ischemic attack (tia), and cerebral infarction without residual deficits long-term (current) use of insulin other specified metabolic disorders background diabetic retinopathy hypertensive chronic kidney disease, unspecified, with chronic kidney disease stage i through stage iv, or unspecified old myocardial infarction sprain of tibiofibular (ligament), distal of ankle 
white m 46 $nan$hematology blood hematocrit  37.9  %; hematology blood hemoglobin  12.3  g dl; hematology blood platelet count  388  k ul; chemistry blood anion gap  16  meq l; chemistry blood bicarbonate  25  meq l; chemistry blood chloride  105  meq l; chemistry blood creatinine  4.9  mg dl; chemistry blood potassium  4.9  meq l; chemistry blood sodium  141  meq l; chemistry blood urea nitrogen  52  mg dl; chemistry blood calcium, total  8.9  mg dl; chemistry blood glucose  36  mg dl$nephrocaps  1  cap ; amlodipine  10  mg ; aspirin  81  mg ; clopidogrel  75  mg ; sevelamer carbonate  800  mg ; heparin  5000  unit ; metoprolol tartrate  25  mg ; diltiazem extended-release  120  mg ; sodium chloride 0.9%  flush  3  ml ; dextrose 50%  12.5  gm ; glucagon  1  mg ; glucose gel  15  g ; senna  1  tab ; docusate sodium  100  mg ; bisacodyl  10  mg ; lactulose  30  ml ; nystatin  500,000  unit ; bactrim  960  mg ; 
constipation, unspecified diabetes with unspecified complication, type i [juvenile type], uncontrolled renal dialysis status hypertensive chronic kidney disease, unspecified, with chronic kidney disease stage v or end stage renal disease other and unspecified hyperlipidemia percutaneous transluminal coronary angioplasty status end stage renal disease coronary atherosclerosis of native coronary artery hyperpotassemia long-term (current) use of insulin hypertensive chronic kidney disease, unspecified, with chronic kidney disease stage v or end stage renal disease hemorrhage complicating a procedure coronary atherosclerosis of native coronary artery long-term (current) use of insulin old myocardial infarction end stage renal disease diabetes with renal manifestations, type ii or unspecified type, not stated as uncontrolled other specified surgical operations and procedures causing abnormal patient reaction, or later complication, without mention of misadventure at time of operation acute kidney failure, unspecified diabetes with neurological manifestations, type i [juvenile type], uncontrolled percutaneous transluminal coronary angioplasty status polyneuropathy in diabetes diabetes with renal manifestations, type i [juvenile type], uncontrolled unspecified fall chronic kidney disease, stage iv (severe) coronary atherosclerosis of native coronary artery diabetes with ophthalmic manifestations, type i [juvenile type], uncontrolled bimalleolar fracture, closed personal history of transient ischemic attack (tia), and cerebral infarction without residual deficits long-term (current) use of insulin other specified metabolic disorders background diabetic retinopathy hypertensive chronic kidney disease, unspecified, with chronic kidney disease stage i through stage iv, or unspecified old myocardial infarction sprain of tibiofibular (ligament), distal of ankle 
white m 46 $nan$chemistry blood anion gap  16  meq l; chemistry blood bicarbonate  25  meq l; chemistry blood chloride  102  meq l; chemistry blood creatinine  5.3  mg dl; chemistry blood potassium  5.5  meq l; chemistry blood sodium  137  meq l; chemistry blood urea nitrogen  53  mg dl; chemistry blood calcium, total  8.9  mg dl; chemistry blood glucose  90  mg dl$nephrocaps  1  cap ; amlodipine  10  mg ; aspirin  81  mg ; clopidogrel  75  mg ; sevelamer carbonate  800  mg ; heparin  5000  unit ; metoprolol tartrate  25  mg ; diltiazem extended-release  120  mg ; sodium chloride 0.9%  flush  3  ml ; dextrose 50%  12.5  gm ; glucagon  1  mg ; glucose gel  15  g ; senna  1  tab ; docusate sodium  100  mg ; bisacodyl  10  mg ; lactulose  30  ml ; nystatin  500,000  unit ; 0.9% sodium chloride  100  ml ; imipenem-cilastatin  250  mg ; clarithromycin  250  mg ; linezolid  600  mg ; 
constipation, unspecified diabetes with unspecified complication, type i [juvenile type], uncontrolled renal dialysis status hypertensive chronic kidney disease, unspecified, with chronic kidney disease stage v or end stage renal disease other and unspecified hyperlipidemia percutaneous transluminal coronary angioplasty status end stage renal disease coronary atherosclerosis of native coronary artery hyperpotassemia long-term (current) use of insulin hypertensive chronic kidney disease, unspecified, with chronic kidney disease stage v or end stage renal disease hemorrhage complicating a procedure coronary atherosclerosis of native coronary artery long-term (current) use of insulin old myocardial infarction end stage renal disease diabetes with renal manifestations, type ii or unspecified type, not stated as uncontrolled other specified surgical operations and procedures causing abnormal patient reaction, or later complication, without mention of misadventure at time of operation acute kidney failure, unspecified diabetes with neurological manifestations, type i [juvenile type], uncontrolled percutaneous transluminal coronary angioplasty status polyneuropathy in diabetes diabetes with renal manifestations, type i [juvenile type], uncontrolled unspecified fall chronic kidney disease, stage iv (severe) coronary atherosclerosis of native coronary artery diabetes with ophthalmic manifestations, type i [juvenile type], uncontrolled bimalleolar fracture, closed personal history of transient ischemic attack (tia), and cerebral infarction without residual deficits long-term (current) use of insulin other specified metabolic disorders background diabetic retinopathy hypertensive chronic kidney disease, unspecified, with chronic kidney disease stage i through stage iv, or unspecified old myocardial infarction sprain of tibiofibular (ligament), distal of ankle 
white m 46 $nan$chemistry blood anion gap  16  meq l; chemistry blood bicarbonate  22  meq l; chemistry blood chloride  103  meq l; chemistry blood chloride  107  meq l; chemistry blood creatinine  5.6  mg dl; chemistry blood potassium  5.3  meq l; chemistry blood potassium  6.4  meq l; chemistry blood sodium  135  meq l; chemistry blood sodium  136  meq l; chemistry blood urea nitrogen  53  mg dl; chemistry urine chloride, urine  49  meq l; chemistry urine creatinine, urine  38  mg dl; chemistry urine creatinine, urine  38  mg dl; chemistry urine potassium, urine  12  meq l; chemistry urine potassium, urine  12  meq l; chemistry urine sodium, urine  82  meq l; chemistry urine sodium, urine  82  meq l; chemistry urine urea nitrogen, urine  272  mg dl; chemistry urine urea nitrogen, urine  272  mg dl; chemistry blood calcium, total  9.0  mg dl; chemistry blood glucose  169  mg dl; chemistry urine 24 hr creatinine  1178  mg 24hr$nephrocaps  1  cap ; amlodipine  10  mg ; aspirin  81  mg ; clopidogrel  75  mg ; sevelamer carbonate  800  mg ; metoprolol tartrate  25  mg ; diltiazem extended-release  120  mg ; sodium chloride 0.9%  flush  3  ml ; dextrose 50%  12.5  gm ; glucagon  1  mg ; glucose gel  15  g ; senna  1  tab ; docusate sodium  100  mg ; bisacodyl  10  mg ; lactulose  30  ml ; nystatin  500,000  unit ; 0.9% sodium chloride  100  ml ; imipenem-cilastatin  250  mg ; clarithromycin  250  mg ; linezolid  600  mg ; furosemide  80  mg ; 0.9% sodium chloride  1000  ml ; insulin  6  unit ; dextrose 50%  25  gm ; insulin  20  unit ; 
constipation, unspecified diabetes with unspecified complication, type i [juvenile type], uncontrolled renal dialysis status hypertensive chronic kidney disease, unspecified, with chronic kidney disease stage v or end stage renal disease other and unspecified hyperlipidemia percutaneous transluminal coronary angioplasty status end stage renal disease coronary atherosclerosis of native coronary artery hyperpotassemia long-term (current) use of insulin hypertensive chronic kidney disease, unspecified, with chronic kidney disease stage v or end stage renal disease hemorrhage complicating a procedure coronary atherosclerosis of native coronary artery long-term (current) use of insulin old myocardial infarction end stage renal disease diabetes with renal manifestations, type ii or unspecified type, not stated as uncontrolled other specified surgical operations and procedures causing abnormal patient reaction, or later complication, without mention of misadventure at time of operation acute kidney failure, unspecified diabetes with neurological manifestations, type i [juvenile type], uncontrolled percutaneous transluminal coronary angioplasty status polyneuropathy in diabetes diabetes with renal manifestations, type i [juvenile type], uncontrolled unspecified fall chronic kidney disease, stage iv (severe) coronary atherosclerosis of native coronary artery diabetes with ophthalmic manifestations, type i [juvenile type], uncontrolled bimalleolar fracture, closed personal history of transient ischemic attack (tia), and cerebral infarction without residual deficits long-term (current) use of insulin other specified metabolic disorders background diabetic retinopathy hypertensive chronic kidney disease, unspecified, with chronic kidney disease stage i through stage iv, or unspecified old myocardial infarction sprain of tibiofibular (ligament), distal of ankle 
white m 46 $nan$hematology blood hematocrit  39.9  %; hematology blood hemoglobin  12.7  g dl; hematology blood platelet count  464  k ul; chemistry blood anion gap  16  meq l; chemistry blood bicarbonate  25  meq l; chemistry blood chloride  103  meq l; chemistry blood creatinine  5.7  mg dl; chemistry blood potassium  5.7  meq l; chemistry blood sodium  138  meq l; chemistry blood urea nitrogen  54  mg dl; chemistry blood calcium, total  8.9  mg dl; chemistry blood glucose  62  mg dl$amlodipine  10  mg ; aspirin  81  mg ; clopidogrel  75  mg ; sevelamer carbonate  800  mg ; metoprolol tartrate  25  mg ; diltiazem extended-release  120  mg ; sodium chloride 0.9%  flush  3  ml ; dextrose 50%  12.5  gm ; glucagon  1  mg ; glucose gel  15  g ; senna  1  tab ; docusate sodium  100  mg ; bisacodyl  10  mg ; lactulose  30  ml ; nystatin  500,000  unit ; 0.9% sodium chloride  100  ml ; imipenem-cilastatin  250  mg ; clarithromycin  250  mg ; linezolid  600  mg ; furosemide  80  mg ; 0.9% sodium chloride  1000  ml ; dextrose 50%  25  gm ; insulin  20  unit ; 
constipation, unspecified diabetes with unspecified complication, type i [juvenile type], uncontrolled renal dialysis status hypertensive chronic kidney disease, unspecified, with chronic kidney disease stage v or end stage renal disease other and unspecified hyperlipidemia percutaneous transluminal coronary angioplasty status end stage renal disease coronary atherosclerosis of native coronary artery hyperpotassemia long-term (current) use of insulin hypertensive chronic kidney disease, unspecified, with chronic kidney disease stage v or end stage renal disease hemorrhage complicating a procedure coronary atherosclerosis of native coronary artery long-term (current) use of insulin old myocardial infarction end stage renal disease diabetes with renal manifestations, type ii or unspecified type, not stated as uncontrolled other specified surgical operations and procedures causing abnormal patient reaction, or later complication, without mention of misadventure at time of operation acute kidney failure, unspecified diabetes with neurological manifestations, type i [juvenile type], uncontrolled percutaneous transluminal coronary angioplasty status polyneuropathy in diabetes diabetes with renal manifestations, type i [juvenile type], uncontrolled unspecified fall chronic kidney disease, stage iv (severe) coronary atherosclerosis of native coronary artery diabetes with ophthalmic manifestations, type i [juvenile type], uncontrolled bimalleolar fracture, closed personal history of transient ischemic attack (tia), and cerebral infarction without residual deficits long-term (current) use of insulin other specified metabolic disorders background diabetic retinopathy hypertensive chronic kidney disease, unspecified, with chronic kidney disease stage i through stage iv, or unspecified old myocardial infarction sprain of tibiofibular (ligament), distal of ankle 
white m 46 $nan$hematology blood hematocrit  39.5  %; hematology blood hemoglobin  12.9  g dl; hematology blood platelet count  483  k ul; chemistry blood anion gap  16  meq l; chemistry blood anion gap  17  meq l; chemistry blood bicarbonate  25  meq l; chemistry blood bicarbonate  24  meq l; chemistry blood chloride  102  meq l; chemistry blood chloride  102  meq l; chemistry blood creatinine  5.6  mg dl; chemistry blood creatinine  5.6  mg dl; chemistry blood potassium  5.1  meq l; chemistry blood potassium  6.8  meq l; chemistry blood sodium  136  meq l; chemistry blood sodium  138  meq l; chemistry blood urea nitrogen  56  mg dl; chemistry blood urea nitrogen  56  mg dl; chemistry blood calcium, total  8.9  mg dl; chemistry blood glucose  80  mg dl; chemistry blood glucose  106  mg dl$amlodipine  10  mg ; aspirin  81  mg ; clopidogrel  75  mg ; sevelamer carbonate  800  mg ; metoprolol tartrate  25  mg ; diltiazem extended-release  120  mg ; sodium chloride 0.9%  flush  3  ml ; dextrose 50%  12.5  gm ; glucagon  1  mg ; glucose gel  15  g ; senna  1  tab ; docusate sodium  100  mg ; bisacodyl  10  mg ; lactulose  30  ml ; nystatin  500,000  unit ; 0.9% sodium chloride  100  ml ; imipenem-cilastatin  250  mg ; clarithromycin  250  mg ; linezolid  600  mg ; sodium polystyrene sulfonate  30  gm ; furosemide  20  mg ; 
constipation, unspecified diabetes with unspecified complication, type i [juvenile type], uncontrolled renal dialysis status hypertensive chronic kidney disease, unspecified, with chronic kidney disease stage v or end stage renal disease other and unspecified hyperlipidemia percutaneous transluminal coronary angioplasty status end stage renal disease coronary atherosclerosis of native coronary artery hyperpotassemia long-term (current) use of insulin hypertensive chronic kidney disease, unspecified, with chronic kidney disease stage v or end stage renal disease hemorrhage complicating a procedure coronary atherosclerosis of native coronary artery long-term (current) use of insulin old myocardial infarction end stage renal disease diabetes with renal manifestations, type ii or unspecified type, not stated as uncontrolled other specified surgical operations and procedures causing abnormal patient reaction, or later complication, without mention of misadventure at time of operation acute kidney failure, unspecified diabetes with neurological manifestations, type i [juvenile type], uncontrolled percutaneous transluminal coronary angioplasty status polyneuropathy in diabetes diabetes with renal manifestations, type i [juvenile type], uncontrolled unspecified fall chronic kidney disease, stage iv (severe) coronary atherosclerosis of native coronary artery diabetes with ophthalmic manifestations, type i [juvenile type], uncontrolled bimalleolar fracture, closed personal history of transient ischemic attack (tia), and cerebral infarction without residual deficits long-term (current) use of insulin other specified metabolic disorders background diabetic retinopathy hypertensive chronic kidney disease, unspecified, with chronic kidney disease stage i through stage iv, or unspecified old myocardial infarction sprain of tibiofibular (ligament), distal of ankle 
white m 46 $nan$hematology blood hematocrit  40.9  %; hematology blood hemoglobin  13.2  g dl; hematology blood platelet count  483  k ul; chemistry blood anion gap  15  meq l; chemistry blood bicarbonate  26  meq l; chemistry blood chloride  102  meq l; chemistry blood creatinine  5.6  mg dl; chemistry blood potassium  5.0  meq l; chemistry blood sodium  138  meq l; chemistry blood urea nitrogen  53  mg dl; chemistry blood calcium, total  8.8  mg dl; chemistry blood glucose  107  mg dl$amlodipine  10  mg ; aspirin  81  mg ; clopidogrel  75  mg ; sevelamer carbonate  800  mg ; metoprolol tartrate  25  mg ; diltiazem extended-release  120  mg ; sodium chloride 0.9%  flush  3  ml ; dextrose 50%  12.5  gm ; glucagon  1  mg ; glucose gel  15  g ; senna  1  tab ; docusate sodium  100  mg ; bisacodyl  10  mg ; lactulose  30  ml ; nystatin  500,000  unit ; 0.9% sodium chloride  100  ml ; imipenem-cilastatin  250  mg ; clarithromycin  250  mg ; linezolid  600  mg ; sodium polystyrene sulfonate  30  gm ; furosemide  20  mg ; furosemide  40  mg ; oxycodone (immediate release)   5-10  mg ; 
constipation, unspecified diabetes with unspecified complication, type i [juvenile type], uncontrolled renal dialysis status hypertensive chronic kidney disease, unspecified, with chronic kidney disease stage v or end stage renal disease other and unspecified hyperlipidemia percutaneous transluminal coronary angioplasty status end stage renal disease coronary atherosclerosis of native coronary artery hyperpotassemia long-term (current) use of insulin hypertensive chronic kidney disease, unspecified, with chronic kidney disease stage v or end stage renal disease hemorrhage complicating a procedure coronary atherosclerosis of native coronary artery long-term (current) use of insulin old myocardial infarction end stage renal disease diabetes with renal manifestations, type ii or unspecified type, not stated as uncontrolled other specified surgical operations and procedures causing abnormal patient reaction, or later complication, without mention of misadventure at time of operation acute kidney failure, unspecified diabetes with neurological manifestations, type i [juvenile type], uncontrolled percutaneous transluminal coronary angioplasty status polyneuropathy in diabetes diabetes with renal manifestations, type i [juvenile type], uncontrolled unspecified fall chronic kidney disease, stage iv (severe) coronary atherosclerosis of native coronary artery diabetes with ophthalmic manifestations, type i [juvenile type], uncontrolled bimalleolar fracture, closed personal history of transient ischemic attack (tia), and cerebral infarction without residual deficits long-term (current) use of insulin other specified metabolic disorders background diabetic retinopathy hypertensive chronic kidney disease, unspecified, with chronic kidney disease stage i through stage iv, or unspecified old myocardial infarction sprain of tibiofibular (ligament), distal of ankle 
white m 46 $nan$chemistry blood anion gap  15  meq l; chemistry blood anion gap  15  meq l; chemistry blood anion gap  20  meq l; chemistry blood bicarbonate  25  meq l; chemistry blood bicarbonate  25  meq l; chemistry blood bicarbonate  23  meq l; chemistry blood chloride  102  meq l; chemistry blood chloride  101  meq l; chemistry blood chloride  101  meq l; chemistry blood creatinine  5.5  mg dl; chemistry blood creatinine  5.8  mg dl; chemistry blood creatinine  5.7  mg dl; chemistry blood potassium  4.5  meq l; chemistry blood potassium  4.9  meq l; chemistry blood potassium  4.8  meq l; chemistry blood sodium  137  meq l; chemistry blood sodium  136  meq l; chemistry blood sodium  139  meq l; chemistry blood urea nitrogen  51  mg dl; chemistry blood urea nitrogen  52  mg dl; chemistry blood urea nitrogen  54  mg dl; chemistry blood calcium, total  8.6  mg dl; chemistry blood calcium, total  9.3  mg dl; chemistry blood glucose  49  mg dl; chemistry blood glucose  101  mg dl; chemistry blood glucose  105  mg dl$amlodipine  10  mg ; aspirin  81  mg ; clopidogrel  75  mg ; sevelamer carbonate  800  mg ; metoprolol tartrate  25  mg ; diltiazem extended-release  120  mg ; sodium chloride 0.9%  flush  3  ml ; dextrose 50%  12.5  gm ; glucagon  1  mg ; glucose gel  15  g ; senna  1  tab ; docusate sodium  100  mg ; bisacodyl  10  mg ; lactulose  30  ml ; nystatin  500,000  unit ; 0.9% sodium chloride  100  ml ; imipenem-cilastatin  250  mg ; clarithromycin  250  mg ; linezolid  600  mg ; furosemide  40  mg ; oxycodone (immediate release)   5-10  mg ; 
constipation, unspecified diabetes with unspecified complication, type i [juvenile type], uncontrolled renal dialysis status hypertensive chronic kidney disease, unspecified, with chronic kidney disease stage v or end stage renal disease other and unspecified hyperlipidemia percutaneous transluminal coronary angioplasty status end stage renal disease coronary atherosclerosis of native coronary artery hyperpotassemia long-term (current) use of insulin hypertensive chronic kidney disease, unspecified, with chronic kidney disease stage v or end stage renal disease hemorrhage complicating a procedure coronary atherosclerosis of native coronary artery long-term (current) use of insulin old myocardial infarction end stage renal disease diabetes with renal manifestations, type ii or unspecified type, not stated as uncontrolled other specified surgical operations and procedures causing abnormal patient reaction, or later complication, without mention of misadventure at time of operation acute kidney failure, unspecified diabetes with neurological manifestations, type i [juvenile type], uncontrolled percutaneous transluminal coronary angioplasty status polyneuropathy in diabetes diabetes with renal manifestations, type i [juvenile type], uncontrolled unspecified fall chronic kidney disease, stage iv (severe) coronary atherosclerosis of native coronary artery diabetes with ophthalmic manifestations, type i [juvenile type], uncontrolled bimalleolar fracture, closed personal history of transient ischemic attack (tia), and cerebral infarction without residual deficits long-term (current) use of insulin other specified metabolic disorders background diabetic retinopathy hypertensive chronic kidney disease, unspecified, with chronic kidney disease stage i through stage iv, or unspecified old myocardial infarction sprain of tibiofibular (ligament), distal of ankle 
white m 46 $nan$hematology blood hematocrit  37.6  %; hematology blood hemoglobin  12.4  g dl; hematology blood platelet count  462  k ul; chemistry blood anion gap  18  meq l; chemistry blood anion gap  16  meq l; chemistry blood bicarbonate  23  meq l; chemistry blood bicarbonate  23  meq l; chemistry blood chloride  105  meq l; chemistry blood chloride  101  meq l; chemistry blood creatinine  5.9  mg dl; chemistry blood creatinine  5.7  mg dl; chemistry blood potassium  4.9  meq l; chemistry blood potassium  5.0  meq l; chemistry blood sodium  141  meq l; chemistry blood sodium  135  meq l; chemistry blood urea nitrogen  58  mg dl; chemistry blood urea nitrogen  59  mg dl; chemistry blood glucose  223  mg dl; chemistry blood glucose  64  mg dl$amlodipine  10  mg ; aspirin  81  mg ; clopidogrel  75  mg ; sevelamer carbonate  800  mg ; metoprolol tartrate  25  mg ; diltiazem extended-release  120  mg ; sodium chloride 0.9%  flush  3  ml ; dextrose 50%  12.5  gm ; glucagon  1  mg ; glucose gel  15  g ; senna  1  tab ; docusate sodium  100  mg ; bisacodyl  10  mg ; lactulose  30  ml ; nystatin  500,000  unit ; 0.9% sodium chloride  100  ml ; imipenem-cilastatin  250  mg ; clarithromycin  250  mg ; linezolid  600  mg ; furosemide  40  mg ; oxycodone (immediate release)   5-10  mg ; insulin  12  unit ; heparin flush (10 units ml)  2  ml ; 
constipation, unspecified diabetes with unspecified complication, type i [juvenile type], uncontrolled renal dialysis status hypertensive chronic kidney disease, unspecified, with chronic kidney disease stage v or end stage renal disease other and unspecified hyperlipidemia percutaneous transluminal coronary angioplasty status end stage renal disease coronary atherosclerosis of native coronary artery hyperpotassemia long-term (current) use of insulin hypertensive chronic kidney disease, unspecified, with chronic kidney disease stage v or end stage renal disease hemorrhage complicating a procedure coronary atherosclerosis of native coronary artery long-term (current) use of insulin old myocardial infarction end stage renal disease diabetes with renal manifestations, type ii or unspecified type, not stated as uncontrolled other specified surgical operations and procedures causing abnormal patient reaction, or later complication, without mention of misadventure at time of operation acute kidney failure, unspecified diabetes with neurological manifestations, type i [juvenile type], uncontrolled percutaneous transluminal coronary angioplasty status polyneuropathy in diabetes diabetes with renal manifestations, type i [juvenile type], uncontrolled unspecified fall chronic kidney disease, stage iv (severe) coronary atherosclerosis of native coronary artery diabetes with ophthalmic manifestations, type i [juvenile type], uncontrolled bimalleolar fracture, closed personal history of transient ischemic attack (tia), and cerebral infarction without residual deficits long-term (current) use of insulin other specified metabolic disorders background diabetic retinopathy hypertensive chronic kidney disease, unspecified, with chronic kidney disease stage i through stage iv, or unspecified old myocardial infarction sprain of tibiofibular (ligament), distal of ankle 
white m 46 $nan$nan$amlodipine  10  mg ; aspirin  81  mg ; clopidogrel  75  mg ; sevelamer carbonate  800  mg ; metoprolol tartrate  25  mg ; diltiazem extended-release  120  mg ; sodium chloride 0.9%  flush  3  ml ; dextrose 50%  12.5  gm ; glucagon  1  mg ; glucose gel  15  g ; senna  1  tab ; docusate sodium  100  mg ; bisacodyl  10  mg ; lactulose  30  ml ; nystatin  500,000  unit ; 0.9% sodium chloride  100  ml ; imipenem-cilastatin  250  mg ; clarithromycin  250  mg ; linezolid  600  mg ; furosemide  40  mg ; oxycodone (immediate release)   5-10  mg ; heparin flush (10 units ml)  2  ml ; 
constipation, unspecified diabetes with unspecified complication, type i [juvenile type], uncontrolled renal dialysis status hypertensive chronic kidney disease, unspecified, with chronic kidney disease stage v or end stage renal disease other and unspecified hyperlipidemia percutaneous transluminal coronary angioplasty status end stage renal disease coronary atherosclerosis of native coronary artery hyperpotassemia long-term (current) use of insulin hypertensive chronic kidney disease, unspecified, with chronic kidney disease stage v or end stage renal disease hemorrhage complicating a procedure coronary atherosclerosis of native coronary artery long-term (current) use of insulin old myocardial infarction end stage renal disease diabetes with renal manifestations, type ii or unspecified type, not stated as uncontrolled other specified surgical operations and procedures causing abnormal patient reaction, or later complication, without mention of misadventure at time of operation acute kidney failure, unspecified diabetes with neurological manifestations, type i [juvenile type], uncontrolled percutaneous transluminal coronary angioplasty status polyneuropathy in diabetes diabetes with renal manifestations, type i [juvenile type], uncontrolled unspecified fall chronic kidney disease, stage iv (severe) coronary atherosclerosis of native coronary artery diabetes with ophthalmic manifestations, type i [juvenile type], uncontrolled bimalleolar fracture, closed personal history of transient ischemic attack (tia), and cerebral infarction without residual deficits long-term (current) use of insulin other specified metabolic disorders background diabetic retinopathy hypertensive chronic kidney disease, unspecified, with chronic kidney disease stage i through stage iv, or unspecified old myocardial infarction sprain of tibiofibular (ligament), distal of ankle 
white m 51 $nan$hematology blood hematocrit  39.2  %; hematology blood hemoglobin  13.9  g dl; hematology blood platelet count  213  k ul; chemistry blood anion gap  15  meq l; chemistry blood bicarbonate  26  meq l; chemistry blood chloride  106  meq l; chemistry blood creatinine  0.9  mg dl; chemistry blood potassium  4.9  meq l; chemistry blood sodium  142  meq l; chemistry blood urea nitrogen  16  mg dl; chemistry blood calcium, total  8.8  mg dl; chemistry blood glucose  113  mg dl$sodium chloride 0.9%  flush  3  ml ; lr  1000  ml ; hydromorphone (dilaudid)  0.5  mg ; ondansetron  4  mg ; dexamethasone  4  mg ; dexamethasone  10  mg ; iso-osmotic sodium chloride  50  ml ; famotidine  20  mg ; docusate sodium  100  mg ; senna  1  tab ; potassium chl 20 meq   1000 ml ns  1000  ml ; iso-osmotic dextrose  50  ml ; cefazolin  1  g ; oxycodone-acetaminophen  1-2  tab ; 
 
white m 51 $nan$nan$sodium chloride 0.9%  flush  3  ml ; hydromorphone (dilaudid)  0.5  mg ; ondansetron  4  mg ; iso-osmotic sodium chloride  50  ml ; famotidine  20  mg ; docusate sodium  100  mg ; senna  1  tab ; potassium chl 20 meq   1000 ml ns  1000  ml ; iso-osmotic dextrose  50  ml ; cefazolin  1  g ; oxycodone-acetaminophen  1-2  tab ; 
 
white m 51 $nan$nan$sodium chloride 0.9%  flush  3  ml ; hydromorphone (dilaudid)  0.5  mg ; ondansetron  4  mg ; iso-osmotic sodium chloride  50  ml ; famotidine  20  mg ; docusate sodium  100  mg ; senna  1  tab ; oxycodone-acetaminophen  1-2  tab ; 
 
white m 51 $nan$nan$sodium chloride 0.9%  flush  3  ml ; hydromorphone (dilaudid)  0.5  mg ; ondansetron  4  mg ; docusate sodium  100  mg ; senna  1  tab ; oxycodone-acetaminophen  1-2  tab ; 
 
unknown f 65 $nan$hematology blood hematocrit  32.4  %; hematology blood hemoglobin  11.2  g dl; hematology blood platelet count  276  k ul; chemistry blood anion gap  14  meq l; chemistry blood bicarbonate  24  meq l; chemistry blood chloride  106  meq l; chemistry blood creatinine  0.6  mg dl; chemistry blood potassium  4.3  meq l; chemistry blood sodium  140  meq l; chemistry blood urea nitrogen  10  mg dl; chemistry blood calcium, total  8.3  mg dl; chemistry blood glucose  123  mg dl$sodium chloride 0.9%  flush  3  ml ; lactated ringers  1000  ml ; 5% dextrose  100  ml ; cefazolin  2  g ; acetaminophen  325-650  mg ; morphine sulfate  2-4  mg ; heparin  5000  unit ; bag  1  bag ; magnesium sulfate  2  gm ; potassium chl 20 meq   1000 ml ns  1000  ml ; oxycodone (immediate release)   2.5  mg ; docusate sodium  100  mg ; fluticasone propionate 110mcg  2  puff ; senna  17.2  mg ; lidocaine 5% patch  1  ptch ; oxycodone (immediate release)   5  mg ; 
 
unknown f 65 $nan$nan$sodium chloride 0.9%  flush  3  ml ; acetaminophen  325-650  mg ; morphine sulfate  2-4  mg ; heparin  5000  unit ; potassium chl 20 meq   1000 ml ns  1000  ml ; docusate sodium  100  mg ; fluticasone propionate 110mcg  2  puff ; senna  17.2  mg ; lidocaine 5% patch  1  ptch ; oxycodone (immediate release)   5  mg ; lisinopril  10  mg ; montelukast  10  mg ; oxycodone (immediate release)   5-10  mg ; senna  8.6  mg ; albuterol 0.083% neb soln  1  neb ; 
 
unknown f 65 $nan$chemistry blood anion gap  10  meq l; chemistry blood bicarbonate  30  meq l; chemistry blood chloride  104  meq l; chemistry blood creatinine  0.5  mg dl; chemistry blood potassium  4.4  meq l; chemistry blood sodium  140  meq l; chemistry blood urea nitrogen  8  mg dl; chemistry blood calcium, total  8.4  mg dl; chemistry blood glucose  115  mg dl$sodium chloride 0.9%  flush  3  ml ; morphine sulfate  2-4  mg ; heparin  5000  unit ; fluticasone propionate 110mcg  2  puff ; montelukast  10  mg ; oxycodone (immediate release)   5-10  mg ; senna  8.6  mg ; albuterol 0.083% neb soln  1  neb ; 
 
unknown f 65 $nan$hematology blood hematocrit  30.2  %; hematology blood hemoglobin  10.4  g dl; hematology blood platelet count  272  k ul; chemistry blood anion gap  12  meq l; chemistry blood bicarbonate  29  meq l; chemistry blood chloride  102  meq l; chemistry blood creatinine  0.5  mg dl; chemistry blood potassium  3.9  meq l; chemistry blood sodium  139  meq l; chemistry blood urea nitrogen  10  mg dl; chemistry blood calcium, total  8.4  mg dl; chemistry blood glucose  129  mg dl$sodium chloride 0.9%  flush  3  ml ; morphine sulfate  2-4  mg ; heparin  5000  unit ; fluticasone propionate 110mcg  2  puff ; montelukast  10  mg ; oxycodone (immediate release)   5-10  mg ; senna  8.6  mg ; albuterol 0.083% neb soln  1  neb ; furosemide  20  mg ; 5% dextrose  250  ml ; heparin sodium  25,000  unit ; 
 
unknown f 65 $nan$hematology blood hematocrit  29.2  %; hematology blood hemoglobin  10.1  g dl; hematology blood platelet count  304  k ul; chemistry blood anion gap  15  meq l; chemistry blood bicarbonate  28  meq l; chemistry blood chloride  100  meq l; chemistry blood creatinine  0.5  mg dl; chemistry blood potassium  4.0  meq l; chemistry blood sodium  139  meq l; chemistry blood urea nitrogen  12  mg dl; chemistry blood calcium, total  8.5  mg dl; chemistry blood glucose  104  mg dl$sodium chloride 0.9%  flush  3  ml ; morphine sulfate  2-4  mg ; fluticasone propionate 110mcg  2  puff ; montelukast  10  mg ; oxycodone (immediate release)   5-10  mg ; senna  8.6  mg ; bisacodyl  10  mg ; 
 
unknown f 65 $nan$hematology blood hematocrit  29.1  %; hematology blood hemoglobin  10.3  g dl; hematology blood platelet count  314  k ul; chemistry blood anion gap  6  meq l; chemistry blood bicarbonate  31  meq l; chemistry blood chloride  102  meq l; chemistry blood creatinine  0.4  mg dl; chemistry blood potassium  4.0  meq l; chemistry blood sodium  135  meq l; chemistry blood urea nitrogen  12  mg dl; chemistry blood calcium, total  8.6  mg dl; chemistry blood glucose  100  mg dl$sodium chloride 0.9%  flush  3  ml ; morphine sulfate  2-4  mg ; fluticasone propionate 110mcg  2  puff ; montelukast  10  mg ; oxycodone (immediate release)   5-10  mg ; senna  8.6  mg ; bisacodyl  10  mg ; 
 
unknown f 65 $nan$hematology blood hematocrit  30.6  %; hematology blood hemoglobin  10.7  g dl; hematology blood platelet count  343  k ul; hematology blood inr(pt)  1.1  $sodium chloride 0.9%  flush  3  ml ; fluticasone propionate 110mcg  2  puff ; montelukast  10  mg ; oxycodone (immediate release)   5-10  mg ; senna  8.6  mg ; bisacodyl  10  mg ; warfarin  5  mg ; 
 
unknown f 65 $nan$hematology blood hematocrit  30.0  %; hematology blood hemoglobin  10.5  g dl; hematology blood platelet count  371  k ul; hematology blood inr(pt)  1.1  $sodium chloride 0.9%  flush  3  ml ; fluticasone propionate 110mcg  2  puff ; montelukast  10  mg ; oxycodone (immediate release)   5-10  mg ; senna  8.6  mg ; bisacodyl  10  mg ; warfarin  5  mg ; warfarin  7.5  mg ; 
 
unknown f 65 $nan$hematology blood hematocrit  32.2  %; hematology blood hemoglobin  11.2  g dl; hematology blood platelet count  435  k ul; chemistry blood anion gap  13  meq l; chemistry blood bicarbonate  27  meq l; chemistry blood chloride  100  meq l; chemistry blood creatinine  0.5  mg dl; chemistry blood potassium  4.1  meq l; chemistry blood sodium  136  meq l; chemistry blood urea nitrogen  12  mg dl; hematology blood inr(pt)  2.2  ; chemistry blood calcium, total  8.8  mg dl; chemistry blood glucose  102  mg dl$sodium chloride 0.9%  flush  3  ml ; fluticasone propionate 110mcg  2  puff ; montelukast  10  mg ; oxycodone (immediate release)   5-10  mg ; senna  8.6  mg ; bisacodyl  10  mg ; warfarin  7.5  mg ; warfarin  2  mg ; 
 
unknown f 65 $nan$hematology blood inr(pt)  3.3  $sodium chloride 0.9%  flush  3  ml ; fluticasone propionate 110mcg  2  puff ; montelukast  10  mg ; oxycodone (immediate release)   5-10  mg ; senna  8.6  mg ; bisacodyl  10  mg ; warfarin  2  mg ; 
 
unknown f 65 $nan$hematology blood inr(pt)  2.5  $sodium chloride 0.9%  flush  3  ml ; fluticasone propionate 110mcg  2  puff ; montelukast  10  mg ; senna  8.6  mg ; bisacodyl  10  mg ; warfarin  1.5  mg ; 
 
other m 39 $temp  98.5  heartrate  75.0  resprate  18.0  o2sat  98.0  sbp  168.0  dbp  93.0  rhythm    pain  7  $hematology blood hematocrit  39.0  %; hematology blood hemoglobin  12.3  g dl; hematology blood platelet count  336  k ul; chemistry blood anion gap  13  meq l; chemistry blood bicarbonate  29  meq l; chemistry blood chloride  97  meq l; chemistry blood creatinine  0.8  mg dl; chemistry blood potassium  4.2  meq l; chemistry blood sodium  139  meq l; chemistry blood urea nitrogen  10  mg dl; chemistry blood calcium, total  9.3  mg dl; chemistry blood glucose  115  mg dl$influenza vaccine quadrivalent  0.5  ml ; sodium chloride 0.9%  flush  3  ml ; heparin  5000  unit ; hydromorphone (dilaudid)  1  mg ; ondansetron  4  mg ; omeprazole  20  mg ; oxycodone (immediate release)  10  mg ; oxycodone sr (oxycontin)  40  mg ; duloxetine  30  mg ; tizanidine  2  mg ; montelukast  10  mg ; lidocaine 5% ointment  4  % ; ipratropium bromide neb  1  puff ; oxycodone sr (oxycontin)  10  mg ; albuterol inhaler  2  puff ; fluticasone propionate nasal  2  spry ; lisinopril  20  mg ; ipratropium bromide neb  1  neb ; ketorolac  30  mg ; 
essential (primary) hypertension unspecified asthma, uncomplicated body mass index (bmi) 50.0-59.9, adult anxiety disorder, unspecified gastro-esophageal reflux disease without esophagitis obstructive sleep apnea (adult) (pediatric) ankylosing spondylitis of multiple sites in spine long term (current) use of systemic steroids obesity, unspecified obstructive sleep apnea (adult) (pediatric) unspecified asthma, uncomplicated body mass index (bmi) 50.0-59.9, adult major depressive disorder, single episode, unspecified ankylosing spondylitis of unspecified sites in spine obesity, unspecified essential (primary) hypertension anxiety disorder, unspecified localized edema obstructive sleep apnea (adult) (pediatric) early satiety ankylosing spondylitis of unspecified sites in spine essential (primary) hypertension unspecified asthma, uncomplicated ankylosing spondylitis of unspecified sites in spine morbid (severe) obesity due to excess calories anxiety disorder, unspecified other chest pain essential (primary) hypertension body mass index (bmi) 50.0-59.9, adult localized edema obstructive sleep apnea (adult) (pediatric) unspecified asthma, uncomplicated other chronic pain dehydration major depressive disorder, single episode, unspecified nausea with vomiting, unspecified fever, unspecified unspecified abdominal pain morbid (severe) obesity due to excess calories unspecified asthma, uncomplicated body mass index (bmi) 50.0-59.9, adult pain in thoracic spine hypovolemia ankylosing spondylitis of unspecified sites in spine obstructive sleep apnea (adult) (pediatric) essential (primary) hypertension anxiety disorder, unspecified localized edema
other m 39 $nan$hematology blood hematocrit  39.8  %; hematology blood hemoglobin  12.4  g dl; hematology blood platelet count  324  k ul; chemistry blood anion gap  15  meq l; chemistry blood bicarbonate  28  meq l; chemistry blood chloride  96  meq l; chemistry blood creatinine  0.8  mg dl; chemistry blood potassium  4.1  meq l; chemistry blood sodium  139  meq l; chemistry blood urea nitrogen  9  mg dl; hematology blood inr(pt)  1.1  ; chemistry urine creatinine, urine  122  mg dl; chemistry blood calcium, total  9.6  mg dl; chemistry blood glucose  110  mg dl; chemistry urine albumin creatinine, urine  4.9  mg g$influenza vaccine quadrivalent  0.5  ml ; sodium chloride 0.9%  flush  3  ml ; heparin  5000  unit ; hydromorphone (dilaudid)  1  mg ; ondansetron  4  mg ; omeprazole  20  mg ; oxycodone (immediate release)  10  mg ; duloxetine  30  mg ; montelukast  10  mg ; lidocaine 5% ointment  4  % ; oxycodone sr (oxycontin)  10  mg ; albuterol inhaler  2  puff ; fluticasone propionate nasal  2  spry ; lisinopril  20  mg ; ipratropium bromide neb  1  neb ; ketorolac  30  mg ; 
essential (primary) hypertension unspecified asthma, uncomplicated body mass index (bmi) 50.0-59.9, adult anxiety disorder, unspecified gastro-esophageal reflux disease without esophagitis obstructive sleep apnea (adult) (pediatric) ankylosing spondylitis of multiple sites in spine long term (current) use of systemic steroids obesity, unspecified obstructive sleep apnea (adult) (pediatric) unspecified asthma, uncomplicated body mass index (bmi) 50.0-59.9, adult major depressive disorder, single episode, unspecified ankylosing spondylitis of unspecified sites in spine obesity, unspecified essential (primary) hypertension anxiety disorder, unspecified localized edema obstructive sleep apnea (adult) (pediatric) early satiety ankylosing spondylitis of unspecified sites in spine essential (primary) hypertension unspecified asthma, uncomplicated ankylosing spondylitis of unspecified sites in spine morbid (severe) obesity due to excess calories anxiety disorder, unspecified other chest pain essential (primary) hypertension body mass index (bmi) 50.0-59.9, adult localized edema obstructive sleep apnea (adult) (pediatric) unspecified asthma, uncomplicated other chronic pain dehydration major depressive disorder, single episode, unspecified nausea with vomiting, unspecified fever, unspecified unspecified abdominal pain morbid (severe) obesity due to excess calories unspecified asthma, uncomplicated body mass index (bmi) 50.0-59.9, adult pain in thoracic spine hypovolemia ankylosing spondylitis of unspecified sites in spine obstructive sleep apnea (adult) (pediatric) essential (primary) hypertension anxiety disorder, unspecified localized edema
other m 39 $nan$nan$influenza vaccine quadrivalent  0.5  ml ; sodium chloride 0.9%  flush  3  ml ; heparin  5000  unit ; ondansetron  4  mg ; omeprazole  20  mg ; oxycodone (immediate release)  10  mg ; duloxetine  30  mg ; montelukast  10  mg ; lidocaine 5% ointment  4  % ; oxycodone sr (oxycontin)  10  mg ; albuterol inhaler  2  puff ; fluticasone propionate nasal  2  spry ; lisinopril  20  mg ; ipratropium bromide neb  1  neb ; 
essential (primary) hypertension unspecified asthma, uncomplicated body mass index (bmi) 50.0-59.9, adult anxiety disorder, unspecified gastro-esophageal reflux disease without esophagitis obstructive sleep apnea (adult) (pediatric) ankylosing spondylitis of multiple sites in spine long term (current) use of systemic steroids obesity, unspecified obstructive sleep apnea (adult) (pediatric) unspecified asthma, uncomplicated body mass index (bmi) 50.0-59.9, adult major depressive disorder, single episode, unspecified ankylosing spondylitis of unspecified sites in spine obesity, unspecified essential (primary) hypertension anxiety disorder, unspecified localized edema obstructive sleep apnea (adult) (pediatric) early satiety ankylosing spondylitis of unspecified sites in spine essential (primary) hypertension unspecified asthma, uncomplicated ankylosing spondylitis of unspecified sites in spine morbid (severe) obesity due to excess calories anxiety disorder, unspecified other chest pain essential (primary) hypertension body mass index (bmi) 50.0-59.9, adult localized edema obstructive sleep apnea (adult) (pediatric) unspecified asthma, uncomplicated other chronic pain dehydration major depressive disorder, single episode, unspecified nausea with vomiting, unspecified fever, unspecified unspecified abdominal pain morbid (severe) obesity due to excess calories unspecified asthma, uncomplicated body mass index (bmi) 50.0-59.9, adult pain in thoracic spine hypovolemia ankylosing spondylitis of unspecified sites in spine obstructive sleep apnea (adult) (pediatric) essential (primary) hypertension anxiety disorder, unspecified localized edema
white f 88 $nan$hematology blood hematocrit  39.5  %; hematology blood hemoglobin  13.6  g dl; hematology blood platelet count  262  k ul; chemistry blood anion gap  13  meq l; chemistry blood bicarbonate  25  meq l; chemistry blood chloride  107  meq l; chemistry blood creatinine  0.6  mg dl; chemistry blood potassium  3.9  meq l; chemistry blood sodium  141  meq l; chemistry blood urea nitrogen  17  mg dl; hematology blood inr(pt)  1.0  ; chemistry blood glucose  115  mg dl$nan
other chest pain coronary atherosclerosis of native coronary artery arthropathy, unspecified, multiple sites old myocardial infarction person boarding or alighting a pedal cycle injured in collision with pedestrian or animal personal history of malignant neoplasm of breast shortness of breath unspecified cataract anxiety state, unspecified congestive heart failure, unspecified unspecified essential hypertension percutaneous transluminal coronary angioplasty status chronic diastolic heart failure postmastectomy lymphedema syndrome chronic diastolic heart failure coronary atherosclerosis of native coronary artery personal history of malignant neoplasm of breast unspecified essential hypertension congestive heart failure, unspecified unspecified polyarthropathy or polyarthritis, site unspecified person boarding or alighting a pedal cycle injured in collision with pedestrian or animal percutaneous transluminal coronary angioplasty status cellulitis and abscess of upper arm and forearm old myocardial infarction unspecified cataract coronary atherosclerosis of unspecified type of vessel, native or graft percutaneous transluminal coronary angioplasty status chest pain, unspecified unspecified essential hypertension person boarding or alighting a pedal cycle injured in collision with pedestrian or animal personal history of malignant neoplasm of breast shortness of breath panic disorder without agoraphobia percutaneous transluminal coronary angioplasty status acquired absence of breast and nipple old myocardial infarction chest pain, unspecified personal history of malignant neoplasm of breast coronary atherosclerosis of native coronary artery shortness of breath postmastectomy lymphedema syndrome person boarding or alighting a pedal cycle injured in collision with pedestrian or animal unspecified essential hypertension lumbago other lymphedema personal history of malignant neoplasm of breast unspecified essential hypertension other postprocedural status
white f 88 $nan$nan$aspirin  325  mg ; atorvastatin  10  mg ; isosorbide dinitrate er  40  mg ; vitamin d  400  unit ; sodium chloride 0.9%  flush  3  ml ; alprazolam  0.5  mg ; ciprofloxacin hcl  250  mg ; heparin  5000  unit ; docusate sodium  100  mg ; metoprolol tartrate  12.5  mg ; atorvastatin  20  mg ; lorazepam  0.5  mg ; acetaminophen  650  mg ; 
other chest pain coronary atherosclerosis of native coronary artery arthropathy, unspecified, multiple sites old myocardial infarction person boarding or alighting a pedal cycle injured in collision with pedestrian or animal personal history of malignant neoplasm of breast shortness of breath unspecified cataract anxiety state, unspecified congestive heart failure, unspecified unspecified essential hypertension percutaneous transluminal coronary angioplasty status chronic diastolic heart failure postmastectomy lymphedema syndrome chronic diastolic heart failure coronary atherosclerosis of native coronary artery personal history of malignant neoplasm of breast unspecified essential hypertension congestive heart failure, unspecified unspecified polyarthropathy or polyarthritis, site unspecified person boarding or alighting a pedal cycle injured in collision with pedestrian or animal percutaneous transluminal coronary angioplasty status cellulitis and abscess of upper arm and forearm old myocardial infarction unspecified cataract coronary atherosclerosis of unspecified type of vessel, native or graft percutaneous transluminal coronary angioplasty status chest pain, unspecified unspecified essential hypertension person boarding or alighting a pedal cycle injured in collision with pedestrian or animal personal history of malignant neoplasm of breast shortness of breath panic disorder without agoraphobia percutaneous transluminal coronary angioplasty status acquired absence of breast and nipple old myocardial infarction chest pain, unspecified personal history of malignant neoplasm of breast coronary atherosclerosis of native coronary artery shortness of breath postmastectomy lymphedema syndrome person boarding or alighting a pedal cycle injured in collision with pedestrian or animal unspecified essential hypertension lumbago other lymphedema personal history of malignant neoplasm of breast unspecified essential hypertension other postprocedural status
white f 88 $nan$hematology blood hematocrit  44.6  %; hematology blood hemoglobin  14.8  g dl; hematology blood platelet count  256  k ul; chemistry blood anion gap  20  meq l; chemistry blood bicarbonate  19  meq l; chemistry blood chloride  105  meq l; chemistry blood creatinine  0.7  mg dl; chemistry blood potassium  4.1  meq l; chemistry blood sodium  140  meq l; chemistry blood urea nitrogen  19  mg dl; chemistry blood calcium, total  9.6  mg dl; chemistry blood glucose  88  mg dl$isosorbide dinitrate er  40  mg ; vitamin d  400  unit ; heparin  5000  unit ; docusate sodium  100  mg ; metoprolol tartrate  12.5  mg ; atorvastatin  20  mg ; lorazepam  0.5  mg ; acetaminophen  650  mg ; hydralazine  10  mg ; isosorbide dinitrate  40  mg ; metoprolol tartrate  6.25  mg ; 
other chest pain coronary atherosclerosis of native coronary artery arthropathy, unspecified, multiple sites old myocardial infarction person boarding or alighting a pedal cycle injured in collision with pedestrian or animal personal history of malignant neoplasm of breast shortness of breath unspecified cataract anxiety state, unspecified congestive heart failure, unspecified unspecified essential hypertension percutaneous transluminal coronary angioplasty status chronic diastolic heart failure postmastectomy lymphedema syndrome chronic diastolic heart failure coronary atherosclerosis of native coronary artery personal history of malignant neoplasm of breast unspecified essential hypertension congestive heart failure, unspecified unspecified polyarthropathy or polyarthritis, site unspecified person boarding or alighting a pedal cycle injured in collision with pedestrian or animal percutaneous transluminal coronary angioplasty status cellulitis and abscess of upper arm and forearm old myocardial infarction unspecified cataract coronary atherosclerosis of unspecified type of vessel, native or graft percutaneous transluminal coronary angioplasty status chest pain, unspecified unspecified essential hypertension person boarding or alighting a pedal cycle injured in collision with pedestrian or animal personal history of malignant neoplasm of breast shortness of breath panic disorder without agoraphobia percutaneous transluminal coronary angioplasty status acquired absence of breast and nipple old myocardial infarction chest pain, unspecified personal history of malignant neoplasm of breast coronary atherosclerosis of native coronary artery shortness of breath postmastectomy lymphedema syndrome person boarding or alighting a pedal cycle injured in collision with pedestrian or animal unspecified essential hypertension lumbago other lymphedema personal history of malignant neoplasm of breast unspecified essential hypertension other postprocedural status
white f 88 $nan$chemistry blood anion gap  16  meq l; chemistry blood bicarbonate  24  meq l; chemistry blood chloride  102  meq l; chemistry blood chloride  105  meq l; chemistry blood creatinine  0.8  mg dl; chemistry blood potassium  3.7  meq l; chemistry blood potassium  7.4  meq l; chemistry blood sodium  135  meq l; chemistry blood sodium  140  meq l; chemistry blood urea nitrogen  26  mg dl; chemistry blood glucose  77  mg dl$vitamin d  400  unit ; heparin  5000  unit ; docusate sodium  100  mg ; atorvastatin  20  mg ; lorazepam  0.5  mg ; hydralazine  10  mg ; isosorbide dinitrate  40  mg ; metoprolol tartrate  6.25  mg ; lisinopril  2.5  mg ; 
other chest pain coronary atherosclerosis of native coronary artery arthropathy, unspecified, multiple sites old myocardial infarction person boarding or alighting a pedal cycle injured in collision with pedestrian or animal personal history of malignant neoplasm of breast shortness of breath unspecified cataract anxiety state, unspecified congestive heart failure, unspecified unspecified essential hypertension percutaneous transluminal coronary angioplasty status chronic diastolic heart failure postmastectomy lymphedema syndrome chronic diastolic heart failure coronary atherosclerosis of native coronary artery personal history of malignant neoplasm of breast unspecified essential hypertension congestive heart failure, unspecified unspecified polyarthropathy or polyarthritis, site unspecified person boarding or alighting a pedal cycle injured in collision with pedestrian or animal percutaneous transluminal coronary angioplasty status cellulitis and abscess of upper arm and forearm old myocardial infarction unspecified cataract coronary atherosclerosis of unspecified type of vessel, native or graft percutaneous transluminal coronary angioplasty status chest pain, unspecified unspecified essential hypertension person boarding or alighting a pedal cycle injured in collision with pedestrian or animal personal history of malignant neoplasm of breast shortness of breath panic disorder without agoraphobia percutaneous transluminal coronary angioplasty status acquired absence of breast and nipple old myocardial infarction chest pain, unspecified personal history of malignant neoplasm of breast coronary atherosclerosis of native coronary artery shortness of breath postmastectomy lymphedema syndrome person boarding or alighting a pedal cycle injured in collision with pedestrian or animal unspecified essential hypertension lumbago other lymphedema personal history of malignant neoplasm of breast unspecified essential hypertension other postprocedural status
white f 54 $temp  98.7  heartrate  71.0  resprate  15.0  o2sat  97.0  sbp  106.0  dbp  71.0  rhythm    pain    ; temp  98.6  heartrate  66.0  resprate  18.0  o2sat  99.0  sbp  139.0  dbp  87.0  rhythm    pain  0  $nan$sodium chloride 0.9%  flush  3-10  ml ; heparin  5000  unit ; ceftriaxone  1  gm ; azithromycin  250  mg ; senna  8.6  mg ; polyethylene glycol  17  g ; 
 
white f 54 $nan$hematology blood hematocrit  40.2  %; hematology blood hemoglobin  13.4  g dl; hematology blood platelet count  162  k ul; chemistry blood anion gap  11  meq l; chemistry blood bicarbonate  29  meq l; chemistry blood chloride  102  meq l; chemistry blood creatinine  0.6  mg dl; chemistry blood potassium  4.6  meq l; chemistry blood sodium  142  meq l; chemistry blood urea nitrogen  10  mg dl; chemistry blood calcium, total  10.1  mg dl; chemistry blood glucose  96  mg dl; chemistry blood lactate dehydrogenase (ld)  160  iu l$sodium chloride 0.9%  flush  3-10  ml ; heparin  5000  unit ; ceftriaxone  1  gm ; azithromycin  250  mg ; senna  8.6  mg ; polyethylene glycol  17  g ; 
 
white f 54 $nan$hematology blood hematocrit  39.6  %; hematology blood hemoglobin  13.4  g dl; hematology blood platelet count  160  k ul; chemistry blood anion gap  10  meq l; chemistry blood bicarbonate  29  meq l; chemistry blood chloride  103  meq l; chemistry blood creatinine  0.7  mg dl; chemistry blood potassium  4.5  meq l; chemistry blood sodium  142  meq l; chemistry blood urea nitrogen  14  mg dl; chemistry blood calcium, total  9.8  mg dl; chemistry blood glucose  106  mg dl$sodium chloride 0.9%  flush  3-10  ml ; heparin  5000  unit ; azithromycin  250  mg ; senna  8.6  mg ; polyethylene glycol  17  g ; 
 
white f 54 $nan$hematology blood hematocrit  39.9  %; hematology blood hemoglobin  13.2  g dl; hematology blood platelet count  151  k ul; chemistry blood anion gap  16  meq l; chemistry blood bicarbonate  27  meq l; chemistry blood chloride  97  meq l; chemistry blood creatinine  0.6  mg dl; chemistry blood potassium  4.6  meq l; chemistry blood sodium  140  meq l; chemistry blood urea nitrogen  15  mg dl; chemistry blood calcium, total  9.9  mg dl; chemistry blood glucose  102  mg dl$sodium chloride 0.9%  flush  3-10  ml ; heparin  5000  unit ; azithromycin  250  mg ; senna  8.6  mg ; polyethylene glycol  17  g ; 
 
white f 54 $nan$nan$sodium chloride 0.9%  flush  3-10  ml ; heparin  5000  unit ; azithromycin  250  mg ; senna  8.6  mg ; polyethylene glycol  17  g ; 
 
white m 76 $nan$nan$aspirin  81  mg ; amlodipine  10  mg ; pravastatin  40  mg ; 
anemia, unspecified hypertrophy (benign) of prostate without urinary obstruction and other lower urinary tract symptom (luts) calculus of kidney insomnia, unspecified other and unspecified hyperlipidemia other constipation hydronephrosis gout, unspecified benign essential hypertension acute kidney failure, unspecified personal history of malignant neoplasm of large intestine retention of urine, unspecified unspecified essential hypertension thrombocytopenia, unspecified gout, unspecified mechanical complication of other vascular device, implant, and graft abdominal aneurysm without mention of rupture fall from other slipping, tripping, or stumbling malignant neoplasm of hepatic flexure injury to bladder and urethra, without mention of open wound into cavity gout, unspecified urinary complications, not elsewhere classified unspecified essential hypertension body mass index 31.0-31.9, adult retention of urine, unspecified osteoarthrosis, unspecified whether generalized or localized, site unspecified removal of other organ (partial) (total) causing abnormal patient reaction, or later complication, without mention of misadventure at time of operation obesity, unspecified other lesion of median nerve unspecified essential hypertension other and unspecified hyperlipidemia abdominal aneurysm without mention of rupture obstructive sleep apnea (adult)(pediatric) gout, unspecified calculus of kidney unspecified essential hypertension gout, unspecified pure hypercholesterolemia abdominal aneurysm without mention of rupture other specified cardiac dysrhythmias unspecified essential hypertension thrombocytopenia, unspecified obstructive sleep apnea (adult)(pediatric) pure hypercholesterolemia gout, unspecified syncope and collapse
white m 76 $nan$hematology blood hematocrit  34.3  %; chemistry blood chloride  103  meq l; chemistry blood creatinine  0.9  mg dl; chemistry blood potassium  4.0  meq l; chemistry blood sodium  137  meq l; chemistry blood urea nitrogen  13  mg dl; blood gas blood lactate  1.0  mmol l$aspirin  81  mg ; amlodipine  10  mg ; pravastatin  40  mg ; sodium chloride 0.9%  flush  3  ml ; oxycodone-acetaminophen (5mg-325mg)  1-2  tab ; d5 1 2ns  1000  ml ; 5% dextrose  1000  ml ; sodium bicarbonate  150  meq ; heparin  5000  unit ; trazodone  100  mg ; lorazepam  1  mg ; tamsulosin  0.4  mg ; fluticasone propionate nasal  2  spry ; 
anemia, unspecified hypertrophy (benign) of prostate without urinary obstruction and other lower urinary tract symptom (luts) calculus of kidney insomnia, unspecified other and unspecified hyperlipidemia other constipation hydronephrosis gout, unspecified benign essential hypertension acute kidney failure, unspecified personal history of malignant neoplasm of large intestine retention of urine, unspecified unspecified essential hypertension thrombocytopenia, unspecified gout, unspecified mechanical complication of other vascular device, implant, and graft abdominal aneurysm without mention of rupture fall from other slipping, tripping, or stumbling malignant neoplasm of hepatic flexure injury to bladder and urethra, without mention of open wound into cavity gout, unspecified urinary complications, not elsewhere classified unspecified essential hypertension body mass index 31.0-31.9, adult retention of urine, unspecified osteoarthrosis, unspecified whether generalized or localized, site unspecified removal of other organ (partial) (total) causing abnormal patient reaction, or later complication, without mention of misadventure at time of operation obesity, unspecified other lesion of median nerve unspecified essential hypertension other and unspecified hyperlipidemia abdominal aneurysm without mention of rupture obstructive sleep apnea (adult)(pediatric) gout, unspecified calculus of kidney unspecified essential hypertension gout, unspecified pure hypercholesterolemia abdominal aneurysm without mention of rupture other specified cardiac dysrhythmias unspecified essential hypertension thrombocytopenia, unspecified obstructive sleep apnea (adult)(pediatric) pure hypercholesterolemia gout, unspecified syncope and collapse
white f 78 $temp  98.2  heartrate  110.0  resprate  32.0  o2sat  94.0  sbp  119.0  dbp  67.0  rhythm    pain  5  $hematology blood hematocrit  37.7  %; hematology blood hemoglobin  12.1  g dl; hematology blood platelet count  201  k ul; chemistry blood anion gap  15  meq l; chemistry blood bicarbonate  19  meq l; chemistry blood chloride  108  meq l; chemistry blood creatinine  0.9  mg dl; chemistry blood potassium  4.2  meq l; chemistry blood sodium  138  meq l; chemistry blood urea nitrogen  24  mg dl; hematology urine wbc  3  # hpf; chemistry blood calcium, total  9.5  mg dl; chemistry blood glucose  69  mg dl; blood gas blood lactate  1.6  mmol l$heparin  5000  unit ; aspirin  325  mg ; atorvastatin  80  mg ; levothyroxine sodium  88  mcg ; omeprazole  20  mg ; acetaminophen  325-650  mg ; albuterol 0.083% neb soln  1  neb ; ipratropium-albuterol neb  1  neb ; metoprolol tartrate  12.5  mg ; tramadol (ultram)  50  mg ; 
dehydration coronary atherosclerosis of native coronary artery unspecified essential hypertension percutaneous transluminal coronary angioplasty status other and unspecified hyperlipidemia unspecified acquired hypothyroidism
white f 78 $nan$nan$heparin  5000  unit ; aspirin  325  mg ; atorvastatin  80  mg ; levothyroxine sodium  88  mcg ; omeprazole  20  mg ; acetaminophen  325-650  mg ; albuterol 0.083% neb soln  1  neb ; ipratropium-albuterol neb  1  neb ; metoprolol tartrate  12.5  mg ; tramadol (ultram)  50  mg ; furosemide  20  mg ; sodium chloride 0.9%  flush  3  ml ; 
dehydration coronary atherosclerosis of native coronary artery unspecified essential hypertension percutaneous transluminal coronary angioplasty status other and unspecified hyperlipidemia unspecified acquired hypothyroidism
white f 78 $nan$hematology blood hematocrit  39.4  %; hematology blood hemoglobin  12.4  g dl; hematology blood platelet count  220  k ul; chemistry blood anion gap  17  meq l; chemistry blood bicarbonate  24  meq l; chemistry blood chloride  102  meq l; chemistry blood creatinine  1.0  mg dl; chemistry blood potassium  3.8  meq l; chemistry blood sodium  139  meq l; chemistry blood urea nitrogen  26  mg dl; chemistry blood calcium, total  9.2  mg dl; chemistry blood glucose  96  mg dl$heparin  5000  unit ; aspirin  325  mg ; atorvastatin  80  mg ; levothyroxine sodium  88  mcg ; omeprazole  20  mg ; acetaminophen  325-650  mg ; albuterol 0.083% neb soln  1  neb ; ipratropium-albuterol neb  1  neb ; metoprolol tartrate  12.5  mg ; sodium chloride 0.9%  flush  3  ml ; ibuprofen  400  mg ; acetaminophen  1000  mg ; polyethylene glycol  17  g ; sodium chloride nasal  1-2  spry ; senna  8.6  mg ; docusate sodium  100  mg ; 
dehydration coronary atherosclerosis of native coronary artery unspecified essential hypertension percutaneous transluminal coronary angioplasty status other and unspecified hyperlipidemia unspecified acquired hypothyroidism
white f 78 $nan$hematology blood hematocrit  41.7  %; hematology blood hemoglobin  13.0  g dl; hematology blood platelet count  239  k ul; chemistry blood anion gap  20  meq l; chemistry blood bicarbonate  24  meq l; chemistry blood chloride  98  meq l; chemistry blood creatinine  1.1  mg dl; chemistry blood potassium  3.5  meq l; chemistry blood sodium  138  meq l; chemistry blood urea nitrogen  21  mg dl; chemistry blood glucose  81  mg dl$heparin  5000  unit ; aspirin  325  mg ; atorvastatin  80  mg ; levothyroxine sodium  88  mcg ; omeprazole  20  mg ; albuterol 0.083% neb soln  1  neb ; ipratropium-albuterol neb  1  neb ; metoprolol tartrate  12.5  mg ; sodium chloride 0.9%  flush  3  ml ; acetaminophen  1000  mg ; polyethylene glycol  17  g ; sodium chloride nasal  1-2  spry ; senna  8.6  mg ; docusate sodium  100  mg ; lidocaine 5% patch  1  ptch ; potassium chloride  40  meq ; calcium carbonate  500  mg ; 
dehydration coronary atherosclerosis of native coronary artery unspecified essential hypertension percutaneous transluminal coronary angioplasty status other and unspecified hyperlipidemia unspecified acquired hypothyroidism
white f 78 $nan$hematology blood hematocrit  44.5  %; hematology blood hemoglobin  14.0  g dl; hematology blood platelet count  297  k ul; chemistry blood anion gap  18  meq l; chemistry blood bicarbonate  24  meq l; chemistry blood chloride  99  meq l; chemistry blood creatinine  1.0  mg dl; chemistry blood potassium  4.3  meq l; chemistry blood sodium  137  meq l; chemistry blood urea nitrogen  18  mg dl; chemistry blood calcium, total  10.0  mg dl; chemistry blood glucose  153  mg dl$heparin  5000  unit ; aspirin  325  mg ; atorvastatin  80  mg ; levothyroxine sodium  88  mcg ; omeprazole  20  mg ; albuterol 0.083% neb soln  1  neb ; ipratropium-albuterol neb  1  neb ; metoprolol tartrate  12.5  mg ; sodium chloride 0.9%  flush  3  ml ; acetaminophen  1000  mg ; polyethylene glycol  17  g ; sodium chloride nasal  1-2  spry ; senna  8.6  mg ; docusate sodium  100  mg ; lidocaine 5% patch  1  ptch ; calcium carbonate  500  mg ; 
dehydration coronary atherosclerosis of native coronary artery unspecified essential hypertension percutaneous transluminal coronary angioplasty status other and unspecified hyperlipidemia unspecified acquired hypothyroidism
white m 62 $temp  97.7  heartrate  60.0  resprate  16.0  o2sat  95.0  sbp  140.0  dbp  73.0  rhythm    pain  0  $hematology blood hematocrit  30.0  %; hematology blood hemoglobin  9.7  g dl; hematology blood platelet count  143  k ul; chemistry blood anion gap  17  meq l; chemistry blood anion gap  17  meq l; chemistry blood bicarbonate  24  meq l; chemistry blood bicarbonate  23  meq l; chemistry blood chloride  105  meq l; chemistry blood chloride  104  meq l; chemistry blood creatinine  2.4  mg dl; chemistry blood creatinine  2.4  mg dl; chemistry blood potassium  3.1  meq l; chemistry blood potassium  3.4  meq l; chemistry blood sodium  143  meq l; chemistry blood sodium  141  meq l; chemistry blood urea nitrogen  41  mg dl; chemistry blood urea nitrogen  40  mg dl; hematology blood inr(pt)  1.9  ; chemistry blood calcium, total  8.2  mg dl; chemistry blood calcium, total  8.3  mg dl; chemistry blood glucose  230  mg dl; chemistry blood glucose  147  mg dl$heparin  5000  unit ; influenza virus vaccine  0.5  ml ; sodium chloride 0.9%  flush  3  ml ; potassium chloride  60  meq ; senna  1  tab ; trazodone  50  mg ; furosemide  80  mg ; warfarin  3.75  mg ; warfarin  2.5  mg ; calcium acetate  667  mg ; fluticasone propionate nasal  1  spry ; mycophenolate sodium  720  mg ; aspirin  325  mg ; atorvastatin  10  mg ; clopidogrel  75  mg ; eplerenone  25  mg ; lisinopril  10  mg ; metoprolol succinate xl  100  mg ; nifedipine cr  30  mg ; omeprazole  40  mg ; sertraline  150  mg ; vitamin d  2000  unit ; nifedipine cr  60  mg ; furosemide  100  mg ; bag  50  ml ; magnesium sulfate  2  gm ; 
car driver injured in collision with two- or three-wheeled motor vehicle in nontraffic accident chronic systolic heart failure hypertensive chronic kidney disease, unspecified, with chronic kidney disease stage i through stage iv, or unspecified chronic kidney disease, stage iv (severe) congestive heart failure, unspecified aortocoronary bypass status gout, unspecified long-term (current) use of anticoagulants pneumonia, organism unspecified atrial fibrillation wegener's granulomatosis esophageal reflux kidney replaced by transplant restless legs syndrome (rls) percutaneous transluminal coronary angioplasty status hypertensive chronic kidney disease, unspecified, with chronic kidney disease stage i through stage iv, or unspecified wegener's granulomatosis chronic kidney disease, stage iii (moderate) mitral valve disorders acute kidney failure, unspecified kidney replaced by transplant other primary cardiomyopathies car driver injured in collision with two- or three-wheeled motor vehicle in nontraffic accident congestive heart failure, unspecified acute on chronic systolic heart failure aortocoronary bypass status atrial fibrillation personal history of noncompliance with medical treatment, presenting hazards to health hypertensive chronic kidney disease, unspecified, with chronic kidney disease stage i through stage iv, or unspecified kidney replaced by transplant acute on chronic systolic heart failure old myocardial infarction aortocoronary bypass status chronic kidney disease, unspecified congestive heart failure, unspecified cardiac pacemaker in situ personal history of transient ischemic attack (tia), and cerebral infarction without residual deficits abnormal coagulation profile pure hypercholesterolemia car driver injured in collision with two- or three-wheeled motor vehicle in nontraffic accident esophageal reflux atrial fibrillation anticoagulants causing adverse effects in therapeutic use hypopotassemia chronic systolic heart failure coronary atherosclerosis of unspecified type of vessel, native or graft unspecified essential hypertension kidney replaced by transplant
white m 62 $nan$nan$heparin  5000  unit ; influenza virus vaccine  0.5  ml ; sodium chloride 0.9%  flush  3  ml ; potassium chloride  60  meq ; senna  1  tab ; trazodone  50  mg ; furosemide  80  mg ; warfarin  3.75  mg ; warfarin  2.5  mg ; calcium acetate  667  mg ; fluticasone propionate nasal  1  spry ; mycophenolate sodium  720  mg ; aspirin  325  mg ; atorvastatin  10  mg ; clopidogrel  75  mg ; eplerenone  25  mg ; lisinopril  10  mg ; metoprolol succinate xl  100  mg ; omeprazole  40  mg ; sertraline  150  mg ; vitamin d  2000  unit ; nifedipine cr  60  mg ; furosemide  100  mg ; bag  50  ml ; magnesium sulfate  2  gm ; tacrolimus  1  mg ; 
car driver injured in collision with two- or three-wheeled motor vehicle in nontraffic accident chronic systolic heart failure hypertensive chronic kidney disease, unspecified, with chronic kidney disease stage i through stage iv, or unspecified chronic kidney disease, stage iv (severe) congestive heart failure, unspecified aortocoronary bypass status gout, unspecified long-term (current) use of anticoagulants pneumonia, organism unspecified atrial fibrillation wegener's granulomatosis esophageal reflux kidney replaced by transplant restless legs syndrome (rls) percutaneous transluminal coronary angioplasty status hypertensive chronic kidney disease, unspecified, with chronic kidney disease stage i through stage iv, or unspecified wegener's granulomatosis chronic kidney disease, stage iii (moderate) mitral valve disorders acute kidney failure, unspecified kidney replaced by transplant other primary cardiomyopathies car driver injured in collision with two- or three-wheeled motor vehicle in nontraffic accident congestive heart failure, unspecified acute on chronic systolic heart failure aortocoronary bypass status atrial fibrillation personal history of noncompliance with medical treatment, presenting hazards to health hypertensive chronic kidney disease, unspecified, with chronic kidney disease stage i through stage iv, or unspecified kidney replaced by transplant acute on chronic systolic heart failure old myocardial infarction aortocoronary bypass status chronic kidney disease, unspecified congestive heart failure, unspecified cardiac pacemaker in situ personal history of transient ischemic attack (tia), and cerebral infarction without residual deficits abnormal coagulation profile pure hypercholesterolemia car driver injured in collision with two- or three-wheeled motor vehicle in nontraffic accident esophageal reflux atrial fibrillation anticoagulants causing adverse effects in therapeutic use hypopotassemia chronic systolic heart failure coronary atherosclerosis of unspecified type of vessel, native or graft unspecified essential hypertension kidney replaced by transplant
white f 74 $temp  98.2  heartrate    resprate  16.0  o2sat  98.0  sbp  116.0  dbp  82.0  rhythm  sr  pain  0  $hematology blood hematocrit  36.6  %; hematology blood hemoglobin  11.9  g dl; hematology blood platelet count  204  k ul; chemistry blood anion gap  16  meq l; chemistry blood bicarbonate  26  meq l; chemistry blood chloride  103  meq l; chemistry blood creatinine  1.4  mg dl; chemistry blood potassium  3.4  meq l; chemistry blood sodium  142  meq l; chemistry blood urea nitrogen  24  mg dl; chemistry urine chloride, urine  51  meq l; chemistry urine creatinine, urine  74  mg dl; chemistry urine potassium, urine  25  meq l; chemistry urine sodium, urine  78  meq l; hematology urine wbc  31  # hpf; chemistry blood calcium, total  10.5  mg dl; chemistry blood albumin  4.1  g dl; chemistry urine protein creatinine ratio  0.2  ratio; chemistry urine calcium, urine  13.1  mg dl; chemistry blood % hemoglobin a1c  5.7  %$sodium chloride 0.9%  flush  3  ml ; furosemide  10  mg ; clopidogrel  600  mg ; heparin  750  unit ; 5% dextrose  250  ml ; heparin sodium  25,000  unit ; senna  1  tab ; metoprolol tartrate  12.5  mg ; docusate sodium  100  mg ; 0.9% sodium chloride  1000  ml ; aspirin  325  mg ; amlodipine  5  mg ; clopidogrel  75  mg ; multivitamins w minerals  1  tab ; vitamin d  400  unit ; 0.45% sodium chloride  1000  ml ; polyethylene glycol  17  g ; 
urinary tract infection, site not specified anxiety state, unspecified chronic kidney disease, unspecified urinary incontinence, unspecified hypertensive chronic kidney disease, unspecified, with chronic kidney disease stage i through stage iv, or unspecified escherichia coli [e. coli] infection in conditions classified elsewhere and of unspecified site essential and other specified forms of tremor other and unspecified hyperlipidemia hypertonicity of bladder 
white f 74 $nan$hematology blood hematocrit  34.3  %; hematology blood hemoglobin  11.1  g dl; hematology blood platelet count  203  k ul; chemistry blood anion gap  13  meq l; chemistry blood bicarbonate  25  meq l; chemistry blood chloride  107  meq l; chemistry blood creatinine  1.4  mg dl; chemistry blood potassium  4.2  meq l; chemistry blood sodium  141  meq l; chemistry blood urea nitrogen  30  mg dl; chemistry blood calcium, total  9.4  mg dl; chemistry blood glucose  103  mg dl$sodium chloride 0.9%  flush  3  ml ; furosemide  10  mg ; clopidogrel  600  mg ; senna  1  tab ; metoprolol tartrate  12.5  mg ; docusate sodium  100  mg ; aspirin  325  mg ; amlodipine  5  mg ; clopidogrel  75  mg ; multivitamins w minerals  1  tab ; vitamin d  400  unit ; polyethylene glycol  17  g ; pravastatin  40  mg ; potassium chloride  40  meq ; bag  50  ml ; magnesium sulfate  2  gm ; heparin  5000  unit ; neutra-phos  1  pkt ; metoprolol succinate xl  25  mg ; lisinopril  5  mg ; 
urinary tract infection, site not specified anxiety state, unspecified chronic kidney disease, unspecified urinary incontinence, unspecified hypertensive chronic kidney disease, unspecified, with chronic kidney disease stage i through stage iv, or unspecified escherichia coli [e. coli] infection in conditions classified elsewhere and of unspecified site essential and other specified forms of tremor other and unspecified hyperlipidemia hypertonicity of bladder 
white f 74 $nan$hematology blood hematocrit  34.9  %; hematology blood hemoglobin  11.2  g dl; hematology blood platelet count  180  k ul; chemistry blood anion gap  11  meq l; chemistry blood bicarbonate  26  meq l; chemistry blood chloride  113  meq l; chemistry blood creatinine  1.4  mg dl; chemistry blood potassium  4.1  meq l; chemistry blood sodium  146  meq l; chemistry blood urea nitrogen  33  mg dl; chemistry blood calcium, total  10.0  mg dl; chemistry blood glucose  139  mg dl$sodium chloride 0.9%  flush  3  ml ; senna  1  tab ; docusate sodium  100  mg ; aspirin  325  mg ; clopidogrel  75  mg ; multivitamins w minerals  1  tab ; vitamin d  400  unit ; polyethylene glycol  17  g ; potassium chloride  40  meq ; bag  50  ml ; magnesium sulfate  2  gm ; heparin  5000  unit ; neutra-phos  1  pkt ; metoprolol succinate xl  25  mg ; lisinopril  5  mg ; rosuvastatin calcium  20  mg ; metoprolol succinate xl  50  mg ; ciprofloxacin hcl  250  mg ; 
urinary tract infection, site not specified anxiety state, unspecified chronic kidney disease, unspecified urinary incontinence, unspecified hypertensive chronic kidney disease, unspecified, with chronic kidney disease stage i through stage iv, or unspecified escherichia coli [e. coli] infection in conditions classified elsewhere and of unspecified site essential and other specified forms of tremor other and unspecified hyperlipidemia hypertonicity of bladder 
white m 66 $nan$nan$bisacodyl  10  mg ; senna  8.6  mg ; docusate sodium  100  mg ; iso-osmotic dextrose  100  ml ; cefazolin  2  g ; sodium chloride 0.9%  flush  3  ml ; 0.45% sodium chloride  1000  ml ; acetaminophen  1000  mg ; oxycodone (immediate release)  5  mg ; hydromorphone (dilaudid)  0.5-1  mg ; diazepam  5  mg ; gabapentin  100  mg ; ciprofloxacin hcl  250  mg ; 
 
white m 66 $nan$nan$bisacodyl  10  mg ; senna  8.6  mg ; docusate sodium  100  mg ; iso-osmotic dextrose  100  ml ; cefazolin  2  g ; sodium chloride 0.9%  flush  3  ml ; 0.45% sodium chloride  1000  ml ; acetaminophen  1000  mg ; oxycodone (immediate release)  5  mg ; hydromorphone (dilaudid)  0.5-1  mg ; diazepam  5  mg ; gabapentin  100  mg ; ciprofloxacin hcl  250  mg ; tamsulosin  0.4  mg ; atorvastatin  10  mg ; lisinopril  20  mg ; metoprolol succinate xl  50  mg ; aspirin  81  mg ; omeprazole  20  mg ; 
 
white m 66 $nan$nan$bisacodyl  10  mg ; senna  8.6  mg ; docusate sodium  100  mg ; sodium chloride 0.9%  flush  3  ml ; acetaminophen  1000  mg ; hydromorphone (dilaudid)  0.5-1  mg ; diazepam  5  mg ; gabapentin  100  mg ; ciprofloxacin hcl  250  mg ; tamsulosin  0.4  mg ; atorvastatin  10  mg ; lisinopril  20  mg ; metoprolol succinate xl  50  mg ; aspirin  81  mg ; omeprazole  20  mg ; oxycodone (immediate release)  5-10  mg ; 
 
unknown m 66 $temp    heartrate  120.0  resprate  12.0  o2sat  95.0  sbp  121.0  dbp  67.0  rhythm    pain  unable   ; temp  97.7  heartrate  83.0  resprate  16.0  o2sat  100.0  sbp  170.0  dbp  83.0  rhythm    pain  unable   $hematology blood hematocrit  34.2  %; hematology blood hematocrit  33.5  %; hematology blood hematocrit  35.1  %; hematology blood hematocrit  33.1  %; hematology blood hemoglobin  11.7  g dl; hematology blood hemoglobin  11.3  g dl; hematology blood platelet count  117  k ul; hematology blood platelet count  113  k ul; chemistry blood anion gap  13  meq l; chemistry blood bicarbonate  24  meq l; chemistry blood chloride  110  meq l; chemistry blood chloride  108  meq l; chemistry blood chloride  108  meq l; chemistry blood creatinine  0.7  mg dl; chemistry blood potassium  5.6  meq l; chemistry blood potassium  4.7  meq l; chemistry blood potassium  4.9  meq l; chemistry blood sodium  141  meq l; chemistry blood sodium  142  meq l; chemistry blood sodium  141  meq l; chemistry blood urea nitrogen  15  mg dl; hematology blood inr(pt)  1.1  ; chemistry blood calcium, total  8.2  mg dl; chemistry blood bilirubin, total  1.1  mg dl; chemistry blood glucose  198  mg dl; chemistry blood lactate dehydrogenase (ld)  187  iu l$influenza vaccine quadrivalent  0.5  ml ; sodium chloride 0.9%  flush  3  ml ; sodium chloride 0.9%  1000  ml ; 0.9% sodium chloride  100  ml ; pantoprazole  80  mg ; fentanyl citrate  25-100  mcg ; thiamine  100  mg ; octreotide acetate  50  mcg ; octreotide acetate  500  mcg ; 0.9% sodium chloride (mini bag plus)  100  ml ; ceftriaxone  1  gm ; fentanyl citrate  2.5  mg ; midazolam  100  mg ; multivitamins  1  tab ; folic acid  1  mg ; chlorhexidine gluconate 0.12% oral rinse  15  ml ; bag  1  bag ; magnesium sulfate  2  gm ; bag  2  bag ; magnesium sulfate  4  gm ; sw  400  ml ; potassium chloride  40  meq ; sw  600  ml ; potassium chloride  60  meq ; sw  800  ml ; potassium chloride  80  meq ; 5% dextrose  250  ml ; thiamine  500  mg ; sucralfate  1  gm ; 
 
unknown m 66 $nan$hematology blood hematocrit  31.9  %; hematology blood hematocrit  30.7  %; hematology blood hemoglobin  10.8  g dl; hematology blood hemoglobin  10.0  g dl; hematology blood platelet count  122  k ul; hematology blood platelet count  117  k ul; chemistry blood anion gap  13  meq l; chemistry blood bicarbonate  25  meq l; chemistry blood chloride  105  meq l; chemistry blood creatinine  0.7  mg dl; chemistry blood potassium  4.6  meq l; chemistry blood sodium  138  meq l; chemistry blood urea nitrogen  22  mg dl; hematology blood inr(pt)  1.2  ; chemistry blood calcium, total  8.3  mg dl; chemistry blood bilirubin, total  0.9  mg dl; chemistry blood glucose  171  mg dl$influenza vaccine quadrivalent  0.5  ml ; sodium chloride 0.9%  flush  3  ml ; sodium chloride 0.9%  1000  ml ; 0.9% sodium chloride  100  ml ; pantoprazole  80  mg ; octreotide acetate  50  mcg ; octreotide acetate  500  mcg ; 0.9% sodium chloride (mini bag plus)  100  ml ; ceftriaxone  1  gm ; folic acid  1  mg ; bag  1  bag ; magnesium sulfate  2  gm ; bag  2  bag ; magnesium sulfate  4  gm ; sw  400  ml ; potassium chloride  40  meq ; sw  600  ml ; potassium chloride  60  meq ; sw  800  ml ; potassium chloride  80  meq ; 5% dextrose  250  ml ; thiamine  500  mg ; acetaminophen  650  mg ; multivitamins  5  ml ; lactulose  60  ml ; lactulose  30  ml ; phenobarbital - icu alcohol withdrawal (initial load   rescue dose)  520  mg ; lactulose enema  1000  ml ; 
 
unknown m 66 $nan$hematology blood hematocrit  31.0  %; hematology blood hemoglobin  10.3  g dl; hematology blood platelet count  123  k ul; chemistry blood anion gap  13  meq l; chemistry blood bicarbonate  27  meq l; chemistry blood chloride  105  meq l; chemistry blood creatinine  0.7  mg dl; chemistry blood potassium  3.6  meq l; chemistry blood sodium  141  meq l; chemistry blood urea nitrogen  16  mg dl; hematology blood inr(pt)  1.2  ; chemistry blood calcium, total  7.5  mg dl; blood gas blood free calcium  1.10  mmol l; blood gas blood lactate  1.0  mmol l$influenza vaccine quadrivalent  0.5  ml ; sodium chloride 0.9%  flush  3  ml ; 0.9% sodium chloride  100  ml ; pantoprazole  80  mg ; octreotide acetate  500  mcg ; 0.9% sodium chloride (mini bag plus)  100  ml ; ceftriaxone  1  gm ; folic acid  1  mg ; bag  1  bag ; magnesium sulfate  2  gm ; bag  2  bag ; magnesium sulfate  4  gm ; sw  400  ml ; potassium chloride  40  meq ; sw  600  ml ; potassium chloride  60  meq ; sw  800  ml ; potassium chloride  80  meq ; 5% dextrose  250  ml ; thiamine  500  mg ; multivitamins  5  ml ; lactulose  60  ml ; lactulose  30  ml ; phenobarbital - icu alcohol withdrawal (initial load   rescue dose)  520  mg ; lactulose enema  1000  ml ; phenobarbital alcohol withdrawal dose taper (days 2-7)  35  mg ; heparin  5000  unit ; vial  1  vial ; pantoprazole  40  mg ; 
 
unknown m 66 $nan$hematology blood hematocrit  29.7  %; hematology blood hemoglobin  10.4  g dl; hematology blood platelet count  129  k ul; chemistry blood anion gap  13  meq l; chemistry blood bicarbonate  26  meq l; chemistry blood chloride  97  meq l; chemistry blood creatinine  0.6  mg dl; chemistry blood potassium  3.9  meq l; chemistry blood sodium  132  meq l; chemistry blood urea nitrogen  14  mg dl; hematology blood inr(pt)  1.2  ; chemistry blood calcium, total  7.8  mg dl; chemistry blood glucose  262  mg dl$influenza vaccine quadrivalent  0.5  ml ; sodium chloride 0.9%  flush  3  ml ; octreotide acetate  500  mcg ; 0.9% sodium chloride (mini bag plus)  100  ml ; ceftriaxone  1  gm ; folic acid  1  mg ; bag  1  bag ; magnesium sulfate  2  gm ; bag  2  bag ; magnesium sulfate  4  gm ; sw  400  ml ; potassium chloride  40  meq ; sw  600  ml ; potassium chloride  60  meq ; sw  800  ml ; potassium chloride  80  meq ; 5% dextrose  250  ml ; thiamine  500  mg ; multivitamins  5  ml ; lactulose  30  ml ; heparin  5000  unit ; vial  1  vial ; pantoprazole  40  mg ; ondansetron  4  mg ; dextrose 50%  12.5  gm ; glucagon  1  mg ; glucose gel  15  g ; insulin  0  unit ; 
 
unknown m 66 $nan$hematology blood hematocrit  29.7  %; hematology blood hemoglobin  10.0  g dl; hematology blood platelet count  157  k ul; chemistry blood anion gap  10  meq l; chemistry blood bicarbonate  28  meq l; chemistry blood chloride  104  meq l; chemistry blood creatinine  0.8  mg dl; chemistry blood potassium  3.8  meq l; chemistry blood sodium  138  meq l; chemistry blood urea nitrogen  23  mg dl; hematology blood inr(pt)  1.2  ; chemistry blood bilirubin, total  1.0  mg dl; chemistry blood glucose  133  mg dl; chemistry blood % hemoglobin a1c  6.3  %$influenza vaccine quadrivalent  0.5  ml ; 0.9% sodium chloride (mini bag plus)  100  ml ; ceftriaxone  1  gm ; folic acid  1  mg ; multivitamins  5  ml ; lactulose  30  ml ; heparin  5000  unit ; vial  1  vial ; pantoprazole  40  mg ; ondansetron  4  mg ; dextrose 50%  12.5  gm ; glucagon  1  mg ; glucose gel  15  g ; insulin  0  unit ; nadolol  20  mg ; 
 
unknown m 66 $nan$hematology blood hematocrit  29.7  %; hematology blood hemoglobin  10.1  g dl; hematology blood platelet count  163  k ul; chemistry blood anion gap  8  meq l; chemistry blood bicarbonate  28  meq l; chemistry blood chloride  103  meq l; chemistry blood creatinine  0.8  mg dl; chemistry blood potassium  3.3  meq l; chemistry blood sodium  136  meq l; chemistry blood urea nitrogen  24  mg dl; hematology blood inr(pt)  1.2  ; chemistry blood calcium, total  8.5  mg dl; chemistry blood bilirubin, total  0.7  mg dl; chemistry blood glucose  138  mg dl$influenza vaccine quadrivalent  0.5  ml ; 0.9% sodium chloride (mini bag plus)  100  ml ; ceftriaxone  1  gm ; folic acid  1  mg ; multivitamins  5  ml ; heparin  5000  unit ; vial  1  vial ; pantoprazole  40  mg ; dextrose 50%  12.5  gm ; glucagon  1  mg ; glucose gel  15  g ; insulin  0  unit ; nadolol  20  mg ; 
 
unknown m 66 $nan$hematology blood hematocrit  30.3  %; hematology blood hemoglobin  10.3  g dl; hematology blood platelet count  159  k ul; chemistry blood anion gap  9  meq l; chemistry blood bicarbonate  27  meq l; chemistry blood chloride  102  meq l; chemistry blood creatinine  0.7  mg dl; chemistry blood potassium  3.6  meq l; chemistry blood sodium  134  meq l; chemistry blood urea nitrogen  21  mg dl; hematology blood inr(pt)  1.2  ; chemistry blood calcium, total  8.3  mg dl; chemistry blood bilirubin, total  0.7  mg dl; chemistry blood glucose  108  mg dl$influenza vaccine quadrivalent  0.5  ml ; 0.9% sodium chloride (mini bag plus)  100  ml ; ceftriaxone  1  gm ; folic acid  1  mg ; heparin  5000  unit ; dextrose 50%  12.5  gm ; glucagon  1  mg ; glucose gel  15  g ; insulin  0  unit ; nadolol  20  mg ; multivitamins w minerals  1  tab ; ondansetron  8  mg ; 
 
unknown m 66 $nan$hematology blood hematocrit  29.0  %; hematology blood hemoglobin  9.7  g dl; hematology blood platelet count  173  k ul; chemistry blood anion gap  11  meq l; chemistry blood bicarbonate  29  meq l; chemistry blood chloride  102  meq l; chemistry blood creatinine  0.7  mg dl; chemistry blood potassium  3.5  meq l; chemistry blood sodium  138  meq l; chemistry blood urea nitrogen  17  mg dl; hematology blood inr(pt)  1.1  ; chemistry blood calcium, total  8.3  mg dl; chemistry blood bilirubin, total  0.6  mg dl; chemistry blood glucose  110  mg dl$0.9% sodium chloride (mini bag plus)  100  ml ; ceftriaxone  1  gm ; folic acid  1  mg ; heparin  5000  unit ; dextrose 50%  12.5  gm ; glucagon  1  mg ; glucose gel  15  g ; insulin  0  unit ; nadolol  20  mg ; multivitamins w minerals  1  tab ; ondansetron  8  mg ; 
 
black african american f 58 $nan$nan$tacrolimus  0.5  mg ; tacrolimus  2  mg ; raltegravir  400  mg ; amlodipine  10  mg ; levothyroxine sodium  25  mcg ; ribavirin  200  mg ; 
hypertensive chronic kidney disease, unspecified, with chronic kidney disease stage i through stage iv, or unspecified anemia, unspecified cirrhosis of liver without mention of alcohol other specified disorders of female genital organs human immunodeficiency virus [hiv] disease unspecified acquired hypothyroidism chronic kidney disease, unspecified liver replaced by transplant person on outside of car injured in collision with two- or three-wheeled motor vehicle in traffic accident human immunodeficiency virus [hiv] disease thrombocytopenia, unspecified obstruction of bile duct osteoporosis, unspecified acute kidney failure, unspecified unspecified acquired hypothyroidism chronic hepatitis c without mention of hepatic coma complications of transplanted liver unspecified essential hypertension surgical operation with transplant of whole organ causing abnormal patient reaction, or later complication, without mention of misadventure at time of operation malignant neoplasm of liver, primary nonspecific elevation of levels of transaminase or lactic acid dehydrogenase [ldh] leukocytopenia, unspecified anemia of other chronic disease unspecified acquired hypothyroidism cirrhosis of liver without mention of alcohol thrombocytopenia, unspecified malignant neoplasm of liver, primary other chronic pulmonary heart diseases mitral valve disorders acquired absence of intestine (large) (small) osteoporosis, unspecified complications of transplanted liver allergy to radiographic dye human immunodeficiency virus [hiv] disease unspecified essential hypertension unspecified viral hepatitis c without hepatic coma edema fever, unspecified antineoplastic and immunosuppressive drugs causing adverse effects in therapeutic use thrombocytopenia, unspecified drug induced headache, not elsewhere classified personal history of noncompliance with medical treatment, presenting hazards to health other specified visual disturbances other neutropenia unspecified acquired hypothyroidism unspecified essential hypertension acute hepatitis c without mention of hepatic coma herpetic gingivostomatitis
black african american f 58 $nan$hematology blood hematocrit  24.4  %; hematology blood hemoglobin  7.6  g dl; hematology blood platelet count  85  k ul; chemistry blood anion gap  13  meq l; chemistry blood bicarbonate  11  meq l; chemistry blood chloride  119  meq l; chemistry blood creatinine  1.9  mg dl; chemistry blood potassium  3.9  meq l; chemistry blood sodium  139  meq l; chemistry blood urea nitrogen  21  mg dl; hematology blood inr(pt)  1.3  ; chemistry blood calcium, total  8.2  mg dl; chemistry blood bilirubin, total  1.2  mg dl; chemistry blood glucose  116  mg dl; chemistry blood lactate dehydrogenase (ld)  247  iu l$tacrolimus  0.5  mg ; tacrolimus  2  mg ; raltegravir  400  mg ; amlodipine  10  mg ; levothyroxine sodium  25  mcg ; ribavirin  200  mg ; sodium chloride 0.9%  flush  3  ml ; 0.9% sodium chloride  1000  ml ; lidocaine viscous 2%  20  ml ; ondansetron odt  4  mg ; prochlorperazine  25  mg ; tramadol (ultram)  50  mg ; zolpidem tartrate  10  mg ; acetaminophen  500  mg ; emtricitabine-tenofovir (truvada)  1  tab ; nystatin oral suspension  5  ml ; hydrocodone-acetaminophen  1  tab ; acyclovir  400  mg ; acyclovir  800  mg ; ursodiol  600  mg ; 5% dextrose  100  ml ; acyclovir  500  mg ; mycophenolate mofetil  250  mg ; docusate sodium  100  mg ; heparin  5000  unit ; ondansetron  4  mg ; vial  1  vial ; epoetin alfa  20,000  unit ; 
hypertensive chronic kidney disease, unspecified, with chronic kidney disease stage i through stage iv, or unspecified anemia, unspecified cirrhosis of liver without mention of alcohol other specified disorders of female genital organs human immunodeficiency virus [hiv] disease unspecified acquired hypothyroidism chronic kidney disease, unspecified liver replaced by transplant person on outside of car injured in collision with two- or three-wheeled motor vehicle in traffic accident human immunodeficiency virus [hiv] disease thrombocytopenia, unspecified obstruction of bile duct osteoporosis, unspecified acute kidney failure, unspecified unspecified acquired hypothyroidism chronic hepatitis c without mention of hepatic coma complications of transplanted liver unspecified essential hypertension surgical operation with transplant of whole organ causing abnormal patient reaction, or later complication, without mention of misadventure at time of operation malignant neoplasm of liver, primary nonspecific elevation of levels of transaminase or lactic acid dehydrogenase [ldh] leukocytopenia, unspecified anemia of other chronic disease unspecified acquired hypothyroidism cirrhosis of liver without mention of alcohol thrombocytopenia, unspecified malignant neoplasm of liver, primary other chronic pulmonary heart diseases mitral valve disorders acquired absence of intestine (large) (small) osteoporosis, unspecified complications of transplanted liver allergy to radiographic dye human immunodeficiency virus [hiv] disease unspecified essential hypertension unspecified viral hepatitis c without hepatic coma edema fever, unspecified antineoplastic and immunosuppressive drugs causing adverse effects in therapeutic use thrombocytopenia, unspecified drug induced headache, not elsewhere classified personal history of noncompliance with medical treatment, presenting hazards to health other specified visual disturbances other neutropenia unspecified acquired hypothyroidism unspecified essential hypertension acute hepatitis c without mention of hepatic coma herpetic gingivostomatitis
black african american f 58 $nan$hematology blood hematocrit  24.4  %; hematology blood hemoglobin  7.5  g dl; hematology blood platelet count  80  k ul; chemistry blood anion gap  12  meq l; chemistry blood bicarbonate  12  meq l; chemistry blood chloride  115  meq l; chemistry blood creatinine  1.6  mg dl; chemistry blood potassium  3.6  meq l; chemistry blood sodium  135  meq l; chemistry blood urea nitrogen  18  mg dl; hematology blood inr(pt)  1.3  ; chemistry urine chloride, urine  53  meq l; chemistry urine creatinine, urine  97  mg dl; chemistry urine potassium, urine  26  meq l; chemistry urine sodium, urine  52  meq l; chemistry urine urea nitrogen, urine  491  mg dl; hematology urine wbc  11  # hpf; chemistry blood calcium, total  8.2  mg dl; chemistry blood bilirubin, total  1.3  mg dl; chemistry blood glucose  135  mg dl$raltegravir  400  mg ; amlodipine  10  mg ; levothyroxine sodium  25  mcg ; sodium chloride 0.9%  flush  3  ml ; lidocaine viscous 2%  20  ml ; ondansetron odt  4  mg ; prochlorperazine  25  mg ; tramadol (ultram)  50  mg ; zolpidem tartrate  10  mg ; emtricitabine-tenofovir (truvada)  1  tab ; hydrocodone-acetaminophen  1  tab ; acyclovir  800  mg ; ursodiol  600  mg ; mycophenolate mofetil  250  mg ; docusate sodium  100  mg ; heparin  5000  unit ; ondansetron  4  mg ; vial  1  vial ; epoetin alfa  20,000  unit ; iso-osmotic sodium chloride  100  ml ; fluconazole  200  mg ; bag  50  ml ; magnesium sulfate  2  gm ; tacrolimus  1  mg ; fluconazole  100  mg ; potassium chloride  40  meq ; neutra-phos  2  pkt ; azithromycin  1200  mg ; atovaquone suspension  1500  mg ; 
hypertensive chronic kidney disease, unspecified, with chronic kidney disease stage i through stage iv, or unspecified anemia, unspecified cirrhosis of liver without mention of alcohol other specified disorders of female genital organs human immunodeficiency virus [hiv] disease unspecified acquired hypothyroidism chronic kidney disease, unspecified liver replaced by transplant person on outside of car injured in collision with two- or three-wheeled motor vehicle in traffic accident human immunodeficiency virus [hiv] disease thrombocytopenia, unspecified obstruction of bile duct osteoporosis, unspecified acute kidney failure, unspecified unspecified acquired hypothyroidism chronic hepatitis c without mention of hepatic coma complications of transplanted liver unspecified essential hypertension surgical operation with transplant of whole organ causing abnormal patient reaction, or later complication, without mention of misadventure at time of operation malignant neoplasm of liver, primary nonspecific elevation of levels of transaminase or lactic acid dehydrogenase [ldh] leukocytopenia, unspecified anemia of other chronic disease unspecified acquired hypothyroidism cirrhosis of liver without mention of alcohol thrombocytopenia, unspecified malignant neoplasm of liver, primary other chronic pulmonary heart diseases mitral valve disorders acquired absence of intestine (large) (small) osteoporosis, unspecified complications of transplanted liver allergy to radiographic dye human immunodeficiency virus [hiv] disease unspecified essential hypertension unspecified viral hepatitis c without hepatic coma edema fever, unspecified antineoplastic and immunosuppressive drugs causing adverse effects in therapeutic use thrombocytopenia, unspecified drug induced headache, not elsewhere classified personal history of noncompliance with medical treatment, presenting hazards to health other specified visual disturbances other neutropenia unspecified acquired hypothyroidism unspecified essential hypertension acute hepatitis c without mention of hepatic coma herpetic gingivostomatitis
black african american f 58 $nan$nan$raltegravir  400  mg ; amlodipine  10  mg ; levothyroxine sodium  25  mcg ; sodium chloride 0.9%  flush  3  ml ; lidocaine viscous 2%  20  ml ; ondansetron odt  4  mg ; prochlorperazine  25  mg ; tramadol (ultram)  50  mg ; zolpidem tartrate  10  mg ; emtricitabine-tenofovir (truvada)  1  tab ; hydrocodone-acetaminophen  1  tab ; acyclovir  800  mg ; ursodiol  600  mg ; mycophenolate mofetil  250  mg ; docusate sodium  100  mg ; heparin  5000  unit ; ondansetron  4  mg ; vial  1  vial ; epoetin alfa  20,000  unit ; bag  50  ml ; magnesium sulfate  2  gm ; tacrolimus  1  mg ; fluconazole  100  mg ; potassium chloride  40  meq ; neutra-phos  2  pkt ; azithromycin  1200  mg ; atovaquone suspension  1500  mg ; 
hypertensive chronic kidney disease, unspecified, with chronic kidney disease stage i through stage iv, or unspecified anemia, unspecified cirrhosis of liver without mention of alcohol other specified disorders of female genital organs human immunodeficiency virus [hiv] disease unspecified acquired hypothyroidism chronic kidney disease, unspecified liver replaced by transplant person on outside of car injured in collision with two- or three-wheeled motor vehicle in traffic accident human immunodeficiency virus [hiv] disease thrombocytopenia, unspecified obstruction of bile duct osteoporosis, unspecified acute kidney failure, unspecified unspecified acquired hypothyroidism chronic hepatitis c without mention of hepatic coma complications of transplanted liver unspecified essential hypertension surgical operation with transplant of whole organ causing abnormal patient reaction, or later complication, without mention of misadventure at time of operation malignant neoplasm of liver, primary nonspecific elevation of levels of transaminase or lactic acid dehydrogenase [ldh] leukocytopenia, unspecified anemia of other chronic disease unspecified acquired hypothyroidism cirrhosis of liver without mention of alcohol thrombocytopenia, unspecified malignant neoplasm of liver, primary other chronic pulmonary heart diseases mitral valve disorders acquired absence of intestine (large) (small) osteoporosis, unspecified complications of transplanted liver allergy to radiographic dye human immunodeficiency virus [hiv] disease unspecified essential hypertension unspecified viral hepatitis c without hepatic coma edema fever, unspecified antineoplastic and immunosuppressive drugs causing adverse effects in therapeutic use thrombocytopenia, unspecified drug induced headache, not elsewhere classified personal history of noncompliance with medical treatment, presenting hazards to health other specified visual disturbances other neutropenia unspecified acquired hypothyroidism unspecified essential hypertension acute hepatitis c without mention of hepatic coma herpetic gingivostomatitis
white f 52 $nan$nan$influenza virus vaccine  0.5  ml ; lr  1000  ml ; 0.9% sodium chloride  100  ml ; cefazolin  2  gm ; heparin  5000  unit ; iso-osmotic sodium chloride  50  ml ; famotidine  20  mg ; prochlorperazine  10  mg ; ondansetron  4  mg ; hydromorphone (dilaudid)  12.5  mg ; chloraseptic throat spray  1  spry ; lorazepam  0.5  mg ; 
 
white f 52 $nan$nan$influenza virus vaccine  0.5  ml ; lr  1000  ml ; 0.9% sodium chloride  100  ml ; cefazolin  2  gm ; heparin  5000  unit ; iso-osmotic sodium chloride  50  ml ; famotidine  20  mg ; prochlorperazine  10  mg ; ondansetron  4  mg ; hydromorphone (dilaudid)  12.5  mg ; chloraseptic throat spray  1  spry ; lorazepam  0.5  mg ; diphenhydramine  25  mg ; sarna lotion  1  appl ; morphine sulfate  50  mg ; oxycodone-acetaminophen elixir  5-10  ml ; escitalopram oxalate  20  mg ; 
 
white f 52 $nan$nan$influenza virus vaccine  0.5  ml ; heparin  5000  unit ; iso-osmotic sodium chloride  50  ml ; famotidine  20  mg ; prochlorperazine  10  mg ; ondansetron  4  mg ; chloraseptic throat spray  1  spry ; lorazepam  0.5  mg ; diphenhydramine  25  mg ; sarna lotion  1  appl ; oxycodone-acetaminophen elixir  5-10  ml ; escitalopram oxalate  20  mg ; 
 
asian f 26 $nan$hematology blood hematocrit  38.6  %; hematology blood hemoglobin  13.5  g dl; hematology blood platelet count  136  k ul$influenza vaccine quadrivalent  0.5  ml ; sodium chloride 0.9%  flush  3  ml ; ondansetron  4  mg ; lactated ringers  1000  ml ; docusate sodium  100  mg ; ibuprofen  600  mg ; acetaminophen  500-1000  mg ; bisacodyl  10  mg ; milk of magnesia  30  ml ; simethicone  80  mg ; calcium carbonate  500  mg ; tetanus-diphtox-acellular pertuss (adacel)  0.5  ml ; 
 
asian f 26 $nan$hematology blood hematocrit  27.5  %$influenza vaccine quadrivalent  0.5  ml ; sodium chloride 0.9%  flush  3  ml ; ondansetron  4  mg ; lactated ringers  1000  ml ; docusate sodium  100  mg ; ibuprofen  600  mg ; acetaminophen  500-1000  mg ; bisacodyl  10  mg ; milk of magnesia  30  ml ; simethicone  80  mg ; calcium carbonate  500  mg ; tetanus-diphtox-acellular pertuss (adacel)  0.5  ml ; dermoplast spray  1  spry ; 
 
asian f 26 $nan$nan$influenza vaccine quadrivalent  0.5  ml ; sodium chloride 0.9%  flush  3  ml ; ondansetron  4  mg ; lactated ringers  1000  ml ; docusate sodium  100  mg ; ibuprofen  600  mg ; acetaminophen  500-1000  mg ; bisacodyl  10  mg ; milk of magnesia  30  ml ; simethicone  80  mg ; calcium carbonate  500  mg ; tetanus-diphtox-acellular pertuss (adacel)  0.5  ml ; dermoplast spray  1  spry ; 
 
white m 63 $nan$nan$clopidogrel  75  mg ; atorvastatin  20  mg ; valsartan  80  mg ; aspirin  325  mg ; 
coronary atherosclerosis of native coronary artery anemia, unspecified unspecified essential hypertension pure hypercholesterolemia aortocoronary bypass status acquired absence of kidney esophageal reflux knee joint replacement atrial fibrillation unspecified essential hypertension pure hypercholesterolemia helicobacter pylori [h. pylori] other iatrogenic hypotension coronary atherosclerosis of native coronary artery obesity, unspecified other and unspecified angina pectoris
white m 63 $nan$hematology blood hematocrit  42.1  %; hematology blood hemoglobin  14.7  g dl; hematology blood platelet count  153  k ul; chemistry blood anion gap  11  meq l; chemistry blood bicarbonate  28  meq l; chemistry blood chloride  106  meq l; chemistry blood creatinine  1.1  mg dl; chemistry blood potassium  4.4  meq l; chemistry blood sodium  141  meq l; chemistry blood urea nitrogen  21  mg dl; hematology blood inr(pt)  1.0  ; chemistry blood calcium, total  9.2  mg dl; chemistry blood glucose  90  mg dl$clopidogrel  75  mg ; atorvastatin  20  mg ; valsartan  80  mg ; aspirin  325  mg ; sodium chloride 0.9%  flush  3  ml ; senna  1  tab ; docusate sodium  100  mg ; heparin  4000  unit ; heparin  1800  unit ; 5% dextrose  250  ml ; heparin sodium  25,000  unit ; morphine sulfate  2  mg ; acetaminophen  1000  mg ; metoprolol tartrate  25  mg ; heparin  5000  unit ; 
coronary atherosclerosis of native coronary artery anemia, unspecified unspecified essential hypertension pure hypercholesterolemia aortocoronary bypass status acquired absence of kidney esophageal reflux knee joint replacement atrial fibrillation unspecified essential hypertension pure hypercholesterolemia helicobacter pylori [h. pylori] other iatrogenic hypotension coronary atherosclerosis of native coronary artery obesity, unspecified other and unspecified angina pectoris
white m 63 $nan$hematology blood hematocrit  46.8  %; hematology blood hemoglobin  15.4  g dl; hematology blood platelet count  186  k ul; chemistry blood anion gap  15  meq l; chemistry blood bicarbonate  24  meq l; chemistry blood chloride  106  meq l; chemistry blood creatinine  1.0  mg dl; chemistry blood potassium  4.2  meq l; chemistry blood sodium  141  meq l; chemistry blood urea nitrogen  21  mg dl; hematology blood inr(pt)  1.1  ; chemistry blood calcium, total  9.7  mg dl; chemistry blood glucose  85  mg dl$clopidogrel  75  mg ; atorvastatin  20  mg ; valsartan  80  mg ; aspirin  325  mg ; sodium chloride 0.9%  flush  3  ml ; senna  1  tab ; docusate sodium  100  mg ; morphine sulfate  2  mg ; acetaminophen  1000  mg ; metoprolol tartrate  25  mg ; heparin  5000  unit ; acetylcysteine 20%  600  mg ; d5 1 2ns  1000  ml ; 1 2 ns  1000  ml ; atropine sulfate  0.5  mg ; 
coronary atherosclerosis of native coronary artery anemia, unspecified unspecified essential hypertension pure hypercholesterolemia aortocoronary bypass status acquired absence of kidney esophageal reflux knee joint replacement atrial fibrillation unspecified essential hypertension pure hypercholesterolemia helicobacter pylori [h. pylori] other iatrogenic hypotension coronary atherosclerosis of native coronary artery obesity, unspecified other and unspecified angina pectoris
white m 63 $nan$nan$clopidogrel  75  mg ; atorvastatin  20  mg ; valsartan  80  mg ; aspirin  325  mg ; sodium chloride 0.9%  flush  3  ml ; senna  1  tab ; docusate sodium  100  mg ; morphine sulfate  2  mg ; acetaminophen  1000  mg ; metoprolol tartrate  25  mg ; heparin  5000  unit ; acetylcysteine 20%  600  mg ; d5 1 2ns  1000  ml ; 1 2 ns  1000  ml ; atropine sulfate  0.5  mg ; 
coronary atherosclerosis of native coronary artery anemia, unspecified unspecified essential hypertension pure hypercholesterolemia aortocoronary bypass status acquired absence of kidney esophageal reflux knee joint replacement atrial fibrillation unspecified essential hypertension pure hypercholesterolemia helicobacter pylori [h. pylori] other iatrogenic hypotension coronary atherosclerosis of native coronary artery obesity, unspecified other and unspecified angina pectoris
white m 63 $nan$nan$allopurinol  300  mg ; atorvastatin  10  mg ; finasteride  5  mg ; fluoxetine  10  mg ; fluticasone propionate nasal  1  spry ; 
 
white m 63 $nan$hematology blood hematocrit  39.8  %; hematology blood hemoglobin  13.9  g dl; hematology blood platelet count  310  k ul; chemistry blood anion gap  12  meq l; chemistry blood bicarbonate  29  meq l; chemistry blood chloride  106  meq l; chemistry blood creatinine  1.3  mg dl; chemistry blood potassium  3.3  meq l; chemistry blood sodium  144  meq l; chemistry blood urea nitrogen  13  mg dl; hematology blood inr(pt)  1.2  ; chemistry blood calcium, total  8.5  mg dl; chemistry blood glucose  90  mg dl; chemistry blood % hemoglobin a1c  5.3  %$allopurinol  300  mg ; atorvastatin  10  mg ; finasteride  5  mg ; fluoxetine  10  mg ; fluticasone propionate nasal  1  spry ; influenza virus vaccine  0.5  ml ; sodium chloride 0.9%  flush  3  ml ; 0.9% sodium chloride  1000  ml ; acetaminophen  325-650  mg ; bisacodyl  10  mg ; senna  1  tab ; hydralazine  10  mg ; insulin  0  unit ; nifed  90  mg ; docusate sodium  100  mg ; 0.9% sodium chloride  100  ml ; levetiracetam  1000  mg ; levetiracetam  500  mg ; hydralazine  25  mg ; tamsulosin  0.4  mg ; tamsulosin  0.8  mg ; zolpidem tartrate  5  mg ; 
 
white m 63 $nan$hematology blood hematocrit  40.4  %; hematology blood hemoglobin  14.3  g dl; hematology blood platelet count  330  k ul; chemistry blood anion gap  12  meq l; chemistry blood bicarbonate  27  meq l; chemistry blood chloride  104  meq l; chemistry blood creatinine  1.1  mg dl; chemistry blood potassium  3.4  meq l; chemistry blood sodium  140  meq l; chemistry blood urea nitrogen  13  mg dl; chemistry blood glucose  86  mg dl$allopurinol  300  mg ; atorvastatin  10  mg ; finasteride  5  mg ; fluoxetine  10  mg ; fluticasone propionate nasal  1  spry ; influenza virus vaccine  0.5  ml ; sodium chloride 0.9%  flush  3  ml ; acetaminophen  325-650  mg ; bisacodyl  10  mg ; senna  1  tab ; insulin  0  unit ; nifed  90  mg ; docusate sodium  100  mg ; 0.9% sodium chloride  100  ml ; levetiracetam  1000  mg ; levetiracetam  500  mg ; hydralazine  25  mg ; tamsulosin  0.8  mg ; zolpidem tartrate  5  mg ; potassium chloride  40  meq ; tramadol (ultram)  50  mg ; 
 
white m 63 $nan$hematology blood hematocrit  36.8  %; hematology blood hemoglobin  13.4  g dl; hematology blood platelet count  293  k ul; chemistry blood anion gap  15  meq l; chemistry blood bicarbonate  25  meq l; chemistry blood chloride  104  meq l; chemistry blood creatinine  1.1  mg dl; chemistry blood potassium  3.1  meq l; chemistry blood sodium  141  meq l; chemistry blood urea nitrogen  10  mg dl; hematology blood inr(pt)  1.2  ; chemistry blood glucose  104  mg dl$allopurinol  300  mg ; atorvastatin  10  mg ; finasteride  5  mg ; fluoxetine  10  mg ; fluticasone propionate nasal  1  spry ; influenza virus vaccine  0.5  ml ; sodium chloride 0.9%  flush  3  ml ; bisacodyl  10  mg ; senna  1  tab ; nifed  90  mg ; docusate sodium  100  mg ; levetiracetam  500  mg ; hydralazine  25  mg ; tamsulosin  0.8  mg ; zolpidem tartrate  5  mg ; potassium chloride  40  meq ; tramadol (ultram)  50  mg ; oxycodone-acetaminophen  1-2  tab ; 
 
white m 63 $nan$hematology blood hematocrit  31.0  %; hematology blood hemoglobin  11.1  g dl; hematology blood platelet count  286  k ul; chemistry blood anion gap  13  meq l; chemistry blood bicarbonate  24  meq l; chemistry blood chloride  109  meq l; chemistry blood creatinine  1.0  mg dl; chemistry blood potassium  3.2  meq l; chemistry blood sodium  143  meq l; chemistry blood urea nitrogen  12  mg dl; chemistry blood calcium, total  8.2  mg dl; chemistry blood glucose  120  mg dl; chemistry blood albumin  3.3  g dl$allopurinol  300  mg ; atorvastatin  10  mg ; finasteride  5  mg ; fluoxetine  10  mg ; fluticasone propionate nasal  1  spry ; influenza virus vaccine  0.5  ml ; sodium chloride 0.9%  flush  3  ml ; bisacodyl  10  mg ; senna  1  tab ; nifed  90  mg ; docusate sodium  100  mg ; levetiracetam  500  mg ; hydralazine  25  mg ; tamsulosin  0.8  mg ; zolpidem tartrate  5  mg ; tramadol (ultram)  50  mg ; oxycodone-acetaminophen  1-2  tab ; d5w  250  ml ; nitroglycerin  100  mg ; acetaminophen  650  mg ; hydromorphone (dilaudid)  0.5-1  mg ; famotidine  20  mg ; 
 
white m 63 $nan$hematology blood hematocrit  30.0  %; hematology blood hemoglobin  10.8  g dl; hematology blood platelet count  297  k ul; chemistry blood anion gap  13  meq l; chemistry blood bicarbonate  23  meq l; chemistry blood chloride  107  meq l; chemistry blood creatinine  0.9  mg dl; chemistry blood potassium  3.5  meq l; chemistry blood sodium  139  meq l; chemistry blood urea nitrogen  11  mg dl; hematology blood inr(pt)  1.2  ; chemistry blood calcium, total  8.2  mg dl; chemistry blood glucose  115  mg dl$allopurinol  300  mg ; atorvastatin  10  mg ; finasteride  5  mg ; fluoxetine  10  mg ; fluticasone propionate nasal  1  spry ; influenza virus vaccine  0.5  ml ; sodium chloride 0.9%  flush  3  ml ; bisacodyl  10  mg ; senna  1  tab ; nifed  90  mg ; docusate sodium  100  mg ; levetiracetam  500  mg ; tamsulosin  0.8  mg ; zolpidem tartrate  5  mg ; tramadol (ultram)  50  mg ; oxycodone-acetaminophen  1-2  tab ; d5w  250  ml ; nitroglycerin  100  mg ; acetaminophen  650  mg ; hydromorphone (dilaudid)  0.5-1  mg ; famotidine  20  mg ; hydralazine  50  mg ; metoprolol tartrate  5  mg ; sw  50  ml ; magnesium sulfate  2  gm ; hydralazine  75  mg ; 0.9% sodium chloride  250  ml ; nicardipine iv  125  mg ; lisinopril  10  mg ; nifedipine  30  mg ; nifedipine  90  mg ; nifedipine cr  90  mg ; 
 
white m 63 $nan$hematology blood hematocrit  33.2  %; hematology blood hemoglobin  11.6  g dl; hematology blood platelet count  308  k ul; chemistry blood anion gap  12  meq l; chemistry blood bicarbonate  25  meq l; chemistry blood chloride  107  meq l; chemistry blood creatinine  1.2  mg dl; chemistry blood potassium  3.1  meq l; chemistry blood sodium  141  meq l; chemistry blood urea nitrogen  19  mg dl; chemistry blood calcium, total  8.5  mg dl; chemistry blood glucose  118  mg dl$allopurinol  300  mg ; atorvastatin  10  mg ; finasteride  5  mg ; fluoxetine  10  mg ; fluticasone propionate nasal  1  spry ; influenza virus vaccine  0.5  ml ; sodium chloride 0.9%  flush  3  ml ; bisacodyl  10  mg ; senna  1  tab ; docusate sodium  100  mg ; levetiracetam  500  mg ; tamsulosin  0.8  mg ; zolpidem tartrate  5  mg ; tramadol (ultram)  50  mg ; oxycodone-acetaminophen  1-2  tab ; acetaminophen  650  mg ; hydromorphone (dilaudid)  0.5-1  mg ; famotidine  20  mg ; metoprolol tartrate  5  mg ; sw  50  ml ; magnesium sulfate  2  gm ; hydralazine  75  mg ; 0.9% sodium chloride  250  ml ; nicardipine iv  125  mg ; lisinopril  10  mg ; nifedipine  30  mg ; nifedipine  90  mg ; nifedipine cr  90  mg ; metoprolol tartrate  2.5  mg ; metoprolol tartrate  12.5  mg ; acetaminophen-caff-butalbital  1-2  tab ; potassium chloride  60  meq ; potassium chloride  80  meq ; 
 
white m 63 $nan$nan$allopurinol  300  mg ; atorvastatin  10  mg ; finasteride  5  mg ; fluoxetine  10  mg ; fluticasone propionate nasal  1  spry ; influenza virus vaccine  0.5  ml ; sodium chloride 0.9%  flush  3  ml ; bisacodyl  10  mg ; senna  1  tab ; docusate sodium  100  mg ; levetiracetam  500  mg ; tamsulosin  0.8  mg ; zolpidem tartrate  5  mg ; tramadol (ultram)  50  mg ; acetaminophen  650  mg ; hydromorphone (dilaudid)  0.5-1  mg ; famotidine  20  mg ; 0.9% sodium chloride  250  ml ; nicardipine iv  125  mg ; nifedipine cr  90  mg ; metoprolol tartrate  2.5  mg ; metoprolol tartrate  12.5  mg ; acetaminophen-caff-butalbital  1-2  tab ; potassium chloride  60  meq ; potassium chloride  80  meq ; 
 
white m 77 $nan$nan$sodium chloride 0.9%  1000  ml ; aspirin  81  mg ; 
 
white m 77 $nan$hematology blood hematocrit  31.6  %; chemistry blood chloride  106  meq l; chemistry blood creatinine  1.1  mg dl; chemistry blood potassium  4.4  meq l; chemistry blood sodium  142  meq l; chemistry blood urea nitrogen  15  mg dl; hematology blood inr(pt)  1.0  $sodium chloride 0.9%  1000  ml ; aspirin  81  mg ; pneumococcal 23-valent polysaccharide vaccine  0.5  ml ; warfarin  5  mg ; heparin  5000  unit ; atorvastatin  20  mg ; trazodone  25  mg ; atenolol  25  mg ; furosemide  40  mg ; 
 
white f 91 $nan$nan$pneumococcal vac polyvalent  0.5  ml ; sodium chloride 0.9%  flush  3  ml ; d5 1 2ns  1000  ml ; lorazepam  0.5  mg ; ciprofloxacin hcl  250  mg ; hydrocodone-acetaminophen  1-2  tab ; furosemide  20  mg ; clopidogrel  75  mg ; atorvastatin  10  mg ; dorzolamide 2% ophth. soln.  1  drop ; heparin  5000  unit ; methocarbamol  500  mg ; atenolol  25  mg ; enalapril maleate  10  mg ; docusate sodium  100  mg ; 
 
other f 26 $nan$nan$naloxone  0.4  mg ; naloxone  40-80  mcg ; 0.9% sodium chloride  250  ml ; metoclopramide  10  mg ; ondansetron  4  mg ; sodium chloride 0.9%  flush  3-10  ml ; 0.9% sodium chloride  100  ml ; insulin human regular  100  unit ; dextrose 50%  12.5  gm ; glucagon  1  mg ; glucose gel  15  g ; lactated ringers  1000  ml ; simethicone  80  mg ; calcium carbonate  500  mg ; 0.9% sodium chloride  1000  ml ; oxytocin  20  unit ; docusate sodium  100  mg ; senna  8.6  mg ; bisacodyl  10  mg ; acetaminophen  1000  mg ; d10w  1000  ml ; insulin  0  unit ; insulin  6  unit ; ketorolac  30  mg ; famotidine  20  mg ; insulin  1-4  unit ; ibuprofen  600  mg ; oxycodone (immediate release)  5-10  mg ; dermoplast spray  1  spry ; insulin  2  unit ; 
 
other f 26 $nan$hematology blood hematocrit  27.4  %; hematology blood hemoglobin  9.2  g dl; hematology blood platelet count  175  k ul; chemistry blood anion gap  12  meq l; chemistry blood bicarbonate  18  meq l; chemistry blood chloride  108  meq l; chemistry blood creatinine  0.9  mg dl; chemistry blood potassium  4.2  meq l; chemistry blood sodium  138  meq l; chemistry blood urea nitrogen  20  mg dl; hematology urine wbc  5  # hpf; chemistry blood calcium, total  8.0  mg dl; chemistry blood glucose  306  mg dl; hematology urine glucose  1000  mg dl$naloxone  0.4  mg ; naloxone  40-80  mcg ; 0.9% sodium chloride  250  ml ; metoclopramide  10  mg ; ondansetron  4  mg ; sodium chloride 0.9%  flush  3-10  ml ; 0.9% sodium chloride  100  ml ; insulin human regular  100  unit ; dextrose 50%  12.5  gm ; glucagon  1  mg ; glucose gel  15  g ; lactated ringers  1000  ml ; simethicone  80  mg ; calcium carbonate  500  mg ; 0.9% sodium chloride  1000  ml ; oxytocin  20  unit ; docusate sodium  100  mg ; senna  8.6  mg ; bisacodyl  10  mg ; acetaminophen  1000  mg ; d10w  1000  ml ; ketorolac  30  mg ; famotidine  20  mg ; ibuprofen  600  mg ; oxycodone (immediate release)  5-10  mg ; dermoplast spray  1  spry ; insulin  2  unit ; insulin  9  unit ; insulin  5  unit ; insulin  3  unit ; insulin  8  unit ; 
 
other f 26 $nan$nan$naloxone  0.4  mg ; naloxone  40-80  mcg ; 0.9% sodium chloride  250  ml ; metoclopramide  10  mg ; ondansetron  4  mg ; sodium chloride 0.9%  flush  3-10  ml ; 0.9% sodium chloride  100  ml ; insulin human regular  100  unit ; dextrose 50%  12.5  gm ; glucagon  1  mg ; glucose gel  15  g ; lactated ringers  1000  ml ; simethicone  80  mg ; calcium carbonate  500  mg ; 0.9% sodium chloride  1000  ml ; oxytocin  20  unit ; docusate sodium  100  mg ; senna  8.6  mg ; bisacodyl  10  mg ; acetaminophen  1000  mg ; d10w  1000  ml ; famotidine  20  mg ; ibuprofen  600  mg ; oxycodone (immediate release)  5-10  mg ; dermoplast spray  1  spry ; insulin  3  unit ; 
 
other f 26 $nan$nan$naloxone  0.4  mg ; naloxone  40-80  mcg ; 0.9% sodium chloride  250  ml ; metoclopramide  10  mg ; ondansetron  4  mg ; sodium chloride 0.9%  flush  3-10  ml ; 0.9% sodium chloride  100  ml ; insulin human regular  100  unit ; dextrose 50%  12.5  gm ; glucagon  1  mg ; glucose gel  15  g ; lactated ringers  1000  ml ; simethicone  80  mg ; calcium carbonate  500  mg ; 0.9% sodium chloride  1000  ml ; oxytocin  20  unit ; docusate sodium  100  mg ; senna  8.6  mg ; bisacodyl  10  mg ; acetaminophen  1000  mg ; d10w  1000  ml ; famotidine  20  mg ; ibuprofen  600  mg ; oxycodone (immediate release)  5-10  mg ; dermoplast spray  1  spry ; insulin  7  unit ; omeprazole  40  mg ; 
 
other f 26 $nan$nan$naloxone  0.4  mg ; naloxone  40-80  mcg ; 0.9% sodium chloride  250  ml ; metoclopramide  10  mg ; ondansetron  4  mg ; sodium chloride 0.9%  flush  3-10  ml ; dextrose 50%  12.5  gm ; glucagon  1  mg ; glucose gel  15  g ; simethicone  80  mg ; calcium carbonate  500  mg ; 0.9% sodium chloride  1000  ml ; oxytocin  20  unit ; docusate sodium  100  mg ; senna  8.6  mg ; bisacodyl  10  mg ; acetaminophen  1000  mg ; ibuprofen  600  mg ; oxycodone (immediate release)  5-10  mg ; dermoplast spray  1  spry ; omeprazole  40  mg ; 
 
black african american f 76 $nan$hematology blood hematocrit  28.7  %; hematology blood hemoglobin  8.2  g dl; hematology blood platelet count  350  k ul; chemistry blood anion gap  15  meq l; chemistry blood anion gap  14  meq l; chemistry blood anion gap  15  meq l; chemistry blood bicarbonate  33  meq l; chemistry blood bicarbonate  37  meq l; chemistry blood bicarbonate  37  meq l; chemistry blood chloride  92  meq l; chemistry blood chloride  93  meq l; chemistry blood chloride  93  meq l; chemistry blood creatinine  1.8  mg dl; chemistry blood creatinine  1.7  mg dl; chemistry blood creatinine  1.8  mg dl; chemistry blood potassium  5.0  meq l; chemistry blood potassium  4.4  meq l; chemistry blood potassium  4.2  meq l; chemistry blood sodium  135  meq l; chemistry blood sodium  140  meq l; chemistry blood sodium  141  meq l; chemistry blood urea nitrogen  71  mg dl; chemistry blood urea nitrogen  67  mg dl; chemistry blood urea nitrogen  65  mg dl; hematology blood inr(pt)  1.0  ; chemistry blood calcium, total  9.1  mg dl; chemistry blood calcium, total  9.8  mg dl; chemistry blood calcium, total  9.8  mg dl; chemistry blood bilirubin, total  0.2  mg dl; chemistry blood glucose  159  mg dl; chemistry blood glucose  115  mg dl; chemistry blood glucose  154  mg dl; chemistry blood lactate dehydrogenase (ld)  386  iu l; blood gas blood free calcium  1.16  mmol l; blood gas blood lactate  1.4  mmol l; blood gas blood lactate  1.2  mmol l; blood gas blood potassium, whole blood  4.6  meq l$heparin  5000  unit ; furosemide  250  mg ; metolazone  5  mg ; insulin  0  unit ; acetaminophen  1000  mg ; amlodipine  10  mg ; anastrozole  1  mg ; aspirin  81  mg ; atorvastatin  80  mg ; bisacodyl  10  mg ; calcium carbonate  500  mg ; dorzolamide 2% timolol 0.5% ophth.  1  drop ; hydralazine  100  mg ; dextrose 50%  12.5  gm ; glucagon  1  mg ; glucose gel  15  g ; latanoprost 0.005% ophth. soln.  1  drop ; lidocaine 5% patch  1  ptch ; metoprolol succinate xl  50  mg ; omeprazole  40  mg ; paroxetine  30  mg ; polyethylene glycol  17  g ; senna  17.2  mg ; sevelamer carbonate  800  mg ; tiotropium bromide  1  cap ; albuterol 0.083% neb soln  1  neb ; tramadol  50  mg ; hydralazine  10  mg ; insulin  4  unit ; isosorbide mononitrate (extended release)  90  mg ; gabapentin  600  mg ; isosorbide mononitrate (extended release)  120  mg ; carvedilol  12.5  mg ; insulin  8  unit ; insulin  36  unit ; 
acute on chronic diastolic (congestive) heart failure type 2 diabetes mellitus with diabetic polyneuropathy type 2 diabetes mellitus with hyperglycemia acute and chronic respiratory failure with hypoxia obstructive sleep apnea (adult) (pediatric) morbid (severe) obesity with alveolar hypoventilation other secondary pulmonary hypertension hypertensive heart and chronic kidney disease with heart failure and stage 1 through stage 4 chronic kidney disease, or unspecified chronic kidney disease fall resulting in striking against other object unspecified place in hospital as the place of occurrence of the external cause metabolic syndrome major depressive disorder, single episode, unspecified fatty (change of) liver, not elsewhere classified chronic kidney disease, unspecified gastro-esophageal reflux disease without esophagitis other chronic pain adverse effect of loop [high-ceiling] diuretics, initial encounter personal history of malignant neoplasm of breast unspecified open-angle glaucoma, stage unspecified age-related osteoporosis without current pathological fracture type 2 diabetes mellitus with diabetic chronic kidney disease other acute kidney failure patient's noncompliance with dietary regimen patient's other noncompliance with medication regimen body mass index (bmi) 39.0-39.9, adult long term (current) use of insulin dependence on supplemental oxygen hyperlipidemia, unspecified venous insufficiency (chronic) (peripheral) type 2 diabetes mellitus with diabetic polyneuropathy hypertensive heart and chronic kidney disease with heart failure and stage 1 through stage 4 chronic kidney disease, or unspecified chronic kidney disease personal history of malignant neoplasm of breast nausea other secondary pulmonary hypertension age-related osteoporosis without current pathological fracture unspecified rotator cuff tear or rupture of right shoulder, not specified as traumatic dependence on supplemental oxygen body mass index (bmi) 45.0-49.9, adult unspecified asthma, uncomplicated nonrheumatic tricuspid (valve) insufficiency portal vein thrombosis acute and chronic respiratory failure with hypoxia carpal tunnel syndrome, unspecified upper limb acute on chronic diastolic (congestive) heart failure chronic kidney disease, unspecified headache iron deficiency anemia, unspecified gastro-esophageal reflux disease without esophagitis
black african american f 76 $nan$hematology blood hematocrit  30.2  %; hematology blood hemoglobin  8.7  g dl; hematology blood platelet count  372  k ul; chemistry blood anion gap  16  meq l; chemistry blood anion gap  14  meq l; chemistry blood bicarbonate  38  meq l; chemistry blood bicarbonate  39  meq l; chemistry blood chloride  89  meq l; chemistry blood chloride  87  meq l; chemistry blood creatinine  1.9  mg dl; chemistry blood creatinine  2.0  mg dl; chemistry blood potassium  3.9  meq l; chemistry blood potassium  4.0  meq l; chemistry blood sodium  139  meq l; chemistry blood sodium  136  meq l; chemistry blood urea nitrogen  72  mg dl; chemistry blood urea nitrogen  73  mg dl; hematology blood inr(pt)  1.0  ; chemistry blood calcium, total  9.7  mg dl; chemistry blood glucose  154  mg dl; chemistry blood glucose  129  mg dl; blood gas blood free calcium  1.13  mmol l; blood gas blood potassium, whole blood  3.7  meq l$5% dextrose  50  ml ; furosemide  160  mg ; heparin  5000  unit ; furosemide  250  mg ; insulin  0  unit ; acetaminophen  1000  mg ; anastrozole  1  mg ; aspirin  81  mg ; atorvastatin  80  mg ; bisacodyl  10  mg ; calcium carbonate  500  mg ; dorzolamide 2% timolol 0.5% ophth.  1  drop ; dextrose 50%  12.5  gm ; glucagon  1  mg ; glucose gel  15  g ; latanoprost 0.005% ophth. soln.  1  drop ; lidocaine 5% patch  1  ptch ; omeprazole  40  mg ; paroxetine  30  mg ; polyethylene glycol  17  g ; senna  17.2  mg ; sevelamer carbonate  800  mg ; tiotropium bromide  1  cap ; albuterol 0.083% neb soln  1  neb ; tramadol  50  mg ; hydralazine  10  mg ; insulin  4  unit ; gabapentin  600  mg ; isosorbide mononitrate (extended release)  120  mg ; carvedilol  12.5  mg ; insulin  8  unit ; insulin  36  unit ; potassium chloride replacement (critical care and oncology)   40  meq ; potassium chloride replacement (critical care and oncology)   60  meq ; potassium chloride replacement (critical care and oncology)   80  meq ; carvedilol  25  mg ; 
acute on chronic diastolic (congestive) heart failure type 2 diabetes mellitus with diabetic polyneuropathy type 2 diabetes mellitus with hyperglycemia acute and chronic respiratory failure with hypoxia obstructive sleep apnea (adult) (pediatric) morbid (severe) obesity with alveolar hypoventilation other secondary pulmonary hypertension hypertensive heart and chronic kidney disease with heart failure and stage 1 through stage 4 chronic kidney disease, or unspecified chronic kidney disease fall resulting in striking against other object unspecified place in hospital as the place of occurrence of the external cause metabolic syndrome major depressive disorder, single episode, unspecified fatty (change of) liver, not elsewhere classified chronic kidney disease, unspecified gastro-esophageal reflux disease without esophagitis other chronic pain adverse effect of loop [high-ceiling] diuretics, initial encounter personal history of malignant neoplasm of breast unspecified open-angle glaucoma, stage unspecified age-related osteoporosis without current pathological fracture type 2 diabetes mellitus with diabetic chronic kidney disease other acute kidney failure patient's noncompliance with dietary regimen patient's other noncompliance with medication regimen body mass index (bmi) 39.0-39.9, adult long term (current) use of insulin dependence on supplemental oxygen hyperlipidemia, unspecified venous insufficiency (chronic) (peripheral) type 2 diabetes mellitus with diabetic polyneuropathy hypertensive heart and chronic kidney disease with heart failure and stage 1 through stage 4 chronic kidney disease, or unspecified chronic kidney disease personal history of malignant neoplasm of breast nausea other secondary pulmonary hypertension age-related osteoporosis without current pathological fracture unspecified rotator cuff tear or rupture of right shoulder, not specified as traumatic dependence on supplemental oxygen body mass index (bmi) 45.0-49.9, adult unspecified asthma, uncomplicated nonrheumatic tricuspid (valve) insufficiency portal vein thrombosis acute and chronic respiratory failure with hypoxia carpal tunnel syndrome, unspecified upper limb acute on chronic diastolic (congestive) heart failure chronic kidney disease, unspecified headache iron deficiency anemia, unspecified gastro-esophageal reflux disease without esophagitis
black african american f 76 $nan$hematology blood hematocrit  29.3  %; hematology blood hemoglobin  8.7  g dl; hematology blood platelet count  397  k ul; chemistry blood anion gap  15  meq l; chemistry blood anion gap  22  meq l; chemistry blood bicarbonate  38  meq l; chemistry blood bicarbonate  34  meq l; chemistry blood chloride  85  meq l; chemistry blood chloride  85  meq l; chemistry blood creatinine  2.3  mg dl; chemistry blood creatinine  2.5  mg dl; chemistry blood potassium  4.0  meq l; chemistry blood potassium  4.0  meq l; chemistry blood sodium  134  meq l; chemistry blood sodium  137  meq l; chemistry blood urea nitrogen  82  mg dl; chemistry blood urea nitrogen  92  mg dl; chemistry blood calcium, total  9.5  mg dl; chemistry blood calcium, total  9.3  mg dl; chemistry blood glucose  263  mg dl; chemistry blood glucose  230  mg dl; chemistry blood albumin  3.7  g dl; blood gas blood lactate  1.9  mmol l$furosemide  160  mg ; heparin  5000  unit ; insulin  0  unit ; acetaminophen  1000  mg ; anastrozole  1  mg ; aspirin  81  mg ; atorvastatin  80  mg ; bisacodyl  10  mg ; calcium carbonate  500  mg ; dorzolamide 2% timolol 0.5% ophth.  1  drop ; dextrose 50%  12.5  gm ; glucagon  1  mg ; glucose gel  15  g ; latanoprost 0.005% ophth. soln.  1  drop ; lidocaine 5% patch  1  ptch ; omeprazole  40  mg ; paroxetine  30  mg ; polyethylene glycol  17  g ; senna  17.2  mg ; sevelamer carbonate  800  mg ; tiotropium bromide  1  cap ; albuterol 0.083% neb soln  1  neb ; tramadol  50  mg ; insulin  4  unit ; gabapentin  600  mg ; isosorbide mononitrate (extended release)  120  mg ; insulin  8  unit ; insulin  36  unit ; potassium chloride replacement (critical care and oncology)   40  meq ; potassium chloride replacement (critical care and oncology)   60  meq ; potassium chloride replacement (critical care and oncology)   80  meq ; carvedilol  25  mg ; metolazone  2.5  mg ; heparin flush (10 units ml)  2  ml ; sodium chloride 0.9%  flush  20  ml ; lidocaine 1% (for picc midline insertions)  5  ml ; gabapentin  200  mg ; 
acute on chronic diastolic (congestive) heart failure type 2 diabetes mellitus with diabetic polyneuropathy type 2 diabetes mellitus with hyperglycemia acute and chronic respiratory failure with hypoxia obstructive sleep apnea (adult) (pediatric) morbid (severe) obesity with alveolar hypoventilation other secondary pulmonary hypertension hypertensive heart and chronic kidney disease with heart failure and stage 1 through stage 4 chronic kidney disease, or unspecified chronic kidney disease fall resulting in striking against other object unspecified place in hospital as the place of occurrence of the external cause metabolic syndrome major depressive disorder, single episode, unspecified fatty (change of) liver, not elsewhere classified chronic kidney disease, unspecified gastro-esophageal reflux disease without esophagitis other chronic pain adverse effect of loop [high-ceiling] diuretics, initial encounter personal history of malignant neoplasm of breast unspecified open-angle glaucoma, stage unspecified age-related osteoporosis without current pathological fracture type 2 diabetes mellitus with diabetic chronic kidney disease other acute kidney failure patient's noncompliance with dietary regimen patient's other noncompliance with medication regimen body mass index (bmi) 39.0-39.9, adult long term (current) use of insulin dependence on supplemental oxygen hyperlipidemia, unspecified venous insufficiency (chronic) (peripheral) type 2 diabetes mellitus with diabetic polyneuropathy hypertensive heart and chronic kidney disease with heart failure and stage 1 through stage 4 chronic kidney disease, or unspecified chronic kidney disease personal history of malignant neoplasm of breast nausea other secondary pulmonary hypertension age-related osteoporosis without current pathological fracture unspecified rotator cuff tear or rupture of right shoulder, not specified as traumatic dependence on supplemental oxygen body mass index (bmi) 45.0-49.9, adult unspecified asthma, uncomplicated nonrheumatic tricuspid (valve) insufficiency portal vein thrombosis acute and chronic respiratory failure with hypoxia carpal tunnel syndrome, unspecified upper limb acute on chronic diastolic (congestive) heart failure chronic kidney disease, unspecified headache iron deficiency anemia, unspecified gastro-esophageal reflux disease without esophagitis
black african american f 76 $nan$hematology blood hematocrit  29.4  %; hematology blood hemoglobin  8.8  g dl; hematology blood platelet count  398  k ul; chemistry blood anion gap  14  meq l; chemistry blood bicarbonate  39  meq l; chemistry blood chloride  84  meq l; chemistry blood creatinine  2.5  mg dl; chemistry blood potassium  3.4  meq l; chemistry blood sodium  134  meq l; chemistry blood urea nitrogen  97  mg dl; hematology urine wbc  8  # hpf; chemistry blood calcium, total  9.3  mg dl; chemistry blood glucose  190  mg dl; blood gas blood free calcium  1.02  mmol l; blood gas blood hematocrit, calculated  29  %; blood gas blood hemoglobin  9.7  g dl; blood gas blood carboxyhemoglobin  1  %; blood gas blood methemoglobin  0  %$heparin  5000  unit ; insulin  0  unit ; acetaminophen  1000  mg ; anastrozole  1  mg ; aspirin  81  mg ; atorvastatin  80  mg ; bisacodyl  10  mg ; calcium carbonate  500  mg ; dorzolamide 2% timolol 0.5% ophth.  1  drop ; dextrose 50%  12.5  gm ; glucagon  1  mg ; glucose gel  15  g ; latanoprost 0.005% ophth. soln.  1  drop ; lidocaine 5% patch  1  ptch ; omeprazole  40  mg ; paroxetine  30  mg ; polyethylene glycol  17  g ; senna  17.2  mg ; sevelamer carbonate  800  mg ; tiotropium bromide  1  cap ; albuterol 0.083% neb soln  1  neb ; tramadol  50  mg ; insulin  4  unit ; isosorbide mononitrate (extended release)  120  mg ; insulin  8  unit ; insulin  36  unit ; potassium chloride replacement (critical care and oncology)   40  meq ; potassium chloride replacement (critical care and oncology)   60  meq ; potassium chloride replacement (critical care and oncology)   80  meq ; carvedilol  25  mg ; heparin flush (10 units ml)  2  ml ; sodium chloride 0.9%  flush  20  ml ; lidocaine 1% (for picc midline insertions)  5  ml ; gabapentin  200  mg ; potassium chloride replacement (critical care and oncology)   10  meq ; alendronate sodium  70  mg ; sarna lotion  1  appl ; 
acute on chronic diastolic (congestive) heart failure type 2 diabetes mellitus with diabetic polyneuropathy type 2 diabetes mellitus with hyperglycemia acute and chronic respiratory failure with hypoxia obstructive sleep apnea (adult) (pediatric) morbid (severe) obesity with alveolar hypoventilation other secondary pulmonary hypertension hypertensive heart and chronic kidney disease with heart failure and stage 1 through stage 4 chronic kidney disease, or unspecified chronic kidney disease fall resulting in striking against other object unspecified place in hospital as the place of occurrence of the external cause metabolic syndrome major depressive disorder, single episode, unspecified fatty (change of) liver, not elsewhere classified chronic kidney disease, unspecified gastro-esophageal reflux disease without esophagitis other chronic pain adverse effect of loop [high-ceiling] diuretics, initial encounter personal history of malignant neoplasm of breast unspecified open-angle glaucoma, stage unspecified age-related osteoporosis without current pathological fracture type 2 diabetes mellitus with diabetic chronic kidney disease other acute kidney failure patient's noncompliance with dietary regimen patient's other noncompliance with medication regimen body mass index (bmi) 39.0-39.9, adult long term (current) use of insulin dependence on supplemental oxygen hyperlipidemia, unspecified venous insufficiency (chronic) (peripheral) type 2 diabetes mellitus with diabetic polyneuropathy hypertensive heart and chronic kidney disease with heart failure and stage 1 through stage 4 chronic kidney disease, or unspecified chronic kidney disease personal history of malignant neoplasm of breast nausea other secondary pulmonary hypertension age-related osteoporosis without current pathological fracture unspecified rotator cuff tear or rupture of right shoulder, not specified as traumatic dependence on supplemental oxygen body mass index (bmi) 45.0-49.9, adult unspecified asthma, uncomplicated nonrheumatic tricuspid (valve) insufficiency portal vein thrombosis acute and chronic respiratory failure with hypoxia carpal tunnel syndrome, unspecified upper limb acute on chronic diastolic (congestive) heart failure chronic kidney disease, unspecified headache iron deficiency anemia, unspecified gastro-esophageal reflux disease without esophagitis
black african american f 76 $nan$hematology blood hematocrit  29.6  %; hematology blood hemoglobin  8.8  g dl; hematology blood platelet count  388  k ul; chemistry blood anion gap  16  meq l; chemistry blood anion gap  19  meq l; chemistry blood bicarbonate  39  meq l; chemistry blood bicarbonate  36  meq l; chemistry blood chloride  85  meq l; chemistry blood chloride  85  meq l; chemistry blood creatinine  2.7  mg dl; chemistry blood creatinine  2.7  mg dl; chemistry blood potassium  3.5  meq l; chemistry blood potassium  4.6  meq l; chemistry blood sodium  136  meq l; chemistry blood sodium  135  meq l; chemistry blood urea nitrogen  105  mg dl; chemistry blood urea nitrogen  109  mg dl; hematology blood inr(pt)  1.0  ; chemistry blood calcium, total  9.1  mg dl; chemistry blood calcium, total  9.5  mg dl; chemistry blood bilirubin, total  0.2  mg dl; chemistry blood glucose  235  mg dl; chemistry blood glucose  121  mg dl; blood gas blood free calcium  1.01  mmol l; blood gas blood potassium, whole blood  3.4  meq l$heparin  5000  unit ; insulin  0  unit ; acetaminophen  1000  mg ; anastrozole  1  mg ; aspirin  81  mg ; atorvastatin  80  mg ; bisacodyl  10  mg ; calcium carbonate  500  mg ; dorzolamide 2% timolol 0.5% ophth.  1  drop ; dextrose 50%  12.5  gm ; glucagon  1  mg ; glucose gel  15  g ; latanoprost 0.005% ophth. soln.  1  drop ; lidocaine 5% patch  1  ptch ; omeprazole  40  mg ; paroxetine  30  mg ; polyethylene glycol  17  g ; senna  17.2  mg ; sevelamer carbonate  800  mg ; tiotropium bromide  1  cap ; albuterol 0.083% neb soln  1  neb ; tramadol  50  mg ; insulin  4  unit ; isosorbide mononitrate (extended release)  120  mg ; insulin  8  unit ; insulin  36  unit ; carvedilol  25  mg ; sodium chloride 0.9%  flush  20  ml ; lidocaine 1% (for picc midline insertions)  5  ml ; gabapentin  200  mg ; alendronate sodium  70  mg ; sarna lotion  1  appl ; 0.9% sodium chloride  1  bag ; calcium gluconate  2  g ; 0.9% sodium chloride  2  bag ; calcium gluconate  4  g ; 
acute on chronic diastolic (congestive) heart failure type 2 diabetes mellitus with diabetic polyneuropathy type 2 diabetes mellitus with hyperglycemia acute and chronic respiratory failure with hypoxia obstructive sleep apnea (adult) (pediatric) morbid (severe) obesity with alveolar hypoventilation other secondary pulmonary hypertension hypertensive heart and chronic kidney disease with heart failure and stage 1 through stage 4 chronic kidney disease, or unspecified chronic kidney disease fall resulting in striking against other object unspecified place in hospital as the place of occurrence of the external cause metabolic syndrome major depressive disorder, single episode, unspecified fatty (change of) liver, not elsewhere classified chronic kidney disease, unspecified gastro-esophageal reflux disease without esophagitis other chronic pain adverse effect of loop [high-ceiling] diuretics, initial encounter personal history of malignant neoplasm of breast unspecified open-angle glaucoma, stage unspecified age-related osteoporosis without current pathological fracture type 2 diabetes mellitus with diabetic chronic kidney disease other acute kidney failure patient's noncompliance with dietary regimen patient's other noncompliance with medication regimen body mass index (bmi) 39.0-39.9, adult long term (current) use of insulin dependence on supplemental oxygen hyperlipidemia, unspecified venous insufficiency (chronic) (peripheral) type 2 diabetes mellitus with diabetic polyneuropathy hypertensive heart and chronic kidney disease with heart failure and stage 1 through stage 4 chronic kidney disease, or unspecified chronic kidney disease personal history of malignant neoplasm of breast nausea other secondary pulmonary hypertension age-related osteoporosis without current pathological fracture unspecified rotator cuff tear or rupture of right shoulder, not specified as traumatic dependence on supplemental oxygen body mass index (bmi) 45.0-49.9, adult unspecified asthma, uncomplicated nonrheumatic tricuspid (valve) insufficiency portal vein thrombosis acute and chronic respiratory failure with hypoxia carpal tunnel syndrome, unspecified upper limb acute on chronic diastolic (congestive) heart failure chronic kidney disease, unspecified headache iron deficiency anemia, unspecified gastro-esophageal reflux disease without esophagitis
black african american f 76 $nan$hematology blood hematocrit  28.7  %; hematology blood hemoglobin  8.6  g dl; hematology blood platelet count  376  k ul; chemistry blood anion gap  14  meq l; chemistry blood bicarbonate  40  meq l; chemistry blood chloride  88  meq l; chemistry blood creatinine  2.3  mg dl; chemistry blood potassium  4.0  meq l; chemistry blood sodium  138  meq l; chemistry blood calcium, total  9.2  mg dl; chemistry blood glucose  101  mg dl$heparin  5000  unit ; insulin  0  unit ; acetaminophen  1000  mg ; anastrozole  1  mg ; aspirin  81  mg ; atorvastatin  80  mg ; bisacodyl  10  mg ; calcium carbonate  500  mg ; dorzolamide 2% timolol 0.5% ophth.  1  drop ; dextrose 50%  12.5  gm ; glucagon  1  mg ; glucose gel  15  g ; latanoprost 0.005% ophth. soln.  1  drop ; lidocaine 5% patch  1  ptch ; omeprazole  40  mg ; paroxetine  30  mg ; polyethylene glycol  17  g ; senna  17.2  mg ; sevelamer carbonate  800  mg ; tiotropium bromide  1  cap ; albuterol 0.083% neb soln  1  neb ; tramadol  50  mg ; insulin  4  unit ; isosorbide mononitrate (extended release)  120  mg ; insulin  8  unit ; insulin  36  unit ; carvedilol  25  mg ; sodium chloride 0.9%  flush  20  ml ; lidocaine 1% (for picc midline insertions)  5  ml ; alendronate sodium  70  mg ; sarna lotion  1  appl ; 0.9% sodium chloride  1  bag ; calcium gluconate  2  g ; 0.9% sodium chloride  2  bag ; calcium gluconate  4  g ; 
acute on chronic diastolic (congestive) heart failure type 2 diabetes mellitus with diabetic polyneuropathy type 2 diabetes mellitus with hyperglycemia acute and chronic respiratory failure with hypoxia obstructive sleep apnea (adult) (pediatric) morbid (severe) obesity with alveolar hypoventilation other secondary pulmonary hypertension hypertensive heart and chronic kidney disease with heart failure and stage 1 through stage 4 chronic kidney disease, or unspecified chronic kidney disease fall resulting in striking against other object unspecified place in hospital as the place of occurrence of the external cause metabolic syndrome major depressive disorder, single episode, unspecified fatty (change of) liver, not elsewhere classified chronic kidney disease, unspecified gastro-esophageal reflux disease without esophagitis other chronic pain adverse effect of loop [high-ceiling] diuretics, initial encounter personal history of malignant neoplasm of breast unspecified open-angle glaucoma, stage unspecified age-related osteoporosis without current pathological fracture type 2 diabetes mellitus with diabetic chronic kidney disease other acute kidney failure patient's noncompliance with dietary regimen patient's other noncompliance with medication regimen body mass index (bmi) 39.0-39.9, adult long term (current) use of insulin dependence on supplemental oxygen hyperlipidemia, unspecified venous insufficiency (chronic) (peripheral) type 2 diabetes mellitus with diabetic polyneuropathy hypertensive heart and chronic kidney disease with heart failure and stage 1 through stage 4 chronic kidney disease, or unspecified chronic kidney disease personal history of malignant neoplasm of breast nausea other secondary pulmonary hypertension age-related osteoporosis without current pathological fracture unspecified rotator cuff tear or rupture of right shoulder, not specified as traumatic dependence on supplemental oxygen body mass index (bmi) 45.0-49.9, adult unspecified asthma, uncomplicated nonrheumatic tricuspid (valve) insufficiency portal vein thrombosis acute and chronic respiratory failure with hypoxia carpal tunnel syndrome, unspecified upper limb acute on chronic diastolic (congestive) heart failure chronic kidney disease, unspecified headache iron deficiency anemia, unspecified gastro-esophageal reflux disease without esophagitis
black african american f 76 $nan$hematology blood hematocrit  29.6  %; hematology blood hemoglobin  8.8  g dl; hematology blood platelet count  375  k ul; chemistry blood anion gap  15  meq l; chemistry blood anion gap  14  meq l; chemistry blood bicarbonate  37  meq l; chemistry blood bicarbonate  40  meq l; chemistry blood chloride  85  meq l; chemistry blood chloride  84  meq l; chemistry blood creatinine  2.5  mg dl; chemistry blood creatinine  2.3  mg dl; chemistry blood potassium  3.9  meq l; chemistry blood potassium  3.5  meq l; chemistry blood sodium  133  meq l; chemistry blood sodium  134  meq l; chemistry blood urea nitrogen  116  mg dl; chemistry blood urea nitrogen  111  mg dl; chemistry blood calcium, total  9.3  mg dl; chemistry blood calcium, total  9.4  mg dl; chemistry blood glucose  55  mg dl; chemistry blood glucose  112  mg dl; blood gas blood free calcium  1.11  mmol l; blood gas blood lactate  1.3  mmol l; blood gas blood hematocrit, calculated  25  %; blood gas blood hemoglobin  8.3  g dl; blood gas blood potassium, whole blood  3.4  meq l$meropenem  500  mg ; heparin  5000  unit ; insulin  0  unit ; acetaminophen  1000  mg ; anastrozole  1  mg ; aspirin  81  mg ; atorvastatin  80  mg ; bisacodyl  10  mg ; calcium carbonate  500  mg ; dorzolamide 2% timolol 0.5% ophth.  1  drop ; dextrose 50%  12.5  gm ; glucagon  1  mg ; glucose gel  15  g ; latanoprost 0.005% ophth. soln.  1  drop ; lidocaine 5% patch  1  ptch ; omeprazole  40  mg ; paroxetine  30  mg ; polyethylene glycol  17  g ; senna  17.2  mg ; sevelamer carbonate  800  mg ; tiotropium bromide  1  cap ; albuterol 0.083% neb soln  1  neb ; tramadol  50  mg ; insulin  4  unit ; isosorbide mononitrate (extended release)  120  mg ; insulin  8  unit ; insulin  36  unit ; carvedilol  25  mg ; sodium chloride 0.9%  flush  20  ml ; lidocaine 1% (for picc midline insertions)  5  ml ; alendronate sodium  70  mg ; sarna lotion  1  appl ; 0.9% sodium chloride  1  bag ; calcium gluconate  2  g ; 0.9% sodium chloride  2  bag ; calcium gluconate  4  g ; sodium chloride 0.9%  flush  10  ml ; 0.9% sodium chloride (mini bag plus)  100  ml ; meropenem  1000  mg ; lorazepam  0.25  mg ; furosemide  200  mg ; sulfameth trimethoprim ss  1  tab ; 
acute on chronic diastolic (congestive) heart failure type 2 diabetes mellitus with diabetic polyneuropathy type 2 diabetes mellitus with hyperglycemia acute and chronic respiratory failure with hypoxia obstructive sleep apnea (adult) (pediatric) morbid (severe) obesity with alveolar hypoventilation other secondary pulmonary hypertension hypertensive heart and chronic kidney disease with heart failure and stage 1 through stage 4 chronic kidney disease, or unspecified chronic kidney disease fall resulting in striking against other object unspecified place in hospital as the place of occurrence of the external cause metabolic syndrome major depressive disorder, single episode, unspecified fatty (change of) liver, not elsewhere classified chronic kidney disease, unspecified gastro-esophageal reflux disease without esophagitis other chronic pain adverse effect of loop [high-ceiling] diuretics, initial encounter personal history of malignant neoplasm of breast unspecified open-angle glaucoma, stage unspecified age-related osteoporosis without current pathological fracture type 2 diabetes mellitus with diabetic chronic kidney disease other acute kidney failure patient's noncompliance with dietary regimen patient's other noncompliance with medication regimen body mass index (bmi) 39.0-39.9, adult long term (current) use of insulin dependence on supplemental oxygen hyperlipidemia, unspecified venous insufficiency (chronic) (peripheral) type 2 diabetes mellitus with diabetic polyneuropathy hypertensive heart and chronic kidney disease with heart failure and stage 1 through stage 4 chronic kidney disease, or unspecified chronic kidney disease personal history of malignant neoplasm of breast nausea other secondary pulmonary hypertension age-related osteoporosis without current pathological fracture unspecified rotator cuff tear or rupture of right shoulder, not specified as traumatic dependence on supplemental oxygen body mass index (bmi) 45.0-49.9, adult unspecified asthma, uncomplicated nonrheumatic tricuspid (valve) insufficiency portal vein thrombosis acute and chronic respiratory failure with hypoxia carpal tunnel syndrome, unspecified upper limb acute on chronic diastolic (congestive) heart failure chronic kidney disease, unspecified headache iron deficiency anemia, unspecified gastro-esophageal reflux disease without esophagitis
black african american f 76 $nan$hematology blood hematocrit  29.5  %; hematology blood hemoglobin  8.6  g dl; hematology blood platelet count  341  k ul; chemistry blood anion gap  16  meq l; chemistry blood anion gap  21  meq l; chemistry blood bicarbonate  38  meq l; chemistry blood bicarbonate  33  meq l; chemistry blood chloride  88  meq l; chemistry blood chloride  86  meq l; chemistry blood creatinine  2.5  mg dl; chemistry blood creatinine  2.7  mg dl; chemistry blood potassium  4.7  meq l; chemistry blood potassium  4.7  meq l; chemistry blood sodium  137  meq l; chemistry blood sodium  135  meq l; chemistry blood urea nitrogen  119  mg dl; chemistry blood urea nitrogen  119  mg dl; chemistry urine creatinine, urine  64  mg dl; chemistry urine urea nitrogen, urine  534  mg dl; chemistry blood calcium, total  9.3  mg dl; chemistry blood calcium, total  9.2  mg dl; chemistry blood glucose  109  mg dl; chemistry blood glucose  280  mg dl; blood gas blood lactate  0.8  mmol l$heparin  5000  unit ; insulin  0  unit ; acetaminophen  1000  mg ; anastrozole  1  mg ; aspirin  81  mg ; atorvastatin  80  mg ; bisacodyl  10  mg ; calcium carbonate  500  mg ; dorzolamide 2% timolol 0.5% ophth.  1  drop ; dextrose 50%  12.5  gm ; glucagon  1  mg ; glucose gel  15  g ; latanoprost 0.005% ophth. soln.  1  drop ; lidocaine 5% patch  1  ptch ; omeprazole  40  mg ; paroxetine  30  mg ; polyethylene glycol  17  g ; senna  17.2  mg ; sevelamer carbonate  800  mg ; tiotropium bromide  1  cap ; albuterol 0.083% neb soln  1  neb ; tramadol  50  mg ; insulin  4  unit ; isosorbide mononitrate (extended release)  120  mg ; insulin  8  unit ; insulin  36  unit ; carvedilol  25  mg ; sodium chloride 0.9%  flush  20  ml ; lidocaine 1% (for picc midline insertions)  5  ml ; alendronate sodium  70  mg ; sarna lotion  1  appl ; 0.9% sodium chloride  1  bag ; calcium gluconate  2  g ; 0.9% sodium chloride  2  bag ; calcium gluconate  4  g ; sodium chloride 0.9%  flush  10  ml ; 0.9% sodium chloride (mini bag plus)  100  ml ; meropenem  1000  mg ; lorazepam  0.25  mg ; furosemide  200  mg ; sulfameth trimethoprim ss  1  tab ; d5w  250  ml ; nitroglycerin  100  mg ; acetazolamide  250  mg ; 
acute on chronic diastolic (congestive) heart failure type 2 diabetes mellitus with diabetic polyneuropathy type 2 diabetes mellitus with hyperglycemia acute and chronic respiratory failure with hypoxia obstructive sleep apnea (adult) (pediatric) morbid (severe) obesity with alveolar hypoventilation other secondary pulmonary hypertension hypertensive heart and chronic kidney disease with heart failure and stage 1 through stage 4 chronic kidney disease, or unspecified chronic kidney disease fall resulting in striking against other object unspecified place in hospital as the place of occurrence of the external cause metabolic syndrome major depressive disorder, single episode, unspecified fatty (change of) liver, not elsewhere classified chronic kidney disease, unspecified gastro-esophageal reflux disease without esophagitis other chronic pain adverse effect of loop [high-ceiling] diuretics, initial encounter personal history of malignant neoplasm of breast unspecified open-angle glaucoma, stage unspecified age-related osteoporosis without current pathological fracture type 2 diabetes mellitus with diabetic chronic kidney disease other acute kidney failure patient's noncompliance with dietary regimen patient's other noncompliance with medication regimen body mass index (bmi) 39.0-39.9, adult long term (current) use of insulin dependence on supplemental oxygen hyperlipidemia, unspecified venous insufficiency (chronic) (peripheral) type 2 diabetes mellitus with diabetic polyneuropathy hypertensive heart and chronic kidney disease with heart failure and stage 1 through stage 4 chronic kidney disease, or unspecified chronic kidney disease personal history of malignant neoplasm of breast nausea other secondary pulmonary hypertension age-related osteoporosis without current pathological fracture unspecified rotator cuff tear or rupture of right shoulder, not specified as traumatic dependence on supplemental oxygen body mass index (bmi) 45.0-49.9, adult unspecified asthma, uncomplicated nonrheumatic tricuspid (valve) insufficiency portal vein thrombosis acute and chronic respiratory failure with hypoxia carpal tunnel syndrome, unspecified upper limb acute on chronic diastolic (congestive) heart failure chronic kidney disease, unspecified headache iron deficiency anemia, unspecified gastro-esophageal reflux disease without esophagitis
black african american f 76 $nan$hematology blood hematocrit  28.0  %; hematology blood hemoglobin  8.1  g dl; hematology blood platelet count  304  k ul; chemistry blood anion gap  16  meq l; chemistry blood anion gap  18  meq l; chemistry blood bicarbonate  37  meq l; chemistry blood bicarbonate  34  meq l; chemistry blood chloride  86  meq l; chemistry blood chloride  85  meq l; chemistry blood creatinine  2.7  mg dl; chemistry blood creatinine  3.1  mg dl; chemistry blood potassium  3.7  meq l; chemistry blood potassium  3.8  meq l; chemistry blood sodium  135  meq l; chemistry blood sodium  133  meq l; chemistry blood urea nitrogen  120  mg dl; chemistry blood urea nitrogen  124  mg dl; chemistry blood calcium, total  8.8  mg dl; chemistry blood calcium, total  9.2  mg dl; chemistry blood glucose  166  mg dl; chemistry blood glucose  272  mg dl; blood gas blood lactate  0.9  mmol l; blood gas blood lactate  1.3  mmol l; blood gas blood hematocrit, calculated  27  %; blood gas blood hematocrit, calculated  27  %; blood gas blood hemoglobin  9.1  g dl; blood gas blood hemoglobin  9.0  g dl; blood gas blood potassium, whole blood  3.0  meq l$heparin  5000  unit ; insulin  0  unit ; acetaminophen  1000  mg ; anastrozole  1  mg ; aspirin  81  mg ; atorvastatin  80  mg ; bisacodyl  10  mg ; calcium carbonate  500  mg ; dorzolamide 2% timolol 0.5% ophth.  1  drop ; dextrose 50%  12.5  gm ; glucagon  1  mg ; glucose gel  15  g ; latanoprost 0.005% ophth. soln.  1  drop ; lidocaine 5% patch  1  ptch ; omeprazole  40  mg ; paroxetine  30  mg ; polyethylene glycol  17  g ; senna  17.2  mg ; sevelamer carbonate  800  mg ; tiotropium bromide  1  cap ; albuterol 0.083% neb soln  1  neb ; tramadol  50  mg ; insulin  4  unit ; insulin  8  unit ; insulin  36  unit ; carvedilol  25  mg ; sodium chloride 0.9%  flush  20  ml ; lidocaine 1% (for picc midline insertions)  5  ml ; alendronate sodium  70  mg ; sarna lotion  1  appl ; 0.9% sodium chloride  1  bag ; calcium gluconate  2  g ; 0.9% sodium chloride  2  bag ; calcium gluconate  4  g ; sodium chloride 0.9%  flush  10  ml ; lorazepam  0.25  mg ; sulfameth trimethoprim ss  1  tab ; d5w  250  ml ; nitroglycerin  100  mg ; acetazolamide  250  mg ; potassium chloride  40  meq ; 
acute on chronic diastolic (congestive) heart failure type 2 diabetes mellitus with diabetic polyneuropathy type 2 diabetes mellitus with hyperglycemia acute and chronic respiratory failure with hypoxia obstructive sleep apnea (adult) (pediatric) morbid (severe) obesity with alveolar hypoventilation other secondary pulmonary hypertension hypertensive heart and chronic kidney disease with heart failure and stage 1 through stage 4 chronic kidney disease, or unspecified chronic kidney disease fall resulting in striking against other object unspecified place in hospital as the place of occurrence of the external cause metabolic syndrome major depressive disorder, single episode, unspecified fatty (change of) liver, not elsewhere classified chronic kidney disease, unspecified gastro-esophageal reflux disease without esophagitis other chronic pain adverse effect of loop [high-ceiling] diuretics, initial encounter personal history of malignant neoplasm of breast unspecified open-angle glaucoma, stage unspecified age-related osteoporosis without current pathological fracture type 2 diabetes mellitus with diabetic chronic kidney disease other acute kidney failure patient's noncompliance with dietary regimen patient's other noncompliance with medication regimen body mass index (bmi) 39.0-39.9, adult long term (current) use of insulin dependence on supplemental oxygen hyperlipidemia, unspecified venous insufficiency (chronic) (peripheral) type 2 diabetes mellitus with diabetic polyneuropathy hypertensive heart and chronic kidney disease with heart failure and stage 1 through stage 4 chronic kidney disease, or unspecified chronic kidney disease personal history of malignant neoplasm of breast nausea other secondary pulmonary hypertension age-related osteoporosis without current pathological fracture unspecified rotator cuff tear or rupture of right shoulder, not specified as traumatic dependence on supplemental oxygen body mass index (bmi) 45.0-49.9, adult unspecified asthma, uncomplicated nonrheumatic tricuspid (valve) insufficiency portal vein thrombosis acute and chronic respiratory failure with hypoxia carpal tunnel syndrome, unspecified upper limb acute on chronic diastolic (congestive) heart failure chronic kidney disease, unspecified headache iron deficiency anemia, unspecified gastro-esophageal reflux disease without esophagitis
black african american f 76 $nan$hematology blood hematocrit  29.6  %; hematology blood hemoglobin  8.6  g dl; hematology blood platelet count  314  k ul; chemistry blood anion gap  16  meq l; chemistry blood anion gap  18  meq l; chemistry blood bicarbonate  37  meq l; chemistry blood bicarbonate  33  meq l; chemistry blood chloride  87  meq l; chemistry blood chloride  86  meq l; chemistry blood creatinine  3.0  mg dl; chemistry blood creatinine  3.2  mg dl; chemistry blood potassium  3.5  meq l; chemistry blood potassium  3.9  meq l; chemistry blood sodium  136  meq l; chemistry blood sodium  133  meq l; chemistry blood urea nitrogen  116  mg dl; chemistry blood urea nitrogen  120  mg dl; chemistry urine creatinine, urine  56  mg dl; chemistry urine sodium, urine  23  meq l; chemistry urine urea nitrogen, urine  406  mg dl; chemistry blood calcium, total  9.0  mg dl; chemistry blood calcium, total  9.0  mg dl; chemistry blood glucose  154  mg dl; chemistry blood glucose  254  mg dl; blood gas blood hematocrit, calculated  27  %; blood gas blood hemoglobin  9.0  g dl$heparin  5000  unit ; insulin  0  unit ; acetaminophen  1000  mg ; anastrozole  1  mg ; aspirin  81  mg ; atorvastatin  80  mg ; bisacodyl  10  mg ; calcium carbonate  500  mg ; dorzolamide 2% timolol 0.5% ophth.  1  drop ; dextrose 50%  12.5  gm ; glucagon  1  mg ; glucose gel  15  g ; latanoprost 0.005% ophth. soln.  1  drop ; lidocaine 5% patch  1  ptch ; paroxetine  30  mg ; polyethylene glycol  17  g ; senna  17.2  mg ; sevelamer carbonate  800  mg ; tiotropium bromide  1  cap ; insulin  4  unit ; insulin  8  unit ; insulin  36  unit ; carvedilol  25  mg ; alendronate sodium  70  mg ; sarna lotion  1  appl ; sodium chloride 0.9%  flush  10  ml ; sulfameth trimethoprim ss  1  tab ; d5w  250  ml ; nitroglycerin  100  mg ; acetazolamide  250  mg ; potassium chloride  40  meq ; sodium chloride 0.9%  flush  3  ml ; sodium chloride 0.9%  1000  ml ; potassium chloride (powder)  20  meq ; torsemide  100  mg ; 
acute on chronic diastolic (congestive) heart failure type 2 diabetes mellitus with diabetic polyneuropathy type 2 diabetes mellitus with hyperglycemia acute and chronic respiratory failure with hypoxia obstructive sleep apnea (adult) (pediatric) morbid (severe) obesity with alveolar hypoventilation other secondary pulmonary hypertension hypertensive heart and chronic kidney disease with heart failure and stage 1 through stage 4 chronic kidney disease, or unspecified chronic kidney disease fall resulting in striking against other object unspecified place in hospital as the place of occurrence of the external cause metabolic syndrome major depressive disorder, single episode, unspecified fatty (change of) liver, not elsewhere classified chronic kidney disease, unspecified gastro-esophageal reflux disease without esophagitis other chronic pain adverse effect of loop [high-ceiling] diuretics, initial encounter personal history of malignant neoplasm of breast unspecified open-angle glaucoma, stage unspecified age-related osteoporosis without current pathological fracture type 2 diabetes mellitus with diabetic chronic kidney disease other acute kidney failure patient's noncompliance with dietary regimen patient's other noncompliance with medication regimen body mass index (bmi) 39.0-39.9, adult long term (current) use of insulin dependence on supplemental oxygen hyperlipidemia, unspecified venous insufficiency (chronic) (peripheral) type 2 diabetes mellitus with diabetic polyneuropathy hypertensive heart and chronic kidney disease with heart failure and stage 1 through stage 4 chronic kidney disease, or unspecified chronic kidney disease personal history of malignant neoplasm of breast nausea other secondary pulmonary hypertension age-related osteoporosis without current pathological fracture unspecified rotator cuff tear or rupture of right shoulder, not specified as traumatic dependence on supplemental oxygen body mass index (bmi) 45.0-49.9, adult unspecified asthma, uncomplicated nonrheumatic tricuspid (valve) insufficiency portal vein thrombosis acute and chronic respiratory failure with hypoxia carpal tunnel syndrome, unspecified upper limb acute on chronic diastolic (congestive) heart failure chronic kidney disease, unspecified headache iron deficiency anemia, unspecified gastro-esophageal reflux disease without esophagitis
black african american f 76 $nan$hematology blood hematocrit  29.8  %; hematology blood hemoglobin  8.6  g dl; hematology blood hemoglobin  8.5  g dl; hematology blood platelet count  304  k ul; chemistry blood anion gap  18  meq l; chemistry blood anion gap  20  meq l; chemistry blood bicarbonate  34  meq l; chemistry blood bicarbonate  29  meq l; chemistry blood chloride  88  meq l; chemistry blood chloride  87  meq l; chemistry blood creatinine  3.0  mg dl; chemistry blood creatinine  3.2  mg dl; chemistry blood potassium  3.2  meq l; chemistry blood potassium  3.7  meq l; chemistry blood sodium  137  meq l; chemistry blood sodium  132  meq l; chemistry blood urea nitrogen  117  mg dl; chemistry blood urea nitrogen  117  mg dl; chemistry blood calcium, total  9.3  mg dl; chemistry blood calcium, total  8.8  mg dl; chemistry blood glucose  143  mg dl; chemistry blood glucose  271  mg dl; blood gas blood lactate  1.2  mmol l; blood gas blood hematocrit, calculated  27  %; blood gas blood hemoglobin  9.0  g dl$heparin  5000  unit ; insulin  0  unit ; acetaminophen  1000  mg ; anastrozole  1  mg ; aspirin  81  mg ; atorvastatin  80  mg ; bisacodyl  10  mg ; calcium carbonate  500  mg ; dorzolamide 2% timolol 0.5% ophth.  1  drop ; dextrose 50%  12.5  gm ; glucagon  1  mg ; glucose gel  15  g ; latanoprost 0.005% ophth. soln.  1  drop ; lidocaine 5% patch  1  ptch ; paroxetine  30  mg ; polyethylene glycol  17  g ; senna  17.2  mg ; sevelamer carbonate  800  mg ; tiotropium bromide  1  cap ; insulin  4  unit ; insulin  8  unit ; insulin  36  unit ; carvedilol  25  mg ; alendronate sodium  70  mg ; sarna lotion  1  appl ; sodium chloride 0.9%  flush  10  ml ; d5w  250  ml ; nitroglycerin  100  mg ; acetazolamide  250  mg ; sodium chloride 0.9%  flush  3  ml ; sodium chloride 0.9%  1000  ml ; potassium chloride (powder)  20  meq ; torsemide  100  mg ; ramelteon  8  mg ; 
acute on chronic diastolic (congestive) heart failure type 2 diabetes mellitus with diabetic polyneuropathy type 2 diabetes mellitus with hyperglycemia acute and chronic respiratory failure with hypoxia obstructive sleep apnea (adult) (pediatric) morbid (severe) obesity with alveolar hypoventilation other secondary pulmonary hypertension hypertensive heart and chronic kidney disease with heart failure and stage 1 through stage 4 chronic kidney disease, or unspecified chronic kidney disease fall resulting in striking against other object unspecified place in hospital as the place of occurrence of the external cause metabolic syndrome major depressive disorder, single episode, unspecified fatty (change of) liver, not elsewhere classified chronic kidney disease, unspecified gastro-esophageal reflux disease without esophagitis other chronic pain adverse effect of loop [high-ceiling] diuretics, initial encounter personal history of malignant neoplasm of breast unspecified open-angle glaucoma, stage unspecified age-related osteoporosis without current pathological fracture type 2 diabetes mellitus with diabetic chronic kidney disease other acute kidney failure patient's noncompliance with dietary regimen patient's other noncompliance with medication regimen body mass index (bmi) 39.0-39.9, adult long term (current) use of insulin dependence on supplemental oxygen hyperlipidemia, unspecified venous insufficiency (chronic) (peripheral) type 2 diabetes mellitus with diabetic polyneuropathy hypertensive heart and chronic kidney disease with heart failure and stage 1 through stage 4 chronic kidney disease, or unspecified chronic kidney disease personal history of malignant neoplasm of breast nausea other secondary pulmonary hypertension age-related osteoporosis without current pathological fracture unspecified rotator cuff tear or rupture of right shoulder, not specified as traumatic dependence on supplemental oxygen body mass index (bmi) 45.0-49.9, adult unspecified asthma, uncomplicated nonrheumatic tricuspid (valve) insufficiency portal vein thrombosis acute and chronic respiratory failure with hypoxia carpal tunnel syndrome, unspecified upper limb acute on chronic diastolic (congestive) heart failure chronic kidney disease, unspecified headache iron deficiency anemia, unspecified gastro-esophageal reflux disease without esophagitis
black african american f 76 $nan$hematology blood hematocrit  28.1  %; hematology blood hemoglobin  8.3  g dl; hematology blood platelet count  288  k ul; chemistry blood anion gap  16  meq l; chemistry blood anion gap  11  meq l; chemistry blood anion gap  16  meq l; chemistry blood bicarbonate  34  meq l; chemistry blood bicarbonate  20  meq l; chemistry blood bicarbonate  33  meq l; chemistry blood chloride  91  meq l; chemistry blood chloride  114  meq l; chemistry blood chloride  91  meq l; chemistry blood creatinine  2.9  mg dl; chemistry blood creatinine  1.6  mg dl; chemistry blood creatinine  3.0  mg dl; chemistry blood potassium  3.2  meq l; chemistry blood potassium  4.0  meq l; chemistry blood potassium  2.2  meq l; chemistry blood sodium  138  meq l; chemistry blood sodium  143  meq l; chemistry blood sodium  136  meq l; chemistry blood urea nitrogen  119  mg dl; chemistry blood urea nitrogen  73  mg dl; chemistry blood urea nitrogen  117  mg dl; chemistry blood calcium, total  8.7  mg dl; chemistry blood calcium, total  9.1  mg dl; chemistry blood bilirubin, total  0.3  mg dl; chemistry blood glucose  156  mg dl; chemistry blood glucose  124  mg dl; chemistry blood glucose  116  mg dl$heparin  5000  unit ; insulin  0  unit ; acetaminophen  1000  mg ; anastrozole  1  mg ; aspirin  81  mg ; atorvastatin  80  mg ; bisacodyl  10  mg ; calcium carbonate  500  mg ; dorzolamide 2% timolol 0.5% ophth.  1  drop ; dextrose 50%  12.5  gm ; glucagon  1  mg ; glucose gel  15  g ; latanoprost 0.005% ophth. soln.  1  drop ; lidocaine 5% patch  1  ptch ; paroxetine  30  mg ; polyethylene glycol  17  g ; senna  17.2  mg ; sevelamer carbonate  800  mg ; tiotropium bromide  1  cap ; insulin  4  unit ; insulin  8  unit ; insulin  36  unit ; carvedilol  25  mg ; alendronate sodium  70  mg ; sarna lotion  1  appl ; sodium chloride 0.9%  flush  10  ml ; acetazolamide  250  mg ; torsemide  100  mg ; ramelteon  8  mg ; potassium chloride  60  meq ; furosemide  100  mg ; 
acute on chronic diastolic (congestive) heart failure type 2 diabetes mellitus with diabetic polyneuropathy type 2 diabetes mellitus with hyperglycemia acute and chronic respiratory failure with hypoxia obstructive sleep apnea (adult) (pediatric) morbid (severe) obesity with alveolar hypoventilation other secondary pulmonary hypertension hypertensive heart and chronic kidney disease with heart failure and stage 1 through stage 4 chronic kidney disease, or unspecified chronic kidney disease fall resulting in striking against other object unspecified place in hospital as the place of occurrence of the external cause metabolic syndrome major depressive disorder, single episode, unspecified fatty (change of) liver, not elsewhere classified chronic kidney disease, unspecified gastro-esophageal reflux disease without esophagitis other chronic pain adverse effect of loop [high-ceiling] diuretics, initial encounter personal history of malignant neoplasm of breast unspecified open-angle glaucoma, stage unspecified age-related osteoporosis without current pathological fracture type 2 diabetes mellitus with diabetic chronic kidney disease other acute kidney failure patient's noncompliance with dietary regimen patient's other noncompliance with medication regimen body mass index (bmi) 39.0-39.9, adult long term (current) use of insulin dependence on supplemental oxygen hyperlipidemia, unspecified venous insufficiency (chronic) (peripheral) type 2 diabetes mellitus with diabetic polyneuropathy hypertensive heart and chronic kidney disease with heart failure and stage 1 through stage 4 chronic kidney disease, or unspecified chronic kidney disease personal history of malignant neoplasm of breast nausea other secondary pulmonary hypertension age-related osteoporosis without current pathological fracture unspecified rotator cuff tear or rupture of right shoulder, not specified as traumatic dependence on supplemental oxygen body mass index (bmi) 45.0-49.9, adult unspecified asthma, uncomplicated nonrheumatic tricuspid (valve) insufficiency portal vein thrombosis acute and chronic respiratory failure with hypoxia carpal tunnel syndrome, unspecified upper limb acute on chronic diastolic (congestive) heart failure chronic kidney disease, unspecified headache iron deficiency anemia, unspecified gastro-esophageal reflux disease without esophagitis
black african american f 76 $nan$hematology blood hematocrit  28.0  %; hematology blood hemoglobin  8.1  g dl; hematology blood platelet count  262  k ul; chemistry blood anion gap  17  meq l; chemistry blood anion gap  17  meq l; chemistry blood bicarbonate  33  meq l; chemistry blood bicarbonate  31  meq l; chemistry blood chloride  91  meq l; chemistry blood chloride  92  meq l; chemistry blood creatinine  2.6  mg dl; chemistry blood creatinine  2.5  mg dl; chemistry blood potassium  3.5  meq l; chemistry blood potassium  3.9  meq l; chemistry blood sodium  137  meq l; chemistry blood sodium  136  meq l; chemistry blood urea nitrogen  110  mg dl; chemistry blood urea nitrogen  107  mg dl; hematology blood inr(pt)  1.1  ; chemistry blood glucose  162  mg dl; chemistry blood glucose  207  mg dl; blood gas blood hematocrit, calculated  26  %; blood gas blood hemoglobin  8.5  g dl$heparin  5000  unit ; insulin  0  unit ; acetaminophen  1000  mg ; anastrozole  1  mg ; aspirin  81  mg ; atorvastatin  80  mg ; bisacodyl  10  mg ; calcium carbonate  500  mg ; dorzolamide 2% timolol 0.5% ophth.  1  drop ; dextrose 50%  12.5  gm ; glucagon  1  mg ; glucose gel  15  g ; latanoprost 0.005% ophth. soln.  1  drop ; lidocaine 5% patch  1  ptch ; paroxetine  30  mg ; polyethylene glycol  17  g ; senna  17.2  mg ; sevelamer carbonate  800  mg ; tiotropium bromide  1  cap ; insulin  4  unit ; insulin  8  unit ; insulin  36  unit ; carvedilol  25  mg ; alendronate sodium  70  mg ; sarna lotion  1  appl ; sodium chloride 0.9%  flush  10  ml ; acetazolamide  250  mg ; torsemide  100  mg ; ramelteon  8  mg ; furosemide  100  mg ; cetirizine  10  mg ; 
acute on chronic diastolic (congestive) heart failure type 2 diabetes mellitus with diabetic polyneuropathy type 2 diabetes mellitus with hyperglycemia acute and chronic respiratory failure with hypoxia obstructive sleep apnea (adult) (pediatric) morbid (severe) obesity with alveolar hypoventilation other secondary pulmonary hypertension hypertensive heart and chronic kidney disease with heart failure and stage 1 through stage 4 chronic kidney disease, or unspecified chronic kidney disease fall resulting in striking against other object unspecified place in hospital as the place of occurrence of the external cause metabolic syndrome major depressive disorder, single episode, unspecified fatty (change of) liver, not elsewhere classified chronic kidney disease, unspecified gastro-esophageal reflux disease without esophagitis other chronic pain adverse effect of loop [high-ceiling] diuretics, initial encounter personal history of malignant neoplasm of breast unspecified open-angle glaucoma, stage unspecified age-related osteoporosis without current pathological fracture type 2 diabetes mellitus with diabetic chronic kidney disease other acute kidney failure patient's noncompliance with dietary regimen patient's other noncompliance with medication regimen body mass index (bmi) 39.0-39.9, adult long term (current) use of insulin dependence on supplemental oxygen hyperlipidemia, unspecified venous insufficiency (chronic) (peripheral) type 2 diabetes mellitus with diabetic polyneuropathy hypertensive heart and chronic kidney disease with heart failure and stage 1 through stage 4 chronic kidney disease, or unspecified chronic kidney disease personal history of malignant neoplasm of breast nausea other secondary pulmonary hypertension age-related osteoporosis without current pathological fracture unspecified rotator cuff tear or rupture of right shoulder, not specified as traumatic dependence on supplemental oxygen body mass index (bmi) 45.0-49.9, adult unspecified asthma, uncomplicated nonrheumatic tricuspid (valve) insufficiency portal vein thrombosis acute and chronic respiratory failure with hypoxia carpal tunnel syndrome, unspecified upper limb acute on chronic diastolic (congestive) heart failure chronic kidney disease, unspecified headache iron deficiency anemia, unspecified gastro-esophageal reflux disease without esophagitis
black african american f 76 $nan$hematology blood hematocrit  29.3  %; hematology blood hemoglobin  8.4  g dl; hematology blood platelet count  267  k ul; chemistry blood anion gap  16  meq l; chemistry blood anion gap  17  meq l; chemistry blood anion gap  17  meq l; chemistry blood bicarbonate  32  meq l; chemistry blood bicarbonate  30  meq l; chemistry blood bicarbonate  32  meq l; chemistry blood chloride  93  meq l; chemistry blood chloride  91  meq l; chemistry blood chloride  91  meq l; chemistry blood creatinine  2.3  mg dl; chemistry blood creatinine  2.3  mg dl; chemistry blood creatinine  2.3  mg dl; chemistry blood potassium  3.8  meq l; chemistry blood potassium  3.7  meq l; chemistry blood potassium  3.7  meq l; chemistry blood sodium  137  meq l; chemistry blood sodium  134  meq l; chemistry blood sodium  136  meq l; chemistry blood urea nitrogen  106  mg dl; chemistry blood urea nitrogen  102  mg dl; chemistry blood urea nitrogen  101  mg dl; chemistry blood calcium, total  8.8  mg dl; chemistry blood calcium, total  9.1  mg dl; chemistry blood glucose  108  mg dl; chemistry blood glucose  207  mg dl; chemistry blood glucose  122  mg dl$heparin  5000  unit ; insulin  0  unit ; acetaminophen  1000  mg ; anastrozole  1  mg ; aspirin  81  mg ; atorvastatin  80  mg ; bisacodyl  10  mg ; calcium carbonate  500  mg ; dorzolamide 2% timolol 0.5% ophth.  1  drop ; dextrose 50%  12.5  gm ; glucagon  1  mg ; glucose gel  15  g ; latanoprost 0.005% ophth. soln.  1  drop ; lidocaine 5% patch  1  ptch ; paroxetine  30  mg ; polyethylene glycol  17  g ; senna  17.2  mg ; sevelamer carbonate  800  mg ; tiotropium bromide  1  cap ; insulin  4  unit ; insulin  8  unit ; insulin  36  unit ; carvedilol  25  mg ; alendronate sodium  70  mg ; sarna lotion  1  appl ; acetazolamide  250  mg ; torsemide  100  mg ; ramelteon  8  mg ; cetirizine  10  mg ; sodium chloride 0.9%  flush  10-20  ml ; potassium chloride  10  meq ; potassium chloride  20  meq ; tramadol  25  mg ; magnesium sulfate  2  gm ; magnesium sulfate  4  gm ; 
acute on chronic diastolic (congestive) heart failure type 2 diabetes mellitus with diabetic polyneuropathy type 2 diabetes mellitus with hyperglycemia acute and chronic respiratory failure with hypoxia obstructive sleep apnea (adult) (pediatric) morbid (severe) obesity with alveolar hypoventilation other secondary pulmonary hypertension hypertensive heart and chronic kidney disease with heart failure and stage 1 through stage 4 chronic kidney disease, or unspecified chronic kidney disease fall resulting in striking against other object unspecified place in hospital as the place of occurrence of the external cause metabolic syndrome major depressive disorder, single episode, unspecified fatty (change of) liver, not elsewhere classified chronic kidney disease, unspecified gastro-esophageal reflux disease without esophagitis other chronic pain adverse effect of loop [high-ceiling] diuretics, initial encounter personal history of malignant neoplasm of breast unspecified open-angle glaucoma, stage unspecified age-related osteoporosis without current pathological fracture type 2 diabetes mellitus with diabetic chronic kidney disease other acute kidney failure patient's noncompliance with dietary regimen patient's other noncompliance with medication regimen body mass index (bmi) 39.0-39.9, adult long term (current) use of insulin dependence on supplemental oxygen hyperlipidemia, unspecified venous insufficiency (chronic) (peripheral) type 2 diabetes mellitus with diabetic polyneuropathy hypertensive heart and chronic kidney disease with heart failure and stage 1 through stage 4 chronic kidney disease, or unspecified chronic kidney disease personal history of malignant neoplasm of breast nausea other secondary pulmonary hypertension age-related osteoporosis without current pathological fracture unspecified rotator cuff tear or rupture of right shoulder, not specified as traumatic dependence on supplemental oxygen body mass index (bmi) 45.0-49.9, adult unspecified asthma, uncomplicated nonrheumatic tricuspid (valve) insufficiency portal vein thrombosis acute and chronic respiratory failure with hypoxia carpal tunnel syndrome, unspecified upper limb acute on chronic diastolic (congestive) heart failure chronic kidney disease, unspecified headache iron deficiency anemia, unspecified gastro-esophageal reflux disease without esophagitis
black african american f 76 $nan$hematology blood hematocrit  29.3  %; hematology blood hemoglobin  8.5  g dl; hematology blood platelet count  284  k ul; chemistry blood anion gap  16  meq l; chemistry blood anion gap  19  meq l; chemistry blood bicarbonate  32  meq l; chemistry blood bicarbonate  30  meq l; chemistry blood chloride  93  meq l; chemistry blood chloride  89  meq l; chemistry blood creatinine  2.2  mg dl; chemistry blood creatinine  2.4  mg dl; chemistry blood potassium  4.3  meq l; chemistry blood potassium  3.8  meq l; chemistry blood sodium  137  meq l; chemistry blood sodium  134  meq l; chemistry blood urea nitrogen  99  mg dl; chemistry blood urea nitrogen  104  mg dl; hematology blood inr(pt)  1.1  ; chemistry blood calcium, total  9.0  mg dl; chemistry blood calcium, total  9.0  mg dl; chemistry blood bilirubin, total  0.2  mg dl; chemistry blood glucose  112  mg dl; chemistry blood glucose  246  mg dl; chemistry blood lactate dehydrogenase (ld)  381  iu l; chemistry blood albumin  3.4  g dl$heparin  5000  unit ; insulin  0  unit ; acetaminophen  1000  mg ; anastrozole  1  mg ; aspirin  81  mg ; atorvastatin  80  mg ; bisacodyl  10  mg ; calcium carbonate  500  mg ; dorzolamide 2% timolol 0.5% ophth.  1  drop ; dextrose 50%  12.5  gm ; glucagon  1  mg ; glucose gel  15  g ; latanoprost 0.005% ophth. soln.  1  drop ; lidocaine 5% patch  1  ptch ; paroxetine  30  mg ; polyethylene glycol  17  g ; senna  17.2  mg ; sevelamer carbonate  800  mg ; tiotropium bromide  1  cap ; insulin  4  unit ; insulin  8  unit ; insulin  36  unit ; carvedilol  25  mg ; alendronate sodium  70  mg ; sarna lotion  1  appl ; ramelteon  8  mg ; cetirizine  10  mg ; sodium chloride 0.9%  flush  10-20  ml ; potassium chloride  20  meq ; tramadol  25  mg ; magnesium sulfate  2  gm ; magnesium sulfate  4  gm ; furosemide  20  mg ; furosemide  40  mg ; 
acute on chronic diastolic (congestive) heart failure type 2 diabetes mellitus with diabetic polyneuropathy type 2 diabetes mellitus with hyperglycemia acute and chronic respiratory failure with hypoxia obstructive sleep apnea (adult) (pediatric) morbid (severe) obesity with alveolar hypoventilation other secondary pulmonary hypertension hypertensive heart and chronic kidney disease with heart failure and stage 1 through stage 4 chronic kidney disease, or unspecified chronic kidney disease fall resulting in striking against other object unspecified place in hospital as the place of occurrence of the external cause metabolic syndrome major depressive disorder, single episode, unspecified fatty (change of) liver, not elsewhere classified chronic kidney disease, unspecified gastro-esophageal reflux disease without esophagitis other chronic pain adverse effect of loop [high-ceiling] diuretics, initial encounter personal history of malignant neoplasm of breast unspecified open-angle glaucoma, stage unspecified age-related osteoporosis without current pathological fracture type 2 diabetes mellitus with diabetic chronic kidney disease other acute kidney failure patient's noncompliance with dietary regimen patient's other noncompliance with medication regimen body mass index (bmi) 39.0-39.9, adult long term (current) use of insulin dependence on supplemental oxygen hyperlipidemia, unspecified venous insufficiency (chronic) (peripheral) type 2 diabetes mellitus with diabetic polyneuropathy hypertensive heart and chronic kidney disease with heart failure and stage 1 through stage 4 chronic kidney disease, or unspecified chronic kidney disease personal history of malignant neoplasm of breast nausea other secondary pulmonary hypertension age-related osteoporosis without current pathological fracture unspecified rotator cuff tear or rupture of right shoulder, not specified as traumatic dependence on supplemental oxygen body mass index (bmi) 45.0-49.9, adult unspecified asthma, uncomplicated nonrheumatic tricuspid (valve) insufficiency portal vein thrombosis acute and chronic respiratory failure with hypoxia carpal tunnel syndrome, unspecified upper limb acute on chronic diastolic (congestive) heart failure chronic kidney disease, unspecified headache iron deficiency anemia, unspecified gastro-esophageal reflux disease without esophagitis
black african american f 76 $nan$hematology blood hematocrit  26.9  %; hematology blood hemoglobin  8.0  g dl; hematology blood platelet count  283  k ul; chemistry blood anion gap  18  meq l; chemistry blood anion gap  18  meq l; chemistry blood bicarbonate  32  meq l; chemistry blood bicarbonate  33  meq l; chemistry blood chloride  87  meq l; chemistry blood chloride  85  meq l; chemistry blood creatinine  2.5  mg dl; chemistry blood creatinine  2.3  mg dl; chemistry blood potassium  3.3  meq l; chemistry blood potassium  4.0  meq l; chemistry blood sodium  134  meq l; chemistry blood sodium  132  meq l; chemistry blood urea nitrogen  114  mg dl; chemistry blood urea nitrogen  115  mg dl; hematology blood inr(pt)  1.1  ; chemistry blood calcium, total  8.8  mg dl; chemistry blood calcium, total  9.1  mg dl; chemistry blood bilirubin, total  0.2  mg dl; chemistry blood glucose  194  mg dl; chemistry blood glucose  173  mg dl; chemistry blood lactate dehydrogenase (ld)  358  iu l; chemistry blood albumin  3.3  g dl$heparin  5000  unit ; insulin  0  unit ; acetaminophen  1000  mg ; anastrozole  1  mg ; aspirin  81  mg ; atorvastatin  80  mg ; bisacodyl  10  mg ; calcium carbonate  500  mg ; dorzolamide 2% timolol 0.5% ophth.  1  drop ; dextrose 50%  12.5  gm ; glucagon  1  mg ; glucose gel  15  g ; latanoprost 0.005% ophth. soln.  1  drop ; lidocaine 5% patch  1  ptch ; paroxetine  30  mg ; polyethylene glycol  17  g ; senna  17.2  mg ; sevelamer carbonate  800  mg ; tiotropium bromide  1  cap ; insulin  4  unit ; insulin  8  unit ; insulin  36  unit ; carvedilol  25  mg ; alendronate sodium  70  mg ; sarna lotion  1  appl ; ramelteon  8  mg ; cetirizine  10  mg ; sodium chloride 0.9%  flush  10-20  ml ; tramadol  25  mg ; magnesium sulfate  2  gm ; magnesium sulfate  4  gm ; furosemide  20  mg ; furosemide  40  mg ; sterile water  50  ml ; potassium chloride replacement (critical care and oncology)   20  meq ; 
acute on chronic diastolic (congestive) heart failure type 2 diabetes mellitus with diabetic polyneuropathy type 2 diabetes mellitus with hyperglycemia acute and chronic respiratory failure with hypoxia obstructive sleep apnea (adult) (pediatric) morbid (severe) obesity with alveolar hypoventilation other secondary pulmonary hypertension hypertensive heart and chronic kidney disease with heart failure and stage 1 through stage 4 chronic kidney disease, or unspecified chronic kidney disease fall resulting in striking against other object unspecified place in hospital as the place of occurrence of the external cause metabolic syndrome major depressive disorder, single episode, unspecified fatty (change of) liver, not elsewhere classified chronic kidney disease, unspecified gastro-esophageal reflux disease without esophagitis other chronic pain adverse effect of loop [high-ceiling] diuretics, initial encounter personal history of malignant neoplasm of breast unspecified open-angle glaucoma, stage unspecified age-related osteoporosis without current pathological fracture type 2 diabetes mellitus with diabetic chronic kidney disease other acute kidney failure patient's noncompliance with dietary regimen patient's other noncompliance with medication regimen body mass index (bmi) 39.0-39.9, adult long term (current) use of insulin dependence on supplemental oxygen hyperlipidemia, unspecified venous insufficiency (chronic) (peripheral) type 2 diabetes mellitus with diabetic polyneuropathy hypertensive heart and chronic kidney disease with heart failure and stage 1 through stage 4 chronic kidney disease, or unspecified chronic kidney disease personal history of malignant neoplasm of breast nausea other secondary pulmonary hypertension age-related osteoporosis without current pathological fracture unspecified rotator cuff tear or rupture of right shoulder, not specified as traumatic dependence on supplemental oxygen body mass index (bmi) 45.0-49.9, adult unspecified asthma, uncomplicated nonrheumatic tricuspid (valve) insufficiency portal vein thrombosis acute and chronic respiratory failure with hypoxia carpal tunnel syndrome, unspecified upper limb acute on chronic diastolic (congestive) heart failure chronic kidney disease, unspecified headache iron deficiency anemia, unspecified gastro-esophageal reflux disease without esophagitis
black african american f 76 $nan$hematology blood hematocrit  26.4  %; hematology blood hemoglobin  7.9  g dl; hematology blood platelet count  302  k ul; chemistry blood anion gap  17  meq l; chemistry blood anion gap  19  meq l; chemistry blood bicarbonate  33  meq l; chemistry blood bicarbonate  30  meq l; chemistry blood chloride  86  meq l; chemistry blood chloride  85  meq l; chemistry blood creatinine  2.4  mg dl; chemistry blood creatinine  2.4  mg dl; chemistry blood potassium  3.3  meq l; chemistry blood potassium  4.7  meq l; chemistry blood sodium  133  meq l; chemistry blood sodium  129  meq l; chemistry blood urea nitrogen  122  mg dl; chemistry blood urea nitrogen  119  mg dl; hematology blood inr(pt)  1.1  ; chemistry blood calcium, total  9.0  mg dl; chemistry blood calcium, total  8.8  mg dl; chemistry blood bilirubin, total  0.2  mg dl; chemistry blood glucose  136  mg dl; chemistry blood glucose  260  mg dl; chemistry blood lactate dehydrogenase (ld)  327  iu l; blood gas blood lactate  1.6  mmol l$sterile water  100  ml ; insulin  0  unit ; acetaminophen  1000  mg ; anastrozole  1  mg ; aspirin  81  mg ; atorvastatin  80  mg ; bisacodyl  10  mg ; calcium carbonate  500  mg ; dorzolamide 2% timolol 0.5% ophth.  1  drop ; dextrose 50%  12.5  gm ; glucagon  1  mg ; glucose gel  15  g ; latanoprost 0.005% ophth. soln.  1  drop ; lidocaine 5% patch  1  ptch ; paroxetine  30  mg ; polyethylene glycol  17  g ; senna  17.2  mg ; sevelamer carbonate  800  mg ; tiotropium bromide  1  cap ; insulin  4  unit ; insulin  8  unit ; insulin  36  unit ; alendronate sodium  70  mg ; sarna lotion  1  appl ; ramelteon  8  mg ; cetirizine  10  mg ; sodium chloride 0.9%  flush  10-20  ml ; tramadol  25  mg ; magnesium sulfate  2  gm ; magnesium sulfate  4  gm ; potassium chloride replacement (critical care and oncology)   20  meq ; 
acute on chronic diastolic (congestive) heart failure type 2 diabetes mellitus with diabetic polyneuropathy type 2 diabetes mellitus with hyperglycemia acute and chronic respiratory failure with hypoxia obstructive sleep apnea (adult) (pediatric) morbid (severe) obesity with alveolar hypoventilation other secondary pulmonary hypertension hypertensive heart and chronic kidney disease with heart failure and stage 1 through stage 4 chronic kidney disease, or unspecified chronic kidney disease fall resulting in striking against other object unspecified place in hospital as the place of occurrence of the external cause metabolic syndrome major depressive disorder, single episode, unspecified fatty (change of) liver, not elsewhere classified chronic kidney disease, unspecified gastro-esophageal reflux disease without esophagitis other chronic pain adverse effect of loop [high-ceiling] diuretics, initial encounter personal history of malignant neoplasm of breast unspecified open-angle glaucoma, stage unspecified age-related osteoporosis without current pathological fracture type 2 diabetes mellitus with diabetic chronic kidney disease other acute kidney failure patient's noncompliance with dietary regimen patient's other noncompliance with medication regimen body mass index (bmi) 39.0-39.9, adult long term (current) use of insulin dependence on supplemental oxygen hyperlipidemia, unspecified venous insufficiency (chronic) (peripheral) type 2 diabetes mellitus with diabetic polyneuropathy hypertensive heart and chronic kidney disease with heart failure and stage 1 through stage 4 chronic kidney disease, or unspecified chronic kidney disease personal history of malignant neoplasm of breast nausea other secondary pulmonary hypertension age-related osteoporosis without current pathological fracture unspecified rotator cuff tear or rupture of right shoulder, not specified as traumatic dependence on supplemental oxygen body mass index (bmi) 45.0-49.9, adult unspecified asthma, uncomplicated nonrheumatic tricuspid (valve) insufficiency portal vein thrombosis acute and chronic respiratory failure with hypoxia carpal tunnel syndrome, unspecified upper limb acute on chronic diastolic (congestive) heart failure chronic kidney disease, unspecified headache iron deficiency anemia, unspecified gastro-esophageal reflux disease without esophagitis
black african american f 76 $nan$hematology blood hematocrit  26.9  %; hematology blood hemoglobin  8.0  g dl; hematology blood platelet count  322  k ul; chemistry blood anion gap  17  meq l; chemistry blood anion gap  18  meq l; chemistry blood bicarbonate  30  meq l; chemistry blood bicarbonate  31  meq l; chemistry blood chloride  94  meq l; chemistry blood chloride  89  meq l; chemistry blood creatinine  2.0  mg dl; chemistry blood creatinine  2.1  mg dl; chemistry blood potassium  3.4  meq l; chemistry blood potassium  4.3  meq l; chemistry blood sodium  138  meq l; chemistry blood sodium  134  meq l; chemistry blood urea nitrogen  105  mg dl; chemistry blood urea nitrogen  115  mg dl; chemistry blood calcium, total  8.3  mg dl; chemistry blood calcium, total  9.0  mg dl; chemistry blood bilirubin, total  0.2  mg dl; chemistry blood glucose  93  mg dl; chemistry blood glucose  173  mg dl; chemistry blood lactate dehydrogenase (ld)  324  iu l; blood gas blood lactate  1.8  mmol l$sterile water  100  ml ; insulin  0  unit ; acetaminophen  1000  mg ; anastrozole  1  mg ; aspirin  81  mg ; atorvastatin  80  mg ; bisacodyl  10  mg ; calcium carbonate  500  mg ; dorzolamide 2% timolol 0.5% ophth.  1  drop ; dextrose 50%  12.5  gm ; glucagon  1  mg ; glucose gel  15  g ; latanoprost 0.005% ophth. soln.  1  drop ; lidocaine 5% patch  1  ptch ; paroxetine  30  mg ; polyethylene glycol  17  g ; senna  17.2  mg ; sevelamer carbonate  800  mg ; tiotropium bromide  1  cap ; insulin  4  unit ; insulin  8  unit ; insulin  36  unit ; alendronate sodium  70  mg ; sarna lotion  1  appl ; ramelteon  8  mg ; cetirizine  10  mg ; sodium chloride 0.9%  flush  10-20  ml ; tramadol  25  mg ; magnesium sulfate  2  gm ; magnesium sulfate  4  gm ; potassium chloride replacement (critical care and oncology)   20  meq ; 5% dextrose  40  ml ; 
acute on chronic diastolic (congestive) heart failure type 2 diabetes mellitus with diabetic polyneuropathy type 2 diabetes mellitus with hyperglycemia acute and chronic respiratory failure with hypoxia obstructive sleep apnea (adult) (pediatric) morbid (severe) obesity with alveolar hypoventilation other secondary pulmonary hypertension hypertensive heart and chronic kidney disease with heart failure and stage 1 through stage 4 chronic kidney disease, or unspecified chronic kidney disease fall resulting in striking against other object unspecified place in hospital as the place of occurrence of the external cause metabolic syndrome major depressive disorder, single episode, unspecified fatty (change of) liver, not elsewhere classified chronic kidney disease, unspecified gastro-esophageal reflux disease without esophagitis other chronic pain adverse effect of loop [high-ceiling] diuretics, initial encounter personal history of malignant neoplasm of breast unspecified open-angle glaucoma, stage unspecified age-related osteoporosis without current pathological fracture type 2 diabetes mellitus with diabetic chronic kidney disease other acute kidney failure patient's noncompliance with dietary regimen patient's other noncompliance with medication regimen body mass index (bmi) 39.0-39.9, adult long term (current) use of insulin dependence on supplemental oxygen hyperlipidemia, unspecified venous insufficiency (chronic) (peripheral) type 2 diabetes mellitus with diabetic polyneuropathy hypertensive heart and chronic kidney disease with heart failure and stage 1 through stage 4 chronic kidney disease, or unspecified chronic kidney disease personal history of malignant neoplasm of breast nausea other secondary pulmonary hypertension age-related osteoporosis without current pathological fracture unspecified rotator cuff tear or rupture of right shoulder, not specified as traumatic dependence on supplemental oxygen body mass index (bmi) 45.0-49.9, adult unspecified asthma, uncomplicated nonrheumatic tricuspid (valve) insufficiency portal vein thrombosis acute and chronic respiratory failure with hypoxia carpal tunnel syndrome, unspecified upper limb acute on chronic diastolic (congestive) heart failure chronic kidney disease, unspecified headache iron deficiency anemia, unspecified gastro-esophageal reflux disease without esophagitis
black african american f 76 $nan$hematology blood hematocrit  28.5  %; hematology blood hemoglobin  8.4  g dl; hematology blood platelet count  355  k ul; chemistry blood anion gap  20  meq l; chemistry blood anion gap  18  meq l; chemistry blood anion gap  15  meq l; chemistry blood bicarbonate  32  meq l; chemistry blood bicarbonate  30  meq l; chemistry blood bicarbonate  34  meq l; chemistry blood chloride  88  meq l; chemistry blood chloride  85  meq l; chemistry blood chloride  85  meq l; chemistry blood creatinine  2.2  mg dl; chemistry blood creatinine  2.0  mg dl; chemistry blood creatinine  2.0  mg dl; chemistry blood potassium  4.0  meq l; chemistry blood potassium  4.3  meq l; chemistry blood potassium  4.0  meq l; chemistry blood sodium  136  meq l; chemistry blood sodium  129  meq l; chemistry blood sodium  130  meq l; chemistry blood urea nitrogen  115  mg dl; chemistry blood urea nitrogen  110  mg dl; chemistry blood urea nitrogen  114  mg dl; hematology blood inr(pt)  1.1  ; chemistry blood calcium, total  9.3  mg dl; chemistry blood calcium, total  9.1  mg dl; chemistry blood calcium, total  9.1  mg dl; chemistry blood bilirubin, total  0.2  mg dl; chemistry blood glucose  202  mg dl; chemistry blood glucose  299  mg dl; chemistry blood glucose  113  mg dl; chemistry blood lactate dehydrogenase (ld)  357  iu l$insulin  0  unit ; acetaminophen  1000  mg ; anastrozole  1  mg ; aspirin  81  mg ; atorvastatin  80  mg ; bisacodyl  10  mg ; calcium carbonate  500  mg ; dorzolamide 2% timolol 0.5% ophth.  1  drop ; dextrose 50%  12.5  gm ; glucagon  1  mg ; glucose gel  15  g ; latanoprost 0.005% ophth. soln.  1  drop ; lidocaine 5% patch  1  ptch ; paroxetine  30  mg ; polyethylene glycol  17  g ; senna  17.2  mg ; sevelamer carbonate  800  mg ; tiotropium bromide  1  cap ; insulin  4  unit ; insulin  8  unit ; insulin  36  unit ; alendronate sodium  70  mg ; sarna lotion  1  appl ; ramelteon  8  mg ; cetirizine  10  mg ; sodium chloride 0.9%  flush  10-20  ml ; tramadol  25  mg ; magnesium sulfate  2  gm ; magnesium sulfate  4  gm ; potassium chloride replacement (critical care and oncology)   20  meq ; hydroxyzine  12.5  mg ; furosemide  80  mg ; 
acute on chronic diastolic (congestive) heart failure type 2 diabetes mellitus with diabetic polyneuropathy type 2 diabetes mellitus with hyperglycemia acute and chronic respiratory failure with hypoxia obstructive sleep apnea (adult) (pediatric) morbid (severe) obesity with alveolar hypoventilation other secondary pulmonary hypertension hypertensive heart and chronic kidney disease with heart failure and stage 1 through stage 4 chronic kidney disease, or unspecified chronic kidney disease fall resulting in striking against other object unspecified place in hospital as the place of occurrence of the external cause metabolic syndrome major depressive disorder, single episode, unspecified fatty (change of) liver, not elsewhere classified chronic kidney disease, unspecified gastro-esophageal reflux disease without esophagitis other chronic pain adverse effect of loop [high-ceiling] diuretics, initial encounter personal history of malignant neoplasm of breast unspecified open-angle glaucoma, stage unspecified age-related osteoporosis without current pathological fracture type 2 diabetes mellitus with diabetic chronic kidney disease other acute kidney failure patient's noncompliance with dietary regimen patient's other noncompliance with medication regimen body mass index (bmi) 39.0-39.9, adult long term (current) use of insulin dependence on supplemental oxygen hyperlipidemia, unspecified venous insufficiency (chronic) (peripheral) type 2 diabetes mellitus with diabetic polyneuropathy hypertensive heart and chronic kidney disease with heart failure and stage 1 through stage 4 chronic kidney disease, or unspecified chronic kidney disease personal history of malignant neoplasm of breast nausea other secondary pulmonary hypertension age-related osteoporosis without current pathological fracture unspecified rotator cuff tear or rupture of right shoulder, not specified as traumatic dependence on supplemental oxygen body mass index (bmi) 45.0-49.9, adult unspecified asthma, uncomplicated nonrheumatic tricuspid (valve) insufficiency portal vein thrombosis acute and chronic respiratory failure with hypoxia carpal tunnel syndrome, unspecified upper limb acute on chronic diastolic (congestive) heart failure chronic kidney disease, unspecified headache iron deficiency anemia, unspecified gastro-esophageal reflux disease without esophagitis
black african american f 76 $nan$hematology blood hematocrit  28.1  %; hematology blood hemoglobin  8.4  g dl; hematology blood platelet count  341  k ul; chemistry blood anion gap  16  meq l; chemistry blood anion gap  19  meq l; chemistry blood bicarbonate  34  meq l; chemistry blood bicarbonate  33  meq l; chemistry blood chloride  85  meq l; chemistry blood chloride  81  meq l; chemistry blood creatinine  1.8  mg dl; chemistry blood creatinine  2.0  mg dl; chemistry blood potassium  3.4  meq l; chemistry blood potassium  3.9  meq l; chemistry blood sodium  132  meq l; chemistry blood sodium  129  meq l; chemistry blood urea nitrogen  114  mg dl; chemistry blood urea nitrogen  115  mg dl; chemistry blood calcium, total  9.1  mg dl; chemistry blood calcium, total  9.3  mg dl; chemistry blood bilirubin, total  0.2  mg dl; chemistry blood glucose  113  mg dl; chemistry blood glucose  196  mg dl$insulin  0  unit ; acetaminophen  1000  mg ; anastrozole  1  mg ; aspirin  81  mg ; atorvastatin  80  mg ; bisacodyl  10  mg ; calcium carbonate  500  mg ; dorzolamide 2% timolol 0.5% ophth.  1  drop ; dextrose 50%  12.5  gm ; glucagon  1  mg ; glucose gel  15  g ; latanoprost 0.005% ophth. soln.  1  drop ; lidocaine 5% patch  1  ptch ; paroxetine  30  mg ; polyethylene glycol  17  g ; senna  17.2  mg ; sevelamer carbonate  800  mg ; tiotropium bromide  1  cap ; insulin  4  unit ; insulin  8  unit ; insulin  36  unit ; alendronate sodium  70  mg ; sarna lotion  1  appl ; ramelteon  8  mg ; cetirizine  10  mg ; sodium chloride 0.9%  flush  10-20  ml ; tramadol  25  mg ; magnesium sulfate  2  gm ; magnesium sulfate  4  gm ; potassium chloride replacement (critical care and oncology)   20  meq ; sodium chloride nasal  1-2  spry ; 
acute on chronic diastolic (congestive) heart failure type 2 diabetes mellitus with diabetic polyneuropathy type 2 diabetes mellitus with hyperglycemia acute and chronic respiratory failure with hypoxia obstructive sleep apnea (adult) (pediatric) morbid (severe) obesity with alveolar hypoventilation other secondary pulmonary hypertension hypertensive heart and chronic kidney disease with heart failure and stage 1 through stage 4 chronic kidney disease, or unspecified chronic kidney disease fall resulting in striking against other object unspecified place in hospital as the place of occurrence of the external cause metabolic syndrome major depressive disorder, single episode, unspecified fatty (change of) liver, not elsewhere classified chronic kidney disease, unspecified gastro-esophageal reflux disease without esophagitis other chronic pain adverse effect of loop [high-ceiling] diuretics, initial encounter personal history of malignant neoplasm of breast unspecified open-angle glaucoma, stage unspecified age-related osteoporosis without current pathological fracture type 2 diabetes mellitus with diabetic chronic kidney disease other acute kidney failure patient's noncompliance with dietary regimen patient's other noncompliance with medication regimen body mass index (bmi) 39.0-39.9, adult long term (current) use of insulin dependence on supplemental oxygen hyperlipidemia, unspecified venous insufficiency (chronic) (peripheral) type 2 diabetes mellitus with diabetic polyneuropathy hypertensive heart and chronic kidney disease with heart failure and stage 1 through stage 4 chronic kidney disease, or unspecified chronic kidney disease personal history of malignant neoplasm of breast nausea other secondary pulmonary hypertension age-related osteoporosis without current pathological fracture unspecified rotator cuff tear or rupture of right shoulder, not specified as traumatic dependence on supplemental oxygen body mass index (bmi) 45.0-49.9, adult unspecified asthma, uncomplicated nonrheumatic tricuspid (valve) insufficiency portal vein thrombosis acute and chronic respiratory failure with hypoxia carpal tunnel syndrome, unspecified upper limb acute on chronic diastolic (congestive) heart failure chronic kidney disease, unspecified headache iron deficiency anemia, unspecified gastro-esophageal reflux disease without esophagitis
black african american f 76 $nan$hematology blood hematocrit  27.7  %; hematology blood hemoglobin  8.3  g dl; hematology blood platelet count  355  k ul; chemistry blood anion gap  17  meq l; chemistry blood anion gap  19  meq l; chemistry blood bicarbonate  36  meq l; chemistry blood bicarbonate  31  meq l; chemistry blood chloride  81  meq l; chemistry blood chloride  80  meq l; chemistry blood creatinine  2.0  mg dl; chemistry blood creatinine  2.1  mg dl; chemistry blood potassium  3.5  meq l; chemistry blood potassium  3.8  meq l; chemistry blood sodium  130  meq l; chemistry blood sodium  126  meq l; chemistry blood urea nitrogen  115  mg dl; chemistry blood urea nitrogen  111  mg dl; chemistry blood calcium, total  9.3  mg dl; chemistry blood calcium, total  9.0  mg dl; chemistry blood glucose  302  mg dl; chemistry blood glucose  186  mg dl; blood gas blood free calcium  1.14  mmol l; blood gas blood lactate  1.9  mmol l; blood gas blood glucose  171  mg dl$insulin  0  unit ; acetaminophen  1000  mg ; anastrozole  1  mg ; aspirin  81  mg ; atorvastatin  80  mg ; bisacodyl  10  mg ; calcium carbonate  500  mg ; dorzolamide 2% timolol 0.5% ophth.  1  drop ; dextrose 50%  12.5  gm ; glucagon  1  mg ; glucose gel  15  g ; latanoprost 0.005% ophth. soln.  1  drop ; lidocaine 5% patch  1  ptch ; paroxetine  30  mg ; polyethylene glycol  17  g ; senna  17.2  mg ; sevelamer carbonate  800  mg ; tiotropium bromide  1  cap ; insulin  4  unit ; insulin  8  unit ; insulin  36  unit ; alendronate sodium  70  mg ; sarna lotion  1  appl ; ramelteon  8  mg ; cetirizine  10  mg ; sodium chloride 0.9%  flush  10-20  ml ; magnesium sulfate  2  gm ; magnesium sulfate  4  gm ; potassium chloride replacement (critical care and oncology)   20  meq ; sodium chloride nasal  1-2  spry ; hydroxyzine  25  mg ; furosemide  120  mg ; 
acute on chronic diastolic (congestive) heart failure type 2 diabetes mellitus with diabetic polyneuropathy type 2 diabetes mellitus with hyperglycemia acute and chronic respiratory failure with hypoxia obstructive sleep apnea (adult) (pediatric) morbid (severe) obesity with alveolar hypoventilation other secondary pulmonary hypertension hypertensive heart and chronic kidney disease with heart failure and stage 1 through stage 4 chronic kidney disease, or unspecified chronic kidney disease fall resulting in striking against other object unspecified place in hospital as the place of occurrence of the external cause metabolic syndrome major depressive disorder, single episode, unspecified fatty (change of) liver, not elsewhere classified chronic kidney disease, unspecified gastro-esophageal reflux disease without esophagitis other chronic pain adverse effect of loop [high-ceiling] diuretics, initial encounter personal history of malignant neoplasm of breast unspecified open-angle glaucoma, stage unspecified age-related osteoporosis without current pathological fracture type 2 diabetes mellitus with diabetic chronic kidney disease other acute kidney failure patient's noncompliance with dietary regimen patient's other noncompliance with medication regimen body mass index (bmi) 39.0-39.9, adult long term (current) use of insulin dependence on supplemental oxygen hyperlipidemia, unspecified venous insufficiency (chronic) (peripheral) type 2 diabetes mellitus with diabetic polyneuropathy hypertensive heart and chronic kidney disease with heart failure and stage 1 through stage 4 chronic kidney disease, or unspecified chronic kidney disease personal history of malignant neoplasm of breast nausea other secondary pulmonary hypertension age-related osteoporosis without current pathological fracture unspecified rotator cuff tear or rupture of right shoulder, not specified as traumatic dependence on supplemental oxygen body mass index (bmi) 45.0-49.9, adult unspecified asthma, uncomplicated nonrheumatic tricuspid (valve) insufficiency portal vein thrombosis acute and chronic respiratory failure with hypoxia carpal tunnel syndrome, unspecified upper limb acute on chronic diastolic (congestive) heart failure chronic kidney disease, unspecified headache iron deficiency anemia, unspecified gastro-esophageal reflux disease without esophagitis
black african american f 76 $nan$hematology blood hematocrit  27.7  %; hematology blood hemoglobin  8.3  g dl; hematology blood platelet count  348  k ul; chemistry blood anion gap  17  meq l; chemistry blood anion gap  21  meq l; chemistry blood bicarbonate  33  meq l; chemistry blood bicarbonate  29  meq l; chemistry blood chloride  83  meq l; chemistry blood chloride  84  meq l; chemistry blood creatinine  2.3  mg dl; chemistry blood creatinine  2.2  mg dl; chemistry blood potassium  3.5  meq l; chemistry blood potassium  4.2  meq l; chemistry blood sodium  129  meq l; chemistry blood sodium  130  meq l; chemistry blood urea nitrogen  117  mg dl; chemistry blood urea nitrogen  116  mg dl; chemistry blood calcium, total  9.5  mg dl; chemistry blood calcium, total  9.1  mg dl; chemistry blood glucose  283  mg dl; chemistry blood glucose  132  mg dl$insulin  0  unit ; acetaminophen  1000  mg ; anastrozole  1  mg ; aspirin  81  mg ; atorvastatin  80  mg ; bisacodyl  10  mg ; calcium carbonate  500  mg ; dorzolamide 2% timolol 0.5% ophth.  1  drop ; dextrose 50%  12.5  gm ; glucagon  1  mg ; glucose gel  15  g ; latanoprost 0.005% ophth. soln.  1  drop ; lidocaine 5% patch  1  ptch ; paroxetine  30  mg ; polyethylene glycol  17  g ; senna  17.2  mg ; sevelamer carbonate  800  mg ; tiotropium bromide  1  cap ; insulin  4  unit ; insulin  8  unit ; insulin  36  unit ; alendronate sodium  70  mg ; sarna lotion  1  appl ; ramelteon  8  mg ; cetirizine  10  mg ; sodium chloride 0.9%  flush  10-20  ml ; magnesium sulfate  2  gm ; magnesium sulfate  4  gm ; potassium chloride replacement (critical care and oncology)   20  meq ; sodium chloride nasal  1-2  spry ; hydroxyzine  25  mg ; metoprolol succinate xl  12.5  mg ; syringe (0.9% sodium chloride)  2  ml ; alteplase (catheter clearance)  1  mg ; 
acute on chronic diastolic (congestive) heart failure type 2 diabetes mellitus with diabetic polyneuropathy type 2 diabetes mellitus with hyperglycemia acute and chronic respiratory failure with hypoxia obstructive sleep apnea (adult) (pediatric) morbid (severe) obesity with alveolar hypoventilation other secondary pulmonary hypertension hypertensive heart and chronic kidney disease with heart failure and stage 1 through stage 4 chronic kidney disease, or unspecified chronic kidney disease fall resulting in striking against other object unspecified place in hospital as the place of occurrence of the external cause metabolic syndrome major depressive disorder, single episode, unspecified fatty (change of) liver, not elsewhere classified chronic kidney disease, unspecified gastro-esophageal reflux disease without esophagitis other chronic pain adverse effect of loop [high-ceiling] diuretics, initial encounter personal history of malignant neoplasm of breast unspecified open-angle glaucoma, stage unspecified age-related osteoporosis without current pathological fracture type 2 diabetes mellitus with diabetic chronic kidney disease other acute kidney failure patient's noncompliance with dietary regimen patient's other noncompliance with medication regimen body mass index (bmi) 39.0-39.9, adult long term (current) use of insulin dependence on supplemental oxygen hyperlipidemia, unspecified venous insufficiency (chronic) (peripheral) type 2 diabetes mellitus with diabetic polyneuropathy hypertensive heart and chronic kidney disease with heart failure and stage 1 through stage 4 chronic kidney disease, or unspecified chronic kidney disease personal history of malignant neoplasm of breast nausea other secondary pulmonary hypertension age-related osteoporosis without current pathological fracture unspecified rotator cuff tear or rupture of right shoulder, not specified as traumatic dependence on supplemental oxygen body mass index (bmi) 45.0-49.9, adult unspecified asthma, uncomplicated nonrheumatic tricuspid (valve) insufficiency portal vein thrombosis acute and chronic respiratory failure with hypoxia carpal tunnel syndrome, unspecified upper limb acute on chronic diastolic (congestive) heart failure chronic kidney disease, unspecified headache iron deficiency anemia, unspecified gastro-esophageal reflux disease without esophagitis
black african american f 76 $nan$hematology blood hematocrit  27.3  %; hematology blood hemoglobin  8.0  g dl; hematology blood platelet count  360  k ul; chemistry blood anion gap  18  meq l; chemistry blood anion gap  19  meq l; chemistry blood bicarbonate  34  meq l; chemistry blood bicarbonate  32  meq l; chemistry blood chloride  87  meq l; chemistry blood chloride  86  meq l; chemistry blood creatinine  2.1  mg dl; chemistry blood creatinine  2.1  mg dl; chemistry blood potassium  3.9  meq l; chemistry blood potassium  4.0  meq l; chemistry blood sodium  135  meq l; chemistry blood sodium  133  meq l; chemistry blood urea nitrogen  118  mg dl; chemistry blood urea nitrogen  115  mg dl; chemistry blood calcium, total  9.3  mg dl; chemistry blood calcium, total  9.2  mg dl; chemistry blood glucose  193  mg dl; chemistry blood glucose  137  mg dl$insulin  0  unit ; acetaminophen  1000  mg ; anastrozole  1  mg ; aspirin  81  mg ; atorvastatin  80  mg ; bisacodyl  10  mg ; calcium carbonate  500  mg ; dorzolamide 2% timolol 0.5% ophth.  1  drop ; dextrose 50%  12.5  gm ; glucagon  1  mg ; glucose gel  15  g ; latanoprost 0.005% ophth. soln.  1  drop ; lidocaine 5% patch  1  ptch ; paroxetine  30  mg ; polyethylene glycol  17  g ; senna  17.2  mg ; sevelamer carbonate  800  mg ; tiotropium bromide  1  cap ; insulin  4  unit ; insulin  8  unit ; insulin  36  unit ; alendronate sodium  70  mg ; sarna lotion  1  appl ; ramelteon  8  mg ; cetirizine  10  mg ; sodium chloride 0.9%  flush  10-20  ml ; sodium chloride nasal  1-2  spry ; hydroxyzine  25  mg ; metoprolol succinate xl  12.5  mg ; syringe (0.9% sodium chloride)  2  ml ; alteplase (catheter clearance)  1  mg ; 
acute on chronic diastolic (congestive) heart failure type 2 diabetes mellitus with diabetic polyneuropathy type 2 diabetes mellitus with hyperglycemia acute and chronic respiratory failure with hypoxia obstructive sleep apnea (adult) (pediatric) morbid (severe) obesity with alveolar hypoventilation other secondary pulmonary hypertension hypertensive heart and chronic kidney disease with heart failure and stage 1 through stage 4 chronic kidney disease, or unspecified chronic kidney disease fall resulting in striking against other object unspecified place in hospital as the place of occurrence of the external cause metabolic syndrome major depressive disorder, single episode, unspecified fatty (change of) liver, not elsewhere classified chronic kidney disease, unspecified gastro-esophageal reflux disease without esophagitis other chronic pain adverse effect of loop [high-ceiling] diuretics, initial encounter personal history of malignant neoplasm of breast unspecified open-angle glaucoma, stage unspecified age-related osteoporosis without current pathological fracture type 2 diabetes mellitus with diabetic chronic kidney disease other acute kidney failure patient's noncompliance with dietary regimen patient's other noncompliance with medication regimen body mass index (bmi) 39.0-39.9, adult long term (current) use of insulin dependence on supplemental oxygen hyperlipidemia, unspecified venous insufficiency (chronic) (peripheral) type 2 diabetes mellitus with diabetic polyneuropathy hypertensive heart and chronic kidney disease with heart failure and stage 1 through stage 4 chronic kidney disease, or unspecified chronic kidney disease personal history of malignant neoplasm of breast nausea other secondary pulmonary hypertension age-related osteoporosis without current pathological fracture unspecified rotator cuff tear or rupture of right shoulder, not specified as traumatic dependence on supplemental oxygen body mass index (bmi) 45.0-49.9, adult unspecified asthma, uncomplicated nonrheumatic tricuspid (valve) insufficiency portal vein thrombosis acute and chronic respiratory failure with hypoxia carpal tunnel syndrome, unspecified upper limb acute on chronic diastolic (congestive) heart failure chronic kidney disease, unspecified headache iron deficiency anemia, unspecified gastro-esophageal reflux disease without esophagitis
black african american f 76 $nan$hematology blood hematocrit  26.6  %; hematology blood hemoglobin  7.9  g dl; hematology blood platelet count  363  k ul; chemistry blood anion gap  20  meq l; chemistry blood anion gap  20  meq l; chemistry blood bicarbonate  32  meq l; chemistry blood bicarbonate  32  meq l; chemistry blood chloride  86  meq l; chemistry blood chloride  85  meq l; chemistry blood creatinine  2.2  mg dl; chemistry blood creatinine  2.2  mg dl; chemistry blood potassium  3.7  meq l; chemistry blood potassium  4.1  meq l; chemistry blood sodium  134  meq l; chemistry blood sodium  133  meq l; chemistry blood urea nitrogen  117  mg dl; chemistry blood urea nitrogen  119  mg dl; chemistry blood calcium, total  9.1  mg dl; chemistry blood calcium, total  9.4  mg dl; chemistry blood glucose  229  mg dl; chemistry blood glucose  136  mg dl$acetaminophen  1000  mg ; anastrozole  1  mg ; aspirin  81  mg ; atorvastatin  80  mg ; bisacodyl  10  mg ; calcium carbonate  500  mg ; dorzolamide 2% timolol 0.5% ophth.  1  drop ; dextrose 50%  12.5  gm ; glucagon  1  mg ; glucose gel  15  g ; latanoprost 0.005% ophth. soln.  1  drop ; lidocaine 5% patch  1  ptch ; paroxetine  30  mg ; polyethylene glycol  17  g ; senna  17.2  mg ; sevelamer carbonate  800  mg ; tiotropium bromide  1  cap ; alendronate sodium  70  mg ; sarna lotion  1  appl ; ramelteon  8  mg ; cetirizine  10  mg ; sodium chloride 0.9%  flush  10-20  ml ; sodium chloride nasal  1-2  spry ; hydroxyzine  25  mg ; metoprolol succinate xl  12.5  mg ; 
acute on chronic diastolic (congestive) heart failure type 2 diabetes mellitus with diabetic polyneuropathy type 2 diabetes mellitus with hyperglycemia acute and chronic respiratory failure with hypoxia obstructive sleep apnea (adult) (pediatric) morbid (severe) obesity with alveolar hypoventilation other secondary pulmonary hypertension hypertensive heart and chronic kidney disease with heart failure and stage 1 through stage 4 chronic kidney disease, or unspecified chronic kidney disease fall resulting in striking against other object unspecified place in hospital as the place of occurrence of the external cause metabolic syndrome major depressive disorder, single episode, unspecified fatty (change of) liver, not elsewhere classified chronic kidney disease, unspecified gastro-esophageal reflux disease without esophagitis other chronic pain adverse effect of loop [high-ceiling] diuretics, initial encounter personal history of malignant neoplasm of breast unspecified open-angle glaucoma, stage unspecified age-related osteoporosis without current pathological fracture type 2 diabetes mellitus with diabetic chronic kidney disease other acute kidney failure patient's noncompliance with dietary regimen patient's other noncompliance with medication regimen body mass index (bmi) 39.0-39.9, adult long term (current) use of insulin dependence on supplemental oxygen hyperlipidemia, unspecified venous insufficiency (chronic) (peripheral) type 2 diabetes mellitus with diabetic polyneuropathy hypertensive heart and chronic kidney disease with heart failure and stage 1 through stage 4 chronic kidney disease, or unspecified chronic kidney disease personal history of malignant neoplasm of breast nausea other secondary pulmonary hypertension age-related osteoporosis without current pathological fracture unspecified rotator cuff tear or rupture of right shoulder, not specified as traumatic dependence on supplemental oxygen body mass index (bmi) 45.0-49.9, adult unspecified asthma, uncomplicated nonrheumatic tricuspid (valve) insufficiency portal vein thrombosis acute and chronic respiratory failure with hypoxia carpal tunnel syndrome, unspecified upper limb acute on chronic diastolic (congestive) heart failure chronic kidney disease, unspecified headache iron deficiency anemia, unspecified gastro-esophageal reflux disease without esophagitis
black african american f 76 $nan$hematology blood hematocrit  25.1  %; hematology blood hemoglobin  7.5  g dl; hematology blood platelet count  347  k ul; chemistry blood anion gap  17  meq l; chemistry blood anion gap  16  meq l; chemistry blood bicarbonate  33  meq l; chemistry blood bicarbonate  34  meq l; chemistry blood chloride  88  meq l; chemistry blood chloride  89  meq l; chemistry blood creatinine  2.1  mg dl; chemistry blood creatinine  2.0  mg dl; chemistry blood potassium  3.7  meq l; chemistry blood potassium  4.0  meq l; chemistry blood sodium  134  meq l; chemistry blood sodium  135  meq l; chemistry blood urea nitrogen  119  mg dl; chemistry blood urea nitrogen  111  mg dl; chemistry blood calcium, total  9.2  mg dl; chemistry blood calcium, total  9.3  mg dl; chemistry blood glucose  201  mg dl; chemistry blood glucose  150  mg dl$acetaminophen  1000  mg ; anastrozole  1  mg ; aspirin  81  mg ; atorvastatin  80  mg ; bisacodyl  10  mg ; calcium carbonate  500  mg ; dorzolamide 2% timolol 0.5% ophth.  1  drop ; dextrose 50%  12.5  gm ; glucagon  1  mg ; glucose gel  15  g ; latanoprost 0.005% ophth. soln.  1  drop ; lidocaine 5% patch  1  ptch ; paroxetine  30  mg ; polyethylene glycol  17  g ; senna  17.2  mg ; sevelamer carbonate  800  mg ; tiotropium bromide  1  cap ; alendronate sodium  70  mg ; sarna lotion  1  appl ; ramelteon  8  mg ; cetirizine  10  mg ; sodium chloride 0.9%  flush  10-20  ml ; sodium chloride nasal  1-2  spry ; hydroxyzine  25  mg ; metoprolol succinate xl  12.5  mg ; 
acute on chronic diastolic (congestive) heart failure type 2 diabetes mellitus with diabetic polyneuropathy type 2 diabetes mellitus with hyperglycemia acute and chronic respiratory failure with hypoxia obstructive sleep apnea (adult) (pediatric) morbid (severe) obesity with alveolar hypoventilation other secondary pulmonary hypertension hypertensive heart and chronic kidney disease with heart failure and stage 1 through stage 4 chronic kidney disease, or unspecified chronic kidney disease fall resulting in striking against other object unspecified place in hospital as the place of occurrence of the external cause metabolic syndrome major depressive disorder, single episode, unspecified fatty (change of) liver, not elsewhere classified chronic kidney disease, unspecified gastro-esophageal reflux disease without esophagitis other chronic pain adverse effect of loop [high-ceiling] diuretics, initial encounter personal history of malignant neoplasm of breast unspecified open-angle glaucoma, stage unspecified age-related osteoporosis without current pathological fracture type 2 diabetes mellitus with diabetic chronic kidney disease other acute kidney failure patient's noncompliance with dietary regimen patient's other noncompliance with medication regimen body mass index (bmi) 39.0-39.9, adult long term (current) use of insulin dependence on supplemental oxygen hyperlipidemia, unspecified venous insufficiency (chronic) (peripheral) type 2 diabetes mellitus with diabetic polyneuropathy hypertensive heart and chronic kidney disease with heart failure and stage 1 through stage 4 chronic kidney disease, or unspecified chronic kidney disease personal history of malignant neoplasm of breast nausea other secondary pulmonary hypertension age-related osteoporosis without current pathological fracture unspecified rotator cuff tear or rupture of right shoulder, not specified as traumatic dependence on supplemental oxygen body mass index (bmi) 45.0-49.9, adult unspecified asthma, uncomplicated nonrheumatic tricuspid (valve) insufficiency portal vein thrombosis acute and chronic respiratory failure with hypoxia carpal tunnel syndrome, unspecified upper limb acute on chronic diastolic (congestive) heart failure chronic kidney disease, unspecified headache iron deficiency anemia, unspecified gastro-esophageal reflux disease without esophagitis
black african american f 76 $nan$hematology blood hematocrit  26.3  %; hematology blood hemoglobin  7.7  g dl; hematology blood platelet count  333  k ul; chemistry blood anion gap  17  meq l; chemistry blood anion gap  18  meq l; chemistry blood anion gap  18  meq l; chemistry blood bicarbonate  34  meq l; chemistry blood bicarbonate  31  meq l; chemistry blood bicarbonate  31  meq l; chemistry blood chloride  88  meq l; chemistry blood chloride  89  meq l; chemistry blood chloride  89  meq l; chemistry blood creatinine  1.8  mg dl; chemistry blood creatinine  1.7  mg dl; chemistry blood creatinine  1.7  mg dl; chemistry blood potassium  3.5  meq l; chemistry blood potassium  3.8  meq l; chemistry blood potassium  4.0  meq l; chemistry blood sodium  135  meq l; chemistry blood sodium  134  meq l; chemistry blood sodium  134  meq l; chemistry blood urea nitrogen  106  mg dl; chemistry blood urea nitrogen  96  mg dl; chemistry blood urea nitrogen  94  mg dl; chemistry blood calcium, total  8.8  mg dl; chemistry blood calcium, total  9.1  mg dl; chemistry blood calcium, total  8.9  mg dl; chemistry blood glucose  320  mg dl; chemistry blood glucose  260  mg dl; chemistry blood glucose  185  mg dl$acetaminophen  1000  mg ; anastrozole  1  mg ; aspirin  81  mg ; atorvastatin  80  mg ; bisacodyl  10  mg ; calcium carbonate  500  mg ; dorzolamide 2% timolol 0.5% ophth.  1  drop ; dextrose 50%  12.5  gm ; glucagon  1  mg ; glucose gel  15  g ; latanoprost 0.005% ophth. soln.  1  drop ; lidocaine 5% patch  1  ptch ; paroxetine  30  mg ; polyethylene glycol  17  g ; senna  17.2  mg ; sevelamer carbonate  800  mg ; tiotropium bromide  1  cap ; alendronate sodium  70  mg ; sarna lotion  1  appl ; ramelteon  8  mg ; cetirizine  10  mg ; sodium chloride 0.9%  flush  10-20  ml ; sodium chloride nasal  1-2  spry ; hydroxyzine  25  mg ; metoprolol succinate xl  12.5  mg ; 
acute on chronic diastolic (congestive) heart failure type 2 diabetes mellitus with diabetic polyneuropathy type 2 diabetes mellitus with hyperglycemia acute and chronic respiratory failure with hypoxia obstructive sleep apnea (adult) (pediatric) morbid (severe) obesity with alveolar hypoventilation other secondary pulmonary hypertension hypertensive heart and chronic kidney disease with heart failure and stage 1 through stage 4 chronic kidney disease, or unspecified chronic kidney disease fall resulting in striking against other object unspecified place in hospital as the place of occurrence of the external cause metabolic syndrome major depressive disorder, single episode, unspecified fatty (change of) liver, not elsewhere classified chronic kidney disease, unspecified gastro-esophageal reflux disease without esophagitis other chronic pain adverse effect of loop [high-ceiling] diuretics, initial encounter personal history of malignant neoplasm of breast unspecified open-angle glaucoma, stage unspecified age-related osteoporosis without current pathological fracture type 2 diabetes mellitus with diabetic chronic kidney disease other acute kidney failure patient's noncompliance with dietary regimen patient's other noncompliance with medication regimen body mass index (bmi) 39.0-39.9, adult long term (current) use of insulin dependence on supplemental oxygen hyperlipidemia, unspecified venous insufficiency (chronic) (peripheral) type 2 diabetes mellitus with diabetic polyneuropathy hypertensive heart and chronic kidney disease with heart failure and stage 1 through stage 4 chronic kidney disease, or unspecified chronic kidney disease personal history of malignant neoplasm of breast nausea other secondary pulmonary hypertension age-related osteoporosis without current pathological fracture unspecified rotator cuff tear or rupture of right shoulder, not specified as traumatic dependence on supplemental oxygen body mass index (bmi) 45.0-49.9, adult unspecified asthma, uncomplicated nonrheumatic tricuspid (valve) insufficiency portal vein thrombosis acute and chronic respiratory failure with hypoxia carpal tunnel syndrome, unspecified upper limb acute on chronic diastolic (congestive) heart failure chronic kidney disease, unspecified headache iron deficiency anemia, unspecified gastro-esophageal reflux disease without esophagitis
black african american f 76 $nan$hematology blood hematocrit  27.7  %; hematology blood hemoglobin  8.0  g dl; hematology blood platelet count  374  k ul; chemistry blood anion gap  15  meq l; chemistry blood anion gap  16  meq l; chemistry blood bicarbonate  35  meq l; chemistry blood bicarbonate  32  meq l; chemistry blood chloride  93  meq l; chemistry blood chloride  92  meq l; chemistry blood creatinine  1.6  mg dl; chemistry blood creatinine  1.7  mg dl; chemistry blood potassium  3.3  meq l; chemistry blood potassium  4.4  meq l; chemistry blood sodium  140  meq l; chemistry blood sodium  136  meq l; chemistry blood urea nitrogen  85  mg dl; chemistry blood urea nitrogen  82  mg dl; chemistry blood calcium, total  9.1  mg dl; chemistry blood calcium, total  9.6  mg dl; chemistry blood glucose  228  mg dl; chemistry blood glucose  125  mg dl$acetaminophen  1000  mg ; anastrozole  1  mg ; aspirin  81  mg ; atorvastatin  80  mg ; bisacodyl  10  mg ; calcium carbonate  500  mg ; dorzolamide 2% timolol 0.5% ophth.  1  drop ; dextrose 50%  12.5  gm ; glucagon  1  mg ; glucose gel  15  g ; latanoprost 0.005% ophth. soln.  1  drop ; lidocaine 5% patch  1  ptch ; paroxetine  30  mg ; polyethylene glycol  17  g ; senna  17.2  mg ; sevelamer carbonate  800  mg ; tiotropium bromide  1  cap ; alendronate sodium  70  mg ; sarna lotion  1  appl ; ramelteon  8  mg ; cetirizine  10  mg ; sodium chloride 0.9%  flush  10-20  ml ; sodium chloride nasal  1-2  spry ; hydroxyzine  25  mg ; metoprolol succinate xl  12.5  mg ; syringe  12  ml ; 
acute on chronic diastolic (congestive) heart failure type 2 diabetes mellitus with diabetic polyneuropathy type 2 diabetes mellitus with hyperglycemia acute and chronic respiratory failure with hypoxia obstructive sleep apnea (adult) (pediatric) morbid (severe) obesity with alveolar hypoventilation other secondary pulmonary hypertension hypertensive heart and chronic kidney disease with heart failure and stage 1 through stage 4 chronic kidney disease, or unspecified chronic kidney disease fall resulting in striking against other object unspecified place in hospital as the place of occurrence of the external cause metabolic syndrome major depressive disorder, single episode, unspecified fatty (change of) liver, not elsewhere classified chronic kidney disease, unspecified gastro-esophageal reflux disease without esophagitis other chronic pain adverse effect of loop [high-ceiling] diuretics, initial encounter personal history of malignant neoplasm of breast unspecified open-angle glaucoma, stage unspecified age-related osteoporosis without current pathological fracture type 2 diabetes mellitus with diabetic chronic kidney disease other acute kidney failure patient's noncompliance with dietary regimen patient's other noncompliance with medication regimen body mass index (bmi) 39.0-39.9, adult long term (current) use of insulin dependence on supplemental oxygen hyperlipidemia, unspecified venous insufficiency (chronic) (peripheral) type 2 diabetes mellitus with diabetic polyneuropathy hypertensive heart and chronic kidney disease with heart failure and stage 1 through stage 4 chronic kidney disease, or unspecified chronic kidney disease personal history of malignant neoplasm of breast nausea other secondary pulmonary hypertension age-related osteoporosis without current pathological fracture unspecified rotator cuff tear or rupture of right shoulder, not specified as traumatic dependence on supplemental oxygen body mass index (bmi) 45.0-49.9, adult unspecified asthma, uncomplicated nonrheumatic tricuspid (valve) insufficiency portal vein thrombosis acute and chronic respiratory failure with hypoxia carpal tunnel syndrome, unspecified upper limb acute on chronic diastolic (congestive) heart failure chronic kidney disease, unspecified headache iron deficiency anemia, unspecified gastro-esophageal reflux disease without esophagitis
black african american f 76 $nan$hematology blood hematocrit  27.3  %; hematology blood hemoglobin  7.8  g dl; hematology blood platelet count  343  k ul; chemistry blood anion gap  13  meq l; chemistry blood bicarbonate  36  meq l; chemistry blood chloride  94  meq l; chemistry blood creatinine  1.6  mg dl; chemistry blood potassium  4.1  meq l; chemistry blood sodium  139  meq l; chemistry blood urea nitrogen  79  mg dl; chemistry blood calcium, total  9.7  mg dl; chemistry blood glucose  111  mg dl$acetaminophen  1000  mg ; anastrozole  1  mg ; aspirin  81  mg ; atorvastatin  80  mg ; bisacodyl  10  mg ; calcium carbonate  500  mg ; dorzolamide 2% timolol 0.5% ophth.  1  drop ; dextrose 50%  12.5  gm ; glucagon  1  mg ; glucose gel  15  g ; latanoprost 0.005% ophth. soln.  1  drop ; lidocaine 5% patch  1  ptch ; paroxetine  30  mg ; polyethylene glycol  17  g ; senna  17.2  mg ; sevelamer carbonate  800  mg ; tiotropium bromide  1  cap ; alendronate sodium  70  mg ; sarna lotion  1  appl ; ramelteon  8  mg ; cetirizine  10  mg ; sodium chloride 0.9%  flush  10-20  ml ; sodium chloride nasal  1-2  spry ; hydroxyzine  25  mg ; metoprolol succinate xl  12.5  mg ; syringe  12  ml ; insulin  6  unit ; insulin  10  unit ; 
acute on chronic diastolic (congestive) heart failure type 2 diabetes mellitus with diabetic polyneuropathy type 2 diabetes mellitus with hyperglycemia acute and chronic respiratory failure with hypoxia obstructive sleep apnea (adult) (pediatric) morbid (severe) obesity with alveolar hypoventilation other secondary pulmonary hypertension hypertensive heart and chronic kidney disease with heart failure and stage 1 through stage 4 chronic kidney disease, or unspecified chronic kidney disease fall resulting in striking against other object unspecified place in hospital as the place of occurrence of the external cause metabolic syndrome major depressive disorder, single episode, unspecified fatty (change of) liver, not elsewhere classified chronic kidney disease, unspecified gastro-esophageal reflux disease without esophagitis other chronic pain adverse effect of loop [high-ceiling] diuretics, initial encounter personal history of malignant neoplasm of breast unspecified open-angle glaucoma, stage unspecified age-related osteoporosis without current pathological fracture type 2 diabetes mellitus with diabetic chronic kidney disease other acute kidney failure patient's noncompliance with dietary regimen patient's other noncompliance with medication regimen body mass index (bmi) 39.0-39.9, adult long term (current) use of insulin dependence on supplemental oxygen hyperlipidemia, unspecified venous insufficiency (chronic) (peripheral) type 2 diabetes mellitus with diabetic polyneuropathy hypertensive heart and chronic kidney disease with heart failure and stage 1 through stage 4 chronic kidney disease, or unspecified chronic kidney disease personal history of malignant neoplasm of breast nausea other secondary pulmonary hypertension age-related osteoporosis without current pathological fracture unspecified rotator cuff tear or rupture of right shoulder, not specified as traumatic dependence on supplemental oxygen body mass index (bmi) 45.0-49.9, adult unspecified asthma, uncomplicated nonrheumatic tricuspid (valve) insufficiency portal vein thrombosis acute and chronic respiratory failure with hypoxia carpal tunnel syndrome, unspecified upper limb acute on chronic diastolic (congestive) heart failure chronic kidney disease, unspecified headache iron deficiency anemia, unspecified gastro-esophageal reflux disease without esophagitis
black african american f 76 $nan$hematology blood hematocrit  27.0  %; hematology blood hemoglobin  7.9  g dl; hematology blood platelet count  343  k ul; chemistry blood anion gap  17  meq l; chemistry blood anion gap  15  meq l; chemistry blood bicarbonate  33  meq l; chemistry blood bicarbonate  32  meq l; chemistry blood chloride  93  meq l; chemistry blood chloride  92  meq l; chemistry blood creatinine  1.6  mg dl; chemistry blood creatinine  1.8  mg dl; chemistry blood potassium  4.5  meq l; chemistry blood potassium  4.9  meq l; chemistry blood sodium  138  meq l; chemistry blood sodium  134  meq l; chemistry blood urea nitrogen  74  mg dl; chemistry blood urea nitrogen  68  mg dl; chemistry blood calcium, total  9.6  mg dl; chemistry blood calcium, total  9.3  mg dl; chemistry blood glucose  300  mg dl; chemistry blood glucose  147  mg dl$acetaminophen  1000  mg ; anastrozole  1  mg ; aspirin  81  mg ; atorvastatin  80  mg ; bisacodyl  10  mg ; calcium carbonate  500  mg ; dorzolamide 2% timolol 0.5% ophth.  1  drop ; dextrose 50%  12.5  gm ; glucagon  1  mg ; glucose gel  15  g ; latanoprost 0.005% ophth. soln.  1  drop ; lidocaine 5% patch  1  ptch ; paroxetine  30  mg ; polyethylene glycol  17  g ; senna  17.2  mg ; sevelamer carbonate  800  mg ; tiotropium bromide  1  cap ; alendronate sodium  70  mg ; sarna lotion  1  appl ; ramelteon  8  mg ; cetirizine  10  mg ; sodium chloride 0.9%  flush  10-20  ml ; sodium chloride nasal  1-2  spry ; hydroxyzine  25  mg ; metoprolol succinate xl  12.5  mg ; insulin  6  unit ; insulin  10  unit ; 
acute on chronic diastolic (congestive) heart failure type 2 diabetes mellitus with diabetic polyneuropathy type 2 diabetes mellitus with hyperglycemia acute and chronic respiratory failure with hypoxia obstructive sleep apnea (adult) (pediatric) morbid (severe) obesity with alveolar hypoventilation other secondary pulmonary hypertension hypertensive heart and chronic kidney disease with heart failure and stage 1 through stage 4 chronic kidney disease, or unspecified chronic kidney disease fall resulting in striking against other object unspecified place in hospital as the place of occurrence of the external cause metabolic syndrome major depressive disorder, single episode, unspecified fatty (change of) liver, not elsewhere classified chronic kidney disease, unspecified gastro-esophageal reflux disease without esophagitis other chronic pain adverse effect of loop [high-ceiling] diuretics, initial encounter personal history of malignant neoplasm of breast unspecified open-angle glaucoma, stage unspecified age-related osteoporosis without current pathological fracture type 2 diabetes mellitus with diabetic chronic kidney disease other acute kidney failure patient's noncompliance with dietary regimen patient's other noncompliance with medication regimen body mass index (bmi) 39.0-39.9, adult long term (current) use of insulin dependence on supplemental oxygen hyperlipidemia, unspecified venous insufficiency (chronic) (peripheral) type 2 diabetes mellitus with diabetic polyneuropathy hypertensive heart and chronic kidney disease with heart failure and stage 1 through stage 4 chronic kidney disease, or unspecified chronic kidney disease personal history of malignant neoplasm of breast nausea other secondary pulmonary hypertension age-related osteoporosis without current pathological fracture unspecified rotator cuff tear or rupture of right shoulder, not specified as traumatic dependence on supplemental oxygen body mass index (bmi) 45.0-49.9, adult unspecified asthma, uncomplicated nonrheumatic tricuspid (valve) insufficiency portal vein thrombosis acute and chronic respiratory failure with hypoxia carpal tunnel syndrome, unspecified upper limb acute on chronic diastolic (congestive) heart failure chronic kidney disease, unspecified headache iron deficiency anemia, unspecified gastro-esophageal reflux disease without esophagitis
black african american f 76 $nan$hematology blood hematocrit  26.5  %; hematology blood hemoglobin  7.7  g dl; hematology blood platelet count  335  k ul; chemistry blood anion gap  17  meq l; chemistry blood anion gap  19  meq l; chemistry blood bicarbonate  31  meq l; chemistry blood bicarbonate  30  meq l; chemistry blood chloride  94  meq l; chemistry blood chloride  92  meq l; chemistry blood creatinine  1.6  mg dl; chemistry blood creatinine  1.6  mg dl; chemistry blood potassium  4.5  meq l; chemistry blood potassium  4.8  meq l; chemistry blood sodium  137  meq l; chemistry blood sodium  136  meq l; chemistry blood urea nitrogen  69  mg dl; chemistry blood urea nitrogen  64  mg dl; chemistry blood calcium, total  9.5  mg dl; chemistry blood calcium, total  9.5  mg dl; chemistry blood glucose  283  mg dl; chemistry blood glucose  178  mg dl$acetaminophen  1000  mg ; anastrozole  1  mg ; aspirin  81  mg ; atorvastatin  80  mg ; bisacodyl  10  mg ; calcium carbonate  500  mg ; dorzolamide 2% timolol 0.5% ophth.  1  drop ; dextrose 50%  12.5  gm ; glucagon  1  mg ; glucose gel  15  g ; latanoprost 0.005% ophth. soln.  1  drop ; lidocaine 5% patch  1  ptch ; paroxetine  30  mg ; polyethylene glycol  17  g ; senna  17.2  mg ; sevelamer carbonate  800  mg ; tiotropium bromide  1  cap ; alendronate sodium  70  mg ; sarna lotion  1  appl ; ramelteon  8  mg ; cetirizine  10  mg ; sodium chloride 0.9%  flush  10-20  ml ; sodium chloride nasal  1-2  spry ; hydroxyzine  25  mg ; metoprolol succinate xl  12.5  mg ; insulin  6  unit ; insulin  10  unit ; bag  2  bag ; 
acute on chronic diastolic (congestive) heart failure type 2 diabetes mellitus with diabetic polyneuropathy type 2 diabetes mellitus with hyperglycemia acute and chronic respiratory failure with hypoxia obstructive sleep apnea (adult) (pediatric) morbid (severe) obesity with alveolar hypoventilation other secondary pulmonary hypertension hypertensive heart and chronic kidney disease with heart failure and stage 1 through stage 4 chronic kidney disease, or unspecified chronic kidney disease fall resulting in striking against other object unspecified place in hospital as the place of occurrence of the external cause metabolic syndrome major depressive disorder, single episode, unspecified fatty (change of) liver, not elsewhere classified chronic kidney disease, unspecified gastro-esophageal reflux disease without esophagitis other chronic pain adverse effect of loop [high-ceiling] diuretics, initial encounter personal history of malignant neoplasm of breast unspecified open-angle glaucoma, stage unspecified age-related osteoporosis without current pathological fracture type 2 diabetes mellitus with diabetic chronic kidney disease other acute kidney failure patient's noncompliance with dietary regimen patient's other noncompliance with medication regimen body mass index (bmi) 39.0-39.9, adult long term (current) use of insulin dependence on supplemental oxygen hyperlipidemia, unspecified venous insufficiency (chronic) (peripheral) type 2 diabetes mellitus with diabetic polyneuropathy hypertensive heart and chronic kidney disease with heart failure and stage 1 through stage 4 chronic kidney disease, or unspecified chronic kidney disease personal history of malignant neoplasm of breast nausea other secondary pulmonary hypertension age-related osteoporosis without current pathological fracture unspecified rotator cuff tear or rupture of right shoulder, not specified as traumatic dependence on supplemental oxygen body mass index (bmi) 45.0-49.9, adult unspecified asthma, uncomplicated nonrheumatic tricuspid (valve) insufficiency portal vein thrombosis acute and chronic respiratory failure with hypoxia carpal tunnel syndrome, unspecified upper limb acute on chronic diastolic (congestive) heart failure chronic kidney disease, unspecified headache iron deficiency anemia, unspecified gastro-esophageal reflux disease without esophagitis
black african american f 76 $nan$chemistry blood anion gap  15  meq l; chemistry blood anion gap  15  meq l; chemistry blood bicarbonate  33  meq l; chemistry blood bicarbonate  31  meq l; chemistry blood chloride  94  meq l; chemistry blood chloride  94  meq l; chemistry blood creatinine  1.5  mg dl; chemistry blood creatinine  1.8  mg dl; chemistry blood potassium  3.9  meq l; chemistry blood potassium  4.4  meq l; chemistry blood sodium  138  meq l; chemistry blood sodium  136  meq l; chemistry blood urea nitrogen  66  mg dl; chemistry blood urea nitrogen  65  mg dl; chemistry blood calcium, total  9.3  mg dl; chemistry blood calcium, total  9.1  mg dl; chemistry blood glucose  188  mg dl; chemistry blood glucose  132  mg dl$acetaminophen  1000  mg ; anastrozole  1  mg ; aspirin  81  mg ; atorvastatin  80  mg ; bisacodyl  10  mg ; calcium carbonate  500  mg ; dorzolamide 2% timolol 0.5% ophth.  1  drop ; dextrose 50%  12.5  gm ; glucagon  1  mg ; glucose gel  15  g ; latanoprost 0.005% ophth. soln.  1  drop ; lidocaine 5% patch  1  ptch ; paroxetine  30  mg ; polyethylene glycol  17  g ; senna  17.2  mg ; sevelamer carbonate  800  mg ; tiotropium bromide  1  cap ; alendronate sodium  70  mg ; sarna lotion  1  appl ; ramelteon  8  mg ; cetirizine  10  mg ; sodium chloride 0.9%  flush  10-20  ml ; sodium chloride nasal  1-2  spry ; hydroxyzine  25  mg ; metoprolol succinate xl  12.5  mg ; insulin  6  unit ; insulin  10  unit ; bag  2  bag ; insulin  14  unit ; 
acute on chronic diastolic (congestive) heart failure type 2 diabetes mellitus with diabetic polyneuropathy type 2 diabetes mellitus with hyperglycemia acute and chronic respiratory failure with hypoxia obstructive sleep apnea (adult) (pediatric) morbid (severe) obesity with alveolar hypoventilation other secondary pulmonary hypertension hypertensive heart and chronic kidney disease with heart failure and stage 1 through stage 4 chronic kidney disease, or unspecified chronic kidney disease fall resulting in striking against other object unspecified place in hospital as the place of occurrence of the external cause metabolic syndrome major depressive disorder, single episode, unspecified fatty (change of) liver, not elsewhere classified chronic kidney disease, unspecified gastro-esophageal reflux disease without esophagitis other chronic pain adverse effect of loop [high-ceiling] diuretics, initial encounter personal history of malignant neoplasm of breast unspecified open-angle glaucoma, stage unspecified age-related osteoporosis without current pathological fracture type 2 diabetes mellitus with diabetic chronic kidney disease other acute kidney failure patient's noncompliance with dietary regimen patient's other noncompliance with medication regimen body mass index (bmi) 39.0-39.9, adult long term (current) use of insulin dependence on supplemental oxygen hyperlipidemia, unspecified venous insufficiency (chronic) (peripheral) type 2 diabetes mellitus with diabetic polyneuropathy hypertensive heart and chronic kidney disease with heart failure and stage 1 through stage 4 chronic kidney disease, or unspecified chronic kidney disease personal history of malignant neoplasm of breast nausea other secondary pulmonary hypertension age-related osteoporosis without current pathological fracture unspecified rotator cuff tear or rupture of right shoulder, not specified as traumatic dependence on supplemental oxygen body mass index (bmi) 45.0-49.9, adult unspecified asthma, uncomplicated nonrheumatic tricuspid (valve) insufficiency portal vein thrombosis acute and chronic respiratory failure with hypoxia carpal tunnel syndrome, unspecified upper limb acute on chronic diastolic (congestive) heart failure chronic kidney disease, unspecified headache iron deficiency anemia, unspecified gastro-esophageal reflux disease without esophagitis
black african american f 76 $nan$hematology blood hematocrit  26.8  %; hematology blood hemoglobin  7.8  g dl; hematology blood platelet count  343  k ul; chemistry blood anion gap  17  meq l; chemistry blood anion gap  16  meq l; chemistry blood bicarbonate  32  meq l; chemistry blood bicarbonate  31  meq l; chemistry blood chloride  93  meq l; chemistry blood chloride  92  meq l; chemistry blood creatinine  1.8  mg dl; chemistry blood creatinine  1.9  mg dl; chemistry blood potassium  4.0  meq l; chemistry blood potassium  4.3  meq l; chemistry blood sodium  138  meq l; chemistry blood sodium  135  meq l; chemistry blood urea nitrogen  69  mg dl; chemistry blood urea nitrogen  68  mg dl; chemistry blood calcium, total  9.2  mg dl; chemistry blood calcium, total  8.9  mg dl; chemistry blood glucose  250  mg dl; chemistry blood glucose  155  mg dl; blood gas blood lactate  1.7  mmol l$acetaminophen  1000  mg ; anastrozole  1  mg ; aspirin  81  mg ; atorvastatin  80  mg ; bisacodyl  10  mg ; calcium carbonate  500  mg ; dorzolamide 2% timolol 0.5% ophth.  1  drop ; dextrose 50%  12.5  gm ; glucagon  1  mg ; glucose gel  15  g ; latanoprost 0.005% ophth. soln.  1  drop ; lidocaine 5% patch  1  ptch ; paroxetine  30  mg ; polyethylene glycol  17  g ; senna  17.2  mg ; sevelamer carbonate  800  mg ; tiotropium bromide  1  cap ; alendronate sodium  70  mg ; sarna lotion  1  appl ; ramelteon  8  mg ; cetirizine  10  mg ; sodium chloride 0.9%  flush  10-20  ml ; sodium chloride nasal  1-2  spry ; hydroxyzine  25  mg ; metoprolol succinate xl  12.5  mg ; insulin  14  unit ; vitamin d  1000  unit ; insulin  12  unit ; insulin  18  unit ; magnesium oxide  400  mg ; fluticasone-salmeterol diskus (250 50)   1  inh ; 
acute on chronic diastolic (congestive) heart failure type 2 diabetes mellitus with diabetic polyneuropathy type 2 diabetes mellitus with hyperglycemia acute and chronic respiratory failure with hypoxia obstructive sleep apnea (adult) (pediatric) morbid (severe) obesity with alveolar hypoventilation other secondary pulmonary hypertension hypertensive heart and chronic kidney disease with heart failure and stage 1 through stage 4 chronic kidney disease, or unspecified chronic kidney disease fall resulting in striking against other object unspecified place in hospital as the place of occurrence of the external cause metabolic syndrome major depressive disorder, single episode, unspecified fatty (change of) liver, not elsewhere classified chronic kidney disease, unspecified gastro-esophageal reflux disease without esophagitis other chronic pain adverse effect of loop [high-ceiling] diuretics, initial encounter personal history of malignant neoplasm of breast unspecified open-angle glaucoma, stage unspecified age-related osteoporosis without current pathological fracture type 2 diabetes mellitus with diabetic chronic kidney disease other acute kidney failure patient's noncompliance with dietary regimen patient's other noncompliance with medication regimen body mass index (bmi) 39.0-39.9, adult long term (current) use of insulin dependence on supplemental oxygen hyperlipidemia, unspecified venous insufficiency (chronic) (peripheral) type 2 diabetes mellitus with diabetic polyneuropathy hypertensive heart and chronic kidney disease with heart failure and stage 1 through stage 4 chronic kidney disease, or unspecified chronic kidney disease personal history of malignant neoplasm of breast nausea other secondary pulmonary hypertension age-related osteoporosis without current pathological fracture unspecified rotator cuff tear or rupture of right shoulder, not specified as traumatic dependence on supplemental oxygen body mass index (bmi) 45.0-49.9, adult unspecified asthma, uncomplicated nonrheumatic tricuspid (valve) insufficiency portal vein thrombosis acute and chronic respiratory failure with hypoxia carpal tunnel syndrome, unspecified upper limb acute on chronic diastolic (congestive) heart failure chronic kidney disease, unspecified headache iron deficiency anemia, unspecified gastro-esophageal reflux disease without esophagitis
black african american f 76 $nan$hematology blood hematocrit  26.0  %; hematology blood hemoglobin  7.5  g dl; hematology blood platelet count  314  k ul; chemistry blood anion gap  16  meq l; chemistry blood anion gap  17  meq l; chemistry blood anion gap  18  meq l; chemistry blood bicarbonate  31  meq l; chemistry blood bicarbonate  29  meq l; chemistry blood bicarbonate  28  meq l; chemistry blood chloride  95  meq l; chemistry blood chloride  93  meq l; chemistry blood chloride  91  meq l; chemistry blood creatinine  1.7  mg dl; chemistry blood creatinine  1.7  mg dl; chemistry blood creatinine  1.8  mg dl; chemistry blood potassium  4.0  meq l; chemistry blood potassium  4.3  meq l; chemistry blood potassium  4.9  meq l; chemistry blood sodium  138  meq l; chemistry blood sodium  135  meq l; chemistry blood sodium  132  meq l; chemistry blood urea nitrogen  72  mg dl; chemistry blood urea nitrogen  71  mg dl; chemistry blood urea nitrogen  74  mg dl; chemistry blood calcium, total  9.1  mg dl; chemistry blood calcium, total  9.0  mg dl; chemistry blood calcium, total  8.8  mg dl; chemistry blood glucose  239  mg dl; chemistry blood glucose  266  mg dl; chemistry blood glucose  166  mg dl$acetaminophen  1000  mg ; anastrozole  1  mg ; aspirin  81  mg ; atorvastatin  80  mg ; bisacodyl  10  mg ; calcium carbonate  500  mg ; dorzolamide 2% timolol 0.5% ophth.  1  drop ; dextrose 50%  12.5  gm ; glucagon  1  mg ; glucose gel  15  g ; latanoprost 0.005% ophth. soln.  1  drop ; lidocaine 5% patch  1  ptch ; paroxetine  30  mg ; polyethylene glycol  17  g ; senna  17.2  mg ; sevelamer carbonate  800  mg ; tiotropium bromide  1  cap ; alendronate sodium  70  mg ; sarna lotion  1  appl ; ramelteon  8  mg ; cetirizine  10  mg ; sodium chloride 0.9%  flush  10-20  ml ; sodium chloride nasal  1-2  spry ; hydroxyzine  25  mg ; metoprolol succinate xl  12.5  mg ; vitamin d  1000  unit ; insulin  12  unit ; insulin  18  unit ; magnesium oxide  400  mg ; fluticasone-salmeterol diskus (250 50)   1  inh ; syringe  16  ml ; hydralazine  20  mg ; 
acute on chronic diastolic (congestive) heart failure type 2 diabetes mellitus with diabetic polyneuropathy type 2 diabetes mellitus with hyperglycemia acute and chronic respiratory failure with hypoxia obstructive sleep apnea (adult) (pediatric) morbid (severe) obesity with alveolar hypoventilation other secondary pulmonary hypertension hypertensive heart and chronic kidney disease with heart failure and stage 1 through stage 4 chronic kidney disease, or unspecified chronic kidney disease fall resulting in striking against other object unspecified place in hospital as the place of occurrence of the external cause metabolic syndrome major depressive disorder, single episode, unspecified fatty (change of) liver, not elsewhere classified chronic kidney disease, unspecified gastro-esophageal reflux disease without esophagitis other chronic pain adverse effect of loop [high-ceiling] diuretics, initial encounter personal history of malignant neoplasm of breast unspecified open-angle glaucoma, stage unspecified age-related osteoporosis without current pathological fracture type 2 diabetes mellitus with diabetic chronic kidney disease other acute kidney failure patient's noncompliance with dietary regimen patient's other noncompliance with medication regimen body mass index (bmi) 39.0-39.9, adult long term (current) use of insulin dependence on supplemental oxygen hyperlipidemia, unspecified venous insufficiency (chronic) (peripheral) type 2 diabetes mellitus with diabetic polyneuropathy hypertensive heart and chronic kidney disease with heart failure and stage 1 through stage 4 chronic kidney disease, or unspecified chronic kidney disease personal history of malignant neoplasm of breast nausea other secondary pulmonary hypertension age-related osteoporosis without current pathological fracture unspecified rotator cuff tear or rupture of right shoulder, not specified as traumatic dependence on supplemental oxygen body mass index (bmi) 45.0-49.9, adult unspecified asthma, uncomplicated nonrheumatic tricuspid (valve) insufficiency portal vein thrombosis acute and chronic respiratory failure with hypoxia carpal tunnel syndrome, unspecified upper limb acute on chronic diastolic (congestive) heart failure chronic kidney disease, unspecified headache iron deficiency anemia, unspecified gastro-esophageal reflux disease without esophagitis
black african american f 76 $nan$hematology blood hematocrit  27.8  %; hematology blood hemoglobin  8.0  g dl; hematology blood platelet count  340  k ul; chemistry blood anion gap  15  meq l; chemistry blood anion gap  16  meq l; chemistry blood bicarbonate  27  meq l; chemistry blood bicarbonate  27  meq l; chemistry blood chloride  95  meq l; chemistry blood chloride  92  meq l; chemistry blood creatinine  1.7  mg dl; chemistry blood creatinine  1.9  mg dl; chemistry blood potassium  4.3  meq l; chemistry blood potassium  4.4  meq l; chemistry blood sodium  138  meq l; chemistry blood sodium  134  meq l; chemistry blood urea nitrogen  73  mg dl; chemistry blood urea nitrogen  75  mg dl; hematology blood inr(pt)  1.0  ; chemistry blood calcium, total  9.2  mg dl; chemistry blood calcium, total  8.8  mg dl; chemistry blood bilirubin, total  0.2  mg dl; chemistry blood glucose  315  mg dl; chemistry blood glucose  163  mg dl; chemistry blood lactate dehydrogenase (ld)  384  iu l; chemistry blood albumin  3.5  g dl$bag  1  bag ; acetaminophen  1000  mg ; anastrozole  1  mg ; aspirin  81  mg ; atorvastatin  80  mg ; bisacodyl  10  mg ; calcium carbonate  500  mg ; dorzolamide 2% timolol 0.5% ophth.  1  drop ; dextrose 50%  12.5  gm ; glucagon  1  mg ; glucose gel  15  g ; latanoprost 0.005% ophth. soln.  1  drop ; lidocaine 5% patch  1  ptch ; paroxetine  30  mg ; polyethylene glycol  17  g ; senna  17.2  mg ; sevelamer carbonate  800  mg ; tiotropium bromide  1  cap ; alendronate sodium  70  mg ; sarna lotion  1  appl ; ramelteon  8  mg ; cetirizine  10  mg ; sodium chloride 0.9%  flush  10-20  ml ; sodium chloride nasal  1-2  spry ; hydroxyzine  25  mg ; metoprolol succinate xl  12.5  mg ; vitamin d  1000  unit ; insulin  12  unit ; insulin  18  unit ; fluticasone-salmeterol diskus (250 50)   1  inh ; syringe  16  ml ; hydralazine  20  mg ; hydromorphone (dilaudid)  1  mg ; sterile water  150  ml ; 5% dextrose  25  ml ; acetazolamide sodium  250  mg ; 
acute on chronic diastolic (congestive) heart failure type 2 diabetes mellitus with diabetic polyneuropathy type 2 diabetes mellitus with hyperglycemia acute and chronic respiratory failure with hypoxia obstructive sleep apnea (adult) (pediatric) morbid (severe) obesity with alveolar hypoventilation other secondary pulmonary hypertension hypertensive heart and chronic kidney disease with heart failure and stage 1 through stage 4 chronic kidney disease, or unspecified chronic kidney disease fall resulting in striking against other object unspecified place in hospital as the place of occurrence of the external cause metabolic syndrome major depressive disorder, single episode, unspecified fatty (change of) liver, not elsewhere classified chronic kidney disease, unspecified gastro-esophageal reflux disease without esophagitis other chronic pain adverse effect of loop [high-ceiling] diuretics, initial encounter personal history of malignant neoplasm of breast unspecified open-angle glaucoma, stage unspecified age-related osteoporosis without current pathological fracture type 2 diabetes mellitus with diabetic chronic kidney disease other acute kidney failure patient's noncompliance with dietary regimen patient's other noncompliance with medication regimen body mass index (bmi) 39.0-39.9, adult long term (current) use of insulin dependence on supplemental oxygen hyperlipidemia, unspecified venous insufficiency (chronic) (peripheral) type 2 diabetes mellitus with diabetic polyneuropathy hypertensive heart and chronic kidney disease with heart failure and stage 1 through stage 4 chronic kidney disease, or unspecified chronic kidney disease personal history of malignant neoplasm of breast nausea other secondary pulmonary hypertension age-related osteoporosis without current pathological fracture unspecified rotator cuff tear or rupture of right shoulder, not specified as traumatic dependence on supplemental oxygen body mass index (bmi) 45.0-49.9, adult unspecified asthma, uncomplicated nonrheumatic tricuspid (valve) insufficiency portal vein thrombosis acute and chronic respiratory failure with hypoxia carpal tunnel syndrome, unspecified upper limb acute on chronic diastolic (congestive) heart failure chronic kidney disease, unspecified headache iron deficiency anemia, unspecified gastro-esophageal reflux disease without esophagitis
black african american f 76 $nan$hematology blood hematocrit  27.5  %; hematology blood hemoglobin  8.0  g dl; hematology blood platelet count  328  k ul; chemistry blood anion gap  17  meq l; chemistry blood anion gap  16  meq l; chemistry blood bicarbonate  29  meq l; chemistry blood bicarbonate  30  meq l; chemistry blood chloride  94  meq l; chemistry blood chloride  92  meq l; chemistry blood creatinine  1.9  mg dl; chemistry blood creatinine  2.0  mg dl; chemistry blood potassium  4.3  meq l; chemistry blood potassium  4.4  meq l; chemistry blood sodium  140  meq l; chemistry blood sodium  138  meq l; chemistry blood urea nitrogen  74  mg dl; chemistry blood urea nitrogen  73  mg dl; hematology blood inr(pt)  1.0  ; chemistry blood calcium, total  9.1  mg dl; chemistry blood calcium, total  9.2  mg dl; chemistry blood bilirubin, total  0.2  mg dl; chemistry blood glucose  169  mg dl; chemistry blood glucose  157  mg dl$bag  1  bag ; acetaminophen  1000  mg ; anastrozole  1  mg ; aspirin  81  mg ; atorvastatin  80  mg ; bisacodyl  10  mg ; calcium carbonate  500  mg ; dorzolamide 2% timolol 0.5% ophth.  1  drop ; dextrose 50%  12.5  gm ; glucagon  1  mg ; glucose gel  15  g ; latanoprost 0.005% ophth. soln.  1  drop ; lidocaine 5% patch  1  ptch ; paroxetine  30  mg ; polyethylene glycol  17  g ; senna  17.2  mg ; sevelamer carbonate  800  mg ; tiotropium bromide  1  cap ; alendronate sodium  70  mg ; sarna lotion  1  appl ; ramelteon  8  mg ; cetirizine  10  mg ; sodium chloride 0.9%  flush  10-20  ml ; sodium chloride nasal  1-2  spry ; hydroxyzine  25  mg ; metoprolol succinate xl  12.5  mg ; vitamin d  1000  unit ; insulin  12  unit ; insulin  18  unit ; fluticasone-salmeterol diskus (250 50)   1  inh ; hydralazine  20  mg ; hydromorphone (dilaudid)  1  mg ; sterile water  150  ml ; 5% dextrose  25  ml ; acetazolamide sodium  250  mg ; triamcinolone acetonide 0.025% ointment  1  appl ; 
acute on chronic diastolic (congestive) heart failure type 2 diabetes mellitus with diabetic polyneuropathy type 2 diabetes mellitus with hyperglycemia acute and chronic respiratory failure with hypoxia obstructive sleep apnea (adult) (pediatric) morbid (severe) obesity with alveolar hypoventilation other secondary pulmonary hypertension hypertensive heart and chronic kidney disease with heart failure and stage 1 through stage 4 chronic kidney disease, or unspecified chronic kidney disease fall resulting in striking against other object unspecified place in hospital as the place of occurrence of the external cause metabolic syndrome major depressive disorder, single episode, unspecified fatty (change of) liver, not elsewhere classified chronic kidney disease, unspecified gastro-esophageal reflux disease without esophagitis other chronic pain adverse effect of loop [high-ceiling] diuretics, initial encounter personal history of malignant neoplasm of breast unspecified open-angle glaucoma, stage unspecified age-related osteoporosis without current pathological fracture type 2 diabetes mellitus with diabetic chronic kidney disease other acute kidney failure patient's noncompliance with dietary regimen patient's other noncompliance with medication regimen body mass index (bmi) 39.0-39.9, adult long term (current) use of insulin dependence on supplemental oxygen hyperlipidemia, unspecified venous insufficiency (chronic) (peripheral) type 2 diabetes mellitus with diabetic polyneuropathy hypertensive heart and chronic kidney disease with heart failure and stage 1 through stage 4 chronic kidney disease, or unspecified chronic kidney disease personal history of malignant neoplasm of breast nausea other secondary pulmonary hypertension age-related osteoporosis without current pathological fracture unspecified rotator cuff tear or rupture of right shoulder, not specified as traumatic dependence on supplemental oxygen body mass index (bmi) 45.0-49.9, adult unspecified asthma, uncomplicated nonrheumatic tricuspid (valve) insufficiency portal vein thrombosis acute and chronic respiratory failure with hypoxia carpal tunnel syndrome, unspecified upper limb acute on chronic diastolic (congestive) heart failure chronic kidney disease, unspecified headache iron deficiency anemia, unspecified gastro-esophageal reflux disease without esophagitis
black african american f 76 $nan$hematology blood hematocrit  26.7  %; hematology blood hemoglobin  7.8  g dl; hematology blood platelet count  305  k ul; chemistry blood anion gap  15  meq l; chemistry blood anion gap  15  meq l; chemistry blood bicarbonate  30  meq l; chemistry blood bicarbonate  30  meq l; chemistry blood chloride  93  meq l; chemistry blood chloride  96  meq l; chemistry blood creatinine  2.1  mg dl; chemistry blood creatinine  1.9  mg dl; chemistry blood potassium  4.1  meq l; chemistry blood potassium  4.4  meq l; chemistry blood sodium  138  meq l; chemistry blood sodium  141  meq l; chemistry blood urea nitrogen  73  mg dl; chemistry blood urea nitrogen  71  mg dl; chemistry blood calcium, total  9.0  mg dl; chemistry blood calcium, total  9.4  mg dl; chemistry blood glucose  178  mg dl; chemistry blood glucose  174  mg dl$bag  1  bag ; acetaminophen  1000  mg ; anastrozole  1  mg ; aspirin  81  mg ; atorvastatin  80  mg ; bisacodyl  10  mg ; calcium carbonate  500  mg ; dorzolamide 2% timolol 0.5% ophth.  1  drop ; dextrose 50%  12.5  gm ; glucagon  1  mg ; glucose gel  15  g ; latanoprost 0.005% ophth. soln.  1  drop ; lidocaine 5% patch  1  ptch ; paroxetine  30  mg ; polyethylene glycol  17  g ; senna  17.2  mg ; sevelamer carbonate  800  mg ; tiotropium bromide  1  cap ; alendronate sodium  70  mg ; sarna lotion  1  appl ; ramelteon  8  mg ; cetirizine  10  mg ; sodium chloride 0.9%  flush  10-20  ml ; sodium chloride nasal  1-2  spry ; hydroxyzine  25  mg ; metoprolol succinate xl  12.5  mg ; vitamin d  1000  unit ; insulin  12  unit ; insulin  18  unit ; fluticasone-salmeterol diskus (250 50)   1  inh ; hydralazine  20  mg ; sterile water  150  ml ; 5% dextrose  25  ml ; acetazolamide sodium  250  mg ; triamcinolone acetonide 0.025% ointment  1  appl ; sildenafil  10  mg ; 
acute on chronic diastolic (congestive) heart failure type 2 diabetes mellitus with diabetic polyneuropathy type 2 diabetes mellitus with hyperglycemia acute and chronic respiratory failure with hypoxia obstructive sleep apnea (adult) (pediatric) morbid (severe) obesity with alveolar hypoventilation other secondary pulmonary hypertension hypertensive heart and chronic kidney disease with heart failure and stage 1 through stage 4 chronic kidney disease, or unspecified chronic kidney disease fall resulting in striking against other object unspecified place in hospital as the place of occurrence of the external cause metabolic syndrome major depressive disorder, single episode, unspecified fatty (change of) liver, not elsewhere classified chronic kidney disease, unspecified gastro-esophageal reflux disease without esophagitis other chronic pain adverse effect of loop [high-ceiling] diuretics, initial encounter personal history of malignant neoplasm of breast unspecified open-angle glaucoma, stage unspecified age-related osteoporosis without current pathological fracture type 2 diabetes mellitus with diabetic chronic kidney disease other acute kidney failure patient's noncompliance with dietary regimen patient's other noncompliance with medication regimen body mass index (bmi) 39.0-39.9, adult long term (current) use of insulin dependence on supplemental oxygen hyperlipidemia, unspecified venous insufficiency (chronic) (peripheral) type 2 diabetes mellitus with diabetic polyneuropathy hypertensive heart and chronic kidney disease with heart failure and stage 1 through stage 4 chronic kidney disease, or unspecified chronic kidney disease personal history of malignant neoplasm of breast nausea other secondary pulmonary hypertension age-related osteoporosis without current pathological fracture unspecified rotator cuff tear or rupture of right shoulder, not specified as traumatic dependence on supplemental oxygen body mass index (bmi) 45.0-49.9, adult unspecified asthma, uncomplicated nonrheumatic tricuspid (valve) insufficiency portal vein thrombosis acute and chronic respiratory failure with hypoxia carpal tunnel syndrome, unspecified upper limb acute on chronic diastolic (congestive) heart failure chronic kidney disease, unspecified headache iron deficiency anemia, unspecified gastro-esophageal reflux disease without esophagitis
black african american f 76 $nan$hematology blood hematocrit  26.7  %; hematology blood hemoglobin  7.8  g dl; hematology blood platelet count  289  k ul; chemistry blood anion gap  14  meq l; chemistry blood bicarbonate  30  meq l; chemistry blood chloride  94  meq l; chemistry blood creatinine  2.0  mg dl; chemistry blood potassium  4.1  meq l; chemistry blood sodium  138  meq l; chemistry blood urea nitrogen  71  mg dl; chemistry blood calcium, total  9.0  mg dl; chemistry blood glucose  176  mg dl$bag  1  bag ; acetaminophen  1000  mg ; anastrozole  1  mg ; aspirin  81  mg ; atorvastatin  80  mg ; bisacodyl  10  mg ; calcium carbonate  500  mg ; dorzolamide 2% timolol 0.5% ophth.  1  drop ; dextrose 50%  12.5  gm ; glucagon  1  mg ; glucose gel  15  g ; latanoprost 0.005% ophth. soln.  1  drop ; lidocaine 5% patch  1  ptch ; paroxetine  30  mg ; polyethylene glycol  17  g ; senna  17.2  mg ; sevelamer carbonate  800  mg ; tiotropium bromide  1  cap ; alendronate sodium  70  mg ; sarna lotion  1  appl ; ramelteon  8  mg ; cetirizine  10  mg ; sodium chloride 0.9%  flush  10-20  ml ; sodium chloride nasal  1-2  spry ; hydroxyzine  25  mg ; metoprolol succinate xl  12.5  mg ; vitamin d  1000  unit ; insulin  12  unit ; insulin  18  unit ; fluticasone-salmeterol diskus (250 50)   1  inh ; hydralazine  20  mg ; sterile water  150  ml ; 5% dextrose  25  ml ; acetazolamide sodium  250  mg ; triamcinolone acetonide 0.025% ointment  1  appl ; sildenafil  10  mg ; sildenafil  20  mg ; torsemide  40  mg ; insulin  38  unit ; 
acute on chronic diastolic (congestive) heart failure type 2 diabetes mellitus with diabetic polyneuropathy type 2 diabetes mellitus with hyperglycemia acute and chronic respiratory failure with hypoxia obstructive sleep apnea (adult) (pediatric) morbid (severe) obesity with alveolar hypoventilation other secondary pulmonary hypertension hypertensive heart and chronic kidney disease with heart failure and stage 1 through stage 4 chronic kidney disease, or unspecified chronic kidney disease fall resulting in striking against other object unspecified place in hospital as the place of occurrence of the external cause metabolic syndrome major depressive disorder, single episode, unspecified fatty (change of) liver, not elsewhere classified chronic kidney disease, unspecified gastro-esophageal reflux disease without esophagitis other chronic pain adverse effect of loop [high-ceiling] diuretics, initial encounter personal history of malignant neoplasm of breast unspecified open-angle glaucoma, stage unspecified age-related osteoporosis without current pathological fracture type 2 diabetes mellitus with diabetic chronic kidney disease other acute kidney failure patient's noncompliance with dietary regimen patient's other noncompliance with medication regimen body mass index (bmi) 39.0-39.9, adult long term (current) use of insulin dependence on supplemental oxygen hyperlipidemia, unspecified venous insufficiency (chronic) (peripheral) type 2 diabetes mellitus with diabetic polyneuropathy hypertensive heart and chronic kidney disease with heart failure and stage 1 through stage 4 chronic kidney disease, or unspecified chronic kidney disease personal history of malignant neoplasm of breast nausea other secondary pulmonary hypertension age-related osteoporosis without current pathological fracture unspecified rotator cuff tear or rupture of right shoulder, not specified as traumatic dependence on supplemental oxygen body mass index (bmi) 45.0-49.9, adult unspecified asthma, uncomplicated nonrheumatic tricuspid (valve) insufficiency portal vein thrombosis acute and chronic respiratory failure with hypoxia carpal tunnel syndrome, unspecified upper limb acute on chronic diastolic (congestive) heart failure chronic kidney disease, unspecified headache iron deficiency anemia, unspecified gastro-esophageal reflux disease without esophagitis
black african american f 76 $nan$hematology blood hematocrit  24.2  %; hematology blood hematocrit  25.3  %; hematology blood hemoglobin  6.9  g dl; hematology blood hemoglobin  7.4  g dl; hematology blood platelet count  282  k ul; hematology blood platelet count  301  k ul; chemistry blood anion gap  15  meq l; chemistry blood bicarbonate  28  meq l; chemistry blood chloride  93  meq l; chemistry blood creatinine  2.1  mg dl; chemistry blood potassium  4.0  meq l; chemistry blood sodium  136  meq l; chemistry blood urea nitrogen  67  mg dl; chemistry blood calcium, total  7.9  mg dl; chemistry blood bilirubin, total  0.2  mg dl; chemistry blood glucose  390  mg dl; chemistry blood lactate dehydrogenase (ld)  326  iu l$bag  1  bag ; acetaminophen  1000  mg ; anastrozole  1  mg ; aspirin  81  mg ; atorvastatin  80  mg ; bisacodyl  10  mg ; calcium carbonate  500  mg ; dorzolamide 2% timolol 0.5% ophth.  1  drop ; dextrose 50%  12.5  gm ; glucagon  1  mg ; glucose gel  15  g ; latanoprost 0.005% ophth. soln.  1  drop ; lidocaine 5% patch  1  ptch ; paroxetine  30  mg ; polyethylene glycol  17  g ; senna  17.2  mg ; sevelamer carbonate  800  mg ; tiotropium bromide  1  cap ; alendronate sodium  70  mg ; sarna lotion  1  appl ; ramelteon  8  mg ; cetirizine  10  mg ; sodium chloride 0.9%  flush  10-20  ml ; sodium chloride nasal  1-2  spry ; hydroxyzine  25  mg ; metoprolol succinate xl  12.5  mg ; vitamin d  1000  unit ; fluticasone-salmeterol diskus (250 50)   1  inh ; sterile water  150  ml ; 5% dextrose  25  ml ; acetazolamide sodium  250  mg ; triamcinolone acetonide 0.025% ointment  1  appl ; torsemide  40  mg ; insulin  38  unit ; 
acute on chronic diastolic (congestive) heart failure type 2 diabetes mellitus with diabetic polyneuropathy type 2 diabetes mellitus with hyperglycemia acute and chronic respiratory failure with hypoxia obstructive sleep apnea (adult) (pediatric) morbid (severe) obesity with alveolar hypoventilation other secondary pulmonary hypertension hypertensive heart and chronic kidney disease with heart failure and stage 1 through stage 4 chronic kidney disease, or unspecified chronic kidney disease fall resulting in striking against other object unspecified place in hospital as the place of occurrence of the external cause metabolic syndrome major depressive disorder, single episode, unspecified fatty (change of) liver, not elsewhere classified chronic kidney disease, unspecified gastro-esophageal reflux disease without esophagitis other chronic pain adverse effect of loop [high-ceiling] diuretics, initial encounter personal history of malignant neoplasm of breast unspecified open-angle glaucoma, stage unspecified age-related osteoporosis without current pathological fracture type 2 diabetes mellitus with diabetic chronic kidney disease other acute kidney failure patient's noncompliance with dietary regimen patient's other noncompliance with medication regimen body mass index (bmi) 39.0-39.9, adult long term (current) use of insulin dependence on supplemental oxygen hyperlipidemia, unspecified venous insufficiency (chronic) (peripheral) type 2 diabetes mellitus with diabetic polyneuropathy hypertensive heart and chronic kidney disease with heart failure and stage 1 through stage 4 chronic kidney disease, or unspecified chronic kidney disease personal history of malignant neoplasm of breast nausea other secondary pulmonary hypertension age-related osteoporosis without current pathological fracture unspecified rotator cuff tear or rupture of right shoulder, not specified as traumatic dependence on supplemental oxygen body mass index (bmi) 45.0-49.9, adult unspecified asthma, uncomplicated nonrheumatic tricuspid (valve) insufficiency portal vein thrombosis acute and chronic respiratory failure with hypoxia carpal tunnel syndrome, unspecified upper limb acute on chronic diastolic (congestive) heart failure chronic kidney disease, unspecified headache iron deficiency anemia, unspecified gastro-esophageal reflux disease without esophagitis
black african american f 76 $nan$hematology blood hematocrit  25.0  %; hematology blood hemoglobin  7.2  g dl; hematology blood platelet count  304  k ul; chemistry blood anion gap  16  meq l; chemistry blood anion gap  14  meq l; chemistry blood bicarbonate  28  meq l; chemistry blood bicarbonate  26  meq l; chemistry blood chloride  96  meq l; chemistry blood chloride  94  meq l; chemistry blood creatinine  2.1  mg dl; chemistry blood creatinine  2.0  mg dl; chemistry blood potassium  4.4  meq l; chemistry blood potassium  4.1  meq l; chemistry blood sodium  138  meq l; chemistry blood sodium  136  meq l; chemistry blood urea nitrogen  70  mg dl; chemistry blood urea nitrogen  70  mg dl; chemistry blood calcium, total  8.9  mg dl; chemistry blood calcium, total  9.1  mg dl; chemistry blood bilirubin, total  0.2  mg dl; chemistry blood glucose  160  mg dl; chemistry blood glucose  267  mg dl$bag  1  bag ; acetaminophen  1000  mg ; anastrozole  1  mg ; aspirin  81  mg ; atorvastatin  80  mg ; bisacodyl  10  mg ; calcium carbonate  500  mg ; dorzolamide 2% timolol 0.5% ophth.  1  drop ; dextrose 50%  12.5  gm ; glucagon  1  mg ; glucose gel  15  g ; latanoprost 0.005% ophth. soln.  1  drop ; lidocaine 5% patch  1  ptch ; paroxetine  30  mg ; polyethylene glycol  17  g ; senna  17.2  mg ; sevelamer carbonate  800  mg ; tiotropium bromide  1  cap ; alendronate sodium  70  mg ; sarna lotion  1  appl ; ramelteon  8  mg ; cetirizine  10  mg ; sodium chloride 0.9%  flush  10-20  ml ; sodium chloride nasal  1-2  spry ; hydroxyzine  25  mg ; metoprolol succinate xl  12.5  mg ; vitamin d  1000  unit ; fluticasone-salmeterol diskus (250 50)   1  inh ; sterile water  150  ml ; triamcinolone acetonide 0.025% ointment  1  appl ; torsemide  40  mg ; insulin  38  unit ; torsemide  80  mg ; 
acute on chronic diastolic (congestive) heart failure type 2 diabetes mellitus with diabetic polyneuropathy type 2 diabetes mellitus with hyperglycemia acute and chronic respiratory failure with hypoxia obstructive sleep apnea (adult) (pediatric) morbid (severe) obesity with alveolar hypoventilation other secondary pulmonary hypertension hypertensive heart and chronic kidney disease with heart failure and stage 1 through stage 4 chronic kidney disease, or unspecified chronic kidney disease fall resulting in striking against other object unspecified place in hospital as the place of occurrence of the external cause metabolic syndrome major depressive disorder, single episode, unspecified fatty (change of) liver, not elsewhere classified chronic kidney disease, unspecified gastro-esophageal reflux disease without esophagitis other chronic pain adverse effect of loop [high-ceiling] diuretics, initial encounter personal history of malignant neoplasm of breast unspecified open-angle glaucoma, stage unspecified age-related osteoporosis without current pathological fracture type 2 diabetes mellitus with diabetic chronic kidney disease other acute kidney failure patient's noncompliance with dietary regimen patient's other noncompliance with medication regimen body mass index (bmi) 39.0-39.9, adult long term (current) use of insulin dependence on supplemental oxygen hyperlipidemia, unspecified venous insufficiency (chronic) (peripheral) type 2 diabetes mellitus with diabetic polyneuropathy hypertensive heart and chronic kidney disease with heart failure and stage 1 through stage 4 chronic kidney disease, or unspecified chronic kidney disease personal history of malignant neoplasm of breast nausea other secondary pulmonary hypertension age-related osteoporosis without current pathological fracture unspecified rotator cuff tear or rupture of right shoulder, not specified as traumatic dependence on supplemental oxygen body mass index (bmi) 45.0-49.9, adult unspecified asthma, uncomplicated nonrheumatic tricuspid (valve) insufficiency portal vein thrombosis acute and chronic respiratory failure with hypoxia carpal tunnel syndrome, unspecified upper limb acute on chronic diastolic (congestive) heart failure chronic kidney disease, unspecified headache iron deficiency anemia, unspecified gastro-esophageal reflux disease without esophagitis
black african american f 76 $nan$hematology blood hematocrit  25.6  %; hematology blood hemoglobin  7.4  g dl; hematology blood platelet count  325  k ul; chemistry blood anion gap  17  meq l; chemistry blood anion gap  14  meq l; chemistry blood bicarbonate  30  meq l; chemistry blood bicarbonate  27  meq l; chemistry blood chloride  92  meq l; chemistry blood chloride  91  meq l; chemistry blood creatinine  2.1  mg dl; chemistry blood creatinine  2.0  mg dl; chemistry blood potassium  4.2  meq l; chemistry blood potassium  4.2  meq l; chemistry blood sodium  136  meq l; chemistry blood sodium  135  meq l; chemistry blood urea nitrogen  73  mg dl; chemistry blood urea nitrogen  76  mg dl; chemistry blood calcium, total  9.2  mg dl; chemistry blood calcium, total  8.9  mg dl; chemistry blood glucose  186  mg dl; chemistry blood glucose  272  mg dl$bag  1  bag ; acetaminophen  1000  mg ; anastrozole  1  mg ; aspirin  81  mg ; atorvastatin  80  mg ; bisacodyl  10  mg ; calcium carbonate  500  mg ; dorzolamide 2% timolol 0.5% ophth.  1  drop ; dextrose 50%  12.5  gm ; glucagon  1  mg ; glucose gel  15  g ; latanoprost 0.005% ophth. soln.  1  drop ; lidocaine 5% patch  1  ptch ; paroxetine  30  mg ; polyethylene glycol  17  g ; senna  17.2  mg ; sevelamer carbonate  800  mg ; tiotropium bromide  1  cap ; alendronate sodium  70  mg ; sarna lotion  1  appl ; ramelteon  8  mg ; cetirizine  10  mg ; sodium chloride 0.9%  flush  10-20  ml ; sodium chloride nasal  1-2  spry ; hydroxyzine  25  mg ; metoprolol succinate xl  12.5  mg ; vitamin d  1000  unit ; fluticasone-salmeterol diskus (250 50)   1  inh ; sterile water  150  ml ; triamcinolone acetonide 0.025% ointment  1  appl ; insulin  38  unit ; torsemide  80  mg ; 
acute on chronic diastolic (congestive) heart failure type 2 diabetes mellitus with diabetic polyneuropathy type 2 diabetes mellitus with hyperglycemia acute and chronic respiratory failure with hypoxia obstructive sleep apnea (adult) (pediatric) morbid (severe) obesity with alveolar hypoventilation other secondary pulmonary hypertension hypertensive heart and chronic kidney disease with heart failure and stage 1 through stage 4 chronic kidney disease, or unspecified chronic kidney disease fall resulting in striking against other object unspecified place in hospital as the place of occurrence of the external cause metabolic syndrome major depressive disorder, single episode, unspecified fatty (change of) liver, not elsewhere classified chronic kidney disease, unspecified gastro-esophageal reflux disease without esophagitis other chronic pain adverse effect of loop [high-ceiling] diuretics, initial encounter personal history of malignant neoplasm of breast unspecified open-angle glaucoma, stage unspecified age-related osteoporosis without current pathological fracture type 2 diabetes mellitus with diabetic chronic kidney disease other acute kidney failure patient's noncompliance with dietary regimen patient's other noncompliance with medication regimen body mass index (bmi) 39.0-39.9, adult long term (current) use of insulin dependence on supplemental oxygen hyperlipidemia, unspecified venous insufficiency (chronic) (peripheral) type 2 diabetes mellitus with diabetic polyneuropathy hypertensive heart and chronic kidney disease with heart failure and stage 1 through stage 4 chronic kidney disease, or unspecified chronic kidney disease personal history of malignant neoplasm of breast nausea other secondary pulmonary hypertension age-related osteoporosis without current pathological fracture unspecified rotator cuff tear or rupture of right shoulder, not specified as traumatic dependence on supplemental oxygen body mass index (bmi) 45.0-49.9, adult unspecified asthma, uncomplicated nonrheumatic tricuspid (valve) insufficiency portal vein thrombosis acute and chronic respiratory failure with hypoxia carpal tunnel syndrome, unspecified upper limb acute on chronic diastolic (congestive) heart failure chronic kidney disease, unspecified headache iron deficiency anemia, unspecified gastro-esophageal reflux disease without esophagitis
black african american f 76 $nan$hematology blood hematocrit  25.1  %; hematology blood hemoglobin  7.4  g dl; hematology blood platelet count  326  k ul; chemistry blood anion gap  17  meq l; chemistry blood bicarbonate  31  meq l; chemistry blood chloride  90  meq l; chemistry blood creatinine  1.9  mg dl; chemistry blood potassium  4.1  meq l; chemistry blood sodium  138  meq l; chemistry blood urea nitrogen  75  mg dl; chemistry blood calcium, total  9.2  mg dl; chemistry blood glucose  183  mg dl$bag  1  bag ; acetaminophen  1000  mg ; anastrozole  1  mg ; aspirin  81  mg ; atorvastatin  80  mg ; bisacodyl  10  mg ; calcium carbonate  500  mg ; dorzolamide 2% timolol 0.5% ophth.  1  drop ; dextrose 50%  12.5  gm ; glucagon  1  mg ; glucose gel  15  g ; latanoprost 0.005% ophth. soln.  1  drop ; lidocaine 5% patch  1  ptch ; paroxetine  30  mg ; polyethylene glycol  17  g ; senna  17.2  mg ; sevelamer carbonate  800  mg ; tiotropium bromide  1  cap ; alendronate sodium  70  mg ; sarna lotion  1  appl ; ramelteon  8  mg ; sodium chloride 0.9%  flush  10-20  ml ; sodium chloride nasal  1-2  spry ; hydroxyzine  25  mg ; vitamin d  1000  unit ; fluticasone-salmeterol diskus (250 50)   1  inh ; sterile water  150  ml ; triamcinolone acetonide 0.025% ointment  1  appl ; insulin  38  unit ; torsemide  80  mg ; 
acute on chronic diastolic (congestive) heart failure type 2 diabetes mellitus with diabetic polyneuropathy type 2 diabetes mellitus with hyperglycemia acute and chronic respiratory failure with hypoxia obstructive sleep apnea (adult) (pediatric) morbid (severe) obesity with alveolar hypoventilation other secondary pulmonary hypertension hypertensive heart and chronic kidney disease with heart failure and stage 1 through stage 4 chronic kidney disease, or unspecified chronic kidney disease fall resulting in striking against other object unspecified place in hospital as the place of occurrence of the external cause metabolic syndrome major depressive disorder, single episode, unspecified fatty (change of) liver, not elsewhere classified chronic kidney disease, unspecified gastro-esophageal reflux disease without esophagitis other chronic pain adverse effect of loop [high-ceiling] diuretics, initial encounter personal history of malignant neoplasm of breast unspecified open-angle glaucoma, stage unspecified age-related osteoporosis without current pathological fracture type 2 diabetes mellitus with diabetic chronic kidney disease other acute kidney failure patient's noncompliance with dietary regimen patient's other noncompliance with medication regimen body mass index (bmi) 39.0-39.9, adult long term (current) use of insulin dependence on supplemental oxygen hyperlipidemia, unspecified venous insufficiency (chronic) (peripheral) type 2 diabetes mellitus with diabetic polyneuropathy hypertensive heart and chronic kidney disease with heart failure and stage 1 through stage 4 chronic kidney disease, or unspecified chronic kidney disease personal history of malignant neoplasm of breast nausea other secondary pulmonary hypertension age-related osteoporosis without current pathological fracture unspecified rotator cuff tear or rupture of right shoulder, not specified as traumatic dependence on supplemental oxygen body mass index (bmi) 45.0-49.9, adult unspecified asthma, uncomplicated nonrheumatic tricuspid (valve) insufficiency portal vein thrombosis acute and chronic respiratory failure with hypoxia carpal tunnel syndrome, unspecified upper limb acute on chronic diastolic (congestive) heart failure chronic kidney disease, unspecified headache iron deficiency anemia, unspecified gastro-esophageal reflux disease without esophagitis
black african american f 76 $nan$hematology blood hematocrit  25.5  %; hematology blood hemoglobin  7.6  g dl; hematology blood platelet count  305  k ul; chemistry blood anion gap  15  meq l; chemistry blood bicarbonate  31  meq l; chemistry blood chloride  88  meq l; chemistry blood creatinine  2.0  mg dl; chemistry blood potassium  4.3  meq l; chemistry blood sodium  134  meq l; chemistry blood urea nitrogen  79  mg dl; hematology blood inr(pt)  1.0  ; chemistry blood calcium, total  9.4  mg dl; chemistry blood bilirubin, total  0.2  mg dl; chemistry blood glucose  163  mg dl$bag  1  bag ; acetaminophen  1000  mg ; anastrozole  1  mg ; aspirin  81  mg ; atorvastatin  80  mg ; bisacodyl  10  mg ; calcium carbonate  500  mg ; dorzolamide 2% timolol 0.5% ophth.  1  drop ; dextrose 50%  12.5  gm ; glucagon  1  mg ; glucose gel  15  g ; latanoprost 0.005% ophth. soln.  1  drop ; lidocaine 5% patch  1  ptch ; paroxetine  30  mg ; polyethylene glycol  17  g ; senna  17.2  mg ; sevelamer carbonate  800  mg ; tiotropium bromide  1  cap ; alendronate sodium  70  mg ; sarna lotion  1  appl ; ramelteon  8  mg ; sodium chloride 0.9%  flush  10-20  ml ; sodium chloride nasal  1-2  spry ; hydroxyzine  25  mg ; vitamin d  1000  unit ; fluticasone-salmeterol diskus (250 50)   1  inh ; sterile water  150  ml ; triamcinolone acetonide 0.025% ointment  1  appl ; insulin  38  unit ; torsemide  80  mg ; spironolactone  12.5  mg ; ipratropium-albuterol neb  1  neb ; fluticasone propionate nasal  2  spry ; 
acute on chronic diastolic (congestive) heart failure type 2 diabetes mellitus with diabetic polyneuropathy type 2 diabetes mellitus with hyperglycemia acute and chronic respiratory failure with hypoxia obstructive sleep apnea (adult) (pediatric) morbid (severe) obesity with alveolar hypoventilation other secondary pulmonary hypertension hypertensive heart and chronic kidney disease with heart failure and stage 1 through stage 4 chronic kidney disease, or unspecified chronic kidney disease fall resulting in striking against other object unspecified place in hospital as the place of occurrence of the external cause metabolic syndrome major depressive disorder, single episode, unspecified fatty (change of) liver, not elsewhere classified chronic kidney disease, unspecified gastro-esophageal reflux disease without esophagitis other chronic pain adverse effect of loop [high-ceiling] diuretics, initial encounter personal history of malignant neoplasm of breast unspecified open-angle glaucoma, stage unspecified age-related osteoporosis without current pathological fracture type 2 diabetes mellitus with diabetic chronic kidney disease other acute kidney failure patient's noncompliance with dietary regimen patient's other noncompliance with medication regimen body mass index (bmi) 39.0-39.9, adult long term (current) use of insulin dependence on supplemental oxygen hyperlipidemia, unspecified venous insufficiency (chronic) (peripheral) type 2 diabetes mellitus with diabetic polyneuropathy hypertensive heart and chronic kidney disease with heart failure and stage 1 through stage 4 chronic kidney disease, or unspecified chronic kidney disease personal history of malignant neoplasm of breast nausea other secondary pulmonary hypertension age-related osteoporosis without current pathological fracture unspecified rotator cuff tear or rupture of right shoulder, not specified as traumatic dependence on supplemental oxygen body mass index (bmi) 45.0-49.9, adult unspecified asthma, uncomplicated nonrheumatic tricuspid (valve) insufficiency portal vein thrombosis acute and chronic respiratory failure with hypoxia carpal tunnel syndrome, unspecified upper limb acute on chronic diastolic (congestive) heart failure chronic kidney disease, unspecified headache iron deficiency anemia, unspecified gastro-esophageal reflux disease without esophagitis
black african american f 76 $nan$hematology blood hematocrit  25.3  %; hematology blood hemoglobin  7.5  g dl; hematology blood platelet count  357  k ul; chemistry blood anion gap  13  meq l; chemistry blood bicarbonate  32  meq l; chemistry blood chloride  90  meq l; chemistry blood creatinine  2.1  mg dl; chemistry blood potassium  4.7  meq l; chemistry blood sodium  135  meq l; chemistry blood urea nitrogen  84  mg dl; hematology blood inr(pt)  1.0  ; chemistry blood calcium, total  9.2  mg dl; chemistry blood glucose  227  mg dl$bag  1  bag ; acetaminophen  1000  mg ; anastrozole  1  mg ; aspirin  81  mg ; atorvastatin  80  mg ; bisacodyl  10  mg ; calcium carbonate  500  mg ; dorzolamide 2% timolol 0.5% ophth.  1  drop ; dextrose 50%  12.5  gm ; glucagon  1  mg ; glucose gel  15  g ; latanoprost 0.005% ophth. soln.  1  drop ; lidocaine 5% patch  1  ptch ; paroxetine  30  mg ; polyethylene glycol  17  g ; senna  17.2  mg ; sevelamer carbonate  800  mg ; alendronate sodium  70  mg ; sarna lotion  1  appl ; ramelteon  8  mg ; sodium chloride 0.9%  flush  10-20  ml ; sodium chloride nasal  1-2  spry ; hydroxyzine  25  mg ; vitamin d  1000  unit ; sterile water  150  ml ; triamcinolone acetonide 0.025% ointment  1  appl ; insulin  38  unit ; torsemide  80  mg ; ipratropium-albuterol neb  1  neb ; fluticasone propionate nasal  2  spry ; spironolactone  25  mg ; 
acute on chronic diastolic (congestive) heart failure type 2 diabetes mellitus with diabetic polyneuropathy type 2 diabetes mellitus with hyperglycemia acute and chronic respiratory failure with hypoxia obstructive sleep apnea (adult) (pediatric) morbid (severe) obesity with alveolar hypoventilation other secondary pulmonary hypertension hypertensive heart and chronic kidney disease with heart failure and stage 1 through stage 4 chronic kidney disease, or unspecified chronic kidney disease fall resulting in striking against other object unspecified place in hospital as the place of occurrence of the external cause metabolic syndrome major depressive disorder, single episode, unspecified fatty (change of) liver, not elsewhere classified chronic kidney disease, unspecified gastro-esophageal reflux disease without esophagitis other chronic pain adverse effect of loop [high-ceiling] diuretics, initial encounter personal history of malignant neoplasm of breast unspecified open-angle glaucoma, stage unspecified age-related osteoporosis without current pathological fracture type 2 diabetes mellitus with diabetic chronic kidney disease other acute kidney failure patient's noncompliance with dietary regimen patient's other noncompliance with medication regimen body mass index (bmi) 39.0-39.9, adult long term (current) use of insulin dependence on supplemental oxygen hyperlipidemia, unspecified venous insufficiency (chronic) (peripheral) type 2 diabetes mellitus with diabetic polyneuropathy hypertensive heart and chronic kidney disease with heart failure and stage 1 through stage 4 chronic kidney disease, or unspecified chronic kidney disease personal history of malignant neoplasm of breast nausea other secondary pulmonary hypertension age-related osteoporosis without current pathological fracture unspecified rotator cuff tear or rupture of right shoulder, not specified as traumatic dependence on supplemental oxygen body mass index (bmi) 45.0-49.9, adult unspecified asthma, uncomplicated nonrheumatic tricuspid (valve) insufficiency portal vein thrombosis acute and chronic respiratory failure with hypoxia carpal tunnel syndrome, unspecified upper limb acute on chronic diastolic (congestive) heart failure chronic kidney disease, unspecified headache iron deficiency anemia, unspecified gastro-esophageal reflux disease without esophagitis
black african american f 76 $nan$hematology blood hematocrit  25.1  %; hematology blood hemoglobin  7.4  g dl; hematology blood platelet count  383  k ul; chemistry blood anion gap  14  meq l; chemistry blood bicarbonate  30  meq l; chemistry blood chloride  90  meq l; chemistry blood creatinine  1.9  mg dl; chemistry blood potassium  4.8  meq l; chemistry blood sodium  134  meq l; chemistry blood urea nitrogen  81  mg dl; chemistry blood calcium, total  9.0  mg dl; chemistry blood glucose  215  mg dl$bag  1  bag ; acetaminophen  1000  mg ; anastrozole  1  mg ; aspirin  81  mg ; atorvastatin  80  mg ; bisacodyl  10  mg ; calcium carbonate  500  mg ; dorzolamide 2% timolol 0.5% ophth.  1  drop ; dextrose 50%  12.5  gm ; glucagon  1  mg ; glucose gel  15  g ; latanoprost 0.005% ophth. soln.  1  drop ; lidocaine 5% patch  1  ptch ; paroxetine  30  mg ; polyethylene glycol  17  g ; senna  17.2  mg ; sevelamer carbonate  800  mg ; alendronate sodium  70  mg ; sarna lotion  1  appl ; ramelteon  8  mg ; sodium chloride 0.9%  flush  10-20  ml ; sodium chloride nasal  1-2  spry ; hydroxyzine  25  mg ; vitamin d  1000  unit ; triamcinolone acetonide 0.025% ointment  1  appl ; insulin  38  unit ; torsemide  80  mg ; ipratropium-albuterol neb  1  neb ; fluticasone propionate nasal  2  spry ; insulin  42  unit ; 
acute on chronic diastolic (congestive) heart failure type 2 diabetes mellitus with diabetic polyneuropathy type 2 diabetes mellitus with hyperglycemia acute and chronic respiratory failure with hypoxia obstructive sleep apnea (adult) (pediatric) morbid (severe) obesity with alveolar hypoventilation other secondary pulmonary hypertension hypertensive heart and chronic kidney disease with heart failure and stage 1 through stage 4 chronic kidney disease, or unspecified chronic kidney disease fall resulting in striking against other object unspecified place in hospital as the place of occurrence of the external cause metabolic syndrome major depressive disorder, single episode, unspecified fatty (change of) liver, not elsewhere classified chronic kidney disease, unspecified gastro-esophageal reflux disease without esophagitis other chronic pain adverse effect of loop [high-ceiling] diuretics, initial encounter personal history of malignant neoplasm of breast unspecified open-angle glaucoma, stage unspecified age-related osteoporosis without current pathological fracture type 2 diabetes mellitus with diabetic chronic kidney disease other acute kidney failure patient's noncompliance with dietary regimen patient's other noncompliance with medication regimen body mass index (bmi) 39.0-39.9, adult long term (current) use of insulin dependence on supplemental oxygen hyperlipidemia, unspecified venous insufficiency (chronic) (peripheral) type 2 diabetes mellitus with diabetic polyneuropathy hypertensive heart and chronic kidney disease with heart failure and stage 1 through stage 4 chronic kidney disease, or unspecified chronic kidney disease personal history of malignant neoplasm of breast nausea other secondary pulmonary hypertension age-related osteoporosis without current pathological fracture unspecified rotator cuff tear or rupture of right shoulder, not specified as traumatic dependence on supplemental oxygen body mass index (bmi) 45.0-49.9, adult unspecified asthma, uncomplicated nonrheumatic tricuspid (valve) insufficiency portal vein thrombosis acute and chronic respiratory failure with hypoxia carpal tunnel syndrome, unspecified upper limb acute on chronic diastolic (congestive) heart failure chronic kidney disease, unspecified headache iron deficiency anemia, unspecified gastro-esophageal reflux disease without esophagitis
black african american f 76 $nan$hematology blood hematocrit  23.9  %; hematology blood hemoglobin  7.1  g dl; hematology blood platelet count  371  k ul; chemistry blood anion gap  16  meq l; chemistry blood bicarbonate  30  meq l; chemistry blood chloride  92  meq l; chemistry blood creatinine  1.9  mg dl; chemistry blood potassium  4.9  meq l; chemistry blood sodium  138  meq l; chemistry blood urea nitrogen  84  mg dl; hematology blood inr(pt)  1.0  ; chemistry blood calcium, total  9.5  mg dl; chemistry blood glucose  203  mg dl; chemistry blood % hemoglobin a1c  7.7  %$acetaminophen  1000  mg ; anastrozole  1  mg ; aspirin  81  mg ; atorvastatin  80  mg ; bisacodyl  10  mg ; calcium carbonate  500  mg ; dorzolamide 2% timolol 0.5% ophth.  1  drop ; dextrose 50%  12.5  gm ; glucagon  1  mg ; glucose gel  15  g ; latanoprost 0.005% ophth. soln.  1  drop ; lidocaine 5% patch  1  ptch ; paroxetine  30  mg ; polyethylene glycol  17  g ; senna  17.2  mg ; sevelamer carbonate  800  mg ; alendronate sodium  70  mg ; sarna lotion  1  appl ; ramelteon  8  mg ; sodium chloride 0.9%  flush  10-20  ml ; sodium chloride nasal  1-2  spry ; hydroxyzine  25  mg ; vitamin d  1000  unit ; triamcinolone acetonide 0.025% ointment  1  appl ; torsemide  80  mg ; ipratropium-albuterol neb  1  neb ; fluticasone propionate nasal  2  spry ; insulin  42  unit ; 
acute on chronic diastolic (congestive) heart failure type 2 diabetes mellitus with diabetic polyneuropathy type 2 diabetes mellitus with hyperglycemia acute and chronic respiratory failure with hypoxia obstructive sleep apnea (adult) (pediatric) morbid (severe) obesity with alveolar hypoventilation other secondary pulmonary hypertension hypertensive heart and chronic kidney disease with heart failure and stage 1 through stage 4 chronic kidney disease, or unspecified chronic kidney disease fall resulting in striking against other object unspecified place in hospital as the place of occurrence of the external cause metabolic syndrome major depressive disorder, single episode, unspecified fatty (change of) liver, not elsewhere classified chronic kidney disease, unspecified gastro-esophageal reflux disease without esophagitis other chronic pain adverse effect of loop [high-ceiling] diuretics, initial encounter personal history of malignant neoplasm of breast unspecified open-angle glaucoma, stage unspecified age-related osteoporosis without current pathological fracture type 2 diabetes mellitus with diabetic chronic kidney disease other acute kidney failure patient's noncompliance with dietary regimen patient's other noncompliance with medication regimen body mass index (bmi) 39.0-39.9, adult long term (current) use of insulin dependence on supplemental oxygen hyperlipidemia, unspecified venous insufficiency (chronic) (peripheral) type 2 diabetes mellitus with diabetic polyneuropathy hypertensive heart and chronic kidney disease with heart failure and stage 1 through stage 4 chronic kidney disease, or unspecified chronic kidney disease personal history of malignant neoplasm of breast nausea other secondary pulmonary hypertension age-related osteoporosis without current pathological fracture unspecified rotator cuff tear or rupture of right shoulder, not specified as traumatic dependence on supplemental oxygen body mass index (bmi) 45.0-49.9, adult unspecified asthma, uncomplicated nonrheumatic tricuspid (valve) insufficiency portal vein thrombosis acute and chronic respiratory failure with hypoxia carpal tunnel syndrome, unspecified upper limb acute on chronic diastolic (congestive) heart failure chronic kidney disease, unspecified headache iron deficiency anemia, unspecified gastro-esophageal reflux disease without esophagitis
black african american f 76 $nan$hematology blood hematocrit  23.4  %; hematology blood hematocrit  25.2  %; hematology blood hemoglobin  6.9  g dl; hematology blood hemoglobin  7.3  g dl; hematology blood platelet count  354  k ul; hematology blood platelet count  392  k ul; chemistry blood anion gap  12  meq l; chemistry blood bicarbonate  31  meq l; chemistry blood chloride  92  meq l; chemistry blood creatinine  1.8  mg dl; chemistry blood potassium  4.6  meq l; chemistry blood sodium  135  meq l; chemistry blood urea nitrogen  79  mg dl; chemistry blood calcium, total  9.6  mg dl; chemistry blood glucose  207  mg dl$acetaminophen  1000  mg ; anastrozole  1  mg ; aspirin  81  mg ; atorvastatin  80  mg ; bisacodyl  10  mg ; calcium carbonate  500  mg ; dorzolamide 2% timolol 0.5% ophth.  1  drop ; dextrose 50%  12.5  gm ; glucagon  1  mg ; glucose gel  15  g ; latanoprost 0.005% ophth. soln.  1  drop ; lidocaine 5% patch  1  ptch ; paroxetine  30  mg ; polyethylene glycol  17  g ; senna  17.2  mg ; sevelamer carbonate  800  mg ; alendronate sodium  70  mg ; sarna lotion  1  appl ; ramelteon  8  mg ; sodium chloride 0.9%  flush  10-20  ml ; sodium chloride nasal  1-2  spry ; hydroxyzine  25  mg ; vitamin d  1000  unit ; triamcinolone acetonide 0.025% ointment  1  appl ; torsemide  80  mg ; ipratropium-albuterol neb  1  neb ; fluticasone propionate nasal  2  spry ; insulin  42  unit ; insulin  15  unit ; insulin  20  unit ; insulin  50  unit ; 
acute on chronic diastolic (congestive) heart failure type 2 diabetes mellitus with diabetic polyneuropathy type 2 diabetes mellitus with hyperglycemia acute and chronic respiratory failure with hypoxia obstructive sleep apnea (adult) (pediatric) morbid (severe) obesity with alveolar hypoventilation other secondary pulmonary hypertension hypertensive heart and chronic kidney disease with heart failure and stage 1 through stage 4 chronic kidney disease, or unspecified chronic kidney disease fall resulting in striking against other object unspecified place in hospital as the place of occurrence of the external cause metabolic syndrome major depressive disorder, single episode, unspecified fatty (change of) liver, not elsewhere classified chronic kidney disease, unspecified gastro-esophageal reflux disease without esophagitis other chronic pain adverse effect of loop [high-ceiling] diuretics, initial encounter personal history of malignant neoplasm of breast unspecified open-angle glaucoma, stage unspecified age-related osteoporosis without current pathological fracture type 2 diabetes mellitus with diabetic chronic kidney disease other acute kidney failure patient's noncompliance with dietary regimen patient's other noncompliance with medication regimen body mass index (bmi) 39.0-39.9, adult long term (current) use of insulin dependence on supplemental oxygen hyperlipidemia, unspecified venous insufficiency (chronic) (peripheral) type 2 diabetes mellitus with diabetic polyneuropathy hypertensive heart and chronic kidney disease with heart failure and stage 1 through stage 4 chronic kidney disease, or unspecified chronic kidney disease personal history of malignant neoplasm of breast nausea other secondary pulmonary hypertension age-related osteoporosis without current pathological fracture unspecified rotator cuff tear or rupture of right shoulder, not specified as traumatic dependence on supplemental oxygen body mass index (bmi) 45.0-49.9, adult unspecified asthma, uncomplicated nonrheumatic tricuspid (valve) insufficiency portal vein thrombosis acute and chronic respiratory failure with hypoxia carpal tunnel syndrome, unspecified upper limb acute on chronic diastolic (congestive) heart failure chronic kidney disease, unspecified headache iron deficiency anemia, unspecified gastro-esophageal reflux disease without esophagitis
black african american f 76 $nan$chemistry blood anion gap  12  meq l; chemistry blood bicarbonate  31  meq l; chemistry blood chloride  93  meq l; chemistry blood creatinine  1.9  mg dl; chemistry blood potassium  5.1  meq l; chemistry blood sodium  136  meq l; chemistry blood urea nitrogen  79  mg dl; hematology blood inr(pt)  1.0  ; chemistry blood calcium, total  9.5  mg dl; chemistry blood bilirubin, total  0.2  mg dl; chemistry blood glucose  123  mg dl; chemistry blood albumin  3.5  g dl$acetaminophen  1000  mg ; anastrozole  1  mg ; aspirin  81  mg ; atorvastatin  80  mg ; bisacodyl  10  mg ; calcium carbonate  500  mg ; dorzolamide 2% timolol 0.5% ophth.  1  drop ; dextrose 50%  12.5  gm ; glucagon  1  mg ; glucose gel  15  g ; latanoprost 0.005% ophth. soln.  1  drop ; lidocaine 5% patch  1  ptch ; paroxetine  30  mg ; polyethylene glycol  17  g ; senna  17.2  mg ; sevelamer carbonate  800  mg ; alendronate sodium  70  mg ; sarna lotion  1  appl ; ramelteon  8  mg ; sodium chloride 0.9%  flush  10-20  ml ; sodium chloride nasal  1-2  spry ; hydroxyzine  25  mg ; vitamin d  1000  unit ; triamcinolone acetonide 0.025% ointment  1  appl ; torsemide  80  mg ; ipratropium-albuterol neb  1  neb ; fluticasone propionate nasal  2  spry ; insulin  15  unit ; insulin  20  unit ; insulin  50  unit ; insulin  17  unit ; 
acute on chronic diastolic (congestive) heart failure type 2 diabetes mellitus with diabetic polyneuropathy type 2 diabetes mellitus with hyperglycemia acute and chronic respiratory failure with hypoxia obstructive sleep apnea (adult) (pediatric) morbid (severe) obesity with alveolar hypoventilation other secondary pulmonary hypertension hypertensive heart and chronic kidney disease with heart failure and stage 1 through stage 4 chronic kidney disease, or unspecified chronic kidney disease fall resulting in striking against other object unspecified place in hospital as the place of occurrence of the external cause metabolic syndrome major depressive disorder, single episode, unspecified fatty (change of) liver, not elsewhere classified chronic kidney disease, unspecified gastro-esophageal reflux disease without esophagitis other chronic pain adverse effect of loop [high-ceiling] diuretics, initial encounter personal history of malignant neoplasm of breast unspecified open-angle glaucoma, stage unspecified age-related osteoporosis without current pathological fracture type 2 diabetes mellitus with diabetic chronic kidney disease other acute kidney failure patient's noncompliance with dietary regimen patient's other noncompliance with medication regimen body mass index (bmi) 39.0-39.9, adult long term (current) use of insulin dependence on supplemental oxygen hyperlipidemia, unspecified venous insufficiency (chronic) (peripheral) type 2 diabetes mellitus with diabetic polyneuropathy hypertensive heart and chronic kidney disease with heart failure and stage 1 through stage 4 chronic kidney disease, or unspecified chronic kidney disease personal history of malignant neoplasm of breast nausea other secondary pulmonary hypertension age-related osteoporosis without current pathological fracture unspecified rotator cuff tear or rupture of right shoulder, not specified as traumatic dependence on supplemental oxygen body mass index (bmi) 45.0-49.9, adult unspecified asthma, uncomplicated nonrheumatic tricuspid (valve) insufficiency portal vein thrombosis acute and chronic respiratory failure with hypoxia carpal tunnel syndrome, unspecified upper limb acute on chronic diastolic (congestive) heart failure chronic kidney disease, unspecified headache iron deficiency anemia, unspecified gastro-esophageal reflux disease without esophagitis
black african american f 76 $nan$hematology blood hematocrit  23.0  %; hematology blood hemoglobin  6.9  g dl; hematology blood platelet count  365  k ul; chemistry blood anion gap  13  meq l; chemistry blood bicarbonate  33  meq l; chemistry blood chloride  93  meq l; chemistry blood creatinine  2.2  mg dl; chemistry blood potassium  5.2  meq l; chemistry blood sodium  139  meq l; chemistry blood urea nitrogen  85  mg dl; chemistry blood calcium, total  9.5  mg dl; chemistry blood glucose  144  mg dl$acetaminophen  1000  mg ; anastrozole  1  mg ; aspirin  81  mg ; atorvastatin  80  mg ; bisacodyl  10  mg ; calcium carbonate  500  mg ; dorzolamide 2% timolol 0.5% ophth.  1  drop ; dextrose 50%  12.5  gm ; glucagon  1  mg ; glucose gel  15  g ; latanoprost 0.005% ophth. soln.  1  drop ; lidocaine 5% patch  1  ptch ; paroxetine  30  mg ; polyethylene glycol  17  g ; senna  17.2  mg ; sevelamer carbonate  800  mg ; alendronate sodium  70  mg ; sarna lotion  1  appl ; ramelteon  8  mg ; sodium chloride 0.9%  flush  10-20  ml ; sodium chloride nasal  1-2  spry ; hydroxyzine  25  mg ; vitamin d  1000  unit ; triamcinolone acetonide 0.025% ointment  1  appl ; torsemide  80  mg ; ipratropium-albuterol neb  1  neb ; fluticasone propionate nasal  2  spry ; insulin  17  unit ; insulin  24  unit ; 
acute on chronic diastolic (congestive) heart failure type 2 diabetes mellitus with diabetic polyneuropathy type 2 diabetes mellitus with hyperglycemia acute and chronic respiratory failure with hypoxia obstructive sleep apnea (adult) (pediatric) morbid (severe) obesity with alveolar hypoventilation other secondary pulmonary hypertension hypertensive heart and chronic kidney disease with heart failure and stage 1 through stage 4 chronic kidney disease, or unspecified chronic kidney disease fall resulting in striking against other object unspecified place in hospital as the place of occurrence of the external cause metabolic syndrome major depressive disorder, single episode, unspecified fatty (change of) liver, not elsewhere classified chronic kidney disease, unspecified gastro-esophageal reflux disease without esophagitis other chronic pain adverse effect of loop [high-ceiling] diuretics, initial encounter personal history of malignant neoplasm of breast unspecified open-angle glaucoma, stage unspecified age-related osteoporosis without current pathological fracture type 2 diabetes mellitus with diabetic chronic kidney disease other acute kidney failure patient's noncompliance with dietary regimen patient's other noncompliance with medication regimen body mass index (bmi) 39.0-39.9, adult long term (current) use of insulin dependence on supplemental oxygen hyperlipidemia, unspecified venous insufficiency (chronic) (peripheral) type 2 diabetes mellitus with diabetic polyneuropathy hypertensive heart and chronic kidney disease with heart failure and stage 1 through stage 4 chronic kidney disease, or unspecified chronic kidney disease personal history of malignant neoplasm of breast nausea other secondary pulmonary hypertension age-related osteoporosis without current pathological fracture unspecified rotator cuff tear or rupture of right shoulder, not specified as traumatic dependence on supplemental oxygen body mass index (bmi) 45.0-49.9, adult unspecified asthma, uncomplicated nonrheumatic tricuspid (valve) insufficiency portal vein thrombosis acute and chronic respiratory failure with hypoxia carpal tunnel syndrome, unspecified upper limb acute on chronic diastolic (congestive) heart failure chronic kidney disease, unspecified headache iron deficiency anemia, unspecified gastro-esophageal reflux disease without esophagitis
black african american f 76 $nan$hematology blood hematocrit  22.6  %; hematology blood hemoglobin  6.8  g dl; hematology blood platelet count  362  k ul; chemistry blood anion gap  16  meq l; chemistry blood bicarbonate  32  meq l; chemistry blood chloride  91  meq l; chemistry blood creatinine  2.3  mg dl; chemistry blood potassium  5.2  meq l; chemistry blood sodium  139  meq l; chemistry blood urea nitrogen  88  mg dl; chemistry blood calcium, total  9.3  mg dl; chemistry blood glucose  185  mg dl$acetaminophen  1000  mg ; anastrozole  1  mg ; aspirin  81  mg ; atorvastatin  80  mg ; bisacodyl  10  mg ; calcium carbonate  500  mg ; dorzolamide 2% timolol 0.5% ophth.  1  drop ; dextrose 50%  12.5  gm ; glucagon  1  mg ; glucose gel  15  g ; latanoprost 0.005% ophth. soln.  1  drop ; lidocaine 5% patch  1  ptch ; paroxetine  30  mg ; polyethylene glycol  17  g ; senna  17.2  mg ; sevelamer carbonate  800  mg ; alendronate sodium  70  mg ; sarna lotion  1  appl ; ramelteon  8  mg ; sodium chloride 0.9%  flush  10-20  ml ; sodium chloride nasal  1-2  spry ; hydroxyzine  25  mg ; vitamin d  1000  unit ; triamcinolone acetonide 0.025% ointment  1  appl ; torsemide  80  mg ; ipratropium-albuterol neb  1  neb ; fluticasone propionate nasal  2  spry ; insulin  24  unit ; insulin  19  unit ; insulin  30  unit ; insulin  60  unit ; 
acute on chronic diastolic (congestive) heart failure type 2 diabetes mellitus with diabetic polyneuropathy type 2 diabetes mellitus with hyperglycemia acute and chronic respiratory failure with hypoxia obstructive sleep apnea (adult) (pediatric) morbid (severe) obesity with alveolar hypoventilation other secondary pulmonary hypertension hypertensive heart and chronic kidney disease with heart failure and stage 1 through stage 4 chronic kidney disease, or unspecified chronic kidney disease fall resulting in striking against other object unspecified place in hospital as the place of occurrence of the external cause metabolic syndrome major depressive disorder, single episode, unspecified fatty (change of) liver, not elsewhere classified chronic kidney disease, unspecified gastro-esophageal reflux disease without esophagitis other chronic pain adverse effect of loop [high-ceiling] diuretics, initial encounter personal history of malignant neoplasm of breast unspecified open-angle glaucoma, stage unspecified age-related osteoporosis without current pathological fracture type 2 diabetes mellitus with diabetic chronic kidney disease other acute kidney failure patient's noncompliance with dietary regimen patient's other noncompliance with medication regimen body mass index (bmi) 39.0-39.9, adult long term (current) use of insulin dependence on supplemental oxygen hyperlipidemia, unspecified venous insufficiency (chronic) (peripheral) type 2 diabetes mellitus with diabetic polyneuropathy hypertensive heart and chronic kidney disease with heart failure and stage 1 through stage 4 chronic kidney disease, or unspecified chronic kidney disease personal history of malignant neoplasm of breast nausea other secondary pulmonary hypertension age-related osteoporosis without current pathological fracture unspecified rotator cuff tear or rupture of right shoulder, not specified as traumatic dependence on supplemental oxygen body mass index (bmi) 45.0-49.9, adult unspecified asthma, uncomplicated nonrheumatic tricuspid (valve) insufficiency portal vein thrombosis acute and chronic respiratory failure with hypoxia carpal tunnel syndrome, unspecified upper limb acute on chronic diastolic (congestive) heart failure chronic kidney disease, unspecified headache iron deficiency anemia, unspecified gastro-esophageal reflux disease without esophagitis
black african american f 76 $nan$hematology blood hematocrit  25.7  %; hematology blood hemoglobin  7.9  g dl; hematology blood platelet count  363  k ul; chemistry blood anion gap  13  meq l; chemistry blood bicarbonate  32  meq l; chemistry blood chloride  93  meq l; chemistry blood creatinine  2.3  mg dl; chemistry blood potassium  5.0  meq l; chemistry blood sodium  138  meq l; chemistry blood urea nitrogen  87  mg dl; chemistry blood calcium, total  9.0  mg dl; chemistry blood glucose  195  mg dl$acetaminophen  1000  mg ; anastrozole  1  mg ; aspirin  81  mg ; atorvastatin  80  mg ; bisacodyl  10  mg ; calcium carbonate  500  mg ; dorzolamide 2% timolol 0.5% ophth.  1  drop ; dextrose 50%  12.5  gm ; glucagon  1  mg ; glucose gel  15  g ; latanoprost 0.005% ophth. soln.  1  drop ; lidocaine 5% patch  1  ptch ; paroxetine  30  mg ; polyethylene glycol  17  g ; senna  17.2  mg ; sevelamer carbonate  800  mg ; alendronate sodium  70  mg ; sarna lotion  1  appl ; ramelteon  8  mg ; sodium chloride 0.9%  flush  10-20  ml ; sodium chloride nasal  1-2  spry ; hydroxyzine  25  mg ; vitamin d  1000  unit ; triamcinolone acetonide 0.025% ointment  1  appl ; torsemide  80  mg ; ipratropium-albuterol neb  1  neb ; fluticasone propionate nasal  2  spry ; insulin  30  unit ; insulin  60  unit ; insulin  100  unit ; 
acute on chronic diastolic (congestive) heart failure type 2 diabetes mellitus with diabetic polyneuropathy type 2 diabetes mellitus with hyperglycemia acute and chronic respiratory failure with hypoxia obstructive sleep apnea (adult) (pediatric) morbid (severe) obesity with alveolar hypoventilation other secondary pulmonary hypertension hypertensive heart and chronic kidney disease with heart failure and stage 1 through stage 4 chronic kidney disease, or unspecified chronic kidney disease fall resulting in striking against other object unspecified place in hospital as the place of occurrence of the external cause metabolic syndrome major depressive disorder, single episode, unspecified fatty (change of) liver, not elsewhere classified chronic kidney disease, unspecified gastro-esophageal reflux disease without esophagitis other chronic pain adverse effect of loop [high-ceiling] diuretics, initial encounter personal history of malignant neoplasm of breast unspecified open-angle glaucoma, stage unspecified age-related osteoporosis without current pathological fracture type 2 diabetes mellitus with diabetic chronic kidney disease other acute kidney failure patient's noncompliance with dietary regimen patient's other noncompliance with medication regimen body mass index (bmi) 39.0-39.9, adult long term (current) use of insulin dependence on supplemental oxygen hyperlipidemia, unspecified venous insufficiency (chronic) (peripheral) type 2 diabetes mellitus with diabetic polyneuropathy hypertensive heart and chronic kidney disease with heart failure and stage 1 through stage 4 chronic kidney disease, or unspecified chronic kidney disease personal history of malignant neoplasm of breast nausea other secondary pulmonary hypertension age-related osteoporosis without current pathological fracture unspecified rotator cuff tear or rupture of right shoulder, not specified as traumatic dependence on supplemental oxygen body mass index (bmi) 45.0-49.9, adult unspecified asthma, uncomplicated nonrheumatic tricuspid (valve) insufficiency portal vein thrombosis acute and chronic respiratory failure with hypoxia carpal tunnel syndrome, unspecified upper limb acute on chronic diastolic (congestive) heart failure chronic kidney disease, unspecified headache iron deficiency anemia, unspecified gastro-esophageal reflux disease without esophagitis
black african american f 76 $nan$nan$acetaminophen  1000  mg ; anastrozole  1  mg ; aspirin  81  mg ; atorvastatin  80  mg ; bisacodyl  10  mg ; calcium carbonate  500  mg ; dorzolamide 2% timolol 0.5% ophth.  1  drop ; dextrose 50%  12.5  gm ; glucagon  1  mg ; glucose gel  15  g ; latanoprost 0.005% ophth. soln.  1  drop ; lidocaine 5% patch  1  ptch ; paroxetine  30  mg ; polyethylene glycol  17  g ; senna  17.2  mg ; sevelamer carbonate  800  mg ; alendronate sodium  70  mg ; sarna lotion  1  appl ; ramelteon  8  mg ; sodium chloride 0.9%  flush  10-20  ml ; sodium chloride nasal  1-2  spry ; hydroxyzine  25  mg ; vitamin d  1000  unit ; triamcinolone acetonide 0.025% ointment  1  appl ; torsemide  80  mg ; ipratropium-albuterol neb  1  neb ; fluticasone propionate nasal  2  spry ; insulin  100  unit ; insulin  120  unit ; 
acute on chronic diastolic (congestive) heart failure type 2 diabetes mellitus with diabetic polyneuropathy type 2 diabetes mellitus with hyperglycemia acute and chronic respiratory failure with hypoxia obstructive sleep apnea (adult) (pediatric) morbid (severe) obesity with alveolar hypoventilation other secondary pulmonary hypertension hypertensive heart and chronic kidney disease with heart failure and stage 1 through stage 4 chronic kidney disease, or unspecified chronic kidney disease fall resulting in striking against other object unspecified place in hospital as the place of occurrence of the external cause metabolic syndrome major depressive disorder, single episode, unspecified fatty (change of) liver, not elsewhere classified chronic kidney disease, unspecified gastro-esophageal reflux disease without esophagitis other chronic pain adverse effect of loop [high-ceiling] diuretics, initial encounter personal history of malignant neoplasm of breast unspecified open-angle glaucoma, stage unspecified age-related osteoporosis without current pathological fracture type 2 diabetes mellitus with diabetic chronic kidney disease other acute kidney failure patient's noncompliance with dietary regimen patient's other noncompliance with medication regimen body mass index (bmi) 39.0-39.9, adult long term (current) use of insulin dependence on supplemental oxygen hyperlipidemia, unspecified venous insufficiency (chronic) (peripheral) type 2 diabetes mellitus with diabetic polyneuropathy hypertensive heart and chronic kidney disease with heart failure and stage 1 through stage 4 chronic kidney disease, or unspecified chronic kidney disease personal history of malignant neoplasm of breast nausea other secondary pulmonary hypertension age-related osteoporosis without current pathological fracture unspecified rotator cuff tear or rupture of right shoulder, not specified as traumatic dependence on supplemental oxygen body mass index (bmi) 45.0-49.9, adult unspecified asthma, uncomplicated nonrheumatic tricuspid (valve) insufficiency portal vein thrombosis acute and chronic respiratory failure with hypoxia carpal tunnel syndrome, unspecified upper limb acute on chronic diastolic (congestive) heart failure chronic kidney disease, unspecified headache iron deficiency anemia, unspecified gastro-esophageal reflux disease without esophagitis
black african american f 76 $nan$nan$acetaminophen  1000  mg ; anastrozole  1  mg ; aspirin  81  mg ; atorvastatin  80  mg ; bisacodyl  10  mg ; calcium carbonate  500  mg ; dorzolamide 2% timolol 0.5% ophth.  1  drop ; dextrose 50%  12.5  gm ; glucagon  1  mg ; glucose gel  15  g ; latanoprost 0.005% ophth. soln.  1  drop ; lidocaine 5% patch  1  ptch ; paroxetine  30  mg ; polyethylene glycol  17  g ; senna  17.2  mg ; sevelamer carbonate  800  mg ; alendronate sodium  70  mg ; sarna lotion  1  appl ; ramelteon  8  mg ; sodium chloride 0.9%  flush  10-20  ml ; sodium chloride nasal  1-2  spry ; hydroxyzine  25  mg ; vitamin d  1000  unit ; triamcinolone acetonide 0.025% ointment  1  appl ; torsemide  80  mg ; ipratropium-albuterol neb  1  neb ; fluticasone propionate nasal  2  spry ; insulin  100  unit ; insulin  120  unit ; 
acute on chronic diastolic (congestive) heart failure type 2 diabetes mellitus with diabetic polyneuropathy type 2 diabetes mellitus with hyperglycemia acute and chronic respiratory failure with hypoxia obstructive sleep apnea (adult) (pediatric) morbid (severe) obesity with alveolar hypoventilation other secondary pulmonary hypertension hypertensive heart and chronic kidney disease with heart failure and stage 1 through stage 4 chronic kidney disease, or unspecified chronic kidney disease fall resulting in striking against other object unspecified place in hospital as the place of occurrence of the external cause metabolic syndrome major depressive disorder, single episode, unspecified fatty (change of) liver, not elsewhere classified chronic kidney disease, unspecified gastro-esophageal reflux disease without esophagitis other chronic pain adverse effect of loop [high-ceiling] diuretics, initial encounter personal history of malignant neoplasm of breast unspecified open-angle glaucoma, stage unspecified age-related osteoporosis without current pathological fracture type 2 diabetes mellitus with diabetic chronic kidney disease other acute kidney failure patient's noncompliance with dietary regimen patient's other noncompliance with medication regimen body mass index (bmi) 39.0-39.9, adult long term (current) use of insulin dependence on supplemental oxygen hyperlipidemia, unspecified venous insufficiency (chronic) (peripheral) type 2 diabetes mellitus with diabetic polyneuropathy hypertensive heart and chronic kidney disease with heart failure and stage 1 through stage 4 chronic kidney disease, or unspecified chronic kidney disease personal history of malignant neoplasm of breast nausea other secondary pulmonary hypertension age-related osteoporosis without current pathological fracture unspecified rotator cuff tear or rupture of right shoulder, not specified as traumatic dependence on supplemental oxygen body mass index (bmi) 45.0-49.9, adult unspecified asthma, uncomplicated nonrheumatic tricuspid (valve) insufficiency portal vein thrombosis acute and chronic respiratory failure with hypoxia carpal tunnel syndrome, unspecified upper limb acute on chronic diastolic (congestive) heart failure chronic kidney disease, unspecified headache iron deficiency anemia, unspecified gastro-esophageal reflux disease without esophagitis
black african american f 76 $nan$nan$acetaminophen  1000  mg ; anastrozole  1  mg ; aspirin  81  mg ; atorvastatin  80  mg ; bisacodyl  10  mg ; calcium carbonate  500  mg ; dorzolamide 2% timolol 0.5% ophth.  1  drop ; dextrose 50%  12.5  gm ; glucagon  1  mg ; glucose gel  15  g ; latanoprost 0.005% ophth. soln.  1  drop ; lidocaine 5% patch  1  ptch ; paroxetine  30  mg ; polyethylene glycol  17  g ; senna  17.2  mg ; sevelamer carbonate  800  mg ; alendronate sodium  70  mg ; sarna lotion  1  appl ; ramelteon  8  mg ; sodium chloride 0.9%  flush  10-20  ml ; sodium chloride nasal  1-2  spry ; hydroxyzine  25  mg ; vitamin d  1000  unit ; triamcinolone acetonide 0.025% ointment  1  appl ; torsemide  80  mg ; ipratropium-albuterol neb  1  neb ; fluticasone propionate nasal  2  spry ; insulin  120  unit ; insulin  130  unit ; insulin  40  unit ; 
acute on chronic diastolic (congestive) heart failure type 2 diabetes mellitus with diabetic polyneuropathy type 2 diabetes mellitus with hyperglycemia acute and chronic respiratory failure with hypoxia obstructive sleep apnea (adult) (pediatric) morbid (severe) obesity with alveolar hypoventilation other secondary pulmonary hypertension hypertensive heart and chronic kidney disease with heart failure and stage 1 through stage 4 chronic kidney disease, or unspecified chronic kidney disease fall resulting in striking against other object unspecified place in hospital as the place of occurrence of the external cause metabolic syndrome major depressive disorder, single episode, unspecified fatty (change of) liver, not elsewhere classified chronic kidney disease, unspecified gastro-esophageal reflux disease without esophagitis other chronic pain adverse effect of loop [high-ceiling] diuretics, initial encounter personal history of malignant neoplasm of breast unspecified open-angle glaucoma, stage unspecified age-related osteoporosis without current pathological fracture type 2 diabetes mellitus with diabetic chronic kidney disease other acute kidney failure patient's noncompliance with dietary regimen patient's other noncompliance with medication regimen body mass index (bmi) 39.0-39.9, adult long term (current) use of insulin dependence on supplemental oxygen hyperlipidemia, unspecified venous insufficiency (chronic) (peripheral) type 2 diabetes mellitus with diabetic polyneuropathy hypertensive heart and chronic kidney disease with heart failure and stage 1 through stage 4 chronic kidney disease, or unspecified chronic kidney disease personal history of malignant neoplasm of breast nausea other secondary pulmonary hypertension age-related osteoporosis without current pathological fracture unspecified rotator cuff tear or rupture of right shoulder, not specified as traumatic dependence on supplemental oxygen body mass index (bmi) 45.0-49.9, adult unspecified asthma, uncomplicated nonrheumatic tricuspid (valve) insufficiency portal vein thrombosis acute and chronic respiratory failure with hypoxia carpal tunnel syndrome, unspecified upper limb acute on chronic diastolic (congestive) heart failure chronic kidney disease, unspecified headache iron deficiency anemia, unspecified gastro-esophageal reflux disease without esophagitis
black african american f 76 $nan$hematology blood hematocrit  26.9  %; hematology blood hemoglobin  8.1  g dl; hematology blood platelet count  385  k ul; chemistry blood anion gap  16  meq l; chemistry blood bicarbonate  29  meq l; chemistry blood chloride  93  meq l; chemistry blood creatinine  2.4  mg dl; chemistry blood potassium  5.2  meq l; chemistry blood sodium  138  meq l; chemistry blood urea nitrogen  94  mg dl; chemistry blood calcium, total  9.6  mg dl; chemistry blood glucose  115  mg dl$acetaminophen  1000  mg ; anastrozole  1  mg ; aspirin  81  mg ; atorvastatin  80  mg ; bisacodyl  10  mg ; calcium carbonate  500  mg ; dorzolamide 2% timolol 0.5% ophth.  1  drop ; dextrose 50%  12.5  gm ; glucagon  1  mg ; glucose gel  15  g ; latanoprost 0.005% ophth. soln.  1  drop ; lidocaine 5% patch  1  ptch ; paroxetine  30  mg ; polyethylene glycol  17  g ; senna  17.2  mg ; sevelamer carbonate  800  mg ; alendronate sodium  70  mg ; sarna lotion  1  appl ; ramelteon  8  mg ; sodium chloride 0.9%  flush  10-20  ml ; sodium chloride nasal  1-2  spry ; hydroxyzine  25  mg ; vitamin d  1000  unit ; triamcinolone acetonide 0.025% ointment  1  appl ; torsemide  80  mg ; ipratropium-albuterol neb  1  neb ; fluticasone propionate nasal  2  spry ; insulin  130  unit ; insulin  40  unit ; torsemide  60  mg ; 
acute on chronic diastolic (congestive) heart failure type 2 diabetes mellitus with diabetic polyneuropathy type 2 diabetes mellitus with hyperglycemia acute and chronic respiratory failure with hypoxia obstructive sleep apnea (adult) (pediatric) morbid (severe) obesity with alveolar hypoventilation other secondary pulmonary hypertension hypertensive heart and chronic kidney disease with heart failure and stage 1 through stage 4 chronic kidney disease, or unspecified chronic kidney disease fall resulting in striking against other object unspecified place in hospital as the place of occurrence of the external cause metabolic syndrome major depressive disorder, single episode, unspecified fatty (change of) liver, not elsewhere classified chronic kidney disease, unspecified gastro-esophageal reflux disease without esophagitis other chronic pain adverse effect of loop [high-ceiling] diuretics, initial encounter personal history of malignant neoplasm of breast unspecified open-angle glaucoma, stage unspecified age-related osteoporosis without current pathological fracture type 2 diabetes mellitus with diabetic chronic kidney disease other acute kidney failure patient's noncompliance with dietary regimen patient's other noncompliance with medication regimen body mass index (bmi) 39.0-39.9, adult long term (current) use of insulin dependence on supplemental oxygen hyperlipidemia, unspecified venous insufficiency (chronic) (peripheral) type 2 diabetes mellitus with diabetic polyneuropathy hypertensive heart and chronic kidney disease with heart failure and stage 1 through stage 4 chronic kidney disease, or unspecified chronic kidney disease personal history of malignant neoplasm of breast nausea other secondary pulmonary hypertension age-related osteoporosis without current pathological fracture unspecified rotator cuff tear or rupture of right shoulder, not specified as traumatic dependence on supplemental oxygen body mass index (bmi) 45.0-49.9, adult unspecified asthma, uncomplicated nonrheumatic tricuspid (valve) insufficiency portal vein thrombosis acute and chronic respiratory failure with hypoxia carpal tunnel syndrome, unspecified upper limb acute on chronic diastolic (congestive) heart failure chronic kidney disease, unspecified headache iron deficiency anemia, unspecified gastro-esophageal reflux disease without esophagitis
black african american f 76 $nan$hematology blood hematocrit  26.3  %; hematology blood hemoglobin  7.8  g dl; hematology blood platelet count  360  k ul; chemistry blood anion gap  16  meq l; chemistry blood bicarbonate  28  meq l; chemistry blood chloride  92  meq l; chemistry blood creatinine  2.5  mg dl; chemistry blood potassium  5.1  meq l; chemistry blood sodium  136  meq l; chemistry blood urea nitrogen  97  mg dl; chemistry blood calcium, total  9.2  mg dl; chemistry blood glucose  113  mg dl$acetaminophen  1000  mg ; anastrozole  1  mg ; aspirin  81  mg ; atorvastatin  80  mg ; bisacodyl  10  mg ; calcium carbonate  500  mg ; dorzolamide 2% timolol 0.5% ophth.  1  drop ; dextrose 50%  12.5  gm ; glucagon  1  mg ; glucose gel  15  g ; latanoprost 0.005% ophth. soln.  1  drop ; lidocaine 5% patch  1  ptch ; paroxetine  30  mg ; polyethylene glycol  17  g ; senna  17.2  mg ; sevelamer carbonate  800  mg ; alendronate sodium  70  mg ; sarna lotion  1  appl ; ramelteon  8  mg ; sodium chloride 0.9%  flush  10-20  ml ; sodium chloride nasal  1-2  spry ; hydroxyzine  25  mg ; vitamin d  1000  unit ; triamcinolone acetonide 0.025% ointment  1  appl ; ipratropium-albuterol neb  1  neb ; fluticasone propionate nasal  2  spry ; insulin  130  unit ; insulin  40  unit ; torsemide  60  mg ; 
acute on chronic diastolic (congestive) heart failure type 2 diabetes mellitus with diabetic polyneuropathy type 2 diabetes mellitus with hyperglycemia acute and chronic respiratory failure with hypoxia obstructive sleep apnea (adult) (pediatric) morbid (severe) obesity with alveolar hypoventilation other secondary pulmonary hypertension hypertensive heart and chronic kidney disease with heart failure and stage 1 through stage 4 chronic kidney disease, or unspecified chronic kidney disease fall resulting in striking against other object unspecified place in hospital as the place of occurrence of the external cause metabolic syndrome major depressive disorder, single episode, unspecified fatty (change of) liver, not elsewhere classified chronic kidney disease, unspecified gastro-esophageal reflux disease without esophagitis other chronic pain adverse effect of loop [high-ceiling] diuretics, initial encounter personal history of malignant neoplasm of breast unspecified open-angle glaucoma, stage unspecified age-related osteoporosis without current pathological fracture type 2 diabetes mellitus with diabetic chronic kidney disease other acute kidney failure patient's noncompliance with dietary regimen patient's other noncompliance with medication regimen body mass index (bmi) 39.0-39.9, adult long term (current) use of insulin dependence on supplemental oxygen hyperlipidemia, unspecified venous insufficiency (chronic) (peripheral) type 2 diabetes mellitus with diabetic polyneuropathy hypertensive heart and chronic kidney disease with heart failure and stage 1 through stage 4 chronic kidney disease, or unspecified chronic kidney disease personal history of malignant neoplasm of breast nausea other secondary pulmonary hypertension age-related osteoporosis without current pathological fracture unspecified rotator cuff tear or rupture of right shoulder, not specified as traumatic dependence on supplemental oxygen body mass index (bmi) 45.0-49.9, adult unspecified asthma, uncomplicated nonrheumatic tricuspid (valve) insufficiency portal vein thrombosis acute and chronic respiratory failure with hypoxia carpal tunnel syndrome, unspecified upper limb acute on chronic diastolic (congestive) heart failure chronic kidney disease, unspecified headache iron deficiency anemia, unspecified gastro-esophageal reflux disease without esophagitis
black african american f 76 $nan$hematology blood hematocrit  25.6  %; hematology blood hemoglobin  7.7  g dl; hematology blood platelet count  349  k ul; chemistry blood anion gap  16  meq l; chemistry blood bicarbonate  28  meq l; chemistry blood chloride  95  meq l; chemistry blood creatinine  2.6  mg dl; chemistry blood potassium  5.1  meq l; chemistry blood sodium  139  meq l; chemistry blood urea nitrogen  102  mg dl; chemistry blood calcium, total  9.0  mg dl; chemistry blood glucose  107  mg dl$acetaminophen  1000  mg ; anastrozole  1  mg ; aspirin  81  mg ; atorvastatin  80  mg ; bisacodyl  10  mg ; calcium carbonate  500  mg ; dorzolamide 2% timolol 0.5% ophth.  1  drop ; dextrose 50%  12.5  gm ; glucagon  1  mg ; glucose gel  15  g ; latanoprost 0.005% ophth. soln.  1  drop ; lidocaine 5% patch  1  ptch ; paroxetine  30  mg ; polyethylene glycol  17  g ; senna  17.2  mg ; sevelamer carbonate  800  mg ; alendronate sodium  70  mg ; sarna lotion  1  appl ; ramelteon  8  mg ; sodium chloride 0.9%  flush  10-20  ml ; sodium chloride nasal  1-2  spry ; hydroxyzine  25  mg ; vitamin d  1000  unit ; triamcinolone acetonide 0.025% ointment  1  appl ; ipratropium-albuterol neb  1  neb ; fluticasone propionate nasal  2  spry ; insulin  130  unit ; insulin  40  unit ; torsemide  60  mg ; 
acute on chronic diastolic (congestive) heart failure type 2 diabetes mellitus with diabetic polyneuropathy type 2 diabetes mellitus with hyperglycemia acute and chronic respiratory failure with hypoxia obstructive sleep apnea (adult) (pediatric) morbid (severe) obesity with alveolar hypoventilation other secondary pulmonary hypertension hypertensive heart and chronic kidney disease with heart failure and stage 1 through stage 4 chronic kidney disease, or unspecified chronic kidney disease fall resulting in striking against other object unspecified place in hospital as the place of occurrence of the external cause metabolic syndrome major depressive disorder, single episode, unspecified fatty (change of) liver, not elsewhere classified chronic kidney disease, unspecified gastro-esophageal reflux disease without esophagitis other chronic pain adverse effect of loop [high-ceiling] diuretics, initial encounter personal history of malignant neoplasm of breast unspecified open-angle glaucoma, stage unspecified age-related osteoporosis without current pathological fracture type 2 diabetes mellitus with diabetic chronic kidney disease other acute kidney failure patient's noncompliance with dietary regimen patient's other noncompliance with medication regimen body mass index (bmi) 39.0-39.9, adult long term (current) use of insulin dependence on supplemental oxygen hyperlipidemia, unspecified venous insufficiency (chronic) (peripheral) type 2 diabetes mellitus with diabetic polyneuropathy hypertensive heart and chronic kidney disease with heart failure and stage 1 through stage 4 chronic kidney disease, or unspecified chronic kidney disease personal history of malignant neoplasm of breast nausea other secondary pulmonary hypertension age-related osteoporosis without current pathological fracture unspecified rotator cuff tear or rupture of right shoulder, not specified as traumatic dependence on supplemental oxygen body mass index (bmi) 45.0-49.9, adult unspecified asthma, uncomplicated nonrheumatic tricuspid (valve) insufficiency portal vein thrombosis acute and chronic respiratory failure with hypoxia carpal tunnel syndrome, unspecified upper limb acute on chronic diastolic (congestive) heart failure chronic kidney disease, unspecified headache iron deficiency anemia, unspecified gastro-esophageal reflux disease without esophagitis
black african american f 76 $nan$hematology blood hematocrit  26.0  %; hematology blood hemoglobin  7.8  g dl; hematology blood platelet count  367  k ul; chemistry blood anion gap  17  meq l; chemistry blood bicarbonate  29  meq l; chemistry blood chloride  93  meq l; chemistry blood creatinine  2.3  mg dl; chemistry blood potassium  4.8  meq l; chemistry blood sodium  139  meq l; chemistry blood urea nitrogen  96  mg dl; chemistry blood calcium, total  9.0  mg dl; chemistry blood glucose  63  mg dl$acetaminophen  1000  mg ; anastrozole  1  mg ; aspirin  81  mg ; atorvastatin  80  mg ; bisacodyl  10  mg ; calcium carbonate  500  mg ; dorzolamide 2% timolol 0.5% ophth.  1  drop ; dextrose 50%  12.5  gm ; glucagon  1  mg ; glucose gel  15  g ; latanoprost 0.005% ophth. soln.  1  drop ; lidocaine 5% patch  1  ptch ; paroxetine  30  mg ; polyethylene glycol  17  g ; senna  17.2  mg ; sevelamer carbonate  800  mg ; alendronate sodium  70  mg ; sarna lotion  1  appl ; ramelteon  8  mg ; sodium chloride 0.9%  flush  10-20  ml ; sodium chloride nasal  1-2  spry ; hydroxyzine  25  mg ; vitamin d  1000  unit ; triamcinolone acetonide 0.025% ointment  1  appl ; ipratropium-albuterol neb  1  neb ; fluticasone propionate nasal  2  spry ; insulin  130  unit ; insulin  40  unit ; insulin  32  unit ; 
acute on chronic diastolic (congestive) heart failure type 2 diabetes mellitus with diabetic polyneuropathy type 2 diabetes mellitus with hyperglycemia acute and chronic respiratory failure with hypoxia obstructive sleep apnea (adult) (pediatric) morbid (severe) obesity with alveolar hypoventilation other secondary pulmonary hypertension hypertensive heart and chronic kidney disease with heart failure and stage 1 through stage 4 chronic kidney disease, or unspecified chronic kidney disease fall resulting in striking against other object unspecified place in hospital as the place of occurrence of the external cause metabolic syndrome major depressive disorder, single episode, unspecified fatty (change of) liver, not elsewhere classified chronic kidney disease, unspecified gastro-esophageal reflux disease without esophagitis other chronic pain adverse effect of loop [high-ceiling] diuretics, initial encounter personal history of malignant neoplasm of breast unspecified open-angle glaucoma, stage unspecified age-related osteoporosis without current pathological fracture type 2 diabetes mellitus with diabetic chronic kidney disease other acute kidney failure patient's noncompliance with dietary regimen patient's other noncompliance with medication regimen body mass index (bmi) 39.0-39.9, adult long term (current) use of insulin dependence on supplemental oxygen hyperlipidemia, unspecified venous insufficiency (chronic) (peripheral) type 2 diabetes mellitus with diabetic polyneuropathy hypertensive heart and chronic kidney disease with heart failure and stage 1 through stage 4 chronic kidney disease, or unspecified chronic kidney disease personal history of malignant neoplasm of breast nausea other secondary pulmonary hypertension age-related osteoporosis without current pathological fracture unspecified rotator cuff tear or rupture of right shoulder, not specified as traumatic dependence on supplemental oxygen body mass index (bmi) 45.0-49.9, adult unspecified asthma, uncomplicated nonrheumatic tricuspid (valve) insufficiency portal vein thrombosis acute and chronic respiratory failure with hypoxia carpal tunnel syndrome, unspecified upper limb acute on chronic diastolic (congestive) heart failure chronic kidney disease, unspecified headache iron deficiency anemia, unspecified gastro-esophageal reflux disease without esophagitis
unknown f 56 $nan$nan$sodium chloride 0.9%  flush  3  ml ; docusate sodium  100  mg ; heparin  5000  unit ; hydrocerin  1  appl ; acetaminophen  1000  mg ; oxycodone (immediate release)   5  mg ; 0.9% sodium chloride  1000  ml ; readi-cat 2 (barium sulfate 2% suspension)  900  ml ; 

unknown f 56 $nan$nan$sodium chloride 0.9%  flush  3  ml ; hydrocerin  1  appl ; acetaminophen  1000  mg ; oxycodone (immediate release)   5  mg ; readi-cat 2 (barium sulfate 2% suspension)  900  ml ; acetylcysteine 20%  600  mg ; senna  1  tab ; vitamin d  50,000  unit ; 

unknown f 56 $nan$nan$sodium chloride 0.9%  flush  3  ml ; hydrocerin  1  appl ; acetaminophen  1000  mg ; oxycodone (immediate release)   5  mg ; acetylcysteine 20%  600  mg ; senna  1  tab ; vitamin d  50,000  unit ; 

unknown f 56 $nan$nan$sodium chloride 0.9%  flush  3  ml ; hydrocerin  1  appl ; acetaminophen  1000  mg ; oxycodone (immediate release)   5  mg ; acetylcysteine 20%  600  mg ; senna  1  tab ; vitamin d  50,000  unit ; bisacodyl  10  mg ; neutra-phos  2  pkt ; polyethylene glycol  17  g ; 

unknown f 56 $nan$nan$sodium chloride 0.9%  flush  3  ml ; hydrocerin  1  appl ; acetaminophen  1000  mg ; oxycodone (immediate release)   5  mg ; senna  1  tab ; bisacodyl  10  mg ; neutra-phos  2  pkt ; polyethylene glycol  17  g ; furosemide  10  mg ; 

unknown f 56 $nan$nan$sodium chloride 0.9%  flush  3  ml ; hydrocerin  1  appl ; acetaminophen  1000  mg ; oxycodone (immediate release)   5  mg ; senna  1  tab ; bisacodyl  10  mg ; polyethylene glycol  17  g ; furosemide  10  mg ; miconazole powder 2%  1  appl ; 

unknown f 56 $nan$nan$sodium chloride 0.9%  flush  3  ml ; hydrocerin  1  appl ; acetaminophen  1000  mg ; oxycodone (immediate release)   5  mg ; senna  1  tab ; bisacodyl  10  mg ; polyethylene glycol  17  g ; miconazole powder 2%  1  appl ; 

unknown f 56 $nan$nan$sodium chloride 0.9%  flush  3  ml ; hydrocerin  1  appl ; acetaminophen  1000  mg ; oxycodone (immediate release)   5  mg ; senna  1  tab ; bisacodyl  10  mg ; polyethylene glycol  17  g ; miconazole powder 2%  1  appl ; 

white f 41 $nan$nan$sodium chloride 0.9%  flush  3  ml ; clonazepam  1  mg ; zolpidem tartrate  10  mg ; oxycodone-acetaminophen elixir  5  ml ; oxycodone-acetaminophen elixir  5-10  ml ; senna  1  tab ; levetiracetam  500  mg ; heparin  5000  unit ; docusate sodium  100  mg ; folic acid  1  mg ; lisinopril  2.5  mg ; metoprolol succinate xl  12.5  mg ; omeprazole  40  mg ; venlafaxine xr  300  mg ; ascorbic acid  500  mg ; calcium carbonate  500  mg ; vitamin d  1000  unit ; ferrous sulfate  325  mg ; thiamine  100  mg ; 0.9% sodium chloride  500  ml ; 0.9% sodium chloride  1000  ml ; tuberculin protein  0.1  ml ; 
calculus of gallbladder without mention of cholecystitis, without mention of obstruction internal hemorrhoids with other complication loss of weight unspecified essential hypertension other and unspecified postsurgical nonabsorption other protein-calorie malnutrition congestive heart failure, unspecified universal ulcerative (chronic) colitis iron deficiency anemia, unspecified other chronic pulmonary heart diseases scoliosis [and kyphoscoliosis], idiopathic precordial pain spondylosis of unspecified site, without mention of myelopathy other specified cardiac dysrhythmias bariatric surgery status other disorders of plasma protein metabolism myalgia and myositis, unspecified cyst and pseudocyst of pancreas depressive disorder, not elsewhere classified acute combined systolic and diastolic heart failure anorexia hepatitis, unspecified epilepsy, unspecified, without mention of intractable epilepsy other iatrogenic hypotension other antihypertensive agents causing adverse effects in therapeutic use unspecified disease of pericardium dehydration 
white f 41 $nan$hematology blood hematocrit  32.5  %; hematology blood hemoglobin  10.7  g dl; hematology blood platelet count  426  k ul; chemistry blood anion gap  9  meq l; chemistry blood bicarbonate  27  meq l; chemistry blood chloride  110  meq l; chemistry blood creatinine  0.6  mg dl; chemistry blood potassium  4.2  meq l; chemistry blood sodium  142  meq l; chemistry blood urea nitrogen  10  mg dl; chemistry blood calcium, total  8.1  mg dl; chemistry blood glucose  71  mg dl$sodium chloride 0.9%  flush  3  ml ; clonazepam  1  mg ; zolpidem tartrate  10  mg ; senna  1  tab ; levetiracetam  500  mg ; heparin  5000  unit ; docusate sodium  100  mg ; folic acid  1  mg ; omeprazole  40  mg ; venlafaxine xr  300  mg ; ascorbic acid  500  mg ; calcium carbonate  500  mg ; vitamin d  1000  unit ; ferrous sulfate  325  mg ; thiamine  100  mg ; 0.9% sodium chloride  500  ml ; 0.9% sodium chloride  1000  ml ; tuberculin protein  0.1  ml ; topiramate (topamax)  100  mg ; 
calculus of gallbladder without mention of cholecystitis, without mention of obstruction internal hemorrhoids with other complication loss of weight unspecified essential hypertension other and unspecified postsurgical nonabsorption other protein-calorie malnutrition congestive heart failure, unspecified universal ulcerative (chronic) colitis iron deficiency anemia, unspecified other chronic pulmonary heart diseases scoliosis [and kyphoscoliosis], idiopathic precordial pain spondylosis of unspecified site, without mention of myelopathy other specified cardiac dysrhythmias bariatric surgery status other disorders of plasma protein metabolism myalgia and myositis, unspecified cyst and pseudocyst of pancreas depressive disorder, not elsewhere classified acute combined systolic and diastolic heart failure anorexia hepatitis, unspecified epilepsy, unspecified, without mention of intractable epilepsy other iatrogenic hypotension other antihypertensive agents causing adverse effects in therapeutic use unspecified disease of pericardium dehydration 
white f 41 $nan$nan$sodium chloride 0.9%  flush  3  ml ; clonazepam  1  mg ; zolpidem tartrate  10  mg ; senna  1  tab ; levetiracetam  500  mg ; heparin  5000  unit ; docusate sodium  100  mg ; folic acid  1  mg ; omeprazole  40  mg ; venlafaxine xr  300  mg ; ascorbic acid  500  mg ; calcium carbonate  500  mg ; vitamin d  1000  unit ; ferrous sulfate  325  mg ; thiamine  100  mg ; topiramate (topamax)  100  mg ; 
calculus of gallbladder without mention of cholecystitis, without mention of obstruction internal hemorrhoids with other complication loss of weight unspecified essential hypertension other and unspecified postsurgical nonabsorption other protein-calorie malnutrition congestive heart failure, unspecified universal ulcerative (chronic) colitis iron deficiency anemia, unspecified other chronic pulmonary heart diseases scoliosis [and kyphoscoliosis], idiopathic precordial pain spondylosis of unspecified site, without mention of myelopathy other specified cardiac dysrhythmias bariatric surgery status other disorders of plasma protein metabolism myalgia and myositis, unspecified cyst and pseudocyst of pancreas depressive disorder, not elsewhere classified acute combined systolic and diastolic heart failure anorexia hepatitis, unspecified epilepsy, unspecified, without mention of intractable epilepsy other iatrogenic hypotension other antihypertensive agents causing adverse effects in therapeutic use unspecified disease of pericardium dehydration 
white m 52 $nan$hematology urine wbc  11-20  # hpf; hematology urine glucose  neg  mg dl; hematology urine bilirubin  neg  mg dl$0.9% sodium chloride  100  ml ; levetiracetam  1000  mg ; 0.9% sodium chloride  1000  ml ; influenza virus vaccine  0.5  ml ; sodium chloride 0.9%  flush  3  ml ; d5ns  1000  ml ; albuterol 0.083% neb soln  1  neb ; iso-osmotic sodium chloride  50  ml ; famotidine  20  mg ; acetaminophen  650  mg ; bisacodyl  10  mg ; hydromorphone (dilaudid)  0.25  mg ; miconazole powder 2%  1  appl ; heparin  5000  unit ; acetylcysteine 20%  1-10  ml ; acetylcysteine 20%  5  ml ; 
intracerebral hemorrhage pneumonia, organism unspecified personal history of methicillin resistant staphylococcus aureus other specified surgical operations and procedures causing abnormal patient reaction, or later complication, without mention of misadventure at time of operation pneumonitis due to inhalation of food or vomitus obstructive hydrocephalus other nervous system complications personal history of malignant neoplasm of brain other symptoms involving digestive system other specified acquired deformity of head fitting and adjustment, other device mechanical complication due to other implant and internal device, not elsewhere classified surgical operation with implant of artificial internal device causing abnormal patient reaction, or later complication,without mention of misadventure at time of operation other specified acquired deformity of head retention of urine, unspecified other postprocedural status personal history of malignant neoplasm of brain other specified acquired deformity of head
white m 52 $nan$hematology blood hematocrit  32.2  %; hematology blood hemoglobin  10.4  g dl; hematology blood platelet count  511  k ul; chemistry blood anion gap  12  meq l; chemistry blood bicarbonate  26  meq l; chemistry blood chloride  106  meq l; chemistry blood creatinine  0.4  mg dl; chemistry blood potassium  4.0  meq l; chemistry blood sodium  140  meq l; chemistry blood urea nitrogen  7  mg dl; chemistry blood calcium, total  8.5  mg dl; chemistry blood glucose  113  mg dl$influenza virus vaccine  0.5  ml ; sodium chloride 0.9%  flush  3  ml ; albuterol 0.083% neb soln  1  neb ; iso-osmotic sodium chloride  50  ml ; famotidine  20  mg ; acetaminophen  650  mg ; bisacodyl  10  mg ; hydromorphone (dilaudid)  0.25  mg ; miconazole powder 2%  1  appl ; heparin  5000  unit ; acetylcysteine 20%  5  ml ; hydromorphone (dilaudid)  2  mg ; ranitidine  150  mg ; 
intracerebral hemorrhage pneumonia, organism unspecified personal history of methicillin resistant staphylococcus aureus other specified surgical operations and procedures causing abnormal patient reaction, or later complication, without mention of misadventure at time of operation pneumonitis due to inhalation of food or vomitus obstructive hydrocephalus other nervous system complications personal history of malignant neoplasm of brain other symptoms involving digestive system other specified acquired deformity of head fitting and adjustment, other device mechanical complication due to other implant and internal device, not elsewhere classified surgical operation with implant of artificial internal device causing abnormal patient reaction, or later complication,without mention of misadventure at time of operation other specified acquired deformity of head retention of urine, unspecified other postprocedural status personal history of malignant neoplasm of brain other specified acquired deformity of head
white m 52 $nan$nan$influenza virus vaccine  0.5  ml ; sodium chloride 0.9%  flush  3  ml ; albuterol 0.083% neb soln  1  neb ; bisacodyl  10  mg ; miconazole powder 2%  1  appl ; heparin  5000  unit ; acetylcysteine 20%  5  ml ; hydromorphone (dilaudid)  2  mg ; ranitidine  150  mg ; 
intracerebral hemorrhage pneumonia, organism unspecified personal history of methicillin resistant staphylococcus aureus other specified surgical operations and procedures causing abnormal patient reaction, or later complication, without mention of misadventure at time of operation pneumonitis due to inhalation of food or vomitus obstructive hydrocephalus other nervous system complications personal history of malignant neoplasm of brain other symptoms involving digestive system other specified acquired deformity of head fitting and adjustment, other device mechanical complication due to other implant and internal device, not elsewhere classified surgical operation with implant of artificial internal device causing abnormal patient reaction, or later complication,without mention of misadventure at time of operation other specified acquired deformity of head retention of urine, unspecified other postprocedural status personal history of malignant neoplasm of brain other specified acquired deformity of head
white f 76 $nan$hematology blood hematocrit  33.4  %; hematology blood hematocrit  33.7  %; hematology blood hematocrit  31.0  %; hematology blood hemoglobin  11.2  g dl; hematology blood hemoglobin  10.8  g dl; hematology blood hemoglobin  10.1  g dl; hematology blood platelet count  238  k ul; hematology blood platelet count  288  k ul; hematology blood platelet count  248  k ul; chemistry blood anion gap  16  meq l; chemistry blood anion gap  17  meq l; chemistry blood anion gap  20  meq l; chemistry blood bicarbonate  24  meq l; chemistry blood bicarbonate  21  meq l; chemistry blood bicarbonate  21  meq l; chemistry blood chloride  97  meq l; chemistry blood chloride  99  meq l; chemistry blood chloride  99  meq l; chemistry blood creatinine  1.1  mg dl; chemistry blood creatinine  1.2  mg dl; chemistry blood creatinine  1.0  mg dl; chemistry blood potassium  3.4  meq l; chemistry blood potassium  4.8  meq l; chemistry blood potassium  4.5  meq l; chemistry blood sodium  134  meq l; chemistry blood sodium  132  meq l; chemistry blood sodium  135  meq l; chemistry blood urea nitrogen  49  mg dl; chemistry blood urea nitrogen  48  mg dl; chemistry blood urea nitrogen  45  mg dl; hematology blood inr(pt)  1.3  ; hematology blood inr(pt)  1.3  ; hematology blood inr(pt)  1.4  ; hematology urine wbc  3  # hpf; chemistry blood calcium, total  7.9  mg dl; chemistry blood calcium, total  7.9  mg dl; chemistry blood calcium, total  7.6  mg dl; chemistry blood bilirubin, total  0.7  mg dl; chemistry blood bilirubin, total  0.5  mg dl; chemistry blood glucose  315  mg dl; chemistry blood glucose  200  mg dl; chemistry blood glucose  403  mg dl; chemistry blood lactate dehydrogenase (ld)  557  iu l; chemistry blood lactate dehydrogenase (ld)  573  iu l; chemistry blood albumin  3.7  g dl; blood gas blood free calcium  1.07  mmol l; blood gas blood lactate  2.2  mmol l; blood gas blood lactate  1.9  mmol l; blood gas blood lactate  3.1  mmol l; blood gas blood lactate  2.0  mmol l; blood gas blood lactate  1.5  mmol l; blood gas blood lactate  1.5  mmol l; blood gas blood chloride, whole blood  98  meq l; blood gas blood potassium, whole blood  3.0  meq l; blood gas blood sodium, whole blood  131  meq l; blood gas blood calculated bicarbonate, whole blood  24  meq l$sodium chloride 0.9%  flush  10  ml ; 0.9% sodium chloride  250  ml ; norepinephrine  8  mg ; docusate sodium  100  mg ; 5% dextrose (excel bag)  500  ml ; amiodarone  600  mg ; soln  50  ml ; fentanyl citrate  2.5  mg ; midazolam  0.5-2  mg ; heparin  1200  unit ; 5% dextrose  250  ml ; heparin sodium  25,000  unit ; bag  1  bag ; magnesium sulfate  2  gm ; bag  2  bag ; magnesium sulfate  4  gm ; 0.9% sodium chloride  1  bag ; calcium gluconate  2  g ; 0.9% sodium chloride  2  bag ; calcium gluconate  4  g ; sterile water  50  ml ; potassium chloride  20  meq ; sterile water  100  ml ; potassium chloride  40  meq ; sterile water  150  ml ; potassium chloride  60  meq ; vial  1  vial ; pantoprazole  40  mg ; chlorhexidine gluconate 0.12% oral rinse  15  ml ; ipratropium bromide mdi  2  puff ; iso-osmotic dextrose  200  ml ; vancomycin  1000  mg ; 0.9% sodium chloride (mini bag plus)  100  ml ; cefepime  2  g ; 5% dextrose  100  ml ; vasopressin  40  unit ; albuterol inhaler  6  puff ; insulin  0  unit ; dextrose 50%  12.5  gm ; glucagon  1  mg ; glucose gel  15  g ; ipratropium bromide mdi  6  puff ; aspirin  81  mg ; 0.9% sodium chloride  100  ml ; midazolam  100  mg ; iso-osmotic dextrose  100  ml ; piperacillin-tazobactam  4.5  g ; 
 
white f 76 $nan$hematology blood hematocrit  29.1  %; hematology blood hematocrit  27.0  %; hematology blood hemoglobin  9.3  g dl; hematology blood hemoglobin  8.7  g dl; hematology blood platelet count  232  k ul; hematology blood platelet count  203  k ul; chemistry blood anion gap  20  meq l; chemistry blood anion gap  23  meq l; chemistry blood bicarbonate  17  meq l; chemistry blood bicarbonate  20  meq l; chemistry blood chloride  102  meq l; chemistry blood chloride  104  meq l; chemistry blood creatinine  1.3  mg dl; chemistry blood creatinine  1.4  mg dl; chemistry blood potassium  4.8  meq l; chemistry blood potassium  5.3  meq l; chemistry blood sodium  134  meq l; chemistry blood sodium  142  meq l; chemistry blood urea nitrogen  31  mg dl; chemistry blood urea nitrogen  30  mg dl; hematology blood inr(pt)  1.4  ; hematology blood inr(pt)  1.7  ; hematology blood inr(pt)  1.9  ; hematology urine wbc  21  # hpf; chemistry blood calcium, total  7.1  mg dl; chemistry blood calcium, total  6.7  mg dl; chemistry blood bilirubin, total  0.6  mg dl; chemistry blood glucose  293  mg dl; chemistry blood glucose  350  mg dl; blood gas blood free calcium  1.03  mmol l; blood gas blood free calcium  0.87  mmol l; blood gas blood lactate  3.6  mmol l; blood gas blood lactate  6.8  mmol l$sodium chloride 0.9%  flush  10  ml ; 0.9% sodium chloride  250  ml ; norepinephrine  8  mg ; docusate sodium  100  mg ; heparin  1200  unit ; 5% dextrose  250  ml ; heparin sodium  25,000  unit ; bag  1  bag ; magnesium sulfate  2  gm ; bag  2  bag ; magnesium sulfate  4  gm ; 0.9% sodium chloride  1  bag ; calcium gluconate  2  g ; 0.9% sodium chloride  2  bag ; calcium gluconate  4  g ; sterile water  50  ml ; potassium chloride  20  meq ; sterile water  100  ml ; potassium chloride  40  meq ; sterile water  150  ml ; potassium chloride  60  meq ; vial  1  vial ; pantoprazole  40  mg ; chlorhexidine gluconate 0.12% oral rinse  15  ml ; 5% dextrose  100  ml ; vasopressin  40  unit ; albuterol inhaler  6  puff ; dextrose 50%  12.5  gm ; glucagon  1  mg ; glucose gel  15  g ; ipratropium bromide mdi  6  puff ; aspirin  81  mg ; 0.9% sodium chloride  100  ml ; midazolam  100  mg ; iso-osmotic dextrose  50  ml ; piperacillin-tazobactam  2.25  g ; amiodarone  200  mg ; acetaminophen iv  1000  mg ; sodium chloride 0.9%  1000  ml ; phenylephrine  60  mg ; 
 
black african american f 33 $nan$hematology blood hematocrit  34.4  %; hematology blood hemoglobin  11.5  g dl; hematology blood platelet count  373  k ul; chemistry blood anion gap  20  meq l; chemistry blood bicarbonate  23  meq l; chemistry blood chloride  96  meq l; chemistry blood creatinine  0.7  mg dl; chemistry blood potassium  2.7  meq l; chemistry blood sodium  136  meq l; chemistry blood urea nitrogen  8  mg dl; hematology urine wbc  0-2  # hpf; chemistry blood calcium, total  10.0  mg dl; chemistry blood glucose  87  mg dl; hematology urine glucose  neg  mg dl; hematology urine bilirubin  sm  mg dl$nan
 
black african american f 33 $nan$chemistry blood anion gap  11  meq l; chemistry blood bicarbonate  22  meq l; chemistry blood chloride  108  meq l; chemistry blood creatinine  0.7  mg dl; chemistry blood potassium  3.5  meq l; chemistry blood sodium  137  meq l; chemistry blood urea nitrogen  5  mg dl; hematology urine wbc  1  # hpf; chemistry blood calcium, total  8.2  mg dl; chemistry blood glucose  95  mg dl$sodium chloride 0.9%  flush  3  ml ; potassium chl 20 meq   1000 ml d5ns  1000  ml ; docusate sodium  100  mg ; acetaminophen  650  mg ; oxazepam  15-30  mg ; calcium carbonate  500  mg ; milk of magnesia  15-30  ml ; ondansetron  4-8  mg ; iso-osmotic sodium chloride  50  ml ; famotidine  20  mg ; bisacodyl  10  mg ; promethazine  6.25  mg ; neutra-phos  1  pkt ; nephrocaps  1  cap ; metoclopramide  10  mg ; 
 
black african american f 33 $nan$chemistry blood anion gap  8  meq l; chemistry blood bicarbonate  23  meq l; chemistry blood chloride  109  meq l; chemistry blood creatinine  0.5  mg dl; chemistry blood potassium  4.0  meq l; chemistry blood sodium  136  meq l; chemistry blood urea nitrogen  2  mg dl; chemistry blood calcium, total  8.2  mg dl; chemistry blood glucose  88  mg dl$sodium chloride 0.9%  flush  3  ml ; potassium chl 20 meq   1000 ml d5ns  1000  ml ; docusate sodium  100  mg ; acetaminophen  650  mg ; oxazepam  15-30  mg ; calcium carbonate  500  mg ; milk of magnesia  15-30  ml ; ondansetron  4-8  mg ; iso-osmotic sodium chloride  50  ml ; famotidine  20  mg ; bisacodyl  10  mg ; promethazine  6.25  mg ; neutra-phos  1  pkt ; nephrocaps  1  cap ; metoclopramide  10  mg ; sw  50  ml ; magnesium sulfate  2  gm ; ondansetron odt  4  mg ; promethazine  12.5  mg ; 
 
black african american f 33 $nan$nan$sodium chloride 0.9%  flush  3  ml ; potassium chl 20 meq   1000 ml d5ns  1000  ml ; docusate sodium  100  mg ; acetaminophen  650  mg ; oxazepam  15-30  mg ; calcium carbonate  500  mg ; milk of magnesia  15-30  ml ; bisacodyl  10  mg ; nephrocaps  1  cap ; sw  50  ml ; magnesium sulfate  2  gm ; ondansetron odt  4  mg ; promethazine  12.5  mg ; 
 
white f 61 $nan$nan$vitamin d  400  unit ; levothyroxine sodium  50  mcg ; 
 
white f 61 $temp  98.0  heartrate  86.0  resprate  16.0  o2sat  98.0  sbp  113.0  dbp  55.0  rhythm    pain    $nan$vitamin d  400  unit ; levothyroxine sodium  50  mcg ; docusate sodium  100  mg ; senna  1  tab ; calcium carbonate  500  mg ; lactated ringers  1000  ml ; 0.9% sodium chloride  100  ml ; hydromorphone  20  mg ; hydromorphone (dilaudid)  2-4  mg ; acetaminophen  650  mg ; milk of magnesia  30  ml ; ondansetron  4  mg ; sodium chloride 0.9%  flush  3  ml ; enoxaparin sodium  40  mg ; cefazolin  2  g ; 
 
white f 61 $nan$hematology blood hematocrit  31.3  %; hematology blood hemoglobin  10.5  g dl; hematology blood platelet count  238  k ul; chemistry blood anion gap  15  meq l; chemistry blood bicarbonate  24  meq l; chemistry blood chloride  100  meq l; chemistry blood creatinine  0.7  mg dl; chemistry blood potassium  3.5  meq l; chemistry blood sodium  135  meq l; chemistry blood urea nitrogen  10  mg dl; chemistry blood calcium, total  8.6  mg dl; chemistry blood glucose  107  mg dl$vitamin d  400  unit ; levothyroxine sodium  50  mcg ; docusate sodium  100  mg ; senna  1  tab ; calcium carbonate  500  mg ; lactated ringers  1000  ml ; acetaminophen  650  mg ; milk of magnesia  30  ml ; ondansetron  4  mg ; sodium chloride 0.9%  flush  3  ml ; enoxaparin sodium  40  mg ; cefazolin  2  g ; oxycodone (immediate release)   5-10  mg ; hydromorphone (dilaudid)  0.25  mg ; 
 
white f 61 $nan$hematology blood hematocrit  29.8  %; hematology blood hemoglobin  10.0  g dl; hematology blood platelet count  232  k ul$vitamin d  400  unit ; levothyroxine sodium  50  mcg ; docusate sodium  100  mg ; senna  1  tab ; calcium carbonate  500  mg ; lactated ringers  1000  ml ; acetaminophen  650  mg ; milk of magnesia  30  ml ; ondansetron  4  mg ; sodium chloride 0.9%  flush  3  ml ; cefazolin  2  g ; hydromorphone (dilaudid)  0.25  mg ; 
 
white f 61 $nan$hematology blood hematocrit  28.0  %; hematology blood hemoglobin  9.4  g dl; hematology blood platelet count  258  k ul; chemistry blood anion gap  13  meq l; chemistry blood bicarbonate  28  meq l; chemistry blood chloride  100  meq l; chemistry blood creatinine  0.5  mg dl; chemistry blood potassium  3.2  meq l; chemistry blood sodium  138  meq l; chemistry blood urea nitrogen  11  mg dl; chemistry blood calcium, total  8.3  mg dl; chemistry blood glucose  128  mg dl$vitamin d  400  unit ; levothyroxine sodium  50  mcg ; docusate sodium  100  mg ; senna  1  tab ; calcium carbonate  500  mg ; lactated ringers  1000  ml ; acetaminophen  650  mg ; milk of magnesia  30  ml ; ondansetron  4  mg ; sodium chloride 0.9%  flush  3  ml ; hydromorphone (dilaudid)  0.25  mg ; potassium chloride  40  meq ; 5% dextrose  500  ml ; lactated ringers  500  ml ; 0.9% sodium chloride  500  ml ; 
 
white f 61 $nan$hematology blood hematocrit  27.0  %; hematology blood hemoglobin  9.0  g dl; hematology blood platelet count  285  k ul; chemistry blood anion gap  11  meq l; chemistry blood bicarbonate  29  meq l; chemistry blood chloride  105  meq l; chemistry blood creatinine  0.5  mg dl; chemistry blood potassium  3.9  meq l; chemistry blood sodium  141  meq l; chemistry blood urea nitrogen  10  mg dl; chemistry blood calcium, total  8.9  mg dl; chemistry blood glucose  115  mg dl$vitamin d  400  unit ; levothyroxine sodium  50  mcg ; docusate sodium  100  mg ; senna  1  tab ; calcium carbonate  500  mg ; acetaminophen  650  mg ; milk of magnesia  30  ml ; ondansetron  4  mg ; sodium chloride 0.9%  flush  3  ml ; hydromorphone (dilaudid)  0.25  mg ; potassium chloride  40  meq ; 5% dextrose  500  ml ; lactated ringers  500  ml ; 0.9% sodium chloride  500  ml ; 
 
white f 61 $nan$hematology blood hematocrit  30.4  %; hematology blood hemoglobin  9.8  g dl; hematology blood platelet count  369  k ul; chemistry blood anion gap  13  meq l; chemistry blood bicarbonate  28  meq l; chemistry blood chloride  103  meq l; chemistry blood creatinine  0.5  mg dl; chemistry blood potassium  3.5  meq l; chemistry blood sodium  140  meq l; chemistry blood urea nitrogen  13  mg dl; chemistry blood glucose  127  mg dl$vitamin d  400  unit ; levothyroxine sodium  50  mcg ; docusate sodium  100  mg ; senna  1  tab ; calcium carbonate  500  mg ; acetaminophen  650  mg ; milk of magnesia  30  ml ; ondansetron  4  mg ; sodium chloride 0.9%  flush  3  ml ; hydromorphone (dilaudid)  0.25  mg ; 
 
white f 61 $nan$nan$vitamin d  400  unit ; levothyroxine sodium  50  mcg ; docusate sodium  100  mg ; senna  1  tab ; calcium carbonate  500  mg ; acetaminophen  650  mg ; milk of magnesia  30  ml ; ondansetron  4  mg ; sodium chloride 0.9%  flush  3  ml ; hydromorphone (dilaudid)  0.25  mg ; oxycodone (immediate release)   2.5-5  mg ; 
 
white m 40 $temp    heartrate    resprate    o2sat    sbp    dbp    rhythm    pain  4  ; temp  97.5  heartrate  88.0  resprate  20.0  o2sat    sbp  134.0  dbp  76.0  rhythm    pain    $hematology blood hematocrit  42.8  %; hematology blood hemoglobin  14.8  g dl; hematology blood platelet count  254  k ul; chemistry blood anion gap  16  meq l; chemistry blood bicarbonate  23  meq l; chemistry blood chloride  105  meq l; chemistry blood creatinine  1.1  mg dl; chemistry blood potassium  3.9  meq l; chemistry blood sodium  140  meq l; chemistry blood urea nitrogen  20  mg dl; chemistry blood bilirubin, total  0.4  mg dl; chemistry blood glucose  102  mg dl; chemistry blood albumin  4.4  g dl; blood gas blood lactate  1.5  mmol l$nan
constipation, unspecified myalgia and myositis, unspecified panic disorder without agoraphobia pure hypercholesterolemia diverticulitis of colon (without mention of hemorrhage) obesity, unspecified irritable bowel syndrome lumbago
white m 40 $temp  98.0  heartrate  86.0  resprate  14.0  o2sat    sbp  108.0  dbp  67.0  rhythm    pain  10  ; temp    heartrate  83.0  resprate  18.0  o2sat  97.0  sbp  119.0  dbp  70.0  rhythm    pain  2  ; temp  98.0  heartrate  85.0  resprate  18.0  o2sat  95.0  sbp  134.0  dbp  72.0  rhythm    pain  8  ; temp  97.7  heartrate  71.0  resprate  18.0  o2sat  100.0  sbp  130.0  dbp  70.0  rhythm    pain  2  $nan$influenza virus vaccine  0.5  ml ; tizanidine  1  mg ; sodium chloride 0.9%  flush  3  ml ; oxycodone-acetaminophen (5mg-325mg)  1-2  tab ; senna  1  tab ; ondansetron  4  mg ; alprazolam  0.5  mg ; dicyclomine  20  mg ; metronidazole (flagyl)  500  mg ; docusate sodium  100  mg ; heparin  5000  unit ; lamotrigine  100  mg ; ciprofloxacin hcl  500  mg ; tizanidine  2  mg ; sarna lotion  1  appl ; 
constipation, unspecified myalgia and myositis, unspecified panic disorder without agoraphobia pure hypercholesterolemia diverticulitis of colon (without mention of hemorrhage) obesity, unspecified irritable bowel syndrome lumbago
white m 40 $nan$hematology blood hematocrit  38.9  %; hematology blood hemoglobin  13.8  g dl; hematology blood platelet count  244  k ul; chemistry blood anion gap  15  meq l; chemistry blood bicarbonate  25  meq l; chemistry blood chloride  100  meq l; chemistry blood creatinine  1.2  mg dl; chemistry blood potassium  3.7  meq l; chemistry blood sodium  136  meq l; chemistry blood urea nitrogen  17  mg dl; chemistry blood glucose  101  mg dl$sodium chloride 0.9%  flush  3  ml ; oxycodone-acetaminophen (5mg-325mg)  1-2  tab ; senna  1  tab ; ondansetron  4  mg ; alprazolam  0.5  mg ; dicyclomine  20  mg ; metronidazole (flagyl)  500  mg ; docusate sodium  100  mg ; heparin  5000  unit ; lamotrigine  100  mg ; ciprofloxacin hcl  500  mg ; sarna lotion  1  appl ; polyethylene glycol  17  g ; milk of magnesia  30  ml ; bisacodyl  10  mg ; lactulose  15  ml ; senna  2  tab ; 
constipation, unspecified myalgia and myositis, unspecified panic disorder without agoraphobia pure hypercholesterolemia diverticulitis of colon (without mention of hemorrhage) obesity, unspecified irritable bowel syndrome lumbago
white m 40 $nan$hematology blood hematocrit  38.4  %; hematology blood hemoglobin  13.3  g dl; hematology blood platelet count  236  k ul; chemistry blood anion gap  13  meq l; chemistry blood anion gap  14  meq l; chemistry blood bicarbonate  27  meq l; chemistry blood bicarbonate  26  meq l; chemistry blood chloride  104  meq l; chemistry blood chloride  103  meq l; chemistry blood creatinine  1.4  mg dl; chemistry blood creatinine  1.3  mg dl; chemistry blood potassium  4.2  meq l; chemistry blood potassium  3.8  meq l; chemistry blood sodium  140  meq l; chemistry blood sodium  139  meq l; chemistry blood urea nitrogen  16  mg dl; chemistry blood urea nitrogen  15  mg dl; chemistry blood glucose  93  mg dl; chemistry blood glucose  98  mg dl$sodium chloride 0.9%  flush  3  ml ; oxycodone-acetaminophen (5mg-325mg)  1-2  tab ; ondansetron  4  mg ; alprazolam  0.5  mg ; dicyclomine  20  mg ; metronidazole (flagyl)  500  mg ; docusate sodium  100  mg ; heparin  5000  unit ; lamotrigine  100  mg ; ciprofloxacin hcl  500  mg ; sarna lotion  1  appl ; polyethylene glycol  17  g ; milk of magnesia  30  ml ; bisacodyl  10  mg ; senna  2  tab ; 0.9% sodium chloride  1000  ml ; 
constipation, unspecified myalgia and myositis, unspecified panic disorder without agoraphobia pure hypercholesterolemia diverticulitis of colon (without mention of hemorrhage) obesity, unspecified irritable bowel syndrome lumbago
white m 74 $temp    heartrate  86.0  resprate  32.0  o2sat  97.0  sbp  141.0  dbp  102.0  rhythm  atrial fibrillation  pain  0  ; temp    heartrate  75.0  resprate  21.0  o2sat  100.0  sbp  158.0  dbp  93.0  rhythm  atrial fibrillation  pain  0  ; temp    heartrate  76.0  resprate  15.0  o2sat  100.0  sbp  158.0  dbp  100.0  rhythm  atrial fibrillation  pain  0  ; temp    heartrate  76.0  resprate  17.0  o2sat  100.0  sbp  134.0  dbp  75.0  rhythm  atrial fibrillation  pain  0  ; temp    heartrate  79.0  resprate  15.0  o2sat  100.0  sbp  141.0  dbp  93.0  rhythm  atrial fibrillation  pain  0  ; temp    heartrate  77.0  resprate  16.0  o2sat  100.0  sbp  138.0  dbp  92.0  rhythm  atrial fibrillation  pain  5  $nan$vitamin d  400  unit ; multivitamins  1  tab ; pravastatin  40  mg ; 
other diuretics causing adverse effects in therapeutic use other acquired absence of organ other and unspecified agents primarily affecting the cardiovascular system causing adverse effects in therapeutic use chronic kidney disease, unspecified hyperpotassemia aftercare for healing pathologic fracture of vertebrae acute venous embolism and thrombosis of axillary veins acidosis chronic diastolic heart failure acute kidney failure, unspecified phlebitis and thrombophlebitis of other sites pulmonary collapse atrial fibrillation disorder of bone and cartilage, unspecified congestive heart failure, unspecified chronic obstructive asthma with (acute) exacerbation mitral valve disorders hypertensive chronic kidney disease, unspecified, with chronic kidney disease stage i through stage iv, or unspecified gout, unspecified anemia in chronic kidney disease lichenification and lichen simplex chronicus long-term (current) use of anticoagulants long-term (current) use of steroids dehydration other chronic pulmonary heart diseases pure hypercholesterolemia staphylococcus infection in conditions classified elsewhere and of unspecified site, other staphylococcus gout, unspecified pathologic fracture of vertebrae acute kidney failure, unspecified myelodysplastic syndrome, unspecified hypertensive chronic kidney disease, unspecified, with chronic kidney disease stage i through stage iv, or unspecified pure hypercholesterolemia asthma, unspecified type, unspecified iron deficiency anemia, unspecified hyperpotassemia other atopic dermatitis and related conditions acute on chronic diastolic heart failure congestive heart failure, unspecified atrial fibrillation long-term (current) use of anticoagulants chronic kidney disease, stage ii (mild) hypercalcemia pulmonary collapse disorders of magnesium metabolism fall from other slipping, tripping, or stumbling open wound of knee, leg [except thigh], and ankle, without mention of complication anemia, unspecified
white m 74 $temp  98.4  heartrate  77.0  resprate  14.0  o2sat  100.0  sbp  129.0  dbp  97.0  rhythm  atrial fibrillation  pain  0  $hematology blood hematocrit  33.1  %; hematology blood hemoglobin  10.4  g dl; hematology blood platelet count  258  k ul; chemistry blood anion gap  14  meq l; chemistry blood bicarbonate  27  meq l; chemistry blood chloride  108  meq l; chemistry blood creatinine  1.5  mg dl; chemistry blood potassium  4.3  meq l; chemistry blood sodium  145  meq l; chemistry blood urea nitrogen  45  mg dl; hematology blood inr(pt)  2.5  ; chemistry blood calcium, total  8.4  mg dl; chemistry blood glucose  118  mg dl$vitamin d  400  unit ; multivitamins  1  tab ; pravastatin  40  mg ; albuterol 0.083% neb soln  1  neb ; ipratropium bromide neb  1  neb ; hydroxyzine  25  mg ; oxycodone-acetaminophen (5mg-325mg)  1  tab ; clobetasol propionate 0.05% cream  1  appl ; fluticasone-salmeterol diskus (500 50)   1  inh ; metoprolol tartrate  100  mg ; d5w  250  ml ; nitroglycerin  100  mg ; senna  1  tab ; docusate sodium  100  mg ; sarna lotion  1  appl ; diltiazem  30  mg ; heparin  5000  unit ; warfarin  3  mg ; warfarin  2  mg ; valsartan  80  mg ; furosemide  40  mg ; bag  50  ml ; magnesium sulfate  2  gm ; 
other diuretics causing adverse effects in therapeutic use other acquired absence of organ other and unspecified agents primarily affecting the cardiovascular system causing adverse effects in therapeutic use chronic kidney disease, unspecified hyperpotassemia aftercare for healing pathologic fracture of vertebrae acute venous embolism and thrombosis of axillary veins acidosis chronic diastolic heart failure acute kidney failure, unspecified phlebitis and thrombophlebitis of other sites pulmonary collapse atrial fibrillation disorder of bone and cartilage, unspecified congestive heart failure, unspecified chronic obstructive asthma with (acute) exacerbation mitral valve disorders hypertensive chronic kidney disease, unspecified, with chronic kidney disease stage i through stage iv, or unspecified gout, unspecified anemia in chronic kidney disease lichenification and lichen simplex chronicus long-term (current) use of anticoagulants long-term (current) use of steroids dehydration other chronic pulmonary heart diseases pure hypercholesterolemia staphylococcus infection in conditions classified elsewhere and of unspecified site, other staphylococcus gout, unspecified pathologic fracture of vertebrae acute kidney failure, unspecified myelodysplastic syndrome, unspecified hypertensive chronic kidney disease, unspecified, with chronic kidney disease stage i through stage iv, or unspecified pure hypercholesterolemia asthma, unspecified type, unspecified iron deficiency anemia, unspecified hyperpotassemia other atopic dermatitis and related conditions acute on chronic diastolic heart failure congestive heart failure, unspecified atrial fibrillation long-term (current) use of anticoagulants chronic kidney disease, stage ii (mild) hypercalcemia pulmonary collapse disorders of magnesium metabolism fall from other slipping, tripping, or stumbling open wound of knee, leg [except thigh], and ankle, without mention of complication anemia, unspecified
white m 74 $nan$hematology blood hematocrit  33.6  %; hematology blood hemoglobin  10.5  g dl; hematology blood platelet count  265  k ul; chemistry blood anion gap  23  meq l; chemistry blood anion gap  13  meq l; chemistry blood bicarbonate  22  meq l; chemistry blood bicarbonate  28  meq l; chemistry blood chloride  103  meq l; chemistry blood chloride  105  meq l; chemistry blood creatinine  1.4  mg dl; chemistry blood creatinine  1.1  mg dl; chemistry blood potassium  4.0  meq l; chemistry blood potassium  4.9  meq l; chemistry blood sodium  143  meq l; chemistry blood sodium  142  meq l; chemistry blood urea nitrogen  43  mg dl; chemistry blood urea nitrogen  38  mg dl; hematology blood inr(pt)  1.7  ; chemistry blood calcium, total  9.3  mg dl; chemistry blood calcium, total  8.9  mg dl; chemistry blood glucose  139  mg dl$vitamin d  400  unit ; multivitamins  1  tab ; pravastatin  40  mg ; albuterol 0.083% neb soln  1  neb ; ipratropium bromide neb  1  neb ; hydroxyzine  25  mg ; oxycodone-acetaminophen (5mg-325mg)  1  tab ; clobetasol propionate 0.05% cream  1  appl ; fluticasone-salmeterol diskus (500 50)   1  inh ; metoprolol tartrate  100  mg ; senna  1  tab ; docusate sodium  100  mg ; sarna lotion  1  appl ; diltiazem  30  mg ; valsartan  80  mg ; sodium chloride 0.9%  flush  3  ml ; diltiazem extended-release  120  mg ; 
other diuretics causing adverse effects in therapeutic use other acquired absence of organ other and unspecified agents primarily affecting the cardiovascular system causing adverse effects in therapeutic use chronic kidney disease, unspecified hyperpotassemia aftercare for healing pathologic fracture of vertebrae acute venous embolism and thrombosis of axillary veins acidosis chronic diastolic heart failure acute kidney failure, unspecified phlebitis and thrombophlebitis of other sites pulmonary collapse atrial fibrillation disorder of bone and cartilage, unspecified congestive heart failure, unspecified chronic obstructive asthma with (acute) exacerbation mitral valve disorders hypertensive chronic kidney disease, unspecified, with chronic kidney disease stage i through stage iv, or unspecified gout, unspecified anemia in chronic kidney disease lichenification and lichen simplex chronicus long-term (current) use of anticoagulants long-term (current) use of steroids dehydration other chronic pulmonary heart diseases pure hypercholesterolemia staphylococcus infection in conditions classified elsewhere and of unspecified site, other staphylococcus gout, unspecified pathologic fracture of vertebrae acute kidney failure, unspecified myelodysplastic syndrome, unspecified hypertensive chronic kidney disease, unspecified, with chronic kidney disease stage i through stage iv, or unspecified pure hypercholesterolemia asthma, unspecified type, unspecified iron deficiency anemia, unspecified hyperpotassemia other atopic dermatitis and related conditions acute on chronic diastolic heart failure congestive heart failure, unspecified atrial fibrillation long-term (current) use of anticoagulants chronic kidney disease, stage ii (mild) hypercalcemia pulmonary collapse disorders of magnesium metabolism fall from other slipping, tripping, or stumbling open wound of knee, leg [except thigh], and ankle, without mention of complication anemia, unspecified
white m 74 $nan$hematology blood hematocrit  35.2  %; hematology blood hemoglobin  11.3  g dl; hematology blood platelet count  362  k ul; chemistry blood anion gap  14  meq l; chemistry blood bicarbonate  27  meq l; chemistry blood chloride  103  meq l; chemistry blood creatinine  1.0  mg dl; chemistry blood potassium  4.3  meq l; chemistry blood sodium  140  meq l; chemistry blood urea nitrogen  30  mg dl; chemistry blood calcium, total  9.3  mg dl; chemistry blood glucose  103  mg dl$vitamin d  400  unit ; multivitamins  1  tab ; pravastatin  40  mg ; albuterol 0.083% neb soln  1  neb ; ipratropium bromide neb  1  neb ; hydroxyzine  25  mg ; oxycodone-acetaminophen (5mg-325mg)  1  tab ; clobetasol propionate 0.05% cream  1  appl ; fluticasone-salmeterol diskus (500 50)   1  inh ; metoprolol tartrate  100  mg ; senna  1  tab ; docusate sodium  100  mg ; sarna lotion  1  appl ; valsartan  80  mg ; sodium chloride 0.9%  flush  3  ml ; diltiazem extended-release  120  mg ; 
other diuretics causing adverse effects in therapeutic use other acquired absence of organ other and unspecified agents primarily affecting the cardiovascular system causing adverse effects in therapeutic use chronic kidney disease, unspecified hyperpotassemia aftercare for healing pathologic fracture of vertebrae acute venous embolism and thrombosis of axillary veins acidosis chronic diastolic heart failure acute kidney failure, unspecified phlebitis and thrombophlebitis of other sites pulmonary collapse atrial fibrillation disorder of bone and cartilage, unspecified congestive heart failure, unspecified chronic obstructive asthma with (acute) exacerbation mitral valve disorders hypertensive chronic kidney disease, unspecified, with chronic kidney disease stage i through stage iv, or unspecified gout, unspecified anemia in chronic kidney disease lichenification and lichen simplex chronicus long-term (current) use of anticoagulants long-term (current) use of steroids dehydration other chronic pulmonary heart diseases pure hypercholesterolemia staphylococcus infection in conditions classified elsewhere and of unspecified site, other staphylococcus gout, unspecified pathologic fracture of vertebrae acute kidney failure, unspecified myelodysplastic syndrome, unspecified hypertensive chronic kidney disease, unspecified, with chronic kidney disease stage i through stage iv, or unspecified pure hypercholesterolemia asthma, unspecified type, unspecified iron deficiency anemia, unspecified hyperpotassemia other atopic dermatitis and related conditions acute on chronic diastolic heart failure congestive heart failure, unspecified atrial fibrillation long-term (current) use of anticoagulants chronic kidney disease, stage ii (mild) hypercalcemia pulmonary collapse disorders of magnesium metabolism fall from other slipping, tripping, or stumbling open wound of knee, leg [except thigh], and ankle, without mention of complication anemia, unspecified
white m 74 $nan$nan$vitamin d  400  unit ; multivitamins  1  tab ; pravastatin  40  mg ; albuterol 0.083% neb soln  1  neb ; ipratropium bromide neb  1  neb ; hydroxyzine  25  mg ; oxycodone-acetaminophen (5mg-325mg)  1  tab ; clobetasol propionate 0.05% cream  1  appl ; fluticasone-salmeterol diskus (500 50)   1  inh ; metoprolol tartrate  100  mg ; senna  1  tab ; docusate sodium  100  mg ; sarna lotion  1  appl ; valsartan  80  mg ; sodium chloride 0.9%  flush  3  ml ; diltiazem extended-release  120  mg ; 
other diuretics causing adverse effects in therapeutic use other acquired absence of organ other and unspecified agents primarily affecting the cardiovascular system causing adverse effects in therapeutic use chronic kidney disease, unspecified hyperpotassemia aftercare for healing pathologic fracture of vertebrae acute venous embolism and thrombosis of axillary veins acidosis chronic diastolic heart failure acute kidney failure, unspecified phlebitis and thrombophlebitis of other sites pulmonary collapse atrial fibrillation disorder of bone and cartilage, unspecified congestive heart failure, unspecified chronic obstructive asthma with (acute) exacerbation mitral valve disorders hypertensive chronic kidney disease, unspecified, with chronic kidney disease stage i through stage iv, or unspecified gout, unspecified anemia in chronic kidney disease lichenification and lichen simplex chronicus long-term (current) use of anticoagulants long-term (current) use of steroids dehydration other chronic pulmonary heart diseases pure hypercholesterolemia staphylococcus infection in conditions classified elsewhere and of unspecified site, other staphylococcus gout, unspecified pathologic fracture of vertebrae acute kidney failure, unspecified myelodysplastic syndrome, unspecified hypertensive chronic kidney disease, unspecified, with chronic kidney disease stage i through stage iv, or unspecified pure hypercholesterolemia asthma, unspecified type, unspecified iron deficiency anemia, unspecified hyperpotassemia other atopic dermatitis and related conditions acute on chronic diastolic heart failure congestive heart failure, unspecified atrial fibrillation long-term (current) use of anticoagulants chronic kidney disease, stage ii (mild) hypercalcemia pulmonary collapse disorders of magnesium metabolism fall from other slipping, tripping, or stumbling open wound of knee, leg [except thigh], and ankle, without mention of complication anemia, unspecified
white f 90 $nan$nan$levothyroxine sodium  75  mcg ; 
acquired absence of intestine (large) (small) hypertensive retinopathy unspecified essential hypertension hydronephrosis calculus of kidney acquired absence of intestine (large) (small) unspecified acquired hypothyroidism unspecified intestinal obstruction osteoarthrosis, localized, not specified whether primary or secondary, lower leg dehydration benign paroxysmal positional vertigo thrombocytopenia, unspecified anxiety state, unspecified person on outside of car injured in collision with heavy transport vehicle or bus in nontraffic accident ileostomy status unspecified acquired hypothyroidism calculus of ureter thrombocytopenia, unspecified benign paroxysmal positional vertigo anxiety state, unspecified unspecified essential hypertension unspecified acquired hypothyroidism other closed fracture of upper end of humerus other specified metabolic disorders unspecified fall urinary tract infection, site not specified benign paroxysmal positional vertigo other specified intestinal obstruction nausea with vomiting unspecified acquired hypothyroidism dysthymic disorder thrombocytopenia, unspecified abdominal pain, periumbilic unspecified essential hypertension thrombocytopenia, unspecified regional enteritis of unspecified site calculus of ureter personal history of tobacco use anxiety state, unspecified calculus of ureter unspecified acquired hypothyroidism hydronephrosis other colostomy and enterostomy complication abdominal pain, other specified site ulcerative colitis, unspecified unspecified acquired hypothyroidism
white f 90 $nan$hematology blood hematocrit  34.6  %; hematology blood hemoglobin  12.1  g dl; hematology blood platelet count  150  k ul; chemistry blood anion gap  14  meq l; chemistry blood bicarbonate  22  meq l; chemistry blood chloride  100  meq l; chemistry blood creatinine  0.7  mg dl; chemistry blood potassium  4.1  meq l; chemistry blood sodium  132  meq l; chemistry blood urea nitrogen  14  mg dl; chemistry blood calcium, total  8.1  mg dl; chemistry blood glucose  94  mg dl$levothyroxine sodium  75  mcg ; 0.45% sodium chloride  1000  ml ; influenza virus vaccine  0.5  ml ; pneumococcal vac polyvalent  0.5  ml ; sodium chloride 0.9%  flush  3  ml ; 0.9% sodium chloride  1000  ml ; morphine sulfate  1-2  mg ; lidocaine viscous 2%  20  ml ; 5% dextrose  100  ml ; acyclovir  600  mg ; iso-osmotic dextrose  50  ml ; clindamycin  600  mg ; artificial tear ointment  1  appl ; heparin  5000  unit ; acetaminophen  650  mg ; erythromycin 0.5% ophth oint  0.5  in ; calcium carbonate  500  mg ; sodium chloride nasal  1-2  spry ; 
acquired absence of intestine (large) (small) hypertensive retinopathy unspecified essential hypertension hydronephrosis calculus of kidney acquired absence of intestine (large) (small) unspecified acquired hypothyroidism unspecified intestinal obstruction osteoarthrosis, localized, not specified whether primary or secondary, lower leg dehydration benign paroxysmal positional vertigo thrombocytopenia, unspecified anxiety state, unspecified person on outside of car injured in collision with heavy transport vehicle or bus in nontraffic accident ileostomy status unspecified acquired hypothyroidism calculus of ureter thrombocytopenia, unspecified benign paroxysmal positional vertigo anxiety state, unspecified unspecified essential hypertension unspecified acquired hypothyroidism other closed fracture of upper end of humerus other specified metabolic disorders unspecified fall urinary tract infection, site not specified benign paroxysmal positional vertigo other specified intestinal obstruction nausea with vomiting unspecified acquired hypothyroidism dysthymic disorder thrombocytopenia, unspecified abdominal pain, periumbilic unspecified essential hypertension thrombocytopenia, unspecified regional enteritis of unspecified site calculus of ureter personal history of tobacco use anxiety state, unspecified calculus of ureter unspecified acquired hypothyroidism hydronephrosis other colostomy and enterostomy complication abdominal pain, other specified site ulcerative colitis, unspecified unspecified acquired hypothyroidism
white f 90 $nan$chemistry blood anion gap  15  meq l; chemistry blood bicarbonate  25  meq l; chemistry blood chloride  99  meq l; chemistry blood creatinine  0.9  mg dl; chemistry blood potassium  4.5  meq l; chemistry blood sodium  134  meq l; chemistry blood urea nitrogen  16  mg dl; chemistry blood calcium, total  8.9  mg dl; chemistry blood glucose  96  mg dl$levothyroxine sodium  75  mcg ; influenza virus vaccine  0.5  ml ; pneumococcal vac polyvalent  0.5  ml ; sodium chloride 0.9%  flush  3  ml ; morphine sulfate  1-2  mg ; lidocaine viscous 2%  20  ml ; 5% dextrose  100  ml ; acyclovir  600  mg ; heparin  5000  unit ; acetaminophen  650  mg ; erythromycin 0.5% ophth oint  0.5  in ; calcium carbonate  500  mg ; sodium chloride nasal  1-2  spry ; 
acquired absence of intestine (large) (small) hypertensive retinopathy unspecified essential hypertension hydronephrosis calculus of kidney acquired absence of intestine (large) (small) unspecified acquired hypothyroidism unspecified intestinal obstruction osteoarthrosis, localized, not specified whether primary or secondary, lower leg dehydration benign paroxysmal positional vertigo thrombocytopenia, unspecified anxiety state, unspecified person on outside of car injured in collision with heavy transport vehicle or bus in nontraffic accident ileostomy status unspecified acquired hypothyroidism calculus of ureter thrombocytopenia, unspecified benign paroxysmal positional vertigo anxiety state, unspecified unspecified essential hypertension unspecified acquired hypothyroidism other closed fracture of upper end of humerus other specified metabolic disorders unspecified fall urinary tract infection, site not specified benign paroxysmal positional vertigo other specified intestinal obstruction nausea with vomiting unspecified acquired hypothyroidism dysthymic disorder thrombocytopenia, unspecified abdominal pain, periumbilic unspecified essential hypertension thrombocytopenia, unspecified regional enteritis of unspecified site calculus of ureter personal history of tobacco use anxiety state, unspecified calculus of ureter unspecified acquired hypothyroidism hydronephrosis other colostomy and enterostomy complication abdominal pain, other specified site ulcerative colitis, unspecified unspecified acquired hypothyroidism
white f 90 $nan$chemistry blood anion gap  11  meq l; chemistry blood bicarbonate  25  meq l; chemistry blood chloride  106  meq l; chemistry blood creatinine  1.0  mg dl; chemistry blood potassium  4.3  meq l; chemistry blood sodium  138  meq l; chemistry blood urea nitrogen  9  mg dl; chemistry blood calcium, total  8.9  mg dl; chemistry blood glucose  94  mg dl$levothyroxine sodium  75  mcg ; influenza virus vaccine  0.5  ml ; pneumococcal vac polyvalent  0.5  ml ; sodium chloride 0.9%  flush  3  ml ; morphine sulfate  1-2  mg ; lidocaine viscous 2%  20  ml ; 5% dextrose  100  ml ; acyclovir  600  mg ; heparin  5000  unit ; acetaminophen  650  mg ; erythromycin 0.5% ophth oint  0.5  in ; calcium carbonate  500  mg ; sodium chloride nasal  1-2  spry ; 
acquired absence of intestine (large) (small) hypertensive retinopathy unspecified essential hypertension hydronephrosis calculus of kidney acquired absence of intestine (large) (small) unspecified acquired hypothyroidism unspecified intestinal obstruction osteoarthrosis, localized, not specified whether primary or secondary, lower leg dehydration benign paroxysmal positional vertigo thrombocytopenia, unspecified anxiety state, unspecified person on outside of car injured in collision with heavy transport vehicle or bus in nontraffic accident ileostomy status unspecified acquired hypothyroidism calculus of ureter thrombocytopenia, unspecified benign paroxysmal positional vertigo anxiety state, unspecified unspecified essential hypertension unspecified acquired hypothyroidism other closed fracture of upper end of humerus other specified metabolic disorders unspecified fall urinary tract infection, site not specified benign paroxysmal positional vertigo other specified intestinal obstruction nausea with vomiting unspecified acquired hypothyroidism dysthymic disorder thrombocytopenia, unspecified abdominal pain, periumbilic unspecified essential hypertension thrombocytopenia, unspecified regional enteritis of unspecified site calculus of ureter personal history of tobacco use anxiety state, unspecified calculus of ureter unspecified acquired hypothyroidism hydronephrosis other colostomy and enterostomy complication abdominal pain, other specified site ulcerative colitis, unspecified unspecified acquired hypothyroidism
white f 90 $nan$nan$levothyroxine sodium  75  mcg ; influenza virus vaccine  0.5  ml ; pneumococcal vac polyvalent  0.5  ml ; sodium chloride 0.9%  flush  3  ml ; morphine sulfate  1-2  mg ; lidocaine viscous 2%  20  ml ; 5% dextrose  100  ml ; acyclovir  600  mg ; heparin  5000  unit ; acetaminophen  650  mg ; erythromycin 0.5% ophth oint  0.5  in ; calcium carbonate  500  mg ; sodium chloride nasal  1-2  spry ; 
acquired absence of intestine (large) (small) hypertensive retinopathy unspecified essential hypertension hydronephrosis calculus of kidney acquired absence of intestine (large) (small) unspecified acquired hypothyroidism unspecified intestinal obstruction osteoarthrosis, localized, not specified whether primary or secondary, lower leg dehydration benign paroxysmal positional vertigo thrombocytopenia, unspecified anxiety state, unspecified person on outside of car injured in collision with heavy transport vehicle or bus in nontraffic accident ileostomy status unspecified acquired hypothyroidism calculus of ureter thrombocytopenia, unspecified benign paroxysmal positional vertigo anxiety state, unspecified unspecified essential hypertension unspecified acquired hypothyroidism other closed fracture of upper end of humerus other specified metabolic disorders unspecified fall urinary tract infection, site not specified benign paroxysmal positional vertigo other specified intestinal obstruction nausea with vomiting unspecified acquired hypothyroidism dysthymic disorder thrombocytopenia, unspecified abdominal pain, periumbilic unspecified essential hypertension thrombocytopenia, unspecified regional enteritis of unspecified site calculus of ureter personal history of tobacco use anxiety state, unspecified calculus of ureter unspecified acquired hypothyroidism hydronephrosis other colostomy and enterostomy complication abdominal pain, other specified site ulcerative colitis, unspecified unspecified acquired hypothyroidism
white f 90 $nan$nan$levothyroxine sodium  75  mcg ; influenza virus vaccine  0.5  ml ; pneumococcal vac polyvalent  0.5  ml ; sodium chloride 0.9%  flush  3  ml ; morphine sulfate  1-2  mg ; lidocaine viscous 2%  20  ml ; 5% dextrose  100  ml ; acyclovir  600  mg ; heparin  5000  unit ; acetaminophen  650  mg ; erythromycin 0.5% ophth oint  0.5  in ; calcium carbonate  500  mg ; sodium chloride nasal  1-2  spry ; 
acquired absence of intestine (large) (small) hypertensive retinopathy unspecified essential hypertension hydronephrosis calculus of kidney acquired absence of intestine (large) (small) unspecified acquired hypothyroidism unspecified intestinal obstruction osteoarthrosis, localized, not specified whether primary or secondary, lower leg dehydration benign paroxysmal positional vertigo thrombocytopenia, unspecified anxiety state, unspecified person on outside of car injured in collision with heavy transport vehicle or bus in nontraffic accident ileostomy status unspecified acquired hypothyroidism calculus of ureter thrombocytopenia, unspecified benign paroxysmal positional vertigo anxiety state, unspecified unspecified essential hypertension unspecified acquired hypothyroidism other closed fracture of upper end of humerus other specified metabolic disorders unspecified fall urinary tract infection, site not specified benign paroxysmal positional vertigo other specified intestinal obstruction nausea with vomiting unspecified acquired hypothyroidism dysthymic disorder thrombocytopenia, unspecified abdominal pain, periumbilic unspecified essential hypertension thrombocytopenia, unspecified regional enteritis of unspecified site calculus of ureter personal history of tobacco use anxiety state, unspecified calculus of ureter unspecified acquired hypothyroidism hydronephrosis other colostomy and enterostomy complication abdominal pain, other specified site ulcerative colitis, unspecified unspecified acquired hypothyroidism
white f 90 $nan$nan$levothyroxine sodium  75  mcg ; influenza virus vaccine  0.5  ml ; pneumococcal vac polyvalent  0.5  ml ; sodium chloride 0.9%  flush  3  ml ; morphine sulfate  1-2  mg ; lidocaine viscous 2%  20  ml ; 5% dextrose  100  ml ; acyclovir  600  mg ; heparin  5000  unit ; acetaminophen  650  mg ; erythromycin 0.5% ophth oint  0.5  in ; calcium carbonate  500  mg ; sodium chloride nasal  1-2  spry ; gabapentin  100  mg ; 
acquired absence of intestine (large) (small) hypertensive retinopathy unspecified essential hypertension hydronephrosis calculus of kidney acquired absence of intestine (large) (small) unspecified acquired hypothyroidism unspecified intestinal obstruction osteoarthrosis, localized, not specified whether primary or secondary, lower leg dehydration benign paroxysmal positional vertigo thrombocytopenia, unspecified anxiety state, unspecified person on outside of car injured in collision with heavy transport vehicle or bus in nontraffic accident ileostomy status unspecified acquired hypothyroidism calculus of ureter thrombocytopenia, unspecified benign paroxysmal positional vertigo anxiety state, unspecified unspecified essential hypertension unspecified acquired hypothyroidism other closed fracture of upper end of humerus other specified metabolic disorders unspecified fall urinary tract infection, site not specified benign paroxysmal positional vertigo other specified intestinal obstruction nausea with vomiting unspecified acquired hypothyroidism dysthymic disorder thrombocytopenia, unspecified abdominal pain, periumbilic unspecified essential hypertension thrombocytopenia, unspecified regional enteritis of unspecified site calculus of ureter personal history of tobacco use anxiety state, unspecified calculus of ureter unspecified acquired hypothyroidism hydronephrosis other colostomy and enterostomy complication abdominal pain, other specified site ulcerative colitis, unspecified unspecified acquired hypothyroidism
white f 90 $nan$nan$levothyroxine sodium  75  mcg ; influenza virus vaccine  0.5  ml ; pneumococcal vac polyvalent  0.5  ml ; sodium chloride 0.9%  flush  3  ml ; morphine sulfate  1-2  mg ; lidocaine viscous 2%  20  ml ; 5% dextrose  100  ml ; acyclovir  600  mg ; heparin  5000  unit ; acetaminophen  650  mg ; erythromycin 0.5% ophth oint  0.5  in ; calcium carbonate  500  mg ; sodium chloride nasal  1-2  spry ; gabapentin  100  mg ; 
acquired absence of intestine (large) (small) hypertensive retinopathy unspecified essential hypertension hydronephrosis calculus of kidney acquired absence of intestine (large) (small) unspecified acquired hypothyroidism unspecified intestinal obstruction osteoarthrosis, localized, not specified whether primary or secondary, lower leg dehydration benign paroxysmal positional vertigo thrombocytopenia, unspecified anxiety state, unspecified person on outside of car injured in collision with heavy transport vehicle or bus in nontraffic accident ileostomy status unspecified acquired hypothyroidism calculus of ureter thrombocytopenia, unspecified benign paroxysmal positional vertigo anxiety state, unspecified unspecified essential hypertension unspecified acquired hypothyroidism other closed fracture of upper end of humerus other specified metabolic disorders unspecified fall urinary tract infection, site not specified benign paroxysmal positional vertigo other specified intestinal obstruction nausea with vomiting unspecified acquired hypothyroidism dysthymic disorder thrombocytopenia, unspecified abdominal pain, periumbilic unspecified essential hypertension thrombocytopenia, unspecified regional enteritis of unspecified site calculus of ureter personal history of tobacco use anxiety state, unspecified calculus of ureter unspecified acquired hypothyroidism hydronephrosis other colostomy and enterostomy complication abdominal pain, other specified site ulcerative colitis, unspecified unspecified acquired hypothyroidism
white f 83 $nan$hematology blood hematocrit  34.8  %; hematology blood hemoglobin  12.1  g dl; hematology blood platelet count  264  k ul; chemistry blood creatinine  1.1  mg dl; chemistry blood urea nitrogen  49  mg dl; hematology blood inr(pt)  1.0  ; hematology urine wbc  0-2  # hpf; blood gas blood lactate  1.9  mmol l; blood gas blood chloride, whole blood  102  meq l; blood gas blood glucose  123  mg dl; blood gas blood potassium, whole blood  4.2  meq l; blood gas blood sodium, whole blood  141  meq l; hematology urine glucose  neg  mg dl; blood gas blood calculated bicarbonate, whole blood  23  meq l; hematology urine bilirubin  neg  mg dl$nan
 
white f 83 $nan$hematology blood hematocrit  30.8  %; hematology blood hemoglobin  10.9  g dl; hematology blood platelet count  240  k ul; chemistry blood anion gap  14  meq l; chemistry blood bicarbonate  22  meq l; chemistry blood chloride  107  meq l; chemistry blood creatinine  0.9  mg dl; chemistry blood potassium  4.3  meq l; chemistry blood sodium  139  meq l; chemistry blood urea nitrogen  40  mg dl; chemistry blood calcium, total  7.6  mg dl; chemistry blood glucose  200  mg dl$influenza virus vaccine  0.5  ml ; sodium chloride 0.9%  flush  3  ml ; lr  1000  ml ; acetaminophen  650  mg ; morphine sulfate  1-4  mg ; metoprolol  5  mg ; insulin  0  unit ; calcium gluconate  2  gm ; calcium gluconate  2-4  gm ; ns  250  ml ; calcium gluconate  4  gm ; famotidine  20  mg ; atenolol  25  mg ; simvastatin  40  mg ; felodipine  10  mg ; albuterol 0.083% neb soln  1  neb ; 
 
white f 83 $nan$hematology blood hematocrit  29.5  %; hematology blood hemoglobin  10.1  g dl; hematology blood platelet count  232  k ul; chemistry blood anion gap  12  meq l; chemistry blood bicarbonate  25  meq l; chemistry blood chloride  109  meq l; chemistry blood creatinine  1.0  mg dl; chemistry blood potassium  4.2  meq l; chemistry blood sodium  142  meq l; chemistry blood urea nitrogen  31  mg dl; chemistry blood calcium, total  8.2  mg dl; chemistry blood glucose  117  mg dl$influenza virus vaccine  0.5  ml ; sodium chloride 0.9%  flush  3  ml ; acetaminophen  650  mg ; morphine sulfate  1-4  mg ; metoprolol  5  mg ; insulin  0  unit ; famotidine  20  mg ; atenolol  25  mg ; simvastatin  40  mg ; felodipine  10  mg ; albuterol 0.083% neb soln  1  neb ; pneumococcal vac polyvalent  0.5  ml ; morphine sulfate  50  mg ; gabapentin  100  mg ; 
 
white f 83 $nan$hematology blood hematocrit  29.0  %; hematology blood hematocrit  29.5  %; hematology blood hemoglobin  9.7  g dl; hematology blood hemoglobin  10.3  g dl; hematology blood platelet count  235  k ul; hematology blood platelet count  229  k ul$influenza virus vaccine  0.5  ml ; sodium chloride 0.9%  flush  3  ml ; acetaminophen  650  mg ; metoprolol  5  mg ; insulin  0  unit ; famotidine  20  mg ; atenolol  25  mg ; simvastatin  40  mg ; felodipine  10  mg ; albuterol 0.083% neb soln  1  neb ; pneumococcal vac polyvalent  0.5  ml ; morphine sulfate  50  mg ; gabapentin  100  mg ; heparin  5000  unit ; ipratropium bromide neb  1  neb ; avapro  300  mg ; 
 
white f 83 $nan$nan$influenza virus vaccine  0.5  ml ; sodium chloride 0.9%  flush  3  ml ; acetaminophen  650  mg ; famotidine  20  mg ; atenolol  25  mg ; simvastatin  40  mg ; felodipine  10  mg ; pneumococcal vac polyvalent  0.5  ml ; morphine sulfate  50  mg ; gabapentin  100  mg ; heparin  5000  unit ; ipratropium bromide neb  1  neb ; avapro  300  mg ; oxycodone sr (oxycontin)  10  mg ; morphine sulfate  1-5  mg ; 
 
white f 83 $nan$hematology urine wbc  6-10  # hpf; hematology urine glucose  neg  mg dl; hematology urine bilirubin  neg  mg dl$influenza virus vaccine  0.5  ml ; sodium chloride 0.9%  flush  3  ml ; acetaminophen  650  mg ; famotidine  20  mg ; atenolol  25  mg ; simvastatin  40  mg ; felodipine  10  mg ; pneumococcal vac polyvalent  0.5  ml ; gabapentin  100  mg ; heparin  5000  unit ; ipratropium bromide neb  1  neb ; avapro  300  mg ; oxycodone sr (oxycontin)  10  mg ; morphine sulfate  1-5  mg ; bisacodyl  10  mg ; senna  1  tab ; docusate sodium  100  mg ; oxycodone (immediate release)   5  mg ; aspirin  81  mg ; ciprofloxacin hcl  500  mg ; 
 
white f 83 $nan$nan$influenza virus vaccine  0.5  ml ; sodium chloride 0.9%  flush  3  ml ; acetaminophen  650  mg ; famotidine  20  mg ; atenolol  25  mg ; simvastatin  40  mg ; felodipine  10  mg ; pneumococcal vac polyvalent  0.5  ml ; gabapentin  100  mg ; heparin  5000  unit ; ipratropium bromide neb  1  neb ; avapro  300  mg ; oxycodone sr (oxycontin)  10  mg ; morphine sulfate  1-5  mg ; bisacodyl  10  mg ; senna  1  tab ; docusate sodium  100  mg ; oxycodone (immediate release)   5  mg ; aspirin  81  mg ; ciprofloxacin hcl  500  mg ; 
 
white m 39 $temp  98.1  heartrate  82.0  resprate  22.0  o2sat  97.0  sbp  138.0  dbp  71.0  rhythm    pain  uta  ; temp    heartrate  128.0  resprate  15.0  o2sat  100.0  sbp  131.0  dbp  84.0  rhythm    pain  uta  ; temp    heartrate  107.0  resprate  16.0  o2sat  100.0  sbp  137.0  dbp  74.0  rhythm    pain  uta  $hematology blood hematocrit  33.7  %; hematology blood hemoglobin  9.5  g dl; hematology blood platelet count  232  k ul; chemistry blood anion gap  14  meq l; chemistry blood bicarbonate  20  meq l; chemistry blood chloride  110  meq l; chemistry blood creatinine  0.8  mg dl; chemistry blood potassium  4.2  meq l; chemistry blood sodium  144  meq l; chemistry blood urea nitrogen  6  mg dl; chemistry blood bilirubin, total  0.3  mg dl; chemistry blood glucose  93  mg dl; chemistry blood albumin  3.8  g dl$nan
physical restraint status apnea, not elsewhere classified alcohol dependence with alcohol-induced psychotic disorder with hallucinations railway station as the place of occurrence of the external cause contusion of scalp, initial encounter other fall from one level to another, initial encounter hyperkalemia laceration without foreign body of oral cavity, initial encounter laceration without foreign body of other part of head, initial encounter body mass index (bmi) 26.0-26.9, adult pain in right shoulder post-traumatic stress disorder, unspecified homelessness bariatric surgery status unspecified place in hospital as the place of occurrence of the external cause postprocedural hematoma of skin and subcutaneous tissue following other procedure unspecified viral hepatitis c without hepatic coma alcoholic hepatitis without ascites alcohol induced acute pancreatitis without necrosis or infection hypokalemia nicotine dependence, cigarettes, uncomplicated conversion disorder with seizures or convulsions other pancytopenia unspecified protein-calorie malnutrition other disorders of bilirubin metabolism opioid dependence, uncomplicated personal history of traumatic brain injury toxic effect of 2-propanol, accidental (unintentional), initial encounter other medical procedures as the cause of abnormal reaction of the patient, or of later complication, without mention of misadventure at the time of the procedure acute pancreatitis without necrosis or infection, unspecified unspecified abdominal pain patient room in hospital as the place of occurrence of the external cause alcohol dependence with intoxication, unspecified pain in right knee unspecified viral hepatitis c without hepatic coma toxic effect of 2-propanol, intentional self-harm, initial encounter alcohol dependence with withdrawal, unspecified personal history of traumatic brain injury post-traumatic stress disorder, unspecified hyperlipidemia, unspecified alcohol dependence with withdrawal, unspecified homelessness epilepsy, unspecified, not intractable, without status epilepticus nicotine dependence, cigarettes, uncomplicated dissociative and conversion disorder, unspecified unspecified viral hepatitis c without hepatic coma hypomagnesemia alcohol dependence with intoxication, unspecified
white m 68 $nan$hematology blood hematocrit  50.4  %; hematology blood hemoglobin  17.2  g dl; hematology blood platelet count  285  k ul; blood gas blood free calcium  1.16  mmol l; blood gas blood lactate  2.3  mmol l; blood gas blood chloride, whole blood  101  meq l; blood gas blood glucose  138  mg dl; blood gas blood hematocrit, calculated  41  %; blood gas blood hemoglobin  13.6  g dl; blood gas blood potassium, whole blood  4.4  meq l; blood gas blood sodium, whole blood  137  meq l$sodium chloride 0.9%  flush  3  ml ; potassium chl 20 meq   1000 ml ns  1000  ml ; acetaminophen  325-650  mg ; ondansetron  4  mg ; hydromorphone (dilaudid)  0.5-1  mg ; oxycodone (immediate release)   5-10  mg ; milk of magnesia  30  ml ; docusate sodium  100  mg ; 
displacement of lumbar intervertebral disc without myelopathy 
white m 68 $nan$nan$sodium chloride 0.9%  flush  3  ml ; potassium chl 20 meq   1000 ml ns  1000  ml ; acetaminophen  325-650  mg ; ondansetron  4  mg ; hydromorphone (dilaudid)  0.5-1  mg ; oxycodone (immediate release)   5-10  mg ; milk of magnesia  30  ml ; docusate sodium  100  mg ; 
displacement of lumbar intervertebral disc without myelopathy 
white f 33 $nan$hematology blood hematocrit  34.9  %; hematology blood hemoglobin  11.9  g dl; hematology blood platelet count  232  k ul$docusate sodium  100  mg ; ibuprofen  600  mg ; acetaminophen  500-1000  mg ; 
 
white f 33 $nan$nan$docusate sodium  100  mg ; ibuprofen  600  mg ; acetaminophen  500-1000  mg ; ranitidine  150  mg ; dermoplast spray  1  spry ; 
 
white f 33 $nan$nan$docusate sodium  100  mg ; ibuprofen  600  mg ; acetaminophen  500-1000  mg ; ranitidine  150  mg ; dermoplast spray  1  spry ; 
 
white m 65 $nan$nan$atorvastatin  40  mg ; aspirin  81  mg ; 
 
white m 65 $nan$hematology blood hematocrit  40.8  %; hematology blood hemoglobin  13.5  g dl; hematology blood platelet count  133  k ul; chemistry blood anion gap  11  meq l; chemistry blood bicarbonate  24  meq l; chemistry blood chloride  102  meq l; chemistry blood chloride  111  meq l; chemistry blood creatinine  0.9  mg dl; chemistry blood creatinine  0.8  mg dl; chemistry blood potassium  4.1  meq l; chemistry blood potassium  4.3  meq l; chemistry blood sodium  139  meq l; chemistry blood sodium  142  meq l; chemistry blood urea nitrogen  13  mg dl; hematology blood inr(pt)  1.2  ; chemistry blood bilirubin, total  0.7  mg dl; chemistry blood albumin  4.3  g dl; blood gas blood free calcium  1.16  mmol l; blood gas blood free calcium  1.30  mmol l; blood gas blood free calcium  1.23  mmol l; blood gas blood free calcium  1.17  mmol l; blood gas blood lactate  1.7  mmol l; blood gas blood lactate  2.8  mmol l; blood gas blood lactate  3.4  mmol l; blood gas blood chloride, whole blood  102  meq l; blood gas blood chloride, whole blood  108  meq l; blood gas blood chloride, whole blood  107  meq l; blood gas blood glucose  109  mg dl; blood gas blood glucose  150  mg dl; blood gas blood glucose  192  mg dl; blood gas blood glucose  194  mg dl; blood gas blood glucose  151  mg dl; blood gas blood glucose  130  mg dl; blood gas blood glucose  139  mg dl; blood gas blood hematocrit, calculated  43  %; blood gas blood hematocrit, calculated  35  %; blood gas blood hematocrit, calculated  36  %; blood gas blood hematocrit, calculated  35  %; blood gas blood hematocrit, calculated  34  %; blood gas blood hematocrit, calculated  40  %; blood gas blood hemoglobin  14.3  g dl; blood gas blood hemoglobin  11.8  g dl; blood gas blood hemoglobin  11.9  g dl; blood gas blood hemoglobin  11.8  g dl; blood gas blood hemoglobin  11.4  g dl; blood gas blood hemoglobin  13.3  g dl; blood gas blood potassium, whole blood  4.1  meq l; blood gas blood potassium, whole blood  4.9  meq l; blood gas blood potassium, whole blood  4.6  meq l; blood gas blood potassium, whole blood  4.9  meq l; blood gas blood potassium, whole blood  3.9  meq l; blood gas blood potassium, whole blood  4.2  meq l; blood gas blood potassium, whole blood  4.3  meq l; blood gas blood sodium, whole blood  140  meq l; blood gas blood sodium, whole blood  139  meq l; blood gas blood sodium, whole blood  139  meq l; blood gas blood sodium, whole blood  141  meq l; chemistry blood % hemoglobin a1c  5.7  %$atorvastatin  40  mg ; aspirin  81  mg ; sodium chloride 0.9%  flush  3  ml ; acetaminophen  325-650  mg ; metoprolol succinate xl  100  mg ; mupirocin nasal ointment 2%  1  appl ; sodium chloride 0.9%  flush  10  ml ; lactated ringers  1000  ml ; 5% dextrose  250  ml ; propofol  1000  mg ; d5w  250  ml ; nitroglycerin  100  mg ; syringe  1  syr ; nitroglycerin  20  mg ; phenylephrine  60  mg ; phenylephrine  12  mg ; glycopyrrolate  0.6  mg ; neostigmine  3  mg ; sterile water  50  ml ; potassium chloride  20  meq ; 0.9% sodium chloride  1  bag ; calcium gluconate  2  g ; bag  50  ml ; magnesium sulfate  2  gm ; morphine sulfate  0.5-5  mg ; metoclopramide  10  mg ; oxycodone-acetaminophen (5mg-325mg)  1-2  tab ; acetaminophen  650  mg ; 0.9% sodium chloride  100  ml ; insulin human regular  100  unit ; dextrose 50%  12.5  gm ; iso-osmotic dextrose  50  ml ; cefazolin  2  g ; epinephrine  2  mg ; norepinephrine  8  mg ; 
 
white m 65 $nan$hematology blood hematocrit  36.8  %; hematology blood hematocrit  33.4  %; hematology blood hemoglobin  11.2  g dl; hematology blood platelet count  107  k ul; chemistry blood anion gap  8  meq l; chemistry blood bicarbonate  25  meq l; chemistry blood chloride  111  meq l; chemistry blood chloride  110  meq l; chemistry blood creatinine  0.8  mg dl; chemistry blood potassium  5.1  meq l; chemistry blood potassium  4.3  meq l; chemistry blood sodium  141  meq l; chemistry blood sodium  139  meq l; chemistry blood urea nitrogen  13  mg dl; chemistry blood glucose  71  mg dl; blood gas blood free calcium  1.05  mmol l; blood gas blood free calcium  1.07  mmol l; blood gas blood free calcium  1.13  mmol l; blood gas blood lactate  3.6  mmol l; blood gas blood lactate  3.8  mmol l; blood gas blood lactate  3.9  mmol l; blood gas blood lactate  4.0  mmol l; blood gas blood glucose  150  mg dl; blood gas blood glucose  144  mg dl; blood gas blood glucose  133  mg dl; blood gas blood glucose  136  mg dl; blood gas blood potassium, whole blood  4.0  meq l; blood gas blood potassium, whole blood  4.5  meq l$sodium chloride 0.9%  flush  10  ml ; 5% dextrose  250  ml ; propofol  1000  mg ; d5w  250  ml ; nitroglycerin  100  mg ; phenylephrine  60  mg ; glycopyrrolate  0.6  mg ; neostigmine  3  mg ; sterile water  50  ml ; potassium chloride  20  meq ; 0.9% sodium chloride  1  bag ; calcium gluconate  2  g ; bag  50  ml ; magnesium sulfate  2  gm ; morphine sulfate  0.5-5  mg ; metoclopramide  10  mg ; oxycodone-acetaminophen (5mg-325mg)  1-2  tab ; acetaminophen  650  mg ; 0.9% sodium chloride  100  ml ; insulin human regular  100  unit ; dextrose 50%  12.5  gm ; iso-osmotic dextrose  50  ml ; cefazolin  2  g ; epinephrine  2  mg ; norepinephrine  8  mg ; chlorhexidine gluconate 0.12% oral rinse  15  ml ; ranitidine  150  mg ; docusate sodium  100  mg ; albumin 5% (25g   500ml)  25  g ; aspirin ec  81  mg ; milk of magnesia  30  ml ; furosemide  20  mg ; glucagon  1  mg ; glucose gel  15  g ; bisacodyl  10  mg ; insulin  0  unit ; warfarin  1  dose ; warfarin  3  mg ; 
 
white m 65 $nan$hematology blood hematocrit  32.6  %; hematology blood hemoglobin  11.0  g dl; hematology blood platelet count  82  k ul; chemistry blood anion gap  13  meq l; chemistry blood bicarbonate  27  meq l; chemistry blood chloride  98  meq l; chemistry blood creatinine  0.8  mg dl; chemistry blood potassium  3.7  meq l; chemistry blood sodium  134  meq l; chemistry blood urea nitrogen  17  mg dl; hematology blood inr(pt)  1.2  ; chemistry blood glucose  134  mg dl$furosemide  20  mg ; glucagon  1  mg ; glucose gel  15  g ; bisacodyl  10  mg ; insulin  0  unit ; warfarin  1  dose ; warfarin  3  mg ; ketorolac  15  mg ; acetaminophen iv  1000  mg ; metoprolol tartrate  12.5  mg ; metoprolol tartrate  25  mg ; amiodarone  400  mg ; warfarin  5  mg ; amiodarone  150  mg ; 
 
white m 65 $nan$hematology blood hematocrit  32.5  %; hematology blood hemoglobin  11.1  g dl; hematology blood platelet count  110  k ul; chemistry blood anion gap  14  meq l; chemistry blood bicarbonate  27  meq l; chemistry blood chloride  97  meq l; chemistry blood creatinine  0.6  mg dl; chemistry blood potassium  3.9  meq l; chemistry blood sodium  134  meq l; chemistry blood urea nitrogen  15  mg dl; hematology blood inr(pt)  1.2  ; chemistry blood calcium, total  8.3  mg dl; chemistry blood glucose  104  mg dl$furosemide  20  mg ; glucagon  1  mg ; glucose gel  15  g ; bisacodyl  10  mg ; insulin  0  unit ; warfarin  1  dose ; ketorolac  15  mg ; acetaminophen iv  1000  mg ; amiodarone  400  mg ; warfarin  5  mg ; amiodarone  150  mg ; metoprolol tartrate  5  mg ; metoprolol tartrate  37.5  mg ; heparin sodium  25,000  unit ; 
 
white m 65 $nan$hematology blood hematocrit  31.0  %; hematology blood hemoglobin  10.5  g dl; hematology blood platelet count  184  k ul; chemistry blood anion gap  13  meq l; chemistry blood bicarbonate  30  meq l; chemistry blood chloride  97  meq l; chemistry blood creatinine  0.7  mg dl; chemistry blood potassium  3.6  meq l; chemistry blood sodium  136  meq l; chemistry blood urea nitrogen  13  mg dl; hematology blood inr(pt)  1.6  ; hematology blood inr(pt)  1.7  ; chemistry blood glucose  106  mg dl$furosemide  20  mg ; glucagon  1  mg ; glucose gel  15  g ; bisacodyl  10  mg ; insulin  0  unit ; warfarin  1  dose ; ketorolac  15  mg ; acetaminophen iv  1000  mg ; amiodarone  400  mg ; metoprolol tartrate  5  mg ; metoprolol tartrate  37.5  mg ; heparin sodium  25,000  unit ; potassium chloride  40  meq ; metoprolol tartrate  50  mg ; 
 
white m 65 $nan$hematology blood inr(pt)  1.9  ; hematology blood inr(pt)  2.0  $bisacodyl  10  mg ; warfarin  1  dose ; ketorolac  15  mg ; acetaminophen iv  1000  mg ; amiodarone  400  mg ; potassium chloride  40  meq ; metoprolol tartrate  50  mg ; 
 
white m 65 $nan$nan$bisacodyl  10  mg ; warfarin  1  dose ; acetaminophen iv  1000  mg ; amiodarone  400  mg ; metoprolol tartrate  50  mg ; 
 
black african american m 64 $nan$nan$insulin  10  unit ; 
 
black african american m 64 $nan$hematology blood hematocrit  36.8  %; hematology blood hemoglobin  12.3  g dl; hematology blood platelet count  191  k ul; chemistry blood anion gap  12  meq l; chemistry blood anion gap  9  meq l; chemistry blood bicarbonate  25  meq l; chemistry blood bicarbonate  27  meq l; chemistry blood chloride  99  meq l; chemistry blood chloride  100  meq l; chemistry blood creatinine  0.9  mg dl; chemistry blood creatinine  0.9  mg dl; chemistry blood potassium  4.2  meq l; chemistry blood potassium  4.3  meq l; chemistry blood sodium  132  meq l; chemistry blood sodium  132  meq l; chemistry blood urea nitrogen  18  mg dl; chemistry blood urea nitrogen  14  mg dl; hematology urine wbc  39  # hpf; chemistry blood calcium, total  8.7  mg dl; chemistry blood bilirubin, total  0.7  mg dl; chemistry blood glucose  241  mg dl; chemistry blood glucose  243  mg dl; blood gas blood lactate  1.5  mmol l; hematology urine glucose  1000  mg dl; chemistry blood % hemoglobin a1c  13.4  %$insulin  10  unit ; hydrochlorothiazide  25  mg ; 0.45% sodium chloride  1000  ml ; sodium chloride 0.9%  flush  3  ml ; 0.9% sodium chloride  1000  ml ; senna  1  tab ; acetaminophen  650  mg ; dextrose 50%  12.5  gm ; glucagon  1  mg ; iso-osmotic dextrose  50  ml ; ceftriaxone  1  gm ; insulin  0  unit ; heparin  5000  unit ; docusate sodium  100  mg ; 
 
black african american m 64 $nan$nan$sodium chloride 0.9%  flush  3  ml ; senna  1  tab ; acetaminophen  650  mg ; dextrose 50%  12.5  gm ; glucagon  1  mg ; iso-osmotic dextrose  50  ml ; ceftriaxone  1  gm ; heparin  5000  unit ; docusate sodium  100  mg ; ciprofloxacin hcl  500  mg ; 
 
white m 63 $nan$hematology blood hematocrit  31.6  %; hematology blood hematocrit  33.4  %; hematology blood hemoglobin  10.4  g dl; hematology blood hemoglobin  10.9  g dl; hematology blood platelet count  473  k ul; hematology blood platelet count  485  k ul; chemistry blood anion gap  18  meq l; chemistry blood bicarbonate  23  meq l; chemistry blood chloride  101  meq l; chemistry blood creatinine  1.1  mg dl; chemistry blood potassium  5.1  meq l; chemistry blood sodium  137  meq l; chemistry blood urea nitrogen  25  mg dl; chemistry blood calcium, total  9.6  mg dl; chemistry blood glucose  222  mg dl$sodium chloride 0.9%  flush  3  ml ; 0.9% sodium chloride  1000  ml ; dextrose 50%  12.5  gm ; glucagon  1  mg ; insulin  0  unit ; heparin  5000  unit ; gabapentin  100  mg ; metformin (glucophage)  850  mg ; triamcinolone acetonide 0.025% cream  1  appl ; insulin  20  unit ; citalopram hydrobromide  20  mg ; fenofibrate nanocrystallized  145  mg ; lisinopril  40  mg ; aspirin  81  mg ; 
 
white m 63 $nan$nan$sodium chloride 0.9%  flush  3  ml ; dextrose 50%  12.5  gm ; glucagon  1  mg ; insulin  0  unit ; heparin  5000  unit ; gabapentin  100  mg ; metformin (glucophage)  850  mg ; triamcinolone acetonide 0.025% cream  1  appl ; insulin  20  unit ; citalopram hydrobromide  20  mg ; fenofibrate nanocrystallized  145  mg ; lisinopril  40  mg ; aspirin  81  mg ; trazodone  50  mg ; 
 
white m 67 $nan$hematology blood hematocrit  42.9  %; hematology blood hemoglobin  14.1  g dl; hematology blood platelet count  100  k ul; chemistry blood anion gap  15  meq l; chemistry blood anion gap  16  meq l; chemistry blood anion gap  15  meq l; chemistry blood bicarbonate  24  meq l; chemistry blood bicarbonate  27  meq l; chemistry blood bicarbonate  27  meq l; chemistry blood chloride  99  meq l; chemistry blood chloride  96  meq l; chemistry blood chloride  95  meq l; chemistry blood creatinine  2.0  mg dl; chemistry blood creatinine  2.0  mg dl; chemistry blood creatinine  2.0  mg dl; chemistry blood potassium  4.4  meq l; chemistry blood potassium  4.0  meq l; chemistry blood potassium  3.8  meq l; chemistry blood sodium  134  meq l; chemistry blood sodium  135  meq l; chemistry blood sodium  133  meq l; chemistry blood urea nitrogen  54  mg dl; chemistry blood urea nitrogen  51  mg dl; chemistry blood urea nitrogen  50  mg dl; hematology blood inr(pt)  2.3  ; hematology blood inr(pt)  2.2  ; chemistry urine chloride, urine  45  meq l; chemistry urine creatinine, urine  51  mg dl; chemistry urine potassium, urine  30  meq l; chemistry urine sodium, urine  51  meq l; chemistry blood calcium, total  9.2  mg dl; chemistry blood calcium, total  9.2  mg dl; chemistry blood calcium, total  9.4  mg dl; chemistry blood glucose  94  mg dl; chemistry blood glucose  87  mg dl; chemistry blood glucose  120  mg dl; chemistry blood % hemoglobin a1c  6.7  %$influenza vaccine quadrivalent  0.5  ml ; pneumococcal 23-valent polysaccharide vaccine  0.5  ml ; sodium chloride 0.9%  flush  3  ml ; docusate sodium  100  mg ; senna  8.6  mg ; amiodarone  200  mg ; aspirin  81  mg ; mesalamine (rectal)  1000  mg ; pravastatin  40  mg ; multivitamins  1  tab ; warfarin  2.5  mg ; calcium carbonate  500  mg ; furosemide  40  mg ; metoprolol succinate xl  25  mg ; spironolactone  25  mg ; hydrochlorothiazide  12.5  mg ; allopurinol  300  mg ; levothyroxine sodium  88  mcg ; furosemide  60  mg ; sodium chloride nasal  1-2  spry ; vitamin d  4000  unit ; potassium chloride  20  meq ; 
 
white m 67 $nan$chemistry blood anion gap  14  meq l; chemistry blood anion gap  16  meq l; chemistry blood bicarbonate  29  meq l; chemistry blood bicarbonate  27  meq l; chemistry blood chloride  96  meq l; chemistry blood chloride  94  meq l; chemistry blood creatinine  2.0  mg dl; chemistry blood creatinine  1.8  mg dl; chemistry blood potassium  3.8  meq l; chemistry blood potassium  3.9  meq l; chemistry blood sodium  135  meq l; chemistry blood sodium  133  meq l; chemistry blood urea nitrogen  48  mg dl; chemistry blood urea nitrogen  44  mg dl; hematology blood inr(pt)  2.1  ; chemistry blood calcium, total  9.1  mg dl; chemistry blood calcium, total  9.2  mg dl; chemistry blood glucose  85  mg dl; chemistry blood glucose  101  mg dl$sodium chloride 0.9%  flush  3  ml ; docusate sodium  100  mg ; senna  8.6  mg ; amiodarone  200  mg ; aspirin  81  mg ; mesalamine (rectal)  1000  mg ; pravastatin  40  mg ; multivitamins  1  tab ; warfarin  2.5  mg ; calcium carbonate  500  mg ; furosemide  40  mg ; metoprolol succinate xl  25  mg ; spironolactone  25  mg ; hydrochlorothiazide  12.5  mg ; allopurinol  300  mg ; levothyroxine sodium  88  mcg ; furosemide  60  mg ; sodium chloride nasal  1-2  spry ; vitamin d  4000  unit ; potassium chloride  20  meq ; 
 
white m 67 $nan$chemistry blood anion gap  15  meq l; chemistry blood anion gap  17  meq l; chemistry blood bicarbonate  26  meq l; chemistry blood bicarbonate  26  meq l; chemistry blood chloride  95  meq l; chemistry blood chloride  93  meq l; chemistry blood creatinine  2.0  mg dl; chemistry blood creatinine  2.1  mg dl; chemistry blood potassium  4.1  meq l; chemistry blood potassium  4.2  meq l; chemistry blood sodium  132  meq l; chemistry blood sodium  132  meq l; chemistry blood urea nitrogen  46  mg dl; chemistry blood urea nitrogen  46  mg dl; hematology blood inr(pt)  2.0  ; chemistry urine chloride, urine  39  meq l; chemistry urine creatinine, urine  62  mg dl; chemistry urine potassium, urine  46  meq l; chemistry urine sodium, urine  35  meq l; chemistry urine urea nitrogen, urine  384  mg dl; chemistry blood calcium, total  9.4  mg dl; chemistry blood calcium, total  9.7  mg dl; chemistry blood glucose  92  mg dl; chemistry blood glucose  93  mg dl; chemistry urine albumin, urine  0.6  mg dl; chemistry urine albumin creatinine, urine  9.7  mg g$sodium chloride 0.9%  flush  3  ml ; docusate sodium  100  mg ; senna  8.6  mg ; amiodarone  200  mg ; aspirin  81  mg ; mesalamine (rectal)  1000  mg ; pravastatin  40  mg ; multivitamins  1  tab ; warfarin  2.5  mg ; calcium carbonate  500  mg ; metoprolol succinate xl  25  mg ; spironolactone  25  mg ; allopurinol  300  mg ; levothyroxine sodium  88  mcg ; furosemide  60  mg ; sodium chloride nasal  1-2  spry ; vitamin d  4000  unit ; potassium chloride  20  meq ; furosemide  80  mg ; 
 
white m 67 $nan$chemistry blood anion gap  16  meq l; chemistry blood bicarbonate  28  meq l; chemistry blood chloride  94  meq l; chemistry blood creatinine  2.1  mg dl; chemistry blood potassium  4.6  meq l; chemistry blood sodium  133  meq l; chemistry blood urea nitrogen  48  mg dl; hematology blood inr(pt)  1.9  ; chemistry blood calcium, total  9.9  mg dl; chemistry blood glucose  97  mg dl$sodium chloride 0.9%  flush  3  ml ; senna  8.6  mg ; amiodarone  200  mg ; aspirin  81  mg ; mesalamine (rectal)  1000  mg ; pravastatin  40  mg ; multivitamins  1  tab ; calcium carbonate  500  mg ; spironolactone  25  mg ; allopurinol  300  mg ; levothyroxine sodium  88  mcg ; sodium chloride nasal  1-2  spry ; vitamin d  4000  unit ; furosemide  80  mg ; warfarin  4  mg ; 
 
white m 67 $nan$chemistry blood anion gap  15  meq l; chemistry blood bicarbonate  27  meq l; chemistry blood chloride  93  meq l; chemistry blood creatinine  2.2  mg dl; chemistry blood potassium  4.1  meq l; chemistry blood sodium  131  meq l; chemistry blood urea nitrogen  48  mg dl; hematology blood inr(pt)  2.1  ; chemistry blood calcium, total  9.8  mg dl; chemistry blood glucose  88  mg dl$sodium chloride 0.9%  flush  3  ml ; senna  8.6  mg ; amiodarone  200  mg ; aspirin  81  mg ; mesalamine (rectal)  1000  mg ; pravastatin  40  mg ; multivitamins  1  tab ; calcium carbonate  500  mg ; spironolactone  25  mg ; allopurinol  300  mg ; levothyroxine sodium  88  mcg ; sodium chloride nasal  1-2  spry ; vitamin d  4000  unit ; warfarin  4  mg ; digoxin  0.125  mg ; torsemide  60  mg ; 
 
white m 67 $nan$chemistry blood anion gap  16  meq l; chemistry blood bicarbonate  29  meq l; chemistry blood chloride  93  meq l; chemistry blood creatinine  2.3  mg dl; chemistry blood potassium  3.7  meq l; chemistry blood sodium  134  meq l; chemistry blood urea nitrogen  56  mg dl; hematology blood inr(pt)  2.4  ; chemistry blood calcium, total  9.2  mg dl; chemistry blood glucose  78  mg dl$sodium chloride 0.9%  flush  3  ml ; senna  8.6  mg ; amiodarone  200  mg ; aspirin  81  mg ; mesalamine (rectal)  1000  mg ; pravastatin  40  mg ; multivitamins  1  tab ; calcium carbonate  500  mg ; spironolactone  25  mg ; allopurinol  300  mg ; levothyroxine sodium  88  mcg ; sodium chloride nasal  1-2  spry ; vitamin d  4000  unit ; warfarin  4  mg ; digoxin  0.125  mg ; torsemide  40  mg ; sarna lotion  1  appl ; 
 
white m 67 $nan$chemistry blood anion gap  16  meq l; chemistry blood bicarbonate  28  meq l; chemistry blood chloride  94  meq l; chemistry blood creatinine  2.3  mg dl; chemistry blood potassium  4.0  meq l; chemistry blood sodium  134  meq l; chemistry blood urea nitrogen  57  mg dl; hematology blood inr(pt)  2.8  ; chemistry blood calcium, total  9.4  mg dl; chemistry blood glucose  77  mg dl$sodium chloride 0.9%  flush  3  ml ; senna  8.6  mg ; amiodarone  200  mg ; aspirin  81  mg ; mesalamine (rectal)  1000  mg ; pravastatin  40  mg ; multivitamins  1  tab ; calcium carbonate  500  mg ; spironolactone  25  mg ; allopurinol  300  mg ; levothyroxine sodium  88  mcg ; sodium chloride nasal  1-2  spry ; vitamin d  4000  unit ; warfarin  4  mg ; digoxin  0.125  mg ; torsemide  40  mg ; sarna lotion  1  appl ; 
 
white m 41 $nan$nan$lisinopril  10  mg ; levothyroxine sodium  175  mcg ; 
 
white m 41 $nan$hematology blood hematocrit  40.5  %; hematology blood hemoglobin  14.6  g dl; hematology blood platelet count  381  k ul; chemistry blood anion gap  16  meq l; chemistry blood bicarbonate  22  meq l; chemistry blood chloride  105  meq l; chemistry blood creatinine  0.9  mg dl; chemistry blood potassium  4.3  meq l; chemistry blood sodium  139  meq l; chemistry blood sodium  141  meq l; chemistry blood sodium  139  meq l; chemistry blood urea nitrogen  17  mg dl; hematology blood inr(pt)  1.2  ; chemistry blood calcium, total  9.4  mg dl; chemistry blood glucose  150  mg dl; hematology urine glucose  neg  mg dl; hematology urine bilirubin  neg  mg dl$lisinopril  10  mg ; levothyroxine sodium  175  mcg ; sodium chloride 0.9%  flush  3  ml ; 0.9% sodium chloride  1000  ml ; dexamethasone  6  mg ; acetaminophen  650  mg ; insulin  0  unit ; soln.  250  ml ; mannitol 20%  50  g ; phenytoin  100  mg ; bisacodyl  10  mg ; senna  1  tab ; docusate sodium  100  mg ; 0.9% sodium chloride  100  ml ; phenytoin sodium  300  mg ; phenytoin  200  mg ; 
 
white m 41 $nan$hematology blood hematocrit  36.0  %; hematology blood hemoglobin  13.1  g dl; hematology blood platelet count  357  k ul; chemistry blood anion gap  11  meq l; chemistry blood bicarbonate  26  meq l; chemistry blood chloride  108  meq l; chemistry blood creatinine  0.9  mg dl; chemistry blood potassium  4.0  meq l; chemistry blood sodium  140  meq l; chemistry blood sodium  141  meq l; chemistry blood sodium  139  meq l; chemistry blood sodium  141  meq l; chemistry blood urea nitrogen  22  mg dl; hematology blood inr(pt)  1.2  ; chemistry blood calcium, total  9.5  mg dl; chemistry blood glucose  143  mg dl$lisinopril  10  mg ; levothyroxine sodium  175  mcg ; sodium chloride 0.9%  flush  3  ml ; dexamethasone  6  mg ; acetaminophen  650  mg ; insulin  0  unit ; soln.  250  ml ; mannitol 20%  50  g ; bisacodyl  10  mg ; senna  1  tab ; docusate sodium  100  mg ; 0.9% sodium chloride  100  ml ; phenytoin sodium  300  mg ; phenytoin  200  mg ; potassium chl 20 meq   1000 ml d5 1 2 ns  1000  ml ; 
 
white m 41 $nan$hematology blood hematocrit  37.7  %; hematology blood hemoglobin  13.3  g dl; hematology blood platelet count  344  k ul; chemistry blood anion gap  14  meq l; chemistry blood bicarbonate  26  meq l; chemistry blood chloride  107  meq l; chemistry blood creatinine  1.0  mg dl; chemistry blood potassium  4.3  meq l; chemistry blood sodium  143  meq l; chemistry blood sodium  142  meq l; chemistry blood sodium  141  meq l; chemistry blood urea nitrogen  29  mg dl; hematology blood inr(pt)  1.2  ; chemistry blood calcium, total  9.6  mg dl; chemistry blood glucose  164  mg dl$lisinopril  10  mg ; levothyroxine sodium  175  mcg ; sodium chloride 0.9%  flush  3  ml ; dexamethasone  6  mg ; acetaminophen  650  mg ; soln.  250  ml ; mannitol 20%  50  g ; bisacodyl  10  mg ; senna  1  tab ; docusate sodium  100  mg ; phenytoin  200  mg ; potassium chl 20 meq   1000 ml d5 1 2 ns  1000  ml ; 
 
white m 41 $nan$hematology blood hematocrit  37.7  %; hematology blood hemoglobin  13.1  g dl; hematology blood platelet count  340  k ul; chemistry blood anion gap  16  meq l; chemistry blood bicarbonate  21  meq l; chemistry blood chloride  102  meq l; chemistry blood creatinine  0.8  mg dl; chemistry blood potassium  4.1  meq l; chemistry blood sodium  138  meq l; chemistry blood sodium  135  meq l; chemistry blood sodium  137  meq l; chemistry blood sodium  138  meq l; chemistry blood urea nitrogen  25  mg dl; chemistry blood calcium, total  9.0  mg dl; chemistry blood glucose  123  mg dl$levothyroxine sodium  175  mcg ; sodium chloride 0.9%  flush  3  ml ; dexamethasone  6  mg ; acetaminophen  650  mg ; soln.  250  ml ; mannitol 20%  50  g ; bisacodyl  10  mg ; senna  1  tab ; docusate sodium  100  mg ; phenytoin  200  mg ; 
 
white m 41 $nan$hematology blood hematocrit  37.5  %; hematology blood hemoglobin  13.3  g dl; hematology blood platelet count  342  k ul; chemistry blood anion gap  14  meq l; chemistry blood bicarbonate  26  meq l; chemistry blood chloride  102  meq l; chemistry blood creatinine  0.8  mg dl; chemistry blood potassium  4.2  meq l; chemistry blood sodium  137  meq l; chemistry blood sodium  138  meq l; chemistry blood sodium  137  meq l; chemistry blood sodium  136  meq l; chemistry blood urea nitrogen  20  mg dl; chemistry blood calcium, total  9.0  mg dl; chemistry blood glucose  129  mg dl; chemistry blood albumin  3.8  g dl; hematology urine glucose  tr  mg dl; hematology urine bilirubin  neg  mg dl$levothyroxine sodium  175  mcg ; sodium chloride 0.9%  flush  3  ml ; dexamethasone  6  mg ; acetaminophen  650  mg ; soln.  250  ml ; mannitol 20%  50  g ; bisacodyl  10  mg ; senna  1  tab ; docusate sodium  100  mg ; phenytoin  200  mg ; potassium chl 20 meq   1000 ml d5ns  1000  ml ; potassium chl 20 meq   1000 ml ns  1000  ml ; phenytoin  300  mg ; lorazepam  0.5  mg ; lorazepam  1-2  mg ; 
 
white m 41 $nan$hematology blood hematocrit  37.1  %; hematology blood hemoglobin  13.1  g dl; hematology blood platelet count  322  k ul; chemistry blood anion gap  11  meq l; chemistry blood bicarbonate  29  meq l; chemistry blood chloride  101  meq l; chemistry blood creatinine  0.7  mg dl; chemistry blood potassium  4.4  meq l; chemistry blood sodium  135  meq l; chemistry blood sodium  137  meq l; chemistry blood sodium  136  meq l; chemistry blood sodium  137  meq l; chemistry blood urea nitrogen  21  mg dl; hematology blood inr(pt)  1.1  ; chemistry blood calcium, total  8.9  mg dl; chemistry blood glucose  137  mg dl; chemistry blood albumin  3.6  g dl$levothyroxine sodium  175  mcg ; sodium chloride 0.9%  flush  3  ml ; dexamethasone  6  mg ; acetaminophen  650  mg ; soln.  250  ml ; mannitol 20%  50  g ; bisacodyl  10  mg ; senna  1  tab ; docusate sodium  100  mg ; phenytoin  200  mg ; potassium chl 20 meq   1000 ml ns  1000  ml ; phenytoin  300  mg ; lorazepam  0.5  mg ; lorazepam  1-2  mg ; levetiracetam  500  mg ; levetiracetam  1000  mg ; 
 
white m 41 $nan$hematology blood hematocrit  37.9  %; hematology blood hemoglobin  13.8  g dl; hematology blood platelet count  323  k ul; chemistry blood anion gap  16  meq l; chemistry blood bicarbonate  23  meq l; chemistry blood chloride  101  meq l; chemistry blood creatinine  0.7  mg dl; chemistry blood potassium  4.5  meq l; chemistry blood sodium  137  meq l; chemistry blood sodium  135  meq l; chemistry blood sodium  137  meq l; chemistry blood urea nitrogen  23  mg dl; chemistry blood calcium, total  8.5  mg dl; chemistry blood glucose  144  mg dl; blood gas blood free calcium  1.10  mmol l; blood gas blood free calcium  1.10  mmol l; blood gas blood lactate  1.7  mmol l; blood gas blood lactate  3.2  mmol l; blood gas blood chloride, whole blood  99  meq l; blood gas blood chloride, whole blood  100  meq l; blood gas blood glucose  99  mg dl; blood gas blood glucose  109  mg dl; blood gas blood hematocrit, calculated  42  %; blood gas blood hematocrit, calculated  44  %; blood gas blood hemoglobin  14.0  g dl; blood gas blood hemoglobin  14.6  g dl; blood gas blood potassium, whole blood  4.1  meq l; blood gas blood potassium, whole blood  4.2  meq l; blood gas blood sodium, whole blood  131  meq l; blood gas blood sodium, whole blood  133  meq l$levothyroxine sodium  175  mcg ; sodium chloride 0.9%  flush  3  ml ; dexamethasone  6  mg ; acetaminophen  650  mg ; soln.  250  ml ; mannitol 20%  50  g ; bisacodyl  10  mg ; senna  1  tab ; docusate sodium  100  mg ; potassium chl 20 meq   1000 ml ns  1000  ml ; levetiracetam  500  mg ; levetiracetam  1000  mg ; 
 
white m 41 $nan$hematology blood hematocrit  38.8  %; hematology blood hematocrit  37.7  %; hematology blood hemoglobin  13.7  g dl; hematology blood hemoglobin  13.3  g dl; hematology blood platelet count  346  k ul; hematology blood platelet count  288  k ul; chemistry blood anion gap  16  meq l; chemistry blood anion gap  15  meq l; chemistry blood bicarbonate  24  meq l; chemistry blood bicarbonate  24  meq l; chemistry blood chloride  101  meq l; chemistry blood chloride  103  meq l; chemistry blood creatinine  0.9  mg dl; chemistry blood creatinine  0.8  mg dl; chemistry blood potassium  4.0  meq l; chemistry blood potassium  4.3  meq l; chemistry blood sodium  137  meq l; chemistry blood sodium  138  meq l; chemistry blood urea nitrogen  21  mg dl; chemistry blood urea nitrogen  22  mg dl; hematology blood inr(pt)  1.1  ; hematology blood inr(pt)  1.2  ; chemistry blood calcium, total  8.7  mg dl; chemistry blood calcium, total  8.3  mg dl; chemistry blood glucose  145  mg dl; chemistry blood glucose  135  mg dl$levothyroxine sodium  175  mcg ; sodium chloride 0.9%  flush  3  ml ; dexamethasone  6  mg ; acetaminophen  650  mg ; bisacodyl  10  mg ; senna  1  tab ; docusate sodium  100  mg ; levetiracetam  1000  mg ; cefazolin  2  g ; vial  1  vial ; pantoprazole sodium  40  mg ; labetalol  10-20  mg ; morphine sulfate  1-4  mg ; hydralazine  10  mg ; 0.9% sodium chloride  250  ml ; nicardipine iv  125  mg ; dexamethasone  4  mg ; lisinopril  20  mg ; heparin  5000  unit ; ondansetron  4  mg ; 
 
white m 41 $nan$hematology blood hematocrit  34.2  %; hematology blood hemoglobin  12.0  g dl; hematology blood platelet count  249  k ul; chemistry blood anion gap  14  meq l; chemistry blood bicarbonate  23  meq l; chemistry blood chloride  102  meq l; chemistry blood creatinine  0.9  mg dl; chemistry blood potassium  4.1  meq l; chemistry blood sodium  135  meq l; chemistry blood urea nitrogen  24  mg dl; chemistry blood calcium, total  8.4  mg dl; chemistry blood glucose  166  mg dl$sodium chloride 0.9%  flush  3  ml ; labetalol  10-20  mg ; morphine sulfate  1-4  mg ; 0.9% sodium chloride  250  ml ; nicardipine iv  125  mg ; lisinopril  20  mg ; heparin  5000  unit ; ondansetron  4  mg ; oxycodone-acetaminophen  1-2  tab ; sodium chloride 0.9%  flush  10  ml ; 
 
white m 41 $nan$hematology blood hematocrit  33.8  %; hematology blood hemoglobin  11.9  g dl; hematology blood platelet count  249  k ul; chemistry blood anion gap  9  meq l; chemistry blood bicarbonate  28  meq l; chemistry blood chloride  102  meq l; chemistry blood creatinine  0.7  mg dl; chemistry blood potassium  4.2  meq l; chemistry blood sodium  135  meq l; chemistry blood urea nitrogen  28  mg dl; hematology blood inr(pt)  1.1  ; chemistry blood calcium, total  8.5  mg dl; chemistry blood glucose  142  mg dl$sodium chloride 0.9%  flush  3  ml ; labetalol  10-20  mg ; morphine sulfate  1-4  mg ; 0.9% sodium chloride  250  ml ; nicardipine iv  125  mg ; lisinopril  20  mg ; heparin  5000  unit ; ondansetron  4  mg ; oxycodone-acetaminophen  1-2  tab ; sodium chloride 0.9%  flush  10  ml ; metformin (glucophage)  1000  mg ; heparin flush (10 units ml)  1  ml ; 
 
white m 41 $nan$nan$sodium chloride 0.9%  flush  3  ml ; 0.9% sodium chloride  250  ml ; nicardipine iv  125  mg ; heparin  5000  unit ; ondansetron  4  mg ; oxycodone-acetaminophen  1-2  tab ; metformin (glucophage)  1000  mg ; heparin flush (10 units ml)  1  ml ; 
 
white m 41 $nan$nan$sodium chloride 0.9%  flush  3  ml ; heparin  5000  unit ; ondansetron  4  mg ; oxycodone-acetaminophen  1-2  tab ; metformin (glucophage)  1000  mg ; heparin flush (10 units ml)  1  ml ; 
 
white f 88 $temp  97.0  heartrate  93.0  resprate  18.0  o2sat  95.0  sbp  172.0  dbp  73.0  rhythm    pain  9  ; temp  102.8  heartrate  98.0  resprate  18.0  o2sat  97.0  sbp  168.0  dbp  72.0  rhythm    pain    $hematology blood hematocrit  31.4  %; hematology blood hemoglobin  10.0  g dl; hematology blood platelet count  301  k ul; chemistry blood anion gap  19  meq l; chemistry blood bicarbonate  21  meq l; chemistry blood chloride  104  meq l; chemistry blood creatinine  1.3  mg dl; chemistry blood potassium  5.1  meq l; chemistry blood sodium  139  meq l; chemistry blood urea nitrogen  29  mg dl; hematology urine wbc  88  # hpf; chemistry blood glucose  102  mg dl; blood gas blood lactate  2.2  mmol l$nan
trigeminal neuralgia personal history of malignant neoplasm of breast myalgia and myositis, unspecified other chest pain calculus of kidney personal history of malignant neoplasm of other parts of uterus hip joint replacement hypertensive chronic kidney disease, unspecified, with chronic kidney disease stage i through stage iv, or unspecified car passenger injured in collision with van in traffic accident passenger in pick-up truck or van injured in collision with railway train or railway vehicle in traffic accident acquired absence of breast and nipple other specified temporomandibular joint disorders iron deficiency anemia, unspecified unspecified acquired hypothyroidism unspecified glaucoma chronic kidney disease, unspecified person boarding or alighting a pedal cycle injured in collision with pedestrian or animal late effect of complications of surgical and medical care unilateral paralysis of vocal cords or larynx, partial restless legs syndrome (rls) cystitis, unspecified hydronephrosis acute kidney failure, unspecified injury to facial nerve calculus of ureter other and unspecified mycoses other specified trigeminal nerve disorders dysphagia, unspecified attention to other artificial opening of urinary tract 
white f 88 $temp  99.8  heartrate  94.0  resprate  18.0  o2sat  97.0  sbp  104.0  dbp  68.0  rhythm    pain  5  ; temp    heartrate  92.0  resprate  17.0  o2sat  98.0  sbp  114.0  dbp  77.0  rhythm    pain  3  $hematology blood hematocrit  27.8  %; hematology blood hemoglobin  8.7  g dl; hematology blood platelet count  230  k ul; chemistry blood anion gap  17  meq l; chemistry blood bicarbonate  19  meq l; chemistry blood chloride  105  meq l; chemistry blood creatinine  1.3  mg dl; chemistry blood potassium  5.1  meq l; chemistry blood sodium  136  meq l; chemistry blood urea nitrogen  27  mg dl; chemistry blood glucose  131  mg dl$influenza vaccine quadrivalent  0.5  ml ; pneumococcal 23-valent polysaccharide vaccine  0.5  ml ; sodium chloride 0.9%  flush  3  ml ; d5 1 2ns  1000  ml ; acetaminophen  650  mg ; morphine sulfate  1-2  mg ; tramadol (ultram)  25  mg ; docusate sodium  100  mg ; senna  17.2  mg ; amlodipine  5  mg ; aspirin  81  mg ; gabapentin  100  mg ; levothyroxine sodium  50  mcg ; ropinirole  0.5  mg ; iso-osmotic dextrose  200  ml ; vancomycin  1000  mg ; heparin  5000  unit ; iso-osmotic dextrose  50  ml ; piperacillin-tazobactam  2.25  g ; 0.9% sodium chloride (mini bag plus)  100  ml ; micafungin  100  mg ; iso-osmotic sodium chloride  400  ml ; fluconazole  800  mg ; acetaminophen (liquid)  650  mg ; sodium chloride 0.9%  1000  ml ; hydromorphone (dilaudid)  0.125  mg ; fleet enema  1  enema ; 
trigeminal neuralgia personal history of malignant neoplasm of breast myalgia and myositis, unspecified other chest pain calculus of kidney personal history of malignant neoplasm of other parts of uterus hip joint replacement hypertensive chronic kidney disease, unspecified, with chronic kidney disease stage i through stage iv, or unspecified car passenger injured in collision with van in traffic accident passenger in pick-up truck or van injured in collision with railway train or railway vehicle in traffic accident acquired absence of breast and nipple other specified temporomandibular joint disorders iron deficiency anemia, unspecified unspecified acquired hypothyroidism unspecified glaucoma chronic kidney disease, unspecified person boarding or alighting a pedal cycle injured in collision with pedestrian or animal late effect of complications of surgical and medical care unilateral paralysis of vocal cords or larynx, partial restless legs syndrome (rls) cystitis, unspecified hydronephrosis acute kidney failure, unspecified injury to facial nerve calculus of ureter other and unspecified mycoses other specified trigeminal nerve disorders dysphagia, unspecified attention to other artificial opening of urinary tract 
white f 88 $nan$hematology blood hematocrit  24.6  %; hematology blood hemoglobin  7.5  g dl; hematology blood platelet count  206  k ul; chemistry blood anion gap  13  meq l; chemistry blood bicarbonate  21  meq l; chemistry blood chloride  105  meq l; chemistry blood creatinine  1.5  mg dl; chemistry blood potassium  4.4  meq l; chemistry blood sodium  135  meq l; chemistry blood urea nitrogen  26  mg dl; chemistry blood glucose  139  mg dl$sodium chloride 0.9%  flush  3  ml ; morphine sulfate  1-2  mg ; tramadol (ultram)  25  mg ; docusate sodium  100  mg ; senna  17.2  mg ; aspirin  81  mg ; gabapentin  100  mg ; levothyroxine sodium  50  mcg ; ropinirole  0.5  mg ; iso-osmotic dextrose  200  ml ; vancomycin  1000  mg ; heparin  5000  unit ; acetaminophen (liquid)  650  mg ; hydromorphone (dilaudid)  0.125  mg ; fleet enema  1  enema ; iso-osmotic sodium chloride  100  ml ; fluconazole  200  mg ; gabapentin  300  mg ; 
trigeminal neuralgia personal history of malignant neoplasm of breast myalgia and myositis, unspecified other chest pain calculus of kidney personal history of malignant neoplasm of other parts of uterus hip joint replacement hypertensive chronic kidney disease, unspecified, with chronic kidney disease stage i through stage iv, or unspecified car passenger injured in collision with van in traffic accident passenger in pick-up truck or van injured in collision with railway train or railway vehicle in traffic accident acquired absence of breast and nipple other specified temporomandibular joint disorders iron deficiency anemia, unspecified unspecified acquired hypothyroidism unspecified glaucoma chronic kidney disease, unspecified person boarding or alighting a pedal cycle injured in collision with pedestrian or animal late effect of complications of surgical and medical care unilateral paralysis of vocal cords or larynx, partial restless legs syndrome (rls) cystitis, unspecified hydronephrosis acute kidney failure, unspecified injury to facial nerve calculus of ureter other and unspecified mycoses other specified trigeminal nerve disorders dysphagia, unspecified attention to other artificial opening of urinary tract 
white f 88 $nan$nan$sodium chloride 0.9%  flush  3  ml ; morphine sulfate  1-2  mg ; tramadol (ultram)  25  mg ; docusate sodium  100  mg ; senna  17.2  mg ; aspirin  81  mg ; levothyroxine sodium  50  mcg ; ropinirole  0.5  mg ; heparin  5000  unit ; acetaminophen (liquid)  650  mg ; hydromorphone (dilaudid)  0.125  mg ; fleet enema  1  enema ; 
trigeminal neuralgia personal history of malignant neoplasm of breast myalgia and myositis, unspecified other chest pain calculus of kidney personal history of malignant neoplasm of other parts of uterus hip joint replacement hypertensive chronic kidney disease, unspecified, with chronic kidney disease stage i through stage iv, or unspecified car passenger injured in collision with van in traffic accident passenger in pick-up truck or van injured in collision with railway train or railway vehicle in traffic accident acquired absence of breast and nipple other specified temporomandibular joint disorders iron deficiency anemia, unspecified unspecified acquired hypothyroidism unspecified glaucoma chronic kidney disease, unspecified person boarding or alighting a pedal cycle injured in collision with pedestrian or animal late effect of complications of surgical and medical care unilateral paralysis of vocal cords or larynx, partial restless legs syndrome (rls) cystitis, unspecified hydronephrosis acute kidney failure, unspecified injury to facial nerve calculus of ureter other and unspecified mycoses other specified trigeminal nerve disorders dysphagia, unspecified attention to other artificial opening of urinary tract 
white f 69 $nan$nan$aspirin  81  mg ; atorvastatin  40  mg ; furosemide  20  mg ; lisinopril  20  mg ; 
 
white f 69 $nan$hematology blood hematocrit  38.8  %; chemistry blood anion gap  9  meq l; chemistry blood bicarbonate  30  meq l; chemistry blood chloride  108  meq l; chemistry blood creatinine  1.2  mg dl; chemistry blood potassium  4.0  meq l; chemistry blood sodium  143  meq l; chemistry blood urea nitrogen  30  mg dl; hematology blood inr(pt)  4.1  $aspirin  81  mg ; atorvastatin  40  mg ; furosemide  20  mg ; lisinopril  20  mg ; influenza virus vaccine  0.5  ml ; pneumococcal vac polyvalent  0.5  ml ; potassium chloride  20  meq ; potassium chloride  40  meq ; potassium chloride  60  meq ; sodium chloride 0.9%  flush  3  ml ; warfarin  2.5  mg ; ketorolac  30  mg ; naproxen  500  mg ; omeprazole  20  mg ; docusate sodium  100  mg ; 
 
white f 69 $nan$nan$aspirin  81  mg ; atorvastatin  40  mg ; furosemide  20  mg ; lisinopril  20  mg ; potassium chloride  20  meq ; potassium chloride  40  meq ; potassium chloride  60  meq ; sodium chloride 0.9%  flush  3  ml ; naproxen  500  mg ; omeprazole  20  mg ; docusate sodium  100  mg ; 
 
white m 70 $temp  97.5  heartrate  87.0  resprate  16.0  o2sat  98.0  sbp  107.0  dbp  52.0  rhythm    pain  0  ; temp  97.8  heartrate  69.0  resprate  12.0  o2sat  99.0  sbp  106.0  dbp  71.0  rhythm    pain  0  ; temp  97.5  heartrate  62.0  resprate  12.0  o2sat  99.0  sbp  87.0  dbp  64.0  rhythm    pain  0  ; temp    heartrate  65.0  resprate  12.0  o2sat  97.0  sbp  100.0  dbp  59.0  rhythm    pain  0  ; temp    heartrate  63.0  resprate  12.0  o2sat  100.0  sbp  102.0  dbp  64.0  rhythm    pain  0  $hematology blood hematocrit  35.4  %; hematology blood hemoglobin  11.6  g dl; hematology blood platelet count  152  k ul; chemistry blood anion gap  16  meq l; chemistry blood bicarbonate  20  meq l; chemistry blood chloride  99  meq l; chemistry blood creatinine  1.7  mg dl; chemistry blood potassium  4.9  meq l; chemistry blood sodium  135  meq l; chemistry blood urea nitrogen  40  mg dl; hematology blood inr(pt)  1.3  ; chemistry blood bilirubin, total  0.9  mg dl; chemistry blood glucose  229  mg dl; chemistry blood albumin  3.8  g dl; blood gas blood lactate  1.7  mmol l; hematology urine glucose  1000  mg dl$nan
occupational exposure to toxic agents in other industries dehydration presence of coronary angioplasty implant and graft atherosclerotic heart disease of native coronary artery without angina pectoris other diseases of stomach and duodenum hepatic failure, unspecified without coma type 2 diabetes mellitus with diabetic polyneuropathy portal hypertension hyperlipidemia, unspecified other cirrhosis of liver iron deficiency anemia, unspecified patient's other noncompliance with medication regimen nonalcoholic steatohepatitis (nash) essential (primary) hypertension orthostatic hypotension major depressive disorder, single episode, unspecified hypovolemia other ascites long term (current) use of insulin pruritus, unspecified acute kidney failure, unspecified type 2 diabetes mellitus with unspecified diabetic retinopathy without macular edema family history of ischemic heart disease unspecified cataract long-term (current) use of insulin depressive disorder, not elsewhere classified body mass index 31.0-31.9, adult other secondary thrombocytopenia esophageal varices in diseases classified elsewhere, without mention of bleeding person boarding or alighting a pedal cycle injured in collision with fixed or stationary object obesity, unspecified other and unspecified hyperlipidemia cirrhosis of liver without mention of alcohol subendocardial infarction, initial episode of care unspecified essential hypertension portal hypertension diabetes mellitus without mention of complication, type ii or unspecified type, not stated as uncontrolled portal hypertension iron deficiency anemia secondary to blood loss (chronic) other drugs and medicinal substances causing adverse effects in therapeutic use accidents occurring in residential institution nephritis and nephropathy, not specified as acute or chronic, with unspecified pathological lesion in kidney hepatic encephalopathy obesity, unspecified long-term (current) use of insulin cirrhosis of liver without mention of alcohol diabetes mellitus without mention of complication, type ii or unspecified type, not stated as uncontrolled esophageal varices in diseases classified elsewhere, with bleeding
white m 70 $temp    heartrate  93.0  resprate  13.0  o2sat  96.0  sbp  118.0  dbp  69.0  rhythm    pain  asleep  $hematology blood hematocrit  32.4  %; hematology blood hemoglobin  10.5  g dl; hematology blood platelet count  127  k ul; chemistry blood anion gap  12  meq l; chemistry blood bicarbonate  22  meq l; chemistry blood chloride  104  meq l; chemistry blood creatinine  1.1  mg dl; chemistry blood potassium  4.4  meq l; chemistry blood sodium  138  meq l; chemistry blood urea nitrogen  36  mg dl; hematology blood inr(pt)  1.4  ; chemistry blood calcium, total  8.6  mg dl; chemistry blood bilirubin, total  0.6  mg dl; chemistry blood glucose  250  mg dl; chemistry blood albumin  3.8  g dl$sodium chloride 0.9%  flush  3-10  ml ; heparin  5000  unit ; aspirin  81  mg ; dextrose 50%  12.5  gm ; glucagon  1  mg ; glucose gel  15  g ; lactulose  30  ml ; multivitamins  1  tab ; latanoprost 0.005% ophth. soln.  2  drop ; mirtazapine  30  mg ; naltrexone  50  mg ; rifaximin  550  mg ; sertraline  50  mg ; ursodiol  500  mg ; gabapentin  300  mg ; atorvastatin  80  mg ; insulin  0  unit ; insulin  30  unit ; ferrous sulfate  325  mg ; vial  1  vial ; ceftriaxone  2  gm ; lidocaine 1%  20  ml ; albumin 25% (12.5g   50ml)  25  g ; 
occupational exposure to toxic agents in other industries dehydration presence of coronary angioplasty implant and graft atherosclerotic heart disease of native coronary artery without angina pectoris other diseases of stomach and duodenum hepatic failure, unspecified without coma type 2 diabetes mellitus with diabetic polyneuropathy portal hypertension hyperlipidemia, unspecified other cirrhosis of liver iron deficiency anemia, unspecified patient's other noncompliance with medication regimen nonalcoholic steatohepatitis (nash) essential (primary) hypertension orthostatic hypotension major depressive disorder, single episode, unspecified hypovolemia other ascites long term (current) use of insulin pruritus, unspecified acute kidney failure, unspecified type 2 diabetes mellitus with unspecified diabetic retinopathy without macular edema family history of ischemic heart disease unspecified cataract long-term (current) use of insulin depressive disorder, not elsewhere classified body mass index 31.0-31.9, adult other secondary thrombocytopenia esophageal varices in diseases classified elsewhere, without mention of bleeding person boarding or alighting a pedal cycle injured in collision with fixed or stationary object obesity, unspecified other and unspecified hyperlipidemia cirrhosis of liver without mention of alcohol subendocardial infarction, initial episode of care unspecified essential hypertension portal hypertension diabetes mellitus without mention of complication, type ii or unspecified type, not stated as uncontrolled portal hypertension iron deficiency anemia secondary to blood loss (chronic) other drugs and medicinal substances causing adverse effects in therapeutic use accidents occurring in residential institution nephritis and nephropathy, not specified as acute or chronic, with unspecified pathological lesion in kidney hepatic encephalopathy obesity, unspecified long-term (current) use of insulin cirrhosis of liver without mention of alcohol diabetes mellitus without mention of complication, type ii or unspecified type, not stated as uncontrolled esophageal varices in diseases classified elsewhere, with bleeding
white m 70 $nan$hematology blood hematocrit  33.4  %; hematology blood hemoglobin  10.8  g dl; hematology blood platelet count  122  k ul; chemistry blood anion gap  13  meq l; chemistry blood bicarbonate  21  meq l; chemistry blood chloride  105  meq l; chemistry blood creatinine  1.0  mg dl; chemistry blood potassium  4.1  meq l; chemistry blood sodium  139  meq l; chemistry blood urea nitrogen  28  mg dl; hematology blood inr(pt)  1.3  ; chemistry blood calcium, total  8.7  mg dl; chemistry blood bilirubin, total  0.7  mg dl; chemistry blood glucose  133  mg dl; chemistry blood albumin  3.7  g dl$sodium chloride 0.9%  flush  3-10  ml ; heparin  5000  unit ; aspirin  81  mg ; dextrose 50%  12.5  gm ; glucagon  1  mg ; glucose gel  15  g ; lactulose  30  ml ; latanoprost 0.005% ophth. soln.  2  drop ; mirtazapine  30  mg ; naltrexone  50  mg ; rifaximin  550  mg ; sertraline  50  mg ; ursodiol  500  mg ; gabapentin  300  mg ; atorvastatin  80  mg ; insulin  0  unit ; insulin  30  unit ; ferrous sulfate  325  mg ; vial  1  vial ; ceftriaxone  2  gm ; lidocaine 1%  20  ml ; albumin 25% (12.5g   50ml)  25  g ; multivitamins w minerals  1  tab ; albumin 25% (12.5g   50ml)  100  g ; 
occupational exposure to toxic agents in other industries dehydration presence of coronary angioplasty implant and graft atherosclerotic heart disease of native coronary artery without angina pectoris other diseases of stomach and duodenum hepatic failure, unspecified without coma type 2 diabetes mellitus with diabetic polyneuropathy portal hypertension hyperlipidemia, unspecified other cirrhosis of liver iron deficiency anemia, unspecified patient's other noncompliance with medication regimen nonalcoholic steatohepatitis (nash) essential (primary) hypertension orthostatic hypotension major depressive disorder, single episode, unspecified hypovolemia other ascites long term (current) use of insulin pruritus, unspecified acute kidney failure, unspecified type 2 diabetes mellitus with unspecified diabetic retinopathy without macular edema family history of ischemic heart disease unspecified cataract long-term (current) use of insulin depressive disorder, not elsewhere classified body mass index 31.0-31.9, adult other secondary thrombocytopenia esophageal varices in diseases classified elsewhere, without mention of bleeding person boarding or alighting a pedal cycle injured in collision with fixed or stationary object obesity, unspecified other and unspecified hyperlipidemia cirrhosis of liver without mention of alcohol subendocardial infarction, initial episode of care unspecified essential hypertension portal hypertension diabetes mellitus without mention of complication, type ii or unspecified type, not stated as uncontrolled portal hypertension iron deficiency anemia secondary to blood loss (chronic) other drugs and medicinal substances causing adverse effects in therapeutic use accidents occurring in residential institution nephritis and nephropathy, not specified as acute or chronic, with unspecified pathological lesion in kidney hepatic encephalopathy obesity, unspecified long-term (current) use of insulin cirrhosis of liver without mention of alcohol diabetes mellitus without mention of complication, type ii or unspecified type, not stated as uncontrolled esophageal varices in diseases classified elsewhere, with bleeding
white m 70 $nan$hematology blood hematocrit  32.1  %; hematology blood hemoglobin  10.5  g dl; hematology blood platelet count  107  k ul; chemistry blood anion gap  14  meq l; chemistry blood bicarbonate  23  meq l; chemistry blood chloride  105  meq l; chemistry blood creatinine  1.0  mg dl; chemistry blood potassium  4.3  meq l; chemistry blood sodium  142  meq l; chemistry blood urea nitrogen  25  mg dl; hematology blood inr(pt)  1.5  ; chemistry blood calcium, total  9.1  mg dl; chemistry blood bilirubin, total  0.8  mg dl; chemistry blood glucose  156  mg dl; chemistry blood albumin  4.3  g dl$sodium chloride 0.9%  flush  3-10  ml ; heparin  5000  unit ; aspirin  81  mg ; dextrose 50%  12.5  gm ; glucagon  1  mg ; glucose gel  15  g ; lactulose  30  ml ; latanoprost 0.005% ophth. soln.  2  drop ; mirtazapine  30  mg ; naltrexone  50  mg ; rifaximin  550  mg ; sertraline  50  mg ; ursodiol  500  mg ; gabapentin  300  mg ; atorvastatin  80  mg ; insulin  0  unit ; insulin  30  unit ; ferrous sulfate  325  mg ; vial  1  vial ; ceftriaxone  2  gm ; multivitamins w minerals  1  tab ; albumin 25% (12.5g   50ml)  100  g ; aspirin  243  mg ; sodium chloride 0.9%  1000  ml ; 
occupational exposure to toxic agents in other industries dehydration presence of coronary angioplasty implant and graft atherosclerotic heart disease of native coronary artery without angina pectoris other diseases of stomach and duodenum hepatic failure, unspecified without coma type 2 diabetes mellitus with diabetic polyneuropathy portal hypertension hyperlipidemia, unspecified other cirrhosis of liver iron deficiency anemia, unspecified patient's other noncompliance with medication regimen nonalcoholic steatohepatitis (nash) essential (primary) hypertension orthostatic hypotension major depressive disorder, single episode, unspecified hypovolemia other ascites long term (current) use of insulin pruritus, unspecified acute kidney failure, unspecified type 2 diabetes mellitus with unspecified diabetic retinopathy without macular edema family history of ischemic heart disease unspecified cataract long-term (current) use of insulin depressive disorder, not elsewhere classified body mass index 31.0-31.9, adult other secondary thrombocytopenia esophageal varices in diseases classified elsewhere, without mention of bleeding person boarding or alighting a pedal cycle injured in collision with fixed or stationary object obesity, unspecified other and unspecified hyperlipidemia cirrhosis of liver without mention of alcohol subendocardial infarction, initial episode of care unspecified essential hypertension portal hypertension diabetes mellitus without mention of complication, type ii or unspecified type, not stated as uncontrolled portal hypertension iron deficiency anemia secondary to blood loss (chronic) other drugs and medicinal substances causing adverse effects in therapeutic use accidents occurring in residential institution nephritis and nephropathy, not specified as acute or chronic, with unspecified pathological lesion in kidney hepatic encephalopathy obesity, unspecified long-term (current) use of insulin cirrhosis of liver without mention of alcohol diabetes mellitus without mention of complication, type ii or unspecified type, not stated as uncontrolled esophageal varices in diseases classified elsewhere, with bleeding
white m 70 $nan$hematology blood hematocrit  33.5  %; hematology blood hemoglobin  10.8  g dl; hematology blood platelet count  115  k ul; chemistry blood anion gap  11  meq l; chemistry blood bicarbonate  23  meq l; chemistry blood chloride  105  meq l; chemistry blood creatinine  0.9  mg dl; chemistry blood potassium  4.6  meq l; chemistry blood sodium  139  meq l; chemistry blood urea nitrogen  22  mg dl; hematology blood inr(pt)  1.4  ; chemistry blood calcium, total  8.8  mg dl; chemistry blood bilirubin, total  0.7  mg dl; chemistry blood glucose  179  mg dl; chemistry blood albumin  4.0  g dl$sodium chloride 0.9%  flush  3-10  ml ; heparin  5000  unit ; aspirin  81  mg ; dextrose 50%  12.5  gm ; glucagon  1  mg ; glucose gel  15  g ; lactulose  30  ml ; latanoprost 0.005% ophth. soln.  2  drop ; mirtazapine  30  mg ; naltrexone  50  mg ; rifaximin  550  mg ; sertraline  50  mg ; ursodiol  500  mg ; gabapentin  300  mg ; atorvastatin  80  mg ; insulin  0  unit ; insulin  30  unit ; ferrous sulfate  325  mg ; multivitamins w minerals  1  tab ; acetaminophen  650  mg ; ciprofloxacin hcl  500  mg ; clopidogrel  75  mg ; neutra-phos  1  pkt ; 
occupational exposure to toxic agents in other industries dehydration presence of coronary angioplasty implant and graft atherosclerotic heart disease of native coronary artery without angina pectoris other diseases of stomach and duodenum hepatic failure, unspecified without coma type 2 diabetes mellitus with diabetic polyneuropathy portal hypertension hyperlipidemia, unspecified other cirrhosis of liver iron deficiency anemia, unspecified patient's other noncompliance with medication regimen nonalcoholic steatohepatitis (nash) essential (primary) hypertension orthostatic hypotension major depressive disorder, single episode, unspecified hypovolemia other ascites long term (current) use of insulin pruritus, unspecified acute kidney failure, unspecified type 2 diabetes mellitus with unspecified diabetic retinopathy without macular edema family history of ischemic heart disease unspecified cataract long-term (current) use of insulin depressive disorder, not elsewhere classified body mass index 31.0-31.9, adult other secondary thrombocytopenia esophageal varices in diseases classified elsewhere, without mention of bleeding person boarding or alighting a pedal cycle injured in collision with fixed or stationary object obesity, unspecified other and unspecified hyperlipidemia cirrhosis of liver without mention of alcohol subendocardial infarction, initial episode of care unspecified essential hypertension portal hypertension diabetes mellitus without mention of complication, type ii or unspecified type, not stated as uncontrolled portal hypertension iron deficiency anemia secondary to blood loss (chronic) other drugs and medicinal substances causing adverse effects in therapeutic use accidents occurring in residential institution nephritis and nephropathy, not specified as acute or chronic, with unspecified pathological lesion in kidney hepatic encephalopathy obesity, unspecified long-term (current) use of insulin cirrhosis of liver without mention of alcohol diabetes mellitus without mention of complication, type ii or unspecified type, not stated as uncontrolled esophageal varices in diseases classified elsewhere, with bleeding
white m 70 $nan$hematology blood hematocrit  35.5  %; hematology blood hemoglobin  11.6  g dl; hematology blood platelet count  123  k ul; chemistry blood anion gap  12  meq l; chemistry blood bicarbonate  22  meq l; chemistry blood chloride  105  meq l; chemistry blood creatinine  0.8  mg dl; chemistry blood potassium  4.6  meq l; chemistry blood sodium  139  meq l; chemistry blood urea nitrogen  24  mg dl; hematology blood inr(pt)  1.3  ; chemistry blood calcium, total  8.9  mg dl; chemistry blood bilirubin, total  1.0  mg dl; chemistry blood glucose  188  mg dl; chemistry blood albumin  4.1  g dl$sodium chloride 0.9%  flush  3-10  ml ; heparin  5000  unit ; aspirin  81  mg ; dextrose 50%  12.5  gm ; glucagon  1  mg ; glucose gel  15  g ; lactulose  30  ml ; latanoprost 0.005% ophth. soln.  2  drop ; mirtazapine  30  mg ; naltrexone  50  mg ; rifaximin  550  mg ; sertraline  50  mg ; ursodiol  500  mg ; gabapentin  300  mg ; atorvastatin  80  mg ; insulin  0  unit ; insulin  30  unit ; ferrous sulfate  325  mg ; multivitamins w minerals  1  tab ; acetaminophen  650  mg ; ciprofloxacin hcl  500  mg ; clopidogrel  75  mg ; neutra-phos  1  pkt ; vitamin d  800  unit ; albumin 25% (12.5g   50ml)  12.5  g ; iso-osmotic dextrose  200  ml ; vancomycin  1000  mg ; iso-osmotic dextrose  100  ml ; piperacillin-tazobactam  4.5  g ; 
occupational exposure to toxic agents in other industries dehydration presence of coronary angioplasty implant and graft atherosclerotic heart disease of native coronary artery without angina pectoris other diseases of stomach and duodenum hepatic failure, unspecified without coma type 2 diabetes mellitus with diabetic polyneuropathy portal hypertension hyperlipidemia, unspecified other cirrhosis of liver iron deficiency anemia, unspecified patient's other noncompliance with medication regimen nonalcoholic steatohepatitis (nash) essential (primary) hypertension orthostatic hypotension major depressive disorder, single episode, unspecified hypovolemia other ascites long term (current) use of insulin pruritus, unspecified acute kidney failure, unspecified type 2 diabetes mellitus with unspecified diabetic retinopathy without macular edema family history of ischemic heart disease unspecified cataract long-term (current) use of insulin depressive disorder, not elsewhere classified body mass index 31.0-31.9, adult other secondary thrombocytopenia esophageal varices in diseases classified elsewhere, without mention of bleeding person boarding or alighting a pedal cycle injured in collision with fixed or stationary object obesity, unspecified other and unspecified hyperlipidemia cirrhosis of liver without mention of alcohol subendocardial infarction, initial episode of care unspecified essential hypertension portal hypertension diabetes mellitus without mention of complication, type ii or unspecified type, not stated as uncontrolled portal hypertension iron deficiency anemia secondary to blood loss (chronic) other drugs and medicinal substances causing adverse effects in therapeutic use accidents occurring in residential institution nephritis and nephropathy, not specified as acute or chronic, with unspecified pathological lesion in kidney hepatic encephalopathy obesity, unspecified long-term (current) use of insulin cirrhosis of liver without mention of alcohol diabetes mellitus without mention of complication, type ii or unspecified type, not stated as uncontrolled esophageal varices in diseases classified elsewhere, with bleeding
white m 70 $nan$hematology blood hematocrit  33.3  %; hematology blood hemoglobin  11.1  g dl; hematology blood platelet count  113  k ul; chemistry blood anion gap  13  meq l; chemistry blood bicarbonate  21  meq l; chemistry blood chloride  105  meq l; chemistry blood creatinine  0.9  mg dl; chemistry blood potassium  4.6  meq l; chemistry blood sodium  139  meq l; chemistry blood urea nitrogen  20  mg dl; hematology blood inr(pt)  1.4  ; chemistry blood calcium, total  8.8  mg dl; chemistry blood bilirubin, total  1.1  mg dl; chemistry blood glucose  232  mg dl; chemistry blood albumin  3.9  g dl$sodium chloride 0.9%  flush  3-10  ml ; heparin  5000  unit ; aspirin  81  mg ; dextrose 50%  12.5  gm ; glucagon  1  mg ; glucose gel  15  g ; lactulose  30  ml ; latanoprost 0.005% ophth. soln.  2  drop ; mirtazapine  30  mg ; naltrexone  50  mg ; rifaximin  550  mg ; sertraline  50  mg ; ursodiol  500  mg ; gabapentin  300  mg ; atorvastatin  80  mg ; insulin  0  unit ; insulin  30  unit ; ferrous sulfate  325  mg ; multivitamins w minerals  1  tab ; acetaminophen  650  mg ; clopidogrel  75  mg ; vitamin d  800  unit ; iso-osmotic dextrose  200  ml ; vancomycin  1000  mg ; iso-osmotic dextrose  100  ml ; piperacillin-tazobactam  4.5  g ; metronidazole  500  mg ; ceftazidime  2  g ; 
occupational exposure to toxic agents in other industries dehydration presence of coronary angioplasty implant and graft atherosclerotic heart disease of native coronary artery without angina pectoris other diseases of stomach and duodenum hepatic failure, unspecified without coma type 2 diabetes mellitus with diabetic polyneuropathy portal hypertension hyperlipidemia, unspecified other cirrhosis of liver iron deficiency anemia, unspecified patient's other noncompliance with medication regimen nonalcoholic steatohepatitis (nash) essential (primary) hypertension orthostatic hypotension major depressive disorder, single episode, unspecified hypovolemia other ascites long term (current) use of insulin pruritus, unspecified acute kidney failure, unspecified type 2 diabetes mellitus with unspecified diabetic retinopathy without macular edema family history of ischemic heart disease unspecified cataract long-term (current) use of insulin depressive disorder, not elsewhere classified body mass index 31.0-31.9, adult other secondary thrombocytopenia esophageal varices in diseases classified elsewhere, without mention of bleeding person boarding or alighting a pedal cycle injured in collision with fixed or stationary object obesity, unspecified other and unspecified hyperlipidemia cirrhosis of liver without mention of alcohol subendocardial infarction, initial episode of care unspecified essential hypertension portal hypertension diabetes mellitus without mention of complication, type ii or unspecified type, not stated as uncontrolled portal hypertension iron deficiency anemia secondary to blood loss (chronic) other drugs and medicinal substances causing adverse effects in therapeutic use accidents occurring in residential institution nephritis and nephropathy, not specified as acute or chronic, with unspecified pathological lesion in kidney hepatic encephalopathy obesity, unspecified long-term (current) use of insulin cirrhosis of liver without mention of alcohol diabetes mellitus without mention of complication, type ii or unspecified type, not stated as uncontrolled esophageal varices in diseases classified elsewhere, with bleeding
white m 70 $nan$hematology blood hematocrit  31.9  %; hematology blood hemoglobin  10.4  g dl; hematology blood platelet count  114  k ul; chemistry blood anion gap  13  meq l; chemistry blood bicarbonate  24  meq l; chemistry blood chloride  101  meq l; chemistry blood creatinine  1.5  mg dl; chemistry blood potassium  4.6  meq l; chemistry blood sodium  138  meq l; chemistry blood urea nitrogen  27  mg dl; hematology blood inr(pt)  1.5  ; chemistry blood calcium, total  9.2  mg dl; chemistry blood bilirubin, total  1.0  mg dl; chemistry blood glucose  169  mg dl; chemistry blood albumin  4.7  g dl$sodium chloride 0.9%  flush  3-10  ml ; heparin  5000  unit ; aspirin  81  mg ; dextrose 50%  12.5  gm ; glucagon  1  mg ; glucose gel  15  g ; lactulose  30  ml ; latanoprost 0.005% ophth. soln.  2  drop ; mirtazapine  30  mg ; naltrexone  50  mg ; rifaximin  550  mg ; sertraline  50  mg ; ursodiol  500  mg ; gabapentin  300  mg ; atorvastatin  80  mg ; insulin  0  unit ; insulin  30  unit ; ferrous sulfate  325  mg ; multivitamins w minerals  1  tab ; acetaminophen  650  mg ; clopidogrel  75  mg ; vitamin d  800  unit ; iso-osmotic dextrose  200  ml ; vancomycin  1000  mg ; metronidazole  500  mg ; ceftazidime  2  g ; albumin 25% (12.5g   50ml)  50  g ; 
occupational exposure to toxic agents in other industries dehydration presence of coronary angioplasty implant and graft atherosclerotic heart disease of native coronary artery without angina pectoris other diseases of stomach and duodenum hepatic failure, unspecified without coma type 2 diabetes mellitus with diabetic polyneuropathy portal hypertension hyperlipidemia, unspecified other cirrhosis of liver iron deficiency anemia, unspecified patient's other noncompliance with medication regimen nonalcoholic steatohepatitis (nash) essential (primary) hypertension orthostatic hypotension major depressive disorder, single episode, unspecified hypovolemia other ascites long term (current) use of insulin pruritus, unspecified acute kidney failure, unspecified type 2 diabetes mellitus with unspecified diabetic retinopathy without macular edema family history of ischemic heart disease unspecified cataract long-term (current) use of insulin depressive disorder, not elsewhere classified body mass index 31.0-31.9, adult other secondary thrombocytopenia esophageal varices in diseases classified elsewhere, without mention of bleeding person boarding or alighting a pedal cycle injured in collision with fixed or stationary object obesity, unspecified other and unspecified hyperlipidemia cirrhosis of liver without mention of alcohol subendocardial infarction, initial episode of care unspecified essential hypertension portal hypertension diabetes mellitus without mention of complication, type ii or unspecified type, not stated as uncontrolled portal hypertension iron deficiency anemia secondary to blood loss (chronic) other drugs and medicinal substances causing adverse effects in therapeutic use accidents occurring in residential institution nephritis and nephropathy, not specified as acute or chronic, with unspecified pathological lesion in kidney hepatic encephalopathy obesity, unspecified long-term (current) use of insulin cirrhosis of liver without mention of alcohol diabetes mellitus without mention of complication, type ii or unspecified type, not stated as uncontrolled esophageal varices in diseases classified elsewhere, with bleeding
white m 70 $nan$hematology blood hematocrit  29.5  %; hematology blood hemoglobin  9.7  g dl; hematology blood platelet count  105  k ul; chemistry blood anion gap  14  meq l; chemistry blood anion gap  12  meq l; chemistry blood bicarbonate  21  meq l; chemistry blood bicarbonate  21  meq l; chemistry blood chloride  103  meq l; chemistry blood chloride  101  meq l; chemistry blood creatinine  1.8  mg dl; chemistry blood creatinine  1.9  mg dl; chemistry blood potassium  4.3  meq l; chemistry blood potassium  4.7  meq l; chemistry blood sodium  136  meq l; chemistry blood sodium  136  meq l; chemistry blood urea nitrogen  32  mg dl; chemistry blood urea nitrogen  33  mg dl; hematology blood inr(pt)  1.6  ; chemistry urine creatinine, urine  173  mg dl; chemistry urine urea nitrogen, urine  506  mg dl; chemistry blood calcium, total  8.9  mg dl; chemistry blood calcium, total  9.3  mg dl; chemistry blood bilirubin, total  0.8  mg dl; chemistry blood glucose  215  mg dl; chemistry blood glucose  305  mg dl; chemistry blood lactate dehydrogenase (ld)  147  iu l$sodium chloride 0.9%  flush  3-10  ml ; heparin  5000  unit ; aspirin  81  mg ; dextrose 50%  12.5  gm ; glucagon  1  mg ; glucose gel  15  g ; lactulose  30  ml ; latanoprost 0.005% ophth. soln.  2  drop ; mirtazapine  30  mg ; naltrexone  50  mg ; rifaximin  550  mg ; sertraline  50  mg ; ursodiol  500  mg ; gabapentin  300  mg ; atorvastatin  80  mg ; insulin  0  unit ; insulin  30  unit ; ferrous sulfate  325  mg ; multivitamins w minerals  1  tab ; acetaminophen  650  mg ; clopidogrel  75  mg ; vitamin d  800  unit ; metronidazole  500  mg ; ceftazidime  2  g ; albumin 25% (12.5g   50ml)  50  g ; insulin  6  unit ; bag  1  bag ; vancomycin  0  md to order daily dose ; magnesium oxide  400  mg ; 
occupational exposure to toxic agents in other industries dehydration presence of coronary angioplasty implant and graft atherosclerotic heart disease of native coronary artery without angina pectoris other diseases of stomach and duodenum hepatic failure, unspecified without coma type 2 diabetes mellitus with diabetic polyneuropathy portal hypertension hyperlipidemia, unspecified other cirrhosis of liver iron deficiency anemia, unspecified patient's other noncompliance with medication regimen nonalcoholic steatohepatitis (nash) essential (primary) hypertension orthostatic hypotension major depressive disorder, single episode, unspecified hypovolemia other ascites long term (current) use of insulin pruritus, unspecified acute kidney failure, unspecified type 2 diabetes mellitus with unspecified diabetic retinopathy without macular edema family history of ischemic heart disease unspecified cataract long-term (current) use of insulin depressive disorder, not elsewhere classified body mass index 31.0-31.9, adult other secondary thrombocytopenia esophageal varices in diseases classified elsewhere, without mention of bleeding person boarding or alighting a pedal cycle injured in collision with fixed or stationary object obesity, unspecified other and unspecified hyperlipidemia cirrhosis of liver without mention of alcohol subendocardial infarction, initial episode of care unspecified essential hypertension portal hypertension diabetes mellitus without mention of complication, type ii or unspecified type, not stated as uncontrolled portal hypertension iron deficiency anemia secondary to blood loss (chronic) other drugs and medicinal substances causing adverse effects in therapeutic use accidents occurring in residential institution nephritis and nephropathy, not specified as acute or chronic, with unspecified pathological lesion in kidney hepatic encephalopathy obesity, unspecified long-term (current) use of insulin cirrhosis of liver without mention of alcohol diabetes mellitus without mention of complication, type ii or unspecified type, not stated as uncontrolled esophageal varices in diseases classified elsewhere, with bleeding
white m 70 $nan$hematology blood hematocrit  28.8  %; hematology blood hemoglobin  9.5  g dl; hematology blood platelet count  102  k ul; chemistry blood anion gap  13  meq l; chemistry blood bicarbonate  20  meq l; chemistry blood chloride  106  meq l; chemistry blood creatinine  1.9  mg dl; chemistry blood potassium  4.8  meq l; chemistry blood sodium  139  meq l; chemistry blood urea nitrogen  39  mg dl; hematology blood inr(pt)  1.6  ; chemistry blood calcium, total  9.2  mg dl; chemistry blood bilirubin, total  0.7  mg dl; chemistry blood glucose  223  mg dl; chemistry blood albumin  4.6  g dl$sodium chloride 0.9%  flush  3-10  ml ; heparin  5000  unit ; aspirin  81  mg ; dextrose 50%  12.5  gm ; glucagon  1  mg ; glucose gel  15  g ; lactulose  30  ml ; latanoprost 0.005% ophth. soln.  2  drop ; mirtazapine  30  mg ; naltrexone  50  mg ; rifaximin  550  mg ; sertraline  50  mg ; ursodiol  500  mg ; gabapentin  300  mg ; atorvastatin  80  mg ; insulin  0  unit ; insulin  30  unit ; ferrous sulfate  325  mg ; multivitamins w minerals  1  tab ; acetaminophen  650  mg ; clopidogrel  75  mg ; vitamin d  800  unit ; metronidazole  500  mg ; ceftazidime  2  g ; magnesium oxide  400  mg ; insulin  4  unit ; 
occupational exposure to toxic agents in other industries dehydration presence of coronary angioplasty implant and graft atherosclerotic heart disease of native coronary artery without angina pectoris other diseases of stomach and duodenum hepatic failure, unspecified without coma type 2 diabetes mellitus with diabetic polyneuropathy portal hypertension hyperlipidemia, unspecified other cirrhosis of liver iron deficiency anemia, unspecified patient's other noncompliance with medication regimen nonalcoholic steatohepatitis (nash) essential (primary) hypertension orthostatic hypotension major depressive disorder, single episode, unspecified hypovolemia other ascites long term (current) use of insulin pruritus, unspecified acute kidney failure, unspecified type 2 diabetes mellitus with unspecified diabetic retinopathy without macular edema family history of ischemic heart disease unspecified cataract long-term (current) use of insulin depressive disorder, not elsewhere classified body mass index 31.0-31.9, adult other secondary thrombocytopenia esophageal varices in diseases classified elsewhere, without mention of bleeding person boarding or alighting a pedal cycle injured in collision with fixed or stationary object obesity, unspecified other and unspecified hyperlipidemia cirrhosis of liver without mention of alcohol subendocardial infarction, initial episode of care unspecified essential hypertension portal hypertension diabetes mellitus without mention of complication, type ii or unspecified type, not stated as uncontrolled portal hypertension iron deficiency anemia secondary to blood loss (chronic) other drugs and medicinal substances causing adverse effects in therapeutic use accidents occurring in residential institution nephritis and nephropathy, not specified as acute or chronic, with unspecified pathological lesion in kidney hepatic encephalopathy obesity, unspecified long-term (current) use of insulin cirrhosis of liver without mention of alcohol diabetes mellitus without mention of complication, type ii or unspecified type, not stated as uncontrolled esophageal varices in diseases classified elsewhere, with bleeding
white m 70 $nan$hematology blood hematocrit  29.0  %; hematology blood hemoglobin  9.5  g dl; hematology blood platelet count  103  k ul; chemistry blood anion gap  17  meq l; chemistry blood bicarbonate  18  meq l; chemistry blood chloride  103  meq l; chemistry blood creatinine  2.1  mg dl; chemistry blood potassium  4.8  meq l; chemistry blood sodium  138  meq l; chemistry blood urea nitrogen  43  mg dl; hematology blood inr(pt)  1.8  ; chemistry blood calcium, total  9.2  mg dl; chemistry blood bilirubin, total  0.8  mg dl; chemistry blood glucose  230  mg dl; chemistry blood lactate dehydrogenase (ld)  159  iu l; chemistry blood albumin  5.0  g dl$sodium chloride 0.9%  flush  3-10  ml ; heparin  5000  unit ; aspirin  81  mg ; dextrose 50%  12.5  gm ; glucagon  1  mg ; glucose gel  15  g ; lactulose  30  ml ; latanoprost 0.005% ophth. soln.  2  drop ; mirtazapine  30  mg ; naltrexone  50  mg ; rifaximin  550  mg ; sertraline  50  mg ; ursodiol  500  mg ; gabapentin  300  mg ; atorvastatin  80  mg ; insulin  0  unit ; insulin  30  unit ; ferrous sulfate  325  mg ; multivitamins w minerals  1  tab ; acetaminophen  650  mg ; clopidogrel  75  mg ; vitamin d  800  unit ; metronidazole  500  mg ; ceftazidime  2  g ; ondansetron  4  mg ; insulin  35  unit ; insulin  2  unit ; lidocaine jelly 2% (glydo)  1  appl ; iso-osmotic dextrose  150  ml ; vancomycin  750  mg ; 
occupational exposure to toxic agents in other industries dehydration presence of coronary angioplasty implant and graft atherosclerotic heart disease of native coronary artery without angina pectoris other diseases of stomach and duodenum hepatic failure, unspecified without coma type 2 diabetes mellitus with diabetic polyneuropathy portal hypertension hyperlipidemia, unspecified other cirrhosis of liver iron deficiency anemia, unspecified patient's other noncompliance with medication regimen nonalcoholic steatohepatitis (nash) essential (primary) hypertension orthostatic hypotension major depressive disorder, single episode, unspecified hypovolemia other ascites long term (current) use of insulin pruritus, unspecified acute kidney failure, unspecified type 2 diabetes mellitus with unspecified diabetic retinopathy without macular edema family history of ischemic heart disease unspecified cataract long-term (current) use of insulin depressive disorder, not elsewhere classified body mass index 31.0-31.9, adult other secondary thrombocytopenia esophageal varices in diseases classified elsewhere, without mention of bleeding person boarding or alighting a pedal cycle injured in collision with fixed or stationary object obesity, unspecified other and unspecified hyperlipidemia cirrhosis of liver without mention of alcohol subendocardial infarction, initial episode of care unspecified essential hypertension portal hypertension diabetes mellitus without mention of complication, type ii or unspecified type, not stated as uncontrolled portal hypertension iron deficiency anemia secondary to blood loss (chronic) other drugs and medicinal substances causing adverse effects in therapeutic use accidents occurring in residential institution nephritis and nephropathy, not specified as acute or chronic, with unspecified pathological lesion in kidney hepatic encephalopathy obesity, unspecified long-term (current) use of insulin cirrhosis of liver without mention of alcohol diabetes mellitus without mention of complication, type ii or unspecified type, not stated as uncontrolled esophageal varices in diseases classified elsewhere, with bleeding
white m 70 $nan$hematology blood hematocrit  30.7  %; hematology blood hemoglobin  9.8  g dl; hematology blood platelet count  113  k ul; chemistry blood anion gap  15  meq l; chemistry blood bicarbonate  19  meq l; chemistry blood chloride  101  meq l; chemistry blood creatinine  2.2  mg dl; chemistry blood potassium  4.8  meq l; chemistry blood sodium  135  meq l; chemistry blood urea nitrogen  45  mg dl; hematology blood inr(pt)  1.8  ; chemistry blood calcium, total  9.2  mg dl; chemistry blood bilirubin, total  0.9  mg dl; chemistry blood glucose  236  mg dl; chemistry blood lactate dehydrogenase (ld)  168  iu l; chemistry blood albumin  5.0  g dl$sodium chloride 0.9%  flush  3-10  ml ; heparin  5000  unit ; aspirin  81  mg ; dextrose 50%  12.5  gm ; glucagon  1  mg ; glucose gel  15  g ; lactulose  30  ml ; latanoprost 0.005% ophth. soln.  2  drop ; mirtazapine  30  mg ; naltrexone  50  mg ; rifaximin  550  mg ; sertraline  50  mg ; ursodiol  500  mg ; gabapentin  300  mg ; atorvastatin  80  mg ; insulin  0  unit ; insulin  30  unit ; ferrous sulfate  325  mg ; multivitamins w minerals  1  tab ; acetaminophen  650  mg ; clopidogrel  75  mg ; vitamin d  800  unit ; metronidazole  500  mg ; ceftazidime  2  g ; ondansetron  4  mg ; insulin  35  unit ; insulin  2  unit ; lidocaine jelly 2% (glydo)  1  appl ; iso-osmotic dextrose  150  ml ; vancomycin  750  mg ; ipratropium-albuterol neb  1  neb ; acetaminophen  500  mg ; simethicone  40-80  mg ; 
occupational exposure to toxic agents in other industries dehydration presence of coronary angioplasty implant and graft atherosclerotic heart disease of native coronary artery without angina pectoris other diseases of stomach and duodenum hepatic failure, unspecified without coma type 2 diabetes mellitus with diabetic polyneuropathy portal hypertension hyperlipidemia, unspecified other cirrhosis of liver iron deficiency anemia, unspecified patient's other noncompliance with medication regimen nonalcoholic steatohepatitis (nash) essential (primary) hypertension orthostatic hypotension major depressive disorder, single episode, unspecified hypovolemia other ascites long term (current) use of insulin pruritus, unspecified acute kidney failure, unspecified type 2 diabetes mellitus with unspecified diabetic retinopathy without macular edema family history of ischemic heart disease unspecified cataract long-term (current) use of insulin depressive disorder, not elsewhere classified body mass index 31.0-31.9, adult other secondary thrombocytopenia esophageal varices in diseases classified elsewhere, without mention of bleeding person boarding or alighting a pedal cycle injured in collision with fixed or stationary object obesity, unspecified other and unspecified hyperlipidemia cirrhosis of liver without mention of alcohol subendocardial infarction, initial episode of care unspecified essential hypertension portal hypertension diabetes mellitus without mention of complication, type ii or unspecified type, not stated as uncontrolled portal hypertension iron deficiency anemia secondary to blood loss (chronic) other drugs and medicinal substances causing adverse effects in therapeutic use accidents occurring in residential institution nephritis and nephropathy, not specified as acute or chronic, with unspecified pathological lesion in kidney hepatic encephalopathy obesity, unspecified long-term (current) use of insulin cirrhosis of liver without mention of alcohol diabetes mellitus without mention of complication, type ii or unspecified type, not stated as uncontrolled esophageal varices in diseases classified elsewhere, with bleeding
white m 70 $nan$hematology blood hematocrit  30.7  %; hematology blood hemoglobin  10.0  g dl; hematology blood platelet count  115  k ul; chemistry blood anion gap  15  meq l; chemistry blood bicarbonate  19  meq l; chemistry blood chloride  93  meq l; chemistry blood creatinine  2.4  mg dl; chemistry blood potassium  4.7  meq l; chemistry blood sodium  127  meq l; chemistry blood urea nitrogen  45  mg dl; hematology blood inr(pt)  1.7  ; chemistry blood calcium, total  9.0  mg dl; chemistry blood bilirubin, total  0.9  mg dl; chemistry blood glucose  333  mg dl$sodium chloride 0.9%  flush  3-10  ml ; heparin  5000  unit ; aspirin  81  mg ; dextrose 50%  12.5  gm ; glucagon  1  mg ; glucose gel  15  g ; lactulose  30  ml ; latanoprost 0.005% ophth. soln.  2  drop ; mirtazapine  30  mg ; naltrexone  50  mg ; rifaximin  550  mg ; sertraline  50  mg ; ursodiol  500  mg ; gabapentin  300  mg ; atorvastatin  80  mg ; insulin  0  unit ; insulin  30  unit ; ferrous sulfate  325  mg ; multivitamins w minerals  1  tab ; acetaminophen  650  mg ; clopidogrel  75  mg ; vitamin d  800  unit ; metronidazole  500  mg ; ceftazidime  2  g ; insulin  35  unit ; insulin  2  unit ; iso-osmotic dextrose  150  ml ; vancomycin  750  mg ; ipratropium-albuterol neb  1  neb ; acetaminophen  500  mg ; simethicone  40-80  mg ; insulin  5  unit ; magnesium sulfate  4  gm ; octreotide acetate  100  mcg ; midodrine  5  mg ; ceftazidime  1  g ; 
occupational exposure to toxic agents in other industries dehydration presence of coronary angioplasty implant and graft atherosclerotic heart disease of native coronary artery without angina pectoris other diseases of stomach and duodenum hepatic failure, unspecified without coma type 2 diabetes mellitus with diabetic polyneuropathy portal hypertension hyperlipidemia, unspecified other cirrhosis of liver iron deficiency anemia, unspecified patient's other noncompliance with medication regimen nonalcoholic steatohepatitis (nash) essential (primary) hypertension orthostatic hypotension major depressive disorder, single episode, unspecified hypovolemia other ascites long term (current) use of insulin pruritus, unspecified acute kidney failure, unspecified type 2 diabetes mellitus with unspecified diabetic retinopathy without macular edema family history of ischemic heart disease unspecified cataract long-term (current) use of insulin depressive disorder, not elsewhere classified body mass index 31.0-31.9, adult other secondary thrombocytopenia esophageal varices in diseases classified elsewhere, without mention of bleeding person boarding or alighting a pedal cycle injured in collision with fixed or stationary object obesity, unspecified other and unspecified hyperlipidemia cirrhosis of liver without mention of alcohol subendocardial infarction, initial episode of care unspecified essential hypertension portal hypertension diabetes mellitus without mention of complication, type ii or unspecified type, not stated as uncontrolled portal hypertension iron deficiency anemia secondary to blood loss (chronic) other drugs and medicinal substances causing adverse effects in therapeutic use accidents occurring in residential institution nephritis and nephropathy, not specified as acute or chronic, with unspecified pathological lesion in kidney hepatic encephalopathy obesity, unspecified long-term (current) use of insulin cirrhosis of liver without mention of alcohol diabetes mellitus without mention of complication, type ii or unspecified type, not stated as uncontrolled esophageal varices in diseases classified elsewhere, with bleeding
white m 70 $nan$hematology blood hematocrit  30.5  %; hematology blood hemoglobin  10.2  g dl; hematology blood platelet count  132  k ul; chemistry blood anion gap  15  meq l; chemistry blood bicarbonate  18  meq l; chemistry blood chloride  95  meq l; chemistry blood creatinine  2.9  mg dl; chemistry blood potassium  5.3  meq l; chemistry blood sodium  128  meq l; chemistry blood urea nitrogen  51  mg dl; hematology blood inr(pt)  1.7  ; chemistry blood calcium, total  8.8  mg dl; chemistry blood bilirubin, total  0.8  mg dl; chemistry blood glucose  344  mg dl; chemistry blood albumin  4.9  g dl$sodium chloride 0.9%  flush  3-10  ml ; heparin  5000  unit ; aspirin  81  mg ; dextrose 50%  12.5  gm ; glucagon  1  mg ; glucose gel  15  g ; lactulose  30  ml ; latanoprost 0.005% ophth. soln.  2  drop ; mirtazapine  30  mg ; naltrexone  50  mg ; rifaximin  550  mg ; sertraline  50  mg ; ursodiol  500  mg ; atorvastatin  80  mg ; ferrous sulfate  325  mg ; multivitamins w minerals  1  tab ; acetaminophen  650  mg ; clopidogrel  75  mg ; vitamin d  800  unit ; metronidazole  500  mg ; ipratropium-albuterol neb  1  neb ; magnesium sulfate  4  gm ; octreotide acetate  100  mcg ; midodrine  5  mg ; ceftazidime  1  g ; 5% dextrose  150  ml ; insulin  8  unit ; insulin  10  unit ; 
occupational exposure to toxic agents in other industries dehydration presence of coronary angioplasty implant and graft atherosclerotic heart disease of native coronary artery without angina pectoris other diseases of stomach and duodenum hepatic failure, unspecified without coma type 2 diabetes mellitus with diabetic polyneuropathy portal hypertension hyperlipidemia, unspecified other cirrhosis of liver iron deficiency anemia, unspecified patient's other noncompliance with medication regimen nonalcoholic steatohepatitis (nash) essential (primary) hypertension orthostatic hypotension major depressive disorder, single episode, unspecified hypovolemia other ascites long term (current) use of insulin pruritus, unspecified acute kidney failure, unspecified type 2 diabetes mellitus with unspecified diabetic retinopathy without macular edema family history of ischemic heart disease unspecified cataract long-term (current) use of insulin depressive disorder, not elsewhere classified body mass index 31.0-31.9, adult other secondary thrombocytopenia esophageal varices in diseases classified elsewhere, without mention of bleeding person boarding or alighting a pedal cycle injured in collision with fixed or stationary object obesity, unspecified other and unspecified hyperlipidemia cirrhosis of liver without mention of alcohol subendocardial infarction, initial episode of care unspecified essential hypertension portal hypertension diabetes mellitus without mention of complication, type ii or unspecified type, not stated as uncontrolled portal hypertension iron deficiency anemia secondary to blood loss (chronic) other drugs and medicinal substances causing adverse effects in therapeutic use accidents occurring in residential institution nephritis and nephropathy, not specified as acute or chronic, with unspecified pathological lesion in kidney hepatic encephalopathy obesity, unspecified long-term (current) use of insulin cirrhosis of liver without mention of alcohol diabetes mellitus without mention of complication, type ii or unspecified type, not stated as uncontrolled esophageal varices in diseases classified elsewhere, with bleeding
white m 70 $nan$hematology blood hematocrit  29.3  %; hematology blood hemoglobin  9.9  g dl; hematology blood platelet count  142  k ul; chemistry blood anion gap  14  meq l; chemistry blood bicarbonate  18  meq l; chemistry blood chloride  95  meq l; chemistry blood creatinine  3.5  mg dl; chemistry blood potassium  4.9  meq l; chemistry blood sodium  127  meq l; chemistry blood urea nitrogen  55  mg dl; hematology blood inr(pt)  1.6  ; chemistry urine creatinine, urine  158  mg dl; chemistry urine urea nitrogen, urine  346  mg dl; hematology urine wbc  5  # hpf; chemistry blood calcium, total  8.9  mg dl; chemistry blood bilirubin, total  0.7  mg dl; chemistry blood glucose  275  mg dl; chemistry blood albumin  4.4  g dl$sodium chloride 0.9%  flush  3-10  ml ; heparin  5000  unit ; aspirin  81  mg ; dextrose 50%  12.5  gm ; glucagon  1  mg ; glucose gel  15  g ; lactulose  30  ml ; latanoprost 0.005% ophth. soln.  2  drop ; mirtazapine  30  mg ; naltrexone  50  mg ; rifaximin  550  mg ; sertraline  50  mg ; ursodiol  500  mg ; atorvastatin  80  mg ; ferrous sulfate  325  mg ; multivitamins w minerals  1  tab ; acetaminophen  650  mg ; clopidogrel  75  mg ; vitamin d  800  unit ; metronidazole  500  mg ; ipratropium-albuterol neb  1  neb ; octreotide acetate  100  mcg ; midodrine  5  mg ; ceftazidime  1  g ; 5% dextrose  150  ml ; 
occupational exposure to toxic agents in other industries dehydration presence of coronary angioplasty implant and graft atherosclerotic heart disease of native coronary artery without angina pectoris other diseases of stomach and duodenum hepatic failure, unspecified without coma type 2 diabetes mellitus with diabetic polyneuropathy portal hypertension hyperlipidemia, unspecified other cirrhosis of liver iron deficiency anemia, unspecified patient's other noncompliance with medication regimen nonalcoholic steatohepatitis (nash) essential (primary) hypertension orthostatic hypotension major depressive disorder, single episode, unspecified hypovolemia other ascites long term (current) use of insulin pruritus, unspecified acute kidney failure, unspecified type 2 diabetes mellitus with unspecified diabetic retinopathy without macular edema family history of ischemic heart disease unspecified cataract long-term (current) use of insulin depressive disorder, not elsewhere classified body mass index 31.0-31.9, adult other secondary thrombocytopenia esophageal varices in diseases classified elsewhere, without mention of bleeding person boarding or alighting a pedal cycle injured in collision with fixed or stationary object obesity, unspecified other and unspecified hyperlipidemia cirrhosis of liver without mention of alcohol subendocardial infarction, initial episode of care unspecified essential hypertension portal hypertension diabetes mellitus without mention of complication, type ii or unspecified type, not stated as uncontrolled portal hypertension iron deficiency anemia secondary to blood loss (chronic) other drugs and medicinal substances causing adverse effects in therapeutic use accidents occurring in residential institution nephritis and nephropathy, not specified as acute or chronic, with unspecified pathological lesion in kidney hepatic encephalopathy obesity, unspecified long-term (current) use of insulin cirrhosis of liver without mention of alcohol diabetes mellitus without mention of complication, type ii or unspecified type, not stated as uncontrolled esophageal varices in diseases classified elsewhere, with bleeding
white m 70 $nan$hematology blood hematocrit  29.6  %; hematology blood hemoglobin  9.9  g dl; hematology blood platelet count  152  k ul; chemistry blood anion gap  17  meq l; chemistry blood anion gap  15  meq l; chemistry blood bicarbonate  17  meq l; chemistry blood bicarbonate  18  meq l; chemistry blood chloride  97  meq l; chemistry blood chloride  97  meq l; chemistry blood creatinine  4.6  mg dl; chemistry blood creatinine  4.5  mg dl; chemistry blood potassium  5.2  meq l; chemistry blood potassium  5.5  meq l; chemistry blood sodium  130  meq l; chemistry blood sodium  131  meq l; chemistry blood urea nitrogen  63  mg dl; chemistry blood urea nitrogen  67  mg dl; hematology blood inr(pt)  1.6  ; chemistry blood calcium, total  8.9  mg dl; chemistry blood calcium, total  9.2  mg dl; chemistry blood bilirubin, total  0.7  mg dl; chemistry blood glucose  361  mg dl; chemistry blood glucose  287  mg dl; chemistry blood lactate dehydrogenase (ld)  208  iu l; chemistry blood albumin  4.5  g dl$sodium chloride 0.9%  flush  3-10  ml ; heparin  5000  unit ; aspirin  81  mg ; dextrose 50%  12.5  gm ; glucagon  1  mg ; glucose gel  15  g ; lactulose  30  ml ; latanoprost 0.005% ophth. soln.  2  drop ; mirtazapine  30  mg ; naltrexone  50  mg ; rifaximin  550  mg ; sertraline  50  mg ; ursodiol  500  mg ; atorvastatin  80  mg ; ferrous sulfate  325  mg ; multivitamins w minerals  1  tab ; acetaminophen  650  mg ; clopidogrel  75  mg ; vitamin d  800  unit ; metronidazole  500  mg ; ipratropium-albuterol neb  1  neb ; midodrine  5  mg ; 5% dextrose  150  ml ; gabapentin  100  mg ; 
occupational exposure to toxic agents in other industries dehydration presence of coronary angioplasty implant and graft atherosclerotic heart disease of native coronary artery without angina pectoris other diseases of stomach and duodenum hepatic failure, unspecified without coma type 2 diabetes mellitus with diabetic polyneuropathy portal hypertension hyperlipidemia, unspecified other cirrhosis of liver iron deficiency anemia, unspecified patient's other noncompliance with medication regimen nonalcoholic steatohepatitis (nash) essential (primary) hypertension orthostatic hypotension major depressive disorder, single episode, unspecified hypovolemia other ascites long term (current) use of insulin pruritus, unspecified acute kidney failure, unspecified type 2 diabetes mellitus with unspecified diabetic retinopathy without macular edema family history of ischemic heart disease unspecified cataract long-term (current) use of insulin depressive disorder, not elsewhere classified body mass index 31.0-31.9, adult other secondary thrombocytopenia esophageal varices in diseases classified elsewhere, without mention of bleeding person boarding or alighting a pedal cycle injured in collision with fixed or stationary object obesity, unspecified other and unspecified hyperlipidemia cirrhosis of liver without mention of alcohol subendocardial infarction, initial episode of care unspecified essential hypertension portal hypertension diabetes mellitus without mention of complication, type ii or unspecified type, not stated as uncontrolled portal hypertension iron deficiency anemia secondary to blood loss (chronic) other drugs and medicinal substances causing adverse effects in therapeutic use accidents occurring in residential institution nephritis and nephropathy, not specified as acute or chronic, with unspecified pathological lesion in kidney hepatic encephalopathy obesity, unspecified long-term (current) use of insulin cirrhosis of liver without mention of alcohol diabetes mellitus without mention of complication, type ii or unspecified type, not stated as uncontrolled esophageal varices in diseases classified elsewhere, with bleeding
white m 70 $nan$hematology blood hematocrit  29.3  %; hematology blood hematocrit  32.8  %; hematology blood hemoglobin  9.9  g dl; hematology blood hemoglobin  11.1  g dl; hematology blood platelet count  146  k ul; hematology blood platelet count  159  k ul; chemistry blood anion gap  17  meq l; chemistry blood anion gap  16  meq l; chemistry blood bicarbonate  18  meq l; chemistry blood bicarbonate  17  meq l; chemistry blood chloride  96  meq l; chemistry blood chloride  96  meq l; chemistry blood creatinine  4.9  mg dl; chemistry blood creatinine  5.4  mg dl; chemistry blood potassium  5.9  meq l; chemistry blood potassium  5.1  meq l; chemistry blood sodium  130  meq l; chemistry blood sodium  130  meq l; chemistry blood urea nitrogen  73  mg dl; chemistry blood urea nitrogen  75  mg dl; hematology blood inr(pt)  1.6  ; hematology blood inr(pt)  1.6  ; chemistry blood calcium, total  8.8  mg dl; chemistry blood calcium, total  9.2  mg dl; chemistry blood bilirubin, total  0.6  mg dl; chemistry blood glucose  281  mg dl; chemistry blood glucose  240  mg dl; chemistry blood lactate dehydrogenase (ld)  208  iu l; chemistry blood albumin  4.3  g dl$sodium chloride 0.9%  flush  3-10  ml ; heparin  5000  unit ; aspirin  81  mg ; dextrose 50%  12.5  gm ; glucagon  1  mg ; glucose gel  15  g ; lactulose  30  ml ; latanoprost 0.005% ophth. soln.  2  drop ; mirtazapine  30  mg ; naltrexone  50  mg ; rifaximin  550  mg ; sertraline  50  mg ; ursodiol  500  mg ; atorvastatin  80  mg ; ferrous sulfate  325  mg ; multivitamins w minerals  1  tab ; acetaminophen  650  mg ; clopidogrel  75  mg ; vitamin d  800  unit ; metronidazole  500  mg ; ipratropium-albuterol neb  1  neb ; midodrine  5  mg ; 5% dextrose  150  ml ; gabapentin  100  mg ; 
occupational exposure to toxic agents in other industries dehydration presence of coronary angioplasty implant and graft atherosclerotic heart disease of native coronary artery without angina pectoris other diseases of stomach and duodenum hepatic failure, unspecified without coma type 2 diabetes mellitus with diabetic polyneuropathy portal hypertension hyperlipidemia, unspecified other cirrhosis of liver iron deficiency anemia, unspecified patient's other noncompliance with medication regimen nonalcoholic steatohepatitis (nash) essential (primary) hypertension orthostatic hypotension major depressive disorder, single episode, unspecified hypovolemia other ascites long term (current) use of insulin pruritus, unspecified acute kidney failure, unspecified type 2 diabetes mellitus with unspecified diabetic retinopathy without macular edema family history of ischemic heart disease unspecified cataract long-term (current) use of insulin depressive disorder, not elsewhere classified body mass index 31.0-31.9, adult other secondary thrombocytopenia esophageal varices in diseases classified elsewhere, without mention of bleeding person boarding or alighting a pedal cycle injured in collision with fixed or stationary object obesity, unspecified other and unspecified hyperlipidemia cirrhosis of liver without mention of alcohol subendocardial infarction, initial episode of care unspecified essential hypertension portal hypertension diabetes mellitus without mention of complication, type ii or unspecified type, not stated as uncontrolled portal hypertension iron deficiency anemia secondary to blood loss (chronic) other drugs and medicinal substances causing adverse effects in therapeutic use accidents occurring in residential institution nephritis and nephropathy, not specified as acute or chronic, with unspecified pathological lesion in kidney hepatic encephalopathy obesity, unspecified long-term (current) use of insulin cirrhosis of liver without mention of alcohol diabetes mellitus without mention of complication, type ii or unspecified type, not stated as uncontrolled esophageal varices in diseases classified elsewhere, with bleeding
white m 70 $nan$hematology blood hematocrit  29.7  %; hematology blood hematocrit  32.6  %; hematology blood hemoglobin  10.0  g dl; hematology blood hemoglobin  10.9  g dl; hematology blood platelet count  168  k ul; hematology blood platelet count  182  k ul; chemistry blood anion gap  17  meq l; chemistry blood anion gap  18  meq l; chemistry blood bicarbonate  16  meq l; chemistry blood bicarbonate  17  meq l; chemistry blood chloride  95  meq l; chemistry blood chloride  95  meq l; chemistry blood creatinine  5.9  mg dl; chemistry blood creatinine  5.1  mg dl; chemistry blood potassium  5.1  meq l; chemistry blood potassium  5.3  meq l; chemistry blood sodium  130  meq l; chemistry blood sodium  128  meq l; chemistry blood urea nitrogen  83  mg dl; chemistry blood urea nitrogen  63  mg dl; hematology blood inr(pt)  1.7  ; chemistry blood calcium, total  8.8  mg dl; chemistry blood calcium, total  9.2  mg dl; chemistry blood bilirubin, total  0.5  mg dl; chemistry blood glucose  348  mg dl; chemistry blood glucose  222  mg dl; chemistry blood lactate dehydrogenase (ld)  231  iu l; chemistry blood albumin  4.3  g dl; blood gas blood potassium, whole blood  5.0  meq l$sodium chloride 0.9%  flush  3-10  ml ; heparin  5000  unit ; aspirin  81  mg ; dextrose 50%  12.5  gm ; glucagon  1  mg ; glucose gel  15  g ; lactulose  30  ml ; latanoprost 0.005% ophth. soln.  2  drop ; mirtazapine  30  mg ; naltrexone  50  mg ; rifaximin  550  mg ; sertraline  50  mg ; ursodiol  500  mg ; atorvastatin  80  mg ; ferrous sulfate  325  mg ; multivitamins w minerals  1  tab ; acetaminophen  650  mg ; clopidogrel  75  mg ; vitamin d  800  unit ; metronidazole  500  mg ; ipratropium-albuterol neb  1  neb ; midodrine  5  mg ; 5% dextrose  150  ml ; gabapentin  100  mg ; heparin dwell (1000 units ml)  1000-4000  unit ; neomycin-polymyxin-bacitracin  1  appl ; insulin  38  unit ; insulin  12  unit ; 
occupational exposure to toxic agents in other industries dehydration presence of coronary angioplasty implant and graft atherosclerotic heart disease of native coronary artery without angina pectoris other diseases of stomach and duodenum hepatic failure, unspecified without coma type 2 diabetes mellitus with diabetic polyneuropathy portal hypertension hyperlipidemia, unspecified other cirrhosis of liver iron deficiency anemia, unspecified patient's other noncompliance with medication regimen nonalcoholic steatohepatitis (nash) essential (primary) hypertension orthostatic hypotension major depressive disorder, single episode, unspecified hypovolemia other ascites long term (current) use of insulin pruritus, unspecified acute kidney failure, unspecified type 2 diabetes mellitus with unspecified diabetic retinopathy without macular edema family history of ischemic heart disease unspecified cataract long-term (current) use of insulin depressive disorder, not elsewhere classified body mass index 31.0-31.9, adult other secondary thrombocytopenia esophageal varices in diseases classified elsewhere, without mention of bleeding person boarding or alighting a pedal cycle injured in collision with fixed or stationary object obesity, unspecified other and unspecified hyperlipidemia cirrhosis of liver without mention of alcohol subendocardial infarction, initial episode of care unspecified essential hypertension portal hypertension diabetes mellitus without mention of complication, type ii or unspecified type, not stated as uncontrolled portal hypertension iron deficiency anemia secondary to blood loss (chronic) other drugs and medicinal substances causing adverse effects in therapeutic use accidents occurring in residential institution nephritis and nephropathy, not specified as acute or chronic, with unspecified pathological lesion in kidney hepatic encephalopathy obesity, unspecified long-term (current) use of insulin cirrhosis of liver without mention of alcohol diabetes mellitus without mention of complication, type ii or unspecified type, not stated as uncontrolled esophageal varices in diseases classified elsewhere, with bleeding
white m 70 $nan$hematology blood hematocrit  29.7  %; hematology blood hematocrit  31.6  %; hematology blood hemoglobin  10.0  g dl; hematology blood hemoglobin  10.5  g dl; hematology blood platelet count  158  k ul; hematology blood platelet count  229  k ul; chemistry blood anion gap  17  meq l; chemistry blood anion gap  19  meq l; chemistry blood bicarbonate  16  meq l; chemistry blood bicarbonate  15  meq l; chemistry blood chloride  94  meq l; chemistry blood chloride  98  meq l; chemistry blood creatinine  5.6  mg dl; chemistry blood creatinine  6.3  mg dl; chemistry blood potassium  5.1  meq l; chemistry blood potassium  5.4  meq l; chemistry blood sodium  130  meq l; chemistry blood sodium  129  meq l; chemistry blood urea nitrogen  73  mg dl; chemistry blood urea nitrogen  75  mg dl; hematology blood inr(pt)  1.6  ; chemistry blood calcium, total  8.6  mg dl; chemistry blood calcium, total  8.9  mg dl; chemistry blood bilirubin, total  0.6  mg dl; chemistry blood glucose  451  mg dl; chemistry blood glucose  446  mg dl; chemistry blood lactate dehydrogenase (ld)  249  iu l; chemistry blood albumin  4.2  g dl$sodium chloride 0.9%  flush  3-10  ml ; heparin  5000  unit ; aspirin  81  mg ; dextrose 50%  12.5  gm ; glucagon  1  mg ; glucose gel  15  g ; lactulose  30  ml ; latanoprost 0.005% ophth. soln.  2  drop ; mirtazapine  30  mg ; naltrexone  50  mg ; rifaximin  550  mg ; sertraline  50  mg ; ursodiol  500  mg ; atorvastatin  80  mg ; ferrous sulfate  325  mg ; multivitamins w minerals  1  tab ; acetaminophen  650  mg ; clopidogrel  75  mg ; vitamin d  800  unit ; metronidazole  500  mg ; ipratropium-albuterol neb  1  neb ; midodrine  5  mg ; 5% dextrose  150  ml ; gabapentin  100  mg ; heparin dwell (1000 units ml)  1000-4000  unit ; neomycin-polymyxin-bacitracin  1  appl ; insulin  15  unit ; vancomycin  500  mg ; insulin  46  unit ; chlorpromazine  6.25  mg ; gastroview (diatrizoate meglumine & sodium)  30  ml ; 
occupational exposure to toxic agents in other industries dehydration presence of coronary angioplasty implant and graft atherosclerotic heart disease of native coronary artery without angina pectoris other diseases of stomach and duodenum hepatic failure, unspecified without coma type 2 diabetes mellitus with diabetic polyneuropathy portal hypertension hyperlipidemia, unspecified other cirrhosis of liver iron deficiency anemia, unspecified patient's other noncompliance with medication regimen nonalcoholic steatohepatitis (nash) essential (primary) hypertension orthostatic hypotension major depressive disorder, single episode, unspecified hypovolemia other ascites long term (current) use of insulin pruritus, unspecified acute kidney failure, unspecified type 2 diabetes mellitus with unspecified diabetic retinopathy without macular edema family history of ischemic heart disease unspecified cataract long-term (current) use of insulin depressive disorder, not elsewhere classified body mass index 31.0-31.9, adult other secondary thrombocytopenia esophageal varices in diseases classified elsewhere, without mention of bleeding person boarding or alighting a pedal cycle injured in collision with fixed or stationary object obesity, unspecified other and unspecified hyperlipidemia cirrhosis of liver without mention of alcohol subendocardial infarction, initial episode of care unspecified essential hypertension portal hypertension diabetes mellitus without mention of complication, type ii or unspecified type, not stated as uncontrolled portal hypertension iron deficiency anemia secondary to blood loss (chronic) other drugs and medicinal substances causing adverse effects in therapeutic use accidents occurring in residential institution nephritis and nephropathy, not specified as acute or chronic, with unspecified pathological lesion in kidney hepatic encephalopathy obesity, unspecified long-term (current) use of insulin cirrhosis of liver without mention of alcohol diabetes mellitus without mention of complication, type ii or unspecified type, not stated as uncontrolled esophageal varices in diseases classified elsewhere, with bleeding
white m 70 $nan$hematology blood hematocrit  31.4  %; hematology blood hematocrit  31.0  %; hematology blood hematocrit  26.9  %; hematology blood hemoglobin  10.3  g dl; hematology blood hemoglobin  10.0  g dl; hematology blood hemoglobin  8.8  g dl; hematology blood platelet count  142  k ul; hematology blood platelet count  145  k ul; hematology blood platelet count  122  k ul; chemistry blood anion gap  18  meq l; chemistry blood anion gap  18  meq l; chemistry blood anion gap  17  meq l; chemistry blood bicarbonate  19  meq l; chemistry blood bicarbonate  19  meq l; chemistry blood bicarbonate  19  meq l; chemistry blood chloride  94  meq l; chemistry blood chloride  93  meq l; chemistry blood chloride  94  meq l; chemistry blood creatinine  5.5  mg dl; chemistry blood creatinine  5.6  mg dl; chemistry blood creatinine  5.7  mg dl; chemistry blood potassium  4.9  meq l; chemistry blood potassium  4.9  meq l; chemistry blood potassium  5.1  meq l; chemistry blood sodium  130  meq l; chemistry blood sodium  130  meq l; chemistry blood sodium  131  meq l; chemistry blood urea nitrogen  57  mg dl; chemistry blood urea nitrogen  57  mg dl; chemistry blood urea nitrogen  60  mg dl; hematology blood inr(pt)  1.6  ; hematology blood inr(pt)  1.6  ; hematology blood inr(pt)  1.6  ; chemistry blood calcium, total  9.2  mg dl; chemistry blood calcium, total  8.6  mg dl; chemistry blood bilirubin, total  0.9  mg dl; chemistry blood bilirubin, total  0.8  mg dl; chemistry blood bilirubin, total  0.6  mg dl; chemistry blood glucose  410  mg dl; chemistry blood glucose  426  mg dl; chemistry blood glucose  438  mg dl; chemistry blood lactate dehydrogenase (ld)  221  iu l; chemistry blood albumin  4.3  g dl; blood gas blood lactate  3.3  mmol l; blood gas blood lactate  3.2  mmol l$pantoprazole  40  mg ; sodium chloride 0.9%  flush  3-10  ml ; heparin  5000  unit ; aspirin  81  mg ; dextrose 50%  12.5  gm ; glucagon  1  mg ; glucose gel  15  g ; lactulose  30  ml ; latanoprost 0.005% ophth. soln.  2  drop ; mirtazapine  30  mg ; naltrexone  50  mg ; rifaximin  550  mg ; sertraline  50  mg ; ursodiol  500  mg ; atorvastatin  80  mg ; ferrous sulfate  325  mg ; multivitamins w minerals  1  tab ; acetaminophen  650  mg ; clopidogrel  75  mg ; vitamin d  800  unit ; ipratropium-albuterol neb  1  neb ; 5% dextrose  150  ml ; gabapentin  100  mg ; heparin dwell (1000 units ml)  1000-4000  unit ; vancomycin  500  mg ; insulin  46  unit ; chlorpromazine  6.25  mg ; gastroview (diatrizoate meglumine & sodium)  30  ml ; meropenem  500  mg ; insulin  18  unit ; 0.9% sodium chloride  100  ml ; octreotide acetate  500  mcg ; insulin  22  unit ; lorazepam  0.5  mg ; 
occupational exposure to toxic agents in other industries dehydration presence of coronary angioplasty implant and graft atherosclerotic heart disease of native coronary artery without angina pectoris other diseases of stomach and duodenum hepatic failure, unspecified without coma type 2 diabetes mellitus with diabetic polyneuropathy portal hypertension hyperlipidemia, unspecified other cirrhosis of liver iron deficiency anemia, unspecified patient's other noncompliance with medication regimen nonalcoholic steatohepatitis (nash) essential (primary) hypertension orthostatic hypotension major depressive disorder, single episode, unspecified hypovolemia other ascites long term (current) use of insulin pruritus, unspecified acute kidney failure, unspecified type 2 diabetes mellitus with unspecified diabetic retinopathy without macular edema family history of ischemic heart disease unspecified cataract long-term (current) use of insulin depressive disorder, not elsewhere classified body mass index 31.0-31.9, adult other secondary thrombocytopenia esophageal varices in diseases classified elsewhere, without mention of bleeding person boarding or alighting a pedal cycle injured in collision with fixed or stationary object obesity, unspecified other and unspecified hyperlipidemia cirrhosis of liver without mention of alcohol subendocardial infarction, initial episode of care unspecified essential hypertension portal hypertension diabetes mellitus without mention of complication, type ii or unspecified type, not stated as uncontrolled portal hypertension iron deficiency anemia secondary to blood loss (chronic) other drugs and medicinal substances causing adverse effects in therapeutic use accidents occurring in residential institution nephritis and nephropathy, not specified as acute or chronic, with unspecified pathological lesion in kidney hepatic encephalopathy obesity, unspecified long-term (current) use of insulin cirrhosis of liver without mention of alcohol diabetes mellitus without mention of complication, type ii or unspecified type, not stated as uncontrolled esophageal varices in diseases classified elsewhere, with bleeding
white m 70 $nan$hematology blood hematocrit  30.0  %; hematology blood hemoglobin  10.1  g dl; hematology blood platelet count  205  k ul; chemistry blood anion gap  15  meq l; chemistry blood anion gap  18  meq l; chemistry blood anion gap  14  meq l; chemistry blood bicarbonate  20  meq l; chemistry blood bicarbonate  21  meq l; chemistry blood bicarbonate  20  meq l; chemistry blood chloride  93  meq l; chemistry blood chloride  92  meq l; chemistry blood chloride  92  meq l; chemistry blood creatinine  5.8  mg dl; chemistry blood creatinine  6.3  mg dl; chemistry blood creatinine  6.3  mg dl; chemistry blood potassium  4.6  meq l; chemistry blood potassium  4.3  meq l; chemistry blood potassium  4.4  meq l; chemistry blood sodium  127  meq l; chemistry blood sodium  127  meq l; chemistry blood sodium  131  meq l; chemistry blood urea nitrogen  48  mg dl; chemistry blood urea nitrogen  54  mg dl; chemistry blood urea nitrogen  55  mg dl; hematology blood inr(pt)  1.6  ; chemistry blood calcium, total  8.9  mg dl; chemistry blood calcium, total  8.8  mg dl; chemistry blood calcium, total  8.9  mg dl; chemistry blood bilirubin, total  0.8  mg dl; chemistry blood glucose  487  mg dl; chemistry blood glucose  466  mg dl; chemistry blood glucose  379  mg dl; chemistry blood albumin  4.4  g dl; blood gas blood glucose  513  mg dl$sodium chloride 0.9%  flush  3-10  ml ; heparin  5000  unit ; aspirin  81  mg ; dextrose 50%  12.5  gm ; glucagon  1  mg ; glucose gel  15  g ; lactulose  30  ml ; latanoprost 0.005% ophth. soln.  2  drop ; mirtazapine  30  mg ; naltrexone  50  mg ; rifaximin  550  mg ; sertraline  50  mg ; ursodiol  500  mg ; atorvastatin  80  mg ; ferrous sulfate  325  mg ; multivitamins w minerals  1  tab ; acetaminophen  650  mg ; clopidogrel  75  mg ; vitamin d  800  unit ; ipratropium-albuterol neb  1  neb ; 5% dextrose  150  ml ; gabapentin  100  mg ; insulin  22  unit ; lorazepam  0.5  mg ; insulin  40  unit ; simethicone  120  mg ; insulin human regular  100  unit ; micafungin  100  mg ; lidocaine 1%  1  ml ; 
occupational exposure to toxic agents in other industries dehydration presence of coronary angioplasty implant and graft atherosclerotic heart disease of native coronary artery without angina pectoris other diseases of stomach and duodenum hepatic failure, unspecified without coma type 2 diabetes mellitus with diabetic polyneuropathy portal hypertension hyperlipidemia, unspecified other cirrhosis of liver iron deficiency anemia, unspecified patient's other noncompliance with medication regimen nonalcoholic steatohepatitis (nash) essential (primary) hypertension orthostatic hypotension major depressive disorder, single episode, unspecified hypovolemia other ascites long term (current) use of insulin pruritus, unspecified acute kidney failure, unspecified type 2 diabetes mellitus with unspecified diabetic retinopathy without macular edema family history of ischemic heart disease unspecified cataract long-term (current) use of insulin depressive disorder, not elsewhere classified body mass index 31.0-31.9, adult other secondary thrombocytopenia esophageal varices in diseases classified elsewhere, without mention of bleeding person boarding or alighting a pedal cycle injured in collision with fixed or stationary object obesity, unspecified other and unspecified hyperlipidemia cirrhosis of liver without mention of alcohol subendocardial infarction, initial episode of care unspecified essential hypertension portal hypertension diabetes mellitus without mention of complication, type ii or unspecified type, not stated as uncontrolled portal hypertension iron deficiency anemia secondary to blood loss (chronic) other drugs and medicinal substances causing adverse effects in therapeutic use accidents occurring in residential institution nephritis and nephropathy, not specified as acute or chronic, with unspecified pathological lesion in kidney hepatic encephalopathy obesity, unspecified long-term (current) use of insulin cirrhosis of liver without mention of alcohol diabetes mellitus without mention of complication, type ii or unspecified type, not stated as uncontrolled esophageal varices in diseases classified elsewhere, with bleeding
white m 70 $nan$hematology blood hematocrit  25.9  %; hematology blood hematocrit  26.5  %; hematology blood hemoglobin  8.8  g dl; hematology blood hemoglobin  9.0  g dl; hematology blood platelet count  127  k ul; hematology blood platelet count  138  k ul; chemistry blood anion gap  20  meq l; chemistry blood anion gap  17  meq l; chemistry blood bicarbonate  20  meq l; chemistry blood bicarbonate  19  meq l; chemistry blood chloride  93  meq l; chemistry blood chloride  94  meq l; chemistry blood creatinine  6.8  mg dl; chemistry blood creatinine  7.1  mg dl; chemistry blood potassium  4.3  meq l; chemistry blood potassium  4.4  meq l; chemistry blood sodium  133  meq l; chemistry blood sodium  130  meq l; chemistry blood urea nitrogen  58  mg dl; chemistry blood urea nitrogen  60  mg dl; hematology blood inr(pt)  1.4  ; chemistry blood calcium, total  9.2  mg dl; chemistry blood calcium, total  9.3  mg dl; chemistry blood bilirubin, total  1.0  mg dl; chemistry blood glucose  338  mg dl; chemistry blood glucose  238  mg dl; chemistry blood albumin  4.4  g dl$sodium chloride 0.9%  flush  3-10  ml ; heparin  5000  unit ; aspirin  81  mg ; dextrose 50%  12.5  gm ; glucagon  1  mg ; glucose gel  15  g ; latanoprost 0.005% ophth. soln.  2  drop ; mirtazapine  30  mg ; naltrexone  50  mg ; rifaximin  550  mg ; sertraline  50  mg ; ursodiol  500  mg ; atorvastatin  80  mg ; ferrous sulfate  325  mg ; multivitamins w minerals  1  tab ; acetaminophen  650  mg ; clopidogrel  75  mg ; vitamin d  800  unit ; ipratropium-albuterol neb  1  neb ; 5% dextrose  150  ml ; gabapentin  100  mg ; lorazepam  0.5  mg ; simethicone  120  mg ; micafungin  100  mg ; lidocaine 1%  1  ml ; 0.9% sodium chloride  250  ml ; insulin human regular  250  units ; insulin  20  unit ; 
occupational exposure to toxic agents in other industries dehydration presence of coronary angioplasty implant and graft atherosclerotic heart disease of native coronary artery without angina pectoris other diseases of stomach and duodenum hepatic failure, unspecified without coma type 2 diabetes mellitus with diabetic polyneuropathy portal hypertension hyperlipidemia, unspecified other cirrhosis of liver iron deficiency anemia, unspecified patient's other noncompliance with medication regimen nonalcoholic steatohepatitis (nash) essential (primary) hypertension orthostatic hypotension major depressive disorder, single episode, unspecified hypovolemia other ascites long term (current) use of insulin pruritus, unspecified acute kidney failure, unspecified type 2 diabetes mellitus with unspecified diabetic retinopathy without macular edema family history of ischemic heart disease unspecified cataract long-term (current) use of insulin depressive disorder, not elsewhere classified body mass index 31.0-31.9, adult other secondary thrombocytopenia esophageal varices in diseases classified elsewhere, without mention of bleeding person boarding or alighting a pedal cycle injured in collision with fixed or stationary object obesity, unspecified other and unspecified hyperlipidemia cirrhosis of liver without mention of alcohol subendocardial infarction, initial episode of care unspecified essential hypertension portal hypertension diabetes mellitus without mention of complication, type ii or unspecified type, not stated as uncontrolled portal hypertension iron deficiency anemia secondary to blood loss (chronic) other drugs and medicinal substances causing adverse effects in therapeutic use accidents occurring in residential institution nephritis and nephropathy, not specified as acute or chronic, with unspecified pathological lesion in kidney hepatic encephalopathy obesity, unspecified long-term (current) use of insulin cirrhosis of liver without mention of alcohol diabetes mellitus without mention of complication, type ii or unspecified type, not stated as uncontrolled esophageal varices in diseases classified elsewhere, with bleeding
white m 70 $nan$hematology blood hematocrit  28.9  %; hematology blood hemoglobin  9.5  g dl; hematology blood platelet count  151  k ul; chemistry blood anion gap  17  meq l; chemistry blood bicarbonate  24  meq l; chemistry blood chloride  94  meq l; chemistry blood creatinine  5.2  mg dl; chemistry blood potassium  4.5  meq l; chemistry blood sodium  135  meq l; chemistry blood urea nitrogen  45  mg dl; hematology blood inr(pt)  1.5  ; chemistry blood calcium, total  9.6  mg dl; chemistry blood bilirubin, total  1.4  mg dl; chemistry blood glucose  320  mg dl; chemistry blood lactate dehydrogenase (ld)  265  iu l; chemistry blood albumin  4.8  g dl$sodium chloride 0.9%  flush  3-10  ml ; heparin  5000  unit ; aspirin  81  mg ; dextrose 50%  12.5  gm ; glucagon  1  mg ; glucose gel  15  g ; latanoprost 0.005% ophth. soln.  2  drop ; mirtazapine  30  mg ; naltrexone  50  mg ; rifaximin  550  mg ; sertraline  50  mg ; ursodiol  500  mg ; atorvastatin  80  mg ; ferrous sulfate  325  mg ; multivitamins w minerals  1  tab ; acetaminophen  650  mg ; clopidogrel  75  mg ; vitamin d  800  unit ; ipratropium-albuterol neb  1  neb ; 5% dextrose  150  ml ; gabapentin  100  mg ; simethicone  120  mg ; micafungin  100  mg ; insulin  20  unit ; insulin  45  unit ; 
occupational exposure to toxic agents in other industries dehydration presence of coronary angioplasty implant and graft atherosclerotic heart disease of native coronary artery without angina pectoris other diseases of stomach and duodenum hepatic failure, unspecified without coma type 2 diabetes mellitus with diabetic polyneuropathy portal hypertension hyperlipidemia, unspecified other cirrhosis of liver iron deficiency anemia, unspecified patient's other noncompliance with medication regimen nonalcoholic steatohepatitis (nash) essential (primary) hypertension orthostatic hypotension major depressive disorder, single episode, unspecified hypovolemia other ascites long term (current) use of insulin pruritus, unspecified acute kidney failure, unspecified type 2 diabetes mellitus with unspecified diabetic retinopathy without macular edema family history of ischemic heart disease unspecified cataract long-term (current) use of insulin depressive disorder, not elsewhere classified body mass index 31.0-31.9, adult other secondary thrombocytopenia esophageal varices in diseases classified elsewhere, without mention of bleeding person boarding or alighting a pedal cycle injured in collision with fixed or stationary object obesity, unspecified other and unspecified hyperlipidemia cirrhosis of liver without mention of alcohol subendocardial infarction, initial episode of care unspecified essential hypertension portal hypertension diabetes mellitus without mention of complication, type ii or unspecified type, not stated as uncontrolled portal hypertension iron deficiency anemia secondary to blood loss (chronic) other drugs and medicinal substances causing adverse effects in therapeutic use accidents occurring in residential institution nephritis and nephropathy, not specified as acute or chronic, with unspecified pathological lesion in kidney hepatic encephalopathy obesity, unspecified long-term (current) use of insulin cirrhosis of liver without mention of alcohol diabetes mellitus without mention of complication, type ii or unspecified type, not stated as uncontrolled esophageal varices in diseases classified elsewhere, with bleeding
white m 70 $nan$hematology blood hematocrit  28.9  %; hematology blood hematocrit  29.2  %; hematology blood hemoglobin  9.7  g dl; hematology blood hemoglobin  9.9  g dl; hematology blood platelet count  183  k ul; hematology blood platelet count  199  k ul; chemistry blood anion gap  20  meq l; chemistry blood anion gap  19  meq l; chemistry blood bicarbonate  23  meq l; chemistry blood bicarbonate  23  meq l; chemistry blood chloride  93  meq l; chemistry blood chloride  91  meq l; chemistry blood creatinine  6.8  mg dl; chemistry blood creatinine  6.8  mg dl; chemistry blood potassium  4.7  meq l; chemistry blood potassium  4.7  meq l; chemistry blood sodium  134  meq l; chemistry blood sodium  135  meq l; chemistry blood urea nitrogen  71  mg dl; chemistry blood urea nitrogen  72  mg dl; hematology blood inr(pt)  1.4  ; chemistry blood calcium, total  9.6  mg dl; chemistry blood calcium, total  9.7  mg dl; chemistry blood bilirubin, total  1.6  mg dl; chemistry blood glucose  174  mg dl; chemistry blood glucose  191  mg dl; chemistry blood lactate dehydrogenase (ld)  306  iu l; chemistry blood albumin  4.5  g dl$sodium chloride 0.9%  flush  3-10  ml ; heparin  5000  unit ; aspirin  81  mg ; dextrose 50%  12.5  gm ; glucagon  1  mg ; glucose gel  15  g ; latanoprost 0.005% ophth. soln.  2  drop ; mirtazapine  30  mg ; naltrexone  50  mg ; rifaximin  550  mg ; sertraline  50  mg ; ursodiol  500  mg ; atorvastatin  80  mg ; ferrous sulfate  325  mg ; multivitamins w minerals  1  tab ; acetaminophen  650  mg ; clopidogrel  75  mg ; vitamin d  800  unit ; ipratropium-albuterol neb  1  neb ; 5% dextrose  150  ml ; gabapentin  100  mg ; simethicone  120  mg ; micafungin  100  mg ; insulin  45  unit ; metoclopramide  10  mg ; 
occupational exposure to toxic agents in other industries dehydration presence of coronary angioplasty implant and graft atherosclerotic heart disease of native coronary artery without angina pectoris other diseases of stomach and duodenum hepatic failure, unspecified without coma type 2 diabetes mellitus with diabetic polyneuropathy portal hypertension hyperlipidemia, unspecified other cirrhosis of liver iron deficiency anemia, unspecified patient's other noncompliance with medication regimen nonalcoholic steatohepatitis (nash) essential (primary) hypertension orthostatic hypotension major depressive disorder, single episode, unspecified hypovolemia other ascites long term (current) use of insulin pruritus, unspecified acute kidney failure, unspecified type 2 diabetes mellitus with unspecified diabetic retinopathy without macular edema family history of ischemic heart disease unspecified cataract long-term (current) use of insulin depressive disorder, not elsewhere classified body mass index 31.0-31.9, adult other secondary thrombocytopenia esophageal varices in diseases classified elsewhere, without mention of bleeding person boarding or alighting a pedal cycle injured in collision with fixed or stationary object obesity, unspecified other and unspecified hyperlipidemia cirrhosis of liver without mention of alcohol subendocardial infarction, initial episode of care unspecified essential hypertension portal hypertension diabetes mellitus without mention of complication, type ii or unspecified type, not stated as uncontrolled portal hypertension iron deficiency anemia secondary to blood loss (chronic) other drugs and medicinal substances causing adverse effects in therapeutic use accidents occurring in residential institution nephritis and nephropathy, not specified as acute or chronic, with unspecified pathological lesion in kidney hepatic encephalopathy obesity, unspecified long-term (current) use of insulin cirrhosis of liver without mention of alcohol diabetes mellitus without mention of complication, type ii or unspecified type, not stated as uncontrolled esophageal varices in diseases classified elsewhere, with bleeding
white m 70 $nan$hematology blood hematocrit  26.2  %; hematology blood hematocrit  23.6  %; hematology blood hematocrit  25.6  %; hematology blood hemoglobin  8.9  g dl; hematology blood hemoglobin  7.8  g dl; hematology blood hemoglobin  8.6  g dl; hematology blood platelet count  149  k ul; hematology blood platelet count  149  k ul; hematology blood platelet count  190  k ul; chemistry blood anion gap  18  meq l; chemistry blood bicarbonate  25  meq l; chemistry blood chloride  90  meq l; chemistry blood creatinine  5.3  mg dl; chemistry blood potassium  4.4  meq l; chemistry blood sodium  133  meq l; chemistry blood urea nitrogen  55  mg dl; hematology blood inr(pt)  1.6  ; hematology blood inr(pt)  1.6  ; chemistry blood calcium, total  9.0  mg dl; chemistry blood bilirubin, total  2.3  mg dl; chemistry blood glucose  256  mg dl; chemistry blood lactate dehydrogenase (ld)  310  iu l; chemistry blood albumin  4.2  g dl$sodium chloride 0.9%  flush  3-10  ml ; heparin  5000  unit ; aspirin  81  mg ; dextrose 50%  12.5  gm ; glucagon  1  mg ; glucose gel  15  g ; latanoprost 0.005% ophth. soln.  2  drop ; mirtazapine  30  mg ; naltrexone  50  mg ; rifaximin  550  mg ; sertraline  50  mg ; ursodiol  500  mg ; atorvastatin  80  mg ; ferrous sulfate  325  mg ; multivitamins w minerals  1  tab ; acetaminophen  650  mg ; clopidogrel  75  mg ; vitamin d  800  unit ; ipratropium-albuterol neb  1  neb ; 5% dextrose  150  ml ; gabapentin  100  mg ; simethicone  120  mg ; micafungin  100  mg ; metoclopramide  10  mg ; d5lr  1000  ml ; 
occupational exposure to toxic agents in other industries dehydration presence of coronary angioplasty implant and graft atherosclerotic heart disease of native coronary artery without angina pectoris other diseases of stomach and duodenum hepatic failure, unspecified without coma type 2 diabetes mellitus with diabetic polyneuropathy portal hypertension hyperlipidemia, unspecified other cirrhosis of liver iron deficiency anemia, unspecified patient's other noncompliance with medication regimen nonalcoholic steatohepatitis (nash) essential (primary) hypertension orthostatic hypotension major depressive disorder, single episode, unspecified hypovolemia other ascites long term (current) use of insulin pruritus, unspecified acute kidney failure, unspecified type 2 diabetes mellitus with unspecified diabetic retinopathy without macular edema family history of ischemic heart disease unspecified cataract long-term (current) use of insulin depressive disorder, not elsewhere classified body mass index 31.0-31.9, adult other secondary thrombocytopenia esophageal varices in diseases classified elsewhere, without mention of bleeding person boarding or alighting a pedal cycle injured in collision with fixed or stationary object obesity, unspecified other and unspecified hyperlipidemia cirrhosis of liver without mention of alcohol subendocardial infarction, initial episode of care unspecified essential hypertension portal hypertension diabetes mellitus without mention of complication, type ii or unspecified type, not stated as uncontrolled portal hypertension iron deficiency anemia secondary to blood loss (chronic) other drugs and medicinal substances causing adverse effects in therapeutic use accidents occurring in residential institution nephritis and nephropathy, not specified as acute or chronic, with unspecified pathological lesion in kidney hepatic encephalopathy obesity, unspecified long-term (current) use of insulin cirrhosis of liver without mention of alcohol diabetes mellitus without mention of complication, type ii or unspecified type, not stated as uncontrolled esophageal varices in diseases classified elsewhere, with bleeding
white m 70 $nan$hematology blood hematocrit  24.0  %; hematology blood hemoglobin  8.0  g dl; hematology blood platelet count  149  k ul; chemistry blood anion gap  20  meq l; chemistry blood bicarbonate  22  meq l; chemistry blood chloride  90  meq l; chemistry blood creatinine  7.0  mg dl; chemistry blood potassium  5.1  meq l; chemistry blood sodium  132  meq l; chemistry blood urea nitrogen  83  mg dl; hematology blood inr(pt)  1.5  ; chemistry blood calcium, total  8.7  mg dl; chemistry blood bilirubin, total  2.8  mg dl; chemistry blood glucose  234  mg dl; chemistry blood lactate dehydrogenase (ld)  286  iu l; chemistry blood albumin  4.1  g dl$sodium chloride 0.9%  flush  3-10  ml ; heparin  5000  unit ; aspirin  81  mg ; dextrose 50%  12.5  gm ; glucagon  1  mg ; glucose gel  15  g ; latanoprost 0.005% ophth. soln.  2  drop ; mirtazapine  30  mg ; naltrexone  50  mg ; rifaximin  550  mg ; sertraline  50  mg ; ursodiol  500  mg ; atorvastatin  80  mg ; ferrous sulfate  325  mg ; multivitamins w minerals  1  tab ; acetaminophen  650  mg ; clopidogrel  75  mg ; vitamin d  800  unit ; ipratropium-albuterol neb  1  neb ; 5% dextrose  150  ml ; gabapentin  100  mg ; simethicone  120  mg ; micafungin  100  mg ; sevelamer carbonate  800  mg ; 
occupational exposure to toxic agents in other industries dehydration presence of coronary angioplasty implant and graft atherosclerotic heart disease of native coronary artery without angina pectoris other diseases of stomach and duodenum hepatic failure, unspecified without coma type 2 diabetes mellitus with diabetic polyneuropathy portal hypertension hyperlipidemia, unspecified other cirrhosis of liver iron deficiency anemia, unspecified patient's other noncompliance with medication regimen nonalcoholic steatohepatitis (nash) essential (primary) hypertension orthostatic hypotension major depressive disorder, single episode, unspecified hypovolemia other ascites long term (current) use of insulin pruritus, unspecified acute kidney failure, unspecified type 2 diabetes mellitus with unspecified diabetic retinopathy without macular edema family history of ischemic heart disease unspecified cataract long-term (current) use of insulin depressive disorder, not elsewhere classified body mass index 31.0-31.9, adult other secondary thrombocytopenia esophageal varices in diseases classified elsewhere, without mention of bleeding person boarding or alighting a pedal cycle injured in collision with fixed or stationary object obesity, unspecified other and unspecified hyperlipidemia cirrhosis of liver without mention of alcohol subendocardial infarction, initial episode of care unspecified essential hypertension portal hypertension diabetes mellitus without mention of complication, type ii or unspecified type, not stated as uncontrolled portal hypertension iron deficiency anemia secondary to blood loss (chronic) other drugs and medicinal substances causing adverse effects in therapeutic use accidents occurring in residential institution nephritis and nephropathy, not specified as acute or chronic, with unspecified pathological lesion in kidney hepatic encephalopathy obesity, unspecified long-term (current) use of insulin cirrhosis of liver without mention of alcohol diabetes mellitus without mention of complication, type ii or unspecified type, not stated as uncontrolled esophageal varices in diseases classified elsewhere, with bleeding
white m 70 $nan$hematology blood hematocrit  25.6  %; hematology blood hemoglobin  8.6  g dl; hematology blood platelet count  191  k ul; chemistry blood anion gap  26  meq l; chemistry blood bicarbonate  18  meq l; chemistry blood chloride  86  meq l; chemistry blood creatinine  8.8  mg dl; chemistry blood potassium  5.1  meq l; chemistry blood sodium  130  meq l; chemistry blood urea nitrogen  109  mg dl; hematology blood inr(pt)  1.4  ; chemistry blood calcium, total  8.8  mg dl; chemistry blood bilirubin, total  2.7  mg dl; chemistry blood glucose  262  mg dl; chemistry blood lactate dehydrogenase (ld)  330  iu l; chemistry blood albumin  4.3  g dl$sodium chloride 0.9%  flush  3-10  ml ; heparin  5000  unit ; aspirin  81  mg ; dextrose 50%  12.5  gm ; glucagon  1  mg ; glucose gel  15  g ; latanoprost 0.005% ophth. soln.  2  drop ; mirtazapine  30  mg ; naltrexone  50  mg ; rifaximin  550  mg ; sertraline  50  mg ; ursodiol  500  mg ; atorvastatin  80  mg ; ferrous sulfate  325  mg ; acetaminophen  650  mg ; clopidogrel  75  mg ; vitamin d  800  unit ; ipratropium-albuterol neb  1  neb ; 5% dextrose  150  ml ; gabapentin  100  mg ; simethicone  120  mg ; micafungin  100  mg ; sevelamer carbonate  800  mg ; nephrocaps  1  cap ; calcium carbonate  500  mg ; 
occupational exposure to toxic agents in other industries dehydration presence of coronary angioplasty implant and graft atherosclerotic heart disease of native coronary artery without angina pectoris other diseases of stomach and duodenum hepatic failure, unspecified without coma type 2 diabetes mellitus with diabetic polyneuropathy portal hypertension hyperlipidemia, unspecified other cirrhosis of liver iron deficiency anemia, unspecified patient's other noncompliance with medication regimen nonalcoholic steatohepatitis (nash) essential (primary) hypertension orthostatic hypotension major depressive disorder, single episode, unspecified hypovolemia other ascites long term (current) use of insulin pruritus, unspecified acute kidney failure, unspecified type 2 diabetes mellitus with unspecified diabetic retinopathy without macular edema family history of ischemic heart disease unspecified cataract long-term (current) use of insulin depressive disorder, not elsewhere classified body mass index 31.0-31.9, adult other secondary thrombocytopenia esophageal varices in diseases classified elsewhere, without mention of bleeding person boarding or alighting a pedal cycle injured in collision with fixed or stationary object obesity, unspecified other and unspecified hyperlipidemia cirrhosis of liver without mention of alcohol subendocardial infarction, initial episode of care unspecified essential hypertension portal hypertension diabetes mellitus without mention of complication, type ii or unspecified type, not stated as uncontrolled portal hypertension iron deficiency anemia secondary to blood loss (chronic) other drugs and medicinal substances causing adverse effects in therapeutic use accidents occurring in residential institution nephritis and nephropathy, not specified as acute or chronic, with unspecified pathological lesion in kidney hepatic encephalopathy obesity, unspecified long-term (current) use of insulin cirrhosis of liver without mention of alcohol diabetes mellitus without mention of complication, type ii or unspecified type, not stated as uncontrolled esophageal varices in diseases classified elsewhere, with bleeding
white m 70 $nan$hematology blood hematocrit  23.6  %; hematology blood hemoglobin  8.1  g dl; hematology blood platelet count  150  k ul; chemistry blood anion gap  22  meq l; chemistry blood bicarbonate  22  meq l; chemistry blood chloride  88  meq l; chemistry blood creatinine  6.3  mg dl; chemistry blood potassium  5.1  meq l; chemistry blood sodium  132  meq l; chemistry blood urea nitrogen  72  mg dl; hematology blood inr(pt)  1.4  ; chemistry blood calcium, total  8.7  mg dl; chemistry blood bilirubin, total  2.8  mg dl; chemistry blood glucose  93  mg dl; chemistry blood lactate dehydrogenase (ld)  339  iu l; chemistry blood albumin  4.1  g dl$sodium chloride 0.9%  flush  3-10  ml ; heparin  5000  unit ; aspirin  81  mg ; dextrose 50%  12.5  gm ; glucagon  1  mg ; glucose gel  15  g ; latanoprost 0.005% ophth. soln.  2  drop ; mirtazapine  30  mg ; naltrexone  50  mg ; rifaximin  550  mg ; sertraline  50  mg ; ursodiol  500  mg ; atorvastatin  80  mg ; ferrous sulfate  325  mg ; acetaminophen  650  mg ; clopidogrel  75  mg ; vitamin d  800  unit ; ipratropium-albuterol neb  1  neb ; 5% dextrose  150  ml ; gabapentin  100  mg ; simethicone  120  mg ; micafungin  100  mg ; sevelamer carbonate  800  mg ; nephrocaps  1  cap ; calcium carbonate  500  mg ; trazodone  25  mg ; metoclopramide  5  mg ; chlorpromazine  25  mg ; 
occupational exposure to toxic agents in other industries dehydration presence of coronary angioplasty implant and graft atherosclerotic heart disease of native coronary artery without angina pectoris other diseases of stomach and duodenum hepatic failure, unspecified without coma type 2 diabetes mellitus with diabetic polyneuropathy portal hypertension hyperlipidemia, unspecified other cirrhosis of liver iron deficiency anemia, unspecified patient's other noncompliance with medication regimen nonalcoholic steatohepatitis (nash) essential (primary) hypertension orthostatic hypotension major depressive disorder, single episode, unspecified hypovolemia other ascites long term (current) use of insulin pruritus, unspecified acute kidney failure, unspecified type 2 diabetes mellitus with unspecified diabetic retinopathy without macular edema family history of ischemic heart disease unspecified cataract long-term (current) use of insulin depressive disorder, not elsewhere classified body mass index 31.0-31.9, adult other secondary thrombocytopenia esophageal varices in diseases classified elsewhere, without mention of bleeding person boarding or alighting a pedal cycle injured in collision with fixed or stationary object obesity, unspecified other and unspecified hyperlipidemia cirrhosis of liver without mention of alcohol subendocardial infarction, initial episode of care unspecified essential hypertension portal hypertension diabetes mellitus without mention of complication, type ii or unspecified type, not stated as uncontrolled portal hypertension iron deficiency anemia secondary to blood loss (chronic) other drugs and medicinal substances causing adverse effects in therapeutic use accidents occurring in residential institution nephritis and nephropathy, not specified as acute or chronic, with unspecified pathological lesion in kidney hepatic encephalopathy obesity, unspecified long-term (current) use of insulin cirrhosis of liver without mention of alcohol diabetes mellitus without mention of complication, type ii or unspecified type, not stated as uncontrolled esophageal varices in diseases classified elsewhere, with bleeding
white m 70 $nan$hematology blood hematocrit  21.7  %; hematology blood hemoglobin  7.6  g dl; hematology blood platelet count  139  k ul; chemistry blood anion gap  25  meq l; chemistry blood bicarbonate  19  meq l; chemistry blood chloride  85  meq l; chemistry blood creatinine  7.9  mg dl; chemistry blood potassium  5.8  meq l; chemistry blood sodium  129  meq l; chemistry blood urea nitrogen  98  mg dl; hematology blood inr(pt)  1.4  ; chemistry blood calcium, total  8.6  mg dl; chemistry blood bilirubin, total  2.8  mg dl; chemistry blood glucose  181  mg dl; chemistry blood albumin  3.9  g dl; blood gas blood lactate  2.2  mmol l$sodium chloride 0.9%  flush  3-10  ml ; heparin  5000  unit ; aspirin  81  mg ; dextrose 50%  12.5  gm ; glucagon  1  mg ; glucose gel  15  g ; latanoprost 0.005% ophth. soln.  2  drop ; mirtazapine  30  mg ; naltrexone  50  mg ; rifaximin  550  mg ; sertraline  50  mg ; ursodiol  500  mg ; atorvastatin  80  mg ; ferrous sulfate  325  mg ; acetaminophen  650  mg ; clopidogrel  75  mg ; vitamin d  800  unit ; ipratropium-albuterol neb  1  neb ; 5% dextrose  150  ml ; gabapentin  100  mg ; simethicone  120  mg ; micafungin  100  mg ; sevelamer carbonate  800  mg ; nephrocaps  1  cap ; chlorpromazine  25  mg ; midodrine  10  mg ; oxycodone (immediate release)  5-10  mg ; glycopyrrolate  1  mg ; chlorpromazine  10  mg ; 
occupational exposure to toxic agents in other industries dehydration presence of coronary angioplasty implant and graft atherosclerotic heart disease of native coronary artery without angina pectoris other diseases of stomach and duodenum hepatic failure, unspecified without coma type 2 diabetes mellitus with diabetic polyneuropathy portal hypertension hyperlipidemia, unspecified other cirrhosis of liver iron deficiency anemia, unspecified patient's other noncompliance with medication regimen nonalcoholic steatohepatitis (nash) essential (primary) hypertension orthostatic hypotension major depressive disorder, single episode, unspecified hypovolemia other ascites long term (current) use of insulin pruritus, unspecified acute kidney failure, unspecified type 2 diabetes mellitus with unspecified diabetic retinopathy without macular edema family history of ischemic heart disease unspecified cataract long-term (current) use of insulin depressive disorder, not elsewhere classified body mass index 31.0-31.9, adult other secondary thrombocytopenia esophageal varices in diseases classified elsewhere, without mention of bleeding person boarding or alighting a pedal cycle injured in collision with fixed or stationary object obesity, unspecified other and unspecified hyperlipidemia cirrhosis of liver without mention of alcohol subendocardial infarction, initial episode of care unspecified essential hypertension portal hypertension diabetes mellitus without mention of complication, type ii or unspecified type, not stated as uncontrolled portal hypertension iron deficiency anemia secondary to blood loss (chronic) other drugs and medicinal substances causing adverse effects in therapeutic use accidents occurring in residential institution nephritis and nephropathy, not specified as acute or chronic, with unspecified pathological lesion in kidney hepatic encephalopathy obesity, unspecified long-term (current) use of insulin cirrhosis of liver without mention of alcohol diabetes mellitus without mention of complication, type ii or unspecified type, not stated as uncontrolled esophageal varices in diseases classified elsewhere, with bleeding
white m 70 $nan$nan$sodium chloride 0.9%  flush  3-10  ml ; aspirin  81  mg ; dextrose 50%  12.5  gm ; glucagon  1  mg ; glucose gel  15  g ; latanoprost 0.005% ophth. soln.  2  drop ; mirtazapine  30  mg ; sertraline  50  mg ; acetaminophen  650  mg ; clopidogrel  75  mg ; ipratropium-albuterol neb  1  neb ; 5% dextrose  150  ml ; gabapentin  100  mg ; simethicone  120  mg ; micafungin  100  mg ; sevelamer carbonate  800  mg ; nephrocaps  1  cap ; oxycodone (immediate release)  5-10  mg ; glycopyrrolate  1  mg ; chlorpromazine  10  mg ; insulin  25  unit ; 
occupational exposure to toxic agents in other industries dehydration presence of coronary angioplasty implant and graft atherosclerotic heart disease of native coronary artery without angina pectoris other diseases of stomach and duodenum hepatic failure, unspecified without coma type 2 diabetes mellitus with diabetic polyneuropathy portal hypertension hyperlipidemia, unspecified other cirrhosis of liver iron deficiency anemia, unspecified patient's other noncompliance with medication regimen nonalcoholic steatohepatitis (nash) essential (primary) hypertension orthostatic hypotension major depressive disorder, single episode, unspecified hypovolemia other ascites long term (current) use of insulin pruritus, unspecified acute kidney failure, unspecified type 2 diabetes mellitus with unspecified diabetic retinopathy without macular edema family history of ischemic heart disease unspecified cataract long-term (current) use of insulin depressive disorder, not elsewhere classified body mass index 31.0-31.9, adult other secondary thrombocytopenia esophageal varices in diseases classified elsewhere, without mention of bleeding person boarding or alighting a pedal cycle injured in collision with fixed or stationary object obesity, unspecified other and unspecified hyperlipidemia cirrhosis of liver without mention of alcohol subendocardial infarction, initial episode of care unspecified essential hypertension portal hypertension diabetes mellitus without mention of complication, type ii or unspecified type, not stated as uncontrolled portal hypertension iron deficiency anemia secondary to blood loss (chronic) other drugs and medicinal substances causing adverse effects in therapeutic use accidents occurring in residential institution nephritis and nephropathy, not specified as acute or chronic, with unspecified pathological lesion in kidney hepatic encephalopathy obesity, unspecified long-term (current) use of insulin cirrhosis of liver without mention of alcohol diabetes mellitus without mention of complication, type ii or unspecified type, not stated as uncontrolled esophageal varices in diseases classified elsewhere, with bleeding
white m 70 $nan$nan$sodium chloride 0.9%  flush  3-10  ml ; aspirin  81  mg ; dextrose 50%  12.5  gm ; glucagon  1  mg ; glucose gel  15  g ; latanoprost 0.005% ophth. soln.  2  drop ; mirtazapine  30  mg ; sertraline  50  mg ; acetaminophen  650  mg ; clopidogrel  75  mg ; ipratropium-albuterol neb  1  neb ; 5% dextrose  150  ml ; gabapentin  100  mg ; simethicone  120  mg ; micafungin  100  mg ; sevelamer carbonate  800  mg ; nephrocaps  1  cap ; oxycodone (immediate release)  5-10  mg ; glycopyrrolate  1  mg ; insulin  25  unit ; nitroglycerin sl  0.3  mg ; 
occupational exposure to toxic agents in other industries dehydration presence of coronary angioplasty implant and graft atherosclerotic heart disease of native coronary artery without angina pectoris other diseases of stomach and duodenum hepatic failure, unspecified without coma type 2 diabetes mellitus with diabetic polyneuropathy portal hypertension hyperlipidemia, unspecified other cirrhosis of liver iron deficiency anemia, unspecified patient's other noncompliance with medication regimen nonalcoholic steatohepatitis (nash) essential (primary) hypertension orthostatic hypotension major depressive disorder, single episode, unspecified hypovolemia other ascites long term (current) use of insulin pruritus, unspecified acute kidney failure, unspecified type 2 diabetes mellitus with unspecified diabetic retinopathy without macular edema family history of ischemic heart disease unspecified cataract long-term (current) use of insulin depressive disorder, not elsewhere classified body mass index 31.0-31.9, adult other secondary thrombocytopenia esophageal varices in diseases classified elsewhere, without mention of bleeding person boarding or alighting a pedal cycle injured in collision with fixed or stationary object obesity, unspecified other and unspecified hyperlipidemia cirrhosis of liver without mention of alcohol subendocardial infarction, initial episode of care unspecified essential hypertension portal hypertension diabetes mellitus without mention of complication, type ii or unspecified type, not stated as uncontrolled portal hypertension iron deficiency anemia secondary to blood loss (chronic) other drugs and medicinal substances causing adverse effects in therapeutic use accidents occurring in residential institution nephritis and nephropathy, not specified as acute or chronic, with unspecified pathological lesion in kidney hepatic encephalopathy obesity, unspecified long-term (current) use of insulin cirrhosis of liver without mention of alcohol diabetes mellitus without mention of complication, type ii or unspecified type, not stated as uncontrolled esophageal varices in diseases classified elsewhere, with bleeding
white f 69 $nan$nan$digoxin  0.125  mg ; 
coronary atherosclerosis of native coronary artery attention to ileostomy person boarding or alighting a pedal cycle injured in collision with other nonmotor vehicle in nontraffic accident family history of malignant neoplasm of gastrointestinal tract anemia in chronic kidney disease osteoarthrosis involving, or with mention of more than one site, but not specified as generalized, site unspecified secondary hyperparathyroidism (of renal origin) personal history of tobacco use nephritis and nephropathy, not specified as acute or chronic, with unspecified pathological lesion in kidney diabetes with peripheral circulatory disorders, type ii or unspecified type, not stated as uncontrolled systemic lupus erythematosus unspecified glaucoma end stage renal disease body mass index 34.0-34.9, adult peripheral angiopathy in diseases classified elsewhere atrial fibrillation acquired absence of intestine (large) (small) cardiac pacemaker in situ family history of malignant neoplasm of breast pedal cycle driver injured in collision with other nonmotor vehicle in nontraffic accident long-term (current) use of anticoagulants renal dialysis status hypertensive chronic kidney disease, unspecified, with chronic kidney disease stage v or end stage renal disease unspecified cataract esophageal reflux immune thrombocytopenic purpura ulcer of heel and midfoot obesity, unspecified long-term (current) use of insulin diabetes with ophthalmic manifestations, type ii or unspecified type, not stated as uncontrolled person on outside of pick-up truck or van injured in collision with railway train or railway vehicle in nontraffic accident venous (peripheral) insufficiency, unspecified moderate nonproliferative diabetic retinopathy atherosclerosis of native arteries of the extremities with ulceration spinal stenosis, lumbar region, without neurogenic claudication head injury, unspecified home accidents contusion of orbital tissues unspecified fall other specified metabolic disorders percutaneous transluminal coronary angioplasty status end stage renal disease other specified cardiac dysrhythmias other specified metabolic disorders acute on chronic diastolic heart failure diabetes with ophthalmic manifestations, type ii or unspecified type, not stated as uncontrolled long-term (current) use of aspirin background diabetic retinopathy
white f 69 $nan$hematology blood hematocrit  32.3  %; hematology blood hematocrit  31.6  %; hematology blood hematocrit  32.3  %; hematology blood hemoglobin  9.7  g dl; hematology blood hemoglobin  10.5  g dl; hematology blood hemoglobin  10.3  g dl; hematology blood platelet count  237  k ul; hematology blood platelet count  242  k ul; hematology blood platelet count  221  k ul; chemistry blood anion gap  16  meq l; chemistry blood anion gap  18  meq l; chemistry blood bicarbonate  31  meq l; chemistry blood bicarbonate  29  meq l; chemistry blood chloride  96  meq l; chemistry blood chloride  96  meq l; chemistry blood creatinine  5.8  mg dl; chemistry blood creatinine  6.0  mg dl; chemistry blood potassium  4.8  meq l; chemistry blood potassium  4.9  meq l; chemistry blood sodium  138  meq l; chemistry blood sodium  138  meq l; chemistry blood urea nitrogen  35  mg dl; chemistry blood urea nitrogen  37  mg dl; hematology blood inr(pt)  2.3  ; chemistry blood calcium, total  8.9  mg dl; chemistry blood calcium, total  9.1  mg dl; chemistry blood glucose  103  mg dl; chemistry blood glucose  98  mg dl; chemistry blood % hemoglobin a1c  6.0  %$digoxin  0.125  mg ; sodium chloride 0.9%  flush  3  ml ; acetaminophen  325-650  mg ; dextrose 50%  12.5  gm ; glucagon  1  mg ; glucose gel  15  g ; nephrocaps  1  cap ; pantoprazole  40  mg ; sevelamer carbonate  800  mg ; iso-osmotic dextrose  200  ml ; vancomycin  1000  mg ; hydromorphone (dilaudid)  0.25  mg ; insulin  0  unit ; gabapentin  300  mg ; metoprolol tartrate  50  mg ; mirtazapine  7.5  mg ; sertraline  175  mg ; tramadol (ultram)  50  mg ; 5% dextrose  50  ml ; phytonadione  2  mg ; heparin  5000  unit ; atorvastatin  40  mg ; amiodarone  200  mg ; sodium chloride 0.9%  1000  ml ; diphenhydramine  50  mg ; iso-osmotic dextrose  100  ml ; vancomycin  500  mg ; 
coronary atherosclerosis of native coronary artery attention to ileostomy person boarding or alighting a pedal cycle injured in collision with other nonmotor vehicle in nontraffic accident family history of malignant neoplasm of gastrointestinal tract anemia in chronic kidney disease osteoarthrosis involving, or with mention of more than one site, but not specified as generalized, site unspecified secondary hyperparathyroidism (of renal origin) personal history of tobacco use nephritis and nephropathy, not specified as acute or chronic, with unspecified pathological lesion in kidney diabetes with peripheral circulatory disorders, type ii or unspecified type, not stated as uncontrolled systemic lupus erythematosus unspecified glaucoma end stage renal disease body mass index 34.0-34.9, adult peripheral angiopathy in diseases classified elsewhere atrial fibrillation acquired absence of intestine (large) (small) cardiac pacemaker in situ family history of malignant neoplasm of breast pedal cycle driver injured in collision with other nonmotor vehicle in nontraffic accident long-term (current) use of anticoagulants renal dialysis status hypertensive chronic kidney disease, unspecified, with chronic kidney disease stage v or end stage renal disease unspecified cataract esophageal reflux immune thrombocytopenic purpura ulcer of heel and midfoot obesity, unspecified long-term (current) use of insulin diabetes with ophthalmic manifestations, type ii or unspecified type, not stated as uncontrolled person on outside of pick-up truck or van injured in collision with railway train or railway vehicle in nontraffic accident venous (peripheral) insufficiency, unspecified moderate nonproliferative diabetic retinopathy atherosclerosis of native arteries of the extremities with ulceration spinal stenosis, lumbar region, without neurogenic claudication head injury, unspecified home accidents contusion of orbital tissues unspecified fall other specified metabolic disorders percutaneous transluminal coronary angioplasty status end stage renal disease other specified cardiac dysrhythmias other specified metabolic disorders acute on chronic diastolic heart failure diabetes with ophthalmic manifestations, type ii or unspecified type, not stated as uncontrolled long-term (current) use of aspirin background diabetic retinopathy
white f 69 $nan$nan$digoxin  0.125  mg ; sodium chloride 0.9%  flush  3  ml ; acetaminophen  325-650  mg ; dextrose 50%  12.5  gm ; glucagon  1  mg ; glucose gel  15  g ; nephrocaps  1  cap ; pantoprazole  40  mg ; sevelamer carbonate  800  mg ; iso-osmotic dextrose  200  ml ; vancomycin  1000  mg ; hydromorphone (dilaudid)  0.25  mg ; insulin  0  unit ; gabapentin  300  mg ; metoprolol tartrate  50  mg ; mirtazapine  7.5  mg ; sertraline  175  mg ; tramadol (ultram)  50  mg ; 5% dextrose  50  ml ; phytonadione  2  mg ; heparin  5000  unit ; atorvastatin  40  mg ; amiodarone  200  mg ; hydromorphone (dilaudid)  0.25-0.5  mg ; clopidogrel  75  mg ; iso-osmotic dextrose  50  ml ; piperacillin-tazobactam  2.25  g ; lorazepam  0.25  mg ; hydromorphone (dilaudid)  2-4  mg ; ciprofloxacin hcl  500  mg ; warfarin  3  mg ; warfarin  1  dose ; 
coronary atherosclerosis of native coronary artery attention to ileostomy person boarding or alighting a pedal cycle injured in collision with other nonmotor vehicle in nontraffic accident family history of malignant neoplasm of gastrointestinal tract anemia in chronic kidney disease osteoarthrosis involving, or with mention of more than one site, but not specified as generalized, site unspecified secondary hyperparathyroidism (of renal origin) personal history of tobacco use nephritis and nephropathy, not specified as acute or chronic, with unspecified pathological lesion in kidney diabetes with peripheral circulatory disorders, type ii or unspecified type, not stated as uncontrolled systemic lupus erythematosus unspecified glaucoma end stage renal disease body mass index 34.0-34.9, adult peripheral angiopathy in diseases classified elsewhere atrial fibrillation acquired absence of intestine (large) (small) cardiac pacemaker in situ family history of malignant neoplasm of breast pedal cycle driver injured in collision with other nonmotor vehicle in nontraffic accident long-term (current) use of anticoagulants renal dialysis status hypertensive chronic kidney disease, unspecified, with chronic kidney disease stage v or end stage renal disease unspecified cataract esophageal reflux immune thrombocytopenic purpura ulcer of heel and midfoot obesity, unspecified long-term (current) use of insulin diabetes with ophthalmic manifestations, type ii or unspecified type, not stated as uncontrolled person on outside of pick-up truck or van injured in collision with railway train or railway vehicle in nontraffic accident venous (peripheral) insufficiency, unspecified moderate nonproliferative diabetic retinopathy atherosclerosis of native arteries of the extremities with ulceration spinal stenosis, lumbar region, without neurogenic claudication head injury, unspecified home accidents contusion of orbital tissues unspecified fall other specified metabolic disorders percutaneous transluminal coronary angioplasty status end stage renal disease other specified cardiac dysrhythmias other specified metabolic disorders acute on chronic diastolic heart failure diabetes with ophthalmic manifestations, type ii or unspecified type, not stated as uncontrolled long-term (current) use of aspirin background diabetic retinopathy
white f 69 $nan$hematology blood hematocrit  28.2  %; hematology blood hemoglobin  9.2  g dl; hematology blood platelet count  204  k ul; chemistry blood anion gap  15  meq l; chemistry blood bicarbonate  29  meq l; chemistry blood chloride  100  meq l; chemistry blood creatinine  5.2  mg dl; chemistry blood potassium  4.6  meq l; chemistry blood sodium  139  meq l; chemistry blood urea nitrogen  25  mg dl; hematology blood inr(pt)  1.2  ; chemistry blood calcium, total  9.3  mg dl; chemistry blood glucose  145  mg dl$digoxin  0.125  mg ; sodium chloride 0.9%  flush  3  ml ; acetaminophen  325-650  mg ; dextrose 50%  12.5  gm ; glucagon  1  mg ; glucose gel  15  g ; nephrocaps  1  cap ; pantoprazole  40  mg ; sevelamer carbonate  800  mg ; iso-osmotic dextrose  200  ml ; vancomycin  1000  mg ; insulin  0  unit ; gabapentin  300  mg ; metoprolol tartrate  50  mg ; mirtazapine  7.5  mg ; sertraline  175  mg ; tramadol (ultram)  50  mg ; heparin  5000  unit ; atorvastatin  40  mg ; amiodarone  200  mg ; clopidogrel  75  mg ; lorazepam  0.25  mg ; hydromorphone (dilaudid)  2-4  mg ; ciprofloxacin hcl  500  mg ; warfarin  3  mg ; warfarin  1  dose ; warfarin  4  mg ; 
coronary atherosclerosis of native coronary artery attention to ileostomy person boarding or alighting a pedal cycle injured in collision with other nonmotor vehicle in nontraffic accident family history of malignant neoplasm of gastrointestinal tract anemia in chronic kidney disease osteoarthrosis involving, or with mention of more than one site, but not specified as generalized, site unspecified secondary hyperparathyroidism (of renal origin) personal history of tobacco use nephritis and nephropathy, not specified as acute or chronic, with unspecified pathological lesion in kidney diabetes with peripheral circulatory disorders, type ii or unspecified type, not stated as uncontrolled systemic lupus erythematosus unspecified glaucoma end stage renal disease body mass index 34.0-34.9, adult peripheral angiopathy in diseases classified elsewhere atrial fibrillation acquired absence of intestine (large) (small) cardiac pacemaker in situ family history of malignant neoplasm of breast pedal cycle driver injured in collision with other nonmotor vehicle in nontraffic accident long-term (current) use of anticoagulants renal dialysis status hypertensive chronic kidney disease, unspecified, with chronic kidney disease stage v or end stage renal disease unspecified cataract esophageal reflux immune thrombocytopenic purpura ulcer of heel and midfoot obesity, unspecified long-term (current) use of insulin diabetes with ophthalmic manifestations, type ii or unspecified type, not stated as uncontrolled person on outside of pick-up truck or van injured in collision with railway train or railway vehicle in nontraffic accident venous (peripheral) insufficiency, unspecified moderate nonproliferative diabetic retinopathy atherosclerosis of native arteries of the extremities with ulceration spinal stenosis, lumbar region, without neurogenic claudication head injury, unspecified home accidents contusion of orbital tissues unspecified fall other specified metabolic disorders percutaneous transluminal coronary angioplasty status end stage renal disease other specified cardiac dysrhythmias other specified metabolic disorders acute on chronic diastolic heart failure diabetes with ophthalmic manifestations, type ii or unspecified type, not stated as uncontrolled long-term (current) use of aspirin background diabetic retinopathy
white f 69 $nan$hematology blood inr(pt)  1.1  $digoxin  0.125  mg ; sodium chloride 0.9%  flush  3  ml ; acetaminophen  325-650  mg ; dextrose 50%  12.5  gm ; glucagon  1  mg ; glucose gel  15  g ; nephrocaps  1  cap ; pantoprazole  40  mg ; sevelamer carbonate  800  mg ; iso-osmotic dextrose  200  ml ; vancomycin  1000  mg ; insulin  0  unit ; gabapentin  300  mg ; metoprolol tartrate  50  mg ; mirtazapine  7.5  mg ; sertraline  175  mg ; tramadol (ultram)  50  mg ; heparin  5000  unit ; atorvastatin  40  mg ; amiodarone  200  mg ; clopidogrel  75  mg ; lorazepam  0.25  mg ; hydromorphone (dilaudid)  2-4  mg ; warfarin  1  dose ; warfarin  4  mg ; 
coronary atherosclerosis of native coronary artery attention to ileostomy person boarding or alighting a pedal cycle injured in collision with other nonmotor vehicle in nontraffic accident family history of malignant neoplasm of gastrointestinal tract anemia in chronic kidney disease osteoarthrosis involving, or with mention of more than one site, but not specified as generalized, site unspecified secondary hyperparathyroidism (of renal origin) personal history of tobacco use nephritis and nephropathy, not specified as acute or chronic, with unspecified pathological lesion in kidney diabetes with peripheral circulatory disorders, type ii or unspecified type, not stated as uncontrolled systemic lupus erythematosus unspecified glaucoma end stage renal disease body mass index 34.0-34.9, adult peripheral angiopathy in diseases classified elsewhere atrial fibrillation acquired absence of intestine (large) (small) cardiac pacemaker in situ family history of malignant neoplasm of breast pedal cycle driver injured in collision with other nonmotor vehicle in nontraffic accident long-term (current) use of anticoagulants renal dialysis status hypertensive chronic kidney disease, unspecified, with chronic kidney disease stage v or end stage renal disease unspecified cataract esophageal reflux immune thrombocytopenic purpura ulcer of heel and midfoot obesity, unspecified long-term (current) use of insulin diabetes with ophthalmic manifestations, type ii or unspecified type, not stated as uncontrolled person on outside of pick-up truck or van injured in collision with railway train or railway vehicle in nontraffic accident venous (peripheral) insufficiency, unspecified moderate nonproliferative diabetic retinopathy atherosclerosis of native arteries of the extremities with ulceration spinal stenosis, lumbar region, without neurogenic claudication head injury, unspecified home accidents contusion of orbital tissues unspecified fall other specified metabolic disorders percutaneous transluminal coronary angioplasty status end stage renal disease other specified cardiac dysrhythmias other specified metabolic disorders acute on chronic diastolic heart failure diabetes with ophthalmic manifestations, type ii or unspecified type, not stated as uncontrolled long-term (current) use of aspirin background diabetic retinopathy
white f 69 $nan$hematology blood hematocrit  27.8  %; hematology blood hemoglobin  9.2  g dl; hematology blood platelet count  223  k ul; chemistry blood anion gap  19  meq l; chemistry blood bicarbonate  27  meq l; chemistry blood chloride  95  meq l; chemistry blood creatinine  5.0  mg dl; chemistry blood potassium  4.6  meq l; chemistry blood sodium  136  meq l; chemistry blood urea nitrogen  28  mg dl; chemistry blood calcium, total  9.8  mg dl; chemistry blood glucose  104  mg dl$digoxin  0.125  mg ; sodium chloride 0.9%  flush  3  ml ; acetaminophen  325-650  mg ; dextrose 50%  12.5  gm ; glucagon  1  mg ; glucose gel  15  g ; nephrocaps  1  cap ; pantoprazole  40  mg ; sevelamer carbonate  800  mg ; insulin  0  unit ; gabapentin  300  mg ; metoprolol tartrate  50  mg ; mirtazapine  7.5  mg ; sertraline  175  mg ; tramadol (ultram)  50  mg ; heparin  5000  unit ; atorvastatin  40  mg ; amiodarone  200  mg ; clopidogrel  75  mg ; lorazepam  0.25  mg ; hydromorphone (dilaudid)  2-4  mg ; warfarin  1  dose ; 
coronary atherosclerosis of native coronary artery attention to ileostomy person boarding or alighting a pedal cycle injured in collision with other nonmotor vehicle in nontraffic accident family history of malignant neoplasm of gastrointestinal tract anemia in chronic kidney disease osteoarthrosis involving, or with mention of more than one site, but not specified as generalized, site unspecified secondary hyperparathyroidism (of renal origin) personal history of tobacco use nephritis and nephropathy, not specified as acute or chronic, with unspecified pathological lesion in kidney diabetes with peripheral circulatory disorders, type ii or unspecified type, not stated as uncontrolled systemic lupus erythematosus unspecified glaucoma end stage renal disease body mass index 34.0-34.9, adult peripheral angiopathy in diseases classified elsewhere atrial fibrillation acquired absence of intestine (large) (small) cardiac pacemaker in situ family history of malignant neoplasm of breast pedal cycle driver injured in collision with other nonmotor vehicle in nontraffic accident long-term (current) use of anticoagulants renal dialysis status hypertensive chronic kidney disease, unspecified, with chronic kidney disease stage v or end stage renal disease unspecified cataract esophageal reflux immune thrombocytopenic purpura ulcer of heel and midfoot obesity, unspecified long-term (current) use of insulin diabetes with ophthalmic manifestations, type ii or unspecified type, not stated as uncontrolled person on outside of pick-up truck or van injured in collision with railway train or railway vehicle in nontraffic accident venous (peripheral) insufficiency, unspecified moderate nonproliferative diabetic retinopathy atherosclerosis of native arteries of the extremities with ulceration spinal stenosis, lumbar region, without neurogenic claudication head injury, unspecified home accidents contusion of orbital tissues unspecified fall other specified metabolic disorders percutaneous transluminal coronary angioplasty status end stage renal disease other specified cardiac dysrhythmias other specified metabolic disorders acute on chronic diastolic heart failure diabetes with ophthalmic manifestations, type ii or unspecified type, not stated as uncontrolled long-term (current) use of aspirin background diabetic retinopathy
white f 69 $nan$hematology blood inr(pt)  1.3  $digoxin  0.125  mg ; sodium chloride 0.9%  flush  3  ml ; acetaminophen  325-650  mg ; dextrose 50%  12.5  gm ; glucagon  1  mg ; glucose gel  15  g ; nephrocaps  1  cap ; pantoprazole  40  mg ; sevelamer carbonate  800  mg ; insulin  0  unit ; gabapentin  300  mg ; metoprolol tartrate  50  mg ; mirtazapine  7.5  mg ; sertraline  175  mg ; tramadol (ultram)  50  mg ; heparin  5000  unit ; atorvastatin  40  mg ; amiodarone  200  mg ; clopidogrel  75  mg ; lorazepam  0.25  mg ; hydromorphone (dilaudid)  2-4  mg ; warfarin  1  dose ; warfarin  6  mg ; guaifenesin  5-10  ml ; nystatin cream  1  appl ; fexofenadine  60  mg ; 
coronary atherosclerosis of native coronary artery attention to ileostomy person boarding or alighting a pedal cycle injured in collision with other nonmotor vehicle in nontraffic accident family history of malignant neoplasm of gastrointestinal tract anemia in chronic kidney disease osteoarthrosis involving, or with mention of more than one site, but not specified as generalized, site unspecified secondary hyperparathyroidism (of renal origin) personal history of tobacco use nephritis and nephropathy, not specified as acute or chronic, with unspecified pathological lesion in kidney diabetes with peripheral circulatory disorders, type ii or unspecified type, not stated as uncontrolled systemic lupus erythematosus unspecified glaucoma end stage renal disease body mass index 34.0-34.9, adult peripheral angiopathy in diseases classified elsewhere atrial fibrillation acquired absence of intestine (large) (small) cardiac pacemaker in situ family history of malignant neoplasm of breast pedal cycle driver injured in collision with other nonmotor vehicle in nontraffic accident long-term (current) use of anticoagulants renal dialysis status hypertensive chronic kidney disease, unspecified, with chronic kidney disease stage v or end stage renal disease unspecified cataract esophageal reflux immune thrombocytopenic purpura ulcer of heel and midfoot obesity, unspecified long-term (current) use of insulin diabetes with ophthalmic manifestations, type ii or unspecified type, not stated as uncontrolled person on outside of pick-up truck or van injured in collision with railway train or railway vehicle in nontraffic accident venous (peripheral) insufficiency, unspecified moderate nonproliferative diabetic retinopathy atherosclerosis of native arteries of the extremities with ulceration spinal stenosis, lumbar region, without neurogenic claudication head injury, unspecified home accidents contusion of orbital tissues unspecified fall other specified metabolic disorders percutaneous transluminal coronary angioplasty status end stage renal disease other specified cardiac dysrhythmias other specified metabolic disorders acute on chronic diastolic heart failure diabetes with ophthalmic manifestations, type ii or unspecified type, not stated as uncontrolled long-term (current) use of aspirin background diabetic retinopathy
white f 69 $nan$hematology blood inr(pt)  1.6  $digoxin  0.125  mg ; sodium chloride 0.9%  flush  3  ml ; acetaminophen  325-650  mg ; dextrose 50%  12.5  gm ; glucagon  1  mg ; glucose gel  15  g ; nephrocaps  1  cap ; pantoprazole  40  mg ; sevelamer carbonate  800  mg ; insulin  0  unit ; gabapentin  300  mg ; metoprolol tartrate  50  mg ; mirtazapine  7.5  mg ; sertraline  175  mg ; tramadol (ultram)  50  mg ; heparin  5000  unit ; atorvastatin  40  mg ; amiodarone  200  mg ; clopidogrel  75  mg ; lorazepam  0.25  mg ; hydromorphone (dilaudid)  2-4  mg ; warfarin  1  dose ; warfarin  6  mg ; guaifenesin  5-10  ml ; nystatin cream  1  appl ; fexofenadine  60  mg ; miconazole powder 2%  1  appl ; 
coronary atherosclerosis of native coronary artery attention to ileostomy person boarding or alighting a pedal cycle injured in collision with other nonmotor vehicle in nontraffic accident family history of malignant neoplasm of gastrointestinal tract anemia in chronic kidney disease osteoarthrosis involving, or with mention of more than one site, but not specified as generalized, site unspecified secondary hyperparathyroidism (of renal origin) personal history of tobacco use nephritis and nephropathy, not specified as acute or chronic, with unspecified pathological lesion in kidney diabetes with peripheral circulatory disorders, type ii or unspecified type, not stated as uncontrolled systemic lupus erythematosus unspecified glaucoma end stage renal disease body mass index 34.0-34.9, adult peripheral angiopathy in diseases classified elsewhere atrial fibrillation acquired absence of intestine (large) (small) cardiac pacemaker in situ family history of malignant neoplasm of breast pedal cycle driver injured in collision with other nonmotor vehicle in nontraffic accident long-term (current) use of anticoagulants renal dialysis status hypertensive chronic kidney disease, unspecified, with chronic kidney disease stage v or end stage renal disease unspecified cataract esophageal reflux immune thrombocytopenic purpura ulcer of heel and midfoot obesity, unspecified long-term (current) use of insulin diabetes with ophthalmic manifestations, type ii or unspecified type, not stated as uncontrolled person on outside of pick-up truck or van injured in collision with railway train or railway vehicle in nontraffic accident venous (peripheral) insufficiency, unspecified moderate nonproliferative diabetic retinopathy atherosclerosis of native arteries of the extremities with ulceration spinal stenosis, lumbar region, without neurogenic claudication head injury, unspecified home accidents contusion of orbital tissues unspecified fall other specified metabolic disorders percutaneous transluminal coronary angioplasty status end stage renal disease other specified cardiac dysrhythmias other specified metabolic disorders acute on chronic diastolic heart failure diabetes with ophthalmic manifestations, type ii or unspecified type, not stated as uncontrolled long-term (current) use of aspirin background diabetic retinopathy
white f 69 $nan$hematology blood hematocrit  28.1  %; hematology blood hemoglobin  8.7  g dl; hematology blood platelet count  225  k ul; chemistry blood anion gap  16  meq l; chemistry blood bicarbonate  28  meq l; chemistry blood chloride  96  meq l; chemistry blood creatinine  5.6  mg dl; chemistry blood potassium  5.9  meq l; chemistry blood sodium  134  meq l; chemistry blood urea nitrogen  32  mg dl; hematology blood inr(pt)  1.9  ; chemistry blood calcium, total  9.6  mg dl; chemistry blood glucose  122  mg dl$digoxin  0.125  mg ; sodium chloride 0.9%  flush  3  ml ; acetaminophen  325-650  mg ; dextrose 50%  12.5  gm ; glucagon  1  mg ; glucose gel  15  g ; nephrocaps  1  cap ; pantoprazole  40  mg ; sevelamer carbonate  800  mg ; insulin  0  unit ; gabapentin  300  mg ; metoprolol tartrate  50  mg ; mirtazapine  7.5  mg ; sertraline  175  mg ; tramadol (ultram)  50  mg ; heparin  5000  unit ; atorvastatin  40  mg ; amiodarone  200  mg ; clopidogrel  75  mg ; lorazepam  0.25  mg ; hydromorphone (dilaudid)  2-4  mg ; warfarin  1  dose ; guaifenesin  5-10  ml ; nystatin cream  1  appl ; fexofenadine  60  mg ; miconazole powder 2%  1  appl ; epoetin alfa  3000  unit ; hydromorphone (dilaudid)  4  mg ; warfarin  5  mg ; 
coronary atherosclerosis of native coronary artery attention to ileostomy person boarding or alighting a pedal cycle injured in collision with other nonmotor vehicle in nontraffic accident family history of malignant neoplasm of gastrointestinal tract anemia in chronic kidney disease osteoarthrosis involving, or with mention of more than one site, but not specified as generalized, site unspecified secondary hyperparathyroidism (of renal origin) personal history of tobacco use nephritis and nephropathy, not specified as acute or chronic, with unspecified pathological lesion in kidney diabetes with peripheral circulatory disorders, type ii or unspecified type, not stated as uncontrolled systemic lupus erythematosus unspecified glaucoma end stage renal disease body mass index 34.0-34.9, adult peripheral angiopathy in diseases classified elsewhere atrial fibrillation acquired absence of intestine (large) (small) cardiac pacemaker in situ family history of malignant neoplasm of breast pedal cycle driver injured in collision with other nonmotor vehicle in nontraffic accident long-term (current) use of anticoagulants renal dialysis status hypertensive chronic kidney disease, unspecified, with chronic kidney disease stage v or end stage renal disease unspecified cataract esophageal reflux immune thrombocytopenic purpura ulcer of heel and midfoot obesity, unspecified long-term (current) use of insulin diabetes with ophthalmic manifestations, type ii or unspecified type, not stated as uncontrolled person on outside of pick-up truck or van injured in collision with railway train or railway vehicle in nontraffic accident venous (peripheral) insufficiency, unspecified moderate nonproliferative diabetic retinopathy atherosclerosis of native arteries of the extremities with ulceration spinal stenosis, lumbar region, without neurogenic claudication head injury, unspecified home accidents contusion of orbital tissues unspecified fall other specified metabolic disorders percutaneous transluminal coronary angioplasty status end stage renal disease other specified cardiac dysrhythmias other specified metabolic disorders acute on chronic diastolic heart failure diabetes with ophthalmic manifestations, type ii or unspecified type, not stated as uncontrolled long-term (current) use of aspirin background diabetic retinopathy
white f 69 $nan$nan$digoxin  0.125  mg ; sodium chloride 0.9%  flush  3  ml ; acetaminophen  325-650  mg ; dextrose 50%  12.5  gm ; glucagon  1  mg ; glucose gel  15  g ; nephrocaps  1  cap ; pantoprazole  40  mg ; sevelamer carbonate  800  mg ; insulin  0  unit ; gabapentin  300  mg ; metoprolol tartrate  50  mg ; mirtazapine  7.5  mg ; sertraline  175  mg ; tramadol (ultram)  50  mg ; heparin  5000  unit ; atorvastatin  40  mg ; amiodarone  200  mg ; clopidogrel  75  mg ; lorazepam  0.25  mg ; hydromorphone (dilaudid)  2-4  mg ; guaifenesin  5-10  ml ; nystatin cream  1  appl ; fexofenadine  60  mg ; miconazole powder 2%  1  appl ; warfarin  5  mg ; 
coronary atherosclerosis of native coronary artery attention to ileostomy person boarding or alighting a pedal cycle injured in collision with other nonmotor vehicle in nontraffic accident family history of malignant neoplasm of gastrointestinal tract anemia in chronic kidney disease osteoarthrosis involving, or with mention of more than one site, but not specified as generalized, site unspecified secondary hyperparathyroidism (of renal origin) personal history of tobacco use nephritis and nephropathy, not specified as acute or chronic, with unspecified pathological lesion in kidney diabetes with peripheral circulatory disorders, type ii or unspecified type, not stated as uncontrolled systemic lupus erythematosus unspecified glaucoma end stage renal disease body mass index 34.0-34.9, adult peripheral angiopathy in diseases classified elsewhere atrial fibrillation acquired absence of intestine (large) (small) cardiac pacemaker in situ family history of malignant neoplasm of breast pedal cycle driver injured in collision with other nonmotor vehicle in nontraffic accident long-term (current) use of anticoagulants renal dialysis status hypertensive chronic kidney disease, unspecified, with chronic kidney disease stage v or end stage renal disease unspecified cataract esophageal reflux immune thrombocytopenic purpura ulcer of heel and midfoot obesity, unspecified long-term (current) use of insulin diabetes with ophthalmic manifestations, type ii or unspecified type, not stated as uncontrolled person on outside of pick-up truck or van injured in collision with railway train or railway vehicle in nontraffic accident venous (peripheral) insufficiency, unspecified moderate nonproliferative diabetic retinopathy atherosclerosis of native arteries of the extremities with ulceration spinal stenosis, lumbar region, without neurogenic claudication head injury, unspecified home accidents contusion of orbital tissues unspecified fall other specified metabolic disorders percutaneous transluminal coronary angioplasty status end stage renal disease other specified cardiac dysrhythmias other specified metabolic disorders acute on chronic diastolic heart failure diabetes with ophthalmic manifestations, type ii or unspecified type, not stated as uncontrolled long-term (current) use of aspirin background diabetic retinopathy
white f 64 $nan$nan$multivitamins  1  cap ; vitamin d  400  unit ; levothyroxine sodium  75  mcg ; aspirin  81  mg ; omeprazole  20  mg ; 
 
white f 64 $nan$hematology blood hematocrit  28.7  %; hematology blood hemoglobin  9.9  g dl; hematology blood platelet count  241  k ul; chemistry blood anion gap  15  meq l; chemistry blood bicarbonate  22  meq l; chemistry blood chloride  104  meq l; chemistry blood creatinine  0.8  mg dl; chemistry blood potassium  4.0  meq l; chemistry blood sodium  137  meq l; chemistry blood urea nitrogen  16  mg dl; hematology blood inr(pt)  1.2  ; chemistry blood calcium, total  8.9  mg dl; chemistry blood glucose  93  mg dl$multivitamins  1  cap ; vitamin d  400  unit ; levothyroxine sodium  75  mcg ; aspirin  81  mg ; omeprazole  20  mg ; warfarin  2.5  mg ; influenza virus vaccine  0.5  ml ; sodium chloride 0.9%  flush  3  ml ; potassium chl 20 meq   1000 ml d5 1 2 ns  1000  ml ; oxycodone (immediate release)   5-10  mg ; 0.9% sodium chloride  100  ml ; cefazolin  2  gm ; promethazine  25  mg ; trazodone  50  mg ; ondansetron  4  mg ; morphine sulfate  50  mg ; lorazepam  0.5  mg ; calcium carbonate  500  mg ; cepacol (menthol)  1  loz ; morphine sulfate  1-5  mg ; warfarin  5  mg ; senna  1  tab ; 
 
white f 64 $nan$hematology blood hematocrit  27.6  %; hematology blood hemoglobin  9.7  g dl; hematology blood platelet count  202  k ul; hematology blood inr(pt)  1.3  $multivitamins  1  cap ; vitamin d  400  unit ; levothyroxine sodium  75  mcg ; aspirin  81  mg ; omeprazole  20  mg ; sodium chloride 0.9%  flush  3  ml ; potassium chl 20 meq   1000 ml d5 1 2 ns  1000  ml ; 0.9% sodium chloride  100  ml ; cefazolin  2  gm ; promethazine  25  mg ; trazodone  50  mg ; ondansetron  4  mg ; lorazepam  0.5  mg ; calcium carbonate  500  mg ; cepacol (menthol)  1  loz ; morphine sulfate  1-5  mg ; warfarin  5  mg ; senna  1  tab ; acetaminophen  650  mg ; ibuprofen  600  mg ; docusate sodium  100  mg ; 
 
white f 64 $nan$hematology blood hematocrit  27.3  %; hematology blood hemoglobin  9.2  g dl; hematology blood platelet count  196  k ul; hematology blood inr(pt)  1.6  $multivitamins  1  cap ; vitamin d  400  unit ; levothyroxine sodium  75  mcg ; aspirin  81  mg ; omeprazole  20  mg ; sodium chloride 0.9%  flush  3  ml ; potassium chl 20 meq   1000 ml d5 1 2 ns  1000  ml ; promethazine  25  mg ; trazodone  50  mg ; ondansetron  4  mg ; calcium carbonate  500  mg ; cepacol (menthol)  1  loz ; morphine sulfate  1-5  mg ; senna  1  tab ; acetaminophen  650  mg ; ibuprofen  600  mg ; docusate sodium  100  mg ; 
 
white f 64 $nan$nan$multivitamins  1  cap ; vitamin d  400  unit ; levothyroxine sodium  75  mcg ; aspirin  81  mg ; omeprazole  20  mg ; sodium chloride 0.9%  flush  3  ml ; potassium chl 20 meq   1000 ml d5 1 2 ns  1000  ml ; promethazine  25  mg ; trazodone  50  mg ; ondansetron  4  mg ; calcium carbonate  500  mg ; cepacol (menthol)  1  loz ; morphine sulfate  1-5  mg ; senna  1  tab ; acetaminophen  650  mg ; ibuprofen  600  mg ; docusate sodium  100  mg ; 
 
white f 74 $temp  97.9  heartrate  67.0  resprate  18.0  o2sat  96.0  sbp  93.0  dbp  49.0  rhythm    pain  5  $hematology blood hematocrit  42.0  %; hematology blood hemoglobin  13.5  g dl; hematology blood platelet count  220  k ul; chemistry blood anion gap  13  meq l; chemistry blood bicarbonate  28  meq l; chemistry blood chloride  102  meq l; chemistry blood creatinine  0.5  mg dl; chemistry blood potassium  4.4  meq l; chemistry blood sodium  139  meq l; chemistry blood urea nitrogen  14  mg dl; hematology blood inr(pt)  3.2  ; chemistry blood calcium, total  9.3  mg dl; chemistry blood glucose  105  mg dl$influenza vaccine quadrivalent  0.5  ml ; sodium chloride 0.9%  flush  3  ml ; docusate sodium  100  mg ; famotidine  20  mg ; levetiracetam  500  mg ; prochlorperazine  10  mg ; senna  8.6  mg ; dexamethasone  4  mg ; ondansetron  4  mg ; acetaminophen  650  mg ; 0.9% sodium chloride  100  ml ; 
migraine, unspecified, without mention of intractable migraine without mention of status migrainosus long-term (current) use of anticoagulants depressive disorder, not elsewhere classified cerebral edema osteoporosis, unspecified contusion of unspecified part of upper limb swelling, mass, or lump in chest chronic pulmonary embolism other chronic pain anticoagulants causing adverse effects in therapeutic use other postprocedural status chronic venous embolism and thrombosis of unspecified deep vessels of lower extremity esophageal reflux backache, unspecified malignant neoplasm of frontal lobe hemiplegia, unspecified, affecting nondominant side compression of brain backache, unspecified facial weakness osteoporosis, unspecified other chronic pain loss of weight cerebral edema malignant neoplasm of frontal lobe sciatica body mass index 31.0-31.9, adult dysarthria esophageal reflux migraine, unspecified, without mention of intractable migraine without mention of status migrainosus 
white f 74 $nan$hematology blood hematocrit  38.3  %; hematology blood hemoglobin  12.5  g dl; hematology blood platelet count  237  k ul; chemistry blood anion gap  14  meq l; chemistry blood bicarbonate  26  meq l; chemistry blood chloride  104  meq l; chemistry blood creatinine  0.6  mg dl; chemistry blood potassium  4.0  meq l; chemistry blood sodium  140  meq l; chemistry blood urea nitrogen  23  mg dl; chemistry blood glucose  121  mg dl$influenza vaccine quadrivalent  0.5  ml ; sodium chloride 0.9%  flush  3  ml ; docusate sodium  100  mg ; famotidine  20  mg ; senna  8.6  mg ; dexamethasone  4  mg ; ondansetron  4  mg ; acetaminophen  650  mg ; 0.9% sodium chloride  100  ml ; warfarin  2  mg ; heparin flush (100 units ml)  5  ml ; heparin flush (10 units ml)  5  ml ; sodium chloride 0.9%  flush  10  ml ; 
migraine, unspecified, without mention of intractable migraine without mention of status migrainosus long-term (current) use of anticoagulants depressive disorder, not elsewhere classified cerebral edema osteoporosis, unspecified contusion of unspecified part of upper limb swelling, mass, or lump in chest chronic pulmonary embolism other chronic pain anticoagulants causing adverse effects in therapeutic use other postprocedural status chronic venous embolism and thrombosis of unspecified deep vessels of lower extremity esophageal reflux backache, unspecified malignant neoplasm of frontal lobe hemiplegia, unspecified, affecting nondominant side compression of brain backache, unspecified facial weakness osteoporosis, unspecified other chronic pain loss of weight cerebral edema malignant neoplasm of frontal lobe sciatica body mass index 31.0-31.9, adult dysarthria esophageal reflux migraine, unspecified, without mention of intractable migraine without mention of status migrainosus 
white f 74 $nan$hematology blood hematocrit  39.5  %; hematology blood hemoglobin  13.1  g dl; hematology blood platelet count  244  k ul; chemistry blood anion gap  13  meq l; chemistry blood bicarbonate  27  meq l; chemistry blood chloride  102  meq l; chemistry blood creatinine  0.5  mg dl; chemistry blood potassium  4.1  meq l; chemistry blood sodium  138  meq l; chemistry blood urea nitrogen  25  mg dl; hematology blood inr(pt)  5.9  ; chemistry blood glucose  103  mg dl$influenza vaccine quadrivalent  0.5  ml ; sodium chloride 0.9%  flush  3  ml ; docusate sodium  100  mg ; famotidine  20  mg ; senna  8.6  mg ; ondansetron  4  mg ; acetaminophen  650  mg ; warfarin  2  mg ; heparin flush (100 units ml)  5  ml ; heparin flush (10 units ml)  5  ml ; sodium chloride 0.9%  flush  10  ml ; 
migraine, unspecified, without mention of intractable migraine without mention of status migrainosus long-term (current) use of anticoagulants depressive disorder, not elsewhere classified cerebral edema osteoporosis, unspecified contusion of unspecified part of upper limb swelling, mass, or lump in chest chronic pulmonary embolism other chronic pain anticoagulants causing adverse effects in therapeutic use other postprocedural status chronic venous embolism and thrombosis of unspecified deep vessels of lower extremity esophageal reflux backache, unspecified malignant neoplasm of frontal lobe hemiplegia, unspecified, affecting nondominant side compression of brain backache, unspecified facial weakness osteoporosis, unspecified other chronic pain loss of weight cerebral edema malignant neoplasm of frontal lobe sciatica body mass index 31.0-31.9, adult dysarthria esophageal reflux migraine, unspecified, without mention of intractable migraine without mention of status migrainosus 
white f 74 $nan$hematology blood inr(pt)  4.7  $influenza vaccine quadrivalent  0.5  ml ; docusate sodium  100  mg ; famotidine  20  mg ; senna  8.6  mg ; ondansetron  4  mg ; acetaminophen  650  mg ; heparin flush (100 units ml)  5  ml ; heparin flush (10 units ml)  5  ml ; sodium chloride 0.9%  flush  10  ml ; 
migraine, unspecified, without mention of intractable migraine without mention of status migrainosus long-term (current) use of anticoagulants depressive disorder, not elsewhere classified cerebral edema osteoporosis, unspecified contusion of unspecified part of upper limb swelling, mass, or lump in chest chronic pulmonary embolism other chronic pain anticoagulants causing adverse effects in therapeutic use other postprocedural status chronic venous embolism and thrombosis of unspecified deep vessels of lower extremity esophageal reflux backache, unspecified malignant neoplasm of frontal lobe hemiplegia, unspecified, affecting nondominant side compression of brain backache, unspecified facial weakness osteoporosis, unspecified other chronic pain loss of weight cerebral edema malignant neoplasm of frontal lobe sciatica body mass index 31.0-31.9, adult dysarthria esophageal reflux migraine, unspecified, without mention of intractable migraine without mention of status migrainosus 
white f 74 $nan$hematology blood hematocrit  39.3  %; hematology blood hemoglobin  13.1  g dl; hematology blood platelet count  214  k ul; chemistry blood anion gap  14  meq l; chemistry blood bicarbonate  27  meq l; chemistry blood chloride  101  meq l; chemistry blood creatinine  0.5  mg dl; chemistry blood potassium  4.2  meq l; chemistry blood sodium  138  meq l; chemistry blood urea nitrogen  21  mg dl; hematology blood inr(pt)  2.4  ; chemistry blood glucose  92  mg dl$influenza vaccine quadrivalent  0.5  ml ; docusate sodium  100  mg ; famotidine  20  mg ; senna  8.6  mg ; ondansetron  4  mg ; acetaminophen  650  mg ; heparin flush (100 units ml)  5  ml ; heparin flush (10 units ml)  5  ml ; sodium chloride 0.9%  flush  10  ml ; 
migraine, unspecified, without mention of intractable migraine without mention of status migrainosus long-term (current) use of anticoagulants depressive disorder, not elsewhere classified cerebral edema osteoporosis, unspecified contusion of unspecified part of upper limb swelling, mass, or lump in chest chronic pulmonary embolism other chronic pain anticoagulants causing adverse effects in therapeutic use other postprocedural status chronic venous embolism and thrombosis of unspecified deep vessels of lower extremity esophageal reflux backache, unspecified malignant neoplasm of frontal lobe hemiplegia, unspecified, affecting nondominant side compression of brain backache, unspecified facial weakness osteoporosis, unspecified other chronic pain loss of weight cerebral edema malignant neoplasm of frontal lobe sciatica body mass index 31.0-31.9, adult dysarthria esophageal reflux migraine, unspecified, without mention of intractable migraine without mention of status migrainosus 
white f 74 $nan$nan$influenza vaccine quadrivalent  0.5  ml ; docusate sodium  100  mg ; famotidine  20  mg ; senna  8.6  mg ; ondansetron  4  mg ; acetaminophen  650  mg ; heparin flush (100 units ml)  5  ml ; heparin flush (10 units ml)  5  ml ; sodium chloride 0.9%  flush  10  ml ; warfarin  1  mg ; 
migraine, unspecified, without mention of intractable migraine without mention of status migrainosus long-term (current) use of anticoagulants depressive disorder, not elsewhere classified cerebral edema osteoporosis, unspecified contusion of unspecified part of upper limb swelling, mass, or lump in chest chronic pulmonary embolism other chronic pain anticoagulants causing adverse effects in therapeutic use other postprocedural status chronic venous embolism and thrombosis of unspecified deep vessels of lower extremity esophageal reflux backache, unspecified malignant neoplasm of frontal lobe hemiplegia, unspecified, affecting nondominant side compression of brain backache, unspecified facial weakness osteoporosis, unspecified other chronic pain loss of weight cerebral edema malignant neoplasm of frontal lobe sciatica body mass index 31.0-31.9, adult dysarthria esophageal reflux migraine, unspecified, without mention of intractable migraine without mention of status migrainosus 
white m 74 $nan$nan$aspirin  325  mg ; clopidogrel  75  mg ; atorvastatin  80  mg ; metoprolol tartrate  12.5  mg ; 
 
white m 74 $nan$nan$iso-osmotic dextrose  50  ml ; aspirin  325  mg ; clopidogrel  75  mg ; atorvastatin  80  mg ; metoprolol tartrate  12.5  mg ; sodium chloride 0.9%  flush  3  ml ; 0.9% sodium chloride  1000  ml ; cefazolin  1  g ; oxycodone (immediate release)   5  mg ; 0.9% sodium chloride  500  ml ; ibuprofen  600  mg ; 
 
white m 80 $nan$nan$simvastatin  40  mg ; 
constipation, unspecified pure hypercholesterolemia other chest pain 
white m 80 $nan$nan$simvastatin  40  mg ; 
constipation, unspecified pure hypercholesterolemia other chest pain 
white m 80 $nan$nan$simvastatin  40  mg ; 
constipation, unspecified pure hypercholesterolemia other chest pain 
hispanic latino f 77 $nan$nan$atenolol  50  mg ; fondaparinux sodium  5  mg ; hydrochlorothiazide  25  mg ; omeprazole  20  mg ; sulfameth trimethoprim ss  1  tab ; valsartan  80  mg ; ondansetron  12  mg ; prednisone  100  mg ; 
family history of other cardiovascular diseases blister of other, multiple, and unspecified sites, without mention of infection osteoarthrosis, localized, not specified whether primary or secondary, lower leg encounter for antineoplastic chemotherapy fluid overload disorder unspecified essential hypertension unspecified accident personal history of venous thrombosis and embolism other malignant lymphomas, lymph nodes of multiple sites accidents occurring in unspecified place personal history of venous thrombosis and embolism encounter for antineoplastic chemotherapy other malignant lymphomas, lymph nodes of axilla and upper limb osteoarthrosis, localized, not specified whether primary or secondary, lower leg family history of other cardiovascular diseases osteoarthrosis, unspecified whether generalized or localized, site unspecified other malignant lymphomas, lymph nodes of multiple sites disorders of bursae and tendons in shoulder region, unspecified personal history of venous thrombosis and embolism unspecified essential hypertension encounter for antineoplastic chemotherapy leukocytosis, unspecified osteoarthrosis, localized, not specified whether primary or secondary, lower leg other malignant lymphomas, intrathoracic lymph nodes obesity, unspecified personal history of venous thrombosis and embolism unspecified essential hypertension encounter for antineoplastic chemotherapy family history of other cardiovascular diseases other malignant lymphomas, lymph nodes of multiple sites diarrhea osteoarthrosis, unspecified whether generalized or localized, site unspecified osteoarthrosis, localized, not specified whether primary or secondary, lower leg unspecified essential hypertension obesity, unspecified encounter for antineoplastic chemotherapy
hispanic latino f 77 $nan$hematology blood hematocrit  30.9  %; hematology blood hematocrit  31.9  %; hematology blood hemoglobin  10.1  g dl; hematology blood hemoglobin  9.9  g dl; hematology blood platelet count  268  k ul; hematology blood platelet count  272  k ul; chemistry blood anion gap  11  meq l; chemistry blood anion gap  13  meq l; chemistry blood bicarbonate  28  meq l; chemistry blood bicarbonate  25  meq l; chemistry blood chloride  105  meq l; chemistry blood chloride  105  meq l; chemistry blood creatinine  0.9  mg dl; chemistry blood creatinine  0.9  mg dl; chemistry blood potassium  4.2  meq l; chemistry blood potassium  4.5  meq l; chemistry blood sodium  140  meq l; chemistry blood sodium  138  meq l; chemistry blood urea nitrogen  14  mg dl; chemistry blood urea nitrogen  15  mg dl; hematology blood inr(pt)  1.2  ; hematology blood inr(pt)  1.2  ; chemistry blood calcium, total  8.8  mg dl; chemistry blood calcium, total  8.8  mg dl; chemistry blood bilirubin, total  0.4  mg dl; chemistry blood bilirubin, total  0.2  mg dl; chemistry blood glucose  115  mg dl; chemistry blood glucose  136  mg dl; chemistry blood lactate dehydrogenase (ld)  199  iu l; chemistry blood lactate dehydrogenase (ld)  196  iu l; chemistry blood albumin  3.7  g dl; chemistry blood albumin  3.6  g dl; hematology blood bands  0  %$atenolol  50  mg ; fondaparinux sodium  5  mg ; hydrochlorothiazide  25  mg ; omeprazole  20  mg ; sulfameth trimethoprim ss  1  tab ; valsartan  80  mg ; ondansetron  12  mg ; prednisone  100  mg ; heparin flush (10 units ml)  5  ml ; heparin flush (100 units ml)  5  ml ; ns  500  ml ; etoposide  75  mg ; vincristine (oncovin)  0.5  mg ; ns  1000  ml ; doxorubicin  15  mg ; sw  50  ml ; potassium chloride  40  meq ; potassium chloride  60  meq ; potassium chloride replacement (oncology)  40  meq ; potassium chloride replacement (oncology)  60  meq ; potassium chloride replacement (oncology)  80  meq ; ns  250  ml ; potassium phosphate  15  mmol ; calcium replacement (oncology)  1  gm ; calcium replacement (oncology)  2  gm ; calcium gluconate  3  gm ; magnesium sulfate  4  gm ; magnesium sulfate  2-4  gm ; magnesium sulfate replacement (oncology)  2  gm ; ondansetron  4  mg ; prochlorperazine  10  mg ; lorazepam  0.5  mg ; acyclovir  400  mg ; oxycodone (immediate release)   2.5-5  mg ; sarna lotion  1  appl ; sodium chloride 0.9%  flush  3  ml ; d5 1 2ns  1000  ml ; chlorhexidine gluconate 0.12% oral rinse  15  ml ; 
family history of other cardiovascular diseases blister of other, multiple, and unspecified sites, without mention of infection osteoarthrosis, localized, not specified whether primary or secondary, lower leg encounter for antineoplastic chemotherapy fluid overload disorder unspecified essential hypertension unspecified accident personal history of venous thrombosis and embolism other malignant lymphomas, lymph nodes of multiple sites accidents occurring in unspecified place personal history of venous thrombosis and embolism encounter for antineoplastic chemotherapy other malignant lymphomas, lymph nodes of axilla and upper limb osteoarthrosis, localized, not specified whether primary or secondary, lower leg family history of other cardiovascular diseases osteoarthrosis, unspecified whether generalized or localized, site unspecified other malignant lymphomas, lymph nodes of multiple sites disorders of bursae and tendons in shoulder region, unspecified personal history of venous thrombosis and embolism unspecified essential hypertension encounter for antineoplastic chemotherapy leukocytosis, unspecified osteoarthrosis, localized, not specified whether primary or secondary, lower leg other malignant lymphomas, intrathoracic lymph nodes obesity, unspecified personal history of venous thrombosis and embolism unspecified essential hypertension encounter for antineoplastic chemotherapy family history of other cardiovascular diseases other malignant lymphomas, lymph nodes of multiple sites diarrhea osteoarthrosis, unspecified whether generalized or localized, site unspecified osteoarthrosis, localized, not specified whether primary or secondary, lower leg unspecified essential hypertension obesity, unspecified encounter for antineoplastic chemotherapy
hispanic latino f 77 $nan$hematology blood hematocrit  31.0  %; hematology blood hemoglobin  9.9  g dl; hematology blood platelet count  268  k ul; chemistry blood anion gap  13  meq l; chemistry blood bicarbonate  26  meq l; chemistry blood chloride  105  meq l; chemistry blood creatinine  0.8  mg dl; chemistry blood potassium  4.1  meq l; chemistry blood sodium  140  meq l; chemistry blood urea nitrogen  17  mg dl; hematology blood inr(pt)  1.2  ; chemistry blood calcium, total  8.9  mg dl; chemistry blood bilirubin, total  0.3  mg dl; chemistry blood glucose  141  mg dl; chemistry blood lactate dehydrogenase (ld)  196  iu l; chemistry blood albumin  3.7  g dl$atenolol  50  mg ; fondaparinux sodium  5  mg ; hydrochlorothiazide  25  mg ; omeprazole  20  mg ; sulfameth trimethoprim ss  1  tab ; valsartan  80  mg ; ondansetron  12  mg ; prednisone  100  mg ; heparin flush (10 units ml)  5  ml ; heparin flush (100 units ml)  5  ml ; ns  500  ml ; etoposide  75  mg ; vincristine (oncovin)  0.5  mg ; ns  1000  ml ; doxorubicin  15  mg ; sw  50  ml ; potassium chloride  40  meq ; potassium chloride  60  meq ; potassium chloride replacement (oncology)  40  meq ; potassium chloride replacement (oncology)  60  meq ; potassium chloride replacement (oncology)  80  meq ; ns  250  ml ; potassium phosphate  15  mmol ; calcium replacement (oncology)  1  gm ; calcium replacement (oncology)  2  gm ; calcium gluconate  3  gm ; magnesium sulfate  4  gm ; magnesium sulfate  2-4  gm ; magnesium sulfate replacement (oncology)  2  gm ; ondansetron  4  mg ; prochlorperazine  10  mg ; lorazepam  0.5  mg ; acyclovir  400  mg ; oxycodone (immediate release)   2.5-5  mg ; sarna lotion  1  appl ; sodium chloride 0.9%  flush  3  ml ; chlorhexidine gluconate 0.12% oral rinse  15  ml ; furosemide  10  mg ; 
family history of other cardiovascular diseases blister of other, multiple, and unspecified sites, without mention of infection osteoarthrosis, localized, not specified whether primary or secondary, lower leg encounter for antineoplastic chemotherapy fluid overload disorder unspecified essential hypertension unspecified accident personal history of venous thrombosis and embolism other malignant lymphomas, lymph nodes of multiple sites accidents occurring in unspecified place personal history of venous thrombosis and embolism encounter for antineoplastic chemotherapy other malignant lymphomas, lymph nodes of axilla and upper limb osteoarthrosis, localized, not specified whether primary or secondary, lower leg family history of other cardiovascular diseases osteoarthrosis, unspecified whether generalized or localized, site unspecified other malignant lymphomas, lymph nodes of multiple sites disorders of bursae and tendons in shoulder region, unspecified personal history of venous thrombosis and embolism unspecified essential hypertension encounter for antineoplastic chemotherapy leukocytosis, unspecified osteoarthrosis, localized, not specified whether primary or secondary, lower leg other malignant lymphomas, intrathoracic lymph nodes obesity, unspecified personal history of venous thrombosis and embolism unspecified essential hypertension encounter for antineoplastic chemotherapy family history of other cardiovascular diseases other malignant lymphomas, lymph nodes of multiple sites diarrhea osteoarthrosis, unspecified whether generalized or localized, site unspecified osteoarthrosis, localized, not specified whether primary or secondary, lower leg unspecified essential hypertension obesity, unspecified encounter for antineoplastic chemotherapy
hispanic latino f 77 $nan$hematology blood hematocrit  26.8  %; hematology blood hemoglobin  8.8  g dl; hematology blood platelet count  230  k ul; chemistry blood anion gap  11  meq l; chemistry blood bicarbonate  28  meq l; chemistry blood chloride  106  meq l; chemistry blood creatinine  0.7  mg dl; chemistry blood potassium  3.5  meq l; chemistry blood sodium  141  meq l; chemistry blood urea nitrogen  14  mg dl; hematology blood inr(pt)  1.2  ; chemistry blood calcium, total  8.5  mg dl; chemistry blood bilirubin, total  0.4  mg dl; chemistry blood glucose  116  mg dl; chemistry blood lactate dehydrogenase (ld)  147  iu l$atenolol  50  mg ; fondaparinux sodium  5  mg ; hydrochlorothiazide  25  mg ; omeprazole  20  mg ; sulfameth trimethoprim ss  1  tab ; valsartan  80  mg ; ondansetron  12  mg ; prednisone  100  mg ; heparin flush (10 units ml)  5  ml ; heparin flush (100 units ml)  5  ml ; ns  500  ml ; etoposide  75  mg ; vincristine (oncovin)  0.5  mg ; ns  1000  ml ; doxorubicin  15  mg ; sw  50  ml ; potassium chloride  40  meq ; potassium chloride  60  meq ; potassium chloride replacement (oncology)  40  meq ; potassium chloride replacement (oncology)  60  meq ; potassium chloride replacement (oncology)  80  meq ; ns  250  ml ; potassium phosphate  15  mmol ; calcium replacement (oncology)  1  gm ; calcium replacement (oncology)  2  gm ; calcium gluconate  3  gm ; magnesium sulfate  4  gm ; magnesium sulfate  2-4  gm ; magnesium sulfate replacement (oncology)  2  gm ; ondansetron  4  mg ; prochlorperazine  10  mg ; lorazepam  0.5  mg ; acyclovir  400  mg ; oxycodone (immediate release)   2.5-5  mg ; sarna lotion  1  appl ; sodium chloride 0.9%  flush  3  ml ; chlorhexidine gluconate 0.12% oral rinse  15  ml ; furosemide  10  mg ; furosemide  20  mg ; 
family history of other cardiovascular diseases blister of other, multiple, and unspecified sites, without mention of infection osteoarthrosis, localized, not specified whether primary or secondary, lower leg encounter for antineoplastic chemotherapy fluid overload disorder unspecified essential hypertension unspecified accident personal history of venous thrombosis and embolism other malignant lymphomas, lymph nodes of multiple sites accidents occurring in unspecified place personal history of venous thrombosis and embolism encounter for antineoplastic chemotherapy other malignant lymphomas, lymph nodes of axilla and upper limb osteoarthrosis, localized, not specified whether primary or secondary, lower leg family history of other cardiovascular diseases osteoarthrosis, unspecified whether generalized or localized, site unspecified other malignant lymphomas, lymph nodes of multiple sites disorders of bursae and tendons in shoulder region, unspecified personal history of venous thrombosis and embolism unspecified essential hypertension encounter for antineoplastic chemotherapy leukocytosis, unspecified osteoarthrosis, localized, not specified whether primary or secondary, lower leg other malignant lymphomas, intrathoracic lymph nodes obesity, unspecified personal history of venous thrombosis and embolism unspecified essential hypertension encounter for antineoplastic chemotherapy family history of other cardiovascular diseases other malignant lymphomas, lymph nodes of multiple sites diarrhea osteoarthrosis, unspecified whether generalized or localized, site unspecified osteoarthrosis, localized, not specified whether primary or secondary, lower leg unspecified essential hypertension obesity, unspecified encounter for antineoplastic chemotherapy
hispanic latino f 77 $nan$hematology blood hematocrit  28.6  %; hematology blood hemoglobin  9.4  g dl; hematology blood platelet count  252  k ul; chemistry blood anion gap  14  meq l; chemistry blood bicarbonate  27  meq l; chemistry blood chloride  102  meq l; chemistry blood creatinine  0.7  mg dl; chemistry blood potassium  3.5  meq l; chemistry blood sodium  139  meq l; chemistry blood urea nitrogen  13  mg dl; hematology blood inr(pt)  1.3  ; chemistry blood calcium, total  8.5  mg dl; chemistry blood bilirubin, total  0.5  mg dl; chemistry blood glucose  137  mg dl; chemistry blood lactate dehydrogenase (ld)  166  iu l$atenolol  50  mg ; fondaparinux sodium  5  mg ; hydrochlorothiazide  25  mg ; omeprazole  20  mg ; sulfameth trimethoprim ss  1  tab ; valsartan  80  mg ; ondansetron  12  mg ; prednisone  100  mg ; heparin flush (10 units ml)  5  ml ; heparin flush (100 units ml)  5  ml ; ns  500  ml ; etoposide  75  mg ; vincristine (oncovin)  0.5  mg ; ns  1000  ml ; doxorubicin  15  mg ; sw  50  ml ; potassium chloride  40  meq ; potassium chloride  60  meq ; potassium chloride replacement (oncology)  40  meq ; potassium chloride replacement (oncology)  60  meq ; potassium chloride replacement (oncology)  80  meq ; ns  250  ml ; potassium phosphate  15  mmol ; calcium replacement (oncology)  1  gm ; calcium replacement (oncology)  2  gm ; calcium gluconate  3  gm ; magnesium sulfate  4  gm ; magnesium sulfate  2-4  gm ; magnesium sulfate replacement (oncology)  2  gm ; ondansetron  4  mg ; prochlorperazine  10  mg ; lorazepam  0.5  mg ; acyclovir  400  mg ; oxycodone (immediate release)   2.5-5  mg ; sarna lotion  1  appl ; sodium chloride 0.9%  flush  3  ml ; chlorhexidine gluconate 0.12% oral rinse  15  ml ; furosemide  20  mg ; furosemide  40  mg ; 
family history of other cardiovascular diseases blister of other, multiple, and unspecified sites, without mention of infection osteoarthrosis, localized, not specified whether primary or secondary, lower leg encounter for antineoplastic chemotherapy fluid overload disorder unspecified essential hypertension unspecified accident personal history of venous thrombosis and embolism other malignant lymphomas, lymph nodes of multiple sites accidents occurring in unspecified place personal history of venous thrombosis and embolism encounter for antineoplastic chemotherapy other malignant lymphomas, lymph nodes of axilla and upper limb osteoarthrosis, localized, not specified whether primary or secondary, lower leg family history of other cardiovascular diseases osteoarthrosis, unspecified whether generalized or localized, site unspecified other malignant lymphomas, lymph nodes of multiple sites disorders of bursae and tendons in shoulder region, unspecified personal history of venous thrombosis and embolism unspecified essential hypertension encounter for antineoplastic chemotherapy leukocytosis, unspecified osteoarthrosis, localized, not specified whether primary or secondary, lower leg other malignant lymphomas, intrathoracic lymph nodes obesity, unspecified personal history of venous thrombosis and embolism unspecified essential hypertension encounter for antineoplastic chemotherapy family history of other cardiovascular diseases other malignant lymphomas, lymph nodes of multiple sites diarrhea osteoarthrosis, unspecified whether generalized or localized, site unspecified osteoarthrosis, localized, not specified whether primary or secondary, lower leg unspecified essential hypertension obesity, unspecified encounter for antineoplastic chemotherapy
hispanic latino f 77 $nan$nan$atenolol  50  mg ; fondaparinux sodium  5  mg ; hydrochlorothiazide  25  mg ; omeprazole  20  mg ; sulfameth trimethoprim ss  1  tab ; valsartan  80  mg ; ondansetron  12  mg ; prednisone  100  mg ; heparin flush (10 units ml)  5  ml ; heparin flush (100 units ml)  5  ml ; ns  500  ml ; etoposide  75  mg ; vincristine (oncovin)  0.5  mg ; ns  1000  ml ; doxorubicin  15  mg ; sw  50  ml ; potassium chloride  40  meq ; potassium chloride  60  meq ; potassium chloride replacement (oncology)  40  meq ; potassium chloride replacement (oncology)  60  meq ; potassium chloride replacement (oncology)  80  meq ; ns  250  ml ; potassium phosphate  15  mmol ; calcium replacement (oncology)  1  gm ; calcium replacement (oncology)  2  gm ; calcium gluconate  3  gm ; magnesium sulfate  4  gm ; magnesium sulfate  2-4  gm ; magnesium sulfate replacement (oncology)  2  gm ; ondansetron  4  mg ; prochlorperazine  10  mg ; lorazepam  0.5  mg ; acyclovir  400  mg ; oxycodone (immediate release)   2.5-5  mg ; sarna lotion  1  appl ; sodium chloride 0.9%  flush  3  ml ; chlorhexidine gluconate 0.12% oral rinse  15  ml ; d5w  150  ml ; cyclophosphamide  1150  mg ; 
family history of other cardiovascular diseases blister of other, multiple, and unspecified sites, without mention of infection osteoarthrosis, localized, not specified whether primary or secondary, lower leg encounter for antineoplastic chemotherapy fluid overload disorder unspecified essential hypertension unspecified accident personal history of venous thrombosis and embolism other malignant lymphomas, lymph nodes of multiple sites accidents occurring in unspecified place personal history of venous thrombosis and embolism encounter for antineoplastic chemotherapy other malignant lymphomas, lymph nodes of axilla and upper limb osteoarthrosis, localized, not specified whether primary or secondary, lower leg family history of other cardiovascular diseases osteoarthrosis, unspecified whether generalized or localized, site unspecified other malignant lymphomas, lymph nodes of multiple sites disorders of bursae and tendons in shoulder region, unspecified personal history of venous thrombosis and embolism unspecified essential hypertension encounter for antineoplastic chemotherapy leukocytosis, unspecified osteoarthrosis, localized, not specified whether primary or secondary, lower leg other malignant lymphomas, intrathoracic lymph nodes obesity, unspecified personal history of venous thrombosis and embolism unspecified essential hypertension encounter for antineoplastic chemotherapy family history of other cardiovascular diseases other malignant lymphomas, lymph nodes of multiple sites diarrhea osteoarthrosis, unspecified whether generalized or localized, site unspecified osteoarthrosis, localized, not specified whether primary or secondary, lower leg unspecified essential hypertension obesity, unspecified encounter for antineoplastic chemotherapy
white f 81 $nan$nan$digoxin  0.125  mg ; aspirin  300  mg ; 
 
white f 81 $nan$hematology blood hematocrit  30.7  %; hematology blood hemoglobin  9.8  g dl; hematology blood platelet count  392  k ul; chemistry blood anion gap  14  meq l; chemistry blood bicarbonate  27  meq l; chemistry blood chloride  106  meq l; chemistry blood creatinine  0.6  mg dl; chemistry blood potassium  3.8  meq l; chemistry blood sodium  143  meq l; chemistry blood urea nitrogen  8  mg dl; hematology blood inr(pt)  2.1  ; chemistry blood calcium, total  9.2  mg dl; chemistry blood glucose  110  mg dl$digoxin  0.125  mg ; aspirin  300  mg ; influenza virus vaccine  0.5  ml ; pneumococcal vac polyvalent  0.5  ml ; sodium chloride 0.9%  flush  3  ml ; 0.9% sodium chloride  1000  ml ; acetaminophen  325-650  mg ; metoprolol tartrate  5  mg ; albuterol 0.083% neb soln  1  neb ; vial  1  vial ; pantoprazole sodium  40  mg ; bisacodyl  10  mg ; lorazepam  0.5  mg ; insulin  0  unit ; 5% dextrose  100  ml ; ciprofloxacin iv  200  mg ; d5w  250  ml ; heparin sodium  25,000  unit ; warfarin  5  mg ; aspirin  81  mg ; furosemide  40  mg ; 
 
white f 81 $nan$hematology blood hematocrit  33.5  %; hematology blood hemoglobin  11.3  g dl; hematology blood platelet count  422  k ul; chemistry blood anion gap  15  meq l; chemistry blood bicarbonate  24  meq l; chemistry blood chloride  103  meq l; chemistry blood creatinine  0.6  mg dl; chemistry blood potassium  3.8  meq l; chemistry blood sodium  138  meq l; chemistry blood urea nitrogen  7  mg dl; hematology blood inr(pt)  2.2  ; chemistry blood calcium, total  9.3  mg dl; chemistry blood glucose  124  mg dl$influenza virus vaccine  0.5  ml ; pneumococcal vac polyvalent  0.5  ml ; sodium chloride 0.9%  flush  3  ml ; 0.9% sodium chloride  1000  ml ; acetaminophen  325-650  mg ; metoprolol tartrate  5  mg ; albuterol 0.083% neb soln  1  neb ; vial  1  vial ; pantoprazole sodium  40  mg ; bisacodyl  10  mg ; lorazepam  0.5  mg ; insulin  0  unit ; 5% dextrose  100  ml ; ciprofloxacin iv  200  mg ; aspirin  81  mg ; furosemide  40  mg ; furosemide  20  mg ; spironolactone  25  mg ; 
 
white f 81 $nan$hematology blood hematocrit  35.1  %; hematology blood hemoglobin  11.2  g dl; hematology blood platelet count  463  k ul; chemistry blood anion gap  19  meq l; chemistry blood bicarbonate  27  meq l; chemistry blood chloride  102  meq l; chemistry blood creatinine  0.6  mg dl; chemistry blood potassium  4.0  meq l; chemistry blood sodium  144  meq l; chemistry blood urea nitrogen  10  mg dl; hematology blood inr(pt)  3.0  ; chemistry blood calcium, total  9.5  mg dl; chemistry blood glucose  163  mg dl$influenza virus vaccine  0.5  ml ; pneumococcal vac polyvalent  0.5  ml ; sodium chloride 0.9%  flush  3  ml ; 0.9% sodium chloride  1000  ml ; acetaminophen  325-650  mg ; metoprolol tartrate  5  mg ; albuterol 0.083% neb soln  1  neb ; vial  1  vial ; pantoprazole sodium  40  mg ; bisacodyl  10  mg ; lorazepam  0.5  mg ; insulin  0  unit ; aspirin  81  mg ; furosemide  40  mg ; furosemide  20  mg ; spironolactone  25  mg ; neutra-phos  1  pkt ; nitrofurantoin monohyd (macrobid)  100  mg ; ipratropium bromide neb  1  neb ; furosemide  10  mg ; 
 
white f 81 $nan$hematology blood hematocrit  33.7  %; hematology blood hemoglobin  10.7  g dl; hematology blood platelet count  433  k ul; chemistry blood anion gap  16  meq l; chemistry blood bicarbonate  29  meq l; chemistry blood chloride  103  meq l; chemistry blood creatinine  0.6  mg dl; chemistry blood potassium  3.9  meq l; chemistry blood sodium  144  meq l; chemistry blood urea nitrogen  13  mg dl; hematology blood inr(pt)  2.3  ; chemistry blood calcium, total  9.3  mg dl; chemistry blood glucose  137  mg dl$influenza virus vaccine  0.5  ml ; pneumococcal vac polyvalent  0.5  ml ; sodium chloride 0.9%  flush  3  ml ; 0.9% sodium chloride  1000  ml ; acetaminophen  325-650  mg ; metoprolol tartrate  5  mg ; albuterol 0.083% neb soln  1  neb ; vial  1  vial ; pantoprazole sodium  40  mg ; bisacodyl  10  mg ; lorazepam  0.5  mg ; insulin  0  unit ; aspirin  81  mg ; furosemide  40  mg ; neutra-phos  1  pkt ; nitrofurantoin monohyd (macrobid)  100  mg ; ipratropium bromide neb  1  neb ; furosemide  10  mg ; ns (mini bag plus)  100  ml ; meropenem  500  mg ; 
 
white f 81 $nan$hematology blood hematocrit  35.3  %; hematology blood hemoglobin  11.3  g dl; hematology blood platelet count  495  k ul; chemistry blood anion gap  16  meq l; chemistry blood bicarbonate  30  meq l; chemistry blood chloride  105  meq l; chemistry blood creatinine  0.6  mg dl; chemistry blood potassium  4.3  meq l; chemistry blood sodium  147  meq l; chemistry blood urea nitrogen  18  mg dl; hematology blood inr(pt)  2.2  ; chemistry blood calcium, total  9.3  mg dl; chemistry blood glucose  129  mg dl$influenza virus vaccine  0.5  ml ; pneumococcal vac polyvalent  0.5  ml ; sodium chloride 0.9%  flush  3  ml ; 0.9% sodium chloride  1000  ml ; acetaminophen  325-650  mg ; metoprolol tartrate  5  mg ; albuterol 0.083% neb soln  1  neb ; vial  1  vial ; pantoprazole sodium  40  mg ; bisacodyl  10  mg ; lorazepam  0.5  mg ; insulin  0  unit ; aspirin  81  mg ; furosemide  40  mg ; neutra-phos  1  pkt ; ipratropium bromide neb  1  neb ; ns (mini bag plus)  100  ml ; meropenem  500  mg ; 
 
white f 81 $nan$hematology blood hematocrit  37.0  %; hematology blood hemoglobin  11.8  g dl; hematology blood platelet count  544  k ul; chemistry blood anion gap  13  meq l; chemistry blood bicarbonate  31  meq l; chemistry blood chloride  104  meq l; chemistry blood creatinine  0.5  mg dl; chemistry blood potassium  4.1  meq l; chemistry blood sodium  144  meq l; chemistry blood urea nitrogen  19  mg dl; hematology blood inr(pt)  2.1  ; chemistry blood calcium, total  9.7  mg dl; chemistry blood glucose  127  mg dl$influenza virus vaccine  0.5  ml ; pneumococcal vac polyvalent  0.5  ml ; sodium chloride 0.9%  flush  3  ml ; acetaminophen  325-650  mg ; metoprolol tartrate  5  mg ; albuterol 0.083% neb soln  1  neb ; vial  1  vial ; pantoprazole sodium  40  mg ; bisacodyl  10  mg ; lorazepam  0.5  mg ; insulin  0  unit ; aspirin  81  mg ; furosemide  40  mg ; neutra-phos  1  pkt ; ipratropium bromide neb  1  neb ; ns (mini bag plus)  100  ml ; meropenem  500  mg ; oxycodone-acetaminophen  1  tab ; metoprolol tartrate  25  mg ; fluticasone-salmeterol diskus (250 50)   1  inh ; spironolactone  50  mg ; 
 
white f 81 $nan$hematology blood hematocrit  38.0  %; hematology blood hemoglobin  12.1  g dl; hematology blood platelet count  549  k ul; chemistry blood anion gap  18  meq l; chemistry blood bicarbonate  27  meq l; chemistry blood chloride  101  meq l; chemistry blood creatinine  0.6  mg dl; chemistry blood potassium  5.1  meq l; chemistry blood sodium  141  meq l; chemistry blood urea nitrogen  17  mg dl; hematology blood inr(pt)  2.3  ; chemistry blood calcium, total  9.9  mg dl; chemistry blood glucose  115  mg dl$influenza virus vaccine  0.5  ml ; pneumococcal vac polyvalent  0.5  ml ; sodium chloride 0.9%  flush  3  ml ; acetaminophen  325-650  mg ; albuterol 0.083% neb soln  1  neb ; vial  1  vial ; pantoprazole sodium  40  mg ; bisacodyl  10  mg ; lorazepam  0.5  mg ; insulin  0  unit ; aspirin  81  mg ; furosemide  40  mg ; neutra-phos  1  pkt ; ipratropium bromide neb  1  neb ; ns (mini bag plus)  100  ml ; meropenem  500  mg ; oxycodone-acetaminophen  1  tab ; metoprolol tartrate  25  mg ; fluticasone-salmeterol diskus (250 50)   1  inh ; spironolactone  50  mg ; oxycodone-acetaminophen elixir  5  ml ; heparin  1600-3200  unit ; 
 
white f 81 $nan$chemistry blood anion gap  16  meq l; chemistry blood bicarbonate  28  meq l; chemistry blood chloride  103  meq l; chemistry blood creatinine  0.6  mg dl; chemistry blood potassium  3.9  meq l; chemistry blood sodium  143  meq l; chemistry blood urea nitrogen  21  mg dl; hematology blood inr(pt)  1.9  ; chemistry blood calcium, total  9.8  mg dl; chemistry blood glucose  104  mg dl$influenza virus vaccine  0.5  ml ; pneumococcal vac polyvalent  0.5  ml ; sodium chloride 0.9%  flush  3  ml ; acetaminophen  325-650  mg ; albuterol 0.083% neb soln  1  neb ; vial  1  vial ; pantoprazole sodium  40  mg ; bisacodyl  10  mg ; lorazepam  0.5  mg ; insulin  0  unit ; aspirin  81  mg ; furosemide  40  mg ; neutra-phos  1  pkt ; ipratropium bromide neb  1  neb ; ns (mini bag plus)  100  ml ; meropenem  500  mg ; metoprolol tartrate  25  mg ; fluticasone-salmeterol diskus (250 50)   1  inh ; spironolactone  50  mg ; oxycodone-acetaminophen elixir  5  ml ; morphine sulfate (oral soln.)  2  mg ; acetaminophen  1000  mg ; nystatin oral suspension  5  ml ; 
 
white f 81 $nan$hematology blood hematocrit  35.9  %; hematology blood hemoglobin  11.7  g dl; hematology blood platelet count  542  k ul; chemistry blood anion gap  15  meq l; chemistry blood bicarbonate  30  meq l; chemistry blood chloride  102  meq l; chemistry blood creatinine  0.6  mg dl; chemistry blood potassium  4.2  meq l; chemistry blood sodium  143  meq l; chemistry blood urea nitrogen  19  mg dl; hematology blood inr(pt)  1.8  ; hematology blood inr(pt)  1.5  ; chemistry blood calcium, total  9.7  mg dl; chemistry blood glucose  97  mg dl$influenza virus vaccine  0.5  ml ; pneumococcal vac polyvalent  0.5  ml ; sodium chloride 0.9%  flush  3  ml ; albuterol 0.083% neb soln  1  neb ; vial  1  vial ; pantoprazole sodium  40  mg ; bisacodyl  10  mg ; lorazepam  0.5  mg ; insulin  0  unit ; aspirin  81  mg ; furosemide  40  mg ; ipratropium bromide neb  1  neb ; ns (mini bag plus)  100  ml ; meropenem  500  mg ; metoprolol tartrate  25  mg ; fluticasone-salmeterol diskus (250 50)   1  inh ; spironolactone  50  mg ; morphine sulfate (oral soln.)  2  mg ; acetaminophen  1000  mg ; nystatin oral suspension  5  ml ; 
 
white f 81 $nan$hematology blood inr(pt)  1.5  ; hematology blood inr(pt)  1.4  ; hematology blood inr(pt)  1.4  $influenza virus vaccine  0.5  ml ; pneumococcal vac polyvalent  0.5  ml ; sodium chloride 0.9%  flush  3  ml ; albuterol 0.083% neb soln  1  neb ; vial  1  vial ; pantoprazole sodium  40  mg ; bisacodyl  10  mg ; lorazepam  0.5  mg ; insulin  0  unit ; aspirin  81  mg ; furosemide  40  mg ; ipratropium bromide neb  1  neb ; ns (mini bag plus)  100  ml ; meropenem  500  mg ; metoprolol tartrate  25  mg ; fluticasone-salmeterol diskus (250 50)   1  inh ; spironolactone  50  mg ; morphine sulfate (oral soln.)  2  mg ; acetaminophen  1000  mg ; nystatin oral suspension  5  ml ; 
 
white f 81 $nan$hematology blood hematocrit  41.1  %; hematology blood hemoglobin  12.7  g dl; hematology blood platelet count  524  k ul; chemistry blood anion gap  16  meq l; chemistry blood bicarbonate  29  meq l; chemistry blood chloride  99  meq l; chemistry blood creatinine  0.6  mg dl; chemistry blood potassium  4.2  meq l; chemistry blood sodium  140  meq l; chemistry blood urea nitrogen  24  mg dl; hematology blood inr(pt)  1.3  ; hematology blood inr(pt)  1.2  ; chemistry blood calcium, total  10.1  mg dl; chemistry blood glucose  101  mg dl$influenza virus vaccine  0.5  ml ; pneumococcal vac polyvalent  0.5  ml ; sodium chloride 0.9%  flush  3  ml ; albuterol 0.083% neb soln  1  neb ; vial  1  vial ; pantoprazole sodium  40  mg ; bisacodyl  10  mg ; lorazepam  0.5  mg ; insulin  0  unit ; aspirin  81  mg ; furosemide  40  mg ; ipratropium bromide neb  1  neb ; ns (mini bag plus)  100  ml ; meropenem  500  mg ; metoprolol tartrate  25  mg ; fluticasone-salmeterol diskus (250 50)   1  inh ; spironolactone  50  mg ; morphine sulfate (oral soln.)  2  mg ; acetaminophen  1000  mg ; nystatin oral suspension  5  ml ; 
 
white f 81 $nan$hematology blood hematocrit  38.1  %; hematology blood hematocrit  35.5  %; hematology blood hemoglobin  12.5  g dl; hematology blood hemoglobin  11.3  g dl; hematology blood platelet count  416  k ul; hematology blood platelet count  386  k ul; chemistry blood anion gap  15  meq l; chemistry blood bicarbonate  30  meq l; chemistry blood chloride  102  meq l; chemistry blood creatinine  0.7  mg dl; chemistry blood potassium  3.8  meq l; chemistry blood sodium  143  meq l; chemistry blood urea nitrogen  22  mg dl; hematology blood inr(pt)  1.3  ; hematology blood inr(pt)  1.4  ; hematology blood inr(pt)  1.3  ; hematology urine wbc  9  # hpf; chemistry blood calcium, total  9.7  mg dl; chemistry blood glucose  141  mg dl$influenza virus vaccine  0.5  ml ; pneumococcal vac polyvalent  0.5  ml ; sodium chloride 0.9%  flush  3  ml ; albuterol 0.083% neb soln  1  neb ; vial  1  vial ; pantoprazole sodium  40  mg ; bisacodyl  10  mg ; lorazepam  0.5  mg ; insulin  0  unit ; aspirin  81  mg ; furosemide  40  mg ; ipratropium bromide neb  1  neb ; metoprolol tartrate  25  mg ; fluticasone-salmeterol diskus (250 50)   1  inh ; spironolactone  50  mg ; morphine sulfate (oral soln.)  2  mg ; acetaminophen  1000  mg ; nystatin oral suspension  5  ml ; 
 
white f 81 $nan$hematology blood hematocrit  33.0  %; hematology blood hemoglobin  10.4  g dl; hematology blood platelet count  292  k ul; chemistry blood anion gap  10  meq l; chemistry blood bicarbonate  32  meq l; chemistry blood chloride  108  meq l; chemistry blood creatinine  0.7  mg dl; chemistry blood potassium  3.2  meq l; chemistry blood sodium  147  meq l; chemistry blood urea nitrogen  20  mg dl; chemistry blood calcium, total  8.9  mg dl; chemistry blood glucose  163  mg dl$influenza virus vaccine  0.5  ml ; pneumococcal vac polyvalent  0.5  ml ; sodium chloride 0.9%  flush  3  ml ; albuterol 0.083% neb soln  1  neb ; vial  1  vial ; pantoprazole sodium  40  mg ; bisacodyl  10  mg ; lorazepam  0.5  mg ; insulin  0  unit ; aspirin  81  mg ; furosemide  40  mg ; ipratropium bromide neb  1  neb ; metoprolol tartrate  25  mg ; fluticasone-salmeterol diskus (250 50)   1  inh ; spironolactone  50  mg ; morphine sulfate (oral soln.)  2  mg ; acetaminophen  1000  mg ; nystatin oral suspension  5  ml ; 
 
white f 81 $nan$hematology blood hematocrit  32.2  %; hematology blood hemoglobin  9.9  g dl; hematology blood platelet count  295  k ul; chemistry blood anion gap  12  meq l; chemistry blood bicarbonate  33  meq l; chemistry blood chloride  108  meq l; chemistry blood creatinine  0.5  mg dl; chemistry blood potassium  3.6  meq l; chemistry blood sodium  149  meq l; chemistry blood urea nitrogen  18  mg dl; hematology blood inr(pt)  1.5  ; hematology blood inr(pt)  1.6  ; chemistry blood calcium, total  9.3  mg dl; chemistry blood bilirubin, total  0.4  mg dl; chemistry blood glucose  133  mg dl; chemistry blood lactate dehydrogenase (ld)  179  iu l; chemistry blood albumin  3.2  g dl; blood gas blood lactate  1.6  mmol l$influenza virus vaccine  0.5  ml ; pneumococcal vac polyvalent  0.5  ml ; sodium chloride 0.9%  flush  3  ml ; albuterol 0.083% neb soln  1  neb ; vial  1  vial ; pantoprazole sodium  40  mg ; bisacodyl  10  mg ; lorazepam  0.5  mg ; insulin  0  unit ; aspirin  81  mg ; furosemide  40  mg ; ipratropium bromide neb  1  neb ; metoprolol tartrate  25  mg ; fluticasone-salmeterol diskus (250 50)   1  inh ; spironolactone  50  mg ; morphine sulfate (oral soln.)  2  mg ; acetaminophen  1000  mg ; nystatin oral suspension  5  ml ; metoprolol tartrate  10  mg ; 1 2 ns  1000  ml ; senna  1  tab ; neutra-phos  2  pkt ; 
 
white f 81 $nan$hematology blood hematocrit  30.7  %; hematology blood hemoglobin  9.8  g dl; hematology blood platelet count  308  k ul; chemistry blood anion gap  11  meq l; chemistry blood bicarbonate  33  meq l; chemistry blood chloride  105  meq l; chemistry blood creatinine  0.4  mg dl; chemistry blood potassium  3.6  meq l; chemistry blood sodium  145  meq l; chemistry blood urea nitrogen  17  mg dl; hematology blood inr(pt)  1.6  ; chemistry blood calcium, total  9.0  mg dl; chemistry blood glucose  115  mg dl$sodium chloride 0.9%  flush  3  ml ; albuterol 0.083% neb soln  1  neb ; vial  1  vial ; pantoprazole sodium  40  mg ; bisacodyl  10  mg ; lorazepam  0.5  mg ; insulin  0  unit ; aspirin  81  mg ; ipratropium bromide neb  1  neb ; fluticasone-salmeterol diskus (250 50)   1  inh ; morphine sulfate (oral soln.)  2  mg ; acetaminophen  1000  mg ; nystatin oral suspension  5  ml ; 1 2 ns  1000  ml ; senna  1  tab ; neutra-phos  2  pkt ; docusate sodium (liquid)  100  mg ; warfarin  7.5  mg ; 
 
white f 81 $nan$hematology blood hematocrit  31.3  %; hematology blood hemoglobin  10.1  g dl; hematology blood platelet count  313  k ul; chemistry blood anion gap  16  meq l; chemistry blood bicarbonate  28  meq l; chemistry blood chloride  103  meq l; chemistry blood creatinine  0.4  mg dl; chemistry blood potassium  3.9  meq l; chemistry blood sodium  143  meq l; chemistry blood urea nitrogen  14  mg dl; hematology blood inr(pt)  1.9  ; hematology blood inr(pt)  2.2  ; hematology blood inr(pt)  2.3  ; chemistry blood calcium, total  9.1  mg dl; chemistry blood glucose  149  mg dl$sodium chloride 0.9%  flush  3  ml ; vial  1  vial ; pantoprazole sodium  40  mg ; bisacodyl  10  mg ; lorazepam  0.5  mg ; insulin  0  unit ; aspirin  81  mg ; fluticasone-salmeterol diskus (250 50)   1  inh ; morphine sulfate (oral soln.)  2  mg ; acetaminophen  1000  mg ; nystatin oral suspension  5  ml ; senna  1  tab ; docusate sodium (liquid)  100  mg ; warfarin  7.5  mg ; morphine sulfate  2  mg ; amlodipine  2.5  mg ; simvastatin  20  mg ; paroxetine  10  mg ; 
 
white f 81 $nan$hematology blood hematocrit  32.3  %; hematology blood hemoglobin  10.0  g dl; hematology blood platelet count  326  k ul; chemistry blood anion gap  12  meq l; chemistry blood bicarbonate  29  meq l; chemistry blood chloride  104  meq l; chemistry blood creatinine  0.4  mg dl; chemistry blood potassium  4.0  meq l; chemistry blood sodium  141  meq l; chemistry blood urea nitrogen  13  mg dl; hematology blood inr(pt)  2.9  ; chemistry blood calcium, total  9.2  mg dl; chemistry blood glucose  104  mg dl$sodium chloride 0.9%  flush  3  ml ; vial  1  vial ; pantoprazole sodium  40  mg ; bisacodyl  10  mg ; lorazepam  0.5  mg ; insulin  0  unit ; aspirin  81  mg ; fluticasone-salmeterol diskus (250 50)   1  inh ; morphine sulfate (oral soln.)  2  mg ; acetaminophen  1000  mg ; nystatin oral suspension  5  ml ; senna  1  tab ; docusate sodium (liquid)  100  mg ; warfarin  7.5  mg ; morphine sulfate  2  mg ; amlodipine  2.5  mg ; simvastatin  20  mg ; paroxetine  10  mg ; 
 
white f 81 $nan$hematology blood hematocrit  33.3  %; hematology blood hemoglobin  10.3  g dl; hematology blood platelet count  359  k ul; chemistry blood anion gap  15  meq l; chemistry blood bicarbonate  27  meq l; chemistry blood chloride  102  meq l; chemistry blood creatinine  0.4  mg dl; chemistry blood potassium  3.9  meq l; chemistry blood sodium  140  meq l; chemistry blood urea nitrogen  11  mg dl; hematology blood inr(pt)  3.6  ; chemistry blood calcium, total  9.0  mg dl; chemistry blood glucose  127  mg dl$sodium chloride 0.9%  flush  3  ml ; vial  1  vial ; pantoprazole sodium  40  mg ; bisacodyl  10  mg ; lorazepam  0.5  mg ; insulin  0  unit ; aspirin  81  mg ; fluticasone-salmeterol diskus (250 50)   1  inh ; morphine sulfate (oral soln.)  2  mg ; acetaminophen  1000  mg ; nystatin oral suspension  5  ml ; senna  1  tab ; docusate sodium (liquid)  100  mg ; amlodipine  2.5  mg ; simvastatin  20  mg ; paroxetine  10  mg ; lansoprazole oral disintegrating tab  30  mg ; 
 
white f 81 $nan$hematology blood hematocrit  33.7  %; hematology blood hemoglobin  10.7  g dl; hematology blood platelet count  403  k ul; chemistry blood anion gap  14  meq l; chemistry blood bicarbonate  26  meq l; chemistry blood chloride  103  meq l; chemistry blood creatinine  0.4  mg dl; chemistry blood potassium  4.2  meq l; chemistry blood sodium  139  meq l; chemistry blood urea nitrogen  10  mg dl; hematology blood inr(pt)  3.7  ; chemistry blood calcium, total  9.0  mg dl; chemistry blood glucose  93  mg dl$sodium chloride 0.9%  flush  3  ml ; bisacodyl  10  mg ; lorazepam  0.5  mg ; insulin  0  unit ; aspirin  81  mg ; fluticasone-salmeterol diskus (250 50)   1  inh ; morphine sulfate (oral soln.)  2  mg ; acetaminophen  1000  mg ; nystatin oral suspension  5  ml ; senna  1  tab ; docusate sodium (liquid)  100  mg ; amlodipine  2.5  mg ; simvastatin  20  mg ; paroxetine  10  mg ; lansoprazole oral disintegrating tab  30  mg ; d5 1 2ns  1000  ml ; 
 
white f 81 $nan$hematology blood hematocrit  33.8  %; hematology blood hemoglobin  10.6  g dl; hematology blood platelet count  399  k ul; chemistry blood anion gap  18  meq l; chemistry blood bicarbonate  24  meq l; chemistry blood chloride  104  meq l; chemistry blood creatinine  0.4  mg dl; chemistry blood potassium  4.1  meq l; chemistry blood sodium  142  meq l; chemistry blood urea nitrogen  9  mg dl; hematology blood inr(pt)  2.8  ; chemistry blood calcium, total  9.0  mg dl; chemistry blood glucose  94  mg dl$sodium chloride 0.9%  flush  3  ml ; bisacodyl  10  mg ; lorazepam  0.5  mg ; insulin  0  unit ; aspirin  81  mg ; fluticasone-salmeterol diskus (250 50)   1  inh ; acetaminophen  1000  mg ; nystatin oral suspension  5  ml ; senna  1  tab ; docusate sodium (liquid)  100  mg ; amlodipine  2.5  mg ; simvastatin  20  mg ; paroxetine  10  mg ; lansoprazole oral disintegrating tab  30  mg ; d5 1 2ns  1000  ml ; iso-osmotic dextrose  200  ml ; vancomycin  1000  mg ; 0.9% sodium chloride  500  ml ; morphine sulfate (oral soln.)  5  mg ; 
 
white f 81 $nan$hematology blood hematocrit  34.3  %; hematology blood hemoglobin  11.0  g dl; hematology blood platelet count  450  k ul; chemistry blood anion gap  12  meq l; chemistry blood bicarbonate  26  meq l; chemistry blood chloride  104  meq l; chemistry blood creatinine  0.4  mg dl; chemistry blood potassium  3.7  meq l; chemistry blood sodium  138  meq l; chemistry blood urea nitrogen  8  mg dl; hematology blood inr(pt)  3.2  ; chemistry blood calcium, total  8.9  mg dl; chemistry blood glucose  117  mg dl$sodium chloride 0.9%  flush  3  ml ; bisacodyl  10  mg ; lorazepam  0.5  mg ; insulin  0  unit ; aspirin  81  mg ; fluticasone-salmeterol diskus (250 50)   1  inh ; acetaminophen  1000  mg ; nystatin oral suspension  5  ml ; senna  1  tab ; docusate sodium (liquid)  100  mg ; amlodipine  2.5  mg ; simvastatin  20  mg ; paroxetine  10  mg ; lansoprazole oral disintegrating tab  30  mg ; iso-osmotic dextrose  200  ml ; vancomycin  1000  mg ; morphine sulfate (oral soln.)  5  mg ; 
 
white f 81 $nan$nan$sodium chloride 0.9%  flush  3  ml ; bisacodyl  10  mg ; lorazepam  0.5  mg ; insulin  0  unit ; aspirin  81  mg ; fluticasone-salmeterol diskus (250 50)   1  inh ; acetaminophen  1000  mg ; nystatin oral suspension  5  ml ; senna  1  tab ; docusate sodium (liquid)  100  mg ; amlodipine  2.5  mg ; simvastatin  20  mg ; paroxetine  10  mg ; lansoprazole oral disintegrating tab  30  mg ; morphine sulfate (oral soln.)  5  mg ; 
 
black african american m 59 $nan$hematology blood hematocrit  37.4  %; hematology blood hemoglobin  11.5  g dl; hematology blood platelet count  143  k ul; chemistry blood anion gap  20  meq l; chemistry blood bicarbonate  19  meq l; chemistry blood chloride  89  meq l; chemistry blood creatinine  2.4  mg dl; chemistry blood potassium  6.8  meq l; chemistry blood sodium  121  meq l; chemistry blood urea nitrogen  22  mg dl; hematology blood inr(pt)  1.2  ; chemistry blood bilirubin, total  0.6  mg dl; chemistry blood glucose  658  mg dl; blood gas blood lactate  1.8  mmol l; blood gas blood potassium, whole blood  5.3  meq l$nan
anemia, unspecified personal history of other infectious and parasitic diseases acute kidney failure, unspecified chronic kidney disease, unspecified pneumonia, organism unspecified diarrhea dehydration liver replaced by transplant thrombocytopenia, unspecified diabetes mellitus without mention of complication, type ii or unspecified type, not stated as uncontrolled car driver injured in collision with two- or three-wheeled motor vehicle in nontraffic accident kidney replaced by transplant person on outside of car injured in collision with two- or three-wheeled motor vehicle in traffic accident hypertensive chronic kidney disease, unspecified, with chronic kidney disease stage i through stage iv, or unspecified gout, unspecified other and unspecified hyperlipidemia hypovolemia other specified cardiac dysrhythmias long-term (current) use of steroids kidney replaced by transplant car driver injured in collision with two- or three-wheeled motor vehicle in nontraffic accident pure hyperglyceridemia coronary atherosclerosis of native coronary artery nausea with vomiting abdominal pain, right lower quadrant gout, unspecified diabetes with other specified manifestations, type ii or unspecified type, not stated as uncontrolled chronic kidney disease, unspecified other nonspecific abnormal serum enzyme levels diarrhea painful respiration person on outside of car injured in collision with two- or three-wheeled motor vehicle in traffic accident liver replaced by transplant complications of transplanted kidney mitral valve disorders hypertensive chronic kidney disease, unspecified, with chronic kidney disease stage i through stage iv, or unspecified anemia in chronic kidney disease chronic kidney disease, unspecified gout, unspecified depressive disorder, not elsewhere classified long-term (current) use of insulin osteoporosis, unspecified surgical operation with transplant of whole organ causing abnormal patient reaction, or later complication, without mention of misadventure at time of operation antineoplastic and immunosuppressive drugs causing adverse effects in therapeutic use complications of transplanted liver chronic hepatitis c without mention of hepatic coma diabetes mellitus without mention of complication, type ii or unspecified type, not stated as uncontrolled acute kidney failure, unspecified
black african american m 59 $nan$hematology blood hematocrit  38.3  %; hematology blood hemoglobin  11.8  g dl; hematology blood platelet count  159  k ul; chemistry blood anion gap  10  meq l; chemistry blood anion gap  14  meq l; chemistry blood bicarbonate  25  meq l; chemistry blood bicarbonate  19  meq l; chemistry blood chloride  103  meq l; chemistry blood chloride  107  meq l; chemistry blood creatinine  2.0  mg dl; chemistry blood creatinine  1.7  mg dl; chemistry blood potassium  3.0  meq l; chemistry blood potassium  4.2  meq l; chemistry blood sodium  135  meq l; chemistry blood sodium  136  meq l; chemistry blood urea nitrogen  19  mg dl; chemistry blood urea nitrogen  21  mg dl; hematology blood inr(pt)  1.0  ; chemistry urine creatinine, urine  152  mg dl; hematology urine wbc  0-2  # hpf; chemistry blood calcium, total  9.0  mg dl; chemistry blood bilirubin, total  0.6  mg dl; chemistry blood glucose  83  mg dl; chemistry blood glucose  117  mg dl; chemistry urine protein creatinine ratio  0.7  ratio; blood gas blood free calcium  1.18  mmol l; blood gas blood lactate  2.8  mmol l; hematology urine glucose  100  mg dl; hematology urine bilirubin  neg  mg dl$d5ns  1000  ml ; oxycodone (immediate release)   5  mg ; pantoprazole  40  mg ; potassium chl 20 meq   1000 ml ns  1000  ml ; azithromycin  500  mg ; potassium chl 20 meq   1000 ml d5 1 2 ns  1000  ml ; insulin  0  unit ; dextrose 50%  12.5  gm ; 1 2 ns  1000  ml ; potassium chloride  60  meq ; docusate sodium (liquid)  100  mg ; heparin  5000  unit ; calcium carbonate  500  mg ; mycophenolate mofetil  500  mg ; ursodiol  300  mg ; pancrelipase 4500  2  cap ; insulin  10  unit ; sirolimus  4  mg ; allopurinol  100  mg ; vitamin d  800  unit ; prednisone  5  mg ; sulfameth trimethoprim ss  1  tab ; aspirin  325  mg ; prednisone  40  mg ; 0.9% sodium chloride  1000  ml ; sodium chloride 0.9%  flush  3  ml ; 
anemia, unspecified personal history of other infectious and parasitic diseases acute kidney failure, unspecified chronic kidney disease, unspecified pneumonia, organism unspecified diarrhea dehydration liver replaced by transplant thrombocytopenia, unspecified diabetes mellitus without mention of complication, type ii or unspecified type, not stated as uncontrolled car driver injured in collision with two- or three-wheeled motor vehicle in nontraffic accident kidney replaced by transplant person on outside of car injured in collision with two- or three-wheeled motor vehicle in traffic accident hypertensive chronic kidney disease, unspecified, with chronic kidney disease stage i through stage iv, or unspecified gout, unspecified other and unspecified hyperlipidemia hypovolemia other specified cardiac dysrhythmias long-term (current) use of steroids kidney replaced by transplant car driver injured in collision with two- or three-wheeled motor vehicle in nontraffic accident pure hyperglyceridemia coronary atherosclerosis of native coronary artery nausea with vomiting abdominal pain, right lower quadrant gout, unspecified diabetes with other specified manifestations, type ii or unspecified type, not stated as uncontrolled chronic kidney disease, unspecified other nonspecific abnormal serum enzyme levels diarrhea painful respiration person on outside of car injured in collision with two- or three-wheeled motor vehicle in traffic accident liver replaced by transplant complications of transplanted kidney mitral valve disorders hypertensive chronic kidney disease, unspecified, with chronic kidney disease stage i through stage iv, or unspecified anemia in chronic kidney disease chronic kidney disease, unspecified gout, unspecified depressive disorder, not elsewhere classified long-term (current) use of insulin osteoporosis, unspecified surgical operation with transplant of whole organ causing abnormal patient reaction, or later complication, without mention of misadventure at time of operation antineoplastic and immunosuppressive drugs causing adverse effects in therapeutic use complications of transplanted liver chronic hepatitis c without mention of hepatic coma diabetes mellitus without mention of complication, type ii or unspecified type, not stated as uncontrolled acute kidney failure, unspecified
black african american m 59 $nan$hematology blood hematocrit  40.6  %; hematology blood hemoglobin  12.1  g dl; hematology blood platelet count  170  k ul; chemistry blood anion gap  18  meq l; chemistry blood anion gap  16  meq l; chemistry blood anion gap  15  meq l; chemistry blood anion gap  17  meq l; chemistry blood bicarbonate  16  meq l; chemistry blood bicarbonate  15  meq l; chemistry blood bicarbonate  15  meq l; chemistry blood bicarbonate  15  meq l; chemistry blood chloride  102  meq l; chemistry blood chloride  101  meq l; chemistry blood chloride  108  meq l; chemistry blood chloride  107  meq l; chemistry blood creatinine  1.8  mg dl; chemistry blood creatinine  1.9  mg dl; chemistry blood creatinine  1.7  mg dl; chemistry blood creatinine  1.7  mg dl; chemistry blood potassium  4.6  meq l; chemistry blood potassium  4.2  meq l; chemistry blood potassium  3.3  meq l; chemistry blood potassium  3.8  meq l; chemistry blood sodium  131  meq l; chemistry blood sodium  128  meq l; chemistry blood sodium  135  meq l; chemistry blood sodium  135  meq l; chemistry blood urea nitrogen  24  mg dl; chemistry blood urea nitrogen  25  mg dl; chemistry blood urea nitrogen  24  mg dl; chemistry blood urea nitrogen  24  mg dl; hematology blood inr(pt)  1.0  ; chemistry blood calcium, total  8.8  mg dl; chemistry blood calcium, total  8.6  mg dl; chemistry blood calcium, total  8.3  mg dl; chemistry blood calcium, total  8.6  mg dl; chemistry blood bilirubin, total  0.3  mg dl; chemistry blood glucose  447  mg dl; chemistry blood glucose  123  mg dl; chemistry blood glucose  137  mg dl; chemistry blood glucose  512  mg dl; chemistry blood albumin  3.5  g dl$oxycodone (immediate release)   5  mg ; pantoprazole  40  mg ; insulin  0  unit ; docusate sodium (liquid)  100  mg ; heparin  5000  unit ; calcium carbonate  500  mg ; mycophenolate mofetil  500  mg ; ursodiol  300  mg ; pancrelipase 4500  2  cap ; insulin  10  unit ; sirolimus  4  mg ; allopurinol  100  mg ; vitamin d  800  unit ; prednisone  5  mg ; sulfameth trimethoprim ss  1  tab ; sodium chloride 0.9%  flush  3  ml ; insulin  13  unit ; insulin  14  unit ; 
anemia, unspecified personal history of other infectious and parasitic diseases acute kidney failure, unspecified chronic kidney disease, unspecified pneumonia, organism unspecified diarrhea dehydration liver replaced by transplant thrombocytopenia, unspecified diabetes mellitus without mention of complication, type ii or unspecified type, not stated as uncontrolled car driver injured in collision with two- or three-wheeled motor vehicle in nontraffic accident kidney replaced by transplant person on outside of car injured in collision with two- or three-wheeled motor vehicle in traffic accident hypertensive chronic kidney disease, unspecified, with chronic kidney disease stage i through stage iv, or unspecified gout, unspecified other and unspecified hyperlipidemia hypovolemia other specified cardiac dysrhythmias long-term (current) use of steroids kidney replaced by transplant car driver injured in collision with two- or three-wheeled motor vehicle in nontraffic accident pure hyperglyceridemia coronary atherosclerosis of native coronary artery nausea with vomiting abdominal pain, right lower quadrant gout, unspecified diabetes with other specified manifestations, type ii or unspecified type, not stated as uncontrolled chronic kidney disease, unspecified other nonspecific abnormal serum enzyme levels diarrhea painful respiration person on outside of car injured in collision with two- or three-wheeled motor vehicle in traffic accident liver replaced by transplant complications of transplanted kidney mitral valve disorders hypertensive chronic kidney disease, unspecified, with chronic kidney disease stage i through stage iv, or unspecified anemia in chronic kidney disease chronic kidney disease, unspecified gout, unspecified depressive disorder, not elsewhere classified long-term (current) use of insulin osteoporosis, unspecified surgical operation with transplant of whole organ causing abnormal patient reaction, or later complication, without mention of misadventure at time of operation antineoplastic and immunosuppressive drugs causing adverse effects in therapeutic use complications of transplanted liver chronic hepatitis c without mention of hepatic coma diabetes mellitus without mention of complication, type ii or unspecified type, not stated as uncontrolled acute kidney failure, unspecified
black african american m 59 $nan$hematology blood hematocrit  35.9  %; hematology blood hemoglobin  11.2  g dl; chemistry blood anion gap  13  meq l; chemistry blood bicarbonate  17  meq l; chemistry blood chloride  113  meq l; chemistry blood creatinine  1.9  mg dl; chemistry blood potassium  3.8  meq l; chemistry blood sodium  139  meq l; chemistry blood urea nitrogen  24  mg dl; hematology blood inr(pt)  1.0  ; chemistry blood calcium, total  8.5  mg dl; chemistry blood bilirubin, total  0.2  mg dl; chemistry blood glucose  239  mg dl$oxycodone (immediate release)   5  mg ; pantoprazole  40  mg ; docusate sodium (liquid)  100  mg ; heparin  5000  unit ; calcium carbonate  500  mg ; mycophenolate mofetil  500  mg ; ursodiol  300  mg ; pancrelipase 4500  2  cap ; sirolimus  4  mg ; allopurinol  100  mg ; vitamin d  800  unit ; prednisone  5  mg ; sulfameth trimethoprim ss  1  tab ; sodium chloride 0.9%  flush  3  ml ; insulin  13  unit ; insulin  14  unit ; 
anemia, unspecified personal history of other infectious and parasitic diseases acute kidney failure, unspecified chronic kidney disease, unspecified pneumonia, organism unspecified diarrhea dehydration liver replaced by transplant thrombocytopenia, unspecified diabetes mellitus without mention of complication, type ii or unspecified type, not stated as uncontrolled car driver injured in collision with two- or three-wheeled motor vehicle in nontraffic accident kidney replaced by transplant person on outside of car injured in collision with two- or three-wheeled motor vehicle in traffic accident hypertensive chronic kidney disease, unspecified, with chronic kidney disease stage i through stage iv, or unspecified gout, unspecified other and unspecified hyperlipidemia hypovolemia other specified cardiac dysrhythmias long-term (current) use of steroids kidney replaced by transplant car driver injured in collision with two- or three-wheeled motor vehicle in nontraffic accident pure hyperglyceridemia coronary atherosclerosis of native coronary artery nausea with vomiting abdominal pain, right lower quadrant gout, unspecified diabetes with other specified manifestations, type ii or unspecified type, not stated as uncontrolled chronic kidney disease, unspecified other nonspecific abnormal serum enzyme levels diarrhea painful respiration person on outside of car injured in collision with two- or three-wheeled motor vehicle in traffic accident liver replaced by transplant complications of transplanted kidney mitral valve disorders hypertensive chronic kidney disease, unspecified, with chronic kidney disease stage i through stage iv, or unspecified anemia in chronic kidney disease chronic kidney disease, unspecified gout, unspecified depressive disorder, not elsewhere classified long-term (current) use of insulin osteoporosis, unspecified surgical operation with transplant of whole organ causing abnormal patient reaction, or later complication, without mention of misadventure at time of operation antineoplastic and immunosuppressive drugs causing adverse effects in therapeutic use complications of transplanted liver chronic hepatitis c without mention of hepatic coma diabetes mellitus without mention of complication, type ii or unspecified type, not stated as uncontrolled acute kidney failure, unspecified
black african american m 59 $nan$hematology blood hematocrit  35.3  %; hematology blood hemoglobin  10.8  g dl; hematology blood platelet count  146  k ul; chemistry blood anion gap  13  meq l; chemistry blood bicarbonate  19  meq l; chemistry blood chloride  106  meq l; chemistry blood creatinine  1.7  mg dl; chemistry blood potassium  3.5  meq l; chemistry blood sodium  134  meq l; chemistry blood urea nitrogen  22  mg dl; hematology blood inr(pt)  0.9  ; chemistry blood calcium, total  8.9  mg dl; chemistry blood bilirubin, total  0.3  mg dl; chemistry blood glucose  237  mg dl$oxycodone (immediate release)   5  mg ; pantoprazole  40  mg ; docusate sodium (liquid)  100  mg ; heparin  5000  unit ; calcium carbonate  500  mg ; mycophenolate mofetil  500  mg ; ursodiol  300  mg ; pancrelipase 4500  2  cap ; sirolimus  4  mg ; allopurinol  100  mg ; vitamin d  800  unit ; prednisone  5  mg ; sulfameth trimethoprim ss  1  tab ; sodium chloride 0.9%  flush  3  ml ; insulin  13  unit ; insulin  20  unit ; 
anemia, unspecified personal history of other infectious and parasitic diseases acute kidney failure, unspecified chronic kidney disease, unspecified pneumonia, organism unspecified diarrhea dehydration liver replaced by transplant thrombocytopenia, unspecified diabetes mellitus without mention of complication, type ii or unspecified type, not stated as uncontrolled car driver injured in collision with two- or three-wheeled motor vehicle in nontraffic accident kidney replaced by transplant person on outside of car injured in collision with two- or three-wheeled motor vehicle in traffic accident hypertensive chronic kidney disease, unspecified, with chronic kidney disease stage i through stage iv, or unspecified gout, unspecified other and unspecified hyperlipidemia hypovolemia other specified cardiac dysrhythmias long-term (current) use of steroids kidney replaced by transplant car driver injured in collision with two- or three-wheeled motor vehicle in nontraffic accident pure hyperglyceridemia coronary atherosclerosis of native coronary artery nausea with vomiting abdominal pain, right lower quadrant gout, unspecified diabetes with other specified manifestations, type ii or unspecified type, not stated as uncontrolled chronic kidney disease, unspecified other nonspecific abnormal serum enzyme levels diarrhea painful respiration person on outside of car injured in collision with two- or three-wheeled motor vehicle in traffic accident liver replaced by transplant complications of transplanted kidney mitral valve disorders hypertensive chronic kidney disease, unspecified, with chronic kidney disease stage i through stage iv, or unspecified anemia in chronic kidney disease chronic kidney disease, unspecified gout, unspecified depressive disorder, not elsewhere classified long-term (current) use of insulin osteoporosis, unspecified surgical operation with transplant of whole organ causing abnormal patient reaction, or later complication, without mention of misadventure at time of operation antineoplastic and immunosuppressive drugs causing adverse effects in therapeutic use complications of transplanted liver chronic hepatitis c without mention of hepatic coma diabetes mellitus without mention of complication, type ii or unspecified type, not stated as uncontrolled acute kidney failure, unspecified
black african american m 59 $nan$hematology blood hematocrit  33.0  %; hematology blood hemoglobin  10.3  g dl; hematology blood platelet count  152  k ul; chemistry blood anion gap  13  meq l; chemistry blood bicarbonate  21  meq l; chemistry blood chloride  107  meq l; chemistry blood creatinine  1.4  mg dl; chemistry blood potassium  3.5  meq l; chemistry blood sodium  137  meq l; chemistry blood urea nitrogen  24  mg dl; chemistry blood calcium, total  8.8  mg dl; chemistry blood glucose  190  mg dl$oxycodone (immediate release)   5  mg ; pantoprazole  40  mg ; calcium carbonate  500  mg ; mycophenolate mofetil  500  mg ; ursodiol  300  mg ; pancrelipase 4500  2  cap ; sirolimus  4  mg ; allopurinol  100  mg ; vitamin d  800  unit ; prednisone  5  mg ; sulfameth trimethoprim ss  1  tab ; sodium chloride 0.9%  flush  3  ml ; insulin  20  unit ; magnesium sulfate  2  gm ; potassium chloride  20  meq ; citalopram hydrobromide  10  mg ; 
anemia, unspecified personal history of other infectious and parasitic diseases acute kidney failure, unspecified chronic kidney disease, unspecified pneumonia, organism unspecified diarrhea dehydration liver replaced by transplant thrombocytopenia, unspecified diabetes mellitus without mention of complication, type ii or unspecified type, not stated as uncontrolled car driver injured in collision with two- or three-wheeled motor vehicle in nontraffic accident kidney replaced by transplant person on outside of car injured in collision with two- or three-wheeled motor vehicle in traffic accident hypertensive chronic kidney disease, unspecified, with chronic kidney disease stage i through stage iv, or unspecified gout, unspecified other and unspecified hyperlipidemia hypovolemia other specified cardiac dysrhythmias long-term (current) use of steroids kidney replaced by transplant car driver injured in collision with two- or three-wheeled motor vehicle in nontraffic accident pure hyperglyceridemia coronary atherosclerosis of native coronary artery nausea with vomiting abdominal pain, right lower quadrant gout, unspecified diabetes with other specified manifestations, type ii or unspecified type, not stated as uncontrolled chronic kidney disease, unspecified other nonspecific abnormal serum enzyme levels diarrhea painful respiration person on outside of car injured in collision with two- or three-wheeled motor vehicle in traffic accident liver replaced by transplant complications of transplanted kidney mitral valve disorders hypertensive chronic kidney disease, unspecified, with chronic kidney disease stage i through stage iv, or unspecified anemia in chronic kidney disease chronic kidney disease, unspecified gout, unspecified depressive disorder, not elsewhere classified long-term (current) use of insulin osteoporosis, unspecified surgical operation with transplant of whole organ causing abnormal patient reaction, or later complication, without mention of misadventure at time of operation antineoplastic and immunosuppressive drugs causing adverse effects in therapeutic use complications of transplanted liver chronic hepatitis c without mention of hepatic coma diabetes mellitus without mention of complication, type ii or unspecified type, not stated as uncontrolled acute kidney failure, unspecified
black african american m 59 $nan$hematology blood hematocrit  32.4  %; hematology blood hemoglobin  10.0  g dl; hematology blood platelet count  157  k ul; chemistry blood anion gap  13  meq l; chemistry blood bicarbonate  21  meq l; chemistry blood chloride  107  meq l; chemistry blood creatinine  1.2  mg dl; chemistry blood potassium  3.9  meq l; chemistry blood sodium  137  meq l; chemistry blood urea nitrogen  22  mg dl; chemistry blood calcium, total  8.3  mg dl; chemistry blood glucose  306  mg dl$pantoprazole  40  mg ; calcium carbonate  500  mg ; mycophenolate mofetil  500  mg ; ursodiol  300  mg ; pancrelipase 4500  2  cap ; sirolimus  4  mg ; allopurinol  100  mg ; vitamin d  800  unit ; prednisone  5  mg ; sulfameth trimethoprim ss  1  tab ; sodium chloride 0.9%  flush  3  ml ; insulin  20  unit ; magnesium sulfate  2  gm ; potassium chloride  20  meq ; citalopram hydrobromide  10  mg ; insulin  30  unit ; insulin  5  unit ; 
anemia, unspecified personal history of other infectious and parasitic diseases acute kidney failure, unspecified chronic kidney disease, unspecified pneumonia, organism unspecified diarrhea dehydration liver replaced by transplant thrombocytopenia, unspecified diabetes mellitus without mention of complication, type ii or unspecified type, not stated as uncontrolled car driver injured in collision with two- or three-wheeled motor vehicle in nontraffic accident kidney replaced by transplant person on outside of car injured in collision with two- or three-wheeled motor vehicle in traffic accident hypertensive chronic kidney disease, unspecified, with chronic kidney disease stage i through stage iv, or unspecified gout, unspecified other and unspecified hyperlipidemia hypovolemia other specified cardiac dysrhythmias long-term (current) use of steroids kidney replaced by transplant car driver injured in collision with two- or three-wheeled motor vehicle in nontraffic accident pure hyperglyceridemia coronary atherosclerosis of native coronary artery nausea with vomiting abdominal pain, right lower quadrant gout, unspecified diabetes with other specified manifestations, type ii or unspecified type, not stated as uncontrolled chronic kidney disease, unspecified other nonspecific abnormal serum enzyme levels diarrhea painful respiration person on outside of car injured in collision with two- or three-wheeled motor vehicle in traffic accident liver replaced by transplant complications of transplanted kidney mitral valve disorders hypertensive chronic kidney disease, unspecified, with chronic kidney disease stage i through stage iv, or unspecified anemia in chronic kidney disease chronic kidney disease, unspecified gout, unspecified depressive disorder, not elsewhere classified long-term (current) use of insulin osteoporosis, unspecified surgical operation with transplant of whole organ causing abnormal patient reaction, or later complication, without mention of misadventure at time of operation antineoplastic and immunosuppressive drugs causing adverse effects in therapeutic use complications of transplanted liver chronic hepatitis c without mention of hepatic coma diabetes mellitus without mention of complication, type ii or unspecified type, not stated as uncontrolled acute kidney failure, unspecified
black african american m 59 $nan$hematology blood hematocrit  31.7  %; hematology blood hemoglobin  10.1  g dl; hematology blood platelet count  179  k ul; chemistry blood anion gap  11  meq l; chemistry blood bicarbonate  25  meq l; chemistry blood chloride  107  meq l; chemistry blood creatinine  1.3  mg dl; chemistry blood potassium  3.8  meq l; chemistry blood sodium  139  meq l; chemistry blood urea nitrogen  24  mg dl; chemistry blood calcium, total  9.0  mg dl; chemistry blood glucose  91  mg dl$pantoprazole  40  mg ; calcium carbonate  500  mg ; mycophenolate mofetil  500  mg ; ursodiol  300  mg ; pancrelipase 4500  2  cap ; sirolimus  4  mg ; allopurinol  100  mg ; vitamin d  800  unit ; prednisone  5  mg ; sulfameth trimethoprim ss  1  tab ; sodium chloride 0.9%  flush  3  ml ; citalopram hydrobromide  10  mg ; insulin  30  unit ; insulin  5  unit ; insulin  35  unit ; 
anemia, unspecified personal history of other infectious and parasitic diseases acute kidney failure, unspecified chronic kidney disease, unspecified pneumonia, organism unspecified diarrhea dehydration liver replaced by transplant thrombocytopenia, unspecified diabetes mellitus without mention of complication, type ii or unspecified type, not stated as uncontrolled car driver injured in collision with two- or three-wheeled motor vehicle in nontraffic accident kidney replaced by transplant person on outside of car injured in collision with two- or three-wheeled motor vehicle in traffic accident hypertensive chronic kidney disease, unspecified, with chronic kidney disease stage i through stage iv, or unspecified gout, unspecified other and unspecified hyperlipidemia hypovolemia other specified cardiac dysrhythmias long-term (current) use of steroids kidney replaced by transplant car driver injured in collision with two- or three-wheeled motor vehicle in nontraffic accident pure hyperglyceridemia coronary atherosclerosis of native coronary artery nausea with vomiting abdominal pain, right lower quadrant gout, unspecified diabetes with other specified manifestations, type ii or unspecified type, not stated as uncontrolled chronic kidney disease, unspecified other nonspecific abnormal serum enzyme levels diarrhea painful respiration person on outside of car injured in collision with two- or three-wheeled motor vehicle in traffic accident liver replaced by transplant complications of transplanted kidney mitral valve disorders hypertensive chronic kidney disease, unspecified, with chronic kidney disease stage i through stage iv, or unspecified anemia in chronic kidney disease chronic kidney disease, unspecified gout, unspecified depressive disorder, not elsewhere classified long-term (current) use of insulin osteoporosis, unspecified surgical operation with transplant of whole organ causing abnormal patient reaction, or later complication, without mention of misadventure at time of operation antineoplastic and immunosuppressive drugs causing adverse effects in therapeutic use complications of transplanted liver chronic hepatitis c without mention of hepatic coma diabetes mellitus without mention of complication, type ii or unspecified type, not stated as uncontrolled acute kidney failure, unspecified
black african american m 59 $nan$hematology blood hematocrit  30.8  %; hematology blood hemoglobin  9.4  g dl; hematology blood platelet count  174  k ul; chemistry blood anion gap  13  meq l; chemistry blood bicarbonate  24  meq l; chemistry blood chloride  108  meq l; chemistry blood creatinine  1.2  mg dl; chemistry blood potassium  4.2  meq l; chemistry blood sodium  141  meq l; chemistry blood urea nitrogen  21  mg dl; hematology blood inr(pt)  0.9  ; chemistry blood calcium, total  8.5  mg dl; chemistry blood bilirubin, total  0.3  mg dl; chemistry blood glucose  93  mg dl$pantoprazole  40  mg ; calcium carbonate  500  mg ; mycophenolate mofetil  500  mg ; ursodiol  300  mg ; pancrelipase 4500  2  cap ; sirolimus  4  mg ; allopurinol  100  mg ; vitamin d  800  unit ; prednisone  5  mg ; sulfameth trimethoprim ss  1  tab ; sodium chloride 0.9%  flush  3  ml ; citalopram hydrobromide  10  mg ; insulin  35  unit ; 
anemia, unspecified personal history of other infectious and parasitic diseases acute kidney failure, unspecified chronic kidney disease, unspecified pneumonia, organism unspecified diarrhea dehydration liver replaced by transplant thrombocytopenia, unspecified diabetes mellitus without mention of complication, type ii or unspecified type, not stated as uncontrolled car driver injured in collision with two- or three-wheeled motor vehicle in nontraffic accident kidney replaced by transplant person on outside of car injured in collision with two- or three-wheeled motor vehicle in traffic accident hypertensive chronic kidney disease, unspecified, with chronic kidney disease stage i through stage iv, or unspecified gout, unspecified other and unspecified hyperlipidemia hypovolemia other specified cardiac dysrhythmias long-term (current) use of steroids kidney replaced by transplant car driver injured in collision with two- or three-wheeled motor vehicle in nontraffic accident pure hyperglyceridemia coronary atherosclerosis of native coronary artery nausea with vomiting abdominal pain, right lower quadrant gout, unspecified diabetes with other specified manifestations, type ii or unspecified type, not stated as uncontrolled chronic kidney disease, unspecified other nonspecific abnormal serum enzyme levels diarrhea painful respiration person on outside of car injured in collision with two- or three-wheeled motor vehicle in traffic accident liver replaced by transplant complications of transplanted kidney mitral valve disorders hypertensive chronic kidney disease, unspecified, with chronic kidney disease stage i through stage iv, or unspecified anemia in chronic kidney disease chronic kidney disease, unspecified gout, unspecified depressive disorder, not elsewhere classified long-term (current) use of insulin osteoporosis, unspecified surgical operation with transplant of whole organ causing abnormal patient reaction, or later complication, without mention of misadventure at time of operation antineoplastic and immunosuppressive drugs causing adverse effects in therapeutic use complications of transplanted liver chronic hepatitis c without mention of hepatic coma diabetes mellitus without mention of complication, type ii or unspecified type, not stated as uncontrolled acute kidney failure, unspecified
white m 73 $temp  97.9  heartrate  98.0  resprate  20.0  o2sat  96.0  sbp  139.0  dbp  44.0  rhythm    pain  6  $hematology blood hematocrit  28.8  %; hematology blood hematocrit  30.4  %; hematology blood hemoglobin  8.9  g dl; hematology blood hemoglobin  9.5  g dl; hematology blood platelet count  135  k ul; hematology blood platelet count  143  k ul; chemistry blood anion gap  21  meq l; chemistry blood anion gap  20  meq l; chemistry blood anion gap  20  meq l; chemistry blood anion gap  20  meq l; chemistry blood bicarbonate  19  meq l; chemistry blood bicarbonate  18  meq l; chemistry blood bicarbonate  19  meq l; chemistry blood bicarbonate  18  meq l; chemistry blood chloride  102  meq l; chemistry blood chloride  102  meq l; chemistry blood chloride  98  meq l; chemistry blood chloride  99  meq l; chemistry blood creatinine  7.5  mg dl; chemistry blood creatinine  7.5  mg dl; chemistry blood creatinine  8.0  mg dl; chemistry blood creatinine  8.2  mg dl; chemistry blood potassium  5.4  meq l; chemistry blood potassium  5.6  meq l; chemistry blood potassium  5.9  meq l; chemistry blood potassium  5.7  meq l; chemistry blood sodium  137  meq l; chemistry blood sodium  137  meq l; chemistry blood sodium  141  meq l; chemistry blood sodium  141  meq l; chemistry blood urea nitrogen  71  mg dl; chemistry blood urea nitrogen  70  mg dl; chemistry blood urea nitrogen  70  mg dl; chemistry blood urea nitrogen  73  mg dl; hematology blood inr(pt)  1.1  ; hematology blood inr(pt)  1.0  ; chemistry urine chloride, urine  32  meq l; chemistry urine creatinine, urine  76  mg dl; chemistry urine creatinine, urine  71  mg dl; chemistry urine sodium, urine  45  meq l; chemistry urine urea nitrogen, urine  324  mg dl; chemistry blood calcium, total  8.1  mg dl; chemistry blood calcium, total  8.5  mg dl; chemistry blood calcium, total  8.9  mg dl; chemistry blood bilirubin, total  0.3  mg dl; chemistry blood glucose  34  mg dl; chemistry blood glucose  147  mg dl; chemistry blood glucose  145  mg dl; chemistry blood glucose  58  mg dl; chemistry blood albumin  3.6  g dl; chemistry urine protein creatinine ratio  1.1  mg mg; chemistry urine protein creatinine ratio  1.6  mg mg; blood gas blood free calcium  1.06  mmol l; blood gas blood free calcium  1.11  mmol l; blood gas blood lactate  1.2  mmol l; blood gas blood lactate  0.7  mmol l; blood gas blood lactate  0.6  mmol l; blood gas blood glucose  53  mg dl; blood gas blood glucose  29  mg dl$lactated ringers  1000  ml ; oxycodone (immediate release)  10  mg ; acetaminophen  1000  mg ; influenza vaccine quadrivalent  0.5  ml ; bisacodyl  10  mg ; senna  8.6  mg ; heparin  5000  unit ; dextrose 50%  12.5  gm ; glucagon  1  mg ; glucose gel  15  g ; d10w  1000  ml ; fenofibrate  145  mg ; amlodipine  10  mg ; atorvastatin  80  mg ; clopidogrel  75  mg ; duloxetine  60  mg ; ferrous sulfate  325  mg ; omeprazole  20  mg ; vial  1  vial ; ceftriaxone  1  gm ; bag  1  bag ; magnesium sulfate  2  gm ; bag  2  bag ; magnesium sulfate  4  gm ; 0.9% sodium chloride  0  bag ; calcium gluconate  0  g ; 0.9% sodium chloride  1  bag ; calcium gluconate  2  g ; 0.9% sodium chloride  2  bag ; calcium gluconate  4  g ; sevelamer carbonate  800  mg ; insulin (regular) for hyperkalemia  10  unit ; dextrose 50%  25  gm ; sodium bicarbonate  650  mg ; furosemide  120  mg ; ondansetron  4  mg ; lidocaine 5% patch  1  ptch ; 
 
white m 73 $nan$hematology blood hematocrit  28.0  %; hematology blood hemoglobin  8.7  g dl; hematology blood platelet count  141  k ul; chemistry blood anion gap  18  meq l; chemistry blood anion gap  18  meq l; chemistry blood bicarbonate  20  meq l; chemistry blood bicarbonate  21  meq l; chemistry blood chloride  98  meq l; chemistry blood chloride  98  meq l; chemistry blood creatinine  8.6  mg dl; chemistry blood creatinine  9.1  mg dl; chemistry blood potassium  5.6  meq l; chemistry blood potassium  5.8  meq l; chemistry blood sodium  136  meq l; chemistry blood sodium  137  meq l; chemistry blood urea nitrogen  79  mg dl; chemistry blood urea nitrogen  83  mg dl; chemistry blood calcium, total  8.7  mg dl; chemistry blood calcium, total  8.6  mg dl; chemistry blood glucose  117  mg dl; chemistry blood glucose  150  mg dl; chemistry blood % hemoglobin a1c  5.5  %$influenza vaccine quadrivalent  0.5  ml ; bisacodyl  10  mg ; senna  8.6  mg ; heparin  5000  unit ; dextrose 50%  12.5  gm ; glucagon  1  mg ; glucose gel  15  g ; fenofibrate  145  mg ; amlodipine  10  mg ; atorvastatin  80  mg ; clopidogrel  75  mg ; duloxetine  60  mg ; ferrous sulfate  325  mg ; vial  1  vial ; ceftriaxone  1  gm ; bag  1  bag ; magnesium sulfate  2  gm ; bag  2  bag ; magnesium sulfate  4  gm ; 0.9% sodium chloride  0  bag ; calcium gluconate  0  g ; 0.9% sodium chloride  1  bag ; calcium gluconate  2  g ; 0.9% sodium chloride  2  bag ; calcium gluconate  4  g ; sevelamer carbonate  800  mg ; insulin (regular) for hyperkalemia  10  unit ; dextrose 50%  25  gm ; sodium bicarbonate  650  mg ; furosemide  120  mg ; ondansetron  4  mg ; sodium chloride 0.9%  flush  3-10  ml ; insulin  0  unit ; gabapentin  100  mg ; 
 
white m 73 $nan$hematology blood hematocrit  28.3  %; hematology blood hemoglobin  9.1  g dl; hematology blood platelet count  136  k ul; chemistry blood anion gap  22  meq l; chemistry blood anion gap  18  meq l; chemistry blood bicarbonate  22  meq l; chemistry blood bicarbonate  17  meq l; chemistry blood chloride  97  meq l; chemistry blood chloride  97  meq l; chemistry blood creatinine  9.3  mg dl; chemistry blood creatinine  9.2  mg dl; chemistry blood potassium  5.8  meq l; chemistry blood potassium  5.9  meq l; chemistry blood sodium  137  meq l; chemistry blood sodium  136  meq l; chemistry blood urea nitrogen  90  mg dl; chemistry blood urea nitrogen  97  mg dl; hematology blood inr(pt)  1.0  ; chemistry blood calcium, total  8.6  mg dl; chemistry blood calcium, total  8.3  mg dl; chemistry blood glucose  121  mg dl; chemistry blood glucose  132  mg dl; blood gas blood potassium, whole blood  5.3  meq l$bisacodyl  10  mg ; senna  8.6  mg ; heparin  5000  unit ; dextrose 50%  12.5  gm ; glucagon  1  mg ; glucose gel  15  g ; atorvastatin  80  mg ; ferrous sulfate  325  mg ; bag  1  bag ; magnesium sulfate  2  gm ; bag  2  bag ; magnesium sulfate  4  gm ; 0.9% sodium chloride  0  bag ; calcium gluconate  0  g ; 0.9% sodium chloride  1  bag ; calcium gluconate  2  g ; 0.9% sodium chloride  2  bag ; calcium gluconate  4  g ; sevelamer carbonate  800  mg ; sodium bicarbonate  650  mg ; sodium chloride 0.9%  flush  3-10  ml ; insulin  0  unit ; furosemide  40  mg ; nicotine patch  14  mg ; furosemide  80  mg ; famotidine  20  mg ; docusate sodium  100  mg ; labetalol  100  mg ; 
 
white m 73 $nan$hematology blood hematocrit  24.4  %; hematology blood hemoglobin  8.0  g dl; hematology blood platelet count  140  k ul; chemistry blood anion gap  21  meq l; chemistry blood anion gap  21  meq l; chemistry blood bicarbonate  21  meq l; chemistry blood bicarbonate  22  meq l; chemistry blood chloride  98  meq l; chemistry blood chloride  97  meq l; chemistry blood creatinine  9.3  mg dl; chemistry blood creatinine  9.3  mg dl; chemistry blood potassium  5.3  meq l; chemistry blood potassium  5.5  meq l; chemistry blood sodium  140  meq l; chemistry blood sodium  140  meq l; chemistry blood urea nitrogen  106  mg dl; chemistry blood urea nitrogen  106  mg dl; hematology blood inr(pt)  1.0  ; chemistry blood calcium, total  8.6  mg dl; chemistry blood calcium, total  8.6  mg dl; chemistry blood bilirubin, total  0.3  mg dl; chemistry blood glucose  119  mg dl; chemistry blood glucose  124  mg dl; chemistry blood lactate dehydrogenase (ld)  215  iu l; chemistry blood albumin  3.2  g dl$bisacodyl  10  mg ; heparin  5000  unit ; dextrose 50%  12.5  gm ; glucagon  1  mg ; glucose gel  15  g ; atorvastatin  80  mg ; ferrous sulfate  325  mg ; sevelamer carbonate  800  mg ; sodium bicarbonate  650  mg ; sodium chloride 0.9%  flush  3-10  ml ; insulin  0  unit ; nicotine patch  14  mg ; furosemide  80  mg ; famotidine  20  mg ; docusate sodium  100  mg ; labetalol  100  mg ; polyethylene glycol  17  g ; aluminum-magnesium hydrox.-simethicone  30  ml ; tuberculin protein  0.1  ml ; 
 
white m 73 $nan$hematology blood hematocrit  23.1  %; hematology blood hemoglobin  7.6  g dl; hematology blood platelet count  132  k ul; chemistry blood anion gap  20  meq l; chemistry blood anion gap  18  meq l; chemistry blood bicarbonate  23  meq l; chemistry blood bicarbonate  26  meq l; chemistry blood chloride  96  meq l; chemistry blood chloride  95  meq l; chemistry blood creatinine  9.4  mg dl; chemistry blood creatinine  6.5  mg dl; chemistry blood potassium  5.8  meq l; chemistry blood potassium  4.9  meq l; chemistry blood sodium  139  meq l; chemistry blood sodium  139  meq l; chemistry blood urea nitrogen  109  mg dl; chemistry blood urea nitrogen  74  mg dl; hematology blood inr(pt)  1.0  ; chemistry blood calcium, total  8.8  mg dl; chemistry blood glucose  113  mg dl; chemistry blood glucose  134  mg dl$bisacodyl  10  mg ; heparin  5000  unit ; dextrose 50%  12.5  gm ; glucagon  1  mg ; glucose gel  15  g ; atorvastatin  80  mg ; sevelamer carbonate  800  mg ; sodium bicarbonate  650  mg ; sodium chloride 0.9%  flush  3-10  ml ; insulin  0  unit ; nicotine patch  14  mg ; famotidine  20  mg ; docusate sodium  100  mg ; labetalol  100  mg ; polyethylene glycol  17  g ; aluminum-magnesium hydrox.-simethicone  30  ml ; tuberculin protein  0.1  ml ; furosemide  60  mg ; sodium chloride 0.9%  1000  ml ; furosemide  200  mg ; heparin dwell (1000 units ml)  1000-4000  unit ; neomycin-polymyxin-bacitracin  1  appl ; 
 
white m 73 $nan$hematology blood hematocrit  25.7  %; hematology blood hemoglobin  8.4  g dl; hematology blood platelet count  173  k ul; chemistry blood anion gap  17  meq l; chemistry blood bicarbonate  27  meq l; chemistry blood chloride  96  meq l; chemistry blood creatinine  7.0  mg dl; chemistry blood potassium  5.2  meq l; chemistry blood sodium  140  meq l; chemistry blood urea nitrogen  82  mg dl; hematology blood inr(pt)  1.1  ; chemistry blood calcium, total  8.9  mg dl; chemistry blood glucose  112  mg dl$bisacodyl  10  mg ; heparin  5000  unit ; dextrose 50%  12.5  gm ; glucagon  1  mg ; glucose gel  15  g ; atorvastatin  80  mg ; sevelamer carbonate  800  mg ; sodium bicarbonate  650  mg ; sodium chloride 0.9%  flush  3-10  ml ; insulin  0  unit ; nicotine patch  14  mg ; docusate sodium  100  mg ; labetalol  100  mg ; polyethylene glycol  17  g ; 
 
white m 73 $nan$hematology blood hematocrit  22.3  %; hematology blood hematocrit  23.6  %; hematology blood hemoglobin  7.5  g dl; hematology blood hemoglobin  7.8  g dl; hematology blood platelet count  160  k ul; hematology blood platelet count  153  k ul; chemistry blood anion gap  17  meq l; chemistry blood anion gap  18  meq l; chemistry blood bicarbonate  24  meq l; chemistry blood bicarbonate  26  meq l; chemistry blood chloride  98  meq l; chemistry blood chloride  97  meq l; chemistry blood creatinine  7.6  mg dl; chemistry blood creatinine  7.5  mg dl; chemistry blood potassium  5.1  meq l; chemistry blood potassium  5.0  meq l; chemistry blood sodium  140  meq l; chemistry blood sodium  140  meq l; chemistry blood urea nitrogen  97  mg dl; chemistry blood urea nitrogen  95  mg dl; hematology blood inr(pt)  1.0  ; chemistry blood calcium, total  8.6  mg dl; chemistry blood calcium, total  8.8  mg dl; chemistry blood glucose  137  mg dl; chemistry blood glucose  160  mg dl$bisacodyl  10  mg ; heparin  5000  unit ; dextrose 50%  12.5  gm ; glucagon  1  mg ; glucose gel  15  g ; atorvastatin  80  mg ; sevelamer carbonate  800  mg ; sodium bicarbonate  650  mg ; sodium chloride 0.9%  flush  3-10  ml ; insulin  0  unit ; nicotine patch  14  mg ; docusate sodium  100  mg ; labetalol  100  mg ; polyethylene glycol  17  g ; simethicone  40  mg ; 
 
white m 73 $nan$hematology blood hematocrit  22.7  %; hematology blood hemoglobin  7.4  g dl; hematology blood platelet count  160  k ul; chemistry blood anion gap  15  meq l; chemistry blood bicarbonate  28  meq l; chemistry blood chloride  95  meq l; chemistry blood creatinine  4.8  mg dl; chemistry blood potassium  4.6  meq l; chemistry blood sodium  138  meq l; chemistry blood urea nitrogen  59  mg dl; hematology blood inr(pt)  1.0  ; chemistry blood calcium, total  8.9  mg dl; chemistry blood glucose  172  mg dl$bisacodyl  10  mg ; heparin  5000  unit ; dextrose 50%  12.5  gm ; glucagon  1  mg ; glucose gel  15  g ; atorvastatin  80  mg ; sevelamer carbonate  800  mg ; sodium bicarbonate  650  mg ; sodium chloride 0.9%  flush  3-10  ml ; insulin  0  unit ; nicotine patch  14  mg ; docusate sodium  100  mg ; labetalol  100  mg ; polyethylene glycol  17  g ; simethicone  40  mg ; ramelteon  8  mg ; labetalol  200  mg ; 
 
white m 73 $nan$hematology blood hematocrit  21.6  %; hematology blood hemoglobin  7.0  g dl; hematology blood platelet count  151  k ul; chemistry blood anion gap  13  meq l; chemistry blood bicarbonate  29  meq l; chemistry blood chloride  96  meq l; chemistry blood creatinine  3.9  mg dl; chemistry blood potassium  4.3  meq l; chemistry blood sodium  138  meq l; chemistry blood urea nitrogen  35  mg dl; hematology blood inr(pt)  1.1  ; chemistry blood calcium, total  8.7  mg dl; chemistry blood glucose  167  mg dl$bisacodyl  10  mg ; heparin  5000  unit ; dextrose 50%  12.5  gm ; glucagon  1  mg ; glucose gel  15  g ; atorvastatin  80  mg ; sevelamer carbonate  800  mg ; sodium chloride 0.9%  flush  3-10  ml ; insulin  0  unit ; nicotine patch  14  mg ; docusate sodium  100  mg ; polyethylene glycol  17  g ; simethicone  40  mg ; ramelteon  8  mg ; labetalol  200  mg ; 
 
white m 73 $nan$hematology blood hematocrit  20.9  %; hematology blood hemoglobin  6.6  g dl; hematology blood platelet count  143  k ul; chemistry blood anion gap  17  meq l; chemistry blood bicarbonate  25  meq l; chemistry blood chloride  95  meq l; chemistry blood creatinine  4.8  mg dl; chemistry blood potassium  4.0  meq l; chemistry blood sodium  137  meq l; chemistry blood urea nitrogen  49  mg dl; hematology blood inr(pt)  1.0  ; chemistry blood calcium, total  8.5  mg dl; chemistry blood glucose  166  mg dl$bisacodyl  10  mg ; heparin  5000  unit ; dextrose 50%  12.5  gm ; glucagon  1  mg ; glucose gel  15  g ; atorvastatin  80  mg ; sevelamer carbonate  800  mg ; sodium chloride 0.9%  flush  3-10  ml ; insulin  0  unit ; nicotine patch  14  mg ; docusate sodium  100  mg ; polyethylene glycol  17  g ; simethicone  40  mg ; labetalol  200  mg ; 0.9% sodium chloride  50  ml ; desmopressin acetate  22  mcg ; oxycodone (immediate release)  5  mg ; 
 
white m 73 $nan$hematology blood hematocrit  23.4  %; hematology blood hemoglobin  7.6  g dl; hematology blood platelet count  136  k ul; chemistry blood anion gap  15  meq l; chemistry blood bicarbonate  27  meq l; chemistry blood chloride  96  meq l; chemistry blood creatinine  3.4  mg dl; chemistry blood potassium  4.3  meq l; chemistry blood sodium  138  meq l; chemistry blood urea nitrogen  30  mg dl; hematology blood inr(pt)  1.1  ; chemistry blood calcium, total  8.5  mg dl; chemistry blood glucose  153  mg dl$bisacodyl  10  mg ; dextrose 50%  12.5  gm ; glucagon  1  mg ; glucose gel  15  g ; atorvastatin  80  mg ; sevelamer carbonate  800  mg ; insulin  0  unit ; nicotine patch  14  mg ; docusate sodium  100  mg ; polyethylene glycol  17  g ; simethicone  40  mg ; labetalol  200  mg ; 
 
white m 73 $nan$hematology blood hematocrit  23.7  %; hematology blood hemoglobin  7.5  g dl; hematology blood platelet count  140  k ul; chemistry blood anion gap  15  meq l; chemistry blood bicarbonate  26  meq l; chemistry blood chloride  96  meq l; chemistry blood creatinine  4.1  mg dl; chemistry blood potassium  3.7  meq l; chemistry blood sodium  137  meq l; chemistry blood urea nitrogen  44  mg dl; chemistry blood urea nitrogen  13  mg dl; chemistry blood calcium, total  8.5  mg dl; chemistry blood glucose  142  mg dl$bisacodyl  10  mg ; dextrose 50%  12.5  gm ; glucagon  1  mg ; glucose gel  15  g ; atorvastatin  80  mg ; sevelamer carbonate  800  mg ; insulin  0  unit ; nicotine patch  14  mg ; docusate sodium  100  mg ; polyethylene glycol  17  g ; simethicone  40  mg ; labetalol  200  mg ; 
 
white m 73 $nan$nan$bisacodyl  10  mg ; dextrose 50%  12.5  gm ; glucagon  1  mg ; glucose gel  15  g ; atorvastatin  80  mg ; sevelamer carbonate  800  mg ; insulin  0  unit ; nicotine patch  14  mg ; docusate sodium  100  mg ; polyethylene glycol  17  g ; simethicone  40  mg ; labetalol  200  mg ; 
 
white f 35 $nan$nan$oxytocin  20  unit ; docusate sodium  100  mg ; oxycodone-acetaminophen  1-2  tab ; ibuprofen  600  mg ; acetaminophen  500-1000  mg ; dibucaine  1  appl ; 
 
white f 35 $nan$nan$oxytocin  20  unit ; docusate sodium  100  mg ; oxycodone-acetaminophen  1-2  tab ; ibuprofen  600  mg ; acetaminophen  500-1000  mg ; dibucaine  1  appl ; 
 
white f 35 $nan$nan$oxytocin  20  unit ; docusate sodium  100  mg ; oxycodone-acetaminophen  1-2  tab ; ibuprofen  600  mg ; acetaminophen  500-1000  mg ; dibucaine  1  appl ; 
 
white f 35 $nan$nan$oxytocin  20  unit ; docusate sodium  100  mg ; oxycodone-acetaminophen  1-2  tab ; ibuprofen  600  mg ; acetaminophen  500-1000  mg ; dibucaine  1  appl ; 
 
white f 93 $temp  97.9  heartrate  62.0  resprate  14.0  o2sat  99.0  sbp  156.0  dbp  50.0  rhythm    pain  0  ; temp  98.1  heartrate  58.0  resprate  16.0  o2sat  99.0  sbp  155.0  dbp  60.0  rhythm    pain  0  $hematology blood hematocrit  37.9  %; hematology blood hemoglobin  12.4  g dl; hematology blood platelet count  190  k ul; chemistry blood anion gap  11  meq l; chemistry blood bicarbonate  30  meq l; chemistry blood chloride  105  meq l; chemistry blood creatinine  0.9  mg dl; chemistry blood potassium  4.5  meq l; chemistry blood sodium  141  meq l; chemistry blood urea nitrogen  21  mg dl; hematology blood inr(pt)  1.0  ; hematology blood inr(pt)  1.0  ; chemistry blood calcium, total  9.3  mg dl; chemistry blood glucose  93  mg dl$sodium chloride 0.9%  flush  3  ml ; acetaminophen  650  mg ; aspirin  81  mg ; furosemide  20  mg ; levothyroxine sodium  25  mcg ; lisinopril  10  mg ; sotalol  60  mg ; heparin  800  unit ; 5% dextrose  250  ml ; heparin sodium  25,000  unit ; senna  8.6  mg ; docusate sodium  100  mg ; venlafaxine xr  75  mg ; 
percutaneous transluminal coronary angioplasty status atrial fibrillation aortic valve disorders dementia, unspecified, without behavioral disturbance cellulitis and abscess of hand, except fingers and thumb unspecified essential hypertension unspecified acquired hypothyroidism urinary tract infection, site not specified coronary atherosclerosis of unspecified type of vessel, native or graft aortocoronary bypass status unspecified hearing loss percutaneous transluminal coronary angioplasty status family history of ischemic heart disease long-term (current) use of anticoagulants aortic valve disorders personal history of colonic polyps aortocoronary bypass status coronary atherosclerosis of unspecified type of vessel, native or graft unspecified acquired hypothyroidism dementia, unspecified, without behavioral disturbance other and unspecified hyperlipidemia atrial fibrillation unspecified glaucoma do not resuscitate status intermediate coronary syndrome person boarding or alighting a pedal cycle injured in collision with fixed or stationary object aortocoronary bypass status other and unspecified hyperlipidemia unspecified hearing loss coronary atherosclerosis of native coronary artery unspecified essential hypertension unspecified acquired hypothyroidism fall from other slipping, tripping, or stumbling glaucoma stage, unspecified acquired absence of both cervix and uterus spinal stenosis, unspecified region atrial fibrillation unspecified acquired hypothyroidism personal history of colonic polyps pure hypercholesterolemia unspecified essential hypertension unspecified hearing loss do not resuscitate status unspecified glaucoma history of fall closed fracture of pubis long-term (current) use of anticoagulants aortocoronary bypass status
white f 93 $nan$chemistry blood anion gap  14  meq l; chemistry blood bicarbonate  23  meq l; chemistry blood chloride  105  meq l; chemistry blood creatinine  0.7  mg dl; chemistry blood potassium  3.8  meq l; chemistry blood sodium  138  meq l; chemistry blood urea nitrogen  22  mg dl; hematology blood inr(pt)  1.1  ; chemistry blood calcium, total  9.0  mg dl; chemistry blood glucose  75  mg dl$sodium chloride 0.9%  flush  3  ml ; acetaminophen  650  mg ; aspirin  81  mg ; furosemide  20  mg ; levothyroxine sodium  25  mcg ; sotalol  60  mg ; heparin  800  unit ; 5% dextrose  250  ml ; heparin sodium  25,000  unit ; senna  8.6  mg ; docusate sodium  100  mg ; venlafaxine xr  75  mg ; apixaban  5  mg ; clopidogrel  75  mg ; 
percutaneous transluminal coronary angioplasty status atrial fibrillation aortic valve disorders dementia, unspecified, without behavioral disturbance cellulitis and abscess of hand, except fingers and thumb unspecified essential hypertension unspecified acquired hypothyroidism urinary tract infection, site not specified coronary atherosclerosis of unspecified type of vessel, native or graft aortocoronary bypass status unspecified hearing loss percutaneous transluminal coronary angioplasty status family history of ischemic heart disease long-term (current) use of anticoagulants aortic valve disorders personal history of colonic polyps aortocoronary bypass status coronary atherosclerosis of unspecified type of vessel, native or graft unspecified acquired hypothyroidism dementia, unspecified, without behavioral disturbance other and unspecified hyperlipidemia atrial fibrillation unspecified glaucoma do not resuscitate status intermediate coronary syndrome person boarding or alighting a pedal cycle injured in collision with fixed or stationary object aortocoronary bypass status other and unspecified hyperlipidemia unspecified hearing loss coronary atherosclerosis of native coronary artery unspecified essential hypertension unspecified acquired hypothyroidism fall from other slipping, tripping, or stumbling glaucoma stage, unspecified acquired absence of both cervix and uterus spinal stenosis, unspecified region atrial fibrillation unspecified acquired hypothyroidism personal history of colonic polyps pure hypercholesterolemia unspecified essential hypertension unspecified hearing loss do not resuscitate status unspecified glaucoma history of fall closed fracture of pubis long-term (current) use of anticoagulants aortocoronary bypass status
white f 93 $nan$nan$sodium chloride 0.9%  flush  3  ml ; acetaminophen  650  mg ; aspirin  81  mg ; furosemide  20  mg ; levothyroxine sodium  25  mcg ; sotalol  60  mg ; senna  8.6  mg ; docusate sodium  100  mg ; venlafaxine xr  75  mg ; clopidogrel  75  mg ; apixaban  2.5  mg ; 
percutaneous transluminal coronary angioplasty status atrial fibrillation aortic valve disorders dementia, unspecified, without behavioral disturbance cellulitis and abscess of hand, except fingers and thumb unspecified essential hypertension unspecified acquired hypothyroidism urinary tract infection, site not specified coronary atherosclerosis of unspecified type of vessel, native or graft aortocoronary bypass status unspecified hearing loss percutaneous transluminal coronary angioplasty status family history of ischemic heart disease long-term (current) use of anticoagulants aortic valve disorders personal history of colonic polyps aortocoronary bypass status coronary atherosclerosis of unspecified type of vessel, native or graft unspecified acquired hypothyroidism dementia, unspecified, without behavioral disturbance other and unspecified hyperlipidemia atrial fibrillation unspecified glaucoma do not resuscitate status intermediate coronary syndrome person boarding or alighting a pedal cycle injured in collision with fixed or stationary object aortocoronary bypass status other and unspecified hyperlipidemia unspecified hearing loss coronary atherosclerosis of native coronary artery unspecified essential hypertension unspecified acquired hypothyroidism fall from other slipping, tripping, or stumbling glaucoma stage, unspecified acquired absence of both cervix and uterus spinal stenosis, unspecified region atrial fibrillation unspecified acquired hypothyroidism personal history of colonic polyps pure hypercholesterolemia unspecified essential hypertension unspecified hearing loss do not resuscitate status unspecified glaucoma history of fall closed fracture of pubis long-term (current) use of anticoagulants aortocoronary bypass status
white m 59 $temp  99.1  heartrate  64.0  resprate  16.0  o2sat  100.0  sbp  106.0  dbp  54.0  rhythm    pain  0  ; temp  99.1  heartrate  64.0  resprate  16.0  o2sat  100.0  sbp  106.0  dbp  54.0  rhythm    pain  0  $hematology blood hematocrit  35.7  %; hematology blood hemoglobin  12.4  g dl; hematology blood platelet count  249  k ul; chemistry blood anion gap  12  meq l; chemistry blood bicarbonate  22  meq l; chemistry blood chloride  105  meq l; chemistry blood creatinine  0.7  mg dl; chemistry blood potassium  3.4  meq l; chemistry blood sodium  136  meq l; chemistry blood urea nitrogen  9  mg dl; hematology blood inr(pt)  1.4  ; chemistry blood calcium, total  8.4  mg dl; chemistry blood glucose  98  mg dl; blood gas blood hematocrit, calculated  40  %; blood gas blood hemoglobin  13.4  g dl$sodium chloride 0.9%  flush  3  ml ; potassium chl 40 meq   1000 ml d5 1 2 ns  1000  ml ; ondansetron  4-8  mg ; acetaminophen  325-650  mg ; fludrocortisone acetate  0.1  mg ; heparin  5000  unit ; dexamethasone  0.5  mg ; trazodone  25  mg ; finasteride  5  mg ; tamsulosin  0.4  mg ; ns  100  ml ; metronidazole (flagyl)  500  mg ; 5% dextrose  200  ml ; ciprofloxacin iv  400  mg ; ciprofloxacin hcl  500  mg ; potassium chloride  40  meq ; potassium chloride  20  meq ; polyethylene glycol  17  g ; 
unspecified intellectual disabilities glucocorticoid deficiency adrenogenital disorders intestinal infection due to other organism, not elsewhere classified other late effects of cerebrovascular disease dehydration other and unspecified noninfectious gastroenteritis and colitis adrenogenital disorders hypotension, unspecified 
white m 59 $nan$nan$sodium chloride 0.9%  flush  3  ml ; ondansetron  4-8  mg ; acetaminophen  325-650  mg ; fludrocortisone acetate  0.1  mg ; heparin  5000  unit ; dexamethasone  0.5  mg ; trazodone  25  mg ; finasteride  5  mg ; tamsulosin  0.4  mg ; ciprofloxacin hcl  500  mg ; potassium chloride  40  meq ; potassium chloride  20  meq ; polyethylene glycol  17  g ; 
unspecified intellectual disabilities glucocorticoid deficiency adrenogenital disorders intestinal infection due to other organism, not elsewhere classified other late effects of cerebrovascular disease dehydration other and unspecified noninfectious gastroenteritis and colitis adrenogenital disorders hypotension, unspecified 
white m 81 $temp  97.6  heartrate  71.0  resprate  17.0  o2sat  100.0  sbp  151.0  dbp  67.0  rhythm    pain  0  $hematology blood hematocrit  30.0  %; hematology blood hemoglobin  10.6  g dl; hematology blood platelet count  234  k ul; chemistry blood anion gap  13  meq l; chemistry blood bicarbonate  23  meq l; chemistry blood chloride  104  meq l; chemistry blood creatinine  1.2  mg dl; chemistry blood potassium  4.2  meq l; chemistry blood sodium  136  meq l; chemistry blood urea nitrogen  23  mg dl; hematology blood inr(pt)  1.0  ; chemistry blood calcium, total  8.4  mg dl; chemistry blood bilirubin, total  5.9  mg dl; chemistry blood glucose  118  mg dl$influenza vaccine quadrivalent  0.5  ml ; sodium chloride 0.9%  flush  3  ml ; heparin  5000  unit ; ondansetron  4  mg ; docusate sodium  100  mg ; senna  8.6  mg ; lactated ringers  1000  ml ; 5% dextrose  200  ml ; ciprofloxacin iv  400  mg ; 
 
white m 81 $nan$hematology blood hematocrit  29.2  %; hematology blood hemoglobin  10.0  g dl; hematology blood platelet count  225  k ul; chemistry blood anion gap  12  meq l; chemistry blood bicarbonate  24  meq l; chemistry blood chloride  106  meq l; chemistry blood creatinine  1.1  mg dl; chemistry blood potassium  3.9  meq l; chemistry blood sodium  138  meq l; chemistry blood urea nitrogen  21  mg dl; chemistry blood calcium, total  8.5  mg dl; chemistry blood bilirubin, total  3.9  mg dl; chemistry blood glucose  75  mg dl$influenza vaccine quadrivalent  0.5  ml ; sodium chloride 0.9%  flush  3  ml ; ondansetron  4  mg ; docusate sodium  100  mg ; senna  8.6  mg ; 5% dextrose  200  ml ; ciprofloxacin iv  400  mg ; 
 
white m 81 $nan$nan$influenza vaccine quadrivalent  0.5  ml ; sodium chloride 0.9%  flush  3  ml ; ondansetron  4  mg ; docusate sodium  100  mg ; senna  8.6  mg ; 5% dextrose  200  ml ; ciprofloxacin iv  400  mg ; 
 
white f 33 $temp  99.1  heartrate  115.0  resprate  23.0  o2sat  96.0  sbp    dbp    rhythm    pain    $hematology blood hematocrit  36.8  %; hematology blood hemoglobin  12.5  g dl; hematology blood platelet count  191  k ul; chemistry blood anion gap  14  meq l; chemistry blood bicarbonate  21  meq l; chemistry blood chloride  99  meq l; chemistry blood creatinine  0.6  mg dl; chemistry blood potassium  4.2  meq l; chemistry blood sodium  130  meq l; chemistry blood urea nitrogen  13  mg dl; hematology blood inr(pt)  1.4  ; hematology urine wbc  6  # hpf; chemistry blood calcium, total  8.2  mg dl; chemistry blood bilirubin, total  0.9  mg dl; chemistry blood glucose  317  mg dl; chemistry blood lactate dehydrogenase (ld)  196  iu l; hematology urine glucose  300  mg dl$insulin  65  unit ; sodium chloride 0.9%  flush  3  ml ; 0.9% sodium chloride  1000  ml ; hydroxyzine  25  mg ; lisinopril  2.5  mg ; naproxen  500  mg ; promethazine  25  mg ; doxycycline hyclate  100  mg ; dextrose 50%  12.5  gm ; glucagon  1  mg ; insulin  0  unit ; hydromorphone (dilaudid)  0.5  mg ; diazepam  5  mg ; bag  100  ml ; magnesium sulfate  4  gm ; clobetasol propionate 0.05% ointment  1  appl ; fluticasone-salmeterol diskus (500 50)   1  inh ; silver sulfadiazine 1% cream  1  appl ; albuterol 0.083% neb soln  1  neb ; heparin  7500  unit ; 
streptococcus infection in conditions classified elsewhere and of unspecified site, streptococcus, group d [enterococcus] lung involvement in other diseases classified elsewhere long-term (current) use of insulin sarcoidosis unspecified iridocyclitis morbid obesity diabetes with other specified manifestations, type ii or unspecified type, not stated as uncontrolled ulcer of calf asthma, unspecified type, unspecified moderate nonproliferative diabetic retinopathy cellulitis and abscess of leg, except foot unspecified essential hypertension depressive disorder, not elsewhere classified diabetes with ophthalmic manifestations, type ii or unspecified type, not stated as uncontrolled degenerative skin disorders other chronic nonalcoholic liver disease methicillin susceptible staphylococcus aureus in conditions classified elsewhere and of unspecified site ulcer of other part of lower limb morbid obesity fever, unspecified degenerative skin disorders cellulitis and abscess of leg, except foot body mass index 40 and over, adult person injured while boarding or alighting from special construction vehicle unspecified essential hypertension unspecified iridocyclitis asthma, unspecified type, unspecified diabetes with other specified manifestations, type ii or unspecified type, uncontrolled diabetes mellitus without mention of complication, type ii or unspecified type, not stated as uncontrolled obesity, unspecified long-term (current) use of insulin other chest pain unspecified essential hypertension venous (peripheral) insufficiency, unspecified unspecified essential hypertension diabetes mellitus without mention of complication, type ii or unspecified type, not stated as uncontrolled chest pain, unspecified other ventral hernia with obstruction
white f 33 $nan$hematology blood hematocrit  34.7  %; hematology blood hemoglobin  12.0  g dl; hematology blood platelet count  202  k ul; chemistry blood anion gap  11  meq l; chemistry blood bicarbonate  28  meq l; chemistry blood chloride  101  meq l; chemistry blood creatinine  0.4  mg dl; chemistry blood potassium  3.9  meq l; chemistry blood sodium  136  meq l; chemistry blood urea nitrogen  10  mg dl; chemistry blood calcium, total  8.2  mg dl; chemistry blood glucose  282  mg dl$insulin  65  unit ; sodium chloride 0.9%  flush  3  ml ; 0.9% sodium chloride  1000  ml ; hydroxyzine  25  mg ; naproxen  500  mg ; promethazine  25  mg ; doxycycline hyclate  100  mg ; dextrose 50%  12.5  gm ; glucagon  1  mg ; hydromorphone (dilaudid)  0.5  mg ; diazepam  5  mg ; bag  100  ml ; magnesium sulfate  4  gm ; clobetasol propionate 0.05% ointment  1  appl ; fluticasone-salmeterol diskus (500 50)   1  inh ; silver sulfadiazine 1% cream  1  appl ; albuterol 0.083% neb soln  1  neb ; heparin  7500  unit ; oxycodone (immediate release)   5  mg ; 
streptococcus infection in conditions classified elsewhere and of unspecified site, streptococcus, group d [enterococcus] lung involvement in other diseases classified elsewhere long-term (current) use of insulin sarcoidosis unspecified iridocyclitis morbid obesity diabetes with other specified manifestations, type ii or unspecified type, not stated as uncontrolled ulcer of calf asthma, unspecified type, unspecified moderate nonproliferative diabetic retinopathy cellulitis and abscess of leg, except foot unspecified essential hypertension depressive disorder, not elsewhere classified diabetes with ophthalmic manifestations, type ii or unspecified type, not stated as uncontrolled degenerative skin disorders other chronic nonalcoholic liver disease methicillin susceptible staphylococcus aureus in conditions classified elsewhere and of unspecified site ulcer of other part of lower limb morbid obesity fever, unspecified degenerative skin disorders cellulitis and abscess of leg, except foot body mass index 40 and over, adult person injured while boarding or alighting from special construction vehicle unspecified essential hypertension unspecified iridocyclitis asthma, unspecified type, unspecified diabetes with other specified manifestations, type ii or unspecified type, uncontrolled diabetes mellitus without mention of complication, type ii or unspecified type, not stated as uncontrolled obesity, unspecified long-term (current) use of insulin other chest pain unspecified essential hypertension venous (peripheral) insufficiency, unspecified unspecified essential hypertension diabetes mellitus without mention of complication, type ii or unspecified type, not stated as uncontrolled chest pain, unspecified other ventral hernia with obstruction
black african american m 59 $temp    heartrate    resprate    o2sat    sbp    dbp    rhythm    pain  critical  ; temp  102.7  heartrate  107.0  resprate  16.0  o2sat  100.0  sbp  152.0  dbp  100.0  rhythm    pain    ; temp  103.8  heartrate  109.0  resprate  17.0  o2sat  100.0  sbp  149.0  dbp  102.0  rhythm    pain  uta  ; temp  101.8  heartrate  99.0  resprate  16.0  o2sat  100.0  sbp  166.0  dbp  96.0  rhythm    pain  uta  ; temp    heartrate  93.0  resprate  16.0  o2sat  100.0  sbp  141.0  dbp  92.0  rhythm    pain  uta  ; temp  99.6  heartrate  88.0  resprate  19.0  o2sat  100.0  sbp  134.0  dbp  87.0  rhythm    pain  uta  ; temp    heartrate  83.0  resprate  18.0  o2sat  100.0  sbp  135.0  dbp  88.0  rhythm    pain  uta  ; temp    heartrate  82.0  resprate  17.0  o2sat  100.0  sbp  140.0  dbp  82.0  rhythm    pain  uta  $nan$0.9% sodium chloride  100  ml ; levetiracetam  1000  mg ; 
 
black african american m 59 $temp  98.7  heartrate  80.0  resprate  15.0  o2sat  100.0  sbp  152.0  dbp  91.0  rhythm    pain  uta  $hematology blood hematocrit  40.2  %; hematology blood hemoglobin  12.9  g dl; hematology blood platelet count  178  k ul; chemistry blood anion gap  13  meq l; chemistry blood bicarbonate  23  meq l; chemistry blood chloride  103  meq l; chemistry blood creatinine  1.0  mg dl; chemistry blood potassium  4.4  meq l; chemistry blood sodium  139  meq l; chemistry blood urea nitrogen  12  mg dl; hematology blood inr(pt)  1.1  ; chemistry blood calcium, total  8.8  mg dl; chemistry blood glucose  115  mg dl$0.9% sodium chloride  250  ml ; 0.9% sodium chloride  100  ml ; levetiracetam  1000  mg ; sodium chloride 0.9%  flush  3-10  ml ; lidocaine jelly 2% (glydo)  1  appl ; acetaminophen  1000  mg ; docusate sodium  100  mg ; heparin  5000  unit ; propofol  1000  mg ; calcium gluconate sliding scale (critical care-ionized calcium)  0  g ; calcium gluconate  2  g ; calcium gluconate  4  g ; bag  1  bag ; magnesium sulfate  2  gm ; bag  2  bag ; magnesium sulfate  4  gm ; sodium chloride 0.9%  1000  ml ; iso-osmotic sodium chloride  1  bag ; famotidine  20  mg ; senna  8.6  mg ; potassium chloride replacement (critical care and oncology)   40  meq ; potassium chloride replacement (critical care and oncology)   60  meq ; potassium chloride replacement (critical care and oncology)   80  meq ; acyclovir  750  mg ; vancomycin  1250  mg ; 0.9% sodium chloride (mini bag plus)  100  ml ; ampicillin sodium  2  g ; vial  1  vial ; ceftriaxone  2  gm ; fentanyl citrate  25-100  mcg ; dexamethasone  4  mg ; chlorhexidine gluconate 0.12% oral rinse  15  ml ; lactated ringers  1000  ml ; dextrose 50%  12.5  gm ; glucagon  1  mg ; glucose gel  15  g ; insulin  0  unit ; 
 
black african american m 59 $nan$hematology blood hematocrit  34.0  %; hematology blood hemoglobin  10.8  g dl; hematology blood platelet count  164  k ul; chemistry blood anion gap  9  meq l; chemistry blood bicarbonate  24  meq l; chemistry blood chloride  110  meq l; chemistry blood creatinine  0.9  mg dl; chemistry blood potassium  4.3  meq l; chemistry blood sodium  143  meq l; chemistry blood urea nitrogen  16  mg dl; hematology blood inr(pt)  1.1  ; chemistry blood calcium, total  8.1  mg dl; chemistry blood glucose  119  mg dl$sodium chloride 0.9%  flush  3-10  ml ; lidocaine jelly 2% (glydo)  1  appl ; acetaminophen  1000  mg ; docusate sodium  100  mg ; heparin  5000  unit ; propofol  1000  mg ; calcium gluconate sliding scale (critical care-ionized calcium)  0  g ; calcium gluconate  2  g ; calcium gluconate  4  g ; bag  1  bag ; magnesium sulfate  2  gm ; bag  2  bag ; magnesium sulfate  4  gm ; sodium chloride 0.9%  1000  ml ; senna  8.6  mg ; potassium chloride replacement (critical care and oncology)   40  meq ; potassium chloride replacement (critical care and oncology)   60  meq ; potassium chloride replacement (critical care and oncology)   80  meq ; fentanyl citrate  25-100  mcg ; dexamethasone  4  mg ; chlorhexidine gluconate 0.12% oral rinse  15  ml ; lactated ringers  1000  ml ; dextrose 50%  12.5  gm ; glucagon  1  mg ; glucose gel  15  g ; insulin  0  unit ; sodium chloride 0.9%  flush  10  ml ; hydralazine  10-20  mg ; labetalol  10-20  mg ; click change <--- to choose a base solution  100  ml ; vancomycin  250  mg ; 0.9% sodium chloride  500  ml ; vancomycin  1500  mg ; dexmedetomidine  0.4  mg ; 
 
black african american m 59 $nan$hematology blood hematocrit  35.3  %; hematology blood hematocrit  35.8  %; hematology blood hemoglobin  11.3  g dl; hematology blood hemoglobin  11.3  g dl; hematology blood platelet count  176  k ul; hematology blood platelet count  177  k ul; chemistry blood anion gap  9  meq l; chemistry blood bicarbonate  22  meq l; chemistry blood chloride  114  meq l; chemistry blood creatinine  0.7  mg dl; chemistry blood potassium  3.6  meq l; chemistry blood sodium  145  meq l; chemistry blood urea nitrogen  12  mg dl; hematology blood inr(pt)  1.1  ; chemistry blood calcium, total  8.0  mg dl; chemistry blood glucose  135  mg dl; hematology blood wbc count  10.9  k ul$sodium chloride 0.9%  flush  3-10  ml ; acetaminophen  1000  mg ; docusate sodium  100  mg ; propofol  1000  mg ; calcium gluconate sliding scale (critical care-ionized calcium)  0  g ; calcium gluconate  2  g ; calcium gluconate  4  g ; bag  1  bag ; magnesium sulfate  2  gm ; bag  2  bag ; magnesium sulfate  4  gm ; sodium chloride 0.9%  1000  ml ; senna  8.6  mg ; potassium chloride replacement (critical care and oncology)   40  meq ; potassium chloride replacement (critical care and oncology)   60  meq ; potassium chloride replacement (critical care and oncology)   80  meq ; dexamethasone  4  mg ; chlorhexidine gluconate 0.12% oral rinse  15  ml ; dextrose 50%  12.5  gm ; glucagon  1  mg ; glucose gel  15  g ; insulin  0  unit ; sodium chloride 0.9%  flush  10  ml ; hydralazine  10-20  mg ; labetalol  10-20  mg ; 0.9% sodium chloride  500  ml ; vancomycin  1500  mg ; dexmedetomidine  0.4  mg ; milk of magnesia  30  ml ; sulfameth trimethoprim ds  1  tab ; bisacodyl  10  mg ; hydralazine  10  mg ; sulfameth trimethoprim ds  2  tab ; 
 
black african american m 59 $nan$hematology blood hematocrit  39.0  %; hematology blood hemoglobin  12.6  g dl; hematology blood platelet count  198  k ul; chemistry blood anion gap  14  meq l; chemistry blood bicarbonate  22  meq l; chemistry blood chloride  109  meq l; chemistry blood creatinine  0.7  mg dl; chemistry blood potassium  3.8  meq l; chemistry blood sodium  145  meq l; chemistry blood urea nitrogen  11  mg dl; chemistry blood calcium, total  8.7  mg dl; chemistry blood glucose  113  mg dl$sodium chloride 0.9%  flush  3-10  ml ; acetaminophen  1000  mg ; calcium gluconate sliding scale (critical care-ionized calcium)  0  g ; calcium gluconate  2  g ; calcium gluconate  4  g ; bag  1  bag ; magnesium sulfate  2  gm ; potassium chloride replacement (critical care and oncology)   40  meq ; potassium chloride replacement (critical care and oncology)   60  meq ; potassium chloride replacement (critical care and oncology)   80  meq ; dextrose 50%  12.5  gm ; glucagon  1  mg ; glucose gel  15  g ; insulin  0  unit ; sodium chloride 0.9%  flush  10  ml ; hydralazine  10  mg ; sulfameth trimethoprim ds  2  tab ; lisinopril  20  mg ; amlodipine  5  mg ; metoprolol tartrate  25  mg ; 
 
black african american m 59 $nan$hematology blood hematocrit  37.4  %; hematology blood hemoglobin  12.3  g dl; hematology blood platelet count  201  k ul; chemistry blood anion gap  13  meq l; chemistry blood bicarbonate  23  meq l; chemistry blood chloride  107  meq l; chemistry blood creatinine  0.8  mg dl; chemistry blood potassium  3.5  meq l; chemistry blood sodium  143  meq l; chemistry blood urea nitrogen  11  mg dl; chemistry blood calcium, total  8.4  mg dl; chemistry blood glucose  81  mg dl$sodium chloride 0.9%  flush  3-10  ml ; acetaminophen  1000  mg ; dextrose 50%  12.5  gm ; glucagon  1  mg ; glucose gel  15  g ; insulin  0  unit ; sulfameth trimethoprim ds  2  tab ; amlodipine  5  mg ; metoprolol tartrate  25  mg ; glycerin supps  1  supp ; 
 
black african american m 59 $nan$hematology blood hematocrit  38.7  %; hematology blood hemoglobin  12.7  g dl; hematology blood platelet count  244  k ul; chemistry blood anion gap  13  meq l; chemistry blood bicarbonate  24  meq l; chemistry blood chloride  102  meq l; chemistry blood creatinine  0.8  mg dl; chemistry blood potassium  3.6  meq l; chemistry blood sodium  139  meq l; chemistry blood urea nitrogen  11  mg dl; chemistry blood calcium, total  8.8  mg dl; chemistry blood glucose  90  mg dl$sodium chloride 0.9%  flush  3-10  ml ; acetaminophen  1000  mg ; dextrose 50%  12.5  gm ; glucagon  1  mg ; glucose gel  15  g ; insulin  0  unit ; sulfameth trimethoprim ds  2  tab ; amlodipine  5  mg ; metoprolol tartrate  25  mg ; glycerin supps  1  supp ; polyethylene glycol  17  g ; 
 
black african american m 59 $nan$hematology blood hematocrit  38.5  %; hematology blood hemoglobin  12.6  g dl; hematology blood platelet count  235  k ul; chemistry blood anion gap  13  meq l; chemistry blood bicarbonate  22  meq l; chemistry blood chloride  104  meq l; chemistry blood creatinine  1.1  mg dl; chemistry blood potassium  4.0  meq l; chemistry blood sodium  139  meq l; chemistry blood urea nitrogen  14  mg dl; chemistry blood calcium, total  8.9  mg dl; chemistry blood glucose  95  mg dl$sodium chloride 0.9%  flush  3-10  ml ; acetaminophen  1000  mg ; dextrose 50%  12.5  gm ; glucagon  1  mg ; glucose gel  15  g ; insulin  0  unit ; sulfameth trimethoprim ds  2  tab ; metoprolol tartrate  25  mg ; glycerin supps  1  supp ; polyethylene glycol  17  g ; amlodipine  10  mg ; sulfameth trimethoprim ds  3  tab ; azithromycin  1200  mg ; 
 
black african american m 59 $nan$nan$sodium chloride 0.9%  flush  3-10  ml ; acetaminophen  1000  mg ; dextrose 50%  12.5  gm ; glucagon  1  mg ; glucose gel  15  g ; insulin  0  unit ; metoprolol tartrate  25  mg ; glycerin supps  1  supp ; amlodipine  10  mg ; sulfameth trimethoprim ds  3  tab ; azithromycin  1200  mg ; 
 
white f 71 $temp  97.3  heartrate  74.0  resprate  15.0  o2sat  99.0  sbp  190.0  dbp  84.0  rhythm    pain    ; temp  97.3  heartrate  76.0  resprate  16.0  o2sat  97.0  sbp  151.0  dbp  55.0  rhythm    pain  0  $hematology blood hematocrit  42.5  %; hematology blood hemoglobin  14.1  g dl; hematology blood platelet count  184  k ul; hematology blood platelet count  170  k ul; chemistry blood anion gap  13  meq l; chemistry blood bicarbonate  28  meq l; chemistry blood chloride  105  meq l; chemistry blood chloride  104  meq l; chemistry blood creatinine  0.7  mg dl; chemistry blood potassium  4.0  meq l; chemistry blood potassium  4.2  meq l; chemistry blood sodium  142  meq l; chemistry blood sodium  140  meq l; chemistry blood urea nitrogen  14  mg dl; chemistry blood glucose  115  mg dl$pneumococcal vac polyvalent  0.5  ml ; sodium chloride 0.9%  flush  3  ml ; heparin  5000  unit ; ascorbic acid  1000  mg ; calcium carbonate  1000  mg ; omeprazole  20  mg ; vitamin d  1000  unit ; aspirin  325  mg ; diazepam  0.5  mg ; oxybutynin  10  mg ; atorvastatin  80  mg ; clopidogrel  75  mg ; lisinopril  5  mg ; diazepam  2.5  mg ; acetaminophen  325-650  mg ; 0.9% sodium chloride  1000  ml ; metoprolol tartrate  25  mg ; 
 
white f 71 $nan$hematology blood hematocrit  44.3  %; hematology blood hemoglobin  14.4  g dl; hematology blood platelet count  202  k ul; chemistry blood anion gap  12  meq l; chemistry blood bicarbonate  31  meq l; chemistry blood chloride  103  meq l; chemistry blood creatinine  0.7  mg dl; chemistry blood potassium  4.0  meq l; chemistry blood sodium  142  meq l; chemistry blood urea nitrogen  12  mg dl; chemistry blood calcium, total  9.3  mg dl; chemistry blood glucose  115  mg dl$pneumococcal vac polyvalent  0.5  ml ; sodium chloride 0.9%  flush  3  ml ; heparin  5000  unit ; ascorbic acid  1000  mg ; calcium carbonate  1000  mg ; omeprazole  20  mg ; vitamin d  1000  unit ; aspirin  325  mg ; oxybutynin  10  mg ; atorvastatin  80  mg ; clopidogrel  75  mg ; lisinopril  5  mg ; diazepam  2.5  mg ; acetaminophen  325-650  mg ; 0.9% sodium chloride  1000  ml ; metoprolol tartrate  25  mg ; diphenhydramine  25  mg ; 
 
white f 47 $nan$hematology blood hematocrit  35.6  %; hematology blood hematocrit  37.3  %; hematology blood hemoglobin  12.1  g dl; hematology blood hemoglobin  12.3  g dl; hematology blood platelet count  201  k ul; hematology blood platelet count  226  k ul; chemistry blood anion gap  10  meq l; chemistry blood bicarbonate  23  meq l; chemistry blood chloride  110  meq l; chemistry blood creatinine  1.0  mg dl; chemistry blood potassium  4.0  meq l; chemistry blood sodium  139  meq l; chemistry blood urea nitrogen  17  mg dl; hematology blood inr(pt)  1.1  ; chemistry blood glucose  96  mg dl$bisacodyl  10  mg ; citalopram  20  mg ; sodium chloride 0.9%  flush  3  ml ; potassium chl 20 meq   1000 ml d5ns  1000  ml ; acetaminophen  325-650  mg ; iso-osmotic dextrose  50  ml ; cefazolin  1  g ; milk of magnesia  30  ml ; 0.9% sodium chloride  100  ml ; hydromorphone  20  mg ; ondansetron  4  mg ; docusate sodium  100  mg ; topiramate (topamax)  150  mg ; promethazine  12.5  mg ; 
 
white f 47 $nan$hematology blood hematocrit  32.1  %; hematology blood hemoglobin  10.8  g dl; hematology blood platelet count  148  k ul; chemistry blood anion gap  9  meq l; chemistry blood bicarbonate  23  meq l; chemistry blood chloride  111  meq l; chemistry blood creatinine  0.8  mg dl; chemistry blood potassium  3.8  meq l; chemistry blood sodium  139  meq l; chemistry blood urea nitrogen  12  mg dl; chemistry blood calcium, total  8.0  mg dl; chemistry blood glucose  117  mg dl$bisacodyl  10  mg ; citalopram  20  mg ; sodium chloride 0.9%  flush  3  ml ; potassium chl 20 meq   1000 ml d5ns  1000  ml ; acetaminophen  325-650  mg ; iso-osmotic dextrose  50  ml ; cefazolin  1  g ; milk of magnesia  30  ml ; ondansetron  4  mg ; docusate sodium  100  mg ; topiramate (topamax)  150  mg ; promethazine  12.5  mg ; yellow cadd cassette  1  cadd ; bupivacaine 0.1%  250  ml ; diazepam  5  mg ; diphenhydramine  25  mg ; acetaminophen  650  mg ; 
 
white f 47 $nan$nan$bisacodyl  10  mg ; citalopram  20  mg ; sodium chloride 0.9%  flush  3  ml ; potassium chl 20 meq   1000 ml d5ns  1000  ml ; milk of magnesia  30  ml ; docusate sodium  100  mg ; topiramate (topamax)  150  mg ; diazepam  5  mg ; diphenhydramine  25  mg ; acetaminophen  650  mg ; bag  50  ml ; magnesium sulfate  2  gm ; phosphorus  250  mg ; 
 
white f 47 $nan$hematology blood hematocrit  32.9  %; hematology blood hemoglobin  11.1  g dl; hematology blood platelet count  182  k ul$bisacodyl  10  mg ; citalopram  20  mg ; sodium chloride 0.9%  flush  3  ml ; potassium chl 20 meq   1000 ml d5ns  1000  ml ; milk of magnesia  30  ml ; docusate sodium  100  mg ; topiramate (topamax)  150  mg ; diazepam  5  mg ; diphenhydramine  25  mg ; acetaminophen  650  mg ; bag  50  ml ; magnesium sulfate  2  gm ; phosphorus  250  mg ; hydromorphone (dilaudid)  2-4  mg ; 
 
white f 47 $nan$hematology blood hematocrit  34.0  %; hematology blood hemoglobin  11.7  g dl; hematology blood platelet count  218  k ul$bisacodyl  10  mg ; citalopram  20  mg ; sodium chloride 0.9%  flush  3  ml ; potassium chl 20 meq   1000 ml d5ns  1000  ml ; milk of magnesia  30  ml ; docusate sodium  100  mg ; topiramate (topamax)  150  mg ; diazepam  5  mg ; diphenhydramine  25  mg ; acetaminophen  650  mg ; hydromorphone (dilaudid)  2-4  mg ; oxycodone (immediate release)   5-10  mg ; methylnaltrexone  12  mg ; 
 
white f 47 $nan$nan$bisacodyl  10  mg ; citalopram  20  mg ; sodium chloride 0.9%  flush  3  ml ; potassium chl 20 meq   1000 ml d5ns  1000  ml ; milk of magnesia  30  ml ; docusate sodium  100  mg ; topiramate (topamax)  150  mg ; diazepam  5  mg ; diphenhydramine  25  mg ; acetaminophen  650  mg ; oxycodone (immediate release)   5-10  mg ; methylnaltrexone  12  mg ; magnesium citrate  300  ml ; 
 
white f 47 $nan$nan$bisacodyl  10  mg ; citalopram  20  mg ; sodium chloride 0.9%  flush  3  ml ; potassium chl 20 meq   1000 ml d5ns  1000  ml ; milk of magnesia  30  ml ; docusate sodium  100  mg ; topiramate (topamax)  150  mg ; diazepam  5  mg ; diphenhydramine  25  mg ; acetaminophen  650  mg ; oxycodone (immediate release)   5-10  mg ; magnesium citrate  300  ml ; 
 
white f 93 $temp  98.0  heartrate  112.0  resprate  18.0  o2sat  93.0  sbp  146.0  dbp  82.0  rhythm    pain  8  ; temp  97.9  heartrate  102.0  resprate  18.0  o2sat  93.0  sbp  115.0  dbp  77.0  rhythm    pain    ; temp  97.5  heartrate  97.0  resprate  16.0  o2sat  95.0  sbp  127.0  dbp  65.0  rhythm    pain    ; temp  98.3  heartrate  95.0  resprate  16.0  o2sat  93.0  sbp  135.0  dbp  69.0  rhythm    pain    $nan$acetaminophen  650  mg ; 
unspecified asthma, uncomplicated acute posthemorrhagic anemia anxiety disorder, unspecified unspecified place or not applicable displaced subtrochanteric fracture of right femur, subsequent encounter for closed fracture with routine healing essential (primary) hypertension exposure to other specified factors, subsequent encounter unspecified fall, initial encounter displaced supracondylar fracture without intracondylar extension of lower end of right femur, initial encounter for closed fracture 
white f 93 $temp  97.5  heartrate  84.0  resprate  18.0  o2sat  97.0  sbp  152.0  dbp  67.0  rhythm    pain  7  $hematology blood hematocrit  29.2  %; hematology blood hemoglobin  9.5  g dl; hematology blood platelet count  274  k ul; chemistry blood anion gap  8  meq l; chemistry blood bicarbonate  33  meq l; chemistry blood chloride  106  meq l; chemistry blood creatinine  1.0  mg dl; chemistry blood potassium  4.3  meq l; chemistry blood sodium  147  meq l; chemistry blood urea nitrogen  30  mg dl; hematology blood inr(pt)  1.2  ; chemistry blood calcium, total  8.8  mg dl; chemistry blood glucose  102  mg dl$acetaminophen  650  mg ; influenza vaccine quadrivalent  0.5  ml ; sodium chloride 0.9%  flush  3-10  ml ; oxycodone (immediate release)  2.5-5  mg ; morphine sulfate  1-2  mg ; bisacodyl  10  mg ; docusate sodium  100  mg ; fluticasone-salmeterol diskus (100 50)  1  inh ; verapamil  120  mg ; sodium chloride 0.9%  1000  ml ; bag  50  ml ; acetaminophen iv  500  mg ; 
unspecified asthma, uncomplicated acute posthemorrhagic anemia anxiety disorder, unspecified unspecified place or not applicable displaced subtrochanteric fracture of right femur, subsequent encounter for closed fracture with routine healing essential (primary) hypertension exposure to other specified factors, subsequent encounter unspecified fall, initial encounter displaced supracondylar fracture without intracondylar extension of lower end of right femur, initial encounter for closed fracture 
white f 93 $nan$hematology blood hematocrit  26.0  %; hematology blood hemoglobin  8.3  g dl; hematology blood platelet count  266  k ul; chemistry blood anion gap  11  meq l; chemistry blood bicarbonate  29  meq l; chemistry blood chloride  104  meq l; chemistry blood creatinine  0.8  mg dl; chemistry blood potassium  4.3  meq l; chemistry blood sodium  144  meq l; chemistry blood urea nitrogen  29  mg dl; chemistry blood calcium, total  8.6  mg dl; chemistry blood glucose  104  mg dl$influenza vaccine quadrivalent  0.5  ml ; sodium chloride 0.9%  flush  3-10  ml ; oxycodone (immediate release)  2.5-5  mg ; morphine sulfate  1-2  mg ; bisacodyl  10  mg ; docusate sodium  100  mg ; fluticasone-salmeterol diskus (100 50)  1  inh ; verapamil  120  mg ; sodium chloride 0.9%  1000  ml ; bag  50  ml ; acetaminophen iv  500  mg ; lactated ringers  1000  ml ; ondansetron  2  mg ; iso-osmotic dextrose  100  ml ; cefazolin  2  g ; acetaminophen iv  1000  mg ; ipratropium-albuterol neb  1  neb ; enoxaparin sodium  40  mg ; enoxaparin sodium  30  mg ; losartan potassium  25  mg ; apixaban  2.5  mg ; 
unspecified asthma, uncomplicated acute posthemorrhagic anemia anxiety disorder, unspecified unspecified place or not applicable displaced subtrochanteric fracture of right femur, subsequent encounter for closed fracture with routine healing essential (primary) hypertension exposure to other specified factors, subsequent encounter unspecified fall, initial encounter displaced supracondylar fracture without intracondylar extension of lower end of right femur, initial encounter for closed fracture 
white f 93 $nan$hematology blood hematocrit  25.3  %; hematology blood hemoglobin  8.0  g dl; hematology blood platelet count  267  k ul; chemistry blood anion gap  10  meq l; chemistry blood bicarbonate  31  meq l; chemistry blood chloride  104  meq l; chemistry blood creatinine  0.8  mg dl; chemistry blood potassium  4.1  meq l; chemistry blood sodium  145  meq l; chemistry blood urea nitrogen  26  mg dl; chemistry blood calcium, total  8.6  mg dl; chemistry blood glucose  103  mg dl$influenza vaccine quadrivalent  0.5  ml ; sodium chloride 0.9%  flush  3-10  ml ; bisacodyl  10  mg ; docusate sodium  100  mg ; fluticasone-salmeterol diskus (100 50)  1  inh ; lactated ringers  1000  ml ; ondansetron  2  mg ; acetaminophen iv  1000  mg ; ipratropium-albuterol neb  1  neb ; enoxaparin sodium  30  mg ; losartan potassium  25  mg ; apixaban  2.5  mg ; hydromorphone (dilaudid)  0.25-0.5  mg ; 
unspecified asthma, uncomplicated acute posthemorrhagic anemia anxiety disorder, unspecified unspecified place or not applicable displaced subtrochanteric fracture of right femur, subsequent encounter for closed fracture with routine healing essential (primary) hypertension exposure to other specified factors, subsequent encounter unspecified fall, initial encounter displaced supracondylar fracture without intracondylar extension of lower end of right femur, initial encounter for closed fracture 
white f 93 $nan$hematology blood hematocrit  27.7  %; hematology blood hematocrit  28.0  %; hematology blood hematocrit  25.6  %; hematology blood hemoglobin  8.6  g dl; hematology blood hemoglobin  8.8  g dl; hematology blood hemoglobin  8.2  g dl; hematology blood platelet count  300  k ul; hematology blood platelet count  331  k ul; hematology blood platelet count  293  k ul; chemistry blood anion gap  12  meq l; chemistry blood anion gap  16  meq l; chemistry blood bicarbonate  29  meq l; chemistry blood bicarbonate  21  meq l; chemistry blood chloride  105  meq l; chemistry blood chloride  106  meq l; chemistry blood creatinine  0.7  mg dl; chemistry blood creatinine  0.7  mg dl; chemistry blood potassium  4.6  meq l; chemistry blood potassium  3.6  meq l; chemistry blood sodium  143  meq l; chemistry blood sodium  146  meq l; chemistry blood urea nitrogen  28  mg dl; chemistry blood urea nitrogen  27  mg dl; chemistry blood calcium, total  9.2  mg dl; chemistry blood calcium, total  9.4  mg dl; chemistry blood glucose  125  mg dl; chemistry blood glucose  121  mg dl$iso-osmotic sodium chloride  1  bag ; bag  1  bag ; influenza vaccine quadrivalent  0.5  ml ; sodium chloride 0.9%  flush  3-10  ml ; bisacodyl  10  mg ; docusate sodium  100  mg ; fluticasone-salmeterol diskus (100 50)  1  inh ; lactated ringers  1000  ml ; ondansetron  2  mg ; acetaminophen iv  1000  mg ; ipratropium-albuterol neb  1  neb ; losartan potassium  25  mg ; apixaban  2.5  mg ; hydromorphone (dilaudid)  0.25-0.5  mg ; heparin  5000  unit ; famotidine  20  mg ; metoprolol tartrate  2.5  mg ; magnesium sulfate  4  gm ; sw  400  ml ; potassium chloride  40  meq ; sw  600  ml ; potassium chloride  60  meq ; sw  800  ml ; potassium chloride  80  meq ; 0.9% sodium chloride  100  ml ; calcium gluconate  2  g ; 0.9% sodium chloride  250  ml ; calcium gluconate  4  g ; sodium chloride 3% inhalation soln  15  ml ; hydralazine  10  mg ; 
unspecified asthma, uncomplicated acute posthemorrhagic anemia anxiety disorder, unspecified unspecified place or not applicable displaced subtrochanteric fracture of right femur, subsequent encounter for closed fracture with routine healing essential (primary) hypertension exposure to other specified factors, subsequent encounter unspecified fall, initial encounter displaced supracondylar fracture without intracondylar extension of lower end of right femur, initial encounter for closed fracture 
white f 93 $nan$hematology blood hematocrit  26.3  %; hematology blood hemoglobin  8.2  g dl; hematology blood platelet count  311  k ul; chemistry blood anion gap  15  meq l; chemistry blood bicarbonate  26  meq l; chemistry blood chloride  108  meq l; chemistry blood creatinine  0.6  mg dl; chemistry blood potassium  3.9  meq l; chemistry blood sodium  149  meq l; chemistry blood urea nitrogen  26  mg dl; hematology blood inr(pt)  1.3  ; chemistry blood calcium, total  9.0  mg dl; chemistry blood glucose  83  mg dl$iso-osmotic sodium chloride  1  bag ; bag  1  bag ; influenza vaccine quadrivalent  0.5  ml ; sodium chloride 0.9%  flush  3-10  ml ; bisacodyl  10  mg ; docusate sodium  100  mg ; fluticasone-salmeterol diskus (100 50)  1  inh ; lactated ringers  1000  ml ; ondansetron  2  mg ; acetaminophen iv  1000  mg ; hydromorphone (dilaudid)  0.25-0.5  mg ; heparin  5000  unit ; famotidine  20  mg ; metoprolol tartrate  2.5  mg ; magnesium sulfate  4  gm ; sw  400  ml ; potassium chloride  40  meq ; sw  600  ml ; potassium chloride  60  meq ; sw  800  ml ; potassium chloride  80  meq ; 0.9% sodium chloride  100  ml ; calcium gluconate  2  g ; 0.9% sodium chloride  250  ml ; calcium gluconate  4  g ; sodium chloride 3% inhalation soln  15  ml ; hydralazine  10  mg ; hyoscyamine  0.125  mg ; 
unspecified asthma, uncomplicated acute posthemorrhagic anemia anxiety disorder, unspecified unspecified place or not applicable displaced subtrochanteric fracture of right femur, subsequent encounter for closed fracture with routine healing essential (primary) hypertension exposure to other specified factors, subsequent encounter unspecified fall, initial encounter displaced supracondylar fracture without intracondylar extension of lower end of right femur, initial encounter for closed fracture 
white f 93 $nan$hematology blood hematocrit  24.9  %; hematology blood hemoglobin  7.7  g dl; hematology blood platelet count  324  k ul; chemistry blood anion gap  14  meq l; chemistry blood anion gap  16  meq l; chemistry blood bicarbonate  24  meq l; chemistry blood bicarbonate  26  meq l; chemistry blood chloride  109  meq l; chemistry blood chloride  107  meq l; chemistry blood creatinine  0.6  mg dl; chemistry blood creatinine  0.6  mg dl; chemistry blood potassium  3.6  meq l; chemistry blood potassium  3.9  meq l; chemistry blood sodium  147  meq l; chemistry blood sodium  149  meq l; chemistry blood urea nitrogen  26  mg dl; chemistry blood urea nitrogen  23  mg dl; hematology blood inr(pt)  1.3  ; chemistry blood calcium, total  9.2  mg dl; chemistry blood calcium, total  9.0  mg dl; chemistry blood glucose  105  mg dl; chemistry blood glucose  80  mg dl$iso-osmotic sodium chloride  1  bag ; influenza vaccine quadrivalent  0.5  ml ; sodium chloride 0.9%  flush  3-10  ml ; bisacodyl  10  mg ; docusate sodium  100  mg ; fluticasone-salmeterol diskus (100 50)  1  inh ; ondansetron  2  mg ; acetaminophen iv  1000  mg ; hydromorphone (dilaudid)  0.25-0.5  mg ; famotidine  20  mg ; hyoscyamine  0.125  mg ; 0.45% sodium chloride  1000  ml ; verapamil sr  240  mg ; multivitamins w minerals  1  tab ; thiamine  100  mg ; verapamil  80  mg ; metoprolol tartrate  5  mg ; 
unspecified asthma, uncomplicated acute posthemorrhagic anemia anxiety disorder, unspecified unspecified place or not applicable displaced subtrochanteric fracture of right femur, subsequent encounter for closed fracture with routine healing essential (primary) hypertension exposure to other specified factors, subsequent encounter unspecified fall, initial encounter displaced supracondylar fracture without intracondylar extension of lower end of right femur, initial encounter for closed fracture 
white f 93 $nan$hematology blood hematocrit  29.1  %; hematology blood hemoglobin  9.1  g dl; hematology blood platelet count  393  k ul; chemistry blood anion gap  16  meq l; chemistry blood bicarbonate  25  meq l; chemistry blood chloride  108  meq l; chemistry blood creatinine  0.5  mg dl; chemistry blood potassium  3.4  meq l; chemistry blood sodium  149  meq l; chemistry blood urea nitrogen  16  mg dl; hematology blood inr(pt)  1.3  ; chemistry blood calcium, total  9.2  mg dl; chemistry blood glucose  84  mg dl$influenza vaccine quadrivalent  0.5  ml ; sodium chloride 0.9%  flush  3-10  ml ; bisacodyl  10  mg ; fluticasone-salmeterol diskus (100 50)  1  inh ; ondansetron  2  mg ; hyoscyamine  0.125  mg ; metoprolol tartrate  5  mg ; hydralazine  5  mg ; d5 1 2ns  1000  ml ; 
unspecified asthma, uncomplicated acute posthemorrhagic anemia anxiety disorder, unspecified unspecified place or not applicable displaced subtrochanteric fracture of right femur, subsequent encounter for closed fracture with routine healing essential (primary) hypertension exposure to other specified factors, subsequent encounter unspecified fall, initial encounter displaced supracondylar fracture without intracondylar extension of lower end of right femur, initial encounter for closed fracture 
white f 93 $nan$nan$influenza vaccine quadrivalent  0.5  ml ; sodium chloride 0.9%  flush  3-10  ml ; bisacodyl  10  mg ; fluticasone-salmeterol diskus (100 50)  1  inh ; ondansetron  2  mg ; 
unspecified asthma, uncomplicated acute posthemorrhagic anemia anxiety disorder, unspecified unspecified place or not applicable displaced subtrochanteric fracture of right femur, subsequent encounter for closed fracture with routine healing essential (primary) hypertension exposure to other specified factors, subsequent encounter unspecified fall, initial encounter displaced supracondylar fracture without intracondylar extension of lower end of right femur, initial encounter for closed fracture 
black african american m 47 $temp    heartrate  94.0  resprate  18.0  o2sat  97.0  sbp  162.0  dbp  101.0  rhythm    pain    ; temp    heartrate  96.0  resprate    o2sat  97.0  sbp  171.0  dbp  99.0  rhythm    pain    $hematology blood hematocrit  40.3  %; hematology blood hemoglobin  12.8  g dl; hematology blood platelet count  223  k ul; chemistry blood anion gap  13  meq l; chemistry blood bicarbonate  26  meq l; chemistry blood chloride  106  meq l; chemistry blood creatinine  1.4  mg dl; chemistry blood potassium  3.8  meq l; chemistry blood sodium  145  meq l; chemistry blood urea nitrogen  17  mg dl; hematology blood inr(pt)  1.3  ; chemistry blood calcium, total  8.8  mg dl; chemistry blood bilirubin, total  0.3  mg dl; chemistry blood glucose  108  mg dl; chemistry blood lactate dehydrogenase (ld)  201  iu l; chemistry blood albumin  3.9  g dl$influenza vaccine quadrivalent  0.5  ml ; acetaminophen  650  mg ; hydralazine  10  mg ; 0.83% sodium chloride  200  ml ; nicardipine iv  40  mg ; captopril  12.5  mg ; gastroview (diatrizoate meglumine & sodium)  30  ml ; sodium chloride 0.9%  1000  ml ; 
 
black african american m 47 $nan$nan$influenza vaccine quadrivalent  0.5  ml ; acetaminophen  650  mg ; hydralazine  10  mg ; 0.83% sodium chloride  200  ml ; nicardipine iv  40  mg ; captopril  12.5  mg ; gastroview (diatrizoate meglumine & sodium)  30  ml ; sodium chloride 0.9%  1000  ml ; captopril  25  mg ; 
 
black african american m 47 $nan$chemistry blood anion gap  9  meq l; chemistry blood bicarbonate  26  meq l; chemistry blood chloride  108  meq l; chemistry blood creatinine  1.2  mg dl; chemistry blood potassium  4.0  meq l; chemistry blood sodium  143  meq l; chemistry blood urea nitrogen  16  mg dl; chemistry blood calcium, total  9.3  mg dl; chemistry blood glucose  98  mg dl$influenza vaccine quadrivalent  0.5  ml ; acetaminophen  650  mg ; hydralazine  10  mg ; 0.83% sodium chloride  200  ml ; nicardipine iv  40  mg ; captopril  25  mg ; hydralazine  10-20  mg ; captopril  37.5  mg ; 
 
black african american m 47 $nan$chemistry blood anion gap  13  meq l; chemistry blood bicarbonate  24  meq l; chemistry blood chloride  108  meq l; chemistry blood creatinine  1.3  mg dl; chemistry blood potassium  4.2  meq l; chemistry blood sodium  145  meq l; chemistry blood urea nitrogen  17  mg dl; chemistry blood calcium, total  9.3  mg dl; chemistry blood glucose  98  mg dl$influenza vaccine quadrivalent  0.5  ml ; acetaminophen  650  mg ; 0.83% sodium chloride  200  ml ; nicardipine iv  40  mg ; hydralazine  10-20  mg ; captopril  37.5  mg ; hydrochlorothiazide  12.5  mg ; captopril  50  mg ; 
 
black african american m 47 $nan$nan$influenza vaccine quadrivalent  0.5  ml ; acetaminophen  650  mg ; 0.83% sodium chloride  200  ml ; nicardipine iv  40  mg ; hydralazine  10-20  mg ; hydrochlorothiazide  12.5  mg ; captopril  50  mg ; 
 
black african american m 47 $nan$nan$influenza vaccine quadrivalent  0.5  ml ; acetaminophen  650  mg ; 0.83% sodium chloride  200  ml ; nicardipine iv  40  mg ; hydralazine  10-20  mg ; hydrochlorothiazide  12.5  mg ; lisinopril  40  mg ; 
 
black african american f 40 $nan$hematology blood hematocrit  31.5  %; hematology blood hemoglobin  10.6  g dl; hematology blood platelet count  226  k ul; hematology urine wbc  2  # hpf$lr  1000  ml ; naloxone hcl  40-80  mcg ; naloxone hcl  0.4  mg ; metoclopramide  10  mg ; ketorolac  15-30  mg ; ondansetron  4  mg ; sodium chloride 0.9%  flush  3  ml ; sodium citrate  30  ml ; oxytocin  20  unit ; docusate sodium  100  mg ; oxycodone-acetaminophen  1-2  tab ; ibuprofen  600  mg ; acetaminophen  500-1000  mg ; bisacodyl  10  mg ; milk of magnesia  30  ml ; dibucaine  1  appl ; simethicone  80  mg ; calcium carbonate  500  mg ; 
 
black african american f 40 $nan$nan$lr  1000  ml ; naloxone hcl  40-80  mcg ; naloxone hcl  0.4  mg ; metoclopramide  10  mg ; ketorolac  15-30  mg ; ondansetron  4  mg ; sodium chloride 0.9%  flush  3  ml ; sodium citrate  30  ml ; oxytocin  20  unit ; docusate sodium  100  mg ; oxycodone-acetaminophen  1-2  tab ; ibuprofen  600  mg ; acetaminophen  500-1000  mg ; bisacodyl  10  mg ; milk of magnesia  30  ml ; dibucaine  1  appl ; simethicone  80  mg ; calcium carbonate  500  mg ; 
 
black african american f 40 $nan$hematology blood hematocrit  26.7  %$lr  1000  ml ; naloxone hcl  40-80  mcg ; naloxone hcl  0.4  mg ; metoclopramide  10  mg ; ondansetron  4  mg ; sodium chloride 0.9%  flush  3  ml ; sodium citrate  30  ml ; oxytocin  20  unit ; docusate sodium  100  mg ; oxycodone-acetaminophen  1-2  tab ; ibuprofen  600  mg ; acetaminophen  500-1000  mg ; bisacodyl  10  mg ; milk of magnesia  30  ml ; dibucaine  1  appl ; simethicone  80  mg ; calcium carbonate  500  mg ; 
 
black african american f 40 $nan$nan$lr  1000  ml ; naloxone hcl  40-80  mcg ; naloxone hcl  0.4  mg ; metoclopramide  10  mg ; ondansetron  4  mg ; sodium chloride 0.9%  flush  3  ml ; sodium citrate  30  ml ; oxytocin  20  unit ; docusate sodium  100  mg ; oxycodone-acetaminophen  1-2  tab ; ibuprofen  600  mg ; acetaminophen  500-1000  mg ; bisacodyl  10  mg ; milk of magnesia  30  ml ; dibucaine  1  appl ; simethicone  80  mg ; calcium carbonate  500  mg ; 
 
white f 69 $nan$nan$atenolol  25  mg ; lisinopril  30  mg ; levothyroxine sodium  125  mcg ; atorvastatin  80  mg ; enoxaparin sodium  40  mg ; 
 
white f 69 $nan$nan$atenolol  25  mg ; lisinopril  30  mg ; levothyroxine sodium  125  mcg ; atorvastatin  80  mg ; enoxaparin sodium  40  mg ; influenza virus vaccine  0.5  ml ; pneumococcal vac polyvalent  0.5  ml ; sodium chloride 0.9%  flush  3  ml ; potassium chl 20 meq   1000 ml d5 1 2 ns  1000  ml ; acetaminophen  650  mg ; oxycodone (immediate release)   5-10  mg ; senna  1  tab ; docusate sodium  100  mg ; lorazepam  0.25  mg ; dextrose 50%  12.5  gm ; glucagon  1  mg ; insulin  0  unit ; ondansetron  4  mg ; hydromorphone (dilaudid)  0.5-1  mg ; d5 1 2ns  1000  ml ; 0.9% sodium chloride  100  ml ; cefazolin  2  gm ; 
 
white f 69 $nan$hematology blood hematocrit  34.6  %; hematology blood hemoglobin  11.9  g dl; hematology blood platelet count  305  k ul; chemistry blood anion gap  14  meq l; chemistry blood bicarbonate  29  meq l; chemistry blood chloride  104  meq l; chemistry blood creatinine  1.1  mg dl; chemistry blood potassium  4.1  meq l; chemistry blood sodium  143  meq l; chemistry blood urea nitrogen  20  mg dl; chemistry blood calcium, total  9.4  mg dl; chemistry blood glucose  160  mg dl$atenolol  25  mg ; lisinopril  30  mg ; levothyroxine sodium  125  mcg ; atorvastatin  80  mg ; enoxaparin sodium  40  mg ; sodium chloride 0.9%  flush  3  ml ; oxycodone (immediate release)   5-10  mg ; senna  1  tab ; docusate sodium  100  mg ; lorazepam  0.25  mg ; dextrose 50%  12.5  gm ; glucagon  1  mg ; insulin  0  unit ; ondansetron  4  mg ; hydromorphone (dilaudid)  0.5-1  mg ; d5 1 2ns  1000  ml ; 0.9% sodium chloride  100  ml ; cefazolin  2  gm ; metformin xr (glucophage xr)  500  mg ; 
 
white f 69 $nan$nan$atenolol  25  mg ; lisinopril  30  mg ; levothyroxine sodium  125  mcg ; atorvastatin  80  mg ; enoxaparin sodium  40  mg ; sodium chloride 0.9%  flush  3  ml ; oxycodone (immediate release)   5-10  mg ; senna  1  tab ; docusate sodium  100  mg ; lorazepam  0.25  mg ; dextrose 50%  12.5  gm ; glucagon  1  mg ; insulin  0  unit ; ondansetron  4  mg ; hydromorphone (dilaudid)  0.5-1  mg ; d5 1 2ns  1000  ml ; 0.9% sodium chloride  100  ml ; cefazolin  2  gm ; metformin xr (glucophage xr)  500  mg ; 
 
white f 69 $nan$nan$atenolol  25  mg ; lisinopril  30  mg ; levothyroxine sodium  125  mcg ; atorvastatin  80  mg ; enoxaparin sodium  40  mg ; sodium chloride 0.9%  flush  3  ml ; oxycodone (immediate release)   5-10  mg ; senna  1  tab ; docusate sodium  100  mg ; lorazepam  0.25  mg ; dextrose 50%  12.5  gm ; glucagon  1  mg ; insulin  0  unit ; ondansetron  4  mg ; hydromorphone (dilaudid)  0.5-1  mg ; d5 1 2ns  1000  ml ; 0.9% sodium chloride  100  ml ; cefazolin  2  gm ; metformin xr (glucophage xr)  500  mg ; 
 
white f 96 $temp    heartrate  73.0  resprate  20.0  o2sat    sbp  158.0  dbp  55.0  rhythm    pain    ; temp  97.9  heartrate  69.0  resprate  22.0  o2sat  100.0  sbp  157.0  dbp  52.0  rhythm    pain  0  $hematology blood hematocrit  33.0  %; hematology blood hemoglobin  9.4  g dl; hematology blood platelet count  208  k ul; chemistry blood anion gap  9  meq l; chemistry blood bicarbonate  42  meq l; chemistry blood chloride  94  meq l; chemistry blood creatinine  0.8  mg dl; chemistry blood potassium  5.1  meq l; chemistry blood sodium  145  meq l; chemistry blood urea nitrogen  16  mg dl; hematology blood inr(pt)  1.0  ; chemistry blood calcium, total  9.3  mg dl; chemistry blood glucose  100  mg dl; blood gas blood lactate  0.7  mmol l$iso-osmotic dextrose  200  ml ; influenza vaccine quadrivalent  0.5  ml ; sodium chloride 0.9%  flush  3-10  ml ; sodium chloride 0.9%  1000  ml ; docusate sodium  100  mg ; senna  8.6  mg ; acetaminophen  650  mg ; heparin  5000  unit ; hydralazine  10  mg ; albuterol 0.083% neb soln  2  neb ; atorvastatin  40  mg ; diltiazem extended-release  120  mg ; furosemide  20  mg ; gabapentin  300  mg ; cyanocobalamin  500  mcg ; isosorbide mononitrate (extended release)  30  mg ; ranitidine  150  mg ; vancomycin  1000  mg ; vial  1  vial ; cefepime  2  g ; iso-osmotic dextrose  150  ml ; vancomycin  750  mg ; 
decreased white blood cell count, unspecified dependence on supplemental oxygen hypertensive heart and chronic kidney disease with heart failure and stage 1 through stage 4 chronic kidney disease, or unspecified chronic kidney disease chronic kidney disease, unspecified paroxysmal atrial fibrillation nutritional anemia, unspecified personal history of malignant neoplasm of other parts of uterus acute and chronic respiratory failure with hypoxia presence of artificial knee joint, bilateral do not resuscitate diarrhea, unspecified chronic respiratory failure with hypercapnia low back pain other disorders of lung acute on chronic diastolic (congestive) heart failure other chronic pain old myocardial infarction gastro-esophageal reflux disease without esophagitis pneumonia, unspecified organism hyperlipidemia, unspecified other chronic pain presence of artificial knee joint, bilateral paroxysmal atrial fibrillation hypo-osmolality and hyponatremia chronic kidney disease, unspecified hyperlipidemia, unspecified chronic respiratory failure with hypercapnia chronic diastolic (congestive) heart failure chronic respiratory failure with hypoxia pseudomonas (aeruginosa) (mallei) (pseudomallei) as the cause of diseases classified elsewhere dehydration personal history of other malignant neoplasm of bronchus and lung acquired absence of both cervix and uterus unspecified escherichia coli [e. coli] as the cause of diseases classified elsewhere dependence on supplemental oxygen do not resuscitate personal history of malignant neoplasm of other parts of uterus hypertensive heart and chronic kidney disease with heart failure and stage 1 through stage 4 chronic kidney disease, or unspecified chronic kidney disease alkalosis atherosclerotic heart disease of native coronary artery without angina pectoris urinary tract infection, site not specified hypertensive heart and chronic kidney disease with heart failure and stage 1 through stage 4 chronic kidney disease, or unspecified chronic kidney disease presence of artificial knee joint, bilateral family history of malignant neoplasm of breast chronic diastolic (congestive) heart failure other chronic pain other disorders of lung paroxysmal atrial fibrillation
white f 96 $nan$hematology blood hematocrit  33.0  %; hematology blood hemoglobin  9.6  g dl; hematology blood platelet count  231  k ul; chemistry blood anion gap  9  meq l; chemistry blood bicarbonate  46  meq l; chemistry blood chloride  85  meq l; chemistry blood creatinine  0.8  mg dl; chemistry blood potassium  3.6  meq l; chemistry blood sodium  142  meq l; chemistry blood urea nitrogen  15  mg dl; chemistry blood calcium, total  9.7  mg dl; chemistry blood glucose  106  mg dl$influenza vaccine quadrivalent  0.5  ml ; sodium chloride 0.9%  flush  3-10  ml ; docusate sodium  100  mg ; senna  8.6  mg ; acetaminophen  650  mg ; heparin  5000  unit ; hydralazine  10  mg ; albuterol 0.083% neb soln  2  neb ; atorvastatin  40  mg ; diltiazem extended-release  120  mg ; furosemide  20  mg ; gabapentin  300  mg ; cyanocobalamin  500  mcg ; isosorbide mononitrate (extended release)  30  mg ; ranitidine  150  mg ; ipratropium-albuterol neb  1  neb ; potassium chloride  40  meq ; 
decreased white blood cell count, unspecified dependence on supplemental oxygen hypertensive heart and chronic kidney disease with heart failure and stage 1 through stage 4 chronic kidney disease, or unspecified chronic kidney disease chronic kidney disease, unspecified paroxysmal atrial fibrillation nutritional anemia, unspecified personal history of malignant neoplasm of other parts of uterus acute and chronic respiratory failure with hypoxia presence of artificial knee joint, bilateral do not resuscitate diarrhea, unspecified chronic respiratory failure with hypercapnia low back pain other disorders of lung acute on chronic diastolic (congestive) heart failure other chronic pain old myocardial infarction gastro-esophageal reflux disease without esophagitis pneumonia, unspecified organism hyperlipidemia, unspecified other chronic pain presence of artificial knee joint, bilateral paroxysmal atrial fibrillation hypo-osmolality and hyponatremia chronic kidney disease, unspecified hyperlipidemia, unspecified chronic respiratory failure with hypercapnia chronic diastolic (congestive) heart failure chronic respiratory failure with hypoxia pseudomonas (aeruginosa) (mallei) (pseudomallei) as the cause of diseases classified elsewhere dehydration personal history of other malignant neoplasm of bronchus and lung acquired absence of both cervix and uterus unspecified escherichia coli [e. coli] as the cause of diseases classified elsewhere dependence on supplemental oxygen do not resuscitate personal history of malignant neoplasm of other parts of uterus hypertensive heart and chronic kidney disease with heart failure and stage 1 through stage 4 chronic kidney disease, or unspecified chronic kidney disease alkalosis atherosclerotic heart disease of native coronary artery without angina pectoris urinary tract infection, site not specified hypertensive heart and chronic kidney disease with heart failure and stage 1 through stage 4 chronic kidney disease, or unspecified chronic kidney disease presence of artificial knee joint, bilateral family history of malignant neoplasm of breast chronic diastolic (congestive) heart failure other chronic pain other disorders of lung paroxysmal atrial fibrillation
white f 96 $nan$hematology blood hematocrit  32.3  %; hematology blood hematocrit  32.4  %; hematology blood hemoglobin  9.2  g dl; hematology blood hemoglobin  9.3  g dl; hematology blood platelet count  194  k ul; hematology blood platelet count  189  k ul; chemistry blood anion gap  17  meq l; chemistry blood anion gap  12  meq l; chemistry blood bicarbonate  40  meq l; chemistry blood bicarbonate  44  meq l; chemistry blood chloride  86  meq l; chemistry blood chloride  86  meq l; chemistry blood creatinine  0.9  mg dl; chemistry blood creatinine  0.9  mg dl; chemistry blood potassium  3.8  meq l; chemistry blood potassium  4.0  meq l; chemistry blood sodium  143  meq l; chemistry blood sodium  142  meq l; chemistry blood urea nitrogen  18  mg dl; chemistry blood urea nitrogen  17  mg dl; chemistry blood calcium, total  9.2  mg dl; chemistry blood calcium, total  9.6  mg dl; chemistry blood glucose  117  mg dl; chemistry blood glucose  113  mg dl$influenza vaccine quadrivalent  0.5  ml ; sodium chloride 0.9%  flush  3-10  ml ; docusate sodium  100  mg ; senna  8.6  mg ; heparin  5000  unit ; atorvastatin  40  mg ; diltiazem extended-release  120  mg ; gabapentin  300  mg ; cyanocobalamin  500  mcg ; isosorbide mononitrate (extended release)  30  mg ; ranitidine  150  mg ; ipratropium-albuterol neb  1  neb ; potassium chloride  40  meq ; trazodone  25  mg ; furosemide  40  mg ; 
decreased white blood cell count, unspecified dependence on supplemental oxygen hypertensive heart and chronic kidney disease with heart failure and stage 1 through stage 4 chronic kidney disease, or unspecified chronic kidney disease chronic kidney disease, unspecified paroxysmal atrial fibrillation nutritional anemia, unspecified personal history of malignant neoplasm of other parts of uterus acute and chronic respiratory failure with hypoxia presence of artificial knee joint, bilateral do not resuscitate diarrhea, unspecified chronic respiratory failure with hypercapnia low back pain other disorders of lung acute on chronic diastolic (congestive) heart failure other chronic pain old myocardial infarction gastro-esophageal reflux disease without esophagitis pneumonia, unspecified organism hyperlipidemia, unspecified other chronic pain presence of artificial knee joint, bilateral paroxysmal atrial fibrillation hypo-osmolality and hyponatremia chronic kidney disease, unspecified hyperlipidemia, unspecified chronic respiratory failure with hypercapnia chronic diastolic (congestive) heart failure chronic respiratory failure with hypoxia pseudomonas (aeruginosa) (mallei) (pseudomallei) as the cause of diseases classified elsewhere dehydration personal history of other malignant neoplasm of bronchus and lung acquired absence of both cervix and uterus unspecified escherichia coli [e. coli] as the cause of diseases classified elsewhere dependence on supplemental oxygen do not resuscitate personal history of malignant neoplasm of other parts of uterus hypertensive heart and chronic kidney disease with heart failure and stage 1 through stage 4 chronic kidney disease, or unspecified chronic kidney disease alkalosis atherosclerotic heart disease of native coronary artery without angina pectoris urinary tract infection, site not specified hypertensive heart and chronic kidney disease with heart failure and stage 1 through stage 4 chronic kidney disease, or unspecified chronic kidney disease presence of artificial knee joint, bilateral family history of malignant neoplasm of breast chronic diastolic (congestive) heart failure other chronic pain other disorders of lung paroxysmal atrial fibrillation
white f 96 $nan$hematology blood hematocrit  31.0  %; hematology blood hemoglobin  9.2  g dl; hematology blood platelet count  194  k ul; chemistry blood anion gap  13  meq l; chemistry blood anion gap  9  meq l; chemistry blood bicarbonate  42  meq l; chemistry blood bicarbonate  45  meq l; chemistry blood chloride  89  meq l; chemistry blood chloride  87  meq l; chemistry blood creatinine  0.9  mg dl; chemistry blood creatinine  0.9  mg dl; chemistry blood potassium  4.6  meq l; chemistry blood potassium  4.4  meq l; chemistry blood sodium  142  meq l; chemistry blood sodium  143  meq l; chemistry blood urea nitrogen  21  mg dl; chemistry blood urea nitrogen  21  mg dl; chemistry blood calcium, total  9.5  mg dl; chemistry blood calcium, total  9.5  mg dl; chemistry blood glucose  96  mg dl; chemistry blood glucose  80  mg dl; blood gas blood lactate  1.1  mmol l; blood gas blood lactate  1.2  mmol l$influenza vaccine quadrivalent  0.5  ml ; sodium chloride 0.9%  flush  3-10  ml ; docusate sodium  100  mg ; senna  8.6  mg ; heparin  5000  unit ; atorvastatin  40  mg ; diltiazem extended-release  120  mg ; gabapentin  300  mg ; cyanocobalamin  500  mcg ; isosorbide mononitrate (extended release)  30  mg ; ranitidine  150  mg ; ipratropium-albuterol neb  1  neb ; potassium chloride  40  meq ; furosemide  40  mg ; gabapentin  100  mg ; furosemide  80  mg ; 
decreased white blood cell count, unspecified dependence on supplemental oxygen hypertensive heart and chronic kidney disease with heart failure and stage 1 through stage 4 chronic kidney disease, or unspecified chronic kidney disease chronic kidney disease, unspecified paroxysmal atrial fibrillation nutritional anemia, unspecified personal history of malignant neoplasm of other parts of uterus acute and chronic respiratory failure with hypoxia presence of artificial knee joint, bilateral do not resuscitate diarrhea, unspecified chronic respiratory failure with hypercapnia low back pain other disorders of lung acute on chronic diastolic (congestive) heart failure other chronic pain old myocardial infarction gastro-esophageal reflux disease without esophagitis pneumonia, unspecified organism hyperlipidemia, unspecified other chronic pain presence of artificial knee joint, bilateral paroxysmal atrial fibrillation hypo-osmolality and hyponatremia chronic kidney disease, unspecified hyperlipidemia, unspecified chronic respiratory failure with hypercapnia chronic diastolic (congestive) heart failure chronic respiratory failure with hypoxia pseudomonas (aeruginosa) (mallei) (pseudomallei) as the cause of diseases classified elsewhere dehydration personal history of other malignant neoplasm of bronchus and lung acquired absence of both cervix and uterus unspecified escherichia coli [e. coli] as the cause of diseases classified elsewhere dependence on supplemental oxygen do not resuscitate personal history of malignant neoplasm of other parts of uterus hypertensive heart and chronic kidney disease with heart failure and stage 1 through stage 4 chronic kidney disease, or unspecified chronic kidney disease alkalosis atherosclerotic heart disease of native coronary artery without angina pectoris urinary tract infection, site not specified hypertensive heart and chronic kidney disease with heart failure and stage 1 through stage 4 chronic kidney disease, or unspecified chronic kidney disease presence of artificial knee joint, bilateral family history of malignant neoplasm of breast chronic diastolic (congestive) heart failure other chronic pain other disorders of lung paroxysmal atrial fibrillation
white f 96 $nan$hematology blood hematocrit  31.3  %; hematology blood hemoglobin  9.4  g dl; hematology blood platelet count  195  k ul; chemistry blood anion gap  12  meq l; chemistry blood bicarbonate  43  meq l; chemistry blood chloride  90  meq l; chemistry blood creatinine  1.0  mg dl; chemistry blood potassium  3.7  meq l; chemistry blood sodium  145  meq l; chemistry blood urea nitrogen  26  mg dl; chemistry blood calcium, total  9.5  mg dl; chemistry blood glucose  101  mg dl$docusate sodium  100  mg ; senna  8.6  mg ; diltiazem extended-release  120  mg ; isosorbide mononitrate (extended release)  30  mg ; ranitidine  150  mg ; ipratropium-albuterol neb  1  neb ; gabapentin  100  mg ; miconazole powder 2%  1  appl ; 
decreased white blood cell count, unspecified dependence on supplemental oxygen hypertensive heart and chronic kidney disease with heart failure and stage 1 through stage 4 chronic kidney disease, or unspecified chronic kidney disease chronic kidney disease, unspecified paroxysmal atrial fibrillation nutritional anemia, unspecified personal history of malignant neoplasm of other parts of uterus acute and chronic respiratory failure with hypoxia presence of artificial knee joint, bilateral do not resuscitate diarrhea, unspecified chronic respiratory failure with hypercapnia low back pain other disorders of lung acute on chronic diastolic (congestive) heart failure other chronic pain old myocardial infarction gastro-esophageal reflux disease without esophagitis pneumonia, unspecified organism hyperlipidemia, unspecified other chronic pain presence of artificial knee joint, bilateral paroxysmal atrial fibrillation hypo-osmolality and hyponatremia chronic kidney disease, unspecified hyperlipidemia, unspecified chronic respiratory failure with hypercapnia chronic diastolic (congestive) heart failure chronic respiratory failure with hypoxia pseudomonas (aeruginosa) (mallei) (pseudomallei) as the cause of diseases classified elsewhere dehydration personal history of other malignant neoplasm of bronchus and lung acquired absence of both cervix and uterus unspecified escherichia coli [e. coli] as the cause of diseases classified elsewhere dependence on supplemental oxygen do not resuscitate personal history of malignant neoplasm of other parts of uterus hypertensive heart and chronic kidney disease with heart failure and stage 1 through stage 4 chronic kidney disease, or unspecified chronic kidney disease alkalosis atherosclerotic heart disease of native coronary artery without angina pectoris urinary tract infection, site not specified hypertensive heart and chronic kidney disease with heart failure and stage 1 through stage 4 chronic kidney disease, or unspecified chronic kidney disease presence of artificial knee joint, bilateral family history of malignant neoplasm of breast chronic diastolic (congestive) heart failure other chronic pain other disorders of lung paroxysmal atrial fibrillation
white f 96 $nan$nan$docusate sodium  100  mg ; senna  8.6  mg ; diltiazem extended-release  120  mg ; isosorbide mononitrate (extended release)  30  mg ; ranitidine  150  mg ; ipratropium-albuterol neb  1  neb ; gabapentin  100  mg ; miconazole powder 2%  1  appl ; 
decreased white blood cell count, unspecified dependence on supplemental oxygen hypertensive heart and chronic kidney disease with heart failure and stage 1 through stage 4 chronic kidney disease, or unspecified chronic kidney disease chronic kidney disease, unspecified paroxysmal atrial fibrillation nutritional anemia, unspecified personal history of malignant neoplasm of other parts of uterus acute and chronic respiratory failure with hypoxia presence of artificial knee joint, bilateral do not resuscitate diarrhea, unspecified chronic respiratory failure with hypercapnia low back pain other disorders of lung acute on chronic diastolic (congestive) heart failure other chronic pain old myocardial infarction gastro-esophageal reflux disease without esophagitis pneumonia, unspecified organism hyperlipidemia, unspecified other chronic pain presence of artificial knee joint, bilateral paroxysmal atrial fibrillation hypo-osmolality and hyponatremia chronic kidney disease, unspecified hyperlipidemia, unspecified chronic respiratory failure with hypercapnia chronic diastolic (congestive) heart failure chronic respiratory failure with hypoxia pseudomonas (aeruginosa) (mallei) (pseudomallei) as the cause of diseases classified elsewhere dehydration personal history of other malignant neoplasm of bronchus and lung acquired absence of both cervix and uterus unspecified escherichia coli [e. coli] as the cause of diseases classified elsewhere dependence on supplemental oxygen do not resuscitate personal history of malignant neoplasm of other parts of uterus hypertensive heart and chronic kidney disease with heart failure and stage 1 through stage 4 chronic kidney disease, or unspecified chronic kidney disease alkalosis atherosclerotic heart disease of native coronary artery without angina pectoris urinary tract infection, site not specified hypertensive heart and chronic kidney disease with heart failure and stage 1 through stage 4 chronic kidney disease, or unspecified chronic kidney disease presence of artificial knee joint, bilateral family history of malignant neoplasm of breast chronic diastolic (congestive) heart failure other chronic pain other disorders of lung paroxysmal atrial fibrillation
hispanic latino f 32 $nan$hematology blood hematocrit  27.3  %$sodium chloride 0.9%  flush  3  ml ; oxytocin  20  unit ; lr  1000  ml ; docusate sodium  100  mg ; oxycodone-acetaminophen  1-2  tab ; ibuprofen  600  mg ; codeine sulfate  30-60  mg ; acetaminophen  500-1000  mg ; bisacodyl  10  mg ; milk of magnesia  30  ml ; dibucaine  1  appl ; simethicone  80  mg ; 
 
hispanic latino f 32 $nan$nan$sodium chloride 0.9%  flush  3  ml ; oxytocin  20  unit ; lr  1000  ml ; docusate sodium  100  mg ; oxycodone-acetaminophen  1-2  tab ; ibuprofen  600  mg ; codeine sulfate  30-60  mg ; acetaminophen  500-1000  mg ; bisacodyl  10  mg ; milk of magnesia  30  ml ; dibucaine  1  appl ; simethicone  80  mg ; 
 
hispanic latino f 32 $nan$nan$sodium chloride 0.9%  flush  3  ml ; oxytocin  20  unit ; lr  1000  ml ; docusate sodium  100  mg ; oxycodone-acetaminophen  1-2  tab ; ibuprofen  600  mg ; codeine sulfate  30-60  mg ; acetaminophen  500-1000  mg ; bisacodyl  10  mg ; milk of magnesia  30  ml ; dibucaine  1  appl ; simethicone  80  mg ; 
 
black african american f 80 $temp  96.2  heartrate  117.0  resprate  16.0  o2sat  100.0  sbp  138.0  dbp  62.0  rhythm    pain  0  ; temp    heartrate  108.0  resprate  18.0  o2sat  100.0  sbp    dbp    rhythm    pain  0  ; temp    heartrate  101.0  resprate  20.0  o2sat  98.0  sbp  140.0  dbp  67.0  rhythm    pain  0  $hematology blood hematocrit  22.6  %; hematology blood hemoglobin  7.3  g dl; hematology blood platelet count  196  k ul; chemistry blood anion gap  14  meq l; chemistry blood bicarbonate  27  meq l; chemistry blood chloride  102  meq l; chemistry blood creatinine  1.0  mg dl; chemistry blood potassium  4.2  meq l; chemistry blood sodium  139  meq l; chemistry blood urea nitrogen  33  mg dl; hematology blood inr(pt)  1.0  ; chemistry blood calcium, total  9.5  mg dl; chemistry blood glucose  165  mg dl; chemistry blood lactate dehydrogenase (ld)  123  iu l; blood gas blood lactate  1.6  mmol l$nan
 
black african american f 80 $temp  98.7  heartrate  102.0  resprate  18.0  o2sat  98.0  sbp  122.0  dbp  57.0  rhythm    pain  0  $hematology blood hematocrit  20.5  %; hematology blood hematocrit  26.0  %; hematology blood hematocrit  26.0  %; hematology blood hematocrit  27.6  %; hematology blood hemoglobin  6.6  g dl; hematology blood hemoglobin  8.7  g dl; hematology blood hemoglobin  8.8  g dl; hematology blood platelet count  161  k ul; hematology blood platelet count  126  k ul; hematology blood platelet count  128  k ul; chemistry blood anion gap  15  meq l; chemistry blood bicarbonate  18  meq l; chemistry blood chloride  111  meq l; chemistry blood creatinine  0.8  mg dl; chemistry blood potassium  3.6  meq l; chemistry blood sodium  140  meq l; chemistry blood urea nitrogen  35  mg dl; chemistry blood bilirubin, total  0.4  mg dl; chemistry blood glucose  249  mg dl$pneumococcal 23-valent polysaccharide vaccine  0.5  ml ; sodium chloride 0.9%  flush  3  ml ; sodium chloride 0.9%  1000  ml ; acetaminophen  650  mg ; vial  1  vial ; pantoprazole  40  mg ; dextrose 50%  12.5  gm ; glucagon  1  mg ; glucose gel  15  g ; insulin  0  unit ; lactated ringers  1000  ml ; moviprep  1  l ; 
 
black african american f 80 $nan$hematology blood hematocrit  25.9  %; hematology blood hematocrit  29.3  %; hematology blood hemoglobin  8.5  g dl; hematology blood hemoglobin  9.5  g dl; hematology blood platelet count  130  k ul; hematology blood platelet count  149  k ul; chemistry blood anion gap  9  meq l; chemistry blood bicarbonate  25  meq l; chemistry blood chloride  115  meq l; chemistry blood creatinine  0.8  mg dl; chemistry blood potassium  3.6  meq l; chemistry blood sodium  145  meq l; chemistry blood urea nitrogen  16  mg dl; chemistry blood glucose  125  mg dl$pneumococcal 23-valent polysaccharide vaccine  0.5  ml ; sodium chloride 0.9%  flush  3  ml ; acetaminophen  650  mg ; dextrose 50%  12.5  gm ; glucagon  1  mg ; glucose gel  15  g ; insulin  0  unit ; lactated ringers  1000  ml ; moviprep  1  l ; 
 
black african american f 80 $nan$hematology blood hematocrit  22.2  %; hematology blood hematocrit  25.8  %; hematology blood hematocrit  29.5  %; hematology blood hemoglobin  7.3  g dl; hematology blood hemoglobin  8.5  g dl; hematology blood platelet count  131  k ul; hematology blood platelet count  126  k ul$pneumococcal 23-valent polysaccharide vaccine  0.5  ml ; sodium chloride 0.9%  flush  3  ml ; acetaminophen  650  mg ; dextrose 50%  12.5  gm ; glucagon  1  mg ; glucose gel  15  g ; insulin  0  unit ; 
 
black african american f 80 $nan$hematology blood hematocrit  30.4  %; hematology blood hematocrit  30.7  %; hematology blood hemoglobin  10.2  g dl; hematology blood platelet count  142  k ul; chemistry blood anion gap  11  meq l; chemistry blood bicarbonate  26  meq l; chemistry blood chloride  109  meq l; chemistry blood creatinine  0.8  mg dl; chemistry blood potassium  3.4  meq l; chemistry blood sodium  143  meq l; chemistry blood urea nitrogen  5  mg dl; chemistry blood calcium, total  8.8  mg dl; chemistry blood glucose  118  mg dl$pneumococcal 23-valent polysaccharide vaccine  0.5  ml ; sodium chloride 0.9%  flush  3  ml ; acetaminophen  650  mg ; dextrose 50%  12.5  gm ; glucagon  1  mg ; glucose gel  15  g ; insulin  0  unit ; 
 
black african american f 80 $nan$hematology blood hematocrit  30.2  %; hematology blood hemoglobin  10.0  g dl; hematology blood platelet count  156  k ul$moviprep  2  l ; pneumococcal 23-valent polysaccharide vaccine  0.5  ml ; sodium chloride 0.9%  flush  3  ml ; acetaminophen  650  mg ; dextrose 50%  12.5  gm ; glucagon  1  mg ; glucose gel  15  g ; insulin  0  unit ; 
 
black african american f 80 $nan$nan$moviprep  2  l ; pneumococcal 23-valent polysaccharide vaccine  0.5  ml ; sodium chloride 0.9%  flush  3  ml ; acetaminophen  650  mg ; dextrose 50%  12.5  gm ; glucagon  1  mg ; glucose gel  15  g ; insulin  0  unit ; amlodipine  5  mg ; metformin (glucophage)  500  mg ; triamterene-hctz (37.5 25)  1  cap ; 
 
black african american f 80 $nan$hematology blood hematocrit  31.2  %; hematology blood hemoglobin  10.4  g dl; hematology blood platelet count  184  k ul$pneumococcal 23-valent polysaccharide vaccine  0.5  ml ; sodium chloride 0.9%  flush  3  ml ; acetaminophen  650  mg ; dextrose 50%  12.5  gm ; glucagon  1  mg ; glucose gel  15  g ; insulin  0  unit ; amlodipine  5  mg ; metformin (glucophage)  500  mg ; triamterene-hctz (37.5 25)  1  cap ; 
 
white m 77 $temp  98.8  heartrate  95.0  resprate  18.0  o2sat  96.0  sbp  126.0  dbp  69.0  rhythm    pain  6  $hematology blood hematocrit  31.3  %; hematology blood hemoglobin  9.5  g dl; hematology blood platelet count  145  k ul; chemistry blood anion gap  16  meq l; chemistry blood bicarbonate  25  meq l; chemistry blood chloride  97  meq l; chemistry blood creatinine  1.2  mg dl; chemistry blood potassium  4.4  meq l; chemistry blood sodium  138  meq l; chemistry blood urea nitrogen  17  mg dl; chemistry blood bilirubin, indirect  1.2  mg dl; chemistry blood bilirubin, total  1.6  mg dl; chemistry blood glucose  78  mg dl; chemistry blood lactate dehydrogenase (ld)  257  iu l; chemistry blood bilirubin, direct  0.4  mg dl$senna  8.6  mg ; lactated ringers  1000  ml ; sodium chloride 0.9%  flush  3-10  ml ; acetaminophen  1000  mg ; apixaban  5  mg ; aspirin  81  mg ; atorvastatin  80  mg ; finasteride  5  mg ; gabapentin  600  mg ; metoprolol succinate xl  100  mg ; omeprazole  20  mg ; oxycodone (immediate release)  10  mg ; tamsulosin  0.4  mg ; metoprolol tartrate  50  mg ; miconazole powder 2%  1  appl ; methadone  10  mg ; polyethylene glycol  17  g ; 
personal history of transient ischemic attack (tia), and cerebral infarction without residual deficits atherosclerotic heart disease of native coronary artery without angina pectoris presence of coronary angioplasty implant and graft elevated white blood cell count, unspecified hypotension, unspecified diverticulosis of large intestine without perforation or abscess without bleeding adverse effect of methadone, initial encounter superficial mycosis, unspecified constipation, unspecified hypertensive heart disease with heart failure subclinical iodine-deficiency hypothyroidism long term (current) use of anticoagulants other chronic pain unspecified atrial fibrillation umbilical hernia without obstruction or gangrene personal history of nicotine dependence long qt syndrome other retention of urine anemia in other chronic diseases classified elsewhere chronic systolic (congestive) heart failure benign prostatic hyperplasia with lower urinary tract symptoms non-pressure chronic ulcer of other part of right foot limited to breakdown of skin anxiety disorder, unspecified full incontinence of feces adult failure to thrive acute kidney failure, unspecified pain in right hip hypovolemia old myocardial infarction viral intestinal infection, unspecified atherosclerotic heart disease of native coronary artery without angina pectoris pain in left hip body mass index (bmi) 45.0-49.9, adult benign prostatic hyperplasia with lower urinary tract symptoms other retention of urine personal history of transient ischemic attack (tia), and cerebral infarction without residual deficits personal history of nicotine dependence constipation, unspecified obesity, unspecified other chronic pain paroxysmal atrial fibrillation hypoxemia chronic systolic (congestive) heart failure long term (current) use of antithrombotics/antiplatelets hypothyroidism, unspecified hypertensive heart disease with heart failure other elevated white blood cell count atherosclerotic heart disease of native coronary artery without angina pectoris
white m 77 $nan$hematology blood hematocrit  29.4  %; hematology blood hemoglobin  8.8  g dl; hematology blood platelet count  146  k ul; chemistry blood anion gap  16  meq l; chemistry blood bicarbonate  23  meq l; chemistry blood chloride  100  meq l; chemistry blood creatinine  1.5  mg dl; chemistry blood potassium  4.3  meq l; chemistry blood sodium  139  meq l; chemistry blood urea nitrogen  24  mg dl; chemistry blood calcium, total  7.8  mg dl; chemistry blood glucose  90  mg dl$senna  8.6  mg ; sodium chloride 0.9%  flush  3-10  ml ; acetaminophen  1000  mg ; apixaban  5  mg ; aspirin  81  mg ; atorvastatin  80  mg ; finasteride  5  mg ; gabapentin  600  mg ; omeprazole  20  mg ; oxycodone (immediate release)  10  mg ; tamsulosin  0.4  mg ; miconazole powder 2%  1  appl ; methadone  10  mg ; polyethylene glycol  17  g ; 
personal history of transient ischemic attack (tia), and cerebral infarction without residual deficits atherosclerotic heart disease of native coronary artery without angina pectoris presence of coronary angioplasty implant and graft elevated white blood cell count, unspecified hypotension, unspecified diverticulosis of large intestine without perforation or abscess without bleeding adverse effect of methadone, initial encounter superficial mycosis, unspecified constipation, unspecified hypertensive heart disease with heart failure subclinical iodine-deficiency hypothyroidism long term (current) use of anticoagulants other chronic pain unspecified atrial fibrillation umbilical hernia without obstruction or gangrene personal history of nicotine dependence long qt syndrome other retention of urine anemia in other chronic diseases classified elsewhere chronic systolic (congestive) heart failure benign prostatic hyperplasia with lower urinary tract symptoms non-pressure chronic ulcer of other part of right foot limited to breakdown of skin anxiety disorder, unspecified full incontinence of feces adult failure to thrive acute kidney failure, unspecified pain in right hip hypovolemia old myocardial infarction viral intestinal infection, unspecified atherosclerotic heart disease of native coronary artery without angina pectoris pain in left hip body mass index (bmi) 45.0-49.9, adult benign prostatic hyperplasia with lower urinary tract symptoms other retention of urine personal history of transient ischemic attack (tia), and cerebral infarction without residual deficits personal history of nicotine dependence constipation, unspecified obesity, unspecified other chronic pain paroxysmal atrial fibrillation hypoxemia chronic systolic (congestive) heart failure long term (current) use of antithrombotics/antiplatelets hypothyroidism, unspecified hypertensive heart disease with heart failure other elevated white blood cell count atherosclerotic heart disease of native coronary artery without angina pectoris
white m 77 $nan$chemistry blood creatinine  1.4  mg dl; chemistry blood urea nitrogen  22  mg dl$senna  8.6  mg ; sodium chloride 0.9%  flush  3-10  ml ; acetaminophen  1000  mg ; apixaban  5  mg ; aspirin  81  mg ; atorvastatin  80  mg ; finasteride  5  mg ; gabapentin  600  mg ; omeprazole  20  mg ; oxycodone (immediate release)  10  mg ; tamsulosin  0.4  mg ; miconazole powder 2%  1  appl ; methadone  10  mg ; polyethylene glycol  17  g ; digoxin  0.125  mg ; 
personal history of transient ischemic attack (tia), and cerebral infarction without residual deficits atherosclerotic heart disease of native coronary artery without angina pectoris presence of coronary angioplasty implant and graft elevated white blood cell count, unspecified hypotension, unspecified diverticulosis of large intestine without perforation or abscess without bleeding adverse effect of methadone, initial encounter superficial mycosis, unspecified constipation, unspecified hypertensive heart disease with heart failure subclinical iodine-deficiency hypothyroidism long term (current) use of anticoagulants other chronic pain unspecified atrial fibrillation umbilical hernia without obstruction or gangrene personal history of nicotine dependence long qt syndrome other retention of urine anemia in other chronic diseases classified elsewhere chronic systolic (congestive) heart failure benign prostatic hyperplasia with lower urinary tract symptoms non-pressure chronic ulcer of other part of right foot limited to breakdown of skin anxiety disorder, unspecified full incontinence of feces adult failure to thrive acute kidney failure, unspecified pain in right hip hypovolemia old myocardial infarction viral intestinal infection, unspecified atherosclerotic heart disease of native coronary artery without angina pectoris pain in left hip body mass index (bmi) 45.0-49.9, adult benign prostatic hyperplasia with lower urinary tract symptoms other retention of urine personal history of transient ischemic attack (tia), and cerebral infarction without residual deficits personal history of nicotine dependence constipation, unspecified obesity, unspecified other chronic pain paroxysmal atrial fibrillation hypoxemia chronic systolic (congestive) heart failure long term (current) use of antithrombotics/antiplatelets hypothyroidism, unspecified hypertensive heart disease with heart failure other elevated white blood cell count atherosclerotic heart disease of native coronary artery without angina pectoris
white m 77 $nan$hematology blood hematocrit  29.0  %; hematology blood hemoglobin  8.7  g dl; hematology blood platelet count  144  k ul; chemistry blood anion gap  11  meq l; chemistry blood bicarbonate  27  meq l; chemistry blood chloride  98  meq l; chemistry blood creatinine  1.3  mg dl; chemistry blood potassium  3.9  meq l; chemistry blood sodium  136  meq l; chemistry blood urea nitrogen  20  mg dl; chemistry blood calcium, total  7.7  mg dl; chemistry blood glucose  96  mg dl$senna  8.6  mg ; sodium chloride 0.9%  flush  3-10  ml ; acetaminophen  1000  mg ; apixaban  5  mg ; aspirin  81  mg ; atorvastatin  80  mg ; finasteride  5  mg ; gabapentin  600  mg ; omeprazole  20  mg ; oxycodone (immediate release)  10  mg ; tamsulosin  0.4  mg ; miconazole powder 2%  1  appl ; methadone  10  mg ; polyethylene glycol  17  g ; digoxin  0.125  mg ; bisacodyl  10  mg ; lidocaine 5% patch  1  ptch ; fleet enema (saline)  1  enema ; oxycodone (immediate release)  2.5  mg ; 
personal history of transient ischemic attack (tia), and cerebral infarction without residual deficits atherosclerotic heart disease of native coronary artery without angina pectoris presence of coronary angioplasty implant and graft elevated white blood cell count, unspecified hypotension, unspecified diverticulosis of large intestine without perforation or abscess without bleeding adverse effect of methadone, initial encounter superficial mycosis, unspecified constipation, unspecified hypertensive heart disease with heart failure subclinical iodine-deficiency hypothyroidism long term (current) use of anticoagulants other chronic pain unspecified atrial fibrillation umbilical hernia without obstruction or gangrene personal history of nicotine dependence long qt syndrome other retention of urine anemia in other chronic diseases classified elsewhere chronic systolic (congestive) heart failure benign prostatic hyperplasia with lower urinary tract symptoms non-pressure chronic ulcer of other part of right foot limited to breakdown of skin anxiety disorder, unspecified full incontinence of feces adult failure to thrive acute kidney failure, unspecified pain in right hip hypovolemia old myocardial infarction viral intestinal infection, unspecified atherosclerotic heart disease of native coronary artery without angina pectoris pain in left hip body mass index (bmi) 45.0-49.9, adult benign prostatic hyperplasia with lower urinary tract symptoms other retention of urine personal history of transient ischemic attack (tia), and cerebral infarction without residual deficits personal history of nicotine dependence constipation, unspecified obesity, unspecified other chronic pain paroxysmal atrial fibrillation hypoxemia chronic systolic (congestive) heart failure long term (current) use of antithrombotics/antiplatelets hypothyroidism, unspecified hypertensive heart disease with heart failure other elevated white blood cell count atherosclerotic heart disease of native coronary artery without angina pectoris
white m 77 $nan$nan$senna  8.6  mg ; sodium chloride 0.9%  flush  3-10  ml ; acetaminophen  1000  mg ; apixaban  5  mg ; aspirin  81  mg ; atorvastatin  80  mg ; finasteride  5  mg ; gabapentin  600  mg ; omeprazole  20  mg ; oxycodone (immediate release)  10  mg ; tamsulosin  0.4  mg ; miconazole powder 2%  1  appl ; methadone  10  mg ; polyethylene glycol  17  g ; digoxin  0.125  mg ; bisacodyl  10  mg ; lidocaine 5% patch  1  ptch ; fleet enema (saline)  1  enema ; oxycodone (immediate release)  2.5  mg ; 
personal history of transient ischemic attack (tia), and cerebral infarction without residual deficits atherosclerotic heart disease of native coronary artery without angina pectoris presence of coronary angioplasty implant and graft elevated white blood cell count, unspecified hypotension, unspecified diverticulosis of large intestine without perforation or abscess without bleeding adverse effect of methadone, initial encounter superficial mycosis, unspecified constipation, unspecified hypertensive heart disease with heart failure subclinical iodine-deficiency hypothyroidism long term (current) use of anticoagulants other chronic pain unspecified atrial fibrillation umbilical hernia without obstruction or gangrene personal history of nicotine dependence long qt syndrome other retention of urine anemia in other chronic diseases classified elsewhere chronic systolic (congestive) heart failure benign prostatic hyperplasia with lower urinary tract symptoms non-pressure chronic ulcer of other part of right foot limited to breakdown of skin anxiety disorder, unspecified full incontinence of feces adult failure to thrive acute kidney failure, unspecified pain in right hip hypovolemia old myocardial infarction viral intestinal infection, unspecified atherosclerotic heart disease of native coronary artery without angina pectoris pain in left hip body mass index (bmi) 45.0-49.9, adult benign prostatic hyperplasia with lower urinary tract symptoms other retention of urine personal history of transient ischemic attack (tia), and cerebral infarction without residual deficits personal history of nicotine dependence constipation, unspecified obesity, unspecified other chronic pain paroxysmal atrial fibrillation hypoxemia chronic systolic (congestive) heart failure long term (current) use of antithrombotics/antiplatelets hypothyroidism, unspecified hypertensive heart disease with heart failure other elevated white blood cell count atherosclerotic heart disease of native coronary artery without angina pectoris
white f 53 $nan$nan$insulin  9  unit ; insulin  10  unit ; 
diabetes mellitus without mention of complication, type ii or unspecified type, not stated as uncontrolled unspecified essential hypertension esophageal reflux personal history of malignant neoplasm of other gastrointestinal tract obstruction of bile duct hyperpotassemia personal history of antineoplastic chemotherapy esophageal reflux hyposmolality and/or hyponatremia obstructive sleep apnea (adult)(pediatric) person boarding or alighting a pedal cycle injured in collision with railway train or railway vehicle personal history of irradiation, presenting hazards to health obstruction of bile duct diabetes mellitus without mention of complication, type ii or unspecified type, uncontrolled other obstruction of duodenum malignant neoplasm of pancreas, part unspecified unspecified essential hypertension malignant neoplasm of pancreas, part unspecified unspecified essential hypertension obstruction of bile duct personal history of antineoplastic chemotherapy obstructive sleep apnea (adult)(pediatric) person boarding or alighting a pedal cycle injured in collision with railway train or railway vehicle personal history of irradiation, presenting hazards to health fitting and adjustment of nonvascular catheter, nec diabetes mellitus without mention of complication, type ii or unspecified type, not stated as uncontrolled anemia, unspecified esophageal reflux esophageal reflux radiological procedure and radiotherapy as the cause of abnormal reaction of patient, or of later complication, without mention of misadventure at time of procedure personal history of malignant neoplasm of other gastrointestinal tract cholangitis anemia, unspecified mechanical complication due to other implant and internal device, not elsewhere classified hyperpotassemia other and unspecified coagulation defects obstructive sleep apnea (adult)(pediatric) sepsis unspecified disorder of intestine late effect of radiation diabetes mellitus without mention of complication, type ii or unspecified type, not stated as uncontrolled surgical operation with implant of artificial internal device causing abnormal patient reaction, or later complication,without mention of misadventure at time of operation malnutrition of moderate degree other septicemia due to gram-negative organisms person boarding or alighting a pedal cycle injured in collision with railway train or railway vehicle thrombocytopenia, unspecified unspecified essential hypertension obstruction of bile duct
white f 53 $nan$nan$insulin  9  unit ; insulin  10  unit ; lisinopril  5  mg ; omeprazole  40  mg ; diltiazem extended-release  360  mg ; sodium chloride 0.9%  flush  3  ml ; hydromorphone (dilaudid)  2-4  mg ; ibuprofen  400  mg ; acetaminophen  325-650  mg ; dextrose 50%  12.5  gm ; glucagon  1  mg ; insulin  0  unit ; ondansetron  4  mg ; 
diabetes mellitus without mention of complication, type ii or unspecified type, not stated as uncontrolled unspecified essential hypertension esophageal reflux personal history of malignant neoplasm of other gastrointestinal tract obstruction of bile duct hyperpotassemia personal history of antineoplastic chemotherapy esophageal reflux hyposmolality and/or hyponatremia obstructive sleep apnea (adult)(pediatric) person boarding or alighting a pedal cycle injured in collision with railway train or railway vehicle personal history of irradiation, presenting hazards to health obstruction of bile duct diabetes mellitus without mention of complication, type ii or unspecified type, uncontrolled other obstruction of duodenum malignant neoplasm of pancreas, part unspecified unspecified essential hypertension malignant neoplasm of pancreas, part unspecified unspecified essential hypertension obstruction of bile duct personal history of antineoplastic chemotherapy obstructive sleep apnea (adult)(pediatric) person boarding or alighting a pedal cycle injured in collision with railway train or railway vehicle personal history of irradiation, presenting hazards to health fitting and adjustment of nonvascular catheter, nec diabetes mellitus without mention of complication, type ii or unspecified type, not stated as uncontrolled anemia, unspecified esophageal reflux esophageal reflux radiological procedure and radiotherapy as the cause of abnormal reaction of patient, or of later complication, without mention of misadventure at time of procedure personal history of malignant neoplasm of other gastrointestinal tract cholangitis anemia, unspecified mechanical complication due to other implant and internal device, not elsewhere classified hyperpotassemia other and unspecified coagulation defects obstructive sleep apnea (adult)(pediatric) sepsis unspecified disorder of intestine late effect of radiation diabetes mellitus without mention of complication, type ii or unspecified type, not stated as uncontrolled surgical operation with implant of artificial internal device causing abnormal patient reaction, or later complication,without mention of misadventure at time of operation malnutrition of moderate degree other septicemia due to gram-negative organisms person boarding or alighting a pedal cycle injured in collision with railway train or railway vehicle thrombocytopenia, unspecified unspecified essential hypertension obstruction of bile duct
black african american f 86 $temp  99.4  heartrate  69.0  resprate  14.0  o2sat    sbp  153.0  dbp  83.0  rhythm    pain    $hematology blood hematocrit  38.4  %; hematology blood hemoglobin  13.0  g dl; hematology blood platelet count  114  k ul; chemistry blood anion gap  12  meq l; chemistry blood bicarbonate  25  meq l; chemistry blood chloride  104  meq l; chemistry blood creatinine  0.6  mg dl; chemistry blood potassium  3.8  meq l; chemistry blood sodium  137  meq l; chemistry blood urea nitrogen  11  mg dl; hematology blood inr(pt)  1.3  ; chemistry blood calcium, total  9.2  mg dl; chemistry blood bilirubin, total  1.3  mg dl; chemistry blood glucose  140  mg dl; chemistry blood lactate dehydrogenase (ld)  165  iu l; chemistry blood albumin  3.6  g dl; chemistry blood % hemoglobin a1c  8.2  %$docusate sodium  100  mg ; heparin  5000  unit ; pneumococcal vac polyvalent  0.5  ml ; sodium chloride 0.9%  flush  3  ml ; senna  2  tab ; trazodone  25  mg ; acetaminophen  1000  mg ; 
 
black african american f 86 $nan$nan$docusate sodium  100  mg ; heparin  5000  unit ; sodium chloride 0.9%  flush  3  ml ; senna  2  tab ; trazodone  25  mg ; acetaminophen  1000  mg ; 
 
hispanic latino f 24 $temp  97.9  heartrate  104.0  resprate  18.0  o2sat  100.0  sbp  143.0  dbp  108.0  rhythm    pain    ; temp  97.9  heartrate  104.0  resprate  20.0  o2sat  100.0  sbp  143.0  dbp  108.0  rhythm    pain  0  $hematology blood hematocrit  36.4  %; hematology blood hemoglobin  12.4  g dl; hematology blood platelet count  196  k ul$docusate sodium  100  mg ; acetaminophen  650  mg ; oxazepam  15-30  mg ; calcium carbonate  500  mg ; milk of magnesia  15-30  ml ; prenatal vitamins  1  tab ; oseltamivir  75  mg ; ipratropium-albuterol neb  1  neb ; sodium chloride 0.9%  flush  3  ml ; chlorpheniramine maleate  4  mg ; sodium chloride nasal  1-2  spry ; cepacol (sore throat lozenge)  2  loz ; 0.9% sodium chloride (mini bag plus)  100  ml ; ceftriaxone  1  gm ; azithromycin  250  mg ; guaifenesin  5-10  ml ; 
diarrhea, unspecified tachycardia, unspecified right upper quadrant pain hypovolemia
hispanic latino f 24 $nan$nan$docusate sodium  100  mg ; acetaminophen  650  mg ; oxazepam  15-30  mg ; calcium carbonate  500  mg ; milk of magnesia  15-30  ml ; prenatal vitamins  1  tab ; oseltamivir  75  mg ; ipratropium-albuterol neb  1  neb ; sodium chloride 0.9%  flush  3  ml ; chlorpheniramine maleate  4  mg ; sodium chloride nasal  1-2  spry ; cepacol (sore throat lozenge)  2  loz ; 0.9% sodium chloride (mini bag plus)  100  ml ; ceftriaxone  1  gm ; azithromycin  250  mg ; guaifenesin  5-10  ml ; 
diarrhea, unspecified tachycardia, unspecified right upper quadrant pain hypovolemia
white f 48 $nan$hematology blood hematocrit  34.0  %; hematology blood hematocrit  34.3  %; hematology blood hemoglobin  11.6  g dl; hematology blood hemoglobin  11.9  g dl; hematology blood platelet count  211  k ul; hematology blood platelet count  192  k ul; chemistry blood anion gap  15  meq l; chemistry blood anion gap  12  meq l; chemistry blood bicarbonate  20  meq l; chemistry blood bicarbonate  23  meq l; chemistry blood chloride  111  meq l; chemistry blood chloride  107  meq l; chemistry blood creatinine  0.7  mg dl; chemistry blood creatinine  0.7  mg dl; chemistry blood potassium  4.2  meq l; chemistry blood potassium  3.6  meq l; chemistry blood sodium  142  meq l; chemistry blood sodium  138  meq l; chemistry blood urea nitrogen  12  mg dl; chemistry blood urea nitrogen  6  mg dl; chemistry blood calcium, total  7.4  mg dl; chemistry blood calcium, total  8.3  mg dl; chemistry blood bilirubin, total  0.3  mg dl; chemistry blood glucose  95  mg dl; chemistry blood glucose  104  mg dl; chemistry blood lactate dehydrogenase (ld)  185  iu l; chemistry blood albumin  3.7  g dl; blood gas blood free calcium  1.06  mmol l; blood gas blood lactate  1.6  mmol l; blood gas blood potassium, whole blood  3.2  meq l$chlorhexidine gluconate 0.12% oral rinse  15  ml ; sodium chloride 0.9%  flush  3  ml ; ns  1000  ml ; acetaminophen  325-650  mg ; heparin  5000  unit ; activated charcoal-sorbitol  50  gm ; propofol  1000  mg ; propofol  200  mg ; neutra-phos  1  pkt ; calcium gluconate  2  gm ; ondansetron  4  mg ; 
 
white f 48 $nan$nan$sodium chloride 0.9%  flush  3  ml ; acetaminophen  325-650  mg ; heparin  5000  unit ; activated charcoal-sorbitol  50  gm ; propofol  1000  mg ; propofol  200  mg ; neutra-phos  1  pkt ; calcium gluconate  2  gm ; ondansetron  4  mg ; potassium chloride  40  meq ; ondansetron odt  4  mg ; 
 
white f 48 $nan$nan$sodium chloride 0.9%  flush  3  ml ; heparin  5000  unit ; ondansetron odt  4  mg ; potassium chloride  20  meq ; 
 
white f 67 $nan$nan$atorvastatin  40  mg ; citalopram hydrobromide  20  mg ; multivitamins  1  tab ; 
 
white f 67 $nan$hematology blood hematocrit  23.6  %; hematology blood hematocrit  26.4  %; hematology blood hemoglobin  7.9  g dl; hematology blood platelet count  344  k ul; chemistry blood anion gap  14  meq l; chemistry blood bicarbonate  26  meq l; chemistry blood chloride  102  meq l; chemistry blood creatinine  0.8  mg dl; chemistry blood potassium  4.0  meq l; chemistry blood sodium  138  meq l; chemistry blood urea nitrogen  20  mg dl; chemistry blood calcium, total  9.6  mg dl; chemistry blood glucose  134  mg dl$atorvastatin  40  mg ; citalopram hydrobromide  20  mg ; multivitamins  1  tab ; 1 2 ns  1000  ml ; pneumococcal vac polyvalent  0.5  ml ; sodium chloride 0.9%  flush  3  ml ; 0.9% sodium chloride  1000  ml ; pantoprazole  40  mg ; ranitidine  150  mg ; dextrose 50%  12.5  gm ; glucagon  1  mg ; insulin  0  unit ; docusate sodium  100  mg ; senna  1  tab ; acetaminophen  325-650  mg ; benzonatate  100  mg ; ferrous sulfate  325  mg ; 
 
white f 67 $nan$hematology blood hematocrit  26.7  %; hematology blood hematocrit  26.2  %; hematology blood hemoglobin  7.3  g dl; hematology blood platelet count  289  k ul; chemistry blood anion gap  13  meq l; chemistry blood bicarbonate  27  meq l; chemistry blood chloride  103  meq l; chemistry blood creatinine  0.8  mg dl; chemistry blood potassium  4.0  meq l; chemistry blood sodium  139  meq l; chemistry blood urea nitrogen  16  mg dl; chemistry blood calcium, total  8.8  mg dl; chemistry blood bilirubin, total  0.5  mg dl; chemistry blood glucose  126  mg dl; chemistry blood albumin  3.9  g dl$atorvastatin  40  mg ; citalopram hydrobromide  20  mg ; multivitamins  1  tab ; pneumococcal vac polyvalent  0.5  ml ; sodium chloride 0.9%  flush  3  ml ; ranitidine  150  mg ; dextrose 50%  12.5  gm ; glucagon  1  mg ; insulin  0  unit ; senna  1  tab ; acetaminophen  325-650  mg ; benzonatate  100  mg ; ferrous sulfate  325  mg ; golytely  4  l ; ondansetron  4  mg ; tucks hemorrhoidal oint 1%  1  appl ; valsartan  160  mg ; 
 
white f 67 $nan$hematology blood hematocrit  25.9  %; hematology blood hemoglobin  7.3  g dl; hematology blood platelet count  348  k ul; chemistry blood anion gap  13  meq l; chemistry blood bicarbonate  28  meq l; chemistry blood chloride  104  meq l; chemistry blood creatinine  0.8  mg dl; chemistry blood potassium  4.2  meq l; chemistry blood sodium  141  meq l; chemistry blood urea nitrogen  17  mg dl; chemistry blood calcium, total  9.0  mg dl; chemistry blood glucose  126  mg dl$atorvastatin  40  mg ; citalopram hydrobromide  20  mg ; multivitamins  1  tab ; pneumococcal vac polyvalent  0.5  ml ; sodium chloride 0.9%  flush  3  ml ; ranitidine  150  mg ; dextrose 50%  12.5  gm ; glucagon  1  mg ; insulin  0  unit ; senna  1  tab ; acetaminophen  325-650  mg ; benzonatate  100  mg ; ferrous sulfate  325  mg ; golytely  4  l ; ondansetron  4  mg ; tucks hemorrhoidal oint 1%  1  appl ; valsartan  160  mg ; metoclopramide  5  mg ; 
 
white f 67 $nan$nan$atorvastatin  40  mg ; citalopram hydrobromide  20  mg ; multivitamins  1  tab ; pneumococcal vac polyvalent  0.5  ml ; sodium chloride 0.9%  flush  3  ml ; ranitidine  150  mg ; dextrose 50%  12.5  gm ; glucagon  1  mg ; insulin  0  unit ; senna  1  tab ; acetaminophen  325-650  mg ; benzonatate  100  mg ; ferrous sulfate  325  mg ; golytely  4  l ; tucks hemorrhoidal oint 1%  1  appl ; valsartan  160  mg ; metoclopramide  5  mg ; lorazepam  0.5-1  mg ; 
 
white m 62 $temp  97.8  heartrate  84.0  resprate  18.0  o2sat  99.0  sbp  112.0  dbp  60.0  rhythm    pain  5  ; temp  97.8  heartrate  78.0  resprate  18.0  o2sat  100.0  sbp  118.0  dbp  58.0  rhythm    pain  0  ; temp  98.96  heartrate  69.0  resprate  17.0  o2sat  100.0  sbp  100.0  dbp  53.0  rhythm    pain  0  ; temp    heartrate  74.0  resprate  16.0  o2sat  100.0  sbp  94.0  dbp  51.0  rhythm    pain  0  ; temp  98.6  heartrate  71.0  resprate  15.0  o2sat  100.0  sbp  105.0  dbp  52.0  rhythm    pain  0  $hematology blood hematocrit  23.7  %; hematology blood hematocrit  11.9  %; hematology blood hemoglobin  7.9  g dl; hematology blood hemoglobin  8.1  g dl; chemistry blood anion gap  15  meq l; chemistry blood bicarbonate  16  meq l; chemistry blood chloride  102  meq l; chemistry blood creatinine  1.5  mg dl; chemistry blood potassium  3.9  meq l; chemistry blood sodium  133  meq l; chemistry blood urea nitrogen  56  mg dl; hematology blood inr(pt)  1.5  ; chemistry blood bilirubin, total  0.4  mg dl; chemistry blood glucose  162  mg dl; chemistry blood lactate dehydrogenase (ld)  159  iu l$sodium chloride 0.9%  flush  3-10  ml ; creon 12  3  cap ; tacrolimus  1.5  mg ; dextrose 50%  12.5  gm ; glucagon  1  mg ; glucose gel  15  g ; insulin  0  unit ; heparin  5000  unit ; atorvastatin  80  mg ; calcium carbonate  1000  mg ; d5 1 2ns  1000  ml ; metoprolol succinate xl  25  mg ; ondansetron  8  mg ; sodium chloride nasal  1-2  spry ; acetaminophen  500  mg ; 
presence of coronary angioplasty implant and graft nicotine dependence, cigarettes, uncomplicated anemia, unspecified unspecified severe protein-calorie malnutrition acute kidney failure, unspecified atherosclerotic heart disease of native coronary artery without angina pectoris acute gastroenteropathy due to norwalk agent unspecified systolic (congestive) heart failure vitamin d deficiency, unspecified hypertensive heart and chronic kidney disease with heart failure and stage 1 through stage 4 chronic kidney disease, or unspecified chronic kidney disease unspecified atrial fibrillation long term (current) use of insulin chronic kidney disease, stage 3 (moderate) long term (current) use of anticoagulants type 2 diabetes mellitus with diabetic chronic kidney disease body mass index (bmi) 20.0-20.9, adult liver transplant status type 2 diabetes mellitus with diabetic peripheral angiopathy without gangrene liver transplant status presence of aortocoronary bypass graft presence of coronary angioplasty implant and graft vitamin d deficiency, unspecified hyperlipidemia, unspecified history of falling nonspecific elevation of levels of transaminase and lactic acid dehydrogenase [ldh] alcohol abuse, uncomplicated long term (current) use of insulin type 2 diabetes mellitus with diabetic chronic kidney disease other and unspecified fall in water transport injuring occupant of small boat, powered hypocalcemia family history of ischemic heart disease and other diseases of the circulatory system adverse effect of other antidysrhythmic drugs, initial encounter hypertensive heart and chronic kidney disease with heart failure and stage 1 through stage 4 chronic kidney disease, or unspecified chronic kidney disease acute kidney failure, unspecified type 2 diabetes mellitus with hyperglycemia chronic systolic (congestive) heart failure chronic kidney disease, unspecified atherosclerotic heart disease of native coronary artery without angina pectoris nicotine dependence, cigarettes, uncomplicated hypomagnesemia other seizures long term (current) use of anticoagulants type 2 diabetes mellitus with diabetic peripheral angiopathy without gangrene delirium due to known physiological condition other fall from one level to another in water transport injuring occupant of other watercraft -- crew unspecified atrial fibrillation peripheral vascular angioplasty status with implants and grafts presence of coronary angioplasty implant and graft
white m 62 $nan$hematology blood hematocrit  24.6  %; hematology blood hemoglobin  8.3  g dl; hematology blood platelet count  203  k ul; chemistry blood anion gap  11  meq l; chemistry blood bicarbonate  19  meq l; chemistry blood chloride  101  meq l; chemistry blood creatinine  1.5  mg dl; chemistry blood potassium  4.1  meq l; chemistry blood sodium  131  meq l; chemistry blood urea nitrogen  42  mg dl; hematology blood inr(pt)  1.3  ; chemistry blood calcium, total  8.4  mg dl; chemistry blood bilirubin, total  0.3  mg dl; chemistry blood glucose  361  mg dl; chemistry blood albumin  2.8  g dl$sodium chloride 0.9%  flush  3-10  ml ; creon 12  3  cap ; tacrolimus  1.5  mg ; dextrose 50%  12.5  gm ; glucagon  1  mg ; glucose gel  15  g ; insulin  0  unit ; heparin  5000  unit ; atorvastatin  80  mg ; calcium carbonate  1000  mg ; d5 1 2ns  1000  ml ; metoprolol succinate xl  25  mg ; ondansetron  8  mg ; sodium chloride nasal  1-2  spry ; acetaminophen  500  mg ; amiodarone  200  mg ; warfarin  1.5  mg ; lactated ringers  1000  ml ; magnesium sulfate  4  gm ; 
presence of coronary angioplasty implant and graft nicotine dependence, cigarettes, uncomplicated anemia, unspecified unspecified severe protein-calorie malnutrition acute kidney failure, unspecified atherosclerotic heart disease of native coronary artery without angina pectoris acute gastroenteropathy due to norwalk agent unspecified systolic (congestive) heart failure vitamin d deficiency, unspecified hypertensive heart and chronic kidney disease with heart failure and stage 1 through stage 4 chronic kidney disease, or unspecified chronic kidney disease unspecified atrial fibrillation long term (current) use of insulin chronic kidney disease, stage 3 (moderate) long term (current) use of anticoagulants type 2 diabetes mellitus with diabetic chronic kidney disease body mass index (bmi) 20.0-20.9, adult liver transplant status type 2 diabetes mellitus with diabetic peripheral angiopathy without gangrene liver transplant status presence of aortocoronary bypass graft presence of coronary angioplasty implant and graft vitamin d deficiency, unspecified hyperlipidemia, unspecified history of falling nonspecific elevation of levels of transaminase and lactic acid dehydrogenase [ldh] alcohol abuse, uncomplicated long term (current) use of insulin type 2 diabetes mellitus with diabetic chronic kidney disease other and unspecified fall in water transport injuring occupant of small boat, powered hypocalcemia family history of ischemic heart disease and other diseases of the circulatory system adverse effect of other antidysrhythmic drugs, initial encounter hypertensive heart and chronic kidney disease with heart failure and stage 1 through stage 4 chronic kidney disease, or unspecified chronic kidney disease acute kidney failure, unspecified type 2 diabetes mellitus with hyperglycemia chronic systolic (congestive) heart failure chronic kidney disease, unspecified atherosclerotic heart disease of native coronary artery without angina pectoris nicotine dependence, cigarettes, uncomplicated hypomagnesemia other seizures long term (current) use of anticoagulants type 2 diabetes mellitus with diabetic peripheral angiopathy without gangrene delirium due to known physiological condition other fall from one level to another in water transport injuring occupant of other watercraft -- crew unspecified atrial fibrillation peripheral vascular angioplasty status with implants and grafts presence of coronary angioplasty implant and graft
white m 62 $nan$hematology blood hematocrit  24.0  %; hematology blood hemoglobin  8.1  g dl; hematology blood platelet count  215  k ul; chemistry blood anion gap  11  meq l; chemistry blood bicarbonate  21  meq l; chemistry blood chloride  100  meq l; chemistry blood creatinine  1.2  mg dl; chemistry blood potassium  4.4  meq l; chemistry blood sodium  132  meq l; chemistry blood urea nitrogen  34  mg dl; hematology blood inr(pt)  1.2  ; chemistry blood calcium, total  8.1  mg dl; chemistry blood bilirubin, total  0.4  mg dl; chemistry blood glucose  245  mg dl; chemistry blood lactate dehydrogenase (ld)  179  iu l; chemistry blood albumin  2.6  g dl$sodium chloride 0.9%  flush  3-10  ml ; creon 12  3  cap ; tacrolimus  1.5  mg ; dextrose 50%  12.5  gm ; glucagon  1  mg ; glucose gel  15  g ; insulin  0  unit ; heparin  5000  unit ; atorvastatin  80  mg ; calcium carbonate  1000  mg ; metoprolol succinate xl  25  mg ; ondansetron  8  mg ; sodium chloride nasal  1-2  spry ; acetaminophen  500  mg ; amiodarone  200  mg ; warfarin  1.5  mg ; magnesium sulfate  4  gm ; magnesium oxide  400  mg ; 
presence of coronary angioplasty implant and graft nicotine dependence, cigarettes, uncomplicated anemia, unspecified unspecified severe protein-calorie malnutrition acute kidney failure, unspecified atherosclerotic heart disease of native coronary artery without angina pectoris acute gastroenteropathy due to norwalk agent unspecified systolic (congestive) heart failure vitamin d deficiency, unspecified hypertensive heart and chronic kidney disease with heart failure and stage 1 through stage 4 chronic kidney disease, or unspecified chronic kidney disease unspecified atrial fibrillation long term (current) use of insulin chronic kidney disease, stage 3 (moderate) long term (current) use of anticoagulants type 2 diabetes mellitus with diabetic chronic kidney disease body mass index (bmi) 20.0-20.9, adult liver transplant status type 2 diabetes mellitus with diabetic peripheral angiopathy without gangrene liver transplant status presence of aortocoronary bypass graft presence of coronary angioplasty implant and graft vitamin d deficiency, unspecified hyperlipidemia, unspecified history of falling nonspecific elevation of levels of transaminase and lactic acid dehydrogenase [ldh] alcohol abuse, uncomplicated long term (current) use of insulin type 2 diabetes mellitus with diabetic chronic kidney disease other and unspecified fall in water transport injuring occupant of small boat, powered hypocalcemia family history of ischemic heart disease and other diseases of the circulatory system adverse effect of other antidysrhythmic drugs, initial encounter hypertensive heart and chronic kidney disease with heart failure and stage 1 through stage 4 chronic kidney disease, or unspecified chronic kidney disease acute kidney failure, unspecified type 2 diabetes mellitus with hyperglycemia chronic systolic (congestive) heart failure chronic kidney disease, unspecified atherosclerotic heart disease of native coronary artery without angina pectoris nicotine dependence, cigarettes, uncomplicated hypomagnesemia other seizures long term (current) use of anticoagulants type 2 diabetes mellitus with diabetic peripheral angiopathy without gangrene delirium due to known physiological condition other fall from one level to another in water transport injuring occupant of other watercraft -- crew unspecified atrial fibrillation peripheral vascular angioplasty status with implants and grafts presence of coronary angioplasty implant and graft
white m 62 $nan$hematology blood hematocrit  24.3  %; hematology blood hemoglobin  8.2  g dl; hematology blood platelet count  190  k ul; chemistry blood anion gap  9  meq l; chemistry blood bicarbonate  22  meq l; chemistry blood chloride  101  meq l; chemistry blood creatinine  1.0  mg dl; chemistry blood potassium  4.6  meq l; chemistry blood sodium  132  meq l; chemistry blood urea nitrogen  29  mg dl; hematology blood inr(pt)  1.2  ; chemistry blood calcium, total  8.3  mg dl; chemistry blood bilirubin, total  0.4  mg dl; chemistry blood glucose  184  mg dl; chemistry blood lactate dehydrogenase (ld)  159  iu l; chemistry blood albumin  2.6  g dl$sodium chloride 0.9%  flush  3-10  ml ; creon 12  3  cap ; tacrolimus  1.5  mg ; dextrose 50%  12.5  gm ; glucagon  1  mg ; glucose gel  15  g ; heparin  5000  unit ; atorvastatin  80  mg ; calcium carbonate  1000  mg ; metoprolol succinate xl  25  mg ; ondansetron  8  mg ; sodium chloride nasal  1-2  spry ; acetaminophen  500  mg ; amiodarone  200  mg ; warfarin  1.5  mg ; magnesium oxide  400  mg ; insulin  15  unit ; bag  2  bag ; 
presence of coronary angioplasty implant and graft nicotine dependence, cigarettes, uncomplicated anemia, unspecified unspecified severe protein-calorie malnutrition acute kidney failure, unspecified atherosclerotic heart disease of native coronary artery without angina pectoris acute gastroenteropathy due to norwalk agent unspecified systolic (congestive) heart failure vitamin d deficiency, unspecified hypertensive heart and chronic kidney disease with heart failure and stage 1 through stage 4 chronic kidney disease, or unspecified chronic kidney disease unspecified atrial fibrillation long term (current) use of insulin chronic kidney disease, stage 3 (moderate) long term (current) use of anticoagulants type 2 diabetes mellitus with diabetic chronic kidney disease body mass index (bmi) 20.0-20.9, adult liver transplant status type 2 diabetes mellitus with diabetic peripheral angiopathy without gangrene liver transplant status presence of aortocoronary bypass graft presence of coronary angioplasty implant and graft vitamin d deficiency, unspecified hyperlipidemia, unspecified history of falling nonspecific elevation of levels of transaminase and lactic acid dehydrogenase [ldh] alcohol abuse, uncomplicated long term (current) use of insulin type 2 diabetes mellitus with diabetic chronic kidney disease other and unspecified fall in water transport injuring occupant of small boat, powered hypocalcemia family history of ischemic heart disease and other diseases of the circulatory system adverse effect of other antidysrhythmic drugs, initial encounter hypertensive heart and chronic kidney disease with heart failure and stage 1 through stage 4 chronic kidney disease, or unspecified chronic kidney disease acute kidney failure, unspecified type 2 diabetes mellitus with hyperglycemia chronic systolic (congestive) heart failure chronic kidney disease, unspecified atherosclerotic heart disease of native coronary artery without angina pectoris nicotine dependence, cigarettes, uncomplicated hypomagnesemia other seizures long term (current) use of anticoagulants type 2 diabetes mellitus with diabetic peripheral angiopathy without gangrene delirium due to known physiological condition other fall from one level to another in water transport injuring occupant of other watercraft -- crew unspecified atrial fibrillation peripheral vascular angioplasty status with implants and grafts presence of coronary angioplasty implant and graft
white m 60 $nan$hematology blood hematocrit  22.9  %; hematology blood hemoglobin  7.1  g dl; hematology blood platelet count  68  k ul; chemistry blood anion gap  16  meq l; chemistry blood bicarbonate  19  meq l; chemistry blood chloride  107  meq l; chemistry blood creatinine  2.5  mg dl; chemistry blood potassium  4.5  meq l; chemistry blood sodium  137  meq l; chemistry blood urea nitrogen  81  mg dl; hematology blood inr(pt)  2.0  ; hematology blood inr(pt)  1.5  ; chemistry blood calcium, total  7.4  mg dl; chemistry blood glucose  366  mg dl; chemistry blood albumin  3.4  g dl; hematology blood bands  4  %; blood gas blood lactate  1.8  mmol l; blood gas blood lactate  2.0  mmol l; blood gas blood lactate  1.4  mmol l$senna  1  tab ; docusate sodium  100  mg ; acetaminophen  325-650  mg ; pantoprazole  40  mg ; ondansetron  4  mg ; tacrolimus  1  mg ; acetaminophen  1000  mg ; insulin  0  unit ; heparin  5000  unit ; iso-osmotic dextrose  200  ml ; vancomycin  1000  mg ; mycophenolate mofetil  500  mg ; furosemide  40  mg ; metoprolol tartrate  100  mg ; amiodarone  200  mg ; insulin  40  unit ; aspirin  81  mg ; folic acid  1  mg ; simvastatin  80  mg ; prednisone  5  mg ; ferrous sulfate  325  mg ; lamivudine  50  mg ; ns  100  ml ; insulin human regular  100  unit ; acetaminophen  500  mg ; iso-osmotic dextrose  50  ml ; piperacillin-tazobactam na  2.25  g ; metronidazole (flagyl)  500  mg ; acetaminophen  650  mg ; prochlorperazine  10  mg ; sw  100  ml ; magnesium sulfate  4  gm ; lidocaine 1%  2  ml ; meperidine  25  mg ; ns (mini bag plus)  100  ml ; meropenem  500  mg ; 
congestive heart failure, unspecified pneumonia, organism unspecified peripheral vascular disease, unspecified diabetes with renal manifestations, type ii or unspecified type, not stated as uncontrolled hypertensive chronic kidney disease, unspecified, with chronic kidney disease stage i through stage iv, or unspecified car driver injured in collision with two- or three-wheeled motor vehicle in nontraffic accident kidney replaced by transplant chronic kidney disease, unspecified hyperpotassemia polyneuropathy in diabetes acute on chronic diastolic heart failure background diabetic retinopathy anemia in chronic kidney disease spontaneous ecchymoses atrial flutter diabetes with neurological manifestations, type ii or unspecified type, not stated as uncontrolled unspecified viral hepatitis c without hepatic coma tachycardia, unspecified pure hypercholesterolemia nephritis and nephropathy, not specified as acute or chronic, in diseases classified elsewhere diabetes with ophthalmic manifestations, type ii or unspecified type, not stated as uncontrolled cellulitis and abscess of upper arm and forearm acute kidney failure, unspecified unspecified viral hepatitis c without hepatic coma heart valve replaced by other means long-term (current) use of steroids diabetes with renal manifestations, type i [juvenile type], not stated as uncontrolled peripheral vascular disease, unspecified light chain (al) amyloidosis kidney replaced by transplant car driver injured in collision with two- or three-wheeled motor vehicle in nontraffic accident dehydration ventral, unspecified, hernia without mention of obstruction or gangrene poisoning by antineoplastic and immunosuppressive drugs diarrhea unspecified car occupant injured in collision with car, pick-up truck or van in nontraffic accident accidental poisoning by primarily systemic agents epilepsy, unspecified, without mention of intractable epilepsy end stage renal disease other and unspecified hyperlipidemia acute kidney failure, unspecified hypertensive chronic kidney disease, unspecified, with chronic kidney disease stage v or end stage renal disease
white m 60 $nan$hematology blood hematocrit  20.2  %; hematology blood hematocrit  23.3  %; hematology blood hematocrit  23.1  %; hematology blood hematocrit  28.0  %; hematology blood hemoglobin  6.4  g dl; hematology blood platelet count  57  k ul; hematology blood platelet count  39  k ul; chemistry blood anion gap  20  meq l; chemistry blood anion gap  22  meq l; chemistry blood bicarbonate  17  meq l; chemistry blood bicarbonate  13  meq l; chemistry blood chloride  111  meq l; chemistry blood chloride  113  meq l; chemistry blood creatinine  2.9  mg dl; chemistry blood creatinine  3.2  mg dl; chemistry blood potassium  4.4  meq l; chemistry blood potassium  4.6  meq l; chemistry blood sodium  144  meq l; chemistry blood sodium  143  meq l; chemistry blood urea nitrogen  76  mg dl; chemistry blood urea nitrogen  82  mg dl; hematology blood inr(pt)  1.7  ; hematology urine wbc  6-10  # hpf; chemistry blood calcium, total  7.1  mg dl; chemistry blood calcium, total  6.3  mg dl; chemistry blood bilirubin, total  1.6  mg dl; chemistry blood glucose  220  mg dl; chemistry blood glucose  307  mg dl; chemistry blood lactate dehydrogenase (ld)  288  iu l; blood gas blood lactate  2.6  mmol l; blood gas blood lactate  1.2  mmol l; blood gas blood lactate  1.2  mmol l; blood gas blood hematocrit, calculated  24  %; blood gas blood hemoglobin  8.0  g dl; hematology urine glucose  neg  mg dl; hematology urine bilirubin  neg  mg dl$ns  1000  ml ; d5w  250  ml ; norepinephrine  8  mg ; senna  1  tab ; docusate sodium  100  mg ; pantoprazole  40  mg ; ondansetron  4  mg ; tacrolimus  1  mg ; insulin  0  unit ; heparin  5000  unit ; iso-osmotic dextrose  200  ml ; vancomycin  1000  mg ; ns  500  ml ; mycophenolate mofetil  500  mg ; amiodarone  200  mg ; insulin  40  unit ; aspirin  81  mg ; folic acid  1  mg ; simvastatin  80  mg ; prednisone  5  mg ; ferrous sulfate  325  mg ; lamivudine  50  mg ; iso-osmotic dextrose  50  ml ; piperacillin-tazobactam na  2.25  g ; acetaminophen  650  mg ; prochlorperazine  10  mg ; sw  100  ml ; magnesium sulfate  4  gm ; lidocaine 1%  2  ml ; meperidine  25  mg ; ns (mini bag plus)  100  ml ; meropenem  500  mg ; furosemide  80  mg ; midazolam  100  mg ; ns  250  ml ; fentanyl citrate  2.5  mg ; chlorhexidine gluconate 0.12% oral rinse  15  ml ; valganciclovir suspension  450  mg ; sodium bicarbonate  150  meq ; 
congestive heart failure, unspecified pneumonia, organism unspecified peripheral vascular disease, unspecified diabetes with renal manifestations, type ii or unspecified type, not stated as uncontrolled hypertensive chronic kidney disease, unspecified, with chronic kidney disease stage i through stage iv, or unspecified car driver injured in collision with two- or three-wheeled motor vehicle in nontraffic accident kidney replaced by transplant chronic kidney disease, unspecified hyperpotassemia polyneuropathy in diabetes acute on chronic diastolic heart failure background diabetic retinopathy anemia in chronic kidney disease spontaneous ecchymoses atrial flutter diabetes with neurological manifestations, type ii or unspecified type, not stated as uncontrolled unspecified viral hepatitis c without hepatic coma tachycardia, unspecified pure hypercholesterolemia nephritis and nephropathy, not specified as acute or chronic, in diseases classified elsewhere diabetes with ophthalmic manifestations, type ii or unspecified type, not stated as uncontrolled cellulitis and abscess of upper arm and forearm acute kidney failure, unspecified unspecified viral hepatitis c without hepatic coma heart valve replaced by other means long-term (current) use of steroids diabetes with renal manifestations, type i [juvenile type], not stated as uncontrolled peripheral vascular disease, unspecified light chain (al) amyloidosis kidney replaced by transplant car driver injured in collision with two- or three-wheeled motor vehicle in nontraffic accident dehydration ventral, unspecified, hernia without mention of obstruction or gangrene poisoning by antineoplastic and immunosuppressive drugs diarrhea unspecified car occupant injured in collision with car, pick-up truck or van in nontraffic accident accidental poisoning by primarily systemic agents epilepsy, unspecified, without mention of intractable epilepsy end stage renal disease other and unspecified hyperlipidemia acute kidney failure, unspecified hypertensive chronic kidney disease, unspecified, with chronic kidney disease stage v or end stage renal disease
white m 60 $nan$hematology blood hematocrit  30.0  %; hematology blood hematocrit  25.8  %; hematology blood hemoglobin  9.4  g dl; hematology blood hemoglobin  8.8  g dl; hematology blood platelet count  38  k ul; hematology blood platelet count  38  k ul; chemistry blood anion gap  17  meq l; chemistry blood anion gap  15  meq l; chemistry blood bicarbonate  19  meq l; chemistry blood bicarbonate  18  meq l; chemistry blood chloride  117  meq l; chemistry blood chloride  115  meq l; chemistry blood creatinine  3.2  mg dl; chemistry blood creatinine  3.3  mg dl; chemistry blood potassium  4.1  meq l; chemistry blood potassium  4.3  meq l; chemistry blood sodium  149  meq l; chemistry blood sodium  144  meq l; chemistry blood urea nitrogen  78  mg dl; chemistry blood urea nitrogen  73  mg dl; hematology blood inr(pt)  2.1  ; hematology blood inr(pt)  3.0  ; chemistry blood calcium, total  6.1  mg dl; chemistry blood calcium, total  7.6  mg dl; chemistry blood bilirubin, total  1.6  mg dl; chemistry blood glucose  156  mg dl; chemistry blood glucose  151  mg dl; hematology blood bands  0  %; blood gas blood free calcium  1.04  mmol l; blood gas blood free calcium  1.13  mmol l; blood gas blood free calcium  0.88  mmol l; blood gas blood free calcium  0.88  mmol l; blood gas blood free calcium  0.98  mmol l; blood gas blood lactate  1.2  mmol l$ns  1000  ml ; d5w  250  ml ; norepinephrine  8  mg ; senna  1  tab ; docusate sodium  100  mg ; pantoprazole  40  mg ; ondansetron  4  mg ; tacrolimus  1  mg ; insulin  0  unit ; heparin  5000  unit ; iso-osmotic dextrose  200  ml ; vancomycin  1000  mg ; ns  500  ml ; mycophenolate mofetil  500  mg ; amiodarone  200  mg ; insulin  40  unit ; aspirin  81  mg ; folic acid  1  mg ; simvastatin  80  mg ; prednisone  5  mg ; ferrous sulfate  325  mg ; lamivudine  50  mg ; iso-osmotic dextrose  50  ml ; piperacillin-tazobactam na  2.25  g ; acetaminophen  650  mg ; prochlorperazine  10  mg ; furosemide  80  mg ; midazolam  100  mg ; ns  250  ml ; fentanyl citrate  2.5  mg ; chlorhexidine gluconate 0.12% oral rinse  15  ml ; valganciclovir suspension  450  mg ; sodium bicarbonate  150  meq ; calcium gluconate  2  gm ; d5w  1000  ml ; calcium gluconate  4  gm ; lansoprazole oral disintegrating tab  30  mg ; phytonadione  10  mg ; tacrolimus  0.5  mg ; calcium carbonate  500  mg ; 
congestive heart failure, unspecified pneumonia, organism unspecified peripheral vascular disease, unspecified diabetes with renal manifestations, type ii or unspecified type, not stated as uncontrolled hypertensive chronic kidney disease, unspecified, with chronic kidney disease stage i through stage iv, or unspecified car driver injured in collision with two- or three-wheeled motor vehicle in nontraffic accident kidney replaced by transplant chronic kidney disease, unspecified hyperpotassemia polyneuropathy in diabetes acute on chronic diastolic heart failure background diabetic retinopathy anemia in chronic kidney disease spontaneous ecchymoses atrial flutter diabetes with neurological manifestations, type ii or unspecified type, not stated as uncontrolled unspecified viral hepatitis c without hepatic coma tachycardia, unspecified pure hypercholesterolemia nephritis and nephropathy, not specified as acute or chronic, in diseases classified elsewhere diabetes with ophthalmic manifestations, type ii or unspecified type, not stated as uncontrolled cellulitis and abscess of upper arm and forearm acute kidney failure, unspecified unspecified viral hepatitis c without hepatic coma heart valve replaced by other means long-term (current) use of steroids diabetes with renal manifestations, type i [juvenile type], not stated as uncontrolled peripheral vascular disease, unspecified light chain (al) amyloidosis kidney replaced by transplant car driver injured in collision with two- or three-wheeled motor vehicle in nontraffic accident dehydration ventral, unspecified, hernia without mention of obstruction or gangrene poisoning by antineoplastic and immunosuppressive drugs diarrhea unspecified car occupant injured in collision with car, pick-up truck or van in nontraffic accident accidental poisoning by primarily systemic agents epilepsy, unspecified, without mention of intractable epilepsy end stage renal disease other and unspecified hyperlipidemia acute kidney failure, unspecified hypertensive chronic kidney disease, unspecified, with chronic kidney disease stage v or end stage renal disease
white m 60 $nan$hematology blood hematocrit  25.6  %; hematology blood hemoglobin  8.2  g dl; hematology blood platelet count  37  k ul; chemistry blood anion gap  16  meq l; chemistry blood anion gap  19  meq l; chemistry blood bicarbonate  17  meq l; chemistry blood bicarbonate  15  meq l; chemistry blood chloride  115  meq l; chemistry blood chloride  114  meq l; chemistry blood creatinine  3.9  mg dl; chemistry blood creatinine  4.4  mg dl; chemistry blood potassium  4.2  meq l; chemistry blood potassium  4.7  meq l; chemistry blood sodium  144  meq l; chemistry blood sodium  143  meq l; chemistry blood urea nitrogen  78  mg dl; chemistry blood urea nitrogen  84  mg dl; hematology blood inr(pt)  4.0  ; chemistry blood calcium, total  7.6  mg dl; chemistry blood calcium, total  8.1  mg dl; chemistry blood bilirubin, indirect  0.2  mg dl; chemistry blood bilirubin, total  0.8  mg dl; chemistry blood glucose  103  mg dl; chemistry blood glucose  183  mg dl; chemistry blood lactate dehydrogenase (ld)  246  iu l; blood gas blood free calcium  1.10  mmol l; blood gas blood free calcium  1.16  mmol l; blood gas blood free calcium  1.13  mmol l; blood gas blood lactate  1.2  mmol l; blood gas blood lactate  1.2  mmol l; chemistry blood bilirubin, direct  0.6  mg dl$d5w  250  ml ; norepinephrine  8  mg ; senna  1  tab ; docusate sodium  100  mg ; ondansetron  4  mg ; insulin  0  unit ; heparin  5000  unit ; iso-osmotic dextrose  200  ml ; vancomycin  1000  mg ; mycophenolate mofetil  500  mg ; amiodarone  200  mg ; insulin  40  unit ; aspirin  81  mg ; folic acid  1  mg ; simvastatin  80  mg ; prednisone  5  mg ; ferrous sulfate  325  mg ; lamivudine  50  mg ; iso-osmotic dextrose  50  ml ; piperacillin-tazobactam na  2.25  g ; acetaminophen  650  mg ; prochlorperazine  10  mg ; midazolam  100  mg ; ns  250  ml ; fentanyl citrate  2.5  mg ; chlorhexidine gluconate 0.12% oral rinse  15  ml ; calcium gluconate  4  gm ; lansoprazole oral disintegrating tab  30  mg ; phytonadione  10  mg ; tacrolimus  0.5  mg ; calcium carbonate  500  mg ; calcium gluconate  3  gm ; vancomycin  750  mg ; sodium bicarbonate  1300  mg ; hydrocortisone na succ.  50  mg ; 
congestive heart failure, unspecified pneumonia, organism unspecified peripheral vascular disease, unspecified diabetes with renal manifestations, type ii or unspecified type, not stated as uncontrolled hypertensive chronic kidney disease, unspecified, with chronic kidney disease stage i through stage iv, or unspecified car driver injured in collision with two- or three-wheeled motor vehicle in nontraffic accident kidney replaced by transplant chronic kidney disease, unspecified hyperpotassemia polyneuropathy in diabetes acute on chronic diastolic heart failure background diabetic retinopathy anemia in chronic kidney disease spontaneous ecchymoses atrial flutter diabetes with neurological manifestations, type ii or unspecified type, not stated as uncontrolled unspecified viral hepatitis c without hepatic coma tachycardia, unspecified pure hypercholesterolemia nephritis and nephropathy, not specified as acute or chronic, in diseases classified elsewhere diabetes with ophthalmic manifestations, type ii or unspecified type, not stated as uncontrolled cellulitis and abscess of upper arm and forearm acute kidney failure, unspecified unspecified viral hepatitis c without hepatic coma heart valve replaced by other means long-term (current) use of steroids diabetes with renal manifestations, type i [juvenile type], not stated as uncontrolled peripheral vascular disease, unspecified light chain (al) amyloidosis kidney replaced by transplant car driver injured in collision with two- or three-wheeled motor vehicle in nontraffic accident dehydration ventral, unspecified, hernia without mention of obstruction or gangrene poisoning by antineoplastic and immunosuppressive drugs diarrhea unspecified car occupant injured in collision with car, pick-up truck or van in nontraffic accident accidental poisoning by primarily systemic agents epilepsy, unspecified, without mention of intractable epilepsy end stage renal disease other and unspecified hyperlipidemia acute kidney failure, unspecified hypertensive chronic kidney disease, unspecified, with chronic kidney disease stage v or end stage renal disease
white m 60 $nan$hematology blood hematocrit  26.3  %; hematology blood hematocrit  26.3  %; hematology blood hemoglobin  8.3  g dl; hematology blood hemoglobin  8.4  g dl; hematology blood platelet count  36  k ul; hematology blood platelet count  40  k ul; chemistry blood anion gap  18  meq l; chemistry blood anion gap  21  meq l; chemistry blood bicarbonate  16  meq l; chemistry blood bicarbonate  14  meq l; chemistry blood chloride  116  meq l; chemistry blood chloride  113  meq l; chemistry blood creatinine  4.8  mg dl; chemistry blood creatinine  5.4  mg dl; chemistry blood potassium  4.7  meq l; chemistry blood potassium  4.5  meq l; chemistry blood sodium  145  meq l; chemistry blood sodium  143  meq l; chemistry blood urea nitrogen  92  mg dl; chemistry blood urea nitrogen  106  mg dl; hematology blood inr(pt)  4.0  ; hematology blood inr(pt)  4.1  ; chemistry urine creatinine, urine  107  mg dl; chemistry blood calcium, total  7.6  mg dl; chemistry blood calcium, total  7.8  mg dl; chemistry blood glucose  150  mg dl; chemistry blood glucose  173  mg dl; hematology blood bands  13  %; chemistry urine protein creatinine ratio  0.9  ratio; blood gas blood free calcium  1.15  mmol l; blood gas blood free calcium  1.12  mmol l; blood gas blood lactate  1.5  mmol l$senna  1  tab ; docusate sodium  100  mg ; ondansetron  4  mg ; mycophenolate mofetil  500  mg ; amiodarone  200  mg ; aspirin  81  mg ; folic acid  1  mg ; simvastatin  80  mg ; ferrous sulfate  325  mg ; lamivudine  50  mg ; acetaminophen  650  mg ; prochlorperazine  10  mg ; midazolam  100  mg ; ns  250  ml ; fentanyl citrate  2.5  mg ; chlorhexidine gluconate 0.12% oral rinse  15  ml ; lansoprazole oral disintegrating tab  30  mg ; calcium carbonate  500  mg ; calcium gluconate  3  gm ; sodium bicarbonate  1300  mg ; hydrocortisone na succ.  50  mg ; vial  1  vial ; epoetin alfa  2000  unit ; calcitriol  0.25  mcg ; 
congestive heart failure, unspecified pneumonia, organism unspecified peripheral vascular disease, unspecified diabetes with renal manifestations, type ii or unspecified type, not stated as uncontrolled hypertensive chronic kidney disease, unspecified, with chronic kidney disease stage i through stage iv, or unspecified car driver injured in collision with two- or three-wheeled motor vehicle in nontraffic accident kidney replaced by transplant chronic kidney disease, unspecified hyperpotassemia polyneuropathy in diabetes acute on chronic diastolic heart failure background diabetic retinopathy anemia in chronic kidney disease spontaneous ecchymoses atrial flutter diabetes with neurological manifestations, type ii or unspecified type, not stated as uncontrolled unspecified viral hepatitis c without hepatic coma tachycardia, unspecified pure hypercholesterolemia nephritis and nephropathy, not specified as acute or chronic, in diseases classified elsewhere diabetes with ophthalmic manifestations, type ii or unspecified type, not stated as uncontrolled cellulitis and abscess of upper arm and forearm acute kidney failure, unspecified unspecified viral hepatitis c without hepatic coma heart valve replaced by other means long-term (current) use of steroids diabetes with renal manifestations, type i [juvenile type], not stated as uncontrolled peripheral vascular disease, unspecified light chain (al) amyloidosis kidney replaced by transplant car driver injured in collision with two- or three-wheeled motor vehicle in nontraffic accident dehydration ventral, unspecified, hernia without mention of obstruction or gangrene poisoning by antineoplastic and immunosuppressive drugs diarrhea unspecified car occupant injured in collision with car, pick-up truck or van in nontraffic accident accidental poisoning by primarily systemic agents epilepsy, unspecified, without mention of intractable epilepsy end stage renal disease other and unspecified hyperlipidemia acute kidney failure, unspecified hypertensive chronic kidney disease, unspecified, with chronic kidney disease stage v or end stage renal disease
white m 60 $nan$hematology blood hematocrit  28.0  %; hematology blood hemoglobin  8.8  g dl; hematology blood platelet count  46  k ul; chemistry blood anion gap  22  meq l; chemistry blood anion gap  20  meq l; chemistry blood bicarbonate  17  meq l; chemistry blood bicarbonate  13  meq l; chemistry blood chloride  113  meq l; chemistry blood chloride  111  meq l; chemistry blood creatinine  5.6  mg dl; chemistry blood creatinine  4.7  mg dl; chemistry blood potassium  4.6  meq l; chemistry blood potassium  3.9  meq l; chemistry blood sodium  143  meq l; chemistry blood sodium  144  meq l; chemistry blood urea nitrogen  119  mg dl; chemistry blood urea nitrogen  103  mg dl; hematology blood inr(pt)  4.0  ; chemistry blood calcium, total  7.5  mg dl; chemistry blood calcium, total  8.0  mg dl; chemistry blood glucose  164  mg dl; chemistry blood glucose  157  mg dl; blood gas blood free calcium  1.05  mmol l; blood gas blood free calcium  1.10  mmol l$senna  1  tab ; docusate sodium  100  mg ; ondansetron  4  mg ; mycophenolate mofetil  500  mg ; amiodarone  200  mg ; aspirin  81  mg ; folic acid  1  mg ; simvastatin  80  mg ; ferrous sulfate  325  mg ; lamivudine  50  mg ; prochlorperazine  10  mg ; midazolam  100  mg ; ns  250  ml ; fentanyl citrate  2.5  mg ; chlorhexidine gluconate 0.12% oral rinse  15  ml ; lansoprazole oral disintegrating tab  30  mg ; calcium carbonate  500  mg ; sodium bicarbonate  1300  mg ; vial  1  vial ; epoetin alfa  2000  unit ; calcitriol  0.25  mcg ; fentanyl citrate  25-100  mcg ; midazolam  0.5-2  mg ; furosemide  100  mg ; furosemide  1000  mg ; d5w  25  ml ; chlorothiazide sodium  250  mg ; 
congestive heart failure, unspecified pneumonia, organism unspecified peripheral vascular disease, unspecified diabetes with renal manifestations, type ii or unspecified type, not stated as uncontrolled hypertensive chronic kidney disease, unspecified, with chronic kidney disease stage i through stage iv, or unspecified car driver injured in collision with two- or three-wheeled motor vehicle in nontraffic accident kidney replaced by transplant chronic kidney disease, unspecified hyperpotassemia polyneuropathy in diabetes acute on chronic diastolic heart failure background diabetic retinopathy anemia in chronic kidney disease spontaneous ecchymoses atrial flutter diabetes with neurological manifestations, type ii or unspecified type, not stated as uncontrolled unspecified viral hepatitis c without hepatic coma tachycardia, unspecified pure hypercholesterolemia nephritis and nephropathy, not specified as acute or chronic, in diseases classified elsewhere diabetes with ophthalmic manifestations, type ii or unspecified type, not stated as uncontrolled cellulitis and abscess of upper arm and forearm acute kidney failure, unspecified unspecified viral hepatitis c without hepatic coma heart valve replaced by other means long-term (current) use of steroids diabetes with renal manifestations, type i [juvenile type], not stated as uncontrolled peripheral vascular disease, unspecified light chain (al) amyloidosis kidney replaced by transplant car driver injured in collision with two- or three-wheeled motor vehicle in nontraffic accident dehydration ventral, unspecified, hernia without mention of obstruction or gangrene poisoning by antineoplastic and immunosuppressive drugs diarrhea unspecified car occupant injured in collision with car, pick-up truck or van in nontraffic accident accidental poisoning by primarily systemic agents epilepsy, unspecified, without mention of intractable epilepsy end stage renal disease other and unspecified hyperlipidemia acute kidney failure, unspecified hypertensive chronic kidney disease, unspecified, with chronic kidney disease stage v or end stage renal disease
white m 60 $nan$hematology blood hematocrit  26.3  %; hematology blood hemoglobin  8.5  g dl; hematology blood platelet count  45  k ul; chemistry blood anion gap  17  meq l; chemistry blood anion gap  21  meq l; chemistry blood bicarbonate  17  meq l; chemistry blood bicarbonate  17  meq l; chemistry blood chloride  111  meq l; chemistry blood chloride  108  meq l; chemistry blood creatinine  4.7  mg dl; chemistry blood creatinine  5.0  mg dl; chemistry blood potassium  3.3  meq l; chemistry blood potassium  3.9  meq l; chemistry blood sodium  142  meq l; chemistry blood sodium  142  meq l; chemistry blood urea nitrogen  79  mg dl; chemistry blood urea nitrogen  126  mg dl; hematology blood inr(pt)  2.4  ; chemistry blood calcium, total  7.9  mg dl; chemistry blood calcium, total  8.7  mg dl; chemistry blood glucose  115  mg dl; chemistry blood glucose  201  mg dl; hematology blood bands  12  %; blood gas blood free calcium  1.08  mmol l; blood gas blood free calcium  1.16  mmol l$senna  1  tab ; docusate sodium  100  mg ; ondansetron  4  mg ; amiodarone  200  mg ; aspirin  81  mg ; folic acid  1  mg ; simvastatin  80  mg ; lamivudine  50  mg ; prochlorperazine  10  mg ; chlorhexidine gluconate 0.12% oral rinse  15  ml ; lansoprazole oral disintegrating tab  30  mg ; calcium carbonate  500  mg ; vial  1  vial ; epoetin alfa  2000  unit ; calcitriol  0.25  mcg ; furosemide  100  mg ; d5w  25  ml ; chlorothiazide sodium  250  mg ; potassium chloride  40  meq ; d5w  50  ml ; ethacrynate sodium  50  mg ; lamivudine  25  mg ; 
congestive heart failure, unspecified pneumonia, organism unspecified peripheral vascular disease, unspecified diabetes with renal manifestations, type ii or unspecified type, not stated as uncontrolled hypertensive chronic kidney disease, unspecified, with chronic kidney disease stage i through stage iv, or unspecified car driver injured in collision with two- or three-wheeled motor vehicle in nontraffic accident kidney replaced by transplant chronic kidney disease, unspecified hyperpotassemia polyneuropathy in diabetes acute on chronic diastolic heart failure background diabetic retinopathy anemia in chronic kidney disease spontaneous ecchymoses atrial flutter diabetes with neurological manifestations, type ii or unspecified type, not stated as uncontrolled unspecified viral hepatitis c without hepatic coma tachycardia, unspecified pure hypercholesterolemia nephritis and nephropathy, not specified as acute or chronic, in diseases classified elsewhere diabetes with ophthalmic manifestations, type ii or unspecified type, not stated as uncontrolled cellulitis and abscess of upper arm and forearm acute kidney failure, unspecified unspecified viral hepatitis c without hepatic coma heart valve replaced by other means long-term (current) use of steroids diabetes with renal manifestations, type i [juvenile type], not stated as uncontrolled peripheral vascular disease, unspecified light chain (al) amyloidosis kidney replaced by transplant car driver injured in collision with two- or three-wheeled motor vehicle in nontraffic accident dehydration ventral, unspecified, hernia without mention of obstruction or gangrene poisoning by antineoplastic and immunosuppressive drugs diarrhea unspecified car occupant injured in collision with car, pick-up truck or van in nontraffic accident accidental poisoning by primarily systemic agents epilepsy, unspecified, without mention of intractable epilepsy end stage renal disease other and unspecified hyperlipidemia acute kidney failure, unspecified hypertensive chronic kidney disease, unspecified, with chronic kidney disease stage v or end stage renal disease
white m 60 $nan$hematology blood hematocrit  26.3  %; hematology blood hemoglobin  8.7  g dl; hematology blood platelet count  44  k ul; chemistry blood anion gap  18  meq l; chemistry blood anion gap  18  meq l; chemistry blood bicarbonate  19  meq l; chemistry blood bicarbonate  18  meq l; chemistry blood chloride  108  meq l; chemistry blood chloride  109  meq l; chemistry blood creatinine  4.8  mg dl; chemistry blood creatinine  4.4  mg dl; chemistry blood potassium  3.6  meq l; chemistry blood potassium  4.2  meq l; chemistry blood sodium  141  meq l; chemistry blood sodium  141  meq l; chemistry blood urea nitrogen  133  mg dl; chemistry blood urea nitrogen  134  mg dl; hematology blood inr(pt)  1.8  ; chemistry blood calcium, total  7.9  mg dl; chemistry blood calcium, total  8.0  mg dl; chemistry blood glucose  98  mg dl; chemistry blood glucose  278  mg dl; hematology blood bands  16  %$senna  1  tab ; docusate sodium  100  mg ; ondansetron  4  mg ; amiodarone  200  mg ; aspirin  81  mg ; folic acid  1  mg ; simvastatin  80  mg ; prochlorperazine  10  mg ; chlorhexidine gluconate 0.12% oral rinse  15  ml ; lansoprazole oral disintegrating tab  30  mg ; calcium carbonate  500  mg ; vial  1  vial ; epoetin alfa  2000  unit ; calcitriol  0.25  mcg ; potassium chloride  40  meq ; d5w  50  ml ; ethacrynate sodium  50  mg ; lamivudine  25  mg ; sw  50  ml ; potassium chloride  20  meq ; metoprolol tartrate  50  mg ; 
congestive heart failure, unspecified pneumonia, organism unspecified peripheral vascular disease, unspecified diabetes with renal manifestations, type ii or unspecified type, not stated as uncontrolled hypertensive chronic kidney disease, unspecified, with chronic kidney disease stage i through stage iv, or unspecified car driver injured in collision with two- or three-wheeled motor vehicle in nontraffic accident kidney replaced by transplant chronic kidney disease, unspecified hyperpotassemia polyneuropathy in diabetes acute on chronic diastolic heart failure background diabetic retinopathy anemia in chronic kidney disease spontaneous ecchymoses atrial flutter diabetes with neurological manifestations, type ii or unspecified type, not stated as uncontrolled unspecified viral hepatitis c without hepatic coma tachycardia, unspecified pure hypercholesterolemia nephritis and nephropathy, not specified as acute or chronic, in diseases classified elsewhere diabetes with ophthalmic manifestations, type ii or unspecified type, not stated as uncontrolled cellulitis and abscess of upper arm and forearm acute kidney failure, unspecified unspecified viral hepatitis c without hepatic coma heart valve replaced by other means long-term (current) use of steroids diabetes with renal manifestations, type i [juvenile type], not stated as uncontrolled peripheral vascular disease, unspecified light chain (al) amyloidosis kidney replaced by transplant car driver injured in collision with two- or three-wheeled motor vehicle in nontraffic accident dehydration ventral, unspecified, hernia without mention of obstruction or gangrene poisoning by antineoplastic and immunosuppressive drugs diarrhea unspecified car occupant injured in collision with car, pick-up truck or van in nontraffic accident accidental poisoning by primarily systemic agents epilepsy, unspecified, without mention of intractable epilepsy end stage renal disease other and unspecified hyperlipidemia acute kidney failure, unspecified hypertensive chronic kidney disease, unspecified, with chronic kidney disease stage v or end stage renal disease
white m 60 $nan$hematology blood hematocrit  24.7  %; hematology blood hemoglobin  8.0  g dl; hematology blood platelet count  38  k ul; chemistry blood anion gap  17  meq l; chemistry blood anion gap  16  meq l; chemistry blood bicarbonate  20  meq l; chemistry blood bicarbonate  20  meq l; chemistry blood chloride  112  meq l; chemistry blood chloride  117  meq l; chemistry blood creatinine  4.1  mg dl; chemistry blood creatinine  3.3  mg dl; chemistry blood potassium  3.8  meq l; chemistry blood potassium  4.2  meq l; chemistry blood sodium  145  meq l; chemistry blood sodium  149  meq l; chemistry blood urea nitrogen  131  mg dl; chemistry blood urea nitrogen  118  mg dl; hematology blood inr(pt)  1.6  ; chemistry blood calcium, total  8.1  mg dl; chemistry blood calcium, total  8.0  mg dl; chemistry blood glucose  148  mg dl; chemistry blood glucose  91  mg dl$senna  1  tab ; docusate sodium  100  mg ; ondansetron  4  mg ; amiodarone  200  mg ; aspirin  81  mg ; folic acid  1  mg ; simvastatin  80  mg ; prochlorperazine  10  mg ; chlorhexidine gluconate 0.12% oral rinse  15  ml ; lansoprazole oral disintegrating tab  30  mg ; calcium carbonate  500  mg ; vial  1  vial ; epoetin alfa  2000  unit ; calcitriol  0.25  mcg ; lamivudine  25  mg ; sw  50  ml ; potassium chloride  20  meq ; metoprolol tartrate  50  mg ; warfarin  5  mg ; 1 2 ns  1000  ml ; bacitracin ointment  1  appl ; 
congestive heart failure, unspecified pneumonia, organism unspecified peripheral vascular disease, unspecified diabetes with renal manifestations, type ii or unspecified type, not stated as uncontrolled hypertensive chronic kidney disease, unspecified, with chronic kidney disease stage i through stage iv, or unspecified car driver injured in collision with two- or three-wheeled motor vehicle in nontraffic accident kidney replaced by transplant chronic kidney disease, unspecified hyperpotassemia polyneuropathy in diabetes acute on chronic diastolic heart failure background diabetic retinopathy anemia in chronic kidney disease spontaneous ecchymoses atrial flutter diabetes with neurological manifestations, type ii or unspecified type, not stated as uncontrolled unspecified viral hepatitis c without hepatic coma tachycardia, unspecified pure hypercholesterolemia nephritis and nephropathy, not specified as acute or chronic, in diseases classified elsewhere diabetes with ophthalmic manifestations, type ii or unspecified type, not stated as uncontrolled cellulitis and abscess of upper arm and forearm acute kidney failure, unspecified unspecified viral hepatitis c without hepatic coma heart valve replaced by other means long-term (current) use of steroids diabetes with renal manifestations, type i [juvenile type], not stated as uncontrolled peripheral vascular disease, unspecified light chain (al) amyloidosis kidney replaced by transplant car driver injured in collision with two- or three-wheeled motor vehicle in nontraffic accident dehydration ventral, unspecified, hernia without mention of obstruction or gangrene poisoning by antineoplastic and immunosuppressive drugs diarrhea unspecified car occupant injured in collision with car, pick-up truck or van in nontraffic accident accidental poisoning by primarily systemic agents epilepsy, unspecified, without mention of intractable epilepsy end stage renal disease other and unspecified hyperlipidemia acute kidney failure, unspecified hypertensive chronic kidney disease, unspecified, with chronic kidney disease stage v or end stage renal disease
white m 60 $nan$hematology blood hematocrit  22.5  %; hematology blood hematocrit  25.0  %; hematology blood hemoglobin  7.3  g dl; hematology blood platelet count  34  k ul; chemistry blood anion gap  15  meq l; chemistry blood bicarbonate  20  meq l; chemistry blood chloride  115  meq l; chemistry blood creatinine  2.7  mg dl; chemistry blood potassium  4.1  meq l; chemistry blood sodium  146  meq l; chemistry blood urea nitrogen  100  mg dl; hematology blood inr(pt)  1.6  ; chemistry blood calcium, total  8.0  mg dl; chemistry blood glucose  90  mg dl$senna  1  tab ; docusate sodium  100  mg ; ondansetron  4  mg ; amiodarone  200  mg ; aspirin  81  mg ; folic acid  1  mg ; simvastatin  80  mg ; prochlorperazine  10  mg ; lansoprazole oral disintegrating tab  30  mg ; calcium carbonate  500  mg ; vial  1  vial ; epoetin alfa  2000  unit ; calcitriol  0.25  mcg ; lamivudine  25  mg ; metoprolol tartrate  50  mg ; warfarin  5  mg ; 1 2 ns  1000  ml ; bacitracin ointment  1  appl ; epoetin alfa  4000  unit ; simethicone  40-80  mg ; 
congestive heart failure, unspecified pneumonia, organism unspecified peripheral vascular disease, unspecified diabetes with renal manifestations, type ii or unspecified type, not stated as uncontrolled hypertensive chronic kidney disease, unspecified, with chronic kidney disease stage i through stage iv, or unspecified car driver injured in collision with two- or three-wheeled motor vehicle in nontraffic accident kidney replaced by transplant chronic kidney disease, unspecified hyperpotassemia polyneuropathy in diabetes acute on chronic diastolic heart failure background diabetic retinopathy anemia in chronic kidney disease spontaneous ecchymoses atrial flutter diabetes with neurological manifestations, type ii or unspecified type, not stated as uncontrolled unspecified viral hepatitis c without hepatic coma tachycardia, unspecified pure hypercholesterolemia nephritis and nephropathy, not specified as acute or chronic, in diseases classified elsewhere diabetes with ophthalmic manifestations, type ii or unspecified type, not stated as uncontrolled cellulitis and abscess of upper arm and forearm acute kidney failure, unspecified unspecified viral hepatitis c without hepatic coma heart valve replaced by other means long-term (current) use of steroids diabetes with renal manifestations, type i [juvenile type], not stated as uncontrolled peripheral vascular disease, unspecified light chain (al) amyloidosis kidney replaced by transplant car driver injured in collision with two- or three-wheeled motor vehicle in nontraffic accident dehydration ventral, unspecified, hernia without mention of obstruction or gangrene poisoning by antineoplastic and immunosuppressive drugs diarrhea unspecified car occupant injured in collision with car, pick-up truck or van in nontraffic accident accidental poisoning by primarily systemic agents epilepsy, unspecified, without mention of intractable epilepsy end stage renal disease other and unspecified hyperlipidemia acute kidney failure, unspecified hypertensive chronic kidney disease, unspecified, with chronic kidney disease stage v or end stage renal disease
white m 60 $nan$hematology blood hematocrit  24.1  %; hematology blood hemoglobin  7.9  g dl; hematology blood platelet count  32  k ul; chemistry blood anion gap  13  meq l; chemistry blood anion gap  14  meq l; chemistry blood bicarbonate  19  meq l; chemistry blood bicarbonate  18  meq l; chemistry blood chloride  120  meq l; chemistry blood chloride  118  meq l; chemistry blood creatinine  1.9  mg dl; chemistry blood creatinine  1.7  mg dl; chemistry blood potassium  4.6  meq l; chemistry blood potassium  5.3  meq l; chemistry blood sodium  147  meq l; chemistry blood sodium  145  meq l; chemistry blood urea nitrogen  70  mg dl; chemistry blood urea nitrogen  60  mg dl; hematology blood inr(pt)  2.1  ; hematology urine wbc  >50  # hpf; chemistry blood calcium, total  8.2  mg dl; chemistry blood glucose  92  mg dl; chemistry blood glucose  120  mg dl; hematology urine glucose  neg  mg dl; hematology urine bilirubin  neg  mg dl$senna  1  tab ; docusate sodium  100  mg ; ondansetron  4  mg ; amiodarone  200  mg ; aspirin  81  mg ; folic acid  1  mg ; simvastatin  80  mg ; prochlorperazine  10  mg ; lansoprazole oral disintegrating tab  30  mg ; calcium carbonate  500  mg ; metoprolol tartrate  50  mg ; warfarin  5  mg ; bacitracin ointment  1  appl ; epoetin alfa  4000  unit ; simethicone  40-80  mg ; d5 1 2ns  1000  ml ; 
congestive heart failure, unspecified pneumonia, organism unspecified peripheral vascular disease, unspecified diabetes with renal manifestations, type ii or unspecified type, not stated as uncontrolled hypertensive chronic kidney disease, unspecified, with chronic kidney disease stage i through stage iv, or unspecified car driver injured in collision with two- or three-wheeled motor vehicle in nontraffic accident kidney replaced by transplant chronic kidney disease, unspecified hyperpotassemia polyneuropathy in diabetes acute on chronic diastolic heart failure background diabetic retinopathy anemia in chronic kidney disease spontaneous ecchymoses atrial flutter diabetes with neurological manifestations, type ii or unspecified type, not stated as uncontrolled unspecified viral hepatitis c without hepatic coma tachycardia, unspecified pure hypercholesterolemia nephritis and nephropathy, not specified as acute or chronic, in diseases classified elsewhere diabetes with ophthalmic manifestations, type ii or unspecified type, not stated as uncontrolled cellulitis and abscess of upper arm and forearm acute kidney failure, unspecified unspecified viral hepatitis c without hepatic coma heart valve replaced by other means long-term (current) use of steroids diabetes with renal manifestations, type i [juvenile type], not stated as uncontrolled peripheral vascular disease, unspecified light chain (al) amyloidosis kidney replaced by transplant car driver injured in collision with two- or three-wheeled motor vehicle in nontraffic accident dehydration ventral, unspecified, hernia without mention of obstruction or gangrene poisoning by antineoplastic and immunosuppressive drugs diarrhea unspecified car occupant injured in collision with car, pick-up truck or van in nontraffic accident accidental poisoning by primarily systemic agents epilepsy, unspecified, without mention of intractable epilepsy end stage renal disease other and unspecified hyperlipidemia acute kidney failure, unspecified hypertensive chronic kidney disease, unspecified, with chronic kidney disease stage v or end stage renal disease
white m 60 $nan$hematology blood hematocrit  22.7  %; hematology blood hemoglobin  7.3  g dl; hematology blood platelet count  40  k ul; chemistry blood anion gap  11  meq l; chemistry blood bicarbonate  20  meq l; chemistry blood chloride  118  meq l; chemistry blood creatinine  1.5  mg dl; chemistry blood potassium  4.8  meq l; chemistry blood sodium  144  meq l; chemistry blood urea nitrogen  48  mg dl; chemistry blood calcium, total  8.2  mg dl; chemistry blood glucose  93  mg dl; hematology blood bands  1  %$senna  1  tab ; docusate sodium  100  mg ; ondansetron  4  mg ; amiodarone  200  mg ; aspirin  81  mg ; folic acid  1  mg ; simvastatin  80  mg ; prochlorperazine  10  mg ; lansoprazole oral disintegrating tab  30  mg ; calcium carbonate  500  mg ; metoprolol tartrate  50  mg ; warfarin  5  mg ; bacitracin ointment  1  appl ; epoetin alfa  4000  unit ; simethicone  40-80  mg ; d5 1 2ns  1000  ml ; 
congestive heart failure, unspecified pneumonia, organism unspecified peripheral vascular disease, unspecified diabetes with renal manifestations, type ii or unspecified type, not stated as uncontrolled hypertensive chronic kidney disease, unspecified, with chronic kidney disease stage i through stage iv, or unspecified car driver injured in collision with two- or three-wheeled motor vehicle in nontraffic accident kidney replaced by transplant chronic kidney disease, unspecified hyperpotassemia polyneuropathy in diabetes acute on chronic diastolic heart failure background diabetic retinopathy anemia in chronic kidney disease spontaneous ecchymoses atrial flutter diabetes with neurological manifestations, type ii or unspecified type, not stated as uncontrolled unspecified viral hepatitis c without hepatic coma tachycardia, unspecified pure hypercholesterolemia nephritis and nephropathy, not specified as acute or chronic, in diseases classified elsewhere diabetes with ophthalmic manifestations, type ii or unspecified type, not stated as uncontrolled cellulitis and abscess of upper arm and forearm acute kidney failure, unspecified unspecified viral hepatitis c without hepatic coma heart valve replaced by other means long-term (current) use of steroids diabetes with renal manifestations, type i [juvenile type], not stated as uncontrolled peripheral vascular disease, unspecified light chain (al) amyloidosis kidney replaced by transplant car driver injured in collision with two- or three-wheeled motor vehicle in nontraffic accident dehydration ventral, unspecified, hernia without mention of obstruction or gangrene poisoning by antineoplastic and immunosuppressive drugs diarrhea unspecified car occupant injured in collision with car, pick-up truck or van in nontraffic accident accidental poisoning by primarily systemic agents epilepsy, unspecified, without mention of intractable epilepsy end stage renal disease other and unspecified hyperlipidemia acute kidney failure, unspecified hypertensive chronic kidney disease, unspecified, with chronic kidney disease stage v or end stage renal disease
white m 60 $nan$hematology blood hematocrit  25.0  %; hematology blood hemoglobin  8.0  g dl; hematology blood platelet count  46  k ul; chemistry blood anion gap  11  meq l; chemistry blood bicarbonate  18  meq l; chemistry blood chloride  120  meq l; chemistry blood creatinine  1.3  mg dl; chemistry blood potassium  5.3  meq l; chemistry blood sodium  144  meq l; chemistry blood urea nitrogen  41  mg dl; hematology blood inr(pt)  4.3  ; chemistry blood calcium, total  8.4  mg dl; chemistry blood glucose  65  mg dl$senna  1  tab ; docusate sodium  100  mg ; ondansetron  4  mg ; amiodarone  200  mg ; aspirin  81  mg ; folic acid  1  mg ; simvastatin  80  mg ; prochlorperazine  10  mg ; lansoprazole oral disintegrating tab  30  mg ; calcium carbonate  500  mg ; metoprolol tartrate  50  mg ; warfarin  5  mg ; bacitracin ointment  1  appl ; epoetin alfa  4000  unit ; simethicone  40-80  mg ; sodium chloride 0.9%  flush  10  ml ; heparin flush (100 units ml)  2  ml ; 
congestive heart failure, unspecified pneumonia, organism unspecified peripheral vascular disease, unspecified diabetes with renal manifestations, type ii or unspecified type, not stated as uncontrolled hypertensive chronic kidney disease, unspecified, with chronic kidney disease stage i through stage iv, or unspecified car driver injured in collision with two- or three-wheeled motor vehicle in nontraffic accident kidney replaced by transplant chronic kidney disease, unspecified hyperpotassemia polyneuropathy in diabetes acute on chronic diastolic heart failure background diabetic retinopathy anemia in chronic kidney disease spontaneous ecchymoses atrial flutter diabetes with neurological manifestations, type ii or unspecified type, not stated as uncontrolled unspecified viral hepatitis c without hepatic coma tachycardia, unspecified pure hypercholesterolemia nephritis and nephropathy, not specified as acute or chronic, in diseases classified elsewhere diabetes with ophthalmic manifestations, type ii or unspecified type, not stated as uncontrolled cellulitis and abscess of upper arm and forearm acute kidney failure, unspecified unspecified viral hepatitis c without hepatic coma heart valve replaced by other means long-term (current) use of steroids diabetes with renal manifestations, type i [juvenile type], not stated as uncontrolled peripheral vascular disease, unspecified light chain (al) amyloidosis kidney replaced by transplant car driver injured in collision with two- or three-wheeled motor vehicle in nontraffic accident dehydration ventral, unspecified, hernia without mention of obstruction or gangrene poisoning by antineoplastic and immunosuppressive drugs diarrhea unspecified car occupant injured in collision with car, pick-up truck or van in nontraffic accident accidental poisoning by primarily systemic agents epilepsy, unspecified, without mention of intractable epilepsy end stage renal disease other and unspecified hyperlipidemia acute kidney failure, unspecified hypertensive chronic kidney disease, unspecified, with chronic kidney disease stage v or end stage renal disease
white m 60 $nan$hematology blood hematocrit  22.7  %; hematology blood hematocrit  23.1  %; hematology blood hematocrit  24.2  %; hematology blood hemoglobin  7.4  g dl; hematology blood platelet count  51  k ul; chemistry blood anion gap  10  meq l; chemistry blood bicarbonate  19  meq l; chemistry blood chloride  117  meq l; chemistry blood creatinine  1.4  mg dl; chemistry blood potassium  5.4  meq l; chemistry blood sodium  141  meq l; chemistry blood urea nitrogen  34  mg dl; hematology blood inr(pt)  6.1  ; hematology blood inr(pt)  6.1  ; chemistry blood calcium, total  8.4  mg dl; chemistry blood glucose  63  mg dl$senna  1  tab ; docusate sodium  100  mg ; ondansetron  4  mg ; amiodarone  200  mg ; aspirin  81  mg ; folic acid  1  mg ; simvastatin  80  mg ; prochlorperazine  10  mg ; calcium carbonate  500  mg ; metoprolol tartrate  50  mg ; bacitracin ointment  1  appl ; epoetin alfa  4000  unit ; simethicone  40-80  mg ; sodium chloride 0.9%  flush  10  ml ; heparin flush (100 units ml)  2  ml ; sulfameth trimethoprim ss  1  tab ; sodium polystyrene sulfonate  30  gm ; 
congestive heart failure, unspecified pneumonia, organism unspecified peripheral vascular disease, unspecified diabetes with renal manifestations, type ii or unspecified type, not stated as uncontrolled hypertensive chronic kidney disease, unspecified, with chronic kidney disease stage i through stage iv, or unspecified car driver injured in collision with two- or three-wheeled motor vehicle in nontraffic accident kidney replaced by transplant chronic kidney disease, unspecified hyperpotassemia polyneuropathy in diabetes acute on chronic diastolic heart failure background diabetic retinopathy anemia in chronic kidney disease spontaneous ecchymoses atrial flutter diabetes with neurological manifestations, type ii or unspecified type, not stated as uncontrolled unspecified viral hepatitis c without hepatic coma tachycardia, unspecified pure hypercholesterolemia nephritis and nephropathy, not specified as acute or chronic, in diseases classified elsewhere diabetes with ophthalmic manifestations, type ii or unspecified type, not stated as uncontrolled cellulitis and abscess of upper arm and forearm acute kidney failure, unspecified unspecified viral hepatitis c without hepatic coma heart valve replaced by other means long-term (current) use of steroids diabetes with renal manifestations, type i [juvenile type], not stated as uncontrolled peripheral vascular disease, unspecified light chain (al) amyloidosis kidney replaced by transplant car driver injured in collision with two- or three-wheeled motor vehicle in nontraffic accident dehydration ventral, unspecified, hernia without mention of obstruction or gangrene poisoning by antineoplastic and immunosuppressive drugs diarrhea unspecified car occupant injured in collision with car, pick-up truck or van in nontraffic accident accidental poisoning by primarily systemic agents epilepsy, unspecified, without mention of intractable epilepsy end stage renal disease other and unspecified hyperlipidemia acute kidney failure, unspecified hypertensive chronic kidney disease, unspecified, with chronic kidney disease stage v or end stage renal disease
white m 60 $nan$hematology blood hematocrit  22.9  %; hematology blood hemoglobin  7.6  g dl; hematology blood platelet count  60  k ul; chemistry blood anion gap  9  meq l; chemistry blood bicarbonate  20  meq l; chemistry blood chloride  116  meq l; chemistry blood creatinine  1.2  mg dl; chemistry blood potassium  5.1  meq l; chemistry blood sodium  140  meq l; chemistry blood urea nitrogen  30  mg dl; hematology blood inr(pt)  7.6  ; chemistry blood calcium, total  8.5  mg dl; chemistry blood glucose  62  mg dl$senna  1  tab ; docusate sodium  100  mg ; ondansetron  4  mg ; amiodarone  200  mg ; aspirin  81  mg ; folic acid  1  mg ; simvastatin  80  mg ; prochlorperazine  10  mg ; calcium carbonate  500  mg ; metoprolol tartrate  50  mg ; bacitracin ointment  1  appl ; epoetin alfa  4000  unit ; simethicone  40-80  mg ; sodium chloride 0.9%  flush  10  ml ; heparin flush (100 units ml)  2  ml ; sulfameth trimethoprim ss  1  tab ; sodium polystyrene sulfonate  30  gm ; furosemide  20  mg ; 
congestive heart failure, unspecified pneumonia, organism unspecified peripheral vascular disease, unspecified diabetes with renal manifestations, type ii or unspecified type, not stated as uncontrolled hypertensive chronic kidney disease, unspecified, with chronic kidney disease stage i through stage iv, or unspecified car driver injured in collision with two- or three-wheeled motor vehicle in nontraffic accident kidney replaced by transplant chronic kidney disease, unspecified hyperpotassemia polyneuropathy in diabetes acute on chronic diastolic heart failure background diabetic retinopathy anemia in chronic kidney disease spontaneous ecchymoses atrial flutter diabetes with neurological manifestations, type ii or unspecified type, not stated as uncontrolled unspecified viral hepatitis c without hepatic coma tachycardia, unspecified pure hypercholesterolemia nephritis and nephropathy, not specified as acute or chronic, in diseases classified elsewhere diabetes with ophthalmic manifestations, type ii or unspecified type, not stated as uncontrolled cellulitis and abscess of upper arm and forearm acute kidney failure, unspecified unspecified viral hepatitis c without hepatic coma heart valve replaced by other means long-term (current) use of steroids diabetes with renal manifestations, type i [juvenile type], not stated as uncontrolled peripheral vascular disease, unspecified light chain (al) amyloidosis kidney replaced by transplant car driver injured in collision with two- or three-wheeled motor vehicle in nontraffic accident dehydration ventral, unspecified, hernia without mention of obstruction or gangrene poisoning by antineoplastic and immunosuppressive drugs diarrhea unspecified car occupant injured in collision with car, pick-up truck or van in nontraffic accident accidental poisoning by primarily systemic agents epilepsy, unspecified, without mention of intractable epilepsy end stage renal disease other and unspecified hyperlipidemia acute kidney failure, unspecified hypertensive chronic kidney disease, unspecified, with chronic kidney disease stage v or end stage renal disease
white m 60 $nan$hematology blood hematocrit  27.2  %; hematology blood hemoglobin  8.9  g dl; hematology blood platelet count  66  k ul; chemistry blood anion gap  11  meq l; chemistry blood bicarbonate  21  meq l; chemistry blood chloride  113  meq l; chemistry blood creatinine  1.4  mg dl; chemistry blood potassium  5.3  meq l; chemistry blood potassium  5.4  meq l; chemistry blood sodium  140  meq l; chemistry blood urea nitrogen  36  mg dl; hematology blood inr(pt)  5.6  ; chemistry blood calcium, total  6.6  mg dl; chemistry blood glucose  74  mg dl$senna  1  tab ; docusate sodium  100  mg ; ondansetron  4  mg ; amiodarone  200  mg ; folic acid  1  mg ; simvastatin  80  mg ; prochlorperazine  10  mg ; calcium carbonate  500  mg ; metoprolol tartrate  50  mg ; bacitracin ointment  1  appl ; epoetin alfa  4000  unit ; simethicone  40-80  mg ; sodium chloride 0.9%  flush  10  ml ; heparin flush (100 units ml)  2  ml ; sulfameth trimethoprim ss  1  tab ; furosemide  20  mg ; 
congestive heart failure, unspecified pneumonia, organism unspecified peripheral vascular disease, unspecified diabetes with renal manifestations, type ii or unspecified type, not stated as uncontrolled hypertensive chronic kidney disease, unspecified, with chronic kidney disease stage i through stage iv, or unspecified car driver injured in collision with two- or three-wheeled motor vehicle in nontraffic accident kidney replaced by transplant chronic kidney disease, unspecified hyperpotassemia polyneuropathy in diabetes acute on chronic diastolic heart failure background diabetic retinopathy anemia in chronic kidney disease spontaneous ecchymoses atrial flutter diabetes with neurological manifestations, type ii or unspecified type, not stated as uncontrolled unspecified viral hepatitis c without hepatic coma tachycardia, unspecified pure hypercholesterolemia nephritis and nephropathy, not specified as acute or chronic, in diseases classified elsewhere diabetes with ophthalmic manifestations, type ii or unspecified type, not stated as uncontrolled cellulitis and abscess of upper arm and forearm acute kidney failure, unspecified unspecified viral hepatitis c without hepatic coma heart valve replaced by other means long-term (current) use of steroids diabetes with renal manifestations, type i [juvenile type], not stated as uncontrolled peripheral vascular disease, unspecified light chain (al) amyloidosis kidney replaced by transplant car driver injured in collision with two- or three-wheeled motor vehicle in nontraffic accident dehydration ventral, unspecified, hernia without mention of obstruction or gangrene poisoning by antineoplastic and immunosuppressive drugs diarrhea unspecified car occupant injured in collision with car, pick-up truck or van in nontraffic accident accidental poisoning by primarily systemic agents epilepsy, unspecified, without mention of intractable epilepsy end stage renal disease other and unspecified hyperlipidemia acute kidney failure, unspecified hypertensive chronic kidney disease, unspecified, with chronic kidney disease stage v or end stage renal disease
white m 60 $nan$hematology blood hematocrit  29.1  %; hematology blood hemoglobin  9.6  g dl; hematology blood platelet count  72  k ul; chemistry blood anion gap  12  meq l; chemistry blood bicarbonate  22  meq l; chemistry blood chloride  112  meq l; chemistry blood creatinine  1.5  mg dl; chemistry blood potassium  5.2  meq l; chemistry blood sodium  141  meq l; chemistry blood urea nitrogen  37  mg dl; hematology blood inr(pt)  5.3  ; chemistry blood calcium, total  8.5  mg dl; chemistry blood glucose  65  mg dl; chemistry blood albumin  3.1  g dl; blood gas blood free calcium  1.16  mmol l$senna  1  tab ; docusate sodium  100  mg ; ondansetron  4  mg ; amiodarone  200  mg ; folic acid  1  mg ; simvastatin  80  mg ; prochlorperazine  10  mg ; calcium carbonate  500  mg ; metoprolol tartrate  50  mg ; bacitracin ointment  1  appl ; epoetin alfa  4000  unit ; simethicone  40-80  mg ; sodium chloride 0.9%  flush  10  ml ; heparin flush (100 units ml)  2  ml ; sulfameth trimethoprim ss  1  tab ; 
congestive heart failure, unspecified pneumonia, organism unspecified peripheral vascular disease, unspecified diabetes with renal manifestations, type ii or unspecified type, not stated as uncontrolled hypertensive chronic kidney disease, unspecified, with chronic kidney disease stage i through stage iv, or unspecified car driver injured in collision with two- or three-wheeled motor vehicle in nontraffic accident kidney replaced by transplant chronic kidney disease, unspecified hyperpotassemia polyneuropathy in diabetes acute on chronic diastolic heart failure background diabetic retinopathy anemia in chronic kidney disease spontaneous ecchymoses atrial flutter diabetes with neurological manifestations, type ii or unspecified type, not stated as uncontrolled unspecified viral hepatitis c without hepatic coma tachycardia, unspecified pure hypercholesterolemia nephritis and nephropathy, not specified as acute or chronic, in diseases classified elsewhere diabetes with ophthalmic manifestations, type ii or unspecified type, not stated as uncontrolled cellulitis and abscess of upper arm and forearm acute kidney failure, unspecified unspecified viral hepatitis c without hepatic coma heart valve replaced by other means long-term (current) use of steroids diabetes with renal manifestations, type i [juvenile type], not stated as uncontrolled peripheral vascular disease, unspecified light chain (al) amyloidosis kidney replaced by transplant car driver injured in collision with two- or three-wheeled motor vehicle in nontraffic accident dehydration ventral, unspecified, hernia without mention of obstruction or gangrene poisoning by antineoplastic and immunosuppressive drugs diarrhea unspecified car occupant injured in collision with car, pick-up truck or van in nontraffic accident accidental poisoning by primarily systemic agents epilepsy, unspecified, without mention of intractable epilepsy end stage renal disease other and unspecified hyperlipidemia acute kidney failure, unspecified hypertensive chronic kidney disease, unspecified, with chronic kidney disease stage v or end stage renal disease
white m 60 $nan$hematology blood hematocrit  28.1  %; hematology blood hemoglobin  8.9  g dl; hematology blood platelet count  74  k ul; chemistry blood anion gap  13  meq l; chemistry blood bicarbonate  20  meq l; chemistry blood chloride  112  meq l; chemistry blood creatinine  1.4  mg dl; chemistry blood potassium  4.9  meq l; chemistry blood sodium  140  meq l; chemistry blood urea nitrogen  39  mg dl; hematology blood inr(pt)  4.9  ; chemistry blood glucose  61  mg dl$senna  1  tab ; docusate sodium  100  mg ; ondansetron  4  mg ; amiodarone  200  mg ; folic acid  1  mg ; simvastatin  80  mg ; prochlorperazine  10  mg ; calcium carbonate  500  mg ; metoprolol tartrate  50  mg ; bacitracin ointment  1  appl ; epoetin alfa  4000  unit ; simethicone  40-80  mg ; sodium chloride 0.9%  flush  10  ml ; heparin flush (100 units ml)  2  ml ; sulfameth trimethoprim ss  1  tab ; insulin  20  unit ; lamivudine  100  mg ; heparin flush (10 units ml)  1  ml ; 
congestive heart failure, unspecified pneumonia, organism unspecified peripheral vascular disease, unspecified diabetes with renal manifestations, type ii or unspecified type, not stated as uncontrolled hypertensive chronic kidney disease, unspecified, with chronic kidney disease stage i through stage iv, or unspecified car driver injured in collision with two- or three-wheeled motor vehicle in nontraffic accident kidney replaced by transplant chronic kidney disease, unspecified hyperpotassemia polyneuropathy in diabetes acute on chronic diastolic heart failure background diabetic retinopathy anemia in chronic kidney disease spontaneous ecchymoses atrial flutter diabetes with neurological manifestations, type ii or unspecified type, not stated as uncontrolled unspecified viral hepatitis c without hepatic coma tachycardia, unspecified pure hypercholesterolemia nephritis and nephropathy, not specified as acute or chronic, in diseases classified elsewhere diabetes with ophthalmic manifestations, type ii or unspecified type, not stated as uncontrolled cellulitis and abscess of upper arm and forearm acute kidney failure, unspecified unspecified viral hepatitis c without hepatic coma heart valve replaced by other means long-term (current) use of steroids diabetes with renal manifestations, type i [juvenile type], not stated as uncontrolled peripheral vascular disease, unspecified light chain (al) amyloidosis kidney replaced by transplant car driver injured in collision with two- or three-wheeled motor vehicle in nontraffic accident dehydration ventral, unspecified, hernia without mention of obstruction or gangrene poisoning by antineoplastic and immunosuppressive drugs diarrhea unspecified car occupant injured in collision with car, pick-up truck or van in nontraffic accident accidental poisoning by primarily systemic agents epilepsy, unspecified, without mention of intractable epilepsy end stage renal disease other and unspecified hyperlipidemia acute kidney failure, unspecified hypertensive chronic kidney disease, unspecified, with chronic kidney disease stage v or end stage renal disease
white f 57 $nan$nan$omeprazole  20  mg ; 
depressive disorder, not elsewhere classified unspecified essential hypertension spinal stenosis, unspecified region anxiety state, unspecified myalgia and myositis, unspecified irritable bowel syndrome osteoarthrosis, unspecified whether generalized or localized, site unspecified thalassemia minor tubal ligation status obstructive sleep apnea (adult)(pediatric) acute hepatitis c without mention of hepatic coma 
white f 57 $nan$hematology blood hematocrit  36.3  %; hematology blood hematocrit  35.8  %; hematology blood hematocrit  32.7  %; hematology blood hemoglobin  11.4  g dl; hematology blood hemoglobin  10.8  g dl; hematology blood hemoglobin  10.4  g dl; hematology blood platelet count  303  k ul; hematology blood platelet count  273  k ul; hematology blood platelet count  255  k ul; chemistry blood anion gap  19  meq l; chemistry blood anion gap  11  meq l; chemistry blood bicarbonate  22  meq l; chemistry blood bicarbonate  27  meq l; chemistry blood chloride  101  meq l; chemistry blood chloride  102  meq l; chemistry blood chloride  106  meq l; chemistry blood creatinine  0.8  mg dl; chemistry blood creatinine  0.7  mg dl; chemistry blood potassium  3.8  meq l; chemistry blood potassium  4.3  meq l; chemistry blood potassium  6.1  meq l; chemistry blood sodium  136  meq l; chemistry blood sodium  137  meq l; chemistry blood sodium  140  meq l; chemistry blood urea nitrogen  12  mg dl; chemistry blood urea nitrogen  12  mg dl; hematology blood inr(pt)  1.4  ; hematology blood inr(pt)  1.3  ; hematology urine wbc  0  # hpf; chemistry blood calcium, total  9.9  mg dl; chemistry blood calcium, total  9.0  mg dl; chemistry blood bilirubin, indirect  4.1  mg dl; chemistry blood bilirubin, total  15.5  mg dl; chemistry blood bilirubin, total  14.7  mg dl; chemistry blood bilirubin, total  13.2  mg dl; chemistry blood glucose  93  mg dl; chemistry blood glucose  99  mg dl; chemistry blood lactate dehydrogenase (ld)  240  iu l; chemistry blood lactate dehydrogenase (ld)  230  iu l; chemistry blood lactate dehydrogenase (ld)  739  iu l; chemistry blood albumin  3.7  g dl; hematology blood bands  1  %; hematology blood bands  5  %; hematology blood bands  0  %; chemistry blood bilirubin, direct  10.6  mg dl; hematology urine glucose  neg  mg dl; hematology urine bilirubin  lg  mg dl$omeprazole  20  mg ; sodium chloride 0.9%  flush  3  ml ; ondansetron  4  mg ; d5ns  1000  ml ; heparin  5000  unit ; 
depressive disorder, not elsewhere classified unspecified essential hypertension spinal stenosis, unspecified region anxiety state, unspecified myalgia and myositis, unspecified irritable bowel syndrome osteoarthrosis, unspecified whether generalized or localized, site unspecified thalassemia minor tubal ligation status obstructive sleep apnea (adult)(pediatric) acute hepatitis c without mention of hepatic coma 
white f 57 $nan$hematology blood hematocrit  32.7  %; hematology blood hemoglobin  10.2  g dl; hematology blood platelet count  259  k ul; chemistry blood anion gap  13  meq l; chemistry blood bicarbonate  25  meq l; chemistry blood chloride  105  meq l; chemistry blood creatinine  0.6  mg dl; chemistry blood potassium  4.1  meq l; chemistry blood sodium  139  meq l; chemistry blood urea nitrogen  10  mg dl; hematology blood inr(pt)  1.2  ; chemistry blood calcium, total  8.5  mg dl; chemistry blood bilirubin, total  12.3  mg dl; chemistry blood glucose  105  mg dl$omeprazole  20  mg ; sodium chloride 0.9%  flush  3  ml ; ondansetron  4  mg ; heparin  5000  unit ; venlafaxine xr  150  mg ; 
depressive disorder, not elsewhere classified unspecified essential hypertension spinal stenosis, unspecified region anxiety state, unspecified myalgia and myositis, unspecified irritable bowel syndrome osteoarthrosis, unspecified whether generalized or localized, site unspecified thalassemia minor tubal ligation status obstructive sleep apnea (adult)(pediatric) acute hepatitis c without mention of hepatic coma 
white f 57 $nan$nan$omeprazole  20  mg ; sodium chloride 0.9%  flush  3  ml ; ondansetron  4  mg ; heparin  5000  unit ; venlafaxine xr  150  mg ; 
depressive disorder, not elsewhere classified unspecified essential hypertension spinal stenosis, unspecified region anxiety state, unspecified myalgia and myositis, unspecified irritable bowel syndrome osteoarthrosis, unspecified whether generalized or localized, site unspecified thalassemia minor tubal ligation status obstructive sleep apnea (adult)(pediatric) acute hepatitis c without mention of hepatic coma 
asian f 90 $temp    heartrate  97.0  resprate  20.0  o2sat  100.0  sbp  105.0  dbp  69.0  rhythm    pain  0  $hematology blood hematocrit  35.4  %; hematology blood hemoglobin  11.3  g dl; hematology blood platelet count  98  k ul; chemistry blood anion gap  17  meq l; chemistry blood bicarbonate  30  meq l; chemistry blood chloride  100  meq l; chemistry blood creatinine  1.9  mg dl; chemistry blood potassium  4.4  meq l; chemistry blood sodium  147  meq l; chemistry blood urea nitrogen  51  mg dl; chemistry blood calcium, total  8.5  mg dl; chemistry blood glucose  95  mg dl$heparin  5000  unit ; sodium chloride 0.9%  flush  3-10  ml ; sodium chloride 0.9%  1000  ml ; docusate sodium  100  mg ; acetaminophen  325-650  mg ; ipratropium-albuterol neb  1  neb ; albuterol 0.083% neb soln  1  neb ; metoprolol tartrate  12.5  mg ; aspirin  81  mg ; aripiprazole  4  mg ; ceftriaxone  1  gm ; azithromycin  500  mg ; aripiprazole  2  mg ; 
constipation, unspecified bipolar disorder, unspecified alzheimer's disease, unspecified acute kidney failure, unspecified do not resuscitate dementia in other diseases classified elsewhere without behavioral disturbance chronic atrial fibrillation pneumonia, unspecified organism severe sepsis with septic shock parkinson's disease facial weakness following cerebral infarction hodgkin lymphoma, unspecified, unspecified site personal history of antineoplastic chemotherapy encounter for immunization acute on chronic diastolic (congestive) heart failure sepsis, unspecified organism toxic encephalopathy hypoxemia hypoxemia unspecified place in unspecified non-institutional (private) residence as the place of occurrence of the external cause do not resuscitate alzheimer's disease, unspecified chronic atrial fibrillation dementia in other diseases classified elsewhere without behavioral disturbance toxic encephalopathy poisoning by other antipsychotics and neuroleptics, accidental (unintentional), initial encounter hodgkin lymphoma, unspecified, unspecified site parkinson's disease schizoaffective disorder, bipolar type influenza due to unidentified influenza virus with other respiratory manifestations acute on chronic diastolic (congestive) heart failure delirium due to known physiological condition do not resuscitate chronic diastolic (congestive) heart failure unspecified dementia without behavioral disturbance personal history of non-hodgkin lymphomas severe sepsis with septic shock sepsis, unspecified organism pneumonia, unspecified organism anemia, unspecified acute kidney failure, unspecified unspecified atrial fibrillation bipolar disorder, unspecified unspecified asthma, uncomplicated personal history of antineoplastic chemotherapy bipolar disorder, unspecified congestive heart failure, unspecified mixed acid-base balance disorder
asian f 90 $nan$hematology blood hematocrit  34.9  %; hematology blood hematocrit  35.9  %; hematology blood hematocrit  35.7  %; hematology blood hemoglobin  11.2  g dl; hematology blood hemoglobin  11.5  g dl; hematology blood hemoglobin  11.1  g dl; hematology blood platelet count  95  k ul; hematology blood platelet count  87  k ul; hematology blood platelet count  86  k ul; chemistry blood anion gap  18  meq l; chemistry blood anion gap  12  meq l; chemistry blood anion gap  14  meq l; chemistry blood bicarbonate  27  meq l; chemistry blood bicarbonate  27  meq l; chemistry blood bicarbonate  30  meq l; chemistry blood chloride  96  meq l; chemistry blood chloride  101  meq l; chemistry blood chloride  99  meq l; chemistry blood creatinine  1.9  mg dl; chemistry blood creatinine  1.5  mg dl; chemistry blood creatinine  1.4  mg dl; chemistry blood potassium  4.6  meq l; chemistry blood potassium  5.0  meq l; chemistry blood potassium  4.5  meq l; chemistry blood sodium  141  meq l; chemistry blood sodium  141  meq l; chemistry blood sodium  142  meq l; chemistry blood urea nitrogen  49  mg dl; chemistry blood urea nitrogen  41  mg dl; chemistry blood urea nitrogen  33  mg dl; hematology blood inr(pt)  1.1  ; chemistry blood calcium, total  9.1  mg dl; chemistry blood calcium, total  8.5  mg dl; chemistry blood bilirubin, total  0.3  mg dl; chemistry blood bilirubin, total  0.3  mg dl; chemistry blood glucose  126  mg dl; chemistry blood glucose  94  mg dl; chemistry blood glucose  202  mg dl; chemistry blood albumin  3.5  g dl; chemistry blood albumin  3.4  g dl; blood gas blood lactate  2.9  mmol l; blood gas blood lactate  4.6  mmol l; blood gas blood lactate  3.4  mmol l$vial  1  vial ; cefepime  1  g ; heparin  5000  unit ; sodium chloride 0.9%  flush  3-10  ml ; docusate sodium  100  mg ; acetaminophen  325-650  mg ; metoprolol tartrate  12.5  mg ; aspirin  81  mg ; ceftriaxone  1  gm ; azithromycin  500  mg ; aripiprazole  2  mg ; d5 1 2ns  1000  ml ; acetaminophen iv  1000  mg ; iso-osmotic dextrose  150  ml ; vancomycin  750  mg ; iso-osmotic dextrose  50  ml ; piperacillin-tazobactam  2.25  g ; d5lr  1000  ml ; divalproex (extended release)  500  mg ; metronidazole  500  mg ; readi-cat 2 (barium sulfate 2% suspension)  900  ml ; metoprolol tartrate  25  mg ; 
constipation, unspecified bipolar disorder, unspecified alzheimer's disease, unspecified acute kidney failure, unspecified do not resuscitate dementia in other diseases classified elsewhere without behavioral disturbance chronic atrial fibrillation pneumonia, unspecified organism severe sepsis with septic shock parkinson's disease facial weakness following cerebral infarction hodgkin lymphoma, unspecified, unspecified site personal history of antineoplastic chemotherapy encounter for immunization acute on chronic diastolic (congestive) heart failure sepsis, unspecified organism toxic encephalopathy hypoxemia hypoxemia unspecified place in unspecified non-institutional (private) residence as the place of occurrence of the external cause do not resuscitate alzheimer's disease, unspecified chronic atrial fibrillation dementia in other diseases classified elsewhere without behavioral disturbance toxic encephalopathy poisoning by other antipsychotics and neuroleptics, accidental (unintentional), initial encounter hodgkin lymphoma, unspecified, unspecified site parkinson's disease schizoaffective disorder, bipolar type influenza due to unidentified influenza virus with other respiratory manifestations acute on chronic diastolic (congestive) heart failure delirium due to known physiological condition do not resuscitate chronic diastolic (congestive) heart failure unspecified dementia without behavioral disturbance personal history of non-hodgkin lymphomas severe sepsis with septic shock sepsis, unspecified organism pneumonia, unspecified organism anemia, unspecified acute kidney failure, unspecified unspecified atrial fibrillation bipolar disorder, unspecified unspecified asthma, uncomplicated personal history of antineoplastic chemotherapy bipolar disorder, unspecified congestive heart failure, unspecified mixed acid-base balance disorder
asian f 90 $nan$hematology blood hematocrit  32.5  %; hematology blood hemoglobin  10.4  g dl; hematology blood platelet count  87  k ul; chemistry blood anion gap  14  meq l; chemistry blood bicarbonate  26  meq l; chemistry blood chloride  100  meq l; chemistry blood creatinine  1.2  mg dl; chemistry blood potassium  4.6  meq l; chemistry blood sodium  140  meq l; chemistry blood urea nitrogen  23  mg dl; hematology urine wbc  1  # hpf; chemistry blood calcium, total  8.6  mg dl; chemistry blood bilirubin, total  0.3  mg dl; chemistry blood glucose  109  mg dl; chemistry blood lactate dehydrogenase (ld)  1016  iu l; hematology blood bands  2  %; blood gas blood lactate  2.7  mmol l; blood gas blood lactate  3.9  mmol l$vial  1  vial ; cefepime  1  g ; heparin  5000  unit ; sodium chloride 0.9%  flush  3-10  ml ; docusate sodium  100  mg ; aspirin  81  mg ; aripiprazole  2  mg ; acetaminophen iv  1000  mg ; d5lr  1000  ml ; divalproex (extended release)  500  mg ; metronidazole  500  mg ; readi-cat 2 (barium sulfate 2% suspension)  900  ml ; metoprolol tartrate  25  mg ; 0.9% sodium chloride (mini bag plus)  100  ml ; cefepime  2  g ; ondansetron  4  mg ; d5ns  1000  ml ; 
constipation, unspecified bipolar disorder, unspecified alzheimer's disease, unspecified acute kidney failure, unspecified do not resuscitate dementia in other diseases classified elsewhere without behavioral disturbance chronic atrial fibrillation pneumonia, unspecified organism severe sepsis with septic shock parkinson's disease facial weakness following cerebral infarction hodgkin lymphoma, unspecified, unspecified site personal history of antineoplastic chemotherapy encounter for immunization acute on chronic diastolic (congestive) heart failure sepsis, unspecified organism toxic encephalopathy hypoxemia hypoxemia unspecified place in unspecified non-institutional (private) residence as the place of occurrence of the external cause do not resuscitate alzheimer's disease, unspecified chronic atrial fibrillation dementia in other diseases classified elsewhere without behavioral disturbance toxic encephalopathy poisoning by other antipsychotics and neuroleptics, accidental (unintentional), initial encounter hodgkin lymphoma, unspecified, unspecified site parkinson's disease schizoaffective disorder, bipolar type influenza due to unidentified influenza virus with other respiratory manifestations acute on chronic diastolic (congestive) heart failure delirium due to known physiological condition do not resuscitate chronic diastolic (congestive) heart failure unspecified dementia without behavioral disturbance personal history of non-hodgkin lymphomas severe sepsis with septic shock sepsis, unspecified organism pneumonia, unspecified organism anemia, unspecified acute kidney failure, unspecified unspecified atrial fibrillation bipolar disorder, unspecified unspecified asthma, uncomplicated personal history of antineoplastic chemotherapy bipolar disorder, unspecified congestive heart failure, unspecified mixed acid-base balance disorder
asian f 90 $nan$nan$heparin  5000  unit ; sodium chloride 0.9%  flush  3-10  ml ; docusate sodium  100  mg ; aspirin  81  mg ; aripiprazole  2  mg ; metronidazole  500  mg ; 0.9% sodium chloride (mini bag plus)  100  ml ; cefepime  2  g ; ondansetron  4  mg ; divalproex sod. sprinkles  250  mg ; metoprolol tartrate  5  mg ; labetalol  10  mg ; furosemide  100  mg ; diltiazem  10  mg ; morphine sulfate  2-8  mg ; hyoscyamine  0.125  mg ; lorazepam  0.5-2  mg ; 5% dextrose  100  ml ; morphine sulfate  100  mg ; allopurinol  100  mg ; 
constipation, unspecified bipolar disorder, unspecified alzheimer's disease, unspecified acute kidney failure, unspecified do not resuscitate dementia in other diseases classified elsewhere without behavioral disturbance chronic atrial fibrillation pneumonia, unspecified organism severe sepsis with septic shock parkinson's disease facial weakness following cerebral infarction hodgkin lymphoma, unspecified, unspecified site personal history of antineoplastic chemotherapy encounter for immunization acute on chronic diastolic (congestive) heart failure sepsis, unspecified organism toxic encephalopathy hypoxemia hypoxemia unspecified place in unspecified non-institutional (private) residence as the place of occurrence of the external cause do not resuscitate alzheimer's disease, unspecified chronic atrial fibrillation dementia in other diseases classified elsewhere without behavioral disturbance toxic encephalopathy poisoning by other antipsychotics and neuroleptics, accidental (unintentional), initial encounter hodgkin lymphoma, unspecified, unspecified site parkinson's disease schizoaffective disorder, bipolar type influenza due to unidentified influenza virus with other respiratory manifestations acute on chronic diastolic (congestive) heart failure delirium due to known physiological condition do not resuscitate chronic diastolic (congestive) heart failure unspecified dementia without behavioral disturbance personal history of non-hodgkin lymphomas severe sepsis with septic shock sepsis, unspecified organism pneumonia, unspecified organism anemia, unspecified acute kidney failure, unspecified unspecified atrial fibrillation bipolar disorder, unspecified unspecified asthma, uncomplicated personal history of antineoplastic chemotherapy bipolar disorder, unspecified congestive heart failure, unspecified mixed acid-base balance disorder
white m 87 $nan$hematology blood hematocrit  31.0  %; hematology blood hematocrit  30.3  %; hematology blood hemoglobin  10.1  g dl; hematology blood hemoglobin  9.8  g dl; hematology blood platelet count  157  k ul; hematology blood platelet count  152  k ul; chemistry blood anion gap  14  meq l; chemistry blood bicarbonate  24  meq l; chemistry blood chloride  107  meq l; chemistry blood creatinine  1.5  mg dl; chemistry blood creatinine  1.6  mg dl; chemistry blood potassium  3.9  meq l; chemistry blood potassium  4.3  meq l; chemistry blood sodium  145  meq l; chemistry blood sodium  143  meq l; chemistry blood urea nitrogen  22  mg dl; chemistry blood urea nitrogen  22  mg dl; hematology blood inr(pt)  1.2  ; chemistry blood calcium, total  9.3  mg dl; chemistry blood glucose  117  mg dl$tamsulosin  0.4  mg ; hydralazine  25  mg ; sodium chloride 0.9%  flush  3-10  ml ; acetaminophen  650  mg ; potassium chloride  20  meq ; potassium chloride  40  meq ; potassium chloride  60  meq ; heparin  5000  unit ; simethicone  40-80  mg ; finasteride  5  mg ; pantoprazole  40  mg ; atenolol  25  mg ; aspirin  81  mg ; ramelteon  8  mg ; simvastatin  40  mg ; magnesium oxide  400  mg ; clopidogrel  75  mg ; 
 
white m 87 $nan$hematology blood hematocrit  27.8  %; hematology blood hematocrit  26.9  %; hematology blood hemoglobin  9.0  g dl; hematology blood hemoglobin  8.7  g dl; hematology blood platelet count  139  k ul; hematology blood platelet count  132  k ul; chemistry blood anion gap  16  meq l; chemistry blood anion gap  13  meq l; chemistry blood bicarbonate  23  meq l; chemistry blood bicarbonate  23  meq l; chemistry blood chloride  108  meq l; chemistry blood chloride  107  meq l; chemistry blood creatinine  1.6  mg dl; chemistry blood creatinine  1.7  mg dl; chemistry blood potassium  4.0  meq l; chemistry blood potassium  4.1  meq l; chemistry blood sodium  144  meq l; chemistry blood sodium  146  meq l; chemistry blood urea nitrogen  21  mg dl; chemistry blood urea nitrogen  25  mg dl; hematology blood inr(pt)  1.3  ; chemistry blood glucose  99  mg dl$sodium chloride 0.9%  flush  3-10  ml ; acetaminophen  650  mg ; potassium chloride  20  meq ; potassium chloride  40  meq ; potassium chloride  60  meq ; simethicone  40-80  mg ; finasteride  5  mg ; pantoprazole  40  mg ; aspirin  81  mg ; ramelteon  8  mg ; simvastatin  40  mg ; magnesium oxide  400  mg ; clopidogrel  75  mg ; ondansetron  4  mg ; iso-osmotic dextrose  50  ml ; cefazolin  2  g ; iso-osmotic dextrose  100  ml ; docusate sodium  100  mg ; senna  8.6  mg ; 
 
white m 87 $nan$hematology blood hematocrit  26.7  %; hematology blood hemoglobin  8.5  g dl; hematology blood platelet count  126  k ul; chemistry blood anion gap  11  meq l; chemistry blood bicarbonate  24  meq l; chemistry blood chloride  104  meq l; chemistry blood creatinine  1.8  mg dl; chemistry blood potassium  4.4  meq l; chemistry blood sodium  139  meq l; chemistry blood urea nitrogen  23  mg dl; chemistry blood glucose  100  mg dl$sodium chloride 0.9%  flush  3-10  ml ; acetaminophen  650  mg ; potassium chloride  20  meq ; potassium chloride  40  meq ; potassium chloride  60  meq ; simethicone  40-80  mg ; finasteride  5  mg ; pantoprazole  40  mg ; aspirin  81  mg ; ramelteon  8  mg ; simvastatin  40  mg ; clopidogrel  75  mg ; ondansetron  4  mg ; docusate sodium  100  mg ; senna  8.6  mg ; bag  1  bag ; magnesium sulfate  2  gm ; hydralazine  50  mg ; carvedilol  6.25  mg ; hydralazine  10  mg ; 
 
white m 87 $nan$nan$sodium chloride 0.9%  flush  3-10  ml ; acetaminophen  650  mg ; potassium chloride  20  meq ; potassium chloride  40  meq ; potassium chloride  60  meq ; simethicone  40-80  mg ; finasteride  5  mg ; pantoprazole  40  mg ; aspirin  81  mg ; ramelteon  8  mg ; simvastatin  40  mg ; clopidogrel  75  mg ; ondansetron  4  mg ; docusate sodium  100  mg ; senna  8.6  mg ; bag  1  bag ; magnesium sulfate  2  gm ; carvedilol  6.25  mg ; hydralazine  10  mg ; 
 
white m 65 $nan$hematology blood hematocrit  23.0  %; hematology blood hematocrit  22.8  %; hematology blood hematocrit  22.7  %; hematology blood hematocrit  23.5  %; hematology blood hemoglobin  7.4  g dl; hematology blood hemoglobin  7.7  g dl; hematology blood platelet count  799  k ul; hematology blood platelet count  740  k ul; chemistry blood anion gap  16  meq l; chemistry blood anion gap  14  meq l; chemistry blood bicarbonate  27  meq l; chemistry blood bicarbonate  26  meq l; chemistry blood chloride  99  meq l; chemistry blood chloride  103  meq l; chemistry blood creatinine  0.8  mg dl; chemistry blood creatinine  0.9  mg dl; chemistry blood potassium  5.1  meq l; chemistry blood potassium  4.9  meq l; chemistry blood sodium  137  meq l; chemistry blood sodium  138  meq l; chemistry blood urea nitrogen  17  mg dl; chemistry blood urea nitrogen  19  mg dl; hematology blood inr(pt)  1.2  ; hematology blood inr(pt)  1.2  ; chemistry blood calcium, total  9.4  mg dl; chemistry blood calcium, total  8.9  mg dl; chemistry blood glucose  133  mg dl; chemistry blood glucose  116  mg dl$sodium chloride 0.9%  flush  3  ml ; morphine sulfate  2  mg ; vial  1  vial ; pantoprazole sodium  40  mg ; senna  1  tab ; acetaminophen w codeine elixir  12.5-25  ml ; fluconazole  200  mg ; dexamethasone  10  mg ; ns (mini bag plus)  100  ml ; ampicillin-sulbactam  3  g ; benzonatate  100  mg ; oxycodone-acetaminophen elixir  5-10  ml ; 
malignant neoplasm of larynx, unspecified unspecified essential hypertension hyposmolality and/or hyponatremia car passenger injured in collision with heavy transport vehicle or bus in nontraffic accident gastrostomy status other specified cardiac dysrhythmias malignant neoplasm of larynx, unspecified unspecified essential hypertension unspecified gastritis and gastroduodenitis, without mention of hemorrhage duodenitis, without mention of hemorrhage passenger in pick-up truck or van injured in collision with railway train or railway vehicle in nontraffic accident attention to gastrostomy delirium due to conditions classified elsewhere retention of urine, unspecified pneumonia, organism unspecified hypercalcemia unspecified essential hypertension malignant neoplasm of larynx, unspecified dehydration 
white m 65 $nan$hematology blood hematocrit  24.0  %; hematology blood hemoglobin  7.9  g dl; hematology blood platelet count  662  k ul; chemistry blood anion gap  14  meq l; chemistry blood bicarbonate  30  meq l; chemistry blood chloride  103  meq l; chemistry blood creatinine  1.1  mg dl; chemistry blood potassium  4.8  meq l; chemistry blood sodium  142  meq l; chemistry blood urea nitrogen  21  mg dl; hematology blood inr(pt)  1.2  ; chemistry blood calcium, total  9.3  mg dl; chemistry blood bilirubin, total  0.2  mg dl; chemistry blood glucose  78  mg dl; hematology urine glucose  neg  mg dl; hematology urine bilirubin  neg  mg dl$sodium chloride 0.9%  flush  3  ml ; morphine sulfate  2  mg ; vial  1  vial ; pantoprazole sodium  40  mg ; senna  1  tab ; acetaminophen w codeine elixir  12.5-25  ml ; fluconazole  200  mg ; ns (mini bag plus)  100  ml ; ampicillin-sulbactam  3  g ; benzonatate  100  mg ; oxycodone-acetaminophen elixir  5-10  ml ; heparin  5000  unit ; morphine sulfate  1-2  mg ; metoprolol tartrate  12.5  mg ; golytely  4  l ; 
malignant neoplasm of larynx, unspecified unspecified essential hypertension hyposmolality and/or hyponatremia car passenger injured in collision with heavy transport vehicle or bus in nontraffic accident gastrostomy status other specified cardiac dysrhythmias malignant neoplasm of larynx, unspecified unspecified essential hypertension unspecified gastritis and gastroduodenitis, without mention of hemorrhage duodenitis, without mention of hemorrhage passenger in pick-up truck or van injured in collision with railway train or railway vehicle in nontraffic accident attention to gastrostomy delirium due to conditions classified elsewhere retention of urine, unspecified pneumonia, organism unspecified hypercalcemia unspecified essential hypertension malignant neoplasm of larynx, unspecified dehydration 
white m 65 $nan$hematology blood hematocrit  24.2  %; hematology blood hemoglobin  8.2  g dl; hematology blood platelet count  641  k ul; chemistry blood anion gap  14  meq l; chemistry blood bicarbonate  32  meq l; chemistry blood chloride  99  meq l; chemistry blood creatinine  0.9  mg dl; chemistry blood potassium  3.8  meq l; chemistry blood sodium  141  meq l; chemistry blood urea nitrogen  13  mg dl; chemistry blood calcium, total  9.1  mg dl; chemistry blood glucose  83  mg dl$sodium chloride 0.9%  flush  3  ml ; vial  1  vial ; pantoprazole sodium  40  mg ; senna  1  tab ; acetaminophen w codeine elixir  12.5-25  ml ; ns (mini bag plus)  100  ml ; ampicillin-sulbactam  3  g ; oxycodone-acetaminophen elixir  5-10  ml ; metoprolol tartrate  12.5  mg ; golytely  4  l ; sarna lotion  1  appl ; 
malignant neoplasm of larynx, unspecified unspecified essential hypertension hyposmolality and/or hyponatremia car passenger injured in collision with heavy transport vehicle or bus in nontraffic accident gastrostomy status other specified cardiac dysrhythmias malignant neoplasm of larynx, unspecified unspecified essential hypertension unspecified gastritis and gastroduodenitis, without mention of hemorrhage duodenitis, without mention of hemorrhage passenger in pick-up truck or van injured in collision with railway train or railway vehicle in nontraffic accident attention to gastrostomy delirium due to conditions classified elsewhere retention of urine, unspecified pneumonia, organism unspecified hypercalcemia unspecified essential hypertension malignant neoplasm of larynx, unspecified dehydration 
white m 65 $nan$hematology blood hematocrit  23.9  %; hematology blood hemoglobin  8.0  g dl; hematology blood platelet count  598  k ul; chemistry blood anion gap  10  meq l; chemistry blood bicarbonate  31  meq l; chemistry blood chloride  98  meq l; chemistry blood creatinine  0.8  mg dl; chemistry blood potassium  4.0  meq l; chemistry blood sodium  135  meq l; chemistry blood urea nitrogen  11  mg dl; chemistry blood calcium, total  8.9  mg dl; chemistry blood glucose  87  mg dl$sw  100  ml ; sodium chloride 0.9%  flush  3  ml ; vial  1  vial ; pantoprazole sodium  40  mg ; senna  1  tab ; acetaminophen w codeine elixir  12.5-25  ml ; ns (mini bag plus)  100  ml ; ampicillin-sulbactam  3  g ; oxycodone-acetaminophen elixir  5-10  ml ; metoprolol tartrate  12.5  mg ; golytely  4  l ; sarna lotion  1  appl ; amoxicillin-clavulanic acid  875  mg ; lr  1000  ml ; magnesium sulfate  4  gm ; metoprolol succinate xl  25  mg ; trazodone  25  mg ; levofloxacin  750  mg ; oxycodone liquid  5-10  mg ; 
malignant neoplasm of larynx, unspecified unspecified essential hypertension hyposmolality and/or hyponatremia car passenger injured in collision with heavy transport vehicle or bus in nontraffic accident gastrostomy status other specified cardiac dysrhythmias malignant neoplasm of larynx, unspecified unspecified essential hypertension unspecified gastritis and gastroduodenitis, without mention of hemorrhage duodenitis, without mention of hemorrhage passenger in pick-up truck or van injured in collision with railway train or railway vehicle in nontraffic accident attention to gastrostomy delirium due to conditions classified elsewhere retention of urine, unspecified pneumonia, organism unspecified hypercalcemia unspecified essential hypertension malignant neoplasm of larynx, unspecified dehydration 
white m 65 $nan$hematology blood hematocrit  25.9  %; hematology blood hemoglobin  8.2  g dl; hematology blood platelet count  595  k ul; chemistry blood anion gap  11  meq l; chemistry blood bicarbonate  32  meq l; chemistry blood chloride  98  meq l; chemistry blood creatinine  0.9  mg dl; chemistry blood potassium  4.4  meq l; chemistry blood sodium  137  meq l; chemistry blood urea nitrogen  10  mg dl; chemistry blood calcium, total  9.3  mg dl; chemistry blood bilirubin, total  0.2  mg dl; chemistry blood glucose  101  mg dl$sw  100  ml ; sodium chloride 0.9%  flush  3  ml ; vial  1  vial ; pantoprazole sodium  40  mg ; senna  1  tab ; golytely  4  l ; sarna lotion  1  appl ; amoxicillin-clavulanic acid  875  mg ; magnesium sulfate  4  gm ; trazodone  25  mg ; levofloxacin  750  mg ; oxycodone liquid  5-10  mg ; metronidazole (flagyl)  500  mg ; lansoprazole oral disintegrating tab  30  mg ; 
malignant neoplasm of larynx, unspecified unspecified essential hypertension hyposmolality and/or hyponatremia car passenger injured in collision with heavy transport vehicle or bus in nontraffic accident gastrostomy status other specified cardiac dysrhythmias malignant neoplasm of larynx, unspecified unspecified essential hypertension unspecified gastritis and gastroduodenitis, without mention of hemorrhage duodenitis, without mention of hemorrhage passenger in pick-up truck or van injured in collision with railway train or railway vehicle in nontraffic accident attention to gastrostomy delirium due to conditions classified elsewhere retention of urine, unspecified pneumonia, organism unspecified hypercalcemia unspecified essential hypertension malignant neoplasm of larynx, unspecified dehydration 
white m 65 $nan$nan$sodium chloride 0.9%  flush  3  ml ; senna  1  tab ; golytely  4  l ; sarna lotion  1  appl ; trazodone  25  mg ; oxycodone liquid  5-10  mg ; lansoprazole oral disintegrating tab  30  mg ; 
malignant neoplasm of larynx, unspecified unspecified essential hypertension hyposmolality and/or hyponatremia car passenger injured in collision with heavy transport vehicle or bus in nontraffic accident gastrostomy status other specified cardiac dysrhythmias malignant neoplasm of larynx, unspecified unspecified essential hypertension unspecified gastritis and gastroduodenitis, without mention of hemorrhage duodenitis, without mention of hemorrhage passenger in pick-up truck or van injured in collision with railway train or railway vehicle in nontraffic accident attention to gastrostomy delirium due to conditions classified elsewhere retention of urine, unspecified pneumonia, organism unspecified hypercalcemia unspecified essential hypertension malignant neoplasm of larynx, unspecified dehydration 
white m 65 $nan$hematology blood hematocrit  25.0  %; hematology blood hemoglobin  8.3  g dl; hematology blood platelet count  563  k ul; chemistry blood anion gap  15  meq l; chemistry blood bicarbonate  30  meq l; chemistry blood chloride  97  meq l; chemistry blood creatinine  0.7  mg dl; chemistry blood potassium  4.4  meq l; chemistry blood sodium  138  meq l; chemistry blood urea nitrogen  14  mg dl; chemistry blood calcium, total  9.1  mg dl; chemistry blood glucose  89  mg dl$sodium chloride 0.9%  flush  3  ml ; senna  1  tab ; golytely  4  l ; sarna lotion  1  appl ; trazodone  25  mg ; oxycodone liquid  5-10  mg ; lansoprazole oral disintegrating tab  30  mg ; 
malignant neoplasm of larynx, unspecified unspecified essential hypertension hyposmolality and/or hyponatremia car passenger injured in collision with heavy transport vehicle or bus in nontraffic accident gastrostomy status other specified cardiac dysrhythmias malignant neoplasm of larynx, unspecified unspecified essential hypertension unspecified gastritis and gastroduodenitis, without mention of hemorrhage duodenitis, without mention of hemorrhage passenger in pick-up truck or van injured in collision with railway train or railway vehicle in nontraffic accident attention to gastrostomy delirium due to conditions classified elsewhere retention of urine, unspecified pneumonia, organism unspecified hypercalcemia unspecified essential hypertension malignant neoplasm of larynx, unspecified dehydration 
white m 65 $nan$hematology blood hematocrit  24.3  %; hematology blood hemoglobin  8.0  g dl; hematology blood platelet count  532  k ul; chemistry blood anion gap  12  meq l; chemistry blood bicarbonate  30  meq l; chemistry blood chloride  97  meq l; chemistry blood creatinine  0.7  mg dl; chemistry blood potassium  4.4  meq l; chemistry blood sodium  135  meq l; chemistry blood urea nitrogen  14  mg dl; chemistry blood calcium, total  8.9  mg dl; chemistry blood glucose  85  mg dl$sodium chloride 0.9%  flush  3  ml ; senna  1  tab ; golytely  4  l ; sarna lotion  1  appl ; trazodone  25  mg ; oxycodone liquid  5-10  mg ; lansoprazole oral disintegrating tab  30  mg ; guaifenesin-dextromethorphan  5  ml ; magnesium sulfate  2  gm ; 
malignant neoplasm of larynx, unspecified unspecified essential hypertension hyposmolality and/or hyponatremia car passenger injured in collision with heavy transport vehicle or bus in nontraffic accident gastrostomy status other specified cardiac dysrhythmias malignant neoplasm of larynx, unspecified unspecified essential hypertension unspecified gastritis and gastroduodenitis, without mention of hemorrhage duodenitis, without mention of hemorrhage passenger in pick-up truck or van injured in collision with railway train or railway vehicle in nontraffic accident attention to gastrostomy delirium due to conditions classified elsewhere retention of urine, unspecified pneumonia, organism unspecified hypercalcemia unspecified essential hypertension malignant neoplasm of larynx, unspecified dehydration 
white m 65 $nan$nan$sodium chloride 0.9%  flush  3  ml ; senna  1  tab ; golytely  4  l ; sarna lotion  1  appl ; trazodone  25  mg ; oxycodone liquid  5-10  mg ; lansoprazole oral disintegrating tab  30  mg ; guaifenesin-dextromethorphan  5  ml ; magnesium sulfate  2  gm ; ondansetron  4  mg ; 
malignant neoplasm of larynx, unspecified unspecified essential hypertension hyposmolality and/or hyponatremia car passenger injured in collision with heavy transport vehicle or bus in nontraffic accident gastrostomy status other specified cardiac dysrhythmias malignant neoplasm of larynx, unspecified unspecified essential hypertension unspecified gastritis and gastroduodenitis, without mention of hemorrhage duodenitis, without mention of hemorrhage passenger in pick-up truck or van injured in collision with railway train or railway vehicle in nontraffic accident attention to gastrostomy delirium due to conditions classified elsewhere retention of urine, unspecified pneumonia, organism unspecified hypercalcemia unspecified essential hypertension malignant neoplasm of larynx, unspecified dehydration 
white m 65 $nan$nan$sodium chloride 0.9%  flush  3  ml ; senna  1  tab ; golytely  4  l ; sarna lotion  1  appl ; trazodone  25  mg ; oxycodone liquid  5-10  mg ; lansoprazole oral disintegrating tab  30  mg ; guaifenesin-dextromethorphan  5  ml ; ondansetron  4  mg ; 
malignant neoplasm of larynx, unspecified unspecified essential hypertension hyposmolality and/or hyponatremia car passenger injured in collision with heavy transport vehicle or bus in nontraffic accident gastrostomy status other specified cardiac dysrhythmias malignant neoplasm of larynx, unspecified unspecified essential hypertension unspecified gastritis and gastroduodenitis, without mention of hemorrhage duodenitis, without mention of hemorrhage passenger in pick-up truck or van injured in collision with railway train or railway vehicle in nontraffic accident attention to gastrostomy delirium due to conditions classified elsewhere retention of urine, unspecified pneumonia, organism unspecified hypercalcemia unspecified essential hypertension malignant neoplasm of larynx, unspecified dehydration 
black african american m 60 $nan$hematology blood hematocrit  26.5  %; hematology blood hematocrit  28.1  %; hematology blood hemoglobin  8.8  g dl; hematology blood platelet count  177  k ul; chemistry blood anion gap  16  meq l; chemistry blood bicarbonate  23  meq l; chemistry blood chloride  100  meq l; chemistry blood creatinine  6.2  mg dl; chemistry blood potassium  5.1  meq l; chemistry blood sodium  134  meq l; chemistry blood urea nitrogen  85  mg dl; chemistry blood glucose  96  mg dl; blood gas blood free calcium  1.35  mmol l; blood gas blood lactate  0.9  mmol l; blood gas blood potassium, whole blood  5.2  meq l$1 2 ns  1000  ml ; heparin flush (10 units ml)  2  ml ; d5 1 2ns  1000  ml ; vial  1  vial ; epoetin alfa  1  dose ; loperamide  2  mg ; sodium chloride nasal  1-2  spry ; acetaminophen  650  mg ; mirtazapine  15  mg ; oxycodone-acetaminophen  1-2  tab ; sodium chloride 0.9%  flush  3  ml ; calcium carbonate  1250  mg ; heparin  5000  unit ; ferrous sulfate  325  mg ; ipratropium bromide mdi  2  puff ; miconazole powder 2%  1  appl ; sevelamer hydrochloride  800  mg ; hydromorphone (dilaudid)  0.12  mg ; metoprolol tartrate  25  mg ; amlodipine  2.5  mg ; folic acid  1  mg ; lidocaine 5% patch  1  ptch ; nephrocaps  1  cap ; omeprazole  20  mg ; d5w  300  ml ; linezolid  600  mg ; 0.9% sodium chloride  50  ml ; daptomycin  350  mg ; ciprofloxacin hcl  500  mg ; 
congestive heart failure, unspecified accidental fall from bed sinoatrial node dysfunction abdominal pain, unspecified site drug-induced delirium end stage renal disease complications of transplanted kidney anemia of other chronic disease hypertensive chronic kidney disease, unspecified, with chronic kidney disease stage v or end stage renal disease benzodiazepine-based tranquilizers causing adverse effects in therapeutic use person on outside of car injured in collision with heavy transport vehicle or bus in nontraffic accident contusion of hip hyperparathyroidism, unspecified septic pulmonary embolism diastolic heart failure, unspecified ileostomy status mitral valve disorders aortic valve disorders antitussives causing adverse effects in therapeutic use surgical operation with transplant of whole organ causing abnormal patient reaction, or later complication, without mention of misadventure at time of operation atrial fibrillation internal hemorrhoids without mention of complication hyposmolality and/or hyponatremia hematoma complicating a procedure pyogenic arthritis, forearm pressure ulcer, stage ii infection and inflammatory reaction due to other internal orthopedic device, implant, and graft hypertensive chronic kidney disease, unspecified, with chronic kidney disease stage v or end stage renal disease chronic diastolic heart failure end stage renal disease acute posthemorrhagic anemia enthesopathy of hip region acute and subacute bacterial endocarditis congestive heart failure, unspecified atrial flutter methicillin susceptible staphylococcus aureus septicemia pressure ulcer, lower back closed fracture of unspecified part of neck of femur chronic vascular insufficiency of intestine other mechanical complication of other internal orthopedic device, implant, and graft other specified disorders of intestine subendocardial infarction, initial episode of care other postoperative infection striking against or struck accidentally by furniture without subsequent fall
black african american m 60 $nan$hematology blood hematocrit  25.2  %; hematology blood hematocrit  26.4  %; hematology blood hemoglobin  8.9  g dl; hematology blood platelet count  169  k ul; chemistry blood anion gap  19  meq l; chemistry blood bicarbonate  19  meq l; chemistry blood chloride  99  meq l; chemistry blood creatinine  7.2  mg dl; chemistry blood potassium  5.9  meq l; chemistry blood sodium  131  meq l; chemistry blood urea nitrogen  97  mg dl; chemistry blood calcium, total  9.5  mg dl; chemistry blood glucose  81  mg dl$heparin flush (10 units ml)  2  ml ; vial  1  vial ; epoetin alfa  1  dose ; loperamide  2  mg ; sodium chloride nasal  1-2  spry ; acetaminophen  650  mg ; oxycodone-acetaminophen  1-2  tab ; sodium chloride 0.9%  flush  3  ml ; calcium carbonate  1250  mg ; ferrous sulfate  325  mg ; ipratropium bromide mdi  2  puff ; miconazole powder 2%  1  appl ; sevelamer hydrochloride  800  mg ; hydromorphone (dilaudid)  0.12  mg ; metoprolol tartrate  25  mg ; amlodipine  2.5  mg ; folic acid  1  mg ; lidocaine 5% patch  1  ptch ; nephrocaps  1  cap ; omeprazole  20  mg ; 0.9% sodium chloride  50  ml ; daptomycin  350  mg ; ciprofloxacin hcl  500  mg ; pantoprazole sodium  40  mg ; hydromorphone (dilaudid)  0.25  mg ; 
congestive heart failure, unspecified accidental fall from bed sinoatrial node dysfunction abdominal pain, unspecified site drug-induced delirium end stage renal disease complications of transplanted kidney anemia of other chronic disease hypertensive chronic kidney disease, unspecified, with chronic kidney disease stage v or end stage renal disease benzodiazepine-based tranquilizers causing adverse effects in therapeutic use person on outside of car injured in collision with heavy transport vehicle or bus in nontraffic accident contusion of hip hyperparathyroidism, unspecified septic pulmonary embolism diastolic heart failure, unspecified ileostomy status mitral valve disorders aortic valve disorders antitussives causing adverse effects in therapeutic use surgical operation with transplant of whole organ causing abnormal patient reaction, or later complication, without mention of misadventure at time of operation atrial fibrillation internal hemorrhoids without mention of complication hyposmolality and/or hyponatremia hematoma complicating a procedure pyogenic arthritis, forearm pressure ulcer, stage ii infection and inflammatory reaction due to other internal orthopedic device, implant, and graft hypertensive chronic kidney disease, unspecified, with chronic kidney disease stage v or end stage renal disease chronic diastolic heart failure end stage renal disease acute posthemorrhagic anemia enthesopathy of hip region acute and subacute bacterial endocarditis congestive heart failure, unspecified atrial flutter methicillin susceptible staphylococcus aureus septicemia pressure ulcer, lower back closed fracture of unspecified part of neck of femur chronic vascular insufficiency of intestine other mechanical complication of other internal orthopedic device, implant, and graft other specified disorders of intestine subendocardial infarction, initial episode of care other postoperative infection striking against or struck accidentally by furniture without subsequent fall
black african american m 60 $nan$hematology blood hematocrit  25.1  %; hematology blood hemoglobin  8.5  g dl; hematology blood platelet count  157  k ul; chemistry blood anion gap  14  meq l; chemistry blood bicarbonate  24  meq l; chemistry blood chloride  101  meq l; chemistry blood creatinine  5.4  mg dl; chemistry blood potassium  4.5  meq l; chemistry blood sodium  134  meq l; chemistry blood urea nitrogen  61  mg dl; chemistry blood calcium, total  9.0  mg dl; chemistry blood glucose  118  mg dl$heparin flush (10 units ml)  2  ml ; vial  1  vial ; epoetin alfa  1  dose ; loperamide  2  mg ; sodium chloride nasal  1-2  spry ; acetaminophen  650  mg ; oxycodone-acetaminophen  1-2  tab ; sodium chloride 0.9%  flush  3  ml ; calcium carbonate  1250  mg ; ferrous sulfate  325  mg ; ipratropium bromide mdi  2  puff ; miconazole powder 2%  1  appl ; sevelamer hydrochloride  800  mg ; metoprolol tartrate  25  mg ; amlodipine  2.5  mg ; folic acid  1  mg ; lidocaine 5% patch  1  ptch ; nephrocaps  1  cap ; omeprazole  20  mg ; 0.9% sodium chloride  50  ml ; daptomycin  350  mg ; ciprofloxacin hcl  500  mg ; pantoprazole sodium  40  mg ; hydromorphone (dilaudid)  0.25  mg ; sarna lotion  1  appl ; 
congestive heart failure, unspecified accidental fall from bed sinoatrial node dysfunction abdominal pain, unspecified site drug-induced delirium end stage renal disease complications of transplanted kidney anemia of other chronic disease hypertensive chronic kidney disease, unspecified, with chronic kidney disease stage v or end stage renal disease benzodiazepine-based tranquilizers causing adverse effects in therapeutic use person on outside of car injured in collision with heavy transport vehicle or bus in nontraffic accident contusion of hip hyperparathyroidism, unspecified septic pulmonary embolism diastolic heart failure, unspecified ileostomy status mitral valve disorders aortic valve disorders antitussives causing adverse effects in therapeutic use surgical operation with transplant of whole organ causing abnormal patient reaction, or later complication, without mention of misadventure at time of operation atrial fibrillation internal hemorrhoids without mention of complication hyposmolality and/or hyponatremia hematoma complicating a procedure pyogenic arthritis, forearm pressure ulcer, stage ii infection and inflammatory reaction due to other internal orthopedic device, implant, and graft hypertensive chronic kidney disease, unspecified, with chronic kidney disease stage v or end stage renal disease chronic diastolic heart failure end stage renal disease acute posthemorrhagic anemia enthesopathy of hip region acute and subacute bacterial endocarditis congestive heart failure, unspecified atrial flutter methicillin susceptible staphylococcus aureus septicemia pressure ulcer, lower back closed fracture of unspecified part of neck of femur chronic vascular insufficiency of intestine other mechanical complication of other internal orthopedic device, implant, and graft other specified disorders of intestine subendocardial infarction, initial episode of care other postoperative infection striking against or struck accidentally by furniture without subsequent fall
black african american m 60 $nan$hematology blood hematocrit  26.6  %; hematology blood hematocrit  26.8  %; hematology blood hemoglobin  8.8  g dl; hematology blood hemoglobin  9.0  g dl; hematology blood platelet count  165  k ul; hematology blood platelet count  165  k ul; chemistry blood anion gap  15  meq l; chemistry blood anion gap  16  meq l; chemistry blood bicarbonate  22  meq l; chemistry blood bicarbonate  21  meq l; chemistry blood chloride  102  meq l; chemistry blood chloride  102  meq l; chemistry blood creatinine  6.8  mg dl; chemistry blood creatinine  7.0  mg dl; chemistry blood potassium  4.4  meq l; chemistry blood potassium  5.0  meq l; chemistry blood sodium  135  meq l; chemistry blood sodium  134  meq l; chemistry blood urea nitrogen  73  mg dl; chemistry blood urea nitrogen  76  mg dl; hematology blood inr(pt)  1.3  ; chemistry blood calcium, total  10.2  mg dl; chemistry blood glucose  132  mg dl; chemistry blood glucose  104  mg dl$heparin flush (10 units ml)  2  ml ; vial  1  vial ; epoetin alfa  1  dose ; loperamide  2  mg ; sodium chloride nasal  1-2  spry ; acetaminophen  650  mg ; oxycodone-acetaminophen  1-2  tab ; sodium chloride 0.9%  flush  3  ml ; calcium carbonate  1250  mg ; ferrous sulfate  325  mg ; ipratropium bromide mdi  2  puff ; miconazole powder 2%  1  appl ; sevelamer hydrochloride  800  mg ; metoprolol tartrate  25  mg ; amlodipine  2.5  mg ; folic acid  1  mg ; lidocaine 5% patch  1  ptch ; nephrocaps  1  cap ; omeprazole  20  mg ; 0.9% sodium chloride  50  ml ; daptomycin  350  mg ; ciprofloxacin hcl  500  mg ; hydromorphone (dilaudid)  0.25  mg ; sarna lotion  1  appl ; oxymetazoline  1  spry ; hydromorphone (dilaudid)  12.5  mg ; 
congestive heart failure, unspecified accidental fall from bed sinoatrial node dysfunction abdominal pain, unspecified site drug-induced delirium end stage renal disease complications of transplanted kidney anemia of other chronic disease hypertensive chronic kidney disease, unspecified, with chronic kidney disease stage v or end stage renal disease benzodiazepine-based tranquilizers causing adverse effects in therapeutic use person on outside of car injured in collision with heavy transport vehicle or bus in nontraffic accident contusion of hip hyperparathyroidism, unspecified septic pulmonary embolism diastolic heart failure, unspecified ileostomy status mitral valve disorders aortic valve disorders antitussives causing adverse effects in therapeutic use surgical operation with transplant of whole organ causing abnormal patient reaction, or later complication, without mention of misadventure at time of operation atrial fibrillation internal hemorrhoids without mention of complication hyposmolality and/or hyponatremia hematoma complicating a procedure pyogenic arthritis, forearm pressure ulcer, stage ii infection and inflammatory reaction due to other internal orthopedic device, implant, and graft hypertensive chronic kidney disease, unspecified, with chronic kidney disease stage v or end stage renal disease chronic diastolic heart failure end stage renal disease acute posthemorrhagic anemia enthesopathy of hip region acute and subacute bacterial endocarditis congestive heart failure, unspecified atrial flutter methicillin susceptible staphylococcus aureus septicemia pressure ulcer, lower back closed fracture of unspecified part of neck of femur chronic vascular insufficiency of intestine other mechanical complication of other internal orthopedic device, implant, and graft other specified disorders of intestine subendocardial infarction, initial episode of care other postoperative infection striking against or struck accidentally by furniture without subsequent fall
black african american m 60 $nan$hematology blood hematocrit  26.0  %; hematology blood hemoglobin  8.6  g dl; hematology blood platelet count  190  k ul; chemistry blood anion gap  19  meq l; chemistry blood bicarbonate  18  meq l; chemistry blood chloride  102  meq l; chemistry blood creatinine  7.7  mg dl; chemistry blood potassium  4.4  meq l; chemistry blood sodium  135  meq l; chemistry blood urea nitrogen  75  mg dl; chemistry blood urea nitrogen  40  mg dl; hematology blood inr(pt)  1.3  ; chemistry blood calcium, total  9.4  mg dl; chemistry blood glucose  107  mg dl$heparin flush (10 units ml)  2  ml ; vial  1  vial ; epoetin alfa  1  dose ; loperamide  2  mg ; sodium chloride nasal  1-2  spry ; acetaminophen  650  mg ; oxycodone-acetaminophen  1-2  tab ; sodium chloride 0.9%  flush  3  ml ; calcium carbonate  1250  mg ; ferrous sulfate  325  mg ; ipratropium bromide mdi  2  puff ; miconazole powder 2%  1  appl ; sevelamer hydrochloride  800  mg ; metoprolol tartrate  25  mg ; amlodipine  2.5  mg ; folic acid  1  mg ; lidocaine 5% patch  1  ptch ; nephrocaps  1  cap ; omeprazole  20  mg ; 0.9% sodium chloride  50  ml ; daptomycin  350  mg ; ciprofloxacin hcl  500  mg ; hydromorphone (dilaudid)  0.25  mg ; sarna lotion  1  appl ; oxymetazoline  1  spry ; hydromorphone (dilaudid)  12.5  mg ; 
congestive heart failure, unspecified accidental fall from bed sinoatrial node dysfunction abdominal pain, unspecified site drug-induced delirium end stage renal disease complications of transplanted kidney anemia of other chronic disease hypertensive chronic kidney disease, unspecified, with chronic kidney disease stage v or end stage renal disease benzodiazepine-based tranquilizers causing adverse effects in therapeutic use person on outside of car injured in collision with heavy transport vehicle or bus in nontraffic accident contusion of hip hyperparathyroidism, unspecified septic pulmonary embolism diastolic heart failure, unspecified ileostomy status mitral valve disorders aortic valve disorders antitussives causing adverse effects in therapeutic use surgical operation with transplant of whole organ causing abnormal patient reaction, or later complication, without mention of misadventure at time of operation atrial fibrillation internal hemorrhoids without mention of complication hyposmolality and/or hyponatremia hematoma complicating a procedure pyogenic arthritis, forearm pressure ulcer, stage ii infection and inflammatory reaction due to other internal orthopedic device, implant, and graft hypertensive chronic kidney disease, unspecified, with chronic kidney disease stage v or end stage renal disease chronic diastolic heart failure end stage renal disease acute posthemorrhagic anemia enthesopathy of hip region acute and subacute bacterial endocarditis congestive heart failure, unspecified atrial flutter methicillin susceptible staphylococcus aureus septicemia pressure ulcer, lower back closed fracture of unspecified part of neck of femur chronic vascular insufficiency of intestine other mechanical complication of other internal orthopedic device, implant, and graft other specified disorders of intestine subendocardial infarction, initial episode of care other postoperative infection striking against or struck accidentally by furniture without subsequent fall
black african american m 60 $nan$chemistry blood urea nitrogen  4  mg dl; chemistry blood urea nitrogen  21  mg dl; chemistry blood urea nitrogen  43  mg dl$heparin flush (10 units ml)  2  ml ; vial  1  vial ; epoetin alfa  1  dose ; loperamide  2  mg ; sodium chloride nasal  1-2  spry ; acetaminophen  650  mg ; oxycodone-acetaminophen  1-2  tab ; sodium chloride 0.9%  flush  3  ml ; calcium carbonate  1250  mg ; ferrous sulfate  325  mg ; ipratropium bromide mdi  2  puff ; miconazole powder 2%  1  appl ; sevelamer hydrochloride  800  mg ; metoprolol tartrate  25  mg ; amlodipine  2.5  mg ; folic acid  1  mg ; lidocaine 5% patch  1  ptch ; nephrocaps  1  cap ; omeprazole  20  mg ; 0.9% sodium chloride  50  ml ; daptomycin  350  mg ; ciprofloxacin hcl  500  mg ; hydromorphone (dilaudid)  0.25  mg ; sarna lotion  1  appl ; oxymetazoline  1  spry ; hydromorphone (dilaudid)  12.5  mg ; 
congestive heart failure, unspecified accidental fall from bed sinoatrial node dysfunction abdominal pain, unspecified site drug-induced delirium end stage renal disease complications of transplanted kidney anemia of other chronic disease hypertensive chronic kidney disease, unspecified, with chronic kidney disease stage v or end stage renal disease benzodiazepine-based tranquilizers causing adverse effects in therapeutic use person on outside of car injured in collision with heavy transport vehicle or bus in nontraffic accident contusion of hip hyperparathyroidism, unspecified septic pulmonary embolism diastolic heart failure, unspecified ileostomy status mitral valve disorders aortic valve disorders antitussives causing adverse effects in therapeutic use surgical operation with transplant of whole organ causing abnormal patient reaction, or later complication, without mention of misadventure at time of operation atrial fibrillation internal hemorrhoids without mention of complication hyposmolality and/or hyponatremia hematoma complicating a procedure pyogenic arthritis, forearm pressure ulcer, stage ii infection and inflammatory reaction due to other internal orthopedic device, implant, and graft hypertensive chronic kidney disease, unspecified, with chronic kidney disease stage v or end stage renal disease chronic diastolic heart failure end stage renal disease acute posthemorrhagic anemia enthesopathy of hip region acute and subacute bacterial endocarditis congestive heart failure, unspecified atrial flutter methicillin susceptible staphylococcus aureus septicemia pressure ulcer, lower back closed fracture of unspecified part of neck of femur chronic vascular insufficiency of intestine other mechanical complication of other internal orthopedic device, implant, and graft other specified disorders of intestine subendocardial infarction, initial episode of care other postoperative infection striking against or struck accidentally by furniture without subsequent fall
black african american m 60 $nan$hematology blood hematocrit  25.4  %; hematology blood hemoglobin  8.3  g dl; hematology blood platelet count  166  k ul; chemistry blood anion gap  12  meq l; chemistry blood bicarbonate  27  meq l; chemistry blood chloride  103  meq l; chemistry blood creatinine  4.7  mg dl; chemistry blood potassium  4.6  meq l; chemistry blood sodium  137  meq l; chemistry blood urea nitrogen  32  mg dl; hematology blood inr(pt)  1.3  ; chemistry blood calcium, total  9.3  mg dl; chemistry blood glucose  88  mg dl$heparin flush (10 units ml)  2  ml ; vial  1  vial ; epoetin alfa  1  dose ; loperamide  2  mg ; sodium chloride nasal  1-2  spry ; acetaminophen  650  mg ; oxycodone-acetaminophen  1-2  tab ; sodium chloride 0.9%  flush  3  ml ; calcium carbonate  1250  mg ; ferrous sulfate  325  mg ; ipratropium bromide mdi  2  puff ; miconazole powder 2%  1  appl ; sevelamer hydrochloride  800  mg ; metoprolol tartrate  25  mg ; amlodipine  2.5  mg ; folic acid  1  mg ; lidocaine 5% patch  1  ptch ; nephrocaps  1  cap ; omeprazole  20  mg ; 0.9% sodium chloride  50  ml ; daptomycin  350  mg ; ciprofloxacin hcl  500  mg ; hydromorphone (dilaudid)  0.25  mg ; sarna lotion  1  appl ; hydroxyzine  25  mg ; lidocaine 1%  20  ml ; 
congestive heart failure, unspecified accidental fall from bed sinoatrial node dysfunction abdominal pain, unspecified site drug-induced delirium end stage renal disease complications of transplanted kidney anemia of other chronic disease hypertensive chronic kidney disease, unspecified, with chronic kidney disease stage v or end stage renal disease benzodiazepine-based tranquilizers causing adverse effects in therapeutic use person on outside of car injured in collision with heavy transport vehicle or bus in nontraffic accident contusion of hip hyperparathyroidism, unspecified septic pulmonary embolism diastolic heart failure, unspecified ileostomy status mitral valve disorders aortic valve disorders antitussives causing adverse effects in therapeutic use surgical operation with transplant of whole organ causing abnormal patient reaction, or later complication, without mention of misadventure at time of operation atrial fibrillation internal hemorrhoids without mention of complication hyposmolality and/or hyponatremia hematoma complicating a procedure pyogenic arthritis, forearm pressure ulcer, stage ii infection and inflammatory reaction due to other internal orthopedic device, implant, and graft hypertensive chronic kidney disease, unspecified, with chronic kidney disease stage v or end stage renal disease chronic diastolic heart failure end stage renal disease acute posthemorrhagic anemia enthesopathy of hip region acute and subacute bacterial endocarditis congestive heart failure, unspecified atrial flutter methicillin susceptible staphylococcus aureus septicemia pressure ulcer, lower back closed fracture of unspecified part of neck of femur chronic vascular insufficiency of intestine other mechanical complication of other internal orthopedic device, implant, and graft other specified disorders of intestine subendocardial infarction, initial episode of care other postoperative infection striking against or struck accidentally by furniture without subsequent fall
black african american m 60 $nan$hematology blood hematocrit  25.0  %; hematology blood hemoglobin  8.2  g dl; hematology blood platelet count  170  k ul; chemistry blood anion gap  14  meq l; chemistry blood bicarbonate  24  meq l; chemistry blood chloride  103  meq l; chemistry blood creatinine  6.2  mg dl; chemistry blood potassium  4.9  meq l; chemistry blood sodium  136  meq l; chemistry blood urea nitrogen  43  mg dl; chemistry blood calcium, total  9.6  mg dl; chemistry blood glucose  110  mg dl$heparin flush (10 units ml)  2  ml ; vial  1  vial ; epoetin alfa  1  dose ; loperamide  2  mg ; sodium chloride nasal  1-2  spry ; acetaminophen  650  mg ; oxycodone-acetaminophen  1-2  tab ; sodium chloride 0.9%  flush  3  ml ; calcium carbonate  1250  mg ; ferrous sulfate  325  mg ; ipratropium bromide mdi  2  puff ; miconazole powder 2%  1  appl ; sevelamer hydrochloride  800  mg ; metoprolol tartrate  25  mg ; amlodipine  2.5  mg ; folic acid  1  mg ; lidocaine 5% patch  1  ptch ; nephrocaps  1  cap ; omeprazole  20  mg ; 0.9% sodium chloride  50  ml ; daptomycin  350  mg ; ciprofloxacin hcl  500  mg ; hydromorphone (dilaudid)  0.25  mg ; sarna lotion  1  appl ; hydroxyzine  25  mg ; lidocaine 1%  20  ml ; 
congestive heart failure, unspecified accidental fall from bed sinoatrial node dysfunction abdominal pain, unspecified site drug-induced delirium end stage renal disease complications of transplanted kidney anemia of other chronic disease hypertensive chronic kidney disease, unspecified, with chronic kidney disease stage v or end stage renal disease benzodiazepine-based tranquilizers causing adverse effects in therapeutic use person on outside of car injured in collision with heavy transport vehicle or bus in nontraffic accident contusion of hip hyperparathyroidism, unspecified septic pulmonary embolism diastolic heart failure, unspecified ileostomy status mitral valve disorders aortic valve disorders antitussives causing adverse effects in therapeutic use surgical operation with transplant of whole organ causing abnormal patient reaction, or later complication, without mention of misadventure at time of operation atrial fibrillation internal hemorrhoids without mention of complication hyposmolality and/or hyponatremia hematoma complicating a procedure pyogenic arthritis, forearm pressure ulcer, stage ii infection and inflammatory reaction due to other internal orthopedic device, implant, and graft hypertensive chronic kidney disease, unspecified, with chronic kidney disease stage v or end stage renal disease chronic diastolic heart failure end stage renal disease acute posthemorrhagic anemia enthesopathy of hip region acute and subacute bacterial endocarditis congestive heart failure, unspecified atrial flutter methicillin susceptible staphylococcus aureus septicemia pressure ulcer, lower back closed fracture of unspecified part of neck of femur chronic vascular insufficiency of intestine other mechanical complication of other internal orthopedic device, implant, and graft other specified disorders of intestine subendocardial infarction, initial episode of care other postoperative infection striking against or struck accidentally by furniture without subsequent fall
black african american m 60 $nan$hematology blood hematocrit  24.2  %; hematology blood hemoglobin  7.7  g dl; hematology blood platelet count  165  k ul$heparin flush (10 units ml)  2  ml ; vial  1  vial ; epoetin alfa  1  dose ; loperamide  2  mg ; sodium chloride nasal  1-2  spry ; acetaminophen  650  mg ; oxycodone-acetaminophen  1-2  tab ; sodium chloride 0.9%  flush  3  ml ; calcium carbonate  1250  mg ; ferrous sulfate  325  mg ; ipratropium bromide mdi  2  puff ; miconazole powder 2%  1  appl ; sevelamer hydrochloride  800  mg ; metoprolol tartrate  25  mg ; amlodipine  2.5  mg ; folic acid  1  mg ; lidocaine 5% patch  1  ptch ; nephrocaps  1  cap ; omeprazole  20  mg ; 0.9% sodium chloride  50  ml ; daptomycin  350  mg ; ciprofloxacin hcl  500  mg ; hydromorphone (dilaudid)  0.25  mg ; sarna lotion  1  appl ; hydroxyzine  25  mg ; 
congestive heart failure, unspecified accidental fall from bed sinoatrial node dysfunction abdominal pain, unspecified site drug-induced delirium end stage renal disease complications of transplanted kidney anemia of other chronic disease hypertensive chronic kidney disease, unspecified, with chronic kidney disease stage v or end stage renal disease benzodiazepine-based tranquilizers causing adverse effects in therapeutic use person on outside of car injured in collision with heavy transport vehicle or bus in nontraffic accident contusion of hip hyperparathyroidism, unspecified septic pulmonary embolism diastolic heart failure, unspecified ileostomy status mitral valve disorders aortic valve disorders antitussives causing adverse effects in therapeutic use surgical operation with transplant of whole organ causing abnormal patient reaction, or later complication, without mention of misadventure at time of operation atrial fibrillation internal hemorrhoids without mention of complication hyposmolality and/or hyponatremia hematoma complicating a procedure pyogenic arthritis, forearm pressure ulcer, stage ii infection and inflammatory reaction due to other internal orthopedic device, implant, and graft hypertensive chronic kidney disease, unspecified, with chronic kidney disease stage v or end stage renal disease chronic diastolic heart failure end stage renal disease acute posthemorrhagic anemia enthesopathy of hip region acute and subacute bacterial endocarditis congestive heart failure, unspecified atrial flutter methicillin susceptible staphylococcus aureus septicemia pressure ulcer, lower back closed fracture of unspecified part of neck of femur chronic vascular insufficiency of intestine other mechanical complication of other internal orthopedic device, implant, and graft other specified disorders of intestine subendocardial infarction, initial episode of care other postoperative infection striking against or struck accidentally by furniture without subsequent fall
black african american m 60 $nan$hematology blood hematocrit  22.8  %; hematology blood hemoglobin  7.5  g dl; hematology blood platelet count  144  k ul$heparin flush (10 units ml)  2  ml ; vial  1  vial ; epoetin alfa  1  dose ; loperamide  2  mg ; sodium chloride nasal  1-2  spry ; acetaminophen  650  mg ; oxycodone-acetaminophen  1-2  tab ; sodium chloride 0.9%  flush  3  ml ; calcium carbonate  1250  mg ; ferrous sulfate  325  mg ; ipratropium bromide mdi  2  puff ; miconazole powder 2%  1  appl ; sevelamer hydrochloride  800  mg ; metoprolol tartrate  25  mg ; amlodipine  2.5  mg ; folic acid  1  mg ; lidocaine 5% patch  1  ptch ; nephrocaps  1  cap ; omeprazole  20  mg ; 0.9% sodium chloride  50  ml ; daptomycin  350  mg ; ciprofloxacin hcl  500  mg ; hydromorphone (dilaudid)  0.25  mg ; sarna lotion  1  appl ; hydroxyzine  25  mg ; 
congestive heart failure, unspecified accidental fall from bed sinoatrial node dysfunction abdominal pain, unspecified site drug-induced delirium end stage renal disease complications of transplanted kidney anemia of other chronic disease hypertensive chronic kidney disease, unspecified, with chronic kidney disease stage v or end stage renal disease benzodiazepine-based tranquilizers causing adverse effects in therapeutic use person on outside of car injured in collision with heavy transport vehicle or bus in nontraffic accident contusion of hip hyperparathyroidism, unspecified septic pulmonary embolism diastolic heart failure, unspecified ileostomy status mitral valve disorders aortic valve disorders antitussives causing adverse effects in therapeutic use surgical operation with transplant of whole organ causing abnormal patient reaction, or later complication, without mention of misadventure at time of operation atrial fibrillation internal hemorrhoids without mention of complication hyposmolality and/or hyponatremia hematoma complicating a procedure pyogenic arthritis, forearm pressure ulcer, stage ii infection and inflammatory reaction due to other internal orthopedic device, implant, and graft hypertensive chronic kidney disease, unspecified, with chronic kidney disease stage v or end stage renal disease chronic diastolic heart failure end stage renal disease acute posthemorrhagic anemia enthesopathy of hip region acute and subacute bacterial endocarditis congestive heart failure, unspecified atrial flutter methicillin susceptible staphylococcus aureus septicemia pressure ulcer, lower back closed fracture of unspecified part of neck of femur chronic vascular insufficiency of intestine other mechanical complication of other internal orthopedic device, implant, and graft other specified disorders of intestine subendocardial infarction, initial episode of care other postoperative infection striking against or struck accidentally by furniture without subsequent fall
black african american m 60 $nan$hematology blood hematocrit  21.8  %; hematology blood hematocrit  27.7  %; hematology blood hemoglobin  7.1  g dl; hematology blood platelet count  129  k ul; chemistry blood anion gap  15  meq l; chemistry blood bicarbonate  22  meq l; chemistry blood chloride  106  meq l; chemistry blood creatinine  7.4  mg dl; chemistry blood potassium  4.8  meq l; chemistry blood sodium  138  meq l; chemistry blood urea nitrogen  50  mg dl; hematology blood inr(pt)  1.2  ; chemistry blood calcium, total  9.9  mg dl; chemistry blood glucose  90  mg dl$heparin flush (10 units ml)  2  ml ; vial  1  vial ; epoetin alfa  1  dose ; loperamide  2  mg ; sodium chloride nasal  1-2  spry ; acetaminophen  650  mg ; oxycodone-acetaminophen  1-2  tab ; sodium chloride 0.9%  flush  3  ml ; calcium carbonate  1250  mg ; ferrous sulfate  325  mg ; ipratropium bromide mdi  2  puff ; miconazole powder 2%  1  appl ; sevelamer hydrochloride  800  mg ; metoprolol tartrate  25  mg ; amlodipine  2.5  mg ; folic acid  1  mg ; lidocaine 5% patch  1  ptch ; nephrocaps  1  cap ; omeprazole  20  mg ; 0.9% sodium chloride  50  ml ; daptomycin  350  mg ; ciprofloxacin hcl  500  mg ; hydromorphone (dilaudid)  0.25  mg ; sarna lotion  1  appl ; hydroxyzine  25  mg ; 
congestive heart failure, unspecified accidental fall from bed sinoatrial node dysfunction abdominal pain, unspecified site drug-induced delirium end stage renal disease complications of transplanted kidney anemia of other chronic disease hypertensive chronic kidney disease, unspecified, with chronic kidney disease stage v or end stage renal disease benzodiazepine-based tranquilizers causing adverse effects in therapeutic use person on outside of car injured in collision with heavy transport vehicle or bus in nontraffic accident contusion of hip hyperparathyroidism, unspecified septic pulmonary embolism diastolic heart failure, unspecified ileostomy status mitral valve disorders aortic valve disorders antitussives causing adverse effects in therapeutic use surgical operation with transplant of whole organ causing abnormal patient reaction, or later complication, without mention of misadventure at time of operation atrial fibrillation internal hemorrhoids without mention of complication hyposmolality and/or hyponatremia hematoma complicating a procedure pyogenic arthritis, forearm pressure ulcer, stage ii infection and inflammatory reaction due to other internal orthopedic device, implant, and graft hypertensive chronic kidney disease, unspecified, with chronic kidney disease stage v or end stage renal disease chronic diastolic heart failure end stage renal disease acute posthemorrhagic anemia enthesopathy of hip region acute and subacute bacterial endocarditis congestive heart failure, unspecified atrial flutter methicillin susceptible staphylococcus aureus septicemia pressure ulcer, lower back closed fracture of unspecified part of neck of femur chronic vascular insufficiency of intestine other mechanical complication of other internal orthopedic device, implant, and graft other specified disorders of intestine subendocardial infarction, initial episode of care other postoperative infection striking against or struck accidentally by furniture without subsequent fall
black african american m 60 $nan$hematology blood hematocrit  26.9  %; hematology blood hemoglobin  8.9  g dl; hematology blood platelet count  106  k ul; chemistry blood anion gap  14  meq l; chemistry blood bicarbonate  25  meq l; chemistry blood chloride  104  meq l; chemistry blood creatinine  6.2  mg dl; chemistry blood potassium  4.9  meq l; chemistry blood sodium  138  meq l; chemistry blood urea nitrogen  37  mg dl; hematology blood inr(pt)  1.3  ; chemistry blood calcium, total  9.5  mg dl; chemistry blood glucose  83  mg dl$heparin flush (10 units ml)  2  ml ; vial  1  vial ; epoetin alfa  1  dose ; loperamide  2  mg ; sodium chloride nasal  1-2  spry ; acetaminophen  650  mg ; oxycodone-acetaminophen  1-2  tab ; sodium chloride 0.9%  flush  3  ml ; calcium carbonate  1250  mg ; ferrous sulfate  325  mg ; ipratropium bromide mdi  2  puff ; sevelamer hydrochloride  800  mg ; metoprolol tartrate  25  mg ; amlodipine  2.5  mg ; folic acid  1  mg ; lidocaine 5% patch  1  ptch ; nephrocaps  1  cap ; omeprazole  20  mg ; 0.9% sodium chloride  50  ml ; daptomycin  350  mg ; ciprofloxacin hcl  500  mg ; hydromorphone (dilaudid)  0.25  mg ; sarna lotion  1  appl ; hydroxyzine  25  mg ; 
congestive heart failure, unspecified accidental fall from bed sinoatrial node dysfunction abdominal pain, unspecified site drug-induced delirium end stage renal disease complications of transplanted kidney anemia of other chronic disease hypertensive chronic kidney disease, unspecified, with chronic kidney disease stage v or end stage renal disease benzodiazepine-based tranquilizers causing adverse effects in therapeutic use person on outside of car injured in collision with heavy transport vehicle or bus in nontraffic accident contusion of hip hyperparathyroidism, unspecified septic pulmonary embolism diastolic heart failure, unspecified ileostomy status mitral valve disorders aortic valve disorders antitussives causing adverse effects in therapeutic use surgical operation with transplant of whole organ causing abnormal patient reaction, or later complication, without mention of misadventure at time of operation atrial fibrillation internal hemorrhoids without mention of complication hyposmolality and/or hyponatremia hematoma complicating a procedure pyogenic arthritis, forearm pressure ulcer, stage ii infection and inflammatory reaction due to other internal orthopedic device, implant, and graft hypertensive chronic kidney disease, unspecified, with chronic kidney disease stage v or end stage renal disease chronic diastolic heart failure end stage renal disease acute posthemorrhagic anemia enthesopathy of hip region acute and subacute bacterial endocarditis congestive heart failure, unspecified atrial flutter methicillin susceptible staphylococcus aureus septicemia pressure ulcer, lower back closed fracture of unspecified part of neck of femur chronic vascular insufficiency of intestine other mechanical complication of other internal orthopedic device, implant, and graft other specified disorders of intestine subendocardial infarction, initial episode of care other postoperative infection striking against or struck accidentally by furniture without subsequent fall
black african american m 60 $nan$hematology blood hematocrit  25.5  %; hematology blood hemoglobin  8.6  g dl; hematology blood platelet count  117  k ul; chemistry blood anion gap  14  meq l; chemistry blood bicarbonate  23  meq l; chemistry blood chloride  105  meq l; chemistry blood creatinine  7.2  mg dl; chemistry blood potassium  4.7  meq l; chemistry blood sodium  137  meq l; chemistry blood urea nitrogen  47  mg dl; chemistry blood urea nitrogen  49  mg dl; chemistry blood urea nitrogen  12  mg dl; hematology blood inr(pt)  1.3  ; chemistry blood calcium, total  9.6  mg dl; chemistry blood glucose  122  mg dl$heparin flush (10 units ml)  2  ml ; vial  1  vial ; epoetin alfa  1  dose ; loperamide  2  mg ; sodium chloride nasal  1-2  spry ; acetaminophen  650  mg ; oxycodone-acetaminophen  1-2  tab ; sodium chloride 0.9%  flush  3  ml ; calcium carbonate  1250  mg ; ferrous sulfate  325  mg ; ipratropium bromide mdi  2  puff ; sevelamer hydrochloride  800  mg ; metoprolol tartrate  25  mg ; amlodipine  2.5  mg ; folic acid  1  mg ; lidocaine 5% patch  1  ptch ; nephrocaps  1  cap ; omeprazole  20  mg ; 0.9% sodium chloride  50  ml ; daptomycin  350  mg ; ciprofloxacin hcl  500  mg ; hydromorphone (dilaudid)  0.25  mg ; sarna lotion  1  appl ; hydroxyzine  25  mg ; 
congestive heart failure, unspecified accidental fall from bed sinoatrial node dysfunction abdominal pain, unspecified site drug-induced delirium end stage renal disease complications of transplanted kidney anemia of other chronic disease hypertensive chronic kidney disease, unspecified, with chronic kidney disease stage v or end stage renal disease benzodiazepine-based tranquilizers causing adverse effects in therapeutic use person on outside of car injured in collision with heavy transport vehicle or bus in nontraffic accident contusion of hip hyperparathyroidism, unspecified septic pulmonary embolism diastolic heart failure, unspecified ileostomy status mitral valve disorders aortic valve disorders antitussives causing adverse effects in therapeutic use surgical operation with transplant of whole organ causing abnormal patient reaction, or later complication, without mention of misadventure at time of operation atrial fibrillation internal hemorrhoids without mention of complication hyposmolality and/or hyponatremia hematoma complicating a procedure pyogenic arthritis, forearm pressure ulcer, stage ii infection and inflammatory reaction due to other internal orthopedic device, implant, and graft hypertensive chronic kidney disease, unspecified, with chronic kidney disease stage v or end stage renal disease chronic diastolic heart failure end stage renal disease acute posthemorrhagic anemia enthesopathy of hip region acute and subacute bacterial endocarditis congestive heart failure, unspecified atrial flutter methicillin susceptible staphylococcus aureus septicemia pressure ulcer, lower back closed fracture of unspecified part of neck of femur chronic vascular insufficiency of intestine other mechanical complication of other internal orthopedic device, implant, and graft other specified disorders of intestine subendocardial infarction, initial episode of care other postoperative infection striking against or struck accidentally by furniture without subsequent fall
black african american m 60 $nan$hematology blood hematocrit  32.8  %; hematology blood hematocrit  32.5  %; hematology blood hemoglobin  10.7  g dl; hematology blood hemoglobin  10.6  g dl; hematology blood platelet count  112  k ul; hematology blood platelet count  118  k ul; chemistry blood anion gap  13  meq l; chemistry blood anion gap  11  meq l; chemistry blood bicarbonate  24  meq l; chemistry blood bicarbonate  23  meq l; chemistry blood chloride  106  meq l; chemistry blood chloride  109  meq l; chemistry blood creatinine  4.2  mg dl; chemistry blood creatinine  4.2  mg dl; chemistry blood potassium  4.6  meq l; chemistry blood potassium  5.0  meq l; chemistry blood sodium  138  meq l; chemistry blood sodium  138  meq l; chemistry blood urea nitrogen  22  mg dl; chemistry blood urea nitrogen  24  mg dl; hematology blood inr(pt)  1.2  ; chemistry blood calcium, total  10.0  mg dl; chemistry blood glucose  91  mg dl; chemistry blood glucose  73  mg dl$heparin flush (10 units ml)  2  ml ; vial  1  vial ; epoetin alfa  1  dose ; loperamide  2  mg ; sodium chloride nasal  1-2  spry ; acetaminophen  650  mg ; oxycodone-acetaminophen  1-2  tab ; sodium chloride 0.9%  flush  3  ml ; calcium carbonate  1250  mg ; ferrous sulfate  325  mg ; ipratropium bromide mdi  2  puff ; sevelamer hydrochloride  800  mg ; metoprolol tartrate  25  mg ; amlodipine  2.5  mg ; folic acid  1  mg ; lidocaine 5% patch  1  ptch ; nephrocaps  1  cap ; omeprazole  20  mg ; 0.9% sodium chloride  50  ml ; daptomycin  350  mg ; ciprofloxacin hcl  500  mg ; hydromorphone (dilaudid)  0.25  mg ; sarna lotion  1  appl ; hydroxyzine  25  mg ; labetalol  10-20  mg ; 0.9% sodium chloride  1000  ml ; 
congestive heart failure, unspecified accidental fall from bed sinoatrial node dysfunction abdominal pain, unspecified site drug-induced delirium end stage renal disease complications of transplanted kidney anemia of other chronic disease hypertensive chronic kidney disease, unspecified, with chronic kidney disease stage v or end stage renal disease benzodiazepine-based tranquilizers causing adverse effects in therapeutic use person on outside of car injured in collision with heavy transport vehicle or bus in nontraffic accident contusion of hip hyperparathyroidism, unspecified septic pulmonary embolism diastolic heart failure, unspecified ileostomy status mitral valve disorders aortic valve disorders antitussives causing adverse effects in therapeutic use surgical operation with transplant of whole organ causing abnormal patient reaction, or later complication, without mention of misadventure at time of operation atrial fibrillation internal hemorrhoids without mention of complication hyposmolality and/or hyponatremia hematoma complicating a procedure pyogenic arthritis, forearm pressure ulcer, stage ii infection and inflammatory reaction due to other internal orthopedic device, implant, and graft hypertensive chronic kidney disease, unspecified, with chronic kidney disease stage v or end stage renal disease chronic diastolic heart failure end stage renal disease acute posthemorrhagic anemia enthesopathy of hip region acute and subacute bacterial endocarditis congestive heart failure, unspecified atrial flutter methicillin susceptible staphylococcus aureus septicemia pressure ulcer, lower back closed fracture of unspecified part of neck of femur chronic vascular insufficiency of intestine other mechanical complication of other internal orthopedic device, implant, and graft other specified disorders of intestine subendocardial infarction, initial episode of care other postoperative infection striking against or struck accidentally by furniture without subsequent fall
black african american m 60 $nan$hematology blood hematocrit  31.9  %; hematology blood hemoglobin  10.1  g dl; hematology blood platelet count  120  k ul; chemistry blood anion gap  12  meq l; chemistry blood bicarbonate  23  meq l; chemistry blood chloride  108  meq l; chemistry blood creatinine  5.5  mg dl; chemistry blood potassium  4.8  meq l; chemistry blood sodium  138  meq l; chemistry blood urea nitrogen  33  mg dl; chemistry blood calcium, total  9.3  mg dl; chemistry blood glucose  115  mg dl$heparin flush (10 units ml)  2  ml ; vial  1  vial ; epoetin alfa  1  dose ; loperamide  2  mg ; sodium chloride nasal  1-2  spry ; acetaminophen  650  mg ; oxycodone-acetaminophen  1-2  tab ; sodium chloride 0.9%  flush  3  ml ; calcium carbonate  1250  mg ; ferrous sulfate  325  mg ; ipratropium bromide mdi  2  puff ; sevelamer hydrochloride  800  mg ; metoprolol tartrate  25  mg ; amlodipine  2.5  mg ; folic acid  1  mg ; lidocaine 5% patch  1  ptch ; nephrocaps  1  cap ; omeprazole  20  mg ; 0.9% sodium chloride  50  ml ; daptomycin  350  mg ; ciprofloxacin hcl  500  mg ; hydromorphone (dilaudid)  0.25  mg ; sarna lotion  1  appl ; hydroxyzine  25  mg ; labetalol  10-20  mg ; hydromorphone (dilaudid)  2-4  mg ; 
congestive heart failure, unspecified accidental fall from bed sinoatrial node dysfunction abdominal pain, unspecified site drug-induced delirium end stage renal disease complications of transplanted kidney anemia of other chronic disease hypertensive chronic kidney disease, unspecified, with chronic kidney disease stage v or end stage renal disease benzodiazepine-based tranquilizers causing adverse effects in therapeutic use person on outside of car injured in collision with heavy transport vehicle or bus in nontraffic accident contusion of hip hyperparathyroidism, unspecified septic pulmonary embolism diastolic heart failure, unspecified ileostomy status mitral valve disorders aortic valve disorders antitussives causing adverse effects in therapeutic use surgical operation with transplant of whole organ causing abnormal patient reaction, or later complication, without mention of misadventure at time of operation atrial fibrillation internal hemorrhoids without mention of complication hyposmolality and/or hyponatremia hematoma complicating a procedure pyogenic arthritis, forearm pressure ulcer, stage ii infection and inflammatory reaction due to other internal orthopedic device, implant, and graft hypertensive chronic kidney disease, unspecified, with chronic kidney disease stage v or end stage renal disease chronic diastolic heart failure end stage renal disease acute posthemorrhagic anemia enthesopathy of hip region acute and subacute bacterial endocarditis congestive heart failure, unspecified atrial flutter methicillin susceptible staphylococcus aureus septicemia pressure ulcer, lower back closed fracture of unspecified part of neck of femur chronic vascular insufficiency of intestine other mechanical complication of other internal orthopedic device, implant, and graft other specified disorders of intestine subendocardial infarction, initial episode of care other postoperative infection striking against or struck accidentally by furniture without subsequent fall
black african american m 60 $nan$nan$heparin flush (10 units ml)  2  ml ; vial  1  vial ; epoetin alfa  1  dose ; loperamide  2  mg ; sodium chloride nasal  1-2  spry ; acetaminophen  650  mg ; sodium chloride 0.9%  flush  3  ml ; calcium carbonate  1250  mg ; ferrous sulfate  325  mg ; ipratropium bromide mdi  2  puff ; sevelamer hydrochloride  800  mg ; metoprolol tartrate  25  mg ; amlodipine  2.5  mg ; folic acid  1  mg ; lidocaine 5% patch  1  ptch ; nephrocaps  1  cap ; omeprazole  20  mg ; 0.9% sodium chloride  50  ml ; daptomycin  350  mg ; ciprofloxacin hcl  500  mg ; sarna lotion  1  appl ; hydroxyzine  25  mg ; hydromorphone (dilaudid)  2-4  mg ; 
congestive heart failure, unspecified accidental fall from bed sinoatrial node dysfunction abdominal pain, unspecified site drug-induced delirium end stage renal disease complications of transplanted kidney anemia of other chronic disease hypertensive chronic kidney disease, unspecified, with chronic kidney disease stage v or end stage renal disease benzodiazepine-based tranquilizers causing adverse effects in therapeutic use person on outside of car injured in collision with heavy transport vehicle or bus in nontraffic accident contusion of hip hyperparathyroidism, unspecified septic pulmonary embolism diastolic heart failure, unspecified ileostomy status mitral valve disorders aortic valve disorders antitussives causing adverse effects in therapeutic use surgical operation with transplant of whole organ causing abnormal patient reaction, or later complication, without mention of misadventure at time of operation atrial fibrillation internal hemorrhoids without mention of complication hyposmolality and/or hyponatremia hematoma complicating a procedure pyogenic arthritis, forearm pressure ulcer, stage ii infection and inflammatory reaction due to other internal orthopedic device, implant, and graft hypertensive chronic kidney disease, unspecified, with chronic kidney disease stage v or end stage renal disease chronic diastolic heart failure end stage renal disease acute posthemorrhagic anemia enthesopathy of hip region acute and subacute bacterial endocarditis congestive heart failure, unspecified atrial flutter methicillin susceptible staphylococcus aureus septicemia pressure ulcer, lower back closed fracture of unspecified part of neck of femur chronic vascular insufficiency of intestine other mechanical complication of other internal orthopedic device, implant, and graft other specified disorders of intestine subendocardial infarction, initial episode of care other postoperative infection striking against or struck accidentally by furniture without subsequent fall
white m 73 $nan$hematology blood hematocrit  39.1  %; hematology blood hematocrit  40.8  %; hematology blood hemoglobin  12.3  g dl; hematology blood hemoglobin  12.7  g dl; hematology blood platelet count  185  k ul; hematology blood platelet count  184  k ul; chemistry blood anion gap  12  meq l; chemistry blood anion gap  10  meq l; chemistry blood bicarbonate  34  meq l; chemistry blood bicarbonate  36  meq l; chemistry blood chloride  102  meq l; chemistry blood chloride  99  meq l; chemistry blood creatinine  1.1  mg dl; chemistry blood creatinine  1.0  mg dl; chemistry blood potassium  3.3  meq l; chemistry blood potassium  3.9  meq l; chemistry blood sodium  145  meq l; chemistry blood sodium  141  meq l; chemistry blood urea nitrogen  20  mg dl; chemistry blood urea nitrogen  21  mg dl; hematology blood inr(pt)  1.1  ; chemistry blood calcium, total  9.1  mg dl; chemistry blood calcium, total  9.5  mg dl; chemistry blood bilirubin, total  1.4  mg dl; chemistry blood glucose  157  mg dl; chemistry blood glucose  206  mg dl; chemistry blood albumin  3.7  g dl; chemistry blood % hemoglobin a1c  6.5  %$pneumococcal 23-valent polysaccharide vaccine  0.5  ml ; sodium chloride 0.9%  flush  3  ml ; docusate sodium  100  mg ; senna  8.6  mg ; heparin  5000  unit ; allopurinol  300  mg ; atorvastatin  20  mg ; dextrose 50%  12.5  gm ; glucagon  1  mg ; glucose gel  15  g ; insulin  0  unit ; potassium chloride  40  meq ; amlodipine  10  mg ; bumetanide  2  mg ; losartan potassium  25  mg ; metoprolol succinate xl  100  mg ; 
 
white m 73 $nan$hematology blood hematocrit  41.7  %; hematology blood hemoglobin  12.7  g dl; hematology blood platelet count  192  k ul; chemistry blood anion gap  14  meq l; chemistry blood bicarbonate  33  meq l; chemistry blood chloride  99  meq l; chemistry blood creatinine  1.0  mg dl; chemistry blood potassium  3.5  meq l; chemistry blood sodium  142  meq l; chemistry blood urea nitrogen  20  mg dl; chemistry blood calcium, total  9.4  mg dl; chemistry blood glucose  152  mg dl; chemistry blood lactate dehydrogenase (ld)  203  iu l$pneumococcal 23-valent polysaccharide vaccine  0.5  ml ; sodium chloride 0.9%  flush  3  ml ; docusate sodium  100  mg ; senna  8.6  mg ; heparin  5000  unit ; allopurinol  300  mg ; atorvastatin  20  mg ; dextrose 50%  12.5  gm ; glucagon  1  mg ; glucose gel  15  g ; potassium chloride  40  meq ; amlodipine  10  mg ; bumetanide  2  mg ; losartan potassium  25  mg ; metoprolol succinate xl  100  mg ; heparin  2200-4500  unit ; 0.9% sodium chloride  250  ml ; heparin sodium  25,000  unit ; mupirocin nasal ointment 2%  1  appl ; potassium chloride  60  meq ; metoprolol succinate xl  50  mg ; 
 
white m 73 $nan$hematology blood hematocrit  42.2  %; hematology blood hemoglobin  13.3  g dl; hematology blood platelet count  203  k ul; chemistry blood anion gap  12  meq l; chemistry blood bicarbonate  33  meq l; chemistry blood chloride  100  meq l; chemistry blood creatinine  1.1  mg dl; chemistry blood potassium  3.8  meq l; chemistry blood sodium  141  meq l; chemistry blood urea nitrogen  21  mg dl; hematology blood inr(pt)  1.1  ; chemistry blood calcium, total  9.4  mg dl; chemistry blood glucose  149  mg dl$pneumococcal 23-valent polysaccharide vaccine  0.5  ml ; sodium chloride 0.9%  flush  3  ml ; docusate sodium  100  mg ; senna  8.6  mg ; allopurinol  300  mg ; atorvastatin  20  mg ; dextrose 50%  12.5  gm ; glucagon  1  mg ; glucose gel  15  g ; amlodipine  10  mg ; bumetanide  2  mg ; losartan potassium  25  mg ; heparin  2200-4500  unit ; 0.9% sodium chloride  250  ml ; heparin sodium  25,000  unit ; mupirocin nasal ointment 2%  1  appl ; potassium chloride  60  meq ; metoprolol succinate xl  50  mg ; metoprolol succinate xl  150  mg ; 
 
white m 73 $nan$hematology blood hematocrit  39.2  %; hematology blood hematocrit  34.5  %; hematology blood hematocrit  30.1  %; hematology blood hemoglobin  12.0  g dl; hematology blood hemoglobin  9.4  g dl; hematology blood hemoglobin  10.9  g dl; hematology blood platelet count  177  k ul; hematology blood platelet count  177  k ul; hematology blood platelet count  171  k ul; chemistry blood anion gap  13  meq l; chemistry blood anion gap  12  meq l; chemistry blood bicarbonate  32  meq l; chemistry blood bicarbonate  27  meq l; chemistry blood chloride  100  meq l; chemistry blood chloride  104  meq l; chemistry blood creatinine  1.0  mg dl; chemistry blood creatinine  1.1  mg dl; chemistry blood potassium  4.2  meq l; chemistry blood potassium  4.0  meq l; chemistry blood sodium  141  meq l; chemistry blood sodium  139  meq l; chemistry blood urea nitrogen  23  mg dl; chemistry blood urea nitrogen  22  mg dl; hematology blood inr(pt)  1.4  ; hematology blood inr(pt)  1.2  ; chemistry blood calcium, total  9.1  mg dl; chemistry blood glucose  163  mg dl; blood gas blood free calcium  1.16  mmol l; blood gas blood free calcium  1.27  mmol l; blood gas blood free calcium  1.26  mmol l; blood gas blood lactate  0.9  mmol l; blood gas blood lactate  3.1  mmol l; blood gas blood chloride, whole blood  99  meq l; blood gas blood chloride, whole blood  105  meq l; blood gas blood glucose  158  mg dl; blood gas blood glucose  161  mg dl; blood gas blood glucose  195  mg dl; blood gas blood glucose  185  mg dl; blood gas blood glucose  168  mg dl; blood gas blood glucose  181  mg dl; blood gas blood hematocrit, calculated  35  %; blood gas blood hematocrit, calculated  27  %; blood gas blood hematocrit, calculated  26  %; blood gas blood hematocrit, calculated  24  %; blood gas blood hematocrit, calculated  30  %; blood gas blood hemoglobin  11.5  g dl; blood gas blood hemoglobin  9.0  g dl; blood gas blood hemoglobin  8.7  g dl; blood gas blood hemoglobin  8.1  g dl; blood gas blood hemoglobin  9.9  g dl; blood gas blood potassium, whole blood  3.9  meq l; blood gas blood potassium, whole blood  5.0  meq l; blood gas blood potassium, whole blood  5.4  meq l; blood gas blood potassium, whole blood  4.8  meq l; blood gas blood potassium, whole blood  4.3  meq l; blood gas blood potassium, whole blood  4.2  meq l; blood gas blood sodium, whole blood  137  meq l; blood gas blood sodium, whole blood  139  meq l; blood gas blood sodium, whole blood  138  meq l$pneumococcal 23-valent polysaccharide vaccine  0.5  ml ; sodium chloride 0.9%  flush  3  ml ; docusate sodium  100  mg ; senna  8.6  mg ; allopurinol  300  mg ; atorvastatin  20  mg ; dextrose 50%  12.5  gm ; glucagon  1  mg ; glucose gel  15  g ; amlodipine  10  mg ; bumetanide  2  mg ; losartan potassium  25  mg ; heparin  2200-4500  unit ; 0.9% sodium chloride  250  ml ; heparin sodium  25,000  unit ; mupirocin nasal ointment 2%  1  appl ; metoprolol succinate xl  150  mg ; sodium chloride 0.9%  flush  10  ml ; aspirin ec  81  mg ; aspirin  81  mg ; milk of magnesia  30  ml ; lactated ringers  1000  ml ; dextrose 5%  1000  ml ; propofol  1000  mg ; d5w  250  ml ; nitroglycerin  100  mg ; syringe  20  ml ; nitroglycerin  8  mg ; 5% dextrose  250  ml ; phenylephrine  60  mg ; syringe  1  syr ; phenylephrine  12  mg ; glycopyrrolate  0.6  mg ; neostigmine  3  mg ; sterile water  50  ml ; potassium chloride  20  meq ; 0.9% sodium chloride  1  bag ; calcium gluconate  2  g ; bag  1  ml ; magnesium sulfate  2  gm ; morphine sulfate  0.5-5  mg ; metoclopramide  10  mg ; oxycodone-acetaminophen (5mg-325mg)  1-2  tab ; acetaminophen  650  mg ; 0.9% sodium chloride  100  ml ; insulin human regular  100  unit ; iso-osmotic dextrose  50  ml ; cefazolin  2  g ; epinephrine  2  mg ; 5% dextrose  100  ml ; amiodarone  150  mg ; 5% dextrose (excel bag)  500  ml ; amiodarone  600  mg ; 
 
white m 73 $nan$hematology blood hematocrit  33.6  %; hematology blood hematocrit  30.6  %; hematology blood hematocrit  31.7  %; hematology blood hemoglobin  10.4  g dl; hematology blood hemoglobin  9.9  g dl; hematology blood hemoglobin  10.2  g dl; hematology blood platelet count  173  k ul; hematology blood platelet count  169  k ul; chemistry blood anion gap  12  meq l; chemistry blood bicarbonate  27  meq l; chemistry blood chloride  104  meq l; chemistry blood chloride  102  meq l; chemistry blood chloride  100  meq l; chemistry blood creatinine  1.5  mg dl; chemistry blood potassium  4.6  meq l; chemistry blood potassium  4.5  meq l; chemistry blood potassium  4.7  meq l; chemistry blood sodium  138  meq l; chemistry blood sodium  136  meq l; chemistry blood sodium  134  meq l; chemistry blood urea nitrogen  23  mg dl; hematology blood inr(pt)  1.2  ; chemistry blood calcium, total  8.4  mg dl; chemistry blood glucose  91  mg dl; chemistry blood glucose  192  mg dl; blood gas blood free calcium  1.16  mmol l; blood gas blood free calcium  1.21  mmol l; blood gas blood free calcium  1.19  mmol l; blood gas blood free calcium  1.17  mmol l; blood gas blood free calcium  1.07  mmol l; blood gas blood free calcium  1.07  mmol l; blood gas blood lactate  3.3  mmol l; blood gas blood lactate  3.1  mmol l; blood gas blood lactate  1.5  mmol l; blood gas blood lactate  1.2  mmol l; blood gas blood lactate  4.7  mmol l; blood gas blood glucose  172  mg dl; blood gas blood glucose  177  mg dl; blood gas blood glucose  117  mg dl; blood gas blood potassium, whole blood  3.9  meq l; blood gas blood potassium, whole blood  4.6  meq l; blood gas blood potassium, whole blood  4.3  meq l$pneumococcal 23-valent polysaccharide vaccine  0.5  ml ; sodium chloride 0.9%  flush  3  ml ; docusate sodium  100  mg ; senna  8.6  mg ; allopurinol  300  mg ; atorvastatin  20  mg ; dextrose 50%  12.5  gm ; glucagon  1  mg ; glucose gel  15  g ; amlodipine  10  mg ; bumetanide  2  mg ; losartan potassium  25  mg ; heparin  2200-4500  unit ; 0.9% sodium chloride  250  ml ; heparin sodium  25,000  unit ; mupirocin nasal ointment 2%  1  appl ; metoprolol succinate xl  150  mg ; sodium chloride 0.9%  flush  10  ml ; aspirin ec  81  mg ; aspirin  81  mg ; milk of magnesia  30  ml ; dextrose 5%  1000  ml ; propofol  1000  mg ; d5w  250  ml ; nitroglycerin  100  mg ; syringe  20  ml ; nitroglycerin  8  mg ; 5% dextrose  250  ml ; phenylephrine  60  mg ; syringe  1  syr ; phenylephrine  12  mg ; glycopyrrolate  0.6  mg ; neostigmine  3  mg ; sterile water  50  ml ; potassium chloride  20  meq ; 0.9% sodium chloride  1  bag ; calcium gluconate  2  g ; bag  1  ml ; magnesium sulfate  2  gm ; morphine sulfate  0.5-5  mg ; metoclopramide  10  mg ; oxycodone-acetaminophen (5mg-325mg)  1-2  tab ; acetaminophen  650  mg ; 0.9% sodium chloride  100  ml ; insulin human regular  100  unit ; iso-osmotic dextrose  50  ml ; cefazolin  2  g ; epinephrine  2  mg ; 5% dextrose (excel bag)  500  ml ; amiodarone  600  mg ; albumin 5% (25g   500ml)  25  g ; ranitidine  150  mg ; 5% dextrose  500  ml ; vancomycin  1500  mg ; chlorhexidine gluconate 0.12% oral rinse  15  ml ; bag  1  bag ; metoprolol tartrate  2.5  mg ; 0.9% sodium chloride  150  ml ; dexmedetomidine  0.6  mg ; furosemide  10  mg ; norepinephrine  8  mg ; 
 
white m 73 $nan$hematology blood hematocrit  33.9  %; hematology blood hematocrit  32.5  %; hematology blood hemoglobin  10.4  g dl; hematology blood hemoglobin  10.3  g dl; hematology blood platelet count  174  k ul; hematology blood platelet count  160  k ul; chemistry blood anion gap  15  meq l; chemistry blood bicarbonate  25  meq l; chemistry blood chloride  100  meq l; chemistry blood chloride  98  meq l; chemistry blood chloride  99  meq l; chemistry blood chloride  100  meq l; chemistry blood creatinine  1.5  mg dl; chemistry blood potassium  4.1  meq l; chemistry blood potassium  5.4  meq l; chemistry blood potassium  4.9  meq l; chemistry blood potassium  4.7  meq l; chemistry blood sodium  135  meq l; chemistry blood sodium  133  meq l; chemistry blood sodium  135  meq l; chemistry blood sodium  137  meq l; chemistry blood urea nitrogen  24  mg dl; hematology blood inr(pt)  1.2  ; chemistry blood calcium, total  9.0  mg dl; chemistry blood bilirubin, total  4.1  mg dl; chemistry blood glucose  154  mg dl; chemistry blood lactate dehydrogenase (ld)  328  iu l; chemistry blood albumin  3.0  g dl; blood gas blood free calcium  1.13  mmol l; blood gas blood free calcium  1.11  mmol l; blood gas blood free calcium  1.17  mmol l; blood gas blood free calcium  1.08  mmol l; blood gas blood lactate  1.5  mmol l; blood gas blood hematocrit, calculated  31  %; blood gas blood hemoglobin  10.3  g dl$pneumococcal 23-valent polysaccharide vaccine  0.5  ml ; sodium chloride 0.9%  flush  10  ml ; aspirin ec  81  mg ; aspirin  81  mg ; milk of magnesia  30  ml ; dextrose 5%  1000  ml ; propofol  1000  mg ; d5w  250  ml ; nitroglycerin  100  mg ; 5% dextrose  250  ml ; phenylephrine  60  mg ; sterile water  50  ml ; potassium chloride  20  meq ; 0.9% sodium chloride  1  bag ; calcium gluconate  2  g ; bag  1  ml ; magnesium sulfate  2  gm ; morphine sulfate  0.5-5  mg ; metoclopramide  10  mg ; oxycodone-acetaminophen (5mg-325mg)  1-2  tab ; acetaminophen  650  mg ; 0.9% sodium chloride  100  ml ; insulin human regular  100  unit ; iso-osmotic dextrose  50  ml ; cefazolin  2  g ; epinephrine  2  mg ; ranitidine  150  mg ; 5% dextrose  500  ml ; vancomycin  1500  mg ; chlorhexidine gluconate 0.12% oral rinse  15  ml ; 0.9% sodium chloride  150  ml ; dexmedetomidine  0.6  mg ; norepinephrine  8  mg ; furosemide  20  mg ; oxycodone (immediate release)   5-10  mg ; soln  100  ml ; acetaminophen iv  1000  mg ; 
 
white m 73 $nan$hematology blood hematocrit  31.3  %; hematology blood hemoglobin  10.0  g dl; hematology blood platelet count  127  k ul; chemistry blood anion gap  15  meq l; chemistry blood anion gap  14  meq l; chemistry blood bicarbonate  28  meq l; chemistry blood bicarbonate  30  meq l; chemistry blood chloride  97  meq l; chemistry blood chloride  98  meq l; chemistry blood creatinine  1.5  mg dl; chemistry blood creatinine  1.5  mg dl; chemistry blood potassium  4.6  meq l; chemistry blood potassium  4.7  meq l; chemistry blood sodium  135  meq l; chemistry blood sodium  137  meq l; chemistry blood urea nitrogen  27  mg dl; chemistry blood urea nitrogen  31  mg dl; hematology blood inr(pt)  1.2  ; chemistry blood calcium, total  9.0  mg dl; chemistry blood calcium, total  8.9  mg dl; chemistry blood glucose  157  mg dl; chemistry blood glucose  167  mg dl; blood gas blood free calcium  1.18  mmol l; blood gas blood free calcium  1.16  mmol l; blood gas blood hematocrit, calculated  29  %; blood gas blood hemoglobin  9.7  g dl$pneumococcal 23-valent polysaccharide vaccine  0.5  ml ; sodium chloride 0.9%  flush  10  ml ; aspirin ec  81  mg ; aspirin  81  mg ; milk of magnesia  30  ml ; dextrose 5%  1000  ml ; d5w  250  ml ; nitroglycerin  100  mg ; 5% dextrose  250  ml ; phenylephrine  60  mg ; sterile water  50  ml ; potassium chloride  20  meq ; 0.9% sodium chloride  1  bag ; calcium gluconate  2  g ; bag  1  ml ; magnesium sulfate  2  gm ; morphine sulfate  0.5-5  mg ; metoclopramide  10  mg ; acetaminophen  650  mg ; 0.9% sodium chloride  100  ml ; insulin human regular  100  unit ; ranitidine  150  mg ; norepinephrine  8  mg ; oxycodone (immediate release)   5-10  mg ; soln  100  ml ; acetaminophen iv  1000  mg ; metoclopramide  5  mg ; amiodarone  400  mg ; warfarin  2  mg ; furosemide  40  mg ; metoprolol tartrate  6.25  mg ; tramadol (ultram)  50  mg ; lactulose  30  ml ; 
 
white m 73 $nan$hematology blood hematocrit  31.1  %; hematology blood hemoglobin  9.6  g dl; hematology blood platelet count  159  k ul; chemistry blood anion gap  11  meq l; chemistry blood bicarbonate  33  meq l; chemistry blood chloride  96  meq l; chemistry blood creatinine  1.5  mg dl; chemistry blood potassium  4.1  meq l; chemistry blood sodium  136  meq l; chemistry blood urea nitrogen  35  mg dl; hematology blood inr(pt)  2.5  ; chemistry blood glucose  109  mg dl$pneumococcal 23-valent polysaccharide vaccine  0.5  ml ; sodium chloride 0.9%  flush  10  ml ; aspirin ec  81  mg ; aspirin  81  mg ; milk of magnesia  30  ml ; dextrose 5%  1000  ml ; d5w  250  ml ; nitroglycerin  100  mg ; 5% dextrose  250  ml ; phenylephrine  60  mg ; sterile water  50  ml ; potassium chloride  20  meq ; 0.9% sodium chloride  1  bag ; calcium gluconate  2  g ; bag  1  ml ; magnesium sulfate  2  gm ; acetaminophen  650  mg ; 0.9% sodium chloride  100  ml ; insulin human regular  100  unit ; norepinephrine  8  mg ; soln  100  ml ; acetaminophen iv  1000  mg ; metoclopramide  5  mg ; amiodarone  400  mg ; warfarin  2  mg ; furosemide  40  mg ; tramadol (ultram)  50  mg ; lactulose  30  ml ; acetaminophen  325-650  mg ; warfarin  1  dose ; bisacodyl  10  mg ; insulin  20  unit ; metoprolol tartrate  12.5  mg ; glipizide  2.5  mg ; senna  17.2  mg ; tramadol (ultram)  25  mg ; warfarin  0  mg ; 
 
white m 73 $nan$hematology blood hematocrit  30.6  %; hematology blood hemoglobin  9.2  g dl; hematology blood platelet count  164  k ul; chemistry blood anion gap  13  meq l; chemistry blood anion gap  11  meq l; chemistry blood bicarbonate  28  meq l; chemistry blood bicarbonate  32  meq l; chemistry blood chloride  95  meq l; chemistry blood chloride  95  meq l; chemistry blood creatinine  1.5  mg dl; chemistry blood creatinine  1.7  mg dl; chemistry blood potassium  4.2  meq l; chemistry blood potassium  4.3  meq l; chemistry blood sodium  132  meq l; chemistry blood sodium  134  meq l; chemistry blood urea nitrogen  38  mg dl; chemistry blood urea nitrogen  40  mg dl; hematology blood inr(pt)  3.6  ; chemistry blood calcium, total  8.9  mg dl; chemistry blood bilirubin, total  3.8  mg dl; chemistry blood glucose  148  mg dl; chemistry blood glucose  92  mg dl; chemistry blood lactate dehydrogenase (ld)  323  iu l; chemistry blood albumin  3.3  g dl$acetaminophen  325-650  mg ; warfarin  1  dose ; bisacodyl  10  mg ; insulin  20  unit ; glipizide  2.5  mg ; tramadol (ultram)  25  mg ; warfarin  0  mg ; albumin 25% (12.5g   50ml)  25  g ; furosemide  80  mg ; metolazone  5  mg ; 
 
white m 73 $nan$chemistry blood anion gap  14  meq l; chemistry blood bicarbonate  30  meq l; chemistry blood chloride  93  meq l; chemistry blood creatinine  1.6  mg dl; chemistry blood potassium  3.9  meq l; chemistry blood sodium  133  meq l; chemistry blood urea nitrogen  45  mg dl; hematology blood inr(pt)  1.6  ; chemistry blood glucose  84  mg dl$acetaminophen  325-650  mg ; warfarin  1  dose ; bisacodyl  10  mg ; insulin  20  unit ; glipizide  2.5  mg ; tramadol (ultram)  25  mg ; metolazone  5  mg ; 
 
white m 73 $nan$hematology blood hematocrit  31.4  %; hematology blood hemoglobin  9.8  g dl; hematology blood platelet count  258  k ul; chemistry blood anion gap  15  meq l; chemistry blood bicarbonate  29  meq l; chemistry blood chloride  91  meq l; chemistry blood creatinine  1.6  mg dl; chemistry blood potassium  3.6  meq l; chemistry blood sodium  131  meq l; chemistry blood urea nitrogen  49  mg dl; hematology blood inr(pt)  1.7  ; chemistry blood glucose  71  mg dl$acetaminophen  325-650  mg ; warfarin  1  dose ; bisacodyl  10  mg ; insulin  20  unit ; glipizide  2.5  mg ; tramadol (ultram)  25  mg ; 
 
white m 73 $nan$nan$acetaminophen  325-650  mg ; warfarin  1  dose ; bisacodyl  10  mg ; insulin  20  unit ; glipizide  2.5  mg ; tramadol (ultram)  25  mg ; 
 
white m 80 $temp  98.1  heartrate  67.0  resprate  18.0  o2sat  100.0  sbp  117.0  dbp  67.0  rhythm    pain  5  $hematology blood hematocrit  33.7  %; hematology blood hemoglobin  11.3  g dl; hematology blood platelet count  168  k ul; chemistry blood anion gap  17  meq l; chemistry blood bicarbonate  21  meq l; chemistry blood chloride  94  meq l; chemistry blood creatinine  1.1  mg dl; chemistry blood potassium  5.4  meq l; chemistry blood sodium  132  meq l; chemistry blood urea nitrogen  22  mg dl; hematology blood inr(pt)  1.4  ; chemistry blood calcium, total  9.0  mg dl; chemistry blood glucose  132  mg dl$sodium chloride 0.9%  flush  3-10  ml ; lidocaine jelly 2% (glydo)  1  appl ; allopurinol  300  mg ; finasteride  5  mg ; metoprolol tartrate  12.5  mg ; omeprazole  40  mg ; tamsulosin  0.4  mg ; docusate sodium  100  mg ; senna  8.6  mg ; albuterol 0.083% neb soln  1  neb ; ipratropium bromide neb  1  neb ; oxycodone (immediate release)  2.5-5  mg ; acetaminophen  650  mg ; spironolactone  25  mg ; furosemide  20  mg ; oxycodone (immediate release)  5-10  mg ; enoxaparin sodium  40  mg ; 
stenosis of larynx obstructive sleep apnea (adult) (pediatric) personal history of malignant neoplasm of larynx benign prostatic hyperplasia without lower urinary tract symptoms chronic obstructive pulmonary disease, unspecified gastro-esophageal reflux disease without esophagitis presence of left artificial knee joint gout, unspecified personal history of nicotine dependence unspecified atrial fibrillation essential (primary) hypertension unilateral inguinal hernia, without obstruction or gangrene, not specified as recurrent long term (current) use of antithrombotics/antiplatelets encounter for change or removal of surgical wound dressing paralysis of vocal cords and larynx, unilateral iron deficiency anemia secondary to blood loss (chronic) other diseases of larynx therapeutic (nonsurgical) and rehabilitative radiological devices associated with adverse incidents other abnormal findings in cerebrospinal fluid obstructive sleep apnea (adult) (pediatric) acute on chronic diastolic (congestive) heart failure acute upper respiratory infection, unspecified gastro-esophageal reflux disease without esophagitis personal history of nicotine dependence benign prostatic hyperplasia without lower urinary tract symptoms acquired absence of other specified parts of digestive tract unspecified atrial fibrillation stenosis of larynx gout, unspecified radiological procedure and radiotherapy as the cause of abnormal reaction of the patient, or of later complication, without mention of misadventure at the time of the procedure long term (current) use of anticoagulants presence of left artificial knee joint hypertensive heart disease with heart failure chronic obstructive pulmonary disease, unspecified anemia, unspecified personal history of malignant neoplasm of larynx personal history of nicotine dependence postprocedural subglottic stenosis unilateral inguinal hernia, without obstruction or gangrene, recurrent obstructive sleep apnea (adult) (pediatric) gout, unspecified gastro-esophageal reflux disease without esophagitis personal history of malignant neoplasm of larynx medical procedure, unspecified as the cause of abnormal reaction of the patient, or of later complication, without mention of misadventure at the time of the procedure chronic obstructive pulmonary disease, unspecified incisional hernia without obstruction or gangrene long term (current) use of anticoagulants acute posthemorrhagic anemia
white m 80 $nan$hematology blood hematocrit  34.0  %; hematology blood hematocrit  30.1  %; hematology blood hemoglobin  11.3  g dl; hematology blood hemoglobin  10.2  g dl; hematology blood platelet count  159  k ul; hematology blood platelet count  130  k ul; chemistry blood anion gap  13  meq l; chemistry blood anion gap  19  meq l; chemistry blood bicarbonate  20  meq l; chemistry blood bicarbonate  21  meq l; chemistry blood chloride  91  meq l; chemistry blood chloride  99  meq l; chemistry blood creatinine  1.4  mg dl; chemistry blood creatinine  1.1  mg dl; chemistry blood potassium  4.5  meq l; chemistry blood potassium  4.6  meq l; chemistry blood sodium  130  meq l; chemistry blood sodium  133  meq l; chemistry blood urea nitrogen  43  mg dl; chemistry blood urea nitrogen  31  mg dl; chemistry urine creatinine, urine  131  mg dl; hematology urine wbc  38  # hpf; chemistry blood calcium, total  8.9  mg dl; chemistry blood glucose  114  mg dl; chemistry blood glucose  146  mg dl; hematology blood bands  6  %; blood gas blood lactate  2.7  mmol l$sodium chloride 0.9%  flush  3-10  ml ; lidocaine jelly 2% (glydo)  1  appl ; allopurinol  300  mg ; finasteride  5  mg ; metoprolol tartrate  12.5  mg ; tamsulosin  0.4  mg ; docusate sodium  100  mg ; senna  8.6  mg ; albuterol 0.083% neb soln  1  neb ; ipratropium bromide neb  1  neb ; acetaminophen  650  mg ; spironolactone  25  mg ; oxycodone (immediate release)  5-10  mg ; enoxaparin sodium  40  mg ; lactated ringers  1000  ml ; quetiapine fumarate  25  mg ; haloperidol  0.5  mg ; ferrous sulfate  325  mg ; sodium chloride 0.9%  1000  ml ; ipratropium-albuterol neb  1  neb ; vancomycin  1000  mg ; metoprolol tartrate  6.25  mg ; acetaminophen  1000  mg ; 0.9% sodium chloride (mini bag plus)  100  ml ; cefepime  2  g ; 
stenosis of larynx obstructive sleep apnea (adult) (pediatric) personal history of malignant neoplasm of larynx benign prostatic hyperplasia without lower urinary tract symptoms chronic obstructive pulmonary disease, unspecified gastro-esophageal reflux disease without esophagitis presence of left artificial knee joint gout, unspecified personal history of nicotine dependence unspecified atrial fibrillation essential (primary) hypertension unilateral inguinal hernia, without obstruction or gangrene, not specified as recurrent long term (current) use of antithrombotics/antiplatelets encounter for change or removal of surgical wound dressing paralysis of vocal cords and larynx, unilateral iron deficiency anemia secondary to blood loss (chronic) other diseases of larynx therapeutic (nonsurgical) and rehabilitative radiological devices associated with adverse incidents other abnormal findings in cerebrospinal fluid obstructive sleep apnea (adult) (pediatric) acute on chronic diastolic (congestive) heart failure acute upper respiratory infection, unspecified gastro-esophageal reflux disease without esophagitis personal history of nicotine dependence benign prostatic hyperplasia without lower urinary tract symptoms acquired absence of other specified parts of digestive tract unspecified atrial fibrillation stenosis of larynx gout, unspecified radiological procedure and radiotherapy as the cause of abnormal reaction of the patient, or of later complication, without mention of misadventure at the time of the procedure long term (current) use of anticoagulants presence of left artificial knee joint hypertensive heart disease with heart failure chronic obstructive pulmonary disease, unspecified anemia, unspecified personal history of malignant neoplasm of larynx personal history of nicotine dependence postprocedural subglottic stenosis unilateral inguinal hernia, without obstruction or gangrene, recurrent obstructive sleep apnea (adult) (pediatric) gout, unspecified gastro-esophageal reflux disease without esophagitis personal history of malignant neoplasm of larynx medical procedure, unspecified as the cause of abnormal reaction of the patient, or of later complication, without mention of misadventure at the time of the procedure chronic obstructive pulmonary disease, unspecified incisional hernia without obstruction or gangrene long term (current) use of anticoagulants acute posthemorrhagic anemia
white m 80 $nan$hematology blood hematocrit  28.5  %; hematology blood hemoglobin  9.6  g dl; hematology blood platelet count  137  k ul; chemistry blood anion gap  15  meq l; chemistry blood bicarbonate  21  meq l; chemistry blood chloride  98  meq l; chemistry blood creatinine  1.0  mg dl; chemistry blood potassium  4.7  meq l; chemistry blood sodium  134  meq l; chemistry blood urea nitrogen  35  mg dl; hematology blood inr(pt)  1.3  ; chemistry blood calcium, total  8.4  mg dl; chemistry blood glucose  118  mg dl$sodium chloride 0.9%  flush  3-10  ml ; allopurinol  300  mg ; finasteride  5  mg ; tamsulosin  0.4  mg ; docusate sodium  100  mg ; senna  8.6  mg ; oxycodone (immediate release)  5-10  mg ; ferrous sulfate  325  mg ; sodium chloride 0.9%  1000  ml ; ipratropium-albuterol neb  1  neb ; vancomycin  1000  mg ; acetaminophen  1000  mg ; 0.9% sodium chloride (mini bag plus)  100  ml ; cefepime  2  g ; metoprolol succinate xl  12.5  mg ; apixaban  5  mg ; polyethylene glycol  17  g ; 
stenosis of larynx obstructive sleep apnea (adult) (pediatric) personal history of malignant neoplasm of larynx benign prostatic hyperplasia without lower urinary tract symptoms chronic obstructive pulmonary disease, unspecified gastro-esophageal reflux disease without esophagitis presence of left artificial knee joint gout, unspecified personal history of nicotine dependence unspecified atrial fibrillation essential (primary) hypertension unilateral inguinal hernia, without obstruction or gangrene, not specified as recurrent long term (current) use of antithrombotics/antiplatelets encounter for change or removal of surgical wound dressing paralysis of vocal cords and larynx, unilateral iron deficiency anemia secondary to blood loss (chronic) other diseases of larynx therapeutic (nonsurgical) and rehabilitative radiological devices associated with adverse incidents other abnormal findings in cerebrospinal fluid obstructive sleep apnea (adult) (pediatric) acute on chronic diastolic (congestive) heart failure acute upper respiratory infection, unspecified gastro-esophageal reflux disease without esophagitis personal history of nicotine dependence benign prostatic hyperplasia without lower urinary tract symptoms acquired absence of other specified parts of digestive tract unspecified atrial fibrillation stenosis of larynx gout, unspecified radiological procedure and radiotherapy as the cause of abnormal reaction of the patient, or of later complication, without mention of misadventure at the time of the procedure long term (current) use of anticoagulants presence of left artificial knee joint hypertensive heart disease with heart failure chronic obstructive pulmonary disease, unspecified anemia, unspecified personal history of malignant neoplasm of larynx personal history of nicotine dependence postprocedural subglottic stenosis unilateral inguinal hernia, without obstruction or gangrene, recurrent obstructive sleep apnea (adult) (pediatric) gout, unspecified gastro-esophageal reflux disease without esophagitis personal history of malignant neoplasm of larynx medical procedure, unspecified as the cause of abnormal reaction of the patient, or of later complication, without mention of misadventure at the time of the procedure chronic obstructive pulmonary disease, unspecified incisional hernia without obstruction or gangrene long term (current) use of anticoagulants acute posthemorrhagic anemia
white m 80 $nan$hematology blood hematocrit  24.6  %; hematology blood hematocrit  25.2  %; hematology blood hemoglobin  8.3  g dl; hematology blood hemoglobin  8.6  g dl; hematology blood platelet count  154  k ul; hematology blood platelet count  154  k ul; chemistry blood anion gap  12  meq l; chemistry blood bicarbonate  22  meq l; chemistry blood chloride  97  meq l; chemistry blood creatinine  1.0  mg dl; chemistry blood potassium  4.3  meq l; chemistry blood sodium  131  meq l; chemistry blood urea nitrogen  34  mg dl; chemistry blood calcium, total  8.1  mg dl; chemistry blood glucose  103  mg dl$iso-osmotic dextrose  200  ml ; sodium chloride 0.9%  flush  3-10  ml ; allopurinol  300  mg ; finasteride  5  mg ; tamsulosin  0.4  mg ; docusate sodium  100  mg ; senna  8.6  mg ; oxycodone (immediate release)  5-10  mg ; ferrous sulfate  325  mg ; ipratropium-albuterol neb  1  neb ; acetaminophen  1000  mg ; metoprolol succinate xl  12.5  mg ; apixaban  5  mg ; polyethylene glycol  17  g ; neutra-phos  2  pkt ; iso-osmotic dextrose  50  ml ; ceftriaxone  1  gm ; 
stenosis of larynx obstructive sleep apnea (adult) (pediatric) personal history of malignant neoplasm of larynx benign prostatic hyperplasia without lower urinary tract symptoms chronic obstructive pulmonary disease, unspecified gastro-esophageal reflux disease without esophagitis presence of left artificial knee joint gout, unspecified personal history of nicotine dependence unspecified atrial fibrillation essential (primary) hypertension unilateral inguinal hernia, without obstruction or gangrene, not specified as recurrent long term (current) use of antithrombotics/antiplatelets encounter for change or removal of surgical wound dressing paralysis of vocal cords and larynx, unilateral iron deficiency anemia secondary to blood loss (chronic) other diseases of larynx therapeutic (nonsurgical) and rehabilitative radiological devices associated with adverse incidents other abnormal findings in cerebrospinal fluid obstructive sleep apnea (adult) (pediatric) acute on chronic diastolic (congestive) heart failure acute upper respiratory infection, unspecified gastro-esophageal reflux disease without esophagitis personal history of nicotine dependence benign prostatic hyperplasia without lower urinary tract symptoms acquired absence of other specified parts of digestive tract unspecified atrial fibrillation stenosis of larynx gout, unspecified radiological procedure and radiotherapy as the cause of abnormal reaction of the patient, or of later complication, without mention of misadventure at the time of the procedure long term (current) use of anticoagulants presence of left artificial knee joint hypertensive heart disease with heart failure chronic obstructive pulmonary disease, unspecified anemia, unspecified personal history of malignant neoplasm of larynx personal history of nicotine dependence postprocedural subglottic stenosis unilateral inguinal hernia, without obstruction or gangrene, recurrent obstructive sleep apnea (adult) (pediatric) gout, unspecified gastro-esophageal reflux disease without esophagitis personal history of malignant neoplasm of larynx medical procedure, unspecified as the cause of abnormal reaction of the patient, or of later complication, without mention of misadventure at the time of the procedure chronic obstructive pulmonary disease, unspecified incisional hernia without obstruction or gangrene long term (current) use of anticoagulants acute posthemorrhagic anemia
white m 80 $nan$hematology blood hematocrit  22.8  %; hematology blood hemoglobin  7.8  g dl; hematology blood platelet count  175  k ul; chemistry blood anion gap  11  meq l; chemistry blood bicarbonate  24  meq l; chemistry blood chloride  97  meq l; chemistry blood creatinine  0.8  mg dl; chemistry blood potassium  3.9  meq l; chemistry blood sodium  132  meq l; chemistry blood urea nitrogen  22  mg dl; chemistry blood calcium, total  8.1  mg dl; chemistry blood glucose  113  mg dl$iso-osmotic dextrose  200  ml ; sodium chloride 0.9%  flush  3-10  ml ; allopurinol  300  mg ; finasteride  5  mg ; tamsulosin  0.4  mg ; docusate sodium  100  mg ; senna  8.6  mg ; oxycodone (immediate release)  5-10  mg ; ferrous sulfate  325  mg ; ipratropium-albuterol neb  1  neb ; acetaminophen  1000  mg ; metoprolol succinate xl  12.5  mg ; apixaban  5  mg ; polyethylene glycol  17  g ; neutra-phos  2  pkt ; iso-osmotic dextrose  50  ml ; ceftriaxone  1  gm ; 
stenosis of larynx obstructive sleep apnea (adult) (pediatric) personal history of malignant neoplasm of larynx benign prostatic hyperplasia without lower urinary tract symptoms chronic obstructive pulmonary disease, unspecified gastro-esophageal reflux disease without esophagitis presence of left artificial knee joint gout, unspecified personal history of nicotine dependence unspecified atrial fibrillation essential (primary) hypertension unilateral inguinal hernia, without obstruction or gangrene, not specified as recurrent long term (current) use of antithrombotics/antiplatelets encounter for change or removal of surgical wound dressing paralysis of vocal cords and larynx, unilateral iron deficiency anemia secondary to blood loss (chronic) other diseases of larynx therapeutic (nonsurgical) and rehabilitative radiological devices associated with adverse incidents other abnormal findings in cerebrospinal fluid obstructive sleep apnea (adult) (pediatric) acute on chronic diastolic (congestive) heart failure acute upper respiratory infection, unspecified gastro-esophageal reflux disease without esophagitis personal history of nicotine dependence benign prostatic hyperplasia without lower urinary tract symptoms acquired absence of other specified parts of digestive tract unspecified atrial fibrillation stenosis of larynx gout, unspecified radiological procedure and radiotherapy as the cause of abnormal reaction of the patient, or of later complication, without mention of misadventure at the time of the procedure long term (current) use of anticoagulants presence of left artificial knee joint hypertensive heart disease with heart failure chronic obstructive pulmonary disease, unspecified anemia, unspecified personal history of malignant neoplasm of larynx personal history of nicotine dependence postprocedural subglottic stenosis unilateral inguinal hernia, without obstruction or gangrene, recurrent obstructive sleep apnea (adult) (pediatric) gout, unspecified gastro-esophageal reflux disease without esophagitis personal history of malignant neoplasm of larynx medical procedure, unspecified as the cause of abnormal reaction of the patient, or of later complication, without mention of misadventure at the time of the procedure chronic obstructive pulmonary disease, unspecified incisional hernia without obstruction or gangrene long term (current) use of anticoagulants acute posthemorrhagic anemia
white m 80 $nan$hematology blood hematocrit  25.0  %; hematology blood hematocrit  25.0  %; hematology blood hemoglobin  8.4  g dl; hematology blood hemoglobin  8.4  g dl; hematology blood platelet count  183  k ul; hematology blood platelet count  197  k ul; chemistry blood anion gap  11  meq l; chemistry blood anion gap  11  meq l; chemistry blood bicarbonate  25  meq l; chemistry blood bicarbonate  25  meq l; chemistry blood chloride  97  meq l; chemistry blood chloride  94  meq l; chemistry blood creatinine  0.8  mg dl; chemistry blood creatinine  0.8  mg dl; chemistry blood potassium  3.9  meq l; chemistry blood potassium  4.0  meq l; chemistry blood sodium  133  meq l; chemistry blood sodium  130  meq l; chemistry blood urea nitrogen  20  mg dl; chemistry blood urea nitrogen  20  mg dl; chemistry blood calcium, total  8.1  mg dl; chemistry blood calcium, total  8.4  mg dl; chemistry blood glucose  112  mg dl; chemistry blood glucose  100  mg dl$iso-osmotic dextrose  200  ml ; sodium chloride 0.9%  flush  3-10  ml ; allopurinol  300  mg ; finasteride  5  mg ; tamsulosin  0.4  mg ; docusate sodium  100  mg ; senna  8.6  mg ; oxycodone (immediate release)  5-10  mg ; ferrous sulfate  325  mg ; ipratropium-albuterol neb  1  neb ; acetaminophen  1000  mg ; metoprolol succinate xl  12.5  mg ; apixaban  5  mg ; polyethylene glycol  17  g ; iso-osmotic dextrose  50  ml ; ceftriaxone  1  gm ; bisacodyl  10  mg ; haloperidol  1  mg ; oxycodone (immediate release)  5  mg ; bag  1  bag ; magnesium sulfate  4  gm ; 
stenosis of larynx obstructive sleep apnea (adult) (pediatric) personal history of malignant neoplasm of larynx benign prostatic hyperplasia without lower urinary tract symptoms chronic obstructive pulmonary disease, unspecified gastro-esophageal reflux disease without esophagitis presence of left artificial knee joint gout, unspecified personal history of nicotine dependence unspecified atrial fibrillation essential (primary) hypertension unilateral inguinal hernia, without obstruction or gangrene, not specified as recurrent long term (current) use of antithrombotics/antiplatelets encounter for change or removal of surgical wound dressing paralysis of vocal cords and larynx, unilateral iron deficiency anemia secondary to blood loss (chronic) other diseases of larynx therapeutic (nonsurgical) and rehabilitative radiological devices associated with adverse incidents other abnormal findings in cerebrospinal fluid obstructive sleep apnea (adult) (pediatric) acute on chronic diastolic (congestive) heart failure acute upper respiratory infection, unspecified gastro-esophageal reflux disease without esophagitis personal history of nicotine dependence benign prostatic hyperplasia without lower urinary tract symptoms acquired absence of other specified parts of digestive tract unspecified atrial fibrillation stenosis of larynx gout, unspecified radiological procedure and radiotherapy as the cause of abnormal reaction of the patient, or of later complication, without mention of misadventure at the time of the procedure long term (current) use of anticoagulants presence of left artificial knee joint hypertensive heart disease with heart failure chronic obstructive pulmonary disease, unspecified anemia, unspecified personal history of malignant neoplasm of larynx personal history of nicotine dependence postprocedural subglottic stenosis unilateral inguinal hernia, without obstruction or gangrene, recurrent obstructive sleep apnea (adult) (pediatric) gout, unspecified gastro-esophageal reflux disease without esophagitis personal history of malignant neoplasm of larynx medical procedure, unspecified as the cause of abnormal reaction of the patient, or of later complication, without mention of misadventure at the time of the procedure chronic obstructive pulmonary disease, unspecified incisional hernia without obstruction or gangrene long term (current) use of anticoagulants acute posthemorrhagic anemia
white m 80 $nan$hematology blood hematocrit  21.8  %; hematology blood hemoglobin  7.1  g dl; hematology blood platelet count  179  k ul; chemistry blood anion gap  9  meq l; chemistry blood anion gap  12  meq l; chemistry blood bicarbonate  25  meq l; chemistry blood bicarbonate  27  meq l; chemistry blood chloride  80  meq l; chemistry blood chloride  96  meq l; chemistry blood creatinine  0.8  mg dl; chemistry blood creatinine  0.7  mg dl; chemistry blood potassium  3.6  meq l; chemistry blood potassium  3.8  meq l; chemistry blood sodium  132  meq l; chemistry blood sodium  117  meq l; chemistry blood urea nitrogen  14  mg dl; chemistry blood urea nitrogen  17  mg dl; hematology blood inr(pt)  1.7  ; chemistry blood calcium, total  7.2  mg dl; chemistry blood calcium, total  8.0  mg dl; chemistry blood glucose  593  mg dl; chemistry blood glucose  108  mg dl; blood gas blood free calcium  1.08  mmol l; blood gas blood lactate  1.6  mmol l$iso-osmotic dextrose  200  ml ; sodium chloride 0.9%  flush  3-10  ml ; allopurinol  300  mg ; finasteride  5  mg ; tamsulosin  0.4  mg ; docusate sodium  100  mg ; senna  8.6  mg ; ferrous sulfate  325  mg ; ipratropium-albuterol neb  1  neb ; acetaminophen  1000  mg ; metoprolol succinate xl  12.5  mg ; apixaban  5  mg ; polyethylene glycol  17  g ; iso-osmotic dextrose  50  ml ; ceftriaxone  1  gm ; bisacodyl  10  mg ; haloperidol  1  mg ; oxycodone (immediate release)  5  mg ; bag  1  bag ; magnesium sulfate  4  gm ; 
stenosis of larynx obstructive sleep apnea (adult) (pediatric) personal history of malignant neoplasm of larynx benign prostatic hyperplasia without lower urinary tract symptoms chronic obstructive pulmonary disease, unspecified gastro-esophageal reflux disease without esophagitis presence of left artificial knee joint gout, unspecified personal history of nicotine dependence unspecified atrial fibrillation essential (primary) hypertension unilateral inguinal hernia, without obstruction or gangrene, not specified as recurrent long term (current) use of antithrombotics/antiplatelets encounter for change or removal of surgical wound dressing paralysis of vocal cords and larynx, unilateral iron deficiency anemia secondary to blood loss (chronic) other diseases of larynx therapeutic (nonsurgical) and rehabilitative radiological devices associated with adverse incidents other abnormal findings in cerebrospinal fluid obstructive sleep apnea (adult) (pediatric) acute on chronic diastolic (congestive) heart failure acute upper respiratory infection, unspecified gastro-esophageal reflux disease without esophagitis personal history of nicotine dependence benign prostatic hyperplasia without lower urinary tract symptoms acquired absence of other specified parts of digestive tract unspecified atrial fibrillation stenosis of larynx gout, unspecified radiological procedure and radiotherapy as the cause of abnormal reaction of the patient, or of later complication, without mention of misadventure at the time of the procedure long term (current) use of anticoagulants presence of left artificial knee joint hypertensive heart disease with heart failure chronic obstructive pulmonary disease, unspecified anemia, unspecified personal history of malignant neoplasm of larynx personal history of nicotine dependence postprocedural subglottic stenosis unilateral inguinal hernia, without obstruction or gangrene, recurrent obstructive sleep apnea (adult) (pediatric) gout, unspecified gastro-esophageal reflux disease without esophagitis personal history of malignant neoplasm of larynx medical procedure, unspecified as the cause of abnormal reaction of the patient, or of later complication, without mention of misadventure at the time of the procedure chronic obstructive pulmonary disease, unspecified incisional hernia without obstruction or gangrene long term (current) use of anticoagulants acute posthemorrhagic anemia
white m 80 $nan$hematology blood hematocrit  26.5  %; hematology blood hemoglobin  8.9  g dl; hematology blood platelet count  226  k ul; chemistry blood anion gap  14  meq l; chemistry blood bicarbonate  24  meq l; chemistry blood chloride  99  meq l; chemistry blood creatinine  0.7  mg dl; chemistry blood potassium  4.0  meq l; chemistry blood sodium  137  meq l; chemistry blood urea nitrogen  16  mg dl; chemistry blood calcium, total  8.2  mg dl; chemistry blood glucose  101  mg dl$sodium chloride 0.9%  flush  3-10  ml ; allopurinol  300  mg ; finasteride  5  mg ; tamsulosin  0.4  mg ; docusate sodium  100  mg ; senna  8.6  mg ; ferrous sulfate  325  mg ; ipratropium-albuterol neb  1  neb ; acetaminophen  1000  mg ; metoprolol succinate xl  12.5  mg ; apixaban  5  mg ; polyethylene glycol  17  g ; iso-osmotic dextrose  50  ml ; ceftriaxone  1  gm ; bisacodyl  10  mg ; oxycodone (immediate release)  5  mg ; heparin flush (10 units ml)  2  ml ; sodium chloride 0.9%  flush  20  ml ; lidocaine 1% (for picc midline insertions)  5  ml ; fluticasone propionate nasal  1  spry ; 
stenosis of larynx obstructive sleep apnea (adult) (pediatric) personal history of malignant neoplasm of larynx benign prostatic hyperplasia without lower urinary tract symptoms chronic obstructive pulmonary disease, unspecified gastro-esophageal reflux disease without esophagitis presence of left artificial knee joint gout, unspecified personal history of nicotine dependence unspecified atrial fibrillation essential (primary) hypertension unilateral inguinal hernia, without obstruction or gangrene, not specified as recurrent long term (current) use of antithrombotics/antiplatelets encounter for change or removal of surgical wound dressing paralysis of vocal cords and larynx, unilateral iron deficiency anemia secondary to blood loss (chronic) other diseases of larynx therapeutic (nonsurgical) and rehabilitative radiological devices associated with adverse incidents other abnormal findings in cerebrospinal fluid obstructive sleep apnea (adult) (pediatric) acute on chronic diastolic (congestive) heart failure acute upper respiratory infection, unspecified gastro-esophageal reflux disease without esophagitis personal history of nicotine dependence benign prostatic hyperplasia without lower urinary tract symptoms acquired absence of other specified parts of digestive tract unspecified atrial fibrillation stenosis of larynx gout, unspecified radiological procedure and radiotherapy as the cause of abnormal reaction of the patient, or of later complication, without mention of misadventure at the time of the procedure long term (current) use of anticoagulants presence of left artificial knee joint hypertensive heart disease with heart failure chronic obstructive pulmonary disease, unspecified anemia, unspecified personal history of malignant neoplasm of larynx personal history of nicotine dependence postprocedural subglottic stenosis unilateral inguinal hernia, without obstruction or gangrene, recurrent obstructive sleep apnea (adult) (pediatric) gout, unspecified gastro-esophageal reflux disease without esophagitis personal history of malignant neoplasm of larynx medical procedure, unspecified as the cause of abnormal reaction of the patient, or of later complication, without mention of misadventure at the time of the procedure chronic obstructive pulmonary disease, unspecified incisional hernia without obstruction or gangrene long term (current) use of anticoagulants acute posthemorrhagic anemia
white m 80 $nan$hematology blood hematocrit  26.2  %; hematology blood hemoglobin  8.8  g dl; hematology blood platelet count  251  k ul; chemistry blood anion gap  14  meq l; chemistry blood bicarbonate  25  meq l; chemistry blood chloride  94  meq l; chemistry blood creatinine  0.8  mg dl; chemistry blood potassium  3.6  meq l; chemistry blood sodium  133  meq l; chemistry blood urea nitrogen  15  mg dl; chemistry blood calcium, total  8.3  mg dl; chemistry blood glucose  96  mg dl$sodium chloride 0.9%  flush  3-10  ml ; allopurinol  300  mg ; finasteride  5  mg ; tamsulosin  0.4  mg ; docusate sodium  100  mg ; senna  8.6  mg ; ferrous sulfate  325  mg ; ipratropium-albuterol neb  1  neb ; acetaminophen  1000  mg ; metoprolol succinate xl  12.5  mg ; apixaban  5  mg ; polyethylene glycol  17  g ; iso-osmotic dextrose  50  ml ; ceftriaxone  1  gm ; bisacodyl  10  mg ; oxycodone (immediate release)  5  mg ; heparin flush (10 units ml)  2  ml ; sodium chloride 0.9%  flush  20  ml ; lidocaine 1% (for picc midline insertions)  5  ml ; fluticasone propionate nasal  1  spry ; acetaminophen  500  mg ; iso-osmotic dextrose  100  ml ; cefazolin  2  g ; potassium chloride  40  meq ; sodium chloride 0.9%  flush  10-20  ml ; magnesium oxide  400  mg ; 
stenosis of larynx obstructive sleep apnea (adult) (pediatric) personal history of malignant neoplasm of larynx benign prostatic hyperplasia without lower urinary tract symptoms chronic obstructive pulmonary disease, unspecified gastro-esophageal reflux disease without esophagitis presence of left artificial knee joint gout, unspecified personal history of nicotine dependence unspecified atrial fibrillation essential (primary) hypertension unilateral inguinal hernia, without obstruction or gangrene, not specified as recurrent long term (current) use of antithrombotics/antiplatelets encounter for change or removal of surgical wound dressing paralysis of vocal cords and larynx, unilateral iron deficiency anemia secondary to blood loss (chronic) other diseases of larynx therapeutic (nonsurgical) and rehabilitative radiological devices associated with adverse incidents other abnormal findings in cerebrospinal fluid obstructive sleep apnea (adult) (pediatric) acute on chronic diastolic (congestive) heart failure acute upper respiratory infection, unspecified gastro-esophageal reflux disease without esophagitis personal history of nicotine dependence benign prostatic hyperplasia without lower urinary tract symptoms acquired absence of other specified parts of digestive tract unspecified atrial fibrillation stenosis of larynx gout, unspecified radiological procedure and radiotherapy as the cause of abnormal reaction of the patient, or of later complication, without mention of misadventure at the time of the procedure long term (current) use of anticoagulants presence of left artificial knee joint hypertensive heart disease with heart failure chronic obstructive pulmonary disease, unspecified anemia, unspecified personal history of malignant neoplasm of larynx personal history of nicotine dependence postprocedural subglottic stenosis unilateral inguinal hernia, without obstruction or gangrene, recurrent obstructive sleep apnea (adult) (pediatric) gout, unspecified gastro-esophageal reflux disease without esophagitis personal history of malignant neoplasm of larynx medical procedure, unspecified as the cause of abnormal reaction of the patient, or of later complication, without mention of misadventure at the time of the procedure chronic obstructive pulmonary disease, unspecified incisional hernia without obstruction or gangrene long term (current) use of anticoagulants acute posthemorrhagic anemia
white m 80 $nan$hematology blood hematocrit  26.4  %; hematology blood hemoglobin  8.6  g dl; hematology blood platelet count  245  k ul; chemistry blood anion gap  8  meq l; chemistry blood bicarbonate  29  meq l; chemistry blood chloride  98  meq l; chemistry blood creatinine  0.7  mg dl; chemistry blood potassium  3.8  meq l; chemistry blood sodium  135  meq l; chemistry blood urea nitrogen  14  mg dl; chemistry blood calcium, total  8.2  mg dl; chemistry blood glucose  92  mg dl$sodium chloride 0.9%  flush  3-10  ml ; allopurinol  300  mg ; finasteride  5  mg ; tamsulosin  0.4  mg ; docusate sodium  100  mg ; senna  8.6  mg ; ferrous sulfate  325  mg ; ipratropium-albuterol neb  1  neb ; metoprolol succinate xl  12.5  mg ; apixaban  5  mg ; polyethylene glycol  17  g ; bisacodyl  10  mg ; oxycodone (immediate release)  5  mg ; fluticasone propionate nasal  1  spry ; iso-osmotic dextrose  100  ml ; cefazolin  2  g ; sodium chloride 0.9%  flush  10-20  ml ; magnesium oxide  400  mg ; potassium chloride  20  meq ; 
stenosis of larynx obstructive sleep apnea (adult) (pediatric) personal history of malignant neoplasm of larynx benign prostatic hyperplasia without lower urinary tract symptoms chronic obstructive pulmonary disease, unspecified gastro-esophageal reflux disease without esophagitis presence of left artificial knee joint gout, unspecified personal history of nicotine dependence unspecified atrial fibrillation essential (primary) hypertension unilateral inguinal hernia, without obstruction or gangrene, not specified as recurrent long term (current) use of antithrombotics/antiplatelets encounter for change or removal of surgical wound dressing paralysis of vocal cords and larynx, unilateral iron deficiency anemia secondary to blood loss (chronic) other diseases of larynx therapeutic (nonsurgical) and rehabilitative radiological devices associated with adverse incidents other abnormal findings in cerebrospinal fluid obstructive sleep apnea (adult) (pediatric) acute on chronic diastolic (congestive) heart failure acute upper respiratory infection, unspecified gastro-esophageal reflux disease without esophagitis personal history of nicotine dependence benign prostatic hyperplasia without lower urinary tract symptoms acquired absence of other specified parts of digestive tract unspecified atrial fibrillation stenosis of larynx gout, unspecified radiological procedure and radiotherapy as the cause of abnormal reaction of the patient, or of later complication, without mention of misadventure at the time of the procedure long term (current) use of anticoagulants presence of left artificial knee joint hypertensive heart disease with heart failure chronic obstructive pulmonary disease, unspecified anemia, unspecified personal history of malignant neoplasm of larynx personal history of nicotine dependence postprocedural subglottic stenosis unilateral inguinal hernia, without obstruction or gangrene, recurrent obstructive sleep apnea (adult) (pediatric) gout, unspecified gastro-esophageal reflux disease without esophagitis personal history of malignant neoplasm of larynx medical procedure, unspecified as the cause of abnormal reaction of the patient, or of later complication, without mention of misadventure at the time of the procedure chronic obstructive pulmonary disease, unspecified incisional hernia without obstruction or gangrene long term (current) use of anticoagulants acute posthemorrhagic anemia
white m 80 $nan$chemistry blood anion gap  7  meq l; chemistry blood bicarbonate  30  meq l; chemistry blood chloride  96  meq l; chemistry blood creatinine  0.7  mg dl; chemistry blood potassium  4.0  meq l; chemistry blood sodium  133  meq l; chemistry blood urea nitrogen  13  mg dl; chemistry blood calcium, total  8.1  mg dl; chemistry blood glucose  93  mg dl; chemistry blood albumin  2.8  g dl$sodium chloride 0.9%  flush  3-10  ml ; allopurinol  300  mg ; finasteride  5  mg ; tamsulosin  0.4  mg ; docusate sodium  100  mg ; senna  8.6  mg ; ferrous sulfate  325  mg ; ipratropium-albuterol neb  1  neb ; metoprolol succinate xl  12.5  mg ; apixaban  5  mg ; polyethylene glycol  17  g ; bisacodyl  10  mg ; oxycodone (immediate release)  5  mg ; fluticasone propionate nasal  1  spry ; iso-osmotic dextrose  100  ml ; cefazolin  2  g ; sodium chloride 0.9%  flush  10-20  ml ; potassium chloride  20  meq ; vitamin d  50,000  unit ; 
stenosis of larynx obstructive sleep apnea (adult) (pediatric) personal history of malignant neoplasm of larynx benign prostatic hyperplasia without lower urinary tract symptoms chronic obstructive pulmonary disease, unspecified gastro-esophageal reflux disease without esophagitis presence of left artificial knee joint gout, unspecified personal history of nicotine dependence unspecified atrial fibrillation essential (primary) hypertension unilateral inguinal hernia, without obstruction or gangrene, not specified as recurrent long term (current) use of antithrombotics/antiplatelets encounter for change or removal of surgical wound dressing paralysis of vocal cords and larynx, unilateral iron deficiency anemia secondary to blood loss (chronic) other diseases of larynx therapeutic (nonsurgical) and rehabilitative radiological devices associated with adverse incidents other abnormal findings in cerebrospinal fluid obstructive sleep apnea (adult) (pediatric) acute on chronic diastolic (congestive) heart failure acute upper respiratory infection, unspecified gastro-esophageal reflux disease without esophagitis personal history of nicotine dependence benign prostatic hyperplasia without lower urinary tract symptoms acquired absence of other specified parts of digestive tract unspecified atrial fibrillation stenosis of larynx gout, unspecified radiological procedure and radiotherapy as the cause of abnormal reaction of the patient, or of later complication, without mention of misadventure at the time of the procedure long term (current) use of anticoagulants presence of left artificial knee joint hypertensive heart disease with heart failure chronic obstructive pulmonary disease, unspecified anemia, unspecified personal history of malignant neoplasm of larynx personal history of nicotine dependence postprocedural subglottic stenosis unilateral inguinal hernia, without obstruction or gangrene, recurrent obstructive sleep apnea (adult) (pediatric) gout, unspecified gastro-esophageal reflux disease without esophagitis personal history of malignant neoplasm of larynx medical procedure, unspecified as the cause of abnormal reaction of the patient, or of later complication, without mention of misadventure at the time of the procedure chronic obstructive pulmonary disease, unspecified incisional hernia without obstruction or gangrene long term (current) use of anticoagulants acute posthemorrhagic anemia
white m 55 $nan$hematology blood hematocrit  34.2  %; hematology blood hematocrit  33.3  %; hematology blood hemoglobin  11.0  g dl; hematology blood hemoglobin  10.6  g dl; hematology blood platelet count  79  k ul; hematology blood platelet count  91  k ul; chemistry blood anion gap  10  meq l; chemistry blood bicarbonate  19  meq l; chemistry blood chloride  108  meq l; chemistry blood creatinine  1.5  mg dl; chemistry blood potassium  4.2  meq l; chemistry blood sodium  137  meq l; chemistry blood urea nitrogen  19  mg dl; chemistry blood calcium, total  7.9  mg dl; chemistry blood glucose  148  mg dl$sodium chloride 0.9%  flush  3-10  ml ; iso-osmotic dextrose  50  ml ; cefazolin  2  g ; ondansetron  4  mg ; bisacodyl  10  mg ; senna  8.6  mg ; oxycodone (immediate release)  5  mg ; dextrose 50%  12.5  gm ; glucagon  1  mg ; glucose gel  15  g ; lorazepam  0.5  mg ; sodium chloride 0.9%  1000  ml ; insulin  0  unit ; aspirin  121.5  mg ; docusate sodium  100  mg ; oxycodone (immediate release)  5-10  mg ; bag  1  bag ; magnesium sulfate  4  gm ; heparin  5000  unit ; 
 
white m 55 $nan$nan$sodium chloride 0.9%  flush  3-10  ml ; iso-osmotic dextrose  50  ml ; cefazolin  2  g ; ondansetron  4  mg ; bisacodyl  10  mg ; senna  8.6  mg ; dextrose 50%  12.5  gm ; glucagon  1  mg ; glucose gel  15  g ; lorazepam  0.5  mg ; sodium chloride 0.9%  1000  ml ; aspirin  121.5  mg ; docusate sodium  100  mg ; oxycodone (immediate release)  5-10  mg ; bag  1  bag ; magnesium sulfate  4  gm ; heparin  5000  unit ; 
 
white f 86 $nan$hematology blood hematocrit  26.0  %; hematology blood hemoglobin  8.8  g dl; hematology blood platelet count  153  k ul; chemistry blood anion gap  14  meq l; chemistry blood bicarbonate  34  meq l; chemistry blood chloride  102  meq l; chemistry blood creatinine  1.6  mg dl; chemistry blood potassium  2.5  meq l; chemistry blood sodium  147  meq l; chemistry blood urea nitrogen  37  mg dl; chemistry blood calcium, total  7.5  mg dl; chemistry blood glucose  105  mg dl$sodium chloride 0.9%  flush  3  ml ; 0.9% sodium chloride  1000  ml ; heparin  5000  unit ; ondansetron  8  mg ; promethazine  6.25  mg ; lorazepam  0.25-0.5  mg ; 0.9% sodium chloride  250  ml ; potassium chloride  20  meq ; 0.9% sodium chloride  500  ml ; potassium chloride  40  meq ; potassium chloride  60  meq ; potassium phosphate  15  mmol ; bag  50  ml ; magnesium sulfate  2  gm ; magnesium sulfate  4  gm ; acetaminophen  650  mg ; 
other nonspecific abnormal serum enzyme levels nonspecific elevation of levels of transaminase or lactic acid dehydrogenase [ldh] other severe protein-calorie malnutrition other obstruction of duodenum other specified hypotension nausea with vomiting leukocytosis, unspecified malignant neoplasm of head of pancreas obstruction of bile duct benign essential hypertension body mass index between 19-24, adult passenger of special construction vehicle injured in traffic accident anemia of other chronic disease hydronephrosis acute kidney failure, unspecified depressive disorder, not elsewhere classified dehydration malignant neoplasm of pancreas, part unspecified obstruction of bile duct urinary tract infection, site not specified hypertensive chronic kidney disease, benign, with chronic kidney disease stage i through stage iv, or unspecified other and unspecified hyperlipidemia constipation, unspecified chronic kidney disease, stage iii (moderate) pure hypercholesterolemia other specified disorders of biliary tract
white f 86 $nan$hematology blood hematocrit  28.1  %; hematology blood hemoglobin  9.7  g dl; hematology blood platelet count  123  k ul; chemistry blood anion gap  14  meq l; chemistry blood bicarbonate  30  meq l; chemistry blood chloride  105  meq l; chemistry blood chloride  106  meq l; chemistry blood creatinine  2.0  mg dl; chemistry blood potassium  3.6  meq l; chemistry blood potassium  3.6  meq l; chemistry blood sodium  146  meq l; chemistry blood sodium  146  meq l; chemistry blood urea nitrogen  36  mg dl; chemistry urine chloride, urine  19  meq l; chemistry urine creatinine, urine  83  mg dl; chemistry urine potassium, urine  40  meq l; chemistry urine sodium, urine  29  meq l; chemistry blood calcium, total  7.5  mg dl; chemistry blood bilirubin, total  2.2  mg dl; chemistry blood glucose  99  mg dl$sodium chloride 0.9%  flush  3  ml ; 0.9% sodium chloride  1000  ml ; heparin  5000  unit ; ondansetron  8  mg ; promethazine  6.25  mg ; lorazepam  0.25-0.5  mg ; acetaminophen  650  mg ; sw  200  ml ; trazodone  25  mg ; lansoprazole oral disintegrating tab  30  mg ; pantoprazole  40  mg ; 
other nonspecific abnormal serum enzyme levels nonspecific elevation of levels of transaminase or lactic acid dehydrogenase [ldh] other severe protein-calorie malnutrition other obstruction of duodenum other specified hypotension nausea with vomiting leukocytosis, unspecified malignant neoplasm of head of pancreas obstruction of bile duct benign essential hypertension body mass index between 19-24, adult passenger of special construction vehicle injured in traffic accident anemia of other chronic disease hydronephrosis acute kidney failure, unspecified depressive disorder, not elsewhere classified dehydration malignant neoplasm of pancreas, part unspecified obstruction of bile duct urinary tract infection, site not specified hypertensive chronic kidney disease, benign, with chronic kidney disease stage i through stage iv, or unspecified other and unspecified hyperlipidemia constipation, unspecified chronic kidney disease, stage iii (moderate) pure hypercholesterolemia other specified disorders of biliary tract
white f 86 $nan$chemistry blood anion gap  13  meq l; chemistry blood bicarbonate  30  meq l; chemistry blood chloride  106  meq l; chemistry blood creatinine  2.4  mg dl; chemistry blood potassium  3.8  meq l; chemistry blood sodium  145  meq l; chemistry blood urea nitrogen  36  mg dl; chemistry blood calcium, total  7.4  mg dl; chemistry blood bilirubin, total  2.2  mg dl; chemistry blood glucose  123  mg dl$sodium chloride 0.9%  flush  3  ml ; heparin  5000  unit ; ondansetron  8  mg ; promethazine  6.25  mg ; lorazepam  0.25-0.5  mg ; acetaminophen  650  mg ; sw  200  ml ; trazodone  25  mg ; lansoprazole oral disintegrating tab  30  mg ; pantoprazole  40  mg ; lorazepam  0.5  mg ; neutra-phos  1  pkt ; ondan  8  mg ; 
other nonspecific abnormal serum enzyme levels nonspecific elevation of levels of transaminase or lactic acid dehydrogenase [ldh] other severe protein-calorie malnutrition other obstruction of duodenum other specified hypotension nausea with vomiting leukocytosis, unspecified malignant neoplasm of head of pancreas obstruction of bile duct benign essential hypertension body mass index between 19-24, adult passenger of special construction vehicle injured in traffic accident anemia of other chronic disease hydronephrosis acute kidney failure, unspecified depressive disorder, not elsewhere classified dehydration malignant neoplasm of pancreas, part unspecified obstruction of bile duct urinary tract infection, site not specified hypertensive chronic kidney disease, benign, with chronic kidney disease stage i through stage iv, or unspecified other and unspecified hyperlipidemia constipation, unspecified chronic kidney disease, stage iii (moderate) pure hypercholesterolemia other specified disorders of biliary tract
white f 86 $nan$hematology blood hematocrit  23.3  %; hematology blood hemoglobin  8.2  g dl; hematology blood platelet count  86  k ul; chemistry blood anion gap  16  meq l; chemistry blood bicarbonate  25  meq l; chemistry blood chloride  109  meq l; chemistry blood creatinine  2.7  mg dl; chemistry blood potassium  3.8  meq l; chemistry blood sodium  146  meq l; chemistry blood urea nitrogen  48  mg dl; chemistry blood calcium, total  7.8  mg dl; chemistry blood bilirubin, total  2.0  mg dl; chemistry blood glucose  116  mg dl$sodium chloride 0.9%  flush  3  ml ; promethazine  6.25  mg ; acetaminophen  650  mg ; trazodone  25  mg ; lansoprazole oral disintegrating tab  30  mg ; neutra-phos  1  pkt ; ondan  8  mg ; 
other nonspecific abnormal serum enzyme levels nonspecific elevation of levels of transaminase or lactic acid dehydrogenase [ldh] other severe protein-calorie malnutrition other obstruction of duodenum other specified hypotension nausea with vomiting leukocytosis, unspecified malignant neoplasm of head of pancreas obstruction of bile duct benign essential hypertension body mass index between 19-24, adult passenger of special construction vehicle injured in traffic accident anemia of other chronic disease hydronephrosis acute kidney failure, unspecified depressive disorder, not elsewhere classified dehydration malignant neoplasm of pancreas, part unspecified obstruction of bile duct urinary tract infection, site not specified hypertensive chronic kidney disease, benign, with chronic kidney disease stage i through stage iv, or unspecified other and unspecified hyperlipidemia constipation, unspecified chronic kidney disease, stage iii (moderate) pure hypercholesterolemia other specified disorders of biliary tract
white f 86 $nan$nan$sodium chloride 0.9%  flush  3  ml ; promethazine  6.25  mg ; acetaminophen  650  mg ; trazodone  25  mg ; lansoprazole oral disintegrating tab  30  mg ; ondan  8  mg ; 
other nonspecific abnormal serum enzyme levels nonspecific elevation of levels of transaminase or lactic acid dehydrogenase [ldh] other severe protein-calorie malnutrition other obstruction of duodenum other specified hypotension nausea with vomiting leukocytosis, unspecified malignant neoplasm of head of pancreas obstruction of bile duct benign essential hypertension body mass index between 19-24, adult passenger of special construction vehicle injured in traffic accident anemia of other chronic disease hydronephrosis acute kidney failure, unspecified depressive disorder, not elsewhere classified dehydration malignant neoplasm of pancreas, part unspecified obstruction of bile duct urinary tract infection, site not specified hypertensive chronic kidney disease, benign, with chronic kidney disease stage i through stage iv, or unspecified other and unspecified hyperlipidemia constipation, unspecified chronic kidney disease, stage iii (moderate) pure hypercholesterolemia other specified disorders of biliary tract
white f 29 $nan$hematology blood hematocrit  38.5  %; hematology blood hemoglobin  13.4  g dl; hematology blood platelet count  175  k ul; chemistry blood anion gap  12  meq l; chemistry blood bicarbonate  24  meq l; chemistry blood chloride  105  meq l; chemistry blood creatinine  0.7  mg dl; chemistry blood potassium  3.8  meq l; chemistry blood sodium  137  meq l; chemistry blood urea nitrogen  9  mg dl; chemistry blood glucose  93  mg dl$nan
 
white f 29 $nan$hematology blood hematocrit  43.5  %; hematology blood hematocrit  38.8  %; hematology blood hemoglobin  14.7  g dl; hematology blood hemoglobin  13.3  g dl; hematology blood platelet count  301  k ul; chemistry blood anion gap  14  meq l; chemistry blood bicarbonate  24  meq l; chemistry blood chloride  101  meq l; chemistry blood creatinine  0.7  mg dl; chemistry blood potassium  3.9  meq l; chemistry blood sodium  135  meq l; chemistry blood urea nitrogen  11  mg dl; chemistry blood calcium, total  9.8  mg dl; chemistry blood bilirubin, total  0.3  mg dl; chemistry blood glucose  249  mg dl; chemistry blood lactate dehydrogenase (ld)  168  iu l; chemistry blood albumin  4.1  g dl; hematology urine glucose  300  mg dl$sodium chloride 0.9%  flush  3  ml ; clonazepam  1  mg ; methadone  5  mg ; methadone  120  mg ; levothyroxine sodium  100  mcg ; fluoxetine  40  mg ; nicotine patch  14  mg ; 
 
white f 29 $nan$hematology blood hematocrit  40.1  %; hematology blood hemoglobin  13.7  g dl; hematology blood platelet count  336  k ul; chemistry blood glucose  98  mg dl; chemistry blood % hemoglobin a1c  5.4  %$sodium chloride 0.9%  flush  3  ml ; clonazepam  1  mg ; methadone  5  mg ; methadone  120  mg ; levothyroxine sodium  100  mcg ; fluoxetine  40  mg ; nicotine patch  14  mg ; multivitamins  1  tab ; acetaminophen  650  mg ; 
 
white f 29 $nan$hematology blood hematocrit  40.8  %; hematology blood hemoglobin  14.0  g dl; hematology blood platelet count  329  k ul; hematology urine glucose  neg  mg dl; hematology urine bilirubin  neg  mg dl$sodium chloride 0.9%  flush  3  ml ; clonazepam  1  mg ; methadone  5  mg ; methadone  120  mg ; levothyroxine sodium  100  mcg ; fluoxetine  40  mg ; nicotine patch  14  mg ; multivitamins  1  tab ; acetaminophen  650  mg ; 
 
white f 29 $nan$hematology blood hematocrit  39.9  %; hematology blood hemoglobin  13.8  g dl; hematology blood platelet count  289  k ul; hematology urine glucose  neg  mg dl; hematology urine bilirubin  neg  mg dl$sodium chloride 0.9%  flush  3  ml ; clonazepam  1  mg ; methadone  5  mg ; methadone  120  mg ; levothyroxine sodium  100  mcg ; fluoxetine  40  mg ; nicotine patch  14  mg ; multivitamins  1  tab ; acetaminophen  650  mg ; 
 
white m 82 $temp  99.2  heartrate  85.0  resprate  22.0  o2sat  95.0  sbp  120.0  dbp  64.0  rhythm    pain  sleep  ; temp    heartrate  89.0  resprate  21.0  o2sat  97.0  sbp  101.0  dbp  59.0  rhythm    pain    $hematology urine wbc  2  # hpf$sodium chloride 0.9%  flush  3-10  ml ; acetaminophen  500-1000  mg ; senna  8.6  mg ; docusate sodium  100  mg ; 0.9% sodium chloride (mini bag plus)  100  ml ; cefepime  2  g ; levothyroxine sodium  88  mcg ; multivitamins  1  tab ; iso-osmotic dextrose  150  ml ; vancomycin  750  mg ; prednisone  5  mg ; tiotropium bromide  1  cap ; oxycodone (immediate release)  5  mg ; enoxaparin sodium  60  mg ; azithromycin  500  mg ; guaifenesin  5-10  ml ; lactated ringers  1000  ml ; sodium chloride 0.9%  1000  ml ; 
 
white m 82 $nan$hematology blood hematocrit  27.9  %; hematology blood hemoglobin  8.8  g dl; hematology blood platelet count  297  k ul; chemistry blood anion gap  13  meq l; chemistry blood bicarbonate  20  meq l; chemistry blood chloride  100  meq l; chemistry blood creatinine  0.8  mg dl; chemistry blood potassium  4.5  meq l; chemistry blood sodium  133  meq l; chemistry blood urea nitrogen  19  mg dl; chemistry blood calcium, total  7.0  mg dl; chemistry blood bilirubin, total  0.6  mg dl; chemistry blood glucose  103  mg dl; chemistry blood lactate dehydrogenase (ld)  241  iu l; chemistry blood albumin  2.8  g dl$sodium chloride 0.9%  flush  3-10  ml ; acetaminophen  500-1000  mg ; senna  8.6  mg ; docusate sodium  100  mg ; levothyroxine sodium  88  mcg ; multivitamins  1  tab ; prednisone  5  mg ; tiotropium bromide  1  cap ; oxycodone (immediate release)  5  mg ; guaifenesin  5-10  ml ; sodium chloride 0.9%  1000  ml ; azithromycin  250  mg ; 0.9% sodium chloride  250  ml ; vancomycin  1250  mg ; lidocaine 5% patch  1  ptch ; iso-osmotic dextrose  50  ml ; ceftriaxone  1  gm ; neutra-phos  1  pkt ; 
 
white m 82 $nan$hematology blood hematocrit  26.3  %; hematology blood hemoglobin  8.3  g dl; hematology blood platelet count  304  k ul; chemistry blood anion gap  12  meq l; chemistry blood bicarbonate  20  meq l; chemistry blood chloride  99  meq l; chemistry blood creatinine  0.7  mg dl; chemistry blood potassium  4.6  meq l; chemistry blood sodium  131  meq l; chemistry blood urea nitrogen  19  mg dl; chemistry blood calcium, total  6.9  mg dl; chemistry blood glucose  107  mg dl; chemistry blood albumin  2.6  g dl$sodium chloride 0.9%  flush  3-10  ml ; acetaminophen  500-1000  mg ; senna  8.6  mg ; docusate sodium  100  mg ; levothyroxine sodium  88  mcg ; multivitamins  1  tab ; prednisone  5  mg ; tiotropium bromide  1  cap ; oxycodone (immediate release)  5  mg ; guaifenesin  5-10  ml ; azithromycin  250  mg ; lidocaine 5% patch  1  ptch ; iso-osmotic dextrose  50  ml ; ceftriaxone  1  gm ; neutra-phos  1  pkt ; 
 
white m 82 $nan$hematology blood hematocrit  24.7  %; hematology blood hemoglobin  7.9  g dl; hematology blood platelet count  268  k ul; chemistry blood anion gap  13  meq l; chemistry blood bicarbonate  21  meq l; chemistry blood chloride  99  meq l; chemistry blood creatinine  0.7  mg dl; chemistry blood potassium  4.7  meq l; chemistry blood sodium  133  meq l; chemistry blood urea nitrogen  17  mg dl; chemistry blood calcium, total  6.8  mg dl; chemistry blood glucose  81  mg dl$sodium chloride 0.9%  flush  3-10  ml ; acetaminophen  500-1000  mg ; senna  8.6  mg ; levothyroxine sodium  88  mcg ; multivitamins  1  tab ; prednisone  5  mg ; tiotropium bromide  1  cap ; oxycodone (immediate release)  5  mg ; guaifenesin  5-10  ml ; azithromycin  250  mg ; lidocaine 5% patch  1  ptch ; iso-osmotic dextrose  50  ml ; ceftriaxone  1  gm ; neutra-phos  1  pkt ; 0.9% sodium chloride  500  ml ; sodium phosphate  30  mmol ; 
 
white m 82 $nan$hematology blood hematocrit  24.3  %; hematology blood hemoglobin  7.7  g dl; hematology blood platelet count  257  k ul; chemistry blood anion gap  14  meq l; chemistry blood bicarbonate  21  meq l; chemistry blood chloride  101  meq l; chemistry blood creatinine  0.6  mg dl; chemistry blood potassium  4.3  meq l; chemistry blood sodium  136  meq l; chemistry blood urea nitrogen  15  mg dl; chemistry blood calcium, total  6.7  mg dl; chemistry blood glucose  88  mg dl; blood gas blood free calcium  0.92  mmol l$sodium chloride 0.9%  flush  3-10  ml ; acetaminophen  500-1000  mg ; senna  8.6  mg ; levothyroxine sodium  88  mcg ; multivitamins  1  tab ; prednisone  5  mg ; tiotropium bromide  1  cap ; oxycodone (immediate release)  5  mg ; guaifenesin  5-10  ml ; azithromycin  250  mg ; lidocaine 5% patch  1  ptch ; iso-osmotic dextrose  50  ml ; ceftriaxone  1  gm ; 0.9% sodium chloride  500  ml ; sodium phosphate  30  mmol ; 0.9% sodium chloride  100  ml ; calcium gluconate  2  g ; calcium gluconate  4  g ; 
 
black african american m 79 $temp    heartrate  85.0  resprate  18.0  o2sat  100.0  sbp  184.0  dbp  92.0  rhythm    pain  0  ; temp    heartrate  88.0  resprate  16.0  o2sat  100.0  sbp  192.0  dbp  78.0  rhythm    pain  0  ; temp    heartrate  67.0  resprate  18.0  o2sat  100.0  sbp  158.0  dbp  81.0  rhythm    pain  0  ; temp    heartrate  83.0  resprate  16.0  o2sat  100.0  sbp  142.0  dbp  72.0  rhythm    pain  0  $nan$enzalutamide (xtandi)  160  mg ; 
dehydration other and unspecified hyperlipidemia acute kidney failure, unspecified chronic kidney disease, unspecified intestinal infection due to other organism, not elsewhere classified diabetes mellitus without mention of complication, type ii or unspecified type, not stated as uncontrolled hypertensive chronic kidney disease, unspecified, with chronic kidney disease stage i through stage iv, or unspecified atrial fibrillation personal history of malignant neoplasm of prostate 
black african american m 79 $temp  98.1  heartrate  73.0  resprate  16.0  o2sat  100.0  sbp  170.0  dbp  66.0  rhythm    pain  0  $hematology blood hematocrit  36.4  %; hematology blood hemoglobin  12.2  g dl; hematology blood platelet count  288  k ul; chemistry blood anion gap  9  meq l; chemistry blood bicarbonate  33  meq l; chemistry blood chloride  105  meq l; chemistry blood creatinine  1.5  mg dl; chemistry blood potassium  3.4  meq l; chemistry blood sodium  144  meq l; chemistry blood urea nitrogen  31  mg dl; hematology blood inr(pt)  1.1  ; chemistry blood calcium, total  9.1  mg dl; chemistry blood bilirubin, total  0.3  mg dl; chemistry blood glucose  127  mg dl; chemistry blood albumin  3.8  g dl; chemistry blood % hemoglobin a1c  6.6  %$bisacodyl  10  mg ; enzalutamide (xtandi)  160  mg ; sodium chloride 0.9%  flush  3  ml ; aspirin  325  mg ; heparin  5000  unit ; metoprolol tartrate  25  mg ; pantoprazole  40  mg ; dextrose 50%  12.5  gm ; glucagon  1  mg ; glucose gel  15  g ; insulin  0  unit ; docusate sodium  100  mg ; senna  1  tab ; acetaminophen  325-650  mg ; solifenacin (vesicare)  10  mg ; 
dehydration other and unspecified hyperlipidemia acute kidney failure, unspecified chronic kidney disease, unspecified intestinal infection due to other organism, not elsewhere classified diabetes mellitus without mention of complication, type ii or unspecified type, not stated as uncontrolled hypertensive chronic kidney disease, unspecified, with chronic kidney disease stage i through stage iv, or unspecified atrial fibrillation personal history of malignant neoplasm of prostate 
black african american m 79 $nan$chemistry blood anion gap  12  meq l; chemistry blood bicarbonate  31  meq l; chemistry blood chloride  103  meq l; chemistry blood creatinine  1.4  mg dl; chemistry blood potassium  3.3  meq l; chemistry blood sodium  143  meq l; chemistry blood urea nitrogen  33  mg dl; chemistry blood calcium, total  8.9  mg dl; chemistry blood glucose  99  mg dl$bisacodyl  10  mg ; enzalutamide (xtandi)  160  mg ; sodium chloride 0.9%  flush  3  ml ; aspirin  325  mg ; heparin  5000  unit ; metoprolol tartrate  25  mg ; pantoprazole  40  mg ; dextrose 50%  12.5  gm ; glucagon  1  mg ; glucose gel  15  g ; insulin  0  unit ; docusate sodium  100  mg ; senna  1  tab ; acetaminophen  325-650  mg ; solifenacin (vesicare)  10  mg ; 
dehydration other and unspecified hyperlipidemia acute kidney failure, unspecified chronic kidney disease, unspecified intestinal infection due to other organism, not elsewhere classified diabetes mellitus without mention of complication, type ii or unspecified type, not stated as uncontrolled hypertensive chronic kidney disease, unspecified, with chronic kidney disease stage i through stage iv, or unspecified atrial fibrillation personal history of malignant neoplasm of prostate 
black african american m 79 $nan$nan$bisacodyl  10  mg ; enzalutamide (xtandi)  160  mg ; sodium chloride 0.9%  flush  3  ml ; aspirin  325  mg ; heparin  5000  unit ; metoprolol tartrate  25  mg ; pantoprazole  40  mg ; dextrose 50%  12.5  gm ; glucagon  1  mg ; glucose gel  15  g ; docusate sodium  100  mg ; senna  1  tab ; acetaminophen  325-650  mg ; solifenacin (vesicare)  10  mg ; potassium chloride  60  meq ; 
dehydration other and unspecified hyperlipidemia acute kidney failure, unspecified chronic kidney disease, unspecified intestinal infection due to other organism, not elsewhere classified diabetes mellitus without mention of complication, type ii or unspecified type, not stated as uncontrolled hypertensive chronic kidney disease, unspecified, with chronic kidney disease stage i through stage iv, or unspecified atrial fibrillation personal history of malignant neoplasm of prostate 
black african american m 79 $nan$nan$bisacodyl  10  mg ; enzalutamide (xtandi)  160  mg ; sodium chloride 0.9%  flush  3  ml ; aspirin  325  mg ; heparin  5000  unit ; metoprolol tartrate  25  mg ; pantoprazole  40  mg ; dextrose 50%  12.5  gm ; glucagon  1  mg ; glucose gel  15  g ; docusate sodium  100  mg ; senna  1  tab ; acetaminophen  325-650  mg ; solifenacin (vesicare)  10  mg ; potassium chloride  60  meq ; 
dehydration other and unspecified hyperlipidemia acute kidney failure, unspecified chronic kidney disease, unspecified intestinal infection due to other organism, not elsewhere classified diabetes mellitus without mention of complication, type ii or unspecified type, not stated as uncontrolled hypertensive chronic kidney disease, unspecified, with chronic kidney disease stage i through stage iv, or unspecified atrial fibrillation personal history of malignant neoplasm of prostate 
white f 44 $nan$hematology blood hematocrit  22.5  %; hematology blood hemoglobin  8.2  g dl; hematology blood platelet count  311  k ul; chemistry blood anion gap  14  meq l; chemistry blood anion gap  16  meq l; chemistry blood bicarbonate  17  meq l; chemistry blood bicarbonate  19  meq l; chemistry blood chloride  108  meq l; chemistry blood chloride  104  meq l; chemistry blood creatinine  4.6  mg dl; chemistry blood creatinine  4.7  mg dl; chemistry blood potassium  4.7  meq l; chemistry blood potassium  4.2  meq l; chemistry blood sodium  134  meq l; chemistry blood sodium  135  meq l; chemistry blood urea nitrogen  41  mg dl; chemistry blood urea nitrogen  43  mg dl; chemistry urine chloride, urine  71  meq l; chemistry urine creatinine, urine  47  mg dl; chemistry urine potassium, urine  22  meq l; chemistry urine sodium, urine  78  meq l; chemistry urine urea nitrogen, urine  215  mg dl; hematology urine wbc  156  # hpf; chemistry blood calcium, total  8.3  mg dl; chemistry blood glucose  67  mg dl; chemistry blood glucose  162  mg dl$tacrolimus  3  mg ; insulin  16  unit ; myfortic  360  mg ; influenza virus vaccine  0.5  ml ; sodium chloride 0.9%  flush  3  ml ; acetaminophen  325-650  mg ; docusate sodium  100  mg ; senna  1  tab ; bisacodyl  10  mg ; dextrose 50%  12.5  gm ; glucagon  1  mg ; sulfameth trimethoprim ss  1  tab ; aspirin  325  mg ; vitamin d  400  unit ; insulin  0  unit ; prednisone  3  mg ; 0.9% sodium chloride  1000  ml ; tramadol (ultram)  50  mg ; 0.9% sodium chloride  50  ml ; daptomycin  350  mg ; 0.9% sodium chloride (mini bag plus)  100  ml ; meropenem  500  mg ; calcium carbonate  500  mg ; heparin  5000  unit ; 
 
white f 44 $nan$hematology blood hematocrit  23.6  %; hematology blood hemoglobin  8.4  g dl; hematology blood platelet count  354  k ul; chemistry blood anion gap  17  meq l; chemistry blood bicarbonate  19  meq l; chemistry blood chloride  105  meq l; chemistry blood creatinine  5.2  mg dl; chemistry blood potassium  4.0  meq l; chemistry blood sodium  137  meq l; chemistry blood urea nitrogen  43  mg dl; hematology blood inr(pt)  1.0  ; hematology urine wbc  0-2  # hpf; chemistry blood calcium, total  8.5  mg dl; chemistry blood glucose  137  mg dl; hematology urine glucose  neg  mg dl; hematology urine bilirubin  neg  mg dl$tacrolimus  3  mg ; insulin  16  unit ; myfortic  360  mg ; influenza virus vaccine  0.5  ml ; sodium chloride 0.9%  flush  3  ml ; acetaminophen  325-650  mg ; docusate sodium  100  mg ; senna  1  tab ; bisacodyl  10  mg ; dextrose 50%  12.5  gm ; glucagon  1  mg ; sulfameth trimethoprim ss  1  tab ; aspirin  325  mg ; vitamin d  400  unit ; insulin  0  unit ; prednisone  3  mg ; tramadol (ultram)  50  mg ; 0.9% sodium chloride  50  ml ; daptomycin  350  mg ; 0.9% sodium chloride (mini bag plus)  100  ml ; meropenem  500  mg ; calcium carbonate  500  mg ; heparin  5000  unit ; polyethylene glycol  17  g ; 
 
white f 44 $nan$nan$tacrolimus  3  mg ; insulin  16  unit ; myfortic  360  mg ; influenza virus vaccine  0.5  ml ; sodium chloride 0.9%  flush  3  ml ; acetaminophen  325-650  mg ; senna  1  tab ; bisacodyl  10  mg ; dextrose 50%  12.5  gm ; glucagon  1  mg ; sulfameth trimethoprim ss  1  tab ; aspirin  325  mg ; vitamin d  400  unit ; insulin  0  unit ; prednisone  3  mg ; tramadol (ultram)  50  mg ; 0.9% sodium chloride (mini bag plus)  100  ml ; meropenem  500  mg ; calcium carbonate  500  mg ; heparin  5000  unit ; polyethylene glycol  17  g ; amlodipine  10  mg ; desmopressin acetate  19  mcg ; iron dextran (test dose)  25  mg ; sevelamer hydrochloride  800  mg ; trazodone  25  mg ; acetaminophen  650  mg ; acetaminophen-caff-butalbital  1  tab ; 
 
white f 44 $nan$hematology blood hematocrit  21.5  %; hematology blood hematocrit  22.5  %; hematology blood hemoglobin  7.8  g dl; hematology blood hemoglobin  8.1  g dl; hematology blood platelet count  299  k ul; hematology blood platelet count  344  k ul; chemistry blood anion gap  15  meq l; chemistry blood anion gap  14  meq l; chemistry blood bicarbonate  19  meq l; chemistry blood bicarbonate  19  meq l; chemistry blood chloride  105  meq l; chemistry blood chloride  106  meq l; chemistry blood creatinine  5.5  mg dl; chemistry blood creatinine  5.5  mg dl; chemistry blood potassium  4.1  meq l; chemistry blood potassium  4.5  meq l; chemistry blood sodium  135  meq l; chemistry blood sodium  134  meq l; chemistry blood urea nitrogen  41  mg dl; chemistry blood urea nitrogen  41  mg dl; chemistry blood calcium, total  8.7  mg dl; chemistry blood glucose  75  mg dl; chemistry blood glucose  80  mg dl$tacrolimus  3  mg ; insulin  16  unit ; myfortic  360  mg ; influenza virus vaccine  0.5  ml ; sodium chloride 0.9%  flush  3  ml ; acetaminophen  325-650  mg ; senna  1  tab ; bisacodyl  10  mg ; dextrose 50%  12.5  gm ; glucagon  1  mg ; sulfameth trimethoprim ss  1  tab ; aspirin  325  mg ; vitamin d  400  unit ; insulin  0  unit ; prednisone  3  mg ; tramadol (ultram)  50  mg ; 0.9% sodium chloride (mini bag plus)  100  ml ; meropenem  500  mg ; calcium carbonate  500  mg ; heparin  5000  unit ; polyethylene glycol  17  g ; amlodipine  10  mg ; desmopressin acetate  19  mcg ; iron dextran (test dose)  25  mg ; sevelamer hydrochloride  800  mg ; trazodone  25  mg ; acetaminophen  650  mg ; acetaminophen-caff-butalbital  1  tab ; amlodipine  5  mg ; ampicillin sodium  1  g ; amoxicillin  500  mg ; 0.9% sodium chloride  100  ml ; ferric gluconate  125  mg ; cepacol (menthol)  1  loz ; 
 
white f 44 $nan$nan$tacrolimus  3  mg ; insulin  16  unit ; myfortic  360  mg ; influenza virus vaccine  0.5  ml ; sodium chloride 0.9%  flush  3  ml ; acetaminophen  325-650  mg ; senna  1  tab ; bisacodyl  10  mg ; dextrose 50%  12.5  gm ; glucagon  1  mg ; sulfameth trimethoprim ss  1  tab ; aspirin  325  mg ; vitamin d  400  unit ; insulin  0  unit ; prednisone  3  mg ; tramadol (ultram)  50  mg ; calcium carbonate  500  mg ; heparin  5000  unit ; polyethylene glycol  17  g ; sevelamer hydrochloride  800  mg ; trazodone  25  mg ; amlodipine  5  mg ; amoxicillin  500  mg ; 0.9% sodium chloride  100  ml ; ferric gluconate  125  mg ; vial  1  vial ; epoetin alfa  4000  unit ; tacrolimus  2  mg ; insulin  14  unit ; 
 
white f 49 $nan$nan$acetaminophen  1000  mg ; pregabalin  50  mg ; heparin  5000  unit ; scopolamine patch  1  ptch ; influenza vaccine quadrivalent  0.5  ml ; sodium chloride 0.9%  flush  3-10  ml ; lactated ringers  1000  ml ; acetaminophen iv  1000  mg ; ondansetron  4  mg ; vial  1  vial ; pantoprazole  40  mg ; morphine sulfate  2-4  mg ; 

white f 49 $nan$nan$heparin  5000  unit ; scopolamine patch  1  ptch ; influenza vaccine quadrivalent  0.5  ml ; sodium chloride 0.9%  flush  3-10  ml ; lactated ringers  1000  ml ; acetaminophen iv  1000  mg ; ondansetron  4  mg ; vial  1  vial ; pantoprazole  40  mg ; morphine sulfate  2-4  mg ; hydromorphone (dilaudid)  0.25-0.5  mg ; bag  1  bag ; magnesium sulfate  2  gm ; hydromorphone (dilaudid)  2  mg ; acetaminophen  500  mg ; hydromorphone (dilaudid)  2-4  mg ; atorvastatin  10  mg ; hydroxychloroquine sulfate  400  mg ; 

white f 49 $nan$nan$scopolamine patch  1  ptch ; influenza vaccine quadrivalent  0.5  ml ; sodium chloride 0.9%  flush  3-10  ml ; hydromorphone (dilaudid)  2-4  mg ; atorvastatin  10  mg ; hydroxychloroquine sulfate  400  mg ; 

white f 57 $temp    heartrate  91.0  resprate  19.0  o2sat  100.0  sbp  122.0  dbp  77.0  rhythm    pain  0  ; temp  99.6  heartrate  91.0  resprate  17.0  o2sat    sbp  119.0  dbp  80.0  rhythm    pain  5  $hematology blood hematocrit  36.3  %; hematology blood hemoglobin  12.0  g dl; hematology blood platelet count  130  k ul; chemistry blood anion gap  14  meq l; chemistry blood bicarbonate  26  meq l; chemistry blood chloride  94  meq l; chemistry blood creatinine  0.9  mg dl; chemistry blood potassium  3.5  meq l; chemistry blood sodium  130  meq l; chemistry blood urea nitrogen  11  mg dl; chemistry blood calcium, total  8.2  mg dl; chemistry blood bilirubin, total  0.4  mg dl; chemistry blood glucose  111  mg dl$sodium chloride 0.9%  flush  3  ml ; heparin  5000  unit ; oseltamivir  75  mg ; levofloxacin  750  mg ; guaifenesin-codeine phosphate  5-10  ml ; albuterol 0.083% neb soln  1  neb ; guaifenesin-dextromethorphan  5-10  ml ; lactated ringers  1000  ml ; ondansetron  4  mg ; lorazepam  0.5  mg ; benzonatate  100  mg ; guaifenesin-codeine phosphate  5  ml ; acetaminophen  650  mg ; benzonatate  200  mg ; 
 
white f 57 $nan$hematology blood hematocrit  36.5  %; hematology blood hemoglobin  12.5  g dl; hematology blood platelet count  130  k ul; chemistry blood anion gap  18  meq l; chemistry blood anion gap  18  meq l; chemistry blood bicarbonate  24  meq l; chemistry blood bicarbonate  21  meq l; chemistry blood chloride  88  meq l; chemistry blood chloride  89  meq l; chemistry blood creatinine  0.7  mg dl; chemistry blood creatinine  0.8  mg dl; chemistry blood potassium  3.3  meq l; chemistry blood potassium  4.5  meq l; chemistry blood sodium  125  meq l; chemistry blood sodium  125  meq l; chemistry blood urea nitrogen  9  mg dl; chemistry blood urea nitrogen  13  mg dl; hematology blood inr(pt)  1.3  ; chemistry urine chloride, urine  69  meq l; chemistry urine chloride, urine  12  meq l; chemistry urine creatinine, urine  102  mg dl; chemistry urine creatinine, urine  97  mg dl; chemistry urine potassium, urine  35  meq l; chemistry urine potassium, urine  25  meq l; chemistry urine sodium, urine  33  meq l; chemistry blood calcium, total  8.1  mg dl; chemistry blood calcium, total  7.2  mg dl; chemistry blood bilirubin, total  0.4  mg dl; chemistry blood glucose  134  mg dl; chemistry blood glucose  119  mg dl; blood gas blood free calcium  1.00  mmol l; blood gas blood lactate  1.3  mmol l; blood gas blood lactate  1.1  mmol l; blood gas blood potassium, whole blood  3.5  meq l$sodium chloride 0.9%  flush  3  ml ; heparin  5000  unit ; oseltamivir  75  mg ; albuterol 0.083% neb soln  1  neb ; ondansetron  4  mg ; lorazepam  0.5  mg ; guaifenesin-codeine phosphate  5  ml ; acetaminophen  650  mg ; benzonatate  200  mg ; promethazine  6.25  mg ; furosemide  20  mg ; influenza vaccine quadrivalent  0.5  ml ; iso-osmotic dextrose  200  ml ; vancomycin  1000  mg ; 0.9% sodium chloride (mini bag plus)  100  ml ; aztreonam  1000  mg ; sodium chloride 0.9%  1000  ml ; propofol  1000  mg ; propofol  200  mg ; fentanyl citrate  2.5  mg ; 0.9% sodium chloride  250  ml ; norepinephrine  8  mg ; meropenem  500  mg ; 
 
white f 57 $nan$hematology blood hematocrit  34.5  %; hematology blood hemoglobin  11.8  g dl; hematology blood platelet count  131  k ul; chemistry blood anion gap  15  meq l; chemistry blood anion gap  14  meq l; chemistry blood bicarbonate  23  meq l; chemistry blood bicarbonate  20  meq l; chemistry blood chloride  94  meq l; chemistry blood chloride  102  meq l; chemistry blood creatinine  0.9  mg dl; chemistry blood creatinine  0.8  mg dl; chemistry blood potassium  3.8  meq l; chemistry blood potassium  4.0  meq l; chemistry blood sodium  128  meq l; chemistry blood sodium  132  meq l; chemistry blood urea nitrogen  15  mg dl; chemistry blood urea nitrogen  14  mg dl; chemistry blood calcium, total  8.0  mg dl; chemistry blood calcium, total  7.8  mg dl; chemistry blood bilirubin, total  0.5  mg dl; chemistry blood glucose  121  mg dl; chemistry blood glucose  128  mg dl; chemistry blood lactate dehydrogenase (ld)  584  iu l; chemistry blood albumin  3.0  g dl; blood gas blood lactate  1.3  mmol l; blood gas blood lactate  1.4  mmol l$sodium chloride 0.9%  flush  3  ml ; heparin  5000  unit ; oseltamivir  75  mg ; albuterol 0.083% neb soln  1  neb ; guaifenesin-codeine phosphate  5  ml ; acetaminophen  650  mg ; benzonatate  200  mg ; influenza vaccine quadrivalent  0.5  ml ; propofol  1000  mg ; propofol  200  mg ; fentanyl citrate  2.5  mg ; 0.9% sodium chloride  250  ml ; norepinephrine  8  mg ; meropenem  500  mg ; sterile water  100  ml ; potassium chloride  40  meq ; bag  1  bag ; magnesium sulfate  2  gm ; 0.9% sodium chloride  1  bag ; calcium gluconate  2  g ; 0.9% sodium chloride  2  bag ; calcium gluconate  4  g ; guaifenesin  5-10  ml ; neutra-phos  2  pkt ; potassium chloride replacement (critical care and oncology)   40  meq ; potassium chloride replacement (critical care and oncology)   60  meq ; potassium chloride replacement (critical care and oncology)   80  meq ; sodium chloride 0.9%  flush  10  ml ; lansoprazole oral disintegrating tab  30  mg ; 
 
white f 57 $nan$hematology blood hematocrit  32.6  %; hematology blood hemoglobin  10.9  g dl; hematology blood platelet count  143  k ul; chemistry blood anion gap  14  meq l; chemistry blood bicarbonate  23  meq l; chemistry blood chloride  104  meq l; chemistry blood creatinine  0.8  mg dl; chemistry blood potassium  4.1  meq l; chemistry blood sodium  137  meq l; chemistry blood urea nitrogen  12  mg dl; chemistry blood calcium, total  7.9  mg dl; chemistry blood glucose  119  mg dl; blood gas blood lactate  1.7  mmol l; blood gas blood lactate  1.4  mmol l$sodium chloride 0.9%  flush  3  ml ; heparin  5000  unit ; oseltamivir  75  mg ; albuterol 0.083% neb soln  1  neb ; guaifenesin-codeine phosphate  5  ml ; acetaminophen  650  mg ; influenza vaccine quadrivalent  0.5  ml ; propofol  1000  mg ; propofol  200  mg ; fentanyl citrate  2.5  mg ; 0.9% sodium chloride  250  ml ; norepinephrine  8  mg ; meropenem  500  mg ; 0.9% sodium chloride  1  bag ; calcium gluconate  2  g ; 0.9% sodium chloride  2  bag ; calcium gluconate  4  g ; guaifenesin  5-10  ml ; potassium chloride replacement (critical care and oncology)   40  meq ; potassium chloride replacement (critical care and oncology)   60  meq ; potassium chloride replacement (critical care and oncology)   80  meq ; sodium chloride 0.9%  flush  10  ml ; lansoprazole oral disintegrating tab  30  mg ; neutra-phos  1  pkt ; 0.9% sodium chloride  500  ml ; vancomycin  1500  mg ; chlorhexidine gluconate 0.12% oral rinse  15  ml ; docusate sodium  100  mg ; senna  8.6  mg ; 
 
white f 57 $nan$hematology blood hematocrit  32.1  %; hematology blood hemoglobin  10.5  g dl; hematology blood platelet count  203  k ul; chemistry blood anion gap  11  meq l; chemistry blood bicarbonate  25  meq l; chemistry blood chloride  106  meq l; chemistry blood creatinine  0.7  mg dl; chemistry blood potassium  4.1  meq l; chemistry blood sodium  138  meq l; chemistry blood urea nitrogen  16  mg dl; chemistry blood calcium, total  7.8  mg dl; chemistry blood glucose  144  mg dl; blood gas blood lactate  1.3  mmol l; blood gas blood lactate  1.3  mmol l$sodium chloride 0.9%  flush  3  ml ; heparin  5000  unit ; oseltamivir  75  mg ; albuterol 0.083% neb soln  1  neb ; guaifenesin-codeine phosphate  5  ml ; acetaminophen  650  mg ; influenza vaccine quadrivalent  0.5  ml ; propofol  1000  mg ; propofol  200  mg ; fentanyl citrate  2.5  mg ; 0.9% sodium chloride  250  ml ; norepinephrine  8  mg ; 0.9% sodium chloride  1  bag ; calcium gluconate  2  g ; 0.9% sodium chloride  2  bag ; calcium gluconate  4  g ; guaifenesin  5-10  ml ; potassium chloride replacement (critical care and oncology)   40  meq ; potassium chloride replacement (critical care and oncology)   60  meq ; potassium chloride replacement (critical care and oncology)   80  meq ; sodium chloride 0.9%  flush  10  ml ; lansoprazole oral disintegrating tab  30  mg ; chlorhexidine gluconate 0.12% oral rinse  15  ml ; docusate sodium  100  mg ; senna  8.6  mg ; albuterol inhaler  6  puff ; 
 
white f 57 $nan$hematology blood hematocrit  31.3  %; hematology blood hemoglobin  10.1  g dl; hematology blood platelet count  263  k ul; chemistry blood anion gap  14  meq l; chemistry blood anion gap  13  meq l; chemistry blood bicarbonate  26  meq l; chemistry blood bicarbonate  28  meq l; chemistry blood chloride  105  meq l; chemistry blood chloride  104  meq l; chemistry blood creatinine  0.7  mg dl; chemistry blood creatinine  0.7  mg dl; chemistry blood potassium  4.3  meq l; chemistry blood potassium  4.3  meq l; chemistry blood sodium  141  meq l; chemistry blood sodium  141  meq l; chemistry blood urea nitrogen  20  mg dl; chemistry blood urea nitrogen  21  mg dl; chemistry blood calcium, total  8.2  mg dl; chemistry blood calcium, total  8.6  mg dl; chemistry blood glucose  148  mg dl; chemistry blood glucose  150  mg dl$sodium chloride 0.9%  flush  3  ml ; heparin  5000  unit ; albuterol 0.083% neb soln  1  neb ; guaifenesin-codeine phosphate  5  ml ; acetaminophen  650  mg ; influenza vaccine quadrivalent  0.5  ml ; propofol  1000  mg ; propofol  200  mg ; fentanyl citrate  2.5  mg ; 0.9% sodium chloride  1  bag ; calcium gluconate  2  g ; 0.9% sodium chloride  2  bag ; calcium gluconate  4  g ; guaifenesin  5-10  ml ; potassium chloride replacement (critical care and oncology)   40  meq ; potassium chloride replacement (critical care and oncology)   60  meq ; potassium chloride replacement (critical care and oncology)   80  meq ; sodium chloride 0.9%  flush  10  ml ; lansoprazole oral disintegrating tab  30  mg ; chlorhexidine gluconate 0.12% oral rinse  15  ml ; albuterol inhaler  6  puff ; 
 
white f 57 $nan$hematology blood hematocrit  31.1  %; hematology blood hemoglobin  10.2  g dl; hematology blood platelet count  339  k ul; chemistry blood anion gap  13  meq l; chemistry blood bicarbonate  31  meq l; chemistry blood chloride  103  meq l; chemistry blood creatinine  0.7  mg dl; chemistry blood potassium  3.7  meq l; chemistry blood sodium  143  meq l; chemistry blood urea nitrogen  21  mg dl; chemistry blood calcium, total  8.4  mg dl; chemistry blood glucose  145  mg dl$sodium chloride 0.9%  flush  3  ml ; heparin  5000  unit ; albuterol 0.083% neb soln  1  neb ; guaifenesin-codeine phosphate  5  ml ; acetaminophen  650  mg ; influenza vaccine quadrivalent  0.5  ml ; propofol  1000  mg ; propofol  200  mg ; fentanyl citrate  2.5  mg ; 0.9% sodium chloride  1  bag ; calcium gluconate  2  g ; 0.9% sodium chloride  2  bag ; calcium gluconate  4  g ; guaifenesin  5-10  ml ; potassium chloride replacement (critical care and oncology)   40  meq ; potassium chloride replacement (critical care and oncology)   60  meq ; potassium chloride replacement (critical care and oncology)   80  meq ; sodium chloride 0.9%  flush  10  ml ; lansoprazole oral disintegrating tab  30  mg ; chlorhexidine gluconate 0.12% oral rinse  15  ml ; albuterol inhaler  6  puff ; furosemide  60  mg ; bisacodyl  10  mg ; dexmedetomidine  0.4  mg ; 
 
white f 57 $nan$hematology blood hematocrit  32.3  %; hematology blood hemoglobin  10.4  g dl; hematology blood platelet count  384  k ul; chemistry blood anion gap  14  meq l; chemistry blood anion gap  13  meq l; chemistry blood bicarbonate  31  meq l; chemistry blood bicarbonate  31  meq l; chemistry blood chloride  102  meq l; chemistry blood chloride  104  meq l; chemistry blood creatinine  0.7  mg dl; chemistry blood creatinine  0.7  mg dl; chemistry blood potassium  3.8  meq l; chemistry blood potassium  4.1  meq l; chemistry blood sodium  143  meq l; chemistry blood sodium  144  meq l; chemistry blood urea nitrogen  20  mg dl; chemistry blood urea nitrogen  24  mg dl; hematology blood inr(pt)  1.2  ; chemistry blood calcium, total  8.6  mg dl; chemistry blood calcium, total  8.7  mg dl; chemistry blood glucose  170  mg dl; chemistry blood glucose  137  mg dl$sodium chloride 0.9%  flush  3  ml ; heparin  5000  unit ; albuterol 0.083% neb soln  1  neb ; guaifenesin-codeine phosphate  5  ml ; acetaminophen  650  mg ; influenza vaccine quadrivalent  0.5  ml ; propofol  1000  mg ; propofol  200  mg ; fentanyl citrate  2.5  mg ; 0.9% sodium chloride  1  bag ; calcium gluconate  2  g ; 0.9% sodium chloride  2  bag ; calcium gluconate  4  g ; guaifenesin  5-10  ml ; potassium chloride replacement (critical care and oncology)   40  meq ; potassium chloride replacement (critical care and oncology)   60  meq ; potassium chloride replacement (critical care and oncology)   80  meq ; sodium chloride 0.9%  flush  10  ml ; lansoprazole oral disintegrating tab  30  mg ; chlorhexidine gluconate 0.12% oral rinse  15  ml ; albuterol inhaler  6  puff ; bisacodyl  10  mg ; dexmedetomidine  0.4  mg ; sw  400  ml ; sw  600  ml ; potassium chloride  60  meq ; sw  800  ml ; potassium chloride  80  meq ; sterile water  150  ml ; sterile water  200  ml ; 
 
white f 57 $nan$hematology blood hematocrit  32.7  %; hematology blood hemoglobin  10.5  g dl; hematology blood platelet count  420  k ul; chemistry blood anion gap  12  meq l; chemistry blood bicarbonate  27  meq l; chemistry blood chloride  107  meq l; chemistry blood creatinine  0.7  mg dl; chemistry blood potassium  4.3  meq l; chemistry blood sodium  142  meq l; chemistry blood urea nitrogen  27  mg dl; hematology urine wbc  2  # hpf; chemistry blood calcium, total  8.5  mg dl; chemistry blood bilirubin, total  0.6  mg dl; chemistry blood glucose  138  mg dl; blood gas blood lactate  1.0  mmol l$sodium chloride 0.9%  flush  3  ml ; heparin  5000  unit ; albuterol 0.083% neb soln  1  neb ; guaifenesin-codeine phosphate  5  ml ; acetaminophen  650  mg ; influenza vaccine quadrivalent  0.5  ml ; propofol  1000  mg ; propofol  200  mg ; fentanyl citrate  2.5  mg ; 0.9% sodium chloride  1  bag ; calcium gluconate  2  g ; 0.9% sodium chloride  2  bag ; calcium gluconate  4  g ; guaifenesin  5-10  ml ; sodium chloride 0.9%  flush  10  ml ; lansoprazole oral disintegrating tab  30  mg ; chlorhexidine gluconate 0.12% oral rinse  15  ml ; albuterol inhaler  6  puff ; bisacodyl  10  mg ; dexmedetomidine  0.4  mg ; sterile water  150  ml ; sterile water  200  ml ; soln  50  ml ; hydralazine  10  mg ; acetaminophen iv  1000  mg ; 
 
white f 57 $nan$hematology blood hematocrit  33.0  %; hematology blood hemoglobin  10.4  g dl; hematology blood platelet count  430  k ul; chemistry blood anion gap  14  meq l; chemistry blood anion gap  13  meq l; chemistry blood anion gap  16  meq l; chemistry blood bicarbonate  28  meq l; chemistry blood bicarbonate  29  meq l; chemistry blood bicarbonate  27  meq l; chemistry blood chloride  105  meq l; chemistry blood chloride  105  meq l; chemistry blood chloride  105  meq l; chemistry blood creatinine  0.8  mg dl; chemistry blood creatinine  0.7  mg dl; chemistry blood creatinine  0.8  mg dl; chemistry blood potassium  3.7  meq l; chemistry blood potassium  3.6  meq l; chemistry blood potassium  4.1  meq l; chemistry blood sodium  143  meq l; chemistry blood sodium  143  meq l; chemistry blood sodium  144  meq l; chemistry blood urea nitrogen  28  mg dl; chemistry blood urea nitrogen  32  mg dl; chemistry blood urea nitrogen  30  mg dl; hematology blood inr(pt)  1.2  ; chemistry blood calcium, total  8.8  mg dl; chemistry blood calcium, total  8.8  mg dl; chemistry blood calcium, total  9.2  mg dl; chemistry blood glucose  144  mg dl; chemistry blood glucose  147  mg dl; chemistry blood glucose  126  mg dl; blood gas blood free calcium  1.12  mmol l; blood gas blood free calcium  1.14  mmol l; blood gas blood lactate  0.8  mmol l; blood gas blood lactate  0.9  mmol l$sodium chloride 0.9%  flush  3  ml ; albuterol 0.083% neb soln  1  neb ; guaifenesin-codeine phosphate  5  ml ; acetaminophen  650  mg ; influenza vaccine quadrivalent  0.5  ml ; 0.9% sodium chloride  1  bag ; calcium gluconate  2  g ; 0.9% sodium chloride  2  bag ; calcium gluconate  4  g ; guaifenesin  5-10  ml ; sodium chloride 0.9%  flush  10  ml ; lansoprazole oral disintegrating tab  30  mg ; chlorhexidine gluconate 0.12% oral rinse  15  ml ; albuterol inhaler  6  puff ; bisacodyl  10  mg ; dexmedetomidine  0.4  mg ; sterile water  150  ml ; sterile water  200  ml ; soln  50  ml ; acetaminophen iv  1000  mg ; soln  100  ml ; polyethylene glycol  17  g ; docusate sodium (liquid)  100  mg ; quetiapine fumarate  25  mg ; lactulose  15  ml ; lactulose  30  ml ; methylnaltrexone  12  mg ; 
 
white f 57 $nan$hematology blood hematocrit  33.2  %; hematology blood hemoglobin  10.6  g dl; hematology blood platelet count  451  k ul; chemistry blood anion gap  15  meq l; chemistry blood bicarbonate  27  meq l; chemistry blood chloride  103  meq l; chemistry blood creatinine  0.7  mg dl; chemistry blood potassium  3.8  meq l; chemistry blood sodium  141  meq l; chemistry blood urea nitrogen  31  mg dl; chemistry blood calcium, total  8.7  mg dl; chemistry blood glucose  126  mg dl; blood gas blood free calcium  1.11  mmol l$albuterol 0.083% neb soln  1  neb ; guaifenesin-codeine phosphate  5  ml ; acetaminophen  650  mg ; influenza vaccine quadrivalent  0.5  ml ; 0.9% sodium chloride  1  bag ; calcium gluconate  2  g ; 0.9% sodium chloride  2  bag ; calcium gluconate  4  g ; guaifenesin  5-10  ml ; sodium chloride 0.9%  flush  10  ml ; lansoprazole oral disintegrating tab  30  mg ; chlorhexidine gluconate 0.12% oral rinse  15  ml ; albuterol inhaler  6  puff ; bisacodyl  10  mg ; dexmedetomidine  0.4  mg ; sterile water  150  ml ; sterile water  200  ml ; soln  50  ml ; docusate sodium (liquid)  100  mg ; quetiapine fumarate  25  mg ; lactulose  30  ml ; methylnaltrexone  12  mg ; furosemide  40  mg ; 
 
white f 57 $nan$hematology blood hematocrit  33.6  %; hematology blood hemoglobin  10.7  g dl; hematology blood platelet count  467  k ul; chemistry blood anion gap  17  meq l; chemistry blood anion gap  11  meq l; chemistry blood bicarbonate  24  meq l; chemistry blood bicarbonate  29  meq l; chemistry blood chloride  105  meq l; chemistry blood chloride  107  meq l; chemistry blood creatinine  0.8  mg dl; chemistry blood creatinine  0.8  mg dl; chemistry blood potassium  3.3  meq l; chemistry blood potassium  4.2  meq l; chemistry blood sodium  143  meq l; chemistry blood sodium  143  meq l; chemistry blood urea nitrogen  31  mg dl; chemistry blood urea nitrogen  27  mg dl; chemistry blood calcium, total  8.9  mg dl; chemistry blood calcium, total  9.0  mg dl; chemistry blood glucose  178  mg dl; chemistry blood glucose  124  mg dl$glucagon  1  mg ; albuterol 0.083% neb soln  1  neb ; guaifenesin-codeine phosphate  5  ml ; acetaminophen  650  mg ; 0.9% sodium chloride  1  bag ; calcium gluconate  2  g ; 0.9% sodium chloride  2  bag ; calcium gluconate  4  g ; guaifenesin  5-10  ml ; sodium chloride 0.9%  flush  10  ml ; lansoprazole oral disintegrating tab  30  mg ; chlorhexidine gluconate 0.12% oral rinse  15  ml ; albuterol inhaler  6  puff ; bisacodyl  10  mg ; dexmedetomidine  0.4  mg ; sterile water  150  ml ; sterile water  200  ml ; soln  50  ml ; docusate sodium (liquid)  100  mg ; quetiapine fumarate  25  mg ; lactulose  30  ml ; ipratropium bromide neb  1  neb ; racepinephrine  0.5  ml ; methylprednisolone sodium succ  125  mg ; vial  1  vial ; pantoprazole  40  mg ; dexamethasone  10  mg ; dextrose 50%  12.5  gm ; glucose gel  15  g ; insulin  0  unit ; 
 
white f 57 $nan$hematology blood hematocrit  31.7  %; hematology blood hemoglobin  9.8  g dl; hematology blood platelet count  456  k ul; chemistry blood anion gap  13  meq l; chemistry blood bicarbonate  26  meq l; chemistry blood chloride  109  meq l; chemistry blood creatinine  0.7  mg dl; chemistry blood potassium  3.7  meq l; chemistry blood sodium  144  meq l; chemistry blood urea nitrogen  33  mg dl; chemistry blood calcium, total  8.9  mg dl; chemistry blood glucose  153  mg dl$glucagon  1  mg ; albuterol 0.083% neb soln  1  neb ; guaifenesin-codeine phosphate  5  ml ; acetaminophen  650  mg ; 0.9% sodium chloride  1  bag ; calcium gluconate  2  g ; 0.9% sodium chloride  2  bag ; calcium gluconate  4  g ; guaifenesin  5-10  ml ; sodium chloride 0.9%  flush  10  ml ; albuterol inhaler  6  puff ; bisacodyl  10  mg ; sterile water  150  ml ; sterile water  200  ml ; lactulose  30  ml ; ipratropium bromide neb  1  neb ; racepinephrine  0.5  ml ; vial  1  vial ; pantoprazole  40  mg ; dextrose 50%  12.5  gm ; glucose gel  15  g ; insulin  0  unit ; dexamethasone  12  mg ; 
 
white f 57 $nan$hematology blood hematocrit  32.8  %; hematology blood hemoglobin  10.4  g dl; hematology blood platelet count  532  k ul; chemistry blood anion gap  14  meq l; chemistry blood anion gap  15  meq l; chemistry blood bicarbonate  26  meq l; chemistry blood bicarbonate  26  meq l; chemistry blood chloride  104  meq l; chemistry blood chloride  97  meq l; chemistry blood creatinine  0.8  mg dl; chemistry blood creatinine  0.8  mg dl; chemistry blood potassium  3.4  meq l; chemistry blood potassium  3.0  meq l; chemistry blood sodium  141  meq l; chemistry blood sodium  135  meq l; chemistry blood urea nitrogen  39  mg dl; chemistry blood urea nitrogen  34  mg dl; hematology blood inr(pt)  1.1  ; chemistry blood calcium, total  9.0  mg dl; chemistry blood calcium, total  9.2  mg dl; chemistry blood bilirubin, total  0.7  mg dl; chemistry blood glucose  106  mg dl; chemistry blood glucose  102  mg dl; chemistry blood lactate dehydrogenase (ld)  242  iu l; chemistry blood albumin  3.5  g dl$glucagon  1  mg ; guaifenesin-codeine phosphate  5  ml ; acetaminophen  650  mg ; 0.9% sodium chloride  1  bag ; calcium gluconate  2  g ; 0.9% sodium chloride  2  bag ; calcium gluconate  4  g ; guaifenesin  5-10  ml ; sodium chloride 0.9%  flush  10  ml ; albuterol inhaler  6  puff ; bisacodyl  10  mg ; sterile water  150  ml ; sterile water  200  ml ; lactulose  30  ml ; vial  1  vial ; pantoprazole  40  mg ; dextrose 50%  12.5  gm ; glucose gel  15  g ; insulin  0  unit ; heparin flush (10 units ml)  1  ml ; 
 
white f 57 $nan$hematology blood hematocrit  34.1  %; hematology blood hemoglobin  11.1  g dl; hematology blood platelet count  519  k ul; chemistry blood anion gap  16  meq l; chemistry blood anion gap  17  meq l; chemistry blood bicarbonate  24  meq l; chemistry blood bicarbonate  24  meq l; chemistry blood chloride  104  meq l; chemistry blood chloride  97  meq l; chemistry blood creatinine  0.8  mg dl; chemistry blood creatinine  0.8  mg dl; chemistry blood potassium  3.8  meq l; chemistry blood potassium  3.2  meq l; chemistry blood sodium  140  meq l; chemistry blood sodium  135  meq l; chemistry blood urea nitrogen  26  mg dl; chemistry blood urea nitrogen  24  mg dl; chemistry blood calcium, total  9.3  mg dl; chemistry blood calcium, total  9.5  mg dl; chemistry blood glucose  106  mg dl; chemistry blood glucose  106  mg dl$glucagon  1  mg ; guaifenesin-codeine phosphate  5  ml ; acetaminophen  650  mg ; guaifenesin  5-10  ml ; sodium chloride 0.9%  flush  10  ml ; albuterol inhaler  6  puff ; bisacodyl  10  mg ; lactulose  30  ml ; dextrose 50%  12.5  gm ; glucose gel  15  g ; insulin  0  unit ; heparin flush (10 units ml)  1  ml ; 
 
white f 57 $nan$nan$glucagon  1  mg ; guaifenesin-codeine phosphate  5  ml ; acetaminophen  650  mg ; guaifenesin  5-10  ml ; sodium chloride 0.9%  flush  10  ml ; albuterol inhaler  6  puff ; bisacodyl  10  mg ; lactulose  30  ml ; dextrose 50%  12.5  gm ; glucose gel  15  g ; insulin  0  unit ; heparin flush (10 units ml)  1  ml ; 
 
white m 90 $temp    heartrate    resprate    o2sat    sbp    dbp    rhythm    pain  prehosp  ; temp    heartrate  74.0  resprate  18.0  o2sat  95.0  sbp  148.0  dbp  68.0  rhythm  normal sinus rhythm  pain  0  ; temp    heartrate  65.0  resprate  18.0  o2sat  96.0  sbp  146.0  dbp  75.0  rhythm  normal sinus rhythm  pain  0  $hematology blood hematocrit  41.1  %; hematology blood hemoglobin  13.7  g dl; hematology blood platelet count  143  k ul; chemistry blood creatinine  0.9  mg dl; chemistry blood creatinine  0.9  mg dl; chemistry blood urea nitrogen  24  mg dl; hematology blood inr(pt)  1.1  ; chemistry blood bilirubin, total  0.3  mg dl; chemistry blood albumin  3.7  g dl; blood gas blood chloride, whole blood  109  meq l; blood gas blood glucose  89  mg dl; blood gas blood potassium, whole blood  3.8  meq l; blood gas blood sodium, whole blood  144  meq l; blood gas blood calculated bicarbonate, whole blood  26  meq l$nan
chronic diastolic (congestive) heart failure encounter for examination for normal comparison and control in clinical research program old myocardial infarction rheumatic disorders of both mitral and aortic valves personal history of nicotine dependence other secondary pulmonary hypertension peripheral vascular disease, unspecified other specified disorders of urethra alzheimer's disease, unspecified atherosclerotic heart disease of native coronary artery without angina pectoris occlusion and stenosis of bilateral carotid arteries iron deficiency anemia, unspecified hypertensive heart disease with heart failure vitamin d deficiency, unspecified dementia in other diseases classified elsewhere without behavioral disturbance thrombocytopenia, unspecified calculus of bile duct without cholangitis or cholecystitis with obstruction nicotine dependence, cigarettes, uncomplicated dementia in other diseases classified elsewhere without behavioral disturbance essential (primary) hypertension peripheral vascular disease, unspecified atherosclerotic heart disease of native coronary artery without angina pectoris alzheimer's disease, unspecified nonrheumatic aortic (valve) stenosis
white m 90 $nan$chemistry blood anion gap  14  meq l; chemistry blood bicarbonate  22  meq l; chemistry blood chloride  108  meq l; chemistry blood creatinine  0.7  mg dl; chemistry blood potassium  3.8  meq l; chemistry blood sodium  144  meq l; chemistry blood urea nitrogen  20  mg dl; chemistry blood calcium, total  9.2  mg dl; chemistry blood glucose  102  mg dl; chemistry blood % hemoglobin a1c  5.8  %$sodium chloride 0.9%  flush  3-10  ml ; sodium chloride 0.9%  1000  ml ; docusate sodium  100  mg ; bisacodyl  10  mg ; acetaminophen  650  mg ; heparin  5000  unit ; aspirin  81  mg ; omeprazole  20  mg ; aspirin  300  mg ; atorvastatin  40  mg ; 
chronic diastolic (congestive) heart failure encounter for examination for normal comparison and control in clinical research program old myocardial infarction rheumatic disorders of both mitral and aortic valves personal history of nicotine dependence other secondary pulmonary hypertension peripheral vascular disease, unspecified other specified disorders of urethra alzheimer's disease, unspecified atherosclerotic heart disease of native coronary artery without angina pectoris occlusion and stenosis of bilateral carotid arteries iron deficiency anemia, unspecified hypertensive heart disease with heart failure vitamin d deficiency, unspecified dementia in other diseases classified elsewhere without behavioral disturbance thrombocytopenia, unspecified calculus of bile duct without cholangitis or cholecystitis with obstruction nicotine dependence, cigarettes, uncomplicated dementia in other diseases classified elsewhere without behavioral disturbance essential (primary) hypertension peripheral vascular disease, unspecified atherosclerotic heart disease of native coronary artery without angina pectoris alzheimer's disease, unspecified nonrheumatic aortic (valve) stenosis
white m 90 $nan$nan$sodium chloride 0.9%  flush  3-10  ml ; sodium chloride 0.9%  1000  ml ; docusate sodium  100  mg ; bisacodyl  10  mg ; acetaminophen  650  mg ; heparin  5000  unit ; omeprazole  20  mg ; atorvastatin  40  mg ; atorvastatin  80  mg ; 
chronic diastolic (congestive) heart failure encounter for examination for normal comparison and control in clinical research program old myocardial infarction rheumatic disorders of both mitral and aortic valves personal history of nicotine dependence other secondary pulmonary hypertension peripheral vascular disease, unspecified other specified disorders of urethra alzheimer's disease, unspecified atherosclerotic heart disease of native coronary artery without angina pectoris occlusion and stenosis of bilateral carotid arteries iron deficiency anemia, unspecified hypertensive heart disease with heart failure vitamin d deficiency, unspecified dementia in other diseases classified elsewhere without behavioral disturbance thrombocytopenia, unspecified calculus of bile duct without cholangitis or cholecystitis with obstruction nicotine dependence, cigarettes, uncomplicated dementia in other diseases classified elsewhere without behavioral disturbance essential (primary) hypertension peripheral vascular disease, unspecified atherosclerotic heart disease of native coronary artery without angina pectoris alzheimer's disease, unspecified nonrheumatic aortic (valve) stenosis
white m 90 $nan$nan$sodium chloride 0.9%  flush  3-10  ml ; sodium chloride 0.9%  1000  ml ; docusate sodium  100  mg ; bisacodyl  10  mg ; acetaminophen  650  mg ; heparin  5000  unit ; omeprazole  20  mg ; atorvastatin  80  mg ; clopidogrel  75  mg ; 
chronic diastolic (congestive) heart failure encounter for examination for normal comparison and control in clinical research program old myocardial infarction rheumatic disorders of both mitral and aortic valves personal history of nicotine dependence other secondary pulmonary hypertension peripheral vascular disease, unspecified other specified disorders of urethra alzheimer's disease, unspecified atherosclerotic heart disease of native coronary artery without angina pectoris occlusion and stenosis of bilateral carotid arteries iron deficiency anemia, unspecified hypertensive heart disease with heart failure vitamin d deficiency, unspecified dementia in other diseases classified elsewhere without behavioral disturbance thrombocytopenia, unspecified calculus of bile duct without cholangitis or cholecystitis with obstruction nicotine dependence, cigarettes, uncomplicated dementia in other diseases classified elsewhere without behavioral disturbance essential (primary) hypertension peripheral vascular disease, unspecified atherosclerotic heart disease of native coronary artery without angina pectoris alzheimer's disease, unspecified nonrheumatic aortic (valve) stenosis
white m 90 $nan$nan$sodium chloride 0.9%  flush  3-10  ml ; docusate sodium  100  mg ; bisacodyl  10  mg ; acetaminophen  650  mg ; heparin  5000  unit ; omeprazole  20  mg ; atorvastatin  80  mg ; clopidogrel  75  mg ; 0.45% sodium chloride  1000  ml ; 
chronic diastolic (congestive) heart failure encounter for examination for normal comparison and control in clinical research program old myocardial infarction rheumatic disorders of both mitral and aortic valves personal history of nicotine dependence other secondary pulmonary hypertension peripheral vascular disease, unspecified other specified disorders of urethra alzheimer's disease, unspecified atherosclerotic heart disease of native coronary artery without angina pectoris occlusion and stenosis of bilateral carotid arteries iron deficiency anemia, unspecified hypertensive heart disease with heart failure vitamin d deficiency, unspecified dementia in other diseases classified elsewhere without behavioral disturbance thrombocytopenia, unspecified calculus of bile duct without cholangitis or cholecystitis with obstruction nicotine dependence, cigarettes, uncomplicated dementia in other diseases classified elsewhere without behavioral disturbance essential (primary) hypertension peripheral vascular disease, unspecified atherosclerotic heart disease of native coronary artery without angina pectoris alzheimer's disease, unspecified nonrheumatic aortic (valve) stenosis
white m 49 $nan$nan$sodium chloride 0.9%  flush  10  ml ; 
pure hypercholesterolemia other and unspecified hyperlipidemia chest pain, unspecified chest pain, unspecified
white m 49 $nan$hematology blood hematocrit  42.1  %; hematology blood hematocrit  23.4  %; hematology blood hematocrit  30.1  %; hematology blood hematocrit  21.6  %; hematology blood hematocrit  26.5  %; hematology blood hematocrit  31.3  %; hematology blood hemoglobin  12.8  g dl; hematology blood hemoglobin  7.3  g dl; hematology blood hemoglobin  9.0  g dl; hematology blood hemoglobin  6.6  g dl; hematology blood hemoglobin  8.4  g dl; hematology blood hemoglobin  9.9  g dl; hematology blood platelet count  47  k ul; hematology blood platelet count  17  k ul; hematology blood platelet count  22  k ul; hematology blood platelet count  32  k ul; hematology blood platelet count  41  k ul; hematology blood platelet count  63  k ul; chemistry blood anion gap  17  meq l; chemistry blood anion gap  18  meq l; chemistry blood anion gap  33  meq l; chemistry blood anion gap  38  meq l; chemistry blood bicarbonate  20  meq l; chemistry blood bicarbonate  10  meq l; chemistry blood bicarbonate  14  meq l; chemistry blood bicarbonate  13  meq l; chemistry blood chloride  111  meq l; chemistry blood chloride  106  meq l; chemistry blood chloride  95  meq l; chemistry blood chloride  121  meq l; chemistry blood creatinine  3.3  mg dl; chemistry blood creatinine  3.4  mg dl; chemistry blood creatinine  2.9  mg dl; chemistry blood creatinine  2.6  mg dl; chemistry blood potassium  3.0  meq l; chemistry blood potassium  4.0  meq l; chemistry blood potassium  3.5  meq l; chemistry blood potassium  3.8  meq l; chemistry blood sodium  145  meq l; chemistry blood sodium  145  meq l; chemistry blood sodium  149  meq l; chemistry blood sodium  142  meq l; chemistry blood urea nitrogen  30  mg dl; chemistry blood urea nitrogen  30  mg dl; chemistry blood urea nitrogen  38  mg dl; chemistry blood urea nitrogen  20  mg dl; hematology blood inr(pt)  1.7  ; hematology blood inr(pt)  3.3  ; hematology blood inr(pt)  2.7  ; hematology blood inr(pt)  3.4  ; hematology blood inr(pt)  4.6  ; chemistry blood calcium, total  8.0  mg dl; chemistry blood calcium, total  8.3  mg dl; chemistry blood calcium, total  8.0  mg dl; chemistry blood bilirubin, total  0.5  mg dl; chemistry blood bilirubin, total  0.6  mg dl; chemistry blood bilirubin, total  0.5  mg dl; chemistry blood glucose  508  mg dl; chemistry blood glucose  113  mg dl; chemistry blood glucose  135  mg dl; chemistry blood glucose  361  mg dl; chemistry blood lactate dehydrogenase (ld)  597  iu l; chemistry blood lactate dehydrogenase (ld)  920  iu l; chemistry blood lactate dehydrogenase (ld)  893  iu l; chemistry blood albumin  1.7  g dl; hematology blood bands  0  %; hematology blood bands  0  %; hematology blood bands  0  %; hematology blood bands  2  %; blood gas blood free calcium  1.10  mmol l; blood gas blood free calcium  1.10  mmol l; blood gas blood free calcium  1.12  mmol l; blood gas blood free calcium  1.41  mmol l; blood gas blood free calcium  1.12  mmol l; blood gas blood free calcium  1.04  mmol l; blood gas blood free calcium  1.00  mmol l; blood gas blood free calcium  1.12  mmol l; blood gas blood free calcium  1.94  mmol l; blood gas blood free calcium  0.93  mmol l; blood gas blood free calcium  0.92  mmol l; blood gas blood free calcium  0.92  mmol l; blood gas blood lactate  9.1  mmol l; blood gas blood lactate  9.1  mmol l; blood gas blood lactate  19.4  mmol l; blood gas blood lactate  17.4  mmol l; blood gas blood lactate  17.2  mmol l; blood gas blood lactate  16.3  mmol l; blood gas blood lactate  15.8  mmol l; blood gas blood lactate  18.8  mmol l; blood gas blood lactate  15.0  mmol l; blood gas blood lactate  12.0  mmol l; blood gas blood lactate  10.2  mmol l; blood gas blood lactate  20.3  mmol l; blood gas blood lactate  9.4  mmol l; blood gas blood lactate  7.8  mmol l; blood gas blood lactate  8.3  mmol l; blood gas blood chloride, whole blood  108  meq l; blood gas blood chloride, whole blood  118  meq l; blood gas blood chloride, whole blood  121  meq l; blood gas blood glucose  103  mg dl; blood gas blood glucose  124  mg dl; blood gas blood glucose  119  mg dl; blood gas blood glucose  97  mg dl; blood gas blood glucose  84  mg dl; blood gas blood glucose  71  mg dl; blood gas blood glucose  211  mg dl; blood gas blood glucose  320  mg dl; blood gas blood glucose  342  mg dl; blood gas blood glucose  404  mg dl; blood gas blood glucose  424  mg dl; blood gas blood hematocrit, calculated  31  %; blood gas blood hemoglobin  10.3  g dl; blood gas blood potassium, whole blood  3.3  meq l; blood gas blood potassium, whole blood  4.0  meq l; blood gas blood potassium, whole blood  3.8  meq l; blood gas blood potassium, whole blood  3.6  meq l; blood gas blood potassium, whole blood  3.2  meq l; blood gas blood potassium, whole blood  3.4  meq l; blood gas blood potassium, whole blood  3.5  meq l; blood gas blood potassium, whole blood  3.2  meq l; blood gas blood potassium, whole blood  3.9  meq l; blood gas blood potassium, whole blood  3.7  meq l; blood gas blood potassium, whole blood  2.8  meq l; blood gas blood sodium, whole blood  143  meq l; blood gas blood sodium, whole blood  140  meq l; blood gas blood sodium, whole blood  144  meq l$sodium chloride 0.9%  flush  10  ml ; sodium chloride 0.9%  flush  3  ml ; 5% dextrose  250  ml ; cisatracurium besylate  100  mg ; heparin  5000  unit ; cisatracurium besylate  15  mg ; 0.9% sodium chloride  250  ml ; norepinephrine  16  mg ; phenylephrine  240  mg ; epinephrine  8  mg ; 5% dextrose  100  ml ; vasopressin  40  unit ; bag  5000  ml ; prismasate (b22 k4)  5000  ml ; bag  1  bag ; citrate dextrose 3% (acd-a) crrt  1000  ml ; sw  100  ml ; potassium chloride  10  meq ; sterile water  50  ml ; potassium chloride  20  meq ; sterile water  100  ml ; potassium chloride  40  meq ; heparin (crrt machine priming)  5000  unit ; neomycin-polymyxin-bacitracin  1  appl ; 5% dextrose  500  ml ; calcium gluconate  20  g ; calcium chloride  1  gm ; 0.9% sodium chloride  100  ml ; insulin human regular  100  unit ; dextrose 50%  12.5  gm ; glucagon  1  mg ; glucose gel  15  g ; cisatracurium besylate  200  mg ; soln  50  ml ; fentanyl citrate  2.5  mg ; sodium bicarbonate  150  meq ; iso-osmotic dextrose  200  ml ; vancomycin  1000  mg ; midazolam  100  mg ; 5% dextrose  50  ml ; clindamycin  900  mg ; albumin 5% (25g   500ml)  25  g ; 0.9% sodium chloride (mini bag plus)  100  ml ; cefepime  2  g ; gentamicin sulfate  620  mg ; hydrocortisone na succ.  100  mg ; prismasate (b32 k2)  5000  ml ; oseltamivir  75  mg ; 5% dextrose  1000  ml ; methylene blue  90  mg ; 0.9% sodium chloride  1  bag ; calcium gluconate  2  g ; 0.9% sodium chloride  2  bag ; calcium gluconate  4  g ; fludrocortisone acetate  0.2  mg ; insulin human regular  250  unit ; vial  1  vial ; pantoprazole  40  mg ; 
pure hypercholesterolemia other and unspecified hyperlipidemia chest pain, unspecified chest pain, unspecified
white m 49 $nan$hematology blood hematocrit  27.4  %; hematology blood hemoglobin  8.7  g dl; hematology blood platelet count  29  k ul; chemistry blood anion gap  45  meq l; chemistry blood bicarbonate  12  meq l; chemistry blood chloride  85  meq l; chemistry blood creatinine  2.9  mg dl; chemistry blood potassium  4.8  meq l; chemistry blood sodium  137  meq l; chemistry blood urea nitrogen  20  mg dl; hematology blood inr(pt)  13.1  ; chemistry blood calcium, total  7.9  mg dl; chemistry blood bilirubin, total  0.5  mg dl; chemistry blood glucose  689  mg dl; chemistry blood lactate dehydrogenase (ld)  2416  iu l; hematology blood bands  5  %; blood gas blood free calcium  0.94  mmol l; blood gas blood lactate  23.4  mmol l$sodium chloride 0.9%  flush  10  ml ; dextrose 50%  12.5  gm ; glucagon  1  mg ; glucose gel  15  g ; soln  50  ml ; fentanyl citrate  2.5  mg ; midazolam  100  mg ; 5% dextrose  50  ml ; clindamycin  900  mg ; 0.9% sodium chloride (mini bag plus)  100  ml ; cefepime  2  g ; hydrocortisone na succ.  100  mg ; 0.9% sodium chloride  1  bag ; calcium gluconate  2  g ; 0.9% sodium chloride  2  bag ; calcium gluconate  4  g ; fludrocortisone acetate  0.2  mg ; insulin human regular  250  unit ; vial  1  vial ; pantoprazole  40  mg ; 
pure hypercholesterolemia other and unspecified hyperlipidemia chest pain, unspecified chest pain, unspecified
white m 79 $nan$nan$pneumococcal 23-valent polysaccharide vaccine  0.5  ml ; sodium chloride 0.9%  flush  3  ml ; lactated ringers  1000  ml ; acetaminophen  650  mg ; oxycodone (immediate release)   2.5  mg ; ondansetron  4  mg ; belladonna & opium (16.2 30mg)  1  supp ; pravastatin  20  mg ; amoxicillin-clavulanic acid  875  mg ; docusate sodium  100  mg ; 
 
white m 79 $nan$nan$pneumococcal 23-valent polysaccharide vaccine  0.5  ml ; sodium chloride 0.9%  flush  3  ml ; lactated ringers  1000  ml ; acetaminophen  650  mg ; oxycodone (immediate release)   2.5  mg ; ondansetron  4  mg ; belladonna & opium (16.2 30mg)  1  supp ; pravastatin  20  mg ; amoxicillin-clavulanic acid  875  mg ; docusate sodium  100  mg ; senna  8.6  mg ; 
 
white f 46 $nan$nan$dexamethasone  20  mg ; 
 
white f 46 $nan$hematology blood hematocrit  28.3  %; hematology blood hematocrit  25.5  %; hematology blood hemoglobin  9.8  g dl; hematology blood hemoglobin  8.9  g dl; hematology blood platelet count  384  k ul; hematology blood platelet count  341  k ul; chemistry blood anion gap  15  meq l; chemistry blood anion gap  12  meq l; chemistry blood bicarbonate  22  meq l; chemistry blood bicarbonate  23  meq l; chemistry blood chloride  106  meq l; chemistry blood chloride  111  meq l; chemistry blood creatinine  2.1  mg dl; chemistry blood creatinine  2.0  mg dl; chemistry blood potassium  4.1  meq l; chemistry blood potassium  4.2  meq l; chemistry blood sodium  139  meq l; chemistry blood sodium  142  meq l; chemistry blood urea nitrogen  25  mg dl; chemistry blood urea nitrogen  26  mg dl; hematology blood inr(pt)  1.1  ; hematology urine wbc  14  # hpf; chemistry blood calcium, total  9.5  mg dl; chemistry blood calcium, total  9.0  mg dl; chemistry blood bilirubin, total  0.2  mg dl; chemistry blood glucose  149  mg dl; chemistry blood glucose  88  mg dl; chemistry blood lactate dehydrogenase (ld)  205  iu l; chemistry blood lactate dehydrogenase (ld)  178  iu l; chemistry blood albumin  4.4  g dl; hematology blood bands  0  %$dexamethasone  20  mg ; pantoprazole  40  mg ; diazepam  2  mg ; oxycodone-acetaminophen  1  tab ; docusate sodium  100  mg ; heparin  5000  unit ; ns  1000  ml ; ciprofloxacin hcl  500  mg ; allopurinol  100  mg ; 
 
white f 46 $nan$hematology blood hematocrit  27.1  %; hematology blood hemoglobin  8.7  g dl; hematology blood platelet count  345  k ul; chemistry blood anion gap  14  meq l; chemistry blood bicarbonate  22  meq l; chemistry blood chloride  109  meq l; chemistry blood creatinine  2.2  mg dl; chemistry blood potassium  4.1  meq l; chemistry blood sodium  141  meq l; chemistry blood urea nitrogen  25  mg dl; chemistry urine creatinine, urine  46  mg dl; chemistry blood calcium, total  9.2  mg dl; chemistry blood bilirubin, total  0.2  mg dl; chemistry blood glucose  83  mg dl; chemistry blood lactate dehydrogenase (ld)  202  iu l; chemistry urine protein creatinine ratio  6.0  ratio; chemistry urine 24 hr creatinine  414  mg 24hr$pantoprazole  40  mg ; diazepam  2  mg ; oxycodone-acetaminophen  1  tab ; docusate sodium  100  mg ; heparin  5000  unit ; ns  1000  ml ; acetaminophen  325-650  mg ; lidocaine 2%  10  ml ; 
 
white f 46 $nan$hematology blood hematocrit  24.8  %; hematology blood hemoglobin  8.1  g dl; hematology blood platelet count  291  k ul; chemistry blood anion gap  14  meq l; chemistry blood bicarbonate  22  meq l; chemistry blood chloride  108  meq l; chemistry blood creatinine  2.0  mg dl; chemistry blood potassium  4.1  meq l; chemistry blood sodium  140  meq l; chemistry blood urea nitrogen  21  mg dl; chemistry urine creatinine, urine  24  mg dl; chemistry blood calcium, total  8.7  mg dl; chemistry blood glucose  87  mg dl; chemistry blood lactate dehydrogenase (ld)  222  iu l; chemistry urine protein creatinine ratio  7.5  ratio$pantoprazole  40  mg ; oxycodone-acetaminophen  1  tab ; docusate sodium  100  mg ; heparin  5000  unit ; acetaminophen  325-650  mg ; lidocaine 2%  10  ml ; promethazine  12.5  mg ; dexamethasone  40  mg ; 
 
white f 46 $nan$hematology blood hematocrit  25.2  %; hematology blood hemoglobin  8.5  g dl; hematology blood platelet count  292  k ul; chemistry blood anion gap  16  meq l; chemistry blood bicarbonate  19  meq l; chemistry blood chloride  110  meq l; chemistry blood creatinine  1.7  mg dl; chemistry blood potassium  4.3  meq l; chemistry blood sodium  141  meq l; chemistry blood urea nitrogen  24  mg dl; chemistry blood calcium, total  8.5  mg dl; chemistry blood bilirubin, total  0.2  mg dl; chemistry blood glucose  205  mg dl; chemistry blood lactate dehydrogenase (ld)  218  iu l; chemistry blood albumin  3.7  g dl; hematology blood bands  0  %$pantoprazole  40  mg ; oxycodone-acetaminophen  1  tab ; docusate sodium  100  mg ; heparin  5000  unit ; acetaminophen  325-650  mg ; promethazine  12.5  mg ; dexamethasone  40  mg ; sodium chloride 0.9%  flush  3  ml ; oxycodone (immediate release)   5  mg ; senna  1  tab ; 1 2 ns  1000  ml ; 
 
white f 46 $nan$hematology blood hematocrit  22.1  %; hematology blood hemoglobin  7.5  g dl; hematology blood platelet count  298  k ul; chemistry blood anion gap  13  meq l; chemistry blood bicarbonate  21  meq l; chemistry blood chloride  112  meq l; chemistry blood creatinine  1.9  mg dl; chemistry blood creatinine  1.7  mg dl; chemistry blood potassium  3.8  meq l; chemistry blood sodium  142  meq l; chemistry blood urea nitrogen  26  mg dl; chemistry blood urea nitrogen  28  mg dl; chemistry blood calcium, total  8.5  mg dl; chemistry blood bilirubin, total  0.2  mg dl; chemistry blood bilirubin, total  0.2  mg dl; chemistry blood glucose  66  mg dl; chemistry blood lactate dehydrogenase (ld)  253  iu l; chemistry blood lactate dehydrogenase (ld)  188  iu l; hematology blood bands  2  %$pantoprazole  40  mg ; oxycodone-acetaminophen  1  tab ; docusate sodium  100  mg ; promethazine  12.5  mg ; sodium chloride 0.9%  flush  3  ml ; oxycodone (immediate release)   5  mg ; senna  1  tab ; 1 2 ns  1000  ml ; nifedipine  10  mg ; syringe (chemo)  2.4  ml ; bortezomib  2.4  mg ; prochlorperazine  10  mg ; prochlorperazine  5-10  mg ; ondansetron  8  mg ; 
 
white f 46 $nan$hematology blood hematocrit  21.8  %; hematology blood hemoglobin  7.5  g dl; hematology blood platelet count  281  k ul; chemistry blood anion gap  14  meq l; chemistry blood bicarbonate  21  meq l; chemistry blood chloride  109  meq l; chemistry blood creatinine  1.6  mg dl; chemistry blood potassium  4.0  meq l; chemistry blood sodium  140  meq l; chemistry blood urea nitrogen  26  mg dl; chemistry blood calcium, total  8.6  mg dl; chemistry blood bilirubin, total  0.2  mg dl; chemistry blood glucose  90  mg dl; chemistry blood lactate dehydrogenase (ld)  174  iu l$pantoprazole  40  mg ; oxycodone-acetaminophen  1  tab ; docusate sodium  100  mg ; sodium chloride 0.9%  flush  3  ml ; oxycodone (immediate release)   5  mg ; senna  1  tab ; 1 2 ns  1000  ml ; syringe (chemo)  2.4  ml ; bortezomib  2.4  mg ; prochlorperazine  10  mg ; prochlorperazine  5-10  mg ; ondansetron  8  mg ; 
 
white f 46 $nan$hematology blood hematocrit  26.5  %; hematology blood hemoglobin  9.0  g dl; hematology blood platelet count  287  k ul; chemistry blood anion gap  11  meq l; chemistry blood bicarbonate  23  meq l; chemistry blood chloride  109  meq l; chemistry blood creatinine  1.8  mg dl; chemistry blood potassium  4.1  meq l; chemistry blood sodium  139  meq l; chemistry blood urea nitrogen  31  mg dl; chemistry blood calcium, total  9.0  mg dl; chemistry blood bilirubin, total  0.2  mg dl; chemistry blood glucose  85  mg dl; chemistry blood lactate dehydrogenase (ld)  184  iu l$pantoprazole  40  mg ; oxycodone-acetaminophen  1  tab ; docusate sodium  100  mg ; sodium chloride 0.9%  flush  3  ml ; oxycodone (immediate release)   5  mg ; senna  1  tab ; 1 2 ns  1000  ml ; prochlorperazine  5-10  mg ; ondansetron  8  mg ; senna  2  tab ; magnesium citrate  300  ml ; 
 
white f 46 $nan$hematology blood hematocrit  26.5  %; hematology blood hemoglobin  9.0  g dl; hematology blood platelet count  326  k ul; chemistry blood anion gap  16  meq l; chemistry blood bicarbonate  21  meq l; chemistry blood chloride  105  meq l; chemistry blood creatinine  1.9  mg dl; chemistry blood potassium  3.3  meq l; chemistry blood sodium  139  meq l; chemistry blood urea nitrogen  32  mg dl; chemistry blood calcium, total  8.6  mg dl; chemistry blood bilirubin, total  0.3  mg dl; chemistry blood glucose  123  mg dl; chemistry blood lactate dehydrogenase (ld)  217  iu l$pantoprazole  40  mg ; oxycodone-acetaminophen  1  tab ; docusate sodium  100  mg ; sodium chloride 0.9%  flush  3  ml ; oxycodone (immediate release)   5  mg ; senna  1  tab ; 1 2 ns  1000  ml ; prochlorperazine  5-10  mg ; ondansetron  8  mg ; magnesium citrate  300  ml ; potassium chloride replacement (oncology)  40  meq ; potassium chloride replacement (oncology)  60  meq ; 
 
white f 46 $nan$hematology blood hematocrit  29.7  %; hematology blood hemoglobin  10.0  g dl; hematology blood platelet count  348  k ul; chemistry blood anion gap  18  meq l; chemistry blood bicarbonate  22  meq l; chemistry blood chloride  103  meq l; chemistry blood creatinine  2.1  mg dl; chemistry blood potassium  4.5  meq l; chemistry blood sodium  138  meq l; chemistry blood urea nitrogen  30  mg dl; hematology urine wbc  5  # hpf; chemistry blood calcium, total  9.5  mg dl; chemistry blood bilirubin, total  0.4  mg dl; chemistry blood glucose  102  mg dl; chemistry blood lactate dehydrogenase (ld)  250  iu l; hematology blood bands  3  %$pantoprazole  40  mg ; oxycodone-acetaminophen  1  tab ; docusate sodium  100  mg ; sodium chloride 0.9%  flush  3  ml ; oxycodone (immediate release)   5  mg ; senna  1  tab ; 1 2 ns  1000  ml ; prochlorperazine  5-10  mg ; ondansetron  8  mg ; potassium chloride replacement (oncology)  40  meq ; potassium chloride replacement (oncology)  60  meq ; 
 
white f 46 $nan$hematology blood hematocrit  23.1  %; hematology blood hematocrit  23.5  %; hematology blood hemoglobin  7.7  g dl; hematology blood hemoglobin  8.2  g dl; hematology blood platelet count  151  k ul; hematology blood platelet count  182  k ul; chemistry blood anion gap  13  meq l; chemistry blood bicarbonate  24  meq l; chemistry blood chloride  107  meq l; chemistry blood creatinine  1.8  mg dl; chemistry blood potassium  4.7  meq l; chemistry blood sodium  139  meq l; chemistry blood urea nitrogen  27  mg dl; chemistry blood calcium, total  9.0  mg dl; chemistry blood bilirubin, total  0.2  mg dl; chemistry blood glucose  105  mg dl; chemistry blood lactate dehydrogenase (ld)  236  iu l; hematology blood bands  6  %$pantoprazole  40  mg ; oxycodone-acetaminophen  1  tab ; docusate sodium  100  mg ; sodium chloride 0.9%  flush  3  ml ; oxycodone (immediate release)   5  mg ; senna  1  tab ; prochlorperazine  5-10  mg ; ondansetron  8  mg ; potassium chloride replacement (oncology)  40  meq ; potassium chloride replacement (oncology)  60  meq ; meperidine  25  mg ; 
 
white f 46 $nan$nan$pantoprazole  40  mg ; oxycodone-acetaminophen  1  tab ; docusate sodium  100  mg ; sodium chloride 0.9%  flush  3  ml ; oxycodone (immediate release)   5  mg ; senna  1  tab ; prochlorperazine  5-10  mg ; ondansetron  8  mg ; potassium chloride replacement (oncology)  40  meq ; potassium chloride replacement (oncology)  60  meq ; meperidine  25  mg ; 
 
asian m 82 $temp  100.4  heartrate  46.0  resprate  15.0  o2sat  99.0  sbp  136.0  dbp  78.0  rhythm    pain  0  ; temp  98.6  heartrate  105.0  resprate  22.0  o2sat  99.0  sbp  123.0  dbp  64.0  rhythm    pain  3  ; temp  98.8  heartrate  97.0  resprate  17.0  o2sat  97.0  sbp  120.0  dbp  66.0  rhythm    pain  3  ; temp  98.0  heartrate  76.0  resprate  19.0  o2sat  100.0  sbp  95.0  dbp  50.0  rhythm    pain  0  ; temp  98.0  heartrate  73.0  resprate  18.0  o2sat  97.0  sbp  89.0  dbp  48.0  rhythm    pain  0  ; temp    heartrate  71.0  resprate  15.0  o2sat  95.0  sbp  99.0  dbp  54.0  rhythm    pain  0  ; temp  98.4  heartrate  78.0  resprate  12.0  o2sat  100.0  sbp  105.0  dbp  52.0  rhythm    pain  0  $hematology blood hematocrit  42.8  %; hematology blood hemoglobin  13.7  g dl; hematology blood platelet count  137  k ul; chemistry blood anion gap  17  meq l; chemistry blood bicarbonate  23  meq l; chemistry blood chloride  101  meq l; chemistry blood creatinine  1.1  mg dl; chemistry blood potassium  3.9  meq l; chemistry blood sodium  137  meq l; chemistry blood urea nitrogen  18  mg dl; hematology blood inr(pt)  2.1  ; chemistry blood bilirubin, total  0.6  mg dl; chemistry blood glucose  89  mg dl; chemistry blood albumin  3.8  g dl; blood gas blood lactate  1.5  mmol l$nan
home accidents concussion with loss of consciousness of unspecified duration syncope and collapse unspecified essential hypertension unspecified fall other specified metabolic disorders atrial fibrillation open wound of forehead, without mention of complication long-term (current) use of anticoagulants 
asian m 82 $nan$hematology blood hematocrit  42.5  %; hematology blood hemoglobin  13.3  g dl; hematology blood platelet count  113  k ul; chemistry blood anion gap  14  meq l; chemistry blood bicarbonate  23  meq l; chemistry blood chloride  103  meq l; chemistry blood creatinine  1.1  mg dl; chemistry blood potassium  3.8  meq l; chemistry blood sodium  136  meq l; chemistry blood urea nitrogen  16  mg dl; hematology blood inr(pt)  1.9  ; hematology urine wbc  0  # hpf; chemistry blood calcium, total  8.1  mg dl; chemistry blood glucose  90  mg dl$influenza vaccine quadrivalent  0.5  ml ; sodium chloride 0.9%  flush  3  ml ; senna  8.6  mg ; enalapril maleate  20  mg ; docusate sodium  100  mg ; digoxin  0.125  mg ; warfarin  2.5  mg ; 
home accidents concussion with loss of consciousness of unspecified duration syncope and collapse unspecified essential hypertension unspecified fall other specified metabolic disorders atrial fibrillation open wound of forehead, without mention of complication long-term (current) use of anticoagulants 
white m 76 $nan$hematology blood hematocrit  43.3  %; hematology blood hemoglobin  14.8  g dl; hematology blood platelet count  270  k ul; chemistry blood anion gap  14  meq l; chemistry blood bicarbonate  30  meq l; chemistry blood chloride  102  meq l; chemistry blood creatinine  1.5  mg dl; chemistry blood potassium  4.2  meq l; chemistry blood sodium  142  meq l; chemistry blood urea nitrogen  30  mg dl; chemistry urine creatinine, urine  60  mg dl; chemistry urine sodium, urine  30  meq l; chemistry blood calcium, total  8.8  mg dl; chemistry blood glucose  73  mg dl; chemistry blood lactate dehydrogenase (ld)  224  iu l$sodium chloride 0.9%  flush  3  ml ; oxycodone (immediate release)   5-10  mg ; oxycodone (immediate release)   15  mg ; aspirin  162  mg ; atenolol  50  mg ; heparin  5000  unit ; simvastatin  5  mg ; pneumococcal vac polyvalent  0.5  ml ; 
 
white m 76 $nan$nan$sodium chloride 0.9%  flush  3  ml ; oxycodone (immediate release)   5-10  mg ; oxycodone (immediate release)   15  mg ; aspirin  162  mg ; atenolol  50  mg ; heparin  5000  unit ; simvastatin  5  mg ; pneumococcal vac polyvalent  0.5  ml ; docusate sodium  100  mg ; donepezil  5  mg ; 
 
white f 82 $nan$nan$aspirin  325  mg ; 
other specified cardiac dysrhythmias other and unspecified hyperlipidemia percutaneous transluminal coronary angioplasty status coronary atherosclerosis of native coronary artery pain in joint, lower leg unspecified contusion of eye fall from other slipping, tripping, or stumbling closed fracture of two ribs
white f 82 $nan$nan$aspirin  325  mg ; oxycodone-acetaminophen  1-2  tab ; acetaminophen  650  mg ; nitroglycerin sl  0.3  mg ; simethicone  40-80  mg ; sodium chloride 0.9%  flush  3  ml ; diphenhydramine  25  mg ; ibuprofen  400  mg ; clindamycin  300  mg ; 
other specified cardiac dysrhythmias other and unspecified hyperlipidemia percutaneous transluminal coronary angioplasty status coronary atherosclerosis of native coronary artery pain in joint, lower leg unspecified contusion of eye fall from other slipping, tripping, or stumbling closed fracture of two ribs
white f 82 $nan$nan$aspirin  325  mg ; oxycodone-acetaminophen  1-2  tab ; acetaminophen  650  mg ; nitroglycerin sl  0.3  mg ; simethicone  40-80  mg ; sodium chloride 0.9%  flush  3  ml ; diphenhydramine  25  mg ; ibuprofen  400  mg ; clindamycin  300  mg ; 
other specified cardiac dysrhythmias other and unspecified hyperlipidemia percutaneous transluminal coronary angioplasty status coronary atherosclerosis of native coronary artery pain in joint, lower leg unspecified contusion of eye fall from other slipping, tripping, or stumbling closed fracture of two ribs
white f 50 $nan$hematology blood hematocrit  35.9  %; hematology blood hemoglobin  12.5  g dl; hematology blood platelet count  188  k ul; chemistry blood anion gap  19  meq l; chemistry blood bicarbonate  19  meq l; chemistry blood chloride  97  meq l; chemistry blood creatinine  0.8  mg dl; chemistry blood potassium  3.0  meq l; chemistry blood sodium  132  meq l; chemistry blood urea nitrogen  15  mg dl; chemistry blood bilirubin, total  1.1  mg dl; chemistry blood glucose  110  mg dl; hematology blood bands  1  %; blood gas blood lactate  1.4  mmol l$nan
excessive or frequent menstruation unspecified symptom associated with female genital organs
white f 50 $nan$hematology blood hematocrit  35.4  %; hematology blood hemoglobin  11.9  g dl; hematology blood platelet count  181  k ul; chemistry blood anion gap  15  meq l; chemistry blood bicarbonate  20  meq l; chemistry blood chloride  105  meq l; chemistry blood creatinine  0.8  mg dl; chemistry blood potassium  3.4  meq l; chemistry blood sodium  137  meq l; chemistry blood urea nitrogen  13  mg dl; chemistry blood calcium, total  9.7  mg dl; chemistry blood glucose  131  mg dl; blood gas blood free calcium  1.21  mmol l; blood gas blood lactate  2.2  mmol l; blood gas blood lactate  1.2  mmol l; blood gas blood glucose  104  mg dl; blood gas blood potassium, whole blood  3.9  meq l$sodium chloride 0.9%  flush  3  ml ; lr  1000  ml ; heparin  5000  unit ; oxycodone (immediate release)   5  mg ; ondansetron  4  mg ; hydromorphone (dilaudid)  0.5-1  mg ; 0.9% sodium chloride  500  ml ; potassium phosphate  30  mmol ; bag  100  ml ; magnesium sulfate  4  gm ; 0.9% sodium chloride (mini bag plus)  100  ml ; ampicillin-sulbactam  3  g ; acetaminophen  650  mg ; 
excessive or frequent menstruation unspecified symptom associated with female genital organs
white f 50 $nan$hematology blood hematocrit  30.1  %; hematology blood hemoglobin  10.6  g dl; hematology blood platelet count  173  k ul; chemistry blood anion gap  13  meq l; chemistry blood bicarbonate  25  meq l; chemistry blood chloride  105  meq l; chemistry blood creatinine  0.6  mg dl; chemistry blood potassium  3.7  meq l; chemistry blood sodium  139  meq l; chemistry blood urea nitrogen  11  mg dl; chemistry blood calcium, total  8.9  mg dl; chemistry blood bilirubin, total  0.7  mg dl; chemistry blood glucose  79  mg dl$sodium chloride 0.9%  flush  3  ml ; heparin  5000  unit ; hydromorphone (dilaudid)  0.5-1  mg ; 0.9% sodium chloride  500  ml ; potassium phosphate  30  mmol ; bag  100  ml ; magnesium sulfate  4  gm ; 0.9% sodium chloride (mini bag plus)  100  ml ; ampicillin-sulbactam  3  g ; acetaminophen  650  mg ; citalopram  60  mg ; ciprofloxacin hcl  500  mg ; metronidazole (flagyl)  500  mg ; 
excessive or frequent menstruation unspecified symptom associated with female genital organs
white f 50 $nan$nan$sodium chloride 0.9%  flush  3  ml ; heparin  5000  unit ; hydromorphone (dilaudid)  0.5-1  mg ; acetaminophen  650  mg ; citalopram  60  mg ; ciprofloxacin hcl  500  mg ; metronidazole (flagyl)  500  mg ; hydromorphone (dilaudid)  2-4  mg ; 
excessive or frequent menstruation unspecified symptom associated with female genital organs
white f 50 $nan$nan$sodium chloride 0.9%  flush  3  ml ; heparin  5000  unit ; acetaminophen  650  mg ; citalopram  60  mg ; ciprofloxacin hcl  500  mg ; metronidazole (flagyl)  500  mg ; hydromorphone (dilaudid)  2-4  mg ; citalopram  40  mg ; gabapentin  300  mg ; 
excessive or frequent menstruation unspecified symptom associated with female genital organs
white f 50 $nan$nan$sodium chloride 0.9%  flush  3  ml ; heparin  5000  unit ; acetaminophen  650  mg ; hydromorphone (dilaudid)  2-4  mg ; citalopram  40  mg ; ipratropium bromide neb  1  neb ; 
excessive or frequent menstruation unspecified symptom associated with female genital organs
white f 50 $nan$hematology blood hematocrit  29.5  %; hematology blood hemoglobin  10.3  g dl; hematology blood platelet count  325  k ul$sodium chloride 0.9%  flush  3  ml ; heparin  5000  unit ; acetaminophen  650  mg ; hydromorphone (dilaudid)  2-4  mg ; citalopram  40  mg ; ipratropium bromide neb  1  neb ; senna  1  tab ; docusate sodium  100  mg ; 
excessive or frequent menstruation unspecified symptom associated with female genital organs
white f 50 $nan$nan$sodium chloride 0.9%  flush  3  ml ; heparin  5000  unit ; acetaminophen  650  mg ; hydromorphone (dilaudid)  2-4  mg ; citalopram  40  mg ; ipratropium bromide neb  1  neb ; senna  1  tab ; docusate sodium  100  mg ; 
excessive or frequent menstruation unspecified symptom associated with female genital organs
black african american f 50 $temp  96.8  heartrate  113.0  resprate  18.0  o2sat  100.0  sbp    dbp    rhythm    pain  2  ; temp  98.5  heartrate  113.0  resprate  16.0  o2sat  98.0  sbp  103.0  dbp  76.0  rhythm    pain    ; temp  97.7  heartrate  106.0  resprate  16.0  o2sat  98.0  sbp  103.0  dbp  75.0  rhythm    pain    ; temp  98.6  heartrate  96.0  resprate  18.0  o2sat  98.0  sbp  101.0  dbp  68.0  rhythm    pain  0  ; temp  98.1  heartrate  95.0  resprate  16.0  o2sat  98.0  sbp  100.0  dbp  65.0  rhythm    pain    ; temp  97.6  heartrate  96.0  resprate  17.0  o2sat  100.0  sbp  104.0  dbp  69.0  rhythm    pain    $hematology blood hematocrit  39.0  %; hematology blood hemoglobin  14.0  g dl; hematology blood platelet count  405  k ul; chemistry blood anion gap  23  meq l; chemistry blood bicarbonate  20  meq l; chemistry blood chloride  103  meq l; chemistry blood creatinine  2.1  mg dl; chemistry blood potassium  3.5  meq l; chemistry blood sodium  146  meq l; chemistry blood urea nitrogen  27  mg dl; chemistry blood bilirubin, indirect  1.4  mg dl; chemistry blood bilirubin, total  2.0  mg dl; chemistry blood glucose  138  mg dl; chemistry blood albumin  5.6  g dl; chemistry blood bilirubin, direct  0.6  mg dl$nan
 
black african american f 50 $temp  98.2  heartrate  76.0  resprate  16.0  o2sat  100.0  sbp  96.0  dbp  62.0  rhythm    pain    $hematology blood hematocrit  28.6  %; hematology blood hemoglobin  10.6  g dl; hematology blood platelet count  263  k ul; chemistry blood anion gap  14  meq l; chemistry blood bicarbonate  26  meq l; chemistry blood chloride  101  meq l; chemistry blood creatinine  1.1  mg dl; chemistry blood potassium  2.9  meq l; chemistry blood sodium  141  meq l; chemistry blood urea nitrogen  22  mg dl; hematology blood inr(pt)  1.2  ; chemistry blood calcium, total  9.4  mg dl; chemistry blood bilirubin, total  2.5  mg dl; chemistry blood glucose  101  mg dl; chemistry blood lactate dehydrogenase (ld)  146  iu l; chemistry blood albumin  4.0  g dl$influenza vaccine quadrivalent  0.5  ml ; heparin  5000  unit ; sodium chloride 0.9%  flush  3-10  ml ; albuterol 0.083% neb soln  1  neb ; senna  8.6  mg ; docusate sodium  100  mg ; ondansetron  4  mg ; trazodone  25  mg ; acetaminophen  325-650  mg ; polyethylene glycol  17  g ; d5lr  1000  ml ; 0.9% sodium chloride  500  ml ; potassium chloride  40  meq ; bag  1  bag ; magnesium sulfate  4  gm ; 
 
black african american f 50 $nan$hematology blood hematocrit  25.8  %; hematology blood hemoglobin  9.5  g dl; hematology blood platelet count  222  k ul; chemistry blood anion gap  14  meq l; chemistry blood bicarbonate  24  meq l; chemistry blood chloride  104  meq l; chemistry blood creatinine  0.9  mg dl; chemistry blood potassium  3.1  meq l; chemistry blood sodium  142  meq l; chemistry blood urea nitrogen  15  mg dl; chemistry blood calcium, total  8.6  mg dl; chemistry blood glucose  111  mg dl$influenza vaccine quadrivalent  0.5  ml ; heparin  5000  unit ; sodium chloride 0.9%  flush  3-10  ml ; albuterol 0.083% neb soln  1  neb ; senna  8.6  mg ; docusate sodium  100  mg ; ondansetron  4  mg ; trazodone  25  mg ; acetaminophen  325-650  mg ; polyethylene glycol  17  g ; d5lr  1000  ml ; 0.9% sodium chloride  500  ml ; potassium chloride  40  meq ; bag  1  bag ; magnesium sulfate  4  gm ; 
 
black african american f 50 $nan$hematology blood hematocrit  26.2  %; hematology blood hemoglobin  9.8  g dl; hematology blood platelet count  208  k ul; chemistry blood anion gap  13  meq l; chemistry blood bicarbonate  24  meq l; chemistry blood chloride  103  meq l; chemistry blood creatinine  1.0  mg dl; chemistry blood potassium  3.0  meq l; chemistry blood sodium  140  meq l; chemistry blood urea nitrogen  10  mg dl; chemistry blood calcium, total  8.8  mg dl; chemistry blood bilirubin, indirect  1.6  mg dl; chemistry blood bilirubin, total  2.4  mg dl; chemistry blood glucose  105  mg dl; chemistry blood lactate dehydrogenase (ld)  172  iu l; chemistry blood albumin  3.5  g dl; chemistry blood bilirubin, direct  0.8  mg dl$influenza vaccine quadrivalent  0.5  ml ; heparin  5000  unit ; sodium chloride 0.9%  flush  3-10  ml ; albuterol 0.083% neb soln  1  neb ; senna  8.6  mg ; docusate sodium  100  mg ; ondansetron  4  mg ; trazodone  25  mg ; acetaminophen  325-650  mg ; polyethylene glycol  17  g ; potassium chl 40 meq   1000 ml d5 1 2 ns  1000  ml ; omeprazole  40  mg ; 
 
black african american f 50 $nan$chemistry blood anion gap  12  meq l; chemistry blood bicarbonate  26  meq l; chemistry blood chloride  103  meq l; chemistry blood creatinine  0.8  mg dl; chemistry blood potassium  3.4  meq l; chemistry blood sodium  141  meq l; chemistry blood urea nitrogen  7  mg dl; chemistry blood calcium, total  8.2  mg dl; chemistry blood glucose  98  mg dl$influenza vaccine quadrivalent  0.5  ml ; heparin  5000  unit ; sodium chloride 0.9%  flush  3-10  ml ; albuterol 0.083% neb soln  1  neb ; senna  8.6  mg ; docusate sodium  100  mg ; ondansetron  4  mg ; trazodone  25  mg ; acetaminophen  325-650  mg ; polyethylene glycol  17  g ; potassium chl 40 meq   1000 ml d5 1 2 ns  1000  ml ; omeprazole  40  mg ; ondansetron odt  4  mg ; phosphorus  500  mg ; prochlorperazine  10  mg ; calcium carbonate  500  mg ; 
 
black african american f 50 $nan$chemistry blood anion gap  13  meq l; chemistry blood bicarbonate  26  meq l; chemistry blood chloride  103  meq l; chemistry blood creatinine  0.8  mg dl; chemistry blood potassium  3.4  meq l; chemistry blood sodium  142  meq l; chemistry blood urea nitrogen  7  mg dl; chemistry blood calcium, total  8.6  mg dl; chemistry blood bilirubin, total  1.6  mg dl; chemistry blood glucose  89  mg dl; chemistry blood lactate dehydrogenase (ld)  170  iu l$influenza vaccine quadrivalent  0.5  ml ; heparin  5000  unit ; sodium chloride 0.9%  flush  3-10  ml ; albuterol 0.083% neb soln  1  neb ; senna  8.6  mg ; docusate sodium  100  mg ; trazodone  25  mg ; acetaminophen  325-650  mg ; polyethylene glycol  17  g ; omeprazole  40  mg ; ondansetron odt  4  mg ; phosphorus  500  mg ; prochlorperazine  10  mg ; calcium carbonate  500  mg ; potassium chloride  60  meq ; 
 
black african american f 50 $nan$hematology blood hematocrit  27.3  %; hematology blood hemoglobin  10.1  g dl; hematology blood platelet count  204  k ul; chemistry blood anion gap  17  meq l; chemistry blood bicarbonate  24  meq l; chemistry blood chloride  97  meq l; chemistry blood creatinine  0.8  mg dl; chemistry blood potassium  3.1  meq l; chemistry blood sodium  138  meq l; chemistry blood urea nitrogen  6  mg dl; chemistry blood calcium, total  8.4  mg dl; chemistry blood bilirubin, total  1.8  mg dl; chemistry blood glucose  85  mg dl; chemistry blood lactate dehydrogenase (ld)  194  iu l; chemistry blood albumin  3.4  g dl$influenza vaccine quadrivalent  0.5  ml ; heparin  5000  unit ; sodium chloride 0.9%  flush  3-10  ml ; albuterol 0.083% neb soln  1  neb ; senna  8.6  mg ; docusate sodium  100  mg ; trazodone  25  mg ; acetaminophen  325-650  mg ; polyethylene glycol  17  g ; omeprazole  40  mg ; phosphorus  500  mg ; prochlorperazine  10  mg ; calcium carbonate  500  mg ; potassium chloride  60  meq ; metoclopramide  5  mg ; 
 
black african american f 50 $nan$nan$heparin  5000  unit ; sodium chloride 0.9%  flush  3-10  ml ; albuterol 0.083% neb soln  1  neb ; senna  8.6  mg ; docusate sodium  100  mg ; trazodone  25  mg ; acetaminophen  325-650  mg ; polyethylene glycol  17  g ; omeprazole  40  mg ; prochlorperazine  10  mg ; calcium carbonate  500  mg ; magnesium oxide  400  mg ; potassium chloride  20  meq ; metoclopramide  10  mg ; 
 
white m 63 $nan$hematology blood hematocrit  43.5  %; hematology blood hemoglobin  14.0  g dl; hematology blood platelet count  303  k ul; chemistry blood anion gap  11  meq l; chemistry blood bicarbonate  26  meq l; chemistry blood chloride  104  meq l; chemistry blood creatinine  0.7  mg dl; chemistry blood potassium  5.2  meq l; chemistry blood sodium  141  meq l; chemistry blood urea nitrogen  19  mg dl; hematology blood inr(pt)  0.9  ; chemistry blood calcium, total  9.7  mg dl; chemistry blood glucose  117  mg dl$dextrose 5%  1000  ml ; betamethasone valerate 0.1% cream  1  appl ; sodium chloride 0.9%  1000  ml ; ondansetron  8  mg ; phosphorus  500  mg ; albuterol 0.083% neb soln  1  neb ; acetaminophen  975  mg ; ranitidine  150  mg ; lorazepam  0.5-1  mg ; meperidine  25-50  mg ; diphenhydramine  25-50  mg ; prochlorperazine  10  mg ; cephalexin  500  mg ; d5 1 2ns  1000  ml ; sodium bicarbonate  50  meq ; diphenoxylate-atropine  1-2  tab ; 5% dextrose  250  ml ; dopamine  400  mg ; naproxen  375  mg ; hydrocerin  1  appl ; sarna lotion  1  appl ; maalox diphenhydramine lidocaine  5  ml ; potassium chloride  40  meq ; potassium chloride  60  meq ; potassium chloride  80  meq ; sterile water  50  ml ; potassium chloride  20  meq ; sterile water  100  ml ; sterile water  150  ml ; bag  1  bag ; magnesium sulfate  4  gm ; sodium bicarbonate  100  meq ; 0.9% sodium chloride  250  ml ; phenylephrine  50  mg ; morphine sulfate ir  15  mg ; 5% dextrose  50  ml ; aldesleukin  53.7  million units ; 
malignant melanoma of skin, unspecified rash and other nonspecific skin eruption secondary malignant neoplasm of unspecified site procedure and treatment not carried out because of other contraindication encounter for antineoplastic chemotherapy prediabetes adverse effect of antineoplastic and immunosuppressive drugs, initial encounter hypocalcemia nausea with vomiting, unspecified other fall from one level to another in water transport injuring occupant of other watercraft -- crew patient room in hospital as the place of occurrence of the external cause oral mucositis (ulcerative) due to antineoplastic therapy acute kidney failure, unspecified hypomagnesemia other and unspecified fall in water transport injuring occupant of small boat, powered pruritus, unspecified eosinophilia toxic encephalopathy nicotine dependence, cigarettes, uncomplicated secondary and unspecified malignant neoplasm of lymph nodes of multiple regions essential (primary) hypertension antineoplastic chemotherapy induced pancytopenia wheezing family history of malignant neoplasm of other organs or systems encounter for examination for normal comparison and control in clinical research program personal history of malignant melanoma of skin diarrhea, unspecified encounter for antineoplastic immunotherapy drug induced fever patient room in hospital as the place of occurrence of the external cause essential (primary) hypertension hyperlipidemia, unspecified hypocalcemia sebaceous cyst adverse effect of antineoplastic and immunosuppressive drugs, initial encounter other and unspecified fall in water transport injuring occupant of small boat, powered nicotine dependence, cigarettes, uncomplicated other fall from one level to another in water transport injuring occupant of other watercraft -- crew encounter for antineoplastic immunotherapy anemia due to antineoplastic chemotherapy drug induced fever secondary and unspecified malignant neoplasm of lymph nodes of multiple regions malignant melanoma of skin, unspecified anuria and oliguria fall on stairs or ladders in water transport injuring unspecified person nonspecific elevation of levels of transaminase and lactic acid dehydrogenase [ldh] other disorders of phosphorus metabolism lymphocytopenia
white m 63 $nan$nan$dextrose 5%  1000  ml ; betamethasone valerate 0.1% cream  1  appl ; sodium chloride 0.9%  1000  ml ; ondansetron  8  mg ; phosphorus  500  mg ; albuterol 0.083% neb soln  1  neb ; acetaminophen  975  mg ; ranitidine  150  mg ; lorazepam  0.5-1  mg ; meperidine  25-50  mg ; diphenhydramine  25-50  mg ; prochlorperazine  10  mg ; cephalexin  500  mg ; d5 1 2ns  1000  ml ; sodium bicarbonate  50  meq ; diphenoxylate-atropine  1-2  tab ; 5% dextrose  250  ml ; dopamine  400  mg ; naproxen  375  mg ; hydrocerin  1  appl ; sarna lotion  1  appl ; maalox diphenhydramine lidocaine  5  ml ; potassium chloride  40  meq ; potassium chloride  60  meq ; potassium chloride  80  meq ; sterile water  50  ml ; potassium chloride  20  meq ; sterile water  100  ml ; sterile water  150  ml ; bag  1  bag ; magnesium sulfate  4  gm ; sodium bicarbonate  100  meq ; 0.9% sodium chloride  250  ml ; phenylephrine  50  mg ; morphine sulfate ir  15  mg ; 5% dextrose  50  ml ; aldesleukin  53.7  million units ; heparin flush (10 units ml)  1  ml ; sodium chloride 0.9%  flush  10  ml ; meperidine  25-100  mg ; 
malignant melanoma of skin, unspecified rash and other nonspecific skin eruption secondary malignant neoplasm of unspecified site procedure and treatment not carried out because of other contraindication encounter for antineoplastic chemotherapy prediabetes adverse effect of antineoplastic and immunosuppressive drugs, initial encounter hypocalcemia nausea with vomiting, unspecified other fall from one level to another in water transport injuring occupant of other watercraft -- crew patient room in hospital as the place of occurrence of the external cause oral mucositis (ulcerative) due to antineoplastic therapy acute kidney failure, unspecified hypomagnesemia other and unspecified fall in water transport injuring occupant of small boat, powered pruritus, unspecified eosinophilia toxic encephalopathy nicotine dependence, cigarettes, uncomplicated secondary and unspecified malignant neoplasm of lymph nodes of multiple regions essential (primary) hypertension antineoplastic chemotherapy induced pancytopenia wheezing family history of malignant neoplasm of other organs or systems encounter for examination for normal comparison and control in clinical research program personal history of malignant melanoma of skin diarrhea, unspecified encounter for antineoplastic immunotherapy drug induced fever patient room in hospital as the place of occurrence of the external cause essential (primary) hypertension hyperlipidemia, unspecified hypocalcemia sebaceous cyst adverse effect of antineoplastic and immunosuppressive drugs, initial encounter other and unspecified fall in water transport injuring occupant of small boat, powered nicotine dependence, cigarettes, uncomplicated other fall from one level to another in water transport injuring occupant of other watercraft -- crew encounter for antineoplastic immunotherapy anemia due to antineoplastic chemotherapy drug induced fever secondary and unspecified malignant neoplasm of lymph nodes of multiple regions malignant melanoma of skin, unspecified anuria and oliguria fall on stairs or ladders in water transport injuring unspecified person nonspecific elevation of levels of transaminase and lactic acid dehydrogenase [ldh] other disorders of phosphorus metabolism lymphocytopenia
white m 63 $nan$hematology blood hematocrit  40.8  %; hematology blood hemoglobin  13.0  g dl; hematology blood platelet count  143  k ul; chemistry blood anion gap  11  meq l; chemistry blood bicarbonate  21  meq l; chemistry blood chloride  108  meq l; chemistry blood creatinine  0.8  mg dl; chemistry blood potassium  4.3  meq l; chemistry blood sodium  140  meq l; chemistry blood urea nitrogen  21  mg dl; hematology blood inr(pt)  1.3  ; chemistry blood calcium, total  8.1  mg dl; chemistry blood bilirubin, total  0.8  mg dl; chemistry blood glucose  98  mg dl; chemistry blood albumin  3.0  g dl$dextrose 5%  1000  ml ; betamethasone valerate 0.1% cream  1  appl ; sodium chloride 0.9%  1000  ml ; ondansetron  8  mg ; phosphorus  500  mg ; albuterol 0.083% neb soln  1  neb ; acetaminophen  975  mg ; ranitidine  150  mg ; lorazepam  0.5-1  mg ; diphenhydramine  25-50  mg ; prochlorperazine  10  mg ; cephalexin  500  mg ; d5 1 2ns  1000  ml ; sodium bicarbonate  50  meq ; diphenoxylate-atropine  1-2  tab ; 5% dextrose  250  ml ; dopamine  400  mg ; naproxen  375  mg ; hydrocerin  1  appl ; sarna lotion  1  appl ; maalox diphenhydramine lidocaine  5  ml ; potassium chloride  40  meq ; potassium chloride  60  meq ; potassium chloride  80  meq ; sterile water  50  ml ; potassium chloride  20  meq ; sterile water  100  ml ; sterile water  150  ml ; bag  1  bag ; magnesium sulfate  4  gm ; sodium bicarbonate  100  meq ; 0.9% sodium chloride  250  ml ; phenylephrine  50  mg ; morphine sulfate ir  15  mg ; heparin flush (10 units ml)  1  ml ; sodium chloride 0.9%  flush  10  ml ; meperidine  25-100  mg ; diphenhydramine  50  mg ; 
malignant melanoma of skin, unspecified rash and other nonspecific skin eruption secondary malignant neoplasm of unspecified site procedure and treatment not carried out because of other contraindication encounter for antineoplastic chemotherapy prediabetes adverse effect of antineoplastic and immunosuppressive drugs, initial encounter hypocalcemia nausea with vomiting, unspecified other fall from one level to another in water transport injuring occupant of other watercraft -- crew patient room in hospital as the place of occurrence of the external cause oral mucositis (ulcerative) due to antineoplastic therapy acute kidney failure, unspecified hypomagnesemia other and unspecified fall in water transport injuring occupant of small boat, powered pruritus, unspecified eosinophilia toxic encephalopathy nicotine dependence, cigarettes, uncomplicated secondary and unspecified malignant neoplasm of lymph nodes of multiple regions essential (primary) hypertension antineoplastic chemotherapy induced pancytopenia wheezing family history of malignant neoplasm of other organs or systems encounter for examination for normal comparison and control in clinical research program personal history of malignant melanoma of skin diarrhea, unspecified encounter for antineoplastic immunotherapy drug induced fever patient room in hospital as the place of occurrence of the external cause essential (primary) hypertension hyperlipidemia, unspecified hypocalcemia sebaceous cyst adverse effect of antineoplastic and immunosuppressive drugs, initial encounter other and unspecified fall in water transport injuring occupant of small boat, powered nicotine dependence, cigarettes, uncomplicated other fall from one level to another in water transport injuring occupant of other watercraft -- crew encounter for antineoplastic immunotherapy anemia due to antineoplastic chemotherapy drug induced fever secondary and unspecified malignant neoplasm of lymph nodes of multiple regions malignant melanoma of skin, unspecified anuria and oliguria fall on stairs or ladders in water transport injuring unspecified person nonspecific elevation of levels of transaminase and lactic acid dehydrogenase [ldh] other disorders of phosphorus metabolism lymphocytopenia
white m 63 $nan$hematology blood hematocrit  37.2  %; hematology blood hemoglobin  11.9  g dl; hematology blood platelet count  109  k ul; chemistry blood anion gap  10  meq l; chemistry blood bicarbonate  22  meq l; chemistry blood chloride  103  meq l; chemistry blood creatinine  0.8  mg dl; chemistry blood potassium  4.3  meq l; chemistry blood sodium  135  meq l; chemistry blood urea nitrogen  24  mg dl; chemistry blood calcium, total  7.9  mg dl; chemistry blood bilirubin, total  0.9  mg dl; chemistry blood glucose  87  mg dl; chemistry blood albumin  3.0  g dl$dextrose 5%  1000  ml ; betamethasone valerate 0.1% cream  1  appl ; sodium chloride 0.9%  1000  ml ; ondansetron  8  mg ; phosphorus  500  mg ; albuterol 0.083% neb soln  1  neb ; acetaminophen  975  mg ; ranitidine  150  mg ; lorazepam  0.5-1  mg ; prochlorperazine  10  mg ; cephalexin  500  mg ; d5 1 2ns  1000  ml ; sodium bicarbonate  50  meq ; diphenoxylate-atropine  1-2  tab ; 5% dextrose  250  ml ; dopamine  400  mg ; naproxen  375  mg ; hydrocerin  1  appl ; sarna lotion  1  appl ; maalox diphenhydramine lidocaine  5  ml ; potassium chloride  40  meq ; potassium chloride  60  meq ; potassium chloride  80  meq ; sterile water  50  ml ; potassium chloride  20  meq ; sterile water  100  ml ; sterile water  150  ml ; bag  1  bag ; magnesium sulfate  4  gm ; sodium bicarbonate  100  meq ; 0.9% sodium chloride  250  ml ; phenylephrine  50  mg ; morphine sulfate ir  15  mg ; heparin flush (10 units ml)  1  ml ; sodium chloride 0.9%  flush  10  ml ; meperidine  25-100  mg ; diphenhydramine  50  mg ; 
malignant melanoma of skin, unspecified rash and other nonspecific skin eruption secondary malignant neoplasm of unspecified site procedure and treatment not carried out because of other contraindication encounter for antineoplastic chemotherapy prediabetes adverse effect of antineoplastic and immunosuppressive drugs, initial encounter hypocalcemia nausea with vomiting, unspecified other fall from one level to another in water transport injuring occupant of other watercraft -- crew patient room in hospital as the place of occurrence of the external cause oral mucositis (ulcerative) due to antineoplastic therapy acute kidney failure, unspecified hypomagnesemia other and unspecified fall in water transport injuring occupant of small boat, powered pruritus, unspecified eosinophilia toxic encephalopathy nicotine dependence, cigarettes, uncomplicated secondary and unspecified malignant neoplasm of lymph nodes of multiple regions essential (primary) hypertension antineoplastic chemotherapy induced pancytopenia wheezing family history of malignant neoplasm of other organs or systems encounter for examination for normal comparison and control in clinical research program personal history of malignant melanoma of skin diarrhea, unspecified encounter for antineoplastic immunotherapy drug induced fever patient room in hospital as the place of occurrence of the external cause essential (primary) hypertension hyperlipidemia, unspecified hypocalcemia sebaceous cyst adverse effect of antineoplastic and immunosuppressive drugs, initial encounter other and unspecified fall in water transport injuring occupant of small boat, powered nicotine dependence, cigarettes, uncomplicated other fall from one level to another in water transport injuring occupant of other watercraft -- crew encounter for antineoplastic immunotherapy anemia due to antineoplastic chemotherapy drug induced fever secondary and unspecified malignant neoplasm of lymph nodes of multiple regions malignant melanoma of skin, unspecified anuria and oliguria fall on stairs or ladders in water transport injuring unspecified person nonspecific elevation of levels of transaminase and lactic acid dehydrogenase [ldh] other disorders of phosphorus metabolism lymphocytopenia
white m 63 $nan$hematology blood hematocrit  37.1  %; hematology blood hemoglobin  11.8  g dl; hematology blood platelet count  95  k ul; chemistry blood anion gap  13  meq l; chemistry blood bicarbonate  19  meq l; chemistry blood bicarbonate  17  meq l; chemistry blood bicarbonate  21  meq l; chemistry blood chloride  107  meq l; chemistry blood creatinine  1.5  mg dl; chemistry blood potassium  4.3  meq l; chemistry blood sodium  139  meq l; chemistry blood urea nitrogen  32  mg dl; hematology blood inr(pt)  1.2  ; chemistry blood calcium, total  7.9  mg dl; chemistry blood bilirubin, total  1.5  mg dl; chemistry blood glucose  99  mg dl; chemistry blood albumin  2.8  g dl$dextrose 5%  1000  ml ; betamethasone valerate 0.1% cream  1  appl ; sodium chloride 0.9%  1000  ml ; ondansetron  8  mg ; phosphorus  500  mg ; albuterol 0.083% neb soln  1  neb ; acetaminophen  975  mg ; ranitidine  150  mg ; lorazepam  0.5-1  mg ; prochlorperazine  10  mg ; cephalexin  500  mg ; d5 1 2ns  1000  ml ; sodium bicarbonate  50  meq ; diphenoxylate-atropine  1-2  tab ; 5% dextrose  250  ml ; dopamine  400  mg ; naproxen  375  mg ; hydrocerin  1  appl ; sarna lotion  1  appl ; maalox diphenhydramine lidocaine  5  ml ; potassium chloride  40  meq ; potassium chloride  60  meq ; potassium chloride  80  meq ; sterile water  50  ml ; potassium chloride  20  meq ; sterile water  100  ml ; sterile water  150  ml ; bag  1  bag ; magnesium sulfate  4  gm ; sodium bicarbonate  100  meq ; 0.9% sodium chloride  250  ml ; phenylephrine  50  mg ; morphine sulfate ir  15  mg ; heparin flush (10 units ml)  1  ml ; sodium chloride 0.9%  flush  10  ml ; meperidine  25-100  mg ; diphenhydramine  50  mg ; iso-osmotic dextrose  200  ml ; vancomycin  1000  mg ; 5% dextrose  100  ml ; 
malignant melanoma of skin, unspecified rash and other nonspecific skin eruption secondary malignant neoplasm of unspecified site procedure and treatment not carried out because of other contraindication encounter for antineoplastic chemotherapy prediabetes adverse effect of antineoplastic and immunosuppressive drugs, initial encounter hypocalcemia nausea with vomiting, unspecified other fall from one level to another in water transport injuring occupant of other watercraft -- crew patient room in hospital as the place of occurrence of the external cause oral mucositis (ulcerative) due to antineoplastic therapy acute kidney failure, unspecified hypomagnesemia other and unspecified fall in water transport injuring occupant of small boat, powered pruritus, unspecified eosinophilia toxic encephalopathy nicotine dependence, cigarettes, uncomplicated secondary and unspecified malignant neoplasm of lymph nodes of multiple regions essential (primary) hypertension antineoplastic chemotherapy induced pancytopenia wheezing family history of malignant neoplasm of other organs or systems encounter for examination for normal comparison and control in clinical research program personal history of malignant melanoma of skin diarrhea, unspecified encounter for antineoplastic immunotherapy drug induced fever patient room in hospital as the place of occurrence of the external cause essential (primary) hypertension hyperlipidemia, unspecified hypocalcemia sebaceous cyst adverse effect of antineoplastic and immunosuppressive drugs, initial encounter other and unspecified fall in water transport injuring occupant of small boat, powered nicotine dependence, cigarettes, uncomplicated other fall from one level to another in water transport injuring occupant of other watercraft -- crew encounter for antineoplastic immunotherapy anemia due to antineoplastic chemotherapy drug induced fever secondary and unspecified malignant neoplasm of lymph nodes of multiple regions malignant melanoma of skin, unspecified anuria and oliguria fall on stairs or ladders in water transport injuring unspecified person nonspecific elevation of levels of transaminase and lactic acid dehydrogenase [ldh] other disorders of phosphorus metabolism lymphocytopenia
white m 63 $nan$hematology blood hematocrit  35.6  %; hematology blood hemoglobin  11.4  g dl; hematology blood platelet count  101  k ul; chemistry blood anion gap  9  meq l; chemistry blood bicarbonate  24  meq l; chemistry blood chloride  108  meq l; chemistry blood creatinine  1.9  mg dl; chemistry blood potassium  4.0  meq l; chemistry blood sodium  141  meq l; chemistry blood urea nitrogen  41  mg dl; chemistry blood calcium, total  7.6  mg dl; chemistry blood glucose  77  mg dl; chemistry blood albumin  2.7  g dl$dextrose 5%  1000  ml ; betamethasone valerate 0.1% cream  1  appl ; sodium chloride 0.9%  1000  ml ; ondansetron  8  mg ; phosphorus  500  mg ; albuterol 0.083% neb soln  1  neb ; ranitidine  150  mg ; lorazepam  0.5-1  mg ; prochlorperazine  10  mg ; cephalexin  500  mg ; d5 1 2ns  1000  ml ; sodium bicarbonate  50  meq ; diphenoxylate-atropine  1-2  tab ; hydrocerin  1  appl ; sarna lotion  1  appl ; maalox diphenhydramine lidocaine  5  ml ; potassium chloride  40  meq ; potassium chloride  60  meq ; potassium chloride  80  meq ; sterile water  50  ml ; potassium chloride  20  meq ; sterile water  100  ml ; sterile water  150  ml ; bag  1  bag ; magnesium sulfate  4  gm ; 0.9% sodium chloride  250  ml ; phenylephrine  50  mg ; morphine sulfate ir  15  mg ; heparin flush (10 units ml)  1  ml ; sodium chloride 0.9%  flush  10  ml ; meperidine  25-100  mg ; diphenhydramine  50  mg ; 5% dextrose  100  ml ; 
malignant melanoma of skin, unspecified rash and other nonspecific skin eruption secondary malignant neoplasm of unspecified site procedure and treatment not carried out because of other contraindication encounter for antineoplastic chemotherapy prediabetes adverse effect of antineoplastic and immunosuppressive drugs, initial encounter hypocalcemia nausea with vomiting, unspecified other fall from one level to another in water transport injuring occupant of other watercraft -- crew patient room in hospital as the place of occurrence of the external cause oral mucositis (ulcerative) due to antineoplastic therapy acute kidney failure, unspecified hypomagnesemia other and unspecified fall in water transport injuring occupant of small boat, powered pruritus, unspecified eosinophilia toxic encephalopathy nicotine dependence, cigarettes, uncomplicated secondary and unspecified malignant neoplasm of lymph nodes of multiple regions essential (primary) hypertension antineoplastic chemotherapy induced pancytopenia wheezing family history of malignant neoplasm of other organs or systems encounter for examination for normal comparison and control in clinical research program personal history of malignant melanoma of skin diarrhea, unspecified encounter for antineoplastic immunotherapy drug induced fever patient room in hospital as the place of occurrence of the external cause essential (primary) hypertension hyperlipidemia, unspecified hypocalcemia sebaceous cyst adverse effect of antineoplastic and immunosuppressive drugs, initial encounter other and unspecified fall in water transport injuring occupant of small boat, powered nicotine dependence, cigarettes, uncomplicated other fall from one level to another in water transport injuring occupant of other watercraft -- crew encounter for antineoplastic immunotherapy anemia due to antineoplastic chemotherapy drug induced fever secondary and unspecified malignant neoplasm of lymph nodes of multiple regions malignant melanoma of skin, unspecified anuria and oliguria fall on stairs or ladders in water transport injuring unspecified person nonspecific elevation of levels of transaminase and lactic acid dehydrogenase [ldh] other disorders of phosphorus metabolism lymphocytopenia
white m 41 $temp  97.7  heartrate  95.0  resprate  18.0  o2sat  100.0  sbp  109.0  dbp  92.0  rhythm    pain  9  ; temp    heartrate  88.0  resprate  15.0  o2sat  99.0  sbp  107.0  dbp  61.0  rhythm    pain  9  $nan$metronidazole  500  mg ; 
unspecified viral hepatitis c without hepatic coma anxiety disorder, unspecified infarction of spleen occlusion and stenosis of other cerebral arteries opioid abuse, uncomplicated sepsis due to methicillin resistant staphylococcus aureus ischemia and infarction of kidney septic arterial embolism major depressive disorder, single episode, unspecified cocaine abuse with intoxication, unspecified non-pressure chronic ulcer of skin of other sites with unspecified severity pain in left shoulder chronic viral hepatitis c other diseases of spleen methicillin resistant staphylococcus aureus infection as the cause of diseases classified elsewhere acute kidney failure, unspecified severe sepsis without septic shock impulse disorder, unspecified anemia, unspecified hypo-osmolality and hyponatremia hypokalemia unspecified asthma, uncomplicated occlusion and stenosis of unspecified cerebral artery thrombocytopenia, unspecified other chronic pain cerebral infarction, unspecified streptococcus, group a, as the cause of diseases classified elsewhere sepsis due to streptococcus, group a metabolic encephalopathy acute and subacute infective endocarditis
white m 41 $temp  97.8  heartrate  88.0  resprate  12.0  o2sat  97.0  sbp  126.0  dbp  79.0  rhythm    pain  5  $hematology blood hematocrit  23.5  %; hematology blood hematocrit  23.8  %; hematology blood hemoglobin  7.6  g dl; hematology blood hemoglobin  7.7  g dl; hematology blood platelet count  199  k ul; hematology blood platelet count  184  k ul; chemistry blood anion gap  18  meq l; chemistry blood anion gap  17  meq l; chemistry blood bicarbonate  18  meq l; chemistry blood bicarbonate  19  meq l; chemistry blood chloride  101  meq l; chemistry blood chloride  103  meq l; chemistry blood creatinine  2.8  mg dl; chemistry blood creatinine  2.3  mg dl; chemistry blood potassium  3.6  meq l; chemistry blood potassium  3.5  meq l; chemistry blood sodium  133  meq l; chemistry blood sodium  135  meq l; chemistry blood urea nitrogen  49  mg dl; chemistry blood urea nitrogen  45  mg dl; hematology blood inr(pt)  1.4  ; hematology blood inr(pt)  1.4  ; chemistry urine creatinine, urine  42  mg dl; chemistry urine potassium, urine  13  meq l; chemistry urine sodium, urine  21  meq l; chemistry blood calcium, total  7.8  mg dl; chemistry blood calcium, total  7.8  mg dl; chemistry blood bilirubin, indirect  0.2  mg dl; chemistry blood bilirubin, total  0.2  mg dl; chemistry blood bilirubin, total  0.2  mg dl; chemistry blood glucose  95  mg dl; chemistry blood glucose  107  mg dl; chemistry blood lactate dehydrogenase (ld)  241  iu l; chemistry blood % hemoglobin a1c  5.5  %$metronidazole  500  mg ; bisacodyl  10  mg ; senna  8.6  mg ; heparin  5000  unit ; iso-osmotic dextrose  200  ml ; vancomycin  1000  mg ; 0.9% sodium chloride (mini bag plus)  100  ml ; ceftriaxone  2  gm ; methocarbamol  750  mg ; acetaminophen  650  mg ; methadone  20  mg ; potassium chloride replacement (critical care and oncology)   40  meq ; potassium chloride replacement (critical care and oncology)   60  meq ; potassium chloride replacement (critical care and oncology)   80  meq ; 0.9% sodium chloride  1  bag ; calcium gluconate  2  g ; 0.9% sodium chloride  2  bag ; calcium gluconate  4  g ; bag  1  bag ; magnesium sulfate  2  gm ; bag  2  bag ; magnesium sulfate  4  gm ; vancomycin oral liquid  125  mg ; 
unspecified viral hepatitis c without hepatic coma anxiety disorder, unspecified infarction of spleen occlusion and stenosis of other cerebral arteries opioid abuse, uncomplicated sepsis due to methicillin resistant staphylococcus aureus ischemia and infarction of kidney septic arterial embolism major depressive disorder, single episode, unspecified cocaine abuse with intoxication, unspecified non-pressure chronic ulcer of skin of other sites with unspecified severity pain in left shoulder chronic viral hepatitis c other diseases of spleen methicillin resistant staphylococcus aureus infection as the cause of diseases classified elsewhere acute kidney failure, unspecified severe sepsis without septic shock impulse disorder, unspecified anemia, unspecified hypo-osmolality and hyponatremia hypokalemia unspecified asthma, uncomplicated occlusion and stenosis of unspecified cerebral artery thrombocytopenia, unspecified other chronic pain cerebral infarction, unspecified streptococcus, group a, as the cause of diseases classified elsewhere sepsis due to streptococcus, group a metabolic encephalopathy acute and subacute infective endocarditis
white m 41 $nan$hematology blood hematocrit  22.6  %; hematology blood hemoglobin  7.4  g dl; hematology blood platelet count  228  k ul; chemistry blood anion gap  13  meq l; chemistry blood bicarbonate  21  meq l; chemistry blood chloride  105  meq l; chemistry blood creatinine  1.5  mg dl; chemistry blood potassium  3.7  meq l; chemistry blood sodium  135  meq l; chemistry blood urea nitrogen  31  mg dl; hematology blood inr(pt)  1.4  ; chemistry blood calcium, total  7.9  mg dl; chemistry blood glucose  109  mg dl$bisacodyl  10  mg ; senna  8.6  mg ; heparin  5000  unit ; 0.9% sodium chloride (mini bag plus)  100  ml ; ceftriaxone  2  gm ; methocarbamol  750  mg ; acetaminophen  650  mg ; vancomycin oral liquid  125  mg ; sodium chloride 0.9%  flush  3  ml ; lidocaine 5% ointment  1  appl ; dicyclomine  20  mg ; clonidine  0.1  mg ; lidocaine 1%  1  ml ; heparin flush (10 units ml)  2  ml ; sodium chloride 0.9%  flush  20  ml ; lidocaine 1% (for picc midline insertions)  5  ml ; methadone  10  mg ; oxycodone (immediate release)  5  mg ; lorazepam  0.5  mg ; 
unspecified viral hepatitis c without hepatic coma anxiety disorder, unspecified infarction of spleen occlusion and stenosis of other cerebral arteries opioid abuse, uncomplicated sepsis due to methicillin resistant staphylococcus aureus ischemia and infarction of kidney septic arterial embolism major depressive disorder, single episode, unspecified cocaine abuse with intoxication, unspecified non-pressure chronic ulcer of skin of other sites with unspecified severity pain in left shoulder chronic viral hepatitis c other diseases of spleen methicillin resistant staphylococcus aureus infection as the cause of diseases classified elsewhere acute kidney failure, unspecified severe sepsis without septic shock impulse disorder, unspecified anemia, unspecified hypo-osmolality and hyponatremia hypokalemia unspecified asthma, uncomplicated occlusion and stenosis of unspecified cerebral artery thrombocytopenia, unspecified other chronic pain cerebral infarction, unspecified streptococcus, group a, as the cause of diseases classified elsewhere sepsis due to streptococcus, group a metabolic encephalopathy acute and subacute infective endocarditis
white m 41 $nan$hematology blood hematocrit  23.2  %; hematology blood hemoglobin  7.4  g dl; hematology blood platelet count  244  k ul; chemistry blood anion gap  14  meq l; chemistry blood bicarbonate  22  meq l; chemistry blood chloride  107  meq l; chemistry blood creatinine  1.3  mg dl; chemistry blood potassium  3.6  meq l; chemistry blood sodium  139  meq l; chemistry blood urea nitrogen  18  mg dl; hematology blood inr(pt)  1.4  ; chemistry blood calcium, total  8.2  mg dl; chemistry blood glucose  104  mg dl$bisacodyl  10  mg ; senna  8.6  mg ; heparin  5000  unit ; 0.9% sodium chloride (mini bag plus)  100  ml ; ceftriaxone  2  gm ; methocarbamol  750  mg ; acetaminophen  650  mg ; vancomycin oral liquid  125  mg ; sodium chloride 0.9%  flush  3  ml ; lidocaine 5% ointment  1  appl ; dicyclomine  20  mg ; clonidine  0.1  mg ; lidocaine 1%  1  ml ; heparin flush (10 units ml)  2  ml ; sodium chloride 0.9%  flush  20  ml ; lidocaine 1% (for picc midline insertions)  5  ml ; methadone  10  mg ; oxycodone (immediate release)  5  mg ; sodium chloride 0.9%  flush  10-20  ml ; methadone  30  mg ; 
unspecified viral hepatitis c without hepatic coma anxiety disorder, unspecified infarction of spleen occlusion and stenosis of other cerebral arteries opioid abuse, uncomplicated sepsis due to methicillin resistant staphylococcus aureus ischemia and infarction of kidney septic arterial embolism major depressive disorder, single episode, unspecified cocaine abuse with intoxication, unspecified non-pressure chronic ulcer of skin of other sites with unspecified severity pain in left shoulder chronic viral hepatitis c other diseases of spleen methicillin resistant staphylococcus aureus infection as the cause of diseases classified elsewhere acute kidney failure, unspecified severe sepsis without septic shock impulse disorder, unspecified anemia, unspecified hypo-osmolality and hyponatremia hypokalemia unspecified asthma, uncomplicated occlusion and stenosis of unspecified cerebral artery thrombocytopenia, unspecified other chronic pain cerebral infarction, unspecified streptococcus, group a, as the cause of diseases classified elsewhere sepsis due to streptococcus, group a metabolic encephalopathy acute and subacute infective endocarditis
white m 41 $nan$hematology blood hematocrit  23.7  %; hematology blood hemoglobin  7.5  g dl; hematology blood platelet count  244  k ul; chemistry blood anion gap  12  meq l; chemistry blood bicarbonate  23  meq l; chemistry blood chloride  107  meq l; chemistry blood creatinine  1.1  mg dl; chemistry blood potassium  3.3  meq l; chemistry blood sodium  139  meq l; chemistry blood urea nitrogen  13  mg dl; hematology blood inr(pt)  1.3  ; chemistry blood calcium, total  8.1  mg dl; chemistry blood glucose  91  mg dl$bisacodyl  10  mg ; senna  8.6  mg ; heparin  5000  unit ; 0.9% sodium chloride (mini bag plus)  100  ml ; ceftriaxone  2  gm ; methocarbamol  750  mg ; acetaminophen  650  mg ; vancomycin oral liquid  125  mg ; sodium chloride 0.9%  flush  3  ml ; lidocaine 5% ointment  1  appl ; dicyclomine  20  mg ; clonidine  0.1  mg ; sodium chloride 0.9%  flush  20  ml ; lidocaine 1% (for picc midline insertions)  5  ml ; oxycodone (immediate release)  5  mg ; sodium chloride 0.9%  flush  10-20  ml ; methadone  30  mg ; sodium chloride 0.9%  1000  ml ; sterile water  100  ml ; potassium chloride  40  meq ; gabapentin  300  mg ; 
unspecified viral hepatitis c without hepatic coma anxiety disorder, unspecified infarction of spleen occlusion and stenosis of other cerebral arteries opioid abuse, uncomplicated sepsis due to methicillin resistant staphylococcus aureus ischemia and infarction of kidney septic arterial embolism major depressive disorder, single episode, unspecified cocaine abuse with intoxication, unspecified non-pressure chronic ulcer of skin of other sites with unspecified severity pain in left shoulder chronic viral hepatitis c other diseases of spleen methicillin resistant staphylococcus aureus infection as the cause of diseases classified elsewhere acute kidney failure, unspecified severe sepsis without septic shock impulse disorder, unspecified anemia, unspecified hypo-osmolality and hyponatremia hypokalemia unspecified asthma, uncomplicated occlusion and stenosis of unspecified cerebral artery thrombocytopenia, unspecified other chronic pain cerebral infarction, unspecified streptococcus, group a, as the cause of diseases classified elsewhere sepsis due to streptococcus, group a metabolic encephalopathy acute and subacute infective endocarditis
white m 41 $nan$hematology blood hematocrit  23.2  %; hematology blood hemoglobin  7.1  g dl; hematology blood platelet count  220  k ul; chemistry blood anion gap  12  meq l; chemistry blood bicarbonate  24  meq l; chemistry blood chloride  108  meq l; chemistry blood creatinine  1.1  mg dl; chemistry blood potassium  3.6  meq l; chemistry blood sodium  140  meq l; chemistry blood urea nitrogen  10  mg dl; chemistry blood calcium, total  8.0  mg dl; chemistry blood glucose  85  mg dl$bisacodyl  10  mg ; senna  8.6  mg ; heparin  5000  unit ; 0.9% sodium chloride (mini bag plus)  100  ml ; ceftriaxone  2  gm ; methocarbamol  750  mg ; acetaminophen  650  mg ; vancomycin oral liquid  125  mg ; sodium chloride 0.9%  flush  3  ml ; lidocaine 5% ointment  1  appl ; dicyclomine  20  mg ; clonidine  0.1  mg ; oxycodone (immediate release)  5  mg ; sodium chloride 0.9%  flush  10-20  ml ; sterile water  100  ml ; potassium chloride  40  meq ; gabapentin  300  mg ; 0.9% sodium chloride  250  ml ; vancomycin  1250  mg ; 
unspecified viral hepatitis c without hepatic coma anxiety disorder, unspecified infarction of spleen occlusion and stenosis of other cerebral arteries opioid abuse, uncomplicated sepsis due to methicillin resistant staphylococcus aureus ischemia and infarction of kidney septic arterial embolism major depressive disorder, single episode, unspecified cocaine abuse with intoxication, unspecified non-pressure chronic ulcer of skin of other sites with unspecified severity pain in left shoulder chronic viral hepatitis c other diseases of spleen methicillin resistant staphylococcus aureus infection as the cause of diseases classified elsewhere acute kidney failure, unspecified severe sepsis without septic shock impulse disorder, unspecified anemia, unspecified hypo-osmolality and hyponatremia hypokalemia unspecified asthma, uncomplicated occlusion and stenosis of unspecified cerebral artery thrombocytopenia, unspecified other chronic pain cerebral infarction, unspecified streptococcus, group a, as the cause of diseases classified elsewhere sepsis due to streptococcus, group a metabolic encephalopathy acute and subacute infective endocarditis
white m 41 $nan$hematology blood hematocrit  21.5  %; hematology blood hemoglobin  6.7  g dl; hematology blood platelet count  193  k ul; chemistry blood anion gap  15  meq l; chemistry blood bicarbonate  21  meq l; chemistry blood chloride  103  meq l; chemistry blood creatinine  1.1  mg dl; chemistry blood potassium  3.5  meq l; chemistry blood sodium  135  meq l; chemistry blood urea nitrogen  9  mg dl; hematology blood inr(pt)  1.4  ; chemistry urine sodium, urine  29  meq l; chemistry blood calcium, total  8.0  mg dl; chemistry blood glucose  154  mg dl$bisacodyl  10  mg ; senna  8.6  mg ; heparin  5000  unit ; 0.9% sodium chloride (mini bag plus)  100  ml ; ceftriaxone  2  gm ; methocarbamol  750  mg ; acetaminophen  650  mg ; vancomycin oral liquid  125  mg ; lidocaine 5% ointment  1  appl ; dicyclomine  20  mg ; clonidine  0.1  mg ; oxycodone (immediate release)  5  mg ; sodium chloride 0.9%  flush  10-20  ml ; gabapentin  300  mg ; 0.9% sodium chloride  250  ml ; vancomycin  1250  mg ; ferrous sulfate  325  mg ; nicotine patch  21  mg ; readi-cat 2 (barium sulfate 2% suspension)  900  ml ; 
unspecified viral hepatitis c without hepatic coma anxiety disorder, unspecified infarction of spleen occlusion and stenosis of other cerebral arteries opioid abuse, uncomplicated sepsis due to methicillin resistant staphylococcus aureus ischemia and infarction of kidney septic arterial embolism major depressive disorder, single episode, unspecified cocaine abuse with intoxication, unspecified non-pressure chronic ulcer of skin of other sites with unspecified severity pain in left shoulder chronic viral hepatitis c other diseases of spleen methicillin resistant staphylococcus aureus infection as the cause of diseases classified elsewhere acute kidney failure, unspecified severe sepsis without septic shock impulse disorder, unspecified anemia, unspecified hypo-osmolality and hyponatremia hypokalemia unspecified asthma, uncomplicated occlusion and stenosis of unspecified cerebral artery thrombocytopenia, unspecified other chronic pain cerebral infarction, unspecified streptococcus, group a, as the cause of diseases classified elsewhere sepsis due to streptococcus, group a metabolic encephalopathy acute and subacute infective endocarditis
white m 41 $nan$hematology blood hematocrit  21.4  %; hematology blood hemoglobin  6.5  g dl; hematology blood platelet count  246  k ul; chemistry blood anion gap  12  meq l; chemistry blood bicarbonate  25  meq l; chemistry blood chloride  105  meq l; chemistry blood creatinine  1.1  mg dl; chemistry blood potassium  3.6  meq l; chemistry blood sodium  138  meq l; chemistry blood urea nitrogen  7  mg dl; chemistry blood calcium, total  8.2  mg dl; chemistry blood bilirubin, total  0.3  mg dl; chemistry blood glucose  79  mg dl$bisacodyl  10  mg ; senna  8.6  mg ; heparin  5000  unit ; 0.9% sodium chloride (mini bag plus)  100  ml ; ceftriaxone  2  gm ; methocarbamol  750  mg ; acetaminophen  650  mg ; vancomycin oral liquid  125  mg ; lidocaine 5% ointment  1  appl ; dicyclomine  20  mg ; clonidine  0.1  mg ; oxycodone (immediate release)  5  mg ; sodium chloride 0.9%  flush  10-20  ml ; gabapentin  300  mg ; 0.9% sodium chloride  250  ml ; vancomycin  1250  mg ; ferrous sulfate  325  mg ; nicotine patch  21  mg ; readi-cat 2 (barium sulfate 2% suspension)  900  ml ; 
unspecified viral hepatitis c without hepatic coma anxiety disorder, unspecified infarction of spleen occlusion and stenosis of other cerebral arteries opioid abuse, uncomplicated sepsis due to methicillin resistant staphylococcus aureus ischemia and infarction of kidney septic arterial embolism major depressive disorder, single episode, unspecified cocaine abuse with intoxication, unspecified non-pressure chronic ulcer of skin of other sites with unspecified severity pain in left shoulder chronic viral hepatitis c other diseases of spleen methicillin resistant staphylococcus aureus infection as the cause of diseases classified elsewhere acute kidney failure, unspecified severe sepsis without septic shock impulse disorder, unspecified anemia, unspecified hypo-osmolality and hyponatremia hypokalemia unspecified asthma, uncomplicated occlusion and stenosis of unspecified cerebral artery thrombocytopenia, unspecified other chronic pain cerebral infarction, unspecified streptococcus, group a, as the cause of diseases classified elsewhere sepsis due to streptococcus, group a metabolic encephalopathy acute and subacute infective endocarditis
white m 41 $nan$hematology blood hematocrit  22.1  %; hematology blood hemoglobin  6.9  g dl; hematology blood platelet count  210  k ul; chemistry blood anion gap  8  meq l; chemistry blood bicarbonate  28  meq l; chemistry blood chloride  102  meq l; chemistry blood creatinine  1.1  mg dl; chemistry blood potassium  3.4  meq l; chemistry blood sodium  135  meq l; chemistry blood urea nitrogen  9  mg dl; chemistry blood calcium, total  8.1  mg dl; chemistry blood glucose  84  mg dl$bisacodyl  10  mg ; senna  8.6  mg ; heparin  5000  unit ; methocarbamol  750  mg ; acetaminophen  650  mg ; vancomycin oral liquid  125  mg ; lidocaine 5% ointment  1  appl ; dicyclomine  20  mg ; clonidine  0.1  mg ; oxycodone (immediate release)  5  mg ; sodium chloride 0.9%  flush  10-20  ml ; gabapentin  300  mg ; 0.9% sodium chloride  250  ml ; vancomycin  1250  mg ; ferrous sulfate  325  mg ; nicotine patch  21  mg ; 
unspecified viral hepatitis c without hepatic coma anxiety disorder, unspecified infarction of spleen occlusion and stenosis of other cerebral arteries opioid abuse, uncomplicated sepsis due to methicillin resistant staphylococcus aureus ischemia and infarction of kidney septic arterial embolism major depressive disorder, single episode, unspecified cocaine abuse with intoxication, unspecified non-pressure chronic ulcer of skin of other sites with unspecified severity pain in left shoulder chronic viral hepatitis c other diseases of spleen methicillin resistant staphylococcus aureus infection as the cause of diseases classified elsewhere acute kidney failure, unspecified severe sepsis without septic shock impulse disorder, unspecified anemia, unspecified hypo-osmolality and hyponatremia hypokalemia unspecified asthma, uncomplicated occlusion and stenosis of unspecified cerebral artery thrombocytopenia, unspecified other chronic pain cerebral infarction, unspecified streptococcus, group a, as the cause of diseases classified elsewhere sepsis due to streptococcus, group a metabolic encephalopathy acute and subacute infective endocarditis
white m 41 $nan$hematology blood hematocrit  25.0  %; hematology blood hemoglobin  7.9  g dl; hematology blood platelet count  257  k ul; chemistry blood anion gap  13  meq l; chemistry blood bicarbonate  26  meq l; chemistry blood chloride  105  meq l; chemistry blood creatinine  1.1  mg dl; chemistry blood potassium  4.1  meq l; chemistry blood sodium  140  meq l; chemistry blood urea nitrogen  9  mg dl; chemistry blood calcium, total  8.3  mg dl; chemistry blood glucose  88  mg dl$bisacodyl  10  mg ; senna  8.6  mg ; heparin  5000  unit ; methocarbamol  750  mg ; acetaminophen  650  mg ; vancomycin oral liquid  125  mg ; lidocaine 5% ointment  1  appl ; dicyclomine  20  mg ; clonidine  0.1  mg ; oxycodone (immediate release)  5  mg ; sodium chloride 0.9%  flush  10-20  ml ; gabapentin  300  mg ; 0.9% sodium chloride  250  ml ; vancomycin  1250  mg ; ferrous sulfate  325  mg ; nicotine patch  21  mg ; 
unspecified viral hepatitis c without hepatic coma anxiety disorder, unspecified infarction of spleen occlusion and stenosis of other cerebral arteries opioid abuse, uncomplicated sepsis due to methicillin resistant staphylococcus aureus ischemia and infarction of kidney septic arterial embolism major depressive disorder, single episode, unspecified cocaine abuse with intoxication, unspecified non-pressure chronic ulcer of skin of other sites with unspecified severity pain in left shoulder chronic viral hepatitis c other diseases of spleen methicillin resistant staphylococcus aureus infection as the cause of diseases classified elsewhere acute kidney failure, unspecified severe sepsis without septic shock impulse disorder, unspecified anemia, unspecified hypo-osmolality and hyponatremia hypokalemia unspecified asthma, uncomplicated occlusion and stenosis of unspecified cerebral artery thrombocytopenia, unspecified other chronic pain cerebral infarction, unspecified streptococcus, group a, as the cause of diseases classified elsewhere sepsis due to streptococcus, group a metabolic encephalopathy acute and subacute infective endocarditis
white m 41 $nan$hematology blood hematocrit  25.5  %; hematology blood hemoglobin  7.9  g dl; hematology blood platelet count  259  k ul; chemistry blood anion gap  13  meq l; chemistry blood bicarbonate  26  meq l; chemistry blood chloride  105  meq l; chemistry blood creatinine  1.0  mg dl; chemistry blood potassium  4.1  meq l; chemistry blood sodium  140  meq l; chemistry blood urea nitrogen  8  mg dl; chemistry blood calcium, total  8.5  mg dl; chemistry blood glucose  80  mg dl$bisacodyl  10  mg ; senna  8.6  mg ; heparin  5000  unit ; methocarbamol  750  mg ; acetaminophen  650  mg ; vancomycin oral liquid  125  mg ; lidocaine 5% ointment  1  appl ; dicyclomine  20  mg ; clonidine  0.1  mg ; sodium chloride 0.9%  flush  10-20  ml ; gabapentin  300  mg ; 0.9% sodium chloride  250  ml ; vancomycin  1250  mg ; ferrous sulfate  325  mg ; 
unspecified viral hepatitis c without hepatic coma anxiety disorder, unspecified infarction of spleen occlusion and stenosis of other cerebral arteries opioid abuse, uncomplicated sepsis due to methicillin resistant staphylococcus aureus ischemia and infarction of kidney septic arterial embolism major depressive disorder, single episode, unspecified cocaine abuse with intoxication, unspecified non-pressure chronic ulcer of skin of other sites with unspecified severity pain in left shoulder chronic viral hepatitis c other diseases of spleen methicillin resistant staphylococcus aureus infection as the cause of diseases classified elsewhere acute kidney failure, unspecified severe sepsis without septic shock impulse disorder, unspecified anemia, unspecified hypo-osmolality and hyponatremia hypokalemia unspecified asthma, uncomplicated occlusion and stenosis of unspecified cerebral artery thrombocytopenia, unspecified other chronic pain cerebral infarction, unspecified streptococcus, group a, as the cause of diseases classified elsewhere sepsis due to streptococcus, group a metabolic encephalopathy acute and subacute infective endocarditis
white m 41 $nan$hematology blood hematocrit  24.0  %; hematology blood hemoglobin  7.4  g dl; hematology blood platelet count  275  k ul; chemistry blood anion gap  12  meq l; chemistry blood bicarbonate  27  meq l; chemistry blood chloride  99  meq l; chemistry blood creatinine  1.1  mg dl; chemistry blood potassium  3.8  meq l; chemistry blood sodium  134  meq l; chemistry blood urea nitrogen  7  mg dl; hematology blood inr(pt)  1.2  ; chemistry blood calcium, total  8.3  mg dl; chemistry blood glucose  78  mg dl$bisacodyl  10  mg ; senna  8.6  mg ; heparin  5000  unit ; methocarbamol  750  mg ; vancomycin oral liquid  125  mg ; lidocaine 5% ointment  1  appl ; dicyclomine  20  mg ; clonidine  0.1  mg ; sodium chloride 0.9%  flush  10-20  ml ; gabapentin  300  mg ; ferrous sulfate  325  mg ; magnesium oxide  400  mg ; 
unspecified viral hepatitis c without hepatic coma anxiety disorder, unspecified infarction of spleen occlusion and stenosis of other cerebral arteries opioid abuse, uncomplicated sepsis due to methicillin resistant staphylococcus aureus ischemia and infarction of kidney septic arterial embolism major depressive disorder, single episode, unspecified cocaine abuse with intoxication, unspecified non-pressure chronic ulcer of skin of other sites with unspecified severity pain in left shoulder chronic viral hepatitis c other diseases of spleen methicillin resistant staphylococcus aureus infection as the cause of diseases classified elsewhere acute kidney failure, unspecified severe sepsis without septic shock impulse disorder, unspecified anemia, unspecified hypo-osmolality and hyponatremia hypokalemia unspecified asthma, uncomplicated occlusion and stenosis of unspecified cerebral artery thrombocytopenia, unspecified other chronic pain cerebral infarction, unspecified streptococcus, group a, as the cause of diseases classified elsewhere sepsis due to streptococcus, group a metabolic encephalopathy acute and subacute infective endocarditis
white m 41 $nan$hematology blood hematocrit  24.2  %; hematology blood hemoglobin  7.4  g dl; hematology blood platelet count  290  k ul; chemistry blood anion gap  13  meq l; chemistry blood bicarbonate  28  meq l; chemistry blood chloride  100  meq l; chemistry blood creatinine  1.1  mg dl; chemistry blood potassium  4.3  meq l; chemistry blood sodium  137  meq l; chemistry blood urea nitrogen  8  mg dl; chemistry blood calcium, total  8.5  mg dl; chemistry blood glucose  84  mg dl$bisacodyl  10  mg ; senna  8.6  mg ; heparin  5000  unit ; methocarbamol  750  mg ; vancomycin oral liquid  125  mg ; lidocaine 5% ointment  1  appl ; dicyclomine  20  mg ; clonidine  0.1  mg ; sodium chloride 0.9%  flush  10-20  ml ; gabapentin  300  mg ; ferrous sulfate  325  mg ; magnesium oxide  400  mg ; mupirocin ointment 2%  1  appl ; 
unspecified viral hepatitis c without hepatic coma anxiety disorder, unspecified infarction of spleen occlusion and stenosis of other cerebral arteries opioid abuse, uncomplicated sepsis due to methicillin resistant staphylococcus aureus ischemia and infarction of kidney septic arterial embolism major depressive disorder, single episode, unspecified cocaine abuse with intoxication, unspecified non-pressure chronic ulcer of skin of other sites with unspecified severity pain in left shoulder chronic viral hepatitis c other diseases of spleen methicillin resistant staphylococcus aureus infection as the cause of diseases classified elsewhere acute kidney failure, unspecified severe sepsis without septic shock impulse disorder, unspecified anemia, unspecified hypo-osmolality and hyponatremia hypokalemia unspecified asthma, uncomplicated occlusion and stenosis of unspecified cerebral artery thrombocytopenia, unspecified other chronic pain cerebral infarction, unspecified streptococcus, group a, as the cause of diseases classified elsewhere sepsis due to streptococcus, group a metabolic encephalopathy acute and subacute infective endocarditis
white m 41 $nan$hematology blood hematocrit  23.8  %; hematology blood hemoglobin  7.3  g dl; hematology blood platelet count  298  k ul; chemistry blood anion gap  13  meq l; chemistry blood bicarbonate  29  meq l; chemistry blood chloride  100  meq l; chemistry blood creatinine  1.1  mg dl; chemistry blood potassium  4.0  meq l; chemistry blood sodium  138  meq l; chemistry blood urea nitrogen  10  mg dl; hematology blood inr(pt)  1.2  ; chemistry blood calcium, total  8.6  mg dl; chemistry blood glucose  90  mg dl$bisacodyl  10  mg ; senna  8.6  mg ; heparin  5000  unit ; vancomycin oral liquid  125  mg ; sodium chloride 0.9%  flush  10-20  ml ; gabapentin  300  mg ; ferrous sulfate  325  mg ; mupirocin ointment 2%  1  appl ; 
unspecified viral hepatitis c without hepatic coma anxiety disorder, unspecified infarction of spleen occlusion and stenosis of other cerebral arteries opioid abuse, uncomplicated sepsis due to methicillin resistant staphylococcus aureus ischemia and infarction of kidney septic arterial embolism major depressive disorder, single episode, unspecified cocaine abuse with intoxication, unspecified non-pressure chronic ulcer of skin of other sites with unspecified severity pain in left shoulder chronic viral hepatitis c other diseases of spleen methicillin resistant staphylococcus aureus infection as the cause of diseases classified elsewhere acute kidney failure, unspecified severe sepsis without septic shock impulse disorder, unspecified anemia, unspecified hypo-osmolality and hyponatremia hypokalemia unspecified asthma, uncomplicated occlusion and stenosis of unspecified cerebral artery thrombocytopenia, unspecified other chronic pain cerebral infarction, unspecified streptococcus, group a, as the cause of diseases classified elsewhere sepsis due to streptococcus, group a metabolic encephalopathy acute and subacute infective endocarditis
white m 41 $nan$hematology blood hematocrit  26.0  %; hematology blood hemoglobin  7.8  g dl; hematology blood platelet count  339  k ul$bisacodyl  10  mg ; senna  8.6  mg ; vancomycin oral liquid  125  mg ; sodium chloride 0.9%  flush  10-20  ml ; gabapentin  300  mg ; ferrous sulfate  325  mg ; mupirocin ointment 2%  1  appl ; lidocaine 5% patch  1  ptch ; nicotine polacrilex  2  mg ; 
unspecified viral hepatitis c without hepatic coma anxiety disorder, unspecified infarction of spleen occlusion and stenosis of other cerebral arteries opioid abuse, uncomplicated sepsis due to methicillin resistant staphylococcus aureus ischemia and infarction of kidney septic arterial embolism major depressive disorder, single episode, unspecified cocaine abuse with intoxication, unspecified non-pressure chronic ulcer of skin of other sites with unspecified severity pain in left shoulder chronic viral hepatitis c other diseases of spleen methicillin resistant staphylococcus aureus infection as the cause of diseases classified elsewhere acute kidney failure, unspecified severe sepsis without septic shock impulse disorder, unspecified anemia, unspecified hypo-osmolality and hyponatremia hypokalemia unspecified asthma, uncomplicated occlusion and stenosis of unspecified cerebral artery thrombocytopenia, unspecified other chronic pain cerebral infarction, unspecified streptococcus, group a, as the cause of diseases classified elsewhere sepsis due to streptococcus, group a metabolic encephalopathy acute and subacute infective endocarditis
white m 41 $nan$nan$bisacodyl  10  mg ; senna  8.6  mg ; vancomycin oral liquid  125  mg ; sodium chloride 0.9%  flush  10-20  ml ; gabapentin  300  mg ; ferrous sulfate  325  mg ; mupirocin ointment 2%  1  appl ; lidocaine 5% patch  1  ptch ; nicotine polacrilex  2  mg ; 
unspecified viral hepatitis c without hepatic coma anxiety disorder, unspecified infarction of spleen occlusion and stenosis of other cerebral arteries opioid abuse, uncomplicated sepsis due to methicillin resistant staphylococcus aureus ischemia and infarction of kidney septic arterial embolism major depressive disorder, single episode, unspecified cocaine abuse with intoxication, unspecified non-pressure chronic ulcer of skin of other sites with unspecified severity pain in left shoulder chronic viral hepatitis c other diseases of spleen methicillin resistant staphylococcus aureus infection as the cause of diseases classified elsewhere acute kidney failure, unspecified severe sepsis without septic shock impulse disorder, unspecified anemia, unspecified hypo-osmolality and hyponatremia hypokalemia unspecified asthma, uncomplicated occlusion and stenosis of unspecified cerebral artery thrombocytopenia, unspecified other chronic pain cerebral infarction, unspecified streptococcus, group a, as the cause of diseases classified elsewhere sepsis due to streptococcus, group a metabolic encephalopathy acute and subacute infective endocarditis
white m 41 $nan$hematology blood hematocrit  25.3  %; hematology blood hemoglobin  7.7  g dl; hematology blood platelet count  365  k ul; chemistry blood anion gap  14  meq l; chemistry blood bicarbonate  28  meq l; chemistry blood chloride  99  meq l; chemistry blood creatinine  1.1  mg dl; chemistry blood potassium  4.1  meq l; chemistry blood sodium  137  meq l; chemistry blood urea nitrogen  9  mg dl; chemistry blood calcium, total  9.0  mg dl; chemistry blood glucose  97  mg dl$bisacodyl  10  mg ; senna  8.6  mg ; vancomycin oral liquid  125  mg ; sodium chloride 0.9%  flush  10-20  ml ; gabapentin  300  mg ; ferrous sulfate  325  mg ; mupirocin ointment 2%  1  appl ; lidocaine 5% patch  1  ptch ; nicotine polacrilex  2  mg ; 
unspecified viral hepatitis c without hepatic coma anxiety disorder, unspecified infarction of spleen occlusion and stenosis of other cerebral arteries opioid abuse, uncomplicated sepsis due to methicillin resistant staphylococcus aureus ischemia and infarction of kidney septic arterial embolism major depressive disorder, single episode, unspecified cocaine abuse with intoxication, unspecified non-pressure chronic ulcer of skin of other sites with unspecified severity pain in left shoulder chronic viral hepatitis c other diseases of spleen methicillin resistant staphylococcus aureus infection as the cause of diseases classified elsewhere acute kidney failure, unspecified severe sepsis without septic shock impulse disorder, unspecified anemia, unspecified hypo-osmolality and hyponatremia hypokalemia unspecified asthma, uncomplicated occlusion and stenosis of unspecified cerebral artery thrombocytopenia, unspecified other chronic pain cerebral infarction, unspecified streptococcus, group a, as the cause of diseases classified elsewhere sepsis due to streptococcus, group a metabolic encephalopathy acute and subacute infective endocarditis
white m 41 $nan$nan$bisacodyl  10  mg ; senna  8.6  mg ; vancomycin oral liquid  125  mg ; sodium chloride 0.9%  flush  10-20  ml ; gabapentin  300  mg ; ferrous sulfate  325  mg ; mupirocin ointment 2%  1  appl ; lidocaine 5% patch  1  ptch ; nicotine polacrilex  2  mg ; 
unspecified viral hepatitis c without hepatic coma anxiety disorder, unspecified infarction of spleen occlusion and stenosis of other cerebral arteries opioid abuse, uncomplicated sepsis due to methicillin resistant staphylococcus aureus ischemia and infarction of kidney septic arterial embolism major depressive disorder, single episode, unspecified cocaine abuse with intoxication, unspecified non-pressure chronic ulcer of skin of other sites with unspecified severity pain in left shoulder chronic viral hepatitis c other diseases of spleen methicillin resistant staphylococcus aureus infection as the cause of diseases classified elsewhere acute kidney failure, unspecified severe sepsis without septic shock impulse disorder, unspecified anemia, unspecified hypo-osmolality and hyponatremia hypokalemia unspecified asthma, uncomplicated occlusion and stenosis of unspecified cerebral artery thrombocytopenia, unspecified other chronic pain cerebral infarction, unspecified streptococcus, group a, as the cause of diseases classified elsewhere sepsis due to streptococcus, group a metabolic encephalopathy acute and subacute infective endocarditis
white m 41 $nan$hematology blood hematocrit  25.3  %; hematology blood hemoglobin  7.7  g dl; hematology blood platelet count  396  k ul; chemistry blood anion gap  14  meq l; chemistry blood bicarbonate  28  meq l; chemistry blood chloride  99  meq l; chemistry blood creatinine  1.2  mg dl; chemistry blood potassium  4.6  meq l; chemistry blood sodium  136  meq l; chemistry blood urea nitrogen  11  mg dl; chemistry blood calcium, total  9.3  mg dl; chemistry blood glucose  88  mg dl$bisacodyl  10  mg ; senna  8.6  mg ; vancomycin oral liquid  125  mg ; sodium chloride 0.9%  flush  10-20  ml ; gabapentin  300  mg ; ferrous sulfate  325  mg ; lidocaine 5% patch  1  ptch ; nicotine polacrilex  2  mg ; 
unspecified viral hepatitis c without hepatic coma anxiety disorder, unspecified infarction of spleen occlusion and stenosis of other cerebral arteries opioid abuse, uncomplicated sepsis due to methicillin resistant staphylococcus aureus ischemia and infarction of kidney septic arterial embolism major depressive disorder, single episode, unspecified cocaine abuse with intoxication, unspecified non-pressure chronic ulcer of skin of other sites with unspecified severity pain in left shoulder chronic viral hepatitis c other diseases of spleen methicillin resistant staphylococcus aureus infection as the cause of diseases classified elsewhere acute kidney failure, unspecified severe sepsis without septic shock impulse disorder, unspecified anemia, unspecified hypo-osmolality and hyponatremia hypokalemia unspecified asthma, uncomplicated occlusion and stenosis of unspecified cerebral artery thrombocytopenia, unspecified other chronic pain cerebral infarction, unspecified streptococcus, group a, as the cause of diseases classified elsewhere sepsis due to streptococcus, group a metabolic encephalopathy acute and subacute infective endocarditis
white m 41 $nan$hematology blood hematocrit  26.3  %; hematology blood hemoglobin  8.0  g dl; hematology blood platelet count  424  k ul; hematology blood inr(pt)  1.2  $bisacodyl  10  mg ; senna  8.6  mg ; vancomycin oral liquid  125  mg ; sodium chloride 0.9%  flush  10-20  ml ; gabapentin  300  mg ; ferrous sulfate  325  mg ; lidocaine 5% patch  1  ptch ; nicotine polacrilex  2  mg ; 
unspecified viral hepatitis c without hepatic coma anxiety disorder, unspecified infarction of spleen occlusion and stenosis of other cerebral arteries opioid abuse, uncomplicated sepsis due to methicillin resistant staphylococcus aureus ischemia and infarction of kidney septic arterial embolism major depressive disorder, single episode, unspecified cocaine abuse with intoxication, unspecified non-pressure chronic ulcer of skin of other sites with unspecified severity pain in left shoulder chronic viral hepatitis c other diseases of spleen methicillin resistant staphylococcus aureus infection as the cause of diseases classified elsewhere acute kidney failure, unspecified severe sepsis without septic shock impulse disorder, unspecified anemia, unspecified hypo-osmolality and hyponatremia hypokalemia unspecified asthma, uncomplicated occlusion and stenosis of unspecified cerebral artery thrombocytopenia, unspecified other chronic pain cerebral infarction, unspecified streptococcus, group a, as the cause of diseases classified elsewhere sepsis due to streptococcus, group a metabolic encephalopathy acute and subacute infective endocarditis
white m 41 $nan$nan$bisacodyl  10  mg ; senna  8.6  mg ; vancomycin oral liquid  125  mg ; sodium chloride 0.9%  flush  10-20  ml ; gabapentin  300  mg ; ferrous sulfate  325  mg ; lidocaine 5% patch  1  ptch ; nicotine polacrilex  2  mg ; 
unspecified viral hepatitis c without hepatic coma anxiety disorder, unspecified infarction of spleen occlusion and stenosis of other cerebral arteries opioid abuse, uncomplicated sepsis due to methicillin resistant staphylococcus aureus ischemia and infarction of kidney septic arterial embolism major depressive disorder, single episode, unspecified cocaine abuse with intoxication, unspecified non-pressure chronic ulcer of skin of other sites with unspecified severity pain in left shoulder chronic viral hepatitis c other diseases of spleen methicillin resistant staphylococcus aureus infection as the cause of diseases classified elsewhere acute kidney failure, unspecified severe sepsis without septic shock impulse disorder, unspecified anemia, unspecified hypo-osmolality and hyponatremia hypokalemia unspecified asthma, uncomplicated occlusion and stenosis of unspecified cerebral artery thrombocytopenia, unspecified other chronic pain cerebral infarction, unspecified streptococcus, group a, as the cause of diseases classified elsewhere sepsis due to streptococcus, group a metabolic encephalopathy acute and subacute infective endocarditis
white m 41 $nan$hematology blood hematocrit  26.9  %; hematology blood hemoglobin  8.2  g dl; hematology blood platelet count  454  k ul; chemistry blood anion gap  16  meq l; chemistry blood bicarbonate  28  meq l; chemistry blood chloride  99  meq l; chemistry blood creatinine  1.1  mg dl; chemistry blood potassium  4.5  meq l; chemistry blood sodium  138  meq l; chemistry blood urea nitrogen  14  mg dl; hematology blood inr(pt)  1.2  ; chemistry blood calcium, total  9.4  mg dl; chemistry blood glucose  84  mg dl$bisacodyl  10  mg ; senna  8.6  mg ; vancomycin oral liquid  125  mg ; sodium chloride 0.9%  flush  10-20  ml ; gabapentin  300  mg ; ferrous sulfate  325  mg ; lidocaine 5% patch  1  ptch ; nicotine polacrilex  2  mg ; 
unspecified viral hepatitis c without hepatic coma anxiety disorder, unspecified infarction of spleen occlusion and stenosis of other cerebral arteries opioid abuse, uncomplicated sepsis due to methicillin resistant staphylococcus aureus ischemia and infarction of kidney septic arterial embolism major depressive disorder, single episode, unspecified cocaine abuse with intoxication, unspecified non-pressure chronic ulcer of skin of other sites with unspecified severity pain in left shoulder chronic viral hepatitis c other diseases of spleen methicillin resistant staphylococcus aureus infection as the cause of diseases classified elsewhere acute kidney failure, unspecified severe sepsis without septic shock impulse disorder, unspecified anemia, unspecified hypo-osmolality and hyponatremia hypokalemia unspecified asthma, uncomplicated occlusion and stenosis of unspecified cerebral artery thrombocytopenia, unspecified other chronic pain cerebral infarction, unspecified streptococcus, group a, as the cause of diseases classified elsewhere sepsis due to streptococcus, group a metabolic encephalopathy acute and subacute infective endocarditis
white m 41 $nan$hematology blood hematocrit  26.3  %; hematology blood hemoglobin  8.0  g dl; hematology blood platelet count  458  k ul; chemistry blood anion gap  13  meq l; chemistry blood bicarbonate  29  meq l; chemistry blood chloride  99  meq l; chemistry blood creatinine  1.2  mg dl; chemistry blood potassium  4.4  meq l; chemistry blood sodium  137  meq l; chemistry blood urea nitrogen  12  mg dl; chemistry blood calcium, total  9.5  mg dl; chemistry blood glucose  91  mg dl$bisacodyl  10  mg ; senna  8.6  mg ; vancomycin oral liquid  125  mg ; sodium chloride 0.9%  flush  10-20  ml ; gabapentin  300  mg ; ferrous sulfate  325  mg ; lidocaine 5% patch  1  ptch ; nicotine polacrilex  2  mg ; iso-osmotic dextrose  150  ml ; vancomycin  750  mg ; 
unspecified viral hepatitis c without hepatic coma anxiety disorder, unspecified infarction of spleen occlusion and stenosis of other cerebral arteries opioid abuse, uncomplicated sepsis due to methicillin resistant staphylococcus aureus ischemia and infarction of kidney septic arterial embolism major depressive disorder, single episode, unspecified cocaine abuse with intoxication, unspecified non-pressure chronic ulcer of skin of other sites with unspecified severity pain in left shoulder chronic viral hepatitis c other diseases of spleen methicillin resistant staphylococcus aureus infection as the cause of diseases classified elsewhere acute kidney failure, unspecified severe sepsis without septic shock impulse disorder, unspecified anemia, unspecified hypo-osmolality and hyponatremia hypokalemia unspecified asthma, uncomplicated occlusion and stenosis of unspecified cerebral artery thrombocytopenia, unspecified other chronic pain cerebral infarction, unspecified streptococcus, group a, as the cause of diseases classified elsewhere sepsis due to streptococcus, group a metabolic encephalopathy acute and subacute infective endocarditis
white m 41 $nan$nan$bisacodyl  10  mg ; senna  8.6  mg ; vancomycin oral liquid  125  mg ; sodium chloride 0.9%  flush  10-20  ml ; gabapentin  300  mg ; ferrous sulfate  325  mg ; lidocaine 5% patch  1  ptch ; nicotine polacrilex  2  mg ; iso-osmotic dextrose  150  ml ; vancomycin  750  mg ; methadone  40  mg ; 
unspecified viral hepatitis c without hepatic coma anxiety disorder, unspecified infarction of spleen occlusion and stenosis of other cerebral arteries opioid abuse, uncomplicated sepsis due to methicillin resistant staphylococcus aureus ischemia and infarction of kidney septic arterial embolism major depressive disorder, single episode, unspecified cocaine abuse with intoxication, unspecified non-pressure chronic ulcer of skin of other sites with unspecified severity pain in left shoulder chronic viral hepatitis c other diseases of spleen methicillin resistant staphylococcus aureus infection as the cause of diseases classified elsewhere acute kidney failure, unspecified severe sepsis without septic shock impulse disorder, unspecified anemia, unspecified hypo-osmolality and hyponatremia hypokalemia unspecified asthma, uncomplicated occlusion and stenosis of unspecified cerebral artery thrombocytopenia, unspecified other chronic pain cerebral infarction, unspecified streptococcus, group a, as the cause of diseases classified elsewhere sepsis due to streptococcus, group a metabolic encephalopathy acute and subacute infective endocarditis
white m 41 $nan$hematology blood hematocrit  25.9  %; hematology blood hemoglobin  7.9  g dl; hematology blood platelet count  471  k ul; chemistry blood anion gap  14  meq l; chemistry blood bicarbonate  27  meq l; chemistry blood chloride  97  meq l; chemistry blood creatinine  1.2  mg dl; chemistry blood potassium  4.2  meq l; chemistry blood sodium  134  meq l; chemistry blood urea nitrogen  14  mg dl; hematology blood inr(pt)  1.1  ; chemistry blood calcium, total  9.0  mg dl; chemistry blood glucose  85  mg dl$bisacodyl  10  mg ; senna  8.6  mg ; sodium chloride 0.9%  flush  10-20  ml ; gabapentin  300  mg ; ferrous sulfate  325  mg ; lidocaine 5% patch  1  ptch ; nicotine polacrilex  2  mg ; iso-osmotic dextrose  150  ml ; vancomycin  750  mg ; methadone  40  mg ; 
unspecified viral hepatitis c without hepatic coma anxiety disorder, unspecified infarction of spleen occlusion and stenosis of other cerebral arteries opioid abuse, uncomplicated sepsis due to methicillin resistant staphylococcus aureus ischemia and infarction of kidney septic arterial embolism major depressive disorder, single episode, unspecified cocaine abuse with intoxication, unspecified non-pressure chronic ulcer of skin of other sites with unspecified severity pain in left shoulder chronic viral hepatitis c other diseases of spleen methicillin resistant staphylococcus aureus infection as the cause of diseases classified elsewhere acute kidney failure, unspecified severe sepsis without septic shock impulse disorder, unspecified anemia, unspecified hypo-osmolality and hyponatremia hypokalemia unspecified asthma, uncomplicated occlusion and stenosis of unspecified cerebral artery thrombocytopenia, unspecified other chronic pain cerebral infarction, unspecified streptococcus, group a, as the cause of diseases classified elsewhere sepsis due to streptococcus, group a metabolic encephalopathy acute and subacute infective endocarditis
white m 41 $nan$nan$bisacodyl  10  mg ; senna  8.6  mg ; sodium chloride 0.9%  flush  10-20  ml ; gabapentin  300  mg ; ferrous sulfate  325  mg ; lidocaine 5% patch  1  ptch ; nicotine polacrilex  2  mg ; 
unspecified viral hepatitis c without hepatic coma anxiety disorder, unspecified infarction of spleen occlusion and stenosis of other cerebral arteries opioid abuse, uncomplicated sepsis due to methicillin resistant staphylococcus aureus ischemia and infarction of kidney septic arterial embolism major depressive disorder, single episode, unspecified cocaine abuse with intoxication, unspecified non-pressure chronic ulcer of skin of other sites with unspecified severity pain in left shoulder chronic viral hepatitis c other diseases of spleen methicillin resistant staphylococcus aureus infection as the cause of diseases classified elsewhere acute kidney failure, unspecified severe sepsis without septic shock impulse disorder, unspecified anemia, unspecified hypo-osmolality and hyponatremia hypokalemia unspecified asthma, uncomplicated occlusion and stenosis of unspecified cerebral artery thrombocytopenia, unspecified other chronic pain cerebral infarction, unspecified streptococcus, group a, as the cause of diseases classified elsewhere sepsis due to streptococcus, group a metabolic encephalopathy acute and subacute infective endocarditis
white m 41 $nan$hematology blood hematocrit  24.1  %; hematology blood hematocrit  21.8  %; hematology blood hematocrit  25.8  %; hematology blood hemoglobin  7.6  g dl; hematology blood hemoglobin  6.8  g dl; hematology blood hemoglobin  8.3  g dl; hematology blood platelet count  438  k ul; hematology blood platelet count  252  k ul; hematology blood platelet count  246  k ul; chemistry blood anion gap  14  meq l; chemistry blood anion gap  14  meq l; chemistry blood bicarbonate  27  meq l; chemistry blood bicarbonate  22  meq l; chemistry blood chloride  99  meq l; chemistry blood chloride  105  meq l; chemistry blood creatinine  1.2  mg dl; chemistry blood creatinine  1.2  mg dl; chemistry blood potassium  4.2  meq l; chemistry blood potassium  4.3  meq l; chemistry blood sodium  136  meq l; chemistry blood sodium  137  meq l; chemistry blood urea nitrogen  15  mg dl; chemistry blood urea nitrogen  15  mg dl; hematology blood inr(pt)  1.3  ; hematology blood inr(pt)  1.4  ; hematology blood inr(pt)  1.3  ; chemistry blood calcium, total  9.5  mg dl; chemistry blood glucose  102  mg dl; blood gas blood free calcium  1.17  mmol l; blood gas blood free calcium  1.37  mmol l; blood gas blood free calcium  1.24  mmol l; blood gas blood lactate  1.4  mmol l; blood gas blood lactate  2.9  mmol l; blood gas blood chloride, whole blood  100  meq l; blood gas blood chloride, whole blood  104  meq l; blood gas blood glucose  97  mg dl; blood gas blood glucose  135  mg dl; blood gas blood glucose  148  mg dl; blood gas blood glucose  162  mg dl; blood gas blood glucose  112  mg dl; blood gas blood glucose  110  mg dl; blood gas blood hematocrit, calculated  23  %; blood gas blood hematocrit, calculated  22  %; blood gas blood hematocrit, calculated  23  %; blood gas blood hematocrit, calculated  22  %; blood gas blood hemoglobin  7.7  g dl; blood gas blood hemoglobin  7.2  g dl; blood gas blood hemoglobin  7.6  g dl; blood gas blood hemoglobin  7.2  g dl; blood gas blood potassium, whole blood  4.0  meq l; blood gas blood potassium, whole blood  4.3  meq l; blood gas blood potassium, whole blood  4.9  meq l; blood gas blood potassium, whole blood  4.1  meq l; blood gas blood potassium, whole blood  4.2  meq l; blood gas blood potassium, whole blood  4.9  meq l; blood gas blood sodium, whole blood  136  meq l; blood gas blood sodium, whole blood  132  meq l; blood gas blood sodium, whole blood  133  meq l$bisacodyl  10  mg ; senna  8.6  mg ; sodium chloride 0.9%  flush  10-20  ml ; gabapentin  300  mg ; ferrous sulfate  325  mg ; lidocaine 5% patch  1  ptch ; nicotine polacrilex  2  mg ; sodium chloride 0.9%  flush  10  ml ; lactated ringers  1000  ml ; dextrose 5%  1000  ml ; propofol  1000  mg ; syringe (iso-osmotic dextrose)  20  ml ; nitroglycerin  8  mg ; 5% dextrose  250  ml ; phenylephrine  60  mg ; syringe (iso-osmotic dextrose)  50  ml ; phenylephrine  12  mg ; sterile water  50  ml ; potassium chloride  20  meq ; bag  1  ml ; 0.9% sodium chloride  100  ml ; insulin human regular  100  unit ; dextrose 50%  12.5  gm ; glucagon  1  mg ; glucose gel  15  g ; iso-osmotic dextrose  50  ml ; cefazolin  2  g ; fentanyl citrate  12.5-50  mcg ; oxycodone (immediate release)  5-10  mg ; ondansetron  4  mg ; neostigmine  3.5  mg ; glycopyrrolate  0.7  mg ; soln  100  ml ; acetaminophen iv  1000  mg ; 
unspecified viral hepatitis c without hepatic coma anxiety disorder, unspecified infarction of spleen occlusion and stenosis of other cerebral arteries opioid abuse, uncomplicated sepsis due to methicillin resistant staphylococcus aureus ischemia and infarction of kidney septic arterial embolism major depressive disorder, single episode, unspecified cocaine abuse with intoxication, unspecified non-pressure chronic ulcer of skin of other sites with unspecified severity pain in left shoulder chronic viral hepatitis c other diseases of spleen methicillin resistant staphylococcus aureus infection as the cause of diseases classified elsewhere acute kidney failure, unspecified severe sepsis without septic shock impulse disorder, unspecified anemia, unspecified hypo-osmolality and hyponatremia hypokalemia unspecified asthma, uncomplicated occlusion and stenosis of unspecified cerebral artery thrombocytopenia, unspecified other chronic pain cerebral infarction, unspecified streptococcus, group a, as the cause of diseases classified elsewhere sepsis due to streptococcus, group a metabolic encephalopathy acute and subacute infective endocarditis
white m 41 $nan$hematology blood hematocrit  27.7  %; hematology blood hematocrit  24.4  %; hematology blood hemoglobin  8.8  g dl; hematology blood hemoglobin  7.8  g dl; hematology blood platelet count  235  k ul; chemistry blood anion gap  14  meq l; chemistry blood bicarbonate  23  meq l; chemistry blood chloride  100  meq l; chemistry blood creatinine  1.2  mg dl; chemistry blood potassium  4.8  meq l; chemistry blood sodium  132  meq l; chemistry blood urea nitrogen  16  mg dl; chemistry blood glucose  118  mg dl; blood gas blood free calcium  1.09  mmol l; blood gas blood free calcium  1.15  mmol l; blood gas blood glucose  126  mg dl; blood gas blood glucose  111  mg dl; blood gas blood potassium, whole blood  4.7  meq l; blood gas blood potassium, whole blood  4.7  meq l$sodium chloride 0.9%  flush  10  ml ; dextrose 5%  1000  ml ; propofol  1000  mg ; syringe (iso-osmotic dextrose)  20  ml ; nitroglycerin  8  mg ; 5% dextrose  250  ml ; phenylephrine  60  mg ; syringe (iso-osmotic dextrose)  50  ml ; phenylephrine  12  mg ; sterile water  50  ml ; potassium chloride  20  meq ; bag  1  ml ; 0.9% sodium chloride  100  ml ; insulin human regular  100  unit ; dextrose 50%  12.5  gm ; glucagon  1  mg ; glucose gel  15  g ; iso-osmotic dextrose  50  ml ; cefazolin  2  g ; fentanyl citrate  12.5-50  mcg ; oxycodone (immediate release)  5-10  mg ; ondansetron  4  mg ; neostigmine  3.5  mg ; glycopyrrolate  0.7  mg ; soln  100  ml ; acetaminophen iv  1000  mg ; chlorhexidine gluconate 0.12% oral rinse  15  ml ; ranitidine  150  mg ; docusate sodium  100  mg ; insulin glargine  (cvicu protocol)  0-50  unit ; insulin  0-10  unit ; metoprolol tartrate  12.5  mg ; furosemide  20  mg ; insulin  0  unit ; aspirin ec  81  mg ; aspirin  81  mg ; milk of magnesia  30  ml ; 
unspecified viral hepatitis c without hepatic coma anxiety disorder, unspecified infarction of spleen occlusion and stenosis of other cerebral arteries opioid abuse, uncomplicated sepsis due to methicillin resistant staphylococcus aureus ischemia and infarction of kidney septic arterial embolism major depressive disorder, single episode, unspecified cocaine abuse with intoxication, unspecified non-pressure chronic ulcer of skin of other sites with unspecified severity pain in left shoulder chronic viral hepatitis c other diseases of spleen methicillin resistant staphylococcus aureus infection as the cause of diseases classified elsewhere acute kidney failure, unspecified severe sepsis without septic shock impulse disorder, unspecified anemia, unspecified hypo-osmolality and hyponatremia hypokalemia unspecified asthma, uncomplicated occlusion and stenosis of unspecified cerebral artery thrombocytopenia, unspecified other chronic pain cerebral infarction, unspecified streptococcus, group a, as the cause of diseases classified elsewhere sepsis due to streptococcus, group a metabolic encephalopathy acute and subacute infective endocarditis
white m 41 $nan$hematology blood hematocrit  22.2  %; hematology blood hematocrit  21.3  %; hematology blood hematocrit  22.5  %; hematology blood hemoglobin  7.0  g dl; hematology blood platelet count  263  k ul; chemistry blood anion gap  13  meq l; chemistry blood bicarbonate  27  meq l; chemistry blood chloride  96  meq l; chemistry blood creatinine  1.1  mg dl; chemistry blood potassium  4.0  meq l; chemistry blood sodium  132  meq l; chemistry blood urea nitrogen  15  mg dl; chemistry blood glucose  100  mg dl$sodium chloride 0.9%  flush  10  ml ; dextrose 5%  1000  ml ; propofol  1000  mg ; sterile water  50  ml ; potassium chloride  20  meq ; bag  1  ml ; 0.9% sodium chloride  100  ml ; insulin human regular  100  unit ; dextrose 50%  12.5  gm ; glucagon  1  mg ; glucose gel  15  g ; fentanyl citrate  12.5-50  mcg ; oxycodone (immediate release)  5-10  mg ; ondansetron  4  mg ; neostigmine  3.5  mg ; glycopyrrolate  0.7  mg ; soln  100  ml ; acetaminophen iv  1000  mg ; docusate sodium  100  mg ; insulin glargine  (cvicu protocol)  0-50  unit ; insulin  0-10  unit ; metoprolol tartrate  12.5  mg ; furosemide  20  mg ; insulin  0  unit ; aspirin ec  81  mg ; milk of magnesia  30  ml ; albuterol 0.083% neb soln  1  neb ; ipratropium bromide neb  1  neb ; 
unspecified viral hepatitis c without hepatic coma anxiety disorder, unspecified infarction of spleen occlusion and stenosis of other cerebral arteries opioid abuse, uncomplicated sepsis due to methicillin resistant staphylococcus aureus ischemia and infarction of kidney septic arterial embolism major depressive disorder, single episode, unspecified cocaine abuse with intoxication, unspecified non-pressure chronic ulcer of skin of other sites with unspecified severity pain in left shoulder chronic viral hepatitis c other diseases of spleen methicillin resistant staphylococcus aureus infection as the cause of diseases classified elsewhere acute kidney failure, unspecified severe sepsis without septic shock impulse disorder, unspecified anemia, unspecified hypo-osmolality and hyponatremia hypokalemia unspecified asthma, uncomplicated occlusion and stenosis of unspecified cerebral artery thrombocytopenia, unspecified other chronic pain cerebral infarction, unspecified streptococcus, group a, as the cause of diseases classified elsewhere sepsis due to streptococcus, group a metabolic encephalopathy acute and subacute infective endocarditis
white m 41 $nan$hematology blood hematocrit  22.5  %; hematology blood hemoglobin  7.1  g dl; hematology blood platelet count  264  k ul; chemistry blood anion gap  13  meq l; chemistry blood bicarbonate  26  meq l; chemistry blood chloride  98  meq l; chemistry blood creatinine  1.0  mg dl; chemistry blood potassium  3.9  meq l; chemistry blood sodium  133  meq l; chemistry blood urea nitrogen  15  mg dl; chemistry blood glucose  97  mg dl$sodium chloride 0.9%  flush  10  ml ; oxycodone (immediate release)  5-10  mg ; ondansetron  4  mg ; soln  100  ml ; acetaminophen iv  1000  mg ; docusate sodium  100  mg ; metoprolol tartrate  12.5  mg ; furosemide  20  mg ; insulin  0  unit ; aspirin ec  81  mg ; milk of magnesia  30  ml ; albuterol 0.083% neb soln  1  neb ; ipratropium bromide neb  1  neb ; 
unspecified viral hepatitis c without hepatic coma anxiety disorder, unspecified infarction of spleen occlusion and stenosis of other cerebral arteries opioid abuse, uncomplicated sepsis due to methicillin resistant staphylococcus aureus ischemia and infarction of kidney septic arterial embolism major depressive disorder, single episode, unspecified cocaine abuse with intoxication, unspecified non-pressure chronic ulcer of skin of other sites with unspecified severity pain in left shoulder chronic viral hepatitis c other diseases of spleen methicillin resistant staphylococcus aureus infection as the cause of diseases classified elsewhere acute kidney failure, unspecified severe sepsis without septic shock impulse disorder, unspecified anemia, unspecified hypo-osmolality and hyponatremia hypokalemia unspecified asthma, uncomplicated occlusion and stenosis of unspecified cerebral artery thrombocytopenia, unspecified other chronic pain cerebral infarction, unspecified streptococcus, group a, as the cause of diseases classified elsewhere sepsis due to streptococcus, group a metabolic encephalopathy acute and subacute infective endocarditis
white m 41 $nan$hematology blood hematocrit  24.2  %; hematology blood hemoglobin  7.7  g dl; hematology blood platelet count  326  k ul; chemistry blood anion gap  15  meq l; chemistry blood bicarbonate  26  meq l; chemistry blood chloride  95  meq l; chemistry blood creatinine  0.9  mg dl; chemistry blood potassium  4.1  meq l; chemistry blood sodium  132  meq l; chemistry blood urea nitrogen  12  mg dl; chemistry blood glucose  84  mg dl$sodium chloride 0.9%  flush  10  ml ; oxycodone (immediate release)  5-10  mg ; ondansetron  4  mg ; soln  100  ml ; acetaminophen iv  1000  mg ; docusate sodium  100  mg ; metoprolol tartrate  12.5  mg ; aspirin ec  81  mg ; milk of magnesia  30  ml ; albuterol 0.083% neb soln  1  neb ; ipratropium bromide neb  1  neb ; syringe (0.9% sodium chloride)  2  ml ; alteplase (catheter clearance)  1  mg ; 
unspecified viral hepatitis c without hepatic coma anxiety disorder, unspecified infarction of spleen occlusion and stenosis of other cerebral arteries opioid abuse, uncomplicated sepsis due to methicillin resistant staphylococcus aureus ischemia and infarction of kidney septic arterial embolism major depressive disorder, single episode, unspecified cocaine abuse with intoxication, unspecified non-pressure chronic ulcer of skin of other sites with unspecified severity pain in left shoulder chronic viral hepatitis c other diseases of spleen methicillin resistant staphylococcus aureus infection as the cause of diseases classified elsewhere acute kidney failure, unspecified severe sepsis without septic shock impulse disorder, unspecified anemia, unspecified hypo-osmolality and hyponatremia hypokalemia unspecified asthma, uncomplicated occlusion and stenosis of unspecified cerebral artery thrombocytopenia, unspecified other chronic pain cerebral infarction, unspecified streptococcus, group a, as the cause of diseases classified elsewhere sepsis due to streptococcus, group a metabolic encephalopathy acute and subacute infective endocarditis
white m 41 $nan$hematology blood hematocrit  23.7  %; hematology blood hemoglobin  7.4  g dl; hematology blood platelet count  344  k ul; chemistry blood anion gap  13  meq l; chemistry blood bicarbonate  28  meq l; chemistry blood chloride  98  meq l; chemistry blood creatinine  1.0  mg dl; chemistry blood potassium  4.5  meq l; chemistry blood sodium  134  meq l; chemistry blood urea nitrogen  12  mg dl; hematology blood inr(pt)  1.3  ; chemistry blood glucose  90  mg dl$sodium chloride 0.9%  flush  10  ml ; oxycodone (immediate release)  5-10  mg ; ondansetron  4  mg ; soln  100  ml ; acetaminophen iv  1000  mg ; docusate sodium  100  mg ; metoprolol tartrate  12.5  mg ; aspirin ec  81  mg ; milk of magnesia  30  ml ; albuterol 0.083% neb soln  1  neb ; ipratropium bromide neb  1  neb ; syringe (0.9% sodium chloride)  2  ml ; alteplase (catheter clearance)  1  mg ; 
unspecified viral hepatitis c without hepatic coma anxiety disorder, unspecified infarction of spleen occlusion and stenosis of other cerebral arteries opioid abuse, uncomplicated sepsis due to methicillin resistant staphylococcus aureus ischemia and infarction of kidney septic arterial embolism major depressive disorder, single episode, unspecified cocaine abuse with intoxication, unspecified non-pressure chronic ulcer of skin of other sites with unspecified severity pain in left shoulder chronic viral hepatitis c other diseases of spleen methicillin resistant staphylococcus aureus infection as the cause of diseases classified elsewhere acute kidney failure, unspecified severe sepsis without septic shock impulse disorder, unspecified anemia, unspecified hypo-osmolality and hyponatremia hypokalemia unspecified asthma, uncomplicated occlusion and stenosis of unspecified cerebral artery thrombocytopenia, unspecified other chronic pain cerebral infarction, unspecified streptococcus, group a, as the cause of diseases classified elsewhere sepsis due to streptococcus, group a metabolic encephalopathy acute and subacute infective endocarditis
white m 41 $nan$hematology blood hematocrit  23.2  %; hematology blood hemoglobin  7.2  g dl; hematology blood platelet count  326  k ul; chemistry blood chloride  100  meq l; chemistry blood creatinine  0.9  mg dl; chemistry blood potassium  4.2  meq l; chemistry blood sodium  136  meq l; chemistry blood urea nitrogen  11  mg dl$sodium chloride 0.9%  flush  10  ml ; oxycodone (immediate release)  5-10  mg ; ondansetron  4  mg ; docusate sodium  100  mg ; metoprolol tartrate  12.5  mg ; aspirin ec  81  mg ; milk of magnesia  30  ml ; albuterol 0.083% neb soln  1  neb ; ipratropium bromide neb  1  neb ; acetaminophen  1000  mg ; gabapentin  400  mg ; polyethylene glycol  17  g ; 
unspecified viral hepatitis c without hepatic coma anxiety disorder, unspecified infarction of spleen occlusion and stenosis of other cerebral arteries opioid abuse, uncomplicated sepsis due to methicillin resistant staphylococcus aureus ischemia and infarction of kidney septic arterial embolism major depressive disorder, single episode, unspecified cocaine abuse with intoxication, unspecified non-pressure chronic ulcer of skin of other sites with unspecified severity pain in left shoulder chronic viral hepatitis c other diseases of spleen methicillin resistant staphylococcus aureus infection as the cause of diseases classified elsewhere acute kidney failure, unspecified severe sepsis without septic shock impulse disorder, unspecified anemia, unspecified hypo-osmolality and hyponatremia hypokalemia unspecified asthma, uncomplicated occlusion and stenosis of unspecified cerebral artery thrombocytopenia, unspecified other chronic pain cerebral infarction, unspecified streptococcus, group a, as the cause of diseases classified elsewhere sepsis due to streptococcus, group a metabolic encephalopathy acute and subacute infective endocarditis
white m 41 $nan$nan$ondansetron  4  mg ; docusate sodium  100  mg ; metoprolol tartrate  12.5  mg ; aspirin ec  81  mg ; acetaminophen  1000  mg ; gabapentin  400  mg ; polyethylene glycol  17  g ; 
unspecified viral hepatitis c without hepatic coma anxiety disorder, unspecified infarction of spleen occlusion and stenosis of other cerebral arteries opioid abuse, uncomplicated sepsis due to methicillin resistant staphylococcus aureus ischemia and infarction of kidney septic arterial embolism major depressive disorder, single episode, unspecified cocaine abuse with intoxication, unspecified non-pressure chronic ulcer of skin of other sites with unspecified severity pain in left shoulder chronic viral hepatitis c other diseases of spleen methicillin resistant staphylococcus aureus infection as the cause of diseases classified elsewhere acute kidney failure, unspecified severe sepsis without septic shock impulse disorder, unspecified anemia, unspecified hypo-osmolality and hyponatremia hypokalemia unspecified asthma, uncomplicated occlusion and stenosis of unspecified cerebral artery thrombocytopenia, unspecified other chronic pain cerebral infarction, unspecified streptococcus, group a, as the cause of diseases classified elsewhere sepsis due to streptococcus, group a metabolic encephalopathy acute and subacute infective endocarditis
white f 60 $nan$nan$influenza virus vaccine  0.5  ml ; sodium chloride 0.9%  flush  3  ml ; lr  1000  ml ; hydromorphone (dilaudid)  0.25  mg ; 
asthma, unspecified type, unspecified obesity, unspecified endometriosis, site unspecified malignant neoplasm of corpus uteri, except isthmus endometriosis of pelvic peritoneum 
white f 47 $nan$nan$venlafaxine xr  75  mg ; sodium chloride 0.9%  flush  3  ml ; lr  1000  ml ; acetaminophen  325-650  mg ; diphenhydramine  25  mg ; d5w  50  ml ; clindamycin  600  mg ; hydromorphone (dilaudid)  0.125  mg ; hydromorphone (dilaudid)  2-4  mg ; milk of magnesia  30  ml ; ondansetron  4  mg ; lorazepam  0.5  mg ; hydroxyzine  25  mg ; docusate sodium  100  mg ; 
acquired absence of breast and nipple persistent vomiting person boarding or alighting a pedal cycle injured in collision with pedestrian or animal personal history of malignant neoplasm of breast scar conditions and fibrosis of skin other specified disorders of skin fat necrosis of breast 
white f 47 $nan$nan$venlafaxine xr  75  mg ; sodium chloride 0.9%  flush  3  ml ; lr  1000  ml ; acetaminophen  325-650  mg ; diphenhydramine  25  mg ; d5w  50  ml ; clindamycin  600  mg ; hydromorphone (dilaudid)  0.125  mg ; hydromorphone (dilaudid)  2-4  mg ; milk of magnesia  30  ml ; ondansetron  4  mg ; lorazepam  0.5  mg ; hydroxyzine  25  mg ; docusate sodium  100  mg ; clindamycin  300  mg ; 
acquired absence of breast and nipple persistent vomiting person boarding or alighting a pedal cycle injured in collision with pedestrian or animal personal history of malignant neoplasm of breast scar conditions and fibrosis of skin other specified disorders of skin fat necrosis of breast 
white f 69 $temp  99.3  heartrate  110.0  resprate  16.0  o2sat  98.0  sbp  108.0  dbp  62.0  rhythm    pain  2  $hematology blood hematocrit  37.9  %; hematology blood hemoglobin  12.6  g dl; hematology blood platelet count  164  k ul; chemistry blood anion gap  16  meq l; chemistry blood anion gap  17  meq l; chemistry blood bicarbonate  20  meq l; chemistry blood bicarbonate  23  meq l; chemistry blood chloride  96  meq l; chemistry blood chloride  94  meq l; chemistry blood creatinine  0.8  mg dl; chemistry blood creatinine  0.8  mg dl; chemistry blood potassium  4.2  meq l; chemistry blood potassium  3.7  meq l; chemistry blood sodium  133  meq l; chemistry blood sodium  133  meq l; chemistry blood urea nitrogen  14  mg dl; chemistry blood urea nitrogen  15  mg dl; hematology blood inr(pt)  1.4  ; hematology urine wbc  2  # hpf; chemistry blood calcium, total  8.3  mg dl; chemistry blood calcium, total  8.4  mg dl; chemistry blood glucose  97  mg dl; chemistry blood glucose  98  mg dl$influenza vaccine quadrivalent  0.5  ml ; sodium chloride 0.9%  flush  3  ml ; heparin  5000  unit ; acetaminophen  1000  mg ; bupropion xl (once daily)  150  mg ; citalopram  40  mg ; gabapentin  600  mg ; levothyroxine sodium  112  mcg ; levothyroxine sodium  25  mcg ; lidocaine 5% patch  1  ptch ; vitamin d  2000  unit ; sumatriptan succinate  25  mg ; gabapentin  900  mg ; neutra-phos  1  pkt ; benzonatate  100  mg ; iso-osmotic dextrose  50  ml ; ceftriaxone  1  gm ; azithromycin  250  mg ; dextromethorphan polistirex  30  mg ; 
obstructive sleep apnea (adult) (pediatric) other forms of scoliosis, lumbar region hypothyroidism, unspecified radiculopathy, lumbar region major depressive disorder, single episode, unspecified 
white f 69 $nan$hematology blood hematocrit  37.6  %; hematology blood hemoglobin  12.6  g dl; hematology blood platelet count  181  k ul; chemistry blood anion gap  14  meq l; chemistry blood bicarbonate  24  meq l; chemistry blood chloride  98  meq l; chemistry blood creatinine  0.8  mg dl; chemistry blood potassium  4.0  meq l; chemistry blood sodium  136  meq l; chemistry blood urea nitrogen  16  mg dl; chemistry blood calcium, total  8.5  mg dl; chemistry blood glucose  112  mg dl$sodium chloride 0.9%  flush  3  ml ; heparin  5000  unit ; bupropion xl (once daily)  150  mg ; citalopram  40  mg ; gabapentin  600  mg ; levothyroxine sodium  112  mcg ; levothyroxine sodium  25  mcg ; lidocaine 5% patch  1  ptch ; vitamin d  2000  unit ; sumatriptan succinate  25  mg ; gabapentin  900  mg ; neutra-phos  1  pkt ; benzonatate  100  mg ; iso-osmotic dextrose  50  ml ; ceftriaxone  1  gm ; azithromycin  250  mg ; dextromethorphan polistirex  30  mg ; levofloxacin  750  mg ; 
obstructive sleep apnea (adult) (pediatric) other forms of scoliosis, lumbar region hypothyroidism, unspecified radiculopathy, lumbar region major depressive disorder, single episode, unspecified 
white f 69 $nan$hematology blood hematocrit  39.7  %; hematology blood hemoglobin  13.1  g dl; hematology blood platelet count  228  k ul; chemistry blood anion gap  15  meq l; chemistry blood bicarbonate  22  meq l; chemistry blood chloride  101  meq l; chemistry blood creatinine  0.9  mg dl; chemistry blood potassium  3.6  meq l; chemistry blood sodium  138  meq l; chemistry blood urea nitrogen  17  mg dl; chemistry blood calcium, total  8.6  mg dl; chemistry blood glucose  142  mg dl$sodium chloride 0.9%  flush  3  ml ; heparin  5000  unit ; bupropion xl (once daily)  150  mg ; citalopram  40  mg ; gabapentin  600  mg ; levothyroxine sodium  112  mcg ; levothyroxine sodium  25  mcg ; lidocaine 5% patch  1  ptch ; vitamin d  2000  unit ; gabapentin  900  mg ; benzonatate  100  mg ; dextromethorphan polistirex  30  mg ; levofloxacin  750  mg ; 
obstructive sleep apnea (adult) (pediatric) other forms of scoliosis, lumbar region hypothyroidism, unspecified radiculopathy, lumbar region major depressive disorder, single episode, unspecified 
white f 69 $nan$hematology blood hematocrit  39.1  %; hematology blood hemoglobin  12.9  g dl; hematology blood platelet count  284  k ul; chemistry blood anion gap  18  meq l; chemistry blood bicarbonate  22  meq l; chemistry blood chloride  101  meq l; chemistry blood creatinine  0.9  mg dl; chemistry blood potassium  3.7  meq l; chemistry blood sodium  141  meq l; chemistry blood urea nitrogen  17  mg dl; chemistry blood calcium, total  9.0  mg dl; chemistry blood glucose  96  mg dl$sodium chloride 0.9%  flush  3  ml ; heparin  5000  unit ; bupropion xl (once daily)  150  mg ; citalopram  40  mg ; gabapentin  600  mg ; levothyroxine sodium  112  mcg ; levothyroxine sodium  25  mcg ; lidocaine 5% patch  1  ptch ; vitamin d  2000  unit ; gabapentin  900  mg ; benzonatate  100  mg ; dextromethorphan polistirex  30  mg ; levofloxacin  750  mg ; 
obstructive sleep apnea (adult) (pediatric) other forms of scoliosis, lumbar region hypothyroidism, unspecified radiculopathy, lumbar region major depressive disorder, single episode, unspecified 
white m 64 $nan$nan$heparin  5000  unit ; 
 
white m 64 $nan$hematology blood hematocrit  40.8  %; hematology blood hematocrit  28.4  %; hematology blood hemoglobin  14.2  g dl; hematology blood hemoglobin  10.2  g dl; hematology blood platelet count  79  k ul; hematology blood platelet count  68  k ul; hematology blood platelet count  80  k ul; hematology blood platelet count  80  k ul; chemistry blood anion gap  11  meq l; chemistry blood anion gap  11  meq l; chemistry blood bicarbonate  28  meq l; chemistry blood bicarbonate  26  meq l; chemistry blood chloride  101  meq l; chemistry blood chloride  103  meq l; chemistry blood creatinine  0.7  mg dl; chemistry blood creatinine  0.6  mg dl; chemistry blood potassium  4.3  meq l; chemistry blood potassium  4.0  meq l; chemistry blood sodium  136  meq l; chemistry blood sodium  136  meq l; chemistry blood urea nitrogen  22  mg dl; chemistry blood urea nitrogen  18  mg dl; hematology blood inr(pt)  3.4  ; hematology blood inr(pt)  2.3  ; hematology blood inr(pt)  1.8  ; hematology blood inr(pt)  1.9  ; hematology blood inr(pt)  1.5  ; chemistry blood calcium, total  9.8  mg dl; chemistry blood calcium, total  8.6  mg dl; chemistry blood bilirubin, indirect  2.3  mg dl; chemistry blood bilirubin, total  1.2  mg dl; chemistry blood bilirubin, total  4.6  mg dl; chemistry blood glucose  228  mg dl; chemistry blood glucose  86  mg dl; chemistry blood albumin  4.0  g dl; chemistry blood albumin  2.7  g dl; blood gas blood free calcium  1.07  mmol l; blood gas blood free calcium  1.17  mmol l; blood gas blood free calcium  1.17  mmol l; blood gas blood free calcium  0.82  mmol l; blood gas blood free calcium  0.91  mmol l; blood gas blood lactate  1.7  mmol l; blood gas blood lactate  1.8  mmol l; blood gas blood lactate  3.2  mmol l; blood gas blood lactate  3.4  mmol l; blood gas blood lactate  2.2  mmol l; blood gas blood lactate  4.1  mmol l; chemistry blood bilirubin, direct  2.3  mg dl; blood gas blood chloride, whole blood  103  meq l; blood gas blood chloride, whole blood  102  meq l; blood gas blood chloride, whole blood  101  meq l; blood gas blood chloride, whole blood  103  meq l; blood gas blood chloride, whole blood  103  meq l; blood gas blood glucose  174  mg dl; blood gas blood glucose  163  mg dl; blood gas blood glucose  205  mg dl; blood gas blood glucose  237  mg dl; blood gas blood glucose  243  mg dl; blood gas blood hematocrit, calculated  35  %; blood gas blood hematocrit, calculated  32  %; blood gas blood hematocrit, calculated  30  %; blood gas blood hematocrit, calculated  32  %; blood gas blood hematocrit, calculated  32  %; blood gas blood hemoglobin  11.5  g dl; blood gas blood hemoglobin  10.6  g dl; blood gas blood hemoglobin  9.9  g dl; blood gas blood hemoglobin  10.7  g dl; blood gas blood hemoglobin  10.6  g dl; blood gas blood potassium, whole blood  4.3  meq l; blood gas blood potassium, whole blood  4.0  meq l; blood gas blood potassium, whole blood  4.6  meq l; blood gas blood potassium, whole blood  4.8  meq l; blood gas blood potassium, whole blood  4.8  meq l; blood gas blood sodium, whole blood  132  meq l; blood gas blood sodium, whole blood  132  meq l; blood gas blood sodium, whole blood  131  meq l; blood gas blood sodium, whole blood  131  meq l; blood gas blood sodium, whole blood  131  meq l; blood gas blood calculated bicarbonate, whole blood  24  meq l; blood gas blood calculated bicarbonate, whole blood  24  meq l; blood gas blood calculated bicarbonate, whole blood  23  meq l; blood gas blood calculated bicarbonate, whole blood  23  meq l$heparin  5000  unit ; fluconazole  400  mg ; mycophenolate mofetil  1000  mg ; glucose gel  15  g ; 0.9% sodium chloride  50  ml ; methylprednisolone sodium succ  500  mg ; 0.9% sodium chloride (mini bag plus)  100  ml ; ampicillin-sulbactam  3  g ; sodium chloride 0.9%  flush  10  ml ; sulfameth trimethoprim suspension  10  ml ; sulfameth trimethoprim ss  1  tab ; valganciclovir oral solution  450  mg ; d5 1 2ns  1000  ml ; iso-osmotic dextrose  200  ml ; vancomycin  1000  mg ; iso-osmotic dextrose  100  ml ; piperacillin-tazobactam  4.5  g ; docusate sodium  100  mg ; iso-osmotic sodium chloride  1  bag ; famotidine  20  mg ; mycophenolate mofetil suspension  1000  mg ; prochlorperazine  5-10  mg ; ondansetron  4  mg ; dextrose 50%  12.5  gm ; glucagon  1  mg ; propofol  1000  mg ; morphine sulfate  1-4  mg ; insulin  0  unit ; insulin  21  unit ; 
 
white m 64 $nan$hematology blood hematocrit  27.5  %; hematology blood hematocrit  33.0  %; hematology blood hematocrit  33.7  %; hematology blood hematocrit  30.2  %; hematology blood hemoglobin  10.0  g dl; hematology blood hemoglobin  11.8  g dl; hematology blood hemoglobin  12.0  g dl; hematology blood hemoglobin  11.4  g dl; hematology blood platelet count  76  k ul; hematology blood platelet count  67  k ul; hematology blood platelet count  71  k ul; hematology blood platelet count  55  k ul; chemistry blood anion gap  13  meq l; chemistry blood anion gap  13  meq l; chemistry blood anion gap  13  meq l; chemistry blood bicarbonate  22  meq l; chemistry blood bicarbonate  21  meq l; chemistry blood bicarbonate  21  meq l; chemistry blood chloride  101  meq l; chemistry blood chloride  102  meq l; chemistry blood chloride  104  meq l; chemistry blood creatinine  0.7  mg dl; chemistry blood creatinine  0.9  mg dl; chemistry blood creatinine  1.1  mg dl; chemistry blood potassium  4.7  meq l; chemistry blood potassium  4.1  meq l; chemistry blood potassium  4.2  meq l; chemistry blood sodium  131  meq l; chemistry blood sodium  132  meq l; chemistry blood sodium  134  meq l; chemistry blood urea nitrogen  20  mg dl; chemistry blood urea nitrogen  25  mg dl; chemistry blood urea nitrogen  30  mg dl; hematology blood inr(pt)  1.5  ; hematology blood inr(pt)  1.4  ; hematology blood inr(pt)  1.6  ; hematology blood inr(pt)  1.9  ; chemistry blood calcium, total  7.7  mg dl; chemistry blood calcium, total  8.0  mg dl; chemistry blood calcium, total  7.9  mg dl; chemistry blood bilirubin, indirect  1.4  mg dl; chemistry blood bilirubin, indirect  0.9  mg dl; chemistry blood bilirubin, total  3.8  mg dl; chemistry blood bilirubin, total  2.4  mg dl; chemistry blood bilirubin, total  1.3  mg dl; chemistry blood glucose  392  mg dl; chemistry blood glucose  246  mg dl; chemistry blood glucose  79  mg dl; chemistry blood albumin  2.6  g dl; chemistry blood albumin  2.6  g dl; chemistry blood albumin  2.5  g dl; blood gas blood free calcium  1.13  mmol l; blood gas blood lactate  2.5  mmol l; blood gas blood lactate  2.5  mmol l; blood gas blood lactate  1.8  mmol l; blood gas blood lactate  1.4  mmol l; chemistry blood bilirubin, direct  2.4  mg dl; chemistry blood bilirubin, direct  1.5  mg dl; blood gas blood chloride, whole blood  101  meq l; blood gas blood glucose  364  mg dl; blood gas blood glucose  77  mg dl; blood gas blood potassium, whole blood  4.6  meq l; blood gas blood sodium, whole blood  127  meq l$heparin  5000  unit ; sodium chloride 0.9%  flush  10  ml ; sulfameth trimethoprim suspension  10  ml ; sulfameth trimethoprim ss  1  tab ; valganciclovir oral solution  450  mg ; iso-osmotic sodium chloride  1  bag ; famotidine  20  mg ; mycophenolate mofetil suspension  1000  mg ; prochlorperazine  5-10  mg ; ondansetron  4  mg ; dextrose 50%  12.5  gm ; glucagon  1  mg ; propofol  1000  mg ; morphine sulfate  1-4  mg ; insulin  0  unit ; insulin  21  unit ; bag  1  bag ; magnesium sulfate  2  gm ; 0.45% sodium chloride  1000  ml ; dextrose 5%  1000  ml ; 0.9% sodium chloride  100  ml ; insulin human regular  100  unit ; methylprednisolone sodium succ  200  mg ; sodium chloride 0.9%  1000  ml ; tacrolimus  1  mg ; insulin  6  unit ; 
 
white m 64 $nan$hematology blood hematocrit  26.6  %; hematology blood hematocrit  28.0  %; hematology blood hematocrit  28.0  %; hematology blood hematocrit  29.1  %; hematology blood hematocrit  30.2  %; hematology blood hemoglobin  10.3  g dl; hematology blood hemoglobin  10.4  g dl; hematology blood hemoglobin  10.5  g dl; hematology blood hemoglobin  10.8  g dl; hematology blood platelet count  47  k ul; hematology blood platelet count  52  k ul; hematology blood platelet count  56  k ul; hematology blood platelet count  55  k ul; chemistry blood anion gap  14  meq l; chemistry blood anion gap  15  meq l; chemistry blood anion gap  14  meq l; chemistry blood bicarbonate  20  meq l; chemistry blood bicarbonate  19  meq l; chemistry blood bicarbonate  21  meq l; chemistry blood chloride  102  meq l; chemistry blood chloride  103  meq l; chemistry blood chloride  102  meq l; chemistry blood creatinine  0.9  mg dl; chemistry blood creatinine  0.8  mg dl; chemistry blood creatinine  0.8  mg dl; chemistry blood potassium  4.5  meq l; chemistry blood potassium  5.0  meq l; chemistry blood potassium  5.5  meq l; chemistry blood sodium  131  meq l; chemistry blood sodium  132  meq l; chemistry blood sodium  131  meq l; chemistry blood urea nitrogen  37  mg dl; chemistry blood urea nitrogen  37  mg dl; chemistry blood urea nitrogen  40  mg dl; hematology blood inr(pt)  1.8  ; hematology blood inr(pt)  1.6  ; chemistry blood calcium, total  7.5  mg dl; chemistry blood calcium, total  7.2  mg dl; chemistry blood calcium, total  7.5  mg dl; chemistry blood bilirubin, total  1.0  mg dl; chemistry blood bilirubin, total  1.0  mg dl; chemistry blood glucose  209  mg dl; chemistry blood glucose  192  mg dl; chemistry blood glucose  323  mg dl; blood gas blood free calcium  1.12  mmol l; blood gas blood free calcium  1.09  mmol l; blood gas blood lactate  2.2  mmol l; blood gas blood lactate  2.4  mmol l$heparin  5000  unit ; sodium chloride 0.9%  flush  10  ml ; sulfameth trimethoprim suspension  10  ml ; sulfameth trimethoprim ss  1  tab ; valganciclovir oral solution  450  mg ; iso-osmotic sodium chloride  1  bag ; famotidine  20  mg ; mycophenolate mofetil suspension  1000  mg ; prochlorperazine  5-10  mg ; ondansetron  4  mg ; dextrose 50%  12.5  gm ; glucagon  1  mg ; propofol  1000  mg ; morphine sulfate  1-4  mg ; bag  1  bag ; magnesium sulfate  2  gm ; 0.45% sodium chloride  1000  ml ; methylprednisolone sodium succ  200  mg ; sodium chloride 0.9%  1000  ml ; insulin  6  unit ; 0.9% sodium chloride  1  bag ; calcium gluconate  2  g ; 0.9% sodium chloride  2  bag ; calcium gluconate  4  g ; methylprednisolone sodium succ  150  mg ; aspirin  81  mg ; hydromorphone (dilaudid)  0.125-0.5  mg ; oxycodone (immediate release)   5-10  mg ; tacrolimus  2  mg ; senna  8.6  mg ; insulin  30  unit ; insulin  20  unit ; heparin flush (10 units ml)  1  ml ; 
 
white m 64 $nan$hematology blood hematocrit  28.7  %; hematology blood hemoglobin  10.0  g dl; hematology blood platelet count  61  k ul; chemistry blood anion gap  11  meq l; chemistry blood bicarbonate  24  meq l; chemistry blood chloride  104  meq l; chemistry blood creatinine  0.7  mg dl; chemistry blood potassium  5.0  meq l; chemistry blood sodium  134  meq l; chemistry blood urea nitrogen  34  mg dl; hematology blood inr(pt)  1.5  ; chemistry blood calcium, total  7.7  mg dl; chemistry blood bilirubin, total  0.7  mg dl; chemistry blood glucose  168  mg dl; chemistry blood albumin  2.4  g dl$heparin  5000  unit ; sulfameth trimethoprim ss  1  tab ; valganciclovir oral solution  450  mg ; prochlorperazine  5-10  mg ; ondansetron  4  mg ; dextrose 50%  12.5  gm ; glucagon  1  mg ; methylprednisolone sodium succ  150  mg ; oxycodone (immediate release)   5-10  mg ; tacrolimus  2  mg ; senna  8.6  mg ; heparin flush (10 units ml)  1  ml ; methylprednisolone sodium succ  100  mg ; aspirin  325  mg ; transplant self medication program  1  bag ; novolog flexpen  0  unit ; sodium chloride 0.9%  flush  3  ml ; tacrolimus  4  mg ; insulin  35  unit ; 
 
white m 64 $nan$hematology blood hematocrit  30.3  %; hematology blood hemoglobin  10.9  g dl; hematology blood platelet count  56  k ul; chemistry blood anion gap  11  meq l; chemistry blood bicarbonate  24  meq l; chemistry blood chloride  105  meq l; chemistry blood creatinine  0.8  mg dl; chemistry blood potassium  4.4  meq l; chemistry blood sodium  136  meq l; chemistry blood urea nitrogen  31  mg dl; chemistry blood calcium, total  7.9  mg dl; chemistry blood bilirubin, total  0.6  mg dl; chemistry blood glucose  92  mg dl; chemistry blood albumin  2.5  g dl$heparin  5000  unit ; prochlorperazine  5-10  mg ; ondansetron  4  mg ; dextrose 50%  12.5  gm ; glucagon  1  mg ; oxycodone (immediate release)   5-10  mg ; tacrolimus  2  mg ; senna  8.6  mg ; heparin flush (10 units ml)  1  ml ; aspirin  325  mg ; transplant self medication program  1  bag ; novolog flexpen  0  unit ; sodium chloride 0.9%  flush  3  ml ; tacrolimus  4  mg ; insulin  35  unit ; albumin 25% (12.5g   50ml)  25  g ; valganciclovir  450  mg ; insulin aspart  0  unit ; tacrolimus  3  mg ; insulin  38  unit ; 
 
white m 64 $nan$hematology blood hematocrit  31.5  %; hematology blood hemoglobin  11.3  g dl; hematology blood platelet count  81  k ul; chemistry blood anion gap  11  meq l; chemistry blood bicarbonate  27  meq l; chemistry blood chloride  102  meq l; chemistry blood creatinine  0.8  mg dl; chemistry blood potassium  4.4  meq l; chemistry blood sodium  136  meq l; chemistry blood urea nitrogen  28  mg dl; chemistry blood calcium, total  8.2  mg dl; chemistry blood bilirubin, total  1.2  mg dl; chemistry blood glucose  95  mg dl; chemistry blood albumin  3.8  g dl$heparin  5000  unit ; prochlorperazine  5-10  mg ; ondansetron  4  mg ; dextrose 50%  12.5  gm ; glucagon  1  mg ; oxycodone (immediate release)   5-10  mg ; senna  8.6  mg ; aspirin  325  mg ; transplant self medication program  1  bag ; novolog flexpen  0  unit ; sodium chloride 0.9%  flush  3  ml ; albumin 25% (12.5g   50ml)  25  g ; tacrolimus  3  mg ; insulin  38  unit ; valganciclovir  900  mg ; lidocaine 1%  2  ml ; insulin lispro  0  unit ; 
 
white m 64 $nan$hematology blood hematocrit  26.0  %; hematology blood hemoglobin  9.2  g dl; hematology blood platelet count  58  k ul; chemistry blood anion gap  12  meq l; chemistry blood bicarbonate  26  meq l; chemistry blood chloride  103  meq l; chemistry blood creatinine  0.8  mg dl; chemistry blood potassium  4.8  meq l; chemistry blood sodium  136  meq l; chemistry blood urea nitrogen  25  mg dl; chemistry blood calcium, total  8.2  mg dl; chemistry blood bilirubin, total  1.0  mg dl; chemistry blood glucose  123  mg dl; chemistry blood albumin  3.9  g dl$heparin  5000  unit ; prochlorperazine  5-10  mg ; ondansetron  4  mg ; dextrose 50%  12.5  gm ; glucagon  1  mg ; oxycodone (immediate release)   5-10  mg ; senna  8.6  mg ; aspirin  325  mg ; transplant self medication program  1  bag ; novolog flexpen  0  unit ; sodium chloride 0.9%  flush  3  ml ; albumin 25% (12.5g   50ml)  25  g ; valganciclovir  900  mg ; insulin lispro  0  unit ; novolog flexpen  0  units ; insulin  24  unit ; 
 
white f 87 $temp  97.9  heartrate  76.0  resprate  14.0  o2sat  97.0  sbp  149.0  dbp  60.0  rhythm    pain  7  ; temp    heartrate  80.0  resprate  20.0  o2sat  96.0  sbp  139.0  dbp  69.0  rhythm    pain  8  ; temp  97.5  heartrate  79.0  resprate  20.0  o2sat    sbp    dbp    rhythm    pain  6  ; temp    heartrate  87.0  resprate  20.0  o2sat  95.0  sbp  128.0  dbp  63.0  rhythm    pain  7  ; temp  98.1  heartrate  79.0  resprate  18.0  o2sat  94.0  sbp  127.0  dbp  63.0  rhythm    pain  7  ; temp    heartrate  65.0  resprate  20.0  o2sat  96.0  sbp  143.0  dbp  62.0  rhythm    pain  10  ; temp  97.3  heartrate  66.0  resprate  18.0  o2sat  99.0  sbp  164.0  dbp  73.0  rhythm    pain  9  $hematology urine wbc  1  # hpf$nan
gastro-esophageal reflux disease without esophagitis essential (primary) hypertension hyperlipidemia, unspecified other lesions of median nerve, right upper limb polyneuropathy, unspecified fall (on) (from) unspecified stairs and steps, initial encounter colles' fracture of right radius, initial encounter for closed fracture 
white f 87 $nan$nan$oxycodone (immediate release)  10  mg ; sodium chloride 0.9%  flush  3-10  ml ; docusate sodium  100  mg ; tramadol  50  mg ; acetaminophen  1000  mg ; oxycodone (immediate release)  2.5  mg ; heparin  5000  unit ; oxycodone (immediate release)  5  mg ; lidocaine 5% patch  1  ptch ; 
gastro-esophageal reflux disease without esophagitis essential (primary) hypertension hyperlipidemia, unspecified other lesions of median nerve, right upper limb polyneuropathy, unspecified fall (on) (from) unspecified stairs and steps, initial encounter colles' fracture of right radius, initial encounter for closed fracture 
white f 87 $nan$nan$sodium chloride 0.9%  flush  3-10  ml ; docusate sodium  100  mg ; tramadol  50  mg ; acetaminophen  1000  mg ; heparin  5000  unit ; oxycodone (immediate release)  5  mg ; ibuprofen  400  mg ; amlodipine  10  mg ; brimonidine tartrate 0.15% ophth.  1  drop ; furosemide  20  mg ; mirtazapine  15  mg ; oxycodone sr (oxycontin)  10  mg ; simvastatin  5  mg ; timolol maleate 0.5%  1  drop ; 
gastro-esophageal reflux disease without esophagitis essential (primary) hypertension hyperlipidemia, unspecified other lesions of median nerve, right upper limb polyneuropathy, unspecified fall (on) (from) unspecified stairs and steps, initial encounter colles' fracture of right radius, initial encounter for closed fracture 
white f 87 $nan$nan$sodium chloride 0.9%  flush  3-10  ml ; docusate sodium  100  mg ; tramadol  50  mg ; acetaminophen  1000  mg ; heparin  5000  unit ; oxycodone (immediate release)  5  mg ; ibuprofen  400  mg ; amlodipine  10  mg ; brimonidine tartrate 0.15% ophth.  1  drop ; furosemide  20  mg ; mirtazapine  15  mg ; oxycodone sr (oxycontin)  10  mg ; simvastatin  5  mg ; timolol maleate 0.5%  1  drop ; 
gastro-esophageal reflux disease without esophagitis essential (primary) hypertension hyperlipidemia, unspecified other lesions of median nerve, right upper limb polyneuropathy, unspecified fall (on) (from) unspecified stairs and steps, initial encounter colles' fracture of right radius, initial encounter for closed fracture 
white f 87 $nan$nan$sodium chloride 0.9%  flush  3-10  ml ; docusate sodium  100  mg ; tramadol  50  mg ; acetaminophen  1000  mg ; heparin  5000  unit ; oxycodone (immediate release)  5  mg ; ibuprofen  400  mg ; amlodipine  10  mg ; brimonidine tartrate 0.15% ophth.  1  drop ; furosemide  20  mg ; mirtazapine  15  mg ; oxycodone sr (oxycontin)  10  mg ; simvastatin  5  mg ; timolol maleate 0.5%  1  drop ; pantoprazole  40  mg ; polyethylene glycol  17  g ; milk of magnesia  30  ml ; senna  8.6  mg ; 
gastro-esophageal reflux disease without esophagitis essential (primary) hypertension hyperlipidemia, unspecified other lesions of median nerve, right upper limb polyneuropathy, unspecified fall (on) (from) unspecified stairs and steps, initial encounter colles' fracture of right radius, initial encounter for closed fracture 
white f 33 $temp  98.0  heartrate  67.0  resprate  14.0  o2sat  98.0  sbp  138.0  dbp  64.0  rhythm    pain  8  ; temp  98.2  heartrate  68.0  resprate  18.0  o2sat  99.0  sbp  136.0  dbp  66.0  rhythm    pain  7  $nan$nicotine patch  7  mg ; lidocaine 5% patch  1  ptch ; 
cutaneous abscess of right hand vascular complications following infusion, transfusion and therapeutic injection, initial encounter other streptococcus as the cause of diseases classified elsewhere methicillin resistant staphylococcus aureus infection as the cause of diseases classified elsewhere anxiety disorder, unspecified patient room in hospital as the place of occurrence of the external cause cellulitis of right upper limb other staphylococcus as the cause of diseases classified elsewhere personal history of infections of the central nervous system phlebitis and thrombophlebitis of other sites atrial septal defect other psychoactive substance abuse, uncomplicated nicotine dependence, cigarettes, uncomplicated gangrene, not elsewhere classified post-traumatic stress disorder, unspecified personal history of other infectious and parasitic diseases other medical procedures as the cause of abnormal reaction of the patient, or of later complication, without mention of misadventure at the time of the procedure 
white f 33 $temp  98.2  heartrate  68.0  resprate  12.0  o2sat  99.0  sbp  130.0  dbp  68.0  rhythm    pain  7  $hematology blood hematocrit  34.2  %; hematology blood hematocrit  37.0  %; hematology blood hemoglobin  11.7  g dl; hematology blood hemoglobin  12.4  g dl; hematology blood platelet count  182  k ul; hematology blood platelet count  185  k ul; chemistry blood anion gap  18  meq l; chemistry blood anion gap  17  meq l; chemistry blood bicarbonate  24  meq l; chemistry blood bicarbonate  25  meq l; chemistry blood chloride  104  meq l; chemistry blood chloride  102  meq l; chemistry blood creatinine  0.9  mg dl; chemistry blood creatinine  0.8  mg dl; chemistry blood potassium  4.0  meq l; chemistry blood potassium  4.2  meq l; chemistry blood sodium  142  meq l; chemistry blood sodium  140  meq l; chemistry blood urea nitrogen  10  mg dl; chemistry blood urea nitrogen  11  mg dl; hematology blood inr(pt)  0.9  ; hematology blood inr(pt)  1.0  ; chemistry blood calcium, total  9.9  mg dl; chemistry blood calcium, total  9.3  mg dl; chemistry blood glucose  73  mg dl; chemistry blood glucose  108  mg dl$nicotine patch  7  mg ; lidocaine 5% patch  1  ptch ; sodium chloride 0.9%  flush  3  ml ; senna  8.6  mg ; docusate sodium  100  mg ; heparin  5000  unit ; cepacol (sore throat lozenge)  2  loz ; oxycodone liquid  5-10  mg ; acetaminophen  1000  mg ; clonazepam  1  mg ; ranitidine  75  mg ; amphetamine-dextroamphetamine  20  mg ; amphetamine-dextroamphetamine xr  20  mg ; amphetamine-dextroamphetamine xr  10  mg ; gabapentin  200  mg ; venlafaxine xr  225  mg ; oxycodone (immediate release)  5-10  mg ; 
cutaneous abscess of right hand vascular complications following infusion, transfusion and therapeutic injection, initial encounter other streptococcus as the cause of diseases classified elsewhere methicillin resistant staphylococcus aureus infection as the cause of diseases classified elsewhere anxiety disorder, unspecified patient room in hospital as the place of occurrence of the external cause cellulitis of right upper limb other staphylococcus as the cause of diseases classified elsewhere personal history of infections of the central nervous system phlebitis and thrombophlebitis of other sites atrial septal defect other psychoactive substance abuse, uncomplicated nicotine dependence, cigarettes, uncomplicated gangrene, not elsewhere classified post-traumatic stress disorder, unspecified personal history of other infectious and parasitic diseases other medical procedures as the cause of abnormal reaction of the patient, or of later complication, without mention of misadventure at the time of the procedure 
white f 33 $nan$hematology blood hematocrit  32.4  %; hematology blood hemoglobin  10.9  g dl; hematology blood platelet count  167  k ul; chemistry blood anion gap  14  meq l; chemistry blood bicarbonate  26  meq l; chemistry blood chloride  105  meq l; chemistry blood creatinine  0.7  mg dl; chemistry blood potassium  3.9  meq l; chemistry blood sodium  141  meq l; chemistry blood urea nitrogen  7  mg dl; hematology blood inr(pt)  0.9  ; chemistry blood calcium, total  8.7  mg dl; chemistry blood glucose  129  mg dl$nicotine patch  7  mg ; lidocaine 5% patch  1  ptch ; sodium chloride 0.9%  flush  3  ml ; senna  8.6  mg ; docusate sodium  100  mg ; heparin  5000  unit ; cepacol (sore throat lozenge)  2  loz ; acetaminophen  1000  mg ; clonazepam  1  mg ; ranitidine  75  mg ; gabapentin  200  mg ; venlafaxine xr  225  mg ; oxycodone (immediate release)  5-10  mg ; fentanyl citrate  25-50  mcg ; meperidine  12.5  mg ; promethazine  6.25  mg ; lactated ringers  1000  ml ; iso-osmotic dextrose  100  ml ; cefazolin  2  g ; cephalexin  500  mg ; 
cutaneous abscess of right hand vascular complications following infusion, transfusion and therapeutic injection, initial encounter other streptococcus as the cause of diseases classified elsewhere methicillin resistant staphylococcus aureus infection as the cause of diseases classified elsewhere anxiety disorder, unspecified patient room in hospital as the place of occurrence of the external cause cellulitis of right upper limb other staphylococcus as the cause of diseases classified elsewhere personal history of infections of the central nervous system phlebitis and thrombophlebitis of other sites atrial septal defect other psychoactive substance abuse, uncomplicated nicotine dependence, cigarettes, uncomplicated gangrene, not elsewhere classified post-traumatic stress disorder, unspecified personal history of other infectious and parasitic diseases other medical procedures as the cause of abnormal reaction of the patient, or of later complication, without mention of misadventure at the time of the procedure 
white f 33 $nan$nan$nicotine patch  7  mg ; lidocaine 5% patch  1  ptch ; sodium chloride 0.9%  flush  3  ml ; senna  8.6  mg ; docusate sodium  100  mg ; heparin  5000  unit ; cepacol (sore throat lozenge)  2  loz ; acetaminophen  1000  mg ; clonazepam  1  mg ; ranitidine  75  mg ; gabapentin  200  mg ; venlafaxine xr  225  mg ; oxycodone (immediate release)  5-10  mg ; 
cutaneous abscess of right hand vascular complications following infusion, transfusion and therapeutic injection, initial encounter other streptococcus as the cause of diseases classified elsewhere methicillin resistant staphylococcus aureus infection as the cause of diseases classified elsewhere anxiety disorder, unspecified patient room in hospital as the place of occurrence of the external cause cellulitis of right upper limb other staphylococcus as the cause of diseases classified elsewhere personal history of infections of the central nervous system phlebitis and thrombophlebitis of other sites atrial septal defect other psychoactive substance abuse, uncomplicated nicotine dependence, cigarettes, uncomplicated gangrene, not elsewhere classified post-traumatic stress disorder, unspecified personal history of other infectious and parasitic diseases other medical procedures as the cause of abnormal reaction of the patient, or of later complication, without mention of misadventure at the time of the procedure 
other m 30 $temp    heartrate  73.0  resprate  16.0  o2sat  98.0  sbp  98.0  dbp  50.0  rhythm    pain    ; temp    heartrate  82.0  resprate  12.0  o2sat    sbp  106.0  dbp  65.0  rhythm    pain    $hematology blood hematocrit  43.8  %; hematology blood hematocrit  40.5  %; hematology blood hemoglobin  14.4  g dl; hematology blood hemoglobin  13.9  g dl; hematology blood platelet count  205  k ul; hematology blood platelet count  199  k ul; chemistry blood anion gap  14  meq l; chemistry blood anion gap  15  meq l; chemistry blood bicarbonate  23  meq l; chemistry blood bicarbonate  23  meq l; chemistry blood chloride  104  meq l; chemistry blood chloride  106  meq l; chemistry blood creatinine  0.9  mg dl; chemistry blood creatinine  0.8  mg dl; chemistry blood potassium  4.8  meq l; chemistry blood potassium  4.5  meq l; chemistry blood sodium  136  meq l; chemistry blood sodium  139  meq l; chemistry blood urea nitrogen  17  mg dl; chemistry blood urea nitrogen  16  mg dl; chemistry blood calcium, total  8.7  mg dl; chemistry blood bilirubin, total  0.2  mg dl; chemistry blood glucose  132  mg dl; blood gas blood lactate  1.1  mmol l; blood gas blood potassium, whole blood  4.9  meq l; blood gas blood potassium, whole blood  2.2  meq l$sodium chloride 0.9%  flush  3  ml ; heparin  5000  unit ; pregabalin  300  mg ; 0.9% sodium chloride  1000  ml ; docusate sodium  100  mg ; mirtazapine  30  mg ; senna  1  tab ; 
rhabdomyolysis other accidents acute kidney failure with lesion of tubular necrosis opioid abuse, unspecified adjustment disorder with depressed mood acute posthemorrhagic anemia hyposmolality and/or hyponatremia acidosis traumatic compartment syndrome of upper extremity carpal tunnel syndrome
other m 30 $nan$nan$sodium chloride 0.9%  flush  3  ml ; heparin  5000  unit ; pregabalin  300  mg ; docusate sodium  100  mg ; mirtazapine  30  mg ; senna  1  tab ; acetaminophen  1000  mg ; 
rhabdomyolysis other accidents acute kidney failure with lesion of tubular necrosis opioid abuse, unspecified adjustment disorder with depressed mood acute posthemorrhagic anemia hyposmolality and/or hyponatremia acidosis traumatic compartment syndrome of upper extremity carpal tunnel syndrome
black african american f 36 $temp  98.6  heartrate  104.0  resprate  16.0  o2sat  98.0  sbp  138.0  dbp  77.0  rhythm    pain  0  $hematology blood hematocrit  37.2  %; hematology blood hemoglobin  12.4  g dl; hematology blood platelet count  182  k ul; chemistry blood anion gap  14  meq l; chemistry blood bicarbonate  29  meq l; chemistry blood chloride  101  meq l; chemistry blood creatinine  0.7  mg dl; chemistry blood potassium  3.7  meq l; chemistry blood sodium  140  meq l; chemistry blood urea nitrogen  11  mg dl; hematology blood inr(pt)  1.1  ; chemistry blood calcium, total  8.6  mg dl; chemistry blood glucose  96  mg dl$sodium chloride 0.9%  flush  3  ml ; heparin  5000  unit ; acetaminophen  325-650  mg ; docusate sodium  100  mg ; senna  17.2  mg ; amlodipine  10  mg ; lorazepam  0.5  mg ; methocarbamol  500  mg ; ondansetron  4-8  mg ; metoclopramide  5-10  mg ; sodium chloride 0.9%  1000  ml ; sertraline  25  mg ; calcium carbonate  500  mg ; ondansetron  8  mg ; 
obesity, unspecified retention of urine, unspecified other disorders of meninges, not elsewhere classified other surgical procedures as the cause of abnormal reaction of the patient, or of later complication, without mention of misadventure at the time of the procedure essential (primary) hypertension body mass index (bmi) 50.0-59.9, adult unspecified place or not applicable anxiety disorder, unspecified personal history of nicotine dependence other postprocedural complications and disorders of nervous system bacteriuria hyperlipidemia, unspecified body mass index (bmi) 50.0-59.9, adult personal history of nicotine dependence compression of brain morbid (severe) obesity due to excess calories anxiety disorder, unspecified encounter for immunization essential (primary) hypertension 
black african american f 36 $nan$chemistry blood anion gap  13  meq l; chemistry blood bicarbonate  29  meq l; chemistry blood chloride  102  meq l; chemistry blood creatinine  0.7  mg dl; chemistry blood potassium  3.5  meq l; chemistry blood sodium  140  meq l; chemistry blood urea nitrogen  6  mg dl; chemistry blood calcium, total  8.7  mg dl; chemistry blood glucose  102  mg dl$sodium chloride 0.9%  flush  3  ml ; heparin  5000  unit ; acetaminophen  325-650  mg ; docusate sodium  100  mg ; senna  17.2  mg ; amlodipine  10  mg ; lorazepam  0.5  mg ; ondansetron  4-8  mg ; metoclopramide  5-10  mg ; sodium chloride 0.9%  1000  ml ; sertraline  25  mg ; calcium carbonate  500  mg ; ondansetron  8  mg ; 
obesity, unspecified retention of urine, unspecified other disorders of meninges, not elsewhere classified other surgical procedures as the cause of abnormal reaction of the patient, or of later complication, without mention of misadventure at the time of the procedure essential (primary) hypertension body mass index (bmi) 50.0-59.9, adult unspecified place or not applicable anxiety disorder, unspecified personal history of nicotine dependence other postprocedural complications and disorders of nervous system bacteriuria hyperlipidemia, unspecified body mass index (bmi) 50.0-59.9, adult personal history of nicotine dependence compression of brain morbid (severe) obesity due to excess calories anxiety disorder, unspecified encounter for immunization essential (primary) hypertension 
black african american f 36 $nan$hematology blood hematocrit  37.5  %; hematology blood hemoglobin  12.3  g dl; hematology blood platelet count  183  k ul; chemistry blood anion gap  17  meq l; chemistry blood bicarbonate  25  meq l; chemistry blood chloride  105  meq l; chemistry blood creatinine  0.7  mg dl; chemistry blood potassium  3.6  meq l; chemistry blood sodium  143  meq l; chemistry blood urea nitrogen  4  mg dl; hematology blood inr(pt)  1.1  ; chemistry blood calcium, total  8.6  mg dl; chemistry blood glucose  93  mg dl$sodium chloride 0.9%  flush  3  ml ; heparin  5000  unit ; acetaminophen  325-650  mg ; docusate sodium  100  mg ; senna  17.2  mg ; amlodipine  10  mg ; lorazepam  0.5  mg ; metoclopramide  5-10  mg ; sodium chloride 0.9%  1000  ml ; sertraline  25  mg ; calcium carbonate  500  mg ; ondansetron  8  mg ; 
obesity, unspecified retention of urine, unspecified other disorders of meninges, not elsewhere classified other surgical procedures as the cause of abnormal reaction of the patient, or of later complication, without mention of misadventure at the time of the procedure essential (primary) hypertension body mass index (bmi) 50.0-59.9, adult unspecified place or not applicable anxiety disorder, unspecified personal history of nicotine dependence other postprocedural complications and disorders of nervous system bacteriuria hyperlipidemia, unspecified body mass index (bmi) 50.0-59.9, adult personal history of nicotine dependence compression of brain morbid (severe) obesity due to excess calories anxiety disorder, unspecified encounter for immunization essential (primary) hypertension 
black african american f 36 $nan$nan$sodium chloride 0.9%  flush  3  ml ; heparin  5000  unit ; acetaminophen  325-650  mg ; docusate sodium  100  mg ; senna  17.2  mg ; amlodipine  10  mg ; lorazepam  0.5  mg ; metoclopramide  5-10  mg ; sertraline  25  mg ; calcium carbonate  500  mg ; ondansetron  8  mg ; 
obesity, unspecified retention of urine, unspecified other disorders of meninges, not elsewhere classified other surgical procedures as the cause of abnormal reaction of the patient, or of later complication, without mention of misadventure at the time of the procedure essential (primary) hypertension body mass index (bmi) 50.0-59.9, adult unspecified place or not applicable anxiety disorder, unspecified personal history of nicotine dependence other postprocedural complications and disorders of nervous system bacteriuria hyperlipidemia, unspecified body mass index (bmi) 50.0-59.9, adult personal history of nicotine dependence compression of brain morbid (severe) obesity due to excess calories anxiety disorder, unspecified encounter for immunization essential (primary) hypertension 
white f 33 $nan$nan$nephrocaps  1  cap ; lidocaine 5% patch  1  ptch ; labetalol  100  mg ; 
panic disorder without agoraphobia osteoarthrosis, localized, not specified whether primary or secondary, ankle and foot scoliosis [and kyphoscoliosis], idiopathic 
white f 33 $nan$nan$nephrocaps  1  cap ; lidocaine 5% patch  1  ptch ; labetalol  100  mg ; docusate sodium  100  mg ; acetaminophen  650  mg ; calcium carbonate  500  mg ; milk of magnesia  15-30  ml ; alprazolam  0.5  mg ; alprazolam  1  mg ; buprenorphine  4  mg ; sodium chloride 0.9%  flush  3  ml ; dextrose 50%  12.5  gm ; glucagon  1  mg ; insulin  0  unit ; 
panic disorder without agoraphobia osteoarthrosis, localized, not specified whether primary or secondary, ankle and foot scoliosis [and kyphoscoliosis], idiopathic 
white f 33 $nan$nan$nephrocaps  1  cap ; lidocaine 5% patch  1  ptch ; labetalol  100  mg ; docusate sodium  100  mg ; acetaminophen  650  mg ; calcium carbonate  500  mg ; milk of magnesia  15-30  ml ; alprazolam  0.5  mg ; alprazolam  1  mg ; sodium chloride 0.9%  flush  3  ml ; dextrose 50%  12.5  gm ; glucagon  1  mg ; insulin  0  unit ; buprenorphine  6  mg ; insulin  5  unit ; 
panic disorder without agoraphobia osteoarthrosis, localized, not specified whether primary or secondary, ankle and foot scoliosis [and kyphoscoliosis], idiopathic 
white f 33 $nan$hematology blood hematocrit  37.5  %; hematology blood hemoglobin  12.2  g dl; hematology blood platelet count  256  k ul; chemistry blood creatinine  0.4  mg dl; chemistry blood % hemoglobin a1c  7.5  %$nephrocaps  1  cap ; lidocaine 5% patch  1  ptch ; labetalol  100  mg ; docusate sodium  100  mg ; acetaminophen  650  mg ; calcium carbonate  500  mg ; milk of magnesia  15-30  ml ; alprazolam  0.5  mg ; alprazolam  1  mg ; sodium chloride 0.9%  flush  3  ml ; dextrose 50%  12.5  gm ; glucagon  1  mg ; buprenorphine  6  mg ; insulin  5  unit ; insulin  10  unit ; insulin  12  unit ; ranitidine  150  mg ; 
panic disorder without agoraphobia osteoarthrosis, localized, not specified whether primary or secondary, ankle and foot scoliosis [and kyphoscoliosis], idiopathic 
white f 33 $nan$nan$nephrocaps  1  cap ; lidocaine 5% patch  1  ptch ; labetalol  100  mg ; docusate sodium  100  mg ; acetaminophen  650  mg ; calcium carbonate  500  mg ; milk of magnesia  15-30  ml ; alprazolam  0.5  mg ; alprazolam  1  mg ; sodium chloride 0.9%  flush  3  ml ; dextrose 50%  12.5  gm ; glucagon  1  mg ; buprenorphine  6  mg ; insulin  12  unit ; ranitidine  150  mg ; insulin  20  unit ; 
panic disorder without agoraphobia osteoarthrosis, localized, not specified whether primary or secondary, ankle and foot scoliosis [and kyphoscoliosis], idiopathic 
white f 33 $nan$nan$nephrocaps  1  cap ; lidocaine 5% patch  1  ptch ; labetalol  100  mg ; docusate sodium  100  mg ; acetaminophen  650  mg ; calcium carbonate  500  mg ; milk of magnesia  15-30  ml ; alprazolam  0.5  mg ; alprazolam  1  mg ; sodium chloride 0.9%  flush  3  ml ; dextrose 50%  12.5  gm ; glucagon  1  mg ; buprenorphine  6  mg ; ranitidine  150  mg ; insulin  20  unit ; insulin  24  unit ; 
panic disorder without agoraphobia osteoarthrosis, localized, not specified whether primary or secondary, ankle and foot scoliosis [and kyphoscoliosis], idiopathic 
white f 33 $nan$nan$nephrocaps  1  cap ; lidocaine 5% patch  1  ptch ; labetalol  100  mg ; docusate sodium  100  mg ; acetaminophen  650  mg ; calcium carbonate  500  mg ; milk of magnesia  15-30  ml ; alprazolam  0.5  mg ; alprazolam  1  mg ; sodium chloride 0.9%  flush  3  ml ; dextrose 50%  12.5  gm ; glucagon  1  mg ; buprenorphine  6  mg ; ranitidine  150  mg ; insulin  24  unit ; insulin  30  unit ; insulin  26  unit ; 
panic disorder without agoraphobia osteoarthrosis, localized, not specified whether primary or secondary, ankle and foot scoliosis [and kyphoscoliosis], idiopathic 
white f 33 $nan$hematology blood hematocrit  37.4  %; hematology blood hemoglobin  12.5  g dl; hematology blood platelet count  254  k ul; chemistry blood creatinine  0.4  mg dl; hematology blood inr(pt)  1.0  ; hematology urine wbc  1  # hpf; hematology urine glucose  1000  mg dl$nephrocaps  1  cap ; lidocaine 5% patch  1  ptch ; docusate sodium  100  mg ; acetaminophen  650  mg ; calcium carbonate  500  mg ; milk of magnesia  15-30  ml ; alprazolam  0.5  mg ; alprazolam  1  mg ; sodium chloride 0.9%  flush  3  ml ; dextrose 50%  12.5  gm ; glucagon  1  mg ; buprenorphine  6  mg ; ranitidine  150  mg ; insulin  40  unit ; insulin  35  unit ; 
panic disorder without agoraphobia osteoarthrosis, localized, not specified whether primary or secondary, ankle and foot scoliosis [and kyphoscoliosis], idiopathic 
white f 33 $nan$nan$nephrocaps  1  cap ; lidocaine 5% patch  1  ptch ; docusate sodium  100  mg ; acetaminophen  650  mg ; calcium carbonate  500  mg ; milk of magnesia  15-30  ml ; alprazolam  0.5  mg ; alprazolam  1  mg ; sodium chloride 0.9%  flush  3  ml ; dextrose 50%  12.5  gm ; glucagon  1  mg ; buprenorphine  6  mg ; ranitidine  150  mg ; insulin  40  unit ; insulin  35  unit ; lr  1000  ml ; bisacodyl  10  mg ; dibucaine  1  appl ; simethicone  80  mg ; ketorolac  30  mg ; acetaminophen  1000  mg ; hydromorphone (dilaudid)  12.5  mg ; epidural bag  1  bag ; bupivacaine 0.1%  250  ml ; 
panic disorder without agoraphobia osteoarthrosis, localized, not specified whether primary or secondary, ankle and foot scoliosis [and kyphoscoliosis], idiopathic 
white f 33 $nan$hematology blood hematocrit  32.5  %; hematology blood hematocrit  32.2  %; hematology blood hemoglobin  10.9  g dl; hematology blood platelet count  252  k ul; chemistry blood creatinine  0.6  mg dl; hematology blood inr(pt)  1.1  $nephrocaps  1  cap ; lidocaine 5% patch  1  ptch ; docusate sodium  100  mg ; acetaminophen  650  mg ; calcium carbonate  500  mg ; milk of magnesia  15-30  ml ; alprazolam  0.5  mg ; alprazolam  1  mg ; sodium chloride 0.9%  flush  3  ml ; dextrose 50%  12.5  gm ; glucagon  1  mg ; buprenorphine  6  mg ; ranitidine  150  mg ; insulin  40  unit ; insulin  35  unit ; lr  1000  ml ; bisacodyl  10  mg ; dibucaine  1  appl ; simethicone  80  mg ; ketorolac  30  mg ; acetaminophen  1000  mg ; hydromorphone (dilaudid)  12.5  mg ; epidural bag  1  bag ; bupivacaine 0.1%  250  ml ; gabapentin  300  mg ; hydromorphone (dilaudid)  0.75-1.25  mg ; heparin  5000  unit ; alprazolam  2  mg ; 5% dextrose  50  ml ; clindamycin  900  mg ; 5% dextrose  250  ml ; gentamicin sulfate  430  mg ; syringe (ns)  50  ml ; ketamine  100  mg ; 
panic disorder without agoraphobia osteoarthrosis, localized, not specified whether primary or secondary, ankle and foot scoliosis [and kyphoscoliosis], idiopathic 
white f 33 $nan$nan$nephrocaps  1  cap ; docusate sodium  100  mg ; calcium carbonate  500  mg ; milk of magnesia  15-30  ml ; alprazolam  0.5  mg ; sodium chloride 0.9%  flush  3  ml ; buprenorphine  6  mg ; ranitidine  150  mg ; lr  1000  ml ; bisacodyl  10  mg ; dibucaine  1  appl ; simethicone  80  mg ; ketorolac  30  mg ; acetaminophen  1000  mg ; epidural bag  1  bag ; bupivacaine 0.1%  250  ml ; gabapentin  300  mg ; hydromorphone (dilaudid)  0.75-1.25  mg ; heparin  5000  unit ; alprazolam  2  mg ; 5% dextrose  50  ml ; clindamycin  900  mg ; 5% dextrose  250  ml ; gentamicin sulfate  430  mg ; syringe (ns)  50  ml ; ketamine  100  mg ; nicotine patch  14  mg ; naproxen  500  mg ; 
panic disorder without agoraphobia osteoarthrosis, localized, not specified whether primary or secondary, ankle and foot scoliosis [and kyphoscoliosis], idiopathic 
white f 33 $nan$chemistry blood anion gap  13  meq l; chemistry blood bicarbonate  24  meq l; chemistry blood chloride  105  meq l; chemistry blood creatinine  0.6  mg dl; chemistry blood potassium  3.7  meq l; chemistry blood sodium  138  meq l; chemistry blood urea nitrogen  9  mg dl; chemistry blood glucose  107  mg dl$nephrocaps  1  cap ; docusate sodium  100  mg ; calcium carbonate  500  mg ; milk of magnesia  15-30  ml ; alprazolam  0.5  mg ; sodium chloride 0.9%  flush  3  ml ; buprenorphine  6  mg ; ranitidine  150  mg ; bisacodyl  10  mg ; dibucaine  1  appl ; simethicone  80  mg ; acetaminophen  1000  mg ; epidural bag  1  bag ; bupivacaine 0.1%  250  ml ; gabapentin  300  mg ; hydromorphone (dilaudid)  0.75-1.25  mg ; heparin  5000  unit ; alprazolam  2  mg ; 5% dextrose  50  ml ; clindamycin  900  mg ; 5% dextrose  250  ml ; gentamicin sulfate  430  mg ; syringe (ns)  50  ml ; ketamine  100  mg ; nicotine patch  14  mg ; hydromorphone (dilaudid)  8-12  mg ; 
panic disorder without agoraphobia osteoarthrosis, localized, not specified whether primary or secondary, ankle and foot scoliosis [and kyphoscoliosis], idiopathic 
white f 33 $nan$nan$nephrocaps  1  cap ; docusate sodium  100  mg ; calcium carbonate  500  mg ; milk of magnesia  15-30  ml ; alprazolam  0.5  mg ; sodium chloride 0.9%  flush  3  ml ; buprenorphine  6  mg ; ranitidine  150  mg ; bisacodyl  10  mg ; dibucaine  1  appl ; simethicone  80  mg ; acetaminophen  1000  mg ; gabapentin  300  mg ; hydromorphone (dilaudid)  0.75-1.25  mg ; heparin  5000  unit ; alprazolam  2  mg ; 5% dextrose  50  ml ; clindamycin  900  mg ; 5% dextrose  250  ml ; gentamicin sulfate  430  mg ; syringe (ns)  50  ml ; ketamine  100  mg ; nicotine patch  14  mg ; hydromorphone (dilaudid)  8-12  mg ; 
panic disorder without agoraphobia osteoarthrosis, localized, not specified whether primary or secondary, ankle and foot scoliosis [and kyphoscoliosis], idiopathic 
white f 33 $nan$nan$nephrocaps  1  cap ; docusate sodium  100  mg ; calcium carbonate  500  mg ; milk of magnesia  15-30  ml ; alprazolam  0.5  mg ; sodium chloride 0.9%  flush  3  ml ; buprenorphine  6  mg ; ranitidine  150  mg ; bisacodyl  10  mg ; dibucaine  1  appl ; simethicone  80  mg ; acetaminophen  1000  mg ; gabapentin  300  mg ; hydromorphone (dilaudid)  0.75-1.25  mg ; heparin  5000  unit ; alprazolam  2  mg ; syringe (ns)  50  ml ; ketamine  100  mg ; nicotine patch  14  mg ; hydromorphone (dilaudid)  8-12  mg ; 
panic disorder without agoraphobia osteoarthrosis, localized, not specified whether primary or secondary, ankle and foot scoliosis [and kyphoscoliosis], idiopathic 
black african american m 60 $temp    heartrate  118.0  resprate  18.0  o2sat  95.0  sbp  139.0  dbp  93.0  rhythm    pain  0  $hematology blood hematocrit  47.1  %; hematology blood hemoglobin  15.4  g dl; hematology blood platelet count  111  k ul; chemistry blood anion gap  11  meq l; chemistry blood bicarbonate  27  meq l; chemistry blood chloride  98  meq l; chemistry blood creatinine  1.7  mg dl; chemistry blood potassium  4.2  meq l; chemistry blood sodium  136  meq l; chemistry blood urea nitrogen  21  mg dl; hematology blood inr(pt)  1.4  ; chemistry blood glucose  92  mg dl; blood gas blood lactate  1.4  mmol l$heparin  5000  unit ; sodium chloride 0.9%  flush  3-10  ml ; acetaminophen  650  mg ; senna  8.6  mg ; lactated ringers  1000  ml ; vial  1  vial ; ceftriaxone  1  gm ; neutra-phos  2  pkt ; 5% dextrose  100  ml ; ciprofloxacin iv  200  mg ; 
 
black african american m 60 $nan$hematology blood hematocrit  45.0  %; hematology blood hemoglobin  14.4  g dl; hematology blood platelet count  105  k ul; chemistry blood anion gap  13  meq l; chemistry blood bicarbonate  24  meq l; chemistry blood chloride  101  meq l; chemistry blood creatinine  1.5  mg dl; chemistry blood potassium  4.2  meq l; chemistry blood sodium  138  meq l; chemistry blood urea nitrogen  18  mg dl; chemistry blood calcium, total  9.0  mg dl; chemistry blood glucose  104  mg dl$heparin  5000  unit ; sodium chloride 0.9%  flush  3-10  ml ; acetaminophen  650  mg ; senna  8.6  mg ; lactated ringers  1000  ml ; neutra-phos  2  pkt ; 5% dextrose  200  ml ; ciprofloxacin iv  400  mg ; ciprofloxacin hcl  500  mg ; 
 
black african american m 60 $nan$hematology blood hematocrit  45.3  %; hematology blood hemoglobin  14.5  g dl; hematology blood platelet count  114  k ul; chemistry blood anion gap  10  meq l; chemistry blood bicarbonate  28  meq l; chemistry blood chloride  98  meq l; chemistry blood creatinine  1.4  mg dl; chemistry blood potassium  3.7  meq l; chemistry blood sodium  136  meq l; chemistry blood urea nitrogen  15  mg dl; chemistry blood calcium, total  8.7  mg dl$heparin  5000  unit ; sodium chloride 0.9%  flush  3-10  ml ; acetaminophen  650  mg ; senna  8.6  mg ; ciprofloxacin hcl  500  mg ; potassium chloride  40  meq ; sulfameth trimethoprim ds  1  tab ; 
 
white m 64 $nan$nan$aspirin  81  mg ; 
 
white m 64 $nan$hematology blood hematocrit  42.5  %; hematology blood hematocrit  44.0  %; hematology blood hemoglobin  14.8  g dl; hematology blood hemoglobin  15.5  g dl; hematology blood platelet count  169  k ul; hematology blood platelet count  153  k ul; chemistry blood anion gap  12  meq l; chemistry blood anion gap  12  meq l; chemistry blood bicarbonate  23  meq l; chemistry blood bicarbonate  25  meq l; chemistry blood chloride  108  meq l; chemistry blood chloride  105  meq l; chemistry blood creatinine  0.7  mg dl; chemistry blood creatinine  0.8  mg dl; chemistry blood potassium  4.1  meq l; chemistry blood potassium  4.1  meq l; chemistry blood sodium  139  meq l; chemistry blood sodium  138  meq l; chemistry blood urea nitrogen  16  mg dl; chemistry blood urea nitrogen  15  mg dl; hematology blood inr(pt)  1.2  ; hematology blood inr(pt)  1.1  ; chemistry blood calcium, total  8.5  mg dl; chemistry blood calcium, total  8.5  mg dl; chemistry blood glucose  105  mg dl; chemistry blood glucose  105  mg dl; blood gas blood free calcium  1.20  mmol l; blood gas blood lactate  1.2  mmol l; blood gas blood chloride, whole blood  103  meq l; blood gas blood glucose  128  mg dl; blood gas blood hematocrit, calculated  47  %; blood gas blood hemoglobin  15.5  g dl; blood gas blood potassium, whole blood  4.2  meq l; blood gas blood sodium, whole blood  137  meq l$aspirin  81  mg ; influenza virus vaccine  0.5  ml ; pneumococcal vac polyvalent  0.5  ml ; sodium chloride 0.9%  flush  3  ml ; heparin  5000  unit ; acetaminophen  650  mg ; senna  1  tab ; docusate sodium  100  mg ; oxycodone-acetaminophen  1  tab ; sotalol  120  mg ; lisinopril  5  mg ; 
 
white m 64 $nan$nan$aspirin  81  mg ; influenza virus vaccine  0.5  ml ; pneumococcal vac polyvalent  0.5  ml ; sodium chloride 0.9%  flush  3  ml ; heparin  5000  unit ; acetaminophen  650  mg ; senna  1  tab ; docusate sodium  100  mg ; sotalol  120  mg ; lisinopril  5  mg ; carvedilol  3.125  mg ; 
 
black african american f 46 $temp  98.9  heartrate  117.0  resprate  16.0  o2sat  100.0  sbp  89.0  dbp  58.0  rhythm    pain  0  ; temp    heartrate    resprate    o2sat    sbp  92.0  dbp  54.0  rhythm    pain    ; temp  99.6  heartrate  99.0  resprate  16.0  o2sat  98.0  sbp  104.0  dbp  64.0  rhythm    pain  0  ; temp  99.5  heartrate  89.0  resprate  18.0  o2sat  100.0  sbp  104.0  dbp  64.0  rhythm    pain  0  ; temp  98.7  heartrate  73.0  resprate  20.0  o2sat  100.0  sbp  105.0  dbp  67.0  rhythm    pain  0  $hematology blood hematocrit  21.1  %; hematology blood hemoglobin  6.6  g dl; hematology blood platelet count  224  k ul; chemistry blood anion gap  8  meq l; chemistry blood bicarbonate  20  meq l; chemistry blood chloride  115  meq l; chemistry blood creatinine  0.7  mg dl; chemistry blood potassium  3.7  meq l; chemistry blood sodium  143  meq l; chemistry blood urea nitrogen  22  mg dl; hematology urine wbc  41  # hpf; chemistry blood calcium, total  8.3  mg dl; chemistry blood bilirubin, total  0.2  mg dl; chemistry blood glucose  100  mg dl; chemistry blood albumin  3.3  g dl; blood gas blood lactate  1.4  mmol l$nan
 
black african american f 46 $temp    heartrate  75.0  resprate  22.0  o2sat  100.0  sbp  92.0  dbp  62.0  rhythm    pain  0  $hematology blood hematocrit  22.9  %; hematology blood hematocrit  27.3  %; hematology blood hemoglobin  7.6  g dl; hematology blood hemoglobin  9.1  g dl; hematology blood platelet count  181  k ul; hematology blood platelet count  178  k ul; chemistry blood anion gap  12  meq l; chemistry blood bicarbonate  18  meq l; chemistry blood chloride  115  meq l; chemistry blood creatinine  0.6  mg dl; chemistry blood potassium  3.5  meq l; chemistry blood sodium  145  meq l; chemistry blood urea nitrogen  16  mg dl; hematology blood inr(pt)  1.1  ; chemistry blood calcium, total  7.8  mg dl; chemistry blood bilirubin, total  0.4  mg dl; chemistry blood glucose  83  mg dl; chemistry blood albumin  3.0  g dl$influenza vaccine quadrivalent  0.5  ml ; sodium chloride 0.9%  flush  3  ml ; acetaminophen  650  mg ; docusate sodium  100  mg ; senna  8.6  mg ; d5ns  1000  ml ; esomeprazole sodium  40  mg ; phenazopyridine  100  mg ; 
 
black african american f 46 $nan$hematology blood hematocrit  26.5  %; hematology blood hemoglobin  9.0  g dl; hematology blood platelet count  182  k ul; chemistry blood anion gap  7  meq l; chemistry blood bicarbonate  19  meq l; chemistry blood chloride  117  meq l; chemistry blood creatinine  0.5  mg dl; chemistry blood potassium  3.1  meq l; chemistry blood sodium  143  meq l; chemistry blood urea nitrogen  8  mg dl; chemistry blood calcium, total  7.9  mg dl; chemistry blood bilirubin, total  0.4  mg dl; chemistry blood glucose  83  mg dl; chemistry blood albumin  2.8  g dl$influenza vaccine quadrivalent  0.5  ml ; sodium chloride 0.9%  flush  3  ml ; acetaminophen  650  mg ; docusate sodium  100  mg ; senna  8.6  mg ; esomeprazole sodium  40  mg ; phenazopyridine  100  mg ; iso-osmotic dextrose  50  ml ; ceftriaxone  1  gm ; potassium chloride  60  meq ; 
 
white f 53 $nan$hematology urine wbc  5  # hpf$nan
 
white f 56 $nan$hematology blood hematocrit  33.4  %; chemistry blood chloride  100  meq l; chemistry blood creatinine  0.4  mg dl; chemistry blood potassium  3.3  meq l; chemistry blood sodium  135  meq l$lisinopril  10  mg ; aspirin  81  mg ; sodium chloride 0.9%  flush  3  ml ; 0.45% sodium chloride  1000  ml ; lactated ringers  1000  ml ; metoprolol tartrate  5  mg ; oxycodone (immediate release)   5-10  mg ; d5w  250  ml ; nitroglycerin  100  mg ; acetaminophen  650  mg ; hydralazine  10  mg ; heparin  5000  unit ; atorvastatin  10  mg ; 
rash and other nonspecific skin eruption tobacco use disorder acquired absence of both cervix and uterus nonspecific abnormal results of function study of liver alcohol abuse, unspecified hyposmolality and/or hyponatremia peripheral vascular disease, unspecified other respiratory abnormalities unspecified deficiency anemia long-term (current) use of aspirin unspecified essential hypertension edema nonspecific (abnormal) findings on radiological and other examination of biliary tract undiagnosed cardiac murmurs other and unspecified hyperlipidemia hypotension, unspecified atherosclerosis of native arteries of the extremities with rest pain unspecified essential hypertension
white f 56 $nan$nan$lisinopril  10  mg ; aspirin  81  mg ; sodium chloride 0.9%  flush  3  ml ; metoprolol tartrate  5  mg ; oxycodone (immediate release)   5-10  mg ; d5w  250  ml ; nitroglycerin  100  mg ; acetaminophen  650  mg ; hydralazine  10  mg ; heparin  5000  unit ; atorvastatin  10  mg ; clopidogrel  75  mg ; potassium chloride  40  meq ; 
rash and other nonspecific skin eruption tobacco use disorder acquired absence of both cervix and uterus nonspecific abnormal results of function study of liver alcohol abuse, unspecified hyposmolality and/or hyponatremia peripheral vascular disease, unspecified other respiratory abnormalities unspecified deficiency anemia long-term (current) use of aspirin unspecified essential hypertension edema nonspecific (abnormal) findings on radiological and other examination of biliary tract undiagnosed cardiac murmurs other and unspecified hyperlipidemia hypotension, unspecified atherosclerosis of native arteries of the extremities with rest pain unspecified essential hypertension
white m 75 $nan$nan$enoxaparin sodium  40  mg ; multivitamins  1  cap ; vitamin d  400  unit ; 
pure hypercholesterolemia syncope and collapse delirium due to conditions classified elsewhere aseptic necrosis of head and neck of femur urinary tract infection, site not specified gross hematuria unspecified essential hypertension fall from other slipping, tripping, or stumbling retention of urine, unspecified hypertrophy (benign) of prostate with urinary obstruction and other lower urinary tract symptoms (luts) urinary frequency 
white m 75 $nan$hematology blood hematocrit  36.2  %; hematology blood hematocrit  34.5  %; hematology blood hemoglobin  12.4  g dl; hematology blood hemoglobin  11.8  g dl; hematology blood platelet count  253  k ul; hematology blood platelet count  259  k ul; chemistry blood anion gap  13  meq l; chemistry blood anion gap  11  meq l; chemistry blood bicarbonate  27  meq l; chemistry blood bicarbonate  27  meq l; chemistry blood chloride  101  meq l; chemistry blood chloride  98  meq l; chemistry blood creatinine  1.0  mg dl; chemistry blood creatinine  1.1  mg dl; chemistry blood potassium  4.7  meq l; chemistry blood potassium  4.2  meq l; chemistry blood sodium  136  meq l; chemistry blood sodium  132  meq l; chemistry blood urea nitrogen  15  mg dl; chemistry blood urea nitrogen  14  mg dl; chemistry blood calcium, total  8.6  mg dl; chemistry blood calcium, total  8.5  mg dl; chemistry blood glucose  132  mg dl; chemistry blood glucose  122  mg dl$enoxaparin sodium  40  mg ; multivitamins  1  cap ; vitamin d  400  unit ; influenza virus vaccine  0.5  ml ; pneumococcal vac polyvalent  0.5  ml ; sodium chloride 0.9%  flush  3  ml ; lr  1000  ml ; hydromorphone (dilaudid)  2  mg ; acetaminophen  650  mg ; 0.9% sodium chloride  100  ml ; cefazolin  2  g ; aluminum-magnesium hydrox.-simethicone  15-30  ml ; bisacodyl  10  mg ; milk of magnesia  30  ml ; ondansetron  4  mg ; hydromorphone (dilaudid)  20  mg ; docusate sodium  100  mg ; senna  1  tab ; calcium carbonate  500  mg ; polyethylene glycol  17  g ; lisinopril  20  mg ; nifedipine cr  60  mg ; omeprazole  20  mg ; ramipril  2.5  mg ; neutra-phos  1  pkt ; 
pure hypercholesterolemia syncope and collapse delirium due to conditions classified elsewhere aseptic necrosis of head and neck of femur urinary tract infection, site not specified gross hematuria unspecified essential hypertension fall from other slipping, tripping, or stumbling retention of urine, unspecified hypertrophy (benign) of prostate with urinary obstruction and other lower urinary tract symptoms (luts) urinary frequency 
white m 75 $nan$hematology blood hematocrit  30.7  %; hematology blood hemoglobin  10.3  g dl; hematology blood platelet count  237  k ul; chemistry blood anion gap  9  meq l; chemistry blood bicarbonate  30  meq l; chemistry blood chloride  98  meq l; chemistry blood creatinine  1.1  mg dl; chemistry blood potassium  3.7  meq l; chemistry blood sodium  133  meq l; chemistry blood urea nitrogen  17  mg dl; hematology urine wbc  5  # hpf; chemistry blood glucose  120  mg dl$enoxaparin sodium  40  mg ; multivitamins  1  cap ; vitamin d  400  unit ; influenza virus vaccine  0.5  ml ; pneumococcal vac polyvalent  0.5  ml ; sodium chloride 0.9%  flush  3  ml ; lr  1000  ml ; hydromorphone (dilaudid)  2  mg ; acetaminophen  650  mg ; 0.9% sodium chloride  100  ml ; cefazolin  2  g ; aluminum-magnesium hydrox.-simethicone  15-30  ml ; bisacodyl  10  mg ; milk of magnesia  30  ml ; ondansetron  4  mg ; hydromorphone (dilaudid)  20  mg ; docusate sodium  100  mg ; senna  1  tab ; calcium carbonate  500  mg ; polyethylene glycol  17  g ; lisinopril  20  mg ; nifedipine cr  60  mg ; omeprazole  20  mg ; ramipril  2.5  mg ; neutra-phos  1  pkt ; haloperidol  0.25  mg ; acetaminophen  1000  mg ; tamsulosin  0.4  mg ; neutra-phos  2  pkt ; 
pure hypercholesterolemia syncope and collapse delirium due to conditions classified elsewhere aseptic necrosis of head and neck of femur urinary tract infection, site not specified gross hematuria unspecified essential hypertension fall from other slipping, tripping, or stumbling retention of urine, unspecified hypertrophy (benign) of prostate with urinary obstruction and other lower urinary tract symptoms (luts) urinary frequency 
white m 75 $nan$hematology blood hematocrit  30.7  %; hematology blood hemoglobin  10.4  g dl; hematology blood platelet count  239  k ul; chemistry blood anion gap  9  meq l; chemistry blood bicarbonate  31  meq l; chemistry blood chloride  97  meq l; chemistry blood creatinine  1.1  mg dl; chemistry blood potassium  4.0  meq l; chemistry blood sodium  133  meq l; chemistry blood urea nitrogen  22  mg dl; chemistry blood glucose  115  mg dl$enoxaparin sodium  40  mg ; multivitamins  1  cap ; vitamin d  400  unit ; influenza virus vaccine  0.5  ml ; pneumococcal vac polyvalent  0.5  ml ; sodium chloride 0.9%  flush  3  ml ; lr  1000  ml ; hydromorphone (dilaudid)  2  mg ; aluminum-magnesium hydrox.-simethicone  15-30  ml ; bisacodyl  10  mg ; milk of magnesia  30  ml ; ondansetron  4  mg ; docusate sodium  100  mg ; senna  1  tab ; calcium carbonate  500  mg ; lisinopril  20  mg ; nifedipine cr  60  mg ; omeprazole  20  mg ; ramipril  2.5  mg ; haloperidol  0.25  mg ; acetaminophen  1000  mg ; tamsulosin  0.4  mg ; neutra-phos  2  pkt ; 
pure hypercholesterolemia syncope and collapse delirium due to conditions classified elsewhere aseptic necrosis of head and neck of femur urinary tract infection, site not specified gross hematuria unspecified essential hypertension fall from other slipping, tripping, or stumbling retention of urine, unspecified hypertrophy (benign) of prostate with urinary obstruction and other lower urinary tract symptoms (luts) urinary frequency 
white m 75 $nan$hematology blood hematocrit  30.0  %; hematology blood hemoglobin  10.1  g dl; hematology blood platelet count  292  k ul$enoxaparin sodium  40  mg ; multivitamins  1  cap ; vitamin d  400  unit ; influenza virus vaccine  0.5  ml ; pneumococcal vac polyvalent  0.5  ml ; sodium chloride 0.9%  flush  3  ml ; lr  1000  ml ; aluminum-magnesium hydrox.-simethicone  15-30  ml ; bisacodyl  10  mg ; ondansetron  4  mg ; docusate sodium  100  mg ; senna  1  tab ; calcium carbonate  500  mg ; lisinopril  20  mg ; nifedipine cr  60  mg ; omeprazole  20  mg ; ramipril  2.5  mg ; haloperidol  0.25  mg ; acetaminophen  1000  mg ; tamsulosin  0.4  mg ; tramadol (ultram)  25  mg ; 
pure hypercholesterolemia syncope and collapse delirium due to conditions classified elsewhere aseptic necrosis of head and neck of femur urinary tract infection, site not specified gross hematuria unspecified essential hypertension fall from other slipping, tripping, or stumbling retention of urine, unspecified hypertrophy (benign) of prostate with urinary obstruction and other lower urinary tract symptoms (luts) urinary frequency 
white m 75 $nan$nan$enoxaparin sodium  40  mg ; multivitamins  1  cap ; vitamin d  400  unit ; influenza virus vaccine  0.5  ml ; pneumococcal vac polyvalent  0.5  ml ; sodium chloride 0.9%  flush  3  ml ; lr  1000  ml ; aluminum-magnesium hydrox.-simethicone  15-30  ml ; bisacodyl  10  mg ; ondansetron  4  mg ; docusate sodium  100  mg ; senna  1  tab ; calcium carbonate  500  mg ; lisinopril  20  mg ; nifedipine cr  60  mg ; omeprazole  20  mg ; ramipril  2.5  mg ; haloperidol  0.25  mg ; acetaminophen  1000  mg ; tamsulosin  0.4  mg ; tramadol (ultram)  25  mg ; 
pure hypercholesterolemia syncope and collapse delirium due to conditions classified elsewhere aseptic necrosis of head and neck of femur urinary tract infection, site not specified gross hematuria unspecified essential hypertension fall from other slipping, tripping, or stumbling retention of urine, unspecified hypertrophy (benign) of prostate with urinary obstruction and other lower urinary tract symptoms (luts) urinary frequency 
white m 69 $nan$hematology blood hematocrit  32.6  %; hematology blood hematocrit  32.3  %; hematology blood hematocrit  34.2  %; hematology blood hemoglobin  11.3  g dl; hematology blood platelet count  403  k ul; chemistry blood anion gap  12  meq l; chemistry blood bicarbonate  30  meq l; chemistry blood chloride  101  meq l; chemistry blood creatinine  0.8  mg dl; chemistry blood potassium  3.9  meq l; chemistry blood sodium  139  meq l; chemistry blood urea nitrogen  11  mg dl; hematology blood inr(pt)  2.7  ; chemistry blood calcium, total  8.4  mg dl; chemistry blood bilirubin, total  0.2  mg dl; chemistry blood glucose  97  mg dl; chemistry blood lactate dehydrogenase (ld)  289  iu l$omeprazole  40  mg ; atenolol  25  mg ; hyoscyamine so4 (time release)  0.375  mg ; sodium chloride 0.9%  flush  3  ml ; acetaminophen  325-650  mg ; senna  1  tab ; warfarin  5  mg ; warfarin  7.5  mg ; metoprolol tartrate  12.5  mg ; docusate sodium  100  mg ; enoxaparin sodium  90  mg ; pravastatin  10  mg ; acetaminophen  1000  mg ; furosemide  10  mg ; potassium chloride  40  meq ; magnesium sulfate  2  gm ; 
atrial flutter other and unspecified hyperlipidemia esophageal reflux unspecified essential hypertension acute idiopathic pericarditis iron deficiency anemia, unspecified
white m 69 $nan$nan$omeprazole  40  mg ; hyoscyamine so4 (time release)  0.375  mg ; sodium chloride 0.9%  flush  3  ml ; senna  1  tab ; warfarin  7.5  mg ; docusate sodium  100  mg ; enoxaparin sodium  90  mg ; pravastatin  10  mg ; acetaminophen  1000  mg ; furosemide  10  mg ; potassium chloride  40  meq ; magnesium sulfate  2  gm ; levofloxacin  250  mg ; levofloxacin  500  mg ; metoprolol succinate xl  50  mg ; warfarin  1  mg ; 
atrial flutter other and unspecified hyperlipidemia esophageal reflux unspecified essential hypertension acute idiopathic pericarditis iron deficiency anemia, unspecified
unknown f 58 $temp  97.7  heartrate  75.0  resprate  22.0  o2sat  98.0  sbp  99.0  dbp  50.0  rhythm  normal sinus rhythm  pain  ett  $hematology blood hematocrit  38.2  %; hematology blood hematocrit  40.3  %; hematology blood hemoglobin  11.5  g dl; hematology blood hemoglobin  11.9  g dl; hematology blood platelet count  142  k ul; hematology blood platelet count  161  k ul; chemistry blood anion gap  7  meq l; chemistry blood anion gap  12  meq l; chemistry blood anion gap  13  meq l; chemistry blood bicarbonate  31  meq l; chemistry blood bicarbonate  31  meq l; chemistry blood bicarbonate  31  meq l; chemistry blood chloride  94  meq l; chemistry blood chloride  94  meq l; chemistry blood chloride  94  meq l; chemistry blood creatinine  0.6  mg dl; chemistry blood creatinine  0.6  mg dl; chemistry blood creatinine  0.7  mg dl; chemistry blood potassium  4.4  meq l; chemistry blood potassium  4.9  meq l; chemistry blood potassium  5.0  meq l; chemistry blood sodium  128  meq l; chemistry blood sodium  132  meq l; chemistry blood sodium  133  meq l; chemistry blood urea nitrogen  15  mg dl; chemistry blood urea nitrogen  17  mg dl; chemistry blood urea nitrogen  19  mg dl; hematology blood inr(pt)  1.3  ; chemistry urine potassium, urine  70  meq l; chemistry urine sodium, urine  27  meq l; chemistry urine urea nitrogen, urine  800  mg dl; hematology urine wbc  16  # hpf; chemistry blood calcium, total  7.8  mg dl; chemistry blood calcium, total  8.0  mg dl; chemistry blood glucose  155  mg dl; chemistry blood glucose  153  mg dl; chemistry blood glucose  124  mg dl; blood gas blood free calcium  1.13  mmol l; blood gas blood free calcium  1.08  mmol l; blood gas blood free calcium  1.09  mmol l; blood gas blood free calcium  0.99  mmol l; blood gas blood lactate  1.2  mmol l; blood gas blood lactate  1.0  mmol l; blood gas blood lactate  1.1  mmol l; blood gas blood lactate  1.3  mmol l$insulin  0  unit ; fentanyl citrate  25-100  mcg ; bisacodyl  10  mg ; dextrose 50%  12.5  gm ; glucagon  1  mg ; glucose gel  15  g ; heparin  5000  unit ; famotidine  20  mg ; aspirin  81  mg ; docusate sodium  100  mg ; simvastatin  20  mg ; 0.9% sodium chloride  100  ml ; midazolam  100  mg ; 0.9% sodium chloride (mini bag plus)  100  ml ; cefepime  2  g ; iso-osmotic dextrose  200  ml ; vancomycin  1000  mg ; 0.9% sodium chloride  1  bag ; calcium gluconate  2  g ; 0.9% sodium chloride  2  bag ; calcium gluconate  4  g ; bag  1  bag ; magnesium sulfate  2  gm ; bag  2  bag ; magnesium sulfate  4  gm ; sw  200  ml ; potassium chloride  20  meq ; sw  400  ml ; potassium chloride  40  meq ; sw  600  ml ; potassium chloride  60  meq ; soln  50  ml ; fentanyl citrate  2.5  mg ; ceftriaxone  1  gm ; azithromycin  500  mg ; miconazole powder 2%  1  appl ; sodium chloride 0.9%  1000  ml ; albuterol inhaler  6  puff ; ipratropium bromide mdi  6  puff ; dexmedetomidine  0.4  mg ; midazolam  1  mg ; 
 
unknown f 58 $nan$hematology blood hematocrit  38.9  %; hematology blood hemoglobin  11.6  g dl; hematology blood platelet count  145  k ul; chemistry blood anion gap  16  meq l; chemistry blood bicarbonate  28  meq l; chemistry blood chloride  96  meq l; chemistry blood creatinine  0.7  mg dl; chemistry blood potassium  4.7  meq l; chemistry blood sodium  135  meq l; chemistry blood urea nitrogen  22  mg dl; chemistry blood calcium, total  8.0  mg dl; chemistry blood glucose  117  mg dl; blood gas blood free calcium  1.08  mmol l; blood gas blood lactate  1.7  mmol l$insulin  0  unit ; bisacodyl  10  mg ; dextrose 50%  12.5  gm ; glucagon  1  mg ; glucose gel  15  g ; heparin  5000  unit ; famotidine  20  mg ; aspirin  81  mg ; docusate sodium  100  mg ; simvastatin  20  mg ; 0.9% sodium chloride  100  ml ; midazolam  100  mg ; 0.9% sodium chloride (mini bag plus)  100  ml ; cefepime  2  g ; iso-osmotic dextrose  200  ml ; vancomycin  1000  mg ; 0.9% sodium chloride  1  bag ; calcium gluconate  2  g ; 0.9% sodium chloride  2  bag ; calcium gluconate  4  g ; bag  1  bag ; magnesium sulfate  2  gm ; bag  2  bag ; magnesium sulfate  4  gm ; sw  200  ml ; potassium chloride  20  meq ; sw  400  ml ; potassium chloride  40  meq ; sw  600  ml ; potassium chloride  60  meq ; miconazole powder 2%  1  appl ; albuterol inhaler  6  puff ; ipratropium bromide mdi  6  puff ; dexmedetomidine  0.4  mg ; midazolam  1  mg ; lactated ringers  1000  ml ; heparin flush (10 units ml)  2  ml ; sodium chloride 0.9%  flush  20  ml ; lidocaine 1% (for picc midline insertions)  5  ml ; azithromycin  250  mg ; phosphorus  500  mg ; midazolam  2  mg ; haloperidol  5  mg ; clobetasol propionate 0.05% ointment  1  appl ; triamcinolone acetonide 0.1% cream  1  appl ; sodium chloride 0.9%  flush  10  ml ; furosemide  20  mg ; 
 
unknown f 58 $nan$hematology blood hematocrit  42.8  %; hematology blood hemoglobin  12.7  g dl; hematology blood platelet count  137  k ul; chemistry blood anion gap  18  meq l; chemistry blood anion gap  14  meq l; chemistry blood bicarbonate  27  meq l; chemistry blood bicarbonate  28  meq l; chemistry blood chloride  94  meq l; chemistry blood chloride  94  meq l; chemistry blood creatinine  0.8  mg dl; chemistry blood creatinine  0.9  mg dl; chemistry blood potassium  4.6  meq l; chemistry blood potassium  5.1  meq l; chemistry blood sodium  134  meq l; chemistry blood sodium  131  meq l; chemistry blood urea nitrogen  32  mg dl; chemistry blood urea nitrogen  37  mg dl; hematology blood inr(pt)  1.4  ; chemistry blood calcium, total  8.6  mg dl; chemistry blood calcium, total  8.6  mg dl; chemistry blood bilirubin, total  0.4  mg dl; chemistry blood glucose  136  mg dl; chemistry blood glucose  229  mg dl; chemistry blood lactate dehydrogenase (ld)  242  iu l; chemistry blood albumin  3.3  g dl; blood gas blood free calcium  1.15  mmol l; blood gas blood lactate  1.5  mmol l$insulin  0  unit ; bisacodyl  10  mg ; dextrose 50%  12.5  gm ; glucagon  1  mg ; glucose gel  15  g ; heparin  5000  unit ; famotidine  20  mg ; aspirin  81  mg ; docusate sodium  100  mg ; simvastatin  20  mg ; 0.9% sodium chloride  1  bag ; calcium gluconate  2  g ; 0.9% sodium chloride  2  bag ; calcium gluconate  4  g ; bag  1  bag ; magnesium sulfate  2  gm ; bag  2  bag ; magnesium sulfate  4  gm ; miconazole powder 2%  1  appl ; albuterol inhaler  6  puff ; ipratropium bromide mdi  6  puff ; dexmedetomidine  0.4  mg ; heparin flush (10 units ml)  2  ml ; sodium chloride 0.9%  flush  20  ml ; lidocaine 1% (for picc midline insertions)  5  ml ; azithromycin  250  mg ; phosphorus  500  mg ; midazolam  2  mg ; haloperidol  5  mg ; clobetasol propionate 0.05% ointment  1  appl ; triamcinolone acetonide 0.1% cream  1  appl ; sodium chloride 0.9%  flush  10  ml ; furosemide  20  mg ; prednisone  40  mg ; multivitamins  1  tab ; d5w  250  ml ; nitroglycerin  100  mg ; senna  8.6  mg ; ipratropium-albuterol neb  1  neb ; 
 
unknown f 58 $nan$hematology blood hematocrit  44.5  %; hematology blood hemoglobin  12.8  g dl; hematology blood platelet count  178  k ul; chemistry blood anion gap  18  meq l; chemistry blood bicarbonate  27  meq l; chemistry blood chloride  94  meq l; chemistry blood creatinine  0.9  mg dl; chemistry blood potassium  4.7  meq l; chemistry blood sodium  134  meq l; chemistry blood urea nitrogen  39  mg dl; chemistry blood calcium, total  8.8  mg dl; chemistry blood glucose  246  mg dl$insulin  0  unit ; bisacodyl  10  mg ; dextrose 50%  12.5  gm ; glucagon  1  mg ; glucose gel  15  g ; heparin  5000  unit ; famotidine  20  mg ; aspirin  81  mg ; docusate sodium  100  mg ; simvastatin  20  mg ; 0.9% sodium chloride  1  bag ; calcium gluconate  2  g ; 0.9% sodium chloride  2  bag ; calcium gluconate  4  g ; bag  1  bag ; magnesium sulfate  2  gm ; bag  2  bag ; magnesium sulfate  4  gm ; miconazole powder 2%  1  appl ; sodium chloride 0.9%  flush  20  ml ; lidocaine 1% (for picc midline insertions)  5  ml ; azithromycin  250  mg ; clobetasol propionate 0.05% ointment  1  appl ; triamcinolone acetonide 0.1% cream  1  appl ; sodium chloride 0.9%  flush  10  ml ; prednisone  40  mg ; multivitamins  1  tab ; d5w  250  ml ; nitroglycerin  100  mg ; senna  8.6  mg ; ipratropium-albuterol neb  1  neb ; ciprofloxacin hcl  500  mg ; insulin  10  unit ; pantoprazole  40  mg ; 
 
unknown f 58 $nan$hematology blood hematocrit  39.9  %; hematology blood hemoglobin  11.4  g dl; hematology blood platelet count  142  k ul; chemistry blood anion gap  9  meq l; chemistry blood bicarbonate  34  meq l; chemistry blood chloride  97  meq l; chemistry blood creatinine  0.6  mg dl; chemistry blood potassium  4.3  meq l; chemistry blood sodium  136  meq l; chemistry blood urea nitrogen  23  mg dl; hematology blood inr(pt)  1.3  ; chemistry blood calcium, total  8.8  mg dl; chemistry blood glucose  244  mg dl; blood gas blood free calcium  1.19  mmol l; blood gas blood lactate  1.2  mmol l$bisacodyl  10  mg ; dextrose 50%  12.5  gm ; glucagon  1  mg ; glucose gel  15  g ; heparin  5000  unit ; famotidine  20  mg ; aspirin  81  mg ; docusate sodium  100  mg ; simvastatin  20  mg ; 0.9% sodium chloride  1  bag ; calcium gluconate  2  g ; 0.9% sodium chloride  2  bag ; calcium gluconate  4  g ; bag  1  bag ; magnesium sulfate  2  gm ; bag  2  bag ; magnesium sulfate  4  gm ; miconazole powder 2%  1  appl ; sodium chloride 0.9%  flush  20  ml ; lidocaine 1% (for picc midline insertions)  5  ml ; clobetasol propionate 0.05% ointment  1  appl ; triamcinolone acetonide 0.1% cream  1  appl ; sodium chloride 0.9%  flush  10  ml ; multivitamins  1  tab ; d5w  250  ml ; nitroglycerin  100  mg ; senna  8.6  mg ; ipratropium-albuterol neb  1  neb ; ciprofloxacin hcl  500  mg ; insulin  10  unit ; pantoprazole  40  mg ; insulin  20  unit ; 
 
unknown f 58 $nan$hematology blood hematocrit  41.0  %; hematology blood hemoglobin  11.9  g dl; hematology blood platelet count  131  k ul; chemistry blood anion gap  12  meq l; chemistry blood anion gap  8  meq l; chemistry blood bicarbonate  37  meq l; chemistry blood bicarbonate  35  meq l; chemistry blood chloride  96  meq l; chemistry blood chloride  96  meq l; chemistry blood creatinine  0.5  mg dl; chemistry blood creatinine  0.7  mg dl; chemistry blood potassium  4.0  meq l; chemistry blood potassium  4.3  meq l; chemistry blood sodium  141  meq l; chemistry blood sodium  135  meq l; chemistry blood urea nitrogen  11  mg dl; chemistry blood urea nitrogen  12  mg dl; chemistry blood calcium, total  8.9  mg dl; chemistry blood calcium, total  9.4  mg dl; chemistry blood glucose  238  mg dl; chemistry blood glucose  410  mg dl; chemistry blood % hemoglobin a1c  6.5  %$bisacodyl  10  mg ; dextrose 50%  12.5  gm ; glucagon  1  mg ; glucose gel  15  g ; heparin  5000  unit ; famotidine  20  mg ; aspirin  81  mg ; simvastatin  20  mg ; 0.9% sodium chloride  1  bag ; calcium gluconate  2  g ; 0.9% sodium chloride  2  bag ; calcium gluconate  4  g ; bag  1  bag ; magnesium sulfate  2  gm ; bag  2  bag ; magnesium sulfate  4  gm ; miconazole powder 2%  1  appl ; sodium chloride 0.9%  flush  20  ml ; lidocaine 1% (for picc midline insertions)  5  ml ; clobetasol propionate 0.05% ointment  1  appl ; triamcinolone acetonide 0.1% cream  1  appl ; sodium chloride 0.9%  flush  10  ml ; multivitamins  1  tab ; ipratropium-albuterol neb  1  neb ; ciprofloxacin hcl  500  mg ; insulin  20  unit ; acetazolamide  500  mg ; insulin  27  unit ; insulin  30  unit ; heparin flush (10 units ml)  1  ml ; 
 
unknown f 58 $nan$hematology blood hematocrit  41.8  %; hematology blood hemoglobin  11.9  g dl; hematology blood platelet count  144  k ul; chemistry blood anion gap  14  meq l; chemistry blood anion gap  11  meq l; chemistry blood bicarbonate  30  meq l; chemistry blood bicarbonate  34  meq l; chemistry blood chloride  97  meq l; chemistry blood chloride  95  meq l; chemistry blood creatinine  0.6  mg dl; chemistry blood creatinine  0.7  mg dl; chemistry blood potassium  5.1  meq l; chemistry blood potassium  4.2  meq l; chemistry blood sodium  136  meq l; chemistry blood sodium  136  meq l; chemistry blood urea nitrogen  11  mg dl; chemistry blood urea nitrogen  14  mg dl; hematology blood inr(pt)  1.1  ; chemistry blood calcium, total  9.2  mg dl; chemistry blood calcium, total  9.8  mg dl; chemistry blood glucose  257  mg dl; chemistry blood glucose  323  mg dl$bisacodyl  10  mg ; dextrose 50%  12.5  gm ; glucagon  1  mg ; glucose gel  15  g ; heparin  5000  unit ; famotidine  20  mg ; aspirin  81  mg ; simvastatin  20  mg ; miconazole powder 2%  1  appl ; clobetasol propionate 0.05% ointment  1  appl ; triamcinolone acetonide 0.1% cream  1  appl ; sodium chloride 0.9%  flush  10  ml ; multivitamins  1  tab ; ipratropium-albuterol neb  1  neb ; ciprofloxacin hcl  500  mg ; insulin  30  unit ; heparin flush (10 units ml)  1  ml ; mupirocin ointment 2%  1  appl ; 
 
unknown f 58 $nan$hematology blood hematocrit  43.3  %; hematology blood hemoglobin  12.2  g dl; hematology blood platelet count  134  k ul; chemistry blood anion gap  11  meq l; chemistry blood anion gap  12  meq l; chemistry blood bicarbonate  36  meq l; chemistry blood bicarbonate  38  meq l; chemistry blood chloride  96  meq l; chemistry blood chloride  94  meq l; chemistry blood creatinine  0.6  mg dl; chemistry blood creatinine  0.6  mg dl; chemistry blood potassium  4.8  meq l; chemistry blood potassium  4.3  meq l; chemistry blood sodium  138  meq l; chemistry blood sodium  140  meq l; chemistry blood urea nitrogen  12  mg dl; chemistry blood urea nitrogen  12  mg dl; hematology blood inr(pt)  1.1  ; chemistry blood calcium, total  9.5  mg dl; chemistry blood calcium, total  9.9  mg dl; chemistry blood glucose  248  mg dl; chemistry blood glucose  176  mg dl; chemistry blood % hemoglobin a1c  6.5  %$bisacodyl  10  mg ; dextrose 50%  12.5  gm ; glucagon  1  mg ; glucose gel  15  g ; heparin  5000  unit ; famotidine  20  mg ; aspirin  81  mg ; simvastatin  20  mg ; miconazole powder 2%  1  appl ; clobetasol propionate 0.05% ointment  1  appl ; triamcinolone acetonide 0.1% cream  1  appl ; sodium chloride 0.9%  flush  10  ml ; multivitamins  1  tab ; ipratropium-albuterol neb  1  neb ; ciprofloxacin hcl  500  mg ; insulin  30  unit ; heparin flush (10 units ml)  1  ml ; mupirocin ointment 2%  1  appl ; 
 
unknown f 58 $nan$hematology blood hematocrit  44.6  %; hematology blood hemoglobin  12.7  g dl; hematology blood platelet count  162  k ul; chemistry blood anion gap  10  meq l; chemistry blood anion gap  15  meq l; chemistry blood bicarbonate  40  meq l; chemistry blood bicarbonate  35  meq l; chemistry blood chloride  93  meq l; chemistry blood chloride  90  meq l; chemistry blood creatinine  0.5  mg dl; chemistry blood creatinine  0.6  mg dl; chemistry blood potassium  4.5  meq l; chemistry blood potassium  4.7  meq l; chemistry blood sodium  138  meq l; chemistry blood sodium  135  meq l; chemistry blood urea nitrogen  12  mg dl; chemistry blood urea nitrogen  17  mg dl; hematology urine wbc  13  # hpf; chemistry blood calcium, total  9.7  mg dl; chemistry blood calcium, total  9.6  mg dl; chemistry blood glucose  381  mg dl; chemistry blood glucose  270  mg dl; hematology urine glucose  1000  mg dl$bisacodyl  10  mg ; dextrose 50%  12.5  gm ; glucagon  1  mg ; glucose gel  15  g ; heparin  5000  unit ; famotidine  20  mg ; aspirin  81  mg ; simvastatin  20  mg ; miconazole powder 2%  1  appl ; clobetasol propionate 0.05% ointment  1  appl ; triamcinolone acetonide 0.1% cream  1  appl ; sodium chloride 0.9%  flush  10  ml ; multivitamins  1  tab ; ipratropium-albuterol neb  1  neb ; ciprofloxacin hcl  500  mg ; insulin  30  unit ; heparin flush (10 units ml)  1  ml ; mupirocin ointment 2%  1  appl ; furosemide  10  mg ; simvastatin  40  mg ; insulin  35  unit ; 
 
unknown f 58 $nan$chemistry blood anion gap  9  meq l; chemistry blood bicarbonate  41  meq l; chemistry blood chloride  94  meq l; chemistry blood creatinine  0.7  mg dl; chemistry blood potassium  4.8  meq l; chemistry blood sodium  139  meq l; chemistry blood urea nitrogen  14  mg dl; chemistry blood calcium, total  9.7  mg dl; chemistry blood glucose  222  mg dl$bisacodyl  10  mg ; dextrose 50%  12.5  gm ; glucagon  1  mg ; glucose gel  15  g ; heparin  5000  unit ; famotidine  20  mg ; aspirin  81  mg ; miconazole powder 2%  1  appl ; clobetasol propionate 0.05% ointment  1  appl ; triamcinolone acetonide 0.1% cream  1  appl ; sodium chloride 0.9%  flush  10  ml ; multivitamins  1  tab ; ipratropium-albuterol neb  1  neb ; ciprofloxacin hcl  500  mg ; heparin flush (10 units ml)  1  ml ; mupirocin ointment 2%  1  appl ; simvastatin  40  mg ; insulin  35  unit ; insulin  8  unit ; sodium chloride 0.9%  flush  3  ml ; 
 
unknown f 58 $nan$hematology blood hematocrit  32.5  %; hematology blood hematocrit  44.0  %; hematology blood hematocrit  43.6  %; hematology blood hemoglobin  9.6  g dl; hematology blood hemoglobin  12.9  g dl; hematology blood platelet count  134  k ul; hematology blood platelet count  151  k ul; chemistry blood anion gap  12  meq l; chemistry blood bicarbonate  33  meq l; chemistry blood chloride  98  meq l; chemistry blood chloride  100  meq l; chemistry blood creatinine  0.6  mg dl; chemistry blood potassium  3.9  meq l; chemistry blood potassium  4.5  meq l; chemistry blood sodium  139  meq l; chemistry blood sodium  141  meq l; chemistry blood urea nitrogen  13  mg dl; hematology blood inr(pt)  1.6  ; hematology blood inr(pt)  1.2  ; blood gas blood free calcium  1.13  mmol l; blood gas blood free calcium  1.28  mmol l; blood gas blood free calcium  1.22  mmol l; blood gas blood lactate  0.9  mmol l; blood gas blood lactate  2.5  mmol l; blood gas blood chloride, whole blood  89  meq l; blood gas blood chloride, whole blood  95  meq l; blood gas blood glucose  260  mg dl; blood gas blood glucose  231  mg dl; blood gas blood glucose  228  mg dl; blood gas blood glucose  238  mg dl; blood gas blood glucose  206  mg dl; blood gas blood glucose  148  mg dl; blood gas blood glucose  131  mg dl; blood gas blood hematocrit, calculated  30  %; blood gas blood hematocrit, calculated  38  %; blood gas blood hematocrit, calculated  30  %; blood gas blood hematocrit, calculated  31  %; blood gas blood hemoglobin  12.7  g dl; blood gas blood hemoglobin  10.1  g dl; blood gas blood hemoglobin  9.9  g dl; blood gas blood hemoglobin  10.4  g dl; blood gas blood potassium, whole blood  5.2  meq l; blood gas blood potassium, whole blood  5.1  meq l; blood gas blood potassium, whole blood  5.5  meq l; blood gas blood potassium, whole blood  4.7  meq l; blood gas blood potassium, whole blood  3.7  meq l; blood gas blood potassium, whole blood  3.7  meq l; blood gas blood sodium, whole blood  137  meq l; blood gas blood sodium, whole blood  133  meq l; blood gas blood sodium, whole blood  136  meq l$bisacodyl  10  mg ; dextrose 50%  12.5  gm ; glucagon  1  mg ; glucose gel  15  g ; heparin  5000  unit ; famotidine  20  mg ; aspirin  81  mg ; miconazole powder 2%  1  appl ; clobetasol propionate 0.05% ointment  1  appl ; triamcinolone acetonide 0.1% cream  1  appl ; multivitamins  1  tab ; ipratropium-albuterol neb  1  neb ; ciprofloxacin hcl  500  mg ; mupirocin ointment 2%  1  appl ; simvastatin  40  mg ; insulin  35  unit ; sodium chloride 0.9%  flush  3  ml ; aspirin ec  81  mg ; milk of magnesia  30  ml ; dextrose 5%  1000  ml ; propofol  1000  mg ; syringe  20  ml ; nitroglycerin  8  mg ; 5% dextrose  250  ml ; phenylephrine  60  mg ; syringe  1  syr ; phenylephrine  12  mg ; glycopyrrolate  0.6  mg ; neostigmine  3  mg ; sterile water  50  ml ; bag  1  ml ; morphine sulfate  0.5-5  mg ; metoclopramide  10  mg ; oxycodone-acetaminophen (5mg-325mg)  1-2  tab ; acetaminophen  650  mg ; insulin reg human (novolin r)  100  unit ; iso-osmotic dextrose  50  ml ; cefazolin  2  g ; soln  100  ml ; acetaminophen iv  1000  mg ; albuterol inhaler  4  puff ; ipratropium bromide mdi  4  puff ; albumin 5% (25g   500ml)  25  g ; naloxone  0.04  mg ; chlorhexidine gluconate 0.12% oral rinse  15  ml ; succinylcholine  100  mg ; propofol  20  mg ; 5% dextrose  200  ml ; ciprofloxacin iv  400  mg ; 
 
unknown f 58 $nan$hematology blood hematocrit  35.5  %; hematology blood hematocrit  33.9  %; hematology blood hematocrit  36.0  %; hematology blood hemoglobin  10.6  g dl; hematology blood hemoglobin  10.5  g dl; hematology blood platelet count  111  k ul; hematology blood platelet count  107  k ul; chemistry blood anion gap  10  meq l; chemistry blood anion gap  11  meq l; chemistry blood bicarbonate  33  meq l; chemistry blood bicarbonate  34  meq l; chemistry blood chloride  97  meq l; chemistry blood chloride  93  meq l; chemistry blood creatinine  0.6  mg dl; chemistry blood creatinine  0.5  mg dl; chemistry blood potassium  3.5  meq l; chemistry blood potassium  3.9  meq l; chemistry blood sodium  136  meq l; chemistry blood sodium  134  meq l; chemistry blood urea nitrogen  13  mg dl; chemistry blood urea nitrogen  10  mg dl; hematology blood inr(pt)  1.2  ; chemistry blood calcium, total  8.6  mg dl; chemistry blood glucose  88  mg dl; chemistry blood glucose  166  mg dl; blood gas blood free calcium  1.10  mmol l; blood gas blood free calcium  1.15  mmol l; blood gas blood glucose  182  mg dl; blood gas blood glucose  160  mg dl; blood gas blood potassium, whole blood  4.1  meq l$aspirin ec  81  mg ; milk of magnesia  30  ml ; dextrose 5%  1000  ml ; syringe  20  ml ; nitroglycerin  8  mg ; 5% dextrose  250  ml ; phenylephrine  60  mg ; syringe  1  syr ; phenylephrine  12  mg ; sterile water  50  ml ; bag  1  ml ; metoclopramide  10  mg ; oxycodone-acetaminophen (5mg-325mg)  1-2  tab ; acetaminophen  650  mg ; insulin reg human (novolin r)  100  unit ; iso-osmotic dextrose  50  ml ; cefazolin  2  g ; soln  100  ml ; acetaminophen iv  1000  mg ; albuterol inhaler  4  puff ; ipratropium bromide mdi  4  puff ; albumin 5% (25g   500ml)  25  g ; naloxone  0.04  mg ; succinylcholine  100  mg ; propofol  20  mg ; 5% dextrose  200  ml ; ciprofloxacin iv  400  mg ; 0.9% sodium chloride  250  ml ; sodium phosphate  30  mmol ; syringe  2  ml ; metoprolol tartrate  5  mg ; metoprolol tartrate  12.5  mg ; 
 
unknown f 58 $nan$nan$aspirin ec  81  mg ; milk of magnesia  30  ml ; dextrose 5%  1000  ml ; syringe  20  ml ; nitroglycerin  8  mg ; 5% dextrose  250  ml ; phenylephrine  60  mg ; syringe  1  syr ; phenylephrine  12  mg ; sterile water  50  ml ; bag  1  ml ; metoclopramide  10  mg ; oxycodone-acetaminophen (5mg-325mg)  1-2  tab ; acetaminophen  650  mg ; soln  100  ml ; acetaminophen iv  1000  mg ; albuterol inhaler  4  puff ; ipratropium bromide mdi  4  puff ; 5% dextrose  200  ml ; ciprofloxacin iv  400  mg ; 0.9% sodium chloride  250  ml ; sodium phosphate  30  mmol ; syringe  2  ml ; metoprolol tartrate  5  mg ; metoprolol tartrate  12.5  mg ; glipizide xl  10  mg ; metoprolol tartrate  25  mg ; metformin (glucophage)  500  mg ; insulin  14  unit ; oxycodone (immediate release)   5  mg ; glipizide  5  mg ; metoprolol tartrate  37.5  mg ; 
 
unknown f 58 $nan$hematology blood hematocrit  33.1  %; hematology blood hematocrit  33.5  %; hematology blood hemoglobin  10.1  g dl; hematology blood hemoglobin  10.1  g dl; hematology blood platelet count  117  k ul; hematology blood platelet count  160  k ul; chemistry blood anion gap  14  meq l; chemistry blood anion gap  14  meq l; chemistry blood bicarbonate  31  meq l; chemistry blood bicarbonate  34  meq l; chemistry blood chloride  90  meq l; chemistry blood chloride  87  meq l; chemistry blood chloride  90  meq l; chemistry blood creatinine  0.6  mg dl; chemistry blood creatinine  0.7  mg dl; chemistry blood creatinine  0.6  mg dl; chemistry blood potassium  4.2  meq l; chemistry blood potassium  3.9  meq l; chemistry blood potassium  3.6  meq l; chemistry blood sodium  131  meq l; chemistry blood sodium  130  meq l; chemistry blood sodium  134  meq l; chemistry blood urea nitrogen  17  mg dl; chemistry blood urea nitrogen  20  mg dl; chemistry blood urea nitrogen  18  mg dl; hematology blood inr(pt)  1.3  ; hematology blood inr(pt)  1.3  ; chemistry blood calcium, total  8.6  mg dl; chemistry blood calcium, total  9.1  mg dl; chemistry blood glucose  274  mg dl; chemistry blood glucose  111  mg dl$aspirin ec  81  mg ; milk of magnesia  30  ml ; syringe  20  ml ; nitroglycerin  8  mg ; 5% dextrose  250  ml ; phenylephrine  60  mg ; syringe  1  syr ; phenylephrine  12  mg ; sterile water  50  ml ; bag  1  ml ; soln  100  ml ; acetaminophen iv  1000  mg ; albuterol inhaler  4  puff ; ipratropium bromide mdi  4  puff ; 5% dextrose  200  ml ; ciprofloxacin iv  400  mg ; oxycodone (immediate release)   5  mg ; metoprolol tartrate  37.5  mg ; metformin (glucophage)  1000  mg ; insulin  50  unit ; syringe  4  ml ; furosemide  40  mg ; 
 
unknown f 58 $nan$nan$aspirin ec  81  mg ; milk of magnesia  30  ml ; syringe  20  ml ; nitroglycerin  8  mg ; 5% dextrose  250  ml ; phenylephrine  60  mg ; syringe  1  syr ; phenylephrine  12  mg ; sterile water  50  ml ; bag  1  ml ; soln  100  ml ; acetaminophen iv  1000  mg ; 5% dextrose  200  ml ; ciprofloxacin iv  400  mg ; oxycodone (immediate release)   5  mg ; metoprolol tartrate  37.5  mg ; metformin (glucophage)  1000  mg ; insulin  50  unit ; 
 
white m 51 $nan$hematology blood hematocrit  41.7  %; hematology blood hemoglobin  13.6  g dl; hematology blood platelet count  264  k ul; chemistry blood anion gap  13  meq l; chemistry blood bicarbonate  24  meq l; chemistry blood chloride  105  meq l; chemistry blood creatinine  0.9  mg dl; chemistry blood potassium  4.3  meq l; chemistry blood sodium  138  meq l; chemistry blood urea nitrogen  16  mg dl; chemistry blood calcium, total  8.0  mg dl; chemistry blood glucose  146  mg dl; blood gas blood hematocrit, calculated  45  %; blood gas blood hemoglobin  14.9  g dl$influenza virus vaccine  0.5  ml ; sodium chloride 0.9%  flush  3  ml ; lactated ringers  1000  ml ; ondansetron  4  mg ; 5% dextrose  100  ml ; naloxone  2  mg ; soln  100  ml ; acetaminophen iv  1000  mg ; lorazepam  0.5  mg ; bupivacaine 0.1%  250  ml ; yellow cadd cassette  1  cadd ; hydromorphone  2500  mcg ; heparin  5000  unit ; potassium chl 20 meq   1000 ml d5 1 2 ns  1000  ml ; bag  100  ml ; magnesium sulfate  4  gm ; 
 
white m 51 $nan$hematology blood hematocrit  34.0  %; hematology blood hemoglobin  10.7  g dl; hematology blood platelet count  183  k ul; chemistry blood anion gap  8  meq l; chemistry blood anion gap  10  meq l; chemistry blood bicarbonate  26  meq l; chemistry blood bicarbonate  24  meq l; chemistry blood chloride  106  meq l; chemistry blood chloride  108  meq l; chemistry blood creatinine  0.8  mg dl; chemistry blood creatinine  0.8  mg dl; chemistry blood potassium  5.5  meq l; chemistry blood potassium  4.2  meq l; chemistry blood sodium  134  meq l; chemistry blood sodium  138  meq l; chemistry blood urea nitrogen  12  mg dl; chemistry blood urea nitrogen  11  mg dl; chemistry blood calcium, total  7.2  mg dl; chemistry blood calcium, total  7.9  mg dl; chemistry blood glucose  116  mg dl; chemistry blood glucose  398  mg dl$influenza virus vaccine  0.5  ml ; sodium chloride 0.9%  flush  3  ml ; ondansetron  4  mg ; 5% dextrose  100  ml ; naloxone  2  mg ; soln  100  ml ; acetaminophen iv  1000  mg ; lorazepam  0.5  mg ; bupivacaine 0.1%  250  ml ; yellow cadd cassette  1  cadd ; hydromorphone  2500  mcg ; heparin  5000  unit ; potassium chl 20 meq   1000 ml d5 1 2 ns  1000  ml ; bag  100  ml ; magnesium sulfate  4  gm ; chloraseptic throat spray  1  spry ; 
 
white m 51 $nan$hematology blood hematocrit  35.8  %; hematology blood hemoglobin  11.7  g dl; hematology blood platelet count  204  k ul; chemistry blood anion gap  10  meq l; chemistry blood bicarbonate  27  meq l; chemistry blood chloride  104  meq l; chemistry blood creatinine  0.7  mg dl; chemistry blood potassium  4.2  meq l; chemistry blood sodium  137  meq l; chemistry blood urea nitrogen  8  mg dl; chemistry blood calcium, total  8.1  mg dl; chemistry blood glucose  99  mg dl$influenza virus vaccine  0.5  ml ; sodium chloride 0.9%  flush  3  ml ; ondansetron  4  mg ; 5% dextrose  100  ml ; naloxone  2  mg ; soln  100  ml ; acetaminophen iv  1000  mg ; lorazepam  0.5  mg ; bupivacaine 0.1%  250  ml ; yellow cadd cassette  1  cadd ; hydromorphone  2500  mcg ; heparin  5000  unit ; potassium chl 20 meq   1000 ml d5 1 2 ns  1000  ml ; chloraseptic throat spray  1  spry ; 0.9% sodium chloride  500  ml ; sodium glycerophosphate  40  mmol ; 
 
white m 51 $nan$chemistry blood anion gap  10  meq l; chemistry blood bicarbonate  29  meq l; chemistry blood chloride  103  meq l; chemistry blood creatinine  0.7  mg dl; chemistry blood potassium  4.4  meq l; chemistry blood sodium  138  meq l; chemistry blood urea nitrogen  7  mg dl; chemistry blood calcium, total  8.4  mg dl; chemistry blood glucose  124  mg dl$sodium chloride 0.9%  flush  3  ml ; ondansetron  4  mg ; 5% dextrose  100  ml ; naloxone  2  mg ; soln  100  ml ; acetaminophen iv  1000  mg ; lorazepam  0.5  mg ; bupivacaine 0.1%  250  ml ; yellow cadd cassette  1  cadd ; hydromorphone  2500  mcg ; heparin  5000  unit ; potassium chl 20 meq   1000 ml d5 1 2 ns  1000  ml ; chloraseptic throat spray  1  spry ; 0.9% sodium chloride  500  ml ; sodium glycerophosphate  40  mmol ; vial  1  vial ; pantoprazole  40  mg ; 
 
white m 51 $nan$chemistry blood anion gap  12  meq l; chemistry blood bicarbonate  26  meq l; chemistry blood chloride  104  meq l; chemistry blood creatinine  0.6  mg dl; chemistry blood potassium  4.1  meq l; chemistry blood sodium  138  meq l; chemistry blood urea nitrogen  7  mg dl; chemistry blood calcium, total  8.9  mg dl; chemistry blood glucose  113  mg dl$sodium chloride 0.9%  flush  3  ml ; ondansetron  4  mg ; 5% dextrose  100  ml ; naloxone  2  mg ; soln  100  ml ; acetaminophen iv  1000  mg ; lorazepam  0.5  mg ; bupivacaine 0.1%  250  ml ; yellow cadd cassette  1  cadd ; hydromorphone  2500  mcg ; heparin  5000  unit ; potassium chl 20 meq   1000 ml d5 1 2 ns  1000  ml ; chloraseptic throat spray  1  spry ; vial  1  vial ; pantoprazole  40  mg ; hydromorphone (dilaudid)  20  mg ; 
 
white m 51 $nan$chemistry blood anion gap  13  meq l; chemistry blood bicarbonate  28  meq l; chemistry blood chloride  102  meq l; chemistry blood creatinine  0.8  mg dl; chemistry blood potassium  3.9  meq l; chemistry blood sodium  139  meq l; chemistry blood urea nitrogen  11  mg dl; chemistry blood calcium, total  9.3  mg dl; chemistry blood glucose  122  mg dl$sodium chloride 0.9%  flush  3  ml ; soln  100  ml ; acetaminophen iv  1000  mg ; lorazepam  0.5  mg ; heparin  5000  unit ; potassium chl 20 meq   1000 ml d5 1 2 ns  1000  ml ; chloraseptic throat spray  1  spry ; vial  1  vial ; pantoprazole  40  mg ; hydromorphone (dilaudid)  20  mg ; 
 
white m 51 $nan$chemistry blood anion gap  12  meq l; chemistry blood bicarbonate  25  meq l; chemistry blood chloride  106  meq l; chemistry blood creatinine  0.7  mg dl; chemistry blood potassium  4.2  meq l; chemistry blood sodium  139  meq l; chemistry blood urea nitrogen  7  mg dl; chemistry blood calcium, total  8.5  mg dl; chemistry blood glucose  100  mg dl$sodium chloride 0.9%  flush  3  ml ; soln  100  ml ; acetaminophen iv  1000  mg ; lorazepam  0.5  mg ; heparin  5000  unit ; potassium chl 20 meq   1000 ml d5 1 2 ns  1000  ml ; chloraseptic throat spray  1  spry ; vial  1  vial ; pantoprazole  40  mg ; hydromorphone (dilaudid)  20  mg ; oxycodone (immediate release)   5-10  mg ; acetaminophen  1000  mg ; 
 
white m 51 $nan$nan$sodium chloride 0.9%  flush  3  ml ; lorazepam  0.5  mg ; heparin  5000  unit ; chloraseptic throat spray  1  spry ; vial  1  vial ; pantoprazole  40  mg ; oxycodone (immediate release)   5-10  mg ; acetaminophen  1000  mg ; 
 
black african american f 45 $nan$hematology blood hematocrit  36.6  %; hematology blood hemoglobin  12.3  g dl; hematology blood platelet count  235  k ul; chemistry blood anion gap  13  meq l; chemistry blood bicarbonate  21  meq l; chemistry blood chloride  107  meq l; chemistry blood creatinine  0.8  mg dl; chemistry blood potassium  4.1  meq l; chemistry blood sodium  137  meq l; chemistry blood urea nitrogen  7  mg dl; hematology blood inr(pt)  1.1  ; chemistry blood bilirubin, total  0.6  mg dl; chemistry blood glucose  121  mg dl; chemistry blood lactate dehydrogenase (ld)  255  iu l; blood gas blood lactate  1.4  mmol l; blood gas blood potassium, whole blood  4.0  meq l; hematology urine glucose  neg  mg dl; hematology urine bilirubin  neg  mg dl$nan
 
black african american f 45 $nan$hematology blood hematocrit  32.6  %; hematology blood hematocrit  32.4  %; hematology blood hemoglobin  10.4  g dl; hematology blood hemoglobin  10.6  g dl; hematology blood platelet count  225  k ul; hematology blood platelet count  186  k ul; chemistry blood anion gap  12  meq l; chemistry blood bicarbonate  20  meq l; chemistry blood chloride  108  meq l; chemistry blood creatinine  0.7  mg dl; chemistry blood potassium  3.6  meq l; chemistry blood sodium  136  meq l; chemistry blood urea nitrogen  5  mg dl; hematology blood inr(pt)  1.2  ; chemistry blood calcium, total  7.6  mg dl; chemistry blood bilirubin, total  1.0  mg dl; chemistry blood bilirubin, total  0.6  mg dl; chemistry blood glucose  107  mg dl; chemistry blood lactate dehydrogenase (ld)  470  iu l; chemistry blood lactate dehydrogenase (ld)  245  iu l; chemistry blood albumin  3.5  g dl; chemistry blood albumin  3.5  g dl$sodium chloride 0.9%  flush  3  ml ; ibuprofen  400  mg ; heparin  5000  unit ; omeprazole  20  mg ; ondansetron odt  4  mg ; senna  1  tab ; docusate sodium  100  mg ; 
 
black african american f 45 $nan$hematology blood hematocrit  31.8  %; hematology blood hemoglobin  10.7  g dl; hematology blood platelet count  199  k ul; chemistry blood anion gap  9  meq l; chemistry blood bicarbonate  23  meq l; chemistry blood chloride  111  meq l; chemistry blood creatinine  0.7  mg dl; chemistry blood potassium  3.9  meq l; chemistry blood sodium  139  meq l; chemistry blood urea nitrogen  7  mg dl; chemistry blood calcium, total  7.8  mg dl; chemistry blood bilirubin, total  0.3  mg dl; chemistry blood glucose  88  mg dl; chemistry blood lactate dehydrogenase (ld)  162  iu l; chemistry blood albumin  3.5  g dl$sodium chloride 0.9%  flush  3  ml ; ibuprofen  400  mg ; heparin  5000  unit ; omeprazole  20  mg ; ondansetron odt  4  mg ; senna  1  tab ; docusate sodium  100  mg ; 
 
white m 54 $nan$hematology blood hematocrit  28.1  %; hematology blood hemoglobin  9.1  g dl; hematology blood platelet count  237  k ul; chemistry blood anion gap  9  meq l; chemistry blood bicarbonate  28  meq l; chemistry blood chloride  104  meq l; chemistry blood creatinine  0.5  mg dl; chemistry blood potassium  3.6  meq l; chemistry blood sodium  137  meq l; chemistry blood urea nitrogen  4  mg dl; hematology blood inr(pt)  1.2  ; hematology urine wbc  7  # hpf; chemistry blood calcium, total  8.0  mg dl; chemistry blood bilirubin, total  0.3  mg dl; chemistry blood glucose  101  mg dl; chemistry blood lactate dehydrogenase (ld)  182  iu l; chemistry blood albumin  2.8  g dl$sodium chloride 0.9%  flush  3  ml ; d5w  100  ml ; gentamicin sulfate  300  mg ; acetaminophen  650  mg ; morphine sr (ms contin)  15  mg ; pantoprazole  40  mg ; ns (mini bag plus)  100  ml ; meropenem  1000  mg ; oxycodone (immediate release)   5  mg ; iso-osmotic dextrose  200  ml ; vancomycin  1000  mg ; ascorbic acid  500  mg ; tizanidine hcl  2  mg ; aquaphor ointment  1  appl ; fondaparinux sodium  2.5  mg ; multivitamins  1  cap ; papain-urea ointment  1  appl ; morphine sr (ms contin)  30  mg ; baclofen  10  mg ; morphine sulfate ir  7.5-15  mg ; 
pseudomonas infection in conditions classified elsewhere and of unspecified site anemia of other chronic disease urinary tract infection, site not specified unspecified protein-calorie malnutrition pressure ulcer, heel other encephalopathy bacteremia quadriplegia, unspecified chronic hepatitis c without mention of hepatic coma pressure ulcer, lower back other and unspecified infection due to central venous catheter 
white m 54 $nan$hematology blood hematocrit  25.9  %; hematology blood hematocrit  25.5  %; hematology blood hemoglobin  8.6  g dl; hematology blood platelet count  237  k ul; chemistry blood anion gap  11  meq l; chemistry blood bicarbonate  28  meq l; chemistry blood chloride  108  meq l; chemistry blood creatinine  0.5  mg dl; chemistry blood potassium  3.9  meq l; chemistry blood sodium  143  meq l; chemistry blood urea nitrogen  5  mg dl; chemistry blood calcium, total  8.5  mg dl; chemistry blood glucose  102  mg dl$sodium chloride 0.9%  flush  3  ml ; acetaminophen  650  mg ; pantoprazole  40  mg ; iso-osmotic dextrose  200  ml ; vancomycin  1000  mg ; ascorbic acid  500  mg ; tizanidine hcl  2  mg ; aquaphor ointment  1  appl ; fondaparinux sodium  2.5  mg ; multivitamins  1  cap ; papain-urea ointment  1  appl ; morphine sr (ms contin)  30  mg ; baclofen  10  mg ; morphine sulfate ir  7.5-15  mg ; 
pseudomonas infection in conditions classified elsewhere and of unspecified site anemia of other chronic disease urinary tract infection, site not specified unspecified protein-calorie malnutrition pressure ulcer, heel other encephalopathy bacteremia quadriplegia, unspecified chronic hepatitis c without mention of hepatic coma pressure ulcer, lower back other and unspecified infection due to central venous catheter 
white m 54 $nan$hematology blood hematocrit  26.4  %; hematology blood hemoglobin  8.4  g dl; hematology blood platelet count  240  k ul; chemistry blood anion gap  11  meq l; chemistry blood bicarbonate  29  meq l; chemistry blood chloride  105  meq l; chemistry blood creatinine  0.5  mg dl; chemistry blood potassium  3.8  meq l; chemistry blood sodium  141  meq l; chemistry blood urea nitrogen  5  mg dl; chemistry blood calcium, total  8.2  mg dl; chemistry blood glucose  109  mg dl; hematology urine glucose  neg  mg dl; hematology urine bilirubin  neg  mg dl$sodium chloride 0.9%  flush  3  ml ; acetaminophen  650  mg ; pantoprazole  40  mg ; ascorbic acid  500  mg ; tizanidine hcl  2  mg ; aquaphor ointment  1  appl ; fondaparinux sodium  2.5  mg ; multivitamins  1  cap ; papain-urea ointment  1  appl ; morphine sr (ms contin)  30  mg ; baclofen  10  mg ; morphine sulfate ir  7.5-15  mg ; 
pseudomonas infection in conditions classified elsewhere and of unspecified site anemia of other chronic disease urinary tract infection, site not specified unspecified protein-calorie malnutrition pressure ulcer, heel other encephalopathy bacteremia quadriplegia, unspecified chronic hepatitis c without mention of hepatic coma pressure ulcer, lower back other and unspecified infection due to central venous catheter 
white m 54 $nan$hematology blood hematocrit  26.4  %; hematology blood hemoglobin  8.9  g dl; hematology blood platelet count  277  k ul; chemistry blood anion gap  8  meq l; chemistry blood bicarbonate  30  meq l; chemistry blood chloride  103  meq l; chemistry blood creatinine  0.5  mg dl; chemistry blood potassium  3.5  meq l; chemistry blood sodium  137  meq l; chemistry blood urea nitrogen  4  mg dl; chemistry blood calcium, total  7.9  mg dl; chemistry blood glucose  158  mg dl$sodium chloride 0.9%  flush  3  ml ; acetaminophen  650  mg ; pantoprazole  40  mg ; ascorbic acid  500  mg ; tizanidine hcl  2  mg ; aquaphor ointment  1  appl ; fondaparinux sodium  2.5  mg ; multivitamins  1  cap ; papain-urea ointment  1  appl ; morphine sr (ms contin)  30  mg ; baclofen  10  mg ; morphine sulfate ir  7.5-15  mg ; senna  1  tab ; baclofen  15  mg ; neutra-phos  2  pkt ; potassium chloride  40  meq ; magnesium sulfate  4  gm ; docusate sodium  100  mg ; 
pseudomonas infection in conditions classified elsewhere and of unspecified site anemia of other chronic disease urinary tract infection, site not specified unspecified protein-calorie malnutrition pressure ulcer, heel other encephalopathy bacteremia quadriplegia, unspecified chronic hepatitis c without mention of hepatic coma pressure ulcer, lower back other and unspecified infection due to central venous catheter 
white m 54 $nan$hematology blood hematocrit  25.4  %; hematology blood hemoglobin  8.6  g dl; hematology blood platelet count  262  k ul; chemistry blood potassium  4.3  meq l; hematology blood inr(pt)  1.2  $sodium chloride 0.9%  flush  3  ml ; acetaminophen  650  mg ; pantoprazole  40  mg ; ascorbic acid  500  mg ; tizanidine hcl  2  mg ; aquaphor ointment  1  appl ; fondaparinux sodium  2.5  mg ; multivitamins  1  cap ; papain-urea ointment  1  appl ; morphine sr (ms contin)  30  mg ; morphine sulfate ir  7.5-15  mg ; senna  1  tab ; baclofen  15  mg ; neutra-phos  2  pkt ; potassium chloride  40  meq ; magnesium sulfate  4  gm ; docusate sodium  100  mg ; baclofen  20  mg ; 
pseudomonas infection in conditions classified elsewhere and of unspecified site anemia of other chronic disease urinary tract infection, site not specified unspecified protein-calorie malnutrition pressure ulcer, heel other encephalopathy bacteremia quadriplegia, unspecified chronic hepatitis c without mention of hepatic coma pressure ulcer, lower back other and unspecified infection due to central venous catheter 
white m 54 $nan$nan$sodium chloride 0.9%  flush  3  ml ; acetaminophen  650  mg ; pantoprazole  40  mg ; ascorbic acid  500  mg ; aquaphor ointment  1  appl ; fondaparinux sodium  2.5  mg ; multivitamins  1  cap ; papain-urea ointment  1  appl ; morphine sr (ms contin)  30  mg ; morphine sulfate ir  7.5-15  mg ; senna  1  tab ; docusate sodium  100  mg ; baclofen  20  mg ; ns  1000  ml ; morphine sr (ms contin)  45  mg ; chlorhexidine gluconate 0.12% oral rinse  15  ml ; 
pseudomonas infection in conditions classified elsewhere and of unspecified site anemia of other chronic disease urinary tract infection, site not specified unspecified protein-calorie malnutrition pressure ulcer, heel other encephalopathy bacteremia quadriplegia, unspecified chronic hepatitis c without mention of hepatic coma pressure ulcer, lower back other and unspecified infection due to central venous catheter 
white m 54 $nan$hematology blood hematocrit  27.0  %; hematology blood hemoglobin  8.9  g dl; hematology blood platelet count  274  k ul; chemistry blood anion gap  8  meq l; chemistry blood bicarbonate  32  meq l; chemistry blood chloride  106  meq l; chemistry blood creatinine  0.8  mg dl; chemistry blood potassium  4.2  meq l; chemistry blood sodium  142  meq l; chemistry blood urea nitrogen  8  mg dl; chemistry blood calcium, total  8.4  mg dl; chemistry blood glucose  106  mg dl; hematology urine glucose  neg  mg dl; hematology urine bilirubin  neg  mg dl$sodium chloride 0.9%  flush  3  ml ; acetaminophen  650  mg ; pantoprazole  40  mg ; ascorbic acid  500  mg ; aquaphor ointment  1  appl ; fondaparinux sodium  2.5  mg ; multivitamins  1  cap ; papain-urea ointment  1  appl ; morphine sulfate ir  7.5-15  mg ; senna  1  tab ; docusate sodium  100  mg ; baclofen  20  mg ; ns  1000  ml ; morphine sr (ms contin)  45  mg ; chlorhexidine gluconate 0.12% oral rinse  15  ml ; 
pseudomonas infection in conditions classified elsewhere and of unspecified site anemia of other chronic disease urinary tract infection, site not specified unspecified protein-calorie malnutrition pressure ulcer, heel other encephalopathy bacteremia quadriplegia, unspecified chronic hepatitis c without mention of hepatic coma pressure ulcer, lower back other and unspecified infection due to central venous catheter 
white m 54 $nan$hematology blood hematocrit  25.4  %; hematology blood hemoglobin  8.2  g dl; hematology blood platelet count  273  k ul; chemistry blood anion gap  10  meq l; chemistry blood bicarbonate  29  meq l; chemistry blood chloride  105  meq l; chemistry blood creatinine  0.9  mg dl; chemistry blood potassium  3.9  meq l; chemistry blood sodium  140  meq l; chemistry blood urea nitrogen  10  mg dl; chemistry blood calcium, total  8.3  mg dl; chemistry blood glucose  104  mg dl$sodium chloride 0.9%  flush  3  ml ; acetaminophen  650  mg ; pantoprazole  40  mg ; ascorbic acid  500  mg ; aquaphor ointment  1  appl ; fondaparinux sodium  2.5  mg ; multivitamins  1  cap ; papain-urea ointment  1  appl ; morphine sulfate ir  7.5-15  mg ; senna  1  tab ; docusate sodium  100  mg ; chlorhexidine gluconate 0.12% oral rinse  15  ml ; 
pseudomonas infection in conditions classified elsewhere and of unspecified site anemia of other chronic disease urinary tract infection, site not specified unspecified protein-calorie malnutrition pressure ulcer, heel other encephalopathy bacteremia quadriplegia, unspecified chronic hepatitis c without mention of hepatic coma pressure ulcer, lower back other and unspecified infection due to central venous catheter 
white m 54 $nan$hematology blood hematocrit  26.3  %; hematology blood hemoglobin  8.2  g dl; hematology blood platelet count  252  k ul; chemistry blood anion gap  10  meq l; chemistry blood bicarbonate  31  meq l; chemistry blood chloride  106  meq l; chemistry blood creatinine  0.9  mg dl; chemistry blood potassium  4.5  meq l; chemistry blood sodium  142  meq l; chemistry blood urea nitrogen  10  mg dl; chemistry blood calcium, total  8.4  mg dl; chemistry blood glucose  96  mg dl$sodium chloride 0.9%  flush  3  ml ; acetaminophen  650  mg ; pantoprazole  40  mg ; ascorbic acid  500  mg ; aquaphor ointment  1  appl ; fondaparinux sodium  2.5  mg ; multivitamins  1  cap ; papain-urea ointment  1  appl ; morphine sulfate ir  7.5-15  mg ; senna  1  tab ; docusate sodium  100  mg ; chlorhexidine gluconate 0.12% oral rinse  15  ml ; calcium carbonate  500  mg ; 
pseudomonas infection in conditions classified elsewhere and of unspecified site anemia of other chronic disease urinary tract infection, site not specified unspecified protein-calorie malnutrition pressure ulcer, heel other encephalopathy bacteremia quadriplegia, unspecified chronic hepatitis c without mention of hepatic coma pressure ulcer, lower back other and unspecified infection due to central venous catheter 
white m 54 $nan$nan$sodium chloride 0.9%  flush  3  ml ; acetaminophen  650  mg ; pantoprazole  40  mg ; ascorbic acid  500  mg ; aquaphor ointment  1  appl ; fondaparinux sodium  2.5  mg ; multivitamins  1  cap ; papain-urea ointment  1  appl ; morphine sulfate ir  7.5-15  mg ; senna  1  tab ; docusate sodium  100  mg ; chlorhexidine gluconate 0.12% oral rinse  15  ml ; calcium carbonate  500  mg ; 
pseudomonas infection in conditions classified elsewhere and of unspecified site anemia of other chronic disease urinary tract infection, site not specified unspecified protein-calorie malnutrition pressure ulcer, heel other encephalopathy bacteremia quadriplegia, unspecified chronic hepatitis c without mention of hepatic coma pressure ulcer, lower back other and unspecified infection due to central venous catheter 
white m 54 $nan$nan$sodium chloride 0.9%  flush  3  ml ; acetaminophen  650  mg ; pantoprazole  40  mg ; ascorbic acid  500  mg ; aquaphor ointment  1  appl ; fondaparinux sodium  2.5  mg ; multivitamins  1  cap ; papain-urea ointment  1  appl ; morphine sulfate ir  7.5-15  mg ; senna  1  tab ; docusate sodium  100  mg ; chlorhexidine gluconate 0.12% oral rinse  15  ml ; calcium carbonate  500  mg ; 
pseudomonas infection in conditions classified elsewhere and of unspecified site anemia of other chronic disease urinary tract infection, site not specified unspecified protein-calorie malnutrition pressure ulcer, heel other encephalopathy bacteremia quadriplegia, unspecified chronic hepatitis c without mention of hepatic coma pressure ulcer, lower back other and unspecified infection due to central venous catheter 
white m 54 $nan$hematology blood hematocrit  25.3  %; hematology blood hemoglobin  8.1  g dl; hematology blood platelet count  245  k ul; chemistry blood anion gap  10  meq l; chemistry blood bicarbonate  31  meq l; chemistry blood chloride  105  meq l; chemistry blood creatinine  1.0  mg dl; chemistry blood potassium  4.1  meq l; chemistry blood sodium  142  meq l; chemistry blood urea nitrogen  15  mg dl; chemistry blood calcium, total  8.3  mg dl; chemistry blood glucose  122  mg dl$sodium chloride 0.9%  flush  3  ml ; pantoprazole  40  mg ; ascorbic acid  500  mg ; aquaphor ointment  1  appl ; fondaparinux sodium  2.5  mg ; multivitamins  1  cap ; papain-urea ointment  1  appl ; morphine sulfate ir  7.5-15  mg ; senna  1  tab ; docusate sodium  100  mg ; chlorhexidine gluconate 0.12% oral rinse  15  ml ; calcium carbonate  500  mg ; 
pseudomonas infection in conditions classified elsewhere and of unspecified site anemia of other chronic disease urinary tract infection, site not specified unspecified protein-calorie malnutrition pressure ulcer, heel other encephalopathy bacteremia quadriplegia, unspecified chronic hepatitis c without mention of hepatic coma pressure ulcer, lower back other and unspecified infection due to central venous catheter 
white m 54 $nan$hematology blood hematocrit  24.7  %; hematology blood hemoglobin  8.0  g dl; hematology blood platelet count  237  k ul; chemistry blood anion gap  9  meq l; chemistry blood bicarbonate  32  meq l; chemistry blood chloride  103  meq l; chemistry blood creatinine  1.0  mg dl; chemistry blood potassium  4.5  meq l; chemistry blood sodium  139  meq l; chemistry blood urea nitrogen  16  mg dl; chemistry blood calcium, total  8.6  mg dl; chemistry blood glucose  109  mg dl$sodium chloride 0.9%  flush  3  ml ; pantoprazole  40  mg ; ascorbic acid  500  mg ; aquaphor ointment  1  appl ; fondaparinux sodium  2.5  mg ; multivitamins  1  cap ; papain-urea ointment  1  appl ; morphine sulfate ir  7.5-15  mg ; senna  1  tab ; docusate sodium  100  mg ; chlorhexidine gluconate 0.12% oral rinse  15  ml ; calcium carbonate  500  mg ; acetaminophen  325  mg ; 
pseudomonas infection in conditions classified elsewhere and of unspecified site anemia of other chronic disease urinary tract infection, site not specified unspecified protein-calorie malnutrition pressure ulcer, heel other encephalopathy bacteremia quadriplegia, unspecified chronic hepatitis c without mention of hepatic coma pressure ulcer, lower back other and unspecified infection due to central venous catheter 
white m 54 $nan$hematology blood hematocrit  24.5  %; hematology blood hemoglobin  8.0  g dl; hematology blood platelet count  246  k ul; chemistry blood anion gap  11  meq l; chemistry blood bicarbonate  30  meq l; chemistry blood chloride  104  meq l; chemistry blood creatinine  1.1  mg dl; chemistry blood potassium  4.4  meq l; chemistry blood sodium  141  meq l; chemistry blood urea nitrogen  18  mg dl; chemistry blood calcium, total  8.3  mg dl; chemistry blood glucose  106  mg dl$sodium chloride 0.9%  flush  3  ml ; pantoprazole  40  mg ; ascorbic acid  500  mg ; aquaphor ointment  1  appl ; fondaparinux sodium  2.5  mg ; multivitamins  1  cap ; papain-urea ointment  1  appl ; morphine sulfate ir  7.5-15  mg ; senna  1  tab ; docusate sodium  100  mg ; chlorhexidine gluconate 0.12% oral rinse  15  ml ; calcium carbonate  500  mg ; acetaminophen  325  mg ; lorazepam  0.5  mg ; 
pseudomonas infection in conditions classified elsewhere and of unspecified site anemia of other chronic disease urinary tract infection, site not specified unspecified protein-calorie malnutrition pressure ulcer, heel other encephalopathy bacteremia quadriplegia, unspecified chronic hepatitis c without mention of hepatic coma pressure ulcer, lower back other and unspecified infection due to central venous catheter 
white m 54 $nan$hematology blood hematocrit  25.6  %; hematology blood hemoglobin  8.3  g dl; hematology blood platelet count  276  k ul; chemistry blood anion gap  12  meq l; chemistry blood bicarbonate  29  meq l; chemistry blood chloride  100  meq l; chemistry blood creatinine  1.0  mg dl; chemistry blood potassium  4.4  meq l; chemistry blood sodium  137  meq l; chemistry blood urea nitrogen  17  mg dl; chemistry blood calcium, total  8.5  mg dl; chemistry blood glucose  94  mg dl$sodium chloride 0.9%  flush  3  ml ; pantoprazole  40  mg ; ascorbic acid  500  mg ; aquaphor ointment  1  appl ; fondaparinux sodium  2.5  mg ; multivitamins  1  cap ; papain-urea ointment  1  appl ; morphine sulfate ir  7.5-15  mg ; senna  1  tab ; docusate sodium  100  mg ; chlorhexidine gluconate 0.12% oral rinse  15  ml ; calcium carbonate  500  mg ; lorazepam  0.5  mg ; zolpidem tartrate  5  mg ; 
pseudomonas infection in conditions classified elsewhere and of unspecified site anemia of other chronic disease urinary tract infection, site not specified unspecified protein-calorie malnutrition pressure ulcer, heel other encephalopathy bacteremia quadriplegia, unspecified chronic hepatitis c without mention of hepatic coma pressure ulcer, lower back other and unspecified infection due to central venous catheter 
white m 54 $nan$hematology blood hematocrit  26.3  %; hematology blood hemoglobin  8.3  g dl; hematology blood platelet count  283  k ul; chemistry blood anion gap  11  meq l; chemistry blood bicarbonate  30  meq l; chemistry blood chloride  103  meq l; chemistry blood creatinine  1.0  mg dl; chemistry blood potassium  4.0  meq l; chemistry blood sodium  140  meq l; chemistry blood urea nitrogen  18  mg dl; chemistry blood calcium, total  8.6  mg dl; chemistry blood glucose  119  mg dl$sodium chloride 0.9%  flush  3  ml ; pantoprazole  40  mg ; ascorbic acid  500  mg ; aquaphor ointment  1  appl ; fondaparinux sodium  2.5  mg ; multivitamins  1  cap ; papain-urea ointment  1  appl ; morphine sulfate ir  7.5-15  mg ; senna  1  tab ; docusate sodium  100  mg ; chlorhexidine gluconate 0.12% oral rinse  15  ml ; calcium carbonate  500  mg ; zolpidem tartrate  5  mg ; lorazepam  1  mg ; trazodone  25  mg ; acetaminophen  500  mg ; 
pseudomonas infection in conditions classified elsewhere and of unspecified site anemia of other chronic disease urinary tract infection, site not specified unspecified protein-calorie malnutrition pressure ulcer, heel other encephalopathy bacteremia quadriplegia, unspecified chronic hepatitis c without mention of hepatic coma pressure ulcer, lower back other and unspecified infection due to central venous catheter 
white m 54 $nan$hematology blood hematocrit  26.4  %; hematology blood hemoglobin  8.8  g dl; hematology blood platelet count  337  k ul; chemistry blood anion gap  10  meq l; chemistry blood bicarbonate  31  meq l; chemistry blood chloride  102  meq l; chemistry blood creatinine  1.1  mg dl; chemistry blood potassium  4.4  meq l; chemistry blood sodium  139  meq l; chemistry blood urea nitrogen  19  mg dl; chemistry blood calcium, total  8.6  mg dl; chemistry blood glucose  92  mg dl$sodium chloride 0.9%  flush  3  ml ; pantoprazole  40  mg ; ascorbic acid  500  mg ; aquaphor ointment  1  appl ; fondaparinux sodium  2.5  mg ; multivitamins  1  cap ; papain-urea ointment  1  appl ; morphine sulfate ir  7.5-15  mg ; senna  1  tab ; docusate sodium  100  mg ; chlorhexidine gluconate 0.12% oral rinse  15  ml ; calcium carbonate  500  mg ; lorazepam  1  mg ; trazodone  25  mg ; acetaminophen  500  mg ; ipratropium bromide neb  1  neb ; diazepam  10  mg ; 
pseudomonas infection in conditions classified elsewhere and of unspecified site anemia of other chronic disease urinary tract infection, site not specified unspecified protein-calorie malnutrition pressure ulcer, heel other encephalopathy bacteremia quadriplegia, unspecified chronic hepatitis c without mention of hepatic coma pressure ulcer, lower back other and unspecified infection due to central venous catheter 
white m 54 $nan$hematology blood hematocrit  25.7  %; hematology blood hemoglobin  8.3  g dl; hematology blood platelet count  312  k ul; chemistry blood anion gap  10  meq l; chemistry blood bicarbonate  31  meq l; chemistry blood chloride  105  meq l; chemistry blood creatinine  1.0  mg dl; chemistry blood potassium  4.5  meq l; chemistry blood sodium  141  meq l; chemistry blood urea nitrogen  20  mg dl; chemistry blood calcium, total  8.8  mg dl; chemistry blood glucose  98  mg dl$sodium chloride 0.9%  flush  3  ml ; pantoprazole  40  mg ; ascorbic acid  500  mg ; aquaphor ointment  1  appl ; fondaparinux sodium  2.5  mg ; multivitamins  1  cap ; papain-urea ointment  1  appl ; morphine sulfate ir  7.5-15  mg ; senna  1  tab ; docusate sodium  100  mg ; chlorhexidine gluconate 0.12% oral rinse  15  ml ; calcium carbonate  500  mg ; trazodone  25  mg ; acetaminophen  500  mg ; ipratropium bromide neb  1  neb ; diazepam  10  mg ; 
pseudomonas infection in conditions classified elsewhere and of unspecified site anemia of other chronic disease urinary tract infection, site not specified unspecified protein-calorie malnutrition pressure ulcer, heel other encephalopathy bacteremia quadriplegia, unspecified chronic hepatitis c without mention of hepatic coma pressure ulcer, lower back other and unspecified infection due to central venous catheter 
white m 54 $nan$hematology blood hematocrit  26.3  %; hematology blood hemoglobin  8.4  g dl; hematology blood platelet count  306  k ul; chemistry blood anion gap  13  meq l; chemistry blood bicarbonate  28  meq l; chemistry blood chloride  103  meq l; chemistry blood creatinine  0.9  mg dl; chemistry blood potassium  4.4  meq l; chemistry blood sodium  140  meq l; chemistry blood urea nitrogen  19  mg dl; hematology urine wbc  6-10  # hpf; chemistry blood calcium, total  8.8  mg dl; chemistry blood glucose  97  mg dl; hematology urine glucose  neg  mg dl; hematology urine bilirubin  neg  mg dl$sodium chloride 0.9%  flush  3  ml ; pantoprazole  40  mg ; ascorbic acid  500  mg ; aquaphor ointment  1  appl ; fondaparinux sodium  2.5  mg ; multivitamins  1  cap ; papain-urea ointment  1  appl ; morphine sulfate ir  7.5-15  mg ; senna  1  tab ; docusate sodium  100  mg ; chlorhexidine gluconate 0.12% oral rinse  15  ml ; calcium carbonate  500  mg ; trazodone  25  mg ; acetaminophen  500  mg ; diazepam  10  mg ; diazepam  5  mg ; 
pseudomonas infection in conditions classified elsewhere and of unspecified site anemia of other chronic disease urinary tract infection, site not specified unspecified protein-calorie malnutrition pressure ulcer, heel other encephalopathy bacteremia quadriplegia, unspecified chronic hepatitis c without mention of hepatic coma pressure ulcer, lower back other and unspecified infection due to central venous catheter 
white m 54 $nan$nan$sodium chloride 0.9%  flush  3  ml ; pantoprazole  40  mg ; ascorbic acid  500  mg ; aquaphor ointment  1  appl ; fondaparinux sodium  2.5  mg ; multivitamins  1  cap ; papain-urea ointment  1  appl ; morphine sulfate ir  7.5-15  mg ; senna  1  tab ; docusate sodium  100  mg ; chlorhexidine gluconate 0.12% oral rinse  15  ml ; calcium carbonate  500  mg ; acetaminophen  500  mg ; diazepam  10  mg ; diazepam  5  mg ; 
pseudomonas infection in conditions classified elsewhere and of unspecified site anemia of other chronic disease urinary tract infection, site not specified unspecified protein-calorie malnutrition pressure ulcer, heel other encephalopathy bacteremia quadriplegia, unspecified chronic hepatitis c without mention of hepatic coma pressure ulcer, lower back other and unspecified infection due to central venous catheter 
white m 54 $nan$hematology blood hematocrit  25.5  %; hematology blood hemoglobin  8.6  g dl; hematology blood platelet count  360  k ul; chemistry blood anion gap  13  meq l; chemistry blood bicarbonate  29  meq l; chemistry blood chloride  104  meq l; chemistry blood creatinine  1.0  mg dl; chemistry blood potassium  4.5  meq l; chemistry blood sodium  141  meq l; chemistry blood urea nitrogen  24  mg dl; chemistry blood calcium, total  9.0  mg dl; chemistry blood glucose  90  mg dl$sodium chloride 0.9%  flush  3  ml ; pantoprazole  40  mg ; ascorbic acid  500  mg ; aquaphor ointment  1  appl ; fondaparinux sodium  2.5  mg ; multivitamins  1  cap ; papain-urea ointment  1  appl ; morphine sulfate ir  7.5-15  mg ; senna  1  tab ; docusate sodium  100  mg ; chlorhexidine gluconate 0.12% oral rinse  15  ml ; calcium carbonate  500  mg ; acetaminophen  500  mg ; diazepam  10  mg ; 
pseudomonas infection in conditions classified elsewhere and of unspecified site anemia of other chronic disease urinary tract infection, site not specified unspecified protein-calorie malnutrition pressure ulcer, heel other encephalopathy bacteremia quadriplegia, unspecified chronic hepatitis c without mention of hepatic coma pressure ulcer, lower back other and unspecified infection due to central venous catheter 
white m 54 $nan$nan$sodium chloride 0.9%  flush  3  ml ; pantoprazole  40  mg ; ascorbic acid  500  mg ; aquaphor ointment  1  appl ; fondaparinux sodium  2.5  mg ; multivitamins  1  cap ; papain-urea ointment  1  appl ; morphine sulfate ir  7.5-15  mg ; senna  1  tab ; docusate sodium  100  mg ; chlorhexidine gluconate 0.12% oral rinse  15  ml ; calcium carbonate  500  mg ; acetaminophen  500  mg ; diazepam  10  mg ; 
pseudomonas infection in conditions classified elsewhere and of unspecified site anemia of other chronic disease urinary tract infection, site not specified unspecified protein-calorie malnutrition pressure ulcer, heel other encephalopathy bacteremia quadriplegia, unspecified chronic hepatitis c without mention of hepatic coma pressure ulcer, lower back other and unspecified infection due to central venous catheter 
white m 54 $nan$hematology urine wbc  11-20  # hpf; hematology urine glucose  neg  mg dl; hematology urine bilirubin  neg  mg dl$sodium chloride 0.9%  flush  3  ml ; pantoprazole  40  mg ; ascorbic acid  500  mg ; aquaphor ointment  1  appl ; fondaparinux sodium  2.5  mg ; multivitamins  1  cap ; papain-urea ointment  1  appl ; morphine sulfate ir  7.5-15  mg ; senna  1  tab ; docusate sodium  100  mg ; chlorhexidine gluconate 0.12% oral rinse  15  ml ; calcium carbonate  500  mg ; acetaminophen  500  mg ; diazepam  10  mg ; zinc sulfate  220  mg ; vitamin b complex w c  1  tab ; morphine   5  mg ; amitriptyline hcl  5  mg ; 
pseudomonas infection in conditions classified elsewhere and of unspecified site anemia of other chronic disease urinary tract infection, site not specified unspecified protein-calorie malnutrition pressure ulcer, heel other encephalopathy bacteremia quadriplegia, unspecified chronic hepatitis c without mention of hepatic coma pressure ulcer, lower back other and unspecified infection due to central venous catheter 
white m 54 $nan$hematology blood hematocrit  28.3  %; hematology blood hemoglobin  9.0  g dl; hematology blood platelet count  341  k ul; chemistry blood anion gap  12  meq l; chemistry blood bicarbonate  30  meq l; chemistry blood chloride  105  meq l; chemistry blood creatinine  0.9  mg dl; chemistry blood potassium  4.4  meq l; chemistry blood sodium  143  meq l; chemistry blood urea nitrogen  26  mg dl; chemistry blood calcium, total  9.3  mg dl; chemistry blood glucose  102  mg dl$sodium chloride 0.9%  flush  3  ml ; pantoprazole  40  mg ; ascorbic acid  500  mg ; aquaphor ointment  1  appl ; fondaparinux sodium  2.5  mg ; multivitamins  1  cap ; papain-urea ointment  1  appl ; senna  1  tab ; docusate sodium  100  mg ; chlorhexidine gluconate 0.12% oral rinse  15  ml ; calcium carbonate  500  mg ; acetaminophen  500  mg ; diazepam  10  mg ; zinc sulfate  220  mg ; vitamin b complex w c  1  tab ; amitriptyline hcl  5  mg ; miconazole powder 2%  1  appl ; ciprofloxacin hcl  500  mg ; 
pseudomonas infection in conditions classified elsewhere and of unspecified site anemia of other chronic disease urinary tract infection, site not specified unspecified protein-calorie malnutrition pressure ulcer, heel other encephalopathy bacteremia quadriplegia, unspecified chronic hepatitis c without mention of hepatic coma pressure ulcer, lower back other and unspecified infection due to central venous catheter 
white m 54 $nan$nan$sodium chloride 0.9%  flush  3  ml ; pantoprazole  40  mg ; ascorbic acid  500  mg ; aquaphor ointment  1  appl ; fondaparinux sodium  2.5  mg ; multivitamins  1  cap ; papain-urea ointment  1  appl ; senna  1  tab ; docusate sodium  100  mg ; chlorhexidine gluconate 0.12% oral rinse  15  ml ; calcium carbonate  500  mg ; acetaminophen  500  mg ; diazepam  10  mg ; zinc sulfate  220  mg ; vitamin b complex w c  1  tab ; amitriptyline hcl  5  mg ; miconazole powder 2%  1  appl ; ciprofloxacin hcl  500  mg ; lactulose  30  ml ; 
pseudomonas infection in conditions classified elsewhere and of unspecified site anemia of other chronic disease urinary tract infection, site not specified unspecified protein-calorie malnutrition pressure ulcer, heel other encephalopathy bacteremia quadriplegia, unspecified chronic hepatitis c without mention of hepatic coma pressure ulcer, lower back other and unspecified infection due to central venous catheter 
white m 54 $nan$nan$sodium chloride 0.9%  flush  3  ml ; pantoprazole  40  mg ; ascorbic acid  500  mg ; aquaphor ointment  1  appl ; fondaparinux sodium  2.5  mg ; multivitamins  1  cap ; papain-urea ointment  1  appl ; senna  1  tab ; docusate sodium  100  mg ; chlorhexidine gluconate 0.12% oral rinse  15  ml ; calcium carbonate  500  mg ; acetaminophen  500  mg ; diazepam  10  mg ; zinc sulfate  220  mg ; vitamin b complex w c  1  tab ; amitriptyline hcl  5  mg ; miconazole powder 2%  1  appl ; ciprofloxacin hcl  500  mg ; lactulose  30  ml ; 
pseudomonas infection in conditions classified elsewhere and of unspecified site anemia of other chronic disease urinary tract infection, site not specified unspecified protein-calorie malnutrition pressure ulcer, heel other encephalopathy bacteremia quadriplegia, unspecified chronic hepatitis c without mention of hepatic coma pressure ulcer, lower back other and unspecified infection due to central venous catheter 
white m 54 $nan$nan$sodium chloride 0.9%  flush  3  ml ; pantoprazole  40  mg ; ascorbic acid  500  mg ; aquaphor ointment  1  appl ; fondaparinux sodium  2.5  mg ; multivitamins  1  cap ; papain-urea ointment  1  appl ; senna  1  tab ; docusate sodium  100  mg ; chlorhexidine gluconate 0.12% oral rinse  15  ml ; calcium carbonate  500  mg ; acetaminophen  500  mg ; diazepam  10  mg ; zinc sulfate  220  mg ; vitamin b complex w c  1  tab ; miconazole powder 2%  1  appl ; ciprofloxacin hcl  500  mg ; trazodone  50  mg ; 
pseudomonas infection in conditions classified elsewhere and of unspecified site anemia of other chronic disease urinary tract infection, site not specified unspecified protein-calorie malnutrition pressure ulcer, heel other encephalopathy bacteremia quadriplegia, unspecified chronic hepatitis c without mention of hepatic coma pressure ulcer, lower back other and unspecified infection due to central venous catheter 
unknown m 66 $nan$hematology blood hematocrit  40.2  %; hematology blood hemoglobin  12.9  g dl; hematology blood platelet count  213  k ul; chemistry blood anion gap  11  meq l; chemistry blood bicarbonate  31  meq l; chemistry blood chloride  99  meq l; chemistry blood creatinine  1.0  mg dl; chemistry blood potassium  4.3  meq l; chemistry blood sodium  137  meq l; chemistry blood urea nitrogen  13  mg dl; chemistry blood calcium, total  8.6  mg dl; chemistry blood glucose  119  mg dl$tiotropium bromide  1  cap ; influenza virus vaccine  0.5  ml ; sodium chloride 0.9%  flush  3  ml ; oxycodone (immediate release)   5-10  mg ; acetaminophen  650  mg ; hydromorphone (dilaudid)  0.5-1  mg ; ondansetron  4  mg ; albuterol 0.083% neb soln  1  neb ; milk of magnesia  30  ml ; lactated ringers  1000  ml ; bisacodyl  10  mg ; albuterol-ipratropium  1-2  puff ; heparin  5000  unit ; docusate sodium  100  mg ; fluticasone-salmeterol diskus (250 50)   1  inh ; 
 
unknown m 66 $nan$nan$tiotropium bromide  1  cap ; influenza virus vaccine  0.5  ml ; sodium chloride 0.9%  flush  3  ml ; oxycodone (immediate release)   5-10  mg ; acetaminophen  650  mg ; hydromorphone (dilaudid)  0.5-1  mg ; ondansetron  4  mg ; albuterol 0.083% neb soln  1  neb ; milk of magnesia  30  ml ; lactated ringers  1000  ml ; bisacodyl  10  mg ; albuterol-ipratropium  1-2  puff ; heparin  5000  unit ; docusate sodium  100  mg ; fluticasone-salmeterol diskus (250 50)   1  inh ; 
 
hispanic latino f 60 $nan$nan$citalopram  40  mg ; levothyroxine sodium  50  mcg ; montelukast sodium  10  mg ; folic acid  1  mg ; tiotropium bromide  1  cap ; fludrocortisone acetate  0.1  mg ; 
 
hispanic latino f 60 $nan$hematology blood hematocrit  33.7  %; hematology blood hemoglobin  11.5  g dl; hematology blood platelet count  202  k ul; chemistry blood anion gap  11  meq l; chemistry blood bicarbonate  30  meq l; chemistry blood chloride  103  meq l; chemistry blood creatinine  1.0  mg dl; chemistry blood potassium  3.5  meq l; chemistry blood sodium  140  meq l; chemistry blood urea nitrogen  15  mg dl; hematology urine wbc  6-10  # hpf; chemistry blood calcium, total  10.0  mg dl; chemistry blood bilirubin, total  0.2  mg dl; chemistry blood glucose  95  mg dl; chemistry blood lactate dehydrogenase (ld)  139  iu l; chemistry blood albumin  4.2  g dl; hematology urine glucose  neg  mg dl; hematology urine bilirubin  neg  mg dl$citalopram  40  mg ; levothyroxine sodium  50  mcg ; montelukast sodium  10  mg ; folic acid  1  mg ; tiotropium bromide  1  cap ; fludrocortisone acetate  0.1  mg ; influenza virus vaccine  0.5  ml ; sodium chloride 0.9%  flush  3  ml ; albuterol inhaler  2  puff ; levetiracetam  1500  mg ; gabapentin  300  mg ; pantoprazole  40  mg ; ranitidine  150  mg ; heparin  5000  unit ; lorazepam  1-2  mg ; azithromycin  250  mg ; acetaminophen  650  mg ; ondansetron odt  4  mg ; 
 
hispanic latino f 60 $nan$nan$citalopram  40  mg ; levothyroxine sodium  50  mcg ; montelukast sodium  10  mg ; folic acid  1  mg ; tiotropium bromide  1  cap ; fludrocortisone acetate  0.1  mg ; influenza virus vaccine  0.5  ml ; sodium chloride 0.9%  flush  3  ml ; albuterol inhaler  2  puff ; gabapentin  300  mg ; pantoprazole  40  mg ; ranitidine  150  mg ; heparin  5000  unit ; lorazepam  1-2  mg ; azithromycin  250  mg ; acetaminophen  650  mg ; ondansetron odt  4  mg ; guaifenesin  5-10  ml ; senna  1  tab ; milk of magnesia  30  ml ; 
 
hispanic latino f 60 $nan$nan$citalopram  40  mg ; levothyroxine sodium  50  mcg ; montelukast sodium  10  mg ; folic acid  1  mg ; tiotropium bromide  1  cap ; sodium chloride 0.9%  flush  3  ml ; albuterol inhaler  2  puff ; gabapentin  300  mg ; pantoprazole  40  mg ; ranitidine  150  mg ; heparin  5000  unit ; lorazepam  1-2  mg ; azithromycin  250  mg ; acetaminophen  650  mg ; ondansetron odt  4  mg ; guaifenesin  5-10  ml ; senna  1  tab ; milk of magnesia  30  ml ; docusate sodium  100  mg ; ondansetron  4  mg ; levetiracetam  250  mg ; levetiracetam  500  mg ; 
 
hispanic latino f 60 $nan$nan$citalopram  40  mg ; levothyroxine sodium  50  mcg ; montelukast sodium  10  mg ; folic acid  1  mg ; tiotropium bromide  1  cap ; sodium chloride 0.9%  flush  3  ml ; albuterol inhaler  2  puff ; gabapentin  300  mg ; pantoprazole  40  mg ; ranitidine  150  mg ; heparin  5000  unit ; lorazepam  1-2  mg ; acetaminophen  650  mg ; guaifenesin  5-10  ml ; senna  1  tab ; milk of magnesia  30  ml ; docusate sodium  100  mg ; ondansetron  4  mg ; levetiracetam  250  mg ; levetiracetam  500  mg ; 
 
hispanic latino f 60 $nan$nan$citalopram  40  mg ; levothyroxine sodium  50  mcg ; montelukast sodium  10  mg ; folic acid  1  mg ; tiotropium bromide  1  cap ; sodium chloride 0.9%  flush  3  ml ; albuterol inhaler  2  puff ; gabapentin  300  mg ; pantoprazole  40  mg ; ranitidine  150  mg ; heparin  5000  unit ; lorazepam  1-2  mg ; acetaminophen  650  mg ; guaifenesin  5-10  ml ; senna  1  tab ; milk of magnesia  30  ml ; docusate sodium  100  mg ; zonisamide  50  mg ; 
 
hispanic latino f 60 $nan$nan$citalopram  40  mg ; levothyroxine sodium  50  mcg ; montelukast sodium  10  mg ; folic acid  1  mg ; tiotropium bromide  1  cap ; sodium chloride 0.9%  flush  3  ml ; albuterol inhaler  2  puff ; gabapentin  300  mg ; pantoprazole  40  mg ; ranitidine  150  mg ; heparin  5000  unit ; lorazepam  1-2  mg ; acetaminophen  650  mg ; guaifenesin  5-10  ml ; senna  1  tab ; milk of magnesia  30  ml ; docusate sodium  100  mg ; zonisamide  100  mg ; 
 
hispanic latino f 60 $nan$nan$citalopram  40  mg ; levothyroxine sodium  50  mcg ; montelukast sodium  10  mg ; folic acid  1  mg ; tiotropium bromide  1  cap ; sodium chloride 0.9%  flush  3  ml ; albuterol inhaler  2  puff ; gabapentin  300  mg ; pantoprazole  40  mg ; ranitidine  150  mg ; heparin  5000  unit ; lorazepam  1-2  mg ; acetaminophen  650  mg ; guaifenesin  5-10  ml ; senna  1  tab ; milk of magnesia  30  ml ; docusate sodium  100  mg ; 
 
hispanic latino f 60 $nan$nan$citalopram  40  mg ; levothyroxine sodium  50  mcg ; montelukast sodium  10  mg ; folic acid  1  mg ; tiotropium bromide  1  cap ; sodium chloride 0.9%  flush  3  ml ; albuterol inhaler  2  puff ; gabapentin  300  mg ; pantoprazole  40  mg ; ranitidine  150  mg ; heparin  5000  unit ; lorazepam  1-2  mg ; acetaminophen  650  mg ; guaifenesin  5-10  ml ; senna  1  tab ; milk of magnesia  30  ml ; docusate sodium  100  mg ; zonisamide  200  mg ; 
 
white f 45 $nan$hematology blood hematocrit  23.9  %; hematology blood hemoglobin  8.4  g dl; hematology blood platelet count  315  k ul$0.9% sodium chloride  100  ml ; cefazolin  2  gm ; hydrocortisone na succ.  75  mg ; sodium chloride 0.9%  flush  3  ml ; morphine sulfate  50  mg ; aspirin  150  mg ; acetaminophen  650  mg ; ondansetron  4  mg ; calcium carbonate  500  mg ; lr  500  ml ; potassium chl 20 meq   1000 ml d5lr  1000  ml ; hydromorphone (dilaudid)  12.5  mg ; 
 
white f 45 $nan$nan$folic acid  1  mg ; 0.9% sodium chloride  100  ml ; cefazolin  2  gm ; sodium chloride 0.9%  flush  3  ml ; aspirin  150  mg ; acetaminophen  650  mg ; ondansetron  4  mg ; calcium carbonate  500  mg ; lr  500  ml ; hydromorphone (dilaudid)  12.5  mg ; heparin  5000  unit ; docusate sodium  100  mg ; hydroxychloroquine sulfate  200  mg ; hydrocortisone na succ.  50  mg ; aspirin  121.5  mg ; ferrous sulfate  325  mg ; hydrocortisone na succ.  25  mg ; ascorbic acid  500  mg ; gabapentin  400  mg ; 
 
white f 45 $nan$hematology blood hematocrit  25.5  %$folic acid  1  mg ; 0.9% sodium chloride  100  ml ; cefazolin  2  gm ; sodium chloride 0.9%  flush  3  ml ; acetaminophen  650  mg ; ondansetron  4  mg ; calcium carbonate  500  mg ; heparin  5000  unit ; docusate sodium  100  mg ; hydroxychloroquine sulfate  200  mg ; hydrocortisone na succ.  50  mg ; ferrous sulfate  325  mg ; ascorbic acid  500  mg ; gabapentin  400  mg ; oxycodone (immediate release)   5-10  mg ; promethazine  25  mg ; hydromorphone (dilaudid)  0.25  mg ; lorazepam  0.5  mg ; zolpidem tartrate  5-10  mg ; 
 
white f 45 $nan$nan$folic acid  1  mg ; 0.9% sodium chloride  100  ml ; cefazolin  2  gm ; sodium chloride 0.9%  flush  3  ml ; acetaminophen  650  mg ; ondansetron  4  mg ; calcium carbonate  500  mg ; heparin  5000  unit ; docusate sodium  100  mg ; hydroxychloroquine sulfate  200  mg ; ferrous sulfate  325  mg ; ascorbic acid  500  mg ; gabapentin  400  mg ; oxycodone (immediate release)   5-10  mg ; promethazine  25  mg ; hydromorphone (dilaudid)  0.25  mg ; lorazepam  0.5  mg ; zolpidem tartrate  5-10  mg ; polyethylene glycol  17  g ; 
 
white f 45 $nan$nan$folic acid  1  mg ; 0.9% sodium chloride  100  ml ; cefazolin  2  gm ; sodium chloride 0.9%  flush  3  ml ; acetaminophen  650  mg ; ondansetron  4  mg ; calcium carbonate  500  mg ; heparin  5000  unit ; docusate sodium  100  mg ; hydroxychloroquine sulfate  200  mg ; ferrous sulfate  325  mg ; ascorbic acid  500  mg ; gabapentin  400  mg ; oxycodone (immediate release)   5-10  mg ; promethazine  25  mg ; lorazepam  0.5  mg ; zolpidem tartrate  5-10  mg ; polyethylene glycol  17  g ; 
 
white f 45 $nan$nan$folic acid  1  mg ; 0.9% sodium chloride  100  ml ; cefazolin  2  gm ; sodium chloride 0.9%  flush  3  ml ; acetaminophen  650  mg ; ondansetron  4  mg ; calcium carbonate  500  mg ; heparin  5000  unit ; docusate sodium  100  mg ; hydroxychloroquine sulfate  200  mg ; ferrous sulfate  325  mg ; ascorbic acid  500  mg ; gabapentin  400  mg ; oxycodone (immediate release)   5-10  mg ; promethazine  25  mg ; lorazepam  0.5  mg ; zolpidem tartrate  5-10  mg ; polyethylene glycol  17  g ; 
 
white f 39 $nan$hematology blood hematocrit  37.2  %; hematology blood hemoglobin  12.9  g dl; hematology blood platelet count  180  k ul$sodium chloride 0.9%  flush  3  ml ; docusate sodium  100  mg ; ibuprofen  600  mg ; acetaminophen  500-1000  mg ; bisacodyl  10  mg ; milk of magnesia  30  ml ; simethicone  80  mg ; calcium carbonate  500  mg ; dermoplast spray  1  spry ; tetanus-diphtox-acellular pertuss (adacel)  0.5  ml ; 
other immediate postpartum hemorrhage, delivered, with mention of postpartum complication other viral diseases in the mother, delivered, with or without mention of antepartum condition second-degree perineal laceration, delivered, with or without mention of antepartum condition elderly primigravida, delivered, with or without mention of antepartum condition motorcycle driver injured in collision with fixed or stationary object in nontraffic accident outcome of delivery, single liveborn genital herpes, unspecified 
white f 39 $nan$nan$sodium chloride 0.9%  flush  3  ml ; docusate sodium  100  mg ; ibuprofen  600  mg ; acetaminophen  500-1000  mg ; bisacodyl  10  mg ; milk of magnesia  30  ml ; simethicone  80  mg ; calcium carbonate  500  mg ; dermoplast spray  1  spry ; tetanus-diphtox-acellular pertuss (adacel)  0.5  ml ; 
other immediate postpartum hemorrhage, delivered, with mention of postpartum complication other viral diseases in the mother, delivered, with or without mention of antepartum condition second-degree perineal laceration, delivered, with or without mention of antepartum condition elderly primigravida, delivered, with or without mention of antepartum condition motorcycle driver injured in collision with fixed or stationary object in nontraffic accident outcome of delivery, single liveborn genital herpes, unspecified 
white f 39 $nan$nan$sodium chloride 0.9%  flush  3  ml ; docusate sodium  100  mg ; ibuprofen  600  mg ; acetaminophen  500-1000  mg ; bisacodyl  10  mg ; milk of magnesia  30  ml ; simethicone  80  mg ; calcium carbonate  500  mg ; dermoplast spray  1  spry ; tetanus-diphtox-acellular pertuss (adacel)  0.5  ml ; 
other immediate postpartum hemorrhage, delivered, with mention of postpartum complication other viral diseases in the mother, delivered, with or without mention of antepartum condition second-degree perineal laceration, delivered, with or without mention of antepartum condition elderly primigravida, delivered, with or without mention of antepartum condition motorcycle driver injured in collision with fixed or stationary object in nontraffic accident outcome of delivery, single liveborn genital herpes, unspecified 
white m 41 $nan$hematology blood hematocrit  39.1  %; hematology blood hemoglobin  13.8  g dl; hematology blood platelet count  198  k ul; chemistry blood anion gap  14  meq l; chemistry blood bicarbonate  28  meq l; chemistry blood chloride  103  meq l; chemistry blood creatinine  1.3  mg dl; chemistry blood potassium  5.2  meq l; chemistry blood sodium  140  meq l; chemistry blood urea nitrogen  19  mg dl; hematology blood inr(pt)  1.0  ; chemistry blood calcium, total  9.8  mg dl; chemistry blood bilirubin, total  0.8  mg dl; chemistry blood glucose  89  mg dl; chemistry blood lactate dehydrogenase (ld)  178  iu l; chemistry blood albumin  4.7  g dl$citalopram  40  mg ; lorazepam  1  mg ; 0.9% sodium chloride  1000  ml ; 0.9% sodium chloride  250  ml ; d5 1 2ns  1000  ml ; sodium bicarbonate  50  meq ; acetaminophen  975  mg ; lorazepam  0.5-1  mg ; meperidine  25-50  mg ; diphenhydramine  25-50  mg ; prochlorperazine  10  mg ; diphenoxylate-atropine  1-2  tab ; d5w  250  ml ; dopamine  400  mg ; 5% dextrose  250  ml ; phenylephrine  60  mg ; potassium chloride  40  meq ; potassium chloride  60  meq ; potassium chloride  80  meq ; sterile water  50  ml ; 0.9% sodium chloride  1  bag ; calcium gluconate  2  gm ; calcium gluconate  3  gm ; potassium phosphate  15  mmol ; naproxen  375  mg ; bag  50  ml ; magnesium sulfate  4  gm ; magnesium sulfate  2-4  gm ; magnesium sulfate  2  gm ; hydrocerin  1  appl ; sarna lotion  1  appl ; gelclair  15  ml ; maalox diphenhydramine lidocaine  5  ml ; docusate sodium  100  mg ; ondansetron  8  mg ; 5% dextrose  50  ml ; aldesleukin  55.5  million units ; heparin flush (10 units ml)  1  ml ; ranitidine  150  mg ; cephalexin  500  mg ; diltiazem hcl  1  appl ; 
 
white m 41 $nan$hematology blood hematocrit  37.3  %; hematology blood hemoglobin  13.6  g dl; hematology blood platelet count  128  k ul; chemistry blood anion gap  18  meq l; chemistry blood bicarbonate  18  meq l; chemistry blood chloride  106  meq l; chemistry blood creatinine  4.8  mg dl; chemistry blood potassium  5.0  meq l; chemistry blood sodium  137  meq l; chemistry blood urea nitrogen  38  mg dl; hematology blood inr(pt)  1.6  ; chemistry blood calcium, total  7.8  mg dl; chemistry blood bilirubin, total  9.3  mg dl; chemistry blood glucose  106  mg dl; chemistry blood albumin  3.3  g dl$citalopram  40  mg ; lorazepam  1  mg ; 0.9% sodium chloride  1000  ml ; 0.9% sodium chloride  250  ml ; d5 1 2ns  1000  ml ; sodium bicarbonate  50  meq ; acetaminophen  975  mg ; lorazepam  0.5-1  mg ; meperidine  25-50  mg ; diphenhydramine  25-50  mg ; prochlorperazine  10  mg ; diphenoxylate-atropine  1-2  tab ; d5w  250  ml ; dopamine  400  mg ; 5% dextrose  250  ml ; phenylephrine  60  mg ; potassium chloride  40  meq ; potassium chloride  60  meq ; potassium chloride  80  meq ; sterile water  50  ml ; 0.9% sodium chloride  1  bag ; calcium gluconate  2  gm ; calcium gluconate  3  gm ; potassium phosphate  15  mmol ; naproxen  375  mg ; bag  50  ml ; magnesium sulfate  4  gm ; magnesium sulfate  2-4  gm ; magnesium sulfate  2  gm ; hydrocerin  1  appl ; sarna lotion  1  appl ; gelclair  15  ml ; maalox diphenhydramine lidocaine  5  ml ; docusate sodium  100  mg ; ondansetron  8  mg ; 5% dextrose  50  ml ; aldesleukin  55.5  million units ; heparin flush (10 units ml)  1  ml ; ranitidine  150  mg ; cephalexin  500  mg ; diltiazem hcl  1  appl ; 
 
white m 41 $nan$hematology blood hematocrit  31.8  %; hematology blood hemoglobin  11.4  g dl; hematology blood platelet count  80  k ul; chemistry blood anion gap  16  meq l; chemistry blood bicarbonate  18  meq l; chemistry blood bicarbonate  21  meq l; chemistry blood chloride  102  meq l; chemistry blood creatinine  6.3  mg dl; chemistry blood creatinine  7.3  mg dl; chemistry blood potassium  4.5  meq l; chemistry blood sodium  134  meq l; chemistry blood urea nitrogen  53  mg dl; chemistry blood calcium, total  7.3  mg dl; chemistry blood bilirubin, total  11.3  mg dl; chemistry blood bilirubin, total  10.8  mg dl; chemistry blood glucose  113  mg dl; chemistry blood albumin  2.8  g dl$citalopram  40  mg ; 0.9% sodium chloride  1000  ml ; d5 1 2ns  1000  ml ; sodium bicarbonate  50  meq ; acetaminophen  975  mg ; lorazepam  0.5-1  mg ; meperidine  25-50  mg ; diphenhydramine  25-50  mg ; prochlorperazine  10  mg ; diphenoxylate-atropine  1-2  tab ; d5w  250  ml ; dopamine  400  mg ; 5% dextrose  250  ml ; phenylephrine  60  mg ; potassium chloride  40  meq ; potassium chloride  60  meq ; potassium chloride  80  meq ; sterile water  50  ml ; 0.9% sodium chloride  1  bag ; calcium gluconate  2  gm ; calcium gluconate  3  gm ; potassium phosphate  15  mmol ; naproxen  375  mg ; bag  50  ml ; magnesium sulfate  4  gm ; magnesium sulfate  2-4  gm ; magnesium sulfate  2  gm ; hydrocerin  1  appl ; sarna lotion  1  appl ; gelclair  15  ml ; maalox diphenhydramine lidocaine  5  ml ; docusate sodium  100  mg ; ondansetron  8  mg ; 5% dextrose  50  ml ; aldesleukin  55.5  million units ; heparin flush (10 units ml)  1  ml ; ranitidine  150  mg ; cephalexin  500  mg ; diltiazem hcl  1  appl ; albuterol 0.083% neb soln  1  neb ; 
 
white m 41 $nan$hematology blood hematocrit  34.4  %; hematology blood hemoglobin  12.5  g dl; hematology blood platelet count  53  k ul; chemistry blood anion gap  23  meq l; chemistry blood bicarbonate  14  meq l; chemistry blood chloride  100  meq l; chemistry blood creatinine  7.9  mg dl; chemistry blood creatinine  9.5  mg dl; chemistry blood potassium  5.5  meq l; chemistry blood sodium  131  meq l; chemistry blood urea nitrogen  58  mg dl; chemistry blood urea nitrogen  63  mg dl; hematology blood inr(pt)  1.1  ; chemistry blood calcium, total  8.2  mg dl; chemistry blood bilirubin, total  9.5  mg dl; chemistry blood bilirubin, total  11.3  mg dl; chemistry blood glucose  113  mg dl; chemistry blood albumin  2.8  g dl$citalopram  40  mg ; 0.9% sodium chloride  1000  ml ; d5 1 2ns  1000  ml ; sodium bicarbonate  50  meq ; acetaminophen  975  mg ; lorazepam  0.5-1  mg ; meperidine  25-50  mg ; diphenhydramine  25-50  mg ; prochlorperazine  10  mg ; diphenoxylate-atropine  1-2  tab ; d5w  250  ml ; dopamine  400  mg ; 5% dextrose  250  ml ; phenylephrine  60  mg ; potassium chloride  40  meq ; potassium chloride  60  meq ; potassium chloride  80  meq ; sterile water  50  ml ; 0.9% sodium chloride  1  bag ; calcium gluconate  2  gm ; calcium gluconate  3  gm ; potassium phosphate  15  mmol ; naproxen  375  mg ; bag  50  ml ; magnesium sulfate  4  gm ; magnesium sulfate  2-4  gm ; magnesium sulfate  2  gm ; hydrocerin  1  appl ; sarna lotion  1  appl ; gelclair  15  ml ; maalox diphenhydramine lidocaine  5  ml ; docusate sodium  100  mg ; ondansetron  8  mg ; 5% dextrose  50  ml ; aldesleukin  55.5  million units ; heparin flush (10 units ml)  1  ml ; ranitidine  150  mg ; cephalexin  500  mg ; diltiazem hcl  1  appl ; albuterol 0.083% neb soln  1  neb ; simethicone  80  mg ; 
 
white m 41 $nan$hematology blood hematocrit  27.1  %; hematology blood hemoglobin  10.1  g dl; hematology blood platelet count  59  k ul; chemistry blood anion gap  18  meq l; chemistry blood bicarbonate  17  meq l; chemistry blood bicarbonate  21  meq l; chemistry blood bicarbonate  20  meq l; chemistry blood chloride  99  meq l; chemistry blood creatinine  10.0  mg dl; chemistry blood creatinine  10.3  mg dl; chemistry blood potassium  4.3  meq l; chemistry blood sodium  133  meq l; chemistry blood urea nitrogen  76  mg dl; chemistry blood calcium, total  7.9  mg dl; chemistry blood bilirubin, total  11.2  mg dl; chemistry blood bilirubin, total  9.8  mg dl; chemistry blood glucose  101  mg dl; chemistry blood albumin  2.6  g dl$citalopram  40  mg ; 0.9% sodium chloride  1000  ml ; d5 1 2ns  1000  ml ; sodium bicarbonate  50  meq ; acetaminophen  975  mg ; lorazepam  0.5-1  mg ; meperidine  25-50  mg ; diphenhydramine  25-50  mg ; prochlorperazine  10  mg ; diphenoxylate-atropine  1-2  tab ; d5w  250  ml ; dopamine  400  mg ; 5% dextrose  250  ml ; phenylephrine  60  mg ; potassium chloride  40  meq ; potassium chloride  60  meq ; potassium chloride  80  meq ; sterile water  50  ml ; 0.9% sodium chloride  1  bag ; calcium gluconate  2  gm ; calcium gluconate  3  gm ; potassium phosphate  15  mmol ; naproxen  375  mg ; bag  50  ml ; magnesium sulfate  4  gm ; magnesium sulfate  2-4  gm ; magnesium sulfate  2  gm ; hydrocerin  1  appl ; sarna lotion  1  appl ; gelclair  15  ml ; maalox diphenhydramine lidocaine  5  ml ; docusate sodium  100  mg ; ondansetron  8  mg ; 5% dextrose  50  ml ; aldesleukin  55.5  million units ; heparin flush (10 units ml)  1  ml ; ranitidine  150  mg ; cephalexin  500  mg ; diltiazem hcl  1  appl ; albuterol 0.083% neb soln  1  neb ; simethicone  80  mg ; cephalexin  250  mg ; citalopram  20  mg ; naproxen  250  mg ; 
 
white m 41 $nan$chemistry blood creatinine  10.8  mg dl; chemistry blood bilirubin, total  8.5  mg dl$0.9% sodium chloride  1000  ml ; d5 1 2ns  1000  ml ; sodium bicarbonate  50  meq ; lorazepam  0.5-1  mg ; meperidine  25-50  mg ; diphenhydramine  25-50  mg ; prochlorperazine  10  mg ; diphenoxylate-atropine  1-2  tab ; d5w  250  ml ; dopamine  400  mg ; 5% dextrose  250  ml ; phenylephrine  60  mg ; potassium chloride  40  meq ; potassium chloride  60  meq ; potassium chloride  80  meq ; sterile water  50  ml ; 0.9% sodium chloride  1  bag ; calcium gluconate  2  gm ; calcium gluconate  3  gm ; potassium phosphate  15  mmol ; bag  50  ml ; magnesium sulfate  4  gm ; magnesium sulfate  2-4  gm ; magnesium sulfate  2  gm ; hydrocerin  1  appl ; sarna lotion  1  appl ; gelclair  15  ml ; maalox diphenhydramine lidocaine  5  ml ; docusate sodium  100  mg ; ondansetron  8  mg ; heparin flush (10 units ml)  1  ml ; diltiazem hcl  1  appl ; albuterol 0.083% neb soln  1  neb ; cephalexin  250  mg ; citalopram  20  mg ; furosemide  40  mg ; 
 
white m 41 $nan$chemistry blood creatinine  9.8  mg dl; chemistry blood bilirubin, total  5.7  mg dl$lorazepam  0.5-1  mg ; meperidine  25-50  mg ; diphenhydramine  25-50  mg ; prochlorperazine  10  mg ; diphenoxylate-atropine  1-2  tab ; d5w  250  ml ; dopamine  400  mg ; 5% dextrose  250  ml ; phenylephrine  60  mg ; potassium chloride  40  meq ; potassium chloride  60  meq ; potassium chloride  80  meq ; sterile water  50  ml ; 0.9% sodium chloride  1  bag ; calcium gluconate  2  gm ; calcium gluconate  3  gm ; potassium phosphate  15  mmol ; bag  50  ml ; magnesium sulfate  4  gm ; magnesium sulfate  2-4  gm ; magnesium sulfate  2  gm ; hydrocerin  1  appl ; sarna lotion  1  appl ; gelclair  15  ml ; maalox diphenhydramine lidocaine  5  ml ; docusate sodium  100  mg ; ondansetron  8  mg ; diltiazem hcl  1  appl ; albuterol 0.083% neb soln  1  neb ; cephalexin  250  mg ; citalopram  20  mg ; furosemide  40  mg ; 
 
white f 37 $temp  97.7  heartrate  63.0  resprate  16.0  o2sat  96.0  sbp  103.0  dbp  68.0  rhythm    pain  5  $hematology blood hematocrit  42.6  %; hematology blood hemoglobin  15.0  g dl; hematology blood platelet count  257  k ul; chemistry blood anion gap  14  meq l; chemistry blood bicarbonate  27  meq l; chemistry blood chloride  103  meq l; chemistry blood creatinine  0.9  mg dl; chemistry blood potassium  3.9  meq l; chemistry blood sodium  140  meq l; chemistry blood urea nitrogen  7  mg dl; chemistry blood bilirubin, indirect  1.2  mg dl; chemistry blood bilirubin, total  5.6  mg dl; chemistry blood glucose  96  mg dl; chemistry blood albumin  4.6  g dl; chemistry blood bilirubin, direct  4.4  mg dl$nan
asthma, unspecified type, unspecified family history of ischemic heart disease other respiratory abnormalities person boarding or alighting a pedal cycle injured in collision with fixed or stationary object multiple sclerosis other chest pain esophageal reflux calculus of kidney extrinsic asthma, unspecified multiple sclerosis other acquired absence of organ vascular disorders of kidney migraine, unspecified, without mention of intractable migraine without mention of status migrainosus multiple sclerosis shortness of breath chest pain, unspecified
white f 37 $temp  97.6  heartrate  60.0  resprate  16.0  o2sat  96.0  sbp  106.0  dbp  64.0  rhythm    pain  5  $hematology blood inr(pt)  1.0  ; chemistry blood calcium, total  8.8  mg dl$influenza vaccine quadrivalent  0.5  ml ; sodium chloride 0.9%  flush  3  ml ; lactated ringers  1000  ml ; heparin  5000  unit ; docusate sodium  100  mg ; gabapentin  600  mg ; gabapentin  900  mg ; omeprazole  20  mg ; pramipexole  0.125  mg ; modafinil  50  mg ; aspirin-caffeine-butalbital  1  cap ; d5ns  1000  ml ; heparin flush (100 units ml)  5  ml ; sodium chloride 0.9%  flush  10  ml ; 
asthma, unspecified type, unspecified family history of ischemic heart disease other respiratory abnormalities person boarding or alighting a pedal cycle injured in collision with fixed or stationary object multiple sclerosis other chest pain esophageal reflux calculus of kidney extrinsic asthma, unspecified multiple sclerosis other acquired absence of organ vascular disorders of kidney migraine, unspecified, without mention of intractable migraine without mention of status migrainosus multiple sclerosis shortness of breath chest pain, unspecified
white f 37 $nan$hematology blood hematocrit  36.6  %; hematology blood hemoglobin  12.5  g dl; hematology blood platelet count  191  k ul; chemistry blood anion gap  15  meq l; chemistry blood bicarbonate  24  meq l; chemistry blood chloride  106  meq l; chemistry blood creatinine  0.6  mg dl; chemistry blood potassium  3.8  meq l; chemistry blood sodium  141  meq l; chemistry blood urea nitrogen  5  mg dl; hematology blood inr(pt)  1.0  ; chemistry blood calcium, total  8.7  mg dl; chemistry blood bilirubin, total  1.8  mg dl$influenza vaccine quadrivalent  0.5  ml ; sodium chloride 0.9%  flush  3  ml ; heparin  5000  unit ; docusate sodium  100  mg ; gabapentin  600  mg ; gabapentin  900  mg ; omeprazole  20  mg ; pramipexole  0.125  mg ; modafinil  50  mg ; aspirin-caffeine-butalbital  1  cap ; d5ns  1000  ml ; heparin flush (100 units ml)  5  ml ; sodium chloride 0.9%  flush  10  ml ; heparin flush (10 units ml)  5  ml ; 
asthma, unspecified type, unspecified family history of ischemic heart disease other respiratory abnormalities person boarding or alighting a pedal cycle injured in collision with fixed or stationary object multiple sclerosis other chest pain esophageal reflux calculus of kidney extrinsic asthma, unspecified multiple sclerosis other acquired absence of organ vascular disorders of kidney migraine, unspecified, without mention of intractable migraine without mention of status migrainosus multiple sclerosis shortness of breath chest pain, unspecified
white f 37 $nan$chemistry blood bilirubin, total  1.4  mg dl$sodium chloride 0.9%  flush  3  ml ; heparin  5000  unit ; docusate sodium  100  mg ; gabapentin  600  mg ; gabapentin  900  mg ; omeprazole  20  mg ; pramipexole  0.125  mg ; modafinil  50  mg ; heparin flush (100 units ml)  5  ml ; sodium chloride 0.9%  flush  10  ml ; heparin flush (10 units ml)  5  ml ; ciprofloxacin hcl  500  mg ; 
asthma, unspecified type, unspecified family history of ischemic heart disease other respiratory abnormalities person boarding or alighting a pedal cycle injured in collision with fixed or stationary object multiple sclerosis other chest pain esophageal reflux calculus of kidney extrinsic asthma, unspecified multiple sclerosis other acquired absence of organ vascular disorders of kidney migraine, unspecified, without mention of intractable migraine without mention of status migrainosus multiple sclerosis shortness of breath chest pain, unspecified
white f 86 $nan$nan$gabapentin  100  mg ; senna  1  tab ; omeprazole  20  mg ; atenolol  25  mg ; nifedipine cr  30  mg ; pravastatin  20  mg ; enoxaparin sodium  40  mg ; calcium carbonate  1000  mg ; vitamin d  800  unit ; 
 
white f 86 $nan$hematology blood hematocrit  32.9  %; hematology blood hemoglobin  10.8  g dl; hematology blood platelet count  156  k ul; chemistry blood anion gap  15  meq l; chemistry blood bicarbonate  29  meq l; chemistry blood chloride  100  meq l; chemistry blood creatinine  0.7  mg dl; chemistry blood potassium  3.6  meq l; chemistry blood sodium  140  meq l; chemistry blood urea nitrogen  12  mg dl; chemistry blood calcium, total  8.7  mg dl; chemistry blood glucose  125  mg dl$gabapentin  100  mg ; senna  1  tab ; omeprazole  20  mg ; atenolol  25  mg ; nifedipine cr  30  mg ; pravastatin  20  mg ; enoxaparin sodium  40  mg ; calcium carbonate  1000  mg ; vitamin d  800  unit ; pneumococcal vac polyvalent  0.5  ml ; sodium chloride 0.9%  flush  3  ml ; d5 1 2ns  1000  ml ; oxycodone (immediate release)   5-10  mg ; acetaminophen  650  mg ; ondansetron  4  mg ; morphine sulfate  1-2  mg ; iso-osmotic dextrose  50  ml ; cefazolin  1  g ; lorazepam  0.5  mg ; docusate sodium  100  mg ; dorzolamide 2% ophth. soln.  1  drop ; oxycodone (immediate release)   2.5  mg ; 
 
white f 86 $nan$hematology blood hematocrit  32.0  %; hematology blood hemoglobin  10.6  g dl; hematology blood platelet count  199  k ul; chemistry blood anion gap  14  meq l; chemistry blood bicarbonate  30  meq l; chemistry blood chloride  102  meq l; chemistry blood creatinine  0.9  mg dl; chemistry blood potassium  3.6  meq l; chemistry blood sodium  142  meq l; chemistry blood urea nitrogen  20  mg dl; chemistry blood glucose  110  mg dl$gabapentin  100  mg ; senna  1  tab ; omeprazole  20  mg ; atenolol  25  mg ; nifedipine cr  30  mg ; pravastatin  20  mg ; enoxaparin sodium  40  mg ; calcium carbonate  1000  mg ; vitamin d  800  unit ; pneumococcal vac polyvalent  0.5  ml ; sodium chloride 0.9%  flush  3  ml ; ondansetron  4  mg ; lorazepam  0.5  mg ; docusate sodium  100  mg ; dorzolamide 2% ophth. soln.  1  drop ; oxycodone (immediate release)   2.5  mg ; acetaminophen  1000  mg ; latanoprost 0.005% ophth. soln.  1  drop ; 0.9% sodium chloride  500  ml ; 
 
white f 86 $nan$hematology blood hematocrit  31.2  %; hematology blood hemoglobin  10.2  g dl; hematology blood platelet count  194  k ul; chemistry blood anion gap  10  meq l; chemistry blood bicarbonate  35  meq l; chemistry blood chloride  98  meq l; chemistry blood creatinine  0.8  mg dl; chemistry blood potassium  3.4  meq l; chemistry blood sodium  140  meq l; chemistry blood urea nitrogen  21  mg dl; chemistry blood glucose  117  mg dl$gabapentin  100  mg ; senna  1  tab ; omeprazole  20  mg ; atenolol  25  mg ; nifedipine cr  30  mg ; pravastatin  20  mg ; enoxaparin sodium  40  mg ; calcium carbonate  1000  mg ; vitamin d  800  unit ; pneumococcal vac polyvalent  0.5  ml ; sodium chloride 0.9%  flush  3  ml ; ondansetron  4  mg ; lorazepam  0.5  mg ; docusate sodium  100  mg ; dorzolamide 2% ophth. soln.  1  drop ; oxycodone (immediate release)   2.5  mg ; acetaminophen  1000  mg ; latanoprost 0.005% ophth. soln.  1  drop ; 0.9% sodium chloride  500  ml ; furosemide  10  mg ; bisacodyl  10  mg ; 
 
white f 86 $nan$hematology blood hematocrit  31.7  %; hematology blood hemoglobin  10.4  g dl; hematology blood platelet count  232  k ul; chemistry blood anion gap  9  meq l; chemistry blood bicarbonate  35  meq l; chemistry blood chloride  100  meq l; chemistry blood creatinine  0.7  mg dl; chemistry blood potassium  3.4  meq l; chemistry blood sodium  141  meq l; chemistry blood urea nitrogen  22  mg dl; chemistry blood glucose  107  mg dl$gabapentin  100  mg ; senna  1  tab ; omeprazole  20  mg ; atenolol  25  mg ; nifedipine cr  30  mg ; pravastatin  20  mg ; enoxaparin sodium  40  mg ; calcium carbonate  1000  mg ; vitamin d  800  unit ; pneumococcal vac polyvalent  0.5  ml ; sodium chloride 0.9%  flush  3  ml ; ondansetron  4  mg ; lorazepam  0.5  mg ; docusate sodium  100  mg ; dorzolamide 2% ophth. soln.  1  drop ; oxycodone (immediate release)   2.5  mg ; acetaminophen  1000  mg ; latanoprost 0.005% ophth. soln.  1  drop ; bisacodyl  10  mg ; 
 
white f 86 $nan$nan$gabapentin  100  mg ; senna  1  tab ; omeprazole  20  mg ; atenolol  25  mg ; nifedipine cr  30  mg ; pravastatin  20  mg ; enoxaparin sodium  40  mg ; calcium carbonate  1000  mg ; vitamin d  800  unit ; pneumococcal vac polyvalent  0.5  ml ; sodium chloride 0.9%  flush  3  ml ; ondansetron  4  mg ; lorazepam  0.5  mg ; docusate sodium  100  mg ; dorzolamide 2% ophth. soln.  1  drop ; oxycodone (immediate release)   2.5  mg ; acetaminophen  1000  mg ; latanoprost 0.005% ophth. soln.  1  drop ; 
 
white f 76 $temp  97.9  heartrate  110.0  resprate  22.0  o2sat  99.0  sbp  146.0  dbp  56.0  rhythm    pain  0  $hematology blood hematocrit  32.1  %; hematology blood hemoglobin  10.0  g dl; hematology blood platelet count  731  k ul; chemistry blood anion gap  14  meq l; chemistry blood bicarbonate  27  meq l; chemistry blood chloride  100  meq l; chemistry blood creatinine  0.5  mg dl; chemistry blood potassium  3.8  meq l; chemistry blood sodium  141  meq l; chemistry blood urea nitrogen  9  mg dl; chemistry blood calcium, total  9.2  mg dl; chemistry blood glucose  99  mg dl$sodium chloride 0.9%  flush  3-10  ml ; albuterol 0.083% neb soln  1  neb ; guaifenesin er  1200  mg ; ondansetron  4  mg ; senna  8.6  mg ; heparin flush (100 units ml)  5  ml ; ipratropium-albuterol neb  1  neb ; cepacol (sore throat lozenge)  1  loz ; 0.9% sodium chloride (mini bag plus)  100  ml ; cefepime  2  g ; enoxaparin sodium  50  mg ; acetylcysteine 20%  6-10  ml ; heparin flush (10 units ml)  5  ml ; sodium chloride 0.9%  flush  10  ml ; sodium chloride 3% inhalation soln  15  ml ; ceftazidime  2  g ; atorvastatin  40  mg ; iso-osmotic dextrose  150  ml ; vancomycin  750  mg ; 
malignant neoplasm of unspecified site of unspecified female breast estrogen receptor negative status [er-] personal history of nicotine dependence acidosis acute respiratory failure with hypoxia other disorders of lung secondary malignant neoplasm of right lung secondary malignant neoplasm of other specified sites toxic gastroenteritis and colitis personal history of antineoplastic chemotherapy generalized enlarged lymph nodes pneumonitis due to inhalation of food and vomit other diseases of bronchus, not elsewhere classified essential (primary) hypertension secondary malignant neoplasm of mediastinum hyperlipidemia, unspecified emphysema, unspecified encounter for examination for normal comparison and control in clinical research program do not resuscitate adverse effect of unspecified systemic antibiotic, initial encounter
white f 76 $nan$hematology blood hematocrit  33.9  %; hematology blood hemoglobin  10.3  g dl; hematology blood platelet count  773  k ul; chemistry blood anion gap  11  meq l; chemistry blood bicarbonate  29  meq l; chemistry blood chloride  101  meq l; chemistry blood creatinine  0.5  mg dl; chemistry blood potassium  4.1  meq l; chemistry blood sodium  141  meq l; chemistry blood urea nitrogen  9  mg dl; chemistry blood calcium, total  9.5  mg dl; chemistry blood glucose  136  mg dl; chemistry blood % hemoglobin a1c  6.1  %$sodium chloride 0.9%  flush  3-10  ml ; albuterol 0.083% neb soln  1  neb ; guaifenesin er  1200  mg ; ondansetron  4  mg ; senna  8.6  mg ; heparin flush (100 units ml)  5  ml ; ipratropium-albuterol neb  1  neb ; cepacol (sore throat lozenge)  1  loz ; enoxaparin sodium  50  mg ; acetylcysteine 20%  6-10  ml ; heparin flush (10 units ml)  5  ml ; sodium chloride 0.9%  flush  10  ml ; sodium chloride 3% inhalation soln  15  ml ; ceftazidime  2  g ; atorvastatin  40  mg ; iso-osmotic dextrose  150  ml ; vancomycin  750  mg ; guaifenesin-codeine phosphate  5-10  ml ; trazodone  25-50  mg ; polyethylene glycol  17  g ; bisacodyl  10  mg ; senna  17.2  mg ; ramelteon  8  mg ; mirtazapine  7.5  mg ; 
malignant neoplasm of unspecified site of unspecified female breast estrogen receptor negative status [er-] personal history of nicotine dependence acidosis acute respiratory failure with hypoxia other disorders of lung secondary malignant neoplasm of right lung secondary malignant neoplasm of other specified sites toxic gastroenteritis and colitis personal history of antineoplastic chemotherapy generalized enlarged lymph nodes pneumonitis due to inhalation of food and vomit other diseases of bronchus, not elsewhere classified essential (primary) hypertension secondary malignant neoplasm of mediastinum hyperlipidemia, unspecified emphysema, unspecified encounter for examination for normal comparison and control in clinical research program do not resuscitate adverse effect of unspecified systemic antibiotic, initial encounter
white f 76 $nan$hematology blood hematocrit  29.2  %; hematology blood hemoglobin  8.9  g dl; hematology blood platelet count  572  k ul; chemistry blood anion gap  8  meq l; chemistry blood bicarbonate  32  meq l; chemistry blood chloride  100  meq l; chemistry blood creatinine  0.4  mg dl; chemistry blood potassium  3.5  meq l; chemistry blood sodium  140  meq l; chemistry blood urea nitrogen  10  mg dl; chemistry blood glucose  87  mg dl$sodium chloride 0.9%  flush  3-10  ml ; albuterol 0.083% neb soln  1  neb ; ondansetron  4  mg ; heparin flush (100 units ml)  5  ml ; ipratropium-albuterol neb  1  neb ; cepacol (sore throat lozenge)  1  loz ; enoxaparin sodium  50  mg ; acetylcysteine 20%  6-10  ml ; heparin flush (10 units ml)  5  ml ; sodium chloride 0.9%  flush  10  ml ; sodium chloride 3% inhalation soln  15  ml ; ceftazidime  2  g ; atorvastatin  40  mg ; iso-osmotic dextrose  150  ml ; vancomycin  750  mg ; guaifenesin-codeine phosphate  5-10  ml ; trazodone  25-50  mg ; polyethylene glycol  17  g ; bisacodyl  10  mg ; senna  17.2  mg ; ramelteon  8  mg ; mirtazapine  7.5  mg ; sodium chloride nasal  1-2  spry ; 
malignant neoplasm of unspecified site of unspecified female breast estrogen receptor negative status [er-] personal history of nicotine dependence acidosis acute respiratory failure with hypoxia other disorders of lung secondary malignant neoplasm of right lung secondary malignant neoplasm of other specified sites toxic gastroenteritis and colitis personal history of antineoplastic chemotherapy generalized enlarged lymph nodes pneumonitis due to inhalation of food and vomit other diseases of bronchus, not elsewhere classified essential (primary) hypertension secondary malignant neoplasm of mediastinum hyperlipidemia, unspecified emphysema, unspecified encounter for examination for normal comparison and control in clinical research program do not resuscitate adverse effect of unspecified systemic antibiotic, initial encounter
white f 76 $nan$nan$sodium chloride 0.9%  flush  3-10  ml ; albuterol 0.083% neb soln  1  neb ; ondansetron  4  mg ; heparin flush (100 units ml)  5  ml ; ipratropium-albuterol neb  1  neb ; cepacol (sore throat lozenge)  1  loz ; enoxaparin sodium  50  mg ; acetylcysteine 20%  6-10  ml ; heparin flush (10 units ml)  5  ml ; sodium chloride 0.9%  flush  10  ml ; sodium chloride 3% inhalation soln  15  ml ; ceftazidime  2  g ; atorvastatin  40  mg ; guaifenesin-codeine phosphate  5-10  ml ; polyethylene glycol  17  g ; bisacodyl  10  mg ; senna  17.2  mg ; ramelteon  8  mg ; mirtazapine  7.5  mg ; sodium chloride nasal  1-2  spry ; 
malignant neoplasm of unspecified site of unspecified female breast estrogen receptor negative status [er-] personal history of nicotine dependence acidosis acute respiratory failure with hypoxia other disorders of lung secondary malignant neoplasm of right lung secondary malignant neoplasm of other specified sites toxic gastroenteritis and colitis personal history of antineoplastic chemotherapy generalized enlarged lymph nodes pneumonitis due to inhalation of food and vomit other diseases of bronchus, not elsewhere classified essential (primary) hypertension secondary malignant neoplasm of mediastinum hyperlipidemia, unspecified emphysema, unspecified encounter for examination for normal comparison and control in clinical research program do not resuscitate adverse effect of unspecified systemic antibiotic, initial encounter
white f 76 $nan$hematology blood hematocrit  28.6  %; hematology blood hemoglobin  8.8  g dl; hematology blood platelet count  500  k ul; chemistry blood anion gap  11  meq l; chemistry blood bicarbonate  32  meq l; chemistry blood chloride  102  meq l; chemistry blood creatinine  0.4  mg dl; chemistry blood potassium  3.2  meq l; chemistry blood sodium  145  meq l; chemistry blood urea nitrogen  10  mg dl; hematology urine wbc  7  # hpf; chemistry blood calcium, total  8.9  mg dl; chemistry blood glucose  84  mg dl; blood gas blood free calcium  1.07  mmol l; blood gas blood lactate  1.4  mmol l$levofloxacin  750  mg ; sodium chloride 0.9%  flush  3-10  ml ; albuterol 0.083% neb soln  1  neb ; ondansetron  4  mg ; heparin flush (100 units ml)  5  ml ; ipratropium-albuterol neb  1  neb ; cepacol (sore throat lozenge)  1  loz ; enoxaparin sodium  50  mg ; acetylcysteine 20%  6-10  ml ; heparin flush (10 units ml)  5  ml ; sodium chloride 0.9%  flush  10  ml ; sodium chloride 3% inhalation soln  15  ml ; ceftazidime  2  g ; atorvastatin  40  mg ; guaifenesin-codeine phosphate  5-10  ml ; polyethylene glycol  17  g ; bisacodyl  10  mg ; senna  17.2  mg ; ramelteon  8  mg ; mirtazapine  7.5  mg ; sodium chloride nasal  1-2  spry ; prednisone  40  mg ; potassium chloride (powder)  40  meq ; vial  1  vial ; cefepime  1  g ; acetaminophen  1000  mg ; bag  1  bag ; magnesium sulfate  4  gm ; fluticasone propionate nasal  1  spry ; caphosol  30  ml ; 
malignant neoplasm of unspecified site of unspecified female breast estrogen receptor negative status [er-] personal history of nicotine dependence acidosis acute respiratory failure with hypoxia other disorders of lung secondary malignant neoplasm of right lung secondary malignant neoplasm of other specified sites toxic gastroenteritis and colitis personal history of antineoplastic chemotherapy generalized enlarged lymph nodes pneumonitis due to inhalation of food and vomit other diseases of bronchus, not elsewhere classified essential (primary) hypertension secondary malignant neoplasm of mediastinum hyperlipidemia, unspecified emphysema, unspecified encounter for examination for normal comparison and control in clinical research program do not resuscitate adverse effect of unspecified systemic antibiotic, initial encounter
white f 76 $nan$hematology blood hematocrit  30.1  %; hematology blood hemoglobin  9.2  g dl; hematology blood platelet count  460  k ul; chemistry blood anion gap  14  meq l; chemistry blood bicarbonate  30  meq l; chemistry blood chloride  101  meq l; chemistry blood creatinine  0.5  mg dl; chemistry blood potassium  3.6  meq l; chemistry blood sodium  145  meq l; chemistry blood urea nitrogen  12  mg dl; chemistry blood calcium, total  8.6  mg dl; chemistry blood bilirubin, total  0.2  mg dl; chemistry blood glucose  144  mg dl; chemistry blood lactate dehydrogenase (ld)  234  iu l; chemistry blood albumin  2.9  g dl$levofloxacin  750  mg ; sodium chloride 0.9%  flush  3-10  ml ; albuterol 0.083% neb soln  1  neb ; ondansetron  4  mg ; heparin flush (100 units ml)  5  ml ; ipratropium-albuterol neb  1  neb ; cepacol (sore throat lozenge)  1  loz ; enoxaparin sodium  50  mg ; acetylcysteine 20%  6-10  ml ; heparin flush (10 units ml)  5  ml ; sodium chloride 0.9%  flush  10  ml ; sodium chloride 3% inhalation soln  15  ml ; atorvastatin  40  mg ; guaifenesin-codeine phosphate  5-10  ml ; polyethylene glycol  17  g ; bisacodyl  10  mg ; senna  17.2  mg ; mirtazapine  7.5  mg ; sodium chloride nasal  1-2  spry ; prednisone  40  mg ; potassium chloride (powder)  40  meq ; vial  1  vial ; cefepime  1  g ; acetaminophen  1000  mg ; bag  1  bag ; magnesium sulfate  4  gm ; fluticasone propionate nasal  1  spry ; caphosol  30  ml ; diphenhydramine  25  mg ; ipratropium bromide neb  1  neb ; mirtazapine  15  mg ; 
malignant neoplasm of unspecified site of unspecified female breast estrogen receptor negative status [er-] personal history of nicotine dependence acidosis acute respiratory failure with hypoxia other disorders of lung secondary malignant neoplasm of right lung secondary malignant neoplasm of other specified sites toxic gastroenteritis and colitis personal history of antineoplastic chemotherapy generalized enlarged lymph nodes pneumonitis due to inhalation of food and vomit other diseases of bronchus, not elsewhere classified essential (primary) hypertension secondary malignant neoplasm of mediastinum hyperlipidemia, unspecified emphysema, unspecified encounter for examination for normal comparison and control in clinical research program do not resuscitate adverse effect of unspecified systemic antibiotic, initial encounter
white f 76 $nan$hematology blood hematocrit  29.7  %; hematology blood hemoglobin  9.1  g dl; hematology blood platelet count  485  k ul; chemistry blood anion gap  11  meq l; chemistry blood bicarbonate  31  meq l; chemistry blood chloride  105  meq l; chemistry blood creatinine  0.5  mg dl; chemistry blood potassium  4.0  meq l; chemistry blood sodium  147  meq l; chemistry blood urea nitrogen  13  mg dl; chemistry blood calcium, total  9.0  mg dl; chemistry blood glucose  75  mg dl$sodium chloride 0.9%  flush  3-10  ml ; albuterol 0.083% neb soln  1  neb ; ondansetron  4  mg ; heparin flush (100 units ml)  5  ml ; cepacol (sore throat lozenge)  1  loz ; enoxaparin sodium  50  mg ; acetylcysteine 20%  6-10  ml ; heparin flush (10 units ml)  5  ml ; sodium chloride 0.9%  flush  10  ml ; sodium chloride 3% inhalation soln  15  ml ; atorvastatin  40  mg ; guaifenesin-codeine phosphate  5-10  ml ; polyethylene glycol  17  g ; bisacodyl  10  mg ; senna  17.2  mg ; sodium chloride nasal  1-2  spry ; vial  1  vial ; cefepime  1  g ; fluticasone propionate nasal  1  spry ; diphenhydramine  25  mg ; ipratropium bromide neb  1  neb ; mirtazapine  15  mg ; 
malignant neoplasm of unspecified site of unspecified female breast estrogen receptor negative status [er-] personal history of nicotine dependence acidosis acute respiratory failure with hypoxia other disorders of lung secondary malignant neoplasm of right lung secondary malignant neoplasm of other specified sites toxic gastroenteritis and colitis personal history of antineoplastic chemotherapy generalized enlarged lymph nodes pneumonitis due to inhalation of food and vomit other diseases of bronchus, not elsewhere classified essential (primary) hypertension secondary malignant neoplasm of mediastinum hyperlipidemia, unspecified emphysema, unspecified encounter for examination for normal comparison and control in clinical research program do not resuscitate adverse effect of unspecified systemic antibiotic, initial encounter
white f 76 $nan$hematology blood hematocrit  29.6  %; hematology blood hemoglobin  9.0  g dl; hematology blood platelet count  391  k ul; chemistry blood anion gap  9  meq l; chemistry blood bicarbonate  33  meq l; chemistry blood chloride  102  meq l; chemistry blood creatinine  0.4  mg dl; chemistry blood potassium  3.5  meq l; chemistry blood sodium  144  meq l; chemistry blood urea nitrogen  8  mg dl; hematology blood inr(pt)  1.1  ; chemistry blood calcium, total  8.6  mg dl; chemistry blood bilirubin, total  0.2  mg dl; chemistry blood glucose  83  mg dl$sodium chloride 0.9%  flush  3-10  ml ; albuterol 0.083% neb soln  1  neb ; ondansetron  4  mg ; heparin flush (100 units ml)  5  ml ; cepacol (sore throat lozenge)  1  loz ; enoxaparin sodium  50  mg ; acetylcysteine 20%  6-10  ml ; heparin flush (10 units ml)  5  ml ; sodium chloride 0.9%  flush  10  ml ; sodium chloride 3% inhalation soln  15  ml ; atorvastatin  40  mg ; guaifenesin-codeine phosphate  5-10  ml ; polyethylene glycol  17  g ; bisacodyl  10  mg ; senna  17.2  mg ; sodium chloride nasal  1-2  spry ; fluticasone propionate nasal  1  spry ; ipratropium bromide neb  1  neb ; mirtazapine  15  mg ; 
malignant neoplasm of unspecified site of unspecified female breast estrogen receptor negative status [er-] personal history of nicotine dependence acidosis acute respiratory failure with hypoxia other disorders of lung secondary malignant neoplasm of right lung secondary malignant neoplasm of other specified sites toxic gastroenteritis and colitis personal history of antineoplastic chemotherapy generalized enlarged lymph nodes pneumonitis due to inhalation of food and vomit other diseases of bronchus, not elsewhere classified essential (primary) hypertension secondary malignant neoplasm of mediastinum hyperlipidemia, unspecified emphysema, unspecified encounter for examination for normal comparison and control in clinical research program do not resuscitate adverse effect of unspecified systemic antibiotic, initial encounter
white f 76 $nan$hematology blood hematocrit  30.7  %; hematology blood hemoglobin  9.5  g dl; hematology blood platelet count  380  k ul; chemistry blood anion gap  8  meq l; chemistry blood bicarbonate  31  meq l; chemistry blood chloride  101  meq l; chemistry blood creatinine  0.4  mg dl; chemistry blood potassium  3.6  meq l; chemistry blood sodium  140  meq l; chemistry blood urea nitrogen  11  mg dl; hematology blood inr(pt)  1.1  ; chemistry blood calcium, total  8.3  mg dl; chemistry blood glucose  85  mg dl$sodium chloride 0.9%  flush  3-10  ml ; albuterol 0.083% neb soln  1  neb ; ondansetron  4  mg ; heparin flush (100 units ml)  5  ml ; cepacol (sore throat lozenge)  1  loz ; enoxaparin sodium  50  mg ; acetylcysteine 20%  6-10  ml ; heparin flush (10 units ml)  5  ml ; sodium chloride 0.9%  flush  10  ml ; sodium chloride 3% inhalation soln  15  ml ; atorvastatin  40  mg ; guaifenesin-codeine phosphate  5-10  ml ; polyethylene glycol  17  g ; bisacodyl  10  mg ; senna  17.2  mg ; sodium chloride nasal  1-2  spry ; fluticasone propionate nasal  1  spry ; ipratropium bromide neb  1  neb ; mirtazapine  15  mg ; 
malignant neoplasm of unspecified site of unspecified female breast estrogen receptor negative status [er-] personal history of nicotine dependence acidosis acute respiratory failure with hypoxia other disorders of lung secondary malignant neoplasm of right lung secondary malignant neoplasm of other specified sites toxic gastroenteritis and colitis personal history of antineoplastic chemotherapy generalized enlarged lymph nodes pneumonitis due to inhalation of food and vomit other diseases of bronchus, not elsewhere classified essential (primary) hypertension secondary malignant neoplasm of mediastinum hyperlipidemia, unspecified emphysema, unspecified encounter for examination for normal comparison and control in clinical research program do not resuscitate adverse effect of unspecified systemic antibiotic, initial encounter
white f 76 $nan$hematology blood hematocrit  30.3  %; hematology blood hemoglobin  9.3  g dl; hematology blood platelet count  353  k ul; chemistry blood anion gap  11  meq l; chemistry blood bicarbonate  29  meq l; chemistry blood chloride  101  meq l; chemistry blood creatinine  0.5  mg dl; chemistry blood potassium  3.6  meq l; chemistry blood sodium  141  meq l; chemistry blood urea nitrogen  12  mg dl; hematology blood inr(pt)  1.1  ; chemistry blood calcium, total  8.6  mg dl; chemistry blood glucose  86  mg dl; hematology blood bands  0  %$sodium chloride 0.9%  flush  3-10  ml ; albuterol 0.083% neb soln  1  neb ; ondansetron  4  mg ; heparin flush (100 units ml)  5  ml ; cepacol (sore throat lozenge)  1  loz ; enoxaparin sodium  50  mg ; acetylcysteine 20%  6-10  ml ; heparin flush (10 units ml)  5  ml ; sodium chloride 0.9%  flush  10  ml ; sodium chloride 3% inhalation soln  15  ml ; atorvastatin  40  mg ; guaifenesin-codeine phosphate  5-10  ml ; polyethylene glycol  17  g ; bisacodyl  10  mg ; senna  17.2  mg ; sodium chloride nasal  1-2  spry ; fluticasone propionate nasal  1  spry ; ipratropium bromide neb  1  neb ; mirtazapine  15  mg ; 
malignant neoplasm of unspecified site of unspecified female breast estrogen receptor negative status [er-] personal history of nicotine dependence acidosis acute respiratory failure with hypoxia other disorders of lung secondary malignant neoplasm of right lung secondary malignant neoplasm of other specified sites toxic gastroenteritis and colitis personal history of antineoplastic chemotherapy generalized enlarged lymph nodes pneumonitis due to inhalation of food and vomit other diseases of bronchus, not elsewhere classified essential (primary) hypertension secondary malignant neoplasm of mediastinum hyperlipidemia, unspecified emphysema, unspecified encounter for examination for normal comparison and control in clinical research program do not resuscitate adverse effect of unspecified systemic antibiotic, initial encounter
white f 76 $nan$hematology blood hematocrit  28.1  %; hematology blood hemoglobin  8.5  g dl; hematology blood platelet count  337  k ul; chemistry blood anion gap  10  meq l; chemistry blood bicarbonate  29  meq l; chemistry blood chloride  103  meq l; chemistry blood creatinine  0.4  mg dl; chemistry blood potassium  3.6  meq l; chemistry blood sodium  142  meq l; chemistry blood urea nitrogen  11  mg dl; chemistry blood bilirubin, indirect  0.2  mg dl; chemistry blood bilirubin, total  0.2  mg dl; chemistry blood lactate dehydrogenase (ld)  278  iu l; hematology blood bands  0  %$sodium chloride 0.9%  flush  3-10  ml ; albuterol 0.083% neb soln  1  neb ; ondansetron  4  mg ; heparin flush (100 units ml)  5  ml ; cepacol (sore throat lozenge)  1  loz ; enoxaparin sodium  50  mg ; acetylcysteine 20%  6-10  ml ; heparin flush (10 units ml)  5  ml ; sodium chloride 0.9%  flush  10  ml ; sodium chloride 3% inhalation soln  15  ml ; atorvastatin  40  mg ; guaifenesin-codeine phosphate  5-10  ml ; polyethylene glycol  17  g ; bisacodyl  10  mg ; senna  17.2  mg ; sodium chloride nasal  1-2  spry ; fluticasone propionate nasal  1  spry ; ipratropium bromide neb  1  neb ; mirtazapine  15  mg ; sodium chloride 0.9%  1000  ml ; 0.9% sodium chloride  100  ml ; inv-pembrolizumab  200  mg ; syringe  4  ml ; inv-eribulin mesylate   2  mg ; ondansetron  8  mg ; 
malignant neoplasm of unspecified site of unspecified female breast estrogen receptor negative status [er-] personal history of nicotine dependence acidosis acute respiratory failure with hypoxia other disorders of lung secondary malignant neoplasm of right lung secondary malignant neoplasm of other specified sites toxic gastroenteritis and colitis personal history of antineoplastic chemotherapy generalized enlarged lymph nodes pneumonitis due to inhalation of food and vomit other diseases of bronchus, not elsewhere classified essential (primary) hypertension secondary malignant neoplasm of mediastinum hyperlipidemia, unspecified emphysema, unspecified encounter for examination for normal comparison and control in clinical research program do not resuscitate adverse effect of unspecified systemic antibiotic, initial encounter
white f 76 $nan$hematology blood hematocrit  28.3  %; hematology blood hemoglobin  8.5  g dl; hematology blood platelet count  350  k ul; chemistry blood anion gap  11  meq l; chemistry blood bicarbonate  28  meq l; chemistry blood chloride  101  meq l; chemistry blood creatinine  0.5  mg dl; chemistry blood potassium  4.0  meq l; chemistry blood sodium  140  meq l; chemistry blood urea nitrogen  10  mg dl; chemistry blood calcium, total  8.7  mg dl; chemistry blood bilirubin, total  0.2  mg dl; chemistry blood glucose  77  mg dl$sodium chloride 0.9%  flush  3-10  ml ; albuterol 0.083% neb soln  1  neb ; ondansetron  4  mg ; heparin flush (100 units ml)  5  ml ; cepacol (sore throat lozenge)  1  loz ; enoxaparin sodium  50  mg ; acetylcysteine 20%  6-10  ml ; heparin flush (10 units ml)  5  ml ; sodium chloride 0.9%  flush  10  ml ; sodium chloride 3% inhalation soln  15  ml ; atorvastatin  40  mg ; guaifenesin-codeine phosphate  5-10  ml ; polyethylene glycol  17  g ; bisacodyl  10  mg ; senna  17.2  mg ; sodium chloride nasal  1-2  spry ; fluticasone propionate nasal  1  spry ; ipratropium bromide neb  1  neb ; mirtazapine  15  mg ; sodium chloride 0.9%  1000  ml ; 0.9% sodium chloride  100  ml ; inv-pembrolizumab  200  mg ; syringe  4  ml ; inv-eribulin mesylate   2  mg ; ondansetron  8  mg ; 
malignant neoplasm of unspecified site of unspecified female breast estrogen receptor negative status [er-] personal history of nicotine dependence acidosis acute respiratory failure with hypoxia other disorders of lung secondary malignant neoplasm of right lung secondary malignant neoplasm of other specified sites toxic gastroenteritis and colitis personal history of antineoplastic chemotherapy generalized enlarged lymph nodes pneumonitis due to inhalation of food and vomit other diseases of bronchus, not elsewhere classified essential (primary) hypertension secondary malignant neoplasm of mediastinum hyperlipidemia, unspecified emphysema, unspecified encounter for examination for normal comparison and control in clinical research program do not resuscitate adverse effect of unspecified systemic antibiotic, initial encounter
white f 76 $nan$hematology blood hematocrit  27.5  %; hematology blood hemoglobin  8.4  g dl; hematology blood platelet count  338  k ul; chemistry blood anion gap  11  meq l; chemistry blood bicarbonate  30  meq l; chemistry blood chloride  100  meq l; chemistry blood creatinine  0.5  mg dl; chemistry blood potassium  4.0  meq l; chemistry blood sodium  141  meq l; chemistry blood urea nitrogen  9  mg dl; hematology blood inr(pt)  1.1  ; chemistry blood calcium, total  8.7  mg dl; chemistry blood bilirubin, total  0.2  mg dl; chemistry blood glucose  85  mg dl$sodium chloride 0.9%  flush  3-10  ml ; albuterol 0.083% neb soln  1  neb ; ondansetron  4  mg ; heparin flush (100 units ml)  5  ml ; cepacol (sore throat lozenge)  1  loz ; enoxaparin sodium  50  mg ; acetylcysteine 20%  6-10  ml ; heparin flush (10 units ml)  5  ml ; sodium chloride 0.9%  flush  10  ml ; sodium chloride 3% inhalation soln  15  ml ; atorvastatin  40  mg ; guaifenesin-codeine phosphate  5-10  ml ; polyethylene glycol  17  g ; bisacodyl  10  mg ; senna  17.2  mg ; sodium chloride nasal  1-2  spry ; fluticasone propionate nasal  1  spry ; ipratropium bromide neb  1  neb ; mirtazapine  15  mg ; sodium chloride 0.9%  1000  ml ; syringe  4  ml ; inv-eribulin mesylate   2  mg ; guaifenesin-dextromethorphan  5  ml ; 
malignant neoplasm of unspecified site of unspecified female breast estrogen receptor negative status [er-] personal history of nicotine dependence acidosis acute respiratory failure with hypoxia other disorders of lung secondary malignant neoplasm of right lung secondary malignant neoplasm of other specified sites toxic gastroenteritis and colitis personal history of antineoplastic chemotherapy generalized enlarged lymph nodes pneumonitis due to inhalation of food and vomit other diseases of bronchus, not elsewhere classified essential (primary) hypertension secondary malignant neoplasm of mediastinum hyperlipidemia, unspecified emphysema, unspecified encounter for examination for normal comparison and control in clinical research program do not resuscitate adverse effect of unspecified systemic antibiotic, initial encounter
white f 76 $nan$nan$sodium chloride 0.9%  flush  3-10  ml ; albuterol 0.083% neb soln  1  neb ; ondansetron  4  mg ; heparin flush (100 units ml)  5  ml ; cepacol (sore throat lozenge)  1  loz ; enoxaparin sodium  50  mg ; acetylcysteine 20%  6-10  ml ; heparin flush (10 units ml)  5  ml ; sodium chloride 0.9%  flush  10  ml ; sodium chloride 3% inhalation soln  15  ml ; atorvastatin  40  mg ; polyethylene glycol  17  g ; bisacodyl  10  mg ; senna  17.2  mg ; sodium chloride nasal  1-2  spry ; fluticasone propionate nasal  1  spry ; ipratropium bromide neb  1  neb ; mirtazapine  15  mg ; sodium chloride 0.9%  1000  ml ; syringe  4  ml ; inv-eribulin mesylate   2  mg ; guaifenesin-dextromethorphan  5  ml ; 
malignant neoplasm of unspecified site of unspecified female breast estrogen receptor negative status [er-] personal history of nicotine dependence acidosis acute respiratory failure with hypoxia other disorders of lung secondary malignant neoplasm of right lung secondary malignant neoplasm of other specified sites toxic gastroenteritis and colitis personal history of antineoplastic chemotherapy generalized enlarged lymph nodes pneumonitis due to inhalation of food and vomit other diseases of bronchus, not elsewhere classified essential (primary) hypertension secondary malignant neoplasm of mediastinum hyperlipidemia, unspecified emphysema, unspecified encounter for examination for normal comparison and control in clinical research program do not resuscitate adverse effect of unspecified systemic antibiotic, initial encounter
white f 76 $nan$nan$albuterol 0.083% neb soln  1  neb ; ondansetron  4  mg ; heparin flush (100 units ml)  5  ml ; cepacol (sore throat lozenge)  1  loz ; enoxaparin sodium  50  mg ; acetylcysteine 20%  6-10  ml ; heparin flush (10 units ml)  5  ml ; sodium chloride 0.9%  flush  10  ml ; sodium chloride 3% inhalation soln  15  ml ; atorvastatin  40  mg ; polyethylene glycol  17  g ; bisacodyl  10  mg ; senna  17.2  mg ; sodium chloride nasal  1-2  spry ; fluticasone propionate nasal  1  spry ; ipratropium bromide neb  1  neb ; mirtazapine  15  mg ; sodium chloride 0.9%  1000  ml ; syringe  4  ml ; inv-eribulin mesylate   2  mg ; guaifenesin-dextromethorphan  5  ml ; 
malignant neoplasm of unspecified site of unspecified female breast estrogen receptor negative status [er-] personal history of nicotine dependence acidosis acute respiratory failure with hypoxia other disorders of lung secondary malignant neoplasm of right lung secondary malignant neoplasm of other specified sites toxic gastroenteritis and colitis personal history of antineoplastic chemotherapy generalized enlarged lymph nodes pneumonitis due to inhalation of food and vomit other diseases of bronchus, not elsewhere classified essential (primary) hypertension secondary malignant neoplasm of mediastinum hyperlipidemia, unspecified emphysema, unspecified encounter for examination for normal comparison and control in clinical research program do not resuscitate adverse effect of unspecified systemic antibiotic, initial encounter
white f 76 $nan$hematology blood hematocrit  25.4  %; hematology blood hemoglobin  7.8  g dl; hematology blood platelet count  403  k ul; chemistry blood anion gap  9  meq l; chemistry blood bicarbonate  31  meq l; chemistry blood chloride  101  meq l; chemistry blood creatinine  0.4  mg dl; chemistry blood potassium  4.0  meq l; chemistry blood sodium  141  meq l; chemistry blood urea nitrogen  8  mg dl; hematology blood inr(pt)  1.1  ; chemistry blood glucose  89  mg dl$albuterol 0.083% neb soln  1  neb ; ondansetron  4  mg ; heparin flush (100 units ml)  5  ml ; cepacol (sore throat lozenge)  1  loz ; enoxaparin sodium  50  mg ; acetylcysteine 20%  6-10  ml ; heparin flush (10 units ml)  5  ml ; sodium chloride 0.9%  flush  10  ml ; sodium chloride 3% inhalation soln  15  ml ; atorvastatin  40  mg ; polyethylene glycol  17  g ; bisacodyl  10  mg ; senna  17.2  mg ; sodium chloride nasal  1-2  spry ; fluticasone propionate nasal  1  spry ; ipratropium bromide neb  1  neb ; mirtazapine  15  mg ; sodium chloride 0.9%  1000  ml ; syringe  4  ml ; inv-eribulin mesylate   2  mg ; guaifenesin-dextromethorphan  5  ml ; benzonatate  100  mg ; benzonatate  200  mg ; 
malignant neoplasm of unspecified site of unspecified female breast estrogen receptor negative status [er-] personal history of nicotine dependence acidosis acute respiratory failure with hypoxia other disorders of lung secondary malignant neoplasm of right lung secondary malignant neoplasm of other specified sites toxic gastroenteritis and colitis personal history of antineoplastic chemotherapy generalized enlarged lymph nodes pneumonitis due to inhalation of food and vomit other diseases of bronchus, not elsewhere classified essential (primary) hypertension secondary malignant neoplasm of mediastinum hyperlipidemia, unspecified emphysema, unspecified encounter for examination for normal comparison and control in clinical research program do not resuscitate adverse effect of unspecified systemic antibiotic, initial encounter
white f 76 $nan$nan$albuterol 0.083% neb soln  1  neb ; ondansetron  4  mg ; heparin flush (100 units ml)  5  ml ; cepacol (sore throat lozenge)  1  loz ; enoxaparin sodium  50  mg ; heparin flush (10 units ml)  5  ml ; sodium chloride 0.9%  flush  10  ml ; atorvastatin  40  mg ; polyethylene glycol  17  g ; bisacodyl  10  mg ; senna  17.2  mg ; sodium chloride nasal  1-2  spry ; fluticasone propionate nasal  1  spry ; mirtazapine  15  mg ; sodium chloride 0.9%  1000  ml ; syringe  4  ml ; inv-eribulin mesylate   2  mg ; benzonatate  200  mg ; tiotropium bromide  1  cap ; 
malignant neoplasm of unspecified site of unspecified female breast estrogen receptor negative status [er-] personal history of nicotine dependence acidosis acute respiratory failure with hypoxia other disorders of lung secondary malignant neoplasm of right lung secondary malignant neoplasm of other specified sites toxic gastroenteritis and colitis personal history of antineoplastic chemotherapy generalized enlarged lymph nodes pneumonitis due to inhalation of food and vomit other diseases of bronchus, not elsewhere classified essential (primary) hypertension secondary malignant neoplasm of mediastinum hyperlipidemia, unspecified emphysema, unspecified encounter for examination for normal comparison and control in clinical research program do not resuscitate adverse effect of unspecified systemic antibiotic, initial encounter
white f 76 $nan$hematology blood hematocrit  23.8  %; hematology blood hemoglobin  7.2  g dl; hematology blood platelet count  462  k ul; chemistry blood anion gap  11  meq l; chemistry blood bicarbonate  30  meq l; chemistry blood chloride  97  meq l; chemistry blood creatinine  0.4  mg dl; chemistry blood potassium  3.8  meq l; chemistry blood sodium  138  meq l; chemistry blood urea nitrogen  8  mg dl; hematology blood inr(pt)  1.1  ; chemistry blood calcium, total  8.6  mg dl; chemistry blood bilirubin, indirect  0.2  mg dl; chemistry blood bilirubin, total  0.2  mg dl; chemistry blood glucose  79  mg dl; chemistry blood lactate dehydrogenase (ld)  171  iu l$albuterol 0.083% neb soln  1  neb ; ondansetron  4  mg ; heparin flush (100 units ml)  5  ml ; cepacol (sore throat lozenge)  1  loz ; enoxaparin sodium  50  mg ; heparin flush (10 units ml)  5  ml ; sodium chloride 0.9%  flush  10  ml ; atorvastatin  40  mg ; polyethylene glycol  17  g ; bisacodyl  10  mg ; senna  17.2  mg ; sodium chloride nasal  1-2  spry ; fluticasone propionate nasal  1  spry ; mirtazapine  15  mg ; sodium chloride 0.9%  1000  ml ; syringe  4  ml ; inv-eribulin mesylate   2  mg ; benzonatate  200  mg ; tiotropium bromide  1  cap ; magnesium oxide  400  mg ; 
malignant neoplasm of unspecified site of unspecified female breast estrogen receptor negative status [er-] personal history of nicotine dependence acidosis acute respiratory failure with hypoxia other disorders of lung secondary malignant neoplasm of right lung secondary malignant neoplasm of other specified sites toxic gastroenteritis and colitis personal history of antineoplastic chemotherapy generalized enlarged lymph nodes pneumonitis due to inhalation of food and vomit other diseases of bronchus, not elsewhere classified essential (primary) hypertension secondary malignant neoplasm of mediastinum hyperlipidemia, unspecified emphysema, unspecified encounter for examination for normal comparison and control in clinical research program do not resuscitate adverse effect of unspecified systemic antibiotic, initial encounter
white f 76 $nan$nan$albuterol 0.083% neb soln  1  neb ; ondansetron  4  mg ; heparin flush (100 units ml)  5  ml ; cepacol (sore throat lozenge)  1  loz ; enoxaparin sodium  50  mg ; heparin flush (10 units ml)  5  ml ; sodium chloride 0.9%  flush  10  ml ; atorvastatin  40  mg ; polyethylene glycol  17  g ; bisacodyl  10  mg ; senna  17.2  mg ; sodium chloride nasal  1-2  spry ; fluticasone propionate nasal  1  spry ; mirtazapine  15  mg ; sodium chloride 0.9%  1000  ml ; syringe  4  ml ; inv-eribulin mesylate   2  mg ; benzonatate  200  mg ; tiotropium bromide  1  cap ; magnesium oxide  400  mg ; readi-cat 2 (barium sulfate 2% suspension)  900  ml ; 
malignant neoplasm of unspecified site of unspecified female breast estrogen receptor negative status [er-] personal history of nicotine dependence acidosis acute respiratory failure with hypoxia other disorders of lung secondary malignant neoplasm of right lung secondary malignant neoplasm of other specified sites toxic gastroenteritis and colitis personal history of antineoplastic chemotherapy generalized enlarged lymph nodes pneumonitis due to inhalation of food and vomit other diseases of bronchus, not elsewhere classified essential (primary) hypertension secondary malignant neoplasm of mediastinum hyperlipidemia, unspecified emphysema, unspecified encounter for examination for normal comparison and control in clinical research program do not resuscitate adverse effect of unspecified systemic antibiotic, initial encounter
white f 76 $nan$nan$albuterol 0.083% neb soln  1  neb ; ondansetron  4  mg ; heparin flush (100 units ml)  5  ml ; cepacol (sore throat lozenge)  1  loz ; enoxaparin sodium  50  mg ; heparin flush (10 units ml)  5  ml ; sodium chloride 0.9%  flush  10  ml ; atorvastatin  40  mg ; polyethylene glycol  17  g ; bisacodyl  10  mg ; senna  17.2  mg ; sodium chloride nasal  1-2  spry ; fluticasone propionate nasal  1  spry ; mirtazapine  15  mg ; sodium chloride 0.9%  1000  ml ; benzonatate  200  mg ; tiotropium bromide  1  cap ; magnesium oxide  400  mg ; readi-cat 2 (barium sulfate 2% suspension)  900  ml ; 
malignant neoplasm of unspecified site of unspecified female breast estrogen receptor negative status [er-] personal history of nicotine dependence acidosis acute respiratory failure with hypoxia other disorders of lung secondary malignant neoplasm of right lung secondary malignant neoplasm of other specified sites toxic gastroenteritis and colitis personal history of antineoplastic chemotherapy generalized enlarged lymph nodes pneumonitis due to inhalation of food and vomit other diseases of bronchus, not elsewhere classified essential (primary) hypertension secondary malignant neoplasm of mediastinum hyperlipidemia, unspecified emphysema, unspecified encounter for examination for normal comparison and control in clinical research program do not resuscitate adverse effect of unspecified systemic antibiotic, initial encounter
white f 38 $nan$hematology blood hematocrit  27.6  %; hematology blood hemoglobin  9.9  g dl; hematology blood platelet count  114  k ul; chemistry blood anion gap  13  meq l; chemistry blood bicarbonate  22  meq l; chemistry blood chloride  106  meq l; chemistry blood creatinine  0.4  mg dl; chemistry blood potassium  3.6  meq l; chemistry blood sodium  137  meq l; chemistry blood urea nitrogen  9  mg dl; chemistry blood calcium, total  7.9  mg dl; chemistry blood glucose  113  mg dl$naloxone  40-80  mcg ; naloxone  0.4  mg ; metoclopramide  10  mg ; ketorolac  15-30  mg ; ondansetron  4  mg ; docusate sodium  100  mg ; oxycodone-acetaminophen  1-2  tab ; ibuprofen  600  mg ; bisacodyl  10  mg ; milk of magnesia  30  ml ; dibucaine  1  appl ; simethicone  80  mg ; calcium carbonate  500  mg ; tetanus-diphtox-acellular pertuss (adacel)  0.5  ml ; potassium chloride  40  meq ; bag  50  ml ; magnesium sulfate  2  gm ; lorazepam  0.5  mg ; influenza virus vaccine  0.5  ml ; acetaminophen  500-1000  mg ; 
outcome of delivery, single liveborn previous cesarean delivery, delivered, with or without mention of antepartum condition pelvic peritoneal adhesions, female (postoperative) (postinfection) other current conditions classifiable elsewhere of mother, delivered, with or without mention of antepartum condition renal agenesis and dysgenesis motorcycle driver injured in collision with fixed or stationary object in nontraffic accident
white f 38 $nan$nan$influenza virus vaccine  0.5  ml ; acetaminophen  500-1000  mg ; 
outcome of delivery, single liveborn previous cesarean delivery, delivered, with or without mention of antepartum condition pelvic peritoneal adhesions, female (postoperative) (postinfection) other current conditions classifiable elsewhere of mother, delivered, with or without mention of antepartum condition renal agenesis and dysgenesis motorcycle driver injured in collision with fixed or stationary object in nontraffic accident
white f 38 $nan$nan$influenza virus vaccine  0.5  ml ; acetaminophen  500-1000  mg ; 
outcome of delivery, single liveborn previous cesarean delivery, delivered, with or without mention of antepartum condition pelvic peritoneal adhesions, female (postoperative) (postinfection) other current conditions classifiable elsewhere of mother, delivered, with or without mention of antepartum condition renal agenesis and dysgenesis motorcycle driver injured in collision with fixed or stationary object in nontraffic accident
white f 38 $nan$nan$influenza virus vaccine  0.5  ml ; acetaminophen  500-1000  mg ; 
outcome of delivery, single liveborn previous cesarean delivery, delivered, with or without mention of antepartum condition pelvic peritoneal adhesions, female (postoperative) (postinfection) other current conditions classifiable elsewhere of mother, delivered, with or without mention of antepartum condition renal agenesis and dysgenesis motorcycle driver injured in collision with fixed or stationary object in nontraffic accident
white f 38 $nan$nan$influenza virus vaccine  0.5  ml ; acetaminophen  500-1000  mg ; 
outcome of delivery, single liveborn previous cesarean delivery, delivered, with or without mention of antepartum condition pelvic peritoneal adhesions, female (postoperative) (postinfection) other current conditions classifiable elsewhere of mother, delivered, with or without mention of antepartum condition renal agenesis and dysgenesis motorcycle driver injured in collision with fixed or stationary object in nontraffic accident
white f 38 $nan$nan$influenza virus vaccine  0.5  ml ; acetaminophen  500-1000  mg ; 
outcome of delivery, single liveborn previous cesarean delivery, delivered, with or without mention of antepartum condition pelvic peritoneal adhesions, female (postoperative) (postinfection) other current conditions classifiable elsewhere of mother, delivered, with or without mention of antepartum condition renal agenesis and dysgenesis motorcycle driver injured in collision with fixed or stationary object in nontraffic accident
white m 61 $temp  99.0  heartrate  80.0  resprate  18.0  o2sat  95.0  sbp  135.0  dbp  64.0  rhythm    pain  0  $hematology blood hematocrit  36.7  %; hematology blood hemoglobin  12.3  g dl; hematology blood platelet count  108  k ul; chemistry blood anion gap  17  meq l; chemistry blood bicarbonate  22  meq l; chemistry blood chloride  102  meq l; chemistry blood creatinine  0.7  mg dl; chemistry blood potassium  4.1  meq l; chemistry blood sodium  137  meq l; chemistry blood urea nitrogen  21  mg dl; chemistry blood calcium, total  8.9  mg dl; chemistry blood glucose  110  mg dl$sodium chloride 0.9%  flush  3  ml ; albuterol inhaler  2  puff ; heparin  5000  unit ; fluticasone-salmeterol diskus (250 50)   1  inh ; aspirin  81  mg ; nifedipine cr  60  mg ; omeprazole  40  mg ; tiotropium bromide  1  cap ; valsartan  320  mg ; levofloxacin  750  mg ; symbicort  1  inh ; 
tobacco use disorder other chronic nonalcoholic liver disease other emphysema eosinophilia unspecified viral hepatitis c without hepatic coma alcohol abuse, unspecified obstructive sleep apnea (adult)(pediatric) benign essential hypertension esophageal reflux 
white m 61 $nan$hematology blood hematocrit  36.3  %; hematology blood hemoglobin  12.2  g dl; hematology blood platelet count  138  k ul; chemistry blood anion gap  15  meq l; chemistry blood bicarbonate  23  meq l; chemistry blood chloride  103  meq l; chemistry blood creatinine  0.6  mg dl; chemistry blood potassium  4.2  meq l; chemistry blood sodium  137  meq l; chemistry blood urea nitrogen  16  mg dl; chemistry blood calcium, total  9.1  mg dl; chemistry blood bilirubin, total  0.5  mg dl; chemistry blood glucose  108  mg dl; chemistry blood lactate dehydrogenase (ld)  158  iu l; chemistry blood albumin  4.0  g dl$sodium chloride 0.9%  flush  3  ml ; albuterol inhaler  2  puff ; heparin  5000  unit ; aspirin  81  mg ; nifedipine cr  60  mg ; omeprazole  40  mg ; tiotropium bromide  1  cap ; valsartan  320  mg ; symbicort  1  inh ; 
tobacco use disorder other chronic nonalcoholic liver disease other emphysema eosinophilia unspecified viral hepatitis c without hepatic coma alcohol abuse, unspecified obstructive sleep apnea (adult)(pediatric) benign essential hypertension esophageal reflux 
white m 88 $nan$hematology blood hematocrit  33.3  %; hematology blood hemoglobin  11.5  g dl; hematology blood platelet count  211  k ul; chemistry blood anion gap  13  meq l; chemistry blood bicarbonate  30  meq l; chemistry blood chloride  100  meq l; chemistry blood creatinine  2.0  mg dl; chemistry blood potassium  4.7  meq l; chemistry blood sodium  138  meq l; chemistry blood urea nitrogen  57  mg dl; hematology blood inr(pt)  1.6  ; chemistry blood calcium, total  9.3  mg dl; chemistry blood glucose  195  mg dl$insulin  55  unit ; simvastatin  40  mg ; influenza virus vaccine  0.5  ml ; pneumococcal vac polyvalent  0.5  ml ; sodium chloride 0.9%  flush  3  ml ; tramadol (ultram)  25  mg ; dextrose 50%  12.5  gm ; glucagon  1  mg ; iso-osmotic dextrose  200  ml ; vancomycin  1000  mg ; ns  100  ml ; metronidazole (flagyl)  500  mg ; insulin  0  unit ; 5% dextrose  200  ml ; ciprofloxacin iv  400  mg ; heparin  5000  unit ; metoprolol tartrate  25  mg ; ranitidine  150  mg ; 5% dextrose  1000  ml ; sodium bicarbonate  150  meq ; insulin  30  unit ; 
 
white m 88 $nan$hematology blood hematocrit  32.5  %; hematology blood hemoglobin  10.8  g dl; hematology blood platelet count  196  k ul; chemistry blood anion gap  14  meq l; chemistry blood bicarbonate  31  meq l; chemistry blood chloride  97  meq l; chemistry blood creatinine  2.0  mg dl; chemistry blood potassium  4.1  meq l; chemistry blood sodium  138  meq l; chemistry blood urea nitrogen  61  mg dl; hematology blood inr(pt)  1.4  ; chemistry blood calcium, total  8.9  mg dl; chemistry blood glucose  35  mg dl; chemistry blood % hemoglobin a1c  7.4  %$insulin  55  unit ; simvastatin  40  mg ; influenza virus vaccine  0.5  ml ; pneumococcal vac polyvalent  0.5  ml ; sodium chloride 0.9%  flush  3  ml ; tramadol (ultram)  25  mg ; dextrose 50%  12.5  gm ; glucagon  1  mg ; iso-osmotic dextrose  200  ml ; vancomycin  1000  mg ; ns  100  ml ; metronidazole (flagyl)  500  mg ; insulin  0  unit ; 5% dextrose  200  ml ; ciprofloxacin iv  400  mg ; heparin  5000  unit ; metoprolol tartrate  25  mg ; ranitidine  150  mg ; 5% dextrose  1000  ml ; sodium bicarbonate  150  meq ; insulin  30  unit ; insulin  15  unit ; 
 
white m 88 $nan$chemistry blood anion gap  9  meq l; chemistry blood bicarbonate  33  meq l; chemistry blood chloride  98  meq l; chemistry blood creatinine  1.9  mg dl; chemistry blood potassium  3.7  meq l; chemistry blood sodium  136  meq l; chemistry blood urea nitrogen  50  mg dl; chemistry blood calcium, total  8.3  mg dl; chemistry blood glucose  73  mg dl$insulin  55  unit ; simvastatin  40  mg ; pneumococcal vac polyvalent  0.5  ml ; sodium chloride 0.9%  flush  3  ml ; tramadol (ultram)  25  mg ; dextrose 50%  12.5  gm ; glucagon  1  mg ; iso-osmotic dextrose  200  ml ; vancomycin  1000  mg ; ns  100  ml ; metronidazole (flagyl)  500  mg ; insulin  0  unit ; 5% dextrose  200  ml ; ciprofloxacin iv  400  mg ; heparin  5000  unit ; metoprolol tartrate  25  mg ; ranitidine  150  mg ; insulin  30  unit ; insulin  15  unit ; doxycycline hyclate  100  mg ; insulin  20  unit ; 
 
black african american m 83 $nan$hematology blood hematocrit  39.0  %; hematology blood hemoglobin  12.6  g dl; hematology blood platelet count  269  k ul; chemistry blood anion gap  15  meq l; chemistry blood bicarbonate  25  meq l; chemistry blood chloride  100  meq l; chemistry blood creatinine  0.7  mg dl; chemistry blood potassium  3.6  meq l; chemistry blood sodium  136  meq l; chemistry blood urea nitrogen  13  mg dl; hematology blood inr(pt)  1.2  ; chemistry blood calcium, total  9.4  mg dl; chemistry blood bilirubin, total  0.3  mg dl; chemistry blood glucose  218  mg dl; chemistry blood lactate dehydrogenase (ld)  431  iu l; chemistry blood albumin  3.6  g dl$sodium chloride 0.9%  flush  3  ml ; docusate sodium  100  mg ; senna  17.2  mg ; multivitamins  1  tab ; heparin  5000  unit ; dextrose 50%  12.5  gm ; glucagon  1  mg ; glucose gel  15  g ; aspirin  81  mg ; acetaminophen  500-1000  mg ; simvastatin  20  mg ; terazosin  1  mg ; fluoxetine  40  mg ; lisinopril  40  mg ; insulin  0  unit ; trazodone  25  mg ; 
unspecified essential hypertension vascular dementia, uncomplicated cerebral atherosclerosis personal history of transient ischemic attack (tia), and cerebral infarction without residual deficits malignant neoplasm of glans penis 
black african american m 83 $nan$chemistry blood anion gap  13  meq l; chemistry blood bicarbonate  25  meq l; chemistry blood chloride  104  meq l; chemistry blood creatinine  0.7  mg dl; chemistry blood potassium  4.6  meq l; chemistry blood sodium  137  meq l; chemistry blood urea nitrogen  11  mg dl; chemistry blood glucose  141  mg dl$sodium chloride 0.9%  flush  3  ml ; docusate sodium  100  mg ; senna  17.2  mg ; multivitamins  1  tab ; heparin  5000  unit ; dextrose 50%  12.5  gm ; glucagon  1  mg ; glucose gel  15  g ; aspirin  81  mg ; acetaminophen  500-1000  mg ; simvastatin  20  mg ; terazosin  1  mg ; fluoxetine  40  mg ; lisinopril  40  mg ; insulin  0  unit ; trazodone  25  mg ; potassium chloride  40  meq ; magnesium oxide  400  mg ; 
unspecified essential hypertension vascular dementia, uncomplicated cerebral atherosclerosis personal history of transient ischemic attack (tia), and cerebral infarction without residual deficits malignant neoplasm of glans penis 
black african american m 83 $nan$nan$sodium chloride 0.9%  flush  3  ml ; docusate sodium  100  mg ; senna  17.2  mg ; multivitamins  1  tab ; heparin  5000  unit ; dextrose 50%  12.5  gm ; glucagon  1  mg ; glucose gel  15  g ; aspirin  81  mg ; acetaminophen  500-1000  mg ; simvastatin  20  mg ; terazosin  1  mg ; fluoxetine  40  mg ; lisinopril  40  mg ; insulin  0  unit ; potassium chloride  40  meq ; magnesium oxide  400  mg ; olanzapine (disintegrating tablet)  2.5  mg ; haloperidol  0.25  mg ; olanzapine (disintegrating tablet)  5  mg ; 
unspecified essential hypertension vascular dementia, uncomplicated cerebral atherosclerosis personal history of transient ischemic attack (tia), and cerebral infarction without residual deficits malignant neoplasm of glans penis 
white f 91 $temp    heartrate  60.0  resprate  16.0  o2sat  97.0  sbp  132.0  dbp  57.0  rhythm    pain  0  ; temp  98.4  heartrate  52.0  resprate  18.0  o2sat  94.0  sbp  121.0  dbp  54.0  rhythm    pain  sleeping  $hematology blood hematocrit  29.4  %; hematology blood hemoglobin  10.0  g dl; hematology blood platelet count  180  k ul; chemistry blood anion gap  16  meq l; chemistry blood bicarbonate  24  meq l; chemistry blood chloride  105  meq l; chemistry blood creatinine  1.3  mg dl; chemistry blood potassium  3.5  meq l; chemistry blood sodium  141  meq l; chemistry blood urea nitrogen  32  mg dl; chemistry blood calcium, total  8.7  mg dl; chemistry blood glucose  108  mg dl$pneumococcal 23-valent polysaccharide vaccine  0.5  ml ; sodium chloride 0.9%  flush  3  ml ; acetaminophen  650  mg ; docusate sodium  100  mg ; heparin  5000  unit ; dextrose 50%  12.5  gm ; glucagon  1  mg ; glucose gel  15  g ; polyethylene glycol  17  g ; insulin  0  unit ; amlodipine  10  mg ; aspirin  81  mg ; fluticasone propionate 110mcg  2  puff ; furosemide  40  mg ; gabapentin  300  mg ; metoprolol succinate xl  50  mg ; nitroglycerin sl  0.3  mg ; ciprofloxacin hcl  250  mg ; insulin  18  unit ; docusate sodium  200  mg ; simvastatin  20  mg ; senna  17.2  mg ; 
 
white f 91 $nan$nan$pneumococcal 23-valent polysaccharide vaccine  0.5  ml ; sodium chloride 0.9%  flush  3  ml ; acetaminophen  650  mg ; heparin  5000  unit ; dextrose 50%  12.5  gm ; glucagon  1  mg ; glucose gel  15  g ; polyethylene glycol  17  g ; insulin  0  unit ; amlodipine  10  mg ; aspirin  81  mg ; fluticasone propionate 110mcg  2  puff ; gabapentin  300  mg ; nitroglycerin sl  0.3  mg ; ciprofloxacin hcl  250  mg ; insulin  18  unit ; docusate sodium  200  mg ; simvastatin  20  mg ; senna  17.2  mg ; 
 
white m 54 $nan$hematology blood hematocrit  28.9  %; hematology blood hematocrit  28.2  %; hematology blood hematocrit  26.6  %; hematology blood hemoglobin  9.0  g dl; hematology blood hemoglobin  8.4  g dl; hematology blood platelet count  69  k ul; hematology blood platelet count  63  k ul; chemistry blood anion gap  12  meq l; chemistry blood bicarbonate  24  meq l; chemistry blood chloride  106  meq l; chemistry blood creatinine  0.8  mg dl; chemistry blood potassium  4.2  meq l; chemistry blood sodium  138  meq l; chemistry blood urea nitrogen  19  mg dl; hematology blood inr(pt)  1.2  ; chemistry blood calcium, total  7.8  mg dl; chemistry blood glucose  180  mg dl; blood gas blood lactate  0.9  mmol l$dextrose 5%  150  ml ; heparin  5000  unit ; sodium chloride 0.9%  flush  3  ml ; lorazepam  1.5  mg ; soln  50  ml ; fentanyl citrate  2.5  mg ; propofol  1000  mg ; iso-osmotic sodium chloride  50  ml ; famotidine  20  mg ; 0.9% sodium chloride (mini bag plus)  100  ml ; ampicillin-sulbactam  3  g ; soln  100  ml ; acetaminophen iv  1000  mg ; dexamethasone  10  mg ; cefepime  2  g ; 0.9% sodium chloride  100  ml ; midazolam  100  mg ; levofloxacin  750  mg ; 0.9% sodium chloride  1000  ml ; iso-osmotic dextrose  200  ml ; vancomycin  1000  mg ; dextrose 50%  12.5  gm ; glucagon  1  mg ; insulin  0  unit ; ns  100  ml ; metronidazole (flagyl)  500  mg ; 
 
white m 54 $nan$hematology blood hematocrit  28.6  %; hematology blood hemoglobin  8.6  g dl; hematology blood platelet count  60  k ul; chemistry blood anion gap  9  meq l; chemistry blood bicarbonate  29  meq l; chemistry blood chloride  109  meq l; chemistry blood creatinine  0.7  mg dl; chemistry blood potassium  4.5  meq l; chemistry blood sodium  142  meq l; chemistry blood urea nitrogen  22  mg dl; hematology blood inr(pt)  1.2  ; chemistry blood calcium, total  8.3  mg dl; chemistry blood glucose  141  mg dl$dextrose 5%  150  ml ; heparin  5000  unit ; sodium chloride 0.9%  flush  3  ml ; soln  50  ml ; fentanyl citrate  2.5  mg ; iso-osmotic sodium chloride  50  ml ; famotidine  20  mg ; soln  100  ml ; acetaminophen iv  1000  mg ; dexamethasone  10  mg ; cefepime  2  g ; 0.9% sodium chloride  100  ml ; midazolam  100  mg ; levofloxacin  750  mg ; 0.9% sodium chloride  1000  ml ; iso-osmotic dextrose  200  ml ; vancomycin  1000  mg ; dextrose 50%  12.5  gm ; glucagon  1  mg ; insulin  0  unit ; ns  100  ml ; metronidazole (flagyl)  500  mg ; 
 
white m 54 $nan$hematology blood hematocrit  28.4  %; hematology blood hemoglobin  8.6  g dl; hematology blood platelet count  70  k ul; chemistry blood anion gap  12  meq l; chemistry blood anion gap  10  meq l; chemistry blood bicarbonate  27  meq l; chemistry blood bicarbonate  26  meq l; chemistry blood chloride  111  meq l; chemistry blood chloride  114  meq l; chemistry blood creatinine  0.8  mg dl; chemistry blood creatinine  0.7  mg dl; chemistry blood potassium  4.2  meq l; chemistry blood potassium  4.2  meq l; chemistry blood sodium  146  meq l; chemistry blood sodium  146  meq l; chemistry blood urea nitrogen  26  mg dl; chemistry blood urea nitrogen  30  mg dl; hematology blood inr(pt)  1.6  ; chemistry blood calcium, total  8.6  mg dl; chemistry blood glucose  141  mg dl; chemistry blood glucose  133  mg dl$heparin  5000  unit ; sodium chloride 0.9%  flush  3  ml ; soln  50  ml ; fentanyl citrate  2.5  mg ; iso-osmotic sodium chloride  50  ml ; famotidine  20  mg ; dexamethasone  10  mg ; cefepime  2  g ; 0.9% sodium chloride  100  ml ; midazolam  100  mg ; dextrose 50%  12.5  gm ; glucagon  1  mg ; insulin  0  unit ; ns  100  ml ; metronidazole (flagyl)  500  mg ; 5% dextrose  250  ml ; vancomycin  1250  mg ; 5% dextrose  200  ml ; ciprofloxacin iv  400  mg ; iso-osmotic dextrose  100  ml ; nafcillin  2  g ; 5% dextrose  500  ml ; 
 
white m 54 $nan$hematology blood hematocrit  28.4  %; hematology blood hemoglobin  8.6  g dl; hematology blood platelet count  79  k ul; chemistry blood anion gap  12  meq l; chemistry blood bicarbonate  27  meq l; chemistry blood chloride  111  meq l; chemistry blood creatinine  0.7  mg dl; chemistry blood potassium  3.9  meq l; chemistry blood sodium  146  meq l; chemistry blood urea nitrogen  26  mg dl; chemistry blood calcium, total  8.2  mg dl; chemistry blood glucose  139  mg dl$heparin  5000  unit ; sodium chloride 0.9%  flush  3  ml ; soln  50  ml ; fentanyl citrate  2.5  mg ; iso-osmotic sodium chloride  50  ml ; famotidine  20  mg ; dexamethasone  10  mg ; 0.9% sodium chloride  100  ml ; midazolam  100  mg ; dextrose 50%  12.5  gm ; glucagon  1  mg ; insulin  0  unit ; ns  100  ml ; metronidazole (flagyl)  500  mg ; 5% dextrose  200  ml ; ciprofloxacin iv  400  mg ; iso-osmotic dextrose  100  ml ; nafcillin  2  g ; 5% dextrose  500  ml ; potassium phosphate  15  mmol ; methadone  90  mg ; omeprazole  20  mg ; lorazepam  0.5  mg ; trazodone  25  mg ; 
 
white m 54 $nan$hematology blood hematocrit  28.0  %; hematology blood hemoglobin  8.8  g dl; hematology blood platelet count  77  k ul; chemistry blood anion gap  12  meq l; chemistry blood bicarbonate  27  meq l; chemistry blood chloride  105  meq l; chemistry blood creatinine  0.8  mg dl; chemistry blood potassium  3.0  meq l; chemistry blood sodium  141  meq l; chemistry blood urea nitrogen  14  mg dl; hematology blood inr(pt)  2.1  ; chemistry blood calcium, total  7.5  mg dl; chemistry blood glucose  123  mg dl$heparin  5000  unit ; sodium chloride 0.9%  flush  3  ml ; soln  50  ml ; fentanyl citrate  2.5  mg ; 0.9% sodium chloride  100  ml ; midazolam  100  mg ; dextrose 50%  12.5  gm ; glucagon  1  mg ; insulin  0  unit ; ns  100  ml ; metronidazole (flagyl)  500  mg ; 5% dextrose  200  ml ; ciprofloxacin iv  400  mg ; iso-osmotic dextrose  100  ml ; nafcillin  2  g ; potassium phosphate  15  mmol ; methadone  90  mg ; omeprazole  20  mg ; lorazepam  0.5  mg ; trazodone  25  mg ; tramadol (ultram)  25  mg ; potassium chloride  60  meq ; 0.9% sodium chloride  500  ml ; potassium phosphate  30  mmol ; acetaminophen  500  mg ; pantoprazole  40  mg ; ondansetron  4  mg ; 
 
white m 54 $nan$hematology blood hematocrit  28.0  %; hematology blood hemoglobin  8.8  g dl; hematology blood platelet count  80  k ul; chemistry blood anion gap  11  meq l; chemistry blood anion gap  11  meq l; chemistry blood bicarbonate  28  meq l; chemistry blood bicarbonate  28  meq l; chemistry blood chloride  102  meq l; chemistry blood chloride  98  meq l; chemistry blood creatinine  0.8  mg dl; chemistry blood creatinine  0.8  mg dl; chemistry blood potassium  3.3  meq l; chemistry blood potassium  2.8  meq l; chemistry blood sodium  138  meq l; chemistry blood sodium  134  meq l; chemistry blood urea nitrogen  11  mg dl; chemistry blood urea nitrogen  8  mg dl; hematology blood inr(pt)  3.0  ; hematology urine wbc  13  # hpf; chemistry blood calcium, total  7.3  mg dl; chemistry blood calcium, total  7.4  mg dl; chemistry blood bilirubin, total  2.0  mg dl; chemistry blood glucose  110  mg dl; chemistry blood glucose  125  mg dl; chemistry blood albumin  2.3  g dl$heparin  5000  unit ; sodium chloride 0.9%  flush  3  ml ; dextrose 50%  12.5  gm ; glucagon  1  mg ; insulin  0  unit ; ns  100  ml ; metronidazole (flagyl)  500  mg ; 5% dextrose  200  ml ; ciprofloxacin iv  400  mg ; iso-osmotic dextrose  100  ml ; nafcillin  2  g ; 0.9% sodium chloride  500  ml ; potassium phosphate  30  mmol ; acetaminophen  500  mg ; pantoprazole  40  mg ; ondansetron  4  mg ; lorazepam  1  mg ; sterile water  100  ml ; potassium chloride  40  meq ; methadone  60  mg ; neutra-phos  2  pkt ; 
 
white m 54 $nan$hematology blood hematocrit  28.7  %; hematology blood hemoglobin  9.1  g dl; hematology blood platelet count  97  k ul; chemistry blood anion gap  12  meq l; chemistry blood anion gap  9  meq l; chemistry blood bicarbonate  25  meq l; chemistry blood bicarbonate  27  meq l; chemistry blood chloride  97  meq l; chemistry blood chloride  103  meq l; chemistry blood creatinine  0.7  mg dl; chemistry blood creatinine  0.7  mg dl; chemistry blood potassium  3.0  meq l; chemistry blood potassium  3.2  meq l; chemistry blood sodium  131  meq l; chemistry blood sodium  136  meq l; chemistry blood urea nitrogen  7  mg dl; chemistry blood urea nitrogen  6  mg dl; hematology blood inr(pt)  3.2  ; chemistry blood calcium, total  7.6  mg dl; chemistry blood calcium, total  7.4  mg dl; chemistry blood bilirubin, total  2.8  mg dl; chemistry blood glucose  126  mg dl; chemistry blood glucose  124  mg dl; hematology blood bands  0  %$heparin  5000  unit ; sodium chloride 0.9%  flush  3  ml ; dextrose 50%  12.5  gm ; glucagon  1  mg ; insulin  0  unit ; ns  100  ml ; metronidazole (flagyl)  500  mg ; 5% dextrose  200  ml ; ciprofloxacin iv  400  mg ; iso-osmotic dextrose  100  ml ; nafcillin  2  g ; acetaminophen  500  mg ; pantoprazole  40  mg ; lorazepam  1  mg ; methadone  60  mg ; neutra-phos  2  pkt ; 
 
white m 54 $nan$hematology blood hematocrit  22.2  %; hematology blood hematocrit  25.0  %; hematology blood hematocrit  26.6  %; hematology blood hemoglobin  6.9  g dl; hematology blood platelet count  102  k ul; chemistry blood anion gap  10  meq l; chemistry blood anion gap  11  meq l; chemistry blood bicarbonate  25  meq l; chemistry blood bicarbonate  26  meq l; chemistry blood chloride  105  meq l; chemistry blood chloride  104  meq l; chemistry blood creatinine  0.6  mg dl; chemistry blood creatinine  0.8  mg dl; chemistry blood potassium  3.2  meq l; chemistry blood potassium  3.5  meq l; chemistry blood sodium  137  meq l; chemistry blood sodium  137  meq l; chemistry blood urea nitrogen  5  mg dl; chemistry blood urea nitrogen  5  mg dl; hematology blood inr(pt)  3.9  ; chemistry blood calcium, total  7.5  mg dl; chemistry blood calcium, total  7.3  mg dl; chemistry blood bilirubin, indirect  0.7  mg dl; chemistry blood bilirubin, total  1.8  mg dl; chemistry blood glucose  107  mg dl; chemistry blood glucose  134  mg dl; chemistry blood lactate dehydrogenase (ld)  357  iu l; chemistry blood albumin  2.3  g dl; hematology blood bands  0  %; chemistry blood bilirubin, direct  1.1  mg dl$heparin  5000  unit ; sodium chloride 0.9%  flush  3  ml ; dextrose 50%  12.5  gm ; glucagon  1  mg ; insulin  0  unit ; ns  100  ml ; metronidazole (flagyl)  500  mg ; 5% dextrose  200  ml ; ciprofloxacin iv  400  mg ; iso-osmotic dextrose  100  ml ; nafcillin  2  g ; pantoprazole  40  mg ; methadone  60  mg ; neutra-phos  1  pkt ; methadone  10  mg ; methadone  80  mg ; methadone  30  mg ; ciprofloxacin hcl  500  mg ; 
 
white m 54 $nan$hematology blood hematocrit  26.6  %; hematology blood hemoglobin  8.4  g dl; hematology blood platelet count  115  k ul; chemistry blood anion gap  7  meq l; chemistry blood bicarbonate  27  meq l; chemistry blood chloride  106  meq l; chemistry blood creatinine  0.8  mg dl; chemistry blood potassium  3.4  meq l; chemistry blood sodium  137  meq l; chemistry blood urea nitrogen  5  mg dl; hematology blood inr(pt)  4.0  ; chemistry blood calcium, total  7.4  mg dl; chemistry blood bilirubin, total  2.1  mg dl; chemistry blood glucose  110  mg dl; chemistry blood lactate dehydrogenase (ld)  373  iu l$heparin  5000  unit ; sodium chloride 0.9%  flush  3  ml ; dextrose 50%  12.5  gm ; glucagon  1  mg ; insulin  0  unit ; iso-osmotic dextrose  100  ml ; nafcillin  2  g ; pantoprazole  40  mg ; neutra-phos  1  pkt ; methadone  30  mg ; ciprofloxacin hcl  500  mg ; 0.9% sodium chloride  250  ml ; phytonadione  5  mg ; phytonadione  10  mg ; 5% dextrose  50  ml ; diphenhydramine  50  mg ; 
 
white m 54 $nan$hematology blood hematocrit  25.0  %; hematology blood hematocrit  26.4  %; hematology blood hemoglobin  8.2  g dl; hematology blood platelet count  121  k ul; chemistry blood anion gap  9  meq l; chemistry blood anion gap  8  meq l; chemistry blood bicarbonate  26  meq l; chemistry blood bicarbonate  27  meq l; chemistry blood chloride  106  meq l; chemistry blood chloride  105  meq l; chemistry blood creatinine  0.8  mg dl; chemistry blood creatinine  0.8  mg dl; chemistry blood potassium  3.2  meq l; chemistry blood potassium  3.5  meq l; chemistry blood sodium  138  meq l; chemistry blood sodium  136  meq l; chemistry blood urea nitrogen  7  mg dl; chemistry blood urea nitrogen  6  mg dl; hematology blood inr(pt)  1.2  ; chemistry blood calcium, total  7.3  mg dl; chemistry blood calcium, total  7.7  mg dl; chemistry blood bilirubin, total  2.4  mg dl; chemistry blood glucose  115  mg dl; chemistry blood glucose  107  mg dl; chemistry blood lactate dehydrogenase (ld)  405  iu l; chemistry blood albumin  2.7  g dl$heparin  5000  unit ; sodium chloride 0.9%  flush  3  ml ; dextrose 50%  12.5  gm ; glucagon  1  mg ; insulin  0  unit ; iso-osmotic dextrose  100  ml ; nafcillin  2  g ; pantoprazole  40  mg ; ciprofloxacin hcl  500  mg ; 0.9% sodium chloride  250  ml ; 5% dextrose  50  ml ; diphenhydramine  50  mg ; neutra-phos  3  pkt ; bag  50  ml ; magnesium sulfate  2  gm ; sodium chloride 0.9%  flush  10  ml ; 
 
white f 33 $nan$hematology blood hematocrit  35.4  %; hematology blood hematocrit  38.3  %; hematology blood hemoglobin  11.9  g dl; hematology blood hemoglobin  12.8  g dl; hematology blood platelet count  110  k ul; hematology blood platelet count  109  k ul; chemistry blood anion gap  15  meq l; chemistry blood bicarbonate  22  meq l; chemistry blood chloride  104  meq l; chemistry blood creatinine  1.0  mg dl; chemistry blood potassium  3.8  meq l; chemistry blood sodium  137  meq l; chemistry blood urea nitrogen  19  mg dl; chemistry blood calcium, total  9.5  mg dl; chemistry blood glucose  182  mg dl$carvedilol  3.125  mg ; escitalopram oxalate  10  mg ; trazodone  150  mg ; influenza vaccine quadrivalent  0.5  ml ; sodium chloride 0.9%  flush  3  ml ; lactated ringers  1000  ml ; acetaminophen  1000  mg ; ketorolac  15  mg ; phenazopyridine  100  mg ; 0.9% sodium chloride (mini bag plus)  100  ml ; ceftriaxone  1  gm ; tamsulosin  0.4  mg ; digoxin  0.25  mg ; cefpodoxime proxetil  200  mg ; 
cardiac pacemaker in situ open wound of wrist, without mention of complication suicidal ideation depressive disorder, not elsewhere classified suicide and self-inflicted injury by cutting and piercing instrument 
white f 33 $nan$nan$carvedilol  3.125  mg ; escitalopram oxalate  10  mg ; trazodone  150  mg ; influenza vaccine quadrivalent  0.5  ml ; sodium chloride 0.9%  flush  3  ml ; lactated ringers  1000  ml ; acetaminophen  1000  mg ; ketorolac  15  mg ; phenazopyridine  100  mg ; tamsulosin  0.4  mg ; digoxin  0.25  mg ; cefpodoxime proxetil  200  mg ; 
cardiac pacemaker in situ open wound of wrist, without mention of complication suicidal ideation depressive disorder, not elsewhere classified suicide and self-inflicted injury by cutting and piercing instrument 
white m 23 $temp  98.1  heartrate  60.0  resprate  18.0  o2sat  100.0  sbp  107.0  dbp  60.0  rhythm    pain  0  $nan$influenza vaccine quadrivalent  0.5  ml ; sodium chloride 0.9%  flush  3  ml ; lactated ringers  1000  ml ; 5% dextrose  200  ml ; ciprofloxacin iv  400  mg ; ns  100  ml ; metronidazole (flagyl)  500  mg ; heparin  5000  unit ; oxycodone (immediate release)   5  mg ; acetaminophen  650  mg ; 
 
white m 23 $nan$nan$sodium chloride 0.9%  flush  3  ml ; heparin  5000  unit ; oxycodone (immediate release)   5  mg ; acetaminophen  650  mg ; 
 
asian f 33 $nan$hematology blood hematocrit  36.5  %; hematology blood hemoglobin  12.3  g dl; hematology blood platelet count  187  k ul$nan
 
asian f 33 $nan$nan$sodium chloride 0.9%  flush  3  ml ; 0.9% sodium chloride  1000  ml ; oxytocin  20  unit ; cetirizine  10  mg ; 0.9% sodium chloride (mini bag plus)  100  ml ; ampicillin sodium  2  g ; lactated ringers  1000  ml ; docusate sodium  100  mg ; ibuprofen  600  mg ; acetaminophen  500-1000  mg ; bisacodyl  10  mg ; milk of magnesia  30  ml ; simethicone  80  mg ; calcium carbonate  500  mg ; dermoplast spray  1  spry ; 5% dextrose  50  ml ; clindamycin  900  mg ; oxycodone (immediate release)  5-10  mg ; naloxone  40-80  mcg ; ketorolac  15-30  mg ; ondansetron  4  mg ; heparin  5000  unit ; 
 
asian f 33 $nan$nan$sodium chloride 0.9%  flush  3  ml ; 0.9% sodium chloride  1000  ml ; oxytocin  20  unit ; cetirizine  10  mg ; 0.9% sodium chloride (mini bag plus)  100  ml ; ampicillin sodium  2  g ; lactated ringers  1000  ml ; docusate sodium  100  mg ; ibuprofen  600  mg ; acetaminophen  500-1000  mg ; bisacodyl  10  mg ; milk of magnesia  30  ml ; simethicone  80  mg ; calcium carbonate  500  mg ; dermoplast spray  1  spry ; 5% dextrose  50  ml ; clindamycin  900  mg ; oxycodone (immediate release)  5-10  mg ; naloxone  40-80  mcg ; ketorolac  15-30  mg ; ondansetron  4  mg ; heparin  5000  unit ; 
 
asian f 33 $nan$nan$sodium chloride 0.9%  flush  3  ml ; cetirizine  10  mg ; docusate sodium  100  mg ; ibuprofen  600  mg ; acetaminophen  500-1000  mg ; bisacodyl  10  mg ; milk of magnesia  30  ml ; simethicone  80  mg ; calcium carbonate  500  mg ; dermoplast spray  1  spry ; oxycodone (immediate release)  5-10  mg ; naloxone  40-80  mcg ; ondansetron  4  mg ; heparin  5000  unit ; 
 
asian f 33 $nan$nan$sodium chloride 0.9%  flush  3  ml ; cetirizine  10  mg ; docusate sodium  100  mg ; ibuprofen  600  mg ; acetaminophen  500-1000  mg ; bisacodyl  10  mg ; milk of magnesia  30  ml ; simethicone  80  mg ; calcium carbonate  500  mg ; dermoplast spray  1  spry ; oxycodone (immediate release)  5-10  mg ; naloxone  40-80  mcg ; ondansetron  4  mg ; heparin  5000  unit ; 
 
asian f 33 $nan$nan$sodium chloride 0.9%  flush  3  ml ; cetirizine  10  mg ; docusate sodium  100  mg ; ibuprofen  600  mg ; acetaminophen  500-1000  mg ; bisacodyl  10  mg ; milk of magnesia  30  ml ; simethicone  80  mg ; calcium carbonate  500  mg ; dermoplast spray  1  spry ; oxycodone (immediate release)  5-10  mg ; naloxone  40-80  mcg ; ondansetron  4  mg ; heparin  5000  unit ; 
 
asian f 33 $nan$nan$sodium chloride 0.9%  flush  3  ml ; cetirizine  10  mg ; docusate sodium  100  mg ; ibuprofen  600  mg ; acetaminophen  500-1000  mg ; bisacodyl  10  mg ; milk of magnesia  30  ml ; simethicone  80  mg ; calcium carbonate  500  mg ; dermoplast spray  1  spry ; oxycodone (immediate release)  5-10  mg ; naloxone  40-80  mcg ; ondansetron  4  mg ; heparin  5000  unit ; 
 
white f 36 $temp  98.2  heartrate  100.0  resprate  18.0  o2sat  95.0  sbp  150.0  dbp  99.0  rhythm    pain  10  ; temp  99.2  heartrate  100.0  resprate  16.0  o2sat  99.0  sbp  131.0  dbp  71.0  rhythm    pain  10  ; temp  99.2  heartrate  98.0  resprate  18.0  o2sat  98.0  sbp  117.0  dbp  76.0  rhythm    pain  10  $hematology blood hematocrit  34.7  %; hematology blood hemoglobin  11.9  g dl; hematology blood platelet count  225  k ul; blood gas blood lactate  1.3  mmol l; blood gas blood chloride, whole blood  101  meq l; blood gas blood glucose  90  mg dl; blood gas blood potassium, whole blood  5.1  meq l; blood gas blood sodium, whole blood  134  meq l; blood gas blood calculated bicarbonate, whole blood  27  meq l$nan
 
white f 36 $temp  98.6  heartrate  102.0  resprate  24.0  o2sat  95.0  sbp  128.0  dbp  69.0  rhythm    pain  10  $hematology urine wbc  2  # hpf$influenza vaccine quadrivalent  0.5  ml ; sodium chloride 0.9%  flush  3-10  ml ; acetaminophen  1000  mg ; oxycodone (immediate release)  5-10  mg ; ondansetron  4  mg ; lactated ringers  1000  ml ; ns  100  ml ; metronidazole  500  mg ; hydromorphone (dilaudid)  0.25  mg ; 0.9% sodium chloride (mini bag plus)  100  ml ; cefepime  2  g ; heparin  5000  unit ; oxycodone--acetaminophen (5mg-325mg)  1-2  tab ; ketorolac  15  mg ; docusate sodium  100  mg ; 
 
white f 36 $nan$hematology blood hematocrit  33.9  %; hematology blood hemoglobin  11.3  g dl; hematology blood platelet count  207  k ul; chemistry blood anion gap  13  meq l; chemistry blood bicarbonate  27  meq l; chemistry blood chloride  101  meq l; chemistry blood creatinine  0.6  mg dl; chemistry blood potassium  3.7  meq l; chemistry blood sodium  141  meq l; chemistry blood urea nitrogen  6  mg dl; chemistry blood calcium, total  8.7  mg dl; chemistry blood glucose  95  mg dl$influenza vaccine quadrivalent  0.5  ml ; sodium chloride 0.9%  flush  3-10  ml ; ondansetron  4  mg ; ns  100  ml ; metronidazole  500  mg ; hydromorphone (dilaudid)  0.25  mg ; 0.9% sodium chloride (mini bag plus)  100  ml ; cefepime  2  g ; heparin  5000  unit ; ketorolac  15  mg ; docusate sodium  100  mg ; polyethylene glycol  17  g ; ciprofloxacin hcl  500  mg ; clindamycin  300  mg ; 
 
white f 36 $nan$hematology blood hematocrit  30.0  %; hematology blood hemoglobin  10.1  g dl; hematology blood platelet count  241  k ul; chemistry blood anion gap  14  meq l; chemistry blood bicarbonate  24  meq l; chemistry blood chloride  102  meq l; chemistry blood creatinine  0.6  mg dl; chemistry blood potassium  3.6  meq l; chemistry blood sodium  140  meq l; chemistry blood urea nitrogen  9  mg dl; hematology urine wbc  21  # hpf; chemistry blood calcium, total  8.6  mg dl; chemistry blood glucose  102  mg dl$influenza vaccine quadrivalent  0.5  ml ; sodium chloride 0.9%  flush  3-10  ml ; heparin  5000  unit ; ketorolac  15  mg ; docusate sodium  100  mg ; polyethylene glycol  17  g ; clindamycin  300  mg ; bag  1  bag ; magnesium sulfate  4  gm ; potassium chloride  40  meq ; clindamycin  450  mg ; 
 
white f 36 $nan$hematology blood hematocrit  29.3  %; hematology blood hemoglobin  9.9  g dl; hematology blood platelet count  264  k ul; chemistry blood anion gap  10  meq l; chemistry blood bicarbonate  25  meq l; chemistry blood chloride  105  meq l; chemistry blood creatinine  0.6  mg dl; chemistry blood potassium  4.2  meq l; chemistry blood sodium  140  meq l; chemistry blood urea nitrogen  9  mg dl; chemistry blood calcium, total  8.1  mg dl; chemistry blood glucose  96  mg dl$influenza vaccine quadrivalent  0.5  ml ; sodium chloride 0.9%  flush  3-10  ml ; heparin  5000  unit ; ketorolac  15  mg ; docusate sodium  100  mg ; polyethylene glycol  17  g ; bag  1  bag ; magnesium sulfate  4  gm ; potassium chloride  40  meq ; clindamycin  450  mg ; vial  1  vial ; ceftriaxone  2  gm ; oxycodone (immediate release)  5  mg ; 
 
white f 36 $nan$hematology blood hematocrit  30.3  %; hematology blood hemoglobin  9.9  g dl; hematology blood platelet count  285  k ul; chemistry blood anion gap  11  meq l; chemistry blood bicarbonate  25  meq l; chemistry blood chloride  102  meq l; chemistry blood creatinine  0.4  mg dl; chemistry blood potassium  4.4  meq l; chemistry blood sodium  138  meq l; chemistry blood urea nitrogen  9  mg dl; chemistry blood calcium, total  8.5  mg dl; chemistry blood glucose  94  mg dl$influenza vaccine quadrivalent  0.5  ml ; sodium chloride 0.9%  flush  3-10  ml ; heparin  5000  unit ; docusate sodium  100  mg ; polyethylene glycol  17  g ; vial  1  vial ; ceftriaxone  2  gm ; oxycodone (immediate release)  5  mg ; metoclopramide  10  mg ; ibuprofen  600  mg ; 
 
white f 36 $nan$hematology blood hematocrit  33.9  %; hematology blood hemoglobin  11.1  g dl; hematology blood platelet count  304  k ul; chemistry blood anion gap  10  meq l; chemistry blood bicarbonate  26  meq l; chemistry blood chloride  103  meq l; chemistry blood creatinine  0.6  mg dl; chemistry blood potassium  4.6  meq l; chemistry blood sodium  139  meq l; chemistry blood urea nitrogen  6  mg dl; chemistry blood calcium, total  8.6  mg dl; chemistry blood glucose  104  mg dl$influenza vaccine quadrivalent  0.5  ml ; sodium chloride 0.9%  flush  3-10  ml ; heparin  5000  unit ; docusate sodium  100  mg ; polyethylene glycol  17  g ; metoclopramide  10  mg ; prochlorperazine  10  mg ; nystatin oral suspension  5  ml ; 
 
white f 36 $nan$hematology blood hematocrit  34.2  %; hematology blood hemoglobin  11.5  g dl; hematology blood platelet count  355  k ul$influenza vaccine quadrivalent  0.5  ml ; sodium chloride 0.9%  flush  3-10  ml ; heparin  5000  unit ; docusate sodium  100  mg ; polyethylene glycol  17  g ; prochlorperazine  10  mg ; nystatin oral suspension  5  ml ; 
 
white f 36 $nan$hematology blood hematocrit  36.2  %; hematology blood hemoglobin  11.8  g dl; hematology blood platelet count  389  k ul$influenza vaccine quadrivalent  0.5  ml ; sodium chloride 0.9%  flush  3-10  ml ; heparin  5000  unit ; docusate sodium  100  mg ; polyethylene glycol  17  g ; prochlorperazine  10  mg ; nystatin oral suspension  5  ml ; ondansetron odt  4  mg ; amoxicillin-clavulanic acid  875  mg ; doxycycline hyclate  100  mg ; 
 
white f 36 $nan$nan$sodium chloride 0.9%  flush  3-10  ml ; heparin  5000  unit ; docusate sodium  100  mg ; polyethylene glycol  17  g ; prochlorperazine  10  mg ; nystatin oral suspension  5  ml ; 
 
white m 66 $temp    heartrate  80.0  resprate  16.0  o2sat  97.0  sbp  125.0  dbp  70.0  rhythm    pain    ; temp  99.2  heartrate  81.0  resprate  20.0  o2sat  96.0  sbp  126.0  dbp  75.0  rhythm    pain  4  $hematology blood hematocrit  31.6  %; hematology blood hemoglobin  10.6  g dl; hematology blood platelet count  195  k ul; chemistry blood anion gap  13  meq l; chemistry blood bicarbonate  18  meq l; chemistry blood chloride  103  meq l; chemistry blood creatinine  0.6  mg dl; chemistry blood potassium  4.7  meq l; chemistry blood sodium  134  meq l; chemistry blood urea nitrogen  15  mg dl; hematology blood inr(pt)  1.7  ; chemistry blood calcium, total  7.9  mg dl; chemistry blood glucose  316  mg dl; chemistry blood % hemoglobin a1c  7.1  %$influenza vaccine quadrivalent  0.5  ml ; heparin  5000  unit ; acetaminophen  500  mg ; oxycodone (immediate release)  5  mg ; ondansetron  4  mg ; potassium chl 40 meq   1000 ml d5 1 2 ns  1000  ml ; dextrose 50%  12.5  gm ; glucagon  1  mg ; glucose gel  15  g ; diazepam - ciwa protocol  10  mg ; acetaminophen  650  mg ; hydromorphone (dilaudid)  0.5  mg ; 0.9% sodium chloride  500  ml ; sodium phosphate  30  mmol ; sodium chloride 0.9%  flush  3-10  ml ; lactated ringers  1000  ml ; insulin  0  unit ; vial  1  vial ; cefepime  2  g ; nortriptyline  25  mg ; enoxaparin sodium  40  mg ; oxycodone (immediate release)  5-10  mg ; bag  1  bag ; magnesium sulfate  4  gm ; insulin  15  unit ; 
hypoxemia anxiety disorder, unspecified acute kidney failure, unspecified long term (current) use of insulin gastro-esophageal reflux disease without esophagitis viral intestinal infection, unspecified other psychoactive substance abuse, uncomplicated type 1 diabetes mellitus with ketoacidosis without coma type 1 diabetes mellitus with diabetic polyneuropathy alcohol abuse, uncomplicated alcoholic cirrhosis of liver without ascites essential (primary) hypertension dysphagia, unspecified other convulsions diabetes with neurological manifestations, type ii or unspecified type, not stated as uncontrolled diabetes with other specified manifestations, type ii or unspecified type, not stated as uncontrolled
white m 66 $nan$hematology blood hematocrit  30.9  %; hematology blood hemoglobin  10.2  g dl; hematology blood platelet count  196  k ul; chemistry blood anion gap  14  meq l; chemistry blood bicarbonate  19  meq l; chemistry blood chloride  99  meq l; chemistry blood creatinine  0.6  mg dl; chemistry blood potassium  4.3  meq l; chemistry blood sodium  132  meq l; chemistry blood urea nitrogen  9  mg dl; chemistry blood calcium, total  8.0  mg dl; chemistry blood bilirubin, total  3.4  mg dl; chemistry blood bilirubin, total  4.1  mg dl; chemistry blood glucose  160  mg dl; chemistry blood % hemoglobin a1c  7.2  %$influenza vaccine quadrivalent  0.5  ml ; dextrose 50%  12.5  gm ; glucagon  1  mg ; glucose gel  15  g ; diazepam - ciwa protocol  10  mg ; acetaminophen  650  mg ; hydromorphone (dilaudid)  0.5  mg ; sodium chloride 0.9%  flush  3-10  ml ; lactated ringers  1000  ml ; vial  1  vial ; cefepime  2  g ; nortriptyline  25  mg ; enoxaparin sodium  40  mg ; oxycodone (immediate release)  5-10  mg ; bag  1  bag ; magnesium sulfate  4  gm ; insulin  15  unit ; milk of magnesia  30  ml ; 
hypoxemia anxiety disorder, unspecified acute kidney failure, unspecified long term (current) use of insulin gastro-esophageal reflux disease without esophagitis viral intestinal infection, unspecified other psychoactive substance abuse, uncomplicated type 1 diabetes mellitus with ketoacidosis without coma type 1 diabetes mellitus with diabetic polyneuropathy alcohol abuse, uncomplicated alcoholic cirrhosis of liver without ascites essential (primary) hypertension dysphagia, unspecified other convulsions diabetes with neurological manifestations, type ii or unspecified type, not stated as uncontrolled diabetes with other specified manifestations, type ii or unspecified type, not stated as uncontrolled
white m 66 $nan$hematology blood hematocrit  32.0  %; hematology blood hemoglobin  10.5  g dl; hematology blood platelet count  212  k ul; chemistry blood anion gap  14  meq l; chemistry blood bicarbonate  22  meq l; chemistry blood chloride  97  meq l; chemistry blood creatinine  0.6  mg dl; chemistry blood potassium  4.6  meq l; chemistry blood sodium  133  meq l; chemistry blood urea nitrogen  10  mg dl; hematology blood inr(pt)  1.6  ; chemistry blood calcium, total  8.1  mg dl; chemistry blood glucose  225  mg dl$influenza vaccine quadrivalent  0.5  ml ; dextrose 50%  12.5  gm ; glucagon  1  mg ; glucose gel  15  g ; diazepam - ciwa protocol  10  mg ; acetaminophen  650  mg ; hydromorphone (dilaudid)  0.5  mg ; sodium chloride 0.9%  flush  3-10  ml ; nortriptyline  25  mg ; enoxaparin sodium  40  mg ; oxycodone (immediate release)  5-10  mg ; milk of magnesia  30  ml ; magnesium oxide  400  mg ; phosphorus  250  mg ; senna  8.6  mg ; atorvastatin  40  mg ; omeprazole  40  mg ; insulin  2  unit ; polyethylene glycol  17  g ; insulin  5  unit ; 
hypoxemia anxiety disorder, unspecified acute kidney failure, unspecified long term (current) use of insulin gastro-esophageal reflux disease without esophagitis viral intestinal infection, unspecified other psychoactive substance abuse, uncomplicated type 1 diabetes mellitus with ketoacidosis without coma type 1 diabetes mellitus with diabetic polyneuropathy alcohol abuse, uncomplicated alcoholic cirrhosis of liver without ascites essential (primary) hypertension dysphagia, unspecified other convulsions diabetes with neurological manifestations, type ii or unspecified type, not stated as uncontrolled diabetes with other specified manifestations, type ii or unspecified type, not stated as uncontrolled
white m 66 $nan$hematology blood hematocrit  30.9  %; hematology blood hemoglobin  10.3  g dl; hematology blood platelet count  249  k ul; chemistry blood anion gap  12  meq l; chemistry blood bicarbonate  23  meq l; chemistry blood chloride  97  meq l; chemistry blood creatinine  0.7  mg dl; chemistry blood potassium  4.4  meq l; chemistry blood sodium  132  meq l; chemistry blood urea nitrogen  9  mg dl; chemistry blood calcium, total  8.3  mg dl; chemistry blood bilirubin, total  4.1  mg dl; chemistry blood glucose  186  mg dl; chemistry blood lactate dehydrogenase (ld)  264  iu l$influenza vaccine quadrivalent  0.5  ml ; dextrose 50%  12.5  gm ; glucagon  1  mg ; glucose gel  15  g ; diazepam - ciwa protocol  10  mg ; acetaminophen  650  mg ; hydromorphone (dilaudid)  0.5  mg ; sodium chloride 0.9%  flush  3-10  ml ; nortriptyline  25  mg ; enoxaparin sodium  40  mg ; oxycodone (immediate release)  5-10  mg ; milk of magnesia  30  ml ; senna  8.6  mg ; atorvastatin  40  mg ; omeprazole  40  mg ; insulin  2  unit ; polyethylene glycol  17  g ; insulin  5  unit ; lactulose  15  ml ; insulin  20  unit ; insulin  4  unit ; 
hypoxemia anxiety disorder, unspecified acute kidney failure, unspecified long term (current) use of insulin gastro-esophageal reflux disease without esophagitis viral intestinal infection, unspecified other psychoactive substance abuse, uncomplicated type 1 diabetes mellitus with ketoacidosis without coma type 1 diabetes mellitus with diabetic polyneuropathy alcohol abuse, uncomplicated alcoholic cirrhosis of liver without ascites essential (primary) hypertension dysphagia, unspecified other convulsions diabetes with neurological manifestations, type ii or unspecified type, not stated as uncontrolled diabetes with other specified manifestations, type ii or unspecified type, not stated as uncontrolled
white m 66 $nan$hematology blood hematocrit  30.9  %; hematology blood hemoglobin  10.2  g dl; hematology blood platelet count  277  k ul; chemistry blood anion gap  11  meq l; chemistry blood bicarbonate  24  meq l; chemistry blood chloride  97  meq l; chemistry blood creatinine  0.7  mg dl; chemistry blood potassium  4.7  meq l; chemistry blood sodium  132  meq l; chemistry blood urea nitrogen  9  mg dl; chemistry blood calcium, total  8.4  mg dl; chemistry blood glucose  210  mg dl$influenza vaccine quadrivalent  0.5  ml ; dextrose 50%  12.5  gm ; glucagon  1  mg ; glucose gel  15  g ; diazepam - ciwa protocol  10  mg ; acetaminophen  650  mg ; hydromorphone (dilaudid)  0.5  mg ; sodium chloride 0.9%  flush  3-10  ml ; nortriptyline  25  mg ; enoxaparin sodium  40  mg ; oxycodone (immediate release)  5-10  mg ; milk of magnesia  30  ml ; senna  8.6  mg ; atorvastatin  40  mg ; omeprazole  40  mg ; polyethylene glycol  17  g ; lactulose  15  ml ; insulin  4  unit ; insulin  24  unit ; 
hypoxemia anxiety disorder, unspecified acute kidney failure, unspecified long term (current) use of insulin gastro-esophageal reflux disease without esophagitis viral intestinal infection, unspecified other psychoactive substance abuse, uncomplicated type 1 diabetes mellitus with ketoacidosis without coma type 1 diabetes mellitus with diabetic polyneuropathy alcohol abuse, uncomplicated alcoholic cirrhosis of liver without ascites essential (primary) hypertension dysphagia, unspecified other convulsions diabetes with neurological manifestations, type ii or unspecified type, not stated as uncontrolled diabetes with other specified manifestations, type ii or unspecified type, not stated as uncontrolled
white m 66 $nan$nan$influenza vaccine quadrivalent  0.5  ml ; dextrose 50%  12.5  gm ; glucagon  1  mg ; glucose gel  15  g ; diazepam - ciwa protocol  10  mg ; acetaminophen  650  mg ; sodium chloride 0.9%  flush  3-10  ml ; nortriptyline  25  mg ; enoxaparin sodium  40  mg ; oxycodone (immediate release)  5-10  mg ; milk of magnesia  30  ml ; senna  8.6  mg ; atorvastatin  40  mg ; omeprazole  40  mg ; polyethylene glycol  17  g ; insulin  4  unit ; insulin  24  unit ; 
hypoxemia anxiety disorder, unspecified acute kidney failure, unspecified long term (current) use of insulin gastro-esophageal reflux disease without esophagitis viral intestinal infection, unspecified other psychoactive substance abuse, uncomplicated type 1 diabetes mellitus with ketoacidosis without coma type 1 diabetes mellitus with diabetic polyneuropathy alcohol abuse, uncomplicated alcoholic cirrhosis of liver without ascites essential (primary) hypertension dysphagia, unspecified other convulsions diabetes with neurological manifestations, type ii or unspecified type, not stated as uncontrolled diabetes with other specified manifestations, type ii or unspecified type, not stated as uncontrolled
hispanic latino f 35 $nan$hematology blood hematocrit  35.2  %; hematology blood hemoglobin  12.1  g dl; hematology blood platelet count  228  k ul$ondansetron  4  mg ; sodium chloride 0.9%  flush  3  ml ; 0.9% sodium chloride  1000  ml ; oxytocin  20  unit ; lr  1000  ml ; docusate sodium  100  mg ; oxycodone-acetaminophen  1-2  tab ; ibuprofen  600  mg ; acetaminophen  500-1000  mg ; bisacodyl  10  mg ; milk of magnesia  30  ml ; dibucaine  1  appl ; simethicone  80  mg ; calcium carbonate  500  mg ; naloxone  40-80  mcg ; metoclopramide  10  mg ; ketorolac  15-30  mg ; levothyroxine sodium  100  mcg ; 
 
hispanic latino f 35 $nan$nan$ondansetron  4  mg ; sodium chloride 0.9%  flush  3  ml ; 0.9% sodium chloride  1000  ml ; oxytocin  20  unit ; lr  1000  ml ; docusate sodium  100  mg ; oxycodone-acetaminophen  1-2  tab ; ibuprofen  600  mg ; acetaminophen  500-1000  mg ; bisacodyl  10  mg ; milk of magnesia  30  ml ; dibucaine  1  appl ; simethicone  80  mg ; calcium carbonate  500  mg ; naloxone  40-80  mcg ; metoclopramide  10  mg ; ketorolac  15-30  mg ; levothyroxine sodium  100  mcg ; 
 
hispanic latino f 35 $nan$nan$ondansetron  4  mg ; sodium chloride 0.9%  flush  3  ml ; 0.9% sodium chloride  1000  ml ; oxytocin  20  unit ; lr  1000  ml ; docusate sodium  100  mg ; oxycodone-acetaminophen  1-2  tab ; ibuprofen  600  mg ; acetaminophen  500-1000  mg ; bisacodyl  10  mg ; milk of magnesia  30  ml ; dibucaine  1  appl ; simethicone  80  mg ; calcium carbonate  500  mg ; naloxone  40-80  mcg ; metoclopramide  10  mg ; levothyroxine sodium  100  mcg ; 
 
hispanic latino f 35 $nan$nan$ondansetron  4  mg ; sodium chloride 0.9%  flush  3  ml ; 0.9% sodium chloride  1000  ml ; oxytocin  20  unit ; lr  1000  ml ; docusate sodium  100  mg ; oxycodone-acetaminophen  1-2  tab ; ibuprofen  600  mg ; acetaminophen  500-1000  mg ; bisacodyl  10  mg ; milk of magnesia  30  ml ; dibucaine  1  appl ; simethicone  80  mg ; calcium carbonate  500  mg ; naloxone  40-80  mcg ; metoclopramide  10  mg ; levothyroxine sodium  100  mcg ; 
 
hispanic latino f 35 $nan$nan$ondansetron  4  mg ; sodium chloride 0.9%  flush  3  ml ; 0.9% sodium chloride  1000  ml ; oxytocin  20  unit ; lr  1000  ml ; docusate sodium  100  mg ; oxycodone-acetaminophen  1-2  tab ; ibuprofen  600  mg ; acetaminophen  500-1000  mg ; bisacodyl  10  mg ; milk of magnesia  30  ml ; dibucaine  1  appl ; simethicone  80  mg ; calcium carbonate  500  mg ; naloxone  40-80  mcg ; metoclopramide  10  mg ; levothyroxine sodium  100  mcg ; 
 
unknown f 77 $nan$nan$insulin  38  unit ; 
 
unknown f 77 $nan$hematology blood hematocrit  39.0  %; hematology blood hematocrit  27.8  %; hematology blood hematocrit  33.5  %; hematology blood hemoglobin  12.8  g dl; hematology blood hemoglobin  8.9  g dl; hematology blood hemoglobin  10.7  g dl; hematology blood platelet count  236  k ul; hematology blood platelet count  241  k ul; hematology blood platelet count  212  k ul; chemistry blood anion gap  14  meq l; chemistry blood anion gap  13  meq l; chemistry blood bicarbonate  28  meq l; chemistry blood bicarbonate  22  meq l; chemistry blood chloride  105  meq l; chemistry blood chloride  113  meq l; chemistry blood creatinine  1.2  mg dl; chemistry blood creatinine  1.0  mg dl; chemistry blood potassium  4.5  meq l; chemistry blood potassium  4.0  meq l; chemistry blood sodium  142  meq l; chemistry blood sodium  144  meq l; chemistry blood urea nitrogen  24  mg dl; chemistry blood urea nitrogen  15  mg dl; hematology blood inr(pt)  1.0  ; hematology blood inr(pt)  1.2  ; hematology blood inr(pt)  1.2  ; hematology urine wbc  15  # hpf; chemistry blood calcium, total  9.1  mg dl; chemistry blood bilirubin, total  0.2  mg dl; chemistry blood glucose  213  mg dl; chemistry blood albumin  4.0  g dl; blood gas blood free calcium  1.15  mmol l; blood gas blood free calcium  1.31  mmol l; blood gas blood free calcium  1.28  mmol l; blood gas blood free calcium  1.23  mmol l; blood gas blood lactate  1.3  mmol l; blood gas blood lactate  3.0  mmol l; blood gas blood lactate  2.4  mmol l; blood gas blood chloride, whole blood  108  meq l; blood gas blood chloride, whole blood  109  meq l; blood gas blood glucose  137  mg dl; blood gas blood glucose  145  mg dl; blood gas blood glucose  148  mg dl; blood gas blood glucose  163  mg dl; blood gas blood glucose  192  mg dl; blood gas blood glucose  155  mg dl; blood gas blood glucose  145  mg dl; blood gas blood hematocrit, calculated  36  %; blood gas blood hematocrit, calculated  21  %; blood gas blood hematocrit, calculated  22  %; blood gas blood hematocrit, calculated  22  %; blood gas blood hematocrit, calculated  27  %; blood gas blood hemoglobin  12.1  g dl; blood gas blood hemoglobin  7.0  g dl; blood gas blood hemoglobin  7.3  g dl; blood gas blood hemoglobin  7.2  g dl; blood gas blood hemoglobin  8.9  g dl; blood gas blood potassium, whole blood  3.9  meq l; blood gas blood potassium, whole blood  4.9  meq l; blood gas blood potassium, whole blood  5.0  meq l; blood gas blood potassium, whole blood  5.4  meq l; blood gas blood potassium, whole blood  4.1  meq l; blood gas blood potassium, whole blood  3.9  meq l; blood gas blood sodium, whole blood  141  meq l; blood gas blood sodium, whole blood  138  meq l; blood gas blood sodium, whole blood  142  meq l; chemistry blood % hemoglobin a1c  7.1  %$insulin  38  unit ; influenza virus vaccine  0.5  ml ; pneumococcal 23-valent polysaccharide vaccine  0.5  ml ; sodium chloride 0.9%  flush  3  ml ; diltiazem extended-release  360  mg ; metoprolol succinate xl  100  mg ; isosorbide mononitrate (extended release)  120  mg ; hydrochlorothiazide  25  mg ; rosuvastatin calcium  20  mg ; aspirin ec  81  mg ; dextrose 50%  12.5  gm ; glucagon  1  mg ; glucose gel  15  g ; folic acid  1  mg ; ascorbic acid  500  mg ; vitamin d  400  unit ; hydralazine  25  mg ; mupirocin nasal ointment 2%  1  appl ; insulin  0  unit ; nitroglycerin sl  0.3  mg ; 5% dextrose  250  ml ; heparin sodium  25,000  unit ; diphenhydramine  25  mg ; ciprofloxacin hcl  500  mg ; milk of magnesia  30  ml ; aspirin  81  mg ; lactated ringers  1000  ml ; dextrose 5%  1  ml ; propofol  1000  mg ; syringe  20  ml ; nitroglycerin  8  mg ; phenylephrine  60  mg ; syringe  1  syr ; phenylephrine  12  mg ; glycopyrrolate  0.6  mg ; neostigmine  3  mg ; sterile water  50  ml ; potassium chloride  20  meq ; 0.9% sodium chloride  1  bag ; calcium gluconate  2  g ; bag  1  ml ; magnesium sulfate  2  gm ; morphine sulfate  0.5-5  mg ; metoclopramide  10  mg ; oxycodone-acetaminophen (5mg-325mg)  1-2  tab ; acetaminophen  650  mg ; 0.9% sodium chloride  100  ml ; insulin human regular  100  unit ; iso-osmotic dextrose  50  ml ; cefazolin  2  g ; 
 
unknown f 77 $nan$hematology blood hematocrit  32.6  %; hematology blood hematocrit  31.3  %; hematology blood hemoglobin  10.0  g dl; hematology blood platelet count  197  k ul; chemistry blood anion gap  12  meq l; chemistry blood bicarbonate  22  meq l; chemistry blood chloride  110  meq l; chemistry blood chloride  110  meq l; chemistry blood chloride  95  meq l; chemistry blood chloride  100  meq l; chemistry blood creatinine  0.9  mg dl; chemistry blood potassium  3.5  meq l; chemistry blood potassium  4.2  meq l; chemistry blood potassium  3.9  meq l; chemistry blood potassium  4.2  meq l; chemistry blood sodium  139  meq l; chemistry blood sodium  140  meq l; chemistry blood sodium  126  meq l; chemistry blood sodium  133  meq l; chemistry blood urea nitrogen  13  mg dl; hematology blood inr(pt)  1.1  ; chemistry blood glucose  87  mg dl; blood gas blood free calcium  1.28  mmol l; blood gas blood free calcium  1.13  mmol l; blood gas blood free calcium  1.05  mmol l; blood gas blood lactate  2.7  mmol l; blood gas blood lactate  2.9  mmol l; blood gas blood lactate  1.8  mmol l; blood gas blood glucose  123  mg dl; blood gas blood glucose  143  mg dl$milk of magnesia  30  ml ; aspirin  81  mg ; dextrose 5%  1  ml ; propofol  1000  mg ; syringe  20  ml ; nitroglycerin  8  mg ; phenylephrine  60  mg ; syringe  1  syr ; phenylephrine  12  mg ; glycopyrrolate  0.6  mg ; neostigmine  3  mg ; sterile water  50  ml ; potassium chloride  20  meq ; 0.9% sodium chloride  1  bag ; calcium gluconate  2  g ; bag  1  ml ; magnesium sulfate  2  gm ; morphine sulfate  0.5-5  mg ; metoclopramide  10  mg ; oxycodone-acetaminophen (5mg-325mg)  1-2  tab ; acetaminophen  650  mg ; 0.9% sodium chloride  100  ml ; insulin human regular  100  unit ; iso-osmotic dextrose  50  ml ; cefazolin  2  g ; amiodarone  150  mg ; 5% dextrose (excel bag)  500  ml ; amiodarone  600  mg ; acetaminophen iv  1000  mg ; metoprolol tartrate  5  mg ; ranitidine  150  mg ; docusate sodium  100  mg ; iso-osmotic dextrose  200  ml ; vancomycin  1000  mg ; chlorhexidine gluconate 0.12% oral rinse  15  ml ; ondansetron  4  mg ; sodium chloride 0.9%  flush  10  ml ; albumin 5% (25g   500ml)  25  g ; metoprolol tartrate  12.5  mg ; furosemide  20  mg ; insulin  40  unit ; tramadol (ultram)  50  mg ; metoprolol tartrate  25  mg ; insulin  20  unit ; 
 
unknown f 77 $nan$hematology blood hematocrit  26.3  %; hematology blood hemoglobin  8.5  g dl; hematology blood platelet count  141  k ul; chemistry blood anion gap  13  meq l; chemistry blood bicarbonate  27  meq l; chemistry blood chloride  101  meq l; chemistry blood creatinine  1.1  mg dl; chemistry blood potassium  3.9  meq l; chemistry blood sodium  137  meq l; chemistry blood urea nitrogen  16  mg dl; hematology blood inr(pt)  1.2  ; chemistry blood calcium, total  8.2  mg dl; chemistry blood bilirubin, total  0.1  mg dl; chemistry blood glucose  210  mg dl; chemistry blood lactate dehydrogenase (ld)  286  iu l; chemistry blood albumin  3.0  g dl; blood gas blood free calcium  1.02  mmol l; blood gas blood free calcium  1.66  mmol l; blood gas blood potassium, whole blood  4.1  meq l$milk of magnesia  30  ml ; dextrose 5%  1  ml ; syringe  20  ml ; nitroglycerin  8  mg ; phenylephrine  60  mg ; syringe  1  syr ; phenylephrine  12  mg ; sterile water  50  ml ; potassium chloride  20  meq ; 0.9% sodium chloride  1  bag ; calcium gluconate  2  g ; bag  1  ml ; magnesium sulfate  2  gm ; morphine sulfate  0.5-5  mg ; metoclopramide  10  mg ; acetaminophen  650  mg ; 0.9% sodium chloride  100  ml ; insulin human regular  100  unit ; iso-osmotic dextrose  50  ml ; cefazolin  2  g ; amiodarone  150  mg ; acetaminophen iv  1000  mg ; metoprolol tartrate  5  mg ; ranitidine  150  mg ; docusate sodium  100  mg ; iso-osmotic dextrose  200  ml ; vancomycin  1000  mg ; ondansetron  4  mg ; sodium chloride 0.9%  flush  10  ml ; albumin 5% (25g   500ml)  25  g ; furosemide  20  mg ; insulin  40  unit ; tramadol (ultram)  50  mg ; metoprolol tartrate  25  mg ; insulin  20  unit ; hydralazine  10  mg ; ibuprofen  400  mg ; cefazolin  1  g ; insulin  50  unit ; cephalexin  250  mg ; insulin  10  unit ; heparin  5000  unit ; furosemide  40  mg ; 
 
unknown f 77 $nan$hematology blood hematocrit  30.5  %; hematology blood hemoglobin  9.9  g dl; hematology blood platelet count  209  k ul; chemistry blood anion gap  14  meq l; chemistry blood bicarbonate  30  meq l; chemistry blood chloride  101  meq l; chemistry blood chloride  99  meq l; chemistry blood creatinine  1.0  mg dl; chemistry blood creatinine  1.0  mg dl; chemistry blood potassium  3.9  meq l; chemistry blood potassium  3.7  meq l; chemistry blood sodium  139  meq l; chemistry blood sodium  139  meq l; chemistry blood urea nitrogen  16  mg dl; chemistry blood urea nitrogen  18  mg dl; hematology urine wbc  12  # hpf; chemistry blood calcium, total  8.7  mg dl; chemistry blood bilirubin, total  0.3  mg dl; chemistry blood glucose  129  mg dl$milk of magnesia  30  ml ; dextrose 5%  1  ml ; syringe  20  ml ; nitroglycerin  8  mg ; phenylephrine  60  mg ; syringe  1  syr ; phenylephrine  12  mg ; sterile water  50  ml ; potassium chloride  20  meq ; 0.9% sodium chloride  1  bag ; calcium gluconate  2  g ; bag  1  ml ; magnesium sulfate  2  gm ; morphine sulfate  0.5-5  mg ; acetaminophen  650  mg ; 0.9% sodium chloride  100  ml ; insulin human regular  100  unit ; acetaminophen iv  1000  mg ; ranitidine  150  mg ; docusate sodium  100  mg ; iso-osmotic dextrose  200  ml ; vancomycin  1000  mg ; ondansetron  4  mg ; sodium chloride 0.9%  flush  10  ml ; insulin  40  unit ; tramadol (ultram)  50  mg ; metoprolol tartrate  25  mg ; hydralazine  10  mg ; ibuprofen  400  mg ; insulin  50  unit ; cephalexin  250  mg ; insulin  10  unit ; heparin  5000  unit ; furosemide  40  mg ; potassium chloride  40  meq ; sw  100  ml ; potassium chloride  10  meq ; bisacodyl  10  mg ; lactulose  45  ml ; senna  17.2  mg ; amiodarone  400  mg ; ondansetron  8  mg ; methylnaltrexone  12  mg ; metoprolol tartrate  50  mg ; soln  100  ml ; senna  8.6  mg ; 
 
unknown f 77 $nan$hematology blood hematocrit  29.0  %; hematology blood hemoglobin  9.0  g dl; hematology blood platelet count  282  k ul; chemistry blood anion gap  16  meq l; chemistry blood bicarbonate  31  meq l; chemistry blood chloride  101  meq l; chemistry blood creatinine  1.3  mg dl; chemistry blood potassium  4.2  meq l; chemistry blood sodium  144  meq l; chemistry blood urea nitrogen  28  mg dl; chemistry blood glucose  87  mg dl$metoprolol tartrate  50  mg ; soln  100  ml ; senna  8.6  mg ; metoprolol tartrate  75  mg ; 
 
unknown f 77 $nan$hematology blood hematocrit  29.0  %; hematology blood hemoglobin  9.2  g dl; hematology blood platelet count  269  k ul$soln  100  ml ; senna  8.6  mg ; metoprolol tartrate  75  mg ; insulin  25  unit ; sodium chloride nasal  1-2  spry ; 
 
unknown f 77 $nan$nan$soln  100  ml ; senna  8.6  mg ; metoprolol tartrate  75  mg ; sodium chloride nasal  1-2  spry ; 
 
white m 91 $temp  98.3  heartrate  88.0  resprate  16.0  o2sat  99.0  sbp  120.0  dbp  57.0  rhythm    pain  0  $nan$clopidogrel  75  mg ; digoxin  0.125  mg ; finasteride  5  mg ; isosorbide mononitrate (extended release)  120  mg ; polyethylene glycol  17  g ; simvastatin  10  mg ; tiotropium bromide  1  cap ; aspirin  81  mg ; cyanocobalamin  1000  mcg ; 
personal history of transient ischemic attack (tia), and cerebral infarction without residual deficits congestive heart failure, unspecified other and unspecified angina pectoris hypertrophy (benign) of prostate with urinary obstruction and other lower urinary tract symptoms (luts) anemia, unspecified chronic systolic heart failure polyneuropathy in diabetes gross hematuria diabetes with neurological manifestations, type ii or unspecified type, not stated as uncontrolled peripheral vascular disease, unspecified other calculus in bladder chronic kidney disease, unspecified coronary atherosclerosis of unspecified type of vessel, native or graft unspecified disorders of arteries and arterioles aortic valve disorders aortocoronary bypass status retention of urine, unspecified hypertrophy (benign) of prostate with urinary obstruction and other lower urinary tract symptoms (luts) aortocoronary bypass status other and unspecified angina pectoris acute posthemorrhagic anemia gross hematuria hyperpotassemia chronic airway obstruction, not elsewhere classified long-term (current) use of insulin polyneuropathy in diabetes chronic kidney disease, stage iii (moderate) other chronic pulmonary heart diseases constipation, unspecified diabetes with neurological manifestations, type ii or unspecified type, not stated as uncontrolled aortic valve disorders acute kidney failure, unspecified pure hypercholesterolemia personal history of transient ischemic attack (tia), and cerebral infarction without residual deficits anemia in chronic kidney disease hyposmolality and/or hyponatremia congestive heart failure, unspecified other calculus in bladder chronic systolic heart failure retention of urine, unspecified pure hypercholesterolemia retention of urine, unspecified hypertrophy (benign) of prostate with urinary obstruction and other lower urinary tract symptoms (luts) other and unspecified angina pectoris personal history of transient ischemic attack (tia), and cerebral infarction without residual deficits other complications due to genitourinary device, implant, and graft diabetes with neurological manifestations, type ii or unspecified type, not stated as uncontrolled gross hematuria
white m 91 $temp  97.6  heartrate  79.0  resprate  18.0  o2sat  96.0  sbp  124.0  dbp  75.0  rhythm    pain  0  $hematology blood hematocrit  24.0  %; hematology blood hemoglobin  8.2  g dl; hematology blood platelet count  154  k ul; chemistry blood anion gap  10  meq l; chemistry blood bicarbonate  30  meq l; chemistry blood chloride  100  meq l; chemistry blood chloride  100  meq l; chemistry blood creatinine  1.3  mg dl; chemistry blood potassium  4.0  meq l; chemistry blood potassium  4.4  meq l; chemistry blood sodium  136  meq l; chemistry blood sodium  137  meq l; chemistry blood urea nitrogen  29  mg dl; chemistry urine chloride, urine  102  meq l; chemistry urine creatinine, urine  30  mg dl; chemistry urine potassium, urine  26  meq l; chemistry urine sodium, urine  84  meq l; chemistry urine urea nitrogen, urine  255  mg dl; hematology urine wbc  4  # hpf; chemistry blood calcium, total  9.3  mg dl; chemistry blood glucose  97  mg dl$clopidogrel  75  mg ; digoxin  0.125  mg ; finasteride  5  mg ; isosorbide mononitrate (extended release)  120  mg ; polyethylene glycol  17  g ; simvastatin  10  mg ; tiotropium bromide  1  cap ; aspirin  81  mg ; cyanocobalamin  1000  mcg ; docusate sodium  100  mg ; buspirone  5  mg ; metoprolol tartrate  12.5  mg ; hydralazine  25  mg ; ranitidine  150  mg ; heparin  5000  unit ; gabapentin  300  mg ; tamsulosin  0.4  mg ; sodium chloride 0.9%  flush  3  ml ; furosemide  40  mg ; albuterol inhaler  1-2  puff ; nitroglycerin sl  0.3  mg ; senna  1  tab ; dextrose 50%  12.5  gm ; glucagon  1  mg ; insulin  0  unit ; furosemide  20  mg ; 
personal history of transient ischemic attack (tia), and cerebral infarction without residual deficits congestive heart failure, unspecified other and unspecified angina pectoris hypertrophy (benign) of prostate with urinary obstruction and other lower urinary tract symptoms (luts) anemia, unspecified chronic systolic heart failure polyneuropathy in diabetes gross hematuria diabetes with neurological manifestations, type ii or unspecified type, not stated as uncontrolled peripheral vascular disease, unspecified other calculus in bladder chronic kidney disease, unspecified coronary atherosclerosis of unspecified type of vessel, native or graft unspecified disorders of arteries and arterioles aortic valve disorders aortocoronary bypass status retention of urine, unspecified hypertrophy (benign) of prostate with urinary obstruction and other lower urinary tract symptoms (luts) aortocoronary bypass status other and unspecified angina pectoris acute posthemorrhagic anemia gross hematuria hyperpotassemia chronic airway obstruction, not elsewhere classified long-term (current) use of insulin polyneuropathy in diabetes chronic kidney disease, stage iii (moderate) other chronic pulmonary heart diseases constipation, unspecified diabetes with neurological manifestations, type ii or unspecified type, not stated as uncontrolled aortic valve disorders acute kidney failure, unspecified pure hypercholesterolemia personal history of transient ischemic attack (tia), and cerebral infarction without residual deficits anemia in chronic kidney disease hyposmolality and/or hyponatremia congestive heart failure, unspecified other calculus in bladder chronic systolic heart failure retention of urine, unspecified pure hypercholesterolemia retention of urine, unspecified hypertrophy (benign) of prostate with urinary obstruction and other lower urinary tract symptoms (luts) other and unspecified angina pectoris personal history of transient ischemic attack (tia), and cerebral infarction without residual deficits other complications due to genitourinary device, implant, and graft diabetes with neurological manifestations, type ii or unspecified type, not stated as uncontrolled gross hematuria
white m 91 $nan$hematology blood hematocrit  27.7  %; hematology blood hemoglobin  9.4  g dl; hematology blood platelet count  159  k ul; chemistry blood anion gap  12  meq l; chemistry blood bicarbonate  31  meq l; chemistry blood chloride  99  meq l; chemistry blood creatinine  1.4  mg dl; chemistry blood potassium  4.1  meq l; chemistry blood sodium  138  meq l; chemistry blood urea nitrogen  33  mg dl; chemistry blood calcium, total  9.2  mg dl; chemistry blood glucose  114  mg dl$digoxin  0.125  mg ; finasteride  5  mg ; isosorbide mononitrate (extended release)  120  mg ; polyethylene glycol  17  g ; simvastatin  10  mg ; tiotropium bromide  1  cap ; aspirin  81  mg ; cyanocobalamin  1000  mcg ; docusate sodium  100  mg ; buspirone  5  mg ; metoprolol tartrate  12.5  mg ; hydralazine  25  mg ; ranitidine  150  mg ; heparin  5000  unit ; gabapentin  300  mg ; tamsulosin  0.4  mg ; sodium chloride 0.9%  flush  3  ml ; furosemide  40  mg ; albuterol inhaler  1-2  puff ; nitroglycerin sl  0.3  mg ; senna  1  tab ; dextrose 50%  12.5  gm ; glucagon  1  mg ; insulin  0  unit ; furosemide  20  mg ; torsemide  20  mg ; 
personal history of transient ischemic attack (tia), and cerebral infarction without residual deficits congestive heart failure, unspecified other and unspecified angina pectoris hypertrophy (benign) of prostate with urinary obstruction and other lower urinary tract symptoms (luts) anemia, unspecified chronic systolic heart failure polyneuropathy in diabetes gross hematuria diabetes with neurological manifestations, type ii or unspecified type, not stated as uncontrolled peripheral vascular disease, unspecified other calculus in bladder chronic kidney disease, unspecified coronary atherosclerosis of unspecified type of vessel, native or graft unspecified disorders of arteries and arterioles aortic valve disorders aortocoronary bypass status retention of urine, unspecified hypertrophy (benign) of prostate with urinary obstruction and other lower urinary tract symptoms (luts) aortocoronary bypass status other and unspecified angina pectoris acute posthemorrhagic anemia gross hematuria hyperpotassemia chronic airway obstruction, not elsewhere classified long-term (current) use of insulin polyneuropathy in diabetes chronic kidney disease, stage iii (moderate) other chronic pulmonary heart diseases constipation, unspecified diabetes with neurological manifestations, type ii or unspecified type, not stated as uncontrolled aortic valve disorders acute kidney failure, unspecified pure hypercholesterolemia personal history of transient ischemic attack (tia), and cerebral infarction without residual deficits anemia in chronic kidney disease hyposmolality and/or hyponatremia congestive heart failure, unspecified other calculus in bladder chronic systolic heart failure retention of urine, unspecified pure hypercholesterolemia retention of urine, unspecified hypertrophy (benign) of prostate with urinary obstruction and other lower urinary tract symptoms (luts) other and unspecified angina pectoris personal history of transient ischemic attack (tia), and cerebral infarction without residual deficits other complications due to genitourinary device, implant, and graft diabetes with neurological manifestations, type ii or unspecified type, not stated as uncontrolled gross hematuria
white m 91 $nan$nan$digoxin  0.125  mg ; finasteride  5  mg ; isosorbide mononitrate (extended release)  120  mg ; polyethylene glycol  17  g ; simvastatin  10  mg ; tiotropium bromide  1  cap ; aspirin  81  mg ; cyanocobalamin  1000  mcg ; docusate sodium  100  mg ; buspirone  5  mg ; metoprolol tartrate  12.5  mg ; hydralazine  25  mg ; ranitidine  150  mg ; heparin  5000  unit ; gabapentin  300  mg ; tamsulosin  0.4  mg ; sodium chloride 0.9%  flush  3  ml ; albuterol inhaler  1-2  puff ; nitroglycerin sl  0.3  mg ; senna  1  tab ; dextrose 50%  12.5  gm ; glucagon  1  mg ; insulin  0  unit ; torsemide  20  mg ; 
personal history of transient ischemic attack (tia), and cerebral infarction without residual deficits congestive heart failure, unspecified other and unspecified angina pectoris hypertrophy (benign) of prostate with urinary obstruction and other lower urinary tract symptoms (luts) anemia, unspecified chronic systolic heart failure polyneuropathy in diabetes gross hematuria diabetes with neurological manifestations, type ii or unspecified type, not stated as uncontrolled peripheral vascular disease, unspecified other calculus in bladder chronic kidney disease, unspecified coronary atherosclerosis of unspecified type of vessel, native or graft unspecified disorders of arteries and arterioles aortic valve disorders aortocoronary bypass status retention of urine, unspecified hypertrophy (benign) of prostate with urinary obstruction and other lower urinary tract symptoms (luts) aortocoronary bypass status other and unspecified angina pectoris acute posthemorrhagic anemia gross hematuria hyperpotassemia chronic airway obstruction, not elsewhere classified long-term (current) use of insulin polyneuropathy in diabetes chronic kidney disease, stage iii (moderate) other chronic pulmonary heart diseases constipation, unspecified diabetes with neurological manifestations, type ii or unspecified type, not stated as uncontrolled aortic valve disorders acute kidney failure, unspecified pure hypercholesterolemia personal history of transient ischemic attack (tia), and cerebral infarction without residual deficits anemia in chronic kidney disease hyposmolality and/or hyponatremia congestive heart failure, unspecified other calculus in bladder chronic systolic heart failure retention of urine, unspecified pure hypercholesterolemia retention of urine, unspecified hypertrophy (benign) of prostate with urinary obstruction and other lower urinary tract symptoms (luts) other and unspecified angina pectoris personal history of transient ischemic attack (tia), and cerebral infarction without residual deficits other complications due to genitourinary device, implant, and graft diabetes with neurological manifestations, type ii or unspecified type, not stated as uncontrolled gross hematuria
other f 42 $temp  97.5  heartrate  56.0  resprate  16.0  o2sat  98.0  sbp  123.0  dbp  60.0  rhythm    pain  "a lot"  ; temp  98.1  heartrate  68.0  resprate  18.0  o2sat  99.0  sbp  125.0  dbp  67.0  rhythm    pain  unable to assess- patient points to chest and does say "hurts"  ; temp  98.2  heartrate  70.0  resprate  12.0  o2sat  97.0  sbp  124.0  dbp  68.0  rhythm    pain  "a little"  ; temp    heartrate  72.0  resprate  14.0  o2sat  98.0  sbp  118.0  dbp  69.0  rhythm    pain  a lot  ; temp  98.2  heartrate  62.0  resprate  16.0  o2sat  96.0  sbp  105.0  dbp  58.0  rhythm    pain    $hematology blood hematocrit  38.6  %; hematology blood hemoglobin  12.7  g dl; hematology blood platelet count  218  k ul; chemistry blood anion gap  11  meq l; chemistry blood bicarbonate  35  meq l; chemistry blood chloride  101  meq l; chemistry blood creatinine  1.0  mg dl; chemistry blood potassium  4.1  meq l; chemistry blood sodium  143  meq l; chemistry blood urea nitrogen  23  mg dl; hematology blood inr(pt)  1.0  ; chemistry blood glucose  95  mg dl; hematology blood bands  0  %$nan
osteoporosis, unspecified chest pain, unspecified
other f 42 $temp  98.2  heartrate  74.0  resprate  16.0  o2sat  98.0  sbp  115.0  dbp  64.0  rhythm  normal sinus rhythm  pain    $hematology blood hematocrit  35.5  %; hematology blood hemoglobin  11.5  g dl; hematology blood platelet count  222  k ul; chemistry blood anion gap  10  meq l; chemistry blood bicarbonate  32  meq l; chemistry blood chloride  107  meq l; chemistry blood creatinine  1.0  mg dl; chemistry blood potassium  4.4  meq l; chemistry blood sodium  145  meq l; chemistry blood urea nitrogen  22  mg dl; chemistry blood glucose  95  mg dl$sodium chloride 0.9%  flush  3  ml ; senna  1  tab ; acetaminophen  1000  mg ; lidocaine viscous 2%  20  ml ; aluminum-magnesium hydrox.-simethicone  15-30  ml ; pantoprazole  40  mg ; acetaminophen  650  mg ; 0.9% sodium chloride  1000  ml ; heparin  5000  unit ; docusate sodium  100  mg ; divalproex (delayed release)  250  mg ; lamotrigine  100  mg ; lamotrigine  25  mg ; psyllium wafer  1  waf ; risperidone  0.25  mg ; calcium carbonate  500  mg ; ibuprofen  800  mg ; citalopram  40  mg ; vitamin d  800  unit ; trazodone  150  mg ; 
osteoporosis, unspecified chest pain, unspecified
white f 82 $nan$hematology blood hematocrit  20.8  %; hematology blood hemoglobin  7.0  g dl; hematology blood platelet count  259  k ul; chemistry blood anion gap  12  meq l; chemistry blood bicarbonate  24  meq l; chemistry blood chloride  108  meq l; chemistry blood creatinine  1.0  mg dl; chemistry blood potassium  4.8  meq l; chemistry blood sodium  139  meq l; chemistry blood urea nitrogen  25  mg dl; chemistry blood calcium, total  8.5  mg dl; chemistry blood glucose  107  mg dl$ferrous sulfate  325  mg ; multivitamins  1  cap ; vitamin d  400  unit ; lisinopril  40  mg ; lisinopril  20  mg ; allopurinol  100  mg ; atenolol  25  mg ; aspirin  81  mg ; sodium chloride 0.9%  flush  3  ml ; lr  1000  ml ; oxycodone (immediate release)   5-10  mg ; acetaminophen  650  mg ; ondansetron  4  mg ; senna  1  tab ; aluminum-magnesium hydrox.-simethicone  15-30  ml ; trazodone  50  mg ; milk of magnesia  30  ml ; ns  100  ml ; cefazolin  2  gm ; morphine sulfate  50  mg ; docusate sodium  100  mg ; famotidine  20  mg ; calcium carbonate  500  mg ; naproxen  500  mg ; sw  50  ml ; magnesium sulfate  2  gm ; 
 
white f 82 $nan$hematology blood hematocrit  29.0  %; hematology blood hematocrit  25.3  %; hematology blood hemoglobin  9.3  g dl; hematology blood platelet count  243  k ul$ferrous sulfate  325  mg ; multivitamins  1  cap ; vitamin d  400  unit ; lisinopril  40  mg ; lisinopril  20  mg ; allopurinol  100  mg ; atenolol  25  mg ; aspirin  81  mg ; sodium chloride 0.9%  flush  3  ml ; lr  1000  ml ; oxycodone (immediate release)   5-10  mg ; acetaminophen  650  mg ; ondansetron  4  mg ; senna  1  tab ; aluminum-magnesium hydrox.-simethicone  15-30  ml ; trazodone  50  mg ; milk of magnesia  30  ml ; ns  100  ml ; cefazolin  2  gm ; morphine sulfate  50  mg ; docusate sodium  100  mg ; famotidine  20  mg ; calcium carbonate  500  mg ; naproxen  500  mg ; sw  50  ml ; magnesium sulfate  2  gm ; pneumococcal vac polyvalent  0.5  ml ; 
 
white f 82 $nan$hematology blood hematocrit  25.9  %; hematology blood hemoglobin  9.0  g dl; hematology blood platelet count  303  k ul$ferrous sulfate  325  mg ; multivitamins  1  cap ; vitamin d  400  unit ; lisinopril  40  mg ; lisinopril  20  mg ; allopurinol  100  mg ; atenolol  25  mg ; aspirin  81  mg ; sodium chloride 0.9%  flush  3  ml ; lr  1000  ml ; oxycodone (immediate release)   5-10  mg ; acetaminophen  650  mg ; ondansetron  4  mg ; senna  1  tab ; aluminum-magnesium hydrox.-simethicone  15-30  ml ; trazodone  50  mg ; milk of magnesia  30  ml ; morphine sulfate  50  mg ; docusate sodium  100  mg ; famotidine  20  mg ; calcium carbonate  500  mg ; naproxen  500  mg ; pneumococcal vac polyvalent  0.5  ml ; enoxaparin sodium  30  mg ; furosemide  20  mg ; hydralazine  10  mg ; furosemide  10  mg ; 
 
white f 82 $nan$nan$ferrous sulfate  325  mg ; multivitamins  1  cap ; vitamin d  400  unit ; lisinopril  40  mg ; lisinopril  20  mg ; allopurinol  100  mg ; atenolol  25  mg ; aspirin  81  mg ; sodium chloride 0.9%  flush  3  ml ; lr  1000  ml ; oxycodone (immediate release)   5-10  mg ; acetaminophen  650  mg ; ondansetron  4  mg ; senna  1  tab ; aluminum-magnesium hydrox.-simethicone  15-30  ml ; trazodone  50  mg ; milk of magnesia  30  ml ; morphine sulfate  50  mg ; docusate sodium  100  mg ; famotidine  20  mg ; calcium carbonate  500  mg ; enoxaparin sodium  30  mg ; furosemide  20  mg ; hydralazine  10  mg ; furosemide  10  mg ; levofloxacin  250  mg ; metronidazole (flagyl)  500  mg ; 
 
white f 82 $nan$hematology blood hematocrit  28.9  %; hematology blood hemoglobin  10.2  g dl; hematology blood platelet count  404  k ul; chemistry blood anion gap  15  meq l; chemistry blood anion gap  11  meq l; chemistry blood bicarbonate  22  meq l; chemistry blood bicarbonate  24  meq l; chemistry blood chloride  105  meq l; chemistry blood chloride  106  meq l; chemistry blood creatinine  1.2  mg dl; chemistry blood creatinine  1.2  mg dl; chemistry blood potassium  4.5  meq l; chemistry blood potassium  4.4  meq l; chemistry blood sodium  137  meq l; chemistry blood sodium  137  meq l; chemistry blood urea nitrogen  39  mg dl; chemistry blood urea nitrogen  43  mg dl; chemistry blood calcium, total  9.2  mg dl; chemistry blood calcium, total  9.5  mg dl; chemistry blood glucose  119  mg dl; chemistry blood glucose  108  mg dl$ferrous sulfate  325  mg ; multivitamins  1  cap ; vitamin d  400  unit ; lisinopril  40  mg ; lisinopril  20  mg ; allopurinol  100  mg ; atenolol  25  mg ; aspirin  81  mg ; sodium chloride 0.9%  flush  3  ml ; lr  1000  ml ; oxycodone (immediate release)   5-10  mg ; acetaminophen  650  mg ; ondansetron  4  mg ; senna  1  tab ; aluminum-magnesium hydrox.-simethicone  15-30  ml ; trazodone  50  mg ; milk of magnesia  30  ml ; morphine sulfate  50  mg ; docusate sodium  100  mg ; famotidine  20  mg ; calcium carbonate  500  mg ; enoxaparin sodium  30  mg ; levofloxacin  250  mg ; metronidazole (flagyl)  500  mg ; atenolol  50  mg ; albuterol 0.083% neb soln  1  neb ; bisacodyl  10  mg ; 
 
white f 82 $nan$nan$ferrous sulfate  325  mg ; multivitamins  1  cap ; vitamin d  400  unit ; lisinopril  40  mg ; lisinopril  20  mg ; allopurinol  100  mg ; aspirin  81  mg ; sodium chloride 0.9%  flush  3  ml ; lr  1000  ml ; oxycodone (immediate release)   5-10  mg ; acetaminophen  650  mg ; ondansetron  4  mg ; senna  1  tab ; aluminum-magnesium hydrox.-simethicone  15-30  ml ; trazodone  50  mg ; milk of magnesia  30  ml ; morphine sulfate  50  mg ; docusate sodium  100  mg ; famotidine  20  mg ; calcium carbonate  500  mg ; enoxaparin sodium  30  mg ; levofloxacin  250  mg ; metronidazole (flagyl)  500  mg ; atenolol  50  mg ; albuterol 0.083% neb soln  1  neb ; bisacodyl  10  mg ; 
 
white f 82 $nan$nan$ferrous sulfate  325  mg ; multivitamins  1  cap ; vitamin d  400  unit ; lisinopril  40  mg ; lisinopril  20  mg ; allopurinol  100  mg ; aspirin  81  mg ; sodium chloride 0.9%  flush  3  ml ; lr  1000  ml ; oxycodone (immediate release)   5-10  mg ; acetaminophen  650  mg ; ondansetron  4  mg ; senna  1  tab ; aluminum-magnesium hydrox.-simethicone  15-30  ml ; trazodone  50  mg ; milk of magnesia  30  ml ; morphine sulfate  50  mg ; docusate sodium  100  mg ; famotidine  20  mg ; calcium carbonate  500  mg ; enoxaparin sodium  30  mg ; levofloxacin  250  mg ; metronidazole (flagyl)  500  mg ; atenolol  50  mg ; albuterol 0.083% neb soln  1  neb ; bisacodyl  10  mg ; 
 
white f 82 $nan$nan$ferrous sulfate  325  mg ; multivitamins  1  cap ; vitamin d  400  unit ; lisinopril  40  mg ; lisinopril  20  mg ; allopurinol  100  mg ; aspirin  81  mg ; sodium chloride 0.9%  flush  3  ml ; lr  1000  ml ; oxycodone (immediate release)   5-10  mg ; acetaminophen  650  mg ; ondansetron  4  mg ; senna  1  tab ; aluminum-magnesium hydrox.-simethicone  15-30  ml ; trazodone  50  mg ; milk of magnesia  30  ml ; morphine sulfate  50  mg ; docusate sodium  100  mg ; famotidine  20  mg ; calcium carbonate  500  mg ; enoxaparin sodium  30  mg ; levofloxacin  250  mg ; metronidazole (flagyl)  500  mg ; atenolol  50  mg ; albuterol 0.083% neb soln  1  neb ; bisacodyl  10  mg ; 
 
white f 23 $temp  97.8  heartrate  56.0  resprate  16.0  o2sat  98.0  sbp  113.0  dbp  74.0  rhythm    pain    $hematology blood hematocrit  38.2  %; hematology blood hemoglobin  12.0  g dl; hematology blood platelet count  225  k ul; chemistry blood anion gap  17  meq l; chemistry blood bicarbonate  23  meq l; chemistry blood chloride  104  meq l; chemistry blood creatinine  0.6  mg dl; chemistry blood potassium  4.5  meq l; chemistry blood sodium  144  meq l; chemistry blood urea nitrogen  8  mg dl; hematology blood inr(pt)  1.1  ; chemistry blood calcium, total  8.9  mg dl; chemistry blood bilirubin, total  3.4  mg dl; chemistry blood glucose  59  mg dl; chemistry blood lactate dehydrogenase (ld)  186  iu l$heparin  5000  unit ; acetaminophen  325-650  mg ; ondansetron  4  mg ; lactated ringers  1000  ml ; risperidone  0.25  mg ; risperidone  0.5  mg ; sertraline  75  mg ; 
 
white f 23 $nan$hematology blood hematocrit  39.2  %; hematology blood hemoglobin  12.6  g dl; hematology blood platelet count  254  k ul; chemistry blood anion gap  14  meq l; chemistry blood bicarbonate  27  meq l; chemistry blood chloride  99  meq l; chemistry blood creatinine  0.6  mg dl; chemistry blood potassium  4.3  meq l; chemistry blood sodium  140  meq l; chemistry blood urea nitrogen  8  mg dl; chemistry blood bilirubin, total  2.7  mg dl; chemistry blood glucose  76  mg dl$heparin  5000  unit ; acetaminophen  325-650  mg ; ondansetron  4  mg ; risperidone  0.25  mg ; risperidone  0.5  mg ; sertraline  75  mg ; 
 
white f 23 $nan$hematology blood hematocrit  36.7  %; hematology blood hemoglobin  11.7  g dl; hematology blood platelet count  225  k ul; chemistry blood anion gap  16  meq l; chemistry blood bicarbonate  25  meq l; chemistry blood chloride  100  meq l; chemistry blood creatinine  0.6  mg dl; chemistry blood potassium  4.4  meq l; chemistry blood sodium  141  meq l; chemistry blood urea nitrogen  9  mg dl; hematology blood inr(pt)  1.1  ; chemistry blood bilirubin, total  1.0  mg dl; chemistry blood glucose  59  mg dl$heparin  5000  unit ; acetaminophen  325-650  mg ; ondansetron  4  mg ; risperidone  0.25  mg ; risperidone  0.5  mg ; sertraline  75  mg ; 
 
white f 23 $nan$nan$heparin  5000  unit ; ondansetron  4  mg ; risperidone  0.25  mg ; risperidone  0.5  mg ; sertraline  75  mg ; sodium chloride 0.9%  flush  3-10  ml ; tramadol  50  mg ; acetaminophen  1000  mg ; ibuprofen  400  mg ; senna  8.6  mg ; docusate sodium  100  mg ; 
 
unknown f 22 $nan$hematology blood hematocrit  29.5  %; hematology blood hematocrit  27.4  %; hematology blood hemoglobin  10.0  g dl; hematology blood hemoglobin  9.3  g dl; hematology blood platelet count  321  k ul; hematology blood platelet count  373  k ul; chemistry blood anion gap  13  meq l; chemistry blood anion gap  15  meq l; chemistry blood bicarbonate  25  meq l; chemistry blood bicarbonate  25  meq l; chemistry blood chloride  105  meq l; chemistry blood chloride  105  meq l; chemistry blood creatinine  0.6  mg dl; chemistry blood creatinine  0.7  mg dl; chemistry blood potassium  4.9  meq l; chemistry blood potassium  4.3  meq l; chemistry blood sodium  138  meq l; chemistry blood sodium  141  meq l; chemistry blood urea nitrogen  17  mg dl; chemistry blood urea nitrogen  18  mg dl; chemistry blood calcium, total  9.0  mg dl; chemistry blood calcium, total  8.9  mg dl; chemistry blood glucose  114  mg dl; chemistry blood glucose  140  mg dl; blood gas blood free calcium  1.13  mmol l; blood gas blood lactate  1.2  mmol l; blood gas blood chloride, whole blood  109  meq l; blood gas blood glucose  94  mg dl; blood gas blood hematocrit, calculated  29  %; blood gas blood hemoglobin  9.5  g dl; blood gas blood potassium, whole blood  4.3  meq l; blood gas blood sodium, whole blood  143  meq l; hematology urine glucose  neg  mg dl; hematology urine bilirubin  neg  mg dl$omeprazole  20  mg ; influenza virus vaccine  0.5  ml ; sodium chloride 0.9%  flush  3  ml ; 0.9% sodium chloride  1000  ml ; artificial tear ointment  1  appl ; ipratropium bromide neb  1  neb ; acetaminophen  325-650  mg ; oxycodone liquid  5-10  mg ; ondansetron  4  mg ; 0.9% sodium chloride  100  ml ; cefazolin  2  g ; potassium chloride (powder)  40  meq ; potassium chloride (powder)  60  meq ; potassium chloride (powder)  80  meq ; bag  100  ml ; magnesium sulfate  4  gm ; bag  50  ml ; magnesium sulfate  2-4  gm ; magnesium sulfate  2  gm ; 0.9% sodium chloride  1  bag ; calcium gluconate  2  g ; calcium gluconate  2-4  g ; 0.9% sodium chloride  2  bag ; calcium gluconate  4  g ; dextrose 50%  12.5  gm ; glucagon  1  mg ; insulin  0  unit ; docusate sodium (liquid)  50  mg ; levetiracetam  1000  mg ; propranolol  20  mg ; amantadine syrup  200  mg ; chlorhexidine gluconate 0.12% oral rinse  15  ml ; folic acid  1  mg ; 0.9% sodium chloride  500  ml ; 
motor vehicle traffic accident involving collision with other vehicle injuring driver of motor vehicle other than motorcycle cerebrospinal fluid otorrhea post traumatic seizures open wound of ear drum, without mention of complication closed fractures involving skull or face with other bones with subarachnoid, subdural, and extradural hemorrhage, with prolonged [more than 24 hours] loss of consciousness, without return to pre-existing conscious level acute respiratory failure obstructive hydrocephalus open wound of external ear, unspecified site, without mention of complication compression of brain pneumonia due to other gram-negative bacteria mechanical complication of gastrostomy precipitous drop in hematocrit acute venous embolism and thrombosis of superficial veins of upper extremity open wound of forehead, without mention of complication closed fracture of mandible, body, other and unspecified closed fracture of other facial bones cerebral edema 
unknown f 22 $nan$hematology blood hematocrit  26.6  %; hematology blood hemoglobin  9.0  g dl; hematology blood platelet count  276  k ul; chemistry blood anion gap  15  meq l; chemistry blood bicarbonate  27  meq l; chemistry blood chloride  102  meq l; chemistry blood creatinine  0.4  mg dl; chemistry blood potassium  4.0  meq l; chemistry blood sodium  140  meq l; chemistry blood urea nitrogen  11  mg dl; hematology blood inr(pt)  1.0  ; chemistry blood calcium, total  8.7  mg dl; chemistry blood glucose  96  mg dl$omeprazole  20  mg ; influenza virus vaccine  0.5  ml ; sodium chloride 0.9%  flush  3  ml ; artificial tear ointment  1  appl ; ipratropium bromide neb  1  neb ; acetaminophen  325-650  mg ; oxycodone liquid  5-10  mg ; ondansetron  4  mg ; 0.9% sodium chloride  100  ml ; cefazolin  2  g ; potassium chloride (powder)  40  meq ; potassium chloride (powder)  60  meq ; potassium chloride (powder)  80  meq ; bag  100  ml ; magnesium sulfate  4  gm ; bag  50  ml ; magnesium sulfate  2-4  gm ; magnesium sulfate  2  gm ; 0.9% sodium chloride  1  bag ; calcium gluconate  2  g ; calcium gluconate  2-4  g ; 0.9% sodium chloride  2  bag ; calcium gluconate  4  g ; dextrose 50%  12.5  gm ; glucagon  1  mg ; insulin  0  unit ; docusate sodium (liquid)  50  mg ; levetiracetam  1000  mg ; propranolol  20  mg ; amantadine syrup  200  mg ; chlorhexidine gluconate 0.12% oral rinse  15  ml ; folic acid  1  mg ; acetaminophen (liquid)  650  mg ; bisacodyl  10  mg ; baclofen  5  mg ; iso-osmotic sodium chloride  50  ml ; famotidine  20  mg ; senna  1  tab ; 
motor vehicle traffic accident involving collision with other vehicle injuring driver of motor vehicle other than motorcycle cerebrospinal fluid otorrhea post traumatic seizures open wound of ear drum, without mention of complication closed fractures involving skull or face with other bones with subarachnoid, subdural, and extradural hemorrhage, with prolonged [more than 24 hours] loss of consciousness, without return to pre-existing conscious level acute respiratory failure obstructive hydrocephalus open wound of external ear, unspecified site, without mention of complication compression of brain pneumonia due to other gram-negative bacteria mechanical complication of gastrostomy precipitous drop in hematocrit acute venous embolism and thrombosis of superficial veins of upper extremity open wound of forehead, without mention of complication closed fracture of mandible, body, other and unspecified closed fracture of other facial bones cerebral edema 
unknown f 22 $nan$nan$influenza virus vaccine  0.5  ml ; sodium chloride 0.9%  flush  3  ml ; artificial tear ointment  1  appl ; ipratropium bromide neb  1  neb ; oxycodone liquid  5-10  mg ; ondansetron  4  mg ; 0.9% sodium chloride  100  ml ; cefazolin  2  g ; docusate sodium (liquid)  50  mg ; levetiracetam  1000  mg ; propranolol  20  mg ; amantadine syrup  200  mg ; chlorhexidine gluconate 0.12% oral rinse  15  ml ; folic acid  1  mg ; acetaminophen (liquid)  650  mg ; bisacodyl  10  mg ; iso-osmotic sodium chloride  50  ml ; famotidine  20  mg ; senna  1  tab ; 
motor vehicle traffic accident involving collision with other vehicle injuring driver of motor vehicle other than motorcycle cerebrospinal fluid otorrhea post traumatic seizures open wound of ear drum, without mention of complication closed fractures involving skull or face with other bones with subarachnoid, subdural, and extradural hemorrhage, with prolonged [more than 24 hours] loss of consciousness, without return to pre-existing conscious level acute respiratory failure obstructive hydrocephalus open wound of external ear, unspecified site, without mention of complication compression of brain pneumonia due to other gram-negative bacteria mechanical complication of gastrostomy precipitous drop in hematocrit acute venous embolism and thrombosis of superficial veins of upper extremity open wound of forehead, without mention of complication closed fracture of mandible, body, other and unspecified closed fracture of other facial bones cerebral edema 
unknown f 22 $nan$nan$influenza virus vaccine  0.5  ml ; sodium chloride 0.9%  flush  3  ml ; artificial tear ointment  1  appl ; ipratropium bromide neb  1  neb ; oxycodone liquid  5-10  mg ; ondansetron  4  mg ; 0.9% sodium chloride  100  ml ; cefazolin  2  g ; docusate sodium (liquid)  50  mg ; levetiracetam  1000  mg ; propranolol  20  mg ; amantadine syrup  200  mg ; chlorhexidine gluconate 0.12% oral rinse  15  ml ; folic acid  1  mg ; acetaminophen (liquid)  650  mg ; bisacodyl  10  mg ; iso-osmotic sodium chloride  50  ml ; famotidine  20  mg ; senna  1  tab ; 
motor vehicle traffic accident involving collision with other vehicle injuring driver of motor vehicle other than motorcycle cerebrospinal fluid otorrhea post traumatic seizures open wound of ear drum, without mention of complication closed fractures involving skull or face with other bones with subarachnoid, subdural, and extradural hemorrhage, with prolonged [more than 24 hours] loss of consciousness, without return to pre-existing conscious level acute respiratory failure obstructive hydrocephalus open wound of external ear, unspecified site, without mention of complication compression of brain pneumonia due to other gram-negative bacteria mechanical complication of gastrostomy precipitous drop in hematocrit acute venous embolism and thrombosis of superficial veins of upper extremity open wound of forehead, without mention of complication closed fracture of mandible, body, other and unspecified closed fracture of other facial bones cerebral edema 
unknown f 22 $nan$nan$influenza virus vaccine  0.5  ml ; sodium chloride 0.9%  flush  3  ml ; artificial tear ointment  1  appl ; ipratropium bromide neb  1  neb ; oxycodone liquid  5-10  mg ; ondansetron  4  mg ; 0.9% sodium chloride  100  ml ; cefazolin  2  g ; docusate sodium (liquid)  50  mg ; levetiracetam  1000  mg ; propranolol  20  mg ; amantadine syrup  200  mg ; chlorhexidine gluconate 0.12% oral rinse  15  ml ; folic acid  1  mg ; acetaminophen (liquid)  650  mg ; bisacodyl  10  mg ; iso-osmotic sodium chloride  50  ml ; famotidine  20  mg ; senna  1  tab ; levetiracetam  1500  mg ; 
motor vehicle traffic accident involving collision with other vehicle injuring driver of motor vehicle other than motorcycle cerebrospinal fluid otorrhea post traumatic seizures open wound of ear drum, without mention of complication closed fractures involving skull or face with other bones with subarachnoid, subdural, and extradural hemorrhage, with prolonged [more than 24 hours] loss of consciousness, without return to pre-existing conscious level acute respiratory failure obstructive hydrocephalus open wound of external ear, unspecified site, without mention of complication compression of brain pneumonia due to other gram-negative bacteria mechanical complication of gastrostomy precipitous drop in hematocrit acute venous embolism and thrombosis of superficial veins of upper extremity open wound of forehead, without mention of complication closed fracture of mandible, body, other and unspecified closed fracture of other facial bones cerebral edema 
white m 32 $temp  98.3  heartrate  90.0  resprate  14.0  o2sat  98.0  sbp  129.0  dbp  78.0  rhythm  normal sinus rhythm  pain  3  $nan$influenza virus vaccine  0.5  ml ; sodium chloride 0.9%  flush  3  ml ; 0.9% sodium chloride  1000  ml ; acetaminophen  325-650  mg ; acetaminophen-caff-butalbital  1-2  tab ; ondansetron  4  mg ; oxycodone (immediate release)   5  mg ; morphine sulfate  2-4  mg ; docusate sodium  100  mg ; senna  1  tab ; tetanus immune globulin  0.5  ml ; phenytoin infatab  100  mg ; 
 
white m 32 $nan$nan$influenza virus vaccine  0.5  ml ; sodium chloride 0.9%  flush  3  ml ; 0.9% sodium chloride  1000  ml ; acetaminophen  325-650  mg ; acetaminophen-caff-butalbital  1-2  tab ; ondansetron  4  mg ; oxycodone (immediate release)   5  mg ; morphine sulfate  2-4  mg ; docusate sodium  100  mg ; senna  1  tab ; tetanus immune globulin  0.5  ml ; phenytoin infatab  100  mg ; 
 
white m 60 $nan$nan$aspirin ec  325  mg ; clopidogrel  75  mg ; fluoxetine  40  mg ; folic acid  1  mg ; ezetimibe  10  mg ; hydrochlorothiazide  12.5  mg ; omeprazole  20  mg ; rosuvastatin calcium  40  mg ; 
 
white m 60 $nan$hematology blood hematocrit  35.8  %; hematology blood platelet count  202  k ul; hematology blood platelet count  203  k ul; hematology blood platelet count  188  k ul; chemistry blood chloride  97  meq l; chemistry blood chloride  101  meq l; chemistry blood creatinine  1.2  mg dl; chemistry blood potassium  3.9  meq l; chemistry blood potassium  4.7  meq l; chemistry blood sodium  137  meq l; chemistry blood sodium  137  meq l; chemistry blood urea nitrogen  30  mg dl$aspirin ec  325  mg ; clopidogrel  75  mg ; fluoxetine  40  mg ; folic acid  1  mg ; ezetimibe  10  mg ; hydrochlorothiazide  12.5  mg ; omeprazole  20  mg ; rosuvastatin calcium  40  mg ; atropine sulfate  0.5  mg ; sw  100  ml ; eptifibatide  75  mg ; oxycodone-acetaminophen  1-2  tab ; acetaminophen  650  mg ; aluminum-magnesium hydrox.-simethicone  30  ml ; simethicone  40-80  mg ; potassium chloride  20  meq ; potassium chloride  40  meq ; potassium chloride  60  meq ; zolpidem tartrate  5-10  mg ; sodium chloride 0.9%  flush  3  ml ; albuterol inhaler  2  puff ; tramadol (ultram)  50  mg ; docusate sodium  100  mg ; fexofenadine  60  mg ; isosorbide dinitrate  10  mg ; metoprolol tartrate  25  mg ; 
 
white m 60 $nan$nan$aspirin ec  325  mg ; clopidogrel  75  mg ; fluoxetine  40  mg ; folic acid  1  mg ; ezetimibe  10  mg ; hydrochlorothiazide  12.5  mg ; omeprazole  20  mg ; rosuvastatin calcium  40  mg ; atropine sulfate  0.5  mg ; oxycodone-acetaminophen  1-2  tab ; acetaminophen  650  mg ; aluminum-magnesium hydrox.-simethicone  30  ml ; simethicone  40-80  mg ; potassium chloride  20  meq ; potassium chloride  40  meq ; potassium chloride  60  meq ; zolpidem tartrate  5-10  mg ; sodium chloride 0.9%  flush  3  ml ; albuterol inhaler  2  puff ; tramadol (ultram)  50  mg ; docusate sodium  100  mg ; fexofenadine  60  mg ; isosorbide dinitrate  10  mg ; metoprolol tartrate  25  mg ; 
 
white f 34 $nan$chemistry blood anion gap  15  meq l; chemistry blood bicarbonate  21  meq l; chemistry blood chloride  106  meq l; chemistry blood creatinine  0.7  mg dl; chemistry blood potassium  3.5  meq l; chemistry blood sodium  138  meq l; chemistry blood urea nitrogen  16  mg dl; chemistry blood calcium, total  8.5  mg dl; chemistry blood glucose  151  mg dl$sodium chloride 0.9%  flush  3  ml ; acetaminophen  325-650  mg ; ibuprofen  400-600  mg ; 0.9% sodium chloride  500  ml ; phenytoin sodium  1350  mg ; clindamycin  300  mg ; nicotine polacrilex  2  mg ; milk of magnesia  30  ml ; lorazepam  4  mg ; phenytoin  200  mg ; phenobarbital  60  mg ; docusate sodium  100  mg ; topiramate (topamax)  50  mg ; propranolol  10  mg ; quetiapine fumarate  200  mg ; 0.9% sodium chloride  1000  ml ; fondaparinux sodium  2.5  mg ; fondaparinux sodium  5  mg ; omeprazole  20  mg ; lorazepam  1  mg ; phenytoin  300  mg ; phenobarbital  90  mg ; lamotrigine  100  mg ; lamotrigine  50  mg ; quetiapine fumarate  400  mg ; trazodone  25  mg ; 
 
white f 34 $nan$hematology blood hematocrit  41.2  %; hematology blood hemoglobin  14.1  g dl; hematology blood platelet count  231  k ul; chemistry blood anion gap  16  meq l; chemistry blood bicarbonate  21  meq l; chemistry blood chloride  107  meq l; chemistry blood creatinine  0.7  mg dl; chemistry blood potassium  3.8  meq l; chemistry blood sodium  140  meq l; chemistry blood urea nitrogen  25  mg dl; chemistry blood glucose  84  mg dl$sodium chloride 0.9%  flush  3  ml ; acetaminophen  325-650  mg ; ibuprofen  400-600  mg ; 0.9% sodium chloride  500  ml ; phenytoin sodium  1350  mg ; clindamycin  300  mg ; nicotine polacrilex  2  mg ; milk of magnesia  30  ml ; lorazepam  4  mg ; phenytoin  200  mg ; phenobarbital  60  mg ; docusate sodium  100  mg ; topiramate (topamax)  50  mg ; propranolol  10  mg ; quetiapine fumarate  200  mg ; fondaparinux sodium  2.5  mg ; fondaparinux sodium  5  mg ; omeprazole  20  mg ; lorazepam  1  mg ; phenytoin  300  mg ; phenobarbital  90  mg ; lamotrigine  100  mg ; lamotrigine  50  mg ; quetiapine fumarate  400  mg ; trazodone  25  mg ; phenytoin  400  mg ; lorazepam  2-4  mg ; 
 
white f 34 $nan$nan$sodium chloride 0.9%  flush  3  ml ; acetaminophen  325-650  mg ; ibuprofen  400-600  mg ; clindamycin  300  mg ; nicotine polacrilex  2  mg ; milk of magnesia  30  ml ; phenobarbital  60  mg ; docusate sodium  100  mg ; topiramate (topamax)  50  mg ; propranolol  10  mg ; quetiapine fumarate  200  mg ; fondaparinux sodium  2.5  mg ; fondaparinux sodium  5  mg ; omeprazole  20  mg ; phenobarbital  90  mg ; lamotrigine  100  mg ; lamotrigine  50  mg ; quetiapine fumarate  400  mg ; trazodone  25  mg ; phenytoin  400  mg ; lorazepam  2-4  mg ; lorazepam  2  mg ; olanzapine (disintegrating tablet)  5  mg ; olanzapine (disintegrating tablet)  2.5  mg ; trazodone  100  mg ; 
 
white f 34 $nan$nan$sodium chloride 0.9%  flush  3  ml ; acetaminophen  325-650  mg ; ibuprofen  400-600  mg ; clindamycin  300  mg ; nicotine polacrilex  2  mg ; milk of magnesia  30  ml ; phenobarbital  60  mg ; docusate sodium  100  mg ; topiramate (topamax)  50  mg ; propranolol  10  mg ; quetiapine fumarate  200  mg ; fondaparinux sodium  2.5  mg ; fondaparinux sodium  5  mg ; omeprazole  20  mg ; phenobarbital  90  mg ; lamotrigine  100  mg ; lamotrigine  50  mg ; quetiapine fumarate  400  mg ; phenytoin  400  mg ; lorazepam  2-4  mg ; lorazepam  2  mg ; olanzapine (disintegrating tablet)  5  mg ; olanzapine (disintegrating tablet)  2.5  mg ; trazodone  100  mg ; 
 
white f 62 $nan$nan$lisinopril  40  mg ; spironolactone  25  mg ; duloxetine  60  mg ; influenza virus vaccine  0.5  ml ; sodium chloride 0.9%  flush  3  ml ; potassium chl 20 meq   1000 ml d5 1 2 ns  1000  ml ; acetaminophen  325-650  mg ; hydromorphone (dilaudid)  12.5  mg ; pantoprazole  40  mg ; insulin  0  unit ; hydroxyzine  25  mg ; 
 
white f 62 $nan$nan$lisinopril  40  mg ; spironolactone  25  mg ; duloxetine  60  mg ; influenza virus vaccine  0.5  ml ; sodium chloride 0.9%  flush  3  ml ; potassium chl 20 meq   1000 ml d5 1 2 ns  1000  ml ; acetaminophen  325-650  mg ; hydromorphone (dilaudid)  12.5  mg ; pantoprazole  40  mg ; insulin  0  unit ; hydroxyzine  25  mg ; dexamethasone  6  mg ; fexofenadine  60  mg ; iso-osmotic dextrose  200  ml ; vancomycin  1000  mg ; methylphenidate  20  mg ; zolpidem tartrate  10  mg ; 0.9% sodium chloride  1000  ml ; sodium chloride nasal  1-2  spry ; 0.9% sodium chloride  500  ml ; metoprolol tartrate  12.5  mg ; magnesium sulfate  2  gm ; oxycodone-acetaminophen elixir  5-10  ml ; fluconazole  200  mg ; 
 
white f 62 $nan$nan$lisinopril  40  mg ; spironolactone  25  mg ; duloxetine  60  mg ; influenza virus vaccine  0.5  ml ; sodium chloride 0.9%  flush  3  ml ; acetaminophen  325-650  mg ; pantoprazole  40  mg ; insulin  0  unit ; dexamethasone  6  mg ; fexofenadine  60  mg ; iso-osmotic dextrose  200  ml ; vancomycin  1000  mg ; methylphenidate  20  mg ; zolpidem tartrate  10  mg ; 0.9% sodium chloride  1000  ml ; sodium chloride nasal  1-2  spry ; 0.9% sodium chloride  500  ml ; metoprolol tartrate  12.5  mg ; magnesium sulfate  2  gm ; oxycodone-acetaminophen elixir  5-10  ml ; fluconazole  200  mg ; lorazepam  0.5  mg ; oxycodone (immediate release)   10  mg ; 
 
white f 62 $nan$nan$lisinopril  40  mg ; spironolactone  25  mg ; duloxetine  60  mg ; influenza virus vaccine  0.5  ml ; sodium chloride 0.9%  flush  3  ml ; acetaminophen  325-650  mg ; pantoprazole  40  mg ; insulin  0  unit ; fexofenadine  60  mg ; methylphenidate  20  mg ; zolpidem tartrate  10  mg ; 0.9% sodium chloride  1000  ml ; sodium chloride nasal  1-2  spry ; lorazepam  0.5  mg ; oxycodone (immediate release)   10  mg ; 
 
black african american f 47 $temp  102.1  heartrate  128.0  resprate  20.0  o2sat  99.0  sbp  148.0  dbp  93.0  rhythm    pain  10  ; temp  102.5  heartrate  113.0  resprate  20.0  o2sat  100.0  sbp  114.0  dbp  89.0  rhythm    pain    ; temp  98.9  heartrate  106.0  resprate  18.0  o2sat  100.0  sbp  119.0  dbp  67.0  rhythm    pain    $hematology blood hematocrit  38.6  %; hematology blood hemoglobin  12.0  g dl; hematology blood platelet count  191  k ul; chemistry blood anion gap  17  meq l; chemistry blood bicarbonate  21  meq l; chemistry blood chloride  99  meq l; chemistry blood creatinine  1.0  mg dl; chemistry blood potassium  4.3  meq l; chemistry blood sodium  137  meq l; chemistry blood urea nitrogen  8  mg dl; chemistry blood glucose  100  mg dl; blood gas blood lactate  0.9  mmol l$nan
 
black african american m 50 $temp  98.3  heartrate  84.0  resprate  16.0  o2sat  100.0  sbp  127.0  dbp  72.0  rhythm    pain  0  $hematology blood hematocrit  29.3  %; hematology blood hemoglobin  9.9  g dl; hematology blood platelet count  244  k ul; chemistry blood anion gap  15  meq l; chemistry blood bicarbonate  20  meq l; chemistry blood chloride  104  meq l; chemistry blood creatinine  1.3  mg dl; chemistry blood potassium  3.9  meq l; chemistry blood sodium  135  meq l; chemistry blood urea nitrogen  22  mg dl; chemistry blood calcium, total  8.2  mg dl; chemistry blood glucose  99  mg dl$influenza vaccine quadrivalent  0.5  ml ; sodium chloride 0.9%  flush  3  ml ; acetaminophen  650  mg ; iso-osmotic dextrose  200  ml ; vancomycin  1000  mg ; 0.9% sodium chloride (mini bag plus)  100  ml ; ampicillin-sulbactam  3  g ; heparin  5000  unit ; amlodipine  10  mg ; atorvastatin  80  mg ; clopidogrel  75  mg ; hydrochlorothiazide  12.5  mg ; lisinopril  40  mg ; metoprolol succinate xl  200  mg ; dextrose 50%  12.5  gm ; glucagon  1  mg ; glucose gel  15  g ; insulin  0  unit ; 
 
black african american m 50 $nan$hematology blood hematocrit  28.0  %; hematology blood hemoglobin  9.1  g dl; hematology blood platelet count  236  k ul; chemistry blood anion gap  13  meq l; chemistry blood bicarbonate  26  meq l; chemistry blood chloride  102  meq l; chemistry blood creatinine  1.4  mg dl; chemistry blood potassium  3.7  meq l; chemistry blood sodium  137  meq l; chemistry blood urea nitrogen  20  mg dl; chemistry blood calcium, total  8.3  mg dl; chemistry blood glucose  155  mg dl$influenza vaccine quadrivalent  0.5  ml ; sodium chloride 0.9%  flush  3  ml ; acetaminophen  650  mg ; iso-osmotic dextrose  200  ml ; vancomycin  1000  mg ; 0.9% sodium chloride (mini bag plus)  100  ml ; ampicillin-sulbactam  3  g ; heparin  5000  unit ; amlodipine  10  mg ; atorvastatin  80  mg ; clopidogrel  75  mg ; hydrochlorothiazide  12.5  mg ; lisinopril  40  mg ; metoprolol succinate xl  200  mg ; dextrose 50%  12.5  gm ; glucagon  1  mg ; glucose gel  15  g ; insulin  0  unit ; potassium chl 40 meq   1000 ml ns  1000  ml ; tramadol (ultram)  50  mg ; 
 
black african american m 50 $nan$hematology blood hematocrit  25.9  %; hematology blood hemoglobin  9.2  g dl; hematology blood platelet count  263  k ul; chemistry blood anion gap  12  meq l; chemistry blood bicarbonate  27  meq l; chemistry blood chloride  103  meq l; chemistry blood creatinine  1.3  mg dl; chemistry blood potassium  3.9  meq l; chemistry blood sodium  138  meq l; chemistry blood urea nitrogen  16  mg dl; chemistry blood glucose  145  mg dl$influenza vaccine quadrivalent  0.5  ml ; sodium chloride 0.9%  flush  3  ml ; acetaminophen  650  mg ; iso-osmotic dextrose  200  ml ; vancomycin  1000  mg ; 0.9% sodium chloride (mini bag plus)  100  ml ; ampicillin-sulbactam  3  g ; heparin  5000  unit ; amlodipine  10  mg ; atorvastatin  80  mg ; clopidogrel  75  mg ; hydrochlorothiazide  12.5  mg ; lisinopril  40  mg ; metoprolol succinate xl  200  mg ; dextrose 50%  12.5  gm ; glucagon  1  mg ; glucose gel  15  g ; insulin  0  unit ; tramadol (ultram)  50  mg ; potassium chl 20 meq   1000 ml d5 1 2 ns  1000  ml ; benzonatate  200  mg ; 
 
black african american m 50 $nan$hematology blood hematocrit  27.8  %; hematology blood hemoglobin  9.7  g dl; hematology blood platelet count  264  k ul; chemistry blood anion gap  12  meq l; chemistry blood bicarbonate  29  meq l; chemistry blood chloride  103  meq l; chemistry blood creatinine  1.3  mg dl; chemistry blood potassium  4.2  meq l; chemistry blood sodium  140  meq l; chemistry blood urea nitrogen  13  mg dl; chemistry blood calcium, total  8.3  mg dl; chemistry blood glucose  167  mg dl$influenza vaccine quadrivalent  0.5  ml ; sodium chloride 0.9%  flush  3  ml ; acetaminophen  650  mg ; iso-osmotic dextrose  200  ml ; vancomycin  1000  mg ; 0.9% sodium chloride (mini bag plus)  100  ml ; ampicillin-sulbactam  3  g ; heparin  5000  unit ; amlodipine  10  mg ; atorvastatin  80  mg ; clopidogrel  75  mg ; hydrochlorothiazide  12.5  mg ; lisinopril  40  mg ; metoprolol succinate xl  200  mg ; dextrose 50%  12.5  gm ; glucagon  1  mg ; glucose gel  15  g ; insulin  0  unit ; benzonatate  200  mg ; hydromorphone (dilaudid)  0.125-0.25  mg ; albuterol 0.083% neb soln  1  neb ; 
 
black african american m 50 $nan$hematology blood hematocrit  26.4  %; hematology blood hemoglobin  9.0  g dl; hematology blood platelet count  296  k ul; chemistry blood anion gap  12  meq l; chemistry blood bicarbonate  27  meq l; chemistry blood chloride  98  meq l; chemistry blood creatinine  1.5  mg dl; chemistry blood potassium  4.0  meq l; chemistry blood sodium  133  meq l; chemistry blood urea nitrogen  17  mg dl; chemistry blood calcium, total  8.4  mg dl; chemistry blood glucose  155  mg dl$influenza vaccine quadrivalent  0.5  ml ; sodium chloride 0.9%  flush  3  ml ; acetaminophen  650  mg ; iso-osmotic dextrose  200  ml ; vancomycin  1000  mg ; 0.9% sodium chloride (mini bag plus)  100  ml ; ampicillin-sulbactam  3  g ; heparin  5000  unit ; amlodipine  10  mg ; atorvastatin  80  mg ; clopidogrel  75  mg ; hydrochlorothiazide  12.5  mg ; lisinopril  40  mg ; metoprolol succinate xl  200  mg ; dextrose 50%  12.5  gm ; glucagon  1  mg ; glucose gel  15  g ; insulin  0  unit ; hydromorphone (dilaudid)  0.125-0.25  mg ; albuterol 0.083% neb soln  1  neb ; 
 
black african american m 50 $nan$nan$influenza vaccine quadrivalent  0.5  ml ; sodium chloride 0.9%  flush  3  ml ; acetaminophen  650  mg ; iso-osmotic dextrose  200  ml ; vancomycin  1000  mg ; 0.9% sodium chloride (mini bag plus)  100  ml ; ampicillin-sulbactam  3  g ; heparin  5000  unit ; amlodipine  10  mg ; atorvastatin  80  mg ; clopidogrel  75  mg ; hydrochlorothiazide  12.5  mg ; lisinopril  40  mg ; metoprolol succinate xl  200  mg ; dextrose 50%  12.5  gm ; glucagon  1  mg ; glucose gel  15  g ; insulin  0  unit ; albuterol 0.083% neb soln  1  neb ; amoxicillin-clavulanic acid  875  mg ; levofloxacin  750  mg ; 
 
black african american m 50 $nan$nan$influenza vaccine quadrivalent  0.5  ml ; sodium chloride 0.9%  flush  3  ml ; acetaminophen  650  mg ; heparin  5000  unit ; amlodipine  10  mg ; atorvastatin  80  mg ; clopidogrel  75  mg ; hydrochlorothiazide  12.5  mg ; lisinopril  40  mg ; metoprolol succinate xl  200  mg ; dextrose 50%  12.5  gm ; glucagon  1  mg ; glucose gel  15  g ; insulin  0  unit ; albuterol 0.083% neb soln  1  neb ; levofloxacin  750  mg ; 
 
black african american m 50 $nan$nan$influenza vaccine quadrivalent  0.5  ml ; sodium chloride 0.9%  flush  3  ml ; acetaminophen  650  mg ; heparin  5000  unit ; amlodipine  10  mg ; atorvastatin  80  mg ; clopidogrel  75  mg ; hydrochlorothiazide  12.5  mg ; lisinopril  40  mg ; metoprolol succinate xl  200  mg ; dextrose 50%  12.5  gm ; glucagon  1  mg ; glucose gel  15  g ; insulin  0  unit ; albuterol 0.083% neb soln  1  neb ; levofloxacin  750  mg ; 
 
white f 88 $temp  97.9  heartrate  67.0  resprate  16.0  o2sat  98.0  sbp  109.0  dbp  53.0  rhythm    pain  8  ; temp  98.8  heartrate  85.0  resprate  18.0  o2sat  98.0  sbp  111.0  dbp  77.0  rhythm    pain  9  ; temp  98.8  heartrate  84.0  resprate  14.0  o2sat  97.0  sbp  109.0  dbp  64.0  rhythm    pain  7  ; temp    heartrate  88.0  resprate  16.0  o2sat  98.0  sbp  112.0  dbp  65.0  rhythm    pain  7  $hematology blood hematocrit  28.6  %; hematology blood hemoglobin  9.4  g dl; hematology blood platelet count  229  k ul; chemistry blood anion gap  18  meq l; chemistry blood bicarbonate  21  meq l; chemistry blood chloride  108  meq l; chemistry blood creatinine  1.5  mg dl; chemistry blood potassium  3.8  meq l; chemistry blood sodium  143  meq l; chemistry blood urea nitrogen  33  mg dl; hematology blood inr(pt)  1.1  ; chemistry blood glucose  185  mg dl$nan
 
white f 88 $temp  98.4  heartrate  82.0  resprate  18.0  o2sat  99.0  sbp  104.0  dbp  66.0  rhythm    pain  5-6  $hematology blood hematocrit  25.5  %; hematology blood hemoglobin  8.5  g dl; hematology blood platelet count  196  k ul$influenza vaccine quadrivalent  0.5  ml ; pneumococcal 23-valent polysaccharide vaccine  0.5  ml ; tetanus-diphtox-acellular pertuss (adacel)  0.5  ml ; sodium chloride 0.9%  flush  3  ml ; lactated ringers  1000  ml ; acetaminophen  650  mg ; morphine sulfate  1-2  mg ; senna  17.2  mg ; vitamin d  800  unit ; calcium carbonate  500  mg ; multivitamins  1  tab ; oxycodone (immediate release)   2.5-5  mg ; ondansetron  4  mg ; enoxaparin sodium  40  mg ; iso-osmotic dextrose  50  ml ; cefazolin  2  g ; docusate sodium  100  mg ; milk of magnesia  30  ml ; bisacodyl  10  mg ; 
 
white f 88 $nan$hematology blood hematocrit  25.0  %; hematology blood hemoglobin  8.1  g dl; hematology blood platelet count  204  k ul; chemistry blood anion gap  13  meq l; chemistry blood bicarbonate  25  meq l; chemistry blood chloride  104  meq l; chemistry blood creatinine  1.1  mg dl; chemistry blood potassium  4.2  meq l; chemistry blood sodium  138  meq l; chemistry blood urea nitrogen  20  mg dl; chemistry blood calcium, total  8.7  mg dl; chemistry blood glucose  150  mg dl$influenza vaccine quadrivalent  0.5  ml ; pneumococcal 23-valent polysaccharide vaccine  0.5  ml ; tetanus-diphtox-acellular pertuss (adacel)  0.5  ml ; sodium chloride 0.9%  flush  3  ml ; acetaminophen  650  mg ; morphine sulfate  1-2  mg ; senna  17.2  mg ; vitamin d  800  unit ; calcium carbonate  500  mg ; multivitamins  1  tab ; oxycodone (immediate release)   2.5-5  mg ; ondansetron  4  mg ; docusate sodium  100  mg ; milk of magnesia  30  ml ; bisacodyl  10  mg ; oxycodone (immediate release)   5-10  mg ; hydromorphone (dilaudid)  0.5  mg ; acetaminophen  1000  mg ; enoxaparin sodium  30  mg ; sodium chloride 0.9%  1000  ml ; 
 
white f 88 $nan$hematology blood hematocrit  23.4  %; hematology blood hemoglobin  7.8  g dl; hematology blood platelet count  213  k ul; chemistry blood anion gap  13  meq l; chemistry blood bicarbonate  23  meq l; chemistry blood chloride  103  meq l; chemistry blood creatinine  1.2  mg dl; chemistry blood potassium  4.3  meq l; chemistry blood sodium  135  meq l; chemistry blood urea nitrogen  26  mg dl; hematology blood inr(pt)  1.1  ; chemistry blood calcium, total  8.5  mg dl; chemistry blood glucose  191  mg dl$influenza vaccine quadrivalent  0.5  ml ; pneumococcal 23-valent polysaccharide vaccine  0.5  ml ; tetanus-diphtox-acellular pertuss (adacel)  0.5  ml ; sodium chloride 0.9%  flush  3  ml ; morphine sulfate  1-2  mg ; senna  17.2  mg ; vitamin d  800  unit ; calcium carbonate  500  mg ; multivitamins  1  tab ; oxycodone (immediate release)   2.5-5  mg ; ondansetron  4  mg ; docusate sodium  100  mg ; milk of magnesia  30  ml ; bisacodyl  10  mg ; oxycodone (immediate release)   5-10  mg ; hydromorphone (dilaudid)  0.5  mg ; acetaminophen  1000  mg ; enoxaparin sodium  30  mg ; sodium chloride 0.9%  1000  ml ; ipratropium-albuterol neb  1  neb ; 
 
white f 88 $nan$hematology blood hematocrit  27.9  %; hematology blood hematocrit  26.9  %; hematology blood hematocrit  24.0  %; hematology blood hemoglobin  8.5  g dl; hematology blood hemoglobin  8.9  g dl; hematology blood hemoglobin  7.8  g dl; hematology blood platelet count  232  k ul; hematology blood platelet count  222  k ul; hematology blood platelet count  232  k ul; chemistry blood anion gap  16  meq l; chemistry blood anion gap  14  meq l; chemistry blood anion gap  11  meq l; chemistry blood bicarbonate  21  meq l; chemistry blood bicarbonate  23  meq l; chemistry blood bicarbonate  25  meq l; chemistry blood chloride  106  meq l; chemistry blood chloride  103  meq l; chemistry blood chloride  106  meq l; chemistry blood creatinine  1.1  mg dl; chemistry blood creatinine  1.0  mg dl; chemistry blood creatinine  1.3  mg dl; chemistry blood potassium  4.6  meq l; chemistry blood potassium  4.1  meq l; chemistry blood potassium  4.4  meq l; chemistry blood sodium  138  meq l; chemistry blood sodium  136  meq l; chemistry blood sodium  138  meq l; chemistry blood urea nitrogen  27  mg dl; chemistry blood urea nitrogen  23  mg dl; chemistry blood urea nitrogen  27  mg dl; hematology blood inr(pt)  1.1  ; hematology blood inr(pt)  1.1  ; chemistry blood calcium, total  8.4  mg dl; chemistry blood calcium, total  8.7  mg dl; chemistry blood calcium, total  8.2  mg dl; chemistry blood bilirubin, total  0.6  mg dl; chemistry blood glucose  88  mg dl; chemistry blood glucose  104  mg dl; chemistry blood glucose  133  mg dl; blood gas blood lactate  3.5  mmol l$sodium chloride 0.9%  flush  3  ml ; morphine sulfate  1-2  mg ; senna  17.2  mg ; vitamin d  800  unit ; calcium carbonate  500  mg ; multivitamins  1  tab ; oxycodone (immediate release)   2.5-5  mg ; ondansetron  4  mg ; docusate sodium  100  mg ; milk of magnesia  30  ml ; bisacodyl  10  mg ; enoxaparin sodium  30  mg ; sodium chloride 0.9%  1000  ml ; ipratropium-albuterol neb  1  neb ; atorvastatin  80  mg ; aspirin  325  mg ; heparin  3000  unit ; heparin  700  unit ; 5% dextrose  250  ml ; heparin sodium  25,000  unit ; azithromycin  500  mg ; 0.9% sodium chloride  50  ml ; cefepime  500  mg ; furosemide  20  mg ; aspirin  81  mg ; iso-osmotic dextrose  200  ml ; vancomycin  1000  mg ; iso-osmotic dextrose  150  ml ; vancomycin  750  mg ; clopidogrel  75  mg ; pantoprazole  40  mg ; 0.9% sodium chloride (mini bag plus)  100  ml ; cefepime  1  g ; furosemide  40  mg ; 0.9% sodium chloride  100  ml ; midazolam  100  mg ; atorvastatin  40  mg ; soln  50  ml ; fentanyl citrate  2.5  mg ; 
 
white f 88 $nan$chemistry blood anion gap  16  meq l; chemistry blood bicarbonate  23  meq l; chemistry blood chloride  106  meq l; chemistry blood creatinine  1.3  mg dl; chemistry blood potassium  4.0  meq l; chemistry blood sodium  141  meq l; chemistry blood urea nitrogen  26  mg dl; hematology blood inr(pt)  1.2  ; hematology urine wbc  7  # hpf; blood gas blood lactate  0.9  mmol l; blood gas blood lactate  0.9  mmol l; blood gas blood lactate  1.2  mmol l; blood gas blood hematocrit, calculated  28  %; blood gas blood hematocrit, calculated  27  %; blood gas blood hemoglobin  9.3  g dl; blood gas blood hemoglobin  8.9  g dl$sodium chloride 0.9%  flush  3  ml ; senna  17.2  mg ; vitamin d  800  unit ; calcium carbonate  500  mg ; multivitamins  1  tab ; oxycodone (immediate release)   2.5-5  mg ; ondansetron  4  mg ; docusate sodium  100  mg ; bisacodyl  10  mg ; ipratropium-albuterol neb  1  neb ; aspirin  81  mg ; clopidogrel  75  mg ; pantoprazole  40  mg ; atorvastatin  40  mg ; soln  50  ml ; fentanyl citrate  2.5  mg ; 0.9% sodium chloride  250  ml ; norepinephrine  8  mg ; furosemide  60  mg ; vial  1  vial ; cefepime  2  g ; albuterol 0.083% neb soln  1  neb ; ipratropium bromide neb  1  neb ; d5w  250  ml ; nitroglycerin  100  mg ; albuterol inhaler  4-8  puff ; ipratropium bromide mdi  4-8  puff ; chlorhexidine gluconate 0.12% oral rinse  15  ml ; docusate sodium (liquid)  100  mg ; 
 
white f 88 $nan$hematology blood hematocrit  22.3  %; hematology blood hemoglobin  7.1  g dl; hematology blood platelet count  251  k ul; chemistry blood anion gap  13  meq l; chemistry blood bicarbonate  25  meq l; chemistry blood chloride  110  meq l; chemistry blood creatinine  1.3  mg dl; chemistry blood potassium  3.5  meq l; chemistry blood sodium  144  meq l; chemistry blood urea nitrogen  27  mg dl; hematology blood inr(pt)  1.3  ; chemistry blood calcium, total  8.1  mg dl; chemistry blood bilirubin, total  0.4  mg dl; chemistry blood glucose  145  mg dl; blood gas blood hematocrit, calculated  24  %; blood gas blood hemoglobin  7.9  g dl$senna  17.2  mg ; vitamin d  800  unit ; calcium carbonate  500  mg ; multivitamins  1  tab ; oxycodone (immediate release)   2.5-5  mg ; ondansetron  4  mg ; bisacodyl  10  mg ; ipratropium-albuterol neb  1  neb ; aspirin  81  mg ; soln  50  ml ; fentanyl citrate  2.5  mg ; 0.9% sodium chloride  250  ml ; norepinephrine  8  mg ; vial  1  vial ; albuterol 0.083% neb soln  1  neb ; ipratropium bromide neb  1  neb ; d5w  250  ml ; nitroglycerin  100  mg ; albuterol inhaler  4-8  puff ; ipratropium bromide mdi  4-8  puff ; chlorhexidine gluconate 0.12% oral rinse  15  ml ; docusate sodium (liquid)  100  mg ; potassium chloride replacement (critical care and oncology)   40  meq ; potassium chloride replacement (critical care and oncology)   60  meq ; sterile water  100  ml ; potassium chloride  40  meq ; sterile water  150  ml ; potassium chloride  60  meq ; sodium chloride 0.9%  flush  10  ml ; metoprolol tartrate  6.25  mg ; sarna lotion  1  appl ; cetirizine  10  mg ; 
 
white f 88 $nan$hematology blood hematocrit  22.8  %; hematology blood hemoglobin  7.5  g dl; hematology blood platelet count  299  k ul; chemistry blood anion gap  14  meq l; chemistry blood anion gap  15  meq l; chemistry blood bicarbonate  22  meq l; chemistry blood bicarbonate  23  meq l; chemistry blood chloride  108  meq l; chemistry blood chloride  106  meq l; chemistry blood creatinine  1.1  mg dl; chemistry blood creatinine  1.2  mg dl; chemistry blood potassium  4.5  meq l; chemistry blood potassium  4.1  meq l; chemistry blood sodium  139  meq l; chemistry blood sodium  140  meq l; chemistry blood urea nitrogen  23  mg dl; chemistry blood urea nitrogen  24  mg dl; hematology blood inr(pt)  1.2  ; chemistry blood calcium, total  8.0  mg dl; chemistry blood glucose  104  mg dl$senna  17.2  mg ; vitamin d  800  unit ; calcium carbonate  500  mg ; multivitamins  1  tab ; oxycodone (immediate release)   2.5-5  mg ; ondansetron  4  mg ; bisacodyl  10  mg ; ipratropium-albuterol neb  1  neb ; aspirin  81  mg ; albuterol 0.083% neb soln  1  neb ; ipratropium bromide neb  1  neb ; d5w  250  ml ; nitroglycerin  100  mg ; albuterol inhaler  4-8  puff ; potassium chloride replacement (critical care and oncology)   60  meq ; sterile water  100  ml ; potassium chloride  40  meq ; sterile water  150  ml ; potassium chloride  60  meq ; sodium chloride 0.9%  flush  10  ml ; metoprolol tartrate  6.25  mg ; sarna lotion  1  appl ; cetirizine  10  mg ; acetaminophen (liquid)  650  mg ; acetaminophen (liquid)  1000  mg ; lisinopril  5  mg ; heparin  5000  unit ; 
 
white f 88 $nan$hematology blood hematocrit  22.9  %; hematology blood hemoglobin  7.4  g dl; hematology blood platelet count  349  k ul; chemistry blood anion gap  14  meq l; chemistry blood anion gap  13  meq l; chemistry blood bicarbonate  25  meq l; chemistry blood bicarbonate  24  meq l; chemistry blood chloride  106  meq l; chemistry blood chloride  105  meq l; chemistry blood creatinine  1.1  mg dl; chemistry blood creatinine  1.0  mg dl; chemistry blood potassium  4.3  meq l; chemistry blood potassium  4.3  meq l; chemistry blood sodium  141  meq l; chemistry blood sodium  138  meq l; chemistry blood urea nitrogen  25  mg dl; chemistry blood urea nitrogen  25  mg dl; hematology blood inr(pt)  1.2  ; chemistry blood calcium, total  8.0  mg dl; chemistry blood calcium, total  8.2  mg dl; chemistry blood glucose  105  mg dl; chemistry blood glucose  99  mg dl$senna  17.2  mg ; vitamin d  800  unit ; calcium carbonate  500  mg ; multivitamins  1  tab ; oxycodone (immediate release)   2.5-5  mg ; ondansetron  4  mg ; bisacodyl  10  mg ; ipratropium-albuterol neb  1  neb ; aspirin  81  mg ; albuterol 0.083% neb soln  1  neb ; d5w  250  ml ; nitroglycerin  100  mg ; potassium chloride replacement (critical care and oncology)   60  meq ; sterile water  100  ml ; potassium chloride  40  meq ; sterile water  150  ml ; potassium chloride  60  meq ; sodium chloride 0.9%  flush  10  ml ; metoprolol tartrate  6.25  mg ; sarna lotion  1  appl ; acetaminophen (liquid)  1000  mg ; lisinopril  5  mg ; heparin  5000  unit ; 
 
white f 88 $nan$hematology blood hematocrit  23.9  %; hematology blood hemoglobin  7.8  g dl; hematology blood platelet count  373  k ul; chemistry blood anion gap  15  meq l; chemistry blood bicarbonate  24  meq l; chemistry blood chloride  106  meq l; chemistry blood creatinine  1.0  mg dl; chemistry blood potassium  4.1  meq l; chemistry blood sodium  141  meq l; chemistry blood urea nitrogen  26  mg dl; hematology blood inr(pt)  1.2  ; chemistry blood calcium, total  7.9  mg dl; chemistry blood glucose  103  mg dl$senna  17.2  mg ; vitamin d  800  unit ; calcium carbonate  500  mg ; multivitamins  1  tab ; oxycodone (immediate release)   2.5-5  mg ; ondansetron  4  mg ; bisacodyl  10  mg ; aspirin  81  mg ; d5w  250  ml ; nitroglycerin  100  mg ; potassium chloride replacement (critical care and oncology)   60  meq ; sterile water  100  ml ; potassium chloride  40  meq ; sterile water  150  ml ; potassium chloride  60  meq ; sodium chloride 0.9%  flush  10  ml ; metoprolol tartrate  6.25  mg ; sarna lotion  1  appl ; acetaminophen (liquid)  1000  mg ; heparin  5000  unit ; lisinopril  7.5  mg ; heparin  1100-2200  unit ; trazodone  25  mg ; 
 
white f 88 $nan$hematology blood hematocrit  22.9  %; hematology blood hemoglobin  7.4  g dl; hematology blood platelet count  399  k ul; chemistry blood anion gap  14  meq l; chemistry blood anion gap  13  meq l; chemistry blood bicarbonate  22  meq l; chemistry blood bicarbonate  26  meq l; chemistry blood chloride  107  meq l; chemistry blood chloride  104  meq l; chemistry blood creatinine  1.1  mg dl; chemistry blood creatinine  1.6  mg dl; chemistry blood potassium  4.0  meq l; chemistry blood potassium  3.9  meq l; chemistry blood sodium  139  meq l; chemistry blood sodium  139  meq l; chemistry blood urea nitrogen  26  mg dl; chemistry blood urea nitrogen  28  mg dl; chemistry blood calcium, total  8.0  mg dl; chemistry blood calcium, total  8.0  mg dl; chemistry blood glucose  109  mg dl; chemistry blood glucose  160  mg dl$senna  17.2  mg ; vitamin d  800  unit ; calcium carbonate  500  mg ; multivitamins  1  tab ; oxycodone (immediate release)   2.5-5  mg ; ondansetron  4  mg ; bisacodyl  10  mg ; aspirin  81  mg ; d5w  250  ml ; nitroglycerin  100  mg ; zolpidem tartrate  2.5  mg ; potassium chloride replacement (critical care and oncology)   60  meq ; sterile water  100  ml ; potassium chloride  40  meq ; sterile water  150  ml ; potassium chloride  60  meq ; sodium chloride 0.9%  flush  10  ml ; sarna lotion  1  appl ; acetaminophen (liquid)  1000  mg ; lisinopril  7.5  mg ; heparin  1100-2200  unit ; trazodone  25  mg ; cepastat (phenol) lozenge  1  loz ; guaifenesin-dextromethorphan  5  ml ; metoprolol succinate xl  25  mg ; torsemide  40  mg ; lisinopril  2.5  mg ; potassium chloride  20  meq ; 
 
white f 88 $nan$hematology blood hematocrit  23.1  %; hematology blood hemoglobin  7.4  g dl; hematology blood platelet count  445  k ul; chemistry blood anion gap  12  meq l; chemistry blood bicarbonate  24  meq l; chemistry blood chloride  106  meq l; chemistry blood creatinine  1.2  mg dl; chemistry blood potassium  4.0  meq l; chemistry blood sodium  138  meq l; chemistry blood urea nitrogen  26  mg dl; chemistry blood calcium, total  8.2  mg dl; chemistry blood glucose  104  mg dl$senna  17.2  mg ; vitamin d  800  unit ; calcium carbonate  500  mg ; multivitamins  1  tab ; oxycodone (immediate release)   2.5-5  mg ; ondansetron  4  mg ; bisacodyl  10  mg ; aspirin  81  mg ; zolpidem tartrate  2.5  mg ; sodium chloride 0.9%  flush  10  ml ; sarna lotion  1  appl ; acetaminophen (liquid)  1000  mg ; cepastat (phenol) lozenge  1  loz ; guaifenesin-dextromethorphan  5  ml ; metoprolol succinate xl  25  mg ; potassium chloride  20  meq ; 
 
white m 36 $temp    heartrate    resprate    o2sat    sbp    dbp    rhythm    pain  8  ; temp  98.1  heartrate  66.0  resprate  16.0  o2sat    sbp  114.0  dbp  98.0  rhythm    pain  8  $hematology blood hematocrit  32.5  %; hematology blood hemoglobin  10.2  g dl; hematology blood platelet count  256  k ul; chemistry blood anion gap  13  meq l; chemistry blood anion gap  13  meq l; chemistry blood bicarbonate  31  meq l; chemistry blood bicarbonate  32  meq l; chemistry blood chloride  103  meq l; chemistry blood chloride  98  meq l; chemistry blood creatinine  0.8  mg dl; chemistry blood creatinine  0.9  mg dl; chemistry blood potassium  4.5  meq l; chemistry blood potassium  5.1  meq l; chemistry blood sodium  142  meq l; chemistry blood sodium  138  meq l; chemistry blood urea nitrogen  13  mg dl; chemistry blood urea nitrogen  11  mg dl; chemistry blood calcium, total  9.4  mg dl; chemistry blood calcium, total  9.4  mg dl; chemistry blood bilirubin, total  0.5  mg dl; chemistry blood glucose  57  mg dl; chemistry blood glucose  102  mg dl$fluticasone-salmeterol diskus (250 50)   1  inh ; omeprazole  40  mg ; atenolol  50  mg ; sodium chloride 0.9%  flush  3  ml ; hydromorphone (dilaudid)  1  mg ; heparin  5000  unit ; 0.9% sodium chloride  100  ml ; calcium gluconate  2  g ; insulin  10  unit ; dextrose 50%  12.5  gm ; d5 1 2ns  1000  ml ; trazodone  25  mg ; 
chronic pancreatitis unspecified essential hypertension alcohol abuse, unspecified hyperosmolality and/or hypernatremia iron deficiency anemia, unspecified unspecified essential hypertension chronic pancreatitis alcohol withdrawal acute alcoholic intoxication in alcoholism, continuous acute pancreatitis other specified diseases of pancreas chronic pancreatitis other specified diseases of pancreas alcohol abuse, in remission acute pancreatitis unspecified essential hypertension hematemesis iron deficiency anemia, unspecified obstruction of bile duct abdominal pain, left upper quadrant unspecified essential hypertension pneumonitis due to inhalation of food or vomitus chronic pancreatitis other and unspecified alcohol dependence, continuous abdominal pain, epigastric chronic pancreatitis pedal cycle driver injured in collision with other nonmotor vehicle in nontraffic accident depressive disorder, not elsewhere classified family history of malignant neoplasm of gastrointestinal tract unspecified essential hypertension esophageal reflux acute pancreatitis other and unspecified alcohol dependence, in remission 
white m 36 $nan$nan$fluticasone-salmeterol diskus (250 50)   1  inh ; omeprazole  40  mg ; atenolol  50  mg ; sodium chloride 0.9%  flush  3  ml ; heparin  5000  unit ; 0.9% sodium chloride  100  ml ; calcium gluconate  2  g ; insulin  10  unit ; dextrose 50%  12.5  gm ; d5 1 2ns  1000  ml ; trazodone  25  mg ; atenolol  25  mg ; hydromorphone (dilaudid)  4  mg ; cosyntropin  250  mcg ; pancrelipase 5000  2  cap ; 
chronic pancreatitis unspecified essential hypertension alcohol abuse, unspecified hyperosmolality and/or hypernatremia iron deficiency anemia, unspecified unspecified essential hypertension chronic pancreatitis alcohol withdrawal acute alcoholic intoxication in alcoholism, continuous acute pancreatitis other specified diseases of pancreas chronic pancreatitis other specified diseases of pancreas alcohol abuse, in remission acute pancreatitis unspecified essential hypertension hematemesis iron deficiency anemia, unspecified obstruction of bile duct abdominal pain, left upper quadrant unspecified essential hypertension pneumonitis due to inhalation of food or vomitus chronic pancreatitis other and unspecified alcohol dependence, continuous abdominal pain, epigastric chronic pancreatitis pedal cycle driver injured in collision with other nonmotor vehicle in nontraffic accident depressive disorder, not elsewhere classified family history of malignant neoplasm of gastrointestinal tract unspecified essential hypertension esophageal reflux acute pancreatitis other and unspecified alcohol dependence, in remission 
asian f 34 $nan$nan$cefazolin  1  g ; sodium chloride 0.9%  flush  3  ml ; potassium chl 20 meq   1000 ml d5 1 2 ns  1000  ml ; acetaminophen  325-650  mg ; ondansetron  4  mg ; iso-osmotic dextrose  50  ml ; scopolamine patch  1  ptch ; hydromorphone (dilaudid)  20  mg ; heparin  5000  unit ; 
prophylactic breast removal personal history of malignant neoplasm of breast acquired absence of breast and nipple genetic susceptibility to malignant neoplasm of breast person boarding or alighting a pedal cycle injured in collision with railway train or railway vehicle person boarding or alighting a pedal cycle injured in collision with pedestrian or animal personal history of antineoplastic chemotherapy personal history of irradiation, presenting hazards to health septicemia due to escherichia coli [e. coli] estrogen receptor positive status [er+] driver of special all-terrain or other off-road motor vehicle injured in traffic accident tobacco use disorder personal history of malignant neoplasm of breast genetic susceptibility to malignant neoplasm of breast depressive disorder, not elsewhere classified personal history of antineoplastic chemotherapy urinary tract infection, site not specified person boarding or alighting a pedal cycle injured in collision with pedestrian or animal sepsis genetic susceptibility to malignant neoplasm of breast personal history of antineoplastic chemotherapy driver of special all-terrain or other off-road motor vehicle injured in traffic accident estrogen receptor positive status [er+] malignant neoplasm of lower-outer quadrant of female breast secondary and unspecified malignant neoplasm of lymph nodes of axilla and upper limb tobacco use disorder antineoplastic chemotherapy induced anemia stomatitis and mucositis, unspecified urinary tract infection, site not specified drug induced neutropenia secondary and unspecified malignant neoplasm of lymph nodes of axilla and upper limb malignant neoplasm of other specified sites of female breast other and unspecified escherichia coli [e. coli] fever presenting with conditions classified elsewhere antineoplastic and immunosuppressive drugs causing adverse effects in therapeutic use 
asian f 34 $nan$nan$cefazolin  1  g ; sodium chloride 0.9%  flush  3  ml ; potassium chl 20 meq   1000 ml d5 1 2 ns  1000  ml ; acetaminophen  325-650  mg ; ondansetron  4  mg ; iso-osmotic dextrose  50  ml ; hydromorphone (dilaudid)  20  mg ; heparin  5000  unit ; tamoxifen citrate  20  mg ; hydromorphone (dilaudid)  2  mg ; hydrocodone-acetaminophen (5mg-325mg)  1  tab ; hydrocodone-acetaminophen (5mg-325mg)  1-2  tab ; 
prophylactic breast removal personal history of malignant neoplasm of breast acquired absence of breast and nipple genetic susceptibility to malignant neoplasm of breast person boarding or alighting a pedal cycle injured in collision with railway train or railway vehicle person boarding or alighting a pedal cycle injured in collision with pedestrian or animal personal history of antineoplastic chemotherapy personal history of irradiation, presenting hazards to health septicemia due to escherichia coli [e. coli] estrogen receptor positive status [er+] driver of special all-terrain or other off-road motor vehicle injured in traffic accident tobacco use disorder personal history of malignant neoplasm of breast genetic susceptibility to malignant neoplasm of breast depressive disorder, not elsewhere classified personal history of antineoplastic chemotherapy urinary tract infection, site not specified person boarding or alighting a pedal cycle injured in collision with pedestrian or animal sepsis genetic susceptibility to malignant neoplasm of breast personal history of antineoplastic chemotherapy driver of special all-terrain or other off-road motor vehicle injured in traffic accident estrogen receptor positive status [er+] malignant neoplasm of lower-outer quadrant of female breast secondary and unspecified malignant neoplasm of lymph nodes of axilla and upper limb tobacco use disorder antineoplastic chemotherapy induced anemia stomatitis and mucositis, unspecified urinary tract infection, site not specified drug induced neutropenia secondary and unspecified malignant neoplasm of lymph nodes of axilla and upper limb malignant neoplasm of other specified sites of female breast other and unspecified escherichia coli [e. coli] fever presenting with conditions classified elsewhere antineoplastic and immunosuppressive drugs causing adverse effects in therapeutic use 
asian f 34 $nan$nan$cefazolin  1  g ; sodium chloride 0.9%  flush  3  ml ; potassium chl 20 meq   1000 ml d5 1 2 ns  1000  ml ; ondansetron  4  mg ; iso-osmotic dextrose  50  ml ; heparin  5000  unit ; tamoxifen citrate  20  mg ; hydrocodone-acetaminophen (5mg-325mg)  1-2  tab ; 
prophylactic breast removal personal history of malignant neoplasm of breast acquired absence of breast and nipple genetic susceptibility to malignant neoplasm of breast person boarding or alighting a pedal cycle injured in collision with railway train or railway vehicle person boarding or alighting a pedal cycle injured in collision with pedestrian or animal personal history of antineoplastic chemotherapy personal history of irradiation, presenting hazards to health septicemia due to escherichia coli [e. coli] estrogen receptor positive status [er+] driver of special all-terrain or other off-road motor vehicle injured in traffic accident tobacco use disorder personal history of malignant neoplasm of breast genetic susceptibility to malignant neoplasm of breast depressive disorder, not elsewhere classified personal history of antineoplastic chemotherapy urinary tract infection, site not specified person boarding or alighting a pedal cycle injured in collision with pedestrian or animal sepsis genetic susceptibility to malignant neoplasm of breast personal history of antineoplastic chemotherapy driver of special all-terrain or other off-road motor vehicle injured in traffic accident estrogen receptor positive status [er+] malignant neoplasm of lower-outer quadrant of female breast secondary and unspecified malignant neoplasm of lymph nodes of axilla and upper limb tobacco use disorder antineoplastic chemotherapy induced anemia stomatitis and mucositis, unspecified urinary tract infection, site not specified drug induced neutropenia secondary and unspecified malignant neoplasm of lymph nodes of axilla and upper limb malignant neoplasm of other specified sites of female breast other and unspecified escherichia coli [e. coli] fever presenting with conditions classified elsewhere antineoplastic and immunosuppressive drugs causing adverse effects in therapeutic use 
asian f 34 $nan$nan$cefazolin  1  g ; sodium chloride 0.9%  flush  3  ml ; potassium chl 20 meq   1000 ml d5 1 2 ns  1000  ml ; ondansetron  4  mg ; iso-osmotic dextrose  50  ml ; tamoxifen citrate  20  mg ; hydrocodone-acetaminophen (5mg-325mg)  1-2  tab ; 
prophylactic breast removal personal history of malignant neoplasm of breast acquired absence of breast and nipple genetic susceptibility to malignant neoplasm of breast person boarding or alighting a pedal cycle injured in collision with railway train or railway vehicle person boarding or alighting a pedal cycle injured in collision with pedestrian or animal personal history of antineoplastic chemotherapy personal history of irradiation, presenting hazards to health septicemia due to escherichia coli [e. coli] estrogen receptor positive status [er+] driver of special all-terrain or other off-road motor vehicle injured in traffic accident tobacco use disorder personal history of malignant neoplasm of breast genetic susceptibility to malignant neoplasm of breast depressive disorder, not elsewhere classified personal history of antineoplastic chemotherapy urinary tract infection, site not specified person boarding or alighting a pedal cycle injured in collision with pedestrian or animal sepsis genetic susceptibility to malignant neoplasm of breast personal history of antineoplastic chemotherapy driver of special all-terrain or other off-road motor vehicle injured in traffic accident estrogen receptor positive status [er+] malignant neoplasm of lower-outer quadrant of female breast secondary and unspecified malignant neoplasm of lymph nodes of axilla and upper limb tobacco use disorder antineoplastic chemotherapy induced anemia stomatitis and mucositis, unspecified urinary tract infection, site not specified drug induced neutropenia secondary and unspecified malignant neoplasm of lymph nodes of axilla and upper limb malignant neoplasm of other specified sites of female breast other and unspecified escherichia coli [e. coli] fever presenting with conditions classified elsewhere antineoplastic and immunosuppressive drugs causing adverse effects in therapeutic use 
white m 79 $temp  98.3  heartrate  112.0  resprate  23.0  o2sat  92.0  sbp  199.0  dbp  98.0  rhythm    pain  0  ; temp  98.3  heartrate  94.0  resprate  19.0  o2sat  96.0  sbp  157.0  dbp  90.0  rhythm    pain  0  $hematology blood hematocrit  48.7  %; hematology blood hemoglobin  15.8  g dl; hematology blood platelet count  241  k ul; chemistry blood anion gap  18  meq l; chemistry blood bicarbonate  22  meq l; chemistry blood chloride  104  meq l; chemistry blood potassium  4.1  meq l; chemistry blood sodium  140  meq l; chemistry blood urea nitrogen  21  mg dl; hematology blood inr(pt)  1.0  ; hematology urine wbc  0  # hpf; chemistry blood calcium, total  9.7  mg dl; chemistry blood bilirubin, total  1.1  mg dl; chemistry blood glucose  155  mg dl; chemistry blood albumin  4.3  g dl$pneumococcal vac polyvalent  0.5  ml ; sodium chloride 0.9%  flush  3  ml ; 0.9% sodium chloride  1000  ml ; acetaminophen  650  mg ; dextrose 50%  12.5  gm ; glucagon  1  mg ; glucose gel  15  g ; hydralazine  5  mg ; insulin  0  unit ; pyridostigmine bromide  2  mg ; iso-osmotic sodium chloride  50  ml ; famotidine  20  mg ; sw  200  ml ; potassium chloride  20  meq ; sw  400  ml ; potassium chloride  40  meq ; sw  600  ml ; potassium chloride  60  meq ; bag  50  ml ; magnesium sulfate  2  gm ; bag  100  ml ; magnesium sulfate  4  gm ; 0.9% sodium chloride  100  ml ; calcium gluconate  2  g ; 0.9% sodium chloride  250  ml ; calcium gluconate  4  g ; simvastatin  20  mg ; 
 
white m 79 $nan$hematology blood hematocrit  48.4  %; hematology blood hemoglobin  15.6  g dl; hematology blood platelet count  224  k ul; chemistry blood anion gap  13  meq l; chemistry blood bicarbonate  24  meq l; chemistry blood chloride  106  meq l; chemistry blood creatinine  1.0  mg dl; chemistry blood potassium  3.9  meq l; chemistry blood sodium  139  meq l; chemistry blood urea nitrogen  16  mg dl; hematology blood inr(pt)  1.0  ; hematology blood inr(pt)  1.0  ; chemistry blood calcium, total  9.3  mg dl; chemistry blood glucose  132  mg dl; chemistry blood % hemoglobin a1c  6.0  %$pneumococcal vac polyvalent  0.5  ml ; sodium chloride 0.9%  flush  3  ml ; acetaminophen  650  mg ; dextrose 50%  12.5  gm ; glucagon  1  mg ; glucose gel  15  g ; hydralazine  5  mg ; insulin  0  unit ; iso-osmotic sodium chloride  50  ml ; famotidine  20  mg ; sw  200  ml ; potassium chloride  20  meq ; sw  400  ml ; potassium chloride  40  meq ; sw  600  ml ; potassium chloride  60  meq ; bag  50  ml ; magnesium sulfate  2  gm ; bag  100  ml ; magnesium sulfate  4  gm ; 0.9% sodium chloride  100  ml ; calcium gluconate  2  g ; 0.9% sodium chloride  250  ml ; calcium gluconate  4  g ; simvastatin  20  mg ; heparin  5000  unit ; pyridostigmine bromide  60  mg ; clopidogrel  75  mg ; 5% dextrose  250  ml ; heparin sodium  25,000  unit ; 
 
white m 79 $nan$hematology blood hematocrit  48.5  %; hematology blood hemoglobin  15.8  g dl; hematology blood platelet count  202  k ul; chemistry blood anion gap  13  meq l; chemistry blood bicarbonate  25  meq l; chemistry blood chloride  102  meq l; chemistry blood creatinine  1.0  mg dl; chemistry blood potassium  3.7  meq l; chemistry blood sodium  136  meq l; chemistry blood urea nitrogen  22  mg dl; hematology blood inr(pt)  1.1  ; hematology blood inr(pt)  1.1  ; chemistry blood calcium, total  9.1  mg dl; chemistry blood glucose  144  mg dl$pneumococcal vac polyvalent  0.5  ml ; sodium chloride 0.9%  flush  3  ml ; acetaminophen  650  mg ; dextrose 50%  12.5  gm ; glucagon  1  mg ; glucose gel  15  g ; hydralazine  5  mg ; insulin  0  unit ; simvastatin  20  mg ; pyridostigmine bromide  60  mg ; 5% dextrose  250  ml ; heparin sodium  25,000  unit ; simvastatin  40  mg ; enoxaparin sodium  80  mg ; iso-osmotic dextrose  50  ml ; ceftriaxone  2  gm ; 
 
white m 79 $nan$hematology blood hematocrit  49.6  %; hematology blood hemoglobin  16.0  g dl; hematology blood platelet count  233  k ul; chemistry blood anion gap  13  meq l; chemistry blood bicarbonate  27  meq l; chemistry blood chloride  103  meq l; chemistry blood creatinine  1.1  mg dl; chemistry blood potassium  4.0  meq l; chemistry blood sodium  139  meq l; chemistry blood urea nitrogen  27  mg dl; chemistry blood calcium, total  9.7  mg dl; chemistry blood glucose  133  mg dl$pneumococcal vac polyvalent  0.5  ml ; sodium chloride 0.9%  flush  3  ml ; acetaminophen  650  mg ; dextrose 50%  12.5  gm ; glucagon  1  mg ; glucose gel  15  g ; hydralazine  5  mg ; insulin  0  unit ; pyridostigmine bromide  60  mg ; simvastatin  40  mg ; enoxaparin sodium  80  mg ; iso-osmotic dextrose  50  ml ; ceftriaxone  2  gm ; iso-osmotic dextrose  200  ml ; vancomycin  1000  mg ; multivitamins  1  tab ; 
 
white m 79 $nan$hematology blood hematocrit  47.1  %; hematology blood hemoglobin  15.6  g dl; hematology blood platelet count  241  k ul; chemistry blood anion gap  15  meq l; chemistry blood bicarbonate  28  meq l; chemistry blood chloride  103  meq l; chemistry blood creatinine  1.2  mg dl; chemistry blood potassium  4.4  meq l; chemistry blood sodium  142  meq l; chemistry blood urea nitrogen  28  mg dl; hematology blood inr(pt)  1.1  ; chemistry blood calcium, total  9.8  mg dl; chemistry blood glucose  130  mg dl$pneumococcal vac polyvalent  0.5  ml ; sodium chloride 0.9%  flush  3  ml ; acetaminophen  650  mg ; dextrose 50%  12.5  gm ; glucagon  1  mg ; glucose gel  15  g ; hydralazine  5  mg ; insulin  0  unit ; pyridostigmine bromide  60  mg ; simvastatin  40  mg ; enoxaparin sodium  80  mg ; iso-osmotic dextrose  50  ml ; ceftriaxone  2  gm ; iso-osmotic dextrose  200  ml ; vancomycin  1000  mg ; multivitamins  1  tab ; nystatin oral suspension  5  ml ; 
 
white m 79 $nan$nan$pneumococcal vac polyvalent  0.5  ml ; sodium chloride 0.9%  flush  3  ml ; acetaminophen  650  mg ; dextrose 50%  12.5  gm ; glucagon  1  mg ; glucose gel  15  g ; hydralazine  5  mg ; insulin  0  unit ; pyridostigmine bromide  60  mg ; simvastatin  40  mg ; enoxaparin sodium  80  mg ; iso-osmotic dextrose  50  ml ; ceftriaxone  2  gm ; multivitamins  1  tab ; nystatin oral suspension  5  ml ; 
 
white m 79 $nan$hematology blood hematocrit  47.5  %; hematology blood hemoglobin  15.3  g dl; hematology blood platelet count  288  k ul; chemistry blood anion gap  16  meq l; chemistry blood bicarbonate  26  meq l; chemistry blood chloride  103  meq l; chemistry blood creatinine  1.1  mg dl; chemistry blood potassium  3.9  meq l; chemistry blood sodium  141  meq l; chemistry blood urea nitrogen  30  mg dl; chemistry blood calcium, total  9.7  mg dl; chemistry blood glucose  214  mg dl$pneumococcal vac polyvalent  0.5  ml ; sodium chloride 0.9%  flush  3  ml ; acetaminophen  650  mg ; dextrose 50%  12.5  gm ; glucagon  1  mg ; glucose gel  15  g ; hydralazine  5  mg ; insulin  0  unit ; pyridostigmine bromide  60  mg ; simvastatin  40  mg ; enoxaparin sodium  80  mg ; multivitamins  1  tab ; nystatin oral suspension  5  ml ; 
 
white m 79 $nan$nan$pneumococcal vac polyvalent  0.5  ml ; sodium chloride 0.9%  flush  3  ml ; acetaminophen  650  mg ; dextrose 50%  12.5  gm ; glucagon  1  mg ; glucose gel  15  g ; hydralazine  5  mg ; insulin  0  unit ; pyridostigmine bromide  60  mg ; simvastatin  40  mg ; enoxaparin sodium  80  mg ; multivitamins  1  tab ; nystatin oral suspension  5  ml ; 
 
hispanic latino f 28 $nan$nan$sodium chloride 0.9%  flush  3  ml ; prenatal vitamins  1  tab ; omeprazole  20  mg ; hydromorphone (dilaudid)  0.5  mg ; 5% dextrose  50  ml ; clindamycin  600  mg ; docusate sodium  100  mg ; oxycodone-acetaminophen (5mg-325mg)  1-2  tab ; ibuprofen  600  mg ; codeine sulfate  30-60  mg ; acetaminophen  500-1000  mg ; bisacodyl  10  mg ; milk of magnesia  30  ml ; simethicone  80  mg ; calcium carbonate  500  mg ; tetanus-diphtox-acellular pertuss (adacel)  0.5  ml ; 
 
hispanic latino f 28 $nan$hematology blood hematocrit  36.5  %$sodium chloride 0.9%  flush  3  ml ; prenatal vitamins  1  tab ; omeprazole  20  mg ; hydromorphone (dilaudid)  0.5  mg ; 5% dextrose  50  ml ; clindamycin  600  mg ; docusate sodium  100  mg ; oxycodone-acetaminophen (5mg-325mg)  1-2  tab ; ibuprofen  600  mg ; codeine sulfate  30-60  mg ; acetaminophen  500-1000  mg ; bisacodyl  10  mg ; milk of magnesia  30  ml ; simethicone  80  mg ; calcium carbonate  500  mg ; tetanus-diphtox-acellular pertuss (adacel)  0.5  ml ; 
 
hispanic latino f 28 $nan$nan$sodium chloride 0.9%  flush  3  ml ; prenatal vitamins  1  tab ; docusate sodium  100  mg ; oxycodone-acetaminophen (5mg-325mg)  1-2  tab ; ibuprofen  600  mg ; codeine sulfate  30-60  mg ; acetaminophen  500-1000  mg ; bisacodyl  10  mg ; milk of magnesia  30  ml ; simethicone  80  mg ; calcium carbonate  500  mg ; tetanus-diphtox-acellular pertuss (adacel)  0.5  ml ; 
 
white m 82 $temp  97.7  heartrate  69.0  resprate  16.0  o2sat  100.0  sbp  148.0  dbp  61.0  rhythm    pain    ; temp    heartrate  68.0  resprate  18.0  o2sat  98.0  sbp  136.0  dbp  68.0  rhythm    pain  0  ; temp  97.3  heartrate  66.0  resprate  18.0  o2sat  99.0  sbp  144.0  dbp  67.0  rhythm    pain    $chemistry blood anion gap  15  meq l; chemistry blood bicarbonate  21  meq l; chemistry blood chloride  106  meq l; chemistry blood creatinine  1.3  mg dl; chemistry blood potassium  4.1  meq l; chemistry blood sodium  138  meq l; chemistry blood urea nitrogen  29  mg dl; chemistry blood calcium, total  10.1  mg dl; chemistry blood glucose  112  mg dl; chemistry blood lactate dehydrogenase (ld)  368  iu l$sodium chloride 0.9%  1000  ml ; pneumococcal 23-valent polysaccharide vaccine  0.5  ml ; carbidopa-levodopa (25-100)  0.5  tab ; simvastatin  40  mg ; amantadine  100  mg ; docusate sodium  100  mg ; senna  8.6  mg ; sodium chloride 0.9%  flush  3  ml ; 
paralysis agitans rheumatoid arthritis other and unspecified hyperlipidemia other disorders of plasma-protein metabolism, not elsewhere classified other and unspecified mitral valve diseases personal history of malignant neoplasm of prostate unspecified essential hypertension personal history of tobacco use accidental fall on or from other stairs or steps accidents occurring in unspecified place subdural hemorrhage following injury without mention of open intracranial wound, with no loss of consciousness urinary tract infection, site not specified spinal stenosis, lumbar region, without neurogenic claudication 
white m 82 $nan$hematology blood hematocrit  42.7  %; hematology blood hemoglobin  14.3  g dl; hematology blood platelet count  162  k ul; chemistry blood anion gap  18  meq l; chemistry blood bicarbonate  20  meq l; chemistry blood chloride  105  meq l; chemistry blood creatinine  1.2  mg dl; chemistry blood potassium  4.2  meq l; chemistry blood sodium  139  meq l; chemistry blood urea nitrogen  25  mg dl; chemistry blood calcium, total  10.5  mg dl; chemistry blood glucose  88  mg dl$pneumococcal 23-valent polysaccharide vaccine  0.5  ml ; carbidopa-levodopa (25-100)  0.5  tab ; simvastatin  40  mg ; amantadine  100  mg ; docusate sodium  100  mg ; senna  8.6  mg ; sodium chloride 0.9%  flush  3  ml ; hydroxychloroquine sulfate  400  mg ; neutra-phos  2  pkt ; artificial tears  1-2  drop ; 0.9% sodium chloride (mini bag plus)  100  ml ; ceftriaxone  1  gm ; docusate sodium  200  mg ; 
paralysis agitans rheumatoid arthritis other and unspecified hyperlipidemia other disorders of plasma-protein metabolism, not elsewhere classified other and unspecified mitral valve diseases personal history of malignant neoplasm of prostate unspecified essential hypertension personal history of tobacco use accidental fall on or from other stairs or steps accidents occurring in unspecified place subdural hemorrhage following injury without mention of open intracranial wound, with no loss of consciousness urinary tract infection, site not specified spinal stenosis, lumbar region, without neurogenic claudication 
white m 82 $nan$nan$pneumococcal 23-valent polysaccharide vaccine  0.5  ml ; carbidopa-levodopa (25-100)  0.5  tab ; simvastatin  40  mg ; amantadine  100  mg ; sodium chloride 0.9%  flush  3  ml ; hydroxychloroquine sulfate  400  mg ; neutra-phos  2  pkt ; artificial tears  1-2  drop ; docusate sodium  200  mg ; senna  17.2  mg ; polyethylene glycol  17  g ; 
paralysis agitans rheumatoid arthritis other and unspecified hyperlipidemia other disorders of plasma-protein metabolism, not elsewhere classified other and unspecified mitral valve diseases personal history of malignant neoplasm of prostate unspecified essential hypertension personal history of tobacco use accidental fall on or from other stairs or steps accidents occurring in unspecified place subdural hemorrhage following injury without mention of open intracranial wound, with no loss of consciousness urinary tract infection, site not specified spinal stenosis, lumbar region, without neurogenic claudication 
white m 82 $nan$hematology blood hematocrit  40.3  %; hematology blood hemoglobin  13.4  g dl; hematology blood platelet count  141  k ul; chemistry blood anion gap  15  meq l; chemistry blood bicarbonate  24  meq l; chemistry blood chloride  103  meq l; chemistry blood creatinine  1.1  mg dl; chemistry blood potassium  4.4  meq l; chemistry blood sodium  138  meq l; chemistry blood urea nitrogen  15  mg dl; chemistry blood calcium, total  10.7  mg dl; chemistry blood glucose  123  mg dl$pneumococcal 23-valent polysaccharide vaccine  0.5  ml ; carbidopa-levodopa (25-100)  0.5  tab ; simvastatin  40  mg ; amantadine  100  mg ; sodium chloride 0.9%  flush  3  ml ; hydroxychloroquine sulfate  400  mg ; neutra-phos  2  pkt ; artificial tears  1-2  drop ; docusate sodium  200  mg ; senna  17.2  mg ; polyethylene glycol  17  g ; 
paralysis agitans rheumatoid arthritis other and unspecified hyperlipidemia other disorders of plasma-protein metabolism, not elsewhere classified other and unspecified mitral valve diseases personal history of malignant neoplasm of prostate unspecified essential hypertension personal history of tobacco use accidental fall on or from other stairs or steps accidents occurring in unspecified place subdural hemorrhage following injury without mention of open intracranial wound, with no loss of consciousness urinary tract infection, site not specified spinal stenosis, lumbar region, without neurogenic claudication 
white m 82 $nan$hematology blood hematocrit  40.7  %; hematology blood hemoglobin  13.7  g dl; hematology blood platelet count  155  k ul; chemistry blood anion gap  15  meq l; chemistry blood bicarbonate  22  meq l; chemistry blood chloride  105  meq l; chemistry blood creatinine  1.0  mg dl; chemistry blood potassium  3.7  meq l; chemistry blood sodium  138  meq l; chemistry blood urea nitrogen  18  mg dl; chemistry blood calcium, total  10.5  mg dl; chemistry blood glucose  135  mg dl$bag  2  bag ; magnesium sulfate  4  gm ; pneumococcal 23-valent polysaccharide vaccine  0.5  ml ; carbidopa-levodopa (25-100)  0.5  tab ; simvastatin  40  mg ; amantadine  100  mg ; sodium chloride 0.9%  flush  3  ml ; hydroxychloroquine sulfate  400  mg ; artificial tears  1-2  drop ; docusate sodium  200  mg ; senna  17.2  mg ; polyethylene glycol  17  g ; potassium chloride  40  meq ; 
paralysis agitans rheumatoid arthritis other and unspecified hyperlipidemia other disorders of plasma-protein metabolism, not elsewhere classified other and unspecified mitral valve diseases personal history of malignant neoplasm of prostate unspecified essential hypertension personal history of tobacco use accidental fall on or from other stairs or steps accidents occurring in unspecified place subdural hemorrhage following injury without mention of open intracranial wound, with no loss of consciousness urinary tract infection, site not specified spinal stenosis, lumbar region, without neurogenic claudication 
white m 60 $nan$nan$hydrochlorothiazide  25  mg ; simvastatin  20  mg ; folic acid  1  mg ; cyanocobalamin  1000  mcg ; quinapril  40  mg ; 
 
white m 60 $nan$hematology blood hematocrit  35.3  %; hematology blood hemoglobin  12.4  g dl; hematology blood platelet count  214  k ul; chemistry blood anion gap  11  meq l; chemistry blood bicarbonate  26  meq l; chemistry blood chloride  107  meq l; chemistry blood creatinine  1.5  mg dl; chemistry blood potassium  3.9  meq l; chemistry blood sodium  140  meq l; chemistry blood urea nitrogen  20  mg dl; chemistry urine creatinine, urine  52  mg dl; chemistry urine sodium, urine  107  meq l; chemistry blood calcium, total  8.3  mg dl; chemistry blood glucose  91  mg dl$hydrochlorothiazide  25  mg ; simvastatin  20  mg ; folic acid  1  mg ; cyanocobalamin  1000  mcg ; quinapril  40  mg ; influenza virus vaccine  0.5  ml ; sodium chloride 0.9%  flush  3  ml ; ns  1000  ml ; diazepam  5  mg ; heparin  5000  unit ; 
 
white m 60 $nan$nan$simvastatin  20  mg ; folic acid  1  mg ; cyanocobalamin  1000  mcg ; influenza virus vaccine  0.5  ml ; sodium chloride 0.9%  flush  3  ml ; diazepam  5  mg ; heparin  5000  unit ; 
 
white m 69 $temp    heartrate    resprate    o2sat    sbp    dbp    rhythm    pain  0  $nan$sodium chloride 0.9%  flush  3  ml ; lorazepam  1  mg ; morphine sulfate (concentrated oral soln)  5  mg ; 
pressure ulcer, stage i do not resuscitate status pneumonia, organism unspecified personal history of malignant neoplasm of rectum, rectosigmoid junction, and anus pressure ulcer, lower back streptococcus infection in conditions classified elsewhere and of unspecified site, streptococcus, group d [enterococcus] portal hypertension person on outside of heavy transport vehicle injured in collision with other nonmotor vehicle in traffic accident asymptomatic human immunodeficiency virus [hiv] infection status anemia, unspecified other specified metabolic disorders acute venous embolism and thrombosis of deep vessels of proximal lower extremity pressure ulcer, stage ii other specified disorders of stomach and duodenum urinary tract infection, site not specified encounter for palliative care other severe protein-calorie malnutrition hyperpotassemia pressure ulcer, stage iii cirrhosis of liver without mention of alcohol pathologic fracture of vertebrae unspecified fall passenger of special construction vehicle injured in traffic accident spontaneous bacterial peritonitis pressure ulcer, heel pressure ulcer, buttock other and unspecified hyperlipidemia chronic viral hepatitis b with hepatic coma without hepatitis delta diarrhea body mass index between 19-24, adult hepatorenal syndrome unspecified site injury hyposmolality and/or hyponatremia acute kidney failure, unspecified unspecified essential hypertension adult failure to thrive other ascites unspecified septicemia infection with microorganisms without mention of resistance to multiple drugs driver of special construction vehicle injured in traffic accident cirrhosis of liver without mention of alcohol personal history of malignant neoplasm of rectum, rectosigmoid junction, and anus body mass index less than 19, adult early satiety chronic viral hepatitis b without mention of hepatic coma without mention of hepatitis delta hyposmolality and/or hyponatremia nutritional marasmus other and unspecified hyperlipidemia
white m 76 $temp  101.2  heartrate  78.0  resprate  23.0  o2sat  95.0  sbp  117.0  dbp  51.0  rhythm    pain  0  $nan$multivitamins  1  tab ; thiamine  100  mg ; vitamin d  1000  unit ; 
obstruction of bile duct personal history of malignant neoplasm of other gastrointestinal tract biliary cirrhosis hypertrophy (benign) of prostate without urinary obstruction and other lower urinary tract symptom (luts) cholangitis retention of urine, unspecified personal history of malignant neoplasm of other gastrointestinal tract obstruction of bile duct hypertrophy (benign) of prostate with urinary obstruction and other lower urinary tract symptoms (luts) 
white m 76 $nan$hematology blood hematocrit  30.1  %; hematology blood hematocrit  29.1  %; hematology blood hemoglobin  9.9  g dl; hematology blood hemoglobin  9.8  g dl; hematology blood platelet count  143  k ul; hematology blood platelet count  118  k ul; chemistry blood anion gap  13  meq l; chemistry blood anion gap  11  meq l; chemistry blood bicarbonate  22  meq l; chemistry blood bicarbonate  25  meq l; chemistry blood chloride  106  meq l; chemistry blood chloride  107  meq l; chemistry blood creatinine  1.4  mg dl; chemistry blood creatinine  1.3  mg dl; chemistry blood potassium  3.9  meq l; chemistry blood potassium  4.0  meq l; chemistry blood sodium  137  meq l; chemistry blood sodium  139  meq l; chemistry blood urea nitrogen  24  mg dl; chemistry blood urea nitrogen  23  mg dl; hematology blood inr(pt)  1.4  ; hematology blood inr(pt)  1.3  ; chemistry blood calcium, total  7.9  mg dl; chemistry blood calcium, total  7.7  mg dl; chemistry blood bilirubin, total  1.2  mg dl; chemistry blood bilirubin, total  1.0  mg dl; chemistry blood glucose  119  mg dl; chemistry blood glucose  195  mg dl$multivitamins  1  tab ; thiamine  100  mg ; vitamin d  1000  unit ; ursodiol  600  mg ; docusate sodium  100  mg ; heparin  5000  unit ; sodium chloride 0.9%  flush  3  ml ; iso-osmotic dextrose  100  ml ; piperacillin-tazobactam  4.5  g ; senna  1  tab ; acetaminophen  500  mg ; 
obstruction of bile duct personal history of malignant neoplasm of other gastrointestinal tract biliary cirrhosis hypertrophy (benign) of prostate without urinary obstruction and other lower urinary tract symptom (luts) cholangitis retention of urine, unspecified personal history of malignant neoplasm of other gastrointestinal tract obstruction of bile duct hypertrophy (benign) of prostate with urinary obstruction and other lower urinary tract symptoms (luts) 
white m 76 $nan$hematology blood hematocrit  27.8  %; hematology blood hemoglobin  9.2  g dl; hematology blood platelet count  86  k ul; chemistry blood anion gap  14  meq l; chemistry blood bicarbonate  23  meq l; chemistry blood chloride  109  meq l; chemistry blood creatinine  1.2  mg dl; chemistry blood potassium  4.1  meq l; chemistry blood sodium  142  meq l; chemistry blood urea nitrogen  23  mg dl; chemistry blood calcium, total  7.9  mg dl; chemistry blood bilirubin, total  0.6  mg dl; chemistry blood glucose  92  mg dl; chemistry blood lactate dehydrogenase (ld)  175  iu l; chemistry blood albumin  3.0  g dl$d5ns  1000  ml ; multivitamins  1  tab ; thiamine  100  mg ; vitamin d  1000  unit ; ursodiol  600  mg ; docusate sodium  100  mg ; heparin  5000  unit ; sodium chloride 0.9%  flush  3  ml ; iso-osmotic dextrose  100  ml ; piperacillin-tazobactam  4.5  g ; senna  1  tab ; acetaminophen  500  mg ; lorazepam  0.5  mg ; acetaminophen iv  1000  mg ; 
obstruction of bile duct personal history of malignant neoplasm of other gastrointestinal tract biliary cirrhosis hypertrophy (benign) of prostate without urinary obstruction and other lower urinary tract symptom (luts) cholangitis retention of urine, unspecified personal history of malignant neoplasm of other gastrointestinal tract obstruction of bile duct hypertrophy (benign) of prostate with urinary obstruction and other lower urinary tract symptoms (luts) 
white m 76 $nan$hematology blood hematocrit  28.5  %; hematology blood hemoglobin  9.4  g dl; hematology blood platelet count  90  k ul; chemistry blood anion gap  10  meq l; chemistry blood bicarbonate  24  meq l; chemistry blood chloride  110  meq l; chemistry blood creatinine  1.0  mg dl; chemistry blood potassium  3.8  meq l; chemistry blood sodium  140  meq l; chemistry blood urea nitrogen  21  mg dl; hematology blood inr(pt)  1.1  ; chemistry blood calcium, total  7.9  mg dl; chemistry blood bilirubin, total  0.5  mg dl; chemistry blood glucose  99  mg dl$multivitamins  1  tab ; thiamine  100  mg ; vitamin d  1000  unit ; ursodiol  600  mg ; docusate sodium  100  mg ; sodium chloride 0.9%  flush  3  ml ; senna  1  tab ; acetaminophen  500  mg ; lorazepam  0.5  mg ; lactated ringers  1000  ml ; 
obstruction of bile duct personal history of malignant neoplasm of other gastrointestinal tract biliary cirrhosis hypertrophy (benign) of prostate without urinary obstruction and other lower urinary tract symptom (luts) cholangitis retention of urine, unspecified personal history of malignant neoplasm of other gastrointestinal tract obstruction of bile duct hypertrophy (benign) of prostate with urinary obstruction and other lower urinary tract symptoms (luts) 
white m 76 $nan$hematology blood hematocrit  29.3  %; hematology blood hemoglobin  9.8  g dl; hematology blood platelet count  121  k ul; chemistry blood anion gap  12  meq l; chemistry blood bicarbonate  24  meq l; chemistry blood chloride  107  meq l; chemistry blood creatinine  0.9  mg dl; chemistry blood potassium  3.5  meq l; chemistry blood sodium  139  meq l; chemistry blood urea nitrogen  16  mg dl; hematology blood inr(pt)  1.1  ; chemistry blood calcium, total  8.3  mg dl; chemistry blood bilirubin, total  0.6  mg dl; chemistry blood glucose  93  mg dl; chemistry blood lactate dehydrogenase (ld)  131  iu l; chemistry blood albumin  3.1  g dl$terazosin  5  mg ; multivitamins  1  tab ; thiamine  100  mg ; vitamin d  1000  unit ; ursodiol  600  mg ; docusate sodium  100  mg ; sodium chloride 0.9%  flush  3  ml ; senna  1  tab ; acetaminophen  500  mg ; neutra-phos  2  pkt ; iso-osmotic sodium chloride  400  ml ; fluconazole  800  mg ; iso-osmotic sodium chloride  200  ml ; fluconazole  400  mg ; potassium chloride  40  meq ; 
obstruction of bile duct personal history of malignant neoplasm of other gastrointestinal tract biliary cirrhosis hypertrophy (benign) of prostate without urinary obstruction and other lower urinary tract symptom (luts) cholangitis retention of urine, unspecified personal history of malignant neoplasm of other gastrointestinal tract obstruction of bile duct hypertrophy (benign) of prostate with urinary obstruction and other lower urinary tract symptoms (luts) 
white m 76 $nan$hematology blood hematocrit  30.9  %; hematology blood hemoglobin  10.2  g dl; hematology blood platelet count  121  k ul; chemistry blood anion gap  13  meq l; chemistry blood bicarbonate  23  meq l; chemistry blood chloride  107  meq l; chemistry blood creatinine  1.1  mg dl; chemistry blood potassium  3.9  meq l; chemistry blood sodium  139  meq l; chemistry blood urea nitrogen  15  mg dl; hematology blood inr(pt)  1.1  ; chemistry blood calcium, total  8.9  mg dl; chemistry blood bilirubin, total  0.7  mg dl; chemistry blood glucose  99  mg dl; chemistry blood albumin  3.6  g dl$terazosin  5  mg ; multivitamins  1  tab ; thiamine  100  mg ; vitamin d  1000  unit ; ursodiol  600  mg ; docusate sodium  100  mg ; sodium chloride 0.9%  flush  3  ml ; senna  1  tab ; acetaminophen  500  mg ; neutra-phos  2  pkt ; iso-osmotic sodium chloride  400  ml ; fluconazole  800  mg ; iso-osmotic sodium chloride  200  ml ; fluconazole  400  mg ; potassium chloride  40  meq ; folic acid  1  mg ; cyanocobalamin  100  mcg ; 
obstruction of bile duct personal history of malignant neoplasm of other gastrointestinal tract biliary cirrhosis hypertrophy (benign) of prostate without urinary obstruction and other lower urinary tract symptom (luts) cholangitis retention of urine, unspecified personal history of malignant neoplasm of other gastrointestinal tract obstruction of bile duct hypertrophy (benign) of prostate with urinary obstruction and other lower urinary tract symptoms (luts) 
white m 76 $nan$hematology blood hematocrit  31.6  %; hematology blood hemoglobin  10.4  g dl; hematology blood platelet count  151  k ul; chemistry blood anion gap  15  meq l; chemistry blood bicarbonate  21  meq l; chemistry blood chloride  108  meq l; chemistry blood creatinine  1.1  mg dl; chemistry blood potassium  4.2  meq l; chemistry blood sodium  140  meq l; chemistry blood urea nitrogen  13  mg dl; hematology blood inr(pt)  1.1  ; chemistry blood calcium, total  8.8  mg dl; chemistry blood bilirubin, total  0.6  mg dl; chemistry blood glucose  105  mg dl; chemistry blood lactate dehydrogenase (ld)  173  iu l; chemistry blood albumin  3.6  g dl$terazosin  5  mg ; multivitamins  1  tab ; thiamine  100  mg ; vitamin d  1000  unit ; ursodiol  600  mg ; docusate sodium  100  mg ; sodium chloride 0.9%  flush  3  ml ; senna  1  tab ; acetaminophen  500  mg ; iso-osmotic sodium chloride  200  ml ; fluconazole  400  mg ; folic acid  1  mg ; cyanocobalamin  100  mcg ; heparin flush (10 units ml)  2  ml ; 
obstruction of bile duct personal history of malignant neoplasm of other gastrointestinal tract biliary cirrhosis hypertrophy (benign) of prostate without urinary obstruction and other lower urinary tract symptom (luts) cholangitis retention of urine, unspecified personal history of malignant neoplasm of other gastrointestinal tract obstruction of bile duct hypertrophy (benign) of prostate with urinary obstruction and other lower urinary tract symptoms (luts) 
white m 76 $nan$hematology blood hematocrit  29.2  %; hematology blood hemoglobin  9.6  g dl; hematology blood platelet count  154  k ul; chemistry blood anion gap  13  meq l; chemistry blood bicarbonate  25  meq l; chemistry blood chloride  107  meq l; chemistry blood creatinine  1.1  mg dl; chemistry blood potassium  3.7  meq l; chemistry blood sodium  141  meq l; chemistry blood urea nitrogen  14  mg dl; hematology blood inr(pt)  1.1  ; chemistry blood calcium, total  8.4  mg dl; chemistry blood bilirubin, total  0.5  mg dl; chemistry blood glucose  91  mg dl; chemistry blood albumin  3.4  g dl$terazosin  5  mg ; multivitamins  1  tab ; thiamine  100  mg ; vitamin d  1000  unit ; ursodiol  600  mg ; docusate sodium  100  mg ; sodium chloride 0.9%  flush  3  ml ; senna  1  tab ; acetaminophen  500  mg ; iso-osmotic sodium chloride  200  ml ; fluconazole  400  mg ; folic acid  1  mg ; cyanocobalamin  100  mcg ; heparin flush (10 units ml)  2  ml ; 
obstruction of bile duct personal history of malignant neoplasm of other gastrointestinal tract biliary cirrhosis hypertrophy (benign) of prostate without urinary obstruction and other lower urinary tract symptom (luts) cholangitis retention of urine, unspecified personal history of malignant neoplasm of other gastrointestinal tract obstruction of bile duct hypertrophy (benign) of prostate with urinary obstruction and other lower urinary tract symptoms (luts) 
white m 76 $nan$hematology blood hematocrit  23.3  %; hematology blood hematocrit  32.0  %; hematology blood hemoglobin  7.6  g dl; hematology blood platelet count  205  k ul; chemistry blood anion gap  11  meq l; chemistry blood bicarbonate  24  meq l; chemistry blood chloride  109  meq l; chemistry blood creatinine  1.0  mg dl; chemistry blood potassium  3.8  meq l; chemistry blood sodium  140  meq l; chemistry blood urea nitrogen  14  mg dl; hematology blood inr(pt)  1.1  ; chemistry blood calcium, total  8.2  mg dl; chemistry blood bilirubin, total  0.3  mg dl; chemistry blood glucose  84  mg dl; chemistry blood lactate dehydrogenase (ld)  159  iu l$terazosin  5  mg ; multivitamins  1  tab ; thiamine  100  mg ; vitamin d  1000  unit ; ursodiol  600  mg ; docusate sodium  100  mg ; sodium chloride 0.9%  flush  3  ml ; senna  1  tab ; acetaminophen  500  mg ; iso-osmotic sodium chloride  200  ml ; fluconazole  400  mg ; folic acid  1  mg ; cyanocobalamin  100  mcg ; heparin flush (10 units ml)  2  ml ; 0.9% sodium chloride (mini bag plus)  100  ml ; *nf* ertapenem sodium  1  gm ; 
obstruction of bile duct personal history of malignant neoplasm of other gastrointestinal tract biliary cirrhosis hypertrophy (benign) of prostate without urinary obstruction and other lower urinary tract symptom (luts) cholangitis retention of urine, unspecified personal history of malignant neoplasm of other gastrointestinal tract obstruction of bile duct hypertrophy (benign) of prostate with urinary obstruction and other lower urinary tract symptoms (luts) 
white m 76 $nan$nan$terazosin  5  mg ; multivitamins  1  tab ; thiamine  100  mg ; vitamin d  1000  unit ; ursodiol  600  mg ; docusate sodium  100  mg ; sodium chloride 0.9%  flush  3  ml ; senna  1  tab ; acetaminophen  500  mg ; iso-osmotic sodium chloride  200  ml ; fluconazole  400  mg ; folic acid  1  mg ; cyanocobalamin  100  mcg ; heparin flush (10 units ml)  2  ml ; 0.9% sodium chloride (mini bag plus)  100  ml ; *nf* ertapenem sodium  1  gm ; 
obstruction of bile duct personal history of malignant neoplasm of other gastrointestinal tract biliary cirrhosis hypertrophy (benign) of prostate without urinary obstruction and other lower urinary tract symptom (luts) cholangitis retention of urine, unspecified personal history of malignant neoplasm of other gastrointestinal tract obstruction of bile duct hypertrophy (benign) of prostate with urinary obstruction and other lower urinary tract symptoms (luts) 
white f 98 $temp  98.0  heartrate  99.0  resprate  16.0  o2sat  98.0  sbp  170.0  dbp  86.0  rhythm    pain  unable  $nan$sodium chloride 0.9%  flush  3  ml ; acetaminophen  650  mg ; docusate sodium  100  mg ; senna  17.2  mg ; trazodone  25  mg ; heparin  5000  unit ; lisinopril  40  mg ; amlodipine  5  mg ; venlafaxine xr  225  mg ; vitamin d  1000  unit ; 
alzheimer's disease anxiety state, unspecified unspecified essential hypertension hyperpotassemia syncope and collapse dementia in conditions classified elsewhere without behavioral disturbance peripheral vascular disease, unspecified do not resuscitate status leukocytosis, unspecified other and unspecified noninfectious gastroenteritis and colitis diarrhea fecal impaction hypopotassemia acute kidney failure, unspecified depressive disorder, not elsewhere classified open wound of foot except toe(s) alone, without mention of complication alpha-1-antitrypsin deficiency home accidents unspecified essential hypertension accidental fall on or from sidewalk curb home accidents acute kidney failure, unspecified other specified metabolic disorders anemia, unspecified anxiety state, unspecified unspecified fall alzheimer's disease contusion of lower leg osteoporosis, unspecified dementia in conditions classified elsewhere without behavioral disturbance depressive disorder, not elsewhere classified unspecified essential hypertension urinary tract infection, site not specified depressive disorder, not elsewhere classified fall resulting in striking against other object metabolic syndrome abrasion or friction burn of face, neck, and scalp except eye, without mention of infection unspecified essential hypertension anemia, unspecified urinary tract infection, site not specified blepharitis, unspecified hypopotassemia dysthymic disorder urinary incontinence, unspecified other persistent mental disorders due to conditions classified elsewhere unspecified essential hypertension friedlnder's bacillus infection in conditions classified elsewhere and of unspecified site hypovolemia
white f 98 $nan$nan$sodium chloride 0.9%  flush  3  ml ; acetaminophen  650  mg ; docusate sodium  100  mg ; senna  17.2  mg ; trazodone  25  mg ; heparin  5000  unit ; lisinopril  40  mg ; amlodipine  5  mg ; venlafaxine xr  225  mg ; vitamin d  1000  unit ; 
alzheimer's disease anxiety state, unspecified unspecified essential hypertension hyperpotassemia syncope and collapse dementia in conditions classified elsewhere without behavioral disturbance peripheral vascular disease, unspecified do not resuscitate status leukocytosis, unspecified other and unspecified noninfectious gastroenteritis and colitis diarrhea fecal impaction hypopotassemia acute kidney failure, unspecified depressive disorder, not elsewhere classified open wound of foot except toe(s) alone, without mention of complication alpha-1-antitrypsin deficiency home accidents unspecified essential hypertension accidental fall on or from sidewalk curb home accidents acute kidney failure, unspecified other specified metabolic disorders anemia, unspecified anxiety state, unspecified unspecified fall alzheimer's disease contusion of lower leg osteoporosis, unspecified dementia in conditions classified elsewhere without behavioral disturbance depressive disorder, not elsewhere classified unspecified essential hypertension urinary tract infection, site not specified depressive disorder, not elsewhere classified fall resulting in striking against other object metabolic syndrome abrasion or friction burn of face, neck, and scalp except eye, without mention of infection unspecified essential hypertension anemia, unspecified urinary tract infection, site not specified blepharitis, unspecified hypopotassemia dysthymic disorder urinary incontinence, unspecified other persistent mental disorders due to conditions classified elsewhere unspecified essential hypertension friedlnder's bacillus infection in conditions classified elsewhere and of unspecified site hypovolemia
white f 98 $nan$nan$acetaminophen  650  mg ; docusate sodium  100  mg ; senna  17.2  mg ; trazodone  25  mg ; heparin  5000  unit ; lisinopril  40  mg ; amlodipine  5  mg ; venlafaxine xr  225  mg ; vitamin d  1000  unit ; 
alzheimer's disease anxiety state, unspecified unspecified essential hypertension hyperpotassemia syncope and collapse dementia in conditions classified elsewhere without behavioral disturbance peripheral vascular disease, unspecified do not resuscitate status leukocytosis, unspecified other and unspecified noninfectious gastroenteritis and colitis diarrhea fecal impaction hypopotassemia acute kidney failure, unspecified depressive disorder, not elsewhere classified open wound of foot except toe(s) alone, without mention of complication alpha-1-antitrypsin deficiency home accidents unspecified essential hypertension accidental fall on or from sidewalk curb home accidents acute kidney failure, unspecified other specified metabolic disorders anemia, unspecified anxiety state, unspecified unspecified fall alzheimer's disease contusion of lower leg osteoporosis, unspecified dementia in conditions classified elsewhere without behavioral disturbance depressive disorder, not elsewhere classified unspecified essential hypertension urinary tract infection, site not specified depressive disorder, not elsewhere classified fall resulting in striking against other object metabolic syndrome abrasion or friction burn of face, neck, and scalp except eye, without mention of infection unspecified essential hypertension anemia, unspecified urinary tract infection, site not specified blepharitis, unspecified hypopotassemia dysthymic disorder urinary incontinence, unspecified other persistent mental disorders due to conditions classified elsewhere unspecified essential hypertension friedlnder's bacillus infection in conditions classified elsewhere and of unspecified site hypovolemia
white f 59 $nan$nan$omeprazole  20  mg ; 
other and unspecified hyperlipidemia acute pancreatitis unspecified essential hypertension esophageal reflux mitral valve disorders diabetes mellitus without mention of complication, type ii or unspecified type, not stated as uncontrolled
white f 59 $nan$hematology blood hematocrit  32.9  %; hematology blood hemoglobin  10.9  g dl; hematology blood platelet count  275  k ul; hematology blood platelet count  249  k ul; chemistry blood anion gap  15  meq l; chemistry blood bicarbonate  31  meq l; chemistry blood chloride  96  meq l; chemistry blood creatinine  1.0  mg dl; chemistry blood potassium  3.8  meq l; chemistry blood potassium  3.8  meq l; chemistry blood sodium  138  meq l; chemistry blood urea nitrogen  13  mg dl; hematology blood inr(pt)  1.0  ; chemistry blood calcium, total  9.6  mg dl; chemistry blood glucose  129  mg dl$omeprazole  20  mg ; nifedipine cr  30  mg ; aspirin  325  mg ; simvastatin  40  mg ; multivitamins  1  tab ; polyethylene glycol  17  g ; clopidogrel  75  mg ; ranitidine  75  mg ; sodium chloride 0.9%  flush  3  ml ; heparin  4000  unit ; heparin  1200  unit ; d5w  250  ml ; heparin sodium  25,000  unit ; nitroglycerin sl  0.3  mg ; metoprolol tartrate  12.5  mg ; morphine sulfate  2-4  mg ; dextrose 50%  12.5  gm ; glucagon  1  mg ; insulin  0  unit ; 1 2 ns  1000  ml ; atropine sulfate  0.5  mg ; iso-osmotic dextrose  50  ml ; cefazolin  1  g ; acetaminophen  325-650  mg ; 
other and unspecified hyperlipidemia acute pancreatitis unspecified essential hypertension esophageal reflux mitral valve disorders diabetes mellitus without mention of complication, type ii or unspecified type, not stated as uncontrolled
white f 59 $nan$nan$nifedipine cr  30  mg ; aspirin  325  mg ; simvastatin  40  mg ; multivitamins  1  tab ; polyethylene glycol  17  g ; clopidogrel  75  mg ; ranitidine  75  mg ; sodium chloride 0.9%  flush  3  ml ; nitroglycerin sl  0.3  mg ; metoprolol tartrate  12.5  mg ; morphine sulfate  2-4  mg ; dextrose 50%  12.5  gm ; glucagon  1  mg ; insulin  0  unit ; atropine sulfate  0.5  mg ; iso-osmotic dextrose  50  ml ; cefazolin  1  g ; acetaminophen  325-650  mg ; 
other and unspecified hyperlipidemia acute pancreatitis unspecified essential hypertension esophageal reflux mitral valve disorders diabetes mellitus without mention of complication, type ii or unspecified type, not stated as uncontrolled
white f 76 $nan$hematology blood hematocrit  32.2  %; hematology blood hemoglobin  11.5  g dl; hematology blood platelet count  180  k ul; chemistry blood anion gap  11  meq l; chemistry blood bicarbonate  28  meq l; chemistry blood chloride  101  meq l; chemistry blood creatinine  1.1  mg dl; chemistry blood potassium  3.3  meq l; chemistry blood sodium  137  meq l; chemistry blood urea nitrogen  17  mg dl; chemistry blood glucose  93  mg dl$influenza virus vaccine  0.5  ml ; pneumococcal vac polyvalent  0.5  ml ; sodium chloride 0.9%  flush  3  ml ; senna  1  tab ; acetaminophen  325-650  mg ; docusate sodium  100  mg ; heparin  5000  unit ; amlodipine  10  mg ; simvastatin  20  mg ; aspirin  81  mg ; 
 
white f 76 $nan$nan$influenza virus vaccine  0.5  ml ; pneumococcal vac polyvalent  0.5  ml ; sodium chloride 0.9%  flush  3  ml ; senna  1  tab ; acetaminophen  325-650  mg ; docusate sodium  100  mg ; heparin  5000  unit ; amlodipine  10  mg ; simvastatin  20  mg ; aspirin  81  mg ; 
 
white m 73 $nan$nan$atenolol  50  mg ; atorvastatin  80  mg ; digoxin  0.125  mg ; lisinopril  40  mg ; sertraline  50  mg ; 
atrial flutter depressive disorder, not elsewhere classified coronary atherosclerosis of unspecified type of vessel, native or graft diabetes mellitus without mention of complication, type ii or unspecified type, not stated as uncontrolled other and unspecified hyperlipidemia aortocoronary bypass status anxiety state, unspecified other specified forms of chronic ischemic heart disease old myocardial infarction unspecified essential hypertension personal history of methicillin resistant staphylococcus aureus 
white m 73 $nan$hematology blood hematocrit  31.8  %; hematology blood hemoglobin  10.8  g dl; hematology blood platelet count  226  k ul; chemistry blood anion gap  14  meq l; chemistry blood bicarbonate  26  meq l; chemistry blood chloride  103  meq l; chemistry blood creatinine  1.4  mg dl; chemistry blood potassium  4.0  meq l; chemistry blood sodium  139  meq l; chemistry blood urea nitrogen  16  mg dl; hematology blood inr(pt)  2.8  ; hematology blood inr(pt)  2.9  ; chemistry blood calcium, total  9.0  mg dl; chemistry blood glucose  87  mg dl$atenolol  50  mg ; atorvastatin  80  mg ; digoxin  0.125  mg ; lisinopril  40  mg ; sertraline  50  mg ; pneumococcal 23-valent polysaccharide vaccine  0.5  ml ; sodium chloride 0.9%  flush  3  ml ; zolpidem tartrate  5  mg ; tamsulosin  0.4  mg ; primidone  25  mg ; 0.9% sodium chloride  500  ml ; insulin  0  unit ; dextrose 50%  12.5  gm ; glucagon  1  mg ; glucose gel  15  g ; warfarin  5  mg ; warfarin  2.5  mg ; simethicone  40-80  mg ; 
atrial flutter depressive disorder, not elsewhere classified coronary atherosclerosis of unspecified type of vessel, native or graft diabetes mellitus without mention of complication, type ii or unspecified type, not stated as uncontrolled other and unspecified hyperlipidemia aortocoronary bypass status anxiety state, unspecified other specified forms of chronic ischemic heart disease old myocardial infarction unspecified essential hypertension personal history of methicillin resistant staphylococcus aureus 
white m 73 $nan$nan$atenolol  50  mg ; atorvastatin  80  mg ; digoxin  0.125  mg ; lisinopril  40  mg ; sertraline  50  mg ; sodium chloride 0.9%  flush  3  ml ; zolpidem tartrate  5  mg ; tamsulosin  0.4  mg ; primidone  25  mg ; insulin  0  unit ; dextrose 50%  12.5  gm ; glucagon  1  mg ; glucose gel  15  g ; warfarin  2.5  mg ; simethicone  40-80  mg ; 
atrial flutter depressive disorder, not elsewhere classified coronary atherosclerosis of unspecified type of vessel, native or graft diabetes mellitus without mention of complication, type ii or unspecified type, not stated as uncontrolled other and unspecified hyperlipidemia aortocoronary bypass status anxiety state, unspecified other specified forms of chronic ischemic heart disease old myocardial infarction unspecified essential hypertension personal history of methicillin resistant staphylococcus aureus 
white f 42 $nan$hematology blood hematocrit  23.2  %; hematology blood hemoglobin  8.2  g dl; hematology blood platelet count  132  k ul$sodium chloride 0.9%  flush  3  ml ; acetaminophen  650  mg ; ondansetron  4  mg ; 
 
white f 42 $nan$nan$sodium chloride 0.9%  flush  3  ml ; acetaminophen  650  mg ; ondansetron  4  mg ; docusate sodium  100  mg ; aspirin  121.5  mg ; heparin  5000  unit ; influenza virus vaccine  0.5  ml ; potassium chl 20 meq   1000 ml d5lr  1000  ml ; aspirin  150  mg ; 0.9% sodium chloride  100  ml ; cefazolin  2  gm ; hydromorphone (dilaudid)  12.5  mg ; 0.9% sodium chloride  1000  ml ; lorazepam  0.5-1  mg ; 
 
white f 42 $nan$hematology blood hematocrit  22.4  %; hematology blood hemoglobin  7.9  g dl; hematology blood platelet count  124  k ul$sodium chloride 0.9%  flush  3  ml ; acetaminophen  650  mg ; ondansetron  4  mg ; docusate sodium  100  mg ; aspirin  121.5  mg ; heparin  5000  unit ; potassium chl 20 meq   1000 ml d5lr  1000  ml ; 0.9% sodium chloride  100  ml ; cefazolin  2  gm ; hydromorphone (dilaudid)  12.5  mg ; 0.9% sodium chloride  1000  ml ; lorazepam  0.5-1  mg ; hydrocodone-acetaminophen  1-2  tab ; hydromorphone (dilaudid)  0.25  mg ; 
 
white f 42 $nan$nan$sodium chloride 0.9%  flush  3  ml ; acetaminophen  650  mg ; ondansetron  4  mg ; docusate sodium  100  mg ; aspirin  121.5  mg ; heparin  5000  unit ; 0.9% sodium chloride  100  ml ; cefazolin  2  gm ; lorazepam  0.5-1  mg ; hydrocodone-acetaminophen  1-2  tab ; hydromorphone (dilaudid)  0.25  mg ; 
 
white f 42 $nan$nan$sodium chloride 0.9%  flush  3  ml ; acetaminophen  650  mg ; ondansetron  4  mg ; docusate sodium  100  mg ; aspirin  121.5  mg ; heparin  5000  unit ; 0.9% sodium chloride  100  ml ; cefazolin  2  gm ; lorazepam  0.5-1  mg ; hydrocodone-acetaminophen  1-2  tab ; hydromorphone (dilaudid)  0.25  mg ; cephalexin  500  mg ; 
 
white f 42 $nan$hematology blood hematocrit  36.8  %; hematology blood hemoglobin  12.3  g dl; hematology blood platelet count  344  k ul; chemistry blood anion gap  14  meq l; chemistry blood bicarbonate  25  meq l; chemistry blood chloride  103  meq l; chemistry blood creatinine  0.8  mg dl; chemistry blood potassium  3.5  meq l; chemistry blood sodium  138  meq l; chemistry blood urea nitrogen  12  mg dl; hematology blood inr(pt)  1.2  ; chemistry blood bilirubin, total  0.5  mg dl; chemistry blood glucose  90  mg dl; chemistry blood albumin  4.2  g dl; hematology urine glucose  neg  mg dl; hematology urine bilirubin  neg  mg dl$nan
congenital hypothyroidism other and unspecified noninfectious gastroenteritis and colitis esophageal reflux depressive disorder, not elsewhere classified long-term (current) use of steroids regional enteritis of unspecified site dysthymic disorder intestinal infection due to other organism, not elsewhere classified irritable bowel syndrome congenital hypothyroidism congenital hypothyroidism regional enteritis of unspecified site dysthymic disorder dysthymic disorder regional enteritis of unspecified site attention deficit disorder with hyperactivity congenital hypothyroidism hemorrhage of gastrointestinal tract, unspecified regional enteritis of unspecified site attention deficit disorder with hyperactivity esophageal reflux unspecified viral infection other diseases of respiratory system, not elsewhere classified long-term (current) use of steroids asthma, unspecified type, unspecified congenital hypothyroidism headache hypovolemia congenital hypothyroidism migraine without aura, without mention of intractable migraine without mention of status migrainosus attention deficit disorder with hyperactivity syncope and collapse dysthymic disorder leukocytosis, unspecified regional enteritis of unspecified site congenital hypothyroidism attention deficit disorder with hyperactivity regional enteritis of large intestine dysthymic disorder dehydration candidiasis of vulva and vagina regional enteritis of large intestine dysthymic disorder attention deficit disorder with hyperactivity mechanical complication due to intrauterine contraceptive device congenital hypothyroidism
white f 42 $nan$hematology blood hematocrit  35.3  %; hematology blood hemoglobin  11.8  g dl; hematology blood platelet count  304  k ul; chemistry blood anion gap  11  meq l; chemistry blood bicarbonate  26  meq l; chemistry blood chloride  105  meq l; chemistry blood creatinine  0.8  mg dl; chemistry blood potassium  3.4  meq l; chemistry blood sodium  139  meq l; chemistry blood urea nitrogen  7  mg dl; chemistry blood calcium, total  8.1  mg dl; chemistry blood bilirubin, total  0.7  mg dl; chemistry blood glucose  93  mg dl$1 2 ns  1000  ml ; influenza virus vaccine  0.5  ml ; sodium chloride 0.9%  flush  3  ml ; 0.9% sodium chloride  1000  ml ; ondansetron  4  mg ; prochlorperazine  10  mg ; acetaminophen  325-650  mg ; hydromorphone (dilaudid)  0.5-1  mg ; vial  1  vial ; pantoprazole  40  mg ; heparin  5000  unit ; calcium carbonate  1000  mg ; hyoscyamine so4 (time release)  0.375  mg ; vitamin d  800  unit ; levothyroxine sodium  100  mcg ; levothyroxine sodium  75  mcg ; prednisone  10  mg ; 
congenital hypothyroidism other and unspecified noninfectious gastroenteritis and colitis esophageal reflux depressive disorder, not elsewhere classified long-term (current) use of steroids regional enteritis of unspecified site dysthymic disorder intestinal infection due to other organism, not elsewhere classified irritable bowel syndrome congenital hypothyroidism congenital hypothyroidism regional enteritis of unspecified site dysthymic disorder dysthymic disorder regional enteritis of unspecified site attention deficit disorder with hyperactivity congenital hypothyroidism hemorrhage of gastrointestinal tract, unspecified regional enteritis of unspecified site attention deficit disorder with hyperactivity esophageal reflux unspecified viral infection other diseases of respiratory system, not elsewhere classified long-term (current) use of steroids asthma, unspecified type, unspecified congenital hypothyroidism headache hypovolemia congenital hypothyroidism migraine without aura, without mention of intractable migraine without mention of status migrainosus attention deficit disorder with hyperactivity syncope and collapse dysthymic disorder leukocytosis, unspecified regional enteritis of unspecified site congenital hypothyroidism attention deficit disorder with hyperactivity regional enteritis of large intestine dysthymic disorder dehydration candidiasis of vulva and vagina regional enteritis of large intestine dysthymic disorder attention deficit disorder with hyperactivity mechanical complication due to intrauterine contraceptive device congenital hypothyroidism
black african american f 35 $nan$hematology blood hematocrit  29.7  %; hematology blood hemoglobin  9.5  g dl; hematology blood platelet count  285  k ul; chemistry blood anion gap  12  meq l; chemistry blood bicarbonate  22  meq l; chemistry blood chloride  103  meq l; chemistry blood creatinine  0.5  mg dl; chemistry blood potassium  3.2  meq l; chemistry blood sodium  134  meq l; chemistry blood urea nitrogen  7  mg dl; hematology blood inr(pt)  1.0  ; hematology urine wbc  3-5  # hpf; chemistry blood calcium, total  8.7  mg dl; chemistry blood glucose  117  mg dl; hematology urine glucose  neg  mg dl; hematology urine bilirubin  neg  mg dl$iso-osmotic dextrose  50  ml ; ceftriaxone  1  gm ; 
 
black african american f 35 $nan$nan$iso-osmotic dextrose  50  ml ; ceftriaxone  1  gm ; docusate sodium  100  mg ; acetaminophen  650  mg ; oxazepam  15-30  mg ; calcium carbonate  500  mg ; milk of magnesia  15-30  ml ; morphine sulfate  1  mg ; oxycodone-acetaminophen  1-2  tab ; lr  1000  ml ; sodium chloride 0.9%  flush  3  ml ; potassium chl 40 meq   1000 ml ns  1000  ml ; sw  50  ml ; magnesium sulfate  2  gm ; nephrocaps  1  cap ; 
 
black african american f 35 $nan$nan$iso-osmotic dextrose  50  ml ; ceftriaxone  1  gm ; docusate sodium  100  mg ; acetaminophen  650  mg ; oxazepam  15-30  mg ; calcium carbonate  500  mg ; milk of magnesia  15-30  ml ; morphine sulfate  1  mg ; oxycodone-acetaminophen  1-2  tab ; sodium chloride 0.9%  flush  3  ml ; sw  50  ml ; magnesium sulfate  2  gm ; nephrocaps  1  cap ; ferrous gluconate  325  mg ; nitrofurantoin monohyd (macrobid)  100  mg ; 
 
hispanic latino m 43 $nan$hematology blood hematocrit  32.2  %; hematology blood hematocrit  30.7  %; hematology blood hemoglobin  10.7  g dl; hematology blood hemoglobin  10.1  g dl; hematology blood platelet count  122  k ul; hematology blood platelet count  124  k ul; chemistry blood anion gap  23  meq l; chemistry blood anion gap  16  meq l; chemistry blood anion gap  21  meq l; chemistry blood anion gap  21  meq l; chemistry blood anion gap  22  meq l; chemistry blood bicarbonate  10  meq l; chemistry blood bicarbonate  9  meq l; chemistry blood bicarbonate  8  meq l; chemistry blood bicarbonate  10  meq l; chemistry blood bicarbonate  7  meq l; chemistry blood chloride  96  meq l; chemistry blood chloride  97  meq l; chemistry blood chloride  100  meq l; chemistry blood chloride  101  meq l; chemistry blood chloride  100  meq l; chemistry blood creatinine  10.7  mg dl; chemistry blood creatinine  10.8  mg dl; chemistry blood creatinine  11.0  mg dl; chemistry blood creatinine  10.8  mg dl; chemistry blood creatinine  10.3  mg dl; chemistry blood potassium  3.3  meq l; chemistry blood potassium  2.1  meq l; chemistry blood potassium  2.2  meq l; chemistry blood potassium  2.5  meq l; chemistry blood potassium  2.8  meq l; chemistry blood sodium  127  meq l; chemistry blood sodium  125  meq l; chemistry blood sodium  125  meq l; chemistry blood sodium  128  meq l; chemistry blood sodium  123  meq l; chemistry blood urea nitrogen  51  mg dl; chemistry blood urea nitrogen  51  mg dl; chemistry blood urea nitrogen  52  mg dl; chemistry blood urea nitrogen  49  mg dl; chemistry blood urea nitrogen  50  mg dl; hematology blood inr(pt)  1.3  ; chemistry blood calcium, total  7.0  mg dl; chemistry blood calcium, total  7.4  mg dl; chemistry blood calcium, total  7.3  mg dl; chemistry blood calcium, total  8.0  mg dl; chemistry blood calcium, total  5.0  mg dl; chemistry blood bilirubin, total  0.2  mg dl; chemistry blood glucose  123  mg dl; chemistry blood glucose  129  mg dl; chemistry blood glucose  112  mg dl; chemistry blood glucose  125  mg dl; chemistry blood glucose  92  mg dl; blood gas blood free calcium  1.05  mmol l; blood gas blood free calcium  1.28  mmol l; blood gas blood free calcium  0.94  mmol l; blood gas blood lactate  2.1  mmol l; blood gas blood lactate  2.5  mmol l$heparin  5000  unit ; ceftriaxone  1  gm ; acetaminophen iv  1000  mg ; magnesium oxide  400  mg ; ondansetron  4  mg ; potassium chloride (powder)  40  meq ; sulfameth trimethoprim ds  1  tab ; magnesium sulfate  4  gm ; potassium chl 40 meq   1000 ml d5 1 2 ns  1000  ml ; 0.9% sodium chloride  2  bag ; calcium gluconate  4  g ; sodium bicarbonate  1300  mg ; 0.9% sodium chloride  1  bag ; calcium gluconate  2  g ; lactated ringers  1000  ml ; potassium chloride  40  meq ; sterile water  100  ml ; sterile water  150  ml ; potassium chloride  60  meq ; sterile water  200  ml ; potassium chloride  80  meq ; bag  1  bag ; magnesium sulfate  2  gm ; bag  2  bag ; dolutegravir  50  mg ; lamivudine  50  mg ; 0.9% sodium chloride (mini bag plus)  100  ml ; 
depressive disorder, not elsewhere classified acute kidney failure, unspecified leukocytopenia, unspecified human immunodeficiency virus [hiv] disease disorders of magnesium metabolism late effects of motor vehicle accident hypopotassemia salmonella gastroenteritis mononeuritis of lower limb, unspecified other pancytopenia chronic kidney disease, unspecified candidal esophagitis tobacco use disorder street and highway accidents late effect of unspecified injury personal history of noncompliance with medical treatment, presenting hazards to health acidosis other specified disorders of rectum and anus anemia of other chronic disease unspecified hereditary and idiopathic peripheral neuropathy major depressive affective disorder, single episode, moderate hypocalcemia disorders of magnesium metabolism hypopotassemia personal history of tobacco use personal history of noncompliance with medical treatment, presenting hazards to health salmonella gastroenteritis acidosis eosinophilia anemia, unspecified human immunodeficiency virus [hiv] disease acute kidney failure, unspecified chronic kidney disease, stage iii (moderate) unspecified disorder of intestine chronic kidney disease, stage iii (moderate) personal history of noncompliance with medical treatment, presenting hazards to health salmonella gastroenteritis need for prophylactic vaccination and inoculation against influenza hypopotassemia cachexia acidosis other specified disorders resulting from impaired renal function acute kidney failure with lesion of tubular necrosis human immunodeficiency virus [hiv] disease anemia of other chronic disease hypocalcemia other and unspecified coagulation defects tobacco use disorder
hispanic latino m 43 $nan$hematology blood hematocrit  22.3  %; hematology blood hematocrit  20.4  %; hematology blood hemoglobin  7.2  g dl; hematology blood hemoglobin  7.0  g dl; hematology blood platelet count  139  k ul; hematology blood platelet count  116  k ul; chemistry blood anion gap  20  meq l; chemistry blood anion gap  21  meq l; chemistry blood anion gap  17  meq l; chemistry blood anion gap  20  meq l; chemistry blood anion gap  18  meq l; chemistry blood anion gap  19  meq l; chemistry blood bicarbonate  12  meq l; chemistry blood bicarbonate  11  meq l; chemistry blood bicarbonate  14  meq l; chemistry blood bicarbonate  9  meq l; chemistry blood bicarbonate  11  meq l; chemistry blood bicarbonate  9  meq l; chemistry blood chloride  103  meq l; chemistry blood chloride  104  meq l; chemistry blood chloride  104  meq l; chemistry blood chloride  101  meq l; chemistry blood chloride  102  meq l; chemistry blood chloride  102  meq l; chemistry blood creatinine  9.9  mg dl; chemistry blood creatinine  9.2  mg dl; chemistry blood creatinine  9.3  mg dl; chemistry blood creatinine  8.8  mg dl; chemistry blood creatinine  9.4  mg dl; chemistry blood creatinine  9.5  mg dl; chemistry blood potassium  3.0  meq l; chemistry blood potassium  3.1  meq l; chemistry blood potassium  3.1  meq l; chemistry blood potassium  3.1  meq l; chemistry blood potassium  3.5  meq l; chemistry blood potassium  2.4  meq l; chemistry blood sodium  129  meq l; chemistry blood sodium  131  meq l; chemistry blood sodium  129  meq l; chemistry blood sodium  129  meq l; chemistry blood sodium  130  meq l; chemistry blood sodium  131  meq l; chemistry blood urea nitrogen  50  mg dl; chemistry blood urea nitrogen  50  mg dl; chemistry blood urea nitrogen  50  mg dl; chemistry blood urea nitrogen  47  mg dl; chemistry blood urea nitrogen  47  mg dl; chemistry blood urea nitrogen  45  mg dl; hematology blood inr(pt)  1.4  ; chemistry urine chloride, urine  89  meq l; chemistry urine creatinine, urine  38  mg dl; chemistry urine potassium, urine  17  meq l; chemistry urine sodium, urine  89  meq l; hematology urine wbc  1  # hpf; hematology urine wbc  1  # hpf; chemistry blood calcium, total  8.0  mg dl; chemistry blood calcium, total  7.5  mg dl; chemistry blood calcium, total  7.3  mg dl; chemistry blood calcium, total  7.3  mg dl; chemistry blood calcium, total  6.7  mg dl; chemistry blood calcium, total  8.2  mg dl; chemistry blood bilirubin, total  0.1  mg dl; chemistry blood glucose  86  mg dl; chemistry blood glucose  163  mg dl; chemistry blood glucose  116  mg dl; chemistry blood glucose  107  mg dl; chemistry blood glucose  139  mg dl; chemistry blood glucose  119  mg dl; chemistry blood albumin  2.2  g dl; blood gas blood free calcium  1.18  mmol l; blood gas blood free calcium  1.13  mmol l; blood gas blood free calcium  1.08  mmol l; blood gas blood free calcium  1.07  mmol l; blood gas blood free calcium  1.17  mmol l; blood gas blood lactate  2.5  mmol l$heparin  5000  unit ; acetaminophen iv  1000  mg ; ondansetron  4  mg ; magnesium sulfate  4  gm ; 0.9% sodium chloride  2  bag ; calcium gluconate  4  g ; 0.9% sodium chloride  1  bag ; calcium gluconate  2  g ; sterile water  100  ml ; sterile water  150  ml ; potassium chloride  60  meq ; sterile water  200  ml ; potassium chloride  80  meq ; bag  1  bag ; magnesium sulfate  2  gm ; bag  2  bag ; dolutegravir  50  mg ; lamivudine  50  mg ; 0.9% sodium chloride (mini bag plus)  100  ml ; sodium bicarbonate  100  meq ; ondansetron  4-8  mg ; 5% dextrose  1000  ml ; sodium bicarbonate  150  meq ; sodium chloride 0.9%  flush  10  ml ; abacavir sulfate  600  mg ; lamivudine  25  mg ; sulfameth trimethoprim ss  1  tab ; sw  400  ml ; sw  600  ml ; sw  800  ml ; neutra-phos  2  pkt ; 
depressive disorder, not elsewhere classified acute kidney failure, unspecified leukocytopenia, unspecified human immunodeficiency virus [hiv] disease disorders of magnesium metabolism late effects of motor vehicle accident hypopotassemia salmonella gastroenteritis mononeuritis of lower limb, unspecified other pancytopenia chronic kidney disease, unspecified candidal esophagitis tobacco use disorder street and highway accidents late effect of unspecified injury personal history of noncompliance with medical treatment, presenting hazards to health acidosis other specified disorders of rectum and anus anemia of other chronic disease unspecified hereditary and idiopathic peripheral neuropathy major depressive affective disorder, single episode, moderate hypocalcemia disorders of magnesium metabolism hypopotassemia personal history of tobacco use personal history of noncompliance with medical treatment, presenting hazards to health salmonella gastroenteritis acidosis eosinophilia anemia, unspecified human immunodeficiency virus [hiv] disease acute kidney failure, unspecified chronic kidney disease, stage iii (moderate) unspecified disorder of intestine chronic kidney disease, stage iii (moderate) personal history of noncompliance with medical treatment, presenting hazards to health salmonella gastroenteritis need for prophylactic vaccination and inoculation against influenza hypopotassemia cachexia acidosis other specified disorders resulting from impaired renal function acute kidney failure with lesion of tubular necrosis human immunodeficiency virus [hiv] disease anemia of other chronic disease hypocalcemia other and unspecified coagulation defects tobacco use disorder
hispanic latino m 43 $nan$hematology blood hematocrit  21.7  %; hematology blood hemoglobin  7.2  g dl; hematology blood platelet count  135  k ul; chemistry blood anion gap  18  meq l; chemistry blood anion gap  17  meq l; chemistry blood anion gap  14  meq l; chemistry blood anion gap  16  meq l; chemistry blood anion gap  16  meq l; chemistry blood anion gap  16  meq l; chemistry blood bicarbonate  15  meq l; chemistry blood bicarbonate  12  meq l; chemistry blood bicarbonate  14  meq l; chemistry blood bicarbonate  13  meq l; chemistry blood bicarbonate  13  meq l; chemistry blood bicarbonate  14  meq l; chemistry blood chloride  107  meq l; chemistry blood chloride  110  meq l; chemistry blood chloride  109  meq l; chemistry blood chloride  108  meq l; chemistry blood chloride  110  meq l; chemistry blood chloride  111  meq l; chemistry blood creatinine  8.3  mg dl; chemistry blood creatinine  8.1  mg dl; chemistry blood creatinine  7.8  mg dl; chemistry blood creatinine  6.9  mg dl; chemistry blood creatinine  6.7  mg dl; chemistry blood creatinine  6.4  mg dl; chemistry blood potassium  3.1  meq l; chemistry blood potassium  3.6  meq l; chemistry blood potassium  3.7  meq l; chemistry blood potassium  3.4  meq l; chemistry blood potassium  3.6  meq l; chemistry blood potassium  3.8  meq l; chemistry blood sodium  135  meq l; chemistry blood sodium  137  meq l; chemistry blood sodium  134  meq l; chemistry blood sodium  133  meq l; chemistry blood sodium  136  meq l; chemistry blood sodium  136  meq l; chemistry blood urea nitrogen  42  mg dl; chemistry blood urea nitrogen  41  mg dl; chemistry blood urea nitrogen  39  mg dl; chemistry blood urea nitrogen  33  mg dl; chemistry blood urea nitrogen  32  mg dl; chemistry blood urea nitrogen  31  mg dl; chemistry blood calcium, total  7.6  mg dl; chemistry blood calcium, total  7.5  mg dl; chemistry blood calcium, total  7.3  mg dl; chemistry blood calcium, total  7.6  mg dl; chemistry blood calcium, total  7.3  mg dl; chemistry blood calcium, total  7.8  mg dl; chemistry blood bilirubin, total  0.1  mg dl; chemistry blood glucose  99  mg dl; chemistry blood glucose  101  mg dl; chemistry blood glucose  114  mg dl; chemistry blood glucose  102  mg dl; chemistry blood glucose  131  mg dl; chemistry blood glucose  140  mg dl; chemistry blood albumin  2.3  g dl; blood gas blood free calcium  1.14  mmol l; blood gas blood free calcium  1.14  mmol l; blood gas blood free calcium  1.13  mmol l; blood gas blood free calcium  1.16  mmol l; blood gas blood free calcium  1.10  mmol l; blood gas blood free calcium  1.17  mmol l; blood gas blood lactate  1.3  mmol l; blood gas blood lactate  1.4  mmol l$heparin  5000  unit ; bag  1  bag ; magnesium sulfate  2  gm ; bag  2  bag ; dolutegravir  50  mg ; 0.9% sodium chloride (mini bag plus)  100  ml ; ondansetron  4-8  mg ; 5% dextrose  1000  ml ; sodium bicarbonate  150  meq ; sodium chloride 0.9%  flush  10  ml ; abacavir sulfate  600  mg ; lamivudine  25  mg ; sulfameth trimethoprim ss  1  tab ; sw  400  ml ; sw  600  ml ; sw  800  ml ; neutra-phos  2  pkt ; 0.9% sodium chloride  250  ml ; sodium phosphate  30  mmol ; 
depressive disorder, not elsewhere classified acute kidney failure, unspecified leukocytopenia, unspecified human immunodeficiency virus [hiv] disease disorders of magnesium metabolism late effects of motor vehicle accident hypopotassemia salmonella gastroenteritis mononeuritis of lower limb, unspecified other pancytopenia chronic kidney disease, unspecified candidal esophagitis tobacco use disorder street and highway accidents late effect of unspecified injury personal history of noncompliance with medical treatment, presenting hazards to health acidosis other specified disorders of rectum and anus anemia of other chronic disease unspecified hereditary and idiopathic peripheral neuropathy major depressive affective disorder, single episode, moderate hypocalcemia disorders of magnesium metabolism hypopotassemia personal history of tobacco use personal history of noncompliance with medical treatment, presenting hazards to health salmonella gastroenteritis acidosis eosinophilia anemia, unspecified human immunodeficiency virus [hiv] disease acute kidney failure, unspecified chronic kidney disease, stage iii (moderate) unspecified disorder of intestine chronic kidney disease, stage iii (moderate) personal history of noncompliance with medical treatment, presenting hazards to health salmonella gastroenteritis need for prophylactic vaccination and inoculation against influenza hypopotassemia cachexia acidosis other specified disorders resulting from impaired renal function acute kidney failure with lesion of tubular necrosis human immunodeficiency virus [hiv] disease anemia of other chronic disease hypocalcemia other and unspecified coagulation defects tobacco use disorder
hispanic latino m 43 $nan$hematology blood hematocrit  20.2  %; hematology blood hematocrit  20.0  %; hematology blood hematocrit  20.1  %; hematology blood hematocrit  21.4  %; hematology blood hemoglobin  6.9  g dl; hematology blood hemoglobin  6.8  g dl; hematology blood hemoglobin  6.7  g dl; hematology blood hemoglobin  7.0  g dl; hematology blood platelet count  141  k ul; hematology blood platelet count  134  k ul; hematology blood platelet count  147  k ul; hematology blood platelet count  141  k ul; chemistry blood anion gap  14  meq l; chemistry blood anion gap  13  meq l; chemistry blood anion gap  13  meq l; chemistry blood anion gap  12  meq l; chemistry blood anion gap  14  meq l; chemistry blood bicarbonate  17  meq l; chemistry blood bicarbonate  16  meq l; chemistry blood bicarbonate  16  meq l; chemistry blood bicarbonate  14  meq l; chemistry blood bicarbonate  14  meq l; chemistry blood chloride  110  meq l; chemistry blood chloride  107  meq l; chemistry blood chloride  108  meq l; chemistry blood chloride  109  meq l; chemistry blood chloride  109  meq l; chemistry blood creatinine  6.0  mg dl; chemistry blood creatinine  5.4  mg dl; chemistry blood creatinine  5.1  mg dl; chemistry blood creatinine  4.8  mg dl; chemistry blood creatinine  4.6  mg dl; chemistry blood potassium  3.4  meq l; chemistry blood potassium  3.2  meq l; chemistry blood potassium  3.6  meq l; chemistry blood potassium  4.1  meq l; chemistry blood potassium  3.4  meq l; chemistry blood sodium  135  meq l; chemistry blood sodium  134  meq l; chemistry blood sodium  133  meq l; chemistry blood sodium  133  meq l; chemistry blood sodium  134  meq l; chemistry blood urea nitrogen  28  mg dl; chemistry blood urea nitrogen  28  mg dl; chemistry blood urea nitrogen  26  mg dl; chemistry blood urea nitrogen  24  mg dl; chemistry blood urea nitrogen  23  mg dl; chemistry blood calcium, total  7.2  mg dl; chemistry blood calcium, total  6.9  mg dl; chemistry blood calcium, total  7.2  mg dl; chemistry blood calcium, total  7.1  mg dl; chemistry blood calcium, total  7.7  mg dl; chemistry blood bilirubin, total  0.1  mg dl; chemistry blood glucose  102  mg dl; chemistry blood glucose  111  mg dl; chemistry blood glucose  112  mg dl; chemistry blood glucose  160  mg dl; chemistry blood glucose  118  mg dl; blood gas blood free calcium  1.10  mmol l; blood gas blood free calcium  1.06  mmol l; blood gas blood free calcium  1.15  mmol l; blood gas blood lactate  1.1  mmol l; blood gas blood lactate  1.1  mmol l$heparin  5000  unit ; bag  1  bag ; magnesium sulfate  2  gm ; bag  2  bag ; dolutegravir  50  mg ; 0.9% sodium chloride (mini bag plus)  100  ml ; ondansetron  4-8  mg ; sodium chloride 0.9%  flush  10  ml ; abacavir sulfate  600  mg ; lamivudine  25  mg ; sulfameth trimethoprim ss  1  tab ; neutra-phos  2  pkt ; 0.9% sodium chloride  250  ml ; sodium phosphate  30  mmol ; azithromycin  1200  mg ; 
depressive disorder, not elsewhere classified acute kidney failure, unspecified leukocytopenia, unspecified human immunodeficiency virus [hiv] disease disorders of magnesium metabolism late effects of motor vehicle accident hypopotassemia salmonella gastroenteritis mononeuritis of lower limb, unspecified other pancytopenia chronic kidney disease, unspecified candidal esophagitis tobacco use disorder street and highway accidents late effect of unspecified injury personal history of noncompliance with medical treatment, presenting hazards to health acidosis other specified disorders of rectum and anus anemia of other chronic disease unspecified hereditary and idiopathic peripheral neuropathy major depressive affective disorder, single episode, moderate hypocalcemia disorders of magnesium metabolism hypopotassemia personal history of tobacco use personal history of noncompliance with medical treatment, presenting hazards to health salmonella gastroenteritis acidosis eosinophilia anemia, unspecified human immunodeficiency virus [hiv] disease acute kidney failure, unspecified chronic kidney disease, stage iii (moderate) unspecified disorder of intestine chronic kidney disease, stage iii (moderate) personal history of noncompliance with medical treatment, presenting hazards to health salmonella gastroenteritis need for prophylactic vaccination and inoculation against influenza hypopotassemia cachexia acidosis other specified disorders resulting from impaired renal function acute kidney failure with lesion of tubular necrosis human immunodeficiency virus [hiv] disease anemia of other chronic disease hypocalcemia other and unspecified coagulation defects tobacco use disorder
hispanic latino m 43 $nan$hematology blood hematocrit  19.3  %; hematology blood hemoglobin  6.3  g dl; hematology blood platelet count  138  k ul; chemistry blood anion gap  15  meq l; chemistry blood anion gap  9  meq l; chemistry blood anion gap  11  meq l; chemistry blood anion gap  11  meq l; chemistry blood anion gap  11  meq l; chemistry blood bicarbonate  15  meq l; chemistry blood bicarbonate  16  meq l; chemistry blood bicarbonate  16  meq l; chemistry blood bicarbonate  16  meq l; chemistry blood bicarbonate  15  meq l; chemistry blood chloride  111  meq l; chemistry blood chloride  113  meq l; chemistry blood chloride  113  meq l; chemistry blood chloride  114  meq l; chemistry blood chloride  113  meq l; chemistry blood creatinine  4.2  mg dl; chemistry blood creatinine  3.7  mg dl; chemistry blood creatinine  3.6  mg dl; chemistry blood creatinine  3.3  mg dl; chemistry blood creatinine  3.0  mg dl; chemistry blood potassium  4.0  meq l; chemistry blood potassium  3.5  meq l; chemistry blood potassium  3.4  meq l; chemistry blood potassium  3.8  meq l; chemistry blood potassium  3.9  meq l; chemistry blood sodium  137  meq l; chemistry blood sodium  133  meq l; chemistry blood sodium  137  meq l; chemistry blood sodium  137  meq l; chemistry blood sodium  136  meq l; chemistry blood urea nitrogen  21  mg dl; chemistry blood urea nitrogen  20  mg dl; chemistry blood urea nitrogen  20  mg dl; chemistry blood urea nitrogen  19  mg dl; chemistry blood urea nitrogen  18  mg dl; chemistry blood calcium, total  7.2  mg dl; chemistry blood calcium, total  6.9  mg dl; chemistry blood calcium, total  6.6  mg dl; chemistry blood calcium, total  7.1  mg dl; chemistry blood calcium, total  7.0  mg dl; chemistry blood glucose  116  mg dl; chemistry blood glucose  136  mg dl; chemistry blood glucose  108  mg dl; chemistry blood glucose  119  mg dl; chemistry blood glucose  106  mg dl; blood gas blood free calcium  1.04  mmol l$heparin  5000  unit ; bag  1  bag ; magnesium sulfate  2  gm ; bag  2  bag ; dolutegravir  50  mg ; 0.9% sodium chloride (mini bag plus)  100  ml ; ondansetron  4-8  mg ; sodium chloride 0.9%  flush  10  ml ; abacavir sulfate  600  mg ; lamivudine  25  mg ; sulfameth trimethoprim ss  1  tab ; neutra-phos  2  pkt ; azithromycin  1200  mg ; 
depressive disorder, not elsewhere classified acute kidney failure, unspecified leukocytopenia, unspecified human immunodeficiency virus [hiv] disease disorders of magnesium metabolism late effects of motor vehicle accident hypopotassemia salmonella gastroenteritis mononeuritis of lower limb, unspecified other pancytopenia chronic kidney disease, unspecified candidal esophagitis tobacco use disorder street and highway accidents late effect of unspecified injury personal history of noncompliance with medical treatment, presenting hazards to health acidosis other specified disorders of rectum and anus anemia of other chronic disease unspecified hereditary and idiopathic peripheral neuropathy major depressive affective disorder, single episode, moderate hypocalcemia disorders of magnesium metabolism hypopotassemia personal history of tobacco use personal history of noncompliance with medical treatment, presenting hazards to health salmonella gastroenteritis acidosis eosinophilia anemia, unspecified human immunodeficiency virus [hiv] disease acute kidney failure, unspecified chronic kidney disease, stage iii (moderate) unspecified disorder of intestine chronic kidney disease, stage iii (moderate) personal history of noncompliance with medical treatment, presenting hazards to health salmonella gastroenteritis need for prophylactic vaccination and inoculation against influenza hypopotassemia cachexia acidosis other specified disorders resulting from impaired renal function acute kidney failure with lesion of tubular necrosis human immunodeficiency virus [hiv] disease anemia of other chronic disease hypocalcemia other and unspecified coagulation defects tobacco use disorder
hispanic latino m 43 $nan$hematology blood hematocrit  21.9  %; hematology blood hemoglobin  7.0  g dl; hematology blood platelet count  143  k ul; chemistry blood anion gap  14  meq l; chemistry blood anion gap  12  meq l; chemistry blood anion gap  6  meq l; chemistry blood anion gap  13  meq l; chemistry blood bicarbonate  16  meq l; chemistry blood bicarbonate  14  meq l; chemistry blood bicarbonate  13  meq l; chemistry blood bicarbonate  14  meq l; chemistry blood chloride  113  meq l; chemistry blood chloride  112  meq l; chemistry blood chloride  113  meq l; chemistry blood chloride  111  meq l; chemistry blood creatinine  2.9  mg dl; chemistry blood creatinine  2.5  mg dl; chemistry blood creatinine  2.4  mg dl; chemistry blood creatinine  2.1  mg dl; chemistry blood potassium  3.5  meq l; chemistry blood potassium  4.0  meq l; chemistry blood potassium  3.9  meq l; chemistry blood potassium  3.7  meq l; chemistry blood sodium  136  meq l; chemistry blood sodium  134  meq l; chemistry blood sodium  131  meq l; chemistry blood sodium  134  meq l; chemistry blood urea nitrogen  17  mg dl; chemistry blood urea nitrogen  17  mg dl; chemistry blood urea nitrogen  16  mg dl; chemistry blood urea nitrogen  14  mg dl; chemistry blood calcium, total  7.0  mg dl; chemistry blood calcium, total  6.8  mg dl; chemistry blood calcium, total  7.1  mg dl; chemistry blood calcium, total  7.3  mg dl; chemistry blood bilirubin, total  0.2  mg dl; chemistry blood glucose  109  mg dl; chemistry blood glucose  110  mg dl; chemistry blood glucose  93  mg dl; chemistry blood glucose  97  mg dl; chemistry blood albumin  2.4  g dl; blood gas blood free calcium  1.05  mmol l; blood gas blood lactate  1.5  mmol l; blood gas blood lactate  1.6  mmol l$heparin  5000  unit ; bag  1  bag ; magnesium sulfate  2  gm ; bag  2  bag ; dolutegravir  50  mg ; 0.9% sodium chloride (mini bag plus)  100  ml ; ondansetron  4-8  mg ; sodium chloride 0.9%  flush  10  ml ; abacavir sulfate  600  mg ; sulfameth trimethoprim ss  1  tab ; neutra-phos  2  pkt ; azithromycin  1200  mg ; vitamin d  50,000  unit ; heparin flush (10 units ml)  1  ml ; 
depressive disorder, not elsewhere classified acute kidney failure, unspecified leukocytopenia, unspecified human immunodeficiency virus [hiv] disease disorders of magnesium metabolism late effects of motor vehicle accident hypopotassemia salmonella gastroenteritis mononeuritis of lower limb, unspecified other pancytopenia chronic kidney disease, unspecified candidal esophagitis tobacco use disorder street and highway accidents late effect of unspecified injury personal history of noncompliance with medical treatment, presenting hazards to health acidosis other specified disorders of rectum and anus anemia of other chronic disease unspecified hereditary and idiopathic peripheral neuropathy major depressive affective disorder, single episode, moderate hypocalcemia disorders of magnesium metabolism hypopotassemia personal history of tobacco use personal history of noncompliance with medical treatment, presenting hazards to health salmonella gastroenteritis acidosis eosinophilia anemia, unspecified human immunodeficiency virus [hiv] disease acute kidney failure, unspecified chronic kidney disease, stage iii (moderate) unspecified disorder of intestine chronic kidney disease, stage iii (moderate) personal history of noncompliance with medical treatment, presenting hazards to health salmonella gastroenteritis need for prophylactic vaccination and inoculation against influenza hypopotassemia cachexia acidosis other specified disorders resulting from impaired renal function acute kidney failure with lesion of tubular necrosis human immunodeficiency virus [hiv] disease anemia of other chronic disease hypocalcemia other and unspecified coagulation defects tobacco use disorder
hispanic latino m 43 $nan$hematology blood hematocrit  21.2  %; hematology blood hemoglobin  7.1  g dl; hematology blood platelet count  156  k ul; chemistry blood anion gap  8  meq l; chemistry blood anion gap  11  meq l; chemistry blood bicarbonate  16  meq l; chemistry blood bicarbonate  16  meq l; chemistry blood chloride  112  meq l; chemistry blood chloride  115  meq l; chemistry blood creatinine  1.8  mg dl; chemistry blood creatinine  1.6  mg dl; chemistry blood potassium  3.4  meq l; chemistry blood potassium  3.5  meq l; chemistry blood sodium  133  meq l; chemistry blood sodium  138  meq l; chemistry blood urea nitrogen  14  mg dl; chemistry blood urea nitrogen  13  mg dl; hematology blood inr(pt)  1.3  ; chemistry blood calcium, total  7.0  mg dl; chemistry blood calcium, total  6.5  mg dl; chemistry blood bilirubin, total  0.1  mg dl; chemistry blood glucose  92  mg dl; chemistry blood glucose  115  mg dl; chemistry blood lactate dehydrogenase (ld)  167  iu l; chemistry blood albumin  2.1  g dl; blood gas blood lactate  1.4  mmol l$heparin  5000  unit ; dolutegravir  50  mg ; 0.9% sodium chloride (mini bag plus)  100  ml ; abacavir sulfate  600  mg ; sulfameth trimethoprim ss  1  tab ; neutra-phos  2  pkt ; azithromycin  1200  mg ; vitamin d  50,000  unit ; heparin flush (10 units ml)  1  ml ; diphenhydramine  25  mg ; cefpodoxime proxetil  200  mg ; 
depressive disorder, not elsewhere classified acute kidney failure, unspecified leukocytopenia, unspecified human immunodeficiency virus [hiv] disease disorders of magnesium metabolism late effects of motor vehicle accident hypopotassemia salmonella gastroenteritis mononeuritis of lower limb, unspecified other pancytopenia chronic kidney disease, unspecified candidal esophagitis tobacco use disorder street and highway accidents late effect of unspecified injury personal history of noncompliance with medical treatment, presenting hazards to health acidosis other specified disorders of rectum and anus anemia of other chronic disease unspecified hereditary and idiopathic peripheral neuropathy major depressive affective disorder, single episode, moderate hypocalcemia disorders of magnesium metabolism hypopotassemia personal history of tobacco use personal history of noncompliance with medical treatment, presenting hazards to health salmonella gastroenteritis acidosis eosinophilia anemia, unspecified human immunodeficiency virus [hiv] disease acute kidney failure, unspecified chronic kidney disease, stage iii (moderate) unspecified disorder of intestine chronic kidney disease, stage iii (moderate) personal history of noncompliance with medical treatment, presenting hazards to health salmonella gastroenteritis need for prophylactic vaccination and inoculation against influenza hypopotassemia cachexia acidosis other specified disorders resulting from impaired renal function acute kidney failure with lesion of tubular necrosis human immunodeficiency virus [hiv] disease anemia of other chronic disease hypocalcemia other and unspecified coagulation defects tobacco use disorder
hispanic latino m 43 $nan$hematology blood hematocrit  21.9  %; hematology blood hematocrit  23.3  %; hematology blood hemoglobin  6.9  g dl; hematology blood hemoglobin  7.4  g dl; hematology blood platelet count  163  k ul; hematology blood platelet count  185  k ul; chemistry blood anion gap  11  meq l; chemistry blood anion gap  12  meq l; chemistry blood bicarbonate  15  meq l; chemistry blood bicarbonate  14  meq l; chemistry blood chloride  116  meq l; chemistry blood chloride  114  meq l; chemistry blood creatinine  1.7  mg dl; chemistry blood creatinine  1.8  mg dl; chemistry blood potassium  3.6  meq l; chemistry blood potassium  3.8  meq l; chemistry blood sodium  138  meq l; chemistry blood sodium  136  meq l; chemistry blood urea nitrogen  11  mg dl; chemistry blood urea nitrogen  10  mg dl; chemistry blood calcium, total  7.2  mg dl; chemistry blood calcium, total  7.1  mg dl; chemistry blood glucose  123  mg dl; chemistry blood glucose  130  mg dl; blood gas blood lactate  1.4  mmol l; blood gas blood lactate  1.9  mmol l; hematology blood wbc count  2.4  k ul$heparin  5000  unit ; dolutegravir  50  mg ; abacavir sulfate  600  mg ; sulfameth trimethoprim ss  1  tab ; neutra-phos  2  pkt ; azithromycin  1200  mg ; vitamin d  50,000  unit ; heparin flush (10 units ml)  1  ml ; diphenhydramine  25  mg ; cefpodoxime proxetil  200  mg ; lamivudine  300  mg ; neutra-phos  3  pkt ; sertraline  50  mg ; phosphorus  500  mg ; calcium carbonate  1000  mg ; diphenoxylate-atropine  1  tab ; 
depressive disorder, not elsewhere classified acute kidney failure, unspecified leukocytopenia, unspecified human immunodeficiency virus [hiv] disease disorders of magnesium metabolism late effects of motor vehicle accident hypopotassemia salmonella gastroenteritis mononeuritis of lower limb, unspecified other pancytopenia chronic kidney disease, unspecified candidal esophagitis tobacco use disorder street and highway accidents late effect of unspecified injury personal history of noncompliance with medical treatment, presenting hazards to health acidosis other specified disorders of rectum and anus anemia of other chronic disease unspecified hereditary and idiopathic peripheral neuropathy major depressive affective disorder, single episode, moderate hypocalcemia disorders of magnesium metabolism hypopotassemia personal history of tobacco use personal history of noncompliance with medical treatment, presenting hazards to health salmonella gastroenteritis acidosis eosinophilia anemia, unspecified human immunodeficiency virus [hiv] disease acute kidney failure, unspecified chronic kidney disease, stage iii (moderate) unspecified disorder of intestine chronic kidney disease, stage iii (moderate) personal history of noncompliance with medical treatment, presenting hazards to health salmonella gastroenteritis need for prophylactic vaccination and inoculation against influenza hypopotassemia cachexia acidosis other specified disorders resulting from impaired renal function acute kidney failure with lesion of tubular necrosis human immunodeficiency virus [hiv] disease anemia of other chronic disease hypocalcemia other and unspecified coagulation defects tobacco use disorder
hispanic latino m 43 $nan$nan$heparin  5000  unit ; dolutegravir  50  mg ; abacavir sulfate  600  mg ; sulfameth trimethoprim ss  1  tab ; azithromycin  1200  mg ; vitamin d  50,000  unit ; heparin flush (10 units ml)  1  ml ; cefpodoxime proxetil  200  mg ; lamivudine  300  mg ; sertraline  50  mg ; phosphorus  500  mg ; calcium carbonate  1000  mg ; diphenoxylate-atropine  1  tab ; 
depressive disorder, not elsewhere classified acute kidney failure, unspecified leukocytopenia, unspecified human immunodeficiency virus [hiv] disease disorders of magnesium metabolism late effects of motor vehicle accident hypopotassemia salmonella gastroenteritis mononeuritis of lower limb, unspecified other pancytopenia chronic kidney disease, unspecified candidal esophagitis tobacco use disorder street and highway accidents late effect of unspecified injury personal history of noncompliance with medical treatment, presenting hazards to health acidosis other specified disorders of rectum and anus anemia of other chronic disease unspecified hereditary and idiopathic peripheral neuropathy major depressive affective disorder, single episode, moderate hypocalcemia disorders of magnesium metabolism hypopotassemia personal history of tobacco use personal history of noncompliance with medical treatment, presenting hazards to health salmonella gastroenteritis acidosis eosinophilia anemia, unspecified human immunodeficiency virus [hiv] disease acute kidney failure, unspecified chronic kidney disease, stage iii (moderate) unspecified disorder of intestine chronic kidney disease, stage iii (moderate) personal history of noncompliance with medical treatment, presenting hazards to health salmonella gastroenteritis need for prophylactic vaccination and inoculation against influenza hypopotassemia cachexia acidosis other specified disorders resulting from impaired renal function acute kidney failure with lesion of tubular necrosis human immunodeficiency virus [hiv] disease anemia of other chronic disease hypocalcemia other and unspecified coagulation defects tobacco use disorder
black african american m 50 $nan$hematology blood hematocrit  35.8  %; hematology blood hemoglobin  12.1  g dl; hematology blood platelet count  248  k ul; chemistry blood anion gap  15  meq l; chemistry blood bicarbonate  23  meq l; chemistry blood chloride  99  meq l; chemistry blood creatinine  0.8  mg dl; chemistry blood potassium  4.0  meq l; chemistry blood sodium  133  meq l; chemistry blood urea nitrogen  20  mg dl; chemistry blood glucose  146  mg dl$lactated ringers  1000  ml ; sodium chloride 0.9%  flush  3  ml ; dextrose 50%  12.5  gm ; glucagon  1  mg ; glucose gel  15  g ; oxycodone (immediate release)  5  mg ; acetaminophen  650  mg ; trazodone  100  mg ; quetiapine fumarate  100  mg ; heparin  5000  unit ; docusate sodium  100  mg ; allopurinol  300  mg ; baclofen  10  mg ; clonidine  0.1  mg ; fentanyl patch  75  mcg h ; hydrochlorothiazide  25  mg ; metformin xr (glucophage xr)  750  mg ; pregabalin  300  mg ; quetiapine fumarate  50  mg ; spironolactone  25  mg ; trandolapril  2  mg ; sertraline  50  mg ; 
nicotine dependence, cigarettes, uncomplicated type 2 diabetes mellitus without complications pneumonia, unspecified organism nonspecific elevation of levels of transaminase and lactic acid dehydrogenase [ldh] other chronic pain dehydration major depressive disorder, single episode, unspecified arthrodesis status essential (primary) hypertension gout, unspecified insomnia, unspecified diabetes mellitus without mention of complication, type ii or unspecified type, uncontrolled unspecified essential hypertension thoracic or lumbosacral neuritis or radiculitis, unspecified spinal stenosis, lumbar region, without neurogenic claudication tobacco use disorder fever, unspecified surgical operation with implant of artificial internal device causing abnormal patient reaction, or later complication,without mention of misadventure at time of operation other mechanical complication of other internal orthopedic device, implant, and graft other complications due to other internal orthopedic device, implant, and graft
black african american m 50 $nan$nan$lactated ringers  1000  ml ; sodium chloride 0.9%  flush  3  ml ; dextrose 50%  12.5  gm ; glucagon  1  mg ; glucose gel  15  g ; oxycodone (immediate release)  5  mg ; acetaminophen  650  mg ; trazodone  100  mg ; quetiapine fumarate  100  mg ; heparin  5000  unit ; docusate sodium  100  mg ; allopurinol  300  mg ; baclofen  10  mg ; clonidine  0.1  mg ; fentanyl patch  75  mcg h ; hydrochlorothiazide  25  mg ; metformin xr (glucophage xr)  750  mg ; quetiapine fumarate  50  mg ; spironolactone  25  mg ; trandolapril  2  mg ; sertraline  50  mg ; lidocaine 5% patch  1  ptch ; atorvastatin  40  mg ; verapamil sr  180  mg ; mirtazapine  45  mg ; 
nicotine dependence, cigarettes, uncomplicated type 2 diabetes mellitus without complications pneumonia, unspecified organism nonspecific elevation of levels of transaminase and lactic acid dehydrogenase [ldh] other chronic pain dehydration major depressive disorder, single episode, unspecified arthrodesis status essential (primary) hypertension gout, unspecified insomnia, unspecified diabetes mellitus without mention of complication, type ii or unspecified type, uncontrolled unspecified essential hypertension thoracic or lumbosacral neuritis or radiculitis, unspecified spinal stenosis, lumbar region, without neurogenic claudication tobacco use disorder fever, unspecified surgical operation with implant of artificial internal device causing abnormal patient reaction, or later complication,without mention of misadventure at time of operation other mechanical complication of other internal orthopedic device, implant, and graft other complications due to other internal orthopedic device, implant, and graft
white f 62 $nan$nan$heparin  5000  unit ; 
unspecified essential hypertension malignant neoplasm of breast (female), unspecified inflammatory disease of breast personal history of tobacco use family history of malignant neoplasm of breast other specified surgical operations and procedures causing abnormal patient reaction, or later complication, without mention of misadventure at time of operation anxiety state, unspecified home accidents infection and inflammatory reaction due to other internal prosthetic device, implant, and graft person boarding or alighting a pedal cycle injured in collision with other nonmotor vehicle in nontraffic accident person boarding or alighting a pedal cycle injured in collision with pedestrian or animal personal history of malignant neoplasm of breast acquired absence of breast and nipple acquired absence of breast and nipple person boarding or alighting a pedal cycle injured in collision with pedestrian or animal other specified disorders of breast personal history of tobacco use personal history of malignant neoplasm of breast malignant neoplasm of other specified sites of female breast 
white f 62 $nan$nan$heparin  5000  unit ; amlodipine  5  mg ; citalopram  20  mg ; levothyroxine sodium  50  mcg ; sodium chloride 0.9%  flush  3  ml ; d5lr  1000  ml ; ondansetron  4  mg ; acetaminophen  325-650  mg ; morphine sulfate  100  mg ; iso-osmotic dextrose  50  ml ; cefazolin  1  g ; lorazepam  0.5  mg ; 
unspecified essential hypertension malignant neoplasm of breast (female), unspecified inflammatory disease of breast personal history of tobacco use family history of malignant neoplasm of breast other specified surgical operations and procedures causing abnormal patient reaction, or later complication, without mention of misadventure at time of operation anxiety state, unspecified home accidents infection and inflammatory reaction due to other internal prosthetic device, implant, and graft person boarding or alighting a pedal cycle injured in collision with other nonmotor vehicle in nontraffic accident person boarding or alighting a pedal cycle injured in collision with pedestrian or animal personal history of malignant neoplasm of breast acquired absence of breast and nipple acquired absence of breast and nipple person boarding or alighting a pedal cycle injured in collision with pedestrian or animal other specified disorders of breast personal history of tobacco use personal history of malignant neoplasm of breast malignant neoplasm of other specified sites of female breast 
white f 62 $nan$nan$amlodipine  5  mg ; citalopram  20  mg ; levothyroxine sodium  50  mcg ; sodium chloride 0.9%  flush  3  ml ; d5lr  1000  ml ; ondansetron  4  mg ; acetaminophen  325-650  mg ; morphine sulfate  100  mg ; iso-osmotic dextrose  50  ml ; cefazolin  1  g ; lorazepam  0.5  mg ; acetaminophen iv  1000  mg ; hydromorphone (dilaudid)  0.12  mg ; potassium chl 20 meq   1000 ml d5 1 2 ns  1000  ml ; calcium carbonate  1000  mg ; 
unspecified essential hypertension malignant neoplasm of breast (female), unspecified inflammatory disease of breast personal history of tobacco use family history of malignant neoplasm of breast other specified surgical operations and procedures causing abnormal patient reaction, or later complication, without mention of misadventure at time of operation anxiety state, unspecified home accidents infection and inflammatory reaction due to other internal prosthetic device, implant, and graft person boarding or alighting a pedal cycle injured in collision with other nonmotor vehicle in nontraffic accident person boarding or alighting a pedal cycle injured in collision with pedestrian or animal personal history of malignant neoplasm of breast acquired absence of breast and nipple acquired absence of breast and nipple person boarding or alighting a pedal cycle injured in collision with pedestrian or animal other specified disorders of breast personal history of tobacco use personal history of malignant neoplasm of breast malignant neoplasm of other specified sites of female breast 
white f 62 $nan$hematology blood hematocrit  34.3  %; hematology blood hemoglobin  11.0  g dl; hematology blood platelet count  236  k ul; chemistry blood anion gap  10  meq l; chemistry blood bicarbonate  28  meq l; chemistry blood chloride  102  meq l; chemistry blood creatinine  0.7  mg dl; chemistry blood potassium  4.1  meq l; chemistry blood sodium  136  meq l; chemistry blood urea nitrogen  10  mg dl; chemistry blood calcium, total  8.8  mg dl; chemistry blood glucose  128  mg dl$amlodipine  5  mg ; citalopram  20  mg ; levothyroxine sodium  50  mcg ; sodium chloride 0.9%  flush  3  ml ; ondansetron  4  mg ; hydromorphone (dilaudid)  0.12  mg ; potassium chl 20 meq   1000 ml d5 1 2 ns  1000  ml ; calcium carbonate  1000  mg ; aspirin  81  mg ; ketorolac  15  mg ; acetaminophen  650  mg ; 0.9% sodium chloride  250  ml ; sodium phosphate  15  mmol ; sodium chloride 0.9%  1000  ml ; 
unspecified essential hypertension malignant neoplasm of breast (female), unspecified inflammatory disease of breast personal history of tobacco use family history of malignant neoplasm of breast other specified surgical operations and procedures causing abnormal patient reaction, or later complication, without mention of misadventure at time of operation anxiety state, unspecified home accidents infection and inflammatory reaction due to other internal prosthetic device, implant, and graft person boarding or alighting a pedal cycle injured in collision with other nonmotor vehicle in nontraffic accident person boarding or alighting a pedal cycle injured in collision with pedestrian or animal personal history of malignant neoplasm of breast acquired absence of breast and nipple acquired absence of breast and nipple person boarding or alighting a pedal cycle injured in collision with pedestrian or animal other specified disorders of breast personal history of tobacco use personal history of malignant neoplasm of breast malignant neoplasm of other specified sites of female breast 
white f 62 $nan$chemistry blood anion gap  10  meq l; chemistry blood bicarbonate  27  meq l; chemistry blood chloride  103  meq l; chemistry blood creatinine  0.7  mg dl; chemistry blood potassium  4.3  meq l; chemistry blood sodium  136  meq l; chemistry blood urea nitrogen  14  mg dl; chemistry blood calcium, total  9.3  mg dl; chemistry blood glucose  135  mg dl$amlodipine  5  mg ; citalopram  20  mg ; levothyroxine sodium  50  mcg ; sodium chloride 0.9%  flush  3  ml ; ondansetron  4  mg ; hydromorphone (dilaudid)  0.12  mg ; potassium chl 20 meq   1000 ml d5 1 2 ns  1000  ml ; calcium carbonate  1000  mg ; aspirin  81  mg ; ketorolac  15  mg ; acetaminophen  650  mg ; 0.9% sodium chloride  250  ml ; sodium phosphate  15  mmol ; sodium chloride 0.9%  1000  ml ; omeprazole  20  mg ; vial  1  vial ; pantoprazole  40  mg ; chloraseptic throat spray  1  spry ; 
unspecified essential hypertension malignant neoplasm of breast (female), unspecified inflammatory disease of breast personal history of tobacco use family history of malignant neoplasm of breast other specified surgical operations and procedures causing abnormal patient reaction, or later complication, without mention of misadventure at time of operation anxiety state, unspecified home accidents infection and inflammatory reaction due to other internal prosthetic device, implant, and graft person boarding or alighting a pedal cycle injured in collision with other nonmotor vehicle in nontraffic accident person boarding or alighting a pedal cycle injured in collision with pedestrian or animal personal history of malignant neoplasm of breast acquired absence of breast and nipple acquired absence of breast and nipple person boarding or alighting a pedal cycle injured in collision with pedestrian or animal other specified disorders of breast personal history of tobacco use personal history of malignant neoplasm of breast malignant neoplasm of other specified sites of female breast 
white f 62 $nan$chemistry blood anion gap  10  meq l; chemistry blood bicarbonate  24  meq l; chemistry blood chloride  104  meq l; chemistry blood creatinine  0.8  mg dl; chemistry blood potassium  4.4  meq l; chemistry blood sodium  134  meq l; chemistry blood urea nitrogen  14  mg dl; chemistry blood calcium, total  9.4  mg dl; chemistry blood glucose  88  mg dl$amlodipine  5  mg ; citalopram  20  mg ; sodium chloride 0.9%  flush  3  ml ; ondansetron  4  mg ; hydromorphone (dilaudid)  0.12  mg ; potassium chl 20 meq   1000 ml d5 1 2 ns  1000  ml ; calcium carbonate  1000  mg ; aspirin  81  mg ; vial  1  vial ; pantoprazole  40  mg ; chloraseptic throat spray  1  spry ; levothyroxine sodium  25  mcg ; 
unspecified essential hypertension malignant neoplasm of breast (female), unspecified inflammatory disease of breast personal history of tobacco use family history of malignant neoplasm of breast other specified surgical operations and procedures causing abnormal patient reaction, or later complication, without mention of misadventure at time of operation anxiety state, unspecified home accidents infection and inflammatory reaction due to other internal prosthetic device, implant, and graft person boarding or alighting a pedal cycle injured in collision with other nonmotor vehicle in nontraffic accident person boarding or alighting a pedal cycle injured in collision with pedestrian or animal personal history of malignant neoplasm of breast acquired absence of breast and nipple acquired absence of breast and nipple person boarding or alighting a pedal cycle injured in collision with pedestrian or animal other specified disorders of breast personal history of tobacco use personal history of malignant neoplasm of breast malignant neoplasm of other specified sites of female breast 
white f 62 $nan$nan$amlodipine  5  mg ; citalopram  20  mg ; sodium chloride 0.9%  flush  3  ml ; ondansetron  4  mg ; hydromorphone (dilaudid)  0.12  mg ; potassium chl 20 meq   1000 ml d5 1 2 ns  1000  ml ; calcium carbonate  1000  mg ; aspirin  81  mg ; vial  1  vial ; pantoprazole  40  mg ; chloraseptic throat spray  1  spry ; levothyroxine sodium  25  mcg ; hydromorphone (dilaudid)  2-4  mg ; 
unspecified essential hypertension malignant neoplasm of breast (female), unspecified inflammatory disease of breast personal history of tobacco use family history of malignant neoplasm of breast other specified surgical operations and procedures causing abnormal patient reaction, or later complication, without mention of misadventure at time of operation anxiety state, unspecified home accidents infection and inflammatory reaction due to other internal prosthetic device, implant, and graft person boarding or alighting a pedal cycle injured in collision with other nonmotor vehicle in nontraffic accident person boarding or alighting a pedal cycle injured in collision with pedestrian or animal personal history of malignant neoplasm of breast acquired absence of breast and nipple acquired absence of breast and nipple person boarding or alighting a pedal cycle injured in collision with pedestrian or animal other specified disorders of breast personal history of tobacco use personal history of malignant neoplasm of breast malignant neoplasm of other specified sites of female breast 
white f 62 $nan$nan$amlodipine  5  mg ; citalopram  20  mg ; sodium chloride 0.9%  flush  3  ml ; ondansetron  4  mg ; calcium carbonate  1000  mg ; aspirin  81  mg ; vial  1  vial ; pantoprazole  40  mg ; chloraseptic throat spray  1  spry ; levothyroxine sodium  25  mcg ; hydromorphone (dilaudid)  2-4  mg ; acetaminophen  1000  mg ; 
unspecified essential hypertension malignant neoplasm of breast (female), unspecified inflammatory disease of breast personal history of tobacco use family history of malignant neoplasm of breast other specified surgical operations and procedures causing abnormal patient reaction, or later complication, without mention of misadventure at time of operation anxiety state, unspecified home accidents infection and inflammatory reaction due to other internal prosthetic device, implant, and graft person boarding or alighting a pedal cycle injured in collision with other nonmotor vehicle in nontraffic accident person boarding or alighting a pedal cycle injured in collision with pedestrian or animal personal history of malignant neoplasm of breast acquired absence of breast and nipple acquired absence of breast and nipple person boarding or alighting a pedal cycle injured in collision with pedestrian or animal other specified disorders of breast personal history of tobacco use personal history of malignant neoplasm of breast malignant neoplasm of other specified sites of female breast 
white f 62 $nan$nan$amlodipine  5  mg ; citalopram  20  mg ; sodium chloride 0.9%  flush  3  ml ; ondansetron  4  mg ; calcium carbonate  1000  mg ; aspirin  81  mg ; chloraseptic throat spray  1  spry ; levothyroxine sodium  25  mcg ; hydromorphone (dilaudid)  2-4  mg ; acetaminophen  1000  mg ; omeprazole  40  mg ; 
unspecified essential hypertension malignant neoplasm of breast (female), unspecified inflammatory disease of breast personal history of tobacco use family history of malignant neoplasm of breast other specified surgical operations and procedures causing abnormal patient reaction, or later complication, without mention of misadventure at time of operation anxiety state, unspecified home accidents infection and inflammatory reaction due to other internal prosthetic device, implant, and graft person boarding or alighting a pedal cycle injured in collision with other nonmotor vehicle in nontraffic accident person boarding or alighting a pedal cycle injured in collision with pedestrian or animal personal history of malignant neoplasm of breast acquired absence of breast and nipple acquired absence of breast and nipple person boarding or alighting a pedal cycle injured in collision with pedestrian or animal other specified disorders of breast personal history of tobacco use personal history of malignant neoplasm of breast malignant neoplasm of other specified sites of female breast 
black african american f 26 $nan$nan$sodium chloride 0.9%  flush  3  ml ; lactated ringers  1000  ml ; sterile water  500  ml ; magnesium sulfate (ob)  20  gm ; acetaminophen  650  mg ; lamotrigine  300  mg ; acetaminophen-caff-butalbital  1-2  tab ; 
39 weeks gestation of pregnancy body mass index (bmi) 45.0-49.9, adult obesity complicating childbirth maternal care for scar from previous cesarean delivery obstructive sleep apnea (adult) (pediatric) other specified complications of labor and delivery single live birth abnormality in fetal heart rate and rhythm complicating labor and delivery unspecified asthma, uncomplicated epilepsy, unspecified, not intractable, without status epilepticus depressive disorder, not elsewhere classified epilepsy, unspecified, without mention of intractable epilepsy esophageal reflux 
black african american f 26 $nan$nan$sodium chloride 0.9%  flush  3  ml ; lactated ringers  1000  ml ; sterile water  500  ml ; magnesium sulfate (ob)  20  gm ; acetaminophen  650  mg ; lamotrigine  300  mg ; acetaminophen-caff-butalbital  1-2  tab ; calcium carbonate  500  mg ; famotidine  20  mg ; 
39 weeks gestation of pregnancy body mass index (bmi) 45.0-49.9, adult obesity complicating childbirth maternal care for scar from previous cesarean delivery obstructive sleep apnea (adult) (pediatric) other specified complications of labor and delivery single live birth abnormality in fetal heart rate and rhythm complicating labor and delivery unspecified asthma, uncomplicated epilepsy, unspecified, not intractable, without status epilepticus depressive disorder, not elsewhere classified epilepsy, unspecified, without mention of intractable epilepsy esophageal reflux 
white m 83 $nan$hematology blood hematocrit  16.2  %; hematology blood hemoglobin  5.2  g dl; hematology blood platelet count  217  k ul; hematology blood inr(pt)  1.6  ; blood gas blood free calcium  1.06  mmol l; blood gas blood free calcium  1.75  mmol l; blood gas blood lactate  8.6  mmol l; blood gas blood lactate  11.4  mmol l; blood gas blood chloride, whole blood  106  meq l; blood gas blood chloride, whole blood  110  meq l; blood gas blood glucose  190  mg dl; blood gas blood glucose  230  mg dl; blood gas blood hematocrit, calculated  24  %; blood gas blood hemoglobin  8.1  g dl; blood gas blood potassium, whole blood  3.7  meq l; blood gas blood potassium, whole blood  3.4  meq l; blood gas blood potassium, whole blood  4.9  meq l; blood gas blood sodium, whole blood  132  meq l; blood gas blood sodium, whole blood  136  meq l$nan
 
white f 29 $nan$nan$influenza vaccine quadrivalent  0.5  ml ; sodium chloride 0.9%  flush  3  ml ; lactated ringers  1000  ml ; oxycodone (immediate release)   5  mg ; heparin  5000  unit ; docusate sodium  100  mg ; 
 
black african american f 65 $nan$nan$insulin  8  unit ; citalopram hydrobromide  20  mg ; fluticasone propionate nasal  2  spry ; simvastatin  40  mg ; insulin  16  unit ; 
coronary atherosclerosis of native coronary artery end stage renal disease secondary hyperparathyroidism (of renal origin) other constipation influenza with pneumonia hypertensive chronic kidney disease, unspecified, with chronic kidney disease stage v or end stage renal disease hyperpotassemia diabetes mellitus without mention of complication, type ii or unspecified type, not stated as uncontrolled pure hypercholesterolemia anemia in chronic kidney disease
black african american f 65 $nan$hematology blood hematocrit  31.0  %; hematology blood hematocrit  35.5  %; hematology blood hemoglobin  10.2  g dl; hematology blood platelet count  173  k ul; chemistry blood anion gap  18  meq l; chemistry blood bicarbonate  28  meq l; chemistry blood chloride  95  meq l; chemistry blood creatinine  4.1  mg dl; chemistry blood potassium  5.0  meq l; chemistry blood sodium  136  meq l; chemistry blood urea nitrogen  14  mg dl; hematology blood inr(pt)  1.3  ; chemistry blood calcium, total  9.3  mg dl; chemistry blood bilirubin, total  0.5  mg dl; chemistry blood glucose  163  mg dl; chemistry blood lactate dehydrogenase (ld)  303  iu l; chemistry blood albumin  3.6  g dl; blood gas blood lactate  2.1  mmol l$insulin  8  unit ; citalopram hydrobromide  20  mg ; fluticasone propionate nasal  2  spry ; simvastatin  40  mg ; insulin  16  unit ; influenza virus vaccine  0.5  ml ; senna  1  tab ; heparin  5000  unit ; omeprazole  20  mg ; oxycodone-acetaminophen  1-2  tab ; morphine sulfate  1-2  mg ; insulin  0  unit ; 5% dextrose  250  ml ; vancomycin  1250  mg ; 5% dextrose  200  ml ; ciprofloxacin iv  400  mg ; amlodipine  10  mg ; 
coronary atherosclerosis of native coronary artery end stage renal disease secondary hyperparathyroidism (of renal origin) other constipation influenza with pneumonia hypertensive chronic kidney disease, unspecified, with chronic kidney disease stage v or end stage renal disease hyperpotassemia diabetes mellitus without mention of complication, type ii or unspecified type, not stated as uncontrolled pure hypercholesterolemia anemia in chronic kidney disease
black african american f 65 $nan$hematology blood hematocrit  28.5  %; hematology blood hematocrit  27.6  %; hematology blood hemoglobin  9.5  g dl; hematology blood platelet count  190  k ul; chemistry blood anion gap  16  meq l; chemistry blood bicarbonate  29  meq l; chemistry blood chloride  96  meq l; chemistry blood creatinine  6.4  mg dl; chemistry blood potassium  3.8  meq l; chemistry blood sodium  137  meq l; chemistry blood urea nitrogen  26  mg dl; chemistry blood calcium, total  9.9  mg dl; chemistry blood bilirubin, total  0.3  mg dl; chemistry blood glucose  59  mg dl; chemistry blood lactate dehydrogenase (ld)  151  iu l; blood gas blood lactate  1.2  mmol l$insulin  8  unit ; citalopram hydrobromide  20  mg ; fluticasone propionate nasal  2  spry ; simvastatin  40  mg ; insulin  16  unit ; influenza virus vaccine  0.5  ml ; senna  1  tab ; heparin  5000  unit ; omeprazole  20  mg ; oxycodone-acetaminophen  1-2  tab ; morphine sulfate  1-2  mg ; insulin  0  unit ; 5% dextrose  250  ml ; vancomycin  1250  mg ; 5% dextrose  200  ml ; ciprofloxacin iv  400  mg ; amlodipine  10  mg ; sodium chloride 0.9%  flush  3  ml ; 5% dextrose  150  ml ; vancomycin  500  mg ; ondansetron  4  mg ; zolpidem tartrate  5  mg ; lisinopril  40  mg ; sodium chloride nasal  1-2  spry ; vancomycin  1500  mg ; bisacodyl  10  mg ; sw  50  ml ; magnesium sulfate  2  gm ; 
coronary atherosclerosis of native coronary artery end stage renal disease secondary hyperparathyroidism (of renal origin) other constipation influenza with pneumonia hypertensive chronic kidney disease, unspecified, with chronic kidney disease stage v or end stage renal disease hyperpotassemia diabetes mellitus without mention of complication, type ii or unspecified type, not stated as uncontrolled pure hypercholesterolemia anemia in chronic kidney disease
black african american f 65 $nan$hematology blood hematocrit  27.5  %; hematology blood hemoglobin  9.2  g dl; hematology blood platelet count  203  k ul; chemistry blood anion gap  20  meq l; chemistry blood bicarbonate  26  meq l; chemistry blood chloride  92  meq l; chemistry blood creatinine  8.3  mg dl; chemistry blood potassium  4.1  meq l; chemistry blood sodium  134  meq l; chemistry blood urea nitrogen  37  mg dl; chemistry blood calcium, total  9.5  mg dl; chemistry blood glucose  47  mg dl$insulin  8  unit ; citalopram hydrobromide  20  mg ; fluticasone propionate nasal  2  spry ; simvastatin  40  mg ; insulin  16  unit ; influenza virus vaccine  0.5  ml ; heparin  5000  unit ; omeprazole  20  mg ; oxycodone-acetaminophen  1-2  tab ; insulin  0  unit ; sodium chloride 0.9%  flush  3  ml ; 5% dextrose  150  ml ; vancomycin  500  mg ; ondansetron  4  mg ; zolpidem tartrate  5  mg ; lisinopril  40  mg ; sodium chloride nasal  1-2  spry ; vancomycin  1500  mg ; bisacodyl  10  mg ; sw  50  ml ; magnesium sulfate  2  gm ; clonidine  0.2  mg ; docusate sodium  100  mg ; polyethylene glycol  17  g ; insulin  10  unit ; 
coronary atherosclerosis of native coronary artery end stage renal disease secondary hyperparathyroidism (of renal origin) other constipation influenza with pneumonia hypertensive chronic kidney disease, unspecified, with chronic kidney disease stage v or end stage renal disease hyperpotassemia diabetes mellitus without mention of complication, type ii or unspecified type, not stated as uncontrolled pure hypercholesterolemia anemia in chronic kidney disease
black african american f 65 $nan$hematology blood hematocrit  28.8  %; hematology blood hemoglobin  9.3  g dl; hematology blood platelet count  207  k ul; chemistry blood anion gap  15  meq l; chemistry blood bicarbonate  28  meq l; chemistry blood chloride  98  meq l; chemistry blood creatinine  4.6  mg dl; chemistry blood potassium  4.2  meq l; chemistry blood sodium  137  meq l; chemistry blood urea nitrogen  16  mg dl; chemistry blood calcium, total  10.3  mg dl; chemistry blood glucose  98  mg dl$citalopram hydrobromide  20  mg ; fluticasone propionate nasal  2  spry ; simvastatin  40  mg ; influenza virus vaccine  0.5  ml ; heparin  5000  unit ; omeprazole  20  mg ; oxycodone-acetaminophen  1-2  tab ; sodium chloride 0.9%  flush  3  ml ; ondansetron  4  mg ; zolpidem tartrate  5  mg ; sodium chloride nasal  1-2  spry ; vancomycin  1500  mg ; bisacodyl  10  mg ; docusate sodium  100  mg ; polyethylene glycol  17  g ; insulin  10  unit ; 
coronary atherosclerosis of native coronary artery end stage renal disease secondary hyperparathyroidism (of renal origin) other constipation influenza with pneumonia hypertensive chronic kidney disease, unspecified, with chronic kidney disease stage v or end stage renal disease hyperpotassemia diabetes mellitus without mention of complication, type ii or unspecified type, not stated as uncontrolled pure hypercholesterolemia anemia in chronic kidney disease
black african american f 65 $nan$nan$citalopram hydrobromide  20  mg ; fluticasone propionate nasal  2  spry ; simvastatin  40  mg ; influenza virus vaccine  0.5  ml ; heparin  5000  unit ; omeprazole  20  mg ; oxycodone-acetaminophen  1-2  tab ; sodium chloride 0.9%  flush  3  ml ; ondansetron  4  mg ; zolpidem tartrate  5  mg ; sodium chloride nasal  1-2  spry ; docusate sodium  100  mg ; insulin  10  unit ; 
coronary atherosclerosis of native coronary artery end stage renal disease secondary hyperparathyroidism (of renal origin) other constipation influenza with pneumonia hypertensive chronic kidney disease, unspecified, with chronic kidney disease stage v or end stage renal disease hyperpotassemia diabetes mellitus without mention of complication, type ii or unspecified type, not stated as uncontrolled pure hypercholesterolemia anemia in chronic kidney disease
asian m 26 $nan$nan$folic acid  1  mg ; 
body mass index less than 19, adult personal history of antineoplastic chemotherapy myelodysplastic syndrome, unspecified other drug-induced pancytopenia driver of special construction vehicle injured in traffic accident fever presenting with conditions classified elsewhere peripheral stem cells replaced by transplant unspecified drug or medicinal substance causing adverse effects in therapeutic use bacterial pneumonia, unspecified depressive disorder, not elsewhere classified peripheral stem cells replaced by transplant other hemochromatosis unspecified viral infection fever, unspecified person on outside of bus injured in collision with pedestrian or animal in traffic accident personal history of antineoplastic chemotherapy zygomycosis [phycomycosis or mucormycosis] examination of participant in clinical trial myelodysplastic syndrome, unspecified unspecified septicemia peripheral stem cells replaced by transplant hemorrhage complicating a procedure myelodysplastic syndrome, unspecified severe sepsis cytomegaloviral disease septic shock other pancytopenia other specified procedures as the cause of abnormal reaction of patient, or of later complication, without mention of misadventure at time of procedure other specified viral infection bacterial pneumonia, unspecified zygomycosis [phycomycosis or mucormycosis] diarrhea acidosis long-term (current) use of other medications other specified antibiotics causing adverse effects in therapeutic use nausea alone pneumonia, organism unspecified neutropenia, unspecified body mass index less than 19, adult depressive disorder, not elsewhere classified fever, unspecified myelodysplastic syndrome, unspecified driver of special construction vehicle injured in traffic accident peripheral stem cells replaced by transplant anemia, unspecified intestinal infection due to clostridium difficile zygomycosis [phycomycosis or mucormycosis] driver of special construction vehicle injured in traffic accident
asian m 26 $nan$hematology blood hematocrit  19.4  %; hematology blood hemoglobin  6.5  g dl; hematology blood platelet count  14  k ul; chemistry blood anion gap  14  meq l; chemistry blood bicarbonate  21  meq l; chemistry blood chloride  109  meq l; chemistry blood creatinine  0.7  mg dl; chemistry blood potassium  3.8  meq l; chemistry blood sodium  140  meq l; chemistry blood urea nitrogen  12  mg dl; hematology urine wbc  2  # hpf; chemistry blood calcium, total  8.0  mg dl; chemistry blood bilirubin, total  0.4  mg dl; chemistry blood glucose  95  mg dl; chemistry blood lactate dehydrogenase (ld)  267  iu l; hematology blood bands  0  %$folic acid  1  mg ; sodium chloride 0.9%  flush  3  ml ; 0.9% sodium chloride  1000  ml ; posaconazole suspension  400  mg ; 0.9% sodium chloride (mini bag plus)  100  ml ; meropenem  500  mg ; albuterol 0.083% neb soln  1  neb ; ondansetron odt  4  mg ; acetaminophen  325-650  mg ; 0.9% sodium chloride  50  ml ; daptomycin  300  mg ; ursodiol  300  mg ; valganciclovir  900  mg ; 
body mass index less than 19, adult personal history of antineoplastic chemotherapy myelodysplastic syndrome, unspecified other drug-induced pancytopenia driver of special construction vehicle injured in traffic accident fever presenting with conditions classified elsewhere peripheral stem cells replaced by transplant unspecified drug or medicinal substance causing adverse effects in therapeutic use bacterial pneumonia, unspecified depressive disorder, not elsewhere classified peripheral stem cells replaced by transplant other hemochromatosis unspecified viral infection fever, unspecified person on outside of bus injured in collision with pedestrian or animal in traffic accident personal history of antineoplastic chemotherapy zygomycosis [phycomycosis or mucormycosis] examination of participant in clinical trial myelodysplastic syndrome, unspecified unspecified septicemia peripheral stem cells replaced by transplant hemorrhage complicating a procedure myelodysplastic syndrome, unspecified severe sepsis cytomegaloviral disease septic shock other pancytopenia other specified procedures as the cause of abnormal reaction of patient, or of later complication, without mention of misadventure at time of procedure other specified viral infection bacterial pneumonia, unspecified zygomycosis [phycomycosis or mucormycosis] diarrhea acidosis long-term (current) use of other medications other specified antibiotics causing adverse effects in therapeutic use nausea alone pneumonia, organism unspecified neutropenia, unspecified body mass index less than 19, adult depressive disorder, not elsewhere classified fever, unspecified myelodysplastic syndrome, unspecified driver of special construction vehicle injured in traffic accident peripheral stem cells replaced by transplant anemia, unspecified intestinal infection due to clostridium difficile zygomycosis [phycomycosis or mucormycosis] driver of special construction vehicle injured in traffic accident
asian m 26 $nan$nan$folic acid  1  mg ; sodium chloride 0.9%  flush  3  ml ; 0.9% sodium chloride  1000  ml ; posaconazole suspension  400  mg ; 0.9% sodium chloride (mini bag plus)  100  ml ; meropenem  500  mg ; albuterol 0.083% neb soln  1  neb ; ondansetron odt  4  mg ; acetaminophen  325-650  mg ; 0.9% sodium chloride  50  ml ; daptomycin  300  mg ; ursodiol  300  mg ; valganciclovir  900  mg ; acetaminophen  650  mg ; diphenhydramine  25  mg ; filgrastim  300  mcg ; 
body mass index less than 19, adult personal history of antineoplastic chemotherapy myelodysplastic syndrome, unspecified other drug-induced pancytopenia driver of special construction vehicle injured in traffic accident fever presenting with conditions classified elsewhere peripheral stem cells replaced by transplant unspecified drug or medicinal substance causing adverse effects in therapeutic use bacterial pneumonia, unspecified depressive disorder, not elsewhere classified peripheral stem cells replaced by transplant other hemochromatosis unspecified viral infection fever, unspecified person on outside of bus injured in collision with pedestrian or animal in traffic accident personal history of antineoplastic chemotherapy zygomycosis [phycomycosis or mucormycosis] examination of participant in clinical trial myelodysplastic syndrome, unspecified unspecified septicemia peripheral stem cells replaced by transplant hemorrhage complicating a procedure myelodysplastic syndrome, unspecified severe sepsis cytomegaloviral disease septic shock other pancytopenia other specified procedures as the cause of abnormal reaction of patient, or of later complication, without mention of misadventure at time of procedure other specified viral infection bacterial pneumonia, unspecified zygomycosis [phycomycosis or mucormycosis] diarrhea acidosis long-term (current) use of other medications other specified antibiotics causing adverse effects in therapeutic use nausea alone pneumonia, organism unspecified neutropenia, unspecified body mass index less than 19, adult depressive disorder, not elsewhere classified fever, unspecified myelodysplastic syndrome, unspecified driver of special construction vehicle injured in traffic accident peripheral stem cells replaced by transplant anemia, unspecified intestinal infection due to clostridium difficile zygomycosis [phycomycosis or mucormycosis] driver of special construction vehicle injured in traffic accident
asian m 26 $nan$hematology blood hematocrit  20.2  %; hematology blood hematocrit  21.8  %; hematology blood hemoglobin  7.1  g dl; hematology blood hemoglobin  7.6  g dl; hematology blood platelet count  23  k ul; hematology blood platelet count  19  k ul; chemistry blood anion gap  10  meq l; chemistry blood bicarbonate  22  meq l; chemistry blood chloride  113  meq l; chemistry blood creatinine  0.7  mg dl; chemistry blood potassium  4.0  meq l; chemistry blood sodium  141  meq l; chemistry blood urea nitrogen  12  mg dl; hematology blood inr(pt)  1.0  ; chemistry blood calcium, total  8.5  mg dl; chemistry blood bilirubin, total  0.4  mg dl; chemistry blood lactate dehydrogenase (ld)  300  iu l; chemistry blood albumin  3.6  g dl; hematology blood bands  1  %; hematology blood bands  0  %$folic acid  1  mg ; sodium chloride 0.9%  flush  3  ml ; 0.9% sodium chloride  1000  ml ; posaconazole suspension  400  mg ; 0.9% sodium chloride (mini bag plus)  100  ml ; meropenem  500  mg ; albuterol 0.083% neb soln  1  neb ; ondansetron odt  4  mg ; acetaminophen  325-650  mg ; 0.9% sodium chloride  50  ml ; daptomycin  300  mg ; ursodiol  300  mg ; valganciclovir  900  mg ; filgrastim  300  mcg ; oxymetazoline  1  spry ; 
body mass index less than 19, adult personal history of antineoplastic chemotherapy myelodysplastic syndrome, unspecified other drug-induced pancytopenia driver of special construction vehicle injured in traffic accident fever presenting with conditions classified elsewhere peripheral stem cells replaced by transplant unspecified drug or medicinal substance causing adverse effects in therapeutic use bacterial pneumonia, unspecified depressive disorder, not elsewhere classified peripheral stem cells replaced by transplant other hemochromatosis unspecified viral infection fever, unspecified person on outside of bus injured in collision with pedestrian or animal in traffic accident personal history of antineoplastic chemotherapy zygomycosis [phycomycosis or mucormycosis] examination of participant in clinical trial myelodysplastic syndrome, unspecified unspecified septicemia peripheral stem cells replaced by transplant hemorrhage complicating a procedure myelodysplastic syndrome, unspecified severe sepsis cytomegaloviral disease septic shock other pancytopenia other specified procedures as the cause of abnormal reaction of patient, or of later complication, without mention of misadventure at time of procedure other specified viral infection bacterial pneumonia, unspecified zygomycosis [phycomycosis or mucormycosis] diarrhea acidosis long-term (current) use of other medications other specified antibiotics causing adverse effects in therapeutic use nausea alone pneumonia, organism unspecified neutropenia, unspecified body mass index less than 19, adult depressive disorder, not elsewhere classified fever, unspecified myelodysplastic syndrome, unspecified driver of special construction vehicle injured in traffic accident peripheral stem cells replaced by transplant anemia, unspecified intestinal infection due to clostridium difficile zygomycosis [phycomycosis or mucormycosis] driver of special construction vehicle injured in traffic accident
asian m 26 $nan$nan$folic acid  1  mg ; sodium chloride 0.9%  flush  3  ml ; 0.9% sodium chloride  1000  ml ; posaconazole suspension  400  mg ; 0.9% sodium chloride (mini bag plus)  100  ml ; meropenem  500  mg ; albuterol 0.083% neb soln  1  neb ; ondansetron odt  4  mg ; acetaminophen  325-650  mg ; 0.9% sodium chloride  50  ml ; daptomycin  300  mg ; ursodiol  300  mg ; valganciclovir  900  mg ; filgrastim  300  mcg ; oxymetazoline  1  spry ; oxycodone (immediate release)   5-10  mg ; 
body mass index less than 19, adult personal history of antineoplastic chemotherapy myelodysplastic syndrome, unspecified other drug-induced pancytopenia driver of special construction vehicle injured in traffic accident fever presenting with conditions classified elsewhere peripheral stem cells replaced by transplant unspecified drug or medicinal substance causing adverse effects in therapeutic use bacterial pneumonia, unspecified depressive disorder, not elsewhere classified peripheral stem cells replaced by transplant other hemochromatosis unspecified viral infection fever, unspecified person on outside of bus injured in collision with pedestrian or animal in traffic accident personal history of antineoplastic chemotherapy zygomycosis [phycomycosis or mucormycosis] examination of participant in clinical trial myelodysplastic syndrome, unspecified unspecified septicemia peripheral stem cells replaced by transplant hemorrhage complicating a procedure myelodysplastic syndrome, unspecified severe sepsis cytomegaloviral disease septic shock other pancytopenia other specified procedures as the cause of abnormal reaction of patient, or of later complication, without mention of misadventure at time of procedure other specified viral infection bacterial pneumonia, unspecified zygomycosis [phycomycosis or mucormycosis] diarrhea acidosis long-term (current) use of other medications other specified antibiotics causing adverse effects in therapeutic use nausea alone pneumonia, organism unspecified neutropenia, unspecified body mass index less than 19, adult depressive disorder, not elsewhere classified fever, unspecified myelodysplastic syndrome, unspecified driver of special construction vehicle injured in traffic accident peripheral stem cells replaced by transplant anemia, unspecified intestinal infection due to clostridium difficile zygomycosis [phycomycosis or mucormycosis] driver of special construction vehicle injured in traffic accident
asian m 26 $nan$hematology blood hematocrit  19.7  %; hematology blood hematocrit  21.1  %; hematology blood hemoglobin  7.0  g dl; hematology blood hemoglobin  7.7  g dl; hematology blood platelet count  43  k ul; hematology blood platelet count  12  k ul; chemistry blood anion gap  10  meq l; chemistry blood anion gap  12  meq l; chemistry blood bicarbonate  20  meq l; chemistry blood bicarbonate  22  meq l; chemistry blood chloride  113  meq l; chemistry blood chloride  106  meq l; chemistry blood creatinine  0.6  mg dl; chemistry blood creatinine  0.6  mg dl; chemistry blood potassium  3.8  meq l; chemistry blood potassium  3.7  meq l; chemistry blood sodium  139  meq l; chemistry blood sodium  136  meq l; chemistry blood urea nitrogen  12  mg dl; chemistry blood urea nitrogen  14  mg dl; hematology blood inr(pt)  1.0  ; hematology blood inr(pt)  1.0  ; chemistry blood calcium, total  8.0  mg dl; chemistry blood calcium, total  7.9  mg dl; chemistry blood bilirubin, total  0.4  mg dl; chemistry blood bilirubin, total  0.5  mg dl; chemistry blood glucose  87  mg dl; chemistry blood glucose  130  mg dl; chemistry blood lactate dehydrogenase (ld)  265  iu l; chemistry blood lactate dehydrogenase (ld)  294  iu l; chemistry blood albumin  3.6  g dl; hematology blood bands  1  %; hematology blood bands  3  %$folic acid  1  mg ; sodium chloride 0.9%  flush  3  ml ; 0.9% sodium chloride  1000  ml ; posaconazole suspension  400  mg ; 0.9% sodium chloride (mini bag plus)  100  ml ; meropenem  500  mg ; albuterol 0.083% neb soln  1  neb ; ondansetron odt  4  mg ; acetaminophen  325-650  mg ; 0.9% sodium chloride  50  ml ; daptomycin  300  mg ; ursodiol  300  mg ; valganciclovir  900  mg ; oxycodone (immediate release)   5-10  mg ; lorazepam  0.5-2  mg ; fentanyl citrate  25-100  mcg ; midazolam  0.5-2  mg ; ondansetron odt  8  mg ; midazolam  5  mg ; fentanyl citrate  250  mcg ; 5% dextrose  125  ml ; ambisome  250  mg ; 0.9% sodium chloride  250  ml ; lorazepam  1  mg ; 5% dextrose  250  ml ; aminocaproic acid  5  gm ; 5% dextrose  100  ml ; lorazepam  1-4  mg ; ondansetron  8  mg ; 
body mass index less than 19, adult personal history of antineoplastic chemotherapy myelodysplastic syndrome, unspecified other drug-induced pancytopenia driver of special construction vehicle injured in traffic accident fever presenting with conditions classified elsewhere peripheral stem cells replaced by transplant unspecified drug or medicinal substance causing adverse effects in therapeutic use bacterial pneumonia, unspecified depressive disorder, not elsewhere classified peripheral stem cells replaced by transplant other hemochromatosis unspecified viral infection fever, unspecified person on outside of bus injured in collision with pedestrian or animal in traffic accident personal history of antineoplastic chemotherapy zygomycosis [phycomycosis or mucormycosis] examination of participant in clinical trial myelodysplastic syndrome, unspecified unspecified septicemia peripheral stem cells replaced by transplant hemorrhage complicating a procedure myelodysplastic syndrome, unspecified severe sepsis cytomegaloviral disease septic shock other pancytopenia other specified procedures as the cause of abnormal reaction of patient, or of later complication, without mention of misadventure at time of procedure other specified viral infection bacterial pneumonia, unspecified zygomycosis [phycomycosis or mucormycosis] diarrhea acidosis long-term (current) use of other medications other specified antibiotics causing adverse effects in therapeutic use nausea alone pneumonia, organism unspecified neutropenia, unspecified body mass index less than 19, adult depressive disorder, not elsewhere classified fever, unspecified myelodysplastic syndrome, unspecified driver of special construction vehicle injured in traffic accident peripheral stem cells replaced by transplant anemia, unspecified intestinal infection due to clostridium difficile zygomycosis [phycomycosis or mucormycosis] driver of special construction vehicle injured in traffic accident
asian m 26 $nan$nan$ondansetron odt  8  mg ; 5% dextrose  125  ml ; ambisome  250  mg ; lorazepam  1  mg ; 5% dextrose  250  ml ; aminocaproic acid  5  gm ; 5% dextrose  100  ml ; lorazepam  1-4  mg ; ondansetron  8  mg ; d5 1 2ns  1000  ml ; aminocaproic acid  2  gm ; 
body mass index less than 19, adult personal history of antineoplastic chemotherapy myelodysplastic syndrome, unspecified other drug-induced pancytopenia driver of special construction vehicle injured in traffic accident fever presenting with conditions classified elsewhere peripheral stem cells replaced by transplant unspecified drug or medicinal substance causing adverse effects in therapeutic use bacterial pneumonia, unspecified depressive disorder, not elsewhere classified peripheral stem cells replaced by transplant other hemochromatosis unspecified viral infection fever, unspecified person on outside of bus injured in collision with pedestrian or animal in traffic accident personal history of antineoplastic chemotherapy zygomycosis [phycomycosis or mucormycosis] examination of participant in clinical trial myelodysplastic syndrome, unspecified unspecified septicemia peripheral stem cells replaced by transplant hemorrhage complicating a procedure myelodysplastic syndrome, unspecified severe sepsis cytomegaloviral disease septic shock other pancytopenia other specified procedures as the cause of abnormal reaction of patient, or of later complication, without mention of misadventure at time of procedure other specified viral infection bacterial pneumonia, unspecified zygomycosis [phycomycosis or mucormycosis] diarrhea acidosis long-term (current) use of other medications other specified antibiotics causing adverse effects in therapeutic use nausea alone pneumonia, organism unspecified neutropenia, unspecified body mass index less than 19, adult depressive disorder, not elsewhere classified fever, unspecified myelodysplastic syndrome, unspecified driver of special construction vehicle injured in traffic accident peripheral stem cells replaced by transplant anemia, unspecified intestinal infection due to clostridium difficile zygomycosis [phycomycosis or mucormycosis] driver of special construction vehicle injured in traffic accident
asian m 26 $nan$hematology blood hematocrit  19.6  %; hematology blood hemoglobin  6.6  g dl; hematology blood platelet count  26  k ul; chemistry blood anion gap  14  meq l; chemistry blood bicarbonate  20  meq l; chemistry blood chloride  106  meq l; chemistry blood creatinine  0.7  mg dl; chemistry blood potassium  3.8  meq l; chemistry blood sodium  136  meq l; chemistry blood urea nitrogen  14  mg dl; chemistry blood calcium, total  8.1  mg dl; chemistry blood bilirubin, total  0.5  mg dl; chemistry blood glucose  102  mg dl; chemistry blood lactate dehydrogenase (ld)  262  iu l; hematology blood bands  3  %$lorazepam  1-4  mg ; loperamide  2  mg ; ns  100  ml ; metronidazole (flagyl)  500  mg ; 
body mass index less than 19, adult personal history of antineoplastic chemotherapy myelodysplastic syndrome, unspecified other drug-induced pancytopenia driver of special construction vehicle injured in traffic accident fever presenting with conditions classified elsewhere peripheral stem cells replaced by transplant unspecified drug or medicinal substance causing adverse effects in therapeutic use bacterial pneumonia, unspecified depressive disorder, not elsewhere classified peripheral stem cells replaced by transplant other hemochromatosis unspecified viral infection fever, unspecified person on outside of bus injured in collision with pedestrian or animal in traffic accident personal history of antineoplastic chemotherapy zygomycosis [phycomycosis or mucormycosis] examination of participant in clinical trial myelodysplastic syndrome, unspecified unspecified septicemia peripheral stem cells replaced by transplant hemorrhage complicating a procedure myelodysplastic syndrome, unspecified severe sepsis cytomegaloviral disease septic shock other pancytopenia other specified procedures as the cause of abnormal reaction of patient, or of later complication, without mention of misadventure at time of procedure other specified viral infection bacterial pneumonia, unspecified zygomycosis [phycomycosis or mucormycosis] diarrhea acidosis long-term (current) use of other medications other specified antibiotics causing adverse effects in therapeutic use nausea alone pneumonia, organism unspecified neutropenia, unspecified body mass index less than 19, adult depressive disorder, not elsewhere classified fever, unspecified myelodysplastic syndrome, unspecified driver of special construction vehicle injured in traffic accident peripheral stem cells replaced by transplant anemia, unspecified intestinal infection due to clostridium difficile zygomycosis [phycomycosis or mucormycosis] driver of special construction vehicle injured in traffic accident
asian m 26 $nan$nan$300 mcg vial  1  vial ; loperamide  2  mg ; vancomycin oral liquid  125  mg ; simethicone  40-80  mg ; 
body mass index less than 19, adult personal history of antineoplastic chemotherapy myelodysplastic syndrome, unspecified other drug-induced pancytopenia driver of special construction vehicle injured in traffic accident fever presenting with conditions classified elsewhere peripheral stem cells replaced by transplant unspecified drug or medicinal substance causing adverse effects in therapeutic use bacterial pneumonia, unspecified depressive disorder, not elsewhere classified peripheral stem cells replaced by transplant other hemochromatosis unspecified viral infection fever, unspecified person on outside of bus injured in collision with pedestrian or animal in traffic accident personal history of antineoplastic chemotherapy zygomycosis [phycomycosis or mucormycosis] examination of participant in clinical trial myelodysplastic syndrome, unspecified unspecified septicemia peripheral stem cells replaced by transplant hemorrhage complicating a procedure myelodysplastic syndrome, unspecified severe sepsis cytomegaloviral disease septic shock other pancytopenia other specified procedures as the cause of abnormal reaction of patient, or of later complication, without mention of misadventure at time of procedure other specified viral infection bacterial pneumonia, unspecified zygomycosis [phycomycosis or mucormycosis] diarrhea acidosis long-term (current) use of other medications other specified antibiotics causing adverse effects in therapeutic use nausea alone pneumonia, organism unspecified neutropenia, unspecified body mass index less than 19, adult depressive disorder, not elsewhere classified fever, unspecified myelodysplastic syndrome, unspecified driver of special construction vehicle injured in traffic accident peripheral stem cells replaced by transplant anemia, unspecified intestinal infection due to clostridium difficile zygomycosis [phycomycosis or mucormycosis] driver of special construction vehicle injured in traffic accident
asian m 26 $nan$nan$300 mcg vial  1  vial ; loperamide  2  mg ; vancomycin oral liquid  125  mg ; simethicone  40-80  mg ; 
body mass index less than 19, adult personal history of antineoplastic chemotherapy myelodysplastic syndrome, unspecified other drug-induced pancytopenia driver of special construction vehicle injured in traffic accident fever presenting with conditions classified elsewhere peripheral stem cells replaced by transplant unspecified drug or medicinal substance causing adverse effects in therapeutic use bacterial pneumonia, unspecified depressive disorder, not elsewhere classified peripheral stem cells replaced by transplant other hemochromatosis unspecified viral infection fever, unspecified person on outside of bus injured in collision with pedestrian or animal in traffic accident personal history of antineoplastic chemotherapy zygomycosis [phycomycosis or mucormycosis] examination of participant in clinical trial myelodysplastic syndrome, unspecified unspecified septicemia peripheral stem cells replaced by transplant hemorrhage complicating a procedure myelodysplastic syndrome, unspecified severe sepsis cytomegaloviral disease septic shock other pancytopenia other specified procedures as the cause of abnormal reaction of patient, or of later complication, without mention of misadventure at time of procedure other specified viral infection bacterial pneumonia, unspecified zygomycosis [phycomycosis or mucormycosis] diarrhea acidosis long-term (current) use of other medications other specified antibiotics causing adverse effects in therapeutic use nausea alone pneumonia, organism unspecified neutropenia, unspecified body mass index less than 19, adult depressive disorder, not elsewhere classified fever, unspecified myelodysplastic syndrome, unspecified driver of special construction vehicle injured in traffic accident peripheral stem cells replaced by transplant anemia, unspecified intestinal infection due to clostridium difficile zygomycosis [phycomycosis or mucormycosis] driver of special construction vehicle injured in traffic accident
asian m 26 $nan$hematology blood hematocrit  26.9  %; hematology blood hemoglobin  9.4  g dl; hematology blood platelet count  12  k ul; chemistry blood anion gap  13  meq l; chemistry blood bicarbonate  23  meq l; chemistry blood chloride  102  meq l; chemistry blood creatinine  0.7  mg dl; chemistry blood potassium  3.9  meq l; chemistry blood sodium  134  meq l; chemistry blood urea nitrogen  12  mg dl; hematology blood inr(pt)  1.1  ; chemistry blood calcium, total  8.8  mg dl; chemistry blood bilirubin, total  0.6  mg dl; chemistry blood glucose  119  mg dl; chemistry blood lactate dehydrogenase (ld)  365  iu l; hematology blood bands  1  %$vancomycin oral liquid  125  mg ; simethicone  40-80  mg ; meropenem  1000  mg ; 
body mass index less than 19, adult personal history of antineoplastic chemotherapy myelodysplastic syndrome, unspecified other drug-induced pancytopenia driver of special construction vehicle injured in traffic accident fever presenting with conditions classified elsewhere peripheral stem cells replaced by transplant unspecified drug or medicinal substance causing adverse effects in therapeutic use bacterial pneumonia, unspecified depressive disorder, not elsewhere classified peripheral stem cells replaced by transplant other hemochromatosis unspecified viral infection fever, unspecified person on outside of bus injured in collision with pedestrian or animal in traffic accident personal history of antineoplastic chemotherapy zygomycosis [phycomycosis or mucormycosis] examination of participant in clinical trial myelodysplastic syndrome, unspecified unspecified septicemia peripheral stem cells replaced by transplant hemorrhage complicating a procedure myelodysplastic syndrome, unspecified severe sepsis cytomegaloviral disease septic shock other pancytopenia other specified procedures as the cause of abnormal reaction of patient, or of later complication, without mention of misadventure at time of procedure other specified viral infection bacterial pneumonia, unspecified zygomycosis [phycomycosis or mucormycosis] diarrhea acidosis long-term (current) use of other medications other specified antibiotics causing adverse effects in therapeutic use nausea alone pneumonia, organism unspecified neutropenia, unspecified body mass index less than 19, adult depressive disorder, not elsewhere classified fever, unspecified myelodysplastic syndrome, unspecified driver of special construction vehicle injured in traffic accident peripheral stem cells replaced by transplant anemia, unspecified intestinal infection due to clostridium difficile zygomycosis [phycomycosis or mucormycosis] driver of special construction vehicle injured in traffic accident
asian m 26 $nan$nan$simethicone  40-80  mg ; meropenem  1000  mg ; levofloxacin  500  mg ; 
body mass index less than 19, adult personal history of antineoplastic chemotherapy myelodysplastic syndrome, unspecified other drug-induced pancytopenia driver of special construction vehicle injured in traffic accident fever presenting with conditions classified elsewhere peripheral stem cells replaced by transplant unspecified drug or medicinal substance causing adverse effects in therapeutic use bacterial pneumonia, unspecified depressive disorder, not elsewhere classified peripheral stem cells replaced by transplant other hemochromatosis unspecified viral infection fever, unspecified person on outside of bus injured in collision with pedestrian or animal in traffic accident personal history of antineoplastic chemotherapy zygomycosis [phycomycosis or mucormycosis] examination of participant in clinical trial myelodysplastic syndrome, unspecified unspecified septicemia peripheral stem cells replaced by transplant hemorrhage complicating a procedure myelodysplastic syndrome, unspecified severe sepsis cytomegaloviral disease septic shock other pancytopenia other specified procedures as the cause of abnormal reaction of patient, or of later complication, without mention of misadventure at time of procedure other specified viral infection bacterial pneumonia, unspecified zygomycosis [phycomycosis or mucormycosis] diarrhea acidosis long-term (current) use of other medications other specified antibiotics causing adverse effects in therapeutic use nausea alone pneumonia, organism unspecified neutropenia, unspecified body mass index less than 19, adult depressive disorder, not elsewhere classified fever, unspecified myelodysplastic syndrome, unspecified driver of special construction vehicle injured in traffic accident peripheral stem cells replaced by transplant anemia, unspecified intestinal infection due to clostridium difficile zygomycosis [phycomycosis or mucormycosis] driver of special construction vehicle injured in traffic accident
asian m 26 $nan$nan$simethicone  40-80  mg ; meropenem  1000  mg ; levofloxacin  500  mg ; 
body mass index less than 19, adult personal history of antineoplastic chemotherapy myelodysplastic syndrome, unspecified other drug-induced pancytopenia driver of special construction vehicle injured in traffic accident fever presenting with conditions classified elsewhere peripheral stem cells replaced by transplant unspecified drug or medicinal substance causing adverse effects in therapeutic use bacterial pneumonia, unspecified depressive disorder, not elsewhere classified peripheral stem cells replaced by transplant other hemochromatosis unspecified viral infection fever, unspecified person on outside of bus injured in collision with pedestrian or animal in traffic accident personal history of antineoplastic chemotherapy zygomycosis [phycomycosis or mucormycosis] examination of participant in clinical trial myelodysplastic syndrome, unspecified unspecified septicemia peripheral stem cells replaced by transplant hemorrhage complicating a procedure myelodysplastic syndrome, unspecified severe sepsis cytomegaloviral disease septic shock other pancytopenia other specified procedures as the cause of abnormal reaction of patient, or of later complication, without mention of misadventure at time of procedure other specified viral infection bacterial pneumonia, unspecified zygomycosis [phycomycosis or mucormycosis] diarrhea acidosis long-term (current) use of other medications other specified antibiotics causing adverse effects in therapeutic use nausea alone pneumonia, organism unspecified neutropenia, unspecified body mass index less than 19, adult depressive disorder, not elsewhere classified fever, unspecified myelodysplastic syndrome, unspecified driver of special construction vehicle injured in traffic accident peripheral stem cells replaced by transplant anemia, unspecified intestinal infection due to clostridium difficile zygomycosis [phycomycosis or mucormycosis] driver of special construction vehicle injured in traffic accident
asian m 26 $nan$hematology blood hematocrit  25.4  %; hematology blood hemoglobin  8.8  g dl; hematology blood platelet count  17  k ul; chemistry blood anion gap  14  meq l; chemistry blood bicarbonate  23  meq l; chemistry blood chloride  101  meq l; chemistry blood creatinine  0.8  mg dl; chemistry blood potassium  4.1  meq l; chemistry blood sodium  134  meq l; chemistry blood urea nitrogen  14  mg dl; hematology blood inr(pt)  1.1  ; chemistry blood calcium, total  8.7  mg dl; chemistry blood bilirubin, total  0.6  mg dl; chemistry blood glucose  92  mg dl; chemistry blood lactate dehydrogenase (ld)  296  iu l; hematology blood bands  0  %$simethicone  40-80  mg ; levofloxacin  500  mg ; 
body mass index less than 19, adult personal history of antineoplastic chemotherapy myelodysplastic syndrome, unspecified other drug-induced pancytopenia driver of special construction vehicle injured in traffic accident fever presenting with conditions classified elsewhere peripheral stem cells replaced by transplant unspecified drug or medicinal substance causing adverse effects in therapeutic use bacterial pneumonia, unspecified depressive disorder, not elsewhere classified peripheral stem cells replaced by transplant other hemochromatosis unspecified viral infection fever, unspecified person on outside of bus injured in collision with pedestrian or animal in traffic accident personal history of antineoplastic chemotherapy zygomycosis [phycomycosis or mucormycosis] examination of participant in clinical trial myelodysplastic syndrome, unspecified unspecified septicemia peripheral stem cells replaced by transplant hemorrhage complicating a procedure myelodysplastic syndrome, unspecified severe sepsis cytomegaloviral disease septic shock other pancytopenia other specified procedures as the cause of abnormal reaction of patient, or of later complication, without mention of misadventure at time of procedure other specified viral infection bacterial pneumonia, unspecified zygomycosis [phycomycosis or mucormycosis] diarrhea acidosis long-term (current) use of other medications other specified antibiotics causing adverse effects in therapeutic use nausea alone pneumonia, organism unspecified neutropenia, unspecified body mass index less than 19, adult depressive disorder, not elsewhere classified fever, unspecified myelodysplastic syndrome, unspecified driver of special construction vehicle injured in traffic accident peripheral stem cells replaced by transplant anemia, unspecified intestinal infection due to clostridium difficile zygomycosis [phycomycosis or mucormycosis] driver of special construction vehicle injured in traffic accident
asian m 26 $nan$nan$simethicone  40-80  mg ; levofloxacin  500  mg ; 
body mass index less than 19, adult personal history of antineoplastic chemotherapy myelodysplastic syndrome, unspecified other drug-induced pancytopenia driver of special construction vehicle injured in traffic accident fever presenting with conditions classified elsewhere peripheral stem cells replaced by transplant unspecified drug or medicinal substance causing adverse effects in therapeutic use bacterial pneumonia, unspecified depressive disorder, not elsewhere classified peripheral stem cells replaced by transplant other hemochromatosis unspecified viral infection fever, unspecified person on outside of bus injured in collision with pedestrian or animal in traffic accident personal history of antineoplastic chemotherapy zygomycosis [phycomycosis or mucormycosis] examination of participant in clinical trial myelodysplastic syndrome, unspecified unspecified septicemia peripheral stem cells replaced by transplant hemorrhage complicating a procedure myelodysplastic syndrome, unspecified severe sepsis cytomegaloviral disease septic shock other pancytopenia other specified procedures as the cause of abnormal reaction of patient, or of later complication, without mention of misadventure at time of procedure other specified viral infection bacterial pneumonia, unspecified zygomycosis [phycomycosis or mucormycosis] diarrhea acidosis long-term (current) use of other medications other specified antibiotics causing adverse effects in therapeutic use nausea alone pneumonia, organism unspecified neutropenia, unspecified body mass index less than 19, adult depressive disorder, not elsewhere classified fever, unspecified myelodysplastic syndrome, unspecified driver of special construction vehicle injured in traffic accident peripheral stem cells replaced by transplant anemia, unspecified intestinal infection due to clostridium difficile zygomycosis [phycomycosis or mucormycosis] driver of special construction vehicle injured in traffic accident
black african american m 75 $temp    heartrate  83.0  resprate  18.0  o2sat  100.0  sbp  160.0  dbp  86.0  rhythm    pain  8  ; temp  97.9  heartrate  72.0  resprate  18.0  o2sat  100.0  sbp  116.0  dbp  55.0  rhythm    pain  0  $hematology blood hematocrit  22.5  %; hematology blood hemoglobin  6.6  g dl; hematology blood platelet count  200  k ul; chemistry blood anion gap  23  meq l; chemistry blood anion gap  26  meq l; chemistry blood anion gap  22  meq l; chemistry blood anion gap  25  meq l; chemistry blood bicarbonate  15  meq l; chemistry blood bicarbonate  15  meq l; chemistry blood bicarbonate  12  meq l; chemistry blood bicarbonate  14  meq l; chemistry blood chloride  108  meq l; chemistry blood chloride  109  meq l; chemistry blood chloride  108  meq l; chemistry blood chloride  106  meq l; chemistry blood creatinine  6.3  mg dl; chemistry blood creatinine  6.7  mg dl; chemistry blood creatinine  6.8  mg dl; chemistry blood creatinine  7.6  mg dl; chemistry blood potassium  5.8  meq l; chemistry blood potassium  4.9  meq l; chemistry blood potassium  5.0  meq l; chemistry blood potassium  6.2  meq l; chemistry blood sodium  139  meq l; chemistry blood sodium  140  meq l; chemistry blood sodium  141  meq l; chemistry blood sodium  141  meq l; chemistry blood urea nitrogen  63  mg dl; chemistry blood urea nitrogen  64  mg dl; chemistry blood urea nitrogen  66  mg dl; chemistry blood urea nitrogen  72  mg dl; hematology blood inr(pt)  1.1  ; chemistry blood calcium, total  8.0  mg dl; chemistry blood calcium, total  7.8  mg dl; chemistry blood calcium, total  7.3  mg dl; chemistry blood calcium, total  7.0  mg dl; chemistry blood bilirubin, total  0.5  mg dl; chemistry blood bilirubin, total  0.5  mg dl; chemistry blood glucose  138  mg dl; chemistry blood glucose  266  mg dl; chemistry blood glucose  124  mg dl; chemistry blood glucose  165  mg dl; chemistry blood lactate dehydrogenase (ld)  288  iu l; chemistry blood lactate dehydrogenase (ld)  240  iu l; blood gas blood lactate  2.4  mmol l; blood gas blood lactate  1.5  mmol l$influenza vaccine quadrivalent  0.5  ml ; pneumococcal 23-valent polysaccharide vaccine  0.5  ml ; sodium chloride 0.9%  flush  3  ml ; acetaminophen  650  mg ; docusate sodium  100  mg ; senna  17.2  mg ; heparin  5000  unit ; insulin (regular) for hyperkalemia  10  unit ; dextrose 50%  25  gm ; 0.9% sodium chloride  1  bag ; calcium gluconate  2  g ; lidocaine jelly 2% (urojet)  1  appl ; aspirin  81  mg ; nifedipine cr  90  mg ; dextrose 50%  12.5  gm ; glucagon  1  mg ; glucose gel  15  g ; insulin  0  unit ; oxycodone (immediate release)  2.5-5  mg ; sodium bicarbonate  1300  mg ; metoprolol tartrate  25  mg ; lactated ringers  1000  ml ; lactic acid 12% lotion  1  appl ; latanoprost 0.005% ophth. soln.  1  drop ; brimonidine tartrate 0.15% ophth.  1  drop ; dorzolamide 2% timolol 0.5% ophth.  1  drop ; 
 
black african american m 75 $nan$hematology blood hematocrit  22.0  %; hematology blood hematocrit  27.8  %; hematology blood hemoglobin  6.5  g dl; hematology blood hemoglobin  8.5  g dl; hematology blood platelet count  175  k ul; hematology blood platelet count  186  k ul; chemistry blood anion gap  25  meq l; chemistry blood anion gap  27  meq l; chemistry blood anion gap  27  meq l; chemistry blood bicarbonate  12  meq l; chemistry blood bicarbonate  13  meq l; chemistry blood bicarbonate  11  meq l; chemistry blood chloride  107  meq l; chemistry blood chloride  106  meq l; chemistry blood chloride  108  meq l; chemistry blood creatinine  7.9  mg dl; chemistry blood creatinine  7.9  mg dl; chemistry blood creatinine  7.9  mg dl; chemistry blood potassium  5.8  meq l; chemistry blood potassium  5.9  meq l; chemistry blood potassium  5.0  meq l; chemistry blood sodium  139  meq l; chemistry blood sodium  138  meq l; chemistry blood sodium  142  meq l; chemistry blood urea nitrogen  78  mg dl; chemistry blood urea nitrogen  80  mg dl; chemistry blood urea nitrogen  82  mg dl; chemistry blood calcium, total  6.3  mg dl; chemistry blood calcium, total  6.6  mg dl; chemistry blood calcium, total  6.4  mg dl; chemistry blood glucose  222  mg dl; chemistry blood glucose  230  mg dl; chemistry blood glucose  217  mg dl; blood gas blood free calcium  0.89  mmol l; blood gas blood free calcium  0.86  mmol l; blood gas blood free calcium  0.86  mmol l; blood gas blood free calcium  0.91  mmol l; blood gas blood lactate  1.7  mmol l; blood gas blood lactate  2.2  mmol l; blood gas blood lactate  2.3  mmol l; blood gas blood chloride, whole blood  111  meq l; blood gas blood glucose  219  mg dl; blood gas blood hematocrit, calculated  26  %; blood gas blood hemoglobin  8.6  g dl; blood gas blood potassium, whole blood  5.5  meq l; blood gas blood sodium, whole blood  137  meq l$sodium chloride 0.9%  flush  3  ml ; acetaminophen  650  mg ; docusate sodium  100  mg ; senna  17.2  mg ; heparin  5000  unit ; aspirin  81  mg ; nifedipine cr  90  mg ; dextrose 50%  12.5  gm ; glucagon  1  mg ; glucose gel  15  g ; oxycodone (immediate release)  2.5-5  mg ; sodium bicarbonate  1300  mg ; metoprolol tartrate  25  mg ; lactic acid 12% lotion  1  appl ; latanoprost 0.005% ophth. soln.  1  drop ; brimonidine tartrate 0.15% ophth.  1  drop ; dorzolamide 2% timolol 0.5% ophth.  1  drop ; iso-osmotic dextrose  50  ml ; cefazolin  2  g ; 0.9% sodium chloride  100  ml ; propofol  1000  mg ; 0.9% sodium chloride  250  ml ; phenylephrine  60  mg ; acetaminophen  1000  mg ; acetaminophen iv  1000  mg ; sodium bicarbonate  50  meq ; calcium acetate  667  mg ; 
 
black african american m 75 $nan$hematology blood hematocrit  21.4  %; hematology blood hemoglobin  6.8  g dl; hematology blood platelet count  140  k ul; chemistry blood anion gap  22  meq l; chemistry blood anion gap  27  meq l; chemistry blood bicarbonate  12  meq l; chemistry blood bicarbonate  13  meq l; chemistry blood chloride  110  meq l; chemistry blood chloride  106  meq l; chemistry blood creatinine  7.5  mg dl; chemistry blood creatinine  8.5  mg dl; chemistry blood potassium  4.4  meq l; chemistry blood potassium  5.0  meq l; chemistry blood sodium  140  meq l; chemistry blood sodium  141  meq l; chemistry blood urea nitrogen  75  mg dl; chemistry blood urea nitrogen  92  mg dl; hematology urine wbc  181  # hpf; chemistry blood calcium, total  6.4  mg dl; chemistry blood calcium, total  5.7  mg dl; chemistry blood glucose  178  mg dl; chemistry blood glucose  139  mg dl; blood gas blood lactate  1.8  mmol l$sodium chloride 0.9%  flush  3  ml ; heparin  5000  unit ; dextrose 50%  12.5  gm ; glucagon  1  mg ; glucose gel  15  g ; lactic acid 12% lotion  1  appl ; latanoprost 0.005% ophth. soln.  1  drop ; brimonidine tartrate 0.15% ophth.  1  drop ; dorzolamide 2% timolol 0.5% ophth.  1  drop ; iso-osmotic dextrose  50  ml ; cefazolin  2  g ; acetaminophen iv  1000  mg ; sodium bicarbonate  50  meq ; iso-osmotic sodium chloride  1  bag ; famotidine  20  mg ; iso-osmotic dextrose  200  ml ; vancomycin  1000  mg ; 5% dextrose  50  ml ; ceftazidime  500  mg ; calcium gluconate  4  g ; chlorhexidine gluconate 0.12% oral rinse  15  ml ; polyethylene glycol  17  g ; 
 
black african american m 75 $nan$hematology blood hematocrit  22.2  %; hematology blood hematocrit  23.8  %; hematology blood hemoglobin  7.1  g dl; hematology blood hemoglobin  7.6  g dl; hematology blood platelet count  136  k ul; hematology blood platelet count  141  k ul; chemistry blood anion gap  24  meq l; chemistry blood anion gap  26  meq l; chemistry blood bicarbonate  15  meq l; chemistry blood bicarbonate  14  meq l; chemistry blood chloride  105  meq l; chemistry blood chloride  105  meq l; chemistry blood creatinine  8.3  mg dl; chemistry blood creatinine  8.0  mg dl; chemistry blood potassium  4.6  meq l; chemistry blood potassium  4.5  meq l; chemistry blood sodium  138  meq l; chemistry blood sodium  141  meq l; chemistry blood urea nitrogen  90  mg dl; chemistry blood urea nitrogen  90  mg dl; hematology blood inr(pt)  1.1  ; hematology urine wbc  8  # hpf; chemistry blood calcium, total  7.1  mg dl; chemistry blood calcium, total  7.0  mg dl; chemistry blood glucose  180  mg dl; chemistry blood glucose  145  mg dl; blood gas blood free calcium  0.92  mmol l; blood gas blood free calcium  0.88  mmol l; blood gas blood free calcium  0.94  mmol l; blood gas blood lactate  2.4  mmol l; blood gas blood lactate  1.2  mmol l; blood gas blood lactate  0.8  mmol l$heparin  5000  unit ; dextrose 50%  12.5  gm ; glucagon  1  mg ; glucose gel  15  g ; lactic acid 12% lotion  1  appl ; latanoprost 0.005% ophth. soln.  1  drop ; brimonidine tartrate 0.15% ophth.  1  drop ; dorzolamide 2% timolol 0.5% ophth.  1  drop ; 5% dextrose  50  ml ; ceftazidime  500  mg ; polyethylene glycol  17  g ; iso-osmotic dextrose  150  ml ; vancomycin  750  mg ; tramadol  25  mg ; 
 
black african american m 75 $nan$hematology blood hematocrit  23.1  %; hematology blood hematocrit  23.0  %; hematology blood hemoglobin  7.2  g dl; hematology blood hemoglobin  7.1  g dl; hematology blood platelet count  140  k ul; hematology blood platelet count  157  k ul; chemistry blood anion gap  24  meq l; chemistry blood bicarbonate  17  meq l; chemistry blood chloride  103  meq l; chemistry blood creatinine  8.4  mg dl; chemistry blood potassium  4.5  meq l; chemistry blood sodium  139  meq l; chemistry blood urea nitrogen  99  mg dl; chemistry blood calcium, total  6.7  mg dl; chemistry blood glucose  235  mg dl; chemistry blood albumin  3.0  g dl; blood gas blood free calcium  0.90  mmol l; blood gas blood free calcium  0.92  mmol l; blood gas blood lactate  1.1  mmol l$heparin  5000  unit ; dextrose 50%  12.5  gm ; glucagon  1  mg ; glucose gel  15  g ; lactic acid 12% lotion  1  appl ; latanoprost 0.005% ophth. soln.  1  drop ; brimonidine tartrate 0.15% ophth.  1  drop ; dorzolamide 2% timolol 0.5% ophth.  1  drop ; 5% dextrose  50  ml ; ceftazidime  500  mg ; polyethylene glycol  17  g ; iso-osmotic dextrose  150  ml ; vancomycin  750  mg ; tramadol  25  mg ; 
 
black african american m 75 $nan$hematology blood hematocrit  25.0  %; hematology blood hemoglobin  8.0  g dl; hematology blood platelet count  135  k ul; chemistry blood anion gap  25  meq l; chemistry blood bicarbonate  17  meq l; chemistry blood chloride  103  meq l; chemistry blood creatinine  7.9  mg dl; chemistry blood potassium  4.5  meq l; chemistry blood sodium  140  meq l; chemistry blood urea nitrogen  104  mg dl; chemistry blood calcium, total  6.9  mg dl; chemistry blood glucose  212  mg dl$heparin  5000  unit ; dextrose 50%  12.5  gm ; glucagon  1  mg ; glucose gel  15  g ; lactic acid 12% lotion  1  appl ; latanoprost 0.005% ophth. soln.  1  drop ; brimonidine tartrate 0.15% ophth.  1  drop ; dorzolamide 2% timolol 0.5% ophth.  1  drop ; 5% dextrose  50  ml ; ceftazidime  500  mg ; polyethylene glycol  17  g ; tramadol  25  mg ; levofloxacin  500  mg ; insulin  5  unit ; 
 
black african american m 75 $nan$blood gas blood free calcium  0.91  mmol l$heparin  5000  unit ; dextrose 50%  12.5  gm ; glucagon  1  mg ; glucose gel  15  g ; lactic acid 12% lotion  1  appl ; latanoprost 0.005% ophth. soln.  1  drop ; brimonidine tartrate 0.15% ophth.  1  drop ; dorzolamide 2% timolol 0.5% ophth.  1  drop ; polyethylene glycol  17  g ; tramadol  25  mg ; levofloxacin  500  mg ; insulin  5  unit ; calcium acetate  1334  mg ; calcitriol  0.25  mcg ; 
 
white m 65 $nan$hematology blood hematocrit  29.9  %; hematology blood hemoglobin  10.3  g dl; hematology blood platelet count  217  k ul; chemistry blood anion gap  14  meq l; chemistry blood bicarbonate  27  meq l; chemistry blood chloride  102  meq l; chemistry blood creatinine  1.2  mg dl; chemistry blood potassium  5.3  meq l; chemistry blood sodium  138  meq l; chemistry blood urea nitrogen  18  mg dl; chemistry blood glucose  111  mg dl$influenza virus vaccine  0.5  ml ; pneumococcal 23-valent polysaccharide vaccine  0.5  ml ; sodium chloride 0.9%  flush  3  ml ; acetaminophen  650  mg ; morphine sulfate  100  mg ; ondansetron  4  mg ; iso-osmotic dextrose  50  ml ; cefazolin  1  g ; 0.9% sodium chloride  1000  ml ; docusate sodium  100  mg ; oxycodone-acetaminophen (5mg-325mg)  1  tab ; hydrocodone-acetaminophen (5mg-500mg)  1  tab ; 
 
white m 65 $nan$nan$influenza virus vaccine  0.5  ml ; pneumococcal 23-valent polysaccharide vaccine  0.5  ml ; sodium chloride 0.9%  flush  3  ml ; acetaminophen  650  mg ; ondansetron  4  mg ; iso-osmotic dextrose  50  ml ; cefazolin  1  g ; 0.9% sodium chloride  1000  ml ; docusate sodium  100  mg ; hydrocodone-acetaminophen (5mg-500mg)  1  tab ; ketorolac  15  mg ; oxycodone-acetaminophen (5mg-325mg)  1-2  tab ; calcium carbonate  500-1000  mg ; valsartan  80  mg ; valsartan  40  mg ; 
 
white m 65 $nan$nan$influenza virus vaccine  0.5  ml ; pneumococcal 23-valent polysaccharide vaccine  0.5  ml ; sodium chloride 0.9%  flush  3  ml ; acetaminophen  650  mg ; ondansetron  4  mg ; 0.9% sodium chloride  1000  ml ; docusate sodium  100  mg ; ketorolac  15  mg ; oxycodone-acetaminophen (5mg-325mg)  1-2  tab ; calcium carbonate  500-1000  mg ; valsartan  40  mg ; 
 
white m 80 $nan$hematology blood hematocrit  34.7  %; chemistry blood chloride  106  meq l; chemistry blood creatinine  1.2  mg dl; chemistry blood potassium  4.7  meq l; chemistry blood sodium  141  meq l; chemistry blood urea nitrogen  29  mg dl$sodium chloride 0.9%  1000  ml ; alprazolam  1  mg ; zolpidem tartrate  5-10  mg ; influenza vaccine quadrivalent  0.5  ml ; amlodipine  2.5  mg ; amlodipine  5  mg ; atenolol  25  mg ; atorvastatin  80  mg ; clopidogrel  75  mg ; gabapentin  300  mg ; hydrochlorothiazide  25  mg ; pantoprazole  40  mg ; sodium chloride 0.9%  flush  3  ml ; aspirin ec  325  mg ; acetaminophen  650  mg ; nitroglycerin sl  0.3  mg ; simethicone  40-80  mg ; dextrose 50%  12.5  gm ; glucagon  1  mg ; glucose gel  15  g ; insulin pump (self administering medication)     ; mesalamine dr  800  mg ; 
long-term (current) use of insulin dysuria chest pain, unspecified aortocoronary bypass status diabetes mellitus without mention of complication, type ii or unspecified type, not stated as uncontrolled unspecified essential hypertension peripheral vascular disease, unspecified personal history of transient ischemic attack (tia), and cerebral infarction without residual deficits insulin pump status personal history of tobacco use esophageal reflux chronic kidney disease, stage iii (moderate) diabetes mellitus without mention of complication, type ii or unspecified type, not stated as uncontrolled coronary atherosclerosis of native coronary artery other and unspecified hyperlipidemia coronary atherosclerosis of autologous vein bypass graft hypertensive chronic kidney disease, unspecified, with chronic kidney disease stage i through stage iv, or unspecified diabetes with renal manifestations, type ii or unspecified type, uncontrolled chronic kidney disease, stage iii (moderate) personal history of tobacco use diabetes with neurological manifestations, type ii or unspecified type, uncontrolled hypertensive chronic kidney disease, benign, with chronic kidney disease stage i through stage iv, or unspecified severe nonproliferative diabetic retinopathy hyperpotassemia diabetes with ophthalmic manifestations, type ii or unspecified type, uncontrolled percutaneous transluminal coronary angioplasty status cataract extraction status diabetic macular edema polyneuropathy in diabetes acute kidney failure, unspecified personal history of transient ischemic attack (tia), and cerebral infarction without residual deficits surgical or other procedure not carried out because of contraindication esophageal reflux dehydration long-term (current) use of insulin atherosclerosis of native arteries of the extremities, unspecified passenger in heavy transport vehicle injured in collision with heavy transport vehicle or bus in nontraffic accident insulin pump status coronary atherosclerosis of autologous vein bypass graft pure hypercholesterolemia old myocardial infarction other specified cardiac dysrhythmias other second degree atrioventricular block unspecified essential hypertension coronary atherosclerosis of native coronary artery atherosclerosis of native arteries of the extremities with intermittent claudication coronary atherosclerosis of autologous vein bypass graft diabetes mellitus without mention of complication, type ii or unspecified type, not stated as uncontrolled
white m 80 $nan$nan$alprazolam  1  mg ; zolpidem tartrate  5-10  mg ; influenza vaccine quadrivalent  0.5  ml ; amlodipine  2.5  mg ; amlodipine  5  mg ; atenolol  25  mg ; atorvastatin  80  mg ; clopidogrel  75  mg ; gabapentin  300  mg ; hydrochlorothiazide  25  mg ; pantoprazole  40  mg ; sodium chloride 0.9%  flush  3  ml ; aspirin ec  325  mg ; acetaminophen  650  mg ; nitroglycerin sl  0.3  mg ; simethicone  40-80  mg ; dextrose 50%  12.5  gm ; glucagon  1  mg ; glucose gel  15  g ; insulin pump (self administering medication)     ; mesalamine dr  800  mg ; 
long-term (current) use of insulin dysuria chest pain, unspecified aortocoronary bypass status diabetes mellitus without mention of complication, type ii or unspecified type, not stated as uncontrolled unspecified essential hypertension peripheral vascular disease, unspecified personal history of transient ischemic attack (tia), and cerebral infarction without residual deficits insulin pump status personal history of tobacco use esophageal reflux chronic kidney disease, stage iii (moderate) diabetes mellitus without mention of complication, type ii or unspecified type, not stated as uncontrolled coronary atherosclerosis of native coronary artery other and unspecified hyperlipidemia coronary atherosclerosis of autologous vein bypass graft hypertensive chronic kidney disease, unspecified, with chronic kidney disease stage i through stage iv, or unspecified diabetes with renal manifestations, type ii or unspecified type, uncontrolled chronic kidney disease, stage iii (moderate) personal history of tobacco use diabetes with neurological manifestations, type ii or unspecified type, uncontrolled hypertensive chronic kidney disease, benign, with chronic kidney disease stage i through stage iv, or unspecified severe nonproliferative diabetic retinopathy hyperpotassemia diabetes with ophthalmic manifestations, type ii or unspecified type, uncontrolled percutaneous transluminal coronary angioplasty status cataract extraction status diabetic macular edema polyneuropathy in diabetes acute kidney failure, unspecified personal history of transient ischemic attack (tia), and cerebral infarction without residual deficits surgical or other procedure not carried out because of contraindication esophageal reflux dehydration long-term (current) use of insulin atherosclerosis of native arteries of the extremities, unspecified passenger in heavy transport vehicle injured in collision with heavy transport vehicle or bus in nontraffic accident insulin pump status coronary atherosclerosis of autologous vein bypass graft pure hypercholesterolemia old myocardial infarction other specified cardiac dysrhythmias other second degree atrioventricular block unspecified essential hypertension coronary atherosclerosis of native coronary artery atherosclerosis of native arteries of the extremities with intermittent claudication coronary atherosclerosis of autologous vein bypass graft diabetes mellitus without mention of complication, type ii or unspecified type, not stated as uncontrolled
white f 75 $nan$nan$provigil  100  mg ; aspirin  81  mg ; multivitamins  1  tab ; carbidopa-levodopa (25-100)  1  tab ; pneumococcal vac polyvalent  0.5  ml ; sodium chloride 0.9%  flush  3  ml ; carbidopa-levodopa (25-100)  1.5  tab ; senna  1  tab ; calcium carbonate  500  mg ; vitamin d  200  unit ; simvastatin  5  mg ; 
 
white f 75 $nan$nan$provigil  100  mg ; aspirin  81  mg ; multivitamins  1  tab ; carbidopa-levodopa (25-100)  1  tab ; pneumococcal vac polyvalent  0.5  ml ; sodium chloride 0.9%  flush  3  ml ; carbidopa-levodopa (25-100)  1.5  tab ; senna  1  tab ; calcium carbonate  500  mg ; vitamin d  200  unit ; simvastatin  5  mg ; alendronate sodium  70  mg ; 
 
white f 75 $nan$nan$provigil  100  mg ; aspirin  81  mg ; multivitamins  1  tab ; carbidopa-levodopa (25-100)  1  tab ; pneumococcal vac polyvalent  0.5  ml ; sodium chloride 0.9%  flush  3  ml ; carbidopa-levodopa (25-100)  1.5  tab ; senna  1  tab ; calcium carbonate  500  mg ; vitamin d  200  unit ; simvastatin  5  mg ; alendronate sodium  70  mg ; acetaminophen  325-650  mg ; heparin  5000  unit ; bisacodyl  10  mg ; docusate sodium  100  mg ; 
 
white f 75 $nan$nan$provigil  100  mg ; aspirin  81  mg ; multivitamins  1  tab ; carbidopa-levodopa (25-100)  1  tab ; pneumococcal vac polyvalent  0.5  ml ; sodium chloride 0.9%  flush  3  ml ; carbidopa-levodopa (25-100)  1.5  tab ; senna  1  tab ; calcium carbonate  500  mg ; vitamin d  200  unit ; simvastatin  5  mg ; alendronate sodium  70  mg ; acetaminophen  325-650  mg ; heparin  5000  unit ; bisacodyl  10  mg ; docusate sodium  100  mg ; ibuprofen  600  mg ; quetiapine fumarate  50  mg ; 
 
white m 72 $nan$nan$azithromycin  1200  mg ; sulfameth trimethoprim ss  1  tab ; 
gastro-esophageal reflux disease without esophagitis personal history of other venous thrombosis and embolism long term (current) use of anticoagulants nonfamilial hypogammaglobulinemia chronic graft-versus-host disease primary osteoarthritis, left shoulder other disorders of iron metabolism unspecified asthma, uncomplicated accident to watercraft causing other injury to unspecified person personal history of leukemia contusion of right elbow, initial encounter operating room of hospital as the place of occurrence of the external cause contusion of right forearm, initial encounter anxiety disorder due to known physiological condition complications of stem cell transplant hemochromatosis, unspecified exposure to other specified factors, initial encounter adjustment disorder with depressed mood other osteonecrosis, left shoulder chronic obstructive pulmonary disease, unspecified acute myeloid leukemia, in remission personal history of venous thrombosis and embolism hereditary hemochromatosis complications of transplanted organ, stem cell home accidents graft-versus-host disease, unspecified hepatitis, unspecified surgical operation with transplant of whole organ causing abnormal patient reaction, or later complication, without mention of misadventure at time of operation need for prophylactic immunotherapy blister of hand(s) except finger(s) alone, without mention of infection other fluid overload unspecified accident cough long-term (current) use of steroids post-transplant lymphoproliferative disorder (ptld) acute myeloid leukemia, without mention of having achieved remission other myopathies complications of transplanted organ, unspecified long-term (current) use of other medications surgical operation with transplant of whole organ causing abnormal patient reaction, or later complication, without mention of misadventure at time of operation personal history of venous thrombosis and embolism other opiates and related narcotics causing adverse effects in therapeutic use post-transplant lymphoproliferative disorder (ptld) acute venous embolism and thrombosis of deep vessels of proximal lower extremity graft-versus-host disease, unspecified acute myeloid leukemia, without mention of having achieved remission personal history of venous thrombosis and embolism disorders of copper metabolism
white m 72 $nan$hematology blood hematocrit  25.2  %; hematology blood hematocrit  24.5  %; hematology blood hemoglobin  8.1  g dl; hematology blood hemoglobin  8.0  g dl; hematology blood platelet count  171  k ul; hematology blood platelet count  170  k ul; chemistry blood anion gap  14  meq l; chemistry blood anion gap  18  meq l; chemistry blood bicarbonate  27  meq l; chemistry blood bicarbonate  24  meq l; chemistry blood chloride  100  meq l; chemistry blood chloride  104  meq l; chemistry blood creatinine  0.6  mg dl; chemistry blood creatinine  0.6  mg dl; chemistry blood potassium  3.7  meq l; chemistry blood potassium  3.6  meq l; chemistry blood sodium  137  meq l; chemistry blood sodium  142  meq l; chemistry blood urea nitrogen  15  mg dl; chemistry blood urea nitrogen  12  mg dl; hematology blood inr(pt)  1.0  ; hematology blood inr(pt)  1.0  ; chemistry blood calcium, total  9.2  mg dl; chemistry blood calcium, total  9.0  mg dl; chemistry blood bilirubin, total  0.7  mg dl; chemistry blood bilirubin, total  0.6  mg dl; chemistry blood glucose  113  mg dl; chemistry blood glucose  112  mg dl; chemistry blood lactate dehydrogenase (ld)  204  iu l; chemistry blood lactate dehydrogenase (ld)  208  iu l; chemistry blood albumin  3.4  g dl; chemistry blood albumin  3.4  g dl$azithromycin  1200  mg ; sulfameth trimethoprim ss  1  tab ; heparin flush (100 units ml)  5  ml ; sodium chloride 0.9%  1000  ml ; acyclovir  400  mg ; betamethasone dipro 0.05% cream  1  appl ; guaifenesin-codeine phosphate  5-10  ml ; dexamethasone oral soln (0.1mg 1ml)  5  ml ; fluticasone propionate 110mcg  2  puff ; folic acid  1  mg ; lorazepam  0.5  mg ; mycophenolate mofetil  500  mg ; nystatin oral suspension  5  ml ; pantoprazole  40  mg ; mupirocin ointment 2%  1  appl ; prednisone  10  mg ; promethazine  12.5  mg ; zinc sulfate  220  mg ; vitamin d  1000  unit ; multivitamins  1  tab ; cyanocobalamin  1000  mcg ; artificial tears  1-2  drop ; moviprep  1  l ; d5 1 2ns  1000  ml ; sterile water  100  ml ; potassium chloride  40  meq ; sterile water  150  ml ; potassium chloride  60  meq ; sterile water  200  ml ; potassium chloride  80  meq ; bag  1  bag ; magnesium sulfate  2  gm ; bag  2  bag ; magnesium sulfate  4  gm ; 0.9% sodium chloride  250  ml ; potassium phosphate  15  mmol ; tacrolimus  0.1  % ; erythromycin 0.5% ophth oint  0.5  in ; heparin flush (10 units ml)  5  ml ; sodium chloride 0.9%  flush  10  ml ; magnesium citrate  300  ml ; 
gastro-esophageal reflux disease without esophagitis personal history of other venous thrombosis and embolism long term (current) use of anticoagulants nonfamilial hypogammaglobulinemia chronic graft-versus-host disease primary osteoarthritis, left shoulder other disorders of iron metabolism unspecified asthma, uncomplicated accident to watercraft causing other injury to unspecified person personal history of leukemia contusion of right elbow, initial encounter operating room of hospital as the place of occurrence of the external cause contusion of right forearm, initial encounter anxiety disorder due to known physiological condition complications of stem cell transplant hemochromatosis, unspecified exposure to other specified factors, initial encounter adjustment disorder with depressed mood other osteonecrosis, left shoulder chronic obstructive pulmonary disease, unspecified acute myeloid leukemia, in remission personal history of venous thrombosis and embolism hereditary hemochromatosis complications of transplanted organ, stem cell home accidents graft-versus-host disease, unspecified hepatitis, unspecified surgical operation with transplant of whole organ causing abnormal patient reaction, or later complication, without mention of misadventure at time of operation need for prophylactic immunotherapy blister of hand(s) except finger(s) alone, without mention of infection other fluid overload unspecified accident cough long-term (current) use of steroids post-transplant lymphoproliferative disorder (ptld) acute myeloid leukemia, without mention of having achieved remission other myopathies complications of transplanted organ, unspecified long-term (current) use of other medications surgical operation with transplant of whole organ causing abnormal patient reaction, or later complication, without mention of misadventure at time of operation personal history of venous thrombosis and embolism other opiates and related narcotics causing adverse effects in therapeutic use post-transplant lymphoproliferative disorder (ptld) acute venous embolism and thrombosis of deep vessels of proximal lower extremity graft-versus-host disease, unspecified acute myeloid leukemia, without mention of having achieved remission personal history of venous thrombosis and embolism disorders of copper metabolism
white m 72 $nan$hematology blood hematocrit  23.3  %; hematology blood hemoglobin  7.4  g dl; hematology blood platelet count  145  k ul; chemistry blood anion gap  11  meq l; chemistry blood bicarbonate  26  meq l; chemistry blood chloride  107  meq l; chemistry blood creatinine  0.4  mg dl; chemistry blood potassium  3.4  meq l; chemistry blood sodium  141  meq l; chemistry blood urea nitrogen  6  mg dl; chemistry blood calcium, total  7.9  mg dl; chemistry blood bilirubin, total  0.4  mg dl; chemistry blood glucose  108  mg dl; chemistry blood lactate dehydrogenase (ld)  215  iu l; chemistry blood albumin  3.0  g dl$azithromycin  1200  mg ; sulfameth trimethoprim ss  1  tab ; heparin flush (100 units ml)  5  ml ; betamethasone dipro 0.05% cream  1  appl ; guaifenesin-codeine phosphate  5-10  ml ; dexamethasone oral soln (0.1mg 1ml)  5  ml ; fluticasone propionate 110mcg  2  puff ; folic acid  1  mg ; lorazepam  0.5  mg ; mycophenolate mofetil  500  mg ; nystatin oral suspension  5  ml ; pantoprazole  40  mg ; mupirocin ointment 2%  1  appl ; prednisone  10  mg ; promethazine  12.5  mg ; zinc sulfate  220  mg ; vitamin d  1000  unit ; multivitamins  1  tab ; cyanocobalamin  1000  mcg ; artificial tears  1-2  drop ; moviprep  1  l ; d5 1 2ns  1000  ml ; sterile water  100  ml ; potassium chloride  40  meq ; sterile water  150  ml ; potassium chloride  60  meq ; sterile water  200  ml ; potassium chloride  80  meq ; bag  1  bag ; magnesium sulfate  2  gm ; bag  2  bag ; magnesium sulfate  4  gm ; 0.9% sodium chloride  250  ml ; potassium phosphate  15  mmol ; tacrolimus  0.1  % ; erythromycin 0.5% ophth oint  0.5  in ; heparin flush (10 units ml)  5  ml ; sodium chloride 0.9%  flush  10  ml ; magnesium citrate  300  ml ; readi-cat 2 (barium sulfate 2% suspension)  900  ml ; thiamine  100  mg ; 0.9% sodium chloride  1  bag ; calcium gluconate  2  g ; 0.9% sodium chloride  2  bag ; calcium gluconate  4  g ; 
gastro-esophageal reflux disease without esophagitis personal history of other venous thrombosis and embolism long term (current) use of anticoagulants nonfamilial hypogammaglobulinemia chronic graft-versus-host disease primary osteoarthritis, left shoulder other disorders of iron metabolism unspecified asthma, uncomplicated accident to watercraft causing other injury to unspecified person personal history of leukemia contusion of right elbow, initial encounter operating room of hospital as the place of occurrence of the external cause contusion of right forearm, initial encounter anxiety disorder due to known physiological condition complications of stem cell transplant hemochromatosis, unspecified exposure to other specified factors, initial encounter adjustment disorder with depressed mood other osteonecrosis, left shoulder chronic obstructive pulmonary disease, unspecified acute myeloid leukemia, in remission personal history of venous thrombosis and embolism hereditary hemochromatosis complications of transplanted organ, stem cell home accidents graft-versus-host disease, unspecified hepatitis, unspecified surgical operation with transplant of whole organ causing abnormal patient reaction, or later complication, without mention of misadventure at time of operation need for prophylactic immunotherapy blister of hand(s) except finger(s) alone, without mention of infection other fluid overload unspecified accident cough long-term (current) use of steroids post-transplant lymphoproliferative disorder (ptld) acute myeloid leukemia, without mention of having achieved remission other myopathies complications of transplanted organ, unspecified long-term (current) use of other medications surgical operation with transplant of whole organ causing abnormal patient reaction, or later complication, without mention of misadventure at time of operation personal history of venous thrombosis and embolism other opiates and related narcotics causing adverse effects in therapeutic use post-transplant lymphoproliferative disorder (ptld) acute venous embolism and thrombosis of deep vessels of proximal lower extremity graft-versus-host disease, unspecified acute myeloid leukemia, without mention of having achieved remission personal history of venous thrombosis and embolism disorders of copper metabolism
white m 72 $nan$hematology blood hematocrit  23.5  %; hematology blood hemoglobin  7.4  g dl; hematology blood platelet count  145  k ul; chemistry blood anion gap  13  meq l; chemistry blood anion gap  16  meq l; chemistry blood bicarbonate  24  meq l; chemistry blood bicarbonate  22  meq l; chemistry blood chloride  107  meq l; chemistry blood chloride  107  meq l; chemistry blood creatinine  0.4  mg dl; chemistry blood creatinine  0.5  mg dl; chemistry blood potassium  3.8  meq l; chemistry blood potassium  4.3  meq l; chemistry blood sodium  140  meq l; chemistry blood sodium  141  meq l; chemistry blood urea nitrogen  5  mg dl; chemistry blood urea nitrogen  4  mg dl; chemistry blood calcium, total  8.3  mg dl; chemistry blood calcium, total  8.2  mg dl; chemistry blood bilirubin, total  0.6  mg dl; chemistry blood glucose  117  mg dl; chemistry blood glucose  103  mg dl; chemistry blood lactate dehydrogenase (ld)  223  iu l; chemistry blood albumin  3.0  g dl$azithromycin  1200  mg ; sulfameth trimethoprim ss  1  tab ; heparin flush (100 units ml)  5  ml ; betamethasone dipro 0.05% cream  1  appl ; guaifenesin-codeine phosphate  5-10  ml ; dexamethasone oral soln (0.1mg 1ml)  5  ml ; fluticasone propionate 110mcg  2  puff ; folic acid  1  mg ; lorazepam  0.5  mg ; mycophenolate mofetil  500  mg ; nystatin oral suspension  5  ml ; pantoprazole  40  mg ; mupirocin ointment 2%  1  appl ; prednisone  10  mg ; promethazine  12.5  mg ; vitamin d  1000  unit ; multivitamins  1  tab ; cyanocobalamin  1000  mcg ; artificial tears  1-2  drop ; d5 1 2ns  1000  ml ; sterile water  100  ml ; potassium chloride  40  meq ; sterile water  150  ml ; potassium chloride  60  meq ; sterile water  200  ml ; potassium chloride  80  meq ; bag  1  bag ; magnesium sulfate  2  gm ; bag  2  bag ; magnesium sulfate  4  gm ; 0.9% sodium chloride  250  ml ; potassium phosphate  15  mmol ; tacrolimus  0.1  % ; erythromycin 0.5% ophth oint  0.5  in ; heparin flush (10 units ml)  5  ml ; sodium chloride 0.9%  flush  10  ml ; readi-cat 2 (barium sulfate 2% suspension)  900  ml ; thiamine  100  mg ; 0.9% sodium chloride  1  bag ; calcium gluconate  2  g ; 0.9% sodium chloride  2  bag ; calcium gluconate  4  g ; rivaroxaban  10  mg ; potassium phosphate  30  mmol ; 
gastro-esophageal reflux disease without esophagitis personal history of other venous thrombosis and embolism long term (current) use of anticoagulants nonfamilial hypogammaglobulinemia chronic graft-versus-host disease primary osteoarthritis, left shoulder other disorders of iron metabolism unspecified asthma, uncomplicated accident to watercraft causing other injury to unspecified person personal history of leukemia contusion of right elbow, initial encounter operating room of hospital as the place of occurrence of the external cause contusion of right forearm, initial encounter anxiety disorder due to known physiological condition complications of stem cell transplant hemochromatosis, unspecified exposure to other specified factors, initial encounter adjustment disorder with depressed mood other osteonecrosis, left shoulder chronic obstructive pulmonary disease, unspecified acute myeloid leukemia, in remission personal history of venous thrombosis and embolism hereditary hemochromatosis complications of transplanted organ, stem cell home accidents graft-versus-host disease, unspecified hepatitis, unspecified surgical operation with transplant of whole organ causing abnormal patient reaction, or later complication, without mention of misadventure at time of operation need for prophylactic immunotherapy blister of hand(s) except finger(s) alone, without mention of infection other fluid overload unspecified accident cough long-term (current) use of steroids post-transplant lymphoproliferative disorder (ptld) acute myeloid leukemia, without mention of having achieved remission other myopathies complications of transplanted organ, unspecified long-term (current) use of other medications surgical operation with transplant of whole organ causing abnormal patient reaction, or later complication, without mention of misadventure at time of operation personal history of venous thrombosis and embolism other opiates and related narcotics causing adverse effects in therapeutic use post-transplant lymphoproliferative disorder (ptld) acute venous embolism and thrombosis of deep vessels of proximal lower extremity graft-versus-host disease, unspecified acute myeloid leukemia, without mention of having achieved remission personal history of venous thrombosis and embolism disorders of copper metabolism
white m 72 $nan$hematology blood hematocrit  23.6  %; hematology blood hemoglobin  7.4  g dl; hematology blood platelet count  146  k ul; chemistry blood anion gap  13  meq l; chemistry blood anion gap  12  meq l; chemistry blood bicarbonate  24  meq l; chemistry blood bicarbonate  26  meq l; chemistry blood chloride  106  meq l; chemistry blood chloride  102  meq l; chemistry blood creatinine  0.5  mg dl; chemistry blood creatinine  0.5  mg dl; chemistry blood potassium  4.4  meq l; chemistry blood potassium  4.1  meq l; chemistry blood sodium  139  meq l; chemistry blood sodium  136  meq l; chemistry blood urea nitrogen  4  mg dl; chemistry blood urea nitrogen  5  mg dl; chemistry blood calcium, total  8.4  mg dl; chemistry blood calcium, total  8.3  mg dl; chemistry blood bilirubin, total  0.5  mg dl; chemistry blood glucose  118  mg dl; chemistry blood glucose  108  mg dl; chemistry blood lactate dehydrogenase (ld)  182  iu l; chemistry blood albumin  3.1  g dl$azithromycin  1200  mg ; sulfameth trimethoprim ss  1  tab ; heparin flush (100 units ml)  5  ml ; betamethasone dipro 0.05% cream  1  appl ; guaifenesin-codeine phosphate  5-10  ml ; dexamethasone oral soln (0.1mg 1ml)  5  ml ; fluticasone propionate 110mcg  2  puff ; folic acid  1  mg ; lorazepam  0.5  mg ; mycophenolate mofetil  500  mg ; nystatin oral suspension  5  ml ; pantoprazole  40  mg ; mupirocin ointment 2%  1  appl ; prednisone  10  mg ; promethazine  12.5  mg ; vitamin d  1000  unit ; multivitamins  1  tab ; cyanocobalamin  1000  mcg ; artificial tears  1-2  drop ; sterile water  100  ml ; potassium chloride  40  meq ; sterile water  150  ml ; potassium chloride  60  meq ; sterile water  200  ml ; potassium chloride  80  meq ; bag  1  bag ; magnesium sulfate  2  gm ; bag  2  bag ; magnesium sulfate  4  gm ; 0.9% sodium chloride  250  ml ; potassium phosphate  15  mmol ; tacrolimus  0.1  % ; erythromycin 0.5% ophth oint  0.5  in ; heparin flush (10 units ml)  5  ml ; sodium chloride 0.9%  flush  10  ml ; thiamine  100  mg ; 0.9% sodium chloride  1  bag ; calcium gluconate  2  g ; 0.9% sodium chloride  2  bag ; calcium gluconate  4  g ; rivaroxaban  10  mg ; potassium phosphate  30  mmol ; 
gastro-esophageal reflux disease without esophagitis personal history of other venous thrombosis and embolism long term (current) use of anticoagulants nonfamilial hypogammaglobulinemia chronic graft-versus-host disease primary osteoarthritis, left shoulder other disorders of iron metabolism unspecified asthma, uncomplicated accident to watercraft causing other injury to unspecified person personal history of leukemia contusion of right elbow, initial encounter operating room of hospital as the place of occurrence of the external cause contusion of right forearm, initial encounter anxiety disorder due to known physiological condition complications of stem cell transplant hemochromatosis, unspecified exposure to other specified factors, initial encounter adjustment disorder with depressed mood other osteonecrosis, left shoulder chronic obstructive pulmonary disease, unspecified acute myeloid leukemia, in remission personal history of venous thrombosis and embolism hereditary hemochromatosis complications of transplanted organ, stem cell home accidents graft-versus-host disease, unspecified hepatitis, unspecified surgical operation with transplant of whole organ causing abnormal patient reaction, or later complication, without mention of misadventure at time of operation need for prophylactic immunotherapy blister of hand(s) except finger(s) alone, without mention of infection other fluid overload unspecified accident cough long-term (current) use of steroids post-transplant lymphoproliferative disorder (ptld) acute myeloid leukemia, without mention of having achieved remission other myopathies complications of transplanted organ, unspecified long-term (current) use of other medications surgical operation with transplant of whole organ causing abnormal patient reaction, or later complication, without mention of misadventure at time of operation personal history of venous thrombosis and embolism other opiates and related narcotics causing adverse effects in therapeutic use post-transplant lymphoproliferative disorder (ptld) acute venous embolism and thrombosis of deep vessels of proximal lower extremity graft-versus-host disease, unspecified acute myeloid leukemia, without mention of having achieved remission personal history of venous thrombosis and embolism disorders of copper metabolism
white m 72 $nan$hematology blood hematocrit  23.4  %; hematology blood hemoglobin  7.4  g dl; hematology blood platelet count  145  k ul; chemistry blood anion gap  11  meq l; chemistry blood anion gap  14  meq l; chemistry blood anion gap  12  meq l; chemistry blood bicarbonate  27  meq l; chemistry blood bicarbonate  26  meq l; chemistry blood bicarbonate  29  meq l; chemistry blood chloride  102  meq l; chemistry blood chloride  103  meq l; chemistry blood chloride  103  meq l; chemistry blood creatinine  0.5  mg dl; chemistry blood creatinine  0.5  mg dl; chemistry blood creatinine  0.5  mg dl; chemistry blood potassium  4.3  meq l; chemistry blood potassium  4.3  meq l; chemistry blood potassium  3.7  meq l; chemistry blood sodium  136  meq l; chemistry blood sodium  139  meq l; chemistry blood sodium  140  meq l; chemistry blood urea nitrogen  9  mg dl; chemistry blood urea nitrogen  10  mg dl; chemistry blood urea nitrogen  11  mg dl; chemistry blood calcium, total  8.3  mg dl; chemistry blood calcium, total  8.2  mg dl; chemistry blood calcium, total  8.3  mg dl; chemistry blood bilirubin, total  0.4  mg dl; chemistry blood glucose  131  mg dl; chemistry blood glucose  95  mg dl; chemistry blood glucose  118  mg dl; chemistry blood lactate dehydrogenase (ld)  207  iu l; chemistry blood albumin  3.1  g dl$azithromycin  1200  mg ; sulfameth trimethoprim ss  1  tab ; heparin flush (100 units ml)  5  ml ; betamethasone dipro 0.05% cream  1  appl ; guaifenesin-codeine phosphate  5-10  ml ; dexamethasone oral soln (0.1mg 1ml)  5  ml ; fluticasone propionate 110mcg  2  puff ; folic acid  1  mg ; lorazepam  0.5  mg ; mycophenolate mofetil  500  mg ; nystatin oral suspension  5  ml ; pantoprazole  40  mg ; mupirocin ointment 2%  1  appl ; prednisone  10  mg ; promethazine  12.5  mg ; vitamin d  1000  unit ; multivitamins  1  tab ; cyanocobalamin  1000  mcg ; artificial tears  1-2  drop ; sterile water  100  ml ; potassium chloride  40  meq ; sterile water  150  ml ; potassium chloride  60  meq ; sterile water  200  ml ; potassium chloride  80  meq ; bag  1  bag ; magnesium sulfate  2  gm ; bag  2  bag ; magnesium sulfate  4  gm ; 0.9% sodium chloride  250  ml ; potassium phosphate  15  mmol ; tacrolimus  0.1  % ; erythromycin 0.5% ophth oint  0.5  in ; heparin flush (10 units ml)  5  ml ; sodium chloride 0.9%  flush  10  ml ; thiamine  100  mg ; 0.9% sodium chloride  1  bag ; calcium gluconate  2  g ; 0.9% sodium chloride  2  bag ; calcium gluconate  4  g ; rivaroxaban  10  mg ; 
gastro-esophageal reflux disease without esophagitis personal history of other venous thrombosis and embolism long term (current) use of anticoagulants nonfamilial hypogammaglobulinemia chronic graft-versus-host disease primary osteoarthritis, left shoulder other disorders of iron metabolism unspecified asthma, uncomplicated accident to watercraft causing other injury to unspecified person personal history of leukemia contusion of right elbow, initial encounter operating room of hospital as the place of occurrence of the external cause contusion of right forearm, initial encounter anxiety disorder due to known physiological condition complications of stem cell transplant hemochromatosis, unspecified exposure to other specified factors, initial encounter adjustment disorder with depressed mood other osteonecrosis, left shoulder chronic obstructive pulmonary disease, unspecified acute myeloid leukemia, in remission personal history of venous thrombosis and embolism hereditary hemochromatosis complications of transplanted organ, stem cell home accidents graft-versus-host disease, unspecified hepatitis, unspecified surgical operation with transplant of whole organ causing abnormal patient reaction, or later complication, without mention of misadventure at time of operation need for prophylactic immunotherapy blister of hand(s) except finger(s) alone, without mention of infection other fluid overload unspecified accident cough long-term (current) use of steroids post-transplant lymphoproliferative disorder (ptld) acute myeloid leukemia, without mention of having achieved remission other myopathies complications of transplanted organ, unspecified long-term (current) use of other medications surgical operation with transplant of whole organ causing abnormal patient reaction, or later complication, without mention of misadventure at time of operation personal history of venous thrombosis and embolism other opiates and related narcotics causing adverse effects in therapeutic use post-transplant lymphoproliferative disorder (ptld) acute venous embolism and thrombosis of deep vessels of proximal lower extremity graft-versus-host disease, unspecified acute myeloid leukemia, without mention of having achieved remission personal history of venous thrombosis and embolism disorders of copper metabolism
white m 72 $nan$hematology blood hematocrit  21.8  %; hematology blood hemoglobin  6.8  g dl; hematology blood platelet count  151  k ul; chemistry blood anion gap  13  meq l; chemistry blood bicarbonate  29  meq l; chemistry blood chloride  107  meq l; chemistry blood creatinine  0.5  mg dl; chemistry blood potassium  4.8  meq l; chemistry blood sodium  144  meq l; chemistry blood urea nitrogen  12  mg dl; chemistry blood calcium, total  8.4  mg dl; chemistry blood bilirubin, total  0.4  mg dl; chemistry blood glucose  96  mg dl; chemistry blood lactate dehydrogenase (ld)  177  iu l; chemistry blood albumin  3.1  g dl$azithromycin  1200  mg ; sulfameth trimethoprim ss  1  tab ; heparin flush (100 units ml)  5  ml ; betamethasone dipro 0.05% cream  1  appl ; guaifenesin-codeine phosphate  5-10  ml ; dexamethasone oral soln (0.1mg 1ml)  5  ml ; fluticasone propionate 110mcg  2  puff ; folic acid  1  mg ; lorazepam  0.5  mg ; mycophenolate mofetil  500  mg ; nystatin oral suspension  5  ml ; pantoprazole  40  mg ; mupirocin ointment 2%  1  appl ; prednisone  10  mg ; promethazine  12.5  mg ; vitamin d  1000  unit ; multivitamins  1  tab ; cyanocobalamin  1000  mcg ; artificial tears  1-2  drop ; sterile water  100  ml ; potassium chloride  40  meq ; sterile water  150  ml ; potassium chloride  60  meq ; sterile water  200  ml ; potassium chloride  80  meq ; bag  1  bag ; magnesium sulfate  2  gm ; bag  2  bag ; magnesium sulfate  4  gm ; 0.9% sodium chloride  250  ml ; potassium phosphate  15  mmol ; tacrolimus  0.1  % ; erythromycin 0.5% ophth oint  0.5  in ; heparin flush (10 units ml)  5  ml ; sodium chloride 0.9%  flush  10  ml ; thiamine  100  mg ; 0.9% sodium chloride  1  bag ; calcium gluconate  2  g ; 0.9% sodium chloride  2  bag ; calcium gluconate  4  g ; rivaroxaban  10  mg ; 
gastro-esophageal reflux disease without esophagitis personal history of other venous thrombosis and embolism long term (current) use of anticoagulants nonfamilial hypogammaglobulinemia chronic graft-versus-host disease primary osteoarthritis, left shoulder other disorders of iron metabolism unspecified asthma, uncomplicated accident to watercraft causing other injury to unspecified person personal history of leukemia contusion of right elbow, initial encounter operating room of hospital as the place of occurrence of the external cause contusion of right forearm, initial encounter anxiety disorder due to known physiological condition complications of stem cell transplant hemochromatosis, unspecified exposure to other specified factors, initial encounter adjustment disorder with depressed mood other osteonecrosis, left shoulder chronic obstructive pulmonary disease, unspecified acute myeloid leukemia, in remission personal history of venous thrombosis and embolism hereditary hemochromatosis complications of transplanted organ, stem cell home accidents graft-versus-host disease, unspecified hepatitis, unspecified surgical operation with transplant of whole organ causing abnormal patient reaction, or later complication, without mention of misadventure at time of operation need for prophylactic immunotherapy blister of hand(s) except finger(s) alone, without mention of infection other fluid overload unspecified accident cough long-term (current) use of steroids post-transplant lymphoproliferative disorder (ptld) acute myeloid leukemia, without mention of having achieved remission other myopathies complications of transplanted organ, unspecified long-term (current) use of other medications surgical operation with transplant of whole organ causing abnormal patient reaction, or later complication, without mention of misadventure at time of operation personal history of venous thrombosis and embolism other opiates and related narcotics causing adverse effects in therapeutic use post-transplant lymphoproliferative disorder (ptld) acute venous embolism and thrombosis of deep vessels of proximal lower extremity graft-versus-host disease, unspecified acute myeloid leukemia, without mention of having achieved remission personal history of venous thrombosis and embolism disorders of copper metabolism
white m 72 $nan$hematology blood hematocrit  25.4  %; hematology blood hemoglobin  8.1  g dl; hematology blood platelet count  163  k ul; chemistry blood anion gap  10  meq l; chemistry blood bicarbonate  32  meq l; chemistry blood chloride  102  meq l; chemistry blood creatinine  0.4  mg dl; chemistry blood potassium  3.9  meq l; chemistry blood sodium  140  meq l; chemistry blood urea nitrogen  14  mg dl; chemistry blood calcium, total  8.4  mg dl; chemistry blood bilirubin, total  0.7  mg dl; chemistry blood glucose  122  mg dl; chemistry blood lactate dehydrogenase (ld)  193  iu l; chemistry blood albumin  2.9  g dl$azithromycin  1200  mg ; sulfameth trimethoprim ss  1  tab ; heparin flush (100 units ml)  5  ml ; betamethasone dipro 0.05% cream  1  appl ; guaifenesin-codeine phosphate  5-10  ml ; dexamethasone oral soln (0.1mg 1ml)  5  ml ; fluticasone propionate 110mcg  2  puff ; folic acid  1  mg ; lorazepam  0.5  mg ; mycophenolate mofetil  500  mg ; nystatin oral suspension  5  ml ; pantoprazole  40  mg ; mupirocin ointment 2%  1  appl ; prednisone  10  mg ; promethazine  12.5  mg ; vitamin d  1000  unit ; multivitamins  1  tab ; cyanocobalamin  1000  mcg ; artificial tears  1-2  drop ; sterile water  100  ml ; potassium chloride  40  meq ; sterile water  150  ml ; potassium chloride  60  meq ; sterile water  200  ml ; potassium chloride  80  meq ; bag  1  bag ; magnesium sulfate  2  gm ; bag  2  bag ; magnesium sulfate  4  gm ; 0.9% sodium chloride  250  ml ; potassium phosphate  15  mmol ; tacrolimus  0.1  % ; erythromycin 0.5% ophth oint  0.5  in ; heparin flush (10 units ml)  5  ml ; sodium chloride 0.9%  flush  10  ml ; thiamine  100  mg ; 0.9% sodium chloride  1  bag ; calcium gluconate  2  g ; 0.9% sodium chloride  2  bag ; calcium gluconate  4  g ; rivaroxaban  10  mg ; 
gastro-esophageal reflux disease without esophagitis personal history of other venous thrombosis and embolism long term (current) use of anticoagulants nonfamilial hypogammaglobulinemia chronic graft-versus-host disease primary osteoarthritis, left shoulder other disorders of iron metabolism unspecified asthma, uncomplicated accident to watercraft causing other injury to unspecified person personal history of leukemia contusion of right elbow, initial encounter operating room of hospital as the place of occurrence of the external cause contusion of right forearm, initial encounter anxiety disorder due to known physiological condition complications of stem cell transplant hemochromatosis, unspecified exposure to other specified factors, initial encounter adjustment disorder with depressed mood other osteonecrosis, left shoulder chronic obstructive pulmonary disease, unspecified acute myeloid leukemia, in remission personal history of venous thrombosis and embolism hereditary hemochromatosis complications of transplanted organ, stem cell home accidents graft-versus-host disease, unspecified hepatitis, unspecified surgical operation with transplant of whole organ causing abnormal patient reaction, or later complication, without mention of misadventure at time of operation need for prophylactic immunotherapy blister of hand(s) except finger(s) alone, without mention of infection other fluid overload unspecified accident cough long-term (current) use of steroids post-transplant lymphoproliferative disorder (ptld) acute myeloid leukemia, without mention of having achieved remission other myopathies complications of transplanted organ, unspecified long-term (current) use of other medications surgical operation with transplant of whole organ causing abnormal patient reaction, or later complication, without mention of misadventure at time of operation personal history of venous thrombosis and embolism other opiates and related narcotics causing adverse effects in therapeutic use post-transplant lymphoproliferative disorder (ptld) acute venous embolism and thrombosis of deep vessels of proximal lower extremity graft-versus-host disease, unspecified acute myeloid leukemia, without mention of having achieved remission personal history of venous thrombosis and embolism disorders of copper metabolism
white m 72 $nan$nan$azithromycin  1200  mg ; sulfameth trimethoprim ss  1  tab ; heparin flush (100 units ml)  5  ml ; betamethasone dipro 0.05% cream  1  appl ; guaifenesin-codeine phosphate  5-10  ml ; dexamethasone oral soln (0.1mg 1ml)  5  ml ; fluticasone propionate 110mcg  2  puff ; folic acid  1  mg ; lorazepam  0.5  mg ; mycophenolate mofetil  500  mg ; nystatin oral suspension  5  ml ; pantoprazole  40  mg ; mupirocin ointment 2%  1  appl ; prednisone  10  mg ; promethazine  12.5  mg ; vitamin d  1000  unit ; multivitamins  1  tab ; cyanocobalamin  1000  mcg ; artificial tears  1-2  drop ; sterile water  100  ml ; potassium chloride  40  meq ; sterile water  150  ml ; potassium chloride  60  meq ; sterile water  200  ml ; potassium chloride  80  meq ; bag  1  bag ; magnesium sulfate  2  gm ; bag  2  bag ; magnesium sulfate  4  gm ; 0.9% sodium chloride  250  ml ; potassium phosphate  15  mmol ; tacrolimus  0.1  % ; erythromycin 0.5% ophth oint  0.5  in ; heparin flush (10 units ml)  5  ml ; sodium chloride 0.9%  flush  10  ml ; thiamine  100  mg ; 0.9% sodium chloride  1  bag ; calcium gluconate  2  g ; 0.9% sodium chloride  2  bag ; calcium gluconate  4  g ; rivaroxaban  10  mg ; 
gastro-esophageal reflux disease without esophagitis personal history of other venous thrombosis and embolism long term (current) use of anticoagulants nonfamilial hypogammaglobulinemia chronic graft-versus-host disease primary osteoarthritis, left shoulder other disorders of iron metabolism unspecified asthma, uncomplicated accident to watercraft causing other injury to unspecified person personal history of leukemia contusion of right elbow, initial encounter operating room of hospital as the place of occurrence of the external cause contusion of right forearm, initial encounter anxiety disorder due to known physiological condition complications of stem cell transplant hemochromatosis, unspecified exposure to other specified factors, initial encounter adjustment disorder with depressed mood other osteonecrosis, left shoulder chronic obstructive pulmonary disease, unspecified acute myeloid leukemia, in remission personal history of venous thrombosis and embolism hereditary hemochromatosis complications of transplanted organ, stem cell home accidents graft-versus-host disease, unspecified hepatitis, unspecified surgical operation with transplant of whole organ causing abnormal patient reaction, or later complication, without mention of misadventure at time of operation need for prophylactic immunotherapy blister of hand(s) except finger(s) alone, without mention of infection other fluid overload unspecified accident cough long-term (current) use of steroids post-transplant lymphoproliferative disorder (ptld) acute myeloid leukemia, without mention of having achieved remission other myopathies complications of transplanted organ, unspecified long-term (current) use of other medications surgical operation with transplant of whole organ causing abnormal patient reaction, or later complication, without mention of misadventure at time of operation personal history of venous thrombosis and embolism other opiates and related narcotics causing adverse effects in therapeutic use post-transplant lymphoproliferative disorder (ptld) acute venous embolism and thrombosis of deep vessels of proximal lower extremity graft-versus-host disease, unspecified acute myeloid leukemia, without mention of having achieved remission personal history of venous thrombosis and embolism disorders of copper metabolism
other m 48 $nan$nan$lisinopril  5  mg ; 
subendocardial infarction, initial episode of care pure hypercholesterolemia coronary atherosclerosis of native coronary artery 
other m 48 $nan$hematology blood hematocrit  40.0  %; hematology blood hemoglobin  13.9  g dl; hematology blood platelet count  240  k ul; chemistry blood anion gap  12  meq l; chemistry blood bicarbonate  29  meq l; chemistry blood chloride  106  meq l; chemistry blood creatinine  1.0  mg dl; chemistry blood potassium  4.7  meq l; chemistry blood sodium  142  meq l; chemistry blood urea nitrogen  9  mg dl; chemistry blood glucose  88  mg dl$lisinopril  5  mg ; sodium chloride 0.9%  flush  3  ml ; heparin  5000  unit ; docusate sodium  100  mg ; senna  1  tab ; acetaminophen  325-650  mg ; metoprolol tartrate  12.5  mg ; aspirin  325  mg ; 
subendocardial infarction, initial episode of care pure hypercholesterolemia coronary atherosclerosis of native coronary artery 
other m 48 $nan$nan$lisinopril  5  mg ; sodium chloride 0.9%  flush  3  ml ; heparin  5000  unit ; docusate sodium  100  mg ; senna  1  tab ; acetaminophen  325-650  mg ; metoprolol tartrate  12.5  mg ; aspirin  325  mg ; 
subendocardial infarction, initial episode of care pure hypercholesterolemia coronary atherosclerosis of native coronary artery 
white f 44 $temp  100.4  heartrate  128.0  resprate  20.0  o2sat  100.0  sbp  136.0  dbp  76.0  rhythm    pain  4  $hematology blood hematocrit  34.7  %; hematology blood hematocrit  31.0  %; hematology blood hematocrit  29.1  %; hematology blood hematocrit  29.3  %; hematology blood hemoglobin  11.2  g dl; hematology blood hemoglobin  10.0  g dl; hematology blood hemoglobin  9.4  g dl; hematology blood hemoglobin  9.5  g dl; hematology blood platelet count  171  k ul; hematology blood platelet count  149  k ul; hematology blood platelet count  143  k ul; hematology blood platelet count  127  k ul; chemistry blood anion gap  13  meq l; chemistry blood anion gap  14  meq l; chemistry blood anion gap  12  meq l; chemistry blood anion gap  12  meq l; chemistry blood bicarbonate  21  meq l; chemistry blood bicarbonate  16  meq l; chemistry blood bicarbonate  15  meq l; chemistry blood bicarbonate  15  meq l; chemistry blood chloride  99  meq l; chemistry blood chloride  101  meq l; chemistry blood chloride  103  meq l; chemistry blood chloride  102  meq l; chemistry blood creatinine  2.5  mg dl; chemistry blood creatinine  2.7  mg dl; chemistry blood creatinine  2.7  mg dl; chemistry blood creatinine  2.4  mg dl; chemistry blood potassium  5.4  meq l; chemistry blood potassium  4.7  meq l; chemistry blood potassium  5.5  meq l; chemistry blood potassium  5.1  meq l; chemistry blood sodium  133  meq l; chemistry blood sodium  131  meq l; chemistry blood sodium  130  meq l; chemistry blood sodium  129  meq l; chemistry blood urea nitrogen  41  mg dl; chemistry blood urea nitrogen  38  mg dl; chemistry blood urea nitrogen  37  mg dl; chemistry blood urea nitrogen  33  mg dl; hematology blood inr(pt)  1.4  ; hematology blood inr(pt)  1.4  ; hematology blood inr(pt)  1.6  ; hematology blood inr(pt)  1.6  ; chemistry urine creatinine, urine  115  mg dl; chemistry urine potassium, urine  45  meq l; chemistry urine sodium, urine  49  meq l; hematology urine wbc  2  # hpf; chemistry blood calcium, total  9.0  mg dl; chemistry blood calcium, total  8.4  mg dl; chemistry blood calcium, total  8.6  mg dl; chemistry blood calcium, total  8.6  mg dl; chemistry blood bilirubin, indirect  0.8  mg dl; chemistry blood bilirubin, total  1.7  mg dl; chemistry blood bilirubin, total  1.7  mg dl; chemistry blood bilirubin, total  1.8  mg dl; chemistry blood bilirubin, total  1.9  mg dl; chemistry blood glucose  93  mg dl; chemistry blood glucose  128  mg dl; chemistry blood glucose  129  mg dl; chemistry blood glucose  135  mg dl; chemistry blood lactate dehydrogenase (ld)  652  iu l; blood gas blood lactate  2.2  mmol l; blood gas blood lactate  1.6  mmol l; blood gas blood lactate  1.6  mmol l; chemistry blood bilirubin, direct  1.1  mg dl$sodium chloride 0.9%  flush  3-10  ml ; omeprazole  40  mg ; fluconazole  200  mg ; mycophenolate sodium dr  720  mg ; ondansetron  4  mg ; oxycodone (immediate release)  2.5  mg ; prednisone  10  mg ; prednisone  2.5  mg ; sulfameth trimethoprim ss  1  tab ; valganciclovir  450  mg ; d5 1 2ns  1000  ml ; heparin  5000  unit ; 0.9% sodium chloride  100  ml ; calcium gluconate  2  g ; 0.9% sodium chloride  250  ml ; calcium gluconate  4  g ; bag  1  bag ; magnesium sulfate  4  gm ; sw  200  ml ; potassium chloride  20  meq ; sw  400  ml ; potassium chloride  40  meq ; 0.9% sodium chloride  500  ml ; sw  600  ml ; potassium chloride  60  meq ; 0.9% sodium chloride  1000  ml ; iso-osmotic dextrose  150  ml ; vancomycin  750  mg ; 5% dextrose  100  ml ; sulfamethoxazole-trimethoprim  80  mg ; iso-osmotic sodium chloride  100  ml ; vial  1  vial ; pantoprazole  40  mg ; iso-osmotic sodium chloride  1  bag ; famotidine  20  mg ; d5ns  1000  ml ; hydromorphone (dilaudid)  0.5-1  mg ; iso-osmotic dextrose  50  ml ; piperacillin-tazobactam  2.25  g ; sodium chloride 0.9%  1000  ml ; bag  50  ml ; acetaminophen iv  500  mg ; tacrolimus  4  mg ; albumin 5% (12.5g   250ml)  25  g ; 5% dextrose  170  ml ; mycophenolate mofetil  1000  mg ; lorazepam  0.5  mg ; methylprednisolone sodium succ  8  mg ; hydrocortisone na succ.  50  mg ; dextrose 50%  12.5  gm ; glucagon  1  mg ; glucose gel  15  g ; insulin  0  unit ; norepinephrine  8  mg ; insulin (regular) for hyperkalemia  10  unit ; dextrose 50%  25  gm ; 
obstruction of bile duct bariatric surgery status gastro-esophageal reflux disease without esophagitis other complications of liver transplant nutritional anemia, unspecified acquired coagulation factor deficiency vertical heterophoria thrombocytopenia, unspecified supraventricular tachycardia unspecified asthma, uncomplicated alcoholic cirrhosis of liver with ascites esophoria bariatric surgery status unspecified place in hospital as the place of occurrence of the external cause awaiting organ transplant status hypo-osmolality and hyponatremia body mass index (bmi) 31.0-31.9, adult portal hypertension secondary esophageal varices without bleeding gastro-esophageal reflux disease without esophagitis insomnia, unspecified physical restraint status acute kidney failure with tubular necrosis other fluid overload moderate protein-calorie malnutrition postprocedural (acute) (chronic) kidney failure delirium due to known physiological condition nonalcoholic steatohepatitis (nash) family history of other infectious and parasitic diseases surgical operation with transplant of whole organ as the cause of abnormal reaction of the patient, or of later complication, without mention of misadventure at the time of the procedure hypo-osmolality and hyponatremia portal hypertension alcoholic cirrhosis of liver with ascites alcohol dependence, in remission unspecified asthma, uncomplicated anemia, unspecified coagulation defect, unspecified cough secondary esophageal varices without bleeding gastro-esophageal reflux disease without esophagitis bariatric surgery status 
white f 44 $nan$hematology blood hematocrit  25.9  %; hematology blood hematocrit  26.2  %; hematology blood hematocrit  26.6  %; hematology blood hemoglobin  8.4  g dl; hematology blood hemoglobin  8.3  g dl; hematology blood hemoglobin  8.5  g dl; hematology blood platelet count  131  k ul; hematology blood platelet count  101  k ul; hematology blood platelet count  92  k ul; chemistry blood anion gap  14  meq l; chemistry blood anion gap  15  meq l; chemistry blood anion gap  12  meq l; chemistry blood bicarbonate  16  meq l; chemistry blood bicarbonate  14  meq l; chemistry blood bicarbonate  13  meq l; chemistry blood chloride  102  meq l; chemistry blood chloride  101  meq l; chemistry blood chloride  105  meq l; chemistry blood creatinine  2.4  mg dl; chemistry blood creatinine  2.4  mg dl; chemistry blood creatinine  2.2  mg dl; chemistry blood potassium  4.2  meq l; chemistry blood potassium  4.7  meq l; chemistry blood potassium  4.9  meq l; chemistry blood sodium  132  meq l; chemistry blood sodium  130  meq l; chemistry blood sodium  131  meq l; chemistry blood urea nitrogen  32  mg dl; chemistry blood urea nitrogen  33  mg dl; chemistry blood urea nitrogen  30  mg dl; hematology blood inr(pt)  1.7  ; hematology blood inr(pt)  1.5  ; hematology blood inr(pt)  1.3  ; chemistry blood calcium, total  7.9  mg dl; chemistry blood calcium, total  7.8  mg dl; chemistry blood calcium, total  7.9  mg dl; chemistry blood bilirubin, indirect  0.6  mg dl; chemistry blood bilirubin, total  1.9  mg dl; chemistry blood bilirubin, total  2.6  mg dl; chemistry blood bilirubin, total  2.3  mg dl; chemistry blood glucose  109  mg dl; chemistry blood glucose  121  mg dl; chemistry blood glucose  112  mg dl; chemistry blood albumin  2.6  g dl; chemistry blood albumin  2.7  g dl; blood gas blood lactate  1.1  mmol l; blood gas blood lactate  1.7  mmol l; chemistry blood bilirubin, direct  1.3  mg dl$sodium chloride 0.9%  flush  3-10  ml ; ondansetron  4  mg ; valganciclovir  450  mg ; heparin  5000  unit ; 0.9% sodium chloride  100  ml ; calcium gluconate  2  g ; 0.9% sodium chloride  250  ml ; calcium gluconate  4  g ; bag  1  bag ; magnesium sulfate  4  gm ; sw  200  ml ; potassium chloride  20  meq ; sw  400  ml ; potassium chloride  40  meq ; 0.9% sodium chloride  500  ml ; sw  600  ml ; potassium chloride  60  meq ; 0.9% sodium chloride  1000  ml ; iso-osmotic dextrose  150  ml ; vancomycin  750  mg ; iso-osmotic sodium chloride  100  ml ; iso-osmotic sodium chloride  1  bag ; famotidine  20  mg ; bag  50  ml ; acetaminophen iv  500  mg ; 5% dextrose  170  ml ; mycophenolate mofetil  1000  mg ; dextrose 50%  12.5  gm ; glucagon  1  mg ; glucose gel  15  g ; insulin  0  unit ; norepinephrine  8  mg ; albumin 5% (12.5g   250ml)  12.5  g ; d5w  300  ml ; linezolid  600  mg ; meropenem  500  mg ; sodium chloride 0.9%  flush  10  ml ; alteplase  10  mg ; 0.9% sodium chloride  50  ml ; alteplase  15  mg ; 5% dextrose  250  ml ; heparin sodium  25,000  unit ; 
obstruction of bile duct bariatric surgery status gastro-esophageal reflux disease without esophagitis other complications of liver transplant nutritional anemia, unspecified acquired coagulation factor deficiency vertical heterophoria thrombocytopenia, unspecified supraventricular tachycardia unspecified asthma, uncomplicated alcoholic cirrhosis of liver with ascites esophoria bariatric surgery status unspecified place in hospital as the place of occurrence of the external cause awaiting organ transplant status hypo-osmolality and hyponatremia body mass index (bmi) 31.0-31.9, adult portal hypertension secondary esophageal varices without bleeding gastro-esophageal reflux disease without esophagitis insomnia, unspecified physical restraint status acute kidney failure with tubular necrosis other fluid overload moderate protein-calorie malnutrition postprocedural (acute) (chronic) kidney failure delirium due to known physiological condition nonalcoholic steatohepatitis (nash) family history of other infectious and parasitic diseases surgical operation with transplant of whole organ as the cause of abnormal reaction of the patient, or of later complication, without mention of misadventure at the time of the procedure hypo-osmolality and hyponatremia portal hypertension alcoholic cirrhosis of liver with ascites alcohol dependence, in remission unspecified asthma, uncomplicated anemia, unspecified coagulation defect, unspecified cough secondary esophageal varices without bleeding gastro-esophageal reflux disease without esophagitis bariatric surgery status 
white f 44 $nan$hematology blood hematocrit  25.4  %; hematology blood hematocrit  26.2  %; hematology blood hematocrit  26.7  %; hematology blood hematocrit  26.0  %; hematology blood hematocrit  25.7  %; hematology blood hematocrit  25.2  %; hematology blood hemoglobin  8.2  g dl; hematology blood hemoglobin  8.2  g dl; hematology blood hemoglobin  8.5  g dl; hematology blood hemoglobin  8.2  g dl; hematology blood hemoglobin  8.4  g dl; hematology blood hemoglobin  7.9  g dl; hematology blood platelet count  92  k ul; hematology blood platelet count  99  k ul; hematology blood platelet count  100  k ul; hematology blood platelet count  86  k ul; hematology blood platelet count  85  k ul; hematology blood platelet count  78  k ul; chemistry blood anion gap  11  meq l; chemistry blood anion gap  10  meq l; chemistry blood anion gap  13  meq l; chemistry blood anion gap  12  meq l; chemistry blood anion gap  10  meq l; chemistry blood anion gap  10  meq l; chemistry blood bicarbonate  15  meq l; chemistry blood bicarbonate  15  meq l; chemistry blood bicarbonate  14  meq l; chemistry blood bicarbonate  13  meq l; chemistry blood bicarbonate  13  meq l; chemistry blood bicarbonate  13  meq l; chemistry blood chloride  107  meq l; chemistry blood chloride  108  meq l; chemistry blood chloride  104  meq l; chemistry blood chloride  106  meq l; chemistry blood chloride  109  meq l; chemistry blood chloride  108  meq l; chemistry blood creatinine  2.2  mg dl; chemistry blood creatinine  2.0  mg dl; chemistry blood creatinine  2.0  mg dl; chemistry blood creatinine  2.0  mg dl; chemistry blood creatinine  2.1  mg dl; chemistry blood creatinine  2.0  mg dl; chemistry blood potassium  4.5  meq l; chemistry blood potassium  4.2  meq l; chemistry blood potassium  4.1  meq l; chemistry blood potassium  4.2  meq l; chemistry blood potassium  5.0  meq l; chemistry blood potassium  4.6  meq l; chemistry blood sodium  132  meq l; chemistry blood sodium  133  meq l; chemistry blood sodium  132  meq l; chemistry blood sodium  131  meq l; chemistry blood sodium  133  meq l; chemistry blood sodium  132  meq l; chemistry blood urea nitrogen  30  mg dl; chemistry blood urea nitrogen  30  mg dl; chemistry blood urea nitrogen  32  mg dl; chemistry blood urea nitrogen  31  mg dl; chemistry blood urea nitrogen  32  mg dl; chemistry blood urea nitrogen  32  mg dl; hematology blood inr(pt)  1.3  ; hematology blood inr(pt)  1.3  ; hematology blood inr(pt)  1.2  ; hematology blood inr(pt)  1.1  ; hematology blood inr(pt)  1.1  ; hematology blood inr(pt)  1.1  ; chemistry blood calcium, total  7.8  mg dl; chemistry blood calcium, total  7.8  mg dl; chemistry blood calcium, total  7.9  mg dl; chemistry blood calcium, total  8.0  mg dl; chemistry blood calcium, total  7.9  mg dl; chemistry blood calcium, total  8.0  mg dl; chemistry blood bilirubin, total  2.2  mg dl; chemistry blood bilirubin, total  2.0  mg dl; chemistry blood bilirubin, total  1.8  mg dl; chemistry blood bilirubin, total  1.7  mg dl; chemistry blood bilirubin, total  1.4  mg dl; chemistry blood bilirubin, total  1.4  mg dl; chemistry blood glucose  100  mg dl; chemistry blood glucose  92  mg dl; chemistry blood glucose  86  mg dl; chemistry blood glucose  103  mg dl; chemistry blood glucose  102  mg dl; chemistry blood glucose  103  mg dl; chemistry blood albumin  2.4  g dl$sodium chloride 0.9%  flush  3-10  ml ; ondansetron  4  mg ; valganciclovir  450  mg ; heparin  5000  unit ; 0.9% sodium chloride  100  ml ; calcium gluconate  2  g ; 0.9% sodium chloride  250  ml ; calcium gluconate  4  g ; bag  1  bag ; magnesium sulfate  4  gm ; sw  200  ml ; potassium chloride  20  meq ; sw  400  ml ; potassium chloride  40  meq ; 0.9% sodium chloride  500  ml ; sw  600  ml ; potassium chloride  60  meq ; 0.9% sodium chloride  1000  ml ; iso-osmotic sodium chloride  100  ml ; iso-osmotic sodium chloride  1  bag ; famotidine  20  mg ; 5% dextrose  170  ml ; mycophenolate mofetil  1000  mg ; dextrose 50%  12.5  gm ; glucagon  1  mg ; glucose gel  15  g ; insulin  0  unit ; norepinephrine  8  mg ; sodium chloride 0.9%  flush  10  ml ; gentamicin sulfate  150  mg ; sodium phosphate  30  mmol ; sarna lotion  1  appl ; 
obstruction of bile duct bariatric surgery status gastro-esophageal reflux disease without esophagitis other complications of liver transplant nutritional anemia, unspecified acquired coagulation factor deficiency vertical heterophoria thrombocytopenia, unspecified supraventricular tachycardia unspecified asthma, uncomplicated alcoholic cirrhosis of liver with ascites esophoria bariatric surgery status unspecified place in hospital as the place of occurrence of the external cause awaiting organ transplant status hypo-osmolality and hyponatremia body mass index (bmi) 31.0-31.9, adult portal hypertension secondary esophageal varices without bleeding gastro-esophageal reflux disease without esophagitis insomnia, unspecified physical restraint status acute kidney failure with tubular necrosis other fluid overload moderate protein-calorie malnutrition postprocedural (acute) (chronic) kidney failure delirium due to known physiological condition nonalcoholic steatohepatitis (nash) family history of other infectious and parasitic diseases surgical operation with transplant of whole organ as the cause of abnormal reaction of the patient, or of later complication, without mention of misadventure at the time of the procedure hypo-osmolality and hyponatremia portal hypertension alcoholic cirrhosis of liver with ascites alcohol dependence, in remission unspecified asthma, uncomplicated anemia, unspecified coagulation defect, unspecified cough secondary esophageal varices without bleeding gastro-esophageal reflux disease without esophagitis bariatric surgery status 
white f 44 $nan$hematology blood hematocrit  24.9  %; hematology blood hematocrit  23.7  %; hematology blood hematocrit  23.9  %; hematology blood hematocrit  24.1  %; hematology blood hematocrit  25.0  %; hematology blood hemoglobin  7.8  g dl; hematology blood hemoglobin  7.5  g dl; hematology blood hemoglobin  7.5  g dl; hematology blood hemoglobin  7.8  g dl; hematology blood hemoglobin  7.9  g dl; hematology blood platelet count  76  k ul; hematology blood platelet count  73  k ul; hematology blood platelet count  76  k ul; hematology blood platelet count  63  k ul; hematology blood platelet count  67  k ul; chemistry blood anion gap  10  meq l; chemistry blood anion gap  12  meq l; chemistry blood anion gap  12  meq l; chemistry blood anion gap  11  meq l; chemistry blood anion gap  11  meq l; chemistry blood bicarbonate  15  meq l; chemistry blood bicarbonate  14  meq l; chemistry blood bicarbonate  13  meq l; chemistry blood bicarbonate  14  meq l; chemistry blood bicarbonate  12  meq l; chemistry blood chloride  108  meq l; chemistry blood chloride  106  meq l; chemistry blood chloride  104  meq l; chemistry blood chloride  106  meq l; chemistry blood chloride  105  meq l; chemistry blood creatinine  1.9  mg dl; chemistry blood creatinine  2.1  mg dl; chemistry blood creatinine  1.9  mg dl; chemistry blood creatinine  1.9  mg dl; chemistry blood creatinine  1.8  mg dl; chemistry blood potassium  4.1  meq l; chemistry blood potassium  4.0  meq l; chemistry blood potassium  3.9  meq l; chemistry blood potassium  4.6  meq l; chemistry blood potassium  4.5  meq l; chemistry blood sodium  131  meq l; chemistry blood sodium  130  meq l; chemistry blood sodium  130  meq l; chemistry blood sodium  132  meq l; chemistry blood sodium  130  meq l; chemistry blood urea nitrogen  33  mg dl; chemistry blood urea nitrogen  32  mg dl; chemistry blood urea nitrogen  31  mg dl; chemistry blood urea nitrogen  31  mg dl; chemistry blood urea nitrogen  30  mg dl; hematology blood inr(pt)  1.1  ; hematology blood inr(pt)  1.1  ; hematology blood inr(pt)  1.0  ; hematology blood inr(pt)  1.1  ; hematology blood inr(pt)  1.1  ; chemistry blood calcium, total  7.6  mg dl; chemistry blood calcium, total  7.8  mg dl; chemistry blood calcium, total  7.8  mg dl; chemistry blood calcium, total  7.8  mg dl; chemistry blood calcium, total  7.8  mg dl; chemistry blood bilirubin, indirect  0.4  mg dl; chemistry blood bilirubin, indirect  0.4  mg dl; chemistry blood bilirubin, indirect  0.5  mg dl; chemistry blood bilirubin, total  1.4  mg dl; chemistry blood bilirubin, total  1.2  mg dl; chemistry blood bilirubin, total  1.3  mg dl; chemistry blood bilirubin, total  1.2  mg dl; chemistry blood bilirubin, total  1.2  mg dl; chemistry blood glucose  96  mg dl; chemistry blood glucose  112  mg dl; chemistry blood glucose  100  mg dl; chemistry blood glucose  114  mg dl; chemistry blood glucose  104  mg dl; chemistry blood lactate dehydrogenase (ld)  259  iu l; chemistry blood albumin  2.1  g dl; blood gas blood lactate  1.0  mmol l; chemistry blood bilirubin, direct  0.9  mg dl; chemistry blood bilirubin, direct  0.8  mg dl; chemistry blood bilirubin, direct  0.7  mg dl$sodium chloride 0.9%  flush  3-10  ml ; ondansetron  4  mg ; 0.9% sodium chloride  100  ml ; calcium gluconate  2  g ; 0.9% sodium chloride  250  ml ; calcium gluconate  4  g ; bag  1  bag ; magnesium sulfate  4  gm ; sw  200  ml ; potassium chloride  20  meq ; sw  400  ml ; potassium chloride  40  meq ; 0.9% sodium chloride  500  ml ; sw  600  ml ; potassium chloride  60  meq ; 0.9% sodium chloride  1000  ml ; dextrose 50%  12.5  gm ; glucagon  1  mg ; glucose gel  15  g ; insulin  0  unit ; norepinephrine  8  mg ; sodium chloride 0.9%  flush  10  ml ; sarna lotion  1  appl ; tacrolimus  2  mg ; hydromorphone (dilaudid)  0.5  mg ; d5lr  1000  ml ; mycophenolate sodium dr  360  mg ; 
obstruction of bile duct bariatric surgery status gastro-esophageal reflux disease without esophagitis other complications of liver transplant nutritional anemia, unspecified acquired coagulation factor deficiency vertical heterophoria thrombocytopenia, unspecified supraventricular tachycardia unspecified asthma, uncomplicated alcoholic cirrhosis of liver with ascites esophoria bariatric surgery status unspecified place in hospital as the place of occurrence of the external cause awaiting organ transplant status hypo-osmolality and hyponatremia body mass index (bmi) 31.0-31.9, adult portal hypertension secondary esophageal varices without bleeding gastro-esophageal reflux disease without esophagitis insomnia, unspecified physical restraint status acute kidney failure with tubular necrosis other fluid overload moderate protein-calorie malnutrition postprocedural (acute) (chronic) kidney failure delirium due to known physiological condition nonalcoholic steatohepatitis (nash) family history of other infectious and parasitic diseases surgical operation with transplant of whole organ as the cause of abnormal reaction of the patient, or of later complication, without mention of misadventure at the time of the procedure hypo-osmolality and hyponatremia portal hypertension alcoholic cirrhosis of liver with ascites alcohol dependence, in remission unspecified asthma, uncomplicated anemia, unspecified coagulation defect, unspecified cough secondary esophageal varices without bleeding gastro-esophageal reflux disease without esophagitis bariatric surgery status 
white f 44 $nan$hematology blood hematocrit  23.1  %; hematology blood hematocrit  22.3  %; hematology blood hematocrit  22.0  %; hematology blood hemoglobin  7.5  g dl; hematology blood hemoglobin  7.3  g dl; hematology blood hemoglobin  7.0  g dl; hematology blood platelet count  66  k ul; hematology blood platelet count  62  k ul; hematology blood platelet count  55  k ul; chemistry blood anion gap  9  meq l; chemistry blood anion gap  12  meq l; chemistry blood bicarbonate  16  meq l; chemistry blood bicarbonate  15  meq l; chemistry blood chloride  105  meq l; chemistry blood chloride  102  meq l; chemistry blood creatinine  1.9  mg dl; chemistry blood creatinine  2.0  mg dl; chemistry blood potassium  4.4  meq l; chemistry blood potassium  4.5  meq l; chemistry blood sodium  130  meq l; chemistry blood sodium  129  meq l; chemistry blood urea nitrogen  31  mg dl; chemistry blood urea nitrogen  29  mg dl; hematology blood inr(pt)  1.1  ; hematology blood inr(pt)  1.2  ; hematology blood inr(pt)  1.2  ; hematology blood inr(pt)  1.2  ; hematology blood inr(pt)  1.1  ; chemistry blood calcium, total  7.7  mg dl; chemistry blood calcium, total  7.7  mg dl; chemistry blood bilirubin, indirect  0.4  mg dl; chemistry blood bilirubin, indirect  0.4  mg dl; chemistry blood bilirubin, total  1.1  mg dl; chemistry blood bilirubin, total  1.2  mg dl; chemistry blood glucose  96  mg dl; chemistry blood glucose  124  mg dl; chemistry blood lactate dehydrogenase (ld)  279  iu l; chemistry blood lactate dehydrogenase (ld)  286  iu l; chemistry blood albumin  2.0  g dl; chemistry blood albumin  2.3  g dl; chemistry blood bilirubin, direct  0.7  mg dl; chemistry blood bilirubin, direct  0.8  mg dl$ondansetron  4  mg ; 0.9% sodium chloride  100  ml ; calcium gluconate  2  g ; 0.9% sodium chloride  250  ml ; calcium gluconate  4  g ; bag  1  bag ; magnesium sulfate  4  gm ; sw  200  ml ; potassium chloride  20  meq ; sw  400  ml ; potassium chloride  40  meq ; 0.9% sodium chloride  500  ml ; sw  600  ml ; potassium chloride  60  meq ; 0.9% sodium chloride  1000  ml ; dextrose 50%  12.5  gm ; glucagon  1  mg ; glucose gel  15  g ; norepinephrine  8  mg ; sodium chloride 0.9%  flush  10  ml ; sarna lotion  1  appl ; tacrolimus  2  mg ; d5lr  1000  ml ; mycophenolate sodium dr  360  mg ; lactated ringers  1000  ml ; tacrolimus  1  mg ; clopidogrel  300  mg ; 
obstruction of bile duct bariatric surgery status gastro-esophageal reflux disease without esophagitis other complications of liver transplant nutritional anemia, unspecified acquired coagulation factor deficiency vertical heterophoria thrombocytopenia, unspecified supraventricular tachycardia unspecified asthma, uncomplicated alcoholic cirrhosis of liver with ascites esophoria bariatric surgery status unspecified place in hospital as the place of occurrence of the external cause awaiting organ transplant status hypo-osmolality and hyponatremia body mass index (bmi) 31.0-31.9, adult portal hypertension secondary esophageal varices without bleeding gastro-esophageal reflux disease without esophagitis insomnia, unspecified physical restraint status acute kidney failure with tubular necrosis other fluid overload moderate protein-calorie malnutrition postprocedural (acute) (chronic) kidney failure delirium due to known physiological condition nonalcoholic steatohepatitis (nash) family history of other infectious and parasitic diseases surgical operation with transplant of whole organ as the cause of abnormal reaction of the patient, or of later complication, without mention of misadventure at the time of the procedure hypo-osmolality and hyponatremia portal hypertension alcoholic cirrhosis of liver with ascites alcohol dependence, in remission unspecified asthma, uncomplicated anemia, unspecified coagulation defect, unspecified cough secondary esophageal varices without bleeding gastro-esophageal reflux disease without esophagitis bariatric surgery status 
white f 44 $nan$hematology blood hematocrit  23.7  %; hematology blood hematocrit  22.3  %; hematology blood hematocrit  24.2  %; hematology blood hemoglobin  7.8  g dl; hematology blood hemoglobin  7.3  g dl; hematology blood hemoglobin  7.9  g dl; hematology blood platelet count  56  k ul; hematology blood platelet count  54  k ul; hematology blood platelet count  65  k ul; chemistry blood anion gap  12  meq l; chemistry blood anion gap  10  meq l; chemistry blood anion gap  13  meq l; chemistry blood bicarbonate  17  meq l; chemistry blood bicarbonate  17  meq l; chemistry blood bicarbonate  14  meq l; chemistry blood chloride  105  meq l; chemistry blood chloride  107  meq l; chemistry blood chloride  102  meq l; chemistry blood creatinine  1.7  mg dl; chemistry blood creatinine  1.6  mg dl; chemistry blood creatinine  1.4  mg dl; chemistry blood potassium  4.3  meq l; chemistry blood potassium  4.4  meq l; chemistry blood potassium  4.9  meq l; chemistry blood sodium  131  meq l; chemistry blood sodium  134  meq l; chemistry blood sodium  132  meq l; chemistry blood urea nitrogen  28  mg dl; chemistry blood urea nitrogen  26  mg dl; chemistry blood urea nitrogen  24  mg dl; hematology blood inr(pt)  1.1  ; hematology blood inr(pt)  1.0  ; hematology blood inr(pt)  1.0  ; chemistry blood calcium, total  7.9  mg dl; chemistry blood calcium, total  7.8  mg dl; chemistry blood calcium, total  8.0  mg dl; chemistry blood bilirubin, total  1.2  mg dl; chemistry blood bilirubin, total  1.1  mg dl; chemistry blood bilirubin, total  1.2  mg dl; chemistry blood glucose  151  mg dl; chemistry blood glucose  137  mg dl; chemistry blood glucose  89  mg dl; chemistry blood albumin  2.4  g dl; chemistry blood albumin  2.1  g dl; chemistry blood albumin  2.6  g dl$ondansetron  4  mg ; 0.9% sodium chloride  100  ml ; calcium gluconate  2  g ; 0.9% sodium chloride  250  ml ; calcium gluconate  4  g ; bag  1  bag ; magnesium sulfate  4  gm ; sw  200  ml ; potassium chloride  20  meq ; sw  400  ml ; potassium chloride  40  meq ; 0.9% sodium chloride  500  ml ; sw  600  ml ; potassium chloride  60  meq ; 0.9% sodium chloride  1000  ml ; dextrose 50%  12.5  gm ; glucagon  1  mg ; glucose gel  15  g ; sodium chloride 0.9%  flush  10  ml ; sarna lotion  1  appl ; mycophenolate sodium dr  360  mg ; tacrolimus  1  mg ; clopidogrel  300  mg ; oxycodone (immediate release)  5  mg ; aspirin  81  mg ; clopidogrel  75  mg ; docusate sodium  100  mg ; oxycodone (immediate release)  5-10  mg ; tacrolimus  0.5  mg ; 
obstruction of bile duct bariatric surgery status gastro-esophageal reflux disease without esophagitis other complications of liver transplant nutritional anemia, unspecified acquired coagulation factor deficiency vertical heterophoria thrombocytopenia, unspecified supraventricular tachycardia unspecified asthma, uncomplicated alcoholic cirrhosis of liver with ascites esophoria bariatric surgery status unspecified place in hospital as the place of occurrence of the external cause awaiting organ transplant status hypo-osmolality and hyponatremia body mass index (bmi) 31.0-31.9, adult portal hypertension secondary esophageal varices without bleeding gastro-esophageal reflux disease without esophagitis insomnia, unspecified physical restraint status acute kidney failure with tubular necrosis other fluid overload moderate protein-calorie malnutrition postprocedural (acute) (chronic) kidney failure delirium due to known physiological condition nonalcoholic steatohepatitis (nash) family history of other infectious and parasitic diseases surgical operation with transplant of whole organ as the cause of abnormal reaction of the patient, or of later complication, without mention of misadventure at the time of the procedure hypo-osmolality and hyponatremia portal hypertension alcoholic cirrhosis of liver with ascites alcohol dependence, in remission unspecified asthma, uncomplicated anemia, unspecified coagulation defect, unspecified cough secondary esophageal varices without bleeding gastro-esophageal reflux disease without esophagitis bariatric surgery status 
white f 44 $nan$hematology blood hematocrit  21.7  %; hematology blood hematocrit  25.4  %; hematology blood hemoglobin  7.0  g dl; hematology blood hemoglobin  8.2  g dl; hematology blood platelet count  72  k ul; hematology blood platelet count  85  k ul; chemistry blood anion gap  12  meq l; chemistry blood anion gap  13  meq l; chemistry blood bicarbonate  17  meq l; chemistry blood bicarbonate  17  meq l; chemistry blood chloride  105  meq l; chemistry blood chloride  104  meq l; chemistry blood creatinine  1.2  mg dl; chemistry blood creatinine  1.2  mg dl; chemistry blood potassium  4.4  meq l; chemistry blood potassium  5.2  meq l; chemistry blood sodium  134  meq l; chemistry blood sodium  134  meq l; chemistry blood urea nitrogen  23  mg dl; chemistry blood urea nitrogen  20  mg dl; hematology blood inr(pt)  1.0  ; hematology blood inr(pt)  1.1  ; chemistry blood calcium, total  8.0  mg dl; chemistry blood calcium, total  8.1  mg dl; chemistry blood bilirubin, total  1.0  mg dl; chemistry blood bilirubin, total  1.2  mg dl; chemistry blood glucose  92  mg dl; chemistry blood glucose  136  mg dl; chemistry blood lactate dehydrogenase (ld)  271  iu l; chemistry blood albumin  2.2  g dl; chemistry blood albumin  2.6  g dl$ondansetron  4  mg ; 0.9% sodium chloride  100  ml ; calcium gluconate  2  g ; 0.9% sodium chloride  250  ml ; calcium gluconate  4  g ; bag  1  bag ; magnesium sulfate  4  gm ; sw  200  ml ; potassium chloride  20  meq ; sw  400  ml ; potassium chloride  40  meq ; 0.9% sodium chloride  500  ml ; sw  600  ml ; potassium chloride  60  meq ; 0.9% sodium chloride  1000  ml ; dextrose 50%  12.5  gm ; glucagon  1  mg ; glucose gel  15  g ; sodium chloride 0.9%  flush  10  ml ; sarna lotion  1  appl ; mycophenolate sodium dr  360  mg ; aspirin  81  mg ; clopidogrel  75  mg ; docusate sodium  100  mg ; oxycodone (immediate release)  5-10  mg ; tacrolimus  0.5  mg ; prednisone  7.5  mg ; valganciclovir  900  mg ; daptomycin  550  mg ; polyethylene glycol  17  g ; fluconazole  400  mg ; potassium chloride replacement (critical care and oncology)   40  meq ; potassium chloride replacement (critical care and oncology)   60  meq ; potassium chloride replacement (critical care and oncology)   80  meq ; acetaminophen  500  mg ; 
obstruction of bile duct bariatric surgery status gastro-esophageal reflux disease without esophagitis other complications of liver transplant nutritional anemia, unspecified acquired coagulation factor deficiency vertical heterophoria thrombocytopenia, unspecified supraventricular tachycardia unspecified asthma, uncomplicated alcoholic cirrhosis of liver with ascites esophoria bariatric surgery status unspecified place in hospital as the place of occurrence of the external cause awaiting organ transplant status hypo-osmolality and hyponatremia body mass index (bmi) 31.0-31.9, adult portal hypertension secondary esophageal varices without bleeding gastro-esophageal reflux disease without esophagitis insomnia, unspecified physical restraint status acute kidney failure with tubular necrosis other fluid overload moderate protein-calorie malnutrition postprocedural (acute) (chronic) kidney failure delirium due to known physiological condition nonalcoholic steatohepatitis (nash) family history of other infectious and parasitic diseases surgical operation with transplant of whole organ as the cause of abnormal reaction of the patient, or of later complication, without mention of misadventure at the time of the procedure hypo-osmolality and hyponatremia portal hypertension alcoholic cirrhosis of liver with ascites alcohol dependence, in remission unspecified asthma, uncomplicated anemia, unspecified coagulation defect, unspecified cough secondary esophageal varices without bleeding gastro-esophageal reflux disease without esophagitis bariatric surgery status 
white f 44 $nan$hematology blood hematocrit  23.8  %; hematology blood hematocrit  26.3  %; hematology blood hemoglobin  7.9  g dl; hematology blood hemoglobin  8.4  g dl; hematology blood platelet count  112  k ul; hematology blood platelet count  122  k ul; chemistry blood anion gap  11  meq l; chemistry blood anion gap  10  meq l; chemistry blood bicarbonate  19  meq l; chemistry blood bicarbonate  22  meq l; chemistry blood chloride  104  meq l; chemistry blood chloride  103  meq l; chemistry blood creatinine  1.0  mg dl; chemistry blood creatinine  0.9  mg dl; chemistry blood potassium  4.7  meq l; chemistry blood potassium  5.1  meq l; chemistry blood sodium  134  meq l; chemistry blood sodium  135  meq l; chemistry blood urea nitrogen  19  mg dl; chemistry blood urea nitrogen  14  mg dl; hematology blood inr(pt)  1.1  ; hematology blood inr(pt)  1.1  ; chemistry blood calcium, total  8.3  mg dl; chemistry blood calcium, total  8.8  mg dl; chemistry blood bilirubin, indirect  0.4  mg dl; chemistry blood bilirubin, total  1.1  mg dl; chemistry blood bilirubin, total  1.2  mg dl; chemistry blood glucose  90  mg dl; chemistry blood glucose  125  mg dl; chemistry blood lactate dehydrogenase (ld)  245  iu l; chemistry blood lactate dehydrogenase (ld)  298  iu l; chemistry blood albumin  2.5  g dl; chemistry blood bilirubin, direct  0.7  mg dl$ondansetron  4  mg ; dextrose 50%  12.5  gm ; glucagon  1  mg ; glucose gel  15  g ; sodium chloride 0.9%  flush  10  ml ; sarna lotion  1  appl ; mycophenolate sodium dr  360  mg ; aspirin  81  mg ; clopidogrel  75  mg ; docusate sodium  100  mg ; oxycodone (immediate release)  5-10  mg ; prednisone  7.5  mg ; valganciclovir  900  mg ; daptomycin  550  mg ; polyethylene glycol  17  g ; fluconazole  400  mg ; acetaminophen  500  mg ; cyanocobalamin  1000  mcg ; multivitamins w minerals  1  tab ; vitamin d  5000  unit ; tacrolimus  3  mg ; 
obstruction of bile duct bariatric surgery status gastro-esophageal reflux disease without esophagitis other complications of liver transplant nutritional anemia, unspecified acquired coagulation factor deficiency vertical heterophoria thrombocytopenia, unspecified supraventricular tachycardia unspecified asthma, uncomplicated alcoholic cirrhosis of liver with ascites esophoria bariatric surgery status unspecified place in hospital as the place of occurrence of the external cause awaiting organ transplant status hypo-osmolality and hyponatremia body mass index (bmi) 31.0-31.9, adult portal hypertension secondary esophageal varices without bleeding gastro-esophageal reflux disease without esophagitis insomnia, unspecified physical restraint status acute kidney failure with tubular necrosis other fluid overload moderate protein-calorie malnutrition postprocedural (acute) (chronic) kidney failure delirium due to known physiological condition nonalcoholic steatohepatitis (nash) family history of other infectious and parasitic diseases surgical operation with transplant of whole organ as the cause of abnormal reaction of the patient, or of later complication, without mention of misadventure at the time of the procedure hypo-osmolality and hyponatremia portal hypertension alcoholic cirrhosis of liver with ascites alcohol dependence, in remission unspecified asthma, uncomplicated anemia, unspecified coagulation defect, unspecified cough secondary esophageal varices without bleeding gastro-esophageal reflux disease without esophagitis bariatric surgery status 
white f 44 $nan$hematology blood hematocrit  23.4  %; hematology blood hematocrit  26.3  %; hematology blood hemoglobin  7.6  g dl; hematology blood hemoglobin  8.5  g dl; hematology blood platelet count  125  k ul; hematology blood platelet count  148  k ul; chemistry blood anion gap  10  meq l; chemistry blood anion gap  12  meq l; chemistry blood bicarbonate  22  meq l; chemistry blood bicarbonate  21  meq l; chemistry blood chloride  102  meq l; chemistry blood chloride  104  meq l; chemistry blood creatinine  1.0  mg dl; chemistry blood creatinine  1.0  mg dl; chemistry blood potassium  4.8  meq l; chemistry blood potassium  4.9  meq l; chemistry blood sodium  134  meq l; chemistry blood sodium  137  meq l; chemistry blood urea nitrogen  14  mg dl; chemistry blood urea nitrogen  13  mg dl; hematology blood inr(pt)  1.1  ; hematology blood inr(pt)  1.1  ; chemistry blood calcium, total  8.3  mg dl; chemistry blood calcium, total  8.3  mg dl; chemistry blood bilirubin, total  1.0  mg dl; chemistry blood bilirubin, total  1.1  mg dl; chemistry blood glucose  92  mg dl; chemistry blood glucose  119  mg dl$ondansetron  4  mg ; dextrose 50%  12.5  gm ; glucagon  1  mg ; glucose gel  15  g ; sodium chloride 0.9%  flush  10  ml ; sarna lotion  1  appl ; mycophenolate sodium dr  360  mg ; aspirin  81  mg ; clopidogrel  75  mg ; docusate sodium  100  mg ; oxycodone (immediate release)  5-10  mg ; prednisone  7.5  mg ; valganciclovir  900  mg ; daptomycin  550  mg ; polyethylene glycol  17  g ; fluconazole  400  mg ; cyanocobalamin  1000  mcg ; multivitamins w minerals  1  tab ; vitamin d  5000  unit ; tacrolimus  3  mg ; calcium carbonate  1000  mg ; sodium phosphate  15  mmol ; phosphorus  500  mg ; furosemide  20  mg ; 
obstruction of bile duct bariatric surgery status gastro-esophageal reflux disease without esophagitis other complications of liver transplant nutritional anemia, unspecified acquired coagulation factor deficiency vertical heterophoria thrombocytopenia, unspecified supraventricular tachycardia unspecified asthma, uncomplicated alcoholic cirrhosis of liver with ascites esophoria bariatric surgery status unspecified place in hospital as the place of occurrence of the external cause awaiting organ transplant status hypo-osmolality and hyponatremia body mass index (bmi) 31.0-31.9, adult portal hypertension secondary esophageal varices without bleeding gastro-esophageal reflux disease without esophagitis insomnia, unspecified physical restraint status acute kidney failure with tubular necrosis other fluid overload moderate protein-calorie malnutrition postprocedural (acute) (chronic) kidney failure delirium due to known physiological condition nonalcoholic steatohepatitis (nash) family history of other infectious and parasitic diseases surgical operation with transplant of whole organ as the cause of abnormal reaction of the patient, or of later complication, without mention of misadventure at the time of the procedure hypo-osmolality and hyponatremia portal hypertension alcoholic cirrhosis of liver with ascites alcohol dependence, in remission unspecified asthma, uncomplicated anemia, unspecified coagulation defect, unspecified cough secondary esophageal varices without bleeding gastro-esophageal reflux disease without esophagitis bariatric surgery status 
white f 44 $nan$hematology blood hematocrit  29.0  %; hematology blood hemoglobin  9.3  g dl; hematology blood platelet count  173  k ul; chemistry blood anion gap  13  meq l; chemistry blood anion gap  10  meq l; chemistry blood bicarbonate  22  meq l; chemistry blood bicarbonate  23  meq l; chemistry blood chloride  102  meq l; chemistry blood chloride  102  meq l; chemistry blood creatinine  1.0  mg dl; chemistry blood creatinine  0.7  mg dl; chemistry blood potassium  4.6  meq l; chemistry blood potassium  4.5  meq l; chemistry blood sodium  137  meq l; chemistry blood sodium  135  meq l; chemistry blood urea nitrogen  15  mg dl; chemistry blood urea nitrogen  12  mg dl; hematology blood inr(pt)  1.2  ; hematology blood inr(pt)  1.3  ; chemistry blood calcium, total  8.4  mg dl; chemistry blood calcium, total  8.1  mg dl; chemistry blood bilirubin, total  1.0  mg dl; chemistry blood glucose  100  mg dl; chemistry blood glucose  101  mg dl$ondansetron  4  mg ; dextrose 50%  12.5  gm ; glucagon  1  mg ; glucose gel  15  g ; sodium chloride 0.9%  flush  10  ml ; sarna lotion  1  appl ; mycophenolate sodium dr  360  mg ; aspirin  81  mg ; clopidogrel  75  mg ; docusate sodium  100  mg ; oxycodone (immediate release)  5-10  mg ; prednisone  7.5  mg ; valganciclovir  900  mg ; daptomycin  550  mg ; polyethylene glycol  17  g ; fluconazole  400  mg ; cyanocobalamin  1000  mcg ; multivitamins w minerals  1  tab ; vitamin d  5000  unit ; calcium carbonate  1000  mg ; furosemide  20  mg ; heparin flush (10 units ml)  2  ml ; sodium chloride 0.9%  flush  20  ml ; lidocaine 1% (for picc midline insertions)  5  ml ; warfarin  2.5  mg ; magnesium oxide  800  mg ; enoxaparin sodium  80  mg ; magnesium oxide  400  mg ; 
obstruction of bile duct bariatric surgery status gastro-esophageal reflux disease without esophagitis other complications of liver transplant nutritional anemia, unspecified acquired coagulation factor deficiency vertical heterophoria thrombocytopenia, unspecified supraventricular tachycardia unspecified asthma, uncomplicated alcoholic cirrhosis of liver with ascites esophoria bariatric surgery status unspecified place in hospital as the place of occurrence of the external cause awaiting organ transplant status hypo-osmolality and hyponatremia body mass index (bmi) 31.0-31.9, adult portal hypertension secondary esophageal varices without bleeding gastro-esophageal reflux disease without esophagitis insomnia, unspecified physical restraint status acute kidney failure with tubular necrosis other fluid overload moderate protein-calorie malnutrition postprocedural (acute) (chronic) kidney failure delirium due to known physiological condition nonalcoholic steatohepatitis (nash) family history of other infectious and parasitic diseases surgical operation with transplant of whole organ as the cause of abnormal reaction of the patient, or of later complication, without mention of misadventure at the time of the procedure hypo-osmolality and hyponatremia portal hypertension alcoholic cirrhosis of liver with ascites alcohol dependence, in remission unspecified asthma, uncomplicated anemia, unspecified coagulation defect, unspecified cough secondary esophageal varices without bleeding gastro-esophageal reflux disease without esophagitis bariatric surgery status 
white f 44 $nan$hematology blood hematocrit  24.7  %; hematology blood hematocrit  26.1  %; hematology blood hemoglobin  7.8  g dl; hematology blood hemoglobin  8.2  g dl; hematology blood platelet count  197  k ul; hematology blood platelet count  201  k ul; chemistry blood anion gap  11  meq l; chemistry blood bicarbonate  25  meq l; chemistry blood chloride  100  meq l; chemistry blood creatinine  0.8  mg dl; chemistry blood potassium  4.8  meq l; chemistry blood sodium  136  meq l; chemistry blood urea nitrogen  15  mg dl; hematology blood inr(pt)  1.2  ; chemistry blood calcium, total  8.4  mg dl; chemistry blood bilirubin, total  0.9  mg dl; chemistry blood glucose  75  mg dl$ondansetron  4  mg ; dextrose 50%  12.5  gm ; glucagon  1  mg ; glucose gel  15  g ; sodium chloride 0.9%  flush  10  ml ; sarna lotion  1  appl ; mycophenolate sodium dr  360  mg ; aspirin  81  mg ; docusate sodium  100  mg ; oxycodone (immediate release)  5-10  mg ; prednisone  7.5  mg ; valganciclovir  900  mg ; daptomycin  550  mg ; polyethylene glycol  17  g ; fluconazole  400  mg ; cyanocobalamin  1000  mcg ; multivitamins w minerals  1  tab ; vitamin d  5000  unit ; calcium carbonate  1000  mg ; heparin flush (10 units ml)  2  ml ; sodium chloride 0.9%  flush  20  ml ; lidocaine 1% (for picc midline insertions)  5  ml ; magnesium oxide  800  mg ; enoxaparin sodium  80  mg ; magnesium oxide  400  mg ; sodium chloride 0.9%  flush  10-20  ml ; 
obstruction of bile duct bariatric surgery status gastro-esophageal reflux disease without esophagitis other complications of liver transplant nutritional anemia, unspecified acquired coagulation factor deficiency vertical heterophoria thrombocytopenia, unspecified supraventricular tachycardia unspecified asthma, uncomplicated alcoholic cirrhosis of liver with ascites esophoria bariatric surgery status unspecified place in hospital as the place of occurrence of the external cause awaiting organ transplant status hypo-osmolality and hyponatremia body mass index (bmi) 31.0-31.9, adult portal hypertension secondary esophageal varices without bleeding gastro-esophageal reflux disease without esophagitis insomnia, unspecified physical restraint status acute kidney failure with tubular necrosis other fluid overload moderate protein-calorie malnutrition postprocedural (acute) (chronic) kidney failure delirium due to known physiological condition nonalcoholic steatohepatitis (nash) family history of other infectious and parasitic diseases surgical operation with transplant of whole organ as the cause of abnormal reaction of the patient, or of later complication, without mention of misadventure at the time of the procedure hypo-osmolality and hyponatremia portal hypertension alcoholic cirrhosis of liver with ascites alcohol dependence, in remission unspecified asthma, uncomplicated anemia, unspecified coagulation defect, unspecified cough secondary esophageal varices without bleeding gastro-esophageal reflux disease without esophagitis bariatric surgery status 
white f 44 $nan$hematology blood hematocrit  25.3  %; hematology blood hemoglobin  7.9  g dl; hematology blood platelet count  217  k ul; chemistry blood anion gap  11  meq l; chemistry blood bicarbonate  25  meq l; chemistry blood chloride  102  meq l; chemistry blood creatinine  0.8  mg dl; chemistry blood potassium  5.1  meq l; chemistry blood sodium  138  meq l; chemistry blood urea nitrogen  14  mg dl; chemistry blood calcium, total  8.6  mg dl; chemistry blood bilirubin, total  0.9  mg dl; chemistry blood glucose  86  mg dl$ondansetron  4  mg ; dextrose 50%  12.5  gm ; glucagon  1  mg ; glucose gel  15  g ; sodium chloride 0.9%  flush  10  ml ; sarna lotion  1  appl ; mycophenolate sodium dr  360  mg ; aspirin  81  mg ; docusate sodium  100  mg ; oxycodone (immediate release)  5-10  mg ; prednisone  7.5  mg ; valganciclovir  900  mg ; daptomycin  550  mg ; polyethylene glycol  17  g ; fluconazole  400  mg ; cyanocobalamin  1000  mcg ; multivitamins w minerals  1  tab ; vitamin d  5000  unit ; calcium carbonate  1000  mg ; enoxaparin sodium  80  mg ; magnesium oxide  400  mg ; sodium chloride 0.9%  flush  10-20  ml ; 
obstruction of bile duct bariatric surgery status gastro-esophageal reflux disease without esophagitis other complications of liver transplant nutritional anemia, unspecified acquired coagulation factor deficiency vertical heterophoria thrombocytopenia, unspecified supraventricular tachycardia unspecified asthma, uncomplicated alcoholic cirrhosis of liver with ascites esophoria bariatric surgery status unspecified place in hospital as the place of occurrence of the external cause awaiting organ transplant status hypo-osmolality and hyponatremia body mass index (bmi) 31.0-31.9, adult portal hypertension secondary esophageal varices without bleeding gastro-esophageal reflux disease without esophagitis insomnia, unspecified physical restraint status acute kidney failure with tubular necrosis other fluid overload moderate protein-calorie malnutrition postprocedural (acute) (chronic) kidney failure delirium due to known physiological condition nonalcoholic steatohepatitis (nash) family history of other infectious and parasitic diseases surgical operation with transplant of whole organ as the cause of abnormal reaction of the patient, or of later complication, without mention of misadventure at the time of the procedure hypo-osmolality and hyponatremia portal hypertension alcoholic cirrhosis of liver with ascites alcohol dependence, in remission unspecified asthma, uncomplicated anemia, unspecified coagulation defect, unspecified cough secondary esophageal varices without bleeding gastro-esophageal reflux disease without esophagitis bariatric surgery status 
white f 44 $nan$hematology blood hematocrit  25.9  %; hematology blood hemoglobin  7.9  g dl; hematology blood platelet count  251  k ul; chemistry blood anion gap  10  meq l; chemistry blood bicarbonate  25  meq l; chemistry blood chloride  100  meq l; chemistry blood creatinine  0.7  mg dl; chemistry blood potassium  5.2  meq l; chemistry blood sodium  135  meq l; chemistry blood urea nitrogen  15  mg dl; hematology blood inr(pt)  1.1  ; chemistry blood calcium, total  8.5  mg dl; chemistry blood bilirubin, total  0.9  mg dl; chemistry blood glucose  76  mg dl$ondansetron  4  mg ; dextrose 50%  12.5  gm ; glucagon  1  mg ; glucose gel  15  g ; sodium chloride 0.9%  flush  10  ml ; sarna lotion  1  appl ; aspirin  81  mg ; docusate sodium  100  mg ; oxycodone (immediate release)  5-10  mg ; prednisone  7.5  mg ; valganciclovir  900  mg ; daptomycin  550  mg ; polyethylene glycol  17  g ; fluconazole  400  mg ; cyanocobalamin  1000  mcg ; multivitamins w minerals  1  tab ; vitamin d  5000  unit ; calcium carbonate  1000  mg ; enoxaparin sodium  80  mg ; sodium chloride 0.9%  flush  10-20  ml ; 
obstruction of bile duct bariatric surgery status gastro-esophageal reflux disease without esophagitis other complications of liver transplant nutritional anemia, unspecified acquired coagulation factor deficiency vertical heterophoria thrombocytopenia, unspecified supraventricular tachycardia unspecified asthma, uncomplicated alcoholic cirrhosis of liver with ascites esophoria bariatric surgery status unspecified place in hospital as the place of occurrence of the external cause awaiting organ transplant status hypo-osmolality and hyponatremia body mass index (bmi) 31.0-31.9, adult portal hypertension secondary esophageal varices without bleeding gastro-esophageal reflux disease without esophagitis insomnia, unspecified physical restraint status acute kidney failure with tubular necrosis other fluid overload moderate protein-calorie malnutrition postprocedural (acute) (chronic) kidney failure delirium due to known physiological condition nonalcoholic steatohepatitis (nash) family history of other infectious and parasitic diseases surgical operation with transplant of whole organ as the cause of abnormal reaction of the patient, or of later complication, without mention of misadventure at the time of the procedure hypo-osmolality and hyponatremia portal hypertension alcoholic cirrhosis of liver with ascites alcohol dependence, in remission unspecified asthma, uncomplicated anemia, unspecified coagulation defect, unspecified cough secondary esophageal varices without bleeding gastro-esophageal reflux disease without esophagitis bariatric surgery status 
white f 44 $nan$hematology blood hematocrit  24.3  %; hematology blood hemoglobin  7.5  g dl; hematology blood platelet count  268  k ul; chemistry blood anion gap  10  meq l; chemistry blood bicarbonate  26  meq l; chemistry blood chloride  103  meq l; chemistry blood creatinine  0.8  mg dl; chemistry blood potassium  5.1  meq l; chemistry blood sodium  139  meq l; chemistry blood urea nitrogen  18  mg dl; hematology urine wbc  2  # hpf; chemistry blood calcium, total  8.6  mg dl; chemistry blood bilirubin, total  0.7  mg dl; chemistry blood glucose  81  mg dl$ondansetron  4  mg ; dextrose 50%  12.5  gm ; glucagon  1  mg ; glucose gel  15  g ; sodium chloride 0.9%  flush  10  ml ; sarna lotion  1  appl ; aspirin  81  mg ; docusate sodium  100  mg ; prednisone  7.5  mg ; valganciclovir  900  mg ; daptomycin  550  mg ; polyethylene glycol  17  g ; fluconazole  400  mg ; cyanocobalamin  1000  mcg ; multivitamins w minerals  1  tab ; vitamin d  5000  unit ; calcium carbonate  1000  mg ; enoxaparin sodium  80  mg ; sodium chloride 0.9%  flush  10-20  ml ; ertapenem sodium  1  g ; 
obstruction of bile duct bariatric surgery status gastro-esophageal reflux disease without esophagitis other complications of liver transplant nutritional anemia, unspecified acquired coagulation factor deficiency vertical heterophoria thrombocytopenia, unspecified supraventricular tachycardia unspecified asthma, uncomplicated alcoholic cirrhosis of liver with ascites esophoria bariatric surgery status unspecified place in hospital as the place of occurrence of the external cause awaiting organ transplant status hypo-osmolality and hyponatremia body mass index (bmi) 31.0-31.9, adult portal hypertension secondary esophageal varices without bleeding gastro-esophageal reflux disease without esophagitis insomnia, unspecified physical restraint status acute kidney failure with tubular necrosis other fluid overload moderate protein-calorie malnutrition postprocedural (acute) (chronic) kidney failure delirium due to known physiological condition nonalcoholic steatohepatitis (nash) family history of other infectious and parasitic diseases surgical operation with transplant of whole organ as the cause of abnormal reaction of the patient, or of later complication, without mention of misadventure at the time of the procedure hypo-osmolality and hyponatremia portal hypertension alcoholic cirrhosis of liver with ascites alcohol dependence, in remission unspecified asthma, uncomplicated anemia, unspecified coagulation defect, unspecified cough secondary esophageal varices without bleeding gastro-esophageal reflux disease without esophagitis bariatric surgery status 
black african american f 42 $nan$hematology blood hematocrit  35.3  %; hematology blood hematocrit  35.0  %; hematology blood hemoglobin  10.8  g dl; hematology blood hemoglobin  10.9  g dl; hematology blood platelet count  283  k ul; hematology blood platelet count  292  k ul; chemistry blood anion gap  12  meq l; chemistry blood anion gap  11  meq l; chemistry blood anion gap  10  meq l; chemistry blood anion gap  10  meq l; chemistry blood bicarbonate  25  meq l; chemistry blood bicarbonate  23  meq l; chemistry blood bicarbonate  24  meq l; chemistry blood bicarbonate  25  meq l; chemistry blood chloride  111  meq l; chemistry blood chloride  108  meq l; chemistry blood chloride  108  meq l; chemistry blood chloride  108  meq l; chemistry blood creatinine  0.5  mg dl; chemistry blood creatinine  0.6  mg dl; chemistry blood creatinine  0.5  mg dl; chemistry blood creatinine  0.5  mg dl; chemistry blood potassium  3.8  meq l; chemistry blood potassium  3.6  meq l; chemistry blood potassium  4.2  meq l; chemistry blood potassium  3.9  meq l; chemistry blood sodium  141  meq l; chemistry blood sodium  138  meq l; chemistry blood sodium  141  meq l; chemistry blood sodium  139  meq l; chemistry blood urea nitrogen  9  mg dl; chemistry blood urea nitrogen  9  mg dl; chemistry blood urea nitrogen  7  mg dl; chemistry blood urea nitrogen  7  mg dl; hematology urine wbc  1  # hpf; chemistry blood calcium, total  7.6  mg dl; chemistry blood calcium, total  7.9  mg dl; chemistry blood calcium, total  7.4  mg dl; chemistry blood calcium, total  8.3  mg dl; chemistry blood glucose  99  mg dl; chemistry blood glucose  81  mg dl; chemistry blood glucose  125  mg dl; chemistry blood glucose  82  mg dl; chemistry blood albumin  3.2  g dl$sodium chloride 0.9%  flush  3  ml ; 0.9% sodium chloride  1000  ml ; heparin  5000  unit ; albuterol inhaler  1  puff ; fluticasone propionate 110mcg  2  puff ; oxycodone (immediate release)   5  mg ; 0.9% sodium chloride  100  ml ; calcium gluconate  2  g ; lactated ringers  1000  ml ; bag  50  ml ; magnesium sulfate  2  gm ; ondansetron  4  mg ; 
 
black african american f 42 $nan$hematology blood hematocrit  33.6  %; hematology blood hemoglobin  10.7  g dl; hematology blood platelet count  295  k ul; chemistry blood anion gap  9  meq l; chemistry blood anion gap  10  meq l; chemistry blood anion gap  14  meq l; chemistry blood bicarbonate  26  meq l; chemistry blood bicarbonate  28  meq l; chemistry blood bicarbonate  25  meq l; chemistry blood chloride  108  meq l; chemistry blood chloride  107  meq l; chemistry blood chloride  102  meq l; chemistry blood creatinine  0.5  mg dl; chemistry blood creatinine  0.5  mg dl; chemistry blood creatinine  0.5  mg dl; chemistry blood potassium  3.9  meq l; chemistry blood potassium  4.0  meq l; chemistry blood potassium  3.7  meq l; chemistry blood sodium  139  meq l; chemistry blood sodium  141  meq l; chemistry blood sodium  137  meq l; chemistry blood urea nitrogen  8  mg dl; chemistry blood urea nitrogen  6  mg dl; chemistry blood urea nitrogen  6  mg dl; chemistry blood calcium, total  8.2  mg dl; chemistry blood calcium, total  8.6  mg dl; chemistry blood calcium, total  8.9  mg dl; chemistry blood glucose  110  mg dl; chemistry blood glucose  92  mg dl; chemistry blood glucose  114  mg dl$sodium chloride 0.9%  flush  3  ml ; heparin  5000  unit ; albuterol inhaler  1  puff ; fluticasone propionate 110mcg  2  puff ; oxycodone (immediate release)   5  mg ; 0.9% sodium chloride  100  ml ; calcium gluconate  2  g ; lactated ringers  1000  ml ; bag  50  ml ; magnesium sulfate  2  gm ; ondansetron  4  mg ; 
 
black african american f 42 $nan$hematology blood hematocrit  33.7  %; hematology blood hemoglobin  10.9  g dl; hematology blood platelet count  329  k ul; chemistry blood anion gap  12  meq l; chemistry blood anion gap  12  meq l; chemistry blood anion gap  14  meq l; chemistry blood bicarbonate  27  meq l; chemistry blood bicarbonate  24  meq l; chemistry blood bicarbonate  25  meq l; chemistry blood chloride  104  meq l; chemistry blood chloride  109  meq l; chemistry blood chloride  105  meq l; chemistry blood creatinine  0.5  mg dl; chemistry blood creatinine  0.5  mg dl; chemistry blood creatinine  0.5  mg dl; chemistry blood potassium  3.5  meq l; chemistry blood potassium  4.2  meq l; chemistry blood potassium  3.9  meq l; chemistry blood sodium  139  meq l; chemistry blood sodium  141  meq l; chemistry blood sodium  140  meq l; chemistry blood urea nitrogen  8  mg dl; chemistry blood urea nitrogen  6  mg dl; chemistry blood urea nitrogen  7  mg dl; chemistry blood calcium, total  8.7  mg dl; chemistry blood calcium, total  8.1  mg dl; chemistry blood calcium, total  8.8  mg dl; chemistry blood glucose  82  mg dl; chemistry blood glucose  95  mg dl; chemistry blood glucose  115  mg dl$sodium chloride 0.9%  flush  3  ml ; heparin  5000  unit ; albuterol inhaler  1  puff ; fluticasone propionate 110mcg  2  puff ; oxycodone (immediate release)   5  mg ; ondansetron  4  mg ; potassium chloride  40  meq ; 
 
black african american f 42 $nan$hematology blood hematocrit  33.8  %; hematology blood hemoglobin  10.8  g dl; hematology blood platelet count  357  k ul; chemistry blood anion gap  13  meq l; chemistry blood anion gap  13  meq l; chemistry blood anion gap  13  meq l; chemistry blood bicarbonate  26  meq l; chemistry blood bicarbonate  28  meq l; chemistry blood bicarbonate  27  meq l; chemistry blood chloride  105  meq l; chemistry blood chloride  106  meq l; chemistry blood chloride  104  meq l; chemistry blood creatinine  0.6  mg dl; chemistry blood creatinine  0.6  mg dl; chemistry blood creatinine  0.5  mg dl; chemistry blood potassium  3.9  meq l; chemistry blood potassium  4.2  meq l; chemistry blood potassium  3.7  meq l; chemistry blood sodium  140  meq l; chemistry blood sodium  143  meq l; chemistry blood sodium  140  meq l; chemistry blood urea nitrogen  8  mg dl; chemistry blood urea nitrogen  5  mg dl; chemistry blood urea nitrogen  8  mg dl; hematology urine wbc  5  # hpf; hematology urine wbc  3  # hpf; chemistry blood calcium, total  8.7  mg dl; chemistry blood calcium, total  8.8  mg dl; chemistry blood calcium, total  8.9  mg dl; chemistry blood glucose  107  mg dl; chemistry blood glucose  89  mg dl; chemistry blood glucose  108  mg dl$sodium chloride 0.9%  flush  3  ml ; heparin  5000  unit ; albuterol inhaler  1  puff ; fluticasone propionate 110mcg  2  puff ; oxycodone (immediate release)   5  mg ; ondansetron  4  mg ; alprazolam  0.25  mg ; 
 
black african american f 42 $nan$hematology blood hematocrit  34.1  %; hematology blood hemoglobin  10.5  g dl; hematology blood platelet count  380  k ul; chemistry blood anion gap  13  meq l; chemistry blood anion gap  10  meq l; chemistry blood bicarbonate  28  meq l; chemistry blood bicarbonate  31  meq l; chemistry blood chloride  105  meq l; chemistry blood chloride  103  meq l; chemistry blood creatinine  0.5  mg dl; chemistry blood creatinine  0.5  mg dl; chemistry blood potassium  4.5  meq l; chemistry blood potassium  4.3  meq l; chemistry blood sodium  141  meq l; chemistry blood sodium  140  meq l; chemistry blood urea nitrogen  6  mg dl; chemistry blood urea nitrogen  6  mg dl; chemistry blood calcium, total  9.0  mg dl; chemistry blood calcium, total  9.6  mg dl; chemistry blood glucose  110  mg dl; chemistry blood glucose  87  mg dl$sodium chloride 0.9%  flush  3  ml ; heparin  5000  unit ; albuterol inhaler  1  puff ; fluticasone propionate 110mcg  2  puff ; oxycodone (immediate release)   5  mg ; ondansetron  4  mg ; alprazolam  0.25  mg ; 
 
black african american f 42 $nan$hematology blood hematocrit  35.2  %; hematology blood hemoglobin  11.2  g dl; hematology blood platelet count  427  k ul; chemistry blood anion gap  12  meq l; chemistry blood bicarbonate  31  meq l; chemistry blood chloride  104  meq l; chemistry blood creatinine  0.6  mg dl; chemistry blood potassium  4.6  meq l; chemistry blood sodium  142  meq l; chemistry blood urea nitrogen  6  mg dl; chemistry blood calcium, total  9.2  mg dl; chemistry blood glucose  86  mg dl$sodium chloride 0.9%  flush  3  ml ; heparin  5000  unit ; albuterol inhaler  1  puff ; fluticasone propionate 110mcg  2  puff ; oxycodone (immediate release)   5  mg ; ondansetron  4  mg ; 
 
black african american f 42 $nan$chemistry blood anion gap  8  meq l; chemistry blood bicarbonate  31  meq l; chemistry blood chloride  105  meq l; chemistry blood creatinine  0.5  mg dl; chemistry blood potassium  4.4  meq l; chemistry blood sodium  140  meq l; chemistry blood urea nitrogen  10  mg dl; chemistry blood calcium, total  8.8  mg dl; chemistry blood glucose  95  mg dl$sodium chloride 0.9%  flush  3  ml ; heparin  5000  unit ; albuterol inhaler  1  puff ; fluticasone propionate 110mcg  2  puff ; oxycodone (immediate release)   5  mg ; ondansetron  4  mg ; 
 
black african american f 42 $nan$nan$sodium chloride 0.9%  flush  3  ml ; heparin  5000  unit ; albuterol inhaler  1  puff ; fluticasone propionate 110mcg  2  puff ; oxycodone (immediate release)   5  mg ; ondansetron  4  mg ; 
 
white f 57 $temp  98.2  heartrate  88.0  resprate  16.0  o2sat  100.0  sbp  97.0  dbp  51.0  rhythm    pain  sleep  $hematology blood hematocrit  32.1  %; hematology blood hemoglobin  10.8  g dl; hematology blood platelet count  241  k ul; chemistry blood anion gap  14  meq l; chemistry blood bicarbonate  21  meq l; chemistry blood chloride  107  meq l; chemistry blood creatinine  0.8  mg dl; chemistry blood potassium  4.4  meq l; chemistry blood sodium  138  meq l; chemistry blood urea nitrogen  21  mg dl; chemistry blood calcium, total  8.9  mg dl; chemistry blood glucose  92  mg dl$influenza vaccine quadrivalent  0.5  ml ; sodium chloride 0.9%  flush  3  ml ; acetaminophen  325-650  mg ; phenobarbital  16.2  mg ; clonazepam  0.5  mg ; zonisamide  400  mg ; escitalopram oxalate  10  mg ; folic acid  1  mg ; lorazepam  0.5-2  mg ; heparin  5000  unit ; phenobarbital  89.1  mg ; senna  8.6  mg ; zonisamide  100  mg ; 
anemia, unspecified esophageal reflux depressive disorder, not elsewhere classified epilepsy, unspecified, with intractable epilepsy mild cognitive impairment, so stated unspecified glaucoma hyposmolality and/or hyponatremia 
white f 57 $nan$nan$influenza vaccine quadrivalent  0.5  ml ; sodium chloride 0.9%  flush  3  ml ; acetaminophen  325-650  mg ; phenobarbital  16.2  mg ; clonazepam  0.5  mg ; escitalopram oxalate  10  mg ; folic acid  1  mg ; lorazepam  0.5-2  mg ; heparin  5000  unit ; phenobarbital  89.1  mg ; senna  8.6  mg ; zonisamide  100  mg ; sodium chloride  1  gm ; latanoprost 0.005% ophth. soln.  1  drop ; zonisamide  600  mg ; 
anemia, unspecified esophageal reflux depressive disorder, not elsewhere classified epilepsy, unspecified, with intractable epilepsy mild cognitive impairment, so stated unspecified glaucoma hyposmolality and/or hyponatremia 
white f 57 $nan$nan$influenza vaccine quadrivalent  0.5  ml ; sodium chloride 0.9%  flush  3  ml ; acetaminophen  325-650  mg ; phenobarbital  16.2  mg ; clonazepam  0.5  mg ; escitalopram oxalate  10  mg ; folic acid  1  mg ; lorazepam  0.5-2  mg ; heparin  5000  unit ; phenobarbital  89.1  mg ; senna  8.6  mg ; zonisamide  100  mg ; sodium chloride  1  gm ; latanoprost 0.005% ophth. soln.  1  drop ; zonisamide  600  mg ; 
anemia, unspecified esophageal reflux depressive disorder, not elsewhere classified epilepsy, unspecified, with intractable epilepsy mild cognitive impairment, so stated unspecified glaucoma hyposmolality and/or hyponatremia 
white m 67 $temp  98.1  heartrate  94.0  resprate  18.0  o2sat  98.0  sbp  155.0  dbp  72.0  rhythm    pain  0  ; temp    heartrate  95.0  resprate  14.0  o2sat  98.0  sbp  147.0  dbp  78.0  rhythm    pain  0 10  ; temp    heartrate  82.0  resprate  18.0  o2sat  98.0  sbp  151.0  dbp  69.0  rhythm    pain  6 10  ; temp    heartrate  82.0  resprate  14.0  o2sat  97.0  sbp  148.0  dbp  79.0  rhythm    pain  6 10  $hematology blood hematocrit  40.2  %; hematology blood hemoglobin  13.8  g dl; hematology blood platelet count  281  k ul; chemistry blood anion gap  17  meq l; chemistry blood bicarbonate  25  meq l; chemistry blood chloride  98  meq l; chemistry blood creatinine  1.3  mg dl; chemistry blood potassium  4.8  meq l; chemistry blood sodium  135  meq l; chemistry blood urea nitrogen  11  mg dl; chemistry blood glucose  30  mg dl; blood gas blood lactate  2.4  mmol l; blood gas blood glucose  31  mg dl$nan
merrf syndrome alcohol abuse, unspecified anemia, unspecified coronary atherosclerosis of unspecified type of vessel, native or graft long-term (current) use of insulin acute kidney failure, unspecified old myocardial infarction tobacco use disorder chronic pancreatitis cocaine abuse, in remission pneumonia, organism unspecified accidental fall from chair unspecified essential hypertension diabetes with other specified manifestations, type ii or unspecified type, not stated as uncontrolled chronic obstructive asthma, unspecified other and unspecified special symptoms or syndromes, not elsewhere classified insulins and antidiabetic agents causing adverse effects in therapeutic use open wound of forehead, without mention of complication home accidents syncope and collapse other and unspecified hyperlipidemia long-term (current) use of insulin cocaine abuse, in remission congestive heart failure, unspecified tobacco use disorder unspecified essential hypertension lumbago hyposmolality and/or hyponatremia substance abuse in family person boarding or alighting a pedal cycle injured in collision with fixed or stationary object subendocardial infarction, initial episode of care family history of ischemic heart disease other nonspecific (abnormal) findings on radiological and other examinations of body structure fever, unspecified alcohol abuse, unspecified chronic obstructive asthma, unspecified diabetes mellitus without mention of complication, type ii or unspecified type, not stated as uncontrolled other chronic pain leukocytosis, unspecified atrial fibrillation long-term (current) use of insulin tobacco use disorder chronic pancreatitis diabetes with other specified manifestations, type ii or unspecified type, not stated as uncontrolled benzodiazepine-based tranquilizers causing adverse effects in therapeutic use pancytopenia drug-induced delirium acidosis
white m 67 $temp    heartrate  92.0  resprate  15.0  o2sat  98.0  sbp  146.0  dbp  83.0  rhythm    pain  0 10  ; temp    heartrate  77.0  resprate  22.0  o2sat  99.0  sbp  150.0  dbp  81.0  rhythm    pain  sleeping  ; temp    heartrate  105.0  resprate  18.0  o2sat  98.0  sbp  122.0  dbp  71.0  rhythm    pain    ; temp    heartrate  88.0  resprate  21.0  o2sat  97.0  sbp  126.0  dbp  67.0  rhythm    pain  sleeping  ; temp  100.3  heartrate    resprate    o2sat    sbp    dbp    rhythm    pain    ; temp    heartrate    resprate    o2sat    sbp    dbp    rhythm    pain  10  ; temp  99.0  heartrate  92.0  resprate  14.0  o2sat  95.0  sbp  106.0  dbp  54.0  rhythm    pain  0  ; temp    heartrate    resprate    o2sat    sbp    dbp    rhythm    pain    ; temp    heartrate  78.0  resprate  22.0  o2sat  95.0  sbp  127.0  dbp  60.0  rhythm    pain  sleeping  ; temp    heartrate  74.0  resprate  25.0  o2sat  95.0  sbp  115.0  dbp  62.0  rhythm    pain    ; temp  98.8  heartrate  86.0  resprate  20.0  o2sat  95.0  sbp  127.0  dbp  51.0  rhythm    pain  4  $chemistry blood anion gap  16  meq l; chemistry blood bicarbonate  25  meq l; chemistry blood chloride  98  meq l; chemistry blood creatinine  1.2  mg dl; chemistry blood potassium  4.1  meq l; chemistry blood sodium  135  meq l; chemistry blood urea nitrogen  10  mg dl; chemistry blood glucose  165  mg dl; blood gas blood lactate  2.0  mmol l$influenza vaccine quadrivalent  0.5  ml ; pneumococcal 23-valent polysaccharide vaccine  0.5  ml ; sodium chloride 0.9%  flush  3  ml ; acetaminophen  650  mg ; docusate sodium  100  mg ; senna  17.2  mg ; diazepam  10  mg ; trazodone  50  mg ; heparin  5000  unit ; albuterol inhaler  2  puff ; amlodipine  5  mg ; aspirin  81  mg ; atorvastatin  80  mg ; clopidogrel  75  mg ; folic acid  1  mg ; gabapentin  600  mg ; metoprolol succinate xl  50  mg ; multivitamins w minerals  1  tab ; tiotropium bromide  1  cap ; oxycodone (immediate release)   5  mg ; ipratropium-albuterol neb  1  neb ; fluticasone-salmeterol diskus (250 50)   1  inh ; insulin  10  unit ; dextrose 50%  12.5  gm ; glucagon  1  mg ; glucose gel  15  g ; insulin  4  unit ; olanzapine (disintegrating tablet)  2.5  mg ; 
merrf syndrome alcohol abuse, unspecified anemia, unspecified coronary atherosclerosis of unspecified type of vessel, native or graft long-term (current) use of insulin acute kidney failure, unspecified old myocardial infarction tobacco use disorder chronic pancreatitis cocaine abuse, in remission pneumonia, organism unspecified accidental fall from chair unspecified essential hypertension diabetes with other specified manifestations, type ii or unspecified type, not stated as uncontrolled chronic obstructive asthma, unspecified other and unspecified special symptoms or syndromes, not elsewhere classified insulins and antidiabetic agents causing adverse effects in therapeutic use open wound of forehead, without mention of complication home accidents syncope and collapse other and unspecified hyperlipidemia long-term (current) use of insulin cocaine abuse, in remission congestive heart failure, unspecified tobacco use disorder unspecified essential hypertension lumbago hyposmolality and/or hyponatremia substance abuse in family person boarding or alighting a pedal cycle injured in collision with fixed or stationary object subendocardial infarction, initial episode of care family history of ischemic heart disease other nonspecific (abnormal) findings on radiological and other examinations of body structure fever, unspecified alcohol abuse, unspecified chronic obstructive asthma, unspecified diabetes mellitus without mention of complication, type ii or unspecified type, not stated as uncontrolled other chronic pain leukocytosis, unspecified atrial fibrillation long-term (current) use of insulin tobacco use disorder chronic pancreatitis diabetes with other specified manifestations, type ii or unspecified type, not stated as uncontrolled benzodiazepine-based tranquilizers causing adverse effects in therapeutic use pancytopenia drug-induced delirium acidosis
white m 67 $nan$hematology blood hematocrit  36.0  %; hematology blood hemoglobin  12.2  g dl; hematology blood platelet count  224  k ul; chemistry blood anion gap  15  meq l; chemistry blood bicarbonate  26  meq l; chemistry blood chloride  97  meq l; chemistry blood creatinine  1.3  mg dl; chemistry blood potassium  4.5  meq l; chemistry blood sodium  133  meq l; chemistry blood urea nitrogen  13  mg dl; chemistry blood calcium, total  8.9  mg dl; chemistry blood glucose  159  mg dl$influenza vaccine quadrivalent  0.5  ml ; pneumococcal 23-valent polysaccharide vaccine  0.5  ml ; sodium chloride 0.9%  flush  3  ml ; acetaminophen  650  mg ; docusate sodium  100  mg ; senna  17.2  mg ; diazepam  10  mg ; trazodone  50  mg ; heparin  5000  unit ; albuterol inhaler  2  puff ; amlodipine  5  mg ; aspirin  81  mg ; atorvastatin  80  mg ; clopidogrel  75  mg ; folic acid  1  mg ; gabapentin  600  mg ; metoprolol succinate xl  50  mg ; multivitamins w minerals  1  tab ; tiotropium bromide  1  cap ; oxycodone (immediate release)   5  mg ; ipratropium-albuterol neb  1  neb ; fluticasone-salmeterol diskus (250 50)   1  inh ; insulin  10  unit ; dextrose 50%  12.5  gm ; glucagon  1  mg ; glucose gel  15  g ; insulin  4  unit ; olanzapine (disintegrating tablet)  2.5  mg ; prednisone  40  mg ; insulin  6  unit ; calcium carbonate  500  mg ; insulin  2  unit ; azithromycin  500  mg ; 
merrf syndrome alcohol abuse, unspecified anemia, unspecified coronary atherosclerosis of unspecified type of vessel, native or graft long-term (current) use of insulin acute kidney failure, unspecified old myocardial infarction tobacco use disorder chronic pancreatitis cocaine abuse, in remission pneumonia, organism unspecified accidental fall from chair unspecified essential hypertension diabetes with other specified manifestations, type ii or unspecified type, not stated as uncontrolled chronic obstructive asthma, unspecified other and unspecified special symptoms or syndromes, not elsewhere classified insulins and antidiabetic agents causing adverse effects in therapeutic use open wound of forehead, without mention of complication home accidents syncope and collapse other and unspecified hyperlipidemia long-term (current) use of insulin cocaine abuse, in remission congestive heart failure, unspecified tobacco use disorder unspecified essential hypertension lumbago hyposmolality and/or hyponatremia substance abuse in family person boarding or alighting a pedal cycle injured in collision with fixed or stationary object subendocardial infarction, initial episode of care family history of ischemic heart disease other nonspecific (abnormal) findings on radiological and other examinations of body structure fever, unspecified alcohol abuse, unspecified chronic obstructive asthma, unspecified diabetes mellitus without mention of complication, type ii or unspecified type, not stated as uncontrolled other chronic pain leukocytosis, unspecified atrial fibrillation long-term (current) use of insulin tobacco use disorder chronic pancreatitis diabetes with other specified manifestations, type ii or unspecified type, not stated as uncontrolled benzodiazepine-based tranquilizers causing adverse effects in therapeutic use pancytopenia drug-induced delirium acidosis
white m 67 $nan$hematology blood hematocrit  34.9  %; hematology blood hemoglobin  11.8  g dl; hematology blood platelet count  215  k ul; chemistry blood anion gap  13  meq l; chemistry blood bicarbonate  27  meq l; chemistry blood chloride  97  meq l; chemistry blood creatinine  1.1  mg dl; chemistry blood potassium  4.1  meq l; chemistry blood sodium  133  meq l; chemistry blood urea nitrogen  17  mg dl; chemistry blood calcium, total  9.1  mg dl; chemistry blood glucose  222  mg dl$influenza vaccine quadrivalent  0.5  ml ; pneumococcal 23-valent polysaccharide vaccine  0.5  ml ; sodium chloride 0.9%  flush  3  ml ; acetaminophen  650  mg ; docusate sodium  100  mg ; senna  17.2  mg ; diazepam  10  mg ; trazodone  50  mg ; heparin  5000  unit ; albuterol inhaler  2  puff ; amlodipine  5  mg ; aspirin  81  mg ; atorvastatin  80  mg ; clopidogrel  75  mg ; folic acid  1  mg ; gabapentin  600  mg ; metoprolol succinate xl  50  mg ; multivitamins w minerals  1  tab ; tiotropium bromide  1  cap ; ipratropium-albuterol neb  1  neb ; fluticasone-salmeterol diskus (250 50)   1  inh ; dextrose 50%  12.5  gm ; glucagon  1  mg ; glucose gel  15  g ; prednisone  40  mg ; calcium carbonate  500  mg ; insulin  2  unit ; azithromycin  500  mg ; insulin  14  unit ; 
merrf syndrome alcohol abuse, unspecified anemia, unspecified coronary atherosclerosis of unspecified type of vessel, native or graft long-term (current) use of insulin acute kidney failure, unspecified old myocardial infarction tobacco use disorder chronic pancreatitis cocaine abuse, in remission pneumonia, organism unspecified accidental fall from chair unspecified essential hypertension diabetes with other specified manifestations, type ii or unspecified type, not stated as uncontrolled chronic obstructive asthma, unspecified other and unspecified special symptoms or syndromes, not elsewhere classified insulins and antidiabetic agents causing adverse effects in therapeutic use open wound of forehead, without mention of complication home accidents syncope and collapse other and unspecified hyperlipidemia long-term (current) use of insulin cocaine abuse, in remission congestive heart failure, unspecified tobacco use disorder unspecified essential hypertension lumbago hyposmolality and/or hyponatremia substance abuse in family person boarding or alighting a pedal cycle injured in collision with fixed or stationary object subendocardial infarction, initial episode of care family history of ischemic heart disease other nonspecific (abnormal) findings on radiological and other examinations of body structure fever, unspecified alcohol abuse, unspecified chronic obstructive asthma, unspecified diabetes mellitus without mention of complication, type ii or unspecified type, not stated as uncontrolled other chronic pain leukocytosis, unspecified atrial fibrillation long-term (current) use of insulin tobacco use disorder chronic pancreatitis diabetes with other specified manifestations, type ii or unspecified type, not stated as uncontrolled benzodiazepine-based tranquilizers causing adverse effects in therapeutic use pancytopenia drug-induced delirium acidosis
white m 67 $nan$hematology blood hematocrit  34.7  %; hematology blood hemoglobin  11.7  g dl; hematology blood platelet count  236  k ul; chemistry blood anion gap  15  meq l; chemistry blood bicarbonate  25  meq l; chemistry blood chloride  98  meq l; chemistry blood creatinine  1.1  mg dl; chemistry blood potassium  3.8  meq l; chemistry blood sodium  134  meq l; chemistry blood urea nitrogen  16  mg dl; chemistry blood calcium, total  9.1  mg dl; chemistry blood glucose  244  mg dl$influenza vaccine quadrivalent  0.5  ml ; pneumococcal 23-valent polysaccharide vaccine  0.5  ml ; sodium chloride 0.9%  flush  3  ml ; acetaminophen  650  mg ; docusate sodium  100  mg ; senna  17.2  mg ; diazepam  10  mg ; trazodone  50  mg ; heparin  5000  unit ; albuterol inhaler  2  puff ; amlodipine  5  mg ; aspirin  81  mg ; atorvastatin  80  mg ; clopidogrel  75  mg ; folic acid  1  mg ; gabapentin  600  mg ; metoprolol succinate xl  50  mg ; multivitamins w minerals  1  tab ; tiotropium bromide  1  cap ; ipratropium-albuterol neb  1  neb ; fluticasone-salmeterol diskus (250 50)   1  inh ; dextrose 50%  12.5  gm ; glucagon  1  mg ; glucose gel  15  g ; prednisone  40  mg ; calcium carbonate  500  mg ; azithromycin  500  mg ; insulin  14  unit ; furosemide  20  mg ; metformin (glucophage)  500  mg ; 
merrf syndrome alcohol abuse, unspecified anemia, unspecified coronary atherosclerosis of unspecified type of vessel, native or graft long-term (current) use of insulin acute kidney failure, unspecified old myocardial infarction tobacco use disorder chronic pancreatitis cocaine abuse, in remission pneumonia, organism unspecified accidental fall from chair unspecified essential hypertension diabetes with other specified manifestations, type ii or unspecified type, not stated as uncontrolled chronic obstructive asthma, unspecified other and unspecified special symptoms or syndromes, not elsewhere classified insulins and antidiabetic agents causing adverse effects in therapeutic use open wound of forehead, without mention of complication home accidents syncope and collapse other and unspecified hyperlipidemia long-term (current) use of insulin cocaine abuse, in remission congestive heart failure, unspecified tobacco use disorder unspecified essential hypertension lumbago hyposmolality and/or hyponatremia substance abuse in family person boarding or alighting a pedal cycle injured in collision with fixed or stationary object subendocardial infarction, initial episode of care family history of ischemic heart disease other nonspecific (abnormal) findings on radiological and other examinations of body structure fever, unspecified alcohol abuse, unspecified chronic obstructive asthma, unspecified diabetes mellitus without mention of complication, type ii or unspecified type, not stated as uncontrolled other chronic pain leukocytosis, unspecified atrial fibrillation long-term (current) use of insulin tobacco use disorder chronic pancreatitis diabetes with other specified manifestations, type ii or unspecified type, not stated as uncontrolled benzodiazepine-based tranquilizers causing adverse effects in therapeutic use pancytopenia drug-induced delirium acidosis
white m 67 $nan$nan$influenza vaccine quadrivalent  0.5  ml ; pneumococcal 23-valent polysaccharide vaccine  0.5  ml ; sodium chloride 0.9%  flush  3  ml ; acetaminophen  650  mg ; docusate sodium  100  mg ; senna  17.2  mg ; diazepam  10  mg ; trazodone  50  mg ; heparin  5000  unit ; albuterol inhaler  2  puff ; amlodipine  5  mg ; aspirin  81  mg ; atorvastatin  80  mg ; clopidogrel  75  mg ; folic acid  1  mg ; gabapentin  600  mg ; metoprolol succinate xl  50  mg ; multivitamins w minerals  1  tab ; tiotropium bromide  1  cap ; ipratropium-albuterol neb  1  neb ; fluticasone-salmeterol diskus (250 50)   1  inh ; dextrose 50%  12.5  gm ; glucagon  1  mg ; glucose gel  15  g ; calcium carbonate  500  mg ; furosemide  20  mg ; metformin (glucophage)  500  mg ; 
merrf syndrome alcohol abuse, unspecified anemia, unspecified coronary atherosclerosis of unspecified type of vessel, native or graft long-term (current) use of insulin acute kidney failure, unspecified old myocardial infarction tobacco use disorder chronic pancreatitis cocaine abuse, in remission pneumonia, organism unspecified accidental fall from chair unspecified essential hypertension diabetes with other specified manifestations, type ii or unspecified type, not stated as uncontrolled chronic obstructive asthma, unspecified other and unspecified special symptoms or syndromes, not elsewhere classified insulins and antidiabetic agents causing adverse effects in therapeutic use open wound of forehead, without mention of complication home accidents syncope and collapse other and unspecified hyperlipidemia long-term (current) use of insulin cocaine abuse, in remission congestive heart failure, unspecified tobacco use disorder unspecified essential hypertension lumbago hyposmolality and/or hyponatremia substance abuse in family person boarding or alighting a pedal cycle injured in collision with fixed or stationary object subendocardial infarction, initial episode of care family history of ischemic heart disease other nonspecific (abnormal) findings on radiological and other examinations of body structure fever, unspecified alcohol abuse, unspecified chronic obstructive asthma, unspecified diabetes mellitus without mention of complication, type ii or unspecified type, not stated as uncontrolled other chronic pain leukocytosis, unspecified atrial fibrillation long-term (current) use of insulin tobacco use disorder chronic pancreatitis diabetes with other specified manifestations, type ii or unspecified type, not stated as uncontrolled benzodiazepine-based tranquilizers causing adverse effects in therapeutic use pancytopenia drug-induced delirium acidosis
black african american f 76 $nan$hematology blood hematocrit  37.6  %; hematology blood hematocrit  32.0  %; hematology blood hemoglobin  12.2  g dl; hematology blood hemoglobin  10.3  g dl; hematology blood platelet count  181  k ul; hematology blood platelet count  175  k ul; chemistry blood anion gap  17  meq l; chemistry blood anion gap  13  meq l; chemistry blood bicarbonate  26  meq l; chemistry blood bicarbonate  27  meq l; chemistry blood chloride  103  meq l; chemistry blood chloride  107  meq l; chemistry blood creatinine  0.9  mg dl; chemistry blood creatinine  0.8  mg dl; chemistry blood potassium  5.0  meq l; chemistry blood potassium  4.8  meq l; chemistry blood sodium  141  meq l; chemistry blood sodium  142  meq l; chemistry blood urea nitrogen  32  mg dl; chemistry blood urea nitrogen  26  mg dl; hematology blood inr(pt)  1.0  ; chemistry blood calcium, total  9.3  mg dl; chemistry blood calcium, total  8.8  mg dl; chemistry blood bilirubin, total  0.4  mg dl; chemistry blood bilirubin, total  0.2  mg dl; chemistry blood glucose  89  mg dl; chemistry blood glucose  166  mg dl; chemistry blood lactate dehydrogenase (ld)  159  iu l; chemistry blood lactate dehydrogenase (ld)  144  iu l; chemistry blood albumin  4.1  g dl$dexamethasone  10  mg ; 5% dextrose  50  ml ; ondansetron  24  mg ; omeprazole  40  mg ; multivitamins  1  tab ; vitamin d  800  unit ; heparin flush (100 units ml)  2  ml ; 0.9% sodium chloride  500  ml ; 0.9% sodium chloride  1000  ml ; fluorouracil  1100  mg ; pneumococcal vac polyvalent  0.5  ml ; heparin flush (10 units ml)  5  ml ; heparin flush (100 units ml)  5  ml ; heparin flush (10 units ml)  2  ml ; ipratropium bromide neb  1  neb ; albuterol 0.083% neb soln  1  neb ; ondansetron  4  mg ; senna  1  tab ; milk of magnesia  30  ml ; fluticasone-salmeterol diskus (250 50)   1  inh ; docusate sodium  100  mg ; calcium carbonate  1000  mg ; heparin  5000  unit ; 
constipation, unspecified malignant neoplasm of other specified part of esophagus chronic airway obstruction, not elsewhere classified personal history of malignant neoplasm of breast person boarding or alighting a pedal cycle injured in collision with pedestrian or animal encounter for antineoplastic chemotherapy body mass index less than 19, adult fluid overload disorder person boarding or alighting a pedal cycle injured in collision with pedestrian or animal personal history of malignant neoplasm of breast depressive disorder, not elsewhere classified unspecified protein-calorie malnutrition thrombocytopenia, unspecified malignant neoplasm of esophagus, unspecified site chronic obstructive asthma, unspecified driver of special construction vehicle injured in traffic accident unspecified essential hypertension 
black african american f 76 $nan$hematology blood hematocrit  30.3  %; hematology blood hematocrit  30.0  %; hematology blood hemoglobin  9.6  g dl; hematology blood platelet count  172  k ul; chemistry blood anion gap  11  meq l; chemistry blood bicarbonate  24  meq l; chemistry blood chloride  111  meq l; chemistry blood creatinine  0.6  mg dl; chemistry blood potassium  4.7  meq l; chemistry blood sodium  141  meq l; chemistry blood urea nitrogen  14  mg dl; hematology blood inr(pt)  1.0  ; chemistry blood calcium, total  8.3  mg dl; chemistry blood glucose  173  mg dl; chemistry blood albumin  3.3  g dl$dexamethasone  10  mg ; 5% dextrose  50  ml ; ondansetron  24  mg ; omeprazole  40  mg ; multivitamins  1  tab ; vitamin d  800  unit ; heparin flush (100 units ml)  2  ml ; 0.9% sodium chloride  500  ml ; 0.9% sodium chloride  1000  ml ; fluorouracil  1100  mg ; heparin flush (10 units ml)  2  ml ; ipratropium bromide neb  1  neb ; albuterol 0.083% neb soln  1  neb ; ondansetron  4  mg ; senna  1  tab ; milk of magnesia  30  ml ; fluticasone-salmeterol diskus (250 50)   1  inh ; docusate sodium  100  mg ; calcium carbonate  1000  mg ; heparin  5000  unit ; 
constipation, unspecified malignant neoplasm of other specified part of esophagus chronic airway obstruction, not elsewhere classified personal history of malignant neoplasm of breast person boarding or alighting a pedal cycle injured in collision with pedestrian or animal encounter for antineoplastic chemotherapy body mass index less than 19, adult fluid overload disorder person boarding or alighting a pedal cycle injured in collision with pedestrian or animal personal history of malignant neoplasm of breast depressive disorder, not elsewhere classified unspecified protein-calorie malnutrition thrombocytopenia, unspecified malignant neoplasm of esophagus, unspecified site chronic obstructive asthma, unspecified driver of special construction vehicle injured in traffic accident unspecified essential hypertension 
black african american f 76 $nan$hematology blood hematocrit  33.0  %; hematology blood hemoglobin  10.6  g dl; hematology blood platelet count  177  k ul; chemistry blood anion gap  12  meq l; chemistry blood bicarbonate  22  meq l; chemistry blood chloride  113  meq l; chemistry blood creatinine  0.7  mg dl; chemistry blood potassium  4.7  meq l; chemistry blood sodium  142  meq l; chemistry blood urea nitrogen  9  mg dl; chemistry blood calcium, total  8.1  mg dl; chemistry blood glucose  150  mg dl$dexamethasone  10  mg ; 5% dextrose  50  ml ; ondansetron  24  mg ; omeprazole  40  mg ; multivitamins  1  tab ; vitamin d  800  unit ; 0.9% sodium chloride  1000  ml ; fluorouracil  1100  mg ; heparin flush (10 units ml)  2  ml ; ipratropium bromide neb  1  neb ; albuterol 0.083% neb soln  1  neb ; ondansetron  4  mg ; senna  1  tab ; milk of magnesia  30  ml ; fluticasone-salmeterol diskus (250 50)   1  inh ; docusate sodium  100  mg ; calcium carbonate  1000  mg ; heparin  5000  unit ; 
constipation, unspecified malignant neoplasm of other specified part of esophagus chronic airway obstruction, not elsewhere classified personal history of malignant neoplasm of breast person boarding or alighting a pedal cycle injured in collision with pedestrian or animal encounter for antineoplastic chemotherapy body mass index less than 19, adult fluid overload disorder person boarding or alighting a pedal cycle injured in collision with pedestrian or animal personal history of malignant neoplasm of breast depressive disorder, not elsewhere classified unspecified protein-calorie malnutrition thrombocytopenia, unspecified malignant neoplasm of esophagus, unspecified site chronic obstructive asthma, unspecified driver of special construction vehicle injured in traffic accident unspecified essential hypertension 
black african american f 76 $nan$hematology blood hematocrit  31.0  %; hematology blood hemoglobin  10.2  g dl; hematology blood platelet count  185  k ul; chemistry blood anion gap  11  meq l; chemistry blood bicarbonate  23  meq l; chemistry blood chloride  113  meq l; chemistry blood creatinine  0.7  mg dl; chemistry blood potassium  4.5  meq l; chemistry blood sodium  142  meq l; chemistry blood urea nitrogen  10  mg dl; chemistry blood calcium, total  8.2  mg dl; chemistry blood glucose  145  mg dl$dexamethasone  10  mg ; 5% dextrose  50  ml ; ondansetron  24  mg ; omeprazole  40  mg ; multivitamins  1  tab ; vitamin d  800  unit ; 0.9% sodium chloride  1000  ml ; fluorouracil  1100  mg ; heparin flush (10 units ml)  2  ml ; ipratropium bromide neb  1  neb ; albuterol 0.083% neb soln  1  neb ; ondansetron  4  mg ; senna  1  tab ; milk of magnesia  30  ml ; fluticasone-salmeterol diskus (250 50)   1  inh ; docusate sodium  100  mg ; calcium carbonate  1000  mg ; heparin  5000  unit ; furosemide  10  mg ; 
constipation, unspecified malignant neoplasm of other specified part of esophagus chronic airway obstruction, not elsewhere classified personal history of malignant neoplasm of breast person boarding or alighting a pedal cycle injured in collision with pedestrian or animal encounter for antineoplastic chemotherapy body mass index less than 19, adult fluid overload disorder person boarding or alighting a pedal cycle injured in collision with pedestrian or animal personal history of malignant neoplasm of breast depressive disorder, not elsewhere classified unspecified protein-calorie malnutrition thrombocytopenia, unspecified malignant neoplasm of esophagus, unspecified site chronic obstructive asthma, unspecified driver of special construction vehicle injured in traffic accident unspecified essential hypertension 
black african american f 76 $nan$nan$dexamethasone  10  mg ; 5% dextrose  50  ml ; ondansetron  24  mg ; omeprazole  40  mg ; multivitamins  1  tab ; vitamin d  800  unit ; fluorouracil  1100  mg ; heparin flush (10 units ml)  2  ml ; ipratropium bromide neb  1  neb ; albuterol 0.083% neb soln  1  neb ; ondansetron  4  mg ; senna  1  tab ; milk of magnesia  30  ml ; fluticasone-salmeterol diskus (250 50)   1  inh ; docusate sodium  100  mg ; calcium carbonate  1000  mg ; heparin  5000  unit ; furosemide  10  mg ; 
constipation, unspecified malignant neoplasm of other specified part of esophagus chronic airway obstruction, not elsewhere classified personal history of malignant neoplasm of breast person boarding or alighting a pedal cycle injured in collision with pedestrian or animal encounter for antineoplastic chemotherapy body mass index less than 19, adult fluid overload disorder person boarding or alighting a pedal cycle injured in collision with pedestrian or animal personal history of malignant neoplasm of breast depressive disorder, not elsewhere classified unspecified protein-calorie malnutrition thrombocytopenia, unspecified malignant neoplasm of esophagus, unspecified site chronic obstructive asthma, unspecified driver of special construction vehicle injured in traffic accident unspecified essential hypertension 
white f 63 $nan$nan$heparin  5000  unit ; 
 
white f 63 $nan$hematology blood hematocrit  41.2  %; hematology blood hemoglobin  13.9  g dl; hematology blood platelet count  239  k ul; chemistry blood anion gap  15  meq l; chemistry blood bicarbonate  23  meq l; chemistry blood chloride  103  meq l; chemistry blood creatinine  0.8  mg dl; chemistry blood potassium  4.1  meq l; chemistry blood sodium  137  meq l; chemistry blood urea nitrogen  12  mg dl; chemistry blood calcium, total  8.7  mg dl; chemistry blood glucose  145  mg dl$heparin  5000  unit ; sodium chloride 0.9%  flush  3  ml ; hydromorphone (dilaudid)  0.5  mg ; ketorolac  15-30  mg ; enoxaparin sodium  40  mg ; lactated ringers  1000  ml ; iso-osmotic dextrose  50  ml ; cefazolin  2  g ; 
 
white f 63 $nan$hematology blood hematocrit  33.9  %; hematology blood hemoglobin  11.6  g dl; hematology blood platelet count  221  k ul; chemistry blood anion gap  10  meq l; chemistry blood bicarbonate  30  meq l; chemistry blood chloride  100  meq l; chemistry blood creatinine  0.7  mg dl; chemistry blood potassium  3.9  meq l; chemistry blood sodium  136  meq l; chemistry blood urea nitrogen  9  mg dl; chemistry blood calcium, total  8.3  mg dl; chemistry blood glucose  103  mg dl$sodium chloride 0.9%  flush  3  ml ; hydromorphone (dilaudid)  0.5  mg ; ketorolac  15-30  mg ; enoxaparin sodium  40  mg ; lactated ringers  1000  ml ; iso-osmotic dextrose  50  ml ; cefazolin  2  g ; triamterene-hydrochlorothiazide  1  cap ; ibuprofen  600  mg ; oxycodone-acetaminophen (5mg-325mg)  1-2  tab ; 
 
white f 79 $nan$nan$aspirin  81  mg ; aspirin  325  mg ; 
 
white f 79 $nan$hematology blood hematocrit  36.0  %; hematology blood hemoglobin  12.8  g dl; hematology blood platelet count  218  k ul; chemistry blood anion gap  12  meq l; chemistry blood bicarbonate  27  meq l; chemistry blood chloride  106  meq l; chemistry blood creatinine  0.7  mg dl; chemistry blood potassium  3.8  meq l; chemistry blood sodium  141  meq l; chemistry blood urea nitrogen  21  mg dl; chemistry blood glucose  100  mg dl$aspirin  81  mg ; aspirin  325  mg ; influenza virus vaccine  0.5  ml ; pneumococcal vac polyvalent  0.5  ml ; sodium chloride 0.9%  flush  3  ml ; acetaminophen  325-650  mg ; docusate sodium  100  mg ; ibuprofen  600  mg ; heparin  5000  unit ; ketorolac  15  mg ; ibuprofen  800  mg ; cyclobenzaprine  10  mg ; 
 
white f 79 $nan$nan$aspirin  325  mg ; influenza virus vaccine  0.5  ml ; pneumococcal vac polyvalent  0.5  ml ; sodium chloride 0.9%  flush  3  ml ; docusate sodium  100  mg ; heparin  5000  unit ; ketorolac  15  mg ; ibuprofen  800  mg ; cyclobenzaprine  10  mg ; 
 
white m 79 $temp  97.7  heartrate  67.0  resprate  20.0  o2sat  96.0  sbp  111.0  dbp  54.0  rhythm    pain    $hematology blood hematocrit  33.9  %; hematology blood hemoglobin  11.0  g dl; hematology blood platelet count  255  k ul; chemistry blood anion gap  16  meq l; chemistry blood bicarbonate  29  meq l; chemistry blood chloride  101  meq l; chemistry blood creatinine  0.8  mg dl; chemistry blood potassium  3.8  meq l; chemistry blood sodium  142  meq l; chemistry blood urea nitrogen  15  mg dl; chemistry blood calcium, total  8.9  mg dl; chemistry blood bilirubin, total  0.3  mg dl; chemistry blood glucose  185  mg dl; chemistry blood lactate dehydrogenase (ld)  155  iu l; chemistry blood % hemoglobin a1c  8.3  %$sodium chloride 0.9%  flush  3  ml ; 0.9% sodium chloride  1000  ml ; acetaminophen  650  mg ; dextrose 50%  12.5  gm ; glucagon  1  mg ; prednisone  10  mg ; prednisone  5  mg ; hydralazine  5  mg ; insulin  0  unit ; prednisone  7.5  mg ; prednisone  15  mg ; heparin  5000  unit ; docusate sodium  200  mg ; aspirin  325  mg ; atorvastatin  80  mg ; levothyroxine sodium  75  mcg ; 
gastroparesis unspecified essential hypertension diabetes mellitus without mention of complication, type ii or unspecified type, not stated as uncontrolled glucocorticoid deficiency dehydration anemia, unspecified long-term (current) use of insulin long-term (current) use of steroids pneumonia, organism unspecified obstructive sleep apnea (adult)(pediatric) panhypopituitarism unspecified acquired hypothyroidism esophageal reflux other and unspecified hyperlipidemia personal history of noncompliance with medical treatment, presenting hazards to health panhypopituitarism long-term (current) use of aspirin acromegaly and gigantism other and unspecified hyperlipidemia other chest pain nausea with vomiting diabetes with neurological manifestations, type ii or unspecified type, not stated as uncontrolled dizziness and giddiness unspecified essential hypertension gastroparesis other respiratory abnormalities esophageal reflux hyposmolality and/or hyponatremia background diabetic retinopathy unspecified acquired hypothyroidism dyspepsia and other specified disorders of function of stomach other and unspecified hyperlipidemia panhypopituitarism diabetes with neurological manifestations, type ii or unspecified type, not stated as uncontrolled gastroparesis unspecified vitamin d deficiency polyneuropathy in diabetes diabetes with ophthalmic manifestations, type ii or unspecified type, not stated as uncontrolled long-term (current) use of steroids other constipation
white m 79 $nan$nan$sodium chloride 0.9%  flush  3  ml ; 0.9% sodium chloride  1000  ml ; acetaminophen  650  mg ; dextrose 50%  12.5  gm ; glucagon  1  mg ; insulin  0  unit ; prednisone  7.5  mg ; prednisone  15  mg ; heparin  5000  unit ; docusate sodium  200  mg ; aspirin  325  mg ; atorvastatin  80  mg ; levothyroxine sodium  75  mcg ; atorvastatin  40  mg ; 
gastroparesis unspecified essential hypertension diabetes mellitus without mention of complication, type ii or unspecified type, not stated as uncontrolled glucocorticoid deficiency dehydration anemia, unspecified long-term (current) use of insulin long-term (current) use of steroids pneumonia, organism unspecified obstructive sleep apnea (adult)(pediatric) panhypopituitarism unspecified acquired hypothyroidism esophageal reflux other and unspecified hyperlipidemia personal history of noncompliance with medical treatment, presenting hazards to health panhypopituitarism long-term (current) use of aspirin acromegaly and gigantism other and unspecified hyperlipidemia other chest pain nausea with vomiting diabetes with neurological manifestations, type ii or unspecified type, not stated as uncontrolled dizziness and giddiness unspecified essential hypertension gastroparesis other respiratory abnormalities esophageal reflux hyposmolality and/or hyponatremia background diabetic retinopathy unspecified acquired hypothyroidism dyspepsia and other specified disorders of function of stomach other and unspecified hyperlipidemia panhypopituitarism diabetes with neurological manifestations, type ii or unspecified type, not stated as uncontrolled gastroparesis unspecified vitamin d deficiency polyneuropathy in diabetes diabetes with ophthalmic manifestations, type ii or unspecified type, not stated as uncontrolled long-term (current) use of steroids other constipation
white m 79 $nan$nan$sodium chloride 0.9%  flush  3  ml ; 0.9% sodium chloride  1000  ml ; acetaminophen  650  mg ; dextrose 50%  12.5  gm ; glucagon  1  mg ; insulin  0  unit ; prednisone  7.5  mg ; prednisone  15  mg ; heparin  5000  unit ; docusate sodium  200  mg ; aspirin  325  mg ; levothyroxine sodium  75  mcg ; atorvastatin  40  mg ; 
gastroparesis unspecified essential hypertension diabetes mellitus without mention of complication, type ii or unspecified type, not stated as uncontrolled glucocorticoid deficiency dehydration anemia, unspecified long-term (current) use of insulin long-term (current) use of steroids pneumonia, organism unspecified obstructive sleep apnea (adult)(pediatric) panhypopituitarism unspecified acquired hypothyroidism esophageal reflux other and unspecified hyperlipidemia personal history of noncompliance with medical treatment, presenting hazards to health panhypopituitarism long-term (current) use of aspirin acromegaly and gigantism other and unspecified hyperlipidemia other chest pain nausea with vomiting diabetes with neurological manifestations, type ii or unspecified type, not stated as uncontrolled dizziness and giddiness unspecified essential hypertension gastroparesis other respiratory abnormalities esophageal reflux hyposmolality and/or hyponatremia background diabetic retinopathy unspecified acquired hypothyroidism dyspepsia and other specified disorders of function of stomach other and unspecified hyperlipidemia panhypopituitarism diabetes with neurological manifestations, type ii or unspecified type, not stated as uncontrolled gastroparesis unspecified vitamin d deficiency polyneuropathy in diabetes diabetes with ophthalmic manifestations, type ii or unspecified type, not stated as uncontrolled long-term (current) use of steroids other constipation
white m 79 $nan$nan$sodium chloride 0.9%  flush  3  ml ; 0.9% sodium chloride  1000  ml ; acetaminophen  650  mg ; dextrose 50%  12.5  gm ; glucagon  1  mg ; insulin  0  unit ; prednisone  7.5  mg ; prednisone  15  mg ; heparin  5000  unit ; docusate sodium  200  mg ; aspirin  325  mg ; levothyroxine sodium  75  mcg ; atorvastatin  40  mg ; 
gastroparesis unspecified essential hypertension diabetes mellitus without mention of complication, type ii or unspecified type, not stated as uncontrolled glucocorticoid deficiency dehydration anemia, unspecified long-term (current) use of insulin long-term (current) use of steroids pneumonia, organism unspecified obstructive sleep apnea (adult)(pediatric) panhypopituitarism unspecified acquired hypothyroidism esophageal reflux other and unspecified hyperlipidemia personal history of noncompliance with medical treatment, presenting hazards to health panhypopituitarism long-term (current) use of aspirin acromegaly and gigantism other and unspecified hyperlipidemia other chest pain nausea with vomiting diabetes with neurological manifestations, type ii or unspecified type, not stated as uncontrolled dizziness and giddiness unspecified essential hypertension gastroparesis other respiratory abnormalities esophageal reflux hyposmolality and/or hyponatremia background diabetic retinopathy unspecified acquired hypothyroidism dyspepsia and other specified disorders of function of stomach other and unspecified hyperlipidemia panhypopituitarism diabetes with neurological manifestations, type ii or unspecified type, not stated as uncontrolled gastroparesis unspecified vitamin d deficiency polyneuropathy in diabetes diabetes with ophthalmic manifestations, type ii or unspecified type, not stated as uncontrolled long-term (current) use of steroids other constipation
white m 92 $nan$nan$amlodipine  5  mg ; finasteride  5  mg ; furosemide  20  mg ; potassium chloride  10  meq ; vitamin d  400  unit ; ferrous sulfate  325  mg ; omeprazole  20  mg ; levothyroxine sodium  150  mcg ; 
atrial fibrillation altered mental status unspecified fall open wound of elbow, without mention of complication other specified metabolic disorders unspecified essential hypertension atrial fibrillation diverticulosis of colon (without mention of hemorrhage) unspecified acquired hypothyroidism iron deficiency anemia, unspecified observation following other accident person boarding or alighting from bus injured in collision with pedal cycle hypertrophy (benign) of prostate without urinary obstruction and other lower urinary tract symptom (luts) bronchiectasis without acute exacerbation depressive disorder, not elsewhere classified other specified cardiac dysrhythmias fall from other slipping, tripping, or stumbling unspecified essential hypertension barrett's esophagus unspecified essential hypertension iron deficiency anemia secondary to blood loss (chronic) atrial fibrillation depressive disorder, not elsewhere classified hypertrophy (benign) of prostate without urinary obstruction and other lower urinary tract symptom (luts) unspecified acquired hypothyroidism hemorrhage of gastrointestinal tract, unspecified acute posthemorrhagic anemia diverticulosis of colon (without mention of hemorrhage) bronchiectasis without acute exacerbation barrett's esophagus iron deficiency anemia secondary to blood loss (chronic) hypertensive chronic kidney disease, unspecified, with chronic kidney disease stage i through stage iv, or unspecified chronic kidney disease, unspecified atrial fibrillation hemorrhage of gastrointestinal tract, unspecified hypertrophy (benign) of prostate without urinary obstruction and other lower urinary tract symptom (luts) unspecified acquired hypothyroidism depressive disorder, not elsewhere classified long-term (current) use of anticoagulants acute kidney failure, unspecified diverticulosis of colon (without mention of hemorrhage) barrett's esophagus hemorrhage of gastrointestinal tract, unspecified abnormality of gait lumbago atrial fibrillation hypertensive chronic kidney disease, unspecified, with chronic kidney disease stage i through stage iv, or unspecified angiodysplasia of intestine (without mention of hemorrhage)
white m 92 $nan$hematology blood hematocrit  39.1  %; hematology blood hemoglobin  13.3  g dl; hematology blood platelet count  213  k ul; chemistry blood anion gap  10  meq l; chemistry blood bicarbonate  29  meq l; chemistry blood chloride  104  meq l; chemistry blood creatinine  1.3  mg dl; chemistry blood potassium  4.0  meq l; chemistry blood sodium  139  meq l; chemistry blood urea nitrogen  21  mg dl; chemistry blood calcium, total  9.3  mg dl; chemistry blood glucose  98  mg dl$amlodipine  5  mg ; finasteride  5  mg ; furosemide  20  mg ; potassium chloride  10  meq ; vitamin d  400  unit ; ferrous sulfate  325  mg ; omeprazole  20  mg ; levothyroxine sodium  150  mcg ; pneumococcal vac polyvalent  0.5  ml ; sodium chloride 0.9%  flush  3  ml ; lorazepam  0.5-1  mg ; senna  1  tab ; acetaminophen  325-650  mg ; buspirone  10  mg ; docusate sodium  100  mg ; tamsulosin  0.4  mg ; venlafaxine  37.5  mg ; heparin  5000  unit ; 
atrial fibrillation altered mental status unspecified fall open wound of elbow, without mention of complication other specified metabolic disorders unspecified essential hypertension atrial fibrillation diverticulosis of colon (without mention of hemorrhage) unspecified acquired hypothyroidism iron deficiency anemia, unspecified observation following other accident person boarding or alighting from bus injured in collision with pedal cycle hypertrophy (benign) of prostate without urinary obstruction and other lower urinary tract symptom (luts) bronchiectasis without acute exacerbation depressive disorder, not elsewhere classified other specified cardiac dysrhythmias fall from other slipping, tripping, or stumbling unspecified essential hypertension barrett's esophagus unspecified essential hypertension iron deficiency anemia secondary to blood loss (chronic) atrial fibrillation depressive disorder, not elsewhere classified hypertrophy (benign) of prostate without urinary obstruction and other lower urinary tract symptom (luts) unspecified acquired hypothyroidism hemorrhage of gastrointestinal tract, unspecified acute posthemorrhagic anemia diverticulosis of colon (without mention of hemorrhage) bronchiectasis without acute exacerbation barrett's esophagus iron deficiency anemia secondary to blood loss (chronic) hypertensive chronic kidney disease, unspecified, with chronic kidney disease stage i through stage iv, or unspecified chronic kidney disease, unspecified atrial fibrillation hemorrhage of gastrointestinal tract, unspecified hypertrophy (benign) of prostate without urinary obstruction and other lower urinary tract symptom (luts) unspecified acquired hypothyroidism depressive disorder, not elsewhere classified long-term (current) use of anticoagulants acute kidney failure, unspecified diverticulosis of colon (without mention of hemorrhage) barrett's esophagus hemorrhage of gastrointestinal tract, unspecified abnormality of gait lumbago atrial fibrillation hypertensive chronic kidney disease, unspecified, with chronic kidney disease stage i through stage iv, or unspecified angiodysplasia of intestine (without mention of hemorrhage)
white m 92 $nan$nan$amlodipine  5  mg ; finasteride  5  mg ; furosemide  20  mg ; vitamin d  400  unit ; ferrous sulfate  325  mg ; omeprazole  20  mg ; levothyroxine sodium  150  mcg ; pneumococcal vac polyvalent  0.5  ml ; sodium chloride 0.9%  flush  3  ml ; lorazepam  0.5-1  mg ; senna  1  tab ; acetaminophen  325-650  mg ; buspirone  10  mg ; docusate sodium  100  mg ; tamsulosin  0.4  mg ; venlafaxine  37.5  mg ; heparin  5000  unit ; 
atrial fibrillation altered mental status unspecified fall open wound of elbow, without mention of complication other specified metabolic disorders unspecified essential hypertension atrial fibrillation diverticulosis of colon (without mention of hemorrhage) unspecified acquired hypothyroidism iron deficiency anemia, unspecified observation following other accident person boarding or alighting from bus injured in collision with pedal cycle hypertrophy (benign) of prostate without urinary obstruction and other lower urinary tract symptom (luts) bronchiectasis without acute exacerbation depressive disorder, not elsewhere classified other specified cardiac dysrhythmias fall from other slipping, tripping, or stumbling unspecified essential hypertension barrett's esophagus unspecified essential hypertension iron deficiency anemia secondary to blood loss (chronic) atrial fibrillation depressive disorder, not elsewhere classified hypertrophy (benign) of prostate without urinary obstruction and other lower urinary tract symptom (luts) unspecified acquired hypothyroidism hemorrhage of gastrointestinal tract, unspecified acute posthemorrhagic anemia diverticulosis of colon (without mention of hemorrhage) bronchiectasis without acute exacerbation barrett's esophagus iron deficiency anemia secondary to blood loss (chronic) hypertensive chronic kidney disease, unspecified, with chronic kidney disease stage i through stage iv, or unspecified chronic kidney disease, unspecified atrial fibrillation hemorrhage of gastrointestinal tract, unspecified hypertrophy (benign) of prostate without urinary obstruction and other lower urinary tract symptom (luts) unspecified acquired hypothyroidism depressive disorder, not elsewhere classified long-term (current) use of anticoagulants acute kidney failure, unspecified diverticulosis of colon (without mention of hemorrhage) barrett's esophagus hemorrhage of gastrointestinal tract, unspecified abnormality of gait lumbago atrial fibrillation hypertensive chronic kidney disease, unspecified, with chronic kidney disease stage i through stage iv, or unspecified angiodysplasia of intestine (without mention of hemorrhage)
other f 22 $temp  100.1  heartrate  90.0  resprate  16.0  o2sat  99.0  sbp  120.0  dbp  78.0  rhythm    pain  2  $hematology blood hematocrit  35.9  %; hematology blood hemoglobin  12.2  g dl; hematology blood platelet count  180  k ul$sodium chloride 0.9%  flush  3  ml ; oxycodone (immediate release)   5  mg ; 5% dextrose  50  ml ; clindamycin  900  mg ; lactated ringers  1000  ml ; ondansetron  4-8  mg ; soln  100  ml ; acetaminophen iv  1000  mg ; docusate sodium  100  mg ; bisacodyl  10  mg ; polyethylene glycol  17  g ; acetaminophen  500-1000  mg ; ibuprofen  600  mg ; 
 
other f 22 $nan$hematology blood hematocrit  35.0  %; hematology blood hemoglobin  11.8  g dl; hematology blood platelet count  179  k ul; hematology blood inr(pt)  1.6  $sodium chloride 0.9%  flush  3  ml ; oxycodone (immediate release)   5  mg ; 5% dextrose  50  ml ; clindamycin  900  mg ; lactated ringers  1000  ml ; ondansetron  4-8  mg ; docusate sodium  100  mg ; bisacodyl  10  mg ; polyethylene glycol  17  g ; acetaminophen  500-1000  mg ; ibuprofen  600  mg ; 5% dextrose  150  ml ; gentamicin sulfate  300  mg ; 
 
other f 22 $nan$hematology blood hematocrit  34.5  %; hematology blood hemoglobin  11.7  g dl; hematology blood platelet count  188  k ul; hematology blood inr(pt)  1.3  $sodium chloride 0.9%  flush  3  ml ; oxycodone (immediate release)   5  mg ; 5% dextrose  50  ml ; clindamycin  900  mg ; ondansetron  4-8  mg ; docusate sodium  100  mg ; bisacodyl  10  mg ; polyethylene glycol  17  g ; acetaminophen  500-1000  mg ; ibuprofen  600  mg ; 5% dextrose  150  ml ; gentamicin sulfate  300  mg ; doxycycline hyclate  100  mg ; metronidazole (flagyl)  500  mg ; 
 
other f 22 $nan$hematology blood hematocrit  35.1  %; hematology blood hemoglobin  11.7  g dl; hematology blood platelet count  207  k ul$sodium chloride 0.9%  flush  3  ml ; oxycodone (immediate release)   5  mg ; ondansetron  4-8  mg ; docusate sodium  100  mg ; bisacodyl  10  mg ; polyethylene glycol  17  g ; acetaminophen  500-1000  mg ; ibuprofen  600  mg ; doxycycline hyclate  100  mg ; metronidazole (flagyl)  500  mg ; 
 
white f 40 $temp  98.3  heartrate  72.0  resprate  16.0  o2sat  98.0  sbp  109.0  dbp  63.0  rhythm    pain  8 10  $hematology blood hematocrit  25.7  %; hematology blood hemoglobin  8.1  g dl; hematology blood platelet count  548  k ul; chemistry blood anion gap  16  meq l; chemistry blood bicarbonate  30  meq l; chemistry blood chloride  100  meq l; chemistry blood creatinine  1.4  mg dl; chemistry blood potassium  4.3  meq l; chemistry blood sodium  142  meq l; chemistry blood urea nitrogen  23  mg dl; hematology blood inr(pt)  1.1  ; chemistry urine chloride, urine  57  meq l; chemistry urine creatinine, urine  48  mg dl; chemistry urine potassium, urine  17  meq l; chemistry urine sodium, urine  69  meq l; chemistry urine urea nitrogen, urine  228  mg dl; chemistry blood calcium, total  9.4  mg dl; chemistry blood bilirubin, total  0.3  mg dl; chemistry blood glucose  105  mg dl$sodium chloride 0.9%  flush  3  ml ; acetaminophen  500  mg ; aspirin  81  mg ; diazepam  2  mg ; gabapentin  300  mg ; hydromorphone (dilaudid)  4-8  mg ; oxycodone sr (oxycontin)  20  mg ; pantoprazole  40  mg ; hydromorphone (dilaudid)  1-2  mg ; bisacodyl  10  mg ; heparin  1800-3600  unit ; 0.9% sodium chloride  250  ml ; heparin sodium  25,000  unit ; docusate sodium  100  mg ; senna  8.6  mg ; desvenlafaxine  100  mg ; warfarin  5  mg ; warfarin  2.5  mg ; 
accidents occurring in residential institution anxiety state, unspecified surgical operation with anastomosis, bypass, or graft, with natural or artificial tissues used as implant causing abnormal patient reaction, or later complication, without mention of misadventure at time of operation depressive disorder, not elsewhere classified other chronic nonalcoholic liver disease esophageal reflux unspecified essential hypertension obstructive sleep apnea (adult)(pediatric) pedal cycle passenger injured in collision with railway train or railway vehicle in nontraffic accident congenital subluxation of hip, unilateral migraine, unspecified, without mention of intractable migraine without mention of status migrainosus pain in joint, pelvic region and thigh other complications due to other internal orthopedic device, implant, and graft unspecified drug dependence, continuous personal history of surgery to heart and great vessels, presenting hazards to health other congenital deformity of hip (joint) obstructive sleep apnea (adult)(pediatric) methicillin susceptible staphylococcus aureus in conditions classified elsewhere and of unspecified site obesity, unspecified unspecified essential hypertension depressive disorder, not elsewhere classified esophageal reflux other postoperative infection other specified surgical operations and procedures causing abnormal patient reaction, or later complication, without mention of misadventure at time of operation anxiety state, unspecified other chronic nonalcoholic liver disease other disorders of lipoid metabolism body mass index 32.0-32.9, adult migraine, unspecified, without mention of intractable migraine without mention of status migrainosus obstructive sleep apnea (adult)(pediatric) other chronic nonalcoholic liver disease other acute postoperative pain personal history of surgery to heart and great vessels, presenting hazards to health depressive disorder, not elsewhere classified other iatrogenic hypotension chondromalacia pedal cycle passenger injured in collision with railway train or railway vehicle in nontraffic accident unspecified essential hypertension other congenital deformity of hip (joint) anxiety state, unspecified esophageal reflux 
white f 40 $nan$hematology blood hematocrit  27.4  %; hematology blood hemoglobin  8.5  g dl; hematology blood platelet count  509  k ul; chemistry blood anion gap  15  meq l; chemistry blood bicarbonate  28  meq l; chemistry blood chloride  102  meq l; chemistry blood creatinine  1.2  mg dl; chemistry blood potassium  3.9  meq l; chemistry blood sodium  141  meq l; chemistry blood urea nitrogen  22  mg dl; hematology blood inr(pt)  1.1  ; chemistry blood calcium, total  9.3  mg dl; chemistry blood glucose  112  mg dl$sodium chloride 0.9%  flush  3  ml ; acetaminophen  500  mg ; aspirin  81  mg ; diazepam  2  mg ; gabapentin  300  mg ; hydromorphone (dilaudid)  4-8  mg ; oxycodone sr (oxycontin)  20  mg ; pantoprazole  40  mg ; bisacodyl  10  mg ; heparin  1800-3600  unit ; 0.9% sodium chloride  250  ml ; heparin sodium  25,000  unit ; docusate sodium  100  mg ; senna  8.6  mg ; desvenlafaxine  100  mg ; warfarin  2.5  mg ; enoxaparin sodium  100  mg ; docusate sodium  200  mg ; 
accidents occurring in residential institution anxiety state, unspecified surgical operation with anastomosis, bypass, or graft, with natural or artificial tissues used as implant causing abnormal patient reaction, or later complication, without mention of misadventure at time of operation depressive disorder, not elsewhere classified other chronic nonalcoholic liver disease esophageal reflux unspecified essential hypertension obstructive sleep apnea (adult)(pediatric) pedal cycle passenger injured in collision with railway train or railway vehicle in nontraffic accident congenital subluxation of hip, unilateral migraine, unspecified, without mention of intractable migraine without mention of status migrainosus pain in joint, pelvic region and thigh other complications due to other internal orthopedic device, implant, and graft unspecified drug dependence, continuous personal history of surgery to heart and great vessels, presenting hazards to health other congenital deformity of hip (joint) obstructive sleep apnea (adult)(pediatric) methicillin susceptible staphylococcus aureus in conditions classified elsewhere and of unspecified site obesity, unspecified unspecified essential hypertension depressive disorder, not elsewhere classified esophageal reflux other postoperative infection other specified surgical operations and procedures causing abnormal patient reaction, or later complication, without mention of misadventure at time of operation anxiety state, unspecified other chronic nonalcoholic liver disease other disorders of lipoid metabolism body mass index 32.0-32.9, adult migraine, unspecified, without mention of intractable migraine without mention of status migrainosus obstructive sleep apnea (adult)(pediatric) other chronic nonalcoholic liver disease other acute postoperative pain personal history of surgery to heart and great vessels, presenting hazards to health depressive disorder, not elsewhere classified other iatrogenic hypotension chondromalacia pedal cycle passenger injured in collision with railway train or railway vehicle in nontraffic accident unspecified essential hypertension other congenital deformity of hip (joint) anxiety state, unspecified esophageal reflux 
white f 40 $nan$hematology blood hematocrit  26.7  %; hematology blood hemoglobin  8.5  g dl; hematology blood platelet count  502  k ul; chemistry blood anion gap  12  meq l; chemistry blood bicarbonate  32  meq l; chemistry blood chloride  100  meq l; chemistry blood creatinine  1.1  mg dl; chemistry blood potassium  4.3  meq l; chemistry blood sodium  140  meq l; chemistry blood urea nitrogen  17  mg dl; hematology blood inr(pt)  1.2  ; chemistry blood calcium, total  9.8  mg dl; chemistry blood glucose  88  mg dl$sodium chloride 0.9%  flush  3  ml ; acetaminophen  500  mg ; aspirin  81  mg ; diazepam  2  mg ; gabapentin  300  mg ; hydromorphone (dilaudid)  4-8  mg ; pantoprazole  40  mg ; senna  8.6  mg ; desvenlafaxine  100  mg ; enoxaparin sodium  100  mg ; docusate sodium  200  mg ; oxycodone sr (oxycontin)  30  mg ; 
accidents occurring in residential institution anxiety state, unspecified surgical operation with anastomosis, bypass, or graft, with natural or artificial tissues used as implant causing abnormal patient reaction, or later complication, without mention of misadventure at time of operation depressive disorder, not elsewhere classified other chronic nonalcoholic liver disease esophageal reflux unspecified essential hypertension obstructive sleep apnea (adult)(pediatric) pedal cycle passenger injured in collision with railway train or railway vehicle in nontraffic accident congenital subluxation of hip, unilateral migraine, unspecified, without mention of intractable migraine without mention of status migrainosus pain in joint, pelvic region and thigh other complications due to other internal orthopedic device, implant, and graft unspecified drug dependence, continuous personal history of surgery to heart and great vessels, presenting hazards to health other congenital deformity of hip (joint) obstructive sleep apnea (adult)(pediatric) methicillin susceptible staphylococcus aureus in conditions classified elsewhere and of unspecified site obesity, unspecified unspecified essential hypertension depressive disorder, not elsewhere classified esophageal reflux other postoperative infection other specified surgical operations and procedures causing abnormal patient reaction, or later complication, without mention of misadventure at time of operation anxiety state, unspecified other chronic nonalcoholic liver disease other disorders of lipoid metabolism body mass index 32.0-32.9, adult migraine, unspecified, without mention of intractable migraine without mention of status migrainosus obstructive sleep apnea (adult)(pediatric) other chronic nonalcoholic liver disease other acute postoperative pain personal history of surgery to heart and great vessels, presenting hazards to health depressive disorder, not elsewhere classified other iatrogenic hypotension chondromalacia pedal cycle passenger injured in collision with railway train or railway vehicle in nontraffic accident unspecified essential hypertension other congenital deformity of hip (joint) anxiety state, unspecified esophageal reflux 
white f 40 $nan$hematology blood hematocrit  26.6  %; hematology blood hemoglobin  8.4  g dl; hematology blood platelet count  452  k ul; chemistry blood anion gap  16  meq l; chemistry blood bicarbonate  27  meq l; chemistry blood chloride  101  meq l; chemistry blood creatinine  1.1  mg dl; chemistry blood potassium  4.4  meq l; chemistry blood sodium  140  meq l; chemistry blood urea nitrogen  17  mg dl; hematology blood inr(pt)  1.3  ; chemistry blood calcium, total  9.5  mg dl; chemistry blood glucose  98  mg dl$sodium chloride 0.9%  flush  3  ml ; acetaminophen  500  mg ; aspirin  81  mg ; diazepam  2  mg ; gabapentin  300  mg ; hydromorphone (dilaudid)  4-8  mg ; pantoprazole  40  mg ; senna  8.6  mg ; desvenlafaxine  100  mg ; enoxaparin sodium  100  mg ; docusate sodium  200  mg ; oxycodone sr (oxycontin)  30  mg ; acetaminophen  650  mg ; oxycodone sr (oxycontin)  10  mg ; 
accidents occurring in residential institution anxiety state, unspecified surgical operation with anastomosis, bypass, or graft, with natural or artificial tissues used as implant causing abnormal patient reaction, or later complication, without mention of misadventure at time of operation depressive disorder, not elsewhere classified other chronic nonalcoholic liver disease esophageal reflux unspecified essential hypertension obstructive sleep apnea (adult)(pediatric) pedal cycle passenger injured in collision with railway train or railway vehicle in nontraffic accident congenital subluxation of hip, unilateral migraine, unspecified, without mention of intractable migraine without mention of status migrainosus pain in joint, pelvic region and thigh other complications due to other internal orthopedic device, implant, and graft unspecified drug dependence, continuous personal history of surgery to heart and great vessels, presenting hazards to health other congenital deformity of hip (joint) obstructive sleep apnea (adult)(pediatric) methicillin susceptible staphylococcus aureus in conditions classified elsewhere and of unspecified site obesity, unspecified unspecified essential hypertension depressive disorder, not elsewhere classified esophageal reflux other postoperative infection other specified surgical operations and procedures causing abnormal patient reaction, or later complication, without mention of misadventure at time of operation anxiety state, unspecified other chronic nonalcoholic liver disease other disorders of lipoid metabolism body mass index 32.0-32.9, adult migraine, unspecified, without mention of intractable migraine without mention of status migrainosus obstructive sleep apnea (adult)(pediatric) other chronic nonalcoholic liver disease other acute postoperative pain personal history of surgery to heart and great vessels, presenting hazards to health depressive disorder, not elsewhere classified other iatrogenic hypotension chondromalacia pedal cycle passenger injured in collision with railway train or railway vehicle in nontraffic accident unspecified essential hypertension other congenital deformity of hip (joint) anxiety state, unspecified esophageal reflux 
white f 40 $nan$nan$sodium chloride 0.9%  flush  3  ml ; aspirin  81  mg ; diazepam  2  mg ; gabapentin  300  mg ; hydromorphone (dilaudid)  4-8  mg ; pantoprazole  40  mg ; senna  8.6  mg ; desvenlafaxine  100  mg ; enoxaparin sodium  100  mg ; docusate sodium  200  mg ; acetaminophen  650  mg ; oxycodone sr (oxycontin)  10  mg ; 
accidents occurring in residential institution anxiety state, unspecified surgical operation with anastomosis, bypass, or graft, with natural or artificial tissues used as implant causing abnormal patient reaction, or later complication, without mention of misadventure at time of operation depressive disorder, not elsewhere classified other chronic nonalcoholic liver disease esophageal reflux unspecified essential hypertension obstructive sleep apnea (adult)(pediatric) pedal cycle passenger injured in collision with railway train or railway vehicle in nontraffic accident congenital subluxation of hip, unilateral migraine, unspecified, without mention of intractable migraine without mention of status migrainosus pain in joint, pelvic region and thigh other complications due to other internal orthopedic device, implant, and graft unspecified drug dependence, continuous personal history of surgery to heart and great vessels, presenting hazards to health other congenital deformity of hip (joint) obstructive sleep apnea (adult)(pediatric) methicillin susceptible staphylococcus aureus in conditions classified elsewhere and of unspecified site obesity, unspecified unspecified essential hypertension depressive disorder, not elsewhere classified esophageal reflux other postoperative infection other specified surgical operations and procedures causing abnormal patient reaction, or later complication, without mention of misadventure at time of operation anxiety state, unspecified other chronic nonalcoholic liver disease other disorders of lipoid metabolism body mass index 32.0-32.9, adult migraine, unspecified, without mention of intractable migraine without mention of status migrainosus obstructive sleep apnea (adult)(pediatric) other chronic nonalcoholic liver disease other acute postoperative pain personal history of surgery to heart and great vessels, presenting hazards to health depressive disorder, not elsewhere classified other iatrogenic hypotension chondromalacia pedal cycle passenger injured in collision with railway train or railway vehicle in nontraffic accident unspecified essential hypertension other congenital deformity of hip (joint) anxiety state, unspecified esophageal reflux 
white m 83 $nan$hematology blood hematocrit  36.2  %; hematology blood hematocrit  36.7  %; hematology blood hematocrit  39.3  %; hematology blood hemoglobin  12.7  g dl; hematology blood hemoglobin  13.5  g dl; hematology blood platelet count  217  k ul; hematology blood platelet count  229  k ul; chemistry blood anion gap  8  meq l; chemistry blood bicarbonate  24  meq l; chemistry blood chloride  102  meq l; chemistry blood creatinine  0.7  mg dl; chemistry blood potassium  3.4  meq l; chemistry blood sodium  131  meq l; chemistry blood urea nitrogen  11  mg dl; chemistry blood bilirubin, total  0.6  mg dl; chemistry blood glucose  83  mg dl; chemistry blood lactate dehydrogenase (ld)  157  iu l$sodium chloride 0.9%  flush  3  ml ; acetaminophen  325-650  mg ; senna  2  tab ; docusate sodium  100  mg ; trazodone  25  mg ; heparin  5000  unit ; aripiprazole  10  mg ; olanzapine  10  mg ; colchicine  0.6  mg ; ibuprofen  600  mg ; omeprazole  20  mg ; multivitamins  1  tab ; potassium chloride  40  meq ; neutra-phos  1  pkt ; calcium carbonate  500  mg ; 
 
white m 83 $nan$nan$sodium chloride 0.9%  flush  3  ml ; acetaminophen  325-650  mg ; senna  2  tab ; docusate sodium  100  mg ; trazodone  25  mg ; heparin  5000  unit ; aripiprazole  10  mg ; olanzapine  10  mg ; colchicine  0.6  mg ; ibuprofen  600  mg ; omeprazole  20  mg ; multivitamins  1  tab ; potassium chloride  40  meq ; neutra-phos  1  pkt ; calcium carbonate  500  mg ; 
 
white m 40 $nan$hematology blood hematocrit  38.5  %; hematology blood hemoglobin  12.5  g dl; hematology blood platelet count  345  k ul; chemistry blood anion gap  13  meq l; chemistry blood bicarbonate  27  meq l; chemistry blood chloride  107  meq l; chemistry blood creatinine  0.9  mg dl; chemistry blood potassium  4.0  meq l; chemistry blood sodium  143  meq l; chemistry blood urea nitrogen  19  mg dl; chemistry blood calcium, total  9.0  mg dl; chemistry blood glucose  84  mg dl$heparin  5000  unit ; 1 2 ns  1000  ml ; sodium chloride 0.9%  flush  3  ml ; multivitamin iv  10  ml ; thiamine  100  mg ; 0.9% sodium chloride  1000  ml ; folic acid  1  mg ; potassium chloride  60  meq ; diazepam  5  mg ; senna  1  tab ; polyethylene glycol  17  g ; acetaminophen  325-650  mg ; cyanocobalamin  1000  mcg ; 
 
white m 40 $nan$hematology blood hematocrit  38.7  %; hematology blood hemoglobin  13.2  g dl; hematology blood platelet count  314  k ul; chemistry blood anion gap  14  meq l; chemistry blood bicarbonate  28  meq l; chemistry blood chloride  105  meq l; chemistry blood creatinine  0.9  mg dl; chemistry blood potassium  3.5  meq l; chemistry blood sodium  143  meq l; chemistry blood urea nitrogen  17  mg dl; chemistry blood calcium, total  9.2  mg dl; chemistry blood glucose  95  mg dl$heparin  5000  unit ; sodium chloride 0.9%  flush  3  ml ; potassium chloride  60  meq ; diazepam  5  mg ; senna  1  tab ; polyethylene glycol  17  g ; acetaminophen  325-650  mg ; cyanocobalamin  1000  mcg ; docusate sodium  100  mg ; 
 
white m 69 $nan$hematology blood hematocrit  34.7  %; hematology blood hemoglobin  11.5  g dl; hematology blood platelet count  403  k ul; chemistry blood anion gap  10  meq l; chemistry blood bicarbonate  32  meq l; chemistry blood chloride  89  meq l; chemistry blood creatinine  1.2  mg dl; chemistry blood potassium  5.5  meq l; chemistry blood sodium  125  meq l; chemistry blood urea nitrogen  14  mg dl; chemistry blood calcium, total  8.7  mg dl; chemistry blood glucose  93  mg dl$sodium chloride 0.9%  flush  3  ml ; guaifenesin-codeine phosphate  5-10  ml ; ibuprofen  200  mg ; benzonatate  100  mg ; clonidine  0.2  mg ; 
nausea alone secondary malignant neoplasm of lung loss of weight personal history of antineoplastic chemotherapy person on outside of bus injured in collision with pedestrian or animal in traffic accident personal history of malignant neoplasm of kidney acquired absence of kidney examination of participant in clinical trial
white m 69 $nan$nan$sodium chloride 0.9%  flush  3  ml ; guaifenesin-codeine phosphate  5-10  ml ; ibuprofen  200  mg ; benzonatate  100  mg ; clonidine  0.2  mg ; tamsulosin  0.4  mg ; 
nausea alone secondary malignant neoplasm of lung loss of weight personal history of antineoplastic chemotherapy person on outside of bus injured in collision with pedestrian or animal in traffic accident personal history of malignant neoplasm of kidney acquired absence of kidney examination of participant in clinical trial
unknown f 36 $nan$hematology blood hematocrit  37.8  %; hematology blood hemoglobin  12.5  g dl; hematology blood platelet count  240  k ul$sodium chloride 0.9%  flush  3  ml ; lactated ringers  1000  ml ; docusate sodium  100  mg ; bisacodyl  10  mg ; milk of magnesia  30  ml ; simethicone  80  mg ; calcium carbonate  500  mg ; influenza vaccine quadrivalent  0.5  ml ; ibuprofen  600  mg ; acetaminophen  500-1000  mg ; tetanus-diphtox-acellular pertuss (adacel)  0.5  ml ; dermoplast spray  1  spry ; oxycodone (immediate release)   5-10  mg ; 
 
unknown f 36 $nan$nan$sodium chloride 0.9%  flush  3  ml ; lactated ringers  1000  ml ; docusate sodium  100  mg ; bisacodyl  10  mg ; milk of magnesia  30  ml ; simethicone  80  mg ; calcium carbonate  500  mg ; influenza vaccine quadrivalent  0.5  ml ; ibuprofen  600  mg ; acetaminophen  500-1000  mg ; tetanus-diphtox-acellular pertuss (adacel)  0.5  ml ; dermoplast spray  1  spry ; oxycodone (immediate release)   5-10  mg ; 
 
unknown f 36 $nan$nan$sodium chloride 0.9%  flush  3  ml ; lactated ringers  1000  ml ; docusate sodium  100  mg ; bisacodyl  10  mg ; milk of magnesia  30  ml ; simethicone  80  mg ; calcium carbonate  500  mg ; influenza vaccine quadrivalent  0.5  ml ; ibuprofen  600  mg ; acetaminophen  500-1000  mg ; tetanus-diphtox-acellular pertuss (adacel)  0.5  ml ; dermoplast spray  1  spry ; oxycodone (immediate release)   5-10  mg ; 
 
other m 74 $nan$hematology blood hematocrit  35.2  %; hematology blood hemoglobin  10.3  g dl; hematology blood platelet count  214  k ul; chemistry blood creatinine  2.5  mg dl; chemistry blood urea nitrogen  51  mg dl; hematology blood inr(pt)  3.3  ; hematology urine wbc  0-2  # hpf; chemistry blood bilirubin, total  2.1  mg dl; blood gas blood free calcium  1.00  mmol l; blood gas blood lactate  7.3  mmol l; blood gas blood lactate  6.0  mmol l; blood gas blood lactate  7.8  mmol l; blood gas blood chloride, whole blood  105  meq l; blood gas blood chloride, whole blood  108  meq l; blood gas blood glucose  160  mg dl; blood gas blood glucose  160  mg dl; blood gas blood potassium, whole blood  5.9  meq l; blood gas blood potassium, whole blood  7.1  meq l; blood gas blood potassium, whole blood  7.0  meq l; blood gas blood sodium, whole blood  142  meq l; blood gas blood sodium, whole blood  141  meq l; hematology urine glucose  neg  mg dl; blood gas blood calculated bicarbonate, whole blood  15  meq l; hematology urine bilirubin  neg  mg dl$nan
 
other m 74 $nan$hematology blood hematocrit  34.1  %; hematology blood hematocrit  29.3  %; hematology blood hemoglobin  10.1  g dl; hematology blood hemoglobin  9.0  g dl; hematology blood platelet count  230  k ul; hematology blood platelet count  177  k ul; chemistry blood anion gap  19  meq l; chemistry blood anion gap  21  meq l; chemistry blood anion gap  18  meq l; chemistry blood anion gap  26  meq l; chemistry blood bicarbonate  19  meq l; chemistry blood bicarbonate  15  meq l; chemistry blood bicarbonate  20  meq l; chemistry blood bicarbonate  16  meq l; chemistry blood chloride  106  meq l; chemistry blood chloride  113  meq l; chemistry blood chloride  115  meq l; chemistry blood chloride  109  meq l; chemistry blood creatinine  2.6  mg dl; chemistry blood creatinine  2.7  mg dl; chemistry blood creatinine  2.7  mg dl; chemistry blood creatinine  2.8  mg dl; chemistry blood potassium  5.9  meq l; chemistry blood potassium  6.3  meq l; chemistry blood potassium  6.7  meq l; chemistry blood potassium  6.1  meq l; chemistry blood sodium  138  meq l; chemistry blood sodium  142  meq l; chemistry blood sodium  147  meq l; chemistry blood sodium  145  meq l; chemistry blood urea nitrogen  53  mg dl; chemistry blood urea nitrogen  53  mg dl; chemistry blood urea nitrogen  53  mg dl; chemistry blood urea nitrogen  57  mg dl; hematology blood inr(pt)  3.1  ; hematology blood inr(pt)  3.1  ; hematology blood inr(pt)  3.1  ; chemistry urine chloride, urine  14  meq l; chemistry urine creatinine, urine  108  mg dl; chemistry urine potassium, urine  89  meq l; chemistry urine sodium, urine  12  meq l; chemistry urine urea nitrogen, urine  248  mg dl; hematology urine wbc  5  # hpf; chemistry blood calcium, total  7.9  mg dl; chemistry blood calcium, total  7.2  mg dl; chemistry blood calcium, total  7.2  mg dl; chemistry blood bilirubin, total  2.0  mg dl; chemistry blood bilirubin, total  1.7  mg dl; chemistry blood bilirubin, total  1.6  mg dl; chemistry blood glucose  197  mg dl; chemistry blood glucose  177  mg dl; chemistry blood glucose  128  mg dl; chemistry blood glucose  158  mg dl; chemistry blood lactate dehydrogenase (ld)  16860  iu l; chemistry blood lactate dehydrogenase (ld)  14274  iu l; chemistry blood albumin  2.8  g dl; hematology blood bands  0  %; blood gas blood free calcium  1.12  mmol l; blood gas blood free calcium  1.06  mmol l; blood gas blood free calcium  1.09  mmol l; blood gas blood free calcium  1.07  mmol l; blood gas blood free calcium  1.07  mmol l; blood gas blood free calcium  1.06  mmol l; blood gas blood lactate  2.8  mmol l; blood gas blood lactate  1.8  mmol l; blood gas blood lactate  1.7  mmol l; blood gas blood lactate  1.8  mmol l; blood gas blood lactate  1.6  mmol l; blood gas blood lactate  1.7  mmol l; blood gas blood lactate  2.2  mmol l; blood gas blood chloride, whole blood  111  meq l; blood gas blood glucose  124  mg dl; blood gas blood glucose  189  mg dl; blood gas blood glucose  161  mg dl; blood gas blood glucose  156  mg dl; blood gas blood glucose  191  mg dl; blood gas blood glucose  179  mg dl; blood gas blood potassium, whole blood  5.8  meq l; blood gas blood potassium, whole blood  5.9  meq l; blood gas blood potassium, whole blood  5.9  meq l; blood gas blood potassium, whole blood  6.2  meq l; blood gas blood potassium, whole blood  6.4  meq l; blood gas blood potassium, whole blood  6.3  meq l; blood gas blood sodium, whole blood  142  meq l; blood gas blood sodium, whole blood  142  meq l; blood gas blood sodium, whole blood  142  meq l$5% dextrose  50  ml ; iso-osmotic dextrose  200  ml ; meropenem  500  mg ; 5% dextrose  200  ml ; 0.45% sodium chloride  1000  ml ; influenza virus vaccine  0.5  ml ; pneumococcal vac polyvalent  0.5  ml ; propofol  1000  mg ; propofol  200  mg ; 5% dextrose  250  ml ; norepinephrine  8  mg ; miconazole powder 2%  1  appl ; vancomycin  1000  mg ; albuterol inhaler  1  puff ; dextrose 50%  12.5  gm ; glucagon  1  mg ; insulin  0  unit ; hydrocortisone na succ.  100  mg ; soln  50  ml ; fentanyl citrate  2.5  mg ; 0.9% sodium chloride  100  ml ; midazolam  100  mg ; dextrose 5%  150  ml ; levofloxacin  750  mg ; acetylcysteine (iv)  12,250  mg ; acetylcysteine (iv)  4085  mg ; 5% dextrose  500  ml ; acetylcysteine (iv)  8165  mg ; oseltamivir  75  mg ; calcium gluconate  2  g ; insulin  10  unit ; dextrose 50%  25  gm ; famotidine  20  mg ; ipratropium bromide mdi  2  puff ; thiamine  100  mg ; ipratropium bromide mdi  8  puff ; albuterol inhaler  8  puff ; sodium polystyrene sulfonate  30  gm ; sodium bicarbonate  50  meq ; vecuronium bromide  10  mg ; cisatracurium besylate  100  mg ; sodium bicarbonate  100  meq ; iso-osmotic dextrose  50  ml ; aztreonam  1000  mg ; acetylcysteine (iv)  15,000  mg ; 5% dextrose  1000  ml ; sodium bicarbonate  150  meq ; 0.9% sodium chloride  1000  ml ; phytonadione  5  mg ; 0.9% sodium chloride (mini bag plus)  100  ml ; hydrocortisone na succ.  50  mg ; iso-osmotic sodium chloride  50  ml ; meropenem  1000  mg ; 5% dextrose  150  ml ; vancomycin  500  mg ; 
 
other m 74 $nan$nan$5% dextrose  50  ml ; iso-osmotic dextrose  200  ml ; influenza virus vaccine  0.5  ml ; pneumococcal vac polyvalent  0.5  ml ; 5% dextrose  250  ml ; norepinephrine  8  mg ; miconazole powder 2%  1  appl ; vancomycin  1000  mg ; dextrose 50%  12.5  gm ; glucagon  1  mg ; insulin  0  unit ; 0.9% sodium chloride  100  ml ; midazolam  100  mg ; 5% dextrose  500  ml ; acetylcysteine (iv)  8165  mg ; oseltamivir  75  mg ; calcium gluconate  2  g ; insulin  10  unit ; dextrose 50%  25  gm ; thiamine  100  mg ; ipratropium bromide mdi  8  puff ; albuterol inhaler  8  puff ; sodium polystyrene sulfonate  30  gm ; sodium bicarbonate  50  meq ; vecuronium bromide  10  mg ; cisatracurium besylate  100  mg ; sodium bicarbonate  100  meq ; 0.9% sodium chloride  1000  ml ; hydrocortisone na succ.  50  mg ; iso-osmotic sodium chloride  50  ml ; meropenem  1000  mg ; 
 
unknown f 71 $nan$hematology blood hematocrit  33.6  %; hematology blood hematocrit  33.2  %; hematology blood hemoglobin  11.6  g dl; hematology blood hemoglobin  11.7  g dl; hematology blood platelet count  277  k ul; hematology blood platelet count  298  k ul; chemistry blood anion gap  13  meq l; chemistry blood anion gap  17  meq l; chemistry blood bicarbonate  27  meq l; chemistry blood bicarbonate  25  meq l; chemistry blood chloride  101  meq l; chemistry blood chloride  98  meq l; chemistry blood creatinine  0.9  mg dl; chemistry blood creatinine  1.1  mg dl; chemistry blood potassium  3.4  meq l; chemistry blood potassium  4.0  meq l; chemistry blood sodium  138  meq l; chemistry blood sodium  136  meq l; chemistry blood urea nitrogen  20  mg dl; chemistry blood urea nitrogen  24  mg dl; chemistry blood glucose  202  mg dl; chemistry blood glucose  261  mg dl; chemistry blood % hemoglobin a1c  7.2  %$heparin  4000  unit ; heparin  1900  unit ; d5w  250  ml ; heparin sodium  25,000  unit ; influenza virus vaccine  0.5  ml ; sodium chloride 0.9%  flush  3  ml ; albuterol 0.083% neb soln  1  neb ; ipratropium bromide neb  1  neb ; pantoprazole  40  mg ; insulin  0  unit ; furosemide  40  mg ; fluticasone-salmeterol (250 50)   1  inh ; insulin  5  unit ; benicar  40  mg ; metoprolol  25  mg ; insulin  48  unit ; clopidogrel bisulfate  75  mg ; aspirin  81  mg ; diltiazem extended-release  120  mg ; diltiazem extended-release  180  mg ; triamterene-hydrochlorothiazide  1  cap ; simvastatin  40  mg ; potassium chloride  40  meq ; diltiazem extended-release  360  mg ; simvastatin  80  mg ; vitamin d  400  unit ; aspirin  243  mg ; insulin  4  unit ; calcium carbonate  500  mg ; insulin  52  unit ; atropine sulfate  0.5  mg ; 
 
unknown f 71 $nan$hematology blood hematocrit  33.9  %; hematology blood hemoglobin  11.5  g dl; hematology blood platelet count  282  k ul; chemistry blood anion gap  12  meq l; chemistry blood bicarbonate  32  meq l; chemistry blood chloride  99  meq l; chemistry blood creatinine  0.8  mg dl; chemistry blood creatinine  1.1  mg dl; chemistry blood potassium  3.6  meq l; chemistry blood potassium  4.3  meq l; chemistry blood sodium  139  meq l; chemistry blood urea nitrogen  23  mg dl; chemistry blood urea nitrogen  25  mg dl; hematology blood inr(pt)  1.0  ; chemistry blood calcium, total  9.0  mg dl; chemistry blood glucose  119  mg dl$sodium chloride 0.9%  flush  3  ml ; albuterol 0.083% neb soln  1  neb ; ipratropium bromide neb  1  neb ; pantoprazole  40  mg ; furosemide  40  mg ; fluticasone-salmeterol (250 50)   1  inh ; benicar  40  mg ; insulin  48  unit ; clopidogrel bisulfate  75  mg ; diltiazem extended-release  180  mg ; triamterene-hydrochlorothiazide  1  cap ; potassium chloride  40  meq ; diltiazem extended-release  360  mg ; simvastatin  80  mg ; vitamin d  400  unit ; aspirin  243  mg ; calcium carbonate  500  mg ; insulin  52  unit ; atropine sulfate  0.5  mg ; d5w  1000  ml ; sodium bicarbonate  150  meq ; aspirin  325  mg ; pneumococcal vac polyvalent  0.5  ml ; furosemide  10  mg ; furosemide  20  mg ; metoprolol  12.5  mg ; heparin  5000  unit ; 
 
unknown f 71 $nan$hematology blood hematocrit  35.6  %; hematology blood hemoglobin  12.0  g dl; hematology blood platelet count  296  k ul; chemistry blood anion gap  15  meq l; chemistry blood bicarbonate  28  meq l; chemistry blood chloride  99  meq l; chemistry blood creatinine  0.9  mg dl; chemistry blood potassium  4.0  meq l; chemistry blood sodium  138  meq l; chemistry blood urea nitrogen  25  mg dl; chemistry blood calcium, total  8.7  mg dl; chemistry blood glucose  98  mg dl$sodium chloride 0.9%  flush  3  ml ; albuterol 0.083% neb soln  1  neb ; ipratropium bromide neb  1  neb ; pantoprazole  40  mg ; fluticasone-salmeterol (250 50)   1  inh ; benicar  40  mg ; insulin  48  unit ; clopidogrel bisulfate  75  mg ; triamterene-hydrochlorothiazide  1  cap ; simvastatin  80  mg ; vitamin d  400  unit ; calcium carbonate  500  mg ; insulin  52  unit ; atropine sulfate  0.5  mg ; d5w  1000  ml ; sodium bicarbonate  150  meq ; aspirin  325  mg ; pneumococcal vac polyvalent  0.5  ml ; furosemide  10  mg ; furosemide  20  mg ; metoprolol  12.5  mg ; heparin  5000  unit ; 
 
white m 63 $nan$hematology blood hematocrit  23.8  %; hematology blood hemoglobin  8.3  g dl; hematology blood platelet count  286  k ul; chemistry blood anion gap  14  meq l; chemistry blood bicarbonate  29  meq l; chemistry blood chloride  98  meq l; chemistry blood creatinine  1.1  mg dl; chemistry blood potassium  3.9  meq l; chemistry blood sodium  137  meq l; chemistry blood urea nitrogen  31  mg dl; chemistry blood calcium, total  8.8  mg dl; chemistry blood bilirubin, total  0.2  mg dl; chemistry blood glucose  114  mg dl; chemistry blood albumin  3.6  g dl; hematology blood bands  0  %; blood gas blood lactate  0.8  mmol l$nan
 
white m 63 $nan$hematology blood hematocrit  24.3  %; hematology blood hemoglobin  8.4  g dl; hematology blood platelet count  259  k ul; chemistry blood anion gap  15  meq l; chemistry blood bicarbonate  28  meq l; chemistry blood chloride  95  meq l; chemistry blood creatinine  1.0  mg dl; chemistry blood potassium  3.9  meq l; chemistry blood sodium  134  meq l; chemistry blood urea nitrogen  23  mg dl; hematology blood inr(pt)  1.1  ; chemistry blood calcium, total  8.7  mg dl; chemistry blood bilirubin, total  0.2  mg dl; chemistry blood glucose  109  mg dl; chemistry blood lactate dehydrogenase (ld)  201  iu l; chemistry blood albumin  3.4  g dl; hematology blood bands  4  %$ns  1000  ml ; sodium chloride 0.9%  flush  3  ml ; d5ns  1000  ml ; acyclovir ointment 5%  1  appl ; lorazepam  0.5  mg ; pantoprazole  40  mg ; ondansetron  8  mg ; oxycodone-acetaminophen elixir  5-10  ml ; hydromorphone (dilaudid)  0.5  mg ; vial  1  vial ; pantoprazole sodium  40  mg ; salagen  5  mg ; hydrochlorothiazide  25  mg ; metoprolol succinate xl  200  mg ; valsartan  320  mg ; aspirin  325  mg ; metoprolol tartrate  50  mg ; heparin  5000  unit ; acetaminophen  650  mg ; 
 
white m 63 $nan$hematology blood hematocrit  24.7  %; hematology blood hemoglobin  8.7  g dl; hematology blood platelet count  286  k ul; chemistry blood anion gap  11  meq l; chemistry blood bicarbonate  28  meq l; chemistry blood chloride  100  meq l; chemistry blood creatinine  0.9  mg dl; chemistry blood potassium  3.5  meq l; chemistry blood sodium  135  meq l; chemistry blood urea nitrogen  20  mg dl; chemistry blood calcium, total  8.6  mg dl; chemistry blood glucose  119  mg dl$sodium chloride 0.9%  flush  3  ml ; acyclovir ointment 5%  1  appl ; lorazepam  0.5  mg ; ondansetron  8  mg ; oxycodone-acetaminophen elixir  5-10  ml ; vial  1  vial ; pantoprazole sodium  40  mg ; salagen  5  mg ; hydrochlorothiazide  25  mg ; valsartan  320  mg ; aspirin  325  mg ; metoprolol tartrate  50  mg ; heparin  5000  unit ; acetaminophen  650  mg ; lidocaine viscous 2%  20  ml ; potassium chloride  20  meq ; sw  50  ml ; magnesium sulfate  2  gm ; senna  1  tab ; caphosol  30  ml ; ns  250  ml ; bisacodyl  10  mg ; docusate sodium  100  mg ; gelclair  15  ml ; zolpidem tartrate  5  mg ; 
 
white m 63 $nan$hematology blood hematocrit  25.6  %; hematology blood hemoglobin  8.9  g dl; hematology blood platelet count  272  k ul; chemistry blood anion gap  19  meq l; chemistry blood bicarbonate  26  meq l; chemistry blood chloride  98  meq l; chemistry blood creatinine  0.9  mg dl; chemistry blood potassium  3.9  meq l; chemistry blood sodium  139  meq l; chemistry blood urea nitrogen  25  mg dl; chemistry blood calcium, total  8.6  mg dl; chemistry blood glucose  101  mg dl$sodium chloride 0.9%  flush  3  ml ; acyclovir ointment 5%  1  appl ; lorazepam  0.5  mg ; ondansetron  8  mg ; oxycodone-acetaminophen elixir  5-10  ml ; vial  1  vial ; pantoprazole sodium  40  mg ; salagen  5  mg ; hydrochlorothiazide  25  mg ; valsartan  320  mg ; aspirin  325  mg ; metoprolol tartrate  50  mg ; heparin  5000  unit ; acetaminophen  650  mg ; lidocaine viscous 2%  20  ml ; sw  50  ml ; magnesium sulfate  2  gm ; senna  1  tab ; caphosol  30  ml ; ns  250  ml ; bisacodyl  10  mg ; gelclair  15  ml ; zolpidem tartrate  5  mg ; oxycodone sr (oxycontin)  30  mg ; 
 
white m 63 $nan$hematology blood hematocrit  25.6  %; hematology blood hemoglobin  8.9  g dl; hematology blood platelet count  270  k ul; chemistry blood anion gap  17  meq l; chemistry blood bicarbonate  28  meq l; chemistry blood chloride  100  meq l; chemistry blood creatinine  1.0  mg dl; chemistry blood potassium  3.8  meq l; chemistry blood sodium  141  meq l; chemistry blood urea nitrogen  28  mg dl; chemistry blood calcium, total  8.8  mg dl; chemistry blood glucose  147  mg dl$sodium chloride 0.9%  flush  3  ml ; acyclovir ointment 5%  1  appl ; lorazepam  0.5  mg ; ondansetron  8  mg ; oxycodone-acetaminophen elixir  5-10  ml ; vial  1  vial ; pantoprazole sodium  40  mg ; hydrochlorothiazide  25  mg ; valsartan  320  mg ; aspirin  325  mg ; metoprolol tartrate  50  mg ; heparin  5000  unit ; acetaminophen  650  mg ; lidocaine viscous 2%  20  ml ; senna  1  tab ; caphosol  30  ml ; bisacodyl  10  mg ; gelclair  15  ml ; zolpidem tartrate  5  mg ; oxycodone sr (oxycontin)  30  mg ; lactulose  30  ml ; nystatin oral suspension  5  ml ; 
 
white m 63 $nan$hematology blood hematocrit  24.0  %; hematology blood hemoglobin  8.3  g dl; hematology blood platelet count  316  k ul; chemistry blood anion gap  15  meq l; chemistry blood bicarbonate  28  meq l; chemistry blood chloride  100  meq l; chemistry blood creatinine  1.2  mg dl; chemistry blood potassium  3.7  meq l; chemistry blood sodium  139  meq l; chemistry blood urea nitrogen  36  mg dl; chemistry blood calcium, total  8.7  mg dl; chemistry blood glucose  122  mg dl$sodium chloride 0.9%  flush  3  ml ; acyclovir ointment 5%  1  appl ; lorazepam  0.5  mg ; ondansetron  8  mg ; oxycodone-acetaminophen elixir  5-10  ml ; vial  1  vial ; pantoprazole sodium  40  mg ; hydrochlorothiazide  25  mg ; valsartan  320  mg ; aspirin  325  mg ; metoprolol tartrate  50  mg ; heparin  5000  unit ; acetaminophen  650  mg ; lidocaine viscous 2%  20  ml ; senna  1  tab ; caphosol  30  ml ; bisacodyl  10  mg ; zolpidem tartrate  5  mg ; lactulose  30  ml ; nystatin oral suspension  5  ml ; fentanyl patch  25  mcg hr ; fentanyl patch  50  mcg hr ; fluconazole  200  mg ; 
 
white m 63 $nan$hematology blood hematocrit  21.6  %; hematology blood hemoglobin  7.5  g dl; hematology blood platelet count  253  k ul; chemistry blood anion gap  11  meq l; chemistry blood bicarbonate  29  meq l; chemistry blood chloride  102  meq l; chemistry blood creatinine  1.3  mg dl; chemistry blood potassium  3.9  meq l; chemistry blood sodium  138  meq l; chemistry blood urea nitrogen  44  mg dl; chemistry blood calcium, total  8.2  mg dl; chemistry blood glucose  140  mg dl$sodium chloride 0.9%  flush  3  ml ; acyclovir ointment 5%  1  appl ; lorazepam  0.5  mg ; ondansetron  8  mg ; oxycodone-acetaminophen elixir  5-10  ml ; vial  1  vial ; pantoprazole sodium  40  mg ; hydrochlorothiazide  25  mg ; valsartan  320  mg ; aspirin  325  mg ; metoprolol tartrate  50  mg ; heparin  5000  unit ; acetaminophen  650  mg ; lidocaine viscous 2%  20  ml ; senna  1  tab ; caphosol  30  ml ; bisacodyl  10  mg ; zolpidem tartrate  5  mg ; fentanyl patch  50  mcg hr ; fluconazole  200  mg ; 
 
white m 63 $nan$hematology blood hematocrit  22.6  %; hematology blood hemoglobin  7.8  g dl; hematology blood platelet count  256  k ul; chemistry blood anion gap  14  meq l; chemistry blood bicarbonate  27  meq l; chemistry blood chloride  103  meq l; chemistry blood creatinine  0.9  mg dl; chemistry blood potassium  4.2  meq l; chemistry blood sodium  140  meq l; chemistry blood urea nitrogen  37  mg dl; chemistry blood calcium, total  8.4  mg dl; chemistry blood glucose  125  mg dl$sodium chloride 0.9%  flush  3  ml ; acyclovir ointment 5%  1  appl ; lorazepam  0.5  mg ; ondansetron  8  mg ; oxycodone-acetaminophen elixir  5-10  ml ; vial  1  vial ; pantoprazole sodium  40  mg ; hydrochlorothiazide  25  mg ; valsartan  320  mg ; aspirin  325  mg ; metoprolol tartrate  50  mg ; heparin  5000  unit ; acetaminophen  650  mg ; lidocaine viscous 2%  20  ml ; senna  1  tab ; caphosol  30  ml ; bisacodyl  10  mg ; zolpidem tartrate  5  mg ; fentanyl patch  50  mcg hr ; fluconazole  200  mg ; hydromorphone (dilaudid)  2-4  mg ; magnesium oxide  800  mg ; 
 
other m 95 $temp    heartrate  133.0  resprate  26.0  o2sat  96.0  sbp  83.0  dbp  52.0  rhythm  atrial fibrillation  pain    ; temp    heartrate  118.0  resprate  18.0  o2sat  96.0  sbp  80.0  dbp  64.0  rhythm  atrial fibrillation  pain    ; temp    heartrate  111.0  resprate  35.0  o2sat  95.0  sbp  111.0  dbp  72.0  rhythm  atrial fibrillation  pain    ; temp    heartrate  97.0  resprate  28.0  o2sat  96.0  sbp  87.0  dbp  44.0  rhythm  atrial fibrillation  pain    ; temp    heartrate  66.0  resprate  29.0  o2sat  96.0  sbp  86.0  dbp  34.0  rhythm  atrial fibrillation  pain    ; temp    heartrate  79.0  resprate  31.0  o2sat  96.0  sbp  96.0  dbp  49.0  rhythm  sinus arrythmia  pain    $nan$simvastatin  20  mg ; aspirin  81  mg ; 
coronary atherosclerosis of native coronary artery paroxysmal tachycardia, unspecified diseases of tricuspid valve mitral valve disorders thrombocytopenia, unspecified percutaneous transluminal coronary angioplasty status atrial fibrillation unspecified glaucoma unspecified essential hypertension pain in joint, shoulder region unspecified glaucoma subendocardial infarction, initial episode of care peripheral vascular disease, unspecified mitral valve disorders coronary atherosclerosis of native coronary artery 
other m 95 $temp    heartrate  98.0  resprate  20.0  o2sat  97.0  sbp  97.0  dbp  47.0  rhythm  sinus arrythmia  pain    ; temp    heartrate  64.0  resprate  17.0  o2sat  97.0  sbp  110.0  dbp  52.0  rhythm    pain    $hematology blood hematocrit  41.7  %; hematology blood hematocrit  41.9  %; hematology blood hemoglobin  14.3  g dl; hematology blood platelet count  107  k ul; chemistry blood anion gap  14  meq l; chemistry blood bicarbonate  20  meq l; chemistry blood chloride  110  meq l; chemistry blood creatinine  1.2  mg dl; chemistry blood potassium  4.1  meq l; chemistry blood sodium  140  meq l; chemistry blood urea nitrogen  33  mg dl; hematology blood inr(pt)  1.3  ; chemistry blood calcium, total  7.7  mg dl; chemistry blood glucose  78  mg dl$simvastatin  20  mg ; aspirin  81  mg ; dorzolamide 2% ophth. soln.  1  drop ; senna  1  tab ; azithromycin  500  mg ; 0.9% sodium chloride  1000  ml ; heparin  5000  unit ; latanoprost 0.005% ophth. soln.  1  drop ; metoprolol tartrate  25  mg ; iso-osmotic dextrose  50  ml ; ceftriaxone  1  gm ; metoprolol tartrate  12.5  mg ; bisacodyl  10  mg ; lactulose  15  ml ; 
coronary atherosclerosis of native coronary artery paroxysmal tachycardia, unspecified diseases of tricuspid valve mitral valve disorders thrombocytopenia, unspecified percutaneous transluminal coronary angioplasty status atrial fibrillation unspecified glaucoma unspecified essential hypertension pain in joint, shoulder region unspecified glaucoma subendocardial infarction, initial episode of care peripheral vascular disease, unspecified mitral valve disorders coronary atherosclerosis of native coronary artery 
other m 95 $nan$hematology blood hematocrit  42.0  %; hematology blood hemoglobin  14.6  g dl; hematology blood platelet count  110  k ul; chemistry blood anion gap  14  meq l; chemistry blood bicarbonate  17  meq l; chemistry blood chloride  111  meq l; chemistry blood creatinine  1.0  mg dl; chemistry blood potassium  4.2  meq l; chemistry blood sodium  138  meq l; chemistry blood urea nitrogen  27  mg dl; hematology blood inr(pt)  1.3  ; hematology blood inr(pt)  1.3  ; chemistry blood calcium, total  7.7  mg dl; chemistry blood bilirubin, total  0.3  mg dl; chemistry blood glucose  79  mg dl; chemistry blood albumin  3.1  g dl$simvastatin  20  mg ; aspirin  81  mg ; dorzolamide 2% ophth. soln.  1  drop ; senna  1  tab ; 0.9% sodium chloride  1000  ml ; heparin  5000  unit ; latanoprost 0.005% ophth. soln.  1  drop ; metoprolol tartrate  25  mg ; metoprolol tartrate  12.5  mg ; bisacodyl  10  mg ; lactulose  15  ml ; mupirocin nasal ointment 2%  1  appl ; ipratropium bromide neb  1-2  neb ; prednisone  40  mg ; levalbuterol neb  1  neb ; 
coronary atherosclerosis of native coronary artery paroxysmal tachycardia, unspecified diseases of tricuspid valve mitral valve disorders thrombocytopenia, unspecified percutaneous transluminal coronary angioplasty status atrial fibrillation unspecified glaucoma unspecified essential hypertension pain in joint, shoulder region unspecified glaucoma subendocardial infarction, initial episode of care peripheral vascular disease, unspecified mitral valve disorders coronary atherosclerosis of native coronary artery 
other m 95 $nan$hematology blood hematocrit  40.8  %; hematology blood hemoglobin  13.8  g dl; hematology blood platelet count  130  k ul; chemistry blood anion gap  15  meq l; chemistry blood bicarbonate  24  meq l; chemistry blood chloride  105  meq l; chemistry blood creatinine  1.0  mg dl; chemistry blood potassium  4.3  meq l; chemistry blood sodium  140  meq l; chemistry blood urea nitrogen  28  mg dl; hematology blood inr(pt)  1.2  ; hematology urine wbc  8  # hpf; chemistry blood calcium, total  8.4  mg dl; chemistry blood glucose  137  mg dl$0.9% sodium chloride  500  ml ; simvastatin  20  mg ; dorzolamide 2% ophth. soln.  1  drop ; senna  1  tab ; latanoprost 0.005% ophth. soln.  1  drop ; metoprolol tartrate  12.5  mg ; bisacodyl  10  mg ; lactulose  15  ml ; ipratropium bromide neb  1-2  neb ; prednisone  40  mg ; levalbuterol neb  1  neb ; mupirocin cream 2%  1  appl ; phenazopyridine  100  mg ; sodium chloride 0.9%  flush  3  ml ; multivitamins  1  tab ; phytonadione  2  mg ; neutra-phos  1  pkt ; 
coronary atherosclerosis of native coronary artery paroxysmal tachycardia, unspecified diseases of tricuspid valve mitral valve disorders thrombocytopenia, unspecified percutaneous transluminal coronary angioplasty status atrial fibrillation unspecified glaucoma unspecified essential hypertension pain in joint, shoulder region unspecified glaucoma subendocardial infarction, initial episode of care peripheral vascular disease, unspecified mitral valve disorders coronary atherosclerosis of native coronary artery 
other m 95 $nan$hematology blood hematocrit  40.6  %; hematology blood hemoglobin  14.0  g dl; hematology blood platelet count  133  k ul; chemistry blood anion gap  14  meq l; chemistry blood bicarbonate  25  meq l; chemistry blood chloride  105  meq l; chemistry blood creatinine  0.9  mg dl; chemistry blood potassium  3.8  meq l; chemistry blood sodium  140  meq l; chemistry blood urea nitrogen  28  mg dl; hematology blood inr(pt)  1.0  ; chemistry blood calcium, total  8.7  mg dl; chemistry blood glucose  96  mg dl$0.9% sodium chloride  500  ml ; simvastatin  20  mg ; dorzolamide 2% ophth. soln.  1  drop ; senna  1  tab ; latanoprost 0.005% ophth. soln.  1  drop ; metoprolol tartrate  12.5  mg ; bisacodyl  10  mg ; lactulose  15  ml ; ipratropium bromide neb  1-2  neb ; prednisone  40  mg ; levalbuterol neb  1  neb ; mupirocin cream 2%  1  appl ; phenazopyridine  100  mg ; sodium chloride 0.9%  flush  3  ml ; multivitamins  1  tab ; phytonadione  2  mg ; neutra-phos  1  pkt ; potassium chloride  20  meq ; 
coronary atherosclerosis of native coronary artery paroxysmal tachycardia, unspecified diseases of tricuspid valve mitral valve disorders thrombocytopenia, unspecified percutaneous transluminal coronary angioplasty status atrial fibrillation unspecified glaucoma unspecified essential hypertension pain in joint, shoulder region unspecified glaucoma subendocardial infarction, initial episode of care peripheral vascular disease, unspecified mitral valve disorders coronary atherosclerosis of native coronary artery 
other m 95 $nan$nan$simvastatin  20  mg ; dorzolamide 2% ophth. soln.  1  drop ; senna  1  tab ; latanoprost 0.005% ophth. soln.  1  drop ; metoprolol tartrate  12.5  mg ; bisacodyl  10  mg ; lactulose  15  ml ; ipratropium bromide neb  1-2  neb ; prednisone  40  mg ; levalbuterol neb  1  neb ; mupirocin cream 2%  1  appl ; phenazopyridine  100  mg ; sodium chloride 0.9%  flush  3  ml ; multivitamins  1  tab ; potassium chloride  20  meq ; 
coronary atherosclerosis of native coronary artery paroxysmal tachycardia, unspecified diseases of tricuspid valve mitral valve disorders thrombocytopenia, unspecified percutaneous transluminal coronary angioplasty status atrial fibrillation unspecified glaucoma unspecified essential hypertension pain in joint, shoulder region unspecified glaucoma subendocardial infarction, initial episode of care peripheral vascular disease, unspecified mitral valve disorders coronary atherosclerosis of native coronary artery 
white f 88 $temp    heartrate  62.0  resprate  18.0  o2sat  94.0  sbp  171.0  dbp  72.0  rhythm    pain  asleep  ; temp  98.5  heartrate    resprate    o2sat    sbp    dbp    rhythm    pain    $hematology blood hematocrit  27.3  %; hematology blood hemoglobin  8.3  g dl; hematology blood platelet count  247  k ul; chemistry blood anion gap  13  meq l; chemistry blood bicarbonate  26  meq l; chemistry blood chloride  107  meq l; chemistry blood creatinine  0.6  mg dl; chemistry blood potassium  3.4  meq l; chemistry blood sodium  146  meq l; chemistry blood urea nitrogen  19  mg dl; hematology blood inr(pt)  1.2  ; chemistry blood calcium, total  8.0  mg dl; chemistry blood glucose  124  mg dl; blood gas blood lactate  1.3  mmol l$sodium chloride 0.9%  flush  3-10  ml ; heparin  5000  unit ; vitamin d  1000  unit ; ipratropium-albuterol neb  1  neb ; lactated ringers  1000  ml ; quetiapine fumarate  12.5  mg ; 5% dextrose  500  ml ; potassium chloride  40  meq ; hydralazine  10  mg ; carbidopa-levodopa (25-100)  1.5  tab ; acetaminophen iv  1000  mg ; polyethylene glycol  17  g ; senna  8.6  mg ; 0.9% sodium chloride  250  ml ; azithromycin   250  mg ; donepezil  10  mg ; fludrocortisone acetate  0.2  mg ; sertraline  75  mg ; acetaminophen  650  mg ; cyanocobalamin  1000  mcg ; nitrofurantoin monohyd (macrobid)  100  mg ; vial  1  vial ; ceftriaxone  1  gm ; doxycycline hyclate  100  mg ; 
elevated blood-pressure reading, without diagnosis of hypertension alzheimer's disease, unspecified other secondary pulmonary hypertension dementia in other diseases classified elsewhere without behavioral disturbance parkinson's disease syncope and collapse
white f 88 $nan$hematology blood hematocrit  26.3  %; hematology blood hematocrit  27.8  %; hematology blood hemoglobin  8.2  g dl; hematology blood hemoglobin  8.6  g dl; hematology blood platelet count  246  k ul; hematology blood platelet count  262  k ul; chemistry blood anion gap  17  meq l; chemistry blood bicarbonate  24  meq l; chemistry blood chloride  111  meq l; chemistry blood creatinine  0.7  mg dl; chemistry blood potassium  4.2  meq l; chemistry blood sodium  152  meq l; chemistry blood urea nitrogen  14  mg dl; chemistry blood calcium, total  8.3  mg dl; chemistry blood glucose  102  mg dl$sodium chloride 0.9%  flush  3-10  ml ; heparin  5000  unit ; vitamin d  1000  unit ; ipratropium-albuterol neb  1  neb ; quetiapine fumarate  12.5  mg ; carbidopa-levodopa (25-100)  1.5  tab ; acetaminophen iv  1000  mg ; polyethylene glycol  17  g ; senna  8.6  mg ; donepezil  10  mg ; sertraline  75  mg ; cyanocobalamin  1000  mcg ; doxycycline hyclate  100  mg ; potassium chloride (powder)  40  meq ; d5 1 2ns  1000  ml ; labetalol  100  mg ; 
elevated blood-pressure reading, without diagnosis of hypertension alzheimer's disease, unspecified other secondary pulmonary hypertension dementia in other diseases classified elsewhere without behavioral disturbance parkinson's disease syncope and collapse
white f 88 $nan$hematology blood hematocrit  27.3  %; hematology blood hemoglobin  8.5  g dl; hematology blood platelet count  256  k ul; chemistry blood anion gap  15  meq l; chemistry blood bicarbonate  24  meq l; chemistry blood chloride  105  meq l; chemistry blood creatinine  0.6  mg dl; chemistry blood potassium  3.9  meq l; chemistry blood sodium  144  meq l; chemistry blood urea nitrogen  8  mg dl; chemistry blood calcium, total  8.0  mg dl; chemistry blood glucose  102  mg dl$sodium chloride 0.9%  flush  3-10  ml ; heparin  5000  unit ; vitamin d  1000  unit ; ipratropium-albuterol neb  1  neb ; quetiapine fumarate  12.5  mg ; carbidopa-levodopa (25-100)  1.5  tab ; polyethylene glycol  17  g ; senna  8.6  mg ; donepezil  10  mg ; sertraline  75  mg ; cyanocobalamin  1000  mcg ; doxycycline hyclate  100  mg ; potassium chloride (powder)  40  meq ; d5 1 2ns  1000  ml ; labetalol  100  mg ; 
elevated blood-pressure reading, without diagnosis of hypertension alzheimer's disease, unspecified other secondary pulmonary hypertension dementia in other diseases classified elsewhere without behavioral disturbance parkinson's disease syncope and collapse
white f 88 $nan$hematology blood hematocrit  26.8  %; hematology blood hemoglobin  8.3  g dl; hematology blood platelet count  261  k ul; chemistry blood anion gap  14  meq l; chemistry blood bicarbonate  25  meq l; chemistry blood chloride  105  meq l; chemistry blood creatinine  0.6  mg dl; chemistry blood potassium  4.3  meq l; chemistry blood sodium  144  meq l; chemistry blood urea nitrogen  9  mg dl; chemistry blood calcium, total  8.1  mg dl; chemistry blood glucose  92  mg dl$sodium chloride 0.9%  flush  3-10  ml ; heparin  5000  unit ; vitamin d  1000  unit ; ipratropium-albuterol neb  1  neb ; quetiapine fumarate  12.5  mg ; carbidopa-levodopa (25-100)  1.5  tab ; polyethylene glycol  17  g ; senna  8.6  mg ; donepezil  10  mg ; sertraline  75  mg ; cyanocobalamin  1000  mcg ; doxycycline hyclate  100  mg ; 
elevated blood-pressure reading, without diagnosis of hypertension alzheimer's disease, unspecified other secondary pulmonary hypertension dementia in other diseases classified elsewhere without behavioral disturbance parkinson's disease syncope and collapse
white f 88 $nan$nan$sodium chloride 0.9%  flush  3-10  ml ; heparin  5000  unit ; vitamin d  1000  unit ; ipratropium-albuterol neb  1  neb ; quetiapine fumarate  12.5  mg ; carbidopa-levodopa (25-100)  1.5  tab ; polyethylene glycol  17  g ; senna  8.6  mg ; donepezil  10  mg ; sertraline  75  mg ; cyanocobalamin  1000  mcg ; doxycycline hyclate  100  mg ; cefpodoxime proxetil  400  mg ; 
elevated blood-pressure reading, without diagnosis of hypertension alzheimer's disease, unspecified other secondary pulmonary hypertension dementia in other diseases classified elsewhere without behavioral disturbance parkinson's disease syncope and collapse
white f 88 $nan$nan$sodium chloride 0.9%  flush  3-10  ml ; heparin  5000  unit ; vitamin d  1000  unit ; ipratropium-albuterol neb  1  neb ; quetiapine fumarate  12.5  mg ; carbidopa-levodopa (25-100)  1.5  tab ; polyethylene glycol  17  g ; senna  8.6  mg ; donepezil  10  mg ; sertraline  75  mg ; cyanocobalamin  1000  mcg ; doxycycline hyclate  100  mg ; cefpodoxime proxetil  400  mg ; 
elevated blood-pressure reading, without diagnosis of hypertension alzheimer's disease, unspecified other secondary pulmonary hypertension dementia in other diseases classified elsewhere without behavioral disturbance parkinson's disease syncope and collapse
hispanic latino m 39 $nan$nan$heparin  5000  unit ; 
percutaneous transluminal coronary angioplasty status unspecified essential hypertension headache unspecified viral meningitis diabetes mellitus without mention of complication, type ii or unspecified type, uncontrolled old myocardial infarction herpetic gingivostomatitis unspecified viral infection rash and other nonspecific skin eruption coronary atherosclerosis of native coronary artery coronary atherosclerosis of native coronary artery calculus of kidney subendocardial infarction, initial episode of care other diseases of lung, not elsewhere classified diabetes mellitus without mention of complication, type ii or unspecified type, not stated as uncontrolled hydronephrosis anxiety state, unspecified unspecified hemorrhoids without mention of complication
hispanic latino m 39 $nan$hematology blood hematocrit  37.6  %; hematology blood hemoglobin  14.1  g dl; hematology blood platelet count  287  k ul; chemistry blood anion gap  11  meq l; chemistry blood bicarbonate  23  meq l; chemistry blood chloride  102  meq l; chemistry blood creatinine  0.5  mg dl; chemistry blood potassium  4.1  meq l; chemistry blood sodium  132  meq l; chemistry blood urea nitrogen  5  mg dl; chemistry blood glucose  233  mg dl; chemistry blood lactate dehydrogenase (ld)  239  iu l; chemistry blood % hemoglobin a1c  11.9  %$heparin  5000  unit ; 0.45% sodium chloride  1000  ml ; influenza virus vaccine  0.5  ml ; sodium chloride 0.9%  flush  3  ml ; 0.9% sodium chloride  1000  ml ; acetaminophen  325-650  mg ; ondansetron  4  mg ; prochlorperazine  10  mg ; dextrose 50%  12.5  gm ; glucagon  1  mg ; insulin  0  unit ; morphine sulfate  4-8  mg ; clotrimazole cream  1  appl ; aspirin  81  mg ; fluconazole  200  mg ; morphine sulfate  2-4  mg ; morphine sulfate  4-6  mg ; 
percutaneous transluminal coronary angioplasty status unspecified essential hypertension headache unspecified viral meningitis diabetes mellitus without mention of complication, type ii or unspecified type, uncontrolled old myocardial infarction herpetic gingivostomatitis unspecified viral infection rash and other nonspecific skin eruption coronary atherosclerosis of native coronary artery coronary atherosclerosis of native coronary artery calculus of kidney subendocardial infarction, initial episode of care other diseases of lung, not elsewhere classified diabetes mellitus without mention of complication, type ii or unspecified type, not stated as uncontrolled hydronephrosis anxiety state, unspecified unspecified hemorrhoids without mention of complication
hispanic latino m 39 $nan$hematology blood hematocrit  39.3  %; hematology blood hemoglobin  13.8  g dl; hematology blood platelet count  225  k ul; chemistry blood anion gap  15  meq l; chemistry blood bicarbonate  22  meq l; chemistry blood chloride  99  meq l; chemistry blood creatinine  0.5  mg dl; chemistry blood potassium  3.7  meq l; chemistry blood sodium  132  meq l; chemistry blood urea nitrogen  6  mg dl; hematology blood inr(pt)  1.1  ; chemistry blood calcium, total  7.9  mg dl; chemistry blood glucose  180  mg dl; chemistry blood lactate dehydrogenase (ld)  171  iu l$heparin  5000  unit ; influenza virus vaccine  0.5  ml ; sodium chloride 0.9%  flush  3  ml ; acetaminophen  325-650  mg ; ondansetron  4  mg ; prochlorperazine  10  mg ; dextrose 50%  12.5  gm ; glucagon  1  mg ; aspirin  81  mg ; fluconazole  200  mg ; morphine sulfate  4-6  mg ; insulin  10  unit ; 0.9% sodium chloride  500  ml ; potassium phosphate  15  mmol ; iso-osmotic sodium chloride  50  ml ; famotidine  20  mg ; 
percutaneous transluminal coronary angioplasty status unspecified essential hypertension headache unspecified viral meningitis diabetes mellitus without mention of complication, type ii or unspecified type, uncontrolled old myocardial infarction herpetic gingivostomatitis unspecified viral infection rash and other nonspecific skin eruption coronary atherosclerosis of native coronary artery coronary atherosclerosis of native coronary artery calculus of kidney subendocardial infarction, initial episode of care other diseases of lung, not elsewhere classified diabetes mellitus without mention of complication, type ii or unspecified type, not stated as uncontrolled hydronephrosis anxiety state, unspecified unspecified hemorrhoids without mention of complication
hispanic latino m 39 $nan$hematology blood hematocrit  37.4  %; hematology blood hemoglobin  12.7  g dl; hematology blood platelet count  229  k ul; chemistry blood anion gap  15  meq l; chemistry blood bicarbonate  22  meq l; chemistry blood chloride  103  meq l; chemistry blood creatinine  0.5  mg dl; chemistry blood potassium  3.7  meq l; chemistry blood sodium  136  meq l; chemistry blood urea nitrogen  9  mg dl; chemistry blood calcium, total  7.7  mg dl; chemistry blood glucose  160  mg dl$heparin  5000  unit ; influenza virus vaccine  0.5  ml ; sodium chloride 0.9%  flush  3  ml ; acetaminophen  325-650  mg ; ondansetron  4  mg ; prochlorperazine  10  mg ; dextrose 50%  12.5  gm ; glucagon  1  mg ; aspirin  81  mg ; morphine sulfate  4-6  mg ; 0.9% sodium chloride  500  ml ; potassium phosphate  15  mmol ; iso-osmotic sodium chloride  50  ml ; famotidine  20  mg ; lisinopril  2.5  mg ; potassium chloride  40  meq ; neutra-phos  2  pkt ; gemfibrozil  600  mg ; metformin (glucophage)  500  mg ; metoprolol tartrate  12.5  mg ; 
percutaneous transluminal coronary angioplasty status unspecified essential hypertension headache unspecified viral meningitis diabetes mellitus without mention of complication, type ii or unspecified type, uncontrolled old myocardial infarction herpetic gingivostomatitis unspecified viral infection rash and other nonspecific skin eruption coronary atherosclerosis of native coronary artery coronary atherosclerosis of native coronary artery calculus of kidney subendocardial infarction, initial episode of care other diseases of lung, not elsewhere classified diabetes mellitus without mention of complication, type ii or unspecified type, not stated as uncontrolled hydronephrosis anxiety state, unspecified unspecified hemorrhoids without mention of complication
hispanic latino m 39 $nan$hematology blood hematocrit  37.1  %; hematology blood hemoglobin  12.5  g dl; hematology blood platelet count  234  k ul; chemistry blood anion gap  15  meq l; chemistry blood bicarbonate  23  meq l; chemistry blood chloride  103  meq l; chemistry blood creatinine  0.5  mg dl; chemistry blood potassium  3.7  meq l; chemistry blood sodium  137  meq l; chemistry blood urea nitrogen  7  mg dl; chemistry blood calcium, total  8.4  mg dl; chemistry blood glucose  200  mg dl; chemistry blood albumin  3.0  g dl$heparin  5000  unit ; influenza virus vaccine  0.5  ml ; sodium chloride 0.9%  flush  3  ml ; acetaminophen  325-650  mg ; ondansetron  4  mg ; prochlorperazine  10  mg ; dextrose 50%  12.5  gm ; glucagon  1  mg ; aspirin  81  mg ; morphine sulfate  4-6  mg ; lisinopril  2.5  mg ; potassium chloride  40  meq ; neutra-phos  2  pkt ; gemfibrozil  600  mg ; metformin (glucophage)  500  mg ; metoprolol tartrate  12.5  mg ; metformin (glucophage)  1000  mg ; 
percutaneous transluminal coronary angioplasty status unspecified essential hypertension headache unspecified viral meningitis diabetes mellitus without mention of complication, type ii or unspecified type, uncontrolled old myocardial infarction herpetic gingivostomatitis unspecified viral infection rash and other nonspecific skin eruption coronary atherosclerosis of native coronary artery coronary atherosclerosis of native coronary artery calculus of kidney subendocardial infarction, initial episode of care other diseases of lung, not elsewhere classified diabetes mellitus without mention of complication, type ii or unspecified type, not stated as uncontrolled hydronephrosis anxiety state, unspecified unspecified hemorrhoids without mention of complication
hispanic latino m 39 $nan$chemistry blood anion gap  17  meq l; chemistry blood bicarbonate  23  meq l; chemistry blood chloride  99  meq l; chemistry blood creatinine  0.5  mg dl; chemistry blood potassium  3.8  meq l; chemistry blood sodium  135  meq l; chemistry blood urea nitrogen  7  mg dl; chemistry blood calcium, total  8.6  mg dl; chemistry blood glucose  204  mg dl$heparin  5000  unit ; influenza virus vaccine  0.5  ml ; sodium chloride 0.9%  flush  3  ml ; acetaminophen  325-650  mg ; ondansetron  4  mg ; prochlorperazine  10  mg ; dextrose 50%  12.5  gm ; glucagon  1  mg ; aspirin  81  mg ; morphine sulfate  4-6  mg ; lisinopril  2.5  mg ; gemfibrozil  600  mg ; metoprolol tartrate  12.5  mg ; metformin (glucophage)  1000  mg ; glipizide  5  mg ; 
percutaneous transluminal coronary angioplasty status unspecified essential hypertension headache unspecified viral meningitis diabetes mellitus without mention of complication, type ii or unspecified type, uncontrolled old myocardial infarction herpetic gingivostomatitis unspecified viral infection rash and other nonspecific skin eruption coronary atherosclerosis of native coronary artery coronary atherosclerosis of native coronary artery calculus of kidney subendocardial infarction, initial episode of care other diseases of lung, not elsewhere classified diabetes mellitus without mention of complication, type ii or unspecified type, not stated as uncontrolled hydronephrosis anxiety state, unspecified unspecified hemorrhoids without mention of complication
hispanic latino m 39 $nan$chemistry blood anion gap  18  meq l; chemistry blood bicarbonate  23  meq l; chemistry blood chloride  99  meq l; chemistry blood creatinine  0.6  mg dl; chemistry blood potassium  4.0  meq l; chemistry blood sodium  136  meq l; chemistry blood urea nitrogen  9  mg dl; chemistry blood calcium, total  9.2  mg dl; chemistry blood glucose  220  mg dl$heparin  5000  unit ; influenza virus vaccine  0.5  ml ; sodium chloride 0.9%  flush  3  ml ; acetaminophen  325-650  mg ; ondansetron  4  mg ; prochlorperazine  10  mg ; dextrose 50%  12.5  gm ; glucagon  1  mg ; aspirin  81  mg ; morphine sulfate  4-6  mg ; lisinopril  2.5  mg ; gemfibrozil  600  mg ; metoprolol tartrate  12.5  mg ; metformin (glucophage)  1000  mg ; glipizide  5  mg ; 
percutaneous transluminal coronary angioplasty status unspecified essential hypertension headache unspecified viral meningitis diabetes mellitus without mention of complication, type ii or unspecified type, uncontrolled old myocardial infarction herpetic gingivostomatitis unspecified viral infection rash and other nonspecific skin eruption coronary atherosclerosis of native coronary artery coronary atherosclerosis of native coronary artery calculus of kidney subendocardial infarction, initial episode of care other diseases of lung, not elsewhere classified diabetes mellitus without mention of complication, type ii or unspecified type, not stated as uncontrolled hydronephrosis anxiety state, unspecified unspecified hemorrhoids without mention of complication
white m 76 $nan$nan$allopurinol  300  mg ; digoxin  0.25  mg ; lamotrigine  150  mg ; heparin  5000  unit ; docusate sodium  100  mg ; sulfameth trimethoprim ds  1  tab ; 
 
white m 76 $nan$hematology blood hematocrit  34.3  %; hematology blood hemoglobin  11.5  g dl; hematology blood platelet count  304  k ul; chemistry blood anion gap  14  meq l; chemistry blood bicarbonate  28  meq l; chemistry blood chloride  104  meq l; chemistry blood potassium  4.1  meq l; chemistry blood sodium  142  meq l; chemistry blood urea nitrogen  17  mg dl; hematology blood inr(pt)  1.2  ; chemistry blood glucose  91  mg dl$allopurinol  300  mg ; digoxin  0.25  mg ; lamotrigine  150  mg ; heparin  5000  unit ; docusate sodium  100  mg ; sulfameth trimethoprim ds  1  tab ; pneumococcal vac polyvalent  0.5  ml ; 0.9% sodium chloride  1000  ml ; pantoprazole  40  mg ; senna  1  tab ; acetaminophen  325-650  mg ; 
 
white m 76 $nan$nan$allopurinol  300  mg ; digoxin  0.25  mg ; lamotrigine  150  mg ; heparin  5000  unit ; docusate sodium  100  mg ; sulfameth trimethoprim ds  1  tab ; pneumococcal vac polyvalent  0.5  ml ; 0.9% sodium chloride  1000  ml ; pantoprazole  40  mg ; senna  1  tab ; acetaminophen  325-650  mg ; 
 
white m 76 $nan$hematology blood hematocrit  33.8  %; hematology blood hemoglobin  10.8  g dl; hematology blood platelet count  308  k ul; chemistry blood anion gap  12  meq l; chemistry blood bicarbonate  28  meq l; chemistry blood chloride  104  meq l; chemistry blood creatinine  0.8  mg dl; chemistry blood potassium  4.1  meq l; chemistry blood sodium  140  meq l; chemistry blood urea nitrogen  17  mg dl; hematology blood inr(pt)  1.2  ; chemistry blood calcium, total  8.6  mg dl; chemistry blood glucose  88  mg dl$allopurinol  300  mg ; digoxin  0.25  mg ; lamotrigine  150  mg ; heparin  5000  unit ; docusate sodium  100  mg ; sulfameth trimethoprim ds  1  tab ; pneumococcal vac polyvalent  0.5  ml ; 0.9% sodium chloride  1000  ml ; pantoprazole  40  mg ; senna  1  tab ; acetaminophen  325-650  mg ; magnesium oxide  400  mg ; 
 
white m 76 $nan$hematology blood hematocrit  34.1  %; hematology blood hemoglobin  11.1  g dl; hematology blood platelet count  304  k ul; chemistry blood anion gap  12  meq l; chemistry blood bicarbonate  28  meq l; chemistry blood chloride  104  meq l; chemistry blood creatinine  0.9  mg dl; chemistry blood potassium  4.3  meq l; chemistry blood sodium  140  meq l; chemistry blood urea nitrogen  23  mg dl; hematology blood inr(pt)  1.1  ; chemistry blood calcium, total  8.8  mg dl; chemistry blood glucose  128  mg dl; hematology urine glucose  neg  mg dl; hematology urine bilirubin  neg  mg dl$allopurinol  300  mg ; digoxin  0.25  mg ; lamotrigine  150  mg ; heparin  5000  unit ; docusate sodium  100  mg ; sulfameth trimethoprim ds  1  tab ; 0.9% sodium chloride  1000  ml ; pantoprazole  40  mg ; senna  1  tab ; acetaminophen  325-650  mg ; magnesium oxide  400  mg ; lorazepam  0.25  mg ; 
 
white m 76 $nan$nan$allopurinol  300  mg ; digoxin  0.25  mg ; lamotrigine  150  mg ; heparin  5000  unit ; docusate sodium  100  mg ; sulfameth trimethoprim ds  1  tab ; pantoprazole  40  mg ; senna  1  tab ; acetaminophen  325-650  mg ; lorazepam  0.25  mg ; 
 
black african american f 22 $nan$nan$sodium chloride 0.9%  flush  3  ml ; lactated ringers  1  ml ; docusate sodium  100  mg ; oxycodone-acetaminophen (5mg-325mg)  1-2  tab ; ibuprofen  600  mg ; codeine sulfate  30-60  mg ; acetaminophen  500-1000  mg ; bisacodyl  10  mg ; milk of magnesia  30  ml ; simethicone  80  mg ; calcium carbonate  500  mg ; tetanus-diphtox-acellular pertuss (adacel)  0.5  ml ; dermoplast spray  1  spry ; 
 
black african american f 22 $nan$hematology blood hematocrit  33.9  %$sodium chloride 0.9%  flush  3  ml ; lactated ringers  1  ml ; docusate sodium  100  mg ; oxycodone-acetaminophen (5mg-325mg)  1-2  tab ; ibuprofen  600  mg ; codeine sulfate  30-60  mg ; acetaminophen  500-1000  mg ; bisacodyl  10  mg ; milk of magnesia  30  ml ; simethicone  80  mg ; calcium carbonate  500  mg ; tetanus-diphtox-acellular pertuss (adacel)  0.5  ml ; dermoplast spray  1  spry ; 
 
black african american f 22 $nan$nan$sodium chloride 0.9%  flush  3  ml ; lactated ringers  1  ml ; docusate sodium  100  mg ; oxycodone-acetaminophen (5mg-325mg)  1-2  tab ; ibuprofen  600  mg ; codeine sulfate  30-60  mg ; acetaminophen  500-1000  mg ; bisacodyl  10  mg ; milk of magnesia  30  ml ; simethicone  80  mg ; calcium carbonate  500  mg ; tetanus-diphtox-acellular pertuss (adacel)  0.5  ml ; dermoplast spray  1  spry ; 
 
black african american f 22 $nan$nan$sodium chloride 0.9%  flush  3  ml ; lactated ringers  1  ml ; docusate sodium  100  mg ; oxycodone-acetaminophen (5mg-325mg)  1-2  tab ; ibuprofen  600  mg ; codeine sulfate  30-60  mg ; acetaminophen  500-1000  mg ; bisacodyl  10  mg ; milk of magnesia  30  ml ; simethicone  80  mg ; calcium carbonate  500  mg ; tetanus-diphtox-acellular pertuss (adacel)  0.5  ml ; dermoplast spray  1  spry ; 
 
white f 64 $temp  98.4  heartrate  92.0  resprate  18.0  o2sat  95.0  sbp  139.0  dbp  72.0  rhythm    pain  0  ; temp  98.4  heartrate  89.0  resprate  18.0  o2sat  96.0  sbp  129.0  dbp  98.0  rhythm    pain  0  ; temp  98.4  heartrate  84.0  resprate  18.0  o2sat  92.0  sbp  133.0  dbp  83.0  rhythm    pain  0  ; temp  98.4  heartrate  86.0  resprate  18.0  o2sat  92.0  sbp  132.0  dbp  71.0  rhythm    pain  0  $nan$sodium chloride 0.9%  flush  3  ml ; albuterol 0.083% neb soln  1  neb ; ipratropium bromide neb  1  neb ; heparin  5000  unit ; ascorbic acid  1000  mg ; clonazepam  1  mg ; docusate sodium  200  mg ; fish oil (omega 3)  1000  mg ; fluticasone propionate 110mcg  2  puff ; fluticasone propionate nasal  2  spry ; fluticasone-salmeterol diskus (500 50)   1  inh ; gabapentin  1200  mg ; ibuprofen  600  mg ; ketoconazole 2%   1  appl ; levothyroxine sodium  25  mcg ; montelukast  10  mg ; multivitamins  1  tab ; oxybutynin  5  mg ; pantoprazole  40  mg ; polyethylene glycol  34  g ; ranitidine  300  mg ; senna  17.2  mg ; tiotropium bromide  1  cap ; vitamin d  2000  unit ; doxepin hcl  325  mg ; fexofenadine  180  mg ; risperidone  6  mg ; prednisone  60  mg ; 
personal history of nicotine dependence hypothyroidism, unspecified constipation, unspecified chronic obstructive pulmonary disease with (acute) exacerbation acute and chronic respiratory failure with hypoxia gastro-esophageal reflux disease without esophagitis dependence on supplemental oxygen obstructive sleep apnea (adult) (pediatric) insomnia, unspecified pneumonia, unspecified organism body mass index (bmi) 40.0-44.9, adult localized edema anxiety disorder, unspecified morbid (severe) obesity with alveolar hypoventilation unspecified asthma, uncomplicated do not resuscitate foreign body accidentally entering other orifice major depressive affective disorder, single episode, unspecified acidosis foreign body in larynx benign essential hypertension other convulsions adrenal cortical steroids causing adverse effects in therapeutic use hypovolemia tobacco use disorder obstructive sleep apnea (adult)(pediatric) malnutrition of mild degree acute respiratory failure other encephalopathy sepsis delirium due to conditions classified elsewhere unspecified septicemia pneumonia due to hemophilus influenzae [h. influenzae] oliguria and anuria chronic obstructive asthma with (acute) exacerbation fall from other slipping, tripping, or stumbling closed fracture of cervical vertebra, unspecified level syncope and collapse closed fracture of metacarpal bone(s), site unspecified dysthymic disorder asthma, unspecified type, unspecified esophageal reflux
white f 64 $nan$hematology blood hematocrit  39.1  %; hematology blood hemoglobin  12.1  g dl; hematology blood platelet count  266  k ul; chemistry blood anion gap  13  meq l; chemistry blood bicarbonate  32  meq l; chemistry blood chloride  99  meq l; chemistry blood creatinine  0.8  mg dl; chemistry blood potassium  4.0  meq l; chemistry blood sodium  140  meq l; chemistry blood urea nitrogen  28  mg dl; chemistry blood glucose  100  mg dl$sodium chloride 0.9%  flush  3  ml ; albuterol 0.083% neb soln  1  neb ; ipratropium bromide neb  1  neb ; heparin  5000  unit ; ascorbic acid  1000  mg ; clonazepam  1  mg ; docusate sodium  200  mg ; fish oil (omega 3)  1000  mg ; fluticasone propionate 110mcg  2  puff ; fluticasone propionate nasal  2  spry ; fluticasone-salmeterol diskus (500 50)   1  inh ; ibuprofen  600  mg ; ketoconazole 2%   1  appl ; levothyroxine sodium  25  mcg ; montelukast  10  mg ; multivitamins  1  tab ; oxybutynin  5  mg ; pantoprazole  40  mg ; polyethylene glycol  34  g ; ranitidine  300  mg ; senna  17.2  mg ; tiotropium bromide  1  cap ; vitamin d  2000  unit ; doxepin hcl  325  mg ; fexofenadine  180  mg ; risperidone  6  mg ; prednisone  60  mg ; methylprednisolone sodium succ  80  mg ; doxycycline hyclate  100  mg ; benzonatate  200  mg ; ipratropium-albuterol neb  1  neb ; 
personal history of nicotine dependence hypothyroidism, unspecified constipation, unspecified chronic obstructive pulmonary disease with (acute) exacerbation acute and chronic respiratory failure with hypoxia gastro-esophageal reflux disease without esophagitis dependence on supplemental oxygen obstructive sleep apnea (adult) (pediatric) insomnia, unspecified pneumonia, unspecified organism body mass index (bmi) 40.0-44.9, adult localized edema anxiety disorder, unspecified morbid (severe) obesity with alveolar hypoventilation unspecified asthma, uncomplicated do not resuscitate foreign body accidentally entering other orifice major depressive affective disorder, single episode, unspecified acidosis foreign body in larynx benign essential hypertension other convulsions adrenal cortical steroids causing adverse effects in therapeutic use hypovolemia tobacco use disorder obstructive sleep apnea (adult)(pediatric) malnutrition of mild degree acute respiratory failure other encephalopathy sepsis delirium due to conditions classified elsewhere unspecified septicemia pneumonia due to hemophilus influenzae [h. influenzae] oliguria and anuria chronic obstructive asthma with (acute) exacerbation fall from other slipping, tripping, or stumbling closed fracture of cervical vertebra, unspecified level syncope and collapse closed fracture of metacarpal bone(s), site unspecified dysthymic disorder asthma, unspecified type, unspecified esophageal reflux
white f 64 $nan$hematology blood hematocrit  39.7  %; hematology blood hemoglobin  12.4  g dl; hematology blood platelet count  278  k ul; chemistry blood anion gap  16  meq l; chemistry blood bicarbonate  31  meq l; chemistry blood chloride  98  meq l; chemistry blood creatinine  0.7  mg dl; chemistry blood potassium  4.4  meq l; chemistry blood sodium  141  meq l; chemistry blood urea nitrogen  30  mg dl; chemistry blood calcium, total  10.3  mg dl; chemistry blood glucose  136  mg dl$sodium chloride 0.9%  flush  3  ml ; albuterol 0.083% neb soln  1  neb ; ipratropium bromide neb  1  neb ; heparin  5000  unit ; ascorbic acid  1000  mg ; clonazepam  1  mg ; docusate sodium  200  mg ; fish oil (omega 3)  1000  mg ; fluticasone propionate 110mcg  2  puff ; fluticasone propionate nasal  2  spry ; fluticasone-salmeterol diskus (500 50)   1  inh ; ibuprofen  600  mg ; ketoconazole 2%   1  appl ; levothyroxine sodium  25  mcg ; montelukast  10  mg ; multivitamins  1  tab ; oxybutynin  5  mg ; pantoprazole  40  mg ; polyethylene glycol  34  g ; ranitidine  300  mg ; senna  17.2  mg ; tiotropium bromide  1  cap ; vitamin d  2000  unit ; doxepin hcl  325  mg ; fexofenadine  180  mg ; risperidone  6  mg ; methylprednisolone sodium succ  80  mg ; doxycycline hyclate  100  mg ; benzonatate  200  mg ; ipratropium-albuterol neb  1  neb ; calcium carbonate  1250  mg ; methylprednisolone sodium succ  125  mg ; 
personal history of nicotine dependence hypothyroidism, unspecified constipation, unspecified chronic obstructive pulmonary disease with (acute) exacerbation acute and chronic respiratory failure with hypoxia gastro-esophageal reflux disease without esophagitis dependence on supplemental oxygen obstructive sleep apnea (adult) (pediatric) insomnia, unspecified pneumonia, unspecified organism body mass index (bmi) 40.0-44.9, adult localized edema anxiety disorder, unspecified morbid (severe) obesity with alveolar hypoventilation unspecified asthma, uncomplicated do not resuscitate foreign body accidentally entering other orifice major depressive affective disorder, single episode, unspecified acidosis foreign body in larynx benign essential hypertension other convulsions adrenal cortical steroids causing adverse effects in therapeutic use hypovolemia tobacco use disorder obstructive sleep apnea (adult)(pediatric) malnutrition of mild degree acute respiratory failure other encephalopathy sepsis delirium due to conditions classified elsewhere unspecified septicemia pneumonia due to hemophilus influenzae [h. influenzae] oliguria and anuria chronic obstructive asthma with (acute) exacerbation fall from other slipping, tripping, or stumbling closed fracture of cervical vertebra, unspecified level syncope and collapse closed fracture of metacarpal bone(s), site unspecified dysthymic disorder asthma, unspecified type, unspecified esophageal reflux
white f 64 $nan$nan$sodium chloride 0.9%  flush  3  ml ; albuterol 0.083% neb soln  1  neb ; ipratropium bromide neb  1  neb ; heparin  5000  unit ; ascorbic acid  1000  mg ; clonazepam  1  mg ; docusate sodium  200  mg ; fish oil (omega 3)  1000  mg ; fluticasone propionate 110mcg  2  puff ; fluticasone propionate nasal  2  spry ; fluticasone-salmeterol diskus (500 50)   1  inh ; ibuprofen  600  mg ; ketoconazole 2%   1  appl ; levothyroxine sodium  25  mcg ; montelukast  10  mg ; multivitamins  1  tab ; oxybutynin  5  mg ; pantoprazole  40  mg ; polyethylene glycol  34  g ; ranitidine  300  mg ; senna  17.2  mg ; tiotropium bromide  1  cap ; vitamin d  2000  unit ; doxepin hcl  325  mg ; fexofenadine  180  mg ; risperidone  6  mg ; doxycycline hyclate  100  mg ; benzonatate  200  mg ; ipratropium-albuterol neb  1  neb ; calcium carbonate  1250  mg ; methylprednisolone sodium succ  125  mg ; ramelteon  8  mg ; 
personal history of nicotine dependence hypothyroidism, unspecified constipation, unspecified chronic obstructive pulmonary disease with (acute) exacerbation acute and chronic respiratory failure with hypoxia gastro-esophageal reflux disease without esophagitis dependence on supplemental oxygen obstructive sleep apnea (adult) (pediatric) insomnia, unspecified pneumonia, unspecified organism body mass index (bmi) 40.0-44.9, adult localized edema anxiety disorder, unspecified morbid (severe) obesity with alveolar hypoventilation unspecified asthma, uncomplicated do not resuscitate foreign body accidentally entering other orifice major depressive affective disorder, single episode, unspecified acidosis foreign body in larynx benign essential hypertension other convulsions adrenal cortical steroids causing adverse effects in therapeutic use hypovolemia tobacco use disorder obstructive sleep apnea (adult)(pediatric) malnutrition of mild degree acute respiratory failure other encephalopathy sepsis delirium due to conditions classified elsewhere unspecified septicemia pneumonia due to hemophilus influenzae [h. influenzae] oliguria and anuria chronic obstructive asthma with (acute) exacerbation fall from other slipping, tripping, or stumbling closed fracture of cervical vertebra, unspecified level syncope and collapse closed fracture of metacarpal bone(s), site unspecified dysthymic disorder asthma, unspecified type, unspecified esophageal reflux
white f 64 $nan$hematology blood hematocrit  41.0  %; hematology blood hemoglobin  12.7  g dl; hematology blood platelet count  283  k ul; chemistry blood anion gap  17  meq l; chemistry blood bicarbonate  27  meq l; chemistry blood chloride  94  meq l; chemistry blood creatinine  0.7  mg dl; chemistry blood potassium  4.4  meq l; chemistry blood sodium  134  meq l; chemistry blood urea nitrogen  34  mg dl; chemistry blood glucose  186  mg dl$sodium chloride 0.9%  flush  3  ml ; albuterol 0.083% neb soln  1  neb ; ipratropium bromide neb  1  neb ; heparin  5000  unit ; ascorbic acid  1000  mg ; clonazepam  1  mg ; docusate sodium  200  mg ; fish oil (omega 3)  1000  mg ; fluticasone propionate 110mcg  2  puff ; fluticasone propionate nasal  2  spry ; fluticasone-salmeterol diskus (500 50)   1  inh ; ibuprofen  600  mg ; ketoconazole 2%   1  appl ; levothyroxine sodium  25  mcg ; montelukast  10  mg ; multivitamins  1  tab ; oxybutynin  5  mg ; pantoprazole  40  mg ; polyethylene glycol  34  g ; ranitidine  300  mg ; senna  17.2  mg ; tiotropium bromide  1  cap ; vitamin d  2000  unit ; doxepin hcl  325  mg ; fexofenadine  180  mg ; risperidone  6  mg ; doxycycline hyclate  100  mg ; benzonatate  200  mg ; ipratropium-albuterol neb  1  neb ; calcium carbonate  1250  mg ; methylprednisolone sodium succ  125  mg ; ramelteon  8  mg ; 
personal history of nicotine dependence hypothyroidism, unspecified constipation, unspecified chronic obstructive pulmonary disease with (acute) exacerbation acute and chronic respiratory failure with hypoxia gastro-esophageal reflux disease without esophagitis dependence on supplemental oxygen obstructive sleep apnea (adult) (pediatric) insomnia, unspecified pneumonia, unspecified organism body mass index (bmi) 40.0-44.9, adult localized edema anxiety disorder, unspecified morbid (severe) obesity with alveolar hypoventilation unspecified asthma, uncomplicated do not resuscitate foreign body accidentally entering other orifice major depressive affective disorder, single episode, unspecified acidosis foreign body in larynx benign essential hypertension other convulsions adrenal cortical steroids causing adverse effects in therapeutic use hypovolemia tobacco use disorder obstructive sleep apnea (adult)(pediatric) malnutrition of mild degree acute respiratory failure other encephalopathy sepsis delirium due to conditions classified elsewhere unspecified septicemia pneumonia due to hemophilus influenzae [h. influenzae] oliguria and anuria chronic obstructive asthma with (acute) exacerbation fall from other slipping, tripping, or stumbling closed fracture of cervical vertebra, unspecified level syncope and collapse closed fracture of metacarpal bone(s), site unspecified dysthymic disorder asthma, unspecified type, unspecified esophageal reflux
white f 64 $nan$nan$sodium chloride 0.9%  flush  3  ml ; albuterol 0.083% neb soln  1  neb ; ipratropium bromide neb  1  neb ; heparin  5000  unit ; ascorbic acid  1000  mg ; clonazepam  1  mg ; docusate sodium  200  mg ; fish oil (omega 3)  1000  mg ; fluticasone propionate 110mcg  2  puff ; fluticasone propionate nasal  2  spry ; fluticasone-salmeterol diskus (500 50)   1  inh ; ibuprofen  600  mg ; ketoconazole 2%   1  appl ; levothyroxine sodium  25  mcg ; montelukast  10  mg ; multivitamins  1  tab ; oxybutynin  5  mg ; pantoprazole  40  mg ; polyethylene glycol  34  g ; ranitidine  300  mg ; senna  17.2  mg ; tiotropium bromide  1  cap ; vitamin d  2000  unit ; doxepin hcl  325  mg ; fexofenadine  180  mg ; risperidone  6  mg ; doxycycline hyclate  100  mg ; benzonatate  200  mg ; ipratropium-albuterol neb  1  neb ; calcium carbonate  1250  mg ; ramelteon  8  mg ; 
personal history of nicotine dependence hypothyroidism, unspecified constipation, unspecified chronic obstructive pulmonary disease with (acute) exacerbation acute and chronic respiratory failure with hypoxia gastro-esophageal reflux disease without esophagitis dependence on supplemental oxygen obstructive sleep apnea (adult) (pediatric) insomnia, unspecified pneumonia, unspecified organism body mass index (bmi) 40.0-44.9, adult localized edema anxiety disorder, unspecified morbid (severe) obesity with alveolar hypoventilation unspecified asthma, uncomplicated do not resuscitate foreign body accidentally entering other orifice major depressive affective disorder, single episode, unspecified acidosis foreign body in larynx benign essential hypertension other convulsions adrenal cortical steroids causing adverse effects in therapeutic use hypovolemia tobacco use disorder obstructive sleep apnea (adult)(pediatric) malnutrition of mild degree acute respiratory failure other encephalopathy sepsis delirium due to conditions classified elsewhere unspecified septicemia pneumonia due to hemophilus influenzae [h. influenzae] oliguria and anuria chronic obstructive asthma with (acute) exacerbation fall from other slipping, tripping, or stumbling closed fracture of cervical vertebra, unspecified level syncope and collapse closed fracture of metacarpal bone(s), site unspecified dysthymic disorder asthma, unspecified type, unspecified esophageal reflux
white f 64 $nan$nan$sodium chloride 0.9%  flush  3  ml ; albuterol 0.083% neb soln  1  neb ; ipratropium bromide neb  1  neb ; heparin  5000  unit ; ascorbic acid  1000  mg ; clonazepam  1  mg ; docusate sodium  200  mg ; fish oil (omega 3)  1000  mg ; fluticasone propionate 110mcg  2  puff ; fluticasone propionate nasal  2  spry ; fluticasone-salmeterol diskus (500 50)   1  inh ; ibuprofen  600  mg ; ketoconazole 2%   1  appl ; levothyroxine sodium  25  mcg ; montelukast  10  mg ; multivitamins  1  tab ; oxybutynin  5  mg ; pantoprazole  40  mg ; polyethylene glycol  34  g ; ranitidine  300  mg ; senna  17.2  mg ; tiotropium bromide  1  cap ; vitamin d  2000  unit ; doxepin hcl  325  mg ; fexofenadine  180  mg ; risperidone  6  mg ; doxycycline hyclate  100  mg ; benzonatate  200  mg ; ipratropium-albuterol neb  1  neb ; calcium carbonate  1250  mg ; ramelteon  8  mg ; 
personal history of nicotine dependence hypothyroidism, unspecified constipation, unspecified chronic obstructive pulmonary disease with (acute) exacerbation acute and chronic respiratory failure with hypoxia gastro-esophageal reflux disease without esophagitis dependence on supplemental oxygen obstructive sleep apnea (adult) (pediatric) insomnia, unspecified pneumonia, unspecified organism body mass index (bmi) 40.0-44.9, adult localized edema anxiety disorder, unspecified morbid (severe) obesity with alveolar hypoventilation unspecified asthma, uncomplicated do not resuscitate foreign body accidentally entering other orifice major depressive affective disorder, single episode, unspecified acidosis foreign body in larynx benign essential hypertension other convulsions adrenal cortical steroids causing adverse effects in therapeutic use hypovolemia tobacco use disorder obstructive sleep apnea (adult)(pediatric) malnutrition of mild degree acute respiratory failure other encephalopathy sepsis delirium due to conditions classified elsewhere unspecified septicemia pneumonia due to hemophilus influenzae [h. influenzae] oliguria and anuria chronic obstructive asthma with (acute) exacerbation fall from other slipping, tripping, or stumbling closed fracture of cervical vertebra, unspecified level syncope and collapse closed fracture of metacarpal bone(s), site unspecified dysthymic disorder asthma, unspecified type, unspecified esophageal reflux
white f 64 $nan$nan$sodium chloride 0.9%  flush  3  ml ; albuterol 0.083% neb soln  1  neb ; heparin  5000  unit ; ascorbic acid  1000  mg ; clonazepam  1  mg ; docusate sodium  200  mg ; fish oil (omega 3)  1000  mg ; fluticasone propionate nasal  2  spry ; fluticasone-salmeterol diskus (500 50)   1  inh ; ibuprofen  600  mg ; ketoconazole 2%   1  appl ; levothyroxine sodium  25  mcg ; montelukast  10  mg ; multivitamins  1  tab ; oxybutynin  5  mg ; pantoprazole  40  mg ; polyethylene glycol  34  g ; ranitidine  300  mg ; senna  17.2  mg ; tiotropium bromide  1  cap ; vitamin d  2000  unit ; doxepin hcl  325  mg ; fexofenadine  180  mg ; risperidone  6  mg ; doxycycline hyclate  100  mg ; benzonatate  200  mg ; ipratropium-albuterol neb  1  neb ; calcium carbonate  1250  mg ; ramelteon  8  mg ; prednisone  50  mg ; 
personal history of nicotine dependence hypothyroidism, unspecified constipation, unspecified chronic obstructive pulmonary disease with (acute) exacerbation acute and chronic respiratory failure with hypoxia gastro-esophageal reflux disease without esophagitis dependence on supplemental oxygen obstructive sleep apnea (adult) (pediatric) insomnia, unspecified pneumonia, unspecified organism body mass index (bmi) 40.0-44.9, adult localized edema anxiety disorder, unspecified morbid (severe) obesity with alveolar hypoventilation unspecified asthma, uncomplicated do not resuscitate foreign body accidentally entering other orifice major depressive affective disorder, single episode, unspecified acidosis foreign body in larynx benign essential hypertension other convulsions adrenal cortical steroids causing adverse effects in therapeutic use hypovolemia tobacco use disorder obstructive sleep apnea (adult)(pediatric) malnutrition of mild degree acute respiratory failure other encephalopathy sepsis delirium due to conditions classified elsewhere unspecified septicemia pneumonia due to hemophilus influenzae [h. influenzae] oliguria and anuria chronic obstructive asthma with (acute) exacerbation fall from other slipping, tripping, or stumbling closed fracture of cervical vertebra, unspecified level syncope and collapse closed fracture of metacarpal bone(s), site unspecified dysthymic disorder asthma, unspecified type, unspecified esophageal reflux
white f 64 $nan$nan$sodium chloride 0.9%  flush  3  ml ; albuterol 0.083% neb soln  1  neb ; heparin  5000  unit ; ascorbic acid  1000  mg ; clonazepam  1  mg ; docusate sodium  200  mg ; fish oil (omega 3)  1000  mg ; fluticasone propionate nasal  2  spry ; fluticasone-salmeterol diskus (500 50)   1  inh ; ibuprofen  600  mg ; ketoconazole 2%   1  appl ; levothyroxine sodium  25  mcg ; montelukast  10  mg ; multivitamins  1  tab ; oxybutynin  5  mg ; pantoprazole  40  mg ; polyethylene glycol  34  g ; ranitidine  300  mg ; senna  17.2  mg ; tiotropium bromide  1  cap ; vitamin d  2000  unit ; doxepin hcl  325  mg ; fexofenadine  180  mg ; risperidone  6  mg ; doxycycline hyclate  100  mg ; benzonatate  200  mg ; ipratropium-albuterol neb  1  neb ; calcium carbonate  1250  mg ; ramelteon  8  mg ; prednisone  50  mg ; 
personal history of nicotine dependence hypothyroidism, unspecified constipation, unspecified chronic obstructive pulmonary disease with (acute) exacerbation acute and chronic respiratory failure with hypoxia gastro-esophageal reflux disease without esophagitis dependence on supplemental oxygen obstructive sleep apnea (adult) (pediatric) insomnia, unspecified pneumonia, unspecified organism body mass index (bmi) 40.0-44.9, adult localized edema anxiety disorder, unspecified morbid (severe) obesity with alveolar hypoventilation unspecified asthma, uncomplicated do not resuscitate foreign body accidentally entering other orifice major depressive affective disorder, single episode, unspecified acidosis foreign body in larynx benign essential hypertension other convulsions adrenal cortical steroids causing adverse effects in therapeutic use hypovolemia tobacco use disorder obstructive sleep apnea (adult)(pediatric) malnutrition of mild degree acute respiratory failure other encephalopathy sepsis delirium due to conditions classified elsewhere unspecified septicemia pneumonia due to hemophilus influenzae [h. influenzae] oliguria and anuria chronic obstructive asthma with (acute) exacerbation fall from other slipping, tripping, or stumbling closed fracture of cervical vertebra, unspecified level syncope and collapse closed fracture of metacarpal bone(s), site unspecified dysthymic disorder asthma, unspecified type, unspecified esophageal reflux
white f 85 $nan$nan$insulin  22  unit ; 
intestinal infection due to other organism, not elsewhere classified anemia of other chronic disease chronic total occlusion of artery of the extremities chronic kidney disease, stage ii (mild) congestive heart failure, unspecified delirium due to conditions classified elsewhere personal history of malignant neoplasm of other parts of uterus personal history of malignant neoplasm of breast venous (peripheral) insufficiency, unspecified constipation, unspecified acute on chronic diastolic heart failure pressure ulcer, stage i diabetes with neurological manifestations, type ii or unspecified type, not stated as uncontrolled chronic airway obstruction, not elsewhere classified person boarding or alighting a pedal cycle injured in collision with pedestrian or animal osteoarthrosis, unspecified whether generalized or localized, site unspecified unspecified acquired hypothyroidism other persistent mental disorders due to conditions classified elsewhere coronary atherosclerosis of native coronary artery atherosclerosis of native arteries of the extremities, unspecified polyneuropathy in diabetes pressure ulcer, heel
white f 85 $nan$hematology blood hematocrit  36.3  %; hematology blood hematocrit  33.0  %; hematology blood hemoglobin  12.8  g dl; hematology blood hemoglobin  11.4  g dl; hematology blood platelet count  275  k ul; hematology blood platelet count  237  k ul; hematology blood platelet count  237  k ul; chemistry blood anion gap  14  meq l; chemistry blood anion gap  13  meq l; chemistry blood anion gap  12  meq l; chemistry blood bicarbonate  25  meq l; chemistry blood bicarbonate  30  meq l; chemistry blood bicarbonate  29  meq l; chemistry blood chloride  97  meq l; chemistry blood chloride  101  meq l; chemistry blood chloride  103  meq l; chemistry blood creatinine  1.1  mg dl; chemistry blood creatinine  1.2  mg dl; chemistry blood creatinine  1.3  mg dl; chemistry blood potassium  4.4  meq l; chemistry blood potassium  4.7  meq l; chemistry blood potassium  4.3  meq l; chemistry blood potassium  4.3  meq l; chemistry blood sodium  132  meq l; chemistry blood sodium  139  meq l; chemistry blood sodium  140  meq l; chemistry blood urea nitrogen  41  mg dl; chemistry blood urea nitrogen  41  mg dl; chemistry blood urea nitrogen  47  mg dl; hematology blood inr(pt)  1.2  ; hematology blood inr(pt)  1.1  ; hematology urine wbc  0-2  # hpf; chemistry blood calcium, total  9.4  mg dl; chemistry blood calcium, total  9.3  mg dl; chemistry blood bilirubin, indirect  0.4  mg dl; chemistry blood bilirubin, total  0.6  mg dl; chemistry blood glucose  285  mg dl; chemistry blood glucose  317  mg dl; chemistry blood glucose  217  mg dl; chemistry blood albumin  3.7  g dl; blood gas blood free calcium  1.21  mmol l; blood gas blood lactate  1.1  mmol l; blood gas blood lactate  0.8  mmol l; chemistry blood bilirubin, direct  0.2  mg dl; blood gas blood chloride, whole blood  98  meq l; blood gas blood glucose  297  mg dl; blood gas blood hematocrit, calculated  41  %; blood gas blood hemoglobin  13.5  g dl; blood gas blood potassium, whole blood  4.3  meq l; blood gas blood potassium, whole blood  4.3  meq l; blood gas blood sodium, whole blood  138  meq l; hematology urine glucose  neg  mg dl; hematology urine bilirubin  neg  mg dl$insulin  22  unit ; aspirin ec  325  mg ; levothyroxine sodium  50  mcg ; simvastatin  80  mg ; isosorbide mononitrate (extended release)  60  mg ; sodium chloride 0.9%  flush  3  ml ; 0.9% sodium chloride  250  ml ; fentanyl citrate  2.5  mg ; 0.9% sodium chloride  100  ml ; midazolam  100  mg ; vial  1  vial ; pantoprazole sodium  40  mg ; albuterol 0.083% neb soln  1  neb ; ipratropium bromide neb  1  neb ; insulin  0  unit ; heparin  5000  unit ; furosemide  40  mg ; carvedilol  12.5  mg ; chlorhexidine gluconate 0.12% oral rinse  15  ml ; albuterol-ipratropium  6-8  puff ; insulin  18  unit ; 
intestinal infection due to other organism, not elsewhere classified anemia of other chronic disease chronic total occlusion of artery of the extremities chronic kidney disease, stage ii (mild) congestive heart failure, unspecified delirium due to conditions classified elsewhere personal history of malignant neoplasm of other parts of uterus personal history of malignant neoplasm of breast venous (peripheral) insufficiency, unspecified constipation, unspecified acute on chronic diastolic heart failure pressure ulcer, stage i diabetes with neurological manifestations, type ii or unspecified type, not stated as uncontrolled chronic airway obstruction, not elsewhere classified person boarding or alighting a pedal cycle injured in collision with pedestrian or animal osteoarthrosis, unspecified whether generalized or localized, site unspecified unspecified acquired hypothyroidism other persistent mental disorders due to conditions classified elsewhere coronary atherosclerosis of native coronary artery atherosclerosis of native arteries of the extremities, unspecified polyneuropathy in diabetes pressure ulcer, heel
white f 85 $nan$hematology blood hematocrit  33.0  %; hematology blood hemoglobin  11.6  g dl; hematology blood platelet count  248  k ul; chemistry blood anion gap  12  meq l; chemistry blood bicarbonate  31  meq l; chemistry blood chloride  106  meq l; chemistry blood creatinine  1.5  mg dl; chemistry blood potassium  3.8  meq l; chemistry blood sodium  145  meq l; chemistry blood urea nitrogen  54  mg dl; chemistry blood calcium, total  8.7  mg dl; chemistry blood glucose  67  mg dl; blood gas blood free calcium  1.23  mmol l; blood gas blood lactate  0.9  mmol l$insulin  22  unit ; levothyroxine sodium  50  mcg ; simvastatin  80  mg ; isosorbide mononitrate (extended release)  60  mg ; sodium chloride 0.9%  flush  3  ml ; 0.9% sodium chloride  250  ml ; fentanyl citrate  2.5  mg ; 0.9% sodium chloride  100  ml ; midazolam  100  mg ; vial  1  vial ; pantoprazole sodium  40  mg ; insulin  0  unit ; heparin  5000  unit ; furosemide  40  mg ; carvedilol  12.5  mg ; chlorhexidine gluconate 0.12% oral rinse  15  ml ; albuterol-ipratropium  6-8  puff ; insulin  18  unit ; aspirin  325  mg ; clopidogrel  75  mg ; lisinopril  5  mg ; furosemide  80  mg ; isosorbide dinitrate  20  mg ; oxycodone (immediate release)   10  mg ; docusate sodium  100  mg ; dextrose 50%  12.5  gm ; olanzapine (disintegrating tablet)  5  mg ; gabapentin  300  mg ; 
intestinal infection due to other organism, not elsewhere classified anemia of other chronic disease chronic total occlusion of artery of the extremities chronic kidney disease, stage ii (mild) congestive heart failure, unspecified delirium due to conditions classified elsewhere personal history of malignant neoplasm of other parts of uterus personal history of malignant neoplasm of breast venous (peripheral) insufficiency, unspecified constipation, unspecified acute on chronic diastolic heart failure pressure ulcer, stage i diabetes with neurological manifestations, type ii or unspecified type, not stated as uncontrolled chronic airway obstruction, not elsewhere classified person boarding or alighting a pedal cycle injured in collision with pedestrian or animal osteoarthrosis, unspecified whether generalized or localized, site unspecified unspecified acquired hypothyroidism other persistent mental disorders due to conditions classified elsewhere coronary atherosclerosis of native coronary artery atherosclerosis of native arteries of the extremities, unspecified polyneuropathy in diabetes pressure ulcer, heel
white f 85 $nan$hematology blood hematocrit  33.2  %; hematology blood hemoglobin  11.8  g dl; hematology blood platelet count  238  k ul; chemistry blood anion gap  12  meq l; chemistry blood bicarbonate  30  meq l; chemistry blood chloride  103  meq l; chemistry blood creatinine  2.2  mg dl; chemistry blood potassium  4.0  meq l; chemistry blood sodium  141  meq l; chemistry blood urea nitrogen  60  mg dl; hematology urine wbc  21-50  # hpf; chemistry blood calcium, total  8.8  mg dl; chemistry blood glucose  89  mg dl; hematology urine glucose  neg  mg dl; hematology urine bilirubin  neg  mg dl$levothyroxine sodium  50  mcg ; simvastatin  80  mg ; sodium chloride 0.9%  flush  3  ml ; vial  1  vial ; pantoprazole sodium  40  mg ; heparin  5000  unit ; carvedilol  12.5  mg ; chlorhexidine gluconate 0.12% oral rinse  15  ml ; albuterol-ipratropium  6-8  puff ; insulin  18  unit ; aspirin  325  mg ; clopidogrel  75  mg ; lisinopril  5  mg ; furosemide  80  mg ; oxycodone (immediate release)   10  mg ; docusate sodium  100  mg ; dextrose 50%  12.5  gm ; olanzapine (disintegrating tablet)  5  mg ; gabapentin  300  mg ; pantoprazole  40  mg ; hyoscyamine  0.125  mg ; olanzapine  5  mg ; gabapentin  600  mg ; iso-osmotic dextrose  50  ml ; ceftriaxone  1  g ; lidocaine jelly 2% (urojet)  1  appl ; acetaminophen  500-1000  mg ; 
intestinal infection due to other organism, not elsewhere classified anemia of other chronic disease chronic total occlusion of artery of the extremities chronic kidney disease, stage ii (mild) congestive heart failure, unspecified delirium due to conditions classified elsewhere personal history of malignant neoplasm of other parts of uterus personal history of malignant neoplasm of breast venous (peripheral) insufficiency, unspecified constipation, unspecified acute on chronic diastolic heart failure pressure ulcer, stage i diabetes with neurological manifestations, type ii or unspecified type, not stated as uncontrolled chronic airway obstruction, not elsewhere classified person boarding or alighting a pedal cycle injured in collision with pedestrian or animal osteoarthrosis, unspecified whether generalized or localized, site unspecified unspecified acquired hypothyroidism other persistent mental disorders due to conditions classified elsewhere coronary atherosclerosis of native coronary artery atherosclerosis of native arteries of the extremities, unspecified polyneuropathy in diabetes pressure ulcer, heel
white f 85 $nan$hematology blood hematocrit  32.2  %; hematology blood hemoglobin  11.5  g dl; hematology blood platelet count  229  k ul; chemistry blood anion gap  15  meq l; chemistry blood anion gap  16  meq l; chemistry blood bicarbonate  27  meq l; chemistry blood bicarbonate  25  meq l; chemistry blood chloride  101  meq l; chemistry blood chloride  101  meq l; chemistry blood creatinine  2.8  mg dl; chemistry blood creatinine  3.0  mg dl; chemistry blood potassium  4.4  meq l; chemistry blood potassium  4.3  meq l; chemistry blood sodium  139  meq l; chemistry blood sodium  138  meq l; chemistry blood urea nitrogen  67  mg dl; chemistry blood urea nitrogen  70  mg dl; chemistry urine chloride, urine  35  meq l; chemistry urine creatinine, urine  149  mg dl; chemistry urine potassium, urine  45  meq l; chemistry urine sodium, urine  51  meq l; chemistry urine urea nitrogen, urine  286  mg dl; hematology urine wbc  44  # hpf; chemistry blood calcium, total  8.5  mg dl; chemistry blood glucose  190  mg dl; chemistry blood glucose  165  mg dl$5% dextrose  100  ml ; levothyroxine sodium  50  mcg ; simvastatin  80  mg ; sodium chloride 0.9%  flush  3  ml ; heparin  5000  unit ; carvedilol  12.5  mg ; chlorhexidine gluconate 0.12% oral rinse  15  ml ; albuterol-ipratropium  6-8  puff ; insulin  18  unit ; aspirin  325  mg ; clopidogrel  75  mg ; lisinopril  5  mg ; oxycodone (immediate release)   10  mg ; gabapentin  300  mg ; pantoprazole  40  mg ; hyoscyamine  0.125  mg ; olanzapine  5  mg ; gabapentin  600  mg ; iso-osmotic dextrose  50  ml ; ceftriaxone  1  g ; lidocaine jelly 2% (urojet)  1  appl ; acetaminophen  500-1000  mg ; albuterol-ipratropium  1-2  puff ; furosemide  120  mg ; metolazone  5  mg ; furosemide  160  mg ; omeprazole  20  mg ; lorazepam  0.5  mg ; 
intestinal infection due to other organism, not elsewhere classified anemia of other chronic disease chronic total occlusion of artery of the extremities chronic kidney disease, stage ii (mild) congestive heart failure, unspecified delirium due to conditions classified elsewhere personal history of malignant neoplasm of other parts of uterus personal history of malignant neoplasm of breast venous (peripheral) insufficiency, unspecified constipation, unspecified acute on chronic diastolic heart failure pressure ulcer, stage i diabetes with neurological manifestations, type ii or unspecified type, not stated as uncontrolled chronic airway obstruction, not elsewhere classified person boarding or alighting a pedal cycle injured in collision with pedestrian or animal osteoarthrosis, unspecified whether generalized or localized, site unspecified unspecified acquired hypothyroidism other persistent mental disorders due to conditions classified elsewhere coronary atherosclerosis of native coronary artery atherosclerosis of native arteries of the extremities, unspecified polyneuropathy in diabetes pressure ulcer, heel
white f 85 $nan$hematology blood hematocrit  29.0  %; hematology blood hemoglobin  10.3  g dl; hematology blood platelet count  220  k ul; chemistry blood anion gap  14  meq l; chemistry blood bicarbonate  27  meq l; chemistry blood chloride  99  meq l; chemistry blood creatinine  3.5  mg dl; chemistry blood potassium  4.4  meq l; chemistry blood sodium  136  meq l; chemistry blood urea nitrogen  79  mg dl; hematology blood inr(pt)  1.1  ; chemistry blood calcium, total  8.1  mg dl; chemistry blood glucose  118  mg dl$5% dextrose  100  ml ; levothyroxine sodium  50  mcg ; simvastatin  80  mg ; sodium chloride 0.9%  flush  3  ml ; heparin  5000  unit ; carvedilol  12.5  mg ; chlorhexidine gluconate 0.12% oral rinse  15  ml ; insulin  18  unit ; aspirin  325  mg ; clopidogrel  75  mg ; oxycodone (immediate release)   10  mg ; gabapentin  300  mg ; pantoprazole  40  mg ; hyoscyamine  0.125  mg ; olanzapine  5  mg ; lidocaine jelly 2% (urojet)  1  appl ; acetaminophen  500-1000  mg ; albuterol-ipratropium  1-2  puff ; furosemide  120  mg ; metolazone  5  mg ; furosemide  160  mg ; omeprazole  20  mg ; lorazepam  0.5  mg ; furosemide  100  mg ; sodium chloride 0.9%  flush  10  ml ; amoxicillin  500  mg ; aluminum hydroxide suspension  30  ml ; 
intestinal infection due to other organism, not elsewhere classified anemia of other chronic disease chronic total occlusion of artery of the extremities chronic kidney disease, stage ii (mild) congestive heart failure, unspecified delirium due to conditions classified elsewhere personal history of malignant neoplasm of other parts of uterus personal history of malignant neoplasm of breast venous (peripheral) insufficiency, unspecified constipation, unspecified acute on chronic diastolic heart failure pressure ulcer, stage i diabetes with neurological manifestations, type ii or unspecified type, not stated as uncontrolled chronic airway obstruction, not elsewhere classified person boarding or alighting a pedal cycle injured in collision with pedestrian or animal osteoarthrosis, unspecified whether generalized or localized, site unspecified unspecified acquired hypothyroidism other persistent mental disorders due to conditions classified elsewhere coronary atherosclerosis of native coronary artery atherosclerosis of native arteries of the extremities, unspecified polyneuropathy in diabetes pressure ulcer, heel
white f 85 $nan$hematology blood hematocrit  29.7  %; hematology blood hemoglobin  10.2  g dl; hematology blood platelet count  220  k ul; chemistry blood anion gap  18  meq l; chemistry blood anion gap  17  meq l; chemistry blood bicarbonate  23  meq l; chemistry blood bicarbonate  25  meq l; chemistry blood chloride  98  meq l; chemistry blood chloride  98  meq l; chemistry blood creatinine  3.9  mg dl; chemistry blood creatinine  4.2  mg dl; chemistry blood potassium  4.6  meq l; chemistry blood potassium  5.0  meq l; chemistry blood sodium  134  meq l; chemistry blood sodium  135  meq l; chemistry blood urea nitrogen  80  mg dl; chemistry blood urea nitrogen  85  mg dl; chemistry blood calcium, total  8.1  mg dl; chemistry blood glucose  186  mg dl; chemistry blood glucose  133  mg dl$levothyroxine sodium  50  mcg ; simvastatin  80  mg ; sodium chloride 0.9%  flush  3  ml ; heparin  5000  unit ; carvedilol  12.5  mg ; insulin  18  unit ; aspirin  325  mg ; clopidogrel  75  mg ; oxycodone (immediate release)   10  mg ; gabapentin  300  mg ; hyoscyamine  0.125  mg ; olanzapine  5  mg ; lidocaine jelly 2% (urojet)  1  appl ; acetaminophen  500-1000  mg ; albuterol-ipratropium  1-2  puff ; omeprazole  20  mg ; lorazepam  0.5  mg ; sodium chloride 0.9%  flush  10  ml ; amoxicillin  500  mg ; aluminum hydroxide suspension  30  ml ; acetaminophen  1000  mg ; senna  1  tab ; oxycodone (immediate release)   5-10  mg ; miconazole powder 2%  1  appl ; 
intestinal infection due to other organism, not elsewhere classified anemia of other chronic disease chronic total occlusion of artery of the extremities chronic kidney disease, stage ii (mild) congestive heart failure, unspecified delirium due to conditions classified elsewhere personal history of malignant neoplasm of other parts of uterus personal history of malignant neoplasm of breast venous (peripheral) insufficiency, unspecified constipation, unspecified acute on chronic diastolic heart failure pressure ulcer, stage i diabetes with neurological manifestations, type ii or unspecified type, not stated as uncontrolled chronic airway obstruction, not elsewhere classified person boarding or alighting a pedal cycle injured in collision with pedestrian or animal osteoarthrosis, unspecified whether generalized or localized, site unspecified unspecified acquired hypothyroidism other persistent mental disorders due to conditions classified elsewhere coronary atherosclerosis of native coronary artery atherosclerosis of native arteries of the extremities, unspecified polyneuropathy in diabetes pressure ulcer, heel
white f 85 $nan$hematology blood hematocrit  26.4  %; hematology blood hemoglobin  9.4  g dl; hematology blood platelet count  232  k ul; chemistry blood anion gap  17  meq l; chemistry blood anion gap  18  meq l; chemistry blood bicarbonate  24  meq l; chemistry blood bicarbonate  24  meq l; chemistry blood chloride  97  meq l; chemistry blood chloride  99  meq l; chemistry blood creatinine  3.7  mg dl; chemistry blood creatinine  3.0  mg dl; chemistry blood potassium  4.9  meq l; chemistry blood potassium  4.9  meq l; chemistry blood sodium  133  meq l; chemistry blood sodium  136  meq l; chemistry blood urea nitrogen  85  mg dl; chemistry blood urea nitrogen  83  mg dl; chemistry urine creatinine, urine  74  mg dl; chemistry urine sodium, urine  48  meq l; chemistry urine urea nitrogen, urine  404  mg dl; hematology urine wbc  5  # hpf; chemistry blood calcium, total  8.6  mg dl; chemistry blood calcium, total  8.4  mg dl; chemistry blood glucose  112  mg dl$levothyroxine sodium  50  mcg ; simvastatin  80  mg ; sodium chloride 0.9%  flush  3  ml ; heparin  5000  unit ; carvedilol  12.5  mg ; insulin  18  unit ; aspirin  325  mg ; clopidogrel  75  mg ; gabapentin  300  mg ; hyoscyamine  0.125  mg ; olanzapine  5  mg ; lidocaine jelly 2% (urojet)  1  appl ; albuterol-ipratropium  1-2  puff ; omeprazole  20  mg ; lorazepam  0.5  mg ; sodium chloride 0.9%  flush  10  ml ; amoxicillin  500  mg ; aluminum hydroxide suspension  30  ml ; acetaminophen  1000  mg ; senna  1  tab ; oxycodone (immediate release)   5-10  mg ; miconazole powder 2%  1  appl ; amoxicillin-clavulanic acid  500  mg ; calcium acetate  667  mg ; 
intestinal infection due to other organism, not elsewhere classified anemia of other chronic disease chronic total occlusion of artery of the extremities chronic kidney disease, stage ii (mild) congestive heart failure, unspecified delirium due to conditions classified elsewhere personal history of malignant neoplasm of other parts of uterus personal history of malignant neoplasm of breast venous (peripheral) insufficiency, unspecified constipation, unspecified acute on chronic diastolic heart failure pressure ulcer, stage i diabetes with neurological manifestations, type ii or unspecified type, not stated as uncontrolled chronic airway obstruction, not elsewhere classified person boarding or alighting a pedal cycle injured in collision with pedestrian or animal osteoarthrosis, unspecified whether generalized or localized, site unspecified unspecified acquired hypothyroidism other persistent mental disorders due to conditions classified elsewhere coronary atherosclerosis of native coronary artery atherosclerosis of native arteries of the extremities, unspecified polyneuropathy in diabetes pressure ulcer, heel
white f 85 $nan$hematology blood hematocrit  29.3  %; hematology blood hematocrit  35.1  %; hematology blood hemoglobin  12.2  g dl; hematology blood platelet count  211  k ul; chemistry blood anion gap  15  meq l; chemistry blood anion gap  13  meq l; chemistry blood bicarbonate  26  meq l; chemistry blood bicarbonate  28  meq l; chemistry blood chloride  96  meq l; chemistry blood chloride  99  meq l; chemistry blood creatinine  2.5  mg dl; chemistry blood creatinine  1.8  mg dl; chemistry blood potassium  5.0  meq l; chemistry blood potassium  5.0  meq l; chemistry blood sodium  132  meq l; chemistry blood sodium  135  meq l; chemistry blood urea nitrogen  76  mg dl; chemistry blood urea nitrogen  68  mg dl; chemistry blood calcium, total  9.2  mg dl; chemistry blood glucose  171  mg dl; chemistry blood glucose  154  mg dl$levothyroxine sodium  50  mcg ; simvastatin  80  mg ; sodium chloride 0.9%  flush  3  ml ; heparin  5000  unit ; carvedilol  12.5  mg ; insulin  18  unit ; aspirin  325  mg ; clopidogrel  75  mg ; gabapentin  300  mg ; hyoscyamine  0.125  mg ; olanzapine  5  mg ; lidocaine jelly 2% (urojet)  1  appl ; albuterol-ipratropium  1-2  puff ; omeprazole  20  mg ; lorazepam  0.5  mg ; sodium chloride 0.9%  flush  10  ml ; acetaminophen  1000  mg ; senna  1  tab ; miconazole powder 2%  1  appl ; amoxicillin-clavulanic acid  500  mg ; calcium acetate  667  mg ; lidocaine 5% patch  1  ptch ; oxycodone (immediate release)   5  mg ; fluticasone propionate nasal  2  spry ; fluticasone-salmeterol diskus (250 50)   1  inh ; 
intestinal infection due to other organism, not elsewhere classified anemia of other chronic disease chronic total occlusion of artery of the extremities chronic kidney disease, stage ii (mild) congestive heart failure, unspecified delirium due to conditions classified elsewhere personal history of malignant neoplasm of other parts of uterus personal history of malignant neoplasm of breast venous (peripheral) insufficiency, unspecified constipation, unspecified acute on chronic diastolic heart failure pressure ulcer, stage i diabetes with neurological manifestations, type ii or unspecified type, not stated as uncontrolled chronic airway obstruction, not elsewhere classified person boarding or alighting a pedal cycle injured in collision with pedestrian or animal osteoarthrosis, unspecified whether generalized or localized, site unspecified unspecified acquired hypothyroidism other persistent mental disorders due to conditions classified elsewhere coronary atherosclerosis of native coronary artery atherosclerosis of native arteries of the extremities, unspecified polyneuropathy in diabetes pressure ulcer, heel
white f 85 $nan$nan$fluticasone propionate nasal  2  spry ; carvedilol  25  mg ; polyethylene glycol  17  g ; 
intestinal infection due to other organism, not elsewhere classified anemia of other chronic disease chronic total occlusion of artery of the extremities chronic kidney disease, stage ii (mild) congestive heart failure, unspecified delirium due to conditions classified elsewhere personal history of malignant neoplasm of other parts of uterus personal history of malignant neoplasm of breast venous (peripheral) insufficiency, unspecified constipation, unspecified acute on chronic diastolic heart failure pressure ulcer, stage i diabetes with neurological manifestations, type ii or unspecified type, not stated as uncontrolled chronic airway obstruction, not elsewhere classified person boarding or alighting a pedal cycle injured in collision with pedestrian or animal osteoarthrosis, unspecified whether generalized or localized, site unspecified unspecified acquired hypothyroidism other persistent mental disorders due to conditions classified elsewhere coronary atherosclerosis of native coronary artery atherosclerosis of native arteries of the extremities, unspecified polyneuropathy in diabetes pressure ulcer, heel
white f 85 $nan$hematology blood hematocrit  30.6  %; hematology blood hematocrit  28.7  %; hematology blood hemoglobin  10.8  g dl; hematology blood hemoglobin  9.9  g dl; hematology blood platelet count  272  k ul; hematology blood platelet count  294  k ul; chemistry blood anion gap  14  meq l; chemistry blood anion gap  11  meq l; chemistry blood bicarbonate  27  meq l; chemistry blood bicarbonate  31  meq l; chemistry blood chloride  102  meq l; chemistry blood chloride  101  meq l; chemistry blood creatinine  1.4  mg dl; chemistry blood creatinine  1.4  mg dl; chemistry blood potassium  5.2  meq l; chemistry blood potassium  4.8  meq l; chemistry blood potassium  4.4  meq l; chemistry blood sodium  138  meq l; chemistry blood sodium  139  meq l; chemistry blood urea nitrogen  56  mg dl; chemistry blood urea nitrogen  53  mg dl; chemistry blood calcium, total  9.2  mg dl; chemistry blood calcium, total  8.9  mg dl; chemistry blood glucose  178  mg dl; chemistry blood glucose  131  mg dl$fluticasone propionate nasal  2  spry ; carvedilol  25  mg ; polyethylene glycol  17  g ; furosemide  60  mg ; bumetanide  2  mg ; sulfameth trimethoprim ss  1  tab ; alteplase (catheter clearance)  2  mg ; sodium polystyrene sulfonate  30  gm ; bisacodyl  10  mg ; 
intestinal infection due to other organism, not elsewhere classified anemia of other chronic disease chronic total occlusion of artery of the extremities chronic kidney disease, stage ii (mild) congestive heart failure, unspecified delirium due to conditions classified elsewhere personal history of malignant neoplasm of other parts of uterus personal history of malignant neoplasm of breast venous (peripheral) insufficiency, unspecified constipation, unspecified acute on chronic diastolic heart failure pressure ulcer, stage i diabetes with neurological manifestations, type ii or unspecified type, not stated as uncontrolled chronic airway obstruction, not elsewhere classified person boarding or alighting a pedal cycle injured in collision with pedestrian or animal osteoarthrosis, unspecified whether generalized or localized, site unspecified unspecified acquired hypothyroidism other persistent mental disorders due to conditions classified elsewhere coronary atherosclerosis of native coronary artery atherosclerosis of native arteries of the extremities, unspecified polyneuropathy in diabetes pressure ulcer, heel
white f 85 $nan$hematology blood hematocrit  29.4  %; hematology blood hemoglobin  10.1  g dl; hematology blood platelet count  328  k ul; chemistry blood anion gap  11  meq l; chemistry blood bicarbonate  31  meq l; chemistry blood chloride  100  meq l; chemistry blood creatinine  1.5  mg dl; chemistry blood potassium  4.2  meq l; chemistry blood sodium  138  meq l; chemistry blood urea nitrogen  49  mg dl; chemistry blood calcium, total  9.1  mg dl; chemistry blood glucose  160  mg dl$fluticasone propionate nasal  2  spry ; carvedilol  25  mg ; bumetanide  2  mg ; sulfameth trimethoprim ss  1  tab ; alteplase (catheter clearance)  2  mg ; bisacodyl  10  mg ; 
intestinal infection due to other organism, not elsewhere classified anemia of other chronic disease chronic total occlusion of artery of the extremities chronic kidney disease, stage ii (mild) congestive heart failure, unspecified delirium due to conditions classified elsewhere personal history of malignant neoplasm of other parts of uterus personal history of malignant neoplasm of breast venous (peripheral) insufficiency, unspecified constipation, unspecified acute on chronic diastolic heart failure pressure ulcer, stage i diabetes with neurological manifestations, type ii or unspecified type, not stated as uncontrolled chronic airway obstruction, not elsewhere classified person boarding or alighting a pedal cycle injured in collision with pedestrian or animal osteoarthrosis, unspecified whether generalized or localized, site unspecified unspecified acquired hypothyroidism other persistent mental disorders due to conditions classified elsewhere coronary atherosclerosis of native coronary artery atherosclerosis of native arteries of the extremities, unspecified polyneuropathy in diabetes pressure ulcer, heel
white f 85 $nan$nan$fluticasone propionate nasal  2  spry ; carvedilol  25  mg ; bumetanide  2  mg ; sulfameth trimethoprim ss  1  tab ; alteplase (catheter clearance)  2  mg ; bisacodyl  10  mg ; 
intestinal infection due to other organism, not elsewhere classified anemia of other chronic disease chronic total occlusion of artery of the extremities chronic kidney disease, stage ii (mild) congestive heart failure, unspecified delirium due to conditions classified elsewhere personal history of malignant neoplasm of other parts of uterus personal history of malignant neoplasm of breast venous (peripheral) insufficiency, unspecified constipation, unspecified acute on chronic diastolic heart failure pressure ulcer, stage i diabetes with neurological manifestations, type ii or unspecified type, not stated as uncontrolled chronic airway obstruction, not elsewhere classified person boarding or alighting a pedal cycle injured in collision with pedestrian or animal osteoarthrosis, unspecified whether generalized or localized, site unspecified unspecified acquired hypothyroidism other persistent mental disorders due to conditions classified elsewhere coronary atherosclerosis of native coronary artery atherosclerosis of native arteries of the extremities, unspecified polyneuropathy in diabetes pressure ulcer, heel
white m 63 $nan$hematology blood hematocrit  35.3  %; hematology blood hemoglobin  11.8  g dl; hematology blood platelet count  222  k ul; chemistry blood anion gap  31  meq l; chemistry blood bicarbonate  18  meq l; chemistry blood chloride  95  meq l; chemistry blood creatinine  7.4  mg dl; chemistry blood potassium  3.5  meq l; chemistry blood sodium  140  meq l; chemistry blood urea nitrogen  50  mg dl; hematology urine wbc  1  # hpf; chemistry blood calcium, total  12.1  mg dl; chemistry blood glucose  162  mg dl; hematology urine glucose  300  mg dl$insulin  15  unit ; sodium chloride 0.9%  flush  3  ml ; heparin  5000  unit ; allopurinol  150  mg ; atorvastatin  80  mg ; dextrose 50%  12.5  gm ; glucagon  1  mg ; glucose gel  15  g ; insulin  0  unit ; aspirin  81  mg ; fish oil (omega 3)  1000  mg ; levothyroxine sodium  88  mcg ; sertraline  250  mg ; sevelamer carbonate  1600  mg ; lidocaine 1%  1  ml ; sodium chloride 0.9%  1000  ml ; insulin  2  unit ; 
hypotension of hemodialysis hypertensive chronic kidney disease with stage 5 chronic kidney disease or end stage renal disease restless legs syndrome hyperlipidemia, unspecified type 2 diabetes mellitus with diabetic chronic kidney disease encounter for examination for normal comparison and control in clinical research program severe sepsis with septic shock other fall on same level, initial encounter dizziness and giddiness hypothyroidism, unspecified anemia in chronic kidney disease major depressive disorder, single episode, unspecified urinary tract infection, site not specified patient bathroom in hospital as the place of occurrence of the external cause end stage renal disease other streptococcal sepsis personal history of malignant neoplasm of prostate chronic gout, unspecified, without tophus (tophi) kidney dialysis as the cause of abnormal reaction of the patient, or of later complication, without mention of misadventure at the time of the procedure personal history of other venous thrombosis and embolism chronic gout, unspecified, without tophus (tophi) end stage renal disease type 2 diabetes mellitus with diabetic nephropathy major depressive disorder, single episode, unspecified anemia in chronic kidney disease osteoarthritis of knee, unspecified hypothyroidism, unspecified awaiting organ transplant status hypertensive chronic kidney disease with stage 5 chronic kidney disease or end stage renal disease personal history of other venous thrombosis and embolism restless legs syndrome personal history of malignant neoplasm of prostate type 2 diabetes mellitus with diabetic chronic kidney disease 
white m 63 $nan$hematology blood hematocrit  32.1  %; hematology blood hemoglobin  10.9  g dl; hematology blood platelet count  221  k ul; chemistry blood anion gap  22  meq l; chemistry blood bicarbonate  23  meq l; chemistry blood chloride  99  meq l; chemistry blood creatinine  8.8  mg dl; chemistry blood potassium  3.1  meq l; chemistry blood sodium  141  meq l; chemistry blood urea nitrogen  54  mg dl; chemistry blood calcium, total  10.6  mg dl; chemistry blood glucose  142  mg dl$sodium chloride 0.9%  flush  3  ml ; heparin  5000  unit ; allopurinol  150  mg ; atorvastatin  80  mg ; dextrose 50%  12.5  gm ; glucagon  1  mg ; glucose gel  15  g ; aspirin  81  mg ; fish oil (omega 3)  1000  mg ; levothyroxine sodium  88  mcg ; sertraline  250  mg ; sevelamer carbonate  1600  mg ; lidocaine 1%  1  ml ; sodium chloride 0.9%  1000  ml ; insulin  2  unit ; insulin  30  unit ; calcium carbonate  500  mg ; 
hypotension of hemodialysis hypertensive chronic kidney disease with stage 5 chronic kidney disease or end stage renal disease restless legs syndrome hyperlipidemia, unspecified type 2 diabetes mellitus with diabetic chronic kidney disease encounter for examination for normal comparison and control in clinical research program severe sepsis with septic shock other fall on same level, initial encounter dizziness and giddiness hypothyroidism, unspecified anemia in chronic kidney disease major depressive disorder, single episode, unspecified urinary tract infection, site not specified patient bathroom in hospital as the place of occurrence of the external cause end stage renal disease other streptococcal sepsis personal history of malignant neoplasm of prostate chronic gout, unspecified, without tophus (tophi) kidney dialysis as the cause of abnormal reaction of the patient, or of later complication, without mention of misadventure at the time of the procedure personal history of other venous thrombosis and embolism chronic gout, unspecified, without tophus (tophi) end stage renal disease type 2 diabetes mellitus with diabetic nephropathy major depressive disorder, single episode, unspecified anemia in chronic kidney disease osteoarthritis of knee, unspecified hypothyroidism, unspecified awaiting organ transplant status hypertensive chronic kidney disease with stage 5 chronic kidney disease or end stage renal disease personal history of other venous thrombosis and embolism restless legs syndrome personal history of malignant neoplasm of prostate type 2 diabetes mellitus with diabetic chronic kidney disease 
white m 63 $nan$nan$sodium chloride 0.9%  flush  3  ml ; heparin  5000  unit ; allopurinol  150  mg ; atorvastatin  80  mg ; dextrose 50%  12.5  gm ; glucagon  1  mg ; glucose gel  15  g ; aspirin  81  mg ; fish oil (omega 3)  1000  mg ; levothyroxine sodium  88  mcg ; sertraline  250  mg ; sevelamer carbonate  1600  mg ; lidocaine 1%  1  ml ; insulin  2  unit ; insulin  30  unit ; calcium carbonate  500  mg ; 
hypotension of hemodialysis hypertensive chronic kidney disease with stage 5 chronic kidney disease or end stage renal disease restless legs syndrome hyperlipidemia, unspecified type 2 diabetes mellitus with diabetic chronic kidney disease encounter for examination for normal comparison and control in clinical research program severe sepsis with septic shock other fall on same level, initial encounter dizziness and giddiness hypothyroidism, unspecified anemia in chronic kidney disease major depressive disorder, single episode, unspecified urinary tract infection, site not specified patient bathroom in hospital as the place of occurrence of the external cause end stage renal disease other streptococcal sepsis personal history of malignant neoplasm of prostate chronic gout, unspecified, without tophus (tophi) kidney dialysis as the cause of abnormal reaction of the patient, or of later complication, without mention of misadventure at the time of the procedure personal history of other venous thrombosis and embolism chronic gout, unspecified, without tophus (tophi) end stage renal disease type 2 diabetes mellitus with diabetic nephropathy major depressive disorder, single episode, unspecified anemia in chronic kidney disease osteoarthritis of knee, unspecified hypothyroidism, unspecified awaiting organ transplant status hypertensive chronic kidney disease with stage 5 chronic kidney disease or end stage renal disease personal history of other venous thrombosis and embolism restless legs syndrome personal history of malignant neoplasm of prostate type 2 diabetes mellitus with diabetic chronic kidney disease 
white m 61 $nan$nan$insulin  36  unit ; aspirin ec  325  mg ; clopidogrel  75  mg ; digoxin  0.25  mg ; quinapril  20  mg ; 
 
white m 61 $nan$hematology blood hematocrit  36.8  %; hematology blood platelet count  204  k ul; hematology blood platelet count  189  k ul; hematology blood platelet count  200  k ul; chemistry blood creatinine  0.9  mg dl; chemistry blood potassium  4.0  meq l; chemistry blood potassium  4.2  meq l; chemistry blood urea nitrogen  11  mg dl$insulin  36  unit ; aspirin ec  325  mg ; clopidogrel  75  mg ; digoxin  0.25  mg ; quinapril  20  mg ; d5 1 2ns  1000  ml ; atropine sulfate  0.5  mg ; sw  100  ml ; eptifibatide  75  mg ; acetaminophen  650  mg ; nitroglycerin sl  0.3  mg ; aluminum-magnesium hydrox.-simethicone  30  ml ; simethicone  40-80  mg ; potassium chloride  20  meq ; potassium chloride  40  meq ; potassium chloride  60  meq ; sodium chloride 0.9%  flush  3  ml ; dextrose 50%  12.5  gm ; glucagon  1  mg ; insulin  0  unit ; 1 2 ns  1000  ml ; nateglinide  120  mg ; metoprolol tartrate  25  mg ; atorvastatin  40  mg ; 
 
white m 61 $nan$nan$insulin  36  unit ; aspirin ec  325  mg ; clopidogrel  75  mg ; digoxin  0.25  mg ; quinapril  20  mg ; atropine sulfate  0.5  mg ; acetaminophen  650  mg ; nitroglycerin sl  0.3  mg ; aluminum-magnesium hydrox.-simethicone  30  ml ; simethicone  40-80  mg ; potassium chloride  20  meq ; potassium chloride  40  meq ; potassium chloride  60  meq ; sodium chloride 0.9%  flush  3  ml ; dextrose 50%  12.5  gm ; glucagon  1  mg ; insulin  0  unit ; nateglinide  120  mg ; metoprolol tartrate  25  mg ; atorvastatin  40  mg ; 
 
unknown f 30 $nan$nan$acetaminophen  1000  mg ; scopolamine patch  1  ptch ; pregabalin  75  mg ; bisacodyl  10  mg ; influenza vaccine quadrivalent  0.5  ml ; sodium chloride 0.9%  flush  3-10  ml ; lactated ringers  1000  ml ; iso-osmotic dextrose  100  ml ; cefazolin  2  g ; oxycodone (immediate release)  5  mg ; hydromorphone (dilaudid)  0.5-1  mg ; diazepam  5  mg ; docusate sodium  100  mg ; senna  8.6  mg ; famotidine  20  mg ; 
 
unknown f 30 $nan$hematology blood hematocrit  36.0  %; hematology blood hemoglobin  11.9  g dl; hematology blood platelet count  219  k ul; chemistry blood anion gap  10  meq l; chemistry blood bicarbonate  24  meq l; chemistry blood chloride  105  meq l; chemistry blood creatinine  0.7  mg dl; chemistry blood potassium  4.2  meq l; chemistry blood sodium  139  meq l; chemistry blood urea nitrogen  7  mg dl; chemistry blood calcium, total  8.4  mg dl; chemistry blood glucose  87  mg dl$acetaminophen  1000  mg ; scopolamine patch  1  ptch ; pregabalin  75  mg ; bisacodyl  10  mg ; influenza vaccine quadrivalent  0.5  ml ; sodium chloride 0.9%  flush  3-10  ml ; lactated ringers  1000  ml ; iso-osmotic dextrose  100  ml ; cefazolin  2  g ; oxycodone (immediate release)  5  mg ; hydromorphone (dilaudid)  0.5-1  mg ; diazepam  5  mg ; docusate sodium  100  mg ; senna  8.6  mg ; famotidine  20  mg ; sodium chloride 0.9%  1000  ml ; 
 
unknown f 30 $nan$nan$scopolamine patch  1  ptch ; bisacodyl  10  mg ; influenza vaccine quadrivalent  0.5  ml ; sodium chloride 0.9%  flush  3-10  ml ; oxycodone (immediate release)  5  mg ; hydromorphone (dilaudid)  0.5-1  mg ; diazepam  5  mg ; docusate sodium  100  mg ; senna  8.6  mg ; famotidine  20  mg ; sodium chloride 0.9%  1000  ml ; 
 
unknown f 30 $nan$nan$bisacodyl  10  mg ; sodium chloride 0.9%  flush  3-10  ml ; hydromorphone (dilaudid)  0.5-1  mg ; diazepam  5  mg ; docusate sodium  100  mg ; senna  8.6  mg ; famotidine  20  mg ; 
 
white f 72 $nan$nan$aspirin  325  mg ; atorvastatin  10  mg ; timolol maleate 0.5%  1  drop ; levofloxacin  500  mg ; sertraline  25  mg ; 
 
white f 72 $nan$hematology blood hematocrit  30.0  %; hematology blood hematocrit  27.0  %; hematology blood hemoglobin  10.2  g dl; hematology blood hemoglobin  9.2  g dl; hematology blood platelet count  263  k ul; hematology blood platelet count  256  k ul; chemistry blood anion gap  13  meq l; chemistry blood anion gap  14  meq l; chemistry blood bicarbonate  25  meq l; chemistry blood bicarbonate  25  meq l; chemistry blood chloride  107  meq l; chemistry blood chloride  106  meq l; chemistry blood creatinine  0.7  mg dl; chemistry blood creatinine  0.7  mg dl; chemistry blood potassium  4.3  meq l; chemistry blood potassium  3.7  meq l; chemistry blood sodium  141  meq l; chemistry blood sodium  141  meq l; chemistry blood urea nitrogen  11  mg dl; chemistry blood urea nitrogen  21  mg dl; hematology blood inr(pt)  1.2  ; hematology blood inr(pt)  1.2  ; chemistry blood calcium, total  8.8  mg dl; chemistry blood calcium, total  8.5  mg dl; chemistry blood glucose  122  mg dl; chemistry blood glucose  176  mg dl$sodium chloride 0.9%  flush  3  ml ; sw  50  ml ; aspirin  325  mg ; atorvastatin  10  mg ; timolol maleate 0.5%  1  drop ; levofloxacin  500  mg ; sertraline  25  mg ; influenza virus vaccine  0.5  ml ; vial  1  vial ; pantoprazole sodium  40  mg ; iso-osmotic dextrose  200  ml ; vancomycin  1000  mg ; methylprednisolone sodium succ  30  mg ; propofol  1000  mg ; metoprolol  25  mg ; heparin  5000  unit ; furosemide  20  mg ; mupirocin nasal ointment 2%  1  appl ; trazodone  25  mg ; acetaminophen  325-650  mg ; potassium chloride  40  meq ; potassium chloride  60  meq ; sw  100  ml ; magnesium sulfate  4  gm ; magnesium sulfate  2  gm ; chlorhexidine gluconate 0.12% oral rinse  15  ml ; senna  1  tab ; bisacodyl  10  mg ; 
 
white f 72 $nan$hematology blood hematocrit  29.8  %; hematology blood hemoglobin  10.1  g dl; hematology blood platelet count  308  k ul; chemistry blood anion gap  13  meq l; chemistry blood bicarbonate  27  meq l; chemistry blood chloride  106  meq l; chemistry blood creatinine  0.7  mg dl; chemistry blood potassium  4.3  meq l; chemistry blood sodium  142  meq l; chemistry blood urea nitrogen  29  mg dl; hematology blood inr(pt)  1.2  ; chemistry blood calcium, total  9.0  mg dl; chemistry blood bilirubin, total  0.4  mg dl; chemistry blood glucose  107  mg dl; chemistry blood % hemoglobin a1c  6.1  %$sodium chloride 0.9%  flush  3  ml ; sw  50  ml ; aspirin  325  mg ; atorvastatin  10  mg ; timolol maleate 0.5%  1  drop ; levofloxacin  500  mg ; sertraline  25  mg ; influenza virus vaccine  0.5  ml ; vial  1  vial ; pantoprazole sodium  40  mg ; iso-osmotic dextrose  200  ml ; vancomycin  1000  mg ; metoprolol  25  mg ; heparin  5000  unit ; furosemide  20  mg ; mupirocin nasal ointment 2%  1  appl ; trazodone  25  mg ; acetaminophen  325-650  mg ; potassium chloride  40  meq ; potassium chloride  60  meq ; sw  100  ml ; magnesium sulfate  4  gm ; magnesium sulfate  2  gm ; chlorhexidine gluconate 0.12% oral rinse  15  ml ; senna  1  tab ; bisacodyl  10  mg ; methylprednisolone sodium succ  20  mg ; docusate sodium  100  mg ; dextrose 5%  150  ml ; levofloxacin  750  mg ; tiotropium bromide  1  cap ; 
 
white f 72 $nan$hematology blood hematocrit  30.1  %; hematology blood hemoglobin  10.1  g dl; hematology blood platelet count  310  k ul; chemistry blood anion gap  11  meq l; chemistry blood bicarbonate  29  meq l; chemistry blood chloride  104  meq l; chemistry blood creatinine  0.7  mg dl; chemistry blood potassium  3.8  meq l; chemistry blood sodium  140  meq l; chemistry blood urea nitrogen  25  mg dl; hematology blood inr(pt)  1.3  ; hematology urine wbc  9  # hpf; chemistry blood calcium, total  9.0  mg dl; chemistry blood glucose  104  mg dl$sodium chloride 0.9%  flush  3  ml ; sw  50  ml ; aspirin  325  mg ; atorvastatin  10  mg ; timolol maleate 0.5%  1  drop ; sertraline  25  mg ; influenza virus vaccine  0.5  ml ; vial  1  vial ; pantoprazole sodium  40  mg ; iso-osmotic dextrose  200  ml ; vancomycin  1000  mg ; metoprolol  25  mg ; heparin  5000  unit ; mupirocin nasal ointment 2%  1  appl ; trazodone  25  mg ; acetaminophen  325-650  mg ; potassium chloride  40  meq ; potassium chloride  60  meq ; sw  100  ml ; magnesium sulfate  4  gm ; magnesium sulfate  2  gm ; chlorhexidine gluconate 0.12% oral rinse  15  ml ; senna  1  tab ; bisacodyl  10  mg ; docusate sodium  100  mg ; dextrose 5%  150  ml ; levofloxacin  750  mg ; tiotropium bromide  1  cap ; fluticasone-salmeterol (100 50)  1  inh ; pantoprazole  40  mg ; 
 
white f 72 $nan$hematology blood hematocrit  30.6  %; hematology blood hemoglobin  10.3  g dl; hematology blood platelet count  318  k ul; chemistry blood anion gap  10  meq l; chemistry blood bicarbonate  31  meq l; chemistry blood chloride  102  meq l; chemistry blood creatinine  0.8  mg dl; chemistry blood potassium  3.6  meq l; chemistry blood sodium  139  meq l; chemistry blood urea nitrogen  19  mg dl; chemistry blood glucose  96  mg dl$sodium chloride 0.9%  flush  3  ml ; sw  50  ml ; aspirin  325  mg ; atorvastatin  10  mg ; timolol maleate 0.5%  1  drop ; sertraline  25  mg ; iso-osmotic dextrose  200  ml ; vancomycin  1000  mg ; metoprolol  25  mg ; heparin  5000  unit ; trazodone  25  mg ; acetaminophen  325-650  mg ; potassium chloride  40  meq ; potassium chloride  60  meq ; sw  100  ml ; magnesium sulfate  4  gm ; magnesium sulfate  2  gm ; chlorhexidine gluconate 0.12% oral rinse  15  ml ; senna  1  tab ; bisacodyl  10  mg ; docusate sodium  100  mg ; tiotropium bromide  1  cap ; fluticasone-salmeterol (100 50)  1  inh ; pantoprazole  40  mg ; d5 1 2ns  1000  ml ; heparin flush cvl  (100 units ml)  1  ml ; 
 
white f 72 $nan$nan$sodium chloride 0.9%  flush  3  ml ; sw  50  ml ; aspirin  325  mg ; atorvastatin  10  mg ; timolol maleate 0.5%  1  drop ; sertraline  25  mg ; metoprolol  25  mg ; heparin  5000  unit ; trazodone  25  mg ; acetaminophen  325-650  mg ; potassium chloride  40  meq ; potassium chloride  60  meq ; sw  100  ml ; magnesium sulfate  4  gm ; magnesium sulfate  2  gm ; chlorhexidine gluconate 0.12% oral rinse  15  ml ; senna  1  tab ; bisacodyl  10  mg ; docusate sodium  100  mg ; tiotropium bromide  1  cap ; fluticasone-salmeterol (100 50)  1  inh ; pantoprazole  40  mg ; heparin flush cvl  (100 units ml)  1  ml ; guaifenesin-dextromethorphan  5  ml ; 
 
white f 72 $nan$hematology blood hematocrit  29.4  %; hematology blood hemoglobin  10.2  g dl; hematology blood platelet count  317  k ul; chemistry blood anion gap  12  meq l; chemistry blood bicarbonate  29  meq l; chemistry blood chloride  101  meq l; chemistry blood creatinine  0.5  mg dl; chemistry blood potassium  3.8  meq l; chemistry blood sodium  138  meq l; chemistry blood urea nitrogen  16  mg dl; hematology blood inr(pt)  1.2  ; hematology urine wbc  3-5  # hpf; chemistry blood glucose  95  mg dl; hematology urine glucose  neg  mg dl; hematology urine bilirubin  neg  mg dl$sodium chloride 0.9%  flush  3  ml ; aspirin  325  mg ; atorvastatin  10  mg ; timolol maleate 0.5%  1  drop ; sertraline  25  mg ; metoprolol  25  mg ; heparin  5000  unit ; trazodone  25  mg ; acetaminophen  325-650  mg ; chlorhexidine gluconate 0.12% oral rinse  15  ml ; senna  1  tab ; bisacodyl  10  mg ; docusate sodium  100  mg ; tiotropium bromide  1  cap ; fluticasone-salmeterol (100 50)  1  inh ; pantoprazole  40  mg ; heparin flush cvl  (100 units ml)  1  ml ; guaifenesin-dextromethorphan  5  ml ; fluconazole  200  mg ; 
 
white f 72 $nan$hematology blood hematocrit  29.4  %; hematology blood hemoglobin  10.0  g dl; hematology blood platelet count  349  k ul; chemistry blood anion gap  13  meq l; chemistry blood bicarbonate  28  meq l; chemistry blood chloride  100  meq l; chemistry blood creatinine  0.6  mg dl; chemistry blood potassium  4.1  meq l; chemistry blood sodium  137  meq l; chemistry blood urea nitrogen  12  mg dl; chemistry blood glucose  101  mg dl$sodium chloride 0.9%  flush  3  ml ; aspirin  325  mg ; atorvastatin  10  mg ; timolol maleate 0.5%  1  drop ; sertraline  25  mg ; metoprolol  25  mg ; heparin  5000  unit ; trazodone  25  mg ; acetaminophen  325-650  mg ; chlorhexidine gluconate 0.12% oral rinse  15  ml ; senna  1  tab ; bisacodyl  10  mg ; docusate sodium  100  mg ; tiotropium bromide  1  cap ; fluticasone-salmeterol (100 50)  1  inh ; pantoprazole  40  mg ; heparin flush cvl  (100 units ml)  1  ml ; guaifenesin-dextromethorphan  5  ml ; fluconazole  200  mg ; 
 
white f 72 $nan$hematology blood hematocrit  30.5  %; hematology blood hemoglobin  10.0  g dl; hematology blood platelet count  347  k ul; chemistry blood anion gap  11  meq l; chemistry blood bicarbonate  29  meq l; chemistry blood chloride  103  meq l; chemistry blood creatinine  0.6  mg dl; chemistry blood potassium  4.0  meq l; chemistry blood sodium  139  meq l; chemistry blood urea nitrogen  7  mg dl; hematology blood inr(pt)  1.3  ; hematology urine wbc  6-10  # hpf; chemistry blood calcium, total  8.7  mg dl; chemistry blood glucose  111  mg dl; hematology urine glucose  neg  mg dl; hematology urine bilirubin  neg  mg dl$sodium chloride 0.9%  flush  3  ml ; aspirin  325  mg ; atorvastatin  10  mg ; timolol maleate 0.5%  1  drop ; sertraline  25  mg ; heparin  5000  unit ; trazodone  25  mg ; acetaminophen  325-650  mg ; chlorhexidine gluconate 0.12% oral rinse  15  ml ; senna  1  tab ; bisacodyl  10  mg ; tiotropium bromide  1  cap ; fluticasone-salmeterol (100 50)  1  inh ; pantoprazole  40  mg ; guaifenesin-dextromethorphan  5  ml ; fluconazole  200  mg ; metoprolol  50  mg ; valtrex  500  mg ; benzonatate  100  mg ; 
 
white f 72 $nan$nan$sodium chloride 0.9%  flush  3  ml ; aspirin  325  mg ; atorvastatin  10  mg ; timolol maleate 0.5%  1  drop ; sertraline  25  mg ; heparin  5000  unit ; trazodone  25  mg ; acetaminophen  325-650  mg ; chlorhexidine gluconate 0.12% oral rinse  15  ml ; senna  1  tab ; bisacodyl  10  mg ; tiotropium bromide  1  cap ; fluticasone-salmeterol (100 50)  1  inh ; pantoprazole  40  mg ; guaifenesin-dextromethorphan  5  ml ; fluconazole  200  mg ; metoprolol  50  mg ; valtrex  500  mg ; benzonatate  100  mg ; 
 
white f 72 $nan$nan$sodium chloride 0.9%  flush  3  ml ; aspirin  325  mg ; atorvastatin  10  mg ; timolol maleate 0.5%  1  drop ; sertraline  25  mg ; heparin  5000  unit ; trazodone  25  mg ; chlorhexidine gluconate 0.12% oral rinse  15  ml ; senna  1  tab ; bisacodyl  10  mg ; tiotropium bromide  1  cap ; fluticasone-salmeterol (100 50)  1  inh ; pantoprazole  40  mg ; metoprolol  50  mg ; valtrex  500  mg ; benzonatate  100  mg ; sulfameth trimethoprim ds  1  tab ; nitrofurantoin monohyd (macrobid)  100  mg ; d5w  100  ml ; acyclovir  500  mg ; 
 
white f 72 $nan$hematology blood hematocrit  30.3  %; hematology blood hematocrit  23.2  %; hematology blood hemoglobin  9.9  g dl; hematology blood hemoglobin  8.1  g dl; hematology blood platelet count  343  k ul; hematology blood platelet count  167  k ul; chemistry blood anion gap  16  meq l; chemistry blood bicarbonate  27  meq l; chemistry blood chloride  100  meq l; chemistry blood creatinine  0.6  mg dl; chemistry blood potassium  3.6  meq l; chemistry blood sodium  139  meq l; chemistry blood urea nitrogen  10  mg dl; hematology blood inr(pt)  1.2  ; hematology blood inr(pt)  1.3  ; hematology urine wbc  0-2  # hpf; chemistry blood calcium, total  8.9  mg dl; chemistry blood glucose  87  mg dl; blood gas blood free calcium  1.09  mmol l; blood gas blood free calcium  1.21  mmol l; blood gas blood lactate  1.4  mmol l; blood gas blood lactate  2.1  mmol l; blood gas blood chloride, whole blood  99  meq l; blood gas blood chloride, whole blood  110  meq l; blood gas blood glucose  113  mg dl; blood gas blood glucose  113  mg dl; blood gas blood glucose  191  mg dl; blood gas blood glucose  155  mg dl; blood gas blood glucose  105  mg dl; blood gas blood hematocrit, calculated  29  %; blood gas blood hematocrit, calculated  18  %; blood gas blood hematocrit, calculated  21  %; blood gas blood hematocrit, calculated  20  %; blood gas blood hematocrit, calculated  24  %; blood gas blood hemoglobin  9.8  g dl; blood gas blood hemoglobin  6.1  g dl; blood gas blood hemoglobin  7.0  g dl; blood gas blood hemoglobin  6.8  g dl; blood gas blood hemoglobin  8.1  g dl; blood gas blood potassium, whole blood  4.1  meq l; blood gas blood potassium, whole blood  3.6  meq l; blood gas blood potassium, whole blood  5.3  meq l; blood gas blood potassium, whole blood  5.3  meq l; blood gas blood potassium, whole blood  4.0  meq l; blood gas blood sodium, whole blood  133  meq l; blood gas blood sodium, whole blood  133  meq l; hematology urine glucose  neg  mg dl; hematology urine bilirubin  neg  mg dl$sodium chloride 0.9%  flush  3  ml ; aspirin  325  mg ; atorvastatin  10  mg ; timolol maleate 0.5%  1  drop ; sertraline  25  mg ; heparin  5000  unit ; trazodone  25  mg ; chlorhexidine gluconate 0.12% oral rinse  15  ml ; senna  1  tab ; bisacodyl  10  mg ; tiotropium bromide  1  cap ; fluticasone-salmeterol (100 50)  1  inh ; pantoprazole  40  mg ; metoprolol  50  mg ; benzonatate  100  mg ; nitrofurantoin monohyd (macrobid)  100  mg ; aspirin ec  81  mg ; aspirin  81  mg ; ns  100  ml ; insulin human regular  100  unit ; lr  1000  ml ; propofol  200  mg ; d5w  250  ml ; nitroglycerin  100  mg ; syringe  1  syr ; nitroglycerin  20  mg ; phenylephrine  60  mg ; phenylephrine  12  mg ; glycopyrrolate  0.6  mg ; neostigmine  3  mg ; potassium chloride  20  meq ; calcium gluconate  2  gm ; meperidine  12.5  mg ; metoclopramide  10  mg ; sucralfate  1  gm ; acetaminophen  650  mg ; dextrose 50%  12.5  gm ; 
 
white f 72 $nan$hematology blood hematocrit  29.6  %; hematology blood hematocrit  29.9  %; hematology blood hematocrit  30.8  %; hematology blood hemoglobin  10.2  g dl; hematology blood hemoglobin  10.7  g dl; hematology blood platelet count  190  k ul; hematology blood platelet count  162  k ul; chemistry blood anion gap  10  meq l; chemistry blood bicarbonate  23  meq l; chemistry blood bicarbonate  23  meq l; chemistry blood chloride  113  meq l; chemistry blood chloride  106  meq l; chemistry blood creatinine  0.5  mg dl; chemistry blood creatinine  0.6  mg dl; chemistry blood potassium  5.6  meq l; chemistry blood potassium  6.3  meq l; chemistry blood sodium  133  meq l; chemistry blood urea nitrogen  10  mg dl; chemistry blood urea nitrogen  8  mg dl; hematology blood inr(pt)  1.4  ; chemistry blood glucose  124  mg dl; blood gas blood free calcium  1.20  mmol l; blood gas blood free calcium  1.07  mmol l; blood gas blood free calcium  1.08  mmol l; blood gas blood lactate  1.1  mmol l; blood gas blood glucose  92  mg dl; blood gas blood glucose  120  mg dl; blood gas blood glucose  113  mg dl; blood gas blood glucose  150  mg dl; blood gas blood potassium, whole blood  4.2  meq l; blood gas blood potassium, whole blood  3.9  meq l; blood gas blood potassium, whole blood  5.4  meq l; blood gas blood potassium, whole blood  4.3  meq l; blood gas blood sodium, whole blood  134  meq l; hematology urine glucose  neg  mg dl; hematology urine bilirubin  neg  mg dl$nitrofurantoin monohyd (macrobid)  100  mg ; aspirin ec  81  mg ; aspirin  81  mg ; ns  100  ml ; insulin human regular  100  unit ; lr  1000  ml ; propofol  200  mg ; d5w  250  ml ; nitroglycerin  100  mg ; syringe  1  syr ; nitroglycerin  20  mg ; phenylephrine  60  mg ; phenylephrine  12  mg ; glycopyrrolate  0.6  mg ; neostigmine  3  mg ; potassium chloride  20  meq ; calcium gluconate  2  gm ; meperidine  12.5  mg ; metoclopramide  10  mg ; sucralfate  1  gm ; acetaminophen  650  mg ; dextrose 50%  12.5  gm ; albuterol  4  puff ; morphine sulfate  2-4  mg ; ipratropium bromide mdi  4  puff ; midazolam  1  mg ; ranitidine  150  mg ; docusate sodium (liquid)  100  mg ; insulin  8  unit ; dextrose 50%  25  gm ; sodium bicarbonate  50  meq ; dexamethasone  6  mg ; 
 
white f 72 $nan$hematology blood hematocrit  28.5  %; hematology blood hematocrit  28.0  %; hematology blood hemoglobin  10.3  g dl; hematology blood hemoglobin  9.6  g dl; hematology blood platelet count  132  k ul; hematology blood platelet count  141  k ul; chemistry blood anion gap  11  meq l; chemistry blood anion gap  11  meq l; chemistry blood bicarbonate  25  meq l; chemistry blood bicarbonate  27  meq l; chemistry blood chloride  101  meq l; chemistry blood chloride  98  meq l; chemistry blood creatinine  0.7  mg dl; chemistry blood creatinine  0.6  mg dl; chemistry blood potassium  4.3  meq l; chemistry blood potassium  3.6  meq l; chemistry blood potassium  4.5  meq l; chemistry blood sodium  133  meq l; chemistry blood sodium  131  meq l; chemistry blood urea nitrogen  10  mg dl; chemistry blood urea nitrogen  11  mg dl; chemistry blood calcium, total  8.5  mg dl; chemistry blood calcium, total  8.5  mg dl; chemistry blood glucose  163  mg dl; chemistry blood glucose  108  mg dl; blood gas blood free calcium  1.06  mmol l$aspirin ec  81  mg ; aspirin  81  mg ; ns  100  ml ; insulin human regular  100  unit ; propofol  200  mg ; d5w  250  ml ; nitroglycerin  100  mg ; phenylephrine  60  mg ; potassium chloride  20  meq ; calcium gluconate  2  gm ; meperidine  12.5  mg ; metoclopramide  10  mg ; sucralfate  1  gm ; acetaminophen  650  mg ; dextrose 50%  12.5  gm ; albuterol  4  puff ; morphine sulfate  2-4  mg ; ipratropium bromide mdi  4  puff ; midazolam  1  mg ; ranitidine  150  mg ; docusate sodium (liquid)  100  mg ; insulin  8  unit ; dextrose 50%  25  gm ; sodium bicarbonate  50  meq ; dexamethasone  6  mg ; hydromorphone (dilaudid)  2  mg ; 
 
white f 72 $nan$hematology blood hematocrit  25.9  %; hematology blood hemoglobin  8.8  g dl; hematology blood platelet count  133  k ul; chemistry blood anion gap  12  meq l; chemistry blood bicarbonate  30  meq l; chemistry blood chloride  89  meq l; chemistry blood creatinine  0.6  mg dl; chemistry blood potassium  3.9  meq l; chemistry blood sodium  127  meq l; chemistry blood urea nitrogen  14  mg dl; hematology blood inr(pt)  1.6  ; hematology urine wbc  6-10  # hpf; chemistry blood calcium, total  7.8  mg dl; chemistry blood glucose  99  mg dl; hematology urine glucose  neg  mg dl; hematology urine bilirubin  neg  mg dl$aspirin ec  81  mg ; aspirin  81  mg ; ns  100  ml ; insulin human regular  100  unit ; propofol  200  mg ; d5w  250  ml ; nitroglycerin  100  mg ; phenylephrine  60  mg ; potassium chloride  20  meq ; calcium gluconate  2  gm ; meperidine  12.5  mg ; metoclopramide  10  mg ; acetaminophen  650  mg ; dextrose 50%  12.5  gm ; albuterol  4  puff ; morphine sulfate  2-4  mg ; ipratropium bromide mdi  4  puff ; ranitidine  150  mg ; docusate sodium (liquid)  100  mg ; hydromorphone (dilaudid)  2  mg ; milk of magnesia  30  ml ; hydromorphone (dilaudid)  2-4  mg ; insulin  0  unit ; cepacol (menthol)  1  loz ; 
 
white f 72 $nan$hematology blood hematocrit  28.5  %; hematology blood hemoglobin  9.5  g dl; hematology blood platelet count  185  k ul; chemistry blood anion gap  14  meq l; chemistry blood bicarbonate  30  meq l; chemistry blood chloride  91  meq l; chemistry blood creatinine  0.6  mg dl; chemistry blood potassium  3.9  meq l; chemistry blood sodium  131  meq l; chemistry blood urea nitrogen  12  mg dl; chemistry blood glucose  109  mg dl$milk of magnesia  30  ml ; hydromorphone (dilaudid)  2-4  mg ; insulin  0  unit ; cepacol (menthol)  1  loz ; 
 
white f 72 $nan$nan$milk of magnesia  30  ml ; hydromorphone (dilaudid)  2-4  mg ; insulin  0  unit ; cepacol (menthol)  1  loz ; 
 
black african american m 49 $temp  99.7  heartrate  97.0  resprate  16.0  o2sat  99.0  sbp  139.0  dbp  94.0  rhythm    pain  8 10  ; temp  98.4  heartrate  92.0  resprate  16.0  o2sat  96.0  sbp  132.0  dbp  105.0  rhythm    pain  9 10  ; temp  98.5  heartrate  87.0  resprate  16.0  o2sat  99.0  sbp  136.0  dbp  97.0  rhythm    pain  8  $nan$amlodipine  10  mg ; hydrochlorothiazide  25  mg ; 
other specified cardiac dysrhythmias tobacco use disorder cocaine dependence, unspecified blood in stool other and unspecified alcohol dependence, unspecified unspecified essential hypertension abdominal pain, generalized right bundle branch block unspecified essential hypertension intestinal or peritoneal adhesions with obstruction (postoperative) (postinfection) other ascites diverticulosis of colon (without mention of hemorrhage) tobacco use disorder paralytic ileus other specified cardiac dysrhythmias unspecified fall head injury, unspecified alcohol abuse, unspecified other specified metabolic disorders cervicalgia pain in joint, lower leg 
black african american m 49 $temp  98.3  heartrate  85.0  resprate    o2sat  100.0  sbp  149.0  dbp  96.0  rhythm    pain  8  $hematology blood hematocrit  42.8  %; hematology blood hemoglobin  14.0  g dl; hematology blood platelet count  187  k ul; chemistry blood anion gap  13  meq l; chemistry blood bicarbonate  30  meq l; chemistry blood chloride  98  meq l; chemistry blood creatinine  0.6  mg dl; chemistry blood potassium  4.0  meq l; chemistry blood sodium  137  meq l; chemistry blood urea nitrogen  11  mg dl; chemistry blood calcium, total  9.6  mg dl; chemistry blood glucose  146  mg dl$amlodipine  10  mg ; hydrochlorothiazide  25  mg ; iso-osmotic dextrose  200  ml ; vancomycin  1000  mg ; docusate sodium  100  mg ; heparin  5000  unit ; influenza virus vaccine  0.5  ml ; sodium chloride 0.9%  flush  3  ml ; senna  1  tab ; 5% dextrose  100  ml ; acyclovir  700  mg ; oxycodone-acetaminophen (5mg-325mg)  1  tab ; iso-osmotic dextrose  50  ml ; ceftriaxone  2  gm ; bag  50  ml ; magnesium sulfate  2  gm ; 
other specified cardiac dysrhythmias tobacco use disorder cocaine dependence, unspecified blood in stool other and unspecified alcohol dependence, unspecified unspecified essential hypertension abdominal pain, generalized right bundle branch block unspecified essential hypertension intestinal or peritoneal adhesions with obstruction (postoperative) (postinfection) other ascites diverticulosis of colon (without mention of hemorrhage) tobacco use disorder paralytic ileus other specified cardiac dysrhythmias unspecified fall head injury, unspecified alcohol abuse, unspecified other specified metabolic disorders cervicalgia pain in joint, lower leg 
black african american m 49 $nan$hematology blood hematocrit  42.2  %; hematology blood hemoglobin  13.5  g dl; hematology blood platelet count  194  k ul; chemistry blood anion gap  15  meq l; chemistry blood bicarbonate  29  meq l; chemistry blood chloride  99  meq l; chemistry blood creatinine  0.7  mg dl; chemistry blood potassium  3.8  meq l; chemistry blood sodium  139  meq l; chemistry blood urea nitrogen  11  mg dl; chemistry blood calcium, total  9.1  mg dl; chemistry blood glucose  95  mg dl$amlodipine  10  mg ; hydrochlorothiazide  25  mg ; docusate sodium  100  mg ; heparin  5000  unit ; sodium chloride 0.9%  flush  3  ml ; senna  1  tab ; 5% dextrose  100  ml ; acyclovir  700  mg ; oxycodone-acetaminophen (5mg-325mg)  1  tab ; iso-osmotic dextrose  50  ml ; ceftriaxone  2  gm ; bag  50  ml ; magnesium sulfate  2  gm ; oxycodone (immediate release)   5  mg ; acetaminophen  1000  mg ; 
other specified cardiac dysrhythmias tobacco use disorder cocaine dependence, unspecified blood in stool other and unspecified alcohol dependence, unspecified unspecified essential hypertension abdominal pain, generalized right bundle branch block unspecified essential hypertension intestinal or peritoneal adhesions with obstruction (postoperative) (postinfection) other ascites diverticulosis of colon (without mention of hemorrhage) tobacco use disorder paralytic ileus other specified cardiac dysrhythmias unspecified fall head injury, unspecified alcohol abuse, unspecified other specified metabolic disorders cervicalgia pain in joint, lower leg 
black african american m 49 $nan$hematology blood hematocrit  42.6  %; hematology blood hemoglobin  13.9  g dl; hematology blood platelet count  204  k ul; chemistry blood anion gap  13  meq l; chemistry blood bicarbonate  31  meq l; chemistry blood chloride  97  meq l; chemistry blood creatinine  0.7  mg dl; chemistry blood potassium  3.9  meq l; chemistry blood sodium  137  meq l; chemistry blood urea nitrogen  11  mg dl; chemistry blood calcium, total  9.2  mg dl; chemistry blood glucose  97  mg dl$amlodipine  10  mg ; hydrochlorothiazide  25  mg ; docusate sodium  100  mg ; heparin  5000  unit ; sodium chloride 0.9%  flush  3  ml ; senna  1  tab ; 5% dextrose  100  ml ; acyclovir  700  mg ; oxycodone (immediate release)   5  mg ; acetaminophen  1000  mg ; ibuprofen  400  mg ; 
other specified cardiac dysrhythmias tobacco use disorder cocaine dependence, unspecified blood in stool other and unspecified alcohol dependence, unspecified unspecified essential hypertension abdominal pain, generalized right bundle branch block unspecified essential hypertension intestinal or peritoneal adhesions with obstruction (postoperative) (postinfection) other ascites diverticulosis of colon (without mention of hemorrhage) tobacco use disorder paralytic ileus other specified cardiac dysrhythmias unspecified fall head injury, unspecified alcohol abuse, unspecified other specified metabolic disorders cervicalgia pain in joint, lower leg 
black african american m 49 $nan$hematology blood hematocrit  44.3  %; hematology blood hemoglobin  14.0  g dl; hematology blood platelet count  222  k ul; chemistry blood anion gap  17  meq l; chemistry blood bicarbonate  28  meq l; chemistry blood chloride  96  meq l; chemistry blood creatinine  0.7  mg dl; chemistry blood potassium  4.2  meq l; chemistry blood sodium  137  meq l; chemistry blood urea nitrogen  14  mg dl; chemistry blood calcium, total  9.3  mg dl; chemistry blood glucose  112  mg dl$amlodipine  10  mg ; hydrochlorothiazide  25  mg ; docusate sodium  100  mg ; heparin  5000  unit ; sodium chloride 0.9%  flush  3  ml ; senna  1  tab ; 5% dextrose  100  ml ; acyclovir  700  mg ; acetaminophen  1000  mg ; 
other specified cardiac dysrhythmias tobacco use disorder cocaine dependence, unspecified blood in stool other and unspecified alcohol dependence, unspecified unspecified essential hypertension abdominal pain, generalized right bundle branch block unspecified essential hypertension intestinal or peritoneal adhesions with obstruction (postoperative) (postinfection) other ascites diverticulosis of colon (without mention of hemorrhage) tobacco use disorder paralytic ileus other specified cardiac dysrhythmias unspecified fall head injury, unspecified alcohol abuse, unspecified other specified metabolic disorders cervicalgia pain in joint, lower leg 
black african american m 49 $nan$nan$amlodipine  10  mg ; hydrochlorothiazide  25  mg ; docusate sodium  100  mg ; heparin  5000  unit ; sodium chloride 0.9%  flush  3  ml ; senna  1  tab ; 5% dextrose  100  ml ; acyclovir  700  mg ; acetaminophen  1000  mg ; 
other specified cardiac dysrhythmias tobacco use disorder cocaine dependence, unspecified blood in stool other and unspecified alcohol dependence, unspecified unspecified essential hypertension abdominal pain, generalized right bundle branch block unspecified essential hypertension intestinal or peritoneal adhesions with obstruction (postoperative) (postinfection) other ascites diverticulosis of colon (without mention of hemorrhage) tobacco use disorder paralytic ileus other specified cardiac dysrhythmias unspecified fall head injury, unspecified alcohol abuse, unspecified other specified metabolic disorders cervicalgia pain in joint, lower leg 
unable to obtain m 68 $nan$nan$levothyroxine sodium  100  mcg ; furosemide  20  mg ; lisinopril  2.5  mg ; sarna lotion  1  appl ; heparin  5000  unit ; senna  1  tab ; docusate sodium  100  mg ; clotrimazole cream  1  appl ; 
 
unable to obtain m 68 $nan$hematology blood hematocrit  48.4  %; hematology blood hematocrit  46.7  %; hematology blood hemoglobin  16.0  g dl; hematology blood hemoglobin  15.2  g dl; hematology blood platelet count  154  k ul; hematology blood platelet count  142  k ul; chemistry blood anion gap  12  meq l; chemistry blood anion gap  9  meq l; chemistry blood bicarbonate  29  meq l; chemistry blood bicarbonate  32  meq l; chemistry blood chloride  99  meq l; chemistry blood chloride  99  meq l; chemistry blood creatinine  0.8  mg dl; chemistry blood creatinine  0.9  mg dl; chemistry blood potassium  3.6  meq l; chemistry blood potassium  3.7  meq l; chemistry blood sodium  136  meq l; chemistry blood sodium  136  meq l; chemistry blood urea nitrogen  11  mg dl; chemistry blood urea nitrogen  11  mg dl; hematology blood inr(pt)  1.3  ; chemistry blood calcium, total  7.8  mg dl; chemistry blood calcium, total  7.9  mg dl; chemistry blood bilirubin, total  0.4  mg dl; chemistry blood glucose  100  mg dl; chemistry blood glucose  129  mg dl; chemistry blood albumin  2.9  g dl$levothyroxine sodium  100  mcg ; furosemide  20  mg ; lisinopril  2.5  mg ; sarna lotion  1  appl ; heparin  5000  unit ; senna  1  tab ; docusate sodium  100  mg ; clotrimazole cream  1  appl ; pneumococcal vac polyvalent  0.5  ml ; sodium chloride 0.9%  flush  3  ml ; acetaminophen  325-650  mg ; albuterol 0.083% neb soln  1  neb ; pantoprazole  40  mg ; 
 
unable to obtain m 68 $nan$nan$levothyroxine sodium  100  mcg ; furosemide  20  mg ; lisinopril  2.5  mg ; heparin  5000  unit ; senna  1  tab ; docusate sodium  100  mg ; clotrimazole cream  1  appl ; pneumococcal vac polyvalent  0.5  ml ; sodium chloride 0.9%  flush  3  ml ; acetaminophen  325-650  mg ; albuterol 0.083% neb soln  1  neb ; pantoprazole  40  mg ; bag  50  ml ; magnesium sulfate  2  gm ; potassium chloride (powder)  20  meq ; citalopram  20  mg ; 
 
unable to obtain m 68 $nan$hematology blood hematocrit  50.0  %; hematology blood hemoglobin  16.3  g dl; hematology blood platelet count  148  k ul; chemistry blood anion gap  12  meq l; chemistry blood bicarbonate  31  meq l; chemistry blood chloride  98  meq l; chemistry blood creatinine  1.0  mg dl; chemistry blood potassium  4.3  meq l; chemistry blood sodium  137  meq l; chemistry blood urea nitrogen  17  mg dl; chemistry blood calcium, total  8.2  mg dl; chemistry blood glucose  106  mg dl$levothyroxine sodium  100  mcg ; furosemide  20  mg ; lisinopril  2.5  mg ; heparin  5000  unit ; senna  1  tab ; docusate sodium  100  mg ; pneumococcal vac polyvalent  0.5  ml ; sodium chloride 0.9%  flush  3  ml ; acetaminophen  325-650  mg ; albuterol 0.083% neb soln  1  neb ; pantoprazole  40  mg ; citalopram  20  mg ; 
 
white m 55 $nan$hematology blood hematocrit  41.0  %; hematology blood hematocrit  42.8  %; hematology blood hemoglobin  14.3  g dl; hematology blood hemoglobin  14.8  g dl; hematology blood platelet count  282  k ul; hematology blood platelet count  311  k ul; chemistry blood anion gap  15  meq l; chemistry blood anion gap  13  meq l; chemistry blood bicarbonate  23  meq l; chemistry blood bicarbonate  25  meq l; chemistry blood chloride  103  meq l; chemistry blood chloride  104  meq l; chemistry blood creatinine  0.6  mg dl; chemistry blood creatinine  0.6  mg dl; chemistry blood potassium  4.6  meq l; chemistry blood potassium  4.4  meq l; chemistry blood sodium  136  meq l; chemistry blood sodium  138  meq l; chemistry blood urea nitrogen  11  mg dl; chemistry blood urea nitrogen  12  mg dl; chemistry blood calcium, total  9.2  mg dl; chemistry blood glucose  310  mg dl$sw  100  ml ; eptifibatide  75  mg ; senna  1  tab ; acetaminophen  325-650  mg ; dextrose 50%  12.5  gm ; glucagon  1  mg ; insulin  0  unit ; sodium chloride 0.9%  flush  3  ml ; metoprolol tartrate  25  mg ; heparin  5000  unit ; docusate sodium  100  mg ; aspirin ec  325  mg ; clopidogrel  75  mg ; atorvastatin  80  mg ; metoprolol tartrate  12.5  mg ; pantoprazole  40  mg ; metoprolol tartrate  37.5  mg ; insulin  26  unit ; insulin  28  unit ; 
 
white m 55 $nan$hematology blood hematocrit  41.4  %; hematology blood hemoglobin  14.5  g dl; hematology blood platelet count  292  k ul; chemistry blood anion gap  14  meq l; chemistry blood bicarbonate  25  meq l; chemistry blood chloride  104  meq l; chemistry blood creatinine  0.7  mg dl; chemistry blood potassium  4.3  meq l; chemistry blood sodium  139  meq l; chemistry blood urea nitrogen  12  mg dl; chemistry blood calcium, total  9.5  mg dl; chemistry blood glucose  268  mg dl$senna  1  tab ; acetaminophen  325-650  mg ; dextrose 50%  12.5  gm ; glucagon  1  mg ; sodium chloride 0.9%  flush  3  ml ; heparin  5000  unit ; aspirin ec  325  mg ; clopidogrel  75  mg ; atorvastatin  80  mg ; pantoprazole  40  mg ; metoprolol tartrate  37.5  mg ; insulin  28  unit ; sw  50  ml ; magnesium sulfate  2  gm ; 
 
white m 55 $nan$hematology blood hematocrit  42.4  %; hematology blood hemoglobin  14.8  g dl; hematology blood platelet count  285  k ul; chemistry blood anion gap  12  meq l; chemistry blood bicarbonate  27  meq l; chemistry blood chloride  104  meq l; chemistry blood creatinine  0.7  mg dl; chemistry blood potassium  4.4  meq l; chemistry blood sodium  139  meq l; chemistry blood urea nitrogen  14  mg dl; chemistry blood calcium, total  9.3  mg dl; chemistry blood glucose  244  mg dl; chemistry blood % hemoglobin a1c  10.1  %$senna  1  tab ; acetaminophen  325-650  mg ; dextrose 50%  12.5  gm ; glucagon  1  mg ; sodium chloride 0.9%  flush  3  ml ; heparin  5000  unit ; aspirin ec  325  mg ; clopidogrel  75  mg ; atorvastatin  80  mg ; pantoprazole  40  mg ; metoprolol tartrate  37.5  mg ; insulin  28  unit ; sw  50  ml ; magnesium sulfate  2  gm ; 
 
hispanic latino f 49 $nan$nan$aspirin  325  mg ; atorvastatin  10  mg ; 
 
hispanic latino f 49 $nan$hematology blood hematocrit  39.2  %; hematology blood hemoglobin  12.8  g dl; hematology blood platelet count  221  k ul; chemistry blood anion gap  16  meq l; chemistry blood bicarbonate  26  meq l; chemistry blood chloride  101  meq l; chemistry blood creatinine  0.5  mg dl; chemistry blood potassium  4.1  meq l; chemistry blood sodium  139  meq l; chemistry blood urea nitrogen  8  mg dl; chemistry blood calcium, total  8.9  mg dl; chemistry blood glucose  248  mg dl; chemistry blood % hemoglobin a1c  11.1  %$aspirin  325  mg ; atorvastatin  10  mg ; sodium chloride 0.9%  flush  3  ml ; insulin  0  unit ; heparin  5000  unit ; lorazepam  1  mg ; sw  100  ml ; magnesium sulfate  4  gm ; 
 
hispanic latino f 49 $nan$nan$aspirin  325  mg ; atorvastatin  10  mg ; sodium chloride 0.9%  flush  3  ml ; insulin  0  unit ; heparin  5000  unit ; lorazepam  1  mg ; sw  100  ml ; magnesium sulfate  4  gm ; 
 
white m 69 $nan$hematology blood hematocrit  45.6  %; hematology blood hemoglobin  15.6  g dl; hematology blood platelet count  279  k ul; chemistry blood anion gap  17  meq l; chemistry blood bicarbonate  27  meq l; chemistry blood chloride  99  meq l; chemistry blood creatinine  1.2  mg dl; chemistry blood potassium  4.5  meq l; chemistry blood sodium  138  meq l; chemistry blood urea nitrogen  14  mg dl; chemistry blood glucose  209  mg dl; blood gas blood lactate  2.2  mmol l$nan
coronary atherosclerosis of native coronary artery percutaneous transluminal coronary angioplasty status cellulitis and abscess of leg, except foot unspecified essential hypertension personal history of tobacco use diabetes mellitus without mention of complication, type ii or unspecified type, not stated as uncontrolled hyposmolality and/or hyponatremia personal history of noncompliance with medical treatment, presenting hazards to health unspecified essential hypertension diarrhea coronary atherosclerosis of native coronary artery other specified disorders of skin cellulitis and abscess of leg, except foot old myocardial infarction diabetes mellitus without mention of complication, type ii or unspecified type, uncontrolled hiccough
white m 69 $temp  98.0  heartrate  73.0  resprate  18.0  o2sat  96.0  sbp  133.0  dbp  65.0  rhythm    pain  4  $hematology blood hematocrit  41.2  %; hematology blood hemoglobin  14.1  g dl; hematology blood platelet count  245  k ul; chemistry blood anion gap  12  meq l; chemistry blood bicarbonate  26  meq l; chemistry blood chloride  101  meq l; chemistry blood creatinine  1.0  mg dl; chemistry blood potassium  4.1  meq l; chemistry blood sodium  135  meq l; chemistry blood urea nitrogen  15  mg dl; chemistry blood glucose  201  mg dl; chemistry blood % hemoglobin a1c  7.6  %$influenza virus vaccine  0.5  ml ; pneumococcal 23-valent polysaccharide vaccine  0.5  ml ; sodium chloride 0.9%  flush  3  ml ; iso-osmotic dextrose  200  ml ; vancomycin  1000  mg ; ciprofloxacin hcl  500  mg ; acetaminophen  325-650  mg ; heparin  5000  unit ; senna  1  tab ; docusate sodium  100  mg ; aspirin  325  mg ; metoprolol succinate xl  25  mg ; dextrose 50%  12.5  gm ; glucagon  1  mg ; glucose gel  15  g ; insulin  0  unit ; lisinopril  5  mg ; insulin  10  unit ; 
coronary atherosclerosis of native coronary artery percutaneous transluminal coronary angioplasty status cellulitis and abscess of leg, except foot unspecified essential hypertension personal history of tobacco use diabetes mellitus without mention of complication, type ii or unspecified type, not stated as uncontrolled hyposmolality and/or hyponatremia personal history of noncompliance with medical treatment, presenting hazards to health unspecified essential hypertension diarrhea coronary atherosclerosis of native coronary artery other specified disorders of skin cellulitis and abscess of leg, except foot old myocardial infarction diabetes mellitus without mention of complication, type ii or unspecified type, uncontrolled hiccough
white m 69 $nan$hematology blood hematocrit  41.6  %; hematology blood hemoglobin  14.3  g dl; hematology blood platelet count  269  k ul; chemistry blood anion gap  13  meq l; chemistry blood bicarbonate  26  meq l; chemistry blood chloride  98  meq l; chemistry blood creatinine  1.0  mg dl; chemistry blood potassium  4.1  meq l; chemistry blood sodium  133  meq l; chemistry blood urea nitrogen  13  mg dl; chemistry blood calcium, total  8.2  mg dl; chemistry blood glucose  211  mg dl$influenza virus vaccine  0.5  ml ; pneumococcal 23-valent polysaccharide vaccine  0.5  ml ; sodium chloride 0.9%  flush  3  ml ; acetaminophen  325-650  mg ; heparin  5000  unit ; senna  1  tab ; docusate sodium  100  mg ; aspirin  325  mg ; metoprolol succinate xl  25  mg ; dextrose 50%  12.5  gm ; glucagon  1  mg ; glucose gel  15  g ; lisinopril  5  mg ; insulin  10  unit ; insulin  12  unit ; 
coronary atherosclerosis of native coronary artery percutaneous transluminal coronary angioplasty status cellulitis and abscess of leg, except foot unspecified essential hypertension personal history of tobacco use diabetes mellitus without mention of complication, type ii or unspecified type, not stated as uncontrolled hyposmolality and/or hyponatremia personal history of noncompliance with medical treatment, presenting hazards to health unspecified essential hypertension diarrhea coronary atherosclerosis of native coronary artery other specified disorders of skin cellulitis and abscess of leg, except foot old myocardial infarction diabetes mellitus without mention of complication, type ii or unspecified type, uncontrolled hiccough
white m 69 $nan$hematology blood hematocrit  44.0  %; hematology blood hemoglobin  15.5  g dl; hematology blood platelet count  285  k ul; chemistry blood anion gap  15  meq l; chemistry blood bicarbonate  23  meq l; chemistry blood chloride  100  meq l; chemistry blood creatinine  1.0  mg dl; chemistry blood potassium  4.4  meq l; chemistry blood sodium  134  meq l; chemistry blood urea nitrogen  14  mg dl; chemistry blood calcium, total  8.6  mg dl; chemistry blood glucose  167  mg dl$pneumococcal 23-valent polysaccharide vaccine  0.5  ml ; sodium chloride 0.9%  flush  3  ml ; acetaminophen  325-650  mg ; heparin  5000  unit ; senna  1  tab ; docusate sodium  100  mg ; aspirin  325  mg ; metoprolol succinate xl  25  mg ; dextrose 50%  12.5  gm ; glucagon  1  mg ; glucose gel  15  g ; lisinopril  5  mg ; insulin  12  unit ; 0.9% sodium chloride  1000  ml ; insulin  14  unit ; 
coronary atherosclerosis of native coronary artery percutaneous transluminal coronary angioplasty status cellulitis and abscess of leg, except foot unspecified essential hypertension personal history of tobacco use diabetes mellitus without mention of complication, type ii or unspecified type, not stated as uncontrolled hyposmolality and/or hyponatremia personal history of noncompliance with medical treatment, presenting hazards to health unspecified essential hypertension diarrhea coronary atherosclerosis of native coronary artery other specified disorders of skin cellulitis and abscess of leg, except foot old myocardial infarction diabetes mellitus without mention of complication, type ii or unspecified type, uncontrolled hiccough
white m 69 $nan$hematology blood hematocrit  47.4  %; hematology blood hemoglobin  16.6  g dl; hematology blood platelet count  326  k ul; chemistry blood anion gap  18  meq l; chemistry blood bicarbonate  23  meq l; chemistry blood chloride  101  meq l; chemistry blood creatinine  1.1  mg dl; chemistry blood potassium  4.8  meq l; chemistry blood sodium  137  meq l; chemistry blood urea nitrogen  14  mg dl; chemistry blood calcium, total  8.9  mg dl; chemistry blood glucose  152  mg dl$pneumococcal 23-valent polysaccharide vaccine  0.5  ml ; sodium chloride 0.9%  flush  3  ml ; acetaminophen  325-650  mg ; heparin  5000  unit ; senna  1  tab ; docusate sodium  100  mg ; aspirin  325  mg ; metoprolol succinate xl  25  mg ; dextrose 50%  12.5  gm ; glucagon  1  mg ; glucose gel  15  g ; lisinopril  5  mg ; 0.9% sodium chloride  1000  ml ; insulin  14  unit ; 
coronary atherosclerosis of native coronary artery percutaneous transluminal coronary angioplasty status cellulitis and abscess of leg, except foot unspecified essential hypertension personal history of tobacco use diabetes mellitus without mention of complication, type ii or unspecified type, not stated as uncontrolled hyposmolality and/or hyponatremia personal history of noncompliance with medical treatment, presenting hazards to health unspecified essential hypertension diarrhea coronary atherosclerosis of native coronary artery other specified disorders of skin cellulitis and abscess of leg, except foot old myocardial infarction diabetes mellitus without mention of complication, type ii or unspecified type, uncontrolled hiccough
black african american f 34 $nan$hematology blood hematocrit  23.1  %; hematology blood hematocrit  22.9  %; hematology blood hematocrit  24.5  %; hematology blood hemoglobin  7.8  g dl; hematology blood hemoglobin  7.8  g dl; hematology blood hemoglobin  8.2  g dl; hematology blood platelet count  112  k ul; hematology blood platelet count  101  k ul; hematology blood platelet count  114  k ul; chemistry blood anion gap  24  meq l; chemistry blood anion gap  18  meq l; chemistry blood anion gap  19  meq l; chemistry blood bicarbonate  15  meq l; chemistry blood bicarbonate  23  meq l; chemistry blood bicarbonate  24  meq l; chemistry blood chloride  99  meq l; chemistry blood chloride  99  meq l; chemistry blood chloride  99  meq l; chemistry blood creatinine  14.4  mg dl; chemistry blood creatinine  10.3  mg dl; chemistry blood creatinine  11.0  mg dl; chemistry blood potassium  4.5  meq l; chemistry blood potassium  3.3  meq l; chemistry blood potassium  4.0  meq l; chemistry blood sodium  133  meq l; chemistry blood sodium  137  meq l; chemistry blood sodium  138  meq l; chemistry blood urea nitrogen  105  mg dl; chemistry blood urea nitrogen  68  mg dl; chemistry blood urea nitrogen  73  mg dl; hematology blood inr(pt)  1.0  ; hematology blood inr(pt)  1.1  ; chemistry blood calcium, total  8.5  mg dl; chemistry blood calcium, total  8.6  mg dl; chemistry blood calcium, total  8.5  mg dl; chemistry blood bilirubin, total  0.6  mg dl; chemistry blood glucose  102  mg dl; chemistry blood glucose  130  mg dl; chemistry blood glucose  86  mg dl$sodium chloride 0.9%  1000  ml ; lidocaine 1%  1  ml ; sodium chloride 0.9%  flush  3  ml ; heparin  5000  unit ; tuberculin protein  0.1  ml ; trazodone  100  mg ; norethindrone-estradiol  1  tab ; labetalol  200  mg ; nephrocaps  1  cap ; calcitriol  0.25  mcg ; amlodipine  5  mg ; 
nephritis and nephropathy, not specified as acute or chronic, with unspecified pathological lesion in kidney mild or unspecified pre-eclampsia, delivered, with or without mention of antepartum condition early onset of delivery, delivered, with or without mention of antepartum condition motorcycle driver injured in collision with fixed or stationary object in nontraffic accident precipitate labor, delivered, with or without mention of antepartum condition acute kidney failure, unspecified outcome of delivery, single liveborn headache unspecified renal disease in pregnancy, without mention of hypertension, antepartum condition or complication unspecified disorder of kidney and ureter headache 
black african american f 34 $nan$hematology blood hematocrit  26.7  %; hematology blood hematocrit  25.1  %; hematology blood hemoglobin  9.1  g dl; hematology blood hemoglobin  8.4  g dl; hematology blood platelet count  135  k ul; hematology blood platelet count  128  k ul; chemistry blood anion gap  17  meq l; chemistry blood anion gap  15  meq l; chemistry blood bicarbonate  29  meq l; chemistry blood bicarbonate  29  meq l; chemistry blood chloride  98  meq l; chemistry blood chloride  99  meq l; chemistry blood creatinine  8.5  mg dl; chemistry blood creatinine  8.8  mg dl; chemistry blood potassium  3.9  meq l; chemistry blood potassium  3.9  meq l; chemistry blood sodium  140  meq l; chemistry blood sodium  139  meq l; chemistry blood urea nitrogen  44  mg dl; chemistry blood urea nitrogen  44  mg dl; chemistry blood calcium, total  8.8  mg dl; chemistry blood calcium, total  8.5  mg dl; chemistry blood glucose  89  mg dl; chemistry blood glucose  98  mg dl$sodium chloride 0.9%  flush  3  ml ; heparin  5000  unit ; trazodone  100  mg ; norethindrone-estradiol  1  tab ; labetalol  200  mg ; nephrocaps  1  cap ; calcitriol  0.25  mcg ; amlodipine  5  mg ; acetaminophen  1000  mg ; 
nephritis and nephropathy, not specified as acute or chronic, with unspecified pathological lesion in kidney mild or unspecified pre-eclampsia, delivered, with or without mention of antepartum condition early onset of delivery, delivered, with or without mention of antepartum condition motorcycle driver injured in collision with fixed or stationary object in nontraffic accident precipitate labor, delivered, with or without mention of antepartum condition acute kidney failure, unspecified outcome of delivery, single liveborn headache unspecified renal disease in pregnancy, without mention of hypertension, antepartum condition or complication unspecified disorder of kidney and ureter headache 
black african american f 34 $nan$hematology blood hematocrit  26.5  %; hematology blood hemoglobin  8.6  g dl; hematology blood platelet count  137  k ul; chemistry blood anion gap  20  meq l; chemistry blood bicarbonate  27  meq l; chemistry blood chloride  98  meq l; chemistry blood creatinine  7.5  mg dl; chemistry blood potassium  4.2  meq l; chemistry blood sodium  141  meq l; chemistry blood urea nitrogen  28  mg dl; chemistry blood calcium, total  9.5  mg dl; chemistry blood glucose  81  mg dl$sodium chloride 0.9%  flush  3  ml ; heparin  5000  unit ; trazodone  100  mg ; norethindrone-estradiol  1  tab ; labetalol  200  mg ; nephrocaps  1  cap ; calcitriol  0.25  mcg ; amlodipine  5  mg ; acetaminophen  1000  mg ; 
nephritis and nephropathy, not specified as acute or chronic, with unspecified pathological lesion in kidney mild or unspecified pre-eclampsia, delivered, with or without mention of antepartum condition early onset of delivery, delivered, with or without mention of antepartum condition motorcycle driver injured in collision with fixed or stationary object in nontraffic accident precipitate labor, delivered, with or without mention of antepartum condition acute kidney failure, unspecified outcome of delivery, single liveborn headache unspecified renal disease in pregnancy, without mention of hypertension, antepartum condition or complication unspecified disorder of kidney and ureter headache 
black african american f 34 $nan$hematology blood hematocrit  26.0  %; hematology blood hemoglobin  8.6  g dl; hematology blood platelet count  144  k ul; chemistry blood anion gap  18  meq l; chemistry blood bicarbonate  27  meq l; chemistry blood chloride  98  meq l; chemistry blood creatinine  9.7  mg dl; chemistry blood potassium  4.2  meq l; chemistry blood sodium  139  meq l; chemistry blood urea nitrogen  46  mg dl; chemistry blood calcium, total  9.7  mg dl; chemistry blood glucose  89  mg dl$sodium chloride 0.9%  flush  3  ml ; heparin  5000  unit ; trazodone  100  mg ; norethindrone-estradiol  1  tab ; labetalol  200  mg ; nephrocaps  1  cap ; calcitriol  0.25  mcg ; amlodipine  5  mg ; acetaminophen  1000  mg ; 
nephritis and nephropathy, not specified as acute or chronic, with unspecified pathological lesion in kidney mild or unspecified pre-eclampsia, delivered, with or without mention of antepartum condition early onset of delivery, delivered, with or without mention of antepartum condition motorcycle driver injured in collision with fixed or stationary object in nontraffic accident precipitate labor, delivered, with or without mention of antepartum condition acute kidney failure, unspecified outcome of delivery, single liveborn headache unspecified renal disease in pregnancy, without mention of hypertension, antepartum condition or complication unspecified disorder of kidney and ureter headache 
black african american f 34 $nan$nan$sodium chloride 0.9%  flush  3  ml ; heparin  5000  unit ; trazodone  100  mg ; norethindrone-estradiol  1  tab ; labetalol  200  mg ; nephrocaps  1  cap ; calcitriol  0.25  mcg ; amlodipine  5  mg ; acetaminophen  1000  mg ; 
nephritis and nephropathy, not specified as acute or chronic, with unspecified pathological lesion in kidney mild or unspecified pre-eclampsia, delivered, with or without mention of antepartum condition early onset of delivery, delivered, with or without mention of antepartum condition motorcycle driver injured in collision with fixed or stationary object in nontraffic accident precipitate labor, delivered, with or without mention of antepartum condition acute kidney failure, unspecified outcome of delivery, single liveborn headache unspecified renal disease in pregnancy, without mention of hypertension, antepartum condition or complication unspecified disorder of kidney and ureter headache 
white f 22 $nan$hematology blood hematocrit  38.8  %; hematology blood hemoglobin  12.8  g dl; hematology blood platelet count  308  k ul; chemistry blood anion gap  14  meq l; chemistry blood bicarbonate  25  meq l; chemistry blood chloride  105  meq l; chemistry blood creatinine  0.7  mg dl; chemistry blood potassium  4.0  meq l; chemistry blood sodium  140  meq l; chemistry blood urea nitrogen  10  mg dl; hematology urine wbc  3  # hpf; chemistry blood calcium, total  9.1  mg dl; chemistry blood bilirubin, total  0.2  mg dl; chemistry blood glucose  76  mg dl; chemistry blood albumin  4.2  g dl$influenza virus vaccine  0.5  ml ; sodium chloride 0.9%  flush  3  ml ; heparin  5000  unit ; clobazam  30  mg ; levetiracetam  2500  mg ; acetaminophen  325-650  mg ; lorazepam  0.5-2  mg ; senna  8.6  mg ; docusate sodium  100  mg ; zarontin (ethosuximide)  750  mg ; clobazam  20  mg ; clobazam  5  mg ; zarontin  500  mg ; 
 
white f 22 $nan$nan$influenza virus vaccine  0.5  ml ; sodium chloride 0.9%  flush  3  ml ; heparin  5000  unit ; levetiracetam  2500  mg ; acetaminophen  325-650  mg ; lorazepam  0.5-2  mg ; senna  8.6  mg ; docusate sodium  100  mg ; zarontin (ethosuximide)  750  mg ; zarontin  500  mg ; 
 
white f 22 $nan$nan$influenza virus vaccine  0.5  ml ; sodium chloride 0.9%  flush  3  ml ; heparin  5000  unit ; levetiracetam  2500  mg ; acetaminophen  325-650  mg ; lorazepam  0.5-2  mg ; senna  8.6  mg ; docusate sodium  100  mg ; zarontin (ethosuximide)  750  mg ; zarontin  500  mg ; 
 
white f 22 $nan$nan$influenza virus vaccine  0.5  ml ; sodium chloride 0.9%  flush  3  ml ; heparin  5000  unit ; levetiracetam  2500  mg ; acetaminophen  325-650  mg ; lorazepam  0.5-2  mg ; senna  8.6  mg ; docusate sodium  100  mg ; zarontin (ethosuximide)  750  mg ; zarontin  500  mg ; clobazam  10  mg ; 
 
white f 22 $nan$nan$influenza virus vaccine  0.5  ml ; sodium chloride 0.9%  flush  3  ml ; heparin  5000  unit ; levetiracetam  2500  mg ; acetaminophen  325-650  mg ; lorazepam  0.5-2  mg ; senna  8.6  mg ; docusate sodium  100  mg ; zarontin (ethosuximide)  750  mg ; zarontin  500  mg ; clobazam  10  mg ; 
 
white f 22 $nan$nan$influenza virus vaccine  0.5  ml ; sodium chloride 0.9%  flush  3  ml ; heparin  5000  unit ; levetiracetam  2500  mg ; acetaminophen  325-650  mg ; lorazepam  0.5-2  mg ; senna  8.6  mg ; docusate sodium  100  mg ; zarontin (ethosuximide)  750  mg ; zarontin  500  mg ; clobazam  10  mg ; lacosamide  50  mg ; 
 
white f 22 $nan$nan$influenza virus vaccine  0.5  ml ; sodium chloride 0.9%  flush  3  ml ; heparin  5000  unit ; levetiracetam  2500  mg ; acetaminophen  325-650  mg ; lorazepam  0.5-2  mg ; senna  8.6  mg ; docusate sodium  100  mg ; zarontin (ethosuximide)  750  mg ; zarontin  500  mg ; lacosamide  200  mg ; 
 
white f 22 $nan$nan$influenza virus vaccine  0.5  ml ; sodium chloride 0.9%  flush  3  ml ; heparin  5000  unit ; levetiracetam  2500  mg ; acetaminophen  325-650  mg ; lorazepam  0.5-2  mg ; senna  8.6  mg ; docusate sodium  100  mg ; zarontin (ethosuximide)  750  mg ; zarontin  500  mg ; lacosamide  200  mg ; 
 
white f 22 $nan$nan$influenza virus vaccine  0.5  ml ; sodium chloride 0.9%  flush  3  ml ; heparin  5000  unit ; levetiracetam  2500  mg ; acetaminophen  325-650  mg ; lorazepam  0.5-2  mg ; senna  8.6  mg ; docusate sodium  100  mg ; zarontin (ethosuximide)  750  mg ; zarontin  500  mg ; lacosamide  200  mg ; 
 
white f 22 $nan$nan$influenza virus vaccine  0.5  ml ; sodium chloride 0.9%  flush  3  ml ; heparin  5000  unit ; levetiracetam  2500  mg ; acetaminophen  325-650  mg ; lorazepam  0.5-2  mg ; senna  8.6  mg ; docusate sodium  100  mg ; zarontin (ethosuximide)  750  mg ; zarontin  500  mg ; lacosamide  200  mg ; 
 
white m 80 $nan$hematology blood hematocrit  39.4  %; hematology blood hemoglobin  14.3  g dl; hematology blood platelet count  331  k ul; chemistry blood anion gap  17  meq l; chemistry blood bicarbonate  25  meq l; chemistry blood chloride  104  meq l; chemistry blood creatinine  0.9  mg dl; chemistry blood potassium  4.1  meq l; chemistry blood sodium  142  meq l; chemistry blood urea nitrogen  13  mg dl; hematology blood inr(pt)  1.4  ; chemistry blood calcium, total  8.9  mg dl; chemistry blood glucose  92  mg dl$influenza virus vaccine  0.5  ml ; sodium chloride 0.9%  flush  3  ml ; albuterol 0.083% neb soln  1  neb ; ipratropium bromide neb  1  neb ; heparin  4000  unit ; heparin  1000  unit ; d5w  250  ml ; heparin sodium  25,000  unit ; heparin  5000  unit ; calcium carbonate  500  mg ; atenolol  50  mg ; atorvastatin  40  mg ; aspirin  325  mg ; multivitamins  1  tab ; guaifenesin  5-10  ml ; guaifenesin  400  mg ; metoprolol tartrate  25  mg ; 
 
white m 80 $nan$hematology blood hematocrit  38.8  %; hematology blood hemoglobin  13.8  g dl; hematology blood platelet count  312  k ul; chemistry blood anion gap  13  meq l; chemistry blood bicarbonate  27  meq l; chemistry blood chloride  105  meq l; chemistry blood creatinine  1.1  mg dl; chemistry blood potassium  4.3  meq l; chemistry blood sodium  141  meq l; chemistry blood urea nitrogen  16  mg dl; hematology blood inr(pt)  1.3  ; chemistry blood calcium, total  9.1  mg dl; chemistry blood glucose  87  mg dl$influenza virus vaccine  0.5  ml ; sodium chloride 0.9%  flush  3  ml ; albuterol 0.083% neb soln  1  neb ; ipratropium bromide neb  1  neb ; calcium carbonate  500  mg ; atorvastatin  40  mg ; aspirin  325  mg ; multivitamins  1  tab ; guaifenesin  400  mg ; metoprolol tartrate  25  mg ; latanoprost 0.005% ophth. soln.  1  drop ; 
 
black african american m 68 $temp  98.8  heartrate  58.0  resprate  22.0  o2sat  98.0  sbp  157.0  dbp  82.0  rhythm    pain  0  $hematology blood hematocrit  39.3  %; hematology blood hemoglobin  13.0  g dl; hematology blood platelet count  257  k ul; chemistry blood anion gap  15  meq l; chemistry blood bicarbonate  23  meq l; chemistry blood chloride  104  meq l; chemistry blood creatinine  0.7  mg dl; chemistry blood potassium  4.0  meq l; chemistry blood sodium  142  meq l; chemistry blood urea nitrogen  7  mg dl; chemistry blood calcium, total  9.2  mg dl; chemistry blood glucose  86  mg dl$heparin  5000  unit ; sodium chloride 0.9%  flush  3-10  ml ; losartan potassium  25  mg ; metoprolol tartrate  25  mg ; omeprazole  20  mg ; tamsulosin  0.4  mg ; loratadine  10  mg ; 
gastro-esophageal reflux disease without esophagitis malignant neoplasm of prostate unspecified atrial flutter localization-related (focal) (partial) symptomatic epilepsy and epileptic syndromes with simple partial seizures, not intractable, without status epilepticus family history of ischemic heart disease and other diseases of the circulatory system dysarthria following cerebral infarction essential (primary) hypertension nicotine dependence, unspecified, uncomplicated other sequelae of cerebral infarction unspecified atrial fibrillation acute systolic (congestive) heart failure cerebral embolism with cerebral infarction other convulsions 
black african american m 68 $nan$nan$sodium chloride 0.9%  flush  3-10  ml ; losartan potassium  25  mg ; omeprazole  20  mg ; tamsulosin  0.4  mg ; loratadine  10  mg ; trospium  20  mg ; 
gastro-esophageal reflux disease without esophagitis malignant neoplasm of prostate unspecified atrial flutter localization-related (focal) (partial) symptomatic epilepsy and epileptic syndromes with simple partial seizures, not intractable, without status epilepticus family history of ischemic heart disease and other diseases of the circulatory system dysarthria following cerebral infarction essential (primary) hypertension nicotine dependence, unspecified, uncomplicated other sequelae of cerebral infarction unspecified atrial fibrillation acute systolic (congestive) heart failure cerebral embolism with cerebral infarction other convulsions 
black african american m 68 $nan$hematology blood hematocrit  41.8  %; hematology blood hemoglobin  13.6  g dl; hematology blood platelet count  300  k ul$sodium chloride 0.9%  flush  3-10  ml ; losartan potassium  25  mg ; omeprazole  20  mg ; tamsulosin  0.4  mg ; loratadine  10  mg ; trospium  20  mg ; prednisone  50  mg ; apixaban  5  mg ; cepacol (sore throat lozenge)  1  loz ; sulfameth trimethoprim ds  1  tab ; 
gastro-esophageal reflux disease without esophagitis malignant neoplasm of prostate unspecified atrial flutter localization-related (focal) (partial) symptomatic epilepsy and epileptic syndromes with simple partial seizures, not intractable, without status epilepticus family history of ischemic heart disease and other diseases of the circulatory system dysarthria following cerebral infarction essential (primary) hypertension nicotine dependence, unspecified, uncomplicated other sequelae of cerebral infarction unspecified atrial fibrillation acute systolic (congestive) heart failure cerebral embolism with cerebral infarction other convulsions 
black african american m 68 $nan$nan$sodium chloride 0.9%  flush  3-10  ml ; losartan potassium  25  mg ; omeprazole  20  mg ; tamsulosin  0.4  mg ; loratadine  10  mg ; trospium  20  mg ; prednisone  50  mg ; apixaban  5  mg ; cepacol (sore throat lozenge)  1  loz ; sulfameth trimethoprim ds  1  tab ; 
gastro-esophageal reflux disease without esophagitis malignant neoplasm of prostate unspecified atrial flutter localization-related (focal) (partial) symptomatic epilepsy and epileptic syndromes with simple partial seizures, not intractable, without status epilepticus family history of ischemic heart disease and other diseases of the circulatory system dysarthria following cerebral infarction essential (primary) hypertension nicotine dependence, unspecified, uncomplicated other sequelae of cerebral infarction unspecified atrial fibrillation acute systolic (congestive) heart failure cerebral embolism with cerebral infarction other convulsions 
black african american m 68 $nan$nan$sodium chloride 0.9%  flush  3-10  ml ; losartan potassium  25  mg ; omeprazole  20  mg ; tamsulosin  0.4  mg ; loratadine  10  mg ; trospium  20  mg ; prednisone  50  mg ; apixaban  5  mg ; cepacol (sore throat lozenge)  1  loz ; sulfameth trimethoprim ds  1  tab ; 
gastro-esophageal reflux disease without esophagitis malignant neoplasm of prostate unspecified atrial flutter localization-related (focal) (partial) symptomatic epilepsy and epileptic syndromes with simple partial seizures, not intractable, without status epilepticus family history of ischemic heart disease and other diseases of the circulatory system dysarthria following cerebral infarction essential (primary) hypertension nicotine dependence, unspecified, uncomplicated other sequelae of cerebral infarction unspecified atrial fibrillation acute systolic (congestive) heart failure cerebral embolism with cerebral infarction other convulsions 
black african american f 56 $nan$chemistry blood bilirubin, total  0.5  mg dl; chemistry blood albumin  4.1  g dl; chemistry blood % hemoglobin a1c  5.5  %$albuterol inhaler  2  puff ; acetaminophen  325  mg ; amlodipine  10  mg ; betamethasone dipro 0.05% oint  1  appl ; ferrous sulfate  325  mg ; theophylline er  400  mg ; vitamin d  1000  unit ; hydroxyzine  25  mg ; haloperidol  5  mg ; lorazepam  2  mg ; benztropine mesylate  1  mg ; fluticasone propionate 110mcg  2  puff ; loratadine  10  mg ; risperidone  1  mg ; fluticasone-salmeterol diskus (500 50)   1  inh ; 
cardiac murmur, unspecified delusional disorders essential (primary) hypertension unspecified asthma, uncomplicated unspecified psychosis not due to a substance or known physiological condition sleep apnea, unspecified unspecified psychosis not due to a substance or known physiological condition essential (primary) hypertension unspecified asthma, uncomplicated headache postmenopausal bleeding unspecified psychosis not due to a substance or known physiological condition assault by other bodily force, initial encounter unspecified asthma, uncomplicated unspecified place or not applicable family history of malignant neoplasm, unspecified migraine, unspecified, not intractable, without status migrainosus rheumatic mitral insufficiency elevated blood-pressure reading, without diagnosis of hypertension delusional disorders tachycardia, unspecified psoriasis, unspecified migraine, unspecified, without mention of intractable migraine without mention of status migrainosus unspecified menopausal and postmenopausal disorder acute posthemorrhagic anemia unspecified disorders of menstruation and other abnormal bleeding from female genital tract other psoriasis asthma, unspecified type, unspecified obesity, unspecified body mass index 45.0-49.9, adult chest pain, unspecified cellulitis and abscess of toe, unspecified
black african american f 56 $nan$nan$albuterol inhaler  2  puff ; acetaminophen  325  mg ; amlodipine  10  mg ; betamethasone dipro 0.05% oint  1  appl ; ferrous sulfate  325  mg ; theophylline er  400  mg ; vitamin d  1000  unit ; hydroxyzine  25  mg ; benztropine mesylate  1  mg ; fluticasone propionate 110mcg  2  puff ; loratadine  10  mg ; risperidone  1  mg ; fluticasone-salmeterol diskus (500 50)   1  inh ; aluminum-magnesium hydrox.-simethicone  15-30  ml ; 
cardiac murmur, unspecified delusional disorders essential (primary) hypertension unspecified asthma, uncomplicated unspecified psychosis not due to a substance or known physiological condition sleep apnea, unspecified unspecified psychosis not due to a substance or known physiological condition essential (primary) hypertension unspecified asthma, uncomplicated headache postmenopausal bleeding unspecified psychosis not due to a substance or known physiological condition assault by other bodily force, initial encounter unspecified asthma, uncomplicated unspecified place or not applicable family history of malignant neoplasm, unspecified migraine, unspecified, not intractable, without status migrainosus rheumatic mitral insufficiency elevated blood-pressure reading, without diagnosis of hypertension delusional disorders tachycardia, unspecified psoriasis, unspecified migraine, unspecified, without mention of intractable migraine without mention of status migrainosus unspecified menopausal and postmenopausal disorder acute posthemorrhagic anemia unspecified disorders of menstruation and other abnormal bleeding from female genital tract other psoriasis asthma, unspecified type, unspecified obesity, unspecified body mass index 45.0-49.9, adult chest pain, unspecified cellulitis and abscess of toe, unspecified
black african american f 56 $nan$chemistry blood anion gap  13  meq l; chemistry blood bicarbonate  27  meq l; chemistry blood chloride  97  meq l; chemistry blood creatinine  0.8  mg dl; chemistry blood potassium  4.8  meq l; chemistry blood sodium  137  meq l; chemistry blood urea nitrogen  13  mg dl; chemistry blood calcium, total  9.8  mg dl; chemistry blood glucose  107  mg dl$albuterol inhaler  2  puff ; acetaminophen  325  mg ; amlodipine  10  mg ; betamethasone dipro 0.05% oint  1  appl ; ferrous sulfate  325  mg ; theophylline er  400  mg ; vitamin d  1000  unit ; hydroxyzine  25  mg ; benztropine mesylate  1  mg ; fluticasone propionate 110mcg  2  puff ; loratadine  10  mg ; risperidone  1  mg ; fluticasone-salmeterol diskus (500 50)   1  inh ; aluminum-magnesium hydrox.-simethicone  15-30  ml ; sodium chloride 0.9%  flush  3  ml ; 
cardiac murmur, unspecified delusional disorders essential (primary) hypertension unspecified asthma, uncomplicated unspecified psychosis not due to a substance or known physiological condition sleep apnea, unspecified unspecified psychosis not due to a substance or known physiological condition essential (primary) hypertension unspecified asthma, uncomplicated headache postmenopausal bleeding unspecified psychosis not due to a substance or known physiological condition assault by other bodily force, initial encounter unspecified asthma, uncomplicated unspecified place or not applicable family history of malignant neoplasm, unspecified migraine, unspecified, not intractable, without status migrainosus rheumatic mitral insufficiency elevated blood-pressure reading, without diagnosis of hypertension delusional disorders tachycardia, unspecified psoriasis, unspecified migraine, unspecified, without mention of intractable migraine without mention of status migrainosus unspecified menopausal and postmenopausal disorder acute posthemorrhagic anemia unspecified disorders of menstruation and other abnormal bleeding from female genital tract other psoriasis asthma, unspecified type, unspecified obesity, unspecified body mass index 45.0-49.9, adult chest pain, unspecified cellulitis and abscess of toe, unspecified
black african american f 56 $nan$nan$albuterol inhaler  2  puff ; acetaminophen  325  mg ; amlodipine  10  mg ; betamethasone dipro 0.05% oint  1  appl ; ferrous sulfate  325  mg ; theophylline er  400  mg ; vitamin d  1000  unit ; hydroxyzine  25  mg ; benztropine mesylate  1  mg ; fluticasone propionate 110mcg  2  puff ; loratadine  10  mg ; risperidone  1  mg ; fluticasone-salmeterol diskus (500 50)   1  inh ; aluminum-magnesium hydrox.-simethicone  15-30  ml ; sodium chloride 0.9%  flush  3  ml ; fluticasone-salmeterol diskus (250 50)   1  inh ; 
cardiac murmur, unspecified delusional disorders essential (primary) hypertension unspecified asthma, uncomplicated unspecified psychosis not due to a substance or known physiological condition sleep apnea, unspecified unspecified psychosis not due to a substance or known physiological condition essential (primary) hypertension unspecified asthma, uncomplicated headache postmenopausal bleeding unspecified psychosis not due to a substance or known physiological condition assault by other bodily force, initial encounter unspecified asthma, uncomplicated unspecified place or not applicable family history of malignant neoplasm, unspecified migraine, unspecified, not intractable, without status migrainosus rheumatic mitral insufficiency elevated blood-pressure reading, without diagnosis of hypertension delusional disorders tachycardia, unspecified psoriasis, unspecified migraine, unspecified, without mention of intractable migraine without mention of status migrainosus unspecified menopausal and postmenopausal disorder acute posthemorrhagic anemia unspecified disorders of menstruation and other abnormal bleeding from female genital tract other psoriasis asthma, unspecified type, unspecified obesity, unspecified body mass index 45.0-49.9, adult chest pain, unspecified cellulitis and abscess of toe, unspecified
black african american f 56 $nan$nan$albuterol inhaler  2  puff ; acetaminophen  325  mg ; amlodipine  10  mg ; betamethasone dipro 0.05% oint  1  appl ; ferrous sulfate  325  mg ; theophylline er  400  mg ; vitamin d  1000  unit ; hydroxyzine  25  mg ; benztropine mesylate  1  mg ; loratadine  10  mg ; risperidone  1  mg ; aluminum-magnesium hydrox.-simethicone  15-30  ml ; sodium chloride 0.9%  flush  3  ml ; fluticasone-salmeterol diskus (250 50)   1  inh ; 
cardiac murmur, unspecified delusional disorders essential (primary) hypertension unspecified asthma, uncomplicated unspecified psychosis not due to a substance or known physiological condition sleep apnea, unspecified unspecified psychosis not due to a substance or known physiological condition essential (primary) hypertension unspecified asthma, uncomplicated headache postmenopausal bleeding unspecified psychosis not due to a substance or known physiological condition assault by other bodily force, initial encounter unspecified asthma, uncomplicated unspecified place or not applicable family history of malignant neoplasm, unspecified migraine, unspecified, not intractable, without status migrainosus rheumatic mitral insufficiency elevated blood-pressure reading, without diagnosis of hypertension delusional disorders tachycardia, unspecified psoriasis, unspecified migraine, unspecified, without mention of intractable migraine without mention of status migrainosus unspecified menopausal and postmenopausal disorder acute posthemorrhagic anemia unspecified disorders of menstruation and other abnormal bleeding from female genital tract other psoriasis asthma, unspecified type, unspecified obesity, unspecified body mass index 45.0-49.9, adult chest pain, unspecified cellulitis and abscess of toe, unspecified
black african american f 56 $nan$nan$albuterol inhaler  2  puff ; acetaminophen  325  mg ; amlodipine  10  mg ; betamethasone dipro 0.05% oint  1  appl ; ferrous sulfate  325  mg ; theophylline er  400  mg ; vitamin d  1000  unit ; hydroxyzine  25  mg ; benztropine mesylate  1  mg ; loratadine  10  mg ; risperidone  1  mg ; aluminum-magnesium hydrox.-simethicone  15-30  ml ; fluticasone-salmeterol diskus (250 50)   1  inh ; 
cardiac murmur, unspecified delusional disorders essential (primary) hypertension unspecified asthma, uncomplicated unspecified psychosis not due to a substance or known physiological condition sleep apnea, unspecified unspecified psychosis not due to a substance or known physiological condition essential (primary) hypertension unspecified asthma, uncomplicated headache postmenopausal bleeding unspecified psychosis not due to a substance or known physiological condition assault by other bodily force, initial encounter unspecified asthma, uncomplicated unspecified place or not applicable family history of malignant neoplasm, unspecified migraine, unspecified, not intractable, without status migrainosus rheumatic mitral insufficiency elevated blood-pressure reading, without diagnosis of hypertension delusional disorders tachycardia, unspecified psoriasis, unspecified migraine, unspecified, without mention of intractable migraine without mention of status migrainosus unspecified menopausal and postmenopausal disorder acute posthemorrhagic anemia unspecified disorders of menstruation and other abnormal bleeding from female genital tract other psoriasis asthma, unspecified type, unspecified obesity, unspecified body mass index 45.0-49.9, adult chest pain, unspecified cellulitis and abscess of toe, unspecified
black african american f 56 $nan$nan$albuterol inhaler  2  puff ; acetaminophen  325  mg ; amlodipine  10  mg ; betamethasone dipro 0.05% oint  1  appl ; ferrous sulfate  325  mg ; theophylline er  400  mg ; vitamin d  1000  unit ; hydroxyzine  25  mg ; benztropine mesylate  1  mg ; loratadine  10  mg ; risperidone  1  mg ; aluminum-magnesium hydrox.-simethicone  15-30  ml ; fluticasone-salmeterol diskus (250 50)   1  inh ; 
cardiac murmur, unspecified delusional disorders essential (primary) hypertension unspecified asthma, uncomplicated unspecified psychosis not due to a substance or known physiological condition sleep apnea, unspecified unspecified psychosis not due to a substance or known physiological condition essential (primary) hypertension unspecified asthma, uncomplicated headache postmenopausal bleeding unspecified psychosis not due to a substance or known physiological condition assault by other bodily force, initial encounter unspecified asthma, uncomplicated unspecified place or not applicable family history of malignant neoplasm, unspecified migraine, unspecified, not intractable, without status migrainosus rheumatic mitral insufficiency elevated blood-pressure reading, without diagnosis of hypertension delusional disorders tachycardia, unspecified psoriasis, unspecified migraine, unspecified, without mention of intractable migraine without mention of status migrainosus unspecified menopausal and postmenopausal disorder acute posthemorrhagic anemia unspecified disorders of menstruation and other abnormal bleeding from female genital tract other psoriasis asthma, unspecified type, unspecified obesity, unspecified body mass index 45.0-49.9, adult chest pain, unspecified cellulitis and abscess of toe, unspecified
black african american f 56 $nan$nan$albuterol inhaler  2  puff ; acetaminophen  325  mg ; amlodipine  10  mg ; betamethasone dipro 0.05% oint  1  appl ; ferrous sulfate  325  mg ; theophylline er  400  mg ; vitamin d  1000  unit ; hydroxyzine  25  mg ; benztropine mesylate  1  mg ; loratadine  10  mg ; aluminum-magnesium hydrox.-simethicone  15-30  ml ; fluticasone-salmeterol diskus (250 50)   1  inh ; paliperidone er  6  mg ; 
cardiac murmur, unspecified delusional disorders essential (primary) hypertension unspecified asthma, uncomplicated unspecified psychosis not due to a substance or known physiological condition sleep apnea, unspecified unspecified psychosis not due to a substance or known physiological condition essential (primary) hypertension unspecified asthma, uncomplicated headache postmenopausal bleeding unspecified psychosis not due to a substance or known physiological condition assault by other bodily force, initial encounter unspecified asthma, uncomplicated unspecified place or not applicable family history of malignant neoplasm, unspecified migraine, unspecified, not intractable, without status migrainosus rheumatic mitral insufficiency elevated blood-pressure reading, without diagnosis of hypertension delusional disorders tachycardia, unspecified psoriasis, unspecified migraine, unspecified, without mention of intractable migraine without mention of status migrainosus unspecified menopausal and postmenopausal disorder acute posthemorrhagic anemia unspecified disorders of menstruation and other abnormal bleeding from female genital tract other psoriasis asthma, unspecified type, unspecified obesity, unspecified body mass index 45.0-49.9, adult chest pain, unspecified cellulitis and abscess of toe, unspecified
black african american f 56 $nan$nan$albuterol inhaler  2  puff ; acetaminophen  325  mg ; amlodipine  10  mg ; betamethasone dipro 0.05% oint  1  appl ; ferrous sulfate  325  mg ; theophylline er  400  mg ; vitamin d  1000  unit ; hydroxyzine  25  mg ; loratadine  10  mg ; aluminum-magnesium hydrox.-simethicone  15-30  ml ; fluticasone-salmeterol diskus (250 50)   1  inh ; paliperidone er  6  mg ; 
cardiac murmur, unspecified delusional disorders essential (primary) hypertension unspecified asthma, uncomplicated unspecified psychosis not due to a substance or known physiological condition sleep apnea, unspecified unspecified psychosis not due to a substance or known physiological condition essential (primary) hypertension unspecified asthma, uncomplicated headache postmenopausal bleeding unspecified psychosis not due to a substance or known physiological condition assault by other bodily force, initial encounter unspecified asthma, uncomplicated unspecified place or not applicable family history of malignant neoplasm, unspecified migraine, unspecified, not intractable, without status migrainosus rheumatic mitral insufficiency elevated blood-pressure reading, without diagnosis of hypertension delusional disorders tachycardia, unspecified psoriasis, unspecified migraine, unspecified, without mention of intractable migraine without mention of status migrainosus unspecified menopausal and postmenopausal disorder acute posthemorrhagic anemia unspecified disorders of menstruation and other abnormal bleeding from female genital tract other psoriasis asthma, unspecified type, unspecified obesity, unspecified body mass index 45.0-49.9, adult chest pain, unspecified cellulitis and abscess of toe, unspecified
black african american f 56 $nan$nan$albuterol inhaler  2  puff ; acetaminophen  325  mg ; amlodipine  10  mg ; betamethasone dipro 0.05% oint  1  appl ; ferrous sulfate  325  mg ; theophylline er  400  mg ; vitamin d  1000  unit ; hydroxyzine  25  mg ; loratadine  10  mg ; aluminum-magnesium hydrox.-simethicone  15-30  ml ; fluticasone-salmeterol diskus (250 50)   1  inh ; paliperidone er  6  mg ; 
cardiac murmur, unspecified delusional disorders essential (primary) hypertension unspecified asthma, uncomplicated unspecified psychosis not due to a substance or known physiological condition sleep apnea, unspecified unspecified psychosis not due to a substance or known physiological condition essential (primary) hypertension unspecified asthma, uncomplicated headache postmenopausal bleeding unspecified psychosis not due to a substance or known physiological condition assault by other bodily force, initial encounter unspecified asthma, uncomplicated unspecified place or not applicable family history of malignant neoplasm, unspecified migraine, unspecified, not intractable, without status migrainosus rheumatic mitral insufficiency elevated blood-pressure reading, without diagnosis of hypertension delusional disorders tachycardia, unspecified psoriasis, unspecified migraine, unspecified, without mention of intractable migraine without mention of status migrainosus unspecified menopausal and postmenopausal disorder acute posthemorrhagic anemia unspecified disorders of menstruation and other abnormal bleeding from female genital tract other psoriasis asthma, unspecified type, unspecified obesity, unspecified body mass index 45.0-49.9, adult chest pain, unspecified cellulitis and abscess of toe, unspecified
black african american f 56 $nan$nan$albuterol inhaler  2  puff ; acetaminophen  325  mg ; amlodipine  10  mg ; betamethasone dipro 0.05% oint  1  appl ; ferrous sulfate  325  mg ; theophylline er  400  mg ; vitamin d  1000  unit ; hydroxyzine  25  mg ; loratadine  10  mg ; aluminum-magnesium hydrox.-simethicone  15-30  ml ; fluticasone-salmeterol diskus (250 50)   1  inh ; paliperidone er  6  mg ; 
cardiac murmur, unspecified delusional disorders essential (primary) hypertension unspecified asthma, uncomplicated unspecified psychosis not due to a substance or known physiological condition sleep apnea, unspecified unspecified psychosis not due to a substance or known physiological condition essential (primary) hypertension unspecified asthma, uncomplicated headache postmenopausal bleeding unspecified psychosis not due to a substance or known physiological condition assault by other bodily force, initial encounter unspecified asthma, uncomplicated unspecified place or not applicable family history of malignant neoplasm, unspecified migraine, unspecified, not intractable, without status migrainosus rheumatic mitral insufficiency elevated blood-pressure reading, without diagnosis of hypertension delusional disorders tachycardia, unspecified psoriasis, unspecified migraine, unspecified, without mention of intractable migraine without mention of status migrainosus unspecified menopausal and postmenopausal disorder acute posthemorrhagic anemia unspecified disorders of menstruation and other abnormal bleeding from female genital tract other psoriasis asthma, unspecified type, unspecified obesity, unspecified body mass index 45.0-49.9, adult chest pain, unspecified cellulitis and abscess of toe, unspecified
black african american f 56 $nan$nan$albuterol inhaler  2  puff ; acetaminophen  325  mg ; amlodipine  10  mg ; betamethasone dipro 0.05% oint  1  appl ; ferrous sulfate  325  mg ; theophylline er  400  mg ; vitamin d  1000  unit ; hydroxyzine  25  mg ; loratadine  10  mg ; aluminum-magnesium hydrox.-simethicone  15-30  ml ; fluticasone-salmeterol diskus (250 50)   1  inh ; paliperidone er  6  mg ; 
cardiac murmur, unspecified delusional disorders essential (primary) hypertension unspecified asthma, uncomplicated unspecified psychosis not due to a substance or known physiological condition sleep apnea, unspecified unspecified psychosis not due to a substance or known physiological condition essential (primary) hypertension unspecified asthma, uncomplicated headache postmenopausal bleeding unspecified psychosis not due to a substance or known physiological condition assault by other bodily force, initial encounter unspecified asthma, uncomplicated unspecified place or not applicable family history of malignant neoplasm, unspecified migraine, unspecified, not intractable, without status migrainosus rheumatic mitral insufficiency elevated blood-pressure reading, without diagnosis of hypertension delusional disorders tachycardia, unspecified psoriasis, unspecified migraine, unspecified, without mention of intractable migraine without mention of status migrainosus unspecified menopausal and postmenopausal disorder acute posthemorrhagic anemia unspecified disorders of menstruation and other abnormal bleeding from female genital tract other psoriasis asthma, unspecified type, unspecified obesity, unspecified body mass index 45.0-49.9, adult chest pain, unspecified cellulitis and abscess of toe, unspecified
black african american f 56 $nan$nan$albuterol inhaler  2  puff ; acetaminophen  325  mg ; amlodipine  10  mg ; betamethasone dipro 0.05% oint  1  appl ; ferrous sulfate  325  mg ; theophylline er  400  mg ; vitamin d  1000  unit ; hydroxyzine  25  mg ; loratadine  10  mg ; aluminum-magnesium hydrox.-simethicone  15-30  ml ; fluticasone-salmeterol diskus (250 50)   1  inh ; paliperidone er  6  mg ; 
cardiac murmur, unspecified delusional disorders essential (primary) hypertension unspecified asthma, uncomplicated unspecified psychosis not due to a substance or known physiological condition sleep apnea, unspecified unspecified psychosis not due to a substance or known physiological condition essential (primary) hypertension unspecified asthma, uncomplicated headache postmenopausal bleeding unspecified psychosis not due to a substance or known physiological condition assault by other bodily force, initial encounter unspecified asthma, uncomplicated unspecified place or not applicable family history of malignant neoplasm, unspecified migraine, unspecified, not intractable, without status migrainosus rheumatic mitral insufficiency elevated blood-pressure reading, without diagnosis of hypertension delusional disorders tachycardia, unspecified psoriasis, unspecified migraine, unspecified, without mention of intractable migraine without mention of status migrainosus unspecified menopausal and postmenopausal disorder acute posthemorrhagic anemia unspecified disorders of menstruation and other abnormal bleeding from female genital tract other psoriasis asthma, unspecified type, unspecified obesity, unspecified body mass index 45.0-49.9, adult chest pain, unspecified cellulitis and abscess of toe, unspecified
black african american f 56 $nan$nan$albuterol inhaler  2  puff ; acetaminophen  325  mg ; amlodipine  10  mg ; betamethasone dipro 0.05% oint  1  appl ; ferrous sulfate  325  mg ; theophylline er  400  mg ; vitamin d  1000  unit ; hydroxyzine  25  mg ; loratadine  10  mg ; aluminum-magnesium hydrox.-simethicone  15-30  ml ; fluticasone-salmeterol diskus (250 50)   1  inh ; paliperidone er  6  mg ; 
cardiac murmur, unspecified delusional disorders essential (primary) hypertension unspecified asthma, uncomplicated unspecified psychosis not due to a substance or known physiological condition sleep apnea, unspecified unspecified psychosis not due to a substance or known physiological condition essential (primary) hypertension unspecified asthma, uncomplicated headache postmenopausal bleeding unspecified psychosis not due to a substance or known physiological condition assault by other bodily force, initial encounter unspecified asthma, uncomplicated unspecified place or not applicable family history of malignant neoplasm, unspecified migraine, unspecified, not intractable, without status migrainosus rheumatic mitral insufficiency elevated blood-pressure reading, without diagnosis of hypertension delusional disorders tachycardia, unspecified psoriasis, unspecified migraine, unspecified, without mention of intractable migraine without mention of status migrainosus unspecified menopausal and postmenopausal disorder acute posthemorrhagic anemia unspecified disorders of menstruation and other abnormal bleeding from female genital tract other psoriasis asthma, unspecified type, unspecified obesity, unspecified body mass index 45.0-49.9, adult chest pain, unspecified cellulitis and abscess of toe, unspecified
black african american f 56 $nan$nan$albuterol inhaler  2  puff ; acetaminophen  325  mg ; amlodipine  10  mg ; betamethasone dipro 0.05% oint  1  appl ; ferrous sulfate  325  mg ; theophylline er  400  mg ; vitamin d  1000  unit ; hydroxyzine  25  mg ; loratadine  10  mg ; aluminum-magnesium hydrox.-simethicone  15-30  ml ; fluticasone-salmeterol diskus (250 50)   1  inh ; paliperidone er  6  mg ; 
cardiac murmur, unspecified delusional disorders essential (primary) hypertension unspecified asthma, uncomplicated unspecified psychosis not due to a substance or known physiological condition sleep apnea, unspecified unspecified psychosis not due to a substance or known physiological condition essential (primary) hypertension unspecified asthma, uncomplicated headache postmenopausal bleeding unspecified psychosis not due to a substance or known physiological condition assault by other bodily force, initial encounter unspecified asthma, uncomplicated unspecified place or not applicable family history of malignant neoplasm, unspecified migraine, unspecified, not intractable, without status migrainosus rheumatic mitral insufficiency elevated blood-pressure reading, without diagnosis of hypertension delusional disorders tachycardia, unspecified psoriasis, unspecified migraine, unspecified, without mention of intractable migraine without mention of status migrainosus unspecified menopausal and postmenopausal disorder acute posthemorrhagic anemia unspecified disorders of menstruation and other abnormal bleeding from female genital tract other psoriasis asthma, unspecified type, unspecified obesity, unspecified body mass index 45.0-49.9, adult chest pain, unspecified cellulitis and abscess of toe, unspecified
black african american f 56 $nan$nan$albuterol inhaler  2  puff ; acetaminophen  325  mg ; amlodipine  10  mg ; betamethasone dipro 0.05% oint  1  appl ; ferrous sulfate  325  mg ; theophylline er  400  mg ; vitamin d  1000  unit ; hydroxyzine  25  mg ; loratadine  10  mg ; aluminum-magnesium hydrox.-simethicone  15-30  ml ; fluticasone-salmeterol diskus (250 50)   1  inh ; paliperidone er  6  mg ; 
cardiac murmur, unspecified delusional disorders essential (primary) hypertension unspecified asthma, uncomplicated unspecified psychosis not due to a substance or known physiological condition sleep apnea, unspecified unspecified psychosis not due to a substance or known physiological condition essential (primary) hypertension unspecified asthma, uncomplicated headache postmenopausal bleeding unspecified psychosis not due to a substance or known physiological condition assault by other bodily force, initial encounter unspecified asthma, uncomplicated unspecified place or not applicable family history of malignant neoplasm, unspecified migraine, unspecified, not intractable, without status migrainosus rheumatic mitral insufficiency elevated blood-pressure reading, without diagnosis of hypertension delusional disorders tachycardia, unspecified psoriasis, unspecified migraine, unspecified, without mention of intractable migraine without mention of status migrainosus unspecified menopausal and postmenopausal disorder acute posthemorrhagic anemia unspecified disorders of menstruation and other abnormal bleeding from female genital tract other psoriasis asthma, unspecified type, unspecified obesity, unspecified body mass index 45.0-49.9, adult chest pain, unspecified cellulitis and abscess of toe, unspecified
black african american f 56 $nan$nan$albuterol inhaler  2  puff ; acetaminophen  325  mg ; amlodipine  10  mg ; betamethasone dipro 0.05% oint  1  appl ; ferrous sulfate  325  mg ; theophylline er  400  mg ; vitamin d  1000  unit ; hydroxyzine  25  mg ; loratadine  10  mg ; aluminum-magnesium hydrox.-simethicone  15-30  ml ; fluticasone-salmeterol diskus (250 50)   1  inh ; paliperidone er  6  mg ; 
cardiac murmur, unspecified delusional disorders essential (primary) hypertension unspecified asthma, uncomplicated unspecified psychosis not due to a substance or known physiological condition sleep apnea, unspecified unspecified psychosis not due to a substance or known physiological condition essential (primary) hypertension unspecified asthma, uncomplicated headache postmenopausal bleeding unspecified psychosis not due to a substance or known physiological condition assault by other bodily force, initial encounter unspecified asthma, uncomplicated unspecified place or not applicable family history of malignant neoplasm, unspecified migraine, unspecified, not intractable, without status migrainosus rheumatic mitral insufficiency elevated blood-pressure reading, without diagnosis of hypertension delusional disorders tachycardia, unspecified psoriasis, unspecified migraine, unspecified, without mention of intractable migraine without mention of status migrainosus unspecified menopausal and postmenopausal disorder acute posthemorrhagic anemia unspecified disorders of menstruation and other abnormal bleeding from female genital tract other psoriasis asthma, unspecified type, unspecified obesity, unspecified body mass index 45.0-49.9, adult chest pain, unspecified cellulitis and abscess of toe, unspecified
black african american f 56 $nan$nan$albuterol inhaler  2  puff ; acetaminophen  325  mg ; amlodipine  10  mg ; betamethasone dipro 0.05% oint  1  appl ; ferrous sulfate  325  mg ; theophylline er  400  mg ; vitamin d  1000  unit ; hydroxyzine  25  mg ; loratadine  10  mg ; aluminum-magnesium hydrox.-simethicone  15-30  ml ; fluticasone-salmeterol diskus (250 50)   1  inh ; paliperidone er  6  mg ; 
cardiac murmur, unspecified delusional disorders essential (primary) hypertension unspecified asthma, uncomplicated unspecified psychosis not due to a substance or known physiological condition sleep apnea, unspecified unspecified psychosis not due to a substance or known physiological condition essential (primary) hypertension unspecified asthma, uncomplicated headache postmenopausal bleeding unspecified psychosis not due to a substance or known physiological condition assault by other bodily force, initial encounter unspecified asthma, uncomplicated unspecified place or not applicable family history of malignant neoplasm, unspecified migraine, unspecified, not intractable, without status migrainosus rheumatic mitral insufficiency elevated blood-pressure reading, without diagnosis of hypertension delusional disorders tachycardia, unspecified psoriasis, unspecified migraine, unspecified, without mention of intractable migraine without mention of status migrainosus unspecified menopausal and postmenopausal disorder acute posthemorrhagic anemia unspecified disorders of menstruation and other abnormal bleeding from female genital tract other psoriasis asthma, unspecified type, unspecified obesity, unspecified body mass index 45.0-49.9, adult chest pain, unspecified cellulitis and abscess of toe, unspecified
black african american f 56 $nan$nan$albuterol inhaler  2  puff ; acetaminophen  325  mg ; amlodipine  10  mg ; betamethasone dipro 0.05% oint  1  appl ; ferrous sulfate  325  mg ; theophylline er  400  mg ; vitamin d  1000  unit ; hydroxyzine  25  mg ; loratadine  10  mg ; aluminum-magnesium hydrox.-simethicone  15-30  ml ; fluticasone-salmeterol diskus (250 50)   1  inh ; paliperidone er  6  mg ; 
cardiac murmur, unspecified delusional disorders essential (primary) hypertension unspecified asthma, uncomplicated unspecified psychosis not due to a substance or known physiological condition sleep apnea, unspecified unspecified psychosis not due to a substance or known physiological condition essential (primary) hypertension unspecified asthma, uncomplicated headache postmenopausal bleeding unspecified psychosis not due to a substance or known physiological condition assault by other bodily force, initial encounter unspecified asthma, uncomplicated unspecified place or not applicable family history of malignant neoplasm, unspecified migraine, unspecified, not intractable, without status migrainosus rheumatic mitral insufficiency elevated blood-pressure reading, without diagnosis of hypertension delusional disorders tachycardia, unspecified psoriasis, unspecified migraine, unspecified, without mention of intractable migraine without mention of status migrainosus unspecified menopausal and postmenopausal disorder acute posthemorrhagic anemia unspecified disorders of menstruation and other abnormal bleeding from female genital tract other psoriasis asthma, unspecified type, unspecified obesity, unspecified body mass index 45.0-49.9, adult chest pain, unspecified cellulitis and abscess of toe, unspecified
white f 82 $temp  98.3  heartrate  87.0  resprate  16.0  o2sat  99.0  sbp  102.0  dbp  47.0  rhythm    pain  7  ; temp    heartrate  90.0  resprate  16.0  o2sat  98.0  sbp  150.0  dbp  53.0  rhythm    pain  7  $hematology blood hematocrit  27.6  %; hematology blood hemoglobin  8.9  g dl; hematology blood platelet count  149  k ul; chemistry blood anion gap  10  meq l; chemistry blood bicarbonate  23  meq l; chemistry blood chloride  110  meq l; chemistry blood creatinine  1.9  mg dl; chemistry blood potassium  5.3  meq l; chemistry blood sodium  143  meq l; chemistry blood urea nitrogen  26  mg dl; chemistry blood glucose  163  mg dl$miconazole powder 2%  1  appl ; sodium chloride 0.9%  flush  3-10  ml ; ramelteon  8  mg ; acetaminophen  650  mg ; polyethylene glycol  17  g ; lactated ringers  1000  ml ; glipizide xl  2.5  mg ; dextrose 50%  12.5  gm ; glucagon  1  mg ; glucose gel  15  g ; lactulose  15  ml ; nifedipine (extended release)  30  mg ; vitamin d  1000  unit ; insulin  0  unit ; 
 
white f 82 $nan$hematology blood hematocrit  24.3  %; hematology blood hemoglobin  7.6  g dl; hematology blood platelet count  129  k ul; chemistry blood anion gap  10  meq l; chemistry blood bicarbonate  22  meq l; chemistry blood chloride  111  meq l; chemistry blood creatinine  1.9  mg dl; chemistry blood potassium  4.6  meq l; chemistry blood sodium  143  meq l; chemistry blood urea nitrogen  26  mg dl; chemistry blood calcium, total  8.9  mg dl; chemistry blood glucose  124  mg dl$miconazole powder 2%  1  appl ; sodium chloride 0.9%  flush  3-10  ml ; ramelteon  8  mg ; acetaminophen  650  mg ; polyethylene glycol  17  g ; glipizide xl  2.5  mg ; dextrose 50%  12.5  gm ; glucagon  1  mg ; glucose gel  15  g ; lactulose  15  ml ; nifedipine (extended release)  30  mg ; vitamin d  1000  unit ; insulin  0  unit ; losartan potassium  100  mg ; 
 
white f 82 $nan$hematology blood hematocrit  28.3  %; hematology blood hemoglobin  9.1  g dl; hematology blood platelet count  125  k ul; chemistry blood anion gap  11  meq l; chemistry blood bicarbonate  25  meq l; chemistry blood chloride  108  meq l; chemistry blood creatinine  1.8  mg dl; chemistry blood potassium  4.1  meq l; chemistry blood sodium  144  meq l; chemistry blood urea nitrogen  24  mg dl; chemistry blood glucose  137  mg dl$miconazole powder 2%  1  appl ; sodium chloride 0.9%  flush  3-10  ml ; ramelteon  8  mg ; acetaminophen  650  mg ; polyethylene glycol  17  g ; glipizide xl  2.5  mg ; dextrose 50%  12.5  gm ; glucagon  1  mg ; glucose gel  15  g ; lactulose  15  ml ; nifedipine (extended release)  30  mg ; vitamin d  1000  unit ; insulin  0  unit ; losartan potassium  100  mg ; 
 
white f 82 $nan$hematology blood hematocrit  28.3  %; hematology blood hemoglobin  9.0  g dl; hematology blood platelet count  146  k ul; chemistry blood anion gap  10  meq l; chemistry blood bicarbonate  25  meq l; chemistry blood chloride  109  meq l; chemistry blood creatinine  1.9  mg dl; chemistry blood potassium  4.2  meq l; chemistry blood sodium  144  meq l; chemistry blood urea nitrogen  24  mg dl; chemistry blood glucose  148  mg dl$miconazole powder 2%  1  appl ; sodium chloride 0.9%  flush  3-10  ml ; ramelteon  8  mg ; acetaminophen  650  mg ; polyethylene glycol  17  g ; glipizide xl  2.5  mg ; dextrose 50%  12.5  gm ; glucagon  1  mg ; glucose gel  15  g ; lactulose  15  ml ; nifedipine (extended release)  30  mg ; vitamin d  1000  unit ; insulin  0  unit ; losartan potassium  100  mg ; 
 
white m 56 $nan$nan$atenolol  100  mg ; allopurinol  200  mg ; 
pneumonia, organism unspecified fluid overload disorder chronic lymphoid leukemia, without mention of having achieved remission encounter for antineoplastic chemotherapy awaiting organ transplant status unspecified essential hypertension pneumonitis due to inhalation of food or vomitus pure hypercholesterolemia unspecified essential hypertension abscess of lung chronic lymphoid leukemia, without mention of having achieved remission chronic lymphoid leukemia, without mention of having achieved remission unspecified essential hypertension other pulmonary embolism and infarction other diseases of lung, not elsewhere classified pneumonitis due to inhalation of food or vomitus hypercalcemia other diseases of lung, not elsewhere classified pure hypercholesterolemia unspecified essential hypertension chronic lymphoid leukemia, without mention of having achieved remission other diseases of lung, not elsewhere classified pure hypercholesterolemia 
white m 56 $nan$hematology blood hematocrit  34.0  %; hematology blood hemoglobin  12.4  g dl; hematology blood platelet count  151  k ul; chemistry blood anion gap  14  meq l; chemistry blood bicarbonate  26  meq l; chemistry blood chloride  106  meq l; chemistry blood creatinine  1.0  mg dl; chemistry blood potassium  4.4  meq l; chemistry blood sodium  142  meq l; chemistry blood urea nitrogen  13  mg dl; hematology blood inr(pt)  1.0  ; chemistry blood calcium, total  8.6  mg dl; chemistry blood bilirubin, total  0.2  mg dl; chemistry blood glucose  109  mg dl; chemistry blood lactate dehydrogenase (ld)  301  iu l; chemistry blood albumin  4.0  g dl; hematology blood bands  4  %$atenolol  100  mg ; allopurinol  200  mg ; influenza virus vaccine  0.5  ml ; sodium chloride 0.9%  flush  3  ml ; diltiazem  120  mg ; amoxicillin-clavulanic acid  500  mg ; acyclovir  400  mg ; fluconazole  200  mg ; lorazepam  0.5-1  mg ; prochlorperazine  10  mg ; insulin  0  unit ; 0.9% sodium chloride  1000  ml ; 0.9% sodium chloride  500  ml ; cisplatin  45  mg ; ns  250  ml ; etoposide  75  mg ; d5w  50  ml ; methylprednisolone sodium succ  500  mg ; 5% dextrose  50  ml ; ondansetron  24  mg ; heparin flush (10 units ml)  2  ml ; 
pneumonia, organism unspecified fluid overload disorder chronic lymphoid leukemia, without mention of having achieved remission encounter for antineoplastic chemotherapy awaiting organ transplant status unspecified essential hypertension pneumonitis due to inhalation of food or vomitus pure hypercholesterolemia unspecified essential hypertension abscess of lung chronic lymphoid leukemia, without mention of having achieved remission chronic lymphoid leukemia, without mention of having achieved remission unspecified essential hypertension other pulmonary embolism and infarction other diseases of lung, not elsewhere classified pneumonitis due to inhalation of food or vomitus hypercalcemia other diseases of lung, not elsewhere classified pure hypercholesterolemia unspecified essential hypertension chronic lymphoid leukemia, without mention of having achieved remission other diseases of lung, not elsewhere classified pure hypercholesterolemia 
white m 56 $nan$hematology blood hematocrit  34.8  %; hematology blood hemoglobin  12.8  g dl; hematology blood platelet count  172  k ul; chemistry blood anion gap  14  meq l; chemistry blood bicarbonate  23  meq l; chemistry blood chloride  104  meq l; chemistry blood creatinine  1.0  mg dl; chemistry blood potassium  4.2  meq l; chemistry blood sodium  137  meq l; chemistry blood urea nitrogen  16  mg dl; hematology blood inr(pt)  1.1  ; chemistry blood calcium, total  9.3  mg dl; chemistry blood bilirubin, total  0.3  mg dl; chemistry blood glucose  164  mg dl; chemistry blood lactate dehydrogenase (ld)  351  iu l; chemistry blood albumin  4.3  g dl; hematology blood bands  2  %$atenolol  100  mg ; allopurinol  200  mg ; sodium chloride 0.9%  flush  3  ml ; diltiazem  120  mg ; amoxicillin-clavulanic acid  500  mg ; acyclovir  400  mg ; fluconazole  200  mg ; lorazepam  0.5-1  mg ; prochlorperazine  10  mg ; 0.9% sodium chloride  500  ml ; cisplatin  45  mg ; ns  250  ml ; etoposide  75  mg ; d5w  50  ml ; methylprednisolone sodium succ  500  mg ; 5% dextrose  50  ml ; ondansetron  24  mg ; heparin flush (10 units ml)  2  ml ; senna  1  tab ; magnesium sulfate  2  gm ; 
pneumonia, organism unspecified fluid overload disorder chronic lymphoid leukemia, without mention of having achieved remission encounter for antineoplastic chemotherapy awaiting organ transplant status unspecified essential hypertension pneumonitis due to inhalation of food or vomitus pure hypercholesterolemia unspecified essential hypertension abscess of lung chronic lymphoid leukemia, without mention of having achieved remission chronic lymphoid leukemia, without mention of having achieved remission unspecified essential hypertension other pulmonary embolism and infarction other diseases of lung, not elsewhere classified pneumonitis due to inhalation of food or vomitus hypercalcemia other diseases of lung, not elsewhere classified pure hypercholesterolemia unspecified essential hypertension chronic lymphoid leukemia, without mention of having achieved remission other diseases of lung, not elsewhere classified pure hypercholesterolemia 
white m 56 $nan$hematology blood hematocrit  32.2  %; hematology blood hemoglobin  11.5  g dl; hematology blood platelet count  200  k ul; chemistry blood anion gap  13  meq l; chemistry blood bicarbonate  24  meq l; chemistry blood chloride  102  meq l; chemistry blood creatinine  0.9  mg dl; chemistry blood potassium  4.1  meq l; chemistry blood sodium  135  meq l; chemistry blood urea nitrogen  21  mg dl; hematology blood inr(pt)  1.0  ; chemistry blood calcium, total  8.8  mg dl; chemistry blood bilirubin, total  0.2  mg dl; chemistry blood glucose  203  mg dl; chemistry blood lactate dehydrogenase (ld)  314  iu l; hematology blood bands  2  %$atenolol  100  mg ; allopurinol  200  mg ; sodium chloride 0.9%  flush  3  ml ; diltiazem  120  mg ; amoxicillin-clavulanic acid  500  mg ; acyclovir  400  mg ; fluconazole  200  mg ; lorazepam  0.5-1  mg ; prochlorperazine  10  mg ; 0.9% sodium chloride  500  ml ; cisplatin  45  mg ; ns  250  ml ; etoposide  75  mg ; d5w  50  ml ; methylprednisolone sodium succ  500  mg ; 5% dextrose  50  ml ; ondansetron  24  mg ; heparin flush (10 units ml)  2  ml ; senna  1  tab ; magnesium sulfate  2  gm ; docusate sodium  100  mg ; 
pneumonia, organism unspecified fluid overload disorder chronic lymphoid leukemia, without mention of having achieved remission encounter for antineoplastic chemotherapy awaiting organ transplant status unspecified essential hypertension pneumonitis due to inhalation of food or vomitus pure hypercholesterolemia unspecified essential hypertension abscess of lung chronic lymphoid leukemia, without mention of having achieved remission chronic lymphoid leukemia, without mention of having achieved remission unspecified essential hypertension other pulmonary embolism and infarction other diseases of lung, not elsewhere classified pneumonitis due to inhalation of food or vomitus hypercalcemia other diseases of lung, not elsewhere classified pure hypercholesterolemia unspecified essential hypertension chronic lymphoid leukemia, without mention of having achieved remission other diseases of lung, not elsewhere classified pure hypercholesterolemia 
white m 56 $nan$hematology blood hematocrit  32.5  %; hematology blood hemoglobin  11.6  g dl; hematology blood platelet count  198  k ul; chemistry blood anion gap  14  meq l; chemistry blood bicarbonate  25  meq l; chemistry blood chloride  100  meq l; chemistry blood creatinine  1.0  mg dl; chemistry blood potassium  4.1  meq l; chemistry blood sodium  135  meq l; chemistry blood urea nitrogen  22  mg dl; hematology blood inr(pt)  1.0  ; chemistry blood calcium, total  8.5  mg dl; chemistry blood bilirubin, total  0.2  mg dl; chemistry blood glucose  160  mg dl; chemistry blood lactate dehydrogenase (ld)  353  iu l; chemistry blood albumin  3.9  g dl$atenolol  100  mg ; allopurinol  200  mg ; sodium chloride 0.9%  flush  3  ml ; diltiazem  120  mg ; amoxicillin-clavulanic acid  500  mg ; acyclovir  400  mg ; fluconazole  200  mg ; lorazepam  0.5-1  mg ; prochlorperazine  10  mg ; 0.9% sodium chloride  500  ml ; cisplatin  45  mg ; ns  250  ml ; etoposide  75  mg ; d5w  50  ml ; methylprednisolone sodium succ  500  mg ; 5% dextrose  50  ml ; ondansetron  24  mg ; heparin flush (10 units ml)  2  ml ; senna  1  tab ; docusate sodium  100  mg ; 
pneumonia, organism unspecified fluid overload disorder chronic lymphoid leukemia, without mention of having achieved remission encounter for antineoplastic chemotherapy awaiting organ transplant status unspecified essential hypertension pneumonitis due to inhalation of food or vomitus pure hypercholesterolemia unspecified essential hypertension abscess of lung chronic lymphoid leukemia, without mention of having achieved remission chronic lymphoid leukemia, without mention of having achieved remission unspecified essential hypertension other pulmonary embolism and infarction other diseases of lung, not elsewhere classified pneumonitis due to inhalation of food or vomitus hypercalcemia other diseases of lung, not elsewhere classified pure hypercholesterolemia unspecified essential hypertension chronic lymphoid leukemia, without mention of having achieved remission other diseases of lung, not elsewhere classified pure hypercholesterolemia 
white m 56 $nan$hematology blood hematocrit  32.8  %; hematology blood hemoglobin  11.8  g dl; hematology blood platelet count  197  k ul; chemistry blood anion gap  14  meq l; chemistry blood bicarbonate  27  meq l; chemistry blood chloride  98  meq l; chemistry blood creatinine  0.9  mg dl; chemistry blood potassium  3.7  meq l; chemistry blood sodium  135  meq l; chemistry blood urea nitrogen  23  mg dl; chemistry blood calcium, total  8.8  mg dl; chemistry blood bilirubin, total  0.3  mg dl; chemistry blood glucose  171  mg dl; chemistry blood lactate dehydrogenase (ld)  330  iu l; chemistry blood albumin  4.1  g dl$atenolol  100  mg ; allopurinol  200  mg ; sodium chloride 0.9%  flush  3  ml ; diltiazem  120  mg ; amoxicillin-clavulanic acid  500  mg ; acyclovir  400  mg ; fluconazole  200  mg ; lorazepam  0.5-1  mg ; prochlorperazine  10  mg ; 0.9% sodium chloride  500  ml ; cisplatin  45  mg ; ns  250  ml ; etoposide  75  mg ; d5w  50  ml ; methylprednisolone sodium succ  500  mg ; 5% dextrose  50  ml ; ondansetron  24  mg ; heparin flush (10 units ml)  2  ml ; senna  1  tab ; docusate sodium  100  mg ; ns  500  ml ; cytarabine  3800  mg ; prednisolone acetate 1% ophth. susp.  2  drop ; 
pneumonia, organism unspecified fluid overload disorder chronic lymphoid leukemia, without mention of having achieved remission encounter for antineoplastic chemotherapy awaiting organ transplant status unspecified essential hypertension pneumonitis due to inhalation of food or vomitus pure hypercholesterolemia unspecified essential hypertension abscess of lung chronic lymphoid leukemia, without mention of having achieved remission chronic lymphoid leukemia, without mention of having achieved remission unspecified essential hypertension other pulmonary embolism and infarction other diseases of lung, not elsewhere classified pneumonitis due to inhalation of food or vomitus hypercalcemia other diseases of lung, not elsewhere classified pure hypercholesterolemia unspecified essential hypertension chronic lymphoid leukemia, without mention of having achieved remission other diseases of lung, not elsewhere classified pure hypercholesterolemia 
white m 56 $nan$hematology blood hematocrit  34.0  %; hematology blood hemoglobin  12.2  g dl; hematology blood platelet count  216  k ul; chemistry blood anion gap  15  meq l; chemistry blood bicarbonate  28  meq l; chemistry blood chloride  94  meq l; chemistry blood creatinine  0.9  mg dl; chemistry blood potassium  3.7  meq l; chemistry blood sodium  133  meq l; chemistry blood urea nitrogen  26  mg dl; hematology blood inr(pt)  1.0  ; chemistry blood calcium, total  9.0  mg dl; chemistry blood bilirubin, total  0.4  mg dl; chemistry blood glucose  180  mg dl; chemistry blood lactate dehydrogenase (ld)  325  iu l; chemistry blood albumin  4.1  g dl$atenolol  100  mg ; allopurinol  200  mg ; sodium chloride 0.9%  flush  3  ml ; diltiazem  120  mg ; amoxicillin-clavulanic acid  500  mg ; acyclovir  400  mg ; fluconazole  200  mg ; lorazepam  0.5-1  mg ; prochlorperazine  10  mg ; d5w  50  ml ; methylprednisolone sodium succ  500  mg ; 5% dextrose  50  ml ; ondansetron  24  mg ; heparin flush (10 units ml)  2  ml ; senna  1  tab ; docusate sodium  100  mg ; ns  500  ml ; cytarabine  3800  mg ; prednisolone acetate 1% ophth. susp.  2  drop ; 
pneumonia, organism unspecified fluid overload disorder chronic lymphoid leukemia, without mention of having achieved remission encounter for antineoplastic chemotherapy awaiting organ transplant status unspecified essential hypertension pneumonitis due to inhalation of food or vomitus pure hypercholesterolemia unspecified essential hypertension abscess of lung chronic lymphoid leukemia, without mention of having achieved remission chronic lymphoid leukemia, without mention of having achieved remission unspecified essential hypertension other pulmonary embolism and infarction other diseases of lung, not elsewhere classified pneumonitis due to inhalation of food or vomitus hypercalcemia other diseases of lung, not elsewhere classified pure hypercholesterolemia unspecified essential hypertension chronic lymphoid leukemia, without mention of having achieved remission other diseases of lung, not elsewhere classified pure hypercholesterolemia 
white m 56 $nan$nan$atenolol  100  mg ; allopurinol  200  mg ; sodium chloride 0.9%  flush  3  ml ; diltiazem  120  mg ; amoxicillin-clavulanic acid  500  mg ; acyclovir  400  mg ; fluconazole  200  mg ; lorazepam  0.5-1  mg ; prochlorperazine  10  mg ; heparin flush (10 units ml)  2  ml ; senna  1  tab ; docusate sodium  100  mg ; prednisolone acetate 1% ophth. susp.  2  drop ; 
pneumonia, organism unspecified fluid overload disorder chronic lymphoid leukemia, without mention of having achieved remission encounter for antineoplastic chemotherapy awaiting organ transplant status unspecified essential hypertension pneumonitis due to inhalation of food or vomitus pure hypercholesterolemia unspecified essential hypertension abscess of lung chronic lymphoid leukemia, without mention of having achieved remission chronic lymphoid leukemia, without mention of having achieved remission unspecified essential hypertension other pulmonary embolism and infarction other diseases of lung, not elsewhere classified pneumonitis due to inhalation of food or vomitus hypercalcemia other diseases of lung, not elsewhere classified pure hypercholesterolemia unspecified essential hypertension chronic lymphoid leukemia, without mention of having achieved remission other diseases of lung, not elsewhere classified pure hypercholesterolemia 
white m 53 $nan$hematology blood hematocrit  30.9  %; hematology blood hemoglobin  10.3  g dl; hematology blood platelet count  380  k ul; chemistry blood anion gap  13  meq l; chemistry blood bicarbonate  24  meq l; chemistry blood chloride  106  meq l; chemistry blood creatinine  0.8  mg dl; chemistry blood potassium  3.9  meq l; chemistry blood sodium  139  meq l; chemistry blood urea nitrogen  19  mg dl; hematology blood inr(pt)  1.1  ; chemistry blood calcium, total  8.9  mg dl; chemistry blood glucose  83  mg dl$acetaminophen  650  mg ; heparin  5000  unit ; hydromorphone (dilaudid)  2-4  mg ; aspirin ec  81  mg ; atorvastatin  10  mg ; docusate sodium  100  mg ; furosemide  20  mg ; lisinopril  5  mg ; metoprolol tartrate  50  mg ; potassium chloride  20  meq ; lisinopril  10  mg ; 
acute posthemorrhagic anemia unspecified essential hypertension tobacco use disorder percutaneous transluminal coronary angioplasty status other and unspecified hyperlipidemia intermediate coronary syndrome family history of ischemic heart disease person boarding or alighting a pedal cycle injured in collision with fixed or stationary object duodenal ulcer, unspecified as acute or chronic, without hemorrhage or perforation, without mention of obstruction long-term (current) use of aspirin osteoarthrosis, unspecified whether generalized or localized, site unspecified old myocardial infarction other acute postoperative pain fever, unspecified coronary atherosclerosis of native coronary artery 
white f 69 $nan$nan$iso-osmotic dextrose  100  ml ; piperacillin-tazobactam  4.5  g ; 
diverticulitis of colon (without mention of hemorrhage) abscess of intestine other and unspecified hyperlipidemia anxiety state, unspecified unspecified essential hypertension esophageal hemorrhage unspecified pleural effusion esophageal reflux other specified disorders of esophagus acute posthemorrhagic anemia esophagitis, unspecified diverticulosis of colon with hemorrhage esophageal reflux iron deficiency anemia, unspecified intestinal bypass or anastomosis status unspecified car occupant injured in collision with railway train or railway vehicle in nontraffic accident unspecified essential hypertension other and unspecified postsurgical nonabsorption acute posthemorrhagic anemia other and unspecified hyperlipidemia peptic ulcer of unspecified site, unspecified as acute or chronic, without mention of hemorrhage or perforation, without mention of obstruction acute posthemorrhagic anemia diverticulosis of colon with hemorrhage iron deficiency anemia secondary to blood loss (chronic) esophageal reflux gastroparesis
white f 69 $nan$hematology blood hematocrit  34.7  %; hematology blood hematocrit  30.0  %; hematology blood hemoglobin  9.7  g dl; hematology blood platelet count  209  k ul; chemistry blood anion gap  12  meq l; chemistry blood bicarbonate  25  meq l; chemistry blood chloride  102  meq l; chemistry blood chloride  103  meq l; chemistry blood creatinine  1.0  mg dl; chemistry blood potassium  5.0  meq l; chemistry blood potassium  4.7  meq l; chemistry blood sodium  137  meq l; chemistry blood sodium  135  meq l; chemistry blood urea nitrogen  14  mg dl; chemistry blood calcium, total  8.5  mg dl; chemistry blood glucose  140  mg dl$iso-osmotic dextrose  100  ml ; piperacillin-tazobactam  4.5  g ; heparin  5000  unit ; sodium chloride 0.9%  flush  3  ml ; lactated ringers  1000  ml ; ondansetron  4  mg ; hydromorphone (dilaudid)  20  mg ; metoclopramide  10  mg ; pantoprazole  40  mg ; ketorolac  15  mg ; potassium chl 20 meq   1000 ml d5 1 2 ns  1000  ml ; 
diverticulitis of colon (without mention of hemorrhage) abscess of intestine other and unspecified hyperlipidemia anxiety state, unspecified unspecified essential hypertension esophageal hemorrhage unspecified pleural effusion esophageal reflux other specified disorders of esophagus acute posthemorrhagic anemia esophagitis, unspecified diverticulosis of colon with hemorrhage esophageal reflux iron deficiency anemia, unspecified intestinal bypass or anastomosis status unspecified car occupant injured in collision with railway train or railway vehicle in nontraffic accident unspecified essential hypertension other and unspecified postsurgical nonabsorption acute posthemorrhagic anemia other and unspecified hyperlipidemia peptic ulcer of unspecified site, unspecified as acute or chronic, without mention of hemorrhage or perforation, without mention of obstruction acute posthemorrhagic anemia diverticulosis of colon with hemorrhage iron deficiency anemia secondary to blood loss (chronic) esophageal reflux gastroparesis
white f 69 $nan$nan$heparin  5000  unit ; sodium chloride 0.9%  flush  3  ml ; ondansetron  4  mg ; hydromorphone (dilaudid)  20  mg ; pantoprazole  40  mg ; ketorolac  15  mg ; potassium chl 20 meq   1000 ml d5 1 2 ns  1000  ml ; oxycodone (immediate release)   5  mg ; simvastatin  20  mg ; 
diverticulitis of colon (without mention of hemorrhage) abscess of intestine other and unspecified hyperlipidemia anxiety state, unspecified unspecified essential hypertension esophageal hemorrhage unspecified pleural effusion esophageal reflux other specified disorders of esophagus acute posthemorrhagic anemia esophagitis, unspecified diverticulosis of colon with hemorrhage esophageal reflux iron deficiency anemia, unspecified intestinal bypass or anastomosis status unspecified car occupant injured in collision with railway train or railway vehicle in nontraffic accident unspecified essential hypertension other and unspecified postsurgical nonabsorption acute posthemorrhagic anemia other and unspecified hyperlipidemia peptic ulcer of unspecified site, unspecified as acute or chronic, without mention of hemorrhage or perforation, without mention of obstruction acute posthemorrhagic anemia diverticulosis of colon with hemorrhage iron deficiency anemia secondary to blood loss (chronic) esophageal reflux gastroparesis
white f 69 $nan$nan$heparin  5000  unit ; sodium chloride 0.9%  flush  3  ml ; pantoprazole  40  mg ; ketorolac  15  mg ; potassium chl 20 meq   1000 ml d5 1 2 ns  1000  ml ; oxycodone (immediate release)   5  mg ; simvastatin  20  mg ; lidocaine 1%  2  ml ; 
diverticulitis of colon (without mention of hemorrhage) abscess of intestine other and unspecified hyperlipidemia anxiety state, unspecified unspecified essential hypertension esophageal hemorrhage unspecified pleural effusion esophageal reflux other specified disorders of esophagus acute posthemorrhagic anemia esophagitis, unspecified diverticulosis of colon with hemorrhage esophageal reflux iron deficiency anemia, unspecified intestinal bypass or anastomosis status unspecified car occupant injured in collision with railway train or railway vehicle in nontraffic accident unspecified essential hypertension other and unspecified postsurgical nonabsorption acute posthemorrhagic anemia other and unspecified hyperlipidemia peptic ulcer of unspecified site, unspecified as acute or chronic, without mention of hemorrhage or perforation, without mention of obstruction acute posthemorrhagic anemia diverticulosis of colon with hemorrhage iron deficiency anemia secondary to blood loss (chronic) esophageal reflux gastroparesis
white f 91 $temp    heartrate  88.0  resprate  16.0  o2sat  99.0  sbp  151.0  dbp  69.0  rhythm  normal sinus rhythm  pain  0  $hematology blood hematocrit  29.5  %; hematology blood hemoglobin  9.7  g dl; hematology blood platelet count  463  k ul; chemistry blood anion gap  17  meq l; chemistry blood anion gap  13  meq l; chemistry blood bicarbonate  23  meq l; chemistry blood bicarbonate  23  meq l; chemistry blood chloride  93  meq l; chemistry blood chloride  96  meq l; chemistry blood creatinine  0.8  mg dl; chemistry blood creatinine  0.7  mg dl; chemistry blood potassium  4.3  meq l; chemistry blood potassium  3.9  meq l; chemistry blood sodium  129  meq l; chemistry blood sodium  128  meq l; chemistry blood urea nitrogen  15  mg dl; chemistry blood urea nitrogen  12  mg dl; hematology blood inr(pt)  1.2  ; chemistry urine chloride, urine  111  meq l; chemistry urine potassium, urine  23  meq l; chemistry urine sodium, urine  103  meq l; chemistry blood calcium, total  9.3  mg dl; chemistry blood bilirubin, total  11.1  mg dl; chemistry blood glucose  108  mg dl; chemistry blood glucose  164  mg dl; chemistry blood albumin  2.8  g dl$influenza virus vaccine  0.5  ml ; pneumococcal 23-valent polysaccharide vaccine  0.5  ml ; 0.9% sodium chloride  1000  ml ; sodium chloride 0.9%  flush  3  ml ; sarna lotion  1  appl ; levothyroxine sodium  100  mcg ; 
 
white f 91 $nan$hematology blood hematocrit  31.4  %; hematology blood hemoglobin  9.9  g dl; hematology blood platelet count  457  k ul; chemistry blood anion gap  14  meq l; chemistry blood bicarbonate  25  meq l; chemistry blood chloride  93  meq l; chemistry blood creatinine  0.8  mg dl; chemistry blood potassium  4.1  meq l; chemistry blood sodium  128  meq l; chemistry blood urea nitrogen  12  mg dl; chemistry blood calcium, total  9.4  mg dl; chemistry blood bilirubin, total  12.6  mg dl; chemistry blood glucose  115  mg dl$influenza virus vaccine  0.5  ml ; pneumococcal 23-valent polysaccharide vaccine  0.5  ml ; 0.9% sodium chloride  1000  ml ; sodium chloride 0.9%  flush  3  ml ; sarna lotion  1  appl ; levothyroxine sodium  100  mcg ; ondansetron  4  mg ; morphine sulfate  1-2  mg ; 
 
white f 91 $nan$hematology blood hematocrit  29.5  %; hematology blood hemoglobin  9.8  g dl; hematology blood platelet count  451  k ul; chemistry blood anion gap  17  meq l; chemistry blood bicarbonate  22  meq l; chemistry blood chloride  97  meq l; chemistry blood creatinine  0.7  mg dl; chemistry blood potassium  3.4  meq l; chemistry blood sodium  133  meq l; chemistry blood urea nitrogen  13  mg dl; chemistry blood calcium, total  8.6  mg dl; chemistry blood bilirubin, total  9.4  mg dl; chemistry blood glucose  90  mg dl$influenza virus vaccine  0.5  ml ; pneumococcal 23-valent polysaccharide vaccine  0.5  ml ; sodium chloride 0.9%  flush  3  ml ; sarna lotion  1  appl ; levothyroxine sodium  100  mcg ; ondansetron  4  mg ; morphine sulfate  1-2  mg ; senna  1  tab ; bisacodyl  10  mg ; polyethylene glycol  17  g ; magnesium sulfate  4  gm ; magnesium oxide  800  mg ; 
 
white f 91 $nan$nan$influenza virus vaccine  0.5  ml ; pneumococcal 23-valent polysaccharide vaccine  0.5  ml ; sodium chloride 0.9%  flush  3  ml ; sarna lotion  1  appl ; levothyroxine sodium  100  mcg ; ondansetron  4  mg ; morphine sulfate  1-2  mg ; senna  1  tab ; bisacodyl  10  mg ; polyethylene glycol  17  g ; magnesium oxide  800  mg ; docusate sodium  100  mg ; 
 
white f 25 $nan$nan$citalopram hydrobromide  20  mg ; ranitidine  75  mg ; topiramate (topamax)  150  mg ; heparin  5000  unit ; metoclopramide  10  mg ; pantoprazole  40  mg ; 
 
white f 25 $nan$hematology blood hematocrit  30.7  %; hematology blood hemoglobin  10.1  g dl; hematology blood platelet count  432  k ul; chemistry blood anion gap  13  meq l; chemistry blood bicarbonate  21  meq l; chemistry blood chloride  108  meq l; chemistry blood creatinine  0.7  mg dl; chemistry blood potassium  3.8  meq l; chemistry blood sodium  138  meq l; chemistry blood urea nitrogen  5  mg dl; hematology blood inr(pt)  1.2  ; chemistry blood calcium, total  9.3  mg dl; chemistry blood bilirubin, total  0.8  mg dl; chemistry blood glucose  73  mg dl$citalopram hydrobromide  20  mg ; ranitidine  75  mg ; topiramate (topamax)  150  mg ; heparin  5000  unit ; metoclopramide  10  mg ; pantoprazole  40  mg ; sodium chloride 0.9%  flush  3  ml ; lorazepam  0.5  mg ; d5 1 2ns  1000  ml ; fentanyl patch  75  mcg hr ; fentanyl pca  10  mcg ; acetaminophen  325  mg ; fentanyl pca  12.5  mcg ; promethazine  25  mg ; hydroxyzine  25  mg ; ondansetron  4  mg ; 
 
white f 25 $nan$nan$citalopram hydrobromide  20  mg ; ranitidine  75  mg ; topiramate (topamax)  150  mg ; heparin  5000  unit ; metoclopramide  10  mg ; pantoprazole  40  mg ; sodium chloride 0.9%  flush  3  ml ; d5 1 2ns  1000  ml ; acetaminophen  325  mg ; fentanyl pca  12.5  mcg ; promethazine  25  mg ; hydroxyzine  25  mg ; 
 
white f 25 $nan$nan$citalopram hydrobromide  20  mg ; ranitidine  75  mg ; topiramate (topamax)  150  mg ; heparin  5000  unit ; metoclopramide  10  mg ; pantoprazole  40  mg ; sodium chloride 0.9%  flush  3  ml ; d5 1 2ns  1000  ml ; acetaminophen  325  mg ; fentanyl pca  12.5  mcg ; promethazine  25  mg ; hydroxyzine  25  mg ; senna  1  tab ; docusate sodium  100  mg ; topiramate (topamax)  50  mg ; mesalamine  1000  mg ; acetaminophen  500  mg ; fentanyl patch  50  mcg hr ; 
 
white f 25 $nan$nan$citalopram hydrobromide  20  mg ; ranitidine  75  mg ; heparin  5000  unit ; metoclopramide  10  mg ; pantoprazole  40  mg ; sodium chloride 0.9%  flush  3  ml ; d5 1 2ns  1000  ml ; promethazine  25  mg ; hydroxyzine  25  mg ; senna  1  tab ; docusate sodium  100  mg ; topiramate (topamax)  50  mg ; mesalamine  1000  mg ; acetaminophen  500  mg ; fentanyl patch  50  mcg hr ; cepacol (menthol)  1  loz ; topiramate (topamax)  100  mg ; oxycodone liquid  5-10  mg ; celebrex  100  mg ; 
 
white f 25 $nan$chemistry blood anion gap  9  meq l; chemistry blood bicarbonate  25  meq l; chemistry blood chloride  110  meq l; chemistry blood creatinine  0.7  mg dl; chemistry blood potassium  3.8  meq l; chemistry blood sodium  140  meq l; chemistry blood urea nitrogen  3  mg dl; chemistry blood calcium, total  9.1  mg dl; chemistry blood glucose  86  mg dl$citalopram hydrobromide  20  mg ; ranitidine  75  mg ; heparin  5000  unit ; metoclopramide  10  mg ; pantoprazole  40  mg ; sodium chloride 0.9%  flush  3  ml ; promethazine  25  mg ; hydroxyzine  25  mg ; senna  1  tab ; docusate sodium  100  mg ; mesalamine  1000  mg ; acetaminophen  500  mg ; fentanyl patch  50  mcg hr ; cepacol (menthol)  1  loz ; topiramate (topamax)  100  mg ; oxycodone liquid  5-10  mg ; celebrex  100  mg ; 
 
white f 25 $nan$nan$citalopram hydrobromide  20  mg ; ranitidine  75  mg ; heparin  5000  unit ; metoclopramide  10  mg ; pantoprazole  40  mg ; sodium chloride 0.9%  flush  3  ml ; promethazine  25  mg ; hydroxyzine  25  mg ; senna  1  tab ; docusate sodium  100  mg ; mesalamine  1000  mg ; acetaminophen  500  mg ; fentanyl patch  50  mcg hr ; cepacol (menthol)  1  loz ; topiramate (topamax)  100  mg ; oxycodone liquid  5-10  mg ; celebrex  100  mg ; ciprofloxacin hcl  250  mg ; metronidazole (flagyl)  500  mg ; ciprofloxacin hcl  500  mg ; diphenhydramine  25  mg ; 
 
white f 25 $nan$nan$citalopram hydrobromide  20  mg ; ranitidine  75  mg ; heparin  5000  unit ; metoclopramide  10  mg ; pantoprazole  40  mg ; sodium chloride 0.9%  flush  3  ml ; promethazine  25  mg ; hydroxyzine  25  mg ; senna  1  tab ; docusate sodium  100  mg ; acetaminophen  500  mg ; fentanyl patch  50  mcg hr ; cepacol (menthol)  1  loz ; topiramate (topamax)  100  mg ; oxycodone liquid  5-10  mg ; celebrex  100  mg ; ciprofloxacin hcl  500  mg ; diphenhydramine  25  mg ; metronidazole (flagyl)  250  mg ; 
 
white m 19 $nan$nan$influenza virus vaccine  0.5  ml ; lactated ringers  1000  ml ; morphine sulfate  2-4  mg ; ondansetron  4  mg ; sodium chloride 0.9%  flush  3  ml ; oxycodone (immediate release)   5-10  mg ; acetaminophen  650  mg ; heparin  5000  unit ; 
 
black african american m 68 $temp    heartrate  86.0  resprate  18.0  o2sat  98.0  sbp  136.0  dbp  71.0  rhythm    pain  0  $nan$ascorbic acid  500  mg ; ferrous sulfate  325  mg ; lisinopril  20  mg ; multivitamins  1  tab ; nadolol  60  mg ; thiamine  100  mg ; 
unspecified gastritis and gastroduodenitis, without mention of hemorrhage esophageal reflux external hemorrhoids without mention of complication esophageal varices in diseases classified elsewhere, with bleeding alcoholic cirrhosis of liver unspecified essential hypertension portal hypertension pneumonia, organism unspecified angiodysplasia of intestine with hemorrhage gastroesophageal laceration-hemorrhage syndrome alcohol abuse, unspecified hemorrhage of rectum and anus chest pain, unspecified microscopic hematuria alcoholic liver damage, unspecified other and unspecified alcohol dependence, continuous other and unspecified noninfectious gastroenteritis and colitis esophageal reflux hemorrhage of rectum and anus anemia of other chronic disease tobacco use disorder benign essential hypertension unspecified deficiency anemia other chest pain esophageal reflux enlargement of lymph nodes cough abdominal pain, generalized loss of weight alcohol abuse, unspecified hepatitis, unspecified tobacco use disorder hemorrhage of gastrointestinal tract, unspecified 
black african american m 68 $temp  97.6  heartrate  80.0  resprate  18.0  o2sat    sbp  123.0  dbp  77.0  rhythm  normal sinus rhythm  pain    $hematology blood hematocrit  29.9  %; hematology blood hematocrit  31.3  %; hematology blood hemoglobin  9.8  g dl; hematology blood platelet count  208  k ul; chemistry blood anion gap  12  meq l; chemistry blood bicarbonate  27  meq l; chemistry blood chloride  107  meq l; chemistry blood creatinine  0.9  mg dl; chemistry blood potassium  3.9  meq l; chemistry blood sodium  142  meq l; chemistry blood urea nitrogen  15  mg dl; hematology blood inr(pt)  1.7  ; chemistry blood calcium, total  9.1  mg dl; chemistry blood bilirubin, total  0.7  mg dl; chemistry blood glucose  109  mg dl; chemistry blood lactate dehydrogenase (ld)  187  iu l$ascorbic acid  500  mg ; ferrous sulfate  325  mg ; lisinopril  20  mg ; multivitamins  1  tab ; nadolol  60  mg ; thiamine  100  mg ; influenza virus vaccine  0.5  ml ; pneumococcal vac polyvalent  0.5  ml ; vial  1  vial ; pantoprazole  40  mg ; morphine sulfate  2-4  mg ; sodium chloride 0.9%  flush  3  ml ; bag  100  ml ; magnesium sulfate  4  gm ; acetaminophen  325-650  mg ; diazepam  10  mg ; folic acid  1  mg ; phytonadione  2  mg ; 
unspecified gastritis and gastroduodenitis, without mention of hemorrhage esophageal reflux external hemorrhoids without mention of complication esophageal varices in diseases classified elsewhere, with bleeding alcoholic cirrhosis of liver unspecified essential hypertension portal hypertension pneumonia, organism unspecified angiodysplasia of intestine with hemorrhage gastroesophageal laceration-hemorrhage syndrome alcohol abuse, unspecified hemorrhage of rectum and anus chest pain, unspecified microscopic hematuria alcoholic liver damage, unspecified other and unspecified alcohol dependence, continuous other and unspecified noninfectious gastroenteritis and colitis esophageal reflux hemorrhage of rectum and anus anemia of other chronic disease tobacco use disorder benign essential hypertension unspecified deficiency anemia other chest pain esophageal reflux enlargement of lymph nodes cough abdominal pain, generalized loss of weight alcohol abuse, unspecified hepatitis, unspecified tobacco use disorder hemorrhage of gastrointestinal tract, unspecified 
black african american m 68 $nan$hematology blood hematocrit  30.3  %; hematology blood hemoglobin  9.5  g dl; hematology blood platelet count  208  k ul; chemistry blood anion gap  9  meq l; chemistry blood bicarbonate  29  meq l; chemistry blood chloride  105  meq l; chemistry blood creatinine  1.0  mg dl; chemistry blood potassium  3.9  meq l; chemistry blood sodium  139  meq l; chemistry blood urea nitrogen  19  mg dl; hematology blood inr(pt)  1.7  ; hematology urine wbc  12  # hpf; chemistry blood calcium, total  9.1  mg dl; chemistry blood bilirubin, total  0.5  mg dl; chemistry blood glucose  100  mg dl; chemistry blood lactate dehydrogenase (ld)  179  iu l$ascorbic acid  500  mg ; ferrous sulfate  325  mg ; lisinopril  20  mg ; multivitamins  1  tab ; nadolol  60  mg ; thiamine  100  mg ; pneumococcal vac polyvalent  0.5  ml ; vial  1  vial ; pantoprazole  40  mg ; morphine sulfate  2-4  mg ; sodium chloride 0.9%  flush  3  ml ; bag  100  ml ; magnesium sulfate  4  gm ; acetaminophen  325-650  mg ; diazepam  10  mg ; folic acid  1  mg ; phytonadione  2  mg ; furosemide  20  mg ; potassium chloride  20  meq ; bag  50  ml ; magnesium sulfate  2  gm ; 
unspecified gastritis and gastroduodenitis, without mention of hemorrhage esophageal reflux external hemorrhoids without mention of complication esophageal varices in diseases classified elsewhere, with bleeding alcoholic cirrhosis of liver unspecified essential hypertension portal hypertension pneumonia, organism unspecified angiodysplasia of intestine with hemorrhage gastroesophageal laceration-hemorrhage syndrome alcohol abuse, unspecified hemorrhage of rectum and anus chest pain, unspecified microscopic hematuria alcoholic liver damage, unspecified other and unspecified alcohol dependence, continuous other and unspecified noninfectious gastroenteritis and colitis esophageal reflux hemorrhage of rectum and anus anemia of other chronic disease tobacco use disorder benign essential hypertension unspecified deficiency anemia other chest pain esophageal reflux enlargement of lymph nodes cough abdominal pain, generalized loss of weight alcohol abuse, unspecified hepatitis, unspecified tobacco use disorder hemorrhage of gastrointestinal tract, unspecified 
black african american m 68 $nan$nan$ascorbic acid  500  mg ; ferrous sulfate  325  mg ; lisinopril  20  mg ; multivitamins  1  tab ; nadolol  60  mg ; thiamine  100  mg ; pneumococcal vac polyvalent  0.5  ml ; sodium chloride 0.9%  flush  3  ml ; acetaminophen  325-650  mg ; folic acid  1  mg ; furosemide  20  mg ; potassium chloride  20  meq ; bag  50  ml ; magnesium sulfate  2  gm ; 
unspecified gastritis and gastroduodenitis, without mention of hemorrhage esophageal reflux external hemorrhoids without mention of complication esophageal varices in diseases classified elsewhere, with bleeding alcoholic cirrhosis of liver unspecified essential hypertension portal hypertension pneumonia, organism unspecified angiodysplasia of intestine with hemorrhage gastroesophageal laceration-hemorrhage syndrome alcohol abuse, unspecified hemorrhage of rectum and anus chest pain, unspecified microscopic hematuria alcoholic liver damage, unspecified other and unspecified alcohol dependence, continuous other and unspecified noninfectious gastroenteritis and colitis esophageal reflux hemorrhage of rectum and anus anemia of other chronic disease tobacco use disorder benign essential hypertension unspecified deficiency anemia other chest pain esophageal reflux enlargement of lymph nodes cough abdominal pain, generalized loss of weight alcohol abuse, unspecified hepatitis, unspecified tobacco use disorder hemorrhage of gastrointestinal tract, unspecified 
hispanic latino m 53 $temp  97.7  heartrate  68.0  resprate  18.0  o2sat  100.0  sbp  126.0  dbp  84.0  rhythm    pain  0  ; temp  97.7  heartrate  72.0  resprate  18.0  o2sat  100.0  sbp  134.0  dbp  82.0  rhythm    pain  0  ; temp  97.7  heartrate  69.0  resprate  18.0  o2sat  100.0  sbp  122.0  dbp  76.0  rhythm    pain  0  ; temp    heartrate  78.0  resprate  20.0  o2sat  96.0  sbp  132.0  dbp  92.0  rhythm    pain  0  ; temp  97.9  heartrate  72.0  resprate  16.0  o2sat  96.0  sbp  120.0  dbp  78.0  rhythm    pain    ; temp    heartrate  88.0  resprate  16.0  o2sat  98.0  sbp  109.0  dbp  62.0  rhythm    pain  0  ; temp    heartrate  81.0  resprate  20.0  o2sat  98.0  sbp  108.0  dbp  65.0  rhythm    pain  0  ; temp  98.0  heartrate  76.0  resprate  18.0  o2sat  95.0  sbp  110.0  dbp  60.0  rhythm    pain  0  $nan$sodium chloride 0.9%  flush  3  ml ; heparin  5000  unit ; aspirin  81  mg ; atorvastatin  20  mg ; omeprazole  20  mg ; metoprolol tartrate  25  mg ; 
acute on chronic systolic (congestive) heart failure gastro-esophageal reflux disease without esophagitis personal history of nicotine dependence dilated cardiomyopathy obstructive sleep apnea (adult) (pediatric) left bundle-branch block, unspecified essential (primary) hypertension dental caries, unspecified chronic gout, unspecified, without tophus (tophi) nonrheumatic mitral (valve) insufficiency family history of ischemic heart disease and other diseases of the circulatory system essential (primary) hypertension adverse effect of loop [high-ceiling] diuretics, initial encounter chronic systolic (congestive) heart failure acute kidney failure with tubular necrosis hyperkalemia personal history of nicotine dependence nonrheumatic mitral (valve) insufficiency obstructive sleep apnea (adult) (pediatric) alcohol dependence, in remission hypovolemia cardiomyopathy, unspecified abnormal electrocardiogram [ecg] [ekg] gastro-esophageal reflux disease without esophagitis hemoptysis unspecified place or not applicable gout, unspecified adverse effect of angiotensin-converting-enzyme inhibitors, initial encounter
hispanic latino m 53 $nan$hematology blood hematocrit  43.6  %; hematology blood hemoglobin  13.9  g dl; hematology blood platelet count  235  k ul; chemistry blood anion gap  14  meq l; chemistry blood bicarbonate  29  meq l; chemistry blood chloride  103  meq l; chemistry blood creatinine  1.2  mg dl; chemistry blood potassium  4.3  meq l; chemistry blood sodium  142  meq l; chemistry blood urea nitrogen  31  mg dl; hematology blood inr(pt)  1.0  ; hematology urine wbc  1  # hpf; chemistry blood calcium, total  9.4  mg dl; chemistry blood bilirubin, total  0.2  mg dl; chemistry blood bilirubin, total  0.3  mg dl; chemistry blood glucose  115  mg dl; chemistry blood lactate dehydrogenase (ld)  161  iu l; chemistry blood lactate dehydrogenase (ld)  161  iu l; chemistry blood albumin  4.0  g dl; chemistry blood % hemoglobin a1c  5.9  %$sodium chloride 0.9%  flush  3  ml ; heparin  5000  unit ; aspirin  81  mg ; atorvastatin  20  mg ; omeprazole  20  mg ; metoprolol tartrate  25  mg ; lisinopril  20  mg ; bag  1  bag ; magnesium sulfate  2  gm ; furosemide  20  mg ; niacinamide  2  tab ; 
acute on chronic systolic (congestive) heart failure gastro-esophageal reflux disease without esophagitis personal history of nicotine dependence dilated cardiomyopathy obstructive sleep apnea (adult) (pediatric) left bundle-branch block, unspecified essential (primary) hypertension dental caries, unspecified chronic gout, unspecified, without tophus (tophi) nonrheumatic mitral (valve) insufficiency family history of ischemic heart disease and other diseases of the circulatory system essential (primary) hypertension adverse effect of loop [high-ceiling] diuretics, initial encounter chronic systolic (congestive) heart failure acute kidney failure with tubular necrosis hyperkalemia personal history of nicotine dependence nonrheumatic mitral (valve) insufficiency obstructive sleep apnea (adult) (pediatric) alcohol dependence, in remission hypovolemia cardiomyopathy, unspecified abnormal electrocardiogram [ecg] [ekg] gastro-esophageal reflux disease without esophagitis hemoptysis unspecified place or not applicable gout, unspecified adverse effect of angiotensin-converting-enzyme inhibitors, initial encounter
hispanic latino m 53 $nan$hematology blood hematocrit  42.8  %; hematology blood hematocrit  30.6  %; hematology blood hematocrit  36.8  %; hematology blood hematocrit  33.4  %; hematology blood hemoglobin  13.3  g dl; hematology blood hemoglobin  9.9  g dl; hematology blood hemoglobin  12.2  g dl; hematology blood platelet count  240  k ul; hematology blood platelet count  174  k ul; hematology blood platelet count  220  k ul; chemistry blood anion gap  15  meq l; chemistry blood anion gap  14  meq l; chemistry blood bicarbonate  29  meq l; chemistry blood bicarbonate  23  meq l; chemistry blood chloride  99  meq l; chemistry blood chloride  105  meq l; chemistry blood creatinine  1.2  mg dl; chemistry blood creatinine  0.9  mg dl; chemistry blood potassium  5.0  meq l; chemistry blood potassium  4.7  meq l; chemistry blood potassium  4.9  meq l; chemistry blood sodium  138  meq l; chemistry blood sodium  137  meq l; chemistry blood urea nitrogen  27  mg dl; chemistry blood urea nitrogen  22  mg dl; hematology blood inr(pt)  1.0  ; hematology blood inr(pt)  1.3  ; hematology blood inr(pt)  1.2  ; chemistry blood calcium, total  9.8  mg dl; chemistry blood calcium, total  8.6  mg dl; chemistry blood bilirubin, total  0.3  mg dl; chemistry blood glucose  112  mg dl; chemistry blood glucose  160  mg dl; chemistry blood lactate dehydrogenase (ld)  150  iu l; blood gas blood free calcium  1.13  mmol l; blood gas blood free calcium  1.22  mmol l; blood gas blood free calcium  1.18  mmol l; blood gas blood free calcium  1.16  mmol l; blood gas blood lactate  1.6  mmol l; blood gas blood lactate  4.0  mmol l; blood gas blood lactate  2.5  mmol l; blood gas blood lactate  4.1  mmol l; blood gas blood chloride, whole blood  105  meq l; blood gas blood chloride, whole blood  108  meq l; blood gas blood glucose  103  mg dl; blood gas blood glucose  120  mg dl; blood gas blood glucose  131  mg dl; blood gas blood glucose  173  mg dl; blood gas blood glucose  136  mg dl; blood gas blood glucose  144  mg dl; blood gas blood hematocrit, calculated  42  %; blood gas blood hematocrit, calculated  32  %; blood gas blood hematocrit, calculated  33  %; blood gas blood hematocrit, calculated  32  %; blood gas blood hemoglobin  14.0  g dl; blood gas blood hemoglobin  10.8  g dl; blood gas blood hemoglobin  11.0  g dl; blood gas blood hemoglobin  10.5  g dl; blood gas blood potassium, whole blood  4.4  meq l; blood gas blood potassium, whole blood  4.8  meq l; blood gas blood potassium, whole blood  5.0  meq l; blood gas blood potassium, whole blood  3.7  meq l; blood gas blood potassium, whole blood  4.5  meq l; blood gas blood sodium, whole blood  136  meq l; blood gas blood sodium, whole blood  135  meq l; blood gas blood sodium, whole blood  135  meq l$cefazolin  2  g ; sodium chloride 0.9%  flush  3  ml ; aspirin  81  mg ; atorvastatin  20  mg ; omeprazole  20  mg ; metoprolol tartrate  25  mg ; bag  1  bag ; magnesium sulfate  2  gm ; furosemide  20  mg ; sodium chloride 0.9%  flush  10  ml ; lactated ringers  1000  ml ; dextrose 5%  1000  ml ; propofol  1000  mg ; syringe (iso-osmotic dextrose)  20  ml ; nitroglycerin  8  mg ; 0.9% sodium chloride  250  ml ; phenylephrine  60  mg ; syringe (iso-osmotic dextrose)  50  ml ; phenylephrine  12  mg ; sterile water  50  ml ; potassium chloride  20  meq ; 0.9% sodium chloride  1  bag ; calcium gluconate  2  g ; bag  1  ml ; acetaminophen  650  mg ; dextrose 50%  12.5  gm ; 0.9% sodium chloride  100  ml ; insulin human regular  100  unit ; glucagon  1  mg ; glucose gel  15  g ; iso-osmotic dextrose  50  ml ; fentanyl citrate  12.5-50  mcg ; oxycodone (immediate release)  5-10  mg ; ondansetron  4  mg ; d5w  100  ml ; milrinone  20  mg ; docusate sodium  100  mg ; 0.9% sodium chloride  500  ml ; vancomycin  1500  mg ; chlorhexidine gluconate 0.12% oral rinse  15  ml ; ketorolac  15  mg ; soln  100  ml ; acetaminophen iv  1000  mg ; dexmedetomidine  0.4  mg ; niacinamide  2  tab ; 
acute on chronic systolic (congestive) heart failure gastro-esophageal reflux disease without esophagitis personal history of nicotine dependence dilated cardiomyopathy obstructive sleep apnea (adult) (pediatric) left bundle-branch block, unspecified essential (primary) hypertension dental caries, unspecified chronic gout, unspecified, without tophus (tophi) nonrheumatic mitral (valve) insufficiency family history of ischemic heart disease and other diseases of the circulatory system essential (primary) hypertension adverse effect of loop [high-ceiling] diuretics, initial encounter chronic systolic (congestive) heart failure acute kidney failure with tubular necrosis hyperkalemia personal history of nicotine dependence nonrheumatic mitral (valve) insufficiency obstructive sleep apnea (adult) (pediatric) alcohol dependence, in remission hypovolemia cardiomyopathy, unspecified abnormal electrocardiogram [ecg] [ekg] gastro-esophageal reflux disease without esophagitis hemoptysis unspecified place or not applicable gout, unspecified adverse effect of angiotensin-converting-enzyme inhibitors, initial encounter
hispanic latino m 53 $nan$hematology blood hematocrit  32.7  %; hematology blood hemoglobin  10.8  g dl; hematology blood platelet count  209  k ul; chemistry blood anion gap  13  meq l; chemistry blood bicarbonate  24  meq l; chemistry blood chloride  105  meq l; chemistry blood creatinine  1.0  mg dl; chemistry blood potassium  5.3  meq l; chemistry blood potassium  5.0  meq l; chemistry blood sodium  137  meq l; chemistry blood urea nitrogen  19  mg dl; hematology blood inr(pt)  1.3  ; chemistry blood calcium, total  8.2  mg dl; chemistry blood bilirubin, total  1.0  mg dl; chemistry blood glucose  111  mg dl; chemistry blood lactate dehydrogenase (ld)  309  iu l; blood gas blood free calcium  1.10  mmol l; blood gas blood free calcium  1.08  mmol l; blood gas blood lactate  2.3  mmol l; blood gas blood lactate  1.8  mmol l; blood gas blood lactate  1.4  mmol l; blood gas blood glucose  113  mg dl; blood gas blood glucose  111  mg dl; blood gas blood hematocrit, calculated  33  %; blood gas blood hemoglobin  11.0  g dl; blood gas blood potassium, whole blood  4.4  meq l$cefazolin  2  g ; sodium chloride 0.9%  flush  10  ml ; dextrose 5%  1000  ml ; propofol  1000  mg ; syringe (iso-osmotic dextrose)  20  ml ; nitroglycerin  8  mg ; 0.9% sodium chloride  250  ml ; phenylephrine  60  mg ; sterile water  50  ml ; potassium chloride  20  meq ; 0.9% sodium chloride  1  bag ; calcium gluconate  2  g ; bag  1  ml ; dextrose 50%  12.5  gm ; 0.9% sodium chloride  100  ml ; insulin human regular  100  unit ; glucagon  1  mg ; glucose gel  15  g ; iso-osmotic dextrose  50  ml ; fentanyl citrate  12.5-50  mcg ; oxycodone (immediate release)  5-10  mg ; ondansetron  4  mg ; d5w  100  ml ; milrinone  20  mg ; docusate sodium  100  mg ; 0.9% sodium chloride  500  ml ; vancomycin  1500  mg ; chlorhexidine gluconate 0.12% oral rinse  15  ml ; ketorolac  15  mg ; soln  100  ml ; acetaminophen iv  1000  mg ; dexmedetomidine  0.4  mg ; albumin 5% (25g   500ml)  25  g ; insulin glargine  (cvicu protocol)  0-50  unit ; insulin  0-10  unit ; metoprolol tartrate  12.5  mg ; aspirin ec  81  mg ; milk of magnesia  30  ml ; insulin  0  unit ; metoprolol tartrate  6.25  mg ; 
acute on chronic systolic (congestive) heart failure gastro-esophageal reflux disease without esophagitis personal history of nicotine dependence dilated cardiomyopathy obstructive sleep apnea (adult) (pediatric) left bundle-branch block, unspecified essential (primary) hypertension dental caries, unspecified chronic gout, unspecified, without tophus (tophi) nonrheumatic mitral (valve) insufficiency family history of ischemic heart disease and other diseases of the circulatory system essential (primary) hypertension adverse effect of loop [high-ceiling] diuretics, initial encounter chronic systolic (congestive) heart failure acute kidney failure with tubular necrosis hyperkalemia personal history of nicotine dependence nonrheumatic mitral (valve) insufficiency obstructive sleep apnea (adult) (pediatric) alcohol dependence, in remission hypovolemia cardiomyopathy, unspecified abnormal electrocardiogram [ecg] [ekg] gastro-esophageal reflux disease without esophagitis hemoptysis unspecified place or not applicable gout, unspecified adverse effect of angiotensin-converting-enzyme inhibitors, initial encounter
hispanic latino m 53 $nan$hematology blood hematocrit  22.6  %; hematology blood hematocrit  21.8  %; hematology blood hematocrit  26.7  %; hematology blood hematocrit  26.4  %; hematology blood hemoglobin  7.2  g dl; hematology blood hemoglobin  7.0  g dl; hematology blood platelet count  106  k ul; hematology blood platelet count  105  k ul; hematology blood platelet count  99  k ul; chemistry blood anion gap  11  meq l; chemistry blood bicarbonate  27  meq l; chemistry blood chloride  102  meq l; chemistry blood creatinine  1.0  mg dl; chemistry blood creatinine  1.0  mg dl; chemistry blood potassium  4.4  meq l; chemistry blood potassium  4.3  meq l; chemistry blood sodium  136  meq l; chemistry blood urea nitrogen  16  mg dl; chemistry blood urea nitrogen  14  mg dl; hematology blood inr(pt)  1.4  ; chemistry blood calcium, total  8.3  mg dl; chemistry blood bilirubin, total  0.7  mg dl; chemistry blood glucose  159  mg dl; chemistry blood lactate dehydrogenase (ld)  246  iu l$cefazolin  2  g ; sodium chloride 0.9%  flush  10  ml ; dextrose 5%  1000  ml ; syringe (iso-osmotic dextrose)  20  ml ; nitroglycerin  8  mg ; 0.9% sodium chloride  250  ml ; phenylephrine  60  mg ; sterile water  50  ml ; potassium chloride  20  meq ; 0.9% sodium chloride  1  bag ; calcium gluconate  2  g ; bag  1  ml ; dextrose 50%  12.5  gm ; glucagon  1  mg ; glucose gel  15  g ; iso-osmotic dextrose  50  ml ; fentanyl citrate  12.5-50  mcg ; oxycodone (immediate release)  5-10  mg ; ondansetron  4  mg ; docusate sodium  100  mg ; 0.9% sodium chloride  500  ml ; vancomycin  1500  mg ; ketorolac  15  mg ; soln  100  ml ; acetaminophen iv  1000  mg ; albumin 5% (25g   500ml)  25  g ; insulin glargine  (cvicu protocol)  0-50  unit ; insulin  0-10  unit ; aspirin ec  81  mg ; milk of magnesia  30  ml ; insulin  0  unit ; metoprolol tartrate  6.25  mg ; insulin  10  unit ; guaifenesin er  1200  mg ; albuterol 0.083% neb soln  1  neb ; 
acute on chronic systolic (congestive) heart failure gastro-esophageal reflux disease without esophagitis personal history of nicotine dependence dilated cardiomyopathy obstructive sleep apnea (adult) (pediatric) left bundle-branch block, unspecified essential (primary) hypertension dental caries, unspecified chronic gout, unspecified, without tophus (tophi) nonrheumatic mitral (valve) insufficiency family history of ischemic heart disease and other diseases of the circulatory system essential (primary) hypertension adverse effect of loop [high-ceiling] diuretics, initial encounter chronic systolic (congestive) heart failure acute kidney failure with tubular necrosis hyperkalemia personal history of nicotine dependence nonrheumatic mitral (valve) insufficiency obstructive sleep apnea (adult) (pediatric) alcohol dependence, in remission hypovolemia cardiomyopathy, unspecified abnormal electrocardiogram [ecg] [ekg] gastro-esophageal reflux disease without esophagitis hemoptysis unspecified place or not applicable gout, unspecified adverse effect of angiotensin-converting-enzyme inhibitors, initial encounter
hispanic latino m 53 $nan$hematology blood hematocrit  26.9  %; hematology blood hemoglobin  8.6  g dl; hematology blood platelet count  110  k ul; chemistry blood anion gap  12  meq l; chemistry blood bicarbonate  28  meq l; chemistry blood chloride  97  meq l; chemistry blood creatinine  0.9  mg dl; chemistry blood potassium  4.4  meq l; chemistry blood potassium  4.7  meq l; chemistry blood potassium  4.6  meq l; chemistry blood sodium  133  meq l; chemistry blood urea nitrogen  14  mg dl; hematology blood inr(pt)  1.2  ; chemistry blood calcium, total  8.4  mg dl; chemistry blood bilirubin, total  0.9  mg dl; chemistry blood glucose  155  mg dl$sodium chloride 0.9%  flush  10  ml ; dextrose 5%  1000  ml ; syringe (iso-osmotic dextrose)  20  ml ; nitroglycerin  8  mg ; 0.9% sodium chloride  250  ml ; phenylephrine  60  mg ; 0.9% sodium chloride  1  bag ; calcium gluconate  2  g ; bag  1  ml ; dextrose 50%  12.5  gm ; glucagon  1  mg ; glucose gel  15  g ; oxycodone (immediate release)  5-10  mg ; ondansetron  4  mg ; docusate sodium  100  mg ; soln  100  ml ; acetaminophen iv  1000  mg ; aspirin ec  81  mg ; milk of magnesia  30  ml ; insulin  10  unit ; guaifenesin er  1200  mg ; albuterol 0.083% neb soln  1  neb ; hydromorphone (dilaudid)  2-4  mg ; acetaminophen  1000  mg ; bisacodyl  10  mg ; polyethylene glycol  17  g ; lactulose  30  ml ; metoprolol tartrate  37.5  mg ; 
acute on chronic systolic (congestive) heart failure gastro-esophageal reflux disease without esophagitis personal history of nicotine dependence dilated cardiomyopathy obstructive sleep apnea (adult) (pediatric) left bundle-branch block, unspecified essential (primary) hypertension dental caries, unspecified chronic gout, unspecified, without tophus (tophi) nonrheumatic mitral (valve) insufficiency family history of ischemic heart disease and other diseases of the circulatory system essential (primary) hypertension adverse effect of loop [high-ceiling] diuretics, initial encounter chronic systolic (congestive) heart failure acute kidney failure with tubular necrosis hyperkalemia personal history of nicotine dependence nonrheumatic mitral (valve) insufficiency obstructive sleep apnea (adult) (pediatric) alcohol dependence, in remission hypovolemia cardiomyopathy, unspecified abnormal electrocardiogram [ecg] [ekg] gastro-esophageal reflux disease without esophagitis hemoptysis unspecified place or not applicable gout, unspecified adverse effect of angiotensin-converting-enzyme inhibitors, initial encounter
hispanic latino m 53 $nan$hematology blood hematocrit  26.6  %; hematology blood hemoglobin  8.5  g dl; hematology blood platelet count  149  k ul; chemistry blood anion gap  12  meq l; chemistry blood bicarbonate  33  meq l; chemistry blood chloride  97  meq l; chemistry blood creatinine  0.9  mg dl; chemistry blood potassium  4.5  meq l; chemistry blood sodium  137  meq l; chemistry blood urea nitrogen  14  mg dl; hematology blood inr(pt)  1.2  ; chemistry blood calcium, total  8.8  mg dl; chemistry blood glucose  125  mg dl$sodium chloride 0.9%  flush  10  ml ; dextrose 5%  1000  ml ; syringe (iso-osmotic dextrose)  20  ml ; nitroglycerin  8  mg ; 0.9% sodium chloride  250  ml ; phenylephrine  60  mg ; 0.9% sodium chloride  1  bag ; calcium gluconate  2  g ; bag  1  ml ; dextrose 50%  12.5  gm ; glucagon  1  mg ; glucose gel  15  g ; ondansetron  4  mg ; docusate sodium  100  mg ; aspirin ec  81  mg ; milk of magnesia  30  ml ; insulin  10  unit ; guaifenesin er  1200  mg ; albuterol 0.083% neb soln  1  neb ; hydromorphone (dilaudid)  2-4  mg ; bisacodyl  10  mg ; polyethylene glycol  17  g ; lactulose  30  ml ; metoprolol tartrate  37.5  mg ; albuterol inhaler  2  puff ; metoprolol succinate xl  75  mg ; 
acute on chronic systolic (congestive) heart failure gastro-esophageal reflux disease without esophagitis personal history of nicotine dependence dilated cardiomyopathy obstructive sleep apnea (adult) (pediatric) left bundle-branch block, unspecified essential (primary) hypertension dental caries, unspecified chronic gout, unspecified, without tophus (tophi) nonrheumatic mitral (valve) insufficiency family history of ischemic heart disease and other diseases of the circulatory system essential (primary) hypertension adverse effect of loop [high-ceiling] diuretics, initial encounter chronic systolic (congestive) heart failure acute kidney failure with tubular necrosis hyperkalemia personal history of nicotine dependence nonrheumatic mitral (valve) insufficiency obstructive sleep apnea (adult) (pediatric) alcohol dependence, in remission hypovolemia cardiomyopathy, unspecified abnormal electrocardiogram [ecg] [ekg] gastro-esophageal reflux disease without esophagitis hemoptysis unspecified place or not applicable gout, unspecified adverse effect of angiotensin-converting-enzyme inhibitors, initial encounter
hispanic latino m 53 $nan$hematology blood hematocrit  25.7  %; hematology blood hemoglobin  8.3  g dl; hematology blood platelet count  166  k ul; chemistry blood anion gap  13  meq l; chemistry blood bicarbonate  31  meq l; chemistry blood chloride  98  meq l; chemistry blood creatinine  0.9  mg dl; chemistry blood potassium  4.4  meq l; chemistry blood sodium  138  meq l; chemistry blood urea nitrogen  20  mg dl; hematology blood inr(pt)  1.1  ; chemistry blood calcium, total  8.8  mg dl; chemistry blood glucose  120  mg dl$sodium chloride 0.9%  flush  10  ml ; dextrose 5%  1000  ml ; syringe (iso-osmotic dextrose)  20  ml ; nitroglycerin  8  mg ; 0.9% sodium chloride  250  ml ; phenylephrine  60  mg ; 0.9% sodium chloride  1  bag ; calcium gluconate  2  g ; bag  1  ml ; dextrose 50%  12.5  gm ; glucagon  1  mg ; glucose gel  15  g ; ondansetron  4  mg ; docusate sodium  100  mg ; aspirin ec  81  mg ; milk of magnesia  30  ml ; guaifenesin er  1200  mg ; albuterol 0.083% neb soln  1  neb ; hydromorphone (dilaudid)  2-4  mg ; bisacodyl  10  mg ; polyethylene glycol  17  g ; lactulose  30  ml ; albuterol inhaler  2  puff ; metoprolol succinate xl  75  mg ; furosemide  40  mg ; metoprolol succinate xl  100  mg ; metoprolol succinate xl  25  mg ; 
acute on chronic systolic (congestive) heart failure gastro-esophageal reflux disease without esophagitis personal history of nicotine dependence dilated cardiomyopathy obstructive sleep apnea (adult) (pediatric) left bundle-branch block, unspecified essential (primary) hypertension dental caries, unspecified chronic gout, unspecified, without tophus (tophi) nonrheumatic mitral (valve) insufficiency family history of ischemic heart disease and other diseases of the circulatory system essential (primary) hypertension adverse effect of loop [high-ceiling] diuretics, initial encounter chronic systolic (congestive) heart failure acute kidney failure with tubular necrosis hyperkalemia personal history of nicotine dependence nonrheumatic mitral (valve) insufficiency obstructive sleep apnea (adult) (pediatric) alcohol dependence, in remission hypovolemia cardiomyopathy, unspecified abnormal electrocardiogram [ecg] [ekg] gastro-esophageal reflux disease without esophagitis hemoptysis unspecified place or not applicable gout, unspecified adverse effect of angiotensin-converting-enzyme inhibitors, initial encounter
unknown m 28 $nan$hematology blood hematocrit  29.7  %; hematology blood hematocrit  28.0  %; hematology blood hematocrit  24.3  %; hematology blood hemoglobin  10.2  g dl; hematology blood hemoglobin  9.8  g dl; hematology blood hemoglobin  8.6  g dl; hematology blood platelet count  192  k ul; hematology blood platelet count  176  k ul; hematology blood platelet count  148  k ul; chemistry blood anion gap  14  meq l; chemistry blood anion gap  17  meq l; chemistry blood anion gap  11  meq l; chemistry blood bicarbonate  19  meq l; chemistry blood bicarbonate  19  meq l; chemistry blood bicarbonate  23  meq l; chemistry blood chloride  111  meq l; chemistry blood chloride  111  meq l; chemistry blood chloride  105  meq l; chemistry blood creatinine  0.8  mg dl; chemistry blood creatinine  0.6  mg dl; chemistry blood creatinine  0.7  mg dl; chemistry blood potassium  5.0  meq l; chemistry blood potassium  3.7  meq l; chemistry blood potassium  3.5  meq l; chemistry blood sodium  139  meq l; chemistry blood sodium  143  meq l; chemistry blood sodium  135  meq l; chemistry blood urea nitrogen  10  mg dl; chemistry blood urea nitrogen  8  mg dl; chemistry blood urea nitrogen  8  mg dl; hematology urine wbc  15  # hpf; chemistry blood calcium, total  7.1  mg dl; chemistry blood calcium, total  7.5  mg dl; chemistry blood calcium, total  7.3  mg dl; chemistry blood glucose  96  mg dl; chemistry blood glucose  106  mg dl; chemistry blood glucose  102  mg dl; blood gas blood free calcium  1.09  mmol l; blood gas blood free calcium  1.07  mmol l; blood gas blood free calcium  1.11  mmol l; blood gas blood free calcium  1.09  mmol l; blood gas blood lactate  2.6  mmol l; blood gas blood lactate  2.4  mmol l; blood gas blood lactate  1.1  mmol l; blood gas blood chloride, whole blood  107  meq l; blood gas blood glucose  131  mg dl; blood gas blood hematocrit, calculated  32  %; blood gas blood hemoglobin  10.6  g dl; blood gas blood potassium, whole blood  4.1  meq l; blood gas blood sodium, whole blood  135  meq l; blood gas blood calculated bicarbonate, whole blood  24  meq l; blood gas blood carboxyhemoglobin  0.6  %; blood gas blood methemoglobin  0.3  %$sterile water  200  ml ; sodium chloride 0.9%  flush  3  ml ; lactated ringers  1000  ml ; propofol  1000  mg ; propofol  200  mg ; morphine sulfate  2-4  mg ; 0.9% sodium chloride  1  bag ; calcium gluconate  2  g ; 0.9% sodium chloride  2  bag ; calcium gluconate  4  g ; magnesium sulfate  2  gm ; magnesium sulfate  4  gm ; sterile water  100  ml ; potassium chloride  40  meq ; sterile water  150  ml ; potassium chloride  60  meq ; potassium chloride  80  meq ; iso-osmotic sodium chloride  1  bag ; famotidine  20  mg ; soln  50  ml ; fentanyl citrate  2.5  mg ; chlorhexidine gluconate 0.12% oral rinse  15  ml ; iso-osmotic dextrose  100  ml ; cefazolin  2  g ; vial  1  vial ; pantoprazole  40  mg ; heparin  5000  unit ; sodium chloride 0.9%  flush  10  ml ; acetaminophen (liquid)  650  mg ; 
 
unknown m 28 $nan$hematology blood hematocrit  26.5  %; hematology blood hematocrit  24.4  %; hematology blood hematocrit  22.5  %; hematology blood hemoglobin  9.1  g dl; hematology blood hemoglobin  8.5  g dl; hematology blood hemoglobin  7.8  g dl; hematology blood platelet count  160  k ul; hematology blood platelet count  169  k ul; hematology blood platelet count  160  k ul; chemistry blood anion gap  12  meq l; chemistry blood anion gap  14  meq l; chemistry blood bicarbonate  23  meq l; chemistry blood bicarbonate  23  meq l; chemistry blood chloride  105  meq l; chemistry blood chloride  103  meq l; chemistry blood creatinine  0.8  mg dl; chemistry blood creatinine  0.7  mg dl; chemistry blood potassium  4.1  meq l; chemistry blood potassium  3.6  meq l; chemistry blood sodium  136  meq l; chemistry blood sodium  136  meq l; chemistry blood urea nitrogen  6  mg dl; chemistry blood urea nitrogen  6  mg dl; chemistry blood calcium, total  7.5  mg dl; chemistry blood calcium, total  7.3  mg dl; chemistry blood glucose  105  mg dl; chemistry blood glucose  131  mg dl; blood gas blood free calcium  1.13  mmol l; blood gas blood free calcium  1.12  mmol l; blood gas blood free calcium  1.08  mmol l; blood gas blood lactate  1.2  mmol l; blood gas blood lactate  1.0  mmol l; blood gas blood lactate  1.0  mmol l; blood gas blood glucose  87  mg dl$sterile water  200  ml ; propofol  1000  mg ; propofol  200  mg ; morphine sulfate  2-4  mg ; 0.9% sodium chloride  1  bag ; calcium gluconate  2  g ; 0.9% sodium chloride  2  bag ; calcium gluconate  4  g ; magnesium sulfate  2  gm ; magnesium sulfate  4  gm ; sterile water  100  ml ; potassium chloride  40  meq ; sterile water  150  ml ; potassium chloride  60  meq ; potassium chloride  80  meq ; soln  50  ml ; fentanyl citrate  2.5  mg ; chlorhexidine gluconate 0.12% oral rinse  15  ml ; iso-osmotic dextrose  100  ml ; cefazolin  2  g ; vial  1  vial ; pantoprazole  40  mg ; heparin  5000  unit ; sodium chloride 0.9%  flush  10  ml ; acetaminophen (liquid)  650  mg ; neutra-phos  2  pkt ; iso-osmotic dextrose  200  ml ; vancomycin  1000  mg ; piperacillin-tazobactam  4.5  g ; gastroview (diatrizoate meglumine & sodium)  30  ml ; 0.9% sodium chloride  250  ml ; norepinephrine  8  mg ; 
 
unknown m 28 $nan$hematology blood hematocrit  28.4  %; hematology blood hematocrit  24.1  %; hematology blood hemoglobin  9.8  g dl; hematology blood hemoglobin  8.3  g dl; hematology blood platelet count  185  k ul; hematology blood platelet count  182  k ul; chemistry blood anion gap  15  meq l; chemistry blood anion gap  13  meq l; chemistry blood bicarbonate  23  meq l; chemistry blood bicarbonate  26  meq l; chemistry blood chloride  102  meq l; chemistry blood chloride  101  meq l; chemistry blood creatinine  0.6  mg dl; chemistry blood creatinine  0.6  mg dl; chemistry blood potassium  3.7  meq l; chemistry blood potassium  3.7  meq l; chemistry blood sodium  136  meq l; chemistry blood sodium  136  meq l; chemistry blood urea nitrogen  6  mg dl; chemistry blood urea nitrogen  6  mg dl; chemistry blood calcium, total  7.6  mg dl; chemistry blood calcium, total  7.5  mg dl; chemistry blood glucose  106  mg dl; chemistry blood glucose  123  mg dl; blood gas blood free calcium  1.08  mmol l; blood gas blood lactate  1.2  mmol l$sterile water  200  ml ; propofol  1000  mg ; propofol  200  mg ; morphine sulfate  2-4  mg ; 0.9% sodium chloride  1  bag ; calcium gluconate  2  g ; 0.9% sodium chloride  2  bag ; calcium gluconate  4  g ; magnesium sulfate  2  gm ; magnesium sulfate  4  gm ; sterile water  100  ml ; potassium chloride  40  meq ; sterile water  150  ml ; potassium chloride  60  meq ; potassium chloride  80  meq ; soln  50  ml ; fentanyl citrate  2.5  mg ; chlorhexidine gluconate 0.12% oral rinse  15  ml ; vial  1  vial ; pantoprazole  40  mg ; heparin  5000  unit ; sodium chloride 0.9%  flush  10  ml ; acetaminophen (liquid)  650  mg ; 0.9% sodium chloride  250  ml ; norepinephrine  8  mg ; sodium phosphate  30  mmol ; 5% dextrose  200  ml ; ciprofloxacin iv  400  mg ; ns  100  ml ; metronidazole  500  mg ; acetaminophen iv  1000  mg ; soln  100  ml ; 
 
unknown m 28 $nan$hematology blood hematocrit  20.6  %; hematology blood hematocrit  24.4  %; hematology blood hematocrit  23.4  %; hematology blood hemoglobin  7.2  g dl; hematology blood hemoglobin  8.3  g dl; hematology blood hemoglobin  8.0  g dl; hematology blood platelet count  190  k ul; hematology blood platelet count  217  k ul; hematology blood platelet count  194  k ul; chemistry blood anion gap  15  meq l; chemistry blood anion gap  15  meq l; chemistry blood bicarbonate  24  meq l; chemistry blood bicarbonate  25  meq l; chemistry blood chloride  101  meq l; chemistry blood chloride  103  meq l; chemistry blood creatinine  0.6  mg dl; chemistry blood creatinine  0.5  mg dl; chemistry blood potassium  3.6  meq l; chemistry blood potassium  3.7  meq l; chemistry blood sodium  136  meq l; chemistry blood sodium  139  meq l; chemistry blood urea nitrogen  5  mg dl; chemistry blood urea nitrogen  5  mg dl; chemistry blood calcium, total  7.6  mg dl; chemistry blood calcium, total  7.3  mg dl; chemistry blood glucose  141  mg dl; chemistry blood glucose  128  mg dl; blood gas blood free calcium  1.08  mmol l; blood gas blood free calcium  1.09  mmol l; blood gas blood lactate  1.1  mmol l; blood gas blood lactate  0.6  mmol l$sterile water  200  ml ; propofol  1000  mg ; propofol  200  mg ; morphine sulfate  2-4  mg ; 0.9% sodium chloride  1  bag ; calcium gluconate  2  g ; 0.9% sodium chloride  2  bag ; calcium gluconate  4  g ; magnesium sulfate  2  gm ; magnesium sulfate  4  gm ; sterile water  100  ml ; potassium chloride  40  meq ; sterile water  150  ml ; potassium chloride  60  meq ; potassium chloride  80  meq ; soln  50  ml ; fentanyl citrate  2.5  mg ; chlorhexidine gluconate 0.12% oral rinse  15  ml ; vial  1  vial ; pantoprazole  40  mg ; heparin  5000  unit ; sodium chloride 0.9%  flush  10  ml ; 0.9% sodium chloride  250  ml ; norepinephrine  8  mg ; 5% dextrose  200  ml ; ciprofloxacin iv  400  mg ; ns  100  ml ; metronidazole  500  mg ; soln  100  ml ; d5 1 2ns  1000  ml ; 0.9% sodium chloride  500  ml ; potassium phosphate  30  mmol ; 0.9% sodium chloride  100  ml ; dexmedetomidine  0.4  mg ; 
 
unknown m 28 $nan$hematology blood hematocrit  24.1  %; hematology blood hematocrit  23.9  %; hematology blood hemoglobin  8.3  g dl; hematology blood hemoglobin  8.4  g dl; hematology blood platelet count  208  k ul; hematology blood platelet count  230  k ul; chemistry blood anion gap  12  meq l; chemistry blood anion gap  11  meq l; chemistry blood bicarbonate  25  meq l; chemistry blood bicarbonate  26  meq l; chemistry blood chloride  107  meq l; chemistry blood chloride  105  meq l; chemistry blood creatinine  0.5  mg dl; chemistry blood creatinine  0.4  mg dl; chemistry blood potassium  4.1  meq l; chemistry blood potassium  3.4  meq l; chemistry blood sodium  140  meq l; chemistry blood sodium  139  meq l; chemistry blood urea nitrogen  6  mg dl; chemistry blood urea nitrogen  6  mg dl; chemistry blood calcium, total  8.0  mg dl; chemistry blood calcium, total  7.7  mg dl; chemistry blood glucose  128  mg dl; chemistry blood glucose  128  mg dl; blood gas blood free calcium  1.09  mmol l; blood gas blood lactate  0.5  mmol l$sterile water  200  ml ; propofol  1000  mg ; propofol  200  mg ; morphine sulfate  2-4  mg ; 0.9% sodium chloride  1  bag ; calcium gluconate  2  g ; 0.9% sodium chloride  2  bag ; calcium gluconate  4  g ; magnesium sulfate  2  gm ; magnesium sulfate  4  gm ; sterile water  100  ml ; potassium chloride  40  meq ; sterile water  150  ml ; potassium chloride  60  meq ; potassium chloride  80  meq ; soln  50  ml ; fentanyl citrate  2.5  mg ; chlorhexidine gluconate 0.12% oral rinse  15  ml ; vial  1  vial ; pantoprazole  40  mg ; heparin  5000  unit ; sodium chloride 0.9%  flush  10  ml ; 0.9% sodium chloride  250  ml ; norepinephrine  8  mg ; d5 1 2ns  1000  ml ; 0.9% sodium chloride  100  ml ; dexmedetomidine  0.4  mg ; potassium phosphate  15  mmol ; midazolam  2-4  mg ; fentanyl citrate  300  mcg ; oxycodone liquid  5-10  mg ; hydromorphone (dilaudid)  0.25-0.5  mg ; ondansetron  4  mg ; 
 
unknown m 28 $nan$nan$sterile water  200  ml ; 0.9% sodium chloride  1  bag ; calcium gluconate  2  g ; 0.9% sodium chloride  2  bag ; calcium gluconate  4  g ; magnesium sulfate  2  gm ; magnesium sulfate  4  gm ; sterile water  100  ml ; potassium chloride  40  meq ; sterile water  150  ml ; potassium chloride  60  meq ; potassium chloride  80  meq ; chlorhexidine gluconate 0.12% oral rinse  15  ml ; vial  1  vial ; pantoprazole  40  mg ; heparin  5000  unit ; sodium chloride 0.9%  flush  10  ml ; 0.9% sodium chloride  250  ml ; norepinephrine  8  mg ; d5 1 2ns  1000  ml ; hydromorphone (dilaudid)  0.25-0.5  mg ; ondansetron  4  mg ; olanzapine  5  mg ; ketorolac  15  mg ; hydromorphone (dilaudid)  0.25  mg ; olanzapine (disintegrating tablet)  5  mg ; olanzapine (disintegrating tablet)  10  mg ; 
 
unknown m 28 $nan$hematology blood hematocrit  26.4  %; hematology blood hemoglobin  9.2  g dl; hematology blood platelet count  330  k ul; chemistry blood anion gap  13  meq l; chemistry blood bicarbonate  23  meq l; chemistry blood chloride  108  meq l; chemistry blood creatinine  0.5  mg dl; chemistry blood potassium  3.3  meq l; chemistry blood sodium  141  meq l; chemistry blood urea nitrogen  9  mg dl; chemistry blood calcium, total  8.1  mg dl; chemistry blood glucose  109  mg dl$vial  1  vial ; pantoprazole  40  mg ; heparin  5000  unit ; sodium chloride 0.9%  flush  10  ml ; ondansetron  4  mg ; hydromorphone (dilaudid)  0.25  mg ; chloraseptic throat spray  1  spry ; albuterol 0.083% neb soln  1  neb ; sodium chloride 3% inhalation soln  15  ml ; 
 
unknown m 28 $nan$hematology blood hematocrit  28.9  %; hematology blood hemoglobin  10.1  g dl; hematology blood platelet count  438  k ul; chemistry blood anion gap  17  meq l; chemistry blood bicarbonate  21  meq l; chemistry blood chloride  105  meq l; chemistry blood creatinine  0.6  mg dl; chemistry blood potassium  3.4  meq l; chemistry blood sodium  140  meq l; chemistry blood urea nitrogen  9  mg dl; chemistry blood calcium, total  8.3  mg dl; chemistry blood glucose  105  mg dl$vial  1  vial ; pantoprazole  40  mg ; heparin  5000  unit ; sodium chloride 0.9%  flush  10  ml ; ondansetron  4  mg ; hydromorphone (dilaudid)  0.25  mg ; chloraseptic throat spray  1  spry ; 
 
unknown m 28 $nan$hematology blood hematocrit  33.9  %; hematology blood hemoglobin  11.5  g dl; hematology blood platelet count  543  k ul; chemistry blood anion gap  17  meq l; chemistry blood bicarbonate  21  meq l; chemistry blood chloride  108  meq l; chemistry blood creatinine  0.6  mg dl; chemistry blood potassium  3.5  meq l; chemistry blood sodium  142  meq l; chemistry blood urea nitrogen  9  mg dl; chemistry blood calcium, total  8.5  mg dl; chemistry blood glucose  106  mg dl$vial  1  vial ; pantoprazole  40  mg ; heparin  5000  unit ; sodium chloride 0.9%  flush  10  ml ; ondansetron  4  mg ; hydromorphone (dilaudid)  0.25  mg ; chloraseptic throat spray  1  spry ; hydromorphone (dilaudid)  2-4  mg ; 
 
unknown m 28 $nan$hematology blood hematocrit  31.6  %; hematology blood hemoglobin  10.6  g dl; hematology blood platelet count  619  k ul; chemistry blood anion gap  14  meq l; chemistry blood anion gap  14  meq l; chemistry blood bicarbonate  22  meq l; chemistry blood bicarbonate  19  meq l; chemistry blood chloride  108  meq l; chemistry blood chloride  112  meq l; chemistry blood creatinine  0.7  mg dl; chemistry blood creatinine  0.5  mg dl; chemistry blood potassium  3.2  meq l; chemistry blood potassium  4.3  meq l; chemistry blood potassium  8.2  meq l; chemistry blood sodium  141  meq l; chemistry blood sodium  137  meq l; chemistry blood urea nitrogen  13  mg dl; chemistry blood urea nitrogen  12  mg dl; chemistry blood calcium, total  8.6  mg dl; chemistry blood calcium, total  7.8  mg dl; chemistry blood glucose  92  mg dl; chemistry blood glucose  93  mg dl$vial  1  vial ; pantoprazole  40  mg ; heparin  5000  unit ; sodium chloride 0.9%  flush  10  ml ; ondansetron  4  mg ; chloraseptic throat spray  1  spry ; hydromorphone (dilaudid)  2-4  mg ; 
 
unknown m 28 $nan$hematology blood hematocrit  32.5  %; hematology blood hemoglobin  10.8  g dl; hematology blood platelet count  700  k ul; chemistry blood anion gap  15  meq l; chemistry blood bicarbonate  24  meq l; chemistry blood chloride  105  meq l; chemistry blood creatinine  0.8  mg dl; chemistry blood potassium  4.3  meq l; chemistry blood sodium  140  meq l; chemistry blood urea nitrogen  16  mg dl; chemistry blood calcium, total  8.8  mg dl; chemistry blood glucose  94  mg dl$heparin  5000  unit ; sodium chloride 0.9%  flush  10  ml ; ondansetron  4  mg ; chloraseptic throat spray  1  spry ; hydromorphone (dilaudid)  2-4  mg ; lidocaine jelly 2% (glydo)  1  appl ; lidocaine 1%  2  ml ; hydromorphone (dilaudid)  0.5  mg ; 
 
unknown m 28 $nan$hematology blood hematocrit  33.6  %; hematology blood hemoglobin  11.3  g dl; hematology blood platelet count  717  k ul; chemistry blood anion gap  18  meq l; chemistry blood bicarbonate  24  meq l; chemistry blood chloride  101  meq l; chemistry blood creatinine  0.7  mg dl; chemistry blood potassium  4.6  meq l; chemistry blood sodium  138  meq l; chemistry blood urea nitrogen  15  mg dl; chemistry blood calcium, total  9.1  mg dl; chemistry blood glucose  97  mg dl$heparin  5000  unit ; sodium chloride 0.9%  flush  10  ml ; ondansetron  4  mg ; chloraseptic throat spray  1  spry ; hydromorphone (dilaudid)  2-4  mg ; lidocaine 1%  2  ml ; hydromorphone (dilaudid)  0.5  mg ; senna  8.6  mg ; polyethylene glycol  17  g ; docusate sodium  100  mg ; 
 
unknown m 28 $nan$hematology blood hematocrit  34.0  %; hematology blood hemoglobin  11.2  g dl; hematology blood platelet count  750  k ul$heparin  5000  unit ; sodium chloride 0.9%  flush  10  ml ; ondansetron  4  mg ; chloraseptic throat spray  1  spry ; hydromorphone (dilaudid)  2-4  mg ; senna  8.6  mg ; polyethylene glycol  17  g ; docusate sodium  100  mg ; olanzapine (disintegrating tablet)  15  mg ; 
 
unknown m 28 $nan$hematology blood hematocrit  33.4  %; hematology blood hemoglobin  11.1  g dl; hematology blood platelet count  706  k ul$heparin  5000  unit ; sodium chloride 0.9%  flush  10  ml ; ondansetron  4  mg ; chloraseptic throat spray  1  spry ; hydromorphone (dilaudid)  2-4  mg ; senna  8.6  mg ; polyethylene glycol  17  g ; docusate sodium  100  mg ; olanzapine (disintegrating tablet)  15  mg ; 
 
unknown m 28 $nan$nan$heparin  5000  unit ; sodium chloride 0.9%  flush  10  ml ; ondansetron  4  mg ; chloraseptic throat spray  1  spry ; hydromorphone (dilaudid)  2-4  mg ; senna  8.6  mg ; polyethylene glycol  17  g ; docusate sodium  100  mg ; olanzapine (disintegrating tablet)  15  mg ; 
 
unknown m 28 $nan$hematology blood hematocrit  33.5  %; hematology blood hemoglobin  10.8  g dl; hematology blood platelet count  727  k ul; chemistry blood anion gap  19  meq l; chemistry blood bicarbonate  23  meq l; chemistry blood chloride  102  meq l; chemistry blood creatinine  0.7  mg dl; chemistry blood potassium  4.6  meq l; chemistry blood sodium  139  meq l; chemistry blood urea nitrogen  21  mg dl; chemistry blood calcium, total  9.7  mg dl; chemistry blood glucose  93  mg dl$heparin  5000  unit ; sodium chloride 0.9%  flush  10  ml ; ondansetron  4  mg ; chloraseptic throat spray  1  spry ; hydromorphone (dilaudid)  2-4  mg ; senna  8.6  mg ; polyethylene glycol  17  g ; docusate sodium  100  mg ; olanzapine (disintegrating tablet)  15  mg ; 
 
unknown m 28 $nan$hematology blood hematocrit  34.5  %; hematology blood hemoglobin  11.6  g dl; hematology blood platelet count  691  k ul$heparin  5000  unit ; sodium chloride 0.9%  flush  10  ml ; ondansetron  4  mg ; chloraseptic throat spray  1  spry ; hydromorphone (dilaudid)  2-4  mg ; senna  8.6  mg ; polyethylene glycol  17  g ; docusate sodium  100  mg ; olanzapine (disintegrating tablet)  15  mg ; 
 
unknown m 28 $nan$hematology blood hematocrit  34.3  %; hematology blood hemoglobin  11.1  g dl; hematology blood platelet count  588  k ul$heparin  5000  unit ; sodium chloride 0.9%  flush  10  ml ; ondansetron  4  mg ; chloraseptic throat spray  1  spry ; hydromorphone (dilaudid)  2-4  mg ; senna  8.6  mg ; polyethylene glycol  17  g ; docusate sodium  100  mg ; olanzapine (disintegrating tablet)  15  mg ; 
 
white f 77 $temp    heartrate  70.0  resprate  20.0  o2sat  95.0  sbp  138.0  dbp  68.0  rhythm  sinus rhythm  pain  8  $nan$amlodipine  5  mg ; citalopram  20  mg ; losartan potassium  100  mg ; bupropion  75  mg ; 
unspecified essential hypertension percutaneous transluminal coronary angioplasty status other and unspecified hyperlipidemia hyposmolality and/or hyponatremia toxic encephalopathy bell's palsy dementia, unspecified, without behavioral disturbance candidiasis of vulva and vagina diabetes mellitus without mention of complication, type ii or unspecified type, uncontrolled coronary atherosclerosis of native coronary artery hypovolemia insomnia, unspecified chest pain, unspecified other and unspecified hyperlipidemia unspecified essential hypertension coronary atherosclerosis of unspecified type of vessel, native or graft percutaneous transluminal coronary angioplasty status diabetes mellitus without mention of complication, type ii or unspecified type, not stated as uncontrolled family history of other cardiovascular diseases 
white f 77 $temp  97.8  heartrate  65.0  resprate  18.0  o2sat  95.0  sbp  127.0  dbp  66.0  rhythm  sinus rhythm  pain  3  $hematology blood hematocrit  35.0  %; hematology blood hemoglobin  12.2  g dl; hematology blood platelet count  166  k ul; chemistry blood anion gap  15  meq l; chemistry blood bicarbonate  26  meq l; chemistry blood chloride  103  meq l; chemistry blood creatinine  1.0  mg dl; chemistry blood potassium  3.6  meq l; chemistry blood sodium  140  meq l; chemistry blood urea nitrogen  24  mg dl; chemistry blood calcium, total  9.7  mg dl; chemistry blood glucose  150  mg dl; chemistry blood albumin  3.8  g dl$amlodipine  5  mg ; citalopram  20  mg ; losartan potassium  100  mg ; bupropion  75  mg ; sucralfate  1  gm ; sodium chloride 0.9%  flush  3  ml ; heparin  5000  unit ; pneumococcal 23-valent polysaccharide vaccine  0.5  ml ; aspirin  81  mg ; atenolol  50  mg ; gabapentin  300  mg ; lactulose  15  ml ; dextrose 50%  12.5  gm ; glucagon  1  mg ; glucose gel  15  g ; simvastatin  10  mg ; simvastatin  20  mg ; insulin  0  unit ; potassium chloride  40  meq ; bag  100  ml ; magnesium sulfate  4  gm ; 
unspecified essential hypertension percutaneous transluminal coronary angioplasty status other and unspecified hyperlipidemia hyposmolality and/or hyponatremia toxic encephalopathy bell's palsy dementia, unspecified, without behavioral disturbance candidiasis of vulva and vagina diabetes mellitus without mention of complication, type ii or unspecified type, uncontrolled coronary atherosclerosis of native coronary artery hypovolemia insomnia, unspecified chest pain, unspecified other and unspecified hyperlipidemia unspecified essential hypertension coronary atherosclerosis of unspecified type of vessel, native or graft percutaneous transluminal coronary angioplasty status diabetes mellitus without mention of complication, type ii or unspecified type, not stated as uncontrolled family history of other cardiovascular diseases 
white f 77 $nan$nan$amlodipine  5  mg ; citalopram  20  mg ; losartan potassium  100  mg ; sucralfate  1  gm ; sodium chloride 0.9%  flush  3  ml ; heparin  5000  unit ; pneumococcal 23-valent polysaccharide vaccine  0.5  ml ; aspirin  81  mg ; atenolol  50  mg ; gabapentin  300  mg ; lactulose  15  ml ; dextrose 50%  12.5  gm ; glucagon  1  mg ; glucose gel  15  g ; simvastatin  20  mg ; insulin  0  unit ; potassium chloride  40  meq ; bag  100  ml ; magnesium sulfate  4  gm ; 
unspecified essential hypertension percutaneous transluminal coronary angioplasty status other and unspecified hyperlipidemia hyposmolality and/or hyponatremia toxic encephalopathy bell's palsy dementia, unspecified, without behavioral disturbance candidiasis of vulva and vagina diabetes mellitus without mention of complication, type ii or unspecified type, uncontrolled coronary atherosclerosis of native coronary artery hypovolemia insomnia, unspecified chest pain, unspecified other and unspecified hyperlipidemia unspecified essential hypertension coronary atherosclerosis of unspecified type of vessel, native or graft percutaneous transluminal coronary angioplasty status diabetes mellitus without mention of complication, type ii or unspecified type, not stated as uncontrolled family history of other cardiovascular diseases 
hispanic latino f 51 $temp  98.0  heartrate  82.0  resprate  16.0  o2sat  100.0  sbp  110.0  dbp  72.0  rhythm    pain  0  $hematology blood hematocrit  40.4  %; hematology blood hemoglobin  14.2  g dl; hematology blood platelet count  269  k ul; chemistry blood anion gap  13  meq l; chemistry blood bicarbonate  26  meq l; chemistry blood chloride  106  meq l; chemistry blood creatinine  0.8  mg dl; chemistry blood potassium  4.0  meq l; chemistry blood sodium  141  meq l; chemistry blood urea nitrogen  19  mg dl; hematology blood inr(pt)  0.9  ; chemistry blood glucose  100  mg dl$influenza virus vaccine  0.5  ml ; sodium chloride 0.9%  flush  3  ml ; hydrocodone-acetaminophen  1  tab ; omeprazole  20  mg ; aspirin  81  mg ; senna  1  tab ; docusate sodium  100  mg ; levetiracetam  1000  mg ; levetiracetam  500  mg ; 
 
hispanic latino f 51 $nan$hematology blood hematocrit  41.8  %; hematology blood hemoglobin  13.9  g dl; hematology blood platelet count  248  k ul; chemistry blood anion gap  13  meq l; chemistry blood bicarbonate  26  meq l; chemistry blood chloride  108  meq l; chemistry blood creatinine  0.7  mg dl; chemistry blood potassium  3.8  meq l; chemistry blood sodium  143  meq l; chemistry blood urea nitrogen  20  mg dl; chemistry blood calcium, total  8.7  mg dl; chemistry blood bilirubin, total  0.3  mg dl; chemistry blood glucose  97  mg dl; chemistry blood lactate dehydrogenase (ld)  143  iu l$influenza virus vaccine  0.5  ml ; sodium chloride 0.9%  flush  3  ml ; hydrocodone-acetaminophen  1  tab ; omeprazole  20  mg ; aspirin  81  mg ; senna  1  tab ; docusate sodium  100  mg ; levetiracetam  1000  mg ; levetiracetam  500  mg ; 0.9% sodium chloride  1000  ml ; 
 
hispanic latino f 51 $nan$nan$influenza virus vaccine  0.5  ml ; sodium chloride 0.9%  flush  3  ml ; hydrocodone-acetaminophen  1  tab ; omeprazole  20  mg ; aspirin  81  mg ; senna  1  tab ; docusate sodium  100  mg ; levetiracetam  500  mg ; 0.9% sodium chloride  1000  ml ; 
 
white m 73 $nan$hematology blood hematocrit  23.5  %; hematology blood hematocrit  26.2  %; hematology blood hematocrit  27.7  %; hematology blood hemoglobin  6.4  g dl; hematology blood hemoglobin  7.3  g dl; hematology blood hemoglobin  7.8  g dl; hematology blood platelet count  263  k ul; hematology blood platelet count  246  k ul; hematology blood platelet count  255  k ul; chemistry blood anion gap  15  meq l; chemistry blood anion gap  14  meq l; chemistry blood bicarbonate  26  meq l; chemistry blood bicarbonate  26  meq l; chemistry blood chloride  104  meq l; chemistry blood chloride  105  meq l; chemistry blood creatinine  0.9  mg dl; chemistry blood creatinine  0.9  mg dl; chemistry blood potassium  4.1  meq l; chemistry blood potassium  4.4  meq l; chemistry blood sodium  141  meq l; chemistry blood sodium  141  meq l; chemistry blood urea nitrogen  16  mg dl; chemistry blood urea nitrogen  17  mg dl; hematology blood inr(pt)  1.3  ; chemistry blood calcium, total  9.4  mg dl; chemistry blood calcium, total  9.0  mg dl; chemistry blood bilirubin, total  0.4  mg dl; chemistry blood glucose  114  mg dl; chemistry blood glucose  125  mg dl; chemistry blood lactate dehydrogenase (ld)  125  iu l$sodium chloride 0.9%  flush  3  ml ; atenolol  25  mg ; atorvastatin  80  mg ; prednisone  2.5  mg ; vial  1  vial ; pantoprazole  40  mg ; dextrose 50%  12.5  gm ; glucagon  1  mg ; glucose gel  15  g ; acetaminophen  650  mg ; insulin  0  unit ; psyllium powder  1  pkt ; docusate sodium  100  mg ; pneumococcal 23-valent polysaccharide vaccine  0.5  ml ; atenolol  12.5  mg ; aspirin  81  mg ; senna  8.6  mg ; 
polymyalgia rheumatica long-term (current) use of steroids atrial fibrillation percutaneous transluminal coronary angioplasty status coronary atherosclerosis of native coronary artery diabetes mellitus without mention of complication, type ii or unspecified type, not stated as uncontrolled other and unspecified hyperlipidemia other specified visual disturbances long-term (current) use of anticoagulants unspecified essential hypertension long-term (current) use of aspirin 
white m 73 $nan$hematology blood hematocrit  29.2  %; hematology blood hemoglobin  8.3  g dl; hematology blood platelet count  249  k ul; chemistry blood anion gap  13  meq l; chemistry blood bicarbonate  26  meq l; chemistry blood chloride  106  meq l; chemistry blood creatinine  0.9  mg dl; chemistry blood potassium  4.2  meq l; chemistry blood sodium  141  meq l; chemistry blood urea nitrogen  15  mg dl; chemistry blood calcium, total  9.1  mg dl; chemistry blood glucose  119  mg dl$moviprep  1  l ; sodium chloride 0.9%  flush  3  ml ; atenolol  25  mg ; atorvastatin  80  mg ; prednisone  2.5  mg ; vial  1  vial ; pantoprazole  40  mg ; dextrose 50%  12.5  gm ; glucagon  1  mg ; glucose gel  15  g ; acetaminophen  650  mg ; insulin  0  unit ; atenolol  12.5  mg ; aspirin  81  mg ; senna  8.6  mg ; ferrous sulfate  325  mg ; 
polymyalgia rheumatica long-term (current) use of steroids atrial fibrillation percutaneous transluminal coronary angioplasty status coronary atherosclerosis of native coronary artery diabetes mellitus without mention of complication, type ii or unspecified type, not stated as uncontrolled other and unspecified hyperlipidemia other specified visual disturbances long-term (current) use of anticoagulants unspecified essential hypertension long-term (current) use of aspirin 
white m 73 $nan$hematology blood hematocrit  28.0  %; hematology blood hemoglobin  7.9  g dl; hematology blood platelet count  226  k ul; chemistry blood anion gap  13  meq l; chemistry blood bicarbonate  25  meq l; chemistry blood chloride  105  meq l; chemistry blood creatinine  1.0  mg dl; chemistry blood potassium  4.1  meq l; chemistry blood sodium  139  meq l; chemistry blood urea nitrogen  17  mg dl; hematology blood inr(pt)  1.2  ; chemistry blood calcium, total  8.5  mg dl; chemistry blood glucose  123  mg dl$sodium chloride 0.9%  flush  3  ml ; atenolol  25  mg ; atorvastatin  80  mg ; prednisone  2.5  mg ; vial  1  vial ; pantoprazole  40  mg ; dextrose 50%  12.5  gm ; glucagon  1  mg ; glucose gel  15  g ; acetaminophen  650  mg ; insulin  0  unit ; atenolol  12.5  mg ; aspirin  81  mg ; senna  8.6  mg ; ferrous sulfate  325  mg ; sodium chloride 0.9%  1000  ml ; simethicone  80  mg ; 
polymyalgia rheumatica long-term (current) use of steroids atrial fibrillation percutaneous transluminal coronary angioplasty status coronary atherosclerosis of native coronary artery diabetes mellitus without mention of complication, type ii or unspecified type, not stated as uncontrolled other and unspecified hyperlipidemia other specified visual disturbances long-term (current) use of anticoagulants unspecified essential hypertension long-term (current) use of aspirin 
white m 73 $nan$hematology blood hematocrit  30.6  %; hematology blood hematocrit  30.1  %; hematology blood hematocrit  29.0  %; hematology blood hemoglobin  8.9  g dl; hematology blood hemoglobin  8.5  g dl; hematology blood hemoglobin  8.4  g dl; hematology blood platelet count  233  k ul; hematology blood platelet count  215  k ul; hematology blood platelet count  223  k ul; chemistry blood anion gap  16  meq l; chemistry blood bicarbonate  24  meq l; chemistry blood chloride  102  meq l; chemistry blood creatinine  1.0  mg dl; chemistry blood potassium  3.9  meq l; chemistry blood sodium  138  meq l; chemistry blood urea nitrogen  17  mg dl; chemistry blood calcium, total  9.1  mg dl; chemistry blood glucose  129  mg dl$sodium chloride 0.9%  flush  3  ml ; atenolol  25  mg ; atorvastatin  80  mg ; prednisone  2.5  mg ; vial  1  vial ; pantoprazole  40  mg ; dextrose 50%  12.5  gm ; glucagon  1  mg ; glucose gel  15  g ; acetaminophen  650  mg ; insulin  0  unit ; atenolol  12.5  mg ; aspirin  81  mg ; senna  8.6  mg ; ferrous sulfate  325  mg ; simethicone  80  mg ; 
polymyalgia rheumatica long-term (current) use of steroids atrial fibrillation percutaneous transluminal coronary angioplasty status coronary atherosclerosis of native coronary artery diabetes mellitus without mention of complication, type ii or unspecified type, not stated as uncontrolled other and unspecified hyperlipidemia other specified visual disturbances long-term (current) use of anticoagulants unspecified essential hypertension long-term (current) use of aspirin 
white m 73 $nan$hematology blood hematocrit  31.3  %; hematology blood hemoglobin  8.9  g dl; hematology blood platelet count  205  k ul$sodium chloride 0.9%  flush  3  ml ; atenolol  25  mg ; atorvastatin  80  mg ; prednisone  2.5  mg ; vial  1  vial ; pantoprazole  40  mg ; dextrose 50%  12.5  gm ; glucagon  1  mg ; glucose gel  15  g ; acetaminophen  650  mg ; insulin  0  unit ; atenolol  12.5  mg ; aspirin  81  mg ; senna  8.6  mg ; ferrous sulfate  325  mg ; 
polymyalgia rheumatica long-term (current) use of steroids atrial fibrillation percutaneous transluminal coronary angioplasty status coronary atherosclerosis of native coronary artery diabetes mellitus without mention of complication, type ii or unspecified type, not stated as uncontrolled other and unspecified hyperlipidemia other specified visual disturbances long-term (current) use of anticoagulants unspecified essential hypertension long-term (current) use of aspirin 
white m 73 $nan$nan$sodium chloride 0.9%  flush  3  ml ; atenolol  25  mg ; atorvastatin  80  mg ; prednisone  2.5  mg ; vial  1  vial ; pantoprazole  40  mg ; dextrose 50%  12.5  gm ; glucagon  1  mg ; glucose gel  15  g ; acetaminophen  650  mg ; insulin  0  unit ; atenolol  12.5  mg ; aspirin  81  mg ; senna  8.6  mg ; ferrous sulfate  325  mg ; 
polymyalgia rheumatica long-term (current) use of steroids atrial fibrillation percutaneous transluminal coronary angioplasty status coronary atherosclerosis of native coronary artery diabetes mellitus without mention of complication, type ii or unspecified type, not stated as uncontrolled other and unspecified hyperlipidemia other specified visual disturbances long-term (current) use of anticoagulants unspecified essential hypertension long-term (current) use of aspirin 
white m 33 $nan$nan$lactulose  15-30  ml ; lidocaine 5% patch  1  ptch ; polyethylene glycol  17  g ; multivitamins  1  tab ; lansoprazole oral disintegrating tab  30  mg ; 
fracture of calcaneus, closed personal history of malignant neoplasm of stomach closed fracture of unspecified part of fibula with tibia other and unspecified alcohol dependence, in remission lumbago opioid abuse, unspecified tobacco use disorder activities involving building and construction closed fracture of lumbar vertebra without mention of spinal cord injury acute pain due to trauma accidental fall from ladder 
white m 33 $nan$hematology blood hematocrit  37.6  %; hematology blood hemoglobin  12.0  g dl; hematology blood platelet count  261  k ul; chemistry blood anion gap  13  meq l; chemistry blood bicarbonate  30  meq l; chemistry blood chloride  101  meq l; chemistry blood creatinine  1.1  mg dl; chemistry blood potassium  4.1  meq l; chemistry blood sodium  140  meq l; chemistry blood urea nitrogen  17  mg dl; chemistry blood calcium, total  9.7  mg dl; chemistry blood glucose  101  mg dl$lactulose  15-30  ml ; lidocaine 5% patch  1  ptch ; polyethylene glycol  17  g ; multivitamins  1  tab ; lansoprazole oral disintegrating tab  30  mg ; sodium chloride 0.9%  flush  3  ml ; potassium chl 20 meq   1000 ml d5 1 2 ns  1000  ml ; gabapentin  300  mg ; oxycodone (immediate release)   5  mg ; clonidine  0.1  mg ; docusate sodium  100  mg ; senna  1  tab ; iso-osmotic dextrose  200  ml ; vancomycin  1000  mg ; acetaminophen  1000  mg ; oxycodone (immediate release)   10-20  mg ; oxycodone sr (oxycontin)  40  mg ; diphenhydramine  25  mg ; gabapentin  400  mg ; hydrocortisone cream 1%  1  appl ; zolpidem tartrate  5  mg ; enoxaparin sodium  40  mg ; gabapentin  600  mg ; 0.9% sodium chloride (mini bag plus)  100  ml ; cefepime  2  g ; 
fracture of calcaneus, closed personal history of malignant neoplasm of stomach closed fracture of unspecified part of fibula with tibia other and unspecified alcohol dependence, in remission lumbago opioid abuse, unspecified tobacco use disorder activities involving building and construction closed fracture of lumbar vertebra without mention of spinal cord injury acute pain due to trauma accidental fall from ladder 
white m 33 $nan$nan$lactulose  15-30  ml ; lidocaine 5% patch  1  ptch ; polyethylene glycol  17  g ; multivitamins  1  tab ; lansoprazole oral disintegrating tab  30  mg ; sodium chloride 0.9%  flush  3  ml ; docusate sodium  100  mg ; senna  1  tab ; iso-osmotic dextrose  200  ml ; vancomycin  1000  mg ; acetaminophen  1000  mg ; oxycodone (immediate release)   10-20  mg ; oxycodone sr (oxycontin)  40  mg ; diphenhydramine  25  mg ; gabapentin  400  mg ; hydrocortisone cream 1%  1  appl ; zolpidem tartrate  5  mg ; enoxaparin sodium  40  mg ; gabapentin  600  mg ; lorazepam  0.5  mg ; 
fracture of calcaneus, closed personal history of malignant neoplasm of stomach closed fracture of unspecified part of fibula with tibia other and unspecified alcohol dependence, in remission lumbago opioid abuse, unspecified tobacco use disorder activities involving building and construction closed fracture of lumbar vertebra without mention of spinal cord injury acute pain due to trauma accidental fall from ladder 
white m 33 $nan$nan$lactulose  15-30  ml ; lidocaine 5% patch  1  ptch ; polyethylene glycol  17  g ; multivitamins  1  tab ; lansoprazole oral disintegrating tab  30  mg ; sodium chloride 0.9%  flush  3  ml ; docusate sodium  100  mg ; senna  1  tab ; acetaminophen  1000  mg ; oxycodone (immediate release)   10-20  mg ; oxycodone sr (oxycontin)  40  mg ; gabapentin  400  mg ; hydrocortisone cream 1%  1  appl ; zolpidem tartrate  5  mg ; enoxaparin sodium  40  mg ; gabapentin  600  mg ; lorazepam  0.5  mg ; 
fracture of calcaneus, closed personal history of malignant neoplasm of stomach closed fracture of unspecified part of fibula with tibia other and unspecified alcohol dependence, in remission lumbago opioid abuse, unspecified tobacco use disorder activities involving building and construction closed fracture of lumbar vertebra without mention of spinal cord injury acute pain due to trauma accidental fall from ladder 
white m 33 $nan$nan$lactulose  15-30  ml ; lidocaine 5% patch  1  ptch ; polyethylene glycol  17  g ; multivitamins  1  tab ; lansoprazole oral disintegrating tab  30  mg ; sodium chloride 0.9%  flush  3  ml ; docusate sodium  100  mg ; senna  1  tab ; acetaminophen  1000  mg ; oxycodone (immediate release)   10-20  mg ; oxycodone sr (oxycontin)  40  mg ; gabapentin  400  mg ; hydrocortisone cream 1%  1  appl ; zolpidem tartrate  5  mg ; enoxaparin sodium  40  mg ; gabapentin  600  mg ; ondansetron  4  mg ; 
fracture of calcaneus, closed personal history of malignant neoplasm of stomach closed fracture of unspecified part of fibula with tibia other and unspecified alcohol dependence, in remission lumbago opioid abuse, unspecified tobacco use disorder activities involving building and construction closed fracture of lumbar vertebra without mention of spinal cord injury acute pain due to trauma accidental fall from ladder 
white m 33 $nan$nan$lactulose  15-30  ml ; lidocaine 5% patch  1  ptch ; polyethylene glycol  17  g ; multivitamins  1  tab ; lansoprazole oral disintegrating tab  30  mg ; sodium chloride 0.9%  flush  3  ml ; docusate sodium  100  mg ; senna  1  tab ; acetaminophen  1000  mg ; oxycodone (immediate release)   10-20  mg ; oxycodone sr (oxycontin)  40  mg ; gabapentin  400  mg ; hydrocortisone cream 1%  1  appl ; zolpidem tartrate  5  mg ; enoxaparin sodium  40  mg ; gabapentin  600  mg ; ondansetron  4  mg ; 
fracture of calcaneus, closed personal history of malignant neoplasm of stomach closed fracture of unspecified part of fibula with tibia other and unspecified alcohol dependence, in remission lumbago opioid abuse, unspecified tobacco use disorder activities involving building and construction closed fracture of lumbar vertebra without mention of spinal cord injury acute pain due to trauma accidental fall from ladder 
white m 33 $nan$nan$lactulose  15-30  ml ; lidocaine 5% patch  1  ptch ; polyethylene glycol  17  g ; multivitamins  1  tab ; lansoprazole oral disintegrating tab  30  mg ; sodium chloride 0.9%  flush  3  ml ; docusate sodium  100  mg ; senna  1  tab ; acetaminophen  1000  mg ; oxycodone (immediate release)   10-20  mg ; oxycodone sr (oxycontin)  40  mg ; gabapentin  400  mg ; hydrocortisone cream 1%  1  appl ; zolpidem tartrate  5  mg ; enoxaparin sodium  40  mg ; gabapentin  600  mg ; 
fracture of calcaneus, closed personal history of malignant neoplasm of stomach closed fracture of unspecified part of fibula with tibia other and unspecified alcohol dependence, in remission lumbago opioid abuse, unspecified tobacco use disorder activities involving building and construction closed fracture of lumbar vertebra without mention of spinal cord injury acute pain due to trauma accidental fall from ladder 
white m 33 $nan$nan$lactulose  15-30  ml ; lidocaine 5% patch  1  ptch ; polyethylene glycol  17  g ; multivitamins  1  tab ; lansoprazole oral disintegrating tab  30  mg ; sodium chloride 0.9%  flush  3  ml ; docusate sodium  100  mg ; senna  1  tab ; acetaminophen  1000  mg ; oxycodone (immediate release)   10-20  mg ; oxycodone sr (oxycontin)  40  mg ; gabapentin  400  mg ; hydrocortisone cream 1%  1  appl ; zolpidem tartrate  5  mg ; enoxaparin sodium  40  mg ; gabapentin  600  mg ; 
fracture of calcaneus, closed personal history of malignant neoplasm of stomach closed fracture of unspecified part of fibula with tibia other and unspecified alcohol dependence, in remission lumbago opioid abuse, unspecified tobacco use disorder activities involving building and construction closed fracture of lumbar vertebra without mention of spinal cord injury acute pain due to trauma accidental fall from ladder 
white m 33 $nan$nan$lactulose  15-30  ml ; lidocaine 5% patch  1  ptch ; polyethylene glycol  17  g ; multivitamins  1  tab ; lansoprazole oral disintegrating tab  30  mg ; sodium chloride 0.9%  flush  3  ml ; docusate sodium  100  mg ; senna  1  tab ; acetaminophen  1000  mg ; oxycodone (immediate release)   10-20  mg ; oxycodone sr (oxycontin)  40  mg ; gabapentin  400  mg ; hydrocortisone cream 1%  1  appl ; zolpidem tartrate  5  mg ; enoxaparin sodium  40  mg ; gabapentin  600  mg ; 
fracture of calcaneus, closed personal history of malignant neoplasm of stomach closed fracture of unspecified part of fibula with tibia other and unspecified alcohol dependence, in remission lumbago opioid abuse, unspecified tobacco use disorder activities involving building and construction closed fracture of lumbar vertebra without mention of spinal cord injury acute pain due to trauma accidental fall from ladder 
hispanic latino m 79 $nan$hematology blood hematocrit  34.5  %; hematology blood hematocrit  26.4  %; hematology blood hematocrit  21.4  %; hematology blood hemoglobin  11.5  g dl; hematology blood hemoglobin  8.3  g dl; hematology blood platelet count  155  k ul; hematology blood platelet count  179  k ul; chemistry blood anion gap  12  meq l; chemistry blood anion gap  14  meq l; chemistry blood bicarbonate  27  meq l; chemistry blood bicarbonate  24  meq l; chemistry blood chloride  107  meq l; chemistry blood chloride  105  meq l; chemistry blood creatinine  0.9  mg dl; chemistry blood creatinine  1.0  mg dl; chemistry blood potassium  4.6  meq l; chemistry blood potassium  4.6  meq l; chemistry blood sodium  141  meq l; chemistry blood sodium  138  meq l; chemistry blood urea nitrogen  13  mg dl; chemistry blood urea nitrogen  19  mg dl; chemistry blood calcium, total  8.3  mg dl; chemistry blood calcium, total  7.7  mg dl; chemistry blood glucose  113  mg dl; chemistry blood glucose  222  mg dl; blood gas blood free calcium  1.12  mmol l; blood gas blood lactate  2.7  mmol l; blood gas blood chloride, whole blood  105  meq l; blood gas blood glucose  121  mg dl; blood gas blood hematocrit, calculated  29  %; blood gas blood hemoglobin  9.8  g dl; blood gas blood potassium, whole blood  4.3  meq l; blood gas blood sodium, whole blood  135  meq l; blood gas blood calculated bicarbonate, whole blood  27  meq l$multivitamins  1  cap ; ferrous sulfate  325  mg ; valsartan  160  mg ; amlodipine  10  mg ; pioglitazone hcl  30  mg ; simvastatin  20  mg ; enoxaparin sodium  40  mg ; glipizide xl  10  mg ; sodium chloride 0.9%  flush  3  ml ; potassium chl 20 meq   1000 ml d5 1 2 ns  1000  ml ; hydromorphone (dilaudid)  12.5  mg ; oxycodone (immediate release)   5-10  mg ; acetaminophen  650  mg ; ns  100  ml ; cefazolin  2  gm ; senna  1  tab ; ondansetron  4  mg ; milk of magnesia  30  ml ; insulin  0  unit ; docusate sodium  100  mg ; famotidine  20  mg ; naproxen  500  mg ; metformin (glucophage)  1000  mg ; ketorolac  15  mg ; sw  100  ml ; magnesium sulfate  4  gm ; lr  1000  ml ; cefazolin  2  g ; 
 
hispanic latino m 79 $nan$hematology blood hematocrit  22.8  %; hematology blood hematocrit  24.6  %; hematology blood hematocrit  24.2  %; hematology blood hematocrit  24.0  %; hematology blood hemoglobin  8.7  g dl; hematology blood platelet count  97  k ul; chemistry blood anion gap  8  meq l; chemistry blood bicarbonate  31  meq l; chemistry blood chloride  104  meq l; chemistry blood creatinine  0.8  mg dl; chemistry blood potassium  4.1  meq l; chemistry blood sodium  139  meq l; chemistry blood urea nitrogen  13  mg dl; hematology blood inr(pt)  1.1  ; hematology blood inr(pt)  1.0  ; chemistry blood calcium, total  7.9  mg dl; chemistry blood glucose  123  mg dl$cefazolin  2  g ; sw  50  ml ; magnesium sulfate  2  gm ; calcium gluconate  2  gm ; morphine sulfate  2-4  mg ; hydromorphone (dilaudid)  1  mg ; lorazepam  0.5  mg ; lorazepam  1  mg ; 
 
hispanic latino m 79 $nan$hematology blood hematocrit  27.6  %; hematology blood hematocrit  27.8  %; hematology blood hematocrit  28.5  %; hematology blood hemoglobin  9.9  g dl; hematology blood platelet count  121  k ul; hematology blood platelet count  125  k ul; chemistry blood anion gap  8  meq l; chemistry blood bicarbonate  34  meq l; chemistry blood chloride  99  meq l; chemistry blood creatinine  0.7  mg dl; chemistry blood potassium  3.7  meq l; chemistry blood sodium  137  meq l; chemistry blood urea nitrogen  8  mg dl; hematology blood inr(pt)  1.0  ; chemistry blood calcium, total  8.1  mg dl; chemistry blood glucose  114  mg dl$sw  50  ml ; magnesium sulfate  2  gm ; calcium gluconate  2  gm ; hydromorphone (dilaudid)  1  mg ; lorazepam  0.5  mg ; lorazepam  1  mg ; calcium carbonate  500  mg ; bisacodyl  10  mg ; 
 
hispanic latino m 79 $nan$hematology blood hematocrit  28.2  %; hematology blood hematocrit  29.6  %; hematology blood hematocrit  28.9  %; hematology blood hemoglobin  9.9  g dl; hematology blood platelet count  194  k ul; chemistry blood anion gap  9  meq l; chemistry blood bicarbonate  33  meq l; chemistry blood chloride  101  meq l; chemistry blood creatinine  0.7  mg dl; chemistry blood potassium  3.7  meq l; chemistry blood sodium  139  meq l; chemistry blood urea nitrogen  9  mg dl; chemistry blood calcium, total  8.1  mg dl; chemistry blood glucose  121  mg dl$hydromorphone (dilaudid)  1  mg ; lorazepam  0.5  mg ; lorazepam  1  mg ; calcium carbonate  500  mg ; bisacodyl  10  mg ; neutra-phos  2  pkt ; lactulose  30  ml ; 
 
hispanic latino m 79 $nan$hematology blood hematocrit  29.0  %; hematology blood hemoglobin  9.7  g dl; hematology blood platelet count  215  k ul; chemistry blood anion gap  10  meq l; chemistry blood bicarbonate  32  meq l; chemistry blood chloride  97  meq l; chemistry blood creatinine  0.7  mg dl; chemistry blood potassium  3.8  meq l; chemistry blood sodium  135  meq l; chemistry blood urea nitrogen  12  mg dl; chemistry blood calcium, total  7.9  mg dl; chemistry blood glucose  116  mg dl$neutra-phos  2  pkt ; neutra-phos  1  pkt ; ns  500  ml ; 
 
hispanic latino m 79 $nan$nan$neutra-phos  1  pkt ; ns  500  ml ; 
 
hispanic latino m 79 $nan$nan$
 
hispanic latino m 79 $nan$nan$
 
hispanic latino m 79 $nan$nan$
 
white m 74 $nan$nan$hydrochlorothiazide  25  mg ; iso-osmotic dextrose  50  ml ; cefazolin  2  g ; pneumococcal 23-valent polysaccharide vaccine  0.5  ml ; sodium chloride 0.9%  flush  3  ml ; potassium chl 20 meq   1000 ml ns  1000  ml ; milk of magnesia  30  ml ; ondansetron  4  mg ; morphine sulfate  1-4  mg ; dextrose 50%  12.5  gm ; glucagon  1  mg ; glucose gel  15  g ; oxycodone (immediate release)   2.5-5  mg ; insulin  0  unit ; albuterol inhaler  2  puff ; amlodipine  5  mg ; atorvastatin  10  mg ; carvedilol  6.25  mg ; acetaminophen  650  mg ; fluticasone-salmeterol diskus (100 50)  1  inh ; pantoprazole  40  mg ; docusate sodium  100  mg ; pregabalin  50  mg ; benazepril  40  mg ; senna  17.2  mg ; 
 
white m 74 $nan$nan$hydrochlorothiazide  25  mg ; pneumococcal 23-valent polysaccharide vaccine  0.5  ml ; sodium chloride 0.9%  flush  3  ml ; milk of magnesia  30  ml ; ondansetron  4  mg ; morphine sulfate  1-4  mg ; dextrose 50%  12.5  gm ; glucagon  1  mg ; glucose gel  15  g ; oxycodone (immediate release)   2.5-5  mg ; insulin  0  unit ; albuterol inhaler  2  puff ; amlodipine  5  mg ; atorvastatin  10  mg ; carvedilol  6.25  mg ; fluticasone-salmeterol diskus (100 50)  1  inh ; pantoprazole  40  mg ; docusate sodium  100  mg ; pregabalin  50  mg ; benazepril  40  mg ; senna  17.2  mg ; bisacodyl  10  mg ; acetaminophen  1000  mg ; tamsulosin  0.4  mg ; bag  2  bag ; magnesium sulfate  4  gm ; 
 
white m 74 $nan$nan$hydrochlorothiazide  25  mg ; pneumococcal 23-valent polysaccharide vaccine  0.5  ml ; sodium chloride 0.9%  flush  3  ml ; milk of magnesia  30  ml ; ondansetron  4  mg ; morphine sulfate  1-4  mg ; dextrose 50%  12.5  gm ; glucagon  1  mg ; glucose gel  15  g ; oxycodone (immediate release)   2.5-5  mg ; albuterol inhaler  2  puff ; amlodipine  5  mg ; atorvastatin  10  mg ; carvedilol  6.25  mg ; fluticasone-salmeterol diskus (100 50)  1  inh ; pantoprazole  40  mg ; docusate sodium  100  mg ; pregabalin  50  mg ; benazepril  40  mg ; senna  17.2  mg ; bisacodyl  10  mg ; acetaminophen  1000  mg ; tamsulosin  0.4  mg ; metformin (glucophage)  500  mg ; 
 
unable to obtain f 83 $nan$nan$sertraline  50  mg ; furosemide  60  mg ; levothyroxine sodium  100  mcg ; atorvastatin  10  mg ; 
esophageal reflux unspecified essential hypertension unspecified acquired hypothyroidism long-term (current) use of anticoagulants chronic airway obstruction, not elsewhere classified congestive heart failure, unspecified atrial fibrillation personal history of venous thrombosis and embolism spondylolisthesis lumbosacral spondylosis without myelopathy
unable to obtain f 83 $nan$hematology blood hematocrit  36.4  %; hematology blood hemoglobin  11.4  g dl; hematology blood platelet count  328  k ul; chemistry blood anion gap  17  meq l; chemistry blood bicarbonate  25  meq l; chemistry blood chloride  105  meq l; chemistry blood creatinine  0.8  mg dl; chemistry blood potassium  4.5  meq l; chemistry blood sodium  142  meq l; chemistry blood urea nitrogen  28  mg dl; hematology blood inr(pt)  1.0  ; chemistry blood calcium, total  9.3  mg dl; chemistry blood glucose  181  mg dl$sertraline  50  mg ; furosemide  60  mg ; levothyroxine sodium  100  mcg ; atorvastatin  10  mg ; clonazepam  0.5  mg ; fluticasone-salmeterol diskus (500 50)   1  inh ; albuterol-ipratropium  1-2  puff ; pantoprazole  40  mg ; potassium chl 20 meq   1000 ml d5 1 2 ns  1000  ml ; metoprolol succinate xl  100  mg ; 
esophageal reflux unspecified essential hypertension unspecified acquired hypothyroidism long-term (current) use of anticoagulants chronic airway obstruction, not elsewhere classified congestive heart failure, unspecified atrial fibrillation personal history of venous thrombosis and embolism spondylolisthesis lumbosacral spondylosis without myelopathy
unable to obtain f 83 $nan$nan$sertraline  50  mg ; furosemide  60  mg ; levothyroxine sodium  100  mcg ; atorvastatin  10  mg ; clonazepam  0.5  mg ; fluticasone-salmeterol diskus (500 50)   1  inh ; albuterol-ipratropium  1-2  puff ; pantoprazole  40  mg ; potassium chl 20 meq   1000 ml d5 1 2 ns  1000  ml ; metoprolol succinate xl  100  mg ; acetaminophen  650  mg ; 
esophageal reflux unspecified essential hypertension unspecified acquired hypothyroidism long-term (current) use of anticoagulants chronic airway obstruction, not elsewhere classified congestive heart failure, unspecified atrial fibrillation personal history of venous thrombosis and embolism spondylolisthesis lumbosacral spondylosis without myelopathy
unable to obtain f 83 $nan$nan$sertraline  50  mg ; furosemide  60  mg ; levothyroxine sodium  100  mcg ; atorvastatin  10  mg ; clonazepam  0.5  mg ; fluticasone-salmeterol diskus (500 50)   1  inh ; albuterol-ipratropium  1-2  puff ; pantoprazole  40  mg ; metoprolol succinate xl  100  mg ; acetaminophen  650  mg ; sodium chloride 0.9%  flush  3  ml ; 5% dextrose  50  ml ; clindamycin  600  mg ; oxycodone (immediate release)   2.5  mg ; morphine sulfate  1-2  mg ; hydromorphone (dilaudid)  0.25  mg ; oxycodone (immediate release)   2.5-5  mg ; 
esophageal reflux unspecified essential hypertension unspecified acquired hypothyroidism long-term (current) use of anticoagulants chronic airway obstruction, not elsewhere classified congestive heart failure, unspecified atrial fibrillation personal history of venous thrombosis and embolism spondylolisthesis lumbosacral spondylosis without myelopathy
unable to obtain f 83 $nan$nan$sertraline  50  mg ; furosemide  60  mg ; levothyroxine sodium  100  mcg ; atorvastatin  10  mg ; clonazepam  0.5  mg ; fluticasone-salmeterol diskus (500 50)   1  inh ; albuterol-ipratropium  1-2  puff ; pantoprazole  40  mg ; metoprolol succinate xl  100  mg ; sodium chloride 0.9%  flush  3  ml ; 5% dextrose  50  ml ; clindamycin  600  mg ; oxycodone (immediate release)   2.5-5  mg ; 
esophageal reflux unspecified essential hypertension unspecified acquired hypothyroidism long-term (current) use of anticoagulants chronic airway obstruction, not elsewhere classified congestive heart failure, unspecified atrial fibrillation personal history of venous thrombosis and embolism spondylolisthesis lumbosacral spondylosis without myelopathy
white f 85 $nan$hematology blood hematocrit  26.6  %; hematology blood hemoglobin  9.0  g dl; hematology blood platelet count  207  k ul; chemistry blood anion gap  20  meq l; chemistry blood anion gap  17  meq l; chemistry blood anion gap  14  meq l; chemistry blood bicarbonate  28  meq l; chemistry blood bicarbonate  29  meq l; chemistry blood bicarbonate  33  meq l; chemistry blood chloride  100  meq l; chemistry blood chloride  98  meq l; chemistry blood chloride  95  meq l; chemistry blood creatinine  3.4  mg dl; chemistry blood creatinine  3.3  mg dl; chemistry blood creatinine  3.4  mg dl; chemistry blood potassium  4.6  meq l; chemistry blood potassium  4.3  meq l; chemistry blood potassium  4.1  meq l; chemistry blood sodium  143  meq l; chemistry blood sodium  140  meq l; chemistry blood sodium  138  meq l; chemistry blood urea nitrogen  66  mg dl; chemistry blood urea nitrogen  65  mg dl; chemistry blood urea nitrogen  63  mg dl; chemistry blood calcium, total  10.2  mg dl; chemistry blood calcium, total  9.9  mg dl; chemistry blood calcium, total  9.6  mg dl; chemistry blood glucose  142  mg dl; chemistry blood glucose  151  mg dl; chemistry blood glucose  183  mg dl$sodium chloride 0.9%  flush  3  ml ; ipratropium bromide neb  1  neb ; calcitriol  0.25  mcg ; furosemide  80  mg ; hydrocodone-acetaminophen  1-2  tab ; nitroglycerin sl  0.3  mg ; dextrose 50%  12.5  gm ; glucagon  1  mg ; insulin  0  unit ; heparin  4000  unit ; heparin  1300  unit ; 5% dextrose  250  ml ; heparin sodium  25,000  unit ; fluticasone propionate 110mcg  2  puff ; metoprolol tartrate  37.5  mg ; sevelamer carbonate  800  mg ; insulin  20  unit ; amlodipine  10  mg ; simvastatin  40  mg ; valsartan  160  mg ; aspirin  325  mg ; allopurinol  200  mg ; isosorbide dinitrate  5  mg ; insulin  26  unit ; heparin  5000  unit ; 
coronary atherosclerosis of unspecified type of vessel, native or graft examination of participant in clinical trial urinary tract infection, site not specified chronic kidney disease, stage v hyperparathyroidism, unspecified other specified forms of chronic ischemic heart disease percutaneous transluminal coronary angioplasty status streptococcus infection in conditions classified elsewhere and of unspecified site, streptococcus, group d [enterococcus] congestive heart failure, unspecified hypertensive chronic kidney disease, unspecified, with chronic kidney disease stage i through stage iv, or unspecified diabetes with renal manifestations, type ii or unspecified type, not stated as uncontrolled person on outside of bus injured in collision with pedestrian or animal in traffic accident anemia in chronic kidney disease aortocoronary bypass status acute on chronic combined systolic and diastolic heart failure acute posthemorrhagic anemia long-term (current) use of anticoagulants other left bundle branch block knee joint replacement anemia in chronic kidney disease hypertensive chronic kidney disease, unspecified, with chronic kidney disease stage i through stage iv, or unspecified chronic kidney disease, stage iv (severe) trigger finger (acquired) retention of urine, unspecified aortocoronary bypass status constipation, unspecified diabetes mellitus without mention of complication, type ii or unspecified type, not stated as uncontrolled surgical operation with implant of artificial internal device causing abnormal patient reaction, or later complication,without mention of misadventure at time of operation osteoarthrosis, localized, not specified whether primary or secondary, lower leg asthma, unspecified type, unspecified hyperparathyroidism, unspecified coronary atherosclerosis of unspecified type of vessel, native or graft anemia, unspecified dysuria other and unspecified hyperlipidemia chronic systolic heart failure esophageal reflux congestive heart failure, unspecified primary hyperparathyroidism hypertensive chronic kidney disease, unspecified, with chronic kidney disease stage i through stage iv, or unspecified asthma, unspecified type, unspecified osteoporosis, unspecified chronic kidney disease, stage iv (severe) gouty tophi of other sites, except ear congestive heart failure, unspecified aortocoronary bypass status anemia in chronic kidney disease diabetes with renal manifestations, type ii or unspecified type, not stated as uncontrolled
white f 85 $nan$chemistry blood anion gap  17  meq l; chemistry blood bicarbonate  30  meq l; chemistry blood chloride  96  meq l; chemistry blood creatinine  3.4  mg dl; chemistry blood potassium  4.1  meq l; chemistry blood sodium  139  meq l; chemistry blood urea nitrogen  69  mg dl; chemistry blood calcium, total  9.6  mg dl; chemistry blood glucose  89  mg dl$sodium chloride 0.9%  flush  3  ml ; ipratropium bromide neb  1  neb ; calcitriol  0.25  mcg ; furosemide  80  mg ; hydrocodone-acetaminophen  1-2  tab ; nitroglycerin sl  0.3  mg ; dextrose 50%  12.5  gm ; glucagon  1  mg ; insulin  0  unit ; fluticasone propionate 110mcg  2  puff ; metoprolol tartrate  37.5  mg ; sevelamer carbonate  800  mg ; insulin  20  unit ; amlodipine  10  mg ; simvastatin  40  mg ; valsartan  160  mg ; aspirin  325  mg ; allopurinol  200  mg ; isosorbide dinitrate  5  mg ; insulin  26  unit ; heparin  5000  unit ; furosemide  120  mg ; torsemide  60  mg ; isosorbide dinitrate er  40  mg ; torsemide  100  mg ; 
coronary atherosclerosis of unspecified type of vessel, native or graft examination of participant in clinical trial urinary tract infection, site not specified chronic kidney disease, stage v hyperparathyroidism, unspecified other specified forms of chronic ischemic heart disease percutaneous transluminal coronary angioplasty status streptococcus infection in conditions classified elsewhere and of unspecified site, streptococcus, group d [enterococcus] congestive heart failure, unspecified hypertensive chronic kidney disease, unspecified, with chronic kidney disease stage i through stage iv, or unspecified diabetes with renal manifestations, type ii or unspecified type, not stated as uncontrolled person on outside of bus injured in collision with pedestrian or animal in traffic accident anemia in chronic kidney disease aortocoronary bypass status acute on chronic combined systolic and diastolic heart failure acute posthemorrhagic anemia long-term (current) use of anticoagulants other left bundle branch block knee joint replacement anemia in chronic kidney disease hypertensive chronic kidney disease, unspecified, with chronic kidney disease stage i through stage iv, or unspecified chronic kidney disease, stage iv (severe) trigger finger (acquired) retention of urine, unspecified aortocoronary bypass status constipation, unspecified diabetes mellitus without mention of complication, type ii or unspecified type, not stated as uncontrolled surgical operation with implant of artificial internal device causing abnormal patient reaction, or later complication,without mention of misadventure at time of operation osteoarthrosis, localized, not specified whether primary or secondary, lower leg asthma, unspecified type, unspecified hyperparathyroidism, unspecified coronary atherosclerosis of unspecified type of vessel, native or graft anemia, unspecified dysuria other and unspecified hyperlipidemia chronic systolic heart failure esophageal reflux congestive heart failure, unspecified primary hyperparathyroidism hypertensive chronic kidney disease, unspecified, with chronic kidney disease stage i through stage iv, or unspecified asthma, unspecified type, unspecified osteoporosis, unspecified chronic kidney disease, stage iv (severe) gouty tophi of other sites, except ear congestive heart failure, unspecified aortocoronary bypass status anemia in chronic kidney disease diabetes with renal manifestations, type ii or unspecified type, not stated as uncontrolled
white f 85 $nan$nan$sodium chloride 0.9%  flush  3  ml ; ipratropium bromide neb  1  neb ; calcitriol  0.25  mcg ; hydrocodone-acetaminophen  1-2  tab ; nitroglycerin sl  0.3  mg ; dextrose 50%  12.5  gm ; glucagon  1  mg ; insulin  0  unit ; fluticasone propionate 110mcg  2  puff ; metoprolol tartrate  37.5  mg ; sevelamer carbonate  800  mg ; insulin  20  unit ; amlodipine  10  mg ; simvastatin  40  mg ; valsartan  160  mg ; aspirin  325  mg ; allopurinol  200  mg ; insulin  26  unit ; heparin  5000  unit ; isosorbide dinitrate er  40  mg ; torsemide  100  mg ; 
coronary atherosclerosis of unspecified type of vessel, native or graft examination of participant in clinical trial urinary tract infection, site not specified chronic kidney disease, stage v hyperparathyroidism, unspecified other specified forms of chronic ischemic heart disease percutaneous transluminal coronary angioplasty status streptococcus infection in conditions classified elsewhere and of unspecified site, streptococcus, group d [enterococcus] congestive heart failure, unspecified hypertensive chronic kidney disease, unspecified, with chronic kidney disease stage i through stage iv, or unspecified diabetes with renal manifestations, type ii or unspecified type, not stated as uncontrolled person on outside of bus injured in collision with pedestrian or animal in traffic accident anemia in chronic kidney disease aortocoronary bypass status acute on chronic combined systolic and diastolic heart failure acute posthemorrhagic anemia long-term (current) use of anticoagulants other left bundle branch block knee joint replacement anemia in chronic kidney disease hypertensive chronic kidney disease, unspecified, with chronic kidney disease stage i through stage iv, or unspecified chronic kidney disease, stage iv (severe) trigger finger (acquired) retention of urine, unspecified aortocoronary bypass status constipation, unspecified diabetes mellitus without mention of complication, type ii or unspecified type, not stated as uncontrolled surgical operation with implant of artificial internal device causing abnormal patient reaction, or later complication,without mention of misadventure at time of operation osteoarthrosis, localized, not specified whether primary or secondary, lower leg asthma, unspecified type, unspecified hyperparathyroidism, unspecified coronary atherosclerosis of unspecified type of vessel, native or graft anemia, unspecified dysuria other and unspecified hyperlipidemia chronic systolic heart failure esophageal reflux congestive heart failure, unspecified primary hyperparathyroidism hypertensive chronic kidney disease, unspecified, with chronic kidney disease stage i through stage iv, or unspecified asthma, unspecified type, unspecified osteoporosis, unspecified chronic kidney disease, stage iv (severe) gouty tophi of other sites, except ear congestive heart failure, unspecified aortocoronary bypass status anemia in chronic kidney disease diabetes with renal manifestations, type ii or unspecified type, not stated as uncontrolled
unknown f 78 $nan$hematology blood hematocrit  33.4  %; hematology blood hematocrit  24.4  %; hematology blood hematocrit  22.1  %; hematology blood hemoglobin  12.2  g dl; hematology blood hemoglobin  8.0  g dl; hematology blood hemoglobin  8.8  g dl; hematology blood platelet count  232  k ul; hematology blood platelet count  127  k ul; hematology blood platelet count  142  k ul; chemistry blood anion gap  10  meq l; chemistry blood anion gap  9  meq l; chemistry blood bicarbonate  24  meq l; chemistry blood bicarbonate  21  meq l; chemistry blood chloride  99  meq l; chemistry blood chloride  108  meq l; chemistry blood creatinine  0.7  mg dl; chemistry blood creatinine  0.7  mg dl; chemistry blood potassium  3.3  meq l; chemistry blood potassium  3.9  meq l; chemistry blood sodium  130  meq l; chemistry blood sodium  134  meq l; chemistry blood urea nitrogen  24  mg dl; chemistry blood urea nitrogen  17  mg dl; hematology blood inr(pt)  1.7  ; hematology blood inr(pt)  1.1  ; hematology blood inr(pt)  1.3  ; chemistry blood bilirubin, total  0.6  mg dl; chemistry blood glucose  141  mg dl; chemistry blood lactate dehydrogenase (ld)  177  iu l; chemistry blood albumin  3.8  g dl; blood gas blood free calcium  1.11  mmol l; blood gas blood free calcium  1.35  mmol l; blood gas blood free calcium  1.20  mmol l; blood gas blood lactate  1.0  mmol l; blood gas blood lactate  2.5  mmol l; blood gas blood chloride, whole blood  104  meq l; blood gas blood chloride, whole blood  103  meq l; blood gas blood glucose  108  mg dl; blood gas blood glucose  179  mg dl; blood gas blood glucose  173  mg dl; blood gas blood glucose  184  mg dl; blood gas blood glucose  115  mg dl; blood gas blood glucose  115  mg dl; blood gas blood hematocrit, calculated  36  %; blood gas blood hematocrit, calculated  24  %; blood gas blood hematocrit, calculated  24  %; blood gas blood hematocrit, calculated  23  %; blood gas blood hemoglobin  12.1  g dl; blood gas blood hemoglobin  8.0  g dl; blood gas blood hemoglobin  8.1  g dl; blood gas blood hemoglobin  7.8  g dl; blood gas blood potassium, whole blood  3.8  meq l; blood gas blood potassium, whole blood  4.3  meq l; blood gas blood potassium, whole blood  4.8  meq l; blood gas blood potassium, whole blood  4.0  meq l; blood gas blood potassium, whole blood  3.9  meq l; blood gas blood sodium, whole blood  136  meq l; blood gas blood sodium, whole blood  130  meq l; blood gas blood sodium, whole blood  130  meq l; chemistry blood % hemoglobin a1c  5.6  %$pneumococcal 23-valent polysaccharide vaccine  0.5  ml ; sodium chloride 0.9%  flush  3  ml ; acetaminophen  325-650  mg ; docusate sodium  100  mg ; mupirocin ointment 2%  1  appl ; atorvastatin  20  mg ; betamethasone valerate 0.1% cream  1  appl ; levothyroxine sodium  25  mcg ; aspirin ec  81  mg ; multivitamins  1  tab ; amlodipine  10  mg ; hydrochlorothiazide  50  mg ; metoprolol succinate xl  100  mg ; valsartan  320  mg ; sodium chloride 0.9%  flush  10  ml ; aspirin  81  mg ; milk of magnesia  30  ml ; lactated ringers  1000  ml ; dextrose 5%  1000  ml ; propofol  1000  mg ; syringe  20  ml ; nitroglycerin  8  mg ; 5% dextrose  250  ml ; phenylephrine  60  mg ; syringe  1  syr ; phenylephrine  12  mg ; glycopyrrolate  0.6  mg ; neostigmine  3  mg ; sterile water  50  ml ; potassium chloride  20  meq ; 0.9% sodium chloride  1  bag ; calcium gluconate  2  g ; bag  1  ml ; magnesium sulfate  2  gm ; morphine sulfate  0.5-5  mg ; oxycodone-acetaminophen (5mg-325mg)  1-2  tab ; acetaminophen  650  mg ; metoclopramide  10  mg ; dextrose 50%  12.5  gm ; 0.9% sodium chloride  100  ml ; insulin human regular  100  unit ; glucagon  1  mg ; glucose gel  15  g ; 
 
unknown f 78 $nan$hematology blood hematocrit  38.3  %; hematology blood hematocrit  40.4  %; hematology blood hemoglobin  13.8  g dl; hematology blood hemoglobin  14.3  g dl; hematology blood platelet count  122  k ul; hematology blood platelet count  136  k ul; chemistry blood anion gap  11  meq l; chemistry blood bicarbonate  19  meq l; chemistry blood chloride  105  meq l; chemistry blood creatinine  0.8  mg dl; chemistry blood potassium  4.8  meq l; chemistry blood sodium  130  meq l; chemistry blood urea nitrogen  20  mg dl; chemistry blood calcium, total  8.2  mg dl; chemistry blood glucose  138  mg dl; blood gas blood free calcium  1.17  mmol l; blood gas blood free calcium  1.20  mmol l; blood gas blood glucose  186  mg dl; blood gas blood glucose  133  mg dl; blood gas blood potassium, whole blood  4.0  meq l$sodium chloride 0.9%  flush  10  ml ; aspirin  81  mg ; milk of magnesia  30  ml ; dextrose 5%  1000  ml ; propofol  1000  mg ; syringe  20  ml ; nitroglycerin  8  mg ; 5% dextrose  250  ml ; phenylephrine  60  mg ; syringe  1  syr ; phenylephrine  12  mg ; glycopyrrolate  0.6  mg ; neostigmine  3  mg ; sterile water  50  ml ; potassium chloride  20  meq ; 0.9% sodium chloride  1  bag ; calcium gluconate  2  g ; bag  1  ml ; magnesium sulfate  2  gm ; morphine sulfate  0.5-5  mg ; acetaminophen  650  mg ; metoclopramide  10  mg ; dextrose 50%  12.5  gm ; 0.9% sodium chloride  100  ml ; insulin human regular  100  unit ; glucagon  1  mg ; glucose gel  15  g ; chlorhexidine gluconate 0.12% oral rinse  15  ml ; ranitidine  150  mg ; iso-osmotic dextrose  200  ml ; vancomycin  1000  mg ; acetaminophen iv  1000  mg ; oxycodone (immediate release)   5-10  mg ; 0.83% sodium chloride  200  ml ; nicardipine iv  40  mg ; hydralazine  10  mg ; metoprolol tartrate  12.5  mg ; furosemide  20  mg ; furosemide  40  mg ; bisacodyl  10  mg ; insulin  0  unit ; 
 
unknown f 78 $nan$hematology blood hematocrit  39.0  %; hematology blood hemoglobin  13.5  g dl; hematology blood platelet count  129  k ul; chemistry blood anion gap  13  meq l; chemistry blood bicarbonate  29  meq l; chemistry blood chloride  96  meq l; chemistry blood creatinine  0.8  mg dl; chemistry blood potassium  3.4  meq l; chemistry blood sodium  135  meq l; chemistry blood urea nitrogen  24  mg dl; chemistry blood glucose  121  mg dl$bisacodyl  10  mg ; insulin  0  unit ; metoprolol tartrate  50  mg ; polyethylene glycol  17  g ; lactulose  15  ml ; tramadol (ultram)  25-50  mg ; potassium chloride  40  meq ; lorazepam  0.5  mg ; 
 
unknown f 78 $nan$hematology blood hematocrit  31.7  %; hematology blood hemoglobin  11.0  g dl; hematology blood platelet count  111  k ul; chemistry blood anion gap  9  meq l; chemistry blood bicarbonate  29  meq l; chemistry blood chloride  98  meq l; chemistry blood creatinine  0.9  mg dl; chemistry blood potassium  4.1  meq l; chemistry blood sodium  132  meq l; chemistry blood urea nitrogen  29  mg dl; chemistry blood glucose  118  mg dl$bisacodyl  10  mg ; insulin  0  unit ; metoprolol tartrate  50  mg ; polyethylene glycol  17  g ; lactulose  15  ml ; tramadol (ultram)  25-50  mg ; potassium chloride  40  meq ; lorazepam  0.5  mg ; ondansetron  4  mg ; guaifenesin er  1200  mg ; albuterol 0.083% neb soln  1  neb ; senna  17.2  mg ; valsartan  80  mg ; bag  1  bag ; 
 
unknown f 78 $nan$hematology blood hematocrit  33.1  %; hematology blood hemoglobin  11.1  g dl; hematology blood platelet count  172  k ul; chemistry blood anion gap  15  meq l; chemistry blood bicarbonate  28  meq l; chemistry blood chloride  94  meq l; chemistry blood creatinine  0.8  mg dl; chemistry blood potassium  4.2  meq l; chemistry blood sodium  133  meq l; chemistry blood urea nitrogen  29  mg dl; hematology blood inr(pt)  1.0  ; chemistry blood glucose  147  mg dl$bisacodyl  10  mg ; insulin  0  unit ; metoprolol tartrate  50  mg ; polyethylene glycol  17  g ; lactulose  15  ml ; tramadol (ultram)  25-50  mg ; lorazepam  0.5  mg ; ondansetron  4  mg ; guaifenesin er  1200  mg ; albuterol 0.083% neb soln  1  neb ; senna  17.2  mg ; valsartan  80  mg ; bag  1  bag ; furosemide  80  mg ; warfarin  3  mg ; 
 
unknown f 78 $nan$hematology blood hematocrit  33.2  %; hematology blood hemoglobin  11.1  g dl; hematology blood platelet count  217  k ul; chemistry blood anion gap  15  meq l; chemistry blood bicarbonate  29  meq l; chemistry blood chloride  96  meq l; chemistry blood creatinine  0.8  mg dl; chemistry blood potassium  3.6  meq l; chemistry blood sodium  136  meq l; chemistry blood urea nitrogen  29  mg dl; hematology blood inr(pt)  1.1  ; chemistry blood glucose  98  mg dl$bisacodyl  10  mg ; polyethylene glycol  17  g ; lactulose  15  ml ; tramadol (ultram)  25-50  mg ; lorazepam  0.5  mg ; ondansetron  4  mg ; guaifenesin er  1200  mg ; albuterol 0.083% neb soln  1  neb ; senna  17.2  mg ; valsartan  80  mg ; furosemide  80  mg ; warfarin  3  mg ; metoprolol tartrate  75  mg ; sodium chloride nasal  1-2  spry ; metolazone  5  mg ; warfarin  1  dose ; 
 
unknown f 78 $nan$chemistry blood anion gap  12  meq l; chemistry blood bicarbonate  29  meq l; chemistry blood chloride  98  meq l; chemistry blood creatinine  0.8  mg dl; chemistry blood potassium  4.2  meq l; chemistry blood sodium  135  meq l; chemistry blood urea nitrogen  24  mg dl; hematology blood inr(pt)  1.1  ; chemistry blood glucose  110  mg dl$bisacodyl  10  mg ; polyethylene glycol  17  g ; lactulose  15  ml ; tramadol (ultram)  25-50  mg ; lorazepam  0.5  mg ; ondansetron  4  mg ; guaifenesin er  1200  mg ; albuterol 0.083% neb soln  1  neb ; senna  17.2  mg ; valsartan  80  mg ; metoprolol tartrate  75  mg ; sodium chloride nasal  1-2  spry ; metolazone  5  mg ; warfarin  1  dose ; hydrochlorothiazide  25  mg ; magnesium oxide  400  mg ; warfarin  5  mg ; hydralazine  25  mg ; 
 
unknown f 78 $nan$hematology blood hematocrit  32.4  %; hematology blood hemoglobin  11.1  g dl; hematology blood platelet count  314  k ul; chemistry blood anion gap  13  meq l; chemistry blood bicarbonate  28  meq l; chemistry blood chloride  97  meq l; chemistry blood creatinine  0.8  mg dl; chemistry blood potassium  3.9  meq l; chemistry blood sodium  134  meq l; chemistry blood urea nitrogen  28  mg dl; hematology blood inr(pt)  1.3  ; chemistry blood glucose  103  mg dl$bisacodyl  10  mg ; polyethylene glycol  17  g ; lactulose  15  ml ; tramadol (ultram)  25-50  mg ; lorazepam  0.5  mg ; ondansetron  4  mg ; guaifenesin er  1200  mg ; albuterol 0.083% neb soln  1  neb ; senna  17.2  mg ; valsartan  80  mg ; sodium chloride nasal  1-2  spry ; warfarin  1  dose ; hydrochlorothiazide  25  mg ; magnesium oxide  400  mg ; warfarin  5  mg ; hydralazine  25  mg ; metoprolol tartrate  100  mg ; valsartan  160  mg ; 
 
unknown f 78 $nan$hematology blood hematocrit  34.9  %; hematology blood hemoglobin  11.6  g dl; hematology blood platelet count  363  k ul; chemistry blood anion gap  16  meq l; chemistry blood bicarbonate  29  meq l; chemistry blood chloride  95  meq l; chemistry blood creatinine  1.1  mg dl; chemistry blood potassium  4.4  meq l; chemistry blood sodium  136  meq l; chemistry blood urea nitrogen  34  mg dl; hematology blood inr(pt)  1.6  ; chemistry blood glucose  109  mg dl$bisacodyl  10  mg ; polyethylene glycol  17  g ; lactulose  15  ml ; tramadol (ultram)  25-50  mg ; lorazepam  0.5  mg ; ondansetron  4  mg ; guaifenesin er  1200  mg ; albuterol 0.083% neb soln  1  neb ; senna  17.2  mg ; sodium chloride nasal  1-2  spry ; warfarin  1  dose ; hydrochlorothiazide  25  mg ; magnesium oxide  400  mg ; metoprolol tartrate  100  mg ; amiodarone  400  mg ; 
 
unknown f 78 $nan$hematology blood hematocrit  34.2  %; hematology blood hemoglobin  11.5  g dl; hematology blood platelet count  408  k ul; chemistry blood anion gap  16  meq l; chemistry blood bicarbonate  26  meq l; chemistry blood chloride  94  meq l; chemistry blood creatinine  0.9  mg dl; chemistry blood potassium  4.4  meq l; chemistry blood sodium  132  meq l; chemistry blood urea nitrogen  32  mg dl; hematology blood inr(pt)  2.1  ; chemistry blood calcium, total  9.0  mg dl; chemistry blood glucose  93  mg dl$bisacodyl  10  mg ; polyethylene glycol  17  g ; lactulose  15  ml ; tramadol (ultram)  25-50  mg ; lorazepam  0.5  mg ; ondansetron  4  mg ; guaifenesin er  1200  mg ; albuterol 0.083% neb soln  1  neb ; senna  17.2  mg ; sodium chloride nasal  1-2  spry ; warfarin  1  dose ; hydrochlorothiazide  25  mg ; magnesium oxide  400  mg ; metoprolol tartrate  100  mg ; amiodarone  400  mg ; warfarin  1  mg ; warfarin  2  mg ; 
 
white f 40 $temp  97.9  heartrate  72.0  resprate  16.0  o2sat  96.0  sbp  122.0  dbp  72.0  rhythm    pain    $hematology blood hematocrit  32.2  %; hematology blood hemoglobin  9.1  g dl; hematology blood platelet count  358  k ul; chemistry blood anion gap  14  meq l; chemistry blood bicarbonate  24  meq l; chemistry blood chloride  105  meq l; chemistry blood creatinine  0.7  mg dl; chemistry blood potassium  3.6  meq l; chemistry blood sodium  143  meq l; chemistry blood urea nitrogen  10  mg dl; chemistry blood calcium, total  9.0  mg dl; chemistry blood bilirubin, total  0.2  mg dl; chemistry blood glucose  169  mg dl$sodium chloride 0.9%  flush  3-10  ml ; clobetasol propionate 0.05% cream  1  appl ; diphenhydramine  50  mg ; ketoconazole 2%   1  appl ; ramelteon  8  mg ; ranitidine (liquid)  150  mg ; sarna lotion  1  appl ; aluminum-magnesium hydrox.-simethicone  15-30  ml ; cetirizine  10  mg ; quetiapine fumarate  50  mg ; levothyroxine sodium  150  mcg ; hydromorphone (dilaudid)  0.5-1  mg ; lorazepam  0.5  mg ; diphenhydramine  25  mg ; hydrocortisone na succ.  20  mg ; ipratropium-albuterol neb  1  neb ; haloperidol  5  mg ; enoxaparin sodium  150  mg ; quetiapine fumarate  100  mg ; trazodone  100  mg ; betamethasone dipro 0.05% oint  1  appl ; fluocinolone acetonide 0.01% cream  1  appl ; 
acute embolism and thrombosis of deep veins of right upper extremity unspecified place or not applicable adverse effect of glucocorticoids and synthetic analogues, sequela morbid (severe) obesity due to excess calories drug-induced adrenocortical insufficiency post-traumatic stress disorder, unspecified other specific personality disorders anemia in other chronic diseases classified elsewhere personal history of nicotine dependence rash and other nonspecific skin eruption presence of cerebrospinal fluid drainage device personal history of pulmonary embolism chronic pain syndrome other medical procedures as the cause of abnormal reaction of the patient, or of later complication, without mention of misadventure at the time of the procedure major depressive disorder, single episode, unspecified other allergy status, other than to drugs and biological substances other specified sepsis psoriasis, unspecified bloodstream infection due to central venous catheter, initial encounter body mass index (bmi) 50.0-59.9, adult anxiety disorder, unspecified other abnormalities of breathing mast cell activation, unspecified other chest pain abuse of other non-psychoactive substances acute embolism and thrombosis of superficial veins of left upper extremity factitious disorder imposed on self, unspecified generalized edema iron deficiency anemia, unspecified cushing's syndrome, unspecified unqualified visual loss, both eyes long term (current) use of anticoagulants thrombosis due to vascular prosthetic devices, implants and grafts, initial encounter hypothyroidism, unspecified candidiasis of skin and nail obstructive sleep apnea (adult) (pediatric) dehydration dysphagia, unspecified bloodstream infection due to central venous catheter, initial encounter insomnia, unspecified ehlers-danlos syndromes body mass index (bmi) 50.0-59.9, adult headache adverse effect of glucocorticoids and synthetic analogues, sequela other specified postprocedural states hypoxemia displacement of other gastrointestinal prosthetic devices, implants and grafts, initial encounter unspecified abdominal pain
white f 40 $nan$nan$sodium chloride 0.9%  flush  3-10  ml ; diphenhydramine  50  mg ; ramelteon  8  mg ; ranitidine (liquid)  150  mg ; sarna lotion  1  appl ; aluminum-magnesium hydrox.-simethicone  15-30  ml ; cetirizine  10  mg ; quetiapine fumarate  50  mg ; levothyroxine sodium  150  mcg ; hydromorphone (dilaudid)  0.5-1  mg ; lorazepam  0.5  mg ; diphenhydramine  25  mg ; hydrocortisone na succ.  20  mg ; ipratropium-albuterol neb  1  neb ; haloperidol  5  mg ; enoxaparin sodium  150  mg ; quetiapine fumarate  100  mg ; trazodone  100  mg ; fluocinolone acetonide 0.01% cream  1  appl ; lactated ringers  1000  ml ; hydrocortisone  10  mg ; ketorolac  30  mg ; 
acute embolism and thrombosis of deep veins of right upper extremity unspecified place or not applicable adverse effect of glucocorticoids and synthetic analogues, sequela morbid (severe) obesity due to excess calories drug-induced adrenocortical insufficiency post-traumatic stress disorder, unspecified other specific personality disorders anemia in other chronic diseases classified elsewhere personal history of nicotine dependence rash and other nonspecific skin eruption presence of cerebrospinal fluid drainage device personal history of pulmonary embolism chronic pain syndrome other medical procedures as the cause of abnormal reaction of the patient, or of later complication, without mention of misadventure at the time of the procedure major depressive disorder, single episode, unspecified other allergy status, other than to drugs and biological substances other specified sepsis psoriasis, unspecified bloodstream infection due to central venous catheter, initial encounter body mass index (bmi) 50.0-59.9, adult anxiety disorder, unspecified other abnormalities of breathing mast cell activation, unspecified other chest pain abuse of other non-psychoactive substances acute embolism and thrombosis of superficial veins of left upper extremity factitious disorder imposed on self, unspecified generalized edema iron deficiency anemia, unspecified cushing's syndrome, unspecified unqualified visual loss, both eyes long term (current) use of anticoagulants thrombosis due to vascular prosthetic devices, implants and grafts, initial encounter hypothyroidism, unspecified candidiasis of skin and nail obstructive sleep apnea (adult) (pediatric) dehydration dysphagia, unspecified bloodstream infection due to central venous catheter, initial encounter insomnia, unspecified ehlers-danlos syndromes body mass index (bmi) 50.0-59.9, adult headache adverse effect of glucocorticoids and synthetic analogues, sequela other specified postprocedural states hypoxemia displacement of other gastrointestinal prosthetic devices, implants and grafts, initial encounter unspecified abdominal pain
white f 40 $nan$hematology blood hematocrit  31.8  %; hematology blood hemoglobin  8.8  g dl; hematology blood platelet count  344  k ul; chemistry blood anion gap  14  meq l; chemistry blood bicarbonate  24  meq l; chemistry blood chloride  104  meq l; chemistry blood creatinine  0.6  mg dl; chemistry blood potassium  3.8  meq l; chemistry blood sodium  142  meq l; chemistry blood urea nitrogen  7  mg dl; chemistry blood calcium, total  9.1  mg dl; chemistry blood bilirubin, total  0.2  mg dl; chemistry blood glucose  147  mg dl$sodium chloride 0.9%  flush  3-10  ml ; ramelteon  8  mg ; sarna lotion  1  appl ; aluminum-magnesium hydrox.-simethicone  15-30  ml ; cetirizine  10  mg ; quetiapine fumarate  50  mg ; levothyroxine sodium  150  mcg ; hydromorphone (dilaudid)  0.5-1  mg ; lorazepam  0.5  mg ; ipratropium-albuterol neb  1  neb ; haloperidol  5  mg ; enoxaparin sodium  150  mg ; quetiapine fumarate  100  mg ; trazodone  100  mg ; fluocinolone acetonide 0.01% cream  1  appl ; hydrocortisone  10  mg ; ketorolac  30  mg ; hydrocortisone  20  mg ; ranitidine  150  mg ; hydromorphone (dilaudid)  0.5  mg ; hydrocortisone na succ.  10  mg ; hydromorphone (dilaudid)  1  mg ; 
acute embolism and thrombosis of deep veins of right upper extremity unspecified place or not applicable adverse effect of glucocorticoids and synthetic analogues, sequela morbid (severe) obesity due to excess calories drug-induced adrenocortical insufficiency post-traumatic stress disorder, unspecified other specific personality disorders anemia in other chronic diseases classified elsewhere personal history of nicotine dependence rash and other nonspecific skin eruption presence of cerebrospinal fluid drainage device personal history of pulmonary embolism chronic pain syndrome other medical procedures as the cause of abnormal reaction of the patient, or of later complication, without mention of misadventure at the time of the procedure major depressive disorder, single episode, unspecified other allergy status, other than to drugs and biological substances other specified sepsis psoriasis, unspecified bloodstream infection due to central venous catheter, initial encounter body mass index (bmi) 50.0-59.9, adult anxiety disorder, unspecified other abnormalities of breathing mast cell activation, unspecified other chest pain abuse of other non-psychoactive substances acute embolism and thrombosis of superficial veins of left upper extremity factitious disorder imposed on self, unspecified generalized edema iron deficiency anemia, unspecified cushing's syndrome, unspecified unqualified visual loss, both eyes long term (current) use of anticoagulants thrombosis due to vascular prosthetic devices, implants and grafts, initial encounter hypothyroidism, unspecified candidiasis of skin and nail obstructive sleep apnea (adult) (pediatric) dehydration dysphagia, unspecified bloodstream infection due to central venous catheter, initial encounter insomnia, unspecified ehlers-danlos syndromes body mass index (bmi) 50.0-59.9, adult headache adverse effect of glucocorticoids and synthetic analogues, sequela other specified postprocedural states hypoxemia displacement of other gastrointestinal prosthetic devices, implants and grafts, initial encounter unspecified abdominal pain
white f 40 $nan$nan$sodium chloride 0.9%  flush  3-10  ml ; ramelteon  8  mg ; sarna lotion  1  appl ; aluminum-magnesium hydrox.-simethicone  15-30  ml ; cetirizine  10  mg ; quetiapine fumarate  50  mg ; levothyroxine sodium  150  mcg ; lorazepam  0.5  mg ; ipratropium-albuterol neb  1  neb ; haloperidol  5  mg ; enoxaparin sodium  150  mg ; quetiapine fumarate  100  mg ; trazodone  100  mg ; fluocinolone acetonide 0.01% cream  1  appl ; ranitidine  150  mg ; hydrocortisone na succ.  10  mg ; senna  17.2  mg ; 
acute embolism and thrombosis of deep veins of right upper extremity unspecified place or not applicable adverse effect of glucocorticoids and synthetic analogues, sequela morbid (severe) obesity due to excess calories drug-induced adrenocortical insufficiency post-traumatic stress disorder, unspecified other specific personality disorders anemia in other chronic diseases classified elsewhere personal history of nicotine dependence rash and other nonspecific skin eruption presence of cerebrospinal fluid drainage device personal history of pulmonary embolism chronic pain syndrome other medical procedures as the cause of abnormal reaction of the patient, or of later complication, without mention of misadventure at the time of the procedure major depressive disorder, single episode, unspecified other allergy status, other than to drugs and biological substances other specified sepsis psoriasis, unspecified bloodstream infection due to central venous catheter, initial encounter body mass index (bmi) 50.0-59.9, adult anxiety disorder, unspecified other abnormalities of breathing mast cell activation, unspecified other chest pain abuse of other non-psychoactive substances acute embolism and thrombosis of superficial veins of left upper extremity factitious disorder imposed on self, unspecified generalized edema iron deficiency anemia, unspecified cushing's syndrome, unspecified unqualified visual loss, both eyes long term (current) use of anticoagulants thrombosis due to vascular prosthetic devices, implants and grafts, initial encounter hypothyroidism, unspecified candidiasis of skin and nail obstructive sleep apnea (adult) (pediatric) dehydration dysphagia, unspecified bloodstream infection due to central venous catheter, initial encounter insomnia, unspecified ehlers-danlos syndromes body mass index (bmi) 50.0-59.9, adult headache adverse effect of glucocorticoids and synthetic analogues, sequela other specified postprocedural states hypoxemia displacement of other gastrointestinal prosthetic devices, implants and grafts, initial encounter unspecified abdominal pain
white f 40 $nan$nan$sodium chloride 0.9%  flush  3-10  ml ; ramelteon  8  mg ; sarna lotion  1  appl ; aluminum-magnesium hydrox.-simethicone  15-30  ml ; cetirizine  10  mg ; quetiapine fumarate  50  mg ; levothyroxine sodium  150  mcg ; lorazepam  0.5  mg ; ipratropium-albuterol neb  1  neb ; haloperidol  5  mg ; enoxaparin sodium  150  mg ; quetiapine fumarate  100  mg ; trazodone  100  mg ; fluocinolone acetonide 0.01% cream  1  appl ; ranitidine  150  mg ; hydrocortisone na succ.  10  mg ; senna  17.2  mg ; polyethylene glycol  17  g ; bisacodyl  10  mg ; 
acute embolism and thrombosis of deep veins of right upper extremity unspecified place or not applicable adverse effect of glucocorticoids and synthetic analogues, sequela morbid (severe) obesity due to excess calories drug-induced adrenocortical insufficiency post-traumatic stress disorder, unspecified other specific personality disorders anemia in other chronic diseases classified elsewhere personal history of nicotine dependence rash and other nonspecific skin eruption presence of cerebrospinal fluid drainage device personal history of pulmonary embolism chronic pain syndrome other medical procedures as the cause of abnormal reaction of the patient, or of later complication, without mention of misadventure at the time of the procedure major depressive disorder, single episode, unspecified other allergy status, other than to drugs and biological substances other specified sepsis psoriasis, unspecified bloodstream infection due to central venous catheter, initial encounter body mass index (bmi) 50.0-59.9, adult anxiety disorder, unspecified other abnormalities of breathing mast cell activation, unspecified other chest pain abuse of other non-psychoactive substances acute embolism and thrombosis of superficial veins of left upper extremity factitious disorder imposed on self, unspecified generalized edema iron deficiency anemia, unspecified cushing's syndrome, unspecified unqualified visual loss, both eyes long term (current) use of anticoagulants thrombosis due to vascular prosthetic devices, implants and grafts, initial encounter hypothyroidism, unspecified candidiasis of skin and nail obstructive sleep apnea (adult) (pediatric) dehydration dysphagia, unspecified bloodstream infection due to central venous catheter, initial encounter insomnia, unspecified ehlers-danlos syndromes body mass index (bmi) 50.0-59.9, adult headache adverse effect of glucocorticoids and synthetic analogues, sequela other specified postprocedural states hypoxemia displacement of other gastrointestinal prosthetic devices, implants and grafts, initial encounter unspecified abdominal pain
white m 45 $nan$nan$5% dextrose  500  ml ; vancomycin  1500  mg ; 
unspecified antibiotic causing adverse effects in therapeutic use nausea with vomiting swelling, mass, or lump in head and neck obstructive sleep apnea (adult)(pediatric) other specified bacterial infections in conditions classified elsewhere and of unspecified site, other gram-negative organisms other postoperative infection accidental puncture or laceration of dura during a procedure other specified surgical operations and procedures causing abnormal patient reaction, or later complication, without mention of misadventure at time of operation staphylococcus infection in conditions classified elsewhere and of unspecified site, other staphylococcus spinal stenosis, lumbar region, without neurogenic claudication obstructive sleep apnea (adult)(pediatric) 
white m 45 $nan$nan$5% dextrose  500  ml ; vancomycin  1500  mg ; docusate sodium  100  mg ; acetaminophen  325-650  mg ; oxycodone (immediate release)   5-10  mg ; ondansetron  4  mg ; sodium chloride 0.9%  flush  10  ml ; 0.9% sodium chloride (mini bag plus)  100  ml ; meropenem  1000  mg ; 
unspecified antibiotic causing adverse effects in therapeutic use nausea with vomiting swelling, mass, or lump in head and neck obstructive sleep apnea (adult)(pediatric) other specified bacterial infections in conditions classified elsewhere and of unspecified site, other gram-negative organisms other postoperative infection accidental puncture or laceration of dura during a procedure other specified surgical operations and procedures causing abnormal patient reaction, or later complication, without mention of misadventure at time of operation staphylococcus infection in conditions classified elsewhere and of unspecified site, other staphylococcus spinal stenosis, lumbar region, without neurogenic claudication obstructive sleep apnea (adult)(pediatric) 
white m 45 $nan$hematology urine wbc  0-2  # hpf; hematology urine glucose  100  mg dl$5% dextrose  500  ml ; vancomycin  1500  mg ; docusate sodium  100  mg ; acetaminophen  325-650  mg ; oxycodone (immediate release)   5-10  mg ; ondansetron  4  mg ; sodium chloride 0.9%  flush  10  ml ; 0.9% sodium chloride (mini bag plus)  100  ml ; meropenem  1000  mg ; potassium chl 20 meq   1000 ml d5 1 2 ns  1000  ml ; sodium chloride 0.9%  flush  3  ml ; potassium chl 20 meq   1000 ml ns  1000  ml ; hydromorphone (dilaudid)  12.5  mg ; 
unspecified antibiotic causing adverse effects in therapeutic use nausea with vomiting swelling, mass, or lump in head and neck obstructive sleep apnea (adult)(pediatric) other specified bacterial infections in conditions classified elsewhere and of unspecified site, other gram-negative organisms other postoperative infection accidental puncture or laceration of dura during a procedure other specified surgical operations and procedures causing abnormal patient reaction, or later complication, without mention of misadventure at time of operation staphylococcus infection in conditions classified elsewhere and of unspecified site, other staphylococcus spinal stenosis, lumbar region, without neurogenic claudication obstructive sleep apnea (adult)(pediatric) 
white m 45 $nan$hematology blood hematocrit  35.8  %; hematology blood hemoglobin  11.8  g dl; hematology blood platelet count  358  k ul$5% dextrose  500  ml ; vancomycin  1500  mg ; docusate sodium  100  mg ; acetaminophen  325-650  mg ; oxycodone (immediate release)   5-10  mg ; sodium chloride 0.9%  flush  10  ml ; 0.9% sodium chloride (mini bag plus)  100  ml ; meropenem  1000  mg ; sodium chloride 0.9%  flush  3  ml ; potassium chl 20 meq   1000 ml ns  1000  ml ; 
unspecified antibiotic causing adverse effects in therapeutic use nausea with vomiting swelling, mass, or lump in head and neck obstructive sleep apnea (adult)(pediatric) other specified bacterial infections in conditions classified elsewhere and of unspecified site, other gram-negative organisms other postoperative infection accidental puncture or laceration of dura during a procedure other specified surgical operations and procedures causing abnormal patient reaction, or later complication, without mention of misadventure at time of operation staphylococcus infection in conditions classified elsewhere and of unspecified site, other staphylococcus spinal stenosis, lumbar region, without neurogenic claudication obstructive sleep apnea (adult)(pediatric) 
white m 45 $nan$nan$5% dextrose  500  ml ; vancomycin  1500  mg ; docusate sodium  100  mg ; acetaminophen  325-650  mg ; oxycodone (immediate release)   5-10  mg ; sodium chloride 0.9%  flush  10  ml ; 0.9% sodium chloride (mini bag plus)  100  ml ; meropenem  1000  mg ; sodium chloride 0.9%  flush  3  ml ; potassium chl 20 meq   1000 ml ns  1000  ml ; 5% dextrose  250  ml ; vancomycin  1250  mg ; 
unspecified antibiotic causing adverse effects in therapeutic use nausea with vomiting swelling, mass, or lump in head and neck obstructive sleep apnea (adult)(pediatric) other specified bacterial infections in conditions classified elsewhere and of unspecified site, other gram-negative organisms other postoperative infection accidental puncture or laceration of dura during a procedure other specified surgical operations and procedures causing abnormal patient reaction, or later complication, without mention of misadventure at time of operation staphylococcus infection in conditions classified elsewhere and of unspecified site, other staphylococcus spinal stenosis, lumbar region, without neurogenic claudication obstructive sleep apnea (adult)(pediatric) 
white m 45 $nan$hematology blood hematocrit  34.9  %; hematology blood hemoglobin  12.1  g dl; hematology blood platelet count  352  k ul; chemistry blood anion gap  12  meq l; chemistry blood bicarbonate  30  meq l; chemistry blood chloride  104  meq l; chemistry blood creatinine  1.2  mg dl; chemistry blood potassium  4.2  meq l; chemistry blood sodium  142  meq l; chemistry blood urea nitrogen  11  mg dl; hematology urine wbc  0-2  # hpf; chemistry blood calcium, total  8.4  mg dl; chemistry blood glucose  118  mg dl; hematology urine glucose  neg  mg dl; hematology urine bilirubin  neg  mg dl$docusate sodium  100  mg ; acetaminophen  325-650  mg ; oxycodone (immediate release)   5-10  mg ; sodium chloride 0.9%  flush  10  ml ; 0.9% sodium chloride (mini bag plus)  100  ml ; meropenem  1000  mg ; sodium chloride 0.9%  flush  3  ml ; potassium chl 20 meq   1000 ml ns  1000  ml ; 5% dextrose  250  ml ; vancomycin  1250  mg ; cefepime  2  g ; 
unspecified antibiotic causing adverse effects in therapeutic use nausea with vomiting swelling, mass, or lump in head and neck obstructive sleep apnea (adult)(pediatric) other specified bacterial infections in conditions classified elsewhere and of unspecified site, other gram-negative organisms other postoperative infection accidental puncture or laceration of dura during a procedure other specified surgical operations and procedures causing abnormal patient reaction, or later complication, without mention of misadventure at time of operation staphylococcus infection in conditions classified elsewhere and of unspecified site, other staphylococcus spinal stenosis, lumbar region, without neurogenic claudication obstructive sleep apnea (adult)(pediatric) 
white m 45 $nan$nan$docusate sodium  100  mg ; acetaminophen  325-650  mg ; oxycodone (immediate release)   5-10  mg ; sodium chloride 0.9%  flush  10  ml ; sodium chloride 0.9%  flush  3  ml ; potassium chl 20 meq   1000 ml ns  1000  ml ; cefepime  2  g ; 
unspecified antibiotic causing adverse effects in therapeutic use nausea with vomiting swelling, mass, or lump in head and neck obstructive sleep apnea (adult)(pediatric) other specified bacterial infections in conditions classified elsewhere and of unspecified site, other gram-negative organisms other postoperative infection accidental puncture or laceration of dura during a procedure other specified surgical operations and procedures causing abnormal patient reaction, or later complication, without mention of misadventure at time of operation staphylococcus infection in conditions classified elsewhere and of unspecified site, other staphylococcus spinal stenosis, lumbar region, without neurogenic claudication obstructive sleep apnea (adult)(pediatric) 
white m 45 $nan$nan$docusate sodium  100  mg ; acetaminophen  325-650  mg ; oxycodone (immediate release)   5-10  mg ; sodium chloride 0.9%  flush  10  ml ; sodium chloride 0.9%  flush  3  ml ; cefepime  2  g ; 
unspecified antibiotic causing adverse effects in therapeutic use nausea with vomiting swelling, mass, or lump in head and neck obstructive sleep apnea (adult)(pediatric) other specified bacterial infections in conditions classified elsewhere and of unspecified site, other gram-negative organisms other postoperative infection accidental puncture or laceration of dura during a procedure other specified surgical operations and procedures causing abnormal patient reaction, or later complication, without mention of misadventure at time of operation staphylococcus infection in conditions classified elsewhere and of unspecified site, other staphylococcus spinal stenosis, lumbar region, without neurogenic claudication obstructive sleep apnea (adult)(pediatric) 
white m 62 $nan$hematology blood hematocrit  45.1  %; chemistry blood chloride  106  meq l; chemistry blood chloride  108  meq l; chemistry blood potassium  5.0  meq l; chemistry blood potassium  6.1  meq l; chemistry blood sodium  136  meq l; chemistry blood sodium  139  meq l$heparin  5000  unit ; sodium chloride 0.9%  flush  3  ml ; lactated ringers  1000  ml ; acetaminophen iv  1000  mg ; vial  1  vial ; pantoprazole  40  mg ; metoprolol tartrate  5  mg ; bupivacaine 0.1%  250  ml ; yellow cadd cassette  1  cadd ; hydromorphone  2500  mcg ; ondansetron  4  mg ; 5% dextrose  100  ml ; naloxone  2  mg ; bag  50  ml ; magnesium sulfate  2  gm ; lorazepam  0.5  mg ; 
leukocytosis, unspecified unspecified essential hypertension calculus of gallbladder without mention of cholecystitis, with obstruction gout, unspecified hiccough personal history of malignant neoplasm of large intestine personal history of tobacco use malignant neoplasm of cardia pulmonary collapse personal history of malignant neoplasm of kidney acquired absence of kidney atrial fibrillation unspecified pleural effusion acute pancreatitis other disorders of neurohypophysis iron deficiency anemia, unspecified anemia, unspecified personal history of tobacco use family history of malignant neoplasm of gastrointestinal tract acquired absence of kidney atrial fibrillation pedal cycle driver injured in collision with other nonmotor vehicle in nontraffic accident personal history of malignant neoplasm of kidney malignant neoplasm of ascending colon gout, unspecified 
white m 62 $nan$hematology blood hematocrit  38.1  %; hematology blood hemoglobin  12.3  g dl; hematology blood platelet count  193  k ul; chemistry blood anion gap  13  meq l; chemistry blood bicarbonate  24  meq l; chemistry blood chloride  107  meq l; chemistry blood creatinine  1.5  mg dl; chemistry blood potassium  4.5  meq l; chemistry blood sodium  139  meq l; chemistry blood urea nitrogen  28  mg dl; chemistry blood calcium, total  8.4  mg dl; chemistry blood glucose  133  mg dl$heparin  5000  unit ; sodium chloride 0.9%  flush  3  ml ; lactated ringers  1000  ml ; acetaminophen iv  1000  mg ; vial  1  vial ; pantoprazole  40  mg ; metoprolol tartrate  5  mg ; bupivacaine 0.1%  250  ml ; yellow cadd cassette  1  cadd ; hydromorphone  2500  mcg ; ondansetron  4  mg ; 5% dextrose  100  ml ; naloxone  2  mg ; bag  50  ml ; magnesium sulfate  2  gm ; lorazepam  0.5  mg ; sarna lotion  1  appl ; chloraseptic throat spray  1  spry ; 
leukocytosis, unspecified unspecified essential hypertension calculus of gallbladder without mention of cholecystitis, with obstruction gout, unspecified hiccough personal history of malignant neoplasm of large intestine personal history of tobacco use malignant neoplasm of cardia pulmonary collapse personal history of malignant neoplasm of kidney acquired absence of kidney atrial fibrillation unspecified pleural effusion acute pancreatitis other disorders of neurohypophysis iron deficiency anemia, unspecified anemia, unspecified personal history of tobacco use family history of malignant neoplasm of gastrointestinal tract acquired absence of kidney atrial fibrillation pedal cycle driver injured in collision with other nonmotor vehicle in nontraffic accident personal history of malignant neoplasm of kidney malignant neoplasm of ascending colon gout, unspecified 
white m 62 $nan$hematology blood hematocrit  37.6  %; hematology blood hematocrit  33.2  %; hematology blood hemoglobin  12.4  g dl; hematology blood hemoglobin  10.9  g dl; hematology blood platelet count  199  k ul; hematology blood platelet count  160  k ul; chemistry blood anion gap  12  meq l; chemistry blood anion gap  14  meq l; chemistry blood bicarbonate  27  meq l; chemistry blood bicarbonate  24  meq l; chemistry blood chloride  106  meq l; chemistry blood chloride  107  meq l; chemistry blood creatinine  1.3  mg dl; chemistry blood creatinine  1.0  mg dl; chemistry blood potassium  4.0  meq l; chemistry blood potassium  3.6  meq l; chemistry blood sodium  141  meq l; chemistry blood sodium  141  meq l; chemistry blood urea nitrogen  23  mg dl; chemistry blood urea nitrogen  17  mg dl; chemistry blood calcium, total  8.6  mg dl; chemistry blood calcium, total  8.3  mg dl; chemistry blood glucose  125  mg dl; chemistry blood glucose  137  mg dl$heparin  5000  unit ; sodium chloride 0.9%  flush  3  ml ; lactated ringers  1000  ml ; acetaminophen iv  1000  mg ; vial  1  vial ; pantoprazole  40  mg ; metoprolol tartrate  5  mg ; bupivacaine 0.1%  250  ml ; yellow cadd cassette  1  cadd ; hydromorphone  2500  mcg ; ondansetron  4  mg ; lorazepam  0.5  mg ; sarna lotion  1  appl ; chloraseptic throat spray  1  spry ; 0.9% sodium chloride  500  ml ; sodium phosphate  30  mmol ; 
leukocytosis, unspecified unspecified essential hypertension calculus of gallbladder without mention of cholecystitis, with obstruction gout, unspecified hiccough personal history of malignant neoplasm of large intestine personal history of tobacco use malignant neoplasm of cardia pulmonary collapse personal history of malignant neoplasm of kidney acquired absence of kidney atrial fibrillation unspecified pleural effusion acute pancreatitis other disorders of neurohypophysis iron deficiency anemia, unspecified anemia, unspecified personal history of tobacco use family history of malignant neoplasm of gastrointestinal tract acquired absence of kidney atrial fibrillation pedal cycle driver injured in collision with other nonmotor vehicle in nontraffic accident personal history of malignant neoplasm of kidney malignant neoplasm of ascending colon gout, unspecified 
white m 62 $nan$nan$heparin  5000  unit ; sodium chloride 0.9%  flush  3  ml ; acetaminophen iv  1000  mg ; vial  1  vial ; pantoprazole  40  mg ; metoprolol tartrate  5  mg ; bupivacaine 0.1%  250  ml ; yellow cadd cassette  1  cadd ; hydromorphone  2500  mcg ; ondansetron  4  mg ; lorazepam  0.5  mg ; sarna lotion  1  appl ; chloraseptic throat spray  1  spry ; 0.9% sodium chloride  500  ml ; sodium phosphate  30  mmol ; potassium chl 20 meq   1000 ml d5 1 2 ns  1000  ml ; 0.9% sodium chloride  250  ml ; potassium chloride  20  meq ; hydromorphone (dilaudid)  20  mg ; 
leukocytosis, unspecified unspecified essential hypertension calculus of gallbladder without mention of cholecystitis, with obstruction gout, unspecified hiccough personal history of malignant neoplasm of large intestine personal history of tobacco use malignant neoplasm of cardia pulmonary collapse personal history of malignant neoplasm of kidney acquired absence of kidney atrial fibrillation unspecified pleural effusion acute pancreatitis other disorders of neurohypophysis iron deficiency anemia, unspecified anemia, unspecified personal history of tobacco use family history of malignant neoplasm of gastrointestinal tract acquired absence of kidney atrial fibrillation pedal cycle driver injured in collision with other nonmotor vehicle in nontraffic accident personal history of malignant neoplasm of kidney malignant neoplasm of ascending colon gout, unspecified 
white m 62 $nan$chemistry blood anion gap  12  meq l; chemistry blood anion gap  15  meq l; chemistry blood bicarbonate  26  meq l; chemistry blood bicarbonate  25  meq l; chemistry blood chloride  105  meq l; chemistry blood chloride  105  meq l; chemistry blood creatinine  1.1  mg dl; chemistry blood creatinine  0.9  mg dl; chemistry blood potassium  4.3  meq l; chemistry blood potassium  4.1  meq l; chemistry blood sodium  139  meq l; chemistry blood sodium  141  meq l; chemistry blood urea nitrogen  14  mg dl; chemistry blood urea nitrogen  11  mg dl; chemistry blood calcium, total  8.5  mg dl; chemistry blood calcium, total  8.5  mg dl; chemistry blood glucose  122  mg dl; chemistry blood glucose  145  mg dl$heparin  5000  unit ; sodium chloride 0.9%  flush  3  ml ; acetaminophen iv  1000  mg ; vial  1  vial ; pantoprazole  40  mg ; metoprolol tartrate  5  mg ; ondansetron  4  mg ; lorazepam  0.5  mg ; sarna lotion  1  appl ; chloraseptic throat spray  1  spry ; potassium chl 20 meq   1000 ml d5 1 2 ns  1000  ml ; 0.9% sodium chloride  250  ml ; potassium chloride  20  meq ; hydromorphone (dilaudid)  20  mg ; oxycodone-acetaminophen elixir  5-10  ml ; lidocaine viscous 2%  20  ml ; cepacol (menthol)  1  loz ; lorazepam  0.25  mg ; 
leukocytosis, unspecified unspecified essential hypertension calculus of gallbladder without mention of cholecystitis, with obstruction gout, unspecified hiccough personal history of malignant neoplasm of large intestine personal history of tobacco use malignant neoplasm of cardia pulmonary collapse personal history of malignant neoplasm of kidney acquired absence of kidney atrial fibrillation unspecified pleural effusion acute pancreatitis other disorders of neurohypophysis iron deficiency anemia, unspecified anemia, unspecified personal history of tobacco use family history of malignant neoplasm of gastrointestinal tract acquired absence of kidney atrial fibrillation pedal cycle driver injured in collision with other nonmotor vehicle in nontraffic accident personal history of malignant neoplasm of kidney malignant neoplasm of ascending colon gout, unspecified 
white m 62 $nan$chemistry blood anion gap  15  meq l; chemistry blood bicarbonate  24  meq l; chemistry blood chloride  105  meq l; chemistry blood creatinine  1.0  mg dl; chemistry blood potassium  4.1  meq l; chemistry blood sodium  140  meq l; chemistry blood urea nitrogen  16  mg dl; chemistry blood calcium, total  8.4  mg dl; chemistry blood glucose  123  mg dl$sodium chloride 0.9%  flush  3  ml ; acetaminophen iv  1000  mg ; vial  1  vial ; pantoprazole  40  mg ; metoprolol tartrate  5  mg ; lorazepam  0.5  mg ; sarna lotion  1  appl ; chloraseptic throat spray  1  spry ; potassium chl 20 meq   1000 ml d5 1 2 ns  1000  ml ; hydromorphone (dilaudid)  20  mg ; lidocaine viscous 2%  20  ml ; cepacol (menthol)  1  loz ; lorazepam  0.25  mg ; 
leukocytosis, unspecified unspecified essential hypertension calculus of gallbladder without mention of cholecystitis, with obstruction gout, unspecified hiccough personal history of malignant neoplasm of large intestine personal history of tobacco use malignant neoplasm of cardia pulmonary collapse personal history of malignant neoplasm of kidney acquired absence of kidney atrial fibrillation unspecified pleural effusion acute pancreatitis other disorders of neurohypophysis iron deficiency anemia, unspecified anemia, unspecified personal history of tobacco use family history of malignant neoplasm of gastrointestinal tract acquired absence of kidney atrial fibrillation pedal cycle driver injured in collision with other nonmotor vehicle in nontraffic accident personal history of malignant neoplasm of kidney malignant neoplasm of ascending colon gout, unspecified 
white m 62 $nan$nan$sodium chloride 0.9%  flush  3  ml ; acetaminophen iv  1000  mg ; vial  1  vial ; pantoprazole  40  mg ; metoprolol tartrate  5  mg ; lorazepam  0.5  mg ; sarna lotion  1  appl ; chloraseptic throat spray  1  spry ; hydromorphone (dilaudid)  20  mg ; lidocaine viscous 2%  20  ml ; cepacol (menthol)  1  loz ; metoprolol succinate xl  100  mg ; allopurinol  50  mg ; oxycodone (immediate release)   5-10  mg ; hydromorphone (dilaudid)  0.125-0.25  mg ; acetaminophen  325-650  mg ; colchicine  0.6  mg ; 
leukocytosis, unspecified unspecified essential hypertension calculus of gallbladder without mention of cholecystitis, with obstruction gout, unspecified hiccough personal history of malignant neoplasm of large intestine personal history of tobacco use malignant neoplasm of cardia pulmonary collapse personal history of malignant neoplasm of kidney acquired absence of kidney atrial fibrillation unspecified pleural effusion acute pancreatitis other disorders of neurohypophysis iron deficiency anemia, unspecified anemia, unspecified personal history of tobacco use family history of malignant neoplasm of gastrointestinal tract acquired absence of kidney atrial fibrillation pedal cycle driver injured in collision with other nonmotor vehicle in nontraffic accident personal history of malignant neoplasm of kidney malignant neoplasm of ascending colon gout, unspecified 
white m 62 $nan$nan$sodium chloride 0.9%  flush  3  ml ; sarna lotion  1  appl ; metoprolol succinate xl  100  mg ; allopurinol  50  mg ; oxycodone (immediate release)   5-10  mg ; hydromorphone (dilaudid)  0.125-0.25  mg ; acetaminophen  325-650  mg ; colchicine  0.6  mg ; 
leukocytosis, unspecified unspecified essential hypertension calculus of gallbladder without mention of cholecystitis, with obstruction gout, unspecified hiccough personal history of malignant neoplasm of large intestine personal history of tobacco use malignant neoplasm of cardia pulmonary collapse personal history of malignant neoplasm of kidney acquired absence of kidney atrial fibrillation unspecified pleural effusion acute pancreatitis other disorders of neurohypophysis iron deficiency anemia, unspecified anemia, unspecified personal history of tobacco use family history of malignant neoplasm of gastrointestinal tract acquired absence of kidney atrial fibrillation pedal cycle driver injured in collision with other nonmotor vehicle in nontraffic accident personal history of malignant neoplasm of kidney malignant neoplasm of ascending colon gout, unspecified 
black african american f 62 $temp    heartrate  74.0  resprate  18.0  o2sat  100.0  sbp  136.0  dbp  65.0  rhythm    pain  0  ; temp  98.0  heartrate  68.0  resprate  20.0  o2sat  100.0  sbp  137.0  dbp  58.0  rhythm    pain  0  ; temp    heartrate  68.0  resprate  19.0  o2sat  100.0  sbp  132.0  dbp  56.0  rhythm    pain    ; temp  98.2  heartrate  70.0  resprate  20.0  o2sat  100.0  sbp  122.0  dbp  75.0  rhythm    pain  0  ; temp    heartrate  79.0  resprate  17.0  o2sat  100.0  sbp  128.0  dbp  78.0  rhythm    pain  asleep  ; temp    heartrate  74.0  resprate  18.0  o2sat  99.0  sbp  124.0  dbp  61.0  rhythm    pain  1  ; temp  98.8  heartrate  72.0  resprate  18.0  o2sat  100.0  sbp  124.0  dbp  64.0  rhythm    pain    $hematology blood hematocrit  35.7  %; hematology blood hemoglobin  10.9  g dl; hematology blood platelet count  247  k ul; chemistry blood anion gap  15  meq l; chemistry blood bicarbonate  24  meq l; chemistry blood chloride  105  meq l; chemistry blood creatinine  0.8  mg dl; chemistry blood potassium  4.0  meq l; chemistry blood sodium  144  meq l; chemistry blood urea nitrogen  18  mg dl; hematology urine wbc  2  # hpf; chemistry blood calcium, total  9.3  mg dl; chemistry blood bilirubin, total  0.2  mg dl; chemistry blood glucose  103  mg dl; chemistry blood albumin  4.1  g dl$nan
long-term (current) use of other medications unspecified essential hypertension other and unspecified hyperlipidemia encounter for therapeutic drug monitoring diabetes mellitus without mention of complication, type ii or unspecified type, not stated as uncontrolled localization-related (focal) (partial) epilepsy and epileptic syndromes with complex partial seizures, with intractable epilepsy
black african american f 62 $nan$hematology blood hematocrit  31.9  %; hematology blood hematocrit  35.3  %; hematology blood hemoglobin  10.1  g dl; hematology blood hemoglobin  11.3  g dl; hematology blood platelet count  234  k ul; hematology blood platelet count  259  k ul; chemistry blood anion gap  13  meq l; chemistry blood anion gap  12  meq l; chemistry blood bicarbonate  25  meq l; chemistry blood bicarbonate  24  meq l; chemistry blood chloride  103  meq l; chemistry blood chloride  107  meq l; chemistry blood creatinine  0.9  mg dl; chemistry blood creatinine  0.8  mg dl; chemistry blood potassium  4.0  meq l; chemistry blood potassium  4.1  meq l; chemistry blood sodium  144  meq l; chemistry blood sodium  140  meq l; chemistry blood urea nitrogen  20  mg dl; chemistry blood urea nitrogen  16  mg dl; hematology blood inr(pt)  1.1  ; chemistry blood calcium, total  9.0  mg dl; chemistry blood calcium, total  9.0  mg dl; chemistry blood bilirubin, total  0.2  mg dl; chemistry blood glucose  127  mg dl; chemistry blood glucose  122  mg dl; chemistry blood albumin  4.0  g dl$sodium chloride 0.9%  flush  3-10  ml ; acetaminophen  650  mg ; docusate sodium  100  mg ; senna  8.6  mg ; dextrose 50%  12.5  gm ; glucagon  1  mg ; glucose gel  15  g ; lorazepam  1  mg ; insulin  0  unit ; zonisamide  600  mg ; levetiracetam  3500  mg ; ramelteon  8  mg ; heparin  5000  unit ; losartan potassium  50  mg ; hydrochlorothiazide  12.5  mg ; simvastatin  20  mg ; perampanel  2  mg ; 
long-term (current) use of other medications unspecified essential hypertension other and unspecified hyperlipidemia encounter for therapeutic drug monitoring diabetes mellitus without mention of complication, type ii or unspecified type, not stated as uncontrolled localization-related (focal) (partial) epilepsy and epileptic syndromes with complex partial seizures, with intractable epilepsy
black african american f 62 $nan$nan$sodium chloride 0.9%  flush  3-10  ml ; acetaminophen  650  mg ; docusate sodium  100  mg ; senna  8.6  mg ; dextrose 50%  12.5  gm ; glucagon  1  mg ; glucose gel  15  g ; lorazepam  1  mg ; insulin  0  unit ; zonisamide  600  mg ; levetiracetam  3500  mg ; ramelteon  8  mg ; heparin  5000  unit ; losartan potassium  50  mg ; hydrochlorothiazide  12.5  mg ; simvastatin  20  mg ; perampanel  2  mg ; 
long-term (current) use of other medications unspecified essential hypertension other and unspecified hyperlipidemia encounter for therapeutic drug monitoring diabetes mellitus without mention of complication, type ii or unspecified type, not stated as uncontrolled localization-related (focal) (partial) epilepsy and epileptic syndromes with complex partial seizures, with intractable epilepsy
black african american f 62 $nan$nan$sodium chloride 0.9%  flush  3-10  ml ; acetaminophen  650  mg ; docusate sodium  100  mg ; senna  8.6  mg ; dextrose 50%  12.5  gm ; glucagon  1  mg ; glucose gel  15  g ; lorazepam  1  mg ; insulin  0  unit ; zonisamide  600  mg ; levetiracetam  3500  mg ; ramelteon  8  mg ; heparin  5000  unit ; losartan potassium  50  mg ; hydrochlorothiazide  12.5  mg ; simvastatin  20  mg ; perampanel  2  mg ; 
long-term (current) use of other medications unspecified essential hypertension other and unspecified hyperlipidemia encounter for therapeutic drug monitoring diabetes mellitus without mention of complication, type ii or unspecified type, not stated as uncontrolled localization-related (focal) (partial) epilepsy and epileptic syndromes with complex partial seizures, with intractable epilepsy
white f 55 $nan$nan$levothyroxine sodium  112  mcg ; hydrochlorothiazide  25  mg ; 
 
white f 55 $nan$nan$levothyroxine sodium  112  mcg ; hydrochlorothiazide  25  mg ; influenza virus vaccine  0.5  ml ; hydromorphone (dilaudid)  0.5-1  mg ; acetaminophen  500-1000  mg ; ibuprofen  600  mg ; sodium chloride 0.9%  flush  3  ml ; zolpidem tartrate  10  mg ; ketorolac  30  mg ; vial  1  vial ; pantoprazole sodium  40  mg ; ondansetron  4  mg ; hydromorphone (dilaudid)  12.5  mg ; 0.9% sodium chloride  250  ml ; docusate sodium  100  mg ; metoclopramide  10  mg ; bisacodyl  15  mg ; senna  2  tab ; tramadol (ultram)  50-100  mg ; lidocaine jelly 2%  1  appl ; pantoprazole  40  mg ; 
 
white f 55 $nan$nan$levothyroxine sodium  112  mcg ; hydrochlorothiazide  25  mg ; influenza virus vaccine  0.5  ml ; sodium chloride 0.9%  flush  3  ml ; zolpidem tartrate  10  mg ; ondansetron  4  mg ; docusate sodium  100  mg ; metoclopramide  10  mg ; bisacodyl  15  mg ; senna  2  tab ; tramadol (ultram)  50-100  mg ; lidocaine jelly 2%  1  appl ; pantoprazole  40  mg ; naproxen  500  mg ; acetaminophen  1000  mg ; 
 
asian f 88 $temp    heartrate  101.0  resprate  17.0  o2sat    sbp  159.0  dbp  96.0  rhythm    pain    ; temp    heartrate  91.0  resprate  19.0  o2sat  95.0  sbp  160.0  dbp  99.0  rhythm    pain  unable  ; temp    heartrate  106.0  resprate  20.0  o2sat    sbp  172.0  dbp  83.0  rhythm    pain    ; temp    heartrate  97.0  resprate  20.0  o2sat  97.0  sbp  162.0  dbp  97.0  rhythm    pain  unable  ; temp  97.0  heartrate  96.0  resprate  20.0  o2sat  97.0  sbp  165.0  dbp  72.0  rhythm    pain  unable  ; temp    heartrate  90.0  resprate  20.0  o2sat  97.0  sbp  147.0  dbp  72.0  rhythm    pain  unable  $hematology blood hematocrit  54.4  %; hematology blood hemoglobin  19.0  g dl; hematology blood platelet count  184  k ul; chemistry blood creatinine  1.0  mg dl; chemistry blood urea nitrogen  27  mg dl; hematology blood inr(pt)  1.0  ; chemistry blood bilirubin, total  1.8  mg dl; chemistry blood albumin  4.5  g dl; blood gas blood lactate  2.9  mmol l; blood gas blood chloride, whole blood  94  meq l; blood gas blood glucose  266  mg dl; blood gas blood potassium, whole blood  5.0  meq l; blood gas blood sodium, whole blood  137  meq l; blood gas blood calculated bicarbonate, whole blood  25  meq l$nan
 
asian f 88 $temp    heartrate  98.0  resprate  21.0  o2sat  97.0  sbp  166.0  dbp  72.0  rhythm  sinus  pain  unable  ; temp  98.2  heartrate  99.0  resprate  20.0  o2sat  97.0  sbp  134.0  dbp  59.0  rhythm  sinus  pain  unable  $hematology blood hematocrit  45.8  %; hematology blood hematocrit  43.2  %; hematology blood hematocrit  40.5  %; hematology blood hemoglobin  16.0  g dl; hematology blood hemoglobin  15.1  g dl; hematology blood hemoglobin  14.0  g dl; hematology blood platelet count  175  k ul; hematology blood platelet count  164  k ul; hematology blood platelet count  166  k ul; chemistry blood anion gap  15  meq l; chemistry blood anion gap  12  meq l; chemistry blood anion gap  13  meq l; chemistry blood bicarbonate  22  meq l; chemistry blood bicarbonate  23  meq l; chemistry blood bicarbonate  19  meq l; chemistry blood chloride  104  meq l; chemistry blood chloride  105  meq l; chemistry blood chloride  110  meq l; chemistry blood creatinine  0.8  mg dl; chemistry blood creatinine  0.7  mg dl; chemistry blood creatinine  0.7  mg dl; chemistry blood potassium  3.4  meq l; chemistry blood potassium  3.4  meq l; chemistry blood potassium  3.4  meq l; chemistry blood sodium  138  meq l; chemistry blood sodium  137  meq l; chemistry blood sodium  139  meq l; chemistry blood urea nitrogen  35  mg dl; chemistry blood urea nitrogen  36  mg dl; chemistry blood urea nitrogen  37  mg dl; hematology urine wbc  9  # hpf; chemistry blood calcium, total  8.6  mg dl; chemistry blood calcium, total  7.4  mg dl; chemistry blood bilirubin, total  1.3  mg dl; chemistry blood glucose  146  mg dl; chemistry blood glucose  166  mg dl; chemistry blood glucose  223  mg dl$pneumococcal 23-valent polysaccharide vaccine  0.5  ml ; sodium chloride 0.9%  flush  3  ml ; dextrose 50%  12.5  gm ; glucagon  1  mg ; glucose gel  15  g ; acetaminophen  325-650  mg ; bisacodyl  10  mg ; hydralazine  10  mg ; 0.9% sodium chloride  1000  ml ; insulin  0  unit ; valsartan  320  mg ; hydrochlorothiazide  12.5  mg ; vitamin d  2000  unit ; metoprolol tartrate  12.5  mg ; metoprolol tartrate  2.5  mg ; neutra-phos  1  pkt ; metoprolol tartrate  5  mg ; metoprolol tartrate  25  mg ; atorvastatin  20  mg ; midazolam  0.5  mg ; vial  1  vial ; pantoprazole  40  mg ; 5% dextrose  100  ml ; diltiazem  125  mg ; amiodarone  150  mg ; 5% dextrose (excel bag)  500  ml ; amiodarone  600  mg ; 0.9% sodium chloride  500  ml ; potassium chloride  40  meq ; potassium chloride  60  meq ; 
 
asian f 88 $nan$hematology blood hematocrit  40.7  %; hematology blood hemoglobin  13.9  g dl; hematology blood platelet count  149  k ul; chemistry blood anion gap  13  meq l; chemistry blood bicarbonate  18  meq l; chemistry blood chloride  109  meq l; chemistry blood creatinine  0.7  mg dl; chemistry blood potassium  3.5  meq l; chemistry blood sodium  136  meq l; chemistry blood urea nitrogen  38  mg dl; chemistry blood calcium, total  7.7  mg dl; chemistry blood glucose  177  mg dl; chemistry blood % hemoglobin a1c  6.8  %$sodium chloride 0.9%  flush  3  ml ; dextrose 50%  12.5  gm ; glucagon  1  mg ; glucose gel  15  g ; acetaminophen  325-650  mg ; bisacodyl  10  mg ; hydralazine  10  mg ; insulin  0  unit ; vitamin d  2000  unit ; neutra-phos  1  pkt ; atorvastatin  20  mg ; vial  1  vial ; pantoprazole  40  mg ; amiodarone  150  mg ; potassium chloride replacement (oncology)  40  meq ; potassium chloride replacement (oncology)  60  meq ; potassium chloride replacement (oncology)  80  meq ; labetalol  10  mg ; ondansetron  4  mg ; labetalol  20  mg ; 
 
asian f 88 $nan$hematology blood hematocrit  39.5  %; hematology blood hemoglobin  13.7  g dl; hematology blood platelet count  148  k ul; chemistry blood anion gap  8  meq l; chemistry blood bicarbonate  20  meq l; chemistry blood chloride  115  meq l; chemistry blood chloride  109  meq l; chemistry blood creatinine  0.6  mg dl; chemistry blood potassium  4.0  meq l; chemistry blood potassium  4.0  meq l; chemistry blood sodium  139  meq l; chemistry blood sodium  142  meq l; chemistry blood urea nitrogen  34  mg dl; chemistry blood calcium, total  7.9  mg dl; chemistry blood glucose  189  mg dl$sodium chloride 0.9%  flush  3  ml ; dextrose 50%  12.5  gm ; glucagon  1  mg ; glucose gel  15  g ; acetaminophen  325-650  mg ; bisacodyl  10  mg ; vitamin d  2000  unit ; atorvastatin  20  mg ; vial  1  vial ; pantoprazole  40  mg ; labetalol  10  mg ; ondansetron  4  mg ; labetalol  20  mg ; labetalol  10-20  mg ; metoprolol tartrate  50  mg ; mannitol  50  g ; soln.  250  ml ; mannitol 20%  50  g ; amlodipine  10  mg ; lactated ringers  1000  ml ; labetalol  20-30  mg ; 
 
asian f 88 $nan$hematology blood hematocrit  39.5  %; hematology blood hemoglobin  13.7  g dl; hematology blood platelet count  158  k ul; chemistry blood anion gap  10  meq l; chemistry blood anion gap  11  meq l; chemistry blood bicarbonate  26  meq l; chemistry blood bicarbonate  26  meq l; chemistry blood chloride  109  meq l; chemistry blood chloride  108  meq l; chemistry blood chloride  107  meq l; chemistry blood chloride  105  meq l; chemistry blood creatinine  0.6  mg dl; chemistry blood creatinine  0.6  mg dl; chemistry blood potassium  3.7  meq l; chemistry blood potassium  3.6  meq l; chemistry blood potassium  4.3  meq l; chemistry blood potassium  3.9  meq l; chemistry blood sodium  141  meq l; chemistry blood sodium  141  meq l; chemistry blood sodium  140  meq l; chemistry blood sodium  139  meq l; chemistry blood urea nitrogen  21  mg dl; chemistry blood urea nitrogen  21  mg dl; chemistry blood calcium, total  7.9  mg dl; chemistry blood calcium, total  8.2  mg dl; chemistry blood glucose  237  mg dl; chemistry blood glucose  183  mg dl$sodium chloride 0.9%  flush  3  ml ; dextrose 50%  12.5  gm ; glucagon  1  mg ; glucose gel  15  g ; acetaminophen  325-650  mg ; bisacodyl  10  mg ; vitamin d  2000  unit ; atorvastatin  20  mg ; vial  1  vial ; pantoprazole  40  mg ; labetalol  20  mg ; metoprolol tartrate  50  mg ; soln.  250  ml ; mannitol 20%  50  g ; amlodipine  10  mg ; lactated ringers  1000  ml ; heparin  5000  unit ; aspirin  81  mg ; labetalol  100  mg ; labetalol  200  mg ; neutra-phos  2  pkt ; 
 
asian f 88 $nan$hematology blood hematocrit  35.0  %; hematology blood hematocrit  42.2  %; hematology blood hematocrit  40.4  %; hematology blood hemoglobin  12.3  g dl; hematology blood hemoglobin  14.3  g dl; hematology blood hemoglobin  14.2  g dl; hematology blood platelet count  140  k ul; hematology blood platelet count  160  k ul; hematology blood platelet count  165  k ul; chemistry blood anion gap  7  meq l; chemistry blood anion gap  13  meq l; chemistry blood anion gap  10  meq l; chemistry blood bicarbonate  21  meq l; chemistry blood bicarbonate  27  meq l; chemistry blood bicarbonate  29  meq l; chemistry blood chloride  91  meq l; chemistry blood chloride  103  meq l; chemistry blood chloride  105  meq l; chemistry blood chloride  100  meq l; chemistry blood creatinine  0.4  mg dl; chemistry blood creatinine  0.6  mg dl; chemistry blood creatinine  0.6  mg dl; chemistry blood potassium  3.5  meq l; chemistry blood potassium  3.8  meq l; chemistry blood potassium  3.7  meq l; chemistry blood potassium  3.9  meq l; chemistry blood sodium  139  meq l; chemistry blood sodium  136  meq l; chemistry blood sodium  135  meq l; chemistry blood sodium  115  meq l; chemistry blood urea nitrogen  19  mg dl; chemistry blood urea nitrogen  19  mg dl; chemistry blood urea nitrogen  23  mg dl; chemistry blood calcium, total  6.7  mg dl; chemistry blood calcium, total  8.8  mg dl; chemistry blood glucose  270  mg dl; chemistry blood glucose  178  mg dl; chemistry blood glucose  126  mg dl$dextrose 50%  12.5  gm ; glucagon  1  mg ; glucose gel  15  g ; acetaminophen  325-650  mg ; bisacodyl  10  mg ; vitamin d  2000  unit ; atorvastatin  20  mg ; metoprolol tartrate  50  mg ; amlodipine  10  mg ; heparin  5000  unit ; aspirin  81  mg ; neutra-phos  2  pkt ; bag  500  ml ; sodium chloride 3% (hypertonic)  500  ml ; etomidate  8  mg ; succinylcholine  60  mg ; 
 
asian f 88 $nan$chemistry blood anion gap  8  meq l; chemistry blood anion gap  12  meq l; chemistry blood anion gap  11  meq l; chemistry blood anion gap  12  meq l; chemistry blood bicarbonate  29  meq l; chemistry blood bicarbonate  25  meq l; chemistry blood bicarbonate  24  meq l; chemistry blood bicarbonate  22  meq l; chemistry blood chloride  105  meq l; chemistry blood chloride  111  meq l; chemistry blood chloride  114  meq l; chemistry blood chloride  120  meq l; chemistry blood creatinine  0.6  mg dl; chemistry blood creatinine  0.7  mg dl; chemistry blood creatinine  0.7  mg dl; chemistry blood creatinine  0.7  mg dl; chemistry blood potassium  3.2  meq l; chemistry blood potassium  5.0  meq l; chemistry blood potassium  4.3  meq l; chemistry blood potassium  4.0  meq l; chemistry blood sodium  139  meq l; chemistry blood sodium  143  meq l; chemistry blood sodium  145  meq l; chemistry blood sodium  150  meq l; chemistry blood urea nitrogen  24  mg dl; chemistry blood urea nitrogen  25  mg dl; chemistry blood urea nitrogen  28  mg dl; chemistry blood urea nitrogen  31  mg dl; hematology blood inr(pt)  1.1  ; chemistry blood calcium, total  8.9  mg dl; chemistry blood calcium, total  8.4  mg dl; chemistry blood calcium, total  8.5  mg dl; chemistry blood calcium, total  8.3  mg dl; chemistry blood glucose  205  mg dl; chemistry blood glucose  170  mg dl; chemistry blood glucose  157  mg dl; chemistry blood glucose  134  mg dl$dextrose 50%  12.5  gm ; glucagon  1  mg ; glucose gel  15  g ; acetaminophen  325-650  mg ; bisacodyl  10  mg ; vitamin d  2000  unit ; atorvastatin  20  mg ; metoprolol tartrate  50  mg ; amlodipine  10  mg ; heparin  5000  unit ; aspirin  81  mg ; bag  500  ml ; sodium chloride 3% (hypertonic)  500  ml ; etomidate  8  mg ; succinylcholine  60  mg ; propofol  1000  mg ; propofol  200  mg ; sterile water  100  ml ; sterile water  150  ml ; sterile water  200  ml ; potassium chloride  80  meq ; iso-osmotic sodium chloride  50  ml ; famotidine  20  mg ; 
 
asian f 88 $nan$hematology blood hematocrit  37.0  %; hematology blood hemoglobin  12.1  g dl; hematology blood platelet count  183  k ul; chemistry blood anion gap  10  meq l; chemistry blood bicarbonate  24  meq l; chemistry blood chloride  120  meq l; chemistry blood chloride  125  meq l; chemistry blood chloride  126  meq l; chemistry blood chloride  130  meq l; chemistry blood creatinine  0.7  mg dl; chemistry blood potassium  3.8  meq l; chemistry blood potassium  3.5  meq l; chemistry blood potassium  3.5  meq l; chemistry blood potassium  3.9  meq l; chemistry blood sodium  150  meq l; chemistry blood sodium  156  meq l; chemistry blood sodium  158  meq l; chemistry blood sodium  159  meq l; chemistry blood urea nitrogen  34  mg dl; chemistry blood calcium, total  8.3  mg dl; chemistry blood glucose  159  mg dl$dextrose 50%  12.5  gm ; glucagon  1  mg ; glucose gel  15  g ; acetaminophen  325-650  mg ; bisacodyl  10  mg ; vitamin d  2000  unit ; atorvastatin  20  mg ; metoprolol tartrate  50  mg ; amlodipine  10  mg ; propofol  1000  mg ; propofol  200  mg ; sterile water  100  ml ; sterile water  150  ml ; sterile water  200  ml ; potassium chloride  80  meq ; iso-osmotic sodium chloride  50  ml ; famotidine  20  mg ; 0.9% sodium chloride  250  ml ; nicardipine iv  50  mg ; 
 
asian f 88 $nan$hematology blood hematocrit  41.4  %; hematology blood hematocrit  40.9  %; hematology blood hemoglobin  13.5  g dl; hematology blood hemoglobin  13.3  g dl; hematology blood platelet count  232  k ul; hematology blood platelet count  247  k ul; chemistry blood anion gap  16  meq l; chemistry blood anion gap  13  meq l; chemistry blood bicarbonate  20  meq l; chemistry blood bicarbonate  23  meq l; chemistry blood chloride  127  meq l; chemistry blood chloride  124  meq l; chemistry blood chloride  124  meq l; chemistry blood chloride  124  meq l; chemistry blood creatinine  0.8  mg dl; chemistry blood creatinine  0.6  mg dl; chemistry blood potassium  3.4  meq l; chemistry blood potassium  4.1  meq l; chemistry blood potassium  3.6  meq l; chemistry blood potassium  3.7  meq l; chemistry blood sodium  157  meq l; chemistry blood sodium  156  meq l; chemistry blood sodium  156  meq l; chemistry blood sodium  156  meq l; chemistry blood sodium  157  meq l; chemistry blood urea nitrogen  40  mg dl; chemistry blood urea nitrogen  48  mg dl; chemistry blood calcium, total  8.3  mg dl; chemistry blood calcium, total  7.9  mg dl; chemistry blood glucose  219  mg dl; chemistry blood glucose  181  mg dl$dextrose 50%  12.5  gm ; glucagon  1  mg ; glucose gel  15  g ; acetaminophen  325-650  mg ; bisacodyl  10  mg ; vitamin d  2000  unit ; atorvastatin  20  mg ; metoprolol tartrate  50  mg ; amlodipine  10  mg ; propofol  1000  mg ; propofol  200  mg ; sterile water  100  ml ; sterile water  150  ml ; sterile water  200  ml ; potassium chloride  80  meq ; iso-osmotic sodium chloride  50  ml ; famotidine  20  mg ; 0.9% sodium chloride  250  ml ; nicardipine iv  50  mg ; dextromethorphan poly complex  30  mg ; chlorhexidine gluconate 0.12% oral rinse  15  ml ; 
 
asian f 88 $nan$hematology blood hematocrit  37.7  %; hematology blood hemoglobin  12.2  g dl; hematology blood platelet count  197  k ul; chemistry blood anion gap  11  meq l; chemistry blood bicarbonate  22  meq l; chemistry blood chloride  127  meq l; chemistry blood chloride  125  meq l; chemistry blood chloride  124  meq l; chemistry blood chloride  128  meq l; chemistry blood creatinine  0.7  mg dl; chemistry blood potassium  4.1  meq l; chemistry blood potassium  3.7  meq l; chemistry blood potassium  4.7  meq l; chemistry blood potassium  3.9  meq l; chemistry blood sodium  158  meq l; chemistry blood sodium  155  meq l; chemistry blood sodium  155  meq l; chemistry blood sodium  157  meq l; chemistry blood urea nitrogen  50  mg dl; chemistry blood calcium, total  7.6  mg dl; chemistry blood glucose  139  mg dl; blood gas blood glucose  166  mg dl; blood gas blood glucose  179  mg dl$dextrose 50%  12.5  gm ; glucagon  1  mg ; glucose gel  15  g ; acetaminophen  325-650  mg ; bisacodyl  10  mg ; vitamin d  2000  unit ; atorvastatin  20  mg ; metoprolol tartrate  50  mg ; amlodipine  10  mg ; sterile water  100  ml ; sterile water  150  ml ; sterile water  200  ml ; potassium chloride  80  meq ; iso-osmotic sodium chloride  50  ml ; famotidine  20  mg ; 0.9% sodium chloride  250  ml ; nicardipine iv  50  mg ; chlorhexidine gluconate 0.12% oral rinse  15  ml ; senna  10  ml ; senna  2  tab ; docusate sodium (liquid)  100  mg ; polyethylene glycol  17  g ; sodium chloride 0.9%  flush  10  ml ; 
 
asian f 88 $nan$chemistry blood chloride  125  meq l; chemistry blood chloride  125  meq l; chemistry blood potassium  3.8  meq l; chemistry blood potassium  3.8  meq l; chemistry blood sodium  155  meq l; chemistry blood sodium  157  meq l$dextrose 50%  12.5  gm ; glucagon  1  mg ; glucose gel  15  g ; acetaminophen  325-650  mg ; vitamin d  2000  unit ; atorvastatin  20  mg ; metoprolol tartrate  50  mg ; amlodipine  10  mg ; sterile water  100  ml ; sterile water  150  ml ; sterile water  200  ml ; potassium chloride  80  meq ; iso-osmotic sodium chloride  50  ml ; famotidine  20  mg ; 0.9% sodium chloride  250  ml ; nicardipine iv  50  mg ; chlorhexidine gluconate 0.12% oral rinse  15  ml ; docusate sodium (liquid)  100  mg ; sodium chloride 0.9%  flush  10  ml ; sulfameth trimethoprim suspension  20  ml ; 
 
asian f 88 $nan$hematology blood hematocrit  38.8  %; hematology blood hemoglobin  13.0  g dl; hematology blood platelet count  212  k ul; chemistry blood anion gap  12  meq l; chemistry blood bicarbonate  23  meq l; chemistry blood chloride  125  meq l; chemistry blood creatinine  0.7  mg dl; chemistry blood potassium  3.6  meq l; chemistry blood sodium  156  meq l; chemistry blood urea nitrogen  52  mg dl; chemistry blood calcium, total  8.3  mg dl; chemistry blood glucose  225  mg dl$dextrose 50%  12.5  gm ; glucagon  1  mg ; glucose gel  15  g ; acetaminophen  325-650  mg ; vitamin d  2000  unit ; atorvastatin  20  mg ; metoprolol tartrate  50  mg ; amlodipine  10  mg ; sterile water  100  ml ; sterile water  150  ml ; sterile water  200  ml ; potassium chloride  80  meq ; 0.9% sodium chloride  250  ml ; nicardipine iv  50  mg ; chlorhexidine gluconate 0.12% oral rinse  15  ml ; docusate sodium (liquid)  100  mg ; sodium chloride 0.9%  flush  10  ml ; sulfameth trimethoprim suspension  20  ml ; 
 
asian f 88 $nan$hematology blood hematocrit  38.7  %; hematology blood hematocrit  38.5  %; hematology blood hemoglobin  12.7  g dl; hematology blood hemoglobin  12.7  g dl; hematology blood platelet count  205  k ul; hematology blood platelet count  219  k ul; chemistry blood anion gap  12  meq l; chemistry blood anion gap  7  meq l; chemistry blood bicarbonate  22  meq l; chemistry blood bicarbonate  29  meq l; chemistry blood chloride  118  meq l; chemistry blood chloride  125  meq l; chemistry blood creatinine  0.7  mg dl; chemistry blood creatinine  0.5  mg dl; chemistry blood potassium  3.6  meq l; chemistry blood potassium  3.3  meq l; chemistry blood sodium  151  meq l; chemistry blood sodium  155  meq l; chemistry blood urea nitrogen  42  mg dl; chemistry blood urea nitrogen  30  mg dl; chemistry blood calcium, total  8.1  mg dl; chemistry blood calcium, total  7.9  mg dl; chemistry blood glucose  123  mg dl; chemistry blood glucose  262  mg dl$dextrose 50%  12.5  gm ; glucagon  1  mg ; glucose gel  15  g ; acetaminophen  325-650  mg ; vitamin d  2000  unit ; atorvastatin  20  mg ; metoprolol tartrate  50  mg ; amlodipine  10  mg ; sterile water  100  ml ; sterile water  150  ml ; sterile water  200  ml ; potassium chloride  80  meq ; 0.9% sodium chloride  250  ml ; nicardipine iv  50  mg ; chlorhexidine gluconate 0.12% oral rinse  15  ml ; docusate sodium (liquid)  100  mg ; sodium chloride 0.9%  flush  10  ml ; sulfameth trimethoprim suspension  20  ml ; 
 
asian f 88 $nan$nan$dextrose 50%  12.5  gm ; glucagon  1  mg ; glucose gel  15  g ; acetaminophen  325-650  mg ; vitamin d  2000  unit ; atorvastatin  20  mg ; sterile water  100  ml ; sterile water  150  ml ; sterile water  200  ml ; potassium chloride  80  meq ; 0.9% sodium chloride  250  ml ; nicardipine iv  50  mg ; chlorhexidine gluconate 0.12% oral rinse  15  ml ; docusate sodium (liquid)  100  mg ; sodium chloride 0.9%  flush  10  ml ; sulfameth trimethoprim suspension  20  ml ; heparin flush (10 units ml)  1  ml ; 
 
asian f 88 $nan$hematology blood hematocrit  36.5  %; hematology blood hemoglobin  12.4  g dl; hematology blood platelet count  207  k ul; chemistry blood anion gap  11  meq l; chemistry blood bicarbonate  30  meq l; chemistry blood chloride  111  meq l; chemistry blood creatinine  0.5  mg dl; chemistry blood potassium  3.9  meq l; chemistry blood sodium  148  meq l; chemistry blood urea nitrogen  30  mg dl; chemistry blood calcium, total  7.8  mg dl; chemistry blood glucose  248  mg dl; blood gas blood lactate  1.5  mmol l$dextrose 50%  12.5  gm ; glucagon  1  mg ; glucose gel  15  g ; acetaminophen  325-650  mg ; vitamin d  2000  unit ; atorvastatin  20  mg ; sterile water  100  ml ; sterile water  150  ml ; sterile water  200  ml ; potassium chloride  80  meq ; 0.9% sodium chloride  250  ml ; nicardipine iv  50  mg ; chlorhexidine gluconate 0.12% oral rinse  15  ml ; docusate sodium (liquid)  100  mg ; sodium chloride 0.9%  flush  10  ml ; sulfameth trimethoprim suspension  20  ml ; heparin flush (10 units ml)  1  ml ; iso-osmotic dextrose  200  ml ; vancomycin  1000  mg ; iso-osmotic dextrose  100  ml ; piperacillin-tazobactam  4.5  g ; 
 
asian f 88 $nan$hematology blood hematocrit  37.0  %; hematology blood hemoglobin  12.8  g dl; hematology blood platelet count  221  k ul; chemistry blood anion gap  8  meq l; chemistry blood bicarbonate  32  meq l; chemistry blood chloride  106  meq l; chemistry blood creatinine  0.6  mg dl; chemistry blood potassium  3.3  meq l; chemistry blood sodium  143  meq l; chemistry blood urea nitrogen  27  mg dl; chemistry blood glucose  342  mg dl$dextrose 50%  12.5  gm ; glucagon  1  mg ; glucose gel  15  g ; acetaminophen  325-650  mg ; vitamin d  2000  unit ; atorvastatin  20  mg ; chlorhexidine gluconate 0.12% oral rinse  15  ml ; docusate sodium (liquid)  100  mg ; sodium chloride 0.9%  flush  10  ml ; heparin flush (10 units ml)  1  ml ; iso-osmotic dextrose  200  ml ; vancomycin  1000  mg ; iso-osmotic dextrose  100  ml ; piperacillin-tazobactam  4.5  g ; 
 
asian f 88 $nan$hematology blood hematocrit  32.5  %; hematology blood hematocrit  34.1  %; hematology blood hematocrit  35.1  %; hematology blood hemoglobin  11.4  g dl; hematology blood hemoglobin  12.0  g dl; hematology blood hemoglobin  12.0  g dl; hematology blood platelet count  207  k ul; hematology blood platelet count  198  k ul; hematology blood platelet count  216  k ul; chemistry blood anion gap  9  meq l; chemistry blood anion gap  8  meq l; chemistry blood bicarbonate  30  meq l; chemistry blood bicarbonate  29  meq l; chemistry blood chloride  107  meq l; chemistry blood chloride  107  meq l; chemistry blood creatinine  0.7  mg dl; chemistry blood creatinine  0.7  mg dl; chemistry blood potassium  3.0  meq l; chemistry blood potassium  4.1  meq l; chemistry blood sodium  143  meq l; chemistry blood sodium  140  meq l; chemistry blood urea nitrogen  29  mg dl; chemistry blood urea nitrogen  28  mg dl; hematology blood inr(pt)  1.1  ; chemistry blood calcium, total  8.0  mg dl; chemistry blood bilirubin, total  0.4  mg dl; chemistry blood glucose  260  mg dl; chemistry blood glucose  260  mg dl; chemistry blood lactate dehydrogenase (ld)  472  iu l$dextrose 50%  12.5  gm ; glucagon  1  mg ; glucose gel  15  g ; acetaminophen  325-650  mg ; vitamin d  2000  unit ; atorvastatin  20  mg ; chlorhexidine gluconate 0.12% oral rinse  15  ml ; docusate sodium (liquid)  100  mg ; sodium chloride 0.9%  flush  10  ml ; heparin flush (10 units ml)  1  ml ; iso-osmotic dextrose  200  ml ; vancomycin  1000  mg ; scopolamine patch  1  ptch ; glycopyrrolate  0.2  mg ; glycopyrrolate  1  mg ; insulin  2  unit ; 
 
asian f 88 $nan$hematology blood hematocrit  33.4  %; hematology blood hemoglobin  11.4  g dl; hematology blood platelet count  210  k ul; chemistry blood anion gap  9  meq l; chemistry blood bicarbonate  30  meq l; chemistry blood chloride  105  meq l; chemistry blood creatinine  0.7  mg dl; chemistry blood potassium  4.1  meq l; chemistry blood sodium  140  meq l; chemistry blood urea nitrogen  25  mg dl; hematology blood inr(pt)  1.0  ; chemistry blood calcium, total  7.9  mg dl; chemistry blood glucose  257  mg dl$dextrose 50%  12.5  gm ; glucagon  1  mg ; glucose gel  15  g ; acetaminophen  325-650  mg ; vitamin d  2000  unit ; atorvastatin  20  mg ; chlorhexidine gluconate 0.12% oral rinse  15  ml ; docusate sodium (liquid)  100  mg ; sodium chloride 0.9%  flush  10  ml ; heparin flush (10 units ml)  1  ml ; iso-osmotic dextrose  200  ml ; vancomycin  1000  mg ; glycopyrrolate  1  mg ; insulin  2  unit ; insulin  4  unit ; 
 
asian f 88 $nan$hematology blood hematocrit  32.1  %; hematology blood hemoglobin  11.2  g dl; hematology blood platelet count  219  k ul; chemistry blood anion gap  12  meq l; chemistry blood bicarbonate  28  meq l; chemistry blood chloride  103  meq l; chemistry blood creatinine  0.9  mg dl; chemistry blood potassium  3.7  meq l; chemistry blood sodium  139  meq l; chemistry blood urea nitrogen  25  mg dl; chemistry blood calcium, total  7.8  mg dl; chemistry blood glucose  324  mg dl$dextrose 50%  12.5  gm ; glucagon  1  mg ; glucose gel  15  g ; acetaminophen  325-650  mg ; vitamin d  2000  unit ; atorvastatin  20  mg ; chlorhexidine gluconate 0.12% oral rinse  15  ml ; docusate sodium (liquid)  100  mg ; sodium chloride 0.9%  flush  10  ml ; heparin flush (10 units ml)  1  ml ; glycopyrrolate  1  mg ; insulin  4  unit ; insulin  6  unit ; insulin  15  unit ; 
 
asian f 88 $nan$hematology blood hematocrit  32.5  %; hematology blood hemoglobin  11.3  g dl; hematology blood platelet count  242  k ul; chemistry blood anion gap  8  meq l; chemistry blood anion gap  11  meq l; chemistry blood anion gap  14  meq l; chemistry blood bicarbonate  31  meq l; chemistry blood bicarbonate  29  meq l; chemistry blood bicarbonate  29  meq l; chemistry blood chloride  105  meq l; chemistry blood chloride  104  meq l; chemistry blood chloride  103  meq l; chemistry blood creatinine  0.8  mg dl; chemistry blood creatinine  0.8  mg dl; chemistry blood creatinine  0.8  mg dl; chemistry blood potassium  3.2  meq l; chemistry blood potassium  4.6  meq l; chemistry blood potassium  3.7  meq l; chemistry blood sodium  141  meq l; chemistry blood sodium  139  meq l; chemistry blood sodium  142  meq l; chemistry blood urea nitrogen  26  mg dl; chemistry blood urea nitrogen  25  mg dl; chemistry blood urea nitrogen  24  mg dl; chemistry blood calcium, total  7.8  mg dl; chemistry blood glucose  332  mg dl; chemistry blood glucose  243  mg dl; chemistry blood glucose  222  mg dl$dextrose 50%  12.5  gm ; glucagon  1  mg ; glucose gel  15  g ; acetaminophen  325-650  mg ; vitamin d  2000  unit ; atorvastatin  20  mg ; chlorhexidine gluconate 0.12% oral rinse  15  ml ; docusate sodium (liquid)  100  mg ; sodium chloride 0.9%  flush  10  ml ; heparin flush (10 units ml)  1  ml ; glycopyrrolate  1  mg ; insulin  15  unit ; potassium chloride (powder)  80  meq ; furosemide  10  mg ; soln.  500  ml ; mannitol 20 %  50  g ; insulin  10  unit ; insulin  30  unit ; insulin  20  unit ; 
 
asian f 88 $nan$hematology blood hematocrit  34.4  %; hematology blood hemoglobin  12.0  g dl; hematology blood platelet count  271  k ul; chemistry blood anion gap  14  meq l; chemistry blood bicarbonate  29  meq l; chemistry blood chloride  102  meq l; chemistry blood chloride  99  meq l; chemistry blood creatinine  0.8  mg dl; chemistry blood potassium  3.5  meq l; chemistry blood potassium  3.7  meq l; chemistry blood sodium  141  meq l; chemistry blood sodium  140  meq l; chemistry blood urea nitrogen  24  mg dl; chemistry blood calcium, total  8.4  mg dl; chemistry blood glucose  203  mg dl$dextrose 50%  12.5  gm ; glucagon  1  mg ; glucose gel  15  g ; acetaminophen  325-650  mg ; vitamin d  2000  unit ; atorvastatin  20  mg ; docusate sodium (liquid)  100  mg ; sodium chloride 0.9%  flush  10  ml ; heparin flush (10 units ml)  1  ml ; glycopyrrolate  1  mg ; potassium chloride (powder)  80  meq ; furosemide  10  mg ; soln.  500  ml ; mannitol 20 %  50  g ; insulin  20  unit ; morphine sulfate  2-4  mg ; morphine sulfate (concentrated oral soln)  10-20  mg ; morphine sulfate (concentrated oral soln)  5-10  mg ; haloperidol  0.5  mg ; acetaminophen  650  mg ; insulin  25  unit ; 
 
asian f 88 $nan$nan$glycopyrrolate  1  mg ; morphine sulfate  2-4  mg ; morphine sulfate (concentrated oral soln)  5-10  mg ; haloperidol  0.5  mg ; acetaminophen  650  mg ; 
 
asian f 88 $nan$nan$glycopyrrolate  1  mg ; morphine sulfate  2-4  mg ; morphine sulfate (concentrated oral soln)  5-10  mg ; haloperidol  0.5  mg ; acetaminophen  650  mg ; 
 
asian f 88 $nan$nan$glycopyrrolate  1  mg ; morphine sulfate  2-4  mg ; morphine sulfate (concentrated oral soln)  5-10  mg ; haloperidol  0.5  mg ; acetaminophen  650  mg ; morphine sulfate (concentrated oral soln)  5-15  mg ; morphine sulfate (concentrated oral soln)  5  mg ; 
 
asian f 88 $nan$nan$glycopyrrolate  1  mg ; morphine sulfate  2-4  mg ; haloperidol  0.5  mg ; morphine sulfate (concentrated oral soln)  5-15  mg ; morphine sulfate (concentrated oral soln)  5  mg ; acetaminophen  1000  mg ; 
 
asian f 88 $nan$nan$glycopyrrolate  1  mg ; morphine sulfate  2-4  mg ; haloperidol  0.5  mg ; morphine sulfate (concentrated oral soln)  5-15  mg ; 
 
asian f 88 $nan$nan$glycopyrrolate  1  mg ; morphine sulfate  2-4  mg ; haloperidol  0.5  mg ; morphine sulfate (concentrated oral soln)  5-15  mg ; 
 
black african american f 89 $nan$hematology blood hematocrit  40.0  %; hematology blood hemoglobin  13.1  g dl; hematology blood platelet count  185  k ul; chemistry blood anion gap  14  meq l; chemistry blood bicarbonate  26  meq l; chemistry blood chloride  100  meq l; chemistry blood creatinine  1.1  mg dl; chemistry blood potassium  4.0  meq l; chemistry blood sodium  140  meq l; chemistry blood urea nitrogen  16  mg dl; chemistry blood calcium, total  9.9  mg dl; chemistry blood glucose  330  mg dl; chemistry blood % hemoglobin a1c  11.3  %$influenza vaccine quadrivalent  0.5  ml ; sodium chloride 0.9%  flush  3-10  ml ; bisacodyl  10  mg ; senna  8.6  mg ; acetaminophen  650  mg ; heparin  5000  unit ; aspirin  81  mg ; atorvastatin  40  mg ; hydralazine  10  mg ; lorazepam  0.5  mg ; levothyroxine sodium  100  mcg ; torsemide  20  mg ; metoprolol tartrate  12.5  mg ; insulin  20  unit ; 
morbid obesity long-term (current) use of insulin unspecified acquired hypothyroidism asthma, unspecified type, with (acute) exacerbation chronic diastolic heart failure congestive heart failure, unspecified diabetes mellitus without mention of complication, type ii or unspecified type, not stated as uncontrolled long-term (current) use of steroids background diabetic retinopathy unspecified acquired hypothyroidism gout, unspecified restless legs syndrome (rls) chest pain, unspecified diabetes with ophthalmic manifestations, type ii or unspecified type, not stated as uncontrolled dehydration chronic diastolic heart failure polyneuropathy in diabetes asthma, unspecified type, unspecified pure hypercholesterolemia nausea with vomiting diabetes with neurological manifestations, type ii or unspecified type, not stated as uncontrolled acute kidney failure, unspecified unspecified essential hypertension 
black african american f 89 $nan$hematology blood hematocrit  39.8  %; hematology blood hemoglobin  13.0  g dl; hematology blood platelet count  185  k ul; chemistry blood anion gap  15  meq l; chemistry blood bicarbonate  28  meq l; chemistry blood chloride  101  meq l; chemistry blood creatinine  1.1  mg dl; chemistry blood potassium  3.6  meq l; chemistry blood sodium  144  meq l; chemistry blood urea nitrogen  19  mg dl; chemistry blood calcium, total  9.9  mg dl; chemistry blood glucose  148  mg dl$sodium chloride 0.9%  flush  3-10  ml ; bisacodyl  10  mg ; senna  8.6  mg ; acetaminophen  650  mg ; heparin  5000  unit ; aspirin  81  mg ; atorvastatin  40  mg ; hydralazine  10  mg ; lorazepam  0.5  mg ; levothyroxine sodium  100  mcg ; torsemide  20  mg ; metoprolol tartrate  12.5  mg ; insulin  20  unit ; dextrose 50%  12.5  gm ; glucagon  1  mg ; glucose gel  15  g ; insulin  4  unit ; insulin  0  unit ; insulin  8  unit ; bag  1  bag ; magnesium sulfate  2  gm ; atorvastatin  80  mg ; 
morbid obesity long-term (current) use of insulin unspecified acquired hypothyroidism asthma, unspecified type, with (acute) exacerbation chronic diastolic heart failure congestive heart failure, unspecified diabetes mellitus without mention of complication, type ii or unspecified type, not stated as uncontrolled long-term (current) use of steroids background diabetic retinopathy unspecified acquired hypothyroidism gout, unspecified restless legs syndrome (rls) chest pain, unspecified diabetes with ophthalmic manifestations, type ii or unspecified type, not stated as uncontrolled dehydration chronic diastolic heart failure polyneuropathy in diabetes asthma, unspecified type, unspecified pure hypercholesterolemia nausea with vomiting diabetes with neurological manifestations, type ii or unspecified type, not stated as uncontrolled acute kidney failure, unspecified unspecified essential hypertension 
black african american f 89 $nan$nan$sodium chloride 0.9%  flush  3-10  ml ; bisacodyl  10  mg ; senna  8.6  mg ; acetaminophen  650  mg ; heparin  5000  unit ; aspirin  81  mg ; hydralazine  10  mg ; lorazepam  0.5  mg ; levothyroxine sodium  100  mcg ; torsemide  20  mg ; metoprolol tartrate  12.5  mg ; insulin  20  unit ; dextrose 50%  12.5  gm ; glucagon  1  mg ; glucose gel  15  g ; insulin  0  unit ; bag  1  bag ; magnesium sulfate  2  gm ; atorvastatin  80  mg ; 
morbid obesity long-term (current) use of insulin unspecified acquired hypothyroidism asthma, unspecified type, with (acute) exacerbation chronic diastolic heart failure congestive heart failure, unspecified diabetes mellitus without mention of complication, type ii or unspecified type, not stated as uncontrolled long-term (current) use of steroids background diabetic retinopathy unspecified acquired hypothyroidism gout, unspecified restless legs syndrome (rls) chest pain, unspecified diabetes with ophthalmic manifestations, type ii or unspecified type, not stated as uncontrolled dehydration chronic diastolic heart failure polyneuropathy in diabetes asthma, unspecified type, unspecified pure hypercholesterolemia nausea with vomiting diabetes with neurological manifestations, type ii or unspecified type, not stated as uncontrolled acute kidney failure, unspecified unspecified essential hypertension 
black african american f 89 $nan$hematology blood hematocrit  43.3  %; hematology blood hemoglobin  14.0  g dl; hematology blood platelet count  226  k ul; chemistry blood anion gap  14  meq l; chemistry blood bicarbonate  30  meq l; chemistry blood chloride  100  meq l; chemistry blood creatinine  1.2  mg dl; chemistry blood potassium  3.4  meq l; chemistry blood sodium  144  meq l; chemistry blood urea nitrogen  18  mg dl; chemistry blood calcium, total  9.5  mg dl; chemistry blood glucose  215  mg dl$sodium chloride 0.9%  flush  3-10  ml ; bisacodyl  10  mg ; senna  8.6  mg ; acetaminophen  650  mg ; heparin  5000  unit ; aspirin  81  mg ; hydralazine  10  mg ; lorazepam  0.5  mg ; levothyroxine sodium  100  mcg ; torsemide  20  mg ; metoprolol tartrate  12.5  mg ; dextrose 50%  12.5  gm ; glucagon  1  mg ; glucose gel  15  g ; atorvastatin  80  mg ; 
morbid obesity long-term (current) use of insulin unspecified acquired hypothyroidism asthma, unspecified type, with (acute) exacerbation chronic diastolic heart failure congestive heart failure, unspecified diabetes mellitus without mention of complication, type ii or unspecified type, not stated as uncontrolled long-term (current) use of steroids background diabetic retinopathy unspecified acquired hypothyroidism gout, unspecified restless legs syndrome (rls) chest pain, unspecified diabetes with ophthalmic manifestations, type ii or unspecified type, not stated as uncontrolled dehydration chronic diastolic heart failure polyneuropathy in diabetes asthma, unspecified type, unspecified pure hypercholesterolemia nausea with vomiting diabetes with neurological manifestations, type ii or unspecified type, not stated as uncontrolled acute kidney failure, unspecified unspecified essential hypertension 
white f 44 $temp  98.3  heartrate  56.0  resprate  16.0  o2sat  99.0  sbp  117.0  dbp  73.0  rhythm    pain    ; temp  98.3  heartrate  58.0  resprate  16.0  o2sat  99.0  sbp  127.0  dbp  76.0  rhythm    pain  0  $nan$sodium chloride 0.9%  flush  3  ml ; 0.9% sodium chloride  1000  ml ; acetaminophen-caff-butalbital  2  tab ; gabapentin  600  mg ; ondansetron  4  mg ; heparin  5000  unit ; bupropion (sustained release)  150  mg ; fluticasone propionate 110mcg  2  puff ; topiramate (topamax)  100  mg ; fluoxetine  20  mg ; ketorolac  15  mg ; methylprednisolone  4  mg ; multivitamins w minerals  1  tab ; hydromorphone (dilaudid)  0.5  mg ; neutra-phos  1  pkt ; sumatriptan succinate  6  mg ; ketorolac  30  mg ; nadolol  40  mg ; hydromorphone (dilaudid)  2-4  mg ; 
chest pain, unspecified dehydration depressive disorder, not elsewhere classified migraine without aura, without mention of intractable migraine without mention of status migrainosus syncope and collapse tension headache variants of migraine, not elsewhere classified, without mention of intractable migraine without mention of status migrainosus 
white f 44 $nan$hematology blood hematocrit  36.5  %; hematology blood hematocrit  36.7  %; hematology blood hemoglobin  11.5  g dl; hematology blood hemoglobin  12.1  g dl; hematology blood platelet count  167  k ul; hematology blood platelet count  183  k ul; chemistry blood anion gap  11  meq l; chemistry blood anion gap  13  meq l; chemistry blood bicarbonate  24  meq l; chemistry blood bicarbonate  23  meq l; chemistry blood chloride  114  meq l; chemistry blood chloride  111  meq l; chemistry blood creatinine  0.7  mg dl; chemistry blood creatinine  0.8  mg dl; chemistry blood potassium  3.5  meq l; chemistry blood potassium  3.8  meq l; chemistry blood sodium  145  meq l; chemistry blood sodium  143  meq l; chemistry blood urea nitrogen  14  mg dl; chemistry blood urea nitrogen  15  mg dl; chemistry blood calcium, total  8.3  mg dl; chemistry blood bilirubin, total  0.1  mg dl; chemistry blood glucose  98  mg dl; chemistry blood glucose  93  mg dl$sodium chloride 0.9%  flush  3  ml ; gabapentin  600  mg ; ondansetron  4  mg ; heparin  5000  unit ; bupropion (sustained release)  150  mg ; topiramate (topamax)  100  mg ; fluoxetine  20  mg ; ketorolac  15  mg ; methylprednisolone  4  mg ; multivitamins w minerals  1  tab ; hydromorphone (dilaudid)  0.5  mg ; neutra-phos  1  pkt ; nadolol  40  mg ; hydromorphone (dilaudid)  2-4  mg ; acetaminophen-caff-butalbital  1  tab ; bupivacaine 0.25%  10-15  ml ; lorazepam  1  mg ; 
chest pain, unspecified dehydration depressive disorder, not elsewhere classified migraine without aura, without mention of intractable migraine without mention of status migrainosus syncope and collapse tension headache variants of migraine, not elsewhere classified, without mention of intractable migraine without mention of status migrainosus 
white f 44 $nan$nan$sodium chloride 0.9%  flush  3  ml ; gabapentin  600  mg ; ondansetron  4  mg ; heparin  5000  unit ; bupropion (sustained release)  150  mg ; topiramate (topamax)  100  mg ; fluoxetine  20  mg ; ketorolac  15  mg ; methylprednisolone  4  mg ; multivitamins w minerals  1  tab ; nadolol  40  mg ; acetaminophen-caff-butalbital  1  tab ; bupivacaine 0.25%  10-15  ml ; lorazepam  1  mg ; ibuprofen  400  mg ; acetaminophen-caff-butalbital  1-2  tab ; 
chest pain, unspecified dehydration depressive disorder, not elsewhere classified migraine without aura, without mention of intractable migraine without mention of status migrainosus syncope and collapse tension headache variants of migraine, not elsewhere classified, without mention of intractable migraine without mention of status migrainosus 
white f 44 $nan$nan$sodium chloride 0.9%  flush  3  ml ; gabapentin  600  mg ; ondansetron  4  mg ; heparin  5000  unit ; bupropion (sustained release)  150  mg ; topiramate (topamax)  100  mg ; fluoxetine  20  mg ; methylprednisolone  4  mg ; multivitamins w minerals  1  tab ; nadolol  40  mg ; lorazepam  1  mg ; ibuprofen  400  mg ; acetaminophen-caff-butalbital  1-2  tab ; zolpidem tartrate  5  mg ; 
chest pain, unspecified dehydration depressive disorder, not elsewhere classified migraine without aura, without mention of intractable migraine without mention of status migrainosus syncope and collapse tension headache variants of migraine, not elsewhere classified, without mention of intractable migraine without mention of status migrainosus 
white f 44 $nan$chemistry blood creatinine  0.7  mg dl; chemistry blood urea nitrogen  23  mg dl$sodium chloride 0.9%  flush  3  ml ; gabapentin  600  mg ; ondansetron  4  mg ; heparin  5000  unit ; bupropion (sustained release)  150  mg ; topiramate (topamax)  100  mg ; fluoxetine  20  mg ; multivitamins w minerals  1  tab ; nadolol  40  mg ; lorazepam  1  mg ; ibuprofen  400  mg ; acetaminophen-caff-butalbital  1-2  tab ; zolpidem tartrate  5  mg ; 
chest pain, unspecified dehydration depressive disorder, not elsewhere classified migraine without aura, without mention of intractable migraine without mention of status migrainosus syncope and collapse tension headache variants of migraine, not elsewhere classified, without mention of intractable migraine without mention of status migrainosus 
white f 44 $nan$nan$sodium chloride 0.9%  flush  3  ml ; gabapentin  600  mg ; ondansetron  4  mg ; heparin  5000  unit ; bupropion (sustained release)  150  mg ; topiramate (topamax)  100  mg ; fluoxetine  20  mg ; multivitamins w minerals  1  tab ; nadolol  40  mg ; lorazepam  1  mg ; ibuprofen  400  mg ; acetaminophen-caff-butalbital  1-2  tab ; zolpidem tartrate  5  mg ; 5% dextrose  100  ml ; acyclovir  600  mg ; 
chest pain, unspecified dehydration depressive disorder, not elsewhere classified migraine without aura, without mention of intractable migraine without mention of status migrainosus syncope and collapse tension headache variants of migraine, not elsewhere classified, without mention of intractable migraine without mention of status migrainosus 
white f 44 $nan$hematology blood hematocrit  40.7  %; hematology blood hemoglobin  12.7  g dl; hematology blood platelet count  186  k ul; chemistry blood anion gap  12  meq l; chemistry blood bicarbonate  26  meq l; chemistry blood chloride  106  meq l; chemistry blood creatinine  0.7  mg dl; chemistry blood potassium  4.3  meq l; chemistry blood sodium  140  meq l; chemistry blood urea nitrogen  25  mg dl; chemistry blood glucose  96  mg dl$sodium chloride 0.9%  flush  3  ml ; gabapentin  600  mg ; ondansetron  4  mg ; heparin  5000  unit ; bupropion (sustained release)  150  mg ; topiramate (topamax)  100  mg ; fluoxetine  20  mg ; multivitamins w minerals  1  tab ; nadolol  40  mg ; lorazepam  1  mg ; ibuprofen  400  mg ; acetaminophen-caff-butalbital  1-2  tab ; zolpidem tartrate  5  mg ; 5% dextrose  100  ml ; acyclovir  600  mg ; lidocaine 1%  10  ml ; 
chest pain, unspecified dehydration depressive disorder, not elsewhere classified migraine without aura, without mention of intractable migraine without mention of status migrainosus syncope and collapse tension headache variants of migraine, not elsewhere classified, without mention of intractable migraine without mention of status migrainosus 
white f 44 $nan$hematology blood hematocrit  38.5  %; hematology blood hemoglobin  12.5  g dl; hematology blood platelet count  175  k ul; chemistry blood anion gap  16  meq l; chemistry blood bicarbonate  27  meq l; chemistry blood chloride  105  meq l; chemistry blood creatinine  0.9  mg dl; chemistry blood potassium  4.1  meq l; chemistry blood sodium  144  meq l; chemistry blood urea nitrogen  26  mg dl; chemistry blood glucose  97  mg dl$sodium chloride 0.9%  flush  3  ml ; gabapentin  600  mg ; ondansetron  4  mg ; heparin  5000  unit ; bupropion (sustained release)  150  mg ; topiramate (topamax)  100  mg ; fluoxetine  20  mg ; multivitamins w minerals  1  tab ; nadolol  40  mg ; lorazepam  1  mg ; ibuprofen  400  mg ; acetaminophen-caff-butalbital  1-2  tab ; zolpidem tartrate  5  mg ; 5% dextrose  100  ml ; acyclovir  600  mg ; lidocaine 1%  10  ml ; 
chest pain, unspecified dehydration depressive disorder, not elsewhere classified migraine without aura, without mention of intractable migraine without mention of status migrainosus syncope and collapse tension headache variants of migraine, not elsewhere classified, without mention of intractable migraine without mention of status migrainosus 
white f 44 $nan$nan$sodium chloride 0.9%  flush  3  ml ; gabapentin  600  mg ; ondansetron  4  mg ; heparin  5000  unit ; bupropion (sustained release)  150  mg ; topiramate (topamax)  100  mg ; fluoxetine  20  mg ; multivitamins w minerals  1  tab ; nadolol  40  mg ; lorazepam  1  mg ; ibuprofen  400  mg ; acetaminophen-caff-butalbital  1-2  tab ; 
chest pain, unspecified dehydration depressive disorder, not elsewhere classified migraine without aura, without mention of intractable migraine without mention of status migrainosus syncope and collapse tension headache variants of migraine, not elsewhere classified, without mention of intractable migraine without mention of status migrainosus 
white f 44 $nan$nan$sodium chloride 0.9%  flush  3  ml ; gabapentin  600  mg ; ondansetron  4  mg ; heparin  5000  unit ; bupropion (sustained release)  150  mg ; topiramate (topamax)  100  mg ; fluoxetine  20  mg ; multivitamins w minerals  1  tab ; nadolol  40  mg ; lorazepam  1  mg ; ibuprofen  400  mg ; acetaminophen-caff-butalbital  1-2  tab ; 
chest pain, unspecified dehydration depressive disorder, not elsewhere classified migraine without aura, without mention of intractable migraine without mention of status migrainosus syncope and collapse tension headache variants of migraine, not elsewhere classified, without mention of intractable migraine without mention of status migrainosus 
white m 44 $nan$chemistry blood anion gap  12  meq l; chemistry blood bicarbonate  30  meq l; chemistry blood chloride  104  meq l; chemistry blood creatinine  0.9  mg dl; chemistry blood potassium  4.3  meq l; chemistry blood sodium  142  meq l; chemistry blood urea nitrogen  15  mg dl; hematology blood inr(pt)  1.1  ; chemistry blood calcium, total  9.3  mg dl; chemistry blood glucose  103  mg dl$sodium chloride 0.9%  flush  3  ml ; tizanidine  4  mg ; acetaminophen  650  mg ; dexamethasone  10  mg ; multivitamins  1  tab ; heparin  5000  unit ; 
 
white m 44 $nan$nan$sodium chloride 0.9%  flush  3  ml ; tizanidine  4  mg ; acetaminophen  650  mg ; multivitamins  1  tab ; heparin  5000  unit ; 
 
white m 56 $nan$hematology blood hematocrit  37.4  %; hematology blood hematocrit  33.5  %; hematology blood hemoglobin  12.6  g dl; hematology blood hemoglobin  11.5  g dl; hematology blood platelet count  306  k ul; hematology blood platelet count  180  k ul; chemistry blood anion gap  16  meq l; chemistry blood anion gap  11  meq l; chemistry blood bicarbonate  22  meq l; chemistry blood bicarbonate  28  meq l; chemistry blood chloride  107  meq l; chemistry blood chloride  106  meq l; chemistry blood creatinine  1.2  mg dl; chemistry blood creatinine  1.1  mg dl; chemistry blood potassium  4.7  meq l; chemistry blood potassium  4.1  meq l; chemistry blood sodium  140  meq l; chemistry blood sodium  141  meq l; chemistry blood urea nitrogen  23  mg dl; chemistry blood urea nitrogen  23  mg dl; hematology blood inr(pt)  1.2  ; hematology blood inr(pt)  1.3  ; chemistry blood glucose  153  mg dl; chemistry blood glucose  140  mg dl; blood gas blood free calcium  1.05  mmol l; blood gas blood free calcium  1.10  mmol l; blood gas blood free calcium  1.07  mmol l; blood gas blood free calcium  1.20  mmol l; blood gas blood free calcium  1.12  mmol l; blood gas blood lactate  1.7  mmol l; blood gas blood lactate  2.1  mmol l; blood gas blood lactate  2.3  mmol l; blood gas blood lactate  2.9  mmol l; blood gas blood lactate  3.2  mmol l; blood gas blood chloride, whole blood  105  meq l; blood gas blood chloride, whole blood  107  meq l; blood gas blood glucose  114  mg dl; blood gas blood glucose  111  mg dl; blood gas blood glucose  106  mg dl; blood gas blood glucose  126  mg dl; blood gas blood glucose  150  mg dl; blood gas blood hematocrit, calculated  42  %; blood gas blood hematocrit, calculated  44  %; blood gas blood hematocrit, calculated  41  %; blood gas blood hematocrit, calculated  38  %; blood gas blood hemoglobin  14.1  g dl; blood gas blood hemoglobin  14.5  g dl; blood gas blood hemoglobin  13.5  g dl; blood gas blood hemoglobin  12.5  g dl; blood gas blood potassium, whole blood  3.7  meq l; blood gas blood potassium, whole blood  4.7  meq l; blood gas blood sodium, whole blood  138  meq l; blood gas blood sodium, whole blood  138  meq l; blood gas blood calculated bicarbonate, whole blood  27  meq l$insulin  0  unit ; bupivacaine 0.1%  250  ml ; yellow cadd cassette  1  cadd ; fentanyl citrate  1000  mcg ; influenza virus vaccine  0.5  ml ; sodium chloride 0.9%  flush  10  ml ; dextrose 50%  12.5  gm ; glucagon  1  mg ; vial  1  vial ; pantoprazole  40  mg ; ondansetron  4  mg ; metoprolol tartrate  5  mg ; lactated ringers  1000  ml ; 
 
white m 56 $nan$nan$insulin  0  unit ; bupivacaine 0.1%  250  ml ; yellow cadd cassette  1  cadd ; fentanyl citrate  1000  mcg ; influenza virus vaccine  0.5  ml ; sodium chloride 0.9%  flush  10  ml ; dextrose 50%  12.5  gm ; glucagon  1  mg ; vial  1  vial ; pantoprazole  40  mg ; ondansetron  4  mg ; metoprolol tartrate  5  mg ; heparin  5000  unit ; heparin flush (10 units ml)  1  ml ; cepacol (menthol)  1  loz ; chloraseptic throat spray  1  spry ; 
 
white m 56 $nan$nan$insulin  0  unit ; bupivacaine 0.1%  250  ml ; yellow cadd cassette  1  cadd ; fentanyl citrate  1000  mcg ; influenza virus vaccine  0.5  ml ; sodium chloride 0.9%  flush  10  ml ; dextrose 50%  12.5  gm ; glucagon  1  mg ; vial  1  vial ; pantoprazole  40  mg ; ondansetron  4  mg ; metoprolol tartrate  5  mg ; heparin  5000  unit ; heparin flush (10 units ml)  1  ml ; cepacol (menthol)  1  loz ; chloraseptic throat spray  1  spry ; soln  100  ml ; acetaminophen iv  1000  mg ; 
 
white m 56 $nan$hematology blood hematocrit  25.8  %; hematology blood hemoglobin  8.8  g dl; hematology blood platelet count  142  k ul; chemistry blood anion gap  16  meq l; chemistry blood bicarbonate  28  meq l; chemistry blood chloride  103  meq l; chemistry blood creatinine  0.8  mg dl; chemistry blood potassium  3.5  meq l; chemistry blood sodium  143  meq l; chemistry blood urea nitrogen  32  mg dl; hematology urine wbc  7  # hpf; chemistry blood bilirubin, total  1.5  mg dl; chemistry blood glucose  157  mg dl$insulin  0  unit ; bupivacaine 0.1%  250  ml ; yellow cadd cassette  1  cadd ; fentanyl citrate  1000  mcg ; sodium chloride 0.9%  flush  10  ml ; dextrose 50%  12.5  gm ; glucagon  1  mg ; vial  1  vial ; pantoprazole  40  mg ; ondansetron  4  mg ; metoprolol tartrate  5  mg ; heparin  5000  unit ; heparin flush (10 units ml)  1  ml ; cepacol (menthol)  1  loz ; chloraseptic throat spray  1  spry ; soln  100  ml ; acetaminophen iv  1000  mg ; furosemide  20  mg ; 0.9% sodium chloride  100  ml ; hydromorphone  20  mg ; 
 
white m 56 $nan$nan$insulin  0  unit ; sodium chloride 0.9%  flush  10  ml ; dextrose 50%  12.5  gm ; glucagon  1  mg ; vial  1  vial ; pantoprazole  40  mg ; ondansetron  4  mg ; metoprolol tartrate  5  mg ; heparin flush (10 units ml)  1  ml ; cepacol (menthol)  1  loz ; chloraseptic throat spray  1  spry ; furosemide  20  mg ; 0.9% sodium chloride  100  ml ; hydromorphone  20  mg ; potassium chl 20 meq   1000 ml d5 1 2 ns  1000  ml ; 0.9% sodium chloride  500  ml ; potassium chloride  40  meq ; metoclopramide  10  mg ; 
 
white m 56 $nan$nan$insulin  0  unit ; sodium chloride 0.9%  flush  10  ml ; dextrose 50%  12.5  gm ; glucagon  1  mg ; ondansetron  4  mg ; heparin flush (10 units ml)  1  ml ; cepacol (menthol)  1  loz ; chloraseptic throat spray  1  spry ; 0.9% sodium chloride  100  ml ; hydromorphone  20  mg ; 0.9% sodium chloride  500  ml ; potassium chloride  40  meq ; docusate sodium  100  mg ; citalopram  20  mg ; metoprolol succinate xl  25  mg ; lisinopril  5  mg ; hydromorphone (dilaudid)  2-4  mg ; oxycodone (immediate release)   5-10  mg ; acetaminophen  1000  mg ; hydromorphone (dilaudid)  0.25-0.5  mg ; 
 
white m 56 $nan$nan$insulin  0  unit ; sodium chloride 0.9%  flush  10  ml ; dextrose 50%  12.5  gm ; glucagon  1  mg ; ondansetron  4  mg ; heparin flush (10 units ml)  1  ml ; cepacol (menthol)  1  loz ; chloraseptic throat spray  1  spry ; docusate sodium  100  mg ; citalopram  20  mg ; metoprolol succinate xl  25  mg ; lisinopril  5  mg ; acetaminophen  1000  mg ; hydromorphone (dilaudid)  0.25-0.5  mg ; hydromorphone (dilaudid)  0.25  mg ; 
 
white m 56 $nan$nan$insulin  0  unit ; sodium chloride 0.9%  flush  10  ml ; dextrose 50%  12.5  gm ; glucagon  1  mg ; ondansetron  4  mg ; heparin flush (10 units ml)  1  ml ; cepacol (menthol)  1  loz ; chloraseptic throat spray  1  spry ; docusate sodium  100  mg ; citalopram  20  mg ; metoprolol succinate xl  25  mg ; lisinopril  5  mg ; acetaminophen  1000  mg ; hydromorphone (dilaudid)  0.25  mg ; 
 
white m 56 $nan$nan$sodium chloride 0.9%  flush  10  ml ; dextrose 50%  12.5  gm ; glucagon  1  mg ; ondansetron  4  mg ; heparin flush (10 units ml)  1  ml ; cepacol (menthol)  1  loz ; chloraseptic throat spray  1  spry ; docusate sodium  100  mg ; citalopram  20  mg ; metoprolol succinate xl  25  mg ; lisinopril  5  mg ; acetaminophen  1000  mg ; pregabalin  150  mg ; simvastatin  20  mg ; vitamin d  400  unit ; 
 
white m 56 $nan$nan$sodium chloride 0.9%  flush  10  ml ; dextrose 50%  12.5  gm ; glucagon  1  mg ; ondansetron  4  mg ; heparin flush (10 units ml)  1  ml ; cepacol (menthol)  1  loz ; chloraseptic throat spray  1  spry ; docusate sodium  100  mg ; citalopram  20  mg ; metoprolol succinate xl  25  mg ; lisinopril  5  mg ; acetaminophen  1000  mg ; pregabalin  150  mg ; simvastatin  20  mg ; vitamin d  400  unit ; 
 
white m 56 $nan$nan$sodium chloride 0.9%  flush  10  ml ; dextrose 50%  12.5  gm ; glucagon  1  mg ; ondansetron  4  mg ; heparin flush (10 units ml)  1  ml ; cepacol (menthol)  1  loz ; chloraseptic throat spray  1  spry ; docusate sodium  100  mg ; citalopram  20  mg ; metoprolol succinate xl  25  mg ; lisinopril  5  mg ; acetaminophen  1000  mg ; pregabalin  150  mg ; simvastatin  20  mg ; vitamin d  400  unit ; sodium chloride 0.9%  flush  3  ml ; 
 
white m 30 $nan$nan$sodium chloride 0.9%  flush  3  ml ; lr  1000  ml ; hydromorphone (dilaudid)  0.25  mg ; ondansetron  4  mg ; 0.9% sodium chloride (mini bag plus)  100  ml ; ampicillin-sulbactam  3  g ; heparin  5000  unit ; acetaminophen  1000  mg ; hydromorphone (dilaudid)  0.5  mg ; morphine sulfate  1-5  mg ; meperidine  12.5  mg ; promethazine hcl  6.25-12.5  mg ; prochlorperazine  2.5-5  mg ; haloperidol  0.25-0.5  mg ; hydromorphone (dilaudid)  0.2-0.6  mg ; hydromorphone (dilaudid)  1  mg ; tramadol (ultram)  50  mg ; hydromorphone (dilaudid)  2-4  mg ; lamotrigine  25  mg ; ketorolac  30  mg ; nicotine polacrilex  2  mg ; 
alcohol abuse, unspecified unspecified episodic mood disorder cocaine abuse, unspecified major depressive affective disorder, recurrent episode, unspecified unemployment major depressive affective disorder, single episode, unspecified other specified family circumstances driver of heavy transport vehicle injured in collision with two- or three-wheeled motor vehicle in nontraffic accident other, mixed, or unspecified drug abuse, unspecified alcohol abuse, unspecified mononeuritis of unspecified site 
white m 30 $nan$nan$sodium chloride 0.9%  flush  3  ml ; ondansetron  4  mg ; heparin  5000  unit ; acetaminophen  1000  mg ; tramadol (ultram)  50  mg ; lamotrigine  25  mg ; ketorolac  30  mg ; nicotine polacrilex  2  mg ; 
alcohol abuse, unspecified unspecified episodic mood disorder cocaine abuse, unspecified major depressive affective disorder, recurrent episode, unspecified unemployment major depressive affective disorder, single episode, unspecified other specified family circumstances driver of heavy transport vehicle injured in collision with two- or three-wheeled motor vehicle in nontraffic accident other, mixed, or unspecified drug abuse, unspecified alcohol abuse, unspecified mononeuritis of unspecified site 
white m 28 $nan$chemistry blood bilirubin, total  0.6  mg dl; chemistry blood lactate dehydrogenase (ld)  133  iu l; chemistry blood albumin  3.8  g dl$influenza vaccine quadrivalent  0.5  ml ; olanzapine (disintegrating tablet)  5  mg ; lorazepam  0.5  mg ; 
major depressive disorder, single episode, unspecified anorexia anxiety disorder, unspecified personal history of nicotine dependence unspecified psychosis not due to a substance or known physiological condition 
white m 28 $nan$nan$influenza vaccine quadrivalent  0.5  ml ; lorazepam  0.5  mg ; risperidone  2  mg ; 
major depressive disorder, single episode, unspecified anorexia anxiety disorder, unspecified personal history of nicotine dependence unspecified psychosis not due to a substance or known physiological condition 
white m 28 $nan$nan$influenza vaccine quadrivalent  0.5  ml ; lorazepam  0.5  mg ; risperidone  2  mg ; 
major depressive disorder, single episode, unspecified anorexia anxiety disorder, unspecified personal history of nicotine dependence unspecified psychosis not due to a substance or known physiological condition 
white m 28 $nan$nan$influenza vaccine quadrivalent  0.5  ml ; lorazepam  0.5  mg ; risperidone  2  mg ; multivitamins  1  tab ; thiamine  100  mg ; cyanocobalamin  100  mcg ; folic acid  1  mg ; risperidone long acting injection  25  mg ; 
major depressive disorder, single episode, unspecified anorexia anxiety disorder, unspecified personal history of nicotine dependence unspecified psychosis not due to a substance or known physiological condition 
white m 28 $nan$nan$influenza vaccine quadrivalent  0.5  ml ; lorazepam  0.5  mg ; risperidone  2  mg ; multivitamins  1  tab ; thiamine  100  mg ; cyanocobalamin  100  mcg ; folic acid  1  mg ; paliperidone palmitate  234  mg ; 
major depressive disorder, single episode, unspecified anorexia anxiety disorder, unspecified personal history of nicotine dependence unspecified psychosis not due to a substance or known physiological condition 
white m 28 $nan$nan$risperidone  1  mg ; influenza vaccine quadrivalent  0.5  ml ; multivitamins  1  tab ; thiamine  100  mg ; cyanocobalamin  100  mcg ; folic acid  1  mg ; paliperidone palmitate  234  mg ; paliperidone er  6  mg ; 
major depressive disorder, single episode, unspecified anorexia anxiety disorder, unspecified personal history of nicotine dependence unspecified psychosis not due to a substance or known physiological condition 
white m 28 $nan$nan$risperidone  1  mg ; influenza vaccine quadrivalent  0.5  ml ; multivitamins  1  tab ; thiamine  100  mg ; cyanocobalamin  100  mcg ; folic acid  1  mg ; paliperidone er  6  mg ; 
major depressive disorder, single episode, unspecified anorexia anxiety disorder, unspecified personal history of nicotine dependence unspecified psychosis not due to a substance or known physiological condition 
white m 28 $nan$nan$influenza vaccine quadrivalent  0.5  ml ; multivitamins  1  tab ; thiamine  100  mg ; cyanocobalamin  100  mcg ; folic acid  1  mg ; paliperidone er  6  mg ; 
major depressive disorder, single episode, unspecified anorexia anxiety disorder, unspecified personal history of nicotine dependence unspecified psychosis not due to a substance or known physiological condition 
white m 28 $nan$nan$influenza vaccine quadrivalent  0.5  ml ; multivitamins  1  tab ; thiamine  100  mg ; cyanocobalamin  100  mcg ; folic acid  1  mg ; paliperidone er  6  mg ; miconazole powder 2%  1  appl ; 
major depressive disorder, single episode, unspecified anorexia anxiety disorder, unspecified personal history of nicotine dependence unspecified psychosis not due to a substance or known physiological condition 
white m 28 $nan$nan$influenza vaccine quadrivalent  0.5  ml ; multivitamins  1  tab ; thiamine  100  mg ; cyanocobalamin  100  mcg ; folic acid  1  mg ; paliperidone er  6  mg ; miconazole powder 2%  1  appl ; 
major depressive disorder, single episode, unspecified anorexia anxiety disorder, unspecified personal history of nicotine dependence unspecified psychosis not due to a substance or known physiological condition 
white m 28 $nan$nan$influenza vaccine quadrivalent  0.5  ml ; multivitamins  1  tab ; thiamine  100  mg ; cyanocobalamin  100  mcg ; folic acid  1  mg ; paliperidone er  6  mg ; miconazole powder 2%  1  appl ; 
major depressive disorder, single episode, unspecified anorexia anxiety disorder, unspecified personal history of nicotine dependence unspecified psychosis not due to a substance or known physiological condition 
white f 65 $temp  98.3  heartrate  79.0  resprate  16.0  o2sat    sbp  151.0  dbp  83.0  rhythm    pain    $hematology blood hematocrit  34.6  %; hematology blood hemoglobin  12.0  g dl; hematology blood platelet count  192  k ul; chemistry blood anion gap  17  meq l; chemistry blood bicarbonate  23  meq l; chemistry blood chloride  104  meq l; chemistry blood creatinine  1.1  mg dl; chemistry blood potassium  4.2  meq l; chemistry blood sodium  140  meq l; chemistry blood urea nitrogen  19  mg dl; chemistry blood calcium, total  9.7  mg dl; chemistry blood glucose  109  mg dl$influenza vaccine quadrivalent  0.5  ml ; pneumococcal 23-valent polysaccharide vaccine  0.5  ml ; sodium chloride 0.9%  flush  3  ml ; ciprofloxacin hcl  500  mg ; clindamycin  300  mg ; heparin  5000  unit ; docusate sodium  100  mg ; multivitamins  1  tab ; polyethylene glycol  17  g ; acetaminophen  325  mg ; amlodipine  5  mg ; docusate sodium  200  mg ; 
unspecified essential hypertension diverticulitis of colon (without mention of hemorrhage) nonspecific (abnormal) findings on radiological and other examination of abdominal area, including retroperitoneum constipation, unspecified abscess of intestine chronic kidney disease, unspecified diverticulitis of colon (without mention of hemorrhage) acute kidney failure, unspecified unspecified essential hypertension disorder of bone and cartilage, unspecified calculus of gallbladder without mention of cholecystitis, with obstruction obstruction of bile duct
white f 65 $nan$nan$influenza vaccine quadrivalent  0.5  ml ; pneumococcal 23-valent polysaccharide vaccine  0.5  ml ; sodium chloride 0.9%  flush  3  ml ; ciprofloxacin hcl  500  mg ; clindamycin  300  mg ; heparin  5000  unit ; multivitamins  1  tab ; acetaminophen  325  mg ; amlodipine  5  mg ; docusate sodium  200  mg ; 
unspecified essential hypertension diverticulitis of colon (without mention of hemorrhage) nonspecific (abnormal) findings on radiological and other examination of abdominal area, including retroperitoneum constipation, unspecified abscess of intestine chronic kidney disease, unspecified diverticulitis of colon (without mention of hemorrhage) acute kidney failure, unspecified unspecified essential hypertension disorder of bone and cartilage, unspecified calculus of gallbladder without mention of cholecystitis, with obstruction obstruction of bile duct
white f 32 $nan$hematology blood hematocrit  36.1  %; hematology blood hemoglobin  12.9  g dl; hematology blood platelet count  205  k ul; hematology urine wbc  3  # hpf$levothyroxine sodium  50  mcg ; naloxone hcl  0.4  mg ; naloxone hcl  40-80  mcg ; metoclopramide  10  mg ; ketorolac  15-30  mg ; ondansetron  4  mg ; docusate sodium  100  mg ; oxycodone-acetaminophen  1-2  tab ; ibuprofen  600  mg ; acetaminophen  500-1000  mg ; bisacodyl  10  mg ; milk of magnesia  30  ml ; dibucaine  1  appl ; simethicone  80  mg ; calcium carbonate  500  mg ; diphenhydramine  25  mg ; ondansetron  8  mg ; lorazepam  0.5  mg ; lorazepam  1  mg ; 
 
white f 32 $nan$nan$levothyroxine sodium  50  mcg ; naloxone hcl  0.4  mg ; naloxone hcl  40-80  mcg ; metoclopramide  10  mg ; ketorolac  15-30  mg ; ondansetron  4  mg ; docusate sodium  100  mg ; oxycodone-acetaminophen  1-2  tab ; ibuprofen  600  mg ; acetaminophen  500-1000  mg ; bisacodyl  10  mg ; milk of magnesia  30  ml ; dibucaine  1  appl ; simethicone  80  mg ; calcium carbonate  500  mg ; diphenhydramine  25  mg ; ondansetron  8  mg ; lorazepam  0.5  mg ; lorazepam  1  mg ; 
 
white f 32 $nan$nan$levothyroxine sodium  50  mcg ; naloxone hcl  0.4  mg ; naloxone hcl  40-80  mcg ; metoclopramide  10  mg ; ondansetron  4  mg ; docusate sodium  100  mg ; oxycodone-acetaminophen  1-2  tab ; ibuprofen  600  mg ; acetaminophen  500-1000  mg ; bisacodyl  10  mg ; milk of magnesia  30  ml ; dibucaine  1  appl ; simethicone  80  mg ; calcium carbonate  500  mg ; diphenhydramine  25  mg ; lorazepam  1  mg ; 
 
white f 32 $nan$nan$levothyroxine sodium  50  mcg ; naloxone hcl  0.4  mg ; naloxone hcl  40-80  mcg ; metoclopramide  10  mg ; ondansetron  4  mg ; docusate sodium  100  mg ; oxycodone-acetaminophen  1-2  tab ; ibuprofen  600  mg ; acetaminophen  500-1000  mg ; bisacodyl  10  mg ; milk of magnesia  30  ml ; dibucaine  1  appl ; simethicone  80  mg ; calcium carbonate  500  mg ; diphenhydramine  25  mg ; lorazepam  1  mg ; 
 
white m 54 $temp    heartrate  105.0  resprate  16.0  o2sat  100.0  sbp  157.0  dbp  98.0  rhythm    pain  0  $hematology blood hematocrit  21.5  %; hematology blood hematocrit  24.0  %; hematology blood hemoglobin  7.2  g dl; hematology blood hemoglobin  8.1  g dl; hematology blood platelet count  168  k ul; hematology blood platelet count  173  k ul; chemistry blood anion gap  20  meq l; chemistry blood bicarbonate  19  meq l; chemistry blood chloride  95  meq l; chemistry blood creatinine  2.1  mg dl; chemistry blood potassium  4.2  meq l; chemistry blood sodium  134  meq l; chemistry blood urea nitrogen  24  mg dl; hematology blood inr(pt)  1.0  ; chemistry urine creatinine, urine  114  mg dl; chemistry urine sodium, urine  32  meq l; chemistry urine urea nitrogen, urine  374  mg dl; hematology urine wbc  6  # hpf; chemistry blood calcium, total  8.1  mg dl; chemistry blood bilirubin, total  4.7  mg dl; chemistry blood glucose  76  mg dl; chemistry urine protein creatinine ratio  1.0  mg mg$influenza vaccine quadrivalent  0.5  ml ; sodium chloride 0.9%  flush  3-10  ml ; heparin  5000  unit ; vial  1  vial ; pantoprazole  40  mg ; ceftriaxone  1  gm ; lorazepam  2  mg ; sarna lotion  1  appl ; polyethylene glycol  17  g ; acetaminophen  500  mg ; docusate sodium  100  mg ; multivitamins  1  tab ; thiamine  100  mg ; folic acid  1  mg ; labetalol  100  mg ; senna  17.2  mg ; 
 
white m 54 $nan$hematology blood hematocrit  21.8  %; hematology blood hematocrit  24.1  %; hematology blood hemoglobin  7.4  g dl; hematology blood hemoglobin  8.4  g dl; hematology blood platelet count  163  k ul; hematology blood platelet count  174  k ul; chemistry blood anion gap  21  meq l; chemistry blood anion gap  18  meq l; chemistry blood bicarbonate  18  meq l; chemistry blood bicarbonate  19  meq l; chemistry blood chloride  98  meq l; chemistry blood chloride  93  meq l; chemistry blood creatinine  2.5  mg dl; chemistry blood creatinine  2.4  mg dl; chemistry blood potassium  4.0  meq l; chemistry blood potassium  4.2  meq l; chemistry blood sodium  137  meq l; chemistry blood sodium  130  meq l; chemistry blood urea nitrogen  24  mg dl; chemistry blood urea nitrogen  22  mg dl; hematology blood inr(pt)  1.0  ; chemistry urine creatinine, urine  154  mg dl; chemistry urine creatinine, urine  176  mg dl; hematology urine wbc  24  # hpf; chemistry blood calcium, total  8.1  mg dl; chemistry blood calcium, total  7.9  mg dl; chemistry blood bilirubin, total  3.7  mg dl; chemistry blood bilirubin, total  4.2  mg dl; chemistry blood glucose  91  mg dl; chemistry blood glucose  113  mg dl; chemistry blood lactate dehydrogenase (ld)  698  iu l; chemistry blood lactate dehydrogenase (ld)  740  iu l; chemistry blood albumin  2.1  g dl; blood gas blood lactate  1.7  mmol l; chemistry urine albumin, urine  141.4  mg dl; chemistry urine albumin creatinine, urine  918.2  mg g$influenza vaccine quadrivalent  0.5  ml ; sodium chloride 0.9%  flush  3-10  ml ; vial  1  vial ; pantoprazole  40  mg ; ceftriaxone  1  gm ; lorazepam  2  mg ; sarna lotion  1  appl ; polyethylene glycol  17  g ; acetaminophen  500  mg ; docusate sodium  100  mg ; multivitamins  1  tab ; thiamine  100  mg ; folic acid  1  mg ; labetalol  100  mg ; senna  17.2  mg ; bag  2  bag ; magnesium sulfate  4  gm ; diphenhydramine  25  mg ; lorazepam  1  mg ; betamethasone dipro 0.05% oint  1  appl ; 
 
white m 54 $nan$hematology blood hematocrit  24.1  %; hematology blood hematocrit  27.0  %; hematology blood hemoglobin  8.3  g dl; hematology blood hemoglobin  9.4  g dl; hematology blood platelet count  172  k ul; hematology blood platelet count  203  k ul; chemistry blood anion gap  15  meq l; chemistry blood anion gap  17  meq l; chemistry blood bicarbonate  20  meq l; chemistry blood bicarbonate  19  meq l; chemistry blood chloride  95  meq l; chemistry blood chloride  95  meq l; chemistry blood creatinine  1.8  mg dl; chemistry blood creatinine  2.1  mg dl; chemistry blood potassium  3.8  meq l; chemistry blood potassium  4.2  meq l; chemistry blood sodium  130  meq l; chemistry blood sodium  131  meq l; chemistry blood urea nitrogen  22  mg dl; chemistry blood urea nitrogen  23  mg dl; hematology blood inr(pt)  1.0  ; chemistry blood calcium, total  8.2  mg dl; chemistry blood bilirubin, total  4.2  mg dl; chemistry blood glucose  95  mg dl; chemistry blood glucose  94  mg dl; chemistry blood lactate dehydrogenase (ld)  705  iu l$sodium chloride 0.9%  flush  3-10  ml ; lorazepam  2  mg ; sarna lotion  1  appl ; polyethylene glycol  17  g ; acetaminophen  500  mg ; docusate sodium  100  mg ; multivitamins  1  tab ; thiamine  100  mg ; folic acid  1  mg ; senna  17.2  mg ; bag  2  bag ; magnesium sulfate  4  gm ; diphenhydramine  25  mg ; lorazepam  1  mg ; betamethasone dipro 0.05% oint  1  appl ; cetirizine  10  mg ; moviprep  1  l ; 0.9% sodium chloride  500  ml ; sodium phosphate  30  mmol ; lactated ringers  1000  ml ; 
 
white m 54 $nan$hematology blood hematocrit  22.4  %; hematology blood hematocrit  28.8  %; hematology blood hemoglobin  7.6  g dl; hematology blood hemoglobin  9.7  g dl; hematology blood platelet count  170  k ul; hematology blood platelet count  231  k ul; chemistry blood anion gap  20  meq l; chemistry blood bicarbonate  16  meq l; chemistry blood chloride  103  meq l; chemistry blood creatinine  2.4  mg dl; chemistry blood potassium  3.6  meq l; chemistry blood sodium  139  meq l; chemistry blood urea nitrogen  23  mg dl; chemistry blood calcium, total  8.2  mg dl; chemistry blood bilirubin, indirect  0.5  mg dl; chemistry blood bilirubin, total  3.9  mg dl; chemistry blood glucose  56  mg dl; chemistry blood lactate dehydrogenase (ld)  600  iu l; chemistry blood albumin  2.0  g dl; chemistry blood bilirubin, direct  3.4  mg dl$sodium chloride 0.9%  flush  3-10  ml ; sarna lotion  1  appl ; polyethylene glycol  17  g ; acetaminophen  500  mg ; docusate sodium  100  mg ; multivitamins  1  tab ; thiamine  100  mg ; folic acid  1  mg ; senna  17.2  mg ; diphenhydramine  25  mg ; betamethasone dipro 0.05% oint  1  appl ; cetirizine  10  mg ; 0.9% sodium chloride  500  ml ; sodium phosphate  30  mmol ; lactated ringers  1000  ml ; labetalol  200  mg ; 
 
white m 54 $nan$hematology blood hematocrit  22.5  %; hematology blood hemoglobin  7.6  g dl; hematology blood platelet count  185  k ul; chemistry blood anion gap  22  meq l; chemistry blood bicarbonate  15  meq l; chemistry blood chloride  99  meq l; chemistry blood creatinine  2.4  mg dl; chemistry blood potassium  3.7  meq l; chemistry blood sodium  136  meq l; chemistry blood urea nitrogen  24  mg dl; hematology blood inr(pt)  1.0  ; chemistry urine creatinine, urine  150  mg dl; chemistry urine creatinine, urine  160  mg dl; chemistry urine sodium, urine  33  meq l; chemistry urine urea nitrogen, urine  397  mg dl; hematology urine wbc  3  # hpf; chemistry blood bilirubin, total  4.0  mg dl; chemistry blood glucose  62  mg dl; chemistry blood lactate dehydrogenase (ld)  539  iu l; chemistry blood albumin  2.0  g dl; chemistry urine protein creatinine ratio  1.2  mg mg$sodium chloride 0.9%  flush  3-10  ml ; sarna lotion  1  appl ; polyethylene glycol  17  g ; acetaminophen  500  mg ; docusate sodium  100  mg ; multivitamins  1  tab ; thiamine  100  mg ; folic acid  1  mg ; senna  17.2  mg ; diphenhydramine  25  mg ; betamethasone dipro 0.05% oint  1  appl ; cetirizine  10  mg ; labetalol  200  mg ; hydroxyzine  25  mg ; 
 
white m 54 $nan$hematology blood hematocrit  21.5  %; hematology blood hemoglobin  7.3  g dl; hematology blood platelet count  208  k ul; chemistry blood anion gap  18  meq l; chemistry blood bicarbonate  16  meq l; chemistry blood chloride  102  meq l; chemistry blood creatinine  2.6  mg dl; chemistry blood potassium  3.6  meq l; chemistry blood sodium  136  meq l; chemistry blood urea nitrogen  24  mg dl; chemistry blood calcium, total  7.9  mg dl; chemistry blood bilirubin, total  3.5  mg dl; chemistry blood glucose  96  mg dl$sodium chloride 0.9%  flush  3-10  ml ; sarna lotion  1  appl ; polyethylene glycol  17  g ; acetaminophen  500  mg ; docusate sodium  100  mg ; multivitamins  1  tab ; thiamine  100  mg ; folic acid  1  mg ; senna  17.2  mg ; betamethasone dipro 0.05% oint  1  appl ; cetirizine  10  mg ; labetalol  200  mg ; hydroxyzine  25  mg ; sodium bicarbonate  1300  mg ; 
 
white m 54 $nan$hematology blood hematocrit  20.9  %; hematology blood hemoglobin  7.0  g dl; hematology blood platelet count  206  k ul; chemistry blood anion gap  15  meq l; chemistry blood bicarbonate  18  meq l; chemistry blood chloride  101  meq l; chemistry blood creatinine  2.4  mg dl; chemistry blood potassium  3.6  meq l; chemistry blood sodium  134  meq l; chemistry blood urea nitrogen  22  mg dl; chemistry blood calcium, total  7.7  mg dl; chemistry blood bilirubin, total  3.6  mg dl; chemistry blood glucose  96  mg dl$sodium chloride 0.9%  flush  3-10  ml ; sarna lotion  1  appl ; polyethylene glycol  17  g ; acetaminophen  500  mg ; docusate sodium  100  mg ; multivitamins  1  tab ; thiamine  100  mg ; folic acid  1  mg ; senna  17.2  mg ; betamethasone dipro 0.05% oint  1  appl ; cetirizine  10  mg ; hydroxyzine  25  mg ; sodium bicarbonate  1300  mg ; famotidine  20  mg ; labetalol  400  mg ; labetalol  600  mg ; 
 
white m 54 $nan$hematology blood hematocrit  24.1  %; hematology blood hematocrit  21.1  %; hematology blood hematocrit  19.9  %; hematology blood hemoglobin  8.2  g dl; hematology blood hemoglobin  7.0  g dl; hematology blood hemoglobin  6.9  g dl; hematology blood platelet count  238  k ul; hematology blood platelet count  187  k ul; hematology blood platelet count  215  k ul; chemistry blood anion gap  17  meq l; chemistry blood bicarbonate  19  meq l; chemistry blood chloride  101  meq l; chemistry blood creatinine  2.2  mg dl; chemistry blood potassium  3.9  meq l; chemistry blood sodium  137  meq l; chemistry blood urea nitrogen  22  mg dl; hematology blood inr(pt)  1.0  ; chemistry blood calcium, total  8.1  mg dl; chemistry blood glucose  84  mg dl; blood gas blood lactate  1.6  mmol l; blood gas blood hematocrit, calculated  23  %; blood gas blood hemoglobin  7.5  g dl$sodium chloride 0.9%  flush  3-10  ml ; sarna lotion  1  appl ; polyethylene glycol  17  g ; acetaminophen  500  mg ; docusate sodium  100  mg ; multivitamins  1  tab ; thiamine  100  mg ; folic acid  1  mg ; senna  17.2  mg ; betamethasone dipro 0.05% oint  1  appl ; cetirizine  10  mg ; hydroxyzine  25  mg ; sodium bicarbonate  1300  mg ; famotidine  20  mg ; labetalol  600  mg ; hydralazine  10  mg ; sodium chloride 0.9%  1000  ml ; 
 
white m 54 $nan$hematology blood hematocrit  22.8  %; hematology blood hematocrit  22.8  %; hematology blood hematocrit  22.2  %; hematology blood hemoglobin  7.8  g dl; hematology blood hemoglobin  7.7  g dl; hematology blood hemoglobin  7.5  g dl; hematology blood platelet count  224  k ul; hematology blood platelet count  229  k ul; hematology blood platelet count  241  k ul; chemistry blood anion gap  16  meq l; chemistry blood bicarbonate  20  meq l; chemistry blood chloride  98  meq l; chemistry blood creatinine  2.5  mg dl; chemistry blood potassium  3.9  meq l; chemistry blood sodium  134  meq l; chemistry blood urea nitrogen  24  mg dl; chemistry blood calcium, total  7.6  mg dl; chemistry blood glucose  89  mg dl$sodium chloride 0.9%  flush  3-10  ml ; sarna lotion  1  appl ; polyethylene glycol  17  g ; acetaminophen  500  mg ; docusate sodium  100  mg ; multivitamins  1  tab ; thiamine  100  mg ; folic acid  1  mg ; senna  17.2  mg ; betamethasone dipro 0.05% oint  1  appl ; cetirizine  10  mg ; hydroxyzine  25  mg ; sodium bicarbonate  1300  mg ; famotidine  20  mg ; hydralazine  10  mg ; sodium chloride 0.9%  1000  ml ; 
 
white m 54 $nan$hematology blood hematocrit  20.8  %; hematology blood hematocrit  21.3  %; hematology blood hematocrit  22.2  %; hematology blood hemoglobin  7.1  g dl; hematology blood hemoglobin  7.0  g dl; hematology blood hemoglobin  7.6  g dl; hematology blood platelet count  230  k ul; hematology blood platelet count  250  k ul; hematology blood platelet count  261  k ul; chemistry blood anion gap  14  meq l; chemistry blood bicarbonate  21  meq l; chemistry blood chloride  100  meq l; chemistry blood creatinine  2.4  mg dl; chemistry blood potassium  4.1  meq l; chemistry blood sodium  135  meq l; chemistry blood urea nitrogen  25  mg dl; chemistry blood calcium, total  7.7  mg dl; chemistry blood bilirubin, indirect  1.0  mg dl; chemistry blood bilirubin, total  3.6  mg dl; chemistry blood glucose  78  mg dl; chemistry blood albumin  1.8  g dl; chemistry blood bilirubin, direct  2.6  mg dl$sodium chloride 0.9%  flush  3-10  ml ; sarna lotion  1  appl ; polyethylene glycol  17  g ; acetaminophen  500  mg ; docusate sodium  100  mg ; multivitamins  1  tab ; thiamine  100  mg ; folic acid  1  mg ; senna  17.2  mg ; betamethasone dipro 0.05% oint  1  appl ; cetirizine  10  mg ; hydroxyzine  25  mg ; sodium bicarbonate  1300  mg ; famotidine  20  mg ; hydralazine  20  mg ; furosemide  20  mg ; 
 
white m 54 $nan$hematology blood hematocrit  21.1  %; hematology blood hematocrit  21.3  %; hematology blood hemoglobin  7.0  g dl; hematology blood hemoglobin  7.1  g dl; hematology blood platelet count  251  k ul; hematology blood platelet count  253  k ul; chemistry blood anion gap  15  meq l; chemistry blood bicarbonate  21  meq l; chemistry blood chloride  100  meq l; chemistry blood creatinine  2.2  mg dl; chemistry blood potassium  4.2  meq l; chemistry blood sodium  136  meq l; chemistry blood urea nitrogen  25  mg dl; chemistry blood glucose  77  mg dl$sodium chloride 0.9%  flush  3-10  ml ; sarna lotion  1  appl ; polyethylene glycol  17  g ; acetaminophen  500  mg ; docusate sodium  100  mg ; multivitamins  1  tab ; thiamine  100  mg ; folic acid  1  mg ; senna  17.2  mg ; betamethasone dipro 0.05% oint  1  appl ; cetirizine  10  mg ; hydroxyzine  25  mg ; sodium bicarbonate  1300  mg ; famotidine  20  mg ; hydralazine  20  mg ; amlodipine  5  mg ; amlodipine  10  mg ; 
 
white m 54 $nan$hematology blood hematocrit  21.3  %; hematology blood hemoglobin  7.0  g dl; hematology blood platelet count  268  k ul; chemistry blood anion gap  14  meq l; chemistry blood bicarbonate  22  meq l; chemistry blood chloride  101  meq l; chemistry blood creatinine  2.3  mg dl; chemistry blood potassium  4.6  meq l; chemistry blood sodium  137  meq l; chemistry blood urea nitrogen  24  mg dl; chemistry blood glucose  79  mg dl$sodium chloride 0.9%  flush  3-10  ml ; sarna lotion  1  appl ; polyethylene glycol  17  g ; acetaminophen  500  mg ; docusate sodium  100  mg ; multivitamins  1  tab ; thiamine  100  mg ; folic acid  1  mg ; senna  17.2  mg ; betamethasone dipro 0.05% oint  1  appl ; cetirizine  10  mg ; hydroxyzine  25  mg ; sodium bicarbonate  1300  mg ; famotidine  20  mg ; amlodipine  10  mg ; 
 
white m 54 $nan$hematology blood hematocrit  23.2  %; hematology blood hemoglobin  7.9  g dl; hematology blood platelet count  268  k ul; chemistry blood anion gap  13  meq l; chemistry blood bicarbonate  22  meq l; chemistry blood chloride  100  meq l; chemistry blood creatinine  2.3  mg dl; chemistry blood potassium  4.5  meq l; chemistry blood sodium  135  meq l; chemistry blood urea nitrogen  23  mg dl; chemistry blood calcium, total  7.7  mg dl; chemistry blood bilirubin, total  3.2  mg dl; chemistry blood glucose  76  mg dl; chemistry blood albumin  1.8  g dl$sodium chloride 0.9%  flush  3-10  ml ; sarna lotion  1  appl ; polyethylene glycol  17  g ; acetaminophen  500  mg ; docusate sodium  100  mg ; multivitamins  1  tab ; thiamine  100  mg ; folic acid  1  mg ; senna  17.2  mg ; betamethasone dipro 0.05% oint  1  appl ; cetirizine  10  mg ; hydroxyzine  25  mg ; sodium bicarbonate  1300  mg ; famotidine  20  mg ; amlodipine  10  mg ; losartan potassium  25  mg ; 
 
white m 35 $nan$hematology blood hematocrit  38.5  %; hematology blood hemoglobin  13.0  g dl; hematology blood platelet count  238  k ul; chemistry blood anion gap  13  meq l; chemistry blood bicarbonate  29  meq l; chemistry blood chloride  102  meq l; chemistry blood creatinine  0.9  mg dl; chemistry blood potassium  4.3  meq l; chemistry blood sodium  140  meq l; chemistry blood urea nitrogen  11  mg dl; chemistry blood calcium, total  8.6  mg dl; chemistry blood glucose  89  mg dl$sodium chloride 0.9%  flush  3  ml ; lr  1000  ml ; ondansetron  4  mg ; heparin  5000  unit ; ketorolac  15  mg ; hydromorphone (dilaudid)  12.5  mg ; metoclopramide  10  mg ; acetaminophen  1000  mg ; hydrocortisone na succ.  100  mg ; insulin  0  unit ; potassium chl 20 meq   1000 ml d5 1 2 ns  1000  ml ; hydrocortisone na succ.  20  mg ; 0.9% sodium chloride  250  ml ; potassium chloride  20  meq ; acetaminophen (liquid)  650  mg ; 
inguinal hernia, without mention of obstruction or gangrene, unilateral or unspecified (not specified as recurrent) regional enteritis of unspecified site bacteremia osteoporosis, unspecified escherichia coli [e. coli] infection in conditions classified elsewhere and of unspecified site other specified intestinal obstruction personal history of other malignant neoplasm of skin regional enteritis of unspecified site osteoporosis, unspecified 
white m 35 $nan$nan$sodium chloride 0.9%  flush  3  ml ; heparin  5000  unit ; ketorolac  15  mg ; hydromorphone (dilaudid)  12.5  mg ; metoclopramide  10  mg ; insulin  0  unit ; potassium chl 20 meq   1000 ml d5 1 2 ns  1000  ml ; hydrocortisone na succ.  20  mg ; 0.9% sodium chloride  250  ml ; potassium chloride  20  meq ; acetaminophen (liquid)  650  mg ; mercaptopurine  62.5  mg ; prednisone  10  mg ; hydromorphone (dilaudid)  2-4  mg ; 
inguinal hernia, without mention of obstruction or gangrene, unilateral or unspecified (not specified as recurrent) regional enteritis of unspecified site bacteremia osteoporosis, unspecified escherichia coli [e. coli] infection in conditions classified elsewhere and of unspecified site other specified intestinal obstruction personal history of other malignant neoplasm of skin regional enteritis of unspecified site osteoporosis, unspecified 
white m 35 $nan$nan$sodium chloride 0.9%  flush  3  ml ; heparin  5000  unit ; insulin  0  unit ; hydrocortisone na succ.  20  mg ; acetaminophen (liquid)  650  mg ; mercaptopurine  62.5  mg ; prednisone  10  mg ; hydromorphone (dilaudid)  2-4  mg ; 0.9% sodium chloride  100  ml ; cefazolin  2  g ; 
inguinal hernia, without mention of obstruction or gangrene, unilateral or unspecified (not specified as recurrent) regional enteritis of unspecified site bacteremia osteoporosis, unspecified escherichia coli [e. coli] infection in conditions classified elsewhere and of unspecified site other specified intestinal obstruction personal history of other malignant neoplasm of skin regional enteritis of unspecified site osteoporosis, unspecified 
white m 35 $nan$nan$sodium chloride 0.9%  flush  3  ml ; heparin  5000  unit ; insulin  0  unit ; acetaminophen (liquid)  650  mg ; mercaptopurine  62.5  mg ; prednisone  10  mg ; hydromorphone (dilaudid)  2-4  mg ; 0.9% sodium chloride  100  ml ; cefazolin  2  g ; 
inguinal hernia, without mention of obstruction or gangrene, unilateral or unspecified (not specified as recurrent) regional enteritis of unspecified site bacteremia osteoporosis, unspecified escherichia coli [e. coli] infection in conditions classified elsewhere and of unspecified site other specified intestinal obstruction personal history of other malignant neoplasm of skin regional enteritis of unspecified site osteoporosis, unspecified 
white m 53 $temp  98.6  heartrate  87.0  resprate  19.0  o2sat  97.0  sbp  148.0  dbp  97.0  rhythm    pain  4  $hematology blood hematocrit  40.7  %; hematology blood hemoglobin  14.5  g dl; hematology blood platelet count  198  k ul$influenza virus vaccine  0.5  ml ; sodium chloride 0.9%  flush  3  ml ; oxycodone (immediate release)   5  mg ; lorazepam  1-2  mg ; albuterol inhaler  2  puff ; loratadine  10  mg ; hydrochlorothiazide  12.5  mg ; lisinopril  10  mg ; montelukast  10  mg ; omeprazole  20  mg ; acetaminophen  1000  mg ; quetiapine fumarate  25-50  mg ; propranolol  20  mg ; ketorolac  15  mg ; gabapentin  300  mg ; bupropion (sustained release)  150  mg ; 
 
white m 53 $nan$hematology blood hematocrit  39.2  %; hematology blood hemoglobin  13.8  g dl; hematology blood platelet count  183  k ul; chemistry blood anion gap  15  meq l; chemistry blood bicarbonate  26  meq l; chemistry blood chloride  98  meq l; chemistry blood creatinine  1.1  mg dl; chemistry blood potassium  4.2  meq l; chemistry blood sodium  135  meq l; chemistry blood urea nitrogen  25  mg dl; chemistry blood calcium, total  9.4  mg dl; chemistry blood lactate dehydrogenase (ld)  164  iu l; chemistry blood albumin  4.6  g dl$influenza virus vaccine  0.5  ml ; sodium chloride 0.9%  flush  3  ml ; oxycodone (immediate release)   5  mg ; lorazepam  1-2  mg ; albuterol inhaler  2  puff ; loratadine  10  mg ; hydrochlorothiazide  12.5  mg ; lisinopril  10  mg ; montelukast  10  mg ; omeprazole  20  mg ; acetaminophen  1000  mg ; quetiapine fumarate  25-50  mg ; propranolol  20  mg ; ketorolac  15  mg ; gabapentin  300  mg ; bupropion (sustained release)  150  mg ; readi-cat 2 (barium sulfate 2% suspension)  900  ml ; 
 
white m 53 $nan$hematology blood hematocrit  40.7  %; hematology blood hemoglobin  14.3  g dl; hematology blood platelet count  204  k ul; chemistry blood anion gap  19  meq l; chemistry blood bicarbonate  24  meq l; chemistry blood chloride  100  meq l; chemistry blood creatinine  1.1  mg dl; chemistry blood potassium  4.2  meq l; chemistry blood sodium  139  meq l; chemistry blood urea nitrogen  20  mg dl; chemistry blood calcium, total  9.7  mg dl; chemistry blood glucose  103  mg dl; chemistry blood lactate dehydrogenase (ld)  201  iu l$sodium chloride 0.9%  flush  3  ml ; oxycodone (immediate release)   5  mg ; albuterol inhaler  2  puff ; loratadine  10  mg ; hydrochlorothiazide  12.5  mg ; lisinopril  10  mg ; montelukast  10  mg ; omeprazole  20  mg ; acetaminophen  1000  mg ; quetiapine fumarate  25-50  mg ; propranolol  20  mg ; gabapentin  300  mg ; bupropion (sustained release)  150  mg ; readi-cat 2 (barium sulfate 2% suspension)  900  ml ; lorazepam  0.5  mg ; oxycodone (immediate release)   10  mg ; lidocaine 5% patch  1  ptch ; 
 
white m 53 $nan$hematology blood hematocrit  40.1  %; hematology blood hemoglobin  14.2  g dl; hematology blood platelet count  204  k ul; chemistry blood anion gap  20  meq l; chemistry blood bicarbonate  21  meq l; chemistry blood chloride  100  meq l; chemistry blood creatinine  1.0  mg dl; chemistry blood potassium  4.5  meq l; chemistry blood sodium  136  meq l; chemistry blood urea nitrogen  23  mg dl; chemistry blood calcium, total  9.9  mg dl; chemistry blood bilirubin, total  0.6  mg dl; chemistry blood glucose  133  mg dl; chemistry blood lactate dehydrogenase (ld)  152  iu l$sodium chloride 0.9%  flush  3  ml ; albuterol inhaler  2  puff ; loratadine  10  mg ; hydrochlorothiazide  12.5  mg ; lisinopril  10  mg ; montelukast  10  mg ; omeprazole  20  mg ; acetaminophen  1000  mg ; quetiapine fumarate  25-50  mg ; propranolol  20  mg ; gabapentin  300  mg ; bupropion (sustained release)  150  mg ; lorazepam  0.5  mg ; oxycodone (immediate release)   10  mg ; lidocaine 5% patch  1  ptch ; dexamethasone  4  mg ; polyethylene glycol  17  g ; pantoprazole  40  mg ; senna  8.6  mg ; docusate sodium  100  mg ; allopurinol  300  mg ; 
 
white m 53 $nan$nan$sodium chloride 0.9%  flush  3  ml ; albuterol inhaler  2  puff ; loratadine  10  mg ; hydrochlorothiazide  12.5  mg ; lisinopril  10  mg ; montelukast  10  mg ; omeprazole  20  mg ; acetaminophen  1000  mg ; quetiapine fumarate  25-50  mg ; propranolol  20  mg ; gabapentin  300  mg ; bupropion (sustained release)  150  mg ; lidocaine 5% patch  1  ptch ; dexamethasone  4  mg ; polyethylene glycol  17  g ; pantoprazole  40  mg ; senna  8.6  mg ; docusate sodium  100  mg ; allopurinol  300  mg ; acetaminophen  325-650  mg ; 
 
white m 67 $nan$hematology blood hematocrit  32.8  %; hematology blood hemoglobin  11.1  g dl; hematology blood platelet count  91  k ul; chemistry blood anion gap  9  meq l; chemistry blood anion gap  11  meq l; chemistry blood bicarbonate  21  meq l; chemistry blood bicarbonate  23  meq l; chemistry blood chloride  108  meq l; chemistry blood chloride  105  meq l; chemistry blood creatinine  0.5  mg dl; chemistry blood creatinine  0.6  mg dl; chemistry blood potassium  3.2  meq l; chemistry blood potassium  4.0  meq l; chemistry blood sodium  135  meq l; chemistry blood sodium  135  meq l; chemistry blood urea nitrogen  16  mg dl; chemistry blood urea nitrogen  17  mg dl; hematology blood inr(pt)  1.5  ; chemistry urine creatinine, urine  110  mg dl; chemistry urine potassium, urine  39  meq l; chemistry blood calcium, total  6.9  mg dl; chemistry blood calcium, total  7.5  mg dl; chemistry blood glucose  88  mg dl; chemistry blood glucose  99  mg dl; chemistry blood lactate dehydrogenase (ld)  226  iu l; chemistry blood lactate dehydrogenase (ld)  176  iu l; blood gas blood free calcium  1.05  mmol l; blood gas blood lactate  1.7  mmol l; chemistry urine calcium, urine  6.4  mg dl$0.9% sodium chloride  2  bag ; ns  100  ml ; sodium chloride 0.9%  flush  3  ml ; lr  1000  ml ; acetaminophen  650  mg ; morphine sulfate  2-4  mg ; 5% dextrose  250  ml ; phenylephrine  60  mg ; albuterol 0.083% neb soln  1  neb ; ipratropium bromide neb  1  neb ; famotidine  20  mg ; metronidazole (flagyl)  500  mg ; 5% dextrose  200  ml ; ciprofloxacin iv  400  mg ; vancomycin oral liquid  250  mg ; insulin  0  unit ; flecainide acetate  50  mg ; sw  100  ml ; potassium chloride  20-40  meq ; potassium chloride  40-60  meq ; potassium chloride  60  meq ; magnesium sulfate  4  gm ; sw  50  ml ; magnesium sulfate  2-4  gm ; magnesium sulfate  2  gm ; calcium gluconate  2  g ; 0.9% sodium chloride  1  bag ; calcium gluconate  2-4  g ; calcium gluconate  4  g ; heparin  5000  unit ; digoxin  0.125  mg ; aspirin  325  mg ; lr  500  ml ; quetiapine fumarate  25  mg ; divalproex (delayed release)  1000  mg ; 
esophageal reflux chronic hepatitis c without mention of hepatic coma other diseases of lung, not elsewhere classified thrombocytopenia, unspecified other bipolar disorders long-term (current) use of aspirin atrial fibrillation other forms of keratitis pneumonitis due to inhalation of food or vomitus anisocoria other staphylococcal septicemia other specified cardiac dysrhythmias sepsis other nonspecific abnormal serum enzyme levels unspecified pleural effusion diarrhea dysphagia, unspecified anemia, unspecified chronic hepatitis c without mention of hepatic coma unspecified deficiency anemia schizoaffective disorder, chronic metabolic encephalopathy paralysis agitans atrial fibrillation pneumonia, organism unspecified thrombocytopenia, unspecified volume depletion, unspecified chronic airway obstruction, not elsewhere classified abrasion or friction burn of hip, thigh, leg, and ankle, without mention of infection unspecified fall other specified metabolic disorders sepsis atrial fibrillation other bipolar disorders unspecified protein-calorie malnutrition other disorders of plasma protein metabolism pneumonia, organism unspecified intestinal infection due to clostridium difficile pancytopenia unspecified septicemia edema bipolar disorder, unspecified hypoxemia esophageal reflux other and unspecified viral and rickettsial vaccines causing adverse effects in therapeutic use personal history of other infectious and parasitic diseases accidents occurring in unspecified place atrial fibrillation
white m 67 $nan$hematology blood hematocrit  29.1  %; hematology blood hemoglobin  9.9  g dl; hematology blood platelet count  98  k ul; chemistry blood anion gap  11  meq l; chemistry blood anion gap  7  meq l; chemistry blood bicarbonate  23  meq l; chemistry blood bicarbonate  23  meq l; chemistry blood chloride  106  meq l; chemistry blood chloride  106  meq l; chemistry blood creatinine  0.6  mg dl; chemistry blood creatinine  0.5  mg dl; chemistry blood potassium  4.1  meq l; chemistry blood potassium  4.0  meq l; chemistry blood sodium  136  meq l; chemistry blood sodium  132  meq l; chemistry blood urea nitrogen  17  mg dl; chemistry blood urea nitrogen  15  mg dl; hematology blood inr(pt)  1.7  ; chemistry urine creatinine, urine  130  mg dl; chemistry urine sodium, urine  12  meq l; chemistry blood calcium, total  7.9  mg dl; chemistry blood calcium, total  7.5  mg dl; chemistry blood bilirubin, total  0.9  mg dl; chemistry blood glucose  95  mg dl; chemistry blood glucose  83  mg dl; chemistry blood lactate dehydrogenase (ld)  138  iu l; chemistry blood albumin  1.9  g dl; blood gas blood free calcium  1.07  mmol l; blood gas blood lactate  2.2  mmol l$0.9% sodium chloride  2  bag ; ns  100  ml ; sodium chloride 0.9%  flush  3  ml ; acetaminophen  650  mg ; morphine sulfate  2-4  mg ; albuterol 0.083% neb soln  1  neb ; ipratropium bromide neb  1  neb ; famotidine  20  mg ; metronidazole (flagyl)  500  mg ; insulin  0  unit ; flecainide acetate  50  mg ; sw  100  ml ; potassium chloride  20-40  meq ; potassium chloride  40-60  meq ; potassium chloride  60  meq ; magnesium sulfate  4  gm ; sw  50  ml ; magnesium sulfate  2-4  gm ; magnesium sulfate  2  gm ; calcium gluconate  2  g ; 0.9% sodium chloride  1  bag ; calcium gluconate  2-4  g ; calcium gluconate  4  g ; heparin  5000  unit ; digoxin  0.125  mg ; aspirin  325  mg ; lr  500  ml ; quetiapine fumarate  25  mg ; divalproex (delayed release)  1000  mg ; ns  500  ml ; hespan  500  ml ; vancomycin oral liquid  500  mg ; vancomycin enema  250  mg ; 0.9% sodium chloride  1000  ml ; 
esophageal reflux chronic hepatitis c without mention of hepatic coma other diseases of lung, not elsewhere classified thrombocytopenia, unspecified other bipolar disorders long-term (current) use of aspirin atrial fibrillation other forms of keratitis pneumonitis due to inhalation of food or vomitus anisocoria other staphylococcal septicemia other specified cardiac dysrhythmias sepsis other nonspecific abnormal serum enzyme levels unspecified pleural effusion diarrhea dysphagia, unspecified anemia, unspecified chronic hepatitis c without mention of hepatic coma unspecified deficiency anemia schizoaffective disorder, chronic metabolic encephalopathy paralysis agitans atrial fibrillation pneumonia, organism unspecified thrombocytopenia, unspecified volume depletion, unspecified chronic airway obstruction, not elsewhere classified abrasion or friction burn of hip, thigh, leg, and ankle, without mention of infection unspecified fall other specified metabolic disorders sepsis atrial fibrillation other bipolar disorders unspecified protein-calorie malnutrition other disorders of plasma protein metabolism pneumonia, organism unspecified intestinal infection due to clostridium difficile pancytopenia unspecified septicemia edema bipolar disorder, unspecified hypoxemia esophageal reflux other and unspecified viral and rickettsial vaccines causing adverse effects in therapeutic use personal history of other infectious and parasitic diseases accidents occurring in unspecified place atrial fibrillation
white m 67 $nan$hematology blood hematocrit  29.9  %; hematology blood hemoglobin  10.1  g dl; hematology blood platelet count  85  k ul; chemistry blood anion gap  7  meq l; chemistry blood bicarbonate  22  meq l; chemistry blood chloride  110  meq l; chemistry blood creatinine  0.5  mg dl; chemistry blood potassium  5.0  meq l; chemistry blood sodium  134  meq l; chemistry blood urea nitrogen  15  mg dl; hematology blood inr(pt)  1.9  ; chemistry blood calcium, total  7.7  mg dl; chemistry blood bilirubin, total  0.9  mg dl; chemistry blood glucose  77  mg dl; chemistry blood lactate dehydrogenase (ld)  125  iu l; blood gas blood free calcium  1.11  mmol l; blood gas blood potassium, whole blood  3.8  meq l$0.9% sodium chloride  2  bag ; ns  100  ml ; sodium chloride 0.9%  flush  3  ml ; acetaminophen  650  mg ; morphine sulfate  2-4  mg ; albuterol 0.083% neb soln  1  neb ; ipratropium bromide neb  1  neb ; famotidine  20  mg ; metronidazole (flagyl)  500  mg ; insulin  0  unit ; flecainide acetate  50  mg ; sw  100  ml ; potassium chloride  20-40  meq ; potassium chloride  40-60  meq ; potassium chloride  60  meq ; magnesium sulfate  4  gm ; sw  50  ml ; magnesium sulfate  2-4  gm ; magnesium sulfate  2  gm ; calcium gluconate  2  g ; 0.9% sodium chloride  1  bag ; calcium gluconate  2-4  g ; calcium gluconate  4  g ; heparin  5000  unit ; digoxin  0.125  mg ; aspirin  325  mg ; quetiapine fumarate  25  mg ; divalproex (delayed release)  1000  mg ; ns  500  ml ; hespan  500  ml ; vancomycin oral liquid  500  mg ; vancomycin enema  250  mg ; 0.9% sodium chloride  1000  ml ; metoprolol tartrate  5  mg ; miconazole powder 2%  1  appl ; sodium chloride 0.9%  flush  10  ml ; 
esophageal reflux chronic hepatitis c without mention of hepatic coma other diseases of lung, not elsewhere classified thrombocytopenia, unspecified other bipolar disorders long-term (current) use of aspirin atrial fibrillation other forms of keratitis pneumonitis due to inhalation of food or vomitus anisocoria other staphylococcal septicemia other specified cardiac dysrhythmias sepsis other nonspecific abnormal serum enzyme levels unspecified pleural effusion diarrhea dysphagia, unspecified anemia, unspecified chronic hepatitis c without mention of hepatic coma unspecified deficiency anemia schizoaffective disorder, chronic metabolic encephalopathy paralysis agitans atrial fibrillation pneumonia, organism unspecified thrombocytopenia, unspecified volume depletion, unspecified chronic airway obstruction, not elsewhere classified abrasion or friction burn of hip, thigh, leg, and ankle, without mention of infection unspecified fall other specified metabolic disorders sepsis atrial fibrillation other bipolar disorders unspecified protein-calorie malnutrition other disorders of plasma protein metabolism pneumonia, organism unspecified intestinal infection due to clostridium difficile pancytopenia unspecified septicemia edema bipolar disorder, unspecified hypoxemia esophageal reflux other and unspecified viral and rickettsial vaccines causing adverse effects in therapeutic use personal history of other infectious and parasitic diseases accidents occurring in unspecified place atrial fibrillation
white m 67 $nan$hematology blood hematocrit  29.1  %; hematology blood hemoglobin  9.8  g dl; hematology blood platelet count  80  k ul; chemistry blood anion gap  10  meq l; chemistry blood bicarbonate  21  meq l; chemistry blood chloride  109  meq l; chemistry blood creatinine  0.5  mg dl; chemistry blood potassium  4.1  meq l; chemistry blood sodium  136  meq l; chemistry blood urea nitrogen  15  mg dl; hematology blood inr(pt)  1.8  ; chemistry blood calcium, total  7.6  mg dl; chemistry blood glucose  112  mg dl$0.9% sodium chloride  2  bag ; ns  100  ml ; sodium chloride 0.9%  flush  3  ml ; acetaminophen  650  mg ; morphine sulfate  2-4  mg ; albuterol 0.083% neb soln  1  neb ; ipratropium bromide neb  1  neb ; famotidine  20  mg ; metronidazole (flagyl)  500  mg ; insulin  0  unit ; flecainide acetate  50  mg ; sw  100  ml ; potassium chloride  20-40  meq ; potassium chloride  40-60  meq ; potassium chloride  60  meq ; magnesium sulfate  4  gm ; sw  50  ml ; magnesium sulfate  2-4  gm ; magnesium sulfate  2  gm ; calcium gluconate  2  g ; 0.9% sodium chloride  1  bag ; calcium gluconate  2-4  g ; calcium gluconate  4  g ; heparin  5000  unit ; digoxin  0.125  mg ; aspirin  325  mg ; quetiapine fumarate  25  mg ; vancomycin oral liquid  500  mg ; miconazole powder 2%  1  appl ; sodium chloride 0.9%  flush  10  ml ; vial  1  vial ; pantoprazole sodium  40  mg ; nitazoxanide  500  mg ; ns (irrigation bottle)  250  ml ; 
esophageal reflux chronic hepatitis c without mention of hepatic coma other diseases of lung, not elsewhere classified thrombocytopenia, unspecified other bipolar disorders long-term (current) use of aspirin atrial fibrillation other forms of keratitis pneumonitis due to inhalation of food or vomitus anisocoria other staphylococcal septicemia other specified cardiac dysrhythmias sepsis other nonspecific abnormal serum enzyme levels unspecified pleural effusion diarrhea dysphagia, unspecified anemia, unspecified chronic hepatitis c without mention of hepatic coma unspecified deficiency anemia schizoaffective disorder, chronic metabolic encephalopathy paralysis agitans atrial fibrillation pneumonia, organism unspecified thrombocytopenia, unspecified volume depletion, unspecified chronic airway obstruction, not elsewhere classified abrasion or friction burn of hip, thigh, leg, and ankle, without mention of infection unspecified fall other specified metabolic disorders sepsis atrial fibrillation other bipolar disorders unspecified protein-calorie malnutrition other disorders of plasma protein metabolism pneumonia, organism unspecified intestinal infection due to clostridium difficile pancytopenia unspecified septicemia edema bipolar disorder, unspecified hypoxemia esophageal reflux other and unspecified viral and rickettsial vaccines causing adverse effects in therapeutic use personal history of other infectious and parasitic diseases accidents occurring in unspecified place atrial fibrillation
white m 67 $nan$hematology blood hematocrit  31.5  %; hematology blood hemoglobin  10.3  g dl; hematology blood platelet count  95  k ul; chemistry blood anion gap  8  meq l; chemistry blood bicarbonate  22  meq l; chemistry blood chloride  110  meq l; chemistry blood creatinine  0.5  mg dl; chemistry blood potassium  4.1  meq l; chemistry blood sodium  136  meq l; chemistry blood urea nitrogen  17  mg dl; hematology blood inr(pt)  1.3  ; chemistry blood calcium, total  7.6  mg dl; chemistry blood glucose  127  mg dl$0.9% sodium chloride  2  bag ; ns  100  ml ; sodium chloride 0.9%  flush  3  ml ; acetaminophen  650  mg ; morphine sulfate  2-4  mg ; albuterol 0.083% neb soln  1  neb ; ipratropium bromide neb  1  neb ; metronidazole (flagyl)  500  mg ; insulin  0  unit ; flecainide acetate  50  mg ; sw  100  ml ; potassium chloride  20-40  meq ; potassium chloride  40-60  meq ; potassium chloride  60  meq ; magnesium sulfate  4  gm ; sw  50  ml ; magnesium sulfate  2-4  gm ; magnesium sulfate  2  gm ; calcium gluconate  2  g ; 0.9% sodium chloride  1  bag ; calcium gluconate  2-4  g ; calcium gluconate  4  g ; digoxin  0.125  mg ; aspirin  325  mg ; quetiapine fumarate  25  mg ; vancomycin oral liquid  500  mg ; miconazole powder 2%  1  appl ; sodium chloride 0.9%  flush  10  ml ; vial  1  vial ; pantoprazole sodium  40  mg ; nitazoxanide  500  mg ; ns (irrigation bottle)  250  ml ; hydrocodone-acetaminophen  1-2  tab ; albumin 25% (12.5g   50ml)  12.5  g ; furosemide  10  mg ; 
esophageal reflux chronic hepatitis c without mention of hepatic coma other diseases of lung, not elsewhere classified thrombocytopenia, unspecified other bipolar disorders long-term (current) use of aspirin atrial fibrillation other forms of keratitis pneumonitis due to inhalation of food or vomitus anisocoria other staphylococcal septicemia other specified cardiac dysrhythmias sepsis other nonspecific abnormal serum enzyme levels unspecified pleural effusion diarrhea dysphagia, unspecified anemia, unspecified chronic hepatitis c without mention of hepatic coma unspecified deficiency anemia schizoaffective disorder, chronic metabolic encephalopathy paralysis agitans atrial fibrillation pneumonia, organism unspecified thrombocytopenia, unspecified volume depletion, unspecified chronic airway obstruction, not elsewhere classified abrasion or friction burn of hip, thigh, leg, and ankle, without mention of infection unspecified fall other specified metabolic disorders sepsis atrial fibrillation other bipolar disorders unspecified protein-calorie malnutrition other disorders of plasma protein metabolism pneumonia, organism unspecified intestinal infection due to clostridium difficile pancytopenia unspecified septicemia edema bipolar disorder, unspecified hypoxemia esophageal reflux other and unspecified viral and rickettsial vaccines causing adverse effects in therapeutic use personal history of other infectious and parasitic diseases accidents occurring in unspecified place atrial fibrillation
white m 67 $nan$hematology blood hematocrit  29.7  %; hematology blood hemoglobin  9.8  g dl; hematology blood platelet count  68  k ul; chemistry blood anion gap  7  meq l; chemistry blood bicarbonate  28  meq l; chemistry blood chloride  108  meq l; chemistry blood creatinine  0.6  mg dl; chemistry blood potassium  3.7  meq l; chemistry blood sodium  139  meq l; chemistry blood urea nitrogen  18  mg dl; chemistry blood calcium, total  7.7  mg dl; chemistry blood glucose  88  mg dl$ns  100  ml ; sodium chloride 0.9%  flush  3  ml ; acetaminophen  650  mg ; morphine sulfate  2-4  mg ; albuterol 0.083% neb soln  1  neb ; ipratropium bromide neb  1  neb ; metronidazole (flagyl)  500  mg ; insulin  0  unit ; flecainide acetate  50  mg ; digoxin  0.125  mg ; aspirin  325  mg ; quetiapine fumarate  25  mg ; vancomycin oral liquid  500  mg ; miconazole powder 2%  1  appl ; sodium chloride 0.9%  flush  10  ml ; vial  1  vial ; pantoprazole sodium  40  mg ; nitazoxanide  500  mg ; hydrocodone-acetaminophen  1-2  tab ; 
esophageal reflux chronic hepatitis c without mention of hepatic coma other diseases of lung, not elsewhere classified thrombocytopenia, unspecified other bipolar disorders long-term (current) use of aspirin atrial fibrillation other forms of keratitis pneumonitis due to inhalation of food or vomitus anisocoria other staphylococcal septicemia other specified cardiac dysrhythmias sepsis other nonspecific abnormal serum enzyme levels unspecified pleural effusion diarrhea dysphagia, unspecified anemia, unspecified chronic hepatitis c without mention of hepatic coma unspecified deficiency anemia schizoaffective disorder, chronic metabolic encephalopathy paralysis agitans atrial fibrillation pneumonia, organism unspecified thrombocytopenia, unspecified volume depletion, unspecified chronic airway obstruction, not elsewhere classified abrasion or friction burn of hip, thigh, leg, and ankle, without mention of infection unspecified fall other specified metabolic disorders sepsis atrial fibrillation other bipolar disorders unspecified protein-calorie malnutrition other disorders of plasma protein metabolism pneumonia, organism unspecified intestinal infection due to clostridium difficile pancytopenia unspecified septicemia edema bipolar disorder, unspecified hypoxemia esophageal reflux other and unspecified viral and rickettsial vaccines causing adverse effects in therapeutic use personal history of other infectious and parasitic diseases accidents occurring in unspecified place atrial fibrillation
white m 67 $nan$chemistry blood anion gap  7  meq l; chemistry blood bicarbonate  29  meq l; chemistry blood chloride  109  meq l; chemistry blood creatinine  0.5  mg dl; chemistry blood potassium  4.0  meq l; chemistry blood sodium  141  meq l; chemistry blood urea nitrogen  21  mg dl; chemistry blood calcium, total  8.0  mg dl; chemistry blood glucose  87  mg dl$ns  100  ml ; sodium chloride 0.9%  flush  3  ml ; acetaminophen  650  mg ; morphine sulfate  2-4  mg ; albuterol 0.083% neb soln  1  neb ; ipratropium bromide neb  1  neb ; metronidazole (flagyl)  500  mg ; insulin  0  unit ; flecainide acetate  50  mg ; digoxin  0.125  mg ; aspirin  325  mg ; quetiapine fumarate  25  mg ; vancomycin oral liquid  500  mg ; miconazole powder 2%  1  appl ; sodium chloride 0.9%  flush  10  ml ; vial  1  vial ; pantoprazole sodium  40  mg ; nitazoxanide  500  mg ; 0.9% sodium chloride  250  ml ; potassium chloride  20  meq ; furosemide  20  mg ; 
esophageal reflux chronic hepatitis c without mention of hepatic coma other diseases of lung, not elsewhere classified thrombocytopenia, unspecified other bipolar disorders long-term (current) use of aspirin atrial fibrillation other forms of keratitis pneumonitis due to inhalation of food or vomitus anisocoria other staphylococcal septicemia other specified cardiac dysrhythmias sepsis other nonspecific abnormal serum enzyme levels unspecified pleural effusion diarrhea dysphagia, unspecified anemia, unspecified chronic hepatitis c without mention of hepatic coma unspecified deficiency anemia schizoaffective disorder, chronic metabolic encephalopathy paralysis agitans atrial fibrillation pneumonia, organism unspecified thrombocytopenia, unspecified volume depletion, unspecified chronic airway obstruction, not elsewhere classified abrasion or friction burn of hip, thigh, leg, and ankle, without mention of infection unspecified fall other specified metabolic disorders sepsis atrial fibrillation other bipolar disorders unspecified protein-calorie malnutrition other disorders of plasma protein metabolism pneumonia, organism unspecified intestinal infection due to clostridium difficile pancytopenia unspecified septicemia edema bipolar disorder, unspecified hypoxemia esophageal reflux other and unspecified viral and rickettsial vaccines causing adverse effects in therapeutic use personal history of other infectious and parasitic diseases accidents occurring in unspecified place atrial fibrillation
white m 67 $nan$hematology blood hematocrit  33.3  %; hematology blood hemoglobin  10.6  g dl; hematology blood platelet count  106  k ul; chemistry blood anion gap  8  meq l; chemistry blood bicarbonate  31  meq l; chemistry blood chloride  106  meq l; chemistry blood creatinine  0.6  mg dl; chemistry blood potassium  3.7  meq l; chemistry blood sodium  141  meq l; chemistry blood urea nitrogen  21  mg dl; chemistry blood calcium, total  7.9  mg dl; chemistry blood glucose  95  mg dl; chemistry blood albumin  2.1  g dl$sodium chloride 0.9%  flush  3  ml ; acetaminophen  650  mg ; morphine sulfate  2-4  mg ; albuterol 0.083% neb soln  1  neb ; ipratropium bromide neb  1  neb ; flecainide acetate  50  mg ; digoxin  0.125  mg ; aspirin  325  mg ; quetiapine fumarate  25  mg ; vancomycin oral liquid  500  mg ; miconazole powder 2%  1  appl ; sodium chloride 0.9%  flush  10  ml ; vial  1  vial ; pantoprazole sodium  40  mg ; neutra-phos  1  pkt ; fondaparinux sodium  2.5  mg ; 
esophageal reflux chronic hepatitis c without mention of hepatic coma other diseases of lung, not elsewhere classified thrombocytopenia, unspecified other bipolar disorders long-term (current) use of aspirin atrial fibrillation other forms of keratitis pneumonitis due to inhalation of food or vomitus anisocoria other staphylococcal septicemia other specified cardiac dysrhythmias sepsis other nonspecific abnormal serum enzyme levels unspecified pleural effusion diarrhea dysphagia, unspecified anemia, unspecified chronic hepatitis c without mention of hepatic coma unspecified deficiency anemia schizoaffective disorder, chronic metabolic encephalopathy paralysis agitans atrial fibrillation pneumonia, organism unspecified thrombocytopenia, unspecified volume depletion, unspecified chronic airway obstruction, not elsewhere classified abrasion or friction burn of hip, thigh, leg, and ankle, without mention of infection unspecified fall other specified metabolic disorders sepsis atrial fibrillation other bipolar disorders unspecified protein-calorie malnutrition other disorders of plasma protein metabolism pneumonia, organism unspecified intestinal infection due to clostridium difficile pancytopenia unspecified septicemia edema bipolar disorder, unspecified hypoxemia esophageal reflux other and unspecified viral and rickettsial vaccines causing adverse effects in therapeutic use personal history of other infectious and parasitic diseases accidents occurring in unspecified place atrial fibrillation
white m 67 $nan$hematology blood hematocrit  30.7  %; hematology blood hemoglobin  10.1  g dl; hematology blood platelet count  92  k ul; chemistry blood anion gap  9  meq l; chemistry blood bicarbonate  32  meq l; chemistry blood chloride  104  meq l; chemistry blood creatinine  0.5  mg dl; chemistry blood potassium  3.7  meq l; chemistry blood sodium  141  meq l; chemistry blood urea nitrogen  23  mg dl; chemistry blood calcium, total  7.5  mg dl; chemistry blood glucose  90  mg dl$sodium chloride 0.9%  flush  3  ml ; acetaminophen  650  mg ; morphine sulfate  2-4  mg ; albuterol 0.083% neb soln  1  neb ; ipratropium bromide neb  1  neb ; flecainide acetate  50  mg ; digoxin  0.125  mg ; aspirin  325  mg ; quetiapine fumarate  25  mg ; vancomycin oral liquid  500  mg ; miconazole powder 2%  1  appl ; sodium chloride 0.9%  flush  10  ml ; vial  1  vial ; pantoprazole sodium  40  mg ; fondaparinux sodium  2.5  mg ; potassium chloride  40  meq ; 
esophageal reflux chronic hepatitis c without mention of hepatic coma other diseases of lung, not elsewhere classified thrombocytopenia, unspecified other bipolar disorders long-term (current) use of aspirin atrial fibrillation other forms of keratitis pneumonitis due to inhalation of food or vomitus anisocoria other staphylococcal septicemia other specified cardiac dysrhythmias sepsis other nonspecific abnormal serum enzyme levels unspecified pleural effusion diarrhea dysphagia, unspecified anemia, unspecified chronic hepatitis c without mention of hepatic coma unspecified deficiency anemia schizoaffective disorder, chronic metabolic encephalopathy paralysis agitans atrial fibrillation pneumonia, organism unspecified thrombocytopenia, unspecified volume depletion, unspecified chronic airway obstruction, not elsewhere classified abrasion or friction burn of hip, thigh, leg, and ankle, without mention of infection unspecified fall other specified metabolic disorders sepsis atrial fibrillation other bipolar disorders unspecified protein-calorie malnutrition other disorders of plasma protein metabolism pneumonia, organism unspecified intestinal infection due to clostridium difficile pancytopenia unspecified septicemia edema bipolar disorder, unspecified hypoxemia esophageal reflux other and unspecified viral and rickettsial vaccines causing adverse effects in therapeutic use personal history of other infectious and parasitic diseases accidents occurring in unspecified place atrial fibrillation
white m 67 $nan$hematology blood hematocrit  32.1  %; hematology blood hemoglobin  10.3  g dl; hematology blood platelet count  101  k ul; chemistry blood anion gap  7  meq l; chemistry blood bicarbonate  33  meq l; chemistry blood chloride  105  meq l; chemistry blood creatinine  0.5  mg dl; chemistry blood potassium  4.5  meq l; chemistry blood sodium  140  meq l; chemistry blood urea nitrogen  24  mg dl; chemistry blood calcium, total  8.0  mg dl; chemistry blood glucose  92  mg dl$sodium chloride 0.9%  flush  3  ml ; acetaminophen  650  mg ; morphine sulfate  2-4  mg ; albuterol 0.083% neb soln  1  neb ; ipratropium bromide neb  1  neb ; flecainide acetate  50  mg ; digoxin  0.125  mg ; aspirin  325  mg ; quetiapine fumarate  25  mg ; vancomycin oral liquid  500  mg ; miconazole powder 2%  1  appl ; sodium chloride 0.9%  flush  10  ml ; vial  1  vial ; pantoprazole sodium  40  mg ; fondaparinux sodium  2.5  mg ; potassium chloride  40  meq ; metoprolol tartrate  2.5  mg ; 
esophageal reflux chronic hepatitis c without mention of hepatic coma other diseases of lung, not elsewhere classified thrombocytopenia, unspecified other bipolar disorders long-term (current) use of aspirin atrial fibrillation other forms of keratitis pneumonitis due to inhalation of food or vomitus anisocoria other staphylococcal septicemia other specified cardiac dysrhythmias sepsis other nonspecific abnormal serum enzyme levels unspecified pleural effusion diarrhea dysphagia, unspecified anemia, unspecified chronic hepatitis c without mention of hepatic coma unspecified deficiency anemia schizoaffective disorder, chronic metabolic encephalopathy paralysis agitans atrial fibrillation pneumonia, organism unspecified thrombocytopenia, unspecified volume depletion, unspecified chronic airway obstruction, not elsewhere classified abrasion or friction burn of hip, thigh, leg, and ankle, without mention of infection unspecified fall other specified metabolic disorders sepsis atrial fibrillation other bipolar disorders unspecified protein-calorie malnutrition other disorders of plasma protein metabolism pneumonia, organism unspecified intestinal infection due to clostridium difficile pancytopenia unspecified septicemia edema bipolar disorder, unspecified hypoxemia esophageal reflux other and unspecified viral and rickettsial vaccines causing adverse effects in therapeutic use personal history of other infectious and parasitic diseases accidents occurring in unspecified place atrial fibrillation
white m 67 $nan$hematology blood hematocrit  29.8  %; hematology blood hemoglobin  9.6  g dl; hematology blood platelet count  69  k ul; chemistry blood anion gap  6  meq l; chemistry blood bicarbonate  32  meq l; chemistry blood chloride  104  meq l; chemistry blood creatinine  0.5  mg dl; chemistry blood potassium  4.8  meq l; chemistry blood sodium  137  meq l; chemistry blood urea nitrogen  22  mg dl; chemistry blood calcium, total  7.8  mg dl; chemistry blood glucose  70  mg dl; hematology urine glucose  neg  mg dl; hematology urine bilirubin  neg  mg dl$sodium chloride 0.9%  flush  3  ml ; acetaminophen  650  mg ; morphine sulfate  2-4  mg ; albuterol 0.083% neb soln  1  neb ; ipratropium bromide neb  1  neb ; flecainide acetate  50  mg ; digoxin  0.125  mg ; aspirin  325  mg ; quetiapine fumarate  25  mg ; vancomycin oral liquid  500  mg ; miconazole powder 2%  1  appl ; sodium chloride 0.9%  flush  10  ml ; vial  1  vial ; pantoprazole sodium  40  mg ; fondaparinux sodium  2.5  mg ; metoprolol tartrate  2.5  mg ; heparin flush (10 units ml)  1  ml ; 
esophageal reflux chronic hepatitis c without mention of hepatic coma other diseases of lung, not elsewhere classified thrombocytopenia, unspecified other bipolar disorders long-term (current) use of aspirin atrial fibrillation other forms of keratitis pneumonitis due to inhalation of food or vomitus anisocoria other staphylococcal septicemia other specified cardiac dysrhythmias sepsis other nonspecific abnormal serum enzyme levels unspecified pleural effusion diarrhea dysphagia, unspecified anemia, unspecified chronic hepatitis c without mention of hepatic coma unspecified deficiency anemia schizoaffective disorder, chronic metabolic encephalopathy paralysis agitans atrial fibrillation pneumonia, organism unspecified thrombocytopenia, unspecified volume depletion, unspecified chronic airway obstruction, not elsewhere classified abrasion or friction burn of hip, thigh, leg, and ankle, without mention of infection unspecified fall other specified metabolic disorders sepsis atrial fibrillation other bipolar disorders unspecified protein-calorie malnutrition other disorders of plasma protein metabolism pneumonia, organism unspecified intestinal infection due to clostridium difficile pancytopenia unspecified septicemia edema bipolar disorder, unspecified hypoxemia esophageal reflux other and unspecified viral and rickettsial vaccines causing adverse effects in therapeutic use personal history of other infectious and parasitic diseases accidents occurring in unspecified place atrial fibrillation
white m 67 $nan$hematology blood hematocrit  31.8  %; hematology blood hemoglobin  10.4  g dl; hematology blood platelet count  66  k ul; chemistry blood anion gap  7  meq l; chemistry blood bicarbonate  32  meq l; chemistry blood chloride  104  meq l; chemistry blood creatinine  0.5  mg dl; chemistry blood potassium  4.8  meq l; chemistry blood sodium  138  meq l; chemistry blood urea nitrogen  19  mg dl; chemistry blood calcium, total  7.8  mg dl; chemistry blood bilirubin, total  1.1  mg dl; chemistry blood glucose  99  mg dl; chemistry blood lactate dehydrogenase (ld)  204  iu l; chemistry blood albumin  2.2  g dl$sodium chloride 0.9%  flush  3  ml ; acetaminophen  650  mg ; morphine sulfate  2-4  mg ; albuterol 0.083% neb soln  1  neb ; ipratropium bromide neb  1  neb ; flecainide acetate  50  mg ; digoxin  0.125  mg ; aspirin  325  mg ; quetiapine fumarate  25  mg ; vancomycin oral liquid  500  mg ; miconazole powder 2%  1  appl ; sodium chloride 0.9%  flush  10  ml ; vial  1  vial ; pantoprazole sodium  40  mg ; fondaparinux sodium  2.5  mg ; metoprolol tartrate  2.5  mg ; heparin flush (10 units ml)  1  ml ; nystatin oral suspension  5  ml ; vancomycin oral liquid  125  mg ; 
esophageal reflux chronic hepatitis c without mention of hepatic coma other diseases of lung, not elsewhere classified thrombocytopenia, unspecified other bipolar disorders long-term (current) use of aspirin atrial fibrillation other forms of keratitis pneumonitis due to inhalation of food or vomitus anisocoria other staphylococcal septicemia other specified cardiac dysrhythmias sepsis other nonspecific abnormal serum enzyme levels unspecified pleural effusion diarrhea dysphagia, unspecified anemia, unspecified chronic hepatitis c without mention of hepatic coma unspecified deficiency anemia schizoaffective disorder, chronic metabolic encephalopathy paralysis agitans atrial fibrillation pneumonia, organism unspecified thrombocytopenia, unspecified volume depletion, unspecified chronic airway obstruction, not elsewhere classified abrasion or friction burn of hip, thigh, leg, and ankle, without mention of infection unspecified fall other specified metabolic disorders sepsis atrial fibrillation other bipolar disorders unspecified protein-calorie malnutrition other disorders of plasma protein metabolism pneumonia, organism unspecified intestinal infection due to clostridium difficile pancytopenia unspecified septicemia edema bipolar disorder, unspecified hypoxemia esophageal reflux other and unspecified viral and rickettsial vaccines causing adverse effects in therapeutic use personal history of other infectious and parasitic diseases accidents occurring in unspecified place atrial fibrillation
white m 67 $nan$hematology blood hematocrit  28.9  %; hematology blood hemoglobin  9.7  g dl; hematology blood platelet count  49  k ul; chemistry blood anion gap  6  meq l; chemistry blood bicarbonate  32  meq l; chemistry blood chloride  103  meq l; chemistry blood creatinine  0.5  mg dl; chemistry blood potassium  4.7  meq l; chemistry blood sodium  136  meq l; chemistry blood urea nitrogen  20  mg dl; chemistry blood calcium, total  7.9  mg dl; chemistry blood glucose  96  mg dl; chemistry blood albumin  2.1  g dl$sodium chloride 0.9%  flush  3  ml ; acetaminophen  650  mg ; morphine sulfate  2-4  mg ; albuterol 0.083% neb soln  1  neb ; ipratropium bromide neb  1  neb ; flecainide acetate  50  mg ; digoxin  0.125  mg ; aspirin  325  mg ; quetiapine fumarate  25  mg ; miconazole powder 2%  1  appl ; sodium chloride 0.9%  flush  10  ml ; vial  1  vial ; pantoprazole sodium  40  mg ; fondaparinux sodium  2.5  mg ; metoprolol tartrate  2.5  mg ; heparin flush (10 units ml)  1  ml ; nystatin oral suspension  5  ml ; vancomycin oral liquid  125  mg ; 5% dextrose  25  ml ; acetazolamide sodium  250  mg ; 
esophageal reflux chronic hepatitis c without mention of hepatic coma other diseases of lung, not elsewhere classified thrombocytopenia, unspecified other bipolar disorders long-term (current) use of aspirin atrial fibrillation other forms of keratitis pneumonitis due to inhalation of food or vomitus anisocoria other staphylococcal septicemia other specified cardiac dysrhythmias sepsis other nonspecific abnormal serum enzyme levels unspecified pleural effusion diarrhea dysphagia, unspecified anemia, unspecified chronic hepatitis c without mention of hepatic coma unspecified deficiency anemia schizoaffective disorder, chronic metabolic encephalopathy paralysis agitans atrial fibrillation pneumonia, organism unspecified thrombocytopenia, unspecified volume depletion, unspecified chronic airway obstruction, not elsewhere classified abrasion or friction burn of hip, thigh, leg, and ankle, without mention of infection unspecified fall other specified metabolic disorders sepsis atrial fibrillation other bipolar disorders unspecified protein-calorie malnutrition other disorders of plasma protein metabolism pneumonia, organism unspecified intestinal infection due to clostridium difficile pancytopenia unspecified septicemia edema bipolar disorder, unspecified hypoxemia esophageal reflux other and unspecified viral and rickettsial vaccines causing adverse effects in therapeutic use personal history of other infectious and parasitic diseases accidents occurring in unspecified place atrial fibrillation
white m 67 $nan$hematology blood hematocrit  29.4  %; hematology blood hemoglobin  9.4  g dl; hematology blood platelet count  54  k ul; chemistry blood anion gap  7  meq l; chemistry blood bicarbonate  29  meq l; chemistry blood chloride  104  meq l; chemistry blood creatinine  0.5  mg dl; chemistry blood potassium  4.1  meq l; chemistry blood sodium  136  meq l; chemistry blood urea nitrogen  21  mg dl; chemistry blood calcium, total  8.0  mg dl; chemistry blood bilirubin, total  1.4  mg dl; chemistry blood glucose  93  mg dl$sodium chloride 0.9%  flush  3  ml ; acetaminophen  650  mg ; morphine sulfate  2-4  mg ; albuterol 0.083% neb soln  1  neb ; ipratropium bromide neb  1  neb ; flecainide acetate  50  mg ; digoxin  0.125  mg ; aspirin  325  mg ; quetiapine fumarate  25  mg ; miconazole powder 2%  1  appl ; sodium chloride 0.9%  flush  10  ml ; vial  1  vial ; pantoprazole sodium  40  mg ; fondaparinux sodium  2.5  mg ; metoprolol tartrate  2.5  mg ; heparin flush (10 units ml)  1  ml ; nystatin oral suspension  5  ml ; vancomycin oral liquid  125  mg ; 5% dextrose  25  ml ; acetazolamide sodium  250  mg ; iso-osmotic dextrose  200  ml ; vancomycin  1000  mg ; iso-osmotic sodium chloride  50  ml ; heparin flush (10 units ml)  2  ml ; iso-osmotic dextrose  100  ml ; piperacillin-tazobactam  4.5  g ; hydromorphone (dilaudid)  0.125  mg ; 
esophageal reflux chronic hepatitis c without mention of hepatic coma other diseases of lung, not elsewhere classified thrombocytopenia, unspecified other bipolar disorders long-term (current) use of aspirin atrial fibrillation other forms of keratitis pneumonitis due to inhalation of food or vomitus anisocoria other staphylococcal septicemia other specified cardiac dysrhythmias sepsis other nonspecific abnormal serum enzyme levels unspecified pleural effusion diarrhea dysphagia, unspecified anemia, unspecified chronic hepatitis c without mention of hepatic coma unspecified deficiency anemia schizoaffective disorder, chronic metabolic encephalopathy paralysis agitans atrial fibrillation pneumonia, organism unspecified thrombocytopenia, unspecified volume depletion, unspecified chronic airway obstruction, not elsewhere classified abrasion or friction burn of hip, thigh, leg, and ankle, without mention of infection unspecified fall other specified metabolic disorders sepsis atrial fibrillation other bipolar disorders unspecified protein-calorie malnutrition other disorders of plasma protein metabolism pneumonia, organism unspecified intestinal infection due to clostridium difficile pancytopenia unspecified septicemia edema bipolar disorder, unspecified hypoxemia esophageal reflux other and unspecified viral and rickettsial vaccines causing adverse effects in therapeutic use personal history of other infectious and parasitic diseases accidents occurring in unspecified place atrial fibrillation
white m 67 $nan$hematology blood hematocrit  28.8  %; hematology blood hemoglobin  9.0  g dl; hematology blood platelet count  53  k ul; chemistry blood anion gap  8  meq l; chemistry blood bicarbonate  24  meq l; chemistry blood chloride  108  meq l; chemistry blood creatinine  0.5  mg dl; chemistry blood potassium  3.8  meq l; chemistry blood sodium  136  meq l; chemistry blood urea nitrogen  20  mg dl; chemistry blood calcium, total  7.9  mg dl; chemistry blood glucose  95  mg dl$sodium chloride 0.9%  flush  3  ml ; acetaminophen  650  mg ; morphine sulfate  2-4  mg ; albuterol 0.083% neb soln  1  neb ; ipratropium bromide neb  1  neb ; flecainide acetate  50  mg ; digoxin  0.125  mg ; aspirin  325  mg ; quetiapine fumarate  25  mg ; miconazole powder 2%  1  appl ; sodium chloride 0.9%  flush  10  ml ; metoprolol tartrate  2.5  mg ; nystatin oral suspension  5  ml ; 5% dextrose  25  ml ; acetazolamide sodium  250  mg ; iso-osmotic sodium chloride  50  ml ; iso-osmotic dextrose  100  ml ; piperacillin-tazobactam  4.5  g ; hydromorphone (dilaudid)  0.125  mg ; 
esophageal reflux chronic hepatitis c without mention of hepatic coma other diseases of lung, not elsewhere classified thrombocytopenia, unspecified other bipolar disorders long-term (current) use of aspirin atrial fibrillation other forms of keratitis pneumonitis due to inhalation of food or vomitus anisocoria other staphylococcal septicemia other specified cardiac dysrhythmias sepsis other nonspecific abnormal serum enzyme levels unspecified pleural effusion diarrhea dysphagia, unspecified anemia, unspecified chronic hepatitis c without mention of hepatic coma unspecified deficiency anemia schizoaffective disorder, chronic metabolic encephalopathy paralysis agitans atrial fibrillation pneumonia, organism unspecified thrombocytopenia, unspecified volume depletion, unspecified chronic airway obstruction, not elsewhere classified abrasion or friction burn of hip, thigh, leg, and ankle, without mention of infection unspecified fall other specified metabolic disorders sepsis atrial fibrillation other bipolar disorders unspecified protein-calorie malnutrition other disorders of plasma protein metabolism pneumonia, organism unspecified intestinal infection due to clostridium difficile pancytopenia unspecified septicemia edema bipolar disorder, unspecified hypoxemia esophageal reflux other and unspecified viral and rickettsial vaccines causing adverse effects in therapeutic use personal history of other infectious and parasitic diseases accidents occurring in unspecified place atrial fibrillation
white m 67 $nan$hematology blood hematocrit  24.7  %; hematology blood hemoglobin  7.9  g dl; hematology blood platelet count  60  k ul; chemistry blood anion gap  8  meq l; chemistry blood anion gap  9  meq l; chemistry blood bicarbonate  22  meq l; chemistry blood bicarbonate  23  meq l; chemistry blood chloride  111  meq l; chemistry blood chloride  111  meq l; chemistry blood creatinine  0.6  mg dl; chemistry blood creatinine  0.6  mg dl; chemistry blood potassium  4.0  meq l; chemistry blood potassium  4.3  meq l; chemistry blood sodium  137  meq l; chemistry blood sodium  139  meq l; chemistry blood urea nitrogen  23  mg dl; chemistry blood urea nitrogen  23  mg dl; chemistry blood calcium, total  8.1  mg dl; chemistry blood glucose  102  mg dl; chemistry blood glucose  84  mg dl$sodium chloride 0.9%  flush  3  ml ; acetaminophen  650  mg ; morphine sulfate  2-4  mg ; albuterol 0.083% neb soln  1  neb ; ipratropium bromide neb  1  neb ; flecainide acetate  50  mg ; digoxin  0.125  mg ; aspirin  325  mg ; quetiapine fumarate  25  mg ; miconazole powder 2%  1  appl ; sodium chloride 0.9%  flush  10  ml ; metoprolol tartrate  2.5  mg ; nystatin oral suspension  5  ml ; hydromorphone (dilaudid)  0.125  mg ; 0.9% sodium chloride  50  ml ; daptomycin  300  mg ; 
esophageal reflux chronic hepatitis c without mention of hepatic coma other diseases of lung, not elsewhere classified thrombocytopenia, unspecified other bipolar disorders long-term (current) use of aspirin atrial fibrillation other forms of keratitis pneumonitis due to inhalation of food or vomitus anisocoria other staphylococcal septicemia other specified cardiac dysrhythmias sepsis other nonspecific abnormal serum enzyme levels unspecified pleural effusion diarrhea dysphagia, unspecified anemia, unspecified chronic hepatitis c without mention of hepatic coma unspecified deficiency anemia schizoaffective disorder, chronic metabolic encephalopathy paralysis agitans atrial fibrillation pneumonia, organism unspecified thrombocytopenia, unspecified volume depletion, unspecified chronic airway obstruction, not elsewhere classified abrasion or friction burn of hip, thigh, leg, and ankle, without mention of infection unspecified fall other specified metabolic disorders sepsis atrial fibrillation other bipolar disorders unspecified protein-calorie malnutrition other disorders of plasma protein metabolism pneumonia, organism unspecified intestinal infection due to clostridium difficile pancytopenia unspecified septicemia edema bipolar disorder, unspecified hypoxemia esophageal reflux other and unspecified viral and rickettsial vaccines causing adverse effects in therapeutic use personal history of other infectious and parasitic diseases accidents occurring in unspecified place atrial fibrillation
white m 67 $nan$hematology blood hematocrit  23.8  %; hematology blood hemoglobin  7.8  g dl; hematology blood platelet count  73  k ul; chemistry blood anion gap  8  meq l; chemistry blood bicarbonate  26  meq l; chemistry blood chloride  112  meq l; chemistry blood creatinine  0.6  mg dl; chemistry blood potassium  4.0  meq l; chemistry blood sodium  142  meq l; chemistry blood urea nitrogen  22  mg dl; chemistry blood calcium, total  7.5  mg dl; chemistry blood glucose  86  mg dl$sodium chloride 0.9%  flush  3  ml ; acetaminophen  650  mg ; morphine sulfate  2-4  mg ; albuterol 0.083% neb soln  1  neb ; ipratropium bromide neb  1  neb ; flecainide acetate  50  mg ; digoxin  0.125  mg ; aspirin  325  mg ; quetiapine fumarate  25  mg ; miconazole powder 2%  1  appl ; sodium chloride 0.9%  flush  10  ml ; metoprolol tartrate  2.5  mg ; nystatin oral suspension  5  ml ; hydromorphone (dilaudid)  0.125  mg ; 0.9% sodium chloride  50  ml ; daptomycin  300  mg ; 
esophageal reflux chronic hepatitis c without mention of hepatic coma other diseases of lung, not elsewhere classified thrombocytopenia, unspecified other bipolar disorders long-term (current) use of aspirin atrial fibrillation other forms of keratitis pneumonitis due to inhalation of food or vomitus anisocoria other staphylococcal septicemia other specified cardiac dysrhythmias sepsis other nonspecific abnormal serum enzyme levels unspecified pleural effusion diarrhea dysphagia, unspecified anemia, unspecified chronic hepatitis c without mention of hepatic coma unspecified deficiency anemia schizoaffective disorder, chronic metabolic encephalopathy paralysis agitans atrial fibrillation pneumonia, organism unspecified thrombocytopenia, unspecified volume depletion, unspecified chronic airway obstruction, not elsewhere classified abrasion or friction burn of hip, thigh, leg, and ankle, without mention of infection unspecified fall other specified metabolic disorders sepsis atrial fibrillation other bipolar disorders unspecified protein-calorie malnutrition other disorders of plasma protein metabolism pneumonia, organism unspecified intestinal infection due to clostridium difficile pancytopenia unspecified septicemia edema bipolar disorder, unspecified hypoxemia esophageal reflux other and unspecified viral and rickettsial vaccines causing adverse effects in therapeutic use personal history of other infectious and parasitic diseases accidents occurring in unspecified place atrial fibrillation
white m 67 $nan$hematology blood hematocrit  24.9  %; hematology blood hemoglobin  8.1  g dl; hematology blood platelet count  92  k ul; chemistry blood anion gap  7  meq l; chemistry blood bicarbonate  26  meq l; chemistry blood chloride  111  meq l; chemistry blood creatinine  0.5  mg dl; chemistry blood potassium  4.0  meq l; chemistry blood sodium  140  meq l; chemistry blood urea nitrogen  22  mg dl; chemistry blood calcium, total  8.1  mg dl; chemistry blood glucose  98  mg dl$sodium chloride 0.9%  flush  3  ml ; acetaminophen  650  mg ; morphine sulfate  2-4  mg ; albuterol 0.083% neb soln  1  neb ; ipratropium bromide neb  1  neb ; flecainide acetate  50  mg ; digoxin  0.125  mg ; aspirin  325  mg ; quetiapine fumarate  25  mg ; miconazole powder 2%  1  appl ; sodium chloride 0.9%  flush  10  ml ; metoprolol tartrate  2.5  mg ; nystatin oral suspension  5  ml ; hydromorphone (dilaudid)  0.125  mg ; 0.9% sodium chloride  50  ml ; daptomycin  300  mg ; hydromorphone (dilaudid)  2  mg ; 
esophageal reflux chronic hepatitis c without mention of hepatic coma other diseases of lung, not elsewhere classified thrombocytopenia, unspecified other bipolar disorders long-term (current) use of aspirin atrial fibrillation other forms of keratitis pneumonitis due to inhalation of food or vomitus anisocoria other staphylococcal septicemia other specified cardiac dysrhythmias sepsis other nonspecific abnormal serum enzyme levels unspecified pleural effusion diarrhea dysphagia, unspecified anemia, unspecified chronic hepatitis c without mention of hepatic coma unspecified deficiency anemia schizoaffective disorder, chronic metabolic encephalopathy paralysis agitans atrial fibrillation pneumonia, organism unspecified thrombocytopenia, unspecified volume depletion, unspecified chronic airway obstruction, not elsewhere classified abrasion or friction burn of hip, thigh, leg, and ankle, without mention of infection unspecified fall other specified metabolic disorders sepsis atrial fibrillation other bipolar disorders unspecified protein-calorie malnutrition other disorders of plasma protein metabolism pneumonia, organism unspecified intestinal infection due to clostridium difficile pancytopenia unspecified septicemia edema bipolar disorder, unspecified hypoxemia esophageal reflux other and unspecified viral and rickettsial vaccines causing adverse effects in therapeutic use personal history of other infectious and parasitic diseases accidents occurring in unspecified place atrial fibrillation
white m 67 $nan$hematology blood hematocrit  26.0  %; hematology blood hemoglobin  8.3  g dl; hematology blood platelet count  113  k ul; chemistry blood anion gap  8  meq l; chemistry blood bicarbonate  26  meq l; chemistry blood chloride  111  meq l; chemistry blood creatinine  0.5  mg dl; chemistry blood potassium  4.2  meq l; chemistry blood sodium  141  meq l; chemistry blood urea nitrogen  19  mg dl; chemistry blood calcium, total  7.8  mg dl; chemistry blood glucose  105  mg dl$sodium chloride 0.9%  flush  3  ml ; acetaminophen  650  mg ; albuterol 0.083% neb soln  1  neb ; ipratropium bromide neb  1  neb ; flecainide acetate  50  mg ; digoxin  0.125  mg ; aspirin  325  mg ; quetiapine fumarate  25  mg ; miconazole powder 2%  1  appl ; sodium chloride 0.9%  flush  10  ml ; metoprolol tartrate  2.5  mg ; nystatin oral suspension  5  ml ; 0.9% sodium chloride  50  ml ; daptomycin  300  mg ; hydromorphone (dilaudid)  2  mg ; 
esophageal reflux chronic hepatitis c without mention of hepatic coma other diseases of lung, not elsewhere classified thrombocytopenia, unspecified other bipolar disorders long-term (current) use of aspirin atrial fibrillation other forms of keratitis pneumonitis due to inhalation of food or vomitus anisocoria other staphylococcal septicemia other specified cardiac dysrhythmias sepsis other nonspecific abnormal serum enzyme levels unspecified pleural effusion diarrhea dysphagia, unspecified anemia, unspecified chronic hepatitis c without mention of hepatic coma unspecified deficiency anemia schizoaffective disorder, chronic metabolic encephalopathy paralysis agitans atrial fibrillation pneumonia, organism unspecified thrombocytopenia, unspecified volume depletion, unspecified chronic airway obstruction, not elsewhere classified abrasion or friction burn of hip, thigh, leg, and ankle, without mention of infection unspecified fall other specified metabolic disorders sepsis atrial fibrillation other bipolar disorders unspecified protein-calorie malnutrition other disorders of plasma protein metabolism pneumonia, organism unspecified intestinal infection due to clostridium difficile pancytopenia unspecified septicemia edema bipolar disorder, unspecified hypoxemia esophageal reflux other and unspecified viral and rickettsial vaccines causing adverse effects in therapeutic use personal history of other infectious and parasitic diseases accidents occurring in unspecified place atrial fibrillation
white m 47 $nan$hematology blood hematocrit  45.2  %; hematology blood hemoglobin  15.6  g dl; hematology blood platelet count  215  k ul; chemistry blood anion gap  14  meq l; chemistry blood bicarbonate  26  meq l; chemistry blood chloride  104  meq l; chemistry blood creatinine  1.0  mg dl; chemistry blood potassium  3.6  meq l; chemistry blood sodium  140  meq l; chemistry blood urea nitrogen  18  mg dl; chemistry blood calcium, total  9.9  mg dl; chemistry blood bilirubin, total  0.7  mg dl; chemistry blood glucose  84  mg dl; chemistry blood lactate dehydrogenase (ld)  154  iu l; chemistry blood albumin  4.5  g dl; chemistry blood % hemoglobin a1c  5.5  %$influenza virus vaccine  0.5  ml ; aspirin  325  mg ; acetaminophen  1000  mg ; sodium chloride 0.9%  flush  3  ml ; 0.9% sodium chloride  1000  ml ; acetaminophen  325-650  mg ; losartan potassium  100  mg ; labetalol  400  mg ; loratadine  10  mg ; heparin  5000  unit ; docusate sodium  100  mg ; senna  1  tab ; hydralazine  10  mg ; dextrose 50%  12.5  gm ; glucagon  1  mg ; glucose gel  15  g ; lorazepam  0.5  mg ; insulin  0  unit ; 
 
white m 47 $nan$nan$influenza virus vaccine  0.5  ml ; aspirin  325  mg ; acetaminophen  1000  mg ; sodium chloride 0.9%  flush  3  ml ; 0.9% sodium chloride  1000  ml ; acetaminophen  325-650  mg ; loratadine  10  mg ; heparin  5000  unit ; docusate sodium  100  mg ; senna  1  tab ; hydralazine  10  mg ; lorazepam  0.5  mg ; labetalol  200  mg ; 
 
white m 60 $nan$nan$insulin  26  unit ; aspirin  325  mg ; rosuvastatin calcium  40  mg ; lisinopril  5  mg ; 
 
white m 60 $nan$hematology blood hematocrit  53.8  %; hematology blood hematocrit  50.2  %; hematology blood hemoglobin  16.6  g dl; hematology blood hemoglobin  16.4  g dl; hematology blood platelet count  210  k ul; hematology blood platelet count  179  k ul; chemistry blood anion gap  15  meq l; chemistry blood anion gap  12  meq l; chemistry blood anion gap  14  meq l; chemistry blood bicarbonate  29  meq l; chemistry blood bicarbonate  27  meq l; chemistry blood bicarbonate  29  meq l; chemistry blood chloride  99  meq l; chemistry blood chloride  102  meq l; chemistry blood chloride  100  meq l; chemistry blood creatinine  1.3  mg dl; chemistry blood creatinine  1.2  mg dl; chemistry blood creatinine  1.2  mg dl; chemistry blood potassium  5.6  meq l; chemistry blood potassium  4.9  meq l; chemistry blood potassium  4.5  meq l; chemistry blood sodium  137  meq l; chemistry blood sodium  136  meq l; chemistry blood sodium  138  meq l; chemistry blood urea nitrogen  23  mg dl; chemistry blood urea nitrogen  22  mg dl; chemistry blood urea nitrogen  22  mg dl; hematology blood inr(pt)  1.4  ; hematology blood inr(pt)  1.4  ; chemistry blood calcium, total  8.8  mg dl; chemistry blood calcium, total  8.8  mg dl; chemistry blood calcium, total  8.8  mg dl; chemistry blood bilirubin, total  1.5  mg dl; chemistry blood glucose  195  mg dl; chemistry blood glucose  148  mg dl; chemistry blood glucose  196  mg dl; chemistry blood lactate dehydrogenase (ld)  294  iu l; chemistry blood albumin  4.3  g dl$insulin  26  unit ; aspirin  325  mg ; rosuvastatin calcium  40  mg ; lisinopril  5  mg ; sodium chloride 0.9%  flush  3  ml ; simethicone  40-80  mg ; diazepam  10  mg ; nitroglycerin sl  0.4  mg ; oxycodone-acetaminophen (5mg-325mg)  1  tab ; dextrose 50%  12.5  gm ; glucagon  1  mg ; glucose gel  15  g ; furosemide  20  mg ; insulin  0  unit ; heparin  5000  unit ; metoprolol tartrate  50  mg ; furosemide  40  mg ; bag  50  ml ; magnesium sulfate  2  gm ; gabapentin  300  mg ; magnesium oxide  400  mg ; 
 
white m 60 $nan$hematology blood hematocrit  52.2  %; hematology blood hemoglobin  16.2  g dl; hematology blood platelet count  161  k ul; chemistry blood anion gap  15  meq l; chemistry blood bicarbonate  29  meq l; chemistry blood chloride  102  meq l; chemistry blood chloride  102  meq l; chemistry blood chloride  98  meq l; chemistry blood creatinine  1.1  mg dl; chemistry blood potassium  4.4  meq l; chemistry blood potassium  4.6  meq l; chemistry blood potassium  4.3  meq l; chemistry blood sodium  141  meq l; chemistry blood sodium  141  meq l; chemistry blood sodium  142  meq l; chemistry blood urea nitrogen  23  mg dl; chemistry blood calcium, total  9.1  mg dl; chemistry blood glucose  163  mg dl$insulin  26  unit ; aspirin  325  mg ; rosuvastatin calcium  40  mg ; lisinopril  5  mg ; sodium chloride 0.9%  flush  3  ml ; simethicone  40-80  mg ; diazepam  10  mg ; oxycodone-acetaminophen (5mg-325mg)  1  tab ; dextrose 50%  12.5  gm ; glucagon  1  mg ; glucose gel  15  g ; furosemide  20  mg ; insulin  0  unit ; heparin  5000  unit ; furosemide  40  mg ; gabapentin  300  mg ; magnesium oxide  400  mg ; carvedilol  6.25  mg ; docusate sodium  100  mg ; carvedilol  12.5  mg ; senna  1  tab ; 
 
white m 60 $nan$hematology blood hematocrit  50.1  %; hematology blood hemoglobin  15.9  g dl; hematology blood platelet count  177  k ul; chemistry blood anion gap  16  meq l; chemistry blood bicarbonate  30  meq l; chemistry blood chloride  98  meq l; chemistry blood chloride  97  meq l; chemistry blood creatinine  1.1  mg dl; chemistry blood potassium  5.0  meq l; chemistry blood potassium  4.3  meq l; chemistry blood sodium  139  meq l; chemistry blood sodium  138  meq l; chemistry blood urea nitrogen  22  mg dl; chemistry blood calcium, total  9.0  mg dl; chemistry blood glucose  190  mg dl$insulin  26  unit ; aspirin  325  mg ; rosuvastatin calcium  40  mg ; lisinopril  5  mg ; sodium chloride 0.9%  flush  3  ml ; simethicone  40-80  mg ; diazepam  10  mg ; oxycodone-acetaminophen (5mg-325mg)  1  tab ; dextrose 50%  12.5  gm ; glucagon  1  mg ; glucose gel  15  g ; insulin  0  unit ; heparin  5000  unit ; furosemide  40  mg ; carvedilol  6.25  mg ; docusate sodium  100  mg ; carvedilol  12.5  mg ; senna  1  tab ; furosemide  80  mg ; 
 
white m 60 $nan$hematology blood hematocrit  50.5  %; hematology blood hemoglobin  15.9  g dl; hematology blood platelet count  189  k ul; chemistry blood anion gap  11  meq l; chemistry blood bicarbonate  35  meq l; chemistry blood chloride  98  meq l; chemistry blood creatinine  1.2  mg dl; chemistry blood potassium  4.7  meq l; chemistry blood sodium  139  meq l; chemistry blood urea nitrogen  28  mg dl; chemistry blood calcium, total  9.3  mg dl; chemistry blood glucose  126  mg dl$insulin  26  unit ; aspirin  325  mg ; rosuvastatin calcium  40  mg ; lisinopril  5  mg ; sodium chloride 0.9%  flush  3  ml ; simethicone  40-80  mg ; diazepam  10  mg ; oxycodone-acetaminophen (5mg-325mg)  1  tab ; dextrose 50%  12.5  gm ; glucagon  1  mg ; glucose gel  15  g ; insulin  0  unit ; heparin  5000  unit ; furosemide  40  mg ; docusate sodium  100  mg ; carvedilol  12.5  mg ; senna  1  tab ; furosemide  80  mg ; insulin  20  unit ; aspirin  81  mg ; 
 
white m 60 $nan$hematology blood hematocrit  51.3  %; hematology blood hemoglobin  16.3  g dl; hematology blood platelet count  176  k ul; chemistry blood anion gap  17  meq l; chemistry blood bicarbonate  30  meq l; chemistry blood chloride  95  meq l; chemistry blood chloride  96  meq l; chemistry blood chloride  97  meq l; chemistry blood creatinine  1.4  mg dl; chemistry blood potassium  4.5  meq l; chemistry blood potassium  4.8  meq l; chemistry blood potassium  4.5  meq l; chemistry blood sodium  140  meq l; chemistry blood sodium  138  meq l; chemistry blood sodium  138  meq l; chemistry blood urea nitrogen  34  mg dl; chemistry blood calcium, total  9.7  mg dl; chemistry blood glucose  122  mg dl$rosuvastatin calcium  40  mg ; lisinopril  5  mg ; sodium chloride 0.9%  flush  3  ml ; simethicone  40-80  mg ; diazepam  10  mg ; oxycodone-acetaminophen (5mg-325mg)  1  tab ; dextrose 50%  12.5  gm ; glucagon  1  mg ; glucose gel  15  g ; heparin  5000  unit ; docusate sodium  100  mg ; carvedilol  12.5  mg ; senna  1  tab ; insulin  20  unit ; aspirin  81  mg ; bisacodyl  10  mg ; polyethylene glycol  17  g ; 
 
white m 60 $nan$hematology blood hematocrit  49.6  %; hematology blood hemoglobin  16.1  g dl; hematology blood platelet count  167  k ul; chemistry blood anion gap  17  meq l; chemistry blood bicarbonate  31  meq l; chemistry blood chloride  94  meq l; chemistry blood creatinine  1.2  mg dl; chemistry blood potassium  4.6  meq l; chemistry blood sodium  137  meq l; chemistry blood urea nitrogen  32  mg dl; chemistry blood calcium, total  9.4  mg dl; chemistry blood glucose  166  mg dl$rosuvastatin calcium  40  mg ; lisinopril  5  mg ; sodium chloride 0.9%  flush  3  ml ; simethicone  40-80  mg ; diazepam  10  mg ; oxycodone-acetaminophen (5mg-325mg)  1  tab ; dextrose 50%  12.5  gm ; glucagon  1  mg ; glucose gel  15  g ; heparin  5000  unit ; docusate sodium  100  mg ; carvedilol  12.5  mg ; senna  1  tab ; aspirin  81  mg ; bisacodyl  10  mg ; polyethylene glycol  17  g ; insulin  15  unit ; 5% dextrose  50  ml ; furosemide  250  mg ; 
 
white m 60 $nan$hematology blood hematocrit  52.0  %; hematology blood hemoglobin  16.7  g dl; hematology blood platelet count  178  k ul; chemistry blood anion gap  15  meq l; chemistry blood bicarbonate  35  meq l; chemistry blood chloride  94  meq l; chemistry blood chloride  90  meq l; chemistry blood creatinine  1.4  mg dl; chemistry blood potassium  4.0  meq l; chemistry blood potassium  4.4  meq l; chemistry blood sodium  139  meq l; chemistry blood sodium  136  meq l; chemistry blood urea nitrogen  31  mg dl; chemistry blood calcium, total  9.4  mg dl; chemistry blood bilirubin, total  1.8  mg dl; chemistry blood glucose  103  mg dl$rosuvastatin calcium  40  mg ; lisinopril  5  mg ; sodium chloride 0.9%  flush  3  ml ; simethicone  40-80  mg ; diazepam  10  mg ; oxycodone-acetaminophen (5mg-325mg)  1  tab ; dextrose 50%  12.5  gm ; glucagon  1  mg ; glucose gel  15  g ; heparin  5000  unit ; docusate sodium  100  mg ; carvedilol  12.5  mg ; senna  1  tab ; aspirin  81  mg ; bisacodyl  10  mg ; polyethylene glycol  17  g ; insulin  15  unit ; 5% dextrose  50  ml ; furosemide  250  mg ; spironolactone  12.5  mg ; 
 
white m 60 $nan$hematology blood hematocrit  48.4  %; hematology blood hemoglobin  15.8  g dl; hematology blood platelet count  159  k ul; chemistry blood anion gap  15  meq l; chemistry blood bicarbonate  33  meq l; chemistry blood chloride  94  meq l; chemistry blood chloride  92  meq l; chemistry blood chloride  91  meq l; chemistry blood creatinine  1.4  mg dl; chemistry blood potassium  4.2  meq l; chemistry blood potassium  4.4  meq l; chemistry blood potassium  4.2  meq l; chemistry blood sodium  137  meq l; chemistry blood sodium  136  meq l; chemistry blood sodium  135  meq l; chemistry blood urea nitrogen  32  mg dl; chemistry blood calcium, total  9.3  mg dl; chemistry blood glucose  125  mg dl$rosuvastatin calcium  40  mg ; lisinopril  5  mg ; sodium chloride 0.9%  flush  3  ml ; simethicone  40-80  mg ; diazepam  10  mg ; oxycodone-acetaminophen (5mg-325mg)  1  tab ; dextrose 50%  12.5  gm ; glucagon  1  mg ; glucose gel  15  g ; heparin  5000  unit ; docusate sodium  100  mg ; carvedilol  12.5  mg ; senna  1  tab ; bisacodyl  10  mg ; polyethylene glycol  17  g ; insulin  15  unit ; spironolactone  12.5  mg ; niacin sr  500  mg ; 
 
white m 60 $nan$hematology blood hematocrit  49.5  %; hematology blood hemoglobin  15.8  g dl; hematology blood platelet count  167  k ul; chemistry blood anion gap  18  meq l; chemistry blood anion gap  14  meq l; chemistry blood bicarbonate  29  meq l; chemistry blood bicarbonate  35  meq l; chemistry blood chloride  92  meq l; chemistry blood chloride  91  meq l; chemistry blood creatinine  1.3  mg dl; chemistry blood creatinine  1.4  mg dl; chemistry blood potassium  4.4  meq l; chemistry blood potassium  4.3  meq l; chemistry blood sodium  135  meq l; chemistry blood sodium  136  meq l; chemistry blood urea nitrogen  32  mg dl; chemistry blood urea nitrogen  34  mg dl; chemistry blood calcium, total  9.3  mg dl; chemistry blood calcium, total  9.3  mg dl; chemistry blood glucose  125  mg dl; chemistry blood glucose  117  mg dl$rosuvastatin calcium  40  mg ; lisinopril  5  mg ; sodium chloride 0.9%  flush  3  ml ; simethicone  40-80  mg ; diazepam  10  mg ; oxycodone-acetaminophen (5mg-325mg)  1  tab ; dextrose 50%  12.5  gm ; glucagon  1  mg ; glucose gel  15  g ; heparin  5000  unit ; docusate sodium  100  mg ; carvedilol  12.5  mg ; senna  1  tab ; bisacodyl  10  mg ; polyethylene glycol  17  g ; insulin  15  unit ; spironolactone  12.5  mg ; niacin sr  500  mg ; acetaminophen  650  mg ; 
 
white m 60 $nan$hematology blood hematocrit  49.8  %; hematology blood hemoglobin  15.9  g dl; hematology blood platelet count  180  k ul; chemistry blood anion gap  12  meq l; chemistry blood bicarbonate  40  meq l; chemistry blood chloride  93  meq l; chemistry blood chloride  90  meq l; chemistry blood creatinine  1.5  mg dl; chemistry blood potassium  4.8  meq l; chemistry blood potassium  4.6  meq l; chemistry blood sodium  138  meq l; chemistry blood sodium  137  meq l; chemistry blood urea nitrogen  31  mg dl; chemistry blood calcium, total  9.8  mg dl; chemistry blood glucose  193  mg dl$rosuvastatin calcium  40  mg ; lisinopril  5  mg ; sodium chloride 0.9%  flush  3  ml ; simethicone  40-80  mg ; diazepam  10  mg ; oxycodone-acetaminophen (5mg-325mg)  1  tab ; dextrose 50%  12.5  gm ; glucagon  1  mg ; glucose gel  15  g ; heparin  5000  unit ; docusate sodium  100  mg ; carvedilol  12.5  mg ; senna  1  tab ; bisacodyl  10  mg ; polyethylene glycol  17  g ; insulin  15  unit ; spironolactone  12.5  mg ; niacin sr  500  mg ; acetaminophen  650  mg ; 
 
white m 60 $nan$hematology blood hematocrit  48.5  %; hematology blood hemoglobin  15.2  g dl; hematology blood platelet count  177  k ul; chemistry blood anion gap  10  meq l; chemistry blood bicarbonate  38  meq l; chemistry blood chloride  94  meq l; chemistry blood chloride  92  meq l; chemistry blood creatinine  1.4  mg dl; chemistry blood potassium  4.6  meq l; chemistry blood potassium  4.4  meq l; chemistry blood sodium  138  meq l; chemistry blood sodium  136  meq l; chemistry blood urea nitrogen  35  mg dl; chemistry blood glucose  135  mg dl$rosuvastatin calcium  40  mg ; lisinopril  5  mg ; sodium chloride 0.9%  flush  3  ml ; simethicone  40-80  mg ; diazepam  10  mg ; oxycodone-acetaminophen (5mg-325mg)  1  tab ; dextrose 50%  12.5  gm ; glucagon  1  mg ; glucose gel  15  g ; heparin  5000  unit ; docusate sodium  100  mg ; carvedilol  12.5  mg ; senna  1  tab ; bisacodyl  10  mg ; polyethylene glycol  17  g ; insulin  15  unit ; spironolactone  12.5  mg ; niacin sr  500  mg ; acetaminophen  650  mg ; oxycodone (immediate release)   5-10  mg ; sarna lotion  1  appl ; acetaminophen  1000  mg ; 
 
white m 60 $nan$hematology blood hematocrit  54.0  %; hematology blood hemoglobin  16.5  g dl; hematology blood platelet count  177  k ul; chemistry blood anion gap  17  meq l; chemistry blood bicarbonate  33  meq l; chemistry blood chloride  92  meq l; chemistry blood chloride  89  meq l; chemistry blood creatinine  1.4  mg dl; chemistry blood potassium  4.6  meq l; chemistry blood potassium  4.5  meq l; chemistry blood sodium  136  meq l; chemistry blood sodium  134  meq l; chemistry blood urea nitrogen  35  mg dl; chemistry blood glucose  242  mg dl; blood gas blood lactate  0.9  mmol l$rosuvastatin calcium  40  mg ; lisinopril  5  mg ; sodium chloride 0.9%  flush  3  ml ; simethicone  40-80  mg ; diazepam  10  mg ; dextrose 50%  12.5  gm ; glucagon  1  mg ; glucose gel  15  g ; heparin  5000  unit ; docusate sodium  100  mg ; carvedilol  12.5  mg ; senna  1  tab ; bisacodyl  10  mg ; polyethylene glycol  17  g ; insulin  15  unit ; spironolactone  12.5  mg ; niacin sr  500  mg ; oxycodone (immediate release)   5-10  mg ; sarna lotion  1  appl ; acetaminophen  1000  mg ; gabapentin  600  mg ; 
 
white m 60 $nan$hematology blood hematocrit  49.2  %; hematology blood hemoglobin  15.3  g dl; hematology blood platelet count  170  k ul; chemistry blood anion gap  15  meq l; chemistry blood bicarbonate  35  meq l; chemistry blood chloride  93  meq l; chemistry blood creatinine  1.3  mg dl; chemistry blood potassium  4.6  meq l; chemistry blood sodium  138  meq l; chemistry blood urea nitrogen  32  mg dl; chemistry blood calcium, total  9.4  mg dl; chemistry blood glucose  126  mg dl$rosuvastatin calcium  40  mg ; lisinopril  5  mg ; sodium chloride 0.9%  flush  3  ml ; simethicone  40-80  mg ; diazepam  10  mg ; dextrose 50%  12.5  gm ; glucagon  1  mg ; glucose gel  15  g ; heparin  5000  unit ; docusate sodium  100  mg ; carvedilol  12.5  mg ; senna  1  tab ; bisacodyl  10  mg ; polyethylene glycol  17  g ; insulin  15  unit ; spironolactone  12.5  mg ; niacin sr  500  mg ; oxycodone (immediate release)   5-10  mg ; sarna lotion  1  appl ; acetaminophen  1000  mg ; gabapentin  600  mg ; 
 
white m 60 $nan$hematology blood hematocrit  46.3  %; hematology blood hemoglobin  14.9  g dl; hematology blood platelet count  183  k ul; chemistry blood anion gap  15  meq l; chemistry blood bicarbonate  32  meq l; chemistry blood chloride  93  meq l; chemistry blood creatinine  1.4  mg dl; chemistry blood potassium  4.8  meq l; chemistry blood sodium  135  meq l; chemistry blood urea nitrogen  32  mg dl; chemistry blood glucose  204  mg dl$rosuvastatin calcium  40  mg ; lisinopril  5  mg ; sodium chloride 0.9%  flush  3  ml ; simethicone  40-80  mg ; diazepam  10  mg ; dextrose 50%  12.5  gm ; glucagon  1  mg ; glucose gel  15  g ; heparin  5000  unit ; docusate sodium  100  mg ; carvedilol  12.5  mg ; senna  1  tab ; bisacodyl  10  mg ; polyethylene glycol  17  g ; insulin  15  unit ; spironolactone  12.5  mg ; niacin sr  500  mg ; oxycodone (immediate release)   5-10  mg ; sarna lotion  1  appl ; acetaminophen  1000  mg ; gabapentin  600  mg ; 
 
white m 60 $nan$hematology blood hematocrit  46.5  %; hematology blood hemoglobin  14.9  g dl; hematology blood platelet count  184  k ul; chemistry blood anion gap  12  meq l; chemistry blood bicarbonate  36  meq l; chemistry blood chloride  95  meq l; chemistry blood creatinine  1.3  mg dl; chemistry blood potassium  4.7  meq l; chemistry blood sodium  138  meq l; chemistry blood urea nitrogen  29  mg dl; chemistry blood bilirubin, total  1.2  mg dl; chemistry blood glucose  94  mg dl; chemistry blood albumin  3.9  g dl; chemistry blood % hemoglobin a1c  8.3  %$rosuvastatin calcium  40  mg ; lisinopril  5  mg ; sodium chloride 0.9%  flush  3  ml ; simethicone  40-80  mg ; diazepam  10  mg ; dextrose 50%  12.5  gm ; glucagon  1  mg ; glucose gel  15  g ; heparin  5000  unit ; docusate sodium  100  mg ; carvedilol  12.5  mg ; senna  1  tab ; bisacodyl  10  mg ; polyethylene glycol  17  g ; insulin  15  unit ; spironolactone  12.5  mg ; niacin sr  500  mg ; oxycodone (immediate release)   5-10  mg ; sarna lotion  1  appl ; acetaminophen  1000  mg ; gabapentin  600  mg ; 
 
white m 60 $nan$hematology blood hematocrit  43.4  %; hematology blood hematocrit  47.9  %; hematology blood hemoglobin  14.8  g dl; hematology blood platelet count  180  k ul; chemistry blood anion gap  14  meq l; chemistry blood bicarbonate  35  meq l; chemistry blood chloride  92  meq l; chemistry blood creatinine  1.4  mg dl; chemistry blood potassium  5.1  meq l; chemistry blood sodium  136  meq l; chemistry blood urea nitrogen  30  mg dl; chemistry blood calcium, total  9.3  mg dl; chemistry blood glucose  114  mg dl$rosuvastatin calcium  40  mg ; lisinopril  5  mg ; sodium chloride 0.9%  flush  3  ml ; simethicone  40-80  mg ; diazepam  10  mg ; epsom salt  1  appl ; dextrose 50%  12.5  gm ; glucagon  1  mg ; glucose gel  15  g ; heparin  5000  unit ; docusate sodium  100  mg ; carvedilol  12.5  mg ; senna  1  tab ; bisacodyl  10  mg ; polyethylene glycol  17  g ; insulin  15  unit ; spironolactone  12.5  mg ; niacin sr  500  mg ; oxycodone (immediate release)   5-10  mg ; sarna lotion  1  appl ; acetaminophen  1000  mg ; gabapentin  600  mg ; 
 
white m 60 $nan$hematology blood hematocrit  46.4  %; hematology blood hemoglobin  15.3  g dl; hematology blood platelet count  169  k ul; chemistry blood anion gap  15  meq l; chemistry blood bicarbonate  32  meq l; chemistry blood chloride  94  meq l; chemistry blood creatinine  1.3  mg dl; chemistry blood potassium  4.7  meq l; chemistry blood sodium  136  meq l; chemistry blood urea nitrogen  32  mg dl; hematology blood inr(pt)  1.2  ; chemistry blood glucose  178  mg dl$rosuvastatin calcium  40  mg ; lisinopril  5  mg ; sodium chloride 0.9%  flush  3  ml ; simethicone  40-80  mg ; diazepam  10  mg ; epsom salt  1  appl ; dextrose 50%  12.5  gm ; glucagon  1  mg ; glucose gel  15  g ; heparin  5000  unit ; docusate sodium  100  mg ; senna  1  tab ; bisacodyl  10  mg ; polyethylene glycol  17  g ; insulin  15  unit ; spironolactone  12.5  mg ; niacin sr  500  mg ; oxycodone (immediate release)   5-10  mg ; sarna lotion  1  appl ; acetaminophen  1000  mg ; gabapentin  600  mg ; metoprolol tartrate  12.5  mg ; mupirocin nasal ointment 2%  1  appl ; 
 
white m 60 $nan$hematology blood hematocrit  45.6  %; hematology blood hemoglobin  15.1  g dl; hematology blood platelet count  160  k ul; chemistry blood anion gap  15  meq l; chemistry blood bicarbonate  30  meq l; chemistry blood chloride  95  meq l; chemistry blood creatinine  1.3  mg dl; chemistry blood potassium  4.6  meq l; chemistry blood sodium  135  meq l; chemistry blood urea nitrogen  30  mg dl; chemistry blood glucose  147  mg dl$rosuvastatin calcium  40  mg ; lisinopril  5  mg ; sodium chloride 0.9%  flush  3  ml ; simethicone  40-80  mg ; diazepam  10  mg ; epsom salt  1  appl ; dextrose 50%  12.5  gm ; glucagon  1  mg ; glucose gel  15  g ; heparin  5000  unit ; docusate sodium  100  mg ; senna  1  tab ; bisacodyl  10  mg ; polyethylene glycol  17  g ; insulin  15  unit ; spironolactone  12.5  mg ; niacin sr  500  mg ; oxycodone (immediate release)   5-10  mg ; sarna lotion  1  appl ; acetaminophen  1000  mg ; gabapentin  600  mg ; mupirocin nasal ointment 2%  1  appl ; 
 
white m 60 $nan$hematology blood hematocrit  33.3  %; hematology blood hemoglobin  10.8  g dl; hematology blood platelet count  136  k ul; hematology blood inr(pt)  1.6  ; blood gas blood free calcium  1.09  mmol l; blood gas blood free calcium  1.14  mmol l; blood gas blood lactate  1.1  mmol l; blood gas blood lactate  2.2  mmol l; blood gas blood chloride, whole blood  94  meq l; blood gas blood chloride, whole blood  98  meq l; blood gas blood glucose  113  mg dl; blood gas blood glucose  155  mg dl; blood gas blood glucose  175  mg dl; blood gas blood glucose  170  mg dl; blood gas blood hematocrit, calculated  44  %; blood gas blood hematocrit, calculated  32  %; blood gas blood hematocrit, calculated  32  %; blood gas blood hematocrit, calculated  33  %; blood gas blood hemoglobin  14.6  g dl; blood gas blood hemoglobin  10.6  g dl; blood gas blood hemoglobin  10.6  g dl; blood gas blood hemoglobin  11.0  g dl; blood gas blood potassium, whole blood  5.1  meq l; blood gas blood potassium, whole blood  5.3  meq l; blood gas blood potassium, whole blood  4.0  meq l; blood gas blood potassium, whole blood  6.4  meq l; blood gas blood sodium, whole blood  134  meq l; blood gas blood sodium, whole blood  133  meq l$rosuvastatin calcium  40  mg ; lisinopril  5  mg ; sodium chloride 0.9%  flush  3  ml ; simethicone  40-80  mg ; diazepam  10  mg ; epsom salt  1  appl ; dextrose 50%  12.5  gm ; glucagon  1  mg ; glucose gel  15  g ; heparin  5000  unit ; docusate sodium  100  mg ; senna  1  tab ; bisacodyl  10  mg ; polyethylene glycol  17  g ; insulin  15  unit ; spironolactone  12.5  mg ; niacin sr  500  mg ; oxycodone (immediate release)   5-10  mg ; sarna lotion  1  appl ; acetaminophen  1000  mg ; gabapentin  600  mg ; mupirocin nasal ointment 2%  1  appl ; pneumococcal vac polyvalent  0.5  ml ; 5% dextrose  500  ml ; vancomycin  1500  mg ; sodium chloride 0.9%  flush  10  ml ; lactated ringers  1000  ml ; 5% dextrose  250  ml ; sterile water  50  ml ; potassium chloride  20  meq ; 0.9% sodium chloride  100  ml ; calcium gluconate  2  g ; morphine sulfate  0.5-5  mg ; metoclopramide  10  mg ; oxycodone-acetaminophen (5mg-325mg)  1-2  tab ; iso-osmotic dextrose  50  ml ; cefazolin  2  g ; insulin human regular  100  unit ; milk of magnesia  30  ml ; aspirin ec  81  mg ; propofol  1000  mg ; d5w  250  ml ; nitroglycerin  100  mg ; glycopyrrolate  0.6  mg ; neostigmine  3  mg ; phenylephrine  60  mg ; 
 
white m 60 $nan$hematology blood hematocrit  39.9  %; hematology blood hematocrit  38.5  %; hematology blood hematocrit  37.2  %; hematology blood hematocrit  32.2  %; hematology blood hematocrit  33.0  %; hematology blood hemoglobin  12.6  g dl; hematology blood hemoglobin  12.4  g dl; hematology blood hemoglobin  10.8  g dl; hematology blood platelet count  161  k ul; hematology blood platelet count  148  k ul; hematology blood platelet count  133  k ul; chemistry blood anion gap  14  meq l; chemistry blood anion gap  14  meq l; chemistry blood anion gap  11  meq l; chemistry blood bicarbonate  28  meq l; chemistry blood bicarbonate  27  meq l; chemistry blood bicarbonate  30  meq l; chemistry blood chloride  101  meq l; chemistry blood chloride  102  meq l; chemistry blood chloride  100  meq l; chemistry blood chloride  103  meq l; chemistry blood creatinine  1.2  mg dl; chemistry blood creatinine  1.1  mg dl; chemistry blood creatinine  1.0  mg dl; chemistry blood potassium  4.4  meq l; chemistry blood potassium  4.8  meq l; chemistry blood potassium  4.4  meq l; chemistry blood potassium  4.6  meq l; chemistry blood sodium  139  meq l; chemistry blood sodium  138  meq l; chemistry blood sodium  136  meq l; chemistry blood sodium  139  meq l; chemistry blood urea nitrogen  28  mg dl; chemistry blood urea nitrogen  25  mg dl; chemistry blood urea nitrogen  19  mg dl; hematology blood inr(pt)  1.4  ; hematology blood inr(pt)  1.4  ; chemistry blood glucose  130  mg dl; chemistry blood glucose  184  mg dl; blood gas blood free calcium  1.14  mmol l; blood gas blood free calcium  1.15  mmol l; blood gas blood free calcium  1.19  mmol l; blood gas blood free calcium  1.13  mmol l; blood gas blood free calcium  1.16  mmol l; blood gas blood free calcium  1.05  mmol l; blood gas blood lactate  2.2  mmol l; blood gas blood lactate  1.5  mmol l; blood gas blood lactate  1.9  mmol l; blood gas blood lactate  1.3  mmol l; blood gas blood chloride, whole blood  100  meq l; blood gas blood glucose  178  mg dl; blood gas blood glucose  162  mg dl; blood gas blood glucose  132  mg dl; blood gas blood glucose  151  mg dl; blood gas blood glucose  150  mg dl; blood gas blood potassium, whole blood  4.1  meq l; blood gas blood potassium, whole blood  4.6  meq l; blood gas blood potassium, whole blood  4.8  meq l; blood gas blood potassium, whole blood  4.3  meq l; blood gas blood potassium, whole blood  4.6  meq l; blood gas blood potassium, whole blood  4.2  meq l; blood gas blood sodium, whole blood  135  meq l; blood gas blood sodium, whole blood  135  meq l$niacin sr  500  mg ; 5% dextrose  500  ml ; vancomycin  1500  mg ; sodium chloride 0.9%  flush  10  ml ; 5% dextrose  250  ml ; sterile water  50  ml ; potassium chloride  20  meq ; 0.9% sodium chloride  100  ml ; calcium gluconate  2  g ; morphine sulfate  0.5-5  mg ; metoclopramide  10  mg ; oxycodone-acetaminophen (5mg-325mg)  1-2  tab ; iso-osmotic dextrose  50  ml ; cefazolin  2  g ; insulin human regular  100  unit ; milk of magnesia  30  ml ; aspirin ec  81  mg ; propofol  1000  mg ; d5w  250  ml ; nitroglycerin  100  mg ; glycopyrrolate  0.6  mg ; neostigmine  3  mg ; phenylephrine  60  mg ; epinephrine  2  mg ; norepinephrine  8  mg ; 0.9% sodium chloride  1  bag ; calcium gluconate  300  mg ; ranitidine  150  mg ; chlorhexidine gluconate 0.12% oral rinse  15  ml ; albumin 5% (25g   500ml)  25  g ; epinephrine  8  mg ; 0.9% sodium chloride  50  ml ; dexmedetomidine  0.2  mg ; 
 
white m 60 $nan$hematology blood hematocrit  30.2  %; hematology blood hematocrit  30.4  %; hematology blood hemoglobin  9.8  g dl; hematology blood hemoglobin  10.0  g dl; hematology blood platelet count  105  k ul; chemistry blood anion gap  15  meq l; chemistry blood anion gap  16  meq l; chemistry blood bicarbonate  28  meq l; chemistry blood bicarbonate  26  meq l; chemistry blood chloride  103  meq l; chemistry blood chloride  98  meq l; chemistry blood creatinine  1.0  mg dl; chemistry blood creatinine  1.2  mg dl; chemistry blood potassium  4.9  meq l; chemistry blood potassium  5.0  meq l; chemistry blood sodium  141  meq l; chemistry blood sodium  135  meq l; chemistry blood urea nitrogen  18  mg dl; chemistry blood urea nitrogen  23  mg dl; chemistry blood calcium, total  9.0  mg dl; chemistry blood calcium, total  8.4  mg dl; chemistry blood glucose  158  mg dl; chemistry blood glucose  186  mg dl; blood gas blood free calcium  1.12  mmol l; blood gas blood lactate  1.2  mmol l$niacin sr  500  mg ; 5% dextrose  500  ml ; vancomycin  1500  mg ; sodium chloride 0.9%  flush  10  ml ; 5% dextrose  250  ml ; sterile water  50  ml ; potassium chloride  20  meq ; 0.9% sodium chloride  100  ml ; calcium gluconate  2  g ; morphine sulfate  0.5-5  mg ; metoclopramide  10  mg ; oxycodone-acetaminophen (5mg-325mg)  1-2  tab ; iso-osmotic dextrose  50  ml ; cefazolin  2  g ; insulin human regular  100  unit ; milk of magnesia  30  ml ; aspirin ec  81  mg ; propofol  1000  mg ; d5w  250  ml ; nitroglycerin  100  mg ; phenylephrine  60  mg ; norepinephrine  8  mg ; 0.9% sodium chloride  1  bag ; calcium gluconate  300  mg ; ranitidine  150  mg ; chlorhexidine gluconate 0.12% oral rinse  15  ml ; albumin 5% (25g   500ml)  25  g ; epinephrine  8  mg ; 0.9% sodium chloride  50  ml ; dexmedetomidine  0.2  mg ; ketorolac  15  mg ; acetaminophen iv  1000  mg ; tramadol (ultram)  50  mg ; amiodarone  400  mg ; amiodarone  150  mg ; 5% dextrose (excel bag)  500  ml ; amiodarone  600  mg ; albumin 5% (12.5g   250ml)  12.5  g ; insulin  10  unit ; 
 
white m 60 $nan$hematology blood hematocrit  27.6  %; hematology blood hemoglobin  9.1  g dl; hematology blood platelet count  100  k ul; chemistry blood anion gap  16  meq l; chemistry blood bicarbonate  25  meq l; chemistry blood chloride  98  meq l; chemistry blood chloride  96  meq l; chemistry blood creatinine  1.3  mg dl; chemistry blood potassium  4.8  meq l; chemistry blood potassium  4.5  meq l; chemistry blood sodium  134  meq l; chemistry blood sodium  131  meq l; chemistry blood urea nitrogen  34  mg dl; hematology blood inr(pt)  1.6  ; chemistry blood calcium, total  9.1  mg dl; chemistry blood glucose  190  mg dl; chemistry blood glucose  118  mg dl; blood gas blood glucose  174  mg dl; blood gas blood potassium, whole blood  5.1  meq l$niacin sr  500  mg ; sodium chloride 0.9%  flush  10  ml ; 5% dextrose  250  ml ; sterile water  50  ml ; potassium chloride  20  meq ; 0.9% sodium chloride  100  ml ; calcium gluconate  2  g ; metoclopramide  10  mg ; insulin human regular  100  unit ; milk of magnesia  30  ml ; aspirin ec  81  mg ; d5w  250  ml ; nitroglycerin  100  mg ; phenylephrine  60  mg ; norepinephrine  8  mg ; 0.9% sodium chloride  1  bag ; calcium gluconate  300  mg ; ranitidine  150  mg ; epinephrine  8  mg ; ketorolac  15  mg ; acetaminophen iv  1000  mg ; tramadol (ultram)  50  mg ; amiodarone  400  mg ; amiodarone  150  mg ; albumin 5% (12.5g   250ml)  12.5  g ; insulin  10  unit ; insulin  12  unit ; 
 
white m 60 $nan$hematology blood hematocrit  29.8  %; hematology blood hemoglobin  9.6  g dl; hematology blood platelet count  181  k ul; chemistry blood anion gap  16  meq l; chemistry blood bicarbonate  29  meq l; chemistry blood chloride  95  meq l; chemistry blood creatinine  1.4  mg dl; chemistry blood potassium  4.8  meq l; chemistry blood sodium  135  meq l; chemistry blood urea nitrogen  40  mg dl; chemistry blood calcium, total  8.2  mg dl; chemistry blood glucose  72  mg dl$niacin sr  500  mg ; sodium chloride 0.9%  flush  10  ml ; 5% dextrose  250  ml ; sterile water  50  ml ; potassium chloride  20  meq ; 0.9% sodium chloride  100  ml ; calcium gluconate  2  g ; insulin human regular  100  unit ; milk of magnesia  30  ml ; aspirin ec  81  mg ; d5w  250  ml ; nitroglycerin  100  mg ; ranitidine  150  mg ; acetaminophen iv  1000  mg ; tramadol (ultram)  50  mg ; amiodarone  400  mg ; metoprolol tartrate  6.25  mg ; albumin 25% (12.5g   50ml)  25  g ; lidocaine 1%  5  ml ; heparin flush (10 units ml)  2  ml ; sodium chloride 0.9%  flush  20  ml ; 
 
white m 60 $nan$hematology blood hematocrit  27.3  %; hematology blood hemoglobin  9.2  g dl; hematology blood platelet count  180  k ul; chemistry blood anion gap  15  meq l; chemistry blood bicarbonate  30  meq l; chemistry blood chloride  92  meq l; chemistry blood creatinine  1.7  mg dl; chemistry blood potassium  4.0  meq l; chemistry blood sodium  133  meq l; chemistry blood urea nitrogen  45  mg dl; hematology blood inr(pt)  1.9  ; hematology urine wbc  9  # hpf; chemistry blood glucose  71  mg dl$5% dextrose  250  ml ; sterile water  50  ml ; potassium chloride  20  meq ; 0.9% sodium chloride  100  ml ; calcium gluconate  2  g ; milk of magnesia  30  ml ; aspirin ec  81  mg ; acetaminophen iv  1000  mg ; tramadol (ultram)  50  mg ; metoprolol tartrate  6.25  mg ; albumin 25% (12.5g   50ml)  25  g ; lidocaine 1%  5  ml ; heparin flush (10 units ml)  2  ml ; sodium chloride 0.9%  flush  20  ml ; metolazone  5  mg ; albumin 25% (12.5g   50ml)  12.5  g ; 
 
white m 60 $nan$hematology blood hematocrit  29.0  %; hematology blood hemoglobin  9.5  g dl; hematology blood platelet count  211  k ul; chemistry blood anion gap  15  meq l; chemistry blood bicarbonate  32  meq l; chemistry blood chloride  93  meq l; chemistry blood creatinine  1.7  mg dl; chemistry blood potassium  4.0  meq l; chemistry blood sodium  136  meq l; chemistry blood urea nitrogen  48  mg dl; chemistry blood glucose  105  mg dl$albumin 25% (12.5g   50ml)  12.5  g ; 
 
white m 60 $nan$hematology blood hematocrit  29.6  %; hematology blood hemoglobin  9.5  g dl; hematology blood platelet count  258  k ul; chemistry blood anion gap  15  meq l; chemistry blood bicarbonate  35  meq l; chemistry blood chloride  92  meq l; chemistry blood chloride  92  meq l; chemistry blood creatinine  1.6  mg dl; chemistry blood potassium  4.4  meq l; chemistry blood potassium  3.8  meq l; chemistry blood sodium  136  meq l; chemistry blood sodium  138  meq l; chemistry blood urea nitrogen  45  mg dl; hematology blood inr(pt)  1.6  ; chemistry blood calcium, total  9.5  mg dl; chemistry blood glucose  105  mg dl$cephalexin  500  mg ; 
 
white m 60 $nan$nan$cephalexin  500  mg ; carvedilol  3.125  mg ; 
 
white m 65 $nan$nan$warfarin  12.5  mg ; 
unspecified essential hypertension other and unspecified angina pectoris coronary atherosclerosis of native coronary artery long-term (current) use of anticoagulants long-term (current) use of aspirin esophageal reflux anxiety state, unspecified personal history of tobacco use family history of ischemic heart disease atrial fibrillation arthropathy, unspecified, site unspecified personal history of venous thrombosis and embolism hypertrophy (benign) of prostate without urinary obstruction and other lower urinary tract symptom (luts) pure hypercholesterolemia person boarding or alighting a pedal cycle injured in collision with fixed or stationary object other forms of migraine, without mention of intractable migraine without mention of status migrainosus displacement of lumbar intervertebral disc without myelopathy displacement of lumbar intervertebral disc without myelopathy migraine, unspecified, without mention of intractable migraine without mention of status migrainosus 
white m 65 $nan$hematology blood hematocrit  44.2  %; hematology blood hemoglobin  12.5  g dl; hematology blood platelet count  180  k ul; chemistry blood anion gap  17  meq l; chemistry blood bicarbonate  23  meq l; chemistry blood chloride  108  meq l; chemistry blood creatinine  0.9  mg dl; chemistry blood potassium  4.4  meq l; chemistry blood sodium  144  meq l; chemistry blood urea nitrogen  16  mg dl; hematology blood inr(pt)  2.1  ; chemistry blood calcium, total  9.2  mg dl; chemistry blood glucose  108  mg dl$warfarin  12.5  mg ; influenza vaccine quadrivalent  0.5  ml ; pneumococcal 23-valent polysaccharide vaccine  0.5  ml ; sodium chloride 0.9%  flush  3  ml ; aspirin ec  81  mg ; clopidogrel  75  mg ; lisinopril  2.5  mg ; multivitamins  1  tab ; topiramate (topamax)  75  mg ; metoprolol tartrate  12.5  mg ; furosemide  20  mg ; amitriptyline  40  mg ; gabapentin  600  mg ; topiramate (topamax)  50  mg ; gabapentin  1200  mg ; atorvastatin  80  mg ; warfarin  10  mg ; metoprolol tartrate  25  mg ; hydrocodone-acetaminophen (5mg-325mg)  1  tab ; 
unspecified essential hypertension other and unspecified angina pectoris coronary atherosclerosis of native coronary artery long-term (current) use of anticoagulants long-term (current) use of aspirin esophageal reflux anxiety state, unspecified personal history of tobacco use family history of ischemic heart disease atrial fibrillation arthropathy, unspecified, site unspecified personal history of venous thrombosis and embolism hypertrophy (benign) of prostate without urinary obstruction and other lower urinary tract symptom (luts) pure hypercholesterolemia person boarding or alighting a pedal cycle injured in collision with fixed or stationary object other forms of migraine, without mention of intractable migraine without mention of status migrainosus displacement of lumbar intervertebral disc without myelopathy displacement of lumbar intervertebral disc without myelopathy migraine, unspecified, without mention of intractable migraine without mention of status migrainosus 
white m 65 $nan$hematology blood hematocrit  40.5  %; hematology blood hemoglobin  11.9  g dl; hematology blood platelet count  173  k ul; chemistry blood anion gap  15  meq l; chemistry blood bicarbonate  26  meq l; chemistry blood chloride  107  meq l; chemistry blood creatinine  1.1  mg dl; chemistry blood potassium  4.9  meq l; chemistry blood sodium  143  meq l; chemistry blood urea nitrogen  19  mg dl; hematology blood inr(pt)  2.7  ; chemistry blood calcium, total  9.2  mg dl; chemistry blood glucose  113  mg dl$warfarin  12.5  mg ; influenza vaccine quadrivalent  0.5  ml ; pneumococcal 23-valent polysaccharide vaccine  0.5  ml ; sodium chloride 0.9%  flush  3  ml ; aspirin ec  81  mg ; clopidogrel  75  mg ; multivitamins  1  tab ; topiramate (topamax)  75  mg ; furosemide  20  mg ; gabapentin  600  mg ; topiramate (topamax)  50  mg ; gabapentin  1200  mg ; atorvastatin  80  mg ; warfarin  10  mg ; metoprolol tartrate  25  mg ; hydrocodone-acetaminophen (5mg-325mg)  1  tab ; hydrocodone-acetaminophen (5mg-325mg)  2  tab ; 
unspecified essential hypertension other and unspecified angina pectoris coronary atherosclerosis of native coronary artery long-term (current) use of anticoagulants long-term (current) use of aspirin esophageal reflux anxiety state, unspecified personal history of tobacco use family history of ischemic heart disease atrial fibrillation arthropathy, unspecified, site unspecified personal history of venous thrombosis and embolism hypertrophy (benign) of prostate without urinary obstruction and other lower urinary tract symptom (luts) pure hypercholesterolemia person boarding or alighting a pedal cycle injured in collision with fixed or stationary object other forms of migraine, without mention of intractable migraine without mention of status migrainosus displacement of lumbar intervertebral disc without myelopathy displacement of lumbar intervertebral disc without myelopathy migraine, unspecified, without mention of intractable migraine without mention of status migrainosus 
white m 65 $nan$hematology blood hematocrit  42.0  %; hematology blood hemoglobin  12.1  g dl; hematology blood platelet count  204  k ul; chemistry blood anion gap  14  meq l; chemistry blood bicarbonate  25  meq l; chemistry blood chloride  108  meq l; chemistry blood creatinine  1.1  mg dl; chemistry blood potassium  4.5  meq l; chemistry blood sodium  142  meq l; chemistry blood urea nitrogen  21  mg dl; hematology blood inr(pt)  2.7  ; chemistry blood calcium, total  9.4  mg dl; chemistry blood glucose  110  mg dl$warfarin  12.5  mg ; influenza vaccine quadrivalent  0.5  ml ; pneumococcal 23-valent polysaccharide vaccine  0.5  ml ; sodium chloride 0.9%  flush  3  ml ; aspirin ec  81  mg ; clopidogrel  75  mg ; multivitamins  1  tab ; topiramate (topamax)  75  mg ; gabapentin  600  mg ; topiramate (topamax)  50  mg ; gabapentin  1200  mg ; atorvastatin  80  mg ; warfarin  10  mg ; hydrocodone-acetaminophen (5mg-325mg)  2  tab ; 
unspecified essential hypertension other and unspecified angina pectoris coronary atherosclerosis of native coronary artery long-term (current) use of anticoagulants long-term (current) use of aspirin esophageal reflux anxiety state, unspecified personal history of tobacco use family history of ischemic heart disease atrial fibrillation arthropathy, unspecified, site unspecified personal history of venous thrombosis and embolism hypertrophy (benign) of prostate without urinary obstruction and other lower urinary tract symptom (luts) pure hypercholesterolemia person boarding or alighting a pedal cycle injured in collision with fixed or stationary object other forms of migraine, without mention of intractable migraine without mention of status migrainosus displacement of lumbar intervertebral disc without myelopathy displacement of lumbar intervertebral disc without myelopathy migraine, unspecified, without mention of intractable migraine without mention of status migrainosus 
white m 65 $nan$chemistry blood anion gap  11  meq l; chemistry blood bicarbonate  27  meq l; chemistry blood chloride  108  meq l; chemistry blood creatinine  1.0  mg dl; chemistry blood potassium  4.4  meq l; chemistry blood sodium  142  meq l; chemistry blood urea nitrogen  22  mg dl; hematology blood inr(pt)  2.6  ; chemistry blood glucose  105  mg dl$warfarin  12.5  mg ; influenza vaccine quadrivalent  0.5  ml ; pneumococcal 23-valent polysaccharide vaccine  0.5  ml ; sodium chloride 0.9%  flush  3  ml ; aspirin ec  81  mg ; clopidogrel  75  mg ; multivitamins  1  tab ; topiramate (topamax)  75  mg ; gabapentin  600  mg ; topiramate (topamax)  50  mg ; gabapentin  1200  mg ; atorvastatin  80  mg ; warfarin  10  mg ; hydrocodone-acetaminophen (5mg-325mg)  2  tab ; dofetilide  500  mcg ; magnesium oxide  400  mg ; metoprolol succinate xl  100  mg ; 
unspecified essential hypertension other and unspecified angina pectoris coronary atherosclerosis of native coronary artery long-term (current) use of anticoagulants long-term (current) use of aspirin esophageal reflux anxiety state, unspecified personal history of tobacco use family history of ischemic heart disease atrial fibrillation arthropathy, unspecified, site unspecified personal history of venous thrombosis and embolism hypertrophy (benign) of prostate without urinary obstruction and other lower urinary tract symptom (luts) pure hypercholesterolemia person boarding or alighting a pedal cycle injured in collision with fixed or stationary object other forms of migraine, without mention of intractable migraine without mention of status migrainosus displacement of lumbar intervertebral disc without myelopathy displacement of lumbar intervertebral disc without myelopathy migraine, unspecified, without mention of intractable migraine without mention of status migrainosus 
white m 65 $nan$chemistry blood anion gap  12  meq l; chemistry blood bicarbonate  28  meq l; chemistry blood chloride  109  meq l; chemistry blood creatinine  1.0  mg dl; chemistry blood potassium  4.9  meq l; chemistry blood sodium  144  meq l; chemistry blood urea nitrogen  22  mg dl; hematology blood inr(pt)  2.6  ; chemistry blood glucose  102  mg dl$warfarin  12.5  mg ; influenza vaccine quadrivalent  0.5  ml ; pneumococcal 23-valent polysaccharide vaccine  0.5  ml ; sodium chloride 0.9%  flush  3  ml ; aspirin ec  81  mg ; clopidogrel  75  mg ; multivitamins  1  tab ; topiramate (topamax)  75  mg ; gabapentin  600  mg ; topiramate (topamax)  50  mg ; gabapentin  1200  mg ; atorvastatin  80  mg ; warfarin  10  mg ; hydrocodone-acetaminophen (5mg-325mg)  2  tab ; dofetilide  500  mcg ; magnesium oxide  400  mg ; metoprolol succinate xl  100  mg ; metoprolol succinate xl  50  mg ; 
unspecified essential hypertension other and unspecified angina pectoris coronary atherosclerosis of native coronary artery long-term (current) use of anticoagulants long-term (current) use of aspirin esophageal reflux anxiety state, unspecified personal history of tobacco use family history of ischemic heart disease atrial fibrillation arthropathy, unspecified, site unspecified personal history of venous thrombosis and embolism hypertrophy (benign) of prostate without urinary obstruction and other lower urinary tract symptom (luts) pure hypercholesterolemia person boarding or alighting a pedal cycle injured in collision with fixed or stationary object other forms of migraine, without mention of intractable migraine without mention of status migrainosus displacement of lumbar intervertebral disc without myelopathy displacement of lumbar intervertebral disc without myelopathy migraine, unspecified, without mention of intractable migraine without mention of status migrainosus 
white m 65 $nan$chemistry blood anion gap  14  meq l; chemistry blood bicarbonate  26  meq l; chemistry blood chloride  107  meq l; chemistry blood creatinine  1.0  mg dl; chemistry blood potassium  4.0  meq l; chemistry blood sodium  143  meq l; chemistry blood urea nitrogen  17  mg dl; hematology blood inr(pt)  2.3  ; chemistry blood calcium, total  9.6  mg dl; chemistry blood glucose  100  mg dl$warfarin  12.5  mg ; influenza vaccine quadrivalent  0.5  ml ; pneumococcal 23-valent polysaccharide vaccine  0.5  ml ; sodium chloride 0.9%  flush  3  ml ; aspirin ec  81  mg ; clopidogrel  75  mg ; multivitamins  1  tab ; topiramate (topamax)  75  mg ; gabapentin  600  mg ; topiramate (topamax)  50  mg ; gabapentin  1200  mg ; atorvastatin  80  mg ; warfarin  10  mg ; magnesium oxide  400  mg ; metoprolol succinate xl  50  mg ; 
unspecified essential hypertension other and unspecified angina pectoris coronary atherosclerosis of native coronary artery long-term (current) use of anticoagulants long-term (current) use of aspirin esophageal reflux anxiety state, unspecified personal history of tobacco use family history of ischemic heart disease atrial fibrillation arthropathy, unspecified, site unspecified personal history of venous thrombosis and embolism hypertrophy (benign) of prostate without urinary obstruction and other lower urinary tract symptom (luts) pure hypercholesterolemia person boarding or alighting a pedal cycle injured in collision with fixed or stationary object other forms of migraine, without mention of intractable migraine without mention of status migrainosus displacement of lumbar intervertebral disc without myelopathy displacement of lumbar intervertebral disc without myelopathy migraine, unspecified, without mention of intractable migraine without mention of status migrainosus 
white m 65 $nan$nan$warfarin  12.5  mg ; influenza vaccine quadrivalent  0.5  ml ; pneumococcal 23-valent polysaccharide vaccine  0.5  ml ; sodium chloride 0.9%  flush  3  ml ; aspirin ec  81  mg ; clopidogrel  75  mg ; multivitamins  1  tab ; topiramate (topamax)  75  mg ; gabapentin  600  mg ; topiramate (topamax)  50  mg ; gabapentin  1200  mg ; atorvastatin  80  mg ; warfarin  10  mg ; magnesium oxide  400  mg ; 
unspecified essential hypertension other and unspecified angina pectoris coronary atherosclerosis of native coronary artery long-term (current) use of anticoagulants long-term (current) use of aspirin esophageal reflux anxiety state, unspecified personal history of tobacco use family history of ischemic heart disease atrial fibrillation arthropathy, unspecified, site unspecified personal history of venous thrombosis and embolism hypertrophy (benign) of prostate without urinary obstruction and other lower urinary tract symptom (luts) pure hypercholesterolemia person boarding or alighting a pedal cycle injured in collision with fixed or stationary object other forms of migraine, without mention of intractable migraine without mention of status migrainosus displacement of lumbar intervertebral disc without myelopathy displacement of lumbar intervertebral disc without myelopathy migraine, unspecified, without mention of intractable migraine without mention of status migrainosus 
white m 76 $nan$nan$acetaminophen  1000  mg ; albuterol inhaler  2  puff ; metoprolol tartrate  12.5  mg ; tamsulosin  0.4  mg ; vitamin d  1000  unit ; sodium chloride 0.9%  flush  3-10  ml ; lactated ringers  1000  ml ; iso-osmotic dextrose  50  ml ; cefazolin  2  g ; oxycodone (immediate release)  2.5-5  mg ; oxycodone (immediate release)  5-20  mg ; hydromorphone (dilaudid)  0.2-0.6  mg ; ondansetron  4  mg ; apixaban  5  mg ; docusate sodium  100  mg ; 
closed fracture of unspecified part of neck of femur other specified metabolic disorders unspecified fall other specified retention of urine other activity involving other sports and athletics played individually methicillin susceptible staphylococcus aureus in conditions classified elsewhere and of unspecified site abscess of anal and rectal regions hypertrophy (benign) of prostate without urinary obstruction and other lower urinary tract symptom (luts) infection with microorganisms resistant to penicillins pedestrian injured in nontraffic accident involving other and unspecified motor vehicles
white m 76 $nan$nan$acetaminophen  1000  mg ; albuterol inhaler  2  puff ; metoprolol tartrate  12.5  mg ; tamsulosin  0.4  mg ; vitamin d  1000  unit ; sodium chloride 0.9%  flush  3-10  ml ; lactated ringers  1000  ml ; iso-osmotic dextrose  50  ml ; cefazolin  2  g ; oxycodone (immediate release)  2.5-5  mg ; oxycodone (immediate release)  5-20  mg ; hydromorphone (dilaudid)  0.2-0.6  mg ; ondansetron  4  mg ; apixaban  5  mg ; docusate sodium  100  mg ; 
closed fracture of unspecified part of neck of femur other specified metabolic disorders unspecified fall other specified retention of urine other activity involving other sports and athletics played individually methicillin susceptible staphylococcus aureus in conditions classified elsewhere and of unspecified site abscess of anal and rectal regions hypertrophy (benign) of prostate without urinary obstruction and other lower urinary tract symptom (luts) infection with microorganisms resistant to penicillins pedestrian injured in nontraffic accident involving other and unspecified motor vehicles
white m 81 $nan$nan$finasteride  5  mg ; multivitamins  1  tab ; 
gross hematuria tobacco use disorder constipation, unspecified solitary pulmonary nodule other ureteric obstruction acute kidney failure, unspecified malignant neoplasm of lateral wall of urinary bladder hydronephrosis other postprocedural status unspecified acquired hypothyroidism nonspecific abnormal results of function study of thyroid unspecified essential hypertension acute posthemorrhagic anemia 
white m 81 $nan$hematology blood hematocrit  19.1  %; hematology blood hematocrit  21.3  %; hematology blood hemoglobin  6.2  g dl; hematology blood hemoglobin  6.8  g dl; hematology blood platelet count  370  k ul; hematology blood platelet count  415  k ul; chemistry blood anion gap  13  meq l; chemistry blood anion gap  12  meq l; chemistry blood bicarbonate  26  meq l; chemistry blood bicarbonate  26  meq l; chemistry blood chloride  107  meq l; chemistry blood chloride  105  meq l; chemistry blood creatinine  2.0  mg dl; chemistry blood creatinine  2.0  mg dl; chemistry blood potassium  4.8  meq l; chemistry blood potassium  4.8  meq l; chemistry blood sodium  141  meq l; chemistry blood sodium  138  meq l; chemistry blood urea nitrogen  36  mg dl; chemistry blood urea nitrogen  34  mg dl; chemistry blood glucose  111  mg dl; chemistry blood glucose  100  mg dl$finasteride  5  mg ; multivitamins  1  tab ; albuterol-ipratropium  1-2  puff ; albuterol 0.083% neb soln  1  neb ; ipratropium bromide neb  1  neb ; sodium chloride 0.9%  flush  3  ml ; d5lr  1000  ml ; acetaminophen  325-650  mg ; oxycodone-acetaminophen (5mg-325mg)  1  tab ; bisacodyl  10  mg ; polyethylene glycol  17  g ; fluticasone-salmeterol diskus (500 50)   1  inh ; docusate sodium  100  mg ; metoprolol tartrate  25  mg ; tamsulosin  0.4  mg ; levothyroxine sodium  75  mcg ; 
gross hematuria tobacco use disorder constipation, unspecified solitary pulmonary nodule other ureteric obstruction acute kidney failure, unspecified malignant neoplasm of lateral wall of urinary bladder hydronephrosis other postprocedural status unspecified acquired hypothyroidism nonspecific abnormal results of function study of thyroid unspecified essential hypertension acute posthemorrhagic anemia 
white m 81 $nan$hematology blood hematocrit  25.7  %$finasteride  5  mg ; multivitamins  1  tab ; albuterol-ipratropium  1-2  puff ; albuterol 0.083% neb soln  1  neb ; ipratropium bromide neb  1  neb ; sodium chloride 0.9%  flush  3  ml ; d5lr  1000  ml ; acetaminophen  325-650  mg ; oxycodone-acetaminophen (5mg-325mg)  1  tab ; bisacodyl  10  mg ; polyethylene glycol  17  g ; fluticasone-salmeterol diskus (500 50)   1  inh ; docusate sodium  100  mg ; metoprolol tartrate  25  mg ; tamsulosin  0.4  mg ; levothyroxine sodium  75  mcg ; lidocaine jelly 2% (urojet)  1  appl ; 
gross hematuria tobacco use disorder constipation, unspecified solitary pulmonary nodule other ureteric obstruction acute kidney failure, unspecified malignant neoplasm of lateral wall of urinary bladder hydronephrosis other postprocedural status unspecified acquired hypothyroidism nonspecific abnormal results of function study of thyroid unspecified essential hypertension acute posthemorrhagic anemia 
black african american f 56 $temp  99.3  heartrate  74.0  resprate  20.0  o2sat  100.0  sbp  131.0  dbp  73.0  rhythm    pain  5  ; temp    heartrate  68.0  resprate  18.0  o2sat  100.0  sbp  139.0  dbp  70.0  rhythm    pain  denies  ; temp    heartrate  64.0  resprate  18.0  o2sat  100.0  sbp  140.0  dbp  66.0  rhythm    pain  0  $hematology blood hematocrit  35.1  %; hematology blood hemoglobin  11.9  g dl; hematology blood platelet count  184  k ul; chemistry blood anion gap  16  meq l; chemistry blood bicarbonate  21  meq l; chemistry blood chloride  107  meq l; chemistry blood creatinine  1.0  mg dl; chemistry blood potassium  3.9  meq l; chemistry blood sodium  144  meq l; chemistry blood urea nitrogen  20  mg dl; chemistry blood glucose  81  mg dl; blood gas blood lactate  1.0  mmol l$nan
other abnormalities of gait and mobility personal history of traumatic brain injury other place in hospital as the place of occurrence of the external cause epilepsy, unspecified, not intractable, without status epilepticus other muscle spasm personal history of nicotine dependence poisoning by benzodiazepines, accidental (unintentional), initial encounter other epilepsy, not intractable, without status epilepticus dissociative and conversion disorder, unspecified post-traumatic stress disorder, unspecified major depressive disorder, single episode, unspecified elevated blood-pressure reading, without diagnosis of hypertension unspecified convulsions personal history of traumatic brain injury epilepsy, unspecified, not intractable, without status epilepticus personal history of traumatic brain injury post-traumatic stress disorder, unspecified personal history of nicotine dependence unsteadiness on feet post-traumatic stress disorder, unspecified personal history of traumatic brain injury other seizures chest pain, unspecified dissociative and conversion disorder, unspecified need for prophylactic vaccination and inoculation against influenza localization-related (focal) (partial) epilepsy and epileptic syndromes with complex partial seizures, without mention of intractable epilepsy personal history of tobacco use personal history of traumatic brain injury bronchitis, not specified as acute or chronic leukocytosis, unspecified urinary incontinence, unspecified abdominal pain, unspecified site other musculoskeletal symptoms referable to limbs tobacco use disorder other chronic pain constipation, unspecified dissociative disorder or reaction, unspecified depressive disorder, not elsewhere classified other acquired absence of organ epilepsy, unspecified, without mention of intractable epilepsy personal history of traumatic brain injury other chest pain posttraumatic stress disorder ganglion of joint other chronic pain dissociative disorder or reaction, unspecified other forms of epilepsy and recurrent seizures, without mention of intractable epilepsy posttraumatic stress disorder
other f 41 $nan$nan$heparin  5000  unit ; 
 
other f 41 $nan$hematology blood hematocrit  37.0  %; hematology blood hemoglobin  11.9  g dl; hematology blood platelet count  264  k ul; chemistry blood anion gap  16  meq l; chemistry blood anion gap  12  meq l; chemistry blood bicarbonate  25  meq l; chemistry blood bicarbonate  28  meq l; chemistry blood chloride  100  meq l; chemistry blood chloride  100  meq l; chemistry blood creatinine  0.7  mg dl; chemistry blood creatinine  0.6  mg dl; chemistry blood potassium  4.1  meq l; chemistry blood potassium  4.2  meq l; chemistry blood sodium  137  meq l; chemistry blood sodium  136  meq l; chemistry blood urea nitrogen  6  mg dl; chemistry blood urea nitrogen  8  mg dl; hematology blood inr(pt)  1.0  ; chemistry blood calcium, total  9.0  mg dl; chemistry blood calcium, total  8.8  mg dl; chemistry blood bilirubin, indirect  1.2  mg dl; chemistry blood bilirubin, indirect  1.2  mg dl; chemistry blood bilirubin, total  5.6  mg dl; chemistry blood bilirubin, total  3.5  mg dl; chemistry blood glucose  105  mg dl; chemistry blood glucose  83  mg dl; chemistry blood bilirubin, direct  4.4  mg dl; chemistry blood bilirubin, direct  2.3  mg dl; hematology urine glucose  neg  mg dl; hematology urine bilirubin  mod  mg dl$heparin  5000  unit ; sodium chloride 0.9%  flush  3  ml ; lr  1000  ml ; hydromorphone (dilaudid)  0.5-3  mg ; 5% dextrose  50  ml ; clindamycin  600  mg ; hydromorphone (dilaudid)  0.5-1  mg ; 
 
other f 41 $nan$hematology blood hematocrit  33.1  %; hematology blood hemoglobin  11.2  g dl; hematology blood platelet count  232  k ul; chemistry blood anion gap  13  meq l; chemistry blood bicarbonate  29  meq l; chemistry blood chloride  98  meq l; chemistry blood creatinine  0.7  mg dl; chemistry blood potassium  4.0  meq l; chemistry blood sodium  136  meq l; chemistry blood urea nitrogen  6  mg dl; chemistry blood calcium, total  8.9  mg dl; chemistry blood bilirubin, total  2.1  mg dl; chemistry blood glucose  88  mg dl$heparin  5000  unit ; sodium chloride 0.9%  flush  3  ml ; 5% dextrose  50  ml ; clindamycin  600  mg ; hydromorphone (dilaudid)  0.5-1  mg ; hydromorphone (dilaudid)  0.5-2  mg ; 
 
other f 41 $nan$hematology blood hematocrit  33.8  %; hematology blood hematocrit  34.9  %; hematology blood hemoglobin  11.5  g dl; hematology blood platelet count  286  k ul; chemistry blood anion gap  13  meq l; chemistry blood bicarbonate  29  meq l; chemistry blood chloride  96  meq l; chemistry blood creatinine  0.6  mg dl; chemistry blood potassium  4.0  meq l; chemistry blood sodium  134  meq l; chemistry blood urea nitrogen  6  mg dl; chemistry blood calcium, total  9.1  mg dl; chemistry blood bilirubin, total  1.6  mg dl; chemistry blood glucose  137  mg dl$heparin  5000  unit ; sodium chloride 0.9%  flush  3  ml ; 5% dextrose  50  ml ; clindamycin  600  mg ; hydromorphone (dilaudid)  0.5-2  mg ; hydromorphone (dilaudid)  2-4  mg ; clindamycin  300  mg ; ursodiol  300  mg ; acetaminophen  325-650  mg ; ciprofloxacin hcl  500  mg ; 
 
other f 41 $nan$hematology blood hematocrit  32.2  %; hematology blood hemoglobin  11.0  g dl; hematology blood platelet count  285  k ul; chemistry blood anion gap  13  meq l; chemistry blood bicarbonate  29  meq l; chemistry blood chloride  100  meq l; chemistry blood creatinine  0.6  mg dl; chemistry blood potassium  4.0  meq l; chemistry blood sodium  138  meq l; chemistry blood urea nitrogen  10  mg dl; chemistry blood bilirubin, total  1.4  mg dl; chemistry blood glucose  88  mg dl$heparin  5000  unit ; sodium chloride 0.9%  flush  3  ml ; hydromorphone (dilaudid)  2-4  mg ; ursodiol  300  mg ; acetaminophen  325-650  mg ; ciprofloxacin hcl  500  mg ; diphenhydramine  25  mg ; bisacodyl  10  mg ; docusate sodium  100  mg ; senna  1  tab ; amoxicillin-clavulanic acid  500  mg ; 
 
other f 41 $nan$hematology blood hematocrit  38.7  %; hematology blood hemoglobin  12.8  g dl; hematology blood platelet count  332  k ul; chemistry blood anion gap  12  meq l; chemistry blood bicarbonate  27  meq l; chemistry blood chloride  101  meq l; chemistry blood creatinine  0.6  mg dl; chemistry blood potassium  3.9  meq l; chemistry blood sodium  136  meq l; chemistry blood urea nitrogen  6  mg dl; chemistry blood bilirubin, total  1.3  mg dl; chemistry blood glucose  100  mg dl$heparin  5000  unit ; sodium chloride 0.9%  flush  3  ml ; hydromorphone (dilaudid)  2-4  mg ; ursodiol  300  mg ; acetaminophen  325-650  mg ; diphenhydramine  25  mg ; bisacodyl  10  mg ; docusate sodium  100  mg ; senna  1  tab ; amoxicillin-clavulanic acid  500  mg ; simethicone  40-80  mg ; 
 
other f 41 $nan$hematology blood hematocrit  39.5  %; hematology blood hemoglobin  13.3  g dl; hematology blood platelet count  422  k ul; chemistry blood anion gap  17  meq l; chemistry blood bicarbonate  25  meq l; chemistry blood chloride  95  meq l; chemistry blood creatinine  0.7  mg dl; chemistry blood potassium  4.3  meq l; chemistry blood sodium  133  meq l; chemistry blood urea nitrogen  8  mg dl; hematology blood inr(pt)  1.1  ; chemistry blood calcium, total  9.4  mg dl; chemistry blood bilirubin, total  1.4  mg dl; chemistry blood glucose  104  mg dl; chemistry blood lactate dehydrogenase (ld)  231  iu l; hematology urine glucose  neg  mg dl; hematology urine bilirubin  neg  mg dl$heparin  5000  unit ; sodium chloride 0.9%  flush  3  ml ; hydromorphone (dilaudid)  2-4  mg ; ursodiol  300  mg ; acetaminophen  325-650  mg ; diphenhydramine  25  mg ; docusate sodium  100  mg ; senna  1  tab ; amoxicillin-clavulanic acid  500  mg ; simethicone  40-80  mg ; d5ns  1000  ml ; 
 
other f 41 $nan$hematology blood hematocrit  33.3  %; hematology blood hemoglobin  11.7  g dl; hematology blood platelet count  354  k ul; chemistry blood anion gap  16  meq l; chemistry blood bicarbonate  23  meq l; chemistry blood chloride  100  meq l; chemistry blood creatinine  0.6  mg dl; chemistry blood potassium  4.9  meq l; chemistry blood sodium  134  meq l; chemistry blood urea nitrogen  8  mg dl; chemistry blood calcium, total  9.1  mg dl; chemistry blood bilirubin, total  1.1  mg dl; chemistry blood glucose  116  mg dl$heparin  5000  unit ; sodium chloride 0.9%  flush  3  ml ; hydromorphone (dilaudid)  2-4  mg ; ursodiol  300  mg ; acetaminophen  325-650  mg ; diphenhydramine  25  mg ; docusate sodium  100  mg ; senna  1  tab ; amoxicillin-clavulanic acid  500  mg ; simethicone  40-80  mg ; 0.9% sodium chloride (mini bag plus)  100  ml ; ampicillin-sulbactam  3  g ; hydromorphone (dilaudid)  2-6  mg ; 
 
other f 41 $nan$hematology blood hematocrit  33.6  %; hematology blood hemoglobin  11.4  g dl; hematology blood platelet count  296  k ul; chemistry blood anion gap  15  meq l; chemistry blood bicarbonate  26  meq l; chemistry blood chloride  96  meq l; chemistry blood creatinine  0.6  mg dl; chemistry blood potassium  4.1  meq l; chemistry blood sodium  133  meq l; chemistry blood urea nitrogen  6  mg dl; chemistry blood bilirubin, total  1.2  mg dl; chemistry blood glucose  102  mg dl; chemistry blood albumin  3.7  g dl$sodium chloride 0.9%  flush  3  ml ; ursodiol  300  mg ; acetaminophen  325-650  mg ; diphenhydramine  25  mg ; docusate sodium  100  mg ; senna  1  tab ; amoxicillin-clavulanic acid  500  mg ; simethicone  40-80  mg ; hydromorphone (dilaudid)  2-6  mg ; hydromorphone (dilaudid)  0.5  mg ; lorazepam  1  mg ; lorazepam  0.5  mg ; 
 
other f 41 $nan$nan$sodium chloride 0.9%  flush  3  ml ; ursodiol  300  mg ; acetaminophen  325-650  mg ; diphenhydramine  25  mg ; docusate sodium  100  mg ; senna  1  tab ; amoxicillin-clavulanic acid  500  mg ; simethicone  40-80  mg ; hydromorphone (dilaudid)  2-6  mg ; hydromorphone (dilaudid)  0.5  mg ; 
 
white f 49 $nan$hematology blood hematocrit  27.5  %; hematology blood hematocrit  32.0  %; hematology blood hematocrit  30.1  %; hematology blood hemoglobin  10.2  g dl; hematology blood platelet count  175  k ul; chemistry blood anion gap  14  meq l; chemistry blood bicarbonate  23  meq l; chemistry blood chloride  106  meq l; chemistry blood creatinine  0.7  mg dl; chemistry blood potassium  3.5  meq l; chemistry blood potassium  4.8  meq l; chemistry blood sodium  138  meq l; chemistry blood urea nitrogen  11  mg dl; chemistry blood calcium, total  8.2  mg dl; chemistry blood bilirubin, total  0.5  mg dl; chemistry blood bilirubin, total  0.5  mg dl; chemistry blood glucose  147  mg dl; chemistry blood albumin  2.5  g dl; chemistry blood albumin  3.1  g dl; blood gas blood free calcium  1.11  mmol l; blood gas blood free calcium  1.05  mmol l; blood gas blood lactate  4.0  mmol l; blood gas blood lactate  5.1  mmol l; blood gas blood chloride, whole blood  103  meq l; blood gas blood chloride, whole blood  107  meq l; blood gas blood glucose  255  mg dl; blood gas blood glucose  266  mg dl; blood gas blood hematocrit, calculated  25  %; blood gas blood hematocrit, calculated  25  %; blood gas blood hemoglobin  8.2  g dl; blood gas blood hemoglobin  8.2  g dl; blood gas blood potassium, whole blood  3.5  meq l; blood gas blood potassium, whole blood  3.5  meq l; blood gas blood sodium, whole blood  134  meq l; blood gas blood sodium, whole blood  134  meq l$morphine sulfate  0.6  mg ; 0.9% sodium chloride  500  ml ; potassium chloride  40  meq ; docusate sodium  100  mg ; heparin  5000  unit ; metoclopramide  10  mg ; sodium chloride 0.9%  flush  3  ml ; d5 1 2ns  1000  ml ; fexofenadine  60  mg ; ondansetron  4  mg ; acetaminophen  325-650  mg ; morphine sulfate  50  mg ; sw  100  ml ; magnesium sulfate  4  gm ; lr  1000  ml ; 0.9% sodium chloride (mini bag plus)  100  ml ; ampicillin-sulbactam  3  g ; naloxone  80  mcg ; 0.9% sodium chloride  100  ml ; naloxone  2  mg ; 
acquired absence of both cervix and uterus pure hypercholesterolemia unspecified essential hypertension personal history of malignant neoplasm of other female genital organs personal history of malignant neoplasm of ovary secondary malignant neoplasm of lung
white f 49 $nan$hematology blood hematocrit  27.1  %; hematology blood hemoglobin  8.9  g dl; hematology blood platelet count  157  k ul; chemistry blood anion gap  16  meq l; chemistry blood bicarbonate  22  meq l; chemistry blood chloride  103  meq l; chemistry blood creatinine  0.6  mg dl; chemistry blood potassium  4.2  meq l; chemistry blood sodium  137  meq l; chemistry blood urea nitrogen  9  mg dl; chemistry blood calcium, total  7.9  mg dl; chemistry blood bilirubin, total  0.6  mg dl; chemistry blood glucose  130  mg dl; chemistry blood albumin  3.0  g dl$morphine sulfate  0.6  mg ; 0.9% sodium chloride  500  ml ; potassium chloride  40  meq ; docusate sodium  100  mg ; heparin  5000  unit ; metoclopramide  10  mg ; sodium chloride 0.9%  flush  3  ml ; d5 1 2ns  1000  ml ; fexofenadine  60  mg ; acetaminophen  325-650  mg ; morphine sulfate  50  mg ; sw  100  ml ; magnesium sulfate  4  gm ; lr  1000  ml ; 0.9% sodium chloride (mini bag plus)  100  ml ; ampicillin-sulbactam  3  g ; naloxone  80  mcg ; 0.9% sodium chloride  100  ml ; naloxone  2  mg ; ascorbic acid  1000  mg ; multivitamins  1  tab ; 
acquired absence of both cervix and uterus pure hypercholesterolemia unspecified essential hypertension personal history of malignant neoplasm of other female genital organs personal history of malignant neoplasm of ovary secondary malignant neoplasm of lung
white f 49 $nan$chemistry blood anion gap  15  meq l; chemistry blood bicarbonate  29  meq l; chemistry blood chloride  101  meq l; chemistry blood creatinine  0.5  mg dl; chemistry blood potassium  3.5  meq l; chemistry blood sodium  141  meq l; chemistry blood urea nitrogen  8  mg dl; chemistry blood calcium, total  8.2  mg dl; chemistry blood bilirubin, total  0.4  mg dl; chemistry blood glucose  122  mg dl; chemistry blood albumin  2.8  g dl$docusate sodium  100  mg ; heparin  5000  unit ; metoclopramide  10  mg ; sodium chloride 0.9%  flush  3  ml ; d5 1 2ns  1000  ml ; fexofenadine  60  mg ; acetaminophen  325-650  mg ; ascorbic acid  1000  mg ; multivitamins  1  tab ; hydrochlorothiazide  25  mg ; 0.9% sodium chloride  1  bag ; calcium gluconate  2  g ; 
acquired absence of both cervix and uterus pure hypercholesterolemia unspecified essential hypertension personal history of malignant neoplasm of other female genital organs personal history of malignant neoplasm of ovary secondary malignant neoplasm of lung
white f 49 $nan$hematology blood hematocrit  22.5  %; hematology blood hemoglobin  7.7  g dl; hematology blood platelet count  201  k ul; chemistry blood anion gap  14  meq l; chemistry blood bicarbonate  34  meq l; chemistry blood chloride  97  meq l; chemistry blood creatinine  0.5  mg dl; chemistry blood potassium  2.9  meq l; chemistry blood sodium  142  meq l; chemistry blood urea nitrogen  8  mg dl; chemistry blood calcium, total  8.0  mg dl; chemistry blood bilirubin, total  0.3  mg dl; chemistry blood glucose  122  mg dl; chemistry blood albumin  2.8  g dl$docusate sodium  100  mg ; heparin  5000  unit ; metoclopramide  10  mg ; sodium chloride 0.9%  flush  3  ml ; fexofenadine  60  mg ; acetaminophen  325-650  mg ; ascorbic acid  1000  mg ; multivitamins  1  tab ; hydrochlorothiazide  25  mg ; 0.9% sodium chloride  1  bag ; calcium gluconate  2  g ; lidocaine viscous 2%  20  ml ; 5% dextrose  500  ml ; potassium phosphate  30  mmol ; chloraseptic throat spray  1  spry ; acetaminophen  1000  mg ; 
acquired absence of both cervix and uterus pure hypercholesterolemia unspecified essential hypertension personal history of malignant neoplasm of other female genital organs personal history of malignant neoplasm of ovary secondary malignant neoplasm of lung
white f 49 $nan$hematology blood hematocrit  29.1  %; hematology blood hematocrit  28.8  %; hematology blood hemoglobin  9.9  g dl; hematology blood platelet count  261  k ul; chemistry blood anion gap  12  meq l; chemistry blood bicarbonate  31  meq l; chemistry blood chloride  101  meq l; chemistry blood creatinine  0.4  mg dl; chemistry blood potassium  3.1  meq l; chemistry blood potassium  3.3  meq l; chemistry blood sodium  141  meq l; chemistry blood urea nitrogen  12  mg dl; chemistry blood calcium, total  8.1  mg dl; chemistry blood bilirubin, total  0.5  mg dl; chemistry blood glucose  114  mg dl; chemistry blood albumin  2.9  g dl$docusate sodium  100  mg ; heparin  5000  unit ; metoclopramide  10  mg ; sodium chloride 0.9%  flush  3  ml ; fexofenadine  60  mg ; ascorbic acid  1000  mg ; multivitamins  1  tab ; lidocaine viscous 2%  20  ml ; 5% dextrose  500  ml ; potassium phosphate  30  mmol ; chloraseptic throat spray  1  spry ; acetaminophen  1000  mg ; milk of magnesia  60  ml ; potassium chl 40 meq   1000 ml d5 1 2 ns  1000  ml ; 
acquired absence of both cervix and uterus pure hypercholesterolemia unspecified essential hypertension personal history of malignant neoplasm of other female genital organs personal history of malignant neoplasm of ovary secondary malignant neoplasm of lung
white f 49 $nan$hematology blood hematocrit  29.1  %; hematology blood hemoglobin  9.9  g dl; hematology blood platelet count  298  k ul; chemistry blood anion gap  10  meq l; chemistry blood bicarbonate  29  meq l; chemistry blood chloride  100  meq l; chemistry blood creatinine  0.6  mg dl; chemistry blood potassium  4.0  meq l; chemistry blood sodium  135  meq l; chemistry blood urea nitrogen  11  mg dl; chemistry blood bilirubin, total  0.5  mg dl; chemistry blood glucose  113  mg dl; chemistry blood albumin  2.8  g dl$docusate sodium  100  mg ; heparin  5000  unit ; metoclopramide  10  mg ; sodium chloride 0.9%  flush  3  ml ; fexofenadine  60  mg ; ascorbic acid  1000  mg ; multivitamins  1  tab ; lidocaine viscous 2%  20  ml ; chloraseptic throat spray  1  spry ; acetaminophen  1000  mg ; milk of magnesia  60  ml ; potassium chl 40 meq   1000 ml d5 1 2 ns  1000  ml ; oxycodone (immediate release)   5-10  mg ; 
acquired absence of both cervix and uterus pure hypercholesterolemia unspecified essential hypertension personal history of malignant neoplasm of other female genital organs personal history of malignant neoplasm of ovary secondary malignant neoplasm of lung
white f 49 $nan$nan$docusate sodium  100  mg ; heparin  5000  unit ; metoclopramide  10  mg ; sodium chloride 0.9%  flush  3  ml ; fexofenadine  60  mg ; ascorbic acid  1000  mg ; multivitamins  1  tab ; lidocaine viscous 2%  20  ml ; chloraseptic throat spray  1  spry ; acetaminophen  1000  mg ; oxycodone (immediate release)   5-10  mg ; 
acquired absence of both cervix and uterus pure hypercholesterolemia unspecified essential hypertension personal history of malignant neoplasm of other female genital organs personal history of malignant neoplasm of ovary secondary malignant neoplasm of lung
white f 49 $nan$nan$docusate sodium  100  mg ; heparin  5000  unit ; metoclopramide  10  mg ; sodium chloride 0.9%  flush  3  ml ; fexofenadine  60  mg ; ascorbic acid  1000  mg ; multivitamins  1  tab ; lidocaine viscous 2%  20  ml ; chloraseptic throat spray  1  spry ; acetaminophen  1000  mg ; oxycodone (immediate release)   5-10  mg ; furosemide  10  mg ; 
acquired absence of both cervix and uterus pure hypercholesterolemia unspecified essential hypertension personal history of malignant neoplasm of other female genital organs personal history of malignant neoplasm of ovary secondary malignant neoplasm of lung
white f 49 $nan$chemistry blood anion gap  11  meq l; chemistry blood bicarbonate  31  meq l; chemistry blood chloride  98  meq l; chemistry blood creatinine  0.5  mg dl; chemistry blood potassium  3.6  meq l; chemistry blood sodium  136  meq l; chemistry blood urea nitrogen  8  mg dl; chemistry blood glucose  119  mg dl; chemistry blood albumin  2.8  g dl$docusate sodium  100  mg ; heparin  5000  unit ; metoclopramide  10  mg ; sodium chloride 0.9%  flush  3  ml ; fexofenadine  60  mg ; ascorbic acid  1000  mg ; multivitamins  1  tab ; lidocaine viscous 2%  20  ml ; chloraseptic throat spray  1  spry ; acetaminophen  1000  mg ; oxycodone (immediate release)   5-10  mg ; furosemide  10  mg ; furosemide  20  mg ; 
acquired absence of both cervix and uterus pure hypercholesterolemia unspecified essential hypertension personal history of malignant neoplasm of other female genital organs personal history of malignant neoplasm of ovary secondary malignant neoplasm of lung
white f 49 $nan$nan$docusate sodium  100  mg ; heparin  5000  unit ; metoclopramide  10  mg ; sodium chloride 0.9%  flush  3  ml ; fexofenadine  60  mg ; ascorbic acid  1000  mg ; multivitamins  1  tab ; lidocaine viscous 2%  20  ml ; chloraseptic throat spray  1  spry ; acetaminophen  1000  mg ; oxycodone (immediate release)   5-10  mg ; furosemide  20  mg ; 
acquired absence of both cervix and uterus pure hypercholesterolemia unspecified essential hypertension personal history of malignant neoplasm of other female genital organs personal history of malignant neoplasm of ovary secondary malignant neoplasm of lung
black african american f 18 $nan$hematology blood hematocrit  35.5  %; hematology blood hemoglobin  12.5  g dl; hematology blood platelet count  354  k ul; chemistry blood anion gap  12  meq l; chemistry blood bicarbonate  26  meq l; chemistry blood chloride  104  meq l; chemistry blood creatinine  0.6  mg dl; chemistry blood potassium  4.0  meq l; chemistry blood sodium  138  meq l; chemistry blood urea nitrogen  11  mg dl; chemistry blood glucose  110  mg dl$nan
 
white f 86 $temp    heartrate  52.0  resprate  16.0  o2sat  97.0  sbp  138.0  dbp  58.0  rhythm    pain    $hematology blood hematocrit  34.3  %; hematology blood hemoglobin  11.4  g dl; hematology blood platelet count  365  k ul; chemistry blood anion gap  17  meq l; chemistry blood bicarbonate  26  meq l; chemistry blood chloride  84  meq l; chemistry blood creatinine  0.9  mg dl; chemistry blood potassium  3.4  meq l; chemistry blood sodium  127  meq l; chemistry blood urea nitrogen  15  mg dl; chemistry urine creatinine, urine  21  mg dl; chemistry urine sodium, urine  54  meq l; chemistry blood calcium, total  9.7  mg dl; chemistry blood glucose  100  mg dl$sodium chloride 0.9%  flush  3-10  ml ; cefpodoxime proxetil  400  mg ; acetaminophen  650  mg ; vitamin d  800  unit ; multivitamins  1  tab ; sodium chloride 0.9%  1000  ml ; allopurinol  100  mg ; aspirin  81  mg ; atenolol  25  mg ; trazodone  50  mg ; rosuvastatin calcium  20  mg ; bag  1  bag ; magnesium sulfate  4  gm ; potassium citrate  40  meq ; rivaroxaban  15  mg ; senna  17.2  mg ; 
hyperosmolality and hypernatremia unspecified atrial fibrillation dysphagia, oropharyngeal phase acute and subacute infective endocarditis proteus (mirabilis) (morganii) as the cause of diseases classified elsewhere restlessness and agitation retention of urine, unspecified bacteremia hemiplegia, unspecified affecting left nondominant side acute nephritic syndrome with other morphologic changes other disorders of intestinal carbohydrate absorption other staphylococcus as the cause of diseases classified elsewhere encounter for examination for normal comparison and control in clinical research program nontraumatic intracerebral hemorrhage, unspecified neurologic neglect syndrome unspecified asthma, uncomplicated essential (primary) hypertension hyperlipidemia, unspecified urinary tract infection, site not specified cerebral infarction due to thrombosis of right middle cerebral artery
white f 86 $nan$hematology blood hematocrit  37.2  %; hematology blood hemoglobin  12.0  g dl; hematology blood platelet count  378  k ul; chemistry blood anion gap  16  meq l; chemistry blood bicarbonate  26  meq l; chemistry blood chloride  87  meq l; chemistry blood creatinine  1.0  mg dl; chemistry blood potassium  3.4  meq l; chemistry blood sodium  129  meq l; chemistry blood urea nitrogen  17  mg dl; chemistry blood calcium, total  9.4  mg dl; chemistry blood glucose  91  mg dl$sodium chloride 0.9%  flush  3-10  ml ; cefpodoxime proxetil  400  mg ; acetaminophen  650  mg ; vitamin d  800  unit ; multivitamins  1  tab ; sodium chloride 0.9%  1000  ml ; allopurinol  100  mg ; aspirin  81  mg ; trazodone  50  mg ; rosuvastatin calcium  20  mg ; bag  1  bag ; magnesium sulfate  4  gm ; potassium citrate  40  meq ; rivaroxaban  15  mg ; senna  17.2  mg ; atenolol  12.5  mg ; potassium citrate  60  meq ; docusate sodium  100  mg ; ramelteon  8  mg ; 
hyperosmolality and hypernatremia unspecified atrial fibrillation dysphagia, oropharyngeal phase acute and subacute infective endocarditis proteus (mirabilis) (morganii) as the cause of diseases classified elsewhere restlessness and agitation retention of urine, unspecified bacteremia hemiplegia, unspecified affecting left nondominant side acute nephritic syndrome with other morphologic changes other disorders of intestinal carbohydrate absorption other staphylococcus as the cause of diseases classified elsewhere encounter for examination for normal comparison and control in clinical research program nontraumatic intracerebral hemorrhage, unspecified neurologic neglect syndrome unspecified asthma, uncomplicated essential (primary) hypertension hyperlipidemia, unspecified urinary tract infection, site not specified cerebral infarction due to thrombosis of right middle cerebral artery
white f 86 $nan$hematology blood hematocrit  34.3  %; hematology blood hemoglobin  11.2  g dl; hematology blood platelet count  341  k ul; chemistry blood anion gap  13  meq l; chemistry blood anion gap  11  meq l; chemistry blood bicarbonate  27  meq l; chemistry blood bicarbonate  28  meq l; chemistry blood chloride  85  meq l; chemistry blood chloride  88  meq l; chemistry blood creatinine  1.4  mg dl; chemistry blood creatinine  1.3  mg dl; chemistry blood potassium  3.3  meq l; chemistry blood potassium  3.6  meq l; chemistry blood sodium  125  meq l; chemistry blood sodium  127  meq l; chemistry blood urea nitrogen  26  mg dl; chemistry blood urea nitrogen  23  mg dl; chemistry blood calcium, total  8.9  mg dl; chemistry blood calcium, total  9.1  mg dl; chemistry blood glucose  100  mg dl; chemistry blood glucose  122  mg dl$sodium chloride 0.9%  flush  3-10  ml ; cefpodoxime proxetil  400  mg ; acetaminophen  650  mg ; vitamin d  800  unit ; multivitamins  1  tab ; allopurinol  100  mg ; aspirin  81  mg ; trazodone  50  mg ; rosuvastatin calcium  20  mg ; rivaroxaban  15  mg ; senna  17.2  mg ; atenolol  12.5  mg ; docusate sodium  100  mg ; ramelteon  8  mg ; polyethylene glycol  17  g ; 
hyperosmolality and hypernatremia unspecified atrial fibrillation dysphagia, oropharyngeal phase acute and subacute infective endocarditis proteus (mirabilis) (morganii) as the cause of diseases classified elsewhere restlessness and agitation retention of urine, unspecified bacteremia hemiplegia, unspecified affecting left nondominant side acute nephritic syndrome with other morphologic changes other disorders of intestinal carbohydrate absorption other staphylococcus as the cause of diseases classified elsewhere encounter for examination for normal comparison and control in clinical research program nontraumatic intracerebral hemorrhage, unspecified neurologic neglect syndrome unspecified asthma, uncomplicated essential (primary) hypertension hyperlipidemia, unspecified urinary tract infection, site not specified cerebral infarction due to thrombosis of right middle cerebral artery
white f 86 $nan$hematology blood hematocrit  35.3  %; hematology blood hemoglobin  11.4  g dl; hematology blood platelet count  328  k ul; chemistry blood anion gap  11  meq l; chemistry blood bicarbonate  27  meq l; chemistry blood chloride  94  meq l; chemistry blood creatinine  1.1  mg dl; chemistry blood potassium  3.7  meq l; chemistry blood sodium  132  meq l; chemistry blood urea nitrogen  20  mg dl; chemistry blood calcium, total  9.2  mg dl; chemistry blood glucose  100  mg dl$sodium chloride 0.9%  flush  3-10  ml ; acetaminophen  650  mg ; vitamin d  800  unit ; multivitamins  1  tab ; allopurinol  100  mg ; aspirin  81  mg ; rosuvastatin calcium  20  mg ; rivaroxaban  15  mg ; senna  17.2  mg ; atenolol  12.5  mg ; docusate sodium  100  mg ; ramelteon  8  mg ; polyethylene glycol  17  g ; 
hyperosmolality and hypernatremia unspecified atrial fibrillation dysphagia, oropharyngeal phase acute and subacute infective endocarditis proteus (mirabilis) (morganii) as the cause of diseases classified elsewhere restlessness and agitation retention of urine, unspecified bacteremia hemiplegia, unspecified affecting left nondominant side acute nephritic syndrome with other morphologic changes other disorders of intestinal carbohydrate absorption other staphylococcus as the cause of diseases classified elsewhere encounter for examination for normal comparison and control in clinical research program nontraumatic intracerebral hemorrhage, unspecified neurologic neglect syndrome unspecified asthma, uncomplicated essential (primary) hypertension hyperlipidemia, unspecified urinary tract infection, site not specified cerebral infarction due to thrombosis of right middle cerebral artery
white f 86 $nan$hematology blood hematocrit  34.8  %; hematology blood hemoglobin  11.1  g dl; hematology blood platelet count  358  k ul; chemistry blood anion gap  11  meq l; chemistry blood bicarbonate  27  meq l; chemistry blood chloride  95  meq l; chemistry blood creatinine  1.0  mg dl; chemistry blood potassium  3.7  meq l; chemistry blood sodium  133  meq l; chemistry blood urea nitrogen  19  mg dl; chemistry blood calcium, total  9.2  mg dl; chemistry blood glucose  169  mg dl$sodium chloride 0.9%  flush  3-10  ml ; acetaminophen  650  mg ; vitamin d  800  unit ; multivitamins  1  tab ; allopurinol  100  mg ; aspirin  81  mg ; rosuvastatin calcium  20  mg ; rivaroxaban  15  mg ; senna  17.2  mg ; atenolol  12.5  mg ; docusate sodium  100  mg ; ramelteon  8  mg ; polyethylene glycol  17  g ; albuterol 0.083% neb soln  1  neb ; 
hyperosmolality and hypernatremia unspecified atrial fibrillation dysphagia, oropharyngeal phase acute and subacute infective endocarditis proteus (mirabilis) (morganii) as the cause of diseases classified elsewhere restlessness and agitation retention of urine, unspecified bacteremia hemiplegia, unspecified affecting left nondominant side acute nephritic syndrome with other morphologic changes other disorders of intestinal carbohydrate absorption other staphylococcus as the cause of diseases classified elsewhere encounter for examination for normal comparison and control in clinical research program nontraumatic intracerebral hemorrhage, unspecified neurologic neglect syndrome unspecified asthma, uncomplicated essential (primary) hypertension hyperlipidemia, unspecified urinary tract infection, site not specified cerebral infarction due to thrombosis of right middle cerebral artery
white f 86 $nan$hematology blood hematocrit  34.8  %; hematology blood hemoglobin  11.1  g dl; hematology blood platelet count  347  k ul; chemistry blood anion gap  15  meq l; chemistry blood bicarbonate  26  meq l; chemistry blood chloride  98  meq l; chemistry blood creatinine  1.0  mg dl; chemistry blood potassium  3.6  meq l; chemistry blood sodium  139  meq l; chemistry blood urea nitrogen  17  mg dl; chemistry blood calcium, total  9.0  mg dl; chemistry blood glucose  101  mg dl$sodium chloride 0.9%  flush  3-10  ml ; acetaminophen  650  mg ; vitamin d  800  unit ; multivitamins  1  tab ; allopurinol  100  mg ; aspirin  81  mg ; rosuvastatin calcium  20  mg ; rivaroxaban  15  mg ; senna  17.2  mg ; atenolol  12.5  mg ; docusate sodium  100  mg ; ramelteon  8  mg ; polyethylene glycol  17  g ; albuterol 0.083% neb soln  1  neb ; magnesium oxide  800  mg ; 
hyperosmolality and hypernatremia unspecified atrial fibrillation dysphagia, oropharyngeal phase acute and subacute infective endocarditis proteus (mirabilis) (morganii) as the cause of diseases classified elsewhere restlessness and agitation retention of urine, unspecified bacteremia hemiplegia, unspecified affecting left nondominant side acute nephritic syndrome with other morphologic changes other disorders of intestinal carbohydrate absorption other staphylococcus as the cause of diseases classified elsewhere encounter for examination for normal comparison and control in clinical research program nontraumatic intracerebral hemorrhage, unspecified neurologic neglect syndrome unspecified asthma, uncomplicated essential (primary) hypertension hyperlipidemia, unspecified urinary tract infection, site not specified cerebral infarction due to thrombosis of right middle cerebral artery
black african american m 71 $temp  98.0  heartrate  64.0  resprate  18.0  o2sat  100.0  sbp  128.0  dbp  42.0  rhythm    pain  3  ; temp    heartrate  66.0  resprate  18.0  o2sat  100.0  sbp  126.0  dbp  45.0  rhythm    pain  3  $hematology blood hematocrit  21.8  %; hematology blood hemoglobin  7.2  g dl; hematology blood platelet count  171  k ul; chemistry blood anion gap  17  meq l; chemistry blood bicarbonate  21  meq l; chemistry blood chloride  111  meq l; chemistry blood creatinine  4.8  mg dl; chemistry blood potassium  3.9  meq l; chemistry blood sodium  149  meq l; chemistry blood urea nitrogen  132  mg dl; hematology blood inr(pt)  1.0  ; chemistry blood calcium, total  9.3  mg dl; chemistry blood glucose  82  mg dl$sodium chloride 0.9%  flush  3-10  ml ; vial  1  vial ; pantoprazole  40  mg ; acetaminophen  650  mg ; senna  8.6  mg ; bisacodyl  10  mg ; vitamin d  2000  unit ; amiodarone  100  mg ; lactated ringers  1000  ml ; vial  2  vial ; calcium gluconate  2  g ; 0.9% sodium chloride  100  ml ; 0.9% sodium chloride  250  ml ; calcium gluconate  4  g ; dextrose 5%  1000  ml ; hydralazine  100  mg ; isosorbide mononitrate (extended release)  120  mg ; 
nicotine dependence, cigarettes, uncomplicated hypertensive heart and chronic kidney disease with heart failure and with stage 5 chronic kidney disease, or end stage renal disease hyperlipidemia, unspecified type 2 diabetes mellitus with diabetic chronic kidney disease end stage renal disease acidosis acute kidney failure, unspecified paroxysmal atrial fibrillation unspecified right bundle-branch block orthostatic hypotension hyperosmolality and hypernatremia dieulafoy lesion (hemorrhagic) of stomach and duodenum presence of xenogenic heart valve combined rheumatic disorders of mitral, aortic and tricuspid valves acute posthemorrhagic anemia chronic diastolic (congestive) heart failure nicotine dependence, cigarettes, uncomplicated dysphagia, unspecified acute kidney failure, unspecified paroxysmal atrial fibrillation esophageal obstruction myalgia acute posthemorrhagic anemia other nonrheumatic aortic valve disorders pain in left shoulder hypertensive heart and chronic kidney disease with heart failure and with stage 5 chronic kidney disease, or end stage renal disease other chest pain other chronic pain personal history of transient ischemic attack (tia), and cerebral infarction without residual deficits chronic diastolic (congestive) heart failure gastro-esophageal reflux disease without esophagitis abnormal weight loss iron deficiency anemia, unspecified abnormal serum enzyme level, unspecified personal history of peptic ulcer disease end stage renal disease dieulafoy lesion (hemorrhagic) of stomach and duodenum type 2 diabetes mellitus with diabetic chronic kidney disease body mass index (bmi) 29.0-29.9, adult anorexia heart failure, unspecified paroxysmal atrial fibrillation nicotine dependence, cigarettes, uncomplicated other fatigue nontoxic multinodular goiter gastro-esophageal reflux disease without esophagitis hypertensive heart and chronic kidney disease with heart failure and stage 1 through stage 4 chronic kidney disease, or unspecified chronic kidney disease syncope and collapse
black african american m 71 $nan$hematology blood hematocrit  22.6  %; hematology blood hematocrit  25.1  %; hematology blood hemoglobin  7.4  g dl; hematology blood hemoglobin  8.1  g dl; hematology blood platelet count  184  k ul; hematology blood platelet count  204  k ul; chemistry blood anion gap  15  meq l; chemistry blood bicarbonate  23  meq l; chemistry blood chloride  109  meq l; chemistry blood creatinine  4.5  mg dl; chemistry blood potassium  3.9  meq l; chemistry blood sodium  147  meq l; chemistry blood urea nitrogen  120  mg dl; chemistry blood glucose  90  mg dl$sodium chloride 0.9%  flush  3-10  ml ; acetaminophen  650  mg ; senna  8.6  mg ; bisacodyl  10  mg ; vitamin d  2000  unit ; amiodarone  100  mg ; vial  2  vial ; calcium gluconate  2  g ; 0.9% sodium chloride  100  ml ; 0.9% sodium chloride  250  ml ; calcium gluconate  4  g ; hydralazine  100  mg ; isosorbide mononitrate (extended release)  120  mg ; torsemide  100  mg ; calcitriol  0.25  mcg ; 
nicotine dependence, cigarettes, uncomplicated hypertensive heart and chronic kidney disease with heart failure and with stage 5 chronic kidney disease, or end stage renal disease hyperlipidemia, unspecified type 2 diabetes mellitus with diabetic chronic kidney disease end stage renal disease acidosis acute kidney failure, unspecified paroxysmal atrial fibrillation unspecified right bundle-branch block orthostatic hypotension hyperosmolality and hypernatremia dieulafoy lesion (hemorrhagic) of stomach and duodenum presence of xenogenic heart valve combined rheumatic disorders of mitral, aortic and tricuspid valves acute posthemorrhagic anemia chronic diastolic (congestive) heart failure nicotine dependence, cigarettes, uncomplicated dysphagia, unspecified acute kidney failure, unspecified paroxysmal atrial fibrillation esophageal obstruction myalgia acute posthemorrhagic anemia other nonrheumatic aortic valve disorders pain in left shoulder hypertensive heart and chronic kidney disease with heart failure and with stage 5 chronic kidney disease, or end stage renal disease other chest pain other chronic pain personal history of transient ischemic attack (tia), and cerebral infarction without residual deficits chronic diastolic (congestive) heart failure gastro-esophageal reflux disease without esophagitis abnormal weight loss iron deficiency anemia, unspecified abnormal serum enzyme level, unspecified personal history of peptic ulcer disease end stage renal disease dieulafoy lesion (hemorrhagic) of stomach and duodenum type 2 diabetes mellitus with diabetic chronic kidney disease body mass index (bmi) 29.0-29.9, adult anorexia heart failure, unspecified paroxysmal atrial fibrillation nicotine dependence, cigarettes, uncomplicated other fatigue nontoxic multinodular goiter gastro-esophageal reflux disease without esophagitis hypertensive heart and chronic kidney disease with heart failure and stage 1 through stage 4 chronic kidney disease, or unspecified chronic kidney disease syncope and collapse
white f 82 $temp  97.9  heartrate  54.0  resprate  16.0  o2sat  100.0  sbp  143.0  dbp  59.0  rhythm    pain  0  ; temp    heartrate  52.0  resprate  15.0  o2sat  100.0  sbp  145.0  dbp  50.0  rhythm    pain  0  ; temp    heartrate  74.0  resprate  16.0  o2sat  100.0  sbp  136.0  dbp  50.0  rhythm    pain  0  ; temp  98.2  heartrate  54.0  resprate  18.0  o2sat  99.0  sbp  151.0  dbp  49.0  rhythm    pain  0  $hematology blood hematocrit  30.9  %; hematology blood hemoglobin  9.7  g dl; hematology blood platelet count  169  k ul; chemistry blood anion gap  13  meq l; chemistry blood bicarbonate  24  meq l; chemistry blood chloride  108  meq l; chemistry blood creatinine  1.6  mg dl; chemistry blood potassium  4.5  meq l; chemistry blood sodium  140  meq l; chemistry blood urea nitrogen  52  mg dl; hematology blood inr(pt)  2.0  ; hematology blood inr(pt)  2.3  ; chemistry blood calcium, total  9.0  mg dl; chemistry blood glucose  87  mg dl$d5 1 2ns  1000  ml ; warfarin  5  mg ; pneumococcal 23-valent polysaccharide vaccine  0.5  ml ; sodium chloride 0.9%  flush  3  ml ; aspirin  81  mg ; doxazosin  1  mg ; lisinopril  10  mg ; nitroglycerin sl  0.4  mg ; omeprazole  20  mg ; simvastatin  80  mg ; vitamin d  800  unit ; metoprolol tartrate  6.25  mg ; acetaminophen  650  mg ; senna  8.6  mg ; 
 
white f 82 $nan$hematology blood hematocrit  29.6  %; hematology blood hemoglobin  9.4  g dl; hematology blood platelet count  160  k ul; chemistry blood anion gap  14  meq l; chemistry blood bicarbonate  22  meq l; chemistry blood chloride  108  meq l; chemistry blood creatinine  1.5  mg dl; chemistry blood potassium  4.8  meq l; chemistry blood sodium  139  meq l; chemistry blood urea nitrogen  47  mg dl; hematology blood inr(pt)  3.0  ; chemistry blood calcium, total  8.9  mg dl; chemistry blood glucose  96  mg dl$d5 1 2ns  1000  ml ; warfarin  5  mg ; pneumococcal 23-valent polysaccharide vaccine  0.5  ml ; sodium chloride 0.9%  flush  3  ml ; aspirin  81  mg ; doxazosin  1  mg ; lisinopril  10  mg ; nitroglycerin sl  0.4  mg ; omeprazole  20  mg ; simvastatin  80  mg ; vitamin d  800  unit ; acetaminophen  650  mg ; senna  8.6  mg ; ferrous sulfate  325  mg ; multivitamins  1  tab ; fish oil (omega 3)  2000  mg ; docusate sodium  100  mg ; warfarin  7.5  mg ; metoprolol tartrate  25  mg ; sodium chloride nasal  1-2  spry ; 
 
white f 82 $nan$nan$d5 1 2ns  1000  ml ; warfarin  5  mg ; pneumococcal 23-valent polysaccharide vaccine  0.5  ml ; sodium chloride 0.9%  flush  3  ml ; aspirin  81  mg ; doxazosin  1  mg ; lisinopril  10  mg ; nitroglycerin sl  0.4  mg ; omeprazole  20  mg ; simvastatin  80  mg ; vitamin d  800  unit ; acetaminophen  650  mg ; senna  8.6  mg ; ferrous sulfate  325  mg ; multivitamins  1  tab ; fish oil (omega 3)  2000  mg ; docusate sodium  100  mg ; warfarin  7.5  mg ; metoprolol tartrate  25  mg ; sodium chloride nasal  1-2  spry ; metoprolol succinate xl  50  mg ; 
 
white f 91 $nan$nan$vitamin d  800  unit ; multivitamins  1  tab ; aspirin  81  mg ; fluticasone propionate nasal  1  spry ; levothyroxine sodium  50  mcg ; 
other specified metabolic disorders unspecified fall disorder of bone and cartilage, unspecified unspecified acquired hypothyroidism congestive heart failure, unspecified closed fracture of lumbar vertebra without mention of spinal cord injury acute kidney failure, unspecified mitral valve disorders esophageal reflux unspecified essential hypertension other persistent mental disorders due to conditions classified elsewhere personal history of malignant neoplasm of large intestine other disorders of neurohypophysis congestive heart failure, unspecified closed fracture of pubis unspecified acquired hypothyroidism personal history of malignant neoplasm of large intestine personal history of tobacco use personal history of traumatic fracture unspecified essential hypertension esophageal reflux history of fall fall from other slipping, tripping, or stumbling mitral valve disorders
white f 91 $nan$hematology blood hematocrit  28.5  %; hematology blood hematocrit  26.2  %; hematology blood hemoglobin  9.6  g dl; hematology blood hemoglobin  9.1  g dl; hematology blood platelet count  249  k ul; hematology blood platelet count  232  k ul; chemistry blood anion gap  20  meq l; chemistry blood anion gap  15  meq l; chemistry blood bicarbonate  20  meq l; chemistry blood bicarbonate  24  meq l; chemistry blood chloride  99  meq l; chemistry blood chloride  99  meq l; chemistry blood chloride  102  meq l; chemistry blood creatinine  2.1  mg dl; chemistry blood creatinine  1.9  mg dl; chemistry blood creatinine  1.5  mg dl; chemistry blood potassium  5.0  meq l; chemistry blood potassium  4.9  meq l; chemistry blood potassium  4.4  meq l; chemistry blood sodium  134  meq l; chemistry blood sodium  133  meq l; chemistry blood sodium  135  meq l; chemistry blood urea nitrogen  41  mg dl; chemistry blood urea nitrogen  39  mg dl; chemistry blood urea nitrogen  35  mg dl; hematology blood inr(pt)  1.2  ; hematology blood inr(pt)  1.1  ; chemistry urine chloride, urine  54  meq l; chemistry urine creatinine, urine  30  mg dl; chemistry urine potassium, urine  26  meq l; chemistry urine sodium, urine  60  meq l; chemistry urine urea nitrogen, urine  359  mg dl; chemistry blood calcium, total  10.2  mg dl; chemistry blood calcium, total  9.6  mg dl; chemistry blood bilirubin, total  0.4  mg dl; chemistry blood glucose  126  mg dl; chemistry blood glucose  104  mg dl; chemistry blood lactate dehydrogenase (ld)  282  iu l; chemistry blood lactate dehydrogenase (ld)  247  iu l; chemistry blood albumin  4.0  g dl; blood gas blood lactate  2.3  mmol l$vitamin d  800  unit ; multivitamins  1  tab ; aspirin  81  mg ; fluticasone propionate nasal  1  spry ; levothyroxine sodium  50  mcg ; 1 2 ns  1000  ml ; bisacodyl  10  mg ; senna  1  tab ; 5% dextrose  250  ml ; isoproterenol  2  mg ; tramadol (ultram)  25  mg ; d5w  250  ml ; dopamine  400  mg ; ondansetron  2-4  mg ; 0.9% sodium chloride  500  ml ; docusate sodium (liquid)  100  mg ; bupropion (sustained release)  100  mg ; vial  1  vial ; pantoprazole  40  mg ; prochlorperazine  10  mg ; docusate sodium  100  mg ; heparin  5000  unit ; acetaminophen  1000  mg ; calcium carbonate  500  mg ; mirtazapine  15  mg ; ranitidine  150  mg ; lorazepam  0.25  mg ; morphine sulfate  0.5  mg ; artificial tears  1-2  drop ; atropine sulfate  1  mg ; 
other specified metabolic disorders unspecified fall disorder of bone and cartilage, unspecified unspecified acquired hypothyroidism congestive heart failure, unspecified closed fracture of lumbar vertebra without mention of spinal cord injury acute kidney failure, unspecified mitral valve disorders esophageal reflux unspecified essential hypertension other persistent mental disorders due to conditions classified elsewhere personal history of malignant neoplasm of large intestine other disorders of neurohypophysis congestive heart failure, unspecified closed fracture of pubis unspecified acquired hypothyroidism personal history of malignant neoplasm of large intestine personal history of tobacco use personal history of traumatic fracture unspecified essential hypertension esophageal reflux history of fall fall from other slipping, tripping, or stumbling mitral valve disorders
white f 91 $nan$hematology blood hematocrit  28.7  %; hematology blood hemoglobin  9.5  g dl; hematology blood platelet count  236  k ul; chemistry blood anion gap  16  meq l; chemistry blood bicarbonate  23  meq l; chemistry blood chloride  101  meq l; chemistry blood creatinine  1.4  mg dl; chemistry blood potassium  4.3  meq l; chemistry blood sodium  136  meq l; chemistry blood urea nitrogen  29  mg dl; hematology blood inr(pt)  1.2  ; chemistry blood calcium, total  9.2  mg dl; chemistry blood glucose  119  mg dl; blood gas blood lactate  0.8  mmol l$vitamin d  800  unit ; multivitamins  1  tab ; aspirin  81  mg ; fluticasone propionate nasal  1  spry ; levothyroxine sodium  50  mcg ; bisacodyl  10  mg ; 5% dextrose  250  ml ; isoproterenol  2  mg ; ondansetron  2-4  mg ; 0.9% sodium chloride  500  ml ; bupropion (sustained release)  100  mg ; vial  1  vial ; pantoprazole  40  mg ; prochlorperazine  10  mg ; heparin  5000  unit ; acetaminophen  1000  mg ; calcium carbonate  500  mg ; ranitidine  150  mg ; morphine sulfate  0.5  mg ; artificial tears  1-2  drop ; atropine sulfate  1  mg ; metoprolol tartrate  12.5  mg ; mirtazapine  7.5  mg ; sw  100  ml ; magnesium sulfate  4  gm ; 0.9% sodium chloride  1000  ml ; polyethylene glycol  17  g ; d5 1 2ns  1000  ml ; 
other specified metabolic disorders unspecified fall disorder of bone and cartilage, unspecified unspecified acquired hypothyroidism congestive heart failure, unspecified closed fracture of lumbar vertebra without mention of spinal cord injury acute kidney failure, unspecified mitral valve disorders esophageal reflux unspecified essential hypertension other persistent mental disorders due to conditions classified elsewhere personal history of malignant neoplasm of large intestine other disorders of neurohypophysis congestive heart failure, unspecified closed fracture of pubis unspecified acquired hypothyroidism personal history of malignant neoplasm of large intestine personal history of tobacco use personal history of traumatic fracture unspecified essential hypertension esophageal reflux history of fall fall from other slipping, tripping, or stumbling mitral valve disorders
white f 91 $nan$hematology blood hematocrit  25.3  %; hematology blood hemoglobin  8.2  g dl; hematology blood platelet count  221  k ul; chemistry blood anion gap  13  meq l; chemistry blood bicarbonate  23  meq l; chemistry blood chloride  103  meq l; chemistry blood creatinine  1.1  mg dl; chemistry blood potassium  4.1  meq l; chemistry blood sodium  135  meq l; chemistry blood urea nitrogen  23  mg dl; hematology blood inr(pt)  1.2  ; chemistry blood calcium, total  8.9  mg dl; chemistry blood bilirubin, total  0.7  mg dl; chemistry blood glucose  115  mg dl$vitamin d  800  unit ; multivitamins  1  tab ; aspirin  81  mg ; fluticasone propionate nasal  1  spry ; levothyroxine sodium  50  mcg ; bisacodyl  10  mg ; 5% dextrose  250  ml ; isoproterenol  2  mg ; ondansetron  2-4  mg ; bupropion (sustained release)  100  mg ; vial  1  vial ; pantoprazole  40  mg ; prochlorperazine  10  mg ; heparin  5000  unit ; acetaminophen  1000  mg ; calcium carbonate  500  mg ; artificial tears  1-2  drop ; mirtazapine  7.5  mg ; sw  100  ml ; magnesium sulfate  4  gm ; polyethylene glycol  17  g ; d5 1 2ns  1000  ml ; neutra-phos  1  pkt ; acetaminophen  325  mg ; 
other specified metabolic disorders unspecified fall disorder of bone and cartilage, unspecified unspecified acquired hypothyroidism congestive heart failure, unspecified closed fracture of lumbar vertebra without mention of spinal cord injury acute kidney failure, unspecified mitral valve disorders esophageal reflux unspecified essential hypertension other persistent mental disorders due to conditions classified elsewhere personal history of malignant neoplasm of large intestine other disorders of neurohypophysis congestive heart failure, unspecified closed fracture of pubis unspecified acquired hypothyroidism personal history of malignant neoplasm of large intestine personal history of tobacco use personal history of traumatic fracture unspecified essential hypertension esophageal reflux history of fall fall from other slipping, tripping, or stumbling mitral valve disorders
white f 91 $nan$hematology blood hematocrit  26.6  %; hematology blood hemoglobin  9.0  g dl; hematology blood platelet count  199  k ul; chemistry blood anion gap  10  meq l; chemistry blood bicarbonate  27  meq l; chemistry blood chloride  102  meq l; chemistry blood creatinine  0.8  mg dl; chemistry blood potassium  3.8  meq l; chemistry blood sodium  135  meq l; chemistry blood urea nitrogen  15  mg dl; hematology blood inr(pt)  1.0  ; hematology urine wbc  6  # hpf; chemistry blood calcium, total  7.9  mg dl; chemistry blood bilirubin, total  0.7  mg dl; chemistry blood glucose  209  mg dl; chemistry blood albumin  3.6  g dl; chemistry blood % hemoglobin a1c  5.4  %$vitamin d  800  unit ; multivitamins  1  tab ; aspirin  81  mg ; fluticasone propionate nasal  1  spry ; levothyroxine sodium  50  mcg ; bisacodyl  10  mg ; 5% dextrose  250  ml ; isoproterenol  2  mg ; ondansetron  2-4  mg ; bupropion (sustained release)  100  mg ; prochlorperazine  10  mg ; calcium carbonate  500  mg ; artificial tears  1-2  drop ; mirtazapine  7.5  mg ; polyethylene glycol  17  g ; neutra-phos  1  pkt ; acetaminophen  325  mg ; furosemide  10  mg ; acetaminophen  650  mg ; potassium chloride  20  meq ; insulin  0  unit ; dextrose 50%  12.5  gm ; glucagon  1  mg ; oxycodone-acetaminophen  1-2  tab ; sodium chloride 0.9%  flush  3  ml ; 
other specified metabolic disorders unspecified fall disorder of bone and cartilage, unspecified unspecified acquired hypothyroidism congestive heart failure, unspecified closed fracture of lumbar vertebra without mention of spinal cord injury acute kidney failure, unspecified mitral valve disorders esophageal reflux unspecified essential hypertension other persistent mental disorders due to conditions classified elsewhere personal history of malignant neoplasm of large intestine other disorders of neurohypophysis congestive heart failure, unspecified closed fracture of pubis unspecified acquired hypothyroidism personal history of malignant neoplasm of large intestine personal history of tobacco use personal history of traumatic fracture unspecified essential hypertension esophageal reflux history of fall fall from other slipping, tripping, or stumbling mitral valve disorders
white f 91 $nan$hematology blood hematocrit  28.9  %; hematology blood hemoglobin  9.5  g dl; hematology blood platelet count  219  k ul; chemistry blood anion gap  13  meq l; chemistry blood bicarbonate  23  meq l; chemistry blood chloride  104  meq l; chemistry blood creatinine  0.9  mg dl; chemistry blood potassium  4.4  meq l; chemistry blood sodium  136  meq l; chemistry blood urea nitrogen  14  mg dl; hematology blood inr(pt)  1.1  ; chemistry blood calcium, total  8.8  mg dl; chemistry blood glucose  113  mg dl$vitamin d  800  unit ; multivitamins  1  tab ; aspirin  81  mg ; fluticasone propionate nasal  1  spry ; levothyroxine sodium  50  mcg ; bisacodyl  10  mg ; ondansetron  2-4  mg ; bupropion (sustained release)  100  mg ; prochlorperazine  10  mg ; calcium carbonate  500  mg ; artificial tears  1-2  drop ; mirtazapine  7.5  mg ; acetaminophen  650  mg ; potassium chloride  20  meq ; dextrose 50%  12.5  gm ; glucagon  1  mg ; sodium chloride 0.9%  flush  3  ml ; ciprofloxacin hcl  500  mg ; metoprolol succinate xl  50  mg ; 
other specified metabolic disorders unspecified fall disorder of bone and cartilage, unspecified unspecified acquired hypothyroidism congestive heart failure, unspecified closed fracture of lumbar vertebra without mention of spinal cord injury acute kidney failure, unspecified mitral valve disorders esophageal reflux unspecified essential hypertension other persistent mental disorders due to conditions classified elsewhere personal history of malignant neoplasm of large intestine other disorders of neurohypophysis congestive heart failure, unspecified closed fracture of pubis unspecified acquired hypothyroidism personal history of malignant neoplasm of large intestine personal history of tobacco use personal history of traumatic fracture unspecified essential hypertension esophageal reflux history of fall fall from other slipping, tripping, or stumbling mitral valve disorders
white f 91 $nan$hematology blood hematocrit  31.0  %; hematology blood hemoglobin  9.7  g dl; hematology blood platelet count  232  k ul; chemistry blood anion gap  12  meq l; chemistry blood bicarbonate  24  meq l; chemistry blood chloride  103  meq l; chemistry blood creatinine  0.9  mg dl; chemistry blood potassium  4.2  meq l; chemistry blood sodium  135  meq l; chemistry blood urea nitrogen  13  mg dl; hematology blood inr(pt)  1.1  ; chemistry blood calcium, total  8.8  mg dl; chemistry blood glucose  111  mg dl$vitamin d  800  unit ; multivitamins  1  tab ; aspirin  81  mg ; fluticasone propionate nasal  1  spry ; levothyroxine sodium  50  mcg ; bisacodyl  10  mg ; ondansetron  2-4  mg ; bupropion (sustained release)  100  mg ; prochlorperazine  10  mg ; calcium carbonate  500  mg ; artificial tears  1-2  drop ; mirtazapine  7.5  mg ; acetaminophen  650  mg ; dextrose 50%  12.5  gm ; glucagon  1  mg ; sodium chloride 0.9%  flush  3  ml ; ciprofloxacin hcl  500  mg ; metoprolol succinate xl  50  mg ; valsartan  80  mg ; 
other specified metabolic disorders unspecified fall disorder of bone and cartilage, unspecified unspecified acquired hypothyroidism congestive heart failure, unspecified closed fracture of lumbar vertebra without mention of spinal cord injury acute kidney failure, unspecified mitral valve disorders esophageal reflux unspecified essential hypertension other persistent mental disorders due to conditions classified elsewhere personal history of malignant neoplasm of large intestine other disorders of neurohypophysis congestive heart failure, unspecified closed fracture of pubis unspecified acquired hypothyroidism personal history of malignant neoplasm of large intestine personal history of tobacco use personal history of traumatic fracture unspecified essential hypertension esophageal reflux history of fall fall from other slipping, tripping, or stumbling mitral valve disorders
white f 91 $nan$nan$vitamin d  800  unit ; multivitamins  1  tab ; aspirin  81  mg ; fluticasone propionate nasal  1  spry ; levothyroxine sodium  50  mcg ; bisacodyl  10  mg ; ondansetron  2-4  mg ; bupropion (sustained release)  100  mg ; prochlorperazine  10  mg ; calcium carbonate  500  mg ; artificial tears  1-2  drop ; mirtazapine  7.5  mg ; acetaminophen  650  mg ; dextrose 50%  12.5  gm ; glucagon  1  mg ; sodium chloride 0.9%  flush  3  ml ; ciprofloxacin hcl  500  mg ; metoprolol succinate xl  50  mg ; valsartan  120  mg ; 
other specified metabolic disorders unspecified fall disorder of bone and cartilage, unspecified unspecified acquired hypothyroidism congestive heart failure, unspecified closed fracture of lumbar vertebra without mention of spinal cord injury acute kidney failure, unspecified mitral valve disorders esophageal reflux unspecified essential hypertension other persistent mental disorders due to conditions classified elsewhere personal history of malignant neoplasm of large intestine other disorders of neurohypophysis congestive heart failure, unspecified closed fracture of pubis unspecified acquired hypothyroidism personal history of malignant neoplasm of large intestine personal history of tobacco use personal history of traumatic fracture unspecified essential hypertension esophageal reflux history of fall fall from other slipping, tripping, or stumbling mitral valve disorders
white f 91 $nan$nan$vitamin d  800  unit ; multivitamins  1  tab ; aspirin  81  mg ; fluticasone propionate nasal  1  spry ; levothyroxine sodium  50  mcg ; bisacodyl  10  mg ; ondansetron  2-4  mg ; bupropion (sustained release)  100  mg ; prochlorperazine  10  mg ; calcium carbonate  500  mg ; artificial tears  1-2  drop ; mirtazapine  7.5  mg ; acetaminophen  650  mg ; dextrose 50%  12.5  gm ; glucagon  1  mg ; sodium chloride 0.9%  flush  3  ml ; ciprofloxacin hcl  500  mg ; metoprolol succinate xl  50  mg ; valsartan  120  mg ; 
other specified metabolic disorders unspecified fall disorder of bone and cartilage, unspecified unspecified acquired hypothyroidism congestive heart failure, unspecified closed fracture of lumbar vertebra without mention of spinal cord injury acute kidney failure, unspecified mitral valve disorders esophageal reflux unspecified essential hypertension other persistent mental disorders due to conditions classified elsewhere personal history of malignant neoplasm of large intestine other disorders of neurohypophysis congestive heart failure, unspecified closed fracture of pubis unspecified acquired hypothyroidism personal history of malignant neoplasm of large intestine personal history of tobacco use personal history of traumatic fracture unspecified essential hypertension esophageal reflux history of fall fall from other slipping, tripping, or stumbling mitral valve disorders
black african american f 60 $nan$nan$insulin  24  unit ; triamterene-hydrochlorothiazide  1  cap ; clopidogrel  75  mg ; paroxetine  40  mg ; aspirin  325  mg ; lisinopril  20  mg ; pravastatin  80  mg ; 
 
black african american f 60 $nan$hematology blood hematocrit  35.6  %; hematology blood hematocrit  36.1  %; hematology blood hemoglobin  11.9  g dl; hematology blood hemoglobin  11.5  g dl; hematology blood platelet count  138  k ul; hematology blood platelet count  117  k ul; chemistry blood anion gap  18  meq l; chemistry blood anion gap  17  meq l; chemistry blood bicarbonate  24  meq l; chemistry blood bicarbonate  26  meq l; chemistry blood chloride  99  meq l; chemistry blood chloride  99  meq l; chemistry blood creatinine  1.4  mg dl; chemistry blood creatinine  1.2  mg dl; chemistry blood potassium  3.8  meq l; chemistry blood potassium  4.3  meq l; chemistry blood sodium  137  meq l; chemistry blood sodium  138  meq l; chemistry blood urea nitrogen  39  mg dl; chemistry blood urea nitrogen  40  mg dl; hematology blood inr(pt)  1.4  ; hematology blood inr(pt)  1.3  ; chemistry blood calcium, total  9.1  mg dl; chemistry blood calcium, total  9.2  mg dl; chemistry blood bilirubin, total  1.4  mg dl; chemistry blood glucose  166  mg dl; chemistry blood glucose  109  mg dl; chemistry blood lactate dehydrogenase (ld)  188  iu l; chemistry blood albumin  3.3  g dl$insulin  24  unit ; triamterene-hydrochlorothiazide  1  cap ; clopidogrel  75  mg ; paroxetine  40  mg ; aspirin  325  mg ; lisinopril  20  mg ; pravastatin  80  mg ; sodium chloride 0.9%  flush  3  ml ; metoprolol tartrate  50  mg ; pantoprazole  40  mg ; insulin  0  unit ; heparin  5000  unit ; docusate sodium  100  mg ; senna  1  tab ; sw  100  ml ; magnesium sulfate  4  gm ; potassium chloride  20  meq ; 
 
black african american f 60 $nan$nan$insulin  24  unit ; triamterene-hydrochlorothiazide  1  cap ; paroxetine  40  mg ; aspirin  325  mg ; lisinopril  20  mg ; pravastatin  80  mg ; sodium chloride 0.9%  flush  3  ml ; metoprolol tartrate  50  mg ; pantoprazole  40  mg ; insulin  0  unit ; heparin  5000  unit ; docusate sodium  100  mg ; senna  1  tab ; sw  100  ml ; magnesium sulfate  4  gm ; potassium chloride  20  meq ; 
 
white f 70 $nan$nan$aspirin  81  mg ; atorvastatin  10  mg ; levothyroxine sodium  50  mcg ; aspirin  325  mg ; 
 
white f 70 $nan$hematology blood hematocrit  39.2  %; hematology blood hemoglobin  13.4  g dl; hematology blood platelet count  250  k ul; chemistry blood anion gap  10  meq l; chemistry blood bicarbonate  29  meq l; chemistry blood chloride  107  meq l; chemistry blood creatinine  0.8  mg dl; chemistry blood potassium  3.9  meq l; chemistry blood sodium  142  meq l; chemistry blood urea nitrogen  15  mg dl; hematology blood inr(pt)  1.2  ; chemistry blood glucose  87  mg dl$aspirin  81  mg ; atorvastatin  10  mg ; levothyroxine sodium  50  mcg ; aspirin  325  mg ; pneumococcal vac polyvalent  0.5  ml ; sodium chloride 0.9%  flush  3  ml ; acetaminophen  650  mg ; senna  1  tab ; docusate sodium  100  mg ; 
 
white f 70 $nan$nan$atorvastatin  10  mg ; levothyroxine sodium  50  mcg ; aspirin  325  mg ; pneumococcal vac polyvalent  0.5  ml ; sodium chloride 0.9%  flush  3  ml ; acetaminophen  650  mg ; senna  1  tab ; docusate sodium  100  mg ; 
 
hispanic latino m 79 $nan$hematology blood hematocrit  34.4  %; hematology blood hemoglobin  10.9  g dl; hematology blood platelet count  148  k ul; chemistry blood anion gap  11  meq l; chemistry blood anion gap  14  meq l; chemistry blood bicarbonate  28  meq l; chemistry blood bicarbonate  27  meq l; chemistry blood chloride  102  meq l; chemistry blood chloride  103  meq l; chemistry blood creatinine  1.1  mg dl; chemistry blood creatinine  1.0  mg dl; chemistry blood potassium  4.3  meq l; chemistry blood potassium  4.2  meq l; chemistry blood sodium  137  meq l; chemistry blood sodium  140  meq l; chemistry blood urea nitrogen  15  mg dl; chemistry blood urea nitrogen  18  mg dl; hematology blood inr(pt)  1.2  ; chemistry blood calcium, total  9.0  mg dl; chemistry blood calcium, total  8.5  mg dl; chemistry blood bilirubin, total  0.5  mg dl; chemistry blood glucose  115  mg dl; chemistry blood glucose  104  mg dl$sodium chloride 0.9%  flush  3  ml ; pneumococcal vac polyvalent  0.5  ml ; heparin  5000  unit ; morphine sulfate  2-4  mg ; acetaminophen  500-1000  mg ; docusate sodium  100  mg ; senna  1  tab ; bisacodyl  10  mg ; albuterol 0.083% neb soln  1  neb ; ipratropium bromide neb  1  neb ; metoprolol tartrate  12.5  mg ; ondansetron  4  mg ; atorvastatin  10  mg ; levothyroxine sodium  50  mcg ; lisinopril  40  mg ; citalopram hydrobromide  20  mg ; tiotropium bromide  1  cap ; aspirin  81  mg ; iso-osmotic dextrose  50  ml ; ceftriaxone  1  gm ; polyethylene glycol  17  g ; azithromycin  250  mg ; aspirin  162  mg ; enoxaparin sodium  100  mg ; zolpidem tartrate  10  mg ; 
unspecified acquired hypothyroidism chronic obstructive asthma with (acute) exacerbation pure hypercholesterolemia unspecified essential hypertension unspecified gastritis and gastroduodenitis, without mention of hemorrhage personal history of malignant neoplasm of bronchus and lung knee joint replacement postinflammatory pulmonary fibrosis secondary and unspecified malignant neoplasm of intrapelvic lymph nodes pneumonia, organism unspecified personal history of colonic polyps hypertrophy (benign) of prostate without urinary obstruction and other lower urinary tract symptom (luts) personal history of malignant neoplasm of thyroid other chronic pulmonary heart diseases osteoarthrosis, unspecified whether generalized or localized, site unspecified personal history of tobacco use postinflammatory pulmonary fibrosis personal history of malignant neoplasm of bronchus and lung other chest pain osteoarthrosis, unspecified whether generalized or localized, site unspecified pure hypercholesterolemia hypertrophy (benign) of prostate without urinary obstruction and other lower urinary tract symptom (luts) secondary and unspecified malignant neoplasm of intrathoracic lymph nodes venous (peripheral) insufficiency, unspecified other and unspecified hyperlipidemia dysthymic disorder hypoxemia personal history of colonic polyps obstructive chronic bronchitis with (acute) exacerbation unspecified gastritis and gastroduodenitis, without mention of hemorrhage personal history of malignant neoplasm of thyroid knee joint replacement chronic airway obstruction, not elsewhere classified hypoxemia right bundle branch block hypertrophy (benign) of prostate without urinary obstruction and other lower urinary tract symptom (luts) unspecified essential hypertension person on outside of heavy transport vehicle injured in collision with other nonmotor vehicle in traffic accident pure hypercholesterolemia other chronic pulmonary heart diseases pneumonia, organism unspecified secondary and unspecified malignant neoplasm of intrathoracic lymph nodes personal history of colonic polyps malignant neoplasm of other parts of bronchus or lung secondary malignant neoplasm of pleura knee joint replacement osteoarthrosis, unspecified whether generalized or localized, site unspecified encounter for palliative care
hispanic latino m 79 $nan$nan$sodium chloride 0.9%  flush  3  ml ; pneumococcal vac polyvalent  0.5  ml ; morphine sulfate  2-4  mg ; acetaminophen  500-1000  mg ; docusate sodium  100  mg ; bisacodyl  10  mg ; albuterol 0.083% neb soln  1  neb ; metoprolol tartrate  12.5  mg ; ondansetron  4  mg ; atorvastatin  10  mg ; levothyroxine sodium  50  mcg ; lisinopril  40  mg ; citalopram hydrobromide  20  mg ; tiotropium bromide  1  cap ; iso-osmotic dextrose  50  ml ; ceftriaxone  1  gm ; polyethylene glycol  17  g ; azithromycin  250  mg ; aspirin  162  mg ; enoxaparin sodium  100  mg ; zolpidem tartrate  10  mg ; aspirin  325  mg ; furosemide  20  mg ; prednisone  40  mg ; ranitidine  150  mg ; diphenhydramine  50  mg ; 
unspecified acquired hypothyroidism chronic obstructive asthma with (acute) exacerbation pure hypercholesterolemia unspecified essential hypertension unspecified gastritis and gastroduodenitis, without mention of hemorrhage personal history of malignant neoplasm of bronchus and lung knee joint replacement postinflammatory pulmonary fibrosis secondary and unspecified malignant neoplasm of intrapelvic lymph nodes pneumonia, organism unspecified personal history of colonic polyps hypertrophy (benign) of prostate without urinary obstruction and other lower urinary tract symptom (luts) personal history of malignant neoplasm of thyroid other chronic pulmonary heart diseases osteoarthrosis, unspecified whether generalized or localized, site unspecified personal history of tobacco use postinflammatory pulmonary fibrosis personal history of malignant neoplasm of bronchus and lung other chest pain osteoarthrosis, unspecified whether generalized or localized, site unspecified pure hypercholesterolemia hypertrophy (benign) of prostate without urinary obstruction and other lower urinary tract symptom (luts) secondary and unspecified malignant neoplasm of intrathoracic lymph nodes venous (peripheral) insufficiency, unspecified other and unspecified hyperlipidemia dysthymic disorder hypoxemia personal history of colonic polyps obstructive chronic bronchitis with (acute) exacerbation unspecified gastritis and gastroduodenitis, without mention of hemorrhage personal history of malignant neoplasm of thyroid knee joint replacement chronic airway obstruction, not elsewhere classified hypoxemia right bundle branch block hypertrophy (benign) of prostate without urinary obstruction and other lower urinary tract symptom (luts) unspecified essential hypertension person on outside of heavy transport vehicle injured in collision with other nonmotor vehicle in traffic accident pure hypercholesterolemia other chronic pulmonary heart diseases pneumonia, organism unspecified secondary and unspecified malignant neoplasm of intrathoracic lymph nodes personal history of colonic polyps malignant neoplasm of other parts of bronchus or lung secondary malignant neoplasm of pleura knee joint replacement osteoarthrosis, unspecified whether generalized or localized, site unspecified encounter for palliative care
hispanic latino m 79 $nan$hematology blood hematocrit  35.0  %; hematology blood hemoglobin  11.5  g dl; hematology blood platelet count  173  k ul; chemistry blood anion gap  13  meq l; chemistry blood bicarbonate  26  meq l; chemistry blood chloride  99  meq l; chemistry blood creatinine  0.9  mg dl; chemistry blood potassium  4.7  meq l; chemistry blood sodium  133  meq l; chemistry blood urea nitrogen  15  mg dl; hematology blood inr(pt)  1.2  ; chemistry blood calcium, total  8.9  mg dl; chemistry blood glucose  136  mg dl$sodium chloride 0.9%  flush  3  ml ; pneumococcal vac polyvalent  0.5  ml ; acetaminophen  500-1000  mg ; docusate sodium  100  mg ; bisacodyl  10  mg ; albuterol 0.083% neb soln  1  neb ; metoprolol tartrate  12.5  mg ; ondansetron  4  mg ; atorvastatin  10  mg ; levothyroxine sodium  50  mcg ; lisinopril  40  mg ; citalopram hydrobromide  20  mg ; tiotropium bromide  1  cap ; iso-osmotic dextrose  50  ml ; ceftriaxone  1  gm ; polyethylene glycol  17  g ; azithromycin  250  mg ; enoxaparin sodium  100  mg ; zolpidem tartrate  10  mg ; aspirin  325  mg ; furosemide  20  mg ; ranitidine  150  mg ; diphenhydramine  50  mg ; 
unspecified acquired hypothyroidism chronic obstructive asthma with (acute) exacerbation pure hypercholesterolemia unspecified essential hypertension unspecified gastritis and gastroduodenitis, without mention of hemorrhage personal history of malignant neoplasm of bronchus and lung knee joint replacement postinflammatory pulmonary fibrosis secondary and unspecified malignant neoplasm of intrapelvic lymph nodes pneumonia, organism unspecified personal history of colonic polyps hypertrophy (benign) of prostate without urinary obstruction and other lower urinary tract symptom (luts) personal history of malignant neoplasm of thyroid other chronic pulmonary heart diseases osteoarthrosis, unspecified whether generalized or localized, site unspecified personal history of tobacco use postinflammatory pulmonary fibrosis personal history of malignant neoplasm of bronchus and lung other chest pain osteoarthrosis, unspecified whether generalized or localized, site unspecified pure hypercholesterolemia hypertrophy (benign) of prostate without urinary obstruction and other lower urinary tract symptom (luts) secondary and unspecified malignant neoplasm of intrathoracic lymph nodes venous (peripheral) insufficiency, unspecified other and unspecified hyperlipidemia dysthymic disorder hypoxemia personal history of colonic polyps obstructive chronic bronchitis with (acute) exacerbation unspecified gastritis and gastroduodenitis, without mention of hemorrhage personal history of malignant neoplasm of thyroid knee joint replacement chronic airway obstruction, not elsewhere classified hypoxemia right bundle branch block hypertrophy (benign) of prostate without urinary obstruction and other lower urinary tract symptom (luts) unspecified essential hypertension person on outside of heavy transport vehicle injured in collision with other nonmotor vehicle in traffic accident pure hypercholesterolemia other chronic pulmonary heart diseases pneumonia, organism unspecified secondary and unspecified malignant neoplasm of intrathoracic lymph nodes personal history of colonic polyps malignant neoplasm of other parts of bronchus or lung secondary malignant neoplasm of pleura knee joint replacement osteoarthrosis, unspecified whether generalized or localized, site unspecified encounter for palliative care
hispanic latino m 79 $nan$hematology blood hematocrit  32.0  %; hematology blood hemoglobin  10.6  g dl; hematology blood platelet count  221  k ul; chemistry blood anion gap  14  meq l; chemistry blood bicarbonate  27  meq l; chemistry blood chloride  101  meq l; chemistry blood creatinine  1.0  mg dl; chemistry blood potassium  3.9  meq l; chemistry blood sodium  138  meq l; chemistry blood urea nitrogen  17  mg dl; hematology blood inr(pt)  1.1  ; chemistry blood calcium, total  8.8  mg dl; chemistry blood bilirubin, total  0.6  mg dl; chemistry blood glucose  86  mg dl$sodium chloride 0.9%  flush  3  ml ; pneumococcal vac polyvalent  0.5  ml ; acetaminophen  500-1000  mg ; docusate sodium  100  mg ; bisacodyl  10  mg ; albuterol 0.083% neb soln  1  neb ; metoprolol tartrate  12.5  mg ; ondansetron  4  mg ; atorvastatin  10  mg ; levothyroxine sodium  50  mcg ; lisinopril  40  mg ; citalopram hydrobromide  20  mg ; tiotropium bromide  1  cap ; polyethylene glycol  17  g ; zolpidem tartrate  10  mg ; fluticasone propionate 110mcg  2  puff ; 
unspecified acquired hypothyroidism chronic obstructive asthma with (acute) exacerbation pure hypercholesterolemia unspecified essential hypertension unspecified gastritis and gastroduodenitis, without mention of hemorrhage personal history of malignant neoplasm of bronchus and lung knee joint replacement postinflammatory pulmonary fibrosis secondary and unspecified malignant neoplasm of intrapelvic lymph nodes pneumonia, organism unspecified personal history of colonic polyps hypertrophy (benign) of prostate without urinary obstruction and other lower urinary tract symptom (luts) personal history of malignant neoplasm of thyroid other chronic pulmonary heart diseases osteoarthrosis, unspecified whether generalized or localized, site unspecified personal history of tobacco use postinflammatory pulmonary fibrosis personal history of malignant neoplasm of bronchus and lung other chest pain osteoarthrosis, unspecified whether generalized or localized, site unspecified pure hypercholesterolemia hypertrophy (benign) of prostate without urinary obstruction and other lower urinary tract symptom (luts) secondary and unspecified malignant neoplasm of intrathoracic lymph nodes venous (peripheral) insufficiency, unspecified other and unspecified hyperlipidemia dysthymic disorder hypoxemia personal history of colonic polyps obstructive chronic bronchitis with (acute) exacerbation unspecified gastritis and gastroduodenitis, without mention of hemorrhage personal history of malignant neoplasm of thyroid knee joint replacement chronic airway obstruction, not elsewhere classified hypoxemia right bundle branch block hypertrophy (benign) of prostate without urinary obstruction and other lower urinary tract symptom (luts) unspecified essential hypertension person on outside of heavy transport vehicle injured in collision with other nonmotor vehicle in traffic accident pure hypercholesterolemia other chronic pulmonary heart diseases pneumonia, organism unspecified secondary and unspecified malignant neoplasm of intrathoracic lymph nodes personal history of colonic polyps malignant neoplasm of other parts of bronchus or lung secondary malignant neoplasm of pleura knee joint replacement osteoarthrosis, unspecified whether generalized or localized, site unspecified encounter for palliative care
hispanic latino m 79 $nan$hematology blood hematocrit  33.3  %; hematology blood hemoglobin  11.7  g dl; hematology blood platelet count  220  k ul; chemistry blood anion gap  11  meq l; chemistry blood bicarbonate  29  meq l; chemistry blood chloride  102  meq l; chemistry blood creatinine  0.8  mg dl; chemistry blood potassium  4.3  meq l; chemistry blood sodium  138  meq l; chemistry blood urea nitrogen  14  mg dl; chemistry blood calcium, total  8.8  mg dl; chemistry blood glucose  88  mg dl$sodium chloride 0.9%  flush  3  ml ; pneumococcal vac polyvalent  0.5  ml ; acetaminophen  500-1000  mg ; docusate sodium  100  mg ; bisacodyl  10  mg ; albuterol 0.083% neb soln  1  neb ; metoprolol tartrate  12.5  mg ; ondansetron  4  mg ; atorvastatin  10  mg ; levothyroxine sodium  50  mcg ; lisinopril  40  mg ; citalopram hydrobromide  20  mg ; tiotropium bromide  1  cap ; polyethylene glycol  17  g ; zolpidem tartrate  10  mg ; fluticasone propionate 110mcg  2  puff ; prednisone  20  mg ; furosemide  40  mg ; spironolactone  12.5  mg ; 
unspecified acquired hypothyroidism chronic obstructive asthma with (acute) exacerbation pure hypercholesterolemia unspecified essential hypertension unspecified gastritis and gastroduodenitis, without mention of hemorrhage personal history of malignant neoplasm of bronchus and lung knee joint replacement postinflammatory pulmonary fibrosis secondary and unspecified malignant neoplasm of intrapelvic lymph nodes pneumonia, organism unspecified personal history of colonic polyps hypertrophy (benign) of prostate without urinary obstruction and other lower urinary tract symptom (luts) personal history of malignant neoplasm of thyroid other chronic pulmonary heart diseases osteoarthrosis, unspecified whether generalized or localized, site unspecified personal history of tobacco use postinflammatory pulmonary fibrosis personal history of malignant neoplasm of bronchus and lung other chest pain osteoarthrosis, unspecified whether generalized or localized, site unspecified pure hypercholesterolemia hypertrophy (benign) of prostate without urinary obstruction and other lower urinary tract symptom (luts) secondary and unspecified malignant neoplasm of intrathoracic lymph nodes venous (peripheral) insufficiency, unspecified other and unspecified hyperlipidemia dysthymic disorder hypoxemia personal history of colonic polyps obstructive chronic bronchitis with (acute) exacerbation unspecified gastritis and gastroduodenitis, without mention of hemorrhage personal history of malignant neoplasm of thyroid knee joint replacement chronic airway obstruction, not elsewhere classified hypoxemia right bundle branch block hypertrophy (benign) of prostate without urinary obstruction and other lower urinary tract symptom (luts) unspecified essential hypertension person on outside of heavy transport vehicle injured in collision with other nonmotor vehicle in traffic accident pure hypercholesterolemia other chronic pulmonary heart diseases pneumonia, organism unspecified secondary and unspecified malignant neoplasm of intrathoracic lymph nodes personal history of colonic polyps malignant neoplasm of other parts of bronchus or lung secondary malignant neoplasm of pleura knee joint replacement osteoarthrosis, unspecified whether generalized or localized, site unspecified encounter for palliative care
hispanic latino m 79 $nan$hematology blood hematocrit  31.0  %; hematology blood hemoglobin  10.4  g dl; hematology blood platelet count  261  k ul; chemistry blood anion gap  10  meq l; chemistry blood bicarbonate  30  meq l; chemistry blood chloride  102  meq l; chemistry blood creatinine  0.9  mg dl; chemistry blood potassium  4.3  meq l; chemistry blood sodium  138  meq l; chemistry blood urea nitrogen  15  mg dl; chemistry blood calcium, total  8.6  mg dl; chemistry blood glucose  92  mg dl$sodium chloride 0.9%  flush  3  ml ; pneumococcal vac polyvalent  0.5  ml ; acetaminophen  500-1000  mg ; docusate sodium  100  mg ; bisacodyl  10  mg ; albuterol 0.083% neb soln  1  neb ; ondansetron  4  mg ; atorvastatin  10  mg ; levothyroxine sodium  50  mcg ; lisinopril  40  mg ; citalopram hydrobromide  20  mg ; tiotropium bromide  1  cap ; polyethylene glycol  17  g ; zolpidem tartrate  10  mg ; fluticasone propionate 110mcg  2  puff ; spironolactone  12.5  mg ; 
unspecified acquired hypothyroidism chronic obstructive asthma with (acute) exacerbation pure hypercholesterolemia unspecified essential hypertension unspecified gastritis and gastroduodenitis, without mention of hemorrhage personal history of malignant neoplasm of bronchus and lung knee joint replacement postinflammatory pulmonary fibrosis secondary and unspecified malignant neoplasm of intrapelvic lymph nodes pneumonia, organism unspecified personal history of colonic polyps hypertrophy (benign) of prostate without urinary obstruction and other lower urinary tract symptom (luts) personal history of malignant neoplasm of thyroid other chronic pulmonary heart diseases osteoarthrosis, unspecified whether generalized or localized, site unspecified personal history of tobacco use postinflammatory pulmonary fibrosis personal history of malignant neoplasm of bronchus and lung other chest pain osteoarthrosis, unspecified whether generalized or localized, site unspecified pure hypercholesterolemia hypertrophy (benign) of prostate without urinary obstruction and other lower urinary tract symptom (luts) secondary and unspecified malignant neoplasm of intrathoracic lymph nodes venous (peripheral) insufficiency, unspecified other and unspecified hyperlipidemia dysthymic disorder hypoxemia personal history of colonic polyps obstructive chronic bronchitis with (acute) exacerbation unspecified gastritis and gastroduodenitis, without mention of hemorrhage personal history of malignant neoplasm of thyroid knee joint replacement chronic airway obstruction, not elsewhere classified hypoxemia right bundle branch block hypertrophy (benign) of prostate without urinary obstruction and other lower urinary tract symptom (luts) unspecified essential hypertension person on outside of heavy transport vehicle injured in collision with other nonmotor vehicle in traffic accident pure hypercholesterolemia other chronic pulmonary heart diseases pneumonia, organism unspecified secondary and unspecified malignant neoplasm of intrathoracic lymph nodes personal history of colonic polyps malignant neoplasm of other parts of bronchus or lung secondary malignant neoplasm of pleura knee joint replacement osteoarthrosis, unspecified whether generalized or localized, site unspecified encounter for palliative care
hispanic latino m 79 $nan$hematology blood hematocrit  34.7  %; hematology blood hemoglobin  11.2  g dl; hematology blood platelet count  335  k ul; chemistry blood anion gap  12  meq l; chemistry blood bicarbonate  29  meq l; chemistry blood chloride  103  meq l; chemistry blood creatinine  0.9  mg dl; chemistry blood potassium  4.0  meq l; chemistry blood sodium  140  meq l; chemistry blood urea nitrogen  9  mg dl; hematology blood inr(pt)  1.1  ; chemistry blood calcium, total  8.6  mg dl; chemistry blood bilirubin, total  0.5  mg dl; chemistry blood glucose  86  mg dl; chemistry blood lactate dehydrogenase (ld)  305  iu l; chemistry blood albumin  3.8  g dl$sodium chloride 0.9%  flush  3  ml ; pneumococcal vac polyvalent  0.5  ml ; acetaminophen  500-1000  mg ; docusate sodium  100  mg ; bisacodyl  10  mg ; albuterol 0.083% neb soln  1  neb ; ondansetron  4  mg ; atorvastatin  10  mg ; levothyroxine sodium  50  mcg ; lisinopril  40  mg ; citalopram hydrobromide  20  mg ; tiotropium bromide  1  cap ; polyethylene glycol  17  g ; zolpidem tartrate  10  mg ; fluticasone propionate 110mcg  2  puff ; spironolactone  12.5  mg ; 
unspecified acquired hypothyroidism chronic obstructive asthma with (acute) exacerbation pure hypercholesterolemia unspecified essential hypertension unspecified gastritis and gastroduodenitis, without mention of hemorrhage personal history of malignant neoplasm of bronchus and lung knee joint replacement postinflammatory pulmonary fibrosis secondary and unspecified malignant neoplasm of intrapelvic lymph nodes pneumonia, organism unspecified personal history of colonic polyps hypertrophy (benign) of prostate without urinary obstruction and other lower urinary tract symptom (luts) personal history of malignant neoplasm of thyroid other chronic pulmonary heart diseases osteoarthrosis, unspecified whether generalized or localized, site unspecified personal history of tobacco use postinflammatory pulmonary fibrosis personal history of malignant neoplasm of bronchus and lung other chest pain osteoarthrosis, unspecified whether generalized or localized, site unspecified pure hypercholesterolemia hypertrophy (benign) of prostate without urinary obstruction and other lower urinary tract symptom (luts) secondary and unspecified malignant neoplasm of intrathoracic lymph nodes venous (peripheral) insufficiency, unspecified other and unspecified hyperlipidemia dysthymic disorder hypoxemia personal history of colonic polyps obstructive chronic bronchitis with (acute) exacerbation unspecified gastritis and gastroduodenitis, without mention of hemorrhage personal history of malignant neoplasm of thyroid knee joint replacement chronic airway obstruction, not elsewhere classified hypoxemia right bundle branch block hypertrophy (benign) of prostate without urinary obstruction and other lower urinary tract symptom (luts) unspecified essential hypertension person on outside of heavy transport vehicle injured in collision with other nonmotor vehicle in traffic accident pure hypercholesterolemia other chronic pulmonary heart diseases pneumonia, organism unspecified secondary and unspecified malignant neoplasm of intrathoracic lymph nodes personal history of colonic polyps malignant neoplasm of other parts of bronchus or lung secondary malignant neoplasm of pleura knee joint replacement osteoarthrosis, unspecified whether generalized or localized, site unspecified encounter for palliative care
hispanic latino m 79 $nan$hematology blood hematocrit  34.4  %; hematology blood hemoglobin  11.3  g dl; hematology blood platelet count  395  k ul; chemistry blood anion gap  12  meq l; chemistry blood bicarbonate  30  meq l; chemistry blood chloride  102  meq l; chemistry blood creatinine  0.9  mg dl; chemistry blood potassium  4.5  meq l; chemistry blood sodium  139  meq l; chemistry blood urea nitrogen  13  mg dl; hematology blood inr(pt)  1.1  ; chemistry blood calcium, total  8.7  mg dl; chemistry blood bilirubin, total  0.5  mg dl; chemistry blood glucose  88  mg dl; chemistry blood lactate dehydrogenase (ld)  277  iu l; chemistry blood albumin  3.7  g dl$sodium chloride 0.9%  flush  3  ml ; pneumococcal vac polyvalent  0.5  ml ; acetaminophen  500-1000  mg ; docusate sodium  100  mg ; albuterol 0.083% neb soln  1  neb ; ondansetron  4  mg ; atorvastatin  10  mg ; lisinopril  40  mg ; citalopram hydrobromide  20  mg ; tiotropium bromide  1  cap ; polyethylene glycol  17  g ; zolpidem tartrate  10  mg ; fluticasone propionate 110mcg  2  puff ; spironolactone  12.5  mg ; prednisone  30  mg ; ibuprofen  400  mg ; famotidine  20  mg ; 
unspecified acquired hypothyroidism chronic obstructive asthma with (acute) exacerbation pure hypercholesterolemia unspecified essential hypertension unspecified gastritis and gastroduodenitis, without mention of hemorrhage personal history of malignant neoplasm of bronchus and lung knee joint replacement postinflammatory pulmonary fibrosis secondary and unspecified malignant neoplasm of intrapelvic lymph nodes pneumonia, organism unspecified personal history of colonic polyps hypertrophy (benign) of prostate without urinary obstruction and other lower urinary tract symptom (luts) personal history of malignant neoplasm of thyroid other chronic pulmonary heart diseases osteoarthrosis, unspecified whether generalized or localized, site unspecified personal history of tobacco use postinflammatory pulmonary fibrosis personal history of malignant neoplasm of bronchus and lung other chest pain osteoarthrosis, unspecified whether generalized or localized, site unspecified pure hypercholesterolemia hypertrophy (benign) of prostate without urinary obstruction and other lower urinary tract symptom (luts) secondary and unspecified malignant neoplasm of intrathoracic lymph nodes venous (peripheral) insufficiency, unspecified other and unspecified hyperlipidemia dysthymic disorder hypoxemia personal history of colonic polyps obstructive chronic bronchitis with (acute) exacerbation unspecified gastritis and gastroduodenitis, without mention of hemorrhage personal history of malignant neoplasm of thyroid knee joint replacement chronic airway obstruction, not elsewhere classified hypoxemia right bundle branch block hypertrophy (benign) of prostate without urinary obstruction and other lower urinary tract symptom (luts) unspecified essential hypertension person on outside of heavy transport vehicle injured in collision with other nonmotor vehicle in traffic accident pure hypercholesterolemia other chronic pulmonary heart diseases pneumonia, organism unspecified secondary and unspecified malignant neoplasm of intrathoracic lymph nodes personal history of colonic polyps malignant neoplasm of other parts of bronchus or lung secondary malignant neoplasm of pleura knee joint replacement osteoarthrosis, unspecified whether generalized or localized, site unspecified encounter for palliative care
hispanic latino m 79 $nan$hematology blood hematocrit  36.5  %; hematology blood hemoglobin  11.7  g dl; hematology blood platelet count  413  k ul; chemistry blood anion gap  11  meq l; chemistry blood bicarbonate  31  meq l; chemistry blood chloride  99  meq l; chemistry blood creatinine  1.0  mg dl; chemistry blood potassium  4.1  meq l; chemistry blood sodium  137  meq l; chemistry blood urea nitrogen  16  mg dl; chemistry blood calcium, total  8.8  mg dl; chemistry blood bilirubin, total  0.5  mg dl; chemistry blood glucose  89  mg dl; chemistry blood lactate dehydrogenase (ld)  260  iu l; chemistry blood albumin  3.8  g dl$sodium chloride 0.9%  flush  3  ml ; pneumococcal vac polyvalent  0.5  ml ; acetaminophen  500-1000  mg ; docusate sodium  100  mg ; albuterol 0.083% neb soln  1  neb ; ondansetron  4  mg ; atorvastatin  10  mg ; lisinopril  40  mg ; citalopram hydrobromide  20  mg ; polyethylene glycol  17  g ; zolpidem tartrate  10  mg ; fluticasone propionate 110mcg  2  puff ; spironolactone  12.5  mg ; prednisone  30  mg ; ibuprofen  400  mg ; famotidine  20  mg ; furosemide  80  mg ; carvedilol  6.25  mg ; 
unspecified acquired hypothyroidism chronic obstructive asthma with (acute) exacerbation pure hypercholesterolemia unspecified essential hypertension unspecified gastritis and gastroduodenitis, without mention of hemorrhage personal history of malignant neoplasm of bronchus and lung knee joint replacement postinflammatory pulmonary fibrosis secondary and unspecified malignant neoplasm of intrapelvic lymph nodes pneumonia, organism unspecified personal history of colonic polyps hypertrophy (benign) of prostate without urinary obstruction and other lower urinary tract symptom (luts) personal history of malignant neoplasm of thyroid other chronic pulmonary heart diseases osteoarthrosis, unspecified whether generalized or localized, site unspecified personal history of tobacco use postinflammatory pulmonary fibrosis personal history of malignant neoplasm of bronchus and lung other chest pain osteoarthrosis, unspecified whether generalized or localized, site unspecified pure hypercholesterolemia hypertrophy (benign) of prostate without urinary obstruction and other lower urinary tract symptom (luts) secondary and unspecified malignant neoplasm of intrathoracic lymph nodes venous (peripheral) insufficiency, unspecified other and unspecified hyperlipidemia dysthymic disorder hypoxemia personal history of colonic polyps obstructive chronic bronchitis with (acute) exacerbation unspecified gastritis and gastroduodenitis, without mention of hemorrhage personal history of malignant neoplasm of thyroid knee joint replacement chronic airway obstruction, not elsewhere classified hypoxemia right bundle branch block hypertrophy (benign) of prostate without urinary obstruction and other lower urinary tract symptom (luts) unspecified essential hypertension person on outside of heavy transport vehicle injured in collision with other nonmotor vehicle in traffic accident pure hypercholesterolemia other chronic pulmonary heart diseases pneumonia, organism unspecified secondary and unspecified malignant neoplasm of intrathoracic lymph nodes personal history of colonic polyps malignant neoplasm of other parts of bronchus or lung secondary malignant neoplasm of pleura knee joint replacement osteoarthrosis, unspecified whether generalized or localized, site unspecified encounter for palliative care
hispanic latino m 79 $nan$hematology blood hematocrit  36.9  %; hematology blood hemoglobin  11.8  g dl; hematology blood platelet count  443  k ul; chemistry blood anion gap  10  meq l; chemistry blood bicarbonate  33  meq l; chemistry blood chloride  97  meq l; chemistry blood creatinine  1.0  mg dl; chemistry blood potassium  4.0  meq l; chemistry blood sodium  136  meq l; chemistry blood urea nitrogen  20  mg dl; chemistry blood calcium, total  9.0  mg dl; chemistry blood bilirubin, total  0.5  mg dl; chemistry blood glucose  84  mg dl; chemistry blood lactate dehydrogenase (ld)  291  iu l$sodium chloride 0.9%  flush  3  ml ; pneumococcal vac polyvalent  0.5  ml ; acetaminophen  500-1000  mg ; docusate sodium  100  mg ; albuterol 0.083% neb soln  1  neb ; ondansetron  4  mg ; atorvastatin  10  mg ; lisinopril  40  mg ; citalopram hydrobromide  20  mg ; polyethylene glycol  17  g ; zolpidem tartrate  10  mg ; fluticasone propionate 110mcg  2  puff ; spironolactone  12.5  mg ; ibuprofen  400  mg ; famotidine  20  mg ; carvedilol  6.25  mg ; 
unspecified acquired hypothyroidism chronic obstructive asthma with (acute) exacerbation pure hypercholesterolemia unspecified essential hypertension unspecified gastritis and gastroduodenitis, without mention of hemorrhage personal history of malignant neoplasm of bronchus and lung knee joint replacement postinflammatory pulmonary fibrosis secondary and unspecified malignant neoplasm of intrapelvic lymph nodes pneumonia, organism unspecified personal history of colonic polyps hypertrophy (benign) of prostate without urinary obstruction and other lower urinary tract symptom (luts) personal history of malignant neoplasm of thyroid other chronic pulmonary heart diseases osteoarthrosis, unspecified whether generalized or localized, site unspecified personal history of tobacco use postinflammatory pulmonary fibrosis personal history of malignant neoplasm of bronchus and lung other chest pain osteoarthrosis, unspecified whether generalized or localized, site unspecified pure hypercholesterolemia hypertrophy (benign) of prostate without urinary obstruction and other lower urinary tract symptom (luts) secondary and unspecified malignant neoplasm of intrathoracic lymph nodes venous (peripheral) insufficiency, unspecified other and unspecified hyperlipidemia dysthymic disorder hypoxemia personal history of colonic polyps obstructive chronic bronchitis with (acute) exacerbation unspecified gastritis and gastroduodenitis, without mention of hemorrhage personal history of malignant neoplasm of thyroid knee joint replacement chronic airway obstruction, not elsewhere classified hypoxemia right bundle branch block hypertrophy (benign) of prostate without urinary obstruction and other lower urinary tract symptom (luts) unspecified essential hypertension person on outside of heavy transport vehicle injured in collision with other nonmotor vehicle in traffic accident pure hypercholesterolemia other chronic pulmonary heart diseases pneumonia, organism unspecified secondary and unspecified malignant neoplasm of intrathoracic lymph nodes personal history of colonic polyps malignant neoplasm of other parts of bronchus or lung secondary malignant neoplasm of pleura knee joint replacement osteoarthrosis, unspecified whether generalized or localized, site unspecified encounter for palliative care
asian f 67 $nan$nan$heparin  5000  unit ; 
nausea with vomiting other chronic nonalcoholic liver disease unspecified essential hypertension other specified diseases of pancreas headache osteoporosis, unspecified calculus of gallbladder and bile duct with other cholecystitis, with obstruction hypopotassemia other and unspecified hyperlipidemia 
asian f 67 $nan$hematology blood hematocrit  29.3  %; hematology blood hematocrit  31.0  %; hematology blood hematocrit  27.3  %; hematology blood hemoglobin  9.4  g dl; hematology blood hemoglobin  8.6  g dl; hematology blood platelet count  206  k ul; hematology blood platelet count  192  k ul; chemistry blood anion gap  9  meq l; chemistry blood anion gap  9  meq l; chemistry blood bicarbonate  26  meq l; chemistry blood bicarbonate  24  meq l; chemistry blood chloride  105  meq l; chemistry blood chloride  107  meq l; chemistry blood creatinine  0.5  mg dl; chemistry blood creatinine  0.5  mg dl; chemistry blood potassium  3.3  meq l; chemistry blood potassium  3.8  meq l; chemistry blood sodium  137  meq l; chemistry blood sodium  136  meq l; chemistry blood urea nitrogen  7  mg dl; chemistry blood urea nitrogen  8  mg dl; hematology blood inr(pt)  1.2  ; chemistry blood calcium, total  7.6  mg dl; chemistry blood calcium, total  7.1  mg dl; chemistry blood bilirubin, total  0.7  mg dl; chemistry blood bilirubin, total  0.5  mg dl; chemistry blood glucose  136  mg dl; chemistry blood glucose  151  mg dl; blood gas blood free calcium  1.01  mmol l; blood gas blood free calcium  0.97  mmol l; blood gas blood lactate  0.9  mmol l; blood gas blood chloride, whole blood  107  meq l; blood gas blood glucose  179  mg dl; blood gas blood hematocrit, calculated  29  %; blood gas blood hematocrit, calculated  25  %; blood gas blood hemoglobin  9.8  g dl; blood gas blood hemoglobin  8.4  g dl; blood gas blood potassium, whole blood  3.2  meq l; blood gas blood potassium, whole blood  3.0  meq l; blood gas blood sodium, whole blood  140  meq l$heparin  5000  unit ; 0.9% sodium chloride  250  ml ; potassium chloride  20  meq ; sodium chloride 0.9%  flush  3  ml ; d5 1 2ns  1000  ml ; ondansetron  4  mg ; 5% dextrose  100  ml ; naloxone  2  mg ; 5% dextrose  150  ml ; vancomycin  500  mg ; 5% dextrose  200  ml ; ciprofloxacin iv  400  mg ; lactated ringers  1  ml ; bupivacaine 0.1%  250  ml ; yellow cadd cassette  1  cadd ; hydromorphone  2500  mcg ; sodium chloride 0.9%  1  ml ; 
nausea with vomiting other chronic nonalcoholic liver disease unspecified essential hypertension other specified diseases of pancreas headache osteoporosis, unspecified calculus of gallbladder and bile duct with other cholecystitis, with obstruction hypopotassemia other and unspecified hyperlipidemia 
asian f 67 $nan$hematology blood hematocrit  25.1  %; hematology blood hemoglobin  8.1  g dl; hematology blood platelet count  179  k ul; chemistry blood anion gap  7  meq l; chemistry blood bicarbonate  26  meq l; chemistry blood chloride  100  meq l; chemistry blood creatinine  0.5  mg dl; chemistry blood potassium  3.3  meq l; chemistry blood sodium  130  meq l; chemistry blood urea nitrogen  5  mg dl; hematology blood inr(pt)  1.1  ; chemistry blood calcium, total  7.4  mg dl; chemistry blood bilirubin, total  0.8  mg dl; chemistry blood glucose  137  mg dl; chemistry blood albumin  2.5  g dl$0.9% sodium chloride  250  ml ; potassium chloride  20  meq ; sodium chloride 0.9%  flush  3  ml ; d5 1 2ns  1000  ml ; ondansetron  4  mg ; 5% dextrose  100  ml ; naloxone  2  mg ; 5% dextrose  150  ml ; vancomycin  500  mg ; 5% dextrose  200  ml ; ciprofloxacin iv  400  mg ; lactated ringers  1  ml ; bupivacaine 0.1%  250  ml ; yellow cadd cassette  1  cadd ; hydromorphone  2500  mcg ; sodium chloride 0.9%  1  ml ; 0.9% sodium chloride  1  bag ; calcium gluconate  2  g ; bag  1  bag ; magnesium sulfate  2  gm ; neutra-phos  2  pkt ; 
nausea with vomiting other chronic nonalcoholic liver disease unspecified essential hypertension other specified diseases of pancreas headache osteoporosis, unspecified calculus of gallbladder and bile duct with other cholecystitis, with obstruction hypopotassemia other and unspecified hyperlipidemia 
asian f 67 $nan$nan$sodium chloride 0.9%  flush  3  ml ; d5 1 2ns  1000  ml ; ondansetron  4  mg ; 5% dextrose  100  ml ; naloxone  2  mg ; lactated ringers  1  ml ; bupivacaine 0.1%  250  ml ; yellow cadd cassette  1  cadd ; hydromorphone  2500  mcg ; 0.9% sodium chloride  1  bag ; calcium gluconate  2  g ; bag  1  bag ; magnesium sulfate  2  gm ; neutra-phos  2  pkt ; phosphorus  500  mg ; 
nausea with vomiting other chronic nonalcoholic liver disease unspecified essential hypertension other specified diseases of pancreas headache osteoporosis, unspecified calculus of gallbladder and bile duct with other cholecystitis, with obstruction hypopotassemia other and unspecified hyperlipidemia 
asian f 67 $nan$hematology blood hematocrit  26.8  %; hematology blood hematocrit  26.9  %; hematology blood hemoglobin  8.6  g dl; hematology blood hemoglobin  8.7  g dl; hematology blood platelet count  213  k ul; hematology blood platelet count  245  k ul; chemistry blood anion gap  10  meq l; chemistry blood anion gap  12  meq l; chemistry blood bicarbonate  26  meq l; chemistry blood bicarbonate  26  meq l; chemistry blood chloride  97  meq l; chemistry blood chloride  99  meq l; chemistry blood creatinine  0.5  mg dl; chemistry blood creatinine  0.4  mg dl; chemistry blood potassium  3.4  meq l; chemistry blood potassium  3.8  meq l; chemistry blood sodium  130  meq l; chemistry blood sodium  133  meq l; chemistry blood urea nitrogen  6  mg dl; chemistry blood urea nitrogen  4  mg dl; hematology blood inr(pt)  0.9  ; chemistry blood calcium, total  7.4  mg dl; chemistry blood calcium, total  8.1  mg dl; chemistry blood bilirubin, total  0.9  mg dl; chemistry blood bilirubin, total  0.6  mg dl; chemistry blood glucose  135  mg dl; chemistry blood glucose  201  mg dl$sodium chloride 0.9%  flush  3  ml ; ondansetron  4  mg ; 5% dextrose  100  ml ; naloxone  2  mg ; bupivacaine 0.1%  250  ml ; yellow cadd cassette  1  cadd ; hydromorphone  2500  mcg ; phosphorus  500  mg ; hydromorphone (dilaudid)  20  mg ; 2  2500  mcg ; potassium chloride  40  meq ; sodium glycerophosphate  20  mmol ; oxycodone (immediate release)   5  mg ; senna  8.6  mg ; docusate sodium  100  mg ; 
nausea with vomiting other chronic nonalcoholic liver disease unspecified essential hypertension other specified diseases of pancreas headache osteoporosis, unspecified calculus of gallbladder and bile duct with other cholecystitis, with obstruction hypopotassemia other and unspecified hyperlipidemia 
asian f 67 $nan$hematology blood hematocrit  26.6  %; hematology blood hemoglobin  8.8  g dl; hematology blood platelet count  266  k ul; chemistry blood anion gap  11  meq l; chemistry blood bicarbonate  28  meq l; chemistry blood chloride  97  meq l; chemistry blood creatinine  0.4  mg dl; chemistry blood potassium  3.8  meq l; chemistry blood sodium  132  meq l; chemistry blood urea nitrogen  3  mg dl; hematology blood inr(pt)  0.9  ; chemistry blood calcium, total  7.9  mg dl; chemistry blood bilirubin, total  0.5  mg dl; chemistry blood glucose  116  mg dl$sodium chloride 0.9%  flush  3  ml ; ondansetron  4  mg ; potassium chloride  40  meq ; sodium glycerophosphate  20  mmol ; oxycodone (immediate release)   5  mg ; senna  8.6  mg ; docusate sodium  100  mg ; neutra-phos  1  pkt ; hydromorphone (dilaudid)  2  mg ; bisacodyl  10  mg ; promethazine  6.25  mg ; 
nausea with vomiting other chronic nonalcoholic liver disease unspecified essential hypertension other specified diseases of pancreas headache osteoporosis, unspecified calculus of gallbladder and bile duct with other cholecystitis, with obstruction hypopotassemia other and unspecified hyperlipidemia 
asian f 67 $nan$hematology blood hematocrit  27.6  %; hematology blood hemoglobin  9.0  g dl; hematology blood platelet count  333  k ul; chemistry blood anion gap  11  meq l; chemistry blood bicarbonate  28  meq l; chemistry blood chloride  93  meq l; chemistry blood creatinine  0.3  mg dl; chemistry blood potassium  3.4  meq l; chemistry blood sodium  129  meq l; chemistry blood urea nitrogen  3  mg dl; chemistry blood calcium, total  7.8  mg dl; chemistry blood glucose  123  mg dl; hematology urine glucose  1000  mg dl$sodium chloride 0.9%  flush  3  ml ; senna  8.6  mg ; docusate sodium  100  mg ; neutra-phos  1  pkt ; hydromorphone (dilaudid)  2  mg ; bisacodyl  10  mg ; promethazine  6.25  mg ; acetaminophen  500  mg ; ciprofloxacin hcl  500  mg ; acetaminophen iv  1000  mg ; hydromorphone (dilaudid)  0.5  mg ; 
nausea with vomiting other chronic nonalcoholic liver disease unspecified essential hypertension other specified diseases of pancreas headache osteoporosis, unspecified calculus of gallbladder and bile duct with other cholecystitis, with obstruction hypopotassemia other and unspecified hyperlipidemia 
asian f 67 $nan$chemistry blood anion gap  10  meq l; chemistry blood anion gap  15  meq l; chemistry blood bicarbonate  27  meq l; chemistry blood bicarbonate  27  meq l; chemistry blood chloride  95  meq l; chemistry blood chloride  94  meq l; chemistry blood creatinine  0.5  mg dl; chemistry blood potassium  3.7  meq l; chemistry blood potassium  3.8  meq l; chemistry blood sodium  128  meq l; chemistry blood sodium  132  meq l; chemistry blood urea nitrogen  5  mg dl; chemistry blood bilirubin, total  0.4  mg dl; chemistry blood glucose  116  mg dl$sodium chloride 0.9%  flush  3  ml ; senna  8.6  mg ; docusate sodium  100  mg ; acetaminophen iv  1000  mg ; hydromorphone (dilaudid)  0.5  mg ; ursodiol  300  mg ; sulfameth trimethoprim ds  1  tab ; lorazepam  0.5  mg ; 
nausea with vomiting other chronic nonalcoholic liver disease unspecified essential hypertension other specified diseases of pancreas headache osteoporosis, unspecified calculus of gallbladder and bile duct with other cholecystitis, with obstruction hypopotassemia other and unspecified hyperlipidemia 
asian f 67 $nan$chemistry blood anion gap  13  meq l; chemistry blood bicarbonate  27  meq l; chemistry blood chloride  96  meq l; chemistry blood creatinine  0.5  mg dl; chemistry blood potassium  3.8  meq l; chemistry blood sodium  132  meq l; chemistry blood urea nitrogen  5  mg dl; chemistry blood calcium, total  7.9  mg dl; chemistry blood bilirubin, total  0.4  mg dl; chemistry blood glucose  115  mg dl$sodium chloride 0.9%  flush  3  ml ; senna  8.6  mg ; docusate sodium  100  mg ; ursodiol  300  mg ; lorazepam  0.5  mg ; acetaminophen  650  mg ; prochlorperazine  10  mg ; 
nausea with vomiting other chronic nonalcoholic liver disease unspecified essential hypertension other specified diseases of pancreas headache osteoporosis, unspecified calculus of gallbladder and bile duct with other cholecystitis, with obstruction hypopotassemia other and unspecified hyperlipidemia 
asian f 67 $nan$chemistry blood anion gap  14  meq l; chemistry blood bicarbonate  24  meq l; chemistry blood chloride  94  meq l; chemistry blood creatinine  0.5  mg dl; chemistry blood potassium  4.0  meq l; chemistry blood sodium  128  meq l; chemistry blood urea nitrogen  5  mg dl; hematology blood inr(pt)  1.0  ; chemistry blood calcium, total  7.9  mg dl; chemistry blood bilirubin, total  0.4  mg dl; chemistry blood glucose  115  mg dl$sodium chloride 0.9%  flush  3  ml ; senna  8.6  mg ; docusate sodium  100  mg ; acetaminophen  650  mg ; prochlorperazine  10  mg ; 
nausea with vomiting other chronic nonalcoholic liver disease unspecified essential hypertension other specified diseases of pancreas headache osteoporosis, unspecified calculus of gallbladder and bile duct with other cholecystitis, with obstruction hypopotassemia other and unspecified hyperlipidemia 
asian f 67 $nan$chemistry blood anion gap  11  meq l; chemistry blood bicarbonate  27  meq l; chemistry blood chloride  96  meq l; chemistry blood creatinine  0.5  mg dl; chemistry blood potassium  4.0  meq l; chemistry blood sodium  130  meq l; chemistry blood urea nitrogen  5  mg dl; hematology blood inr(pt)  0.9  ; chemistry blood calcium, total  8.2  mg dl; chemistry blood bilirubin, total  0.2  mg dl; chemistry blood glucose  122  mg dl$sodium chloride 0.9%  flush  3  ml ; senna  8.6  mg ; docusate sodium  100  mg ; acetaminophen  650  mg ; prochlorperazine  10  mg ; 
nausea with vomiting other chronic nonalcoholic liver disease unspecified essential hypertension other specified diseases of pancreas headache osteoporosis, unspecified calculus of gallbladder and bile duct with other cholecystitis, with obstruction hypopotassemia other and unspecified hyperlipidemia 
asian f 67 $nan$hematology blood hematocrit  28.2  %; hematology blood hematocrit  29.5  %; hematology blood hemoglobin  8.9  g dl; hematology blood hemoglobin  9.4  g dl; hematology blood platelet count  563  k ul; hematology blood platelet count  609  k ul; chemistry blood anion gap  15  meq l; chemistry blood bicarbonate  26  meq l; chemistry blood chloride  98  meq l; chemistry blood creatinine  0.4  mg dl; chemistry blood potassium  4.7  meq l; chemistry blood sodium  134  meq l; chemistry blood urea nitrogen  6  mg dl; chemistry blood bilirubin, total  0.3  mg dl; chemistry blood glucose  103  mg dl$sodium chloride 0.9%  flush  3  ml ; senna  8.6  mg ; docusate sodium  100  mg ; acetaminophen  650  mg ; prochlorperazine  10  mg ; hydromorphone (dilaudid)  0.25  mg ; 
nausea with vomiting other chronic nonalcoholic liver disease unspecified essential hypertension other specified diseases of pancreas headache osteoporosis, unspecified calculus of gallbladder and bile duct with other cholecystitis, with obstruction hypopotassemia other and unspecified hyperlipidemia 
asian f 67 $nan$nan$sodium chloride 0.9%  flush  3  ml ; senna  8.6  mg ; docusate sodium  100  mg ; acetaminophen  650  mg ; prochlorperazine  10  mg ; 
nausea with vomiting other chronic nonalcoholic liver disease unspecified essential hypertension other specified diseases of pancreas headache osteoporosis, unspecified calculus of gallbladder and bile duct with other cholecystitis, with obstruction hypopotassemia other and unspecified hyperlipidemia 
white f 89 $temp  97.7  heartrate  70.0  resprate  16.0  o2sat  100.0  sbp  160.0  dbp  71.0  rhythm    pain  0  ; temp  98.4  heartrate  71.0  resprate  16.0  o2sat  99.0  sbp  151.0  dbp  69.0  rhythm    pain    $hematology blood hematocrit  31.4  %; hematology blood hemoglobin  10.1  g dl; hematology blood platelet count  226  k ul; chemistry blood anion gap  14  meq l; chemistry blood bicarbonate  25  meq l; chemistry blood chloride  102  meq l; chemistry blood creatinine  0.6  mg dl; chemistry blood potassium  4.2  meq l; chemistry blood sodium  137  meq l; chemistry blood urea nitrogen  12  mg dl; hematology blood inr(pt)  1.1  ; hematology urine wbc  9  # hpf; chemistry blood bilirubin, indirect  0.5  mg dl; chemistry blood bilirubin, total  3.7  mg dl; chemistry blood glucose  106  mg dl; chemistry blood albumin  3.7  g dl; blood gas blood lactate  0.7  mmol l; chemistry blood bilirubin, direct  3.2  mg dl; hematology urine glucose  150  mg dl$nan
unspecified essential hypertension diabetes mellitus without mention of complication, type ii or unspecified type, not stated as uncontrolled contusion of face, scalp, and neck except eye(s) personal history of malignant neoplasm of breast closed fracture of dorsal [thoracic] vertebra without mention of spinal cord injury person boarding or alighting a pedal cycle injured in collision with pedestrian or animal anxiety state, unspecified knee joint replacement other accident caused by striking against or being struck accidentally by objects or persons other and unspecified hyperlipidemia
white f 89 $temp  98.4  heartrate  66.0  resprate  16.0  o2sat  95.0  sbp  124.0  dbp  57.0  rhythm    pain  1  $hematology blood hematocrit  33.4  %; hematology blood hemoglobin  10.6  g dl; hematology blood platelet count  206  k ul; chemistry blood anion gap  12  meq l; chemistry blood bicarbonate  28  meq l; chemistry blood chloride  100  meq l; chemistry blood creatinine  0.7  mg dl; chemistry blood potassium  4.1  meq l; chemistry blood sodium  136  meq l; chemistry blood urea nitrogen  11  mg dl; hematology blood inr(pt)  1.2  ; chemistry blood calcium, total  9.0  mg dl; chemistry blood bilirubin, total  4.0  mg dl; chemistry blood glucose  113  mg dl; chemistry blood lactate dehydrogenase (ld)  286  iu l; chemistry blood albumin  3.7  g dl$d5lr  1000  ml ; lactated ringers  1000  ml ; pneumococcal 23-valent polysaccharide vaccine  0.5  ml ; heparin  5000  unit ; sodium chloride 0.9%  flush  3  ml ; docusate sodium  100  mg ; senna  8.6  mg ; morphine sulfate  1-2  mg ; 5% dextrose  200  ml ; ciprofloxacin iv  400  mg ; ns  100  ml ; metronidazole  500  mg ; ondansetron  4  mg ; pregabalin  50  mg ; sertraline  100  mg ; sertraline  50  mg ; simvastatin  20  mg ; aspirin  81  mg ; multivitamins  1  tab ; brimonidine tartrate 0.15% ophth.  1  drop ; dorzolamide 2% timolol 0.5% ophth.  1  drop ; vial  1  vial ; pantoprazole  40  mg ; gabapentin  300  mg ; 
unspecified essential hypertension diabetes mellitus without mention of complication, type ii or unspecified type, not stated as uncontrolled contusion of face, scalp, and neck except eye(s) personal history of malignant neoplasm of breast closed fracture of dorsal [thoracic] vertebra without mention of spinal cord injury person boarding or alighting a pedal cycle injured in collision with pedestrian or animal anxiety state, unspecified knee joint replacement other accident caused by striking against or being struck accidentally by objects or persons other and unspecified hyperlipidemia
white f 89 $nan$hematology blood hematocrit  29.5  %; hematology blood hemoglobin  9.4  g dl; hematology blood platelet count  194  k ul; chemistry blood anion gap  11  meq l; chemistry blood bicarbonate  28  meq l; chemistry blood chloride  104  meq l; chemistry blood creatinine  0.7  mg dl; chemistry blood potassium  3.8  meq l; chemistry blood sodium  139  meq l; chemistry blood urea nitrogen  7  mg dl; hematology blood inr(pt)  1.1  ; chemistry blood calcium, total  8.9  mg dl; chemistry blood bilirubin, total  1.7  mg dl; chemistry blood glucose  125  mg dl; chemistry blood lactate dehydrogenase (ld)  178  iu l; chemistry blood albumin  3.3  g dl$d5lr  1000  ml ; pneumococcal 23-valent polysaccharide vaccine  0.5  ml ; heparin  5000  unit ; sodium chloride 0.9%  flush  3  ml ; docusate sodium  100  mg ; senna  8.6  mg ; morphine sulfate  1-2  mg ; 5% dextrose  200  ml ; ciprofloxacin iv  400  mg ; ns  100  ml ; metronidazole  500  mg ; ondansetron  4  mg ; pregabalin  50  mg ; sertraline  100  mg ; sertraline  50  mg ; simvastatin  20  mg ; aspirin  81  mg ; multivitamins  1  tab ; brimonidine tartrate 0.15% ophth.  1  drop ; dorzolamide 2% timolol 0.5% ophth.  1  drop ; vial  1  vial ; pantoprazole  40  mg ; gabapentin  300  mg ; bag  1  bag ; magnesium sulfate  2  gm ; latanoprost 0.005% ophth. soln.  1  drop ; captopril  12.5  mg ; 
unspecified essential hypertension diabetes mellitus without mention of complication, type ii or unspecified type, not stated as uncontrolled contusion of face, scalp, and neck except eye(s) personal history of malignant neoplasm of breast closed fracture of dorsal [thoracic] vertebra without mention of spinal cord injury person boarding or alighting a pedal cycle injured in collision with pedestrian or animal anxiety state, unspecified knee joint replacement other accident caused by striking against or being struck accidentally by objects or persons other and unspecified hyperlipidemia
white f 89 $nan$hematology blood hematocrit  30.5  %; hematology blood hemoglobin  9.7  g dl; hematology blood platelet count  198  k ul; chemistry blood anion gap  11  meq l; chemistry blood bicarbonate  28  meq l; chemistry blood chloride  103  meq l; chemistry blood creatinine  0.6  mg dl; chemistry blood potassium  3.6  meq l; chemistry blood sodium  138  meq l; chemistry blood urea nitrogen  6  mg dl; hematology blood inr(pt)  1.1  ; chemistry blood calcium, total  8.7  mg dl; chemistry blood bilirubin, total  0.9  mg dl; chemistry blood glucose  127  mg dl; chemistry blood lactate dehydrogenase (ld)  182  iu l$pneumococcal 23-valent polysaccharide vaccine  0.5  ml ; heparin  5000  unit ; sodium chloride 0.9%  flush  3  ml ; senna  8.6  mg ; morphine sulfate  1-2  mg ; 5% dextrose  200  ml ; ciprofloxacin iv  400  mg ; ns  100  ml ; metronidazole  500  mg ; ondansetron  4  mg ; pregabalin  50  mg ; sertraline  100  mg ; sertraline  50  mg ; simvastatin  20  mg ; aspirin  81  mg ; multivitamins  1  tab ; brimonidine tartrate 0.15% ophth.  1  drop ; dorzolamide 2% timolol 0.5% ophth.  1  drop ; vial  1  vial ; pantoprazole  40  mg ; gabapentin  300  mg ; bag  1  bag ; magnesium sulfate  2  gm ; latanoprost 0.005% ophth. soln.  1  drop ; captopril  12.5  mg ; acetaminophen iv  1000  mg ; potassium chl 20 meq   1000 ml d5lr  1000  ml ; lisinopril  5  mg ; 
unspecified essential hypertension diabetes mellitus without mention of complication, type ii or unspecified type, not stated as uncontrolled contusion of face, scalp, and neck except eye(s) personal history of malignant neoplasm of breast closed fracture of dorsal [thoracic] vertebra without mention of spinal cord injury person boarding or alighting a pedal cycle injured in collision with pedestrian or animal anxiety state, unspecified knee joint replacement other accident caused by striking against or being struck accidentally by objects or persons other and unspecified hyperlipidemia
white f 89 $nan$hematology blood hematocrit  30.9  %; hematology blood hemoglobin  9.7  g dl; hematology blood platelet count  201  k ul; chemistry blood anion gap  13  meq l; chemistry blood bicarbonate  26  meq l; chemistry blood chloride  103  meq l; chemistry blood creatinine  0.6  mg dl; chemistry blood potassium  3.9  meq l; chemistry blood sodium  138  meq l; chemistry blood urea nitrogen  6  mg dl; chemistry blood bilirubin, total  0.8  mg dl; chemistry blood glucose  160  mg dl; chemistry blood lactate dehydrogenase (ld)  161  iu l$pneumococcal 23-valent polysaccharide vaccine  0.5  ml ; heparin  5000  unit ; sodium chloride 0.9%  flush  3  ml ; senna  8.6  mg ; morphine sulfate  1-2  mg ; 5% dextrose  200  ml ; ciprofloxacin iv  400  mg ; ondansetron  4  mg ; pregabalin  50  mg ; sertraline  100  mg ; sertraline  50  mg ; simvastatin  20  mg ; aspirin  81  mg ; multivitamins  1  tab ; brimonidine tartrate 0.15% ophth.  1  drop ; dorzolamide 2% timolol 0.5% ophth.  1  drop ; vial  1  vial ; pantoprazole  40  mg ; gabapentin  300  mg ; latanoprost 0.005% ophth. soln.  1  drop ; acetaminophen iv  1000  mg ; potassium chl 20 meq   1000 ml d5lr  1000  ml ; lisinopril  10  mg ; ciprofloxacin hcl  500  mg ; 
unspecified essential hypertension diabetes mellitus without mention of complication, type ii or unspecified type, not stated as uncontrolled contusion of face, scalp, and neck except eye(s) personal history of malignant neoplasm of breast closed fracture of dorsal [thoracic] vertebra without mention of spinal cord injury person boarding or alighting a pedal cycle injured in collision with pedestrian or animal anxiety state, unspecified knee joint replacement other accident caused by striking against or being struck accidentally by objects or persons other and unspecified hyperlipidemia
white f 89 $nan$hematology blood hematocrit  31.1  %; hematology blood hemoglobin  9.8  g dl; hematology blood platelet count  193  k ul; chemistry blood anion gap  12  meq l; chemistry blood bicarbonate  26  meq l; chemistry blood chloride  102  meq l; chemistry blood creatinine  0.6  mg dl; chemistry blood potassium  4.1  meq l; chemistry blood sodium  136  meq l; chemistry blood urea nitrogen  8  mg dl; chemistry blood bilirubin, total  0.6  mg dl; chemistry blood glucose  123  mg dl$pneumococcal 23-valent polysaccharide vaccine  0.5  ml ; heparin  5000  unit ; sodium chloride 0.9%  flush  3  ml ; senna  8.6  mg ; ondansetron  4  mg ; pregabalin  50  mg ; sertraline  100  mg ; sertraline  50  mg ; simvastatin  20  mg ; aspirin  81  mg ; multivitamins  1  tab ; brimonidine tartrate 0.15% ophth.  1  drop ; dorzolamide 2% timolol 0.5% ophth.  1  drop ; gabapentin  300  mg ; latanoprost 0.005% ophth. soln.  1  drop ; lisinopril  10  mg ; ciprofloxacin hcl  500  mg ; 
unspecified essential hypertension diabetes mellitus without mention of complication, type ii or unspecified type, not stated as uncontrolled contusion of face, scalp, and neck except eye(s) personal history of malignant neoplasm of breast closed fracture of dorsal [thoracic] vertebra without mention of spinal cord injury person boarding or alighting a pedal cycle injured in collision with pedestrian or animal anxiety state, unspecified knee joint replacement other accident caused by striking against or being struck accidentally by objects or persons other and unspecified hyperlipidemia
white m 56 $nan$hematology blood hematocrit  37.2  %; hematology blood hemoglobin  12.9  g dl; hematology blood platelet count  175  k ul; chemistry blood anion gap  12  meq l; chemistry blood bicarbonate  22  meq l; chemistry blood chloride  112  meq l; chemistry blood creatinine  1.0  mg dl; chemistry blood potassium  3.7  meq l; chemistry blood sodium  142  meq l; chemistry blood urea nitrogen  10  mg dl; chemistry blood glucose  84  mg dl$aspirin  81  mg ; escitalopram oxalate  20  mg ; lisinopril  5  mg ; fluticasone propionate nasal  2  spry ; multivitamins  1  tab ; influenza virus vaccine  0.5  ml ; sodium chloride 0.9%  flush  3  ml ; acetaminophen  650  mg ; albuterol inhaler  1  puff ; hydromorphone (dilaudid)  2  mg ; diazepam  5  mg ; hydromorphone (dilaudid)  1  mg ; albuterol inhaler  1-2  puff ; bupropion (sustained release)  150  mg ; hydromorphone (dilaudid)  4  mg ; tizanidine  2-4  mg ; tramadol (ultram)  50-100  mg ; fish oil (omega 3)  1000  mg ; gabapentin  900  mg ; heparin  5000  unit ; docusate sodium  100  mg ; senna  1  tab ; 
arthrodesis status other chronic pain unspecified essential hypertension cervicalgia fever, unspecified depressive disorder, not elsewhere classified chronic hepatitis c without mention of hepatic coma lumbago person boarding or alighting a car injured in collision with railway train or railway vehicle other respiratory abnormalities cervicalgia arthrodesis status depressive disorder, not elsewhere classified person boarding or alighting a car injured in collision with railway train or railway vehicle other chronic pain diarrhea chronic hepatitis c without mention of hepatic coma unspecified essential hypertension lumbago osteoarthrosis, unspecified whether generalized or localized, site unspecified personal history of venous thrombosis and embolism unspecified essential hypertension personal history of venous thrombosis and embolism cervical spondylosis without myelopathy long-term (current) use of anticoagulants obesity, unspecified chronic hepatitis c without mention of hepatic coma displacement of lumbar intervertebral disc without myelopathy person boarding or alighting a car injured in collision with railway train or railway vehicle bacteremia depressive disorder, not elsewhere classified personal history of other infectious and parasitic diseases acute venous embolism and thrombosis of deep vessels of proximal lower extremity other and unspecified disc disorder, lumbar region other postprocedural status arthrodesis status unspecified osteomyelitis, other specified sites constipation, unspecified methicillin susceptible staphylococcus aureus in conditions classified elsewhere and of unspecified site unspecified essential hypertension unspecified essential hypertension retention of urine, unspecified arthrodesis status chronic hepatitis c without mention of hepatic coma depressive disorder, not elsewhere classified person boarding or alighting a car injured in collision with railway train or railway vehicle other and unspecified disc disorder, lumbar region other chronic pain
white m 56 $nan$nan$fluticasone propionate nasal  2  spry ; multivitamins  1  tab ; albuterol inhaler  1-2  puff ; bupropion (sustained release)  150  mg ; hydromorphone (dilaudid)  4  mg ; tizanidine  2-4  mg ; tramadol (ultram)  50-100  mg ; fish oil (omega 3)  1000  mg ; gabapentin  900  mg ; heparin  5000  unit ; docusate sodium  100  mg ; senna  1  tab ; sulfameth trimethoprim ds  1  tab ; polyethylene glycol  17  g ; 
arthrodesis status other chronic pain unspecified essential hypertension cervicalgia fever, unspecified depressive disorder, not elsewhere classified chronic hepatitis c without mention of hepatic coma lumbago person boarding or alighting a car injured in collision with railway train or railway vehicle other respiratory abnormalities cervicalgia arthrodesis status depressive disorder, not elsewhere classified person boarding or alighting a car injured in collision with railway train or railway vehicle other chronic pain diarrhea chronic hepatitis c without mention of hepatic coma unspecified essential hypertension lumbago osteoarthrosis, unspecified whether generalized or localized, site unspecified personal history of venous thrombosis and embolism unspecified essential hypertension personal history of venous thrombosis and embolism cervical spondylosis without myelopathy long-term (current) use of anticoagulants obesity, unspecified chronic hepatitis c without mention of hepatic coma displacement of lumbar intervertebral disc without myelopathy person boarding or alighting a car injured in collision with railway train or railway vehicle bacteremia depressive disorder, not elsewhere classified personal history of other infectious and parasitic diseases acute venous embolism and thrombosis of deep vessels of proximal lower extremity other and unspecified disc disorder, lumbar region other postprocedural status arthrodesis status unspecified osteomyelitis, other specified sites constipation, unspecified methicillin susceptible staphylococcus aureus in conditions classified elsewhere and of unspecified site unspecified essential hypertension unspecified essential hypertension retention of urine, unspecified arthrodesis status chronic hepatitis c without mention of hepatic coma depressive disorder, not elsewhere classified person boarding or alighting a car injured in collision with railway train or railway vehicle other and unspecified disc disorder, lumbar region other chronic pain
white m 56 $nan$nan$fluticasone propionate nasal  2  spry ; multivitamins  1  tab ; albuterol inhaler  1-2  puff ; bupropion (sustained release)  150  mg ; tizanidine  2-4  mg ; tramadol (ultram)  50-100  mg ; fish oil (omega 3)  1000  mg ; gabapentin  900  mg ; heparin  5000  unit ; docusate sodium  100  mg ; senna  1  tab ; sulfameth trimethoprim ds  1  tab ; polyethylene glycol  17  g ; 
arthrodesis status other chronic pain unspecified essential hypertension cervicalgia fever, unspecified depressive disorder, not elsewhere classified chronic hepatitis c without mention of hepatic coma lumbago person boarding or alighting a car injured in collision with railway train or railway vehicle other respiratory abnormalities cervicalgia arthrodesis status depressive disorder, not elsewhere classified person boarding or alighting a car injured in collision with railway train or railway vehicle other chronic pain diarrhea chronic hepatitis c without mention of hepatic coma unspecified essential hypertension lumbago osteoarthrosis, unspecified whether generalized or localized, site unspecified personal history of venous thrombosis and embolism unspecified essential hypertension personal history of venous thrombosis and embolism cervical spondylosis without myelopathy long-term (current) use of anticoagulants obesity, unspecified chronic hepatitis c without mention of hepatic coma displacement of lumbar intervertebral disc without myelopathy person boarding or alighting a car injured in collision with railway train or railway vehicle bacteremia depressive disorder, not elsewhere classified personal history of other infectious and parasitic diseases acute venous embolism and thrombosis of deep vessels of proximal lower extremity other and unspecified disc disorder, lumbar region other postprocedural status arthrodesis status unspecified osteomyelitis, other specified sites constipation, unspecified methicillin susceptible staphylococcus aureus in conditions classified elsewhere and of unspecified site unspecified essential hypertension unspecified essential hypertension retention of urine, unspecified arthrodesis status chronic hepatitis c without mention of hepatic coma depressive disorder, not elsewhere classified person boarding or alighting a car injured in collision with railway train or railway vehicle other and unspecified disc disorder, lumbar region other chronic pain
white f 90 $temp    heartrate  67.0  resprate  18.0  o2sat  100.0  sbp  138.0  dbp  48.0  rhythm    pain  0  ; temp  97.3  heartrate  61.0  resprate  18.0  o2sat  100.0  sbp  127.0  dbp  63.0  rhythm    pain  0  $hematology blood hematocrit  24.8  %; hematology blood hemoglobin  8.0  g dl; hematology blood platelet count  114  k ul; chemistry blood anion gap  20  meq l; chemistry blood bicarbonate  21  meq l; chemistry blood chloride  106  meq l; chemistry blood creatinine  1.9  mg dl; chemistry blood potassium  4.7  meq l; chemistry blood sodium  142  meq l; chemistry blood urea nitrogen  44  mg dl; hematology blood inr(pt)  2.4  ; chemistry blood calcium, total  9.0  mg dl; chemistry blood glucose  99  mg dl; blood gas blood lactate  1.6  mmol l$sodium chloride 0.9%  flush  3  ml ; docusate sodium  100  mg ; senna  17.2  mg ; sodium chloride 0.9%  1000  ml ; phytonadione  5  mg ; acetaminophen  650  mg ; atorvastatin  20  mg ; multivitamins  1  tab ; oxycodone (immediate release)  2.5  mg ; vitamin d  2000  unit ; ondansetron  4  mg ; omeprazole  20  mg ; levothyroxine sodium  25  mcg ; 0.9% sodium chloride (mini bag plus)  100  ml ; ceftriaxone  1  gm ; lansoprazole oral disintegrating tab  30  mg ; warfarin  1  dose ; warfarin  1.5  mg ; 
peripheral vascular disease, unspecified long term (current) use of anticoagulants pneumonitis due to inhalation of food and vomit toxic encephalopathy myelodysplastic syndrome, unspecified personal history of other venous thrombosis and embolism unspecified dementia without behavioral disturbance hyperlipidemia, unspecified gastro-esophageal reflux disease without esophagitis monoclonal gammopathy hypothyroidism, unspecified dehydration delirium due to known physiological condition adverse effect of drugs affecting uric acid metabolism, initial encounter chronic diastolic (congestive) heart failure chronic gout, unspecified, with tophus (tophi) chronic kidney disease, unspecified personal history of transient ischemic attack (tia), and cerebral infarction without residual deficits hypovolemia adult failure to thrive unspecified place in other specified residential institution as the place of occurrence of the external cause hyperosmolality and hypernatremia paroxysmal atrial fibrillation type 2 diabetes mellitus with diabetic chronic kidney disease acidosis chest pain, unspecified diarrhea, unspecified other secondary thrombocytopenia acute kidney failure, unspecified do not resuscitate hypertensive chronic kidney disease with stage 1 through stage 4 chronic kidney disease, or unspecified chronic kidney disease cellulitis of right lower limb essential (primary) hypertension peripheral vascular disease, unspecified unspecified dementia without behavioral disturbance paroxysmal atrial fibrillation anemia, unspecified gout, unspecified hypothyroidism, unspecified myelodysplastic syndrome, unspecified hyperlipidemia, unspecified anemia in other chronic diseases classified elsewhere type 2 diabetes mellitus without complications chronic diastolic (congestive) heart failure gastro-esophageal reflux disease without esophagitis hypertensive chronic kidney disease with stage 1 through stage 4 chronic kidney disease, or unspecified chronic kidney disease chronic kidney disease, unspecified low back pain
white f 90 $nan$hematology blood hematocrit  23.9  %; hematology blood hemoglobin  7.5  g dl; hematology blood platelet count  105  k ul; chemistry blood anion gap  18  meq l; chemistry blood bicarbonate  23  meq l; chemistry blood chloride  109  meq l; chemistry blood creatinine  1.8  mg dl; chemistry blood potassium  4.4  meq l; chemistry blood sodium  146  meq l; chemistry blood urea nitrogen  43  mg dl; hematology blood inr(pt)  1.4  ; chemistry blood calcium, total  8.8  mg dl; chemistry blood glucose  99  mg dl$sodium chloride 0.9%  flush  3  ml ; docusate sodium  100  mg ; senna  17.2  mg ; acetaminophen  650  mg ; atorvastatin  20  mg ; multivitamins  1  tab ; oxycodone (immediate release)  2.5  mg ; vitamin d  2000  unit ; ondansetron  4  mg ; levothyroxine sodium  25  mcg ; 0.9% sodium chloride (mini bag plus)  100  ml ; ceftriaxone  1  gm ; lansoprazole oral disintegrating tab  30  mg ; warfarin  1  dose ; warfarin  1.5  mg ; argatroban  50  mg ; warfarin  4  mg ; 
peripheral vascular disease, unspecified long term (current) use of anticoagulants pneumonitis due to inhalation of food and vomit toxic encephalopathy myelodysplastic syndrome, unspecified personal history of other venous thrombosis and embolism unspecified dementia without behavioral disturbance hyperlipidemia, unspecified gastro-esophageal reflux disease without esophagitis monoclonal gammopathy hypothyroidism, unspecified dehydration delirium due to known physiological condition adverse effect of drugs affecting uric acid metabolism, initial encounter chronic diastolic (congestive) heart failure chronic gout, unspecified, with tophus (tophi) chronic kidney disease, unspecified personal history of transient ischemic attack (tia), and cerebral infarction without residual deficits hypovolemia adult failure to thrive unspecified place in other specified residential institution as the place of occurrence of the external cause hyperosmolality and hypernatremia paroxysmal atrial fibrillation type 2 diabetes mellitus with diabetic chronic kidney disease acidosis chest pain, unspecified diarrhea, unspecified other secondary thrombocytopenia acute kidney failure, unspecified do not resuscitate hypertensive chronic kidney disease with stage 1 through stage 4 chronic kidney disease, or unspecified chronic kidney disease cellulitis of right lower limb essential (primary) hypertension peripheral vascular disease, unspecified unspecified dementia without behavioral disturbance paroxysmal atrial fibrillation anemia, unspecified gout, unspecified hypothyroidism, unspecified myelodysplastic syndrome, unspecified hyperlipidemia, unspecified anemia in other chronic diseases classified elsewhere type 2 diabetes mellitus without complications chronic diastolic (congestive) heart failure gastro-esophageal reflux disease without esophagitis hypertensive chronic kidney disease with stage 1 through stage 4 chronic kidney disease, or unspecified chronic kidney disease chronic kidney disease, unspecified low back pain
white f 90 $nan$hematology blood hematocrit  25.1  %; hematology blood hemoglobin  8.0  g dl; hematology blood platelet count  116  k ul; chemistry blood anion gap  17  meq l; chemistry blood bicarbonate  24  meq l; chemistry blood chloride  107  meq l; chemistry blood creatinine  1.7  mg dl; chemistry blood potassium  4.1  meq l; chemistry blood sodium  144  meq l; chemistry blood urea nitrogen  34  mg dl; hematology blood inr(pt)  1.6  ; hematology blood inr(pt)  1.7  ; hematology blood inr(pt)  1.7  ; chemistry blood calcium, total  9.1  mg dl; chemistry blood glucose  133  mg dl$sodium chloride 0.9%  flush  3  ml ; docusate sodium  100  mg ; senna  17.2  mg ; acetaminophen  650  mg ; atorvastatin  20  mg ; multivitamins  1  tab ; oxycodone (immediate release)  2.5  mg ; vitamin d  2000  unit ; ondansetron  4  mg ; levothyroxine sodium  25  mcg ; 0.9% sodium chloride (mini bag plus)  100  ml ; ceftriaxone  1  gm ; lansoprazole oral disintegrating tab  30  mg ; warfarin  1  dose ; argatroban  50  mg ; warfarin  4  mg ; warfarin  2.5  mg ; warfarin  2  mg ; hydralazine  10  mg ; 
peripheral vascular disease, unspecified long term (current) use of anticoagulants pneumonitis due to inhalation of food and vomit toxic encephalopathy myelodysplastic syndrome, unspecified personal history of other venous thrombosis and embolism unspecified dementia without behavioral disturbance hyperlipidemia, unspecified gastro-esophageal reflux disease without esophagitis monoclonal gammopathy hypothyroidism, unspecified dehydration delirium due to known physiological condition adverse effect of drugs affecting uric acid metabolism, initial encounter chronic diastolic (congestive) heart failure chronic gout, unspecified, with tophus (tophi) chronic kidney disease, unspecified personal history of transient ischemic attack (tia), and cerebral infarction without residual deficits hypovolemia adult failure to thrive unspecified place in other specified residential institution as the place of occurrence of the external cause hyperosmolality and hypernatremia paroxysmal atrial fibrillation type 2 diabetes mellitus with diabetic chronic kidney disease acidosis chest pain, unspecified diarrhea, unspecified other secondary thrombocytopenia acute kidney failure, unspecified do not resuscitate hypertensive chronic kidney disease with stage 1 through stage 4 chronic kidney disease, or unspecified chronic kidney disease cellulitis of right lower limb essential (primary) hypertension peripheral vascular disease, unspecified unspecified dementia without behavioral disturbance paroxysmal atrial fibrillation anemia, unspecified gout, unspecified hypothyroidism, unspecified myelodysplastic syndrome, unspecified hyperlipidemia, unspecified anemia in other chronic diseases classified elsewhere type 2 diabetes mellitus without complications chronic diastolic (congestive) heart failure gastro-esophageal reflux disease without esophagitis hypertensive chronic kidney disease with stage 1 through stage 4 chronic kidney disease, or unspecified chronic kidney disease chronic kidney disease, unspecified low back pain
white f 90 $nan$hematology blood hematocrit  25.5  %; hematology blood hemoglobin  8.0  g dl; hematology blood platelet count  108  k ul; chemistry blood anion gap  17  meq l; chemistry blood bicarbonate  26  meq l; chemistry blood chloride  106  meq l; chemistry blood creatinine  1.6  mg dl; chemistry blood potassium  4.0  meq l; chemistry blood sodium  145  meq l; chemistry blood urea nitrogen  32  mg dl; hematology blood inr(pt)  2.2  ; chemistry blood calcium, total  9.1  mg dl; chemistry blood glucose  117  mg dl$sodium chloride 0.9%  flush  3  ml ; docusate sodium  100  mg ; senna  17.2  mg ; acetaminophen  650  mg ; atorvastatin  20  mg ; multivitamins  1  tab ; oxycodone (immediate release)  2.5  mg ; vitamin d  2000  unit ; ondansetron  4  mg ; levothyroxine sodium  25  mcg ; lansoprazole oral disintegrating tab  30  mg ; warfarin  1  dose ; argatroban  50  mg ; warfarin  2.5  mg ; warfarin  2  mg ; hydralazine  10  mg ; 
peripheral vascular disease, unspecified long term (current) use of anticoagulants pneumonitis due to inhalation of food and vomit toxic encephalopathy myelodysplastic syndrome, unspecified personal history of other venous thrombosis and embolism unspecified dementia without behavioral disturbance hyperlipidemia, unspecified gastro-esophageal reflux disease without esophagitis monoclonal gammopathy hypothyroidism, unspecified dehydration delirium due to known physiological condition adverse effect of drugs affecting uric acid metabolism, initial encounter chronic diastolic (congestive) heart failure chronic gout, unspecified, with tophus (tophi) chronic kidney disease, unspecified personal history of transient ischemic attack (tia), and cerebral infarction without residual deficits hypovolemia adult failure to thrive unspecified place in other specified residential institution as the place of occurrence of the external cause hyperosmolality and hypernatremia paroxysmal atrial fibrillation type 2 diabetes mellitus with diabetic chronic kidney disease acidosis chest pain, unspecified diarrhea, unspecified other secondary thrombocytopenia acute kidney failure, unspecified do not resuscitate hypertensive chronic kidney disease with stage 1 through stage 4 chronic kidney disease, or unspecified chronic kidney disease cellulitis of right lower limb essential (primary) hypertension peripheral vascular disease, unspecified unspecified dementia without behavioral disturbance paroxysmal atrial fibrillation anemia, unspecified gout, unspecified hypothyroidism, unspecified myelodysplastic syndrome, unspecified hyperlipidemia, unspecified anemia in other chronic diseases classified elsewhere type 2 diabetes mellitus without complications chronic diastolic (congestive) heart failure gastro-esophageal reflux disease without esophagitis hypertensive chronic kidney disease with stage 1 through stage 4 chronic kidney disease, or unspecified chronic kidney disease chronic kidney disease, unspecified low back pain
white f 90 $nan$hematology blood hematocrit  21.7  %; hematology blood hemoglobin  6.8  g dl; hematology blood platelet count  100  k ul; chemistry blood anion gap  17  meq l; chemistry blood bicarbonate  25  meq l; chemistry blood chloride  107  meq l; chemistry blood creatinine  1.7  mg dl; chemistry blood potassium  4.0  meq l; chemistry blood sodium  145  meq l; chemistry blood urea nitrogen  41  mg dl; hematology blood inr(pt)  3.3  ; hematology blood inr(pt)  5.3  ; chemistry blood calcium, total  8.6  mg dl; chemistry blood glucose  145  mg dl$sodium chloride 0.9%  flush  3  ml ; docusate sodium  100  mg ; senna  17.2  mg ; acetaminophen  650  mg ; atorvastatin  20  mg ; multivitamins  1  tab ; oxycodone (immediate release)  2.5  mg ; vitamin d  2000  unit ; ondansetron  4  mg ; levothyroxine sodium  25  mcg ; lansoprazole oral disintegrating tab  30  mg ; warfarin  1  dose ; argatroban  50  mg ; carvedilol  6.25  mg ; amlodipine  10  mg ; allopurinol  100  mg ; multivitamins w minerals  1  tab ; calcium carbonate  500  mg ; 
peripheral vascular disease, unspecified long term (current) use of anticoagulants pneumonitis due to inhalation of food and vomit toxic encephalopathy myelodysplastic syndrome, unspecified personal history of other venous thrombosis and embolism unspecified dementia without behavioral disturbance hyperlipidemia, unspecified gastro-esophageal reflux disease without esophagitis monoclonal gammopathy hypothyroidism, unspecified dehydration delirium due to known physiological condition adverse effect of drugs affecting uric acid metabolism, initial encounter chronic diastolic (congestive) heart failure chronic gout, unspecified, with tophus (tophi) chronic kidney disease, unspecified personal history of transient ischemic attack (tia), and cerebral infarction without residual deficits hypovolemia adult failure to thrive unspecified place in other specified residential institution as the place of occurrence of the external cause hyperosmolality and hypernatremia paroxysmal atrial fibrillation type 2 diabetes mellitus with diabetic chronic kidney disease acidosis chest pain, unspecified diarrhea, unspecified other secondary thrombocytopenia acute kidney failure, unspecified do not resuscitate hypertensive chronic kidney disease with stage 1 through stage 4 chronic kidney disease, or unspecified chronic kidney disease cellulitis of right lower limb essential (primary) hypertension peripheral vascular disease, unspecified unspecified dementia without behavioral disturbance paroxysmal atrial fibrillation anemia, unspecified gout, unspecified hypothyroidism, unspecified myelodysplastic syndrome, unspecified hyperlipidemia, unspecified anemia in other chronic diseases classified elsewhere type 2 diabetes mellitus without complications chronic diastolic (congestive) heart failure gastro-esophageal reflux disease without esophagitis hypertensive chronic kidney disease with stage 1 through stage 4 chronic kidney disease, or unspecified chronic kidney disease chronic kidney disease, unspecified low back pain
white f 90 $nan$hematology blood hematocrit  25.6  %; hematology blood hematocrit  26.0  %; hematology blood hemoglobin  8.2  g dl; hematology blood hemoglobin  8.3  g dl; hematology blood platelet count  93  k ul; hematology blood platelet count  99  k ul; chemistry blood anion gap  19  meq l; chemistry blood bicarbonate  24  meq l; chemistry blood chloride  108  meq l; chemistry blood creatinine  1.8  mg dl; chemistry blood potassium  4.2  meq l; chemistry blood sodium  147  meq l; chemistry blood urea nitrogen  47  mg dl; hematology blood inr(pt)  2.9  ; chemistry blood calcium, total  8.8  mg dl; chemistry blood glucose  114  mg dl$sodium chloride 0.9%  flush  3  ml ; docusate sodium  100  mg ; senna  17.2  mg ; acetaminophen  650  mg ; atorvastatin  20  mg ; multivitamins  1  tab ; oxycodone (immediate release)  2.5  mg ; vitamin d  2000  unit ; ondansetron  4  mg ; levothyroxine sodium  25  mcg ; lansoprazole oral disintegrating tab  30  mg ; carvedilol  6.25  mg ; amlodipine  10  mg ; allopurinol  100  mg ; multivitamins w minerals  1  tab ; calcium carbonate  500  mg ; 
peripheral vascular disease, unspecified long term (current) use of anticoagulants pneumonitis due to inhalation of food and vomit toxic encephalopathy myelodysplastic syndrome, unspecified personal history of other venous thrombosis and embolism unspecified dementia without behavioral disturbance hyperlipidemia, unspecified gastro-esophageal reflux disease without esophagitis monoclonal gammopathy hypothyroidism, unspecified dehydration delirium due to known physiological condition adverse effect of drugs affecting uric acid metabolism, initial encounter chronic diastolic (congestive) heart failure chronic gout, unspecified, with tophus (tophi) chronic kidney disease, unspecified personal history of transient ischemic attack (tia), and cerebral infarction without residual deficits hypovolemia adult failure to thrive unspecified place in other specified residential institution as the place of occurrence of the external cause hyperosmolality and hypernatremia paroxysmal atrial fibrillation type 2 diabetes mellitus with diabetic chronic kidney disease acidosis chest pain, unspecified diarrhea, unspecified other secondary thrombocytopenia acute kidney failure, unspecified do not resuscitate hypertensive chronic kidney disease with stage 1 through stage 4 chronic kidney disease, or unspecified chronic kidney disease cellulitis of right lower limb essential (primary) hypertension peripheral vascular disease, unspecified unspecified dementia without behavioral disturbance paroxysmal atrial fibrillation anemia, unspecified gout, unspecified hypothyroidism, unspecified myelodysplastic syndrome, unspecified hyperlipidemia, unspecified anemia in other chronic diseases classified elsewhere type 2 diabetes mellitus without complications chronic diastolic (congestive) heart failure gastro-esophageal reflux disease without esophagitis hypertensive chronic kidney disease with stage 1 through stage 4 chronic kidney disease, or unspecified chronic kidney disease chronic kidney disease, unspecified low back pain
white f 90 $nan$hematology blood hematocrit  26.3  %; hematology blood hemoglobin  8.3  g dl; hematology blood platelet count  104  k ul; chemistry blood anion gap  15  meq l; chemistry blood bicarbonate  29  meq l; chemistry blood chloride  109  meq l; chemistry blood creatinine  1.8  mg dl; chemistry blood potassium  4.3  meq l; chemistry blood sodium  149  meq l; chemistry blood urea nitrogen  56  mg dl; hematology blood inr(pt)  2.8  ; chemistry blood calcium, total  9.0  mg dl; chemistry blood glucose  132  mg dl$sodium chloride 0.9%  flush  3  ml ; docusate sodium  100  mg ; senna  17.2  mg ; acetaminophen  650  mg ; atorvastatin  20  mg ; oxycodone (immediate release)  2.5  mg ; vitamin d  2000  unit ; ondansetron  4  mg ; levothyroxine sodium  25  mcg ; lansoprazole oral disintegrating tab  30  mg ; carvedilol  6.25  mg ; amlodipine  10  mg ; allopurinol  100  mg ; multivitamins w minerals  1  tab ; calcium carbonate  500  mg ; dextrose 5%  1000  ml ; 
peripheral vascular disease, unspecified long term (current) use of anticoagulants pneumonitis due to inhalation of food and vomit toxic encephalopathy myelodysplastic syndrome, unspecified personal history of other venous thrombosis and embolism unspecified dementia without behavioral disturbance hyperlipidemia, unspecified gastro-esophageal reflux disease without esophagitis monoclonal gammopathy hypothyroidism, unspecified dehydration delirium due to known physiological condition adverse effect of drugs affecting uric acid metabolism, initial encounter chronic diastolic (congestive) heart failure chronic gout, unspecified, with tophus (tophi) chronic kidney disease, unspecified personal history of transient ischemic attack (tia), and cerebral infarction without residual deficits hypovolemia adult failure to thrive unspecified place in other specified residential institution as the place of occurrence of the external cause hyperosmolality and hypernatremia paroxysmal atrial fibrillation type 2 diabetes mellitus with diabetic chronic kidney disease acidosis chest pain, unspecified diarrhea, unspecified other secondary thrombocytopenia acute kidney failure, unspecified do not resuscitate hypertensive chronic kidney disease with stage 1 through stage 4 chronic kidney disease, or unspecified chronic kidney disease cellulitis of right lower limb essential (primary) hypertension peripheral vascular disease, unspecified unspecified dementia without behavioral disturbance paroxysmal atrial fibrillation anemia, unspecified gout, unspecified hypothyroidism, unspecified myelodysplastic syndrome, unspecified hyperlipidemia, unspecified anemia in other chronic diseases classified elsewhere type 2 diabetes mellitus without complications chronic diastolic (congestive) heart failure gastro-esophageal reflux disease without esophagitis hypertensive chronic kidney disease with stage 1 through stage 4 chronic kidney disease, or unspecified chronic kidney disease chronic kidney disease, unspecified low back pain
white f 90 $nan$hematology blood hematocrit  25.4  %; hematology blood hemoglobin  7.9  g dl; hematology blood platelet count  101  k ul; chemistry blood anion gap  15  meq l; chemistry blood anion gap  17  meq l; chemistry blood bicarbonate  29  meq l; chemistry blood bicarbonate  26  meq l; chemistry blood chloride  103  meq l; chemistry blood chloride  101  meq l; chemistry blood creatinine  1.8  mg dl; chemistry blood creatinine  1.7  mg dl; chemistry blood potassium  4.4  meq l; chemistry blood potassium  4.3  meq l; chemistry blood sodium  143  meq l; chemistry blood sodium  140  meq l; chemistry blood urea nitrogen  63  mg dl; chemistry blood urea nitrogen  61  mg dl; hematology blood inr(pt)  2.9  ; chemistry blood calcium, total  8.6  mg dl; chemistry blood calcium, total  8.7  mg dl; chemistry blood glucose  125  mg dl; chemistry blood glucose  127  mg dl$sodium chloride 0.9%  flush  3  ml ; docusate sodium  100  mg ; senna  17.2  mg ; acetaminophen  650  mg ; atorvastatin  20  mg ; oxycodone (immediate release)  2.5  mg ; vitamin d  2000  unit ; ondansetron  4  mg ; levothyroxine sodium  25  mcg ; lansoprazole oral disintegrating tab  30  mg ; carvedilol  6.25  mg ; amlodipine  10  mg ; allopurinol  100  mg ; multivitamins w minerals  1  tab ; calcium carbonate  500  mg ; dextrose 5%  1000  ml ; 
peripheral vascular disease, unspecified long term (current) use of anticoagulants pneumonitis due to inhalation of food and vomit toxic encephalopathy myelodysplastic syndrome, unspecified personal history of other venous thrombosis and embolism unspecified dementia without behavioral disturbance hyperlipidemia, unspecified gastro-esophageal reflux disease without esophagitis monoclonal gammopathy hypothyroidism, unspecified dehydration delirium due to known physiological condition adverse effect of drugs affecting uric acid metabolism, initial encounter chronic diastolic (congestive) heart failure chronic gout, unspecified, with tophus (tophi) chronic kidney disease, unspecified personal history of transient ischemic attack (tia), and cerebral infarction without residual deficits hypovolemia adult failure to thrive unspecified place in other specified residential institution as the place of occurrence of the external cause hyperosmolality and hypernatremia paroxysmal atrial fibrillation type 2 diabetes mellitus with diabetic chronic kidney disease acidosis chest pain, unspecified diarrhea, unspecified other secondary thrombocytopenia acute kidney failure, unspecified do not resuscitate hypertensive chronic kidney disease with stage 1 through stage 4 chronic kidney disease, or unspecified chronic kidney disease cellulitis of right lower limb essential (primary) hypertension peripheral vascular disease, unspecified unspecified dementia without behavioral disturbance paroxysmal atrial fibrillation anemia, unspecified gout, unspecified hypothyroidism, unspecified myelodysplastic syndrome, unspecified hyperlipidemia, unspecified anemia in other chronic diseases classified elsewhere type 2 diabetes mellitus without complications chronic diastolic (congestive) heart failure gastro-esophageal reflux disease without esophagitis hypertensive chronic kidney disease with stage 1 through stage 4 chronic kidney disease, or unspecified chronic kidney disease chronic kidney disease, unspecified low back pain
white f 90 $nan$nan$sodium chloride 0.9%  flush  3  ml ; docusate sodium  100  mg ; senna  17.2  mg ; acetaminophen  650  mg ; atorvastatin  20  mg ; oxycodone (immediate release)  2.5  mg ; vitamin d  2000  unit ; ondansetron  4  mg ; levothyroxine sodium  25  mcg ; lansoprazole oral disintegrating tab  30  mg ; carvedilol  6.25  mg ; amlodipine  10  mg ; allopurinol  100  mg ; multivitamins w minerals  1  tab ; calcium carbonate  500  mg ; 
peripheral vascular disease, unspecified long term (current) use of anticoagulants pneumonitis due to inhalation of food and vomit toxic encephalopathy myelodysplastic syndrome, unspecified personal history of other venous thrombosis and embolism unspecified dementia without behavioral disturbance hyperlipidemia, unspecified gastro-esophageal reflux disease without esophagitis monoclonal gammopathy hypothyroidism, unspecified dehydration delirium due to known physiological condition adverse effect of drugs affecting uric acid metabolism, initial encounter chronic diastolic (congestive) heart failure chronic gout, unspecified, with tophus (tophi) chronic kidney disease, unspecified personal history of transient ischemic attack (tia), and cerebral infarction without residual deficits hypovolemia adult failure to thrive unspecified place in other specified residential institution as the place of occurrence of the external cause hyperosmolality and hypernatremia paroxysmal atrial fibrillation type 2 diabetes mellitus with diabetic chronic kidney disease acidosis chest pain, unspecified diarrhea, unspecified other secondary thrombocytopenia acute kidney failure, unspecified do not resuscitate hypertensive chronic kidney disease with stage 1 through stage 4 chronic kidney disease, or unspecified chronic kidney disease cellulitis of right lower limb essential (primary) hypertension peripheral vascular disease, unspecified unspecified dementia without behavioral disturbance paroxysmal atrial fibrillation anemia, unspecified gout, unspecified hypothyroidism, unspecified myelodysplastic syndrome, unspecified hyperlipidemia, unspecified anemia in other chronic diseases classified elsewhere type 2 diabetes mellitus without complications chronic diastolic (congestive) heart failure gastro-esophageal reflux disease without esophagitis hypertensive chronic kidney disease with stage 1 through stage 4 chronic kidney disease, or unspecified chronic kidney disease chronic kidney disease, unspecified low back pain
white f 50 $temp  98.2  heartrate  101.0  resprate  18.0  o2sat  98.0  sbp  109.0  dbp  79.0  rhythm    pain    ; temp  98.0  heartrate  89.0  resprate  18.0  o2sat  97.0  sbp  105.0  dbp  52.0  rhythm    pain    $hematology blood hematocrit  36.6  %; hematology blood hemoglobin  11.8  g dl; hematology blood platelet count  397  k ul; chemistry blood anion gap  15  meq l; chemistry blood bicarbonate  25  meq l; chemistry blood chloride  101  meq l; chemistry blood creatinine  0.6  mg dl; chemistry blood potassium  3.9  meq l; chemistry blood sodium  137  meq l; chemistry blood urea nitrogen  10  mg dl; hematology blood inr(pt)  1.1  ; chemistry blood calcium, total  9.4  mg dl; chemistry blood bilirubin, total  7.8  mg dl; chemistry blood glucose  102  mg dl; chemistry blood albumin  3.5  g dl$iso-osmotic dextrose  100  ml ; piperacillin-tazobactam  4.5  g ; influenza vaccine quadrivalent  0.5  ml ; sodium chloride 0.9%  flush  3  ml ; docusate sodium  100  mg ; senna  8.6  mg ; heparin  5000  unit ; acetaminophen  650  mg ; metoclopramide  10  mg ; ursodiol  300  mg ; diphenhydramine  25  mg ; sarna lotion  1  appl ; 
esophageal reflux obesity, unspecified obstruction of bile duct body mass index 33.0-33.9, adult
white f 50 $nan$hematology blood hematocrit  35.4  %; hematology blood hemoglobin  11.8  g dl; hematology blood platelet count  411  k ul; chemistry blood anion gap  16  meq l; chemistry blood bicarbonate  24  meq l; chemistry blood chloride  101  meq l; chemistry blood creatinine  0.6  mg dl; chemistry blood potassium  4.1  meq l; chemistry blood sodium  137  meq l; chemistry blood urea nitrogen  7  mg dl; hematology blood inr(pt)  1.0  ; chemistry blood calcium, total  9.4  mg dl; chemistry blood bilirubin, total  5.8  mg dl; chemistry blood glucose  104  mg dl; chemistry blood lactate dehydrogenase (ld)  154  iu l; chemistry blood albumin  3.5  g dl$influenza vaccine quadrivalent  0.5  ml ; sodium chloride 0.9%  flush  3  ml ; docusate sodium  100  mg ; senna  8.6  mg ; heparin  5000  unit ; acetaminophen  650  mg ; metoclopramide  10  mg ; ursodiol  300  mg ; diphenhydramine  25  mg ; sarna lotion  1  appl ; 
esophageal reflux obesity, unspecified obstruction of bile duct body mass index 33.0-33.9, adult
white f 50 $nan$hematology blood hematocrit  35.8  %; hematology blood hemoglobin  11.9  g dl; hematology blood platelet count  431  k ul; chemistry blood anion gap  15  meq l; chemistry blood bicarbonate  26  meq l; chemistry blood chloride  100  meq l; chemistry blood creatinine  0.6  mg dl; chemistry blood potassium  4.0  meq l; chemistry blood sodium  137  meq l; chemistry blood urea nitrogen  9  mg dl; hematology blood inr(pt)  1.0  ; chemistry blood calcium, total  9.7  mg dl; chemistry blood bilirubin, total  4.6  mg dl; chemistry blood glucose  111  mg dl$influenza vaccine quadrivalent  0.5  ml ; sodium chloride 0.9%  flush  3  ml ; docusate sodium  100  mg ; senna  8.6  mg ; heparin  5000  unit ; acetaminophen  650  mg ; metoclopramide  10  mg ; ursodiol  300  mg ; sarna lotion  1  appl ; levofloxacin  500  mg ; 
esophageal reflux obesity, unspecified obstruction of bile duct body mass index 33.0-33.9, adult
white f 50 $nan$nan$influenza vaccine quadrivalent  0.5  ml ; sodium chloride 0.9%  flush  3  ml ; docusate sodium  100  mg ; senna  8.6  mg ; heparin  5000  unit ; acetaminophen  650  mg ; metoclopramide  10  mg ; ursodiol  300  mg ; sarna lotion  1  appl ; levofloxacin  500  mg ; 
esophageal reflux obesity, unspecified obstruction of bile duct body mass index 33.0-33.9, adult
unknown f 37 $nan$hematology blood hematocrit  25.9  %; hematology blood hematocrit  25.0  %; hematology blood hematocrit  25.3  %; hematology blood hematocrit  24.7  %; hematology blood hemoglobin  8.9  g dl; hematology blood hemoglobin  8.3  g dl; hematology blood hemoglobin  8.2  g dl; hematology blood hemoglobin  8.0  g dl; hematology blood platelet count  60  k ul; hematology blood platelet count  62  k ul; hematology blood platelet count  65  k ul; hematology blood platelet count  71  k ul; chemistry blood anion gap  31  meq l; chemistry blood anion gap  28  meq l; chemistry blood anion gap  26  meq l; chemistry blood bicarbonate  24  meq l; chemistry blood bicarbonate  26  meq l; chemistry blood bicarbonate  25  meq l; chemistry blood chloride  97  meq l; chemistry blood chloride  98  meq l; chemistry blood chloride  100  meq l; chemistry blood creatinine  4.0  mg dl; chemistry blood creatinine  3.8  mg dl; chemistry blood creatinine  3.6  mg dl; chemistry blood potassium  3.6  meq l; chemistry blood potassium  3.8  meq l; chemistry blood potassium  4.1  meq l; chemistry blood sodium  148  meq l; chemistry blood sodium  147  meq l; chemistry blood sodium  148  meq l; chemistry blood urea nitrogen  173  mg dl; chemistry blood urea nitrogen  176  mg dl; chemistry blood urea nitrogen  174  mg dl; hematology blood inr(pt)  2.2  ; hematology blood inr(pt)  2.4  ; hematology blood inr(pt)  2.6  ; hematology blood inr(pt)  2.4  ; chemistry urine chloride, urine  48  meq l; chemistry urine creatinine, urine  39  mg dl; chemistry urine potassium, urine  40  meq l; chemistry urine sodium, urine  18  meq l; hematology urine wbc  34  # hpf; chemistry blood calcium, total  7.4  mg dl; chemistry blood calcium, total  7.6  mg dl; chemistry blood calcium, total  7.8  mg dl; chemistry blood bilirubin, indirect  7.3  mg dl; chemistry blood bilirubin, indirect  8.3  mg dl; chemistry blood bilirubin, total  21.3  mg dl; chemistry blood bilirubin, total  20.5  mg dl; chemistry blood glucose  188  mg dl; chemistry blood glucose  179  mg dl; chemistry blood glucose  190  mg dl; chemistry blood lactate dehydrogenase (ld)  478  iu l; chemistry blood albumin  4.1  g dl; blood gas blood free calcium  0.79  mmol l; blood gas blood free calcium  0.86  mmol l; blood gas blood free calcium  0.85  mmol l; blood gas blood free calcium  0.83  mmol l; blood gas blood lactate  1.9  mmol l; blood gas blood lactate  1.7  mmol l; blood gas blood lactate  2.0  mmol l; chemistry blood bilirubin, direct  12.2  mg dl; chemistry blood bilirubin, direct  14.0  mg dl; blood gas blood glucose  164  mg dl; blood gas blood hematocrit, calculated  28  %; blood gas blood hemoglobin  9.3  g dl; blood gas blood potassium, whole blood  4.5  meq l; blood gas blood potassium, whole blood  3.5  meq l$influenza virus vaccine  0.5  ml ; fentanyl citrate  25-100  mcg ; bisacodyl  10  mg ; vial  1  vial ; pantoprazole  40  mg ; 0.9% sodium chloride  250  ml ; calcium gluconate  4  g ; insulin  0  unit ; soln  50  ml ; fentanyl citrate  2.5  mg ; propofol  1000  mg ; propofol  200  mg ; methylprednisolone sodium succ  60  mg ; dextrose 5%  150  ml ; levofloxacin  750  mg ; dextrose 50%  12.5  gm ; glucagon  1  mg ; glucose gel  15  g ; albuterol 0.083% neb soln  1  neb ; ipratropium bromide neb  1  neb ; furosemide  160  mg ; albuterol inhaler  6-10  puff ; phytonadione  10  mg ; potassium chloride  40  meq ; potassium chloride  60  meq ; potassium chloride  80  meq ; lactulose  30  ml ; docusate sodium (liquid)  100  mg ; chlorhexidine gluconate 0.12% oral rinse  15  ml ; lansoprazole oral disintegrating tab  30  mg ; senna  1  tab ; calcium acetate  1334  mg ; ipratropium bromide mdi  4-6  puff ; polyethylene glycol  17  g ; iso-osmotic dextrose  200  ml ; vancomycin  1000  mg ; 0.9% sodium chloride (mini bag plus)  100  ml ; cefepime  2  g ; 5% dextrose  50  ml ; midazolam  0.5-2  mg ; aluminum hydroxide suspension  5  ml ; coq10 200mg  1  dose ; 
 
unknown f 37 $nan$hematology blood hematocrit  25.0  %; hematology blood hemoglobin  7.8  g dl; hematology blood platelet count  54  k ul; chemistry blood anion gap  25  meq l; chemistry blood anion gap  24  meq l; chemistry blood bicarbonate  25  meq l; chemistry blood bicarbonate  25  meq l; chemistry blood chloride  100  meq l; chemistry blood chloride  100  meq l; chemistry blood creatinine  3.8  mg dl; chemistry blood creatinine  3.3  mg dl; chemistry blood potassium  4.3  meq l; chemistry blood potassium  4.0  meq l; chemistry blood sodium  146  meq l; chemistry blood sodium  145  meq l; chemistry blood urea nitrogen  178  mg dl; chemistry blood urea nitrogen  177  mg dl; hematology blood inr(pt)  2.5  ; hematology blood inr(pt)  2.6  ; chemistry blood calcium, total  7.9  mg dl; chemistry blood calcium, total  8.3  mg dl; chemistry blood bilirubin, indirect  5.6  mg dl; chemistry blood bilirubin, total  20.3  mg dl; chemistry blood glucose  193  mg dl; chemistry blood lactate dehydrogenase (ld)  543  iu l; chemistry blood albumin  3.7  g dl; blood gas blood free calcium  1.00  mmol l; blood gas blood free calcium  0.99  mmol l; blood gas blood free calcium  0.88  mmol l; blood gas blood lactate  1.9  mmol l; blood gas blood lactate  2.0  mmol l; chemistry blood bilirubin, direct  14.7  mg dl$influenza virus vaccine  0.5  ml ; bisacodyl  10  mg ; 0.9% sodium chloride  250  ml ; calcium gluconate  4  g ; insulin  0  unit ; methylprednisolone sodium succ  60  mg ; dextrose 5%  150  ml ; levofloxacin  750  mg ; dextrose 50%  12.5  gm ; glucagon  1  mg ; glucose gel  15  g ; albuterol 0.083% neb soln  1  neb ; albuterol inhaler  6-10  puff ; potassium chloride  40  meq ; potassium chloride  60  meq ; potassium chloride  80  meq ; lactulose  30  ml ; docusate sodium (liquid)  100  mg ; chlorhexidine gluconate 0.12% oral rinse  15  ml ; lansoprazole oral disintegrating tab  30  mg ; senna  1  tab ; ipratropium bromide mdi  4-6  puff ; polyethylene glycol  17  g ; iso-osmotic dextrose  200  ml ; vancomycin  1000  mg ; 0.9% sodium chloride (mini bag plus)  100  ml ; cefepime  2  g ; 5% dextrose  50  ml ; midazolam  0.5-2  mg ; aluminum hydroxide suspension  5  ml ; 0.9% sodium chloride  100  ml ; calcium gluconate  2  gm ; readi-cat 2 (barium sulfate 2% suspension)  900  ml ; calcium chloride  4  gm ; calcium gluconate  2  g ; chlorothiazide sodium  500  mg ; furosemide  250  mg ; furosemide  200  mg ; coq10 200mg  1  dose ; 
 
unknown f 37 $nan$hematology blood hematocrit  25.8  %; hematology blood hemoglobin  8.3  g dl; hematology blood platelet count  55  k ul; chemistry blood anion gap  25  meq l; chemistry blood anion gap  24  meq l; chemistry blood anion gap  23  meq l; chemistry blood anion gap  24  meq l; chemistry blood bicarbonate  24  meq l; chemistry blood bicarbonate  26  meq l; chemistry blood bicarbonate  27  meq l; chemistry blood bicarbonate  26  meq l; chemistry blood chloride  101  meq l; chemistry blood chloride  99  meq l; chemistry blood chloride  100  meq l; chemistry blood chloride  101  meq l; chemistry blood creatinine  3.3  mg dl; chemistry blood creatinine  3.1  mg dl; chemistry blood creatinine  3.0  mg dl; chemistry blood creatinine  3.0  mg dl; chemistry blood potassium  3.7  meq l; chemistry blood potassium  3.5  meq l; chemistry blood potassium  3.5  meq l; chemistry blood potassium  3.7  meq l; chemistry blood sodium  146  meq l; chemistry blood sodium  145  meq l; chemistry blood sodium  146  meq l; chemistry blood sodium  147  meq l; chemistry blood urea nitrogen  178  mg dl; chemistry blood urea nitrogen  179  mg dl; chemistry blood urea nitrogen  168  mg dl; chemistry blood urea nitrogen  179  mg dl; hematology blood inr(pt)  2.5  ; chemistry blood calcium, total  8.0  mg dl; chemistry blood calcium, total  8.4  mg dl; chemistry blood calcium, total  8.4  mg dl; chemistry blood calcium, total  8.8  mg dl; chemistry blood bilirubin, indirect  4.5  mg dl; chemistry blood bilirubin, total  21.3  mg dl; chemistry blood glucose  166  mg dl; chemistry blood glucose  178  mg dl; chemistry blood glucose  185  mg dl; chemistry blood lactate dehydrogenase (ld)  592  iu l; chemistry blood albumin  3.7  g dl; blood gas blood free calcium  0.94  mmol l; blood gas blood free calcium  0.85  mmol l; blood gas blood free calcium  0.96  mmol l; blood gas blood free calcium  0.93  mmol l; blood gas blood free calcium  0.98  mmol l; blood gas blood free calcium  0.94  mmol l; blood gas blood lactate  2.2  mmol l; blood gas blood lactate  1.7  mmol l; blood gas blood lactate  1.5  mmol l; blood gas blood lactate  1.8  mmol l; blood gas blood lactate  2.1  mmol l; chemistry blood bilirubin, direct  16.8  mg dl$influenza virus vaccine  0.5  ml ; bisacodyl  10  mg ; insulin  0  unit ; methylprednisolone sodium succ  60  mg ; dextrose 5%  150  ml ; levofloxacin  750  mg ; dextrose 50%  12.5  gm ; glucagon  1  mg ; glucose gel  15  g ; albuterol inhaler  6-10  puff ; lactulose  30  ml ; docusate sodium (liquid)  100  mg ; chlorhexidine gluconate 0.12% oral rinse  15  ml ; lansoprazole oral disintegrating tab  30  mg ; senna  1  tab ; ipratropium bromide mdi  4-6  puff ; polyethylene glycol  17  g ; midazolam  0.5-2  mg ; aluminum hydroxide suspension  5  ml ; calcium chloride  4  gm ; calcium gluconate  2  g ; chlorothiazide sodium  500  mg ; furosemide  200  mg ; 0.9% sodium chloride  50  ml ; desmopressin acetate  54  mcg ; cisatracurium besylate  36  mg ; 5% dextrose  250  ml ; cisatracurium besylate  200  mg ; calcium chloride  1  gm ; midazolam  100  mg ; calcium chloride  2  gm ; heparin flush (1000 units ml)  4000-11000  unit ; heparin flush (10 units ml)  1  ml ; bag  5000  ml ; prismasate (b22 k4)  5000  ml ; bag  1  bag ; citrate dextrose 3% (acd-a) crrt  1000  ml ; sodium citrate 4%  2-8  ml ; sw  100  ml ; potassium chloride  10  meq ; sterile water  50  ml ; potassium chloride  20  meq ; sterile water  100  ml ; 5% dextrose  500  ml ; calcium gluconate  20  gm ; neomycin-polymyxin-bacitracin  1  appl ; heparin (crrt machine priming)  5000  unit ; coq10 200mg  1  dose ; 
 
unknown f 37 $nan$hematology blood hematocrit  24.0  %; hematology blood hematocrit  24.8  %; hematology blood hematocrit  23.0  %; hematology blood hemoglobin  7.7  g dl; hematology blood hemoglobin  7.9  g dl; hematology blood hemoglobin  7.6  g dl; hematology blood platelet count  57  k ul; hematology blood platelet count  58  k ul; hematology blood platelet count  50  k ul; chemistry blood anion gap  23  meq l; chemistry blood anion gap  21  meq l; chemistry blood anion gap  23  meq l; chemistry blood anion gap  22  meq l; chemistry blood bicarbonate  25  meq l; chemistry blood bicarbonate  26  meq l; chemistry blood bicarbonate  24  meq l; chemistry blood bicarbonate  25  meq l; chemistry blood chloride  99  meq l; chemistry blood chloride  100  meq l; chemistry blood chloride  98  meq l; chemistry blood chloride  100  meq l; chemistry blood creatinine  2.1  mg dl; chemistry blood creatinine  1.8  mg dl; chemistry blood creatinine  2.4  mg dl; chemistry blood potassium  3.6  meq l; chemistry blood potassium  3.8  meq l; chemistry blood potassium  3.9  meq l; chemistry blood potassium  4.1  meq l; chemistry blood sodium  143  meq l; chemistry blood sodium  143  meq l; chemistry blood sodium  141  meq l; chemistry blood sodium  143  meq l; chemistry blood urea nitrogen  152  mg dl; chemistry blood urea nitrogen  143  mg dl; chemistry blood urea nitrogen  128  mg dl; hematology blood inr(pt)  2.4  ; hematology blood inr(pt)  2.5  ; hematology blood inr(pt)  2.4  ; chemistry blood calcium, total  10.3  mg dl; chemistry blood calcium, total  10.6  mg dl; chemistry blood calcium, total  10.2  mg dl; chemistry blood bilirubin, total  21.4  mg dl; chemistry blood glucose  220  mg dl; chemistry blood glucose  191  mg dl; chemistry blood glucose  171  mg dl; chemistry blood glucose  193  mg dl; chemistry blood lactate dehydrogenase (ld)  703  iu l; chemistry blood albumin  3.7  g dl; blood gas blood free calcium  1.00  mmol l; blood gas blood free calcium  1.09  mmol l; blood gas blood free calcium  1.03  mmol l; blood gas blood free calcium  1.10  mmol l; blood gas blood free calcium  1.18  mmol l; blood gas blood free calcium  0.92  mmol l; blood gas blood lactate  2.2  mmol l; blood gas blood lactate  2.3  mmol l; blood gas blood lactate  2.3  mmol l; blood gas blood glucose  151  mg dl; blood gas blood potassium, whole blood  4.1  meq l$influenza virus vaccine  0.5  ml ; bisacodyl  10  mg ; insulin  0  unit ; methylprednisolone sodium succ  60  mg ; dextrose 5%  150  ml ; levofloxacin  750  mg ; dextrose 50%  12.5  gm ; glucagon  1  mg ; glucose gel  15  g ; albuterol inhaler  6-10  puff ; lactulose  30  ml ; docusate sodium (liquid)  100  mg ; chlorhexidine gluconate 0.12% oral rinse  15  ml ; lansoprazole oral disintegrating tab  30  mg ; senna  1  tab ; ipratropium bromide mdi  4-6  puff ; polyethylene glycol  17  g ; aluminum hydroxide suspension  5  ml ; 0.9% sodium chloride  50  ml ; desmopressin acetate  54  mcg ; cisatracurium besylate  36  mg ; calcium chloride  1  gm ; midazolam  100  mg ; calcium chloride  2  gm ; heparin flush (1000 units ml)  4000-11000  unit ; heparin flush (10 units ml)  1  ml ; bag  5000  ml ; prismasate (b22 k4)  5000  ml ; bag  1  bag ; citrate dextrose 3% (acd-a) crrt  1000  ml ; sodium citrate 4%  2-8  ml ; sw  100  ml ; potassium chloride  10  meq ; sterile water  50  ml ; potassium chloride  20  meq ; sterile water  100  ml ; 5% dextrose  500  ml ; calcium gluconate  20  gm ; neomycin-polymyxin-bacitracin  1  appl ; heparin (crrt machine priming)  5000  unit ; dextrose 5%  100  ml ; levofloxacin  500  mg ; sodium chloride 0.9%  flush  10  ml ; coq10 200mg  1  dose ; 
 
unknown f 37 $nan$hematology blood hematocrit  23.8  %; hematology blood hematocrit  26.1  %; hematology blood hematocrit  27.5  %; hematology blood hemoglobin  7.7  g dl; hematology blood hemoglobin  8.3  g dl; hematology blood hemoglobin  8.4  g dl; hematology blood platelet count  50  k ul; hematology blood platelet count  50  k ul; hematology blood platelet count  67  k ul; chemistry blood anion gap  20  meq l; chemistry blood anion gap  17  meq l; chemistry blood anion gap  20  meq l; chemistry blood anion gap  22  meq l; chemistry blood bicarbonate  26  meq l; chemistry blood bicarbonate  26  meq l; chemistry blood bicarbonate  23  meq l; chemistry blood bicarbonate  21  meq l; chemistry blood chloride  99  meq l; chemistry blood chloride  100  meq l; chemistry blood chloride  99  meq l; chemistry blood chloride  100  meq l; chemistry blood creatinine  1.5  mg dl; chemistry blood creatinine  1.5  mg dl; chemistry blood creatinine  1.8  mg dl; chemistry blood potassium  4.3  meq l; chemistry blood potassium  4.4  meq l; chemistry blood potassium  4.3  meq l; chemistry blood potassium  4.4  meq l; chemistry blood sodium  141  meq l; chemistry blood sodium  139  meq l; chemistry blood sodium  138  meq l; chemistry blood sodium  139  meq l; chemistry blood urea nitrogen  116  mg dl; chemistry blood urea nitrogen  109  mg dl; chemistry blood urea nitrogen  95  mg dl; hematology blood inr(pt)  2.3  ; hematology blood inr(pt)  2.5  ; hematology blood inr(pt)  2.7  ; chemistry blood calcium, total  10.3  mg dl; chemistry blood calcium, total  10.1  mg dl; chemistry blood calcium, total  9.9  mg dl; chemistry blood bilirubin, total  21.2  mg dl; chemistry blood glucose  179  mg dl; chemistry blood glucose  196  mg dl; chemistry blood glucose  189  mg dl; chemistry blood glucose  175  mg dl; chemistry blood lactate dehydrogenase (ld)  754  iu l; blood gas blood free calcium  1.07  mmol l; blood gas blood free calcium  1.07  mmol l; blood gas blood free calcium  1.06  mmol l; blood gas blood free calcium  1.08  mmol l; blood gas blood free calcium  1.08  mmol l; blood gas blood lactate  1.9  mmol l; blood gas blood lactate  2.0  mmol l; blood gas blood lactate  3.2  mmol l; blood gas blood lactate  3.6  mmol l; blood gas blood lactate  4.7  mmol l; blood gas blood lactate  4.7  mmol l; blood gas blood lactate  4.8  mmol l; blood gas blood lactate  4.7  mmol l; blood gas blood lactate  4.1  mmol l; blood gas blood potassium, whole blood  4.4  meq l$influenza virus vaccine  0.5  ml ; bisacodyl  10  mg ; insulin  0  unit ; methylprednisolone sodium succ  60  mg ; dextrose 50%  12.5  gm ; glucagon  1  mg ; glucose gel  15  g ; albuterol inhaler  6-10  puff ; chlorhexidine gluconate 0.12% oral rinse  15  ml ; ipratropium bromide mdi  4-6  puff ; midazolam  100  mg ; heparin flush (1000 units ml)  4000-11000  unit ; heparin flush (10 units ml)  1  ml ; bag  1  bag ; citrate dextrose 3% (acd-a) crrt  1000  ml ; sodium citrate 4%  2-8  ml ; sw  100  ml ; potassium chloride  10  meq ; sterile water  50  ml ; potassium chloride  20  meq ; sterile water  100  ml ; 5% dextrose  500  ml ; calcium gluconate  20  gm ; neomycin-polymyxin-bacitracin  1  appl ; heparin (crrt machine priming)  5000  unit ; dextrose 5%  100  ml ; levofloxacin  500  mg ; sodium chloride 0.9%  flush  10  ml ; norepinephrine  8  mg ; heparin  5000  unit ; maalox diphenhydramine lidocaine  15  ml ; coq10 200mg  1  dose ; 
 
unknown f 37 $nan$hematology blood hematocrit  30.3  %; hematology blood hemoglobin  9.1  g dl; hematology blood platelet count  76  k ul; chemistry blood anion gap  24  meq l; chemistry blood anion gap  22  meq l; chemistry blood bicarbonate  21  meq l; chemistry blood bicarbonate  21  meq l; chemistry blood chloride  99  meq l; chemistry blood chloride  100  meq l; chemistry blood creatinine  1.2  mg dl; chemistry blood potassium  4.4  meq l; chemistry blood potassium  4.4  meq l; chemistry blood sodium  140  meq l; chemistry blood sodium  139  meq l; chemistry blood urea nitrogen  82  mg dl; hematology blood inr(pt)  2.5  ; chemistry blood calcium, total  10.6  mg dl; chemistry blood bilirubin, total  22.9  mg dl; chemistry blood glucose  167  mg dl; chemistry blood glucose  168  mg dl; chemistry blood lactate dehydrogenase (ld)  1121  iu l; chemistry blood albumin  3.7  g dl; blood gas blood free calcium  1.12  mmol l; blood gas blood free calcium  1.13  mmol l; blood gas blood lactate  4.7  mmol l; blood gas blood lactate  4.9  mmol l$influenza virus vaccine  0.5  ml ; bisacodyl  10  mg ; insulin  0  unit ; dextrose 50%  12.5  gm ; glucagon  1  mg ; glucose gel  15  g ; albuterol inhaler  6-10  puff ; chlorhexidine gluconate 0.12% oral rinse  15  ml ; ipratropium bromide mdi  4-6  puff ; midazolam  100  mg ; heparin flush (1000 units ml)  4000-11000  unit ; heparin flush (10 units ml)  1  ml ; bag  1  bag ; citrate dextrose 3% (acd-a) crrt  1000  ml ; sodium citrate 4%  2-8  ml ; sw  100  ml ; potassium chloride  10  meq ; sterile water  50  ml ; potassium chloride  20  meq ; sterile water  100  ml ; 5% dextrose  500  ml ; calcium gluconate  20  gm ; neomycin-polymyxin-bacitracin  1  appl ; heparin (crrt machine priming)  5000  unit ; sodium chloride 0.9%  flush  10  ml ; heparin  5000  unit ; maalox diphenhydramine lidocaine  15  ml ; prismasate (b32 k2)  5000  ml ; cisatracurium besylate  100  mg ; cisatracurium besylate  38  mg ; 5% dextrose  1000  ml ; sodium bicarbonate  150  meq ; desmopressin acetate  57  mcg ; coq10 200mg  1  dose ; 
 
white f 57 $nan$nan$influenza vaccine quadrivalent  0.5  ml ; sodium chloride 0.9%  flush  3  ml ; ondansetron  4  mg ; lactated ringers  1000  ml ; hydromorphone (dilaudid)  0.25  mg ; acetaminophen iv  1000  mg ; clindamycin  300  mg ; oxycodone-acetaminophen (5mg-325mg)  1  tab ; chlorhexidine gluconate 0.12% oral rinse  15  ml ; 
 
black african american f 62 $temp  98.4  heartrate  59.0  resprate  18.0  o2sat  100.0  sbp  126.0  dbp  51.0  rhythm    pain  0  $hematology blood hematocrit  35.4  %; hematology blood hemoglobin  11.9  g dl; hematology blood platelet count  209  k ul; chemistry blood anion gap  10  meq l; chemistry blood bicarbonate  30  meq l; chemistry blood chloride  103  meq l; chemistry blood creatinine  0.6  mg dl; chemistry blood potassium  4.0  meq l; chemistry blood sodium  139  meq l; chemistry blood urea nitrogen  11  mg dl; chemistry blood calcium, total  9.2  mg dl; chemistry blood glucose  187  mg dl; chemistry blood albumin  3.9  g dl; hematology urine glucose  100  mg dl$sodium chloride 0.9%  flush  3  ml ; heparin  5000  unit ; d5ns  1000  ml ; dextrose 50%  12.5  gm ; glucagon  1  mg ; glucose gel  15  g ; insulin  0  unit ; lactated ringers  1000  ml ; naproxen  500  mg ; amlodipine  10  mg ; aspirin  81  mg ; moexipril  15  mg ; omeprazole  20  mg ; metoprolol tartrate  50  mg ; insulin  30  unit ; insulin  7  unit ; metformin (glucophage)  1000  mg ; 
 
black african american f 62 $nan$nan$sodium chloride 0.9%  flush  3  ml ; heparin  5000  unit ; dextrose 50%  12.5  gm ; glucagon  1  mg ; glucose gel  15  g ; naproxen  500  mg ; amlodipine  10  mg ; aspirin  81  mg ; moexipril  15  mg ; omeprazole  20  mg ; insulin  7  unit ; metformin (glucophage)  1000  mg ; atorvastatin  80  mg ; 
 
white f 39 $nan$hematology blood hematocrit  32.0  %; hematology blood hemoglobin  10.6  g dl; hematology blood platelet count  287  k ul$ondansetron  4  mg ; naloxone  40-80  mcg ; metoclopramide  10  mg ; ketorolac  15-30  mg ; docusate sodium  100  mg ; oxycodone-acetaminophen  1-2  tab ; ibuprofen  600  mg ; acetaminophen  500-1000  mg ; bisacodyl  10  mg ; milk of magnesia  30  ml ; calcium carbonate  500  mg ; simethicone  80  mg ; 
 
white f 39 $nan$nan$ondansetron  4  mg ; naloxone  40-80  mcg ; metoclopramide  10  mg ; ketorolac  15-30  mg ; docusate sodium  100  mg ; oxycodone-acetaminophen  1-2  tab ; ibuprofen  600  mg ; acetaminophen  500-1000  mg ; bisacodyl  10  mg ; milk of magnesia  30  ml ; calcium carbonate  500  mg ; simethicone  80  mg ; 
 
white f 39 $nan$nan$ondansetron  4  mg ; naloxone  40-80  mcg ; metoclopramide  10  mg ; docusate sodium  100  mg ; oxycodone-acetaminophen  1-2  tab ; ibuprofen  600  mg ; acetaminophen  500-1000  mg ; bisacodyl  10  mg ; milk of magnesia  30  ml ; calcium carbonate  500  mg ; simethicone  80  mg ; 
 
white f 39 $nan$nan$ondansetron  4  mg ; naloxone  40-80  mcg ; metoclopramide  10  mg ; docusate sodium  100  mg ; oxycodone-acetaminophen  1-2  tab ; ibuprofen  600  mg ; acetaminophen  500-1000  mg ; bisacodyl  10  mg ; milk of magnesia  30  ml ; calcium carbonate  500  mg ; simethicone  80  mg ; 
 
white f 39 $nan$nan$ondansetron  4  mg ; naloxone  40-80  mcg ; metoclopramide  10  mg ; docusate sodium  100  mg ; oxycodone-acetaminophen  1-2  tab ; ibuprofen  600  mg ; acetaminophen  500-1000  mg ; bisacodyl  10  mg ; milk of magnesia  30  ml ; calcium carbonate  500  mg ; simethicone  80  mg ; 
 
white f 32 $nan$hematology blood hematocrit  34.5  %; hematology blood hemoglobin  11.5  g dl; hematology blood platelet count  316  k ul; chemistry blood anion gap  9  meq l; chemistry blood bicarbonate  29  meq l; chemistry blood chloride  103  meq l; chemistry blood creatinine  0.7  mg dl; chemistry blood potassium  4.2  meq l; chemistry blood sodium  137  meq l; chemistry blood urea nitrogen  11  mg dl; hematology urine wbc  3-5  # hpf; chemistry blood glucose  95  mg dl; hematology urine glucose  neg  mg dl; hematology urine bilirubin  neg  mg dl$nan
unspecified viral infection attention deficit disorder without mention of hyperactivity unspecified episodic mood disorder cannabis abuse, unspecified
white f 32 $nan$nan$aluminum-magnesium hydrox.-simethicone  30  ml ; milk of magnesia  30  ml ; acetaminophen  650  mg ; albuterol mdi  1-2  puff ; trazodone  25  mg ; fluticasone propionate nasal  1  spry ; methylphenidate  10  mg ; zovia 1 35e (28)  0  tab ; nexium  40  mg ; methylphenidate  20  mg ; lorazepam  1  mg ; trazodone  50-100  mg ; 
unspecified viral infection attention deficit disorder without mention of hyperactivity unspecified episodic mood disorder cannabis abuse, unspecified
white f 32 $nan$hematology urine wbc  2  # hpf; hematology urine glucose  neg  mg dl; hematology urine bilirubin  neg  mg dl$aluminum-magnesium hydrox.-simethicone  30  ml ; milk of magnesia  30  ml ; acetaminophen  650  mg ; albuterol mdi  1-2  puff ; trazodone  25  mg ; fluticasone propionate nasal  1  spry ; methylphenidate  10  mg ; zovia 1 35e (28)  0  tab ; nexium  40  mg ; methylphenidate  20  mg ; trazodone  50-100  mg ; lamotrigine  25  mg ; 
unspecified viral infection attention deficit disorder without mention of hyperactivity unspecified episodic mood disorder cannabis abuse, unspecified
white f 32 $nan$nan$aluminum-magnesium hydrox.-simethicone  30  ml ; milk of magnesia  30  ml ; acetaminophen  650  mg ; albuterol mdi  1-2  puff ; fluticasone propionate nasal  1  spry ; methylphenidate  10  mg ; zovia 1 35e (28)  0  tab ; nexium  40  mg ; methylphenidate  20  mg ; trazodone  50-100  mg ; lamotrigine  25  mg ; 
unspecified viral infection attention deficit disorder without mention of hyperactivity unspecified episodic mood disorder cannabis abuse, unspecified
white f 32 $nan$nan$aluminum-magnesium hydrox.-simethicone  30  ml ; milk of magnesia  30  ml ; acetaminophen  650  mg ; albuterol mdi  1-2  puff ; fluticasone propionate nasal  1  spry ; methylphenidate  10  mg ; zovia 1 35e (28)  0  tab ; nexium  40  mg ; methylphenidate  20  mg ; trazodone  50-100  mg ; lamotrigine  25  mg ; 
unspecified viral infection attention deficit disorder without mention of hyperactivity unspecified episodic mood disorder cannabis abuse, unspecified
white f 32 $nan$chemistry blood bilirubin, total  0.2  mg dl; chemistry blood lactate dehydrogenase (ld)  169  iu l$aluminum-magnesium hydrox.-simethicone  30  ml ; milk of magnesia  30  ml ; acetaminophen  650  mg ; albuterol mdi  1-2  puff ; fluticasone propionate nasal  1  spry ; methylphenidate  10  mg ; zovia 1 35e (28)  0  tab ; nexium  40  mg ; methylphenidate  20  mg ; trazodone  50-100  mg ; lamotrigine  25  mg ; 
unspecified viral infection attention deficit disorder without mention of hyperactivity unspecified episodic mood disorder cannabis abuse, unspecified
unknown m 76 $nan$hematology blood hematocrit  38.6  %; hematology blood hematocrit  34.8  %; hematology blood hemoglobin  11.9  g dl; hematology blood hemoglobin  10.6  g dl; hematology blood platelet count  147  k ul; hematology blood platelet count  116  k ul; chemistry blood anion gap  8  meq l; chemistry blood anion gap  10  meq l; chemistry blood bicarbonate  25  meq l; chemistry blood bicarbonate  25  meq l; chemistry blood chloride  108  meq l; chemistry blood chloride  106  meq l; chemistry blood creatinine  1.0  mg dl; chemistry blood creatinine  1.0  mg dl; chemistry blood potassium  4.3  meq l; chemistry blood potassium  4.4  meq l; chemistry blood sodium  141  meq l; chemistry blood sodium  141  meq l; chemistry blood urea nitrogen  24  mg dl; chemistry blood urea nitrogen  22  mg dl; hematology blood inr(pt)  1.2  ; hematology blood inr(pt)  1.2  ; chemistry blood calcium, total  8.2  mg dl; chemistry blood bilirubin, total  0.7  mg dl; chemistry blood glucose  88  mg dl; chemistry blood albumin  3.8  g dl$clopidogrel  75  mg ; aspirin  325  mg ; clopidogrel  300  mg ; acetaminophen  650  mg ; ondansetron  4  mg ; sodium chloride 0.9%  flush  3-10  ml ; docusate sodium  100  mg ; heparin  5000  unit ; bag  1  bag ; magnesium sulfate  2  gm ; magnesium sulfate  4  gm ; potassium chloride replacement (critical care and oncology)   40  meq ; potassium chloride replacement (critical care and oncology)   60  meq ; potassium chloride replacement (critical care and oncology)   80  meq ; 0.9% sodium chloride  100  ml ; calcium gluconate  2  g ; 0.9% sodium chloride  250  ml ; calcium gluconate  4  g ; 5% dextrose  100  ml ; cefazolin  2  g ; ramelteon  8  mg ; allopurinol  300  mg ; atorvastatin  40  mg ; divalproex (delayed release)  250  mg ; ferrous sulfate  650  mg ; multivitamins  1  tab ; vitamin d  2000  unit ; senna  8.6  mg ; metoprolol succinate xl  25  mg ; 
 
unknown m 76 $nan$hematology blood hematocrit  36.1  %; hematology blood hemoglobin  11.1  g dl; hematology blood platelet count  119  k ul; chemistry blood anion gap  9  meq l; chemistry blood anion gap  9  meq l; chemistry blood bicarbonate  28  meq l; chemistry blood bicarbonate  31  meq l; chemistry blood chloride  105  meq l; chemistry blood chloride  103  meq l; chemistry blood creatinine  1.0  mg dl; chemistry blood creatinine  1.0  mg dl; chemistry blood potassium  4.3  meq l; chemistry blood potassium  4.3  meq l; chemistry blood sodium  142  meq l; chemistry blood sodium  143  meq l; chemistry blood urea nitrogen  20  mg dl; chemistry blood urea nitrogen  21  mg dl; hematology blood inr(pt)  1.1  ; chemistry blood calcium, total  8.4  mg dl; chemistry blood calcium, total  8.5  mg dl; chemistry blood bilirubin, total  0.5  mg dl; chemistry blood glucose  112  mg dl; chemistry blood glucose  92  mg dl$clopidogrel  75  mg ; aspirin  325  mg ; clopidogrel  300  mg ; acetaminophen  650  mg ; ondansetron  4  mg ; sodium chloride 0.9%  flush  3-10  ml ; docusate sodium  100  mg ; heparin  5000  unit ; bag  1  bag ; magnesium sulfate  2  gm ; magnesium sulfate  4  gm ; potassium chloride replacement (critical care and oncology)   40  meq ; potassium chloride replacement (critical care and oncology)   60  meq ; potassium chloride replacement (critical care and oncology)   80  meq ; 0.9% sodium chloride  100  ml ; calcium gluconate  2  g ; 0.9% sodium chloride  250  ml ; calcium gluconate  4  g ; 5% dextrose  100  ml ; cefazolin  2  g ; ramelteon  8  mg ; allopurinol  300  mg ; atorvastatin  40  mg ; divalproex (delayed release)  250  mg ; multivitamins  1  tab ; vitamin d  2000  unit ; senna  8.6  mg ; metoprolol succinate xl  25  mg ; aspirin  81  mg ; fenofibrate  145  mg ; ferrous sulfate  325  mg ; furosemide  20  mg ; fluticasone-salmeterol diskus (100 50)  1  inh ; 
 
unknown m 76 $nan$hematology blood hematocrit  34.9  %; hematology blood hemoglobin  10.8  g dl; hematology blood platelet count  106  k ul; chemistry blood anion gap  8  meq l; chemistry blood bicarbonate  29  meq l; chemistry blood chloride  107  meq l; chemistry blood creatinine  0.9  mg dl; chemistry blood potassium  4.1  meq l; chemistry blood sodium  144  meq l; chemistry blood urea nitrogen  21  mg dl; chemistry blood calcium, total  8.5  mg dl; chemistry blood bilirubin, total  0.5  mg dl; chemistry blood glucose  102  mg dl; chemistry blood lactate dehydrogenase (ld)  234  iu l$clopidogrel  75  mg ; acetaminophen  650  mg ; ondansetron  4  mg ; sodium chloride 0.9%  flush  3-10  ml ; docusate sodium  100  mg ; magnesium sulfate  4  gm ; potassium chloride replacement (critical care and oncology)   40  meq ; potassium chloride replacement (critical care and oncology)   60  meq ; potassium chloride replacement (critical care and oncology)   80  meq ; 0.9% sodium chloride  100  ml ; calcium gluconate  2  g ; 0.9% sodium chloride  250  ml ; calcium gluconate  4  g ; ramelteon  8  mg ; allopurinol  300  mg ; atorvastatin  40  mg ; divalproex (delayed release)  250  mg ; multivitamins  1  tab ; vitamin d  2000  unit ; senna  8.6  mg ; metoprolol succinate xl  25  mg ; aspirin  81  mg ; fenofibrate  145  mg ; ferrous sulfate  325  mg ; furosemide  20  mg ; fluticasone-salmeterol diskus (100 50)  1  inh ; sodium chloride 0.9%  flush  10  ml ; ipratropium-albuterol neb  1  neb ; 
 
unknown m 76 $nan$hematology blood hematocrit  34.3  %; hematology blood hemoglobin  10.5  g dl; hematology blood platelet count  100  k ul; chemistry blood anion gap  10  meq l; chemistry blood bicarbonate  26  meq l; chemistry blood chloride  106  meq l; chemistry blood creatinine  0.8  mg dl; chemistry blood potassium  4.3  meq l; chemistry blood sodium  142  meq l; chemistry blood urea nitrogen  21  mg dl; chemistry blood calcium, total  8.4  mg dl; chemistry blood glucose  105  mg dl$clopidogrel  75  mg ; acetaminophen  650  mg ; ondansetron  4  mg ; sodium chloride 0.9%  flush  3-10  ml ; docusate sodium  100  mg ; ramelteon  8  mg ; allopurinol  300  mg ; atorvastatin  40  mg ; divalproex (delayed release)  250  mg ; multivitamins  1  tab ; vitamin d  2000  unit ; senna  8.6  mg ; aspirin  81  mg ; fenofibrate  145  mg ; ferrous sulfate  325  mg ; fluticasone-salmeterol diskus (100 50)  1  inh ; sodium chloride 0.9%  flush  10  ml ; ipratropium-albuterol neb  1  neb ; leflunomide  20  mg ; 
 
white m 58 $temp  96.5  heartrate  98.0  resprate  24.0  o2sat  99.0  sbp  128.0  dbp  72.0  rhythm    pain  8  ; temp  98.4  heartrate  89.0  resprate  24.0  o2sat  97.0  sbp  146.0  dbp  86.0  rhythm    pain  8  ; temp    heartrate  76.0  resprate  20.0  o2sat  97.0  sbp  143.0  dbp  80.0  rhythm    pain  2  ; temp  98.6  heartrate  78.0  resprate  16.0  o2sat  98.0  sbp  126.0  dbp  71.0  rhythm    pain  0  $hematology blood hematocrit  42.5  %; hematology blood hemoglobin  14.4  g dl; hematology blood platelet count  212  k ul; chemistry blood anion gap  25  meq l; chemistry blood bicarbonate  16  meq l; chemistry blood chloride  101  meq l; chemistry blood creatinine  1.1  mg dl; chemistry blood potassium  4.0  meq l; chemistry blood sodium  142  meq l; chemistry blood urea nitrogen  16  mg dl; chemistry blood calcium, total  9.6  mg dl; chemistry blood bilirubin, total  0.8  mg dl; chemistry blood glucose  143  mg dl; chemistry blood albumin  4.3  g dl; blood gas blood lactate  6.1  mmol l; blood gas blood lactate  7.0  mmol l$nan
 
white m 58 $temp    heartrate  74.0  resprate  16.0  o2sat  97.0  sbp  128.0  dbp  74.0  rhythm    pain  0  ; temp  98.4  heartrate  79.0  resprate  16.0  o2sat  98.0  sbp  113.0  dbp  75.0  rhythm    pain  0  ; temp    heartrate  70.0  resprate  16.0  o2sat  95.0  sbp  116.0  dbp  61.0  rhythm    pain  0  ; temp  98.5  heartrate  55.0  resprate  18.0  o2sat  96.0  sbp  122.0  dbp  70.0  rhythm    pain  0  ; temp  98.2  heartrate  67.0  resprate  18.0  o2sat  97.0  sbp  106.0  dbp  66.0  rhythm    pain    $chemistry blood anion gap  12  meq l; chemistry blood bicarbonate  24  meq l; chemistry blood chloride  109  meq l; chemistry blood creatinine  0.9  mg dl; chemistry blood potassium  3.9  meq l; chemistry blood sodium  145  meq l; chemistry blood urea nitrogen  11  mg dl; chemistry blood calcium, total  9.2  mg dl; chemistry blood bilirubin, total  0.5  mg dl; chemistry blood glucose  106  mg dl; chemistry blood albumin  3.8  g dl$heparin  5000  unit ; sodium chloride 0.9%  flush  3-10  ml ; lactated ringers  1000  ml ; senna  8.6  mg ; docusate sodium  100  mg ; acetaminophen  650  mg ; 
 
white m 58 $nan$hematology blood hematocrit  40.9  %; hematology blood hemoglobin  13.0  g dl; hematology blood platelet count  181  k ul; chemistry blood anion gap  13  meq l; chemistry blood bicarbonate  26  meq l; chemistry blood chloride  108  meq l; chemistry blood creatinine  0.9  mg dl; chemistry blood potassium  4.3  meq l; chemistry blood sodium  147  meq l; chemistry blood urea nitrogen  8  mg dl; hematology blood inr(pt)  1.3  ; chemistry blood calcium, total  8.9  mg dl; chemistry blood bilirubin, total  0.6  mg dl; chemistry blood glucose  79  mg dl$heparin  5000  unit ; sodium chloride 0.9%  flush  3-10  ml ; lactated ringers  1000  ml ; senna  8.6  mg ; docusate sodium  100  mg ; acetaminophen  650  mg ; 
 
black african american f 57 $nan$hematology blood hematocrit  33.1  %; hematology blood hematocrit  33.5  %; hematology blood hematocrit  33.2  %; hematology blood hematocrit  32.4  %; hematology blood hemoglobin  10.8  g dl; hematology blood hemoglobin  10.6  g dl; hematology blood hemoglobin  10.5  g dl; hematology blood hemoglobin  10.2  g dl; hematology blood platelet count  233  k ul; hematology blood platelet count  226  k ul; hematology blood platelet count  222  k ul; hematology blood platelet count  195  k ul; chemistry blood anion gap  14  meq l; chemistry blood bicarbonate  27  meq l; chemistry blood chloride  102  meq l; chemistry blood creatinine  0.5  mg dl; chemistry blood potassium  3.5  meq l; chemistry blood sodium  139  meq l; chemistry blood urea nitrogen  10  mg dl; chemistry blood calcium, total  8.7  mg dl; chemistry blood glucose  152  mg dl$sodium chloride 0.9%  flush  3  ml ; d5 1 2ns  1000  ml ; hydromorphone (dilaudid)  0.5  mg ; 0.9% sodium chloride  100  ml ; hydromorphone  20  mg ; dextrose 50%  12.5  gm ; glucagon  1  mg ; glucose gel  15  g ; sw  400  ml ; potassium chloride  40  meq ; sw  600  ml ; potassium chloride  60  meq ; sw  800  ml ; potassium chloride  80  meq ; 0.9% sodium chloride  1  bag ; calcium gluconate  2  g ; 0.9% sodium chloride  2  bag ; calcium gluconate  4  g ; bag  1  bag ; magnesium sulfate  2  gm ; bag  2  bag ; magnesium sulfate  4  gm ; iso-osmotic sodium chloride  1  bag ; famotidine  20  mg ; acetaminophen iv  1000  mg ; insulin  0  unit ; sterile water  100  ml ; sterile water  150  ml ; sterile water  200  ml ; sodium chloride 0.9%  flush  10  ml ; ondansetron  4  mg ; 
 
black african american f 57 $nan$hematology blood hematocrit  33.6  %; hematology blood hemoglobin  10.9  g dl; hematology blood platelet count  221  k ul; chemistry blood anion gap  13  meq l; chemistry blood bicarbonate  27  meq l; chemistry blood chloride  102  meq l; chemistry blood creatinine  0.5  mg dl; chemistry blood potassium  3.7  meq l; chemistry blood sodium  138  meq l; chemistry blood urea nitrogen  8  mg dl; chemistry blood calcium, total  8.7  mg dl; chemistry blood glucose  106  mg dl$sodium chloride 0.9%  flush  3  ml ; d5 1 2ns  1000  ml ; 0.9% sodium chloride  100  ml ; hydromorphone  20  mg ; dextrose 50%  12.5  gm ; glucagon  1  mg ; glucose gel  15  g ; 0.9% sodium chloride  1  bag ; calcium gluconate  2  g ; 0.9% sodium chloride  2  bag ; calcium gluconate  4  g ; bag  1  bag ; magnesium sulfate  2  gm ; bag  2  bag ; magnesium sulfate  4  gm ; iso-osmotic sodium chloride  1  bag ; famotidine  20  mg ; acetaminophen iv  1000  mg ; insulin  0  unit ; sterile water  100  ml ; sterile water  150  ml ; sterile water  200  ml ; sodium chloride 0.9%  flush  10  ml ; ondansetron  4  mg ; oxycodone (immediate release)  5  mg ; oxycodone (immediate release)  5-10  mg ; 
 
black african american f 57 $nan$hematology blood hematocrit  34.6  %; hematology blood hemoglobin  11.2  g dl; hematology blood platelet count  224  k ul$sodium chloride 0.9%  flush  3  ml ; dextrose 50%  12.5  gm ; glucagon  1  mg ; glucose gel  15  g ; 0.9% sodium chloride  1  bag ; calcium gluconate  2  g ; 0.9% sodium chloride  2  bag ; calcium gluconate  4  g ; bag  1  bag ; magnesium sulfate  2  gm ; bag  2  bag ; magnesium sulfate  4  gm ; insulin  0  unit ; sterile water  100  ml ; sterile water  150  ml ; sterile water  200  ml ; sodium chloride 0.9%  flush  10  ml ; ondansetron  4  mg ; oxycodone (immediate release)  5-10  mg ; heparin  5000  unit ; acetaminophen  325-650  mg ; tramadol  50  mg ; senna  8.6  mg ; 
 
black african american f 57 $nan$nan$dextrose 50%  12.5  gm ; glucagon  1  mg ; glucose gel  15  g ; insulin  0  unit ; ondansetron  4  mg ; heparin  5000  unit ; acetaminophen  325-650  mg ; tramadol  50  mg ; senna  8.6  mg ; docusate sodium  100  mg ; lidocaine 5% patch  1  ptch ; acetaminophen  1000  mg ; hydromorphone (dilaudid)  2-4  mg ; acetaminophen  650  mg ; 
 
black african american f 57 $nan$nan$dextrose 50%  12.5  gm ; glucagon  1  mg ; glucose gel  15  g ; insulin  0  unit ; ondansetron  4  mg ; heparin  5000  unit ; senna  8.6  mg ; docusate sodium  100  mg ; lidocaine 5% patch  1  ptch ; hydromorphone (dilaudid)  2-4  mg ; acetaminophen  650  mg ; 
 
white m 60 $temp  98.8  heartrate  67.0  resprate  16.0  o2sat  98.0  sbp  123.0  dbp  66.0  rhythm    pain  0  $hematology blood hematocrit  27.3  %; hematology blood hemoglobin  8.6  g dl; hematology blood platelet count  271  k ul; chemistry blood anion gap  16  meq l; chemistry blood bicarbonate  16  meq l; chemistry blood chloride  109  meq l; chemistry blood creatinine  1.9  mg dl; chemistry blood potassium  3.5  meq l; chemistry blood sodium  141  meq l; chemistry blood urea nitrogen  47  mg dl; chemistry blood calcium, total  8.3  mg dl; chemistry blood glucose  108  mg dl$sodium chloride 0.9%  flush  3-10  ml ; lactated ringers  1000  ml ; iso-osmotic dextrose  100  ml ; cefazolin  2  g ; acetaminophen  1000  mg ; morphine sulfate  1-2  mg ; oxycodone (immediate release)  5  mg ; allopurinol  300  mg ; amlodipine  2.5  mg ; pravastatin  80  mg ; ranitidine  150  mg ; docusate sodium  100  mg ; bisacodyl  10  mg ; senna  8.6  mg ; fenofibrate  145  mg ; tamsulosin  0.4  mg ; valsartan-hydrochlorothiazide  1  tab ; 
 
white m 60 $nan$hematology blood hematocrit  23.2  %; hematology blood hematocrit  27.2  %; hematology blood hemoglobin  7.3  g dl; hematology blood hemoglobin  8.6  g dl; hematology blood platelet count  258  k ul; hematology blood platelet count  239  k ul; chemistry blood anion gap  14  meq l; chemistry blood anion gap  13  meq l; chemistry blood bicarbonate  18  meq l; chemistry blood bicarbonate  17  meq l; chemistry blood chloride  110  meq l; chemistry blood chloride  107  meq l; chemistry blood creatinine  1.6  mg dl; chemistry blood creatinine  1.3  mg dl; chemistry blood potassium  3.1  meq l; chemistry blood potassium  3.8  meq l; chemistry blood sodium  142  meq l; chemistry blood sodium  137  meq l; chemistry blood urea nitrogen  36  mg dl; chemistry blood urea nitrogen  32  mg dl; chemistry blood calcium, total  8.5  mg dl; chemistry blood calcium, total  8.8  mg dl; chemistry blood glucose  100  mg dl; chemistry blood glucose  114  mg dl$sodium chloride 0.9%  flush  3-10  ml ; acetaminophen  1000  mg ; morphine sulfate  1-2  mg ; oxycodone (immediate release)  5  mg ; allopurinol  300  mg ; amlodipine  2.5  mg ; pravastatin  80  mg ; ranitidine  150  mg ; docusate sodium  100  mg ; bisacodyl  10  mg ; senna  8.6  mg ; fenofibrate  145  mg ; tamsulosin  0.4  mg ; valsartan-hydrochlorothiazide  1  tab ; aspirin  325  mg ; 5% dextrose  500  ml ; potassium chloride  40  meq ; potassium chloride  20  meq ; 
 
white m 60 $nan$hematology blood hematocrit  25.8  %; hematology blood hemoglobin  8.1  g dl; hematology blood platelet count  251  k ul; chemistry blood anion gap  16  meq l; chemistry blood bicarbonate  15  meq l; chemistry blood chloride  111  meq l; chemistry blood creatinine  1.3  mg dl; chemistry blood potassium  3.9  meq l; chemistry blood sodium  142  meq l; chemistry blood urea nitrogen  27  mg dl; chemistry blood calcium, total  8.8  mg dl; chemistry blood glucose  94  mg dl$sodium chloride 0.9%  flush  3-10  ml ; acetaminophen  1000  mg ; morphine sulfate  1-2  mg ; oxycodone (immediate release)  5  mg ; allopurinol  300  mg ; amlodipine  2.5  mg ; pravastatin  80  mg ; ranitidine  150  mg ; docusate sodium  100  mg ; bisacodyl  10  mg ; senna  8.6  mg ; fenofibrate  145  mg ; tamsulosin  0.4  mg ; valsartan-hydrochlorothiazide  1  tab ; aspirin  325  mg ; 5% dextrose  500  ml ; potassium chloride  40  meq ; potassium chloride  20  meq ; diphenhydramine  25  mg ; 
 
white f 49 $temp  99.7  heartrate  78.0  resprate  16.0  o2sat  98.0  sbp  94.0  dbp  54.0  rhythm    pain  3  ; temp  99.7  heartrate  78.0  resprate  16.0  o2sat  98.0  sbp  94.0  dbp  54.0  rhythm    pain  3  $hematology blood hematocrit  30.7  %; hematology blood hemoglobin  9.9  g dl; hematology blood platelet count  159  k ul; chemistry blood anion gap  14  meq l; chemistry blood bicarbonate  24  meq l; chemistry blood chloride  104  meq l; chemistry blood creatinine  0.6  mg dl; chemistry blood potassium  3.3  meq l; chemistry blood sodium  139  meq l; chemistry blood urea nitrogen  7  mg dl; chemistry blood calcium, total  8.1  mg dl; chemistry blood glucose  89  mg dl$sodium chloride 0.9%  flush  3  ml ; heparin  5000  unit ; sodium chloride 0.9%  1000  ml ; acetaminophen  650  mg ; ondansetron  4  mg ; iso-osmotic dextrose  150  ml ; vancomycin  750  mg ; iso-osmotic dextrose  100  ml ; cefazolin  2  g ; ibuprofen  600  mg ; oxycodone (immediate release)  5-10  mg ; acetaminophen  1000  mg ; 
regional enteritis of unspecified site ileostomy status hydronephrosis malignant neoplasm of ovary pelvic peritoneal adhesions, female (postoperative) (postinfection) acute kidney failure, unspecified other ureteric obstruction person on outside of car injured in collision with heavy transport vehicle or bus in nontraffic accident
white f 49 $nan$hematology blood hematocrit  32.2  %; hematology blood hemoglobin  10.3  g dl; hematology blood platelet count  190  k ul; chemistry blood anion gap  13  meq l; chemistry blood bicarbonate  26  meq l; chemistry blood chloride  106  meq l; chemistry blood creatinine  0.6  mg dl; chemistry blood potassium  3.8  meq l; chemistry blood sodium  141  meq l; chemistry blood urea nitrogen  7  mg dl; chemistry blood calcium, total  8.4  mg dl; chemistry blood glucose  80  mg dl$sodium chloride 0.9%  flush  3  ml ; heparin  5000  unit ; sodium chloride 0.9%  1000  ml ; ondansetron  4  mg ; iso-osmotic dextrose  150  ml ; vancomycin  750  mg ; iso-osmotic dextrose  100  ml ; cefazolin  2  g ; oxycodone (immediate release)  5-10  mg ; acetaminophen  1000  mg ; sulfameth trimethoprim ds  2  tab ; 
regional enteritis of unspecified site ileostomy status hydronephrosis malignant neoplasm of ovary pelvic peritoneal adhesions, female (postoperative) (postinfection) acute kidney failure, unspecified other ureteric obstruction person on outside of car injured in collision with heavy transport vehicle or bus in nontraffic accident
white f 49 $nan$hematology blood hematocrit  32.2  %; hematology blood hemoglobin  10.2  g dl; hematology blood platelet count  208  k ul; chemistry blood anion gap  14  meq l; chemistry blood bicarbonate  26  meq l; chemistry blood chloride  106  meq l; chemistry blood creatinine  0.7  mg dl; chemistry blood potassium  4.1  meq l; chemistry blood sodium  142  meq l; chemistry blood urea nitrogen  5  mg dl; chemistry blood calcium, total  8.5  mg dl; chemistry blood glucose  79  mg dl$sodium chloride 0.9%  flush  3  ml ; heparin  5000  unit ; ondansetron  4  mg ; iso-osmotic dextrose  100  ml ; cefazolin  2  g ; oxycodone (immediate release)  5-10  mg ; acetaminophen  1000  mg ; cephalexin  500  mg ; iso-osmotic dextrose  200  ml ; vancomycin  1000  mg ; 
regional enteritis of unspecified site ileostomy status hydronephrosis malignant neoplasm of ovary pelvic peritoneal adhesions, female (postoperative) (postinfection) acute kidney failure, unspecified other ureteric obstruction person on outside of car injured in collision with heavy transport vehicle or bus in nontraffic accident
white f 65 $temp  98.6  heartrate  93.0  resprate  18.0  o2sat  96.0  sbp  127.0  dbp  70.0  rhythm    pain    $hematology blood hematocrit  26.3  %; hematology blood hemoglobin  8.1  g dl; hematology blood platelet count  605  k ul; chemistry blood anion gap  16  meq l; chemistry blood bicarbonate  26  meq l; chemistry blood chloride  100  meq l; chemistry blood creatinine  0.5  mg dl; chemistry blood potassium  3.6  meq l; chemistry blood sodium  138  meq l; chemistry blood calcium, total  8.3  mg dl; chemistry blood glucose  93  mg dl$sodium chloride 0.9%  flush  3  ml ; lactated ringers  1000  ml ; acetaminophen  650  mg ; heparin  5000  unit ; cyclobenzaprine  10  mg ; omeprazole  40  mg ; aspirin  81  mg ; ondansetron  4-8  mg ; hydromorphone (dilaudid)  2-4  mg ; potassium chloride (powder)  40  meq ; bag  2  bag ; magnesium sulfate  4  gm ; potassium chloride  40  meq ; metoclopramide  10  mg ; nystatin cream  1  appl ; 
acidosis fibromyalgia body mass index (bmi) 37.0-37.9, adult obesity, unspecified systemic lupus erythematosus, unspecified presence of left artificial knee joint acute respiratory failure, unspecified whether with hypoxia or hypercapnia intestinal adhesions [bands] with obstruction (postinfection) physical restraint status pneumonia due to klebsiella pneumoniae other ascites anuria and oliguria hypothyroidism, unspecified ileus, unspecified rheumatoid arthritis without rheumatoid factor, multiple sites other urogenital candidiasis postprocedural hypotension gastro-esophageal reflux disease without esophagitis iron deficiency anemia, unspecified personal history of nicotine dependence fever, unspecified unspecified intestinal obstruction rheumatoid arthritis without rheumatoid factor, unspecified site dehydration iron deficiency anemia, unspecified fibromyalgia hypothyroidism, unspecified myalgia and myositis, unspecified rheumatoid arthritis esophageal reflux osteoarthrosis, localized, not specified whether primary or secondary, lower leg body mass index 37.0-37.9, adult iron deficiency anemia, unspecified unspecified acquired hypothyroidism right bundle branch block obesity, unspecified myalgia and myositis, unspecified rheumatoid arthritis bacteremia other vitamin b12 deficiency anemia intestinal infection due to campylobacter iron deficiency anemia, unspecified other and unspecified postsurgical nonabsorption pneumonia, organism unspecified unspecified acquired hypothyroidism iron deficiency anemia, unspecified unspecified car occupant injured in collision with railway train or railway vehicle in nontraffic accident intestinal bypass or anastomosis status
white f 65 $nan$hematology blood hematocrit  27.0  %; hematology blood hemoglobin  8.4  g dl; hematology blood platelet count  634  k ul; chemistry blood anion gap  14  meq l; chemistry blood bicarbonate  27  meq l; chemistry blood chloride  98  meq l; chemistry blood creatinine  0.5  mg dl; chemistry blood potassium  4.1  meq l; chemistry blood sodium  135  meq l; chemistry blood urea nitrogen  3  mg dl; hematology blood inr(pt)  1.1  ; chemistry blood calcium, total  8.4  mg dl; chemistry blood glucose  94  mg dl; chemistry blood albumin  2.9  g dl$sodium chloride 0.9%  flush  3  ml ; acetaminophen  650  mg ; heparin  5000  unit ; cyclobenzaprine  10  mg ; omeprazole  40  mg ; aspirin  81  mg ; ondansetron  4-8  mg ; hydromorphone (dilaudid)  2-4  mg ; metoclopramide  10  mg ; nystatin cream  1  appl ; metoclopramide  5  mg ; levothyroxine sodium  125  mcg ; d5 1 2ns  1000  ml ; 
acidosis fibromyalgia body mass index (bmi) 37.0-37.9, adult obesity, unspecified systemic lupus erythematosus, unspecified presence of left artificial knee joint acute respiratory failure, unspecified whether with hypoxia or hypercapnia intestinal adhesions [bands] with obstruction (postinfection) physical restraint status pneumonia due to klebsiella pneumoniae other ascites anuria and oliguria hypothyroidism, unspecified ileus, unspecified rheumatoid arthritis without rheumatoid factor, multiple sites other urogenital candidiasis postprocedural hypotension gastro-esophageal reflux disease without esophagitis iron deficiency anemia, unspecified personal history of nicotine dependence fever, unspecified unspecified intestinal obstruction rheumatoid arthritis without rheumatoid factor, unspecified site dehydration iron deficiency anemia, unspecified fibromyalgia hypothyroidism, unspecified myalgia and myositis, unspecified rheumatoid arthritis esophageal reflux osteoarthrosis, localized, not specified whether primary or secondary, lower leg body mass index 37.0-37.9, adult iron deficiency anemia, unspecified unspecified acquired hypothyroidism right bundle branch block obesity, unspecified myalgia and myositis, unspecified rheumatoid arthritis bacteremia other vitamin b12 deficiency anemia intestinal infection due to campylobacter iron deficiency anemia, unspecified other and unspecified postsurgical nonabsorption pneumonia, organism unspecified unspecified acquired hypothyroidism iron deficiency anemia, unspecified unspecified car occupant injured in collision with railway train or railway vehicle in nontraffic accident intestinal bypass or anastomosis status
white f 65 $nan$hematology blood hematocrit  27.0  %; hematology blood hemoglobin  8.3  g dl; hematology blood platelet count  644  k ul; chemistry blood anion gap  15  meq l; chemistry blood bicarbonate  26  meq l; chemistry blood chloride  98  meq l; chemistry blood creatinine  0.6  mg dl; chemistry blood potassium  4.1  meq l; chemistry blood sodium  135  meq l; chemistry blood urea nitrogen  3  mg dl; chemistry blood calcium, total  8.1  mg dl; chemistry blood glucose  81  mg dl$sodium chloride 0.9%  flush  3  ml ; acetaminophen  650  mg ; heparin  5000  unit ; cyclobenzaprine  10  mg ; omeprazole  40  mg ; aspirin  81  mg ; ondansetron  4-8  mg ; hydromorphone (dilaudid)  2-4  mg ; nystatin cream  1  appl ; levothyroxine sodium  125  mcg ; senna  8.6  mg ; docusate sodium  100  mg ; bag  1  bag ; magnesium sulfate  2  gm ; 
acidosis fibromyalgia body mass index (bmi) 37.0-37.9, adult obesity, unspecified systemic lupus erythematosus, unspecified presence of left artificial knee joint acute respiratory failure, unspecified whether with hypoxia or hypercapnia intestinal adhesions [bands] with obstruction (postinfection) physical restraint status pneumonia due to klebsiella pneumoniae other ascites anuria and oliguria hypothyroidism, unspecified ileus, unspecified rheumatoid arthritis without rheumatoid factor, multiple sites other urogenital candidiasis postprocedural hypotension gastro-esophageal reflux disease without esophagitis iron deficiency anemia, unspecified personal history of nicotine dependence fever, unspecified unspecified intestinal obstruction rheumatoid arthritis without rheumatoid factor, unspecified site dehydration iron deficiency anemia, unspecified fibromyalgia hypothyroidism, unspecified myalgia and myositis, unspecified rheumatoid arthritis esophageal reflux osteoarthrosis, localized, not specified whether primary or secondary, lower leg body mass index 37.0-37.9, adult iron deficiency anemia, unspecified unspecified acquired hypothyroidism right bundle branch block obesity, unspecified myalgia and myositis, unspecified rheumatoid arthritis bacteremia other vitamin b12 deficiency anemia intestinal infection due to campylobacter iron deficiency anemia, unspecified other and unspecified postsurgical nonabsorption pneumonia, organism unspecified unspecified acquired hypothyroidism iron deficiency anemia, unspecified unspecified car occupant injured in collision with railway train or railway vehicle in nontraffic accident intestinal bypass or anastomosis status
white f 65 $nan$hematology blood hematocrit  29.2  %; hematology blood hemoglobin  8.9  g dl; hematology blood platelet count  669  k ul; chemistry blood anion gap  16  meq l; chemistry blood bicarbonate  25  meq l; chemistry blood chloride  100  meq l; chemistry blood creatinine  0.6  mg dl; chemistry blood potassium  4.2  meq l; chemistry blood sodium  137  meq l; chemistry blood urea nitrogen  4  mg dl; chemistry blood calcium, total  8.2  mg dl; chemistry blood glucose  82  mg dl$sodium chloride 0.9%  flush  3  ml ; acetaminophen  650  mg ; heparin  5000  unit ; cyclobenzaprine  10  mg ; omeprazole  40  mg ; aspirin  81  mg ; ondansetron  4-8  mg ; hydromorphone (dilaudid)  2-4  mg ; nystatin cream  1  appl ; levothyroxine sodium  125  mcg ; senna  8.6  mg ; docusate sodium  100  mg ; bag  1  bag ; magnesium sulfate  2  gm ; levothyroxine sodium  250  mcg ; dronabinol  5  mg ; 
acidosis fibromyalgia body mass index (bmi) 37.0-37.9, adult obesity, unspecified systemic lupus erythematosus, unspecified presence of left artificial knee joint acute respiratory failure, unspecified whether with hypoxia or hypercapnia intestinal adhesions [bands] with obstruction (postinfection) physical restraint status pneumonia due to klebsiella pneumoniae other ascites anuria and oliguria hypothyroidism, unspecified ileus, unspecified rheumatoid arthritis without rheumatoid factor, multiple sites other urogenital candidiasis postprocedural hypotension gastro-esophageal reflux disease without esophagitis iron deficiency anemia, unspecified personal history of nicotine dependence fever, unspecified unspecified intestinal obstruction rheumatoid arthritis without rheumatoid factor, unspecified site dehydration iron deficiency anemia, unspecified fibromyalgia hypothyroidism, unspecified myalgia and myositis, unspecified rheumatoid arthritis esophageal reflux osteoarthrosis, localized, not specified whether primary or secondary, lower leg body mass index 37.0-37.9, adult iron deficiency anemia, unspecified unspecified acquired hypothyroidism right bundle branch block obesity, unspecified myalgia and myositis, unspecified rheumatoid arthritis bacteremia other vitamin b12 deficiency anemia intestinal infection due to campylobacter iron deficiency anemia, unspecified other and unspecified postsurgical nonabsorption pneumonia, organism unspecified unspecified acquired hypothyroidism iron deficiency anemia, unspecified unspecified car occupant injured in collision with railway train or railway vehicle in nontraffic accident intestinal bypass or anastomosis status
white f 65 $nan$hematology blood hematocrit  29.9  %; hematology blood hemoglobin  9.3  g dl; hematology blood platelet count  681  k ul; chemistry blood anion gap  13  meq l; chemistry blood bicarbonate  27  meq l; chemistry blood chloride  97  meq l; chemistry blood creatinine  0.5  mg dl; chemistry blood potassium  4.2  meq l; chemistry blood sodium  133  meq l; chemistry blood urea nitrogen  5  mg dl; chemistry blood calcium, total  8.7  mg dl; chemistry blood glucose  105  mg dl$sodium chloride 0.9%  flush  3  ml ; acetaminophen  650  mg ; heparin  5000  unit ; cyclobenzaprine  10  mg ; aspirin  81  mg ; ondansetron  4-8  mg ; hydromorphone (dilaudid)  2-4  mg ; nystatin cream  1  appl ; levothyroxine sodium  125  mcg ; senna  8.6  mg ; docusate sodium  100  mg ; levothyroxine sodium  250  mcg ; dronabinol  5  mg ; lidocaine 1%  10  ml ; 
acidosis fibromyalgia body mass index (bmi) 37.0-37.9, adult obesity, unspecified systemic lupus erythematosus, unspecified presence of left artificial knee joint acute respiratory failure, unspecified whether with hypoxia or hypercapnia intestinal adhesions [bands] with obstruction (postinfection) physical restraint status pneumonia due to klebsiella pneumoniae other ascites anuria and oliguria hypothyroidism, unspecified ileus, unspecified rheumatoid arthritis without rheumatoid factor, multiple sites other urogenital candidiasis postprocedural hypotension gastro-esophageal reflux disease without esophagitis iron deficiency anemia, unspecified personal history of nicotine dependence fever, unspecified unspecified intestinal obstruction rheumatoid arthritis without rheumatoid factor, unspecified site dehydration iron deficiency anemia, unspecified fibromyalgia hypothyroidism, unspecified myalgia and myositis, unspecified rheumatoid arthritis esophageal reflux osteoarthrosis, localized, not specified whether primary or secondary, lower leg body mass index 37.0-37.9, adult iron deficiency anemia, unspecified unspecified acquired hypothyroidism right bundle branch block obesity, unspecified myalgia and myositis, unspecified rheumatoid arthritis bacteremia other vitamin b12 deficiency anemia intestinal infection due to campylobacter iron deficiency anemia, unspecified other and unspecified postsurgical nonabsorption pneumonia, organism unspecified unspecified acquired hypothyroidism iron deficiency anemia, unspecified unspecified car occupant injured in collision with railway train or railway vehicle in nontraffic accident intestinal bypass or anastomosis status
white f 65 $nan$hematology blood hematocrit  29.8  %; hematology blood hemoglobin  9.1  g dl; hematology blood platelet count  651  k ul; chemistry blood anion gap  13  meq l; chemistry blood bicarbonate  27  meq l; chemistry blood chloride  102  meq l; chemistry blood creatinine  0.5  mg dl; chemistry blood potassium  4.4  meq l; chemistry blood sodium  138  meq l; chemistry blood urea nitrogen  6  mg dl; chemistry blood calcium, total  8.5  mg dl; chemistry blood glucose  112  mg dl$sodium chloride 0.9%  flush  3  ml ; acetaminophen  650  mg ; heparin  5000  unit ; cyclobenzaprine  10  mg ; aspirin  81  mg ; ondansetron  4-8  mg ; hydromorphone (dilaudid)  2-4  mg ; nystatin cream  1  appl ; levothyroxine sodium  125  mcg ; senna  8.6  mg ; docusate sodium  100  mg ; levothyroxine sodium  250  mcg ; dronabinol  5  mg ; lidocaine 1%  10  ml ; 
acidosis fibromyalgia body mass index (bmi) 37.0-37.9, adult obesity, unspecified systemic lupus erythematosus, unspecified presence of left artificial knee joint acute respiratory failure, unspecified whether with hypoxia or hypercapnia intestinal adhesions [bands] with obstruction (postinfection) physical restraint status pneumonia due to klebsiella pneumoniae other ascites anuria and oliguria hypothyroidism, unspecified ileus, unspecified rheumatoid arthritis without rheumatoid factor, multiple sites other urogenital candidiasis postprocedural hypotension gastro-esophageal reflux disease without esophagitis iron deficiency anemia, unspecified personal history of nicotine dependence fever, unspecified unspecified intestinal obstruction rheumatoid arthritis without rheumatoid factor, unspecified site dehydration iron deficiency anemia, unspecified fibromyalgia hypothyroidism, unspecified myalgia and myositis, unspecified rheumatoid arthritis esophageal reflux osteoarthrosis, localized, not specified whether primary or secondary, lower leg body mass index 37.0-37.9, adult iron deficiency anemia, unspecified unspecified acquired hypothyroidism right bundle branch block obesity, unspecified myalgia and myositis, unspecified rheumatoid arthritis bacteremia other vitamin b12 deficiency anemia intestinal infection due to campylobacter iron deficiency anemia, unspecified other and unspecified postsurgical nonabsorption pneumonia, organism unspecified unspecified acquired hypothyroidism iron deficiency anemia, unspecified unspecified car occupant injured in collision with railway train or railway vehicle in nontraffic accident intestinal bypass or anastomosis status
white f 65 $nan$chemistry blood anion gap  11  meq l; chemistry blood bicarbonate  28  meq l; chemistry blood chloride  101  meq l; chemistry blood creatinine  0.5  mg dl; chemistry blood potassium  3.9  meq l; chemistry blood sodium  136  meq l; chemistry blood urea nitrogen  7  mg dl; chemistry blood calcium, total  8.7  mg dl; chemistry blood glucose  93  mg dl$sodium chloride 0.9%  flush  3  ml ; acetaminophen  650  mg ; heparin  5000  unit ; cyclobenzaprine  10  mg ; aspirin  81  mg ; ondansetron  4-8  mg ; hydromorphone (dilaudid)  2-4  mg ; nystatin cream  1  appl ; levothyroxine sodium  125  mcg ; senna  8.6  mg ; docusate sodium  100  mg ; levothyroxine sodium  250  mcg ; dronabinol  5  mg ; collagenase ointment  1  appl ; 
acidosis fibromyalgia body mass index (bmi) 37.0-37.9, adult obesity, unspecified systemic lupus erythematosus, unspecified presence of left artificial knee joint acute respiratory failure, unspecified whether with hypoxia or hypercapnia intestinal adhesions [bands] with obstruction (postinfection) physical restraint status pneumonia due to klebsiella pneumoniae other ascites anuria and oliguria hypothyroidism, unspecified ileus, unspecified rheumatoid arthritis without rheumatoid factor, multiple sites other urogenital candidiasis postprocedural hypotension gastro-esophageal reflux disease without esophagitis iron deficiency anemia, unspecified personal history of nicotine dependence fever, unspecified unspecified intestinal obstruction rheumatoid arthritis without rheumatoid factor, unspecified site dehydration iron deficiency anemia, unspecified fibromyalgia hypothyroidism, unspecified myalgia and myositis, unspecified rheumatoid arthritis esophageal reflux osteoarthrosis, localized, not specified whether primary or secondary, lower leg body mass index 37.0-37.9, adult iron deficiency anemia, unspecified unspecified acquired hypothyroidism right bundle branch block obesity, unspecified myalgia and myositis, unspecified rheumatoid arthritis bacteremia other vitamin b12 deficiency anemia intestinal infection due to campylobacter iron deficiency anemia, unspecified other and unspecified postsurgical nonabsorption pneumonia, organism unspecified unspecified acquired hypothyroidism iron deficiency anemia, unspecified unspecified car occupant injured in collision with railway train or railway vehicle in nontraffic accident intestinal bypass or anastomosis status
white f 65 $nan$hematology blood hematocrit  29.3  %; hematology blood hemoglobin  9.2  g dl; hematology blood platelet count  599  k ul; chemistry blood anion gap  11  meq l; chemistry blood bicarbonate  28  meq l; chemistry blood chloride  97  meq l; chemistry blood creatinine  0.5  mg dl; chemistry blood potassium  4.1  meq l; chemistry blood sodium  132  meq l; chemistry blood urea nitrogen  8  mg dl; chemistry blood calcium, total  8.4  mg dl; chemistry blood bilirubin, total  0.5  mg dl; chemistry blood glucose  95  mg dl; chemistry blood albumin  2.8  g dl$sodium chloride 0.9%  flush  3  ml ; acetaminophen  650  mg ; heparin  5000  unit ; cyclobenzaprine  10  mg ; aspirin  81  mg ; ondansetron  4-8  mg ; hydromorphone (dilaudid)  2-4  mg ; nystatin cream  1  appl ; levothyroxine sodium  125  mcg ; senna  8.6  mg ; docusate sodium  100  mg ; levothyroxine sodium  250  mcg ; dronabinol  5  mg ; collagenase ointment  1  appl ; ondansetron  4  mg ; dakins 1 2 strength  1  appl ; heparin flush (10 units ml)  2  ml ; sodium chloride 0.9%  flush  20  ml ; lidocaine 1% (for picc midline insertions)  5  ml ; sodium chloride 0.9%  flush  10-20  ml ; 
acidosis fibromyalgia body mass index (bmi) 37.0-37.9, adult obesity, unspecified systemic lupus erythematosus, unspecified presence of left artificial knee joint acute respiratory failure, unspecified whether with hypoxia or hypercapnia intestinal adhesions [bands] with obstruction (postinfection) physical restraint status pneumonia due to klebsiella pneumoniae other ascites anuria and oliguria hypothyroidism, unspecified ileus, unspecified rheumatoid arthritis without rheumatoid factor, multiple sites other urogenital candidiasis postprocedural hypotension gastro-esophageal reflux disease without esophagitis iron deficiency anemia, unspecified personal history of nicotine dependence fever, unspecified unspecified intestinal obstruction rheumatoid arthritis without rheumatoid factor, unspecified site dehydration iron deficiency anemia, unspecified fibromyalgia hypothyroidism, unspecified myalgia and myositis, unspecified rheumatoid arthritis esophageal reflux osteoarthrosis, localized, not specified whether primary or secondary, lower leg body mass index 37.0-37.9, adult iron deficiency anemia, unspecified unspecified acquired hypothyroidism right bundle branch block obesity, unspecified myalgia and myositis, unspecified rheumatoid arthritis bacteremia other vitamin b12 deficiency anemia intestinal infection due to campylobacter iron deficiency anemia, unspecified other and unspecified postsurgical nonabsorption pneumonia, organism unspecified unspecified acquired hypothyroidism iron deficiency anemia, unspecified unspecified car occupant injured in collision with railway train or railway vehicle in nontraffic accident intestinal bypass or anastomosis status
white f 65 $nan$hematology blood hematocrit  29.8  %; hematology blood hemoglobin  9.5  g dl; hematology blood platelet count  559  k ul; chemistry blood anion gap  10  meq l; chemistry blood bicarbonate  22  meq l; chemistry blood chloride  106  meq l; chemistry blood creatinine  0.3  mg dl; chemistry blood potassium  3.3  meq l; chemistry blood sodium  135  meq l; chemistry blood urea nitrogen  8  mg dl; chemistry blood calcium, total  6.9  mg dl; chemistry blood glucose  78  mg dl$sodium chloride 0.9%  flush  3  ml ; acetaminophen  650  mg ; heparin  5000  unit ; cyclobenzaprine  10  mg ; aspirin  81  mg ; hydromorphone (dilaudid)  2-4  mg ; nystatin cream  1  appl ; levothyroxine sodium  125  mcg ; senna  8.6  mg ; docusate sodium  100  mg ; levothyroxine sodium  250  mcg ; dronabinol  5  mg ; collagenase ointment  1  appl ; dakins 1 2 strength  1  appl ; heparin flush (10 units ml)  2  ml ; sodium chloride 0.9%  flush  20  ml ; lidocaine 1% (for picc midline insertions)  5  ml ; sodium chloride 0.9%  flush  10-20  ml ; potassium chloride  60  meq ; 0.9% sodium chloride  500  ml ; 0.9% sodium chloride  250  ml ; potassium chloride  20  meq ; 0.9% sodium chloride  1  bag ; calcium gluconate  2  g ; hydromorphone (dilaudid)  0.125  mg ; scopolamine patch  1  ptch ; lorazepam  0.5  mg ; promethazine  6.25  mg ; 
acidosis fibromyalgia body mass index (bmi) 37.0-37.9, adult obesity, unspecified systemic lupus erythematosus, unspecified presence of left artificial knee joint acute respiratory failure, unspecified whether with hypoxia or hypercapnia intestinal adhesions [bands] with obstruction (postinfection) physical restraint status pneumonia due to klebsiella pneumoniae other ascites anuria and oliguria hypothyroidism, unspecified ileus, unspecified rheumatoid arthritis without rheumatoid factor, multiple sites other urogenital candidiasis postprocedural hypotension gastro-esophageal reflux disease without esophagitis iron deficiency anemia, unspecified personal history of nicotine dependence fever, unspecified unspecified intestinal obstruction rheumatoid arthritis without rheumatoid factor, unspecified site dehydration iron deficiency anemia, unspecified fibromyalgia hypothyroidism, unspecified myalgia and myositis, unspecified rheumatoid arthritis esophageal reflux osteoarthrosis, localized, not specified whether primary or secondary, lower leg body mass index 37.0-37.9, adult iron deficiency anemia, unspecified unspecified acquired hypothyroidism right bundle branch block obesity, unspecified myalgia and myositis, unspecified rheumatoid arthritis bacteremia other vitamin b12 deficiency anemia intestinal infection due to campylobacter iron deficiency anemia, unspecified other and unspecified postsurgical nonabsorption pneumonia, organism unspecified unspecified acquired hypothyroidism iron deficiency anemia, unspecified unspecified car occupant injured in collision with railway train or railway vehicle in nontraffic accident intestinal bypass or anastomosis status
white f 65 $nan$chemistry blood anion gap  15  meq l; chemistry blood bicarbonate  25  meq l; chemistry blood chloride  98  meq l; chemistry blood creatinine  0.4  mg dl; chemistry blood potassium  4.1  meq l; chemistry blood sodium  134  meq l; chemistry blood urea nitrogen  7  mg dl; chemistry blood calcium, total  8.9  mg dl; chemistry blood glucose  142  mg dl$sodium chloride 0.9%  flush  3  ml ; acetaminophen  650  mg ; heparin  5000  unit ; cyclobenzaprine  10  mg ; aspirin  81  mg ; hydromorphone (dilaudid)  2-4  mg ; nystatin cream  1  appl ; levothyroxine sodium  125  mcg ; senna  8.6  mg ; docusate sodium  100  mg ; levothyroxine sodium  250  mcg ; dronabinol  5  mg ; collagenase ointment  1  appl ; sodium chloride 0.9%  flush  10-20  ml ; 0.9% sodium chloride  500  ml ; 0.9% sodium chloride  250  ml ; potassium chloride  20  meq ; 0.9% sodium chloride  1  bag ; calcium gluconate  2  g ; hydromorphone (dilaudid)  0.125  mg ; scopolamine patch  1  ptch ; lorazepam  0.5  mg ; promethazine  6.25  mg ; 
acidosis fibromyalgia body mass index (bmi) 37.0-37.9, adult obesity, unspecified systemic lupus erythematosus, unspecified presence of left artificial knee joint acute respiratory failure, unspecified whether with hypoxia or hypercapnia intestinal adhesions [bands] with obstruction (postinfection) physical restraint status pneumonia due to klebsiella pneumoniae other ascites anuria and oliguria hypothyroidism, unspecified ileus, unspecified rheumatoid arthritis without rheumatoid factor, multiple sites other urogenital candidiasis postprocedural hypotension gastro-esophageal reflux disease without esophagitis iron deficiency anemia, unspecified personal history of nicotine dependence fever, unspecified unspecified intestinal obstruction rheumatoid arthritis without rheumatoid factor, unspecified site dehydration iron deficiency anemia, unspecified fibromyalgia hypothyroidism, unspecified myalgia and myositis, unspecified rheumatoid arthritis esophageal reflux osteoarthrosis, localized, not specified whether primary or secondary, lower leg body mass index 37.0-37.9, adult iron deficiency anemia, unspecified unspecified acquired hypothyroidism right bundle branch block obesity, unspecified myalgia and myositis, unspecified rheumatoid arthritis bacteremia other vitamin b12 deficiency anemia intestinal infection due to campylobacter iron deficiency anemia, unspecified other and unspecified postsurgical nonabsorption pneumonia, organism unspecified unspecified acquired hypothyroidism iron deficiency anemia, unspecified unspecified car occupant injured in collision with railway train or railway vehicle in nontraffic accident intestinal bypass or anastomosis status
white f 65 $nan$chemistry blood anion gap  11  meq l; chemistry blood bicarbonate  27  meq l; chemistry blood chloride  99  meq l; chemistry blood creatinine  0.4  mg dl; chemistry blood potassium  4.0  meq l; chemistry blood sodium  133  meq l; chemistry blood urea nitrogen  9  mg dl; chemistry blood calcium, total  8.6  mg dl; chemistry blood glucose  120  mg dl$sodium chloride 0.9%  flush  3  ml ; acetaminophen  650  mg ; heparin  5000  unit ; cyclobenzaprine  10  mg ; aspirin  81  mg ; hydromorphone (dilaudid)  2-4  mg ; nystatin cream  1  appl ; levothyroxine sodium  125  mcg ; senna  8.6  mg ; docusate sodium  100  mg ; levothyroxine sodium  250  mcg ; dronabinol  5  mg ; collagenase ointment  1  appl ; sodium chloride 0.9%  flush  10-20  ml ; hydromorphone (dilaudid)  0.125  mg ; scopolamine patch  1  ptch ; lorazepam  0.5  mg ; promethazine  6.25  mg ; fleet enema  1  enema ; acetaminophen iv  1000  mg ; 
acidosis fibromyalgia body mass index (bmi) 37.0-37.9, adult obesity, unspecified systemic lupus erythematosus, unspecified presence of left artificial knee joint acute respiratory failure, unspecified whether with hypoxia or hypercapnia intestinal adhesions [bands] with obstruction (postinfection) physical restraint status pneumonia due to klebsiella pneumoniae other ascites anuria and oliguria hypothyroidism, unspecified ileus, unspecified rheumatoid arthritis without rheumatoid factor, multiple sites other urogenital candidiasis postprocedural hypotension gastro-esophageal reflux disease without esophagitis iron deficiency anemia, unspecified personal history of nicotine dependence fever, unspecified unspecified intestinal obstruction rheumatoid arthritis without rheumatoid factor, unspecified site dehydration iron deficiency anemia, unspecified fibromyalgia hypothyroidism, unspecified myalgia and myositis, unspecified rheumatoid arthritis esophageal reflux osteoarthrosis, localized, not specified whether primary or secondary, lower leg body mass index 37.0-37.9, adult iron deficiency anemia, unspecified unspecified acquired hypothyroidism right bundle branch block obesity, unspecified myalgia and myositis, unspecified rheumatoid arthritis bacteremia other vitamin b12 deficiency anemia intestinal infection due to campylobacter iron deficiency anemia, unspecified other and unspecified postsurgical nonabsorption pneumonia, organism unspecified unspecified acquired hypothyroidism iron deficiency anemia, unspecified unspecified car occupant injured in collision with railway train or railway vehicle in nontraffic accident intestinal bypass or anastomosis status
white f 65 $nan$hematology blood hematocrit  31.2  %; hematology blood hemoglobin  9.5  g dl; hematology blood platelet count  492  k ul; chemistry blood anion gap  11  meq l; chemistry blood bicarbonate  27  meq l; chemistry blood chloride  100  meq l; chemistry blood creatinine  0.4  mg dl; chemistry blood potassium  4.0  meq l; chemistry blood sodium  134  meq l; chemistry blood urea nitrogen  13  mg dl; chemistry blood calcium, total  8.5  mg dl; chemistry blood glucose  119  mg dl$sodium chloride 0.9%  flush  3  ml ; acetaminophen  650  mg ; heparin  5000  unit ; cyclobenzaprine  10  mg ; aspirin  81  mg ; hydromorphone (dilaudid)  2-4  mg ; nystatin cream  1  appl ; levothyroxine sodium  125  mcg ; senna  8.6  mg ; docusate sodium  100  mg ; levothyroxine sodium  250  mcg ; dronabinol  5  mg ; collagenase ointment  1  appl ; sodium chloride 0.9%  flush  10-20  ml ; hydromorphone (dilaudid)  0.125  mg ; scopolamine patch  1  ptch ; lorazepam  0.5  mg ; promethazine  6.25  mg ; fleet enema  1  enema ; acetaminophen iv  1000  mg ; calcium carbonate  500  mg ; simethicone  40-80  mg ; dronabinol  7.5  mg ; 
acidosis fibromyalgia body mass index (bmi) 37.0-37.9, adult obesity, unspecified systemic lupus erythematosus, unspecified presence of left artificial knee joint acute respiratory failure, unspecified whether with hypoxia or hypercapnia intestinal adhesions [bands] with obstruction (postinfection) physical restraint status pneumonia due to klebsiella pneumoniae other ascites anuria and oliguria hypothyroidism, unspecified ileus, unspecified rheumatoid arthritis without rheumatoid factor, multiple sites other urogenital candidiasis postprocedural hypotension gastro-esophageal reflux disease without esophagitis iron deficiency anemia, unspecified personal history of nicotine dependence fever, unspecified unspecified intestinal obstruction rheumatoid arthritis without rheumatoid factor, unspecified site dehydration iron deficiency anemia, unspecified fibromyalgia hypothyroidism, unspecified myalgia and myositis, unspecified rheumatoid arthritis esophageal reflux osteoarthrosis, localized, not specified whether primary or secondary, lower leg body mass index 37.0-37.9, adult iron deficiency anemia, unspecified unspecified acquired hypothyroidism right bundle branch block obesity, unspecified myalgia and myositis, unspecified rheumatoid arthritis bacteremia other vitamin b12 deficiency anemia intestinal infection due to campylobacter iron deficiency anemia, unspecified other and unspecified postsurgical nonabsorption pneumonia, organism unspecified unspecified acquired hypothyroidism iron deficiency anemia, unspecified unspecified car occupant injured in collision with railway train or railway vehicle in nontraffic accident intestinal bypass or anastomosis status
white f 65 $nan$chemistry blood anion gap  13  meq l; chemistry blood bicarbonate  26  meq l; chemistry blood chloride  96  meq l; chemistry blood creatinine  0.3  mg dl; chemistry blood potassium  4.5  meq l; chemistry blood sodium  130  meq l; chemistry blood urea nitrogen  19  mg dl; chemistry blood calcium, total  8.6  mg dl; chemistry blood glucose  111  mg dl$sodium chloride 0.9%  flush  3  ml ; acetaminophen  650  mg ; heparin  5000  unit ; cyclobenzaprine  10  mg ; aspirin  81  mg ; hydromorphone (dilaudid)  2-4  mg ; nystatin cream  1  appl ; levothyroxine sodium  125  mcg ; senna  8.6  mg ; docusate sodium  100  mg ; levothyroxine sodium  250  mcg ; collagenase ointment  1  appl ; sodium chloride 0.9%  flush  10-20  ml ; hydromorphone (dilaudid)  0.125  mg ; lorazepam  0.5  mg ; promethazine  6.25  mg ; calcium carbonate  500  mg ; simethicone  40-80  mg ; dronabinol  7.5  mg ; 
acidosis fibromyalgia body mass index (bmi) 37.0-37.9, adult obesity, unspecified systemic lupus erythematosus, unspecified presence of left artificial knee joint acute respiratory failure, unspecified whether with hypoxia or hypercapnia intestinal adhesions [bands] with obstruction (postinfection) physical restraint status pneumonia due to klebsiella pneumoniae other ascites anuria and oliguria hypothyroidism, unspecified ileus, unspecified rheumatoid arthritis without rheumatoid factor, multiple sites other urogenital candidiasis postprocedural hypotension gastro-esophageal reflux disease without esophagitis iron deficiency anemia, unspecified personal history of nicotine dependence fever, unspecified unspecified intestinal obstruction rheumatoid arthritis without rheumatoid factor, unspecified site dehydration iron deficiency anemia, unspecified fibromyalgia hypothyroidism, unspecified myalgia and myositis, unspecified rheumatoid arthritis esophageal reflux osteoarthrosis, localized, not specified whether primary or secondary, lower leg body mass index 37.0-37.9, adult iron deficiency anemia, unspecified unspecified acquired hypothyroidism right bundle branch block obesity, unspecified myalgia and myositis, unspecified rheumatoid arthritis bacteremia other vitamin b12 deficiency anemia intestinal infection due to campylobacter iron deficiency anemia, unspecified other and unspecified postsurgical nonabsorption pneumonia, organism unspecified unspecified acquired hypothyroidism iron deficiency anemia, unspecified unspecified car occupant injured in collision with railway train or railway vehicle in nontraffic accident intestinal bypass or anastomosis status
white f 85 $nan$hematology blood hematocrit  26.9  %; hematology blood hemoglobin  8.1  g dl; hematology blood platelet count  208  k ul; chemistry blood anion gap  17  meq l; chemistry blood bicarbonate  22  meq l; chemistry blood chloride  102  meq l; chemistry blood creatinine  1.0  mg dl; chemistry blood potassium  4.5  meq l; chemistry blood sodium  136  meq l; chemistry blood urea nitrogen  27  mg dl; hematology blood inr(pt)  1.1  ; hematology urine wbc  2  # hpf; chemistry blood calcium, total  8.4  mg dl; chemistry blood bilirubin, total  0.3  mg dl; chemistry blood glucose  86  mg dl; hematology urine glucose  neg  mg dl; hematology urine bilirubin  neg  mg dl$pneumococcal 23-valent polysaccharide vaccine  0.5  ml ; sodium chloride 0.9%  flush  3  ml ; potassium chl 20 meq   1000 ml d5 1 2 ns  1000  ml ; heparin  5000  unit ; hydromorphone (dilaudid)  0.25  mg ; acetaminophen iv  1000  mg ; hydromorphone (dilaudid)  0.5-0.75  mg ; hydromorphone (dilaudid)  0.5-1  mg ; sodium chloride 0.9%  1000  ml ; tramadol  25  mg ; trazodone  25  mg ; morphine sulfate  1-2  mg ; 
 
white f 85 $nan$hematology blood hematocrit  26.7  %; hematology blood hemoglobin  7.8  g dl; hematology blood platelet count  214  k ul; chemistry blood anion gap  15  meq l; chemistry blood anion gap  15  meq l; chemistry blood bicarbonate  23  meq l; chemistry blood bicarbonate  22  meq l; chemistry blood chloride  104  meq l; chemistry blood chloride  102  meq l; chemistry blood creatinine  0.9  mg dl; chemistry blood creatinine  0.8  mg dl; chemistry blood potassium  5.1  meq l; chemistry blood potassium  4.8  meq l; chemistry blood sodium  137  meq l; chemistry blood sodium  134  meq l; chemistry blood urea nitrogen  20  mg dl; chemistry blood urea nitrogen  17  mg dl; hematology urine wbc  8  # hpf; chemistry blood calcium, total  8.8  mg dl; chemistry blood calcium, total  8.3  mg dl; chemistry blood glucose  88  mg dl; chemistry blood glucose  86  mg dl$bag  1  bag ; sodium chloride 0.9%  1000  ml ; trazodone  25  mg ; morphine sulfate  1-2  mg ; lorazepam  1  mg ; hydromorphone (dilaudid)  1  mg ; quetiapine fumarate  25  mg ; enoxaparin sodium  40  mg ; silver sulfadiazine 1% cream  1  appl ; levothyroxine sodium  88  mcg ; senna  8.6  mg ; d5 1 2ns  1000  ml ; magnesium sulfate  2  gm ; acetaminophen  650  mg ; 
 
white f 85 $nan$hematology blood hematocrit  22.5  %; hematology blood hemoglobin  7.0  g dl; hematology blood platelet count  204  k ul; chemistry blood anion gap  16  meq l; chemistry blood bicarbonate  22  meq l; chemistry blood chloride  101  meq l; chemistry blood creatinine  0.9  mg dl; chemistry blood potassium  3.9  meq l; chemistry blood sodium  135  meq l; chemistry blood urea nitrogen  18  mg dl; chemistry blood calcium, total  8.0  mg dl; chemistry blood glucose  116  mg dl$bag  1  bag ; trazodone  25  mg ; morphine sulfate  1-2  mg ; quetiapine fumarate  25  mg ; enoxaparin sodium  40  mg ; silver sulfadiazine 1% cream  1  appl ; levothyroxine sodium  88  mcg ; senna  8.6  mg ; d5 1 2ns  1000  ml ; magnesium sulfate  2  gm ; acetaminophen  650  mg ; docusate sodium  100  mg ; potassium chloride  40  meq ; neutra-phos  2  pkt ; 
 
white f 85 $nan$hematology blood hematocrit  23.3  %; hematology blood hematocrit  25.3  %; hematology blood hemoglobin  7.4  g dl; hematology blood hemoglobin  7.8  g dl; hematology blood platelet count  174  k ul; hematology blood platelet count  218  k ul; chemistry blood anion gap  12  meq l; chemistry blood bicarbonate  22  meq l; chemistry blood chloride  102  meq l; chemistry blood creatinine  0.7  mg dl; chemistry blood potassium  4.3  meq l; chemistry blood sodium  132  meq l; chemistry blood urea nitrogen  17  mg dl; chemistry blood calcium, total  8.2  mg dl; chemistry blood glucose  106  mg dl$trazodone  25  mg ; morphine sulfate  1-2  mg ; enoxaparin sodium  40  mg ; silver sulfadiazine 1% cream  1  appl ; levothyroxine sodium  88  mcg ; senna  8.6  mg ; d5 1 2ns  1000  ml ; acetaminophen  650  mg ; docusate sodium  100  mg ; potassium chloride  40  meq ; neutra-phos  2  pkt ; 
 
white f 85 $nan$hematology blood hematocrit  24.6  %; hematology blood hemoglobin  7.6  g dl; hematology blood platelet count  228  k ul; chemistry blood anion gap  12  meq l; chemistry blood bicarbonate  25  meq l; chemistry blood chloride  101  meq l; chemistry blood creatinine  0.6  mg dl; chemistry blood potassium  4.3  meq l; chemistry blood sodium  134  meq l; chemistry blood urea nitrogen  13  mg dl; chemistry blood calcium, total  8.7  mg dl; chemistry blood glucose  87  mg dl$trazodone  25  mg ; morphine sulfate  1-2  mg ; enoxaparin sodium  40  mg ; silver sulfadiazine 1% cream  1  appl ; levothyroxine sodium  88  mcg ; senna  8.6  mg ; d5 1 2ns  1000  ml ; acetaminophen  650  mg ; docusate sodium  100  mg ; 0.9% sodium chloride  1  bag ; calcium gluconate  2  g ; 0.9% sodium chloride  250  ml ; sodium phosphate  15  mmol ; 
 
white f 85 $nan$hematology blood hematocrit  24.7  %; hematology blood hemoglobin  7.5  g dl; hematology blood platelet count  263  k ul; chemistry blood anion gap  18  meq l; chemistry blood bicarbonate  22  meq l; chemistry blood chloride  98  meq l; chemistry blood creatinine  0.6  mg dl; chemistry blood potassium  4.5  meq l; chemistry blood sodium  133  meq l; chemistry blood urea nitrogen  13  mg dl; hematology blood inr(pt)  1.0  ; chemistry blood calcium, total  8.2  mg dl; chemistry blood glucose  91  mg dl$trazodone  25  mg ; morphine sulfate  1-2  mg ; enoxaparin sodium  40  mg ; silver sulfadiazine 1% cream  1  appl ; levothyroxine sodium  88  mcg ; senna  8.6  mg ; d5 1 2ns  1000  ml ; acetaminophen  650  mg ; docusate sodium  100  mg ; 0.9% sodium chloride  1  bag ; calcium gluconate  2  g ; 0.9% sodium chloride  250  ml ; sodium phosphate  15  mmol ; lactated ringers  1000  ml ; bag  2  bag ; magnesium sulfate  4  gm ; 
 
white f 85 $nan$hematology blood hematocrit  24.0  %; hematology blood hemoglobin  7.3  g dl; hematology blood platelet count  277  k ul; chemistry blood anion gap  12  meq l; chemistry blood bicarbonate  25  meq l; chemistry blood chloride  99  meq l; chemistry blood creatinine  0.6  mg dl; chemistry blood potassium  4.1  meq l; chemistry blood sodium  132  meq l; chemistry blood urea nitrogen  14  mg dl; hematology blood inr(pt)  1.1  ; chemistry blood calcium, total  8.0  mg dl; chemistry blood glucose  117  mg dl$trazodone  25  mg ; morphine sulfate  1-2  mg ; silver sulfadiazine 1% cream  1  appl ; levothyroxine sodium  88  mcg ; senna  8.6  mg ; acetaminophen  650  mg ; docusate sodium  100  mg ; 
 
white f 85 $nan$hematology blood hematocrit  25.9  %; hematology blood hemoglobin  7.9  g dl; hematology blood platelet count  302  k ul; chemistry blood anion gap  11  meq l; chemistry blood bicarbonate  26  meq l; chemistry blood chloride  101  meq l; chemistry blood creatinine  0.6  mg dl; chemistry blood potassium  4.2  meq l; chemistry blood sodium  134  meq l; chemistry blood urea nitrogen  13  mg dl; hematology blood inr(pt)  1.1  ; chemistry blood calcium, total  8.7  mg dl; chemistry blood glucose  97  mg dl$trazodone  25  mg ; morphine sulfate  1-2  mg ; silver sulfadiazine 1% cream  1  appl ; levothyroxine sodium  88  mcg ; senna  8.6  mg ; acetaminophen  650  mg ; docusate sodium  100  mg ; 0.9% sodium chloride  2  bag ; calcium gluconate  4  g ; metoprolol tartrate  2.5  mg ; ciprofloxacin hcl  500  mg ; 
 
white f 85 $nan$hematology blood hematocrit  25.3  %; hematology blood hemoglobin  7.8  g dl; hematology blood platelet count  318  k ul; chemistry blood anion gap  15  meq l; chemistry blood anion gap  14  meq l; chemistry blood bicarbonate  25  meq l; chemistry blood bicarbonate  26  meq l; chemistry blood chloride  97  meq l; chemistry blood chloride  100  meq l; chemistry blood creatinine  0.7  mg dl; chemistry blood creatinine  0.6  mg dl; chemistry blood potassium  3.9  meq l; chemistry blood potassium  4.3  meq l; chemistry blood sodium  133  meq l; chemistry blood sodium  136  meq l; chemistry blood urea nitrogen  15  mg dl; chemistry blood urea nitrogen  15  mg dl; hematology blood inr(pt)  1.0  ; chemistry blood calcium, total  8.5  mg dl; chemistry blood calcium, total  8.1  mg dl; chemistry blood glucose  110  mg dl; chemistry blood glucose  96  mg dl$trazodone  25  mg ; morphine sulfate  1-2  mg ; silver sulfadiazine 1% cream  1  appl ; levothyroxine sodium  88  mcg ; senna  8.6  mg ; acetaminophen  650  mg ; docusate sodium  100  mg ; 0.9% sodium chloride  2  bag ; calcium gluconate  4  g ; metoprolol tartrate  2.5  mg ; ciprofloxacin hcl  500  mg ; 
 
white f 85 $nan$hematology blood hematocrit  25.1  %; hematology blood hemoglobin  7.6  g dl; hematology blood platelet count  291  k ul; chemistry blood anion gap  12  meq l; chemistry blood bicarbonate  26  meq l; chemistry blood chloride  101  meq l; chemistry blood creatinine  0.7  mg dl; chemistry blood potassium  4.2  meq l; chemistry blood sodium  135  meq l; chemistry blood urea nitrogen  16  mg dl; hematology blood inr(pt)  1.0  ; chemistry blood calcium, total  8.2  mg dl; chemistry blood glucose  104  mg dl$trazodone  25  mg ; morphine sulfate  1-2  mg ; silver sulfadiazine 1% cream  1  appl ; levothyroxine sodium  88  mcg ; senna  8.6  mg ; acetaminophen  650  mg ; docusate sodium  100  mg ; ciprofloxacin hcl  500  mg ; bisacodyl  10  mg ; iso-osmotic dextrose  50  ml ; cefazolin  2  g ; 
 
white f 85 $nan$hematology blood hematocrit  24.1  %; hematology blood hemoglobin  7.1  g dl; hematology blood platelet count  282  k ul; chemistry blood anion gap  14  meq l; chemistry blood bicarbonate  25  meq l; chemistry blood chloride  97  meq l; chemistry blood creatinine  0.8  mg dl; chemistry blood potassium  4.3  meq l; chemistry blood sodium  132  meq l; chemistry blood urea nitrogen  12  mg dl; hematology blood inr(pt)  1.2  ; hematology urine wbc  42  # hpf; chemistry blood calcium, total  7.6  mg dl; chemistry blood glucose  84  mg dl$trazodone  25  mg ; silver sulfadiazine 1% cream  1  appl ; levothyroxine sodium  88  mcg ; senna  8.6  mg ; acetaminophen  650  mg ; docusate sodium  100  mg ; ciprofloxacin hcl  500  mg ; bisacodyl  10  mg ; iso-osmotic dextrose  50  ml ; cefazolin  2  g ; warfarin  1  mg ; acetaminophen  1000  mg ; tramadol  50  mg ; 0.9% sodium chloride (mini bag plus)  100  ml ; ceftazidime  1  g ; iso-osmotic dextrose  200  ml ; vancomycin  1000  mg ; ipratropium-albuterol neb  1  neb ; warfarin  2.5  mg ; enoxaparin sodium  30  mg ; warfarin  1  dose ; 
 
white f 85 $nan$hematology blood hematocrit  26.1  %; hematology blood hemoglobin  7.8  g dl; hematology blood platelet count  310  k ul; chemistry blood anion gap  14  meq l; chemistry blood bicarbonate  24  meq l; chemistry blood chloride  98  meq l; chemistry blood creatinine  0.8  mg dl; chemistry blood potassium  4.0  meq l; chemistry blood sodium  132  meq l; chemistry blood urea nitrogen  14  mg dl; hematology blood inr(pt)  1.3  ; chemistry blood calcium, total  8.1  mg dl; chemistry blood glucose  113  mg dl$trazodone  25  mg ; silver sulfadiazine 1% cream  1  appl ; levothyroxine sodium  88  mcg ; senna  8.6  mg ; docusate sodium  100  mg ; bisacodyl  10  mg ; acetaminophen  1000  mg ; iso-osmotic dextrose  200  ml ; vancomycin  1000  mg ; ipratropium-albuterol neb  1  neb ; warfarin  2.5  mg ; enoxaparin sodium  30  mg ; warfarin  1  dose ; oxycodone (immediate release)  2.5  mg ; warfarin  4  mg ; 
 
white f 85 $nan$hematology blood hematocrit  24.2  %; hematology blood hemoglobin  7.4  g dl; hematology blood platelet count  329  k ul; chemistry blood anion gap  13  meq l; chemistry blood bicarbonate  25  meq l; chemistry blood chloride  99  meq l; chemistry blood creatinine  0.8  mg dl; chemistry blood potassium  4.0  meq l; chemistry blood sodium  133  meq l; chemistry blood urea nitrogen  13  mg dl; hematology blood inr(pt)  1.7  ; chemistry blood calcium, total  8.2  mg dl; chemistry blood glucose  100  mg dl$trazodone  25  mg ; silver sulfadiazine 1% cream  1  appl ; levothyroxine sodium  88  mcg ; senna  8.6  mg ; docusate sodium  100  mg ; bisacodyl  10  mg ; acetaminophen  1000  mg ; ipratropium-albuterol neb  1  neb ; enoxaparin sodium  30  mg ; warfarin  1  dose ; oxycodone (immediate release)  2.5  mg ; warfarin  4  mg ; metoprolol succinate xl  12.5  mg ; warfarin  2  mg ; 
 
white f 85 $nan$hematology blood hematocrit  26.4  %; hematology blood hemoglobin  8.1  g dl; hematology blood platelet count  372  k ul; chemistry blood anion gap  13  meq l; chemistry blood bicarbonate  26  meq l; chemistry blood chloride  101  meq l; chemistry blood creatinine  0.7  mg dl; chemistry blood potassium  4.0  meq l; chemistry blood sodium  136  meq l; chemistry blood urea nitrogen  9  mg dl; hematology blood inr(pt)  1.6  ; chemistry blood calcium, total  8.5  mg dl; chemistry blood glucose  96  mg dl$trazodone  25  mg ; silver sulfadiazine 1% cream  1  appl ; levothyroxine sodium  88  mcg ; senna  8.6  mg ; docusate sodium  100  mg ; bisacodyl  10  mg ; acetaminophen  1000  mg ; ipratropium-albuterol neb  1  neb ; enoxaparin sodium  30  mg ; warfarin  1  dose ; oxycodone (immediate release)  2.5  mg ; metoprolol succinate xl  12.5  mg ; warfarin  2  mg ; 
 
white f 85 $nan$hematology blood hematocrit  28.8  %; hematology blood hemoglobin  8.7  g dl; hematology blood platelet count  343  k ul; chemistry blood anion gap  16  meq l; chemistry blood bicarbonate  24  meq l; chemistry blood chloride  102  meq l; chemistry blood creatinine  0.7  mg dl; chemistry blood potassium  4.0  meq l; chemistry blood sodium  138  meq l; chemistry blood urea nitrogen  10  mg dl; hematology blood inr(pt)  1.3  ; chemistry blood calcium, total  8.5  mg dl; chemistry blood bilirubin, total  0.5  mg dl; chemistry blood glucose  103  mg dl$trazodone  25  mg ; silver sulfadiazine 1% cream  1  appl ; levothyroxine sodium  88  mcg ; senna  8.6  mg ; docusate sodium  100  mg ; bisacodyl  10  mg ; acetaminophen  1000  mg ; ipratropium-albuterol neb  1  neb ; warfarin  1  dose ; oxycodone (immediate release)  2.5  mg ; warfarin  3  mg ; 
 
white f 85 $nan$nan$trazodone  25  mg ; silver sulfadiazine 1% cream  1  appl ; levothyroxine sodium  88  mcg ; senna  8.6  mg ; docusate sodium  100  mg ; bisacodyl  10  mg ; acetaminophen  1000  mg ; ipratropium-albuterol neb  1  neb ; warfarin  1  dose ; oxycodone (immediate release)  2.5  mg ; warfarin  3  mg ; 
 
white m 57 $nan$hematology blood hematocrit  32.8  %; hematology blood hemoglobin  10.8  g dl; hematology blood platelet count  81  k ul; chemistry blood anion gap  11  meq l; chemistry blood bicarbonate  23  meq l; chemistry blood chloride  103  meq l; chemistry blood creatinine  0.9  mg dl; chemistry blood potassium  5.2  meq l; chemistry blood sodium  137  meq l; chemistry blood urea nitrogen  14  mg dl; hematology blood inr(pt)  1.1  ; hematology blood inr(pt)  1.1  ; chemistry blood calcium, total  8.4  mg dl; chemistry blood glucose  199  mg dl; chemistry blood lactate dehydrogenase (ld)  209  iu l$heparin flush (10 units ml)  2  ml ; sodium chloride 0.9%  flush  10  ml ; sodium chloride 0.9%  1000  ml ; acyclovir  400  mg ; folic acid  1  mg ; magnesium oxide  400  mg ; magnesium oxide  800  mg ; multivitamins  1  tab ; omeprazole  40  mg ; bag  1  bag ; magnesium sulfate  2  gm ; bag  2  bag ; magnesium sulfate  4  gm ; ursodiol  300  mg ; tacrolimus  2  mg ; fluconazole  400  mg ; sulfameth trimethoprim ds  1  tab ; lidocaine 2%  20  ml ; lorazepam  0.5  mg ; 
benign prostatic hyperplasia with lower urinary tract symptoms gastro-esophageal reflux disease without esophagitis sialoadenitis, unspecified encounter for examination for normal comparison and control in clinical research program oral mucositis (ulcerative), unspecified nocturia other nonspecific abnormal finding of lung field acute myeloblastic leukemia, in remission toxic gastroenteritis and colitis patient room in hospital as the place of occurrence of the external cause fever presenting with conditions classified elsewhere neutropenia, unspecified constipation, unspecified adverse effect of antineoplastic and immunosuppressive drugs, initial encounter residual hemorrhoidal skin tags nausea with vomiting, unspecified thrombocytopenia, unspecified chronic pulmonary edema acute myeloblastic leukemia, not having achieved remission hypoxemia unspecified atrial fibrillation fluid overload, unspecified toxic encephalopathy nonspecific elevation of levels of transaminase and lactic acid dehydrogenase [ldh] adverse effect of antifungal antibiotics, systemically used, initial encounter syndrome of inappropriate secretion of antidiuretic hormone chronic sinusitis, unspecified acute posthemorrhagic anemia abnormal weight loss neutropenia, unspecified adverse effect of glucocorticoids and synthetic analogues, initial encounter patient room in hospital as the place of occurrence of the external cause melena unspecified bacterial pneumonia gastro-esophageal reflux disease without esophagitis fever presenting with conditions classified elsewhere
white m 57 $nan$hematology blood hematocrit  30.3  %; hematology blood hemoglobin  10.1  g dl; hematology blood platelet count  80  k ul; chemistry blood anion gap  13  meq l; chemistry blood bicarbonate  23  meq l; chemistry blood chloride  102  meq l; chemistry blood creatinine  1.0  mg dl; chemistry blood potassium  4.6  meq l; chemistry blood sodium  138  meq l; chemistry blood urea nitrogen  14  mg dl; hematology blood inr(pt)  1.1  ; chemistry blood calcium, total  8.4  mg dl; chemistry blood bilirubin, total  0.2  mg dl; chemistry blood glucose  129  mg dl; chemistry blood lactate dehydrogenase (ld)  243  iu l$heparin flush (10 units ml)  2  ml ; sodium chloride 0.9%  flush  10  ml ; acyclovir  400  mg ; folic acid  1  mg ; magnesium oxide  400  mg ; magnesium oxide  800  mg ; multivitamins  1  tab ; omeprazole  40  mg ; bag  1  bag ; magnesium sulfate  2  gm ; bag  2  bag ; magnesium sulfate  4  gm ; ursodiol  300  mg ; fluconazole  400  mg ; lidocaine 2%  20  ml ; lorazepam  0.5  mg ; tacrolimus  1  mg ; 
benign prostatic hyperplasia with lower urinary tract symptoms gastro-esophageal reflux disease without esophagitis sialoadenitis, unspecified encounter for examination for normal comparison and control in clinical research program oral mucositis (ulcerative), unspecified nocturia other nonspecific abnormal finding of lung field acute myeloblastic leukemia, in remission toxic gastroenteritis and colitis patient room in hospital as the place of occurrence of the external cause fever presenting with conditions classified elsewhere neutropenia, unspecified constipation, unspecified adverse effect of antineoplastic and immunosuppressive drugs, initial encounter residual hemorrhoidal skin tags nausea with vomiting, unspecified thrombocytopenia, unspecified chronic pulmonary edema acute myeloblastic leukemia, not having achieved remission hypoxemia unspecified atrial fibrillation fluid overload, unspecified toxic encephalopathy nonspecific elevation of levels of transaminase and lactic acid dehydrogenase [ldh] adverse effect of antifungal antibiotics, systemically used, initial encounter syndrome of inappropriate secretion of antidiuretic hormone chronic sinusitis, unspecified acute posthemorrhagic anemia abnormal weight loss neutropenia, unspecified adverse effect of glucocorticoids and synthetic analogues, initial encounter patient room in hospital as the place of occurrence of the external cause melena unspecified bacterial pneumonia gastro-esophageal reflux disease without esophagitis fever presenting with conditions classified elsewhere
white m 57 $nan$nan$heparin flush (10 units ml)  2  ml ; sodium chloride 0.9%  flush  10  ml ; acyclovir  400  mg ; folic acid  1  mg ; magnesium oxide  400  mg ; magnesium oxide  800  mg ; multivitamins  1  tab ; omeprazole  40  mg ; bag  1  bag ; magnesium sulfate  2  gm ; bag  2  bag ; magnesium sulfate  4  gm ; ursodiol  300  mg ; fluconazole  400  mg ; tacrolimus  1  mg ; 
benign prostatic hyperplasia with lower urinary tract symptoms gastro-esophageal reflux disease without esophagitis sialoadenitis, unspecified encounter for examination for normal comparison and control in clinical research program oral mucositis (ulcerative), unspecified nocturia other nonspecific abnormal finding of lung field acute myeloblastic leukemia, in remission toxic gastroenteritis and colitis patient room in hospital as the place of occurrence of the external cause fever presenting with conditions classified elsewhere neutropenia, unspecified constipation, unspecified adverse effect of antineoplastic and immunosuppressive drugs, initial encounter residual hemorrhoidal skin tags nausea with vomiting, unspecified thrombocytopenia, unspecified chronic pulmonary edema acute myeloblastic leukemia, not having achieved remission hypoxemia unspecified atrial fibrillation fluid overload, unspecified toxic encephalopathy nonspecific elevation of levels of transaminase and lactic acid dehydrogenase [ldh] adverse effect of antifungal antibiotics, systemically used, initial encounter syndrome of inappropriate secretion of antidiuretic hormone chronic sinusitis, unspecified acute posthemorrhagic anemia abnormal weight loss neutropenia, unspecified adverse effect of glucocorticoids and synthetic analogues, initial encounter patient room in hospital as the place of occurrence of the external cause melena unspecified bacterial pneumonia gastro-esophageal reflux disease without esophagitis fever presenting with conditions classified elsewhere
white f 43 $temp  98.0  heartrate  76.0  resprate  18.0  o2sat  100.0  sbp  105.0  dbp  63.0  rhythm    pain  5  $hematology blood hematocrit  37.9  %; hematology blood hemoglobin  12.7  g dl; hematology blood platelet count  293  k ul; chemistry blood anion gap  14  meq l; chemistry blood bicarbonate  24  meq l; chemistry blood chloride  106  meq l; chemistry blood creatinine  0.7  mg dl; chemistry blood potassium  3.8  meq l; chemistry blood sodium  140  meq l; chemistry blood urea nitrogen  10  mg dl; hematology blood inr(pt)  1.0  ; chemistry blood glucose  96  mg dl$nan
 
white f 43 $nan$nan$sodium chloride 0.9%  flush  3  ml ; d5lr  1000  ml ; acetaminophen  1000  mg ; oxycodone (immediate release)   5-10  mg ; ondansetron  4  mg ; iso-osmotic dextrose  50  ml ; cefazolin  1  g ; hydromorphone (dilaudid)  0.25  mg ; hydromorphone (dilaudid)  2-4  mg ; ketorolac  30  mg ; milk of magnesia  30  ml ; docusate sodium  100  mg ; senna  8.6  mg ; 
 
white f 59 $temp  98.1  heartrate  85.0  resprate  18.0  o2sat  100.0  sbp  136.0  dbp  96.0  rhythm    pain  0  $hematology blood hematocrit  34.2  %; hematology blood hemoglobin  11.7  g dl; hematology blood platelet count  207  k ul; chemistry blood anion gap  10  meq l; chemistry blood bicarbonate  27  meq l; chemistry blood chloride  97  meq l; chemistry blood creatinine  0.8  mg dl; chemistry blood potassium  4.1  meq l; chemistry blood sodium  134  meq l; chemistry blood urea nitrogen  10  mg dl; chemistry blood glucose  110  mg dl$influenza vaccine quadrivalent  0.5  ml ; sodium chloride 0.9%  flush  3-10  ml ; heparin  5000  unit ; acetaminophen  500  mg ; loratadine  10  mg ; promethazine  25  mg ; ibuprofen  800  mg ; aspirin  81  mg ; carbamazepine  200  mg ; senna  8.6  mg ; polyethylene glycol  17  g ; bisacodyl  10  mg ; doxycycline hyclate  100  mg ; ondansetron  4  mg ; hydrocortisone (rectal) 2.5% cream  1  appl ; 
allergic rhinitis, cause unspecified body mass index 36.0-36.9, adult paraplegia vascular myelopathies displacement of thoracic intervertebral disc without myelopathy overweight retention of urine, unspecified other chest pain elevated blood pressure reading without diagnosis of hypertension person boarding or alighting a pedal cycle injured in collision with fixed or stationary object asthma, unspecified type, unspecified family history of ischemic heart disease
white f 59 $nan$hematology blood hematocrit  33.7  %; hematology blood hemoglobin  11.3  g dl; hematology blood platelet count  190  k ul; chemistry blood anion gap  13  meq l; chemistry blood bicarbonate  23  meq l; chemistry blood chloride  99  meq l; chemistry blood creatinine  0.6  mg dl; chemistry blood potassium  4.2  meq l; chemistry blood sodium  135  meq l; chemistry blood urea nitrogen  14  mg dl; chemistry blood calcium, total  9.1  mg dl; chemistry blood glucose  90  mg dl$influenza vaccine quadrivalent  0.5  ml ; sodium chloride 0.9%  flush  3-10  ml ; heparin  5000  unit ; acetaminophen  500  mg ; loratadine  10  mg ; promethazine  25  mg ; aspirin  81  mg ; carbamazepine  200  mg ; senna  8.6  mg ; polyethylene glycol  17  g ; bisacodyl  10  mg ; ondansetron  4  mg ; hydrocortisone (rectal) 2.5% cream  1  appl ; amitriptyline  25  mg ; heparin flush (10 units ml)  2  ml ; sodium chloride 0.9%  flush  10  ml ; 
allergic rhinitis, cause unspecified body mass index 36.0-36.9, adult paraplegia vascular myelopathies displacement of thoracic intervertebral disc without myelopathy overweight retention of urine, unspecified other chest pain elevated blood pressure reading without diagnosis of hypertension person boarding or alighting a pedal cycle injured in collision with fixed or stationary object asthma, unspecified type, unspecified family history of ischemic heart disease
white f 59 $nan$nan$sodium chloride 0.9%  flush  3-10  ml ; heparin  5000  unit ; acetaminophen  500  mg ; loratadine  10  mg ; promethazine  25  mg ; aspirin  81  mg ; carbamazepine  200  mg ; senna  8.6  mg ; polyethylene glycol  17  g ; bisacodyl  10  mg ; hydrocortisone (rectal) 2.5% cream  1  appl ; amitriptyline  25  mg ; heparin flush (10 units ml)  2  ml ; sodium chloride 0.9%  flush  10  ml ; 
allergic rhinitis, cause unspecified body mass index 36.0-36.9, adult paraplegia vascular myelopathies displacement of thoracic intervertebral disc without myelopathy overweight retention of urine, unspecified other chest pain elevated blood pressure reading without diagnosis of hypertension person boarding or alighting a pedal cycle injured in collision with fixed or stationary object asthma, unspecified type, unspecified family history of ischemic heart disease
white f 57 $temp  98.6  heartrate  89.0  resprate  18.0  o2sat  94.0  sbp  135.0  dbp  78.0  rhythm    pain  0  ; temp  98.4  heartrate  84.0  resprate  18.0  o2sat  97.0  sbp  143.0  dbp  87.0  rhythm    pain  0  $nan$influenza vaccine quadrivalent  0.5  ml ; heparin  5000  unit ; acetaminophen  500-1000  mg ; dextrose 50%  12.5  gm ; glucagon  1  mg ; glucose gel  15  g ; acetaminophen-caff-butalbital  1-2  tab ; insulin  0  unit ; dexamethasone  4  mg ; 5% dextrose  100  ml ; acyclovir  500  mg ; iso-osmotic dextrose  200  ml ; vancomycin  1000  mg ; 
cerebral edema other b-complex deficiencies unspecified essential hypertension benign neoplasm of cerebral meninges bariatric surgery status homonymous bilateral field defects diabetes mellitus without mention of complication, type ii or unspecified type, not stated as uncontrolled personal history of malignant neoplasm of breast person boarding or alighting a pedal cycle injured in collision with pedestrian or animal 
white f 57 $nan$hematology blood hematocrit  35.1  %; hematology blood hemoglobin  12.1  g dl; hematology blood platelet count  364  k ul; chemistry blood anion gap  12  meq l; chemistry blood bicarbonate  28  meq l; chemistry blood chloride  98  meq l; chemistry blood creatinine  0.5  mg dl; chemistry blood potassium  4.0  meq l; chemistry blood sodium  134  meq l; chemistry blood urea nitrogen  13  mg dl; hematology blood inr(pt)  1.0  ; hematology urine wbc  3  # hpf; chemistry blood calcium, total  11.2  mg dl; chemistry blood glucose  213  mg dl; chemistry blood albumin  3.6  g dl; hematology urine glucose  1000  mg dl$heparin  5000  unit ; acetaminophen  500-1000  mg ; dextrose 50%  12.5  gm ; glucagon  1  mg ; glucose gel  15  g ; acetaminophen-caff-butalbital  1-2  tab ; insulin  0  unit ; 5% dextrose  100  ml ; acyclovir  500  mg ; iso-osmotic dextrose  200  ml ; vancomycin  1000  mg ; sodium chloride 0.9%  flush  3  ml ; ns  100  ml ; metronidazole (flagyl)  500  mg ; 0.9% sodium chloride (mini bag plus)  100  ml ; ceftriaxone  2  gm ; oxycodone (immediate release)   5-10  mg ; sodium chloride 0.9%  1000  ml ; furosemide  20  mg ; 
cerebral edema other b-complex deficiencies unspecified essential hypertension benign neoplasm of cerebral meninges bariatric surgery status homonymous bilateral field defects diabetes mellitus without mention of complication, type ii or unspecified type, not stated as uncontrolled personal history of malignant neoplasm of breast person boarding or alighting a pedal cycle injured in collision with pedestrian or animal 
white f 57 $nan$nan$heparin  5000  unit ; acetaminophen  500-1000  mg ; dextrose 50%  12.5  gm ; glucagon  1  mg ; glucose gel  15  g ; insulin  0  unit ; 5% dextrose  100  ml ; acyclovir  500  mg ; iso-osmotic dextrose  200  ml ; vancomycin  1000  mg ; sodium chloride 0.9%  flush  3  ml ; ns  100  ml ; metronidazole (flagyl)  500  mg ; 0.9% sodium chloride (mini bag plus)  100  ml ; ceftriaxone  2  gm ; oxycodone (immediate release)   5-10  mg ; sodium chloride 0.9%  1000  ml ; furosemide  20  mg ; 0.9% sodium chloride  100  ml ; levetiracetam  500  mg ; morphine sulfate  2-4  mg ; dexamethasone  2  mg ; 0.83% sodium chloride  200  ml ; nicardipine iv  40  mg ; 
cerebral edema other b-complex deficiencies unspecified essential hypertension benign neoplasm of cerebral meninges bariatric surgery status homonymous bilateral field defects diabetes mellitus without mention of complication, type ii or unspecified type, not stated as uncontrolled personal history of malignant neoplasm of breast person boarding or alighting a pedal cycle injured in collision with pedestrian or animal 
white f 57 $nan$hematology blood hematocrit  33.3  %; hematology blood hemoglobin  11.0  g dl; hematology blood platelet count  307  k ul; chemistry blood anion gap  11  meq l; chemistry blood bicarbonate  28  meq l; chemistry blood chloride  103  meq l; chemistry blood creatinine  0.4  mg dl; chemistry blood potassium  3.8  meq l; chemistry blood sodium  138  meq l; chemistry blood urea nitrogen  7  mg dl; hematology blood inr(pt)  1.0  ; chemistry blood calcium, total  10.4  mg dl; chemistry blood glucose  208  mg dl$acetaminophen  500-1000  mg ; dextrose 50%  12.5  gm ; glucagon  1  mg ; glucose gel  15  g ; insulin  0  unit ; 5% dextrose  100  ml ; acyclovir  500  mg ; iso-osmotic dextrose  200  ml ; vancomycin  1000  mg ; ns  100  ml ; metronidazole (flagyl)  500  mg ; 0.9% sodium chloride (mini bag plus)  100  ml ; ceftriaxone  2  gm ; 0.9% sodium chloride  100  ml ; levetiracetam  500  mg ; morphine sulfate  2-4  mg ; dexamethasone  2  mg ; 0.83% sodium chloride  200  ml ; nicardipine iv  40  mg ; neutra-phos  2  pkt ; 
cerebral edema other b-complex deficiencies unspecified essential hypertension benign neoplasm of cerebral meninges bariatric surgery status homonymous bilateral field defects diabetes mellitus without mention of complication, type ii or unspecified type, not stated as uncontrolled personal history of malignant neoplasm of breast person boarding or alighting a pedal cycle injured in collision with pedestrian or animal 
white f 57 $nan$hematology blood hematocrit  34.0  %; hematology blood hemoglobin  11.0  g dl; hematology blood platelet count  319  k ul; chemistry blood anion gap  12  meq l; chemistry blood bicarbonate  28  meq l; chemistry blood chloride  102  meq l; chemistry blood creatinine  0.3  mg dl; chemistry blood potassium  3.5  meq l; chemistry blood sodium  138  meq l; chemistry blood urea nitrogen  6  mg dl; hematology blood inr(pt)  1.0  ; chemistry blood calcium, total  10.1  mg dl; chemistry blood glucose  168  mg dl$acetaminophen  500-1000  mg ; dextrose 50%  12.5  gm ; glucagon  1  mg ; glucose gel  15  g ; insulin  0  unit ; iso-osmotic dextrose  200  ml ; vancomycin  1000  mg ; ns  100  ml ; metronidazole (flagyl)  500  mg ; 0.9% sodium chloride (mini bag plus)  100  ml ; ceftriaxone  2  gm ; 0.9% sodium chloride  100  ml ; levetiracetam  500  mg ; morphine sulfate  2-4  mg ; dexamethasone  2  mg ; 0.83% sodium chloride  200  ml ; nicardipine iv  40  mg ; neutra-phos  2  pkt ; docusate sodium  100  mg ; senna  17.2  mg ; famotidine  20  mg ; oxycodone (immediate release)   10-15  mg ; heparin flush (10 units ml)  2  ml ; sodium chloride 0.9%  flush  20  ml ; lidocaine 1% (for picc midline insertions)  5  ml ; neutra-phos  1  pkt ; 
cerebral edema other b-complex deficiencies unspecified essential hypertension benign neoplasm of cerebral meninges bariatric surgery status homonymous bilateral field defects diabetes mellitus without mention of complication, type ii or unspecified type, not stated as uncontrolled personal history of malignant neoplasm of breast person boarding or alighting a pedal cycle injured in collision with pedestrian or animal 
white f 57 $nan$hematology blood hematocrit  33.3  %; hematology blood hemoglobin  11.1  g dl; hematology blood platelet count  338  k ul; chemistry blood anion gap  14  meq l; chemistry blood bicarbonate  29  meq l; chemistry blood chloride  95  meq l; chemistry blood creatinine  0.4  mg dl; chemistry blood potassium  3.4  meq l; chemistry blood sodium  135  meq l; chemistry blood urea nitrogen  8  mg dl; hematology blood inr(pt)  1.0  ; chemistry blood calcium, total  10.5  mg dl; chemistry blood glucose  207  mg dl$docusate sodium  100  mg ; senna  17.2  mg ; famotidine  20  mg ; oxycodone (immediate release)   10-15  mg ; heparin flush (10 units ml)  2  ml ; sodium chloride 0.9%  flush  20  ml ; lidocaine 1% (for picc midline insertions)  5  ml ; neutra-phos  1  pkt ; cefepime  2  g ; sodium chloride 0.9%  flush  10-20  ml ; sodium chloride 0.9%  flush  10  ml ; phosphorus  500  mg ; bag  1  bag ; magnesium sulfate  2  gm ; 
cerebral edema other b-complex deficiencies unspecified essential hypertension benign neoplasm of cerebral meninges bariatric surgery status homonymous bilateral field defects diabetes mellitus without mention of complication, type ii or unspecified type, not stated as uncontrolled personal history of malignant neoplasm of breast person boarding or alighting a pedal cycle injured in collision with pedestrian or animal 
white f 57 $nan$hematology blood hematocrit  33.3  %; hematology blood hemoglobin  11.0  g dl; hematology blood platelet count  318  k ul; chemistry blood anion gap  9  meq l; chemistry blood bicarbonate  33  meq l; chemistry blood chloride  100  meq l; chemistry blood creatinine  0.3  mg dl; chemistry blood potassium  3.2  meq l; chemistry blood sodium  139  meq l; chemistry blood urea nitrogen  8  mg dl; chemistry blood calcium, total  10.9  mg dl; chemistry blood glucose  187  mg dl$docusate sodium  100  mg ; senna  17.2  mg ; famotidine  20  mg ; oxycodone (immediate release)   10-15  mg ; sodium chloride 0.9%  flush  20  ml ; lidocaine 1% (for picc midline insertions)  5  ml ; cefepime  2  g ; sodium chloride 0.9%  flush  10-20  ml ; sodium chloride 0.9%  flush  10  ml ; phosphorus  500  mg ; bag  1  bag ; magnesium sulfate  2  gm ; potassium chloride  60  meq ; 5% dextrose  250  ml ; vancomycin  1250  mg ; 
cerebral edema other b-complex deficiencies unspecified essential hypertension benign neoplasm of cerebral meninges bariatric surgery status homonymous bilateral field defects diabetes mellitus without mention of complication, type ii or unspecified type, not stated as uncontrolled personal history of malignant neoplasm of breast person boarding or alighting a pedal cycle injured in collision with pedestrian or animal 
white f 57 $nan$nan$docusate sodium  100  mg ; senna  17.2  mg ; famotidine  20  mg ; oxycodone (immediate release)   10-15  mg ; sodium chloride 0.9%  flush  20  ml ; lidocaine 1% (for picc midline insertions)  5  ml ; cefepime  2  g ; sodium chloride 0.9%  flush  10-20  ml ; sodium chloride 0.9%  flush  10  ml ; potassium chloride  60  meq ; 5% dextrose  250  ml ; vancomycin  1250  mg ; 
cerebral edema other b-complex deficiencies unspecified essential hypertension benign neoplasm of cerebral meninges bariatric surgery status homonymous bilateral field defects diabetes mellitus without mention of complication, type ii or unspecified type, not stated as uncontrolled personal history of malignant neoplasm of breast person boarding or alighting a pedal cycle injured in collision with pedestrian or animal 
other f 44 $nan$nan$syringe  2  ml ; betamethasone na. phos acet  12  mg ; sodium chloride 0.9%  flush  3  ml ; docusate sodium  100  mg ; acetaminophen  650  mg ; oxazepam  15-30  mg ; calcium carbonate  500  mg ; milk of magnesia  15-30  ml ; prenatal vitamins  1  tab ; bisacodyl  10  mg ; 
 
other f 44 $nan$nan$syringe  2  ml ; betamethasone na. phos acet  12  mg ; sodium chloride 0.9%  flush  3  ml ; docusate sodium  100  mg ; acetaminophen  650  mg ; oxazepam  15-30  mg ; calcium carbonate  500  mg ; milk of magnesia  15-30  ml ; prenatal vitamins  1  tab ; bisacodyl  10  mg ; thyroid  15  mg ; thyroid  30  mg ; 
 
white f 52 $nan$hematology blood hematocrit  39.0  %; chemistry blood anion gap  14  meq l; chemistry blood bicarbonate  29  meq l; chemistry blood chloride  102  meq l; chemistry blood creatinine  0.8  mg dl; chemistry blood potassium  4.0  meq l; chemistry blood sodium  141  meq l; chemistry blood urea nitrogen  8  mg dl; chemistry blood calcium, total  8.6  mg dl; chemistry blood glucose  111  mg dl$lr  1000  ml ; heparin  5000  unit ; morphine sulfate  1  mg ; prochlorperazine  10  mg ; ondansetron  4  mg ; metoprolol tartrate  5  mg ; albuterol 0.083% neb soln  1  neb ; ns  100  ml ; cefazolin  2  gm ; hydromorphone (dilaudid)  0.25  mg ; vial  1  vial ; pantoprazole sodium  40  mg ; 
 
white f 52 $nan$hematology blood hematocrit  41.9  %; chemistry blood anion gap  15  meq l; chemistry blood bicarbonate  25  meq l; chemistry blood chloride  103  meq l; chemistry blood creatinine  0.6  mg dl; chemistry blood potassium  3.7  meq l; chemistry blood sodium  139  meq l; chemistry blood urea nitrogen  10  mg dl; chemistry blood calcium, total  8.6  mg dl; chemistry blood glucose  112  mg dl$lr  1000  ml ; heparin  5000  unit ; prochlorperazine  10  mg ; ondansetron  4  mg ; metoprolol tartrate  5  mg ; albuterol 0.083% neb soln  1  neb ; ns  100  ml ; cefazolin  2  gm ; vial  1  vial ; pantoprazole sodium  40  mg ; sw  50  ml ; magnesium sulfate  2  gm ; hydrocodone-acetaminophen  1-2  tab ; 
 
white f 52 $nan$hematology blood hematocrit  42.9  %$heparin  5000  unit ; prochlorperazine  10  mg ; albuterol 0.083% neb soln  1  neb ; hydrocodone-acetaminophen  1-2  tab ; hydrochlorothiazide  25  mg ; levothyroxine sodium  100  mcg ; multivitamins  1  cap ; multivitamins  5  ml ; neutra-phos  2  pkt ; propranolol hcl  60  mg ; ranitidine (liquid)  150  mg ; 
 
white f 46 $nan$hematology blood hematocrit  36.1  %; hematology blood hemoglobin  11.6  g dl; hematology blood platelet count  232  k ul; chemistry blood anion gap  11  meq l; chemistry blood bicarbonate  26  meq l; chemistry blood chloride  103  meq l; chemistry blood creatinine  0.7  mg dl; chemistry blood potassium  3.7  meq l; chemistry blood sodium  136  meq l; chemistry blood urea nitrogen  9  mg dl; chemistry blood calcium, total  8.2  mg dl; chemistry blood glucose  126  mg dl$sodium chloride 0.9%  flush  3  ml ; sodium chloride 0.9%  1000  ml ; hydromorphone (dilaudid)  0.5  mg ; acetaminophen  500-1000  mg ; oxycodone (immediate release)   5-10  mg ; ondansetron  4  mg ; tacrolimus  4  mg ; enoxaparin sodium  30  mg ; mycophenolate mofetil  500  mg ; hydrochlorothiazide  12.5  mg ; losartan potassium  50  mg ; magnesium oxide  280  mg ; phosphorus  250  mg ; 
unspecified essential hypertension dehydration other and unspecified hyperlipidemia abdominal pain, right upper quadrant kidney replaced by transplant nonspecific abnormal results of function study of kidney car driver injured in collision with two- or three-wheeled motor vehicle in nontraffic accident nephritis and nephropathy, not specified as acute or chronic, with unspecified pathological lesion in kidney end stage renal disease nephritis and nephropathy, not specified as acute or chronic, with unspecified pathological lesion in kidney other and unspecified hyperlipidemia hypertensive chronic kidney disease, unspecified, with chronic kidney disease stage v or end stage renal disease
hispanic latino m 38 $temp    heartrate  95.0  resprate  28.0  o2sat  94.0  sbp  105.0  dbp  72.0  rhythm    pain  10  ; temp    heartrate  95.0  resprate  38.0  o2sat  97.0  sbp  104.0  dbp  78.0  rhythm    pain  0-1  ; temp  98.6  heartrate  90.0  resprate  30.0  o2sat  95.0  sbp  117.0  dbp  77.0  rhythm    pain  0-5  ; temp    heartrate  98.0  resprate  26.0  o2sat  96.0  sbp  134.0  dbp  87.0  rhythm    pain    ; temp  98.4  heartrate  106.0  resprate  24.0  o2sat  96.0  sbp  125.0  dbp  88.0  rhythm    pain  0  $nan$bisacodyl  10  mg ; polyethylene glycol  17  g ; 
esophageal reflux other specified surgical operations and procedures causing abnormal patient reaction, or later complication, without mention of misadventure at time of operation other specified analgesics and antipyretics causing adverse effects in therapeutic use other digestive system complications diaphragmatic hernia without mention of obstruction or gangrene paralytic ileus
hispanic latino m 38 $nan$nan$bisacodyl  10  mg ; polyethylene glycol  17  g ; sodium chloride 0.9%  flush  3  ml ; potassium chl 20 meq   1000 ml d5 1 2 ns  1000  ml ; metoclopramide  10  mg ; omeprazole  20  mg ; docusate sodium  100  mg ; acetaminophen  650  mg ; senna  1  tab ; hydromorphone (dilaudid)  0.5  mg ; 
esophageal reflux other specified surgical operations and procedures causing abnormal patient reaction, or later complication, without mention of misadventure at time of operation other specified analgesics and antipyretics causing adverse effects in therapeutic use other digestive system complications diaphragmatic hernia without mention of obstruction or gangrene paralytic ileus
hispanic latino m 38 $nan$nan$bisacodyl  10  mg ; polyethylene glycol  17  g ; sodium chloride 0.9%  flush  3  ml ; metoclopramide  10  mg ; omeprazole  20  mg ; docusate sodium  100  mg ; acetaminophen  650  mg ; senna  1  tab ; hydromorphone (dilaudid)  0.5  mg ; hydromorphone (dilaudid)  0.25  mg ; 
esophageal reflux other specified surgical operations and procedures causing abnormal patient reaction, or later complication, without mention of misadventure at time of operation other specified analgesics and antipyretics causing adverse effects in therapeutic use other digestive system complications diaphragmatic hernia without mention of obstruction or gangrene paralytic ileus
white m 72 $nan$hematology blood hematocrit  50.8  %; hematology blood hemoglobin  16.6  g dl; hematology blood platelet count  271  k ul; chemistry blood anion gap  16  meq l; chemistry blood anion gap  13  meq l; chemistry blood bicarbonate  25  meq l; chemistry blood bicarbonate  26  meq l; chemistry blood chloride  96  meq l; chemistry blood chloride  94  meq l; chemistry blood creatinine  1.3  mg dl; chemistry blood creatinine  1.4  mg dl; chemistry blood potassium  3.6  meq l; chemistry blood potassium  4.3  meq l; chemistry blood sodium  133  meq l; chemistry blood sodium  129  meq l; chemistry blood urea nitrogen  18  mg dl; chemistry blood urea nitrogen  19  mg dl; chemistry blood calcium, total  10.1  mg dl; chemistry blood bilirubin, total  0.5  mg dl; chemistry blood glucose  116  mg dl; chemistry blood glucose  264  mg dl; chemistry blood lactate dehydrogenase (ld)  254  iu l; chemistry blood % hemoglobin a1c  14.7  %$pneumococcal vac polyvalent  0.5  ml ; sodium chloride 0.9%  flush  3  ml ; d5 1 2ns  1000  ml ; 0.9% sodium chloride  100  ml ; insulin human regular  100  unit ; iso-osmotic dextrose  50  ml ; ceftriaxone  2  g ; acetaminophen  325-650  mg ; senna  1  tab ; iso-osmotic dextrose  200  ml ; vancomycin  1000  mg ; 0.9% sodium chloride  500  ml ; potassium chloride  40  meq ; 5% dextrose  100  ml ; acyclovir  450  mg ; 0.9% sodium chloride  1000  ml ; insulin  0  unit ; heparin  5000  unit ; metoprolol tartrate  25  mg ; insulin  10  unit ; potassium chloride  60  meq ; hydrochlorothiazide  25  mg ; sw  50  ml ; magnesium sulfate  2  gm ; enoxaparin sodium  30  mg ; enoxaparin sodium  40  mg ; insulin  14  unit ; 
 
white m 72 $nan$hematology blood hematocrit  45.0  %; hematology blood hemoglobin  14.7  g dl; hematology blood platelet count  235  k ul; chemistry blood anion gap  15  meq l; chemistry blood bicarbonate  22  meq l; chemistry blood chloride  101  meq l; chemistry blood creatinine  1.4  mg dl; chemistry blood potassium  4.9  meq l; chemistry blood sodium  133  meq l; chemistry blood urea nitrogen  20  mg dl; chemistry blood glucose  189  mg dl$pneumococcal vac polyvalent  0.5  ml ; sodium chloride 0.9%  flush  3  ml ; acetaminophen  325-650  mg ; senna  1  tab ; metoprolol tartrate  25  mg ; insulin  10  unit ; enoxaparin sodium  40  mg ; d5ns  0  ml ; insulin  20  unit ; polyethylene glycol  17  g ; docusate sodium  100  mg ; 
 
white m 72 $nan$hematology blood hematocrit  46.3  %; hematology blood hemoglobin  15.1  g dl; hematology blood platelet count  256  k ul; chemistry blood anion gap  14  meq l; chemistry blood bicarbonate  26  meq l; chemistry blood chloride  97  meq l; chemistry blood creatinine  1.3  mg dl; chemistry blood potassium  4.2  meq l; chemistry blood sodium  133  meq l; chemistry blood urea nitrogen  19  mg dl; chemistry blood glucose  143  mg dl$pneumococcal vac polyvalent  0.5  ml ; sodium chloride 0.9%  flush  3  ml ; acetaminophen  325-650  mg ; senna  1  tab ; metoprolol tartrate  25  mg ; enoxaparin sodium  40  mg ; insulin  20  unit ; polyethylene glycol  17  g ; docusate sodium  100  mg ; 
 
white m 72 $nan$hematology blood hematocrit  43.7  %; hematology blood hemoglobin  14.7  g dl; hematology blood platelet count  241  k ul; chemistry blood anion gap  12  meq l; chemistry blood bicarbonate  29  meq l; chemistry blood chloride  101  meq l; chemistry blood creatinine  1.3  mg dl; chemistry blood potassium  4.2  meq l; chemistry blood sodium  138  meq l; chemistry blood urea nitrogen  23  mg dl; chemistry blood glucose  100  mg dl$pneumococcal vac polyvalent  0.5  ml ; sodium chloride 0.9%  flush  3  ml ; acetaminophen  325-650  mg ; senna  1  tab ; metoprolol tartrate  25  mg ; enoxaparin sodium  40  mg ; docusate sodium  100  mg ; lisinopril  5  mg ; 
 
white m 72 $nan$nan$pneumococcal vac polyvalent  0.5  ml ; sodium chloride 0.9%  flush  3  ml ; acetaminophen  325-650  mg ; senna  1  tab ; metoprolol tartrate  25  mg ; enoxaparin sodium  40  mg ; docusate sodium  100  mg ; lisinopril  5  mg ; 
 
white m 81 $nan$hematology blood hematocrit  27.8  %; hematology blood hematocrit  23.8  %; hematology blood hematocrit  29.7  %; hematology blood hematocrit  23.9  %; hematology blood hematocrit  35.5  %; hematology blood hemoglobin  9.4  g dl; hematology blood hemoglobin  8.4  g dl; hematology blood hemoglobin  12.3  g dl; hematology blood platelet count  144  k ul; hematology blood platelet count  156  k ul; hematology blood platelet count  100  k ul; chemistry blood anion gap  10  meq l; chemistry blood bicarbonate  28  meq l; chemistry blood bicarbonate  26  meq l; chemistry blood chloride  109  meq l; chemistry blood chloride  106  meq l; chemistry blood creatinine  0.9  mg dl; chemistry blood creatinine  1.0  mg dl; chemistry blood potassium  5.0  meq l; chemistry blood sodium  137  meq l; chemistry blood urea nitrogen  17  mg dl; chemistry blood urea nitrogen  15  mg dl; hematology blood inr(pt)  1.5  ; hematology blood inr(pt)  1.5  ; hematology blood inr(pt)  1.3  ; chemistry blood glucose  136  mg dl; blood gas blood free calcium  1.14  mmol l; blood gas blood free calcium  1.29  mmol l; blood gas blood free calcium  1.13  mmol l; blood gas blood lactate  1.3  mmol l; blood gas blood lactate  2.2  mmol l; blood gas blood chloride, whole blood  103  meq l; blood gas blood chloride, whole blood  105  meq l; blood gas blood glucose  109  mg dl; blood gas blood glucose  145  mg dl; blood gas blood glucose  127  mg dl; blood gas blood glucose  135  mg dl; blood gas blood glucose  137  mg dl; blood gas blood glucose  149  mg dl; blood gas blood glucose  98  mg dl; blood gas blood glucose  76  mg dl; blood gas blood hematocrit, calculated  36  %; blood gas blood hematocrit, calculated  26  %; blood gas blood hematocrit, calculated  28  %; blood gas blood hematocrit, calculated  30  %; blood gas blood hemoglobin  12.0  g dl; blood gas blood hemoglobin  8.8  g dl; blood gas blood hemoglobin  9.2  g dl; blood gas blood hemoglobin  9.9  g dl; blood gas blood potassium, whole blood  3.9  meq l; blood gas blood potassium, whole blood  4.5  meq l; blood gas blood potassium, whole blood  4.3  meq l; blood gas blood potassium, whole blood  4.0  meq l; blood gas blood potassium, whole blood  3.9  meq l; blood gas blood potassium, whole blood  4.1  meq l; blood gas blood potassium, whole blood  4.0  meq l; blood gas blood sodium, whole blood  139  meq l; blood gas blood sodium, whole blood  136  meq l; blood gas blood sodium, whole blood  135  meq l$aspirin ec  81  mg ; aspirin  81  mg ; ranitidine  150  mg ; sodium chloride 0.9%  flush  10  ml ; lr  1000  ml ; propofol  1000  mg ; propofol  200  mg ; d5w  250  ml ; nitroglycerin  100  mg ; syringe  1  syr ; nitroglycerin  20  mg ; phenylephrine  60  mg ; phenylephrine  12  mg ; glycopyrrolate  0.6  mg ; neostigmine  3  mg ; sw  50  ml ; potassium chloride  20  meq ; calcium gluconate  2  gm ; magnesium sulfate  2  gm ; morphine sulfate  0.5-4  mg ; metoclopramide  10  mg ; ns  100  ml ; cefazolin  2  g ; oxycodone-acetaminophen  1-2  tab ; sucralfate  1  gm ; acetaminophen  650  mg ; insulin human regular  100  unit ; dextrose 50%  12.5  gm ; protamine sulfate  50  mg ; chlorhexidine gluconate 0.12% oral rinse  15  ml ; docusate sodium  100  mg ; docusate sodium (liquid)  100  mg ; 
 
white m 81 $nan$hematology blood hematocrit  32.1  %; hematology blood hematocrit  26.3  %; hematology blood hemoglobin  9.3  g dl; hematology blood platelet count  106  k ul; chemistry blood anion gap  8  meq l; chemistry blood bicarbonate  30  meq l; chemistry blood chloride  101  meq l; chemistry blood creatinine  1.1  mg dl; chemistry blood potassium  4.4  meq l; chemistry blood sodium  135  meq l; chemistry blood urea nitrogen  22  mg dl; chemistry blood glucose  113  mg dl; blood gas blood free calcium  1.15  mmol l; blood gas blood glucose  150  mg dl; blood gas blood potassium, whole blood  5.0  meq l$aspirin ec  81  mg ; ranitidine  150  mg ; sodium chloride 0.9%  flush  10  ml ; d5w  250  ml ; nitroglycerin  100  mg ; phenylephrine  60  mg ; sw  50  ml ; potassium chloride  20  meq ; calcium gluconate  2  gm ; magnesium sulfate  2  gm ; metoclopramide  10  mg ; ns  100  ml ; cefazolin  2  g ; oxycodone-acetaminophen  1-2  tab ; acetaminophen  650  mg ; insulin human regular  100  unit ; dextrose 50%  12.5  gm ; docusate sodium  100  mg ; allopurinol  100  mg ; finasteride  5  mg ; atorvastatin  10  mg ; furosemide  10  mg ; tamsulosin  0.4  mg ; 
 
white m 81 $nan$hematology blood hematocrit  23.8  %; hematology blood hemoglobin  8.2  g dl; hematology blood platelet count  102  k ul; chemistry blood anion gap  9  meq l; chemistry blood bicarbonate  32  meq l; chemistry blood chloride  100  meq l; chemistry blood creatinine  1.1  mg dl; chemistry blood potassium  4.2  meq l; chemistry blood sodium  137  meq l; chemistry blood urea nitrogen  21  mg dl; chemistry blood calcium, total  8.3  mg dl; chemistry blood glucose  130  mg dl; blood gas blood free calcium  1.11  mmol l$aspirin ec  81  mg ; ranitidine  150  mg ; sodium chloride 0.9%  flush  10  ml ; d5w  250  ml ; nitroglycerin  100  mg ; phenylephrine  60  mg ; sw  50  ml ; potassium chloride  20  meq ; calcium gluconate  2  gm ; magnesium sulfate  2  gm ; metoclopramide  10  mg ; oxycodone-acetaminophen  1-2  tab ; acetaminophen  650  mg ; insulin human regular  100  unit ; dextrose 50%  12.5  gm ; docusate sodium  100  mg ; allopurinol  100  mg ; finasteride  5  mg ; furosemide  10  mg ; tamsulosin  0.4  mg ; niacin  1500  mg ; clopidogrel  75  mg ; milk of magnesia  30  ml ; sodium chloride 0.9%  flush  3  ml ; insulin  0  unit ; iso-osmotic dextrose  50  ml ; cefazolin  1  g ; metoprolol tartrate  12.5  mg ; niacin  1000  mg ; 
 
white m 81 $nan$hematology blood hematocrit  26.8  %; hematology blood hematocrit  30.8  %; hematology blood hemoglobin  10.5  g dl; hematology blood platelet count  123  k ul$niacin  1500  mg ; clopidogrel  75  mg ; milk of magnesia  30  ml ; sodium chloride 0.9%  flush  3  ml ; insulin  0  unit ; iso-osmotic dextrose  50  ml ; cefazolin  1  g ; metoprolol tartrate  12.5  mg ; niacin  1000  mg ; 
 
white m 81 $nan$hematology blood hematocrit  30.6  %; hematology blood hematocrit  28.0  %; hematology blood hemoglobin  9.5  g dl; hematology blood platelet count  152  k ul$niacin  1500  mg ; clopidogrel  75  mg ; milk of magnesia  30  ml ; sodium chloride 0.9%  flush  3  ml ; insulin  0  unit ; metoprolol tartrate  12.5  mg ; niacin  1000  mg ; 
 
white m 81 $nan$nan$niacin  1500  mg ; clopidogrel  75  mg ; milk of magnesia  30  ml ; sodium chloride 0.9%  flush  3  ml ; insulin  0  unit ; metoprolol tartrate  12.5  mg ; niacin  1000  mg ; furosemide  20  mg ; bisacodyl  10  mg ; 
 
white m 81 $nan$chemistry blood anion gap  12  meq l; chemistry blood bicarbonate  34  meq l; chemistry blood chloride  97  meq l; chemistry blood creatinine  1.2  mg dl; chemistry blood potassium  4.6  meq l; chemistry blood sodium  138  meq l; chemistry blood urea nitrogen  20  mg dl; chemistry blood glucose  136  mg dl$niacin  1500  mg ; clopidogrel  75  mg ; milk of magnesia  30  ml ; sodium chloride 0.9%  flush  3  ml ; insulin  0  unit ; metoprolol tartrate  12.5  mg ; niacin  1000  mg ; bisacodyl  10  mg ; furosemide  40  mg ; potassium chloride  40  meq ; acetazolamide  500  mg ; metoprolol tartrate  25  mg ; 
 
white m 69 $nan$nan$aspirin ec  81  mg ; lisinopril  10  mg ; rivaroxaban  20  mg ; dronedarone  400  mg ; metoprolol tartrate  50  mg ; simvastatin  20  mg ; 
paroxysmal tachycardia, unspecified unspecified essential hypertension other and unspecified hyperlipidemia 
white m 69 $nan$nan$aspirin ec  81  mg ; lisinopril  10  mg ; rivaroxaban  20  mg ; dronedarone  400  mg ; metoprolol tartrate  50  mg ; simvastatin  20  mg ; sodium chloride 0.9%  flush  3  ml ; acetaminophen  500-1000  mg ; potassium chloride  20  meq ; potassium chloride  40  meq ; potassium chloride  60  meq ; oxycodone (immediate release)   5  mg ; trazodone  25  mg ; simethicone  40-80  mg ; cepacol (menthol)  1  loz ; 
paroxysmal tachycardia, unspecified unspecified essential hypertension other and unspecified hyperlipidemia 
white f 71 $temp    heartrate  99.0  resprate  20.0  o2sat  95.0  sbp  101.0  dbp  84.0  rhythm    pain  0  ; temp  97.9  heartrate  97.0  resprate  23.0  o2sat    sbp  124.0  dbp  80.0  rhythm    pain    $nan$aspirin  325  mg ; atorvastatin  80  mg ; citalopram  10  mg ; lisinopril  20  mg ; omeprazole  20  mg ; 
 
white f 71 $temp    heartrate  130.0  resprate  22.0  o2sat  96.0  sbp  108.0  dbp  78.0  rhythm    pain  0  ; temp  98.2  heartrate  100.0  resprate  18.0  o2sat  96.0  sbp  120.0  dbp  58.0  rhythm  atrial flutter  pain  0  $hematology blood hematocrit  43.4  %; hematology blood hemoglobin  14.1  g dl; hematology blood platelet count  178  k ul; chemistry blood anion gap  14  meq l; chemistry blood bicarbonate  28  meq l; chemistry blood chloride  107  meq l; chemistry blood creatinine  1.0  mg dl; chemistry blood potassium  3.9  meq l; chemistry blood sodium  145  meq l; chemistry blood urea nitrogen  18  mg dl; hematology blood inr(pt)  1.0  ; chemistry blood calcium, total  9.2  mg dl; chemistry blood glucose  95  mg dl$aspirin  325  mg ; atorvastatin  80  mg ; citalopram  10  mg ; lisinopril  20  mg ; omeprazole  20  mg ; pneumococcal vac polyvalent  0.5  ml ; sodium chloride 0.9%  flush  3  ml ; heparin  1800-3600  unit ; 5% dextrose  250  ml ; heparin sodium  25,000  unit ; diltiazem  30  mg ; 
 
white f 71 $nan$hematology blood hematocrit  38.1  %; hematology blood hemoglobin  12.4  g dl; hematology blood platelet count  158  k ul; chemistry blood anion gap  12  meq l; chemistry blood bicarbonate  27  meq l; chemistry blood chloride  106  meq l; chemistry blood creatinine  0.9  mg dl; chemistry blood potassium  4.1  meq l; chemistry blood sodium  141  meq l; chemistry blood urea nitrogen  20  mg dl; hematology blood inr(pt)  1.1  ; chemistry blood calcium, total  8.9  mg dl; chemistry blood glucose  86  mg dl$aspirin  325  mg ; atorvastatin  80  mg ; citalopram  10  mg ; lisinopril  20  mg ; omeprazole  20  mg ; pneumococcal vac polyvalent  0.5  ml ; sodium chloride 0.9%  flush  3  ml ; dabigatran etexilate  150  mg ; 
 
white f 68 $nan$nan$omeprazole  20  mg ; 
migraine, unspecified, without mention of intractable migraine without mention of status migrainosus other malignant lymphomas, unspecified site, extranodal and solid organ sites esophageal reflux encounter for antineoplastic chemotherapy esophageal reflux encounter for antineoplastic chemotherapy migraine, unspecified, without mention of intractable migraine without mention of status migrainosus other malignant lymphomas, unspecified site, extranodal and solid organ sites encounter for antineoplastic chemotherapy other malignant lymphomas, lymph nodes of head, face, and neck migraine, unspecified, without mention of intractable migraine without mention of status migrainosus esophageal reflux anemia, unspecified personal history of malignant neoplasm of breast large cell lymphoma, unspecified site, extranodal and solid organ sites candidiasis of mouth migraine, unspecified, without mention of intractable migraine without mention of status migrainosus fever dehydration person boarding or alighting a pedal cycle injured in collision with pedestrian or animal other specified cardiac dysrhythmias neutropenia, unspecified anemia, unspecified person boarding or alighting a pedal cycle injured in collision with pedestrian or animal personal history of malignant neoplasm of breast dehydration other malignant lymphomas, unspecified site, extranodal and solid organ sites diarrhea other drugs and medicinal substances causing adverse effects in therapeutic use anemia in neoplastic disease long-term (current) use of aspirin gastric ulcer, unspecified as acute or chronic, without mention of hemorrhage or perforation, without mention of obstruction person boarding or alighting a pedal cycle injured in collision with pedestrian or animal other malaise and fatigue esophageal reflux headache personal history of malignant neoplasm of breast abdominal pain, other specified site anemia, unspecified 
white f 68 $nan$hematology blood hematocrit  24.9  %; hematology blood hemoglobin  8.7  g dl; hematology blood platelet count  142  k ul; chemistry blood anion gap  9  meq l; chemistry blood bicarbonate  34  meq l; chemistry blood chloride  102  meq l; chemistry blood creatinine  1.0  mg dl; chemistry blood potassium  3.3  meq l; chemistry blood sodium  142  meq l; chemistry blood urea nitrogen  18  mg dl; hematology blood inr(pt)  1.0  ; chemistry blood calcium, total  8.7  mg dl; chemistry blood bilirubin, total  0.2  mg dl; chemistry blood glucose  108  mg dl; chemistry blood lactate dehydrogenase (ld)  125  iu l; chemistry blood albumin  3.6  g dl; hematology blood bands  2  %$omeprazole  20  mg ; heparin flush (10 units ml)  2  ml ; d5w  500  ml ; methotrexate sodium  5810  mg ; d5w  50  ml ; ondansetron  24  mg ; d5w  1000  ml ; sodium bicarbonate  150  meq ; d5 1 2ns  1000  ml ; sodium bicarbonate  50  meq ; sodium bicarbonate  1300  mg ; prochlorperazine  10  mg ; lorazepam  0.5-1  mg ; oxycodone (immediate release)   5-10  mg ; sodium bicarbonate  650  mg ; morphine sulfate ir  15  mg ; potassium chloride replacement (oncology)  40  meq ; potassium chloride replacement (oncology)  60  meq ; potassium chloride replacement (oncology)  80  meq ; calcium replacement (oncology)  1  gm ; calcium replacement (oncology)  2  gm ; d5w  250  ml ; calcium gluconate  3  gm ; sw  100  ml ; magnesium sulfate  4  gm ; sw  50  ml ; magnesium sulfate  2-4  gm ; magnesium sulfate  2  gm ; 
migraine, unspecified, without mention of intractable migraine without mention of status migrainosus other malignant lymphomas, unspecified site, extranodal and solid organ sites esophageal reflux encounter for antineoplastic chemotherapy esophageal reflux encounter for antineoplastic chemotherapy migraine, unspecified, without mention of intractable migraine without mention of status migrainosus other malignant lymphomas, unspecified site, extranodal and solid organ sites encounter for antineoplastic chemotherapy other malignant lymphomas, lymph nodes of head, face, and neck migraine, unspecified, without mention of intractable migraine without mention of status migrainosus esophageal reflux anemia, unspecified personal history of malignant neoplasm of breast large cell lymphoma, unspecified site, extranodal and solid organ sites candidiasis of mouth migraine, unspecified, without mention of intractable migraine without mention of status migrainosus fever dehydration person boarding or alighting a pedal cycle injured in collision with pedestrian or animal other specified cardiac dysrhythmias neutropenia, unspecified anemia, unspecified person boarding or alighting a pedal cycle injured in collision with pedestrian or animal personal history of malignant neoplasm of breast dehydration other malignant lymphomas, unspecified site, extranodal and solid organ sites diarrhea other drugs and medicinal substances causing adverse effects in therapeutic use anemia in neoplastic disease long-term (current) use of aspirin gastric ulcer, unspecified as acute or chronic, without mention of hemorrhage or perforation, without mention of obstruction person boarding or alighting a pedal cycle injured in collision with pedestrian or animal other malaise and fatigue esophageal reflux headache personal history of malignant neoplasm of breast abdominal pain, other specified site anemia, unspecified 
white f 68 $nan$hematology blood hematocrit  25.1  %; hematology blood hemoglobin  8.8  g dl; hematology blood platelet count  138  k ul; chemistry blood anion gap  8  meq l; chemistry blood bicarbonate  31  meq l; chemistry blood chloride  108  meq l; chemistry blood creatinine  0.7  mg dl; chemistry blood potassium  4.0  meq l; chemistry blood sodium  143  meq l; chemistry blood urea nitrogen  16  mg dl; hematology blood inr(pt)  1.1  ; chemistry blood calcium, total  7.9  mg dl; chemistry blood bilirubin, total  0.2  mg dl; chemistry blood glucose  100  mg dl; chemistry blood lactate dehydrogenase (ld)  141  iu l; hematology blood bands  0  %$omeprazole  20  mg ; heparin flush (10 units ml)  2  ml ; d5w  500  ml ; methotrexate sodium  5810  mg ; d5w  50  ml ; ondansetron  24  mg ; sodium bicarbonate  1300  mg ; prochlorperazine  10  mg ; lorazepam  0.5-1  mg ; oxycodone (immediate release)   5-10  mg ; sodium bicarbonate  650  mg ; morphine sulfate ir  15  mg ; potassium chloride replacement (oncology)  40  meq ; potassium chloride replacement (oncology)  60  meq ; potassium chloride replacement (oncology)  80  meq ; calcium replacement (oncology)  1  gm ; calcium replacement (oncology)  2  gm ; d5w  250  ml ; calcium gluconate  3  gm ; sw  100  ml ; magnesium sulfate  4  gm ; sw  50  ml ; magnesium sulfate  2-4  gm ; magnesium sulfate  2  gm ; potassium phosphate  15  mmol ; potassium chloride  40  meq ; ns  1000  ml ; potassium chloride  60  meq ; leucovorin calcium  25  mg ; zolpidem tartrate  10  mg ; 
migraine, unspecified, without mention of intractable migraine without mention of status migrainosus other malignant lymphomas, unspecified site, extranodal and solid organ sites esophageal reflux encounter for antineoplastic chemotherapy esophageal reflux encounter for antineoplastic chemotherapy migraine, unspecified, without mention of intractable migraine without mention of status migrainosus other malignant lymphomas, unspecified site, extranodal and solid organ sites encounter for antineoplastic chemotherapy other malignant lymphomas, lymph nodes of head, face, and neck migraine, unspecified, without mention of intractable migraine without mention of status migrainosus esophageal reflux anemia, unspecified personal history of malignant neoplasm of breast large cell lymphoma, unspecified site, extranodal and solid organ sites candidiasis of mouth migraine, unspecified, without mention of intractable migraine without mention of status migrainosus fever dehydration person boarding or alighting a pedal cycle injured in collision with pedestrian or animal other specified cardiac dysrhythmias neutropenia, unspecified anemia, unspecified person boarding or alighting a pedal cycle injured in collision with pedestrian or animal personal history of malignant neoplasm of breast dehydration other malignant lymphomas, unspecified site, extranodal and solid organ sites diarrhea other drugs and medicinal substances causing adverse effects in therapeutic use anemia in neoplastic disease long-term (current) use of aspirin gastric ulcer, unspecified as acute or chronic, without mention of hemorrhage or perforation, without mention of obstruction person boarding or alighting a pedal cycle injured in collision with pedestrian or animal other malaise and fatigue esophageal reflux headache personal history of malignant neoplasm of breast abdominal pain, other specified site anemia, unspecified 
white f 68 $nan$nan$omeprazole  20  mg ; heparin flush (10 units ml)  2  ml ; sodium bicarbonate  1300  mg ; prochlorperazine  10  mg ; lorazepam  0.5-1  mg ; oxycodone (immediate release)   5-10  mg ; sodium bicarbonate  650  mg ; morphine sulfate ir  15  mg ; potassium chloride replacement (oncology)  40  meq ; potassium chloride replacement (oncology)  60  meq ; potassium chloride replacement (oncology)  80  meq ; calcium replacement (oncology)  1  gm ; calcium replacement (oncology)  2  gm ; d5w  250  ml ; calcium gluconate  3  gm ; sw  100  ml ; magnesium sulfate  4  gm ; sw  50  ml ; magnesium sulfate  2-4  gm ; magnesium sulfate  2  gm ; potassium phosphate  15  mmol ; potassium chloride  40  meq ; ns  1000  ml ; potassium chloride  60  meq ; leucovorin calcium  25  mg ; zolpidem tartrate  10  mg ; 
migraine, unspecified, without mention of intractable migraine without mention of status migrainosus other malignant lymphomas, unspecified site, extranodal and solid organ sites esophageal reflux encounter for antineoplastic chemotherapy esophageal reflux encounter for antineoplastic chemotherapy migraine, unspecified, without mention of intractable migraine without mention of status migrainosus other malignant lymphomas, unspecified site, extranodal and solid organ sites encounter for antineoplastic chemotherapy other malignant lymphomas, lymph nodes of head, face, and neck migraine, unspecified, without mention of intractable migraine without mention of status migrainosus esophageal reflux anemia, unspecified personal history of malignant neoplasm of breast large cell lymphoma, unspecified site, extranodal and solid organ sites candidiasis of mouth migraine, unspecified, without mention of intractable migraine without mention of status migrainosus fever dehydration person boarding or alighting a pedal cycle injured in collision with pedestrian or animal other specified cardiac dysrhythmias neutropenia, unspecified anemia, unspecified person boarding or alighting a pedal cycle injured in collision with pedestrian or animal personal history of malignant neoplasm of breast dehydration other malignant lymphomas, unspecified site, extranodal and solid organ sites diarrhea other drugs and medicinal substances causing adverse effects in therapeutic use anemia in neoplastic disease long-term (current) use of aspirin gastric ulcer, unspecified as acute or chronic, without mention of hemorrhage or perforation, without mention of obstruction person boarding or alighting a pedal cycle injured in collision with pedestrian or animal other malaise and fatigue esophageal reflux headache personal history of malignant neoplasm of breast abdominal pain, other specified site anemia, unspecified 
white f 68 $nan$nan$omeprazole  20  mg ; heparin flush (10 units ml)  2  ml ; sodium bicarbonate  1300  mg ; prochlorperazine  10  mg ; lorazepam  0.5-1  mg ; oxycodone (immediate release)   5-10  mg ; sodium bicarbonate  650  mg ; morphine sulfate ir  15  mg ; potassium chloride replacement (oncology)  40  meq ; potassium chloride replacement (oncology)  60  meq ; potassium chloride replacement (oncology)  80  meq ; calcium replacement (oncology)  1  gm ; calcium replacement (oncology)  2  gm ; d5w  250  ml ; calcium gluconate  3  gm ; sw  100  ml ; magnesium sulfate  4  gm ; sw  50  ml ; magnesium sulfate  2-4  gm ; magnesium sulfate  2  gm ; potassium phosphate  15  mmol ; potassium chloride  40  meq ; ns  1000  ml ; potassium chloride  60  meq ; leucovorin calcium  25  mg ; zolpidem tartrate  10  mg ; 
migraine, unspecified, without mention of intractable migraine without mention of status migrainosus other malignant lymphomas, unspecified site, extranodal and solid organ sites esophageal reflux encounter for antineoplastic chemotherapy esophageal reflux encounter for antineoplastic chemotherapy migraine, unspecified, without mention of intractable migraine without mention of status migrainosus other malignant lymphomas, unspecified site, extranodal and solid organ sites encounter for antineoplastic chemotherapy other malignant lymphomas, lymph nodes of head, face, and neck migraine, unspecified, without mention of intractable migraine without mention of status migrainosus esophageal reflux anemia, unspecified personal history of malignant neoplasm of breast large cell lymphoma, unspecified site, extranodal and solid organ sites candidiasis of mouth migraine, unspecified, without mention of intractable migraine without mention of status migrainosus fever dehydration person boarding or alighting a pedal cycle injured in collision with pedestrian or animal other specified cardiac dysrhythmias neutropenia, unspecified anemia, unspecified person boarding or alighting a pedal cycle injured in collision with pedestrian or animal personal history of malignant neoplasm of breast dehydration other malignant lymphomas, unspecified site, extranodal and solid organ sites diarrhea other drugs and medicinal substances causing adverse effects in therapeutic use anemia in neoplastic disease long-term (current) use of aspirin gastric ulcer, unspecified as acute or chronic, without mention of hemorrhage or perforation, without mention of obstruction person boarding or alighting a pedal cycle injured in collision with pedestrian or animal other malaise and fatigue esophageal reflux headache personal history of malignant neoplasm of breast abdominal pain, other specified site anemia, unspecified 
white f 74 $temp  97.7  heartrate  87.0  resprate  22.0  o2sat  99.0  sbp  121.0  dbp  63.0  rhythm    pain  0  ; temp    heartrate  89.0  resprate  20.0  o2sat  99.0  sbp  130.0  dbp  64.0  rhythm    pain  0  $hematology blood hematocrit  37.3  %; hematology blood hemoglobin  12.3  g dl; hematology blood platelet count  267  k ul; chemistry blood anion gap  16  meq l; chemistry blood bicarbonate  24  meq l; chemistry blood chloride  99  meq l; chemistry blood creatinine  0.7  mg dl; chemistry blood potassium  4.2  meq l; chemistry blood sodium  135  meq l; chemistry blood urea nitrogen  19  mg dl; chemistry blood bilirubin, total  0.5  mg dl; chemistry blood glucose  221  mg dl; chemistry blood albumin  3.6  g dl; blood gas blood lactate  1.2  mmol l$nan
 
white f 74 $temp  97.7  heartrate  82.0  resprate  20.0  o2sat  100.0  sbp  126.0  dbp  68.0  rhythm    pain  0  $hematology blood hematocrit  32.2  %; hematology blood hemoglobin  10.8  g dl; hematology blood platelet count  255  k ul; chemistry blood anion gap  10  meq l; chemistry blood bicarbonate  28  meq l; chemistry blood chloride  104  meq l; chemistry blood creatinine  0.5  mg dl; chemistry blood potassium  3.7  meq l; chemistry blood sodium  138  meq l; chemistry blood urea nitrogen  13  mg dl; chemistry blood calcium, total  8.8  mg dl; chemistry blood glucose  107  mg dl$0.45% sodium chloride  1000  ml ; influenza vaccine quadrivalent  0.5  ml ; sodium chloride 0.9%  flush  3  ml ; sodium chloride 0.9%  1000  ml ; albuterol 0.083% neb soln  1  neb ; heparin  5000  unit ; citalopram  20  mg ; divalproex (delayed release)  500  mg ; quetiapine fumarate  25  mg ; guaifenesin  5-10  ml ; dextrose 50%  12.5  gm ; glucagon  1  mg ; glucose gel  15  g ; insulin  0  unit ; vitamin d  1000  unit ; trazodone  50  mg ; 0.9% sodium chloride (mini bag plus)  100  ml ; ceftriaxone  1  gm ; azithromycin  250  mg ; 
 
white f 74 $nan$hematology blood hematocrit  32.3  %; hematology blood hemoglobin  10.9  g dl; hematology blood platelet count  268  k ul; chemistry blood anion gap  12  meq l; chemistry blood bicarbonate  25  meq l; chemistry blood chloride  104  meq l; chemistry blood creatinine  0.4  mg dl; chemistry blood potassium  3.4  meq l; chemistry blood sodium  138  meq l; chemistry blood urea nitrogen  13  mg dl; chemistry blood calcium, total  8.7  mg dl; chemistry blood glucose  128  mg dl$influenza vaccine quadrivalent  0.5  ml ; sodium chloride 0.9%  flush  3  ml ; albuterol 0.083% neb soln  1  neb ; heparin  5000  unit ; citalopram  20  mg ; divalproex (delayed release)  500  mg ; quetiapine fumarate  25  mg ; guaifenesin  5-10  ml ; dextrose 50%  12.5  gm ; glucagon  1  mg ; glucose gel  15  g ; insulin  0  unit ; vitamin d  1000  unit ; trazodone  50  mg ; 0.9% sodium chloride (mini bag plus)  100  ml ; ceftriaxone  1  gm ; azithromycin  250  mg ; potassium chloride  40  meq ; magnesium oxide  400  mg ; potassium chloride (powder)  40  meq ; 
 
black african american m 61 $nan$hematology blood hematocrit  36.9  %; hematology blood hematocrit  37.8  %; hematology blood hemoglobin  12.7  g dl; hematology blood platelet count  315  k ul; chemistry blood anion gap  12  meq l; chemistry blood bicarbonate  25  meq l; chemistry blood chloride  104  meq l; chemistry blood creatinine  1.0  mg dl; chemistry blood potassium  4.1  meq l; chemistry blood potassium  4.2  meq l; chemistry blood sodium  137  meq l; chemistry blood urea nitrogen  11  mg dl; chemistry blood calcium, total  8.7  mg dl; chemistry blood bilirubin, total  1.0  mg dl; chemistry blood glucose  121  mg dl; blood gas blood potassium, whole blood  2.9  meq l$sodium chloride 0.9%  flush  3  ml ; ondansetron  4-8  mg ; diazepam  5  mg ; 1 2 ns  1000  ml ; ondansetron  4  mg ; prochlorperazine  10  mg ; promethazine  6.25  mg ; docusate sodium  100  mg ; senna  1  tab ; azithromycin  250  mg ; meclizine  12.5  mg ; heparin  5000  unit ; triamterene-hydrochlorothiazide  1  cap ; metformin (glucophage)  500  mg ; felodipine  20  mg ; 
 
black african american m 61 $nan$hematology blood hematocrit  36.2  %; hematology blood hemoglobin  12.6  g dl; hematology blood platelet count  322  k ul; chemistry blood anion gap  14  meq l; chemistry blood bicarbonate  26  meq l; chemistry blood chloride  104  meq l; chemistry blood creatinine  1.1  mg dl; chemistry blood potassium  3.9  meq l; chemistry blood sodium  140  meq l; chemistry blood urea nitrogen  15  mg dl; chemistry blood calcium, total  8.9  mg dl; chemistry blood glucose  128  mg dl$1 2 ns  1000  ml ; ondansetron  4  mg ; prochlorperazine  10  mg ; promethazine  6.25  mg ; docusate sodium  100  mg ; senna  1  tab ; azithromycin  250  mg ; meclizine  12.5  mg ; heparin  5000  unit ; triamterene-hydrochlorothiazide  1  cap ; metformin (glucophage)  500  mg ; felodipine  20  mg ; debrox 6.5%  5-10  drop ; 
 
black african american m 61 $nan$nan$ondansetron  4  mg ; prochlorperazine  10  mg ; promethazine  6.25  mg ; docusate sodium  100  mg ; senna  1  tab ; azithromycin  250  mg ; meclizine  12.5  mg ; heparin  5000  unit ; triamterene-hydrochlorothiazide  1  cap ; metformin (glucophage)  500  mg ; felodipine  20  mg ; debrox 6.5%  5-10  drop ; 
 
white f 61 $nan$nan$lorazepam  0.5  mg ; quetiapine fumarate  25  mg ; acetaminophen  650  mg ; aluminum-magnesium hydrox.-simethicone  30  ml ; milk of magnesia  30  ml ; hydroxyzine  25  mg ; escitalopram oxalate  20  mg ; quetiapine fumarate  50  mg ; 
suicidal ideation depressive disorder, not elsewhere classified anxiety state, unspecified dependent personality disorder major depressive affective disorder, recurrent episode, severe, without mention of psychotic behavior suicidal ideation loss of weight suicidal ideation depressive disorder, not elsewhere classified 
white f 61 $nan$nan$acetaminophen  650  mg ; aluminum-magnesium hydrox.-simethicone  30  ml ; milk of magnesia  30  ml ; hydroxyzine  25  mg ; escitalopram oxalate  20  mg ; quetiapine fumarate  50  mg ; quetiapine fumarate  100  mg ; 
suicidal ideation depressive disorder, not elsewhere classified anxiety state, unspecified dependent personality disorder major depressive affective disorder, recurrent episode, severe, without mention of psychotic behavior suicidal ideation loss of weight suicidal ideation depressive disorder, not elsewhere classified 
white f 61 $nan$nan$acetaminophen  650  mg ; aluminum-magnesium hydrox.-simethicone  30  ml ; milk of magnesia  30  ml ; hydroxyzine  25  mg ; escitalopram oxalate  20  mg ; quetiapine fumarate  100  mg ; quetiapine fumarate  125  mg ; senna  1  tab ; docusate sodium  100  mg ; 
suicidal ideation depressive disorder, not elsewhere classified anxiety state, unspecified dependent personality disorder major depressive affective disorder, recurrent episode, severe, without mention of psychotic behavior suicidal ideation loss of weight suicidal ideation depressive disorder, not elsewhere classified 
white f 61 $nan$nan$acetaminophen  650  mg ; aluminum-magnesium hydrox.-simethicone  30  ml ; milk of magnesia  30  ml ; hydroxyzine  25  mg ; escitalopram oxalate  20  mg ; quetiapine fumarate  125  mg ; senna  1  tab ; docusate sodium  100  mg ; 
suicidal ideation depressive disorder, not elsewhere classified anxiety state, unspecified dependent personality disorder major depressive affective disorder, recurrent episode, severe, without mention of psychotic behavior suicidal ideation loss of weight suicidal ideation depressive disorder, not elsewhere classified 
white f 61 $nan$nan$acetaminophen  650  mg ; aluminum-magnesium hydrox.-simethicone  30  ml ; milk of magnesia  30  ml ; hydroxyzine  25  mg ; escitalopram oxalate  20  mg ; quetiapine fumarate  125  mg ; senna  1  tab ; docusate sodium  100  mg ; quetiapine fumarate  150  mg ; 
suicidal ideation depressive disorder, not elsewhere classified anxiety state, unspecified dependent personality disorder major depressive affective disorder, recurrent episode, severe, without mention of psychotic behavior suicidal ideation loss of weight suicidal ideation depressive disorder, not elsewhere classified 
white f 61 $nan$nan$acetaminophen  650  mg ; aluminum-magnesium hydrox.-simethicone  30  ml ; milk of magnesia  30  ml ; hydroxyzine  25  mg ; escitalopram oxalate  20  mg ; docusate sodium  100  mg ; quetiapine fumarate  150  mg ; bisacodyl  10  mg ; 
suicidal ideation depressive disorder, not elsewhere classified anxiety state, unspecified dependent personality disorder major depressive affective disorder, recurrent episode, severe, without mention of psychotic behavior suicidal ideation loss of weight suicidal ideation depressive disorder, not elsewhere classified 
white f 61 $nan$nan$acetaminophen  650  mg ; aluminum-magnesium hydrox.-simethicone  30  ml ; milk of magnesia  30  ml ; escitalopram oxalate  20  mg ; quetiapine fumarate  150  mg ; bisacodyl  10  mg ; 
suicidal ideation depressive disorder, not elsewhere classified anxiety state, unspecified dependent personality disorder major depressive affective disorder, recurrent episode, severe, without mention of psychotic behavior suicidal ideation loss of weight suicidal ideation depressive disorder, not elsewhere classified 
white f 61 $nan$nan$acetaminophen  650  mg ; aluminum-magnesium hydrox.-simethicone  30  ml ; milk of magnesia  30  ml ; escitalopram oxalate  20  mg ; quetiapine fumarate  150  mg ; bisacodyl  10  mg ; quetiapine fumarate  200  mg ; 
suicidal ideation depressive disorder, not elsewhere classified anxiety state, unspecified dependent personality disorder major depressive affective disorder, recurrent episode, severe, without mention of psychotic behavior suicidal ideation loss of weight suicidal ideation depressive disorder, not elsewhere classified 
white f 61 $nan$nan$acetaminophen  650  mg ; aluminum-magnesium hydrox.-simethicone  30  ml ; milk of magnesia  30  ml ; escitalopram oxalate  20  mg ; quetiapine fumarate  200  mg ; magnesium citrate  300  ml ; 
suicidal ideation depressive disorder, not elsewhere classified anxiety state, unspecified dependent personality disorder major depressive affective disorder, recurrent episode, severe, without mention of psychotic behavior suicidal ideation loss of weight suicidal ideation depressive disorder, not elsewhere classified 
white f 61 $nan$nan$acetaminophen  650  mg ; aluminum-magnesium hydrox.-simethicone  30  ml ; milk of magnesia  30  ml ; escitalopram oxalate  20  mg ; quetiapine fumarate  200  mg ; magnesium citrate  300  ml ; 
suicidal ideation depressive disorder, not elsewhere classified anxiety state, unspecified dependent personality disorder major depressive affective disorder, recurrent episode, severe, without mention of psychotic behavior suicidal ideation loss of weight suicidal ideation depressive disorder, not elsewhere classified 
white f 61 $nan$nan$acetaminophen  650  mg ; aluminum-magnesium hydrox.-simethicone  30  ml ; milk of magnesia  30  ml ; escitalopram oxalate  20  mg ; quetiapine fumarate  200  mg ; 
suicidal ideation depressive disorder, not elsewhere classified anxiety state, unspecified dependent personality disorder major depressive affective disorder, recurrent episode, severe, without mention of psychotic behavior suicidal ideation loss of weight suicidal ideation depressive disorder, not elsewhere classified 
white m 59 $nan$hematology blood hematocrit  52.2  %; hematology blood hematocrit  54.7  %; hematology blood hemoglobin  17.3  g dl; hematology blood hemoglobin  17.7  g dl; hematology blood platelet count  141  k ul; hematology blood platelet count  131  k ul; chemistry blood anion gap  16  meq l; chemistry blood anion gap  14  meq l; chemistry blood bicarbonate  26  meq l; chemistry blood bicarbonate  28  meq l; chemistry blood chloride  108  meq l; chemistry blood chloride  106  meq l; chemistry blood creatinine  1.3  mg dl; chemistry blood creatinine  1.3  mg dl; chemistry blood potassium  3.9  meq l; chemistry blood potassium  3.9  meq l; chemistry blood sodium  146  meq l; chemistry blood sodium  144  meq l; chemistry blood urea nitrogen  45  mg dl; chemistry blood urea nitrogen  47  mg dl; hematology blood inr(pt)  1.4  ; chemistry blood calcium, total  10.5  mg dl; chemistry blood calcium, total  10.8  mg dl; chemistry blood bilirubin, total  29.7  mg dl; chemistry blood bilirubin, total  32.0  mg dl; chemistry blood glucose  102  mg dl; chemistry blood glucose  111  mg dl; chemistry blood albumin  3.0  g dl; chemistry blood albumin  3.2  g dl$sodium chloride 0.9%  flush  3  ml ; heparin flush (10 units ml)  1  ml ; sodium chloride 0.9%  flush  10  ml ; folic acid  1  mg ; olanzapine (disintegrating tablet)  2.5  mg ; lactulose  30  ml ; heparin  5000  unit ; thiamine  100  mg ; multivitamins w minerals  1  tab ; furosemide  40  mg ; spironolactone  100  mg ; 
other secondary thrombocytopenia tobacco use disorder other ascites esophageal varices in diseases classified elsewhere, without mention of bleeding other and unspecified alcohol dependence, unspecified cannabis abuse, unspecified portal hypertension calculus of bile duct without mention of cholecystitis, with obstruction acute alcoholic hepatitis other and unspecified coagulation defects esophageal reflux acute pancreatitis unspecified peritonitis alcoholic cirrhosis of liver alcohol abuse, in remission unspecified fall other specified hypotension cannabis abuse, unspecified cirrhosis of liver without mention of alcohol home accidents unspecified gastritis and gastroduodenitis, without mention of hemorrhage other specified metabolic disorders unspecified disorder of liver esophageal varices in diseases classified elsewhere, without mention of bleeding bimalleolar fracture, closed tobacco use disorder unspecified viral hepatitis c without hepatic coma 
white m 59 $nan$hematology blood hematocrit  44.9  %; hematology blood hematocrit  44.8  %; hematology blood hematocrit  44.1  %; hematology blood hemoglobin  15.1  g dl; hematology blood hemoglobin  14.8  g dl; hematology blood hemoglobin  14.9  g dl; hematology blood platelet count  131  k ul; hematology blood platelet count  134  k ul; hematology blood platelet count  133  k ul; chemistry blood anion gap  13  meq l; chemistry blood bicarbonate  25  meq l; chemistry blood chloride  99  meq l; chemistry blood creatinine  1.3  mg dl; chemistry blood potassium  3.5  meq l; chemistry blood sodium  133  meq l; chemistry blood urea nitrogen  49  mg dl; hematology blood inr(pt)  1.5  ; chemistry blood calcium, total  10.2  mg dl; chemistry blood bilirubin, total  30.8  mg dl; chemistry blood glucose  99  mg dl; chemistry blood albumin  2.7  g dl$sodium chloride 0.9%  flush  3  ml ; heparin flush (10 units ml)  1  ml ; sodium chloride 0.9%  flush  10  ml ; folic acid  1  mg ; olanzapine (disintegrating tablet)  2.5  mg ; heparin  5000  unit ; thiamine  100  mg ; multivitamins w minerals  1  tab ; furosemide  40  mg ; spironolactone  100  mg ; lidocaine 1%  10  ml ; 0.9% sodium chloride  100  ml ; octreotide acetate  500  mcg ; octreotide acetate  50  mcg ; ondansetron  2  mg ; vial  2  vial ; pantoprazole  80  mg ; 0.9% sodium chloride (mini bag plus)  100  ml ; ceftriaxone  1  gm ; 
other secondary thrombocytopenia tobacco use disorder other ascites esophageal varices in diseases classified elsewhere, without mention of bleeding other and unspecified alcohol dependence, unspecified cannabis abuse, unspecified portal hypertension calculus of bile duct without mention of cholecystitis, with obstruction acute alcoholic hepatitis other and unspecified coagulation defects esophageal reflux acute pancreatitis unspecified peritonitis alcoholic cirrhosis of liver alcohol abuse, in remission unspecified fall other specified hypotension cannabis abuse, unspecified cirrhosis of liver without mention of alcohol home accidents unspecified gastritis and gastroduodenitis, without mention of hemorrhage other specified metabolic disorders unspecified disorder of liver esophageal varices in diseases classified elsewhere, without mention of bleeding bimalleolar fracture, closed tobacco use disorder unspecified viral hepatitis c without hepatic coma 
white m 59 $nan$hematology blood hematocrit  42.0  %; hematology blood hematocrit  42.0  %; hematology blood hemoglobin  13.9  g dl; hematology blood hemoglobin  13.8  g dl; hematology blood platelet count  125  k ul; hematology blood platelet count  127  k ul; chemistry blood anion gap  15  meq l; chemistry blood bicarbonate  24  meq l; chemistry blood chloride  97  meq l; chemistry blood creatinine  1.6  mg dl; chemistry blood potassium  3.6  meq l; chemistry blood sodium  132  meq l; chemistry blood urea nitrogen  57  mg dl; chemistry blood calcium, total  9.6  mg dl; chemistry blood bilirubin, total  31.1  mg dl; chemistry blood glucose  131  mg dl$sodium chloride 0.9%  flush  3  ml ; heparin flush (10 units ml)  1  ml ; sodium chloride 0.9%  flush  10  ml ; folic acid  1  mg ; olanzapine (disintegrating tablet)  2.5  mg ; heparin  5000  unit ; thiamine  100  mg ; multivitamins w minerals  1  tab ; lidocaine 1%  10  ml ; octreotide acetate  50  mcg ; ondansetron  2  mg ; vial  2  vial ; pantoprazole  80  mg ; 0.9% sodium chloride (mini bag plus)  100  ml ; ceftriaxone  1  gm ; sucralfate  1  gm ; rifaximin  550  mg ; ceftriaxone  2  gm ; albumin 25% (12.5g   50ml)  100  g ; 
other secondary thrombocytopenia tobacco use disorder other ascites esophageal varices in diseases classified elsewhere, without mention of bleeding other and unspecified alcohol dependence, unspecified cannabis abuse, unspecified portal hypertension calculus of bile duct without mention of cholecystitis, with obstruction acute alcoholic hepatitis other and unspecified coagulation defects esophageal reflux acute pancreatitis unspecified peritonitis alcoholic cirrhosis of liver alcohol abuse, in remission unspecified fall other specified hypotension cannabis abuse, unspecified cirrhosis of liver without mention of alcohol home accidents unspecified gastritis and gastroduodenitis, without mention of hemorrhage other specified metabolic disorders unspecified disorder of liver esophageal varices in diseases classified elsewhere, without mention of bleeding bimalleolar fracture, closed tobacco use disorder unspecified viral hepatitis c without hepatic coma 
white m 59 $nan$hematology blood hematocrit  40.3  %; hematology blood hemoglobin  13.4  g dl; hematology blood platelet count  121  k ul; chemistry blood anion gap  15  meq l; chemistry blood bicarbonate  23  meq l; chemistry blood chloride  99  meq l; chemistry blood creatinine  1.2  mg dl; chemistry blood potassium  3.4  meq l; chemistry blood sodium  134  meq l; chemistry blood urea nitrogen  41  mg dl; hematology blood inr(pt)  1.5  ; chemistry blood calcium, total  10.1  mg dl; chemistry blood bilirubin, total  34.3  mg dl; chemistry blood glucose  108  mg dl; chemistry blood albumin  3.5  g dl$sodium chloride 0.9%  flush  3  ml ; heparin flush (10 units ml)  1  ml ; sodium chloride 0.9%  flush  10  ml ; folic acid  1  mg ; olanzapine (disintegrating tablet)  2.5  mg ; heparin  5000  unit ; thiamine  100  mg ; multivitamins w minerals  1  tab ; ondansetron  2  mg ; sucralfate  1  gm ; rifaximin  550  mg ; albumin 25% (12.5g   50ml)  100  g ; tramadol (ultram)  25  mg ; bag  1  bag ; magnesium sulfate  2  gm ; phosphorus  500  mg ; 
other secondary thrombocytopenia tobacco use disorder other ascites esophageal varices in diseases classified elsewhere, without mention of bleeding other and unspecified alcohol dependence, unspecified cannabis abuse, unspecified portal hypertension calculus of bile duct without mention of cholecystitis, with obstruction acute alcoholic hepatitis other and unspecified coagulation defects esophageal reflux acute pancreatitis unspecified peritonitis alcoholic cirrhosis of liver alcohol abuse, in remission unspecified fall other specified hypotension cannabis abuse, unspecified cirrhosis of liver without mention of alcohol home accidents unspecified gastritis and gastroduodenitis, without mention of hemorrhage other specified metabolic disorders unspecified disorder of liver esophageal varices in diseases classified elsewhere, without mention of bleeding bimalleolar fracture, closed tobacco use disorder unspecified viral hepatitis c without hepatic coma 
white m 59 $nan$hematology blood hematocrit  40.0  %; hematology blood hemoglobin  13.6  g dl; hematology blood platelet count  122  k ul; chemistry blood anion gap  18  meq l; chemistry blood bicarbonate  20  meq l; chemistry blood chloride  99  meq l; chemistry blood creatinine  1.0  mg dl; chemistry blood potassium  3.7  meq l; chemistry blood sodium  133  meq l; chemistry blood urea nitrogen  30  mg dl; hematology blood inr(pt)  1.5  ; chemistry blood calcium, total  10.1  mg dl; chemistry blood bilirubin, total  36.7  mg dl; chemistry blood glucose  103  mg dl; chemistry blood albumin  3.1  g dl$sodium chloride 0.9%  flush  3  ml ; heparin flush (10 units ml)  1  ml ; sodium chloride 0.9%  flush  10  ml ; folic acid  1  mg ; olanzapine (disintegrating tablet)  2.5  mg ; heparin  5000  unit ; thiamine  100  mg ; multivitamins w minerals  1  tab ; ondansetron  2  mg ; sucralfate  1  gm ; rifaximin  550  mg ; tramadol (ultram)  25  mg ; bag  1  bag ; magnesium sulfate  2  gm ; phosphorus  500  mg ; potassium chloride  40  meq ; 
other secondary thrombocytopenia tobacco use disorder other ascites esophageal varices in diseases classified elsewhere, without mention of bleeding other and unspecified alcohol dependence, unspecified cannabis abuse, unspecified portal hypertension calculus of bile duct without mention of cholecystitis, with obstruction acute alcoholic hepatitis other and unspecified coagulation defects esophageal reflux acute pancreatitis unspecified peritonitis alcoholic cirrhosis of liver alcohol abuse, in remission unspecified fall other specified hypotension cannabis abuse, unspecified cirrhosis of liver without mention of alcohol home accidents unspecified gastritis and gastroduodenitis, without mention of hemorrhage other specified metabolic disorders unspecified disorder of liver esophageal varices in diseases classified elsewhere, without mention of bleeding bimalleolar fracture, closed tobacco use disorder unspecified viral hepatitis c without hepatic coma 
white m 59 $nan$hematology blood hematocrit  38.7  %; hematology blood hematocrit  33.5  %; hematology blood hemoglobin  12.9  g dl; hematology blood hemoglobin  11.1  g dl; hematology blood platelet count  115  k ul; hematology blood platelet count  132  k ul; chemistry blood anion gap  17  meq l; chemistry blood bicarbonate  20  meq l; chemistry blood chloride  100  meq l; chemistry blood creatinine  1.1  mg dl; chemistry blood potassium  3.8  meq l; chemistry blood sodium  133  meq l; chemistry blood urea nitrogen  23  mg dl; hematology blood inr(pt)  1.5  ; chemistry blood calcium, total  10.4  mg dl; chemistry blood bilirubin, total  36.1  mg dl; chemistry blood glucose  109  mg dl; chemistry blood albumin  3.8  g dl$sodium chloride 0.9%  flush  3  ml ; heparin flush (10 units ml)  1  ml ; sodium chloride 0.9%  flush  10  ml ; folic acid  1  mg ; olanzapine (disintegrating tablet)  2.5  mg ; heparin  5000  unit ; thiamine  100  mg ; multivitamins w minerals  1  tab ; ondansetron  2  mg ; sucralfate  1  gm ; rifaximin  550  mg ; potassium chloride  40  meq ; lidocaine 5% patch  1  ptch ; albumin 5% (25g   500ml)  25  g ; 
other secondary thrombocytopenia tobacco use disorder other ascites esophageal varices in diseases classified elsewhere, without mention of bleeding other and unspecified alcohol dependence, unspecified cannabis abuse, unspecified portal hypertension calculus of bile duct without mention of cholecystitis, with obstruction acute alcoholic hepatitis other and unspecified coagulation defects esophageal reflux acute pancreatitis unspecified peritonitis alcoholic cirrhosis of liver alcohol abuse, in remission unspecified fall other specified hypotension cannabis abuse, unspecified cirrhosis of liver without mention of alcohol home accidents unspecified gastritis and gastroduodenitis, without mention of hemorrhage other specified metabolic disorders unspecified disorder of liver esophageal varices in diseases classified elsewhere, without mention of bleeding bimalleolar fracture, closed tobacco use disorder unspecified viral hepatitis c without hepatic coma 
white m 59 $nan$hematology blood hematocrit  33.7  %; hematology blood hematocrit  30.0  %; hematology blood hematocrit  29.9  %; hematology blood hematocrit  31.0  %; hematology blood hematocrit  31.9  %; hematology blood hematocrit  31.2  %; hematology blood hemoglobin  10.9  g dl; hematology blood hemoglobin  10.2  g dl; hematology blood hemoglobin  10.1  g dl; hematology blood hemoglobin  10.3  g dl; hematology blood hemoglobin  10.3  g dl; hematology blood hemoglobin  10.1  g dl; hematology blood platelet count  111  k ul; hematology blood platelet count  133  k ul; hematology blood platelet count  150  k ul; chemistry blood anion gap  19  meq l; chemistry blood anion gap  14  meq l; chemistry blood bicarbonate  20  meq l; chemistry blood bicarbonate  21  meq l; chemistry blood chloride  100  meq l; chemistry blood chloride  103  meq l; chemistry blood creatinine  1.1  mg dl; chemistry blood creatinine  1.1  mg dl; chemistry blood potassium  4.6  meq l; chemistry blood potassium  3.3  meq l; chemistry blood sodium  134  meq l; chemistry blood sodium  135  meq l; chemistry blood urea nitrogen  25  mg dl; chemistry blood urea nitrogen  24  mg dl; hematology blood inr(pt)  1.6  ; hematology urine wbc  15  # hpf; chemistry blood calcium, total  10.1  mg dl; chemistry blood calcium, total  10.1  mg dl; chemistry blood bilirubin, total  31.8  mg dl; chemistry blood glucose  106  mg dl; chemistry blood glucose  125  mg dl; chemistry blood lactate dehydrogenase (ld)  140  iu l; chemistry blood albumin  3.6  g dl; blood gas blood free calcium  1.33  mmol l; blood gas blood free calcium  1.32  mmol l; blood gas blood lactate  1.0  mmol l; blood gas blood lactate  1.1  mmol l; blood gas blood lactate  1.5  mmol l; blood gas blood lactate  2.7  mmol l$sodium chloride 0.9%  flush  3  ml ; heparin flush (10 units ml)  1  ml ; sodium chloride 0.9%  flush  10  ml ; folic acid  1  mg ; olanzapine (disintegrating tablet)  2.5  mg ; heparin  5000  unit ; thiamine  100  mg ; multivitamins w minerals  1  tab ; ondansetron  2  mg ; sucralfate  1  gm ; rifaximin  550  mg ; lidocaine 5% patch  1  ptch ; albumin 5% (25g   500ml)  25  g ; readi-cat 2 (barium sulfate 2% suspension)  900  ml ; soln  50  ml ; fentanyl citrate  2.5  mg ; propofol  1000  mg ; 5% dextrose  250  ml ; phenylephrine  60  mg ; midazolam  1  mg ; fentanyl citrate  300  mcg ; propofol  300  mg ; sw  200  ml ; potassium chloride  20  meq ; sw  400  ml ; sw  600  ml ; potassium chloride  60  meq ; bag  2  bag ; magnesium sulfate  4  gm ; 0.9% sodium chloride  1  bag ; calcium gluconate  2  g ; 0.9% sodium chloride  2  bag ; calcium gluconate  4  g ; 
other secondary thrombocytopenia tobacco use disorder other ascites esophageal varices in diseases classified elsewhere, without mention of bleeding other and unspecified alcohol dependence, unspecified cannabis abuse, unspecified portal hypertension calculus of bile duct without mention of cholecystitis, with obstruction acute alcoholic hepatitis other and unspecified coagulation defects esophageal reflux acute pancreatitis unspecified peritonitis alcoholic cirrhosis of liver alcohol abuse, in remission unspecified fall other specified hypotension cannabis abuse, unspecified cirrhosis of liver without mention of alcohol home accidents unspecified gastritis and gastroduodenitis, without mention of hemorrhage other specified metabolic disorders unspecified disorder of liver esophageal varices in diseases classified elsewhere, without mention of bleeding bimalleolar fracture, closed tobacco use disorder unspecified viral hepatitis c without hepatic coma 
white m 59 $nan$hematology blood hematocrit  29.1  %; hematology blood hematocrit  29.3  %; hematology blood hematocrit  29.1  %; hematology blood hematocrit  28.8  %; hematology blood hemoglobin  9.6  g dl; hematology blood hemoglobin  9.6  g dl; hematology blood hemoglobin  9.6  g dl; hematology blood platelet count  137  k ul; hematology blood platelet count  131  k ul; chemistry blood anion gap  17  meq l; chemistry blood anion gap  18  meq l; chemistry blood bicarbonate  19  meq l; chemistry blood bicarbonate  17  meq l; chemistry blood chloride  102  meq l; chemistry blood chloride  101  meq l; chemistry blood creatinine  1.3  mg dl; chemistry blood creatinine  1.3  mg dl; chemistry blood potassium  3.7  meq l; chemistry blood potassium  3.8  meq l; chemistry blood sodium  134  meq l; chemistry blood sodium  132  meq l; chemistry blood urea nitrogen  28  mg dl; chemistry blood urea nitrogen  28  mg dl; hematology blood inr(pt)  1.5  ; chemistry blood calcium, total  10.3  mg dl; chemistry blood calcium, total  10.1  mg dl; chemistry blood bilirubin, total  31.9  mg dl; chemistry blood glucose  132  mg dl; chemistry blood glucose  117  mg dl; chemistry blood albumin  3.6  g dl; blood gas blood free calcium  1.35  mmol l; blood gas blood lactate  1.4  mmol l; blood gas blood lactate  1.2  mmol l; blood gas blood lactate  1.6  mmol l$midodrine  5  mg ; vial  1  vial ; pantoprazole  40  mg ; sodium chloride 0.9%  flush  3  ml ; heparin flush (10 units ml)  1  ml ; sodium chloride 0.9%  flush  10  ml ; folic acid  1  mg ; olanzapine (disintegrating tablet)  2.5  mg ; thiamine  100  mg ; multivitamins w minerals  1  tab ; sucralfate  1  gm ; rifaximin  550  mg ; lidocaine 5% patch  1  ptch ; soln  50  ml ; fentanyl citrate  2.5  mg ; propofol  1000  mg ; 5% dextrose  250  ml ; phenylephrine  60  mg ; midazolam  1  mg ; fentanyl citrate  300  mcg ; propofol  300  mg ; sw  200  ml ; potassium chloride  20  meq ; sw  400  ml ; sw  600  ml ; potassium chloride  60  meq ; bag  2  bag ; magnesium sulfate  4  gm ; 0.9% sodium chloride  1  bag ; calcium gluconate  2  g ; 0.9% sodium chloride  2  bag ; calcium gluconate  4  g ; albumin 5%  25  g ; heparin flush (10 units ml)  2  ml ; sodium chloride 0.9%  flush  20  ml ; lidocaine 1% (for picc midline insertions)  5  ml ; midodrine  10  mg ; 
other secondary thrombocytopenia tobacco use disorder other ascites esophageal varices in diseases classified elsewhere, without mention of bleeding other and unspecified alcohol dependence, unspecified cannabis abuse, unspecified portal hypertension calculus of bile duct without mention of cholecystitis, with obstruction acute alcoholic hepatitis other and unspecified coagulation defects esophageal reflux acute pancreatitis unspecified peritonitis alcoholic cirrhosis of liver alcohol abuse, in remission unspecified fall other specified hypotension cannabis abuse, unspecified cirrhosis of liver without mention of alcohol home accidents unspecified gastritis and gastroduodenitis, without mention of hemorrhage other specified metabolic disorders unspecified disorder of liver esophageal varices in diseases classified elsewhere, without mention of bleeding bimalleolar fracture, closed tobacco use disorder unspecified viral hepatitis c without hepatic coma 
white m 59 $nan$hematology blood hematocrit  26.7  %; hematology blood hematocrit  26.8  %; hematology blood hematocrit  27.3  %; hematology blood hemoglobin  8.9  g dl; hematology blood hemoglobin  8.8  g dl; hematology blood hemoglobin  9.1  g dl; hematology blood platelet count  113  k ul; chemistry blood anion gap  15  meq l; chemistry blood bicarbonate  18  meq l; chemistry blood chloride  103  meq l; chemistry blood creatinine  1.3  mg dl; chemistry blood potassium  3.4  meq l; chemistry blood sodium  133  meq l; chemistry blood urea nitrogen  28  mg dl; hematology blood inr(pt)  1.5  ; chemistry urine chloride, urine  25  meq l; chemistry urine creatinine, urine  76  mg dl; chemistry urine potassium, urine  27  meq l; chemistry urine sodium, urine  23  meq l; chemistry urine urea nitrogen, urine  543  mg dl; chemistry blood calcium, total  10.4  mg dl; chemistry blood bilirubin, total  32.1  mg dl; chemistry blood glucose  147  mg dl; chemistry blood lactate dehydrogenase (ld)  118  iu l; chemistry blood albumin  3.6  g dl$vial  1  vial ; pantoprazole  40  mg ; sodium chloride 0.9%  flush  3  ml ; heparin flush (10 units ml)  1  ml ; sodium chloride 0.9%  flush  10  ml ; folic acid  1  mg ; olanzapine (disintegrating tablet)  2.5  mg ; thiamine  100  mg ; multivitamins w minerals  1  tab ; sucralfate  1  gm ; rifaximin  550  mg ; lidocaine 5% patch  1  ptch ; 5% dextrose  250  ml ; phenylephrine  60  mg ; bag  2  bag ; magnesium sulfate  4  gm ; 0.9% sodium chloride  1  bag ; calcium gluconate  2  g ; 0.9% sodium chloride  2  bag ; calcium gluconate  4  g ; albumin 5%  25  g ; heparin flush (10 units ml)  2  ml ; sodium chloride 0.9%  flush  20  ml ; lidocaine 1% (for picc midline insertions)  5  ml ; midodrine  10  mg ; 0.9% sodium chloride  250  ml ; norepinephrine  8  mg ; sodium chloride 0.9%  flush  10-20  ml ; 
other secondary thrombocytopenia tobacco use disorder other ascites esophageal varices in diseases classified elsewhere, without mention of bleeding other and unspecified alcohol dependence, unspecified cannabis abuse, unspecified portal hypertension calculus of bile duct without mention of cholecystitis, with obstruction acute alcoholic hepatitis other and unspecified coagulation defects esophageal reflux acute pancreatitis unspecified peritonitis alcoholic cirrhosis of liver alcohol abuse, in remission unspecified fall other specified hypotension cannabis abuse, unspecified cirrhosis of liver without mention of alcohol home accidents unspecified gastritis and gastroduodenitis, without mention of hemorrhage other specified metabolic disorders unspecified disorder of liver esophageal varices in diseases classified elsewhere, without mention of bleeding bimalleolar fracture, closed tobacco use disorder unspecified viral hepatitis c without hepatic coma 
white m 59 $nan$hematology blood hematocrit  27.1  %; hematology blood hemoglobin  9.0  g dl; hematology blood platelet count  124  k ul; chemistry blood anion gap  15  meq l; chemistry blood bicarbonate  18  meq l; chemistry blood chloride  103  meq l; chemistry blood creatinine  1.3  mg dl; chemistry blood potassium  3.3  meq l; chemistry blood sodium  133  meq l; chemistry blood urea nitrogen  28  mg dl; hematology blood inr(pt)  1.6  ; chemistry blood calcium, total  10.8  mg dl; chemistry blood bilirubin, total  32.8  mg dl; chemistry blood glucose  138  mg dl$vial  1  vial ; pantoprazole  40  mg ; sodium chloride 0.9%  flush  3  ml ; heparin flush (10 units ml)  1  ml ; sodium chloride 0.9%  flush  10  ml ; folic acid  1  mg ; olanzapine (disintegrating tablet)  2.5  mg ; thiamine  100  mg ; multivitamins w minerals  1  tab ; sucralfate  1  gm ; rifaximin  550  mg ; lidocaine 5% patch  1  ptch ; 5% dextrose  250  ml ; phenylephrine  60  mg ; bag  2  bag ; magnesium sulfate  4  gm ; 0.9% sodium chloride  1  bag ; calcium gluconate  2  g ; 0.9% sodium chloride  2  bag ; calcium gluconate  4  g ; sodium chloride 0.9%  flush  20  ml ; lidocaine 1% (for picc midline insertions)  5  ml ; midodrine  10  mg ; 0.9% sodium chloride  250  ml ; norepinephrine  8  mg ; sodium chloride 0.9%  flush  10-20  ml ; lidocaine jelly 2% (urojet)  1  appl ; 
other secondary thrombocytopenia tobacco use disorder other ascites esophageal varices in diseases classified elsewhere, without mention of bleeding other and unspecified alcohol dependence, unspecified cannabis abuse, unspecified portal hypertension calculus of bile duct without mention of cholecystitis, with obstruction acute alcoholic hepatitis other and unspecified coagulation defects esophageal reflux acute pancreatitis unspecified peritonitis alcoholic cirrhosis of liver alcohol abuse, in remission unspecified fall other specified hypotension cannabis abuse, unspecified cirrhosis of liver without mention of alcohol home accidents unspecified gastritis and gastroduodenitis, without mention of hemorrhage other specified metabolic disorders unspecified disorder of liver esophageal varices in diseases classified elsewhere, without mention of bleeding bimalleolar fracture, closed tobacco use disorder unspecified viral hepatitis c without hepatic coma 
white m 59 $nan$hematology blood hematocrit  26.9  %; hematology blood hemoglobin  9.2  g dl; hematology blood platelet count  140  k ul; chemistry blood anion gap  14  meq l; chemistry blood bicarbonate  18  meq l; chemistry blood chloride  103  meq l; chemistry blood creatinine  1.1  mg dl; chemistry blood potassium  3.4  meq l; chemistry blood sodium  132  meq l; chemistry blood urea nitrogen  24  mg dl; hematology blood inr(pt)  1.7  ; chemistry blood calcium, total  11.2  mg dl; chemistry blood bilirubin, total  33.1  mg dl; chemistry blood glucose  139  mg dl$vial  1  vial ; pantoprazole  40  mg ; sodium chloride 0.9%  flush  3  ml ; heparin flush (10 units ml)  1  ml ; sodium chloride 0.9%  flush  10  ml ; folic acid  1  mg ; olanzapine (disintegrating tablet)  2.5  mg ; thiamine  100  mg ; multivitamins w minerals  1  tab ; sucralfate  1  gm ; rifaximin  550  mg ; lidocaine 5% patch  1  ptch ; 5% dextrose  250  ml ; phenylephrine  60  mg ; bag  2  bag ; magnesium sulfate  4  gm ; sodium chloride 0.9%  flush  20  ml ; lidocaine 1% (for picc midline insertions)  5  ml ; midodrine  10  mg ; 0.9% sodium chloride  250  ml ; norepinephrine  8  mg ; sodium chloride 0.9%  flush  10-20  ml ; lidocaine jelly 2% (urojet)  1  appl ; potassium chloride (powder)  40  meq ; 
other secondary thrombocytopenia tobacco use disorder other ascites esophageal varices in diseases classified elsewhere, without mention of bleeding other and unspecified alcohol dependence, unspecified cannabis abuse, unspecified portal hypertension calculus of bile duct without mention of cholecystitis, with obstruction acute alcoholic hepatitis other and unspecified coagulation defects esophageal reflux acute pancreatitis unspecified peritonitis alcoholic cirrhosis of liver alcohol abuse, in remission unspecified fall other specified hypotension cannabis abuse, unspecified cirrhosis of liver without mention of alcohol home accidents unspecified gastritis and gastroduodenitis, without mention of hemorrhage other specified metabolic disorders unspecified disorder of liver esophageal varices in diseases classified elsewhere, without mention of bleeding bimalleolar fracture, closed tobacco use disorder unspecified viral hepatitis c without hepatic coma 
white m 59 $nan$hematology blood hematocrit  27.7  %; hematology blood hemoglobin  9.6  g dl; hematology blood platelet count  142  k ul; chemistry blood anion gap  14  meq l; chemistry blood bicarbonate  19  meq l; chemistry blood chloride  105  meq l; chemistry blood creatinine  1.1  mg dl; chemistry blood potassium  3.4  meq l; chemistry blood sodium  135  meq l; chemistry blood urea nitrogen  26  mg dl; hematology blood inr(pt)  1.7  ; chemistry blood calcium, total  11.2  mg dl; chemistry blood bilirubin, total  34.3  mg dl; chemistry blood glucose  133  mg dl$vial  1  vial ; pantoprazole  40  mg ; sodium chloride 0.9%  flush  3  ml ; sodium chloride 0.9%  flush  10  ml ; folic acid  1  mg ; olanzapine (disintegrating tablet)  2.5  mg ; thiamine  100  mg ; multivitamins w minerals  1  tab ; sucralfate  1  gm ; rifaximin  550  mg ; lidocaine 5% patch  1  ptch ; bag  2  bag ; magnesium sulfate  4  gm ; sodium chloride 0.9%  flush  20  ml ; lidocaine 1% (for picc midline insertions)  5  ml ; midodrine  10  mg ; sodium chloride 0.9%  flush  10-20  ml ; potassium chloride (powder)  40  meq ; lidocaine 1%  5  ml ; 
other secondary thrombocytopenia tobacco use disorder other ascites esophageal varices in diseases classified elsewhere, without mention of bleeding other and unspecified alcohol dependence, unspecified cannabis abuse, unspecified portal hypertension calculus of bile duct without mention of cholecystitis, with obstruction acute alcoholic hepatitis other and unspecified coagulation defects esophageal reflux acute pancreatitis unspecified peritonitis alcoholic cirrhosis of liver alcohol abuse, in remission unspecified fall other specified hypotension cannabis abuse, unspecified cirrhosis of liver without mention of alcohol home accidents unspecified gastritis and gastroduodenitis, without mention of hemorrhage other specified metabolic disorders unspecified disorder of liver esophageal varices in diseases classified elsewhere, without mention of bleeding bimalleolar fracture, closed tobacco use disorder unspecified viral hepatitis c without hepatic coma 
white m 59 $nan$hematology blood hematocrit  27.0  %; hematology blood hemoglobin  9.3  g dl; hematology blood platelet count  113  k ul; chemistry blood anion gap  17  meq l; chemistry blood bicarbonate  18  meq l; chemistry blood chloride  101  meq l; chemistry blood creatinine  1.2  mg dl; chemistry blood potassium  3.7  meq l; chemistry blood sodium  132  meq l; chemistry blood urea nitrogen  29  mg dl; hematology blood inr(pt)  1.7  ; chemistry blood calcium, total  11.1  mg dl; chemistry blood bilirubin, total  33.4  mg dl; chemistry blood glucose  163  mg dl$vial  1  vial ; pantoprazole  40  mg ; sodium chloride 0.9%  flush  3  ml ; sodium chloride 0.9%  flush  10  ml ; folic acid  1  mg ; olanzapine (disintegrating tablet)  2.5  mg ; thiamine  100  mg ; multivitamins w minerals  1  tab ; sucralfate  1  gm ; rifaximin  550  mg ; lidocaine 5% patch  1  ptch ; sodium chloride 0.9%  flush  20  ml ; midodrine  10  mg ; sodium chloride 0.9%  flush  10-20  ml ; lidocaine 1%  5  ml ; albumin 25% (12.5g   50ml)  75  g ; 
other secondary thrombocytopenia tobacco use disorder other ascites esophageal varices in diseases classified elsewhere, without mention of bleeding other and unspecified alcohol dependence, unspecified cannabis abuse, unspecified portal hypertension calculus of bile duct without mention of cholecystitis, with obstruction acute alcoholic hepatitis other and unspecified coagulation defects esophageal reflux acute pancreatitis unspecified peritonitis alcoholic cirrhosis of liver alcohol abuse, in remission unspecified fall other specified hypotension cannabis abuse, unspecified cirrhosis of liver without mention of alcohol home accidents unspecified gastritis and gastroduodenitis, without mention of hemorrhage other specified metabolic disorders unspecified disorder of liver esophageal varices in diseases classified elsewhere, without mention of bleeding bimalleolar fracture, closed tobacco use disorder unspecified viral hepatitis c without hepatic coma 
white m 59 $nan$hematology blood hematocrit  25.8  %; hematology blood hemoglobin  8.7  g dl; hematology blood platelet count  101  k ul; chemistry blood anion gap  14  meq l; chemistry blood bicarbonate  20  meq l; chemistry blood chloride  100  meq l; chemistry blood creatinine  1.4  mg dl; chemistry blood potassium  3.5  meq l; chemistry blood sodium  130  meq l; chemistry blood urea nitrogen  37  mg dl; hematology blood inr(pt)  1.8  ; chemistry blood calcium, total  11.2  mg dl; chemistry blood bilirubin, total  35.9  mg dl; chemistry blood glucose  143  mg dl; chemistry blood albumin  3.4  g dl; hematology blood bands  0  %$vial  1  vial ; pantoprazole  40  mg ; sodium chloride 0.9%  flush  10  ml ; folic acid  1  mg ; olanzapine (disintegrating tablet)  2.5  mg ; thiamine  100  mg ; sucralfate  1  gm ; rifaximin  550  mg ; lidocaine 5% patch  1  ptch ; sodium chloride 0.9%  flush  20  ml ; sodium chloride 0.9%  flush  10-20  ml ; albumin 25% (12.5g   50ml)  75  g ; 
other secondary thrombocytopenia tobacco use disorder other ascites esophageal varices in diseases classified elsewhere, without mention of bleeding other and unspecified alcohol dependence, unspecified cannabis abuse, unspecified portal hypertension calculus of bile duct without mention of cholecystitis, with obstruction acute alcoholic hepatitis other and unspecified coagulation defects esophageal reflux acute pancreatitis unspecified peritonitis alcoholic cirrhosis of liver alcohol abuse, in remission unspecified fall other specified hypotension cannabis abuse, unspecified cirrhosis of liver without mention of alcohol home accidents unspecified gastritis and gastroduodenitis, without mention of hemorrhage other specified metabolic disorders unspecified disorder of liver esophageal varices in diseases classified elsewhere, without mention of bleeding bimalleolar fracture, closed tobacco use disorder unspecified viral hepatitis c without hepatic coma 
white m 59 $nan$hematology blood hematocrit  26.1  %; hematology blood hemoglobin  8.7  g dl; hematology blood platelet count  92  k ul; chemistry blood anion gap  15  meq l; chemistry blood bicarbonate  20  meq l; chemistry blood chloride  99  meq l; chemistry blood creatinine  1.7  mg dl; chemistry blood potassium  3.7  meq l; chemistry blood sodium  130  meq l; chemistry blood urea nitrogen  47  mg dl; hematology blood inr(pt)  1.7  ; chemistry blood calcium, total  10.5  mg dl; chemistry blood bilirubin, total  34.5  mg dl; chemistry blood glucose  160  mg dl; blood gas blood free calcium  1.36  mmol l$vial  1  vial ; pantoprazole  40  mg ; sodium chloride 0.9%  flush  10  ml ; folic acid  1  mg ; olanzapine (disintegrating tablet)  2.5  mg ; thiamine  100  mg ; sucralfate  1  gm ; rifaximin  550  mg ; lidocaine 5% patch  1  ptch ; sodium chloride 0.9%  flush  20  ml ; sodium chloride 0.9%  flush  10-20  ml ; syringe  0.2  ml ; midodrine  7.5  mg ; 
other secondary thrombocytopenia tobacco use disorder other ascites esophageal varices in diseases classified elsewhere, without mention of bleeding other and unspecified alcohol dependence, unspecified cannabis abuse, unspecified portal hypertension calculus of bile duct without mention of cholecystitis, with obstruction acute alcoholic hepatitis other and unspecified coagulation defects esophageal reflux acute pancreatitis unspecified peritonitis alcoholic cirrhosis of liver alcohol abuse, in remission unspecified fall other specified hypotension cannabis abuse, unspecified cirrhosis of liver without mention of alcohol home accidents unspecified gastritis and gastroduodenitis, without mention of hemorrhage other specified metabolic disorders unspecified disorder of liver esophageal varices in diseases classified elsewhere, without mention of bleeding bimalleolar fracture, closed tobacco use disorder unspecified viral hepatitis c without hepatic coma 
white m 59 $nan$hematology blood hematocrit  18.3  %; hematology blood hematocrit  20.7  %; hematology blood hematocrit  19.7  %; hematology blood hemoglobin  6.5  g dl; hematology blood hemoglobin  6.4  g dl; hematology blood hemoglobin  7.0  g dl; hematology blood platelet count  88  k ul; hematology blood platelet count  85  k ul; chemistry blood anion gap  16  meq l; chemistry blood anion gap  17  meq l; chemistry blood bicarbonate  19  meq l; chemistry blood bicarbonate  18  meq l; chemistry blood chloride  99  meq l; chemistry blood chloride  99  meq l; chemistry blood creatinine  2.1  mg dl; chemistry blood creatinine  3.3  mg dl; chemistry blood potassium  3.9  meq l; chemistry blood potassium  4.2  meq l; chemistry blood sodium  130  meq l; chemistry blood sodium  130  meq l; chemistry blood urea nitrogen  55  mg dl; chemistry blood urea nitrogen  69  mg dl; hematology blood inr(pt)  1.9  ; chemistry blood calcium, total  9.5  mg dl; chemistry blood bilirubin, total  30.7  mg dl; chemistry blood glucose  162  mg dl; chemistry blood glucose  156  mg dl; hematology blood bands  0  %$vial  1  vial ; pantoprazole  40  mg ; sodium chloride 0.9%  flush  10  ml ; olanzapine (disintegrating tablet)  2.5  mg ; lidocaine 5% patch  1  ptch ; sodium chloride 0.9%  flush  20  ml ; sodium chloride 0.9%  flush  10-20  ml ; syringe  0.2  ml ; midodrine  7.5  mg ; hydromorphone (dilaudid)  0.125-0.5  mg ; hydromorphone (dilaudid)  0.5-1.5  mg ; lorazepam  0.5-1  mg ; hydromorphone  20  mg ; 
other secondary thrombocytopenia tobacco use disorder other ascites esophageal varices in diseases classified elsewhere, without mention of bleeding other and unspecified alcohol dependence, unspecified cannabis abuse, unspecified portal hypertension calculus of bile duct without mention of cholecystitis, with obstruction acute alcoholic hepatitis other and unspecified coagulation defects esophageal reflux acute pancreatitis unspecified peritonitis alcoholic cirrhosis of liver alcohol abuse, in remission unspecified fall other specified hypotension cannabis abuse, unspecified cirrhosis of liver without mention of alcohol home accidents unspecified gastritis and gastroduodenitis, without mention of hemorrhage other specified metabolic disorders unspecified disorder of liver esophageal varices in diseases classified elsewhere, without mention of bleeding bimalleolar fracture, closed tobacco use disorder unspecified viral hepatitis c without hepatic coma 
white m 59 $nan$nan$vial  1  vial ; pantoprazole  40  mg ; sodium chloride 0.9%  flush  10  ml ; lidocaine 5% patch  1  ptch ; sodium chloride 0.9%  flush  20  ml ; sodium chloride 0.9%  flush  10-20  ml ; hydromorphone  20  mg ; 
other secondary thrombocytopenia tobacco use disorder other ascites esophageal varices in diseases classified elsewhere, without mention of bleeding other and unspecified alcohol dependence, unspecified cannabis abuse, unspecified portal hypertension calculus of bile duct without mention of cholecystitis, with obstruction acute alcoholic hepatitis other and unspecified coagulation defects esophageal reflux acute pancreatitis unspecified peritonitis alcoholic cirrhosis of liver alcohol abuse, in remission unspecified fall other specified hypotension cannabis abuse, unspecified cirrhosis of liver without mention of alcohol home accidents unspecified gastritis and gastroduodenitis, without mention of hemorrhage other specified metabolic disorders unspecified disorder of liver esophageal varices in diseases classified elsewhere, without mention of bleeding bimalleolar fracture, closed tobacco use disorder unspecified viral hepatitis c without hepatic coma 
white m 81 $nan$hematology blood hematocrit  38.5  %; hematology blood hemoglobin  13.3  g dl; hematology blood platelet count  115  k ul; chemistry blood anion gap  10  meq l; chemistry blood bicarbonate  24  meq l; chemistry blood chloride  105  meq l; chemistry blood creatinine  1.1  mg dl; chemistry blood potassium  4.3  meq l; chemistry blood sodium  139  meq l; chemistry blood urea nitrogen  13  mg dl; hematology blood inr(pt)  1.1  ; chemistry blood glucose  122  mg dl$aspirin  81  mg ; clopidogrel  75  mg ; influenza vaccine quadrivalent  0.5  ml ; sodium chloride 0.9%  flush  3-10  ml ; heparin  5000  unit ; atorvastatin  40  mg ; acetaminophen  650  mg ; 
presence of prosthetic heart valve unspecified place in hospital as the place of occurrence of the external cause adverse effect of local anesthetics, initial encounter umbilical hernia with obstruction, without gangrene benign prostatic hyperplasia without lower urinary tract symptoms essential (primary) hypertension hypotension due to drugs thrombocytopenia, unspecified hyperlipidemia, unspecified malignant neoplasm of bladder, unspecified
white m 81 $nan$hematology blood hematocrit  36.7  %; hematology blood hemoglobin  12.8  g dl; hematology blood platelet count  121  k ul; chemistry blood creatinine  1.1  mg dl; chemistry blood potassium  4.1  meq l; chemistry blood sodium  142  meq l; chemistry blood urea nitrogen  14  mg dl$aspirin  81  mg ; clopidogrel  75  mg ; influenza vaccine quadrivalent  0.5  ml ; sodium chloride 0.9%  flush  3-10  ml ; heparin  5000  unit ; atorvastatin  40  mg ; acetaminophen  650  mg ; losartan potassium  25  mg ; senna  8.6  mg ; polyethylene glycol  17  g ; 
presence of prosthetic heart valve unspecified place in hospital as the place of occurrence of the external cause adverse effect of local anesthetics, initial encounter umbilical hernia with obstruction, without gangrene benign prostatic hyperplasia without lower urinary tract symptoms essential (primary) hypertension hypotension due to drugs thrombocytopenia, unspecified hyperlipidemia, unspecified malignant neoplasm of bladder, unspecified
white m 81 $nan$nan$aspirin  81  mg ; clopidogrel  75  mg ; influenza vaccine quadrivalent  0.5  ml ; sodium chloride 0.9%  flush  3-10  ml ; heparin  5000  unit ; atorvastatin  40  mg ; acetaminophen  650  mg ; losartan potassium  25  mg ; senna  8.6  mg ; polyethylene glycol  17  g ; magnesium oxide  800  mg ; 
presence of prosthetic heart valve unspecified place in hospital as the place of occurrence of the external cause adverse effect of local anesthetics, initial encounter umbilical hernia with obstruction, without gangrene benign prostatic hyperplasia without lower urinary tract symptoms essential (primary) hypertension hypotension due to drugs thrombocytopenia, unspecified hyperlipidemia, unspecified malignant neoplasm of bladder, unspecified
white f 33 $temp  98.0  heartrate  86.0  resprate  18.0  o2sat  100.0  sbp  137.0  dbp  92.0  rhythm    pain    $hematology blood hematocrit  36.7  %; hematology blood hematocrit  34.2  %; hematology blood hematocrit  34.8  %; hematology blood hemoglobin  11.8  g dl; hematology blood hemoglobin  10.7  g dl; hematology blood hemoglobin  11.2  g dl; hematology blood platelet count  232  k ul; hematology blood platelet count  218  k ul; hematology blood platelet count  205  k ul; chemistry blood anion gap  11  meq l; chemistry blood anion gap  10  meq l; chemistry blood bicarbonate  31  meq l; chemistry blood bicarbonate  32  meq l; chemistry blood chloride  95  meq l; chemistry blood chloride  97  meq l; chemistry blood creatinine  1.4  mg dl; chemistry blood creatinine  1.1  mg dl; chemistry blood potassium  3.5  meq l; chemistry blood potassium  5.3  meq l; chemistry blood sodium  132  meq l; chemistry blood sodium  135  meq l; chemistry blood urea nitrogen  28  mg dl; chemistry blood urea nitrogen  27  mg dl; hematology blood inr(pt)  1.6  ; hematology blood inr(pt)  1.5  ; chemistry blood calcium, total  7.8  mg dl; chemistry blood bilirubin, total  5.8  mg dl; chemistry blood glucose  108  mg dl; chemistry blood glucose  82  mg dl; hematology blood bands  0  %; hematology blood bands  0  %; blood gas blood lactate  2.4  mmol l$sodium chloride 0.9%  flush  3  ml ; pantoprazole  40  mg ; flecainide acetate  150  mg ; acyclovir  400  mg ; potassium chl 20 meq   1000 ml d5 1 2 ns  1000  ml ; furosemide  40  mg ; levothyroxine sodium  50  mcg ; metoprolol succinate xl  50  mg ; prednisone  15  mg ; spironolactone  25  mg ; hydromorphone (dilaudid)  2  mg ; 5% dextrose  50  ml ; clindamycin  600  mg ; iso-osmotic dextrose  200  ml ; vancomycin  1000  mg ; 
cirrhosis of liver without mention of alcohol acute myeloid leukemia, without mention of having achieved remission acute pharyngitis peripheral stem cells replaced by transplant long-term (current) use of other medications chronic graft-versus-host disease unspecified acquired hypothyroidism atrial fibrillation accidents occurring in unspecified place other malaise and fatigue awaiting organ transplant status other specified surgical operations and procedures causing abnormal patient reaction, or later complication, without mention of misadventure at time of operation other ascites chills (without fever) mechanical complication due to other implant and internal device, not elsewhere classified edema other disease of nasal cavity and sinuses diseases of tricuspid valve bacteremia cirrhosis of liver without mention of alcohol surgical operation with transplant of whole organ causing abnormal patient reaction, or later complication, without mention of misadventure at time of operation atrial fibrillation influenza with pneumonia portal hypertension acute myeloid leukemia, in remission complications of transplanted organ, stem cell acute kidney failure with lesion of tubular necrosis chronic graft-versus-host disease hyposmolality and/or hyponatremia atrial fibrillation urinary tract infection, site not specified atrial fibrillation dehydration surgical operation with transplant of whole organ causing abnormal patient reaction, or later complication, without mention of misadventure at time of operation cirrhosis of liver without mention of alcohol complications of transplanted bone marrow acute myeloid leukemia, without mention of having achieved remission acute kidney failure, unspecified chronic graft-versus-host disease acute myeloid leukemia, in remission atrial fibrillation surgical operation with transplant of whole organ causing abnormal patient reaction, or later complication, without mention of misadventure at time of operation awaiting organ transplant status cirrhosis of liver without mention of alcohol complications of transplanted bone marrow acute upper respiratory infections of unspecified site chronic graft-versus-host disease unspecified acquired hypothyroidism
white f 33 $nan$hematology blood hematocrit  30.6  %; hematology blood hemoglobin  10.3  g dl; hematology blood platelet count  229  k ul; hematology blood inr(pt)  1.6  $sodium chloride 0.9%  flush  3  ml ; pantoprazole  40  mg ; flecainide acetate  150  mg ; acyclovir  400  mg ; furosemide  40  mg ; levothyroxine sodium  50  mcg ; metoprolol succinate xl  50  mg ; prednisone  15  mg ; spironolactone  25  mg ; hydromorphone (dilaudid)  2  mg ; iso-osmotic dextrose  200  ml ; vancomycin  1000  mg ; enoxaparin sodium  40  mg ; lidocaine 1%  5  ml ; heparin flush (10 units ml)  2  ml ; sodium chloride 0.9%  flush  20  ml ; ondansetron  4  mg ; 
cirrhosis of liver without mention of alcohol acute myeloid leukemia, without mention of having achieved remission acute pharyngitis peripheral stem cells replaced by transplant long-term (current) use of other medications chronic graft-versus-host disease unspecified acquired hypothyroidism atrial fibrillation accidents occurring in unspecified place other malaise and fatigue awaiting organ transplant status other specified surgical operations and procedures causing abnormal patient reaction, or later complication, without mention of misadventure at time of operation other ascites chills (without fever) mechanical complication due to other implant and internal device, not elsewhere classified edema other disease of nasal cavity and sinuses diseases of tricuspid valve bacteremia cirrhosis of liver without mention of alcohol surgical operation with transplant of whole organ causing abnormal patient reaction, or later complication, without mention of misadventure at time of operation atrial fibrillation influenza with pneumonia portal hypertension acute myeloid leukemia, in remission complications of transplanted organ, stem cell acute kidney failure with lesion of tubular necrosis chronic graft-versus-host disease hyposmolality and/or hyponatremia atrial fibrillation urinary tract infection, site not specified atrial fibrillation dehydration surgical operation with transplant of whole organ causing abnormal patient reaction, or later complication, without mention of misadventure at time of operation cirrhosis of liver without mention of alcohol complications of transplanted bone marrow acute myeloid leukemia, without mention of having achieved remission acute kidney failure, unspecified chronic graft-versus-host disease acute myeloid leukemia, in remission atrial fibrillation surgical operation with transplant of whole organ causing abnormal patient reaction, or later complication, without mention of misadventure at time of operation awaiting organ transplant status cirrhosis of liver without mention of alcohol complications of transplanted bone marrow acute upper respiratory infections of unspecified site chronic graft-versus-host disease unspecified acquired hypothyroidism
white f 33 $nan$hematology blood hematocrit  34.5  %$sodium chloride 0.9%  flush  3  ml ; pantoprazole  40  mg ; flecainide acetate  150  mg ; acyclovir  400  mg ; furosemide  40  mg ; levothyroxine sodium  50  mcg ; metoprolol succinate xl  50  mg ; prednisone  15  mg ; spironolactone  25  mg ; hydromorphone (dilaudid)  2  mg ; iso-osmotic dextrose  200  ml ; vancomycin  1000  mg ; enoxaparin sodium  40  mg ; lidocaine 1%  5  ml ; heparin flush (10 units ml)  2  ml ; sodium chloride 0.9%  flush  20  ml ; ondansetron  4  mg ; 
cirrhosis of liver without mention of alcohol acute myeloid leukemia, without mention of having achieved remission acute pharyngitis peripheral stem cells replaced by transplant long-term (current) use of other medications chronic graft-versus-host disease unspecified acquired hypothyroidism atrial fibrillation accidents occurring in unspecified place other malaise and fatigue awaiting organ transplant status other specified surgical operations and procedures causing abnormal patient reaction, or later complication, without mention of misadventure at time of operation other ascites chills (without fever) mechanical complication due to other implant and internal device, not elsewhere classified edema other disease of nasal cavity and sinuses diseases of tricuspid valve bacteremia cirrhosis of liver without mention of alcohol surgical operation with transplant of whole organ causing abnormal patient reaction, or later complication, without mention of misadventure at time of operation atrial fibrillation influenza with pneumonia portal hypertension acute myeloid leukemia, in remission complications of transplanted organ, stem cell acute kidney failure with lesion of tubular necrosis chronic graft-versus-host disease hyposmolality and/or hyponatremia atrial fibrillation urinary tract infection, site not specified atrial fibrillation dehydration surgical operation with transplant of whole organ causing abnormal patient reaction, or later complication, without mention of misadventure at time of operation cirrhosis of liver without mention of alcohol complications of transplanted bone marrow acute myeloid leukemia, without mention of having achieved remission acute kidney failure, unspecified chronic graft-versus-host disease acute myeloid leukemia, in remission atrial fibrillation surgical operation with transplant of whole organ causing abnormal patient reaction, or later complication, without mention of misadventure at time of operation awaiting organ transplant status cirrhosis of liver without mention of alcohol complications of transplanted bone marrow acute upper respiratory infections of unspecified site chronic graft-versus-host disease unspecified acquired hypothyroidism
white f 33 $nan$chemistry blood anion gap  17  meq l; chemistry blood bicarbonate  27  meq l; chemistry blood chloride  98  meq l; chemistry blood creatinine  2.4  mg dl; chemistry blood potassium  4.5  meq l; chemistry blood sodium  137  meq l; chemistry blood urea nitrogen  48  mg dl; chemistry blood glucose  140  mg dl$sodium chloride 0.9%  flush  3  ml ; pantoprazole  40  mg ; flecainide acetate  150  mg ; acyclovir  400  mg ; furosemide  40  mg ; levothyroxine sodium  50  mcg ; metoprolol succinate xl  50  mg ; prednisone  15  mg ; spironolactone  25  mg ; hydromorphone (dilaudid)  2  mg ; enoxaparin sodium  40  mg ; ondansetron  4  mg ; 
cirrhosis of liver without mention of alcohol acute myeloid leukemia, without mention of having achieved remission acute pharyngitis peripheral stem cells replaced by transplant long-term (current) use of other medications chronic graft-versus-host disease unspecified acquired hypothyroidism atrial fibrillation accidents occurring in unspecified place other malaise and fatigue awaiting organ transplant status other specified surgical operations and procedures causing abnormal patient reaction, or later complication, without mention of misadventure at time of operation other ascites chills (without fever) mechanical complication due to other implant and internal device, not elsewhere classified edema other disease of nasal cavity and sinuses diseases of tricuspid valve bacteremia cirrhosis of liver without mention of alcohol surgical operation with transplant of whole organ causing abnormal patient reaction, or later complication, without mention of misadventure at time of operation atrial fibrillation influenza with pneumonia portal hypertension acute myeloid leukemia, in remission complications of transplanted organ, stem cell acute kidney failure with lesion of tubular necrosis chronic graft-versus-host disease hyposmolality and/or hyponatremia atrial fibrillation urinary tract infection, site not specified atrial fibrillation dehydration surgical operation with transplant of whole organ causing abnormal patient reaction, or later complication, without mention of misadventure at time of operation cirrhosis of liver without mention of alcohol complications of transplanted bone marrow acute myeloid leukemia, without mention of having achieved remission acute kidney failure, unspecified chronic graft-versus-host disease acute myeloid leukemia, in remission atrial fibrillation surgical operation with transplant of whole organ causing abnormal patient reaction, or later complication, without mention of misadventure at time of operation awaiting organ transplant status cirrhosis of liver without mention of alcohol complications of transplanted bone marrow acute upper respiratory infections of unspecified site chronic graft-versus-host disease unspecified acquired hypothyroidism
white f 33 $nan$chemistry blood anion gap  10  meq l; chemistry blood bicarbonate  32  meq l; chemistry blood chloride  101  meq l; chemistry blood creatinine  2.4  mg dl; chemistry blood potassium  4.0  meq l; chemistry blood sodium  139  meq l; chemistry blood urea nitrogen  47  mg dl; chemistry urine chloride, urine  84  meq l; chemistry urine creatinine, urine  62  mg dl; chemistry urine potassium, urine  35  meq l; chemistry urine sodium, urine  50  meq l; chemistry urine urea nitrogen, urine  430  mg dl; hematology urine wbc  4  # hpf; chemistry blood glucose  81  mg dl$sodium chloride 0.9%  flush  3  ml ; pantoprazole  40  mg ; flecainide acetate  150  mg ; acyclovir  400  mg ; furosemide  40  mg ; levothyroxine sodium  50  mcg ; metoprolol succinate xl  50  mg ; prednisone  15  mg ; spironolactone  25  mg ; hydromorphone (dilaudid)  2  mg ; enoxaparin sodium  40  mg ; ondansetron  4  mg ; sodium chloride 0.9%  1000  ml ; heparin  5000  unit ; senna  8.6  mg ; 
cirrhosis of liver without mention of alcohol acute myeloid leukemia, without mention of having achieved remission acute pharyngitis peripheral stem cells replaced by transplant long-term (current) use of other medications chronic graft-versus-host disease unspecified acquired hypothyroidism atrial fibrillation accidents occurring in unspecified place other malaise and fatigue awaiting organ transplant status other specified surgical operations and procedures causing abnormal patient reaction, or later complication, without mention of misadventure at time of operation other ascites chills (without fever) mechanical complication due to other implant and internal device, not elsewhere classified edema other disease of nasal cavity and sinuses diseases of tricuspid valve bacteremia cirrhosis of liver without mention of alcohol surgical operation with transplant of whole organ causing abnormal patient reaction, or later complication, without mention of misadventure at time of operation atrial fibrillation influenza with pneumonia portal hypertension acute myeloid leukemia, in remission complications of transplanted organ, stem cell acute kidney failure with lesion of tubular necrosis chronic graft-versus-host disease hyposmolality and/or hyponatremia atrial fibrillation urinary tract infection, site not specified atrial fibrillation dehydration surgical operation with transplant of whole organ causing abnormal patient reaction, or later complication, without mention of misadventure at time of operation cirrhosis of liver without mention of alcohol complications of transplanted bone marrow acute myeloid leukemia, without mention of having achieved remission acute kidney failure, unspecified chronic graft-versus-host disease acute myeloid leukemia, in remission atrial fibrillation surgical operation with transplant of whole organ causing abnormal patient reaction, or later complication, without mention of misadventure at time of operation awaiting organ transplant status cirrhosis of liver without mention of alcohol complications of transplanted bone marrow acute upper respiratory infections of unspecified site chronic graft-versus-host disease unspecified acquired hypothyroidism
white f 33 $nan$hematology blood hematocrit  31.0  %; hematology blood hematocrit  30.2  %; hematology blood hemoglobin  9.8  g dl; hematology blood hemoglobin  9.4  g dl; hematology blood platelet count  220  k ul; hematology blood platelet count  216  k ul; chemistry blood anion gap  14  meq l; chemistry blood anion gap  11  meq l; chemistry blood bicarbonate  27  meq l; chemistry blood bicarbonate  31  meq l; chemistry blood chloride  99  meq l; chemistry blood chloride  101  meq l; chemistry blood creatinine  2.3  mg dl; chemistry blood creatinine  2.3  mg dl; chemistry blood potassium  3.9  meq l; chemistry blood potassium  3.9  meq l; chemistry blood sodium  136  meq l; chemistry blood sodium  139  meq l; chemistry blood urea nitrogen  49  mg dl; chemistry blood urea nitrogen  50  mg dl; hematology blood inr(pt)  1.5  ; hematology blood inr(pt)  1.5  ; chemistry blood calcium, total  8.3  mg dl; chemistry blood calcium, total  8.5  mg dl; chemistry blood bilirubin, indirect  2.9  mg dl; chemistry blood bilirubin, total  6.9  mg dl; chemistry blood bilirubin, total  6.5  mg dl; chemistry blood glucose  79  mg dl; chemistry blood glucose  123  mg dl; chemistry blood albumin  2.2  g dl; chemistry blood bilirubin, direct  4.0  mg dl$sodium chloride 0.9%  flush  3  ml ; pantoprazole  40  mg ; flecainide acetate  150  mg ; acyclovir  400  mg ; furosemide  40  mg ; prednisone  15  mg ; spironolactone  25  mg ; hydromorphone (dilaudid)  2  mg ; ondansetron  4  mg ; heparin  5000  unit ; senna  8.6  mg ; cyclosporine   25  mg ; metoprolol tartrate  25  mg ; docusate sodium  100  mg ; lactated ringers  1000  ml ; cyclosporine (neoral) modified  25  mg ; 
cirrhosis of liver without mention of alcohol acute myeloid leukemia, without mention of having achieved remission acute pharyngitis peripheral stem cells replaced by transplant long-term (current) use of other medications chronic graft-versus-host disease unspecified acquired hypothyroidism atrial fibrillation accidents occurring in unspecified place other malaise and fatigue awaiting organ transplant status other specified surgical operations and procedures causing abnormal patient reaction, or later complication, without mention of misadventure at time of operation other ascites chills (without fever) mechanical complication due to other implant and internal device, not elsewhere classified edema other disease of nasal cavity and sinuses diseases of tricuspid valve bacteremia cirrhosis of liver without mention of alcohol surgical operation with transplant of whole organ causing abnormal patient reaction, or later complication, without mention of misadventure at time of operation atrial fibrillation influenza with pneumonia portal hypertension acute myeloid leukemia, in remission complications of transplanted organ, stem cell acute kidney failure with lesion of tubular necrosis chronic graft-versus-host disease hyposmolality and/or hyponatremia atrial fibrillation urinary tract infection, site not specified atrial fibrillation dehydration surgical operation with transplant of whole organ causing abnormal patient reaction, or later complication, without mention of misadventure at time of operation cirrhosis of liver without mention of alcohol complications of transplanted bone marrow acute myeloid leukemia, without mention of having achieved remission acute kidney failure, unspecified chronic graft-versus-host disease acute myeloid leukemia, in remission atrial fibrillation surgical operation with transplant of whole organ causing abnormal patient reaction, or later complication, without mention of misadventure at time of operation awaiting organ transplant status cirrhosis of liver without mention of alcohol complications of transplanted bone marrow acute upper respiratory infections of unspecified site chronic graft-versus-host disease unspecified acquired hypothyroidism
white f 33 $nan$hematology blood hematocrit  28.9  %; hematology blood hemoglobin  9.0  g dl; hematology blood platelet count  207  k ul; chemistry blood anion gap  12  meq l; chemistry blood bicarbonate  31  meq l; chemistry blood chloride  98  meq l; chemistry blood creatinine  2.2  mg dl; chemistry blood potassium  4.0  meq l; chemistry blood sodium  137  meq l; chemistry blood urea nitrogen  50  mg dl; hematology blood inr(pt)  1.5  ; chemistry blood calcium, total  8.4  mg dl; chemistry blood bilirubin, total  6.6  mg dl; chemistry blood glucose  76  mg dl$sodium chloride 0.9%  flush  3  ml ; pantoprazole  40  mg ; acyclovir  400  mg ; prednisone  15  mg ; hydromorphone (dilaudid)  2  mg ; ondansetron  4  mg ; heparin  5000  unit ; senna  8.6  mg ; docusate sodium  100  mg ; cyclosporine (neoral) modified  25  mg ; metoprolol tartrate  12.5  mg ; flecainide acetate  75  mg ; 
cirrhosis of liver without mention of alcohol acute myeloid leukemia, without mention of having achieved remission acute pharyngitis peripheral stem cells replaced by transplant long-term (current) use of other medications chronic graft-versus-host disease unspecified acquired hypothyroidism atrial fibrillation accidents occurring in unspecified place other malaise and fatigue awaiting organ transplant status other specified surgical operations and procedures causing abnormal patient reaction, or later complication, without mention of misadventure at time of operation other ascites chills (without fever) mechanical complication due to other implant and internal device, not elsewhere classified edema other disease of nasal cavity and sinuses diseases of tricuspid valve bacteremia cirrhosis of liver without mention of alcohol surgical operation with transplant of whole organ causing abnormal patient reaction, or later complication, without mention of misadventure at time of operation atrial fibrillation influenza with pneumonia portal hypertension acute myeloid leukemia, in remission complications of transplanted organ, stem cell acute kidney failure with lesion of tubular necrosis chronic graft-versus-host disease hyposmolality and/or hyponatremia atrial fibrillation urinary tract infection, site not specified atrial fibrillation dehydration surgical operation with transplant of whole organ causing abnormal patient reaction, or later complication, without mention of misadventure at time of operation cirrhosis of liver without mention of alcohol complications of transplanted bone marrow acute myeloid leukemia, without mention of having achieved remission acute kidney failure, unspecified chronic graft-versus-host disease acute myeloid leukemia, in remission atrial fibrillation surgical operation with transplant of whole organ causing abnormal patient reaction, or later complication, without mention of misadventure at time of operation awaiting organ transplant status cirrhosis of liver without mention of alcohol complications of transplanted bone marrow acute upper respiratory infections of unspecified site chronic graft-versus-host disease unspecified acquired hypothyroidism
white f 33 $nan$hematology blood hematocrit  27.8  %; hematology blood hemoglobin  8.7  g dl; hematology blood platelet count  184  k ul; chemistry blood anion gap  10  meq l; chemistry blood bicarbonate  32  meq l; chemistry blood chloride  100  meq l; chemistry blood creatinine  2.2  mg dl; chemistry blood potassium  3.6  meq l; chemistry blood sodium  138  meq l; chemistry blood urea nitrogen  48  mg dl; hematology blood inr(pt)  1.5  ; chemistry blood calcium, total  8.5  mg dl; chemistry blood bilirubin, total  6.0  mg dl; chemistry blood glucose  99  mg dl$sodium chloride 0.9%  flush  3  ml ; pantoprazole  40  mg ; acyclovir  400  mg ; prednisone  15  mg ; ondansetron  4  mg ; heparin  5000  unit ; senna  8.6  mg ; docusate sodium  100  mg ; cyclosporine (neoral) modified  25  mg ; metoprolol tartrate  12.5  mg ; flecainide acetate  75  mg ; sodium chloride 0.9%  flush  10-20  ml ; 
cirrhosis of liver without mention of alcohol acute myeloid leukemia, without mention of having achieved remission acute pharyngitis peripheral stem cells replaced by transplant long-term (current) use of other medications chronic graft-versus-host disease unspecified acquired hypothyroidism atrial fibrillation accidents occurring in unspecified place other malaise and fatigue awaiting organ transplant status other specified surgical operations and procedures causing abnormal patient reaction, or later complication, without mention of misadventure at time of operation other ascites chills (without fever) mechanical complication due to other implant and internal device, not elsewhere classified edema other disease of nasal cavity and sinuses diseases of tricuspid valve bacteremia cirrhosis of liver without mention of alcohol surgical operation with transplant of whole organ causing abnormal patient reaction, or later complication, without mention of misadventure at time of operation atrial fibrillation influenza with pneumonia portal hypertension acute myeloid leukemia, in remission complications of transplanted organ, stem cell acute kidney failure with lesion of tubular necrosis chronic graft-versus-host disease hyposmolality and/or hyponatremia atrial fibrillation urinary tract infection, site not specified atrial fibrillation dehydration surgical operation with transplant of whole organ causing abnormal patient reaction, or later complication, without mention of misadventure at time of operation cirrhosis of liver without mention of alcohol complications of transplanted bone marrow acute myeloid leukemia, without mention of having achieved remission acute kidney failure, unspecified chronic graft-versus-host disease acute myeloid leukemia, in remission atrial fibrillation surgical operation with transplant of whole organ causing abnormal patient reaction, or later complication, without mention of misadventure at time of operation awaiting organ transplant status cirrhosis of liver without mention of alcohol complications of transplanted bone marrow acute upper respiratory infections of unspecified site chronic graft-versus-host disease unspecified acquired hypothyroidism
white f 33 $nan$nan$sodium chloride 0.9%  flush  3  ml ; pantoprazole  40  mg ; acyclovir  400  mg ; prednisone  15  mg ; ondansetron  4  mg ; senna  8.6  mg ; docusate sodium  100  mg ; cyclosporine (neoral) modified  25  mg ; metoprolol tartrate  12.5  mg ; flecainide acetate  75  mg ; sodium chloride 0.9%  flush  10-20  ml ; 
cirrhosis of liver without mention of alcohol acute myeloid leukemia, without mention of having achieved remission acute pharyngitis peripheral stem cells replaced by transplant long-term (current) use of other medications chronic graft-versus-host disease unspecified acquired hypothyroidism atrial fibrillation accidents occurring in unspecified place other malaise and fatigue awaiting organ transplant status other specified surgical operations and procedures causing abnormal patient reaction, or later complication, without mention of misadventure at time of operation other ascites chills (without fever) mechanical complication due to other implant and internal device, not elsewhere classified edema other disease of nasal cavity and sinuses diseases of tricuspid valve bacteremia cirrhosis of liver without mention of alcohol surgical operation with transplant of whole organ causing abnormal patient reaction, or later complication, without mention of misadventure at time of operation atrial fibrillation influenza with pneumonia portal hypertension acute myeloid leukemia, in remission complications of transplanted organ, stem cell acute kidney failure with lesion of tubular necrosis chronic graft-versus-host disease hyposmolality and/or hyponatremia atrial fibrillation urinary tract infection, site not specified atrial fibrillation dehydration surgical operation with transplant of whole organ causing abnormal patient reaction, or later complication, without mention of misadventure at time of operation cirrhosis of liver without mention of alcohol complications of transplanted bone marrow acute myeloid leukemia, without mention of having achieved remission acute kidney failure, unspecified chronic graft-versus-host disease acute myeloid leukemia, in remission atrial fibrillation surgical operation with transplant of whole organ causing abnormal patient reaction, or later complication, without mention of misadventure at time of operation awaiting organ transplant status cirrhosis of liver without mention of alcohol complications of transplanted bone marrow acute upper respiratory infections of unspecified site chronic graft-versus-host disease unspecified acquired hypothyroidism
asian f 38 $nan$nan$naloxone  40-80  mcg ; naloxone  0.4  mg ; ketorolac  15-30  mg ; ondansetron  4  mg ; influenza vaccine quadrivalent  0.5  ml ; sodium chloride 0.9%  flush  3  ml ; docusate sodium  100  mg ; ibuprofen  600  mg ; acetaminophen  500-1000  mg ; bisacodyl  10  mg ; milk of magnesia  30  ml ; oxycodone (immediate release)   5-10  mg ; tetanus-diphtox-acellular pertuss (adacel)  0.5  ml ; calcium carbonate  500  mg ; simethicone  80  mg ; 
cervical incompetence, delivered, with or without mention of antepartum condition premature rupture of membranes, delivered, with or without mention of antepartum condition early onset of delivery, delivered, with or without mention of antepartum condition motorcycle driver injured in collision with fixed or stationary object in nontraffic accident cervical shortening, delivered, with or without mention of antepartum condition outcome of delivery, single liveborn cervical incompetence, antepartum condition or complication 
asian f 38 $nan$nan$naloxone  40-80  mcg ; naloxone  0.4  mg ; ketorolac  15-30  mg ; ondansetron  4  mg ; influenza vaccine quadrivalent  0.5  ml ; sodium chloride 0.9%  flush  3  ml ; docusate sodium  100  mg ; ibuprofen  600  mg ; acetaminophen  500-1000  mg ; bisacodyl  10  mg ; milk of magnesia  30  ml ; oxycodone (immediate release)   5-10  mg ; tetanus-diphtox-acellular pertuss (adacel)  0.5  ml ; calcium carbonate  500  mg ; simethicone  80  mg ; 
cervical incompetence, delivered, with or without mention of antepartum condition premature rupture of membranes, delivered, with or without mention of antepartum condition early onset of delivery, delivered, with or without mention of antepartum condition motorcycle driver injured in collision with fixed or stationary object in nontraffic accident cervical shortening, delivered, with or without mention of antepartum condition outcome of delivery, single liveborn cervical incompetence, antepartum condition or complication 
asian f 38 $nan$nan$naloxone  40-80  mcg ; naloxone  0.4  mg ; ondansetron  4  mg ; influenza vaccine quadrivalent  0.5  ml ; sodium chloride 0.9%  flush  3  ml ; docusate sodium  100  mg ; ibuprofen  600  mg ; acetaminophen  500-1000  mg ; bisacodyl  10  mg ; milk of magnesia  30  ml ; oxycodone (immediate release)   5-10  mg ; tetanus-diphtox-acellular pertuss (adacel)  0.5  ml ; calcium carbonate  500  mg ; simethicone  80  mg ; 
cervical incompetence, delivered, with or without mention of antepartum condition premature rupture of membranes, delivered, with or without mention of antepartum condition early onset of delivery, delivered, with or without mention of antepartum condition motorcycle driver injured in collision with fixed or stationary object in nontraffic accident cervical shortening, delivered, with or without mention of antepartum condition outcome of delivery, single liveborn cervical incompetence, antepartum condition or complication 
asian f 38 $nan$nan$naloxone  40-80  mcg ; naloxone  0.4  mg ; ondansetron  4  mg ; influenza vaccine quadrivalent  0.5  ml ; sodium chloride 0.9%  flush  3  ml ; docusate sodium  100  mg ; ibuprofen  600  mg ; acetaminophen  500-1000  mg ; bisacodyl  10  mg ; milk of magnesia  30  ml ; oxycodone (immediate release)   5-10  mg ; tetanus-diphtox-acellular pertuss (adacel)  0.5  ml ; calcium carbonate  500  mg ; simethicone  80  mg ; 
cervical incompetence, delivered, with or without mention of antepartum condition premature rupture of membranes, delivered, with or without mention of antepartum condition early onset of delivery, delivered, with or without mention of antepartum condition motorcycle driver injured in collision with fixed or stationary object in nontraffic accident cervical shortening, delivered, with or without mention of antepartum condition outcome of delivery, single liveborn cervical incompetence, antepartum condition or complication 
asian f 38 $nan$nan$naloxone  40-80  mcg ; naloxone  0.4  mg ; ondansetron  4  mg ; influenza vaccine quadrivalent  0.5  ml ; sodium chloride 0.9%  flush  3  ml ; docusate sodium  100  mg ; ibuprofen  600  mg ; acetaminophen  500-1000  mg ; bisacodyl  10  mg ; milk of magnesia  30  ml ; oxycodone (immediate release)   5-10  mg ; tetanus-diphtox-acellular pertuss (adacel)  0.5  ml ; calcium carbonate  500  mg ; simethicone  80  mg ; 
cervical incompetence, delivered, with or without mention of antepartum condition premature rupture of membranes, delivered, with or without mention of antepartum condition early onset of delivery, delivered, with or without mention of antepartum condition motorcycle driver injured in collision with fixed or stationary object in nontraffic accident cervical shortening, delivered, with or without mention of antepartum condition outcome of delivery, single liveborn cervical incompetence, antepartum condition or complication 
white f 47 $nan$hematology blood hematocrit  30.8  %; hematology blood hematocrit  30.4  %; hematology blood hemoglobin  9.8  g dl; hematology blood hemoglobin  9.9  g dl; hematology blood platelet count  575  k ul; hematology blood platelet count  614  k ul; chemistry blood anion gap  16  meq l; chemistry blood anion gap  13  meq l; chemistry blood bicarbonate  25  meq l; chemistry blood bicarbonate  26  meq l; chemistry blood chloride  99  meq l; chemistry blood chloride  100  meq l; chemistry blood creatinine  0.6  mg dl; chemistry blood creatinine  0.6  mg dl; chemistry blood potassium  4.5  meq l; chemistry blood potassium  5.2  meq l; chemistry blood sodium  139  meq l; chemistry blood sodium  140  meq l; chemistry blood urea nitrogen  9  mg dl; chemistry blood urea nitrogen  9  mg dl; hematology blood inr(pt)  1.2  ; hematology blood inr(pt)  1.2  ; chemistry blood calcium, total  9.6  mg dl; chemistry blood calcium, total  10.0  mg dl; chemistry blood glucose  158  mg dl; chemistry blood glucose  97  mg dl; chemistry blood lactate dehydrogenase (ld)  346  iu l; chemistry blood lactate dehydrogenase (ld)  308  iu l; chemistry blood albumin  3.8  g dl; hematology blood bands  0  %$vial  0  vial ; heparin flush (10 units ml)  5  ml ; heparin flush (100 units ml)  5  ml ; sodium chloride 0.9%  flush  10  ml ; sulfameth trimethoprim ds  1  tab ; levothyroxine sodium  88  mcg ; pantoprazole  40  mg ; prednisone  10  mg ; prochlorperazine  10  mg ; ondansetron  8  mg ; heparin flush (10 units ml)  2  ml ; sodium chloride 0.9%  flush  20  ml ; lidocaine 1% (for picc midline insertions)  5  ml ; 5% dextrose  50  ml ; ondansetron  16  mg ; lorazepam  0.5-1  mg ; 0.45% sodium chloride  1000  ml ; diphenhydramine  50  mg ; dexamethasone  20  mg ; 5% dextrose  250  ml ; liposomal doxorubicin (doxil)  54  mg ; mesna  4550  mg ; 0.9% sodium chloride  1000  ml ; ifosfamide  4550  mg ; iso-osmotic sodium chloride  1  bag ; famotidine  20  mg ; heparin  5000  unit ; sodium chloride 0.9%  flush  3-10  ml ; bag  1  bag ; magnesium sulfate  2  gm ; bag  2  bag ; magnesium sulfate  4  gm ; potassium chloride replacement (critical care and oncology)   40  meq ; potassium chloride replacement (critical care and oncology)   60  meq ; potassium chloride replacement (critical care and oncology)   80  meq ; calcium gluconate  0  g ; vial  2  vial ; calcium gluconate  2  g ; vial  4  vial ; calcium gluconate  4  g ; prednisone  80  mg ; dexamethasone  12  mg ; 
pleural effusion, not elsewhere classified personal history of nicotine dependence malignant neoplasm of mediastinum, part unspecified compression of vein gastro-esophageal reflux disease without esophagitis exposure to radiofrequency, initial encounter encounter for antineoplastic chemotherapy fluid overload, unspecified hypothyroidism, unspecified acute pulmonary manifestations due to radiation personal history of hodgkin lymphoma adverse effect of antineoplastic and immunosuppressive drugs, initial encounter hypothyroidism, unspecified anemia due to antineoplastic chemotherapy secondary malignant neoplasm of right lung unspecified place in unspecified non-institutional (private) residence as the place of occurrence of the external cause malignant neoplasm of posterior mediastinum personal history of nicotine dependence personal history of hodgkin lymphoma compression of vein malignant neoplasm of anterior mediastinum gastro-esophageal reflux disease without esophagitis other coronavirus as the cause of diseases classified elsewhere encounter for antineoplastic chemotherapy fluid overload, unspecified pneumonia, unspecified organism encounter for antineoplastic chemotherapy essential (hemorrhagic) thrombocythemia personal history of hodgkin lymphoma malignant neoplasm of peripheral nerves and autonomic nervous system, unspecified shortness of breath unspecified place in hospital as the place of occurrence of the external cause personal history of nicotine dependence hypothyroidism, unspecified adverse effect of glucocorticoids and synthetic analogues, initial encounter pericardial effusion (noninflammatory) elevated white blood cell count, unspecified localized edema gastro-esophageal reflux disease without esophagitis esophageal obstruction other adrenocortical insufficiency adverse effect of antineoplastic and immunosuppressive drugs, sequela anemia in neoplastic disease adverse effect of glucocorticoids and synthetic analogues, sequela gastro-esophageal reflux disease without esophagitis secondary malignant neoplasm of right lung malignant neoplasm of peripheral nerves of thorax personal history of nicotine dependence
white f 47 $nan$hematology blood hematocrit  27.4  %; hematology blood hemoglobin  8.8  g dl; hematology blood platelet count  606  k ul; chemistry blood anion gap  14  meq l; chemistry blood bicarbonate  23  meq l; chemistry blood chloride  106  meq l; chemistry blood creatinine  0.6  mg dl; chemistry blood potassium  5.0  meq l; chemistry blood sodium  143  meq l; chemistry blood urea nitrogen  13  mg dl; hematology blood inr(pt)  1.2  ; hematology urine wbc  2  # hpf; chemistry blood calcium, total  9.3  mg dl; chemistry blood glucose  120  mg dl$vial  0  vial ; heparin flush (10 units ml)  5  ml ; heparin flush (100 units ml)  5  ml ; sodium chloride 0.9%  flush  10  ml ; sulfameth trimethoprim ds  1  tab ; levothyroxine sodium  88  mcg ; pantoprazole  40  mg ; prednisone  10  mg ; prochlorperazine  10  mg ; ondansetron  8  mg ; sodium chloride 0.9%  flush  20  ml ; 5% dextrose  50  ml ; ondansetron  16  mg ; lorazepam  0.5-1  mg ; 0.45% sodium chloride  1000  ml ; diphenhydramine  50  mg ; dexamethasone  20  mg ; 5% dextrose  250  ml ; liposomal doxorubicin (doxil)  54  mg ; mesna  4550  mg ; 0.9% sodium chloride  1000  ml ; ifosfamide  4550  mg ; iso-osmotic sodium chloride  1  bag ; famotidine  20  mg ; heparin  5000  unit ; sodium chloride 0.9%  flush  3-10  ml ; bag  1  bag ; magnesium sulfate  2  gm ; bag  2  bag ; magnesium sulfate  4  gm ; potassium chloride replacement (critical care and oncology)   40  meq ; potassium chloride replacement (critical care and oncology)   60  meq ; potassium chloride replacement (critical care and oncology)   80  meq ; calcium gluconate  0  g ; vial  2  vial ; calcium gluconate  2  g ; vial  4  vial ; calcium gluconate  4  g ; dexamethasone  12  mg ; sodium chloride 0.9%  1000  ml ; ramelteon  8  mg ; prednisone  5  mg ; 
pleural effusion, not elsewhere classified personal history of nicotine dependence malignant neoplasm of mediastinum, part unspecified compression of vein gastro-esophageal reflux disease without esophagitis exposure to radiofrequency, initial encounter encounter for antineoplastic chemotherapy fluid overload, unspecified hypothyroidism, unspecified acute pulmonary manifestations due to radiation personal history of hodgkin lymphoma adverse effect of antineoplastic and immunosuppressive drugs, initial encounter hypothyroidism, unspecified anemia due to antineoplastic chemotherapy secondary malignant neoplasm of right lung unspecified place in unspecified non-institutional (private) residence as the place of occurrence of the external cause malignant neoplasm of posterior mediastinum personal history of nicotine dependence personal history of hodgkin lymphoma compression of vein malignant neoplasm of anterior mediastinum gastro-esophageal reflux disease without esophagitis other coronavirus as the cause of diseases classified elsewhere encounter for antineoplastic chemotherapy fluid overload, unspecified pneumonia, unspecified organism encounter for antineoplastic chemotherapy essential (hemorrhagic) thrombocythemia personal history of hodgkin lymphoma malignant neoplasm of peripheral nerves and autonomic nervous system, unspecified shortness of breath unspecified place in hospital as the place of occurrence of the external cause personal history of nicotine dependence hypothyroidism, unspecified adverse effect of glucocorticoids and synthetic analogues, initial encounter pericardial effusion (noninflammatory) elevated white blood cell count, unspecified localized edema gastro-esophageal reflux disease without esophagitis esophageal obstruction other adrenocortical insufficiency adverse effect of antineoplastic and immunosuppressive drugs, sequela anemia in neoplastic disease adverse effect of glucocorticoids and synthetic analogues, sequela gastro-esophageal reflux disease without esophagitis secondary malignant neoplasm of right lung malignant neoplasm of peripheral nerves of thorax personal history of nicotine dependence
white f 47 $nan$hematology blood hematocrit  28.1  %; hematology blood hemoglobin  8.9  g dl; hematology blood platelet count  639  k ul; chemistry blood anion gap  15  meq l; chemistry blood bicarbonate  23  meq l; chemistry blood chloride  102  meq l; chemistry blood creatinine  0.7  mg dl; chemistry blood potassium  4.1  meq l; chemistry blood sodium  140  meq l; chemistry blood urea nitrogen  11  mg dl; hematology blood inr(pt)  1.1  ; chemistry blood calcium, total  9.3  mg dl; chemistry blood glucose  81  mg dl; hematology blood bands  0  %$vial  0  vial ; heparin flush (10 units ml)  5  ml ; heparin flush (100 units ml)  5  ml ; sodium chloride 0.9%  flush  10  ml ; sulfameth trimethoprim ds  1  tab ; levothyroxine sodium  88  mcg ; pantoprazole  40  mg ; prochlorperazine  10  mg ; ondansetron  8  mg ; heparin  5000  unit ; bag  1  bag ; magnesium sulfate  2  gm ; bag  2  bag ; magnesium sulfate  4  gm ; potassium chloride replacement (critical care and oncology)   40  meq ; potassium chloride replacement (critical care and oncology)   60  meq ; potassium chloride replacement (critical care and oncology)   80  meq ; calcium gluconate  0  g ; vial  2  vial ; calcium gluconate  2  g ; vial  4  vial ; calcium gluconate  4  g ; sodium chloride 0.9%  1000  ml ; ramelteon  8  mg ; prednisone  5  mg ; docusate sodium  100  mg ; furosemide  20  mg ; 
pleural effusion, not elsewhere classified personal history of nicotine dependence malignant neoplasm of mediastinum, part unspecified compression of vein gastro-esophageal reflux disease without esophagitis exposure to radiofrequency, initial encounter encounter for antineoplastic chemotherapy fluid overload, unspecified hypothyroidism, unspecified acute pulmonary manifestations due to radiation personal history of hodgkin lymphoma adverse effect of antineoplastic and immunosuppressive drugs, initial encounter hypothyroidism, unspecified anemia due to antineoplastic chemotherapy secondary malignant neoplasm of right lung unspecified place in unspecified non-institutional (private) residence as the place of occurrence of the external cause malignant neoplasm of posterior mediastinum personal history of nicotine dependence personal history of hodgkin lymphoma compression of vein malignant neoplasm of anterior mediastinum gastro-esophageal reflux disease without esophagitis other coronavirus as the cause of diseases classified elsewhere encounter for antineoplastic chemotherapy fluid overload, unspecified pneumonia, unspecified organism encounter for antineoplastic chemotherapy essential (hemorrhagic) thrombocythemia personal history of hodgkin lymphoma malignant neoplasm of peripheral nerves and autonomic nervous system, unspecified shortness of breath unspecified place in hospital as the place of occurrence of the external cause personal history of nicotine dependence hypothyroidism, unspecified adverse effect of glucocorticoids and synthetic analogues, initial encounter pericardial effusion (noninflammatory) elevated white blood cell count, unspecified localized edema gastro-esophageal reflux disease without esophagitis esophageal obstruction other adrenocortical insufficiency adverse effect of antineoplastic and immunosuppressive drugs, sequela anemia in neoplastic disease adverse effect of glucocorticoids and synthetic analogues, sequela gastro-esophageal reflux disease without esophagitis secondary malignant neoplasm of right lung malignant neoplasm of peripheral nerves of thorax personal history of nicotine dependence
white f 47 $nan$hematology blood hematocrit  28.2  %; hematology blood hemoglobin  9.0  g dl; hematology blood platelet count  627  k ul; chemistry blood anion gap  12  meq l; chemistry blood bicarbonate  24  meq l; chemistry blood chloride  105  meq l; chemistry blood creatinine  0.6  mg dl; chemistry blood potassium  4.3  meq l; chemistry blood sodium  141  meq l; chemistry blood urea nitrogen  10  mg dl; hematology blood inr(pt)  1.1  ; chemistry blood calcium, total  9.2  mg dl; chemistry blood bilirubin, total  0.2  mg dl; chemistry blood glucose  76  mg dl; chemistry blood lactate dehydrogenase (ld)  240  iu l$vial  0  vial ; heparin flush (10 units ml)  5  ml ; heparin flush (100 units ml)  5  ml ; sodium chloride 0.9%  flush  10  ml ; sulfameth trimethoprim ds  1  tab ; levothyroxine sodium  88  mcg ; pantoprazole  40  mg ; prochlorperazine  10  mg ; ondansetron  8  mg ; heparin  5000  unit ; bag  1  bag ; magnesium sulfate  2  gm ; bag  2  bag ; magnesium sulfate  4  gm ; potassium chloride replacement (critical care and oncology)   40  meq ; potassium chloride replacement (critical care and oncology)   60  meq ; potassium chloride replacement (critical care and oncology)   80  meq ; calcium gluconate  0  g ; vial  2  vial ; calcium gluconate  2  g ; vial  4  vial ; calcium gluconate  4  g ; sodium chloride 0.9%  1000  ml ; ramelteon  8  mg ; prednisone  5  mg ; docusate sodium  100  mg ; furosemide  20  mg ; benzonatate  100  mg ; guaifenesin er  600  mg ; 
pleural effusion, not elsewhere classified personal history of nicotine dependence malignant neoplasm of mediastinum, part unspecified compression of vein gastro-esophageal reflux disease without esophagitis exposure to radiofrequency, initial encounter encounter for antineoplastic chemotherapy fluid overload, unspecified hypothyroidism, unspecified acute pulmonary manifestations due to radiation personal history of hodgkin lymphoma adverse effect of antineoplastic and immunosuppressive drugs, initial encounter hypothyroidism, unspecified anemia due to antineoplastic chemotherapy secondary malignant neoplasm of right lung unspecified place in unspecified non-institutional (private) residence as the place of occurrence of the external cause malignant neoplasm of posterior mediastinum personal history of nicotine dependence personal history of hodgkin lymphoma compression of vein malignant neoplasm of anterior mediastinum gastro-esophageal reflux disease without esophagitis other coronavirus as the cause of diseases classified elsewhere encounter for antineoplastic chemotherapy fluid overload, unspecified pneumonia, unspecified organism encounter for antineoplastic chemotherapy essential (hemorrhagic) thrombocythemia personal history of hodgkin lymphoma malignant neoplasm of peripheral nerves and autonomic nervous system, unspecified shortness of breath unspecified place in hospital as the place of occurrence of the external cause personal history of nicotine dependence hypothyroidism, unspecified adverse effect of glucocorticoids and synthetic analogues, initial encounter pericardial effusion (noninflammatory) elevated white blood cell count, unspecified localized edema gastro-esophageal reflux disease without esophagitis esophageal obstruction other adrenocortical insufficiency adverse effect of antineoplastic and immunosuppressive drugs, sequela anemia in neoplastic disease adverse effect of glucocorticoids and synthetic analogues, sequela gastro-esophageal reflux disease without esophagitis secondary malignant neoplasm of right lung malignant neoplasm of peripheral nerves of thorax personal history of nicotine dependence
white f 47 $nan$nan$vial  0  vial ; heparin flush (10 units ml)  5  ml ; heparin flush (100 units ml)  5  ml ; sodium chloride 0.9%  flush  10  ml ; sulfameth trimethoprim ds  1  tab ; levothyroxine sodium  88  mcg ; pantoprazole  40  mg ; prochlorperazine  10  mg ; ondansetron  8  mg ; heparin  5000  unit ; bag  1  bag ; magnesium sulfate  2  gm ; bag  2  bag ; magnesium sulfate  4  gm ; potassium chloride replacement (critical care and oncology)   40  meq ; potassium chloride replacement (critical care and oncology)   60  meq ; potassium chloride replacement (critical care and oncology)   80  meq ; calcium gluconate  0  g ; vial  2  vial ; calcium gluconate  2  g ; vial  4  vial ; calcium gluconate  4  g ; sodium chloride 0.9%  1000  ml ; ramelteon  8  mg ; prednisone  5  mg ; docusate sodium  100  mg ; benzonatate  100  mg ; guaifenesin er  600  mg ; guaifenesin-codeine phosphate  5-10  ml ; 
pleural effusion, not elsewhere classified personal history of nicotine dependence malignant neoplasm of mediastinum, part unspecified compression of vein gastro-esophageal reflux disease without esophagitis exposure to radiofrequency, initial encounter encounter for antineoplastic chemotherapy fluid overload, unspecified hypothyroidism, unspecified acute pulmonary manifestations due to radiation personal history of hodgkin lymphoma adverse effect of antineoplastic and immunosuppressive drugs, initial encounter hypothyroidism, unspecified anemia due to antineoplastic chemotherapy secondary malignant neoplasm of right lung unspecified place in unspecified non-institutional (private) residence as the place of occurrence of the external cause malignant neoplasm of posterior mediastinum personal history of nicotine dependence personal history of hodgkin lymphoma compression of vein malignant neoplasm of anterior mediastinum gastro-esophageal reflux disease without esophagitis other coronavirus as the cause of diseases classified elsewhere encounter for antineoplastic chemotherapy fluid overload, unspecified pneumonia, unspecified organism encounter for antineoplastic chemotherapy essential (hemorrhagic) thrombocythemia personal history of hodgkin lymphoma malignant neoplasm of peripheral nerves and autonomic nervous system, unspecified shortness of breath unspecified place in hospital as the place of occurrence of the external cause personal history of nicotine dependence hypothyroidism, unspecified adverse effect of glucocorticoids and synthetic analogues, initial encounter pericardial effusion (noninflammatory) elevated white blood cell count, unspecified localized edema gastro-esophageal reflux disease without esophagitis esophageal obstruction other adrenocortical insufficiency adverse effect of antineoplastic and immunosuppressive drugs, sequela anemia in neoplastic disease adverse effect of glucocorticoids and synthetic analogues, sequela gastro-esophageal reflux disease without esophagitis secondary malignant neoplasm of right lung malignant neoplasm of peripheral nerves of thorax personal history of nicotine dependence
white m 60 $nan$nan$potassium chl 20 meq   1000 ml d5 1 2 ns  1000  ml ; albuterol inhaler  1  puff ; influenza vaccine quadrivalent  0.5  ml ; sodium chloride 0.9%  flush  3  ml ; hydromorphone (dilaudid)  0.25  mg ; omeprazole  20  mg ; ondansetron  4  mg ; heparin  5000  unit ; iso-osmotic dextrose  50  ml ; cefazolin  1  g ; diphenhydramine  50  mg ; trazodone  50  mg ; acetaminophen  650  mg ; 

white m 60 $nan$nan$potassium chl 20 meq   1000 ml d5 1 2 ns  1000  ml ; albuterol inhaler  1  puff ; influenza vaccine quadrivalent  0.5  ml ; sodium chloride 0.9%  flush  3  ml ; hydromorphone (dilaudid)  0.25  mg ; omeprazole  20  mg ; ondansetron  4  mg ; heparin  5000  unit ; iso-osmotic dextrose  50  ml ; cefazolin  1  g ; trazodone  50  mg ; acetaminophen  650  mg ; aspirin  325  mg ; 

black african american m 55 $nan$hematology blood hematocrit  32.8  %; hematology blood hematocrit  26.0  %; hematology blood hematocrit  24.8  %; hematology blood hemoglobin  11.5  g dl; hematology blood hemoglobin  9.0  g dl; hematology blood hemoglobin  8.3  g dl; hematology blood platelet count  119  k ul; hematology blood platelet count  140  k ul; hematology blood platelet count  116  k ul; chemistry blood anion gap  11  meq l; chemistry blood anion gap  12  meq l; chemistry blood anion gap  10  meq l; chemistry blood bicarbonate  25  meq l; chemistry blood bicarbonate  18  meq l; chemistry blood bicarbonate  20  meq l; chemistry blood chloride  100  meq l; chemistry blood chloride  105  meq l; chemistry blood chloride  108  meq l; chemistry blood creatinine  0.8  mg dl; chemistry blood creatinine  1.1  mg dl; chemistry blood creatinine  1.0  mg dl; chemistry blood potassium  4.8  meq l; chemistry blood potassium  4.7  meq l; chemistry blood potassium  4.8  meq l; chemistry blood sodium  131  meq l; chemistry blood sodium  130  meq l; chemistry blood sodium  133  meq l; chemistry blood urea nitrogen  13  mg dl; chemistry blood urea nitrogen  16  mg dl; chemistry blood urea nitrogen  15  mg dl; hematology blood inr(pt)  1.2  ; hematology blood inr(pt)  1.2  ; hematology urine wbc  3  # hpf; hematology urine wbc  8  # hpf; chemistry blood calcium, total  6.8  mg dl; chemistry blood calcium, total  7.2  mg dl; chemistry blood calcium, total  5.7  mg dl; chemistry blood bilirubin, total  0.3  mg dl; chemistry blood bilirubin, total  0.2  mg dl; chemistry blood glucose  204  mg dl; chemistry blood glucose  210  mg dl; chemistry blood glucose  210  mg dl; chemistry blood lactate dehydrogenase (ld)  1794  iu l; chemistry blood lactate dehydrogenase (ld)  1414  iu l; chemistry blood albumin  2.8  g dl; hematology blood bands  10  %; blood gas blood lactate  1.6  mmol l; blood gas blood lactate  1.7  mmol l; hematology blood wbc count  3.5  k ul$5% dextrose  250  ml ; sodium chloride 0.9%  flush  3  ml ; acetaminophen  325-650  mg ; soln  50  ml ; fentanyl citrate  2.5  mg ; 0.9% sodium chloride  100  ml ; midazolam  100  mg ; iso-osmotic dextrose  50  ml ; ceftriaxone  1  gm ; azithromycin  250  mg ; albuterol inhaler  4-8  puff ; ipratropium bromide mdi  4  puff ; bisacodyl  10  mg ; famotidine  20  mg ; ceftriaxone  2  gm ; azithromycin  500  mg ; docusate sodium (liquid)  100  mg ; senna  1  tab ; heparin  5000  unit ; iso-osmotic dextrose  200  ml ; vancomycin  1000  mg ; chlorhexidine gluconate 0.12% oral rinse  15  ml ; prednisone  40  mg ; 5% dextrose  500  ml ; sulfameth trimethoprim  450  mg ; methylprednisolone sodium succ  30  mg ; 0.9% sodium chloride  500  ml ; 0.9% sodium chloride  1000  ml ; norepinephrine  8  mg ; cisatracurium besylate  100  mg ; insulin  0  unit ; 0.9% sodium chloride  2  bag ; calcium gluconate  4  g ; neutra-phos  2  pkt ; 
 
black african american m 55 $nan$hematology blood hematocrit  26.1  %; hematology blood hemoglobin  9.0  g dl; hematology blood platelet count  176  k ul; chemistry blood anion gap  14  meq l; chemistry blood anion gap  14  meq l; chemistry blood bicarbonate  19  meq l; chemistry blood bicarbonate  17  meq l; chemistry blood chloride  107  meq l; chemistry blood chloride  107  meq l; chemistry blood creatinine  1.4  mg dl; chemistry blood creatinine  1.4  mg dl; chemistry blood potassium  4.8  meq l; chemistry blood potassium  4.8  meq l; chemistry blood sodium  135  meq l; chemistry blood sodium  133  meq l; chemistry blood urea nitrogen  20  mg dl; chemistry blood urea nitrogen  21  mg dl; hematology blood inr(pt)  1.1  ; chemistry blood calcium, total  7.1  mg dl; chemistry blood bilirubin, total  0.3  mg dl; chemistry blood glucose  139  mg dl; chemistry blood glucose  171  mg dl; chemistry blood lactate dehydrogenase (ld)  1923  iu l; blood gas blood free calcium  1.13  mmol l; blood gas blood lactate  2.1  mmol l; blood gas blood lactate  2.2  mmol l; blood gas blood lactate  2.4  mmol l$5% dextrose  250  ml ; sodium chloride 0.9%  flush  3  ml ; acetaminophen  325-650  mg ; albuterol inhaler  4-8  puff ; ipratropium bromide mdi  4  puff ; bisacodyl  10  mg ; famotidine  20  mg ; ceftriaxone  2  gm ; azithromycin  500  mg ; docusate sodium (liquid)  100  mg ; senna  1  tab ; heparin  5000  unit ; iso-osmotic dextrose  200  ml ; vancomycin  1000  mg ; chlorhexidine gluconate 0.12% oral rinse  15  ml ; 5% dextrose  500  ml ; sulfameth trimethoprim  450  mg ; methylprednisolone sodium succ  30  mg ; 0.9% sodium chloride  500  ml ; 0.9% sodium chloride  1000  ml ; norepinephrine  8  mg ; cisatracurium besylate  100  mg ; insulin  0  unit ; 0.9% sodium chloride  2  bag ; calcium gluconate  4  g ; neutra-phos  2  pkt ; ns (mini bag plus)  100  ml ; piperacillin-tazobactam  4.5  gm ; cisatracurium besylate  18  mg ; piperacillin-tazobactam  4.5  g ; d5w  300  ml ; linezolid  600  mg ; iso-osmotic dextrose  100  ml ; piperacillin-tazobactam na  4.5  g ; 
 
black african american m 55 $nan$hematology blood hematocrit  24.5  %; hematology blood hemoglobin  8.4  g dl; hematology blood platelet count  234  k ul; chemistry blood anion gap  14  meq l; chemistry blood anion gap  12  meq l; chemistry blood bicarbonate  16  meq l; chemistry blood bicarbonate  19  meq l; chemistry blood chloride  106  meq l; chemistry blood chloride  105  meq l; chemistry blood creatinine  1.4  mg dl; chemistry blood creatinine  1.6  mg dl; chemistry blood potassium  4.4  meq l; chemistry blood potassium  4.9  meq l; chemistry blood sodium  132  meq l; chemistry blood sodium  131  meq l; chemistry blood urea nitrogen  22  mg dl; chemistry blood urea nitrogen  26  mg dl; hematology blood inr(pt)  1.1  ; chemistry urine creatinine, urine  24  mg dl; chemistry urine potassium, urine  5  meq l; chemistry urine sodium, urine  25  meq l; chemistry blood calcium, total  7.5  mg dl; chemistry blood bilirubin, total  0.4  mg dl; chemistry blood glucose  136  mg dl; chemistry blood lactate dehydrogenase (ld)  1559  iu l; blood gas blood lactate  2.6  mmol l; blood gas blood lactate  3.0  mmol l; blood gas blood lactate  2.4  mmol l$sodium chloride 0.9%  flush  3  ml ; acetaminophen  325-650  mg ; albuterol inhaler  4-8  puff ; ipratropium bromide mdi  4  puff ; bisacodyl  10  mg ; famotidine  20  mg ; azithromycin  500  mg ; docusate sodium (liquid)  100  mg ; senna  1  tab ; heparin  5000  unit ; chlorhexidine gluconate 0.12% oral rinse  15  ml ; 5% dextrose  500  ml ; sulfameth trimethoprim  450  mg ; methylprednisolone sodium succ  30  mg ; norepinephrine  8  mg ; insulin  0  unit ; ns (mini bag plus)  100  ml ; piperacillin-tazobactam  4.5  gm ; cisatracurium besylate  18  mg ; piperacillin-tazobactam  4.5  g ; iso-osmotic dextrose  100  ml ; piperacillin-tazobactam na  4.5  g ; 0.9% sodium chloride  1  bag ; calcium gluconate  2  g ; 
 
black african american m 55 $nan$hematology blood hematocrit  24.5  %; hematology blood hematocrit  23.9  %; hematology blood hemoglobin  8.4  g dl; hematology blood hemoglobin  8.2  g dl; hematology blood platelet count  289  k ul; hematology blood platelet count  303  k ul; chemistry blood anion gap  16  meq l; chemistry blood anion gap  14  meq l; chemistry blood bicarbonate  18  meq l; chemistry blood bicarbonate  19  meq l; chemistry blood chloride  106  meq l; chemistry blood chloride  107  meq l; chemistry blood creatinine  1.5  mg dl; chemistry blood creatinine  1.5  mg dl; chemistry blood potassium  5.4  meq l; chemistry blood potassium  5.5  meq l; chemistry blood sodium  135  meq l; chemistry blood sodium  134  meq l; chemistry blood urea nitrogen  28  mg dl; chemistry blood urea nitrogen  28  mg dl; hematology blood inr(pt)  1.1  ; chemistry blood calcium, total  7.6  mg dl; chemistry blood bilirubin, total  0.4  mg dl; chemistry blood glucose  115  mg dl; chemistry blood glucose  125  mg dl; chemistry blood lactate dehydrogenase (ld)  1207  iu l; blood gas blood lactate  2.8  mmol l; blood gas blood lactate  2.7  mmol l$sodium chloride 0.9%  flush  3  ml ; acetaminophen  325-650  mg ; albuterol inhaler  4-8  puff ; bisacodyl  10  mg ; famotidine  20  mg ; azithromycin  500  mg ; docusate sodium (liquid)  100  mg ; senna  1  tab ; heparin  5000  unit ; chlorhexidine gluconate 0.12% oral rinse  15  ml ; 5% dextrose  500  ml ; sulfameth trimethoprim  450  mg ; methylprednisolone sodium succ  30  mg ; insulin  0  unit ; iso-osmotic dextrose  100  ml ; piperacillin-tazobactam na  4.5  g ; 0.9% sodium chloride  1  bag ; calcium gluconate  2  g ; sulfameth trimethoprim  400  mg ; sodium polystyrene sulfonate  30  gm ; sodium chloride 0.9%  flush  10  ml ; 
 
black african american m 55 $nan$hematology blood hematocrit  23.6  %; hematology blood hemoglobin  8.1  g dl; hematology blood platelet count  353  k ul; chemistry blood anion gap  16  meq l; chemistry blood anion gap  15  meq l; chemistry blood bicarbonate  17  meq l; chemistry blood bicarbonate  19  meq l; chemistry blood chloride  104  meq l; chemistry blood chloride  101  meq l; chemistry blood creatinine  1.5  mg dl; chemistry blood creatinine  1.4  mg dl; chemistry blood potassium  5.2  meq l; chemistry blood potassium  5.5  meq l; chemistry blood sodium  132  meq l; chemistry blood sodium  129  meq l; chemistry blood urea nitrogen  29  mg dl; chemistry blood urea nitrogen  29  mg dl; hematology blood inr(pt)  1.0  ; chemistry blood calcium, total  7.6  mg dl; chemistry blood calcium, total  7.7  mg dl; chemistry blood bilirubin, total  0.6  mg dl; chemistry blood glucose  172  mg dl; chemistry blood glucose  256  mg dl; chemistry blood lactate dehydrogenase (ld)  1073  iu l; blood gas blood free calcium  1.18  mmol l; blood gas blood lactate  2.7  mmol l; blood gas blood lactate  3.2  mmol l; blood gas blood lactate  3.4  mmol l; blood gas blood lactate  3.6  mmol l; blood gas blood methemoglobin  2  %$sodium chloride 0.9%  flush  3  ml ; acetaminophen  325-650  mg ; albuterol inhaler  4-8  puff ; bisacodyl  10  mg ; famotidine  20  mg ; azithromycin  500  mg ; docusate sodium (liquid)  100  mg ; senna  1  tab ; heparin  5000  unit ; chlorhexidine gluconate 0.12% oral rinse  15  ml ; methylprednisolone sodium succ  30  mg ; insulin  0  unit ; iso-osmotic dextrose  100  ml ; piperacillin-tazobactam na  4.5  g ; sulfameth trimethoprim  400  mg ; sodium polystyrene sulfonate  30  gm ; sodium chloride 0.9%  flush  10  ml ; chlorpromazine  25  mg ; chlorpromazine  50  mg ; polyethylene glycol  17  g ; furosemide  20  mg ; 
 
black african american m 55 $nan$hematology blood hematocrit  22.2  %; hematology blood hematocrit  24.9  %; hematology blood hemoglobin  7.5  g dl; hematology blood platelet count  340  k ul; chemistry blood anion gap  18  meq l; chemistry blood anion gap  16  meq l; chemistry blood bicarbonate  18  meq l; chemistry blood bicarbonate  22  meq l; chemistry blood chloride  101  meq l; chemistry blood chloride  108  meq l; chemistry blood chloride  109  meq l; chemistry blood creatinine  1.5  mg dl; chemistry blood creatinine  1.5  mg dl; chemistry blood creatinine  1.4  mg dl; chemistry blood potassium  5.8  meq l; chemistry blood potassium  5.8  meq l; chemistry blood potassium  5.5  meq l; chemistry blood potassium  5.0  meq l; chemistry blood sodium  131  meq l; chemistry blood sodium  140  meq l; chemistry blood sodium  137  meq l; chemistry blood urea nitrogen  30  mg dl; chemistry blood urea nitrogen  34  mg dl; hematology blood inr(pt)  1.1  ; hematology urine wbc  24  # hpf; chemistry blood calcium, total  7.8  mg dl; chemistry blood calcium, total  7.6  mg dl; chemistry blood calcium, total  7.8  mg dl; chemistry blood bilirubin, indirect  0.3  mg dl; chemistry blood bilirubin, total  1.6  mg dl; chemistry blood glucose  234  mg dl; chemistry blood glucose  136  mg dl; chemistry blood lactate dehydrogenase (ld)  987  iu l; chemistry blood albumin  2.6  g dl; blood gas blood free calcium  1.17  mmol l; blood gas blood lactate  2.6  mmol l; chemistry blood bilirubin, direct  1.3  mg dl$sodium chloride 0.9%  flush  3  ml ; acetaminophen  325-650  mg ; albuterol inhaler  4-8  puff ; bisacodyl  10  mg ; famotidine  20  mg ; azithromycin  500  mg ; docusate sodium (liquid)  100  mg ; senna  1  tab ; heparin  5000  unit ; chlorhexidine gluconate 0.12% oral rinse  15  ml ; methylprednisolone sodium succ  30  mg ; insulin  0  unit ; iso-osmotic dextrose  100  ml ; piperacillin-tazobactam na  4.5  g ; sulfameth trimethoprim  400  mg ; sodium chloride 0.9%  flush  10  ml ; chlorpromazine  50  mg ; polyethylene glycol  17  g ; furosemide  20  mg ; insulin  10  unit ; dextrose 50%  25  gm ; lactulose  30  ml ; 
 
black african american m 55 $nan$hematology blood hematocrit  25.6  %; hematology blood hemoglobin  8.7  g dl; hematology blood platelet count  294  k ul; chemistry blood anion gap  14  meq l; chemistry blood bicarbonate  23  meq l; chemistry blood chloride  111  meq l; chemistry blood creatinine  1.3  mg dl; chemistry blood creatinine  1.4  mg dl; chemistry blood potassium  5.2  meq l; chemistry blood potassium  5.0  meq l; chemistry blood sodium  143  meq l; chemistry blood urea nitrogen  38  mg dl; hematology blood inr(pt)  1.2  ; chemistry blood calcium, total  7.8  mg dl; chemistry blood bilirubin, indirect  0.5  mg dl; chemistry blood bilirubin, total  3.2  mg dl; chemistry blood glucose  97  mg dl; chemistry blood lactate dehydrogenase (ld)  876  iu l; blood gas blood lactate  2.2  mmol l; chemistry blood bilirubin, direct  2.7  mg dl$sodium chloride 0.9%  flush  3  ml ; acetaminophen  325-650  mg ; albuterol inhaler  4-8  puff ; bisacodyl  10  mg ; famotidine  20  mg ; azithromycin  500  mg ; docusate sodium (liquid)  100  mg ; senna  1  tab ; heparin  5000  unit ; chlorhexidine gluconate 0.12% oral rinse  15  ml ; insulin  0  unit ; iso-osmotic dextrose  100  ml ; piperacillin-tazobactam na  4.5  g ; sodium chloride 0.9%  flush  10  ml ; chlorpromazine  50  mg ; polyethylene glycol  17  g ; insulin  10  unit ; dextrose 50%  25  gm ; lactulose  30  ml ; vecuronium bromide  10  mg ; metoprolol tartrate  5  mg ; propofol  1000  mg ; dextrose 5%  150  ml ; levofloxacin  750  mg ; 
 
black african american m 55 $nan$hematology blood hematocrit  23.3  %; hematology blood hemoglobin  7.8  g dl; hematology blood platelet count  275  k ul; chemistry blood anion gap  15  meq l; chemistry blood anion gap  16  meq l; chemistry blood bicarbonate  26  meq l; chemistry blood bicarbonate  26  meq l; chemistry blood chloride  109  meq l; chemistry blood chloride  110  meq l; chemistry blood creatinine  1.5  mg dl; chemistry blood creatinine  1.7  mg dl; chemistry blood potassium  6.0  meq l; chemistry blood potassium  5.9  meq l; chemistry blood sodium  144  meq l; chemistry blood sodium  146  meq l; chemistry blood urea nitrogen  42  mg dl; chemistry blood urea nitrogen  47  mg dl; hematology blood inr(pt)  1.3  ; chemistry blood calcium, total  7.6  mg dl; chemistry blood bilirubin, total  2.3  mg dl; chemistry blood glucose  161  mg dl; chemistry blood glucose  218  mg dl; chemistry blood lactate dehydrogenase (ld)  746  iu l; blood gas blood glucose  127  mg dl; blood gas blood potassium, whole blood  5.3  meq l$sodium chloride 0.9%  flush  3  ml ; acetaminophen  325-650  mg ; albuterol inhaler  4-8  puff ; famotidine  20  mg ; docusate sodium (liquid)  100  mg ; senna  1  tab ; heparin  5000  unit ; chlorhexidine gluconate 0.12% oral rinse  15  ml ; insulin  0  unit ; iso-osmotic dextrose  100  ml ; piperacillin-tazobactam na  4.5  g ; sodium chloride 0.9%  flush  10  ml ; chlorpromazine  50  mg ; vecuronium bromide  10  mg ; dextrose 5%  150  ml ; levofloxacin  750  mg ; furosemide  10  mg ; vancomycin  1250  mg ; 0.9% sodium chloride  250  ml ; caspofungin *nf*  70  mg ; dextrose 50%  50  gm ; d5 1 2ns  1000  ml ; methylprednisolone sodium succ  60  mg ; 
 
black african american m 55 $nan$hematology blood hematocrit  23.0  %; hematology blood hemoglobin  7.6  g dl; hematology blood platelet count  296  k ul; chemistry blood anion gap  15  meq l; chemistry blood anion gap  14  meq l; chemistry blood bicarbonate  27  meq l; chemistry blood bicarbonate  29  meq l; chemistry blood chloride  110  meq l; chemistry blood chloride  110  meq l; chemistry blood creatinine  1.6  mg dl; chemistry blood creatinine  1.7  mg dl; chemistry blood potassium  5.2  meq l; chemistry blood potassium  4.4  meq l; chemistry blood sodium  147  meq l; chemistry blood sodium  149  meq l; chemistry blood urea nitrogen  47  mg dl; chemistry blood urea nitrogen  53  mg dl; hematology blood inr(pt)  1.2  ; chemistry urine chloride, urine  10  meq l; chemistry urine creatinine, urine  92  mg dl; chemistry urine potassium, urine  31  meq l; chemistry urine sodium, urine  23  meq l; hematology urine wbc  10  # hpf; chemistry blood calcium, total  7.9  mg dl; chemistry blood calcium, total  8.1  mg dl; chemistry blood bilirubin, total  1.3  mg dl; chemistry blood glucose  181  mg dl; chemistry blood glucose  249  mg dl; chemistry blood lactate dehydrogenase (ld)  698  iu l; chemistry blood albumin  2.5  g dl; blood gas blood lactate  2.3  mmol l; blood gas blood lactate  2.1  mmol l; blood gas blood glucose  243  mg dl; blood gas blood potassium, whole blood  4.8  meq l; blood gas blood potassium, whole blood  4.6  meq l$sodium chloride 0.9%  flush  3  ml ; acetaminophen  325-650  mg ; albuterol inhaler  4-8  puff ; famotidine  20  mg ; docusate sodium (liquid)  100  mg ; senna  1  tab ; heparin  5000  unit ; chlorhexidine gluconate 0.12% oral rinse  15  ml ; insulin  0  unit ; iso-osmotic dextrose  100  ml ; piperacillin-tazobactam na  4.5  g ; sodium chloride 0.9%  flush  10  ml ; dextrose 5%  150  ml ; levofloxacin  750  mg ; furosemide  10  mg ; vancomycin  1250  mg ; 0.9% sodium chloride  250  ml ; caspofungin *nf*  70  mg ; dextrose 50%  50  gm ; d5 1 2ns  1000  ml ; methylprednisolone sodium succ  60  mg ; 
 
black african american m 55 $nan$hematology blood hematocrit  22.8  %; hematology blood hemoglobin  7.8  g dl; hematology blood platelet count  278  k ul; chemistry blood anion gap  14  meq l; chemistry blood anion gap  13  meq l; chemistry blood bicarbonate  27  meq l; chemistry blood bicarbonate  28  meq l; chemistry blood chloride  110  meq l; chemistry blood chloride  110  meq l; chemistry blood creatinine  1.7  mg dl; chemistry blood creatinine  1.8  mg dl; chemistry blood potassium  4.2  meq l; chemistry blood potassium  4.0  meq l; chemistry blood sodium  147  meq l; chemistry blood sodium  147  meq l; chemistry blood urea nitrogen  60  mg dl; chemistry blood urea nitrogen  62  mg dl; hematology urine wbc  29  # hpf; chemistry blood calcium, total  7.7  mg dl; chemistry blood bilirubin, total  1.1  mg dl; chemistry blood glucose  239  mg dl; chemistry blood glucose  245  mg dl; chemistry blood lactate dehydrogenase (ld)  656  iu l; blood gas blood lactate  2.3  mmol l$sodium chloride 0.9%  flush  3  ml ; acetaminophen  325-650  mg ; albuterol inhaler  4-8  puff ; famotidine  20  mg ; docusate sodium (liquid)  100  mg ; senna  1  tab ; heparin  5000  unit ; chlorhexidine gluconate 0.12% oral rinse  15  ml ; insulin  0  unit ; iso-osmotic dextrose  100  ml ; piperacillin-tazobactam na  4.5  g ; sodium chloride 0.9%  flush  10  ml ; dextrose 5%  150  ml ; levofloxacin  750  mg ; vancomycin  1250  mg ; methylprednisolone sodium succ  60  mg ; metoprolol tartrate  25  mg ; hydralazine  10  mg ; insulin  20  unit ; ns  100  ml ; metronidazole (flagyl)  500  mg ; artificial tear ointment  1  appl ; insulin human regular  100  unit ; 
 
black african american m 55 $nan$hematology blood hematocrit  24.7  %; hematology blood hematocrit  25.4  %; hematology blood hemoglobin  9.0  g dl; hematology blood platelet count  230  k ul; chemistry blood anion gap  15  meq l; chemistry blood anion gap  15  meq l; chemistry blood bicarbonate  27  meq l; chemistry blood bicarbonate  25  meq l; chemistry blood chloride  107  meq l; chemistry blood chloride  105  meq l; chemistry blood creatinine  1.9  mg dl; chemistry blood creatinine  1.4  mg dl; chemistry blood potassium  4.1  meq l; chemistry blood potassium  3.5  meq l; chemistry blood sodium  145  meq l; chemistry blood sodium  141  meq l; chemistry blood urea nitrogen  66  mg dl; chemistry blood urea nitrogen  50  mg dl; hematology blood inr(pt)  1.3  ; chemistry urine chloride, urine  14  meq l; chemistry urine creatinine, urine  91  mg dl; chemistry urine potassium, urine  23  meq l; chemistry urine sodium, urine  77  meq l; chemistry urine urea nitrogen, urine  1447  mg dl; chemistry blood calcium, total  7.7  mg dl; chemistry blood calcium, total  7.7  mg dl; chemistry blood bilirubin, total  1.5  mg dl; chemistry blood glucose  219  mg dl; chemistry blood glucose  101  mg dl; chemistry blood lactate dehydrogenase (ld)  635  iu l; blood gas blood free calcium  1.10  mmol l; blood gas blood free calcium  1.06  mmol l; blood gas blood lactate  2.5  mmol l; blood gas blood lactate  2.4  mmol l; blood gas blood glucose  71  mg dl$sodium chloride 0.9%  flush  3  ml ; acetaminophen  325-650  mg ; albuterol inhaler  4-8  puff ; famotidine  20  mg ; docusate sodium (liquid)  100  mg ; senna  1  tab ; heparin  5000  unit ; chlorhexidine gluconate 0.12% oral rinse  15  ml ; iso-osmotic dextrose  100  ml ; piperacillin-tazobactam na  4.5  g ; sodium chloride 0.9%  flush  10  ml ; dextrose 5%  150  ml ; levofloxacin  750  mg ; vancomycin  1250  mg ; methylprednisolone sodium succ  60  mg ; hydralazine  10  mg ; ns  100  ml ; metronidazole (flagyl)  500  mg ; artificial tear ointment  1  appl ; insulin human regular  100  unit ; 5% dextrose  1000  ml ; micafungin  100  mg ; potassium chloride  40  meq ; 5% dextrose  100  ml ; doxycycline hyclate  100  mg ; levofloxacin  500  mg ; 
 
black african american m 55 $nan$hematology blood hematocrit  26.2  %; hematology blood hemoglobin  9.0  g dl; hematology blood platelet count  218  k ul; chemistry blood anion gap  14  meq l; chemistry blood anion gap  14  meq l; chemistry blood bicarbonate  24  meq l; chemistry blood bicarbonate  23  meq l; chemistry blood chloride  102  meq l; chemistry blood chloride  102  meq l; chemistry blood creatinine  1.4  mg dl; chemistry blood creatinine  1.5  mg dl; chemistry blood potassium  3.9  meq l; chemistry blood potassium  3.7  meq l; chemistry blood sodium  136  meq l; chemistry blood sodium  138  meq l; chemistry blood sodium  135  meq l; chemistry blood urea nitrogen  47  mg dl; chemistry blood urea nitrogen  48  mg dl; chemistry blood calcium, total  7.9  mg dl; chemistry blood calcium, total  7.5  mg dl; chemistry blood bilirubin, total  1.3  mg dl; chemistry blood glucose  163  mg dl; chemistry blood glucose  98  mg dl; chemistry blood lactate dehydrogenase (ld)  532  iu l; chemistry blood albumin  2.3  g dl; blood gas blood lactate  3.3  mmol l$sodium chloride 0.9%  flush  3  ml ; acetaminophen  325-650  mg ; albuterol inhaler  4-8  puff ; famotidine  20  mg ; heparin  5000  unit ; chlorhexidine gluconate 0.12% oral rinse  15  ml ; iso-osmotic dextrose  100  ml ; piperacillin-tazobactam na  4.5  g ; sodium chloride 0.9%  flush  10  ml ; methylprednisolone sodium succ  60  mg ; artificial tear ointment  1  appl ; micafungin  100  mg ; potassium chloride  40  meq ; levofloxacin  500  mg ; 5% dextrose  150  ml ; metoprolol tartrate  12.5  mg ; 0.9% sodium chloride  150  ml ; sulfameth trimethoprim ss  1  tab ; 
 
black african american m 55 $nan$hematology blood hematocrit  29.0  %; hematology blood hemoglobin  10.2  g dl; hematology blood platelet count  256  k ul; chemistry blood anion gap  17  meq l; chemistry blood bicarbonate  22  meq l; chemistry blood chloride  104  meq l; chemistry blood creatinine  1.7  mg dl; chemistry blood potassium  3.7  meq l; chemistry blood sodium  139  meq l; chemistry blood urea nitrogen  52  mg dl; hematology blood inr(pt)  1.2  ; chemistry blood calcium, total  8.0  mg dl; chemistry blood bilirubin, total  1.5  mg dl; chemistry blood glucose  104  mg dl; chemistry blood lactate dehydrogenase (ld)  548  iu l; blood gas blood lactate  2.2  mmol l; blood gas blood glucose  81  mg dl$sodium chloride 0.9%  flush  3  ml ; acetaminophen  325-650  mg ; albuterol inhaler  4-8  puff ; famotidine  20  mg ; heparin  5000  unit ; chlorhexidine gluconate 0.12% oral rinse  15  ml ; iso-osmotic dextrose  100  ml ; piperacillin-tazobactam na  4.5  g ; sodium chloride 0.9%  flush  10  ml ; methylprednisolone sodium succ  60  mg ; artificial tear ointment  1  appl ; micafungin  100  mg ; levofloxacin  500  mg ; sulfameth trimethoprim ss  1  tab ; succinylcholine  100  mg ; 
 
black african american m 55 $nan$hematology blood hematocrit  30.0  %; hematology blood hemoglobin  10.1  g dl; hematology blood platelet count  273  k ul; chemistry blood anion gap  16  meq l; chemistry blood bicarbonate  23  meq l; chemistry blood chloride  106  meq l; chemistry blood creatinine  1.4  mg dl; chemistry blood potassium  4.6  meq l; chemistry blood sodium  140  meq l; chemistry blood urea nitrogen  46  mg dl; hematology blood inr(pt)  1.1  ; chemistry blood calcium, total  8.2  mg dl; chemistry blood bilirubin, total  1.3  mg dl; chemistry blood glucose  115  mg dl; chemistry blood lactate dehydrogenase (ld)  613  iu l; blood gas blood lactate  2.4  mmol l; blood gas blood lactate  2.0  mmol l; blood gas blood lactate  1.6  mmol l; blood gas blood glucose  116  mg dl$sodium chloride 0.9%  flush  3  ml ; acetaminophen  325-650  mg ; albuterol inhaler  4-8  puff ; famotidine  20  mg ; heparin  5000  unit ; chlorhexidine gluconate 0.12% oral rinse  15  ml ; iso-osmotic dextrose  100  ml ; piperacillin-tazobactam na  4.5  g ; sodium chloride 0.9%  flush  10  ml ; artificial tear ointment  1  appl ; micafungin  100  mg ; levofloxacin  500  mg ; succinylcholine  100  mg ; sulfameth trimethoprim ds  2  tab ; senna  5  ml ; 
 
black african american m 55 $nan$hematology blood hematocrit  23.7  %; hematology blood hematocrit  23.6  %; hematology blood hemoglobin  8.1  g dl; hematology blood hemoglobin  7.9  g dl; hematology blood platelet count  251  k ul; hematology blood platelet count  237  k ul; chemistry blood anion gap  15  meq l; chemistry blood bicarbonate  23  meq l; chemistry blood chloride  107  meq l; chemistry blood creatinine  1.2  mg dl; chemistry blood potassium  5.0  meq l; chemistry blood sodium  140  meq l; chemistry blood urea nitrogen  40  mg dl; chemistry blood calcium, total  7.9  mg dl; chemistry blood bilirubin, total  0.7  mg dl; chemistry blood glucose  119  mg dl; chemistry blood lactate dehydrogenase (ld)  527  iu l; blood gas blood lactate  1.9  mmol l; blood gas blood lactate  1.5  mmol l; blood gas blood lactate  1.5  mmol l$sodium chloride 0.9%  flush  3  ml ; acetaminophen  325-650  mg ; albuterol inhaler  4-8  puff ; famotidine  20  mg ; heparin  5000  unit ; chlorhexidine gluconate 0.12% oral rinse  15  ml ; iso-osmotic dextrose  100  ml ; piperacillin-tazobactam na  4.5  g ; sodium chloride 0.9%  flush  10  ml ; artificial tear ointment  1  appl ; micafungin  100  mg ; levofloxacin  500  mg ; sulfameth trimethoprim ds  2  tab ; senna  5  ml ; docusate sodium  100  mg ; insulin  30  unit ; 
 
black african american m 55 $nan$hematology blood hematocrit  25.2  %; hematology blood hematocrit  24.9  %; hematology blood hemoglobin  8.3  g dl; hematology blood hemoglobin  8.3  g dl; hematology blood platelet count  259  k ul; hematology blood platelet count  278  k ul; chemistry blood anion gap  13  meq l; chemistry blood bicarbonate  23  meq l; chemistry blood chloride  106  meq l; chemistry blood creatinine  1.1  mg dl; chemistry blood potassium  4.6  meq l; chemistry blood sodium  137  meq l; chemistry blood urea nitrogen  36  mg dl; hematology blood inr(pt)  1.1  ; chemistry blood calcium, total  7.9  mg dl; chemistry blood bilirubin, total  0.7  mg dl; chemistry blood glucose  91  mg dl; chemistry blood lactate dehydrogenase (ld)  478  iu l; blood gas blood lactate  1.6  mmol l$sodium chloride 0.9%  flush  3  ml ; acetaminophen  325-650  mg ; albuterol inhaler  4-8  puff ; famotidine  20  mg ; heparin  5000  unit ; chlorhexidine gluconate 0.12% oral rinse  15  ml ; iso-osmotic dextrose  100  ml ; piperacillin-tazobactam na  4.5  g ; sodium chloride 0.9%  flush  10  ml ; artificial tear ointment  1  appl ; micafungin  100  mg ; levofloxacin  500  mg ; sulfameth trimethoprim ds  2  tab ; senna  5  ml ; docusate sodium  100  mg ; insulin  30  unit ; 
 
black african american m 55 $nan$hematology blood hematocrit  26.6  %; hematology blood hemoglobin  9.1  g dl; hematology blood platelet count  331  k ul; chemistry blood anion gap  14  meq l; chemistry blood bicarbonate  24  meq l; chemistry blood chloride  103  meq l; chemistry blood creatinine  1.0  mg dl; chemistry blood potassium  4.5  meq l; chemistry blood sodium  136  meq l; chemistry blood urea nitrogen  31  mg dl; hematology blood inr(pt)  1.0  ; chemistry blood calcium, total  8.5  mg dl; chemistry blood bilirubin, total  0.7  mg dl; chemistry blood glucose  95  mg dl; chemistry blood lactate dehydrogenase (ld)  493  iu l; chemistry blood albumin  2.8  g dl; blood gas blood lactate  0.9  mmol l; blood gas blood lactate  1.2  mmol l$sodium chloride 0.9%  flush  3  ml ; acetaminophen  325-650  mg ; albuterol inhaler  4-8  puff ; famotidine  20  mg ; heparin  5000  unit ; chlorhexidine gluconate 0.12% oral rinse  15  ml ; iso-osmotic dextrose  100  ml ; piperacillin-tazobactam na  4.5  g ; sodium chloride 0.9%  flush  10  ml ; artificial tear ointment  1  appl ; senna  5  ml ; docusate sodium  100  mg ; insulin  30  unit ; methylprednisolone sodium succ  15  mg ; 
 
black african american m 55 $nan$hematology blood hematocrit  30.5  %; hematology blood hemoglobin  10.5  g dl; hematology blood platelet count  372  k ul; chemistry blood anion gap  15  meq l; chemistry blood anion gap  15  meq l; chemistry blood bicarbonate  26  meq l; chemistry blood bicarbonate  27  meq l; chemistry blood chloride  105  meq l; chemistry blood chloride  101  meq l; chemistry blood creatinine  1.0  mg dl; chemistry blood creatinine  0.9  mg dl; chemistry blood potassium  4.6  meq l; chemistry blood potassium  4.1  meq l; chemistry blood sodium  141  meq l; chemistry blood sodium  139  meq l; chemistry blood urea nitrogen  28  mg dl; chemistry blood urea nitrogen  25  mg dl; chemistry blood calcium, total  8.3  mg dl; chemistry blood bilirubin, total  0.8  mg dl; chemistry blood glucose  99  mg dl; chemistry blood glucose  121  mg dl; chemistry blood lactate dehydrogenase (ld)  532  iu l; blood gas blood lactate  1.0  mmol l$sodium chloride 0.9%  flush  3  ml ; acetaminophen  325-650  mg ; albuterol inhaler  4-8  puff ; famotidine  20  mg ; heparin  5000  unit ; chlorhexidine gluconate 0.12% oral rinse  15  ml ; iso-osmotic dextrose  100  ml ; piperacillin-tazobactam na  4.5  g ; sodium chloride 0.9%  flush  10  ml ; artificial tear ointment  1  appl ; senna  5  ml ; docusate sodium  100  mg ; insulin  30  unit ; methylprednisolone sodium succ  15  mg ; metoprolol tartrate  50  mg ; 
 
black african american m 55 $nan$hematology blood hematocrit  30.8  %; hematology blood hemoglobin  10.7  g dl; hematology blood platelet count  390  k ul; chemistry blood anion gap  15  meq l; chemistry blood bicarbonate  26  meq l; chemistry blood chloride  99  meq l; chemistry blood creatinine  0.8  mg dl; chemistry blood potassium  4.6  meq l; chemistry blood sodium  135  meq l; chemistry blood urea nitrogen  27  mg dl; chemistry blood calcium, total  8.6  mg dl; chemistry blood bilirubin, total  0.8  mg dl; chemistry blood glucose  146  mg dl; chemistry blood lactate dehydrogenase (ld)  673  iu l; blood gas blood free calcium  1.11  mmol l$sodium chloride 0.9%  flush  3  ml ; acetaminophen  325-650  mg ; albuterol inhaler  4-8  puff ; famotidine  20  mg ; heparin  5000  unit ; chlorhexidine gluconate 0.12% oral rinse  15  ml ; sodium chloride 0.9%  flush  10  ml ; artificial tear ointment  1  appl ; senna  5  ml ; docusate sodium  100  mg ; insulin  30  unit ; methylprednisolone sodium succ  15  mg ; metoprolol tartrate  50  mg ; 
 
black african american m 55 $nan$hematology blood hematocrit  31.2  %; hematology blood hemoglobin  10.5  g dl; hematology blood platelet count  398  k ul; chemistry blood anion gap  16  meq l; chemistry blood bicarbonate  25  meq l; chemistry blood chloride  100  meq l; chemistry blood creatinine  0.7  mg dl; chemistry blood potassium  3.9  meq l; chemistry blood potassium  4.3  meq l; chemistry blood sodium  138  meq l; chemistry blood sodium  137  meq l; chemistry blood urea nitrogen  23  mg dl; chemistry blood calcium, total  8.8  mg dl; chemistry blood glucose  76  mg dl$sodium chloride 0.9%  flush  3  ml ; acetaminophen  325-650  mg ; albuterol inhaler  4-8  puff ; famotidine  20  mg ; heparin  5000  unit ; chlorhexidine gluconate 0.12% oral rinse  15  ml ; sodium chloride 0.9%  flush  10  ml ; artificial tear ointment  1  appl ; senna  5  ml ; docusate sodium  100  mg ; insulin  30  unit ; methylprednisolone sodium succ  15  mg ; sodium phosphate  15  mmol ; prednisone  15  mg ; metoprolol tartrate  75  mg ; 
 
black african american m 55 $nan$hematology blood hematocrit  29.3  %; hematology blood hemoglobin  9.6  g dl; hematology blood platelet count  397  k ul; chemistry blood anion gap  15  meq l; chemistry blood bicarbonate  24  meq l; chemistry blood chloride  103  meq l; chemistry blood creatinine  0.8  mg dl; chemistry blood potassium  3.7  meq l; chemistry blood sodium  138  meq l; chemistry blood urea nitrogen  27  mg dl; chemistry blood calcium, total  8.5  mg dl; chemistry blood bilirubin, total  0.6  mg dl; chemistry blood glucose  135  mg dl$sodium chloride 0.9%  flush  3  ml ; acetaminophen  325-650  mg ; albuterol inhaler  4-8  puff ; famotidine  20  mg ; heparin  5000  unit ; chlorhexidine gluconate 0.12% oral rinse  15  ml ; sodium chloride 0.9%  flush  10  ml ; artificial tear ointment  1  appl ; senna  5  ml ; docusate sodium  100  mg ; sodium phosphate  15  mmol ; prednisone  15  mg ; metoprolol tartrate  75  mg ; albuterol 0.083% neb soln  1  neb ; ipratropium bromide neb  1  neb ; 
 
black african american m 55 $nan$hematology blood hematocrit  29.6  %; hematology blood hemoglobin  9.8  g dl; hematology blood platelet count  379  k ul; chemistry blood anion gap  13  meq l; chemistry blood bicarbonate  26  meq l; chemistry blood chloride  103  meq l; chemistry blood creatinine  0.8  mg dl; chemistry blood potassium  4.2  meq l; chemistry blood sodium  138  meq l; chemistry blood urea nitrogen  22  mg dl; chemistry blood calcium, total  8.5  mg dl; chemistry blood glucose  106  mg dl$sodium chloride 0.9%  flush  3  ml ; acetaminophen  325-650  mg ; famotidine  20  mg ; heparin  5000  unit ; sodium chloride 0.9%  flush  10  ml ; artificial tear ointment  1  appl ; senna  5  ml ; docusate sodium  100  mg ; prednisone  15  mg ; metoprolol tartrate  75  mg ; albuterol 0.083% neb soln  1  neb ; ipratropium bromide neb  1  neb ; prednisone  10  mg ; 
 
black african american m 55 $nan$hematology blood hematocrit  34.0  %; hematology blood hemoglobin  11.1  g dl; hematology blood platelet count  425  k ul; chemistry blood anion gap  12  meq l; chemistry blood bicarbonate  25  meq l; chemistry blood chloride  103  meq l; chemistry blood creatinine  0.8  mg dl; chemistry blood potassium  4.2  meq l; chemistry blood sodium  136  meq l; chemistry blood urea nitrogen  26  mg dl; chemistry blood calcium, total  8.6  mg dl; chemistry blood glucose  126  mg dl$sodium chloride 0.9%  flush  3  ml ; acetaminophen  325-650  mg ; famotidine  20  mg ; heparin  5000  unit ; sodium chloride 0.9%  flush  10  ml ; artificial tear ointment  1  appl ; senna  5  ml ; docusate sodium  100  mg ; metoprolol tartrate  75  mg ; albuterol 0.083% neb soln  1  neb ; ipratropium bromide neb  1  neb ; prednisone  10  mg ; acetaminophen  650  mg ; 
 
black african american m 55 $nan$hematology blood hematocrit  34.4  %; hematology blood hemoglobin  11.5  g dl; hematology blood platelet count  402  k ul; chemistry blood anion gap  17  meq l; chemistry blood bicarbonate  24  meq l; chemistry blood chloride  105  meq l; chemistry blood creatinine  0.9  mg dl; chemistry blood potassium  4.4  meq l; chemistry blood sodium  142  meq l; chemistry blood urea nitrogen  24  mg dl; chemistry blood calcium, total  8.8  mg dl; chemistry blood glucose  78  mg dl$sodium chloride 0.9%  flush  3  ml ; acetaminophen  325-650  mg ; famotidine  20  mg ; heparin  5000  unit ; sodium chloride 0.9%  flush  10  ml ; artificial tear ointment  1  appl ; metoprolol tartrate  75  mg ; albuterol 0.083% neb soln  1  neb ; ipratropium bromide neb  1  neb ; prednisone  10  mg ; acetaminophen  650  mg ; 
 
black african american m 55 $nan$hematology blood hematocrit  34.8  %; hematology blood hemoglobin  11.1  g dl; hematology blood platelet count  360  k ul; chemistry blood anion gap  17  meq l; chemistry blood bicarbonate  23  meq l; chemistry blood chloride  100  meq l; chemistry blood creatinine  0.8  mg dl; chemistry blood potassium  4.1  meq l; chemistry blood sodium  136  meq l; chemistry blood urea nitrogen  23  mg dl; chemistry blood glucose  70  mg dl$sodium chloride 0.9%  flush  3  ml ; famotidine  20  mg ; heparin  5000  unit ; sodium chloride 0.9%  flush  10  ml ; artificial tear ointment  1  appl ; metoprolol tartrate  75  mg ; albuterol 0.083% neb soln  1  neb ; ipratropium bromide neb  1  neb ; prednisone  10  mg ; acetaminophen  650  mg ; insulin  15  unit ; 
 
black african american m 55 $nan$hematology blood hematocrit  32.9  %; hematology blood hemoglobin  10.8  g dl; hematology blood platelet count  329  k ul; chemistry blood anion gap  15  meq l; chemistry blood bicarbonate  24  meq l; chemistry blood chloride  101  meq l; chemistry blood creatinine  0.8  mg dl; chemistry blood potassium  3.8  meq l; chemistry blood sodium  136  meq l; chemistry blood urea nitrogen  17  mg dl; chemistry blood glucose  93  mg dl$sodium chloride 0.9%  flush  3  ml ; famotidine  20  mg ; heparin  5000  unit ; sodium chloride 0.9%  flush  10  ml ; artificial tear ointment  1  appl ; metoprolol tartrate  75  mg ; albuterol 0.083% neb soln  1  neb ; ipratropium bromide neb  1  neb ; prednisone  10  mg ; acetaminophen  650  mg ; insulin  15  unit ; trazodone  25  mg ; prednisone  7.5  mg ; lisinopril  5  mg ; 
 
black african american m 55 $nan$nan$sodium chloride 0.9%  flush  3  ml ; famotidine  20  mg ; heparin  5000  unit ; sodium chloride 0.9%  flush  10  ml ; artificial tear ointment  1  appl ; metoprolol tartrate  75  mg ; albuterol 0.083% neb soln  1  neb ; ipratropium bromide neb  1  neb ; acetaminophen  650  mg ; insulin  15  unit ; trazodone  25  mg ; prednisone  7.5  mg ; lisinopril  5  mg ; 
 
black african american m 55 $nan$nan$sodium chloride 0.9%  flush  3  ml ; famotidine  20  mg ; heparin  5000  unit ; sodium chloride 0.9%  flush  10  ml ; artificial tear ointment  1  appl ; metoprolol tartrate  75  mg ; albuterol 0.083% neb soln  1  neb ; ipratropium bromide neb  1  neb ; acetaminophen  650  mg ; insulin  15  unit ; trazodone  25  mg ; prednisone  7.5  mg ; lisinopril  5  mg ; 
 
white f 57 $temp    heartrate  61.0  resprate  17.0  o2sat  95.0  sbp  105.0  dbp  49.0  rhythm    pain  0  ; temp    heartrate  64.0  resprate  19.0  o2sat  97.0  sbp  109.0  dbp  51.0  rhythm    pain  0  $hematology blood hematocrit  38.0  %; hematology blood hemoglobin  12.4  g dl; hematology blood platelet count  267  k ul; chemistry blood anion gap  15  meq l; chemistry blood bicarbonate  31  meq l; chemistry blood chloride  100  meq l; chemistry blood creatinine  1.5  mg dl; chemistry blood potassium  3.3  meq l; chemistry blood sodium  143  meq l; chemistry blood urea nitrogen  23  mg dl; chemistry blood calcium, total  9.2  mg dl; chemistry blood glucose  95  mg dl$sodium chloride 0.9%  flush  3  ml ; heparin  5000  unit ; amiodarone  200  mg ; aspirin ec  81  mg ; docusate sodium  100  mg ; gabapentin  600  mg ; omeprazole  20  mg ; paroxetine  30  mg ; simvastatin  10  mg ; acetaminophen  650  mg ; senna  8.6  mg ; metoprolol tartrate  12.5  mg ; potassium chloride  80  meq ; spironolactone  25  mg ; trazodone  25  mg ; 
acute diastolic (congestive) heart failure major depressive disorder, single episode, unspecified encounter for immunization left bundle-branch block, unspecified gastro-esophageal reflux disease without esophagitis obesity, unspecified unspecified atrial fibrillation obstructive hypertrophic cardiomyopathy presence of cardiac pacemaker personal history of nicotine dependence other chronic pain obstructive sleep apnea (adult) (pediatric) body mass index (bmi) 37.0-37.9, adult esophageal reflux postoperative shock, cardiogenic body mass index 36.0-36.9, adult cardiac complications, not elsewhere classified hypoxemia tobacco use disorder orthostatic hypotension other specified surgical operations and procedures causing abnormal patient reaction, or later complication, without mention of misadventure at time of operation person boarding or alighting a car injured in collision with railway train or railway vehicle cardiomegaly fitting and adjustment of cardiac pacemaker accidents occurring in residential institution other chronic pain benign neoplasm of adrenal gland other iatrogenic hypotension other secondary thrombocytopenia obstructive sleep apnea (adult)(pediatric) other specified conduction disorders hypertrophic obstructive cardiomyopathy atrial fibrillation acute kidney failure, unspecified acute posthemorrhagic anemia obesity, unspecified osteoarthrosis involving, or with mention of more than one site, but not specified as generalized, site unspecified paroxysmal ventricular tachycardia anxiety state, unspecified chronic airway obstruction, not elsewhere classified acute on chronic diastolic heart failure knee joint replacement arthrodesis status delirium due to conditions classified elsewhere acute respiratory failure following trauma and surgery long-term (current) use of aspirin leukocytosis, unspecified congestive heart failure, unspecified
white f 57 $nan$hematology blood hematocrit  36.8  %; hematology blood hemoglobin  12.0  g dl; hematology blood platelet count  268  k ul; chemistry blood anion gap  15  meq l; chemistry blood bicarbonate  28  meq l; chemistry blood chloride  101  meq l; chemistry blood creatinine  1.3  mg dl; chemistry blood potassium  3.9  meq l; chemistry blood sodium  140  meq l; chemistry blood urea nitrogen  24  mg dl; chemistry blood calcium, total  9.7  mg dl; chemistry blood glucose  113  mg dl$sodium chloride 0.9%  flush  3  ml ; heparin  5000  unit ; aspirin ec  81  mg ; docusate sodium  100  mg ; gabapentin  600  mg ; omeprazole  20  mg ; paroxetine  30  mg ; simvastatin  10  mg ; acetaminophen  650  mg ; senna  8.6  mg ; metoprolol tartrate  12.5  mg ; potassium chloride  80  meq ; trazodone  25  mg ; spironolactone  12.5  mg ; potassium chloride  20  meq ; polyethylene glycol  17  g ; torsemide  80  mg ; oxycodone (immediate release)   5  mg ; nitroglycerin sl  0.3  mg ; morphine sulfate  2-4  mg ; bisacodyl  10  mg ; torsemide  40  mg ; 
acute diastolic (congestive) heart failure major depressive disorder, single episode, unspecified encounter for immunization left bundle-branch block, unspecified gastro-esophageal reflux disease without esophagitis obesity, unspecified unspecified atrial fibrillation obstructive hypertrophic cardiomyopathy presence of cardiac pacemaker personal history of nicotine dependence other chronic pain obstructive sleep apnea (adult) (pediatric) body mass index (bmi) 37.0-37.9, adult esophageal reflux postoperative shock, cardiogenic body mass index 36.0-36.9, adult cardiac complications, not elsewhere classified hypoxemia tobacco use disorder orthostatic hypotension other specified surgical operations and procedures causing abnormal patient reaction, or later complication, without mention of misadventure at time of operation person boarding or alighting a car injured in collision with railway train or railway vehicle cardiomegaly fitting and adjustment of cardiac pacemaker accidents occurring in residential institution other chronic pain benign neoplasm of adrenal gland other iatrogenic hypotension other secondary thrombocytopenia obstructive sleep apnea (adult)(pediatric) other specified conduction disorders hypertrophic obstructive cardiomyopathy atrial fibrillation acute kidney failure, unspecified acute posthemorrhagic anemia obesity, unspecified osteoarthrosis involving, or with mention of more than one site, but not specified as generalized, site unspecified paroxysmal ventricular tachycardia anxiety state, unspecified chronic airway obstruction, not elsewhere classified acute on chronic diastolic heart failure knee joint replacement arthrodesis status delirium due to conditions classified elsewhere acute respiratory failure following trauma and surgery long-term (current) use of aspirin leukocytosis, unspecified congestive heart failure, unspecified
white f 57 $nan$hematology blood hematocrit  34.9  %; hematology blood hemoglobin  11.4  g dl; hematology blood platelet count  251  k ul; chemistry blood anion gap  14  meq l; chemistry blood bicarbonate  28  meq l; chemistry blood chloride  100  meq l; chemistry blood creatinine  1.3  mg dl; chemistry blood potassium  3.4  meq l; chemistry blood sodium  139  meq l; chemistry blood urea nitrogen  25  mg dl; chemistry blood calcium, total  8.5  mg dl; chemistry blood glucose  98  mg dl$sodium chloride 0.9%  flush  3  ml ; heparin  5000  unit ; aspirin ec  81  mg ; docusate sodium  100  mg ; gabapentin  600  mg ; omeprazole  20  mg ; paroxetine  30  mg ; simvastatin  10  mg ; acetaminophen  650  mg ; senna  8.6  mg ; metoprolol tartrate  12.5  mg ; trazodone  25  mg ; spironolactone  12.5  mg ; potassium chloride  20  meq ; polyethylene glycol  17  g ; torsemide  80  mg ; morphine sulfate  2-4  mg ; bisacodyl  10  mg ; torsemide  40  mg ; morphine sulfate ir  15  mg ; potassium chloride  40  meq ; 
acute diastolic (congestive) heart failure major depressive disorder, single episode, unspecified encounter for immunization left bundle-branch block, unspecified gastro-esophageal reflux disease without esophagitis obesity, unspecified unspecified atrial fibrillation obstructive hypertrophic cardiomyopathy presence of cardiac pacemaker personal history of nicotine dependence other chronic pain obstructive sleep apnea (adult) (pediatric) body mass index (bmi) 37.0-37.9, adult esophageal reflux postoperative shock, cardiogenic body mass index 36.0-36.9, adult cardiac complications, not elsewhere classified hypoxemia tobacco use disorder orthostatic hypotension other specified surgical operations and procedures causing abnormal patient reaction, or later complication, without mention of misadventure at time of operation person boarding or alighting a car injured in collision with railway train or railway vehicle cardiomegaly fitting and adjustment of cardiac pacemaker accidents occurring in residential institution other chronic pain benign neoplasm of adrenal gland other iatrogenic hypotension other secondary thrombocytopenia obstructive sleep apnea (adult)(pediatric) other specified conduction disorders hypertrophic obstructive cardiomyopathy atrial fibrillation acute kidney failure, unspecified acute posthemorrhagic anemia obesity, unspecified osteoarthrosis involving, or with mention of more than one site, but not specified as generalized, site unspecified paroxysmal ventricular tachycardia anxiety state, unspecified chronic airway obstruction, not elsewhere classified acute on chronic diastolic heart failure knee joint replacement arthrodesis status delirium due to conditions classified elsewhere acute respiratory failure following trauma and surgery long-term (current) use of aspirin leukocytosis, unspecified congestive heart failure, unspecified
white f 57 $nan$hematology blood hematocrit  36.0  %; hematology blood hemoglobin  11.7  g dl; hematology blood platelet count  251  k ul; chemistry blood anion gap  18  meq l; chemistry blood bicarbonate  27  meq l; chemistry blood chloride  102  meq l; chemistry blood creatinine  1.5  mg dl; chemistry blood potassium  4.0  meq l; chemistry blood sodium  143  meq l; chemistry blood urea nitrogen  23  mg dl; hematology urine wbc  1  # hpf; chemistry blood calcium, total  9.2  mg dl; chemistry blood glucose  93  mg dl$sodium chloride 0.9%  flush  3  ml ; heparin  5000  unit ; aspirin ec  81  mg ; docusate sodium  100  mg ; gabapentin  600  mg ; omeprazole  20  mg ; paroxetine  30  mg ; simvastatin  10  mg ; acetaminophen  650  mg ; senna  8.6  mg ; metoprolol tartrate  12.5  mg ; trazodone  25  mg ; polyethylene glycol  17  g ; bisacodyl  10  mg ; morphine sulfate ir  15  mg ; potassium chloride  40  meq ; lactulose  15  ml ; tramadol (ultram)  50  mg ; 
acute diastolic (congestive) heart failure major depressive disorder, single episode, unspecified encounter for immunization left bundle-branch block, unspecified gastro-esophageal reflux disease without esophagitis obesity, unspecified unspecified atrial fibrillation obstructive hypertrophic cardiomyopathy presence of cardiac pacemaker personal history of nicotine dependence other chronic pain obstructive sleep apnea (adult) (pediatric) body mass index (bmi) 37.0-37.9, adult esophageal reflux postoperative shock, cardiogenic body mass index 36.0-36.9, adult cardiac complications, not elsewhere classified hypoxemia tobacco use disorder orthostatic hypotension other specified surgical operations and procedures causing abnormal patient reaction, or later complication, without mention of misadventure at time of operation person boarding or alighting a car injured in collision with railway train or railway vehicle cardiomegaly fitting and adjustment of cardiac pacemaker accidents occurring in residential institution other chronic pain benign neoplasm of adrenal gland other iatrogenic hypotension other secondary thrombocytopenia obstructive sleep apnea (adult)(pediatric) other specified conduction disorders hypertrophic obstructive cardiomyopathy atrial fibrillation acute kidney failure, unspecified acute posthemorrhagic anemia obesity, unspecified osteoarthrosis involving, or with mention of more than one site, but not specified as generalized, site unspecified paroxysmal ventricular tachycardia anxiety state, unspecified chronic airway obstruction, not elsewhere classified acute on chronic diastolic heart failure knee joint replacement arthrodesis status delirium due to conditions classified elsewhere acute respiratory failure following trauma and surgery long-term (current) use of aspirin leukocytosis, unspecified congestive heart failure, unspecified
white f 57 $nan$hematology blood hematocrit  38.8  %; hematology blood hemoglobin  12.9  g dl; hematology blood platelet count  278  k ul; chemistry blood anion gap  18  meq l; chemistry blood anion gap  16  meq l; chemistry blood bicarbonate  26  meq l; chemistry blood bicarbonate  27  meq l; chemistry blood chloride  93  meq l; chemistry blood chloride  95  meq l; chemistry blood creatinine  1.6  mg dl; chemistry blood creatinine  1.6  mg dl; chemistry blood potassium  3.7  meq l; chemistry blood potassium  3.7  meq l; chemistry blood sodium  133  meq l; chemistry blood sodium  134  meq l; chemistry blood urea nitrogen  25  mg dl; chemistry blood urea nitrogen  25  mg dl; chemistry blood calcium, total  9.9  mg dl; chemistry blood calcium, total  10.3  mg dl; chemistry blood glucose  215  mg dl; chemistry blood glucose  155  mg dl$sodium chloride 0.9%  flush  3  ml ; heparin  5000  unit ; aspirin ec  81  mg ; docusate sodium  100  mg ; gabapentin  600  mg ; omeprazole  20  mg ; paroxetine  30  mg ; simvastatin  10  mg ; acetaminophen  650  mg ; senna  8.6  mg ; metoprolol tartrate  12.5  mg ; trazodone  25  mg ; polyethylene glycol  17  g ; bisacodyl  10  mg ; lactulose  15  ml ; tramadol (ultram)  50  mg ; metoprolol succinate xl  25  mg ; 
acute diastolic (congestive) heart failure major depressive disorder, single episode, unspecified encounter for immunization left bundle-branch block, unspecified gastro-esophageal reflux disease without esophagitis obesity, unspecified unspecified atrial fibrillation obstructive hypertrophic cardiomyopathy presence of cardiac pacemaker personal history of nicotine dependence other chronic pain obstructive sleep apnea (adult) (pediatric) body mass index (bmi) 37.0-37.9, adult esophageal reflux postoperative shock, cardiogenic body mass index 36.0-36.9, adult cardiac complications, not elsewhere classified hypoxemia tobacco use disorder orthostatic hypotension other specified surgical operations and procedures causing abnormal patient reaction, or later complication, without mention of misadventure at time of operation person boarding or alighting a car injured in collision with railway train or railway vehicle cardiomegaly fitting and adjustment of cardiac pacemaker accidents occurring in residential institution other chronic pain benign neoplasm of adrenal gland other iatrogenic hypotension other secondary thrombocytopenia obstructive sleep apnea (adult)(pediatric) other specified conduction disorders hypertrophic obstructive cardiomyopathy atrial fibrillation acute kidney failure, unspecified acute posthemorrhagic anemia obesity, unspecified osteoarthrosis involving, or with mention of more than one site, but not specified as generalized, site unspecified paroxysmal ventricular tachycardia anxiety state, unspecified chronic airway obstruction, not elsewhere classified acute on chronic diastolic heart failure knee joint replacement arthrodesis status delirium due to conditions classified elsewhere acute respiratory failure following trauma and surgery long-term (current) use of aspirin leukocytosis, unspecified congestive heart failure, unspecified
white f 37 $nan$hematology blood hematocrit  35.3  %; hematology blood hemoglobin  11.9  g dl; hematology blood platelet count  318  k ul$naloxone  40-80  mcg ; 0.9% sodium chloride  250  ml ; naloxone  0.4  mg ; metoclopramide  10  mg ; ketorolac  15-30  mg ; ondansetron  4  mg ; sodium chloride 0.9%  flush  3  ml ; lactated ringers  1000  ml ; docusate sodium  100  mg ; oxycodone-acetaminophen (5mg-325mg)  1-2  tab ; ibuprofen  600  mg ; acetaminophen  500-1000  mg ; bisacodyl  10  mg ; milk of magnesia  30  ml ; simethicone  80  mg ; calcium carbonate  500  mg ; tetanus-diphtox-acellular pertuss (adacel)  0.5  ml ; 
infection of amniotic cavity, delivered, with or without mention of antepartum condition other current conditions classifiable elsewhere of mother, delivered, with or without mention of antepartum condition carrier or suspected carrier of group b streptococcus secondary uterine inertia, delivered, with or without mention of antepartum condition motorcycle driver injured in collision with fixed or stationary object in nontraffic accident outcome of delivery, single liveborn
white f 37 $nan$nan$naloxone  40-80  mcg ; 0.9% sodium chloride  250  ml ; naloxone  0.4  mg ; metoclopramide  10  mg ; ketorolac  15-30  mg ; ondansetron  4  mg ; sodium chloride 0.9%  flush  3  ml ; lactated ringers  1000  ml ; docusate sodium  100  mg ; oxycodone-acetaminophen (5mg-325mg)  1-2  tab ; ibuprofen  600  mg ; acetaminophen  500-1000  mg ; bisacodyl  10  mg ; milk of magnesia  30  ml ; simethicone  80  mg ; calcium carbonate  500  mg ; tetanus-diphtox-acellular pertuss (adacel)  0.5  ml ; 
infection of amniotic cavity, delivered, with or without mention of antepartum condition other current conditions classifiable elsewhere of mother, delivered, with or without mention of antepartum condition carrier or suspected carrier of group b streptococcus secondary uterine inertia, delivered, with or without mention of antepartum condition motorcycle driver injured in collision with fixed or stationary object in nontraffic accident outcome of delivery, single liveborn
white f 37 $nan$nan$naloxone  40-80  mcg ; 0.9% sodium chloride  250  ml ; naloxone  0.4  mg ; metoclopramide  10  mg ; ondansetron  4  mg ; sodium chloride 0.9%  flush  3  ml ; lactated ringers  1000  ml ; docusate sodium  100  mg ; oxycodone-acetaminophen (5mg-325mg)  1-2  tab ; ibuprofen  600  mg ; acetaminophen  500-1000  mg ; bisacodyl  10  mg ; milk of magnesia  30  ml ; simethicone  80  mg ; calcium carbonate  500  mg ; tetanus-diphtox-acellular pertuss (adacel)  0.5  ml ; 
infection of amniotic cavity, delivered, with or without mention of antepartum condition other current conditions classifiable elsewhere of mother, delivered, with or without mention of antepartum condition carrier or suspected carrier of group b streptococcus secondary uterine inertia, delivered, with or without mention of antepartum condition motorcycle driver injured in collision with fixed or stationary object in nontraffic accident outcome of delivery, single liveborn
white f 37 $nan$hematology urine wbc  9  # hpf$naloxone  40-80  mcg ; 0.9% sodium chloride  250  ml ; naloxone  0.4  mg ; metoclopramide  10  mg ; ondansetron  4  mg ; sodium chloride 0.9%  flush  3  ml ; lactated ringers  1000  ml ; docusate sodium  100  mg ; oxycodone-acetaminophen (5mg-325mg)  1-2  tab ; ibuprofen  600  mg ; acetaminophen  500-1000  mg ; bisacodyl  10  mg ; milk of magnesia  30  ml ; simethicone  80  mg ; calcium carbonate  500  mg ; tetanus-diphtox-acellular pertuss (adacel)  0.5  ml ; 
infection of amniotic cavity, delivered, with or without mention of antepartum condition other current conditions classifiable elsewhere of mother, delivered, with or without mention of antepartum condition carrier or suspected carrier of group b streptococcus secondary uterine inertia, delivered, with or without mention of antepartum condition motorcycle driver injured in collision with fixed or stationary object in nontraffic accident outcome of delivery, single liveborn
white f 37 $nan$nan$naloxone  40-80  mcg ; 0.9% sodium chloride  250  ml ; naloxone  0.4  mg ; metoclopramide  10  mg ; ondansetron  4  mg ; sodium chloride 0.9%  flush  3  ml ; lactated ringers  1000  ml ; docusate sodium  100  mg ; oxycodone-acetaminophen (5mg-325mg)  1-2  tab ; ibuprofen  600  mg ; acetaminophen  500-1000  mg ; bisacodyl  10  mg ; milk of magnesia  30  ml ; simethicone  80  mg ; calcium carbonate  500  mg ; tetanus-diphtox-acellular pertuss (adacel)  0.5  ml ; 
infection of amniotic cavity, delivered, with or without mention of antepartum condition other current conditions classifiable elsewhere of mother, delivered, with or without mention of antepartum condition carrier or suspected carrier of group b streptococcus secondary uterine inertia, delivered, with or without mention of antepartum condition motorcycle driver injured in collision with fixed or stationary object in nontraffic accident outcome of delivery, single liveborn
other f 34 $nan$nan$sodium chloride 0.9%  flush  3  ml ; 0.9% sodium chloride  1000  ml ; oxytocin  20  unit ; lactated ringers  1000  ml ; docusate sodium  100  mg ; oxycodone-acetaminophen (5mg-325mg)  1-2  tab ; ibuprofen  600  mg ; codeine sulfate  30-60  mg ; acetaminophen  500-1000  mg ; bisacodyl  10  mg ; milk of magnesia  30  ml ; simethicone  80  mg ; calcium carbonate  500  mg ; dermoplast spray  1  spry ; 
other specified complications of pregnancy, antepartum condition or complication calculus of gallbladder without mention of cholecystitis, without mention of obstruction acute pancreatitis 
other f 34 $nan$nan$sodium chloride 0.9%  flush  3  ml ; 0.9% sodium chloride  1000  ml ; oxytocin  20  unit ; lactated ringers  1000  ml ; docusate sodium  100  mg ; oxycodone-acetaminophen (5mg-325mg)  1-2  tab ; ibuprofen  600  mg ; codeine sulfate  30-60  mg ; acetaminophen  500-1000  mg ; bisacodyl  10  mg ; milk of magnesia  30  ml ; simethicone  80  mg ; calcium carbonate  500  mg ; dermoplast spray  1  spry ; 
other specified complications of pregnancy, antepartum condition or complication calculus of gallbladder without mention of cholecystitis, without mention of obstruction acute pancreatitis 
other f 34 $nan$hematology blood hematocrit  34.9  %; hematology blood hemoglobin  11.3  g dl; hematology blood platelet count  238  k ul; chemistry blood anion gap  15  meq l; chemistry blood bicarbonate  25  meq l; chemistry blood chloride  96  meq l; chemistry blood creatinine  0.5  mg dl; chemistry blood potassium  3.6  meq l; chemistry blood sodium  132  meq l; chemistry blood urea nitrogen  9  mg dl; chemistry blood calcium, total  9.0  mg dl; chemistry blood bilirubin, total  0.2  mg dl; chemistry blood glucose  84  mg dl; chemistry blood lactate dehydrogenase (ld)  210  iu l; chemistry blood albumin  3.2  g dl$sodium chloride 0.9%  flush  3  ml ; 0.9% sodium chloride  1000  ml ; oxytocin  20  unit ; lactated ringers  1000  ml ; docusate sodium  100  mg ; oxycodone-acetaminophen (5mg-325mg)  1-2  tab ; ibuprofen  600  mg ; codeine sulfate  30-60  mg ; acetaminophen  500-1000  mg ; bisacodyl  10  mg ; milk of magnesia  30  ml ; simethicone  80  mg ; calcium carbonate  500  mg ; dermoplast spray  1  spry ; famotidine  20  mg ; 
other specified complications of pregnancy, antepartum condition or complication calculus of gallbladder without mention of cholecystitis, without mention of obstruction acute pancreatitis 
other f 34 $nan$nan$sodium chloride 0.9%  flush  3  ml ; 0.9% sodium chloride  1000  ml ; oxytocin  20  unit ; lactated ringers  1000  ml ; docusate sodium  100  mg ; oxycodone-acetaminophen (5mg-325mg)  1-2  tab ; ibuprofen  600  mg ; codeine sulfate  30-60  mg ; acetaminophen  500-1000  mg ; bisacodyl  10  mg ; milk of magnesia  30  ml ; simethicone  80  mg ; calcium carbonate  500  mg ; dermoplast spray  1  spry ; famotidine  20  mg ; 
other specified complications of pregnancy, antepartum condition or complication calculus of gallbladder without mention of cholecystitis, without mention of obstruction acute pancreatitis 
white m 32 $nan$hematology blood hematocrit  41.4  %; hematology blood hematocrit  38.7  %; hematology blood hemoglobin  14.3  g dl; hematology blood hemoglobin  13.4  g dl; hematology blood platelet count  205  k ul; hematology blood platelet count  183  k ul; chemistry blood anion gap  25  meq l; chemistry blood anion gap  18  meq l; chemistry blood bicarbonate  18  meq l; chemistry blood bicarbonate  21  meq l; chemistry blood chloride  100  meq l; chemistry blood chloride  103  meq l; chemistry blood creatinine  0.9  mg dl; chemistry blood creatinine  0.8  mg dl; chemistry blood potassium  4.0  meq l; chemistry blood potassium  5.3  meq l; chemistry blood sodium  139  meq l; chemistry blood sodium  137  meq l; chemistry blood urea nitrogen  14  mg dl; chemistry blood urea nitrogen  13  mg dl; hematology blood inr(pt)  1.1  ; hematology blood inr(pt)  1.1  ; chemistry blood calcium, total  9.7  mg dl; chemistry blood calcium, total  8.9  mg dl; chemistry blood glucose  137  mg dl; chemistry blood glucose  198  mg dl$quetiapine fumarate  12.5  mg ; divalproex (delayed release)  250  mg ; 0.9% sodium chloride  100  ml ; levetiracetam  2000  mg ; sodium chloride 0.9%  1000  ml ; hydralazine  10-20  mg ; bisacodyl  10  mg ; morphine sulfate  1-2  mg ; acetaminophen  325-650  mg ; oxycodone (immediate release)  5-10  mg ; ondansetron  4  mg ; albuterol 0.083% neb soln  1  neb ; trazodone  25  mg ; acetaminophen  1000  mg ; miconazole powder 2%  1  appl ; artificial tears preserv. free  1-2  drop ; haloperidol  0.25  mg ; 
thrombocytopenia, unspecified acute posthemorrhagic anemia traumatic cerebral edema without loss of consciousness, initial encounter acute respiratory failure, unspecified whether with hypoxia or hypercapnia schizoaffective disorder, unspecified other specified bacterial agents as the cause of diseases classified elsewhere ventilator associated pneumonia unspecified street and highway as the place of occurrence of the external cause pedestrian injured in traffic accident involving unspecified motor vehicles, initial encounter hiccough ventricular tachycardia unspecified convulsions fracture of unspecified part of left clavicle, initial encounter for closed fracture laceration of muscle and tendon of head, initial encounter urinary tract infection, site not specified other specified fracture of left pubis, initial encounter for closed fracture patient room in hospital as the place of occurrence of the external cause methicillin susceptible staphylococcus aureus infection as the cause of diseases classified elsewhere other medical procedures as the cause of abnormal reaction of the patient, or of later complication, without mention of misadventure at the time of the procedure bradycardia, unspecified hypotension due to drugs physical restraint status contusion of lung, unilateral, initial encounter traumatic subarachnoid hemorrhage with loss of consciousness of unspecified duration, initial encounter other specified disorders of brain retention of urine, unspecified alkalosis unspecified protein-calorie malnutrition traumatic subdural hemorrhage with loss of consciousness of unspecified duration, initial encounter adverse effect of unspecified antiepileptic and sedative-hypnotic drugs, initial encounter encounter for attention to gastrostomy enterocolitis due to clostridium difficile hyperosmolality and hypernatremia 
white m 32 $nan$hematology urine wbc  5  # hpf$quetiapine fumarate  12.5  mg ; divalproex (delayed release)  250  mg ; sodium chloride 0.9%  1000  ml ; hydralazine  10-20  mg ; bisacodyl  10  mg ; morphine sulfate  1-2  mg ; acetaminophen  325-650  mg ; oxycodone (immediate release)  5-10  mg ; ondansetron  4  mg ; albuterol 0.083% neb soln  1  neb ; trazodone  25  mg ; acetaminophen  1000  mg ; miconazole powder 2%  1  appl ; artificial tears preserv. free  1-2  drop ; haloperidol  0.25  mg ; docusate sodium  100  mg ; citalopram  40  mg ; amantadine  100  mg ; multivitamins w minerals liquid  15  ml ; valproic acid  250  mg ; quetiapine fumarate  25  mg ; senna  17.2  mg ; trazodone  50  mg ; 
thrombocytopenia, unspecified acute posthemorrhagic anemia traumatic cerebral edema without loss of consciousness, initial encounter acute respiratory failure, unspecified whether with hypoxia or hypercapnia schizoaffective disorder, unspecified other specified bacterial agents as the cause of diseases classified elsewhere ventilator associated pneumonia unspecified street and highway as the place of occurrence of the external cause pedestrian injured in traffic accident involving unspecified motor vehicles, initial encounter hiccough ventricular tachycardia unspecified convulsions fracture of unspecified part of left clavicle, initial encounter for closed fracture laceration of muscle and tendon of head, initial encounter urinary tract infection, site not specified other specified fracture of left pubis, initial encounter for closed fracture patient room in hospital as the place of occurrence of the external cause methicillin susceptible staphylococcus aureus infection as the cause of diseases classified elsewhere other medical procedures as the cause of abnormal reaction of the patient, or of later complication, without mention of misadventure at the time of the procedure bradycardia, unspecified hypotension due to drugs physical restraint status contusion of lung, unilateral, initial encounter traumatic subarachnoid hemorrhage with loss of consciousness of unspecified duration, initial encounter other specified disorders of brain retention of urine, unspecified alkalosis unspecified protein-calorie malnutrition traumatic subdural hemorrhage with loss of consciousness of unspecified duration, initial encounter adverse effect of unspecified antiepileptic and sedative-hypnotic drugs, initial encounter encounter for attention to gastrostomy enterocolitis due to clostridium difficile hyperosmolality and hypernatremia 
white m 32 $nan$hematology blood hematocrit  35.7  %; hematology blood hemoglobin  12.4  g dl; hematology blood platelet count  146  k ul; chemistry blood anion gap  14  meq l; chemistry blood bicarbonate  29  meq l; chemistry blood chloride  105  meq l; chemistry blood creatinine  0.6  mg dl; chemistry blood potassium  3.4  meq l; chemistry blood sodium  145  meq l; chemistry blood urea nitrogen  9  mg dl; hematology blood inr(pt)  1.1  ; chemistry blood calcium, total  8.7  mg dl; chemistry blood glucose  91  mg dl$quetiapine fumarate  12.5  mg ; hydralazine  10-20  mg ; bisacodyl  10  mg ; morphine sulfate  1-2  mg ; acetaminophen  325-650  mg ; oxycodone (immediate release)  5-10  mg ; ondansetron  4  mg ; albuterol 0.083% neb soln  1  neb ; trazodone  25  mg ; acetaminophen  1000  mg ; miconazole powder 2%  1  appl ; artificial tears preserv. free  1-2  drop ; haloperidol  0.25  mg ; amantadine  100  mg ; multivitamins w minerals liquid  15  ml ; valproic acid  250  mg ; senna  17.2  mg ; trazodone  50  mg ; citalopram  20  mg ; sodium chloride 0.9%  flush  3  ml ; heparin  5000  unit ; 
thrombocytopenia, unspecified acute posthemorrhagic anemia traumatic cerebral edema without loss of consciousness, initial encounter acute respiratory failure, unspecified whether with hypoxia or hypercapnia schizoaffective disorder, unspecified other specified bacterial agents as the cause of diseases classified elsewhere ventilator associated pneumonia unspecified street and highway as the place of occurrence of the external cause pedestrian injured in traffic accident involving unspecified motor vehicles, initial encounter hiccough ventricular tachycardia unspecified convulsions fracture of unspecified part of left clavicle, initial encounter for closed fracture laceration of muscle and tendon of head, initial encounter urinary tract infection, site not specified other specified fracture of left pubis, initial encounter for closed fracture patient room in hospital as the place of occurrence of the external cause methicillin susceptible staphylococcus aureus infection as the cause of diseases classified elsewhere other medical procedures as the cause of abnormal reaction of the patient, or of later complication, without mention of misadventure at the time of the procedure bradycardia, unspecified hypotension due to drugs physical restraint status contusion of lung, unilateral, initial encounter traumatic subarachnoid hemorrhage with loss of consciousness of unspecified duration, initial encounter other specified disorders of brain retention of urine, unspecified alkalosis unspecified protein-calorie malnutrition traumatic subdural hemorrhage with loss of consciousness of unspecified duration, initial encounter adverse effect of unspecified antiepileptic and sedative-hypnotic drugs, initial encounter encounter for attention to gastrostomy enterocolitis due to clostridium difficile hyperosmolality and hypernatremia 
white m 32 $nan$nan$quetiapine fumarate  12.5  mg ; hydralazine  10-20  mg ; bisacodyl  10  mg ; morphine sulfate  1-2  mg ; acetaminophen  325-650  mg ; oxycodone (immediate release)  5-10  mg ; ondansetron  4  mg ; albuterol 0.083% neb soln  1  neb ; trazodone  25  mg ; acetaminophen  1000  mg ; miconazole powder 2%  1  appl ; artificial tears preserv. free  1-2  drop ; haloperidol  0.25  mg ; amantadine  100  mg ; multivitamins w minerals liquid  15  ml ; valproic acid  250  mg ; senna  17.2  mg ; trazodone  50  mg ; citalopram  20  mg ; sodium chloride 0.9%  flush  3  ml ; heparin  5000  unit ; hydralazine  10  mg ; 
thrombocytopenia, unspecified acute posthemorrhagic anemia traumatic cerebral edema without loss of consciousness, initial encounter acute respiratory failure, unspecified whether with hypoxia or hypercapnia schizoaffective disorder, unspecified other specified bacterial agents as the cause of diseases classified elsewhere ventilator associated pneumonia unspecified street and highway as the place of occurrence of the external cause pedestrian injured in traffic accident involving unspecified motor vehicles, initial encounter hiccough ventricular tachycardia unspecified convulsions fracture of unspecified part of left clavicle, initial encounter for closed fracture laceration of muscle and tendon of head, initial encounter urinary tract infection, site not specified other specified fracture of left pubis, initial encounter for closed fracture patient room in hospital as the place of occurrence of the external cause methicillin susceptible staphylococcus aureus infection as the cause of diseases classified elsewhere other medical procedures as the cause of abnormal reaction of the patient, or of later complication, without mention of misadventure at the time of the procedure bradycardia, unspecified hypotension due to drugs physical restraint status contusion of lung, unilateral, initial encounter traumatic subarachnoid hemorrhage with loss of consciousness of unspecified duration, initial encounter other specified disorders of brain retention of urine, unspecified alkalosis unspecified protein-calorie malnutrition traumatic subdural hemorrhage with loss of consciousness of unspecified duration, initial encounter adverse effect of unspecified antiepileptic and sedative-hypnotic drugs, initial encounter encounter for attention to gastrostomy enterocolitis due to clostridium difficile hyperosmolality and hypernatremia 
white m 32 $nan$nan$quetiapine fumarate  12.5  mg ; bisacodyl  10  mg ; oxycodone (immediate release)  5-10  mg ; ondansetron  4  mg ; albuterol 0.083% neb soln  1  neb ; acetaminophen  1000  mg ; miconazole powder 2%  1  appl ; artificial tears preserv. free  1-2  drop ; amantadine  100  mg ; multivitamins w minerals liquid  15  ml ; valproic acid  250  mg ; senna  17.2  mg ; trazodone  50  mg ; citalopram  20  mg ; sodium chloride 0.9%  flush  3  ml ; heparin  5000  unit ; hydralazine  10  mg ; 
thrombocytopenia, unspecified acute posthemorrhagic anemia traumatic cerebral edema without loss of consciousness, initial encounter acute respiratory failure, unspecified whether with hypoxia or hypercapnia schizoaffective disorder, unspecified other specified bacterial agents as the cause of diseases classified elsewhere ventilator associated pneumonia unspecified street and highway as the place of occurrence of the external cause pedestrian injured in traffic accident involving unspecified motor vehicles, initial encounter hiccough ventricular tachycardia unspecified convulsions fracture of unspecified part of left clavicle, initial encounter for closed fracture laceration of muscle and tendon of head, initial encounter urinary tract infection, site not specified other specified fracture of left pubis, initial encounter for closed fracture patient room in hospital as the place of occurrence of the external cause methicillin susceptible staphylococcus aureus infection as the cause of diseases classified elsewhere other medical procedures as the cause of abnormal reaction of the patient, or of later complication, without mention of misadventure at the time of the procedure bradycardia, unspecified hypotension due to drugs physical restraint status contusion of lung, unilateral, initial encounter traumatic subarachnoid hemorrhage with loss of consciousness of unspecified duration, initial encounter other specified disorders of brain retention of urine, unspecified alkalosis unspecified protein-calorie malnutrition traumatic subdural hemorrhage with loss of consciousness of unspecified duration, initial encounter adverse effect of unspecified antiepileptic and sedative-hypnotic drugs, initial encounter encounter for attention to gastrostomy enterocolitis due to clostridium difficile hyperosmolality and hypernatremia 
white m 32 $nan$nan$quetiapine fumarate  12.5  mg ; bisacodyl  10  mg ; oxycodone (immediate release)  5-10  mg ; ondansetron  4  mg ; albuterol 0.083% neb soln  1  neb ; acetaminophen  1000  mg ; miconazole powder 2%  1  appl ; artificial tears preserv. free  1-2  drop ; amantadine  100  mg ; multivitamins w minerals liquid  15  ml ; valproic acid  250  mg ; senna  17.2  mg ; trazodone  50  mg ; citalopram  20  mg ; sodium chloride 0.9%  flush  3  ml ; heparin  5000  unit ; hydralazine  10  mg ; oxycodone (immediate release)  5  mg ; 
thrombocytopenia, unspecified acute posthemorrhagic anemia traumatic cerebral edema without loss of consciousness, initial encounter acute respiratory failure, unspecified whether with hypoxia or hypercapnia schizoaffective disorder, unspecified other specified bacterial agents as the cause of diseases classified elsewhere ventilator associated pneumonia unspecified street and highway as the place of occurrence of the external cause pedestrian injured in traffic accident involving unspecified motor vehicles, initial encounter hiccough ventricular tachycardia unspecified convulsions fracture of unspecified part of left clavicle, initial encounter for closed fracture laceration of muscle and tendon of head, initial encounter urinary tract infection, site not specified other specified fracture of left pubis, initial encounter for closed fracture patient room in hospital as the place of occurrence of the external cause methicillin susceptible staphylococcus aureus infection as the cause of diseases classified elsewhere other medical procedures as the cause of abnormal reaction of the patient, or of later complication, without mention of misadventure at the time of the procedure bradycardia, unspecified hypotension due to drugs physical restraint status contusion of lung, unilateral, initial encounter traumatic subarachnoid hemorrhage with loss of consciousness of unspecified duration, initial encounter other specified disorders of brain retention of urine, unspecified alkalosis unspecified protein-calorie malnutrition traumatic subdural hemorrhage with loss of consciousness of unspecified duration, initial encounter adverse effect of unspecified antiepileptic and sedative-hypnotic drugs, initial encounter encounter for attention to gastrostomy enterocolitis due to clostridium difficile hyperosmolality and hypernatremia 
white f 37 $nan$nan$sodium chloride 0.9%  flush  3  ml ; ondansetron  4  mg ; docusate sodium  100  mg ; ibuprofen  600  mg ; acetaminophen  500-1000  mg ; bisacodyl  10  mg ; milk of magnesia  30  ml ; simethicone  80  mg ; calcium carbonate  500  mg ; tetanus-diphtox-acellular pertuss (adacel)  0.5  ml ; dermoplast spray  1  spry ; levothyroxine sodium  75  mcg ; 
hypothyroidism, unspecified 8 weeks gestation of pregnancy tension-type headache, unspecified, not intractable other hypotension lower abdominal pain, unspecified endocrine, nutritional and metabolic diseases complicating pregnancy, first trimester other specified pregnancy related conditions, first trimester 
white f 37 $nan$nan$sodium chloride 0.9%  flush  3  ml ; ondansetron  4  mg ; docusate sodium  100  mg ; ibuprofen  600  mg ; acetaminophen  500-1000  mg ; bisacodyl  10  mg ; milk of magnesia  30  ml ; simethicone  80  mg ; calcium carbonate  500  mg ; tetanus-diphtox-acellular pertuss (adacel)  0.5  ml ; dermoplast spray  1  spry ; levothyroxine sodium  75  mcg ; oxycodone (immediate release)  5  mg ; albuterol inhaler  1-2  puff ; 
hypothyroidism, unspecified 8 weeks gestation of pregnancy tension-type headache, unspecified, not intractable other hypotension lower abdominal pain, unspecified endocrine, nutritional and metabolic diseases complicating pregnancy, first trimester other specified pregnancy related conditions, first trimester 
white f 37 $nan$nan$sodium chloride 0.9%  flush  3  ml ; ondansetron  4  mg ; docusate sodium  100  mg ; ibuprofen  600  mg ; acetaminophen  500-1000  mg ; bisacodyl  10  mg ; milk of magnesia  30  ml ; simethicone  80  mg ; calcium carbonate  500  mg ; tetanus-diphtox-acellular pertuss (adacel)  0.5  ml ; dermoplast spray  1  spry ; levothyroxine sodium  75  mcg ; oxycodone (immediate release)  5  mg ; albuterol inhaler  1-2  puff ; lorazepam  0.5  mg ; 
hypothyroidism, unspecified 8 weeks gestation of pregnancy tension-type headache, unspecified, not intractable other hypotension lower abdominal pain, unspecified endocrine, nutritional and metabolic diseases complicating pregnancy, first trimester other specified pregnancy related conditions, first trimester 
white m 63 $nan$nan$fludrocortisone acetate  0.1  mg ; fluoxetine  10  mg ; lisinopril  5  mg ; vitamin d  400  unit ; simvastatin  10  mg ; 
diabetes with neurological manifestations, type i [juvenile type], not stated as uncontrolled urgency of urination nocturia urinary frequency hypertrophy (benign) of prostate with urinary obstruction and other lower urinary tract symptoms (luts) polyneuropathy in diabetes
white m 63 $nan$hematology blood hematocrit  32.0  %; hematology blood hemoglobin  11.1  g dl; hematology blood platelet count  323  k ul; chemistry blood anion gap  13  meq l; chemistry blood bicarbonate  30  meq l; chemistry blood chloride  98  meq l; chemistry blood creatinine  1.2  mg dl; chemistry blood potassium  3.8  meq l; chemistry blood sodium  137  meq l; chemistry blood urea nitrogen  26  mg dl; hematology blood inr(pt)  1.0  ; chemistry blood calcium, total  9.2  mg dl; chemistry blood glucose  233  mg dl$fludrocortisone acetate  0.1  mg ; fluoxetine  10  mg ; lisinopril  5  mg ; vitamin d  400  unit ; simvastatin  10  mg ; influenza virus vaccine  0.5  ml ; sodium chloride 0.9%  flush  3  ml ; potassium chl 20 meq   1000 ml d5 1 2 ns  1000  ml ; 0.9% sodium chloride (mini bag plus)  100  ml ; ampicillin-sulbactam  1.5  g ; dextrose 50%  12.5  gm ; glucagon  1  mg ; insulin  0  unit ; tamsulosin  0.4  mg ; insulin  15  unit ; oxycodone (immediate release)   5-10  mg ; acetaminophen  325-650  mg ; 
diabetes with neurological manifestations, type i [juvenile type], not stated as uncontrolled urgency of urination nocturia urinary frequency hypertrophy (benign) of prostate with urinary obstruction and other lower urinary tract symptoms (luts) polyneuropathy in diabetes
white m 63 $nan$nan$fludrocortisone acetate  0.1  mg ; fluoxetine  10  mg ; lisinopril  5  mg ; vitamin d  400  unit ; simvastatin  10  mg ; influenza virus vaccine  0.5  ml ; sodium chloride 0.9%  flush  3  ml ; potassium chl 20 meq   1000 ml d5 1 2 ns  1000  ml ; 0.9% sodium chloride (mini bag plus)  100  ml ; ampicillin-sulbactam  1.5  g ; dextrose 50%  12.5  gm ; glucagon  1  mg ; insulin  0  unit ; tamsulosin  0.4  mg ; insulin  15  unit ; oxycodone (immediate release)   5-10  mg ; acetaminophen  325-650  mg ; hydromorphone (dilaudid)  0.25  mg ; metoprolol tartrate  5  mg ; ondansetron  4  mg ; metoclopramide  10  mg ; senna  1  tab ; 
diabetes with neurological manifestations, type i [juvenile type], not stated as uncontrolled urgency of urination nocturia urinary frequency hypertrophy (benign) of prostate with urinary obstruction and other lower urinary tract symptoms (luts) polyneuropathy in diabetes
white m 84 $temp  98.4  heartrate  84.0  resprate  28.0  o2sat  100.0  sbp  101.0  dbp  61.0  rhythm    pain    ; temp    heartrate  81.0  resprate  18.0  o2sat  100.0  sbp  110.0  dbp  66.0  rhythm    pain  01  ; temp    heartrate  80.0  resprate  22.0  o2sat  100.0  sbp  91.0  dbp  55.0  rhythm    pain    $hematology blood hematocrit  31.1  %; hematology blood hemoglobin  9.8  g dl; hematology blood platelet count  157  k ul; chemistry blood anion gap  13  meq l; chemistry blood anion gap  11  meq l; chemistry blood bicarbonate  29  meq l; chemistry blood bicarbonate  30  meq l; chemistry blood chloride  99  meq l; chemistry blood chloride  101  meq l; chemistry blood creatinine  1.0  mg dl; chemistry blood creatinine  1.0  mg dl; chemistry blood potassium  3.8  meq l; chemistry blood potassium  4.1  meq l; chemistry blood sodium  137  meq l; chemistry blood sodium  138  meq l; chemistry blood urea nitrogen  44  mg dl; chemistry blood urea nitrogen  39  mg dl; chemistry blood calcium, total  8.8  mg dl; chemistry blood glucose  144  mg dl; chemistry blood glucose  99  mg dl$sodium chloride 0.9%  flush  3  ml ; lidocaine jelly 2% (urojet)  1  appl ; heparin  5000  unit ; amiodarone  200  mg ; levothyroxine sodium  50  mcg ; digoxin  0.125  mg ; spironolactone  25  mg ; acetaminophen  650  mg ; simvastatin  20  mg ; clopidogrel  75  mg ; tamsulosin  0.4  mg ; aspirin  81  mg ; lisinopril  2.5  mg ; furosemide  40  mg ; amiodarone  100  mg ; carvedilol  3.125  mg ; 
 
white m 84 $nan$hematology blood hematocrit  29.7  %; hematology blood hematocrit  31.8  %; hematology blood hemoglobin  9.2  g dl; hematology blood hemoglobin  10.1  g dl; hematology blood platelet count  151  k ul; hematology blood platelet count  181  k ul; chemistry blood anion gap  12  meq l; chemistry blood bicarbonate  30  meq l; chemistry blood chloride  103  meq l; chemistry blood creatinine  1.0  mg dl; chemistry blood potassium  3.8  meq l; chemistry blood sodium  141  meq l; chemistry blood urea nitrogen  40  mg dl; hematology blood inr(pt)  1.4  ; chemistry blood calcium, total  8.9  mg dl; chemistry blood bilirubin, total  0.5  mg dl; chemistry blood glucose  90  mg dl$sodium chloride 0.9%  flush  3  ml ; lidocaine jelly 2% (urojet)  1  appl ; heparin  5000  unit ; digoxin  0.125  mg ; spironolactone  25  mg ; acetaminophen  650  mg ; simvastatin  20  mg ; clopidogrel  75  mg ; tamsulosin  0.4  mg ; aspirin  81  mg ; lisinopril  2.5  mg ; furosemide  40  mg ; amiodarone  100  mg ; carvedilol  3.125  mg ; sodium chloride 0.9%  1000  ml ; levothyroxine sodium  100  mcg ; potassium chloride  20  meq ; 
 
white m 84 $nan$hematology blood hematocrit  33.5  %; hematology blood hemoglobin  10.2  g dl; hematology blood platelet count  164  k ul; chemistry blood anion gap  11  meq l; chemistry blood bicarbonate  31  meq l; chemistry blood chloride  99  meq l; chemistry blood creatinine  1.0  mg dl; chemistry blood potassium  4.4  meq l; chemistry blood sodium  137  meq l; chemistry blood urea nitrogen  44  mg dl; chemistry blood calcium, total  8.8  mg dl; chemistry blood glucose  104  mg dl; chemistry blood albumin  3.5  g dl$sodium chloride 0.9%  flush  3  ml ; heparin  5000  unit ; digoxin  0.125  mg ; acetaminophen  650  mg ; simvastatin  20  mg ; clopidogrel  75  mg ; tamsulosin  0.4  mg ; aspirin  81  mg ; lisinopril  2.5  mg ; amiodarone  100  mg ; carvedilol  3.125  mg ; sodium chloride 0.9%  1000  ml ; levothyroxine sodium  100  mcg ; potassium chloride  20  meq ; trazodone  25  mg ; spironolactone  12.5  mg ; 
 
white m 84 $nan$hematology blood hematocrit  34.5  %; hematology blood hemoglobin  10.5  g dl; hematology blood platelet count  162  k ul; chemistry blood anion gap  15  meq l; chemistry blood anion gap  14  meq l; chemistry blood bicarbonate  29  meq l; chemistry blood bicarbonate  28  meq l; chemistry blood chloride  98  meq l; chemistry blood chloride  99  meq l; chemistry blood creatinine  0.9  mg dl; chemistry blood creatinine  1.0  mg dl; chemistry blood potassium  4.6  meq l; chemistry blood potassium  5.1  meq l; chemistry blood sodium  137  meq l; chemistry blood sodium  136  meq l; chemistry blood urea nitrogen  43  mg dl; chemistry blood urea nitrogen  42  mg dl; hematology blood inr(pt)  1.3  ; chemistry blood calcium, total  9.1  mg dl; chemistry blood calcium, total  9.0  mg dl; chemistry blood glucose  209  mg dl; chemistry blood glucose  113  mg dl$sodium chloride 0.9%  flush  3  ml ; heparin  5000  unit ; digoxin  0.125  mg ; acetaminophen  650  mg ; simvastatin  20  mg ; clopidogrel  75  mg ; tamsulosin  0.4  mg ; aspirin  81  mg ; lisinopril  2.5  mg ; amiodarone  100  mg ; carvedilol  3.125  mg ; levothyroxine sodium  100  mcg ; trazodone  25  mg ; spironolactone  12.5  mg ; multivitamins w minerals  1  tab ; nitroglycerin sl  0.4  mg ; aluminum-magnesium hydrox.-simethicone  30  ml ; maalox diphenhydramine lidocaine  15  ml ; torsemide  5  mg ; 
 
white m 84 $nan$hematology blood hematocrit  30.9  %; hematology blood hematocrit  33.8  %; hematology blood hemoglobin  9.1  g dl; hematology blood hemoglobin  10.3  g dl; hematology blood platelet count  156  k ul; hematology blood platelet count  162  k ul; chemistry blood anion gap  12  meq l; chemistry blood anion gap  14  meq l; chemistry blood anion gap  14  meq l; chemistry blood bicarbonate  27  meq l; chemistry blood bicarbonate  28  meq l; chemistry blood bicarbonate  31  meq l; chemistry blood chloride  102  meq l; chemistry blood chloride  101  meq l; chemistry blood chloride  101  meq l; chemistry blood creatinine  1.0  mg dl; chemistry blood creatinine  1.0  mg dl; chemistry blood creatinine  1.2  mg dl; chemistry blood potassium  4.8  meq l; chemistry blood potassium  5.3  meq l; chemistry blood potassium  5.5  meq l; chemistry blood sodium  136  meq l; chemistry blood sodium  138  meq l; chemistry blood sodium  140  meq l; chemistry blood urea nitrogen  41  mg dl; chemistry blood urea nitrogen  42  mg dl; chemistry blood urea nitrogen  44  mg dl; chemistry blood calcium, total  8.4  mg dl; chemistry blood calcium, total  8.7  mg dl; chemistry blood calcium, total  9.0  mg dl; chemistry blood glucose  104  mg dl; chemistry blood glucose  110  mg dl; chemistry blood glucose  220  mg dl$sodium chloride 0.9%  flush  3  ml ; heparin  5000  unit ; digoxin  0.125  mg ; acetaminophen  650  mg ; simvastatin  20  mg ; clopidogrel  75  mg ; tamsulosin  0.4  mg ; aspirin  81  mg ; lisinopril  2.5  mg ; amiodarone  100  mg ; carvedilol  3.125  mg ; levothyroxine sodium  100  mcg ; spironolactone  12.5  mg ; multivitamins w minerals  1  tab ; nitroglycerin sl  0.4  mg ; maalox diphenhydramine lidocaine  15  ml ; torsemide  5  mg ; nitroglycerin sl  0.3  mg ; 0.9% sodium chloride  250  ml ; 
 
white m 84 $nan$hematology blood hematocrit  33.2  %; hematology blood hemoglobin  10.3  g dl; hematology blood platelet count  162  k ul; chemistry blood anion gap  15  meq l; chemistry blood bicarbonate  30  meq l; chemistry blood chloride  100  meq l; chemistry blood creatinine  1.1  mg dl; chemistry blood potassium  5.5  meq l; chemistry blood sodium  139  meq l; chemistry blood urea nitrogen  44  mg dl; hematology urine wbc  1  # hpf; chemistry blood calcium, total  9.6  mg dl; chemistry blood glucose  97  mg dl$sodium chloride 0.9%  flush  3  ml ; heparin  5000  unit ; digoxin  0.125  mg ; acetaminophen  650  mg ; simvastatin  20  mg ; clopidogrel  75  mg ; tamsulosin  0.4  mg ; aspirin  81  mg ; amiodarone  100  mg ; levothyroxine sodium  100  mcg ; multivitamins w minerals  1  tab ; 0.9% sodium chloride  250  ml ; 5% dextrose  50  ml ; furosemide  250  mg ; lidocaine 1%  5  ml ; heparin flush (10 units ml)  2  ml ; sodium chloride 0.9%  flush  20  ml ; 
 
white m 84 $nan$hematology blood hematocrit  29.8  %; hematology blood hemoglobin  9.4  g dl; hematology blood platelet count  144  k ul; chemistry blood anion gap  13  meq l; chemistry blood bicarbonate  28  meq l; chemistry blood chloride  103  meq l; chemistry blood creatinine  1.0  mg dl; chemistry blood potassium  5.1  meq l; chemistry blood sodium  139  meq l; chemistry blood urea nitrogen  40  mg dl; hematology blood inr(pt)  1.3  ; chemistry blood calcium, total  8.9  mg dl; chemistry blood glucose  97  mg dl$sodium chloride 0.9%  flush  3  ml ; heparin  5000  unit ; digoxin  0.125  mg ; acetaminophen  650  mg ; simvastatin  20  mg ; clopidogrel  75  mg ; tamsulosin  0.4  mg ; aspirin  81  mg ; amiodarone  100  mg ; levothyroxine sodium  100  mcg ; multivitamins w minerals  1  tab ; lidocaine 1%  5  ml ; heparin flush (10 units ml)  2  ml ; sodium chloride 0.9%  flush  20  ml ; mirtazapine  15  mg ; mirtazapine  7.5  mg ; 
 
white m 84 $nan$hematology blood hematocrit  28.2  %; hematology blood hemoglobin  8.5  g dl; hematology blood platelet count  148  k ul; chemistry blood anion gap  13  meq l; chemistry blood anion gap  16  meq l; chemistry blood bicarbonate  28  meq l; chemistry blood bicarbonate  28  meq l; chemistry blood chloride  105  meq l; chemistry blood chloride  104  meq l; chemistry blood creatinine  0.9  mg dl; chemistry blood creatinine  1.0  mg dl; chemistry blood potassium  4.8  meq l; chemistry blood potassium  5.0  meq l; chemistry blood sodium  141  meq l; chemistry blood sodium  143  meq l; chemistry blood urea nitrogen  39  mg dl; chemistry blood urea nitrogen  42  mg dl; hematology blood inr(pt)  1.3  ; chemistry blood calcium, total  8.5  mg dl; chemistry blood bilirubin, total  0.5  mg dl; chemistry blood glucose  94  mg dl; chemistry blood glucose  103  mg dl; chemistry blood albumin  3.6  g dl$sodium chloride 0.9%  flush  3  ml ; heparin  5000  unit ; digoxin  0.125  mg ; acetaminophen  650  mg ; simvastatin  20  mg ; clopidogrel  75  mg ; tamsulosin  0.4  mg ; aspirin  81  mg ; amiodarone  100  mg ; levothyroxine sodium  100  mcg ; multivitamins w minerals  1  tab ; lidocaine 1%  5  ml ; sodium chloride 0.9%  flush  20  ml ; mirtazapine  7.5  mg ; syringe (inhalation)  5  ml ; 
 
white m 84 $nan$hematology blood hematocrit  27.8  %; hematology blood hemoglobin  8.7  g dl; hematology blood platelet count  139  k ul; chemistry blood anion gap  14  meq l; chemistry blood anion gap  14  meq l; chemistry blood bicarbonate  28  meq l; chemistry blood bicarbonate  27  meq l; chemistry blood chloride  105  meq l; chemistry blood chloride  103  meq l; chemistry blood creatinine  0.9  mg dl; chemistry blood creatinine  1.0  mg dl; chemistry blood potassium  5.2  meq l; chemistry blood potassium  4.2  meq l; chemistry blood sodium  142  meq l; chemistry blood sodium  140  meq l; chemistry blood urea nitrogen  39  mg dl; chemistry blood urea nitrogen  39  mg dl; chemistry blood calcium, total  8.6  mg dl; chemistry blood glucose  141  mg dl; chemistry blood glucose  102  mg dl$sodium chloride 0.9%  flush  3  ml ; heparin  5000  unit ; digoxin  0.125  mg ; acetaminophen  650  mg ; simvastatin  20  mg ; clopidogrel  75  mg ; tamsulosin  0.4  mg ; aspirin  81  mg ; amiodarone  100  mg ; levothyroxine sodium  100  mcg ; multivitamins w minerals  1  tab ; lidocaine 1%  5  ml ; sodium chloride 0.9%  flush  20  ml ; torsemide  10  mg ; sodium chloride 0.9%  flush  10-20  ml ; 
 
white m 84 $nan$hematology blood hematocrit  26.5  %; hematology blood hematocrit  32.1  %; hematology blood hemoglobin  8.4  g dl; hematology blood hemoglobin  9.5  g dl; hematology blood platelet count  141  k ul; hematology blood platelet count  276  k ul; chemistry blood anion gap  12  meq l; chemistry blood anion gap  15  meq l; chemistry blood anion gap  18  meq l; chemistry blood bicarbonate  31  meq l; chemistry blood bicarbonate  28  meq l; chemistry blood bicarbonate  28  meq l; chemistry blood chloride  104  meq l; chemistry blood chloride  103  meq l; chemistry blood chloride  101  meq l; chemistry blood creatinine  1.1  mg dl; chemistry blood creatinine  1.1  mg dl; chemistry blood creatinine  1.2  mg dl; chemistry blood potassium  4.3  meq l; chemistry blood potassium  4.6  meq l; chemistry blood potassium  4.6  meq l; chemistry blood sodium  143  meq l; chemistry blood sodium  141  meq l; chemistry blood sodium  142  meq l; chemistry blood urea nitrogen  39  mg dl; chemistry blood urea nitrogen  39  mg dl; chemistry blood urea nitrogen  41  mg dl; hematology blood inr(pt)  1.2  ; chemistry blood calcium, total  8.7  mg dl; chemistry blood calcium, total  8.8  mg dl; chemistry blood calcium, total  9.1  mg dl; chemistry blood glucose  134  mg dl; chemistry blood glucose  90  mg dl; chemistry blood glucose  93  mg dl$sodium chloride 0.9%  flush  3  ml ; heparin  5000  unit ; digoxin  0.125  mg ; acetaminophen  650  mg ; simvastatin  20  mg ; clopidogrel  75  mg ; tamsulosin  0.4  mg ; aspirin  81  mg ; amiodarone  100  mg ; levothyroxine sodium  100  mcg ; multivitamins w minerals  1  tab ; lidocaine 1%  5  ml ; sodium chloride 0.9%  flush  20  ml ; torsemide  10  mg ; sodium chloride 0.9%  flush  10-20  ml ; d5w  250  ml ; dopamine  400  mg ; aspirin  325  mg ; atorvastatin  80  mg ; heparin  4000  unit ; heparin  1100  unit ; 5% dextrose  250  ml ; heparin sodium  25,000  unit ; 
 
white m 84 $nan$hematology blood hematocrit  24.7  %; hematology blood hematocrit  27.3  %; hematology blood hemoglobin  7.6  g dl; hematology blood hemoglobin  8.1  g dl; hematology blood platelet count  140  k ul; chemistry blood anion gap  13  meq l; chemistry blood anion gap  16  meq l; chemistry blood bicarbonate  29  meq l; chemistry blood bicarbonate  29  meq l; chemistry blood chloride  103  meq l; chemistry blood chloride  101  meq l; chemistry blood creatinine  1.1  mg dl; chemistry blood creatinine  1.3  mg dl; chemistry blood potassium  4.1  meq l; chemistry blood potassium  4.2  meq l; chemistry blood sodium  141  meq l; chemistry blood sodium  142  meq l; chemistry blood urea nitrogen  43  mg dl; chemistry blood urea nitrogen  48  mg dl; hematology blood inr(pt)  1.3  ; chemistry blood calcium, total  8.4  mg dl; chemistry blood calcium, total  8.8  mg dl; chemistry blood glucose  221  mg dl; chemistry blood glucose  95  mg dl$sodium chloride 0.9%  flush  3  ml ; digoxin  0.125  mg ; acetaminophen  650  mg ; clopidogrel  75  mg ; tamsulosin  0.4  mg ; amiodarone  100  mg ; levothyroxine sodium  100  mcg ; multivitamins w minerals  1  tab ; lidocaine 1%  5  ml ; sodium chloride 0.9%  flush  20  ml ; sodium chloride 0.9%  flush  10-20  ml ; d5w  250  ml ; dopamine  400  mg ; aspirin  325  mg ; atorvastatin  80  mg ; heparin  4000  unit ; heparin  1100  unit ; 5% dextrose  250  ml ; heparin sodium  25,000  unit ; docusate sodium  100  mg ; senna  17.2  mg ; nitroglycerin  100  mg ; sodium chloride 0.9%  flush  10  ml ; lorazepam  0.25  mg ; isosorbide dinitrate  10  mg ; 
 
white m 84 $nan$hematology blood hematocrit  24.0  %; hematology blood hemoglobin  7.5  g dl; hematology blood platelet count  178  k ul; chemistry blood anion gap  9  meq l; chemistry blood anion gap  10  meq l; chemistry blood bicarbonate  32  meq l; chemistry blood bicarbonate  30  meq l; chemistry blood chloride  102  meq l; chemistry blood chloride  103  meq l; chemistry blood creatinine  1.0  mg dl; chemistry blood creatinine  1.0  mg dl; chemistry blood potassium  3.8  meq l; chemistry blood potassium  4.0  meq l; chemistry blood sodium  139  meq l; chemistry blood sodium  139  meq l; chemistry blood urea nitrogen  42  mg dl; chemistry blood urea nitrogen  41  mg dl; chemistry blood calcium, total  8.0  mg dl; chemistry blood calcium, total  8.3  mg dl; chemistry blood glucose  128  mg dl; chemistry blood glucose  112  mg dl$digoxin  0.125  mg ; clopidogrel  75  mg ; amiodarone  100  mg ; levothyroxine sodium  100  mcg ; multivitamins w minerals  1  tab ; aspirin  325  mg ; atorvastatin  80  mg ; docusate sodium  100  mg ; senna  17.2  mg ; sodium chloride 0.9%  flush  10  ml ; lorazepam  0.25  mg ; isosorbide dinitrate  10  mg ; lorazepam  0.5  mg ; potassium chloride replacement (critical care and oncology)   40  meq ; potassium chloride replacement (critical care and oncology)   60  meq ; potassium chloride replacement (critical care and oncology)   80  meq ; syringe (0.9% sodium chloride)  2  ml ; alteplase (catheter clearance)  1  mg ; ranolazine  500  mg ; neutra-phos  1  pkt ; 
 
white m 84 $nan$hematology blood hematocrit  24.8  %; hematology blood hemoglobin  7.5  g dl; hematology blood platelet count  192  k ul; chemistry blood anion gap  10  meq l; chemistry blood bicarbonate  30  meq l; chemistry blood chloride  102  meq l; chemistry blood creatinine  1.1  mg dl; chemistry blood potassium  4.3  meq l; chemistry blood sodium  138  meq l; chemistry blood urea nitrogen  41  mg dl; chemistry blood calcium, total  8.3  mg dl; chemistry blood glucose  142  mg dl$digoxin  0.125  mg ; clopidogrel  75  mg ; amiodarone  100  mg ; levothyroxine sodium  100  mcg ; multivitamins w minerals  1  tab ; atorvastatin  80  mg ; docusate sodium  100  mg ; senna  17.2  mg ; sodium chloride 0.9%  flush  10  ml ; isosorbide dinitrate  10  mg ; lorazepam  0.5  mg ; potassium chloride replacement (critical care and oncology)   40  meq ; potassium chloride replacement (critical care and oncology)   60  meq ; potassium chloride replacement (critical care and oncology)   80  meq ; syringe (0.9% sodium chloride)  2  ml ; alteplase (catheter clearance)  1  mg ; ranolazine  500  mg ; neutra-phos  1  pkt ; furosemide  80  mg ; morphine sulfate  0.5  mg ; morphine sulfate  1  mg ; isosorbide dinitrate  20  mg ; 
 
white m 84 $nan$hematology blood hematocrit  23.4  %; hematology blood hemoglobin  7.4  g dl; hematology blood platelet count  211  k ul; chemistry blood anion gap  13  meq l; chemistry blood anion gap  15  meq l; chemistry blood bicarbonate  32  meq l; chemistry blood bicarbonate  31  meq l; chemistry blood chloride  99  meq l; chemistry blood chloride  99  meq l; chemistry blood creatinine  1.2  mg dl; chemistry blood creatinine  1.3  mg dl; chemistry blood potassium  3.9  meq l; chemistry blood potassium  4.0  meq l; chemistry blood sodium  140  meq l; chemistry blood sodium  141  meq l; chemistry blood urea nitrogen  46  mg dl; chemistry blood urea nitrogen  47  mg dl; hematology urine wbc  6  # hpf; chemistry blood calcium, total  8.4  mg dl; chemistry blood calcium, total  8.4  mg dl; chemistry blood glucose  98  mg dl; chemistry blood glucose  141  mg dl$digoxin  0.125  mg ; clopidogrel  75  mg ; amiodarone  100  mg ; levothyroxine sodium  100  mcg ; multivitamins w minerals  1  tab ; atorvastatin  80  mg ; docusate sodium  100  mg ; senna  17.2  mg ; sodium chloride 0.9%  flush  10  ml ; potassium chloride replacement (critical care and oncology)   40  meq ; potassium chloride replacement (critical care and oncology)   60  meq ; potassium chloride replacement (critical care and oncology)   80  meq ; ranolazine  500  mg ; furosemide  80  mg ; morphine sulfate  0.5  mg ; morphine sulfate  1  mg ; isosorbide dinitrate  20  mg ; 
 
white m 84 $nan$hematology blood hematocrit  23.1  %; hematology blood hemoglobin  6.9  g dl; hematology blood platelet count  199  k ul; chemistry blood anion gap  12  meq l; chemistry blood anion gap  14  meq l; chemistry blood bicarbonate  35  meq l; chemistry blood bicarbonate  34  meq l; chemistry blood chloride  97  meq l; chemistry blood chloride  100  meq l; chemistry blood creatinine  1.1  mg dl; chemistry blood creatinine  1.1  mg dl; chemistry blood potassium  3.2  meq l; chemistry blood potassium  3.7  meq l; chemistry blood sodium  141  meq l; chemistry blood sodium  144  meq l; chemistry blood urea nitrogen  44  mg dl; chemistry blood urea nitrogen  41  mg dl; chemistry blood calcium, total  8.1  mg dl; chemistry blood calcium, total  8.4  mg dl; chemistry blood glucose  139  mg dl; chemistry blood glucose  101  mg dl$digoxin  0.125  mg ; clopidogrel  75  mg ; amiodarone  100  mg ; levothyroxine sodium  100  mcg ; multivitamins w minerals  1  tab ; atorvastatin  80  mg ; docusate sodium  100  mg ; senna  17.2  mg ; sodium chloride 0.9%  flush  10  ml ; potassium chloride replacement (critical care and oncology)   40  meq ; potassium chloride replacement (critical care and oncology)   60  meq ; potassium chloride replacement (critical care and oncology)   80  meq ; ranolazine  500  mg ; isosorbide dinitrate  20  mg ; sodium chloride nasal  1-2  spry ; 
 
white m 84 $nan$hematology blood hematocrit  25.7  %; hematology blood hematocrit  25.8  %; hematology blood hemoglobin  7.7  g dl; hematology blood hemoglobin  8.1  g dl; hematology blood platelet count  200  k ul; chemistry blood anion gap  11  meq l; chemistry blood anion gap  11  meq l; chemistry blood bicarbonate  36  meq l; chemistry blood bicarbonate  37  meq l; chemistry blood chloride  98  meq l; chemistry blood chloride  98  meq l; chemistry blood creatinine  1.0  mg dl; chemistry blood creatinine  1.1  mg dl; chemistry blood potassium  3.6  meq l; chemistry blood potassium  4.0  meq l; chemistry blood sodium  141  meq l; chemistry blood sodium  142  meq l; chemistry blood urea nitrogen  37  mg dl; chemistry blood urea nitrogen  40  mg dl; hematology blood inr(pt)  1.3  ; chemistry blood calcium, total  8.4  mg dl; chemistry blood calcium, total  8.5  mg dl; chemistry blood glucose  143  mg dl; chemistry blood glucose  120  mg dl$digoxin  0.125  mg ; clopidogrel  75  mg ; levothyroxine sodium  100  mcg ; multivitamins w minerals  1  tab ; atorvastatin  80  mg ; docusate sodium  100  mg ; senna  17.2  mg ; sodium chloride 0.9%  flush  10  ml ; potassium chloride replacement (critical care and oncology)   40  meq ; potassium chloride replacement (critical care and oncology)   60  meq ; potassium chloride replacement (critical care and oncology)   80  meq ; ranolazine  500  mg ; isosorbide dinitrate  20  mg ; sodium chloride nasal  1-2  spry ; nitroglycerin ointment  2%  0.5  in ; guaifenesin  5-10  ml ; oxymetazoline  1  spry ; benzonatate  100  mg ; 
 
white m 84 $nan$hematology blood hematocrit  24.9  %; hematology blood hemoglobin  8.0  g dl; hematology blood platelet count  201  k ul; chemistry blood anion gap  11  meq l; chemistry blood bicarbonate  37  meq l; chemistry blood chloride  96  meq l; chemistry blood creatinine  0.9  mg dl; chemistry blood potassium  3.3  meq l; chemistry blood sodium  141  meq l; chemistry blood urea nitrogen  38  mg dl; hematology blood inr(pt)  1.4  ; chemistry blood calcium, total  8.5  mg dl; chemistry blood glucose  102  mg dl$digoxin  0.125  mg ; levothyroxine sodium  100  mcg ; multivitamins w minerals  1  tab ; atorvastatin  80  mg ; docusate sodium  100  mg ; senna  17.2  mg ; sodium chloride 0.9%  flush  10  ml ; potassium chloride replacement (critical care and oncology)   40  meq ; potassium chloride replacement (critical care and oncology)   60  meq ; potassium chloride replacement (critical care and oncology)   80  meq ; ranolazine  500  mg ; guaifenesin  5-10  ml ; benzonatate  100  mg ; torsemide  80  mg ; nitroglycerin ointment  2%  1  in ; 
 
white m 84 $nan$hematology blood hematocrit  26.4  %; hematology blood hemoglobin  8.2  g dl; hematology blood platelet count  269  k ul; chemistry blood anion gap  10  meq l; chemistry blood bicarbonate  40  meq l; chemistry blood chloride  94  meq l; chemistry blood creatinine  1.1  mg dl; chemistry blood potassium  3.8  meq l; chemistry blood sodium  140  meq l; chemistry blood urea nitrogen  39  mg dl; chemistry blood calcium, total  8.4  mg dl; chemistry blood glucose  142  mg dl$digoxin  0.125  mg ; levothyroxine sodium  100  mcg ; multivitamins w minerals  1  tab ; atorvastatin  80  mg ; docusate sodium  100  mg ; senna  17.2  mg ; sodium chloride 0.9%  flush  10  ml ; potassium chloride replacement (critical care and oncology)   40  meq ; potassium chloride replacement (critical care and oncology)   60  meq ; potassium chloride replacement (critical care and oncology)   80  meq ; ranolazine  500  mg ; guaifenesin  5-10  ml ; benzonatate  100  mg ; torsemide  80  mg ; nitroglycerin ointment  2%  1  in ; lidocaine viscous 2%  15  ml ; 
 
white m 84 $nan$hematology blood hematocrit  28.9  %; hematology blood hemoglobin  8.7  g dl; hematology blood platelet count  343  k ul; chemistry blood anion gap  15  meq l; chemistry blood bicarbonate  35  meq l; chemistry blood chloride  93  meq l; chemistry blood creatinine  1.0  mg dl; chemistry blood potassium  4.3  meq l; chemistry blood sodium  139  meq l; chemistry blood urea nitrogen  40  mg dl; chemistry blood calcium, total  8.9  mg dl; chemistry blood glucose  81  mg dl$digoxin  0.125  mg ; levothyroxine sodium  100  mcg ; multivitamins w minerals  1  tab ; atorvastatin  80  mg ; docusate sodium  100  mg ; senna  17.2  mg ; sodium chloride 0.9%  flush  10  ml ; potassium chloride replacement (critical care and oncology)   40  meq ; potassium chloride replacement (critical care and oncology)   60  meq ; potassium chloride replacement (critical care and oncology)   80  meq ; ranolazine  500  mg ; benzonatate  100  mg ; nitroglycerin ointment  2%  1  in ; lidocaine viscous 2%  15  ml ; 
 
white m 84 $nan$nan$digoxin  0.125  mg ; levothyroxine sodium  100  mcg ; multivitamins w minerals  1  tab ; atorvastatin  80  mg ; docusate sodium  100  mg ; senna  17.2  mg ; sodium chloride 0.9%  flush  10  ml ; potassium chloride replacement (critical care and oncology)   40  meq ; potassium chloride replacement (critical care and oncology)   60  meq ; potassium chloride replacement (critical care and oncology)   80  meq ; ranolazine  500  mg ; benzonatate  100  mg ; nitroglycerin ointment  2%  1  in ; lidocaine viscous 2%  15  ml ; bisacodyl  10  mg ; fleet enema  1  enema ; 
 
white m 84 $nan$nan$docusate sodium  100  mg ; senna  17.2  mg ; sodium chloride 0.9%  flush  10  ml ; ranolazine  500  mg ; benzonatate  100  mg ; nitroglycerin ointment  2%  1  in ; lidocaine viscous 2%  15  ml ; bisacodyl  10  mg ; fleet enema  1  enema ; glycopyrrolate  0.1  mg ; morphine sulfate  1-5  mg ; 
 
other f 29 $nan$hematology blood hematocrit  37.8  %; hematology blood hemoglobin  13.1  g dl; hematology blood platelet count  423  k ul; chemistry blood anion gap  16  meq l; chemistry blood bicarbonate  26  meq l; chemistry blood chloride  102  meq l; chemistry blood creatinine  0.7  mg dl; chemistry blood potassium  5.0  meq l; chemistry blood sodium  139  meq l; chemistry blood urea nitrogen  15  mg dl; chemistry blood glucose  93  mg dl; hematology urine glucose  neg  mg dl; hematology urine bilirubin  neg  mg dl$nan
 
other f 29 $nan$hematology blood hematocrit  36.7  %; hematology blood hemoglobin  12.7  g dl; hematology blood platelet count  386  k ul; chemistry blood anion gap  13  meq l; chemistry blood bicarbonate  27  meq l; chemistry blood chloride  107  meq l; chemistry blood creatinine  0.7  mg dl; chemistry blood potassium  4.6  meq l; chemistry blood sodium  142  meq l; chemistry blood urea nitrogen  8  mg dl; chemistry blood calcium, total  8.8  mg dl; chemistry blood glucose  94  mg dl$sodium chloride 0.9%  flush  3  ml ; lr  1000  ml ; morphine sulfate  1-2  mg ; ondansetron  4  mg ; iso-osmotic sodium chloride  50  ml ; famotidine  20  mg ; heparin  5000  unit ; acetaminophen  500-1000  mg ; diphenhydramine  25  mg ; 
 
other f 29 $nan$hematology blood hematocrit  34.4  %; hematology blood hemoglobin  12.4  g dl; hematology blood platelet count  353  k ul; chemistry blood anion gap  11  meq l; chemistry blood bicarbonate  28  meq l; chemistry blood chloride  105  meq l; chemistry blood creatinine  0.8  mg dl; chemistry blood potassium  4.1  meq l; chemistry blood sodium  140  meq l; chemistry blood urea nitrogen  6  mg dl; chemistry blood calcium, total  9.3  mg dl; chemistry blood glucose  85  mg dl$sodium chloride 0.9%  flush  3  ml ; lr  1000  ml ; morphine sulfate  1-2  mg ; ondansetron  4  mg ; iso-osmotic sodium chloride  50  ml ; famotidine  20  mg ; heparin  5000  unit ; acetaminophen  500-1000  mg ; diphenhydramine  25  mg ; 
 
other f 29 $nan$nan$sodium chloride 0.9%  flush  3  ml ; lr  1000  ml ; morphine sulfate  1-2  mg ; ondansetron  4  mg ; iso-osmotic sodium chloride  50  ml ; famotidine  20  mg ; heparin  5000  unit ; acetaminophen  500-1000  mg ; diphenhydramine  25  mg ; 
 
black african american f 61 $temp  98.3  heartrate  74.0  resprate  18.0  o2sat  100.0  sbp  136.0  dbp  77.0  rhythm    pain  5  $hematology blood hematocrit  34.6  %; hematology blood hemoglobin  11.7  g dl; hematology blood platelet count  289  k ul; chemistry blood anion gap  14  meq l; chemistry blood bicarbonate  23  meq l; chemistry blood chloride  107  meq l; chemistry blood creatinine  0.8  mg dl; chemistry blood potassium  3.6  meq l; chemistry blood sodium  140  meq l; chemistry blood urea nitrogen  20  mg dl; chemistry blood bilirubin, total  0.2  mg dl; chemistry blood glucose  132  mg dl; chemistry blood albumin  4.1  g dl$influenza virus vaccine  0.5  ml ; sodium chloride 0.9%  flush  3  ml ; heparin  5000  unit ; iso-osmotic dextrose  200  ml ; vancomycin  1000  mg ; 0.9% sodium chloride (mini bag plus)  100  ml ; ampicillin-sulbactam  1.5  g ; clobetasol propionate 0.05% ointment  1  appl ; acetaminophen  650  mg ; oxycodone (immediate release)   5  mg ; nicotine patch  21  mg ; prednisone  60  mg ; senna  1  tab ; docusate sodium  100  mg ; metronidazole topical 1 % gel  1  appl ; 
hypercalcemia chronic hepatitis c without mention of hepatic coma pyoderma gangrenosum lump or mass in breast nonspecific reaction to tuberculin skin test without active tuberculosis 
black african american f 61 $nan$hematology blood hemoglobin  12.0  g dl; chemistry blood anion gap  14  meq l; chemistry blood bicarbonate  22  meq l; chemistry blood chloride  107  meq l; chemistry blood creatinine  0.6  mg dl; chemistry blood potassium  4.5  meq l; chemistry blood sodium  138  meq l; chemistry blood urea nitrogen  22  mg dl; chemistry blood calcium, total  9.4  mg dl; chemistry blood glucose  123  mg dl$influenza virus vaccine  0.5  ml ; sodium chloride 0.9%  flush  3  ml ; heparin  5000  unit ; iso-osmotic dextrose  200  ml ; vancomycin  1000  mg ; 0.9% sodium chloride (mini bag plus)  100  ml ; ampicillin-sulbactam  1.5  g ; acetaminophen  650  mg ; oxycodone (immediate release)   5  mg ; nicotine patch  21  mg ; prednisone  60  mg ; senna  1  tab ; docusate sodium  100  mg ; metronidazole topical 1 % gel  1  appl ; hepatitis b vaccine  1  ml ; amoxicillin-clavulanic acid  875  mg ; sulfameth trimethoprim ds  1  tab ; 
hypercalcemia chronic hepatitis c without mention of hepatic coma pyoderma gangrenosum lump or mass in breast nonspecific reaction to tuberculin skin test without active tuberculosis 
white f 63 $nan$nan$sodium chloride 0.9%  1000  ml ; 
 
white f 63 $nan$nan$sodium chloride 0.9%  1000  ml ; sodium chloride 0.9%  flush  3  ml ; acetaminophen  325-650  mg ; iso-osmotic dextrose  50  ml ; cefazolin  1  g ; hydralazine  10  mg ; senna  8.6  mg ; polyethylene glycol  17  g ; ondansetron  4  mg ; loratadine  10  mg ; cyclobenzaprine  10  mg ; amitriptyline  25  mg ; sumatriptan succinate  6  mg ; lorazepam  0.5  mg ; fentanyl pca  2.5  mg ; docusate sodium  400  mg ; multivitamins  1  tab ; calcium carbonate  500  mg ; topiramate (topamax)  75  mg ; omeprazole  20  mg ; levothyroxine sodium  100  mcg ; calcitonin salmon  200  unit ; gabapentin  100  mg ; clonazepam  2  mg ; simethicone  80  mg ; bisacodyl  30  mg ; 
 
white f 63 $nan$hematology blood hematocrit  35.5  %; hematology blood hematocrit  35.9  %; hematology blood hemoglobin  11.5  g dl; hematology blood hemoglobin  11.9  g dl; hematology blood platelet count  182  k ul; hematology blood platelet count  198  k ul; chemistry blood anion gap  14  meq l; chemistry blood anion gap  13  meq l; chemistry blood bicarbonate  21  meq l; chemistry blood bicarbonate  21  meq l; chemistry blood chloride  100  meq l; chemistry blood chloride  108  meq l; chemistry blood creatinine  0.5  mg dl; chemistry blood creatinine  0.5  mg dl; chemistry blood potassium  3.4  meq l; chemistry blood potassium  2.9  meq l; chemistry blood sodium  132  meq l; chemistry blood sodium  139  meq l; chemistry blood urea nitrogen  7  mg dl; chemistry blood urea nitrogen  9  mg dl; hematology blood inr(pt)  1.3  ; hematology blood inr(pt)  1.6  ; chemistry blood calcium, total  8.5  mg dl; chemistry blood calcium, total  8.9  mg dl; chemistry blood glucose  126  mg dl; chemistry blood glucose  140  mg dl$sodium chloride 0.9%  1000  ml ; sodium chloride 0.9%  flush  3  ml ; acetaminophen  325-650  mg ; iso-osmotic dextrose  50  ml ; cefazolin  1  g ; hydralazine  10  mg ; senna  8.6  mg ; polyethylene glycol  17  g ; ondansetron  4  mg ; loratadine  10  mg ; cyclobenzaprine  10  mg ; amitriptyline  25  mg ; sumatriptan succinate  6  mg ; lorazepam  0.5  mg ; fentanyl pca  2.5  mg ; docusate sodium  400  mg ; multivitamins  1  tab ; calcium carbonate  500  mg ; topiramate (topamax)  75  mg ; omeprazole  20  mg ; levothyroxine sodium  100  mcg ; calcitonin salmon  200  unit ; gabapentin  100  mg ; clonazepam  2  mg ; simethicone  80  mg ; bisacodyl  30  mg ; oxycodone (immediate release)   5-10  mg ; heparin  5000  unit ; oxycodone-acetaminophen (5mg-325mg)  1-2  tab ; cevimeline  30  mg ; vilazodone  40  mg ; potassium chloride  40  meq ; morphine sulfate ir  15-30  mg ; fentanyl patch  100  mcg h ; gabapentin  200  mg ; ciprofloxacin hcl  250  mg ; gabapentin  300  mg ; gabapentin  400  mg ; vitamin d  5000  unit ; phosphorus  500  mg ; 
 
white f 63 $nan$chemistry blood anion gap  12  meq l; chemistry blood bicarbonate  22  meq l; chemistry blood chloride  106  meq l; chemistry blood creatinine  0.5  mg dl; chemistry blood potassium  3.3  meq l; chemistry blood sodium  137  meq l; chemistry blood urea nitrogen  8  mg dl; chemistry blood calcium, total  8.6  mg dl; chemistry blood glucose  109  mg dl$sodium chloride 0.9%  1000  ml ; sodium chloride 0.9%  flush  3  ml ; hydralazine  10  mg ; senna  8.6  mg ; polyethylene glycol  17  g ; ondansetron  4  mg ; loratadine  10  mg ; cyclobenzaprine  10  mg ; amitriptyline  25  mg ; lorazepam  0.5  mg ; docusate sodium  400  mg ; multivitamins  1  tab ; calcium carbonate  500  mg ; topiramate (topamax)  75  mg ; omeprazole  20  mg ; levothyroxine sodium  100  mcg ; calcitonin salmon  200  unit ; clonazepam  2  mg ; simethicone  80  mg ; bisacodyl  30  mg ; heparin  5000  unit ; cevimeline  30  mg ; vilazodone  40  mg ; potassium chloride  40  meq ; morphine sulfate ir  15-30  mg ; fentanyl patch  100  mcg h ; gabapentin  200  mg ; ciprofloxacin hcl  250  mg ; gabapentin  400  mg ; vitamin d  5000  unit ; phosphorus  500  mg ; morphine sulfate ir  30  mg ; 
 
white f 63 $nan$nan$sodium chloride 0.9%  1000  ml ; sodium chloride 0.9%  flush  3  ml ; hydralazine  10  mg ; senna  8.6  mg ; polyethylene glycol  17  g ; ondansetron  4  mg ; loratadine  10  mg ; cyclobenzaprine  10  mg ; amitriptyline  25  mg ; lorazepam  0.5  mg ; docusate sodium  400  mg ; multivitamins  1  tab ; calcium carbonate  500  mg ; topiramate (topamax)  75  mg ; omeprazole  20  mg ; levothyroxine sodium  100  mcg ; calcitonin salmon  200  unit ; clonazepam  2  mg ; simethicone  80  mg ; bisacodyl  30  mg ; heparin  5000  unit ; cevimeline  30  mg ; vilazodone  40  mg ; fentanyl patch  100  mcg h ; gabapentin  200  mg ; ciprofloxacin hcl  250  mg ; gabapentin  400  mg ; vitamin d  5000  unit ; morphine sulfate ir  30  mg ; phosphorus  250  mg ; 
 
white f 70 $nan$nan$paroxetine  10  mg ; hydrochlorothiazide  25  mg ; atenolol  25  mg ; 
chest pain, unspecified backache, unspecified abdominal pain, left upper quadrant unspecified essential hypertension obesity, unspecified 
white f 70 $nan$nan$paroxetine  10  mg ; hydrochlorothiazide  25  mg ; atenolol  25  mg ; sodium chloride 0.9%  flush  3  ml ; docusate sodium  100  mg ; oxycodone-acetaminophen  1-2  tab ; ketorolac  15  mg ; 
chest pain, unspecified backache, unspecified abdominal pain, left upper quadrant unspecified essential hypertension obesity, unspecified 
white f 70 $nan$nan$paroxetine  10  mg ; hydrochlorothiazide  25  mg ; atenolol  25  mg ; sodium chloride 0.9%  flush  3  ml ; docusate sodium  100  mg ; oxycodone-acetaminophen  1-2  tab ; ketorolac  15  mg ; 
chest pain, unspecified backache, unspecified abdominal pain, left upper quadrant unspecified essential hypertension obesity, unspecified 
white f 59 $nan$nan$aspirin  325  mg ; amlodipine  5  mg ; 
unspecified essential hypertension other premature beats arthropathy, unspecified, site unspecified 
white f 59 $nan$nan$aspirin  325  mg ; amlodipine  5  mg ; sodium chloride 0.9%  flush  3  ml ; acetaminophen  650  mg ; potassium chloride  20  meq ; potassium chloride  40  meq ; potassium chloride  60  meq ; aluminum-magnesium hydrox.-simethicone  30  ml ; trazodone  25  mg ; albuterol inhaler  2  puff ; bupropion (sustained release)  200  mg ; ibuprofen  400  mg ; 
unspecified essential hypertension other premature beats arthropathy, unspecified, site unspecified 
white m 67 $nan$hematology blood hematocrit  30.7  %; hematology blood hemoglobin  10.0  g dl; hematology blood platelet count  133  k ul; chemistry blood anion gap  10  meq l; chemistry blood bicarbonate  27  meq l; chemistry blood chloride  112  meq l; chemistry blood creatinine  0.7  mg dl; chemistry blood potassium  3.8  meq l; chemistry blood sodium  145  meq l; chemistry blood urea nitrogen  6  mg dl; hematology blood inr(pt)  1.3  ; chemistry blood calcium, total  7.4  mg dl; chemistry blood bilirubin, total  1.0  mg dl; chemistry blood glucose  87  mg dl; chemistry blood lactate dehydrogenase (ld)  197  iu l; chemistry blood albumin  2.6  g dl$sodium chloride 0.9%  flush  10  ml ; heparin  5000  unit ; flecainide acetate  50  mg ; acetaminophen  325-650  mg ; 5% dextrose  100  ml ; tobramycin sulfate  160  mg ; ns (mini bag plus)  100  ml ; meropenem  500  mg ; 0.9% sodium chloride  1000  ml ; albuterol 0.083% neb soln  1  neb ; miconazole powder 2%  1  appl ; ipratropium bromide neb  1  neb ; meperidine  50  mg ; iso-osmotic dextrose  200  ml ; vancomycin  1000  mg ; cholestyramine  4  gm ; divalproex (delayed release)  500  mg ; aspirin  325  mg ; digoxin  0.125  mg ; ferrous sulfate  325  mg ; olanzapine  5  mg ; ranitidine  75  mg ; multivitamins  1  tab ; 0.9% sodium chloride  500  ml ; 
unspecified deficiency anemia thrombocytopenia, unspecified unspecified fall abrasion or friction burn of hip, thigh, leg, and ankle, without mention of infection other specified metabolic disorders chronic airway obstruction, not elsewhere classified volume depletion, unspecified chronic hepatitis c without mention of hepatic coma pneumonia, organism unspecified atrial fibrillation paralysis agitans metabolic encephalopathy schizoaffective disorder, chronic atrial fibrillation edema unspecified septicemia pancytopenia intestinal infection due to clostridium difficile pneumonia, organism unspecified unspecified protein-calorie malnutrition other bipolar disorders sepsis other disorders of plasma protein metabolism atrial fibrillation bipolar disorder, unspecified hypoxemia esophageal reflux other and unspecified viral and rickettsial vaccines causing adverse effects in therapeutic use personal history of other infectious and parasitic diseases accidents occurring in unspecified place iron deficiency anemia, unspecified incontinence of feces shock, unspecified alcohol abuse, in remission other specified cardiac dysrhythmias other iatrogenic hypotension personal history of other specified diseases 
white m 67 $nan$hematology blood hematocrit  27.7  %; hematology blood hematocrit  29.4  %; hematology blood hemoglobin  9.2  g dl; hematology blood platelet count  150  k ul; chemistry blood anion gap  11  meq l; chemistry blood bicarbonate  25  meq l; chemistry blood chloride  108  meq l; chemistry blood creatinine  0.7  mg dl; chemistry blood potassium  3.6  meq l; chemistry blood sodium  140  meq l; chemistry blood urea nitrogen  6  mg dl; chemistry blood calcium, total  7.9  mg dl; chemistry blood glucose  82  mg dl$sodium chloride 0.9%  flush  10  ml ; heparin  5000  unit ; flecainide acetate  50  mg ; acetaminophen  325-650  mg ; ns (mini bag plus)  100  ml ; meropenem  500  mg ; 0.9% sodium chloride  1000  ml ; albuterol 0.083% neb soln  1  neb ; miconazole powder 2%  1  appl ; meperidine  50  mg ; iso-osmotic dextrose  200  ml ; vancomycin  1000  mg ; divalproex (delayed release)  500  mg ; aspirin  325  mg ; digoxin  0.125  mg ; ferrous sulfate  325  mg ; ranitidine  75  mg ; multivitamins  1  tab ; 0.9% sodium chloride  500  ml ; divalproex (delayed release)  1000  mg ; metoprolol tartrate  25  mg ; 
unspecified deficiency anemia thrombocytopenia, unspecified unspecified fall abrasion or friction burn of hip, thigh, leg, and ankle, without mention of infection other specified metabolic disorders chronic airway obstruction, not elsewhere classified volume depletion, unspecified chronic hepatitis c without mention of hepatic coma pneumonia, organism unspecified atrial fibrillation paralysis agitans metabolic encephalopathy schizoaffective disorder, chronic atrial fibrillation edema unspecified septicemia pancytopenia intestinal infection due to clostridium difficile pneumonia, organism unspecified unspecified protein-calorie malnutrition other bipolar disorders sepsis other disorders of plasma protein metabolism atrial fibrillation bipolar disorder, unspecified hypoxemia esophageal reflux other and unspecified viral and rickettsial vaccines causing adverse effects in therapeutic use personal history of other infectious and parasitic diseases accidents occurring in unspecified place iron deficiency anemia, unspecified incontinence of feces shock, unspecified alcohol abuse, in remission other specified cardiac dysrhythmias other iatrogenic hypotension personal history of other specified diseases 
white m 67 $nan$hematology blood hematocrit  28.3  %; hematology blood hemoglobin  9.2  g dl; hematology blood platelet count  193  k ul; chemistry blood anion gap  11  meq l; chemistry blood bicarbonate  24  meq l; chemistry blood chloride  108  meq l; chemistry blood creatinine  0.8  mg dl; chemistry blood potassium  4.4  meq l; chemistry blood sodium  139  meq l; chemistry blood urea nitrogen  7  mg dl; chemistry blood calcium, total  9.1  mg dl; chemistry blood glucose  113  mg dl; hematology blood bands  2  %$sodium chloride 0.9%  flush  10  ml ; heparin  5000  unit ; flecainide acetate  50  mg ; acetaminophen  325-650  mg ; albuterol 0.083% neb soln  1  neb ; miconazole powder 2%  1  appl ; iso-osmotic dextrose  200  ml ; vancomycin  1000  mg ; divalproex (delayed release)  500  mg ; aspirin  325  mg ; digoxin  0.125  mg ; ferrous sulfate  325  mg ; ranitidine  75  mg ; multivitamins  1  tab ; divalproex (delayed release)  1000  mg ; metoprolol tartrate  25  mg ; 0.9% sodium chloride  250  ml ; furosemide  20  mg ; metoprolol tartrate  12.5  mg ; 
unspecified deficiency anemia thrombocytopenia, unspecified unspecified fall abrasion or friction burn of hip, thigh, leg, and ankle, without mention of infection other specified metabolic disorders chronic airway obstruction, not elsewhere classified volume depletion, unspecified chronic hepatitis c without mention of hepatic coma pneumonia, organism unspecified atrial fibrillation paralysis agitans metabolic encephalopathy schizoaffective disorder, chronic atrial fibrillation edema unspecified septicemia pancytopenia intestinal infection due to clostridium difficile pneumonia, organism unspecified unspecified protein-calorie malnutrition other bipolar disorders sepsis other disorders of plasma protein metabolism atrial fibrillation bipolar disorder, unspecified hypoxemia esophageal reflux other and unspecified viral and rickettsial vaccines causing adverse effects in therapeutic use personal history of other infectious and parasitic diseases accidents occurring in unspecified place iron deficiency anemia, unspecified incontinence of feces shock, unspecified alcohol abuse, in remission other specified cardiac dysrhythmias other iatrogenic hypotension personal history of other specified diseases 
white m 67 $nan$hematology blood hematocrit  29.9  %; hematology blood hemoglobin  9.9  g dl; hematology blood platelet count  178  k ul; chemistry blood anion gap  10  meq l; chemistry blood bicarbonate  29  meq l; chemistry blood chloride  105  meq l; chemistry blood creatinine  0.7  mg dl; chemistry blood potassium  3.9  meq l; chemistry blood sodium  140  meq l; chemistry blood urea nitrogen  8  mg dl; chemistry blood calcium, total  8.0  mg dl; chemistry blood glucose  90  mg dl$sodium chloride 0.9%  flush  10  ml ; heparin  5000  unit ; flecainide acetate  50  mg ; acetaminophen  325-650  mg ; albuterol 0.083% neb soln  1  neb ; miconazole powder 2%  1  appl ; iso-osmotic dextrose  200  ml ; vancomycin  1000  mg ; divalproex (delayed release)  500  mg ; aspirin  325  mg ; digoxin  0.125  mg ; ferrous sulfate  325  mg ; ranitidine  75  mg ; multivitamins  1  tab ; divalproex (delayed release)  1000  mg ; metoprolol tartrate  25  mg ; 0.9% sodium chloride  250  ml ; furosemide  20  mg ; metoprolol tartrate  12.5  mg ; divalproex sod. sprinkles  500  mg ; xopenex  0.63  mg ; 
unspecified deficiency anemia thrombocytopenia, unspecified unspecified fall abrasion or friction burn of hip, thigh, leg, and ankle, without mention of infection other specified metabolic disorders chronic airway obstruction, not elsewhere classified volume depletion, unspecified chronic hepatitis c without mention of hepatic coma pneumonia, organism unspecified atrial fibrillation paralysis agitans metabolic encephalopathy schizoaffective disorder, chronic atrial fibrillation edema unspecified septicemia pancytopenia intestinal infection due to clostridium difficile pneumonia, organism unspecified unspecified protein-calorie malnutrition other bipolar disorders sepsis other disorders of plasma protein metabolism atrial fibrillation bipolar disorder, unspecified hypoxemia esophageal reflux other and unspecified viral and rickettsial vaccines causing adverse effects in therapeutic use personal history of other infectious and parasitic diseases accidents occurring in unspecified place iron deficiency anemia, unspecified incontinence of feces shock, unspecified alcohol abuse, in remission other specified cardiac dysrhythmias other iatrogenic hypotension personal history of other specified diseases 
white m 67 $nan$hematology blood hematocrit  28.9  %; hematology blood hemoglobin  9.7  g dl; hematology blood platelet count  153  k ul; chemistry blood anion gap  11  meq l; chemistry blood bicarbonate  29  meq l; chemistry blood chloride  103  meq l; chemistry blood creatinine  0.7  mg dl; chemistry blood potassium  4.0  meq l; chemistry blood sodium  139  meq l; chemistry blood urea nitrogen  10  mg dl; hematology urine wbc  3-5  # hpf; chemistry blood calcium, total  8.1  mg dl; chemistry blood glucose  84  mg dl; hematology blood bands  2  %; hematology urine glucose  neg  mg dl; hematology urine bilirubin  neg  mg dl$sodium chloride 0.9%  flush  10  ml ; heparin  5000  unit ; flecainide acetate  50  mg ; acetaminophen  325-650  mg ; albuterol 0.083% neb soln  1  neb ; miconazole powder 2%  1  appl ; iso-osmotic dextrose  200  ml ; vancomycin  1000  mg ; aspirin  325  mg ; digoxin  0.125  mg ; ferrous sulfate  325  mg ; ranitidine  75  mg ; metoprolol tartrate  12.5  mg ; divalproex sod. sprinkles  500  mg ; xopenex  0.63  mg ; divalproex sod. sprinkles  1000  mg ; erythromycin 0.5% ophth oint  0.5  in ; 
unspecified deficiency anemia thrombocytopenia, unspecified unspecified fall abrasion or friction burn of hip, thigh, leg, and ankle, without mention of infection other specified metabolic disorders chronic airway obstruction, not elsewhere classified volume depletion, unspecified chronic hepatitis c without mention of hepatic coma pneumonia, organism unspecified atrial fibrillation paralysis agitans metabolic encephalopathy schizoaffective disorder, chronic atrial fibrillation edema unspecified septicemia pancytopenia intestinal infection due to clostridium difficile pneumonia, organism unspecified unspecified protein-calorie malnutrition other bipolar disorders sepsis other disorders of plasma protein metabolism atrial fibrillation bipolar disorder, unspecified hypoxemia esophageal reflux other and unspecified viral and rickettsial vaccines causing adverse effects in therapeutic use personal history of other infectious and parasitic diseases accidents occurring in unspecified place iron deficiency anemia, unspecified incontinence of feces shock, unspecified alcohol abuse, in remission other specified cardiac dysrhythmias other iatrogenic hypotension personal history of other specified diseases 
white m 67 $nan$hematology blood hematocrit  31.6  %; hematology blood hematocrit  29.9  %; hematology blood hemoglobin  10.7  g dl; hematology blood hemoglobin  9.8  g dl; hematology blood platelet count  163  k ul; hematology blood platelet count  139  k ul; chemistry blood anion gap  12  meq l; chemistry blood anion gap  13  meq l; chemistry blood bicarbonate  29  meq l; chemistry blood bicarbonate  25  meq l; chemistry blood chloride  101  meq l; chemistry blood chloride  105  meq l; chemistry blood creatinine  0.7  mg dl; chemistry blood creatinine  0.6  mg dl; chemistry blood potassium  4.0  meq l; chemistry blood potassium  8.6  meq l; chemistry blood sodium  133  meq l; chemistry blood sodium  139  meq l; chemistry blood urea nitrogen  12  mg dl; chemistry blood urea nitrogen  10  mg dl; hematology blood inr(pt)  1.3  ; chemistry blood calcium, total  8.0  mg dl; chemistry blood calcium, total  7.5  mg dl; chemistry blood glucose  97  mg dl; chemistry blood glucose  81  mg dl; hematology blood bands  0  %$sodium chloride 0.9%  flush  10  ml ; heparin  5000  unit ; flecainide acetate  50  mg ; acetaminophen  325-650  mg ; albuterol 0.083% neb soln  1  neb ; miconazole powder 2%  1  appl ; aspirin  325  mg ; digoxin  0.125  mg ; ferrous sulfate  325  mg ; ranitidine  75  mg ; metoprolol tartrate  12.5  mg ; divalproex sod. sprinkles  500  mg ; divalproex sod. sprinkles  1000  mg ; erythromycin 0.5% ophth oint  0.5  in ; 0.9% sodium chloride  1  bag ; calcium gluconate  2  g ; 0.9% sodium chloride  1-2  bag ; calcium gluconate  2-4  g ; 0.9% sodium chloride  2  bag ; calcium gluconate  4  g ; sw  100  ml ; magnesium sulfate  4  gm ; magnesium sulfate  2-4  gm ; sw  50  ml ; magnesium sulfate  2  gm ; metronidazole (flagyl)  500  mg ; potassium chloride  20-40  meq ; potassium chloride  40-60  meq ; sw  600  ml ; potassium chloride  60  meq ; 
unspecified deficiency anemia thrombocytopenia, unspecified unspecified fall abrasion or friction burn of hip, thigh, leg, and ankle, without mention of infection other specified metabolic disorders chronic airway obstruction, not elsewhere classified volume depletion, unspecified chronic hepatitis c without mention of hepatic coma pneumonia, organism unspecified atrial fibrillation paralysis agitans metabolic encephalopathy schizoaffective disorder, chronic atrial fibrillation edema unspecified septicemia pancytopenia intestinal infection due to clostridium difficile pneumonia, organism unspecified unspecified protein-calorie malnutrition other bipolar disorders sepsis other disorders of plasma protein metabolism atrial fibrillation bipolar disorder, unspecified hypoxemia esophageal reflux other and unspecified viral and rickettsial vaccines causing adverse effects in therapeutic use personal history of other infectious and parasitic diseases accidents occurring in unspecified place iron deficiency anemia, unspecified incontinence of feces shock, unspecified alcohol abuse, in remission other specified cardiac dysrhythmias other iatrogenic hypotension personal history of other specified diseases 
white m 67 $nan$hematology blood hematocrit  29.8  %; hematology blood hemoglobin  9.8  g dl; hematology blood platelet count  175  k ul; chemistry blood anion gap  10  meq l; chemistry blood bicarbonate  28  meq l; chemistry blood chloride  104  meq l; chemistry blood creatinine  0.6  mg dl; chemistry blood potassium  4.1  meq l; chemistry blood sodium  138  meq l; chemistry blood urea nitrogen  12  mg dl; chemistry blood calcium, total  8.0  mg dl; chemistry blood glucose  99  mg dl$sodium chloride 0.9%  flush  10  ml ; heparin  5000  unit ; flecainide acetate  50  mg ; acetaminophen  325-650  mg ; albuterol 0.083% neb soln  1  neb ; miconazole powder 2%  1  appl ; aspirin  325  mg ; digoxin  0.125  mg ; ferrous sulfate  325  mg ; ranitidine  75  mg ; metoprolol tartrate  12.5  mg ; divalproex sod. sprinkles  500  mg ; divalproex sod. sprinkles  1000  mg ; erythromycin 0.5% ophth oint  0.5  in ; 0.9% sodium chloride  1  bag ; calcium gluconate  2  g ; 0.9% sodium chloride  1-2  bag ; calcium gluconate  2-4  g ; 0.9% sodium chloride  2  bag ; calcium gluconate  4  g ; sw  100  ml ; magnesium sulfate  4  gm ; magnesium sulfate  2-4  gm ; sw  50  ml ; magnesium sulfate  2  gm ; metronidazole (flagyl)  500  mg ; potassium chloride  20-40  meq ; potassium chloride  40-60  meq ; sw  600  ml ; potassium chloride  60  meq ; artificial tears  1-2  drop ; 
unspecified deficiency anemia thrombocytopenia, unspecified unspecified fall abrasion or friction burn of hip, thigh, leg, and ankle, without mention of infection other specified metabolic disorders chronic airway obstruction, not elsewhere classified volume depletion, unspecified chronic hepatitis c without mention of hepatic coma pneumonia, organism unspecified atrial fibrillation paralysis agitans metabolic encephalopathy schizoaffective disorder, chronic atrial fibrillation edema unspecified septicemia pancytopenia intestinal infection due to clostridium difficile pneumonia, organism unspecified unspecified protein-calorie malnutrition other bipolar disorders sepsis other disorders of plasma protein metabolism atrial fibrillation bipolar disorder, unspecified hypoxemia esophageal reflux other and unspecified viral and rickettsial vaccines causing adverse effects in therapeutic use personal history of other infectious and parasitic diseases accidents occurring in unspecified place iron deficiency anemia, unspecified incontinence of feces shock, unspecified alcohol abuse, in remission other specified cardiac dysrhythmias other iatrogenic hypotension personal history of other specified diseases 
white m 67 $nan$hematology blood hematocrit  33.9  %; hematology blood hemoglobin  11.0  g dl; hematology blood platelet count  182  k ul; chemistry blood anion gap  12  meq l; chemistry blood bicarbonate  28  meq l; chemistry blood chloride  104  meq l; chemistry blood creatinine  0.7  mg dl; chemistry blood potassium  4.2  meq l; chemistry blood sodium  140  meq l; chemistry blood urea nitrogen  12  mg dl; hematology blood inr(pt)  1.4  ; chemistry blood calcium, total  7.9  mg dl; chemistry blood bilirubin, total  0.8  mg dl; chemistry blood glucose  101  mg dl; chemistry blood albumin  2.6  g dl$sodium chloride 0.9%  flush  10  ml ; heparin  5000  unit ; flecainide acetate  50  mg ; acetaminophen  325-650  mg ; albuterol 0.083% neb soln  1  neb ; miconazole powder 2%  1  appl ; aspirin  325  mg ; digoxin  0.125  mg ; ferrous sulfate  325  mg ; ranitidine  75  mg ; metoprolol tartrate  12.5  mg ; divalproex sod. sprinkles  500  mg ; divalproex sod. sprinkles  1000  mg ; 0.9% sodium chloride  1  bag ; calcium gluconate  2  g ; 0.9% sodium chloride  1-2  bag ; calcium gluconate  2-4  g ; 0.9% sodium chloride  2  bag ; calcium gluconate  4  g ; sw  100  ml ; magnesium sulfate  4  gm ; magnesium sulfate  2-4  gm ; sw  50  ml ; magnesium sulfate  2  gm ; metronidazole (flagyl)  500  mg ; potassium chloride  20-40  meq ; potassium chloride  40-60  meq ; sw  600  ml ; potassium chloride  60  meq ; artificial tears  1-2  drop ; methylphenidate  5  mg ; 
unspecified deficiency anemia thrombocytopenia, unspecified unspecified fall abrasion or friction burn of hip, thigh, leg, and ankle, without mention of infection other specified metabolic disorders chronic airway obstruction, not elsewhere classified volume depletion, unspecified chronic hepatitis c without mention of hepatic coma pneumonia, organism unspecified atrial fibrillation paralysis agitans metabolic encephalopathy schizoaffective disorder, chronic atrial fibrillation edema unspecified septicemia pancytopenia intestinal infection due to clostridium difficile pneumonia, organism unspecified unspecified protein-calorie malnutrition other bipolar disorders sepsis other disorders of plasma protein metabolism atrial fibrillation bipolar disorder, unspecified hypoxemia esophageal reflux other and unspecified viral and rickettsial vaccines causing adverse effects in therapeutic use personal history of other infectious and parasitic diseases accidents occurring in unspecified place iron deficiency anemia, unspecified incontinence of feces shock, unspecified alcohol abuse, in remission other specified cardiac dysrhythmias other iatrogenic hypotension personal history of other specified diseases 
white m 67 $nan$hematology blood hematocrit  30.2  %; hematology blood hemoglobin  9.6  g dl; hematology blood platelet count  166  k ul; chemistry blood anion gap  10  meq l; chemistry blood bicarbonate  29  meq l; chemistry blood chloride  106  meq l; chemistry blood creatinine  0.7  mg dl; chemistry blood potassium  4.1  meq l; chemistry blood sodium  141  meq l; chemistry blood urea nitrogen  12  mg dl; hematology blood inr(pt)  1.4  ; hematology urine wbc  >50  # hpf; chemistry blood calcium, total  8.0  mg dl; chemistry blood glucose  121  mg dl; hematology urine glucose  neg  mg dl; hematology urine bilirubin  neg  mg dl; hematology urine calcium oxalate crystals  occ  $sodium chloride 0.9%  flush  10  ml ; flecainide acetate  50  mg ; acetaminophen  325-650  mg ; albuterol 0.083% neb soln  1  neb ; miconazole powder 2%  1  appl ; aspirin  325  mg ; digoxin  0.125  mg ; ferrous sulfate  325  mg ; ranitidine  75  mg ; divalproex sod. sprinkles  500  mg ; divalproex sod. sprinkles  1000  mg ; 0.9% sodium chloride  1  bag ; calcium gluconate  2  g ; 0.9% sodium chloride  1-2  bag ; calcium gluconate  2-4  g ; 0.9% sodium chloride  2  bag ; calcium gluconate  4  g ; sw  100  ml ; magnesium sulfate  4  gm ; magnesium sulfate  2-4  gm ; sw  50  ml ; magnesium sulfate  2  gm ; metronidazole (flagyl)  500  mg ; potassium chloride  20-40  meq ; potassium chloride  40-60  meq ; sw  600  ml ; potassium chloride  60  meq ; artificial tears  1-2  drop ; methylphenidate  5  mg ; 
unspecified deficiency anemia thrombocytopenia, unspecified unspecified fall abrasion or friction burn of hip, thigh, leg, and ankle, without mention of infection other specified metabolic disorders chronic airway obstruction, not elsewhere classified volume depletion, unspecified chronic hepatitis c without mention of hepatic coma pneumonia, organism unspecified atrial fibrillation paralysis agitans metabolic encephalopathy schizoaffective disorder, chronic atrial fibrillation edema unspecified septicemia pancytopenia intestinal infection due to clostridium difficile pneumonia, organism unspecified unspecified protein-calorie malnutrition other bipolar disorders sepsis other disorders of plasma protein metabolism atrial fibrillation bipolar disorder, unspecified hypoxemia esophageal reflux other and unspecified viral and rickettsial vaccines causing adverse effects in therapeutic use personal history of other infectious and parasitic diseases accidents occurring in unspecified place iron deficiency anemia, unspecified incontinence of feces shock, unspecified alcohol abuse, in remission other specified cardiac dysrhythmias other iatrogenic hypotension personal history of other specified diseases 
white m 67 $nan$hematology blood hematocrit  33.3  %; hematology blood hemoglobin  10.5  g dl; hematology blood platelet count  155  k ul; chemistry blood anion gap  12  meq l; chemistry blood bicarbonate  28  meq l; chemistry blood chloride  105  meq l; chemistry blood creatinine  0.7  mg dl; chemistry blood potassium  4.1  meq l; chemistry blood sodium  141  meq l; chemistry blood urea nitrogen  12  mg dl; chemistry blood calcium, total  7.9  mg dl; chemistry blood glucose  86  mg dl$sodium chloride 0.9%  flush  10  ml ; flecainide acetate  50  mg ; acetaminophen  325-650  mg ; albuterol 0.083% neb soln  1  neb ; miconazole powder 2%  1  appl ; aspirin  325  mg ; digoxin  0.125  mg ; ferrous sulfate  325  mg ; ranitidine  75  mg ; divalproex sod. sprinkles  500  mg ; divalproex sod. sprinkles  1000  mg ; metronidazole (flagyl)  500  mg ; artificial tears  1-2  drop ; methylphenidate  5  mg ; citalopram hydrobromide  20  mg ; 
unspecified deficiency anemia thrombocytopenia, unspecified unspecified fall abrasion or friction burn of hip, thigh, leg, and ankle, without mention of infection other specified metabolic disorders chronic airway obstruction, not elsewhere classified volume depletion, unspecified chronic hepatitis c without mention of hepatic coma pneumonia, organism unspecified atrial fibrillation paralysis agitans metabolic encephalopathy schizoaffective disorder, chronic atrial fibrillation edema unspecified septicemia pancytopenia intestinal infection due to clostridium difficile pneumonia, organism unspecified unspecified protein-calorie malnutrition other bipolar disorders sepsis other disorders of plasma protein metabolism atrial fibrillation bipolar disorder, unspecified hypoxemia esophageal reflux other and unspecified viral and rickettsial vaccines causing adverse effects in therapeutic use personal history of other infectious and parasitic diseases accidents occurring in unspecified place iron deficiency anemia, unspecified incontinence of feces shock, unspecified alcohol abuse, in remission other specified cardiac dysrhythmias other iatrogenic hypotension personal history of other specified diseases 
white m 67 $nan$hematology blood hematocrit  30.0  %; hematology blood hemoglobin  9.4  g dl; hematology blood platelet count  155  k ul; chemistry blood anion gap  10  meq l; chemistry blood bicarbonate  33  meq l; chemistry blood chloride  104  meq l; chemistry blood creatinine  0.7  mg dl; chemistry blood potassium  4.5  meq l; chemistry blood sodium  142  meq l; chemistry blood urea nitrogen  10  mg dl; chemistry blood calcium, total  8.3  mg dl; chemistry blood glucose  86  mg dl$sodium chloride 0.9%  flush  10  ml ; flecainide acetate  50  mg ; acetaminophen  325-650  mg ; albuterol 0.083% neb soln  1  neb ; miconazole powder 2%  1  appl ; aspirin  325  mg ; digoxin  0.125  mg ; ferrous sulfate  325  mg ; ranitidine  75  mg ; divalproex sod. sprinkles  500  mg ; divalproex sod. sprinkles  1000  mg ; metronidazole (flagyl)  500  mg ; artificial tears  1-2  drop ; methylphenidate  5  mg ; citalopram hydrobromide  20  mg ; 
unspecified deficiency anemia thrombocytopenia, unspecified unspecified fall abrasion or friction burn of hip, thigh, leg, and ankle, without mention of infection other specified metabolic disorders chronic airway obstruction, not elsewhere classified volume depletion, unspecified chronic hepatitis c without mention of hepatic coma pneumonia, organism unspecified atrial fibrillation paralysis agitans metabolic encephalopathy schizoaffective disorder, chronic atrial fibrillation edema unspecified septicemia pancytopenia intestinal infection due to clostridium difficile pneumonia, organism unspecified unspecified protein-calorie malnutrition other bipolar disorders sepsis other disorders of plasma protein metabolism atrial fibrillation bipolar disorder, unspecified hypoxemia esophageal reflux other and unspecified viral and rickettsial vaccines causing adverse effects in therapeutic use personal history of other infectious and parasitic diseases accidents occurring in unspecified place iron deficiency anemia, unspecified incontinence of feces shock, unspecified alcohol abuse, in remission other specified cardiac dysrhythmias other iatrogenic hypotension personal history of other specified diseases 
white m 67 $nan$hematology blood hematocrit  28.9  %; hematology blood hemoglobin  9.5  g dl; hematology blood platelet count  144  k ul; chemistry blood anion gap  8  meq l; chemistry blood bicarbonate  31  meq l; chemistry blood chloride  104  meq l; chemistry blood creatinine  0.6  mg dl; chemistry blood potassium  4.5  meq l; chemistry blood sodium  138  meq l; chemistry blood urea nitrogen  10  mg dl; chemistry blood calcium, total  8.1  mg dl; chemistry blood glucose  82  mg dl$sodium chloride 0.9%  flush  10  ml ; flecainide acetate  50  mg ; acetaminophen  325-650  mg ; albuterol 0.083% neb soln  1  neb ; miconazole powder 2%  1  appl ; aspirin  325  mg ; digoxin  0.125  mg ; ferrous sulfate  325  mg ; ranitidine  75  mg ; divalproex sod. sprinkles  500  mg ; divalproex sod. sprinkles  1000  mg ; metronidazole (flagyl)  500  mg ; artificial tears  1-2  drop ; methylphenidate  5  mg ; citalopram hydrobromide  20  mg ; 
unspecified deficiency anemia thrombocytopenia, unspecified unspecified fall abrasion or friction burn of hip, thigh, leg, and ankle, without mention of infection other specified metabolic disorders chronic airway obstruction, not elsewhere classified volume depletion, unspecified chronic hepatitis c without mention of hepatic coma pneumonia, organism unspecified atrial fibrillation paralysis agitans metabolic encephalopathy schizoaffective disorder, chronic atrial fibrillation edema unspecified septicemia pancytopenia intestinal infection due to clostridium difficile pneumonia, organism unspecified unspecified protein-calorie malnutrition other bipolar disorders sepsis other disorders of plasma protein metabolism atrial fibrillation bipolar disorder, unspecified hypoxemia esophageal reflux other and unspecified viral and rickettsial vaccines causing adverse effects in therapeutic use personal history of other infectious and parasitic diseases accidents occurring in unspecified place iron deficiency anemia, unspecified incontinence of feces shock, unspecified alcohol abuse, in remission other specified cardiac dysrhythmias other iatrogenic hypotension personal history of other specified diseases 
white m 67 $nan$hematology blood hematocrit  30.5  %; hematology blood hemoglobin  10.0  g dl; hematology blood platelet count  138  k ul; chemistry blood anion gap  11  meq l; chemistry blood bicarbonate  30  meq l; chemistry blood chloride  103  meq l; chemistry blood creatinine  0.7  mg dl; chemistry blood potassium  4.7  meq l; chemistry blood sodium  139  meq l; chemistry blood urea nitrogen  9  mg dl; chemistry blood glucose  81  mg dl$sodium chloride 0.9%  flush  10  ml ; flecainide acetate  50  mg ; acetaminophen  325-650  mg ; albuterol 0.083% neb soln  1  neb ; miconazole powder 2%  1  appl ; aspirin  325  mg ; digoxin  0.125  mg ; ferrous sulfate  325  mg ; ranitidine  75  mg ; divalproex sod. sprinkles  500  mg ; divalproex sod. sprinkles  1000  mg ; metronidazole (flagyl)  500  mg ; artificial tears  1-2  drop ; methylphenidate  5  mg ; citalopram hydrobromide  20  mg ; 
unspecified deficiency anemia thrombocytopenia, unspecified unspecified fall abrasion or friction burn of hip, thigh, leg, and ankle, without mention of infection other specified metabolic disorders chronic airway obstruction, not elsewhere classified volume depletion, unspecified chronic hepatitis c without mention of hepatic coma pneumonia, organism unspecified atrial fibrillation paralysis agitans metabolic encephalopathy schizoaffective disorder, chronic atrial fibrillation edema unspecified septicemia pancytopenia intestinal infection due to clostridium difficile pneumonia, organism unspecified unspecified protein-calorie malnutrition other bipolar disorders sepsis other disorders of plasma protein metabolism atrial fibrillation bipolar disorder, unspecified hypoxemia esophageal reflux other and unspecified viral and rickettsial vaccines causing adverse effects in therapeutic use personal history of other infectious and parasitic diseases accidents occurring in unspecified place iron deficiency anemia, unspecified incontinence of feces shock, unspecified alcohol abuse, in remission other specified cardiac dysrhythmias other iatrogenic hypotension personal history of other specified diseases 
white m 64 $nan$hematology blood hematocrit  25.9  %; hematology blood hematocrit  28.3  %; hematology blood hematocrit  29.4  %; hematology blood hemoglobin  8.5  g dl; hematology blood hemoglobin  9.0  g dl; hematology blood hemoglobin  9.7  g dl; hematology blood platelet count  269  k ul; hematology blood platelet count  336  k ul; hematology blood platelet count  292  k ul; chemistry blood anion gap  22  meq l; chemistry blood anion gap  28  meq l; chemistry blood anion gap  24  meq l; chemistry blood anion gap  24  meq l; chemistry blood bicarbonate  21  meq l; chemistry blood bicarbonate  16  meq l; chemistry blood bicarbonate  16  meq l; chemistry blood bicarbonate  15  meq l; chemistry blood chloride  91  meq l; chemistry blood chloride  91  meq l; chemistry blood chloride  94  meq l; chemistry blood chloride  96  meq l; chemistry blood creatinine  11.2  mg dl; chemistry blood creatinine  11.4  mg dl; chemistry blood creatinine  10.9  mg dl; chemistry blood creatinine  11.2  mg dl; chemistry blood potassium  4.2  meq l; chemistry blood potassium  4.7  meq l; chemistry blood potassium  4.7  meq l; chemistry blood potassium  4.6  meq l; chemistry blood sodium  130  meq l; chemistry blood sodium  129  meq l; chemistry blood sodium  130  meq l; chemistry blood sodium  130  meq l; chemistry blood urea nitrogen  89  mg dl; chemistry blood urea nitrogen  89  mg dl; chemistry blood urea nitrogen  83  mg dl; chemistry blood urea nitrogen  85  mg dl; hematology blood inr(pt)  1.1  ; hematology blood inr(pt)  1.2  ; hematology urine wbc  3-5  # hpf; chemistry blood calcium, total  8.6  mg dl; chemistry blood calcium, total  8.1  mg dl; chemistry blood calcium, total  8.7  mg dl; chemistry blood bilirubin, total  0.2  mg dl; chemistry blood bilirubin, total  0.4  mg dl; chemistry blood glucose  247  mg dl; chemistry blood glucose  189  mg dl; chemistry blood glucose  177  mg dl; chemistry blood glucose  219  mg dl; chemistry blood lactate dehydrogenase (ld)  269  iu l; chemistry blood albumin  2.8  g dl; chemistry blood albumin  2.0  g dl; blood gas blood free calcium  1.16  mmol l; blood gas blood free calcium  1.06  mmol l; blood gas blood free calcium  1.21  mmol l; blood gas blood free calcium  1.18  mmol l; blood gas blood lactate  1.0  mmol l; blood gas blood lactate  1.2  mmol l; blood gas blood lactate  1.2  mmol l; blood gas blood lactate  1.4  mmol l; blood gas blood lactate  1.8  mmol l; blood gas blood lactate  3.8  mmol l; blood gas blood lactate  2.3  mmol l; blood gas blood lactate  2.2  mmol l; blood gas blood chloride, whole blood  93  meq l; blood gas blood chloride, whole blood  97  meq l; blood gas blood glucose  228  mg dl; blood gas blood glucose  202  mg dl; blood gas blood hematocrit, calculated  29  %; blood gas blood hematocrit, calculated  25  %; blood gas blood hemoglobin  9.7  g dl; blood gas blood hemoglobin  8.4  g dl; blood gas blood potassium, whole blood  4.5  meq l; blood gas blood potassium, whole blood  4.4  meq l; blood gas blood potassium, whole blood  4.2  meq l; blood gas blood sodium, whole blood  127  meq l; blood gas blood sodium, whole blood  127  meq l; hematology urine glucose  neg  mg dl; hematology urine bilirubin  sm  mg dl$iso-osmotic dextrose  200  ml ; 1 2 ns  1000  ml ; vancomycin  1000  mg ; 0.9% sodium chloride (mini bag plus)  100  ml ; piperacillin-tazobactam  4.5  gm ; heparin  1000  unit ; 5% dextrose  250  ml ; heparin sodium  25,000  unit ; dextrose 50%  12.5  gm ; glucagon  1  mg ; insulin  0  unit ; promethazine  12.5  mg ; morphine sulfate  2  mg ; iso-osmotic dextrose  50  ml ; piperacillin-tazobactam  2.25  g ; 0.9% sodium chloride  250  ml ; norepinephrine  8  mg ; soln  50  ml ; fentanyl citrate  2.5  mg ; 0.9% sodium chloride  100  ml ; midazolam  100  mg ; 0.9% sodium chloride  500  ml ; iso-osmotic sodium chloride  50  ml ; famotidine  20  mg ; ns  100  ml ; metronidazole (flagyl)  500  mg ; insulin  34  unit ; sevelamer carbonate  2400  mg ; chlorhexidine gluconate 0.12% oral rinse  15  ml ; promethazine  25  mg ; aspirin  325  mg ; atorvastatin  80  mg ; calcitriol  0.5  mcg ; nephrocaps  1  cap ; clopidogrel  75  mg ; aspirin  300  mg ; sodium chloride 0.9%  flush  10  ml ; lr  1000  ml ; epinephrine  2  mg ; insulin human regular  100  unit ; calcium gluconate  2  g ; heparin  5000  unit ; bag  5000  ml ; prismasate (b32 k2)  5000  ml ; 5% dextrose  500  ml ; calcium gluconate  20  gm ; sw  100  ml ; potassium chloride  10  meq ; insulin  60  unit ; sw  50  ml ; potassium chloride  20-40  meq ; potassium chloride  40-60  meq ; potassium chloride  60  meq ; potassium phosphate  15  mmol ; potassium phosphate  15-30  mmol ; magnesium sulfate  4  gm ; magnesium sulfate  2-4  gm ; magnesium sulfate  2  gm ; 
peripheral angiopathy in diseases classified elsewhere background diabetic retinopathy diabetes with peripheral circulatory disorders, type i [juvenile type], not stated as uncontrolled diabetes with neurological manifestations, type i [juvenile type], not stated as uncontrolled hypertensive chronic kidney disease, unspecified, with chronic kidney disease stage v or end stage renal disease polyneuropathy in diabetes congestive heart failure, unspecified aortocoronary bypass status personal history of tobacco use other toe(s) amputation status percutaneous transluminal coronary angioplasty status old myocardial infarction anemia in chronic kidney disease above knee amputation status diabetes with ophthalmic manifestations, type i [juvenile type], not stated as uncontrolled diabetes with renal manifestations, type i [juvenile type], not stated as uncontrolled end stage renal disease subendocardial infarction, initial episode of care end stage renal disease pure hypercholesterolemia peripheral angiopathy in diseases classified elsewhere mitral valve disorders above knee amputation status diabetes with renal manifestations, type ii or unspecified type, not stated as uncontrolled diabetes with peripheral circulatory disorders, type ii or unspecified type, not stated as uncontrolled percutaneous transluminal coronary angioplasty status ventral, unspecified, hernia without mention of obstruction or gangrene aortocoronary bypass status hypertensive chronic kidney disease, unspecified, with chronic kidney disease stage v or end stage renal disease peripheral angiopathy in diseases classified elsewhere other specified antibiotics causing adverse effects in therapeutic use cellulitis and abscess of leg, except foot long-term (current) use of insulin diabetes with peripheral circulatory disorders, type i [juvenile type], not stated as uncontrolled percutaneous transluminal coronary angioplasty status dermatitis due to drugs and medicines taken internally end stage renal disease diabetes with renal manifestations, type i [juvenile type], not stated as uncontrolled ulcer of other part of foot diabetes with ophthalmic manifestations, type i [juvenile type], not stated as uncontrolled iron deficiency anemia, unspecified hypertensive chronic kidney disease, unspecified, with chronic kidney disease stage v or end stage renal disease background diabetic retinopathy other toe(s) amputation status polyneuropathy in diabetes other suppurative peritonitis acute upper respiratory infections of unspecified site unspecified viral infection
white m 64 $nan$hematology blood hematocrit  28.0  %; hematology blood hematocrit  28.4  %; hematology blood hemoglobin  9.5  g dl; hematology blood hemoglobin  9.2  g dl; hematology blood platelet count  291  k ul; hematology blood platelet count  305  k ul; chemistry blood anion gap  21  meq l; chemistry blood anion gap  24  meq l; chemistry blood anion gap  19  meq l; chemistry blood anion gap  17  meq l; chemistry blood bicarbonate  18  meq l; chemistry blood bicarbonate  17  meq l; chemistry blood bicarbonate  21  meq l; chemistry blood bicarbonate  23  meq l; chemistry blood chloride  98  meq l; chemistry blood chloride  95  meq l; chemistry blood chloride  97  meq l; chemistry blood chloride  96  meq l; chemistry blood creatinine  9.8  mg dl; chemistry blood creatinine  8.1  mg dl; chemistry blood creatinine  6.0  mg dl; chemistry blood potassium  4.5  meq l; chemistry blood potassium  4.9  meq l; chemistry blood potassium  4.3  meq l; chemistry blood potassium  4.1  meq l; chemistry blood sodium  132  meq l; chemistry blood sodium  131  meq l; chemistry blood sodium  133  meq l; chemistry blood sodium  132  meq l; chemistry blood urea nitrogen  75  mg dl; chemistry blood urea nitrogen  66  mg dl; chemistry blood urea nitrogen  46  mg dl; hematology blood inr(pt)  1.2  ; chemistry blood calcium, total  8.5  mg dl; chemistry blood calcium, total  8.6  mg dl; chemistry blood calcium, total  8.7  mg dl; chemistry blood glucose  55  mg dl; chemistry blood glucose  142  mg dl; chemistry blood glucose  93  mg dl; chemistry blood glucose  77  mg dl; chemistry blood albumin  2.1  g dl; blood gas blood free calcium  1.18  mmol l; blood gas blood free calcium  1.08  mmol l; blood gas blood free calcium  1.04  mmol l; blood gas blood free calcium  1.05  mmol l; blood gas blood lactate  1.6  mmol l; blood gas blood lactate  1.8  mmol l; blood gas blood chloride, whole blood  101  meq l; blood gas blood glucose  88  mg dl; blood gas blood hematocrit, calculated  33  %; blood gas blood hemoglobin  10.9  g dl; blood gas blood potassium, whole blood  4.3  meq l; blood gas blood sodium, whole blood  129  meq l$iso-osmotic dextrose  200  ml ; vancomycin  1000  mg ; soln  50  ml ; fentanyl citrate  2.5  mg ; ns  100  ml ; metronidazole (flagyl)  500  mg ; chlorhexidine gluconate 0.12% oral rinse  15  ml ; aspirin  300  mg ; sodium chloride 0.9%  flush  10  ml ; lr  1000  ml ; epinephrine  2  mg ; insulin human regular  100  unit ; calcium gluconate  2  g ; heparin  5000  unit ; bag  5000  ml ; prismasate (b32 k2)  5000  ml ; 5% dextrose  500  ml ; calcium gluconate  20  gm ; sw  100  ml ; potassium chloride  10  meq ; sw  50  ml ; potassium chloride  20-40  meq ; potassium chloride  40-60  meq ; potassium chloride  60  meq ; potassium phosphate  15  mmol ; potassium phosphate  15-30  mmol ; magnesium sulfate  4  gm ; magnesium sulfate  2-4  gm ; magnesium sulfate  2  gm ; sodium citrate 4%  3  ml ; citrate dextrose 3% (acd-a) crrt  1000  ml ; amiodarone  150  mg ; 5% dextrose (excel bag)  250  ml ; amiodarone  600  mg ; digoxin  0.25  mg ; digoxin  0.125  mg ; 
peripheral angiopathy in diseases classified elsewhere background diabetic retinopathy diabetes with peripheral circulatory disorders, type i [juvenile type], not stated as uncontrolled diabetes with neurological manifestations, type i [juvenile type], not stated as uncontrolled hypertensive chronic kidney disease, unspecified, with chronic kidney disease stage v or end stage renal disease polyneuropathy in diabetes congestive heart failure, unspecified aortocoronary bypass status personal history of tobacco use other toe(s) amputation status percutaneous transluminal coronary angioplasty status old myocardial infarction anemia in chronic kidney disease above knee amputation status diabetes with ophthalmic manifestations, type i [juvenile type], not stated as uncontrolled diabetes with renal manifestations, type i [juvenile type], not stated as uncontrolled end stage renal disease subendocardial infarction, initial episode of care end stage renal disease pure hypercholesterolemia peripheral angiopathy in diseases classified elsewhere mitral valve disorders above knee amputation status diabetes with renal manifestations, type ii or unspecified type, not stated as uncontrolled diabetes with peripheral circulatory disorders, type ii or unspecified type, not stated as uncontrolled percutaneous transluminal coronary angioplasty status ventral, unspecified, hernia without mention of obstruction or gangrene aortocoronary bypass status hypertensive chronic kidney disease, unspecified, with chronic kidney disease stage v or end stage renal disease peripheral angiopathy in diseases classified elsewhere other specified antibiotics causing adverse effects in therapeutic use cellulitis and abscess of leg, except foot long-term (current) use of insulin diabetes with peripheral circulatory disorders, type i [juvenile type], not stated as uncontrolled percutaneous transluminal coronary angioplasty status dermatitis due to drugs and medicines taken internally end stage renal disease diabetes with renal manifestations, type i [juvenile type], not stated as uncontrolled ulcer of other part of foot diabetes with ophthalmic manifestations, type i [juvenile type], not stated as uncontrolled iron deficiency anemia, unspecified hypertensive chronic kidney disease, unspecified, with chronic kidney disease stage v or end stage renal disease background diabetic retinopathy other toe(s) amputation status polyneuropathy in diabetes other suppurative peritonitis acute upper respiratory infections of unspecified site unspecified viral infection
white m 64 $nan$hematology blood hematocrit  26.1  %; hematology blood hematocrit  27.6  %; hematology blood hemoglobin  9.0  g dl; hematology blood hemoglobin  9.1  g dl; hematology blood platelet count  324  k ul; hematology blood platelet count  323  k ul; chemistry blood anion gap  19  meq l; chemistry blood anion gap  20  meq l; chemistry blood bicarbonate  24  meq l; chemistry blood bicarbonate  24  meq l; chemistry blood chloride  94  meq l; chemistry blood chloride  93  meq l; chemistry blood creatinine  4.7  mg dl; chemistry blood creatinine  3.8  mg dl; chemistry blood potassium  4.2  meq l; chemistry blood potassium  3.6  meq l; chemistry blood potassium  4.0  meq l; chemistry blood sodium  133  meq l; chemistry blood sodium  133  meq l; chemistry blood urea nitrogen  35  mg dl; chemistry blood urea nitrogen  26  mg dl; chemistry blood calcium, total  8.4  mg dl; chemistry blood calcium, total  8.6  mg dl; chemistry blood bilirubin, total  0.5  mg dl; chemistry blood glucose  158  mg dl; chemistry blood glucose  162  mg dl; blood gas blood free calcium  1.01  mmol l; blood gas blood free calcium  1.02  mmol l; blood gas blood free calcium  1.09  mmol l; blood gas blood free calcium  1.08  mmol l; blood gas blood free calcium  0.91  mmol l; blood gas blood lactate  2.2  mmol l; blood gas blood lactate  1.6  mmol l; blood gas blood lactate  3.2  mmol l; blood gas blood lactate  1.8  mmol l; blood gas blood lactate  1.7  mmol l; blood gas blood glucose  151  mg dl; blood gas blood glucose  99  mg dl; blood gas blood glucose  161  mg dl; blood gas blood glucose  132  mg dl; blood gas blood potassium, whole blood  4.2  meq l; blood gas blood potassium, whole blood  3.7  meq l; blood gas blood potassium, whole blood  3.5  meq l; blood gas blood potassium, whole blood  2.7  meq l$soln  50  ml ; fentanyl citrate  2.5  mg ; chlorhexidine gluconate 0.12% oral rinse  15  ml ; aspirin  300  mg ; sodium chloride 0.9%  flush  10  ml ; epinephrine  2  mg ; insulin human regular  100  unit ; calcium gluconate  2  g ; heparin  5000  unit ; bag  5000  ml ; prismasate (b32 k2)  5000  ml ; 5% dextrose  500  ml ; calcium gluconate  20  gm ; sw  100  ml ; potassium chloride  10  meq ; sw  50  ml ; potassium chloride  20-40  meq ; potassium chloride  40-60  meq ; potassium chloride  60  meq ; potassium phosphate  15  mmol ; potassium phosphate  15-30  mmol ; magnesium sulfate  4  gm ; magnesium sulfate  2-4  gm ; magnesium sulfate  2  gm ; sodium citrate 4%  3  ml ; citrate dextrose 3% (acd-a) crrt  1000  ml ; amiodarone  150  mg ; digoxin  0.125  mg ; midazolam  0.5-2  mg ; metoprolol tartrate  5  mg ; 
peripheral angiopathy in diseases classified elsewhere background diabetic retinopathy diabetes with peripheral circulatory disorders, type i [juvenile type], not stated as uncontrolled diabetes with neurological manifestations, type i [juvenile type], not stated as uncontrolled hypertensive chronic kidney disease, unspecified, with chronic kidney disease stage v or end stage renal disease polyneuropathy in diabetes congestive heart failure, unspecified aortocoronary bypass status personal history of tobacco use other toe(s) amputation status percutaneous transluminal coronary angioplasty status old myocardial infarction anemia in chronic kidney disease above knee amputation status diabetes with ophthalmic manifestations, type i [juvenile type], not stated as uncontrolled diabetes with renal manifestations, type i [juvenile type], not stated as uncontrolled end stage renal disease subendocardial infarction, initial episode of care end stage renal disease pure hypercholesterolemia peripheral angiopathy in diseases classified elsewhere mitral valve disorders above knee amputation status diabetes with renal manifestations, type ii or unspecified type, not stated as uncontrolled diabetes with peripheral circulatory disorders, type ii or unspecified type, not stated as uncontrolled percutaneous transluminal coronary angioplasty status ventral, unspecified, hernia without mention of obstruction or gangrene aortocoronary bypass status hypertensive chronic kidney disease, unspecified, with chronic kidney disease stage v or end stage renal disease peripheral angiopathy in diseases classified elsewhere other specified antibiotics causing adverse effects in therapeutic use cellulitis and abscess of leg, except foot long-term (current) use of insulin diabetes with peripheral circulatory disorders, type i [juvenile type], not stated as uncontrolled percutaneous transluminal coronary angioplasty status dermatitis due to drugs and medicines taken internally end stage renal disease diabetes with renal manifestations, type i [juvenile type], not stated as uncontrolled ulcer of other part of foot diabetes with ophthalmic manifestations, type i [juvenile type], not stated as uncontrolled iron deficiency anemia, unspecified hypertensive chronic kidney disease, unspecified, with chronic kidney disease stage v or end stage renal disease background diabetic retinopathy other toe(s) amputation status polyneuropathy in diabetes other suppurative peritonitis acute upper respiratory infections of unspecified site unspecified viral infection
white m 64 $nan$hematology blood hematocrit  28.3  %; hematology blood hemoglobin  9.3  g dl; hematology blood platelet count  349  k ul; chemistry blood anion gap  16  meq l; chemistry blood anion gap  12  meq l; chemistry blood bicarbonate  26  meq l; chemistry blood bicarbonate  27  meq l; chemistry blood chloride  95  meq l; chemistry blood chloride  97  meq l; chemistry blood creatinine  3.1  mg dl; chemistry blood creatinine  2.7  mg dl; chemistry blood potassium  3.9  meq l; chemistry blood potassium  4.2  meq l; chemistry blood sodium  133  meq l; chemistry blood sodium  132  meq l; chemistry blood urea nitrogen  23  mg dl; chemistry blood urea nitrogen  22  mg dl; hematology blood inr(pt)  1.4  ; chemistry blood calcium, total  9.5  mg dl; chemistry blood calcium, total  9.3  mg dl; chemistry blood bilirubin, total  0.7  mg dl; chemistry blood glucose  154  mg dl; chemistry blood glucose  133  mg dl; chemistry blood albumin  2.0  g dl; blood gas blood free calcium  1.13  mmol l; blood gas blood free calcium  1.13  mmol l; blood gas blood free calcium  1.01  mmol l; blood gas blood free calcium  1.05  mmol l; blood gas blood lactate  1.7  mmol l; blood gas blood lactate  1.5  mmol l; blood gas blood chloride, whole blood  100  meq l; blood gas blood glucose  153  mg dl; blood gas blood glucose  125  mg dl; blood gas blood potassium, whole blood  3.7  meq l; blood gas blood potassium, whole blood  3.2  meq l; blood gas blood sodium, whole blood  133  meq l$chlorhexidine gluconate 0.12% oral rinse  15  ml ; aspirin  300  mg ; sodium chloride 0.9%  flush  10  ml ; insulin human regular  100  unit ; calcium gluconate  2  g ; heparin  5000  unit ; bag  5000  ml ; prismasate (b32 k2)  5000  ml ; 5% dextrose  500  ml ; calcium gluconate  20  gm ; sw  100  ml ; potassium chloride  10  meq ; sw  50  ml ; potassium chloride  20-40  meq ; potassium chloride  40-60  meq ; potassium chloride  60  meq ; potassium phosphate  15  mmol ; potassium phosphate  15-30  mmol ; magnesium sulfate  4  gm ; magnesium sulfate  2-4  gm ; magnesium sulfate  2  gm ; citrate dextrose 3% (acd-a) crrt  1000  ml ; midazolam  0.5-2  mg ; metoprolol tartrate  5  mg ; propofol  1000  mg ; propofol  200  mg ; prismasate (b22 k4)  5000  ml ; vancomycin  1250  mg ; digoxin  0.5  mg ; meropenem  1000  mg ; 
peripheral angiopathy in diseases classified elsewhere background diabetic retinopathy diabetes with peripheral circulatory disorders, type i [juvenile type], not stated as uncontrolled diabetes with neurological manifestations, type i [juvenile type], not stated as uncontrolled hypertensive chronic kidney disease, unspecified, with chronic kidney disease stage v or end stage renal disease polyneuropathy in diabetes congestive heart failure, unspecified aortocoronary bypass status personal history of tobacco use other toe(s) amputation status percutaneous transluminal coronary angioplasty status old myocardial infarction anemia in chronic kidney disease above knee amputation status diabetes with ophthalmic manifestations, type i [juvenile type], not stated as uncontrolled diabetes with renal manifestations, type i [juvenile type], not stated as uncontrolled end stage renal disease subendocardial infarction, initial episode of care end stage renal disease pure hypercholesterolemia peripheral angiopathy in diseases classified elsewhere mitral valve disorders above knee amputation status diabetes with renal manifestations, type ii or unspecified type, not stated as uncontrolled diabetes with peripheral circulatory disorders, type ii or unspecified type, not stated as uncontrolled percutaneous transluminal coronary angioplasty status ventral, unspecified, hernia without mention of obstruction or gangrene aortocoronary bypass status hypertensive chronic kidney disease, unspecified, with chronic kidney disease stage v or end stage renal disease peripheral angiopathy in diseases classified elsewhere other specified antibiotics causing adverse effects in therapeutic use cellulitis and abscess of leg, except foot long-term (current) use of insulin diabetes with peripheral circulatory disorders, type i [juvenile type], not stated as uncontrolled percutaneous transluminal coronary angioplasty status dermatitis due to drugs and medicines taken internally end stage renal disease diabetes with renal manifestations, type i [juvenile type], not stated as uncontrolled ulcer of other part of foot diabetes with ophthalmic manifestations, type i [juvenile type], not stated as uncontrolled iron deficiency anemia, unspecified hypertensive chronic kidney disease, unspecified, with chronic kidney disease stage v or end stage renal disease background diabetic retinopathy other toe(s) amputation status polyneuropathy in diabetes other suppurative peritonitis acute upper respiratory infections of unspecified site unspecified viral infection
white m 64 $nan$hematology blood hematocrit  28.3  %; hematology blood hematocrit  28.5  %; hematology blood hemoglobin  9.0  g dl; hematology blood hemoglobin  8.8  g dl; hematology blood platelet count  327  k ul; hematology blood platelet count  300  k ul; chemistry blood anion gap  13  meq l; chemistry blood anion gap  19  meq l; chemistry blood bicarbonate  24  meq l; chemistry blood bicarbonate  19  meq l; chemistry blood chloride  101  meq l; chemistry blood chloride  100  meq l; chemistry blood creatinine  2.8  mg dl; chemistry blood creatinine  3.8  mg dl; chemistry blood potassium  4.2  meq l; chemistry blood potassium  5.2  meq l; chemistry blood sodium  134  meq l; chemistry blood sodium  133  meq l; chemistry blood urea nitrogen  23  mg dl; chemistry blood urea nitrogen  34  mg dl; hematology blood inr(pt)  1.1  ; chemistry blood calcium, total  8.8  mg dl; chemistry blood calcium, total  8.9  mg dl; chemistry blood bilirubin, total  0.9  mg dl; chemistry blood bilirubin, total  1.2  mg dl; chemistry blood glucose  242  mg dl; chemistry blood glucose  177  mg dl; chemistry blood albumin  2.0  g dl; blood gas blood free calcium  1.19  mmol l; blood gas blood free calcium  1.31  mmol l; blood gas blood free calcium  1.23  mmol l; blood gas blood lactate  1.1  mmol l; blood gas blood lactate  1.4  mmol l; blood gas blood lactate  1.0  mmol l; blood gas blood chloride, whole blood  96  meq l; blood gas blood chloride, whole blood  98  meq l; blood gas blood chloride, whole blood  104  meq l; blood gas blood glucose  174  mg dl; blood gas blood glucose  179  mg dl; blood gas blood glucose  100  mg dl; blood gas blood potassium, whole blood  4.1  meq l; blood gas blood potassium, whole blood  4.1  meq l; blood gas blood potassium, whole blood  3.9  meq l; blood gas blood sodium, whole blood  131  meq l; blood gas blood sodium, whole blood  131  meq l; blood gas blood sodium, whole blood  135  meq l$chlorhexidine gluconate 0.12% oral rinse  15  ml ; aspirin  300  mg ; sodium chloride 0.9%  flush  10  ml ; insulin human regular  100  unit ; calcium gluconate  2  g ; heparin  5000  unit ; 5% dextrose  500  ml ; calcium gluconate  20  gm ; sw  100  ml ; potassium chloride  10  meq ; sw  50  ml ; potassium chloride  20-40  meq ; potassium chloride  40-60  meq ; potassium chloride  60  meq ; potassium phosphate  15  mmol ; potassium phosphate  15-30  mmol ; magnesium sulfate  4  gm ; magnesium sulfate  2-4  gm ; magnesium sulfate  2  gm ; citrate dextrose 3% (acd-a) crrt  1000  ml ; midazolam  0.5-2  mg ; propofol  1000  mg ; propofol  200  mg ; vancomycin  1250  mg ; digoxin  0.5  mg ; meropenem  1000  mg ; meropenem  500  mg ; syringe (0.9% sodium chloride)  1  ml ; alteplase (catheter clearance)  1  mg ; syringe (0.9% sodium chloride)  1.2  ml ; syringe (0.9% sodium chloride)  1.3  ml ; 
peripheral angiopathy in diseases classified elsewhere background diabetic retinopathy diabetes with peripheral circulatory disorders, type i [juvenile type], not stated as uncontrolled diabetes with neurological manifestations, type i [juvenile type], not stated as uncontrolled hypertensive chronic kidney disease, unspecified, with chronic kidney disease stage v or end stage renal disease polyneuropathy in diabetes congestive heart failure, unspecified aortocoronary bypass status personal history of tobacco use other toe(s) amputation status percutaneous transluminal coronary angioplasty status old myocardial infarction anemia in chronic kidney disease above knee amputation status diabetes with ophthalmic manifestations, type i [juvenile type], not stated as uncontrolled diabetes with renal manifestations, type i [juvenile type], not stated as uncontrolled end stage renal disease subendocardial infarction, initial episode of care end stage renal disease pure hypercholesterolemia peripheral angiopathy in diseases classified elsewhere mitral valve disorders above knee amputation status diabetes with renal manifestations, type ii or unspecified type, not stated as uncontrolled diabetes with peripheral circulatory disorders, type ii or unspecified type, not stated as uncontrolled percutaneous transluminal coronary angioplasty status ventral, unspecified, hernia without mention of obstruction or gangrene aortocoronary bypass status hypertensive chronic kidney disease, unspecified, with chronic kidney disease stage v or end stage renal disease peripheral angiopathy in diseases classified elsewhere other specified antibiotics causing adverse effects in therapeutic use cellulitis and abscess of leg, except foot long-term (current) use of insulin diabetes with peripheral circulatory disorders, type i [juvenile type], not stated as uncontrolled percutaneous transluminal coronary angioplasty status dermatitis due to drugs and medicines taken internally end stage renal disease diabetes with renal manifestations, type i [juvenile type], not stated as uncontrolled ulcer of other part of foot diabetes with ophthalmic manifestations, type i [juvenile type], not stated as uncontrolled iron deficiency anemia, unspecified hypertensive chronic kidney disease, unspecified, with chronic kidney disease stage v or end stage renal disease background diabetic retinopathy other toe(s) amputation status polyneuropathy in diabetes other suppurative peritonitis acute upper respiratory infections of unspecified site unspecified viral infection
white m 64 $nan$hematology blood hematocrit  27.1  %; hematology blood hemoglobin  8.8  g dl; hematology blood platelet count  311  k ul; chemistry blood anion gap  17  meq l; chemistry blood anion gap  16  meq l; chemistry blood bicarbonate  18  meq l; chemistry blood bicarbonate  20  meq l; chemistry blood chloride  104  meq l; chemistry blood chloride  105  meq l; chemistry blood creatinine  3.6  mg dl; chemistry blood creatinine  3.3  mg dl; chemistry blood potassium  4.3  meq l; chemistry blood potassium  4.4  meq l; chemistry blood sodium  135  meq l; chemistry blood sodium  137  meq l; chemistry blood urea nitrogen  36  mg dl; chemistry blood urea nitrogen  35  mg dl; hematology urine wbc  0-2  # hpf; chemistry blood calcium, total  8.8  mg dl; chemistry blood calcium, total  8.2  mg dl; chemistry blood bilirubin, total  1.0  mg dl; chemistry blood glucose  142  mg dl; chemistry blood glucose  182  mg dl; blood gas blood free calcium  1.28  mmol l; blood gas blood free calcium  1.19  mmol l; blood gas blood free calcium  1.12  mmol l; blood gas blood free calcium  1.11  mmol l; blood gas blood lactate  1.8  mmol l; blood gas blood lactate  1.3  mmol l; blood gas blood lactate  1.4  mmol l; blood gas blood chloride, whole blood  102  meq l; blood gas blood glucose  224  mg dl; blood gas blood glucose  182  mg dl; blood gas blood glucose  136  mg dl; blood gas blood glucose  136  mg dl; blood gas blood glucose  111  mg dl; blood gas blood potassium, whole blood  4.4  meq l; blood gas blood potassium, whole blood  4.1  meq l; blood gas blood potassium, whole blood  4.0  meq l; blood gas blood potassium, whole blood  3.9  meq l; blood gas blood sodium, whole blood  131  meq l; hematology urine glucose  tr  mg dl; hematology urine bilirubin  neg  mg dl$chlorhexidine gluconate 0.12% oral rinse  15  ml ; aspirin  300  mg ; sodium chloride 0.9%  flush  10  ml ; insulin human regular  100  unit ; calcium gluconate  2  g ; heparin  5000  unit ; 5% dextrose  500  ml ; calcium gluconate  20  gm ; sw  100  ml ; potassium chloride  10  meq ; sw  50  ml ; potassium chloride  20-40  meq ; potassium chloride  40-60  meq ; potassium chloride  60  meq ; potassium phosphate  15  mmol ; potassium phosphate  15-30  mmol ; magnesium sulfate  4  gm ; magnesium sulfate  2-4  gm ; magnesium sulfate  2  gm ; citrate dextrose 3% (acd-a) crrt  1000  ml ; midazolam  0.5-2  mg ; propofol  1000  mg ; propofol  200  mg ; vancomycin  1250  mg ; meropenem  500  mg ; syringe (0.9% sodium chloride)  1  ml ; alteplase (catheter clearance)  1  mg ; syringe (0.9% sodium chloride)  1.2  ml ; syringe (0.9% sodium chloride)  1.3  ml ; sodium citrate 4%  2.5  ml ; 
peripheral angiopathy in diseases classified elsewhere background diabetic retinopathy diabetes with peripheral circulatory disorders, type i [juvenile type], not stated as uncontrolled diabetes with neurological manifestations, type i [juvenile type], not stated as uncontrolled hypertensive chronic kidney disease, unspecified, with chronic kidney disease stage v or end stage renal disease polyneuropathy in diabetes congestive heart failure, unspecified aortocoronary bypass status personal history of tobacco use other toe(s) amputation status percutaneous transluminal coronary angioplasty status old myocardial infarction anemia in chronic kidney disease above knee amputation status diabetes with ophthalmic manifestations, type i [juvenile type], not stated as uncontrolled diabetes with renal manifestations, type i [juvenile type], not stated as uncontrolled end stage renal disease subendocardial infarction, initial episode of care end stage renal disease pure hypercholesterolemia peripheral angiopathy in diseases classified elsewhere mitral valve disorders above knee amputation status diabetes with renal manifestations, type ii or unspecified type, not stated as uncontrolled diabetes with peripheral circulatory disorders, type ii or unspecified type, not stated as uncontrolled percutaneous transluminal coronary angioplasty status ventral, unspecified, hernia without mention of obstruction or gangrene aortocoronary bypass status hypertensive chronic kidney disease, unspecified, with chronic kidney disease stage v or end stage renal disease peripheral angiopathy in diseases classified elsewhere other specified antibiotics causing adverse effects in therapeutic use cellulitis and abscess of leg, except foot long-term (current) use of insulin diabetes with peripheral circulatory disorders, type i [juvenile type], not stated as uncontrolled percutaneous transluminal coronary angioplasty status dermatitis due to drugs and medicines taken internally end stage renal disease diabetes with renal manifestations, type i [juvenile type], not stated as uncontrolled ulcer of other part of foot diabetes with ophthalmic manifestations, type i [juvenile type], not stated as uncontrolled iron deficiency anemia, unspecified hypertensive chronic kidney disease, unspecified, with chronic kidney disease stage v or end stage renal disease background diabetic retinopathy other toe(s) amputation status polyneuropathy in diabetes other suppurative peritonitis acute upper respiratory infections of unspecified site unspecified viral infection
white m 64 $nan$hematology blood hematocrit  26.2  %; hematology blood hematocrit  25.9  %; hematology blood hemoglobin  8.2  g dl; hematology blood hemoglobin  8.7  g dl; hematology blood platelet count  259  k ul; hematology blood platelet count  295  k ul; chemistry blood anion gap  16  meq l; chemistry blood anion gap  19  meq l; chemistry blood bicarbonate  22  meq l; chemistry blood bicarbonate  20  meq l; chemistry blood chloride  101  meq l; chemistry blood chloride  100  meq l; chemistry blood creatinine  2.7  mg dl; chemistry blood creatinine  2.4  mg dl; chemistry blood creatinine  2.2  mg dl; chemistry blood potassium  4.2  meq l; chemistry blood potassium  4.2  meq l; chemistry blood potassium  4.3  meq l; chemistry blood sodium  135  meq l; chemistry blood sodium  135  meq l; chemistry blood urea nitrogen  33  mg dl; chemistry blood urea nitrogen  31  mg dl; chemistry blood urea nitrogen  31  mg dl; chemistry blood calcium, total  8.9  mg dl; chemistry blood calcium, total  8.5  mg dl; chemistry blood bilirubin, total  1.0  mg dl; chemistry blood glucose  138  mg dl; chemistry blood glucose  144  mg dl; chemistry blood glucose  99  mg dl; blood gas blood free calcium  1.14  mmol l; blood gas blood free calcium  1.15  mmol l; blood gas blood free calcium  1.07  mmol l; blood gas blood free calcium  1.12  mmol l; blood gas blood lactate  1.6  mmol l; blood gas blood lactate  1.5  mmol l; blood gas blood lactate  1.4  mmol l; blood gas blood lactate  1.6  mmol l; blood gas blood glucose  137  mg dl; blood gas blood glucose  151  mg dl; blood gas blood glucose  139  mg dl; blood gas blood potassium, whole blood  3.8  meq l; blood gas blood potassium, whole blood  4.1  meq l$chlorhexidine gluconate 0.12% oral rinse  15  ml ; aspirin  300  mg ; sodium chloride 0.9%  flush  10  ml ; insulin human regular  100  unit ; calcium gluconate  2  g ; heparin  5000  unit ; 5% dextrose  500  ml ; calcium gluconate  20  gm ; sw  100  ml ; potassium chloride  10  meq ; sw  50  ml ; potassium chloride  20-40  meq ; potassium chloride  40-60  meq ; potassium chloride  60  meq ; potassium phosphate  15  mmol ; potassium phosphate  15-30  mmol ; magnesium sulfate  4  gm ; magnesium sulfate  2-4  gm ; magnesium sulfate  2  gm ; citrate dextrose 3% (acd-a) crrt  1000  ml ; midazolam  0.5-2  mg ; propofol  1000  mg ; propofol  200  mg ; vancomycin  1250  mg ; meropenem  500  mg ; amiodarone  400  mg ; 
peripheral angiopathy in diseases classified elsewhere background diabetic retinopathy diabetes with peripheral circulatory disorders, type i [juvenile type], not stated as uncontrolled diabetes with neurological manifestations, type i [juvenile type], not stated as uncontrolled hypertensive chronic kidney disease, unspecified, with chronic kidney disease stage v or end stage renal disease polyneuropathy in diabetes congestive heart failure, unspecified aortocoronary bypass status personal history of tobacco use other toe(s) amputation status percutaneous transluminal coronary angioplasty status old myocardial infarction anemia in chronic kidney disease above knee amputation status diabetes with ophthalmic manifestations, type i [juvenile type], not stated as uncontrolled diabetes with renal manifestations, type i [juvenile type], not stated as uncontrolled end stage renal disease subendocardial infarction, initial episode of care end stage renal disease pure hypercholesterolemia peripheral angiopathy in diseases classified elsewhere mitral valve disorders above knee amputation status diabetes with renal manifestations, type ii or unspecified type, not stated as uncontrolled diabetes with peripheral circulatory disorders, type ii or unspecified type, not stated as uncontrolled percutaneous transluminal coronary angioplasty status ventral, unspecified, hernia without mention of obstruction or gangrene aortocoronary bypass status hypertensive chronic kidney disease, unspecified, with chronic kidney disease stage v or end stage renal disease peripheral angiopathy in diseases classified elsewhere other specified antibiotics causing adverse effects in therapeutic use cellulitis and abscess of leg, except foot long-term (current) use of insulin diabetes with peripheral circulatory disorders, type i [juvenile type], not stated as uncontrolled percutaneous transluminal coronary angioplasty status dermatitis due to drugs and medicines taken internally end stage renal disease diabetes with renal manifestations, type i [juvenile type], not stated as uncontrolled ulcer of other part of foot diabetes with ophthalmic manifestations, type i [juvenile type], not stated as uncontrolled iron deficiency anemia, unspecified hypertensive chronic kidney disease, unspecified, with chronic kidney disease stage v or end stage renal disease background diabetic retinopathy other toe(s) amputation status polyneuropathy in diabetes other suppurative peritonitis acute upper respiratory infections of unspecified site unspecified viral infection
white m 64 $nan$hematology blood hematocrit  25.9  %; hematology blood hemoglobin  8.2  g dl; hematology blood platelet count  337  k ul; chemistry blood anion gap  17  meq l; chemistry blood anion gap  17  meq l; chemistry blood bicarbonate  21  meq l; chemistry blood bicarbonate  22  meq l; chemistry blood chloride  100  meq l; chemistry blood chloride  99  meq l; chemistry blood creatinine  1.9  mg dl; chemistry blood creatinine  1.8  mg dl; chemistry blood potassium  4.3  meq l; chemistry blood potassium  4.1  meq l; chemistry blood sodium  134  meq l; chemistry blood sodium  134  meq l; chemistry blood urea nitrogen  29  mg dl; chemistry blood urea nitrogen  28  mg dl; hematology blood inr(pt)  1.0  ; chemistry blood calcium, total  8.5  mg dl; chemistry blood calcium, total  8.4  mg dl; chemistry blood bilirubin, total  0.9  mg dl; chemistry blood glucose  134  mg dl; chemistry blood glucose  89  mg dl; chemistry blood albumin  2.2  g dl; blood gas blood free calcium  1.11  mmol l; blood gas blood free calcium  1.12  mmol l; blood gas blood free calcium  1.12  mmol l; blood gas blood free calcium  1.14  mmol l; blood gas blood free calcium  1.12  mmol l; blood gas blood lactate  1.5  mmol l; blood gas blood lactate  1.4  mmol l; blood gas blood lactate  1.3  mmol l; blood gas blood lactate  1.3  mmol l; blood gas blood lactate  1.2  mmol l; blood gas blood glucose  110  mg dl; blood gas blood glucose  145  mg dl; blood gas blood glucose  132  mg dl; blood gas blood glucose  128  mg dl; blood gas blood potassium, whole blood  4.1  meq l; blood gas blood potassium, whole blood  4.0  meq l; blood gas blood potassium, whole blood  3.8  meq l; blood gas blood potassium, whole blood  3.8  meq l$chlorhexidine gluconate 0.12% oral rinse  15  ml ; sodium chloride 0.9%  flush  10  ml ; insulin human regular  100  unit ; calcium gluconate  2  g ; heparin  5000  unit ; 5% dextrose  500  ml ; calcium gluconate  20  gm ; sw  100  ml ; potassium chloride  10  meq ; sw  50  ml ; potassium chloride  20-40  meq ; potassium chloride  40-60  meq ; potassium chloride  60  meq ; potassium phosphate  15  mmol ; potassium phosphate  15-30  mmol ; magnesium sulfate  4  gm ; magnesium sulfate  2-4  gm ; magnesium sulfate  2  gm ; citrate dextrose 3% (acd-a) crrt  1000  ml ; midazolam  0.5-2  mg ; propofol  1000  mg ; propofol  200  mg ; vancomycin  1250  mg ; meropenem  500  mg ; amiodarone  400  mg ; hydromorphone (dilaudid)  2-4  mg ; 
peripheral angiopathy in diseases classified elsewhere background diabetic retinopathy diabetes with peripheral circulatory disorders, type i [juvenile type], not stated as uncontrolled diabetes with neurological manifestations, type i [juvenile type], not stated as uncontrolled hypertensive chronic kidney disease, unspecified, with chronic kidney disease stage v or end stage renal disease polyneuropathy in diabetes congestive heart failure, unspecified aortocoronary bypass status personal history of tobacco use other toe(s) amputation status percutaneous transluminal coronary angioplasty status old myocardial infarction anemia in chronic kidney disease above knee amputation status diabetes with ophthalmic manifestations, type i [juvenile type], not stated as uncontrolled diabetes with renal manifestations, type i [juvenile type], not stated as uncontrolled end stage renal disease subendocardial infarction, initial episode of care end stage renal disease pure hypercholesterolemia peripheral angiopathy in diseases classified elsewhere mitral valve disorders above knee amputation status diabetes with renal manifestations, type ii or unspecified type, not stated as uncontrolled diabetes with peripheral circulatory disorders, type ii or unspecified type, not stated as uncontrolled percutaneous transluminal coronary angioplasty status ventral, unspecified, hernia without mention of obstruction or gangrene aortocoronary bypass status hypertensive chronic kidney disease, unspecified, with chronic kidney disease stage v or end stage renal disease peripheral angiopathy in diseases classified elsewhere other specified antibiotics causing adverse effects in therapeutic use cellulitis and abscess of leg, except foot long-term (current) use of insulin diabetes with peripheral circulatory disorders, type i [juvenile type], not stated as uncontrolled percutaneous transluminal coronary angioplasty status dermatitis due to drugs and medicines taken internally end stage renal disease diabetes with renal manifestations, type i [juvenile type], not stated as uncontrolled ulcer of other part of foot diabetes with ophthalmic manifestations, type i [juvenile type], not stated as uncontrolled iron deficiency anemia, unspecified hypertensive chronic kidney disease, unspecified, with chronic kidney disease stage v or end stage renal disease background diabetic retinopathy other toe(s) amputation status polyneuropathy in diabetes other suppurative peritonitis acute upper respiratory infections of unspecified site unspecified viral infection
white m 64 $nan$hematology blood hematocrit  25.1  %; hematology blood hematocrit  25.5  %; hematology blood hemoglobin  8.3  g dl; hematology blood hemoglobin  8.4  g dl; hematology blood platelet count  414  k ul; hematology blood platelet count  361  k ul; chemistry blood anion gap  17  meq l; chemistry blood anion gap  17  meq l; chemistry blood bicarbonate  22  meq l; chemistry blood bicarbonate  20  meq l; chemistry blood chloride  100  meq l; chemistry blood chloride  99  meq l; chemistry blood creatinine  1.7  mg dl; chemistry blood creatinine  1.6  mg dl; chemistry blood potassium  4.7  meq l; chemistry blood potassium  4.1  meq l; chemistry blood sodium  134  meq l; chemistry blood sodium  132  meq l; chemistry blood urea nitrogen  28  mg dl; chemistry blood urea nitrogen  27  mg dl; hematology blood inr(pt)  1.0  ; hematology urine wbc  3-5  # hpf; chemistry blood calcium, total  8.9  mg dl; chemistry blood calcium, total  8.5  mg dl; chemistry blood bilirubin, total  0.9  mg dl; chemistry blood glucose  143  mg dl; chemistry blood glucose  150  mg dl; chemistry blood albumin  2.2  g dl; hematology blood bands  10  %; blood gas blood free calcium  1.12  mmol l; blood gas blood free calcium  1.15  mmol l; blood gas blood free calcium  1.15  mmol l; blood gas blood free calcium  1.01  mmol l; blood gas blood lactate  1.3  mmol l; blood gas blood lactate  1.3  mmol l; blood gas blood lactate  1.6  mmol l; blood gas blood lactate  1.7  mmol l; blood gas blood glucose  144  mg dl; blood gas blood glucose  154  mg dl; blood gas blood glucose  100  mg dl; blood gas blood potassium, whole blood  4.0  meq l; blood gas blood potassium, whole blood  4.3  meq l; blood gas blood potassium, whole blood  4.0  meq l; blood gas blood potassium, whole blood  3.3  meq l; hematology urine glucose  tr  mg dl; hematology urine bilirubin  neg  mg dl$chlorhexidine gluconate 0.12% oral rinse  15  ml ; sodium chloride 0.9%  flush  10  ml ; insulin human regular  100  unit ; calcium gluconate  2  g ; heparin  5000  unit ; 5% dextrose  500  ml ; calcium gluconate  20  gm ; sw  100  ml ; potassium chloride  10  meq ; sw  50  ml ; potassium chloride  20-40  meq ; potassium chloride  40-60  meq ; potassium chloride  60  meq ; potassium phosphate  15  mmol ; potassium phosphate  15-30  mmol ; magnesium sulfate  4  gm ; magnesium sulfate  2-4  gm ; magnesium sulfate  2  gm ; citrate dextrose 3% (acd-a) crrt  1000  ml ; midazolam  0.5-2  mg ; propofol  1000  mg ; propofol  200  mg ; vancomycin  1250  mg ; amiodarone  400  mg ; hydromorphone (dilaudid)  2-4  mg ; metoclopramide  10  mg ; hydromorphone (dilaudid)  0.5-1  mg ; 0.9% sodium chloride  50  ml ; dexmedetomidine  0.2  mg ; 
peripheral angiopathy in diseases classified elsewhere background diabetic retinopathy diabetes with peripheral circulatory disorders, type i [juvenile type], not stated as uncontrolled diabetes with neurological manifestations, type i [juvenile type], not stated as uncontrolled hypertensive chronic kidney disease, unspecified, with chronic kidney disease stage v or end stage renal disease polyneuropathy in diabetes congestive heart failure, unspecified aortocoronary bypass status personal history of tobacco use other toe(s) amputation status percutaneous transluminal coronary angioplasty status old myocardial infarction anemia in chronic kidney disease above knee amputation status diabetes with ophthalmic manifestations, type i [juvenile type], not stated as uncontrolled diabetes with renal manifestations, type i [juvenile type], not stated as uncontrolled end stage renal disease subendocardial infarction, initial episode of care end stage renal disease pure hypercholesterolemia peripheral angiopathy in diseases classified elsewhere mitral valve disorders above knee amputation status diabetes with renal manifestations, type ii or unspecified type, not stated as uncontrolled diabetes with peripheral circulatory disorders, type ii or unspecified type, not stated as uncontrolled percutaneous transluminal coronary angioplasty status ventral, unspecified, hernia without mention of obstruction or gangrene aortocoronary bypass status hypertensive chronic kidney disease, unspecified, with chronic kidney disease stage v or end stage renal disease peripheral angiopathy in diseases classified elsewhere other specified antibiotics causing adverse effects in therapeutic use cellulitis and abscess of leg, except foot long-term (current) use of insulin diabetes with peripheral circulatory disorders, type i [juvenile type], not stated as uncontrolled percutaneous transluminal coronary angioplasty status dermatitis due to drugs and medicines taken internally end stage renal disease diabetes with renal manifestations, type i [juvenile type], not stated as uncontrolled ulcer of other part of foot diabetes with ophthalmic manifestations, type i [juvenile type], not stated as uncontrolled iron deficiency anemia, unspecified hypertensive chronic kidney disease, unspecified, with chronic kidney disease stage v or end stage renal disease background diabetic retinopathy other toe(s) amputation status polyneuropathy in diabetes other suppurative peritonitis acute upper respiratory infections of unspecified site unspecified viral infection
white m 64 $nan$hematology blood hematocrit  30.3  %; hematology blood hematocrit  28.9  %; hematology blood hematocrit  29.2  %; hematology blood hemoglobin  9.4  g dl; hematology blood hemoglobin  9.5  g dl; hematology blood platelet count  399  k ul; hematology blood platelet count  417  k ul; chemistry blood anion gap  16  meq l; chemistry blood anion gap  14  meq l; chemistry blood bicarbonate  22  meq l; chemistry blood bicarbonate  22  meq l; chemistry blood chloride  100  meq l; chemistry blood chloride  100  meq l; chemistry blood creatinine  1.8  mg dl; chemistry blood creatinine  1.6  mg dl; chemistry blood potassium  4.2  meq l; chemistry blood potassium  3.9  meq l; chemistry blood sodium  134  meq l; chemistry blood sodium  132  meq l; chemistry blood urea nitrogen  29  mg dl; chemistry blood urea nitrogen  30  mg dl; chemistry blood calcium, total  9.1  mg dl; chemistry blood calcium, total  8.8  mg dl; chemistry blood bilirubin, total  1.2  mg dl; chemistry blood glucose  170  mg dl; chemistry blood glucose  110  mg dl; blood gas blood free calcium  1.14  mmol l; blood gas blood free calcium  1.14  mmol l; blood gas blood free calcium  1.19  mmol l; blood gas blood free calcium  1.18  mmol l; blood gas blood free calcium  1.20  mmol l; blood gas blood lactate  2.7  mmol l; blood gas blood lactate  1.3  mmol l; blood gas blood lactate  1.2  mmol l; blood gas blood lactate  1.4  mmol l; blood gas blood lactate  1.6  mmol l; blood gas blood glucose  121  mg dl; blood gas blood glucose  107  mg dl; blood gas blood glucose  138  mg dl; blood gas blood glucose  170  mg dl; blood gas blood glucose  126  mg dl; blood gas blood potassium, whole blood  3.9  meq l; blood gas blood potassium, whole blood  3.8  meq l; blood gas blood potassium, whole blood  3.7  meq l; blood gas blood potassium, whole blood  4.0  meq l; blood gas blood potassium, whole blood  3.6  meq l$chlorhexidine gluconate 0.12% oral rinse  15  ml ; sodium chloride 0.9%  flush  10  ml ; insulin human regular  100  unit ; calcium gluconate  2  g ; heparin  5000  unit ; 5% dextrose  500  ml ; calcium gluconate  20  gm ; sw  100  ml ; potassium chloride  10  meq ; sw  50  ml ; potassium chloride  20-40  meq ; potassium chloride  40-60  meq ; potassium chloride  60  meq ; potassium phosphate  15  mmol ; potassium phosphate  15-30  mmol ; magnesium sulfate  4  gm ; magnesium sulfate  2-4  gm ; magnesium sulfate  2  gm ; citrate dextrose 3% (acd-a) crrt  1000  ml ; midazolam  0.5-2  mg ; vancomycin  1250  mg ; amiodarone  400  mg ; hydromorphone (dilaudid)  2-4  mg ; hydromorphone (dilaudid)  0.5-1  mg ; 0.9% sodium chloride  50  ml ; dexmedetomidine  0.2  mg ; vial  1  vial ; epoetin alfa  4000  unit ; ferrous sulfate  325  mg ; 
peripheral angiopathy in diseases classified elsewhere background diabetic retinopathy diabetes with peripheral circulatory disorders, type i [juvenile type], not stated as uncontrolled diabetes with neurological manifestations, type i [juvenile type], not stated as uncontrolled hypertensive chronic kidney disease, unspecified, with chronic kidney disease stage v or end stage renal disease polyneuropathy in diabetes congestive heart failure, unspecified aortocoronary bypass status personal history of tobacco use other toe(s) amputation status percutaneous transluminal coronary angioplasty status old myocardial infarction anemia in chronic kidney disease above knee amputation status diabetes with ophthalmic manifestations, type i [juvenile type], not stated as uncontrolled diabetes with renal manifestations, type i [juvenile type], not stated as uncontrolled end stage renal disease subendocardial infarction, initial episode of care end stage renal disease pure hypercholesterolemia peripheral angiopathy in diseases classified elsewhere mitral valve disorders above knee amputation status diabetes with renal manifestations, type ii or unspecified type, not stated as uncontrolled diabetes with peripheral circulatory disorders, type ii or unspecified type, not stated as uncontrolled percutaneous transluminal coronary angioplasty status ventral, unspecified, hernia without mention of obstruction or gangrene aortocoronary bypass status hypertensive chronic kidney disease, unspecified, with chronic kidney disease stage v or end stage renal disease peripheral angiopathy in diseases classified elsewhere other specified antibiotics causing adverse effects in therapeutic use cellulitis and abscess of leg, except foot long-term (current) use of insulin diabetes with peripheral circulatory disorders, type i [juvenile type], not stated as uncontrolled percutaneous transluminal coronary angioplasty status dermatitis due to drugs and medicines taken internally end stage renal disease diabetes with renal manifestations, type i [juvenile type], not stated as uncontrolled ulcer of other part of foot diabetes with ophthalmic manifestations, type i [juvenile type], not stated as uncontrolled iron deficiency anemia, unspecified hypertensive chronic kidney disease, unspecified, with chronic kidney disease stage v or end stage renal disease background diabetic retinopathy other toe(s) amputation status polyneuropathy in diabetes other suppurative peritonitis acute upper respiratory infections of unspecified site unspecified viral infection
white m 64 $nan$hematology blood hematocrit  28.3  %; hematology blood hematocrit  26.4  %; hematology blood hemoglobin  9.3  g dl; hematology blood hemoglobin  8.5  g dl; hematology blood platelet count  459  k ul; hematology blood platelet count  427  k ul; chemistry blood anion gap  16  meq l; chemistry blood anion gap  15  meq l; chemistry blood bicarbonate  21  meq l; chemistry blood bicarbonate  20  meq l; chemistry blood chloride  100  meq l; chemistry blood chloride  102  meq l; chemistry blood creatinine  1.9  mg dl; chemistry blood creatinine  2.7  mg dl; chemistry blood potassium  4.5  meq l; chemistry blood potassium  4.2  meq l; chemistry blood sodium  132  meq l; chemistry blood sodium  133  meq l; chemistry blood urea nitrogen  39  mg dl; chemistry blood urea nitrogen  53  mg dl; hematology blood inr(pt)  1.0  ; hematology urine wbc  3-5  # hpf; chemistry blood calcium, total  9.2  mg dl; chemistry blood calcium, total  9.1  mg dl; chemistry blood bilirubin, total  0.6  mg dl; chemistry blood glucose  145  mg dl; chemistry blood glucose  71  mg dl; blood gas blood free calcium  1.28  mmol l; blood gas blood free calcium  1.30  mmol l; blood gas blood free calcium  1.28  mmol l; blood gas blood lactate  1.3  mmol l; blood gas blood lactate  1.1  mmol l; blood gas blood lactate  1.0  mmol l; blood gas blood glucose  143  mg dl; blood gas blood glucose  117  mg dl; blood gas blood glucose  69  mg dl; blood gas blood potassium, whole blood  4.2  meq l; blood gas blood potassium, whole blood  4.1  meq l; blood gas blood potassium, whole blood  4.0  meq l; hematology urine glucose  neg  mg dl; hematology urine bilirubin  sm  mg dl$chlorhexidine gluconate 0.12% oral rinse  15  ml ; sodium chloride 0.9%  flush  10  ml ; insulin human regular  100  unit ; calcium gluconate  2  g ; heparin  5000  unit ; 5% dextrose  500  ml ; calcium gluconate  20  gm ; sw  100  ml ; potassium chloride  10  meq ; sw  50  ml ; potassium chloride  20-40  meq ; potassium chloride  40-60  meq ; potassium chloride  60  meq ; potassium phosphate  15  mmol ; potassium phosphate  15-30  mmol ; magnesium sulfate  4  gm ; magnesium sulfate  2-4  gm ; magnesium sulfate  2  gm ; citrate dextrose 3% (acd-a) crrt  1000  ml ; midazolam  0.5-2  mg ; vancomycin  1250  mg ; amiodarone  400  mg ; hydromorphone (dilaudid)  2-4  mg ; hydromorphone (dilaudid)  0.5-1  mg ; vial  1  vial ; epoetin alfa  4000  unit ; ferrous sulfate  325  mg ; syringe (0.9% sodium chloride)  2.5  ml ; olanzapine (disintegrating tablet)  2.5  mg ; propofol  20  mg ; heparin flush (1000 units ml)  4000-11000  unit ; olanzapine (disintegrating tablet)  5  mg ; 
peripheral angiopathy in diseases classified elsewhere background diabetic retinopathy diabetes with peripheral circulatory disorders, type i [juvenile type], not stated as uncontrolled diabetes with neurological manifestations, type i [juvenile type], not stated as uncontrolled hypertensive chronic kidney disease, unspecified, with chronic kidney disease stage v or end stage renal disease polyneuropathy in diabetes congestive heart failure, unspecified aortocoronary bypass status personal history of tobacco use other toe(s) amputation status percutaneous transluminal coronary angioplasty status old myocardial infarction anemia in chronic kidney disease above knee amputation status diabetes with ophthalmic manifestations, type i [juvenile type], not stated as uncontrolled diabetes with renal manifestations, type i [juvenile type], not stated as uncontrolled end stage renal disease subendocardial infarction, initial episode of care end stage renal disease pure hypercholesterolemia peripheral angiopathy in diseases classified elsewhere mitral valve disorders above knee amputation status diabetes with renal manifestations, type ii or unspecified type, not stated as uncontrolled diabetes with peripheral circulatory disorders, type ii or unspecified type, not stated as uncontrolled percutaneous transluminal coronary angioplasty status ventral, unspecified, hernia without mention of obstruction or gangrene aortocoronary bypass status hypertensive chronic kidney disease, unspecified, with chronic kidney disease stage v or end stage renal disease peripheral angiopathy in diseases classified elsewhere other specified antibiotics causing adverse effects in therapeutic use cellulitis and abscess of leg, except foot long-term (current) use of insulin diabetes with peripheral circulatory disorders, type i [juvenile type], not stated as uncontrolled percutaneous transluminal coronary angioplasty status dermatitis due to drugs and medicines taken internally end stage renal disease diabetes with renal manifestations, type i [juvenile type], not stated as uncontrolled ulcer of other part of foot diabetes with ophthalmic manifestations, type i [juvenile type], not stated as uncontrolled iron deficiency anemia, unspecified hypertensive chronic kidney disease, unspecified, with chronic kidney disease stage v or end stage renal disease background diabetic retinopathy other toe(s) amputation status polyneuropathy in diabetes other suppurative peritonitis acute upper respiratory infections of unspecified site unspecified viral infection
white m 64 $nan$hematology blood hematocrit  28.7  %; hematology blood hematocrit  28.1  %; hematology blood hemoglobin  9.3  g dl; hematology blood hemoglobin  9.0  g dl; hematology blood platelet count  479  k ul; hematology blood platelet count  496  k ul; chemistry blood anion gap  19  meq l; chemistry blood anion gap  15  meq l; chemistry blood bicarbonate  19  meq l; chemistry blood bicarbonate  22  meq l; chemistry blood chloride  101  meq l; chemistry blood chloride  102  meq l; chemistry blood creatinine  2.5  mg dl; chemistry blood creatinine  2.3  mg dl; chemistry blood potassium  4.8  meq l; chemistry blood potassium  4.1  meq l; chemistry blood sodium  134  meq l; chemistry blood sodium  135  meq l; chemistry blood urea nitrogen  45  mg dl; chemistry blood urea nitrogen  41  mg dl; hematology blood inr(pt)  1.2  ; hematology blood inr(pt)  1.2  ; hematology urine wbc  19  # hpf; chemistry blood calcium, total  9.0  mg dl; chemistry blood calcium, total  9.1  mg dl; chemistry blood bilirubin, total  0.7  mg dl; chemistry blood bilirubin, total  0.7  mg dl; chemistry blood glucose  164  mg dl; chemistry blood glucose  135  mg dl; chemistry blood albumin  2.6  g dl; hematology blood bands  1  %; hematology blood bands  1  %; blood gas blood free calcium  1.22  mmol l; blood gas blood free calcium  1.18  mmol l; blood gas blood free calcium  1.20  mmol l; blood gas blood free calcium  1.16  mmol l; blood gas blood lactate  1.3  mmol l; blood gas blood lactate  1.7  mmol l; blood gas blood lactate  1.1  mmol l; blood gas blood glucose  128  mg dl; blood gas blood potassium, whole blood  4.2  meq l; blood gas blood potassium, whole blood  4.3  meq l; blood gas blood potassium, whole blood  4.0  meq l; hematology urine glucose  70  mg dl$chlorhexidine gluconate 0.12% oral rinse  15  ml ; sodium chloride 0.9%  flush  10  ml ; insulin human regular  100  unit ; calcium gluconate  2  g ; heparin  5000  unit ; 5% dextrose  500  ml ; calcium gluconate  20  gm ; sw  100  ml ; potassium chloride  10  meq ; sw  50  ml ; potassium chloride  20-40  meq ; potassium chloride  40-60  meq ; potassium chloride  60  meq ; potassium phosphate  15  mmol ; potassium phosphate  15-30  mmol ; magnesium sulfate  4  gm ; magnesium sulfate  2-4  gm ; magnesium sulfate  2  gm ; citrate dextrose 3% (acd-a) crrt  1000  ml ; midazolam  0.5-2  mg ; amiodarone  400  mg ; hydromorphone (dilaudid)  2-4  mg ; hydromorphone (dilaudid)  0.5-1  mg ; vial  1  vial ; epoetin alfa  4000  unit ; ferrous sulfate  325  mg ; syringe (0.9% sodium chloride)  2.5  ml ; olanzapine (disintegrating tablet)  2.5  mg ; propofol  20  mg ; heparin flush (1000 units ml)  4000-11000  unit ; olanzapine (disintegrating tablet)  5  mg ; 
peripheral angiopathy in diseases classified elsewhere background diabetic retinopathy diabetes with peripheral circulatory disorders, type i [juvenile type], not stated as uncontrolled diabetes with neurological manifestations, type i [juvenile type], not stated as uncontrolled hypertensive chronic kidney disease, unspecified, with chronic kidney disease stage v or end stage renal disease polyneuropathy in diabetes congestive heart failure, unspecified aortocoronary bypass status personal history of tobacco use other toe(s) amputation status percutaneous transluminal coronary angioplasty status old myocardial infarction anemia in chronic kidney disease above knee amputation status diabetes with ophthalmic manifestations, type i [juvenile type], not stated as uncontrolled diabetes with renal manifestations, type i [juvenile type], not stated as uncontrolled end stage renal disease subendocardial infarction, initial episode of care end stage renal disease pure hypercholesterolemia peripheral angiopathy in diseases classified elsewhere mitral valve disorders above knee amputation status diabetes with renal manifestations, type ii or unspecified type, not stated as uncontrolled diabetes with peripheral circulatory disorders, type ii or unspecified type, not stated as uncontrolled percutaneous transluminal coronary angioplasty status ventral, unspecified, hernia without mention of obstruction or gangrene aortocoronary bypass status hypertensive chronic kidney disease, unspecified, with chronic kidney disease stage v or end stage renal disease peripheral angiopathy in diseases classified elsewhere other specified antibiotics causing adverse effects in therapeutic use cellulitis and abscess of leg, except foot long-term (current) use of insulin diabetes with peripheral circulatory disorders, type i [juvenile type], not stated as uncontrolled percutaneous transluminal coronary angioplasty status dermatitis due to drugs and medicines taken internally end stage renal disease diabetes with renal manifestations, type i [juvenile type], not stated as uncontrolled ulcer of other part of foot diabetes with ophthalmic manifestations, type i [juvenile type], not stated as uncontrolled iron deficiency anemia, unspecified hypertensive chronic kidney disease, unspecified, with chronic kidney disease stage v or end stage renal disease background diabetic retinopathy other toe(s) amputation status polyneuropathy in diabetes other suppurative peritonitis acute upper respiratory infections of unspecified site unspecified viral infection
white m 64 $nan$hematology blood hematocrit  28.2  %; hematology blood hematocrit  26.2  %; hematology blood hemoglobin  9.1  g dl; hematology blood hemoglobin  8.8  g dl; hematology blood platelet count  526  k ul; hematology blood platelet count  500  k ul; chemistry blood anion gap  15  meq l; chemistry blood anion gap  15  meq l; chemistry blood bicarbonate  22  meq l; chemistry blood bicarbonate  22  meq l; chemistry blood chloride  103  meq l; chemistry blood chloride  104  meq l; chemistry blood creatinine  2.1  mg dl; chemistry blood creatinine  2.0  mg dl; chemistry blood potassium  4.3  meq l; chemistry blood potassium  4.7  meq l; chemistry blood sodium  136  meq l; chemistry blood sodium  136  meq l; chemistry blood urea nitrogen  38  mg dl; chemistry blood urea nitrogen  36  mg dl; hematology blood inr(pt)  1.2  ; chemistry blood calcium, total  9.1  mg dl; chemistry blood calcium, total  9.0  mg dl; chemistry blood bilirubin, total  0.5  mg dl; chemistry blood glucose  76  mg dl; chemistry blood glucose  82  mg dl; hematology blood bands  0  %; blood gas blood free calcium  1.16  mmol l; blood gas blood free calcium  1.19  mmol l; blood gas blood free calcium  1.11  mmol l; blood gas blood free calcium  1.18  mmol l; blood gas blood lactate  1.1  mmol l; blood gas blood lactate  1.1  mmol l; blood gas blood lactate  1.1  mmol l; blood gas blood lactate  1.1  mmol l; blood gas blood glucose  74  mg dl; blood gas blood glucose  79  mg dl; blood gas blood potassium, whole blood  3.7  meq l; blood gas blood potassium, whole blood  3.8  meq l; blood gas blood potassium, whole blood  4.3  meq l$chlorhexidine gluconate 0.12% oral rinse  15  ml ; sodium chloride 0.9%  flush  10  ml ; insulin human regular  100  unit ; calcium gluconate  2  g ; heparin  5000  unit ; 5% dextrose  500  ml ; calcium gluconate  20  gm ; sw  100  ml ; potassium chloride  10  meq ; sw  50  ml ; potassium chloride  20-40  meq ; potassium chloride  40-60  meq ; potassium chloride  60  meq ; potassium phosphate  15  mmol ; potassium phosphate  15-30  mmol ; magnesium sulfate  4  gm ; magnesium sulfate  2-4  gm ; magnesium sulfate  2  gm ; citrate dextrose 3% (acd-a) crrt  1000  ml ; midazolam  0.5-2  mg ; amiodarone  400  mg ; hydromorphone (dilaudid)  2-4  mg ; hydromorphone (dilaudid)  0.5-1  mg ; vial  1  vial ; epoetin alfa  4000  unit ; ferrous sulfate  325  mg ; propofol  20  mg ; heparin flush (1000 units ml)  4000-11000  unit ; olanzapine (disintegrating tablet)  5  mg ; digoxin  0.1  mg ; 
peripheral angiopathy in diseases classified elsewhere background diabetic retinopathy diabetes with peripheral circulatory disorders, type i [juvenile type], not stated as uncontrolled diabetes with neurological manifestations, type i [juvenile type], not stated as uncontrolled hypertensive chronic kidney disease, unspecified, with chronic kidney disease stage v or end stage renal disease polyneuropathy in diabetes congestive heart failure, unspecified aortocoronary bypass status personal history of tobacco use other toe(s) amputation status percutaneous transluminal coronary angioplasty status old myocardial infarction anemia in chronic kidney disease above knee amputation status diabetes with ophthalmic manifestations, type i [juvenile type], not stated as uncontrolled diabetes with renal manifestations, type i [juvenile type], not stated as uncontrolled end stage renal disease subendocardial infarction, initial episode of care end stage renal disease pure hypercholesterolemia peripheral angiopathy in diseases classified elsewhere mitral valve disorders above knee amputation status diabetes with renal manifestations, type ii or unspecified type, not stated as uncontrolled diabetes with peripheral circulatory disorders, type ii or unspecified type, not stated as uncontrolled percutaneous transluminal coronary angioplasty status ventral, unspecified, hernia without mention of obstruction or gangrene aortocoronary bypass status hypertensive chronic kidney disease, unspecified, with chronic kidney disease stage v or end stage renal disease peripheral angiopathy in diseases classified elsewhere other specified antibiotics causing adverse effects in therapeutic use cellulitis and abscess of leg, except foot long-term (current) use of insulin diabetes with peripheral circulatory disorders, type i [juvenile type], not stated as uncontrolled percutaneous transluminal coronary angioplasty status dermatitis due to drugs and medicines taken internally end stage renal disease diabetes with renal manifestations, type i [juvenile type], not stated as uncontrolled ulcer of other part of foot diabetes with ophthalmic manifestations, type i [juvenile type], not stated as uncontrolled iron deficiency anemia, unspecified hypertensive chronic kidney disease, unspecified, with chronic kidney disease stage v or end stage renal disease background diabetic retinopathy other toe(s) amputation status polyneuropathy in diabetes other suppurative peritonitis acute upper respiratory infections of unspecified site unspecified viral infection
white m 64 $nan$hematology blood hematocrit  28.1  %; hematology blood hemoglobin  9.4  g dl; hematology blood platelet count  571  k ul; chemistry blood anion gap  15  meq l; chemistry blood bicarbonate  20  meq l; chemistry blood chloride  105  meq l; chemistry blood creatinine  2.1  mg dl; chemistry blood potassium  4.9  meq l; chemistry blood sodium  135  meq l; chemistry blood urea nitrogen  35  mg dl; chemistry blood calcium, total  9.1  mg dl; chemistry blood bilirubin, total  0.5  mg dl; chemistry blood glucose  142  mg dl; blood gas blood free calcium  1.20  mmol l; blood gas blood free calcium  1.18  mmol l; blood gas blood free calcium  1.11  mmol l; blood gas blood lactate  1.3  mmol l; blood gas blood lactate  1.1  mmol l; blood gas blood lactate  1.0  mmol l; blood gas blood glucose  135  mg dl; blood gas blood glucose  135  mg dl; blood gas blood glucose  152  mg dl; blood gas blood potassium, whole blood  4.5  meq l; blood gas blood potassium, whole blood  4.1  meq l$sodium chloride 0.9%  flush  10  ml ; insulin human regular  100  unit ; calcium gluconate  2  g ; heparin  5000  unit ; 5% dextrose  500  ml ; calcium gluconate  20  gm ; sw  100  ml ; potassium chloride  10  meq ; sw  50  ml ; potassium chloride  20-40  meq ; potassium chloride  40-60  meq ; potassium chloride  60  meq ; potassium phosphate  15  mmol ; potassium phosphate  15-30  mmol ; magnesium sulfate  4  gm ; magnesium sulfate  2-4  gm ; magnesium sulfate  2  gm ; citrate dextrose 3% (acd-a) crrt  1000  ml ; amiodarone  400  mg ; hydromorphone (dilaudid)  2-4  mg ; hydromorphone (dilaudid)  0.5-1  mg ; vial  1  vial ; epoetin alfa  4000  unit ; ferrous sulfate  325  mg ; heparin flush (1000 units ml)  4000-11000  unit ; olanzapine (disintegrating tablet)  5  mg ; digoxin  0.1  mg ; 
peripheral angiopathy in diseases classified elsewhere background diabetic retinopathy diabetes with peripheral circulatory disorders, type i [juvenile type], not stated as uncontrolled diabetes with neurological manifestations, type i [juvenile type], not stated as uncontrolled hypertensive chronic kidney disease, unspecified, with chronic kidney disease stage v or end stage renal disease polyneuropathy in diabetes congestive heart failure, unspecified aortocoronary bypass status personal history of tobacco use other toe(s) amputation status percutaneous transluminal coronary angioplasty status old myocardial infarction anemia in chronic kidney disease above knee amputation status diabetes with ophthalmic manifestations, type i [juvenile type], not stated as uncontrolled diabetes with renal manifestations, type i [juvenile type], not stated as uncontrolled end stage renal disease subendocardial infarction, initial episode of care end stage renal disease pure hypercholesterolemia peripheral angiopathy in diseases classified elsewhere mitral valve disorders above knee amputation status diabetes with renal manifestations, type ii or unspecified type, not stated as uncontrolled diabetes with peripheral circulatory disorders, type ii or unspecified type, not stated as uncontrolled percutaneous transluminal coronary angioplasty status ventral, unspecified, hernia without mention of obstruction or gangrene aortocoronary bypass status hypertensive chronic kidney disease, unspecified, with chronic kidney disease stage v or end stage renal disease peripheral angiopathy in diseases classified elsewhere other specified antibiotics causing adverse effects in therapeutic use cellulitis and abscess of leg, except foot long-term (current) use of insulin diabetes with peripheral circulatory disorders, type i [juvenile type], not stated as uncontrolled percutaneous transluminal coronary angioplasty status dermatitis due to drugs and medicines taken internally end stage renal disease diabetes with renal manifestations, type i [juvenile type], not stated as uncontrolled ulcer of other part of foot diabetes with ophthalmic manifestations, type i [juvenile type], not stated as uncontrolled iron deficiency anemia, unspecified hypertensive chronic kidney disease, unspecified, with chronic kidney disease stage v or end stage renal disease background diabetic retinopathy other toe(s) amputation status polyneuropathy in diabetes other suppurative peritonitis acute upper respiratory infections of unspecified site unspecified viral infection
white m 64 $nan$hematology blood hematocrit  26.7  %; hematology blood hematocrit  25.8  %; hematology blood hemoglobin  8.6  g dl; hematology blood hemoglobin  8.3  g dl; hematology blood platelet count  514  k ul; hematology blood platelet count  416  k ul; chemistry blood anion gap  14  meq l; chemistry blood anion gap  14  meq l; chemistry blood bicarbonate  21  meq l; chemistry blood bicarbonate  23  meq l; chemistry blood chloride  107  meq l; chemistry blood chloride  103  meq l; chemistry blood creatinine  3.1  mg dl; chemistry blood creatinine  3.5  mg dl; chemistry blood potassium  5.0  meq l; chemistry blood potassium  4.2  meq l; chemistry blood sodium  137  meq l; chemistry blood sodium  136  meq l; chemistry blood urea nitrogen  55  mg dl; chemistry blood urea nitrogen  61  mg dl; chemistry blood calcium, total  9.1  mg dl; chemistry blood calcium, total  9.1  mg dl; chemistry blood bilirubin, total  0.5  mg dl; chemistry blood glucose  135  mg dl; chemistry blood glucose  115  mg dl$sodium chloride 0.9%  flush  10  ml ; insulin human regular  100  unit ; calcium gluconate  2  g ; heparin  5000  unit ; 5% dextrose  500  ml ; calcium gluconate  20  gm ; sw  100  ml ; potassium chloride  10  meq ; sw  50  ml ; potassium chloride  20-40  meq ; potassium chloride  40-60  meq ; potassium chloride  60  meq ; potassium phosphate  15  mmol ; potassium phosphate  15-30  mmol ; magnesium sulfate  4  gm ; magnesium sulfate  2-4  gm ; magnesium sulfate  2  gm ; citrate dextrose 3% (acd-a) crrt  1000  ml ; amiodarone  400  mg ; hydromorphone (dilaudid)  2-4  mg ; hydromorphone (dilaudid)  0.5-1  mg ; vial  1  vial ; epoetin alfa  4000  unit ; ferrous sulfate  325  mg ; heparin flush (1000 units ml)  4000-11000  unit ; olanzapine (disintegrating tablet)  5  mg ; collagenase ointment  1  appl ; amiodarone  200  mg ; 
peripheral angiopathy in diseases classified elsewhere background diabetic retinopathy diabetes with peripheral circulatory disorders, type i [juvenile type], not stated as uncontrolled diabetes with neurological manifestations, type i [juvenile type], not stated as uncontrolled hypertensive chronic kidney disease, unspecified, with chronic kidney disease stage v or end stage renal disease polyneuropathy in diabetes congestive heart failure, unspecified aortocoronary bypass status personal history of tobacco use other toe(s) amputation status percutaneous transluminal coronary angioplasty status old myocardial infarction anemia in chronic kidney disease above knee amputation status diabetes with ophthalmic manifestations, type i [juvenile type], not stated as uncontrolled diabetes with renal manifestations, type i [juvenile type], not stated as uncontrolled end stage renal disease subendocardial infarction, initial episode of care end stage renal disease pure hypercholesterolemia peripheral angiopathy in diseases classified elsewhere mitral valve disorders above knee amputation status diabetes with renal manifestations, type ii or unspecified type, not stated as uncontrolled diabetes with peripheral circulatory disorders, type ii or unspecified type, not stated as uncontrolled percutaneous transluminal coronary angioplasty status ventral, unspecified, hernia without mention of obstruction or gangrene aortocoronary bypass status hypertensive chronic kidney disease, unspecified, with chronic kidney disease stage v or end stage renal disease peripheral angiopathy in diseases classified elsewhere other specified antibiotics causing adverse effects in therapeutic use cellulitis and abscess of leg, except foot long-term (current) use of insulin diabetes with peripheral circulatory disorders, type i [juvenile type], not stated as uncontrolled percutaneous transluminal coronary angioplasty status dermatitis due to drugs and medicines taken internally end stage renal disease diabetes with renal manifestations, type i [juvenile type], not stated as uncontrolled ulcer of other part of foot diabetes with ophthalmic manifestations, type i [juvenile type], not stated as uncontrolled iron deficiency anemia, unspecified hypertensive chronic kidney disease, unspecified, with chronic kidney disease stage v or end stage renal disease background diabetic retinopathy other toe(s) amputation status polyneuropathy in diabetes other suppurative peritonitis acute upper respiratory infections of unspecified site unspecified viral infection
white m 64 $nan$hematology blood hematocrit  26.1  %; hematology blood hemoglobin  8.6  g dl; hematology blood platelet count  481  k ul; chemistry blood anion gap  14  meq l; chemistry blood bicarbonate  23  meq l; chemistry blood chloride  104  meq l; chemistry blood creatinine  4.1  mg dl; chemistry blood potassium  4.8  meq l; chemistry blood sodium  136  meq l; chemistry blood urea nitrogen  72  mg dl; chemistry blood calcium, total  9.2  mg dl; chemistry blood bilirubin, total  0.4  mg dl; chemistry blood glucose  109  mg dl$sodium chloride 0.9%  flush  10  ml ; insulin human regular  100  unit ; calcium gluconate  2  g ; heparin  5000  unit ; 5% dextrose  500  ml ; calcium gluconate  20  gm ; sw  100  ml ; potassium chloride  10  meq ; sw  50  ml ; potassium chloride  20-40  meq ; potassium chloride  40-60  meq ; potassium chloride  60  meq ; potassium phosphate  15  mmol ; potassium phosphate  15-30  mmol ; magnesium sulfate  4  gm ; magnesium sulfate  2-4  gm ; magnesium sulfate  2  gm ; citrate dextrose 3% (acd-a) crrt  1000  ml ; hydromorphone (dilaudid)  2-4  mg ; hydromorphone (dilaudid)  0.5-1  mg ; vial  1  vial ; epoetin alfa  4000  unit ; ferrous sulfate  325  mg ; heparin flush (1000 units ml)  4000-11000  unit ; olanzapine (disintegrating tablet)  5  mg ; collagenase ointment  1  appl ; amiodarone  200  mg ; diltiazem  5  mg ; metoprolol tartrate  25  mg ; sevelamer carbonate  800  mg ; 
peripheral angiopathy in diseases classified elsewhere background diabetic retinopathy diabetes with peripheral circulatory disorders, type i [juvenile type], not stated as uncontrolled diabetes with neurological manifestations, type i [juvenile type], not stated as uncontrolled hypertensive chronic kidney disease, unspecified, with chronic kidney disease stage v or end stage renal disease polyneuropathy in diabetes congestive heart failure, unspecified aortocoronary bypass status personal history of tobacco use other toe(s) amputation status percutaneous transluminal coronary angioplasty status old myocardial infarction anemia in chronic kidney disease above knee amputation status diabetes with ophthalmic manifestations, type i [juvenile type], not stated as uncontrolled diabetes with renal manifestations, type i [juvenile type], not stated as uncontrolled end stage renal disease subendocardial infarction, initial episode of care end stage renal disease pure hypercholesterolemia peripheral angiopathy in diseases classified elsewhere mitral valve disorders above knee amputation status diabetes with renal manifestations, type ii or unspecified type, not stated as uncontrolled diabetes with peripheral circulatory disorders, type ii or unspecified type, not stated as uncontrolled percutaneous transluminal coronary angioplasty status ventral, unspecified, hernia without mention of obstruction or gangrene aortocoronary bypass status hypertensive chronic kidney disease, unspecified, with chronic kidney disease stage v or end stage renal disease peripheral angiopathy in diseases classified elsewhere other specified antibiotics causing adverse effects in therapeutic use cellulitis and abscess of leg, except foot long-term (current) use of insulin diabetes with peripheral circulatory disorders, type i [juvenile type], not stated as uncontrolled percutaneous transluminal coronary angioplasty status dermatitis due to drugs and medicines taken internally end stage renal disease diabetes with renal manifestations, type i [juvenile type], not stated as uncontrolled ulcer of other part of foot diabetes with ophthalmic manifestations, type i [juvenile type], not stated as uncontrolled iron deficiency anemia, unspecified hypertensive chronic kidney disease, unspecified, with chronic kidney disease stage v or end stage renal disease background diabetic retinopathy other toe(s) amputation status polyneuropathy in diabetes other suppurative peritonitis acute upper respiratory infections of unspecified site unspecified viral infection
white m 64 $nan$hematology blood hematocrit  26.9  %; hematology blood hemoglobin  8.5  g dl; hematology blood platelet count  403  k ul; chemistry blood anion gap  17  meq l; chemistry blood bicarbonate  18  meq l; chemistry blood chloride  103  meq l; chemistry blood creatinine  5.5  mg dl; chemistry blood potassium  4.9  meq l; chemistry blood sodium  133  meq l; chemistry blood urea nitrogen  101  mg dl; hematology blood inr(pt)  1.1  ; chemistry blood calcium, total  9.7  mg dl; chemistry blood glucose  147  mg dl$sodium chloride 0.9%  flush  10  ml ; calcium gluconate  2  g ; heparin  5000  unit ; sw  50  ml ; potassium chloride  20-40  meq ; potassium chloride  40-60  meq ; potassium chloride  60  meq ; potassium phosphate  15  mmol ; potassium phosphate  15-30  mmol ; magnesium sulfate  4  gm ; magnesium sulfate  2-4  gm ; magnesium sulfate  2  gm ; hydromorphone (dilaudid)  2-4  mg ; hydromorphone (dilaudid)  0.5-1  mg ; ferrous sulfate  325  mg ; heparin flush (1000 units ml)  4000-11000  unit ; olanzapine (disintegrating tablet)  5  mg ; collagenase ointment  1  appl ; amiodarone  200  mg ; metoprolol tartrate  25  mg ; sevelamer carbonate  800  mg ; midazolam  2  mg ; insulin  10  unit ; midazolam  1-4  mg ; haloperidol  1-5  mg ; haloperidol  2  mg ; 
peripheral angiopathy in diseases classified elsewhere background diabetic retinopathy diabetes with peripheral circulatory disorders, type i [juvenile type], not stated as uncontrolled diabetes with neurological manifestations, type i [juvenile type], not stated as uncontrolled hypertensive chronic kidney disease, unspecified, with chronic kidney disease stage v or end stage renal disease polyneuropathy in diabetes congestive heart failure, unspecified aortocoronary bypass status personal history of tobacco use other toe(s) amputation status percutaneous transluminal coronary angioplasty status old myocardial infarction anemia in chronic kidney disease above knee amputation status diabetes with ophthalmic manifestations, type i [juvenile type], not stated as uncontrolled diabetes with renal manifestations, type i [juvenile type], not stated as uncontrolled end stage renal disease subendocardial infarction, initial episode of care end stage renal disease pure hypercholesterolemia peripheral angiopathy in diseases classified elsewhere mitral valve disorders above knee amputation status diabetes with renal manifestations, type ii or unspecified type, not stated as uncontrolled diabetes with peripheral circulatory disorders, type ii or unspecified type, not stated as uncontrolled percutaneous transluminal coronary angioplasty status ventral, unspecified, hernia without mention of obstruction or gangrene aortocoronary bypass status hypertensive chronic kidney disease, unspecified, with chronic kidney disease stage v or end stage renal disease peripheral angiopathy in diseases classified elsewhere other specified antibiotics causing adverse effects in therapeutic use cellulitis and abscess of leg, except foot long-term (current) use of insulin diabetes with peripheral circulatory disorders, type i [juvenile type], not stated as uncontrolled percutaneous transluminal coronary angioplasty status dermatitis due to drugs and medicines taken internally end stage renal disease diabetes with renal manifestations, type i [juvenile type], not stated as uncontrolled ulcer of other part of foot diabetes with ophthalmic manifestations, type i [juvenile type], not stated as uncontrolled iron deficiency anemia, unspecified hypertensive chronic kidney disease, unspecified, with chronic kidney disease stage v or end stage renal disease background diabetic retinopathy other toe(s) amputation status polyneuropathy in diabetes other suppurative peritonitis acute upper respiratory infections of unspecified site unspecified viral infection
white m 64 $nan$hematology blood hematocrit  26.9  %; hematology blood hematocrit  25.3  %; hematology blood hematocrit  26.7  %; hematology blood hemoglobin  8.8  g dl; hematology blood hemoglobin  8.3  g dl; hematology blood hemoglobin  8.1  g dl; hematology blood platelet count  515  k ul; hematology blood platelet count  439  k ul; chemistry blood anion gap  20  meq l; chemistry blood anion gap  27  meq l; chemistry blood anion gap  25  meq l; chemistry blood bicarbonate  17  meq l; chemistry blood bicarbonate  18  meq l; chemistry blood bicarbonate  14  meq l; chemistry blood chloride  101  meq l; chemistry blood chloride  99  meq l; chemistry blood chloride  103  meq l; chemistry blood creatinine  6.8  mg dl; chemistry blood creatinine  6.1  mg dl; chemistry blood creatinine  6.4  mg dl; chemistry blood potassium  5.2  meq l; chemistry blood potassium  5.5  meq l; chemistry blood potassium  6.6  meq l; chemistry blood sodium  133  meq l; chemistry blood sodium  139  meq l; chemistry blood sodium  134  meq l; chemistry blood urea nitrogen  132  mg dl; chemistry blood urea nitrogen  122  mg dl; chemistry blood urea nitrogen  131  mg dl; hematology blood inr(pt)  1.1  ; hematology blood inr(pt)  1.4  ; chemistry blood calcium, total  9.9  mg dl; chemistry blood calcium, total  9.2  mg dl; chemistry blood calcium, total  11.7  mg dl; chemistry blood bilirubin, indirect  0.2  mg dl; chemistry blood bilirubin, total  0.4  mg dl; chemistry blood bilirubin, total  0.5  mg dl; chemistry blood bilirubin, total  0.5  mg dl; chemistry blood glucose  516  mg dl; chemistry blood glucose  372  mg dl; chemistry blood glucose  230  mg dl; chemistry blood albumin  2.2  g dl; hematology blood bands  4  %; blood gas blood free calcium  1.34  mmol l; blood gas blood lactate  1.9  mmol l; blood gas blood lactate  3.5  mmol l; blood gas blood lactate  2.2  mmol l; blood gas blood lactate  4.7  mmol l; chemistry blood bilirubin, direct  0.3  mg dl; blood gas blood glucose  205  mg dl; hematology urine glucose  100  mg dl; hematology urine bilirubin  neg  mg dl$sodium chloride 0.9%  flush  10  ml ; calcium gluconate  2  g ; heparin  5000  unit ; sw  50  ml ; potassium chloride  20-40  meq ; potassium chloride  40-60  meq ; potassium chloride  60  meq ; potassium phosphate  15  mmol ; potassium phosphate  15-30  mmol ; magnesium sulfate  4  gm ; magnesium sulfate  2-4  gm ; magnesium sulfate  2  gm ; ferrous sulfate  325  mg ; heparin flush (1000 units ml)  4000-11000  unit ; olanzapine (disintegrating tablet)  5  mg ; collagenase ointment  1  appl ; amiodarone  200  mg ; metoprolol tartrate  25  mg ; sevelamer carbonate  800  mg ; insulin  10  unit ; sodium citrate 4%  1.5  ml ; potassium chloride  20  meq ; haloperidol  2.5  mg ; d10w  1000  ml ; rocuronium  100  mg ; etomidate  20  mg ; fentanyl citrate  100-200  mcg ; 
peripheral angiopathy in diseases classified elsewhere background diabetic retinopathy diabetes with peripheral circulatory disorders, type i [juvenile type], not stated as uncontrolled diabetes with neurological manifestations, type i [juvenile type], not stated as uncontrolled hypertensive chronic kidney disease, unspecified, with chronic kidney disease stage v or end stage renal disease polyneuropathy in diabetes congestive heart failure, unspecified aortocoronary bypass status personal history of tobacco use other toe(s) amputation status percutaneous transluminal coronary angioplasty status old myocardial infarction anemia in chronic kidney disease above knee amputation status diabetes with ophthalmic manifestations, type i [juvenile type], not stated as uncontrolled diabetes with renal manifestations, type i [juvenile type], not stated as uncontrolled end stage renal disease subendocardial infarction, initial episode of care end stage renal disease pure hypercholesterolemia peripheral angiopathy in diseases classified elsewhere mitral valve disorders above knee amputation status diabetes with renal manifestations, type ii or unspecified type, not stated as uncontrolled diabetes with peripheral circulatory disorders, type ii or unspecified type, not stated as uncontrolled percutaneous transluminal coronary angioplasty status ventral, unspecified, hernia without mention of obstruction or gangrene aortocoronary bypass status hypertensive chronic kidney disease, unspecified, with chronic kidney disease stage v or end stage renal disease peripheral angiopathy in diseases classified elsewhere other specified antibiotics causing adverse effects in therapeutic use cellulitis and abscess of leg, except foot long-term (current) use of insulin diabetes with peripheral circulatory disorders, type i [juvenile type], not stated as uncontrolled percutaneous transluminal coronary angioplasty status dermatitis due to drugs and medicines taken internally end stage renal disease diabetes with renal manifestations, type i [juvenile type], not stated as uncontrolled ulcer of other part of foot diabetes with ophthalmic manifestations, type i [juvenile type], not stated as uncontrolled iron deficiency anemia, unspecified hypertensive chronic kidney disease, unspecified, with chronic kidney disease stage v or end stage renal disease background diabetic retinopathy other toe(s) amputation status polyneuropathy in diabetes other suppurative peritonitis acute upper respiratory infections of unspecified site unspecified viral infection
white m 64 $nan$nan$sodium chloride 0.9%  flush  10  ml ; calcium gluconate  2  g ; heparin  5000  unit ; sw  50  ml ; potassium chloride  20-40  meq ; potassium chloride  40-60  meq ; potassium chloride  60  meq ; potassium phosphate  15  mmol ; potassium phosphate  15-30  mmol ; magnesium sulfate  4  gm ; magnesium sulfate  2-4  gm ; magnesium sulfate  2  gm ; ferrous sulfate  325  mg ; heparin flush (1000 units ml)  4000-11000  unit ; olanzapine (disintegrating tablet)  5  mg ; collagenase ointment  1  appl ; amiodarone  200  mg ; metoprolol tartrate  25  mg ; sevelamer carbonate  800  mg ; sodium citrate 4%  1.5  ml ; potassium chloride  20  meq ; haloperidol  2.5  mg ; d10w  1000  ml ; rocuronium  100  mg ; etomidate  20  mg ; fentanyl citrate  100-200  mcg ; 
peripheral angiopathy in diseases classified elsewhere background diabetic retinopathy diabetes with peripheral circulatory disorders, type i [juvenile type], not stated as uncontrolled diabetes with neurological manifestations, type i [juvenile type], not stated as uncontrolled hypertensive chronic kidney disease, unspecified, with chronic kidney disease stage v or end stage renal disease polyneuropathy in diabetes congestive heart failure, unspecified aortocoronary bypass status personal history of tobacco use other toe(s) amputation status percutaneous transluminal coronary angioplasty status old myocardial infarction anemia in chronic kidney disease above knee amputation status diabetes with ophthalmic manifestations, type i [juvenile type], not stated as uncontrolled diabetes with renal manifestations, type i [juvenile type], not stated as uncontrolled end stage renal disease subendocardial infarction, initial episode of care end stage renal disease pure hypercholesterolemia peripheral angiopathy in diseases classified elsewhere mitral valve disorders above knee amputation status diabetes with renal manifestations, type ii or unspecified type, not stated as uncontrolled diabetes with peripheral circulatory disorders, type ii or unspecified type, not stated as uncontrolled percutaneous transluminal coronary angioplasty status ventral, unspecified, hernia without mention of obstruction or gangrene aortocoronary bypass status hypertensive chronic kidney disease, unspecified, with chronic kidney disease stage v or end stage renal disease peripheral angiopathy in diseases classified elsewhere other specified antibiotics causing adverse effects in therapeutic use cellulitis and abscess of leg, except foot long-term (current) use of insulin diabetes with peripheral circulatory disorders, type i [juvenile type], not stated as uncontrolled percutaneous transluminal coronary angioplasty status dermatitis due to drugs and medicines taken internally end stage renal disease diabetes with renal manifestations, type i [juvenile type], not stated as uncontrolled ulcer of other part of foot diabetes with ophthalmic manifestations, type i [juvenile type], not stated as uncontrolled iron deficiency anemia, unspecified hypertensive chronic kidney disease, unspecified, with chronic kidney disease stage v or end stage renal disease background diabetic retinopathy other toe(s) amputation status polyneuropathy in diabetes other suppurative peritonitis acute upper respiratory infections of unspecified site unspecified viral infection
white m 43 $nan$nan$hydrochlorothiazide  25  mg ; 
other acquired deformity of other parts of limb late effects of other accidents mechanical complication due to graft of other tissue, not elsewhere classified late effect of crushing unspecified essential hypertension long-term (current) use of aspirin varus deformity of wrist (acquired) crushing injury of forearm injury to digital blood vessels tobacco use disorder injury to digital nerve, upper limb open fracture of other bone of wrist accidents caused by woodworking and forming machines traumatic amputation of other finger(s) (complete) (partial), without mention of complication closed fracture of base of thumb [first] metacarpal open fracture of shaft of radius with ulna multiple open fractures of hand bones 
white m 43 $nan$nan$hydrochlorothiazide  25  mg ; influenza virus vaccine  0.5  ml ; sodium chloride 0.9%  flush  3  ml ; potassium chl 20 meq   1000 ml d5 1 2 ns  1000  ml ; acetaminophen  650  mg ; morphine sulfate  2-4  mg ; oxycodone (immediate release)   5-10  mg ; ondansetron  4  mg ; 
other acquired deformity of other parts of limb late effects of other accidents mechanical complication due to graft of other tissue, not elsewhere classified late effect of crushing unspecified essential hypertension long-term (current) use of aspirin varus deformity of wrist (acquired) crushing injury of forearm injury to digital blood vessels tobacco use disorder injury to digital nerve, upper limb open fracture of other bone of wrist accidents caused by woodworking and forming machines traumatic amputation of other finger(s) (complete) (partial), without mention of complication closed fracture of base of thumb [first] metacarpal open fracture of shaft of radius with ulna multiple open fractures of hand bones 
white m 43 $nan$nan$hydrochlorothiazide  25  mg ; influenza virus vaccine  0.5  ml ; sodium chloride 0.9%  flush  3  ml ; potassium chl 20 meq   1000 ml d5 1 2 ns  1000  ml ; acetaminophen  650  mg ; morphine sulfate  2-4  mg ; oxycodone (immediate release)   5-10  mg ; ondansetron  4  mg ; 
other acquired deformity of other parts of limb late effects of other accidents mechanical complication due to graft of other tissue, not elsewhere classified late effect of crushing unspecified essential hypertension long-term (current) use of aspirin varus deformity of wrist (acquired) crushing injury of forearm injury to digital blood vessels tobacco use disorder injury to digital nerve, upper limb open fracture of other bone of wrist accidents caused by woodworking and forming machines traumatic amputation of other finger(s) (complete) (partial), without mention of complication closed fracture of base of thumb [first] metacarpal open fracture of shaft of radius with ulna multiple open fractures of hand bones 
black african american f 66 $temp    heartrate  85.0  resprate  36.0  o2sat  96.0  sbp  194.0  dbp  80.0  rhythm    pain  0  ; temp    heartrate  78.0  resprate  33.0  o2sat  99.0  sbp  196.0  dbp  59.0  rhythm    pain    ; temp  98.4  heartrate  88.0  resprate  28.0  o2sat  98.0  sbp  178.0  dbp  54.0  rhythm    pain  0  $nan$aspirin  81  mg ; lidocaine 5% patch  1  ptch ; omeprazole  20  mg ; atorvastatin  80  mg ; cinacalcet  60  mg ; isosorbide mononitrate (extended release)  30  mg ; levothyroxine sodium  75  mcg ; losartan potassium  50  mg ; 
coronary atherosclerosis of native coronary artery surgical operation with transplant of whole organ causing abnormal patient reaction, or later complication, without mention of misadventure at time of operation asthma, unspecified type, unspecified other and unspecified hyperlipidemia hypertensive chronic kidney disease, unspecified, with chronic kidney disease stage v or end stage renal disease esophageal reflux nephritis and nephropathy, not specified as acute or chronic, with unspecified pathological lesion in kidney epilepsy, unspecified, without mention of intractable epilepsy other chronic pulmonary heart diseases end stage renal disease complications of transplanted kidney unspecified acquired hypothyroidism kidney replaced by transplant hypovolemia unspecified acquired hypothyroidism thrombocytopenia, unspecified leukocytopenia, unspecified backache, unspecified pain in limb asthma, unspecified type, unspecified long-term (current) use of aspirin diarrhea anemia in chronic kidney disease end stage renal disease nausea with vomiting long-term (current) use of non-steroidal anti-inflammatories (nsaid) coronary atherosclerosis of unspecified type of vessel, native or graft anxiety state, unspecified esophageal reflux hypertensive chronic kidney disease, unspecified, with chronic kidney disease stage v or end stage renal disease primary hyperparathyroidism epilepsy, unspecified, without mention of intractable epilepsy portal hypertension nephritis and nephropathy, not specified as acute or chronic, with unspecified pathological lesion in kidney personal history of tobacco use car driver injured in collision with two- or three-wheeled motor vehicle in nontraffic accident other chronic pain other and unspecified hyperlipidemia dizziness and giddiness percutaneous transluminal coronary angioplasty status congestive heart failure, unspecified asthma, unspecified type, unspecified epilepsy, unspecified, without mention of intractable epilepsy nephritis and nephropathy, not specified as acute or chronic, with unspecified pathological lesion in kidney coronary atherosclerosis of native coronary artery anxiety state, unspecified end stage renal disease other and unspecified hyperlipidemia
black african american f 66 $temp  98.6  heartrate  77.0  resprate  22.0  o2sat  100.0  sbp  135.0  dbp  44.0  rhythm  sinus rhythm  pain  0  $hematology blood hematocrit  33.5  %; hematology blood hemoglobin  10.1  g dl; hematology blood platelet count  92  k ul; chemistry blood anion gap  20  meq l; chemistry blood bicarbonate  28  meq l; chemistry blood chloride  97  meq l; chemistry blood creatinine  4.7  mg dl; chemistry blood potassium  5.6  meq l; chemistry blood sodium  139  meq l; chemistry blood urea nitrogen  22  mg dl; hematology blood inr(pt)  1.1  ; chemistry blood calcium, total  10.0  mg dl; chemistry blood glucose  153  mg dl$aspirin  81  mg ; lidocaine 5% patch  1  ptch ; omeprazole  20  mg ; atorvastatin  80  mg ; cinacalcet  60  mg ; isosorbide mononitrate (extended release)  30  mg ; levothyroxine sodium  75  mcg ; losartan potassium  50  mg ; sodium chloride 0.9%  flush  3  ml ; senna  1  tab ; acetaminophen  325-650  mg ; albuterol 0.083% neb soln  1  neb ; oxycodone (immediate release)   5  mg ; lorazepam  0.5  mg ; sevelamer carbonate  800  mg ; ipratropium bromide neb  1  neb ; docusate sodium  100  mg ; fluticasone propionate 110mcg  2  puff ; fluticasone-salmeterol diskus (250 50)   1  inh ; metoprolol tartrate  50  mg ; albuterol inhaler  1-2  puff ; levetiracetam  500  mg ; 0.9% sodium chloride  250  ml ; lidocaine 1%  1  ml ; paricalcitol  7  mcg ; vial  1  vial ; epoetin alfa  4000  unit ; 
coronary atherosclerosis of native coronary artery surgical operation with transplant of whole organ causing abnormal patient reaction, or later complication, without mention of misadventure at time of operation asthma, unspecified type, unspecified other and unspecified hyperlipidemia hypertensive chronic kidney disease, unspecified, with chronic kidney disease stage v or end stage renal disease esophageal reflux nephritis and nephropathy, not specified as acute or chronic, with unspecified pathological lesion in kidney epilepsy, unspecified, without mention of intractable epilepsy other chronic pulmonary heart diseases end stage renal disease complications of transplanted kidney unspecified acquired hypothyroidism kidney replaced by transplant hypovolemia unspecified acquired hypothyroidism thrombocytopenia, unspecified leukocytopenia, unspecified backache, unspecified pain in limb asthma, unspecified type, unspecified long-term (current) use of aspirin diarrhea anemia in chronic kidney disease end stage renal disease nausea with vomiting long-term (current) use of non-steroidal anti-inflammatories (nsaid) coronary atherosclerosis of unspecified type of vessel, native or graft anxiety state, unspecified esophageal reflux hypertensive chronic kidney disease, unspecified, with chronic kidney disease stage v or end stage renal disease primary hyperparathyroidism epilepsy, unspecified, without mention of intractable epilepsy portal hypertension nephritis and nephropathy, not specified as acute or chronic, with unspecified pathological lesion in kidney personal history of tobacco use car driver injured in collision with two- or three-wheeled motor vehicle in nontraffic accident other chronic pain other and unspecified hyperlipidemia dizziness and giddiness percutaneous transluminal coronary angioplasty status congestive heart failure, unspecified asthma, unspecified type, unspecified epilepsy, unspecified, without mention of intractable epilepsy nephritis and nephropathy, not specified as acute or chronic, with unspecified pathological lesion in kidney coronary atherosclerosis of native coronary artery anxiety state, unspecified end stage renal disease other and unspecified hyperlipidemia
black african american f 66 $nan$hematology blood hematocrit  33.1  %; hematology blood hemoglobin  9.8  g dl; hematology blood platelet count  109  k ul; chemistry blood anion gap  11  meq l; chemistry blood bicarbonate  33  meq l; chemistry blood chloride  98  meq l; chemistry blood creatinine  3.2  mg dl; chemistry blood potassium  4.0  meq l; chemistry blood sodium  138  meq l; chemistry blood urea nitrogen  17  mg dl; chemistry blood calcium, total  9.2  mg dl; chemistry blood glucose  84  mg dl$aspirin  81  mg ; lidocaine 5% patch  1  ptch ; omeprazole  20  mg ; atorvastatin  80  mg ; cinacalcet  60  mg ; isosorbide mononitrate (extended release)  30  mg ; levothyroxine sodium  75  mcg ; losartan potassium  50  mg ; sodium chloride 0.9%  flush  3  ml ; senna  1  tab ; acetaminophen  325-650  mg ; oxycodone (immediate release)   5  mg ; lorazepam  0.5  mg ; sevelamer carbonate  800  mg ; ipratropium bromide neb  1  neb ; docusate sodium  100  mg ; fluticasone propionate 110mcg  2  puff ; fluticasone-salmeterol diskus (250 50)   1  inh ; metoprolol tartrate  50  mg ; albuterol inhaler  1-2  puff ; levetiracetam  500  mg ; 0.9% sodium chloride  250  ml ; lidocaine 1%  1  ml ; paricalcitol  7  mcg ; vial  1  vial ; epoetin alfa  4000  unit ; 
coronary atherosclerosis of native coronary artery surgical operation with transplant of whole organ causing abnormal patient reaction, or later complication, without mention of misadventure at time of operation asthma, unspecified type, unspecified other and unspecified hyperlipidemia hypertensive chronic kidney disease, unspecified, with chronic kidney disease stage v or end stage renal disease esophageal reflux nephritis and nephropathy, not specified as acute or chronic, with unspecified pathological lesion in kidney epilepsy, unspecified, without mention of intractable epilepsy other chronic pulmonary heart diseases end stage renal disease complications of transplanted kidney unspecified acquired hypothyroidism kidney replaced by transplant hypovolemia unspecified acquired hypothyroidism thrombocytopenia, unspecified leukocytopenia, unspecified backache, unspecified pain in limb asthma, unspecified type, unspecified long-term (current) use of aspirin diarrhea anemia in chronic kidney disease end stage renal disease nausea with vomiting long-term (current) use of non-steroidal anti-inflammatories (nsaid) coronary atherosclerosis of unspecified type of vessel, native or graft anxiety state, unspecified esophageal reflux hypertensive chronic kidney disease, unspecified, with chronic kidney disease stage v or end stage renal disease primary hyperparathyroidism epilepsy, unspecified, without mention of intractable epilepsy portal hypertension nephritis and nephropathy, not specified as acute or chronic, with unspecified pathological lesion in kidney personal history of tobacco use car driver injured in collision with two- or three-wheeled motor vehicle in nontraffic accident other chronic pain other and unspecified hyperlipidemia dizziness and giddiness percutaneous transluminal coronary angioplasty status congestive heart failure, unspecified asthma, unspecified type, unspecified epilepsy, unspecified, without mention of intractable epilepsy nephritis and nephropathy, not specified as acute or chronic, with unspecified pathological lesion in kidney coronary atherosclerosis of native coronary artery anxiety state, unspecified end stage renal disease other and unspecified hyperlipidemia
black african american f 66 $nan$hematology blood hematocrit  35.3  %; hematology blood hemoglobin  10.3  g dl; hematology blood platelet count  110  k ul; chemistry blood anion gap  12  meq l; chemistry blood bicarbonate  31  meq l; chemistry blood chloride  99  meq l; chemistry blood creatinine  4.4  mg dl; chemistry blood potassium  4.4  meq l; chemistry blood sodium  138  meq l; chemistry blood urea nitrogen  26  mg dl; chemistry blood calcium, total  9.4  mg dl; chemistry blood glucose  74  mg dl$aspirin  81  mg ; lidocaine 5% patch  1  ptch ; omeprazole  20  mg ; atorvastatin  80  mg ; cinacalcet  60  mg ; isosorbide mononitrate (extended release)  30  mg ; levothyroxine sodium  75  mcg ; losartan potassium  50  mg ; sodium chloride 0.9%  flush  3  ml ; senna  1  tab ; acetaminophen  325-650  mg ; oxycodone (immediate release)   5  mg ; lorazepam  0.5  mg ; sevelamer carbonate  800  mg ; ipratropium bromide neb  1  neb ; docusate sodium  100  mg ; fluticasone propionate 110mcg  2  puff ; fluticasone-salmeterol diskus (250 50)   1  inh ; metoprolol tartrate  50  mg ; albuterol inhaler  1-2  puff ; levetiracetam  500  mg ; lidocaine 1%  1  ml ; 
coronary atherosclerosis of native coronary artery surgical operation with transplant of whole organ causing abnormal patient reaction, or later complication, without mention of misadventure at time of operation asthma, unspecified type, unspecified other and unspecified hyperlipidemia hypertensive chronic kidney disease, unspecified, with chronic kidney disease stage v or end stage renal disease esophageal reflux nephritis and nephropathy, not specified as acute or chronic, with unspecified pathological lesion in kidney epilepsy, unspecified, without mention of intractable epilepsy other chronic pulmonary heart diseases end stage renal disease complications of transplanted kidney unspecified acquired hypothyroidism kidney replaced by transplant hypovolemia unspecified acquired hypothyroidism thrombocytopenia, unspecified leukocytopenia, unspecified backache, unspecified pain in limb asthma, unspecified type, unspecified long-term (current) use of aspirin diarrhea anemia in chronic kidney disease end stage renal disease nausea with vomiting long-term (current) use of non-steroidal anti-inflammatories (nsaid) coronary atherosclerosis of unspecified type of vessel, native or graft anxiety state, unspecified esophageal reflux hypertensive chronic kidney disease, unspecified, with chronic kidney disease stage v or end stage renal disease primary hyperparathyroidism epilepsy, unspecified, without mention of intractable epilepsy portal hypertension nephritis and nephropathy, not specified as acute or chronic, with unspecified pathological lesion in kidney personal history of tobacco use car driver injured in collision with two- or three-wheeled motor vehicle in nontraffic accident other chronic pain other and unspecified hyperlipidemia dizziness and giddiness percutaneous transluminal coronary angioplasty status congestive heart failure, unspecified asthma, unspecified type, unspecified epilepsy, unspecified, without mention of intractable epilepsy nephritis and nephropathy, not specified as acute or chronic, with unspecified pathological lesion in kidney coronary atherosclerosis of native coronary artery anxiety state, unspecified end stage renal disease other and unspecified hyperlipidemia
black african american f 66 $nan$hematology blood hematocrit  33.9  %; hematology blood hemoglobin  10.0  g dl; hematology blood platelet count  116  k ul; chemistry blood anion gap  13  meq l; chemistry blood bicarbonate  30  meq l; chemistry blood chloride  98  meq l; chemistry blood creatinine  3.6  mg dl; chemistry blood potassium  4.4  meq l; chemistry blood sodium  137  meq l; chemistry blood urea nitrogen  22  mg dl; chemistry blood calcium, total  10.6  mg dl; chemistry blood glucose  75  mg dl$aspirin  81  mg ; lidocaine 5% patch  1  ptch ; omeprazole  20  mg ; atorvastatin  80  mg ; cinacalcet  60  mg ; isosorbide mononitrate (extended release)  30  mg ; levothyroxine sodium  75  mcg ; losartan potassium  50  mg ; sodium chloride 0.9%  flush  3  ml ; senna  1  tab ; acetaminophen  325-650  mg ; oxycodone (immediate release)   5  mg ; lorazepam  0.5  mg ; sevelamer carbonate  800  mg ; ipratropium bromide neb  1  neb ; docusate sodium  100  mg ; fluticasone propionate 110mcg  2  puff ; fluticasone-salmeterol diskus (250 50)   1  inh ; metoprolol tartrate  50  mg ; albuterol inhaler  1-2  puff ; levetiracetam  500  mg ; lidocaine 1%  1  ml ; 
coronary atherosclerosis of native coronary artery surgical operation with transplant of whole organ causing abnormal patient reaction, or later complication, without mention of misadventure at time of operation asthma, unspecified type, unspecified other and unspecified hyperlipidemia hypertensive chronic kidney disease, unspecified, with chronic kidney disease stage v or end stage renal disease esophageal reflux nephritis and nephropathy, not specified as acute or chronic, with unspecified pathological lesion in kidney epilepsy, unspecified, without mention of intractable epilepsy other chronic pulmonary heart diseases end stage renal disease complications of transplanted kidney unspecified acquired hypothyroidism kidney replaced by transplant hypovolemia unspecified acquired hypothyroidism thrombocytopenia, unspecified leukocytopenia, unspecified backache, unspecified pain in limb asthma, unspecified type, unspecified long-term (current) use of aspirin diarrhea anemia in chronic kidney disease end stage renal disease nausea with vomiting long-term (current) use of non-steroidal anti-inflammatories (nsaid) coronary atherosclerosis of unspecified type of vessel, native or graft anxiety state, unspecified esophageal reflux hypertensive chronic kidney disease, unspecified, with chronic kidney disease stage v or end stage renal disease primary hyperparathyroidism epilepsy, unspecified, without mention of intractable epilepsy portal hypertension nephritis and nephropathy, not specified as acute or chronic, with unspecified pathological lesion in kidney personal history of tobacco use car driver injured in collision with two- or three-wheeled motor vehicle in nontraffic accident other chronic pain other and unspecified hyperlipidemia dizziness and giddiness percutaneous transluminal coronary angioplasty status congestive heart failure, unspecified asthma, unspecified type, unspecified epilepsy, unspecified, without mention of intractable epilepsy nephritis and nephropathy, not specified as acute or chronic, with unspecified pathological lesion in kidney coronary atherosclerosis of native coronary artery anxiety state, unspecified end stage renal disease other and unspecified hyperlipidemia
black african american f 66 $nan$hematology blood hematocrit  31.3  %; hematology blood hemoglobin  9.5  g dl; hematology blood platelet count  129  k ul; chemistry blood anion gap  15  meq l; chemistry blood bicarbonate  27  meq l; chemistry blood chloride  98  meq l; chemistry blood creatinine  4.5  mg dl; chemistry blood potassium  4.8  meq l; chemistry blood sodium  135  meq l; chemistry blood urea nitrogen  29  mg dl; chemistry blood calcium, total  10.2  mg dl; chemistry blood glucose  71  mg dl$aspirin  81  mg ; lidocaine 5% patch  1  ptch ; omeprazole  20  mg ; atorvastatin  80  mg ; cinacalcet  60  mg ; isosorbide mononitrate (extended release)  30  mg ; levothyroxine sodium  75  mcg ; losartan potassium  50  mg ; sodium chloride 0.9%  flush  3  ml ; senna  1  tab ; acetaminophen  325-650  mg ; oxycodone (immediate release)   5  mg ; lorazepam  0.5  mg ; sevelamer carbonate  800  mg ; ipratropium bromide neb  1  neb ; docusate sodium  100  mg ; fluticasone propionate 110mcg  2  puff ; fluticasone-salmeterol diskus (250 50)   1  inh ; metoprolol tartrate  50  mg ; albuterol inhaler  1-2  puff ; levetiracetam  500  mg ; lidocaine 1%  1  ml ; nephrocaps  1  cap ; 
coronary atherosclerosis of native coronary artery surgical operation with transplant of whole organ causing abnormal patient reaction, or later complication, without mention of misadventure at time of operation asthma, unspecified type, unspecified other and unspecified hyperlipidemia hypertensive chronic kidney disease, unspecified, with chronic kidney disease stage v or end stage renal disease esophageal reflux nephritis and nephropathy, not specified as acute or chronic, with unspecified pathological lesion in kidney epilepsy, unspecified, without mention of intractable epilepsy other chronic pulmonary heart diseases end stage renal disease complications of transplanted kidney unspecified acquired hypothyroidism kidney replaced by transplant hypovolemia unspecified acquired hypothyroidism thrombocytopenia, unspecified leukocytopenia, unspecified backache, unspecified pain in limb asthma, unspecified type, unspecified long-term (current) use of aspirin diarrhea anemia in chronic kidney disease end stage renal disease nausea with vomiting long-term (current) use of non-steroidal anti-inflammatories (nsaid) coronary atherosclerosis of unspecified type of vessel, native or graft anxiety state, unspecified esophageal reflux hypertensive chronic kidney disease, unspecified, with chronic kidney disease stage v or end stage renal disease primary hyperparathyroidism epilepsy, unspecified, without mention of intractable epilepsy portal hypertension nephritis and nephropathy, not specified as acute or chronic, with unspecified pathological lesion in kidney personal history of tobacco use car driver injured in collision with two- or three-wheeled motor vehicle in nontraffic accident other chronic pain other and unspecified hyperlipidemia dizziness and giddiness percutaneous transluminal coronary angioplasty status congestive heart failure, unspecified asthma, unspecified type, unspecified epilepsy, unspecified, without mention of intractable epilepsy nephritis and nephropathy, not specified as acute or chronic, with unspecified pathological lesion in kidney coronary atherosclerosis of native coronary artery anxiety state, unspecified end stage renal disease other and unspecified hyperlipidemia
black african american f 66 $nan$nan$aspirin  81  mg ; lidocaine 5% patch  1  ptch ; omeprazole  20  mg ; atorvastatin  80  mg ; cinacalcet  60  mg ; isosorbide mononitrate (extended release)  30  mg ; levothyroxine sodium  75  mcg ; losartan potassium  50  mg ; sodium chloride 0.9%  flush  3  ml ; senna  1  tab ; acetaminophen  325-650  mg ; oxycodone (immediate release)   5  mg ; lorazepam  0.5  mg ; sevelamer carbonate  800  mg ; ipratropium bromide neb  1  neb ; docusate sodium  100  mg ; fluticasone propionate 110mcg  2  puff ; fluticasone-salmeterol diskus (250 50)   1  inh ; metoprolol tartrate  50  mg ; albuterol inhaler  1-2  puff ; levetiracetam  500  mg ; lidocaine 1%  1  ml ; nephrocaps  1  cap ; 
coronary atherosclerosis of native coronary artery surgical operation with transplant of whole organ causing abnormal patient reaction, or later complication, without mention of misadventure at time of operation asthma, unspecified type, unspecified other and unspecified hyperlipidemia hypertensive chronic kidney disease, unspecified, with chronic kidney disease stage v or end stage renal disease esophageal reflux nephritis and nephropathy, not specified as acute or chronic, with unspecified pathological lesion in kidney epilepsy, unspecified, without mention of intractable epilepsy other chronic pulmonary heart diseases end stage renal disease complications of transplanted kidney unspecified acquired hypothyroidism kidney replaced by transplant hypovolemia unspecified acquired hypothyroidism thrombocytopenia, unspecified leukocytopenia, unspecified backache, unspecified pain in limb asthma, unspecified type, unspecified long-term (current) use of aspirin diarrhea anemia in chronic kidney disease end stage renal disease nausea with vomiting long-term (current) use of non-steroidal anti-inflammatories (nsaid) coronary atherosclerosis of unspecified type of vessel, native or graft anxiety state, unspecified esophageal reflux hypertensive chronic kidney disease, unspecified, with chronic kidney disease stage v or end stage renal disease primary hyperparathyroidism epilepsy, unspecified, without mention of intractable epilepsy portal hypertension nephritis and nephropathy, not specified as acute or chronic, with unspecified pathological lesion in kidney personal history of tobacco use car driver injured in collision with two- or three-wheeled motor vehicle in nontraffic accident other chronic pain other and unspecified hyperlipidemia dizziness and giddiness percutaneous transluminal coronary angioplasty status congestive heart failure, unspecified asthma, unspecified type, unspecified epilepsy, unspecified, without mention of intractable epilepsy nephritis and nephropathy, not specified as acute or chronic, with unspecified pathological lesion in kidney coronary atherosclerosis of native coronary artery anxiety state, unspecified end stage renal disease other and unspecified hyperlipidemia
white m 54 $nan$hematology blood hematocrit  33.7  %; hematology blood hemoglobin  12.5  g dl; hematology blood platelet count  192  k ul$influenza vaccine quadrivalent  0.5  ml ; sodium chloride 0.9%  flush  3  ml ; lactated ringers  1000  ml ; dextrose 50%  12.5  gm ; glucagon  1  mg ; glucose gel  15  g ; heparin  5000  unit ; insulin  0  unit ; iso-osmotic dextrose  100  ml ; piperacillin-tazobactam  4.5  g ; oxycodone (immediate release)   5  mg ; ibuprofen  400  mg ; insulin pump (self administering medication)     ; amoxicillin-clavulanic acid  875  mg ; 
insulin pump status other specified procedures as the cause of abnormal reaction of patient, or of later complication, without mention of misadventure at time of procedure other and unspecified hyperlipidemia peritoneal abscess unspecified essential hypertension diabetes with ophthalmic manifestations, type i [juvenile type], not stated as uncontrolled background diabetic retinopathy long-term (current) use of insulin other postoperative infection long-term (current) use of insulin unspecified sleep apnea insulin pump status peritoneal abscess other and unspecified hyperlipidemia unspecified essential hypertension background diabetic retinopathy diabetes with ophthalmic manifestations, type i [juvenile type], uncontrolled acute appendicitis with peritoneal abscess diabetes with ophthalmic manifestations, type i [juvenile type], not stated as uncontrolled background diabetic retinopathy insulin pump status long-term (current) use of insulin other and unspecified hyperlipidemia unspecified essential hypertension
white m 54 $nan$nan$sodium chloride 0.9%  flush  3  ml ; dextrose 50%  12.5  gm ; glucagon  1  mg ; glucose gel  15  g ; heparin  5000  unit ; oxycodone (immediate release)   5  mg ; ibuprofen  400  mg ; insulin pump (self administering medication)     ; amoxicillin-clavulanic acid  875  mg ; 
insulin pump status other specified procedures as the cause of abnormal reaction of patient, or of later complication, without mention of misadventure at time of procedure other and unspecified hyperlipidemia peritoneal abscess unspecified essential hypertension diabetes with ophthalmic manifestations, type i [juvenile type], not stated as uncontrolled background diabetic retinopathy long-term (current) use of insulin other postoperative infection long-term (current) use of insulin unspecified sleep apnea insulin pump status peritoneal abscess other and unspecified hyperlipidemia unspecified essential hypertension background diabetic retinopathy diabetes with ophthalmic manifestations, type i [juvenile type], uncontrolled acute appendicitis with peritoneal abscess diabetes with ophthalmic manifestations, type i [juvenile type], not stated as uncontrolled background diabetic retinopathy insulin pump status long-term (current) use of insulin other and unspecified hyperlipidemia unspecified essential hypertension
black african american f 66 $temp  97.3  heartrate  86.0  resprate  18.0  o2sat  98.0  sbp  145.0  dbp  73.0  rhythm    pain  2  $hematology blood hematocrit  29.3  %; hematology blood hemoglobin  9.4  g dl; hematology blood platelet count  324  k ul; chemistry blood anion gap  14  meq l; chemistry blood bicarbonate  31  meq l; chemistry blood chloride  97  meq l; chemistry blood creatinine  2.4  mg dl; chemistry blood potassium  4.3  meq l; chemistry blood sodium  138  meq l; chemistry blood urea nitrogen  44  mg dl; hematology blood inr(pt)  3.0  ; chemistry blood glucose  164  mg dl$sodium chloride 0.9%  flush  3  ml ; ipratropium bromide neb  1  neb ; albuterol 0.083% neb soln  1  neb ; furosemide  80  mg ; docusate sodium  100  mg ; multivitamins  1  tab ; ranitidine  300  mg ; sulfameth trimethoprim ss  1  tab ; warfarin  2  mg ; fluticasone-salmeterol diskus (250 50)   1  inh ; oxycodone-acetaminophen (5mg-325mg)  1-2  tab ; amiodarone  200  mg ; metoprolol succinate xl  200  mg ; prednisone  60  mg ; levofloxacin  750  mg ; 
systolic heart failure, unspecified personal history of malignant neoplasm of bronchus and lung atrial fibrillation person boarding or alighting a pedal cycle injured in collision with pedestrian or animal congestive heart failure, unspecified rheumatoid arthritis asthma, unspecified type, unspecified hypertensive chronic kidney disease, unspecified, with chronic kidney disease stage i through stage iv, or unspecified chronic kidney disease, stage iii (moderate) other chronic pain personal history of malignant neoplasm of breast myalgia and myositis, unspecified other and unspecified hyperlipidemia personal history of malignant neoplasm of bronchus and lung personal history of antineoplastic chemotherapy atrial fibrillation esophageal reflux rheumatoid arthritis chronic pain syndrome acute kidney failure, unspecified tetracycline group causing adverse effects in therapeutic use hypertensive chronic kidney disease, unspecified, with chronic kidney disease stage i through stage iv, or unspecified long-term (current) use of steroids person boarding or alighting a pedal cycle injured in collision with railway train or railway vehicle personal history of irradiation, presenting hazards to health acute pancreatitis congestive heart failure, unspecified personal history of malignant neoplasm of trachea chronic airway obstruction, not elsewhere classified personal history of malignant neoplasm of breast chronic systolic heart failure chronic kidney disease, stage iii (moderate) person boarding or alighting a pedal cycle injured in collision with pedestrian or animal depressive disorder, not elsewhere classified toxic encephalopathy obesity, unspecified rheumatoid arthritis myalgia and myositis, unspecified congestive heart failure, unspecified other and unspecified hyperlipidemia car passenger injured in collision with sport utility vehicle in traffic accident personal history of noncompliance with medical treatment, presenting hazards to health personal history of antineoplastic chemotherapy acute kidney failure, unspecified personal history of malignant neoplasm of breast shoulder joint replacement atrial fibrillation depressive disorder, not elsewhere classified
black african american f 66 $nan$chemistry blood anion gap  19  meq l; chemistry blood bicarbonate  27  meq l; chemistry blood chloride  95  meq l; chemistry blood creatinine  2.3  mg dl; chemistry blood potassium  4.0  meq l; chemistry blood sodium  137  meq l; chemistry blood urea nitrogen  45  mg dl; hematology blood inr(pt)  2.3  ; chemistry blood glucose  137  mg dl$sodium chloride 0.9%  flush  3  ml ; ipratropium bromide neb  1  neb ; albuterol 0.083% neb soln  1  neb ; furosemide  80  mg ; docusate sodium  100  mg ; multivitamins  1  tab ; ranitidine  300  mg ; sulfameth trimethoprim ss  1  tab ; warfarin  2  mg ; fluticasone-salmeterol diskus (250 50)   1  inh ; oxycodone-acetaminophen (5mg-325mg)  1-2  tab ; amiodarone  200  mg ; metoprolol succinate xl  200  mg ; prednisone  60  mg ; levofloxacin  750  mg ; warfarin  0.5  mg ; nicotine patch  14  mg ; torsemide  40  mg ; 
systolic heart failure, unspecified personal history of malignant neoplasm of bronchus and lung atrial fibrillation person boarding or alighting a pedal cycle injured in collision with pedestrian or animal congestive heart failure, unspecified rheumatoid arthritis asthma, unspecified type, unspecified hypertensive chronic kidney disease, unspecified, with chronic kidney disease stage i through stage iv, or unspecified chronic kidney disease, stage iii (moderate) other chronic pain personal history of malignant neoplasm of breast myalgia and myositis, unspecified other and unspecified hyperlipidemia personal history of malignant neoplasm of bronchus and lung personal history of antineoplastic chemotherapy atrial fibrillation esophageal reflux rheumatoid arthritis chronic pain syndrome acute kidney failure, unspecified tetracycline group causing adverse effects in therapeutic use hypertensive chronic kidney disease, unspecified, with chronic kidney disease stage i through stage iv, or unspecified long-term (current) use of steroids person boarding or alighting a pedal cycle injured in collision with railway train or railway vehicle personal history of irradiation, presenting hazards to health acute pancreatitis congestive heart failure, unspecified personal history of malignant neoplasm of trachea chronic airway obstruction, not elsewhere classified personal history of malignant neoplasm of breast chronic systolic heart failure chronic kidney disease, stage iii (moderate) person boarding or alighting a pedal cycle injured in collision with pedestrian or animal depressive disorder, not elsewhere classified toxic encephalopathy obesity, unspecified rheumatoid arthritis myalgia and myositis, unspecified congestive heart failure, unspecified other and unspecified hyperlipidemia car passenger injured in collision with sport utility vehicle in traffic accident personal history of noncompliance with medical treatment, presenting hazards to health personal history of antineoplastic chemotherapy acute kidney failure, unspecified personal history of malignant neoplasm of breast shoulder joint replacement atrial fibrillation depressive disorder, not elsewhere classified
black african american f 66 $nan$hematology blood hematocrit  30.4  %; hematology blood hemoglobin  9.9  g dl; hematology blood platelet count  339  k ul; chemistry blood anion gap  18  meq l; chemistry blood bicarbonate  31  meq l; chemistry blood chloride  93  meq l; chemistry blood creatinine  2.3  mg dl; chemistry blood potassium  3.8  meq l; chemistry blood sodium  138  meq l; chemistry blood urea nitrogen  41  mg dl; hematology blood inr(pt)  2.6  ; chemistry blood calcium, total  8.6  mg dl; chemistry blood glucose  233  mg dl$sodium chloride 0.9%  flush  3  ml ; ipratropium bromide neb  1  neb ; albuterol 0.083% neb soln  1  neb ; docusate sodium  100  mg ; multivitamins  1  tab ; ranitidine  300  mg ; sulfameth trimethoprim ss  1  tab ; fluticasone-salmeterol diskus (250 50)   1  inh ; oxycodone-acetaminophen (5mg-325mg)  1-2  tab ; amiodarone  200  mg ; metoprolol succinate xl  200  mg ; prednisone  60  mg ; levofloxacin  750  mg ; warfarin  0.5  mg ; nicotine patch  14  mg ; torsemide  20  mg ; warfarin  1  mg ; torsemide  60  mg ; 
systolic heart failure, unspecified personal history of malignant neoplasm of bronchus and lung atrial fibrillation person boarding or alighting a pedal cycle injured in collision with pedestrian or animal congestive heart failure, unspecified rheumatoid arthritis asthma, unspecified type, unspecified hypertensive chronic kidney disease, unspecified, with chronic kidney disease stage i through stage iv, or unspecified chronic kidney disease, stage iii (moderate) other chronic pain personal history of malignant neoplasm of breast myalgia and myositis, unspecified other and unspecified hyperlipidemia personal history of malignant neoplasm of bronchus and lung personal history of antineoplastic chemotherapy atrial fibrillation esophageal reflux rheumatoid arthritis chronic pain syndrome acute kidney failure, unspecified tetracycline group causing adverse effects in therapeutic use hypertensive chronic kidney disease, unspecified, with chronic kidney disease stage i through stage iv, or unspecified long-term (current) use of steroids person boarding or alighting a pedal cycle injured in collision with railway train or railway vehicle personal history of irradiation, presenting hazards to health acute pancreatitis congestive heart failure, unspecified personal history of malignant neoplasm of trachea chronic airway obstruction, not elsewhere classified personal history of malignant neoplasm of breast chronic systolic heart failure chronic kidney disease, stage iii (moderate) person boarding or alighting a pedal cycle injured in collision with pedestrian or animal depressive disorder, not elsewhere classified toxic encephalopathy obesity, unspecified rheumatoid arthritis myalgia and myositis, unspecified congestive heart failure, unspecified other and unspecified hyperlipidemia car passenger injured in collision with sport utility vehicle in traffic accident personal history of noncompliance with medical treatment, presenting hazards to health personal history of antineoplastic chemotherapy acute kidney failure, unspecified personal history of malignant neoplasm of breast shoulder joint replacement atrial fibrillation depressive disorder, not elsewhere classified
black african american f 66 $nan$hematology blood hematocrit  31.1  %; hematology blood hemoglobin  10.1  g dl; hematology blood platelet count  357  k ul; chemistry blood anion gap  19  meq l; chemistry blood bicarbonate  29  meq l; chemistry blood chloride  89  meq l; chemistry blood creatinine  2.3  mg dl; chemistry blood potassium  4.1  meq l; chemistry blood sodium  133  meq l; chemistry blood urea nitrogen  43  mg dl; hematology blood inr(pt)  3.2  ; chemistry blood glucose  258  mg dl$sodium chloride 0.9%  flush  3  ml ; ipratropium bromide neb  1  neb ; albuterol 0.083% neb soln  1  neb ; multivitamins  1  tab ; ranitidine  300  mg ; sulfameth trimethoprim ss  1  tab ; fluticasone-salmeterol diskus (250 50)   1  inh ; oxycodone-acetaminophen (5mg-325mg)  1-2  tab ; amiodarone  200  mg ; metoprolol succinate xl  200  mg ; prednisone  60  mg ; levofloxacin  750  mg ; nicotine patch  14  mg ; warfarin  1  mg ; torsemide  60  mg ; senna  34.4  mg ; 
systolic heart failure, unspecified personal history of malignant neoplasm of bronchus and lung atrial fibrillation person boarding or alighting a pedal cycle injured in collision with pedestrian or animal congestive heart failure, unspecified rheumatoid arthritis asthma, unspecified type, unspecified hypertensive chronic kidney disease, unspecified, with chronic kidney disease stage i through stage iv, or unspecified chronic kidney disease, stage iii (moderate) other chronic pain personal history of malignant neoplasm of breast myalgia and myositis, unspecified other and unspecified hyperlipidemia personal history of malignant neoplasm of bronchus and lung personal history of antineoplastic chemotherapy atrial fibrillation esophageal reflux rheumatoid arthritis chronic pain syndrome acute kidney failure, unspecified tetracycline group causing adverse effects in therapeutic use hypertensive chronic kidney disease, unspecified, with chronic kidney disease stage i through stage iv, or unspecified long-term (current) use of steroids person boarding or alighting a pedal cycle injured in collision with railway train or railway vehicle personal history of irradiation, presenting hazards to health acute pancreatitis congestive heart failure, unspecified personal history of malignant neoplasm of trachea chronic airway obstruction, not elsewhere classified personal history of malignant neoplasm of breast chronic systolic heart failure chronic kidney disease, stage iii (moderate) person boarding or alighting a pedal cycle injured in collision with pedestrian or animal depressive disorder, not elsewhere classified toxic encephalopathy obesity, unspecified rheumatoid arthritis myalgia and myositis, unspecified congestive heart failure, unspecified other and unspecified hyperlipidemia car passenger injured in collision with sport utility vehicle in traffic accident personal history of noncompliance with medical treatment, presenting hazards to health personal history of antineoplastic chemotherapy acute kidney failure, unspecified personal history of malignant neoplasm of breast shoulder joint replacement atrial fibrillation depressive disorder, not elsewhere classified
black african american f 66 $nan$hematology blood hematocrit  30.7  %; hematology blood hemoglobin  10.0  g dl; hematology blood platelet count  352  k ul; chemistry blood anion gap  18  meq l; chemistry blood bicarbonate  28  meq l; chemistry blood chloride  91  meq l; chemistry blood creatinine  2.6  mg dl; chemistry blood potassium  4.2  meq l; chemistry blood sodium  133  meq l; chemistry blood urea nitrogen  53  mg dl; hematology blood inr(pt)  3.0  ; chemistry blood glucose  162  mg dl$sodium chloride 0.9%  flush  3  ml ; ipratropium bromide neb  1  neb ; albuterol 0.083% neb soln  1  neb ; multivitamins  1  tab ; ranitidine  300  mg ; sulfameth trimethoprim ss  1  tab ; fluticasone-salmeterol diskus (250 50)   1  inh ; oxycodone-acetaminophen (5mg-325mg)  1-2  tab ; amiodarone  200  mg ; metoprolol succinate xl  200  mg ; prednisone  60  mg ; nicotine patch  14  mg ; senna  34.4  mg ; lidocaine viscous 2%  15  ml ; senna  8.6  mg ; polyethylene glycol  17  g ; losartan potassium  50  mg ; prednisone  20  mg ; 
systolic heart failure, unspecified personal history of malignant neoplasm of bronchus and lung atrial fibrillation person boarding or alighting a pedal cycle injured in collision with pedestrian or animal congestive heart failure, unspecified rheumatoid arthritis asthma, unspecified type, unspecified hypertensive chronic kidney disease, unspecified, with chronic kidney disease stage i through stage iv, or unspecified chronic kidney disease, stage iii (moderate) other chronic pain personal history of malignant neoplasm of breast myalgia and myositis, unspecified other and unspecified hyperlipidemia personal history of malignant neoplasm of bronchus and lung personal history of antineoplastic chemotherapy atrial fibrillation esophageal reflux rheumatoid arthritis chronic pain syndrome acute kidney failure, unspecified tetracycline group causing adverse effects in therapeutic use hypertensive chronic kidney disease, unspecified, with chronic kidney disease stage i through stage iv, or unspecified long-term (current) use of steroids person boarding or alighting a pedal cycle injured in collision with railway train or railway vehicle personal history of irradiation, presenting hazards to health acute pancreatitis congestive heart failure, unspecified personal history of malignant neoplasm of trachea chronic airway obstruction, not elsewhere classified personal history of malignant neoplasm of breast chronic systolic heart failure chronic kidney disease, stage iii (moderate) person boarding or alighting a pedal cycle injured in collision with pedestrian or animal depressive disorder, not elsewhere classified toxic encephalopathy obesity, unspecified rheumatoid arthritis myalgia and myositis, unspecified congestive heart failure, unspecified other and unspecified hyperlipidemia car passenger injured in collision with sport utility vehicle in traffic accident personal history of noncompliance with medical treatment, presenting hazards to health personal history of antineoplastic chemotherapy acute kidney failure, unspecified personal history of malignant neoplasm of breast shoulder joint replacement atrial fibrillation depressive disorder, not elsewhere classified
black african american f 66 $nan$nan$sodium chloride 0.9%  flush  3  ml ; ipratropium bromide neb  1  neb ; albuterol 0.083% neb soln  1  neb ; multivitamins  1  tab ; ranitidine  300  mg ; sulfameth trimethoprim ss  1  tab ; fluticasone-salmeterol diskus (250 50)   1  inh ; oxycodone-acetaminophen (5mg-325mg)  1-2  tab ; amiodarone  200  mg ; metoprolol succinate xl  200  mg ; nicotine patch  14  mg ; senna  34.4  mg ; lidocaine viscous 2%  15  ml ; losartan potassium  50  mg ; prednisone  20  mg ; tiotropium bromide  1  cap ; 
systolic heart failure, unspecified personal history of malignant neoplasm of bronchus and lung atrial fibrillation person boarding or alighting a pedal cycle injured in collision with pedestrian or animal congestive heart failure, unspecified rheumatoid arthritis asthma, unspecified type, unspecified hypertensive chronic kidney disease, unspecified, with chronic kidney disease stage i through stage iv, or unspecified chronic kidney disease, stage iii (moderate) other chronic pain personal history of malignant neoplasm of breast myalgia and myositis, unspecified other and unspecified hyperlipidemia personal history of malignant neoplasm of bronchus and lung personal history of antineoplastic chemotherapy atrial fibrillation esophageal reflux rheumatoid arthritis chronic pain syndrome acute kidney failure, unspecified tetracycline group causing adverse effects in therapeutic use hypertensive chronic kidney disease, unspecified, with chronic kidney disease stage i through stage iv, or unspecified long-term (current) use of steroids person boarding or alighting a pedal cycle injured in collision with railway train or railway vehicle personal history of irradiation, presenting hazards to health acute pancreatitis congestive heart failure, unspecified personal history of malignant neoplasm of trachea chronic airway obstruction, not elsewhere classified personal history of malignant neoplasm of breast chronic systolic heart failure chronic kidney disease, stage iii (moderate) person boarding or alighting a pedal cycle injured in collision with pedestrian or animal depressive disorder, not elsewhere classified toxic encephalopathy obesity, unspecified rheumatoid arthritis myalgia and myositis, unspecified congestive heart failure, unspecified other and unspecified hyperlipidemia car passenger injured in collision with sport utility vehicle in traffic accident personal history of noncompliance with medical treatment, presenting hazards to health personal history of antineoplastic chemotherapy acute kidney failure, unspecified personal history of malignant neoplasm of breast shoulder joint replacement atrial fibrillation depressive disorder, not elsewhere classified
white f 89 $temp    heartrate  64.0  resprate  15.0  o2sat  98.0  sbp  109.0  dbp  47.0  rhythm    pain  0  ; temp    heartrate  59.0  resprate  18.0  o2sat  100.0  sbp  118.0  dbp  76.0  rhythm    pain  0  ; temp    heartrate  76.0  resprate    o2sat  100.0  sbp    dbp    rhythm    pain    ; temp  98.2  heartrate  66.0  resprate  18.0  o2sat  100.0  sbp  123.0  dbp  56.0  rhythm    pain  0  $hematology urine wbc  9  # hpf$nan
accidental fall on or from sidewalk curb family history of ischemic heart disease alpha-1-antitrypsin deficiency unspecified pedal cyclist injured in collision with heavy transport vehicle or bus in nontraffic accident syncope and collapse personal history of allergy to sulfonamides unspecified acquired hypothyroidism other closed fractures of distal end of radius (alone) osteoarthrosis, localized, not specified whether primary or secondary, lower leg person boarding or alighting a pedal cycle injured in collision with fixed or stationary object
asian m 46 $temp    heartrate  66.0  resprate  17.0  o2sat  97.0  sbp  91.0  dbp  49.0  rhythm    pain  0  ; temp    heartrate  73.0  resprate  16.0  o2sat  99.0  sbp  104.0  dbp  63.0  rhythm    pain  0  ; temp    heartrate  63.0  resprate  16.0  o2sat  99.0  sbp  106.0  dbp  68.0  rhythm    pain    ; temp  98.0  heartrate    resprate    o2sat    sbp    dbp    rhythm    pain  0  $hematology blood hematocrit  42.1  %; hematology blood hemoglobin  13.8  g dl; hematology blood platelet count  240  k ul$nan
 
white m 33 $temp  98.1  heartrate  65.0  resprate  14.0  o2sat  99.0  sbp  144.0  dbp  93.0  rhythm    pain  9  $hematology blood hematocrit  38.2  %; hematology blood hemoglobin  12.6  g dl; hematology blood platelet count  327  k ul; chemistry blood anion gap  12  meq l; chemistry blood bicarbonate  26  meq l; chemistry blood chloride  102  meq l; chemistry blood creatinine  0.7  mg dl; chemistry blood potassium  5.6  meq l; chemistry blood sodium  134  meq l; chemistry blood urea nitrogen  9  mg dl; hematology blood inr(pt)  1.1  ; chemistry blood glucose  396  mg dl$sodium chloride 0.9%  flush  3  ml ; potassium chl 20 meq   1000 ml d5 1 2 ns  1000  ml ; oxycodone (immediate release)   5-10  mg ; morphine sulfate  2-4  mg ; acetaminophen  325-650  mg ; ondansetron  4  mg ; docusate sodium  100  mg ; enoxaparin sodium  40  mg ; acetaminophen  650  mg ; oxycodone (immediate release)   5-15  mg ; d5 1 2ns  1000  ml ; 
anemia, unspecified tobacco use disorder staphylococcus infection in conditions classified elsewhere and of unspecified site, other staphylococcus opioid type dependence, continuous cocaine dependence, continuous cellulitis and abscess of hand, except fingers and thumb
white f 83 $temp    heartrate  65.0  resprate  21.0  o2sat    sbp    dbp    rhythm  96 2  pain  0  $hematology blood hematocrit  34.3  %; hematology blood hematocrit  34.1  %; hematology blood hemoglobin  11.5  g dl; hematology blood hemoglobin  10.9  g dl; hematology blood platelet count  254  k ul; hematology blood platelet count  231  k ul; chemistry blood anion gap  20  meq l; chemistry blood anion gap  20  meq l; chemistry blood bicarbonate  23  meq l; chemistry blood bicarbonate  21  meq l; chemistry blood chloride  91  meq l; chemistry blood chloride  100  meq l; chemistry blood creatinine  0.7  mg dl; chemistry blood creatinine  0.7  mg dl; chemistry blood potassium  3.2  meq l; chemistry blood potassium  4.0  meq l; chemistry blood sodium  131  meq l; chemistry blood sodium  137  meq l; chemistry blood urea nitrogen  17  mg dl; chemistry blood urea nitrogen  21  mg dl; chemistry blood calcium, total  8.8  mg dl; chemistry blood calcium, total  8.6  mg dl; chemistry blood glucose  239  mg dl; chemistry blood glucose  158  mg dl$omeprazole  20  mg ; influenza vaccine quadrivalent  0.5  ml ; pneumococcal 23-valent polysaccharide vaccine  0.5  ml ; bisacodyl  10  mg ; senna  8.6  mg ; ipratropium-albuterol neb  1  neb ; guaifenesin  5-10  ml ; acetaminophen  325  mg ; sodium chloride 0.9%  1000  ml ; atorvastatin  10  mg ; escitalopram oxalate  5  mg ; gabapentin  300  mg ; vitamin d  1000  unit ; acetaminophen  650  mg ; dextrose 50%  12.5  gm ; glucagon  1  mg ; glucose gel  15  g ; insulin  0  unit ; potassium chloride replacement (critical care and oncology)   40  meq ; potassium chloride replacement (critical care and oncology)   60  meq ; potassium chloride replacement (critical care and oncology)   80  meq ; bag  1  bag ; magnesium sulfate  2  gm ; bag  2  bag ; magnesium sulfate  4  gm ; apixaban  5  mg ; sodium chloride 0.9%  flush  3  ml ; 
 
white f 83 $nan$hematology blood hematocrit  32.8  %; hematology blood hemoglobin  10.6  g dl; hematology blood platelet count  226  k ul; chemistry blood anion gap  18  meq l; chemistry blood bicarbonate  23  meq l; chemistry blood chloride  97  meq l; chemistry blood creatinine  0.6  mg dl; chemistry blood potassium  3.9  meq l; chemistry blood sodium  134  meq l; chemistry blood urea nitrogen  13  mg dl; chemistry blood glucose  172  mg dl$omeprazole  20  mg ; influenza vaccine quadrivalent  0.5  ml ; pneumococcal 23-valent polysaccharide vaccine  0.5  ml ; bisacodyl  10  mg ; senna  8.6  mg ; ipratropium-albuterol neb  1  neb ; guaifenesin  5-10  ml ; atorvastatin  10  mg ; escitalopram oxalate  5  mg ; gabapentin  300  mg ; vitamin d  1000  unit ; acetaminophen  650  mg ; dextrose 50%  12.5  gm ; glucagon  1  mg ; glucose gel  15  g ; insulin  0  unit ; potassium chloride replacement (critical care and oncology)   40  meq ; potassium chloride replacement (critical care and oncology)   60  meq ; potassium chloride replacement (critical care and oncology)   80  meq ; bag  1  bag ; magnesium sulfate  2  gm ; bag  2  bag ; magnesium sulfate  4  gm ; apixaban  5  mg ; sodium chloride 0.9%  flush  3  ml ; 0.9% sodium chloride (mini bag plus)  100  ml ; ceftriaxone  1  gm ; azithromycin  250  mg ; amlodipine  5  mg ; losartan potassium  50  mg ; metoprolol succinate xl  25  mg ; 
 
white f 83 $nan$hematology blood hematocrit  33.8  %; hematology blood hemoglobin  10.9  g dl; hematology blood platelet count  240  k ul; chemistry blood anion gap  23  meq l; chemistry blood bicarbonate  20  meq l; chemistry blood chloride  102  meq l; chemistry blood creatinine  0.7  mg dl; chemistry blood potassium  3.9  meq l; chemistry blood sodium  141  meq l; chemistry blood urea nitrogen  19  mg dl; chemistry blood glucose  192  mg dl$omeprazole  20  mg ; influenza vaccine quadrivalent  0.5  ml ; pneumococcal 23-valent polysaccharide vaccine  0.5  ml ; bisacodyl  10  mg ; senna  8.6  mg ; ipratropium-albuterol neb  1  neb ; guaifenesin  5-10  ml ; atorvastatin  10  mg ; escitalopram oxalate  5  mg ; gabapentin  300  mg ; vitamin d  1000  unit ; acetaminophen  650  mg ; dextrose 50%  12.5  gm ; glucagon  1  mg ; glucose gel  15  g ; insulin  0  unit ; potassium chloride replacement (critical care and oncology)   40  meq ; potassium chloride replacement (critical care and oncology)   60  meq ; potassium chloride replacement (critical care and oncology)   80  meq ; bag  1  bag ; magnesium sulfate  2  gm ; bag  2  bag ; magnesium sulfate  4  gm ; apixaban  5  mg ; sodium chloride 0.9%  flush  3  ml ; metoprolol succinate xl  25  mg ; aspirin  81  mg ; 
 
white f 83 $nan$nan$omeprazole  20  mg ; influenza vaccine quadrivalent  0.5  ml ; pneumococcal 23-valent polysaccharide vaccine  0.5  ml ; bisacodyl  10  mg ; senna  8.6  mg ; ipratropium-albuterol neb  1  neb ; guaifenesin  5-10  ml ; atorvastatin  10  mg ; escitalopram oxalate  5  mg ; gabapentin  300  mg ; vitamin d  1000  unit ; acetaminophen  650  mg ; dextrose 50%  12.5  gm ; glucagon  1  mg ; glucose gel  15  g ; insulin  0  unit ; potassium chloride replacement (critical care and oncology)   40  meq ; potassium chloride replacement (critical care and oncology)   60  meq ; potassium chloride replacement (critical care and oncology)   80  meq ; bag  1  bag ; magnesium sulfate  2  gm ; bag  2  bag ; magnesium sulfate  4  gm ; apixaban  5  mg ; sodium chloride 0.9%  flush  3  ml ; metoprolol succinate xl  25  mg ; aspirin  81  mg ; chlorthalidone  25  mg ; 
 
black african american m 36 $temp  97.4  heartrate  104.0  resprate  16.0  o2sat  97.0  sbp  202.0  dbp  104.0  rhythm    pain  10  ; temp    heartrate  100.0  resprate  16.0  o2sat  97.0  sbp  200.0  dbp  92.0  rhythm    pain  10  ; temp    heartrate  97.0  resprate  17.0  o2sat  97.0  sbp  208.0  dbp  90.0  rhythm    pain  asleep  $hematology blood hematocrit  35.6  %; hematology blood hemoglobin  11.3  g dl; hematology blood platelet count  186  k ul; chemistry blood anion gap  19  meq l; chemistry blood bicarbonate  22  meq l; chemistry blood chloride  100  meq l; chemistry blood creatinine  1.2  mg dl; chemistry blood potassium  7.1  meq l; chemistry blood sodium  134  meq l; chemistry blood urea nitrogen  16  mg dl; chemistry blood bilirubin, total  1.2  mg dl; chemistry blood glucose  162  mg dl; chemistry blood albumin  4.9  g dl$nan
neuromuscular dysfunction of bladder, unspecified anemia, unspecified insomnia, unspecified gastroparesis pancreas transplant status personal history of urinary (tract) infections essential (primary) hypertension type 2 diabetes mellitus with diabetic autonomic (poly)neuropathy kidney transplant status nausea with vomiting, unspecified essential (primary) hypertension other specified anemias kidney transplant status other place in hospital as the place of occurrence of the external cause other complications of anesthesia, initial encounter gastroparesis pancreas transplant status bronchitis and pneumonitis due to chemicals, gases, fumes and vapors epigastric pain neuromuscular dysfunction of bladder, unspecified other transplanted tissue rejection anemia in chronic kidney disease non-pressure chronic ulcer of other part of right foot with unspecified severity gastroparesis neuromuscular dysfunction of bladder, unspecified fever, unspecified insomnia, unspecified essential (primary) hypertension urinary tract infection, site not specified kidney transplant status long term (current) use of systemic steroids type 2 diabetes mellitus with diabetic neuropathy, unspecified gastroparesis neurogenic bladder nos car driver injured in collision with two- or three-wheeled motor vehicle in nontraffic accident kidney replaced by transplant diabetes with neurological manifestations, type ii or unspecified type, not stated as uncontrolled long-term (current) use of steroids long-term (current) use of aspirin pancreas replaced by transplant severe sepsis long-term (current) use of aspirin surgical operation with transplant of whole organ causing abnormal patient reaction, or later complication, without mention of misadventure at time of operation acute kidney failure, unspecified neurogenic bladder nos unspecified essential hypertension diabetes with neurological manifestations, type ii or unspecified type, not stated as uncontrolled complications of transplanted kidney
black african american m 36 $temp    heartrate  95.0  resprate  18.0  o2sat  97.0  sbp  206.0  dbp  99.0  rhythm    pain    ; temp    heartrate  87.0  resprate  22.0  o2sat  98.0  sbp  192.0  dbp  90.0  rhythm    pain    ; temp  97.6  heartrate  88.0  resprate  14.0  o2sat  98.0  sbp  150.0  dbp  67.0  rhythm    pain  4  $hematology blood hematocrit  34.9  %; hematology blood hemoglobin  10.7  g dl; hematology blood platelet count  169  k ul; chemistry blood anion gap  16  meq l; chemistry blood bicarbonate  24  meq l; chemistry blood chloride  104  meq l; chemistry blood creatinine  0.9  mg dl; chemistry blood potassium  3.8  meq l; chemistry blood sodium  140  meq l; chemistry blood urea nitrogen  15  mg dl; hematology urine wbc  1  # hpf; chemistry blood calcium, total  9.1  mg dl; chemistry blood bilirubin, total  1.1  mg dl; chemistry blood glucose  112  mg dl; chemistry blood lactate dehydrogenase (ld)  251  iu l$sodium chloride 0.9%  flush  3  ml ; hydromorphone (dilaudid)  1-2  mg ; lorazepam  0.5  mg ; prochlorperazine  10  mg ; heparin  5000  unit ; aspirin  81  mg ; ondansetron  4  mg ; tamsulosin  0.4  mg ; tramadol  50  mg ; trazodone  50  mg ; vitamin d  1000  unit ; dapsone  100  mg ; mycophenolate sodium dr  720  mg ; prednisone  5  mg ; sodium bicarbonate  650  mg ; tacrolimus  0.5  mg ; tacrolimus  3  mg ; zolpidem tartrate  10  mg ; 0.45% sodium chloride  1000  ml ; labetalol  100  mg ; hydromorphone (dilaudid)  0.25  mg ; famotidine  20  mg ; pantoprazole  40  mg ; 
neuromuscular dysfunction of bladder, unspecified anemia, unspecified insomnia, unspecified gastroparesis pancreas transplant status personal history of urinary (tract) infections essential (primary) hypertension type 2 diabetes mellitus with diabetic autonomic (poly)neuropathy kidney transplant status nausea with vomiting, unspecified essential (primary) hypertension other specified anemias kidney transplant status other place in hospital as the place of occurrence of the external cause other complications of anesthesia, initial encounter gastroparesis pancreas transplant status bronchitis and pneumonitis due to chemicals, gases, fumes and vapors epigastric pain neuromuscular dysfunction of bladder, unspecified other transplanted tissue rejection anemia in chronic kidney disease non-pressure chronic ulcer of other part of right foot with unspecified severity gastroparesis neuromuscular dysfunction of bladder, unspecified fever, unspecified insomnia, unspecified essential (primary) hypertension urinary tract infection, site not specified kidney transplant status long term (current) use of systemic steroids type 2 diabetes mellitus with diabetic neuropathy, unspecified gastroparesis neurogenic bladder nos car driver injured in collision with two- or three-wheeled motor vehicle in nontraffic accident kidney replaced by transplant diabetes with neurological manifestations, type ii or unspecified type, not stated as uncontrolled long-term (current) use of steroids long-term (current) use of aspirin pancreas replaced by transplant severe sepsis long-term (current) use of aspirin surgical operation with transplant of whole organ causing abnormal patient reaction, or later complication, without mention of misadventure at time of operation acute kidney failure, unspecified neurogenic bladder nos unspecified essential hypertension diabetes with neurological manifestations, type ii or unspecified type, not stated as uncontrolled complications of transplanted kidney
black african american m 36 $nan$hematology blood hematocrit  33.2  %; hematology blood hematocrit  32.5  %; hematology blood hemoglobin  10.0  g dl; hematology blood hemoglobin  9.9  g dl; hematology blood platelet count  162  k ul; hematology blood platelet count  163  k ul; chemistry blood anion gap  11  meq l; chemistry blood anion gap  15  meq l; chemistry blood bicarbonate  27  meq l; chemistry blood bicarbonate  24  meq l; chemistry blood chloride  102  meq l; chemistry blood chloride  100  meq l; chemistry blood creatinine  1.1  mg dl; chemistry blood creatinine  1.1  mg dl; chemistry blood potassium  3.9  meq l; chemistry blood potassium  3.6  meq l; chemistry blood sodium  136  meq l; chemistry blood sodium  135  meq l; chemistry blood urea nitrogen  12  mg dl; chemistry blood urea nitrogen  11  mg dl; hematology blood inr(pt)  1.1  ; chemistry blood calcium, total  8.9  mg dl; chemistry blood bilirubin, total  1.0  mg dl; chemistry blood glucose  88  mg dl; chemistry blood glucose  103  mg dl; chemistry blood albumin  4.2  g dl$sodium chloride 0.9%  flush  3  ml ; lorazepam  0.5  mg ; prochlorperazine  10  mg ; heparin  5000  unit ; aspirin  81  mg ; ondansetron  4  mg ; tamsulosin  0.4  mg ; tramadol  50  mg ; trazodone  50  mg ; vitamin d  1000  unit ; dapsone  100  mg ; mycophenolate sodium dr  720  mg ; prednisone  5  mg ; sodium bicarbonate  650  mg ; tacrolimus  0.5  mg ; tacrolimus  3  mg ; zolpidem tartrate  10  mg ; hydromorphone (dilaudid)  0.25  mg ; famotidine  20  mg ; pantoprazole  40  mg ; tramadol  100  mg ; lorazepam  0.5-1  mg ; sucralfate  1  gm ; hydromorphone (dilaudid)  0.125  mg ; hydralazine  25  mg ; albumin 25% (12.5g   50ml)  25  g ; 
neuromuscular dysfunction of bladder, unspecified anemia, unspecified insomnia, unspecified gastroparesis pancreas transplant status personal history of urinary (tract) infections essential (primary) hypertension type 2 diabetes mellitus with diabetic autonomic (poly)neuropathy kidney transplant status nausea with vomiting, unspecified essential (primary) hypertension other specified anemias kidney transplant status other place in hospital as the place of occurrence of the external cause other complications of anesthesia, initial encounter gastroparesis pancreas transplant status bronchitis and pneumonitis due to chemicals, gases, fumes and vapors epigastric pain neuromuscular dysfunction of bladder, unspecified other transplanted tissue rejection anemia in chronic kidney disease non-pressure chronic ulcer of other part of right foot with unspecified severity gastroparesis neuromuscular dysfunction of bladder, unspecified fever, unspecified insomnia, unspecified essential (primary) hypertension urinary tract infection, site not specified kidney transplant status long term (current) use of systemic steroids type 2 diabetes mellitus with diabetic neuropathy, unspecified gastroparesis neurogenic bladder nos car driver injured in collision with two- or three-wheeled motor vehicle in nontraffic accident kidney replaced by transplant diabetes with neurological manifestations, type ii or unspecified type, not stated as uncontrolled long-term (current) use of steroids long-term (current) use of aspirin pancreas replaced by transplant severe sepsis long-term (current) use of aspirin surgical operation with transplant of whole organ causing abnormal patient reaction, or later complication, without mention of misadventure at time of operation acute kidney failure, unspecified neurogenic bladder nos unspecified essential hypertension diabetes with neurological manifestations, type ii or unspecified type, not stated as uncontrolled complications of transplanted kidney
black african american m 36 $nan$hematology blood hematocrit  33.0  %; hematology blood hemoglobin  9.9  g dl; hematology blood platelet count  159  k ul; chemistry blood anion gap  15  meq l; chemistry blood bicarbonate  26  meq l; chemistry blood chloride  101  meq l; chemistry blood creatinine  1.1  mg dl; chemistry blood potassium  3.5  meq l; chemistry blood sodium  138  meq l; chemistry blood urea nitrogen  10  mg dl; hematology blood inr(pt)  1.1  ; chemistry blood calcium, total  9.0  mg dl; chemistry blood bilirubin, total  1.1  mg dl; chemistry blood glucose  98  mg dl; chemistry blood albumin  4.1  g dl$sodium chloride 0.9%  flush  3  ml ; lorazepam  0.5  mg ; prochlorperazine  10  mg ; aspirin  81  mg ; ondansetron  4  mg ; tamsulosin  0.4  mg ; tramadol  50  mg ; trazodone  50  mg ; vitamin d  1000  unit ; dapsone  100  mg ; mycophenolate sodium dr  720  mg ; prednisone  5  mg ; sodium bicarbonate  650  mg ; tacrolimus  0.5  mg ; tacrolimus  3  mg ; zolpidem tartrate  10  mg ; tramadol  100  mg ; lorazepam  0.5-1  mg ; hydromorphone (dilaudid)  0.125  mg ; hydralazine  25  mg ; amlodipine  5  mg ; hydralazine  20  mg ; hyoscyamine  0.125  mg ; ondansetron  8  mg ; hydromorphone (dilaudid)  2  mg ; 
neuromuscular dysfunction of bladder, unspecified anemia, unspecified insomnia, unspecified gastroparesis pancreas transplant status personal history of urinary (tract) infections essential (primary) hypertension type 2 diabetes mellitus with diabetic autonomic (poly)neuropathy kidney transplant status nausea with vomiting, unspecified essential (primary) hypertension other specified anemias kidney transplant status other place in hospital as the place of occurrence of the external cause other complications of anesthesia, initial encounter gastroparesis pancreas transplant status bronchitis and pneumonitis due to chemicals, gases, fumes and vapors epigastric pain neuromuscular dysfunction of bladder, unspecified other transplanted tissue rejection anemia in chronic kidney disease non-pressure chronic ulcer of other part of right foot with unspecified severity gastroparesis neuromuscular dysfunction of bladder, unspecified fever, unspecified insomnia, unspecified essential (primary) hypertension urinary tract infection, site not specified kidney transplant status long term (current) use of systemic steroids type 2 diabetes mellitus with diabetic neuropathy, unspecified gastroparesis neurogenic bladder nos car driver injured in collision with two- or three-wheeled motor vehicle in nontraffic accident kidney replaced by transplant diabetes with neurological manifestations, type ii or unspecified type, not stated as uncontrolled long-term (current) use of steroids long-term (current) use of aspirin pancreas replaced by transplant severe sepsis long-term (current) use of aspirin surgical operation with transplant of whole organ causing abnormal patient reaction, or later complication, without mention of misadventure at time of operation acute kidney failure, unspecified neurogenic bladder nos unspecified essential hypertension diabetes with neurological manifestations, type ii or unspecified type, not stated as uncontrolled complications of transplanted kidney
black african american m 36 $nan$hematology blood hematocrit  34.3  %; hematology blood hemoglobin  10.2  g dl; hematology blood platelet count  175  k ul; chemistry blood anion gap  19  meq l; chemistry blood bicarbonate  26  meq l; chemistry blood chloride  100  meq l; chemistry blood creatinine  1.3  mg dl; chemistry blood potassium  3.7  meq l; chemistry blood sodium  141  meq l; chemistry blood urea nitrogen  13  mg dl; hematology blood inr(pt)  1.0  ; chemistry blood calcium, total  9.3  mg dl; chemistry blood bilirubin, total  1.0  mg dl; chemistry blood glucose  90  mg dl; chemistry blood albumin  4.0  g dl$sodium chloride 0.9%  flush  3  ml ; lorazepam  0.5  mg ; prochlorperazine  10  mg ; aspirin  81  mg ; tamsulosin  0.4  mg ; tramadol  50  mg ; trazodone  50  mg ; vitamin d  1000  unit ; dapsone  100  mg ; mycophenolate sodium dr  720  mg ; prednisone  5  mg ; sodium bicarbonate  650  mg ; tacrolimus  0.5  mg ; tacrolimus  3  mg ; zolpidem tartrate  10  mg ; amlodipine  5  mg ; hyoscyamine  0.125  mg ; ondansetron  8  mg ; hydromorphone (dilaudid)  2  mg ; sodium chloride 0.9%  1000  ml ; 
neuromuscular dysfunction of bladder, unspecified anemia, unspecified insomnia, unspecified gastroparesis pancreas transplant status personal history of urinary (tract) infections essential (primary) hypertension type 2 diabetes mellitus with diabetic autonomic (poly)neuropathy kidney transplant status nausea with vomiting, unspecified essential (primary) hypertension other specified anemias kidney transplant status other place in hospital as the place of occurrence of the external cause other complications of anesthesia, initial encounter gastroparesis pancreas transplant status bronchitis and pneumonitis due to chemicals, gases, fumes and vapors epigastric pain neuromuscular dysfunction of bladder, unspecified other transplanted tissue rejection anemia in chronic kidney disease non-pressure chronic ulcer of other part of right foot with unspecified severity gastroparesis neuromuscular dysfunction of bladder, unspecified fever, unspecified insomnia, unspecified essential (primary) hypertension urinary tract infection, site not specified kidney transplant status long term (current) use of systemic steroids type 2 diabetes mellitus with diabetic neuropathy, unspecified gastroparesis neurogenic bladder nos car driver injured in collision with two- or three-wheeled motor vehicle in nontraffic accident kidney replaced by transplant diabetes with neurological manifestations, type ii or unspecified type, not stated as uncontrolled long-term (current) use of steroids long-term (current) use of aspirin pancreas replaced by transplant severe sepsis long-term (current) use of aspirin surgical operation with transplant of whole organ causing abnormal patient reaction, or later complication, without mention of misadventure at time of operation acute kidney failure, unspecified neurogenic bladder nos unspecified essential hypertension diabetes with neurological manifestations, type ii or unspecified type, not stated as uncontrolled complications of transplanted kidney
black african american m 36 $nan$nan$sodium chloride 0.9%  flush  3  ml ; lorazepam  0.5  mg ; prochlorperazine  10  mg ; aspirin  81  mg ; tamsulosin  0.4  mg ; tramadol  50  mg ; trazodone  50  mg ; vitamin d  1000  unit ; dapsone  100  mg ; mycophenolate sodium dr  720  mg ; prednisone  5  mg ; sodium bicarbonate  650  mg ; tacrolimus  0.5  mg ; tacrolimus  3  mg ; zolpidem tartrate  10  mg ; ondansetron  8  mg ; hydromorphone (dilaudid)  2  mg ; sodium chloride 0.9%  1000  ml ; amlodipine  2.5  mg ; maalox diphenhydramine lidocaine  15-30  ml ; hydromorphone (dilaudid)  1  mg ; heparin flush (10 units ml)  2  ml ; sodium chloride 0.9%  flush  20  ml ; lidocaine 1% (for picc midline insertions)  5  ml ; lorazepam  1  mg ; sodium chloride 0.9%  flush  10  ml ; 
neuromuscular dysfunction of bladder, unspecified anemia, unspecified insomnia, unspecified gastroparesis pancreas transplant status personal history of urinary (tract) infections essential (primary) hypertension type 2 diabetes mellitus with diabetic autonomic (poly)neuropathy kidney transplant status nausea with vomiting, unspecified essential (primary) hypertension other specified anemias kidney transplant status other place in hospital as the place of occurrence of the external cause other complications of anesthesia, initial encounter gastroparesis pancreas transplant status bronchitis and pneumonitis due to chemicals, gases, fumes and vapors epigastric pain neuromuscular dysfunction of bladder, unspecified other transplanted tissue rejection anemia in chronic kidney disease non-pressure chronic ulcer of other part of right foot with unspecified severity gastroparesis neuromuscular dysfunction of bladder, unspecified fever, unspecified insomnia, unspecified essential (primary) hypertension urinary tract infection, site not specified kidney transplant status long term (current) use of systemic steroids type 2 diabetes mellitus with diabetic neuropathy, unspecified gastroparesis neurogenic bladder nos car driver injured in collision with two- or three-wheeled motor vehicle in nontraffic accident kidney replaced by transplant diabetes with neurological manifestations, type ii or unspecified type, not stated as uncontrolled long-term (current) use of steroids long-term (current) use of aspirin pancreas replaced by transplant severe sepsis long-term (current) use of aspirin surgical operation with transplant of whole organ causing abnormal patient reaction, or later complication, without mention of misadventure at time of operation acute kidney failure, unspecified neurogenic bladder nos unspecified essential hypertension diabetes with neurological manifestations, type ii or unspecified type, not stated as uncontrolled complications of transplanted kidney
black african american m 36 $nan$hematology blood hematocrit  29.8  %; hematology blood hemoglobin  9.1  g dl; hematology blood platelet count  159  k ul; chemistry blood anion gap  13  meq l; chemistry blood bicarbonate  27  meq l; chemistry blood chloride  104  meq l; chemistry blood creatinine  1.1  mg dl; chemistry blood potassium  3.5  meq l; chemistry blood sodium  140  meq l; chemistry blood urea nitrogen  8  mg dl; hematology blood inr(pt)  1.1  ; chemistry blood calcium, total  8.7  mg dl; chemistry blood bilirubin, total  1.0  mg dl; chemistry blood glucose  87  mg dl; chemistry blood albumin  4.0  g dl$sodium chloride 0.9%  flush  3  ml ; prochlorperazine  10  mg ; aspirin  81  mg ; tamsulosin  0.4  mg ; tramadol  50  mg ; trazodone  50  mg ; vitamin d  1000  unit ; dapsone  100  mg ; mycophenolate sodium dr  720  mg ; prednisone  5  mg ; sodium bicarbonate  650  mg ; tacrolimus  0.5  mg ; tacrolimus  3  mg ; zolpidem tartrate  10  mg ; ondansetron  8  mg ; maalox diphenhydramine lidocaine  15-30  ml ; heparin flush (10 units ml)  2  ml ; sodium chloride 0.9%  flush  20  ml ; lidocaine 1% (for picc midline insertions)  5  ml ; lorazepam  1  mg ; sodium chloride 0.9%  flush  10  ml ; potassium chloride  60  meq ; bag  2  bag ; magnesium sulfate  4  gm ; polyethylene glycol  17  g ; 
neuromuscular dysfunction of bladder, unspecified anemia, unspecified insomnia, unspecified gastroparesis pancreas transplant status personal history of urinary (tract) infections essential (primary) hypertension type 2 diabetes mellitus with diabetic autonomic (poly)neuropathy kidney transplant status nausea with vomiting, unspecified essential (primary) hypertension other specified anemias kidney transplant status other place in hospital as the place of occurrence of the external cause other complications of anesthesia, initial encounter gastroparesis pancreas transplant status bronchitis and pneumonitis due to chemicals, gases, fumes and vapors epigastric pain neuromuscular dysfunction of bladder, unspecified other transplanted tissue rejection anemia in chronic kidney disease non-pressure chronic ulcer of other part of right foot with unspecified severity gastroparesis neuromuscular dysfunction of bladder, unspecified fever, unspecified insomnia, unspecified essential (primary) hypertension urinary tract infection, site not specified kidney transplant status long term (current) use of systemic steroids type 2 diabetes mellitus with diabetic neuropathy, unspecified gastroparesis neurogenic bladder nos car driver injured in collision with two- or three-wheeled motor vehicle in nontraffic accident kidney replaced by transplant diabetes with neurological manifestations, type ii or unspecified type, not stated as uncontrolled long-term (current) use of steroids long-term (current) use of aspirin pancreas replaced by transplant severe sepsis long-term (current) use of aspirin surgical operation with transplant of whole organ causing abnormal patient reaction, or later complication, without mention of misadventure at time of operation acute kidney failure, unspecified neurogenic bladder nos unspecified essential hypertension diabetes with neurological manifestations, type ii or unspecified type, not stated as uncontrolled complications of transplanted kidney
black african american m 36 $nan$hematology blood hematocrit  29.8  %; hematology blood hemoglobin  9.1  g dl; hematology blood platelet count  180  k ul; chemistry blood anion gap  12  meq l; chemistry blood bicarbonate  28  meq l; chemistry blood chloride  103  meq l; chemistry blood creatinine  1.2  mg dl; chemistry blood potassium  4.3  meq l; chemistry blood sodium  139  meq l; chemistry blood urea nitrogen  10  mg dl; hematology blood inr(pt)  1.0  ; chemistry blood calcium, total  9.0  mg dl; chemistry blood glucose  98  mg dl$sodium chloride 0.9%  flush  3  ml ; prochlorperazine  10  mg ; aspirin  81  mg ; tamsulosin  0.4  mg ; tramadol  50  mg ; trazodone  50  mg ; vitamin d  1000  unit ; dapsone  100  mg ; mycophenolate sodium dr  720  mg ; prednisone  5  mg ; sodium bicarbonate  650  mg ; tacrolimus  0.5  mg ; tacrolimus  3  mg ; zolpidem tartrate  10  mg ; ondansetron  8  mg ; heparin flush (10 units ml)  2  ml ; sodium chloride 0.9%  flush  20  ml ; lidocaine 1% (for picc midline insertions)  5  ml ; sodium chloride 0.9%  flush  10  ml ; potassium chloride  60  meq ; bag  2  bag ; magnesium sulfate  4  gm ; polyethylene glycol  17  g ; promethazine  25  mg ; promethazine  6.25  mg ; promethazine  12.5  mg ; hydromorphone (dilaudid)  2-4  mg ; 
neuromuscular dysfunction of bladder, unspecified anemia, unspecified insomnia, unspecified gastroparesis pancreas transplant status personal history of urinary (tract) infections essential (primary) hypertension type 2 diabetes mellitus with diabetic autonomic (poly)neuropathy kidney transplant status nausea with vomiting, unspecified essential (primary) hypertension other specified anemias kidney transplant status other place in hospital as the place of occurrence of the external cause other complications of anesthesia, initial encounter gastroparesis pancreas transplant status bronchitis and pneumonitis due to chemicals, gases, fumes and vapors epigastric pain neuromuscular dysfunction of bladder, unspecified other transplanted tissue rejection anemia in chronic kidney disease non-pressure chronic ulcer of other part of right foot with unspecified severity gastroparesis neuromuscular dysfunction of bladder, unspecified fever, unspecified insomnia, unspecified essential (primary) hypertension urinary tract infection, site not specified kidney transplant status long term (current) use of systemic steroids type 2 diabetes mellitus with diabetic neuropathy, unspecified gastroparesis neurogenic bladder nos car driver injured in collision with two- or three-wheeled motor vehicle in nontraffic accident kidney replaced by transplant diabetes with neurological manifestations, type ii or unspecified type, not stated as uncontrolled long-term (current) use of steroids long-term (current) use of aspirin pancreas replaced by transplant severe sepsis long-term (current) use of aspirin surgical operation with transplant of whole organ causing abnormal patient reaction, or later complication, without mention of misadventure at time of operation acute kidney failure, unspecified neurogenic bladder nos unspecified essential hypertension diabetes with neurological manifestations, type ii or unspecified type, not stated as uncontrolled complications of transplanted kidney
black african american m 36 $nan$hematology blood hematocrit  31.5  %; hematology blood hemoglobin  9.3  g dl; hematology blood platelet count  187  k ul; chemistry blood anion gap  12  meq l; chemistry blood bicarbonate  28  meq l; chemistry blood chloride  102  meq l; chemistry blood creatinine  1.3  mg dl; chemistry blood potassium  4.1  meq l; chemistry blood sodium  138  meq l; chemistry blood urea nitrogen  12  mg dl; chemistry blood calcium, total  9.3  mg dl; chemistry blood glucose  103  mg dl$sodium chloride 0.9%  flush  3  ml ; prochlorperazine  10  mg ; aspirin  81  mg ; tamsulosin  0.4  mg ; tramadol  50  mg ; trazodone  50  mg ; vitamin d  1000  unit ; dapsone  100  mg ; mycophenolate sodium dr  720  mg ; prednisone  5  mg ; sodium bicarbonate  650  mg ; tacrolimus  0.5  mg ; tacrolimus  3  mg ; zolpidem tartrate  10  mg ; ondansetron  8  mg ; heparin flush (10 units ml)  2  ml ; sodium chloride 0.9%  flush  20  ml ; lidocaine 1% (for picc midline insertions)  5  ml ; sodium chloride 0.9%  flush  10  ml ; polyethylene glycol  17  g ; promethazine  12.5  mg ; hydromorphone (dilaudid)  2-4  mg ; 
neuromuscular dysfunction of bladder, unspecified anemia, unspecified insomnia, unspecified gastroparesis pancreas transplant status personal history of urinary (tract) infections essential (primary) hypertension type 2 diabetes mellitus with diabetic autonomic (poly)neuropathy kidney transplant status nausea with vomiting, unspecified essential (primary) hypertension other specified anemias kidney transplant status other place in hospital as the place of occurrence of the external cause other complications of anesthesia, initial encounter gastroparesis pancreas transplant status bronchitis and pneumonitis due to chemicals, gases, fumes and vapors epigastric pain neuromuscular dysfunction of bladder, unspecified other transplanted tissue rejection anemia in chronic kidney disease non-pressure chronic ulcer of other part of right foot with unspecified severity gastroparesis neuromuscular dysfunction of bladder, unspecified fever, unspecified insomnia, unspecified essential (primary) hypertension urinary tract infection, site not specified kidney transplant status long term (current) use of systemic steroids type 2 diabetes mellitus with diabetic neuropathy, unspecified gastroparesis neurogenic bladder nos car driver injured in collision with two- or three-wheeled motor vehicle in nontraffic accident kidney replaced by transplant diabetes with neurological manifestations, type ii or unspecified type, not stated as uncontrolled long-term (current) use of steroids long-term (current) use of aspirin pancreas replaced by transplant severe sepsis long-term (current) use of aspirin surgical operation with transplant of whole organ causing abnormal patient reaction, or later complication, without mention of misadventure at time of operation acute kidney failure, unspecified neurogenic bladder nos unspecified essential hypertension diabetes with neurological manifestations, type ii or unspecified type, not stated as uncontrolled complications of transplanted kidney
white f 88 $nan$nan$omeprazole  40  mg ; 
fitting and adjustment of nonvascular catheter, nec calculus of bile duct without mention of cholecystitis, with obstruction unspecified essential hypertension urge incontinence anemia, unspecified paralysis agitans lumbago chronic pancreatitis cholangitis unspecified essential hypertension acute diastolic heart failure congestive heart failure, unspecified chronic pancreatitis streptococcus infection in conditions classified elsewhere and of unspecified site, streptococcus, group d [enterococcus] diverticulosis of colon (without mention of hemorrhage) bacteremia paralysis agitans esophageal reflux anemia, unspecified escherichia coli [e. coli] infection in conditions classified elsewhere and of unspecified site osteoporosis, unspecified urinary incontinence, unspecified thrombocytopenia, unspecified calculus of bile duct without mention of cholecystitis, without mention of obstruction
white f 88 $nan$hematology blood hematocrit  36.3  %; hematology blood hematocrit  36.7  %; hematology blood hemoglobin  11.9  g dl; hematology blood hemoglobin  11.9  g dl; hematology blood platelet count  183  k ul; hematology blood platelet count  207  k ul; chemistry blood anion gap  12  meq l; chemistry blood bicarbonate  26  meq l; chemistry blood chloride  110  meq l; chemistry blood creatinine  0.9  mg dl; chemistry blood potassium  3.6  meq l; chemistry blood sodium  144  meq l; chemistry blood urea nitrogen  14  mg dl; chemistry blood glucose  77  mg dl$omeprazole  40  mg ; 0.9% sodium chloride  1000  ml ; sodium chloride 0.9%  flush  3  ml ; ondansetron  4  mg ; docusate sodium  100  mg ; senna  1  tab ; acetaminophen  325-650  mg ; ciprofloxacin hcl  500  mg ; carbidopa-levodopa (25-100)  1  tab ; prednisolone acetate 1% ophth. susp.  1  drop ; heparin  5000  unit ; potassium chloride  20  meq ; lisinopril  40  mg ; 
fitting and adjustment of nonvascular catheter, nec calculus of bile duct without mention of cholecystitis, with obstruction unspecified essential hypertension urge incontinence anemia, unspecified paralysis agitans lumbago chronic pancreatitis cholangitis unspecified essential hypertension acute diastolic heart failure congestive heart failure, unspecified chronic pancreatitis streptococcus infection in conditions classified elsewhere and of unspecified site, streptococcus, group d [enterococcus] diverticulosis of colon (without mention of hemorrhage) bacteremia paralysis agitans esophageal reflux anemia, unspecified escherichia coli [e. coli] infection in conditions classified elsewhere and of unspecified site osteoporosis, unspecified urinary incontinence, unspecified thrombocytopenia, unspecified calculus of bile duct without mention of cholecystitis, without mention of obstruction
white f 88 $nan$hematology blood hematocrit  37.8  %; hematology blood hematocrit  39.0  %; hematology blood hemoglobin  12.1  g dl; hematology blood hemoglobin  12.8  g dl; hematology blood platelet count  231  k ul; hematology blood platelet count  223  k ul; chemistry blood anion gap  13  meq l; chemistry blood bicarbonate  26  meq l; chemistry blood chloride  107  meq l; chemistry blood creatinine  0.9  mg dl; chemistry blood potassium  3.6  meq l; chemistry blood sodium  142  meq l; chemistry blood urea nitrogen  10  mg dl; chemistry blood calcium, total  9.2  mg dl; chemistry blood glucose  114  mg dl$omeprazole  40  mg ; sodium chloride 0.9%  flush  3  ml ; ondansetron  4  mg ; docusate sodium  100  mg ; senna  1  tab ; acetaminophen  325-650  mg ; carbidopa-levodopa (25-100)  1  tab ; prednisolone acetate 1% ophth. susp.  1  drop ; heparin  5000  unit ; potassium chloride  20  meq ; lisinopril  40  mg ; creon 12  1  cap ; nifedipine cr  30  mg ; 
fitting and adjustment of nonvascular catheter, nec calculus of bile duct without mention of cholecystitis, with obstruction unspecified essential hypertension urge incontinence anemia, unspecified paralysis agitans lumbago chronic pancreatitis cholangitis unspecified essential hypertension acute diastolic heart failure congestive heart failure, unspecified chronic pancreatitis streptococcus infection in conditions classified elsewhere and of unspecified site, streptococcus, group d [enterococcus] diverticulosis of colon (without mention of hemorrhage) bacteremia paralysis agitans esophageal reflux anemia, unspecified escherichia coli [e. coli] infection in conditions classified elsewhere and of unspecified site osteoporosis, unspecified urinary incontinence, unspecified thrombocytopenia, unspecified calculus of bile duct without mention of cholecystitis, without mention of obstruction